id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
37769188|NCT01461980|69285680|FG000|Overall Study|Other|9|||
37769189|NCT01461980|69285681|FG001|Overall Study|Other|8|||
37769190|NCT01461980|69285682|FG002|Overall Study|Other|6|||
37769191|NCT01461980|69285680|FG000|Overall Study|Medication error|7|||
37769192|NCT01461980|69285681|FG001|Overall Study|Medication error|5|||
37769193|NCT01461980|69285682|FG002|Overall Study|Medication error|6|||
37769194|NCT01461980|69285680|FG000|Overall Study|Adverse Event|12|||
37769195|NCT01461980|69285681|FG001|Overall Study|Adverse Event|5|||
37769196|NCT01461980|69285682|FG002|Overall Study|Adverse Event|6|||
37769197|NCT01461980|69285680|FG000|Overall Study|Protocol Violation|12|||
37769198|NCT01461980|69285681|FG001|Overall Study|Protocol Violation|19|||
37769199|NCT01461980|69285682|FG002|Overall Study|Protocol Violation|16|||
37769200|NCT01461980|69285680|FG000|Overall Study|No longer meets eligibility criteria|18|||
38043875|NCT01886872|69731923|FG000|Overall Study|Ineligible|7|||
38043876|NCT01886872|69731924|FG001|Overall Study|Ineligible|4|||
38043877|NCT01886872|69731925|FG002|Overall Study|Ineligible|12|||
38043878|NCT01386385|69731939|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
38043879|NCT01386385|69731940|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
38043880|NCT01386385|69731941|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
37769201|NCT01461980|69285681|FG001|Overall Study|No longer meets eligibility criteria|9|||
37769202|NCT01461980|69285682|FG002|Overall Study|No longer meets eligibility criteria|19|||
37769203|NCT01461980|69285680|FG000|Overall Study|Lost to Follow-up|52|||
37769204|NCT01461980|69285681|FG001|Overall Study|Lost to Follow-up|53|||
37769205|NCT01461980|69285682|FG002|Overall Study|Lost to Follow-up|51|||
37769206|NCT01461980|69285680|FG000|Overall Study|No longer willing to participate|52|||
37769207|NCT01461980|69285681|FG001|Overall Study|No longer willing to participate|38|||
37769208|NCT01461980|69285682|FG002|Overall Study|No longer willing to participate|54|||
37769209|NCT01461980|69285680|FG000|Overall Study|Randomized but not vaccinated|4|||
37769210|NCT01461980|69285681|FG001|Overall Study|Randomized but not vaccinated|8|||
37769211|NCT01461980|69285682|FG002|Overall Study|Randomized but not vaccinated|7|||
37769212|NCT01424501|69285697|FG000|Overall Study|Withdrawal by Subject|1|||
37952227|NCT00585533|69639199|FG000|Overall Study|objective or symptomatic progression|9|||
37952228|NCT00628862|69639206|FG000|Overall Study|Adverse Event|6|||
37952229|NCT00628862|69639207|FG001|Overall Study|Adverse Event|8|||
37952230|NCT00628862|69639208|FG002|Overall Study|Adverse Event|10|||
37952231|NCT00628862|69639206|FG000|Overall Study|Withdrawal by Subject|4|||
37952232|NCT00628862|69639207|FG001|Overall Study|Withdrawal by Subject|6|||
37952233|NCT00628862|69639208|FG002|Overall Study|Withdrawal by Subject|11|||
37952234|NCT00628862|69639206|FG000|Overall Study|Lost to Follow-up|0|||
37952235|NCT00628862|69639207|FG001|Overall Study|Lost to Follow-up|2|||
37952236|NCT00628862|69639208|FG002|Overall Study|Lost to Follow-up|1|||
37952237|NCT00628862|69639206|FG000|Overall Study|Protocol Violation|1|||
38043881|NCT01386385|69731942|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
38043882|NCT01386385|69731943|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
38043883|NCT01386385|69731944|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
38043884|NCT01386385|69731945|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
37952238|NCT00628862|69639207|FG001|Overall Study|Protocol Violation|0|||
37952239|NCT00628862|69639208|FG002|Overall Study|Protocol Violation|0|||
37952240|NCT00628862|69639206|FG000|Overall Study|COPD Exacerbation|0|||
37952241|NCT00628862|69639207|FG001|Overall Study|COPD Exacerbation|1|||
37860728|NCT01144377|69544196|FG000|52 Week Treatment Period|Adverse Event|0|||
37860729|NCT01144377|69544197|FG001|52 Week Treatment Period|Adverse Event|0|||
37860730|NCT01144377|69544198|FG002|52 Week Treatment Period|Adverse Event|3|||
37860731|NCT01144377|69544199|FG003|52 Week Treatment Period|Adverse Event|2|||
37860732|NCT01144377|69544200|FG004|52 Week Treatment Period|Adverse Event|1|||
37860733|NCT01144377|69544196|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
37860734|NCT01144377|69544197|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
37860735|NCT01144377|69544198|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
37860736|NCT01144377|69544199|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
37860737|NCT01144377|69544200|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
37860738|NCT01144377|69544196|FG000|52 Week Treatment Period|Protocol Violation|0|||
37860739|NCT01144377|69544197|FG001|52 Week Treatment Period|Protocol Violation|0|||
37860740|NCT01144377|69544198|FG002|52 Week Treatment Period|Protocol Violation|0|||
37860741|NCT01144377|69544199|FG003|52 Week Treatment Period|Protocol Violation|0|||
37860742|NCT01144377|69544200|FG004|52 Week Treatment Period|Protocol Violation|1|||
37860743|NCT01144377|69544196|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
37860744|NCT01144377|69544197|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
37860745|NCT01144377|69544198|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
37860746|NCT01144377|69544199|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
38043885|NCT01386385|69731946|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
37860747|NCT01144377|69544200|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
37860748|NCT01144377|69544196|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
37952242|NCT00628862|69639208|FG002|Overall Study|COPD Exacerbation|0|||
38043886|NCT01386385|69731939|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
38043887|NCT01386385|69731940|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
38043888|NCT01386385|69731941|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
38043889|NCT01386385|69731942|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
38043890|NCT01386385|69731943|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
38043891|NCT01386385|69731944|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
38043892|NCT01386385|69731945|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
38043893|NCT01386385|69731946|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
38043894|NCT01386385|69731939|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
38043895|NCT01386385|69731940|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
38043896|NCT01386385|69731941|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
38043897|NCT01386385|69731942|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
38043898|NCT01386385|69731943|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
38043899|NCT01386385|69731944|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
37860749|NCT01144377|69544197|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
37860750|NCT01144377|69544198|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
37860751|NCT01144377|69544199|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
37860752|NCT01144377|69544200|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
37860753|NCT01144377|69544196|FG000|52 Week Treatment Period|Sponsor Decision|0|||
37860754|NCT01144377|69544197|FG001|52 Week Treatment Period|Sponsor Decision|0|||
37860755|NCT01144377|69544198|FG002|52 Week Treatment Period|Sponsor Decision|0|||
37860756|NCT01144377|69544199|FG003|52 Week Treatment Period|Sponsor Decision|0|||
37860757|NCT01144377|69544200|FG004|52 Week Treatment Period|Sponsor Decision|1|||
37860758|NCT01144377|69544196|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
37860759|NCT01144377|69544197|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
37860760|NCT01144377|69544198|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
37860761|NCT01144377|69544199|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
37860762|NCT01144377|69544200|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
37860763|NCT01144377|69544196|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
37952243|NCT00584987|69639220|FG000|Overall Study|Protocol Violation|1|||
37952244|NCT00584987|69639221|FG001|Overall Study|Protocol Violation|1|||
37952245|NCT00584987|69639222|FG002|Overall Study|Protocol Violation|1|||
37860764|NCT01144377|69544197|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
37860765|NCT01144377|69544198|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
37860766|NCT01144377|69544199|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
37860767|NCT01144377|69544200|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
37860768|NCT01144377|69544196|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
37860769|NCT01144377|69544197|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
37860770|NCT01144377|69544198|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
37860771|NCT01144377|69544199|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
37860772|NCT01144377|69544200|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
37860773|NCT00950599|69544222|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
37860774|NCT00950599|69544223|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
37860775|NCT00950599|69544224|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
37860776|NCT00950599|69544225|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
38043900|NCT01386385|69731945|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
38043901|NCT01386385|69731946|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
38043902|NCT01386385|69731939|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
38043903|NCT01386385|69731940|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
38043904|NCT01386385|69731941|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
38043905|NCT01386385|69731942|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
38043906|NCT01386385|69731943|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
38043907|NCT01386385|69731944|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
38043908|NCT01386385|69731945|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
38043909|NCT01386385|69731946|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
37677774|NCT01364727|69152844|FG000|Overall Study|Not Eligible|2|||
37677775|NCT02633215|69152852|FG000|Overall Study|Lost to Follow-up|2|||
37677776|NCT02633215|69152853|FG001|Overall Study|Lost to Follow-up|3|||
37677777|NCT01364649|69152861|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
37677778|NCT01364649|69152862|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
37952246|NCT00584987|69639223|FG003|Overall Study|Protocol Violation|0|||
37952247|NCT00584987|69639220|FG000|Overall Study|Adverse Event|0|||
37952248|NCT00584987|69639221|FG001|Overall Study|Adverse Event|0|||
37952249|NCT00584987|69639222|FG002|Overall Study|Adverse Event|0|||
37952250|NCT00584987|69639223|FG003|Overall Study|Adverse Event|1|||
37952251|NCT00727961|69639233|FG000|Overall Study|Lost to Follow-up|1|||
37952252|NCT00727961|69639233|FG000|Overall Study|Adverse Event|4|||
37952253|NCT00727961|69639233|FG000|Overall Study|Patient's refusal|2|||
37952254|NCT00727961|69639233|FG000|Overall Study|Progression|30|||
37952255|NCT00568958|69639239|FG000|Allocation|Withdrawal by Subject|7|||
37952256|NCT00568958|69639240|FG001|Allocation|Withdrawal by Subject|3|||
37677779|NCT01364649|69152861|FG000|Overall Study|Lack of Efficacy|6|||
37677780|NCT01364649|69152862|FG001|Overall Study|Lack of Efficacy|0|||
37677781|NCT01364649|69152861|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
37677782|NCT01364649|69152862|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
37677783|NCT01364649|69152861|FG000|Overall Study|Protocol Deviations|4|||
37677784|NCT01364649|69152862|FG001|Overall Study|Protocol Deviations|8|||
37677785|NCT01364649|69152861|FG000|Overall Study|Withdrawal of Consent|9|||
37677786|NCT01364649|69152862|FG001|Overall Study|Withdrawal of Consent|7|||
37677787|NCT01364649|69152861|FG000|Overall Study|Lost to Follow-up|12|||
37677788|NCT01364649|69152862|FG001|Overall Study|Lost to Follow-up|13|||
37677789|NCT01364649|69152861|FG000|Overall Study|Other|4|||
37677790|NCT01364649|69152862|FG001|Overall Study|Other|1|||
37677791|NCT02588261|69152870|FG000|Overall Study|Study Terminated by Sponsor|157|||
37677792|NCT02588261|69152871|FG001|Overall Study|Study Terminated by Sponsor|142|||
37677793|NCT02588261|69152870|FG000|Overall Study|Protocol Deviation|1|||
37677794|NCT02588261|69152871|FG001|Overall Study|Protocol Deviation|0|||
37677795|NCT02588261|69152870|FG000|Overall Study|Death|1|||
37677796|NCT02588261|69152871|FG001|Overall Study|Death|2|||
37677797|NCT02588261|69152870|FG000|Overall Study|Withdrawal by Subject|12|||
37677798|NCT02588261|69152871|FG001|Overall Study|Withdrawal by Subject|8|||
37677799|NCT02588261|69152870|FG000|Overall Study|Noncompliance with Study Drug|0|||
37677800|NCT02588261|69152871|FG001|Overall Study|Noncompliance with Study Drug|1|||
37677801|NCT02588261|69152870|FG000|Overall Study|Miscellaneous|5|||
37677802|NCT02588261|69152871|FG001|Overall Study|Miscellaneous|4|||
37677803|NCT02588261|69152870|FG000|Overall Study|Progressive Disease|61|||
37677804|NCT02588261|69152871|FG001|Overall Study|Progressive Disease|82|||
37677805|NCT02588261|69152870|FG000|Overall Study|Adverse Event|29|||
37677806|NCT02588261|69152871|FG001|Overall Study|Adverse Event|24|||
37677807|NCT02588261|69152870|FG000|Overall Study|Lost to Follow-up|1|||
37677808|NCT02588261|69152871|FG001|Overall Study|Lost to Follow-up|0|||
37677809|NCT01359449|69152879|FG000|Overall Study|Lost to Follow-up|1|||
37677810|NCT01359449|69152880|FG001|Overall Study|Lost to Follow-up|0|||
37677811|NCT01359449|69152879|FG000|Overall Study|Protocol Violation|0|||
37677812|NCT01359449|69152880|FG001|Overall Study|Protocol Violation|2|||
37677813|NCT01359449|69152879|FG000|Overall Study|Withdrawal by Subject|3|||
37677814|NCT01359449|69152880|FG001|Overall Study|Withdrawal by Subject|2|||
37677815|NCT01672723|69152886|FG000|First Intervention|Adverse Event|3|||
37860777|NCT00950599|69544226|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
37860778|NCT00950599|69544227|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
37677816|NCT01672723|69152887|FG001|First Intervention|Adverse Event|0|||
37677817|NCT02632747|69152895|FG000|Wash-out Period|Adverse Event|1|||
37677818|NCT02632747|69152896|FG001|Wash-out Period|Adverse Event|0|||
37677819|NCT02520531|69152915|FG000|Overall Study|Revision of study device components|2|||
37677820|NCT02520531|69152916|FG001|Overall Study|Revision of study device components|2|||
37677821|NCT02520531|69152915|FG000|Overall Study|Death|1|||
37677822|NCT02520531|69152916|FG001|Overall Study|Death|2|||
37677823|NCT02520531|69152915|FG000|Overall Study|Lost to Follow-up|1|||
37860779|NCT00950599|69544228|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
37952257|NCT00568958|69639239|FG000|Allocation|Physician Decision|2|||
37677824|NCT02520531|69152916|FG001|Overall Study|Lost to Follow-up|1|||
37677825|NCT02520531|69152915|FG000|Overall Study|Meet exclusion criterion|0|||
37952258|NCT00568958|69639240|FG001|Allocation|Physician Decision|0|||
37677826|NCT02520531|69152916|FG001|Overall Study|Meet exclusion criterion|1|||
37677827|NCT02520531|69152915|FG000|Overall Study|Withdrawal by Subject|1|||
37677828|NCT02520531|69152916|FG001|Overall Study|Withdrawal by Subject|0|||
37677829|NCT02520531|69152915|FG000|Overall Study|Not study device|1|||
37677830|NCT02520531|69152916|FG001|Overall Study|Not study device|0|||
37677831|NCT01671319|69152922|FG000|Overall Study|Withdrawal by Subject|1|||
37860780|NCT00950599|69544229|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
37860781|NCT00950599|69544230|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
37860782|NCT00950599|69544231|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
37860783|NCT00950599|69544222|FG000|Double-Blind Treatment Period|Adverse Event|0|||
37860784|NCT00950599|69544223|FG001|Double-Blind Treatment Period|Adverse Event|1|||
37860785|NCT00950599|69544224|FG002|Double-Blind Treatment Period|Adverse Event|1|||
37860786|NCT00950599|69544225|FG003|Double-Blind Treatment Period|Adverse Event|1|||
37860787|NCT00950599|69544226|FG004|Double-Blind Treatment Period|Adverse Event|1|||
37860788|NCT00950599|69544227|FG005|Double-Blind Treatment Period|Adverse Event|1|||
37860789|NCT00950599|69544228|FG006|Double-Blind Treatment Period|Adverse Event|0|||
37860790|NCT00950599|69544229|FG007|Double-Blind Treatment Period|Adverse Event|0|||
37860791|NCT00950599|69544230|FG008|Double-Blind Treatment Period|Adverse Event|0|||
37860792|NCT00950599|69544231|FG009|Double-Blind Treatment Period|Adverse Event|0|||
37860793|NCT00950599|69544222|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
37860794|NCT00950599|69544223|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
37860795|NCT00950599|69544224|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
37677832|NCT01670539|69152926|FG000|Overall Study|Death|3|||
37677833|NCT01670539|69152927|FG001|Overall Study|Death|5|||
37677834|NCT01670539|69152926|FG000|Overall Study|Withdrawal by Subject|3|||
37677835|NCT01670539|69152927|FG001|Overall Study|Withdrawal by Subject|0|||
37677836|NCT02516163|69152934|FG000|Overall Study|Withdrawal by Subject|1|||
37677837|NCT02516163|69152934|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
37677838|NCT02516163|69152934|FG000|Overall Study|Unfit/delay in surgery|3|||
37677839|NCT02516163|69152934|FG000|Overall Study|Use of incorrect measurement technique|5|||
37677840|NCT02516163|69152934|FG000|Overall Study|Data not recorded|2|||
37677841|NCT02516163|69152934|FG000|Overall Study|MRI contraindication exclusion|6|||
37860796|NCT00950599|69544225|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
37860797|NCT00950599|69544226|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
37860798|NCT00950599|69544227|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
37860799|NCT00950599|69544228|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
37860800|NCT00950599|69544229|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
37860801|NCT00950599|69544230|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
37860802|NCT00950599|69544231|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
37860803|NCT00950599|69544222|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
37860804|NCT00950599|69544223|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
37860805|NCT00950599|69544224|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
37860806|NCT00950599|69544225|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
37860807|NCT00950599|69544226|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
37860808|NCT00950599|69544227|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
37860809|NCT00950599|69544228|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
37860810|NCT00950599|69544229|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
37677842|NCT02589665|69152942|FG000|Induction Period|Did not receive drug|0|||
37677843|NCT02589665|69152943|FG001|Induction Period|Did not receive drug|0|||
37677844|NCT02589665|69152944|FG002|Induction Period|Did not receive drug|0|||
37677845|NCT02589665|69152945|FG003|Induction Period|Did not receive drug|1|||
37677846|NCT02589665|69152946|FG004|Induction Period|Did not receive drug|0|||
37677847|NCT02589665|69152947|FG005|Induction Period|Did not receive drug|0|||
37677848|NCT02589665|69152948|FG006|Induction Period|Did not receive drug|0|||
37677849|NCT02589665|69152949|FG007|Induction Period|Did not receive drug|0|||
37677850|NCT02589665|69152950|FG008|Induction Period|Did not receive drug|0|||
37677851|NCT02589665|69152951|FG009|Induction Period|Did not receive drug|0|||
37860811|NCT00950599|69544230|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
37860812|NCT00950599|69544231|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
37677852|NCT02589665|69152942|FG000|Induction Period|Adverse Event|3|||
37677853|NCT02589665|69152943|FG001|Induction Period|Adverse Event|0|||
37677854|NCT02589665|69152944|FG002|Induction Period|Adverse Event|2|||
37677855|NCT02589665|69152945|FG003|Induction Period|Adverse Event|2|||
37677856|NCT02589665|69152946|FG004|Induction Period|Adverse Event|0|||
37677857|NCT02589665|69152947|FG005|Induction Period|Adverse Event|0|||
37677858|NCT02589665|69152948|FG006|Induction Period|Adverse Event|0|||
37677859|NCT02589665|69152949|FG007|Induction Period|Adverse Event|0|||
37860813|NCT00950599|69544222|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
37860814|NCT00950599|69544223|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
37860815|NCT00950599|69544224|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
37860816|NCT00950599|69544225|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
37860817|NCT00950599|69544226|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
37677860|NCT02589665|69152950|FG008|Induction Period|Adverse Event|0|||
37860818|NCT00950599|69544227|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
37860819|NCT00950599|69544228|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
37860820|NCT00950599|69544229|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
37860821|NCT00950599|69544230|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
37860822|NCT00950599|69544231|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
37860823|NCT00950599|69544222|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
37860824|NCT00950599|69544223|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
37860825|NCT00950599|69544224|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
37860826|NCT00950599|69544225|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
37860827|NCT00950599|69544226|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
37860828|NCT00950599|69544227|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
37860829|NCT00950599|69544228|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
37860830|NCT00950599|69544229|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
37860831|NCT00950599|69544230|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
37860832|NCT00950599|69544231|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
37860833|NCT00950599|69544222|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
37860834|NCT00950599|69544223|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
37860835|NCT00950599|69544224|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
37860836|NCT00950599|69544225|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
37860837|NCT00950599|69544226|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
37860838|NCT00950599|69544227|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
37860839|NCT00950599|69544228|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
37860840|NCT00950599|69544229|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
37860841|NCT00950599|69544230|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
37860842|NCT00950599|69544231|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
37860843|NCT00950599|69544222|FG000|Follow-Up Period|Adverse Event|0|||
37860844|NCT00950599|69544223|FG001|Follow-Up Period|Adverse Event|0|||
37860845|NCT00950599|69544224|FG002|Follow-Up Period|Adverse Event|0|||
37860846|NCT00950599|69544225|FG003|Follow-Up Period|Adverse Event|0|||
37860847|NCT00950599|69544226|FG004|Follow-Up Period|Adverse Event|0|||
37860848|NCT00950599|69544227|FG005|Follow-Up Period|Adverse Event|0|||
37860849|NCT00950599|69544228|FG006|Follow-Up Period|Adverse Event|0|||
37860850|NCT00950599|69544229|FG007|Follow-Up Period|Adverse Event|0|||
37860851|NCT00950599|69544230|FG008|Follow-Up Period|Adverse Event|1|||
37860852|NCT00950599|69544231|FG009|Follow-Up Period|Adverse Event|0|||
37860853|NCT00950599|69544222|FG000|Follow-Up Period|Lack of Efficacy|0|||
37860854|NCT00950599|69544223|FG001|Follow-Up Period|Lack of Efficacy|0|||
37860855|NCT00950599|69544224|FG002|Follow-Up Period|Lack of Efficacy|0|||
37860856|NCT00950599|69544225|FG003|Follow-Up Period|Lack of Efficacy|0|||
37952259|NCT00568958|69639239|FG000|Follow-Up|Withdrawal by Subject|6|||
37952260|NCT00568958|69639240|FG001|Follow-Up|Withdrawal by Subject|6|||
37952261|NCT00568958|69639239|FG000|Follow-Up|Physician Decision|1|||
37952262|NCT00568958|69639240|FG001|Follow-Up|Physician Decision|1|||
37952263|NCT00568958|69639239|FG000|Follow-Up|Family Emergency|1|||
37952264|NCT00568958|69639240|FG001|Follow-Up|Family Emergency|0|||
37952265|NCT00568958|69639239|FG000|Follow-Up|Adverse Event|1|||
37952266|NCT00568958|69639240|FG001|Follow-Up|Adverse Event|0|||
37952267|NCT00727649|69639248|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
37952268|NCT00727649|69639249|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
37952269|NCT00727649|69639248|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
37952270|NCT00727649|69639249|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
37952271|NCT00727649|69639248|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
37952272|NCT00727649|69639249|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
37952273|NCT00727649|69639248|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
37952274|NCT00727649|69639249|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
37952275|NCT00727649|69639248|FG000|Second Intervention (4-weeks)|Death|1|||
37860857|NCT00950599|69544226|FG004|Follow-Up Period|Lack of Efficacy|0|||
37860858|NCT00950599|69544227|FG005|Follow-Up Period|Lack of Efficacy|0|||
37860859|NCT00950599|69544228|FG006|Follow-Up Period|Lack of Efficacy|0|||
37952276|NCT00727649|69639249|FG001|Second Intervention (4-weeks)|Death|0|||
37952277|NCT00727649|69639248|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
37952278|NCT00727649|69639249|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
37952279|NCT00727649|69639248|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
37952280|NCT00727649|69639249|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
37952281|NCT00568334|69639259|FG000|Overall Study|Withdrawal by Subject|0|||
37952282|NCT00568334|69639260|FG001|Overall Study|Withdrawal by Subject|1|||
37952283|NCT00568334|69639259|FG000|Overall Study|Lost to Follow-up|1|||
37952284|NCT00568334|69639260|FG001|Overall Study|Lost to Follow-up|0|||
37952285|NCT00727571|69639270|FG000|Overall Study|Ineligibility determined|1|||
37952286|NCT00727571|69639271|FG001|Overall Study|Ineligibility determined|1|||
37952287|NCT00727571|69639272|FG002|Overall Study|Ineligibility determined|1|||
37952288|NCT00727571|69639273|FG003|Overall Study|Ineligibility determined|0|||
37952289|NCT00727571|69639270|FG000|Overall Study|Death|0|||
37952290|NCT00727571|69639271|FG001|Overall Study|Death|19|||
37952291|NCT00727571|69639272|FG002|Overall Study|Death|5|||
37952292|NCT00727571|69639273|FG003|Overall Study|Death|1|||
37952293|NCT00727571|69639270|FG000|Overall Study|Physician Decision|0|||
37952294|NCT00727571|69639271|FG001|Overall Study|Physician Decision|5|||
37952295|NCT00727571|69639272|FG002|Overall Study|Physician Decision|0|||
37952296|NCT00727571|69639273|FG003|Overall Study|Physician Decision|0|||
37952297|NCT00727571|69639270|FG000|Overall Study|Withdrawal by Subject|0|||
37952298|NCT00727571|69639271|FG001|Overall Study|Withdrawal by Subject|10|||
37952299|NCT00727571|69639272|FG002|Overall Study|Withdrawal by Subject|11|||
37952300|NCT00727571|69639273|FG003|Overall Study|Withdrawal by Subject|0|||
37952301|NCT00727571|69639270|FG000|Overall Study|Subject Non Compliance|0|||
37952302|NCT00727571|69639271|FG001|Overall Study|Subject Non Compliance|6|||
37952303|NCT00727571|69639272|FG002|Overall Study|Subject Non Compliance|0|||
37952304|NCT00727571|69639273|FG003|Overall Study|Subject Non Compliance|4|||
37952305|NCT00727571|69639270|FG000|Overall Study|Dismissed from nursing home|0|||
37952306|NCT00727571|69639271|FG001|Overall Study|Dismissed from nursing home|9|||
37952307|NCT00727571|69639272|FG002|Overall Study|Dismissed from nursing home|5|||
37952308|NCT00727571|69639273|FG003|Overall Study|Dismissed from nursing home|0|||
37952309|NCT00727571|69639270|FG000|Overall Study|Hospitalization|0|||
37952310|NCT00727571|69639271|FG001|Overall Study|Hospitalization|1|||
37952311|NCT00727571|69639272|FG002|Overall Study|Hospitalization|0|||
37952312|NCT00727571|69639273|FG003|Overall Study|Hospitalization|1|||
37952313|NCT00727571|69639270|FG000|Overall Study|AE not leading to hospitalization|0|||
37952314|NCT00727571|69639271|FG001|Overall Study|AE not leading to hospitalization|0|||
37952315|NCT00727571|69639272|FG002|Overall Study|AE not leading to hospitalization|2|||
37952316|NCT00727571|69639273|FG003|Overall Study|AE not leading to hospitalization|0|||
37952317|NCT00727571|69639270|FG000|Overall Study|Other|0|||
37952318|NCT00727571|69639271|FG001|Overall Study|Other|4|||
37952319|NCT00727571|69639272|FG002|Overall Study|Other|6|||
37952320|NCT00727571|69639273|FG003|Overall Study|Other|0|||
37952321|NCT00225277|69639285|FG000|Overall Study|Adverse Event|30|||
37952322|NCT00225277|69639286|FG001|Overall Study|Adverse Event|34|||
37952323|NCT00225277|69639285|FG000|Overall Study|Lack of Efficacy|4|||
37952324|NCT00225277|69639286|FG001|Overall Study|Lack of Efficacy|1|||
37952325|NCT00225277|69639285|FG000|Overall Study|Lost to Follow-up|4|||
37952326|NCT00225277|69639286|FG001|Overall Study|Lost to Follow-up|6|||
37952327|NCT00225277|69639285|FG000|Overall Study|Physician Decision|6|||
37952328|NCT00225277|69639286|FG001|Overall Study|Physician Decision|8|||
37952329|NCT00225277|69639285|FG000|Overall Study|Protocol Violation|6|||
37952330|NCT00225277|69639286|FG001|Overall Study|Protocol Violation|3|||
37952331|NCT00225277|69639285|FG000|Overall Study|Withdrawal by Subject|40|||
37952332|NCT00225277|69639286|FG001|Overall Study|Withdrawal by Subject|34|||
37952333|NCT00225277|69639285|FG000|Overall Study|Other|7|||
37952334|NCT00225277|69639286|FG001|Overall Study|Other|9|||
37952335|NCT00567996|69639295|FG000|Overall Study|Adverse Event|18|||
37952336|NCT00567996|69639296|FG001|Overall Study|Adverse Event|16|||
37952337|NCT00567996|69639297|FG002|Overall Study|Adverse Event|13|||
37952338|NCT00567996|69639295|FG000|Overall Study|Protocol Deviation|9|||
37677861|NCT02589665|69152951|FG009|Induction Period|Adverse Event|0|||
37677862|NCT02589665|69152942|FG000|Induction Period|Withdrawal by Subject|0|||
37677863|NCT02589665|69152943|FG001|Induction Period|Withdrawal by Subject|1|||
37677864|NCT02589665|69152944|FG002|Induction Period|Withdrawal by Subject|0|||
37677865|NCT02589665|69152945|FG003|Induction Period|Withdrawal by Subject|1|||
37677866|NCT02589665|69152946|FG004|Induction Period|Withdrawal by Subject|0|||
37677867|NCT02589665|69152947|FG005|Induction Period|Withdrawal by Subject|0|||
37677868|NCT02589665|69152948|FG006|Induction Period|Withdrawal by Subject|0|||
37677869|NCT02589665|69152949|FG007|Induction Period|Withdrawal by Subject|0|||
37677870|NCT02589665|69152950|FG008|Induction Period|Withdrawal by Subject|0|||
37677871|NCT02589665|69152951|FG009|Induction Period|Withdrawal by Subject|0|||
37677872|NCT02589665|69152942|FG000|Induction Period|Protocol Violation|0|||
37952339|NCT00567996|69639296|FG001|Overall Study|Protocol Deviation|11|||
37952340|NCT00567996|69639297|FG002|Overall Study|Protocol Deviation|13|||
37952341|NCT00567996|69639295|FG000|Overall Study|Withdrawal by Subject|8|||
37952342|NCT00567996|69639296|FG001|Overall Study|Withdrawal by Subject|12|||
37952343|NCT00567996|69639297|FG002|Overall Study|Withdrawal by Subject|22|||
37952344|NCT00567996|69639295|FG000|Overall Study|Abnormal Lab value(s)|2|||
37677873|NCT02589665|69152943|FG001|Induction Period|Protocol Violation|1|||
37860860|NCT00950599|69544229|FG007|Follow-Up Period|Lack of Efficacy|0|||
37952345|NCT00567996|69639296|FG001|Overall Study|Abnormal Lab value(s)|1|||
37952346|NCT00567996|69639297|FG002|Overall Study|Abnormal Lab value(s)|2|||
37952347|NCT00567996|69639295|FG000|Overall Study|Abnormal test procedure result(s)|2|||
37952348|NCT00567996|69639296|FG001|Overall Study|Abnormal test procedure result(s)|1|||
37952349|NCT00567996|69639297|FG002|Overall Study|Abnormal test procedure result(s)|1|||
37952350|NCT00567996|69639295|FG000|Overall Study|Lost to Follow-up|2|||
37952351|NCT00567996|69639296|FG001|Overall Study|Lost to Follow-up|5|||
37952352|NCT00567996|69639297|FG002|Overall Study|Lost to Follow-up|2|||
37952353|NCT00567996|69639295|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
37952354|NCT00567996|69639296|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
37952355|NCT00567996|69639297|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
37952356|NCT00567996|69639295|FG000|Overall Study|Administrative problems|1|||
37952357|NCT00567996|69639296|FG001|Overall Study|Administrative problems|1|||
37952358|NCT00567996|69639297|FG002|Overall Study|Administrative problems|0|||
37952359|NCT00567996|69639295|FG000|Overall Study|Death|1|||
37952360|NCT00567996|69639296|FG001|Overall Study|Death|0|||
37952361|NCT00567996|69639297|FG002|Overall Study|Death|2|||
37952362|NCT00567996|69639295|FG000|Overall Study|Patient's inability to use the device|0|||
37952363|NCT00567996|69639296|FG001|Overall Study|Patient's inability to use the device|1|||
37952364|NCT00567996|69639297|FG002|Overall Study|Patient's inability to use the device|0|||
37952365|NCT00224887|69639311|FG000|Overall Study|Pregnancy|6|||
37952366|NCT00224887|69639312|FG001|Overall Study|Pregnancy|6|||
37952367|NCT00148759|69639320|FG000|Overall Study|Withdrawal by Subject|1|||
37952368|NCT00148759|69639321|FG001|Overall Study|Withdrawal by Subject|1|||
37952369|NCT00148759|69639320|FG000|Overall Study|Lost to Follow-up|1|||
37952370|NCT00148759|69639321|FG001|Overall Study|Lost to Follow-up|0|||
37952371|NCT00717275|69639327|FG000|Overall Study|Premature study termination.|3|||
37952372|NCT00584909|69639331|FG000|Overall Study|Adverse Event|4|||
37952373|NCT00147823|69639337|FG000|Overall Study|Lost to Follow-up|6|||
37952374|NCT00147823|69639338|FG001|Overall Study|Lost to Follow-up|12|||
37952375|NCT00147823|69639337|FG000|Overall Study|Physician Decision|1|||
37952376|NCT00147823|69639338|FG001|Overall Study|Physician Decision|0|||
37952377|NCT00147823|69639337|FG000|Overall Study|Withdrawal by Subject|0|||
37952378|NCT00147823|69639338|FG001|Overall Study|Withdrawal by Subject|1|||
37952379|NCT00147823|69639337|FG000|Overall Study|Did not receive vitoss due to infection|6|||
37952380|NCT00147823|69639338|FG001|Overall Study|Did not receive vitoss due to infection|2|||
37952381|NCT00717197|69639344|FG000|Overall Study|Unable to purchase study drug|5|||
37952382|NCT00717197|69639344|FG000|Overall Study|Tumor Progression|1|||
37952383|NCT00717197|69639344|FG000|Overall Study|Physician Decision|1|||
37952384|NCT00147745|69639351|FG000|Overall Study|Withdrawal by Subject|1|||
37952385|NCT00147745|69639352|FG001|Overall Study|Withdrawal by Subject|0|||
37952386|NCT00147745|69639353|FG002|Overall Study|Withdrawal by Subject|0|||
37952387|NCT00642902|69639365|FG000|Overall Study|Adverse Event|0|||
37952388|NCT00642902|69639366|FG001|Overall Study|Adverse Event|1|||
37952389|NCT00642902|69639367|FG002|Overall Study|Adverse Event|3|||
37952390|NCT00642902|69639368|FG003|Overall Study|Adverse Event|1|||
37952391|NCT00642902|69639365|FG000|Overall Study|Lost to Follow-up|1|||
37952392|NCT00642902|69639366|FG001|Overall Study|Lost to Follow-up|1|||
37952393|NCT00642902|69639367|FG002|Overall Study|Lost to Follow-up|0|||
37952394|NCT00642902|69639368|FG003|Overall Study|Lost to Follow-up|0|||
37952395|NCT00642902|69639365|FG000|Overall Study|Lack of Efficacy|0|||
37952396|NCT00642902|69639366|FG001|Overall Study|Lack of Efficacy|3|||
37952397|NCT00642902|69639367|FG002|Overall Study|Lack of Efficacy|3|||
37952398|NCT00642902|69639368|FG003|Overall Study|Lack of Efficacy|0|||
37952399|NCT00642902|69639365|FG000|Overall Study|Death|1|||
37952400|NCT00642902|69639366|FG001|Overall Study|Death|0|||
37952401|NCT00642902|69639367|FG002|Overall Study|Death|0|||
37952402|NCT00642902|69639368|FG003|Overall Study|Death|0|||
37952403|NCT00642902|69639365|FG000|Overall Study|Premature termination of clinical trial|37|||
37952404|NCT00642902|69639366|FG001|Overall Study|Premature termination of clinical trial|32|||
37952405|NCT00642902|69639367|FG002|Overall Study|Premature termination of clinical trial|35|||
37952406|NCT00642902|69639368|FG003|Overall Study|Premature termination of clinical trial|35|||
37952407|NCT00642902|69639365|FG000|Overall Study|Randomized, but not treated|0|||
37952408|NCT00642902|69639366|FG001|Overall Study|Randomized, but not treated|0|||
37952409|NCT00642902|69639367|FG002|Overall Study|Randomized, but not treated|1|||
37952410|NCT00642902|69639368|FG003|Overall Study|Randomized, but not treated|0|||
37952411|NCT00642902|69639365|FG000|Overall Study|Other|1|||
37952412|NCT00642902|69639366|FG001|Overall Study|Other|5|||
37952413|NCT00642902|69639367|FG002|Overall Study|Other|1|||
37952414|NCT00642902|69639368|FG003|Overall Study|Other|4|||
37952415|NCT00224107|69639380|FG000|Overall Study|Adverse Event|20|||
37952416|NCT00224107|69639381|FG001|Overall Study|Adverse Event|6|||
37952417|NCT00224107|69639380|FG000|Overall Study|Protocol Violation|2|||
37952418|NCT00224107|69639381|FG001|Overall Study|Protocol Violation|3|||
37952419|NCT00224107|69639380|FG000|Overall Study|Withdrawal by Subject|1|||
37952420|NCT00224107|69639381|FG001|Overall Study|Withdrawal by Subject|4|||
37952421|NCT00224107|69639380|FG000|Overall Study|Lack of Efficacy|2|||
37952422|NCT00224107|69639381|FG001|Overall Study|Lack of Efficacy|0|||
37952423|NCT00224107|69639380|FG000|Overall Study|Lost to Follow-up|4|||
37952424|NCT00224107|69639381|FG001|Overall Study|Lost to Follow-up|0|||
37952425|NCT00224107|69639380|FG000|Overall Study|Physician Decision|1|||
37952426|NCT00224107|69639381|FG001|Overall Study|Physician Decision|0|||
37952427|NCT00224107|69639380|FG000|Overall Study|Other|1|||
37952428|NCT00224107|69639381|FG001|Overall Study|Other|1|||
37952429|NCT00720083|69639389|FG000|Overall Study|Ineligible|1|||
37952430|NCT00720083|69639390|FG001|Overall Study|Ineligible|2|||
37952431|NCT00209131|69639398|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
37952432|NCT00209131|69639399|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
37952433|NCT00224029|69639405|FG000|Overall Study|Lost to Follow-up|1|||
37952434|NCT00224029|69639405|FG000|Overall Study|Withdrawal by Subject|4|||
37952435|NCT00224029|69639405|FG000|Overall Study|Other|1|||
37952436|NCT00223795|69639409|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
37952437|NCT00223795|69639410|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
37952438|NCT00223795|69639409|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
37952439|NCT00223795|69639410|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
37952440|NCT00719849|69639419|FG000|Overall Study|Death|0|||
37952441|NCT00719849|69639420|FG001|Overall Study|Death|1|||
37952442|NCT03907683|69639426|FG000|Overall Study|Pregnancy|1|||
37952443|NCT03907683|69639426|FG000|Overall Study|Withdrawal by Subject|1|||
37952444|NCT00626522|69639436|FG000|Overall Study|Protocol Violation|0|||
37952445|NCT00626522|69639437|FG001|Overall Study|Protocol Violation|0|||
37952446|NCT00626522|69639438|FG002|Overall Study|Protocol Violation|0|||
37952447|NCT00626522|69639439|FG003|Overall Study|Protocol Violation|0|||
37952448|NCT00626522|69639440|FG004|Overall Study|Protocol Violation|1|||
37952449|NCT00626522|69639441|FG005|Overall Study|Protocol Violation|0|||
37952450|NCT00626522|69639436|FG000|Overall Study|Adverse Event|2|||
37952451|NCT00626522|69639437|FG001|Overall Study|Adverse Event|1|||
37952452|NCT00626522|69639438|FG002|Overall Study|Adverse Event|2|||
37952453|NCT00626522|69639439|FG003|Overall Study|Adverse Event|0|||
37952454|NCT00626522|69639440|FG004|Overall Study|Adverse Event|1|||
37952455|NCT00626522|69639441|FG005|Overall Study|Adverse Event|1|||
37952456|NCT00626522|69639436|FG000|Overall Study|Withdrawal by Subject|2|||
37952457|NCT00626522|69639437|FG001|Overall Study|Withdrawal by Subject|5|||
37952458|NCT00626522|69639438|FG002|Overall Study|Withdrawal by Subject|5|||
37952459|NCT00626522|69639439|FG003|Overall Study|Withdrawal by Subject|0|||
37952460|NCT00626522|69639440|FG004|Overall Study|Withdrawal by Subject|4|||
37952461|NCT00626522|69639441|FG005|Overall Study|Withdrawal by Subject|1|||
37952462|NCT00626522|69639436|FG000|Overall Study|COPD exacerbation|0|||
37952463|NCT00626522|69639437|FG001|Overall Study|COPD exacerbation|0|||
37952464|NCT00626522|69639438|FG002|Overall Study|COPD exacerbation|0|||
37952465|NCT00626522|69639439|FG003|Overall Study|COPD exacerbation|1|||
37952466|NCT00626522|69639440|FG004|Overall Study|COPD exacerbation|1|||
37952467|NCT00626522|69639441|FG005|Overall Study|COPD exacerbation|0|||
37952468|NCT00626522|69639436|FG000|Overall Study|Lost to Follow-up|0|||
37952469|NCT00626522|69639437|FG001|Overall Study|Lost to Follow-up|1|||
37952470|NCT00626522|69639438|FG002|Overall Study|Lost to Follow-up|0|||
37952471|NCT00626522|69639439|FG003|Overall Study|Lost to Follow-up|0|||
37952472|NCT00626522|69639440|FG004|Overall Study|Lost to Follow-up|0|||
37952473|NCT00626522|69639441|FG005|Overall Study|Lost to Follow-up|0|||
37952474|NCT00626522|69639436|FG000|Overall Study|Inconsistent reason reported|1|||
37952475|NCT00626522|69639437|FG001|Overall Study|Inconsistent reason reported|0|||
37952476|NCT00626522|69639438|FG002|Overall Study|Inconsistent reason reported|0|||
37952477|NCT00626522|69639439|FG003|Overall Study|Inconsistent reason reported|0|||
37952478|NCT00626522|69639440|FG004|Overall Study|Inconsistent reason reported|0|||
37952479|NCT00626522|69639441|FG005|Overall Study|Inconsistent reason reported|0|||
37952480|NCT00626522|69639436|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
37952481|NCT00626522|69639437|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
37952482|NCT00626522|69639438|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
37952483|NCT00626522|69639439|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
37952484|NCT00626522|69639440|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
37952485|NCT00626522|69639441|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
37952486|NCT00540423|69639466|FG000|Double-Blind Treatment Period|Adverse Event|0|||
37952487|NCT00540423|69639467|FG001|Double-Blind Treatment Period|Adverse Event|1|||
37952488|NCT00540423|69639468|FG002|Double-Blind Treatment Period|Adverse Event|0|||
37952489|NCT00540423|69639466|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
37952490|NCT00540423|69639467|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
37952491|NCT00540423|69639468|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
37952492|NCT00566982|69639488|FG000|Overall Study|Adverse Event|6|||
37952493|NCT00566982|69639489|FG001|Overall Study|Adverse Event|48|||
37952494|NCT00566982|69639488|FG000|Overall Study|Withdrawal by Subject|1|||
37677874|NCT02589665|69152944|FG002|Induction Period|Protocol Violation|0|||
37952495|NCT00566982|69639489|FG001|Overall Study|Withdrawal by Subject|14|||
37952496|NCT00566982|69639488|FG000|Overall Study|Protocol Violation|1|||
37952497|NCT00566982|69639489|FG001|Overall Study|Protocol Violation|4|||
37952498|NCT00566982|69639488|FG000|Overall Study|Lost to Follow-up|0|||
37952499|NCT00566982|69639489|FG001|Overall Study|Lost to Follow-up|1|||
37952500|NCT00566982|69639488|FG000|Overall Study|Other-family problems & doctor's request|0|||
37952501|NCT00566982|69639489|FG001|Overall Study|Other-family problems & doctor's request|2|||
37952502|NCT00624338|69639501|FG000|Overall Study|Adverse Event|14|||
37952503|NCT00624338|69639502|FG001|Overall Study|Adverse Event|14|||
37677875|NCT02589665|69152945|FG003|Induction Period|Protocol Violation|0|||
37677876|NCT02589665|69152946|FG004|Induction Period|Protocol Violation|0|||
37677877|NCT02589665|69152947|FG005|Induction Period|Protocol Violation|0|||
37677878|NCT02589665|69152948|FG006|Induction Period|Protocol Violation|0|||
37769213|NCT01424501|69285698|FG001|Overall Study|Withdrawal by Subject|0|||
37677879|NCT02589665|69152949|FG007|Induction Period|Protocol Violation|0|||
37677880|NCT02589665|69152950|FG008|Induction Period|Protocol Violation|0|||
37677881|NCT02589665|69152951|FG009|Induction Period|Protocol Violation|0|||
37677882|NCT02589665|69152942|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
37677883|NCT02589665|69152943|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
37677884|NCT02589665|69152944|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
37677885|NCT02589665|69152945|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
37677886|NCT02589665|69152946|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
37677887|NCT02589665|69152947|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
37677888|NCT02589665|69152948|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
37677889|NCT02589665|69152949|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
37677890|NCT02589665|69152950|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
37677891|NCT02589665|69152951|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
37677892|NCT02589665|69152942|FG000|Maintenance Period|Withdrawal by Subject|0|||
37677893|NCT02589665|69152943|FG001|Maintenance Period|Withdrawal by Subject|0|||
37677894|NCT02589665|69152944|FG002|Maintenance Period|Withdrawal by Subject|0|||
37677895|NCT02589665|69152945|FG003|Maintenance Period|Withdrawal by Subject|0|||
37677896|NCT02589665|69152946|FG004|Maintenance Period|Withdrawal by Subject|4|||
37677897|NCT02589665|69152947|FG005|Maintenance Period|Withdrawal by Subject|2|||
37677898|NCT02589665|69152948|FG006|Maintenance Period|Withdrawal by Subject|4|||
37677899|NCT02589665|69152949|FG007|Maintenance Period|Withdrawal by Subject|0|||
37677900|NCT02589665|69152950|FG008|Maintenance Period|Withdrawal by Subject|0|||
37677901|NCT02589665|69152951|FG009|Maintenance Period|Withdrawal by Subject|0|||
37677902|NCT02589665|69152942|FG000|Maintenance Period|Lack of Efficacy|0|||
37677903|NCT02589665|69152943|FG001|Maintenance Period|Lack of Efficacy|0|||
37677904|NCT02589665|69152944|FG002|Maintenance Period|Lack of Efficacy|0|||
37677905|NCT02589665|69152945|FG003|Maintenance Period|Lack of Efficacy|0|||
37677906|NCT02589665|69152946|FG004|Maintenance Period|Lack of Efficacy|2|||
37677907|NCT02589665|69152947|FG005|Maintenance Period|Lack of Efficacy|1|||
37677908|NCT02589665|69152948|FG006|Maintenance Period|Lack of Efficacy|0|||
37677909|NCT02589665|69152949|FG007|Maintenance Period|Lack of Efficacy|0|||
37677910|NCT02589665|69152950|FG008|Maintenance Period|Lack of Efficacy|0|||
37677911|NCT02589665|69152951|FG009|Maintenance Period|Lack of Efficacy|0|||
37677912|NCT02589665|69152942|FG000|Maintenance Period|Adverse Event|0|||
37677913|NCT02589665|69152943|FG001|Maintenance Period|Adverse Event|0|||
37677914|NCT02589665|69152944|FG002|Maintenance Period|Adverse Event|0|||
37677915|NCT02589665|69152945|FG003|Maintenance Period|Adverse Event|0|||
37677916|NCT02589665|69152946|FG004|Maintenance Period|Adverse Event|0|||
37677917|NCT02589665|69152947|FG005|Maintenance Period|Adverse Event|0|||
37769214|NCT01424501|69285699|FG002|Overall Study|Withdrawal by Subject|1|||
37769215|NCT01424501|69285700|FG003|Overall Study|Withdrawal by Subject|0|||
37769216|NCT01424501|69285701|FG004|Overall Study|Withdrawal by Subject|0|||
37769217|NCT01424501|69285702|FG005|Overall Study|Withdrawal by Subject|0|||
37769218|NCT01424501|69285697|FG000|Overall Study|Lost to Follow-up|0|||
37769219|NCT01424501|69285698|FG001|Overall Study|Lost to Follow-up|1|||
37677918|NCT02589665|69152948|FG006|Maintenance Period|Adverse Event|2|||
37677919|NCT02589665|69152949|FG007|Maintenance Period|Adverse Event|0|||
37677920|NCT02589665|69152950|FG008|Maintenance Period|Adverse Event|0|||
37677921|NCT02589665|69152951|FG009|Maintenance Period|Adverse Event|0|||
37677922|NCT02589665|69152942|FG000|Maintenance Period|Lost to Follow-up|0|||
37677923|NCT02589665|69152943|FG001|Maintenance Period|Lost to Follow-up|0|||
37677924|NCT02589665|69152944|FG002|Maintenance Period|Lost to Follow-up|0|||
37677925|NCT02589665|69152945|FG003|Maintenance Period|Lost to Follow-up|0|||
37677926|NCT02589665|69152946|FG004|Maintenance Period|Lost to Follow-up|0|||
37677927|NCT02589665|69152947|FG005|Maintenance Period|Lost to Follow-up|1|||
37677928|NCT02589665|69152948|FG006|Maintenance Period|Lost to Follow-up|0|||
37677929|NCT02589665|69152949|FG007|Maintenance Period|Lost to Follow-up|0|||
37677930|NCT02589665|69152950|FG008|Maintenance Period|Lost to Follow-up|0|||
37677931|NCT02589665|69152951|FG009|Maintenance Period|Lost to Follow-up|0|||
37677932|NCT02589665|69152942|FG000|Maintenance Period|Physician Decision|0|||
37677933|NCT02589665|69152943|FG001|Maintenance Period|Physician Decision|0|||
37677934|NCT02589665|69152944|FG002|Maintenance Period|Physician Decision|0|||
37677935|NCT02589665|69152945|FG003|Maintenance Period|Physician Decision|0|||
37677936|NCT02589665|69152946|FG004|Maintenance Period|Physician Decision|0|||
37677937|NCT02589665|69152947|FG005|Maintenance Period|Physician Decision|1|||
37677938|NCT02589665|69152948|FG006|Maintenance Period|Physician Decision|0|||
37677939|NCT02589665|69152949|FG007|Maintenance Period|Physician Decision|0|||
37677940|NCT02589665|69152950|FG008|Maintenance Period|Physician Decision|0|||
37677941|NCT02589665|69152951|FG009|Maintenance Period|Physician Decision|0|||
37677942|NCT02589665|69152942|FG000|Maintenance Period|Reason Not Collected|0|||
37677943|NCT02589665|69152943|FG001|Maintenance Period|Reason Not Collected|0|||
37677944|NCT02589665|69152944|FG002|Maintenance Period|Reason Not Collected|0|||
37677945|NCT02589665|69152945|FG003|Maintenance Period|Reason Not Collected|0|||
37677946|NCT02589665|69152946|FG004|Maintenance Period|Reason Not Collected|0|||
37677947|NCT02589665|69152947|FG005|Maintenance Period|Reason Not Collected|1|||
37677948|NCT02589665|69152948|FG006|Maintenance Period|Reason Not Collected|1|||
37677949|NCT02589665|69152949|FG007|Maintenance Period|Reason Not Collected|0|||
37677950|NCT02589665|69152950|FG008|Maintenance Period|Reason Not Collected|0|||
37769220|NCT01424501|69285699|FG002|Overall Study|Lost to Follow-up|1|||
37677951|NCT02589665|69152951|FG009|Maintenance Period|Reason Not Collected|0|||
37677952|NCT02589665|69152942|FG000|Induction Extension Period|Adverse Event|0|||
37677953|NCT02589665|69152943|FG001|Induction Extension Period|Adverse Event|0|||
37677954|NCT02589665|69152944|FG002|Induction Extension Period|Adverse Event|0|||
37677955|NCT02589665|69152945|FG003|Induction Extension Period|Adverse Event|0|||
37677956|NCT02589665|69152946|FG004|Induction Extension Period|Adverse Event|0|||
37677957|NCT02589665|69152947|FG005|Induction Extension Period|Adverse Event|0|||
37677958|NCT02589665|69152948|FG006|Induction Extension Period|Adverse Event|0|||
37677959|NCT02589665|69152949|FG007|Induction Extension Period|Adverse Event|0|||
37677960|NCT02589665|69152950|FG008|Induction Extension Period|Adverse Event|4|||
37677961|NCT02589665|69152951|FG009|Induction Extension Period|Adverse Event|0|||
37677962|NCT02589665|69152942|FG000|Induction Extension Period|Lack of Efficacy|0|||
37677963|NCT02589665|69152943|FG001|Induction Extension Period|Lack of Efficacy|0|||
37677964|NCT02589665|69152944|FG002|Induction Extension Period|Lack of Efficacy|0|||
37677965|NCT02589665|69152945|FG003|Induction Extension Period|Lack of Efficacy|0|||
37677966|NCT02589665|69152946|FG004|Induction Extension Period|Lack of Efficacy|0|||
37677967|NCT02589665|69152947|FG005|Induction Extension Period|Lack of Efficacy|0|||
37677968|NCT02589665|69152948|FG006|Induction Extension Period|Lack of Efficacy|0|||
37677969|NCT02589665|69152949|FG007|Induction Extension Period|Lack of Efficacy|0|||
37677970|NCT02589665|69152950|FG008|Induction Extension Period|Lack of Efficacy|3|||
37677971|NCT02589665|69152951|FG009|Induction Extension Period|Lack of Efficacy|0|||
37677972|NCT02589665|69152942|FG000|Induction Extension Period|Withdrawal by Subject|0|||
37677973|NCT02589665|69152943|FG001|Induction Extension Period|Withdrawal by Subject|0|||
37677974|NCT02589665|69152944|FG002|Induction Extension Period|Withdrawal by Subject|0|||
37677975|NCT02589665|69152945|FG003|Induction Extension Period|Withdrawal by Subject|0|||
37677976|NCT02589665|69152946|FG004|Induction Extension Period|Withdrawal by Subject|0|||
37677977|NCT02589665|69152947|FG005|Induction Extension Period|Withdrawal by Subject|0|||
37677978|NCT02589665|69152948|FG006|Induction Extension Period|Withdrawal by Subject|0|||
37677979|NCT02589665|69152949|FG007|Induction Extension Period|Withdrawal by Subject|2|||
37677980|NCT02589665|69152950|FG008|Induction Extension Period|Withdrawal by Subject|3|||
37677981|NCT02589665|69152951|FG009|Induction Extension Period|Withdrawal by Subject|0|||
37677982|NCT02589665|69152942|FG000|Induction Extension Period|Physician Decision|0|||
37677983|NCT02589665|69152943|FG001|Induction Extension Period|Physician Decision|0|||
37677984|NCT02589665|69152944|FG002|Induction Extension Period|Physician Decision|0|||
37677985|NCT02589665|69152945|FG003|Induction Extension Period|Physician Decision|0|||
37677986|NCT02589665|69152946|FG004|Induction Extension Period|Physician Decision|0|||
37677987|NCT02589665|69152947|FG005|Induction Extension Period|Physician Decision|0|||
37677988|NCT02589665|69152948|FG006|Induction Extension Period|Physician Decision|0|||
37677989|NCT02589665|69152949|FG007|Induction Extension Period|Physician Decision|0|||
37677990|NCT02589665|69152950|FG008|Induction Extension Period|Physician Decision|1|||
37677991|NCT02589665|69152951|FG009|Induction Extension Period|Physician Decision|0|||
37677992|NCT02589665|69152942|FG000|Induction Extension Period|Reason Not Collected|0|||
37677993|NCT02589665|69152943|FG001|Induction Extension Period|Reason Not Collected|0|||
37677994|NCT02589665|69152944|FG002|Induction Extension Period|Reason Not Collected|0|||
37677995|NCT02589665|69152945|FG003|Induction Extension Period|Reason Not Collected|0|||
37677996|NCT02589665|69152946|FG004|Induction Extension Period|Reason Not Collected|0|||
37677997|NCT02589665|69152947|FG005|Induction Extension Period|Reason Not Collected|0|||
37677998|NCT02589665|69152948|FG006|Induction Extension Period|Reason Not Collected|0|||
37677999|NCT02589665|69152949|FG007|Induction Extension Period|Reason Not Collected|0|||
37678000|NCT02589665|69152950|FG008|Induction Extension Period|Reason Not Collected|1|||
37678001|NCT02589665|69152951|FG009|Induction Extension Period|Reason Not Collected|0|||
37678002|NCT02589665|69152942|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
37678003|NCT02589665|69152943|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
37678004|NCT02589665|69152944|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
37678005|NCT02589665|69152945|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
37678006|NCT02589665|69152946|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
37769221|NCT01424501|69285700|FG003|Overall Study|Lost to Follow-up|0|||
37769222|NCT01424501|69285701|FG004|Overall Study|Lost to Follow-up|0|||
37678007|NCT02589665|69152947|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
37678008|NCT02589665|69152948|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
37678009|NCT02589665|69152949|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
37678010|NCT02589665|69152950|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
37678011|NCT02589665|69152951|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
37678012|NCT02589665|69152942|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
37678013|NCT02589665|69152943|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
37678014|NCT02589665|69152944|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
37678015|NCT02589665|69152945|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
37678016|NCT02589665|69152946|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
37678017|NCT02589665|69152947|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
37678018|NCT02589665|69152948|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
37678019|NCT02589665|69152949|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
37678020|NCT02589665|69152950|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
37678021|NCT02589665|69152951|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
37678022|NCT02589665|69152942|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
37678023|NCT02589665|69152943|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
37678024|NCT02589665|69152944|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
37678025|NCT02589665|69152945|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
37678026|NCT02589665|69152946|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
37678027|NCT02589665|69152947|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
37678028|NCT02589665|69152948|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
37678029|NCT02589665|69152949|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
37678030|NCT02589665|69152950|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
37678031|NCT02589665|69152951|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
37678032|NCT02589665|69152942|FG000|Maintenance Extension Period|Adverse Event|0|||
37678033|NCT02589665|69152943|FG001|Maintenance Extension Period|Adverse Event|0|||
37678034|NCT02589665|69152944|FG002|Maintenance Extension Period|Adverse Event|0|||
37678035|NCT02589665|69152945|FG003|Maintenance Extension Period|Adverse Event|0|||
37678036|NCT02589665|69152946|FG004|Maintenance Extension Period|Adverse Event|0|||
37678037|NCT02589665|69152947|FG005|Maintenance Extension Period|Adverse Event|0|||
37678038|NCT02589665|69152948|FG006|Maintenance Extension Period|Adverse Event|0|||
37678039|NCT02589665|69152949|FG007|Maintenance Extension Period|Adverse Event|0|||
37678040|NCT02589665|69152950|FG008|Maintenance Extension Period|Adverse Event|0|||
37678041|NCT02589665|69152951|FG009|Maintenance Extension Period|Adverse Event|2|||
37678042|NCT02589665|69152942|FG000|Maintenance Extension Period|Non-responder|0|||
37678043|NCT02589665|69152943|FG001|Maintenance Extension Period|Non-responder|0|||
37678044|NCT02589665|69152944|FG002|Maintenance Extension Period|Non-responder|0|||
37678045|NCT02589665|69152945|FG003|Maintenance Extension Period|Non-responder|0|||
37678046|NCT02589665|69152946|FG004|Maintenance Extension Period|Non-responder|0|||
37678047|NCT02589665|69152947|FG005|Maintenance Extension Period|Non-responder|0|||
37678048|NCT02589665|69152948|FG006|Maintenance Extension Period|Non-responder|0|||
37678049|NCT02589665|69152949|FG007|Maintenance Extension Period|Non-responder|0|||
37678050|NCT02589665|69152950|FG008|Maintenance Extension Period|Non-responder|0|||
37678051|NCT02589665|69152951|FG009|Maintenance Extension Period|Non-responder|1|||
37678052|NCT01905397|69152977|FG000|Overall Study|Death|0|||
37678053|NCT01905397|69152978|FG001|Overall Study|Death|1|||
37678054|NCT01905397|69152977|FG000|Overall Study|Withdrawal by Subject|2|||
37678055|NCT01905397|69152978|FG001|Overall Study|Withdrawal by Subject|0|||
37678056|NCT01905397|69152977|FG000|Overall Study|Surgery canceled/aborted|9|||
37678057|NCT01905397|69152978|FG001|Overall Study|Surgery canceled/aborted|5|||
37678058|NCT01905397|69152977|FG000|Overall Study|Incision < 7 cm|2|||
37678059|NCT01905397|69152978|FG001|Overall Study|Incision < 7 cm|0|||
37678060|NCT01905397|69152977|FG000|Overall Study|Wrong treatment|1|||
37678061|NCT01905397|69152978|FG001|Overall Study|Wrong treatment|1|||
37678062|NCT01905397|69152977|FG000|Overall Study|Device not applied|3|||
37678063|NCT01905397|69152978|FG001|Overall Study|Device not applied|0|||
37678064|NCT01905397|69152977|FG000|Overall Study|Dressing not applied in operating room|1|||
37678065|NCT01905397|69152978|FG001|Overall Study|Dressing not applied in operating room|0|||
37678066|NCT01905397|69152977|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
37678067|NCT01905397|69152978|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
37678068|NCT01362595|69152984|FG000|Overall Study|Screen failure|10|||
37678069|NCT01362595|69152984|FG000|Overall Study|Withdrawal by Subject|2|||
37678070|NCT02519595|69152991|FG000|Overall Study|Protocol Violation|8|||
37678071|NCT02519595|69152992|FG001|Overall Study|Protocol Violation|22|||
37678072|NCT02519595|69152993|FG002|Overall Study|Protocol Violation|16|||
37678073|NCT00660673|69153005|FG000|Overall Study|Adverse Event|84|||
37678074|NCT00660673|69153005|FG000|Overall Study|Lack of Efficacy|7|||
37678075|NCT00660673|69153005|FG000|Overall Study|Withdrawal by Subject|22|||
37678076|NCT00660673|69153005|FG000|Overall Study|Administrative|2|||
37678077|NCT00660673|69153005|FG000|Overall Study|Protocol Violation|2|||
37678078|NCT02630563|69153020|FG000|Overall Study|Administrative|1|||
37678079|NCT02588339|69153034|FG000|Overall Study|Withdrawal by Subject|1|||
37678080|NCT02588339|69153034|FG000|Overall Study|GVHD Progression prior to treatment|2|||
37678081|NCT02629159|69153041|FG000|Overall Study|Adverse Event|17|||
37678082|NCT02629159|69153042|FG001|Overall Study|Adverse Event|20|||
37678083|NCT02629159|69153043|FG002|Overall Study|Adverse Event|22|||
37678084|NCT02629159|69153041|FG000|Overall Study|Withdrawal by Subject|22|||
37678085|NCT02629159|69153042|FG001|Overall Study|Withdrawal by Subject|11|||
37678086|NCT02629159|69153043|FG002|Overall Study|Withdrawal by Subject|15|||
37678087|NCT02629159|69153041|FG000|Overall Study|Lost to Follow-up|7|||
37678088|NCT02629159|69153042|FG001|Overall Study|Lost to Follow-up|4|||
37678089|NCT02629159|69153043|FG002|Overall Study|Lost to Follow-up|5|||
37678090|NCT02629159|69153041|FG000|Overall Study|Lack of Efficacy|4|||
37678091|NCT02629159|69153042|FG001|Overall Study|Lack of Efficacy|0|||
37678092|NCT02629159|69153043|FG002|Overall Study|Lack of Efficacy|1|||
37678093|NCT02629159|69153041|FG000|Overall Study|Other|6|||
37678094|NCT02629159|69153042|FG001|Overall Study|Other|4|||
37678095|NCT02629159|69153043|FG002|Overall Study|Other|8|||
37678096|NCT02628769|69153054|FG000|First Intervention|Adverse Event|1|||
37678097|NCT02628769|69153055|FG001|First Intervention|Adverse Event|0|||
37678098|NCT02628769|69153054|FG000|First Intervention|Withdrawal by Subject|0|||
37678099|NCT02628769|69153055|FG001|First Intervention|Withdrawal by Subject|1|||
37678100|NCT02628769|69153054|FG000|Second Intervention|Adverse Event|2|||
37678101|NCT02628769|69153055|FG001|Second Intervention|Adverse Event|0|||
37678102|NCT02628769|69153054|FG000|Second Intervention|Physician Decision|0|||
37678103|NCT02628769|69153055|FG001|Second Intervention|Physician Decision|1|||
37678104|NCT02626819|69153063|FG000|Overall Study|Lost to Follow-up|3|||
37678105|NCT02626819|69153064|FG001|Overall Study|Lost to Follow-up|2|||
37678106|NCT02626819|69153063|FG000|Overall Study|Withdrawal by Subject|1|||
37678107|NCT02626819|69153064|FG001|Overall Study|Withdrawal by Subject|0|||
37678108|NCT02626819|69153063|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
37678109|NCT02626819|69153064|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
37678110|NCT02630251|69153074|FG000|Overall Study|Physician Decision|0|||
37678111|NCT02630251|69153075|FG001|Overall Study|Physician Decision|0|||
37678112|NCT02630251|69153076|FG002|Overall Study|Physician Decision|1|||
37678113|NCT02630251|69153077|FG003|Overall Study|Physician Decision|0|||
37678114|NCT02518113|69153091|FG000|Overall Study|Adverse Event|1|||
37678115|NCT02518113|69153092|FG001|Overall Study|Adverse Event|0|||
37678116|NCT02518113|69153093|FG002|Overall Study|Adverse Event|1|||
37678117|NCT02518113|69153094|FG003|Overall Study|Adverse Event|0|||
37678118|NCT02518113|69153091|FG000|Overall Study|Death|1|||
37678119|NCT02518113|69153092|FG001|Overall Study|Death|2|||
37678120|NCT02518113|69153093|FG002|Overall Study|Death|0|||
37678121|NCT02518113|69153094|FG003|Overall Study|Death|0|||
37678122|NCT02518113|69153091|FG000|Overall Study|Physician Decision|0|||
37678123|NCT02518113|69153092|FG001|Overall Study|Physician Decision|1|||
37678124|NCT02518113|69153093|FG002|Overall Study|Physician Decision|0|||
37678125|NCT02518113|69153094|FG003|Overall Study|Physician Decision|0|||
37678126|NCT02518113|69153091|FG000|Overall Study|Progressive Disease|1|||
37678127|NCT02518113|69153092|FG001|Overall Study|Progressive Disease|2|||
37678128|NCT02518113|69153093|FG002|Overall Study|Progressive Disease|3|||
37678129|NCT02518113|69153094|FG003|Overall Study|Progressive Disease|0|||
37678130|NCT02629861|69153110|FG000|Overall Study|Adverse Event|7|||
37678131|NCT02629861|69153111|FG001|Overall Study|Adverse Event|5|||
37678132|NCT02629861|69153112|FG002|Overall Study|Adverse Event|4|||
37678133|NCT02629861|69153110|FG000|Overall Study|Withdrawal by Subject|5|||
37678134|NCT02629861|69153111|FG001|Overall Study|Withdrawal by Subject|8|||
37678135|NCT02629861|69153112|FG002|Overall Study|Withdrawal by Subject|13|||
37678136|NCT02629861|69153110|FG000|Overall Study|Protocol Violation|2|||
37678137|NCT02629861|69153111|FG001|Overall Study|Protocol Violation|3|||
37678138|NCT02629861|69153112|FG002|Overall Study|Protocol Violation|7|||
37678139|NCT02629861|69153110|FG000|Overall Study|Lost to Follow-up|12|||
37678140|NCT02629861|69153111|FG001|Overall Study|Lost to Follow-up|9|||
37678141|NCT02629861|69153112|FG002|Overall Study|Lost to Follow-up|4|||
37678142|NCT02629861|69153110|FG000|Overall Study|Other|1|||
37678143|NCT02629861|69153111|FG001|Overall Study|Other|1|||
37678144|NCT02629861|69153112|FG002|Overall Study|Other|0|||
37678145|NCT02629861|69153110|FG000|Overall Study|Pregnancy|2|||
37678146|NCT02629861|69153111|FG001|Overall Study|Pregnancy|1|||
37678147|NCT02629861|69153112|FG002|Overall Study|Pregnancy|0|||
37678148|NCT02482935|69153120|FG000|Period 1|Withdrawal by Subject|1|||
37678149|NCT02482935|69153121|FG001|Period 1|Withdrawal by Subject|0|||
37678150|NCT02513823|69153127|FG000|Overall Study|Lost to Follow-up|4|||
37678151|NCT02513823|69153127|FG000|Overall Study|Physician Decision|1|||
37678152|NCT02513745|69153133|FG000|Overall Study|Criteria at time of surgery not met.|3|||
37678153|NCT02513745|69153134|FG001|Overall Study|Criteria at time of surgery not met.|3|||
37678154|NCT02477553|69153142|FG000|Overall Study|Screening up-to-date|12|||
37678155|NCT02477553|69153143|FG001|Overall Study|Screening up-to-date|13|||
37678156|NCT02477553|69153142|FG000|Overall Study|No MD visit|1|||
37678157|NCT02477553|69153143|FG001|Overall Study|No MD visit|1|||
37678158|NCT02477553|69153142|FG000|Overall Study|Workup consistent w/CRC|1|||
37678159|NCT02477553|69153143|FG001|Overall Study|Workup consistent w/CRC|1|||
37678160|NCT02477553|69153142|FG000|Overall Study|Technical issues with intervention|2|||
37678161|NCT02477553|69153143|FG001|Overall Study|Technical issues with intervention|0|||
37678162|NCT02477553|69153142|FG000|Overall Study|Elevated risk for CRC|2|||
37678163|NCT02477553|69153143|FG001|Overall Study|Elevated risk for CRC|2|||
37678164|NCT02477553|69153142|FG000|Overall Study|MD advised against screening|1|||
37678165|NCT02477553|69153143|FG001|Overall Study|MD advised against screening|3|||
37678166|NCT02477553|69153142|FG000|Overall Study|patient deceased|1|||
37678167|NCT02477553|69153143|FG001|Overall Study|patient deceased|0|||
37678168|NCT01665911|69153149|FG000|Overall Study|Protocol Violation|4|||
37678169|NCT01665911|69153149|FG000|Overall Study|Withdrawal by Subject|1|||
37678170|NCT01665911|69153149|FG000|Overall Study|Adverse Event|1|||
37678171|NCT02452359|69153154|FG000|Overall Study|Adverse Event|1|||
37678172|NCT02452359|69153154|FG000|Overall Study|Lost to Follow-up|15|||
37678173|NCT02452359|69153154|FG000|Overall Study|Pregnancy|1|||
37678174|NCT02452359|69153154|FG000|Overall Study|Withdrawal by Subject|4|||
37678175|NCT02476617|69153158|FG000|Overall Study|Adverse Event|1|||
37678176|NCT02476617|69153158|FG000|Overall Study|Lost to Follow-up|1|||
37678177|NCT01665599|69153175|FG000|Overall Study|Adverse Event|1|||
37678178|NCT01665599|69153175|FG000|Overall Study|Consent Withdrawn|1|||
37678179|NCT01665599|69153175|FG000|Overall Study|Investigator/Sponsor decision|1|||
37678180|NCT01665599|69153175|FG000|Overall Study|Death|1|||
37678181|NCT01665599|69153175|FG000|Overall Study|Lost to Follow-up|2|||
37678182|NCT01665599|69153175|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
37678183|NCT01665599|69153175|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
37678184|NCT01671085|69153181|FG000|Overall Study|Withdrawal by Subject|1|||
37678185|NCT01671085|69153182|FG001|Overall Study|Withdrawal by Subject|0|||
37678186|NCT02510001|69153197|FG000|Overall Study|Early disease progression|0|||
37678187|NCT02510001|69153198|FG001|Overall Study|Early disease progression|0|||
37678188|NCT02510001|69153199|FG002|Overall Study|Early disease progression|0|||
37678189|NCT02510001|69153200|FG003|Overall Study|Early disease progression|1|||
37678190|NCT02510001|69153201|FG004|Overall Study|Early disease progression|1|||
37678191|NCT02510001|69153202|FG005|Overall Study|Early disease progression|1|||
37678192|NCT02510001|69153203|FG006|Overall Study|Early disease progression|0|||
37678193|NCT02510001|69153204|FG007|Overall Study|Early disease progression|0|||
37678194|NCT02510001|69153197|FG000|Overall Study|Adverse Event|0|||
37678195|NCT02510001|69153198|FG001|Overall Study|Adverse Event|0|||
37678196|NCT02510001|69153199|FG002|Overall Study|Adverse Event|0|||
37678197|NCT02510001|69153200|FG003|Overall Study|Adverse Event|1|||
37678198|NCT02510001|69153201|FG004|Overall Study|Adverse Event|2|||
37678199|NCT02510001|69153202|FG005|Overall Study|Adverse Event|1|||
37678200|NCT02510001|69153203|FG006|Overall Study|Adverse Event|2|||
37678201|NCT02510001|69153204|FG007|Overall Study|Adverse Event|5|||
37678202|NCT02510001|69153197|FG000|Overall Study|Physician Decision|0|||
37678203|NCT02510001|69153198|FG001|Overall Study|Physician Decision|0|||
37678204|NCT02510001|69153199|FG002|Overall Study|Physician Decision|0|||
37678205|NCT02510001|69153200|FG003|Overall Study|Physician Decision|0|||
37678206|NCT02510001|69153201|FG004|Overall Study|Physician Decision|1|||
37678207|NCT02510001|69153202|FG005|Overall Study|Physician Decision|0|||
37678208|NCT02510001|69153203|FG006|Overall Study|Physician Decision|0|||
37678209|NCT02510001|69153204|FG007|Overall Study|Physician Decision|0|||
37678210|NCT02510001|69153197|FG000|Overall Study|Withdrawal by Subject|0|||
37678211|NCT02510001|69153198|FG001|Overall Study|Withdrawal by Subject|0|||
37678212|NCT02510001|69153199|FG002|Overall Study|Withdrawal by Subject|0|||
37678213|NCT02510001|69153200|FG003|Overall Study|Withdrawal by Subject|0|||
37678214|NCT02510001|69153201|FG004|Overall Study|Withdrawal by Subject|0|||
37678215|NCT02510001|69153202|FG005|Overall Study|Withdrawal by Subject|0|||
37678216|NCT02510001|69153203|FG006|Overall Study|Withdrawal by Subject|0|||
37678217|NCT02510001|69153204|FG007|Overall Study|Withdrawal by Subject|2|||
37678218|NCT02452047|69153243|FG000|Overall Study|Adverse Event|0|||
37678219|NCT02452047|69153244|FG001|Overall Study|Adverse Event|1|||
37678220|NCT02452047|69153245|FG002|Overall Study|Adverse Event|1|||
37678221|NCT02452047|69153243|FG000|Overall Study|Death|1|||
37678222|NCT02452047|69153244|FG001|Overall Study|Death|3|||
37678223|NCT02452047|69153245|FG002|Overall Study|Death|1|||
37678224|NCT02452047|69153243|FG000|Overall Study|Physician Decision|1|||
37678225|NCT02452047|69153244|FG001|Overall Study|Physician Decision|0|||
37860861|NCT00950599|69544230|FG008|Follow-Up Period|Lack of Efficacy|3|||
37678226|NCT02452047|69153245|FG002|Overall Study|Physician Decision|0|||
37678227|NCT02452047|69153243|FG000|Overall Study|Lost to Follow-up|1|||
37860862|NCT00950599|69544231|FG009|Follow-Up Period|Lack of Efficacy|0|||
37678228|NCT02452047|69153244|FG001|Overall Study|Lost to Follow-up|1|||
37678229|NCT02452047|69153245|FG002|Overall Study|Lost to Follow-up|0|||
37678230|NCT02452047|69153243|FG000|Overall Study|Withdrawal by Subject|1|||
37678231|NCT02452047|69153244|FG001|Overall Study|Withdrawal by Subject|0|||
37678232|NCT02452047|69153245|FG002|Overall Study|Withdrawal by Subject|0|||
37678233|NCT02475369|69153253|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
37678234|NCT02475369|69153254|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
37678235|NCT02474589|69153267|FG000|Overall Study|Adverse Event|6|||
37678236|NCT02474589|69153268|FG001|Overall Study|Adverse Event|2|||
37678237|NCT02474589|69153267|FG000|Overall Study|Lost to Follow-up|6|||
37678238|NCT02474589|69153268|FG001|Overall Study|Lost to Follow-up|1|||
37678239|NCT02474589|69153267|FG000|Overall Study|Protocol Violation|4|||
37678240|NCT02474589|69153268|FG001|Overall Study|Protocol Violation|1|||
37678241|NCT02474589|69153267|FG000|Overall Study|Withdrawal by Subject|4|||
37678242|NCT02474589|69153268|FG001|Overall Study|Withdrawal by Subject|0|||
37678243|NCT02474589|69153267|FG000|Overall Study|Inability to complete study procedures|5|||
37678244|NCT02474589|69153268|FG001|Overall Study|Inability to complete study procedures|1|||
37678245|NCT02586233|69153281|FG000|Overall Study|Randomized but did not receive treatment|0|||
37678246|NCT02586233|69153282|FG001|Overall Study|Randomized but did not receive treatment|1|||
37678247|NCT02586233|69153283|FG002|Overall Study|Randomized but did not receive treatment|0|||
37678248|NCT02586233|69153284|FG003|Overall Study|Randomized but did not receive treatment|0|||
37678249|NCT02586233|69153285|FG004|Overall Study|Randomized but did not receive treatment|0|||
37678250|NCT02586233|69153286|FG005|Overall Study|Randomized but did not receive treatment|2|||
37678251|NCT02586233|69153287|FG006|Overall Study|Randomized but did not receive treatment|2|||
37678252|NCT02586233|69153281|FG000|Overall Study|Death|0|||
37678253|NCT02586233|69153282|FG001|Overall Study|Death|1|||
37678254|NCT02586233|69153283|FG002|Overall Study|Death|0|||
37678255|NCT02586233|69153284|FG003|Overall Study|Death|0|||
37678256|NCT02586233|69153285|FG004|Overall Study|Death|2|||
37678257|NCT02586233|69153286|FG005|Overall Study|Death|0|||
37678258|NCT02586233|69153287|FG006|Overall Study|Death|0|||
37678259|NCT02474355|69153307|FG000|Overall Study|Other|43|||
37678260|NCT02474355|69153307|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
37678261|NCT02474355|69153307|FG000|Overall Study|Lost to Follow-up|98|||
37678262|NCT02474355|69153307|FG000|Overall Study|Withdrawal by Subject|124|||
37678263|NCT02474355|69153307|FG000|Overall Study|Death|1361|||
37678264|NCT02474199|69153313|FG000|Overall Study|Lost to Follow-up|1|||
37678265|NCT02474199|69153314|FG001|Overall Study|Lost to Follow-up|0|||
37678266|NCT02474199|69153315|FG002|Overall Study|Lost to Follow-up|0|||
37678267|NCT02474199|69153316|FG003|Overall Study|Lost to Follow-up|0|||
37678268|NCT02474199|69153313|FG000|Overall Study|Withdrawal by Subject|1|||
37678269|NCT02474199|69153314|FG001|Overall Study|Withdrawal by Subject|2|||
37678270|NCT02474199|69153315|FG002|Overall Study|Withdrawal by Subject|0|||
37678271|NCT02474199|69153316|FG003|Overall Study|Withdrawal by Subject|1|||
37678272|NCT02474199|69153313|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
37678273|NCT02474199|69153314|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
37678274|NCT02474199|69153315|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
37678275|NCT02474199|69153316|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
37678276|NCT02474199|69153313|FG000|Overall Study|Did not meet eligibility criteria|0|||
37678277|NCT02474199|69153314|FG001|Overall Study|Did not meet eligibility criteria|0|||
37678278|NCT02474199|69153315|FG002|Overall Study|Did not meet eligibility criteria|2|||
37678279|NCT02474199|69153316|FG003|Overall Study|Did not meet eligibility criteria|2|||
37678280|NCT02450487|69153323|FG000|Overall Study|Lost to Follow-up|3|||
37678281|NCT02473965|69153330|FG000|Overall Study|Adverse Event|6|||
37678282|NCT02473965|69153331|FG001|Overall Study|Adverse Event|4|||
37678283|NCT02473965|69153330|FG000|Overall Study|MG worsening|4|||
37678284|NCT02473965|69153331|FG001|Overall Study|MG worsening|1|||
37678285|NCT02473965|69153330|FG000|Overall Study|Withdrawal by Subject|2|||
37678286|NCT02473965|69153331|FG001|Overall Study|Withdrawal by Subject|3|||
37678287|NCT02473965|69153330|FG000|Overall Study|Physician Decision|0|||
37678288|NCT02473965|69153331|FG001|Overall Study|Physician Decision|2|||
37678289|NCT02472795|69153342|FG000|Overall Study|Adverse Event|0|||
37678290|NCT02472795|69153343|FG001|Overall Study|Adverse Event|1|||
37678291|NCT02472795|69153344|FG002|Overall Study|Adverse Event|0|||
37678292|NCT02472795|69153345|FG003|Overall Study|Adverse Event|0|||
37678293|NCT02472795|69153346|FG004|Overall Study|Adverse Event|2|||
37678294|NCT02472795|69153342|FG000|Overall Study|Withdrawal by Subject|0|||
37678295|NCT02472795|69153343|FG001|Overall Study|Withdrawal by Subject|0|||
37678296|NCT02472795|69153344|FG002|Overall Study|Withdrawal by Subject|0|||
37678297|NCT02472795|69153345|FG003|Overall Study|Withdrawal by Subject|0|||
37678298|NCT02472795|69153346|FG004|Overall Study|Withdrawal by Subject|1|||
37678299|NCT02507349|69153360|FG000|Overall Study|Death|12|||
37678300|NCT02507349|69153361|FG001|Overall Study|Death|16|||
37678301|NCT02507349|69153360|FG000|Overall Study|Withdrawal by Subject|1|||
37678302|NCT02507349|69153361|FG001|Overall Study|Withdrawal by Subject|1|||
37678303|NCT02507349|69153360|FG000|Overall Study|Lost to Follow-up|174|||
37678304|NCT02507349|69153361|FG001|Overall Study|Lost to Follow-up|144|||
37678305|NCT02506881|69153371|FG000|First Intervention (Day 1)|Protocol Violation|0|||
37678306|NCT02506881|69153372|FG001|First Intervention (Day 1)|Protocol Violation|0|||
37678307|NCT02506881|69153373|FG002|First Intervention (Day 1)|Protocol Violation|1|||
37678308|NCT02506881|69153374|FG003|First Intervention (Day 1)|Protocol Violation|0|||
37678309|NCT02506881|69153371|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
37678310|NCT02506881|69153372|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
37678311|NCT02506881|69153373|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
37678312|NCT02506881|69153374|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
37678313|NCT02506881|69153371|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
37678314|NCT02506881|69153372|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
37678315|NCT02506881|69153373|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
37678316|NCT02506881|69153374|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
37678317|NCT02506257|69153398|FG000|Overall Study|Adverse Event|0|||
37678318|NCT02506257|69153399|FG001|Overall Study|Adverse Event|2|||
37678319|NCT02506257|69153400|FG002|Overall Study|Adverse Event|3|||
37678320|NCT02506257|69153401|FG003|Overall Study|Adverse Event|0|||
37678321|NCT02506257|69153398|FG000|Overall Study|Protocol Violation|0|||
37678322|NCT02506257|69153399|FG001|Overall Study|Protocol Violation|0|||
37678323|NCT02506257|69153400|FG002|Overall Study|Protocol Violation|1|||
37678324|NCT02506257|69153401|FG003|Overall Study|Protocol Violation|0|||
37678325|NCT02506101|69153413|FG000|Overall Study|Transportation issues|1|||
37678326|NCT02506101|69153414|FG001|Overall Study|Transportation issues|0|||
37678327|NCT02506101|69153413|FG000|Overall Study|No enrollment and staff unavailability|1|||
37678328|NCT02506101|69153414|FG001|Overall Study|No enrollment and staff unavailability|0|||
37678329|NCT01671007|69153429|FG000|Overall Study|Other reasons than listed|166|||
37678330|NCT01671007|69153430|FG001|Overall Study|Other reasons than listed|373|||
37678331|NCT01671007|69153431|FG002|Overall Study|Other reasons than listed|197|||
37678332|NCT01671007|69153432|FG003|Overall Study|Other reasons than listed|228|||
37678333|NCT01671007|69153433|FG004|Overall Study|Other reasons than listed|14|||
37678334|NCT01671007|69153434|FG005|Overall Study|Other reasons than listed|71|||
37678335|NCT01671007|69153435|FG006|Overall Study|Other reasons than listed|17|||
37678336|NCT01671007|69153436|FG007|Overall Study|Other reasons than listed|66|||
37678337|NCT01671007|69153437|FG008|Overall Study|Other reasons than listed|0|||
37678338|NCT01671007|69153429|FG000|Overall Study|Withdrawal by Subject|36|||
37678339|NCT01671007|69153430|FG001|Overall Study|Withdrawal by Subject|59|||
37678340|NCT01671007|69153431|FG002|Overall Study|Withdrawal by Subject|53|||
37678341|NCT01671007|69153432|FG003|Overall Study|Withdrawal by Subject|58|||
37678342|NCT01671007|69153433|FG004|Overall Study|Withdrawal by Subject|4|||
37678343|NCT01671007|69153434|FG005|Overall Study|Withdrawal by Subject|15|||
37678344|NCT01671007|69153435|FG006|Overall Study|Withdrawal by Subject|1|||
37678345|NCT01671007|69153436|FG007|Overall Study|Withdrawal by Subject|19|||
37678346|NCT01671007|69153437|FG008|Overall Study|Withdrawal by Subject|0|||
37678347|NCT01671007|69153429|FG000|Overall Study|Lost to Follow-up|93|||
37678348|NCT01671007|69153430|FG001|Overall Study|Lost to Follow-up|142|||
37678349|NCT01671007|69153431|FG002|Overall Study|Lost to Follow-up|91|||
37678350|NCT01671007|69153432|FG003|Overall Study|Lost to Follow-up|63|||
37678351|NCT01671007|69153433|FG004|Overall Study|Lost to Follow-up|7|||
37678352|NCT01671007|69153434|FG005|Overall Study|Lost to Follow-up|20|||
37678353|NCT01671007|69153435|FG006|Overall Study|Lost to Follow-up|2|||
37678354|NCT01671007|69153436|FG007|Overall Study|Lost to Follow-up|28|||
37678355|NCT01671007|69153437|FG008|Overall Study|Lost to Follow-up|0|||
37678356|NCT01671007|69153429|FG000|Overall Study|No end of study case report form|3|||
37678357|NCT01671007|69153430|FG001|Overall Study|No end of study case report form|1|||
37678358|NCT01671007|69153431|FG002|Overall Study|No end of study case report form|0|||
37678359|NCT01671007|69153432|FG003|Overall Study|No end of study case report form|2|||
37678360|NCT01671007|69153433|FG004|Overall Study|No end of study case report form|0|||
37678361|NCT01671007|69153434|FG005|Overall Study|No end of study case report form|0|||
37678362|NCT01671007|69153435|FG006|Overall Study|No end of study case report form|0|||
37678363|NCT01671007|69153436|FG007|Overall Study|No end of study case report form|0|||
37678364|NCT01671007|69153437|FG008|Overall Study|No end of study case report form|0|||
37678365|NCT01671007|69153429|FG000|Overall Study|Not eligible|23|||
37678366|NCT01671007|69153430|FG001|Overall Study|Not eligible|76|||
37678367|NCT01671007|69153431|FG002|Overall Study|Not eligible|25|||
37678368|NCT01671007|69153432|FG003|Overall Study|Not eligible|17|||
37678369|NCT01671007|69153433|FG004|Overall Study|Not eligible|0|||
37678370|NCT01671007|69153434|FG005|Overall Study|Not eligible|6|||
37678371|NCT01671007|69153435|FG006|Overall Study|Not eligible|1|||
37678372|NCT01671007|69153436|FG007|Overall Study|Not eligible|19|||
37678373|NCT01671007|69153437|FG008|Overall Study|Not eligible|0|||
37678374|NCT02505945|69153450|FG000|Overall Study|Withdrawal by Subject|13|||
37678375|NCT02505945|69153451|FG001|Overall Study|Withdrawal by Subject|2|||
37678376|NCT02505945|69153450|FG000|Overall Study|Adverse Event|1|||
37678377|NCT02505945|69153451|FG001|Overall Study|Adverse Event|0|||
37678378|NCT02505945|69153450|FG000|Overall Study|Physician Decision|2|||
37678379|NCT02505945|69153451|FG001|Overall Study|Physician Decision|1|||
37678380|NCT02505945|69153450|FG000|Overall Study|Lost to Follow-up|6|||
37678381|NCT02505945|69153451|FG001|Overall Study|Lost to Follow-up|1|||
37678382|NCT02505867|69153459|FG000|Overall Study|Lack of Efficacy|6|||
37678383|NCT02505867|69153460|FG001|Overall Study|Lack of Efficacy|6|||
37678384|NCT02472639|69153468|FG000|Overall Study|Physician Decision|4|||
37678385|NCT02472639|69153469|FG001|Overall Study|Physician Decision|3|||
37678386|NCT02472405|69153475|FG000|Overall Study|Lost to Follow-up|9|||
37678387|NCT02472405|69153475|FG000|Overall Study|Adverse Event|1|||
37678388|NCT02448771|69153481|FG000|Overall Study|Disease Progression|30|||
37678389|NCT02448771|69153481|FG000|Overall Study|Unacceptable Toxicity|1|||
37678390|NCT02448771|69153481|FG000|Overall Study|Physician Decision|3|||
37678391|NCT02448771|69153481|FG000|Overall Study|Started new therapy|2|||
37678392|NCT02504541|69153486|FG000|Overall Study|Adverse Event|4|||
37678393|NCT02504541|69153486|FG000|Overall Study|Withdrawal by Subject|4|||
37678394|NCT02504541|69153486|FG000|Overall Study|Lost to Follow-up|1|||
37678395|NCT02504541|69153486|FG000|Overall Study|Met Stopping Criteria|1|||
37678396|NCT02504541|69153486|FG000|Overall Study|Protocol Violation|2|||
37678397|NCT02504541|69153486|FG000|Overall Study|Termination by Sponsor|1|||
37678398|NCT02504541|69153486|FG000|Overall Study|Other|2|||
37678399|NCT02504541|69153486|FG000|Overall Study|Multiple|5|||
37678400|NCT02448537|69153493|FG000|Overall Study|Withdrawal by Subject|1|||
37678401|NCT02448537|69153494|FG001|Overall Study|Withdrawal by Subject|1|||
37678402|NCT02448537|69153495|FG002|Overall Study|Withdrawal by Subject|1|||
37678403|NCT02504151|69153505|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
37678404|NCT02504151|69153506|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
37678405|NCT02504151|69153505|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
37678406|NCT02504151|69153506|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
37678407|NCT02504151|69153505|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
37678408|NCT02504151|69153506|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
37678409|NCT02504151|69153505|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
37678410|NCT02504151|69153506|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
37678411|NCT02448381|69153514|FG000|Overall Study|Adverse Event|2|||
37678412|NCT02448381|69153515|FG001|Overall Study|Adverse Event|0|||
37678413|NCT02448381|69153514|FG000|Overall Study|Lost to Follow-up|16|||
37678414|NCT02448381|69153515|FG001|Overall Study|Lost to Follow-up|9|||
37678415|NCT02448381|69153514|FG000|Overall Study|Physician Decision|1|||
37678416|NCT02448381|69153515|FG001|Overall Study|Physician Decision|1|||
37678417|NCT02448381|69153514|FG000|Overall Study|Pregnancy|1|||
37678418|NCT02448381|69153515|FG001|Overall Study|Pregnancy|0|||
37678419|NCT02448381|69153514|FG000|Overall Study|Withdrawal by Subject|13|||
37678420|NCT02448381|69153515|FG001|Overall Study|Withdrawal by Subject|9|||
37678421|NCT02448381|69153514|FG000|Overall Study|Noncompliance with Study Procedures|2|||
37678422|NCT02448381|69153515|FG001|Overall Study|Noncompliance with Study Procedures|0|||
37678423|NCT02448225|69153527|FG000|Overall Study|Withdrawal by Subject|1|||
37678424|NCT02448225|69153527|FG000|Overall Study|Did not get FSPG scan|18|||
37678425|NCT02448225|69153527|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
37678426|NCT02503215|69153534|FG000|Overall Study|Unable to wear compression stockings|1|||
37678427|NCT02503215|69153534|FG000|Overall Study|Unable to use positive airway pressure|2|||
37678428|NCT02447991|69153540|FG000|Overall Study|Withdrawn by subject - no data|0|||
37678429|NCT02447991|69153541|FG001|Overall Study|Withdrawn by subject - no data|2|||
37678430|NCT02447991|69153540|FG000|Overall Study|Withdrawn by Subject - with data|4|||
37678431|NCT02447991|69153541|FG001|Overall Study|Withdrawn by Subject - with data|4|||
37678432|NCT02447991|69153540|FG000|Overall Study|Lost to Follow-up - no data|3|||
37678433|NCT02447991|69153541|FG001|Overall Study|Lost to Follow-up - no data|6|||
37678434|NCT02447991|69153540|FG000|Overall Study|Lost to follow-up - with data|0|||
37860863|NCT00950599|69544222|FG000|Follow-Up Period|Lost to Follow-up|0|||
37860864|NCT00950599|69544223|FG001|Follow-Up Period|Lost to Follow-up|0|||
37678435|NCT02447991|69153541|FG001|Overall Study|Lost to follow-up - with data|3|||
37678436|NCT02447991|69153540|FG000|Overall Study|End of study - no treatment results|3|||
37678437|NCT02447991|69153541|FG001|Overall Study|End of study - no treatment results|6|||
37678438|NCT02447991|69153540|FG000|Overall Study|End of study - partial treatment results|0|||
37678439|NCT02447991|69153541|FG001|Overall Study|End of study - partial treatment results|9|||
37678440|NCT02586155|69153553|FG000|Overall Study|Adverse Event|2|||
37678441|NCT02586155|69153554|FG001|Overall Study|Adverse Event|3|||
37678442|NCT02586155|69153553|FG000|Overall Study|Withdrawal by Subject|31|||
37678443|NCT02586155|69153554|FG001|Overall Study|Withdrawal by Subject|24|||
37678444|NCT02586155|69153553|FG000|Overall Study|Lost to Follow-up|7|||
37678445|NCT02586155|69153554|FG001|Overall Study|Lost to Follow-up|13|||
37678446|NCT02586155|69153553|FG000|Overall Study|Death|61|||
37678447|NCT02586155|69153554|FG001|Overall Study|Death|72|||
37678448|NCT02586155|69153553|FG000|Overall Study|Other reasons|26|||
37678449|NCT02586155|69153554|FG001|Overall Study|Other reasons|15|||
37678450|NCT02446743|69153562|FG000|Overall Study|Withdrawal by Subject|1|||
37678451|NCT02446743|69153563|FG001|Overall Study|Withdrawal by Subject|1|||
37678452|NCT02446743|69153562|FG000|Overall Study|Lost to Follow-up|1|||
37678453|NCT02446743|69153563|FG001|Overall Study|Lost to Follow-up|0|||
37678454|NCT02446743|69153562|FG000|Overall Study|Adverse Event|1|||
37678455|NCT02446743|69153563|FG001|Overall Study|Adverse Event|1|||
37678456|NCT02446743|69153562|FG000|Overall Study|Other|2|||
37678457|NCT02446743|69153563|FG001|Overall Study|Other|3|||
37678458|NCT02586077|69153578|FG000|Overall Study|Withdrawal by Subject|1|||
37678459|NCT02586077|69153578|FG000|Overall Study|Physician Decision|4|||
37678460|NCT02586077|69153578|FG000|Overall Study|Lost to Follow-up|3|||
37678461|NCT02583425|69153583|FG000|Screening|Did not meet entry criteria|12|||
37678462|NCT02583425|69153583|FG000|Baseline|Did not meet continued criteria|5|||
37678463|NCT02583425|69153583|FG000|Treatment Period|Adverse Event|1|||
37678464|NCT02581163|69153588|FG000|Overall Study|Failure to return|15|||
37678465|NCT02581163|69153588|FG000|Overall Study|Insufficient virological response|3|||
37678466|NCT02581163|69153588|FG000|Overall Study|Withdrew consent|1|||
37678467|NCT02581163|69153588|FG000|Overall Study|Death|1|||
37678468|NCT02581163|69153588|FG000|Overall Study|Other, not specified|9|||
37678469|NCT02627677|69153598|FG000|Overall Study|Adverse event (not progressive disease)|1|||
37678470|NCT02627677|69153599|FG001|Overall Study|Adverse event (not progressive disease)|4|||
37678471|NCT02627677|69153600|FG002|Overall Study|Adverse event (not progressive disease)|1|||
37678472|NCT02627677|69153598|FG000|Overall Study|Progressive disease|1|||
37678473|NCT02627677|69153599|FG001|Overall Study|Progressive disease|3|||
37678474|NCT02627677|69153600|FG002|Overall Study|Progressive disease|0|||
37678475|NCT02627677|69153598|FG000|Overall Study|Lack of Efficacy|1|||
37678476|NCT02627677|69153599|FG001|Overall Study|Lack of Efficacy|2|||
37678477|NCT02627677|69153600|FG002|Overall Study|Lack of Efficacy|0|||
37678478|NCT02627677|69153598|FG000|Overall Study|Lost to Follow-up|0|||
37678479|NCT02627677|69153599|FG001|Overall Study|Lost to Follow-up|0|||
37678480|NCT02627677|69153600|FG002|Overall Study|Lost to Follow-up|1|||
37678481|NCT02627677|69153598|FG000|Overall Study|Pregnancy|0|||
37678482|NCT02627677|69153599|FG001|Overall Study|Pregnancy|1|||
37678483|NCT02627677|69153600|FG002|Overall Study|Pregnancy|0|||
37678484|NCT02627677|69153598|FG000|Overall Study|Study Terminated by Sponsor|5|||
37678485|NCT02627677|69153599|FG001|Overall Study|Study Terminated by Sponsor|10|||
37678486|NCT02627677|69153600|FG002|Overall Study|Study Terminated by Sponsor|6|||
37678487|NCT02627677|69153598|FG000|Overall Study|Physician Decision|0|||
37678488|NCT02627677|69153599|FG001|Overall Study|Physician Decision|0|||
37678489|NCT02627677|69153600|FG002|Overall Study|Physician Decision|2|||
37678490|NCT02627677|69153598|FG000|Overall Study|Withdrawal by Subject|2|||
37678491|NCT02627677|69153599|FG001|Overall Study|Withdrawal by Subject|1|||
37678492|NCT02627677|69153600|FG002|Overall Study|Withdrawal by Subject|1|||
37678493|NCT02627677|69153598|FG000|Overall Study|Reason not Specified|0|||
37678494|NCT02627677|69153599|FG001|Overall Study|Reason not Specified|0|||
37678495|NCT02627677|69153600|FG002|Overall Study|Reason not Specified|1|||
37678496|NCT02627677|69153598|FG000|Overall Study|Randomized but not Treated|1|||
37678497|NCT02627677|69153599|FG001|Overall Study|Randomized but not Treated|0|||
37678498|NCT02627677|69153600|FG002|Overall Study|Randomized but not Treated|0|||
37678499|NCT02501811|69153613|FG000|Overall Study|Death|1|||
37678500|NCT02501811|69153614|FG001|Overall Study|Death|3|||
37678501|NCT02501811|69153615|FG002|Overall Study|Death|2|||
37678502|NCT02501811|69153616|FG003|Overall Study|Death|3|||
37678503|NCT02501811|69153613|FG000|Overall Study|Withdrawal by Subject|3|||
37678504|NCT02501811|69153614|FG001|Overall Study|Withdrawal by Subject|3|||
37678505|NCT02501811|69153615|FG002|Overall Study|Withdrawal by Subject|2|||
37678506|NCT02501811|69153616|FG003|Overall Study|Withdrawal by Subject|3|||
37678507|NCT02501811|69153613|FG000|Overall Study|Lost to Follow-up|0|||
37678508|NCT02501811|69153614|FG001|Overall Study|Lost to Follow-up|0|||
37678509|NCT02501811|69153615|FG002|Overall Study|Lost to Follow-up|2|||
37678510|NCT02501811|69153616|FG003|Overall Study|Lost to Follow-up|1|||
37678511|NCT02585999|69153626|FG000|Overall Study|Lost to Follow-up|1|||
37678512|NCT02585999|69153626|FG000|Overall Study|Protocol Violation|1|||
37678513|NCT02582255|69153633|FG000|Overall Study|Protocol Violation|0|||
37678514|NCT02582255|69153634|FG001|Overall Study|Protocol Violation|3|||
37678515|NCT02500719|69153643|FG000|Overall Study|Lost to Follow-up|2|||
37678516|NCT02500719|69153644|FG001|Overall Study|Lost to Follow-up|3|||
37678517|NCT02500719|69153643|FG000|Overall Study|Trauma history|1|||
37678518|NCT02500719|69153644|FG001|Overall Study|Trauma history|0|||
37678519|NCT02500719|69153643|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
37678520|NCT02500719|69153644|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
37678521|NCT02500719|69153643|FG000|Overall Study|Did not meet criteria for PTSD|0|||
37678522|NCT02500719|69153644|FG001|Overall Study|Did not meet criteria for PTSD|1|||
37678523|NCT02500719|69153643|FG000|Overall Study|Claustrophobia|0|||
37678524|NCT02500719|69153644|FG001|Overall Study|Claustrophobia|1|||
37678525|NCT02500719|69153643|FG000|Overall Study|History of head trauma|0|||
37678526|NCT02500719|69153644|FG001|Overall Study|History of head trauma|1|||
37678527|NCT02500641|69153652|FG000|Overall Study|Adverse Event|0|||
37678528|NCT02500641|69153653|FG001|Overall Study|Adverse Event|2|||
37678529|NCT02500641|69153652|FG000|Overall Study|Withdrawal by Subject|4|||
37769223|NCT01424501|69285702|FG005|Overall Study|Lost to Follow-up|0|||
37678530|NCT02500641|69153653|FG001|Overall Study|Withdrawal by Subject|5|||
37678531|NCT02500641|69153652|FG000|Overall Study|Unable to follow study procedures|3|||
37678532|NCT02500641|69153653|FG001|Overall Study|Unable to follow study procedures|2|||
37678533|NCT02500641|69153652|FG000|Overall Study|Protocol Violation|1|||
37678534|NCT02500641|69153653|FG001|Overall Study|Protocol Violation|2|||
37678535|NCT02500641|69153652|FG000|Overall Study|Lost to Follow-up|1|||
37678536|NCT02500641|69153653|FG001|Overall Study|Lost to Follow-up|0|||
37678537|NCT02500641|69153652|FG000|Overall Study|Sponsor decision|1|||
37678538|NCT02500641|69153653|FG001|Overall Study|Sponsor decision|0|||
37678539|NCT02500641|69153652|FG000|Overall Study|Non compliance to study drug|0|||
37678540|NCT02500641|69153653|FG001|Overall Study|Non compliance to study drug|1|||
37678541|NCT02499783|69153661|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
37678542|NCT02499783|69153662|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
37678543|NCT02499783|69153663|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
37678544|NCT02499783|69153661|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
37678545|NCT02499783|69153662|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
37678546|NCT02499783|69153663|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
37678547|NCT02499783|69153661|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
37678548|NCT02499783|69153662|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
37678549|NCT02499783|69153663|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
37678550|NCT02499783|69153661|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
37678551|NCT02499783|69153662|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
37678552|NCT02499783|69153663|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
37678553|NCT02499783|69153661|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
37678554|NCT02499783|69153662|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
37678555|NCT02499783|69153663|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
37678556|NCT02499783|69153661|FG000|DB Period: Weeks 0-8|Other|1|||
37678557|NCT02499783|69153662|FG001|DB Period: Weeks 0-8|Other|1|||
37678558|NCT02499783|69153663|FG002|DB Period: Weeks 0-8|Other|0|||
37678559|NCT02499783|69153661|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
37678560|NCT02499783|69153662|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
37678561|NCT02499783|69153663|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
37678562|NCT02499783|69153661|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
37678563|NCT02499783|69153662|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
37678564|NCT02499783|69153663|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
37678565|NCT02499783|69153661|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
37678566|NCT02499783|69153662|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
37678567|NCT02499783|69153663|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
37678568|NCT02499783|69153661|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
37678569|NCT02499783|69153662|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
37678570|NCT02499783|69153663|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
37678571|NCT02468193|69153673|FG000|Overall Study|Adverse Event|4|||
37678572|NCT02468193|69153673|FG000|Overall Study|Subject/ Guardian decision|2|||
37678573|NCT02466555|69153693|FG000|Overall Study|Lost to Follow-up|2|||
37678574|NCT02466399|69153700|FG000|Overall Study|Adverse Event|1|||
37678575|NCT02466399|69153701|FG001|Overall Study|Adverse Event|0|||
37678576|NCT02466399|69153700|FG000|Overall Study|Early exit due to family emergency|1|||
37678577|NCT02466399|69153701|FG001|Overall Study|Early exit due to family emergency|0|||
37678578|NCT02465931|69153709|FG000|Overall Study|Lost to Follow-up|9|||
37678579|NCT02465931|69153710|FG001|Overall Study|Lost to Follow-up|11|||
37678580|NCT02465931|69153709|FG000|Overall Study|Protocol Violation|1|||
37678581|NCT02465931|69153710|FG001|Overall Study|Protocol Violation|0|||
37678582|NCT02465931|69153709|FG000|Overall Study|Withdrawal by Subject|1|||
37678583|NCT02465931|69153710|FG001|Overall Study|Withdrawal by Subject|0|||
37678584|NCT02465463|69153718|FG000|Overall Study|Lost to Follow-up|2|||
37678585|NCT02465463|69153719|FG001|Overall Study|Lost to Follow-up|1|||
37678586|NCT02465463|69153718|FG000|Overall Study|Death|1|||
37678587|NCT02465463|69153719|FG001|Overall Study|Death|0|||
37678588|NCT02465463|69153718|FG000|Overall Study|Protocol Violation|1|||
37678589|NCT02465463|69153719|FG001|Overall Study|Protocol Violation|0|||
37678590|NCT02464059|69153726|FG000|Overall Study|Lost to Follow-up|6|||
37678591|NCT02463357|69153735|FG000|Overall Study|Withdrawal by Subject|1|||
37678592|NCT02463357|69153736|FG001|Overall Study|Withdrawal by Subject|0|||
37678593|NCT02463357|69153737|FG002|Overall Study|Withdrawal by Subject|0|||
37678594|NCT02463357|69153738|FG003|Overall Study|Withdrawal by Subject|0|||
37678595|NCT02463357|69153739|FG004|Overall Study|Withdrawal by Subject|0|||
37678596|NCT02463357|69153735|FG000|Overall Study|Withdrawal by Subject|0|||
37678597|NCT02463357|69153736|FG001|Overall Study|Withdrawal by Subject|0|||
37678598|NCT02463357|69153737|FG002|Overall Study|Withdrawal by Subject|0|||
37678599|NCT02463357|69153738|FG003|Overall Study|Withdrawal by Subject|0|||
37678600|NCT02463357|69153739|FG004|Overall Study|Withdrawal by Subject|1|||
37678601|NCT02579759|69153754|FG000|Overall Study|Protocol Violation|2|||
37678602|NCT02579759|69153755|FG001|Overall Study|Protocol Violation|0|||
37678603|NCT02579759|69153756|FG002|Overall Study|Protocol Violation|0|||
37678604|NCT02579759|69153754|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
37678605|NCT02579759|69153755|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
37678606|NCT02579759|69153756|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
37678607|NCT02579759|69153754|FG000|Overall Study|BfArM hold|13|||
37678608|NCT02579759|69153755|FG001|Overall Study|BfArM hold|12|||
37678609|NCT02579759|69153756|FG002|Overall Study|BfArM hold|12|||
37678610|NCT02579759|69153754|FG000|Overall Study|Sponsor stopped Dose 2|0|||
37678611|NCT02579759|69153755|FG001|Overall Study|Sponsor stopped Dose 2|41|||
37678612|NCT02579759|69153756|FG002|Overall Study|Sponsor stopped Dose 2|0|||
37678613|NCT02579759|69153754|FG000|Overall Study|Non compliance|0|||
37678614|NCT02579759|69153755|FG001|Overall Study|Non compliance|1|||
37678615|NCT02579759|69153756|FG002|Overall Study|Non compliance|0|||
37678616|NCT02579759|69153754|FG000|Overall Study|Pregnancy|0|||
37678617|NCT02579759|69153755|FG001|Overall Study|Pregnancy|1|||
37678618|NCT02579759|69153756|FG002|Overall Study|Pregnancy|0|||
37678619|NCT02579759|69153754|FG000|Overall Study|Inclusion/exclusion criteria|0|||
37678620|NCT02579759|69153755|FG001|Overall Study|Inclusion/exclusion criteria|0|||
37678621|NCT02579759|69153756|FG002|Overall Study|Inclusion/exclusion criteria|1|||
37678622|NCT02579759|69153754|FG000|Overall Study|Adverse Event|4|||
37678623|NCT02579759|69153755|FG001|Overall Study|Adverse Event|3|||
37678624|NCT02579759|69153756|FG002|Overall Study|Adverse Event|1|||
37678625|NCT02579759|69153754|FG000|Overall Study|Withdrawal by Subject|3|||
37678626|NCT02579759|69153755|FG001|Overall Study|Withdrawal by Subject|3|||
37678627|NCT02579759|69153756|FG002|Overall Study|Withdrawal by Subject|5|||
37678628|NCT02579759|69153754|FG000|Overall Study|Lost to Follow-up|2|||
37678629|NCT02579759|69153755|FG001|Overall Study|Lost to Follow-up|2|||
37678630|NCT02579759|69153756|FG002|Overall Study|Lost to Follow-up|2|||
37678631|NCT02445963|69153770|FG000|Overall Study|Lost to Follow-up|1|||
37678632|NCT02445963|69153771|FG001|Overall Study|Lost to Follow-up|0|||
37678633|NCT02445963|69153772|FG002|Overall Study|Lost to Follow-up|0|||
37678634|NCT02445963|69153773|FG003|Overall Study|Lost to Follow-up|0|||
37678635|NCT02445963|69153770|FG000|Overall Study|Change in employment|1|||
37678636|NCT02445963|69153771|FG001|Overall Study|Change in employment|0|||
37678637|NCT02445963|69153772|FG002|Overall Study|Change in employment|0|||
37678638|NCT02445963|69153773|FG003|Overall Study|Change in employment|0|||
37678639|NCT02445963|69153770|FG000|Overall Study|Symptoms post-vaccination|0|||
37678640|NCT02445963|69153771|FG001|Overall Study|Symptoms post-vaccination|0|||
37678641|NCT02445963|69153772|FG002|Overall Study|Symptoms post-vaccination|1|||
37678642|NCT02445963|69153773|FG003|Overall Study|Symptoms post-vaccination|0|||
37678643|NCT02499159|69153787|FG000|Randomization|Protocol Violation|1|||
37678644|NCT02499159|69153788|FG001|Randomization|Protocol Violation|1|||
37678645|NCT02499159|69153787|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
37678646|NCT02499159|69153788|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
37678647|NCT02499159|69153787|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
37678648|NCT02499159|69153788|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
37678649|NCT02499159|69153787|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
37678650|NCT02499159|69153788|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
37678651|NCT02499159|69153787|FG000|30-Day Follow-Up Phone Call|Other|1|||
37678652|NCT02499159|69153788|FG001|30-Day Follow-Up Phone Call|Other|0|||
37678653|NCT01664039|69153796|FG000|Overall Study|Adverse Event|3|||
37678654|NCT01664039|69153797|FG001|Overall Study|Adverse Event|4|||
37678655|NCT01664039|69153796|FG000|Overall Study|Lost to Follow-up|1|||
37678656|NCT01664039|69153797|FG001|Overall Study|Lost to Follow-up|1|||
37678657|NCT01664039|69153796|FG000|Overall Study|Withdrawal by Subject|1|||
37678658|NCT01664039|69153797|FG001|Overall Study|Withdrawal by Subject|3|||
37678659|NCT01664039|69153796|FG000|Overall Study|Noncompliance|1|||
37678660|NCT01664039|69153797|FG001|Overall Study|Noncompliance|1|||
37678661|NCT02445573|69153805|FG000|Overall Study|Withdrawal by Subject|1|||
37678662|NCT02445573|69153806|FG001|Overall Study|Withdrawal by Subject|1|||
37678663|NCT02445573|69153805|FG000|Overall Study|Lost to Follow-up|0|||
37678664|NCT02445573|69153806|FG001|Overall Study|Lost to Follow-up|1|||
37678665|NCT02445339|69153814|FG000|Overall Study|Physician Decision|1|||
37678666|NCT02445339|69153815|FG001|Overall Study|Physician Decision|0|||
37678667|NCT02445339|69153814|FG000|Overall Study|Lost to Follow-up|11|||
37678668|NCT02445339|69153815|FG001|Overall Study|Lost to Follow-up|15|||
37678669|NCT02579603|69153823|FG000|Overall Study|Not treated|1|||
37678670|NCT02579603|69153824|FG001|Overall Study|Not treated|0|||
37678671|NCT02579603|69153823|FG000|Overall Study|Adverse Event|2|||
37678672|NCT02579603|69153824|FG001|Overall Study|Adverse Event|2|||
37678673|NCT02579603|69153823|FG000|Overall Study|Other than stated|1|||
37678674|NCT02579603|69153824|FG001|Overall Study|Other than stated|0|||
37678675|NCT02625259|69153836|FG000|First Intervention (Day 1)|Other|0|||
37678676|NCT02625259|69153837|FG001|First Intervention (Day 1)|Other|0|||
37678677|NCT02625259|69153838|FG002|First Intervention (Day 1)|Other|1|||
37678678|NCT02625259|69153839|FG003|First Intervention (Day 1)|Other|0|||
37678679|NCT02625259|69153840|FG004|First Intervention (Day 1)|Other|0|||
37678680|NCT02625259|69153836|FG000|First Intervention (Day 1)|Adverse Event|2|||
37678681|NCT02625259|69153837|FG001|First Intervention (Day 1)|Adverse Event|1|||
37678682|NCT02625259|69153838|FG002|First Intervention (Day 1)|Adverse Event|0|||
37678683|NCT02625259|69153839|FG003|First Intervention (Day 1)|Adverse Event|0|||
37678684|NCT02625259|69153840|FG004|First Intervention (Day 1)|Adverse Event|0|||
37678685|NCT02625259|69153836|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
37678686|NCT02625259|69153837|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
37678687|NCT02625259|69153838|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
37769224|NCT01401959|69285783|FG000|Enrolled|Withdrawal by Subject|1|||
37678688|NCT02625259|69153839|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
37678689|NCT02625259|69153840|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
37678690|NCT02577107|69153857|FG000|Overall Study|Protocol deviation|0|||
37678691|NCT02577107|69153858|FG001|Overall Study|Protocol deviation|1|||
37678692|NCT02444793|69153868|FG000|Overall Study|Lost to Follow-up|2|||
37678693|NCT02444793|69153869|FG001|Overall Study|Lost to Follow-up|2|||
37678694|NCT02444793|69153870|FG002|Overall Study|Lost to Follow-up|0|||
37678695|NCT02444793|69153871|FG003|Overall Study|Lost to Follow-up|0|||
37678696|NCT02444793|69153868|FG000|Overall Study|Death|0|||
37678697|NCT02444793|69153869|FG001|Overall Study|Death|3|||
37678698|NCT02444793|69153870|FG002|Overall Study|Death|0|||
37678699|NCT02444793|69153871|FG003|Overall Study|Death|0|||
37678700|NCT02444793|69153868|FG000|Overall Study|Other|0|||
37678701|NCT02444793|69153869|FG001|Overall Study|Other|0|||
37678702|NCT02444793|69153870|FG002|Overall Study|Other|2|||
37678703|NCT02444793|69153871|FG003|Overall Study|Other|0|||
37678704|NCT02444793|69153868|FG000|Overall Study|Objective progression or relapse|9|||
37678705|NCT02444793|69153869|FG001|Overall Study|Objective progression or relapse|1|||
37678706|NCT02444793|69153870|FG002|Overall Study|Objective progression or relapse|2|||
37678707|NCT02444793|69153871|FG003|Overall Study|Objective progression or relapse|3|||
37678708|NCT02624713|69153884|FG000|Overall Study|Lost to Follow-up|14|||
37678709|NCT02624713|69153885|FG001|Overall Study|Lost to Follow-up|0|||
37678710|NCT02624791|69153892|FG000|Overall Study|Withdrawal by Subject|2|||
37678711|NCT02624791|69153893|FG001|Overall Study|Withdrawal by Subject|0|||
37678712|NCT02624791|69153894|FG002|Overall Study|Withdrawal by Subject|0|||
37678713|NCT02624791|69153895|FG003|Overall Study|Withdrawal by Subject|0|||
37678714|NCT02624791|69153896|FG004|Overall Study|Withdrawal by Subject|0|||
37678715|NCT02624791|69153897|FG005|Overall Study|Withdrawal by Subject|0|||
37678716|NCT02577029|69153909|FG000|Overall Study|Adverse Event|1|||
37678717|NCT02577029|69153910|FG001|Overall Study|Adverse Event|0|||
37678718|NCT02577029|69153911|FG002|Overall Study|Adverse Event|2|||
37678719|NCT02577029|69153912|FG003|Overall Study|Adverse Event|0|||
37678720|NCT02577029|69153913|FG004|Overall Study|Adverse Event|1|||
37678721|NCT02577029|69153914|FG005|Overall Study|Adverse Event|0|||
37678722|NCT02577029|69153915|FG006|Overall Study|Adverse Event|0|||
37678723|NCT02577029|69153916|FG007|Overall Study|Adverse Event|0|||
37678724|NCT02577029|69153909|FG000|Overall Study|Withdrawal by Subject|0|||
37678725|NCT02577029|69153910|FG001|Overall Study|Withdrawal by Subject|0|||
37678726|NCT02577029|69153911|FG002|Overall Study|Withdrawal by Subject|0|||
37678727|NCT02577029|69153912|FG003|Overall Study|Withdrawal by Subject|0|||
37678728|NCT02577029|69153913|FG004|Overall Study|Withdrawal by Subject|0|||
37678729|NCT02577029|69153914|FG005|Overall Study|Withdrawal by Subject|1|||
37678730|NCT02577029|69153915|FG006|Overall Study|Withdrawal by Subject|0|||
37678731|NCT02577029|69153916|FG007|Overall Study|Withdrawal by Subject|0|||
37678732|NCT02577029|69153909|FG000|Overall Study|Sponsor Termination of the Study|9|||
37678733|NCT02577029|69153910|FG001|Overall Study|Sponsor Termination of the Study|2|||
37678734|NCT02577029|69153911|FG002|Overall Study|Sponsor Termination of the Study|5|||
37678735|NCT02577029|69153912|FG003|Overall Study|Sponsor Termination of the Study|12|||
37678736|NCT02577029|69153913|FG004|Overall Study|Sponsor Termination of the Study|10|||
37678737|NCT02577029|69153914|FG005|Overall Study|Sponsor Termination of the Study|12|||
37678738|NCT02577029|69153915|FG006|Overall Study|Sponsor Termination of the Study|12|||
37678739|NCT02577029|69153916|FG007|Overall Study|Sponsor Termination of the Study|12|||
37678740|NCT02577887|69153934|FG000|Overall Study|Death|93|||
37678741|NCT02577887|69153934|FG000|Overall Study|Protocol Violation|125|||
37678742|NCT02577887|69153934|FG000|Overall Study|Withdrawal by Subject|80|||
37678743|NCT03597347|69153941|FG000|Overall Study|Withdrawal by Subject|1|||
37678744|NCT03597347|69153942|FG001|Overall Study|Withdrawal by Subject|1|||
37678745|NCT03597347|69153943|FG002|Overall Study|Withdrawal by Subject|0|||
37678746|NCT03597347|69153941|FG000|Overall Study|Withdrawal due to Covid-19|3|||
37678747|NCT03597347|69153942|FG001|Overall Study|Withdrawal due to Covid-19|0|||
37678748|NCT03597347|69153943|FG002|Overall Study|Withdrawal due to Covid-19|0|||
37678749|NCT03597347|69153941|FG000|Overall Study|Sponsor decision to terminate study|3|||
37678750|NCT03597347|69153942|FG001|Overall Study|Sponsor decision to terminate study|2|||
37678751|NCT03597347|69153943|FG002|Overall Study|Sponsor decision to terminate study|4|||
37678752|NCT02576951|69153955|FG000|Overall Study|Lost to Follow-up|0|||
37678753|NCT02576951|69153956|FG001|Overall Study|Lost to Follow-up|0|||
37769225|NCT01401959|69285784|FG001|Enrolled|Withdrawal by Subject|0|||
37678754|NCT02576951|69153957|FG002|Overall Study|Lost to Follow-up|2|||
37678755|NCT02576951|69153958|FG003|Overall Study|Lost to Follow-up|2|||
37678756|NCT02576951|69153955|FG000|Overall Study|Withdrawal by Subject|1|||
37678757|NCT02576951|69153956|FG001|Overall Study|Withdrawal by Subject|0|||
37678758|NCT02576951|69153957|FG002|Overall Study|Withdrawal by Subject|0|||
37678759|NCT02576951|69153958|FG003|Overall Study|Withdrawal by Subject|2|||
37678760|NCT02576951|69153955|FG000|Overall Study|Protocol Violation|0|||
37678761|NCT02576951|69153956|FG001|Overall Study|Protocol Violation|0|||
37678762|NCT02576951|69153957|FG002|Overall Study|Protocol Violation|0|||
37678763|NCT02576951|69153958|FG003|Overall Study|Protocol Violation|1|||
37678764|NCT02621047|69153973|FG000|Overall Study|Adverse Event|0|||
37678765|NCT02621047|69153974|FG001|Overall Study|Adverse Event|0|||
37678766|NCT02621047|69153975|FG002|Overall Study|Adverse Event|1|||
37678767|NCT02443155|69153988|FG000|Overall Study|Adverse Event|3|||
37678768|NCT02443155|69153989|FG001|Overall Study|Adverse Event|4|||
37678769|NCT02443155|69153990|FG002|Overall Study|Adverse Event|1|||
37678770|NCT02443155|69153991|FG003|Overall Study|Adverse Event|2|||
37678771|NCT02443155|69153988|FG000|Overall Study|Unclassified|0|||
37678772|NCT02443155|69153989|FG001|Overall Study|Unclassified|0|||
37678773|NCT02443155|69153990|FG002|Overall Study|Unclassified|2|||
37678774|NCT02443155|69153991|FG003|Overall Study|Unclassified|1|||
37678775|NCT02443155|69153988|FG000|Overall Study|Withdrawal by Subject|4|||
37678776|NCT02443155|69153989|FG001|Overall Study|Withdrawal by Subject|7|||
37678777|NCT02443155|69153990|FG002|Overall Study|Withdrawal by Subject|3|||
37678778|NCT02443155|69153991|FG003|Overall Study|Withdrawal by Subject|9|||
37678779|NCT02443155|69153988|FG000|Overall Study|Pregnancy|3|||
37678780|NCT02443155|69153989|FG001|Overall Study|Pregnancy|1|||
37678781|NCT02443155|69153990|FG002|Overall Study|Pregnancy|1|||
37678782|NCT02443155|69153991|FG003|Overall Study|Pregnancy|2|||
37678783|NCT02443155|69153988|FG000|Overall Study|Lost to Follow-up|1|||
37678784|NCT02443155|69153989|FG001|Overall Study|Lost to Follow-up|2|||
37678785|NCT02443155|69153990|FG002|Overall Study|Lost to Follow-up|0|||
37678786|NCT02443155|69153991|FG003|Overall Study|Lost to Follow-up|1|||
37678787|NCT02443155|69153988|FG000|Overall Study|Protocol Violation|1|||
37678788|NCT02443155|69153989|FG001|Overall Study|Protocol Violation|0|||
37678789|NCT02443155|69153990|FG002|Overall Study|Protocol Violation|1|||
37678790|NCT02443155|69153991|FG003|Overall Study|Protocol Violation|1|||
37678791|NCT02443155|69153988|FG000|Overall Study|Death|0|||
37678792|NCT02443155|69153989|FG001|Overall Study|Death|0|||
37678793|NCT02443155|69153990|FG002|Overall Study|Death|1|||
37678794|NCT02443155|69153991|FG003|Overall Study|Death|0|||
37678795|NCT02460159|69154004|FG000|Overall Study|Adverse Event|4|||
37678796|NCT02460159|69154005|FG001|Overall Study|Adverse Event|1|||
37678797|NCT02460159|69154004|FG000|Overall Study|Withdrawal by Subject|2|||
37678798|NCT02460159|69154005|FG001|Overall Study|Withdrawal by Subject|0|||
37678799|NCT02498067|69154011|FG000|Overall Study|Lost to Follow-up|22|||
37678800|NCT02498067|69154011|FG000|Overall Study|Did not meet inclusion criteria|11|||
37678801|NCT02497755|69154019|FG000|Overall Study|Protocol Violation|1|||
37678802|NCT02497755|69154020|FG001|Overall Study|Protocol Violation|0|||
37678803|NCT02619175|69154029|FG000|Overall Study|Withdrawal by Subject|1|||
37678804|NCT02619175|69154030|FG001|Overall Study|Withdrawal by Subject|0|||
37678805|NCT02619175|69154029|FG000|Overall Study|foot pain|1|||
37678806|NCT02619175|69154030|FG001|Overall Study|foot pain|0|||
37678807|NCT01360021|69154047|FG000|Overall Study|Eligibility criteria + other|2|||
37678808|NCT01360021|69154048|FG001|Overall Study|Eligibility criteria + other|1|||
37678809|NCT01360021|69154049|FG002|Overall Study|Eligibility criteria + other|1|||
37678810|NCT01360021|69154047|FG000|Overall Study|Protocol Violation|0|||
37678811|NCT01360021|69154048|FG001|Overall Study|Protocol Violation|0|||
37678812|NCT01360021|69154049|FG002|Overall Study|Protocol Violation|1|||
37678813|NCT01360021|69154047|FG000|Overall Study|Withdrawal by Subject|4|||
37678814|NCT01360021|69154048|FG001|Overall Study|Withdrawal by Subject|0|||
37678815|NCT01360021|69154049|FG002|Overall Study|Withdrawal by Subject|2|||
37678816|NCT01360021|69154047|FG000|Overall Study|Adverse Event|2|||
37678817|NCT01360021|69154048|FG001|Overall Study|Adverse Event|3|||
37678818|NCT01360021|69154049|FG002|Overall Study|Adverse Event|3|||
37678819|NCT02497287|69154066|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
37678820|NCT02497287|69154066|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
37678821|NCT02497287|69154066|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
37678822|NCT02497287|69154066|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
37678823|NCT02497287|69154066|FG000|Induction Phase (4 Weeks)|Other|13|||
37678824|NCT02497287|69154066|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
37678825|NCT02497287|69154066|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
37678826|NCT02497287|69154066|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
37678827|NCT02497287|69154066|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
37678828|NCT02497287|69154066|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
37678829|NCT02497287|69154066|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
37678830|NCT02497287|69154066|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
37678831|NCT02497287|69154066|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
37860865|NCT00950599|69544224|FG002|Follow-Up Period|Lost to Follow-up|0|||
37678832|NCT02497287|69154066|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
37678833|NCT02497287|69154066|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
37678834|NCT02497287|69154066|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
37678835|NCT02497287|69154066|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
37678836|NCT02497287|69154066|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
37678837|NCT02497287|69154066|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
37678838|NCT02497287|69154066|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
37678839|NCT02497287|69154066|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
37678840|NCT02497287|69154066|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
37678841|NCT02497287|69154066|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
37678842|NCT02497287|69154066|FG000|Follow-up Phase (4 Week)|Other|1|||
37678843|NCT02458287|69154076|FG000|Overall Study|Adverse Event|0|||
37678844|NCT02458287|69154077|FG001|Overall Study|Adverse Event|0|||
37678845|NCT02458287|69154078|FG002|Overall Study|Adverse Event|0|||
37678846|NCT02458287|69154079|FG003|Overall Study|Adverse Event|1|||
37678847|NCT02458287|69154076|FG000|Overall Study|Lost to Follow-up|0|||
37678848|NCT02458287|69154077|FG001|Overall Study|Lost to Follow-up|1|||
37678849|NCT02458287|69154078|FG002|Overall Study|Lost to Follow-up|1|||
37678850|NCT02458287|69154079|FG003|Overall Study|Lost to Follow-up|0|||
37678851|NCT02458287|69154076|FG000|Overall Study|Protocol Violation|0|||
37678852|NCT02458287|69154077|FG001|Overall Study|Protocol Violation|1|||
37678853|NCT02458287|69154078|FG002|Overall Study|Protocol Violation|0|||
37678854|NCT02458287|69154079|FG003|Overall Study|Protocol Violation|0|||
37678855|NCT02458287|69154076|FG000|Overall Study|Withdrawal by Subject|0|||
37678856|NCT02458287|69154077|FG001|Overall Study|Withdrawal by Subject|2|||
37678857|NCT02458287|69154078|FG002|Overall Study|Withdrawal by Subject|2|||
37678858|NCT02458287|69154079|FG003|Overall Study|Withdrawal by Subject|1|||
37678859|NCT02458287|69154076|FG000|Overall Study|Relocated Out of State|0|||
37678860|NCT02458287|69154077|FG001|Overall Study|Relocated Out of State|0|||
37678861|NCT02458287|69154078|FG002|Overall Study|Relocated Out of State|0|||
37678862|NCT02458287|69154079|FG003|Overall Study|Relocated Out of State|1|||
37678863|NCT02441517|69154095|FG000|Overall Study|Lost to Follow-up|1|||
37678864|NCT02441517|69154095|FG000|Overall Study|Withdrawal by Subject|2|||
37678865|NCT02441517|69154095|FG000|Overall Study|Study Terminated by Sponsor|1|||
37678866|NCT02457819|69154099|FG000|Overall Study|reason not given|8|||
37678867|NCT02457819|69154099|FG000|Overall Study|Withdrawal by Subject|24|||
37678868|NCT02457819|69154099|FG000|Overall Study|Protocol Violation|1|||
37678869|NCT02457819|69154099|FG000|Overall Study|non compliance with study drug|4|||
37678870|NCT02457819|69154099|FG000|Overall Study|Lost to Follow-up|10|||
37678871|NCT02457819|69154099|FG000|Overall Study|Lack of Efficacy|19|||
37678872|NCT02457819|69154099|FG000|Overall Study|Adverse Event|33|||
37678873|NCT02496039|69154103|FG000|Overall Study|Adverse Event|3|||
37678874|NCT02496039|69154103|FG000|Overall Study|Protocol Violation|1|||
37678875|NCT02441283|69154107|FG000|Overall Study|Withdrew consent|15|||
37678876|NCT02441283|69154107|FG000|Overall Study|Lost to Follow-up|42|||
37678877|NCT02441283|69154107|FG000|Overall Study|Death|1|||
37678878|NCT02441283|69154107|FG000|Overall Study|Other, not specified|32|||
37678879|NCT02495883|69154113|FG000|Overall Study|Excessive head motion|1|||
37678880|NCT02495883|69154114|FG001|Overall Study|Excessive head motion|0|||
37678881|NCT02495025|69154121|FG000|Overall Study|Lost to Follow-up|21|||
37678882|NCT02495025|69154122|FG001|Overall Study|Lost to Follow-up|14|||
37678883|NCT02495025|69154121|FG000|Overall Study|Withdrawal by Subject|5|||
37678884|NCT02495025|69154122|FG001|Overall Study|Withdrawal by Subject|0|||
37678885|NCT02439957|69154130|FG000|Overall Study|Study Terminated|3|||
37678886|NCT02439957|69154131|FG001|Overall Study|Study Terminated|3|||
37678887|NCT02494401|69154139|FG000|Overall Study|Lost to Follow-up|22|||
37678888|NCT02494401|69154140|FG001|Overall Study|Lost to Follow-up|25|||
37678889|NCT02494401|69154139|FG000|Overall Study|Withdrawal by Subject|3|||
37678890|NCT02494401|69154140|FG001|Overall Study|Withdrawal by Subject|2|||
37678891|NCT02457195|69154146|FG000|Overall Study|Adverse Event|3|||
37678892|NCT02457195|69154146|FG000|Overall Study|Protocol Violation|2|||
37678893|NCT02457195|69154146|FG000|Overall Study|Withdrawal by Subject|4|||
37678894|NCT02456727|69154152|FG000|Overall Study|Lost to Follow-up|63|||
37678895|NCT02456727|69154153|FG001|Overall Study|Lost to Follow-up|65|||
37678896|NCT02456727|69154152|FG000|Overall Study|Death|2|||
37678897|NCT02456727|69154153|FG001|Overall Study|Death|1|||
37678898|NCT02456727|69154152|FG000|Overall Study|Withdrawal by Subject|1|||
37678899|NCT02456727|69154153|FG001|Overall Study|Withdrawal by Subject|10|||
37678900|NCT02456727|69154152|FG000|Overall Study|Never Initiated Treatment|43|||
37678901|NCT02456727|69154153|FG001|Overall Study|Never Initiated Treatment|30|||
37678902|NCT02456103|69154175|FG000|Overall Study|Study Closure|207|||
37678903|NCT02456103|69154175|FG000|Overall Study|Physician Decision|1|||
37678904|NCT02456103|69154175|FG000|Overall Study|Required prohibited medications|5|||
37678905|NCT02456103|69154175|FG000|Overall Study|Protocol Violation|1|||
37678906|NCT02456103|69154175|FG000|Overall Study|Adverse Event|5|||
37678907|NCT02456103|69154175|FG000|Overall Study|Abnormal Laboratory Value|2|||
37678908|NCT02456103|69154175|FG000|Overall Study|Lost to Follow-up|1|||
37678909|NCT02456103|69154175|FG000|Overall Study|Withdrawal by Subject|24|||
37678910|NCT01653327|69154179|FG000|Overall Study|Withdrawal by Subject|1|||
37678911|NCT02493855|69154188|FG000|Overall Study|Non-compliance|1|||
37678912|NCT02493855|69154189|FG001|Overall Study|Non-compliance|0|||
37678913|NCT02493855|69154190|FG002|Overall Study|Non-compliance|0|||
37678914|NCT02493855|69154188|FG000|Overall Study|Adverse Event|0|||
37678915|NCT02493855|69154189|FG001|Overall Study|Adverse Event|1|||
37678916|NCT02493855|69154190|FG002|Overall Study|Adverse Event|0|||
37678917|NCT02493855|69154188|FG000|Overall Study|Withdrawal by Subject|1|||
37678918|NCT02493855|69154189|FG001|Overall Study|Withdrawal by Subject|0|||
37678919|NCT02493855|69154190|FG002|Overall Study|Withdrawal by Subject|0|||
37678920|NCT02438787|69154201|FG000|Overall Study|Adverse Event|1|||
37678921|NCT02438787|69154202|FG001|Overall Study|Adverse Event|0|||
37678922|NCT02438787|69154203|FG002|Overall Study|Adverse Event|2|||
37678923|NCT02438787|69154201|FG000|Overall Study|Lack of Efficacy|1|||
37678924|NCT02438787|69154202|FG001|Overall Study|Lack of Efficacy|2|||
37678925|NCT02438787|69154203|FG002|Overall Study|Lack of Efficacy|0|||
37678926|NCT02438787|69154201|FG000|Overall Study|Lost to Follow-up|0|||
37678927|NCT02438787|69154202|FG001|Overall Study|Lost to Follow-up|1|||
37678928|NCT02438787|69154203|FG002|Overall Study|Lost to Follow-up|0|||
37678929|NCT02438787|69154201|FG000|Overall Study|Protocol Violation|0|||
37678930|NCT02438787|69154202|FG001|Overall Study|Protocol Violation|0|||
37678931|NCT02438787|69154203|FG002|Overall Study|Protocol Violation|1|||
37678932|NCT02438787|69154201|FG000|Overall Study|Withdrawal by Subject|15|||
37678933|NCT02438787|69154202|FG001|Overall Study|Withdrawal by Subject|7|||
37678934|NCT02438787|69154203|FG002|Overall Study|Withdrawal by Subject|10|||
37678935|NCT02438787|69154201|FG000|Overall Study|Study discontinued by sponsor|64|||
37678936|NCT02438787|69154202|FG001|Overall Study|Study discontinued by sponsor|72|||
37678937|NCT02438787|69154203|FG002|Overall Study|Study discontinued by sponsor|69|||
37678938|NCT02438787|69154201|FG000|Overall Study|Other|0|||
37678939|NCT02438787|69154202|FG001|Overall Study|Other|1|||
37678940|NCT02438787|69154203|FG002|Overall Study|Other|0|||
37678941|NCT02438787|69154201|FG000|Overall Study|Site terminated by sponsor|0|||
37678942|NCT02438787|69154202|FG001|Overall Study|Site terminated by sponsor|0|||
37678943|NCT02438787|69154203|FG002|Overall Study|Site terminated by sponsor|1|||
37678944|NCT02493777|69154218|FG000|Overall Study|Lost to Follow-up|0|||
37678945|NCT02493777|69154219|FG001|Overall Study|Lost to Follow-up|1|||
37678946|NCT02616601|69154228|FG000|Overall Study|Withdrawal by Subject|4|||
37678947|NCT02616601|69154229|FG001|Overall Study|Withdrawal by Subject|4|||
37678948|NCT02616601|69154230|FG002|Overall Study|Withdrawal by Subject|3|||
37678949|NCT02616601|69154228|FG000|Overall Study|Adverse Event|2|||
37678950|NCT02616601|69154229|FG001|Overall Study|Adverse Event|0|||
37678951|NCT02616601|69154230|FG002|Overall Study|Adverse Event|2|||
37678952|NCT02616601|69154228|FG000|Overall Study|Death|1|||
37678953|NCT02616601|69154229|FG001|Overall Study|Death|0|||
37678954|NCT02616601|69154230|FG002|Overall Study|Death|0|||
37678955|NCT02616601|69154228|FG000|Overall Study|Lost to Follow-up|1|||
37678956|NCT02616601|69154229|FG001|Overall Study|Lost to Follow-up|0|||
37678957|NCT02616601|69154230|FG002|Overall Study|Lost to Follow-up|1|||
37678958|NCT02616601|69154228|FG000|Overall Study|Non-Compliance with Test Article|1|||
37678959|NCT02616601|69154229|FG001|Overall Study|Non-Compliance with Test Article|0|||
37678960|NCT02616601|69154230|FG002|Overall Study|Non-Compliance with Test Article|1|||
37678961|NCT02492997|69154240|FG000|Overall Study|Withdrawal by Subject|1|||
37678962|NCT02492997|69154241|FG001|Overall Study|Withdrawal by Subject|0|||
37678963|NCT02492997|69154240|FG000|Overall Study|Gained Weight|1|||
37678964|NCT02492997|69154241|FG001|Overall Study|Gained Weight|0|||
37678965|NCT02492997|69154240|FG000|Overall Study|Lost to Follow-up|0|||
37678966|NCT02492997|69154241|FG001|Overall Study|Lost to Follow-up|1|||
37678967|NCT02437305|69154249|FG000|Overall Study|Lost to Follow-up|18|||
37678968|NCT02437305|69154250|FG001|Overall Study|Lost to Follow-up|12|||
37678969|NCT02492841|69154259|FG000|Overall Study|Lost to Follow-up|34|||
37678970|NCT02492841|69154260|FG001|Overall Study|Lost to Follow-up|31|||
37678971|NCT02492841|69154261|FG002|Overall Study|Lost to Follow-up|35|||
37678972|NCT02436915|69154274|FG000|Overall Study|Withdrawal by Subject|0|||
37678973|NCT02436915|69154275|FG001|Overall Study|Withdrawal by Subject|1|||
37678974|NCT02492763|69154287|FG000|Overall Study|Withdrawal by Subject|0|||
37678975|NCT02492763|69154288|FG001|Overall Study|Withdrawal by Subject|2|||
37678976|NCT02492763|69154289|FG002|Overall Study|Withdrawal by Subject|1|||
37678977|NCT02492763|69154290|FG003|Overall Study|Withdrawal by Subject|0|||
37678978|NCT02492763|69154287|FG000|Overall Study|Adverse Event|3|||
37678979|NCT02492763|69154288|FG001|Overall Study|Adverse Event|1|||
37678980|NCT02492763|69154289|FG002|Overall Study|Adverse Event|1|||
37860866|NCT00950599|69544225|FG003|Follow-Up Period|Lost to Follow-up|0|||
37678981|NCT02492763|69154290|FG003|Overall Study|Adverse Event|2|||
37678982|NCT02492763|69154287|FG000|Overall Study|Death|0|||
37678983|NCT02492763|69154288|FG001|Overall Study|Death|0|||
37678984|NCT02492763|69154289|FG002|Overall Study|Death|1|||
37678985|NCT02492763|69154290|FG003|Overall Study|Death|0|||
37678986|NCT02492763|69154287|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
37678987|NCT02492763|69154288|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
37678988|NCT02492763|69154289|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
37678989|NCT02492763|69154290|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
37678990|NCT02492763|69154287|FG000|Overall Study|Lost to Follow-up|0|||
37678991|NCT02492763|69154288|FG001|Overall Study|Lost to Follow-up|0|||
37678992|NCT02492763|69154289|FG002|Overall Study|Lost to Follow-up|1|||
37678993|NCT02492763|69154290|FG003|Overall Study|Lost to Follow-up|0|||
37678994|NCT02492763|69154287|FG000|Overall Study|Non-Compliance With Study Drug|0|||
37678995|NCT02492763|69154288|FG001|Overall Study|Non-Compliance With Study Drug|1|||
37678996|NCT02492763|69154289|FG002|Overall Study|Non-Compliance With Study Drug|0|||
37678997|NCT02492763|69154290|FG003|Overall Study|Non-Compliance With Study Drug|0|||
37678998|NCT02492763|69154287|FG000|Overall Study|Screen Failure|0|||
37678999|NCT02492763|69154288|FG001|Overall Study|Screen Failure|0|||
37679000|NCT02492763|69154289|FG002|Overall Study|Screen Failure|0|||
37679001|NCT02492763|69154290|FG003|Overall Study|Screen Failure|1|||
37679002|NCT02492763|69154287|FG000|Overall Study|Study Terminated by Sponsor|13|||
37679003|NCT02492763|69154288|FG001|Overall Study|Study Terminated by Sponsor|10|||
37679004|NCT02492763|69154289|FG002|Overall Study|Study Terminated by Sponsor|6|||
37679005|NCT02492763|69154290|FG003|Overall Study|Study Terminated by Sponsor|10|||
37679006|NCT02491671|69154302|FG000|Overall Study|Adverse Event|6|||
37679007|NCT02491671|69154303|FG001|Overall Study|Adverse Event|8|||
37679008|NCT02491671|69154302|FG000|Overall Study|Death|0|||
37679009|NCT02491671|69154303|FG001|Overall Study|Death|2|||
37679010|NCT02491671|69154302|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
37679011|NCT02491671|69154303|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
37679012|NCT02453841|69154309|FG000|Overall Study|Protocol Violation|1|||
37679013|NCT02453841|69154309|FG000|Overall Study|Unable to obtain blood samples|2|||
37679014|NCT02453685|69154315|FG000|Overall Study|Adverse Event|0|||
37679015|NCT02453685|69154316|FG001|Overall Study|Adverse Event|1|||
37679016|NCT02453685|69154315|FG000|Overall Study|Protocol Violation|7|||
37679017|NCT02453685|69154316|FG001|Overall Study|Protocol Violation|4|||
37679018|NCT02453685|69154315|FG000|Overall Study|Lost to Follow-up|0|||
37679019|NCT02453685|69154316|FG001|Overall Study|Lost to Follow-up|1|||
37679020|NCT02453685|69154315|FG000|Overall Study|Withdrawal by Subject|8|||
37679021|NCT02453685|69154316|FG001|Overall Study|Withdrawal by Subject|4|||
37679022|NCT02453685|69154315|FG000|Overall Study|Unclassified|4|||
37679023|NCT02453685|69154316|FG001|Overall Study|Unclassified|2|||
37679024|NCT02436759|69154324|FG000|Overall Study|Adverse Event|3|||
37679025|NCT02436759|69154325|FG001|Overall Study|Adverse Event|0|||
37679026|NCT02436759|69154324|FG000|Overall Study|Protocol Violation|1|||
37679027|NCT02436759|69154325|FG001|Overall Study|Protocol Violation|0|||
37679028|NCT02436759|69154324|FG000|Overall Study|Withdrawal by Subject|0|||
37679029|NCT02436759|69154325|FG001|Overall Study|Withdrawal by Subject|1|||
37679030|NCT02436681|69154331|FG000|Overall Study|Lost to Follow-up|10|||
37679031|NCT02436681|69154331|FG000|Overall Study|Withdrawal by Subject|2|||
37679032|NCT02436681|69154331|FG000|Overall Study|Death|2|||
37679033|NCT02436135|69154337|FG000|Overall Study|Progressive Disease|3|||
37679034|NCT02436135|69154338|FG001|Overall Study|Progressive Disease|1|||
37679035|NCT02436135|69154337|FG000|Overall Study|Investigator Discretion|1|||
37679036|NCT02436135|69154338|FG001|Overall Study|Investigator Discretion|2|||
37679037|NCT02436135|69154337|FG000|Overall Study|Adverse Event|1|||
37679038|NCT02436135|69154338|FG001|Overall Study|Adverse Event|0|||
37679039|NCT02436135|69154337|FG000|Overall Study|Withdrawal by Participant|1|||
37679040|NCT02436135|69154338|FG001|Overall Study|Withdrawal by Participant|0|||
37679041|NCT02436135|69154337|FG000|Overall Study|Study Terminated By Sponsor|0|||
37679042|NCT02436135|69154338|FG001|Overall Study|Study Terminated By Sponsor|1|||
37679043|NCT02489799|69154346|FG000|Overall Study|Lost to Follow-up|4|||
37679044|NCT02489799|69154347|FG001|Overall Study|Lost to Follow-up|1|||
37679045|NCT02489799|69154346|FG000|Overall Study|Failure to Maintain Eligibility|4|||
37679046|NCT02489799|69154347|FG001|Overall Study|Failure to Maintain Eligibility|6|||
37679047|NCT02489799|69154346|FG000|Overall Study|Withdrawal by Subject|1|||
37679048|NCT02489799|69154347|FG001|Overall Study|Withdrawal by Subject|1|||
37679049|NCT02489799|69154346|FG000|Overall Study|Death|0|||
37679050|NCT02489799|69154347|FG001|Overall Study|Death|1|||
37679051|NCT02435277|69154357|FG000|Overall Study|Adverse Event|1|||
37679052|NCT02435277|69154358|FG001|Overall Study|Adverse Event|1|||
37679053|NCT02435277|69154359|FG002|Overall Study|Adverse Event|0|||
37679054|NCT02435277|69154360|FG003|Overall Study|Adverse Event|0|||
37679055|NCT02435277|69154357|FG000|Overall Study|Withdrawal by Subject|1|||
37679056|NCT02435277|69154358|FG001|Overall Study|Withdrawal by Subject|0|||
37679057|NCT02435277|69154359|FG002|Overall Study|Withdrawal by Subject|0|||
37679058|NCT02435277|69154360|FG003|Overall Study|Withdrawal by Subject|0|||
37679059|NCT02420223|69154372|FG000|Overall Study|Adverse Event|1|||
37679060|NCT02420223|69154373|FG001|Overall Study|Adverse Event|0|||
37769226|NCT01401959|69285785|FG002|Enrolled|Withdrawal by Subject|0|||
37679061|NCT02420223|69154372|FG000|Overall Study|Physician Decision|0|||
37679062|NCT02420223|69154373|FG001|Overall Study|Physician Decision|2|||
37679063|NCT02433483|69154379|FG000|Overall Study|Unacceptable toxicity|1|||
37679064|NCT02433483|69154379|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
37679065|NCT02419755|69154385|FG000|Overall Study|Death|1|||
37679066|NCT02419755|69154386|FG001|Overall Study|Death|3|||
37679067|NCT02419755|69154385|FG000|Overall Study|Relapse|0|||
37679068|NCT02419755|69154386|FG001|Overall Study|Relapse|1|||
37679069|NCT02419755|69154385|FG000|Overall Study|Ineligible|1|||
37679070|NCT02419755|69154386|FG001|Overall Study|Ineligible|0|||
37679071|NCT02419755|69154385|FG000|Overall Study|Withdrawal by Subject|1|||
37769227|NCT01401959|69285783|FG000|Treated|Disease Progression|2|||
37679072|NCT02419755|69154386|FG001|Overall Study|Withdrawal by Subject|0|||
37679073|NCT02488551|69154396|FG000|Overall Study|Lost to Follow-up|4|||
37679074|NCT02488551|69154397|FG001|Overall Study|Lost to Follow-up|7|||
37679075|NCT02488551|69154398|FG002|Overall Study|Lost to Follow-up|0|||
37679076|NCT02488551|69154399|FG003|Overall Study|Lost to Follow-up|0|||
37679077|NCT02488551|69154396|FG000|Overall Study|Military Deployment|1|||
37679078|NCT02488551|69154397|FG001|Overall Study|Military Deployment|1|||
37679079|NCT02488551|69154398|FG002|Overall Study|Military Deployment|0|||
37679080|NCT02488551|69154399|FG003|Overall Study|Military Deployment|0|||
37679081|NCT02488239|69154409|FG000|Overall Study|Death|3|||
37679082|NCT02488239|69154409|FG000|Overall Study|Withdrawal by Subject|3|||
37679083|NCT02488239|69154409|FG000|Overall Study|Physician Decision|2|||
37679084|NCT02488239|69154409|FG000|Overall Study|Consent ineligible|1|||
37679085|NCT02488239|69154409|FG000|Overall Study|Did not undergo implant procedure|1|||
37679086|NCT02488005|69154414|FG000|Overall Study|Lost to Follow-up|2|||
37679087|NCT02487771|69154420|FG000|Overall Study|Lost to Follow-up|2|||
37679088|NCT02487771|69154421|FG001|Overall Study|Lost to Follow-up|3|||
37679089|NCT02487771|69154420|FG000|Overall Study|Moved out of area|5|||
37679090|NCT02487771|69154421|FG001|Overall Study|Moved out of area|6|||
37679091|NCT02487771|69154420|FG000|Overall Study|Withdrawal by Subject|3|||
37679092|NCT02487771|69154421|FG001|Overall Study|Withdrawal by Subject|5|||
37679093|NCT01359943|69154430|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
37679094|NCT01359943|69154431|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
37679095|NCT01359943|69154432|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
37679096|NCT01359943|69154430|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
37679097|NCT01359943|69154431|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
37679098|NCT01359943|69154432|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
37679099|NCT01359943|69154430|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
37679100|NCT01359943|69154431|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
37679101|NCT01359943|69154432|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
37679102|NCT01359943|69154430|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
37679103|NCT01359943|69154431|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
37679104|NCT01359943|69154432|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
37679105|NCT01359943|69154430|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
37679106|NCT01359943|69154431|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
37679107|NCT01359943|69154432|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
37679108|NCT01359943|69154430|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
37679109|NCT01359943|69154431|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
37679110|NCT01359943|69154432|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
37679111|NCT01359943|69154430|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
37679112|NCT01359943|69154431|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
37679113|NCT01359943|69154432|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
37679114|NCT01359943|69154430|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
37679115|NCT01359943|69154431|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
37679116|NCT01359943|69154432|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
37679117|NCT01359943|69154430|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
37679118|NCT01359943|69154431|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
37679119|NCT01359943|69154432|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
37679120|NCT01359943|69154430|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
37679121|NCT01359943|69154431|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
37679122|NCT01359943|69154432|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
37679123|NCT01359943|69154430|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
37679124|NCT01359943|69154431|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
37679125|NCT01359943|69154432|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
37679126|NCT01359943|69154430|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
37679127|NCT01359943|69154431|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
37679128|NCT01359943|69154432|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
37679129|NCT01359943|69154430|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
37679130|NCT01359943|69154431|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
37679131|NCT01359943|69154432|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
37679132|NCT01359943|69154430|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
37679133|NCT01359943|69154431|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
37679134|NCT01359943|69154432|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
37679135|NCT01359943|69154430|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
37679136|NCT01359943|69154431|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
37679137|NCT01359943|69154432|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
37679138|NCT02432703|69154444|FG000|Overall Study|Adverse Event|1|||
37679139|NCT02432703|69154445|FG001|Overall Study|Adverse Event|4|||
37679140|NCT02432703|69154444|FG000|Overall Study|Lack of Efficacy|1|||
37679141|NCT02432703|69154445|FG001|Overall Study|Lack of Efficacy|0|||
37679142|NCT02432703|69154444|FG000|Overall Study|Lost to Follow-up|5|||
37679143|NCT02432703|69154445|FG001|Overall Study|Lost to Follow-up|3|||
37679144|NCT02432703|69154444|FG000|Overall Study|Withdrawal by Subject|9|||
37679145|NCT02432703|69154445|FG001|Overall Study|Withdrawal by Subject|6|||
37679146|NCT02432703|69154444|FG000|Overall Study|Other|6|||
37679147|NCT02432703|69154445|FG001|Overall Study|Other|5|||
37679148|NCT02486757|69154451|FG000|Overall Study|Lost to Follow-up|1|||
37679149|NCT02418819|69154459|FG000|Overall Study|Adverse Event|0|||
37679150|NCT02418819|69154460|FG001|Overall Study|Adverse Event|0|||
37679151|NCT02418819|69154461|FG002|Overall Study|Adverse Event|1|||
37679152|NCT02418819|69154462|FG003|Overall Study|Adverse Event|0|||
37679153|NCT02418819|69154459|FG000|Overall Study|Lost to Follow-up|1|||
37679154|NCT02418819|69154460|FG001|Overall Study|Lost to Follow-up|0|||
37679155|NCT02418819|69154461|FG002|Overall Study|Lost to Follow-up|0|||
37679156|NCT02418819|69154462|FG003|Overall Study|Lost to Follow-up|0|||
37679157|NCT02418819|69154459|FG000|Overall Study|No longer meets eligibility criteria|0|||
37679158|NCT02418819|69154460|FG001|Overall Study|No longer meets eligibility criteria|0|||
37679159|NCT02418819|69154461|FG002|Overall Study|No longer meets eligibility criteria|1|||
37679160|NCT02418819|69154462|FG003|Overall Study|No longer meets eligibility criteria|0|||
37679161|NCT02418819|69154459|FG000|Overall Study|No longer willing to participate|0|||
37679162|NCT02418819|69154460|FG001|Overall Study|No longer willing to participate|0|||
37679163|NCT02418819|69154461|FG002|Overall Study|No longer willing to participate|2|||
37679164|NCT02418819|69154462|FG003|Overall Study|No longer willing to participate|1|||
37679165|NCT02576639|69154477|FG000|Overall Study|Withdrawal by Subject|1|||
37679166|NCT02576639|69154478|FG001|Overall Study|Withdrawal by Subject|2|||
37679167|NCT02576639|69154479|FG002|Overall Study|Withdrawal by Subject|1|||
37679168|NCT02576639|69154480|FG003|Overall Study|Withdrawal by Subject|0|||
37679169|NCT02576639|69154481|FG004|Overall Study|Withdrawal by Subject|1|||
37679170|NCT02576639|69154477|FG000|Overall Study|Adverse Event|1|||
37679171|NCT02576639|69154478|FG001|Overall Study|Adverse Event|0|||
37679172|NCT02576639|69154479|FG002|Overall Study|Adverse Event|1|||
37679173|NCT02576639|69154480|FG003|Overall Study|Adverse Event|1|||
37679174|NCT02576639|69154481|FG004|Overall Study|Adverse Event|2|||
37679175|NCT02576639|69154477|FG000|Overall Study|Physician Decision|0|||
37679176|NCT02576639|69154478|FG001|Overall Study|Physician Decision|0|||
37679177|NCT02576639|69154479|FG002|Overall Study|Physician Decision|0|||
37679178|NCT02576639|69154480|FG003|Overall Study|Physician Decision|0|||
37679179|NCT02576639|69154481|FG004|Overall Study|Physician Decision|1|||
37679180|NCT02418585|69154499|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
37679181|NCT02418585|69154500|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
37679182|NCT02418585|69154499|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
37679183|NCT02418585|69154500|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
37679184|NCT02418585|69154499|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
37679185|NCT02418585|69154500|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
37679186|NCT02418585|69154499|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
37679187|NCT02418585|69154500|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
37679188|NCT02418585|69154499|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
37679189|NCT02418585|69154500|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
37679190|NCT02418585|69154499|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
37679191|NCT02418585|69154500|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
37679192|NCT02418585|69154499|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
37679193|NCT02418585|69154500|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
37679194|NCT02418585|69154499|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
37679195|NCT02418585|69154500|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
37679196|NCT02418585|69154499|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
37679197|NCT02418585|69154500|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
37679198|NCT02418585|69154499|FG000|Follow-up Phase (24 Weeks)|Other|3|||
37679199|NCT02418585|69154500|FG001|Follow-up Phase (24 Weeks)|Other|2|||
37679200|NCT02417961|69154508|FG000|Overall Study|Adverse Event|1|||
37679201|NCT02417961|69154508|FG000|Overall Study|Lost to Follow-up|1|||
37679202|NCT02417961|69154508|FG000|Overall Study|Withdrawal by Subject|2|||
37679203|NCT01596127|69154512|FG000|Overall Study|Patient Ineligible|1|||
37679204|NCT01595581|69154518|FG000|Overall Study|Withdrawal by Subject|1|||
37679205|NCT01595581|69154519|FG001|Overall Study|Withdrawal by Subject|0|||
37679206|NCT01610687|69154527|FG000|Overall Study|Lack of Efficacy|26|||
37679207|NCT01610687|69154527|FG000|Overall Study|Adverse Event|18|||
37679208|NCT01610687|69154527|FG000|Overall Study|Moved out of area|6|||
37679209|NCT01610687|69154527|FG000|Overall Study|Withdrawal by Subject|7|||
37679210|NCT01610687|69154527|FG000|Overall Study|Lost to Follow-up|4|||
37679211|NCT01610687|69154527|FG000|Overall Study|Symptom control without study medication|2|||
37679212|NCT01610687|69154527|FG000|Overall Study|Unable to make journey|1|||
37679213|NCT01610687|69154527|FG000|Overall Study|Death|1|||
37679214|NCT01610687|69154527|FG000|Overall Study|Cannabis affecting job|1|||
37679215|NCT01610687|69154527|FG000|Overall Study|Felt more alter without study medication|1|||
37860867|NCT00950599|69544226|FG004|Follow-Up Period|Lost to Follow-up|0|||
37679216|NCT02615509|69154531|FG000|Overall Study|Lost to Follow-up|134|||
37679217|NCT02615509|69154531|FG000|Overall Study|Death|4|||
37679218|NCT02615509|69154531|FG000|Overall Study|Withdrawal by Subject|8|||
37679219|NCT02575079|69154537|FG000|Overall Study|Death|3|||
37679220|NCT02575079|69154538|FG001|Overall Study|Death|0|||
37679221|NCT02575079|69154537|FG000|Overall Study|Withdrawal by Subject|3|||
37679222|NCT02575079|69154538|FG001|Overall Study|Withdrawal by Subject|0|||
37679223|NCT02614183|69154546|FG000|Double Blind Treatment Phase|Adverse Event|10|||
37679224|NCT02614183|69154547|FG001|Double Blind Treatment Phase|Adverse Event|9|||
37679225|NCT02614183|69154548|FG002|Double Blind Treatment Phase|Adverse Event|7|||
37679226|NCT02614183|69154546|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
37679227|NCT02614183|69154547|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
37679228|NCT02614183|69154548|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
37679229|NCT02614183|69154546|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
37679230|NCT02614183|69154547|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
37679231|NCT02614183|69154548|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
37679232|NCT02614183|69154546|FG000|Double Blind Treatment Phase|Physician Decision|7|||
37679233|NCT02614183|69154547|FG001|Double Blind Treatment Phase|Physician Decision|3|||
37679234|NCT02614183|69154548|FG002|Double Blind Treatment Phase|Physician Decision|2|||
37679235|NCT02614183|69154546|FG000|Double Blind Treatment Phase|Pregnancy|2|||
37679236|NCT02614183|69154547|FG001|Double Blind Treatment Phase|Pregnancy|1|||
37679237|NCT02614183|69154548|FG002|Double Blind Treatment Phase|Pregnancy|3|||
37679238|NCT02614183|69154546|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
37679239|NCT02614183|69154547|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
37679240|NCT02614183|69154548|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
37679241|NCT02614183|69154546|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
37679242|NCT02614183|69154547|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
37679243|NCT02614183|69154548|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
37679244|NCT02614183|69154546|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
37679245|NCT02614183|69154547|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
37679246|NCT02614183|69154548|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
37679247|NCT02614183|69154546|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
37679248|NCT02614183|69154547|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
37679249|NCT02614183|69154548|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
37679250|NCT02614183|69154546|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
37679251|NCT02614183|69154547|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
37679252|NCT02614183|69154548|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
37679253|NCT02614183|69154546|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
37679254|NCT02614183|69154547|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
37679255|NCT02614183|69154548|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
37679256|NCT02614183|69154546|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
37679257|NCT02614183|69154547|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
37679258|NCT02614183|69154548|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
37679259|NCT02612155|69154573|FG000|Overall Study|Death|1|||
37679260|NCT02612155|69154574|FG001|Overall Study|Death|1|||
37679261|NCT02612155|69154573|FG000|Overall Study|Lost to Follow-up|2|||
37679262|NCT02612155|69154574|FG001|Overall Study|Lost to Follow-up|2|||
37679263|NCT02614729|69154582|FG000|Overall Study|Withdrawal by Subject|1|||
37679264|NCT02614729|69154583|FG001|Overall Study|Withdrawal by Subject|0|||
37679265|NCT02613871|69154591|FG000|Overall Study|Death|2|||
37679266|NCT02613871|69154591|FG000|Overall Study|Withdrew Consent|1|||
37679267|NCT05021081|69154597|FG000|Phase 2|Subject enrolled in error|1|||
37679268|NCT05021081|69154598|FG001|Phase 2|Subject enrolled in error|1|||
37679269|NCT05021081|69154599|FG002|Phase 2|Subject enrolled in error|0|||
37679270|NCT02612077|69154615|FG000|Overall Study|Adverse Event|3|||
37679271|NCT02612077|69154615|FG000|Overall Study|Withdrawal by Subject|9|||
37679272|NCT02612077|69154615|FG000|Overall Study|Protocol Violation|28|||
37679273|NCT02612077|69154615|FG000|Overall Study|Lost to Follow-up|20|||
37679274|NCT02612077|69154615|FG000|Overall Study|Death|377|||
37679275|NCT02612077|69154615|FG000|Overall Study|Moved or Changed Medical Team|23|||
37679276|NCT02612077|69154615|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
37679277|NCT02612077|69154615|FG000|Overall Study|Disease Progression|3|||
37679278|NCT02612077|69154615|FG000|Overall Study|Unknown reason|2|||
37679279|NCT02613481|69154622|FG000|Overall Study|Lost to Follow-up|7|||
37679280|NCT02613481|69154622|FG000|Overall Study|Withdrawal by Subject|2|||
37679281|NCT02613403|69154630|FG000|Overall Study|Lost to Follow-up|0|||
37769228|NCT01401959|69285784|FG001|Treated|Disease Progression|2|||
37769229|NCT01401959|69285785|FG002|Treated|Disease Progression|1|||
37769230|NCT01401959|69285783|FG000|Treated|Adverse Event|4|||
37679282|NCT02613403|69154631|FG001|Overall Study|Lost to Follow-up|1|||
37679283|NCT02613403|69154632|FG002|Overall Study|Lost to Follow-up|0|||
37679284|NCT02613403|69154633|FG003|Overall Study|Lost to Follow-up|0|||
37679285|NCT02613403|69154634|FG004|Overall Study|Lost to Follow-up|0|||
37679286|NCT02613403|69154630|FG000|Overall Study|Withdrawal by Subject|2|||
37769231|NCT01401959|69285784|FG001|Treated|Adverse Event|3|||
37769232|NCT01401959|69285785|FG002|Treated|Adverse Event|2|||
37679287|NCT02613403|69154631|FG001|Overall Study|Withdrawal by Subject|0|||
37679288|NCT02613403|69154632|FG002|Overall Study|Withdrawal by Subject|0|||
37679289|NCT02613403|69154633|FG003|Overall Study|Withdrawal by Subject|0|||
37679290|NCT02613403|69154634|FG004|Overall Study|Withdrawal by Subject|0|||
37679291|NCT02572817|69154646|FG000|Overall Study|Death|6|||
37679292|NCT02572817|69154647|FG001|Overall Study|Death|3|||
37679293|NCT02572817|69154646|FG000|Overall Study|Lost to Follow-up|3|||
37679294|NCT02572817|69154647|FG001|Overall Study|Lost to Follow-up|3|||
37679295|NCT02566109|69154653|FG000|Overall Study|Withdrawal by Subject|1|||
37679296|NCT02566031|69154659|FG000|Overall Study|Patient/guardian decision|14|||
37679297|NCT02566031|69154660|FG001|Overall Study|Patient/guardian decision|7|||
37679298|NCT02566031|69154659|FG000|Overall Study|Protocol deviation|2|||
37679299|NCT02566031|69154660|FG001|Overall Study|Protocol deviation|3|||
37679300|NCT02566031|69154659|FG000|Overall Study|Adverse Event|3|||
37679301|NCT02566031|69154660|FG001|Overall Study|Adverse Event|1|||
37679302|NCT02566031|69154659|FG000|Overall Study|Lost to Follow-up|1|||
37679303|NCT02566031|69154660|FG001|Overall Study|Lost to Follow-up|1|||
37679304|NCT02569853|69154669|FG000|Overall Study|Adverse Event|2|||
37679305|NCT02569853|69154670|FG001|Overall Study|Adverse Event|0|||
37679306|NCT02569853|69154669|FG000|Overall Study|Withdrawal by Subject|3|||
37679307|NCT02569853|69154670|FG001|Overall Study|Withdrawal by Subject|2|||
37679308|NCT02569853|69154669|FG000|Overall Study|Lost to Follow-up|3|||
37679309|NCT02569853|69154670|FG001|Overall Study|Lost to Follow-up|3|||
37679310|NCT02569853|69154669|FG000|Overall Study|Protocol Violation|1|||
37679311|NCT02569853|69154670|FG001|Overall Study|Protocol Violation|1|||
37679312|NCT02569853|69154669|FG000|Overall Study|Did not experience migraine attack|10|||
37679313|NCT02569853|69154670|FG001|Overall Study|Did not experience migraine attack|7|||
37679314|NCT02569853|69154669|FG000|Overall Study|Physician Decision|1|||
37679315|NCT02569853|69154670|FG001|Overall Study|Physician Decision|1|||
37679316|NCT02570711|69154680|FG000|Overall Study|Death|1|||
37679317|NCT02570711|69154681|FG001|Overall Study|Death|0|||
37679318|NCT02570711|69154680|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
37679319|NCT02570711|69154681|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
37679320|NCT02570165|69154694|FG000|Overall Study|Adverse Event|1|||
37679321|NCT02570165|69154695|FG001|Overall Study|Adverse Event|0|||
37679322|NCT02570165|69154696|FG002|Overall Study|Adverse Event|2|||
37679323|NCT02570165|69154697|FG003|Overall Study|Adverse Event|0|||
37679324|NCT02570165|69154698|FG004|Overall Study|Adverse Event|0|||
37679325|NCT02570165|69154699|FG005|Overall Study|Adverse Event|0|||
37679326|NCT02570165|69154700|FG006|Overall Study|Adverse Event|0|||
37679327|NCT02570165|69154694|FG000|Overall Study|Lack of Efficacy|0|||
37679328|NCT02570165|69154695|FG001|Overall Study|Lack of Efficacy|1|||
37679329|NCT02570165|69154696|FG002|Overall Study|Lack of Efficacy|0|||
37679330|NCT02570165|69154697|FG003|Overall Study|Lack of Efficacy|0|||
37679331|NCT02570165|69154698|FG004|Overall Study|Lack of Efficacy|4|||
37679332|NCT02570165|69154699|FG005|Overall Study|Lack of Efficacy|0|||
37679333|NCT02570165|69154700|FG006|Overall Study|Lack of Efficacy|0|||
37679334|NCT02570165|69154694|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
37679335|NCT02570165|69154695|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
37679336|NCT02570165|69154696|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
37679337|NCT02570165|69154697|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
37679338|NCT02570165|69154698|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
37679339|NCT02570165|69154699|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
37679340|NCT02570165|69154700|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
37679341|NCT02570165|69154694|FG000|Overall Study|Lost to Follow-up|0|||
37679342|NCT02570165|69154695|FG001|Overall Study|Lost to Follow-up|0|||
37679343|NCT02570165|69154696|FG002|Overall Study|Lost to Follow-up|1|||
37679344|NCT02570165|69154697|FG003|Overall Study|Lost to Follow-up|1|||
37679345|NCT02570165|69154698|FG004|Overall Study|Lost to Follow-up|0|||
37679346|NCT02570165|69154699|FG005|Overall Study|Lost to Follow-up|0|||
37679347|NCT02570165|69154700|FG006|Overall Study|Lost to Follow-up|0|||
37679348|NCT02570165|69154694|FG000|Overall Study|Physician Decision|0|||
37679349|NCT02570165|69154695|FG001|Overall Study|Physician Decision|1|||
37679350|NCT02570165|69154696|FG002|Overall Study|Physician Decision|0|||
37679351|NCT02570165|69154697|FG003|Overall Study|Physician Decision|0|||
37679352|NCT02570165|69154698|FG004|Overall Study|Physician Decision|0|||
37679353|NCT02570165|69154699|FG005|Overall Study|Physician Decision|0|||
37679354|NCT02570165|69154700|FG006|Overall Study|Physician Decision|0|||
37679355|NCT02570165|69154694|FG000|Overall Study|Withdrawal by Subject|0|||
37679356|NCT02570165|69154695|FG001|Overall Study|Withdrawal by Subject|0|||
37679357|NCT02570165|69154696|FG002|Overall Study|Withdrawal by Subject|0|||
37679358|NCT02570165|69154697|FG003|Overall Study|Withdrawal by Subject|2|||
37679359|NCT02570165|69154698|FG004|Overall Study|Withdrawal by Subject|1|||
37679360|NCT02570165|69154699|FG005|Overall Study|Withdrawal by Subject|0|||
37679361|NCT02570165|69154700|FG006|Overall Study|Withdrawal by Subject|0|||
37679362|NCT02570165|69154694|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
37679363|NCT02570165|69154695|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
37679364|NCT02570165|69154696|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
37679365|NCT02570165|69154697|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
37679366|NCT02570165|69154698|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
37679367|NCT02570165|69154699|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
37679368|NCT02570165|69154700|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
37679369|NCT02570165|69154694|FG000|Overall Study|Withdrawal Request by GSK|0|||
37679370|NCT02570165|69154695|FG001|Overall Study|Withdrawal Request by GSK|0|||
37679371|NCT02570165|69154696|FG002|Overall Study|Withdrawal Request by GSK|2|||
37679372|NCT02570165|69154697|FG003|Overall Study|Withdrawal Request by GSK|0|||
37679373|NCT02570165|69154698|FG004|Overall Study|Withdrawal Request by GSK|0|||
37679374|NCT02570165|69154699|FG005|Overall Study|Withdrawal Request by GSK|0|||
37679375|NCT02570165|69154700|FG006|Overall Study|Withdrawal Request by GSK|0|||
37679376|NCT02564471|69154720|FG000|Overall Study|Adverse Event|1|||
37679377|NCT02564471|69154721|FG001|Overall Study|Adverse Event|0|||
37679378|NCT02564471|69154722|FG002|Overall Study|Adverse Event|0|||
37679379|NCT02564471|69154723|FG003|Overall Study|Adverse Event|0|||
37679380|NCT02564471|69154720|FG000|Overall Study|Withdrawal by Subject|2|||
37679381|NCT02564471|69154721|FG001|Overall Study|Withdrawal by Subject|1|||
37679382|NCT02564471|69154722|FG002|Overall Study|Withdrawal by Subject|3|||
37679383|NCT02564471|69154723|FG003|Overall Study|Withdrawal by Subject|0|||
37679384|NCT02564471|69154720|FG000|Overall Study|Lost to Follow-up|0|||
37679385|NCT02564471|69154721|FG001|Overall Study|Lost to Follow-up|2|||
37679386|NCT02564471|69154722|FG002|Overall Study|Lost to Follow-up|0|||
37679387|NCT02564471|69154723|FG003|Overall Study|Lost to Follow-up|0|||
37679388|NCT02563067|69154736|FG000|Overall Study|Subject/guardian decision|14|||
37679389|NCT02563067|69154737|FG001|Overall Study|Subject/guardian decision|20|||
37679390|NCT02563067|69154738|FG002|Overall Study|Subject/guardian decision|16|||
37679391|NCT02563067|69154736|FG000|Overall Study|Physician Decision|0|||
37679392|NCT02563067|69154737|FG001|Overall Study|Physician Decision|1|||
37679393|NCT02563067|69154738|FG002|Overall Study|Physician Decision|3|||
37679394|NCT02563067|69154736|FG000|Overall Study|Lost to Follow-up|1|||
37679395|NCT02563067|69154737|FG001|Overall Study|Lost to Follow-up|2|||
37679396|NCT02563067|69154738|FG002|Overall Study|Lost to Follow-up|0|||
37679397|NCT02563067|69154736|FG000|Overall Study|Technical problems|0|||
37679398|NCT02563067|69154737|FG001|Overall Study|Technical problems|1|||
37679399|NCT02563067|69154738|FG002|Overall Study|Technical problems|0|||
37679400|NCT02563067|69154736|FG000|Overall Study|Lack of Efficacy|1|||
37679401|NCT02563067|69154737|FG001|Overall Study|Lack of Efficacy|0|||
37679402|NCT02563067|69154738|FG002|Overall Study|Lack of Efficacy|0|||
37679403|NCT02563067|69154736|FG000|Overall Study|Death|0|||
37679404|NCT02563067|69154737|FG001|Overall Study|Death|1|||
37679405|NCT02563067|69154738|FG002|Overall Study|Death|1|||
37679406|NCT02563067|69154736|FG000|Overall Study|Adverse Event|2|||
37679407|NCT02563067|69154737|FG001|Overall Study|Adverse Event|1|||
37679408|NCT02563067|69154738|FG002|Overall Study|Adverse Event|0|||
37679409|NCT02563067|69154736|FG000|Overall Study|Death post Treatment/safety period|1|||
37679410|NCT02563067|69154737|FG001|Overall Study|Death post Treatment/safety period|0|||
37679411|NCT02563067|69154738|FG002|Overall Study|Death post Treatment/safety period|0|||
37679412|NCT02568683|69154748|FG000|Overall Study|Death|0|||
37679413|NCT02568683|69154749|FG001|Overall Study|Death|2|||
37679414|NCT02568683|69154748|FG000|Overall Study|Withdrew Consent|1|||
37679415|NCT02568683|69154749|FG001|Overall Study|Withdrew Consent|0|||
37679416|NCT02568683|69154748|FG000|Overall Study|Study Terminated By Sponsor|5|||
37679417|NCT02568683|69154749|FG001|Overall Study|Study Terminated By Sponsor|2|||
37679418|NCT02563925|69154755|FG000|Overall Study|Withdrawal by Subject|2|||
37679419|NCT01663727|69154762|FG000|Overall Study|Death|161|||
37679420|NCT01663727|69154763|FG001|Overall Study|Death|155|||
37679421|NCT01663727|69154762|FG000|Overall Study|Lost to Follow-up|10|||
37679422|NCT01663727|69154763|FG001|Overall Study|Lost to Follow-up|8|||
37679423|NCT01663727|69154762|FG000|Overall Study|Withdrawal by Subject|18|||
37679424|NCT01663727|69154763|FG001|Overall Study|Withdrawal by Subject|25|||
37679425|NCT01663727|69154762|FG000|Overall Study|Study Terminated|51|||
37679426|NCT01663727|69154763|FG001|Overall Study|Study Terminated|50|||
37679427|NCT01663727|69154762|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
37679428|NCT01663727|69154763|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
37679429|NCT01663727|69154762|FG000|Overall Study|Withdrawal prior to dosing.|1|||
37679430|NCT01663727|69154763|FG001|Overall Study|Withdrawal prior to dosing.|0|||
37679431|NCT02614261|69154772|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
37679432|NCT02614261|69154773|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
37679433|NCT02614261|69154774|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
37679434|NCT02614261|69154775|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
37679435|NCT02614261|69154772|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
37679436|NCT02614261|69154773|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
37679437|NCT02614261|69154774|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
37679438|NCT02614261|69154775|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
37679439|NCT02614261|69154772|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
37679440|NCT02614261|69154773|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
37769233|NCT01401959|69285783|FG000|Treated|Withdrawal by Subject|1|||
37679441|NCT02614261|69154774|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
37679442|NCT02614261|69154775|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
37679443|NCT02614261|69154772|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
37679444|NCT02614261|69154773|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
37679445|NCT02614261|69154774|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
37679446|NCT02614261|69154775|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
37679447|NCT02614261|69154772|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
37679448|NCT02614261|69154773|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
37679449|NCT02614261|69154774|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
37679450|NCT02614261|69154775|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
37679451|NCT02614261|69154772|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
37679452|NCT02614261|69154773|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
37679453|NCT02614261|69154774|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
37679454|NCT02614261|69154775|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
37679455|NCT02614261|69154772|FG000|Double-Blind Treatment Phase|Screen failure|0|||
37679456|NCT02614261|69154773|FG001|Double-Blind Treatment Phase|Screen failure|1|||
37679457|NCT02614261|69154774|FG002|Double-Blind Treatment Phase|Screen failure|2|||
37679458|NCT02614261|69154775|FG003|Double-Blind Treatment Phase|Screen failure|0|||
37679459|NCT02614261|69154772|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
37679460|NCT02614261|69154773|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
37679461|NCT02614261|69154774|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
37679462|NCT02614261|69154775|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
37679463|NCT02614261|69154772|FG000|Open-Label Extension Phase|Adverse Event|23|||
37679464|NCT02614261|69154773|FG001|Open-Label Extension Phase|Adverse Event|12|||
37679465|NCT02614261|69154774|FG002|Open-Label Extension Phase|Adverse Event|11|||
37679466|NCT02614261|69154775|FG003|Open-Label Extension Phase|Adverse Event|0|||
37679467|NCT02614261|69154772|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
37679468|NCT02614261|69154773|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
37679469|NCT02614261|69154774|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
37679470|NCT02614261|69154775|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
37679471|NCT02614261|69154772|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
37679472|NCT02614261|69154773|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
37679473|NCT02614261|69154774|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
37679474|NCT02614261|69154775|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
37679475|NCT02614261|69154772|FG000|Open-Label Extension Phase|Physician Decision|2|||
37679476|NCT02614261|69154773|FG001|Open-Label Extension Phase|Physician Decision|0|||
37679477|NCT02614261|69154774|FG002|Open-Label Extension Phase|Physician Decision|0|||
37679478|NCT02614261|69154775|FG003|Open-Label Extension Phase|Physician Decision|0|||
37679479|NCT02614261|69154772|FG000|Open-Label Extension Phase|Pregnancy|1|||
37679480|NCT02614261|69154773|FG001|Open-Label Extension Phase|Pregnancy|2|||
37679481|NCT02614261|69154774|FG002|Open-Label Extension Phase|Pregnancy|1|||
37679482|NCT02614261|69154775|FG003|Open-Label Extension Phase|Pregnancy|0|||
37679483|NCT02614261|69154772|FG000|Open-Label Extension Phase|Protocol Violation|3|||
37679484|NCT02614261|69154773|FG001|Open-Label Extension Phase|Protocol Violation|4|||
37679485|NCT02614261|69154774|FG002|Open-Label Extension Phase|Protocol Violation|1|||
37679486|NCT02614261|69154775|FG003|Open-Label Extension Phase|Protocol Violation|0|||
37679487|NCT02614261|69154772|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
37679488|NCT02614261|69154773|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
37679489|NCT02614261|69154774|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
37679490|NCT02614261|69154775|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
37679491|NCT02614261|69154772|FG000|Follow-up Phase|Adverse Event|2|||
37679492|NCT02614261|69154773|FG001|Follow-up Phase|Adverse Event|0|||
37679493|NCT02614261|69154774|FG002|Follow-up Phase|Adverse Event|1|||
37679494|NCT02614261|69154775|FG003|Follow-up Phase|Adverse Event|0|||
37679495|NCT02614261|69154772|FG000|Follow-up Phase|Lost to Follow-up|12|||
37679496|NCT02614261|69154773|FG001|Follow-up Phase|Lost to Follow-up|5|||
37679497|NCT02614261|69154774|FG002|Follow-up Phase|Lost to Follow-up|2|||
37679498|NCT02614261|69154775|FG003|Follow-up Phase|Lost to Follow-up|0|||
37679499|NCT02614261|69154772|FG000|Follow-up Phase|Physician Decision|5|||
37679500|NCT02614261|69154773|FG001|Follow-up Phase|Physician Decision|1|||
37679501|NCT02614261|69154774|FG002|Follow-up Phase|Physician Decision|0|||
37679502|NCT02614261|69154775|FG003|Follow-up Phase|Physician Decision|0|||
37679503|NCT02614261|69154772|FG000|Follow-up Phase|Pregnancy|0|||
37679504|NCT02614261|69154773|FG001|Follow-up Phase|Pregnancy|1|||
37679505|NCT02614261|69154774|FG002|Follow-up Phase|Pregnancy|0|||
37679506|NCT02614261|69154775|FG003|Follow-up Phase|Pregnancy|0|||
37679507|NCT02614261|69154772|FG000|Follow-up Phase|Protocol Violation|1|||
37679508|NCT02614261|69154773|FG001|Follow-up Phase|Protocol Violation|0|||
37679509|NCT02614261|69154774|FG002|Follow-up Phase|Protocol Violation|0|||
37679510|NCT02614261|69154775|FG003|Follow-up Phase|Protocol Violation|0|||
37679511|NCT02614261|69154772|FG000|Follow-up Phase|Withdrawal by Subject|12|||
37679512|NCT02614261|69154773|FG001|Follow-up Phase|Withdrawal by Subject|4|||
37679513|NCT02614261|69154774|FG002|Follow-up Phase|Withdrawal by Subject|11|||
37679514|NCT02614261|69154775|FG003|Follow-up Phase|Withdrawal by Subject|0|||
37679515|NCT02614261|69154772|FG000|Israel Addendum|Withdrawal by Subject|0|||
37679516|NCT02614261|69154773|FG001|Israel Addendum|Withdrawal by Subject|0|||
37679517|NCT02614261|69154774|FG002|Israel Addendum|Withdrawal by Subject|0|||
37679518|NCT02614261|69154775|FG003|Israel Addendum|Withdrawal by Subject|4|||
37679519|NCT01594411|69154801|FG000|Overall Study|Lost to Follow-up|2|||
37679520|NCT01594333|69154810|FG000|Overall Study|Death|96|||
37679521|NCT01594333|69154811|FG001|Overall Study|Death|83|||
37679522|NCT01594333|69154810|FG000|Overall Study|Lost to Follow-up|5|||
37679523|NCT01594333|69154811|FG001|Overall Study|Lost to Follow-up|5|||
37679524|NCT01594333|69154810|FG000|Overall Study|Withdrawal by Subject|60|||
37679525|NCT01594333|69154811|FG001|Overall Study|Withdrawal by Subject|63|||
37679526|NCT02609659|69154817|FG000|Overall Study|Adverse Event|1|||
37679527|NCT02609659|69154817|FG000|Overall Study|Lost to Follow-up|6|||
37679528|NCT02609659|69154817|FG000|Overall Study|Other|1|||
37679529|NCT02612779|69154823|FG000|Overall Study|Administrative reason by sponsor|4|||
37679530|NCT02612779|69154824|FG001|Overall Study|Administrative reason by sponsor|1|||
37679531|NCT02612779|69154823|FG000|Overall Study|No longer meet study criteria|0|||
37679532|NCT02612779|69154824|FG001|Overall Study|No longer meet study criteria|1|||
37679533|NCT02612779|69154823|FG000|Overall Study|Disease progression|29|||
37679534|NCT02612779|69154824|FG001|Overall Study|Disease progression|2|||
37679535|NCT02612779|69154823|FG000|Overall Study|Study drug toxicity|10|||
37679536|NCT02612779|69154824|FG001|Overall Study|Study drug toxicity|1|||
37679537|NCT02612779|69154823|FG000|Overall Study|Death|1|||
37679538|NCT02612779|69154824|FG001|Overall Study|Death|0|||
37679539|NCT02612779|69154823|FG000|Overall Study|Adverse event unrelated to study drug|5|||
37679540|NCT02612779|69154824|FG001|Overall Study|Adverse event unrelated to study drug|0|||
37679541|NCT02612779|69154823|FG000|Overall Study|Participant withdrew consent|4|||
37679542|NCT02612779|69154824|FG001|Overall Study|Participant withdrew consent|0|||
37679543|NCT02612779|69154823|FG000|Overall Study|Lost to Follow-up|1|||
37679544|NCT02612779|69154824|FG001|Overall Study|Lost to Follow-up|0|||
37679545|NCT02612779|69154823|FG000|Overall Study|Maximum clinical benefit|10|||
37679546|NCT02612779|69154824|FG001|Overall Study|Maximum clinical benefit|1|||
37679547|NCT02612779|69154823|FG000|Overall Study|Other reasons|4|||
37679548|NCT02612779|69154824|FG001|Overall Study|Other reasons|0|||
37679549|NCT02612623|69154835|FG000|Overall Study|Withdrawal by Subject|0|||
37679550|NCT02612623|69154836|FG001|Overall Study|Withdrawal by Subject|1|||
37679551|NCT02612623|69154837|FG002|Overall Study|Withdrawal by Subject|0|||
37679552|NCT02612623|69154838|FG003|Overall Study|Withdrawal by Subject|0|||
37679553|NCT02612623|69154835|FG000|Overall Study|Adverse Event|1|||
37679554|NCT02612623|69154836|FG001|Overall Study|Adverse Event|0|||
37679555|NCT02612623|69154837|FG002|Overall Study|Adverse Event|1|||
37679556|NCT02612623|69154838|FG003|Overall Study|Adverse Event|0|||
37679557|NCT02607865|69154852|FG000|Overall Study|Lost to Follow-up|9|||
37679558|NCT02607865|69154853|FG001|Overall Study|Lost to Follow-up|7|||
37679559|NCT02607865|69154854|FG002|Overall Study|Lost to Follow-up|7|||
37679560|NCT02607865|69154855|FG003|Overall Study|Lost to Follow-up|5|||
37679561|NCT02607865|69154852|FG000|Overall Study|Withdrawal by Subject|18|||
37679562|NCT02607865|69154853|FG001|Overall Study|Withdrawal by Subject|18|||
37679563|NCT02607865|69154854|FG002|Overall Study|Withdrawal by Subject|17|||
37679564|NCT02607865|69154855|FG003|Overall Study|Withdrawal by Subject|8|||
37679565|NCT02607865|69154852|FG000|Overall Study|Death|5|||
37679566|NCT02607865|69154853|FG001|Overall Study|Death|4|||
37679567|NCT02607865|69154854|FG002|Overall Study|Death|1|||
37679568|NCT02607865|69154855|FG003|Overall Study|Death|3|||
37679569|NCT02607865|69154852|FG000|Overall Study|Unclassified|1|||
37679570|NCT02607865|69154853|FG001|Overall Study|Unclassified|1|||
37679571|NCT02607865|69154854|FG002|Overall Study|Unclassified|2|||
37679572|NCT02607865|69154855|FG003|Overall Study|Unclassified|0|||
37679573|NCT01668667|69154869|FG000|Overall Study|Adverse Event|3|||
37679574|NCT01668667|69154870|FG001|Overall Study|Adverse Event|6|||
37679575|NCT01668667|69154871|FG002|Overall Study|Adverse Event|4|||
37679576|NCT01668667|69154872|FG003|Overall Study|Adverse Event|4|||
37679577|NCT01668667|69154869|FG000|Overall Study|Lack of Efficacy|3|||
37679578|NCT01668667|69154870|FG001|Overall Study|Lack of Efficacy|2|||
37679579|NCT01668667|69154871|FG002|Overall Study|Lack of Efficacy|2|||
37679580|NCT01668667|69154872|FG003|Overall Study|Lack of Efficacy|3|||
37679581|NCT01668667|69154869|FG000|Overall Study|Protocol Violation|6|||
37679582|NCT01668667|69154870|FG001|Overall Study|Protocol Violation|10|||
37679583|NCT01668667|69154871|FG002|Overall Study|Protocol Violation|12|||
37679584|NCT01668667|69154872|FG003|Overall Study|Protocol Violation|5|||
37679585|NCT01668667|69154869|FG000|Overall Study|Lost to Follow-up|9|||
37860868|NCT00950599|69544227|FG005|Follow-Up Period|Lost to Follow-up|0|||
37679586|NCT01668667|69154870|FG001|Overall Study|Lost to Follow-up|4|||
37679587|NCT01668667|69154871|FG002|Overall Study|Lost to Follow-up|7|||
37679588|NCT01668667|69154872|FG003|Overall Study|Lost to Follow-up|6|||
37679589|NCT01668667|69154869|FG000|Overall Study|Physician Decision|3|||
37679590|NCT01668667|69154870|FG001|Overall Study|Physician Decision|0|||
37679591|NCT01668667|69154871|FG002|Overall Study|Physician Decision|1|||
37679592|NCT01668667|69154872|FG003|Overall Study|Physician Decision|0|||
37679593|NCT01668667|69154869|FG000|Overall Study|Withdrawal by Subject|7|||
37769234|NCT01401959|69285784|FG001|Treated|Withdrawal by Subject|2|||
37679594|NCT01668667|69154870|FG001|Overall Study|Withdrawal by Subject|4|||
37679595|NCT01668667|69154871|FG002|Overall Study|Withdrawal by Subject|5|||
37679596|NCT01668667|69154872|FG003|Overall Study|Withdrawal by Subject|5|||
37679597|NCT02608879|69154885|FG000|Overall Study|Lost to Follow-up|1|||
37679598|NCT02608879|69154886|FG001|Overall Study|Lost to Follow-up|0|||
37679599|NCT02608879|69154887|FG002|Overall Study|Lost to Follow-up|0|||
37679600|NCT02608879|69154885|FG000|Overall Study|Did not meet continuation criteria|0|||
37679601|NCT02608879|69154886|FG001|Overall Study|Did not meet continuation criteria|0|||
37679602|NCT02608879|69154887|FG002|Overall Study|Did not meet continuation criteria|3|||
37679603|NCT02608099|69154897|FG000|Overall Study|Ablation procedure not initiated|3|||
37679604|NCT02608099|69154898|FG001|Overall Study|Ablation procedure not initiated|2|||
37679605|NCT01668589|69154908|FG000|Overall Study|Lost to Follow-up|29|||
37679606|NCT01668589|69154909|FG001|Overall Study|Lost to Follow-up|37|||
37679607|NCT01668589|69154910|FG002|Overall Study|Lost to Follow-up|15|||
37679608|NCT01668589|69154911|FG003|Overall Study|Lost to Follow-up|5|||
37679609|NCT01668589|69154908|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
37679610|NCT01668589|69154909|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
37679611|NCT01668589|69154910|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
37679612|NCT01668589|69154911|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
37679613|NCT01668589|69154908|FG000|Overall Study|Death|12|||
37679614|NCT01668589|69154909|FG001|Overall Study|Death|3|||
37679615|NCT01668589|69154910|FG002|Overall Study|Death|2|||
37679616|NCT01668589|69154911|FG003|Overall Study|Death|11|||
37679617|NCT01668589|69154908|FG000|Overall Study|Other|44|||
37679618|NCT01668589|69154909|FG001|Overall Study|Other|10|||
37679619|NCT01668589|69154910|FG002|Overall Study|Other|7|||
37679620|NCT01668589|69154911|FG003|Overall Study|Other|15|||
37679621|NCT02432235|69154933|FG000|Overall Study|Death|1|||
37679622|NCT02432235|69154934|FG001|Overall Study|Death|1|||
37679623|NCT02432235|69154935|FG002|Overall Study|Death|2|||
37679624|NCT02432235|69154936|FG003|Overall Study|Death|2|||
37679625|NCT02432235|69154937|FG004|Overall Study|Death|1|||
37679626|NCT02432235|69154938|FG005|Overall Study|Death|3|||
37679627|NCT02432235|69154939|FG006|Overall Study|Death|11|||
37679628|NCT02432235|69154940|FG007|Overall Study|Death|15|||
37679629|NCT02432235|69154941|FG008|Overall Study|Death|15|||
37679630|NCT02432235|69154942|FG009|Overall Study|Death|3|||
37679631|NCT02432235|69154943|FG010|Overall Study|Death|1|||
37679632|NCT02432235|69154944|FG011|Overall Study|Death|0|||
37679633|NCT02432235|69154933|FG000|Overall Study|Withdrawal by Subject|0|||
37679634|NCT02432235|69154934|FG001|Overall Study|Withdrawal by Subject|1|||
37679635|NCT02432235|69154935|FG002|Overall Study|Withdrawal by Subject|0|||
37679636|NCT02432235|69154936|FG003|Overall Study|Withdrawal by Subject|0|||
37679637|NCT02432235|69154937|FG004|Overall Study|Withdrawal by Subject|0|||
37679638|NCT02432235|69154938|FG005|Overall Study|Withdrawal by Subject|2|||
37679639|NCT02432235|69154939|FG006|Overall Study|Withdrawal by Subject|5|||
37679640|NCT02432235|69154940|FG007|Overall Study|Withdrawal by Subject|3|||
37679641|NCT02432235|69154941|FG008|Overall Study|Withdrawal by Subject|1|||
37679642|NCT02432235|69154942|FG009|Overall Study|Withdrawal by Subject|0|||
37679643|NCT02432235|69154943|FG010|Overall Study|Withdrawal by Subject|0|||
37679644|NCT02432235|69154944|FG011|Overall Study|Withdrawal by Subject|0|||
37679645|NCT02432235|69154933|FG000|Overall Study|Lost to Follow-up|0|||
37679646|NCT02432235|69154934|FG001|Overall Study|Lost to Follow-up|0|||
37679647|NCT02432235|69154935|FG002|Overall Study|Lost to Follow-up|0|||
37679648|NCT02432235|69154936|FG003|Overall Study|Lost to Follow-up|0|||
37679649|NCT02432235|69154937|FG004|Overall Study|Lost to Follow-up|0|||
37679650|NCT02432235|69154938|FG005|Overall Study|Lost to Follow-up|1|||
37679651|NCT02432235|69154939|FG006|Overall Study|Lost to Follow-up|0|||
37679652|NCT02432235|69154940|FG007|Overall Study|Lost to Follow-up|0|||
37679653|NCT02432235|69154941|FG008|Overall Study|Lost to Follow-up|1|||
37679654|NCT02432235|69154942|FG009|Overall Study|Lost to Follow-up|0|||
37679655|NCT02432235|69154943|FG010|Overall Study|Lost to Follow-up|0|||
37679656|NCT02432235|69154944|FG011|Overall Study|Lost to Follow-up|0|||
37679657|NCT02432235|69154933|FG000|Overall Study|Miscellaneous|0|||
37679658|NCT02432235|69154934|FG001|Overall Study|Miscellaneous|0|||
37679659|NCT02432235|69154935|FG002|Overall Study|Miscellaneous|0|||
37679660|NCT02432235|69154936|FG003|Overall Study|Miscellaneous|0|||
37679661|NCT02432235|69154937|FG004|Overall Study|Miscellaneous|1|||
37679662|NCT02432235|69154938|FG005|Overall Study|Miscellaneous|6|||
37679663|NCT02432235|69154939|FG006|Overall Study|Miscellaneous|2|||
37679664|NCT02432235|69154940|FG007|Overall Study|Miscellaneous|2|||
37679665|NCT02432235|69154941|FG008|Overall Study|Miscellaneous|4|||
37679666|NCT02432235|69154942|FG009|Overall Study|Miscellaneous|0|||
37679667|NCT02432235|69154943|FG010|Overall Study|Miscellaneous|0|||
37679668|NCT02432235|69154944|FG011|Overall Study|Miscellaneous|1|||
37679669|NCT02431533|69154974|FG000|Overall Study|Withdrawal by Subject|1|||
37679670|NCT02431533|69154975|FG001|Overall Study|Withdrawal by Subject|3|||
37679671|NCT02431533|69154974|FG000|Overall Study|Developed Exclusionary criteria|1|||
37679672|NCT02431533|69154975|FG001|Overall Study|Developed Exclusionary criteria|0|||
37679673|NCT02416791|69154984|FG000|6 Months|Lost to Follow-up|0|||
37679674|NCT02416791|69154985|FG001|6 Months|Lost to Follow-up|0|||
37679675|NCT02416791|69154986|FG002|6 Months|Lost to Follow-up|1|||
37679676|NCT02414841|69154996|FG000|Overall Study|Withdrawal by Subject|7|||
37679677|NCT02414841|69154997|FG001|Overall Study|Withdrawal by Subject|5|||
37679678|NCT02414841|69154996|FG000|Overall Study|Lost to Follow-up|13|||
37679679|NCT02414841|69154997|FG001|Overall Study|Lost to Follow-up|6|||
37679680|NCT02414841|69154996|FG000|Overall Study|Death|17|||
37679681|NCT02414841|69154997|FG001|Overall Study|Death|14|||
37679682|NCT02414841|69154996|FG000|Overall Study|Received a Kidney Transplant|13|||
37679683|NCT02414841|69154997|FG001|Overall Study|Received a Kidney Transplant|4|||
37679684|NCT02414841|69154996|FG000|Overall Study|Randomized But Not Treated|6|||
37679685|NCT02414841|69154997|FG001|Overall Study|Randomized But Not Treated|4|||
37679686|NCT02413593|69155005|FG000|Overall Study|Lost to Follow-up|3|||
37679687|NCT02413593|69155005|FG000|Overall Study|Adverse Event|1|||
37679688|NCT01652703|69155015|FG000|Overall Study|Withdrawal by Subject|0|||
37679689|NCT01652703|69155016|FG001|Overall Study|Withdrawal by Subject|1|||
37679690|NCT01652703|69155017|FG002|Overall Study|Withdrawal by Subject|3|||
37679691|NCT01652703|69155018|FG003|Overall Study|Withdrawal by Subject|1|||
37679692|NCT01652703|69155019|FG004|Overall Study|Withdrawal by Subject|0|||
37679693|NCT01652703|69155020|FG005|Overall Study|Withdrawal by Subject|1|||
37679694|NCT01652703|69155015|FG000|Overall Study|Other|0|||
37679695|NCT01652703|69155016|FG001|Overall Study|Other|0|||
37679696|NCT01652703|69155017|FG002|Overall Study|Other|0|||
37679697|NCT01652703|69155018|FG003|Overall Study|Other|1|||
37679698|NCT01652703|69155019|FG004|Overall Study|Other|1|||
37679699|NCT01652703|69155020|FG005|Overall Study|Other|1|||
37679700|NCT01652469|69155036|FG000|Overall Study|Withdrawal by Subject|1|||
37679701|NCT01652469|69155037|FG001|Overall Study|Withdrawal by Subject|4|||
37679702|NCT01652469|69155036|FG000|Overall Study|Lost to Follow-up|0|||
37679703|NCT01652469|69155037|FG001|Overall Study|Lost to Follow-up|2|||
37679704|NCT02429427|69155045|FG000|Overall Study|Adverse Event|220|||
37679705|NCT02429427|69155046|FG001|Overall Study|Adverse Event|92|||
37679706|NCT02429427|69155045|FG000|Overall Study|Protocol Violation|10|||
37679707|NCT02429427|69155046|FG001|Overall Study|Protocol Violation|6|||
37679708|NCT02429427|69155045|FG000|Overall Study|Lost to Follow-up|15|||
37679709|NCT02429427|69155046|FG001|Overall Study|Lost to Follow-up|6|||
37679710|NCT02429427|69155045|FG000|Overall Study|Withdrawal by Subject|64|||
37679711|NCT02429427|69155046|FG001|Overall Study|Withdrawal by Subject|34|||
37679712|NCT02429427|69155045|FG000|Overall Study|Other|62|||
37679713|NCT02429427|69155046|FG001|Overall Study|Other|41|||
37679714|NCT02412735|69155055|FG000|Overall Study|Adverse Event|0|||
37679715|NCT02412735|69155056|FG001|Overall Study|Adverse Event|1|||
37679716|NCT02412735|69155057|FG002|Overall Study|Adverse Event|2|||
37679717|NCT02412735|69155055|FG000|Overall Study|Withdrawal by Subject|23|||
37679718|NCT02412735|69155056|FG001|Overall Study|Withdrawal by Subject|27|||
37679719|NCT02412735|69155057|FG002|Overall Study|Withdrawal by Subject|22|||
37679720|NCT02412735|69155055|FG000|Overall Study|Investigator Decision|3|||
37679721|NCT02412735|69155056|FG001|Overall Study|Investigator Decision|3|||
37679722|NCT02412735|69155057|FG002|Overall Study|Investigator Decision|2|||
37679723|NCT02412735|69155055|FG000|Overall Study|Lost to Follow-up|17|||
37679724|NCT02412735|69155056|FG001|Overall Study|Lost to Follow-up|11|||
37679725|NCT02412735|69155057|FG002|Overall Study|Lost to Follow-up|18|||
37679726|NCT02412735|69155055|FG000|Overall Study|Reason not Specified|3|||
37679727|NCT02412735|69155056|FG001|Overall Study|Reason not Specified|2|||
37679728|NCT02412735|69155057|FG002|Overall Study|Reason not Specified|2|||
37679729|NCT02412657|69155068|FG000|Overall Study|Lost to Follow-up|1|||
37679730|NCT02412657|69155069|FG001|Overall Study|Lost to Follow-up|0|||
37679731|NCT02412657|69155070|FG002|Overall Study|Lost to Follow-up|0|||
37679732|NCT02412657|69155068|FG000|Overall Study|Protocol Violation|0|||
37679733|NCT02412657|69155069|FG001|Overall Study|Protocol Violation|2|||
37679734|NCT02412657|69155070|FG002|Overall Study|Protocol Violation|3|||
37679735|NCT02428413|69155080|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
37679736|NCT02428413|69155081|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
37679737|NCT02428413|69155080|FG000|Overall Study|Protocol Violation|1|||
37679738|NCT02428413|69155081|FG001|Overall Study|Protocol Violation|2|||
37679739|NCT02428413|69155080|FG000|Overall Study|Case Cancelled|2|||
37679740|NCT02428413|69155081|FG001|Overall Study|Case Cancelled|0|||
37679741|NCT02428413|69155080|FG000|Overall Study|Missed Cases|1|||
37679742|NCT02428413|69155081|FG001|Overall Study|Missed Cases|2|||
37679743|NCT02428413|69155080|FG000|Overall Study|Nurse Refusal|1|||
37679744|NCT02428413|69155081|FG001|Overall Study|Nurse Refusal|0|||
37679745|NCT02412111|69155089|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
37679746|NCT02412111|69155090|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
37679747|NCT02412111|69155091|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
37679748|NCT02412111|69155089|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
37679749|NCT02412111|69155090|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
37679750|NCT02412111|69155091|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
37679751|NCT02412111|69155089|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
37679752|NCT02412111|69155090|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
37679753|NCT02412111|69155091|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
37679754|NCT02412111|69155089|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
37679755|NCT02412111|69155090|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
37679756|NCT02412111|69155091|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
37679757|NCT02412111|69155089|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
37679758|NCT02412111|69155090|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
37679759|NCT02412111|69155091|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
37679760|NCT02412111|69155089|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
37679761|NCT02412111|69155090|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
37679762|NCT02412111|69155091|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
37679763|NCT02412111|69155089|FG000|Active Comparator Period (8 Weeks)|Other|0|||
37679764|NCT02412111|69155090|FG001|Active Comparator Period (8 Weeks)|Other|0|||
37679765|NCT02412111|69155091|FG002|Active Comparator Period (8 Weeks)|Other|2|||
37679766|NCT02427477|69155103|FG000|Period 1|Adverse Event|1|||
37679767|NCT02427477|69155104|FG001|Period 1|Adverse Event|0|||
37679768|NCT02427399|69155115|FG000|Overall Study|Protocol Violation|14|||
37679769|NCT02427399|69155116|FG001|Overall Study|Protocol Violation|16|||
37679770|NCT02427399|69155117|FG002|Overall Study|Protocol Violation|12|||
37679771|NCT02427399|69155118|FG003|Overall Study|Protocol Violation|18|||
37679772|NCT02427399|69155119|FG004|Overall Study|Protocol Violation|15|||
37679773|NCT02426541|69155133|FG000|Overall Study|Protocol Violation|1|||
37679774|NCT02426541|69155134|FG001|Overall Study|Protocol Violation|0|||
37679775|NCT02484651|69155142|FG000|Overall Study|Patients' data files were corrupted.|1|||
37679776|NCT02484651|69155143|FG001|Overall Study|Patients' data files were corrupted.|1|||
37679777|NCT02484651|69155142|FG000|Overall Study|BIS monitoring failed.|1|||
37679778|NCT02484651|69155143|FG001|Overall Study|BIS monitoring failed.|1|||
37679779|NCT02484651|69155142|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
37679780|NCT02484651|69155143|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
37679781|NCT02410551|69155150|FG000|Overall Study|Adverse Event|1|||
37679782|NCT02410551|69155150|FG000|Overall Study|Withdrawal by Subject|1|||
37679783|NCT02410551|69155150|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
37679784|NCT02424591|69155157|FG000|Overall Study|Protocol Violation|2|||
37679785|NCT02424591|69155158|FG001|Overall Study|Protocol Violation|3|||
37679786|NCT02408523|69155166|FG000|Overall Study|Adverse Event|4|||
37679787|NCT02408523|69155167|FG001|Overall Study|Adverse Event|10|||
37679788|NCT02408523|69155166|FG000|Overall Study|Lack of Efficacy|0|||
37679789|NCT02408523|69155167|FG001|Overall Study|Lack of Efficacy|1|||
37679790|NCT02408523|69155166|FG000|Overall Study|Protocol Violation|1|||
37679791|NCT02408523|69155167|FG001|Overall Study|Protocol Violation|2|||
37679792|NCT02408523|69155166|FG000|Overall Study|Lost to Follow-up|2|||
37679793|NCT02408523|69155167|FG001|Overall Study|Lost to Follow-up|3|||
37679794|NCT02408523|69155166|FG000|Overall Study|Withdrawal by Subject|3|||
37679795|NCT02408523|69155167|FG001|Overall Study|Withdrawal by Subject|1|||
37679796|NCT02408523|69155166|FG000|Overall Study|Sponsor request|1|||
37679797|NCT02408523|69155167|FG001|Overall Study|Sponsor request|0|||
37679798|NCT02408523|69155166|FG000|Overall Study|Did not satisfy extension conditions|0|||
37679799|NCT02408523|69155167|FG001|Overall Study|Did not satisfy extension conditions|1|||
37679800|NCT02603419|69155187|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
37679801|NCT02603419|69155188|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
37679802|NCT02603419|69155189|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
37679803|NCT02603419|69155190|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
37679804|NCT02603419|69155191|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
37679805|NCT02603419|69155192|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
37679806|NCT02603419|69155187|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
37679807|NCT02603419|69155188|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
37679808|NCT02603419|69155189|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
37679809|NCT02603419|69155190|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
37769235|NCT01401959|69285785|FG002|Treated|Withdrawal by Subject|2|||
37769236|NCT01401959|69285783|FG000|Treated|Protocol Violation|0|||
37769237|NCT01401959|69285784|FG001|Treated|Protocol Violation|1|||
37769238|NCT01401959|69285785|FG002|Treated|Protocol Violation|0|||
37769239|NCT01478048|69285815|FG000|Overall Study|Disease Progression|52|||
37769240|NCT01478048|69285816|FG001|Overall Study|Disease Progression|35|||
37769241|NCT01478048|69285815|FG000|Overall Study|study drug toxicity|11|||
37769242|NCT01478048|69285816|FG001|Overall Study|study drug toxicity|14|||
37769243|NCT01478048|69285815|FG000|Overall Study|Adverse Event|2|||
37769244|NCT01478048|69285816|FG001|Overall Study|Adverse Event|11|||
37769245|NCT01478048|69285815|FG000|Overall Study|subject request to discontinue treatment|3|||
37769246|NCT01478048|69285816|FG001|Overall Study|subject request to discontinue treatment|5|||
37679810|NCT02603419|69155191|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
37679811|NCT02603419|69155192|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
37679812|NCT02603419|69155187|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
37679813|NCT02603419|69155188|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
37679814|NCT02603419|69155189|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
37679815|NCT02603419|69155190|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
37679816|NCT02603419|69155191|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
37679817|NCT02603419|69155192|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
37679818|NCT02603419|69155187|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
37679819|NCT02603419|69155188|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
37679820|NCT02603419|69155189|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
37679821|NCT02603419|69155190|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
37679822|NCT02603419|69155191|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
37679823|NCT02603419|69155192|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
37679824|NCT02603419|69155187|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
37679825|NCT02603419|69155188|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
37679826|NCT02603419|69155189|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
37679827|NCT02603419|69155190|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
37679828|NCT02603419|69155191|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
37679829|NCT02603419|69155192|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
37679830|NCT02603419|69155187|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
37679831|NCT02603419|69155188|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
37679832|NCT02603419|69155189|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
37679833|NCT02603419|69155190|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
37679834|NCT02603419|69155191|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
37679835|NCT02603419|69155192|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
37679836|NCT02603419|69155187|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
37679837|NCT02603419|69155188|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
37679838|NCT02603419|69155189|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
37679839|NCT02603419|69155190|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
37679840|NCT02603419|69155191|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
37679841|NCT02603419|69155192|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
37679842|NCT02603419|69155187|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
37679843|NCT02603419|69155188|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
37679844|NCT02603419|69155189|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
37679845|NCT02603419|69155190|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
37679846|NCT02603419|69155191|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
37679847|NCT02603419|69155192|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
37679848|NCT02603419|69155187|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
37679849|NCT02603419|69155188|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
37679850|NCT02603419|69155189|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
37679851|NCT02603419|69155190|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
37679852|NCT02603419|69155191|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
37679853|NCT02603419|69155192|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
37679854|NCT02603419|69155187|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
37679855|NCT02603419|69155188|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
37679856|NCT02603419|69155189|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
37679857|NCT02603419|69155190|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
37679858|NCT02603419|69155191|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
37679859|NCT02603419|69155192|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
37679860|NCT01668355|69155209|FG000|Overall Study|Death|3|||
37679861|NCT01668355|69155210|FG001|Overall Study|Death|1|||
37679862|NCT01668355|69155209|FG000|Overall Study|Withdrawal by Subject|6|||
37769247|NCT01478048|69285815|FG000|Overall Study|Withdrawal by Subject|2|||
37679863|NCT01668355|69155210|FG001|Overall Study|Withdrawal by Subject|1|||
37679864|NCT01667731|69155222|FG000|Overall Study|Enrolled but not treated|0|||
37679865|NCT01667731|69155223|FG001|Overall Study|Enrolled but not treated|0|||
37679866|NCT01667731|69155224|FG002|Overall Study|Enrolled but not treated|0|||
37679867|NCT01667731|69155225|FG003|Overall Study|Enrolled but not treated|0|||
37769248|NCT01478048|69285816|FG001|Overall Study|Withdrawal by Subject|5|||
37679868|NCT01667731|69155226|FG004|Overall Study|Enrolled but not treated|1|||
37679869|NCT01667731|69155222|FG000|Overall Study|Efficacy Failure|1|||
37679870|NCT01667731|69155223|FG001|Overall Study|Efficacy Failure|12|||
37679871|NCT01667731|69155224|FG002|Overall Study|Efficacy Failure|0|||
37679872|NCT01667731|69155225|FG003|Overall Study|Efficacy Failure|1|||
37679873|NCT01667731|69155226|FG004|Overall Study|Efficacy Failure|24|||
37679874|NCT01667731|69155222|FG000|Overall Study|Lost to Follow-up|2|||
37679875|NCT01667731|69155223|FG001|Overall Study|Lost to Follow-up|3|||
37679876|NCT01667731|69155224|FG002|Overall Study|Lost to Follow-up|1|||
37679877|NCT01667731|69155225|FG003|Overall Study|Lost to Follow-up|1|||
37679878|NCT01667731|69155226|FG004|Overall Study|Lost to Follow-up|2|||
37679879|NCT01667731|69155222|FG000|Overall Study|Subject Withdrew Consent|2|||
37679880|NCT01667731|69155223|FG001|Overall Study|Subject Withdrew Consent|0|||
37679881|NCT01667731|69155224|FG002|Overall Study|Subject Withdrew Consent|1|||
37679882|NCT01667731|69155225|FG003|Overall Study|Subject Withdrew Consent|0|||
37679883|NCT01667731|69155226|FG004|Overall Study|Subject Withdrew Consent|1|||
37679884|NCT01667731|69155222|FG000|Overall Study|Death|0|||
37679885|NCT01667731|69155223|FG001|Overall Study|Death|1|||
37679886|NCT01667731|69155224|FG002|Overall Study|Death|0|||
37679887|NCT01667731|69155225|FG003|Overall Study|Death|0|||
37679888|NCT01667731|69155226|FG004|Overall Study|Death|0|||
37679889|NCT02605837|69155241|FG000|Overall Study|Adverse Event|3|||
37679890|NCT02605837|69155242|FG001|Overall Study|Adverse Event|1|||
37679891|NCT02605837|69155241|FG000|Overall Study|Non-Compliance with Study Drug|0|||
37679892|NCT02605837|69155242|FG001|Overall Study|Non-Compliance with Study Drug|1|||
37679893|NCT02605837|69155241|FG000|Overall Study|Withdrawal by Subject|8|||
37679894|NCT02605837|69155242|FG001|Overall Study|Withdrawal by Subject|8|||
37679895|NCT02605837|69155241|FG000|Overall Study|Physician Decision|0|||
37679896|NCT02605837|69155242|FG001|Overall Study|Physician Decision|1|||
37679897|NCT02423343|69155255|FG000|Overall Study|Withdrawal by Subject|0|||
37679898|NCT02423343|69155256|FG001|Overall Study|Withdrawal by Subject|1|||
37679899|NCT02423343|69155257|FG002|Overall Study|Withdrawal by Subject|0|||
37679900|NCT02423343|69155258|FG003|Overall Study|Withdrawal by Subject|0|||
37679901|NCT02423343|69155259|FG004|Overall Study|Withdrawal by Subject|0|||
37679902|NCT02423343|69155260|FG005|Overall Study|Withdrawal by Subject|0|||
37679903|NCT02423343|69155255|FG000|Overall Study|Progressive Disease|0|||
37679904|NCT02423343|69155256|FG001|Overall Study|Progressive Disease|0|||
37679905|NCT02423343|69155257|FG002|Overall Study|Progressive Disease|0|||
37679906|NCT02423343|69155258|FG003|Overall Study|Progressive Disease|0|||
37679907|NCT02423343|69155259|FG004|Overall Study|Progressive Disease|2|||
37679908|NCT02423343|69155260|FG005|Overall Study|Progressive Disease|0|||
37679909|NCT02423343|69155255|FG000|Overall Study|Adverse Event|0|||
37679910|NCT02423343|69155256|FG001|Overall Study|Adverse Event|0|||
37679911|NCT02423343|69155257|FG002|Overall Study|Adverse Event|0|||
37679912|NCT02423343|69155258|FG003|Overall Study|Adverse Event|0|||
37679913|NCT02423343|69155259|FG004|Overall Study|Adverse Event|2|||
37679914|NCT02423343|69155260|FG005|Overall Study|Adverse Event|0|||
37679915|NCT02423343|69155255|FG000|Overall Study|Death|0|||
37679916|NCT02423343|69155256|FG001|Overall Study|Death|0|||
37679917|NCT02423343|69155257|FG002|Overall Study|Death|0|||
37679918|NCT02423343|69155258|FG003|Overall Study|Death|0|||
37679919|NCT02423343|69155259|FG004|Overall Study|Death|1|||
37679920|NCT02423343|69155260|FG005|Overall Study|Death|0|||
37679921|NCT02605447|69155288|FG000|Overall Study|Death|66|||
37679922|NCT02605447|69155288|FG000|Overall Study|Physician Decision|1|||
37679923|NCT02605447|69155288|FG000|Overall Study|Lost to Follow-up|24|||
37679924|NCT02605447|69155288|FG000|Overall Study|Withdrawal by Subject|10|||
37679925|NCT02605447|69155288|FG000|Overall Study|Not disclosed|1|||
37679926|NCT02485899|69155295|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
37679927|NCT02485899|69155296|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
37679928|NCT02485899|69155295|FG000|Overall Study|Withdrawal by Subject|1|||
37679929|NCT02485899|69155296|FG001|Overall Study|Withdrawal by Subject|0|||
37679930|NCT02485899|69155295|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
37679931|NCT02485899|69155296|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
37679932|NCT02423109|69155302|FG000|Lens 1|Adverse Event|1|||
37679933|NCT02423109|69155303|FG001|Lens 1|Adverse Event|0|||
37679934|NCT02420691|69155311|FG000|Overall Study|Adverse Event|3|||
37679935|NCT02420691|69155311|FG000|Overall Study|Withdrawal by Subject|3|||
37679936|NCT02406651|69155315|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
37679937|NCT02406261|69155322|FG000|Period 1|Lost to Follow-up|2|||
37679938|NCT02406261|69155323|FG001|Period 1|Lost to Follow-up|0|||
37679939|NCT02406261|69155322|FG000|Period 1|Adverse Event|1|||
37679940|NCT02406261|69155323|FG001|Period 1|Adverse Event|0|||
37679941|NCT02406261|69155322|FG000|Period 2|Physician Decision|0|||
37679942|NCT02406261|69155323|FG001|Period 2|Physician Decision|1|||
37679943|NCT02406261|69155322|FG000|Period 2|Protocol Violation|0|||
37679944|NCT02406261|69155323|FG001|Period 2|Protocol Violation|1|||
37679945|NCT02406261|69155322|FG000|Period 2|Withdrawal by Subject|0|||
37679946|NCT02406261|69155323|FG001|Period 2|Withdrawal by Subject|1|||
37679947|NCT02405091|69155333|FG000|Overall Study|Adverse Event|16|||
37679948|NCT02405091|69155334|FG001|Overall Study|Adverse Event|10|||
37679949|NCT02405091|69155335|FG002|Overall Study|Adverse Event|0|||
37679950|NCT02405091|69155333|FG000|Overall Study|Protocol Violation|1|||
37679951|NCT02405091|69155334|FG001|Overall Study|Protocol Violation|0|||
37679952|NCT02405091|69155335|FG002|Overall Study|Protocol Violation|0|||
37679953|NCT02405091|69155333|FG000|Overall Study|Noncompliance|1|||
37679954|NCT02405091|69155334|FG001|Overall Study|Noncompliance|6|||
37679955|NCT02405091|69155335|FG002|Overall Study|Noncompliance|2|||
37679956|NCT02405091|69155333|FG000|Overall Study|Withdrawal by Subject|4|||
37679957|NCT02405091|69155334|FG001|Overall Study|Withdrawal by Subject|8|||
37679958|NCT02405091|69155335|FG002|Overall Study|Withdrawal by Subject|0|||
37679959|NCT02405091|69155333|FG000|Overall Study|Death|0|||
37679960|NCT02405091|69155334|FG001|Overall Study|Death|1|||
37679961|NCT02405091|69155335|FG002|Overall Study|Death|0|||
37679962|NCT02405091|69155333|FG000|Overall Study|Lost to Follow-up|5|||
37679963|NCT02405091|69155334|FG001|Overall Study|Lost to Follow-up|6|||
37679964|NCT02405091|69155335|FG002|Overall Study|Lost to Follow-up|0|||
37679965|NCT02405091|69155333|FG000|Overall Study|Physician Decision|2|||
37679966|NCT02405091|69155334|FG001|Overall Study|Physician Decision|2|||
37679967|NCT02405091|69155335|FG002|Overall Study|Physician Decision|0|||
37679968|NCT02485353|69155346|FG000|Overall Study|Death|1|||
37679969|NCT02485353|69155346|FG000|Overall Study|Disease Progression|1|||
37679970|NCT02603107|69155352|FG000|Randomized Phase|Withdrew consent|8|||
37679971|NCT02603107|69155353|FG001|Randomized Phase|Withdrew consent|15|||
37679972|NCT02603107|69155352|FG000|Randomized Phase|Lost to Follow-up|1|||
37679973|NCT02603107|69155353|FG001|Randomized Phase|Lost to Follow-up|3|||
37679974|NCT02603107|69155352|FG000|Randomized Phase|Adverse Event|2|||
37679975|NCT02603107|69155353|FG001|Randomized Phase|Adverse Event|0|||
37679976|NCT02603107|69155352|FG000|Randomized Phase|Death|1|||
37679977|NCT02603107|69155353|FG001|Randomized Phase|Death|1|||
37679978|NCT02603107|69155352|FG000|Randomized Phase|Non-compliance with study drug|1|||
37679979|NCT02603107|69155353|FG001|Randomized Phase|Non-compliance with study drug|1|||
37679980|NCT02603107|69155352|FG000|Randomized Phase|Investigator's discretion|0|||
37679981|NCT02603107|69155353|FG001|Randomized Phase|Investigator's discretion|1|||
37679982|NCT02603107|69155352|FG000|Randomized Phase|Lack of Efficacy|1|||
37679983|NCT02603107|69155353|FG001|Randomized Phase|Lack of Efficacy|0|||
37679984|NCT02603107|69155352|FG000|Randomized Phase|Protocol Violation|1|||
37679985|NCT02603107|69155353|FG001|Randomized Phase|Protocol Violation|0|||
37679986|NCT02603107|69155352|FG000|Optional Extension Phase|Lost to Follow-up|3|||
37679987|NCT02603107|69155353|FG001|Optional Extension Phase|Lost to Follow-up|3|||
37679988|NCT02603107|69155352|FG000|Optional Extension Phase|Withdrew consent|3|||
37679989|NCT02603107|69155353|FG001|Optional Extension Phase|Withdrew consent|2|||
37679990|NCT02603107|69155352|FG000|Optional Extension Phase|Investigator's discretion|2|||
37679991|NCT02603107|69155353|FG001|Optional Extension Phase|Investigator's discretion|2|||
37679992|NCT02603107|69155352|FG000|Optional Extension Phase|Pregnancy|0|||
37679993|NCT02603107|69155353|FG001|Optional Extension Phase|Pregnancy|3|||
37679994|NCT02603107|69155352|FG000|Optional Extension Phase|Adverse Event|0|||
37679995|NCT02603107|69155353|FG001|Optional Extension Phase|Adverse Event|2|||
37679996|NCT02603107|69155352|FG000|Optional Extension Phase|Not treated in extension phase|0|||
37679997|NCT02603107|69155353|FG001|Optional Extension Phase|Not treated in extension phase|1|||
37679998|NCT02603107|69155352|FG000|Optional Extension Phase|Protocol Violation|1|||
37679999|NCT02603107|69155353|FG001|Optional Extension Phase|Protocol Violation|0|||
37680000|NCT02484729|69155371|FG000|Overall Study|Failure of IntelliCap Error|0|||
37680001|NCT02484729|69155372|FG001|Overall Study|Failure of IntelliCap Error|0|||
37680002|NCT02484729|69155373|FG002|Overall Study|Failure of IntelliCap Error|0|||
37680003|NCT02484729|69155374|FG003|Overall Study|Failure of IntelliCap Error|0|||
37680004|NCT02484729|69155375|FG004|Overall Study|Failure of IntelliCap Error|0|||
37680005|NCT02484729|69155376|FG005|Overall Study|Failure of IntelliCap Error|0|||
37680006|NCT02484729|69155377|FG006|Overall Study|Failure of IntelliCap Error|0|||
37680007|NCT02484729|69155378|FG007|Overall Study|Failure of IntelliCap Error|0|||
37680008|NCT02484729|69155379|FG008|Overall Study|Failure of IntelliCap Error|0|||
37680009|NCT02484729|69155380|FG009|Overall Study|Failure of IntelliCap Error|1|||
37680010|NCT02601625|69155418|FG000|Overall Study|Lost to Follow-up|0|||
37680011|NCT02601625|69155419|FG001|Overall Study|Lost to Follow-up|0|||
37680012|NCT02601625|69155420|FG002|Overall Study|Lost to Follow-up|1|||
37680013|NCT02601625|69155421|FG003|Overall Study|Lost to Follow-up|1|||
37680014|NCT02601469|69155447|FG000|Overall Study|Enrolled in Error|1|||
37680015|NCT02601469|69155448|FG001|Overall Study|Enrolled in Error|0|||
37680016|NCT02604589|69155457|FG000|Overall Study|catheter dislodgement|0|||
37680017|NCT02604589|69155458|FG001|Overall Study|catheter dislodgement|0|||
37680018|NCT02604589|69155459|FG002|Overall Study|catheter dislodgement|1|||
37680019|NCT02601001|69155470|FG000|Dosing Period 2|Adverse Event|0|||
37680020|NCT02601001|69155471|FG001|Dosing Period 2|Adverse Event|0|||
37680021|NCT02601001|69155472|FG002|Dosing Period 2|Adverse Event|0|||
37680022|NCT02601001|69155473|FG003|Dosing Period 2|Adverse Event|0|||
37680023|NCT02601001|69155474|FG004|Dosing Period 2|Adverse Event|0|||
37680024|NCT02601001|69155475|FG005|Dosing Period 2|Adverse Event|0|||
37680025|NCT02601001|69155476|FG006|Dosing Period 2|Adverse Event|1|||
37680026|NCT02604199|69155501|FG000|Overall Study|Pregnancy|0|||
37680027|NCT02604199|69155502|FG001|Overall Study|Pregnancy|0|||
37680028|NCT02604199|69155503|FG002|Overall Study|Pregnancy|0|||
37680029|NCT02604199|69155504|FG003|Overall Study|Pregnancy|1|||
37680030|NCT02604199|69155501|FG000|Overall Study|Study terminated by sponsor|0|||
37680031|NCT02604199|69155502|FG001|Overall Study|Study terminated by sponsor|2|||
37680032|NCT02604199|69155503|FG002|Overall Study|Study terminated by sponsor|0|||
37680033|NCT02604199|69155504|FG003|Overall Study|Study terminated by sponsor|2|||
37680034|NCT02604199|69155501|FG000|Overall Study|Withdrawal by Subject|0|||
37680035|NCT02604199|69155502|FG001|Overall Study|Withdrawal by Subject|1|||
37680036|NCT02604199|69155503|FG002|Overall Study|Withdrawal by Subject|0|||
37680037|NCT02604199|69155504|FG003|Overall Study|Withdrawal by Subject|0|||
37680038|NCT02600845|69155517|FG000|Overall Study|Reason Not Specified|3|||
37680039|NCT02600845|69155517|FG000|Overall Study|Non-compliance with Study Procedures|10|||
37680040|NCT02600845|69155517|FG000|Overall Study|Consent Withdrawal|5|||
37680041|NCT02599129|69155523|FG000|Overall Study|Lack of Efficacy|2|||
37680042|NCT02599129|69155524|FG001|Overall Study|Lack of Efficacy|2|||
37680043|NCT02599129|69155523|FG000|Overall Study|Lost to Follow-up|1|||
37680044|NCT02599129|69155524|FG001|Overall Study|Lost to Follow-up|0|||
37680045|NCT02599129|69155523|FG000|Overall Study|Withdrawal by Subject|2|||
37680046|NCT02599129|69155524|FG001|Overall Study|Withdrawal by Subject|1|||
37680047|NCT02596711|69155533|FG000|Overall Study|Lost to Follow-up|1|||
37680048|NCT02596711|69155534|FG001|Overall Study|Lost to Follow-up|2|||
37680049|NCT02596711|69155535|FG002|Overall Study|Lost to Follow-up|3|||
37680050|NCT02596009|69155543|FG000|Overall Study|Administrative problems|0|||
37680051|NCT02596009|69155544|FG001|Overall Study|Administrative problems|1|||
37680052|NCT02596009|69155545|FG002|Overall Study|Administrative problems|0|||
37680053|NCT02596009|69155546|FG003|Overall Study|Administrative problems|0|||
37680054|NCT02596009|69155547|FG004|Overall Study|Administrative problems|0|||
37680055|NCT02596009|69155548|FG005|Overall Study|Administrative problems|0|||
37680056|NCT02590939|69155556|FG000|Overall Study|Withdrawal by Subject|3|||
37680057|NCT02590939|69155557|FG001|Overall Study|Withdrawal by Subject|1|||
37680058|NCT02590939|69155556|FG000|Overall Study|Failed the nociceptive test|2|||
37680059|NCT02590939|69155557|FG001|Overall Study|Failed the nociceptive test|1|||
37680060|NCT04351087|69155565|FG000|Overall Study|Lost to Follow-up|7|||
37680061|NCT04351087|69155566|FG001|Overall Study|Lost to Follow-up|3|||
37680062|NCT04351087|69155565|FG000|Overall Study|Withdrawal by Subject|3|||
37680063|NCT04351087|69155566|FG001|Overall Study|Withdrawal by Subject|4|||
37680064|NCT04351087|69155565|FG000|Overall Study|Lack of Efficacy|3|||
37680065|NCT04351087|69155566|FG001|Overall Study|Lack of Efficacy|2|||
37680066|NCT02598193|69155572|FG000|Overall Study|Adverse Event|13|||
37680067|NCT02598193|69155572|FG000|Overall Study|Withdrawal by Subject|1|||
37680068|NCT02598193|69155572|FG000|Overall Study|Listed in active lung transplant list|1|||
37680069|NCT02598193|69155572|FG000|Overall Study|Does not want to take Nintedanib|1|||
37680070|NCT02595073|69155578|FG000|Overall Study|Progressive Disease|0|||
37680071|NCT02595073|69155579|FG001|Overall Study|Progressive Disease|1|||
37680072|NCT02595073|69155578|FG000|Overall Study|Protocol Violation|2|||
37680073|NCT02595073|69155579|FG001|Overall Study|Protocol Violation|0|||
37680074|NCT02593825|69155587|FG000|Intervention|Lost to Follow-up|10|||
37680075|NCT02593825|69155588|FG001|Intervention|Lost to Follow-up|12|||
37680076|NCT02388165|69155598|FG000|Overall Study|Study terminated by sponsor|5|||
37680077|NCT02388165|69155599|FG001|Overall Study|Study terminated by sponsor|5|||
37680078|NCT02388165|69155598|FG000|Overall Study|Other|11|||
37680079|NCT02388165|69155599|FG001|Overall Study|Other|13|||
37680080|NCT02388165|69155598|FG000|Overall Study|No longer meet eligibility criteria|40|||
37680081|NCT02388165|69155599|FG001|Overall Study|No longer meet eligibility criteria|43|||
37680082|NCT02388165|69155598|FG000|Overall Study|Withdrawal of consent|31|||
37680083|NCT02388165|69155599|FG001|Overall Study|Withdrawal of consent|32|||
37680084|NCT02388165|69155598|FG000|Overall Study|Lost to Follow-up|19|||
37680085|NCT02388165|69155599|FG001|Overall Study|Lost to Follow-up|20|||
37680086|NCT02388165|69155598|FG000|Overall Study|Death|13|||
37769249|NCT01478048|69285815|FG000|Overall Study|non-specified|6|||
37680087|NCT02388165|69155599|FG001|Overall Study|Death|10|||
37680088|NCT02388165|69155598|FG000|Overall Study|Adverse Event|3|||
37680089|NCT02388165|69155599|FG001|Overall Study|Adverse Event|5|||
37680090|NCT02388165|69155598|FG000|Overall Study|Did not meet entrance criteria|5|||
37680091|NCT02388165|69155599|FG001|Overall Study|Did not meet entrance criteria|2|||
37680092|NCT02404545|69155607|FG000|Overall Study|Sponsor Termination|6|||
37680093|NCT02404545|69155608|FG001|Overall Study|Sponsor Termination|6|||
37680094|NCT02420379|69155617|FG000|Overall Study|Withdrawal by Subject|0|||
37680095|NCT02420379|69155618|FG001|Overall Study|Withdrawal by Subject|3|||
37680096|NCT02420379|69155617|FG000|Overall Study|Unable to complete due to schooling|0|||
37680097|NCT02420379|69155618|FG001|Overall Study|Unable to complete due to schooling|1|||
37680098|NCT02420379|69155617|FG000|Overall Study|Transitioned to commercial drug|1|||
37680099|NCT02420379|69155618|FG001|Overall Study|Transitioned to commercial drug|0|||
37680100|NCT02347761|69155627|FG000|All Collected|Death|1|||
37680101|NCT02347761|69155628|FG001|All Collected|Death|0|||
37680102|NCT02347761|69155629|FG002|All Collected|Death|0|||
37680103|NCT02347761|69155627|FG000|All Collected|Lost to Follow-up|3|||
37680104|NCT02347761|69155628|FG001|All Collected|Lost to Follow-up|2|||
37680105|NCT02347761|69155629|FG002|All Collected|Lost to Follow-up|3|||
37680106|NCT02347761|69155627|FG000|All Collected|Withdrawal by Subject|11|||
37680107|NCT02347761|69155628|FG001|All Collected|Withdrawal by Subject|11|||
37680108|NCT02347761|69155629|FG002|All Collected|Withdrawal by Subject|22|||
37680109|NCT02347761|69155627|FG000|All Collected|invetigator disretion|2|||
37680110|NCT02347761|69155628|FG001|All Collected|invetigator disretion|0|||
37680111|NCT02347761|69155629|FG002|All Collected|invetigator disretion|0|||
37680112|NCT02347761|69155627|FG000|All Collected|instillation site pain|0|||
37680113|NCT02347761|69155628|FG001|All Collected|instillation site pain|0|||
37680114|NCT02347761|69155629|FG002|All Collected|instillation site pain|1|||
37680115|NCT02347761|69155627|FG000|All Collected|exacerbation of COPD|0|||
37680116|NCT02347761|69155628|FG001|All Collected|exacerbation of COPD|0|||
37680117|NCT02347761|69155629|FG002|All Collected|exacerbation of COPD|1|||
37680118|NCT02347761|69155627|FG000|All Collected|moved/travel|0|||
37680119|NCT02347761|69155628|FG001|All Collected|moved/travel|1|||
37769250|NCT01478048|69285816|FG001|Overall Study|non-specified|4|||
37769251|NCT01478048|69285815|FG000|Overall Study|poor/non-compliance|0|||
37769252|NCT01478048|69285816|FG001|Overall Study|poor/non-compliance|1|||
37769253|NCT01478048|69285815|FG000|Overall Study|no longer meets study criteria|1|||
37769254|NCT01478048|69285816|FG001|Overall Study|no longer meets study criteria|0|||
37769255|NCT01424189|69285824|FG000|Overall Study|Adverse Event|1|||
37769256|NCT01424189|69285825|FG001|Overall Study|Adverse Event|0|||
37769257|NCT01424189|69285824|FG000|Overall Study|Lost to Follow-up|4|||
37769258|NCT01424189|69285825|FG001|Overall Study|Lost to Follow-up|1|||
37769259|NCT01424189|69285824|FG000|Overall Study|Withdrawal by Subject|4|||
37769260|NCT01424189|69285825|FG001|Overall Study|Withdrawal by Subject|4|||
37769261|NCT01424189|69285824|FG000|Overall Study|Subject moved|1|||
37769262|NCT01424189|69285825|FG001|Overall Study|Subject moved|0|||
37680120|NCT02347761|69155629|FG002|All Collected|moved/travel|0|||
37680121|NCT02347761|69155627|FG000|On Study Treatment|Lack of Efficacy|2|||
37680122|NCT02347761|69155628|FG001|On Study Treatment|Lack of Efficacy|3|||
37680123|NCT02347761|69155629|FG002|On Study Treatment|Lack of Efficacy|4|||
37680124|NCT02347761|69155627|FG000|On Study Treatment|non-compliance with study medication|0|||
37680125|NCT02347761|69155628|FG001|On Study Treatment|non-compliance with study medication|0|||
37680126|NCT02347761|69155629|FG002|On Study Treatment|non-compliance with study medication|2|||
37680127|NCT02347761|69155627|FG000|On Study Treatment|Withdrawal by Subject|7|||
37680128|NCT02347761|69155628|FG001|On Study Treatment|Withdrawal by Subject|3|||
37680129|NCT02347761|69155629|FG002|On Study Treatment|Withdrawal by Subject|5|||
37680130|NCT02347761|69155627|FG000|On Study Treatment|move/travel|2|||
37680131|NCT02347761|69155628|FG001|On Study Treatment|move/travel|6|||
37680132|NCT02347761|69155629|FG002|On Study Treatment|move/travel|5|||
37680133|NCT02347761|69155627|FG000|On Study Treatment|dissastisfaction with device|2|||
37680134|NCT02347761|69155628|FG001|On Study Treatment|dissastisfaction with device|1|||
37680135|NCT02347761|69155629|FG002|On Study Treatment|dissastisfaction with device|4|||
37680136|NCT02347761|69155627|FG000|On Study Treatment|Lost to Follow-up|2|||
37680137|NCT02347761|69155628|FG001|On Study Treatment|Lost to Follow-up|1|||
37680138|NCT02347761|69155629|FG002|On Study Treatment|Lost to Follow-up|1|||
37680139|NCT02347761|69155627|FG000|On Study Treatment|investigator discretion|2|||
37680140|NCT02347761|69155628|FG001|On Study Treatment|investigator discretion|0|||
37680141|NCT02347761|69155629|FG002|On Study Treatment|investigator discretion|0|||
37680142|NCT02347761|69155627|FG000|On Study Treatment|durg not working|0|||
37680143|NCT02347761|69155628|FG001|On Study Treatment|durg not working|1|||
37680144|NCT02347761|69155629|FG002|On Study Treatment|durg not working|1|||
37680145|NCT02347761|69155627|FG000|On Study Treatment|Adverse Event|10|||
37680146|NCT02347761|69155628|FG001|On Study Treatment|Adverse Event|8|||
37680147|NCT02347761|69155629|FG002|On Study Treatment|Adverse Event|20|||
37680148|NCT02596945|69155637|FG000|Overall Study|No documentation of study drug dosing|3|||
37680149|NCT02596945|69155637|FG000|Overall Study|Other|32|||
37680150|NCT02596945|69155637|FG000|Overall Study|Change to hemodialysis|15|||
37680151|NCT02596945|69155637|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
37680152|NCT02596945|69155637|FG000|Overall Study|Withdrawal by Subject|1|||
37680153|NCT02596945|69155637|FG000|Overall Study|Missing|1|||
37680154|NCT02404389|69155655|FG000|Overall Study|Adverse Event|1|||
37680155|NCT02404389|69155656|FG001|Overall Study|Adverse Event|0|||
37680156|NCT02404389|69155657|FG002|Overall Study|Adverse Event|1|||
37680157|NCT02404389|69155658|FG003|Overall Study|Adverse Event|0|||
37680158|NCT02404389|69155659|FG004|Overall Study|Adverse Event|2|||
37769263|NCT01424189|69285824|FG000|Overall Study|Death|3|||
37769264|NCT01424189|69285825|FG001|Overall Study|Death|1|||
37769265|NCT01401647|69285838|FG000|Overall Study|Withdrawal by Subject|1|||
37680159|NCT02404389|69155655|FG000|Overall Study|Subject/guardian decision|1|||
37769266|NCT01401647|69285839|FG001|Overall Study|Withdrawal by Subject|5|||
37769267|NCT01401647|69285840|FG002|Overall Study|Withdrawal by Subject|2|||
37680160|NCT02404389|69155656|FG001|Overall Study|Subject/guardian decision|0|||
37680161|NCT02404389|69155657|FG002|Overall Study|Subject/guardian decision|0|||
37680162|NCT02404389|69155658|FG003|Overall Study|Subject/guardian decision|1|||
37680163|NCT02404389|69155659|FG004|Overall Study|Subject/guardian decision|1|||
37680164|NCT01667419|69155677|FG000|Overall Study|Reason Not Specified|1|||
37680165|NCT01667419|69155678|FG001|Overall Study|Reason Not Specified|0|||
37680166|NCT01667419|69155679|FG002|Overall Study|Reason Not Specified|0|||
37680167|NCT01667419|69155680|FG003|Overall Study|Reason Not Specified|0|||
37680168|NCT01667419|69155677|FG000|Overall Study|Withdrawal by Subject|16|||
37680169|NCT01667419|69155678|FG001|Overall Study|Withdrawal by Subject|8|||
37680170|NCT01667419|69155679|FG002|Overall Study|Withdrawal by Subject|9|||
37680171|NCT01667419|69155680|FG003|Overall Study|Withdrawal by Subject|8|||
37680172|NCT01667419|69155677|FG000|Overall Study|Non-compliance|0|||
37680173|NCT01667419|69155678|FG001|Overall Study|Non-compliance|0|||
37680174|NCT01667419|69155679|FG002|Overall Study|Non-compliance|0|||
37680175|NCT01667419|69155680|FG003|Overall Study|Non-compliance|1|||
37680176|NCT01667419|69155677|FG000|Overall Study|Protocol Violation|1|||
37680177|NCT01667419|69155678|FG001|Overall Study|Protocol Violation|0|||
37680178|NCT01667419|69155679|FG002|Overall Study|Protocol Violation|0|||
37680179|NCT01667419|69155680|FG003|Overall Study|Protocol Violation|0|||
37680180|NCT01667419|69155677|FG000|Overall Study|Lost to Follow-up|7|||
37680181|NCT01667419|69155678|FG001|Overall Study|Lost to Follow-up|6|||
37680182|NCT01667419|69155679|FG002|Overall Study|Lost to Follow-up|2|||
37680183|NCT01667419|69155680|FG003|Overall Study|Lost to Follow-up|4|||
37680184|NCT01667419|69155677|FG000|Overall Study|Death|18|||
37680185|NCT01667419|69155678|FG001|Overall Study|Death|33|||
37680186|NCT01667419|69155679|FG002|Overall Study|Death|25|||
37680187|NCT01667419|69155680|FG003|Overall Study|Death|26|||
37680188|NCT02588833|69155697|FG000|Part 1|Withdrawal by Subject|1|||
37680189|NCT02588833|69155698|FG001|Part 1|Withdrawal by Subject|0|||
37680190|NCT02588833|69155697|FG000|Part 2A|Physician Decision|0|||
37680191|NCT02588833|69155698|FG001|Part 2A|Physician Decision|1|||
37680192|NCT02588833|69155697|FG000|Part 2A|Withdrawal by Subject|0|||
37680193|NCT02588833|69155698|FG001|Part 2A|Withdrawal by Subject|1|||
37680194|NCT02588833|69155697|FG000|Part 2B|Adverse Event|0|||
37680195|NCT02588833|69155698|FG001|Part 2B|Adverse Event|1|||
37680196|NCT02588833|69155697|FG000|Part 2C|Adverse Event|0|||
37680197|NCT02588833|69155698|FG001|Part 2C|Adverse Event|1|||
37680198|NCT02588833|69155697|FG000|Part 2C|Withdrawal by Subject|0|||
37680199|NCT02588833|69155698|FG001|Part 2C|Withdrawal by Subject|1|||
37680200|NCT02588833|69155697|FG000|Part 3 (Safety Follow-up)|Other|0|||
37680201|NCT02588833|69155698|FG001|Part 3 (Safety Follow-up)|Other|2|||
37680202|NCT01667107|69155707|FG000|Overall Study|Adverse Event|4|||
37680203|NCT01667107|69155708|FG001|Overall Study|Adverse Event|3|||
37680204|NCT01667107|69155707|FG000|Overall Study|Tolerability issues|0|||
37680205|NCT01667107|69155708|FG001|Overall Study|Tolerability issues|2|||
37680206|NCT01667107|69155707|FG000|Overall Study|Protocol Violation|0|||
37680207|NCT01667107|69155708|FG001|Overall Study|Protocol Violation|1|||
37680208|NCT01667107|69155707|FG000|Overall Study|Lack of Efficacy|0|||
37680209|NCT01667107|69155708|FG001|Overall Study|Lack of Efficacy|1|||
37680210|NCT02590003|69155732|FG000|Overall Study|Death|1|||
37680211|NCT02590003|69155733|FG001|Overall Study|Death|2|||
37680212|NCT02404311|69155762|FG000|Part A: Month 0-18|Death|2|||
37680213|NCT02404311|69155763|FG001|Part A: Month 0-18|Death|0|||
37680214|NCT02404311|69155764|FG002|Part A: Month 0-18|Death|0|||
37680215|NCT02404311|69155765|FG003|Part A: Month 0-18|Death|0|||
37680216|NCT02404311|69155766|FG004|Part A: Month 0-18|Death|0|||
37680217|NCT02404311|69155762|FG000|Part A: Month 0-18|Physician Decision|1|||
37680218|NCT02404311|69155763|FG001|Part A: Month 0-18|Physician Decision|0|||
37680219|NCT02404311|69155764|FG002|Part A: Month 0-18|Physician Decision|0|||
37680220|NCT02404311|69155765|FG003|Part A: Month 0-18|Physician Decision|0|||
37680221|NCT02404311|69155766|FG004|Part A: Month 0-18|Physician Decision|0|||
37680222|NCT02404311|69155762|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
37680223|NCT02404311|69155763|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
37680224|NCT02404311|69155764|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
37680225|NCT02404311|69155765|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
37680226|NCT02404311|69155766|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
37680227|NCT02404311|69155762|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
37680228|NCT02404311|69155763|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
37680229|NCT02404311|69155764|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
37680230|NCT02404311|69155765|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
37680231|NCT02404311|69155766|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
37680232|NCT02404311|69155762|FG000|Part A: Month 0-18|HIV Infection|6|||
37680233|NCT02404311|69155763|FG001|Part A: Month 0-18|HIV Infection|2|||
37769268|NCT01401647|69285838|FG000|Overall Study|Lost to Follow-up|3|||
37680234|NCT02404311|69155764|FG002|Part A: Month 0-18|HIV Infection|0|||
37680235|NCT02404311|69155765|FG003|Part A: Month 0-18|HIV Infection|0|||
37680236|NCT02404311|69155766|FG004|Part A: Month 0-18|HIV Infection|0|||
37680237|NCT02404311|69155762|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
37680238|NCT02404311|69155763|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
37680239|NCT02404311|69155764|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
37680240|NCT02404311|69155765|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
37680241|NCT02404311|69155766|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
37680242|NCT01650519|69155780|FG000|Overall Study|Withdrawal by Subject|1|||
37680243|NCT01650519|69155781|FG001|Overall Study|Withdrawal by Subject|0|||
37680244|NCT01650285|69155787|FG000|Overall Study|Adverse Event|1|||
37680245|NCT02347527|69155795|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
37680246|NCT02347527|69155796|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
37680247|NCT02347527|69155797|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
37680248|NCT02347527|69155798|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
37680249|NCT02347527|69155795|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
37680250|NCT02347527|69155796|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
37680251|NCT02347527|69155797|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
37680252|NCT02347527|69155798|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
37680253|NCT02347527|69155795|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
37680254|NCT02347527|69155796|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
37680255|NCT02347527|69155797|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
37680256|NCT02347527|69155798|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
37680257|NCT02347527|69155795|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
37680258|NCT02347527|69155796|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
37680259|NCT02347527|69155797|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
37680260|NCT02347527|69155798|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
37680261|NCT02347527|69155795|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
37680262|NCT02347527|69155796|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
37680263|NCT02347527|69155797|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
37680264|NCT02347527|69155798|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
37680265|NCT02386839|69155812|FG000|Overall Study|Death|1|||
37680266|NCT02386839|69155813|FG001|Overall Study|Death|0|||
37680267|NCT02386839|69155812|FG000|Overall Study|Withdrawal by Subject|9|||
37680268|NCT02386839|69155813|FG001|Overall Study|Withdrawal by Subject|10|||
37680269|NCT02386839|69155812|FG000|Overall Study|Lost to Follow-up|4|||
37680270|NCT02386839|69155813|FG001|Overall Study|Lost to Follow-up|4|||
37680271|NCT02386839|69155812|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
37680272|NCT02386839|69155813|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
37680273|NCT02386839|69155812|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
37680274|NCT02386839|69155813|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
37680275|NCT02386839|69155812|FG000|Overall Study|Other (unspecified)|1|||
37680276|NCT02386839|69155813|FG001|Overall Study|Other (unspecified)|0|||
37680277|NCT01649271|69155825|FG000|Overall Study|Progressive disease|4|||
37680278|NCT01649271|69155826|FG001|Overall Study|Progressive disease|5|||
37680279|NCT01649271|69155825|FG000|Overall Study|Other Adverse Event|0|||
37680280|NCT01649271|69155826|FG001|Overall Study|Other Adverse Event|2|||
37680281|NCT01649271|69155825|FG000|Overall Study|Withdrawal by Subject|1|||
37680282|NCT01649271|69155826|FG001|Overall Study|Withdrawal by Subject|0|||
37680283|NCT01649271|69155825|FG000|Overall Study|Other than stated above|1|||
37680284|NCT01649271|69155826|FG001|Overall Study|Other than stated above|0|||
37680285|NCT02385669|69155833|FG000|Overall Study|Adverse Event|2|||
37680286|NCT02402907|69155839|FG000|Overall Study|Delivered vaginally|9|||
37680287|NCT02402907|69155840|FG001|Overall Study|Delivered vaginally|3|||
37680288|NCT02402907|69155839|FG000|Overall Study|Delivered outside of Sinai|1|||
37680289|NCT02402907|69155840|FG001|Overall Study|Delivered outside of Sinai|1|||
37680290|NCT02402907|69155839|FG000|Overall Study|Lost to follow up after C-Section|10|||
37680291|NCT02402907|69155840|FG001|Overall Study|Lost to follow up after C-Section|23|||
37680292|NCT02345889|69155850|FG000|Overall Study|Inadequate Bowel Prep|17|||
37680293|NCT02345889|69155851|FG001|Overall Study|Inadequate Bowel Prep|16|||
37680294|NCT02345889|69155852|FG002|Overall Study|Inadequate Bowel Prep|18|||
37680295|NCT02345889|69155853|FG003|Overall Study|Inadequate Bowel Prep|14|||
37680296|NCT02345889|69155850|FG000|Overall Study|Polyposis identified during procedure|1|||
37680297|NCT02345889|69155851|FG001|Overall Study|Polyposis identified during procedure|1|||
37680298|NCT02345889|69155852|FG002|Overall Study|Polyposis identified during procedure|0|||
37680299|NCT02345889|69155853|FG003|Overall Study|Polyposis identified during procedure|1|||
37680300|NCT02345889|69155850|FG000|Overall Study|Recognized ineligible post-randomization|1|||
37680301|NCT02345889|69155851|FG001|Overall Study|Recognized ineligible post-randomization|0|||
37680302|NCT02345889|69155852|FG002|Overall Study|Recognized ineligible post-randomization|2|||
37769269|NCT01401647|69285839|FG001|Overall Study|Lost to Follow-up|3|||
37952504|NCT00624338|69639503|FG002|Overall Study|Adverse Event|18|||
37680303|NCT02345889|69155853|FG003|Overall Study|Recognized ineligible post-randomization|1|||
37769270|NCT01401647|69285840|FG002|Overall Study|Lost to Follow-up|1|||
37769271|NCT01499810|69285848|FG000|Overall Study|Lost to Follow-up|10|||
37769272|NCT01499810|69285848|FG000|Overall Study|Protocol Violation|1|||
37769273|NCT01499810|69285848|FG000|Overall Study|Withdrawal by Subject|1|||
37769274|NCT01423253|69285853|FG000|Overall Study|Adverse Event|2|||
37769275|NCT01423253|69285853|FG000|Overall Study|Lack of Efficacy|2|||
37769276|NCT01423253|69285853|FG000|Overall Study|Lost to Follow-up|1|||
37769277|NCT01423253|69285853|FG000|Overall Study|Protocol Violation|2|||
37769278|NCT01423253|69285853|FG000|Overall Study|Withdrawal by Subject|2|||
37769279|NCT01477892|69285859|FG000|Overall Study|Withdrawal by Subject|0|||
37769280|NCT01477892|69285860|FG001|Overall Study|Withdrawal by Subject|2|||
37769281|NCT01422239|69285873|FG000|Overall Study|Lost to Follow-up|4|||
37769282|NCT01422239|69285874|FG001|Overall Study|Lost to Follow-up|3|||
37769283|NCT01499576|69285880|FG000|Overall Study|Physician Decision|12|||
37769284|NCT01499576|69285880|FG000|Overall Study|Withdrawal by Subject|9|||
37769285|NCT01476722|69285894|FG000|Overall Study|Adverse Event|1|||
37769286|NCT01476644|69285907|FG000|Overall Study|Death|5|||
37769287|NCT01476644|69285907|FG000|Overall Study|moved to another state|2|||
37769288|NCT01476644|69285907|FG000|Overall Study|Lost to Follow-up|19|||
37769289|NCT01476644|69285907|FG000|Overall Study|Withdrawal by Subject|13|||
37769290|NCT01421459|69285931|FG000|Overall Study|Adverse Event|6|||
37769291|NCT01421459|69285932|FG001|Overall Study|Adverse Event|10|||
37769292|NCT01421459|69285931|FG000|Overall Study|Death|1|||
37769293|NCT01421459|69285932|FG001|Overall Study|Death|1|||
37769294|NCT01421459|69285931|FG000|Overall Study|Lack of Efficacy|1|||
37769295|NCT01421459|69285932|FG001|Overall Study|Lack of Efficacy|2|||
37769296|NCT01421459|69285931|FG000|Overall Study|Lost to Follow-up|8|||
37769297|NCT01421459|69285932|FG001|Overall Study|Lost to Follow-up|9|||
37769298|NCT01421459|69285931|FG000|Overall Study|Physician Decision|9|||
37769299|NCT01421459|69285932|FG001|Overall Study|Physician Decision|9|||
37769300|NCT01421459|69285931|FG000|Overall Study|Protocol Violation|8|||
37769301|NCT01421459|69285932|FG001|Overall Study|Protocol Violation|5|||
37769302|NCT01421459|69285931|FG000|Overall Study|Withdrawal by Subject|12|||
37769303|NCT01421459|69285932|FG001|Overall Study|Withdrawal by Subject|16|||
37769304|NCT01498952|69285940|FG000|Overall Study|Death|2|||
37769305|NCT01498952|69285941|FG001|Overall Study|Death|2|||
37769306|NCT01498952|69285942|FG002|Overall Study|Death|0|||
37769307|NCT01498952|69285943|FG003|Overall Study|Death|0|||
37769308|NCT01498952|69285944|FG004|Overall Study|Death|0|||
37769309|NCT01461044|69285976|FG000|Overall Study|Death|58|||
37769310|NCT01461044|69285977|FG001|Overall Study|Death|35|||
37769311|NCT01461044|69285976|FG000|Overall Study|Lost to Follow-up|12|||
37769312|NCT01461044|69285977|FG001|Overall Study|Lost to Follow-up|5|||
37769313|NCT01421303|69286010|FG000|Overall Study|Lost to Follow-up|13|||
37769314|NCT01421303|69286010|FG000|Overall Study|Non compliance with study procedure|1|||
37769315|NCT01421303|69286010|FG000|Overall Study|Other|7|||
37769316|NCT01421303|69286010|FG000|Overall Study|Withdrawal by Subject|1|||
37769317|NCT01475474|69286014|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
37769318|NCT01475474|69286014|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
37769319|NCT01400243|69286021|FG000|Overall Study|Protocol Violation|8|||
37769320|NCT01400243|69286022|FG001|Overall Study|Protocol Violation|11|||
37769321|NCT01475162|69286039|FG000|Overall Study|Physician Decision|1|||
37769322|NCT01475162|69286039|FG000|Overall Study|Death|10|||
37769323|NCT01475162|69286039|FG000|Overall Study|Study closed for safety|3|||
37769324|NCT01421225|69286046|FG000|Overall Study|Withdrawal by Subject|0|||
37769325|NCT01421225|69286047|FG001|Overall Study|Withdrawal by Subject|1|||
37769326|NCT01498640|69286063|FG000|Overall Study|Lost to Follow-up|1|||
37769327|NCT01498640|69286063|FG000|Overall Study|Death|1|||
37769328|NCT01498640|69286063|FG000|Overall Study|Other|3|||
37769329|NCT01498484|69286075|FG000|Overall Study|Death|6|||
37769330|NCT01498484|69286076|FG001|Overall Study|Death|3|||
37769331|NCT01498484|69286077|FG002|Overall Study|Death|1|||
37769332|NCT01498484|69286078|FG003|Overall Study|Death|1|||
37769333|NCT01498484|69286079|FG004|Overall Study|Death|0|||
37769334|NCT01498484|69286080|FG005|Overall Study|Death|0|||
37769335|NCT01498484|69286081|FG006|Overall Study|Death|10|||
37769336|NCT01498484|69286082|FG007|Overall Study|Death|1|||
37769337|NCT01498484|69286083|FG008|Overall Study|Death|0|||
37769338|NCT01498484|69286075|FG000|Overall Study|Physician Decision|3|||
37769339|NCT01498484|69286076|FG001|Overall Study|Physician Decision|2|||
37769340|NCT01498484|69286077|FG002|Overall Study|Physician Decision|1|||
37769341|NCT01498484|69286078|FG003|Overall Study|Physician Decision|1|||
37769342|NCT01498484|69286079|FG004|Overall Study|Physician Decision|0|||
37769343|NCT01498484|69286080|FG005|Overall Study|Physician Decision|0|||
37769344|NCT01498484|69286081|FG006|Overall Study|Physician Decision|8|||
37769345|NCT01498484|69286082|FG007|Overall Study|Physician Decision|13|||
37769346|NCT01498484|69286083|FG008|Overall Study|Physician Decision|1|||
37769347|NCT01498484|69286075|FG000|Overall Study|Adverse Event|0|||
37769348|NCT01498484|69286076|FG001|Overall Study|Adverse Event|0|||
37769349|NCT01498484|69286077|FG002|Overall Study|Adverse Event|0|||
37769350|NCT01498484|69286078|FG003|Overall Study|Adverse Event|0|||
37769351|NCT01498484|69286079|FG004|Overall Study|Adverse Event|0|||
37769352|NCT01498484|69286080|FG005|Overall Study|Adverse Event|1|||
37769353|NCT01498484|69286081|FG006|Overall Study|Adverse Event|0|||
37769354|NCT01498484|69286082|FG007|Overall Study|Adverse Event|0|||
37769355|NCT01498484|69286083|FG008|Overall Study|Adverse Event|0|||
37769356|NCT01498484|69286075|FG000|Overall Study|Withdrawal by Subject|0|||
37769357|NCT01498484|69286076|FG001|Overall Study|Withdrawal by Subject|0|||
37769358|NCT01498484|69286077|FG002|Overall Study|Withdrawal by Subject|0|||
37769359|NCT01498484|69286078|FG003|Overall Study|Withdrawal by Subject|1|||
37769360|NCT01498484|69286079|FG004|Overall Study|Withdrawal by Subject|0|||
37769361|NCT01498484|69286080|FG005|Overall Study|Withdrawal by Subject|0|||
37769362|NCT01498484|69286081|FG006|Overall Study|Withdrawal by Subject|1|||
37769363|NCT01498484|69286082|FG007|Overall Study|Withdrawal by Subject|0|||
37769364|NCT01498484|69286083|FG008|Overall Study|Withdrawal by Subject|0|||
37769365|NCT01498484|69286075|FG000|Overall Study|Other|5|||
37769366|NCT01498484|69286076|FG001|Overall Study|Other|2|||
37769367|NCT01498484|69286077|FG002|Overall Study|Other|0|||
37769368|NCT01498484|69286078|FG003|Overall Study|Other|0|||
37769369|NCT01498484|69286079|FG004|Overall Study|Other|1|||
37769370|NCT01498484|69286080|FG005|Overall Study|Other|0|||
37769371|NCT01498484|69286081|FG006|Overall Study|Other|3|||
37769372|NCT01498484|69286082|FG007|Overall Study|Other|0|||
37769373|NCT01498484|69286083|FG008|Overall Study|Other|1|||
37769374|NCT01474772|69286092|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
37769375|NCT01474772|69286093|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
37769376|NCT01474772|69286092|FG000|Period 1|AE not Related to Study Drug|1|||
37769377|NCT01474772|69286093|FG001|Period 1|AE not Related to Study Drug|0|||
37769378|NCT01474772|69286092|FG000|Period 1|Withdrawal by Subject|3|||
37769379|NCT01474772|69286093|FG001|Period 1|Withdrawal by Subject|1|||
37769380|NCT01474772|69286092|FG000|Period 1|Lost to Follow-up|1|||
37769381|NCT01474772|69286093|FG001|Period 1|Lost to Follow-up|0|||
37769382|NCT01474772|69286092|FG000|Period 1|Reason not Specified|1|||
37769383|NCT01474772|69286093|FG001|Period 1|Reason not Specified|1|||
37769384|NCT01474772|69286092|FG000|Washout|AE not Related to Study Drug|2|||
37769385|NCT01474772|69286093|FG001|Washout|AE not Related to Study Drug|0|||
37769386|NCT01474772|69286092|FG000|Washout|Withdrawal by Subject|1|||
37769387|NCT01474772|69286093|FG001|Washout|Withdrawal by Subject|0|||
37769388|NCT01474772|69286092|FG000|Washout|Lost to Follow-up|0|||
37769389|NCT01474772|69286093|FG001|Washout|Lost to Follow-up|1|||
37769390|NCT01474772|69286092|FG000|Washout|Reason not Specified|0|||
37769391|NCT01474772|69286093|FG001|Washout|Reason not Specified|1|||
37769392|NCT01474772|69286092|FG000|Period 2|Death|0|||
37769393|NCT01474772|69286093|FG001|Period 2|Death|1|||
37769394|NCT01474772|69286092|FG000|Period 2|AE Related to Study Drug|0|||
37769395|NCT01474772|69286093|FG001|Period 2|AE Related to Study Drug|1|||
37769396|NCT01474772|69286092|FG000|Period 2|AE not Related to Study Drug|4|||
37769397|NCT01474772|69286093|FG001|Period 2|AE not Related to Study Drug|1|||
37769398|NCT01474772|69286092|FG000|Period 2|Lack of Efficacy|1|||
37769399|NCT01474772|69286093|FG001|Period 2|Lack of Efficacy|0|||
37769400|NCT01474772|69286092|FG000|Period 2|Withdrawal by Subject|3|||
37769401|NCT01474772|69286093|FG001|Period 2|Withdrawal by Subject|4|||
37769402|NCT01474772|69286092|FG000|Period 2|Lost to Follow-up|1|||
37769403|NCT01474772|69286093|FG001|Period 2|Lost to Follow-up|1|||
37769404|NCT01474772|69286092|FG000|Period 2|Reason not Specified|0|||
37769405|NCT01474772|69286093|FG001|Period 2|Reason not Specified|2|||
37769406|NCT01474772|69286092|FG000|Follow-up|AE not Related to Study Drug|0|||
37769407|NCT01474772|69286093|FG001|Follow-up|AE not Related to Study Drug|1|||
37769408|NCT01421147|69286101|FG000|Treatment Period|Adverse Event|2|||
37769409|NCT01421147|69286102|FG001|Treatment Period|Adverse Event|3|||
37769410|NCT01421147|69286101|FG000|Treatment Period|Lost to Follow-up|2|||
37769411|NCT01421147|69286102|FG001|Treatment Period|Lost to Follow-up|1|||
37769412|NCT01421147|69286101|FG000|Treatment Period|Physician Decision|2|||
37769413|NCT01421147|69286102|FG001|Treatment Period|Physician Decision|2|||
37769414|NCT01421147|69286101|FG000|Treatment Period|Withdrawal by Subject|10|||
37769415|NCT01421147|69286102|FG001|Treatment Period|Withdrawal by Subject|5|||
37769416|NCT01421147|69286101|FG000|Extension Period|Adverse Event|0|||
37769417|NCT01421147|69286102|FG001|Extension Period|Adverse Event|2|||
37769418|NCT01421147|69286101|FG000|Extension Period|Death|0|||
37769419|NCT01421147|69286102|FG001|Extension Period|Death|1|||
37769420|NCT01421147|69286101|FG000|Extension Period|Lost to Follow-up|2|||
37769421|NCT01421147|69286102|FG001|Extension Period|Lost to Follow-up|5|||
37769422|NCT01421147|69286101|FG000|Extension Period|Physician Decision|1|||
37769423|NCT01421147|69286102|FG001|Extension Period|Physician Decision|0|||
37769424|NCT01421147|69286101|FG000|Extension Period|Withdrawal by Subject|5|||
37769425|NCT01421147|69286102|FG001|Extension Period|Withdrawal by Subject|3|||
37769426|NCT01497938|69286119|FG000|Overall Study|Adverse Event|0|||
37769427|NCT01497938|69286120|FG001|Overall Study|Adverse Event|1|||
37769428|NCT01497938|69286119|FG000|Overall Study|Physician Decision|0|||
37769429|NCT01497938|69286120|FG001|Overall Study|Physician Decision|1|||
37769430|NCT01497938|69286119|FG000|Overall Study|Withdrawal by Subject|4|||
37769431|NCT01497938|69286120|FG001|Overall Study|Withdrawal by Subject|0|||
37769432|NCT01497938|69286119|FG000|Overall Study|Device Violation|1|||
37769433|NCT01497938|69286120|FG001|Overall Study|Device Violation|0|||
37769434|NCT01460342|69286170|FG000|Overall Study|Adverse Event|5|||
37769435|NCT01460342|69286171|FG001|Overall Study|Adverse Event|4|||
37769436|NCT01460342|69286170|FG000|Overall Study|Lost to Follow-up|1|||
37769437|NCT01460342|69286171|FG001|Overall Study|Lost to Follow-up|2|||
37769438|NCT01460342|69286170|FG000|Overall Study|Protocol Violation|0|||
37769439|NCT01460342|69286171|FG001|Overall Study|Protocol Violation|1|||
37769440|NCT01460342|69286170|FG000|Overall Study|Withdrawal by Subject|3|||
37769441|NCT01460342|69286171|FG001|Overall Study|Withdrawal by Subject|4|||
37769442|NCT01460342|69286170|FG000|Overall Study|Physician Decision|1|||
37769443|NCT01460342|69286171|FG001|Overall Study|Physician Decision|3|||
37769444|NCT01460342|69286170|FG000|Overall Study|Lack of Efficacy|1|||
37769445|NCT01460342|69286171|FG001|Overall Study|Lack of Efficacy|0|||
37769446|NCT01459796|69286203|FG000|Overall Study|Non compliance with protocol|2|||
37769447|NCT01459796|69286204|FG001|Overall Study|Non compliance with protocol|4|||
37769448|NCT01459796|69286203|FG000|Overall Study|Adverse Event|5|||
37769449|NCT01459796|69286204|FG001|Overall Study|Adverse Event|5|||
37769450|NCT01459796|69286203|FG000|Overall Study|Withdrawal by Subject|6|||
37769451|NCT01459796|69286204|FG001|Overall Study|Withdrawal by Subject|3|||
37769452|NCT01459796|69286203|FG000|Overall Study|Lost to Follow-up|5|||
37769453|NCT01459796|69286204|FG001|Overall Study|Lost to Follow-up|4|||
37769454|NCT01459796|69286203|FG000|Overall Study|Reason unspecified|1|||
37769455|NCT01459796|69286204|FG001|Overall Study|Reason unspecified|2|||
37769456|NCT01459796|69286203|FG000|Overall Study|Decision by the sponsor|75|||
37769457|NCT01459796|69286204|FG001|Overall Study|Decision by the sponsor|108|||
37769458|NCT01459718|69286214|FG000|Overall Study|Physician Decision|1|||
37769459|NCT01459718|69286214|FG000|Overall Study|Lost to Follow-up|1|||
37769460|NCT01459718|69286214|FG000|Overall Study|Adverse Event|1|||
37769461|NCT04008069|69286218|FG000|Open-Label Period|Adverse Event|1|||
37769462|NCT04008069|69286219|FG001|Open-Label Period|Adverse Event|0|||
37769463|NCT04008069|69286220|FG002|Open-Label Period|Adverse Event|0|||
37769464|NCT04008069|69286218|FG000|Open-Label Period|Lack of Efficacy|4|||
37769465|NCT04008069|69286219|FG001|Open-Label Period|Lack of Efficacy|0|||
37769466|NCT04008069|69286220|FG002|Open-Label Period|Lack of Efficacy|0|||
37769467|NCT04008069|69286218|FG000|Randomized-Withdrawal Period|Adverse Event|0|||
37769468|NCT04008069|69286219|FG001|Randomized-Withdrawal Period|Adverse Event|1|||
37769469|NCT04008069|69286220|FG002|Randomized-Withdrawal Period|Adverse Event|2|||
37769470|NCT04008069|69286218|FG000|Randomized-Withdrawal Period|Lack of Efficacy|0|||
37769471|NCT04008069|69286219|FG001|Randomized-Withdrawal Period|Lack of Efficacy|0|||
37769472|NCT04008069|69286220|FG002|Randomized-Withdrawal Period|Lack of Efficacy|1|||
37769473|NCT01474538|69286240|FG000|Treatment Period 1|Death|1|||
37769474|NCT01474538|69286241|FG001|Treatment Period 1|Death|0|||
37769475|NCT01474538|69286240|FG000|Treatment Period 1|Physician Decision|1|||
37769476|NCT01474538|69286241|FG001|Treatment Period 1|Physician Decision|0|||
37769477|NCT01474538|69286240|FG000|Treatment Period 1|Withdrawal by Subject|1|||
37769478|NCT01474538|69286241|FG001|Treatment Period 1|Withdrawal by Subject|3|||
37769479|NCT01474538|69286240|FG000|Treatment Period 1|Protocol Violation|0|||
37769480|NCT01474538|69286241|FG001|Treatment Period 1|Protocol Violation|1|||
37769481|NCT01474538|69286240|FG000|Treatment Period 2|Death|1|||
37769482|NCT01474538|69286241|FG001|Treatment Period 2|Death|0|||
37769483|NCT01474538|69286240|FG000|Treatment Period 2|Adverse Event|1|||
37769484|NCT01474538|69286241|FG001|Treatment Period 2|Adverse Event|1|||
37769485|NCT01474538|69286240|FG000|Treatment Period 2|Withdrawal by Subject|2|||
37769486|NCT01474538|69286241|FG001|Treatment Period 2|Withdrawal by Subject|0|||
37769487|NCT01474538|69286240|FG000|Treatment Period 2|Sponsor decision|1|||
37769488|NCT01474538|69286241|FG001|Treatment Period 2|Sponsor decision|0|||
37769489|NCT01474538|69286240|FG000|Treatment Period 2|Physician Decision|0|||
37769490|NCT01474538|69286241|FG001|Treatment Period 2|Physician Decision|1|||
37769491|NCT01474538|69286240|FG000|Treatment Period 2|Protocol Violation|1|||
37769492|NCT01474538|69286241|FG001|Treatment Period 2|Protocol Violation|0|||
37769493|NCT02647788|69286249|FG000|Overall Study|Lost to Follow-up|13|||
37769494|NCT02647788|69286250|FG001|Overall Study|Lost to Follow-up|11|||
37769495|NCT02647788|69286249|FG000|Overall Study|Did not want opiate|0|||
37769496|NCT02647788|69286250|FG001|Overall Study|Did not want opiate|1|||
37769497|NCT02647788|69286249|FG000|Overall Study|Withdrawal by Subject|1|||
37769498|NCT02647788|69286250|FG001|Overall Study|Withdrawal by Subject|0|||
37769499|NCT02647788|69286249|FG000|Overall Study|Felt itchy with assigned medication|1|||
37769500|NCT02647788|69286250|FG001|Overall Study|Felt itchy with assigned medication|0|||
37769501|NCT02647788|69286249|FG000|Overall Study|Felt nauseous with assigned medication|1|||
37769502|NCT02647788|69286250|FG001|Overall Study|Felt nauseous with assigned medication|1|||
37769503|NCT01459016|69286256|FG000|Overall Study|Withdrawal by Subject|11|||
37769504|NCT01459016|69286256|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
37769505|NCT01458392|69286298|FG000|Overall Study|Death|2|||
37769506|NCT01458392|69286299|FG001|Overall Study|Death|11|||
37769507|NCT01458392|69286300|FG002|Overall Study|Death|22|||
37769508|NCT01458392|69286298|FG000|Overall Study|At the discretion of the sponsor|0|||
37769509|NCT01458392|69286299|FG001|Overall Study|At the discretion of the sponsor|2|||
37769510|NCT01458392|69286300|FG002|Overall Study|At the discretion of the sponsor|7|||
37769511|NCT01458392|69286298|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
37769512|NCT01458392|69286299|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
37769513|NCT01458392|69286300|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
37769514|NCT01421069|69286312|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
37769515|NCT01421069|69286312|FG000|Parent Study|Failed to return|3|||
37769516|NCT01421069|69286312|FG000|Parent Study|Withdrawal by Subject|1|||
37769517|NCT01421069|69286312|FG000|Parent Study|Lost to Follow-up|2|||
37769518|NCT01421069|69286312|FG000|Parent Study|Lack of Efficacy|1|||
37769519|NCT01421069|69286312|FG000|Overall Period for Extension Study|Other|2|||
37769520|NCT01421069|69286312|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
37769521|NCT01421069|69286312|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
37769522|NCT01421069|69286312|FG000|Overall Period for Extension Study|Pregnancy|1|||
37769523|NCT01421069|69286312|FG000|Overall Period for Extension Study|Adverse Event|1|||
37860869|NCT00950599|69544228|FG006|Follow-Up Period|Lost to Follow-up|0|||
37860870|NCT00950599|69544229|FG007|Follow-Up Period|Lost to Follow-up|0|||
37860871|NCT00950599|69544230|FG008|Follow-Up Period|Lost to Follow-up|5|||
37860872|NCT00950599|69544231|FG009|Follow-Up Period|Lost to Follow-up|1|||
37860873|NCT00950599|69544222|FG000|Follow-Up Period|Physician Decision|0|||
37860874|NCT00950599|69544223|FG001|Follow-Up Period|Physician Decision|0|||
37860875|NCT00950599|69544224|FG002|Follow-Up Period|Physician Decision|0|||
37860876|NCT00950599|69544225|FG003|Follow-Up Period|Physician Decision|0|||
37860877|NCT00950599|69544226|FG004|Follow-Up Period|Physician Decision|0|||
37860878|NCT00950599|69544227|FG005|Follow-Up Period|Physician Decision|0|||
37860879|NCT00950599|69544228|FG006|Follow-Up Period|Physician Decision|0|||
37860880|NCT00950599|69544229|FG007|Follow-Up Period|Physician Decision|0|||
37860881|NCT00950599|69544230|FG008|Follow-Up Period|Physician Decision|1|||
37860882|NCT00950599|69544231|FG009|Follow-Up Period|Physician Decision|0|||
37860883|NCT00950599|69544222|FG000|Follow-Up Period|Poor/Noncompliance|0|||
37860884|NCT00950599|69544223|FG001|Follow-Up Period|Poor/Noncompliance|0|||
37860885|NCT00950599|69544224|FG002|Follow-Up Period|Poor/Noncompliance|0|||
37860886|NCT00950599|69544225|FG003|Follow-Up Period|Poor/Noncompliance|0|||
37860887|NCT00950599|69544226|FG004|Follow-Up Period|Poor/Noncompliance|0|||
37860888|NCT00950599|69544227|FG005|Follow-Up Period|Poor/Noncompliance|0|||
37860889|NCT00950599|69544228|FG006|Follow-Up Period|Poor/Noncompliance|0|||
37860890|NCT00950599|69544229|FG007|Follow-Up Period|Poor/Noncompliance|0|||
37860891|NCT00950599|69544230|FG008|Follow-Up Period|Poor/Noncompliance|1|||
37860892|NCT00950599|69544231|FG009|Follow-Up Period|Poor/Noncompliance|0|||
37860893|NCT00950599|69544222|FG000|Follow-Up Period|Subject withdrew Consent|0|||
37860894|NCT00950599|69544223|FG001|Follow-Up Period|Subject withdrew Consent|0|||
37860895|NCT00950599|69544224|FG002|Follow-Up Period|Subject withdrew Consent|0|||
37860896|NCT00950599|69544225|FG003|Follow-Up Period|Subject withdrew Consent|0|||
37860897|NCT00950599|69544226|FG004|Follow-Up Period|Subject withdrew Consent|0|||
37860898|NCT00950599|69544227|FG005|Follow-Up Period|Subject withdrew Consent|0|||
37860899|NCT00950599|69544228|FG006|Follow-Up Period|Subject withdrew Consent|0|||
37860900|NCT00950599|69544229|FG007|Follow-Up Period|Subject withdrew Consent|0|||
37860901|NCT00950599|69544230|FG008|Follow-Up Period|Subject withdrew Consent|2|||
37860902|NCT00950599|69544231|FG009|Follow-Up Period|Subject withdrew Consent|1|||
37860903|NCT01144299|69544256|FG000|Overall Study|Lost to Follow-up|1|||
37860904|NCT01144299|69544257|FG001|Overall Study|Lost to Follow-up|0|||
37860905|NCT01144299|69544256|FG000|Overall Study|Withdrawal by Subject|1|||
37860906|NCT01144299|69544257|FG001|Overall Study|Withdrawal by Subject|0|||
37860907|NCT01143207|69544263|FG000|Overall Study|Lost to Follow-up|2|||
37860908|NCT01143051|69544273|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
37860909|NCT01143051|69544274|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
37860910|NCT01143051|69544275|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
37860911|NCT01143051|69544276|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
37860912|NCT01143051|69544277|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
37860913|NCT01143051|69544278|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
37860914|NCT01143051|69544273|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
37860915|NCT01143051|69544274|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
37860916|NCT01143051|69544275|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
37860917|NCT01143051|69544276|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
37860918|NCT01143051|69544277|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
37860919|NCT01143051|69544278|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
37860920|NCT01142661|69544288|FG000|Overall Study|Adverse Event|2|||
37860921|NCT01142661|69544288|FG000|Overall Study|Withdrawal by Subject|1|||
37860922|NCT01142661|69544288|FG000|Overall Study|Physician Decision|1|||
37860923|NCT01142193|69544294|FG000|Overall Study|Adverse Event|12|||
37860924|NCT01142193|69544295|FG001|Overall Study|Adverse Event|4|||
37860925|NCT01142193|69544294|FG000|Overall Study|Lack of Efficacy|2|||
37860926|NCT01142193|69544295|FG001|Overall Study|Lack of Efficacy|1|||
37860927|NCT01142193|69544294|FG000|Overall Study|Physician Decision|1|||
37860928|NCT01142193|69544295|FG001|Overall Study|Physician Decision|1|||
37860929|NCT01142193|69544294|FG000|Overall Study|Withdrawal by Subject|4|||
37860930|NCT01142193|69544295|FG001|Overall Study|Withdrawal by Subject|3|||
37860931|NCT01142193|69544294|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
37860932|NCT01142193|69544295|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
37860933|NCT01142193|69544294|FG000|Overall Study|Other|1|||
37860934|NCT01142193|69544295|FG001|Overall Study|Other|2|||
37860935|NCT01142115|69544301|FG000|First Intervention|Lack of Efficacy|1|||
37860936|NCT01142115|69544302|FG001|First Intervention|Lack of Efficacy|1|||
37860937|NCT01142115|69544301|FG000|First Intervention|Adverse Event|1|||
37860938|NCT01142115|69544302|FG001|First Intervention|Adverse Event|0|||
37860939|NCT01140477|69544309|FG000|Overall Study|Lost to Follow-up|4|||
37860940|NCT01140477|69544310|FG001|Overall Study|Lost to Follow-up|0|||
37860941|NCT01140477|69544309|FG000|Overall Study|Withdrawal by Subject|1|||
37860942|NCT01140477|69544310|FG001|Overall Study|Withdrawal by Subject|4|||
37860943|NCT01140477|69544309|FG000|Overall Study|Surgical complication preventing implant|2|||
37860944|NCT01140477|69544310|FG001|Overall Study|Surgical complication preventing implant|0|||
37860945|NCT01140477|69544309|FG000|Overall Study|Death|1|||
37860946|NCT01140477|69544310|FG001|Overall Study|Death|1|||
37860947|NCT01140477|69544309|FG000|Overall Study|Subject explanted|0|||
37860948|NCT01140477|69544310|FG001|Overall Study|Subject explanted|1|||
37860949|NCT01139775|69544319|FG000|Overall Study|Adverse Event|0|||
37860950|NCT01139775|69544320|FG001|Overall Study|Adverse Event|6|||
37860951|NCT01139775|69544321|FG002|Overall Study|Adverse Event|2|||
37860952|NCT01139775|69544319|FG000|Overall Study|Protocol Violation|0|||
37860953|NCT01139775|69544320|FG001|Overall Study|Protocol Violation|5|||
37860954|NCT01139775|69544321|FG002|Overall Study|Protocol Violation|0|||
37860955|NCT01139775|69544319|FG000|Overall Study|Withdrawal by Subject|1|||
37860956|NCT01139775|69544320|FG001|Overall Study|Withdrawal by Subject|0|||
37860957|NCT01139775|69544321|FG002|Overall Study|Withdrawal by Subject|2|||
37860958|NCT01139775|69544319|FG000|Overall Study|Physician Decision|0|||
37860959|NCT01139775|69544320|FG001|Overall Study|Physician Decision|2|||
37860960|NCT01139775|69544321|FG002|Overall Study|Physician Decision|2|||
37860961|NCT01283516|69544340|FG000|Overall Study|Adverse Event|0|||
37860962|NCT01283516|69544341|FG001|Overall Study|Adverse Event|0|||
37860963|NCT01283516|69544342|FG002|Overall Study|Adverse Event|0|||
37860964|NCT01283516|69544343|FG003|Overall Study|Adverse Event|0|||
37860965|NCT01283516|69544344|FG004|Overall Study|Adverse Event|0|||
37860966|NCT01283516|69544345|FG005|Overall Study|Adverse Event|0|||
37860967|NCT01283516|69544346|FG006|Overall Study|Adverse Event|2|||
37860968|NCT01283516|69544347|FG007|Overall Study|Adverse Event|0|||
37860969|NCT01283516|69544348|FG008|Overall Study|Adverse Event|28|||
37860970|NCT01283516|69544340|FG000|Overall Study|Death|0|||
37860971|NCT01283516|69544341|FG001|Overall Study|Death|0|||
37860972|NCT01283516|69544342|FG002|Overall Study|Death|0|||
37860973|NCT01283516|69544343|FG003|Overall Study|Death|0|||
37860974|NCT01283516|69544344|FG004|Overall Study|Death|0|||
37860975|NCT01283516|69544345|FG005|Overall Study|Death|1|||
37860976|NCT01283516|69544346|FG006|Overall Study|Death|0|||
37860977|NCT01283516|69544347|FG007|Overall Study|Death|1|||
37860978|NCT01283516|69544348|FG008|Overall Study|Death|12|||
37860979|NCT01283516|69544340|FG000|Overall Study|Disease Progression|2|||
37860980|NCT01283516|69544341|FG001|Overall Study|Disease Progression|2|||
37860981|NCT01283516|69544342|FG002|Overall Study|Disease Progression|3|||
37860982|NCT01283516|69544343|FG003|Overall Study|Disease Progression|3|||
37860983|NCT01283516|69544344|FG004|Overall Study|Disease Progression|13|||
37860984|NCT01283516|69544345|FG005|Overall Study|Disease Progression|8|||
37860985|NCT01283516|69544346|FG006|Overall Study|Disease Progression|6|||
37860986|NCT01283516|69544347|FG007|Overall Study|Disease Progression|3|||
37860987|NCT01283516|69544348|FG008|Overall Study|Disease Progression|139|||
37860988|NCT01283516|69544340|FG000|Overall Study|Withdrawal by Subject|0|||
37860989|NCT01283516|69544341|FG001|Overall Study|Withdrawal by Subject|0|||
37860990|NCT01283516|69544342|FG002|Overall Study|Withdrawal by Subject|0|||
37860991|NCT01283516|69544343|FG003|Overall Study|Withdrawal by Subject|0|||
37769524|NCT01421069|69286312|FG000|Overall Period for Extension Study|Protocol Violation|1|||
37860992|NCT01283516|69544344|FG004|Overall Study|Withdrawal by Subject|1|||
37860993|NCT01283516|69544345|FG005|Overall Study|Withdrawal by Subject|0|||
37860994|NCT01283516|69544346|FG006|Overall Study|Withdrawal by Subject|1|||
37860995|NCT01283516|69544347|FG007|Overall Study|Withdrawal by Subject|0|||
37860996|NCT01283516|69544348|FG008|Overall Study|Withdrawal by Subject|36|||
37860997|NCT01283516|69544340|FG000|Overall Study|Administrative problems|0|||
37860998|NCT01283516|69544341|FG001|Overall Study|Administrative problems|0|||
37860999|NCT01283516|69544342|FG002|Overall Study|Administrative problems|0|||
37861000|NCT01283516|69544343|FG003|Overall Study|Administrative problems|0|||
37861001|NCT01283516|69544344|FG004|Overall Study|Administrative problems|0|||
37861002|NCT01283516|69544345|FG005|Overall Study|Administrative problems|1|||
37861003|NCT01283516|69544346|FG006|Overall Study|Administrative problems|1|||
37861004|NCT01283516|69544347|FG007|Overall Study|Administrative problems|1|||
37861005|NCT01283516|69544348|FG008|Overall Study|Administrative problems|39|||
37861006|NCT01283516|69544340|FG000|Overall Study|Lost to Follow-up|0|||
37861007|NCT01283516|69544341|FG001|Overall Study|Lost to Follow-up|0|||
37861008|NCT01283516|69544342|FG002|Overall Study|Lost to Follow-up|0|||
37861009|NCT01283516|69544343|FG003|Overall Study|Lost to Follow-up|0|||
37861010|NCT01283516|69544344|FG004|Overall Study|Lost to Follow-up|0|||
37861011|NCT01283516|69544345|FG005|Overall Study|Lost to Follow-up|0|||
37861012|NCT01283516|69544346|FG006|Overall Study|Lost to Follow-up|0|||
37861013|NCT01283516|69544347|FG007|Overall Study|Lost to Follow-up|0|||
37861014|NCT01283516|69544348|FG008|Overall Study|Lost to Follow-up|1|||
37861015|NCT01137435|69544376|FG000|Overall Study|Lost to Follow-up|24|||
37861016|NCT01137435|69544376|FG000|Overall Study|Off label usage|4|||
37861017|NCT01283282|69544380|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
37861018|NCT01283282|69544381|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
37861019|NCT01283282|69544380|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
37861020|NCT01283282|69544381|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
37861021|NCT01283282|69544380|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
37861022|NCT01283282|69544381|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
37861023|NCT01282814|69544390|FG000|First Intervention|Emesis During Dosing Interval|0|||
37861024|NCT01282814|69544391|FG001|First Intervention|Emesis During Dosing Interval|3|||
37861025|NCT01282814|69544390|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
37861026|NCT01282814|69544391|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
37861027|NCT00941863|69544402|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
37861028|NCT00941863|69544403|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
37861029|NCT00941863|69544404|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
37861030|NCT00941863|69544405|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
37861031|NCT00941863|69544406|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
37861032|NCT00941863|69544402|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
37861033|NCT00941863|69544403|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
37861034|NCT00941863|69544404|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
37861035|NCT00941863|69544405|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
37861036|NCT00941863|69544406|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
37861037|NCT00941863|69544402|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
37861038|NCT00941863|69544403|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
37861039|NCT00941863|69544404|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
37861040|NCT00941863|69544405|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
37861041|NCT00941863|69544406|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
37861042|NCT00941863|69544402|FG000|Until Primary Completion Date (PCD)|Death|0|||
37861043|NCT00941863|69544403|FG001|Until Primary Completion Date (PCD)|Death|0|||
37861044|NCT00941863|69544404|FG002|Until Primary Completion Date (PCD)|Death|1|||
37861045|NCT00941863|69544405|FG003|Until Primary Completion Date (PCD)|Death|2|||
37861046|NCT00941863|69544406|FG004|Until Primary Completion Date (PCD)|Death|7|||
37861047|NCT00941863|69544402|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
37861048|NCT00941863|69544403|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
37861049|NCT00941863|69544404|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
37861050|NCT00941863|69544405|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
37861051|NCT00941863|69544406|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
37861052|NCT00941863|69544402|FG000|Continued After PCD|Withdrawal by Subject|0|||
37861053|NCT00941863|69544403|FG001|Continued After PCD|Withdrawal by Subject|0|||
37861054|NCT00941863|69544404|FG002|Continued After PCD|Withdrawal by Subject|0|||
37861055|NCT00941863|69544405|FG003|Continued After PCD|Withdrawal by Subject|0|||
37861056|NCT00941863|69544406|FG004|Continued After PCD|Withdrawal by Subject|1|||
37861057|NCT00941863|69544402|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
37861058|NCT00941863|69544403|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
37861059|NCT00941863|69544404|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
37861060|NCT00941863|69544405|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
37861061|NCT00941863|69544406|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
37861062|NCT01282424|69544422|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
37861063|NCT01282424|69544422|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
37861064|NCT01282424|69544422|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
37861065|NCT01282424|69544422|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
37861066|NCT01282424|69544422|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
37861067|NCT01282424|69544422|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
37861068|NCT01282424|69544422|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
37861069|NCT01282424|69544422|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
37861070|NCT01281956|69544426|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
37861071|NCT01281956|69544427|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
37861072|NCT00949975|69544440|FG000|Overall Study|Voluntary discontinuation|6|||
37861073|NCT00949975|69544441|FG001|Overall Study|Voluntary discontinuation|5|||
37861074|NCT00949975|69544442|FG002|Overall Study|Voluntary discontinuation|3|||
37861075|NCT00949975|69544443|FG003|Overall Study|Voluntary discontinuation|6|||
37861076|NCT00949975|69544440|FG000|Overall Study|Adverse Event|11|||
37861077|NCT00949975|69544441|FG001|Overall Study|Adverse Event|11|||
37861078|NCT00949975|69544442|FG002|Overall Study|Adverse Event|10|||
37861079|NCT00949975|69544443|FG003|Overall Study|Adverse Event|10|||
37861080|NCT00949975|69544440|FG000|Overall Study|Safety reason|0|||
37861081|NCT00949975|69544441|FG001|Overall Study|Safety reason|1|||
37861082|NCT00949975|69544442|FG002|Overall Study|Safety reason|0|||
37861083|NCT00949975|69544443|FG003|Overall Study|Safety reason|0|||
37861084|NCT00949975|69544440|FG000|Overall Study|Study-specific criteria|0|||
37861085|NCT00949975|69544441|FG001|Overall Study|Study-specific criteria|1|||
37861086|NCT00949975|69544442|FG002|Overall Study|Study-specific criteria|1|||
37861087|NCT00949975|69544443|FG003|Overall Study|Study-specific criteria|0|||
37861088|NCT00949975|69544440|FG000|Overall Study|Incorrect enrolment|5|||
37861089|NCT00949975|69544441|FG001|Overall Study|Incorrect enrolment|10|||
37861090|NCT00949975|69544442|FG002|Overall Study|Incorrect enrolment|4|||
37861091|NCT00949975|69544443|FG003|Overall Study|Incorrect enrolment|7|||
37861092|NCT00949975|69544440|FG000|Overall Study|Severe non-compliance|3|||
37861093|NCT00949975|69544441|FG001|Overall Study|Severe non-compliance|1|||
37861094|NCT00949975|69544442|FG002|Overall Study|Severe non-compliance|0|||
37861095|NCT00949975|69544443|FG003|Overall Study|Severe non-compliance|2|||
37861096|NCT00949975|69544440|FG000|Overall Study|Lost to Follow-up|1|||
37861097|NCT00949975|69544441|FG001|Overall Study|Lost to Follow-up|0|||
37861098|NCT00949975|69544442|FG002|Overall Study|Lost to Follow-up|1|||
37861099|NCT00949975|69544443|FG003|Overall Study|Lost to Follow-up|3|||
37861100|NCT00949975|69544440|FG000|Overall Study|Other|1|||
37861101|NCT00949975|69544441|FG001|Overall Study|Other|0|||
37861102|NCT00949975|69544442|FG002|Overall Study|Other|0|||
37861103|NCT00949975|69544443|FG003|Overall Study|Other|0|||
37861104|NCT00939055|69544455|FG000|Overall Study|Discontinuation prior to procedure|4|||
37861105|NCT00939055|69544456|FG001|Overall Study|Discontinuation prior to procedure|0|||
37861106|NCT01136967|69544465|FG000|Overall Study|Adverse Event|9|||
37861107|NCT01136967|69544466|FG001|Overall Study|Adverse Event|12|||
37861108|NCT01136967|69544465|FG000|Overall Study|Participant Choice|8|||
37861109|NCT01136967|69544466|FG001|Overall Study|Participant Choice|3|||
37861110|NCT01136967|69544465|FG000|Overall Study|Lost to Follow-up|0|||
37861111|NCT01136967|69544466|FG001|Overall Study|Lost to Follow-up|1|||
37861112|NCT01136967|69544465|FG000|Overall Study|Withdrawal by Subject|1|||
37861113|NCT01136967|69544466|FG001|Overall Study|Withdrawal by Subject|2|||
37861114|NCT01136967|69544465|FG000|Overall Study|Clinical Progression|3|||
37861115|NCT01136967|69544466|FG001|Overall Study|Clinical Progression|5|||
37861116|NCT01136967|69544465|FG000|Overall Study|Radiation|1|||
37861117|NCT01136967|69544466|FG001|Overall Study|Radiation|0|||
37861118|NCT01136967|69544465|FG000|Overall Study|Non-compliance|1|||
37861119|NCT01136967|69544466|FG001|Overall Study|Non-compliance|0|||
37861120|NCT01136967|69544465|FG000|Overall Study|Investigator's Choice|1|||
37861121|NCT01136967|69544466|FG001|Overall Study|Investigator's Choice|1|||
37861122|NCT01136967|69544465|FG000|Overall Study|Increase in Lesion Size|0|||
37861123|NCT01136967|69544466|FG001|Overall Study|Increase in Lesion Size|2|||
37861124|NCT01136967|69544465|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
37861125|NCT01136967|69544466|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
37861126|NCT01218516|69544474|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
37861127|NCT01218516|69544475|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
37861128|NCT01218516|69544476|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
37861129|NCT01218516|69544477|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
37861130|NCT01218516|69544474|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
37861131|NCT01218516|69544475|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
37861132|NCT01218516|69544476|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
37861133|NCT01218516|69544477|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
37861134|NCT01218516|69544474|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
37861135|NCT01218516|69544475|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
37861136|NCT01218516|69544476|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
37861137|NCT01218516|69544477|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
37861138|NCT01218516|69544474|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
37861139|NCT01218516|69544475|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
37861140|NCT01218516|69544476|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
37861141|NCT01218516|69544477|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
37861142|NCT01218516|69544474|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
37861143|NCT01218516|69544475|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
37861144|NCT01218516|69544476|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
37861145|NCT01218516|69544477|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
37861146|NCT01218516|69544474|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
37861147|NCT01218516|69544475|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
37861148|NCT01218516|69544476|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
37952505|NCT00624338|69639501|FG000|Overall Study|Lost to Follow-up|1|||
37861149|NCT01218516|69544477|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
37861150|NCT01218516|69544474|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
37861151|NCT01218516|69544475|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
37861152|NCT01218516|69544476|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
37861153|NCT01218516|69544477|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
37861154|NCT01218516|69544474|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
37861155|NCT01218516|69544475|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
37861156|NCT01218516|69544476|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
37861157|NCT01218516|69544477|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
37861158|NCT01218516|69544474|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
37861159|NCT01218516|69544475|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
37861160|NCT01218516|69544476|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
37861161|NCT01218516|69544477|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
37861162|NCT01218516|69544474|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
37861163|NCT01218516|69544475|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
37861164|NCT01218516|69544476|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
37861165|NCT01218516|69544477|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
37861166|NCT01218516|69544474|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
37861167|NCT01218516|69544475|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
37861168|NCT01218516|69544476|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
37861169|NCT01218516|69544477|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
37861170|NCT01218516|69544474|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
37861171|NCT01218516|69544475|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
37861172|NCT01218516|69544476|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
37861173|NCT01218516|69544477|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
37861174|NCT00938431|69544490|FG000|Overall Study|Adverse Event|5|||
37861175|NCT00938431|69544491|FG001|Overall Study|Adverse Event|8|||
37861176|NCT00938431|69544492|FG002|Overall Study|Adverse Event|6|||
37861177|NCT00938431|69544490|FG000|Overall Study|Lack of Efficacy|0|||
37861178|NCT00938431|69544491|FG001|Overall Study|Lack of Efficacy|1|||
37861179|NCT00938431|69544492|FG002|Overall Study|Lack of Efficacy|0|||
37861180|NCT00938431|69544490|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
37861181|NCT00938431|69544491|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
37861182|NCT00938431|69544492|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
37861183|NCT00938431|69544490|FG000|Overall Study|Dosing compliance issue|0|||
37861184|NCT00938431|69544491|FG001|Overall Study|Dosing compliance issue|0|||
37861185|NCT00938431|69544492|FG002|Overall Study|Dosing compliance issue|1|||
37861186|NCT00938431|69544490|FG000|Overall Study|Reached maximum dose early|0|||
37861187|NCT00938431|69544491|FG001|Overall Study|Reached maximum dose early|0|||
37861188|NCT00938431|69544492|FG002|Overall Study|Reached maximum dose early|1|||
37861189|NCT01136811|69544504|FG000|Overall Study|Physician Decision|11|||
37861190|NCT00949117|69544510|FG000|Overall Study|Lack of Efficacy|2|||
37861191|NCT00949117|69544511|FG001|Overall Study|Lack of Efficacy|3|||
37861192|NCT00949117|69544510|FG000|Overall Study|Protocol Violation|1|||
37861193|NCT00949117|69544511|FG001|Overall Study|Protocol Violation|1|||
37861194|NCT00949117|69544510|FG000|Overall Study|Adverse Event|0|||
37861195|NCT00949117|69544511|FG001|Overall Study|Adverse Event|1|||
37861196|NCT00938041|69544519|FG000|Overall Study|Lost to Follow-up|6|||
37861197|NCT00938041|69544519|FG000|Overall Study|Received Alternative Therapy|1|||
37861198|NCT00938041|69544519|FG000|Overall Study|Progressive Disease|5|||
37861199|NCT00938041|69544519|FG000|Overall Study|Death|12|||
37861200|NCT00938041|69544519|FG000|Overall Study|Adrenal Insufficiency|3|||
37769525|NCT01421069|69286312|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
37769526|NCT01421069|69286312|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
37861201|NCT01218438|69544523|FG000|Epoch 1|Physician Decision|2|||
37861202|NCT01218438|69544523|FG000|Epoch 1|Adverse Event|1|||
37861203|NCT01218438|69544523|FG000|Epoch 3|Withdrawal by Subject|3|||
37861204|NCT01218438|69544523|FG000|Epoch 3|Adverse Event|1|||
37861205|NCT01218438|69544523|FG000|Epoch 4|Physician Decision|1|||
37861206|NCT01218438|69544523|FG000|Epoch 4|Withdrawal by Subject|2|||
37861207|NCT00935701|69544597|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
37861208|NCT01277510|69544604|FG000|Double-blind Phase|Non-compliance|0|||
37861209|NCT01277510|69544605|FG001|Double-blind Phase|Non-compliance|1|||
37861210|NCT01277510|69544604|FG000|Double-blind Phase|Adverse Event|1|||
37861211|NCT01277510|69544605|FG001|Double-blind Phase|Adverse Event|0|||
37861212|NCT01277510|69544604|FG000|Double-blind Phase|Withdrawal by Subject|2|||
37861213|NCT01277510|69544605|FG001|Double-blind Phase|Withdrawal by Subject|0|||
37861214|NCT01277510|69544604|FG000|Double-blind Phase|Administrative decision|7|||
37861215|NCT01277510|69544605|FG001|Double-blind Phase|Administrative decision|9|||
37861216|NCT01277510|69544604|FG000|Double-blind Phase|Death|0|||
37861217|NCT01277510|69544605|FG001|Double-blind Phase|Death|1|||
37861218|NCT01277510|69544604|FG000|Double-blind Phase|Protocol-specified criteria|2|||
37861219|NCT01277510|69544605|FG001|Double-blind Phase|Protocol-specified criteria|6|||
37952506|NCT00624338|69639502|FG001|Overall Study|Lost to Follow-up|0|||
37952507|NCT00624338|69639503|FG002|Overall Study|Lost to Follow-up|0|||
37952508|NCT00624338|69639501|FG000|Overall Study|Lack of Efficacy|11|||
37952509|NCT00624338|69639502|FG001|Overall Study|Lack of Efficacy|3|||
37952510|NCT00624338|69639503|FG002|Overall Study|Lack of Efficacy|14|||
37952511|NCT00624338|69639501|FG000|Overall Study|Protocol Violation|3|||
37952512|NCT00624338|69639502|FG001|Overall Study|Protocol Violation|3|||
37952513|NCT00624338|69639503|FG002|Overall Study|Protocol Violation|2|||
37952514|NCT00624338|69639501|FG000|Overall Study|Death|0|||
37952515|NCT00624338|69639502|FG001|Overall Study|Death|2|||
37952516|NCT00624338|69639503|FG002|Overall Study|Death|0|||
37952517|NCT00624338|69639501|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
37952518|NCT00624338|69639502|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
37952519|NCT00624338|69639503|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
37952520|NCT00624338|69639501|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
37952521|NCT00624338|69639502|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
37952522|NCT00624338|69639503|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
37952523|NCT00624338|69639501|FG000|Overall Study|Other|15|||
37952524|NCT00624338|69639502|FG001|Overall Study|Other|5|||
37952525|NCT00624338|69639503|FG002|Overall Study|Other|9|||
37952526|NCT00624338|69639501|FG000|Overall Study|Randomized but not treated|2|||
37952527|NCT00624338|69639502|FG001|Overall Study|Randomized but not treated|1|||
37952528|NCT00624338|69639503|FG002|Overall Study|Randomized but not treated|3|||
37952529|NCT03977454|69639513|FG000|Overall Study|immediate postoperative revision|2|||
37861220|NCT01277510|69544604|FG000|Double-blind Phase|Other|1|||
37861221|NCT01277510|69544605|FG001|Double-blind Phase|Other|1|||
37861222|NCT01277510|69544604|FG000|Open-label Phase|Administrative decision|4|||
37861223|NCT01277510|69544605|FG001|Open-label Phase|Administrative decision|3|||
37861224|NCT01277510|69544604|FG000|Open-label Phase|Protocol-specified criteria|1|||
37861225|NCT01277510|69544605|FG001|Open-label Phase|Protocol-specified criteria|0|||
37861226|NCT01277510|69544604|FG000|Open-label Phase|Never received investigational product|2|||
37861227|NCT01277510|69544605|FG001|Open-label Phase|Never received investigational product|0|||
37861228|NCT00937495|69544613|FG000|Overall Study|Protocol Violation|2|||
37861229|NCT01268306|69544617|FG000|Overall Study|Lost to Follow-up|1|||
37861230|NCT00936715|69544621|FG000|Overall Study|Investigators Discretion|1|||
37861231|NCT00936715|69544621|FG000|Overall Study|Protocol Violation|1|||
37861232|NCT00936715|69544621|FG000|Overall Study|Safety or Tolerability Reasons|4|||
37861233|NCT01267994|69544625|FG000|Overall Study|Adverse Event|2|||
37861234|NCT00934843|69544632|FG000|Overall Study|Protocol Violation|0|||
37861235|NCT00934843|69544633|FG001|Overall Study|Protocol Violation|1|||
37861236|NCT01266902|69544641|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
37861237|NCT01266902|69544642|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
37861238|NCT01266902|69544643|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
37861239|NCT01266902|69544641|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
37861240|NCT01266902|69544642|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
37861241|NCT01266902|69544643|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
37861242|NCT01266902|69544641|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
37861243|NCT01266902|69544642|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
37861244|NCT01266902|69544643|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
37861245|NCT01266902|69544641|FG000|Period 1 (Main Study)|Adverse Event|3|||
37861246|NCT01266902|69544642|FG001|Period 1 (Main Study)|Adverse Event|11|||
37861247|NCT01266902|69544643|FG002|Period 1 (Main Study)|Adverse Event|0|||
37861248|NCT01266902|69544641|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
37861249|NCT01266902|69544642|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
37861250|NCT01266902|69544643|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
37861251|NCT01266902|69544641|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
37861252|NCT01266902|69544642|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
37861253|NCT01266902|69544643|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
37861254|NCT01266902|69544641|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
37861255|NCT01266902|69544642|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
37861256|NCT01266902|69544643|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
37861257|NCT01266902|69544641|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
37861258|NCT01266902|69544642|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
37861259|NCT01266902|69544643|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
37861260|NCT01266902|69544641|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
37861261|NCT01266902|69544642|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
37861262|NCT01266902|69544643|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
37861263|NCT01266902|69544641|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
37861264|NCT01266902|69544642|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
37861265|NCT01266902|69544643|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
37861266|NCT01266824|69544653|FG000|Overall Study|Study terminated prior to completion|2|||
37861267|NCT01266824|69544654|FG001|Overall Study|Study terminated prior to completion|3|||
37861268|NCT01266590|69544660|FG000|Overall Study|Adverse Event|3|||
37861269|NCT01266590|69544660|FG000|Overall Study|Lost to Follow-up|1|||
37861270|NCT01266590|69544660|FG000|Overall Study|Withdrawal by Subject|1|||
37861271|NCT01266590|69544660|FG000|Overall Study|Physician Decision|1|||
37861272|NCT01266122|69544669|FG000|Overall Study|Lost to Follow-up|6|||
37861273|NCT01266122|69544670|FG001|Overall Study|Lost to Follow-up|6|||
37861274|NCT01265498|69544678|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
37861275|NCT01265498|69544679|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
37861276|NCT01265420|69544685|FG000|Overall Study|Lost to Follow-up|1|||
37952530|NCT03977454|69639514|FG001|Overall Study|immediate postoperative revision|2|||
37952531|NCT00538785|69639522|FG000|Overall Study|Death|9|||
37952532|NCT00538785|69639523|FG001|Overall Study|Death|10|||
37952533|NCT00538785|69639522|FG000|Overall Study|Withdrawal of consent|9|||
37952534|NCT00538785|69639523|FG001|Overall Study|Withdrawal of consent|7|||
37952535|NCT00538785|69639522|FG000|Overall Study|Lost to Follow-up|1|||
37952536|NCT00538785|69639523|FG001|Overall Study|Lost to Follow-up|0|||
37952537|NCT00538629|69639529|FG000|Overall Study|At subject's request|1|||
37952538|NCT00538629|69639529|FG000|Overall Study|Adverse Event|2|||
37952539|NCT00538629|69639529|FG000|Overall Study|Lack of Efficacy|12|||
37952540|NCT00538629|69639529|FG000|Overall Study|Lost to Follow-up|6|||
37952541|NCT00538629|69639529|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
37952542|NCT00622700|69639536|FG000|Core Treatment Period|Randomized but Not Treated|0|||
37952543|NCT00622700|69639537|FG001|Core Treatment Period|Randomized but Not Treated|2|||
37952544|NCT00622700|69639538|FG002|Core Treatment Period|Randomized but Not Treated|2|||
37952545|NCT00622700|69639539|FG003|Core Treatment Period|Randomized but Not Treated|0|||
37952546|NCT00622700|69639540|FG004|Core Treatment Period|Randomized but Not Treated|0|||
37952547|NCT00622700|69639541|FG005|Core Treatment Period|Randomized but Not Treated|0|||
37952548|NCT00622700|69639542|FG006|Core Treatment Period|Randomized but Not Treated|0|||
37952549|NCT00622700|69639536|FG000|Core Treatment Period|Adverse Event|18|||
37952550|NCT00622700|69639537|FG001|Core Treatment Period|Adverse Event|25|||
37952551|NCT00622700|69639538|FG002|Core Treatment Period|Adverse Event|18|||
37952552|NCT00622700|69639539|FG003|Core Treatment Period|Adverse Event|0|||
37952553|NCT00622700|69639540|FG004|Core Treatment Period|Adverse Event|0|||
37952554|NCT00622700|69639541|FG005|Core Treatment Period|Adverse Event|0|||
37952555|NCT00622700|69639542|FG006|Core Treatment Period|Adverse Event|0|||
37952556|NCT00622700|69639536|FG000|Core Treatment Period|Lack of Efficacy|19|||
37952557|NCT00622700|69639537|FG001|Core Treatment Period|Lack of Efficacy|6|||
37952558|NCT00622700|69639538|FG002|Core Treatment Period|Lack of Efficacy|12|||
37952559|NCT00622700|69639539|FG003|Core Treatment Period|Lack of Efficacy|0|||
37952560|NCT00622700|69639540|FG004|Core Treatment Period|Lack of Efficacy|0|||
37952561|NCT00622700|69639541|FG005|Core Treatment Period|Lack of Efficacy|0|||
37952562|NCT00622700|69639542|FG006|Core Treatment Period|Lack of Efficacy|0|||
37952563|NCT00622700|69639536|FG000|Core Treatment Period|Lost to Follow-up|1|||
37952564|NCT00622700|69639537|FG001|Core Treatment Period|Lost to Follow-up|1|||
37952565|NCT00622700|69639538|FG002|Core Treatment Period|Lost to Follow-up|1|||
37952566|NCT00622700|69639539|FG003|Core Treatment Period|Lost to Follow-up|0|||
37952567|NCT00622700|69639540|FG004|Core Treatment Period|Lost to Follow-up|0|||
37952568|NCT00622700|69639541|FG005|Core Treatment Period|Lost to Follow-up|0|||
37952569|NCT00622700|69639542|FG006|Core Treatment Period|Lost to Follow-up|0|||
37952570|NCT00622700|69639536|FG000|Core Treatment Period|Death|1|||
37952571|NCT00622700|69639537|FG001|Core Treatment Period|Death|0|||
37952572|NCT00622700|69639538|FG002|Core Treatment Period|Death|0|||
37952573|NCT00622700|69639539|FG003|Core Treatment Period|Death|0|||
37952574|NCT00622700|69639540|FG004|Core Treatment Period|Death|0|||
37952575|NCT00622700|69639541|FG005|Core Treatment Period|Death|0|||
37952576|NCT00622700|69639542|FG006|Core Treatment Period|Death|0|||
37952577|NCT00622700|69639536|FG000|Core Treatment Period|Progressive Disease|3|||
37952578|NCT00622700|69639537|FG001|Core Treatment Period|Progressive Disease|1|||
37952579|NCT00622700|69639538|FG002|Core Treatment Period|Progressive Disease|0|||
37952580|NCT00622700|69639539|FG003|Core Treatment Period|Progressive Disease|0|||
37952581|NCT00622700|69639540|FG004|Core Treatment Period|Progressive Disease|0|||
37952582|NCT00622700|69639541|FG005|Core Treatment Period|Progressive Disease|0|||
37952583|NCT00622700|69639542|FG006|Core Treatment Period|Progressive Disease|0|||
37952584|NCT00622700|69639536|FG000|Core Treatment Period|Withdrawal by Subject|12|||
37952585|NCT00622700|69639537|FG001|Core Treatment Period|Withdrawal by Subject|18|||
37952586|NCT00622700|69639538|FG002|Core Treatment Period|Withdrawal by Subject|15|||
37952587|NCT00622700|69639539|FG003|Core Treatment Period|Withdrawal by Subject|0|||
37952588|NCT00622700|69639540|FG004|Core Treatment Period|Withdrawal by Subject|0|||
37952589|NCT00622700|69639541|FG005|Core Treatment Period|Withdrawal by Subject|0|||
37861277|NCT01264718|69544691|FG000|Overall Study|Lost to Follow-up|3|||
37952590|NCT00622700|69639542|FG006|Core Treatment Period|Withdrawal by Subject|0|||
37952591|NCT00622700|69639536|FG000|Core Treatment Period|Other than specified above|2|||
37952592|NCT00622700|69639537|FG001|Core Treatment Period|Other than specified above|2|||
37952593|NCT00622700|69639538|FG002|Core Treatment Period|Other than specified above|5|||
37952594|NCT00622700|69639539|FG003|Core Treatment Period|Other than specified above|0|||
37952595|NCT00622700|69639540|FG004|Core Treatment Period|Other than specified above|0|||
37952596|NCT00622700|69639541|FG005|Core Treatment Period|Other than specified above|0|||
37952597|NCT00622700|69639542|FG006|Core Treatment Period|Other than specified above|0|||
37952598|NCT00622700|69639536|FG000|Extension Treatment Period|Adverse Event|0|||
37952599|NCT00622700|69639537|FG001|Extension Treatment Period|Adverse Event|0|||
37952600|NCT00622700|69639538|FG002|Extension Treatment Period|Adverse Event|0|||
37952601|NCT00622700|69639539|FG003|Extension Treatment Period|Adverse Event|5|||
37952602|NCT00622700|69639540|FG004|Extension Treatment Period|Adverse Event|9|||
37952603|NCT00622700|69639541|FG005|Extension Treatment Period|Adverse Event|6|||
37952604|NCT00622700|69639542|FG006|Extension Treatment Period|Adverse Event|8|||
37952605|NCT00622700|69639536|FG000|Extension Treatment Period|Lack of Efficacy|0|||
37952606|NCT00622700|69639537|FG001|Extension Treatment Period|Lack of Efficacy|0|||
37952607|NCT00622700|69639538|FG002|Extension Treatment Period|Lack of Efficacy|0|||
37952608|NCT00622700|69639539|FG003|Extension Treatment Period|Lack of Efficacy|2|||
37952609|NCT00622700|69639540|FG004|Extension Treatment Period|Lack of Efficacy|8|||
37952610|NCT00622700|69639541|FG005|Extension Treatment Period|Lack of Efficacy|1|||
37952611|NCT00622700|69639542|FG006|Extension Treatment Period|Lack of Efficacy|9|||
37952612|NCT00622700|69639536|FG000|Extension Treatment Period|Protocol Violation|0|||
37952613|NCT00622700|69639537|FG001|Extension Treatment Period|Protocol Violation|0|||
37952614|NCT00622700|69639538|FG002|Extension Treatment Period|Protocol Violation|0|||
37952615|NCT00622700|69639539|FG003|Extension Treatment Period|Protocol Violation|0|||
37952616|NCT00622700|69639540|FG004|Extension Treatment Period|Protocol Violation|0|||
37952617|NCT00622700|69639541|FG005|Extension Treatment Period|Protocol Violation|2|||
37952618|NCT00622700|69639542|FG006|Extension Treatment Period|Protocol Violation|0|||
37952619|NCT00622700|69639536|FG000|Extension Treatment Period|Lost to Follow-up|0|||
37952620|NCT00622700|69639537|FG001|Extension Treatment Period|Lost to Follow-up|0|||
37952621|NCT00622700|69639538|FG002|Extension Treatment Period|Lost to Follow-up|0|||
37952622|NCT00622700|69639539|FG003|Extension Treatment Period|Lost to Follow-up|0|||
37952623|NCT00622700|69639540|FG004|Extension Treatment Period|Lost to Follow-up|1|||
37952624|NCT00622700|69639541|FG005|Extension Treatment Period|Lost to Follow-up|0|||
37952625|NCT00622700|69639542|FG006|Extension Treatment Period|Lost to Follow-up|0|||
37952626|NCT00622700|69639536|FG000|Extension Treatment Period|Progressive Disease|0|||
37952627|NCT00622700|69639537|FG001|Extension Treatment Period|Progressive Disease|0|||
37952628|NCT00622700|69639538|FG002|Extension Treatment Period|Progressive Disease|0|||
37952629|NCT00622700|69639539|FG003|Extension Treatment Period|Progressive Disease|1|||
37952630|NCT00622700|69639540|FG004|Extension Treatment Period|Progressive Disease|2|||
37952631|NCT00622700|69639541|FG005|Extension Treatment Period|Progressive Disease|0|||
37952632|NCT00622700|69639542|FG006|Extension Treatment Period|Progressive Disease|2|||
37952633|NCT00622700|69639536|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
37952634|NCT00622700|69639537|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
37952635|NCT00622700|69639538|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
37952636|NCT00622700|69639539|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
37952637|NCT00622700|69639540|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
37952638|NCT00622700|69639541|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
37952639|NCT00622700|69639542|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
37952640|NCT00622700|69639536|FG000|Extension Treatment Period|Missing|0|||
37952641|NCT00622700|69639537|FG001|Extension Treatment Period|Missing|0|||
37952642|NCT00622700|69639538|FG002|Extension Treatment Period|Missing|0|||
37952643|NCT00622700|69639539|FG003|Extension Treatment Period|Missing|2|||
37952644|NCT00622700|69639540|FG004|Extension Treatment Period|Missing|3|||
37952645|NCT00622700|69639541|FG005|Extension Treatment Period|Missing|1|||
37952646|NCT00622700|69639542|FG006|Extension Treatment Period|Missing|0|||
37952647|NCT00622700|69639536|FG000|Extension Treatment Period|Other than specified above|0|||
37952648|NCT00622700|69639537|FG001|Extension Treatment Period|Other than specified above|0|||
37952649|NCT00622700|69639538|FG002|Extension Treatment Period|Other than specified above|0|||
37952650|NCT00622700|69639539|FG003|Extension Treatment Period|Other than specified above|0|||
37952651|NCT00622700|69639540|FG004|Extension Treatment Period|Other than specified above|0|||
37952652|NCT00622700|69639541|FG005|Extension Treatment Period|Other than specified above|1|||
37952653|NCT00622700|69639542|FG006|Extension Treatment Period|Other than specified above|1|||
37952654|NCT00538473|69639561|FG000|Overall Study|Adverse Event|1|||
37952655|NCT00538473|69639562|FG001|Overall Study|Adverse Event|0|||
37952656|NCT00622466|69639568|FG000|Overall Study|Death|1|||
37952657|NCT00622466|69639568|FG000|Overall Study|Adverse Event|1|||
37952658|NCT00622466|69639568|FG000|Overall Study|Withdrawal by Subject|2|||
37952659|NCT00537771|69639574|FG000|Overall Study|Withdrawal by Subject|6|||
37952660|NCT00537771|69639575|FG001|Overall Study|Withdrawal by Subject|23|||
37952661|NCT00537771|69639574|FG000|Overall Study|Adverse Event|8|||
37952662|NCT00537771|69639575|FG001|Overall Study|Adverse Event|15|||
37952663|NCT00537771|69639574|FG000|Overall Study|Lost to Follow-up|9|||
37952664|NCT00537771|69639575|FG001|Overall Study|Lost to Follow-up|15|||
37952665|NCT00537771|69639574|FG000|Overall Study|Protocol Violation|2|||
37952666|NCT00537771|69639575|FG001|Overall Study|Protocol Violation|6|||
37952667|NCT00537771|69639574|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
37952668|NCT00537771|69639575|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
37952669|NCT00623480|69639583|FG000|Overall Study|Lost to Follow-up|0|||
37952670|NCT00623480|69639584|FG001|Overall Study|Lost to Follow-up|1|||
37952671|NCT00623480|69639583|FG000|Overall Study|Withdrawal by Subject|2|||
37952672|NCT00623480|69639584|FG001|Overall Study|Withdrawal by Subject|4|||
37952673|NCT00623480|69639583|FG000|Overall Study|Lack of Efficacy|1|||
37952674|NCT00623480|69639584|FG001|Overall Study|Lack of Efficacy|0|||
37952675|NCT00623480|69639583|FG000|Overall Study|Non-compliant with study medication|4|||
37952676|NCT00623480|69639584|FG001|Overall Study|Non-compliant with study medication|0|||
37952677|NCT00623480|69639583|FG000|Overall Study|Protocol Violation|0|||
37952678|NCT00623480|69639584|FG001|Overall Study|Protocol Violation|1|||
37952679|NCT00623480|69639583|FG000|Overall Study|Site closed by sponsor|0|||
37952680|NCT00623480|69639584|FG001|Overall Study|Site closed by sponsor|1|||
37952681|NCT02513667|69639592|FG000|Overall Study|Withdrawal by Subject|0|||
37952682|NCT02513667|69639593|FG001|Overall Study|Withdrawal by Subject|1|||
37952683|NCT03823911|69639602|FG000|Overall Study|Lost to Follow-up|1|||
37952684|NCT03823911|69639603|FG001|Overall Study|Lost to Follow-up|5|||
37952685|NCT03823911|69639604|FG002|Overall Study|Lost to Follow-up|2|||
37952686|NCT03823911|69639602|FG000|Overall Study|Did not meet eligibility criteria|13|||
37952687|NCT03823911|69639603|FG001|Overall Study|Did not meet eligibility criteria|7|||
37952688|NCT03823911|69639604|FG002|Overall Study|Did not meet eligibility criteria|4|||
37952689|NCT03823911|69639602|FG000|Overall Study|Death|0|||
37952690|NCT03823911|69639603|FG001|Overall Study|Death|1|||
37952691|NCT03823911|69639604|FG002|Overall Study|Death|0|||
37952692|NCT00621764|69639615|FG000|Overall Study|Protocol Violation|0|||
37952693|NCT00621764|69639616|FG001|Overall Study|Protocol Violation|0|||
37952694|NCT00621764|69639617|FG002|Overall Study|Protocol Violation|0|||
37952695|NCT00621764|69639618|FG003|Overall Study|Protocol Violation|1|||
37952696|NCT00510718|69639636|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
37952697|NCT00510718|69639637|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
37952698|NCT00510718|69639636|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
37952699|NCT00510718|69639637|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
37952700|NCT00510718|69639636|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
37952701|NCT00510718|69639637|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
37952702|NCT00510718|69639636|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
37952703|NCT00510718|69639637|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
37952704|NCT00510718|69639636|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
37952705|NCT00510718|69639637|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
37952706|NCT00510718|69639636|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
37952707|NCT00510718|69639637|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
37952708|NCT00537381|69639658|FG000|Overall Study|Adverse Event|13|||
37952709|NCT00537381|69639659|FG001|Overall Study|Adverse Event|9|||
37952710|NCT00537381|69639658|FG000|Overall Study|Death|3|||
37952711|NCT00537381|69639659|FG001|Overall Study|Death|3|||
37952712|NCT00537381|69639658|FG000|Overall Study|Withdrawal by Subject|5|||
37952713|NCT00537381|69639659|FG001|Overall Study|Withdrawal by Subject|14|||
37952714|NCT00537381|69639658|FG000|Overall Study|Physician Decision|7|||
37952715|NCT00537381|69639659|FG001|Overall Study|Physician Decision|6|||
37952716|NCT00537381|69639658|FG000|Overall Study|Disease Progression|9|||
38043910|NCT01386385|69731939|FG000|Phase II Concurrent CRT|Adverse Event|0|||
38043911|NCT01386385|69731940|FG001|Phase II Concurrent CRT|Adverse Event|0|||
38043912|NCT01386385|69731941|FG002|Phase II Concurrent CRT|Adverse Event|0|||
38043913|NCT01386385|69731942|FG003|Phase II Concurrent CRT|Adverse Event|0|||
38043914|NCT01386385|69731943|FG004|Phase II Concurrent CRT|Adverse Event|0|||
38043915|NCT01386385|69731944|FG005|Phase II Concurrent CRT|Adverse Event|0|||
38043916|NCT01386385|69731945|FG006|Phase II Concurrent CRT|Adverse Event|3|||
38043917|NCT01386385|69731946|FG007|Phase II Concurrent CRT|Adverse Event|3|||
38043918|NCT01386385|69731939|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
38043919|NCT01386385|69731940|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
38043920|NCT01386385|69731941|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
38043921|NCT01386385|69731942|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
38043922|NCT01386385|69731943|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
38043923|NCT01386385|69731944|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
38043924|NCT01386385|69731945|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
38043925|NCT01386385|69731946|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
38043926|NCT01386385|69731939|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
38043927|NCT01386385|69731940|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
38043928|NCT01386385|69731941|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
38043929|NCT01386385|69731942|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
38043930|NCT01386385|69731943|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
38043931|NCT01386385|69731944|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
38043932|NCT01386385|69731945|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
38043933|NCT01386385|69731946|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
38043934|NCT01386385|69731939|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
38043935|NCT01386385|69731940|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
38043936|NCT01386385|69731941|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
38043937|NCT01386385|69731942|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
38043938|NCT01386385|69731943|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
38043939|NCT01386385|69731944|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
38043940|NCT01386385|69731945|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
38043941|NCT01386385|69731946|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
38043942|NCT01386385|69731939|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
38043943|NCT01386385|69731940|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
38043944|NCT01386385|69731941|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
38043945|NCT01386385|69731942|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
38043946|NCT01386385|69731943|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
38043947|NCT01386385|69731944|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
38043948|NCT01386385|69731945|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
38043949|NCT01386385|69731946|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
38043950|NCT01275677|69731969|FG000|Overall Study|Not at risk for recurrence.|1|||
38043951|NCT01275677|69731970|FG001|Overall Study|Not at risk for recurrence.|1|||
38043952|NCT01275677|69731969|FG000|Overall Study|No follow-up|26|||
38043953|NCT01275677|69731970|FG001|Overall Study|No follow-up|37|||
38043954|NCT01275677|69731969|FG000|Overall Study|No clinical follow up.|1|||
38043955|NCT01275677|69731970|FG001|Overall Study|No clinical follow up.|4|||
38043956|NCT01274338|69731982|FG000|Overall Study|Lack of Efficacy|72|||
38043957|NCT01274338|69731983|FG001|Overall Study|Lack of Efficacy|108|||
38043958|NCT01274338|69731984|FG002|Overall Study|Lack of Efficacy|116|||
38043959|NCT01274338|69731985|FG003|Overall Study|Lack of Efficacy|0|||
38043960|NCT01274338|69731986|FG004|Overall Study|Lack of Efficacy|0|||
38043961|NCT01274338|69731987|FG005|Overall Study|Lack of Efficacy|0|||
38043962|NCT01274338|69731982|FG000|Overall Study|Adverse Event|272|||
38043963|NCT01274338|69731983|FG001|Overall Study|Adverse Event|105|||
38043964|NCT01274338|69731984|FG002|Overall Study|Adverse Event|180|||
38043965|NCT01274338|69731985|FG003|Overall Study|Adverse Event|1|||
38043966|NCT01274338|69731986|FG004|Overall Study|Adverse Event|0|||
38043967|NCT01274338|69731987|FG005|Overall Study|Adverse Event|0|||
38043968|NCT01274338|69731982|FG000|Overall Study|Death|8|||
38043969|NCT01274338|69731983|FG001|Overall Study|Death|1|||
38043970|NCT01274338|69731984|FG002|Overall Study|Death|0|||
38043971|NCT01274338|69731985|FG003|Overall Study|Death|0|||
38043972|NCT01274338|69731986|FG004|Overall Study|Death|0|||
38043973|NCT01274338|69731987|FG005|Overall Study|Death|0|||
38043974|NCT01274338|69731982|FG000|Overall Study|Withdrawal by Subject|27|||
38043975|NCT01274338|69731983|FG001|Overall Study|Withdrawal by Subject|99|||
38043976|NCT01274338|69731984|FG002|Overall Study|Withdrawal by Subject|17|||
38043977|NCT01274338|69731985|FG003|Overall Study|Withdrawal by Subject|0|||
38043978|NCT01274338|69731986|FG004|Overall Study|Withdrawal by Subject|0|||
38043979|NCT01274338|69731987|FG005|Overall Study|Withdrawal by Subject|0|||
38043980|NCT01274338|69731982|FG000|Overall Study|Did not start treatment|8|||
38043981|NCT01274338|69731983|FG001|Overall Study|Did not start treatment|116|||
38043982|NCT01274338|69731984|FG002|Overall Study|Did not start treatment|7|||
38043983|NCT01274338|69731985|FG003|Overall Study|Did not start treatment|0|||
38043984|NCT01274338|69731986|FG004|Overall Study|Did not start treatment|0|||
38043985|NCT01274338|69731987|FG005|Overall Study|Did not start treatment|0|||
38043986|NCT01274338|69731982|FG000|Overall Study|Alternative therapy|0|||
38043987|NCT01274338|69731983|FG001|Overall Study|Alternative therapy|1|||
38043988|NCT01274338|69731984|FG002|Overall Study|Alternative therapy|0|||
38043989|NCT01274338|69731985|FG003|Overall Study|Alternative therapy|0|||
38043990|NCT01274338|69731986|FG004|Overall Study|Alternative therapy|0|||
38043991|NCT01274338|69731987|FG005|Overall Study|Alternative therapy|0|||
38043992|NCT01274338|69731982|FG000|Overall Study|Other complicating diseases|0|||
38043993|NCT01274338|69731983|FG001|Overall Study|Other complicating diseases|3|||
38043994|NCT01274338|69731984|FG002|Overall Study|Other complicating diseases|1|||
38043995|NCT01274338|69731985|FG003|Overall Study|Other complicating diseases|0|||
38043996|NCT01274338|69731986|FG004|Overall Study|Other complicating diseases|0|||
38043997|NCT01274338|69731987|FG005|Overall Study|Other complicating diseases|0|||
38043998|NCT01274338|69731982|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
38043999|NCT01274338|69731983|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
38044000|NCT01274338|69731984|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
38044001|NCT01274338|69731985|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
38044002|NCT01274338|69731986|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
38044003|NCT01274338|69731987|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
38044004|NCT01274338|69731982|FG000|Overall Study|Pregnancy|0|||
38044005|NCT01274338|69731983|FG001|Overall Study|Pregnancy|0|||
38044006|NCT01274338|69731984|FG002|Overall Study|Pregnancy|1|||
38044007|NCT01274338|69731985|FG003|Overall Study|Pregnancy|0|||
38044008|NCT01274338|69731986|FG004|Overall Study|Pregnancy|0|||
38044009|NCT01274338|69731987|FG005|Overall Study|Pregnancy|0|||
38044010|NCT01274338|69731982|FG000|Overall Study|Reason not reported|12|||
38044011|NCT01274338|69731983|FG001|Overall Study|Reason not reported|21|||
38044012|NCT01274338|69731984|FG002|Overall Study|Reason not reported|3|||
38044013|NCT01274338|69731985|FG003|Overall Study|Reason not reported|0|||
38044014|NCT01274338|69731986|FG004|Overall Study|Reason not reported|1|||
38044015|NCT01274338|69731987|FG005|Overall Study|Reason not reported|0|||
38044016|NCT01236560|69732006|FG000|Overall Study|Adverse Event|0|||
38044017|NCT01236560|69732007|FG001|Overall Study|Adverse Event|2|||
38044018|NCT01236560|69732008|FG002|Overall Study|Adverse Event|1|||
38044019|NCT01236560|69732009|FG003|Overall Study|Adverse Event|3|||
38044020|NCT01236560|69732010|FG004|Overall Study|Adverse Event|0|||
38044021|NCT01236560|69732011|FG005|Overall Study|Adverse Event|0|||
38044022|NCT01236560|69732006|FG000|Overall Study|Death|0|||
38044023|NCT01236560|69732007|FG001|Overall Study|Death|1|||
38044024|NCT01236560|69732008|FG002|Overall Study|Death|0|||
38044025|NCT01236560|69732009|FG003|Overall Study|Death|1|||
38044026|NCT01236560|69732010|FG004|Overall Study|Death|0|||
38044027|NCT01236560|69732011|FG005|Overall Study|Death|0|||
38044028|NCT01236560|69732006|FG000|Overall Study|Lost to Follow-up|0|||
38044029|NCT01236560|69732007|FG001|Overall Study|Lost to Follow-up|1|||
38044030|NCT01236560|69732008|FG002|Overall Study|Lost to Follow-up|1|||
38044031|NCT01236560|69732009|FG003|Overall Study|Lost to Follow-up|0|||
38044032|NCT01236560|69732010|FG004|Overall Study|Lost to Follow-up|0|||
38044033|NCT01236560|69732011|FG005|Overall Study|Lost to Follow-up|0|||
38044034|NCT01236560|69732006|FG000|Overall Study|Physician Decision|0|||
38044035|NCT01236560|69732007|FG001|Overall Study|Physician Decision|1|||
38044036|NCT01236560|69732008|FG002|Overall Study|Physician Decision|8|||
38044037|NCT01236560|69732009|FG003|Overall Study|Physician Decision|0|||
38044038|NCT01236560|69732010|FG004|Overall Study|Physician Decision|0|||
38044039|NCT01236560|69732011|FG005|Overall Study|Physician Decision|0|||
38044040|NCT01236560|69732006|FG000|Overall Study|Withdrawal by Subject|0|||
38044041|NCT01236560|69732007|FG001|Overall Study|Withdrawal by Subject|0|||
38044042|NCT01236560|69732008|FG002|Overall Study|Withdrawal by Subject|1|||
38044043|NCT01236560|69732009|FG003|Overall Study|Withdrawal by Subject|2|||
38044044|NCT01236560|69732010|FG004|Overall Study|Withdrawal by Subject|0|||
38044045|NCT01236560|69732011|FG005|Overall Study|Withdrawal by Subject|0|||
38044046|NCT01236560|69732006|FG000|Overall Study|Progressive disease|5|||
38044047|NCT01236560|69732007|FG001|Overall Study|Progressive disease|19|||
38044048|NCT01236560|69732008|FG002|Overall Study|Progressive disease|9|||
38044049|NCT01236560|69732009|FG003|Overall Study|Progressive disease|16|||
38044050|NCT01236560|69732010|FG004|Overall Study|Progressive disease|0|||
38044051|NCT01236560|69732011|FG005|Overall Study|Progressive disease|0|||
38044052|NCT01193842|69732026|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
38044053|NCT01193842|69732027|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
38044054|NCT01193842|69732028|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
38044055|NCT01193842|69732029|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
38044056|NCT01193842|69732030|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
38044057|NCT01193842|69732026|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
38044058|NCT01193842|69732027|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
38044059|NCT01193842|69732028|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
38044060|NCT01193842|69732029|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
38044061|NCT01193842|69732030|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
38044062|NCT01193842|69732026|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
38044063|NCT01193842|69732027|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
38044064|NCT01193842|69732028|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
38044065|NCT01193842|69732029|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
38044066|NCT01193842|69732030|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
38044067|NCT01193842|69732026|FG000|Phase II: Randomized Groups|Death|0|||
38044068|NCT01193842|69732027|FG001|Phase II: Randomized Groups|Death|0|||
38044069|NCT01193842|69732028|FG002|Phase II: Randomized Groups|Death|0|||
38044070|NCT01193842|69732029|FG003|Phase II: Randomized Groups|Death|1|||
38044071|NCT01193842|69732030|FG004|Phase II: Randomized Groups|Death|1|||
38044072|NCT01193842|69732026|FG000|Phase II: Randomized Groups|Adverse Event|0|||
38044073|NCT01193842|69732027|FG001|Phase II: Randomized Groups|Adverse Event|0|||
38044074|NCT01193842|69732028|FG002|Phase II: Randomized Groups|Adverse Event|0|||
38044075|NCT01193842|69732029|FG003|Phase II: Randomized Groups|Adverse Event|5|||
38044076|NCT01193842|69732030|FG004|Phase II: Randomized Groups|Adverse Event|3|||
38044077|NCT01193842|69732026|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
38044078|NCT01193842|69732027|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
38044079|NCT01193842|69732028|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
38044080|NCT01193842|69732029|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
38044081|NCT01193842|69732030|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
38044082|NCT01193842|69732026|FG000|Phase II: Randomized Groups|Ineligible|0|||
38044083|NCT01193842|69732027|FG001|Phase II: Randomized Groups|Ineligible|0|||
38044084|NCT01193842|69732028|FG002|Phase II: Randomized Groups|Ineligible|0|||
38044085|NCT01193842|69732029|FG003|Phase II: Randomized Groups|Ineligible|0|||
38044086|NCT01193842|69732030|FG004|Phase II: Randomized Groups|Ineligible|1|||
38044087|NCT01193842|69732026|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
38044088|NCT01193842|69732027|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
38044089|NCT01193842|69732028|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
38044090|NCT01193842|69732029|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
38044091|NCT01193842|69732030|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
38044092|NCT01116648|69732076|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
38044093|NCT01116648|69732077|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
38044094|NCT01116648|69732078|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
38044095|NCT01116648|69732079|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
38044096|NCT01116648|69732080|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
38044097|NCT01116648|69732081|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
38044098|NCT01116648|69732082|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
38044099|NCT01116648|69732083|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
38044100|NCT01116648|69732084|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
38044101|NCT01116648|69732085|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
38044102|NCT01116648|69732086|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
38044103|NCT01116648|69732087|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
38044104|NCT01116648|69732088|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
38044105|NCT01116648|69732089|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
38044106|NCT01116648|69732090|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
38044107|NCT00980460|69732137|FG000|Overall Study|Death|0|||
38044108|NCT00980460|69732138|FG001|Overall Study|Death|0|||
38044109|NCT00980460|69732139|FG002|Overall Study|Death|1|||
38044110|NCT00980460|69732140|FG003|Overall Study|Death|2|||
38044111|NCT00980460|69732141|FG004|Overall Study|Death|1|||
38044112|NCT00980460|69732137|FG000|Overall Study|Lack of Efficacy|0|||
38044113|NCT00980460|69732138|FG001|Overall Study|Lack of Efficacy|0|||
38044114|NCT00980460|69732139|FG002|Overall Study|Lack of Efficacy|10|||
38044115|NCT00980460|69732140|FG003|Overall Study|Lack of Efficacy|6|||
38044116|NCT00980460|69732141|FG004|Overall Study|Lack of Efficacy|8|||
38044117|NCT00980460|69732137|FG000|Overall Study|Lost to Follow-up|0|||
38044118|NCT00980460|69732138|FG001|Overall Study|Lost to Follow-up|0|||
38044119|NCT00980460|69732139|FG002|Overall Study|Lost to Follow-up|0|||
38044120|NCT00980460|69732140|FG003|Overall Study|Lost to Follow-up|1|||
38044121|NCT00980460|69732141|FG004|Overall Study|Lost to Follow-up|0|||
38044122|NCT00980460|69732137|FG000|Overall Study|Physician Decision|0|||
38044123|NCT00980460|69732138|FG001|Overall Study|Physician Decision|0|||
38044124|NCT00980460|69732139|FG002|Overall Study|Physician Decision|11|||
38044125|NCT00980460|69732140|FG003|Overall Study|Physician Decision|5|||
38044126|NCT00980460|69732141|FG004|Overall Study|Physician Decision|3|||
38044127|NCT00980460|69732137|FG000|Overall Study|Withdrawal by Subject|0|||
38044128|NCT00980460|69732138|FG001|Overall Study|Withdrawal by Subject|0|||
38044129|NCT00980460|69732139|FG002|Overall Study|Withdrawal by Subject|1|||
38044130|NCT00980460|69732140|FG003|Overall Study|Withdrawal by Subject|0|||
38044131|NCT00980460|69732141|FG004|Overall Study|Withdrawal by Subject|0|||
38044132|NCT00980460|69732137|FG000|Overall Study|Ineligible|0|||
38044133|NCT00980460|69732138|FG001|Overall Study|Ineligible|2|||
38044134|NCT00980460|69732139|FG002|Overall Study|Ineligible|3|||
38044135|NCT00980460|69732140|FG003|Overall Study|Ineligible|1|||
38044136|NCT00980460|69732141|FG004|Overall Study|Ineligible|4|||
38044137|NCT00980460|69732137|FG000|Overall Study|Refusal of further therapy|0|||
38044138|NCT00980460|69732138|FG001|Overall Study|Refusal of further therapy|2|||
38044139|NCT00980460|69732139|FG002|Overall Study|Refusal of further therapy|3|||
38044140|NCT00980460|69732140|FG003|Overall Study|Refusal of further therapy|2|||
38044141|NCT00980460|69732141|FG004|Overall Study|Refusal of further therapy|0|||
38044142|NCT00980460|69732137|FG000|Overall Study|No therapy within 42 days of resection|0|||
38044143|NCT00980460|69732138|FG001|Overall Study|No therapy within 42 days of resection|0|||
38044144|NCT00980460|69732139|FG002|Overall Study|No therapy within 42 days of resection|3|||
38044145|NCT00980460|69732140|FG003|Overall Study|No therapy within 42 days of resection|1|||
37769527|NCT01421069|69286312|FG000|Active Treatment Period|Other|1|||
37769528|NCT01421069|69286312|FG000|Active Treatment Period|No longer willing to participate in study|8|||
38044146|NCT00980460|69732141|FG004|Overall Study|No therapy within 42 days of resection|0|||
38044147|NCT00980460|69732137|FG000|Overall Study|No transplant by protocol timepoints|0|||
38044148|NCT00980460|69732138|FG001|Overall Study|No transplant by protocol timepoints|0|||
38044149|NCT00980460|69732139|FG002|Overall Study|No transplant by protocol timepoints|3|||
38044150|NCT00980460|69732140|FG003|Overall Study|No transplant by protocol timepoints|0|||
38044151|NCT00980460|69732141|FG004|Overall Study|No transplant by protocol timepoints|0|||
38044152|NCT00855465|69732162|FG000|Treatment Period|Adverse Event|4|||
38044153|NCT00855465|69732163|FG001|Treatment Period|Adverse Event|2|||
38044154|NCT00855465|69732162|FG000|Treatment Period|Death|2|||
38044155|NCT00855465|69732163|FG001|Treatment Period|Death|2|||
38044156|NCT00855465|69732162|FG000|Treatment Period|Lack of Efficacy|2|||
38044157|NCT00855465|69732163|FG001|Treatment Period|Lack of Efficacy|1|||
38044158|NCT00855465|69732162|FG000|Treatment Period|Non-compliance|1|||
38044159|NCT00855465|69732163|FG001|Treatment Period|Non-compliance|0|||
38044160|NCT00855465|69732162|FG000|Treatment Period|Protocol Violation|2|||
38044161|NCT00855465|69732163|FG001|Treatment Period|Protocol Violation|0|||
38044162|NCT00855465|69732162|FG000|Treatment Period|Withdrawal by Subject|2|||
38044163|NCT00855465|69732163|FG001|Treatment Period|Withdrawal by Subject|0|||
38044164|NCT00855465|69732162|FG000|Treatment Period|Not treated|1|||
38044165|NCT00855465|69732163|FG001|Treatment Period|Not treated|0|||
38044166|NCT00855465|69732162|FG000|Follow-up Period (FUP)|Adverse Event|0|||
38044167|NCT00855465|69732163|FG001|Follow-up Period (FUP)|Adverse Event|1|||
38044168|NCT00855465|69732162|FG000|Follow-up Period (FUP)|Death|0|||
38044169|NCT00855465|69732163|FG001|Follow-up Period (FUP)|Death|1|||
38044170|NCT00855465|69732162|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
38044171|NCT00855465|69732163|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
38044172|NCT00855465|69732162|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
38044173|NCT00855465|69732163|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
38044174|NCT00855465|69732162|FG000|Follow-up Period (FUP)|Missing|1|||
38044175|NCT00855465|69732163|FG001|Follow-up Period (FUP)|Missing|0|||
38044176|NCT00843882|69732172|FG000|Step 1|Lack of Efficacy|14|||
38044177|NCT00843882|69732173|FG001|Step 1|Lack of Efficacy|10|||
38044178|NCT00843882|69732174|FG002|Step 1|Lack of Efficacy|21|||
38044179|NCT00843882|69732172|FG000|Step 1|Adverse Event|8|||
38044180|NCT00843882|69732173|FG001|Step 1|Adverse Event|17|||
38044181|NCT00843882|69732174|FG002|Step 1|Adverse Event|20|||
38044182|NCT00843882|69732172|FG000|Step 1|Death|1|||
38044183|NCT00843882|69732173|FG001|Step 1|Death|2|||
38044184|NCT00843882|69732174|FG002|Step 1|Death|4|||
38044185|NCT00843882|69732172|FG000|Step 1|Withdrawal by Subject|6|||
38044186|NCT00843882|69732173|FG001|Step 1|Withdrawal by Subject|12|||
38044187|NCT00843882|69732174|FG002|Step 1|Withdrawal by Subject|9|||
38044188|NCT00843882|69732172|FG000|Step 1|Physician Decision|0|||
38044189|NCT00843882|69732173|FG001|Step 1|Physician Decision|5|||
38044190|NCT00843882|69732174|FG002|Step 1|Physician Decision|1|||
38044191|NCT00843882|69732172|FG000|Step 1|Patient and physician's decision|0|||
38044192|NCT00843882|69732173|FG001|Step 1|Patient and physician's decision|0|||
38044193|NCT00843882|69732174|FG002|Step 1|Patient and physician's decision|1|||
38044194|NCT00843882|69732172|FG000|Step 1|Other complicating disease|1|||
38044195|NCT00843882|69732173|FG001|Step 1|Other complicating disease|3|||
38044196|NCT00843882|69732174|FG002|Step 1|Other complicating disease|4|||
38044197|NCT00843882|69732172|FG000|Step 1|Alternative therapy|0|||
38044198|NCT00843882|69732173|FG001|Step 1|Alternative therapy|1|||
38044199|NCT00843882|69732174|FG002|Step 1|Alternative therapy|1|||
38044200|NCT00843882|69732172|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
38044201|NCT00843882|69732173|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
38044202|NCT00843882|69732174|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
38044203|NCT00843882|69732172|FG000|Step 1|Off treatment reason unknown|0|||
38044204|NCT00843882|69732173|FG001|Step 1|Off treatment reason unknown|1|||
38044205|NCT00843882|69732174|FG002|Step 1|Off treatment reason unknown|4|||
38044206|NCT00843882|69732172|FG000|Step 1|Never started treatment|2|||
38044207|NCT00843882|69732173|FG001|Step 1|Never started treatment|0|||
38044208|NCT00843882|69732174|FG002|Step 1|Never started treatment|0|||
38044209|NCT00843882|69732172|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
38044210|NCT00843882|69732173|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
38044211|NCT00843882|69732174|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
38044212|NCT00843882|69732172|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
38044213|NCT00843882|69732173|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
38044214|NCT00843882|69732174|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
38044215|NCT00843882|69732172|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
38044216|NCT00843882|69732173|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
38044217|NCT00843882|69732174|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
38044218|NCT00843882|69732172|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
38044219|NCT00843882|69732173|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
38044220|NCT00843882|69732174|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
38044221|NCT00843882|69732172|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
38044222|NCT00843882|69732173|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
38044223|NCT00843882|69732174|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
38044224|NCT00843882|69732172|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
38044225|NCT00843882|69732173|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
38044226|NCT00843882|69732174|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
38044227|NCT00843882|69732172|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
38044228|NCT00843882|69732173|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
38044229|NCT00843882|69732174|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
38044230|NCT00770809|69732190|FG000|Overall Study|Adverse Event|9|||
38044231|NCT00770809|69732191|FG001|Overall Study|Adverse Event|1|||
38044232|NCT00770809|69732192|FG002|Overall Study|Adverse Event|12|||
38044233|NCT00770809|69732190|FG000|Overall Study|Death|1|||
38044234|NCT00770809|69732191|FG001|Overall Study|Death|0|||
38044235|NCT00770809|69732192|FG002|Overall Study|Death|0|||
38044236|NCT00770809|69732190|FG000|Overall Study|Withdrawal by Subject|3|||
38044237|NCT00770809|69732191|FG001|Overall Study|Withdrawal by Subject|3|||
38044238|NCT00770809|69732192|FG002|Overall Study|Withdrawal by Subject|7|||
38044239|NCT00770809|69732190|FG000|Overall Study|Progression|2|||
38044240|NCT00770809|69732191|FG001|Overall Study|Progression|2|||
38044241|NCT00770809|69732192|FG002|Overall Study|Progression|0|||
38044242|NCT00770809|69732190|FG000|Overall Study|Complicating illness|0|||
38044243|NCT00770809|69732191|FG001|Overall Study|Complicating illness|0|||
38044244|NCT00770809|69732192|FG002|Overall Study|Complicating illness|1|||
38044245|NCT00770809|69732190|FG000|Overall Study|Other Medical Reasons|2|||
38044246|NCT00770809|69732191|FG001|Overall Study|Other Medical Reasons|4|||
38044247|NCT00770809|69732192|FG002|Overall Study|Other Medical Reasons|3|||
38044248|NCT00644228|69732202|FG000|Randomization & Eligibility|Ineligible|31|||
38044249|NCT00644228|69732203|FG001|Randomization & Eligibility|Ineligible|21|||
38044250|NCT00644228|69732202|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
38044251|NCT00644228|69732203|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
38044252|NCT00644228|69732202|FG000|Randomization & Eligibility|Invalid Consent|0|||
38044253|NCT00644228|69732203|FG001|Randomization & Eligibility|Invalid Consent|1|||
38044254|NCT00644228|69732202|FG000|Induction Therapy|Adverse Event|22|||
38044255|NCT00644228|69732203|FG001|Induction Therapy|Adverse Event|55|||
38044256|NCT00644228|69732202|FG000|Induction Therapy|Withdrawal by Subject|10|||
38044257|NCT00644228|69732203|FG001|Induction Therapy|Withdrawal by Subject|3|||
38044258|NCT00644228|69732202|FG000|Induction Therapy|Progression/Relapse|24|||
38044259|NCT00644228|69732203|FG001|Induction Therapy|Progression/Relapse|12|||
38044260|NCT00644228|69732202|FG000|Induction Therapy|Death|3|||
38044261|NCT00644228|69732203|FG001|Induction Therapy|Death|7|||
38044262|NCT00644228|69732202|FG000|Induction Therapy|Not Protocol-Specified|24|||
38044263|NCT00644228|69732203|FG001|Induction Therapy|Not Protocol-Specified|28|||
38044264|NCT00644228|69732202|FG000|Maintenance|Adverse Event|27|||
38044265|NCT00644228|69732203|FG001|Maintenance|Adverse Event|31|||
38044266|NCT00644228|69732202|FG000|Maintenance|Withdrawal by Subject|6|||
38044267|NCT00644228|69732203|FG001|Maintenance|Withdrawal by Subject|4|||
38044268|NCT00644228|69732202|FG000|Maintenance|Progression/Relapse|67|||
38044269|NCT00644228|69732203|FG001|Maintenance|Progression/Relapse|42|||
38044270|NCT00644228|69732202|FG000|Maintenance|Death|3|||
38044271|NCT00644228|69732203|FG001|Maintenance|Death|3|||
38044272|NCT00644228|69732202|FG000|Maintenance|Not Protocol-Specified|14|||
38044273|NCT00644228|69732203|FG001|Maintenance|Not Protocol-Specified|15|||
38044274|NCT00644228|69732202|FG000|Maintenance|On Treatment|26|||
38044275|NCT00644228|69732203|FG001|Maintenance|On Treatment|40|||
38044276|NCT00602641|69732211|FG000|Overall Study|Never started protocol therapy|6|||
38044277|NCT00602641|69732212|FG001|Overall Study|Never started protocol therapy|2|||
38044278|NCT00602641|69732211|FG000|Overall Study|Still on treatment at time of analysis|8|||
38044279|NCT00602641|69732212|FG001|Overall Study|Still on treatment at time of analysis|15|||
38044280|NCT00602641|69732211|FG000|Overall Study|Adverse Event|62|||
38044281|NCT00602641|69732212|FG001|Overall Study|Adverse Event|53|||
38044282|NCT00602641|69732211|FG000|Overall Study|Disease progression|38|||
38044283|NCT00602641|69732212|FG001|Overall Study|Disease progression|55|||
38044284|NCT00602641|69732211|FG000|Overall Study|Death|6|||
38044285|NCT00602641|69732212|FG001|Overall Study|Death|5|||
38044286|NCT00602641|69732211|FG000|Overall Study|Withdrawal by Subject|15|||
38044287|NCT00602641|69732212|FG001|Overall Study|Withdrawal by Subject|12|||
38044288|NCT00602641|69732211|FG000|Overall Study|Alternative therapy|5|||
38044289|NCT00602641|69732212|FG001|Overall Study|Alternative therapy|2|||
38044290|NCT00602641|69732211|FG000|Overall Study|Other Complicating Disease|5|||
38044291|NCT00602641|69732212|FG001|Overall Study|Other Complicating Disease|2|||
38044292|NCT00602641|69732211|FG000|Overall Study|Physician Decision|5|||
38044293|NCT00602641|69732212|FG001|Overall Study|Physician Decision|4|||
38044294|NCT00602641|69732211|FG000|Overall Study|Administrative Closure|1|||
38044295|NCT00602641|69732212|FG001|Overall Study|Administrative Closure|1|||
38044296|NCT00602641|69732211|FG000|Overall Study|Other|3|||
38044297|NCT00602641|69732212|FG001|Overall Study|Other|1|||
38044298|NCT00601900|69732220|FG000|Overall Study|Withdrawal by Subject|0|||
38044299|NCT00601900|69732221|FG001|Overall Study|Withdrawal by Subject|3|||
38044300|NCT00588770|69732229|FG000|Overall Study|Disease progression|85|||
38044301|NCT00588770|69732230|FG001|Overall Study|Disease progression|68|||
38044302|NCT00588770|69732229|FG000|Overall Study|Adverse Event|29|||
37769529|NCT01421069|69286312|FG000|Active Treatment Period|Insufficient clinical response|1|||
38044303|NCT00588770|69732230|FG001|Overall Study|Adverse Event|58|||
38044304|NCT00588770|69732229|FG000|Overall Study|Death|13|||
38044305|NCT00588770|69732230|FG001|Overall Study|Death|22|||
38044306|NCT00588770|69732229|FG000|Overall Study|Withdrawal by Subject|15|||
38044307|NCT00588770|69732230|FG001|Overall Study|Withdrawal by Subject|25|||
38044308|NCT00588770|69732229|FG000|Overall Study|Alternative therapy|2|||
38044309|NCT00588770|69732230|FG001|Overall Study|Alternative therapy|4|||
38044310|NCT00588770|69732229|FG000|Overall Study|Other complicating disease|3|||
38044311|NCT00588770|69732230|FG001|Overall Study|Other complicating disease|2|||
38044312|NCT00588770|69732229|FG000|Overall Study|Not start protocol therapy|0|||
38044313|NCT00588770|69732230|FG001|Overall Study|Not start protocol therapy|9|||
38044314|NCT00588770|69732229|FG000|Overall Study|Lack of Efficacy|8|||
38044315|NCT00588770|69732230|FG001|Overall Study|Lack of Efficacy|10|||
38044316|NCT00588770|69732229|FG000|Overall Study|Physician discretion|2|||
38044317|NCT00588770|69732230|FG001|Overall Study|Physician discretion|0|||
38044318|NCT00588770|69732229|FG000|Overall Study|Patient non-compliance|2|||
38044319|NCT00588770|69732230|FG001|Overall Study|Patient non-compliance|2|||
38044320|NCT00569127|69732238|FG000|Overall Study|Adverse Event|57|||
38044321|NCT00569127|69732239|FG001|Overall Study|Adverse Event|47|||
38044322|NCT00569127|69732238|FG000|Overall Study|Withdrawal by Subject|13|||
38044323|NCT00569127|69732239|FG001|Overall Study|Withdrawal by Subject|27|||
38044324|NCT00569127|69732238|FG000|Overall Study|Progression|99|||
38044325|NCT00569127|69732239|FG001|Overall Study|Progression|100|||
38044326|NCT00569127|69732238|FG000|Overall Study|Death|4|||
38044327|NCT00569127|69732239|FG001|Overall Study|Death|3|||
38044328|NCT00569127|69732238|FG000|Overall Study|Other|20|||
38044329|NCT00569127|69732239|FG001|Overall Study|Other|19|||
38044330|NCT00569127|69732238|FG000|Overall Study|Lost to Follow-up|0|||
38044331|NCT00569127|69732239|FG001|Overall Study|Lost to Follow-up|3|||
38044332|NCT00569127|69732238|FG000|Overall Study|Not Eligible|14|||
38044333|NCT00569127|69732239|FG001|Overall Study|Not Eligible|11|||
38044334|NCT00569127|69732238|FG000|Overall Study|Still on Treatment|7|||
38044335|NCT00569127|69732239|FG001|Overall Study|Still on Treatment|3|||
38044336|NCT00433511|69732248|FG000|Step 1|Adverse Event|50|||
38044337|NCT00433511|69732249|FG001|Step 1|Adverse Event|157|||
38044338|NCT00433511|69732250|FG002|Step 1|Adverse Event|153|||
38044339|NCT00433511|69732248|FG000|Step 1|Withdrawal by Subject|45|||
38044340|NCT00433511|69732249|FG001|Step 1|Withdrawal by Subject|143|||
38044341|NCT00433511|69732250|FG002|Step 1|Withdrawal by Subject|154|||
38044342|NCT00433511|69732248|FG000|Step 1|Death|3|||
38044343|NCT00433511|69732249|FG001|Step 1|Death|1|||
37769530|NCT01421069|69286312|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
37769531|NCT01421069|69286312|FG000|Active Treatment Period|Pregnancy|1|||
37769532|NCT01421069|69286312|FG000|Active Treatment Period|Adverse Event|1|||
37769533|NCT01421069|69286312|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
37769534|NCT01421069|69286312|FG000|Active Treatment Period|Enrolled in observational period|29|||
37769535|NCT01421069|69286312|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
37769536|NCT01421069|69286312|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
38044344|NCT00433511|69732250|FG002|Step 1|Death|1|||
38044345|NCT00433511|69732248|FG000|Step 1|Physician Decision|1|||
38044346|NCT00433511|69732249|FG001|Step 1|Physician Decision|4|||
38044347|NCT00433511|69732250|FG002|Step 1|Physician Decision|3|||
38044348|NCT00433511|69732248|FG000|Step 1|Never started protocol therapy|28|||
38044349|NCT00433511|69732249|FG001|Step 1|Never started protocol therapy|64|||
38044350|NCT00433511|69732250|FG002|Step 1|Never started protocol therapy|66|||
38044351|NCT00433511|69732248|FG000|Step 1|Alternative therapy|2|||
38044352|NCT00433511|69732249|FG001|Step 1|Alternative therapy|1|||
38044353|NCT00433511|69732250|FG002|Step 1|Alternative therapy|3|||
38044354|NCT00433511|69732248|FG000|Step 1|Disease progression, relapse|5|||
38044355|NCT00433511|69732249|FG001|Step 1|Disease progression, relapse|3|||
38044356|NCT00433511|69732250|FG002|Step 1|Disease progression, relapse|3|||
38044357|NCT00433511|69732248|FG000|Step 1|Other complicating disease|2|||
38044358|NCT00433511|69732249|FG001|Step 1|Other complicating disease|6|||
38044359|NCT00433511|69732250|FG002|Step 1|Other complicating disease|3|||
38044360|NCT00433511|69732248|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
38044361|NCT00433511|69732249|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
38044362|NCT00433511|69732250|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
38044363|NCT00433511|69732248|FG000|Step 1|Suspected recurrence|0|||
38044364|NCT00433511|69732249|FG001|Step 1|Suspected recurrence|1|||
38044365|NCT00433511|69732250|FG002|Step 1|Suspected recurrence|0|||
38044366|NCT00433511|69732248|FG000|Step 1|Insurance/drug distribution issues|0|||
38044367|NCT00433511|69732249|FG001|Step 1|Insurance/drug distribution issues|1|||
38044368|NCT00433511|69732250|FG002|Step 1|Insurance/drug distribution issues|2|||
38044369|NCT00433511|69732248|FG000|Step 1|Patient moved|0|||
38044370|NCT00433511|69732249|FG001|Step 1|Patient moved|0|||
38044371|NCT00433511|69732250|FG002|Step 1|Patient moved|1|||
38044372|NCT00433511|69732248|FG000|Step 2 (Arm D)|Adverse Event|0|||
38044373|NCT00433511|69732249|FG001|Step 2 (Arm D)|Adverse Event|0|||
38044374|NCT00433511|69732250|FG002|Step 2 (Arm D)|Adverse Event|135|||
38044375|NCT00433511|69732248|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
38044376|NCT00433511|69732249|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
38044377|NCT00433511|69732250|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
38044378|NCT00433511|69732248|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
38044379|NCT00433511|69732249|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
38044380|NCT00433511|69732250|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
38044381|NCT00433511|69732248|FG000|Step 2 (Arm D)|Physician Decision|0|||
37769537|NCT01421069|69286312|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
37769538|NCT01421069|69286312|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
37769539|NCT01421069|69286312|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
38044382|NCT00433511|69732249|FG001|Step 2 (Arm D)|Physician Decision|0|||
38044383|NCT00433511|69732250|FG002|Step 2 (Arm D)|Physician Decision|9|||
38044384|NCT00433511|69732248|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
38044385|NCT00433511|69732249|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
38044386|NCT00433511|69732250|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
38044387|NCT00433511|69732248|FG000|Step 2 (Arm D)|Other complicating disease|0|||
38044388|NCT00433511|69732249|FG001|Step 2 (Arm D)|Other complicating disease|0|||
38044389|NCT00433511|69732250|FG002|Step 2 (Arm D)|Other complicating disease|3|||
38044390|NCT00433511|69732248|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
38044391|NCT00433511|69732249|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
38044392|NCT00433511|69732250|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
38044393|NCT00433511|69732248|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
38044394|NCT00433511|69732249|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
38044395|NCT00433511|69732250|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
38044396|NCT00433511|69732248|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
38044397|NCT00433511|69732249|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
38044398|NCT00433511|69732250|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
38044399|NCT00433511|69732248|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
38044400|NCT00433511|69732249|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
38044401|NCT00433511|69732250|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
38044402|NCT00408005|69732263|FG000|Induction|Adverse Event|19|||
38044403|NCT00408005|69732264|FG001|Induction|Adverse Event|3|||
38044404|NCT00408005|69732265|FG002|Induction|Adverse Event|0|||
38044405|NCT00408005|69732266|FG003|Induction|Adverse Event|0|||
38044406|NCT00408005|69732267|FG004|Induction|Adverse Event|0|||
38044407|NCT00408005|69732268|FG005|Induction|Adverse Event|0|||
38044408|NCT00408005|69732269|FG006|Induction|Adverse Event|0|||
38044409|NCT00408005|69732270|FG007|Induction|Adverse Event|0|||
38044410|NCT00408005|69732263|FG000|Induction|Death|6|||
38044411|NCT00408005|69732264|FG001|Induction|Death|0|||
38044412|NCT00408005|69732265|FG002|Induction|Death|0|||
38044413|NCT00408005|69732266|FG003|Induction|Death|0|||
38044414|NCT00408005|69732267|FG004|Induction|Death|0|||
38044415|NCT00408005|69732268|FG005|Induction|Death|0|||
38044416|NCT00408005|69732269|FG006|Induction|Death|0|||
38044417|NCT00408005|69732270|FG007|Induction|Death|0|||
38044418|NCT00408005|69732263|FG000|Induction|Physician Decision|83|||
38044419|NCT00408005|69732264|FG001|Induction|Physician Decision|9|||
38044420|NCT00408005|69732265|FG002|Induction|Physician Decision|0|||
38044421|NCT00408005|69732266|FG003|Induction|Physician Decision|0|||
38044422|NCT00408005|69732267|FG004|Induction|Physician Decision|0|||
38044423|NCT00408005|69732268|FG005|Induction|Physician Decision|0|||
38044424|NCT00408005|69732269|FG006|Induction|Physician Decision|0|||
38044425|NCT00408005|69732270|FG007|Induction|Physician Decision|0|||
38044426|NCT00408005|69732263|FG000|Induction|Withdrawal by Subject|2|||
38044427|NCT00408005|69732264|FG001|Induction|Withdrawal by Subject|4|||
38044428|NCT00408005|69732265|FG002|Induction|Withdrawal by Subject|0|||
38044429|NCT00408005|69732266|FG003|Induction|Withdrawal by Subject|0|||
38044430|NCT00408005|69732267|FG004|Induction|Withdrawal by Subject|0|||
38044431|NCT00408005|69732268|FG005|Induction|Withdrawal by Subject|0|||
38044432|NCT00408005|69732269|FG006|Induction|Withdrawal by Subject|0|||
38044433|NCT00408005|69732270|FG007|Induction|Withdrawal by Subject|0|||
38044434|NCT00408005|69732263|FG000|Induction|Ineligible|33|||
38044435|NCT00408005|69732264|FG001|Induction|Ineligible|14|||
38044436|NCT00408005|69732265|FG002|Induction|Ineligible|0|||
38044437|NCT00408005|69732266|FG003|Induction|Ineligible|0|||
38044438|NCT00408005|69732267|FG004|Induction|Ineligible|0|||
38044439|NCT00408005|69732268|FG005|Induction|Ineligible|0|||
38044440|NCT00408005|69732269|FG006|Induction|Ineligible|0|||
38044441|NCT00408005|69732270|FG007|Induction|Ineligible|0|||
38044442|NCT00408005|69732263|FG000|Induction|Refusal of Further Protocol Therapy|225|||
38044443|NCT00408005|69732264|FG001|Induction|Refusal of Further Protocol Therapy|44|||
38044444|NCT00408005|69732265|FG002|Induction|Refusal of Further Protocol Therapy|0|||
38044445|NCT00408005|69732266|FG003|Induction|Refusal of Further Protocol Therapy|0|||
38044446|NCT00408005|69732267|FG004|Induction|Refusal of Further Protocol Therapy|0|||
38044447|NCT00408005|69732268|FG005|Induction|Refusal of Further Protocol Therapy|0|||
38044448|NCT00408005|69732269|FG006|Induction|Refusal of Further Protocol Therapy|0|||
38044449|NCT00408005|69732270|FG007|Induction|Refusal of Further Protocol Therapy|0|||
38044450|NCT00408005|69732263|FG000|Induction|Entered another COG therapeutic protocol|4|||
38044451|NCT00408005|69732264|FG001|Induction|Entered another COG therapeutic protocol|0|||
38044452|NCT00408005|69732265|FG002|Induction|Entered another COG therapeutic protocol|0|||
38044453|NCT00408005|69732266|FG003|Induction|Entered another COG therapeutic protocol|0|||
38044454|NCT00408005|69732267|FG004|Induction|Entered another COG therapeutic protocol|0|||
38044455|NCT00408005|69732268|FG005|Induction|Entered another COG therapeutic protocol|0|||
38044456|NCT00408005|69732269|FG006|Induction|Entered another COG therapeutic protocol|0|||
38044457|NCT00408005|69732270|FG007|Induction|Entered another COG therapeutic protocol|0|||
38044458|NCT00408005|69732263|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
38044459|NCT00408005|69732264|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
38044460|NCT00408005|69732265|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
38044461|NCT00408005|69732266|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
38044462|NCT00408005|69732267|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
38044463|NCT00408005|69732268|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
38044464|NCT00408005|69732269|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
38044465|NCT00408005|69732270|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
38044466|NCT00408005|69732263|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
38044467|NCT00408005|69732264|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
38044468|NCT00408005|69732265|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
38044469|NCT00408005|69732266|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
38044470|NCT00408005|69732267|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
38044471|NCT00408005|69732268|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
38044472|NCT00408005|69732269|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
38044473|NCT00408005|69732270|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
38044474|NCT00408005|69732263|FG000|Induction|Progressive Disease|0|||
38044475|NCT00408005|69732264|FG001|Induction|Progressive Disease|1|||
38044476|NCT00408005|69732265|FG002|Induction|Progressive Disease|0|||
38044477|NCT00408005|69732266|FG003|Induction|Progressive Disease|0|||
38044478|NCT00408005|69732267|FG004|Induction|Progressive Disease|0|||
38044479|NCT00408005|69732268|FG005|Induction|Progressive Disease|0|||
38044480|NCT00408005|69732269|FG006|Induction|Progressive Disease|0|||
38044481|NCT00408005|69732270|FG007|Induction|Progressive Disease|0|||
38044482|NCT00408005|69732263|FG000|Induction|Inevaluable|18|||
38044483|NCT00408005|69732264|FG001|Induction|Inevaluable|14|||
38044484|NCT00408005|69732265|FG002|Induction|Inevaluable|0|||
38044485|NCT00408005|69732266|FG003|Induction|Inevaluable|0|||
38044486|NCT00408005|69732267|FG004|Induction|Inevaluable|0|||
38044487|NCT00408005|69732268|FG005|Induction|Inevaluable|0|||
38044488|NCT00408005|69732269|FG006|Induction|Inevaluable|0|||
38044489|NCT00408005|69732270|FG007|Induction|Inevaluable|0|||
38044490|NCT00408005|69732263|FG000|Induction|Failed to Complete Randomization|3|||
38044491|NCT00408005|69732264|FG001|Induction|Failed to Complete Randomization|2|||
38044492|NCT00408005|69732265|FG002|Induction|Failed to Complete Randomization|0|||
38044493|NCT00408005|69732266|FG003|Induction|Failed to Complete Randomization|0|||
38044494|NCT00408005|69732267|FG004|Induction|Failed to Complete Randomization|0|||
38044495|NCT00408005|69732268|FG005|Induction|Failed to Complete Randomization|0|||
38044496|NCT00408005|69732269|FG006|Induction|Failed to Complete Randomization|0|||
38044497|NCT00408005|69732270|FG007|Induction|Failed to Complete Randomization|0|||
38044498|NCT00408005|69732263|FG000|Induction|Protocol Deviation|3|||
38044499|NCT00408005|69732264|FG001|Induction|Protocol Deviation|1|||
38044500|NCT00408005|69732265|FG002|Induction|Protocol Deviation|0|||
38044501|NCT00408005|69732266|FG003|Induction|Protocol Deviation|0|||
38044502|NCT00408005|69732267|FG004|Induction|Protocol Deviation|0|||
38044503|NCT00408005|69732268|FG005|Induction|Protocol Deviation|0|||
38044504|NCT00408005|69732269|FG006|Induction|Protocol Deviation|0|||
38044505|NCT00408005|69732270|FG007|Induction|Protocol Deviation|0|||
38044506|NCT00408005|69732263|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
38044507|NCT00408005|69732264|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
38044508|NCT00408005|69732265|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
38044509|NCT00408005|69732266|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
38044510|NCT00408005|69732267|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
38044511|NCT00408005|69732268|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
38044512|NCT00408005|69732269|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
38044513|NCT00408005|69732270|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
38044514|NCT00408005|69732263|FG000|Induction|Recurrent leukemia|1|||
38044515|NCT00408005|69732264|FG001|Induction|Recurrent leukemia|0|||
38044516|NCT00408005|69732265|FG002|Induction|Recurrent leukemia|0|||
38044517|NCT00408005|69732266|FG003|Induction|Recurrent leukemia|0|||
38044518|NCT00408005|69732267|FG004|Induction|Recurrent leukemia|0|||
38044519|NCT00408005|69732268|FG005|Induction|Recurrent leukemia|0|||
38044520|NCT00408005|69732269|FG006|Induction|Recurrent leukemia|0|||
38044521|NCT00408005|69732270|FG007|Induction|Recurrent leukemia|0|||
38044522|NCT00408005|69732263|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
38044523|NCT00408005|69732264|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
38044524|NCT00408005|69732265|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
38044525|NCT00408005|69732266|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
38044526|NCT00408005|69732267|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
38044527|NCT00408005|69732268|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
38044528|NCT00408005|69732269|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
38044529|NCT00408005|69732270|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
38044530|NCT00408005|69732263|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
38044531|NCT00408005|69732264|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
38044532|NCT00408005|69732265|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
38044533|NCT00408005|69732266|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
38044534|NCT00408005|69732267|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
38044535|NCT00408005|69732268|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
38044536|NCT00408005|69732269|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
38044537|NCT00408005|69732270|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
38044538|NCT00408005|69732263|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
38044539|NCT00408005|69732264|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
38044540|NCT00408005|69732265|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
38044541|NCT00408005|69732266|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
38044542|NCT00408005|69732267|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
38044543|NCT00408005|69732268|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
38044544|NCT00408005|69732269|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
38044545|NCT00408005|69732270|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
38044546|NCT00408005|69732263|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
38044547|NCT00408005|69732264|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
38044548|NCT00408005|69732265|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
38044549|NCT00408005|69732266|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
38044550|NCT00408005|69732267|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
38044551|NCT00408005|69732268|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
38044552|NCT00408005|69732269|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
38044553|NCT00408005|69732270|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
38044554|NCT00408005|69732263|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
38044555|NCT00408005|69732264|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
38044556|NCT00408005|69732265|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
38044557|NCT00408005|69732266|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
38044558|NCT00408005|69732267|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
38044559|NCT00408005|69732268|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
38044560|NCT00408005|69732269|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
38044561|NCT00408005|69732270|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
38044562|NCT00408005|69732263|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
38044563|NCT00408005|69732264|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
38044564|NCT00408005|69732265|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
38044565|NCT00408005|69732266|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
38044566|NCT00408005|69732267|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
38044567|NCT00408005|69732268|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
38044568|NCT00408005|69732269|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
38044569|NCT00408005|69732270|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
38044570|NCT00408005|69732263|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
38044571|NCT00408005|69732264|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
38044572|NCT00408005|69732265|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
38044573|NCT00408005|69732266|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
38044574|NCT00408005|69732267|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
38044575|NCT00408005|69732268|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
38044576|NCT00408005|69732269|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
38044577|NCT00408005|69732270|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
38044578|NCT00408005|69732263|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
38044579|NCT00408005|69732264|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
38044580|NCT00408005|69732265|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
38044581|NCT00408005|69732266|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
38044582|NCT00408005|69732267|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
38044583|NCT00408005|69732268|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
38044584|NCT00408005|69732269|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
38044585|NCT00408005|69732270|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
38044586|NCT00408005|69732263|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
38044587|NCT00408005|69732264|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
38044588|NCT00408005|69732265|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
38044589|NCT00408005|69732266|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
38044590|NCT00408005|69732267|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
38044591|NCT00408005|69732268|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
38044592|NCT00408005|69732269|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
38044593|NCT00408005|69732270|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
38044594|NCT00408005|69732263|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
38044595|NCT00408005|69732264|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
38044596|NCT00408005|69732265|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
38044597|NCT00408005|69732266|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
38044598|NCT00408005|69732267|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
38044599|NCT00408005|69732268|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
38044600|NCT00408005|69732269|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
38044601|NCT00408005|69732270|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
38044602|NCT00408005|69732263|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
38044603|NCT00408005|69732264|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
38044604|NCT00408005|69732265|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
38044605|NCT00408005|69732266|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
38044606|NCT00408005|69732267|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
38044607|NCT00408005|69732268|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
38044608|NCT00408005|69732269|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
38044609|NCT00408005|69732270|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
38044610|NCT00408005|69732263|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
38044611|NCT00408005|69732264|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
38044612|NCT00408005|69732265|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
38044613|NCT00408005|69732266|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
38044614|NCT00408005|69732267|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
38044615|NCT00408005|69732268|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
38044616|NCT00408005|69732269|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
38044617|NCT00408005|69732270|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
38044618|NCT00408005|69732263|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
38044619|NCT00408005|69732264|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
38044620|NCT00408005|69732265|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
38044621|NCT00408005|69732266|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
38044622|NCT00408005|69732267|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
38044623|NCT00408005|69732268|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
38044624|NCT00408005|69732269|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
38044625|NCT00408005|69732270|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
38044626|NCT00408005|69732263|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
38044627|NCT00408005|69732264|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
38044628|NCT00408005|69732265|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
38044629|NCT00408005|69732266|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
38044630|NCT00408005|69732267|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
38044631|NCT00408005|69732268|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
38044632|NCT00408005|69732269|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
38044633|NCT00408005|69732270|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
38044634|NCT00324805|69732292|FG000|Overall Study|Adverse Event|62|||
38044635|NCT00324805|69732293|FG001|Overall Study|Adverse Event|203|||
38044636|NCT00324805|69732292|FG000|Overall Study|Progression|7|||
38044637|NCT00324805|69732293|FG001|Overall Study|Progression|35|||
38044638|NCT00324805|69732292|FG000|Overall Study|Withdrawal by Subject|51|||
38044639|NCT00324805|69732293|FG001|Overall Study|Withdrawal by Subject|174|||
38044640|NCT00324805|69732292|FG000|Overall Study|Death|6|||
38044641|NCT00324805|69732293|FG001|Overall Study|Death|9|||
38044642|NCT00324805|69732292|FG000|Overall Study|Alternative therapy|4|||
38044643|NCT00324805|69732293|FG001|Overall Study|Alternative therapy|8|||
38044644|NCT00324805|69732292|FG000|Overall Study|Other complicating disease|1|||
38044645|NCT00324805|69732293|FG001|Overall Study|Other complicating disease|9|||
38044646|NCT00324805|69732292|FG000|Overall Study|Other reasons|7|||
38044647|NCT00324805|69732293|FG001|Overall Study|Other reasons|26|||
38044648|NCT00324805|69732292|FG000|Overall Study|Other|0|||
38044649|NCT00324805|69732293|FG001|Overall Study|Other|2|||
38044650|NCT00324805|69732292|FG000|Overall Study|Did not start therapy|12|||
38044651|NCT00324805|69732293|FG001|Overall Study|Did not start therapy|17|||
38044652|NCT00098475|69732312|FG000|Step 1|Progressive disease|33|||
38044653|NCT00098475|69732313|FG001|Step 1|Progressive disease|35|||
38044654|NCT00098475|69732314|FG002|Step 1|Progressive disease|2|||
38044655|NCT00098475|69732315|FG003|Step 1|Progressive disease|1|||
38044656|NCT00098475|69732312|FG000|Step 1|Adverse Event|56|||
38044657|NCT00098475|69732313|FG001|Step 1|Adverse Event|37|||
38044658|NCT00098475|69732314|FG002|Step 1|Adverse Event|0|||
38044659|NCT00098475|69732315|FG003|Step 1|Adverse Event|1|||
38044660|NCT00098475|69732312|FG000|Step 1|Death|8|||
38044661|NCT00098475|69732313|FG001|Step 1|Death|5|||
38044662|NCT00098475|69732314|FG002|Step 1|Death|0|||
38044663|NCT00098475|69732315|FG003|Step 1|Death|1|||
38044664|NCT00098475|69732312|FG000|Step 1|Withdrawal by Subject|14|||
38044665|NCT00098475|69732313|FG001|Step 1|Withdrawal by Subject|11|||
38044666|NCT00098475|69732314|FG002|Step 1|Withdrawal by Subject|0|||
38044667|NCT00098475|69732315|FG003|Step 1|Withdrawal by Subject|0|||
38044668|NCT00098475|69732312|FG000|Step 1|Physician Decision|5|||
38044669|NCT00098475|69732313|FG001|Step 1|Physician Decision|2|||
38044670|NCT00098475|69732314|FG002|Step 1|Physician Decision|0|||
38044671|NCT00098475|69732315|FG003|Step 1|Physician Decision|0|||
38044672|NCT00098475|69732312|FG000|Step 1|Alternative therapy|31|||
38044673|NCT00098475|69732313|FG001|Step 1|Alternative therapy|43|||
38044674|NCT00098475|69732314|FG002|Step 1|Alternative therapy|1|||
38044675|NCT00098475|69732315|FG003|Step 1|Alternative therapy|0|||
38044676|NCT00098475|69732312|FG000|Step 1|Other disease|2|||
38044677|NCT00098475|69732313|FG001|Step 1|Other disease|1|||
38044678|NCT00098475|69732314|FG002|Step 1|Other disease|1|||
38044679|NCT00098475|69732315|FG003|Step 1|Other disease|0|||
38044680|NCT00098475|69732312|FG000|Step 1|Never started treatment|0|||
38044681|NCT00098475|69732313|FG001|Step 1|Never started treatment|2|||
38044682|NCT00098475|69732314|FG002|Step 1|Never started treatment|0|||
38044683|NCT00098475|69732315|FG003|Step 1|Never started treatment|0|||
38044684|NCT00098475|69732312|FG000|Step 1|Still on treatment as of this analysis|14|||
38044685|NCT00098475|69732313|FG001|Step 1|Still on treatment as of this analysis|27|||
38044686|NCT00098475|69732314|FG002|Step 1|Still on treatment as of this analysis|0|||
38044687|NCT00098475|69732315|FG003|Step 1|Still on treatment as of this analysis|0|||
38044688|NCT00098475|69732312|FG000|Step 1|Knee surgery|1|||
38044689|NCT00098475|69732313|FG001|Step 1|Knee surgery|0|||
38044690|NCT00098475|69732314|FG002|Step 1|Knee surgery|0|||
38044691|NCT00098475|69732315|FG003|Step 1|Knee surgery|0|||
38044692|NCT00098475|69732312|FG000|Step 1|Complications|1|||
38044693|NCT00098475|69732313|FG001|Step 1|Complications|0|||
38044694|NCT00098475|69732314|FG002|Step 1|Complications|0|||
38044695|NCT00098475|69732315|FG003|Step 1|Complications|0|||
38044696|NCT00098475|69732312|FG000|Step 1|Cannot comply due to other tx|0|||
38044697|NCT00098475|69732313|FG001|Step 1|Cannot comply due to other tx|1|||
38044698|NCT00098475|69732314|FG002|Step 1|Cannot comply due to other tx|0|||
38044699|NCT00098475|69732315|FG003|Step 1|Cannot comply due to other tx|0|||
38044700|NCT00098475|69732312|FG000|Step 1|Both patient and physician's decision|2|||
38044701|NCT00098475|69732313|FG001|Step 1|Both patient and physician's decision|1|||
38044702|NCT00098475|69732314|FG002|Step 1|Both patient and physician's decision|0|||
38044703|NCT00098475|69732315|FG003|Step 1|Both patient and physician's decision|0|||
38044704|NCT00098475|69732312|FG000|Step 1|Incorrect disease assessment|2|||
38044705|NCT00098475|69732313|FG001|Step 1|Incorrect disease assessment|0|||
38044706|NCT00098475|69732314|FG002|Step 1|Incorrect disease assessment|0|||
38044707|NCT00098475|69732315|FG003|Step 1|Incorrect disease assessment|0|||
38044708|NCT00098475|69732312|FG000|Step 1|Off treatment for > specified timeframe|1|||
38044709|NCT00098475|69732313|FG001|Step 1|Off treatment for > specified timeframe|1|||
38044710|NCT00098475|69732314|FG002|Step 1|Off treatment for > specified timeframe|0|||
38044711|NCT00098475|69732315|FG003|Step 1|Off treatment for > specified timeframe|0|||
38044712|NCT00098475|69732312|FG000|Step 1|Declining performance status|0|||
38044713|NCT00098475|69732313|FG001|Step 1|Declining performance status|1|||
38044714|NCT00098475|69732314|FG002|Step 1|Declining performance status|0|||
38044715|NCT00098475|69732315|FG003|Step 1|Declining performance status|0|||
38044716|NCT00098475|69732312|FG000|Step 1|Insurance issue|0|||
38044717|NCT00098475|69732313|FG001|Step 1|Insurance issue|1|||
38044718|NCT00098475|69732314|FG002|Step 1|Insurance issue|0|||
38044719|NCT00098475|69732315|FG003|Step 1|Insurance issue|0|||
38044720|NCT00098475|69732312|FG000|Step 1|Rising paraprotein|0|||
38044721|NCT00098475|69732313|FG001|Step 1|Rising paraprotein|1|||
38044722|NCT00098475|69732314|FG002|Step 1|Rising paraprotein|0|||
38044723|NCT00098475|69732315|FG003|Step 1|Rising paraprotein|0|||
38044724|NCT00098475|69732312|FG000|Step 1|Referred to other physicians|0|||
38044725|NCT00098475|69732313|FG001|Step 1|Referred to other physicians|1|||
38044726|NCT00098475|69732314|FG002|Step 1|Referred to other physicians|0|||
38044727|NCT00098475|69732315|FG003|Step 1|Referred to other physicians|0|||
38044728|NCT00098475|69732312|FG000|Step 1|Criteria to continue treatment not met|0|||
38044729|NCT00098475|69732313|FG001|Step 1|Criteria to continue treatment not met|1|||
38044730|NCT00098475|69732314|FG002|Step 1|Criteria to continue treatment not met|0|||
38044731|NCT00098475|69732315|FG003|Step 1|Criteria to continue treatment not met|0|||
38044732|NCT00098475|69732312|FG000|Step 1|Misinterpretation of lab data|0|||
38044733|NCT00098475|69732313|FG001|Step 1|Misinterpretation of lab data|1|||
38044734|NCT00098475|69732314|FG002|Step 1|Misinterpretation of lab data|0|||
38044735|NCT00098475|69732315|FG003|Step 1|Misinterpretation of lab data|0|||
38044736|NCT00098475|69732312|FG000|Step 1|Patient fell with fracture|1|||
38044737|NCT00098475|69732313|FG001|Step 1|Patient fell with fracture|0|||
38044738|NCT00098475|69732314|FG002|Step 1|Patient fell with fracture|0|||
38044739|NCT00098475|69732315|FG003|Step 1|Patient fell with fracture|0|||
38044740|NCT00098475|69732312|FG000|Step 1|Not documented|0|||
38044741|NCT00098475|69732313|FG001|Step 1|Not documented|1|||
38044742|NCT00098475|69732314|FG002|Step 1|Not documented|0|||
38044743|NCT00098475|69732315|FG003|Step 1|Not documented|0|||
38044744|NCT00098475|69732312|FG000|Step 2|Disease progression|1|||
38044745|NCT00098475|69732313|FG001|Step 2|Disease progression|4|||
38044746|NCT00098475|69732314|FG002|Step 2|Disease progression|0|||
38044747|NCT00098475|69732315|FG003|Step 2|Disease progression|0|||
38044748|NCT00098475|69732312|FG000|Step 2|Adverse Event|2|||
38044749|NCT00098475|69732313|FG001|Step 2|Adverse Event|0|||
38044750|NCT00098475|69732314|FG002|Step 2|Adverse Event|0|||
38044751|NCT00098475|69732315|FG003|Step 2|Adverse Event|0|||
38044752|NCT00098475|69732312|FG000|Step 2|Withdrawal by Subject|0|||
38044753|NCT00098475|69732313|FG001|Step 2|Withdrawal by Subject|2|||
38044754|NCT00098475|69732314|FG002|Step 2|Withdrawal by Subject|0|||
38044755|NCT00098475|69732315|FG003|Step 2|Withdrawal by Subject|0|||
38044756|NCT00098475|69732312|FG000|Step 2|Physician Decision|0|||
38044757|NCT00098475|69732313|FG001|Step 2|Physician Decision|1|||
38044758|NCT00098475|69732314|FG002|Step 2|Physician Decision|0|||
38044759|NCT00098475|69732315|FG003|Step 2|Physician Decision|0|||
38044760|NCT00098475|69732312|FG000|Step 2|Alternative therapy|1|||
38044761|NCT00098475|69732313|FG001|Step 2|Alternative therapy|2|||
38044762|NCT00098475|69732314|FG002|Step 2|Alternative therapy|0|||
38044763|NCT00098475|69732315|FG003|Step 2|Alternative therapy|0|||
38044764|NCT00098475|69732312|FG000|Step 2|Never started treatment|1|||
38044765|NCT00098475|69732313|FG001|Step 2|Never started treatment|1|||
38044766|NCT00098475|69732314|FG002|Step 2|Never started treatment|0|||
38044767|NCT00098475|69732315|FG003|Step 2|Never started treatment|0|||
38044768|NCT00026312|69732327|FG000|Overall Study|Adverse Event|0|||
38044769|NCT00026312|69732328|FG001|Overall Study|Adverse Event|32|||
38044770|NCT00026312|69732327|FG000|Overall Study|Death|1|||
38044771|NCT00026312|69732328|FG001|Overall Study|Death|7|||
38044772|NCT00026312|69732327|FG000|Overall Study|Lack of Efficacy|19|||
38044773|NCT00026312|69732328|FG001|Overall Study|Lack of Efficacy|114|||
38044774|NCT00026312|69732327|FG000|Overall Study|Lost to Follow-up|0|||
38044775|NCT00026312|69732328|FG001|Overall Study|Lost to Follow-up|5|||
38044776|NCT00026312|69732327|FG000|Overall Study|Physician Decision|1|||
38044777|NCT00026312|69732328|FG001|Overall Study|Physician Decision|37|||
38044778|NCT00026312|69732327|FG000|Overall Study|Protocol Violation|0|||
38044779|NCT00026312|69732328|FG001|Overall Study|Protocol Violation|3|||
38044780|NCT00026312|69732327|FG000|Overall Study|Withdrawal by Subject|1|||
38044781|NCT00026312|69732328|FG001|Overall Study|Withdrawal by Subject|6|||
38044782|NCT00026312|69732327|FG000|Overall Study|Ineligible|4|||
38044783|NCT00026312|69732328|FG001|Overall Study|Ineligible|5|||
38044784|NCT00026312|69732327|FG000|Overall Study|Entry onto another COG study|0|||
38044785|NCT00026312|69732328|FG001|Overall Study|Entry onto another COG study|1|||
38044786|NCT00026312|69732327|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
38044787|NCT00026312|69732328|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
38044788|NCT03136484|69732344|FG000|Overall Study|Withdrawal by Subject|19|||
38044789|NCT03136484|69732345|FG001|Overall Study|Withdrawal by Subject|14|||
38044790|NCT03136484|69732344|FG000|Overall Study|Lost to Follow-up|7|||
38044791|NCT03136484|69732345|FG001|Overall Study|Lost to Follow-up|8|||
38044792|NCT03136484|69732344|FG000|Overall Study|Death|1|||
38044793|NCT03136484|69732345|FG001|Overall Study|Death|0|||
38044794|NCT03922711|69732354|FG000|Overall Study|Adverse Event|3|||
38044795|NCT03922711|69732355|FG001|Overall Study|Adverse Event|2|||
38044796|NCT03922711|69732356|FG002|Overall Study|Adverse Event|2|||
38044797|NCT03922711|69732354|FG000|Overall Study|Protocol Violation|1|||
38044798|NCT03922711|69732355|FG001|Overall Study|Protocol Violation|0|||
38044799|NCT03922711|69732356|FG002|Overall Study|Protocol Violation|0|||
38044800|NCT03922711|69732354|FG000|Overall Study|Withdrawal by Subject|0|||
38044801|NCT03922711|69732355|FG001|Overall Study|Withdrawal by Subject|3|||
38044802|NCT03922711|69732356|FG002|Overall Study|Withdrawal by Subject|1|||
38044803|NCT03922711|69732354|FG000|Overall Study|Not further specified|0|||
38044804|NCT03922711|69732355|FG001|Overall Study|Not further specified|0|||
38044805|NCT03922711|69732356|FG002|Overall Study|Not further specified|1|||
38044806|NCT02877680|69732365|FG000|Overall Study|Lost to Follow-up|1|||
38044807|NCT02877680|69732366|FG001|Overall Study|Lost to Follow-up|1|||
38044808|NCT03141086|69732378|FG000|Overall Study|Study Terminated By Sponsor|1|||
38044809|NCT03141086|69732379|FG001|Overall Study|Study Terminated By Sponsor|1|||
38044810|NCT03141086|69732378|FG000|Overall Study|Withdrawal by Subject|0|||
38044811|NCT03141086|69732379|FG001|Overall Study|Withdrawal by Subject|1|||
38044812|NCT03141086|69732378|FG000|Overall Study|Protocol Violation|0|||
38044813|NCT03141086|69732379|FG001|Overall Study|Protocol Violation|1|||
38044814|NCT03141086|69732378|FG000|Overall Study|Adverse Event|0|||
38044815|NCT03141086|69732379|FG001|Overall Study|Adverse Event|2|||
38044816|NCT03135548|69732388|FG000|Overall Study|Lost to Follow-up|3|||
38044817|NCT03135548|69732389|FG001|Overall Study|Lost to Follow-up|0|||
38044818|NCT03135548|69732390|FG002|Overall Study|Lost to Follow-up|0|||
38044819|NCT03135548|69732388|FG000|Overall Study|Withdrawal by Subject|2|||
38044820|NCT03135548|69732389|FG001|Overall Study|Withdrawal by Subject|2|||
38044821|NCT03135548|69732390|FG002|Overall Study|Withdrawal by Subject|1|||
38044822|NCT03135548|69732388|FG000|Overall Study|Other than listed|0|||
38044823|NCT03135548|69732389|FG001|Overall Study|Other than listed|2|||
38044824|NCT03135548|69732390|FG002|Overall Study|Other than listed|2|||
38044825|NCT03134222|69732401|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
38044826|NCT03134222|69732402|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
38044827|NCT03134222|69732403|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
38044828|NCT03134222|69732404|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
38044829|NCT03134222|69732405|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
38044830|NCT03134222|69732401|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
38044831|NCT03134222|69732402|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
38044832|NCT03134222|69732403|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
38044833|NCT03134222|69732404|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
38044834|NCT03134222|69732405|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
38044835|NCT03134222|69732401|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
38044836|NCT03134222|69732402|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
38044837|NCT03134222|69732403|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
38044838|NCT03134222|69732404|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
38044839|NCT03134222|69732405|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
38044840|NCT03134222|69732401|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
38044841|NCT03134222|69732402|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
38044842|NCT03134222|69732403|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
38044843|NCT03134222|69732404|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
38044844|NCT03134222|69732405|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
38044845|NCT03134222|69732401|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
38044846|NCT03134222|69732402|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
38044847|NCT03134222|69732403|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
38044848|NCT03134222|69732404|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
38044849|NCT03134222|69732405|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
38044850|NCT03134222|69732401|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
38044851|NCT03134222|69732402|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
38044852|NCT03134222|69732403|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
38044853|NCT03134222|69732404|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
38044854|NCT03134222|69732405|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
38044855|NCT03134222|69732401|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
38044856|NCT03134222|69732402|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
38044857|NCT03134222|69732403|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
38044858|NCT03134222|69732404|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
38044859|NCT03134222|69732405|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
38044860|NCT03134222|69732401|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
38044861|NCT03134222|69732402|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
38044862|NCT03134222|69732403|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
38044863|NCT03134222|69732404|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
38044864|NCT03134222|69732405|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
38044865|NCT03769753|69732415|FG000|Overall Study|Not Treated|6|||
38044866|NCT03769753|69732415|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
38044867|NCT03263923|69732430|FG000|Overall Study|Withdrawal by Subject|10|||
38044868|NCT03263923|69732431|FG001|Overall Study|Withdrawal by Subject|8|||
38044869|NCT03263923|69732430|FG000|Overall Study|Lost to Follow-up|15|||
38044870|NCT03263923|69732431|FG001|Overall Study|Lost to Follow-up|13|||
38044871|NCT03139604|69732441|FG000|Overall Study|Other|7|||
38044872|NCT03139604|69732442|FG001|Overall Study|Other|3|||
38044873|NCT03139604|69732441|FG000|Overall Study|Withdrawal by Subject|16|||
38044874|NCT03139604|69732442|FG001|Overall Study|Withdrawal by Subject|17|||
38044875|NCT03139604|69732441|FG000|Overall Study|Physician Decision|1|||
38044876|NCT03139604|69732442|FG001|Overall Study|Physician Decision|2|||
38044877|NCT03139604|69732441|FG000|Overall Study|Lost to Follow-up|3|||
38044878|NCT03139604|69732442|FG001|Overall Study|Lost to Follow-up|1|||
38044879|NCT03139604|69732441|FG000|Overall Study|Death|65|||
38044880|NCT03139604|69732442|FG001|Overall Study|Death|67|||
38044881|NCT03139604|69732441|FG000|Overall Study|Study Terminated by Sponsor|122|||
38044882|NCT03139604|69732442|FG001|Overall Study|Study Terminated by Sponsor|127|||
38044883|NCT03139604|69732441|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
38044884|NCT03139604|69732442|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
38044885|NCT03139448|69732451|FG000|Overall Study|Lack of Efficacy|6|||
38044886|NCT03139448|69732452|FG001|Overall Study|Lack of Efficacy|7|||
38044887|NCT03139448|69732451|FG000|Overall Study|Location of procedure changed|2|||
38044888|NCT03139448|69732452|FG001|Overall Study|Location of procedure changed|8|||
38044889|NCT03139448|69732451|FG000|Overall Study|Withdrawal by Subject|3|||
38044890|NCT03139448|69732452|FG001|Overall Study|Withdrawal by Subject|6|||
38044891|NCT03139448|69732451|FG000|Overall Study|Screen fail|1|||
38044892|NCT03139448|69732452|FG001|Overall Study|Screen fail|3|||
38044893|NCT03139448|69732451|FG000|Overall Study|Physician Decision|0|||
38044894|NCT03139448|69732452|FG001|Overall Study|Physician Decision|2|||
38044895|NCT02875340|69732458|FG000|Overall Study|Death|2|||
38044896|NCT02875340|69732458|FG000|Overall Study|Withdrawal by Subject|2|||
38044897|NCT02875340|69732458|FG000|Overall Study|Physician Decision|3|||
38044898|NCT02875340|69732458|FG000|Overall Study|Adverse Event|1|||
38044899|NCT03237325|69732470|FG000|Overall Study|Lost to Follow-up|3|||
38044900|NCT03237325|69732471|FG001|Overall Study|Lost to Follow-up|5|||
38044901|NCT03237325|69732470|FG000|Overall Study|Physician Decision|2|||
38044902|NCT03237325|69732471|FG001|Overall Study|Physician Decision|4|||
38044903|NCT03237325|69732470|FG000|Overall Study|Withdrawal by Subject|9|||
38044904|NCT03237325|69732471|FG001|Overall Study|Withdrawal by Subject|12|||
38044905|NCT03237325|69732470|FG000|Overall Study|Noncompliance with Study Procedures|1|||
38044906|NCT03237325|69732471|FG001|Overall Study|Noncompliance with Study Procedures|1|||
38044907|NCT03237325|69732470|FG000|Overall Study|Termination by Sponsor|0|||
38044908|NCT03237325|69732471|FG001|Overall Study|Termination by Sponsor|1|||
38044909|NCT03237325|69732470|FG000|Overall Study|Reason other than described|0|||
38044910|NCT03237325|69732471|FG001|Overall Study|Reason other than described|2|||
38044911|NCT03113383|69732477|FG000|Overall Study|Death|4|||
38044912|NCT03113383|69732478|FG001|Overall Study|Death|0|||
38044913|NCT03131960|69732499|FG000|Overall Study|Adverse Event|0|||
38044914|NCT03131960|69732500|FG001|Overall Study|Adverse Event|1|||
38044915|NCT03225170|69732509|FG000|Overall Study|Lost to Follow-up|4|||
38044916|NCT03225170|69732510|FG001|Overall Study|Lost to Follow-up|4|||
38044917|NCT03225170|69732511|FG002|Overall Study|Lost to Follow-up|0|||
38044918|NCT03225170|69732509|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
38044919|NCT03225170|69732510|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
38044920|NCT03225170|69732511|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
38044921|NCT02115139|69732517|FG000|Overall Study|Protocol Violation|1|||
38044922|NCT02115139|69732517|FG000|Overall Study|treatment discontinuation|6|||
38044923|NCT01763827|69732565|FG000|Overall Study|Withdrawal by Subject|1|||
38044924|NCT01763827|69732566|FG001|Overall Study|Withdrawal by Subject|0|||
38044925|NCT01763827|69732567|FG002|Overall Study|Withdrawal by Subject|0|||
38044926|NCT01763827|69732568|FG003|Overall Study|Withdrawal by Subject|0|||
38044927|NCT01763827|69732569|FG004|Overall Study|Withdrawal by Subject|2|||
38044928|NCT01763827|69732570|FG005|Overall Study|Withdrawal by Subject|0|||
38044929|NCT01763827|69732565|FG000|Overall Study|Decision by sponsor|2|||
38044930|NCT01763827|69732566|FG001|Overall Study|Decision by sponsor|0|||
38044931|NCT01763827|69732567|FG002|Overall Study|Decision by sponsor|3|||
38044932|NCT01763827|69732568|FG003|Overall Study|Decision by sponsor|0|||
38044933|NCT01763827|69732569|FG004|Overall Study|Decision by sponsor|2|||
38044934|NCT01763827|69732570|FG005|Overall Study|Decision by sponsor|1|||
38044935|NCT01763827|69732565|FG000|Overall Study|Lost to Follow-up|0|||
38044936|NCT01763827|69732566|FG001|Overall Study|Lost to Follow-up|1|||
38044937|NCT01763827|69732567|FG002|Overall Study|Lost to Follow-up|1|||
38044938|NCT01763827|69732568|FG003|Overall Study|Lost to Follow-up|1|||
38044939|NCT01763827|69732569|FG004|Overall Study|Lost to Follow-up|2|||
38044940|NCT01763827|69732570|FG005|Overall Study|Lost to Follow-up|1|||
38044941|NCT01732783|69732623|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
38044942|NCT01732783|69732624|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
38044943|NCT01732783|69732625|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
38044944|NCT01732783|69732623|FG000|Overall Study|Death|13|||
37769540|NCT01421069|69286312|FG000|2b. Retreatment Period|Protocol Violation|1|||
38044945|NCT01732783|69732624|FG001|Overall Study|Death|4|||
38044946|NCT01732783|69732625|FG002|Overall Study|Death|1|||
38044947|NCT01732783|69732623|FG000|Overall Study|Lost to Follow-up|7|||
38044948|NCT01732783|69732624|FG001|Overall Study|Lost to Follow-up|1|||
38044949|NCT01732783|69732625|FG002|Overall Study|Lost to Follow-up|1|||
38044950|NCT01732783|69732623|FG000|Overall Study|Administrative Decision|8|||
38044951|NCT01732783|69732624|FG001|Overall Study|Administrative Decision|2|||
38044952|NCT01732783|69732625|FG002|Overall Study|Administrative Decision|1|||
38044953|NCT01732783|69732623|FG000|Overall Study|Withdrawal by Subject|1|||
38044954|NCT01732783|69732624|FG001|Overall Study|Withdrawal by Subject|0|||
38044955|NCT01732783|69732625|FG002|Overall Study|Withdrawal by Subject|0|||
38044956|NCT02787850|69732652|FG000|Overall Study|Withdrawal by Subject|0|||
38044957|NCT02787850|69732653|FG001|Overall Study|Withdrawal by Subject|1|||
38044958|NCT01375777|69732677|FG000|Overall Study|Withdrawal by Subject|0|||
38044959|NCT01375777|69732678|FG001|Overall Study|Withdrawal by Subject|2|||
38044960|NCT01375777|69732679|FG002|Overall Study|Withdrawal by Subject|1|||
38044961|NCT01375777|69732680|FG003|Overall Study|Withdrawal by Subject|0|||
38044962|NCT01375777|69732681|FG004|Overall Study|Withdrawal by Subject|1|||
38044963|NCT01375777|69732682|FG005|Overall Study|Withdrawal by Subject|1|||
38044964|NCT01375777|69732683|FG006|Overall Study|Withdrawal by Subject|1|||
38044965|NCT01375777|69732684|FG007|Overall Study|Withdrawal by Subject|2|||
38044966|NCT01375777|69732685|FG008|Overall Study|Withdrawal by Subject|1|||
38044967|NCT01375777|69732677|FG000|Overall Study|Lost to Follow-up|1|||
38044968|NCT01375777|69732678|FG001|Overall Study|Lost to Follow-up|0|||
38044969|NCT01375777|69732679|FG002|Overall Study|Lost to Follow-up|0|||
38044970|NCT01375777|69732680|FG003|Overall Study|Lost to Follow-up|0|||
38044971|NCT01375777|69732681|FG004|Overall Study|Lost to Follow-up|0|||
38044972|NCT01375777|69732682|FG005|Overall Study|Lost to Follow-up|0|||
38044973|NCT01375777|69732683|FG006|Overall Study|Lost to Follow-up|1|||
38044974|NCT01375777|69732684|FG007|Overall Study|Lost to Follow-up|0|||
38044975|NCT01375777|69732685|FG008|Overall Study|Lost to Follow-up|0|||
38044976|NCT01375777|69732677|FG000|Overall Study|Other|1|||
38044977|NCT01375777|69732678|FG001|Overall Study|Other|1|||
38044978|NCT01375777|69732679|FG002|Overall Study|Other|0|||
38044979|NCT01375777|69732680|FG003|Overall Study|Other|0|||
38044980|NCT01375777|69732681|FG004|Overall Study|Other|0|||
38044981|NCT01375777|69732682|FG005|Overall Study|Other|0|||
38044982|NCT01375777|69732683|FG006|Overall Study|Other|0|||
38044983|NCT01375777|69732684|FG007|Overall Study|Other|0|||
38044984|NCT01375777|69732685|FG008|Overall Study|Other|1|||
38044985|NCT02431702|69732705|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
38044986|NCT02431702|69732706|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
38044987|NCT02431702|69732707|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
38044988|NCT02431702|69732708|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
38044989|NCT02431702|69732709|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
38044990|NCT02431702|69732710|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
38044991|NCT02431702|69732711|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
38044992|NCT02431702|69732705|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
38044993|NCT02431702|69732706|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
38044994|NCT02431702|69732707|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
38044995|NCT02431702|69732708|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
38044996|NCT02431702|69732709|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
38044997|NCT02431702|69732710|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
38044998|NCT02431702|69732711|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
38044999|NCT02431702|69732705|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
38045000|NCT02431702|69732706|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
38045001|NCT02431702|69732707|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
38045002|NCT02431702|69732708|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
38045003|NCT02431702|69732709|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
38045004|NCT02431702|69732710|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
38045005|NCT02431702|69732711|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
38045006|NCT02431702|69732705|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
38045007|NCT02431702|69732706|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
38045008|NCT02431702|69732707|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
38045009|NCT02431702|69732708|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
38045010|NCT02431702|69732709|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
38045011|NCT02431702|69732710|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
38045012|NCT02431702|69732711|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
38045013|NCT02431702|69732705|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
38045014|NCT02431702|69732706|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
38045015|NCT02431702|69732707|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
38045016|NCT02431702|69732708|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
38045017|NCT02431702|69732709|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
37769541|NCT01421069|69286312|FG000|Observational Period|Other|1|||
37861278|NCT01264718|69544692|FG001|Overall Study|Lost to Follow-up|2|||
37861279|NCT01264718|69544691|FG000|Overall Study|Withdrawal by Subject|9|||
37861280|NCT01264718|69544692|FG001|Overall Study|Withdrawal by Subject|15|||
37861281|NCT01264718|69544691|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
38045018|NCT02431702|69732710|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
38045019|NCT02431702|69732711|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
38045020|NCT02431702|69732705|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
38045021|NCT02431702|69732706|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
38045022|NCT02431702|69732707|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
38045023|NCT02431702|69732708|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
38045024|NCT02431702|69732709|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
38045025|NCT02431702|69732710|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
38045026|NCT02431702|69732711|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
38045027|NCT02431702|69732705|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
38045028|NCT02431702|69732706|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
38045029|NCT02431702|69732707|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
38045030|NCT02431702|69732708|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
38045031|NCT02431702|69732709|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
38045032|NCT02431702|69732710|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
38045033|NCT02431702|69732711|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
38045034|NCT02431702|69732705|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
38045035|NCT02431702|69732706|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
38045036|NCT02431702|69732707|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
38045037|NCT02431702|69732708|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
38045038|NCT02431702|69732709|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
38045039|NCT02431702|69732710|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
38045040|NCT02431702|69732711|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
38045041|NCT02431702|69732705|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
38045042|NCT02431702|69732706|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
38045043|NCT02431702|69732707|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
38045044|NCT02431702|69732708|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
38045045|NCT02431702|69732709|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
38045046|NCT02431702|69732710|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
38045047|NCT02431702|69732711|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
38045048|NCT02431702|69732705|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
38045049|NCT02431702|69732706|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
38045050|NCT02431702|69732707|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
38045051|NCT02431702|69732708|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
38045052|NCT02431702|69732709|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
38045053|NCT02431702|69732710|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
38045054|NCT02431702|69732711|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
38045055|NCT02431702|69732705|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
38045056|NCT02431702|69732706|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
38045057|NCT02431702|69732707|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
38045058|NCT02431702|69732708|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
38045059|NCT02431702|69732709|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
38045060|NCT02431702|69732710|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
38045061|NCT02431702|69732711|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
38045062|NCT02431702|69732705|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
38045063|NCT02431702|69732706|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
38045064|NCT02431702|69732707|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
38045065|NCT02431702|69732708|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
38045066|NCT02431702|69732709|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
38045067|NCT02431702|69732710|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
38045068|NCT02431702|69732711|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
38045069|NCT02431702|69732705|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
38045070|NCT02431702|69732706|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
37769542|NCT01421069|69286312|FG000|Observational Period|No longer willing to participate in study|4|||
37769543|NCT01421069|69286312|FG000|Observational Period|Lost to Follow-up|3|||
37769544|NCT01473836|69286344|FG000|Overall Study|Adverse Event|4|||
37769545|NCT01473836|69286344|FG000|Overall Study|Lack of Efficacy|1|||
37769546|NCT01473836|69286344|FG000|Overall Study|Does not meet entrance criteria|1|||
37769547|NCT01473758|69286384|FG000|Cycle 1|Adverse Event|10|||
37769548|NCT01473758|69286385|FG001|Cycle 1|Adverse Event|2|||
37769549|NCT01473758|69286386|FG002|Cycle 1|Adverse Event|0|||
37769550|NCT01473758|69286387|FG003|Cycle 1|Adverse Event|0|||
37769551|NCT01473758|69286384|FG000|Cycle 1|Withdrawal by Subject|1|||
37769552|NCT01473758|69286385|FG001|Cycle 1|Withdrawal by Subject|1|||
37769553|NCT01473758|69286386|FG002|Cycle 1|Withdrawal by Subject|0|||
37769554|NCT01473758|69286387|FG003|Cycle 1|Withdrawal by Subject|0|||
37769555|NCT01473758|69286384|FG000|Cycle 2|Adverse Event|0|||
37769556|NCT01473758|69286385|FG001|Cycle 2|Adverse Event|0|||
37769557|NCT01473758|69286386|FG002|Cycle 2|Adverse Event|5|||
37769558|NCT01473758|69286387|FG003|Cycle 2|Adverse Event|0|||
37769559|NCT01420679|69286397|FG000|Overall Study|Disease Progression|3|||
37769560|NCT01420679|69286398|FG001|Overall Study|Disease Progression|2|||
37769561|NCT01420679|69286397|FG000|Overall Study|Adverse Event|4|||
37769562|NCT01420679|69286398|FG001|Overall Study|Adverse Event|0|||
37769563|NCT01420679|69286397|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
37769564|NCT01420679|69286398|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
37769565|NCT01420679|69286397|FG000|Overall Study|Patient Decision|1|||
37769566|NCT01420679|69286398|FG001|Overall Study|Patient Decision|0|||
38045071|NCT02431702|69732707|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
38045072|NCT02431702|69732708|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
37769567|NCT01420679|69286397|FG000|Overall Study|Investigator Decision|1|||
37769568|NCT01420679|69286398|FG001|Overall Study|Investigator Decision|2|||
37769569|NCT01420679|69286397|FG000|Overall Study|Sponsor Decision|3|||
37769570|NCT01420679|69286398|FG001|Overall Study|Sponsor Decision|3|||
37769571|NCT01420679|69286397|FG000|Overall Study|Other|1|||
37769572|NCT01420679|69286398|FG001|Overall Study|Other|0|||
37769573|NCT01496846|69286415|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
37769574|NCT01496846|69286416|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
37769575|NCT01496846|69286417|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
37769576|NCT01496846|69286418|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
37769577|NCT01496846|69286419|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
37769578|NCT01496846|69286420|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
37769579|NCT00964002|69286431|FG000|Overall Study|Protocol Violation|8|||
37769580|NCT01399697|69286443|FG000|Overall Study|Adverse Event|13|||
37769581|NCT01399697|69286444|FG001|Overall Study|Adverse Event|3|||
37769582|NCT01399697|69286445|FG002|Overall Study|Adverse Event|1|||
37769583|NCT01399697|69286443|FG000|Overall Study|Lost to Follow-up|2|||
37769584|NCT01399697|69286444|FG001|Overall Study|Lost to Follow-up|0|||
37769585|NCT01399697|69286445|FG002|Overall Study|Lost to Follow-up|0|||
37769586|NCT01399697|69286443|FG000|Overall Study|Withdrawal by Subject|8|||
37769587|NCT01399697|69286444|FG001|Overall Study|Withdrawal by Subject|0|||
37769588|NCT01399697|69286445|FG002|Overall Study|Withdrawal by Subject|0|||
37769589|NCT01399697|69286443|FG000|Overall Study|Investigator Decisión|1|||
37769590|NCT01399697|69286444|FG001|Overall Study|Investigator Decisión|0|||
37769591|NCT01399697|69286445|FG002|Overall Study|Investigator Decisión|2|||
37769592|NCT01399697|69286443|FG000|Overall Study|Lack of Efficacy|9|||
37769593|NCT01399697|69286444|FG001|Overall Study|Lack of Efficacy|0|||
37769594|NCT01399697|69286445|FG002|Overall Study|Lack of Efficacy|1|||
37769595|NCT01399697|69286443|FG000|Overall Study|Protocol Violation|2|||
37769596|NCT01399697|69286444|FG001|Overall Study|Protocol Violation|0|||
37769597|NCT01399697|69286445|FG002|Overall Study|Protocol Violation|0|||
37769598|NCT01399697|69286443|FG000|Overall Study|Non-Compliant|1|||
37769599|NCT01399697|69286444|FG001|Overall Study|Non-Compliant|0|||
37769600|NCT01399697|69286445|FG002|Overall Study|Non-Compliant|0|||
37769601|NCT01399697|69286443|FG000|Overall Study|Inclusion Error|2|||
37769602|NCT01399697|69286444|FG001|Overall Study|Inclusion Error|0|||
38045073|NCT02431702|69732709|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
38045074|NCT02431702|69732710|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
38045075|NCT02431702|69732711|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
38045076|NCT02431702|69732705|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
38045077|NCT02431702|69732706|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
38045078|NCT02431702|69732707|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
37769603|NCT01399697|69286445|FG002|Overall Study|Inclusion Error|0|||
37769604|NCT01399697|69286443|FG000|Overall Study|Positive result for hepatitis B|1|||
37952717|NCT00537381|69639659|FG001|Overall Study|Disease Progression|18|||
37769605|NCT01399697|69286444|FG001|Overall Study|Positive result for hepatitis B|0|||
37769606|NCT01399697|69286445|FG002|Overall Study|Positive result for hepatitis B|0|||
37769607|NCT01399697|69286443|FG000|Overall Study|Clinical RA remission|1|||
37769608|NCT01399697|69286444|FG001|Overall Study|Clinical RA remission|0|||
37769609|NCT01399697|69286445|FG002|Overall Study|Clinical RA remission|0|||
37769610|NCT01399697|69286443|FG000|Overall Study|Sponsor Decision|1|||
37769611|NCT01399697|69286444|FG001|Overall Study|Sponsor Decision|0|||
37769612|NCT01399697|69286445|FG002|Overall Study|Sponsor Decision|0|||
37769613|NCT01473602|69286479|FG000|Overall Study|Adverse Event|1|||
37769614|NCT01473602|69286480|FG001|Overall Study|Adverse Event|2|||
37769615|NCT01473602|69286479|FG000|Overall Study|Death|0|||
37769616|NCT01473602|69286480|FG001|Overall Study|Death|1|||
37769617|NCT01473602|69286479|FG000|Overall Study|Lost to Follow-up|1|||
37769618|NCT01473602|69286480|FG001|Overall Study|Lost to Follow-up|1|||
37769619|NCT01473602|69286479|FG000|Overall Study|Withdrawal by Subject|5|||
37769620|NCT01473602|69286480|FG001|Overall Study|Withdrawal by Subject|4|||
37769621|NCT01473602|69286479|FG000|Overall Study|Physician Decision|1|||
37769622|NCT01473602|69286480|FG001|Overall Study|Physician Decision|0|||
37769623|NCT01496612|69286488|FG000|1st Intervention|Adverse Event|1|||
37769624|NCT01496612|69286489|FG001|1st Intervention|Adverse Event|0|||
37769625|NCT01496612|69286488|FG000|1st Intervention|Withdrawal by Subject|1|||
37769626|NCT01496612|69286489|FG001|1st Intervention|Withdrawal by Subject|0|||
37769627|NCT00790218|69286506|FG000|Overall Study|Death|1|||
37769628|NCT00790218|69286507|FG001|Overall Study|Death|0|||
37769629|NCT00790218|69286508|FG002|Overall Study|Death|0|||
37769630|NCT01457924|69286534|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
37769631|NCT01457924|69286535|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
37769632|NCT01457924|69286536|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
37769633|NCT01457924|69286537|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
37769634|NCT01457924|69286538|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
37769635|NCT01457924|69286534|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
37769636|NCT01457924|69286535|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
37769637|NCT01457924|69286536|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
37769638|NCT01457924|69286537|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
37769639|NCT01457924|69286538|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
37769640|NCT01457924|69286534|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
37769641|NCT01457924|69286535|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
37769642|NCT01457924|69286536|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
37769643|NCT01457924|69286537|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
37769644|NCT01457924|69286538|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
37769645|NCT01457924|69286534|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
37769646|NCT01457924|69286535|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
37769647|NCT01457924|69286536|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
37769648|NCT01457924|69286537|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
37769649|NCT01457924|69286538|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
37769650|NCT01457924|69286534|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
37769651|NCT01457924|69286535|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
37769652|NCT01457924|69286536|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
37769653|NCT01457924|69286537|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
37769654|NCT01457924|69286538|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
37769655|NCT01457924|69286534|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
37769656|NCT01457924|69286535|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
37769657|NCT01457924|69286536|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
37769658|NCT01457924|69286537|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
37769659|NCT01457924|69286538|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
37769660|NCT01457924|69286534|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
37769661|NCT01457924|69286535|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
37769662|NCT01457924|69286536|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
37769663|NCT01457924|69286537|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
37769664|NCT01457924|69286538|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
37769665|NCT01457924|69286534|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
37769666|NCT01457924|69286535|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
37769667|NCT01457924|69286536|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
37769668|NCT01457924|69286537|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
37769669|NCT01457924|69286538|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
37769670|NCT01457924|69286534|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
37769671|NCT01457924|69286535|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
37769672|NCT01457924|69286536|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
37769673|NCT01457924|69286537|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
37769674|NCT01457924|69286538|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
37769675|NCT01457924|69286534|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
37769676|NCT01457924|69286535|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
37769677|NCT01457924|69286536|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
37769678|NCT01457924|69286537|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
37769679|NCT01457924|69286538|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
37769680|NCT01457924|69286534|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
37769681|NCT01457924|69286535|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
37769682|NCT01457924|69286536|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
37769683|NCT01457924|69286537|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
37769684|NCT01457924|69286538|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
37769685|NCT01457924|69286534|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
37769686|NCT01457924|69286535|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
37769687|NCT01457924|69286536|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
37769688|NCT01457924|69286537|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
37769689|NCT01457924|69286538|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
37769690|NCT01457924|69286534|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
37769691|NCT01457924|69286535|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
37769692|NCT01457924|69286536|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
37769693|NCT01457924|69286537|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
37769694|NCT01457924|69286538|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
37769695|NCT01399619|69286559|FG000|Overall Study|Adverse Event|10|||
37769696|NCT01399619|69286560|FG001|Overall Study|Adverse Event|0|||
37769697|NCT01399619|69286561|FG002|Overall Study|Adverse Event|4|||
37769698|NCT01399619|69286562|FG003|Overall Study|Adverse Event|10|||
37769699|NCT01399619|69286559|FG000|Overall Study|Lack of Efficacy|9|||
37769700|NCT01399619|69286560|FG001|Overall Study|Lack of Efficacy|0|||
37769701|NCT01399619|69286561|FG002|Overall Study|Lack of Efficacy|5|||
37769702|NCT01399619|69286562|FG003|Overall Study|Lack of Efficacy|0|||
37769703|NCT01399619|69286559|FG000|Overall Study|Withdrawal by Subject|6|||
37769704|NCT01399619|69286560|FG001|Overall Study|Withdrawal by Subject|0|||
37769705|NCT01399619|69286561|FG002|Overall Study|Withdrawal by Subject|3|||
37769706|NCT01399619|69286562|FG003|Overall Study|Withdrawal by Subject|4|||
37769707|NCT01399619|69286559|FG000|Overall Study|Protocol Violation|0|||
37769708|NCT01399619|69286560|FG001|Overall Study|Protocol Violation|0|||
37769709|NCT01399619|69286561|FG002|Overall Study|Protocol Violation|0|||
37769710|NCT01399619|69286562|FG003|Overall Study|Protocol Violation|1|||
37769711|NCT01399619|69286559|FG000|Overall Study|Not treated|0|||
37769712|NCT01399619|69286560|FG001|Overall Study|Not treated|0|||
37769713|NCT01399619|69286561|FG002|Overall Study|Not treated|0|||
37769714|NCT01399619|69286562|FG003|Overall Study|Not treated|2|||
37769715|NCT01496456|69286577|FG000|Overall Study|Protocol Violation|1|||
37769716|NCT01496456|69286577|FG000|Overall Study|Lost to Follow-up|7|||
37769717|NCT04999111|69286740|FG000|Overall Study|Lost to Follow-up|0|||
37769718|NCT04999111|69286741|FG001|Overall Study|Lost to Follow-up|3|||
37769719|NCT04999111|69286742|FG002|Overall Study|Lost to Follow-up|1|||
37769720|NCT04999111|69286743|FG003|Overall Study|Lost to Follow-up|1|||
37769721|NCT04999111|69286744|FG004|Overall Study|Lost to Follow-up|1|||
37769722|NCT04999111|69286745|FG005|Overall Study|Lost to Follow-up|1|||
37769723|NCT04999111|69286740|FG000|Overall Study|Physician Decision|0|||
37769724|NCT04999111|69286741|FG001|Overall Study|Physician Decision|0|||
37769725|NCT04999111|69286742|FG002|Overall Study|Physician Decision|0|||
37769726|NCT04999111|69286743|FG003|Overall Study|Physician Decision|1|||
37769727|NCT04999111|69286744|FG004|Overall Study|Physician Decision|0|||
37769728|NCT04999111|69286745|FG005|Overall Study|Physician Decision|0|||
37769729|NCT04999111|69286740|FG000|Overall Study|Withdrawal by Subject|3|||
37769730|NCT04999111|69286741|FG001|Overall Study|Withdrawal by Subject|3|||
37769731|NCT04999111|69286742|FG002|Overall Study|Withdrawal by Subject|2|||
37769732|NCT04999111|69286743|FG003|Overall Study|Withdrawal by Subject|1|||
37769733|NCT04999111|69286744|FG004|Overall Study|Withdrawal by Subject|3|||
37769734|NCT04999111|69286745|FG005|Overall Study|Withdrawal by Subject|0|||
37769735|NCT04999111|69286740|FG000|Overall Study|Other|1|||
37769736|NCT04999111|69286741|FG001|Overall Study|Other|1|||
37769737|NCT04999111|69286742|FG002|Overall Study|Other|1|||
37769738|NCT04999111|69286743|FG003|Overall Study|Other|0|||
37769739|NCT04999111|69286744|FG004|Overall Study|Other|0|||
37769740|NCT04999111|69286745|FG005|Overall Study|Other|0|||
37769741|NCT04999111|69286740|FG000|Overall Study|Ongoing|326|||
37769742|NCT04999111|69286741|FG001|Overall Study|Ongoing|321|||
37769743|NCT04999111|69286742|FG002|Overall Study|Ongoing|112|||
37769744|NCT04999111|69286743|FG003|Overall Study|Ongoing|323|||
37769745|NCT04999111|69286744|FG004|Overall Study|Ongoing|322|||
37769746|NCT04999111|69286745|FG005|Overall Study|Ongoing|105|||
37769747|NCT04999111|69286740|FG000|Overall Study|Randomized but not vaccinated|1|||
37769748|NCT04999111|69286741|FG001|Overall Study|Randomized but not vaccinated|2|||
37769749|NCT04999111|69286742|FG002|Overall Study|Randomized but not vaccinated|0|||
37769750|NCT04999111|69286743|FG003|Overall Study|Randomized but not vaccinated|3|||
37769751|NCT04999111|69286744|FG004|Overall Study|Randomized but not vaccinated|3|||
37769752|NCT04999111|69286745|FG005|Overall Study|Randomized but not vaccinated|0|||
37769753|NCT01673646|69286806|FG000|Overall Study|Adverse Event|2|||
37769754|NCT01673646|69286807|FG001|Overall Study|Adverse Event|1|||
37680304|NCT02345889|69155850|FG000|Overall Study|Ulcerative Colitis identified|1|||
37680305|NCT02345889|69155851|FG001|Overall Study|Ulcerative Colitis identified|0|||
37680306|NCT02345889|69155852|FG002|Overall Study|Ulcerative Colitis identified|0|||
37680307|NCT02345889|69155853|FG003|Overall Study|Ulcerative Colitis identified|0|||
37680308|NCT02345889|69155850|FG000|Overall Study|Cecum not intubated|1|||
37769755|NCT01673646|69286808|FG002|Overall Study|Adverse Event|1|||
37769756|NCT01673646|69286806|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
37769757|NCT01673646|69286807|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
37769758|NCT01673646|69286808|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
37769759|NCT01673646|69286806|FG000|Overall Study|Condition no longer requires study drug|0|||
37769760|NCT01673646|69286807|FG001|Overall Study|Condition no longer requires study drug|1|||
37769761|NCT01673646|69286808|FG002|Overall Study|Condition no longer requires study drug|0|||
37769762|NCT01673646|69286806|FG000|Overall Study|Withdrawal by Subject|0|||
37769763|NCT01673646|69286807|FG001|Overall Study|Withdrawal by Subject|2|||
37769764|NCT01673646|69286808|FG002|Overall Study|Withdrawal by Subject|2|||
37769765|NCT01673646|69286806|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
37769766|NCT01673646|69286807|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
37769767|NCT01673646|69286808|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
37769768|NCT02647944|69286848|FG000|Overall Study|Withdrawal by Subject|0|||
37769769|NCT02647944|69286849|FG001|Overall Study|Withdrawal by Subject|3|||
37769770|NCT02647944|69286848|FG000|Overall Study|Adverse Event|2|||
37769771|NCT02647944|69286849|FG001|Overall Study|Adverse Event|0|||
37769772|NCT01397825|69286904|FG000|Overall Study|Progressive Disease|10|||
37769773|NCT01397825|69286905|FG001|Overall Study|Progressive Disease|3|||
37769774|NCT01397825|69286906|FG002|Overall Study|Progressive Disease|11|||
37769775|NCT01397825|69286907|FG003|Overall Study|Progressive Disease|1|||
37769776|NCT01397825|69286908|FG004|Overall Study|Progressive Disease|0|||
37769777|NCT01397825|69286904|FG000|Overall Study|Symptomatic Deterioration|2|||
37769778|NCT01397825|69286905|FG001|Overall Study|Symptomatic Deterioration|0|||
37769779|NCT01397825|69286906|FG002|Overall Study|Symptomatic Deterioration|4|||
37769780|NCT01397825|69286907|FG003|Overall Study|Symptomatic Deterioration|0|||
37769781|NCT01397825|69286908|FG004|Overall Study|Symptomatic Deterioration|0|||
37769782|NCT01397825|69286904|FG000|Overall Study|Adverse Event|0|||
37769783|NCT01397825|69286905|FG001|Overall Study|Adverse Event|1|||
37769784|NCT01397825|69286906|FG002|Overall Study|Adverse Event|5|||
37769785|NCT01397825|69286907|FG003|Overall Study|Adverse Event|1|||
37769786|NCT01397825|69286908|FG004|Overall Study|Adverse Event|0|||
37769787|NCT01397825|69286904|FG000|Overall Study|Withdrawal by Subject|1|||
37769788|NCT01397825|69286905|FG001|Overall Study|Withdrawal by Subject|0|||
37769789|NCT01397825|69286906|FG002|Overall Study|Withdrawal by Subject|5|||
37769790|NCT01397825|69286907|FG003|Overall Study|Withdrawal by Subject|1|||
37769791|NCT01397825|69286908|FG004|Overall Study|Withdrawal by Subject|0|||
37769792|NCT01397747|69286931|FG000|Overall Study|Multitarget DNA test excluded|689|||
37769793|NCT01397747|69286931|FG000|Overall Study|Colonoscopy excluded|304|||
37769794|NCT01397747|69286931|FG000|Overall Study|FIT excluded|34|||
37769795|NCT01397201|69286969|FG000|Overall Study|Not treated|0|||
37769796|NCT01397201|69286970|FG001|Overall Study|Not treated|0|||
37769797|NCT01397201|69286971|FG002|Overall Study|Not treated|1|||
37769798|NCT01397201|69286972|FG003|Overall Study|Not treated|0|||
37769799|NCT01397201|69286973|FG004|Overall Study|Not treated|0|||
37769800|NCT01397201|69286969|FG000|Overall Study|Not yet defined|3|||
37769801|NCT01397201|69286970|FG001|Overall Study|Not yet defined|6|||
37769802|NCT01397201|69286971|FG002|Overall Study|Not yet defined|5|||
37769803|NCT01397201|69286972|FG003|Overall Study|Not yet defined|5|||
37769804|NCT01397201|69286973|FG004|Overall Study|Not yet defined|4|||
37769805|NCT01397201|69286969|FG000|Overall Study|Adverse Event|2|||
37769806|NCT01397201|69286970|FG001|Overall Study|Adverse Event|0|||
37769807|NCT01397201|69286971|FG002|Overall Study|Adverse Event|0|||
37769808|NCT01397201|69286972|FG003|Overall Study|Adverse Event|0|||
37769809|NCT01397201|69286973|FG004|Overall Study|Adverse Event|0|||
37769810|NCT01393613|69287007|FG000|Overall Study|Adverse Event|11|||
37769811|NCT01393613|69287008|FG001|Overall Study|Adverse Event|11|||
37769812|NCT01393613|69287009|FG002|Overall Study|Adverse Event|13|||
37769813|NCT01393613|69287010|FG003|Overall Study|Adverse Event|22|||
37769814|NCT01393613|69287007|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
37769815|NCT01393613|69287008|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
37769816|NCT01393613|69287009|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
37769817|NCT01393613|69287010|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
37769818|NCT01393613|69287007|FG000|Overall Study|Physician Decision|2|||
37769819|NCT01393613|69287008|FG001|Overall Study|Physician Decision|0|||
37769820|NCT01393613|69287009|FG002|Overall Study|Physician Decision|0|||
37769821|NCT01393613|69287010|FG003|Overall Study|Physician Decision|1|||
37680309|NCT02345889|69155851|FG001|Overall Study|Cecum not intubated|0|||
37680310|NCT02345889|69155852|FG002|Overall Study|Cecum not intubated|0|||
37680311|NCT02345889|69155853|FG003|Overall Study|Cecum not intubated|0|||
37680312|NCT02345811|69155863|FG000|First Intervention|Withdrawal by Subject|1|||
37680313|NCT02345811|69155864|FG001|First Intervention|Withdrawal by Subject|1|||
37769822|NCT01393613|69287007|FG000|Overall Study|Withdrawal by Subject|15|||
37769823|NCT01393613|69287008|FG001|Overall Study|Withdrawal by Subject|25|||
37769824|NCT01393613|69287009|FG002|Overall Study|Withdrawal by Subject|23|||
37769825|NCT01393613|69287010|FG003|Overall Study|Withdrawal by Subject|21|||
37769826|NCT01393613|69287007|FG000|Overall Study|Protocol Deviation|2|||
37769827|NCT01393613|69287008|FG001|Overall Study|Protocol Deviation|1|||
37769828|NCT01393613|69287009|FG002|Overall Study|Protocol Deviation|0|||
37769829|NCT01393613|69287010|FG003|Overall Study|Protocol Deviation|0|||
37769830|NCT01393613|69287007|FG000|Overall Study|Lack of Efficacy|9|||
37769831|NCT01393613|69287008|FG001|Overall Study|Lack of Efficacy|20|||
37769832|NCT01393613|69287009|FG002|Overall Study|Lack of Efficacy|16|||
37769833|NCT01393613|69287010|FG003|Overall Study|Lack of Efficacy|21|||
37769834|NCT01396421|69287060|FG000|Overall Study|Lost to Follow-up|0|||
37769835|NCT01396421|69287061|FG001|Overall Study|Lost to Follow-up|0|||
37769836|NCT01396421|69287062|FG002|Overall Study|Lost to Follow-up|0|||
37769837|NCT01396421|69287063|FG003|Overall Study|Lost to Follow-up|1|||
37769838|NCT01396421|69287060|FG000|Overall Study|Adverse Event|17|||
37769839|NCT01396421|69287061|FG001|Overall Study|Adverse Event|15|||
37769840|NCT01396421|69287062|FG002|Overall Study|Adverse Event|12|||
37769841|NCT01396421|69287063|FG003|Overall Study|Adverse Event|32|||
37769842|NCT01396421|69287060|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
37769843|NCT01396421|69287061|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
37769844|NCT01396421|69287062|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
37769845|NCT01396421|69287063|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
37769846|NCT01396421|69287060|FG000|Overall Study|Physician Decision|1|||
37769847|NCT01396421|69287061|FG001|Overall Study|Physician Decision|1|||
37769848|NCT01396421|69287062|FG002|Overall Study|Physician Decision|0|||
37769849|NCT01396421|69287063|FG003|Overall Study|Physician Decision|3|||
37769850|NCT01396421|69287060|FG000|Overall Study|Withdrawal by Subject|31|||
37769851|NCT01396421|69287061|FG001|Overall Study|Withdrawal by Subject|24|||
37769852|NCT01396421|69287062|FG002|Overall Study|Withdrawal by Subject|13|||
37769853|NCT01396421|69287063|FG003|Overall Study|Withdrawal by Subject|21|||
37769854|NCT01396421|69287060|FG000|Overall Study|Protocol Deviation|2|||
37769855|NCT01396421|69287061|FG001|Overall Study|Protocol Deviation|1|||
37769856|NCT01396421|69287062|FG002|Overall Study|Protocol Deviation|1|||
37769857|NCT01396421|69287063|FG003|Overall Study|Protocol Deviation|0|||
37769858|NCT01396421|69287060|FG000|Overall Study|Lack of Efficacy|7|||
37769859|NCT01396421|69287061|FG001|Overall Study|Lack of Efficacy|17|||
37769860|NCT01396421|69287062|FG002|Overall Study|Lack of Efficacy|7|||
37769861|NCT01396421|69287063|FG003|Overall Study|Lack of Efficacy|18|||
37769862|NCT01396265|69287121|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
37769863|NCT02647866|69287166|FG000|Overall Study|Adverse Event|0|||
37769864|NCT02647866|69287167|FG001|Overall Study|Adverse Event|0|||
37769865|NCT02647866|69287168|FG002|Overall Study|Adverse Event|2|||
37769866|NCT02647866|69287169|FG003|Overall Study|Adverse Event|2|||
37769867|NCT02647866|69287170|FG004|Overall Study|Adverse Event|1|||
37769868|NCT02647866|69287166|FG000|Overall Study|Disease Worsening|3|||
37769869|NCT02647866|69287167|FG001|Overall Study|Disease Worsening|1|||
37769870|NCT02647866|69287168|FG002|Overall Study|Disease Worsening|0|||
37769871|NCT02647866|69287169|FG003|Overall Study|Disease Worsening|0|||
37769872|NCT02647866|69287170|FG004|Overall Study|Disease Worsening|1|||
37769873|NCT02647866|69287166|FG000|Overall Study|Withdrawal by Subject|1|||
37769874|NCT02647866|69287167|FG001|Overall Study|Withdrawal by Subject|1|||
37769875|NCT02647866|69287168|FG002|Overall Study|Withdrawal by Subject|2|||
37769876|NCT02647866|69287169|FG003|Overall Study|Withdrawal by Subject|4|||
37769877|NCT02647866|69287170|FG004|Overall Study|Withdrawal by Subject|4|||
37769878|NCT02647866|69287166|FG000|Overall Study|Physician Decision|0|||
37769879|NCT02647866|69287167|FG001|Overall Study|Physician Decision|1|||
37769880|NCT02647866|69287168|FG002|Overall Study|Physician Decision|1|||
37769881|NCT02647866|69287169|FG003|Overall Study|Physician Decision|0|||
37769882|NCT02647866|69287170|FG004|Overall Study|Physician Decision|2|||
37769883|NCT02647866|69287166|FG000|Overall Study|Death|0|||
37769884|NCT02647866|69287167|FG001|Overall Study|Death|1|||
37769885|NCT02647866|69287168|FG002|Overall Study|Death|0|||
37769886|NCT02647866|69287169|FG003|Overall Study|Death|0|||
37769887|NCT02647866|69287170|FG004|Overall Study|Death|0|||
37769888|NCT02647866|69287166|FG000|Overall Study|Subject moved to different country|1|||
37769889|NCT02647866|69287167|FG001|Overall Study|Subject moved to different country|0|||
37769890|NCT02647866|69287168|FG002|Overall Study|Subject moved to different country|0|||
37769891|NCT02647866|69287169|FG003|Overall Study|Subject moved to different country|0|||
37769892|NCT02647866|69287170|FG004|Overall Study|Subject moved to different country|0|||
37769893|NCT01396187|69287230|FG000|Overall Study|Adverse Event|0|||
37769894|NCT01396187|69287231|FG001|Overall Study|Adverse Event|1|||
37769895|NCT01396187|69287232|FG002|Overall Study|Adverse Event|0|||
37769896|NCT01396187|69287233|FG003|Overall Study|Adverse Event|0|||
37769897|NCT01396187|69287234|FG004|Overall Study|Adverse Event|0|||
37769898|NCT01396187|69287230|FG000|Overall Study|Withdrawal by Subject|0|||
37769899|NCT01396187|69287231|FG001|Overall Study|Withdrawal by Subject|1|||
37769900|NCT01396187|69287232|FG002|Overall Study|Withdrawal by Subject|1|||
37769901|NCT01396187|69287233|FG003|Overall Study|Withdrawal by Subject|0|||
37769902|NCT01396187|69287234|FG004|Overall Study|Withdrawal by Subject|0|||
37769903|NCT01396187|69287230|FG000|Overall Study|Other|1|||
37769904|NCT01396187|69287231|FG001|Overall Study|Other|1|||
37769905|NCT01396187|69287232|FG002|Overall Study|Other|0|||
37769906|NCT01396187|69287233|FG003|Overall Study|Other|0|||
37769907|NCT01396187|69287234|FG004|Overall Study|Other|1|||
37769908|NCT01392677|69287281|FG000|Overall Study|Adverse Event|3|||
37769909|NCT01392677|69287282|FG001|Overall Study|Adverse Event|1|||
37769910|NCT01392677|69287281|FG000|Overall Study|Withdrawal by Subject|0|||
37769911|NCT01392677|69287282|FG001|Overall Study|Withdrawal by Subject|2|||
37769912|NCT01392677|69287281|FG000|Overall Study|Incorrect enrollment|2|||
37769913|NCT01392677|69287282|FG001|Overall Study|Incorrect enrollment|3|||
37769914|NCT01392677|69287281|FG000|Overall Study|Other reason|3|||
37769915|NCT01392677|69287282|FG001|Overall Study|Other reason|2|||
37769916|NCT01392443|69287331|FG000|Overall Study|Disease progression|30|||
37769917|NCT01392443|69287331|FG000|Overall Study|Adverse Event|24|||
37769918|NCT01392443|69287331|FG000|Overall Study|Death|7|||
37769919|NCT01392443|69287331|FG000|Overall Study|Withdrawal by Subject|5|||
37769920|NCT01392443|69287331|FG000|Overall Study|Lost to Follow-up|1|||
37769921|NCT01392443|69287331|FG000|Overall Study|Protocol Violation|1|||
37769922|NCT01391819|69287335|FG000|Overall Study|Withdrawal by Subject|56|||
37769923|NCT01391819|69287335|FG000|Overall Study|Migrated/moved from study area|82|||
37769924|NCT01391819|69287335|FG000|Overall Study|Lost to Follow-up|252|||
37769925|NCT01391819|69287335|FG000|Overall Study|Death|3|||
37769926|NCT01391819|69287335|FG000|Overall Study|Other|9|||
37769927|NCT03845023|69287346|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
37769928|NCT03845023|69287347|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
37769929|NCT03845023|69287348|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
37769930|NCT03845023|69287349|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
37769931|NCT03845023|69287346|FG000|Follow-Up (14 Days)|Adverse Event|0|||
37769932|NCT03845023|69287347|FG001|Follow-Up (14 Days)|Adverse Event|0|||
37769933|NCT03845023|69287348|FG002|Follow-Up (14 Days)|Adverse Event|1|||
37769934|NCT03845023|69287349|FG003|Follow-Up (14 Days)|Adverse Event|1|||
37769935|NCT01395017|69287411|FG000|Overall Study|Lost to Follow-up|1|||
37769936|NCT01395017|69287412|FG001|Overall Study|Lost to Follow-up|0|||
37769937|NCT01395017|69287411|FG000|Overall Study|Adverse Event|26|||
37769938|NCT01395017|69287412|FG001|Overall Study|Adverse Event|12|||
37769939|NCT01395017|69287411|FG000|Overall Study|Physician Decision|11|||
37769940|NCT01395017|69287412|FG001|Overall Study|Physician Decision|15|||
37769941|NCT01395017|69287411|FG000|Overall Study|Withdrawal by Subject|14|||
37769942|NCT01395017|69287412|FG001|Overall Study|Withdrawal by Subject|8|||
37769943|NCT01395017|69287411|FG000|Overall Study|Protocol deviation|1|||
37769944|NCT01395017|69287412|FG001|Overall Study|Protocol deviation|2|||
37769945|NCT01395017|69287411|FG000|Overall Study|Death|4|||
37769946|NCT01395017|69287412|FG001|Overall Study|Death|3|||
37769947|NCT01395017|69287411|FG000|Overall Study|Disease progression|42|||
37769948|NCT01395017|69287412|FG001|Overall Study|Disease progression|58|||
37769949|NCT01395017|69287411|FG000|Overall Study|Sponsor discontinued study|1|||
37769950|NCT01395017|69287412|FG001|Overall Study|Sponsor discontinued study|4|||
37769951|NCT02647320|69287441|FG000|Overall Study|Adverse Event|0|||
37769952|NCT02647320|69287442|FG001|Overall Study|Adverse Event|1|||
37769953|NCT02647320|69287443|FG002|Overall Study|Adverse Event|3|||
37769954|NCT02647320|69287444|FG003|Overall Study|Adverse Event|2|||
37769955|NCT02647320|69287445|FG004|Overall Study|Adverse Event|1|||
37769956|NCT02647320|69287441|FG000|Overall Study|Protocol Violation|0|||
37769957|NCT02647320|69287442|FG001|Overall Study|Protocol Violation|0|||
37769958|NCT02647320|69287443|FG002|Overall Study|Protocol Violation|3|||
37769959|NCT02647320|69287444|FG003|Overall Study|Protocol Violation|0|||
37769960|NCT02647320|69287445|FG004|Overall Study|Protocol Violation|0|||
37769961|NCT02647320|69287441|FG000|Overall Study|Withdrawal by Subject|7|||
37769962|NCT02647320|69287442|FG001|Overall Study|Withdrawal by Subject|4|||
37769963|NCT02647320|69287443|FG002|Overall Study|Withdrawal by Subject|2|||
37769964|NCT02647320|69287444|FG003|Overall Study|Withdrawal by Subject|2|||
37769965|NCT02647320|69287445|FG004|Overall Study|Withdrawal by Subject|7|||
37769966|NCT02647320|69287441|FG000|Overall Study|Persistent hyperglycemia|0|||
37769967|NCT02647320|69287442|FG001|Overall Study|Persistent hyperglycemia|1|||
37769968|NCT02647320|69287443|FG002|Overall Study|Persistent hyperglycemia|1|||
37769969|NCT02647320|69287444|FG003|Overall Study|Persistent hyperglycemia|1|||
37769970|NCT02647320|69287445|FG004|Overall Study|Persistent hyperglycemia|1|||
37769971|NCT02647320|69287441|FG000|Overall Study|Study terminated by sponsor|1|||
37769972|NCT02647320|69287442|FG001|Overall Study|Study terminated by sponsor|1|||
37769973|NCT02647320|69287443|FG002|Overall Study|Study terminated by sponsor|1|||
37769974|NCT02647320|69287444|FG003|Overall Study|Study terminated by sponsor|1|||
37769975|NCT02647320|69287445|FG004|Overall Study|Study terminated by sponsor|2|||
37769976|NCT02647320|69287441|FG000|Overall Study|Reason not provided|0|||
37769977|NCT02647320|69287442|FG001|Overall Study|Reason not provided|0|||
37769978|NCT02647320|69287443|FG002|Overall Study|Reason not provided|1|||
37769979|NCT02647320|69287444|FG003|Overall Study|Reason not provided|0|||
37769980|NCT02647320|69287445|FG004|Overall Study|Reason not provided|2|||
37769981|NCT02647320|69287441|FG000|Overall Study|Lost to Follow-up|1|||
37769982|NCT02647320|69287442|FG001|Overall Study|Lost to Follow-up|1|||
37769983|NCT02647320|69287443|FG002|Overall Study|Lost to Follow-up|0|||
37769984|NCT02647320|69287444|FG003|Overall Study|Lost to Follow-up|0|||
37769985|NCT02647320|69287445|FG004|Overall Study|Lost to Follow-up|0|||
37769986|NCT02647320|69287441|FG000|Overall Study|Develop anemia|1|||
37769987|NCT02647320|69287442|FG001|Overall Study|Develop anemia|0|||
37769988|NCT02647320|69287443|FG002|Overall Study|Develop anemia|0|||
37769989|NCT02647320|69287444|FG003|Overall Study|Develop anemia|0|||
37769990|NCT02647320|69287445|FG004|Overall Study|Develop anemia|0|||
37769991|NCT02647320|69287441|FG000|Overall Study|Lack of Efficacy|0|||
37769992|NCT02647320|69287442|FG001|Overall Study|Lack of Efficacy|0|||
37769993|NCT02647320|69287443|FG002|Overall Study|Lack of Efficacy|0|||
37769994|NCT02647320|69287444|FG003|Overall Study|Lack of Efficacy|1|||
37769995|NCT02647320|69287445|FG004|Overall Study|Lack of Efficacy|0|||
37769996|NCT02647320|69287441|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
37769997|NCT02647320|69287442|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
37769998|NCT02647320|69287443|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
37769999|NCT02647320|69287444|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
37770000|NCT02647320|69287445|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
37770001|NCT03458325|69287468|FG000|Overall Study|Withdrawal by Subject|1|||
37952718|NCT00537381|69639658|FG000|Overall Study|Sponsor decision|14|||
37952719|NCT00537381|69639659|FG001|Overall Study|Sponsor decision|9|||
37770004|NCT02644122|69287514|FG000|Overall Study|Withdrawal by Subject|1|||
37770005|NCT01394939|69287540|FG000|Overall Study|Adverse Event|1|||
37770006|NCT01394939|69287541|FG001|Overall Study|Adverse Event|3|||
37770007|NCT01394939|69287542|FG002|Overall Study|Adverse Event|0|||
37770008|NCT01394939|69287543|FG003|Overall Study|Adverse Event|2|||
37770009|NCT01394939|69287540|FG000|Overall Study|Death|0|||
37770010|NCT01394939|69287541|FG001|Overall Study|Death|2|||
37770011|NCT01394939|69287542|FG002|Overall Study|Death|0|||
37770012|NCT01394939|69287543|FG003|Overall Study|Death|0|||
37770013|NCT01394939|69287540|FG000|Overall Study|Physician Decision|0|||
37770014|NCT01394939|69287541|FG001|Overall Study|Physician Decision|1|||
37770015|NCT01394939|69287542|FG002|Overall Study|Physician Decision|0|||
37770016|NCT01394939|69287543|FG003|Overall Study|Physician Decision|0|||
37770017|NCT01394939|69287540|FG000|Overall Study|Withdrawal by Subject|0|||
37770018|NCT01394939|69287541|FG001|Overall Study|Withdrawal by Subject|2|||
37770019|NCT01394939|69287542|FG002|Overall Study|Withdrawal by Subject|0|||
37770020|NCT01394939|69287543|FG003|Overall Study|Withdrawal by Subject|2|||
37770021|NCT01394939|69287540|FG000|Overall Study|Others|0|||
37770022|NCT01394939|69287541|FG001|Overall Study|Others|2|||
37770023|NCT01394939|69287542|FG002|Overall Study|Others|0|||
37770024|NCT01394939|69287543|FG003|Overall Study|Others|3|||
37770025|NCT01394627|69287561|FG000|First Intervention (1 Day)|poor intravenous access|0|||
37770026|NCT01394627|69287562|FG001|First Intervention (1 Day)|poor intravenous access|1|||
37770027|NCT01394627|69287561|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
37770028|NCT01394627|69287562|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
37770029|NCT01391663|69287581|FG000|Overall Study|Withdrawal by Subject|0|||
37770030|NCT01391663|69287582|FG001|Overall Study|Withdrawal by Subject|0|||
37770031|NCT01391663|69287583|FG002|Overall Study|Withdrawal by Subject|1|||
37770032|NCT01391663|69287584|FG003|Overall Study|Withdrawal by Subject|0|||
37770033|NCT02641392|69287605|FG000|Overall Study|Lost to Follow-up|0|||
37770034|NCT02641392|69287606|FG001|Overall Study|Lost to Follow-up|0|||
37770035|NCT02641392|69287607|FG002|Overall Study|Lost to Follow-up|2|||
37770036|NCT02641392|69287605|FG000|Overall Study|Withdrawal by Subject|0|||
37770037|NCT02641392|69287606|FG001|Overall Study|Withdrawal by Subject|0|||
37770038|NCT02641392|69287607|FG002|Overall Study|Withdrawal by Subject|17|||
37770039|NCT02641392|69287605|FG000|Overall Study|Adverse Event|0|||
37770040|NCT02641392|69287606|FG001|Overall Study|Adverse Event|1|||
37770041|NCT02641392|69287607|FG002|Overall Study|Adverse Event|25|||
37770042|NCT02641392|69287605|FG000|Overall Study|Study Terminated by Sponsor|4|||
37770043|NCT02641392|69287606|FG001|Overall Study|Study Terminated by Sponsor|12|||
37770044|NCT02641392|69287607|FG002|Overall Study|Study Terminated by Sponsor|144|||
37770045|NCT02641392|69287605|FG000|Overall Study|Lack of Efficacy|0|||
37770046|NCT02641392|69287606|FG001|Overall Study|Lack of Efficacy|0|||
37770047|NCT02641392|69287607|FG002|Overall Study|Lack of Efficacy|101|||
37770048|NCT02641392|69287605|FG000|Overall Study|Miscellaneous|0|||
37770049|NCT02641392|69287606|FG001|Overall Study|Miscellaneous|0|||
37770050|NCT02641392|69287607|FG002|Overall Study|Miscellaneous|3|||
37770051|NCT02641392|69287605|FG000|Overall Study|Death|0|||
37770052|NCT02641392|69287606|FG001|Overall Study|Death|0|||
37770053|NCT02641392|69287607|FG002|Overall Study|Death|1|||
37770054|NCT04440007|69287617|FG000|Overall Study|Adverse Event|0|||
37770055|NCT04440007|69287618|FG001|Overall Study|Adverse Event|1|||
37770056|NCT04440007|69287617|FG000|Overall Study|Lost to Follow-up|1|||
37770057|NCT04440007|69287618|FG001|Overall Study|Lost to Follow-up|3|||
37770058|NCT04440007|69287617|FG000|Overall Study|Death|7|||
37770059|NCT04440007|69287618|FG001|Overall Study|Death|2|||
37770060|NCT04440007|69287617|FG000|Overall Study|Physician Decision|1|||
37770061|NCT04440007|69287618|FG001|Overall Study|Physician Decision|1|||
37770062|NCT04440007|69287617|FG000|Overall Study|Withdrawal by Subject|2|||
37770063|NCT04440007|69287618|FG001|Overall Study|Withdrawal by Subject|1|||
37770064|NCT04440007|69287617|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
37770065|NCT04440007|69287618|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
37770066|NCT04440007|69287617|FG000|Overall Study|Discontinued prior to dosing|0|||
37770067|NCT04440007|69287618|FG001|Overall Study|Discontinued prior to dosing|2|||
37770068|NCT01391507|69287628|FG000|Overall Study|Death|0|||
37770069|NCT01391507|69287629|FG001|Overall Study|Death|0|||
37770070|NCT01391507|69287630|FG002|Overall Study|Death|0|||
37770071|NCT01391507|69287631|FG003|Overall Study|Death|1|||
37770072|NCT01391507|69287628|FG000|Overall Study|Adverse Event|1|||
37770073|NCT01391507|69287629|FG001|Overall Study|Adverse Event|1|||
37770074|NCT01391507|69287630|FG002|Overall Study|Adverse Event|2|||
37770075|NCT01391507|69287631|FG003|Overall Study|Adverse Event|2|||
37770076|NCT01391507|69287628|FG000|Overall Study|Withdrawal by Subject|1|||
37770077|NCT01391507|69287629|FG001|Overall Study|Withdrawal by Subject|2|||
37770078|NCT01391507|69287630|FG002|Overall Study|Withdrawal by Subject|1|||
37770079|NCT01391507|69287631|FG003|Overall Study|Withdrawal by Subject|1|||
37770080|NCT01391507|69287628|FG000|Overall Study|Lack of Efficacy|0|||
37770081|NCT01391507|69287629|FG001|Overall Study|Lack of Efficacy|0|||
37770082|NCT01391507|69287630|FG002|Overall Study|Lack of Efficacy|0|||
37770083|NCT01391507|69287631|FG003|Overall Study|Lack of Efficacy|1|||
37770084|NCT01391507|69287628|FG000|Overall Study|Protocol Violation|2|||
37770085|NCT01391507|69287629|FG001|Overall Study|Protocol Violation|1|||
37770086|NCT01391507|69287630|FG002|Overall Study|Protocol Violation|1|||
37770087|NCT01391507|69287631|FG003|Overall Study|Protocol Violation|2|||
37770088|NCT01473524|69287653|FG000|DB Phase|Adverse Event|4|||
37770089|NCT01473524|69287654|FG001|DB Phase|Adverse Event|8|||
37770090|NCT01473524|69287655|FG002|DB Phase|Adverse Event|2|||
37770091|NCT01473524|69287656|FG003|DB Phase|Adverse Event|0|||
37770092|NCT01473524|69287657|FG004|DB Phase|Adverse Event|0|||
37770093|NCT01473524|69287658|FG005|DB Phase|Adverse Event|0|||
37770094|NCT01473524|69287653|FG000|DB Phase|Death|1|||
37770095|NCT01473524|69287654|FG001|DB Phase|Death|0|||
37770096|NCT01473524|69287655|FG002|DB Phase|Death|0|||
37770097|NCT01473524|69287656|FG003|DB Phase|Death|0|||
37770098|NCT01473524|69287657|FG004|DB Phase|Death|0|||
37770099|NCT01473524|69287658|FG005|DB Phase|Death|0|||
37770100|NCT01473524|69287653|FG000|DB Phase|Withdrawal by Subject|2|||
37770101|NCT01473524|69287654|FG001|DB Phase|Withdrawal by Subject|1|||
37770102|NCT01473524|69287655|FG002|DB Phase|Withdrawal by Subject|1|||
37770103|NCT01473524|69287656|FG003|DB Phase|Withdrawal by Subject|0|||
37770104|NCT01473524|69287657|FG004|DB Phase|Withdrawal by Subject|0|||
37770105|NCT01473524|69287658|FG005|DB Phase|Withdrawal by Subject|0|||
37770106|NCT01473524|69287653|FG000|LTSE Phase|Withdrawal by Subject|0|||
37770107|NCT01473524|69287654|FG001|LTSE Phase|Withdrawal by Subject|0|||
37770108|NCT01473524|69287655|FG002|LTSE Phase|Withdrawal by Subject|0|||
37770109|NCT01473524|69287656|FG003|LTSE Phase|Withdrawal by Subject|3|||
37770110|NCT01473524|69287657|FG004|LTSE Phase|Withdrawal by Subject|3|||
37770111|NCT01473524|69287658|FG005|LTSE Phase|Withdrawal by Subject|6|||
37770112|NCT01473524|69287653|FG000|LTSE Phase|Death|0|||
37770113|NCT01473524|69287654|FG001|LTSE Phase|Death|0|||
37770114|NCT01473524|69287655|FG002|LTSE Phase|Death|0|||
37770115|NCT01473524|69287656|FG003|LTSE Phase|Death|0|||
37770116|NCT01473524|69287657|FG004|LTSE Phase|Death|1|||
37770117|NCT01473524|69287658|FG005|LTSE Phase|Death|0|||
37770118|NCT01473524|69287653|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
37770119|NCT01473524|69287654|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
37770120|NCT01473524|69287655|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
37770121|NCT01473524|69287656|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
37770122|NCT01473524|69287657|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
37770123|NCT01473524|69287658|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
37770124|NCT01473524|69287653|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
37770125|NCT01473524|69287654|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
37770126|NCT01473524|69287655|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
37770127|NCT01473524|69287656|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
37770128|NCT01473524|69287657|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
37770129|NCT01473524|69287658|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
37770130|NCT01473524|69287653|FG000|LTSE Phase|Lost to Follow-up|0|||
37770131|NCT01473524|69287654|FG001|LTSE Phase|Lost to Follow-up|0|||
37770132|NCT01473524|69287655|FG002|LTSE Phase|Lost to Follow-up|0|||
37770133|NCT01473524|69287656|FG003|LTSE Phase|Lost to Follow-up|1|||
37770134|NCT01473524|69287657|FG004|LTSE Phase|Lost to Follow-up|3|||
37770135|NCT01473524|69287658|FG005|LTSE Phase|Lost to Follow-up|2|||
37770136|NCT01473524|69287653|FG000|LTSE Phase|Principal Investigator Decision|0|||
37770137|NCT01473524|69287654|FG001|LTSE Phase|Principal Investigator Decision|0|||
37770138|NCT01473524|69287655|FG002|LTSE Phase|Principal Investigator Decision|0|||
37770139|NCT01473524|69287656|FG003|LTSE Phase|Principal Investigator Decision|1|||
37770140|NCT01473524|69287657|FG004|LTSE Phase|Principal Investigator Decision|1|||
37770141|NCT01473524|69287658|FG005|LTSE Phase|Principal Investigator Decision|3|||
37770142|NCT01473524|69287653|FG000|LTSE Phase|Liver Transplantation|0|||
37770143|NCT01473524|69287654|FG001|LTSE Phase|Liver Transplantation|0|||
37770144|NCT01473524|69287655|FG002|LTSE Phase|Liver Transplantation|0|||
37770145|NCT01473524|69287656|FG003|LTSE Phase|Liver Transplantation|0|||
37770146|NCT01473524|69287657|FG004|LTSE Phase|Liver Transplantation|0|||
37770147|NCT01473524|69287658|FG005|LTSE Phase|Liver Transplantation|1|||
37770148|NCT01473524|69287653|FG000|LTSE Phase|Pregnancy|0|||
37770149|NCT01473524|69287654|FG001|LTSE Phase|Pregnancy|0|||
37770150|NCT01473524|69287655|FG002|LTSE Phase|Pregnancy|0|||
37770151|NCT01473524|69287656|FG003|LTSE Phase|Pregnancy|1|||
37770152|NCT01473524|69287657|FG004|LTSE Phase|Pregnancy|0|||
37770153|NCT01473524|69287658|FG005|LTSE Phase|Pregnancy|0|||
37770154|NCT01473524|69287653|FG000|LTSE Phase|Protocol Violation|0|||
37770155|NCT01473524|69287654|FG001|LTSE Phase|Protocol Violation|0|||
37770156|NCT01473524|69287655|FG002|LTSE Phase|Protocol Violation|0|||
37770157|NCT01473524|69287656|FG003|LTSE Phase|Protocol Violation|0|||
37770158|NCT01473524|69287657|FG004|LTSE Phase|Protocol Violation|0|||
37770159|NCT01473524|69287658|FG005|LTSE Phase|Protocol Violation|1|||
37770160|NCT01390649|69287689|FG000|Overall Study|Physician Decision|1|||
37770161|NCT01390181|69287693|FG000|Overall Study|Lost to Follow-up|1|||
37770162|NCT01390181|69287693|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
37770163|NCT02641080|69287699|FG000|Overall Study|Physician Decision|2|||
37770164|NCT02641080|69287700|FG001|Overall Study|Physician Decision|0|||
37770165|NCT02641080|69287699|FG000|Overall Study|Withdrawal by Subject|0|||
37770166|NCT02641080|69287700|FG001|Overall Study|Withdrawal by Subject|1|||
37770167|NCT02641080|69287699|FG000|Overall Study|Rehab Center denied use of pumps|0|||
37770168|NCT02641080|69287700|FG001|Overall Study|Rehab Center denied use of pumps|3|||
37770169|NCT02641080|69287699|FG000|Overall Study|Lost to Follow-up|0|||
37770170|NCT02641080|69287700|FG001|Overall Study|Lost to Follow-up|3|||
37770171|NCT01457846|69287708|FG000|Overall Study|Death before treatment|1|||
37770172|NCT01457846|69287709|FG001|Overall Study|Death before treatment|2|||
37770173|NCT01457846|69287708|FG000|Overall Study|Did not receive treatment|0|||
37770174|NCT01457846|69287709|FG001|Overall Study|Did not receive treatment|1|||
37770175|NCT01457846|69287708|FG000|Overall Study|Death|27|||
37770176|NCT01457846|69287709|FG001|Overall Study|Death|16|||
37770177|NCT01457846|69287708|FG000|Overall Study|Unclassified reason for not completed|11|||
37770178|NCT01457846|69287709|FG001|Overall Study|Unclassified reason for not completed|10|||
37770179|NCT01457846|69287708|FG000|Overall Study|Withdrawal by Subject|1|||
37770180|NCT01457846|69287709|FG001|Overall Study|Withdrawal by Subject|1|||
37770181|NCT01457846|69287708|FG000|Overall Study|Lost to Follow-up|1|||
37770182|NCT01457846|69287709|FG001|Overall Study|Lost to Follow-up|0|||
37770183|NCT01496066|69287721|FG000|Overall Study|Lost to Follow-up|8|||
37770184|NCT01496066|69287722|FG001|Overall Study|Lost to Follow-up|5|||
37770185|NCT01496066|69287721|FG000|Overall Study|Explant|3|||
37770186|NCT01496066|69287722|FG001|Overall Study|Explant|0|||
37770187|NCT01496066|69287721|FG000|Overall Study|Death|1|||
37770188|NCT01496066|69287722|FG001|Overall Study|Death|4|||
37770189|NCT01389323|69287735|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
37770190|NCT01389323|69287735|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
37770191|NCT01389323|69287735|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
37770192|NCT01389323|69287735|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
37770193|NCT01389323|69287735|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
37770194|NCT01389323|69287735|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
37770195|NCT01389323|69287735|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
37770196|NCT01389323|69287735|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
37770197|NCT01389323|69287735|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
37770198|NCT01389323|69287735|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
37770199|NCT01389323|69287735|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
37770200|NCT01389245|69287746|FG000|Overall Study|Protocol Violation|10|||
37770201|NCT01389245|69287746|FG000|Overall Study|Lost to Follow-up|3|||
37770202|NCT01389245|69287746|FG000|Overall Study|Withdrawal by Subject|2|||
37770203|NCT01494818|69287752|FG000|Overall Study|Relocation|1|||
37770204|NCT01494818|69287753|FG001|Overall Study|Relocation|2|||
37770205|NCT01494818|69287752|FG000|Overall Study|Lost to Follow-up|1|||
37770206|NCT01494818|69287753|FG001|Overall Study|Lost to Follow-up|0|||
37770207|NCT01494584|69287759|FG000|Overall Study|Study Closed/Terminated|1|||
37770208|NCT01388543|69287784|FG000|Day 14|Adverse Event|1|||
37770209|NCT01388543|69287785|FG001|Day 14|Adverse Event|4|||
37770210|NCT00512317|69287804|FG000|Overall Study|Insufficient clinical response|36|||
37770211|NCT00512317|69287804|FG000|Overall Study|Withdrawal by Subject|23|||
37770212|NCT00512317|69287804|FG000|Overall Study|Sponsor closure of study|21|||
37770213|NCT00512317|69287804|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
37770214|NCT00512317|69287804|FG000|Overall Study|Adverse Event|13|||
37770215|NCT00512317|69287804|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
37770216|NCT00512317|69287804|FG000|Overall Study|Lost to Follow-up|2|||
37770217|NCT00512317|69287804|FG000|Overall Study|Other|2|||
37770218|NCT01494506|69287820|FG000|Overall Study|Lack of Efficacy|77|||
37770219|NCT01494506|69287821|FG001|Overall Study|Lack of Efficacy|83|||
37770220|NCT01494506|69287822|FG002|Overall Study|Lack of Efficacy|57|||
37770221|NCT01494506|69287820|FG000|Overall Study|Adverse Event|17|||
37770222|NCT01494506|69287821|FG001|Overall Study|Adverse Event|10|||
37770223|NCT01494506|69287822|FG002|Overall Study|Adverse Event|11|||
37770224|NCT01494506|69287820|FG000|Overall Study|Death|9|||
37770225|NCT01494506|69287821|FG001|Overall Study|Death|5|||
37770226|NCT01494506|69287822|FG002|Overall Study|Death|2|||
37770227|NCT01494506|69287820|FG000|Overall Study|Physician Decision|7|||
37770228|NCT01494506|69287821|FG001|Overall Study|Physician Decision|5|||
37770229|NCT01494506|69287822|FG002|Overall Study|Physician Decision|4|||
37770230|NCT01494506|69287820|FG000|Overall Study|Withdrawal by Subject|17|||
37770231|NCT01494506|69287821|FG001|Overall Study|Withdrawal by Subject|20|||
37770232|NCT01494506|69287822|FG002|Overall Study|Withdrawal by Subject|14|||
37770233|NCT01494506|69287820|FG000|Overall Study|Clinical Deterioration|21|||
37770234|NCT01494506|69287821|FG001|Overall Study|Clinical Deterioration|17|||
37770235|NCT01494506|69287822|FG002|Overall Study|Clinical Deterioration|13|||
37770236|NCT01494506|69287820|FG000|Overall Study|Sponsor Decision|0|||
37770237|NCT01494506|69287821|FG001|Overall Study|Sponsor Decision|0|||
37770238|NCT01494506|69287822|FG002|Overall Study|Sponsor Decision|1|||
37770239|NCT01494506|69287820|FG000|Overall Study|Other|0|||
37770240|NCT01494506|69287821|FG001|Overall Study|Other|3|||
37770241|NCT01494506|69287822|FG002|Overall Study|Other|1|||
37770242|NCT02643420|69287834|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
37770243|NCT02643420|69287835|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
37770244|NCT02643420|69287834|FG000|Overall Study|Withdrawal by Subject|25|||
37770245|NCT02643420|69287835|FG001|Overall Study|Withdrawal by Subject|19|||
37770246|NCT02643420|69287834|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
37770247|NCT02643420|69287835|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
37770248|NCT02643420|69287834|FG000|Overall Study|Lost to Follow-up|6|||
37770249|NCT02643420|69287835|FG001|Overall Study|Lost to Follow-up|10|||
37770250|NCT02643420|69287834|FG000|Overall Study|Investigator Decision|2|||
37770251|NCT02643420|69287835|FG001|Overall Study|Investigator Decision|4|||
37770252|NCT02643420|69287834|FG000|Overall Study|Sponsor decision|1|||
37770253|NCT02643420|69287835|FG001|Overall Study|Sponsor decision|1|||
37770254|NCT02643420|69287834|FG000|Overall Study|Death|0|||
37770255|NCT02643420|69287835|FG001|Overall Study|Death|2|||
37770256|NCT02643420|69287834|FG000|Overall Study|Reason not Specified|8|||
37770257|NCT02643420|69287835|FG001|Overall Study|Reason not Specified|7|||
37770258|NCT01456130|69287858|FG000|Overall Study|Adverse Event|4|||
37770259|NCT01456130|69287858|FG000|Overall Study|Voluntary Withdrawal|1|||
37770260|NCT01456130|69287858|FG000|Overall Study|Lack of Efficacy|4|||
37770261|NCT01456130|69287858|FG000|Overall Study|Other|1|||
37770262|NCT01456052|69287865|FG000|Overall Study|Adverse Event|1|||
37770263|NCT01456052|69287866|FG001|Overall Study|Adverse Event|1|||
37770264|NCT01456052|69287867|FG002|Overall Study|Adverse Event|2|||
37770265|NCT01456052|69287865|FG000|Overall Study|Consent withdrawn|0|||
37770266|NCT01456052|69287866|FG001|Overall Study|Consent withdrawn|2|||
37770267|NCT01456052|69287867|FG002|Overall Study|Consent withdrawn|1|||
37770268|NCT01456052|69287865|FG000|Overall Study|Protocol Violation|0|||
37770269|NCT01456052|69287866|FG001|Overall Study|Protocol Violation|1|||
37770270|NCT01456052|69287867|FG002|Overall Study|Protocol Violation|0|||
37770271|NCT01456052|69287865|FG000|Overall Study|Physician Decision|1|||
37770272|NCT01456052|69287866|FG001|Overall Study|Physician Decision|0|||
37770273|NCT01456052|69287867|FG002|Overall Study|Physician Decision|1|||
37770274|NCT01456052|69287865|FG000|Overall Study|Treatment Failure|0|||
37770275|NCT01456052|69287866|FG001|Overall Study|Treatment Failure|1|||
37770276|NCT01456052|69287867|FG002|Overall Study|Treatment Failure|1|||
37770277|NCT01387607|69287878|FG000|Overall Study|Adverse Event|23|||
37770278|NCT01387607|69287879|FG001|Overall Study|Adverse Event|11|||
37770279|NCT01387607|69287878|FG000|Overall Study|Lack of Efficacy|8|||
37770280|NCT01387607|69287879|FG001|Overall Study|Lack of Efficacy|6|||
37770281|NCT01387607|69287878|FG000|Overall Study|Lost to Follow-up|2|||
37770282|NCT01387607|69287879|FG001|Overall Study|Lost to Follow-up|1|||
37770283|NCT01387607|69287878|FG000|Overall Study|No longer meets eligibility criteria|0|||
37770284|NCT01387607|69287879|FG001|Overall Study|No longer meets eligibility criteria|1|||
37770285|NCT01387607|69287878|FG000|Overall Study|Protocol Violation|1|||
37770286|NCT01387607|69287879|FG001|Overall Study|Protocol Violation|5|||
37770287|NCT01387607|69287878|FG000|Overall Study|Withdrawal by Subject|13|||
37770288|NCT01387607|69287879|FG001|Overall Study|Withdrawal by Subject|14|||
37952720|NCT00537381|69639658|FG000|Overall Study|Other|5|||
37770289|NCT01387607|69287878|FG000|Overall Study|Other|1|||
37770290|NCT01387607|69287879|FG001|Overall Study|Other|1|||
37952721|NCT00537381|69639659|FG001|Overall Study|Other|3|||
37770291|NCT01387607|69287878|FG000|Overall Study|Randomized, not treated|3|||
37770292|NCT01387607|69287879|FG001|Overall Study|Randomized, not treated|6|||
37770293|NCT03451045|69287888|FG000|Overall Study|Lack of Efficacy|3|||
37770294|NCT03451045|69287889|FG001|Overall Study|Lack of Efficacy|2|||
37770295|NCT03451045|69287890|FG002|Overall Study|Lack of Efficacy|2|||
37770296|NCT03451045|69287888|FG000|Overall Study|Physician Decision|1|||
37770297|NCT03451045|69287889|FG001|Overall Study|Physician Decision|1|||
37770298|NCT03451045|69287890|FG002|Overall Study|Physician Decision|1|||
37770299|NCT03451045|69287888|FG000|Overall Study|Withdrawal by Subject|4|||
37770300|NCT03451045|69287889|FG001|Overall Study|Withdrawal by Subject|0|||
37770301|NCT03451045|69287890|FG002|Overall Study|Withdrawal by Subject|5|||
37770302|NCT03451045|69287888|FG000|Overall Study|Pregnancy|0|||
37770303|NCT03451045|69287889|FG001|Overall Study|Pregnancy|0|||
37770304|NCT03451045|69287890|FG002|Overall Study|Pregnancy|2|||
37770305|NCT03451045|69287888|FG000|Overall Study|Adverse Event|7|||
37770306|NCT03451045|69287889|FG001|Overall Study|Adverse Event|1|||
37770307|NCT03451045|69287890|FG002|Overall Study|Adverse Event|3|||
37770308|NCT03451045|69287888|FG000|Overall Study|Non-compliance with study|2|||
37770309|NCT03451045|69287889|FG001|Overall Study|Non-compliance with study|0|||
37770310|NCT03451045|69287890|FG002|Overall Study|Non-compliance with study|1|||
37770311|NCT03451045|69287888|FG000|Overall Study|any other reason|10|||
37770312|NCT03451045|69287889|FG001|Overall Study|any other reason|2|||
37770313|NCT03451045|69287890|FG002|Overall Study|any other reason|13|||
37770314|NCT03219567|69287901|FG000|Overall Study|Withdrawal by Subject|0|||
37770315|NCT03219567|69287902|FG001|Overall Study|Withdrawal by Subject|1|||
37770316|NCT01386125|69287911|FG000|Overall Study|Lost to Follow-up|3|||
37770317|NCT01386125|69287912|FG001|Overall Study|Lost to Follow-up|9|||
37770318|NCT01386125|69287911|FG000|Overall Study|Physician Decision|0|||
37770319|NCT01386125|69287912|FG001|Overall Study|Physician Decision|1|||
37770320|NCT01386125|69287911|FG000|Overall Study|Protocol Violation|5|||
37770321|NCT01386125|69287912|FG001|Overall Study|Protocol Violation|7|||
37770322|NCT01386125|69287911|FG000|Overall Study|Disease Progress|1|||
37770323|NCT01386125|69287912|FG001|Overall Study|Disease Progress|2|||
37770324|NCT01386125|69287911|FG000|Overall Study|Withdrawal by Subject|13|||
37770325|NCT01386125|69287912|FG001|Overall Study|Withdrawal by Subject|12|||
37770326|NCT01386125|69287911|FG000|Overall Study|Adverse Event|2|||
37770327|NCT01386125|69287912|FG001|Overall Study|Adverse Event|5|||
37770328|NCT01386125|69287911|FG000|Overall Study|Lack of Efficacy|0|||
37770329|NCT01386125|69287912|FG001|Overall Study|Lack of Efficacy|1|||
37770330|NCT01386125|69287911|FG000|Overall Study|Participant Leaving Country|1|||
37770331|NCT01386125|69287912|FG001|Overall Study|Participant Leaving Country|0|||
37770332|NCT01384877|69287920|FG000|Treatment 2|Lost to Follow-up|2|||
37770333|NCT01384877|69287921|FG001|Treatment 2|Lost to Follow-up|2|||
37770334|NCT00114517|69287931|FG000|Overall Study|Adverse Event|6|||
37770335|NCT00114517|69287932|FG001|Overall Study|Adverse Event|1|||
37770336|NCT00114517|69287933|FG002|Overall Study|Adverse Event|6|||
37770337|NCT00114517|69287934|FG003|Overall Study|Adverse Event|3|||
37770338|NCT00114517|69287931|FG000|Overall Study|Lost to Follow-up|2|||
37770339|NCT00114517|69287932|FG001|Overall Study|Lost to Follow-up|2|||
37770340|NCT00114517|69287933|FG002|Overall Study|Lost to Follow-up|2|||
37770341|NCT00114517|69287934|FG003|Overall Study|Lost to Follow-up|1|||
37770342|NCT00114517|69287931|FG000|Overall Study|Too busy|3|||
37770343|NCT00114517|69287932|FG001|Overall Study|Too busy|1|||
37770344|NCT00114517|69287933|FG002|Overall Study|Too busy|1|||
37770345|NCT00114517|69287934|FG003|Overall Study|Too busy|2|||
37770346|NCT00114517|69287931|FG000|Overall Study|Moved from area|0|||
37770347|NCT00114517|69287932|FG001|Overall Study|Moved from area|3|||
37770348|NCT00114517|69287933|FG002|Overall Study|Moved from area|2|||
37770349|NCT00114517|69287934|FG003|Overall Study|Moved from area|1|||
37770350|NCT00114517|69287931|FG000|Overall Study|Did not want estradiol|1|||
37770351|NCT00114517|69287932|FG001|Overall Study|Did not want estradiol|1|||
37770352|NCT00114517|69287933|FG002|Overall Study|Did not want estradiol|0|||
37770353|NCT00114517|69287934|FG003|Overall Study|Did not want estradiol|0|||
37770354|NCT00114517|69287931|FG000|Overall Study|Armed-services duty|0|||
37770355|NCT00114517|69287932|FG001|Overall Study|Armed-services duty|1|||
37770356|NCT00114517|69287933|FG002|Overall Study|Armed-services duty|0|||
37770357|NCT00114517|69287934|FG003|Overall Study|Armed-services duty|1|||
37770358|NCT00114517|69287931|FG000|Overall Study|Competing family issue|0|||
37770359|NCT00114517|69287932|FG001|Overall Study|Competing family issue|1|||
37770360|NCT00114517|69287933|FG002|Overall Study|Competing family issue|0|||
37770361|NCT00114517|69287934|FG003|Overall Study|Competing family issue|1|||
38045079|NCT02431702|69732708|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
37770362|NCT00114517|69287931|FG000|Overall Study|Physician Decision|0|||
37770363|NCT00114517|69287932|FG001|Overall Study|Physician Decision|1|||
37770364|NCT00114517|69287933|FG002|Overall Study|Physician Decision|0|||
37770365|NCT00114517|69287934|FG003|Overall Study|Physician Decision|0|||
37770366|NCT00114517|69287931|FG000|Overall Study|Lost interest|0|||
37770367|NCT00114517|69287932|FG001|Overall Study|Lost interest|0|||
37770368|NCT00114517|69287933|FG002|Overall Study|Lost interest|1|||
37770369|NCT00114517|69287934|FG003|Overall Study|Lost interest|0|||
37770370|NCT00114517|69287931|FG000|Overall Study|Weight increase|0|||
37770371|NCT00114517|69287932|FG001|Overall Study|Weight increase|0|||
37770372|NCT00114517|69287933|FG002|Overall Study|Weight increase|1|||
37770373|NCT00114517|69287934|FG003|Overall Study|Weight increase|0|||
37770374|NCT00114517|69287931|FG000|Overall Study|Concern about blood clots|0|||
37770375|NCT00114517|69287932|FG001|Overall Study|Concern about blood clots|0|||
37770376|NCT00114517|69287933|FG002|Overall Study|Concern about blood clots|1|||
37770377|NCT00114517|69287934|FG003|Overall Study|Concern about blood clots|0|||
37770378|NCT00114517|69287931|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
37770379|NCT00114517|69287932|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
37770380|NCT00114517|69287933|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
37770381|NCT00114517|69287934|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
37770382|NCT01384019|69287987|FG000|Overall Study|Withdrawal by Subject|3|||
37770383|NCT01384019|69287988|FG001|Overall Study|Withdrawal by Subject|0|||
37770384|NCT01384019|69287987|FG000|Overall Study|Death|1|||
37770385|NCT01384019|69287988|FG001|Overall Study|Death|0|||
37770386|NCT01384019|69287987|FG000|Overall Study|MRI refusal|6|||
37770387|NCT01384019|69287988|FG001|Overall Study|MRI refusal|6|||
37770388|NCT00033631|69287996|FG000|Overall Study|Protocol Violation|14|||
37770389|NCT00033631|69287997|FG001|Overall Study|Protocol Violation|11|||
37770390|NCT00033631|69287996|FG000|Overall Study|Withdrawal by Subject|4|||
37770391|NCT00033631|69287997|FG001|Overall Study|Withdrawal by Subject|4|||
37770392|NCT01471574|69288008|FG000|Treatment Period|Lack of Efficacy|12|||
37770393|NCT01471574|69288009|FG001|Treatment Period|Lack of Efficacy|4|||
37770394|NCT01471574|69288010|FG002|Treatment Period|Lack of Efficacy|14|||
37770395|NCT01471574|69288011|FG003|Treatment Period|Lack of Efficacy|1|||
37770396|NCT01471574|69288008|FG000|Treatment Period|Adverse Event|7|||
37770397|NCT01471574|69288009|FG001|Treatment Period|Adverse Event|3|||
37770398|NCT01471574|69288010|FG002|Treatment Period|Adverse Event|6|||
37770399|NCT01471574|69288011|FG003|Treatment Period|Adverse Event|1|||
37770400|NCT01471574|69288008|FG000|Treatment Period|Withdrawal by Subject|5|||
37770401|NCT01471574|69288009|FG001|Treatment Period|Withdrawal by Subject|1|||
37770402|NCT01471574|69288010|FG002|Treatment Period|Withdrawal by Subject|1|||
37770403|NCT01471574|69288011|FG003|Treatment Period|Withdrawal by Subject|0|||
37770404|NCT01471574|69288008|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
37770405|NCT01471574|69288009|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
37770406|NCT01471574|69288010|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
37770407|NCT01471574|69288011|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
37770408|NCT01471574|69288008|FG000|Treatment Period|Lost to Follow-up|1|||
37770409|NCT01471574|69288009|FG001|Treatment Period|Lost to Follow-up|2|||
37770410|NCT01471574|69288010|FG002|Treatment Period|Lost to Follow-up|2|||
37770411|NCT01471574|69288011|FG003|Treatment Period|Lost to Follow-up|0|||
37770412|NCT01471574|69288008|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
37770413|NCT01471574|69288009|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
37770414|NCT01471574|69288010|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
37770415|NCT01471574|69288011|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
37770416|NCT01471574|69288008|FG000|Treatment Period|Other|1|||
37770417|NCT01471574|69288009|FG001|Treatment Period|Other|0|||
37770418|NCT01471574|69288010|FG002|Treatment Period|Other|0|||
37770419|NCT01471574|69288011|FG003|Treatment Period|Other|0|||
37770420|NCT01471574|69288008|FG000|Follow-up Period|Withdrawal by Subject|3|||
37770421|NCT01471574|69288009|FG001|Follow-up Period|Withdrawal by Subject|0|||
37770422|NCT01471574|69288010|FG002|Follow-up Period|Withdrawal by Subject|3|||
37770423|NCT01471574|69288011|FG003|Follow-up Period|Withdrawal by Subject|1|||
37770424|NCT01471574|69288008|FG000|Follow-up Period|Lost to Follow-up|4|||
37770425|NCT01471574|69288009|FG001|Follow-up Period|Lost to Follow-up|1|||
37770426|NCT01471574|69288010|FG002|Follow-up Period|Lost to Follow-up|3|||
37770427|NCT01471574|69288011|FG003|Follow-up Period|Lost to Follow-up|2|||
37770428|NCT01471574|69288008|FG000|Follow-up Period|Death|0|||
37770429|NCT01471574|69288009|FG001|Follow-up Period|Death|0|||
37770430|NCT01471574|69288010|FG002|Follow-up Period|Death|1|||
37770431|NCT01471574|69288011|FG003|Follow-up Period|Death|0|||
37770432|NCT01471574|69288008|FG000|Follow-up Period|Follow-up no longer required|0|||
37770433|NCT01471574|69288009|FG001|Follow-up Period|Follow-up no longer required|1|||
37770434|NCT01471574|69288010|FG002|Follow-up Period|Follow-up no longer required|0|||
37770435|NCT01471574|69288011|FG003|Follow-up Period|Follow-up no longer required|0|||
37770436|NCT01383707|69288027|FG000|Overall Study|Consent withdrawal|6|||
37770437|NCT01383707|69288027|FG000|Overall Study|Death|19|||
37770438|NCT01383707|69288027|FG000|Overall Study|Other|8|||
37770439|NCT01383707|69288027|FG000|Overall Study|Sponsor's decision|2|||
37770440|NCT01383707|69288027|FG000|Overall Study|Adverse Event|14|||
37770441|NCT01383707|69288027|FG000|Overall Study|Progressive disease|23|||
37770442|NCT01383317|69288033|FG000|Overall Study|Lost to Follow-up|2|||
37770443|NCT01383317|69288034|FG001|Overall Study|Lost to Follow-up|1|||
37770444|NCT01383317|69288033|FG000|Overall Study|Death|1|||
37770445|NCT01383317|69288034|FG001|Overall Study|Death|0|||
37770446|NCT01383317|69288033|FG000|Overall Study|Adverse Event|0|||
37770447|NCT01383317|69288034|FG001|Overall Study|Adverse Event|1|||
37770448|NCT01455428|69288042|FG000|Overall Study|Protocol Violation|2|||
37770449|NCT01455428|69288043|FG001|Overall Study|Protocol Violation|1|||
37770450|NCT01455428|69288042|FG000|Overall Study|Adverse Event|6|||
37770451|NCT01455428|69288043|FG001|Overall Study|Adverse Event|2|||
37770452|NCT01455428|69288042|FG000|Overall Study|Lost to Follow-up|1|||
37770453|NCT01455428|69288043|FG001|Overall Study|Lost to Follow-up|1|||
37770454|NCT01455428|69288042|FG000|Overall Study|Withdrawal by Subject|2|||
37770455|NCT01455428|69288043|FG001|Overall Study|Withdrawal by Subject|5|||
37770456|NCT01455428|69288042|FG000|Overall Study|Did not meet entrance criteria|0|||
37770457|NCT01455428|69288043|FG001|Overall Study|Did not meet entrance criteria|2|||
37770458|NCT01455428|69288042|FG000|Overall Study|Insufficient clinical response|0|||
37770459|NCT01455428|69288043|FG001|Overall Study|Insufficient clinical response|2|||
37770460|NCT01455428|69288042|FG000|Overall Study|Did not receive treatment|1|||
37770461|NCT01455428|69288043|FG001|Overall Study|Did not receive treatment|1|||
37770462|NCT01455428|69288042|FG000|Overall Study|Other|2|||
37770463|NCT01455428|69288043|FG001|Overall Study|Other|4|||
37770464|NCT01383161|69288051|FG000|Overall Study|Adverse Event|5|||
37770465|NCT01383161|69288052|FG001|Overall Study|Adverse Event|1|||
37770466|NCT01383161|69288051|FG000|Overall Study|Withdrawal by Subject|0|||
37770467|NCT01383161|69288052|FG001|Overall Study|Withdrawal by Subject|2|||
37770468|NCT01383161|69288051|FG000|Overall Study|Lack of Efficacy|0|||
37770469|NCT01383161|69288052|FG001|Overall Study|Lack of Efficacy|1|||
37770470|NCT01382225|69288078|FG000|Overall Study|Adverse Event|3|||
37770471|NCT01382225|69288079|FG001|Overall Study|Adverse Event|2|||
37770472|NCT01382225|69288078|FG000|Overall Study|Protocol Violation|2|||
37770473|NCT01382225|69288079|FG001|Overall Study|Protocol Violation|1|||
37770474|NCT01382225|69288078|FG000|Overall Study|Subject Withdrew Consent|5|||
37770475|NCT01382225|69288079|FG001|Overall Study|Subject Withdrew Consent|2|||
37770476|NCT01382225|69288078|FG000|Overall Study|Other|4|||
37770477|NCT01382225|69288079|FG001|Overall Study|Other|2|||
37770478|NCT01381679|69288085|FG000|Overall Study|Adverse Event|3|||
37770479|NCT01381679|69288085|FG000|Overall Study|Lost to Follow-up|885|||
37770480|NCT01455194|69288092|FG000|Overall Study|Screen Failure|20|||
37770481|NCT01455194|69288093|FG001|Overall Study|Screen Failure|0|||
37770482|NCT01455194|69288094|FG002|Overall Study|Screen Failure|0|||
37770483|NCT01455194|69288095|FG003|Overall Study|Screen Failure|0|||
37770484|NCT01455194|69288092|FG000|Overall Study|Randomisation Failure|90|||
37770485|NCT01455194|69288093|FG001|Overall Study|Randomisation Failure|0|||
37770486|NCT01455194|69288094|FG002|Overall Study|Randomisation Failure|0|||
37770487|NCT01455194|69288095|FG003|Overall Study|Randomisation Failure|0|||
37770488|NCT01455194|69288092|FG000|Overall Study|Deterioration in asthma|12|||
37770489|NCT01455194|69288093|FG001|Overall Study|Deterioration in asthma|6|||
37770490|NCT01455194|69288094|FG002|Overall Study|Deterioration in asthma|14|||
37770491|NCT01455194|69288095|FG003|Overall Study|Deterioration in asthma|9|||
37770492|NCT01455194|69288092|FG000|Overall Study|Adverse Event|1|||
37770493|NCT01455194|69288093|FG001|Overall Study|Adverse Event|1|||
37770494|NCT01455194|69288094|FG002|Overall Study|Adverse Event|1|||
37770495|NCT01455194|69288095|FG003|Overall Study|Adverse Event|3|||
37770496|NCT01455194|69288092|FG000|Overall Study|Withdrawal by Subject|21|||
37770497|NCT01455194|69288093|FG001|Overall Study|Withdrawal by Subject|16|||
37770498|NCT01455194|69288094|FG002|Overall Study|Withdrawal by Subject|12|||
37770499|NCT01455194|69288095|FG003|Overall Study|Withdrawal by Subject|9|||
37770500|NCT01455194|69288092|FG000|Overall Study|Lost to Follow-up|2|||
37770501|NCT01455194|69288093|FG001|Overall Study|Lost to Follow-up|0|||
37770502|NCT01455194|69288094|FG002|Overall Study|Lost to Follow-up|1|||
37770503|NCT01455194|69288095|FG003|Overall Study|Lost to Follow-up|1|||
37770504|NCT01455194|69288092|FG000|Overall Study|Pregnancy|0|||
37770505|NCT01455194|69288093|FG001|Overall Study|Pregnancy|1|||
37770506|NCT01455194|69288094|FG002|Overall Study|Pregnancy|1|||
37770507|NCT01455194|69288095|FG003|Overall Study|Pregnancy|0|||
37770508|NCT01455194|69288092|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
37770509|NCT01455194|69288093|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
37770510|NCT01455194|69288094|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
37770511|NCT01455194|69288095|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
37770512|NCT01455194|69288092|FG000|Overall Study|Miscellaneous|4|||
37770513|NCT01455194|69288093|FG001|Overall Study|Miscellaneous|5|||
37770514|NCT01455194|69288094|FG002|Overall Study|Miscellaneous|1|||
37770515|NCT01455194|69288095|FG003|Overall Study|Miscellaneous|4|||
37770516|NCT01454726|69288119|FG000|Overall Study|Withdrawal by Subject|0|||
37770517|NCT01454726|69288120|FG001|Overall Study|Withdrawal by Subject|1|||
37770518|NCT01361568|69288132|FG000|Overall Study|Adverse Event|0|||
37770519|NCT01361568|69288133|FG001|Overall Study|Adverse Event|0|||
37770520|NCT01361568|69288134|FG002|Overall Study|Adverse Event|0|||
37770521|NCT01361568|69288135|FG003|Overall Study|Adverse Event|0|||
37770522|NCT01361568|69288136|FG004|Overall Study|Adverse Event|1|||
37770523|NCT01361568|69288137|FG005|Overall Study|Adverse Event|0|||
37770524|NCT01361568|69288132|FG000|Overall Study|Physician Decision|0|||
37770525|NCT01361568|69288133|FG001|Overall Study|Physician Decision|0|||
37770526|NCT01361568|69288134|FG002|Overall Study|Physician Decision|0|||
37770527|NCT01361568|69288135|FG003|Overall Study|Physician Decision|0|||
37770528|NCT01361568|69288136|FG004|Overall Study|Physician Decision|0|||
37770529|NCT01361568|69288137|FG005|Overall Study|Physician Decision|1|||
37770530|NCT01361568|69288132|FG000|Overall Study|Withdrawal by Subject|2|||
37770531|NCT01361568|69288133|FG001|Overall Study|Withdrawal by Subject|1|||
37770532|NCT01361568|69288134|FG002|Overall Study|Withdrawal by Subject|0|||
37770533|NCT01361568|69288135|FG003|Overall Study|Withdrawal by Subject|0|||
37770534|NCT01361568|69288136|FG004|Overall Study|Withdrawal by Subject|0|||
37770535|NCT01361568|69288137|FG005|Overall Study|Withdrawal by Subject|1|||
37770536|NCT03084367|69288152|FG000|Overall Study|Lost to Follow-up|32|||
37770537|NCT03084367|69288152|FG000|Overall Study|Withdrawal by Subject|4|||
37770538|NCT03084367|69288152|FG000|Overall Study|Other|1|||
37770539|NCT01454570|69288165|FG000|Overall Study|Withdrawal by Subject|2|||
37770540|NCT01454570|69288165|FG000|Overall Study|Screen Failure|7|||
37770541|NCT01494350|69288178|FG000|Overall Study|Worsening of lesion|1|||
37770542|NCT03281629|69288188|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
37770543|NCT03281629|69288189|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
37770544|NCT03281629|69288188|FG000|Overall Study|Death|0|||
37770545|NCT03281629|69288189|FG001|Overall Study|Death|1|||
37770546|NCT03281629|69288188|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
37770547|NCT03281629|69288189|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
37770548|NCT00218543|69288195|FG000|Overall Study|Lost to Follow-up|8|||
37770549|NCT00218543|69288195|FG000|Overall Study|relocated|1|||
37770550|NCT00218543|69288195|FG000|Overall Study|Withdrawal by Subject|1|||
37770551|NCT00218543|69288195|FG000|Overall Study|Physician Decision|3|||
37770552|NCT00218543|69288195|FG000|Overall Study|Adverse Event|2|||
37770553|NCT00216671|69288210|FG000|Overall Study|Adverse Event|4|||
37770554|NCT00216671|69288211|FG001|Overall Study|Adverse Event|9|||
37770555|NCT00216671|69288210|FG000|Overall Study|Pregnancy|0|||
37770556|NCT00216671|69288211|FG001|Overall Study|Pregnancy|1|||
37770557|NCT00216671|69288210|FG000|Overall Study|Withdrawal by Subject|4|||
37770558|NCT00216671|69288211|FG001|Overall Study|Withdrawal by Subject|2|||
37770559|NCT00216671|69288210|FG000|Overall Study|Refused Injections|3|||
37770560|NCT00216671|69288211|FG001|Overall Study|Refused Injections|13|||
37770561|NCT00216671|69288210|FG000|Overall Study|No Need to Continue Medication|1|||
37770562|NCT00216671|69288211|FG001|Overall Study|No Need to Continue Medication|1|||
37770563|NCT00216671|69288210|FG000|Overall Study|Insufficient Response|9|||
37770564|NCT00216671|69288211|FG001|Overall Study|Insufficient Response|4|||
37770565|NCT00216671|69288210|FG000|Overall Study|Lost to Follow-up|3|||
37770566|NCT00216671|69288211|FG001|Overall Study|Lost to Follow-up|5|||
37770567|NCT00216671|69288210|FG000|Overall Study|Non compliant|2|||
37770568|NCT00216671|69288211|FG001|Overall Study|Non compliant|2|||
37770569|NCT00216671|69288210|FG000|Overall Study|Ineligible|0|||
37770570|NCT00216671|69288211|FG001|Overall Study|Ineligible|2|||
37770571|NCT00216671|69288210|FG000|Overall Study|Physician Decision|1|||
37770572|NCT00216671|69288211|FG001|Overall Study|Physician Decision|1|||
37770573|NCT00216671|69288210|FG000|Overall Study|Protocol Violation|3|||
37770574|NCT00216671|69288211|FG001|Overall Study|Protocol Violation|5|||
37770575|NCT00216671|69288210|FG000|Overall Study|Relapse|1|||
37770576|NCT00216671|69288211|FG001|Overall Study|Relapse|0|||
37770577|NCT00216671|69288210|FG000|Overall Study|Investigator Illness|0|||
37770578|NCT00216671|69288211|FG001|Overall Study|Investigator Illness|1|||
37770579|NCT00216671|69288210|FG000|Overall Study|Patient Moved|0|||
37770580|NCT00216671|69288211|FG001|Overall Study|Patient Moved|1|||
37770581|NCT00216671|69288210|FG000|Overall Study|Ineligible, no efficacy data|2|||
37770582|NCT00216671|69288211|FG001|Overall Study|Ineligible, no efficacy data|2|||
37770583|NCT00216671|69288210|FG000|Overall Study|Insufficient Response Adverse Event|2|||
37770584|NCT00216671|69288211|FG001|Overall Study|Insufficient Response Adverse Event|1|||
37770585|NCT00216203|69288217|FG000|Overall Study|Withdrawal by Subject|2|||
37770586|NCT02644668|69288252|FG000|Overall Study|Adverse Event|2|||
37770587|NCT02644668|69288253|FG001|Overall Study|Adverse Event|0|||
37770588|NCT02644668|69288254|FG002|Overall Study|Adverse Event|1|||
37770589|NCT02644668|69288252|FG000|Overall Study|Protocol Violation|0|||
37770590|NCT02644668|69288253|FG001|Overall Study|Protocol Violation|0|||
37770591|NCT02644668|69288254|FG002|Overall Study|Protocol Violation|1|||
37770592|NCT02644668|69288252|FG000|Overall Study|Withdrawal by Subject|0|||
37770593|NCT02644668|69288253|FG001|Overall Study|Withdrawal by Subject|0|||
37770594|NCT02644668|69288254|FG002|Overall Study|Withdrawal by Subject|1|||
37770595|NCT02644356|69288273|FG000|Overall Study|Withdrawal by Subject|2|||
37770596|NCT01494038|69288314|FG000|Overall Study|Protocol Violation|1|||
37770597|NCT01494038|69288315|FG001|Overall Study|Protocol Violation|1|||
37770598|NCT01494038|69288314|FG000|Overall Study|Lost to Follow-up|18|||
37770599|NCT01494038|69288315|FG001|Overall Study|Lost to Follow-up|20|||
37770600|NCT01494038|69288314|FG000|Overall Study|Withdrawal by Subject|44|||
37770601|NCT01494038|69288315|FG001|Overall Study|Withdrawal by Subject|34|||
37770602|NCT01494038|69288314|FG000|Overall Study|Not able to get to clinic|21|||
37770603|NCT01494038|69288315|FG001|Overall Study|Not able to get to clinic|15|||
37770604|NCT01494038|69288314|FG000|Overall Study|Not willing to adhere to reqs|2|||
37770605|NCT01494038|69288315|FG001|Overall Study|Not willing to adhere to reqs|9|||
37770606|NCT01494038|69288314|FG000|Overall Study|Death|2|||
37770607|NCT01494038|69288315|FG001|Overall Study|Death|4|||
37770608|NCT02640612|69288352|FG000|Overall Study|Adverse Event|6|||
37770609|NCT02640612|69288353|FG001|Overall Study|Adverse Event|7|||
37770610|NCT02640612|69288354|FG002|Overall Study|Adverse Event|2|||
37770611|NCT02640612|69288352|FG000|Overall Study|Death|1|||
37770612|NCT02640612|69288353|FG001|Overall Study|Death|0|||
37770613|NCT02640612|69288354|FG002|Overall Study|Death|0|||
37770614|NCT02640612|69288352|FG000|Overall Study|Withdrawal by Subject|10|||
37770615|NCT02640612|69288353|FG001|Overall Study|Withdrawal by Subject|3|||
37770616|NCT02640612|69288354|FG002|Overall Study|Withdrawal by Subject|3|||
37770617|NCT02640612|69288352|FG000|Overall Study|Lost to Follow-up|4|||
37770618|NCT02640612|69288353|FG001|Overall Study|Lost to Follow-up|1|||
37770619|NCT02640612|69288354|FG002|Overall Study|Lost to Follow-up|1|||
37770620|NCT02640612|69288352|FG000|Overall Study|Protocol Violation|0|||
37770621|NCT02640612|69288353|FG001|Overall Study|Protocol Violation|2|||
37770622|NCT02640612|69288354|FG002|Overall Study|Protocol Violation|0|||
37770623|NCT02640612|69288352|FG000|Overall Study|Lack of Efficacy|1|||
37770624|NCT02640612|69288353|FG001|Overall Study|Lack of Efficacy|1|||
37770625|NCT02640612|69288354|FG002|Overall Study|Lack of Efficacy|0|||
37770626|NCT00639769|69288362|FG000|Overall Study|Death|2|||
37770627|NCT00639769|69288362|FG000|Overall Study|Adverse Event|7|||
37770628|NCT00639769|69288362|FG000|Overall Study|Lack of Efficacy|1|||
37770629|NCT00639769|69288362|FG000|Overall Study|Disease progression|26|||
37770630|NCT00639769|69288362|FG000|Overall Study|Withdrawal by Subject|4|||
37770631|NCT00639457|69288368|FG000|Overall Study|Withdrawal by Subject|2|||
37770632|NCT00639457|69288369|FG001|Overall Study|Withdrawal by Subject|3|||
37770633|NCT00639379|69288375|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
37770634|NCT00639379|69288376|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
37770635|NCT00639379|69288375|FG000|Period 1 - 2 Weeks|lens issue|3|||
37770636|NCT00639379|69288376|FG001|Period 1 - 2 Weeks|lens issue|0|||
37770637|NCT00639223|69288384|FG000|Overall Study|Lost to Follow-up|0|||
37770638|NCT00639223|69288385|FG001|Overall Study|Lost to Follow-up|2|||
37770639|NCT00638989|69288394|FG000|Overall Study|Lost to Follow-up|0|||
37770640|NCT00638989|69288395|FG001|Overall Study|Lost to Follow-up|0|||
37770641|NCT00638989|69288396|FG002|Overall Study|Lost to Follow-up|1|||
37770642|NCT00637273|69288417|FG000|Overall Study|Adverse Event|11|||
37770643|NCT00637273|69288418|FG001|Overall Study|Adverse Event|5|||
37770644|NCT00637273|69288419|FG002|Overall Study|Adverse Event|7|||
37770645|NCT00637273|69288417|FG000|Overall Study|Lost to Follow-up|8|||
37770646|NCT00637273|69288418|FG001|Overall Study|Lost to Follow-up|9|||
37770647|NCT00637273|69288419|FG002|Overall Study|Lost to Follow-up|13|||
37770648|NCT00637273|69288417|FG000|Overall Study|Protocol Violation|2|||
37770649|NCT00637273|69288418|FG001|Overall Study|Protocol Violation|4|||
37770650|NCT00637273|69288419|FG002|Overall Study|Protocol Violation|1|||
37770651|NCT00637273|69288417|FG000|Overall Study|Withdrawal of Consent|18|||
37770652|NCT00637273|69288418|FG001|Overall Study|Withdrawal of Consent|6|||
37770653|NCT00637273|69288419|FG002|Overall Study|Withdrawal of Consent|18|||
37770654|NCT00637273|69288417|FG000|Overall Study|Investigator Decision|1|||
37770655|NCT00637273|69288418|FG001|Overall Study|Investigator Decision|3|||
37770656|NCT00637273|69288419|FG002|Overall Study|Investigator Decision|1|||
37770657|NCT00637273|69288417|FG000|Overall Study|Administrative|2|||
37770658|NCT00637273|69288418|FG001|Overall Study|Administrative|0|||
37770659|NCT00637273|69288419|FG002|Overall Study|Administrative|0|||
37770660|NCT00637273|69288417|FG000|Overall Study|Loss of Glucose Control|1|||
37770661|NCT00637273|69288418|FG001|Overall Study|Loss of Glucose Control|1|||
37770662|NCT00637273|69288419|FG002|Overall Study|Loss of Glucose Control|1|||
37770663|NCT00988351|69288429|FG000|Overall Study|Withdrawal by Subject|8|||
37770664|NCT00988351|69288430|FG001|Overall Study|Withdrawal by Subject|0|||
37770665|NCT00988351|69288429|FG000|Overall Study|Lost to Follow-up|6|||
37770666|NCT00988351|69288430|FG001|Overall Study|Lost to Follow-up|9|||
37770667|NCT00988351|69288429|FG000|Overall Study|not using CPAP|5|||
37770668|NCT00988351|69288430|FG001|Overall Study|not using CPAP|3|||
37770669|NCT00988117|69288436|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
37770670|NCT00988117|69288436|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
37770671|NCT00637195|69288443|FG000|Overall Study|Lost to Follow-up|1|||
37770672|NCT00637195|69288444|FG001|Overall Study|Lost to Follow-up|0|||
37770673|NCT00637195|69288443|FG000|Overall Study|Other|2|||
37770674|NCT00637195|69288444|FG001|Overall Study|Other|0|||
37770675|NCT00637195|69288443|FG000|Overall Study|Withdrawal by Subject|0|||
37770676|NCT00637195|69288444|FG001|Overall Study|Withdrawal by Subject|1|||
37770677|NCT00636961|69288462|FG000|Period 1|Administrative problems|1|||
37770678|NCT00636961|69288463|FG001|Period 1|Administrative problems|1|||
37770679|NCT00636961|69288462|FG000|Period 2|Adverse Event|1|||
37770680|NCT00636961|69288463|FG001|Period 2|Adverse Event|0|||
37770681|NCT00635089|69288478|FG000|Overall Study|Adverse Event|7|||
37770682|NCT00635089|69288478|FG000|Overall Study|Lack of Efficacy|28|||
37770683|NCT00635089|69288478|FG000|Overall Study|Protocol Deviation|4|||
37770684|NCT00635089|69288478|FG000|Overall Study|Lost to Follow-up|8|||
37770685|NCT00635089|69288478|FG000|Overall Study|Other|31|||
37770686|NCT01493414|69288495|FG000|Overall Study|Adverse Event|405|||
37770687|NCT01493414|69288495|FG000|Overall Study|Disease progression|204|||
37770688|NCT01493414|69288495|FG000|Overall Study|Death|101|||
37770689|NCT01493414|69288495|FG000|Overall Study|Physician Decision|93|||
37770690|NCT01493414|69288495|FG000|Overall Study|Withdrawal by Subject|79|||
37770691|NCT01493414|69288495|FG000|Overall Study|Protocol deviation|27|||
37770692|NCT01493414|69288495|FG000|Overall Study|Administrative problems|25|||
37770693|NCT01493414|69288495|FG000|Overall Study|Lost to Follow-up|16|||
37770694|NCT00634543|69288505|FG000|Overall Study|Other|1|||
37770695|NCT00634543|69288506|FG001|Overall Study|Other|2|||
37770696|NCT00634543|69288505|FG000|Overall Study|Protocol Violation|3|||
37770697|NCT00634543|69288506|FG001|Overall Study|Protocol Violation|3|||
37770698|NCT00634543|69288505|FG000|Overall Study|Adverse Event|11|||
37770699|NCT00634543|69288506|FG001|Overall Study|Adverse Event|11|||
37770700|NCT00634543|69288505|FG000|Overall Study|Withdrawal by Subject|4|||
37770701|NCT00634543|69288506|FG001|Overall Study|Withdrawal by Subject|4|||
37770702|NCT00634543|69288505|FG000|Overall Study|Lost to Follow-up|0|||
37770703|NCT00634543|69288506|FG001|Overall Study|Lost to Follow-up|1|||
37770704|NCT00985465|69288514|FG000|Overall Study|Withdrawal by Subject|1|||
37770705|NCT00985465|69288515|FG001|Overall Study|Withdrawal by Subject|2|||
37770706|NCT00985465|69288514|FG000|Overall Study|Considered to be part of the other group|0|||
37770707|NCT00985465|69288515|FG001|Overall Study|Considered to be part of the other group|1|||
37770708|NCT01049919|69288524|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
37770709|NCT01049919|69288525|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
37770710|NCT01049919|69288524|FG000|Overall Study|Withdrawal by Subject|5|||
37770711|NCT01049919|69288525|FG001|Overall Study|Withdrawal by Subject|0|||
37770712|NCT01049919|69288524|FG000|Overall Study|Lost to Follow-up|6|||
37770713|NCT01049919|69288525|FG001|Overall Study|Lost to Follow-up|1|||
37770714|NCT01049919|69288524|FG000|Overall Study|Physician Decision|2|||
37770715|NCT01049919|69288525|FG001|Overall Study|Physician Decision|0|||
37770716|NCT01049919|69288524|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
37770717|NCT01049919|69288525|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
37770718|NCT01049919|69288524|FG000|Overall Study|Early study termination by sponsor.|2|||
37770719|NCT01049919|69288525|FG001|Overall Study|Early study termination by sponsor.|0|||
37770720|NCT01049373|69288533|FG000|Overall Study|Protocol Violation|9|||
37770721|NCT01049373|69288534|FG001|Overall Study|Protocol Violation|9|||
37770722|NCT01049373|69288533|FG000|Overall Study|Withdrawal by Subject|8|||
37770723|NCT01049373|69288534|FG001|Overall Study|Withdrawal by Subject|5|||
37770724|NCT01049373|69288533|FG000|Overall Study|Adverse Event|3|||
37770725|NCT01049373|69288534|FG001|Overall Study|Adverse Event|3|||
37770726|NCT01049373|69288533|FG000|Overall Study|Lost to Follow-up|9|||
37770727|NCT01049373|69288534|FG001|Overall Study|Lost to Follow-up|4|||
37770728|NCT01049373|69288533|FG000|Overall Study|no evaluable study values|9|||
37770729|NCT01049373|69288534|FG001|Overall Study|no evaluable study values|21|||
37770730|NCT01049373|69288533|FG000|Overall Study|Other|1|||
37770731|NCT01049373|69288534|FG001|Overall Study|Other|1|||
37770732|NCT01049373|69288533|FG000|Overall Study|Non-cooperation|0|||
37770733|NCT01049373|69288534|FG001|Overall Study|Non-cooperation|1|||
37770734|NCT00985231|69288544|FG000|Overall Study|ineligible|1|||
37770735|NCT00985231|69288545|FG001|Overall Study|ineligible|0|||
37770736|NCT00985231|69288544|FG000|Overall Study|Protocol Violation|1|||
37770737|NCT00985231|69288545|FG001|Overall Study|Protocol Violation|0|||
37770738|NCT00985231|69288544|FG000|Overall Study|Withdrawal by Subject|1|||
37770739|NCT00985231|69288545|FG001|Overall Study|Withdrawal by Subject|0|||
37770740|NCT00985231|69288544|FG000|Overall Study|Lost to Follow-up|0|||
37770741|NCT00985231|69288545|FG001|Overall Study|Lost to Follow-up|1|||
37770742|NCT00985231|69288544|FG000|Overall Study|Study related symptoms & complaints|0|||
37770743|NCT00985231|69288545|FG001|Overall Study|Study related symptoms & complaints|2|||
37770744|NCT01048671|69288565|FG000|Overall Study|Protocol Violation|0|||
37770745|NCT01048671|69288566|FG001|Overall Study|Protocol Violation|1|||
37770746|NCT01048671|69288567|FG002|Overall Study|Protocol Violation|1|||
37770747|NCT01360866|69288579|FG000|Overall Study|Lost to Follow-up|11|||
37770748|NCT01360866|69288580|FG001|Overall Study|Lost to Follow-up|28|||
37770749|NCT01360866|69288581|FG002|Overall Study|Lost to Follow-up|41|||
37770750|NCT01360866|69288582|FG003|Overall Study|Lost to Follow-up|0|||
37770751|NCT01360866|69288579|FG000|Overall Study|Adverse Event|56|||
37770752|NCT01360866|69288580|FG001|Overall Study|Adverse Event|61|||
37770753|NCT01360866|69288581|FG002|Overall Study|Adverse Event|134|||
37770754|NCT01360866|69288582|FG003|Overall Study|Adverse Event|6|||
37770755|NCT01360866|69288579|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
37770756|NCT01360866|69288580|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
37770757|NCT01360866|69288581|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
37770758|NCT01360866|69288582|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
37770759|NCT01360866|69288579|FG000|Overall Study|Withdrawn by Investigator|9|||
37770760|NCT01360866|69288580|FG001|Overall Study|Withdrawn by Investigator|8|||
37770761|NCT01360866|69288581|FG002|Overall Study|Withdrawn by Investigator|31|||
37770762|NCT01360866|69288582|FG003|Overall Study|Withdrawn by Investigator|2|||
37770763|NCT01360866|69288579|FG000|Overall Study|Withdrawal by participant|79|||
37770764|NCT01360866|69288580|FG001|Overall Study|Withdrawal by participant|89|||
37770765|NCT01360866|69288581|FG002|Overall Study|Withdrawal by participant|168|||
37770766|NCT01360866|69288582|FG003|Overall Study|Withdrawal by participant|8|||
37770767|NCT01360866|69288579|FG000|Overall Study|Protocol Deviation|25|||
37770768|NCT01360866|69288580|FG001|Overall Study|Protocol Deviation|33|||
37770769|NCT01360866|69288581|FG002|Overall Study|Protocol Deviation|61|||
37770770|NCT01360866|69288582|FG003|Overall Study|Protocol Deviation|2|||
37770771|NCT01360866|69288579|FG000|Overall Study|Lack of Efficacy|30|||
37770772|NCT01360866|69288580|FG001|Overall Study|Lack of Efficacy|40|||
37770773|NCT01360866|69288581|FG002|Overall Study|Lack of Efficacy|30|||
37770774|NCT01360866|69288582|FG003|Overall Study|Lack of Efficacy|4|||
37770775|NCT00985153|69288596|FG000|Overall Study|Lost to Follow-up|16|||
37770776|NCT00985153|69288597|FG001|Overall Study|Lost to Follow-up|19|||
37770777|NCT00985153|69288598|FG002|Overall Study|Lost to Follow-up|17|||
37770778|NCT00985153|69288599|FG003|Overall Study|Lost to Follow-up|20|||
37770779|NCT00985153|69288596|FG000|Overall Study|Protocol Violation|3|||
37770780|NCT00985153|69288597|FG001|Overall Study|Protocol Violation|2|||
37770781|NCT00985153|69288598|FG002|Overall Study|Protocol Violation|4|||
37770782|NCT00985153|69288599|FG003|Overall Study|Protocol Violation|3|||
38045080|NCT02431702|69732709|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
38045081|NCT02431702|69732710|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
38045082|NCT02431702|69732711|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
38045083|NCT02431702|69732705|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
38045084|NCT02431702|69732706|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
38045085|NCT02431702|69732707|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
38045086|NCT02431702|69732708|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
38045087|NCT02431702|69732709|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
38045088|NCT02431702|69732710|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
38045089|NCT02431702|69732711|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
38045090|NCT02086552|69732727|FG000|Overall Study|Withdrawal by Subject|1|||
38045091|NCT03131570|69732772|FG000|Overall Study|Adverse Event|1|||
38045092|NCT03131570|69732773|FG001|Overall Study|Adverse Event|0|||
38045093|NCT02930018|69732783|FG000|Overall Study|Lost to Follow-up|1|||
38045094|NCT02930018|69732784|FG001|Overall Study|Lost to Follow-up|1|||
38045095|NCT02930018|69732783|FG000|Overall Study|Withdrawal by Subject|5|||
38045096|NCT02930018|69732784|FG001|Overall Study|Withdrawal by Subject|2|||
38045097|NCT02875028|69732792|FG000|Washout Period|Withdrawal by Subject|0|||
38045098|NCT02875028|69732793|FG001|Washout Period|Withdrawal by Subject|1|||
38045099|NCT00943618|69732804|FG000|Overall Study|Lost to Follow-up|38|||
38045100|NCT00943618|69732805|FG001|Overall Study|Lost to Follow-up|48|||
38045101|NCT00943618|69732806|FG002|Overall Study|Lost to Follow-up|20|||
38045102|NCT00943618|69732804|FG000|Overall Study|Discontinued Medication|17|||
38045103|NCT00943618|69732805|FG001|Overall Study|Discontinued Medication|29|||
38045104|NCT00943618|69732806|FG002|Overall Study|Discontinued Medication|11|||
38045105|NCT02710084|69732816|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
37770783|NCT00985153|69288596|FG000|Overall Study|Withdrawal by Subject|6|||
37770784|NCT00985153|69288597|FG001|Overall Study|Withdrawal by Subject|11|||
37770785|NCT00985153|69288598|FG002|Overall Study|Withdrawal by Subject|11|||
37770786|NCT00985153|69288599|FG003|Overall Study|Withdrawal by Subject|10|||
37770787|NCT00985153|69288596|FG000|Overall Study|Missed One or More Bleeds|7|||
37770788|NCT00985153|69288597|FG001|Overall Study|Missed One or More Bleeds|7|||
37770789|NCT00985153|69288598|FG002|Overall Study|Missed One or More Bleeds|8|||
37770790|NCT00985153|69288599|FG003|Overall Study|Missed One or More Bleeds|10|||
37770791|NCT00985153|69288596|FG000|Overall Study|Incomplete Safety Follow-up|3|||
37770792|NCT00985153|69288597|FG001|Overall Study|Incomplete Safety Follow-up|5|||
37770793|NCT00985153|69288598|FG002|Overall Study|Incomplete Safety Follow-up|4|||
37770794|NCT00985153|69288599|FG003|Overall Study|Incomplete Safety Follow-up|4|||
37770795|NCT01047345|69288611|FG000|Base Study|Adverse Event|3|||
37770796|NCT01047345|69288612|FG001|Base Study|Adverse Event|0|||
37770797|NCT01047345|69288613|FG002|Base Study|Adverse Event|0|||
37770798|NCT01047345|69288611|FG000|Base Study|Lost to Follow-up|4|||
37770799|NCT01047345|69288612|FG001|Base Study|Lost to Follow-up|1|||
37770800|NCT01047345|69288613|FG002|Base Study|Lost to Follow-up|0|||
37770801|NCT01047345|69288611|FG000|Base Study|Protocol Violation|3|||
37770802|NCT01047345|69288612|FG001|Base Study|Protocol Violation|1|||
37770803|NCT01047345|69288613|FG002|Base Study|Protocol Violation|0|||
37770804|NCT01047345|69288611|FG000|Base Study|Withdrawal by Subject|12|||
37770805|NCT01047345|69288612|FG001|Base Study|Withdrawal by Subject|4|||
37770806|NCT01047345|69288613|FG002|Base Study|Withdrawal by Subject|0|||
37770807|NCT01047345|69288611|FG000|Extension|Withdrawal by Subject|0|||
37770808|NCT01047345|69288612|FG001|Extension|Withdrawal by Subject|0|||
37770809|NCT01047345|69288613|FG002|Extension|Withdrawal by Subject|1|||
37770810|NCT01047345|69288611|FG000|Extension|Lost to Follow-up|0|||
37770811|NCT01047345|69288612|FG001|Extension|Lost to Follow-up|0|||
37770812|NCT01047345|69288613|FG002|Extension|Lost to Follow-up|5|||
37770813|NCT01046877|69288621|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
37770814|NCT01046877|69288621|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
37770815|NCT00984061|69288625|FG000|Clarithromycin Alone|Protocol Violation|1|||
37770816|NCT01046643|69288634|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
37770817|NCT01046643|69288635|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
37770818|NCT01046643|69288636|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
37770819|NCT01046643|69288637|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
37770820|NCT00983905|69288647|FG000|Theophylline Alone|Adverse Event|1|||
37770821|NCT00983905|69288647|FG000|Colchicine Alone|Adverse Event|2|||
37770822|NCT01046565|69288654|FG000|Overall Study|Adverse Event|2|||
37770823|NCT01046565|69288654|FG000|Overall Study|Withdrawal by Subject|7|||
37770824|NCT00983827|69288663|FG000|Overall Study|Withdrawal by Subject|1|||
37770825|NCT00983749|69288669|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
37770826|NCT00983749|69288670|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
37770827|NCT01046253|69288678|FG000|Second Intervention|Adverse Event|0|||
37770828|NCT01046253|69288679|FG001|Second Intervention|Adverse Event|1|||
37770829|NCT01046253|69288678|FG000|Second Intervention|Protocol Violation|0|||
37770830|NCT01046253|69288679|FG001|Second Intervention|Protocol Violation|1|||
37770831|NCT00983515|69288685|FG000|Ritonavir Alone|liver panel out of range|6|||
37770832|NCT00983515|69288685|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
37770833|NCT00982735|69288692|FG000|Overall Study|Lost to Follow-up|6|||
37770834|NCT00982735|69288692|FG000|Overall Study|Patient ineligible for trial|224|||
37770835|NCT01361178|69288698|FG000|Overall Study|Death|13|||
37770836|NCT01361178|69288699|FG001|Overall Study|Death|0|||
37770837|NCT00981799|69288709|FG000|Overall Study|Adverse Event|1|||
37770838|NCT00981799|69288710|FG001|Overall Study|Adverse Event|1|||
37770839|NCT00981799|69288711|FG002|Overall Study|Adverse Event|0|||
37770840|NCT00981799|69288712|FG003|Overall Study|Adverse Event|0|||
37770841|NCT00981175|69288726|FG000|Primary Dose Vaccination|Adverse Event|1|||
37770842|NCT00981175|69288727|FG001|Primary Dose Vaccination|Adverse Event|0|||
37770843|NCT00981175|69288726|FG000|Primary Dose Vaccination|Protocol Violation|0|||
37770844|NCT00981175|69288727|FG001|Primary Dose Vaccination|Protocol Violation|1|||
37770845|NCT00981175|69288726|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
37770846|NCT00981175|69288727|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
37770847|NCT00981175|69288726|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
37770848|NCT00981175|69288727|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
37770849|NCT00981019|69288740|FG000|Overall Study|Did not respond|65|||
37770850|NCT00981019|69288740|FG000|Overall Study|Did not match target population|94|||
37770851|NCT00981019|69288740|FG000|Overall Study|Inadvertent exclusion|239|||
37770852|NCT00981019|69288740|FG000|Overall Study|Hit the survey after closure|79|||
37770853|NCT01045161|69288747|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
37770854|NCT01045161|69288748|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
37770855|NCT01045161|69288749|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
37770856|NCT01045161|69288747|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
37770857|NCT01045161|69288748|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
37770858|NCT01045161|69288749|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
37770859|NCT01045161|69288747|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
37770860|NCT01045161|69288748|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
37770861|NCT01045161|69288749|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
37770862|NCT01045161|69288747|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
37770863|NCT01045161|69288748|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
37770864|NCT01045161|69288749|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
37770865|NCT01045161|69288747|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
37770866|NCT01045161|69288748|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
37770867|NCT01045161|69288749|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
38045106|NCT02710084|69732817|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
37770868|NCT01045161|69288747|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
37770869|NCT01045161|69288748|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
37770870|NCT01045161|69288749|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
37770871|NCT01045161|69288747|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
37770872|NCT01045161|69288748|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
37770873|NCT01045161|69288749|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
37770874|NCT01045161|69288747|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
37770875|NCT01045161|69288748|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
37770876|NCT01045161|69288749|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
37770877|NCT01045161|69288747|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
37770878|NCT01045161|69288748|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
37770879|NCT01045161|69288749|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
37770880|NCT01045161|69288747|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
37770881|NCT01045161|69288748|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
37770882|NCT01045161|69288749|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
37770883|NCT01045161|69288747|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
37770884|NCT01045161|69288748|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
37770885|NCT01045161|69288749|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
37770886|NCT01045161|69288747|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
37770887|NCT01045161|69288748|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
37770888|NCT01045161|69288749|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
37770889|NCT01045161|69288747|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
37770890|NCT01045161|69288748|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
37770891|NCT01045161|69288749|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
37770892|NCT01045161|69288747|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
37770893|NCT01045161|69288748|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
37770894|NCT01045161|69288749|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
37770895|NCT00633217|69288768|FG000|Overall Study|Adverse Event|5|||
37770896|NCT00633217|69288769|FG001|Overall Study|Adverse Event|9|||
37770897|NCT00633217|69288768|FG000|Overall Study|Lack of Efficacy|0|||
37770898|NCT00633217|69288769|FG001|Overall Study|Lack of Efficacy|2|||
37770899|NCT00633217|69288768|FG000|Overall Study|Protocol Violation|3|||
37770900|NCT00633217|69288769|FG001|Overall Study|Protocol Violation|7|||
37770901|NCT00633217|69288768|FG000|Overall Study|Lost to Follow-up|2|||
37770902|NCT00633217|69288769|FG001|Overall Study|Lost to Follow-up|2|||
37770903|NCT00633217|69288768|FG000|Overall Study|Investigator Discretion|2|||
37770904|NCT00633217|69288769|FG001|Overall Study|Investigator Discretion|0|||
37770905|NCT00633217|69288768|FG000|Overall Study|Withdrew Consent|3|||
37770906|NCT00633217|69288769|FG001|Overall Study|Withdrew Consent|3|||
37770907|NCT01673490|69288775|FG000|Overall Study|Lost to Follow-up|1|||
37770908|NCT01673490|69288775|FG000|Overall Study|Adverse Event|3|||
37770909|NCT01673490|69288775|FG000|Overall Study|Withdrawal by Subject|3|||
37770910|NCT00215657|69288787|FG000|Overall Study|Adverse Event|5|||
37770911|NCT00215657|69288788|FG001|Overall Study|Adverse Event|1|||
37770912|NCT00215657|69288789|FG002|Overall Study|Adverse Event|3|||
37770913|NCT00215657|69288790|FG003|Overall Study|Adverse Event|0|||
37770914|NCT00215657|69288791|FG004|Overall Study|Adverse Event|3|||
37770915|NCT00215657|69288792|FG005|Overall Study|Adverse Event|1|||
37770916|NCT00215657|69288793|FG006|Overall Study|Adverse Event|0|||
37770917|NCT00215657|69288794|FG007|Overall Study|Adverse Event|3|||
37770918|NCT00215657|69288787|FG000|Overall Study|Withdrawal by Subject|6|||
37770919|NCT00215657|69288788|FG001|Overall Study|Withdrawal by Subject|3|||
37770920|NCT00215657|69288789|FG002|Overall Study|Withdrawal by Subject|3|||
37770921|NCT00215657|69288790|FG003|Overall Study|Withdrawal by Subject|1|||
37770922|NCT00215657|69288791|FG004|Overall Study|Withdrawal by Subject|6|||
37770923|NCT00215657|69288792|FG005|Overall Study|Withdrawal by Subject|1|||
37770924|NCT00215657|69288793|FG006|Overall Study|Withdrawal by Subject|10|||
37770925|NCT00215657|69288794|FG007|Overall Study|Withdrawal by Subject|3|||
37770926|NCT00215657|69288787|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
37770927|NCT00215657|69288788|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
37770928|NCT00215657|69288789|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
37770929|NCT00215657|69288790|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
37770930|NCT00215657|69288791|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
37770931|NCT00215657|69288792|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
37770932|NCT00215657|69288793|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
37770933|NCT00215657|69288794|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
37770934|NCT00215657|69288787|FG000|Overall Study|Insufficient testosterone response|5|||
37770935|NCT00215657|69288788|FG001|Overall Study|Insufficient testosterone response|4|||
37770936|NCT00215657|69288789|FG002|Overall Study|Insufficient testosterone response|1|||
37770937|NCT00215657|69288790|FG003|Overall Study|Insufficient testosterone response|12|||
37770938|NCT00215657|69288791|FG004|Overall Study|Insufficient testosterone response|8|||
37770939|NCT00215657|69288792|FG005|Overall Study|Insufficient testosterone response|12|||
37770940|NCT00215657|69288793|FG006|Overall Study|Insufficient testosterone response|4|||
37770941|NCT00215657|69288794|FG007|Overall Study|Insufficient testosterone response|7|||
37770942|NCT00215657|69288787|FG000|Overall Study|Other|3|||
37770943|NCT00215657|69288788|FG001|Overall Study|Other|1|||
37770944|NCT00215657|69288789|FG002|Overall Study|Other|2|||
37770945|NCT00215657|69288790|FG003|Overall Study|Other|3|||
37770946|NCT00215657|69288791|FG004|Overall Study|Other|5|||
37770947|NCT00215657|69288792|FG005|Overall Study|Other|4|||
37770948|NCT00215657|69288793|FG006|Overall Study|Other|6|||
37770949|NCT00215657|69288794|FG007|Overall Study|Other|1|||
37770950|NCT00633061|69288814|FG000|Overall Study|Study closed|86|||
37770951|NCT00633061|69288815|FG001|Overall Study|Study closed|0|||
37770952|NCT00632827|69288823|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
37770953|NCT00632827|69288823|FG000|Overall Study|Death|2|||
37770954|NCT00632827|69288823|FG000|Overall Study|Adverse Event|5|||
37770955|NCT00632827|69288823|FG000|Overall Study|Lost to Follow-up|1|||
37770956|NCT00214019|69288828|FG000|Overall Study|Lost to Follow-up|11|||
37770957|NCT00214019|69288828|FG000|Overall Study|Withdrawal by Subject|2|||
37770958|NCT00214019|69288828|FG000|Overall Study|Screen Failed prior to randomization|17|||
37770959|NCT00210119|69288835|FG000|Overall Study|Protocol Violation|1|||
37770960|NCT00210119|69288835|FG000|Overall Study|Withdrawal by Subject|1|||
37770961|NCT01044459|69288841|FG000|Overall Study|Withdrawal by Subject|21|||
37770962|NCT01044459|69288842|FG001|Overall Study|Withdrawal by Subject|28|||
37770963|NCT01044459|69288841|FG000|Overall Study|Terminated by Sponsor|22|||
37770964|NCT01044459|69288842|FG001|Overall Study|Terminated by Sponsor|21|||
37770965|NCT01044459|69288841|FG000|Overall Study|Adverse Event|22|||
37770966|NCT01044459|69288842|FG001|Overall Study|Adverse Event|20|||
37770967|NCT01044459|69288841|FG000|Overall Study|Lack of Efficacy|23|||
37770968|NCT01044459|69288842|FG001|Overall Study|Lack of Efficacy|12|||
37770969|NCT01044459|69288841|FG000|Overall Study|Protocol Violation|11|||
37770970|NCT01044459|69288842|FG001|Overall Study|Protocol Violation|16|||
37770971|NCT01044459|69288841|FG000|Overall Study|Other Reason|7|||
37770972|NCT01044459|69288842|FG001|Overall Study|Other Reason|14|||
37770973|NCT01044459|69288841|FG000|Overall Study|COPD exacerbation|9|||
37770974|NCT01044459|69288842|FG001|Overall Study|COPD exacerbation|8|||
37770975|NCT01044459|69288841|FG000|Overall Study|Lost to Follow-up|18|||
37770976|NCT01044459|69288842|FG001|Overall Study|Lost to Follow-up|12|||
37770977|NCT00980005|69288850|FG000|Overall Study|Withdrawal by Subject|6|||
37770978|NCT00980005|69288851|FG001|Overall Study|Withdrawal by Subject|17|||
37770979|NCT00980005|69288850|FG000|Overall Study|Lost to Follow-up|37|||
37770980|NCT00980005|69288851|FG001|Overall Study|Lost to Follow-up|43|||
37770981|NCT00980005|69288850|FG000|Overall Study|Other|4|||
37770982|NCT00980005|69288851|FG001|Overall Study|Other|3|||
37770983|NCT01044303|69288861|FG000|Overall Study|Lost to Follow-up|2|||
37770984|NCT00983437|69288868|FG000|Overall Study|Adverse Event|9|||
37770985|NCT00983437|69288868|FG000|Overall Study|Lack of Efficacy|1|||
37770986|NCT00983437|69288868|FG000|Overall Study|Withdrawal by Subject|8|||
37770987|NCT00983437|69288868|FG000|Overall Study|Noncompliance to Study Procedures|1|||
37770988|NCT00983437|69288868|FG000|Overall Study|Lost to Follow-up|2|||
37770989|NCT00983437|69288868|FG000|Overall Study|Other Reason|26|||
37770990|NCT01042977|69288874|FG000|Overall Study|Adverse Event|4|||
37770991|NCT01042977|69288875|FG001|Overall Study|Adverse Event|12|||
37770992|NCT01042977|69288874|FG000|Overall Study|Death|2|||
37770993|NCT01042977|69288875|FG001|Overall Study|Death|1|||
37770994|NCT01042977|69288874|FG000|Overall Study|Withdrawal by Subject|8|||
37770995|NCT01042977|69288875|FG001|Overall Study|Withdrawal by Subject|16|||
37770996|NCT01042977|69288874|FG000|Overall Study|Lost to Follow-up|0|||
37770997|NCT01042977|69288875|FG001|Overall Study|Lost to Follow-up|2|||
37770998|NCT01042977|69288874|FG000|Overall Study|Poor/non-compliance|3|||
37770999|NCT01042977|69288875|FG001|Overall Study|Poor/non-compliance|4|||
37771000|NCT01042977|69288874|FG000|Overall Study|Subject no longer meets study criteria|15|||
37771001|NCT01042977|69288875|FG001|Overall Study|Subject no longer meets study criteria|13|||
37771002|NCT01042977|69288874|FG000|Overall Study|Incorrect enrollment|6|||
37771003|NCT01042977|69288875|FG001|Overall Study|Incorrect enrollment|4|||
37771004|NCT01042977|69288874|FG000|Overall Study|Safety|0|||
37771005|NCT01042977|69288875|FG001|Overall Study|Safety|2|||
37771006|NCT01042977|69288874|FG000|Overall Study|Administrative reason by sponsor|0|||
37771007|NCT01042977|69288875|FG001|Overall Study|Administrative reason by sponsor|1|||
37771008|NCT01042977|69288874|FG000|Overall Study|Various|3|||
37771009|NCT01042977|69288875|FG001|Overall Study|Various|0|||
37771010|NCT01041573|69288885|FG000|Overall Study|Withdrawal by Subject|2|||
37771011|NCT01041573|69288886|FG001|Overall Study|Withdrawal by Subject|5|||
37771012|NCT01041573|69288887|FG002|Overall Study|Withdrawal by Subject|2|||
37771013|NCT01041573|69288888|FG003|Overall Study|Withdrawal by Subject|0|||
37771014|NCT01041573|69288885|FG000|Overall Study|Death|1|||
37771015|NCT01041573|69288886|FG001|Overall Study|Death|0|||
37771016|NCT01041573|69288887|FG002|Overall Study|Death|0|||
37771017|NCT01041573|69288888|FG003|Overall Study|Death|0|||
37771018|NCT01041573|69288885|FG000|Overall Study|Lost to Follow-up|0|||
37771019|NCT01041573|69288886|FG001|Overall Study|Lost to Follow-up|1|||
37771020|NCT01041573|69288887|FG002|Overall Study|Lost to Follow-up|2|||
37771021|NCT01041573|69288888|FG003|Overall Study|Lost to Follow-up|1|||
37771022|NCT01041573|69288885|FG000|Overall Study|Adverse Event|0|||
37771023|NCT01041573|69288886|FG001|Overall Study|Adverse Event|2|||
37771024|NCT01041573|69288887|FG002|Overall Study|Adverse Event|0|||
37771025|NCT01041573|69288888|FG003|Overall Study|Adverse Event|0|||
37771026|NCT01041573|69288885|FG000|Overall Study|relocation|1|||
37771027|NCT01041573|69288886|FG001|Overall Study|relocation|4|||
37771028|NCT01041573|69288887|FG002|Overall Study|relocation|3|||
37771029|NCT01041573|69288888|FG003|Overall Study|relocation|1|||
37771030|NCT01041573|69288885|FG000|Overall Study|further blood extraction|0|||
37771031|NCT01041573|69288886|FG001|Overall Study|further blood extraction|1|||
37771032|NCT01041573|69288887|FG002|Overall Study|further blood extraction|0|||
37771033|NCT01041573|69288888|FG003|Overall Study|further blood extraction|0|||
37771034|NCT01041573|69288885|FG000|Overall Study|positive to anti-HCV|1|||
37771035|NCT01041573|69288886|FG001|Overall Study|positive to anti-HCV|0|||
37771036|NCT01041573|69288887|FG002|Overall Study|positive to anti-HCV|0|||
37771037|NCT01041573|69288888|FG003|Overall Study|positive to anti-HCV|0|||
37771038|NCT01041495|69288915|FG000|Overall Study|Withdrawal by Subject|2|||
37771039|NCT01041495|69288916|FG001|Overall Study|Withdrawal by Subject|5|||
37771040|NCT01041495|69288915|FG000|Overall Study|Adverse Event|2|||
37771041|NCT01041495|69288916|FG001|Overall Study|Adverse Event|1|||
37771042|NCT01041495|69288915|FG000|Overall Study|Lost to Follow-up|0|||
37771043|NCT01041495|69288916|FG001|Overall Study|Lost to Follow-up|1|||
37771044|NCT01041417|69288924|FG000|Overall Study|Adverse Event|5|||
37771045|NCT01041417|69288925|FG001|Overall Study|Adverse Event|2|||
37771046|NCT01041417|69288924|FG000|Overall Study|Lost to Follow-up|1|||
37771047|NCT01041417|69288925|FG001|Overall Study|Lost to Follow-up|1|||
37771048|NCT01041417|69288924|FG000|Overall Study|Death|1|||
37771049|NCT01041417|69288925|FG001|Overall Study|Death|0|||
37771050|NCT01040871|69288935|FG000|Overall Study|Adverse Event|6|||
37771051|NCT01040871|69288936|FG001|Overall Study|Adverse Event|2|||
37771052|NCT01040871|69288935|FG000|Overall Study|Withdrawal by Subject|2|||
37771053|NCT01040871|69288936|FG001|Overall Study|Withdrawal by Subject|0|||
37771054|NCT01040871|69288935|FG000|Overall Study|Death|1|||
37771055|NCT01040871|69288936|FG001|Overall Study|Death|3|||
37771056|NCT01040871|69288935|FG000|Overall Study|Lack of Efficacy|1|||
37771057|NCT01040871|69288936|FG001|Overall Study|Lack of Efficacy|1|||
37771058|NCT01040871|69288935|FG000|Overall Study|drug supply issue|1|||
37771059|NCT01040871|69288936|FG001|Overall Study|drug supply issue|0|||
37771060|NCT01040871|69288935|FG000|Overall Study|Randomized and Not Treated|2|||
37771061|NCT01040871|69288936|FG001|Overall Study|Randomized and Not Treated|1|||
37771062|NCT01040169|69288944|FG000|Overall Study|Lost to Follow-up|3|||
37771063|NCT01040169|69288945|FG001|Overall Study|Lost to Follow-up|8|||
37771064|NCT01673178|69288965|FG000|Overall Study|Lost to Follow-up|0|||
37771065|NCT01673178|69288966|FG001|Overall Study|Lost to Follow-up|1|||
37771066|NCT01673178|69288967|FG002|Overall Study|Lost to Follow-up|0|||
37771067|NCT01673178|69288968|FG003|Overall Study|Lost to Follow-up|0|||
37771068|NCT01673178|69288969|FG004|Overall Study|Lost to Follow-up|0|||
37771069|NCT01673178|69288965|FG000|Overall Study|Withdrawal by Subject|0|||
37771070|NCT01673178|69288966|FG001|Overall Study|Withdrawal by Subject|0|||
37771071|NCT01673178|69288967|FG002|Overall Study|Withdrawal by Subject|1|||
37771072|NCT01673178|69288968|FG003|Overall Study|Withdrawal by Subject|4|||
37771073|NCT01673178|69288969|FG004|Overall Study|Withdrawal by Subject|2|||
37771074|NCT01673178|69288965|FG000|Overall Study|Protocol Violation|1|||
37771075|NCT01673178|69288966|FG001|Overall Study|Protocol Violation|1|||
37771076|NCT01673178|69288967|FG002|Overall Study|Protocol Violation|0|||
37771077|NCT01673178|69288968|FG003|Overall Study|Protocol Violation|1|||
38045107|NCT02849990|69732824|FG000|Overall Study|Adverse Event|1|||
37771078|NCT01673178|69288969|FG004|Overall Study|Protocol Violation|0|||
37771079|NCT01673178|69288965|FG000|Overall Study|Adverse Event|1|||
37771080|NCT01673178|69288966|FG001|Overall Study|Adverse Event|0|||
37771081|NCT01673178|69288967|FG002|Overall Study|Adverse Event|0|||
37771082|NCT01673178|69288968|FG003|Overall Study|Adverse Event|2|||
37771083|NCT01673178|69288969|FG004|Overall Study|Adverse Event|0|||
37771084|NCT01673178|69288965|FG000|Overall Study|Other|1|||
37771085|NCT01673178|69288966|FG001|Overall Study|Other|0|||
37771086|NCT01673178|69288967|FG002|Overall Study|Other|2|||
37771087|NCT01673178|69288968|FG003|Overall Study|Other|1|||
37771088|NCT01673178|69288969|FG004|Overall Study|Other|0|||
37771089|NCT03593213|69288998|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
37771090|NCT03593213|69288999|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
37771091|NCT03593213|69289000|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
37771092|NCT03593213|69289001|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
37771093|NCT03593213|69288998|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
38045108|NCT02849990|69732824|FG000|Overall Study|Withdrawal by Subject|1|||
37771094|NCT03593213|69288999|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
37771095|NCT03593213|69289000|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
37771096|NCT03593213|69289001|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
37771097|NCT03593213|69288998|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
37771098|NCT03593213|69288999|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
37771099|NCT03593213|69289000|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
37771100|NCT03593213|69289001|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
37771101|NCT03593213|69288998|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
37771102|NCT03593213|69288999|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
37771103|NCT03593213|69289000|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
37771104|NCT03593213|69289001|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
37771105|NCT03593213|69288998|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
37771106|NCT03593213|69288999|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
37771107|NCT03593213|69289000|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
37771108|NCT03593213|69289001|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
37771109|NCT03593213|69288998|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
37771110|NCT03593213|69288999|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
37771111|NCT03593213|69289000|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
37771112|NCT03593213|69289001|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
37771113|NCT03593213|69288998|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
37771114|NCT03593213|69288999|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
37771115|NCT03593213|69289000|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
37771116|NCT03593213|69289001|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
37771117|NCT03593213|69288998|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
37771118|NCT03593213|69288999|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
37771119|NCT03593213|69289000|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
37771120|NCT03593213|69289001|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
37771121|NCT03593213|69288998|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
37771122|NCT03593213|69288999|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
37771123|NCT03593213|69289000|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
37771124|NCT03593213|69289001|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
37771125|NCT03593213|69288998|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
37771126|NCT03593213|69288999|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
37771127|NCT03593213|69289000|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
37771128|NCT03593213|69289001|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
37771129|NCT03593213|69288998|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
37771130|NCT03593213|69288999|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
37771131|NCT03593213|69289000|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
37771132|NCT03593213|69289001|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
37771133|NCT03593213|69288998|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
37771134|NCT03593213|69288999|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
37771135|NCT03593213|69289000|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
37771136|NCT03593213|69289001|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
37771137|NCT03593213|69288998|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
37771138|NCT03593213|69288999|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
37771139|NCT03593213|69289000|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
37771140|NCT03593213|69289001|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
37771141|NCT03593213|69288998|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
37771142|NCT03593213|69288999|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
37771143|NCT03593213|69289000|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
37771144|NCT03593213|69289001|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
37771145|NCT03593213|69288998|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
37771146|NCT03593213|69288999|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
37771147|NCT03593213|69289000|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
37771148|NCT03593213|69289001|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
37771149|NCT03593213|69288998|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
37771150|NCT03593213|69288999|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
37771151|NCT03593213|69289000|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
37771152|NCT03593213|69289001|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
37771153|NCT03593213|69288998|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
37771154|NCT03593213|69288999|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
37771155|NCT03593213|69289000|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
37771156|NCT03593213|69289001|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
37771157|NCT03593213|69288998|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
37771158|NCT03593213|69288999|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
37771159|NCT03593213|69289000|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
37771160|NCT03593213|69289001|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
37771161|NCT03593213|69288998|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
37771162|NCT03593213|69288999|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
37771163|NCT03593213|69289000|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
37771164|NCT03593213|69289001|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
37771165|NCT00013611|69289045|FG000|Overall Study|Lost to Follow-up|91|||
37771166|NCT00013611|69289046|FG001|Overall Study|Lost to Follow-up|100|||
37771167|NCT00010257|69289054|FG000|Overall Study|Withdrawal by Subject|1|||
37771168|NCT00010257|69289055|FG001|Overall Study|Withdrawal by Subject|0|||
37771169|NCT00211757|69289093|FG000|Overall Study|Withdrawal by Subject|1|||
37771170|NCT00211757|69289094|FG001|Overall Study|Withdrawal by Subject|1|||
37771171|NCT00211757|69289093|FG000|Overall Study|Lack of Efficacy|0|||
37771172|NCT00211757|69289094|FG001|Overall Study|Lack of Efficacy|1|||
37771173|NCT02639052|69289111|FG000|Overall Study|Lost to Follow-up|1|||
37771174|NCT02635776|69289218|FG000|Overall Study|Physician Decision|1|||
37771175|NCT02635776|69289219|FG001|Overall Study|Physician Decision|0|||
37771176|NCT02635776|69289218|FG000|Overall Study|Adverse Event|51|||
37771177|NCT02635776|69289219|FG001|Overall Study|Adverse Event|3|||
37771178|NCT02635776|69289218|FG000|Overall Study|Withdrawal by Subject|41|||
37771179|NCT02635776|69289219|FG001|Overall Study|Withdrawal by Subject|7|||
37771180|NCT02635776|69289218|FG000|Overall Study|Lost to Follow-up|4|||
37771181|NCT02635776|69289219|FG001|Overall Study|Lost to Follow-up|0|||
37771182|NCT02635776|69289218|FG000|Overall Study|Other reasons|5|||
37771183|NCT02635776|69289219|FG001|Overall Study|Other reasons|1|||
37771184|NCT02704403|69289233|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
37771185|NCT02704403|69289234|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
37771186|NCT02704403|69289233|FG000|Overall Study|Administrative reasons by sponsor|1251|||
37771187|NCT02704403|69289234|FG001|Overall Study|Administrative reasons by sponsor|616|||
37771188|NCT02704403|69289233|FG000|Overall Study|Death|4|||
37771189|NCT02704403|69289234|FG001|Overall Study|Death|3|||
37771190|NCT02704403|69289233|FG000|Overall Study|Endpoint event|52|||
37771191|NCT02704403|69289234|FG001|Overall Study|Endpoint event|24|||
37771192|NCT02704403|69289233|FG000|Overall Study|Lost to Follow-up|22|||
37771193|NCT02704403|69289234|FG001|Overall Study|Lost to Follow-up|11|||
37771194|NCT02704403|69289233|FG000|Overall Study|Protocol Violation|15|||
37771195|NCT02704403|69289234|FG001|Overall Study|Protocol Violation|15|||
37771196|NCT02704403|69289233|FG000|Overall Study|Adverse Event|2|||
37771197|NCT02704403|69289234|FG001|Overall Study|Adverse Event|0|||
37771198|NCT02704403|69289233|FG000|Overall Study|Withdrawal by Subject|85|||
37771199|NCT02704403|69289234|FG001|Overall Study|Withdrawal by Subject|45|||
37771200|NCT02704403|69289233|FG000|Overall Study|Investigator decision|1|||
37771201|NCT02704403|69289234|FG001|Overall Study|Investigator decision|1|||
37771202|NCT02704403|69289233|FG000|Overall Study|Follow-up not possible|1|||
37771203|NCT02704403|69289234|FG001|Overall Study|Follow-up not possible|2|||
37771204|NCT02636868|69289269|FG000|Overall Study|Death|0|||
37771205|NCT02636868|69289270|FG001|Overall Study|Death|1|||
37771206|NCT02636868|69289271|FG002|Overall Study|Death|2|||
37771207|NCT02635386|69289352|FG000|Overall Study|Pregnancy|2|||
37771208|NCT02635386|69289353|FG001|Overall Study|Pregnancy|0|||
37771209|NCT02635386|69289354|FG002|Overall Study|Pregnancy|0|||
37771210|NCT02635386|69289355|FG003|Overall Study|Pregnancy|0|||
37771211|NCT02635386|69289356|FG004|Overall Study|Pregnancy|2|||
37771212|NCT02635386|69289352|FG000|Overall Study|Withdrawal by Subject|1|||
37771213|NCT02635386|69289353|FG001|Overall Study|Withdrawal by Subject|1|||
37771214|NCT02635386|69289354|FG002|Overall Study|Withdrawal by Subject|0|||
37771215|NCT02635386|69289355|FG003|Overall Study|Withdrawal by Subject|1|||
37771216|NCT02635386|69289356|FG004|Overall Study|Withdrawal by Subject|0|||
37771217|NCT02635386|69289352|FG000|Overall Study|Physician Decision|0|||
37771218|NCT02635386|69289353|FG001|Overall Study|Physician Decision|1|||
37771219|NCT02635386|69289354|FG002|Overall Study|Physician Decision|0|||
37771220|NCT02635386|69289355|FG003|Overall Study|Physician Decision|0|||
38045109|NCT02017964|69732828|FG000|Overall Study|Patient deemed ineligible|1|||
38045110|NCT01956110|69732834|FG000|Overall Study|Protocol Violation|25|||
38045111|NCT01956110|69732835|FG001|Overall Study|Protocol Violation|11|||
37771221|NCT02635386|69289356|FG004|Overall Study|Physician Decision|0|||
37771222|NCT02635386|69289352|FG000|Overall Study|Moved Out of State|0|||
37771223|NCT02635386|69289353|FG001|Overall Study|Moved Out of State|1|||
37771224|NCT02635386|69289354|FG002|Overall Study|Moved Out of State|0|||
37771225|NCT02635386|69289355|FG003|Overall Study|Moved Out of State|0|||
37771226|NCT02635386|69289356|FG004|Overall Study|Moved Out of State|0|||
37771227|NCT02635386|69289352|FG000|Overall Study|Noncompliant|0|||
37771228|NCT02635386|69289353|FG001|Overall Study|Noncompliant|2|||
37771229|NCT02635386|69289354|FG002|Overall Study|Noncompliant|1|||
37771230|NCT02635386|69289355|FG003|Overall Study|Noncompliant|1|||
37771231|NCT02635386|69289356|FG004|Overall Study|Noncompliant|1|||
37771232|NCT02635386|69289352|FG000|Overall Study|side effects|0|||
37771233|NCT02635386|69289353|FG001|Overall Study|side effects|0|||
37771234|NCT02635386|69289354|FG002|Overall Study|side effects|1|||
37771235|NCT02635386|69289355|FG003|Overall Study|side effects|4|||
37771236|NCT02635386|69289356|FG004|Overall Study|side effects|6|||
37771237|NCT02635386|69289352|FG000|Overall Study|needed other major surgery|0|||
37771238|NCT02635386|69289353|FG001|Overall Study|needed other major surgery|1|||
37771239|NCT02635386|69289354|FG002|Overall Study|needed other major surgery|0|||
37771240|NCT02635386|69289355|FG003|Overall Study|needed other major surgery|0|||
37771241|NCT02635386|69289356|FG004|Overall Study|needed other major surgery|0|||
37771242|NCT02635386|69289352|FG000|Overall Study|Other medical problems not drug related|0|||
37771243|NCT02635386|69289353|FG001|Overall Study|Other medical problems not drug related|0|||
37771244|NCT02635386|69289354|FG002|Overall Study|Other medical problems not drug related|0|||
37771245|NCT02635386|69289355|FG003|Overall Study|Other medical problems not drug related|1|||
37771246|NCT02635386|69289356|FG004|Overall Study|Other medical problems not drug related|0|||
37771247|NCT02634606|69289463|FG000|Overall Study|unable to obtain the drug at start|13|||
37771248|NCT01672866|69289509|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
37771249|NCT01672866|69289510|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
37771250|NCT01672866|69289511|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
37771251|NCT01672866|69289509|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
37771252|NCT01672866|69289510|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
37771253|NCT01672866|69289511|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
37771254|NCT01672866|69289509|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
37771255|NCT01672866|69289510|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
37771256|NCT01672866|69289511|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
37771257|NCT01672866|69289509|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
37771258|NCT01672866|69289510|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
37771259|NCT01672866|69289511|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
37771260|NCT01672866|69289509|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
37771261|NCT01672866|69289510|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
37771262|NCT01672866|69289511|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
37771263|NCT01672866|69289509|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
37771264|NCT01672866|69289510|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
37771265|NCT01672866|69289511|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
37771266|NCT01672866|69289509|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
37771267|NCT01672866|69289510|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
37771268|NCT01672866|69289511|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
37771269|NCT01672866|69289509|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
37771270|NCT01672866|69289510|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
37771271|NCT01672866|69289511|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
37771272|NCT01672866|69289509|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
37771273|NCT01672866|69289510|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
37771274|NCT01672866|69289511|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
37771275|NCT01672866|69289509|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
37771276|NCT01672866|69289510|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
38045112|NCT01956110|69732834|FG000|Overall Study|Adverse Event|9|||
37771277|NCT01672866|69289511|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
37771278|NCT01672866|69289509|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
37771279|NCT01672866|69289510|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
37771280|NCT01672866|69289511|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
37771281|NCT01672866|69289509|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
37771282|NCT01672866|69289510|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
37771283|NCT01672866|69289511|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
37771284|NCT01672866|69289509|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
37771285|NCT01672866|69289510|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
37771286|NCT01672866|69289511|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
37771287|NCT04465877|69289737|FG000|Overall Study|Noncompliant with study requirements|0|||
37771288|NCT04465877|69289738|FG001|Overall Study|Noncompliant with study requirements|0|||
37771289|NCT04465877|69289739|FG002|Overall Study|Noncompliant with study requirements|1|||
37771290|NCT04465877|69289740|FG003|Overall Study|Noncompliant with study requirements|0|||
37771291|NCT04267133|69289797|FG000|Overall Study|Withdrawal by Subject|1|||
37771292|NCT04267133|69289797|FG000|Overall Study|Adverse Event|4|||
37771293|NCT02631876|69289928|FG000|Overall Study|Death|96|||
37771294|NCT02631876|69289929|FG001|Overall Study|Death|50|||
37771295|NCT02631876|69289928|FG000|Overall Study|Investigator's discretion|1|||
37771296|NCT02631876|69289929|FG001|Overall Study|Investigator's discretion|0|||
37771297|NCT02631876|69289928|FG000|Overall Study|Lost to Follow-up|2|||
37771298|NCT02631876|69289929|FG001|Overall Study|Lost to Follow-up|0|||
37771299|NCT02631876|69289928|FG000|Overall Study|Withdrawal by Subject|16|||
37771300|NCT02631876|69289929|FG001|Overall Study|Withdrawal by Subject|9|||
37771301|NCT02631876|69289928|FG000|Overall Study|Other than specified|4|||
37771302|NCT02631876|69289929|FG001|Overall Study|Other than specified|4|||
37771303|NCT02633046|69289958|FG000|Overall Study|Adverse Event|8|||
37771304|NCT02633046|69289958|FG000|Overall Study|Physician Decision|7|||
37771305|NCT02633046|69289958|FG000|Overall Study|Withdrawal by Subject|8|||
37771306|NCT02633046|69289958|FG000|Overall Study|Increased proteinuria|2|||
37771307|NCT02633046|69289958|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
37771308|NCT02633046|69289958|FG000|Overall Study|Mutual decision patient and physician|1|||
37771309|NCT01672788|69290017|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
37771310|NCT01672788|69290018|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
37771311|NCT01672788|69290019|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
37771312|NCT01672788|69290020|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
37771313|NCT02632110|69290035|FG000|Overall Study|Withdrawal by Subject|1|||
37771314|NCT02632110|69290036|FG001|Overall Study|Withdrawal by Subject|1|||
37771315|NCT02632110|69290037|FG002|Overall Study|Withdrawal by Subject|0|||
37771316|NCT02632110|69290038|FG003|Overall Study|Withdrawal by Subject|0|||
37771317|NCT02632110|69290039|FG004|Overall Study|Withdrawal by Subject|1|||
37771318|NCT02632110|69290040|FG005|Overall Study|Withdrawal by Subject|1|||
37771319|NCT02632110|69290041|FG006|Overall Study|Withdrawal by Subject|3|||
37771320|NCT02632110|69290042|FG007|Overall Study|Withdrawal by Subject|3|||
37771321|NCT02632110|69290043|FG008|Overall Study|Withdrawal by Subject|1|||
37771322|NCT02632110|69290044|FG009|Overall Study|Withdrawal by Subject|1|||
37771323|NCT01672710|69290286|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
37771324|NCT01672710|69290287|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
37771325|NCT01672710|69290286|FG000|3 Month Follow up|Lost to Follow-up|2|||
37771326|NCT01672710|69290287|FG001|3 Month Follow up|Lost to Follow-up|3|||
37771327|NCT01672710|69290286|FG000|3 Month Follow up|follow up due after termination date|4|||
37771328|NCT01672710|69290287|FG001|3 Month Follow up|follow up due after termination date|1|||
37771329|NCT02630472|69290322|FG000|Overall Study|Physician Decision|10|||
37771330|NCT02630472|69290323|FG001|Overall Study|Physician Decision|0|||
37771331|NCT01670526|69290359|FG000|Overall Study|Withdrawal by Subject|3|||
37771332|NCT01670526|69290360|FG001|Overall Study|Withdrawal by Subject|1|||
37771333|NCT01670526|69290359|FG000|Overall Study|Lost to Follow-up|9|||
37771334|NCT01670526|69290360|FG001|Overall Study|Lost to Follow-up|5|||
37771335|NCT02630706|69290404|FG000|Overall Study|Adverse Event|2|||
37771336|NCT02630706|69290405|FG001|Overall Study|Adverse Event|1|||
37771337|NCT02630706|69290406|FG002|Overall Study|Adverse Event|1|||
37771338|NCT02630706|69290404|FG000|Overall Study|Lost to Follow-up|0|||
37771339|NCT02630706|69290405|FG001|Overall Study|Lost to Follow-up|1|||
37771340|NCT02630706|69290406|FG002|Overall Study|Lost to Follow-up|2|||
37771341|NCT02630706|69290404|FG000|Overall Study|Physician Decision|1|||
37771342|NCT02630706|69290405|FG001|Overall Study|Physician Decision|1|||
37771343|NCT02630706|69290406|FG002|Overall Study|Physician Decision|0|||
37771344|NCT02630706|69290404|FG000|Overall Study|Pregnancy|0|||
37771345|NCT02630706|69290405|FG001|Overall Study|Pregnancy|1|||
37771346|NCT02630706|69290406|FG002|Overall Study|Pregnancy|0|||
37861282|NCT01264718|69544692|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
37771347|NCT02630706|69290404|FG000|Overall Study|Withdrawal by Subject|4|||
37771348|NCT02630706|69290405|FG001|Overall Study|Withdrawal by Subject|5|||
37771349|NCT02630706|69290406|FG002|Overall Study|Withdrawal by Subject|7|||
37771350|NCT02089997|69290583|FG000|Overall Study|Case report forms uncollected|99|||
37771351|NCT02089997|69290583|FG000|Overall Study|Protocol Violation|147|||
37771352|NCT01363661|69290589|FG000|Overall Study|Adverse Event|9|||
37771353|NCT01363661|69290590|FG001|Overall Study|Adverse Event|2|||
37771354|NCT01363661|69290589|FG000|Overall Study|Withdrawal by Subject|1|||
37771355|NCT01363661|69290590|FG001|Overall Study|Withdrawal by Subject|1|||
37771356|NCT01363661|69290589|FG000|Overall Study|Protocol Violation|1|||
37771357|NCT01363661|69290590|FG001|Overall Study|Protocol Violation|0|||
37771358|NCT01363661|69290589|FG000|Overall Study|Lost to Follow-up|3|||
37771359|NCT01363661|69290590|FG001|Overall Study|Lost to Follow-up|1|||
37771360|NCT02628600|69290598|FG000|Overall Study|Death|2|||
37771361|NCT02628600|69290599|FG001|Overall Study|Death|1|||
37771362|NCT02628600|69290598|FG000|Overall Study|Adverse Event|3|||
37771363|NCT02628600|69290599|FG001|Overall Study|Adverse Event|20|||
37771364|NCT02628600|69290598|FG000|Overall Study|Protocol Violation|0|||
37771365|NCT02628600|69290599|FG001|Overall Study|Protocol Violation|1|||
37771366|NCT02628600|69290598|FG000|Overall Study|Lack of Efficacy|2|||
37771367|NCT02628600|69290599|FG001|Overall Study|Lack of Efficacy|0|||
37771368|NCT02628600|69290598|FG000|Overall Study|Withdrawal by Subject|13|||
37771369|NCT02628600|69290599|FG001|Overall Study|Withdrawal by Subject|8|||
37771370|NCT02628600|69290598|FG000|Overall Study|Lost to Follow-up|1|||
37771371|NCT02628600|69290599|FG001|Overall Study|Lost to Follow-up|0|||
37771372|NCT02628600|69290598|FG000|Overall Study|Physician Decision|2|||
37771373|NCT02628600|69290599|FG001|Overall Study|Physician Decision|2|||
37771374|NCT02628600|69290598|FG000|Overall Study|Other not specified|1|||
37771375|NCT02628600|69290599|FG001|Overall Study|Other not specified|0|||
37771376|NCT00591318|69290616|FG000|Overall Study|Lack of Efficacy|2|||
37771377|NCT00591318|69290617|FG001|Overall Study|Lack of Efficacy|0|||
37771378|NCT00591318|69290616|FG000|Overall Study|Adverse Event|2|||
37771379|NCT00591318|69290617|FG001|Overall Study|Adverse Event|0|||
37771380|NCT01360632|69290630|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
37771381|NCT01360632|69290631|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
37771382|NCT01360632|69290632|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
37771383|NCT01360632|69290633|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
37771384|NCT01360632|69290634|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
37771385|NCT01360632|69290630|FG000|Phase A (8 Weeks)|Adverse Event|60|||
37771386|NCT01360632|69290631|FG001|Phase A (8 Weeks)|Adverse Event|0|||
37771387|NCT01360632|69290632|FG002|Phase A (8 Weeks)|Adverse Event|0|||
37771388|NCT01360632|69290633|FG003|Phase A (8 Weeks)|Adverse Event|0|||
37771389|NCT01360632|69290634|FG004|Phase A (8 Weeks)|Adverse Event|0|||
37771390|NCT01360632|69290630|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
37771391|NCT01360632|69290631|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
37771392|NCT01360632|69290632|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
37771393|NCT01360632|69290633|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
37771394|NCT01360632|69290634|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
37771395|NCT01360632|69290630|FG000|Phase A (8 Weeks)|Physician Decision|10|||
37771396|NCT01360632|69290631|FG001|Phase A (8 Weeks)|Physician Decision|0|||
37771397|NCT01360632|69290632|FG002|Phase A (8 Weeks)|Physician Decision|0|||
37771398|NCT01360632|69290633|FG003|Phase A (8 Weeks)|Physician Decision|0|||
37771399|NCT01360632|69290634|FG004|Phase A (8 Weeks)|Physician Decision|0|||
37861283|NCT01264016|69544698|FG000|Overall Study|Withdrawal by Subject|1|||
37861284|NCT01264016|69544698|FG000|Overall Study|Felt faint at sight of blood|1|||
37861285|NCT01263782|69544707|FG000|Overall Study|Death|0|||
37861286|NCT01263782|69544708|FG001|Overall Study|Death|0|||
37861287|NCT01263782|69544709|FG002|Overall Study|Death|1|||
37861288|NCT01263782|69544710|FG003|Overall Study|Death|0|||
37861289|NCT01263782|69544707|FG000|Overall Study|Progressive disease|0|||
37861290|NCT01263782|69544708|FG001|Overall Study|Progressive disease|0|||
37861291|NCT01263782|69544709|FG002|Overall Study|Progressive disease|0|||
37861292|NCT01263782|69544710|FG003|Overall Study|Progressive disease|1|||
37861293|NCT01263782|69544707|FG000|Overall Study|Too early|0|||
37861294|NCT01263782|69544708|FG001|Overall Study|Too early|0|||
37861295|NCT01263782|69544709|FG002|Overall Study|Too early|1|||
37861296|NCT01263782|69544710|FG003|Overall Study|Too early|0|||
37861297|NCT01263782|69544707|FG000|Overall Study|Inevaluable|0|||
37861298|NCT01263782|69544708|FG001|Overall Study|Inevaluable|0|||
37861299|NCT01263782|69544709|FG002|Overall Study|Inevaluable|1|||
37861300|NCT01263782|69544710|FG003|Overall Study|Inevaluable|0|||
37861301|NCT01263704|69544720|FG000|Overall Study|Progressive disease|18|||
37861302|NCT01263704|69544720|FG000|Overall Study|Adverse Event|3|||
37771400|NCT01360632|69290630|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
37771401|NCT01360632|69290631|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
37771402|NCT01360632|69290632|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
37771403|NCT01360632|69290633|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
37771404|NCT01360632|69290634|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
37771405|NCT01360632|69290630|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
37771406|NCT01360632|69290631|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
37771407|NCT01360632|69290632|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
37861303|NCT01263704|69544720|FG000|Overall Study|Death|2|||
37861304|NCT01263704|69544720|FG000|Overall Study|Patient withdrew consent|2|||
37861305|NCT01263704|69544720|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
37861306|NCT01263704|69544720|FG000|Overall Study|Lost to Follow-up|1|||
37861307|NCT01263704|69544720|FG000|Overall Study|Colon metastases|1|||
37861308|NCT01263704|69544720|FG000|Overall Study|Principal Investigator (PI) decision|1|||
37861309|NCT01263470|69544730|FG000|Overall Study|Adverse Event|2|||
37861310|NCT01263470|69544731|FG001|Overall Study|Adverse Event|2|||
37861311|NCT01263470|69544732|FG002|Overall Study|Adverse Event|1|||
37861312|NCT01263470|69544733|FG003|Overall Study|Adverse Event|1|||
37861313|NCT01263470|69544734|FG004|Overall Study|Adverse Event|2|||
37861314|NCT01263470|69544735|FG005|Overall Study|Adverse Event|2|||
37861315|NCT01263470|69544730|FG000|Overall Study|Protocol Violation|0|||
37861316|NCT01263470|69544731|FG001|Overall Study|Protocol Violation|1|||
37861317|NCT01263470|69544732|FG002|Overall Study|Protocol Violation|0|||
37861318|NCT01263470|69544733|FG003|Overall Study|Protocol Violation|0|||
37861319|NCT01263470|69544734|FG004|Overall Study|Protocol Violation|0|||
37861320|NCT01263470|69544735|FG005|Overall Study|Protocol Violation|1|||
37861321|NCT01263470|69544730|FG000|Overall Study|Withdrawal by Subject|0|||
37861322|NCT01263470|69544731|FG001|Overall Study|Withdrawal by Subject|1|||
37861323|NCT01263470|69544732|FG002|Overall Study|Withdrawal by Subject|1|||
37861324|NCT01263470|69544733|FG003|Overall Study|Withdrawal by Subject|2|||
37861325|NCT01263470|69544734|FG004|Overall Study|Withdrawal by Subject|0|||
37861326|NCT01263470|69544735|FG005|Overall Study|Withdrawal by Subject|2|||
37861327|NCT01263470|69544730|FG000|Overall Study|Lack of Efficacy|0|||
37861328|NCT01263470|69544731|FG001|Overall Study|Lack of Efficacy|0|||
37861329|NCT01263470|69544732|FG002|Overall Study|Lack of Efficacy|2|||
37861330|NCT01263470|69544733|FG003|Overall Study|Lack of Efficacy|0|||
37861331|NCT01263470|69544734|FG004|Overall Study|Lack of Efficacy|0|||
37861332|NCT01263470|69544735|FG005|Overall Study|Lack of Efficacy|0|||
37861333|NCT01263470|69544730|FG000|Overall Study|Participant Unavailability|0|||
37861334|NCT01263470|69544731|FG001|Overall Study|Participant Unavailability|1|||
37861335|NCT01263470|69544732|FG002|Overall Study|Participant Unavailability|0|||
37861336|NCT01263470|69544733|FG003|Overall Study|Participant Unavailability|0|||
37861337|NCT01263470|69544734|FG004|Overall Study|Participant Unavailability|0|||
37861338|NCT01263470|69544735|FG005|Overall Study|Participant Unavailability|0|||
37861339|NCT01263470|69544730|FG000|Overall Study|Study Drug Non-compliance|0|||
37861340|NCT01263470|69544731|FG001|Overall Study|Study Drug Non-compliance|0|||
37861341|NCT01263470|69544732|FG002|Overall Study|Study Drug Non-compliance|0|||
37861342|NCT01263470|69544733|FG003|Overall Study|Study Drug Non-compliance|0|||
37861343|NCT01263470|69544734|FG004|Overall Study|Study Drug Non-compliance|1|||
37861344|NCT01263470|69544735|FG005|Overall Study|Study Drug Non-compliance|0|||
37861345|NCT01262456|69544752|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
37861346|NCT01262456|69544753|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
37861347|NCT01262456|69544754|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
37861348|NCT01262456|69544752|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
37861349|NCT01262456|69544753|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
37861350|NCT01262456|69544754|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
37861351|NCT01262456|69544752|FG000|3-Month Double-Blind Period|Adverse Event|6|||
37861352|NCT01262456|69544753|FG001|3-Month Double-Blind Period|Adverse Event|4|||
37861353|NCT01262456|69544754|FG002|3-Month Double-Blind Period|Adverse Event|8|||
37861354|NCT01262456|69544752|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
37861355|NCT01262456|69544753|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
37861356|NCT01262456|69544754|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
37861357|NCT01262456|69544752|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
37861358|NCT01262456|69544753|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
37861359|NCT01262456|69544754|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
37861360|NCT01262456|69544752|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
37861361|NCT01262456|69544753|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
37861362|NCT01262456|69544754|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
37861363|NCT01262456|69544752|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
37861364|NCT01262456|69544753|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
37861365|NCT01262456|69544754|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
37861366|NCT01262456|69544752|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
37861367|NCT01262456|69544753|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
37861368|NCT01262456|69544754|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
37861369|NCT01262456|69544752|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
37861370|NCT01262456|69544753|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
37861371|NCT01262456|69544754|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
37861372|NCT00932893|69544772|FG000|Overall Study|Death|115|||
37861373|NCT00932893|69544773|FG001|Overall Study|Death|24|||
37861374|NCT00932893|69544772|FG000|Overall Study|Lost to Follow-up|8|||
37861375|NCT00932893|69544773|FG001|Overall Study|Lost to Follow-up|0|||
37861376|NCT00932893|69544772|FG000|Overall Study|Withdrawal by Subject|5|||
37861377|NCT00932893|69544773|FG001|Overall Study|Withdrawal by Subject|2|||
37861378|NCT00932893|69544772|FG000|Overall Study|Other|5|||
37861379|NCT00932893|69544773|FG001|Overall Study|Other|144|||
37861380|NCT01260896|69544782|FG000|First Intervention|Withdrawn Due to Emesis|2|||
37861381|NCT01260896|69544783|FG001|First Intervention|Withdrawn Due to Emesis|0|||
37861382|NCT00932737|69544791|FG000|Overall Study|Not treated in second episode|1|||
37861383|NCT00932737|69544792|FG001|Overall Study|Not treated in second episode|0|||
37861384|NCT00932737|69544791|FG000|Overall Study|Adverse Event|0|||
37861385|NCT00932737|69544792|FG001|Overall Study|Adverse Event|1|||
37861386|NCT00939523|69544798|FG000|Overall Study|Lack of Efficacy|1|||
37861387|NCT00939523|69544798|FG000|Overall Study|Physician Decision|2|||
37861388|NCT01260584|69544806|FG000|Period 1|Protocol Violation|0|||
37861389|NCT01260584|69544807|FG001|Period 1|Protocol Violation|0|||
37861390|NCT01260584|69544808|FG002|Period 1|Protocol Violation|1|||
37861391|NCT01260584|69544809|FG003|Period 1|Protocol Violation|1|||
37861392|NCT01260584|69544806|FG000|Period 1|Adverse Event|0|||
37861393|NCT01260584|69544807|FG001|Period 1|Adverse Event|0|||
37861394|NCT01260584|69544808|FG002|Period 1|Adverse Event|1|||
37861395|NCT01260584|69544809|FG003|Period 1|Adverse Event|0|||
37861396|NCT01260584|69544806|FG000|Period 2|Protocol Violation|0|||
37861397|NCT01260584|69544807|FG001|Period 2|Protocol Violation|2|||
37861398|NCT01260584|69544808|FG002|Period 2|Protocol Violation|3|||
37861399|NCT01260584|69544809|FG003|Period 2|Protocol Violation|1|||
37861400|NCT01260584|69544806|FG000|Period 2|Adverse Event|1|||
37861401|NCT01260584|69544807|FG001|Period 2|Adverse Event|0|||
37861402|NCT01260584|69544808|FG002|Period 2|Adverse Event|2|||
37861403|NCT01260584|69544809|FG003|Period 2|Adverse Event|0|||
37861404|NCT01260584|69544806|FG000|Period 2|Withdrawal by Subject|0|||
37861405|NCT01260584|69544807|FG001|Period 2|Withdrawal by Subject|1|||
37861406|NCT01260584|69544808|FG002|Period 2|Withdrawal by Subject|0|||
37861407|NCT01260584|69544809|FG003|Period 2|Withdrawal by Subject|0|||
37861408|NCT00927589|69544819|FG000|Overall Study|Death|1|||
37861409|NCT00927589|69544819|FG000|Overall Study|Physician Decision|1|||
37861410|NCT00927589|69544819|FG000|Overall Study|Withdrawal by Subject|3|||
37861411|NCT00927589|69544819|FG000|Overall Study|Adverse Event|2|||
37861412|NCT00927589|69544819|FG000|Overall Study|Disease Progression|8|||
37861413|NCT00927589|69544819|FG000|Overall Study|Non-compliance|1|||
37861414|NCT00932425|69544825|FG000|Overall Study|Lost to Follow-up|0|||
37861415|NCT00932425|69544826|FG001|Overall Study|Lost to Follow-up|1|||
37861416|NCT00932425|69544825|FG000|Overall Study|Withdrawal by Subject|0|||
37861417|NCT00932425|69544826|FG001|Overall Study|Withdrawal by Subject|1|||
37861418|NCT05867342|69544832|FG000|Overall Study|Investigator Decision|3|||
37861419|NCT05867342|69544833|FG001|Overall Study|Investigator Decision|3|||
37861420|NCT04340362|69544868|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
37861421|NCT03980808|69544890|FG000|Overall Study|Lost to Follow-up|2|||
37861422|NCT03980808|69544891|FG001|Overall Study|Lost to Follow-up|2|||
37861423|NCT03943953|69544908|FG000|Trial of ITG 1|Lost to Follow-up|19|||
37861424|NCT03943953|69544909|FG001|Trial of ITG 1|Lost to Follow-up|1|||
37861425|NCT03943953|69544908|FG000|Trial of ITG 2|Lost to Follow-up|8|||
37861426|NCT03943953|69544909|FG001|Trial of ITG 2|Lost to Follow-up|0|||
37861427|NCT03943953|69544908|FG000|Trial of ITG 3|Lost to Follow-up|2|||
37861428|NCT03943953|69544909|FG001|Trial of ITG 3|Lost to Follow-up|0|||
37861429|NCT03943953|69544908|FG000|Trial of ITG 4|Lost to Follow-up|2|||
37861430|NCT03943953|69544909|FG001|Trial of ITG 4|Lost to Follow-up|0|||
37861431|NCT03670628|69544919|FG000|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|8|||
37861432|NCT03670628|69544920|FG001|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|3|||
37861433|NCT03670628|69544919|FG000|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|4|||
37861434|NCT03670628|69544920|FG001|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|6|||
37861435|NCT03637764|69544930|FG000|Overall Study|Adverse Event|2|||
37861436|NCT03637764|69544931|FG001|Overall Study|Adverse Event|0|||
37861437|NCT03637764|69544932|FG002|Overall Study|Adverse Event|0|||
37861438|NCT03637764|69544933|FG003|Overall Study|Adverse Event|1|||
37861439|NCT03637764|69544930|FG000|Overall Study|Progressive Disease|23|||
37861440|NCT03637764|69544931|FG001|Overall Study|Progressive Disease|23|||
37861441|NCT03637764|69544932|FG002|Overall Study|Progressive Disease|18|||
37861442|NCT03637764|69544933|FG003|Overall Study|Progressive Disease|31|||
37861443|NCT03637764|69544930|FG000|Overall Study|Withdrawal by Subject|1|||
37861444|NCT03637764|69544931|FG001|Overall Study|Withdrawal by Subject|3|||
37861445|NCT03637764|69544932|FG002|Overall Study|Withdrawal by Subject|0|||
37861446|NCT03637764|69544933|FG003|Overall Study|Withdrawal by Subject|1|||
37861447|NCT03483116|69544963|FG000|Overall Study|Adverse Event|0|||
37861448|NCT03483116|69544964|FG001|Overall Study|Adverse Event|1|||
37861449|NCT03483116|69544965|FG002|Overall Study|Adverse Event|0|||
37861450|NCT03483116|69544966|FG003|Overall Study|Adverse Event|1|||
37861451|NCT03483116|69544963|FG000|Overall Study|Protocol Violation|1|||
37861452|NCT03483116|69544964|FG001|Overall Study|Protocol Violation|0|||
37861453|NCT03483116|69544965|FG002|Overall Study|Protocol Violation|0|||
37861454|NCT03483116|69544966|FG003|Overall Study|Protocol Violation|7|||
37861455|NCT03483116|69544963|FG000|Overall Study|Lost to Follow-up|9|||
37861456|NCT03483116|69544964|FG001|Overall Study|Lost to Follow-up|4|||
37861457|NCT03483116|69544965|FG002|Overall Study|Lost to Follow-up|9|||
37861458|NCT03483116|69544966|FG003|Overall Study|Lost to Follow-up|5|||
37861459|NCT03483116|69544963|FG000|Overall Study|Death|1|||
37861460|NCT03483116|69544964|FG001|Overall Study|Death|0|||
37861461|NCT03483116|69544965|FG002|Overall Study|Death|2|||
37861462|NCT03483116|69544966|FG003|Overall Study|Death|1|||
37861463|NCT03483116|69544963|FG000|Overall Study|Withdrawal by Subject|14|||
37861464|NCT03483116|69544964|FG001|Overall Study|Withdrawal by Subject|16|||
37861465|NCT03483116|69544965|FG002|Overall Study|Withdrawal by Subject|14|||
37861466|NCT03483116|69544966|FG003|Overall Study|Withdrawal by Subject|16|||
37861467|NCT03483116|69544963|FG000|Overall Study|Unknown other reason|3|||
37861468|NCT03483116|69544964|FG001|Overall Study|Unknown other reason|2|||
37861469|NCT03483116|69544965|FG002|Overall Study|Unknown other reason|1|||
37861470|NCT03483116|69544966|FG003|Overall Study|Unknown other reason|1|||
37861471|NCT02811861|69544997|FG000|Overall Study|Radiological Disease Progression|123|||
37861472|NCT02811861|69544998|FG001|Overall Study|Radiological Disease Progression|97|||
37861473|NCT02811861|69544999|FG002|Overall Study|Radiological Disease Progression|174|||
37861474|NCT02811861|69544997|FG000|Overall Study|Clinical Disease Progression|20|||
37861475|NCT02811861|69544998|FG001|Overall Study|Clinical Disease Progression|19|||
37861476|NCT02811861|69544999|FG002|Overall Study|Clinical Disease Progression|22|||
37861477|NCT02811861|69544997|FG000|Overall Study|Adverse Event|63|||
37861478|NCT02811861|69544998|FG001|Overall Study|Adverse Event|60|||
37861479|NCT02811861|69544999|FG002|Overall Study|Adverse Event|41|||
37861480|NCT02811861|69544997|FG000|Overall Study|Lost to Follow-up|0|||
37861481|NCT02811861|69544998|FG001|Overall Study|Lost to Follow-up|0|||
37861482|NCT02811861|69544999|FG002|Overall Study|Lost to Follow-up|1|||
37861483|NCT02811861|69544997|FG000|Overall Study|Subject Choice|29|||
37861484|NCT02811861|69544998|FG001|Overall Study|Subject Choice|17|||
37861485|NCT02811861|69544999|FG002|Overall Study|Subject Choice|23|||
37861486|NCT02811861|69544997|FG000|Overall Study|Withdrawal by Subject|4|||
37861487|NCT02811861|69544998|FG001|Overall Study|Withdrawal by Subject|4|||
37861488|NCT02811861|69544999|FG002|Overall Study|Withdrawal by Subject|9|||
37861489|NCT02811861|69544997|FG000|Overall Study|Other|4|||
37861490|NCT02811861|69544998|FG001|Overall Study|Other|13|||
37861491|NCT02811861|69544999|FG002|Overall Study|Other|3|||
37861492|NCT02811861|69544997|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
37861493|NCT02811861|69544998|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
37861494|NCT02811861|69544999|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
37861495|NCT02811861|69544997|FG000|Overall Study|Randomized but not treated|2|||
37861496|NCT02811861|69544998|FG001|Overall Study|Randomized but not treated|3|||
37861497|NCT02811861|69544999|FG002|Overall Study|Randomized but not treated|17|||
37861498|NCT02700451|69545010|FG000|Overall Study|Protocol Violation|2|||
37861499|NCT02700451|69545011|FG001|Overall Study|Protocol Violation|2|||
37861500|NCT02700451|69545012|FG002|Overall Study|Protocol Violation|3|||
37861501|NCT02700451|69545010|FG000|Overall Study|Discontinued intervention|14|||
37861502|NCT02700451|69545011|FG001|Overall Study|Discontinued intervention|15|||
37861503|NCT02700451|69545012|FG002|Overall Study|Discontinued intervention|14|||
37861504|NCT02623426|69545023|FG000|Overall Study|Lost to Follow-up|0|||
37861505|NCT02623426|69545024|FG001|Overall Study|Lost to Follow-up|0|||
37861506|NCT02623426|69545025|FG002|Overall Study|Lost to Follow-up|1|||
37861507|NCT02623426|69545023|FG000|Overall Study|Withdrawal by Subject|1|||
37861508|NCT02623426|69545024|FG001|Overall Study|Withdrawal by Subject|2|||
37861509|NCT02623426|69545025|FG002|Overall Study|Withdrawal by Subject|2|||
37861510|NCT02580058|69545036|FG000|Overall Study|Adverse Event|16|||
37861511|NCT02580058|69545037|FG001|Overall Study|Adverse Event|30|||
37861512|NCT02580058|69545038|FG002|Overall Study|Adverse Event|20|||
37861513|NCT02580058|69545036|FG000|Overall Study|Death|4|||
37861514|NCT02580058|69545037|FG001|Overall Study|Death|4|||
37861515|NCT02580058|69545038|FG002|Overall Study|Death|5|||
37861516|NCT02580058|69545036|FG000|Overall Study|Physician Decision|1|||
37861517|NCT02580058|69545037|FG001|Overall Study|Physician Decision|3|||
37861518|NCT02580058|69545038|FG002|Overall Study|Physician Decision|11|||
37861519|NCT02580058|69545036|FG000|Overall Study|Other|5|||
37861520|NCT02580058|69545037|FG001|Overall Study|Other|1|||
37861521|NCT02580058|69545038|FG002|Overall Study|Other|3|||
37861522|NCT02580058|69545036|FG000|Overall Study|Withdrawal by Subject|4|||
37861523|NCT02580058|69545037|FG001|Overall Study|Withdrawal by Subject|7|||
37861524|NCT02580058|69545038|FG002|Overall Study|Withdrawal by Subject|31|||
37861525|NCT02580058|69545036|FG000|Overall Study|Global Deterioration of Health Status|19|||
37861526|NCT02580058|69545037|FG001|Overall Study|Global Deterioration of Health Status|18|||
37861527|NCT02580058|69545038|FG002|Overall Study|Global Deterioration of Health Status|24|||
37861528|NCT02580058|69545036|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
37861529|NCT02580058|69545037|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
37861530|NCT02580058|69545038|FG002|Overall Study|No Longer Meets Eligibility Criteria|2|||
37861531|NCT02580058|69545036|FG000|Overall Study|Progressive Disease|137|||
37861532|NCT02580058|69545037|FG001|Overall Study|Progressive Disease|125|||
37861533|NCT02580058|69545038|FG002|Overall Study|Progressive Disease|94|||
37861534|NCT02580058|69545036|FG000|Overall Study|Non-Compliance With Study Drug|1|||
37861535|NCT02580058|69545037|FG001|Overall Study|Non-Compliance With Study Drug|0|||
37861536|NCT02580058|69545038|FG002|Overall Study|Non-Compliance With Study Drug|0|||
37861537|NCT02539394|69545050|FG000|Overall Study|Protocol Violation|1|||
37861538|NCT02539394|69545051|FG001|Overall Study|Protocol Violation|3|||
37861539|NCT02539394|69545050|FG000|Overall Study|Lost to Follow-up|1|||
37861540|NCT02539394|69545051|FG001|Overall Study|Lost to Follow-up|2|||
37861541|NCT02539394|69545050|FG000|Overall Study|Incomplete dataset|6|||
37861542|NCT02539394|69545051|FG001|Overall Study|Incomplete dataset|6|||
37861543|NCT02412670|69545065|FG000|Overall Study|Adverse Event|4|||
37861544|NCT02412670|69545066|FG001|Overall Study|Adverse Event|1|||
37861545|NCT02412670|69545065|FG000|Overall Study|Physician Decision|1|||
37861546|NCT02412670|69545066|FG001|Overall Study|Physician Decision|0|||
37861547|NCT02412670|69545065|FG000|Overall Study|Withdrawal by Subject|1|||
37861548|NCT02412670|69545066|FG001|Overall Study|Withdrawal by Subject|0|||
37861549|NCT02412670|69545065|FG000|Overall Study|Ineligible|1|||
37861550|NCT02412670|69545066|FG001|Overall Study|Ineligible|0|||
37861551|NCT05111145|69545086|FG000|Overall Study|Commercial drug is available for participant|76|||
37861552|NCT05111145|69545086|FG000|Overall Study|Participant enrolled in another qualified Vertex study|10|||
37861553|NCT04823130|69545105|FG000|Overall Study|Withdrawal by Subject|2|||
37861554|NCT04823130|69545106|FG001|Overall Study|Withdrawal by Subject|3|||
37861555|NCT04823130|69545105|FG000|Overall Study|Failure to meet inclusion criteria|6|||
37861556|NCT04823130|69545106|FG001|Overall Study|Failure to meet inclusion criteria|4|||
37861557|NCT04823130|69545105|FG000|Overall Study|Other-unspecified|1|||
37861558|NCT04823130|69545106|FG001|Overall Study|Other-unspecified|0|||
37861559|NCT04402385|69545165|FG000|Overall Study|Withdrawal by Subject|4|||
37861560|NCT04402385|69545166|FG001|Overall Study|Withdrawal by Subject|4|||
37861561|NCT04402385|69545165|FG000|Overall Study|Lost to Follow-up|1|||
37861562|NCT04402385|69545166|FG001|Overall Study|Lost to Follow-up|1|||
37861563|NCT04402385|69545165|FG000|Overall Study|Physician Decision|0|||
37861564|NCT04402385|69545166|FG001|Overall Study|Physician Decision|1|||
37861565|NCT03785210|69545176|FG000|Overall Study|Principal investigator decision - clinical progression|1|||
37861566|NCT03785210|69545177|FG001|Overall Study|Principal investigator decision - clinical progression|6|||
37861567|NCT03750968|69545185|FG000|Overall Study|Adverse Event|2|||
37861568|NCT03750968|69545186|FG001|Overall Study|Adverse Event|0|||
37861569|NCT03750968|69545185|FG000|Overall Study|Lost to Follow-up|1|||
37861570|NCT03750968|69545186|FG001|Overall Study|Lost to Follow-up|3|||
37861571|NCT03690388|69545198|FG000|Overall Study|Adverse Event|8|||
37861572|NCT03690388|69545199|FG001|Overall Study|Adverse Event|1|||
37861573|NCT03690388|69545198|FG000|Overall Study|Radiographic Progression|14|||
37861574|NCT03690388|69545199|FG001|Overall Study|Radiographic Progression|29|||
37861575|NCT03690388|69545198|FG000|Overall Study|Clinical deterioration|10|||
37861576|NCT03690388|69545199|FG001|Overall Study|Clinical deterioration|6|||
37861577|NCT03690388|69545198|FG000|Overall Study|Withdrawal by Subject|2|||
37861578|NCT03690388|69545199|FG001|Overall Study|Withdrawal by Subject|0|||
37861579|NCT03690388|69545198|FG000|Overall Study|Lack of Efficacy|1|||
37861580|NCT03690388|69545199|FG001|Overall Study|Lack of Efficacy|0|||
37861581|NCT03690388|69545198|FG000|Overall Study|Lost to Follow-up|1|||
37861582|NCT03690388|69545199|FG001|Overall Study|Lost to Follow-up|0|||
37861583|NCT03619213|69545211|FG000|Overall Study|Lost to Follow-up|2|||
37861584|NCT03619213|69545212|FG001|Overall Study|Lost to Follow-up|1|||
37861585|NCT03619213|69545211|FG000|Overall Study|Withdrawal by Subject|8|||
37861586|NCT03619213|69545212|FG001|Overall Study|Withdrawal by Subject|10|||
37861587|NCT03342690|69545218|FG000|Overall Study|Missing Information|9|||
37861588|NCT03342690|69545218|FG000|Overall Study|Protocol Violation|16|||
37861589|NCT03257267|69545237|FG000|Overall Study|Adverse Event|9|||
37861590|NCT03257267|69545238|FG001|Overall Study|Adverse Event|7|||
37861591|NCT03257267|69545237|FG000|Overall Study|Death|92|||
37861592|NCT03257267|69545238|FG001|Overall Study|Death|95|||
37861593|NCT03257267|69545237|FG000|Overall Study|Lost to Follow-up|2|||
37861594|NCT03257267|69545238|FG001|Overall Study|Lost to Follow-up|2|||
37861595|NCT03257267|69545237|FG000|Overall Study|Non-compliance with Study Drug|0|||
37952722|NCT03791398|69639670|FG000|Overall Study|Progression of Disease Under Study|2|||
37952723|NCT03791398|69639671|FG001|Overall Study|Progression of Disease Under Study|0|||
37952724|NCT03791398|69639672|FG002|Overall Study|Progression of Disease Under Study|0|||
37861596|NCT03257267|69545238|FG001|Overall Study|Non-compliance with Study Drug|1|||
37861597|NCT03257267|69545237|FG000|Overall Study|Participant Decision|34|||
37861598|NCT03257267|69545238|FG001|Overall Study|Participant Decision|42|||
37861599|NCT03257267|69545237|FG000|Overall Study|Physician Decision|1|||
37861600|NCT03257267|69545238|FG001|Overall Study|Physician Decision|3|||
37861601|NCT03257267|69545237|FG000|Overall Study|Disease Progression|98|||
37861602|NCT03257267|69545238|FG001|Overall Study|Disease Progression|117|||
37861603|NCT03257267|69545237|FG000|Overall Study|Withdrawal of Consent|8|||
37861604|NCT03257267|69545238|FG001|Overall Study|Withdrawal of Consent|26|||
37861605|NCT03257267|69545237|FG000|Overall Study|Study Ongoing|53|||
37861606|NCT03257267|69545238|FG001|Overall Study|Study Ongoing|11|||
37861607|NCT02991456|69545255|FG000|Overall Study|Adverse Event|2|||
37861608|NCT02991456|69545256|FG001|Overall Study|Adverse Event|0|||
37861609|NCT02991456|69545255|FG000|Overall Study|Lost to Follow-up|0|||
37861610|NCT02991456|69545256|FG001|Overall Study|Lost to Follow-up|2|||
37861611|NCT02991456|69545255|FG000|Overall Study|Withdrawal by Subject|1|||
37861612|NCT02991456|69545256|FG001|Overall Study|Withdrawal by Subject|0|||
37861613|NCT02842827|69545273|FG000|Overall Study|Adverse Event|0|||
37861614|NCT02842827|69545274|FG001|Overall Study|Adverse Event|1|||
37861615|NCT02842827|69545275|FG002|Overall Study|Adverse Event|0|||
37861616|NCT02842827|69545276|FG003|Overall Study|Adverse Event|1|||
37861617|NCT02842827|69545277|FG004|Overall Study|Adverse Event|0|||
37861618|NCT02842827|69545278|FG005|Overall Study|Adverse Event|1|||
37861619|NCT02842827|69545279|FG006|Overall Study|Adverse Event|0|||
37861620|NCT02842827|69545280|FG007|Overall Study|Adverse Event|0|||
37861621|NCT02842827|69545273|FG000|Overall Study|Death|1|||
37861622|NCT02842827|69545274|FG001|Overall Study|Death|0|||
37861623|NCT02842827|69545275|FG002|Overall Study|Death|2|||
37861624|NCT02842827|69545276|FG003|Overall Study|Death|3|||
37861625|NCT02842827|69545277|FG004|Overall Study|Death|2|||
37861626|NCT02842827|69545278|FG005|Overall Study|Death|1|||
37861627|NCT02842827|69545279|FG006|Overall Study|Death|0|||
37861628|NCT02842827|69545280|FG007|Overall Study|Death|4|||
37861629|NCT02842827|69545273|FG000|Overall Study|Physician Decision|1|||
37861630|NCT02842827|69545274|FG001|Overall Study|Physician Decision|3|||
37861631|NCT02842827|69545275|FG002|Overall Study|Physician Decision|0|||
37861632|NCT02842827|69545276|FG003|Overall Study|Physician Decision|0|||
37861633|NCT02842827|69545277|FG004|Overall Study|Physician Decision|1|||
37861634|NCT02842827|69545278|FG005|Overall Study|Physician Decision|4|||
37861635|NCT02842827|69545279|FG006|Overall Study|Physician Decision|2|||
37861636|NCT02842827|69545280|FG007|Overall Study|Physician Decision|1|||
37861637|NCT02842827|69545273|FG000|Overall Study|Protocol Defined Disease Progression|0|||
37861638|NCT02842827|69545274|FG001|Overall Study|Protocol Defined Disease Progression|0|||
37861639|NCT02842827|69545275|FG002|Overall Study|Protocol Defined Disease Progression|0|||
37861640|NCT02842827|69545276|FG003|Overall Study|Protocol Defined Disease Progression|0|||
37861641|NCT02842827|69545277|FG004|Overall Study|Protocol Defined Disease Progression|0|||
37861642|NCT02842827|69545278|FG005|Overall Study|Protocol Defined Disease Progression|1|||
37861643|NCT02842827|69545279|FG006|Overall Study|Protocol Defined Disease Progression|0|||
37861644|NCT02842827|69545280|FG007|Overall Study|Protocol Defined Disease Progression|0|||
37861645|NCT02842827|69545273|FG000|Overall Study|Participant Withdrawal of Consent|1|||
37861646|NCT02842827|69545274|FG001|Overall Study|Participant Withdrawal of Consent|2|||
37861647|NCT02842827|69545275|FG002|Overall Study|Participant Withdrawal of Consent|2|||
37861648|NCT02842827|69545276|FG003|Overall Study|Participant Withdrawal of Consent|2|||
37861649|NCT02842827|69545277|FG004|Overall Study|Participant Withdrawal of Consent|2|||
37861650|NCT02842827|69545278|FG005|Overall Study|Participant Withdrawal of Consent|1|||
37861651|NCT02842827|69545279|FG006|Overall Study|Participant Withdrawal of Consent|2|||
37861652|NCT02842827|69545280|FG007|Overall Study|Participant Withdrawal of Consent|1|||
37861653|NCT02432274|69545306|FG000|Overall Study|Death|2|||
37861654|NCT02432274|69545307|FG001|Overall Study|Death|6|||
37861655|NCT02432274|69545308|FG002|Overall Study|Death|7|||
37861656|NCT02432274|69545309|FG003|Overall Study|Death|0|||
37861657|NCT02432274|69545310|FG004|Overall Study|Death|27|||
37861658|NCT02432274|69545311|FG005|Overall Study|Death|7|||
37861659|NCT02432274|69545312|FG006|Overall Study|Death|9|||
37861660|NCT02432274|69545313|FG007|Overall Study|Death|14|||
37861661|NCT02432274|69545306|FG000|Overall Study|Withdrawal of Consent|0|||
37861662|NCT02432274|69545307|FG001|Overall Study|Withdrawal of Consent|0|||
37861663|NCT02432274|69545308|FG002|Overall Study|Withdrawal of Consent|0|||
37861664|NCT02432274|69545309|FG003|Overall Study|Withdrawal of Consent|0|||
37861665|NCT02432274|69545310|FG004|Overall Study|Withdrawal of Consent|2|||
37861666|NCT02432274|69545311|FG005|Overall Study|Withdrawal of Consent|0|||
37861667|NCT02432274|69545312|FG006|Overall Study|Withdrawal of Consent|1|||
37861668|NCT02432274|69545313|FG007|Overall Study|Withdrawal of Consent|2|||
37861669|NCT02393859|69545349|FG000|Overall Study|Decision by Sponsor|2|||
37861670|NCT02393859|69545350|FG001|Overall Study|Decision by Sponsor|4|||
37861671|NCT02393859|69545349|FG000|Overall Study|Withdrawal by Subject|11|||
37861672|NCT02393859|69545350|FG001|Overall Study|Withdrawal by Subject|6|||
37861673|NCT02393859|69545349|FG000|Overall Study|Death|27|||
37861674|NCT02393859|69545350|FG001|Overall Study|Death|10|||
37861675|NCT02393859|69545349|FG000|Overall Study|Lost to Follow-up|1|||
37861676|NCT02393859|69545350|FG001|Overall Study|Lost to Follow-up|1|||
37861677|NCT02096588|69545359|FG000|Overall Study|Lack of Efficacy|2|||
37861678|NCT02096588|69545360|FG001|Overall Study|Lack of Efficacy|0|||
37861679|NCT02096588|69545359|FG000|Overall Study|Withdrawal by Subject|0|||
37861680|NCT02096588|69545360|FG001|Overall Study|Withdrawal by Subject|1|||
37861681|NCT01359592|69545366|FG000|Initial Registration|Adverse Event|1|||
37861682|NCT01359592|69545367|FG001|Initial Registration|Adverse Event|0|||
37861683|NCT01359592|69545368|FG002|Initial Registration|Adverse Event|0|||
37861684|NCT01359592|69545369|FG003|Initial Registration|Adverse Event|0|||
37861685|NCT01359592|69545366|FG000|Initial Registration|Death|1|||
37861686|NCT01359592|69545367|FG001|Initial Registration|Death|0|||
37861687|NCT01359592|69545368|FG002|Initial Registration|Death|0|||
37861688|NCT01359592|69545369|FG003|Initial Registration|Death|0|||
37861689|NCT01359592|69545366|FG000|Initial Registration|Other reason not protocol specified|1|||
37861690|NCT01359592|69545367|FG001|Initial Registration|Other reason not protocol specified|0|||
37861691|NCT01359592|69545368|FG002|Initial Registration|Other reason not protocol specified|0|||
37861692|NCT01359592|69545369|FG003|Initial Registration|Other reason not protocol specified|0|||
37861693|NCT01359592|69545366|FG000|Initial Registration|Ineligible|26|||
37861694|NCT01359592|69545367|FG001|Initial Registration|Ineligible|0|||
37861695|NCT01359592|69545368|FG002|Initial Registration|Ineligible|0|||
37861696|NCT01359592|69545369|FG003|Initial Registration|Ineligible|0|||
37861697|NCT01359592|69545366|FG000|PET-Directed Therapy|Adverse Event|0|||
37861698|NCT01359592|69545367|FG001|PET-Directed Therapy|Adverse Event|0|||
37861699|NCT01359592|69545368|FG002|PET-Directed Therapy|Adverse Event|1|||
37861700|NCT01359592|69545369|FG003|PET-Directed Therapy|Adverse Event|0|||
37861701|NCT01359592|69545366|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
37861702|NCT01359592|69545367|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
37861703|NCT01359592|69545368|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
37861704|NCT01359592|69545369|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
37861705|NCT01359592|69545366|FG000|PET-Directed Therapy|Ineligible|0|||
37861706|NCT01359592|69545367|FG001|PET-Directed Therapy|Ineligible|0|||
37861707|NCT01359592|69545368|FG002|PET-Directed Therapy|Ineligible|24|||
37861708|NCT01359592|69545369|FG003|PET-Directed Therapy|Ineligible|0|||
37861709|NCT00699816|69545386|FG000|Overall Study|Protocol Violation|1|||
37861710|NCT00699816|69545387|FG001|Overall Study|Protocol Violation|3|||
37861711|NCT00697073|69545393|FG000|Overall Study|Withdrawal by Subject|2|||
37861712|NCT00697073|69545393|FG000|Overall Study|Pregnancy|1|||
37861713|NCT00697073|69545393|FG000|Overall Study|non compliance and other|6|||
37861714|NCT00653432|69545399|FG000|Overall Study|Adverse Event|4|||
37861715|NCT00653432|69545400|FG001|Overall Study|Adverse Event|1|||
37952725|NCT00517192|69639678|FG000|Overall Study|Adverse Event|1|||
37952726|NCT00517192|69639679|FG001|Overall Study|Adverse Event|1|||
37952727|NCT00517192|69639678|FG000|Overall Study|Lost to Follow-up|1|||
37952728|NCT00517192|69639679|FG001|Overall Study|Lost to Follow-up|1|||
37952729|NCT00517192|69639678|FG000|Overall Study|Withdrawal by Subject|1|||
37952730|NCT00517192|69639679|FG001|Overall Study|Withdrawal by Subject|0|||
37952731|NCT00517192|69639678|FG000|Overall Study|Early termination of the trial|16|||
37952732|NCT00517192|69639679|FG001|Overall Study|Early termination of the trial|18|||
37952733|NCT00625820|69639685|FG000|Overall Study|Withdrawal by Subject|1|||
37952734|NCT00145327|69639693|FG000|Overall Study|Withdrawal by Subject|77|||
37952735|NCT00145327|69639694|FG001|Overall Study|Withdrawal by Subject|72|||
37952736|NCT00145327|69639695|FG002|Overall Study|Withdrawal by Subject|164|||
37952737|NCT00145327|69639693|FG000|Overall Study|Death|26|||
37952738|NCT00145327|69639694|FG001|Overall Study|Death|18|||
37952739|NCT00145327|69639695|FG002|Overall Study|Death|30|||
37952740|NCT00145327|69639693|FG000|Overall Study|Adverse Event|14|||
37952741|NCT00145327|69639694|FG001|Overall Study|Adverse Event|11|||
37952742|NCT00145327|69639695|FG002|Overall Study|Adverse Event|22|||
37952743|NCT00145327|69639693|FG000|Overall Study|Lost to Follow-up|9|||
37952744|NCT00145327|69639694|FG001|Overall Study|Lost to Follow-up|14|||
37952745|NCT00145327|69639695|FG002|Overall Study|Lost to Follow-up|14|||
37952746|NCT00145327|69639693|FG000|Overall Study|Administrative problems|12|||
37952747|NCT00145327|69639694|FG001|Overall Study|Administrative problems|9|||
37952748|NCT00145327|69639695|FG002|Overall Study|Administrative problems|13|||
37952749|NCT00145327|69639693|FG000|Overall Study|Protocol Violation|2|||
37952750|NCT00145327|69639694|FG001|Overall Study|Protocol Violation|0|||
37952751|NCT00145327|69639695|FG002|Overall Study|Protocol Violation|2|||
37952752|NCT00145327|69639693|FG000|Overall Study|Abnormal laboratory value(s)|1|||
37952753|NCT00145327|69639694|FG001|Overall Study|Abnormal laboratory value(s)|0|||
37952754|NCT00145327|69639695|FG002|Overall Study|Abnormal laboratory value(s)|2|||
37952755|NCT00145327|69639693|FG000|Overall Study|Missing - not stated|1|||
37952756|NCT00145327|69639694|FG001|Overall Study|Missing - not stated|0|||
37861716|NCT00653432|69545399|FG000|Overall Study|Withdrawal by Subject|4|||
37861717|NCT00653432|69545400|FG001|Overall Study|Withdrawal by Subject|5|||
37952757|NCT00145327|69639695|FG002|Overall Study|Missing - not stated|1|||
37952758|NCT00510484|69639705|FG000|Wash-out Period|Adverse Event|0|||
37952759|NCT00510484|69639706|FG001|Wash-out Period|Adverse Event|1|||
37952760|NCT00622388|69639712|FG000|Overall Study|Disease Progression|47|||
37952761|NCT00622388|69639712|FG000|Overall Study|Adverse Event|6|||
37952762|NCT00622388|69639712|FG000|Overall Study|Protocol Violation|3|||
37952763|NCT00622388|69639712|FG000|Overall Study|Participant Refusal|1|||
37952764|NCT00622388|69639712|FG000|Overall Study|Death|3|||
37952765|NCT00622388|69639712|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
37952766|NCT00622388|69639712|FG000|Overall Study|Took Prohibited Medication|2|||
37952767|NCT00622388|69639712|FG000|Overall Study|Withdrew Consent|1|||
37952768|NCT00622388|69639712|FG000|Overall Study|Insurance Expired|1|||
37952769|NCT01156389|69639719|FG000|Overall Study|Elevated liver enzymes|4|||
37952770|NCT01156389|69639720|FG001|Overall Study|Elevated liver enzymes|0|||
37952771|NCT01156389|69639719|FG000|Overall Study|Vomiting|0|||
37952772|NCT01156389|69639720|FG001|Overall Study|Vomiting|1|||
37952773|NCT01105767|69639729|FG000|Overall Study|Lost to Follow-up|1160|||
37952774|NCT01105767|69639730|FG001|Overall Study|Lost to Follow-up|1614|||
37952775|NCT01105767|69639731|FG002|Overall Study|Lost to Follow-up|1184|||
37952776|NCT03693430|69639741|FG000|Overall Study|Lost to Follow-up|3|||
37952777|NCT03693430|69639742|FG001|Overall Study|Lost to Follow-up|14|||
37952778|NCT03693430|69639741|FG000|Overall Study|Death|1|||
37952779|NCT03693430|69639742|FG001|Overall Study|Death|0|||
37952780|NCT03693430|69639741|FG000|Overall Study|Withdrawal by Subject|0|||
37952781|NCT03693430|69639742|FG001|Overall Study|Withdrawal by Subject|4|||
37952782|NCT00625742|69639748|FG000|Overall Study|Disease Progression|2|||
37952783|NCT00625742|69639748|FG000|Overall Study|Withdrawal by Subject|1|||
37952784|NCT00625742|69639748|FG000|Overall Study|Adverse Event|4|||
37952785|NCT00625742|69639748|FG000|Overall Study|Lost to Follow-up|4|||
37952786|NCT00625742|69639748|FG000|Overall Study|Ineligible|1|||
37952787|NCT00621296|69639761|FG000|Overall Study|Adverse Event|2|||
37952788|NCT00621296|69639761|FG000|Overall Study|Lack of Efficacy|1|||
37952789|NCT00621296|69639761|FG000|Overall Study|Physician Decision|7|||
37952790|NCT00621296|69639761|FG000|Overall Study|Unmatch Criteria|1|||
37952791|NCT00621296|69639761|FG000|Overall Study|Stopping Criteria|3|||
37952792|NCT00537303|69639767|FG000|Overall Study|Adverse Event|1|||
37952793|NCT00537303|69639768|FG001|Overall Study|Adverse Event|4|||
37952794|NCT00537303|69639767|FG000|Overall Study|Lack of Efficacy|6|||
37952795|NCT00537303|69639768|FG001|Overall Study|Lack of Efficacy|7|||
37952796|NCT00537303|69639767|FG000|Overall Study|Protocol Violation|8|||
37952797|NCT00537303|69639768|FG001|Overall Study|Protocol Violation|4|||
37952798|NCT00537303|69639767|FG000|Overall Study|Withdrawal criteria|3|||
37952799|NCT00537303|69639768|FG001|Overall Study|Withdrawal criteria|3|||
37952800|NCT00537303|69639767|FG000|Overall Study|Unclassified|8|||
37952801|NCT00537303|69639768|FG001|Overall Study|Unclassified|7|||
37952802|NCT00505414|69639776|FG000|Titration Phase|Adverse Event|0|||
37952803|NCT00505414|69639777|FG001|Titration Phase|Adverse Event|0|||
37952804|NCT00505414|69639778|FG002|Titration Phase|Adverse Event|0|||
37952805|NCT00505414|69639779|FG003|Titration Phase|Adverse Event|8|||
37952806|NCT00505414|69639780|FG004|Titration Phase|Adverse Event|3|||
37952807|NCT00505414|69639776|FG000|Titration Phase|Death|0|||
37952808|NCT00505414|69639777|FG001|Titration Phase|Death|0|||
37952809|NCT00505414|69639778|FG002|Titration Phase|Death|0|||
37952810|NCT00505414|69639779|FG003|Titration Phase|Death|2|||
37952811|NCT00505414|69639780|FG004|Titration Phase|Death|0|||
37952812|NCT00505414|69639776|FG000|Titration Phase|Lack of Efficacy|0|||
37952813|NCT00505414|69639777|FG001|Titration Phase|Lack of Efficacy|0|||
37952814|NCT00505414|69639778|FG002|Titration Phase|Lack of Efficacy|0|||
37952815|NCT00505414|69639779|FG003|Titration Phase|Lack of Efficacy|10|||
37952816|NCT00505414|69639780|FG004|Titration Phase|Lack of Efficacy|1|||
37952817|NCT00505414|69639776|FG000|Titration Phase|Protocol Violation|0|||
37952818|NCT00505414|69639777|FG001|Titration Phase|Protocol Violation|0|||
37952819|NCT00505414|69639778|FG002|Titration Phase|Protocol Violation|0|||
37952820|NCT00505414|69639779|FG003|Titration Phase|Protocol Violation|0|||
37952821|NCT00505414|69639780|FG004|Titration Phase|Protocol Violation|1|||
37952822|NCT00505414|69639776|FG000|Titration Phase|Withdrawal by Subject|0|||
37952823|NCT00505414|69639777|FG001|Titration Phase|Withdrawal by Subject|0|||
37952824|NCT00505414|69639778|FG002|Titration Phase|Withdrawal by Subject|0|||
37952825|NCT00505414|69639779|FG003|Titration Phase|Withdrawal by Subject|3|||
37952826|NCT00505414|69639780|FG004|Titration Phase|Withdrawal by Subject|4|||
37952827|NCT00505414|69639776|FG000|Titration Phase|Underlying disease and therapy required|0|||
37952828|NCT00505414|69639777|FG001|Titration Phase|Underlying disease and therapy required|0|||
37952829|NCT00505414|69639778|FG002|Titration Phase|Underlying disease and therapy required|0|||
37952830|NCT00505414|69639779|FG003|Titration Phase|Underlying disease and therapy required|7|||
37952831|NCT00505414|69639780|FG004|Titration Phase|Underlying disease and therapy required|3|||
37952832|NCT00505414|69639776|FG000|Maintenance Phase|Adverse Event|2|||
37952833|NCT00505414|69639777|FG001|Maintenance Phase|Adverse Event|2|||
37952834|NCT00505414|69639778|FG002|Maintenance Phase|Adverse Event|3|||
37952835|NCT00505414|69639779|FG003|Maintenance Phase|Adverse Event|0|||
37952836|NCT00505414|69639780|FG004|Maintenance Phase|Adverse Event|0|||
37952837|NCT00505414|69639776|FG000|Maintenance Phase|Death|2|||
37952838|NCT00505414|69639777|FG001|Maintenance Phase|Death|0|||
37952839|NCT00505414|69639778|FG002|Maintenance Phase|Death|1|||
37952840|NCT00505414|69639779|FG003|Maintenance Phase|Death|0|||
37952841|NCT00505414|69639780|FG004|Maintenance Phase|Death|0|||
37952842|NCT00505414|69639776|FG000|Maintenance Phase|Lack of Efficacy|2|||
37952843|NCT00505414|69639777|FG001|Maintenance Phase|Lack of Efficacy|1|||
37952844|NCT00505414|69639778|FG002|Maintenance Phase|Lack of Efficacy|1|||
37952845|NCT00505414|69639779|FG003|Maintenance Phase|Lack of Efficacy|0|||
37952846|NCT00505414|69639780|FG004|Maintenance Phase|Lack of Efficacy|0|||
37952847|NCT00505414|69639776|FG000|Maintenance Phase|Withdrawal by Subject|0|||
37952848|NCT00505414|69639777|FG001|Maintenance Phase|Withdrawal by Subject|0|||
37952849|NCT00505414|69639778|FG002|Maintenance Phase|Withdrawal by Subject|1|||
37952850|NCT00505414|69639779|FG003|Maintenance Phase|Withdrawal by Subject|0|||
37952851|NCT00505414|69639780|FG004|Maintenance Phase|Withdrawal by Subject|0|||
37952852|NCT00505414|69639776|FG000|Maintenance Phase|underlying disease and therapy required|0|||
37952853|NCT00505414|69639777|FG001|Maintenance Phase|underlying disease and therapy required|2|||
37952854|NCT00505414|69639778|FG002|Maintenance Phase|underlying disease and therapy required|2|||
37952855|NCT00505414|69639779|FG003|Maintenance Phase|underlying disease and therapy required|0|||
37952856|NCT00505414|69639780|FG004|Maintenance Phase|underlying disease and therapy required|0|||
37952857|NCT00144781|69639814|FG000|Overall Study|Adverse Event|0|||
37952858|NCT00144781|69639815|FG001|Overall Study|Adverse Event|1|||
37952859|NCT00144781|69639816|FG002|Overall Study|Adverse Event|0|||
37952860|NCT00144781|69639817|FG003|Overall Study|Adverse Event|0|||
37952861|NCT00144781|69639814|FG000|Overall Study|Non-compliant|0|||
37952862|NCT00144781|69639815|FG001|Overall Study|Non-compliant|1|||
37952863|NCT00144781|69639816|FG002|Overall Study|Non-compliant|0|||
37952864|NCT00144781|69639817|FG003|Overall Study|Non-compliant|0|||
37952865|NCT00621140|69639833|FG000|Overall Study|Adverse Event|4|||
37952866|NCT00621140|69639834|FG001|Overall Study|Adverse Event|5|||
37952867|NCT00621140|69639833|FG000|Overall Study|Lost to Follow-up|1|||
37952868|NCT00621140|69639834|FG001|Overall Study|Lost to Follow-up|2|||
37952869|NCT00621140|69639833|FG000|Overall Study|Withdrawal by Subject|4|||
37952870|NCT00621140|69639834|FG001|Overall Study|Withdrawal by Subject|6|||
37952871|NCT00621140|69639833|FG000|Overall Study|Other incl. lack of efficacy|6|||
37952872|NCT00621140|69639834|FG001|Overall Study|Other incl. lack of efficacy|5|||
37952873|NCT00207727|69639845|FG000|Overall Study|Withdrawal by Subject|0|||
37952874|NCT00207727|69639846|FG001|Overall Study|Withdrawal by Subject|0|||
37952875|NCT00207727|69639847|FG002|Overall Study|Withdrawal by Subject|0|||
37952876|NCT00207727|69639848|FG003|Overall Study|Withdrawal by Subject|0|||
37952877|NCT00207727|69639849|FG004|Overall Study|Withdrawal by Subject|1|||
37952878|NCT00207727|69639845|FG000|Overall Study|Lost to Follow-up|0|||
37952879|NCT00207727|69639846|FG001|Overall Study|Lost to Follow-up|1|||
37952880|NCT00207727|69639847|FG002|Overall Study|Lost to Follow-up|0|||
37952881|NCT00207727|69639848|FG003|Overall Study|Lost to Follow-up|0|||
37952882|NCT00207727|69639849|FG004|Overall Study|Lost to Follow-up|0|||
37952883|NCT00207727|69639845|FG000|Overall Study|Other|38|||
37952884|NCT00207727|69639846|FG001|Overall Study|Other|41|||
37952885|NCT00207727|69639847|FG002|Overall Study|Other|41|||
37952886|NCT00207727|69639848|FG003|Overall Study|Other|37|||
37952887|NCT00207727|69639849|FG004|Overall Study|Other|33|||
37952888|NCT00504556|69639866|FG000|Overall Study|Adverse Event|11|||
37952889|NCT00504556|69639867|FG001|Overall Study|Adverse Event|11|||
37952890|NCT00504556|69639868|FG002|Overall Study|Adverse Event|14|||
37952891|NCT00504556|69639869|FG003|Overall Study|Adverse Event|13|||
37952892|NCT00504556|69639870|FG004|Overall Study|Adverse Event|5|||
37952893|NCT00504556|69639866|FG000|Overall Study|Death|3|||
37952894|NCT00504556|69639867|FG001|Overall Study|Death|3|||
37952895|NCT00504556|69639868|FG002|Overall Study|Death|1|||
37952896|NCT00504556|69639869|FG003|Overall Study|Death|0|||
37952897|NCT00504556|69639870|FG004|Overall Study|Death|2|||
37952898|NCT00504556|69639866|FG000|Overall Study|Protocol Violation|1|||
37952899|NCT00504556|69639867|FG001|Overall Study|Protocol Violation|3|||
37952900|NCT00504556|69639868|FG002|Overall Study|Protocol Violation|2|||
37952901|NCT00504556|69639869|FG003|Overall Study|Protocol Violation|1|||
37952902|NCT00504556|69639870|FG004|Overall Study|Protocol Violation|2|||
37952903|NCT00504556|69639866|FG000|Overall Study|Lost to Follow-up|0|||
37952904|NCT00504556|69639867|FG001|Overall Study|Lost to Follow-up|0|||
37952905|NCT00504556|69639868|FG002|Overall Study|Lost to Follow-up|1|||
37952906|NCT00504556|69639869|FG003|Overall Study|Lost to Follow-up|1|||
37952907|NCT00504556|69639870|FG004|Overall Study|Lost to Follow-up|1|||
37952908|NCT00504556|69639866|FG000|Overall Study|Withdrawal by Subject|16|||
37952909|NCT00504556|69639867|FG001|Overall Study|Withdrawal by Subject|16|||
37952910|NCT00504556|69639868|FG002|Overall Study|Withdrawal by Subject|7|||
37952911|NCT00504556|69639869|FG003|Overall Study|Withdrawal by Subject|8|||
37952912|NCT00504556|69639870|FG004|Overall Study|Withdrawal by Subject|12|||
37952913|NCT00504556|69639866|FG000|Overall Study|administrative reasons|0|||
37952914|NCT00504556|69639867|FG001|Overall Study|administrative reasons|2|||
37952915|NCT00504556|69639868|FG002|Overall Study|administrative reasons|2|||
37952916|NCT00504556|69639869|FG003|Overall Study|administrative reasons|1|||
37952917|NCT00504556|69639870|FG004|Overall Study|administrative reasons|2|||
37952918|NCT00504556|69639866|FG000|Overall Study|did not meet entry criteria|2|||
37952919|NCT00504556|69639867|FG001|Overall Study|did not meet entry criteria|0|||
37952920|NCT00504556|69639868|FG002|Overall Study|did not meet entry criteria|1|||
37952921|NCT00504556|69639869|FG003|Overall Study|did not meet entry criteria|1|||
37952922|NCT00504556|69639870|FG004|Overall Study|did not meet entry criteria|0|||
37952923|NCT00504556|69639866|FG000|Overall Study|data monitor committee decision|0|||
37952924|NCT00504556|69639867|FG001|Overall Study|data monitor committee decision|0|||
37952925|NCT00504556|69639868|FG002|Overall Study|data monitor committee decision|0|||
37952926|NCT00504556|69639869|FG003|Overall Study|data monitor committee decision|100|||
37952927|NCT00504556|69639870|FG004|Overall Study|data monitor committee decision|0|||
37952928|NCT00504556|69639866|FG000|Overall Study|Other|2|||
37952929|NCT00504556|69639867|FG001|Overall Study|Other|2|||
37952930|NCT00504556|69639868|FG002|Overall Study|Other|2|||
37952931|NCT00504556|69639869|FG003|Overall Study|Other|3|||
37952932|NCT00504556|69639870|FG004|Overall Study|Other|0|||
37952933|NCT00504556|69639866|FG000|Overall Study|not in safety analysis set|0|||
37952934|NCT00504556|69639867|FG001|Overall Study|not in safety analysis set|1|||
37952935|NCT00504556|69639868|FG002|Overall Study|not in safety analysis set|1|||
37952936|NCT00504556|69639869|FG003|Overall Study|not in safety analysis set|0|||
37952937|NCT00504556|69639870|FG004|Overall Study|not in safety analysis set|1|||
37952938|NCT00206323|69639884|FG000|Overall Study|Lack of Efficacy|4|||
37952939|NCT00206323|69639885|FG001|Overall Study|Lack of Efficacy|1|||
37952940|NCT00206323|69639884|FG000|Overall Study|Adverse Event|1|||
37952941|NCT00206323|69639885|FG001|Overall Study|Adverse Event|1|||
37952942|NCT00206323|69639884|FG000|Overall Study|Lost to Follow-up|1|||
37952943|NCT00206323|69639885|FG001|Overall Study|Lost to Follow-up|1|||
37952944|NCT03903159|69639891|FG000|Overall Study|Discharged with Staff Approval|2|||
37952945|NCT03903159|69639891|FG000|Overall Study|Discharged at Staff Request|2|||
37952946|NCT03903159|69639891|FG000|Overall Study|Discharged Against Staff Advice|1|||
37952947|NCT00205855|69639895|FG000|Overall Study|Only received temporary implants|16|||
37952948|NCT00205855|69639895|FG000|Overall Study|Withdrawal by Subject|5|||
37952949|NCT00536991|69639899|FG000|Overall Study|Withdrawal by Subject|10|||
37952950|NCT00536991|69639899|FG000|Overall Study|Physician Decision|1|||
37952951|NCT00536991|69639899|FG000|Overall Study|patient ineligible|2|||
37952952|NCT00504166|69639906|FG000|Overall Study|Adverse Event|1|||
37952953|NCT00504166|69639907|FG001|Overall Study|Adverse Event|4|||
37952954|NCT00504166|69639906|FG000|Overall Study|Withdrawal by Subject|3|||
37952955|NCT00504166|69639907|FG001|Overall Study|Withdrawal by Subject|6|||
37952956|NCT00504166|69639906|FG000|Overall Study|Physician Decision|1|||
37952957|NCT00504166|69639907|FG001|Overall Study|Physician Decision|1|||
37952958|NCT00504166|69639906|FG000|Overall Study|Lost to Follow-up|1|||
37952959|NCT00504166|69639907|FG001|Overall Study|Lost to Follow-up|3|||
37952960|NCT00509236|69639915|FG000|Overall Study|Adverse Event|7|||
37952961|NCT00509236|69639916|FG001|Overall Study|Adverse Event|9|||
37952962|NCT00509236|69639915|FG000|Overall Study|Withdrawal by Subject|5|||
37952963|NCT00509236|69639916|FG001|Overall Study|Withdrawal by Subject|10|||
37952964|NCT00509236|69639915|FG000|Overall Study|Protocol Violation|3|||
37952965|NCT00509236|69639916|FG001|Overall Study|Protocol Violation|0|||
37952966|NCT00509236|69639915|FG000|Overall Study|Excluded Medication|1|||
37952967|NCT00509236|69639916|FG001|Overall Study|Excluded Medication|1|||
37952968|NCT00509236|69639915|FG000|Overall Study|Scheduled Kidney Transplant|1|||
37952969|NCT00509236|69639916|FG001|Overall Study|Scheduled Kidney Transplant|0|||
37952970|NCT00508924|69639926|FG000|Overall Study|Protocol Violation|0|||
37952971|NCT00508924|69639927|FG001|Overall Study|Protocol Violation|0|||
37952972|NCT00508924|69639928|FG002|Overall Study|Protocol Violation|1|||
37952973|NCT00508924|69639929|FG003|Overall Study|Protocol Violation|1|||
37952974|NCT00620750|69639939|FG000|Overall Study|Lost to Follow-up|25|||
37952975|NCT00508144|69639943|FG000|Overall Study|Not eligible|6|||
37952976|NCT00508144|69639943|FG000|Overall Study|Death|5|||
37952977|NCT00621842|69639947|FG000|Overall Study|Adverse Event|6|||
37952978|NCT00621842|69639947|FG000|Overall Study|Withdrawal by Subject|7|||
37952979|NCT00621842|69639947|FG000|Overall Study|Protocol Violation|4|||
37952980|NCT00621842|69639947|FG000|Overall Study|Lack of Efficacy|2|||
37952981|NCT00503776|69639955|FG000|Overall Study|Withdrawal by Subject|1|||
37952982|NCT00503776|69639956|FG001|Overall Study|Withdrawal by Subject|0|||
37952983|NCT00503776|69639957|FG002|Overall Study|Withdrawal by Subject|1|||
37952984|NCT00503776|69639958|FG003|Overall Study|Withdrawal by Subject|1|||
37952985|NCT00503776|69639955|FG000|Overall Study|Physician Decision|0|||
37952986|NCT00503776|69639956|FG001|Overall Study|Physician Decision|0|||
37952987|NCT00503776|69639957|FG002|Overall Study|Physician Decision|1|||
37952988|NCT00503776|69639958|FG003|Overall Study|Physician Decision|1|||
37952989|NCT00619112|69639975|FG000|Overall Study|Adverse Event|1|||
37952990|NCT00619112|69639976|FG001|Overall Study|Adverse Event|2|||
37952991|NCT00619502|69639987|FG000|Overall Study|Lost to Follow-up|8|||
37952992|NCT00619502|69639988|FG001|Overall Study|Lost to Follow-up|10|||
37952993|NCT00618956|69639998|FG000|Overall Study|Adverse Event|10|||
37952994|NCT00618956|69639999|FG001|Overall Study|Adverse Event|34|||
37952995|NCT00618956|69639998|FG000|Overall Study|Lack of Efficacy|2|||
37952996|NCT00618956|69639999|FG001|Overall Study|Lack of Efficacy|1|||
37952997|NCT00618956|69639998|FG000|Overall Study|Withdrawal by Subject|5|||
37952998|NCT00618956|69639999|FG001|Overall Study|Withdrawal by Subject|7|||
37952999|NCT00618956|69639998|FG000|Overall Study|Lost to Follow-up|4|||
37953000|NCT00618956|69639999|FG001|Overall Study|Lost to Follow-up|5|||
37953001|NCT00618956|69639998|FG000|Overall Study|Protocol Violation|2|||
37953002|NCT00618956|69639999|FG001|Overall Study|Protocol Violation|2|||
37953003|NCT00618956|69639998|FG000|Overall Study|did not meet criteria, non-compliance|2|||
37953004|NCT00618956|69639999|FG001|Overall Study|did not meet criteria, non-compliance|1|||
37953005|NCT00716417|69640021|FG000|Overall Study|Adverse Event|0|||
37953006|NCT00716417|69640022|FG001|Overall Study|Adverse Event|0|||
37953007|NCT00716417|69640023|FG002|Overall Study|Adverse Event|2|||
37953008|NCT00716417|69640024|FG003|Overall Study|Adverse Event|1|||
37953009|NCT00716417|69640025|FG004|Overall Study|Adverse Event|0|||
37953010|NCT00716417|69640026|FG005|Overall Study|Adverse Event|0|||
37953011|NCT00716417|69640027|FG006|Overall Study|Adverse Event|3|||
37953012|NCT00716417|69640028|FG007|Overall Study|Adverse Event|1|||
37953013|NCT00716417|69640029|FG008|Overall Study|Adverse Event|0|||
37953014|NCT00716417|69640030|FG009|Overall Study|Adverse Event|3|||
37953015|NCT00716417|69640021|FG000|Overall Study|Withdrawal by Subject|0|||
37953016|NCT00716417|69640022|FG001|Overall Study|Withdrawal by Subject|1|||
37953017|NCT00716417|69640023|FG002|Overall Study|Withdrawal by Subject|0|||
37953018|NCT00716417|69640024|FG003|Overall Study|Withdrawal by Subject|2|||
37953019|NCT00716417|69640025|FG004|Overall Study|Withdrawal by Subject|0|||
37953020|NCT00716417|69640026|FG005|Overall Study|Withdrawal by Subject|0|||
37953021|NCT00716417|69640027|FG006|Overall Study|Withdrawal by Subject|1|||
37953022|NCT00716417|69640028|FG007|Overall Study|Withdrawal by Subject|0|||
37953023|NCT00716417|69640029|FG008|Overall Study|Withdrawal by Subject|0|||
37953024|NCT00716417|69640030|FG009|Overall Study|Withdrawal by Subject|0|||
37953025|NCT00716417|69640021|FG000|Overall Study|Progressive disease|3|||
37953026|NCT00716417|69640022|FG001|Overall Study|Progressive disease|5|||
37953027|NCT00716417|69640023|FG002|Overall Study|Progressive disease|3|||
37953028|NCT00716417|69640024|FG003|Overall Study|Progressive disease|8|||
37953029|NCT00716417|69640025|FG004|Overall Study|Progressive disease|0|||
37953030|NCT00716417|69640026|FG005|Overall Study|Progressive disease|3|||
37953031|NCT00716417|69640027|FG006|Overall Study|Progressive disease|3|||
37953032|NCT00716417|69640028|FG007|Overall Study|Progressive disease|1|||
37953033|NCT00716417|69640029|FG008|Overall Study|Progressive disease|5|||
37953034|NCT00716417|69640030|FG009|Overall Study|Progressive disease|0|||
37953035|NCT00716417|69640021|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
37953036|NCT00716417|69640022|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
37953037|NCT00716417|69640023|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
37953038|NCT00716417|69640024|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
37953039|NCT00716417|69640025|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
37953040|NCT00716417|69640026|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
37953041|NCT00716417|69640027|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
37953042|NCT00716417|69640028|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
37953043|NCT00716417|69640029|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
37953044|NCT00716417|69640030|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
37953045|NCT00716417|69640021|FG000|Overall Study|On patient request due to toxicities|0|||
37953046|NCT00716417|69640022|FG001|Overall Study|On patient request due to toxicities|0|||
37953047|NCT00716417|69640023|FG002|Overall Study|On patient request due to toxicities|0|||
37953048|NCT00716417|69640024|FG003|Overall Study|On patient request due to toxicities|0|||
37953049|NCT00716417|69640025|FG004|Overall Study|On patient request due to toxicities|0|||
37953050|NCT00716417|69640026|FG005|Overall Study|On patient request due to toxicities|0|||
37953051|NCT00716417|69640027|FG006|Overall Study|On patient request due to toxicities|0|||
37953052|NCT00716417|69640028|FG007|Overall Study|On patient request due to toxicities|1|||
37953053|NCT00716417|69640029|FG008|Overall Study|On patient request due to toxicities|0|||
37953054|NCT00716417|69640030|FG009|Overall Study|On patient request due to toxicities|0|||
37953055|NCT00719537|69640056|FG000|Overall Study|Withdrawal by Subject|1|||
37953056|NCT00719537|69640057|FG001|Overall Study|Withdrawal by Subject|0|||
37953057|NCT00719537|69640056|FG000|Overall Study|Lost to Follow-up|0|||
37953058|NCT00719537|69640057|FG001|Overall Study|Lost to Follow-up|1|||
37953059|NCT00715949|69640063|FG000|Overall Study|could not finish first test|4|||
37953060|NCT00503698|69640069|FG000|Overall Study|Protocol Violation|5|||
37953061|NCT00503698|69640070|FG001|Overall Study|Protocol Violation|6|||
37953062|NCT00503698|69640069|FG000|Overall Study|Adverse Event|52|||
37953063|NCT00503698|69640070|FG001|Overall Study|Adverse Event|41|||
37953064|NCT00503698|69640069|FG000|Overall Study|Death|1|||
37953065|NCT00503698|69640070|FG001|Overall Study|Death|0|||
37953066|NCT00503698|69640069|FG000|Overall Study|Lack of Efficacy|3|||
37953067|NCT00503698|69640070|FG001|Overall Study|Lack of Efficacy|4|||
37953068|NCT00503698|69640069|FG000|Overall Study|Trial terminated|216|||
37953069|NCT00503698|69640070|FG001|Overall Study|Trial terminated|253|||
37953070|NCT00503698|69640069|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
37953071|NCT00503698|69640070|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
37953072|NCT00503698|69640069|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
37953073|NCT00503698|69640070|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
37953074|NCT00503698|69640069|FG000|Overall Study|Any condition in exclusion criteria|4|||
37953075|NCT00503698|69640070|FG001|Overall Study|Any condition in exclusion criteria|6|||
37953076|NCT00503698|69640069|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
37953077|NCT00503698|69640070|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
37953078|NCT00503698|69640069|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
37953079|NCT00503698|69640070|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
37953080|NCT00503698|69640069|FG000|Overall Study|Critically ill|2|||
37953081|NCT00503698|69640070|FG001|Overall Study|Critically ill|0|||
37953082|NCT00503698|69640069|FG000|Overall Study|Unclassified|48|||
37953083|NCT00503698|69640070|FG001|Overall Study|Unclassified|32|||
37953084|NCT00503698|69640069|FG000|Overall Study|Not exposed to trial drug|11|||
37953085|NCT00503698|69640070|FG001|Overall Study|Not exposed to trial drug|6|||
37953086|NCT00573794|69640085|FG000|Overall Study|Adverse Event|81|||
37953087|NCT00573794|69640085|FG000|Overall Study|Withdrew Consent|90|||
37953088|NCT00573794|69640085|FG000|Overall Study|Lost to Follow-up|13|||
37953089|NCT00573794|69640085|FG000|Overall Study|Protocol Violation|6|||
37953090|NCT00573794|69640085|FG000|Overall Study|Lack of Efficacy|94|||
37953091|NCT00573794|69640085|FG000|Overall Study|Other|46|||
37953092|NCT00715793|69640089|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
37953093|NCT00715793|69640090|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
37953094|NCT00715793|69640089|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
37953095|NCT00715793|69640090|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
37953096|NCT00718523|69640099|FG000|Overall Study|Withdrawal by Subject|5|||
37953097|NCT00718523|69640100|FG001|Overall Study|Withdrawal by Subject|7|||
37953098|NCT00718523|69640099|FG000|Overall Study|Death|13|||
37953099|NCT00718523|69640100|FG001|Overall Study|Death|17|||
37953100|NCT00715559|69640106|FG000|Overall Study|medication not tolerated - nausea|1|||
37953101|NCT00620282|69640122|FG000|Overall Study|Adverse Event|0|||
37953102|NCT00620282|69640123|FG001|Overall Study|Adverse Event|1|||
37953103|NCT00620282|69640124|FG002|Overall Study|Adverse Event|0|||
37953104|NCT00620282|69640122|FG000|Overall Study|Arterial line unable to be placed|0|||
37953105|NCT00620282|69640123|FG001|Overall Study|Arterial line unable to be placed|0|||
37953106|NCT00620282|69640124|FG002|Overall Study|Arterial line unable to be placed|1|||
37953107|NCT00620282|69640122|FG000|Overall Study|Withdrawal by Subject|0|||
37953108|NCT00620282|69640123|FG001|Overall Study|Withdrawal by Subject|1|||
37953109|NCT00620282|69640124|FG002|Overall Study|Withdrawal by Subject|0|||
37953110|NCT00515086|69640136|FG000|Overall Study|Adverse Event|1|||
37953111|NCT00515086|69640137|FG001|Overall Study|Adverse Event|1|||
37953112|NCT00515086|69640138|FG002|Overall Study|Adverse Event|2|||
37953113|NCT00515086|69640139|FG003|Overall Study|Adverse Event|3|||
37953114|NCT00515086|69640136|FG000|Overall Study|Administrative|1|||
37953115|NCT00515086|69640137|FG001|Overall Study|Administrative|1|||
37953116|NCT00515086|69640138|FG002|Overall Study|Administrative|0|||
37953117|NCT00515086|69640139|FG003|Overall Study|Administrative|0|||
37953118|NCT00515086|69640136|FG000|Overall Study|Withdrawal by Subject|1|||
37953119|NCT00515086|69640137|FG001|Overall Study|Withdrawal by Subject|0|||
37953120|NCT00515086|69640138|FG002|Overall Study|Withdrawal by Subject|0|||
37953121|NCT00515086|69640139|FG003|Overall Study|Withdrawal by Subject|1|||
37953122|NCT00515086|69640136|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
37953123|NCT00515086|69640137|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
37953124|NCT00515086|69640138|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
37953125|NCT00515086|69640139|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
37953126|NCT00515086|69640136|FG000|Overall Study|Lost to Follow-up|1|||
37953127|NCT00515086|69640137|FG001|Overall Study|Lost to Follow-up|0|||
37953128|NCT00515086|69640138|FG002|Overall Study|Lost to Follow-up|0|||
37953129|NCT00515086|69640139|FG003|Overall Study|Lost to Follow-up|0|||
37953130|NCT00515086|69640136|FG000|Overall Study|Study drug no longer required|0|||
37953131|NCT00515086|69640137|FG001|Overall Study|Study drug no longer required|1|||
37953132|NCT00515086|69640138|FG002|Overall Study|Study drug no longer required|0|||
37953133|NCT00515086|69640139|FG003|Overall Study|Study drug no longer required|0|||
37953134|NCT00515086|69640136|FG000|Overall Study|Death|2|||
37953135|NCT00515086|69640137|FG001|Overall Study|Death|0|||
37953136|NCT00515086|69640138|FG002|Overall Study|Death|0|||
37953137|NCT00515086|69640139|FG003|Overall Study|Death|0|||
37953138|NCT00618410|69640155|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
37953139|NCT00618410|69640156|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
37953140|NCT00618722|69640166|FG000|Overall Study|Refusal of Treatment|0|||
37953141|NCT00618722|69640167|FG001|Overall Study|Refusal of Treatment|0|||
37953142|NCT00618722|69640168|FG002|Overall Study|Refusal of Treatment|1|||
37953143|NCT00618722|69640169|FG003|Overall Study|Refusal of Treatment|0|||
37953144|NCT00618722|69640166|FG000|Overall Study|Patient Request|1|||
37953145|NCT00618722|69640167|FG001|Overall Study|Patient Request|1|||
37953146|NCT00618722|69640168|FG002|Overall Study|Patient Request|1|||
37953147|NCT00618722|69640169|FG003|Overall Study|Patient Request|1|||
37953148|NCT00618722|69640166|FG000|Overall Study|Inability to Complete Study Procedure|0|||
37953149|NCT00618722|69640167|FG001|Overall Study|Inability to Complete Study Procedure|1|||
38045113|NCT01956110|69732835|FG001|Overall Study|Adverse Event|10|||
37953150|NCT00618722|69640168|FG002|Overall Study|Inability to Complete Study Procedure|0|||
37953151|NCT00618722|69640169|FG003|Overall Study|Inability to Complete Study Procedure|0|||
37953152|NCT00618722|69640166|FG000|Overall Study|Lost to Follow-up|2|||
37953153|NCT00618722|69640167|FG001|Overall Study|Lost to Follow-up|0|||
37953154|NCT00618722|69640168|FG002|Overall Study|Lost to Follow-up|0|||
37953155|NCT00618722|69640169|FG003|Overall Study|Lost to Follow-up|2|||
37953156|NCT00618722|69640166|FG000|Overall Study|Miscellaneous Reasons|0|||
37953157|NCT00618722|69640167|FG001|Overall Study|Miscellaneous Reasons|0|||
37953158|NCT00618722|69640168|FG002|Overall Study|Miscellaneous Reasons|1|||
37953159|NCT00618722|69640169|FG003|Overall Study|Miscellaneous Reasons|1|||
37953160|NCT00507442|69640183|FG000|Overall Study|Adverse Event|8|||
37953161|NCT00507442|69640184|FG001|Overall Study|Adverse Event|11|||
37953162|NCT00507442|69640185|FG002|Overall Study|Adverse Event|4|||
37953163|NCT00507442|69640186|FG003|Overall Study|Adverse Event|1|||
37953164|NCT00507442|69640183|FG000|Overall Study|Protocol Violation|0|||
37953165|NCT00507442|69640184|FG001|Overall Study|Protocol Violation|1|||
37953166|NCT00507442|69640185|FG002|Overall Study|Protocol Violation|0|||
37953167|NCT00507442|69640186|FG003|Overall Study|Protocol Violation|0|||
37953168|NCT00507442|69640183|FG000|Overall Study|Lost to Follow-up|0|||
37953169|NCT00507442|69640184|FG001|Overall Study|Lost to Follow-up|0|||
37953170|NCT00507442|69640185|FG002|Overall Study|Lost to Follow-up|1|||
37953171|NCT00507442|69640186|FG003|Overall Study|Lost to Follow-up|0|||
37953172|NCT00507442|69640183|FG000|Overall Study|Physician Decision|0|||
37953173|NCT00507442|69640184|FG001|Overall Study|Physician Decision|2|||
37953174|NCT00507442|69640185|FG002|Overall Study|Physician Decision|4|||
37953175|NCT00507442|69640186|FG003|Overall Study|Physician Decision|1|||
37953176|NCT00507442|69640183|FG000|Overall Study|Progressive Disease|2|||
37953177|NCT00507442|69640184|FG001|Overall Study|Progressive Disease|4|||
37953178|NCT00507442|69640185|FG002|Overall Study|Progressive Disease|2|||
37953179|NCT00507442|69640186|FG003|Overall Study|Progressive Disease|0|||
37953180|NCT00507442|69640183|FG000|Overall Study|Withdrawal by Subject|4|||
37953181|NCT00507442|69640184|FG001|Overall Study|Withdrawal by Subject|4|||
37953182|NCT00507442|69640185|FG002|Overall Study|Withdrawal by Subject|2|||
37953183|NCT00507442|69640186|FG003|Overall Study|Withdrawal by Subject|1|||
37953184|NCT00507442|69640183|FG000|Overall Study|Other|2|||
37953185|NCT00507442|69640184|FG001|Overall Study|Other|5|||
37953186|NCT00507442|69640185|FG002|Overall Study|Other|2|||
37953187|NCT00507442|69640186|FG003|Overall Study|Other|2|||
37953188|NCT00619892|69640202|FG000|Overall Study|Adverse Event|3|||
37953189|NCT00619892|69640203|FG001|Overall Study|Adverse Event|0|||
37953190|NCT00619892|69640202|FG000|Overall Study|Lost to Follow-up|0|||
37953191|NCT00619892|69640203|FG001|Overall Study|Lost to Follow-up|1|||
37953192|NCT00619892|69640202|FG000|Overall Study|Intercurrent illness|0|||
37953193|NCT00619892|69640203|FG001|Overall Study|Intercurrent illness|1|||
37953194|NCT00507130|69640215|FG000|Overall Study|Lost to Follow-up|0|||
38045114|NCT01956110|69732834|FG000|Overall Study|Personal reasons|1|||
37861718|NCT00653432|69545399|FG000|Overall Study|Lost to Follow-up|7|||
37861719|NCT00653432|69545400|FG001|Overall Study|Lost to Follow-up|6|||
37861720|NCT00653432|69545399|FG000|Overall Study|Use/Need of Con Therapy|2|||
37861721|NCT00653432|69545400|FG001|Overall Study|Use/Need of Con Therapy|1|||
37861722|NCT00653432|69545399|FG000|Overall Study|Other - Reason Not Provided|5|||
37861723|NCT00653432|69545400|FG001|Overall Study|Other - Reason Not Provided|3|||
37861724|NCT00446043|69545419|FG000|Overall Study|Adverse Event|9|||
37861725|NCT00446043|69545419|FG000|Overall Study|Withdrawal by Subject|70|||
37861726|NCT00446043|69545419|FG000|Overall Study|Protocol Violation|2|||
37861727|NCT00446043|69545419|FG000|Overall Study|Lost to Follow-up|42|||
37861728|NCT00446043|69545419|FG000|Overall Study|Pregnancy|2|||
37861729|NCT00400725|69545426|FG000|Initial Phase (up to 4 Weeks)|Adverse Event|1|||
37861730|NCT00400725|69545427|FG001|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
37861731|NCT00400725|69545428|FG002|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
37861732|NCT00400725|69545426|FG000|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|14|||
37861733|NCT00400725|69545427|FG001|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
37861734|NCT00400725|69545428|FG002|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
37861735|NCT00400725|69545426|FG000|Initial Phase (up to 4 Weeks)|Lost to Follow-up|1|||
37861736|NCT00400725|69545427|FG001|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
37861737|NCT00400725|69545428|FG002|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
37861738|NCT00400725|69545426|FG000|Initial Phase (up to 4 Weeks)|Other|1|||
37861739|NCT00400725|69545427|FG001|Initial Phase (up to 4 Weeks)|Other|0|||
37953195|NCT00507130|69640216|FG001|Overall Study|Lost to Follow-up|0|||
37953196|NCT00507130|69640217|FG002|Overall Study|Lost to Follow-up|1|||
37953197|NCT00507130|69640218|FG003|Overall Study|Lost to Follow-up|1|||
37953198|NCT00507130|69640215|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
37953199|NCT00507130|69640216|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
37953200|NCT00507130|69640217|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
37953201|NCT00507130|69640218|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
37953202|NCT00503308|69640230|FG000|Overall Study|Protocol Violation|2|||
37953203|NCT00503308|69640231|FG001|Overall Study|Protocol Violation|1|||
37953204|NCT03893565|69640242|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
37953205|NCT03893565|69640243|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
37953206|NCT03893565|69640244|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
37953207|NCT03893565|69640245|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
37953208|NCT03893565|69640246|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
37953209|NCT03893565|69640247|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
37953210|NCT03893565|69640248|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
37953211|NCT03893565|69640249|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
37953212|NCT03893565|69640250|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
37953213|NCT03893565|69640242|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
37953214|NCT03893565|69640243|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
37953215|NCT03893565|69640244|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
37953216|NCT03893565|69640245|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
37953217|NCT03893565|69640246|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
37953218|NCT03893565|69640247|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
37953219|NCT03893565|69640248|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
37953220|NCT03893565|69640249|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
37953221|NCT03893565|69640250|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
37953222|NCT03893565|69640242|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
37953223|NCT03893565|69640243|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
37953224|NCT03893565|69640244|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
37953225|NCT03893565|69640245|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
37953226|NCT03893565|69640246|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
37953227|NCT03893565|69640247|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
37953228|NCT03893565|69640248|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
37953229|NCT03893565|69640249|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
37953230|NCT03893565|69640250|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
37953231|NCT03893565|69640242|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
37953232|NCT03893565|69640243|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
37953233|NCT03893565|69640244|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
37953234|NCT03893565|69640245|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
37953235|NCT03893565|69640246|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
37953236|NCT03893565|69640247|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
37953237|NCT03893565|69640248|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
37953238|NCT03893565|69640249|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
37953239|NCT03893565|69640250|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
37953240|NCT03893565|69640242|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
37953241|NCT03893565|69640243|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
37953242|NCT03893565|69640244|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
37953243|NCT03893565|69640245|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
37953244|NCT03893565|69640246|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
37953245|NCT03893565|69640247|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
37953246|NCT03893565|69640248|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
37953247|NCT03893565|69640249|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
37953248|NCT03893565|69640250|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
37953249|NCT03893565|69640242|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
37953250|NCT03893565|69640243|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
37953251|NCT03893565|69640244|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
37953252|NCT03893565|69640245|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
37953253|NCT03893565|69640246|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
37953254|NCT03893565|69640247|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
37953255|NCT03893565|69640248|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
37953256|NCT03893565|69640249|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
37953257|NCT03893565|69640250|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
37953258|NCT03893565|69640242|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
37953259|NCT03893565|69640243|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
37953260|NCT03893565|69640244|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
37953261|NCT03893565|69640245|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
37953262|NCT03893565|69640246|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
37953263|NCT03893565|69640247|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
37953264|NCT03893565|69640248|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
38045115|NCT01956110|69732835|FG001|Overall Study|Personal reasons|1|||
37953265|NCT03893565|69640249|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
37953266|NCT03893565|69640250|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
37953267|NCT03893565|69640242|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
37953268|NCT03893565|69640243|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
37953269|NCT03893565|69640244|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
37953270|NCT03893565|69640245|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
37953271|NCT03893565|69640246|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
37953272|NCT03893565|69640247|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
37953273|NCT03893565|69640248|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
37953274|NCT03893565|69640249|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
37953275|NCT03893565|69640250|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
37953276|NCT03893565|69640242|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
37953277|NCT03893565|69640243|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
37953278|NCT03893565|69640244|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
37953279|NCT03893565|69640245|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
37953280|NCT03893565|69640246|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
37953281|NCT03893565|69640247|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
37953282|NCT03893565|69640248|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
37953283|NCT03893565|69640249|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
37953284|NCT03893565|69640250|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
37953285|NCT03893565|69640242|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
37953286|NCT03893565|69640243|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
37953287|NCT03893565|69640244|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
37953288|NCT03893565|69640245|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
37953289|NCT03893565|69640246|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
37953290|NCT03893565|69640247|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
37953291|NCT03893565|69640248|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
37953292|NCT03893565|69640249|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
37953293|NCT03893565|69640250|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
37953294|NCT03893565|69640242|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
37953295|NCT03893565|69640243|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
37953296|NCT03893565|69640244|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
37953297|NCT03893565|69640245|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
37953298|NCT03893565|69640246|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
37953299|NCT03893565|69640247|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
37953300|NCT03893565|69640248|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
37953301|NCT03893565|69640249|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
37953302|NCT03893565|69640250|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
37953303|NCT03893565|69640242|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
37953304|NCT03893565|69640243|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
37953305|NCT03893565|69640244|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
37953306|NCT03893565|69640245|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
37953307|NCT03893565|69640246|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
37953308|NCT03893565|69640247|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
37953309|NCT03893565|69640248|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
37953310|NCT03893565|69640249|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
37953311|NCT03893565|69640250|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
37953312|NCT03893565|69640242|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
37953313|NCT03893565|69640243|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
37953314|NCT03893565|69640244|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
37953315|NCT03893565|69640245|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
37953316|NCT03893565|69640246|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
37953317|NCT03893565|69640247|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
37953318|NCT03893565|69640248|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
37953319|NCT03893565|69640249|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
37953320|NCT03893565|69640250|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
37953321|NCT03893565|69640242|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
37953322|NCT03893565|69640243|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
37953323|NCT03893565|69640244|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
37953324|NCT03893565|69640245|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
37953325|NCT03893565|69640246|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
38045116|NCT03116828|69732866|FG000|Overall Study|Adverse Event|1|||
38045117|NCT03116828|69732867|FG001|Overall Study|Adverse Event|10|||
38045118|NCT03116828|69732866|FG000|Overall Study|Withdrawal by Subject|4|||
38045119|NCT03116828|69732867|FG001|Overall Study|Withdrawal by Subject|8|||
37953326|NCT03893565|69640247|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
37953327|NCT03893565|69640248|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
37953328|NCT03893565|69640249|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
37953329|NCT03893565|69640250|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
37953330|NCT03893565|69640242|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
37953331|NCT03893565|69640243|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
37953332|NCT03893565|69640244|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
37953333|NCT03893565|69640245|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
37953334|NCT03893565|69640246|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
37953335|NCT03893565|69640247|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
37953336|NCT03893565|69640248|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
37953337|NCT03893565|69640249|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
37953338|NCT03893565|69640250|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
37953339|NCT03893565|69640242|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
37953340|NCT03893565|69640243|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
37953341|NCT03893565|69640244|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
37953342|NCT03893565|69640245|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
37953343|NCT03893565|69640246|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
37953344|NCT03893565|69640247|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
37953345|NCT03893565|69640248|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
37953346|NCT03893565|69640249|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
37953347|NCT03893565|69640250|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
37953348|NCT00502996|69640269|FG000|Overall Study|Lost to Follow-up|9|||
37953349|NCT00502996|69640269|FG000|Overall Study|Protocol Violation|2|||
37953350|NCT00502996|69640269|FG000|Overall Study|Treatment failure|25|||
37953351|NCT00502996|69640269|FG000|Overall Study|Withdrawal Informed Consent|6|||
37953352|NCT00502996|69640269|FG000|Overall Study|Adverse Event|2|||
37953353|NCT00715403|69640280|FG000|Overall Study|Progressive disease|0|||
37953354|NCT00715403|69640281|FG001|Overall Study|Progressive disease|1|||
37953355|NCT00715403|69640282|FG002|Overall Study|Progressive disease|3|||
37953356|NCT00715403|69640283|FG003|Overall Study|Progressive disease|9|||
37953357|NCT00715403|69640284|FG004|Overall Study|Progressive disease|5|||
37953358|NCT00715403|69640285|FG005|Overall Study|Progressive disease|14|||
37953359|NCT00715403|69640286|FG006|Overall Study|Progressive disease|1|||
37953360|NCT00715403|69640280|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
37953361|NCT00715403|69640281|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
37953362|NCT00715403|69640282|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
37953363|NCT00715403|69640283|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
37953364|NCT00715403|69640284|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
37953365|NCT00715403|69640285|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
37953366|NCT00715403|69640286|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
37953367|NCT00715403|69640280|FG000|Overall Study|Other Adverse Event than DLT|1|||
37953368|NCT00715403|69640281|FG001|Overall Study|Other Adverse Event than DLT|0|||
37953369|NCT00715403|69640282|FG002|Overall Study|Other Adverse Event than DLT|0|||
37953370|NCT00715403|69640283|FG003|Overall Study|Other Adverse Event than DLT|0|||
37953371|NCT00715403|69640284|FG004|Overall Study|Other Adverse Event than DLT|0|||
37953372|NCT00715403|69640285|FG005|Overall Study|Other Adverse Event than DLT|2|||
37953373|NCT00715403|69640286|FG006|Overall Study|Other Adverse Event than DLT|0|||
37953374|NCT00715403|69640280|FG000|Overall Study|Protocol Violation|0|||
37953375|NCT00715403|69640281|FG001|Overall Study|Protocol Violation|0|||
37953376|NCT00715403|69640282|FG002|Overall Study|Protocol Violation|0|||
37953377|NCT00715403|69640283|FG003|Overall Study|Protocol Violation|0|||
37953378|NCT00715403|69640284|FG004|Overall Study|Protocol Violation|0|||
37953379|NCT00715403|69640285|FG005|Overall Study|Protocol Violation|1|||
37953380|NCT00715403|69640286|FG006|Overall Study|Protocol Violation|0|||
37953381|NCT00715403|69640280|FG000|Overall Study|Other reason not defined above|0|||
37953382|NCT00715403|69640281|FG001|Overall Study|Other reason not defined above|0|||
37953383|NCT00715403|69640282|FG002|Overall Study|Other reason not defined above|1|||
37953384|NCT00715403|69640283|FG003|Overall Study|Other reason not defined above|0|||
37953385|NCT00715403|69640284|FG004|Overall Study|Other reason not defined above|1|||
37953386|NCT00715403|69640285|FG005|Overall Study|Other reason not defined above|1|||
37953387|NCT00715403|69640286|FG006|Overall Study|Other reason not defined above|0|||
37953388|NCT00502840|69640302|FG000|Overall Study|Adverse Event|5|||
37953389|NCT00502840|69640302|FG000|Overall Study|Additional or changed therapy|48|||
37953390|NCT00502840|69640302|FG000|Overall Study|Lack of Efficacy|11|||
37953391|NCT00502840|69640302|FG000|Overall Study|Protocol Violation|4|||
37953392|NCT00502840|69640302|FG000|Overall Study|Withdrawal by Subject|5|||
37953393|NCT00502840|69640302|FG000|Overall Study|Lost to Follow-up|6|||
37953394|NCT00502840|69640302|FG000|Overall Study|Administrative problems|1|||
38045120|NCT03116828|69732866|FG000|Overall Study|OTHER|3|||
38045121|NCT03116828|69732867|FG001|Overall Study|OTHER|3|||
37953395|NCT00502840|69640302|FG000|Overall Study|Other|20|||
37953396|NCT00515008|69640309|FG000|Overall Study|Lost to Follow-up|1|||
37953397|NCT00515008|69640310|FG001|Overall Study|Lost to Follow-up|0|||
37953398|NCT00515008|69640309|FG000|Overall Study|Declined|0|||
37953399|NCT00515008|69640310|FG001|Overall Study|Declined|3|||
37953400|NCT00515008|69640309|FG000|Overall Study|Left the Boston Area|1|||
37953401|NCT00515008|69640310|FG001|Overall Study|Left the Boston Area|1|||
37953402|NCT00515008|69640309|FG000|Overall Study|Scheduling conflict|1|||
37953403|NCT00515008|69640310|FG001|Overall Study|Scheduling conflict|0|||
37953404|NCT00514540|69640319|FG000|First-Line Chemo|Withdrawal by Subject|1|||
37953405|NCT00514540|69640319|FG000|First-Line Chemo|Protocol Violation|7|||
37953406|NCT00514540|69640319|FG000|Second-Line|Physician/Patient Decision|31|||
37953407|NCT00713609|69640337|FG000|Overall Study|Adverse Event|2|||
37953408|NCT00713609|69640338|FG001|Overall Study|Adverse Event|0|||
37953409|NCT00713609|69640339|FG002|Overall Study|Adverse Event|2|||
38045122|NCT03938272|69732875|FG000|Overall Study|Withdrawal by Subject|1|||
38045123|NCT03938272|69732876|FG001|Overall Study|Withdrawal by Subject|0|||
38045124|NCT03938272|69732875|FG000|Overall Study|Physician Decision|0|||
38045125|NCT03938272|69732876|FG001|Overall Study|Physician Decision|2|||
38045126|NCT03938272|69732875|FG000|Overall Study|Study termination by sponsor|10|||
38045127|NCT03938272|69732876|FG001|Overall Study|Study termination by sponsor|8|||
38045128|NCT03126344|69732894|FG000|Overall Study|Lost to Follow-up|0|||
38045129|NCT03126344|69732895|FG001|Overall Study|Lost to Follow-up|0|||
38045130|NCT03126344|69732896|FG002|Overall Study|Lost to Follow-up|5|||
38045131|NCT03115112|69732917|FG000|Overall Study|Adverse Event|5|||
38045132|NCT03115112|69732918|FG001|Overall Study|Adverse Event|1|||
38045133|NCT03115112|69732917|FG000|Overall Study|Withdrawal by Subject|4|||
38045134|NCT03115112|69732918|FG001|Overall Study|Withdrawal by Subject|2|||
38045135|NCT03115112|69732917|FG000|Overall Study|Lost to Follow-up|0|||
38045136|NCT03115112|69732918|FG001|Overall Study|Lost to Follow-up|1|||
38045137|NCT03115112|69732917|FG000|Overall Study|Death|1|||
38045138|NCT03115112|69732918|FG001|Overall Study|Death|0|||
38045139|NCT03115112|69732917|FG000|Overall Study|Pregnancy|1|||
38045140|NCT03115112|69732918|FG001|Overall Study|Pregnancy|0|||
38045141|NCT03115112|69732917|FG000|Overall Study|Site closure|1|||
38045142|NCT03115112|69732918|FG001|Overall Study|Site closure|1|||
38045143|NCT03556358|69732937|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
38045144|NCT03556358|69732938|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
38045145|NCT03556358|69732937|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
38045146|NCT03556358|69732938|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
38045147|NCT03556358|69732937|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
38045148|NCT03556358|69732938|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
38045149|NCT03556358|69732937|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
38045150|NCT03556358|69732938|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
38045151|NCT03556358|69732937|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
38045152|NCT03556358|69732938|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
38045153|NCT03556358|69732937|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
38045154|NCT03556358|69732938|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
38045155|NCT03556358|69732937|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
38045156|NCT03556358|69732938|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
38045157|NCT03118934|69732965|FG000|Overall Study|Adverse Event|0|||
38045158|NCT03118934|69732966|FG001|Overall Study|Adverse Event|0|||
38045159|NCT03118934|69732967|FG002|Overall Study|Adverse Event|0|||
38045160|NCT03118934|69732968|FG003|Overall Study|Adverse Event|0|||
38045161|NCT03118934|69732969|FG004|Overall Study|Adverse Event|0|||
38045162|NCT03118934|69732970|FG005|Overall Study|Adverse Event|1|||
38045163|NCT03118934|69732965|FG000|Overall Study|Physician Decision|0|||
38045164|NCT03118934|69732966|FG001|Overall Study|Physician Decision|0|||
38045165|NCT03118934|69732967|FG002|Overall Study|Physician Decision|0|||
38045166|NCT03118934|69732968|FG003|Overall Study|Physician Decision|0|||
38045167|NCT03118934|69732969|FG004|Overall Study|Physician Decision|0|||
38045168|NCT03118934|69732970|FG005|Overall Study|Physician Decision|1|||
38045169|NCT03118934|69732965|FG000|Overall Study|Discontinued prior to exposure|0|||
38045170|NCT03118934|69732966|FG001|Overall Study|Discontinued prior to exposure|1|||
38045171|NCT03118934|69732967|FG002|Overall Study|Discontinued prior to exposure|1|||
38045172|NCT03118934|69732968|FG003|Overall Study|Discontinued prior to exposure|1|||
38045173|NCT03118934|69732969|FG004|Overall Study|Discontinued prior to exposure|2|||
37953410|NCT00713609|69640340|FG003|Overall Study|Adverse Event|2|||
37953411|NCT00713609|69640341|FG004|Overall Study|Adverse Event|3|||
37953412|NCT00713609|69640342|FG005|Overall Study|Adverse Event|1|||
37953413|NCT00713609|69640337|FG000|Overall Study|Lost to Follow-up|5|||
37953414|NCT00713609|69640338|FG001|Overall Study|Lost to Follow-up|7|||
37953415|NCT00713609|69640339|FG002|Overall Study|Lost to Follow-up|5|||
37953416|NCT00713609|69640340|FG003|Overall Study|Lost to Follow-up|5|||
38045174|NCT03118934|69732970|FG005|Overall Study|Discontinued prior to exposure|0|||
38045175|NCT03114488|69732980|FG000|Time Period 2|Withdrawal by Subject|1|||
38045176|NCT03114488|69732981|FG001|Time Period 2|Withdrawal by Subject|3|||
38045177|NCT03135262|69733000|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
38045178|NCT03135262|69733001|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
38045179|NCT03135262|69733002|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
38045180|NCT03135262|69733003|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
38045181|NCT03135262|69733004|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
38045182|NCT03135262|69733000|FG000|Overall Study|Progression of disease|0|||
38045183|NCT03135262|69733001|FG001|Overall Study|Progression of disease|0|||
38045184|NCT03135262|69733002|FG002|Overall Study|Progression of disease|0|||
38045185|NCT03135262|69733003|FG003|Overall Study|Progression of disease|1|||
38045186|NCT03135262|69733004|FG004|Overall Study|Progression of disease|0|||
38045187|NCT03135262|69733000|FG000|Overall Study|Death|6|||
38045188|NCT03135262|69733001|FG001|Overall Study|Death|2|||
38045189|NCT03135262|69733002|FG002|Overall Study|Death|2|||
38045190|NCT03135262|69733003|FG003|Overall Study|Death|2|||
38045191|NCT03135262|69733004|FG004|Overall Study|Death|0|||
38045192|NCT03135262|69733000|FG000|Overall Study|Withdrawal by Subject|0|||
38045193|NCT03135262|69733001|FG001|Overall Study|Withdrawal by Subject|0|||
38045194|NCT03135262|69733002|FG002|Overall Study|Withdrawal by Subject|1|||
38045195|NCT03135262|69733003|FG003|Overall Study|Withdrawal by Subject|0|||
38045196|NCT03135262|69733004|FG004|Overall Study|Withdrawal by Subject|1|||
38045197|NCT03135262|69733000|FG000|Overall Study|Study terminated by sponsor|2|||
38045198|NCT03135262|69733001|FG001|Overall Study|Study terminated by sponsor|4|||
38045199|NCT03135262|69733002|FG002|Overall Study|Study terminated by sponsor|4|||
38045200|NCT03135262|69733003|FG003|Overall Study|Study terminated by sponsor|3|||
38045201|NCT03135262|69733004|FG004|Overall Study|Study terminated by sponsor|0|||
38045202|NCT03535194|69733039|FG000|Induction Period|Adverse Event|2|||
38045203|NCT03535194|69733040|FG001|Induction Period|Adverse Event|2|||
38045204|NCT03535194|69733041|FG002|Induction Period|Adverse Event|1|||
38045205|NCT03535194|69733042|FG003|Induction Period|Adverse Event|3|||
38045206|NCT03535194|69733043|FG004|Induction Period|Adverse Event|0|||
38045207|NCT03535194|69733039|FG000|Induction Period|Death|0|||
38045208|NCT03535194|69733040|FG001|Induction Period|Death|1|||
38045209|NCT03535194|69733041|FG002|Induction Period|Death|0|||
38045210|NCT03535194|69733042|FG003|Induction Period|Death|0|||
38045211|NCT03535194|69733043|FG004|Induction Period|Death|0|||
38045212|NCT03535194|69733039|FG000|Induction Period|Lack of Efficacy|1|||
38045213|NCT03535194|69733040|FG001|Induction Period|Lack of Efficacy|3|||
38045214|NCT03535194|69733041|FG002|Induction Period|Lack of Efficacy|2|||
38045215|NCT03535194|69733042|FG003|Induction Period|Lack of Efficacy|2|||
38045216|NCT03535194|69733043|FG004|Induction Period|Lack of Efficacy|0|||
38045217|NCT03535194|69733039|FG000|Induction Period|Lost to Follow-up|3|||
38045218|NCT03535194|69733040|FG001|Induction Period|Lost to Follow-up|5|||
38045219|NCT03535194|69733041|FG002|Induction Period|Lost to Follow-up|2|||
38045220|NCT03535194|69733042|FG003|Induction Period|Lost to Follow-up|3|||
38045221|NCT03535194|69733043|FG004|Induction Period|Lost to Follow-up|0|||
38045222|NCT03535194|69733039|FG000|Induction Period|Physician Decision|1|||
38045223|NCT03535194|69733040|FG001|Induction Period|Physician Decision|1|||
38045224|NCT03535194|69733041|FG002|Induction Period|Physician Decision|0|||
38045225|NCT03535194|69733042|FG003|Induction Period|Physician Decision|0|||
38045226|NCT03535194|69733043|FG004|Induction Period|Physician Decision|0|||
38045227|NCT03535194|69733039|FG000|Induction Period|Protocol Violation|1|||
38045228|NCT03535194|69733040|FG001|Induction Period|Protocol Violation|0|||
38045229|NCT03535194|69733041|FG002|Induction Period|Protocol Violation|0|||
38045230|NCT03535194|69733042|FG003|Induction Period|Protocol Violation|1|||
38045231|NCT03535194|69733043|FG004|Induction Period|Protocol Violation|0|||
38045232|NCT03535194|69733039|FG000|Induction Period|Screen Failure|0|||
38045233|NCT03535194|69733040|FG001|Induction Period|Screen Failure|1|||
38045234|NCT03535194|69733041|FG002|Induction Period|Screen Failure|0|||
38045235|NCT03535194|69733042|FG003|Induction Period|Screen Failure|0|||
38045236|NCT03535194|69733043|FG004|Induction Period|Screen Failure|0|||
38045237|NCT03535194|69733039|FG000|Induction Period|Withdrawal by Subject|3|||
38045238|NCT03535194|69733040|FG001|Induction Period|Withdrawal by Subject|4|||
38045239|NCT03535194|69733041|FG002|Induction Period|Withdrawal by Subject|3|||
38045240|NCT03535194|69733042|FG003|Induction Period|Withdrawal by Subject|2|||
38045241|NCT03535194|69733043|FG004|Induction Period|Withdrawal by Subject|0|||
38045242|NCT03535194|69733039|FG000|Maintenance Period|Adverse Event|6|||
38045243|NCT03535194|69733040|FG001|Maintenance Period|Adverse Event|5|||
38045244|NCT03535194|69733041|FG002|Maintenance Period|Adverse Event|1|||
38045245|NCT03535194|69733042|FG003|Maintenance Period|Adverse Event|11|||
38045246|NCT03535194|69733043|FG004|Maintenance Period|Adverse Event|4|||
38045247|NCT03535194|69733039|FG000|Maintenance Period|Lack of Efficacy|3|||
38045248|NCT03535194|69733040|FG001|Maintenance Period|Lack of Efficacy|2|||
38045249|NCT03535194|69733041|FG002|Maintenance Period|Lack of Efficacy|5|||
38045250|NCT03535194|69733042|FG003|Maintenance Period|Lack of Efficacy|9|||
38045251|NCT03535194|69733043|FG004|Maintenance Period|Lack of Efficacy|0|||
38045252|NCT03535194|69733039|FG000|Maintenance Period|Lost to Follow-up|4|||
38045253|NCT03535194|69733040|FG001|Maintenance Period|Lost to Follow-up|2|||
38045254|NCT03535194|69733041|FG002|Maintenance Period|Lost to Follow-up|1|||
38045255|NCT03535194|69733042|FG003|Maintenance Period|Lost to Follow-up|5|||
38045256|NCT03535194|69733043|FG004|Maintenance Period|Lost to Follow-up|2|||
38045257|NCT03535194|69733039|FG000|Maintenance Period|Other|1|||
38045258|NCT03535194|69733040|FG001|Maintenance Period|Other|2|||
38045259|NCT03535194|69733041|FG002|Maintenance Period|Other|0|||
38045260|NCT03535194|69733042|FG003|Maintenance Period|Other|0|||
38045261|NCT03535194|69733043|FG004|Maintenance Period|Other|0|||
38045262|NCT03535194|69733039|FG000|Maintenance Period|Physician Decision|1|||
38045263|NCT03535194|69733040|FG001|Maintenance Period|Physician Decision|2|||
38045264|NCT03535194|69733041|FG002|Maintenance Period|Physician Decision|0|||
38045265|NCT03535194|69733042|FG003|Maintenance Period|Physician Decision|2|||
38045266|NCT03535194|69733043|FG004|Maintenance Period|Physician Decision|0|||
38045267|NCT03535194|69733039|FG000|Maintenance Period|Pregnancy|0|||
38045268|NCT03535194|69733040|FG001|Maintenance Period|Pregnancy|0|||
38045269|NCT03535194|69733041|FG002|Maintenance Period|Pregnancy|0|||
38045270|NCT03535194|69733042|FG003|Maintenance Period|Pregnancy|2|||
38045271|NCT03535194|69733043|FG004|Maintenance Period|Pregnancy|0|||
38045272|NCT03535194|69733039|FG000|Maintenance Period|Protocol Violation|0|||
38045273|NCT03535194|69733040|FG001|Maintenance Period|Protocol Violation|1|||
38045274|NCT03535194|69733041|FG002|Maintenance Period|Protocol Violation|0|||
38045275|NCT03535194|69733042|FG003|Maintenance Period|Protocol Violation|0|||
38045276|NCT03535194|69733043|FG004|Maintenance Period|Protocol Violation|0|||
38045277|NCT03535194|69733039|FG000|Maintenance Period|Withdrawal by Subject|7|||
38045278|NCT03535194|69733040|FG001|Maintenance Period|Withdrawal by Subject|2|||
38045279|NCT03535194|69733041|FG002|Maintenance Period|Withdrawal by Subject|1|||
38045280|NCT03535194|69733042|FG003|Maintenance Period|Withdrawal by Subject|8|||
38045281|NCT03535194|69733043|FG004|Maintenance Period|Withdrawal by Subject|0|||
38045282|NCT03535194|69733039|FG000|Post-Treatment Followup Period|Adverse Event|4|||
38045283|NCT03535194|69733040|FG001|Post-Treatment Followup Period|Adverse Event|5|||
38045284|NCT03535194|69733041|FG002|Post-Treatment Followup Period|Adverse Event|1|||
38045285|NCT03535194|69733042|FG003|Post-Treatment Followup Period|Adverse Event|8|||
38045286|NCT03535194|69733043|FG004|Post-Treatment Followup Period|Adverse Event|0|||
38045287|NCT03535194|69733039|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
38045288|NCT03535194|69733040|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
38045289|NCT03535194|69733041|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
38045290|NCT03535194|69733042|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
38045291|NCT03535194|69733043|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
38045292|NCT03535194|69733039|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
38045293|NCT03535194|69733040|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
38045294|NCT03535194|69733041|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
38045295|NCT03535194|69733042|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
38045296|NCT03535194|69733043|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
38045297|NCT03535194|69733039|FG000|Post-Treatment Followup Period|Other|1|||
38045298|NCT03535194|69733040|FG001|Post-Treatment Followup Period|Other|0|||
38045299|NCT03535194|69733041|FG002|Post-Treatment Followup Period|Other|0|||
38045300|NCT03535194|69733042|FG003|Post-Treatment Followup Period|Other|5|||
38045301|NCT03535194|69733043|FG004|Post-Treatment Followup Period|Other|0|||
38045302|NCT03535194|69733039|FG000|Post-Treatment Followup Period|Physician Decision|0|||
38045303|NCT03535194|69733040|FG001|Post-Treatment Followup Period|Physician Decision|2|||
38045304|NCT03535194|69733041|FG002|Post-Treatment Followup Period|Physician Decision|1|||
38045305|NCT03535194|69733042|FG003|Post-Treatment Followup Period|Physician Decision|1|||
38045306|NCT03535194|69733043|FG004|Post-Treatment Followup Period|Physician Decision|0|||
38045307|NCT03535194|69733039|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
38045308|NCT03535194|69733040|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
38045309|NCT03535194|69733041|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
38045310|NCT03535194|69733042|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
38045311|NCT03535194|69733043|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
38045312|NCT03559530|69733067|FG000|Overall Study|non-location of medical records|44|||
38045313|NCT03559530|69733068|FG001|Overall Study|non-location of medical records|0|||
38045314|NCT03559530|69733067|FG000|Overall Study|culture results not considered for treat|29|||
38045315|NCT03559530|69733068|FG001|Overall Study|culture results not considered for treat|0|||
38045316|NCT03559530|69733067|FG000|Overall Study|duplicate cases|8|||
38045317|NCT03559530|69733068|FG001|Overall Study|duplicate cases|0|||
38045318|NCT03559530|69733067|FG000|Overall Study|other species of Acinetobacte|7|||
38045319|NCT03559530|69733068|FG001|Overall Study|other species of Acinetobacte|0|||
38045320|NCT03559530|69733067|FG000|Overall Study|contamination / colonization|3|||
38045321|NCT03559530|69733068|FG001|Overall Study|contamination / colonization|0|||
38045322|NCT03124784|69733096|FG000|Overall Study|Adverse Event|1|||
38045323|NCT03124784|69733096|FG000|Overall Study|Computer/Equip Malfunction|1|||
38045324|NCT03531840|69733104|FG000|Overall Study|Death on study|3|||
38045325|NCT03531840|69733105|FG001|Overall Study|Death on study|2|||
38045326|NCT03531840|69733106|FG002|Overall Study|Death on study|1|||
38045327|NCT03531840|69733107|FG003|Overall Study|Death on study|2|||
38045328|NCT03531840|69733104|FG000|Overall Study|Death during follow up|2|||
38045329|NCT03531840|69733105|FG001|Overall Study|Death during follow up|3|||
38045330|NCT03531840|69733106|FG002|Overall Study|Death during follow up|4|||
38045331|NCT03531840|69733107|FG003|Overall Study|Death during follow up|1|||
38045332|NCT03110900|69733124|FG000|Overall Study|Sponsor withdrew|1|||
38045333|NCT03110900|69733125|FG001|Overall Study|Sponsor withdrew|1|||
38045334|NCT03867734|69733131|FG000|Overall Study|Lost to Follow-up|2|||
38045335|NCT03446456|69733141|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
38045336|NCT03446456|69733142|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
38045337|NCT03446456|69733141|FG000|Overall Study|Lost to Follow-up|1|||
38045338|NCT03446456|69733142|FG001|Overall Study|Lost to Follow-up|3|||
38045339|NCT03446456|69733141|FG000|Overall Study|Participant failed the toxicology test|1|||
38045340|NCT03446456|69733142|FG001|Overall Study|Participant failed the toxicology test|0|||
38045341|NCT03446456|69733141|FG000|Overall Study|Break down of the experimental equipment|1|||
38045342|NCT03446456|69733142|FG001|Overall Study|Break down of the experimental equipment|0|||
38045343|NCT03495102|69733151|FG000|Overall Study|Adverse Event|5|||
38045344|NCT03495102|69733152|FG001|Overall Study|Adverse Event|7|||
38045345|NCT03495102|69733153|FG002|Overall Study|Adverse Event|10|||
38045346|NCT03495102|69733151|FG000|Overall Study|Death|3|||
38045347|NCT03495102|69733152|FG001|Overall Study|Death|4|||
38045348|NCT03495102|69733153|FG002|Overall Study|Death|4|||
38045349|NCT03495102|69733151|FG000|Overall Study|Lost to Follow-up|15|||
38045350|NCT03495102|69733152|FG001|Overall Study|Lost to Follow-up|16|||
38045351|NCT03495102|69733153|FG002|Overall Study|Lost to Follow-up|17|||
38045352|NCT03495102|69733151|FG000|Overall Study|Physician Decision|2|||
38045353|NCT03495102|69733152|FG001|Overall Study|Physician Decision|0|||
38045354|NCT03495102|69733153|FG002|Overall Study|Physician Decision|2|||
38045355|NCT03495102|69733151|FG000|Overall Study|Withdrawal by Subject|25|||
38045356|NCT03495102|69733152|FG001|Overall Study|Withdrawal by Subject|36|||
38045357|NCT03495102|69733153|FG002|Overall Study|Withdrawal by Subject|18|||
38045358|NCT03495102|69733151|FG000|Overall Study|Protocol Violation|1|||
38045359|NCT03495102|69733152|FG001|Overall Study|Protocol Violation|1|||
38045360|NCT03495102|69733153|FG002|Overall Study|Protocol Violation|0|||
38045361|NCT03495102|69733151|FG000|Overall Study|Site Closure|3|||
38045362|NCT03495102|69733152|FG001|Overall Study|Site Closure|1|||
38045363|NCT03495102|69733153|FG002|Overall Study|Site Closure|2|||
38045364|NCT03495102|69733151|FG000|Overall Study|Non-compliance|1|||
38045365|NCT03495102|69733152|FG001|Overall Study|Non-compliance|0|||
38045366|NCT03495102|69733153|FG002|Overall Study|Non-compliance|0|||
38045367|NCT03495102|69733151|FG000|Overall Study|Participant Duplicated at Another Site|0|||
38045368|NCT03495102|69733152|FG001|Overall Study|Participant Duplicated at Another Site|0|||
38045369|NCT03495102|69733153|FG002|Overall Study|Participant Duplicated at Another Site|1|||
38045370|NCT03495102|69733151|FG000|Overall Study|Primary Care Physician Recommendation|0|||
38045371|NCT03495102|69733152|FG001|Overall Study|Primary Care Physician Recommendation|1|||
38045372|NCT03495102|69733153|FG002|Overall Study|Primary Care Physician Recommendation|0|||
38045373|NCT03495102|69733151|FG000|Overall Study|Relocated to Another Country|0|||
38045374|NCT03495102|69733152|FG001|Overall Study|Relocated to Another Country|1|||
38045375|NCT03495102|69733153|FG002|Overall Study|Relocated to Another Country|0|||
38045376|NCT03495102|69733151|FG000|Overall Study|Participant was in Rehabilitation|1|||
38045377|NCT03495102|69733152|FG001|Overall Study|Participant was in Rehabilitation|0|||
38045378|NCT03495102|69733153|FG002|Overall Study|Participant was in Rehabilitation|0|||
38045379|NCT03105362|69733161|FG000|Overall Study|Withdrawal by Subject|1|||
38045380|NCT03105362|69733161|FG000|Overall Study|Lost to Follow-up|1|||
38045381|NCT03559218|69733170|FG000|Overall Study|Withdrawal by Subject|1|||
38045382|NCT03559218|69733171|FG001|Overall Study|Withdrawal by Subject|0|||
38045383|NCT03104816|69733180|FG000|Overall Study|Lack of Efficacy|0|||
38045384|NCT03104816|69733181|FG001|Overall Study|Lack of Efficacy|2|||
38045385|NCT03104816|69733182|FG002|Overall Study|Lack of Efficacy|0|||
38045386|NCT03104816|69733180|FG000|Overall Study|Protocol Violation|2|||
38045387|NCT03104816|69733181|FG001|Overall Study|Protocol Violation|0|||
38045388|NCT03104816|69733182|FG002|Overall Study|Protocol Violation|2|||
38045389|NCT03559062|69733193|FG000|Overall Study|Other|0|||
38045390|NCT03559062|69733194|FG001|Overall Study|Other|1|||
38045391|NCT03559062|69733195|FG002|Overall Study|Other|0|||
38045392|NCT00089791|69733206|FG000|Overall Study|Physician Decision|6|||
38045393|NCT00089791|69733207|FG001|Overall Study|Physician Decision|3|||
38045394|NCT00089791|69733206|FG000|Overall Study|Adverse Event|81|||
38045395|NCT00089791|69733207|FG001|Overall Study|Adverse Event|93|||
38045396|NCT00089791|69733206|FG000|Overall Study|Withdrawal by Subject|403|||
38045397|NCT00089791|69733207|FG001|Overall Study|Withdrawal by Subject|344|||
38045398|NCT00089791|69733206|FG000|Overall Study|Death|78|||
38045399|NCT00089791|69733207|FG001|Overall Study|Death|62|||
38045400|NCT00089791|69733206|FG000|Overall Study|Disease progression|7|||
38045401|NCT00089791|69733207|FG001|Overall Study|Disease progression|3|||
38045402|NCT00089791|69733206|FG000|Overall Study|Ineligibility determined|12|||
38045403|NCT00089791|69733207|FG001|Overall Study|Ineligibility determined|9|||
38045404|NCT00089791|69733206|FG000|Overall Study|Lost to Follow-up|57|||
38045405|NCT00089791|69733207|FG001|Overall Study|Lost to Follow-up|57|||
38045406|NCT00089791|69733206|FG000|Overall Study|Noncompliance|17|||
38045407|NCT00089791|69733207|FG001|Overall Study|Noncompliance|13|||
38045408|NCT00089791|69733206|FG000|Overall Study|Other|20|||
38045409|NCT00089791|69733207|FG001|Overall Study|Other|32|||
38045410|NCT00089791|69733206|FG000|Overall Study|Protocol deviation|12|||
38045411|NCT00089791|69733207|FG001|Overall Study|Protocol deviation|10|||
38045412|NCT00089791|69733206|FG000|Overall Study|Requirement for alternative therapy|7|||
38045413|NCT00089791|69733207|FG001|Overall Study|Requirement for alternative therapy|4|||
38045414|NCT03558672|69733213|FG000|Overall Study|Study Early Termination|10|||
38045415|NCT03558516|69733219|FG000|Overall Study|Protocol Violation|2|||
38045416|NCT03558516|69733220|FG001|Overall Study|Protocol Violation|2|||
38045417|NCT03557970|69733228|FG000|Overall Study|Study closure|1|||
38045418|NCT03557970|69733229|FG001|Overall Study|Study closure|0|||
38045419|NCT03557970|69733228|FG000|Overall Study|Physician Decision|0|||
38045420|NCT03557970|69733229|FG001|Overall Study|Physician Decision|1|||
38045421|NCT03557970|69733228|FG000|Overall Study|Death|0|||
38045422|NCT03557970|69733229|FG001|Overall Study|Death|1|||
38045423|NCT02815280|69733237|FG000|Double-Blind Phase|Adverse Event|1|||
38045424|NCT02815280|69733238|FG001|Double-Blind Phase|Adverse Event|1|||
38045425|NCT02815280|69733237|FG000|Double-Blind Phase|Lost to Follow-up|10|||
38045426|NCT02815280|69733238|FG001|Double-Blind Phase|Lost to Follow-up|9|||
38045427|NCT02815280|69733237|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
38045428|NCT02815280|69733238|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
38045429|NCT02815280|69733237|FG000|Double-Blind Phase|Protocol Violation|2|||
38045430|NCT02815280|69733238|FG001|Double-Blind Phase|Protocol Violation|2|||
38045431|NCT02815280|69733237|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
38045432|NCT02815280|69733238|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
38045433|NCT02815280|69733237|FG000|Open-Label Phase|Adverse Event|2|||
38045434|NCT02815280|69733238|FG001|Open-Label Phase|Adverse Event|3|||
38045435|NCT02815280|69733237|FG000|Open-Label Phase|Lost to Follow-up|18|||
38045436|NCT02815280|69733238|FG001|Open-Label Phase|Lost to Follow-up|9|||
38045437|NCT02815280|69733237|FG000|Open-Label Phase|Withdrawal by Subject|33|||
38045438|NCT02815280|69733238|FG001|Open-Label Phase|Withdrawal by Subject|18|||
38045439|NCT02815280|69733237|FG000|Open-Label Phase|Protocol Violation|3|||
38045440|NCT02815280|69733238|FG001|Open-Label Phase|Protocol Violation|0|||
38045441|NCT02815280|69733237|FG000|Open-Label Phase|Administrative|26|||
38045442|NCT02815280|69733238|FG001|Open-Label Phase|Administrative|12|||
38045443|NCT02815280|69733237|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
38045444|NCT02815280|69733238|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
38045445|NCT02737930|69733250|FG000|Overall Study|Withdrawal by Subject|0|||
37953417|NCT00713609|69640341|FG004|Overall Study|Lost to Follow-up|7|||
37953418|NCT00713609|69640342|FG005|Overall Study|Lost to Follow-up|0|||
37953419|NCT00713609|69640337|FG000|Overall Study|Lack of Efficacy|1|||
37953420|NCT00713609|69640338|FG001|Overall Study|Lack of Efficacy|3|||
37953421|NCT00713609|69640339|FG002|Overall Study|Lack of Efficacy|0|||
37953422|NCT00713609|69640340|FG003|Overall Study|Lack of Efficacy|0|||
37953423|NCT00713609|69640341|FG004|Overall Study|Lack of Efficacy|1|||
38045446|NCT02737930|69733251|FG001|Overall Study|Withdrawal by Subject|1|||
38045447|NCT03493698|69733257|FG000|Treatment Period C|Adverse Event|1|||
38045448|NCT03493698|69733257|FG000|Treatment Period C|Withdrawal by Subject|1|||
38045449|NCT02737852|69733271|FG000|Overall Study|Withdrawal by Subject|2|||
38045450|NCT03528174|69733275|FG000|Overall Study|Adverse Event|1|||
38045451|NCT03528174|69733275|FG000|Overall Study|sensors dislodged|1|||
38045452|NCT03109184|69733285|FG000|Overall Study|Lost to Follow-up|6|||
38045453|NCT03109184|69733286|FG001|Overall Study|Lost to Follow-up|6|||
38045454|NCT03109184|69733285|FG000|Overall Study|Withdrawal by Subject|1|||
38045455|NCT03109184|69733286|FG001|Overall Study|Withdrawal by Subject|1|||
38045456|NCT03493386|69733304|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
38045457|NCT03493386|69733305|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
38045458|NCT03493386|69733306|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
38045459|NCT03493386|69733307|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
37953424|NCT00713609|69640342|FG005|Overall Study|Lack of Efficacy|0|||
37953425|NCT00713609|69640337|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
37953426|NCT00713609|69640338|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
38045460|NCT03478644|69733326|FG000|Phase 2|Withdrawal by Subject|2|||
38045461|NCT03478644|69733327|FG001|Phase 2|Withdrawal by Subject|1|||
38045462|NCT03478644|69733326|FG000|Phase 2|Lost to Follow-up|1|||
38045463|NCT03478644|69733327|FG001|Phase 2|Lost to Follow-up|0|||
38045464|NCT03527550|69733335|FG000|Overall Study|Lost to Follow-up|4|||
38045465|NCT03527550|69733336|FG001|Overall Study|Lost to Follow-up|2|||
38045466|NCT03527550|69733335|FG000|Overall Study|Withdrawal by Subject|4|||
38045467|NCT03527550|69733336|FG001|Overall Study|Withdrawal by Subject|1|||
38045468|NCT03527550|69733335|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
38045469|NCT03527550|69733336|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
38045470|NCT03475056|69733346|FG000|Overall Study|Lost to Follow-up|0|||
38045471|NCT03475056|69733347|FG001|Overall Study|Lost to Follow-up|1|||
38045472|NCT03475056|69733346|FG000|Overall Study|Moved from Area|0|||
38045473|NCT03475056|69733347|FG001|Overall Study|Moved from Area|2|||
38045474|NCT00938912|69733354|FG000|Overall Study|Withdrawal by Subject|28|||
38045475|NCT00938912|69733354|FG000|Overall Study|Lost to Follow-up|4|||
38045476|NCT00938912|69733354|FG000|Overall Study|Lack of Efficacy|43|||
38045477|NCT00938912|69733354|FG000|Overall Study|Adverse event, non-fatal|24|||
38045478|NCT00938912|69733354|FG000|Overall Study|Adverse event, fatal|1|||
38045479|NCT00938912|69733354|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
38045480|NCT00938912|69733354|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
38045481|NCT00938912|69733354|FG000|Overall Study|Participant needed prohibit medication|1|||
38045482|NCT00938912|69733354|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
38045483|NCT00938912|69733354|FG000|Overall Study|Did not meet Eligibility criteria|1|||
38045484|NCT00938912|69733354|FG000|Overall Study|Participant relocated not related to AE|1|||
38045485|NCT00938912|69733354|FG000|Overall Study|Participant moved to another city|1|||
38045486|NCT00938912|69733354|FG000|Overall Study|Participant experienced break through seizures|1|||
38045487|NCT00938912|69733354|FG000|Overall Study|No longer wished to participate in the study|1|||
38045488|NCT00938912|69733354|FG000|Overall Study|Protocol Deviation|2|||
38045489|NCT03473808|69733361|FG000|Overall Study|Withdrawal by Subject|1|||
38045490|NCT03473340|69733367|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
38045491|NCT03473340|69733368|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
38045492|NCT03473340|69733367|FG000|Overall Study|Withdrawal by Subject|1|||
38045493|NCT03473340|69733368|FG001|Overall Study|Withdrawal by Subject|0|||
38045494|NCT03473340|69733367|FG000|Overall Study|Lost to Follow-up|1|||
38045495|NCT03473340|69733368|FG001|Overall Study|Lost to Follow-up|2|||
38045496|NCT03490032|69733377|FG000|Overall Study|family issue (child custody)|1|||
38045497|NCT03490032|69733378|FG001|Overall Study|family issue (child custody)|0|||
38045498|NCT03490032|69733379|FG002|Overall Study|family issue (child custody)|0|||
38045499|NCT03489720|69733399|FG000|Overall Study|Withdrawal by Subject|2|||
38045500|NCT03489720|69733400|FG001|Overall Study|Withdrawal by Subject|0|||
38045501|NCT03527160|69733412|FG000|Overall Study|No urine collected|13|||
38045502|NCT03527160|69733412|FG000|Overall Study|No clinical serum creatinine collected|6|||
38045503|NCT03527160|69733412|FG000|Overall Study|Did not meet inclusion|2|||
38045504|NCT03739138|69733422|FG000|Overall Study|Death|0|||
38045505|NCT03739138|69733423|FG001|Overall Study|Death|7|||
38045506|NCT03739138|69733424|FG002|Overall Study|Death|4|||
38045507|NCT03739138|69733425|FG003|Overall Study|Death|13|||
38045508|NCT03739138|69733426|FG004|Overall Study|Death|0|||
38045509|NCT03739138|69733422|FG000|Overall Study|Lost to Follow-up|0|||
38045510|NCT03739138|69733423|FG001|Overall Study|Lost to Follow-up|0|||
38045511|NCT03739138|69733424|FG002|Overall Study|Lost to Follow-up|1|||
38045512|NCT03739138|69733425|FG003|Overall Study|Lost to Follow-up|0|||
38045513|NCT03739138|69733426|FG004|Overall Study|Lost to Follow-up|0|||
38045514|NCT03739138|69733422|FG000|Overall Study|Study Terminated By Sponsor|0|||
38045515|NCT03739138|69733423|FG001|Overall Study|Study Terminated By Sponsor|0|||
38045516|NCT03739138|69733424|FG002|Overall Study|Study Terminated By Sponsor|0|||
38045517|NCT03739138|69733425|FG003|Overall Study|Study Terminated By Sponsor|4|||
38045518|NCT03739138|69733426|FG004|Overall Study|Study Terminated By Sponsor|0|||
38045519|NCT03739138|69733422|FG000|Overall Study|Withdrawal by Subject|0|||
38045520|NCT03739138|69733423|FG001|Overall Study|Withdrawal by Subject|0|||
38045521|NCT03739138|69733424|FG002|Overall Study|Withdrawal by Subject|0|||
38045522|NCT03739138|69733425|FG003|Overall Study|Withdrawal by Subject|1|||
38045523|NCT03739138|69733426|FG004|Overall Study|Withdrawal by Subject|0|||
38045524|NCT03472326|69733436|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
38045525|NCT03472326|69733437|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
38045526|NCT03472326|69733438|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
38045527|NCT03472326|69733439|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
38045528|NCT03472326|69733436|FG000|Part 2: Combination Therapy|Pregnancy|0|||
38045529|NCT03472326|69733437|FG001|Part 2: Combination Therapy|Pregnancy|0|||
38045530|NCT03472326|69733438|FG002|Part 2: Combination Therapy|Pregnancy|0|||
38045531|NCT03472326|69733439|FG003|Part 2: Combination Therapy|Pregnancy|1|||
38045532|NCT02737618|69733448|FG000|Overall Study|Withdrawal by Subject|9|||
38045533|NCT03472014|69733452|FG000|Overall Study|Lost to Follow-up|4|||
38045534|NCT03526458|69733458|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
37953427|NCT00713609|69640339|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
38045535|NCT03526458|69733459|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
38045536|NCT03526458|69733458|FG000|Overall Study|Stone passed, surgery cancelled|2|||
38045537|NCT03526458|69733459|FG001|Overall Study|Stone passed, surgery cancelled|1|||
38045538|NCT03526458|69733458|FG000|Overall Study|Withdrawal by Subject|1|||
38045539|NCT03526458|69733459|FG001|Overall Study|Withdrawal by Subject|0|||
38045540|NCT03526458|69733458|FG000|Overall Study|Physician Decision|2|||
38045541|NCT03526458|69733459|FG001|Overall Study|Physician Decision|1|||
38045542|NCT03526458|69733458|FG000|Overall Study|Lack of equipment|1|||
38045543|NCT03526458|69733459|FG001|Overall Study|Lack of equipment|1|||
38045544|NCT03488238|69733465|FG000|Overall Study|Equipment malfunction|1|||
38045545|NCT03488238|69733465|FG000|Overall Study|Adverse Event|1|||
38045546|NCT03525834|69733469|FG000|Overall Study|Progressive disease|1|||
38045547|NCT03525444|69733511|FG000|Overall Study|Adverse Event|0|||
38045548|NCT03525444|69733512|FG001|Overall Study|Adverse Event|1|||
38045549|NCT03525444|69733511|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
38045550|NCT03525444|69733512|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
38045551|NCT03525444|69733511|FG000|Overall Study|Other|0|||
38045552|NCT03525444|69733512|FG001|Overall Study|Other|1|||
38045553|NCT03487848|69733519|FG000|Overall Study|Lost to Follow-up|1|||
38045554|NCT03524664|69733525|FG000|Overall Study|Withdrawal by Subject|1|||
38045555|NCT03524664|69733526|FG001|Overall Study|Withdrawal by Subject|2|||
38045556|NCT03524664|69733525|FG000|Overall Study|Lost to Follow-up|4|||
38045557|NCT03524664|69733526|FG001|Overall Study|Lost to Follow-up|13|||
38045558|NCT04377620|69733535|FG000|Overall Study|Death|42|||
38045559|NCT04377620|69733536|FG001|Overall Study|Death|48|||
38045560|NCT04377620|69733537|FG002|Overall Study|Death|36|||
38045561|NCT04377620|69733535|FG000|Overall Study|Withdrawal by Subject|0|||
38045562|NCT04377620|69733536|FG001|Overall Study|Withdrawal by Subject|2|||
38045563|NCT04377620|69733537|FG002|Overall Study|Withdrawal by Subject|0|||
38045564|NCT03486834|69733549|FG000|Overall Study|Withdrawal by Subject|46|||
38045565|NCT03486834|69733550|FG001|Overall Study|Withdrawal by Subject|46|||
38045566|NCT03486834|69733551|FG002|Overall Study|Withdrawal by Subject|52|||
38045567|NCT03486834|69733549|FG000|Overall Study|Adverse Event|8|||
38045568|NCT03486834|69733550|FG001|Overall Study|Adverse Event|7|||
38045569|NCT03486834|69733551|FG002|Overall Study|Adverse Event|0|||
38045570|NCT03486834|69733549|FG000|Overall Study|Lost to Follow-up|41|||
38045571|NCT03486834|69733550|FG001|Overall Study|Lost to Follow-up|24|||
38045572|NCT03486834|69733551|FG002|Overall Study|Lost to Follow-up|39|||
38045573|NCT03486834|69733549|FG000|Overall Study|Non-compliance with Study Drug|2|||
38045574|NCT03486834|69733550|FG001|Overall Study|Non-compliance with Study Drug|2|||
38045575|NCT03486834|69733551|FG002|Overall Study|Non-compliance with Study Drug|0|||
38045576|NCT03486834|69733549|FG000|Overall Study|Physician Decision|5|||
38045577|NCT03486834|69733550|FG001|Overall Study|Physician Decision|2|||
38045578|NCT03486834|69733551|FG002|Overall Study|Physician Decision|3|||
38045579|NCT03486834|69733549|FG000|Overall Study|Pregnancy|10|||
38045580|NCT03486834|69733550|FG001|Overall Study|Pregnancy|12|||
38045581|NCT03486834|69733551|FG002|Overall Study|Pregnancy|12|||
38045582|NCT03486834|69733549|FG000|Overall Study|Protocol Deviation|2|||
38045583|NCT03486834|69733550|FG001|Overall Study|Protocol Deviation|3|||
38045584|NCT03486834|69733551|FG002|Overall Study|Protocol Deviation|3|||
38045585|NCT03486834|69733549|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
38045586|NCT03486834|69733550|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
38045587|NCT03486834|69733551|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
38045588|NCT03486834|69733549|FG000|Overall Study|Randomized but not treated|4|||
38045589|NCT03486834|69733550|FG001|Overall Study|Randomized but not treated|4|||
38045590|NCT03486834|69733551|FG002|Overall Study|Randomized but not treated|1|||
38045591|NCT03522948|69733561|FG000|Overall Study|Lost to Follow-up|1|||
38045592|NCT03406078|69733567|FG000|Overall Study|Death|1|||
38045593|NCT03406078|69733568|FG001|Overall Study|Death|0|||
38045594|NCT03406078|69733567|FG000|Overall Study|Lost to Follow-up|0|||
38045595|NCT03406078|69733568|FG001|Overall Study|Lost to Follow-up|1|||
38045596|NCT03406078|69733567|FG000|Overall Study|Withdrawal by Subject|5|||
38045597|NCT03406078|69733568|FG001|Overall Study|Withdrawal by Subject|2|||
38045598|NCT03634033|69733581|FG000|Overall Study|Did not have a post-assessment|384|||
38045599|NCT03634033|69733582|FG001|Overall Study|Did not have a post-assessment|291|||
38045600|NCT03634033|69733583|FG002|Overall Study|Did not have a post-assessment|114|||
38045601|NCT03634033|69733584|FG003|Overall Study|Did not have a post-assessment|161|||
38045602|NCT03634033|69733585|FG004|Overall Study|Did not have a post-assessment|5|||
38045603|NCT03634033|69733586|FG005|Overall Study|Did not have a post-assessment|0|||
38045604|NCT03634033|69733587|FG006|Overall Study|Did not have a post-assessment|0|||
38045605|NCT03634033|69733581|FG000|Overall Study|Death|0|||
38045606|NCT03634033|69733582|FG001|Overall Study|Death|0|||
38045607|NCT03634033|69733583|FG002|Overall Study|Death|0|||
38045608|NCT03634033|69733584|FG003|Overall Study|Death|0|||
38045609|NCT03634033|69733585|FG004|Overall Study|Death|0|||
38045610|NCT03634033|69733586|FG005|Overall Study|Death|7|||
38045611|NCT03634033|69733587|FG006|Overall Study|Death|7|||
38045612|NCT03634033|69733581|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
38045613|NCT03634033|69733582|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
38045614|NCT03634033|69733583|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
38045615|NCT03634033|69733584|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
38045616|NCT03634033|69733585|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
38045617|NCT03634033|69733586|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
38045618|NCT03634033|69733587|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
38045619|NCT03634033|69733581|FG000|Overall Study|Lost to Follow-up|0|||
38045620|NCT03634033|69733582|FG001|Overall Study|Lost to Follow-up|0|||
38045621|NCT03634033|69733583|FG002|Overall Study|Lost to Follow-up|0|||
38045622|NCT03634033|69733584|FG003|Overall Study|Lost to Follow-up|0|||
38045623|NCT03634033|69733585|FG004|Overall Study|Lost to Follow-up|0|||
38045624|NCT03634033|69733586|FG005|Overall Study|Lost to Follow-up|1|||
38045625|NCT03634033|69733587|FG006|Overall Study|Lost to Follow-up|2|||
38045626|NCT03634033|69733581|FG000|Overall Study|Withdrawal by Subject|0|||
38045627|NCT03634033|69733582|FG001|Overall Study|Withdrawal by Subject|0|||
38045628|NCT03634033|69733583|FG002|Overall Study|Withdrawal by Subject|0|||
38045629|NCT03634033|69733584|FG003|Overall Study|Withdrawal by Subject|0|||
38045630|NCT03634033|69733585|FG004|Overall Study|Withdrawal by Subject|0|||
38045631|NCT03634033|69733586|FG005|Overall Study|Withdrawal by Subject|0|||
38045632|NCT03634033|69733587|FG006|Overall Study|Withdrawal by Subject|1|||
38045633|NCT03103100|69733621|FG000|Overall Study|Adverse Event|1|||
38045634|NCT03103100|69733622|FG001|Overall Study|Adverse Event|0|||
38045635|NCT03103100|69733623|FG002|Overall Study|Adverse Event|0|||
38045636|NCT03103100|69733621|FG000|Overall Study|Physician Decision|1|||
38045637|NCT03103100|69733622|FG001|Overall Study|Physician Decision|0|||
38045638|NCT03103100|69733623|FG002|Overall Study|Physician Decision|2|||
38045639|NCT03438006|69733631|FG000|Overall Study|Adverse Event|1|||
38045640|NCT03438006|69733631|FG000|Overall Study|Lost to Follow-up|67|||
38045641|NCT03438006|69733631|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
38045642|NCT03438006|69733631|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
38045643|NCT04206020|69733637|FG000|Overall Study|Adverse Event|1|||
38045644|NCT04206020|69733638|FG001|Overall Study|Adverse Event|4|||
38045645|NCT04206020|69733637|FG000|Overall Study|Protocol Violation|2|||
38045646|NCT04206020|69733638|FG001|Overall Study|Protocol Violation|0|||
38045647|NCT04206020|69733637|FG000|Overall Study|Withdrawal by Subject|2|||
38045648|NCT04206020|69733638|FG001|Overall Study|Withdrawal by Subject|0|||
38045649|NCT04206020|69733637|FG000|Overall Study|Lost to Follow-up|2|||
38045650|NCT04206020|69733638|FG001|Overall Study|Lost to Follow-up|0|||
38045651|NCT04206020|69733637|FG000|Overall Study|Pregnancy|0|||
38045652|NCT04206020|69733638|FG001|Overall Study|Pregnancy|1|||
38045653|NCT04206020|69733637|FG000|Overall Study|Unable to attend visits|1|||
38045654|NCT04206020|69733638|FG001|Overall Study|Unable to attend visits|2|||
38045655|NCT03466086|69733644|FG000|Period 1|Sponsor decision due to study timeline|1|||
38045656|NCT03466086|69733645|FG001|Period 1|Sponsor decision due to study timeline|0|||
38045657|NCT03466086|69733644|FG000|Period 1|Withdrawal by Subject|1|||
38045658|NCT03466086|69733645|FG001|Period 1|Withdrawal by Subject|0|||
38045659|NCT03101462|69733653|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
38045660|NCT03101462|69733654|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
38045661|NCT02873936|69733663|FG000|Overall Study|Withdrew Consent|4|||
38045662|NCT02873936|69733664|FG001|Overall Study|Withdrew Consent|11|||
38045663|NCT02873936|69733665|FG002|Overall Study|Withdrew Consent|20|||
38045664|NCT02873936|69733663|FG000|Overall Study|Investigator's Discretion|3|||
38045665|NCT02873936|69733664|FG001|Overall Study|Investigator's Discretion|5|||
38045666|NCT02873936|69733665|FG002|Overall Study|Investigator's Discretion|4|||
38045667|NCT02873936|69733663|FG000|Overall Study|Adverse Event|3|||
38045668|NCT02873936|69733664|FG001|Overall Study|Adverse Event|5|||
38045669|NCT02873936|69733665|FG002|Overall Study|Adverse Event|3|||
38045670|NCT02873936|69733663|FG000|Overall Study|Protocol Violation|0|||
38045671|NCT02873936|69733664|FG001|Overall Study|Protocol Violation|1|||
38045672|NCT02873936|69733665|FG002|Overall Study|Protocol Violation|3|||
38045673|NCT02873936|69733663|FG000|Overall Study|Lost to Follow-up|1|||
38045674|NCT02873936|69733664|FG001|Overall Study|Lost to Follow-up|1|||
38045675|NCT02873936|69733665|FG002|Overall Study|Lost to Follow-up|1|||
38045676|NCT02873936|69733663|FG000|Overall Study|Non-compliance With Study Drug|1|||
38045677|NCT02873936|69733664|FG001|Overall Study|Non-compliance With Study Drug|0|||
38045678|NCT02873936|69733665|FG002|Overall Study|Non-compliance With Study Drug|1|||
38045679|NCT02873936|69733663|FG000|Overall Study|Randomized but not Dosed|1|||
38045680|NCT02873936|69733664|FG001|Overall Study|Randomized but not Dosed|0|||
38045681|NCT02873936|69733665|FG002|Overall Study|Randomized but not Dosed|0|||
38045682|NCT02874794|69733675|FG000|Overall Study|Physician Decision|3|||
38045683|NCT02874794|69733676|FG001|Overall Study|Physician Decision|2|||
38045684|NCT02874794|69733675|FG000|Overall Study|Withdrawal by Subject|2|||
38045685|NCT02874794|69733676|FG001|Overall Study|Withdrawal by Subject|8|||
38045686|NCT02874794|69733675|FG000|Overall Study|Death|2|||
38045687|NCT02874794|69733676|FG001|Overall Study|Death|1|||
38045688|NCT03102710|69733688|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
38045689|NCT03102710|69733689|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
38045690|NCT03102710|69733690|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
38045691|NCT03102710|69733688|FG000|Overall Study|Technical issues during final MRI scan|0|||
38045692|NCT03102710|69733689|FG001|Overall Study|Technical issues during final MRI scan|1|||
38045693|NCT03102710|69733690|FG002|Overall Study|Technical issues during final MRI scan|0|||
38045694|NCT03102710|69733688|FG000|Overall Study|Nausea during MRI scan|0|||
38045695|NCT03102710|69733689|FG001|Overall Study|Nausea during MRI scan|1|||
38045696|NCT03102710|69733690|FG002|Overall Study|Nausea during MRI scan|0|||
38045697|NCT03102710|69733688|FG000|Overall Study|Subject unable to attend final session|0|||
38045698|NCT03102710|69733689|FG001|Overall Study|Subject unable to attend final session|1|||
38045699|NCT03102710|69733690|FG002|Overall Study|Subject unable to attend final session|0|||
38045700|NCT03101150|69733700|FG000|Overall Study|Lost to Follow-up|2|||
38045701|NCT03101150|69733701|FG001|Overall Study|Lost to Follow-up|4|||
38045702|NCT03101150|69733700|FG000|Overall Study|Miscarriage|3|||
38045703|NCT03101150|69733701|FG001|Overall Study|Miscarriage|6|||
38045704|NCT03101930|69733710|FG000|Overall Study|Withdrawal by Subject|2|||
38045705|NCT03101930|69733711|FG001|Overall Study|Withdrawal by Subject|1|||
38045706|NCT03101930|69733712|FG002|Overall Study|Withdrawal by Subject|2|||
38045707|NCT02928848|69733722|FG000|Arm 2|Withdrawal by Subject|1|||
38045708|NCT02928848|69733723|FG001|Arm 2|Withdrawal by Subject|0|||
38045709|NCT02928770|69733731|FG000|Overall Study|Withdrawal by Subject|2|||
38045710|NCT03100838|69733735|FG000|Overall Study|Adverse Event|1|||
38045711|NCT03100838|69733736|FG001|Overall Study|Adverse Event|0|||
38045712|NCT03100838|69733737|FG002|Overall Study|Adverse Event|0|||
38045713|NCT03100838|69733738|FG003|Overall Study|Adverse Event|0|||
38045714|NCT03100838|69733735|FG000|Overall Study|Physician Decision|1|||
38045715|NCT03100838|69733736|FG001|Overall Study|Physician Decision|1|||
38045716|NCT03100838|69733737|FG002|Overall Study|Physician Decision|1|||
38045717|NCT03100838|69733738|FG003|Overall Study|Physician Decision|1|||
38045718|NCT03100838|69733735|FG000|Overall Study|Pregnancy|0|||
38045719|NCT03100838|69733736|FG001|Overall Study|Pregnancy|1|||
38045720|NCT03100838|69733737|FG002|Overall Study|Pregnancy|0|||
38045721|NCT03100838|69733738|FG003|Overall Study|Pregnancy|0|||
38045722|NCT03100838|69733735|FG000|Overall Study|Lost to Follow-up|0|||
38045723|NCT03100838|69733736|FG001|Overall Study|Lost to Follow-up|0|||
38045724|NCT03100838|69733737|FG002|Overall Study|Lost to Follow-up|1|||
38045725|NCT03100838|69733738|FG003|Overall Study|Lost to Follow-up|0|||
38045726|NCT03480750|69733754|FG000|Overall Study|Withdrawal by Subject|0|||
38045727|NCT03480750|69733755|FG001|Overall Study|Withdrawal by Subject|1|||
38045728|NCT03480750|69733756|FG002|Overall Study|Withdrawal by Subject|0|||
38045729|NCT03480750|69733757|FG003|Overall Study|Withdrawal by Subject|0|||
38045730|NCT03480750|69733758|FG004|Overall Study|Withdrawal by Subject|0|||
38045731|NCT03480750|69733759|FG005|Overall Study|Withdrawal by Subject|0|||
38045732|NCT03480750|69733754|FG000|Overall Study|The interruption in Trientine shippment|0|||
38045733|NCT03480750|69733755|FG001|Overall Study|The interruption in Trientine shippment|0|||
38045734|NCT03480750|69733756|FG002|Overall Study|The interruption in Trientine shippment|0|||
38045735|NCT03480750|69733757|FG003|Overall Study|The interruption in Trientine shippment|0|||
38045736|NCT03480750|69733758|FG004|Overall Study|The interruption in Trientine shippment|0|||
38045737|NCT03480750|69733759|FG005|Overall Study|The interruption in Trientine shippment|1|||
38045738|NCT03412734|69733784|FG000|Overall Study|Incorrect labeling of samples|2|||
38045739|NCT03412734|69733785|FG001|Overall Study|Incorrect labeling of samples|0|||
38045740|NCT03412734|69733784|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
38045741|NCT03412734|69733785|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
38045742|NCT02374814|69733797|FG000|Overall Study|Lost to Follow-up|1|||
38045743|NCT02374814|69733798|FG001|Overall Study|Lost to Follow-up|1|||
38045744|NCT02374814|69733799|FG002|Overall Study|Lost to Follow-up|0|||
38045745|NCT02374814|69733800|FG003|Overall Study|Lost to Follow-up|1|||
38045746|NCT02374814|69733801|FG004|Overall Study|Lost to Follow-up|0|||
38045747|NCT02374814|69733802|FG005|Overall Study|Lost to Follow-up|0|||
38045748|NCT02374814|69733797|FG000|Overall Study|Withdrawal by Subject|0|||
38045749|NCT02374814|69733798|FG001|Overall Study|Withdrawal by Subject|0|||
38045750|NCT02374814|69733799|FG002|Overall Study|Withdrawal by Subject|1|||
38045751|NCT02374814|69733800|FG003|Overall Study|Withdrawal by Subject|1|||
38045752|NCT02374814|69733801|FG004|Overall Study|Withdrawal by Subject|0|||
38045753|NCT02374814|69733802|FG005|Overall Study|Withdrawal by Subject|0|||
38045754|NCT04608344|69733826|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
38045755|NCT04608344|69733827|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
38045756|NCT04608344|69733826|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
38045757|NCT04608344|69733827|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
38045758|NCT03433482|69733845|FG000|Overall Study|Lost to Follow-up|1|||
38045759|NCT03433482|69733846|FG001|Overall Study|Lost to Follow-up|0|||
38045760|NCT03433482|69733847|FG002|Overall Study|Lost to Follow-up|1|||
38045761|NCT03433482|69733848|FG003|Overall Study|Lost to Follow-up|1|||
38045762|NCT03433482|69733845|FG000|Overall Study|Withdrawal by Subject|0|||
38045763|NCT03433482|69733846|FG001|Overall Study|Withdrawal by Subject|0|||
38045764|NCT03433482|69733847|FG002|Overall Study|Withdrawal by Subject|1|||
38045765|NCT03433482|69733848|FG003|Overall Study|Withdrawal by Subject|0|||
38045766|NCT03433482|69733845|FG000|Overall Study|Unknown reason|0|||
38045767|NCT03433482|69733846|FG001|Overall Study|Unknown reason|0|||
38045768|NCT03433482|69733847|FG002|Overall Study|Unknown reason|2|||
38045769|NCT03433482|69733848|FG003|Overall Study|Unknown reason|0|||
38045770|NCT03432858|69733861|FG000|Overall Study|Protocol Violation|2|||
38045771|NCT03432858|69733862|FG001|Overall Study|Protocol Violation|1|||
38045772|NCT03432858|69733863|FG002|Overall Study|Protocol Violation|9|||
38045773|NCT03432858|69733861|FG000|Overall Study|Withdrawal by Subject|0|||
38045774|NCT03432858|69733862|FG001|Overall Study|Withdrawal by Subject|1|||
38045775|NCT03432858|69733863|FG002|Overall Study|Withdrawal by Subject|1|||
38045776|NCT03432858|69733861|FG000|Overall Study|Procedure canceled/rescheduled|0|||
38045777|NCT03432858|69733862|FG001|Overall Study|Procedure canceled/rescheduled|9|||
38045778|NCT03432858|69733863|FG002|Overall Study|Procedure canceled/rescheduled|6|||
38045779|NCT03432858|69733861|FG000|Overall Study|Required postop mobilization with splinting|0|||
38045780|NCT03432858|69733862|FG001|Overall Study|Required postop mobilization with splinting|0|||
38045781|NCT03432858|69733863|FG002|Overall Study|Required postop mobilization with splinting|1|||
38045782|NCT03432390|69733873|FG000|Apnea Period|Protocol Violation|2|||
38045783|NCT03432390|69733874|FG001|Apnea Period|Protocol Violation|2|||
38045784|NCT03456960|69733886|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
38045785|NCT03456960|69733887|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
38045786|NCT03456960|69733888|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
38045787|NCT03456960|69733889|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
38045788|NCT03456960|69733890|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
38045789|NCT03456960|69733891|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
38045790|NCT03456960|69733886|FG000|Period 2 (1 Day)|Adverse Event|1|||
38045791|NCT03456960|69733887|FG001|Period 2 (1 Day)|Adverse Event|0|||
38045792|NCT03456960|69733888|FG002|Period 2 (1 Day)|Adverse Event|0|||
38045793|NCT03456960|69733889|FG003|Period 2 (1 Day)|Adverse Event|1|||
38045794|NCT03456960|69733890|FG004|Period 2 (1 Day)|Adverse Event|0|||
38045795|NCT03456960|69733891|FG005|Period 2 (1 Day)|Adverse Event|0|||
38045796|NCT03430986|69733909|FG000|24-week Control Period|Adverse Event|1|||
38045797|NCT03430986|69733910|FG001|24-week Control Period|Adverse Event|0|||
38045798|NCT03430986|69733909|FG000|24-week Control Period|Lost to Follow-up|2|||
38045799|NCT03430986|69733910|FG001|24-week Control Period|Lost to Follow-up|2|||
38045800|NCT03430986|69733909|FG000|24-week Control Period|Withdrawal by Participant|5|||
38045801|NCT03430986|69733910|FG001|24-week Control Period|Withdrawal by Participant|0|||
38045802|NCT03430986|69733909|FG000|24-week Control Period|Protocol Deviation|0|||
38045803|NCT03430986|69733910|FG001|24-week Control Period|Protocol Deviation|2|||
38045804|NCT03430986|69733909|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
38045805|NCT03430986|69733910|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
38045806|NCT03430986|69733909|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
38045807|NCT03430986|69733910|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
38045808|NCT03448536|69733921|FG000|Overall Study|Protocol Violation|2|||
38045809|NCT03448536|69733922|FG001|Overall Study|Protocol Violation|0|||
38045810|NCT03448536|69733921|FG000|Overall Study|Pregnancy|1|||
38045811|NCT03448536|69733922|FG001|Overall Study|Pregnancy|0|||
38045812|NCT03448536|69733921|FG000|Overall Study|Withdrawal by Subject|1|||
38045813|NCT03448536|69733922|FG001|Overall Study|Withdrawal by Subject|2|||
38045814|NCT03448536|69733921|FG000|Overall Study|Lost to Follow-up|3|||
38045815|NCT03448536|69733922|FG001|Overall Study|Lost to Follow-up|2|||
38045816|NCT03448536|69733921|FG000|Overall Study|Inadequate pain reporter|1|||
38045817|NCT03448536|69733922|FG001|Overall Study|Inadequate pain reporter|0|||
38045818|NCT03448536|69733921|FG000|Overall Study|Other|3|||
38045819|NCT03448536|69733922|FG001|Overall Study|Other|0|||
38045820|NCT03448536|69733921|FG000|Overall Study|Physician Decision|1|||
38045821|NCT03448536|69733922|FG001|Overall Study|Physician Decision|0|||
38045822|NCT03448224|69733930|FG000|Overall Study|Provided same answer to every question|1|||
38045823|NCT03448224|69733931|FG001|Overall Study|Provided same answer to every question|0|||
38045824|NCT03424044|69733937|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
38045825|NCT03424044|69733938|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
38045826|NCT03424044|69733939|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
38045827|NCT03424044|69733940|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
38045828|NCT03424044|69733941|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
38045829|NCT03424044|69733942|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
38045830|NCT03424044|69733943|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
38045831|NCT03424044|69733944|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
38045832|NCT03424044|69733945|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
38045833|NCT03424044|69733937|FG000|First Intervention (76 Hours)|Adverse Event|0|||
38045834|NCT03424044|69733938|FG001|First Intervention (76 Hours)|Adverse Event|0|||
38045835|NCT03424044|69733939|FG002|First Intervention (76 Hours)|Adverse Event|0|||
38045836|NCT03424044|69733940|FG003|First Intervention (76 Hours)|Adverse Event|0|||
38045837|NCT03424044|69733941|FG004|First Intervention (76 Hours)|Adverse Event|1|||
38045838|NCT03424044|69733942|FG005|First Intervention (76 Hours)|Adverse Event|0|||
38045839|NCT03424044|69733943|FG006|First Intervention (76 Hours)|Adverse Event|0|||
38045840|NCT03424044|69733944|FG007|First Intervention (76 Hours)|Adverse Event|0|||
38045841|NCT03424044|69733945|FG008|First Intervention (76 Hours)|Adverse Event|0|||
38045842|NCT03424044|69733937|FG000|First Intervention (76 Hours)|device issues|0|||
38045843|NCT03424044|69733938|FG001|First Intervention (76 Hours)|device issues|0|||
38045844|NCT03424044|69733939|FG002|First Intervention (76 Hours)|device issues|0|||
38045845|NCT03424044|69733940|FG003|First Intervention (76 Hours)|device issues|0|||
38045846|NCT03424044|69733941|FG004|First Intervention (76 Hours)|device issues|0|||
38045847|NCT03424044|69733942|FG005|First Intervention (76 Hours)|device issues|0|||
38045848|NCT03424044|69733943|FG006|First Intervention (76 Hours)|device issues|1|||
38045849|NCT03424044|69733944|FG007|First Intervention (76 Hours)|device issues|1|||
38045850|NCT03424044|69733945|FG008|First Intervention (76 Hours)|device issues|1|||
38045851|NCT03424044|69733937|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
38045852|NCT03424044|69733938|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
38045853|NCT03424044|69733939|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
38045854|NCT03424044|69733940|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
38045855|NCT03424044|69733941|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
38045856|NCT03424044|69733942|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
38045857|NCT03424044|69733943|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
38045858|NCT03424044|69733944|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
38045859|NCT03424044|69733945|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
38045860|NCT03424044|69733937|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
38045861|NCT03424044|69733938|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
38045862|NCT03424044|69733939|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
38045863|NCT03424044|69733940|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
38045864|NCT03424044|69733941|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
38045865|NCT03424044|69733942|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
38045866|NCT03424044|69733943|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
38045867|NCT03424044|69733944|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
38045868|NCT03424044|69733945|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
38045869|NCT03422250|69733959|FG000|Intervention|Adverse Event|0|||
38045870|NCT03422250|69733960|FG001|Intervention|Adverse Event|1|||
38045871|NCT03422250|69733961|FG002|Intervention|Adverse Event|0|||
38045872|NCT03422250|69733962|FG003|Intervention|Adverse Event|1|||
38045873|NCT03422250|69733959|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
38045874|NCT03422250|69733960|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
38045875|NCT03422250|69733961|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
38045876|NCT03422250|69733962|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
38045877|NCT03422250|69733959|FG000|Follow-up|Withdrawal by Subject|0|||
38045878|NCT03422250|69733960|FG001|Follow-up|Withdrawal by Subject|0|||
38045879|NCT03422250|69733961|FG002|Follow-up|Withdrawal by Subject|0|||
38045880|NCT03422250|69733962|FG003|Follow-up|Withdrawal by Subject|1|||
38045881|NCT03422250|69733959|FG000|Follow-up|Adverse Event|0|||
38045882|NCT03422250|69733960|FG001|Follow-up|Adverse Event|0|||
38045883|NCT03422250|69733961|FG002|Follow-up|Adverse Event|0|||
38045884|NCT03422250|69733962|FG003|Follow-up|Adverse Event|1|||
38045885|NCT01266031|69733977|FG000|Overall Study|Not treated|0|||
38045886|NCT01266031|69733978|FG001|Overall Study|Not treated|3|||
38045887|NCT01266031|69733979|FG002|Overall Study|Not treated|2|||
38045888|NCT00075725|69734010|FG000|Overall Study|Adverse Event|6|||
38045889|NCT00075725|69734011|FG001|Overall Study|Adverse Event|6|||
38045890|NCT00075725|69734012|FG002|Overall Study|Adverse Event|20|||
38045891|NCT00075725|69734013|FG003|Overall Study|Adverse Event|8|||
38045892|NCT00075725|69734014|FG004|Overall Study|Adverse Event|4|||
38045893|NCT00075725|69734015|FG005|Overall Study|Adverse Event|38|||
38045894|NCT00075725|69734016|FG006|Overall Study|Adverse Event|3|||
38045895|NCT00075725|69734017|FG007|Overall Study|Adverse Event|51|||
38045896|NCT00075725|69734018|FG008|Overall Study|Adverse Event|15|||
38045897|NCT00075725|69734019|FG009|Overall Study|Adverse Event|4|||
38045898|NCT00075725|69734020|FG010|Overall Study|Adverse Event|2|||
38045899|NCT00075725|69734021|FG011|Overall Study|Adverse Event|2|||
38045900|NCT00075725|69734010|FG000|Overall Study|Death|3|||
38045901|NCT00075725|69734011|FG001|Overall Study|Death|5|||
38045902|NCT00075725|69734012|FG002|Overall Study|Death|10|||
38045903|NCT00075725|69734013|FG003|Overall Study|Death|2|||
38045904|NCT00075725|69734014|FG004|Overall Study|Death|3|||
38045905|NCT00075725|69734015|FG005|Overall Study|Death|25|||
38045906|NCT00075725|69734016|FG006|Overall Study|Death|4|||
38045907|NCT00075725|69734017|FG007|Overall Study|Death|22|||
38045908|NCT00075725|69734018|FG008|Overall Study|Death|14|||
38045909|NCT00075725|69734019|FG009|Overall Study|Death|4|||
38045910|NCT00075725|69734020|FG010|Overall Study|Death|3|||
38045911|NCT00075725|69734021|FG011|Overall Study|Death|0|||
38045912|NCT00075725|69734010|FG000|Overall Study|Lost to Follow-up|1|||
38045913|NCT00075725|69734011|FG001|Overall Study|Lost to Follow-up|1|||
38045914|NCT00075725|69734012|FG002|Overall Study|Lost to Follow-up|4|||
38045915|NCT00075725|69734013|FG003|Overall Study|Lost to Follow-up|1|||
38045916|NCT00075725|69734014|FG004|Overall Study|Lost to Follow-up|0|||
38045917|NCT00075725|69734015|FG005|Overall Study|Lost to Follow-up|13|||
38045918|NCT00075725|69734016|FG006|Overall Study|Lost to Follow-up|2|||
38045919|NCT00075725|69734017|FG007|Overall Study|Lost to Follow-up|4|||
38045920|NCT00075725|69734018|FG008|Overall Study|Lost to Follow-up|1|||
38045921|NCT00075725|69734019|FG009|Overall Study|Lost to Follow-up|0|||
38045922|NCT00075725|69734020|FG010|Overall Study|Lost to Follow-up|0|||
38045923|NCT00075725|69734021|FG011|Overall Study|Lost to Follow-up|0|||
38045924|NCT00075725|69734010|FG000|Overall Study|Physician Decision|2|||
38045925|NCT00075725|69734011|FG001|Overall Study|Physician Decision|6|||
38045926|NCT00075725|69734012|FG002|Overall Study|Physician Decision|5|||
38045927|NCT00075725|69734013|FG003|Overall Study|Physician Decision|8|||
38045928|NCT00075725|69734014|FG004|Overall Study|Physician Decision|4|||
38045929|NCT00075725|69734015|FG005|Overall Study|Physician Decision|19|||
38045930|NCT00075725|69734016|FG006|Overall Study|Physician Decision|3|||
38045931|NCT00075725|69734017|FG007|Overall Study|Physician Decision|17|||
38045932|NCT00075725|69734018|FG008|Overall Study|Physician Decision|5|||
38045933|NCT00075725|69734019|FG009|Overall Study|Physician Decision|0|||
38045934|NCT00075725|69734020|FG010|Overall Study|Physician Decision|1|||
38045935|NCT00075725|69734021|FG011|Overall Study|Physician Decision|0|||
38045936|NCT00075725|69734010|FG000|Overall Study|Pregnancy|0|||
38045937|NCT00075725|69734011|FG001|Overall Study|Pregnancy|0|||
38045938|NCT00075725|69734012|FG002|Overall Study|Pregnancy|0|||
38045939|NCT00075725|69734013|FG003|Overall Study|Pregnancy|0|||
38045940|NCT00075725|69734014|FG004|Overall Study|Pregnancy|0|||
38045941|NCT00075725|69734015|FG005|Overall Study|Pregnancy|1|||
38045942|NCT00075725|69734016|FG006|Overall Study|Pregnancy|0|||
38045943|NCT00075725|69734017|FG007|Overall Study|Pregnancy|1|||
38045944|NCT00075725|69734018|FG008|Overall Study|Pregnancy|0|||
38045945|NCT00075725|69734019|FG009|Overall Study|Pregnancy|0|||
38045946|NCT00075725|69734020|FG010|Overall Study|Pregnancy|0|||
38045947|NCT00075725|69734021|FG011|Overall Study|Pregnancy|0|||
38045948|NCT00075725|69734010|FG000|Overall Study|Protocol Violation|1|||
38045949|NCT00075725|69734011|FG001|Overall Study|Protocol Violation|1|||
38045950|NCT00075725|69734012|FG002|Overall Study|Protocol Violation|0|||
38045951|NCT00075725|69734013|FG003|Overall Study|Protocol Violation|3|||
38045952|NCT00075725|69734014|FG004|Overall Study|Protocol Violation|3|||
38045953|NCT00075725|69734015|FG005|Overall Study|Protocol Violation|2|||
38045954|NCT00075725|69734016|FG006|Overall Study|Protocol Violation|1|||
38045955|NCT00075725|69734017|FG007|Overall Study|Protocol Violation|2|||
38045956|NCT00075725|69734018|FG008|Overall Study|Protocol Violation|3|||
38045957|NCT00075725|69734019|FG009|Overall Study|Protocol Violation|0|||
38045958|NCT00075725|69734020|FG010|Overall Study|Protocol Violation|0|||
38045959|NCT00075725|69734021|FG011|Overall Study|Protocol Violation|1|||
38045960|NCT00075725|69734010|FG000|Overall Study|Withdrawal by Subject|12|||
38045961|NCT00075725|69734011|FG001|Overall Study|Withdrawal by Subject|3|||
38045962|NCT00075725|69734012|FG002|Overall Study|Withdrawal by Subject|6|||
38045963|NCT00075725|69734013|FG003|Overall Study|Withdrawal by Subject|10|||
38045964|NCT00075725|69734014|FG004|Overall Study|Withdrawal by Subject|6|||
38045965|NCT00075725|69734015|FG005|Overall Study|Withdrawal by Subject|27|||
38045966|NCT00075725|69734016|FG006|Overall Study|Withdrawal by Subject|7|||
38045967|NCT00075725|69734017|FG007|Overall Study|Withdrawal by Subject|31|||
38045968|NCT00075725|69734018|FG008|Overall Study|Withdrawal by Subject|10|||
38045969|NCT00075725|69734019|FG009|Overall Study|Withdrawal by Subject|2|||
38045970|NCT00075725|69734020|FG010|Overall Study|Withdrawal by Subject|0|||
38045971|NCT00075725|69734021|FG011|Overall Study|Withdrawal by Subject|0|||
38045972|NCT00075725|69734010|FG000|Overall Study|Disease Progression, all other reasons|17|||
38045973|NCT00075725|69734011|FG001|Overall Study|Disease Progression, all other reasons|5|||
38045974|NCT00075725|69734012|FG002|Overall Study|Disease Progression, all other reasons|33|||
38045975|NCT00075725|69734013|FG003|Overall Study|Disease Progression, all other reasons|6|||
38045976|NCT00075725|69734014|FG004|Overall Study|Disease Progression, all other reasons|21|||
38045977|NCT00075725|69734015|FG005|Overall Study|Disease Progression, all other reasons|59|||
38045978|NCT00075725|69734016|FG006|Overall Study|Disease Progression, all other reasons|20|||
38045979|NCT00075725|69734017|FG007|Overall Study|Disease Progression, all other reasons|46|||
38045980|NCT00075725|69734018|FG008|Overall Study|Disease Progression, all other reasons|21|||
38045981|NCT00075725|69734019|FG009|Overall Study|Disease Progression, all other reasons|4|||
38045982|NCT00075725|69734020|FG010|Overall Study|Disease Progression, all other reasons|0|||
38045983|NCT00075725|69734021|FG011|Overall Study|Disease Progression, all other reasons|5|||
38045984|NCT00075725|69734010|FG000|Overall Study|Patient off treatment|0|||
38045985|NCT00075725|69734011|FG001|Overall Study|Patient off treatment|0|||
38045986|NCT00075725|69734012|FG002|Overall Study|Patient off treatment|1|||
38045987|NCT00075725|69734013|FG003|Overall Study|Patient off treatment|2|||
38045988|NCT00075725|69734014|FG004|Overall Study|Patient off treatment|1|||
38045989|NCT00075725|69734015|FG005|Overall Study|Patient off treatment|0|||
38045990|NCT00075725|69734016|FG006|Overall Study|Patient off treatment|0|||
38045991|NCT00075725|69734017|FG007|Overall Study|Patient off treatment|2|||
38045992|NCT00075725|69734018|FG008|Overall Study|Patient off treatment|1|||
38045993|NCT00075725|69734019|FG009|Overall Study|Patient off treatment|0|||
38045994|NCT00075725|69734020|FG010|Overall Study|Patient off treatment|0|||
38045995|NCT00075725|69734021|FG011|Overall Study|Patient off treatment|0|||
38045996|NCT00075725|69734010|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
38045997|NCT00075725|69734011|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
38045998|NCT00075725|69734012|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
38045999|NCT00075725|69734013|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
38046000|NCT00075725|69734014|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
38046001|NCT00075725|69734015|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
38046002|NCT00075725|69734016|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
38046003|NCT00075725|69734017|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
38046004|NCT00075725|69734018|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
38046005|NCT00075725|69734019|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
38046006|NCT00075725|69734020|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
38046007|NCT00075725|69734021|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
38046008|NCT00075725|69734010|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
38046009|NCT00075725|69734011|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
38046010|NCT00075725|69734012|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
38046011|NCT00075725|69734013|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
38046012|NCT00075725|69734014|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
38046013|NCT00075725|69734015|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
38046014|NCT00075725|69734016|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
38046015|NCT00075725|69734017|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
38046016|NCT00075725|69734018|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
38046017|NCT00075725|69734019|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
38046018|NCT00075725|69734020|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
38046019|NCT00075725|69734021|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
38046020|NCT00075725|69734010|FG000|Overall Study|Pt non compliant with therapy|2|||
38046021|NCT00075725|69734011|FG001|Overall Study|Pt non compliant with therapy|1|||
38046022|NCT00075725|69734012|FG002|Overall Study|Pt non compliant with therapy|1|||
38046023|NCT00075725|69734013|FG003|Overall Study|Pt non compliant with therapy|0|||
38046024|NCT00075725|69734014|FG004|Overall Study|Pt non compliant with therapy|2|||
38046025|NCT00075725|69734015|FG005|Overall Study|Pt non compliant with therapy|14|||
38046026|NCT00075725|69734016|FG006|Overall Study|Pt non compliant with therapy|2|||
38046027|NCT00075725|69734017|FG007|Overall Study|Pt non compliant with therapy|5|||
38046028|NCT00075725|69734018|FG008|Overall Study|Pt non compliant with therapy|3|||
38046029|NCT00075725|69734019|FG009|Overall Study|Pt non compliant with therapy|0|||
38046030|NCT00075725|69734020|FG010|Overall Study|Pt non compliant with therapy|0|||
38046031|NCT00075725|69734021|FG011|Overall Study|Pt non compliant with therapy|0|||
38046032|NCT00075725|69734010|FG000|Overall Study|Pt age out of range for treatment|0|||
38046033|NCT00075725|69734011|FG001|Overall Study|Pt age out of range for treatment|1|||
38046034|NCT00075725|69734012|FG002|Overall Study|Pt age out of range for treatment|0|||
38046035|NCT00075725|69734013|FG003|Overall Study|Pt age out of range for treatment|0|||
38046036|NCT00075725|69734014|FG004|Overall Study|Pt age out of range for treatment|0|||
38046037|NCT00075725|69734015|FG005|Overall Study|Pt age out of range for treatment|1|||
38046038|NCT00075725|69734016|FG006|Overall Study|Pt age out of range for treatment|0|||
38046039|NCT00075725|69734017|FG007|Overall Study|Pt age out of range for treatment|1|||
38046040|NCT00075725|69734018|FG008|Overall Study|Pt age out of range for treatment|0|||
38046041|NCT00075725|69734019|FG009|Overall Study|Pt age out of range for treatment|0|||
38046042|NCT00075725|69734020|FG010|Overall Study|Pt age out of range for treatment|0|||
38046043|NCT00075725|69734021|FG011|Overall Study|Pt age out of range for treatment|0|||
38046044|NCT00075725|69734010|FG000|Overall Study|Insurance issues|0|||
38046045|NCT00075725|69734011|FG001|Overall Study|Insurance issues|1|||
38046046|NCT00075725|69734012|FG002|Overall Study|Insurance issues|0|||
38046047|NCT00075725|69734013|FG003|Overall Study|Insurance issues|1|||
38046048|NCT00075725|69734014|FG004|Overall Study|Insurance issues|1|||
38046049|NCT00075725|69734015|FG005|Overall Study|Insurance issues|1|||
38046050|NCT00075725|69734016|FG006|Overall Study|Insurance issues|0|||
38046051|NCT00075725|69734017|FG007|Overall Study|Insurance issues|1|||
38046052|NCT00075725|69734018|FG008|Overall Study|Insurance issues|0|||
38046053|NCT00075725|69734019|FG009|Overall Study|Insurance issues|0|||
38046054|NCT00075725|69734020|FG010|Overall Study|Insurance issues|0|||
38046055|NCT00075725|69734021|FG011|Overall Study|Insurance issues|0|||
38046056|NCT00075725|69734010|FG000|Overall Study|MRD positive after extended ind|0|||
38046057|NCT00075725|69734011|FG001|Overall Study|MRD positive after extended ind|1|||
38046058|NCT00075725|69734012|FG002|Overall Study|MRD positive after extended ind|1|||
38046059|NCT00075725|69734013|FG003|Overall Study|MRD positive after extended ind|0|||
38046060|NCT00075725|69734014|FG004|Overall Study|MRD positive after extended ind|1|||
38046061|NCT00075725|69734015|FG005|Overall Study|MRD positive after extended ind|2|||
38046062|NCT00075725|69734016|FG006|Overall Study|MRD positive after extended ind|0|||
38046063|NCT00075725|69734017|FG007|Overall Study|MRD positive after extended ind|1|||
38046064|NCT00075725|69734018|FG008|Overall Study|MRD positive after extended ind|0|||
38046065|NCT00075725|69734019|FG009|Overall Study|MRD positive after extended ind|0|||
38046066|NCT00075725|69734020|FG010|Overall Study|MRD positive after extended ind|0|||
38046067|NCT00075725|69734021|FG011|Overall Study|MRD positive after extended ind|0|||
38046068|NCT00075725|69734010|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
38046069|NCT00075725|69734011|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
38046070|NCT00075725|69734012|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
38046071|NCT00075725|69734013|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
38046072|NCT00075725|69734014|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
38046073|NCT00075725|69734015|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
38046074|NCT00075725|69734016|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
38046075|NCT00075725|69734017|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
38046076|NCT00075725|69734018|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
38046077|NCT00075725|69734019|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
38046078|NCT00075725|69734020|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
38046079|NCT00075725|69734021|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
38046080|NCT00075725|69734010|FG000|Overall Study|Inevaluable|1|||
38046081|NCT00075725|69734011|FG001|Overall Study|Inevaluable|1|||
38046082|NCT00075725|69734012|FG002|Overall Study|Inevaluable|4|||
38046083|NCT00075725|69734013|FG003|Overall Study|Inevaluable|2|||
38046084|NCT00075725|69734014|FG004|Overall Study|Inevaluable|2|||
38046085|NCT00075725|69734015|FG005|Overall Study|Inevaluable|9|||
38046086|NCT00075725|69734016|FG006|Overall Study|Inevaluable|1|||
38046087|NCT00075725|69734017|FG007|Overall Study|Inevaluable|11|||
38046088|NCT00075725|69734018|FG008|Overall Study|Inevaluable|2|||
38046089|NCT00075725|69734019|FG009|Overall Study|Inevaluable|0|||
38046090|NCT00075725|69734020|FG010|Overall Study|Inevaluable|1|||
38046091|NCT00075725|69734021|FG011|Overall Study|Inevaluable|0|||
38046092|NCT00075725|69734010|FG000|Overall Study|Other|4|||
38046093|NCT00075725|69734011|FG001|Overall Study|Other|2|||
38046094|NCT00075725|69734012|FG002|Overall Study|Other|1|||
38046095|NCT00075725|69734013|FG003|Overall Study|Other|1|||
38046096|NCT00075725|69734014|FG004|Overall Study|Other|1|||
38046097|NCT00075725|69734015|FG005|Overall Study|Other|4|||
38046098|NCT00075725|69734016|FG006|Overall Study|Other|2|||
38046099|NCT00075725|69734017|FG007|Overall Study|Other|9|||
38046100|NCT00075725|69734018|FG008|Overall Study|Other|2|||
38046101|NCT00075725|69734019|FG009|Overall Study|Other|1|||
38046102|NCT00075725|69734020|FG010|Overall Study|Other|0|||
38046103|NCT00075725|69734021|FG011|Overall Study|Other|3|||
38046104|NCT00075725|69734010|FG000|Overall Study|Pt trying to find a BM donor|0|||
38046105|NCT00075725|69734011|FG001|Overall Study|Pt trying to find a BM donor|1|||
38046106|NCT00075725|69734012|FG002|Overall Study|Pt trying to find a BM donor|0|||
38046107|NCT00075725|69734013|FG003|Overall Study|Pt trying to find a BM donor|0|||
38046108|NCT00075725|69734014|FG004|Overall Study|Pt trying to find a BM donor|0|||
38046109|NCT00075725|69734015|FG005|Overall Study|Pt trying to find a BM donor|0|||
38046110|NCT00075725|69734016|FG006|Overall Study|Pt trying to find a BM donor|0|||
38046111|NCT00075725|69734017|FG007|Overall Study|Pt trying to find a BM donor|0|||
38046112|NCT00075725|69734018|FG008|Overall Study|Pt trying to find a BM donor|0|||
38046113|NCT00075725|69734019|FG009|Overall Study|Pt trying to find a BM donor|0|||
38046114|NCT00075725|69734020|FG010|Overall Study|Pt trying to find a BM donor|0|||
38046115|NCT00075725|69734021|FG011|Overall Study|Pt trying to find a BM donor|0|||
38046116|NCT00075725|69734010|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
38046117|NCT00075725|69734011|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
38046118|NCT00075725|69734012|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
38046119|NCT00075725|69734013|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
38046120|NCT00075725|69734014|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
38046121|NCT00075725|69734015|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
38046122|NCT00075725|69734016|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
38046123|NCT00075725|69734017|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
38046124|NCT00075725|69734018|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
38046125|NCT00075725|69734019|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
38046126|NCT00075725|69734020|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
38046127|NCT00075725|69734021|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
38046128|NCT00075725|69734010|FG000|Overall Study|Unsuccessful institutional transfer|0|||
38046129|NCT00075725|69734011|FG001|Overall Study|Unsuccessful institutional transfer|0|||
38046130|NCT00075725|69734012|FG002|Overall Study|Unsuccessful institutional transfer|2|||
38046131|NCT00075725|69734013|FG003|Overall Study|Unsuccessful institutional transfer|0|||
38046132|NCT00075725|69734014|FG004|Overall Study|Unsuccessful institutional transfer|0|||
38046133|NCT00075725|69734015|FG005|Overall Study|Unsuccessful institutional transfer|0|||
38046134|NCT00075725|69734016|FG006|Overall Study|Unsuccessful institutional transfer|0|||
38046135|NCT00075725|69734017|FG007|Overall Study|Unsuccessful institutional transfer|0|||
38046136|NCT00075725|69734018|FG008|Overall Study|Unsuccessful institutional transfer|0|||
38046137|NCT00075725|69734019|FG009|Overall Study|Unsuccessful institutional transfer|1|||
38046138|NCT00075725|69734020|FG010|Overall Study|Unsuccessful institutional transfer|0|||
38046139|NCT00075725|69734021|FG011|Overall Study|Unsuccessful institutional transfer|0|||
38046140|NCT00075725|69734010|FG000|Overall Study|specimen(s) not submitted|0|||
38046141|NCT00075725|69734011|FG001|Overall Study|specimen(s) not submitted|0|||
38046142|NCT00075725|69734012|FG002|Overall Study|specimen(s) not submitted|2|||
38046143|NCT00075725|69734013|FG003|Overall Study|specimen(s) not submitted|0|||
38046144|NCT00075725|69734014|FG004|Overall Study|specimen(s) not submitted|0|||
38046145|NCT00075725|69734015|FG005|Overall Study|specimen(s) not submitted|0|||
38046146|NCT00075725|69734016|FG006|Overall Study|specimen(s) not submitted|0|||
38046147|NCT00075725|69734017|FG007|Overall Study|specimen(s) not submitted|0|||
38046148|NCT00075725|69734018|FG008|Overall Study|specimen(s) not submitted|0|||
38046149|NCT00075725|69734019|FG009|Overall Study|specimen(s) not submitted|0|||
38046150|NCT00075725|69734020|FG010|Overall Study|specimen(s) not submitted|0|||
38046151|NCT00075725|69734021|FG011|Overall Study|specimen(s) not submitted|0|||
38046152|NCT00075725|69734010|FG000|Overall Study|Pt went to transplant|0|||
38046153|NCT00075725|69734011|FG001|Overall Study|Pt went to transplant|0|||
38046154|NCT00075725|69734012|FG002|Overall Study|Pt went to transplant|0|||
38046155|NCT00075725|69734013|FG003|Overall Study|Pt went to transplant|1|||
38046156|NCT00075725|69734014|FG004|Overall Study|Pt went to transplant|0|||
38046157|NCT00075725|69734015|FG005|Overall Study|Pt went to transplant|1|||
38046158|NCT00075725|69734016|FG006|Overall Study|Pt went to transplant|0|||
38046159|NCT00075725|69734017|FG007|Overall Study|Pt went to transplant|0|||
38046160|NCT00075725|69734018|FG008|Overall Study|Pt went to transplant|0|||
38046161|NCT00075725|69734019|FG009|Overall Study|Pt went to transplant|0|||
38046162|NCT00075725|69734020|FG010|Overall Study|Pt went to transplant|0|||
38046163|NCT00075725|69734021|FG011|Overall Study|Pt went to transplant|0|||
38046164|NCT00075725|69734010|FG000|Overall Study|Pt received additional steroids|0|||
38046165|NCT00075725|69734011|FG001|Overall Study|Pt received additional steroids|0|||
38046166|NCT00075725|69734012|FG002|Overall Study|Pt received additional steroids|0|||
38046167|NCT00075725|69734013|FG003|Overall Study|Pt received additional steroids|1|||
38046168|NCT00075725|69734014|FG004|Overall Study|Pt received additional steroids|0|||
38046169|NCT00075725|69734015|FG005|Overall Study|Pt received additional steroids|0|||
38046170|NCT00075725|69734016|FG006|Overall Study|Pt received additional steroids|0|||
38046171|NCT00075725|69734017|FG007|Overall Study|Pt received additional steroids|0|||
38046172|NCT00075725|69734018|FG008|Overall Study|Pt received additional steroids|0|||
38046173|NCT00075725|69734019|FG009|Overall Study|Pt received additional steroids|0|||
38046174|NCT00075725|69734020|FG010|Overall Study|Pt received additional steroids|0|||
38046175|NCT00075725|69734021|FG011|Overall Study|Pt received additional steroids|0|||
38046176|NCT00075725|69734010|FG000|Overall Study|Pt relocated|0|||
38046177|NCT00075725|69734011|FG001|Overall Study|Pt relocated|0|||
38046178|NCT00075725|69734012|FG002|Overall Study|Pt relocated|0|||
38046179|NCT00075725|69734013|FG003|Overall Study|Pt relocated|2|||
38046180|NCT00075725|69734014|FG004|Overall Study|Pt relocated|0|||
38046181|NCT00075725|69734015|FG005|Overall Study|Pt relocated|1|||
38046182|NCT00075725|69734016|FG006|Overall Study|Pt relocated|1|||
38046183|NCT00075725|69734017|FG007|Overall Study|Pt relocated|2|||
38046184|NCT00075725|69734018|FG008|Overall Study|Pt relocated|1|||
38046185|NCT00075725|69734019|FG009|Overall Study|Pt relocated|0|||
38046186|NCT00075725|69734020|FG010|Overall Study|Pt relocated|0|||
38046187|NCT00075725|69734021|FG011|Overall Study|Pt relocated|0|||
38046188|NCT00075725|69734010|FG000|Overall Study|Institution Terminated|0|||
38046189|NCT00075725|69734011|FG001|Overall Study|Institution Terminated|0|||
38046190|NCT00075725|69734012|FG002|Overall Study|Institution Terminated|0|||
38046191|NCT00075725|69734013|FG003|Overall Study|Institution Terminated|0|||
38046192|NCT00075725|69734014|FG004|Overall Study|Institution Terminated|1|||
38046193|NCT00075725|69734015|FG005|Overall Study|Institution Terminated|0|||
38046194|NCT00075725|69734016|FG006|Overall Study|Institution Terminated|0|||
38046195|NCT00075725|69734017|FG007|Overall Study|Institution Terminated|3|||
38046196|NCT00075725|69734018|FG008|Overall Study|Institution Terminated|0|||
38046197|NCT00075725|69734019|FG009|Overall Study|Institution Terminated|0|||
38046198|NCT00075725|69734020|FG010|Overall Study|Institution Terminated|0|||
38046199|NCT00075725|69734021|FG011|Overall Study|Institution Terminated|0|||
38046200|NCT00075725|69734010|FG000|Overall Study|Study Closure|1|||
38046201|NCT00075725|69734011|FG001|Overall Study|Study Closure|0|||
38046202|NCT00075725|69734012|FG002|Overall Study|Study Closure|0|||
38046203|NCT00075725|69734013|FG003|Overall Study|Study Closure|0|||
38046204|NCT00075725|69734014|FG004|Overall Study|Study Closure|1|||
38046205|NCT00075725|69734015|FG005|Overall Study|Study Closure|3|||
38046206|NCT00075725|69734016|FG006|Overall Study|Study Closure|0|||
38046207|NCT00075725|69734017|FG007|Overall Study|Study Closure|1|||
38046208|NCT00075725|69734018|FG008|Overall Study|Study Closure|0|||
38046209|NCT00075725|69734019|FG009|Overall Study|Study Closure|0|||
38046210|NCT00075725|69734020|FG010|Overall Study|Study Closure|0|||
38046211|NCT00075725|69734021|FG011|Overall Study|Study Closure|0|||
38046212|NCT00075725|69734010|FG000|Overall Study|Other complications|0|||
38046213|NCT00075725|69734011|FG001|Overall Study|Other complications|0|||
38046214|NCT00075725|69734012|FG002|Overall Study|Other complications|0|||
38046215|NCT00075725|69734013|FG003|Overall Study|Other complications|0|||
38046216|NCT00075725|69734014|FG004|Overall Study|Other complications|0|||
38046217|NCT00075725|69734015|FG005|Overall Study|Other complications|1|||
38046218|NCT00075725|69734016|FG006|Overall Study|Other complications|0|||
38046219|NCT00075725|69734017|FG007|Overall Study|Other complications|0|||
38046220|NCT00075725|69734018|FG008|Overall Study|Other complications|0|||
38046221|NCT00075725|69734019|FG009|Overall Study|Other complications|0|||
38046222|NCT00075725|69734020|FG010|Overall Study|Other complications|0|||
38046223|NCT00075725|69734021|FG011|Overall Study|Other complications|0|||
38046224|NCT00075725|69734010|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
38046225|NCT00075725|69734011|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
38046226|NCT00075725|69734012|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
38046227|NCT00075725|69734013|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
38046228|NCT00075725|69734014|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
38046229|NCT00075725|69734015|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
38046230|NCT00075725|69734016|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
38046231|NCT00075725|69734017|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
38046232|NCT00075725|69734018|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
38046233|NCT00075725|69734019|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
38046234|NCT00075725|69734020|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
38046235|NCT00075725|69734021|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
38046236|NCT00075725|69734010|FG000|Overall Study|Pt incarcerated|0|||
38046237|NCT00075725|69734011|FG001|Overall Study|Pt incarcerated|0|||
38046238|NCT00075725|69734012|FG002|Overall Study|Pt incarcerated|0|||
38046239|NCT00075725|69734013|FG003|Overall Study|Pt incarcerated|0|||
38046240|NCT00075725|69734014|FG004|Overall Study|Pt incarcerated|0|||
38046241|NCT00075725|69734015|FG005|Overall Study|Pt incarcerated|0|||
38046242|NCT00075725|69734016|FG006|Overall Study|Pt incarcerated|0|||
38046243|NCT00075725|69734017|FG007|Overall Study|Pt incarcerated|1|||
38046244|NCT00075725|69734018|FG008|Overall Study|Pt incarcerated|0|||
38046245|NCT00075725|69734019|FG009|Overall Study|Pt incarcerated|0|||
38046246|NCT00075725|69734020|FG010|Overall Study|Pt incarcerated|0|||
38046247|NCT00075725|69734021|FG011|Overall Study|Pt incarcerated|0|||
38046248|NCT02953782|69734060|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
38046249|NCT02953782|69734061|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
38046250|NCT02953782|69734062|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
38046251|NCT02953782|69734063|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
38046252|NCT02953782|69734064|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
38046253|NCT02953782|69734065|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
38046254|NCT02953782|69734066|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
38046255|NCT02953782|69734067|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
38046256|NCT02953782|69734060|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
38046257|NCT02953782|69734061|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
38046258|NCT02953782|69734062|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
38046259|NCT02953782|69734063|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
38046260|NCT02953782|69734064|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
38046261|NCT02953782|69734065|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
38046262|NCT02953782|69734066|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
38046263|NCT02953782|69734067|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
38046264|NCT02953782|69734060|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
38046265|NCT02953782|69734061|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
38046266|NCT02953782|69734062|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
38046267|NCT02953782|69734063|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
38046268|NCT02953782|69734064|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
38046269|NCT02953782|69734065|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
38046270|NCT02953782|69734066|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
38046271|NCT02953782|69734067|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
38046272|NCT02953782|69734060|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
38046273|NCT02953782|69734061|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
38046274|NCT02953782|69734062|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
38046275|NCT02953782|69734063|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
38046276|NCT02953782|69734064|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
38046277|NCT02953782|69734065|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
38046278|NCT02953782|69734066|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
38046279|NCT02953782|69734067|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
38046280|NCT02953782|69734060|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
38046281|NCT02953782|69734061|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
38046282|NCT02953782|69734062|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
38046283|NCT02953782|69734063|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
38046284|NCT02953782|69734064|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
38046285|NCT02953782|69734065|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
38046286|NCT02953782|69734066|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
38046287|NCT02953782|69734067|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
38046288|NCT02953782|69734060|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
38046289|NCT02953782|69734061|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
38046290|NCT02953782|69734062|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
38046291|NCT02953782|69734063|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
38046292|NCT02953782|69734064|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
38046293|NCT02953782|69734065|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
38046294|NCT02953782|69734066|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
38046295|NCT02953782|69734067|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
38046296|NCT02953782|69734060|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
38046297|NCT02953782|69734061|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
38046298|NCT02953782|69734062|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
38046299|NCT02953782|69734063|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
38046300|NCT02953782|69734064|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
38046301|NCT02953782|69734065|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
38046302|NCT02953782|69734066|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
38046303|NCT02953782|69734067|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
38046304|NCT02953782|69734060|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
38046305|NCT02953782|69734061|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
38046306|NCT02953782|69734062|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
38046307|NCT02953782|69734063|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
38046308|NCT02953782|69734064|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
38046309|NCT02953782|69734065|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
38046310|NCT02953782|69734066|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
38046311|NCT02953782|69734067|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
38046312|NCT03760081|69734090|FG000|Overall Study|Miscellaneous|0|||
38046313|NCT03760081|69734091|FG001|Overall Study|Miscellaneous|1|||
38046314|NCT03760081|69734090|FG000|Overall Study|Progressive Disease|5|||
38046315|NCT03760081|69734091|FG001|Overall Study|Progressive Disease|10|||
38046316|NCT03760081|69734090|FG000|Overall Study|Death|1|||
38046317|NCT03760081|69734091|FG001|Overall Study|Death|1|||
38046318|NCT03422172|69734099|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
38046319|NCT03422172|69734099|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
38046320|NCT03422172|69734099|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
38046321|NCT00057863|69734108|FG000|Overall Study|Death|1|||
38046322|NCT00057863|69734108|FG000|Overall Study|Withdrawal by Subject|2|||
38046323|NCT00075023|69734114|FG000|Pilot Study|Physician Decision|1|||
38046324|NCT00075023|69734115|FG001|Pilot Study|Physician Decision|2|||
38046325|NCT00075023|69734114|FG000|Pilot Study|Withdrawal by Subject|1|||
38046326|NCT00075023|69734115|FG001|Pilot Study|Withdrawal by Subject|0|||
38046327|NCT00074711|69734124|FG000|Overall Study|Withdrawal by Subject|1|||
38046328|NCT00074711|69734125|FG001|Overall Study|Withdrawal by Subject|1|||
38046329|NCT00074711|69734124|FG000|Overall Study|Lost to Follow-up|10|||
38046330|NCT00074711|69734125|FG001|Overall Study|Lost to Follow-up|8|||
38046331|NCT00074711|69734124|FG000|Overall Study|Participant stopped study drug|4|||
38046332|NCT00074711|69734125|FG001|Overall Study|Participant stopped study drug|6|||
38046333|NCT03420300|69734131|FG000|Overall Study|Death|2|||
38046334|NCT03419598|69734135|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
38046335|NCT03407430|69734143|FG000|Washout|Protocol Violation|1|||
38046336|NCT03407430|69734144|FG001|Washout|Protocol Violation|0|||
38046337|NCT03407118|69734157|FG000|Period 2|Withdrawal by Subject|1|||
38046338|NCT03407118|69734158|FG001|Period 2|Withdrawal by Subject|0|||
38046339|NCT03406962|69734164|FG000|Overall Study|Death|2|||
38046340|NCT03406962|69734164|FG000|Overall Study|Adverse Event|1|||
38046341|NCT03406260|69734175|FG000|Period 1|Adverse Event|0|||
38046342|NCT03406260|69734176|FG001|Period 1|Adverse Event|0|||
38046343|NCT03406260|69734177|FG002|Period 1|Adverse Event|0|||
38046344|NCT03406260|69734178|FG003|Period 1|Adverse Event|0|||
38046345|NCT03406260|69734179|FG004|Period 1|Adverse Event|1|||
38046346|NCT03406260|69734180|FG005|Period 1|Adverse Event|0|||
38046347|NCT03419364|69734193|FG000|Overall Study|Delivery due to maternal condition|2|||
38046348|NCT03419364|69734194|FG001|Overall Study|Delivery due to maternal condition|0|||
38046349|NCT03419364|69734195|FG002|Overall Study|Delivery due to maternal condition|0|||
38046350|NCT02954172|69734205|FG000|Overall Study|Protocol Violation|3|||
38046351|NCT02954172|69734206|FG001|Overall Study|Protocol Violation|0|||
38046352|NCT02954172|69734205|FG000|Overall Study|allergic reaction|2|||
38046353|NCT02954172|69734206|FG001|Overall Study|allergic reaction|1|||
38046354|NCT02954172|69734205|FG000|Overall Study|non-measurable lesions at baseline|1|||
38046355|NCT02954172|69734206|FG001|Overall Study|non-measurable lesions at baseline|2|||
38046356|NCT02953938|69734215|FG000|Overall Study|Adverse Event|0|||
38046357|NCT02953938|69734216|FG001|Overall Study|Adverse Event|1|||
38046358|NCT02953938|69734215|FG000|Overall Study|Withdrawal by Subject|1|||
38046359|NCT02953938|69734216|FG001|Overall Study|Withdrawal by Subject|1|||
38046360|NCT03758443|69734227|FG000|Induction Period|Adverse Event|2|||
38046361|NCT03758443|69734228|FG001|Induction Period|Adverse Event|4|||
38046362|NCT03758443|69734229|FG002|Induction Period|Adverse Event|2|||
38046363|NCT03758443|69734230|FG003|Induction Period|Adverse Event|3|||
38046364|NCT03758443|69734227|FG000|Induction Period|Physician Decision|1|||
38046365|NCT03758443|69734228|FG001|Induction Period|Physician Decision|1|||
38046366|NCT03758443|69734229|FG002|Induction Period|Physician Decision|3|||
38046367|NCT03758443|69734230|FG003|Induction Period|Physician Decision|0|||
38046368|NCT03758443|69734227|FG000|Induction Period|Protocol Violation|0|||
38046369|NCT03758443|69734228|FG001|Induction Period|Protocol Violation|0|||
38046370|NCT03758443|69734229|FG002|Induction Period|Protocol Violation|0|||
38046371|NCT03758443|69734230|FG003|Induction Period|Protocol Violation|1|||
38046372|NCT03758443|69734227|FG000|Induction Period|Withdrawal by Subject|3|||
38046373|NCT03758443|69734228|FG001|Induction Period|Withdrawal by Subject|2|||
38046374|NCT03758443|69734229|FG002|Induction Period|Withdrawal by Subject|2|||
38046375|NCT03758443|69734230|FG003|Induction Period|Withdrawal by Subject|4|||
38046376|NCT03758443|69734227|FG000|Extended Induction Period|Adverse Event|1|||
38046377|NCT03758443|69734228|FG001|Extended Induction Period|Adverse Event|1|||
38046378|NCT03758443|69734229|FG002|Extended Induction Period|Adverse Event|0|||
38046379|NCT03758443|69734230|FG003|Extended Induction Period|Adverse Event|1|||
38046380|NCT03758443|69734227|FG000|Extended Induction Period|Lost to Follow-up|1|||
38046381|NCT03758443|69734228|FG001|Extended Induction Period|Lost to Follow-up|0|||
38046382|NCT03758443|69734229|FG002|Extended Induction Period|Lost to Follow-up|0|||
38046383|NCT03758443|69734230|FG003|Extended Induction Period|Lost to Follow-up|0|||
38046384|NCT03758443|69734227|FG000|Extended Induction Period|Physician Decision|2|||
38046385|NCT03758443|69734228|FG001|Extended Induction Period|Physician Decision|1|||
38046386|NCT03758443|69734229|FG002|Extended Induction Period|Physician Decision|2|||
38046387|NCT03758443|69734230|FG003|Extended Induction Period|Physician Decision|2|||
38046388|NCT03758443|69734227|FG000|Extended Induction Period|Protocol Violation|0|||
38046389|NCT03758443|69734228|FG001|Extended Induction Period|Protocol Violation|0|||
38046390|NCT03758443|69734229|FG002|Extended Induction Period|Protocol Violation|0|||
38046391|NCT03758443|69734230|FG003|Extended Induction Period|Protocol Violation|1|||
38046392|NCT03758443|69734227|FG000|Extended Induction Period|Withdrawal by Subject|8|||
38046393|NCT03758443|69734228|FG001|Extended Induction Period|Withdrawal by Subject|1|||
38046394|NCT03758443|69734229|FG002|Extended Induction Period|Withdrawal by Subject|7|||
38046395|NCT03758443|69734230|FG003|Extended Induction Period|Withdrawal by Subject|3|||
38046396|NCT03758443|69734227|FG000|Extended Induction Period|Miscellaneous|1|||
38046397|NCT03758443|69734228|FG001|Extended Induction Period|Miscellaneous|0|||
38046398|NCT03758443|69734229|FG002|Extended Induction Period|Miscellaneous|0|||
38046399|NCT03758443|69734230|FG003|Extended Induction Period|Miscellaneous|0|||
38046400|NCT03758443|69734227|FG000|Maintenance Period|Adverse Event|1|||
38046401|NCT03758443|69734228|FG001|Maintenance Period|Adverse Event|2|||
38046402|NCT03758443|69734229|FG002|Maintenance Period|Adverse Event|0|||
38046403|NCT03758443|69734230|FG003|Maintenance Period|Adverse Event|0|||
38046404|NCT03758443|69734227|FG000|Maintenance Period|Lost to Follow-up|0|||
38046405|NCT03758443|69734228|FG001|Maintenance Period|Lost to Follow-up|0|||
38046406|NCT03758443|69734229|FG002|Maintenance Period|Lost to Follow-up|0|||
38046407|NCT03758443|69734230|FG003|Maintenance Period|Lost to Follow-up|1|||
38046408|NCT03758443|69734227|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
38046409|NCT03758443|69734228|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
38046410|NCT03758443|69734229|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
38046411|NCT03758443|69734230|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
38046412|NCT03758443|69734227|FG000|Maintenance Period|Protocol Violation|0|||
38046413|NCT03758443|69734228|FG001|Maintenance Period|Protocol Violation|1|||
38046414|NCT03758443|69734229|FG002|Maintenance Period|Protocol Violation|0|||
38046415|NCT03758443|69734230|FG003|Maintenance Period|Protocol Violation|0|||
38046416|NCT03758443|69734227|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
38046417|NCT03758443|69734228|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
38046418|NCT03758443|69734229|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
38046419|NCT03758443|69734230|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
38046420|NCT03758443|69734227|FG000|Maintenance Period|Withdrawal by Subject|1|||
38046421|NCT03758443|69734228|FG001|Maintenance Period|Withdrawal by Subject|0|||
38046422|NCT03758443|69734229|FG002|Maintenance Period|Withdrawal by Subject|1|||
38046423|NCT03758443|69734230|FG003|Maintenance Period|Withdrawal by Subject|1|||
38046424|NCT03758443|69734227|FG000|Maintenance Period|Miscellaneous|0|||
38046425|NCT03758443|69734228|FG001|Maintenance Period|Miscellaneous|0|||
38046426|NCT03758443|69734229|FG002|Maintenance Period|Miscellaneous|1|||
38046427|NCT03758443|69734230|FG003|Maintenance Period|Miscellaneous|0|||
38046428|NCT03442764|69734252|FG000|Overall Study|Adverse Event|1|||
38046429|NCT03442764|69734253|FG001|Overall Study|Adverse Event|0|||
38046430|NCT03442764|69734254|FG002|Overall Study|Adverse Event|0|||
38046431|NCT03442296|69734265|FG000|3 Month Follow-up|Death|3|||
38046432|NCT03442296|69734266|FG001|3 Month Follow-up|Death|1|||
38046433|NCT03442296|69734265|FG000|3 Month Follow-up|Lost to Follow-up|1|||
38046434|NCT03442296|69734266|FG001|3 Month Follow-up|Lost to Follow-up|1|||
38046435|NCT03442296|69734265|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
38046436|NCT03442296|69734266|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
38046437|NCT03442296|69734265|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
38046438|NCT03442296|69734266|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
38046439|NCT03442296|69734265|FG000|12 Month Follow-up|Incomplete measurement|1|||
38046440|NCT03442296|69734266|FG001|12 Month Follow-up|Incomplete measurement|1|||
38046441|NCT03441984|69734274|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
38046442|NCT03441984|69734275|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
38046443|NCT03441984|69734276|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
38046444|NCT03441984|69734277|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
38046445|NCT03441984|69734278|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
38046446|NCT03441984|69734279|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
38046447|NCT03441984|69734280|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
38046448|NCT03441984|69734281|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
38046449|NCT03441984|69734282|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
38046450|NCT03441984|69734283|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
38046451|NCT03441984|69734284|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
38046452|NCT03441984|69734285|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
38046453|NCT03441360|69734303|FG000|Overall Study|Radiological disease progression|5|||
38046454|NCT03441360|69734304|FG001|Overall Study|Radiological disease progression|6|||
38046455|NCT03441360|69734305|FG002|Overall Study|Radiological disease progression|4|||
38046456|NCT03441360|69734303|FG000|Overall Study|Clinical disease progression|2|||
38046457|NCT03441360|69734304|FG001|Overall Study|Clinical disease progression|2|||
38046458|NCT03441360|69734305|FG002|Overall Study|Clinical disease progression|0|||
38046459|NCT03441360|69734303|FG000|Overall Study|Adverse Event|1|||
38046460|NCT03441360|69734304|FG001|Overall Study|Adverse Event|0|||
38046461|NCT03441360|69734305|FG002|Overall Study|Adverse Event|1|||
38046462|NCT01347840|69734313|FG000|Overall Study|Withdrawal by Subject|1|||
38046463|NCT01347762|69734321|FG000|Overall Study|Lost to Follow-up|0|||
38046464|NCT01347762|69734322|FG001|Overall Study|Lost to Follow-up|1|||
38046465|NCT01347762|69734323|FG002|Overall Study|Lost to Follow-up|6|||
38046466|NCT01347762|69734324|FG003|Overall Study|Lost to Follow-up|5|||
38046467|NCT01347762|69734321|FG000|Overall Study|Withdrawal by Subject|4|||
38046468|NCT01347762|69734322|FG001|Overall Study|Withdrawal by Subject|1|||
38046469|NCT01347762|69734323|FG002|Overall Study|Withdrawal by Subject|3|||
38046470|NCT01347762|69734324|FG003|Overall Study|Withdrawal by Subject|3|||
38046471|NCT03438396|69734334|FG000|Overall Study|Reason Not Specified|9|||
38046472|NCT03438396|69734334|FG000|Overall Study|Withdrawal by Subject|5|||
38046473|NCT03438396|69734334|FG000|Overall Study|Lost to Follow-up|2|||
38046474|NCT03438396|69734334|FG000|Overall Study|Death|85|||
38046475|NCT03438396|69734334|FG000|Overall Study|Not treated|1|||
38046476|NCT00073307|69734340|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
38046477|NCT00073307|69734341|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
38046478|NCT00073307|69734342|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
38046479|NCT00073307|69734340|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
38046480|NCT00073307|69734341|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
38046481|NCT00073307|69734342|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
38046482|NCT00073307|69734340|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
38046483|NCT00073307|69734341|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
38046484|NCT00073307|69734342|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
38046485|NCT00073307|69734340|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
38046486|NCT00073307|69734341|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
38046487|NCT00073307|69734342|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
38046488|NCT00073307|69734340|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
38046489|NCT00073307|69734341|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
38046490|NCT00073307|69734342|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
38046491|NCT00073307|69734340|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
38046492|NCT00073307|69734341|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
38046493|NCT00073307|69734342|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
38046494|NCT00073307|69734340|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
38046495|NCT00073307|69734341|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
38046496|NCT00073307|69734342|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
38046497|NCT00073307|69734340|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
38046498|NCT00073307|69734341|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
38046499|NCT00073307|69734342|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
38046500|NCT00073307|69734340|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
38046501|NCT00073307|69734341|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
38046502|NCT00073307|69734342|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
38046503|NCT00073307|69734340|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
38046504|NCT00073307|69734341|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
38046505|NCT00073307|69734342|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
38046506|NCT00073307|69734340|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
38046507|NCT00073307|69734341|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
38046508|NCT00073307|69734342|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
38046509|NCT00073307|69734340|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
38046510|NCT00073307|69734341|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
38046511|NCT00073307|69734342|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
38046512|NCT00073307|69734340|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
38046513|NCT00073307|69734341|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
38046514|NCT00073307|69734342|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
38046515|NCT00073307|69734340|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
38046516|NCT00073307|69734341|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
38046517|NCT00073307|69734342|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
38046518|NCT00073307|69734340|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
38046519|NCT00073307|69734341|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
38046520|NCT00073307|69734342|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
38046521|NCT00073307|69734340|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
38046522|NCT00073307|69734341|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
38046523|NCT00073307|69734342|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
38046524|NCT00073307|69734340|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
38046525|NCT00073307|69734341|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
38046526|NCT00073307|69734342|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
38046527|NCT00073307|69734340|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
38046528|NCT00073307|69734341|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
38046529|NCT00073307|69734342|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
38046530|NCT00073307|69734340|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
38046531|NCT00073307|69734341|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
38046532|NCT00073307|69734342|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
38046533|NCT03388164|69734353|FG000|Overall Study|Withdrawal by Subject|3|||
38046534|NCT03388164|69734354|FG001|Overall Study|Withdrawal by Subject|1|||
38046535|NCT03403374|69734360|FG000|Overall Study|Lost to Follow-up|1|||
38046536|NCT03387462|69734364|FG000|Overall Study|Lost to Follow-up|1|||
38046537|NCT03756883|69734371|FG000|Overall Study|Adverse Event|2|||
38046538|NCT03756883|69734372|FG001|Overall Study|Adverse Event|2|||
38046539|NCT03756883|69734373|FG002|Overall Study|Adverse Event|2|||
38046540|NCT03756883|69734371|FG000|Overall Study|Lack of Efficacy|0|||
38046541|NCT03756883|69734372|FG001|Overall Study|Lack of Efficacy|1|||
38046542|NCT03756883|69734373|FG002|Overall Study|Lack of Efficacy|2|||
38046543|NCT03756883|69734371|FG000|Overall Study|Lost to Follow-up|3|||
38046544|NCT03756883|69734372|FG001|Overall Study|Lost to Follow-up|3|||
38046545|NCT03756883|69734373|FG002|Overall Study|Lost to Follow-up|0|||
38046546|NCT03756883|69734371|FG000|Overall Study|Protocol Violation|2|||
38046547|NCT03756883|69734372|FG001|Overall Study|Protocol Violation|0|||
38046548|NCT03756883|69734373|FG002|Overall Study|Protocol Violation|1|||
38046549|NCT03756883|69734371|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
38046550|NCT03756883|69734372|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
38046551|NCT03756883|69734373|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
38046552|NCT03756883|69734371|FG000|Overall Study|Withdrawal by Subject|4|||
38046553|NCT03756883|69734372|FG001|Overall Study|Withdrawal by Subject|1|||
38046554|NCT03756883|69734373|FG002|Overall Study|Withdrawal by Subject|0|||
38046555|NCT03756883|69734371|FG000|Overall Study|Other Reasons|2|||
38046556|NCT03756883|69734372|FG001|Overall Study|Other Reasons|4|||
38046557|NCT03756883|69734373|FG002|Overall Study|Other Reasons|0|||
38046558|NCT03386994|69734384|FG000|Overall Study|Lung transplant|1|||
38046559|NCT03386994|69734384|FG000|Overall Study|Adverse Event|14|||
38046560|NCT03386994|69734384|FG000|Overall Study|Lost to Follow-up|4|||
38046561|NCT03386994|69734384|FG000|Overall Study|Withdrawal by Subject|3|||
38046562|NCT03386994|69734384|FG000|Overall Study|Death|16|||
38046563|NCT03756571|69734401|FG000|Overall Study|Lost to Follow-up|1|||
38046564|NCT03756571|69734402|FG001|Overall Study|Lost to Follow-up|1|||
38046565|NCT03386448|69734410|FG000|Overall Study|Adverse Event|0|||
38046566|NCT03386448|69734411|FG001|Overall Study|Adverse Event|2|||
38046567|NCT02951988|69734420|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
38046568|NCT02951988|69734421|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
38046569|NCT02951988|69734422|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
38046570|NCT02951988|69734423|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
38046571|NCT02951988|69734420|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
38046572|NCT02951988|69734421|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
38046573|NCT02951988|69734422|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
38046574|NCT02951988|69734423|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
38046575|NCT02951988|69734420|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
38046576|NCT02951988|69734421|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
38046577|NCT02951988|69734422|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
38046578|NCT02951988|69734423|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
38046579|NCT02951988|69734420|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
38046580|NCT02951988|69734421|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
38046581|NCT02951988|69734422|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
38046582|NCT02951988|69734423|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
38046583|NCT02951988|69734420|FG000|Open-Label Treatment Period|Protocol Violation|22|||
38046584|NCT02951988|69734421|FG001|Open-Label Treatment Period|Protocol Violation|0|||
38046585|NCT02951988|69734422|FG002|Open-Label Treatment Period|Protocol Violation|0|||
38046586|NCT02951988|69734423|FG003|Open-Label Treatment Period|Protocol Violation|0|||
38046587|NCT02951988|69734420|FG000|Open-Label Treatment Period|Pregnancy|2|||
38046588|NCT02951988|69734421|FG001|Open-Label Treatment Period|Pregnancy|0|||
38046589|NCT02951988|69734422|FG002|Open-Label Treatment Period|Pregnancy|0|||
38046590|NCT02951988|69734423|FG003|Open-Label Treatment Period|Pregnancy|0|||
38046591|NCT02951988|69734420|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
38046592|NCT02951988|69734421|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
38046593|NCT02951988|69734422|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
38046594|NCT02951988|69734423|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
38046595|NCT02951988|69734420|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
38046596|NCT02951988|69734421|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
38046597|NCT02951988|69734422|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
38046598|NCT02951988|69734423|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
38046599|NCT02951988|69734420|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
38046600|NCT02951988|69734421|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
38046601|NCT02951988|69734422|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
38046602|NCT02951988|69734423|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
38046603|NCT02951988|69734420|FG000|Open-Label Treatment Period|Adverse Event|45|||
38046604|NCT02951988|69734421|FG001|Open-Label Treatment Period|Adverse Event|0|||
38046605|NCT02951988|69734422|FG002|Open-Label Treatment Period|Adverse Event|0|||
38046606|NCT02951988|69734423|FG003|Open-Label Treatment Period|Adverse Event|0|||
38046607|NCT02951988|69734420|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
37953428|NCT00713609|69640340|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
37953429|NCT00713609|69640341|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
37953430|NCT00713609|69640342|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
37953431|NCT00713609|69640337|FG000|Overall Study|Withdrawal by Subject|6|||
37953432|NCT00713609|69640338|FG001|Overall Study|Withdrawal by Subject|1|||
37953433|NCT00713609|69640339|FG002|Overall Study|Withdrawal by Subject|5|||
37953434|NCT00713609|69640340|FG003|Overall Study|Withdrawal by Subject|1|||
37953435|NCT00713609|69640341|FG004|Overall Study|Withdrawal by Subject|5|||
37953436|NCT00713609|69640342|FG005|Overall Study|Withdrawal by Subject|7|||
37953437|NCT00713609|69640337|FG000|Overall Study|Protocol Violation|6|||
37953438|NCT00713609|69640338|FG001|Overall Study|Protocol Violation|3|||
37953439|NCT00713609|69640339|FG002|Overall Study|Protocol Violation|1|||
37953440|NCT00713609|69640340|FG003|Overall Study|Protocol Violation|1|||
37953441|NCT00713609|69640341|FG004|Overall Study|Protocol Violation|2|||
37953442|NCT00713609|69640342|FG005|Overall Study|Protocol Violation|0|||
37953443|NCT00513682|69640356|FG000|Washout Phase|Adverse Event|2|||
38046608|NCT02951988|69734421|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
38046609|NCT02951988|69734422|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
38046610|NCT02951988|69734423|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
38046611|NCT02951988|69734420|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
37953444|NCT00493012|69640365|FG000|Overall Study|Lost to Follow-up|18|||
37953445|NCT00493012|69640366|FG001|Overall Study|Lost to Follow-up|17|||
37953446|NCT05144477|69640374|FG000|Overall Study|Withdrawal by Subject|1|||
37953447|NCT05144477|69640375|FG001|Overall Study|Withdrawal by Subject|1|||
38046612|NCT02951988|69734421|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
38046613|NCT02951988|69734422|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
38046614|NCT02951988|69734423|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
38046615|NCT02951988|69734420|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
38046616|NCT02951988|69734421|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
38046617|NCT02951988|69734422|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
38046618|NCT02951988|69734423|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
38046619|NCT02951988|69734420|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
38046620|NCT02951988|69734421|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
38046621|NCT02951988|69734422|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
38046622|NCT02951988|69734423|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
38046623|NCT02951988|69734420|FG000|Double-Blind Treatment Period|Pregnancy|0|||
38046624|NCT02951988|69734421|FG001|Double-Blind Treatment Period|Pregnancy|1|||
38046625|NCT02951988|69734422|FG002|Double-Blind Treatment Period|Pregnancy|1|||
38046626|NCT02951988|69734423|FG003|Double-Blind Treatment Period|Pregnancy|0|||
38046627|NCT02951988|69734420|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
38046628|NCT02951988|69734421|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
38046629|NCT02951988|69734422|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
38046630|NCT02951988|69734423|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
38046631|NCT02951988|69734420|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
38046632|NCT02951988|69734421|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
38046633|NCT02951988|69734422|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
38046634|NCT02951988|69734423|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
38046635|NCT02951988|69734420|FG000|Double-Blind Treatment Period|Adverse Event|0|||
38046636|NCT02951988|69734421|FG001|Double-Blind Treatment Period|Adverse Event|8|||
38046637|NCT02951988|69734422|FG002|Double-Blind Treatment Period|Adverse Event|3|||
38046638|NCT02951988|69734423|FG003|Double-Blind Treatment Period|Adverse Event|6|||
38046639|NCT02951988|69734420|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
38046640|NCT02951988|69734421|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
38046641|NCT02951988|69734422|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
38046642|NCT02951988|69734423|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
38046643|NCT00009737|69734435|FG000|Overall Study|Adverse Event|112|||
38046644|NCT00009737|69734436|FG001|Overall Study|Adverse Event|75|||
38046645|NCT00009737|69734435|FG000|Overall Study|Death|4|||
38046646|NCT00009737|69734436|FG001|Overall Study|Death|6|||
38046647|NCT00009737|69734435|FG000|Overall Study|Lack of Efficacy|17|||
38046648|NCT00009737|69734436|FG001|Overall Study|Lack of Efficacy|15|||
38046649|NCT00009737|69734435|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
38046650|NCT00009737|69734436|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
38046651|NCT00009737|69734435|FG000|Overall Study|Other Protocol Violation|1|||
38046652|NCT00009737|69734436|FG001|Overall Study|Other Protocol Violation|0|||
38046653|NCT00009737|69734435|FG000|Overall Study|Refused Treatment|15|||
38046654|NCT00009737|69734436|FG001|Overall Study|Refused Treatment|16|||
38046655|NCT00009737|69734435|FG000|Overall Study|Lost to Follow-up|1|||
38046656|NCT00009737|69734436|FG001|Overall Study|Lost to Follow-up|1|||
38046657|NCT00009737|69734435|FG000|Overall Study|Administrative/Other Reasons|7|||
38046658|NCT00009737|69734436|FG001|Overall Study|Administrative/Other Reasons|1|||
38046659|NCT03417102|69734444|FG000|Overall Study|Adverse Event|0|||
38046660|NCT03417102|69734445|FG001|Overall Study|Adverse Event|1|||
38046661|NCT03417102|69734444|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
38046662|NCT03417102|69734445|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
38046663|NCT03417102|69734444|FG000|Overall Study|Other|0|||
38046664|NCT03417102|69734445|FG001|Overall Study|Other|1|||
38046665|NCT03417024|69734451|FG000|Overall Study|Study Termination prior to follow-up|11|||
38046666|NCT03417024|69734451|FG000|Overall Study|Physician Decision|2|||
38046667|NCT00028769|69734455|FG000|Overall Study|Adverse Event|2|||
38046668|NCT00028769|69734455|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
38046669|NCT00028769|69734455|FG000|Overall Study|Progression or Death|31|||
38046670|NCT00028769|69734455|FG000|Overall Study|Other - Not Protocol Specified|1|||
38046671|NCT00028769|69734455|FG000|Overall Study|Ineligible|5|||
38046672|NCT00028769|69734455|FG000|Overall Study|Not Analyzable|1|||
38046673|NCT02953314|69734461|FG000|Overall Study|Adverse Event|0|||
38046674|NCT02953314|69734462|FG001|Overall Study|Adverse Event|1|||
38046675|NCT02953314|69734461|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
38046676|NCT02953314|69734462|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
38046677|NCT03402750|69734470|FG000|Overall Study|Lost to Follow-up|2|||
38046678|NCT03402750|69734471|FG001|Overall Study|Lost to Follow-up|1|||
38046679|NCT00007475|69734480|FG000|Overall Study|Withdrawal by Subject|1|||
38046680|NCT00007475|69734481|FG001|Overall Study|Withdrawal by Subject|0|||
38046681|NCT00007475|69734482|FG002|Overall Study|Withdrawal by Subject|0|||
38046682|NCT00007475|69734483|FG003|Overall Study|Withdrawal by Subject|0|||
38046683|NCT00007475|69734480|FG000|Overall Study|Adverse Event|3|||
38046684|NCT00007475|69734481|FG001|Overall Study|Adverse Event|0|||
37953448|NCT00617708|69640391|FG000|Overall Study|Adverse Event|0|||
37953449|NCT00617708|69640392|FG001|Overall Study|Adverse Event|6|||
37953450|NCT00617708|69640393|FG002|Overall Study|Adverse Event|9|||
37953451|NCT00617708|69640391|FG000|Overall Study|Withdrawal by Subject|1|||
37953452|NCT00617708|69640392|FG001|Overall Study|Withdrawal by Subject|1|||
37953453|NCT00617708|69640393|FG002|Overall Study|Withdrawal by Subject|7|||
37953454|NCT00617708|69640391|FG000|Overall Study|Death|0|||
37953455|NCT00617708|69640392|FG001|Overall Study|Death|6|||
37953456|NCT00617708|69640393|FG002|Overall Study|Death|5|||
37953457|NCT00617708|69640391|FG000|Overall Study|Progression/Relapse|7|||
37953458|NCT00617708|69640392|FG001|Overall Study|Progression/Relapse|40|||
37953459|NCT00617708|69640393|FG002|Overall Study|Progression/Relapse|36|||
37953460|NCT00617708|69640391|FG000|Overall Study|Not protocol specified|1|||
37953461|NCT00617708|69640392|FG001|Overall Study|Not protocol specified|4|||
37953462|NCT00617708|69640393|FG002|Overall Study|Not protocol specified|2|||
37953463|NCT00617708|69640391|FG000|Overall Study|Not eligible|1|||
37953464|NCT00617708|69640392|FG001|Overall Study|Not eligible|3|||
37953465|NCT00617708|69640393|FG002|Overall Study|Not eligible|5|||
37953466|NCT03894969|69640408|FG000|Overall Study|Adverse Event|0|||
37953467|NCT03894969|69640409|FG001|Overall Study|Adverse Event|2|||
37953468|NCT03894969|69640410|FG002|Overall Study|Adverse Event|0|||
37953469|NCT03894969|69640411|FG003|Overall Study|Adverse Event|1|||
37953470|NCT03894969|69640412|FG004|Overall Study|Adverse Event|2|||
37953471|NCT03894969|69640408|FG000|Overall Study|Lost to Follow-up|3|||
37953472|NCT03894969|69640409|FG001|Overall Study|Lost to Follow-up|1|||
37953473|NCT03894969|69640410|FG002|Overall Study|Lost to Follow-up|1|||
37953474|NCT03894969|69640411|FG003|Overall Study|Lost to Follow-up|0|||
37953475|NCT03894969|69640412|FG004|Overall Study|Lost to Follow-up|0|||
37953476|NCT03894969|69640408|FG000|Overall Study|Withdrawal by Subject|2|||
37953477|NCT03894969|69640409|FG001|Overall Study|Withdrawal by Subject|1|||
37953478|NCT03894969|69640410|FG002|Overall Study|Withdrawal by Subject|3|||
37953479|NCT03894969|69640411|FG003|Overall Study|Withdrawal by Subject|4|||
37953480|NCT03894969|69640412|FG004|Overall Study|Withdrawal by Subject|8|||
37953481|NCT03894969|69640408|FG000|Overall Study|Other|0|||
37953482|NCT03894969|69640409|FG001|Overall Study|Other|0|||
37953483|NCT03894969|69640410|FG002|Overall Study|Other|0|||
37953484|NCT03894969|69640411|FG003|Overall Study|Other|0|||
37953485|NCT03894969|69640412|FG004|Overall Study|Other|3|||
37953486|NCT03894969|69640408|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
37953487|NCT03894969|69640409|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
37953488|NCT03894969|69640410|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
37953489|NCT03894969|69640411|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
37953490|NCT03894969|69640412|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
37953491|NCT03894969|69640408|FG000|Overall Study|Solicited Adverse Event|0|||
37953492|NCT03894969|69640409|FG001|Overall Study|Solicited Adverse Event|1|||
37953493|NCT03894969|69640410|FG002|Overall Study|Solicited Adverse Event|0|||
37953494|NCT03894969|69640411|FG003|Overall Study|Solicited Adverse Event|0|||
37953495|NCT03894969|69640412|FG004|Overall Study|Solicited Adverse Event|0|||
37953496|NCT03894813|69640428|FG000|Overall Study|Adverse Event|1|||
37953497|NCT03894813|69640429|FG001|Overall Study|Adverse Event|1|||
37953498|NCT03894813|69640428|FG000|Overall Study|Lack of Efficacy|3|||
37953499|NCT03894813|69640429|FG001|Overall Study|Lack of Efficacy|3|||
37953500|NCT03894813|69640428|FG000|Overall Study|Lost to Follow-up|1|||
37953501|NCT03894813|69640429|FG001|Overall Study|Lost to Follow-up|0|||
37953502|NCT03894813|69640428|FG000|Overall Study|Pregnancy|2|||
37953503|NCT03894813|69640429|FG001|Overall Study|Pregnancy|1|||
37953504|NCT03894813|69640428|FG000|Overall Study|Protocol Violation|3|||
37953505|NCT03894813|69640429|FG001|Overall Study|Protocol Violation|7|||
37953506|NCT03894813|69640428|FG000|Overall Study|Withdrawal by Subject|1|||
37953507|NCT03894813|69640429|FG001|Overall Study|Withdrawal by Subject|3|||
37953508|NCT03894813|69640428|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
37953509|NCT03894813|69640429|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
37953510|NCT00615992|69640435|FG000|Overall Study|Protocol Violation|67|||
37953511|NCT03892707|69640441|FG000|Overall Study|Screen failure|6|||
37953512|NCT03892707|69640442|FG001|Overall Study|Screen failure|0|||
37953513|NCT03892707|69640441|FG000|Overall Study|Pain resolution|0|||
37953514|NCT03892707|69640442|FG001|Overall Study|Pain resolution|4|||
37953515|NCT03892707|69640441|FG000|Overall Study|Withdrawal by Subject|0|||
37953516|NCT03892707|69640442|FG001|Overall Study|Withdrawal by Subject|1|||
37953517|NCT03892707|69640441|FG000|Overall Study|Other (long business trip)|0|||
37953518|NCT03892707|69640442|FG001|Overall Study|Other (long business trip)|1|||
37953519|NCT00615914|69640449|FG000|Overall Study|Adverse Event|274|||
37953520|NCT00615914|69640449|FG000|Overall Study|Death|20|||
37953521|NCT00615914|69640449|FG000|Overall Study|Lack of Efficacy|59|||
37953522|NCT00615914|69640449|FG000|Overall Study|Lost to Follow-up|187|||
38046685|NCT00007475|69734482|FG002|Overall Study|Adverse Event|0|||
37953523|NCT00615914|69640449|FG000|Overall Study|Withdrawal by Subject|16|||
37953524|NCT00615914|69640449|FG000|Overall Study|Physician Decision|4|||
38046686|NCT00007475|69734483|FG003|Overall Study|Adverse Event|0|||
38046687|NCT00025883|69734495|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
38046688|NCT00025883|69734495|FG000|Overall Study|no baseline data|1|||
38046689|NCT00025883|69734495|FG000|Overall Study|Death|1|||
38046690|NCT00025883|69734495|FG000|Overall Study|Adverse Event|1|||
38046691|NCT00025883|69734495|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
38046692|NCT00072293|69734502|FG000|Overall Study|Lost to Follow-up|1|||
38046693|NCT00072293|69734503|FG001|Overall Study|Lost to Follow-up|1|||
38046694|NCT00072293|69734502|FG000|Overall Study|Withdrawal by Subject|0|||
38046695|NCT00072293|69734503|FG001|Overall Study|Withdrawal by Subject|1|||
38046696|NCT03753763|69734511|FG000|Overall Study|Adverse Event|2|||
38046697|NCT03753763|69734512|FG001|Overall Study|Adverse Event|0|||
38046698|NCT03753763|69734511|FG000|Overall Study|Withdrawal by Subject|3|||
38046699|NCT03753763|69734512|FG001|Overall Study|Withdrawal by Subject|1|||
38046700|NCT03753763|69734511|FG000|Overall Study|clinical deterioration|1|||
38046701|NCT03753763|69734512|FG001|Overall Study|clinical deterioration|0|||
38046702|NCT03384966|69734521|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
38046703|NCT03384966|69734522|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
38046704|NCT03384966|69734523|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
38046705|NCT03384966|69734521|FG000|Follow-up Period|Adverse Event|1|||
38046706|NCT03384966|69734522|FG001|Follow-up Period|Adverse Event|0|||
38046707|NCT03384966|69734523|FG002|Follow-up Period|Adverse Event|0|||
38046708|NCT03402126|69734540|FG000|Overall Study|Lost to Follow-up|6|||
38046709|NCT03402126|69734540|FG000|Overall Study|Protocol Violation|10|||
38046710|NCT03402126|69734540|FG000|Overall Study|Sponsor request/Study termination|29|||
38046711|NCT03402126|69734540|FG000|Overall Study|Study product no longer in use|1|||
38046712|NCT03402126|69734540|FG000|Overall Study|Technical problems|1|||
38046713|NCT03402126|69734540|FG000|Overall Study|Withdrawal by Subject|6|||
38046714|NCT03402126|69734540|FG000|Overall Study|Physician Decision|2|||
38046715|NCT03402126|69734540|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
38046716|NCT03402126|69734540|FG000|Overall Study|Death|4|||
38046717|NCT03355326|69734546|FG000|Overall Study|Protocol Violation|3|||
38046718|NCT03355326|69734547|FG001|Overall Study|Protocol Violation|3|||
38046719|NCT03353220|69734553|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
38046720|NCT03353220|69734554|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
38046721|NCT03751657|69734562|FG000|Overall Study|Physician Decision|0|||
38046722|NCT03751657|69734563|FG001|Overall Study|Physician Decision|1|||
38046723|NCT03751657|69734562|FG000|Overall Study|Withdrawal by Subject|1|||
38046724|NCT03751657|69734563|FG001|Overall Study|Withdrawal by Subject|1|||
38046725|NCT03751657|69734562|FG000|Overall Study|Lost to Follow-up|2|||
38046726|NCT03751657|69734563|FG001|Overall Study|Lost to Follow-up|1|||
38046727|NCT00025259|69734576|FG000|Overall Study|Death|1|||
38046728|NCT00025259|69734577|FG001|Overall Study|Death|3|||
38046729|NCT00025259|69734578|FG002|Overall Study|Death|0|||
38046730|NCT00025259|69734579|FG003|Overall Study|Death|3|||
38046731|NCT00025259|69734580|FG004|Overall Study|Death|0|||
38046732|NCT00025259|69734581|FG005|Overall Study|Death|1|||
38046733|NCT00025259|69734582|FG006|Overall Study|Death|2|||
38046734|NCT00025259|69734576|FG000|Overall Study|Lack of Efficacy|2|||
38046735|NCT00025259|69734577|FG001|Overall Study|Lack of Efficacy|46|||
38046736|NCT00025259|69734578|FG002|Overall Study|Lack of Efficacy|60|||
38046737|NCT00025259|69734579|FG003|Overall Study|Lack of Efficacy|78|||
38046738|NCT00025259|69734580|FG004|Overall Study|Lack of Efficacy|11|||
38046739|NCT00025259|69734581|FG005|Overall Study|Lack of Efficacy|30|||
37953525|NCT00615914|69640449|FG000|Overall Study|No data was collected.|65|||
37953526|NCT00615914|69640449|FG000|Overall Study|No treatment|2|||
37953527|NCT00615914|69640449|FG000|Overall Study|Irregularly enrolled patients|10|||
37953528|NCT00513604|69640459|FG000|Overall Study|Not treated|2|||
37953529|NCT00513604|69640460|FG001|Overall Study|Not treated|0|||
37953530|NCT00513604|69640461|FG002|Overall Study|Not treated|1|||
37953531|NCT00513604|69640462|FG003|Overall Study|Not treated|0|||
37953532|NCT00513604|69640463|FG004|Overall Study|Not treated|0|||
37953533|NCT00513604|69640459|FG000|Overall Study|Death during treatment|0|||
37953534|NCT00513604|69640460|FG001|Overall Study|Death during treatment|3|||
37953535|NCT00513604|69640461|FG002|Overall Study|Death during treatment|2|||
37953536|NCT00513604|69640462|FG003|Overall Study|Death during treatment|0|||
37953537|NCT00513604|69640463|FG004|Overall Study|Death during treatment|0|||
38046740|NCT00025259|69734582|FG006|Overall Study|Lack of Efficacy|38|||
38046741|NCT00025259|69734576|FG000|Overall Study|Lost to Follow-up|2|||
38046742|NCT00025259|69734577|FG001|Overall Study|Lost to Follow-up|9|||
38046743|NCT00025259|69734578|FG002|Overall Study|Lost to Follow-up|13|||
38046744|NCT00025259|69734579|FG003|Overall Study|Lost to Follow-up|13|||
38046745|NCT00025259|69734580|FG004|Overall Study|Lost to Follow-up|1|||
38046746|NCT00025259|69734581|FG005|Overall Study|Lost to Follow-up|3|||
38046747|NCT00025259|69734582|FG006|Overall Study|Lost to Follow-up|1|||
38046748|NCT00025259|69734576|FG000|Overall Study|Physician Decision|12|||
38046749|NCT00025259|69734577|FG001|Overall Study|Physician Decision|1|||
38046750|NCT00025259|69734578|FG002|Overall Study|Physician Decision|0|||
38046751|NCT00025259|69734579|FG003|Overall Study|Physician Decision|5|||
38046752|NCT00025259|69734580|FG004|Overall Study|Physician Decision|4|||
38046753|NCT00025259|69734581|FG005|Overall Study|Physician Decision|2|||
38046754|NCT00025259|69734582|FG006|Overall Study|Physician Decision|1|||
38046755|NCT00025259|69734576|FG000|Overall Study|Protocol Violation|3|||
38046756|NCT00025259|69734577|FG001|Overall Study|Protocol Violation|2|||
38046757|NCT00025259|69734578|FG002|Overall Study|Protocol Violation|2|||
38046758|NCT00025259|69734579|FG003|Overall Study|Protocol Violation|1|||
38046759|NCT00025259|69734580|FG004|Overall Study|Protocol Violation|2|||
38046760|NCT00025259|69734581|FG005|Overall Study|Protocol Violation|1|||
38046761|NCT00025259|69734582|FG006|Overall Study|Protocol Violation|3|||
38046762|NCT00025259|69734576|FG000|Overall Study|Withdrawal by Subject|9|||
38046763|NCT00025259|69734577|FG001|Overall Study|Withdrawal by Subject|27|||
38046764|NCT00025259|69734578|FG002|Overall Study|Withdrawal by Subject|6|||
38046765|NCT00025259|69734579|FG003|Overall Study|Withdrawal by Subject|14|||
38046766|NCT00025259|69734580|FG004|Overall Study|Withdrawal by Subject|11|||
38046767|NCT00025259|69734581|FG005|Overall Study|Withdrawal by Subject|8|||
38046768|NCT00025259|69734582|FG006|Overall Study|Withdrawal by Subject|3|||
38046769|NCT00025259|69734576|FG000|Overall Study|Ineligible|14|||
38046770|NCT00025259|69734577|FG001|Overall Study|Ineligible|1|||
38046771|NCT00025259|69734578|FG002|Overall Study|Ineligible|0|||
38046772|NCT00025259|69734579|FG003|Overall Study|Ineligible|0|||
38046773|NCT00025259|69734580|FG004|Overall Study|Ineligible|6|||
38046774|NCT00025259|69734581|FG005|Overall Study|Ineligible|0|||
38046775|NCT00025259|69734582|FG006|Overall Study|Ineligible|1|||
38046776|NCT00025259|69734576|FG000|Overall Study|Randomization error|1|||
38046777|NCT00025259|69734577|FG001|Overall Study|Randomization error|0|||
38046778|NCT00025259|69734578|FG002|Overall Study|Randomization error|0|||
38046779|NCT00025259|69734579|FG003|Overall Study|Randomization error|0|||
38046780|NCT00025259|69734580|FG004|Overall Study|Randomization error|1|||
38046781|NCT00025259|69734581|FG005|Overall Study|Randomization error|7|||
38046782|NCT00025259|69734582|FG006|Overall Study|Randomization error|2|||
38046783|NCT00025259|69734576|FG000|Overall Study|Adverse Event|1|||
38046784|NCT00025259|69734577|FG001|Overall Study|Adverse Event|0|||
38046785|NCT00025259|69734578|FG002|Overall Study|Adverse Event|0|||
38046786|NCT00025259|69734579|FG003|Overall Study|Adverse Event|0|||
38046787|NCT00025259|69734580|FG004|Overall Study|Adverse Event|0|||
38046788|NCT00025259|69734581|FG005|Overall Study|Adverse Event|0|||
38046789|NCT00025259|69734582|FG006|Overall Study|Adverse Event|0|||
38046790|NCT03351738|69734607|FG000|Overall Study|Withdrawal by Subject|0|||
38046791|NCT03351738|69734608|FG001|Overall Study|Withdrawal by Subject|1|||
38046792|NCT03351738|69734609|FG002|Overall Study|Withdrawal by Subject|0|||
38046793|NCT03351738|69734610|FG003|Overall Study|Withdrawal by Subject|1|||
38046794|NCT03351738|69734611|FG004|Overall Study|Withdrawal by Subject|0|||
38046795|NCT03351738|69734612|FG005|Overall Study|Withdrawal by Subject|0|||
38046796|NCT03351114|69734631|FG000|Overall Study|Withdrawal by Subject|1|||
38046797|NCT03350256|69734635|FG000|Overall Study|Inclusion/exclusion violation|4|||
38046798|NCT03350256|69734635|FG000|Overall Study|Recommended for other therapies|2|||
38046799|NCT03350256|69734635|FG000|Overall Study|Protocol Violation|3|||
38046800|NCT03350256|69734635|FG000|Overall Study|Non compliance|2|||
38046801|NCT03350256|69734635|FG000|Overall Study|Denial by insurance|1|||
38046802|NCT03350256|69734635|FG000|Overall Study|Adverse Event|2|||
38046803|NCT03350256|69734635|FG000|Overall Study|Trial failure|12|||
38046804|NCT03350256|69734635|FG000|Overall Study|Did not proceed to permanent implant|3|||
38046805|NCT03350256|69734635|FG000|Overall Study|Withdrawal by Subject|3|||
38046806|NCT03350256|69734635|FG000|Overall Study|Subject moving out of state|1|||
38046807|NCT03350256|69734635|FG000|Overall Study|Lost to Follow-up|1|||
38046808|NCT03350256|69734635|FG000|Overall Study|Lack of Efficacy|2|||
38046809|NCT00024167|69734642|FG000|Overall Study|Death|53|||
38046810|NCT00024167|69734643|FG001|Overall Study|Death|47|||
38046811|NCT00022763|69734652|FG000|Overall Study|Adverse Event|1|||
38046812|NCT00022763|69734653|FG001|Overall Study|Adverse Event|2|||
38046813|NCT00022763|69734652|FG000|Overall Study|Injection Site Reactions|0|||
38046814|NCT00022763|69734653|FG001|Overall Study|Injection Site Reactions|2|||
38046815|NCT00022763|69734652|FG000|Overall Study|Death|0|||
38046816|NCT00022763|69734653|FG001|Overall Study|Death|1|||
38046817|NCT00022763|69734652|FG000|Overall Study|Lost to Follow-up|0|||
38046818|NCT00022763|69734653|FG001|Overall Study|Lost to Follow-up|3|||
38046819|NCT00022763|69734652|FG000|Overall Study|Withdrawal by Subject|4|||
38046820|NCT00022763|69734653|FG001|Overall Study|Withdrawal by Subject|7|||
38046821|NCT00022763|69734652|FG000|Overall Study|Insufficient Therapy|1|||
38046822|NCT00022763|69734653|FG001|Overall Study|Insufficient Therapy|0|||
38046823|NCT00022763|69734652|FG000|Overall Study|Admin|3|||
38046824|NCT00022763|69734653|FG001|Overall Study|Admin|2|||
38046825|NCT00071513|69734660|FG000|Intervention Component|Withdrawal by Subject|2|||
38046826|NCT00071513|69734661|FG001|Intervention Component|Withdrawal by Subject|3|||
38046827|NCT00071513|69734660|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
38046828|NCT00071513|69734661|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
38046829|NCT00006389|69734669|FG000|Overall Study|Adverse Event|1|||
38046830|NCT00006305|69734678|FG000|Overall Study|Withdrawal by Subject|17|||
38046831|NCT00006305|69734679|FG001|Overall Study|Withdrawal by Subject|10|||
38046832|NCT00006305|69734680|FG002|Overall Study|Withdrawal by Subject|15|||
38046833|NCT00006305|69734681|FG003|Overall Study|Withdrawal by Subject|14|||
38046834|NCT03529773|69734731|FG000|Overall Study|Adverse Event|0|||
38046835|NCT03529773|69734732|FG001|Overall Study|Adverse Event|0|||
38046836|NCT03529773|69734733|FG002|Overall Study|Adverse Event|0|||
38046837|NCT03529773|69734734|FG003|Overall Study|Adverse Event|0|||
38046838|NCT03529773|69734735|FG004|Overall Study|Adverse Event|0|||
38046839|NCT03529773|69734736|FG005|Overall Study|Adverse Event|0|||
38046840|NCT03529773|69734737|FG006|Overall Study|Adverse Event|0|||
38046841|NCT03529773|69734738|FG007|Overall Study|Adverse Event|0|||
38046842|NCT03529773|69734739|FG008|Overall Study|Adverse Event|0|||
38046843|NCT03529773|69734740|FG009|Overall Study|Adverse Event|0|||
38046844|NCT03529773|69734741|FG010|Overall Study|Adverse Event|0|||
38046845|NCT03529773|69734742|FG011|Overall Study|Adverse Event|0|||
38046846|NCT03529773|69734743|FG012|Overall Study|Adverse Event|0|||
38046847|NCT03529773|69734744|FG013|Overall Study|Adverse Event|0|||
38046848|NCT03529773|69734745|FG014|Overall Study|Adverse Event|0|||
38046849|NCT03529773|69734746|FG015|Overall Study|Adverse Event|0|||
38046850|NCT03529773|69734747|FG016|Overall Study|Adverse Event|0|||
38046851|NCT03529773|69734748|FG017|Overall Study|Adverse Event|0|||
38046852|NCT03529773|69734749|FG018|Overall Study|Adverse Event|0|||
38046853|NCT03529773|69734750|FG019|Overall Study|Adverse Event|0|||
38046854|NCT03529773|69734751|FG020|Overall Study|Adverse Event|0|||
38046855|NCT03529773|69734752|FG021|Overall Study|Adverse Event|0|||
38046856|NCT03529773|69734753|FG022|Overall Study|Adverse Event|0|||
38046857|NCT03529773|69734754|FG023|Overall Study|Adverse Event|0|||
38046858|NCT03529773|69734755|FG024|Overall Study|Adverse Event|0|||
38046859|NCT03529773|69734756|FG025|Overall Study|Adverse Event|0|||
38046860|NCT03529773|69734757|FG026|Overall Study|Adverse Event|0|||
38046861|NCT03529773|69734758|FG027|Overall Study|Adverse Event|0|||
38046862|NCT03529773|69734759|FG028|Overall Study|Adverse Event|0|||
38046863|NCT03529773|69734760|FG029|Overall Study|Adverse Event|0|||
38046864|NCT03529773|69734761|FG030|Overall Study|Adverse Event|1|||
38046865|NCT03529773|69734762|FG031|Overall Study|Adverse Event|0|||
38046866|NCT03529773|69734763|FG032|Overall Study|Adverse Event|0|||
38046867|NCT03529773|69734764|FG033|Overall Study|Adverse Event|0|||
38046868|NCT03529773|69734765|FG034|Overall Study|Adverse Event|0|||
38046869|NCT03529773|69734766|FG035|Overall Study|Adverse Event|1|||
38046870|NCT03529773|69734767|FG036|Overall Study|Adverse Event|0|||
38046871|NCT03529773|69734768|FG037|Overall Study|Adverse Event|0|||
38046872|NCT03529773|69734769|FG038|Overall Study|Adverse Event|1|||
38046873|NCT03529773|69734770|FG039|Overall Study|Adverse Event|1|||
38046874|NCT03529773|69734731|FG000|Overall Study|Death|0|||
37861740|NCT00400725|69545428|FG002|Initial Phase (up to 4 Weeks)|Other|0|||
37861741|NCT00400725|69545426|FG000|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
37861742|NCT00400725|69545427|FG001|Maintenance Phase (up to 6 Months)|Lack of Efficacy|1|||
37861743|NCT00400725|69545428|FG002|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
37861744|NCT00400725|69545426|FG000|Maintenance Phase (up to 6 Months)|Adverse Event|0|||
37861745|NCT00400725|69545427|FG001|Maintenance Phase (up to 6 Months)|Adverse Event|2|||
37861746|NCT00400725|69545428|FG002|Maintenance Phase (up to 6 Months)|Adverse Event|4|||
37861747|NCT00400725|69545426|FG000|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|0|||
37861748|NCT00400725|69545427|FG001|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|11|||
37861749|NCT00400725|69545428|FG002|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|21|||
37861750|NCT00400725|69545426|FG000|Maintenance Phase (up to 6 Months)|Lost to Follow-up|0|||
37861751|NCT00400725|69545427|FG001|Maintenance Phase (up to 6 Months)|Lost to Follow-up|1|||
37861752|NCT00400725|69545428|FG002|Maintenance Phase (up to 6 Months)|Lost to Follow-up|2|||
37861753|NCT00400725|69545426|FG000|Maintenance Phase (up to 6 Months)|Other|0|||
37861754|NCT00400725|69545427|FG001|Maintenance Phase (up to 6 Months)|Other|1|||
37861755|NCT00400725|69545428|FG002|Maintenance Phase (up to 6 Months)|Other|2|||
37861756|NCT00932113|69545444|FG000|Overall Study|Lost to Follow-up|1|||
37861757|NCT00932113|69545445|FG001|Overall Study|Lost to Follow-up|0|||
37861758|NCT00931801|69545454|FG000|Overall Study|Adverse Event|0|||
37861759|NCT00931801|69545455|FG001|Overall Study|Adverse Event|0|||
37861760|NCT00931801|69545456|FG002|Overall Study|Adverse Event|1|||
37861761|NCT00931801|69545454|FG000|Overall Study|Lost to Follow-up|0|||
37861762|NCT00931801|69545455|FG001|Overall Study|Lost to Follow-up|1|||
37861763|NCT00931801|69545456|FG002|Overall Study|Lost to Follow-up|0|||
37861764|NCT00931801|69545454|FG000|Overall Study|Withdrawal by Subject|1|||
38046875|NCT03529773|69734732|FG001|Overall Study|Death|0|||
38046876|NCT03529773|69734733|FG002|Overall Study|Death|0|||
38046877|NCT03529773|69734734|FG003|Overall Study|Death|0|||
38046878|NCT03529773|69734735|FG004|Overall Study|Death|0|||
38046879|NCT03529773|69734736|FG005|Overall Study|Death|0|||
38046880|NCT03529773|69734737|FG006|Overall Study|Death|0|||
38046881|NCT03529773|69734738|FG007|Overall Study|Death|0|||
38046882|NCT03529773|69734739|FG008|Overall Study|Death|0|||
38046883|NCT03529773|69734740|FG009|Overall Study|Death|0|||
38046884|NCT03529773|69734741|FG010|Overall Study|Death|0|||
38046885|NCT03529773|69734742|FG011|Overall Study|Death|0|||
38046886|NCT03529773|69734743|FG012|Overall Study|Death|1|||
38046887|NCT03529773|69734744|FG013|Overall Study|Death|0|||
38046888|NCT03529773|69734745|FG014|Overall Study|Death|0|||
38046889|NCT03529773|69734746|FG015|Overall Study|Death|0|||
38046890|NCT03529773|69734747|FG016|Overall Study|Death|0|||
38046891|NCT03529773|69734748|FG017|Overall Study|Death|0|||
38046892|NCT03529773|69734749|FG018|Overall Study|Death|0|||
38046893|NCT03529773|69734750|FG019|Overall Study|Death|1|||
38046894|NCT03529773|69734751|FG020|Overall Study|Death|0|||
38046895|NCT03529773|69734752|FG021|Overall Study|Death|0|||
38046896|NCT03529773|69734753|FG022|Overall Study|Death|1|||
38046897|NCT03529773|69734754|FG023|Overall Study|Death|0|||
38046898|NCT03529773|69734755|FG024|Overall Study|Death|0|||
38046899|NCT03529773|69734756|FG025|Overall Study|Death|0|||
38046900|NCT03529773|69734757|FG026|Overall Study|Death|0|||
38046901|NCT03529773|69734758|FG027|Overall Study|Death|0|||
38046902|NCT03529773|69734759|FG028|Overall Study|Death|0|||
38046903|NCT03529773|69734760|FG029|Overall Study|Death|0|||
38046904|NCT03529773|69734761|FG030|Overall Study|Death|0|||
38046905|NCT03529773|69734762|FG031|Overall Study|Death|0|||
38046906|NCT03529773|69734763|FG032|Overall Study|Death|0|||
38046907|NCT03529773|69734764|FG033|Overall Study|Death|1|||
38046908|NCT03529773|69734765|FG034|Overall Study|Death|1|||
38046909|NCT03529773|69734766|FG035|Overall Study|Death|0|||
38046910|NCT03529773|69734767|FG036|Overall Study|Death|1|||
38046911|NCT03529773|69734768|FG037|Overall Study|Death|0|||
38046912|NCT03529773|69734769|FG038|Overall Study|Death|0|||
38046913|NCT03529773|69734770|FG039|Overall Study|Death|0|||
38046914|NCT03529773|69734731|FG000|Overall Study|Lost to Follow-up|0|||
38046915|NCT03529773|69734732|FG001|Overall Study|Lost to Follow-up|0|||
38046916|NCT03529773|69734733|FG002|Overall Study|Lost to Follow-up|1|||
38046917|NCT03529773|69734734|FG003|Overall Study|Lost to Follow-up|0|||
38046918|NCT03529773|69734735|FG004|Overall Study|Lost to Follow-up|1|||
38046919|NCT03529773|69734736|FG005|Overall Study|Lost to Follow-up|1|||
38046920|NCT03529773|69734737|FG006|Overall Study|Lost to Follow-up|0|||
38046921|NCT03529773|69734738|FG007|Overall Study|Lost to Follow-up|0|||
38046922|NCT03529773|69734739|FG008|Overall Study|Lost to Follow-up|0|||
38046923|NCT03529773|69734740|FG009|Overall Study|Lost to Follow-up|0|||
38046924|NCT03529773|69734741|FG010|Overall Study|Lost to Follow-up|0|||
38046925|NCT03529773|69734742|FG011|Overall Study|Lost to Follow-up|0|||
38046926|NCT03529773|69734743|FG012|Overall Study|Lost to Follow-up|0|||
38046927|NCT03529773|69734744|FG013|Overall Study|Lost to Follow-up|1|||
38046928|NCT03529773|69734745|FG014|Overall Study|Lost to Follow-up|4|||
38046929|NCT03529773|69734746|FG015|Overall Study|Lost to Follow-up|1|||
38046930|NCT03529773|69734747|FG016|Overall Study|Lost to Follow-up|1|||
38046931|NCT03529773|69734748|FG017|Overall Study|Lost to Follow-up|0|||
38046932|NCT03529773|69734749|FG018|Overall Study|Lost to Follow-up|1|||
38046933|NCT03529773|69734750|FG019|Overall Study|Lost to Follow-up|1|||
38046934|NCT03529773|69734751|FG020|Overall Study|Lost to Follow-up|2|||
38046935|NCT03529773|69734752|FG021|Overall Study|Lost to Follow-up|4|||
38046936|NCT03529773|69734753|FG022|Overall Study|Lost to Follow-up|3|||
38046937|NCT03529773|69734754|FG023|Overall Study|Lost to Follow-up|4|||
38046938|NCT03529773|69734755|FG024|Overall Study|Lost to Follow-up|3|||
38046939|NCT03529773|69734756|FG025|Overall Study|Lost to Follow-up|5|||
38046940|NCT03529773|69734757|FG026|Overall Study|Lost to Follow-up|5|||
38046941|NCT03529773|69734758|FG027|Overall Study|Lost to Follow-up|0|||
38046942|NCT03529773|69734759|FG028|Overall Study|Lost to Follow-up|0|||
38046943|NCT03529773|69734760|FG029|Overall Study|Lost to Follow-up|0|||
38046944|NCT03529773|69734761|FG030|Overall Study|Lost to Follow-up|1|||
38046945|NCT03529773|69734762|FG031|Overall Study|Lost to Follow-up|0|||
38046946|NCT03529773|69734763|FG032|Overall Study|Lost to Follow-up|0|||
38046947|NCT03529773|69734764|FG033|Overall Study|Lost to Follow-up|1|||
38046948|NCT03529773|69734765|FG034|Overall Study|Lost to Follow-up|1|||
38046949|NCT03529773|69734766|FG035|Overall Study|Lost to Follow-up|0|||
38046950|NCT03529773|69734767|FG036|Overall Study|Lost to Follow-up|0|||
38046951|NCT03529773|69734768|FG037|Overall Study|Lost to Follow-up|3|||
38046952|NCT03529773|69734769|FG038|Overall Study|Lost to Follow-up|1|||
38046953|NCT03529773|69734770|FG039|Overall Study|Lost to Follow-up|1|||
38046954|NCT03529773|69734731|FG000|Overall Study|No longer meets eligibility criteria|0|||
38046955|NCT03529773|69734732|FG001|Overall Study|No longer meets eligibility criteria|0|||
38046956|NCT03529773|69734733|FG002|Overall Study|No longer meets eligibility criteria|0|||
38046957|NCT03529773|69734734|FG003|Overall Study|No longer meets eligibility criteria|0|||
38046958|NCT03529773|69734735|FG004|Overall Study|No longer meets eligibility criteria|0|||
38046959|NCT03529773|69734736|FG005|Overall Study|No longer meets eligibility criteria|0|||
38046960|NCT03529773|69734737|FG006|Overall Study|No longer meets eligibility criteria|0|||
38046961|NCT03529773|69734738|FG007|Overall Study|No longer meets eligibility criteria|0|||
38046962|NCT03529773|69734739|FG008|Overall Study|No longer meets eligibility criteria|0|||
38046963|NCT03529773|69734740|FG009|Overall Study|No longer meets eligibility criteria|0|||
38046964|NCT03529773|69734741|FG010|Overall Study|No longer meets eligibility criteria|0|||
38046965|NCT03529773|69734742|FG011|Overall Study|No longer meets eligibility criteria|0|||
38046966|NCT03529773|69734743|FG012|Overall Study|No longer meets eligibility criteria|0|||
38046967|NCT03529773|69734744|FG013|Overall Study|No longer meets eligibility criteria|0|||
38046968|NCT03529773|69734745|FG014|Overall Study|No longer meets eligibility criteria|0|||
38046969|NCT03529773|69734746|FG015|Overall Study|No longer meets eligibility criteria|0|||
38046970|NCT03529773|69734747|FG016|Overall Study|No longer meets eligibility criteria|0|||
38046971|NCT03529773|69734748|FG017|Overall Study|No longer meets eligibility criteria|0|||
38046972|NCT03529773|69734749|FG018|Overall Study|No longer meets eligibility criteria|0|||
38046973|NCT03529773|69734750|FG019|Overall Study|No longer meets eligibility criteria|0|||
38046974|NCT03529773|69734751|FG020|Overall Study|No longer meets eligibility criteria|0|||
38046975|NCT03529773|69734752|FG021|Overall Study|No longer meets eligibility criteria|0|||
38046976|NCT03529773|69734753|FG022|Overall Study|No longer meets eligibility criteria|1|||
37953538|NCT00534105|69640477|FG000|Overall Study|Lost to Follow-up|23|||
37953539|NCT00534105|69640478|FG001|Overall Study|Lost to Follow-up|39|||
37953540|NCT00573248|69640493|FG000|Overall Study|scheduling conflicts|15|||
38046977|NCT03529773|69734754|FG023|Overall Study|No longer meets eligibility criteria|0|||
38046978|NCT03529773|69734755|FG024|Overall Study|No longer meets eligibility criteria|0|||
38046979|NCT03529773|69734756|FG025|Overall Study|No longer meets eligibility criteria|0|||
38046980|NCT03529773|69734757|FG026|Overall Study|No longer meets eligibility criteria|0|||
38046981|NCT03529773|69734758|FG027|Overall Study|No longer meets eligibility criteria|0|||
38046982|NCT03529773|69734759|FG028|Overall Study|No longer meets eligibility criteria|0|||
38046983|NCT03529773|69734760|FG029|Overall Study|No longer meets eligibility criteria|0|||
38046984|NCT03529773|69734761|FG030|Overall Study|No longer meets eligibility criteria|0|||
38046985|NCT03529773|69734762|FG031|Overall Study|No longer meets eligibility criteria|0|||
38046986|NCT03529773|69734763|FG032|Overall Study|No longer meets eligibility criteria|0|||
38046987|NCT03529773|69734764|FG033|Overall Study|No longer meets eligibility criteria|0|||
38046988|NCT03529773|69734765|FG034|Overall Study|No longer meets eligibility criteria|0|||
38046989|NCT03529773|69734766|FG035|Overall Study|No longer meets eligibility criteria|0|||
37953541|NCT00573248|69640494|FG001|Overall Study|scheduling conflicts|11|||
37953542|NCT00532935|69640502|FG000|Overall Study|Adverse Event|11|||
38046990|NCT03529773|69734767|FG036|Overall Study|No longer meets eligibility criteria|0|||
38046991|NCT03529773|69734768|FG037|Overall Study|No longer meets eligibility criteria|0|||
38046992|NCT03529773|69734769|FG038|Overall Study|No longer meets eligibility criteria|1|||
38046993|NCT03529773|69734770|FG039|Overall Study|No longer meets eligibility criteria|0|||
38046994|NCT03529773|69734731|FG000|Overall Study|Other|0|||
38046995|NCT03529773|69734732|FG001|Overall Study|Other|0|||
38046996|NCT03529773|69734733|FG002|Overall Study|Other|0|||
38046997|NCT03529773|69734734|FG003|Overall Study|Other|0|||
38046998|NCT03529773|69734735|FG004|Overall Study|Other|0|||
37953543|NCT00532935|69640503|FG001|Overall Study|Adverse Event|12|||
37953544|NCT00532935|69640502|FG000|Overall Study|Lack of Efficacy|0|||
37953545|NCT00532935|69640503|FG001|Overall Study|Lack of Efficacy|3|||
37953546|NCT00532935|69640502|FG000|Overall Study|Lost to Follow-up|10|||
37953547|NCT00532935|69640503|FG001|Overall Study|Lost to Follow-up|6|||
37953548|NCT00532935|69640502|FG000|Overall Study|Physician Decision|4|||
37953549|NCT00532935|69640503|FG001|Overall Study|Physician Decision|5|||
37953550|NCT00532935|69640502|FG000|Overall Study|Pregnancy|1|||
37953551|NCT00532935|69640503|FG001|Overall Study|Pregnancy|0|||
37953552|NCT00532935|69640502|FG000|Overall Study|Protocol Violation|4|||
37953553|NCT00532935|69640503|FG001|Overall Study|Protocol Violation|2|||
37953554|NCT00532935|69640502|FG000|Overall Study|Withdrawal by Subject|10|||
37953555|NCT00532935|69640503|FG001|Overall Study|Withdrawal by Subject|9|||
37953556|NCT00532935|69640502|FG000|Overall Study|Protocol Specific Criteria|11|||
37953557|NCT00532935|69640503|FG001|Overall Study|Protocol Specific Criteria|15|||
37953558|NCT03016312|69640511|FG000|Overall Study|Death|194|||
37953559|NCT03016312|69640512|FG001|Overall Study|Death|164|||
37953560|NCT03016312|69640511|FG000|Overall Study|Lost to Follow-up|11|||
37953561|NCT03016312|69640512|FG001|Overall Study|Lost to Follow-up|12|||
38046999|NCT03529773|69734736|FG005|Overall Study|Other|0|||
38047000|NCT03529773|69734737|FG006|Overall Study|Other|0|||
38047001|NCT03529773|69734738|FG007|Overall Study|Other|0|||
38047002|NCT03529773|69734739|FG008|Overall Study|Other|0|||
38047003|NCT03529773|69734740|FG009|Overall Study|Other|0|||
37953562|NCT03016312|69640511|FG000|Overall Study|Started new therapy, loss of contact|2|||
37953563|NCT03016312|69640512|FG001|Overall Study|Started new therapy, loss of contact|1|||
38047004|NCT03529773|69734741|FG010|Overall Study|Other|0|||
38047005|NCT03529773|69734742|FG011|Overall Study|Other|0|||
38047006|NCT03529773|69734743|FG012|Overall Study|Other|1|||
38047007|NCT03529773|69734744|FG013|Overall Study|Other|0|||
38047008|NCT03529773|69734745|FG014|Overall Study|Other|2|||
37953564|NCT03016312|69640511|FG000|Overall Study|Physician Decision|0|||
37953565|NCT03016312|69640512|FG001|Overall Study|Physician Decision|2|||
38047009|NCT03529773|69734746|FG015|Overall Study|Other|0|||
38047010|NCT03529773|69734747|FG016|Overall Study|Other|0|||
38047011|NCT03529773|69734748|FG017|Overall Study|Other|3|||
38047012|NCT03529773|69734749|FG018|Overall Study|Other|0|||
38047013|NCT03529773|69734750|FG019|Overall Study|Other|0|||
37953566|NCT03016312|69640511|FG000|Overall Study|Withdrawal by Subject|34|||
37953567|NCT03016312|69640512|FG001|Overall Study|Withdrawal by Subject|39|||
38047014|NCT03529773|69734751|FG020|Overall Study|Other|1|||
37953568|NCT00512902|69640518|FG000|Overall Study|Adverse Event|7|||
37953569|NCT00512902|69640518|FG000|Overall Study|Lost to Follow-up|1|||
37953570|NCT00492232|69640524|FG000|Placebo Run-in|Adverse Event|0|||
37953571|NCT00492232|69640525|FG001|Placebo Run-in|Adverse Event|2|||
37953572|NCT00492232|69640524|FG000|Placebo Run-in|Protocol Violation|0|||
37953573|NCT00492232|69640525|FG001|Placebo Run-in|Protocol Violation|3|||
37953574|NCT00492232|69640524|FG000|Placebo Run-in|Lost to Follow-up|0|||
38047015|NCT03529773|69734752|FG021|Overall Study|Other|0|||
38047016|NCT03529773|69734753|FG022|Overall Study|Other|1|||
38047017|NCT03529773|69734754|FG023|Overall Study|Other|0|||
38047018|NCT03529773|69734755|FG024|Overall Study|Other|3|||
38047019|NCT03529773|69734756|FG025|Overall Study|Other|2|||
38047020|NCT03529773|69734757|FG026|Overall Study|Other|2|||
38047021|NCT03529773|69734758|FG027|Overall Study|Other|0|||
38047022|NCT03529773|69734759|FG028|Overall Study|Other|0|||
38047023|NCT03529773|69734760|FG029|Overall Study|Other|0|||
38047024|NCT03529773|69734761|FG030|Overall Study|Other|0|||
38047025|NCT03529773|69734762|FG031|Overall Study|Other|0|||
38047026|NCT03529773|69734763|FG032|Overall Study|Other|0|||
38047027|NCT03529773|69734764|FG033|Overall Study|Other|0|||
38047028|NCT03529773|69734765|FG034|Overall Study|Other|1|||
38047029|NCT03529773|69734766|FG035|Overall Study|Other|1|||
38047030|NCT03529773|69734767|FG036|Overall Study|Other|0|||
38047031|NCT03529773|69734768|FG037|Overall Study|Other|0|||
38047032|NCT03529773|69734769|FG038|Overall Study|Other|0|||
38047033|NCT03529773|69734770|FG039|Overall Study|Other|0|||
38047034|NCT03529773|69734731|FG000|Overall Study|Physician Decision|0|||
38047035|NCT03529773|69734732|FG001|Overall Study|Physician Decision|0|||
38047036|NCT03529773|69734733|FG002|Overall Study|Physician Decision|0|||
38047037|NCT03529773|69734734|FG003|Overall Study|Physician Decision|0|||
38047038|NCT03529773|69734735|FG004|Overall Study|Physician Decision|0|||
38047039|NCT03529773|69734736|FG005|Overall Study|Physician Decision|0|||
38047040|NCT03529773|69734737|FG006|Overall Study|Physician Decision|0|||
38047041|NCT03529773|69734738|FG007|Overall Study|Physician Decision|0|||
38047042|NCT03529773|69734739|FG008|Overall Study|Physician Decision|0|||
38047043|NCT03529773|69734740|FG009|Overall Study|Physician Decision|0|||
38047044|NCT03529773|69734741|FG010|Overall Study|Physician Decision|0|||
38047045|NCT03529773|69734742|FG011|Overall Study|Physician Decision|0|||
38047046|NCT03529773|69734743|FG012|Overall Study|Physician Decision|0|||
38047047|NCT03529773|69734744|FG013|Overall Study|Physician Decision|0|||
38047048|NCT03529773|69734745|FG014|Overall Study|Physician Decision|0|||
38047049|NCT03529773|69734746|FG015|Overall Study|Physician Decision|0|||
38047050|NCT03529773|69734747|FG016|Overall Study|Physician Decision|0|||
38047051|NCT03529773|69734748|FG017|Overall Study|Physician Decision|0|||
38047052|NCT03529773|69734749|FG018|Overall Study|Physician Decision|0|||
38047053|NCT03529773|69734750|FG019|Overall Study|Physician Decision|1|||
38047054|NCT03529773|69734751|FG020|Overall Study|Physician Decision|1|||
38047055|NCT03529773|69734752|FG021|Overall Study|Physician Decision|0|||
38047056|NCT03529773|69734753|FG022|Overall Study|Physician Decision|0|||
38047057|NCT03529773|69734754|FG023|Overall Study|Physician Decision|0|||
38047058|NCT03529773|69734755|FG024|Overall Study|Physician Decision|0|||
38047059|NCT03529773|69734756|FG025|Overall Study|Physician Decision|0|||
38047060|NCT03529773|69734757|FG026|Overall Study|Physician Decision|0|||
38047061|NCT03529773|69734758|FG027|Overall Study|Physician Decision|0|||
38047062|NCT03529773|69734759|FG028|Overall Study|Physician Decision|0|||
38047063|NCT03529773|69734760|FG029|Overall Study|Physician Decision|0|||
38047064|NCT03529773|69734761|FG030|Overall Study|Physician Decision|0|||
38047065|NCT03529773|69734762|FG031|Overall Study|Physician Decision|0|||
37953575|NCT00492232|69640525|FG001|Placebo Run-in|Lost to Follow-up|3|||
37953576|NCT00492232|69640524|FG000|Placebo Run-in|Withdrawal by Subject|0|||
37953577|NCT00492232|69640525|FG001|Placebo Run-in|Withdrawal by Subject|8|||
37953578|NCT00492232|69640524|FG000|Placebo Run-in|Pregnancy|0|||
37953579|NCT00492232|69640525|FG001|Placebo Run-in|Pregnancy|1|||
38047066|NCT03529773|69734763|FG032|Overall Study|Physician Decision|0|||
38047067|NCT03529773|69734764|FG033|Overall Study|Physician Decision|0|||
38047068|NCT03529773|69734765|FG034|Overall Study|Physician Decision|0|||
38047069|NCT03529773|69734766|FG035|Overall Study|Physician Decision|0|||
38047070|NCT03529773|69734767|FG036|Overall Study|Physician Decision|0|||
38047071|NCT03529773|69734768|FG037|Overall Study|Physician Decision|0|||
38047072|NCT03529773|69734769|FG038|Overall Study|Physician Decision|0|||
38047073|NCT03529773|69734770|FG039|Overall Study|Physician Decision|0|||
38047074|NCT03529773|69734731|FG000|Overall Study|Protocol Violation|0|||
38047075|NCT03529773|69734732|FG001|Overall Study|Protocol Violation|0|||
38047076|NCT03529773|69734733|FG002|Overall Study|Protocol Violation|0|||
38047077|NCT03529773|69734734|FG003|Overall Study|Protocol Violation|0|||
37953580|NCT00492232|69640524|FG000|Placebo Run-in|Entrance criteria not met|0|||
37953581|NCT00492232|69640525|FG001|Placebo Run-in|Entrance criteria not met|45|||
37953582|NCT00492232|69640524|FG000|Placebo Run-in|Other|0|||
37953583|NCT00492232|69640525|FG001|Placebo Run-in|Other|6|||
37953584|NCT00492232|69640524|FG000|Placebo Run-in|Missing|0|||
37953585|NCT00492232|69640525|FG001|Placebo Run-in|Missing|2|||
37953586|NCT00492232|69640524|FG000|Double-Blind Treatment|Adverse Event|1|||
37953587|NCT00492232|69640525|FG001|Double-Blind Treatment|Adverse Event|2|||
37953588|NCT00492232|69640524|FG000|Double-Blind Treatment|Protocol Violation|3|||
37953589|NCT00492232|69640525|FG001|Double-Blind Treatment|Protocol Violation|7|||
37953590|NCT00492232|69640524|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
37953591|NCT00492232|69640525|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
37953592|NCT00492232|69640524|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
37953593|NCT00492232|69640525|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
37953594|NCT00492232|69640524|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
37953595|NCT00492232|69640525|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
37953596|NCT00492232|69640524|FG000|Double-Blind Treatment|Other|6|||
37953597|NCT00492232|69640525|FG001|Double-Blind Treatment|Other|5|||
37953598|NCT00492232|69640524|FG000|Double-Blind Treatment|Randomized not treated|1|||
37953599|NCT00492232|69640525|FG001|Double-Blind Treatment|Randomized not treated|0|||
37953600|NCT00492232|69640524|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
37953601|NCT00492232|69640525|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
37953602|NCT00491764|69640537|FG000|Overall Study|Adverse Event|1|||
37953603|NCT00491764|69640538|FG001|Overall Study|Adverse Event|2|||
37953604|NCT00491764|69640539|FG002|Overall Study|Adverse Event|4|||
37953605|NCT00491764|69640540|FG003|Overall Study|Adverse Event|4|||
37953606|NCT00491764|69640541|FG004|Overall Study|Adverse Event|0|||
37953607|NCT00491764|69640542|FG005|Overall Study|Adverse Event|1|||
37953608|NCT00491764|69640537|FG000|Overall Study|Lost to Follow-up|0|||
37953609|NCT00491764|69640538|FG001|Overall Study|Lost to Follow-up|1|||
37953610|NCT00491764|69640539|FG002|Overall Study|Lost to Follow-up|0|||
37953611|NCT00491764|69640540|FG003|Overall Study|Lost to Follow-up|1|||
37953612|NCT00491764|69640541|FG004|Overall Study|Lost to Follow-up|0|||
37953613|NCT00491764|69640542|FG005|Overall Study|Lost to Follow-up|3|||
37953614|NCT00491764|69640537|FG000|Overall Study|Withdrawal by Subject|2|||
37953615|NCT00491764|69640538|FG001|Overall Study|Withdrawal by Subject|3|||
37953616|NCT00491764|69640539|FG002|Overall Study|Withdrawal by Subject|1|||
37953617|NCT00491764|69640540|FG003|Overall Study|Withdrawal by Subject|2|||
37953618|NCT00491764|69640541|FG004|Overall Study|Withdrawal by Subject|2|||
37953619|NCT00491764|69640542|FG005|Overall Study|Withdrawal by Subject|4|||
37953620|NCT00491764|69640537|FG000|Overall Study|Non Compliance with the Protocol|1|||
37953621|NCT00491764|69640538|FG001|Overall Study|Non Compliance with the Protocol|0|||
37953622|NCT00491764|69640539|FG002|Overall Study|Non Compliance with the Protocol|0|||
37953623|NCT00491764|69640540|FG003|Overall Study|Non Compliance with the Protocol|0|||
37953624|NCT00491764|69640541|FG004|Overall Study|Non Compliance with the Protocol|0|||
37953625|NCT00491764|69640542|FG005|Overall Study|Non Compliance with the Protocol|0|||
37953626|NCT00491764|69640537|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
37953627|NCT00491764|69640538|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
37953628|NCT00491764|69640539|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
37953629|NCT00491764|69640540|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
37953630|NCT00491764|69640541|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
37953631|NCT00491764|69640542|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
37953632|NCT00491764|69640537|FG000|Overall Study|Administrative|1|||
37953633|NCT00491764|69640538|FG001|Overall Study|Administrative|0|||
37953634|NCT00491764|69640539|FG002|Overall Study|Administrative|2|||
37953635|NCT00491764|69640540|FG003|Overall Study|Administrative|1|||
37953636|NCT00491764|69640541|FG004|Overall Study|Administrative|0|||
37953637|NCT00491764|69640542|FG005|Overall Study|Administrative|0|||
37953638|NCT00491608|69640556|FG000|Overall Study|Death|2|||
37953639|NCT00491608|69640556|FG000|Overall Study|Withdrawal by Subject|1|||
37953640|NCT00615836|69640564|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
37953641|NCT00615836|69640565|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
37953642|NCT00615836|69640566|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
37953643|NCT00615836|69640567|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
37953644|NCT00615836|69640568|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
37953645|NCT00615836|69640564|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
37953646|NCT00615836|69640565|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
37953647|NCT00615836|69640566|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
37953648|NCT00615836|69640567|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
37953649|NCT00615836|69640568|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
37953650|NCT00615836|69640564|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
37953651|NCT00615836|69640565|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
37953652|NCT00615836|69640566|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
37953653|NCT00615836|69640567|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
38047078|NCT03529773|69734735|FG004|Overall Study|Protocol Violation|0|||
38047079|NCT03529773|69734736|FG005|Overall Study|Protocol Violation|0|||
38047080|NCT03529773|69734737|FG006|Overall Study|Protocol Violation|0|||
38047081|NCT03529773|69734738|FG007|Overall Study|Protocol Violation|0|||
38047082|NCT03529773|69734739|FG008|Overall Study|Protocol Violation|0|||
38047083|NCT03529773|69734740|FG009|Overall Study|Protocol Violation|0|||
38047084|NCT03529773|69734741|FG010|Overall Study|Protocol Violation|0|||
38047085|NCT03529773|69734742|FG011|Overall Study|Protocol Violation|0|||
38047086|NCT03529773|69734743|FG012|Overall Study|Protocol Violation|0|||
38047087|NCT03529773|69734744|FG013|Overall Study|Protocol Violation|0|||
38047088|NCT03529773|69734745|FG014|Overall Study|Protocol Violation|0|||
38047089|NCT03529773|69734746|FG015|Overall Study|Protocol Violation|0|||
38047090|NCT03529773|69734747|FG016|Overall Study|Protocol Violation|0|||
38047091|NCT03529773|69734748|FG017|Overall Study|Protocol Violation|0|||
38047092|NCT03529773|69734749|FG018|Overall Study|Protocol Violation|0|||
38047093|NCT03529773|69734750|FG019|Overall Study|Protocol Violation|0|||
38047094|NCT03529773|69734751|FG020|Overall Study|Protocol Violation|0|||
38047095|NCT03529773|69734752|FG021|Overall Study|Protocol Violation|0|||
38047096|NCT03529773|69734753|FG022|Overall Study|Protocol Violation|0|||
38047097|NCT03529773|69734754|FG023|Overall Study|Protocol Violation|0|||
38047098|NCT03529773|69734755|FG024|Overall Study|Protocol Violation|0|||
38047099|NCT03529773|69734756|FG025|Overall Study|Protocol Violation|0|||
38047100|NCT03529773|69734757|FG026|Overall Study|Protocol Violation|0|||
38047101|NCT03529773|69734758|FG027|Overall Study|Protocol Violation|0|||
38047102|NCT03529773|69734759|FG028|Overall Study|Protocol Violation|0|||
38047103|NCT03529773|69734760|FG029|Overall Study|Protocol Violation|0|||
38047104|NCT03529773|69734761|FG030|Overall Study|Protocol Violation|1|||
38047105|NCT03529773|69734762|FG031|Overall Study|Protocol Violation|0|||
38047106|NCT03529773|69734763|FG032|Overall Study|Protocol Violation|0|||
38047107|NCT03529773|69734764|FG033|Overall Study|Protocol Violation|0|||
38047108|NCT03529773|69734765|FG034|Overall Study|Protocol Violation|0|||
38047109|NCT03529773|69734766|FG035|Overall Study|Protocol Violation|0|||
38047110|NCT03529773|69734767|FG036|Overall Study|Protocol Violation|0|||
38047111|NCT03529773|69734768|FG037|Overall Study|Protocol Violation|0|||
38047112|NCT03529773|69734769|FG038|Overall Study|Protocol Violation|0|||
38047113|NCT03529773|69734770|FG039|Overall Study|Protocol Violation|0|||
38047114|NCT03529773|69734731|FG000|Overall Study|Withdrawal by Subject|0|||
38047115|NCT03529773|69734732|FG001|Overall Study|Withdrawal by Subject|0|||
38047116|NCT03529773|69734733|FG002|Overall Study|Withdrawal by Subject|0|||
38047117|NCT03529773|69734734|FG003|Overall Study|Withdrawal by Subject|0|||
38047118|NCT03529773|69734735|FG004|Overall Study|Withdrawal by Subject|0|||
38047119|NCT03529773|69734736|FG005|Overall Study|Withdrawal by Subject|0|||
38047120|NCT03529773|69734737|FG006|Overall Study|Withdrawal by Subject|0|||
38047121|NCT03529773|69734738|FG007|Overall Study|Withdrawal by Subject|1|||
38047122|NCT03529773|69734739|FG008|Overall Study|Withdrawal by Subject|0|||
38047123|NCT03529773|69734740|FG009|Overall Study|Withdrawal by Subject|1|||
38047124|NCT03529773|69734741|FG010|Overall Study|Withdrawal by Subject|1|||
38047125|NCT03529773|69734742|FG011|Overall Study|Withdrawal by Subject|0|||
38047126|NCT03529773|69734743|FG012|Overall Study|Withdrawal by Subject|0|||
38047127|NCT03529773|69734744|FG013|Overall Study|Withdrawal by Subject|0|||
38047128|NCT03529773|69734745|FG014|Overall Study|Withdrawal by Subject|0|||
38047129|NCT03529773|69734746|FG015|Overall Study|Withdrawal by Subject|3|||
38047130|NCT03529773|69734747|FG016|Overall Study|Withdrawal by Subject|0|||
38047131|NCT03529773|69734748|FG017|Overall Study|Withdrawal by Subject|2|||
38047132|NCT03529773|69734749|FG018|Overall Study|Withdrawal by Subject|3|||
38047133|NCT03529773|69734750|FG019|Overall Study|Withdrawal by Subject|1|||
38047134|NCT03529773|69734751|FG020|Overall Study|Withdrawal by Subject|3|||
38047135|NCT03529773|69734752|FG021|Overall Study|Withdrawal by Subject|1|||
38047136|NCT03529773|69734753|FG022|Overall Study|Withdrawal by Subject|1|||
38047137|NCT03529773|69734754|FG023|Overall Study|Withdrawal by Subject|2|||
38047138|NCT03529773|69734755|FG024|Overall Study|Withdrawal by Subject|2|||
38047139|NCT03529773|69734756|FG025|Overall Study|Withdrawal by Subject|4|||
38047140|NCT03529773|69734757|FG026|Overall Study|Withdrawal by Subject|2|||
38047141|NCT03529773|69734758|FG027|Overall Study|Withdrawal by Subject|1|||
38047142|NCT03529773|69734759|FG028|Overall Study|Withdrawal by Subject|1|||
38047143|NCT03529773|69734760|FG029|Overall Study|Withdrawal by Subject|0|||
38047144|NCT03529773|69734761|FG030|Overall Study|Withdrawal by Subject|0|||
38047145|NCT03529773|69734762|FG031|Overall Study|Withdrawal by Subject|0|||
38047146|NCT03529773|69734763|FG032|Overall Study|Withdrawal by Subject|0|||
38047147|NCT03529773|69734764|FG033|Overall Study|Withdrawal by Subject|0|||
38047148|NCT03529773|69734765|FG034|Overall Study|Withdrawal by Subject|1|||
38047149|NCT03529773|69734766|FG035|Overall Study|Withdrawal by Subject|2|||
38047150|NCT03529773|69734767|FG036|Overall Study|Withdrawal by Subject|0|||
38047151|NCT03529773|69734768|FG037|Overall Study|Withdrawal by Subject|2|||
38047152|NCT03529773|69734769|FG038|Overall Study|Withdrawal by Subject|1|||
38047153|NCT03529773|69734770|FG039|Overall Study|Withdrawal by Subject|1|||
38047154|NCT03529773|69734731|FG000|Overall Study|Screen Failure|0|||
38047155|NCT03529773|69734732|FG001|Overall Study|Screen Failure|0|||
38047156|NCT03529773|69734733|FG002|Overall Study|Screen Failure|0|||
38047157|NCT03529773|69734734|FG003|Overall Study|Screen Failure|0|||
38047158|NCT03529773|69734735|FG004|Overall Study|Screen Failure|0|||
38047159|NCT03529773|69734736|FG005|Overall Study|Screen Failure|0|||
38047160|NCT03529773|69734737|FG006|Overall Study|Screen Failure|0|||
38047161|NCT03529773|69734738|FG007|Overall Study|Screen Failure|0|||
38047162|NCT03529773|69734739|FG008|Overall Study|Screen Failure|0|||
38047163|NCT03529773|69734740|FG009|Overall Study|Screen Failure|0|||
38047164|NCT03529773|69734741|FG010|Overall Study|Screen Failure|0|||
38047165|NCT03529773|69734742|FG011|Overall Study|Screen Failure|0|||
38047166|NCT03529773|69734743|FG012|Overall Study|Screen Failure|0|||
38047167|NCT03529773|69734744|FG013|Overall Study|Screen Failure|0|||
38047168|NCT03529773|69734745|FG014|Overall Study|Screen Failure|0|||
38047169|NCT03529773|69734746|FG015|Overall Study|Screen Failure|0|||
38047170|NCT03529773|69734747|FG016|Overall Study|Screen Failure|0|||
38047171|NCT03529773|69734748|FG017|Overall Study|Screen Failure|0|||
38047172|NCT03529773|69734749|FG018|Overall Study|Screen Failure|0|||
38047173|NCT03529773|69734750|FG019|Overall Study|Screen Failure|0|||
38047174|NCT03529773|69734751|FG020|Overall Study|Screen Failure|0|||
38047175|NCT03529773|69734752|FG021|Overall Study|Screen Failure|0|||
38047176|NCT03529773|69734753|FG022|Overall Study|Screen Failure|0|||
38047177|NCT03529773|69734754|FG023|Overall Study|Screen Failure|0|||
38047178|NCT03529773|69734755|FG024|Overall Study|Screen Failure|0|||
38047179|NCT03529773|69734756|FG025|Overall Study|Screen Failure|0|||
38047180|NCT03529773|69734757|FG026|Overall Study|Screen Failure|0|||
38047181|NCT03529773|69734758|FG027|Overall Study|Screen Failure|0|||
38047182|NCT03529773|69734759|FG028|Overall Study|Screen Failure|0|||
38047183|NCT03529773|69734760|FG029|Overall Study|Screen Failure|0|||
38047184|NCT03529773|69734761|FG030|Overall Study|Screen Failure|0|||
38047185|NCT03529773|69734762|FG031|Overall Study|Screen Failure|0|||
38047186|NCT03529773|69734763|FG032|Overall Study|Screen Failure|0|||
38047187|NCT03529773|69734764|FG033|Overall Study|Screen Failure|0|||
38047188|NCT03529773|69734765|FG034|Overall Study|Screen Failure|0|||
38047189|NCT03529773|69734766|FG035|Overall Study|Screen Failure|0|||
38047190|NCT03529773|69734767|FG036|Overall Study|Screen Failure|1|||
38047191|NCT03529773|69734768|FG037|Overall Study|Screen Failure|1|||
38047192|NCT03529773|69734769|FG038|Overall Study|Screen Failure|0|||
38047193|NCT03529773|69734770|FG039|Overall Study|Screen Failure|1|||
38047194|NCT03529773|69734731|FG000|Overall Study|Randomized but not vaccinated|0|||
38047195|NCT03529773|69734732|FG001|Overall Study|Randomized but not vaccinated|0|||
38047196|NCT03529773|69734733|FG002|Overall Study|Randomized but not vaccinated|0|||
38047197|NCT03529773|69734734|FG003|Overall Study|Randomized but not vaccinated|0|||
38047198|NCT03529773|69734735|FG004|Overall Study|Randomized but not vaccinated|0|||
38047199|NCT03529773|69734736|FG005|Overall Study|Randomized but not vaccinated|0|||
38047200|NCT03529773|69734737|FG006|Overall Study|Randomized but not vaccinated|0|||
38047201|NCT03529773|69734738|FG007|Overall Study|Randomized but not vaccinated|0|||
38047202|NCT03529773|69734739|FG008|Overall Study|Randomized but not vaccinated|0|||
38047203|NCT03529773|69734740|FG009|Overall Study|Randomized but not vaccinated|0|||
38047204|NCT03529773|69734741|FG010|Overall Study|Randomized but not vaccinated|0|||
38047205|NCT03529773|69734742|FG011|Overall Study|Randomized but not vaccinated|0|||
38047206|NCT03529773|69734743|FG012|Overall Study|Randomized but not vaccinated|0|||
38047207|NCT03529773|69734744|FG013|Overall Study|Randomized but not vaccinated|0|||
38047208|NCT03529773|69734745|FG014|Overall Study|Randomized but not vaccinated|0|||
38047209|NCT03529773|69734746|FG015|Overall Study|Randomized but not vaccinated|0|||
38047210|NCT03529773|69734747|FG016|Overall Study|Randomized but not vaccinated|0|||
38047211|NCT03529773|69734748|FG017|Overall Study|Randomized but not vaccinated|1|||
38047212|NCT03529773|69734749|FG018|Overall Study|Randomized but not vaccinated|0|||
38047213|NCT03529773|69734750|FG019|Overall Study|Randomized but not vaccinated|0|||
38047214|NCT03529773|69734751|FG020|Overall Study|Randomized but not vaccinated|0|||
38047215|NCT03529773|69734752|FG021|Overall Study|Randomized but not vaccinated|0|||
38047216|NCT03529773|69734753|FG022|Overall Study|Randomized but not vaccinated|0|||
38047217|NCT03529773|69734754|FG023|Overall Study|Randomized but not vaccinated|0|||
38047218|NCT03529773|69734755|FG024|Overall Study|Randomized but not vaccinated|0|||
38047219|NCT03529773|69734756|FG025|Overall Study|Randomized but not vaccinated|0|||
38047220|NCT03529773|69734757|FG026|Overall Study|Randomized but not vaccinated|0|||
37680314|NCT02344173|69155872|FG000|Procedure|Ablation Procedure Not Performed|7|||
38047221|NCT03529773|69734758|FG027|Overall Study|Randomized but not vaccinated|1|||
38047222|NCT03529773|69734759|FG028|Overall Study|Randomized but not vaccinated|0|||
38047223|NCT03529773|69734760|FG029|Overall Study|Randomized but not vaccinated|0|||
38047224|NCT03529773|69734761|FG030|Overall Study|Randomized but not vaccinated|0|||
38047225|NCT03529773|69734762|FG031|Overall Study|Randomized but not vaccinated|0|||
38047226|NCT03529773|69734763|FG032|Overall Study|Randomized but not vaccinated|0|||
38047227|NCT03529773|69734764|FG033|Overall Study|Randomized but not vaccinated|0|||
38047228|NCT03529773|69734765|FG034|Overall Study|Randomized but not vaccinated|0|||
38047229|NCT03529773|69734766|FG035|Overall Study|Randomized but not vaccinated|0|||
38047230|NCT03529773|69734767|FG036|Overall Study|Randomized but not vaccinated|0|||
38047231|NCT03529773|69734768|FG037|Overall Study|Randomized but not vaccinated|0|||
38047232|NCT03529773|69734769|FG038|Overall Study|Randomized but not vaccinated|0|||
38047233|NCT03529773|69734770|FG039|Overall Study|Randomized but not vaccinated|0|||
38047234|NCT03799211|69734875|FG000|Overall Study|Lost to Follow-up|2|||
38047235|NCT03799211|69734876|FG001|Overall Study|Lost to Follow-up|13|||
38047236|NCT03799211|69734875|FG000|Overall Study|Withdrawal by Subject|2|||
38047237|NCT03799211|69734876|FG001|Overall Study|Withdrawal by Subject|0|||
38047238|NCT03349710|69734888|FG000|Treatment Period|Death|0|||
38047239|NCT03349710|69734889|FG001|Treatment Period|Death|0|||
38047240|NCT03349710|69734890|FG002|Treatment Period|Death|1|||
38047241|NCT03349710|69734891|FG003|Treatment Period|Death|0|||
38047242|NCT03349710|69734888|FG000|Treatment Period|Disease Progression|0|||
38047243|NCT03349710|69734889|FG001|Treatment Period|Disease Progression|2|||
38047244|NCT03349710|69734890|FG002|Treatment Period|Disease Progression|0|||
38047245|NCT03349710|69734891|FG003|Treatment Period|Disease Progression|1|||
38047246|NCT03349710|69734888|FG000|Treatment Period|Study Drug Toxicity|1|||
38047247|NCT03349710|69734889|FG001|Treatment Period|Study Drug Toxicity|0|||
38047248|NCT03349710|69734890|FG002|Treatment Period|Study Drug Toxicity|1|||
38047249|NCT03349710|69734891|FG003|Treatment Period|Study Drug Toxicity|1|||
37953654|NCT00615836|69640568|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
38047250|NCT03349710|69734888|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
38047251|NCT03349710|69734889|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
38047252|NCT03349710|69734890|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
38047253|NCT03349710|69734891|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
38047254|NCT03349710|69734888|FG000|Treatment Period|admin reason by sponsor|0|||
38047255|NCT03349710|69734889|FG001|Treatment Period|admin reason by sponsor|7|||
38047256|NCT03349710|69734890|FG002|Treatment Period|admin reason by sponsor|0|||
38047257|NCT03349710|69734891|FG003|Treatment Period|admin reason by sponsor|19|||
38047258|NCT03349710|69734888|FG000|Treatment Period|Other Reason|2|||
38047259|NCT03349710|69734889|FG001|Treatment Period|Other Reason|0|||
38047260|NCT03349710|69734890|FG002|Treatment Period|Other Reason|2|||
38047261|NCT03349710|69734891|FG003|Treatment Period|Other Reason|1|||
38047262|NCT03349710|69734888|FG000|Treatment Period|completed|6|||
38047263|NCT03349710|69734889|FG001|Treatment Period|completed|0|||
38047264|NCT03349710|69734890|FG002|Treatment Period|completed|18|||
38047265|NCT03349710|69734891|FG003|Treatment Period|completed|1|||
38047266|NCT03349710|69734888|FG000|Treatment Period|participant request to discontinue|0|||
38047267|NCT03349710|69734889|FG001|Treatment Period|participant request to discontinue|0|||
38047268|NCT03349710|69734890|FG002|Treatment Period|participant request to discontinue|4|||
38047269|NCT03349710|69734891|FG003|Treatment Period|participant request to discontinue|0|||
38047270|NCT03349710|69734888|FG000|Treatment Period|participant withdrew consent|1|||
38047271|NCT03349710|69734889|FG001|Treatment Period|participant withdrew consent|0|||
38047272|NCT03349710|69734890|FG002|Treatment Period|participant withdrew consent|0|||
38047273|NCT03349710|69734891|FG003|Treatment Period|participant withdrew consent|0|||
38047274|NCT03511053|69734901|FG000|Overall Study|Withdrawal by Subject|1|||
38047275|NCT03377634|69734907|FG000|Study Period|Adverse Event|1|||
38047276|NCT03377634|69734908|FG001|Study Period|Adverse Event|0|||
38047277|NCT03377634|69734907|FG000|Study Period|Withdrawal by Subject|1|||
38047278|NCT03377634|69734908|FG001|Study Period|Withdrawal by Subject|0|||
38047279|NCT03528369|69734917|FG000|Overall Study|Withdrawal by Subject|2|||
38047280|NCT03528369|69734918|FG001|Overall Study|Withdrawal by Subject|0|||
38047281|NCT03528369|69734919|FG002|Overall Study|Withdrawal by Subject|0|||
38047282|NCT03528369|69734917|FG000|Overall Study|Lost to Follow-up|1|||
38047283|NCT03528369|69734918|FG001|Overall Study|Lost to Follow-up|0|||
37953655|NCT00615836|69640564|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
37953656|NCT00615836|69640565|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
37953657|NCT00615836|69640566|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
37953658|NCT00615836|69640567|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
37953659|NCT00615836|69640568|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
37953660|NCT00615836|69640564|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
37953661|NCT00615836|69640565|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
37953662|NCT00615836|69640566|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
37953663|NCT00615836|69640567|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
37953664|NCT00615836|69640568|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
37953665|NCT00615836|69640564|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
37953666|NCT00615836|69640565|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
37953667|NCT00615836|69640566|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
37953668|NCT00615836|69640567|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
38047284|NCT03528369|69734919|FG002|Overall Study|Lost to Follow-up|0|||
38047285|NCT03528369|69734917|FG000|Overall Study|Adverse Event|0|||
38047286|NCT03528369|69734918|FG001|Overall Study|Adverse Event|1|||
38047287|NCT03528369|69734919|FG002|Overall Study|Adverse Event|0|||
38047288|NCT00006011|69734930|FG000|Overall Study|Disease progression|13|||
38047289|NCT00006011|69734931|FG001|Overall Study|Disease progression|6|||
38047290|NCT00006011|69734932|FG002|Overall Study|Disease progression|26|||
38047291|NCT00006011|69734930|FG000|Overall Study|Refused further treatment|15|||
38047292|NCT00006011|69734931|FG001|Overall Study|Refused further treatment|13|||
38047293|NCT00006011|69734932|FG002|Overall Study|Refused further treatment|26|||
38047294|NCT00006011|69734930|FG000|Overall Study|Adverse Event|15|||
38047295|NCT00006011|69734931|FG001|Overall Study|Adverse Event|39|||
38047296|NCT00006011|69734932|FG002|Overall Study|Adverse Event|5|||
38047297|NCT00006011|69734930|FG000|Overall Study|Death|0|||
38047298|NCT00006011|69734931|FG001|Overall Study|Death|1|||
38047299|NCT00006011|69734932|FG002|Overall Study|Death|2|||
38047300|NCT00006011|69734930|FG000|Overall Study|Other|4|||
38047301|NCT00006011|69734931|FG001|Overall Study|Other|2|||
38047302|NCT00006011|69734932|FG002|Overall Study|Other|5|||
38047303|NCT00006011|69734930|FG000|Overall Study|Ineligible|18|||
38047304|NCT00006011|69734931|FG001|Overall Study|Ineligible|16|||
38047305|NCT00006011|69734932|FG002|Overall Study|Ineligible|9|||
38047306|NCT03377556|69734938|FG000|Overall Study|Adverse Event|5|||
38047307|NCT03377556|69734938|FG000|Overall Study|Refusal unrelated to adverse events|1|||
38047308|NCT03377556|69734938|FG000|Overall Study|Progression/relapse|38|||
38047309|NCT03377556|69734938|FG000|Overall Study|Death|3|||
38047310|NCT03750955|69734944|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
38047311|NCT03750955|69734945|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
38047312|NCT03750955|69734944|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
38047313|NCT03750955|69734945|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
38047314|NCT00005879|69734955|FG000|Overall Study|Withdrawal by Subject|8|||
38047315|NCT00005879|69734956|FG001|Overall Study|Withdrawal by Subject|10|||
38047316|NCT03510663|69734970|FG000|Overall Study|Withdrawal by Subject|0|||
38047317|NCT03510663|69734971|FG001|Overall Study|Withdrawal by Subject|1|||
38047318|NCT03510663|69734972|FG002|Overall Study|Withdrawal by Subject|0|||
38047319|NCT03510663|69734973|FG003|Overall Study|Withdrawal by Subject|0|||
38047320|NCT03510663|69734974|FG004|Overall Study|Withdrawal by Subject|0|||
38047321|NCT03510663|69734975|FG005|Overall Study|Withdrawal by Subject|0|||
38047322|NCT03510663|69734976|FG006|Overall Study|Withdrawal by Subject|0|||
38047323|NCT03510663|69734977|FG007|Overall Study|Withdrawal by Subject|0|||
38047324|NCT03510273|69734987|FG000|Overall Study|Withdrawal by Subject|2|||
38047325|NCT03510273|69734987|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
38047326|NCT03510273|69734987|FG000|Overall Study|Moved away from study area|4|||
38047327|NCT03582813|69734997|FG000|Overall Study|Lost to Follow-up|18|||
38047328|NCT03582813|69734998|FG001|Overall Study|Lost to Follow-up|21|||
38047329|NCT03582813|69734997|FG000|Overall Study|Withdrawal by Subject|1|||
38047330|NCT03582813|69734998|FG001|Overall Study|Withdrawal by Subject|0|||
38047331|NCT03480009|69735008|FG000|Overall Study|Lost to Follow-up|4|||
38047332|NCT03480009|69735009|FG001|Overall Study|Lost to Follow-up|5|||
38047333|NCT03480009|69735010|FG002|Overall Study|Lost to Follow-up|4|||
38047334|NCT03480009|69735011|FG003|Overall Study|Lost to Follow-up|0|||
38047335|NCT03399786|69735026|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
38047336|NCT03399786|69735027|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
38047337|NCT03399786|69735028|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
38047338|NCT03399786|69735029|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
38047339|NCT03399786|69735026|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
38047340|NCT03399786|69735027|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
38047341|NCT03399786|69735028|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
38047342|NCT03399786|69735029|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
38047343|NCT03399786|69735026|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
38047344|NCT03399786|69735027|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
38047345|NCT03399786|69735028|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
38047346|NCT03399786|69735029|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
38047347|NCT03505593|69735037|FG000|Overall Study|Withdrawal by Subject|1|||
38047348|NCT03505593|69735037|FG000|Overall Study|Died before procedure|1|||
38047349|NCT03505593|69735037|FG000|Overall Study|Anatomical abnormality|1|||
38047350|NCT03505593|69735037|FG000|Overall Study|Unable to pass through esophagus|1|||
38047351|NCT03505593|69735037|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
38047352|NCT03504189|69735041|FG000|Overall Study|Withdrawal by Subject|1|||
38047353|NCT03504189|69735041|FG000|Overall Study|Screening Failure|1|||
38047354|NCT03504189|69735041|FG000|Overall Study|Device Failure|2|||
38047355|NCT03374358|69735052|FG000|Overall Study|Withdrawal by Subject|0|||
38047356|NCT03374358|69735053|FG001|Overall Study|Withdrawal by Subject|2|||
38047357|NCT03372096|69735059|FG000|Overall Study|Study Closed|8|||
38047358|NCT00004859|69735068|FG000|Overall Study|Lack of Efficacy|43|||
38047359|NCT00004859|69735069|FG001|Overall Study|Lack of Efficacy|113|||
38047360|NCT00004859|69735068|FG000|Overall Study|Adverse Event|31|||
38047361|NCT00004859|69735069|FG001|Overall Study|Adverse Event|93|||
38047362|NCT00004859|69735068|FG000|Overall Study|Death|5|||
38047363|NCT00004859|69735069|FG001|Overall Study|Death|5|||
38047364|NCT00004859|69735068|FG000|Overall Study|Withdrawal by Subject|7|||
38047365|NCT00004859|69735069|FG001|Overall Study|Withdrawal by Subject|33|||
38047366|NCT00004859|69735068|FG000|Overall Study|Protocol Violation|2|||
38047367|NCT00004859|69735069|FG001|Overall Study|Protocol Violation|2|||
38047368|NCT00004859|69735068|FG000|Overall Study|other disease|0|||
38047369|NCT00004859|69735069|FG001|Overall Study|other disease|3|||
38047370|NCT00004859|69735068|FG000|Overall Study|error|3|||
38047371|NCT00004859|69735069|FG001|Overall Study|error|1|||
38047372|NCT00004859|69735068|FG000|Overall Study|missing data|14|||
38047373|NCT00004859|69735069|FG001|Overall Study|missing data|11|||
38047374|NCT00004859|69735068|FG000|Overall Study|Other|13|||
38047375|NCT00004859|69735069|FG001|Overall Study|Other|21|||
38047376|NCT03500679|69735079|FG000|Overall Study|Lost to Follow-up|6|||
38047377|NCT03500679|69735080|FG001|Overall Study|Lost to Follow-up|3|||
38047378|NCT03500679|69735079|FG000|Overall Study|Withdrawal by Subject|3|||
38047379|NCT03500679|69735080|FG001|Overall Study|Withdrawal by Subject|0|||
38047380|NCT03348930|69735086|FG000|Washout (1 Week)|Lost to Follow-up|1|||
38047381|NCT03348930|69735087|FG001|Washout (1 Week)|Lost to Follow-up|1|||
38047382|NCT03500211|69735095|FG000|Overall Study|Withdrawal by Subject|1|||
38047383|NCT03500211|69735096|FG001|Overall Study|Withdrawal by Subject|1|||
38047384|NCT03478683|69735104|FG000|Overall Study|Adverse Event|5|||
38047385|NCT03478683|69735105|FG001|Overall Study|Adverse Event|3|||
38047386|NCT03478683|69735104|FG000|Overall Study|Lost to Follow-up|0|||
38047387|NCT03478683|69735105|FG001|Overall Study|Lost to Follow-up|5|||
38047388|NCT03478683|69735104|FG000|Overall Study|Physician Decision|1|||
38047389|NCT03478683|69735105|FG001|Overall Study|Physician Decision|3|||
38047390|NCT03478683|69735104|FG000|Overall Study|Withdrawal by Subject|7|||
38047391|NCT03478683|69735105|FG001|Overall Study|Withdrawal by Subject|7|||
38047392|NCT03478371|69735111|FG000|Overall Study|non-compliance|1|||
38047393|NCT03478371|69735111|FG000|Overall Study|Lost to Follow-up|4|||
38047394|NCT03477903|69735121|FG000|Overall Study|Study Terminated by Sponsor|1|||
38047395|NCT03475875|69735125|FG000|Period 1|Lost to Follow-up|1|||
38047396|NCT03475875|69735126|FG001|Period 1|Lost to Follow-up|0|||
38047397|NCT03475875|69735125|FG000|Period 1|Adverse Event|2|||
38047398|NCT03475875|69735126|FG001|Period 1|Adverse Event|1|||
38047399|NCT03475875|69735125|FG000|Period 2|Adverse Event|3|||
38047400|NCT03475875|69735126|FG001|Period 2|Adverse Event|0|||
38047401|NCT03475875|69735125|FG000|Period 2|Protocol Violation|0|||
38047402|NCT03475875|69735126|FG001|Period 2|Protocol Violation|1|||
38047403|NCT03474081|69735134|FG000|Overall Study|Adverse Event|6|||
38047404|NCT03474081|69735135|FG001|Overall Study|Adverse Event|3|||
38047405|NCT03474081|69735134|FG000|Overall Study|Lost to Follow-up|2|||
38047406|NCT03474081|69735135|FG001|Overall Study|Lost to Follow-up|1|||
38047407|NCT03474081|69735134|FG000|Overall Study|Physician Decision|3|||
38047408|NCT03474081|69735135|FG001|Overall Study|Physician Decision|2|||
38047409|NCT03474081|69735134|FG000|Overall Study|Withdrawal by Subject|5|||
38047410|NCT03474081|69735135|FG001|Overall Study|Withdrawal by Subject|7|||
38047411|NCT03474081|69735134|FG000|Overall Study|Investigator site closed|1|||
38047412|NCT03474081|69735135|FG001|Overall Study|Investigator site closed|0|||
38047413|NCT03346434|69735147|FG000|Overall Study|Randomized in Error|0|||
38047414|NCT03346434|69735148|FG001|Overall Study|Randomized in Error|0|||
38047415|NCT03346434|69735149|FG002|Overall Study|Randomized in Error|0|||
38047416|NCT03346434|69735150|FG003|Overall Study|Randomized in Error|0|||
38047417|NCT03346434|69735151|FG004|Overall Study|Randomized in Error|1|||
38047418|NCT03346434|69735152|FG005|Overall Study|Randomized in Error|0|||
38047419|NCT03346434|69735147|FG000|Overall Study|Withdrawal by Subject|0|||
38047420|NCT03346434|69735148|FG001|Overall Study|Withdrawal by Subject|0|||
38047421|NCT03346434|69735149|FG002|Overall Study|Withdrawal by Subject|1|||
38047422|NCT03346434|69735150|FG003|Overall Study|Withdrawal by Subject|0|||
38047423|NCT03346434|69735151|FG004|Overall Study|Withdrawal by Subject|1|||
38047424|NCT03346434|69735152|FG005|Overall Study|Withdrawal by Subject|0|||
38047425|NCT03346434|69735147|FG000|Overall Study|Lost to Follow-up|0|||
38047426|NCT03346434|69735148|FG001|Overall Study|Lost to Follow-up|0|||
38047427|NCT03346434|69735149|FG002|Overall Study|Lost to Follow-up|0|||
38047428|NCT03346434|69735150|FG003|Overall Study|Lost to Follow-up|0|||
38047429|NCT03346434|69735151|FG004|Overall Study|Lost to Follow-up|1|||
38047430|NCT03346434|69735152|FG005|Overall Study|Lost to Follow-up|1|||
38047431|NCT03346434|69735147|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
38047432|NCT03346434|69735148|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
38047433|NCT03346434|69735149|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
38047434|NCT03346434|69735150|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
38047435|NCT03346434|69735151|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
38047436|NCT03346434|69735152|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
38047437|NCT03393000|69735170|FG000|Overall Study|Death|11|||
38047438|NCT03393000|69735170|FG000|Overall Study|Withdrawal by Subject|2|||
38047439|NCT03393000|69735170|FG000|Overall Study|Physician Decision|1|||
38047440|NCT03370770|69735174|FG000|Overall Study|Patient was followed in another hospital center|1|||
38047441|NCT03370770|69735174|FG000|Overall Study|Progressive Disease|98|||
38047442|NCT03370770|69735174|FG000|Overall Study|Adverse Event|2|||
38047443|NCT03370770|69735174|FG000|Overall Study|Death|5|||
38047444|NCT03473301|69735181|FG000|Overall Study|Protocol Violation|4|||
38047445|NCT03473301|69735182|FG001|Overall Study|Protocol Violation|0|||
38047446|NCT03473301|69735183|FG002|Overall Study|Protocol Violation|0|||
38047447|NCT03473301|69735181|FG000|Overall Study|Withdrawal by Subject|0|||
38047448|NCT03473301|69735182|FG001|Overall Study|Withdrawal by Subject|1|||
38047449|NCT03473301|69735183|FG002|Overall Study|Withdrawal by Subject|0|||
38047450|NCT03473301|69735181|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
38047451|NCT03473301|69735182|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
38047452|NCT03473301|69735183|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
38047453|NCT03390426|69735195|FG000|Overall Study|Protocol Violation|0|||
38047454|NCT03390426|69735196|FG001|Overall Study|Protocol Violation|1|||
38047455|NCT03472521|69735204|FG000|Overall Study|Lost to Follow-up|3|||
38047456|NCT03472521|69735205|FG001|Overall Study|Lost to Follow-up|2|||
38047457|NCT03472521|69735204|FG000|Overall Study|Discontinued intervention|3|||
38047458|NCT03472521|69735205|FG001|Overall Study|Discontinued intervention|1|||
38047459|NCT02906020|69735221|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
38047460|NCT02906020|69735222|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
38047461|NCT02906020|69735223|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
38047462|NCT02906020|69735224|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
38047463|NCT02906020|69735225|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
38047464|NCT02906020|69735226|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
38047465|NCT02906020|69735227|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
38047466|NCT02906020|69735228|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
38047467|NCT02906020|69735229|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
38047468|NCT02906020|69735230|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
38047469|NCT02906020|69735231|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
38047470|NCT02906020|69735232|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
38047471|NCT02906020|69735233|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
38047472|NCT02906020|69735234|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
38047473|NCT02906020|69735235|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
38047474|NCT02906020|69735236|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
38047475|NCT02906020|69735221|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
38047476|NCT02906020|69735222|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
38047477|NCT02906020|69735223|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
38047478|NCT02906020|69735224|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
38047479|NCT02906020|69735225|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
38047480|NCT02906020|69735226|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
38047481|NCT02906020|69735227|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
38047482|NCT02906020|69735228|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
38047483|NCT02906020|69735229|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
38047484|NCT02906020|69735230|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
38047485|NCT02906020|69735231|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
38047486|NCT02906020|69735232|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
38047487|NCT02906020|69735233|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
38047488|NCT02906020|69735234|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
38047489|NCT02906020|69735235|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
38047490|NCT02906020|69735236|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
38047491|NCT02906020|69735221|FG000|Part 2: Double-blind Treatment Period|Other|0|||
38047492|NCT02906020|69735222|FG001|Part 2: Double-blind Treatment Period|Other|0|||
38047493|NCT02906020|69735223|FG002|Part 2: Double-blind Treatment Period|Other|0|||
38047494|NCT02906020|69735224|FG003|Part 2: Double-blind Treatment Period|Other|0|||
38047495|NCT02906020|69735225|FG004|Part 2: Double-blind Treatment Period|Other|0|||
38047496|NCT02906020|69735226|FG005|Part 2: Double-blind Treatment Period|Other|0|||
38047497|NCT02906020|69735227|FG006|Part 2: Double-blind Treatment Period|Other|0|||
38047498|NCT02906020|69735228|FG007|Part 2: Double-blind Treatment Period|Other|0|||
38047499|NCT02906020|69735229|FG008|Part 2: Double-blind Treatment Period|Other|6|||
37680315|NCT02344173|69155872|FG000|12-month Visit|Death|8|||
38047500|NCT02906020|69735230|FG009|Part 2: Double-blind Treatment Period|Other|10|||
38047501|NCT02906020|69735231|FG010|Part 2: Double-blind Treatment Period|Other|0|||
38047502|NCT02906020|69735232|FG011|Part 2: Double-blind Treatment Period|Other|0|||
38047503|NCT02906020|69735233|FG012|Part 2: Double-blind Treatment Period|Other|0|||
38047504|NCT02906020|69735234|FG013|Part 2: Double-blind Treatment Period|Other|0|||
38047505|NCT02906020|69735235|FG014|Part 2: Double-blind Treatment Period|Other|0|||
38047506|NCT02906020|69735236|FG015|Part 2: Double-blind Treatment Period|Other|0|||
38047507|NCT02906020|69735221|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
38047508|NCT02906020|69735222|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
38047509|NCT02906020|69735223|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
38047510|NCT02906020|69735224|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
38047511|NCT02906020|69735225|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
38047512|NCT02906020|69735226|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
38047513|NCT02906020|69735227|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
38047514|NCT02906020|69735228|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
38047515|NCT02906020|69735229|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
38047516|NCT02906020|69735230|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
38047517|NCT02906020|69735231|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
38047518|NCT02906020|69735232|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
38047519|NCT02906020|69735233|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
38047520|NCT02906020|69735234|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
38047521|NCT02906020|69735235|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
38047522|NCT02906020|69735236|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
38047523|NCT02906020|69735221|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
38047524|NCT02906020|69735222|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
38047525|NCT02906020|69735223|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
38047526|NCT02906020|69735224|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
38047527|NCT02906020|69735225|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
38047528|NCT02906020|69735226|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
37953669|NCT00615836|69640568|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
37953670|NCT00615836|69640564|FG000|Extension Study (FE992026 CS31)|Other|10|||
37953671|NCT00615836|69640565|FG001|Extension Study (FE992026 CS31)|Other|7|||
37953672|NCT00615836|69640566|FG002|Extension Study (FE992026 CS31)|Other|8|||
37953673|NCT00615836|69640567|FG003|Extension Study (FE992026 CS31)|Other|8|||
37953674|NCT00615836|69640568|FG004|Extension Study (FE992026 CS31)|Other|0|||
37953675|NCT00615836|69640564|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
37953676|NCT00615836|69640565|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
37953677|NCT00615836|69640566|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
37953678|NCT00615836|69640567|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
37953679|NCT00615836|69640568|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
37953680|NCT00615836|69640564|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
37953681|NCT00615836|69640565|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
37953682|NCT00615836|69640566|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
37953683|NCT00615836|69640567|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
37953684|NCT00615836|69640568|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
37953685|NCT00491530|69640587|FG000|Overall Study|Adverse Event|6|||
37953686|NCT00491530|69640588|FG001|Overall Study|Adverse Event|1|||
37953687|NCT00491530|69640589|FG002|Overall Study|Adverse Event|2|||
37953688|NCT00491530|69640587|FG000|Overall Study|Withdrawal by Subject|3|||
37953689|NCT00491530|69640588|FG001|Overall Study|Withdrawal by Subject|0|||
37953690|NCT00491530|69640589|FG002|Overall Study|Withdrawal by Subject|0|||
37953691|NCT00491530|69640587|FG000|Overall Study|Lost to Follow-up|3|||
37953692|NCT00491530|69640588|FG001|Overall Study|Lost to Follow-up|2|||
37953693|NCT00491530|69640589|FG002|Overall Study|Lost to Follow-up|2|||
37953694|NCT00491530|69640587|FG000|Overall Study|Lack of Efficacy|0|||
37953695|NCT00491530|69640588|FG001|Overall Study|Lack of Efficacy|1|||
37953696|NCT00491530|69640589|FG002|Overall Study|Lack of Efficacy|0|||
37953697|NCT00491530|69640587|FG000|Overall Study|Investigator Discretion|0|||
37953698|NCT00491530|69640588|FG001|Overall Study|Investigator Discretion|1|||
37953699|NCT00491530|69640589|FG002|Overall Study|Investigator Discretion|0|||
37953700|NCT00491530|69640587|FG000|Overall Study|Patient Request|0|||
37953701|NCT00491530|69640588|FG001|Overall Study|Patient Request|1|||
37953702|NCT00491530|69640589|FG002|Overall Study|Patient Request|0|||
37953703|NCT00491530|69640587|FG000|Overall Study|Use of Prohibited Medication|0|||
37953704|NCT00491530|69640588|FG001|Overall Study|Use of Prohibited Medication|0|||
37953705|NCT00491530|69640589|FG002|Overall Study|Use of Prohibited Medication|1|||
37953706|NCT00617240|69640599|FG000|Overall Study|Lack of Efficacy|1|||
37953707|NCT00617240|69640600|FG001|Overall Study|Lack of Efficacy|0|||
37953708|NCT00615290|69640606|FG000|Overall Study|Adverse Event|2|||
37953709|NCT00615290|69640606|FG000|Overall Study|Lost to Follow-up|3|||
37953710|NCT00615290|69640606|FG000|Overall Study|Withdrawal by Subject|1|||
37953711|NCT00615290|69640606|FG000|Overall Study|Other|2|||
37953712|NCT00501046|69640612|FG000|Overall Study|Adverse Event|21|||
38047529|NCT02906020|69735227|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
38047530|NCT02906020|69735228|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
37953713|NCT00501046|69640613|FG001|Overall Study|Adverse Event|25|||
38047531|NCT02906020|69735229|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
38047532|NCT02906020|69735230|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
38047533|NCT02906020|69735231|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
38047534|NCT02906020|69735232|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
38047535|NCT02906020|69735233|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
38047536|NCT02906020|69735234|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
38047537|NCT02906020|69735235|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
38047538|NCT02906020|69735236|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
38047539|NCT02906020|69735221|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
38047540|NCT02906020|69735222|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
38047541|NCT02906020|69735223|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
38047542|NCT02906020|69735224|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
38047543|NCT02906020|69735225|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
38047544|NCT02906020|69735226|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
38047545|NCT02906020|69735227|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
38047546|NCT02906020|69735228|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
38047547|NCT02906020|69735229|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
38047548|NCT02906020|69735230|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
38047549|NCT02906020|69735231|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
38047550|NCT02906020|69735232|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
38047551|NCT02906020|69735233|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
38047552|NCT02906020|69735234|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
38047553|NCT02906020|69735235|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
38047554|NCT02906020|69735236|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
38047555|NCT02906020|69735221|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
38047556|NCT02906020|69735222|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
38047557|NCT02906020|69735223|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
38047558|NCT02906020|69735224|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
38047559|NCT02906020|69735225|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
38047560|NCT02906020|69735226|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
38047561|NCT02906020|69735227|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
38047562|NCT02906020|69735228|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
38047563|NCT02906020|69735229|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
38047564|NCT02906020|69735230|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
38047565|NCT02906020|69735231|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
38047566|NCT02906020|69735232|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
38047567|NCT02906020|69735233|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
38047568|NCT02906020|69735234|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
38047569|NCT02906020|69735235|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
38047570|NCT02906020|69735236|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
38047571|NCT02906020|69735221|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
38047572|NCT02906020|69735222|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
38047573|NCT02906020|69735223|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
38047574|NCT02906020|69735224|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
38047575|NCT02906020|69735225|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
38047576|NCT02906020|69735226|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
38047577|NCT02906020|69735227|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
38047578|NCT02906020|69735228|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
38047579|NCT02906020|69735229|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
38047580|NCT02906020|69735230|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
38047581|NCT02906020|69735231|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
38047582|NCT02906020|69735232|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
38047583|NCT02906020|69735233|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
37953714|NCT00501046|69640612|FG000|Overall Study|Death|23|||
37953715|NCT00501046|69640613|FG001|Overall Study|Death|30|||
37953716|NCT00501046|69640612|FG000|Overall Study|Lost to Follow-up|14|||
37953717|NCT00501046|69640613|FG001|Overall Study|Lost to Follow-up|13|||
37953718|NCT00501046|69640612|FG000|Overall Study|Physician Decision|7|||
37953719|NCT00501046|69640613|FG001|Overall Study|Physician Decision|2|||
37953720|NCT00501046|69640612|FG000|Overall Study|Pregnancy|0|||
37953721|NCT00501046|69640613|FG001|Overall Study|Pregnancy|3|||
37953722|NCT00501046|69640612|FG000|Overall Study|Protocol Violation|2|||
37953723|NCT00501046|69640613|FG001|Overall Study|Protocol Violation|1|||
37953724|NCT00501046|69640612|FG000|Overall Study|Withdrawal by Subject|84|||
37953725|NCT00501046|69640613|FG001|Overall Study|Withdrawal by Subject|83|||
38047584|NCT02906020|69735234|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
38047585|NCT02906020|69735235|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
38047586|NCT02906020|69735236|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
38047587|NCT02906020|69735221|FG000|Part 2: Long-term Follow-up Period|Other|0|||
38047588|NCT02906020|69735222|FG001|Part 2: Long-term Follow-up Period|Other|0|||
38047589|NCT02906020|69735223|FG002|Part 2: Long-term Follow-up Period|Other|0|||
38047590|NCT02906020|69735224|FG003|Part 2: Long-term Follow-up Period|Other|0|||
38047591|NCT02906020|69735225|FG004|Part 2: Long-term Follow-up Period|Other|0|||
38047592|NCT02906020|69735226|FG005|Part 2: Long-term Follow-up Period|Other|0|||
38047593|NCT02906020|69735227|FG006|Part 2: Long-term Follow-up Period|Other|0|||
38047594|NCT02906020|69735228|FG007|Part 2: Long-term Follow-up Period|Other|0|||
38047595|NCT02906020|69735229|FG008|Part 2: Long-term Follow-up Period|Other|0|||
38047596|NCT02906020|69735230|FG009|Part 2: Long-term Follow-up Period|Other|0|||
38047597|NCT02906020|69735231|FG010|Part 2: Long-term Follow-up Period|Other|0|||
38047598|NCT02906020|69735232|FG011|Part 2: Long-term Follow-up Period|Other|0|||
38047599|NCT02906020|69735233|FG012|Part 2: Long-term Follow-up Period|Other|13|||
38047600|NCT02906020|69735234|FG013|Part 2: Long-term Follow-up Period|Other|8|||
38047601|NCT02906020|69735235|FG014|Part 2: Long-term Follow-up Period|Other|3|||
38047602|NCT02906020|69735236|FG015|Part 2: Long-term Follow-up Period|Other|2|||
37680316|NCT02344173|69155872|FG000|12-month Visit|Withdrawal by Subject|30|||
37680317|NCT02344173|69155872|FG000|12-month Visit|Lost to Follow-up|58|||
38047603|NCT03499353|69735264|FG000|Treatment|Adverse Event|3|||
38047604|NCT03499353|69735264|FG000|Treatment|Progressive Disease|10|||
38047605|NCT03499353|69735264|FG000|Treatment|Other|1|||
38047606|NCT03499353|69735264|FG000|Treatment|Withdrawal by Subject|2|||
38047607|NCT03499353|69735264|FG000|Long-Term Follow-up|Death|2|||
38047608|NCT03499353|69735264|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
38047609|NCT03499353|69735264|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
38047610|NCT00004259|69735272|FG000|Overall Study|Protocol Violation|1|||
38047611|NCT00004259|69735273|FG001|Overall Study|Protocol Violation|2|||
38047612|NCT00004259|69735274|FG002|Overall Study|Protocol Violation|0|||
38047613|NCT00004259|69735275|FG003|Overall Study|Protocol Violation|0|||
38047614|NCT00004259|69735272|FG000|Overall Study|Withdrawal by Subject|0|||
38047615|NCT00004259|69735273|FG001|Overall Study|Withdrawal by Subject|2|||
38047616|NCT00004259|69735274|FG002|Overall Study|Withdrawal by Subject|0|||
38047617|NCT00004259|69735275|FG003|Overall Study|Withdrawal by Subject|0|||
38047618|NCT03365934|69735299|FG000|Overall Study|Adverse Event|1|||
38047619|NCT03365934|69735299|FG000|Overall Study|Withdrawal by Subject|1|||
38047620|NCT03468855|69735308|FG000|Overall Study|Adverse Event|2|||
38047621|NCT03468855|69735308|FG000|Overall Study|Lost to Follow-up|5|||
38047622|NCT03468855|69735308|FG000|Overall Study|Withdrawal by Subject|3|||
38047623|NCT03468855|69735308|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
38047624|NCT03738865|69735314|FG000|Overall Study|Withdrawal by Subject|3|||
38047625|NCT03738865|69735315|FG001|Overall Study|Withdrawal by Subject|3|||
38047626|NCT03738865|69735314|FG000|Overall Study|Adverse Event|2|||
38047627|NCT03738865|69735315|FG001|Overall Study|Adverse Event|0|||
38047628|NCT03738865|69735314|FG000|Overall Study|Physician Decision|0|||
38047629|NCT03738865|69735315|FG001|Overall Study|Physician Decision|1|||
38047630|NCT03524157|69735324|FG000|Overall Study|cytology not readable|0|||
38047631|NCT03524157|69735325|FG001|Overall Study|cytology not readable|0|||
38047632|NCT03524157|69735326|FG002|Overall Study|cytology not readable|1|||
38047633|NCT03437733|69735340|FG000|Overall Study|Eligibility criteria not met|0|||
38047634|NCT03437733|69735341|FG001|Overall Study|Eligibility criteria not met|3|||
38047635|NCT03468543|69735349|FG000|Overall Study|Protocol stopping rules met|3|||
38047636|NCT03467763|69735353|FG000|Overall Study|Lost to Follow-up|1|||
38047637|NCT03467763|69735353|FG000|Overall Study|Protocol Violation|2|||
38047638|NCT00004031|69735361|FG000|Overall Study|Adverse Event|5|||
38047639|NCT00004031|69735362|FG001|Overall Study|Adverse Event|0|||
38047640|NCT00004031|69735361|FG000|Overall Study|Refusal unrelated to adverse events|2|||
38047641|NCT00004031|69735362|FG001|Overall Study|Refusal unrelated to adverse events|11|||
38047642|NCT00004031|69735361|FG000|Overall Study|Progression/relapse|9|||
38047643|NCT00004031|69735362|FG001|Overall Study|Progression/relapse|4|||
38047644|NCT00004031|69735361|FG000|Overall Study|Death|3|||
38047645|NCT00004031|69735362|FG001|Overall Study|Death|1|||
38047646|NCT00004031|69735361|FG000|Overall Study|Other- not protocol specified|3|||
38047647|NCT00004031|69735362|FG001|Overall Study|Other- not protocol specified|3|||
38047648|NCT00004031|69735361|FG000|Overall Study|Reason under review|3|||
38047649|NCT00004031|69735362|FG001|Overall Study|Reason under review|2|||
38047650|NCT03467217|69735372|FG000|Overall Study|Trial stopped early|5|||
38047651|NCT03467217|69735373|FG001|Overall Study|Trial stopped early|2|||
38047652|NCT03467217|69735372|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
38047653|NCT03467217|69735373|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
38047654|NCT03467217|69735372|FG000|Overall Study|Lost to Follow-up|0|||
38047655|NCT03467217|69735373|FG001|Overall Study|Lost to Follow-up|2|||
38047656|NCT00003875|69735379|FG000|Overall Study|Screen Failed|1|||
38047657|NCT03495453|69735385|FG000|Overall Study|Withdrawal by Subject|0|||
38047658|NCT03495453|69735386|FG001|Overall Study|Withdrawal by Subject|1|||
38047659|NCT03364686|69735392|FG000|Overall Study|Physician Decision|2|||
38047660|NCT03437577|69735399|FG000|Pre-Randomization|Withdrawal by Subject|0|||
38047661|NCT03437577|69735400|FG001|Pre-Randomization|Withdrawal by Subject|0|||
38047662|NCT03437577|69735401|FG002|Pre-Randomization|Withdrawal by Subject|10|||
38047663|NCT03437577|69735399|FG000|Post-Randomization|Physician Decision|0|||
38047664|NCT03437577|69735400|FG001|Post-Randomization|Physician Decision|2|||
38047665|NCT03437577|69735401|FG002|Post-Randomization|Physician Decision|0|||
38047666|NCT03336528|69735409|FG000|Overall Study|Protocol Violation|1|||
38047667|NCT03336528|69735410|FG001|Overall Study|Protocol Violation|1|||
38047668|NCT03336528|69735409|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
38047669|NCT03336528|69735410|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
38047670|NCT03336528|69735409|FG000|Overall Study|Did not receive study medication|1|||
38047671|NCT03336528|69735410|FG001|Overall Study|Did not receive study medication|2|||
38047672|NCT03364608|69735418|FG000|Overall Study|Withdrawal by Subject|4|||
38047673|NCT03364608|69735418|FG000|Overall Study|Protocol Violation|2|||
38047674|NCT03364608|69735418|FG000|Overall Study|Lost to Follow-up|2|||
38047675|NCT00003869|69735432|FG000|Overall Study|Adverse Event|14|||
38047676|NCT00003869|69735433|FG001|Overall Study|Adverse Event|3|||
38047677|NCT00003869|69735432|FG000|Overall Study|Withdrawal by Subject|21|||
38047678|NCT00003869|69735433|FG001|Overall Study|Withdrawal by Subject|3|||
38047679|NCT00003869|69735432|FG000|Overall Study|Death|1|||
38047680|NCT00003869|69735433|FG001|Overall Study|Death|2|||
38047681|NCT00003869|69735432|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
38047682|NCT00003869|69735433|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
38047683|NCT03344640|69735441|FG000|Overall Study|Adverse Event|1|||
38047684|NCT03344640|69735442|FG001|Overall Study|Adverse Event|0|||
38047685|NCT03344640|69735441|FG000|Overall Study|Physician Decision|1|||
38047686|NCT03344640|69735442|FG001|Overall Study|Physician Decision|1|||
38047687|NCT03344640|69735441|FG000|Overall Study|Withdrawal by Subject|1|||
38047688|NCT03344640|69735442|FG001|Overall Study|Withdrawal by Subject|2|||
38047689|NCT03344640|69735441|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
38047690|NCT03344640|69735442|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
38047691|NCT03344562|69735450|FG000|Overall Study|Withdrawal by Subject|2|||
38047692|NCT03344562|69735451|FG001|Overall Study|Withdrawal by Subject|0|||
38047693|NCT00003659|69735457|FG000|Overall Study|Withdrawal by Subject|3|||
38047694|NCT03494985|69735465|FG000|Overall Study|Adverse Event|3|||
38047695|NCT03494985|69735466|FG001|Overall Study|Adverse Event|2|||
38047696|NCT03494985|69735467|FG002|Overall Study|Adverse Event|3|||
38047697|NCT03494985|69735468|FG003|Overall Study|Adverse Event|0|||
38047698|NCT03494985|69735465|FG000|Overall Study|Other (Withdrawal of consent)|2|||
38047699|NCT03494985|69735466|FG001|Overall Study|Other (Withdrawal of consent)|3|||
38047700|NCT03494985|69735467|FG002|Overall Study|Other (Withdrawal of consent)|2|||
38047701|NCT03494985|69735468|FG003|Overall Study|Other (Withdrawal of consent)|5|||
38047702|NCT03494985|69735465|FG000|Overall Study|Other (Not specified)|0|||
38047703|NCT03494985|69735466|FG001|Overall Study|Other (Not specified)|1|||
38047704|NCT03494985|69735467|FG002|Overall Study|Other (Not specified)|1|||
38047705|NCT03494985|69735468|FG003|Overall Study|Other (Not specified)|0|||
38047707|NCT00003509|69735482|FG000|Overall Study|Not evaluable|5|||
38047708|NCT03344172|69735488|FG000|Overall Study|Received <1 dose of treatment|1|||
38047709|NCT03344172|69735489|FG001|Overall Study|Received <1 dose of treatment|0|||
38047710|NCT03465891|69735497|FG000|Overall Study|Withdrawal by Subject|0|||
38047711|NCT03465891|69735498|FG001|Overall Study|Withdrawal by Subject|1|||
38047712|NCT03465891|69735497|FG000|Overall Study|Disease progression|1|||
38047713|NCT03465891|69735498|FG001|Overall Study|Disease progression|0|||
38047714|NCT03363906|69735504|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
38047715|NCT03363906|69735505|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
38047716|NCT03363906|69735504|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
38047717|NCT03363906|69735505|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
38047718|NCT03363906|69735504|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
38047719|NCT03363906|69735505|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
38047720|NCT03363906|69735504|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
38047721|NCT03363906|69735505|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
38047722|NCT00003473|69735511|FG000|Overall Study|Three patients were not evaluable.|3|||
38047723|NCT03343626|69735523|FG000|Overall Study|Lost to Follow-up|4|||
38047724|NCT03343626|69735524|FG001|Overall Study|Lost to Follow-up|3|||
38047725|NCT03343626|69735525|FG002|Overall Study|Lost to Follow-up|2|||
38047726|NCT03343626|69735526|FG003|Overall Study|Lost to Follow-up|5|||
38047727|NCT03343626|69735527|FG004|Overall Study|Lost to Follow-up|4|||
38047728|NCT03343626|69735528|FG005|Overall Study|Lost to Follow-up|4|||
38047729|NCT03343626|69735529|FG006|Overall Study|Lost to Follow-up|4|||
38047730|NCT03343626|69735530|FG007|Overall Study|Lost to Follow-up|7|||
38047731|NCT03343626|69735523|FG000|Overall Study|Withdrawal of Consent|2|||
38047732|NCT03343626|69735524|FG001|Overall Study|Withdrawal of Consent|1|||
38047733|NCT03343626|69735525|FG002|Overall Study|Withdrawal of Consent|0|||
38047734|NCT03343626|69735526|FG003|Overall Study|Withdrawal of Consent|3|||
38047735|NCT03343626|69735527|FG004|Overall Study|Withdrawal of Consent|3|||
38047736|NCT03343626|69735528|FG005|Overall Study|Withdrawal of Consent|1|||
38047737|NCT03343626|69735529|FG006|Overall Study|Withdrawal of Consent|1|||
38047738|NCT03343626|69735530|FG007|Overall Study|Withdrawal of Consent|2|||
38047739|NCT03343626|69735523|FG000|Overall Study|Reason not Specified|0|||
38047740|NCT03343626|69735524|FG001|Overall Study|Reason not Specified|1|||
38047741|NCT03343626|69735525|FG002|Overall Study|Reason not Specified|0|||
38047742|NCT03343626|69735526|FG003|Overall Study|Reason not Specified|0|||
38047743|NCT03343626|69735527|FG004|Overall Study|Reason not Specified|0|||
38047744|NCT03343626|69735528|FG005|Overall Study|Reason not Specified|0|||
38047745|NCT03343626|69735529|FG006|Overall Study|Reason not Specified|0|||
38047746|NCT03343626|69735530|FG007|Overall Study|Reason not Specified|1|||
38047747|NCT03343626|69735523|FG000|Overall Study|Data Entry Error|0|||
38047748|NCT03343626|69735524|FG001|Overall Study|Data Entry Error|0|||
38047749|NCT03343626|69735525|FG002|Overall Study|Data Entry Error|0|||
38047750|NCT03343626|69735526|FG003|Overall Study|Data Entry Error|0|||
38047751|NCT03343626|69735527|FG004|Overall Study|Data Entry Error|0|||
38047752|NCT03343626|69735528|FG005|Overall Study|Data Entry Error|0|||
38047753|NCT03343626|69735529|FG006|Overall Study|Data Entry Error|0|||
38047754|NCT03343626|69735530|FG007|Overall Study|Data Entry Error|1|||
38047755|NCT03334422|69735555|FG000|Overall Study|Adverse Event|1|||
38047756|NCT03334422|69735556|FG001|Overall Study|Adverse Event|3|||
38047757|NCT03334422|69735557|FG002|Overall Study|Adverse Event|2|||
38047758|NCT03334422|69735558|FG003|Overall Study|Adverse Event|2|||
38047759|NCT03334422|69735555|FG000|Overall Study|Lack of Efficacy|10|||
38047760|NCT03334422|69735556|FG001|Overall Study|Lack of Efficacy|2|||
38047761|NCT03334422|69735557|FG002|Overall Study|Lack of Efficacy|7|||
38047762|NCT03334422|69735558|FG003|Overall Study|Lack of Efficacy|3|||
38047763|NCT03334422|69735555|FG000|Overall Study|Withdrawal by Subject|8|||
38047764|NCT03334422|69735556|FG001|Overall Study|Withdrawal by Subject|3|||
38047765|NCT03334422|69735557|FG002|Overall Study|Withdrawal by Subject|1|||
38047766|NCT03334422|69735558|FG003|Overall Study|Withdrawal by Subject|0|||
38047767|NCT03334422|69735555|FG000|Overall Study|Lost to Follow-up|0|||
38047768|NCT03334422|69735556|FG001|Overall Study|Lost to Follow-up|0|||
38047769|NCT03334422|69735557|FG002|Overall Study|Lost to Follow-up|0|||
38047770|NCT03334422|69735558|FG003|Overall Study|Lost to Follow-up|1|||
38047771|NCT03334422|69735555|FG000|Overall Study|Inability to obtain laboratory samples|0|||
38047772|NCT03334422|69735556|FG001|Overall Study|Inability to obtain laboratory samples|1|||
38047773|NCT03334422|69735557|FG002|Overall Study|Inability to obtain laboratory samples|0|||
38047774|NCT03334422|69735558|FG003|Overall Study|Inability to obtain laboratory samples|0|||
38047775|NCT03334422|69735555|FG000|Overall Study|Pregnancy|0|||
38047776|NCT03334422|69735556|FG001|Overall Study|Pregnancy|1|||
38047777|NCT03334422|69735557|FG002|Overall Study|Pregnancy|0|||
38047778|NCT03334422|69735558|FG003|Overall Study|Pregnancy|0|||
38047779|NCT03362190|69735577|FG000|Overall Study|Adverse Event|0|||
38047780|NCT03362190|69735578|FG001|Overall Study|Adverse Event|0|||
38047781|NCT03362190|69735579|FG002|Overall Study|Adverse Event|0|||
38047782|NCT03362190|69735580|FG003|Overall Study|Adverse Event|1|||
38047783|NCT03362190|69735577|FG000|Overall Study|Withdrawal by Subject|0|||
38047784|NCT03362190|69735578|FG001|Overall Study|Withdrawal by Subject|0|||
38047785|NCT03362190|69735579|FG002|Overall Study|Withdrawal by Subject|0|||
38047786|NCT03362190|69735580|FG003|Overall Study|Withdrawal by Subject|1|||
38047787|NCT02323126|69735596|FG000|Overall Study|Patient / guardian decision|0|||
38047788|NCT02323126|69735597|FG001|Overall Study|Patient / guardian decision|1|||
38047789|NCT02323126|69735598|FG002|Overall Study|Patient / guardian decision|2|||
38047790|NCT02323126|69735596|FG000|Overall Study|Progressive disease|14|||
38047791|NCT02323126|69735597|FG001|Overall Study|Progressive disease|8|||
38047792|NCT02323126|69735598|FG002|Overall Study|Progressive disease|14|||
38047793|NCT02323126|69735596|FG000|Overall Study|Physician Decision|0|||
38047794|NCT02323126|69735597|FG001|Overall Study|Physician Decision|1|||
38047795|NCT02323126|69735598|FG002|Overall Study|Physician Decision|3|||
38047796|NCT02323126|69735596|FG000|Overall Study|Death|1|||
38047797|NCT02323126|69735597|FG001|Overall Study|Death|1|||
38047798|NCT02323126|69735598|FG002|Overall Study|Death|4|||
38047799|NCT02323126|69735596|FG000|Overall Study|Adverse Event|3|||
38047800|NCT02323126|69735597|FG001|Overall Study|Adverse Event|5|||
38047801|NCT02323126|69735598|FG002|Overall Study|Adverse Event|7|||
38047802|NCT03491553|69735615|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
38047803|NCT03491553|69735616|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
38047804|NCT03491553|69735617|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
38047805|NCT03491553|69735618|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
38047806|NCT03491553|69735619|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
38047807|NCT03491553|69735620|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
38047808|NCT03491553|69735615|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
38047809|NCT03491553|69735616|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
38047810|NCT03491553|69735617|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
38047811|NCT03491553|69735618|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
38047812|NCT03491553|69735619|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
38047813|NCT03491553|69735620|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
38047814|NCT00003377|69735641|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
38047815|NCT00003377|69735642|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
38047816|NCT00003377|69735643|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
37953726|NCT00501046|69640612|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
37953727|NCT00501046|69640613|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
37953728|NCT00533949|69640623|FG000|Overall Study|Protocol Violation|12|||
37953729|NCT00533949|69640624|FG001|Overall Study|Protocol Violation|12|||
37953730|NCT00533949|69640625|FG002|Overall Study|Protocol Violation|9|||
37953731|NCT00533949|69640626|FG003|Overall Study|Protocol Violation|9|||
37953732|NCT00533949|69640623|FG000|Overall Study|Withdrawal by Subject|3|||
37953733|NCT00533949|69640624|FG001|Overall Study|Withdrawal by Subject|2|||
37953734|NCT00533949|69640625|FG002|Overall Study|Withdrawal by Subject|1|||
37953735|NCT00533949|69640626|FG003|Overall Study|Withdrawal by Subject|1|||
37953736|NCT00485134|69640652|FG000|Overall Study|Lost to Follow-up|1|||
38047817|NCT00003377|69735644|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
38047818|NCT00003377|69735645|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
38047819|NCT00003377|69735641|FG000|Period II|Ureteral stent complications|0|||
38047820|NCT00003377|69735642|FG001|Period II|Ureteral stent complications|0|||
38047821|NCT00003377|69735643|FG002|Period II|Ureteral stent complications|0|||
38047822|NCT00003377|69735644|FG003|Period II|Ureteral stent complications|0|||
38047823|NCT00003377|69735645|FG004|Period II|Ureteral stent complications|1|||
38047824|NCT00651742|69735658|FG000|Overall Study|Objective Disease Progression|22|||
38047825|NCT00651742|69735658|FG000|Overall Study|Toxicity|3|||
38047826|NCT00651742|69735658|FG000|Overall Study|Investigator Judgment|1|||
38047827|NCT00651742|69735658|FG000|Overall Study|Withdrawal of Consent|1|||
38047828|NCT00651742|69735658|FG000|Overall Study|Enrolled but not treated|1|||
38047829|NCT00002651|69735664|FG000|Induction|Adverse Event|44|||
38047830|NCT00002651|69735665|FG001|Induction|Adverse Event|0|||
38047831|NCT00002651|69735666|FG002|Induction|Adverse Event|0|||
38047832|NCT00002651|69735664|FG000|Induction|Refusal unrelated to adverse event|50|||
38047833|NCT00002651|69735665|FG001|Induction|Refusal unrelated to adverse event|0|||
38047834|NCT00002651|69735666|FG002|Induction|Refusal unrelated to adverse event|0|||
38047835|NCT00002651|69735664|FG000|Induction|Progression/relapse|274|||
38047836|NCT00002651|69735665|FG001|Induction|Progression/relapse|0|||
38047837|NCT00002651|69735666|FG002|Induction|Progression/relapse|0|||
38047838|NCT00002651|69735664|FG000|Induction|Death|62|||
38047839|NCT00002651|69735665|FG001|Induction|Death|0|||
38047840|NCT00002651|69735666|FG002|Induction|Death|0|||
38047841|NCT00002651|69735664|FG000|Induction|Other|823|||
38047842|NCT00002651|69735665|FG001|Induction|Other|0|||
38047843|NCT00002651|69735666|FG002|Induction|Other|0|||
38047844|NCT00002651|69735664|FG000|Induction|not eligible|90|||
38047845|NCT00002651|69735665|FG001|Induction|not eligible|0|||
38047846|NCT00002651|69735666|FG002|Induction|not eligible|0|||
38047847|NCT00002651|69735664|FG000|Consolidation and Randomization|Adverse Event|0|||
38047848|NCT00002651|69735665|FG001|Consolidation and Randomization|Adverse Event|36|||
38047849|NCT00002651|69735666|FG002|Consolidation and Randomization|Adverse Event|14|||
38047850|NCT00002651|69735664|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
38047851|NCT00002651|69735665|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
38047852|NCT00002651|69735666|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
38047853|NCT00002651|69735664|FG000|Consolidation and Randomization|Progression/relapse|0|||
38047854|NCT00002651|69735665|FG001|Consolidation and Randomization|Progression/relapse|295|||
38047855|NCT00002651|69735666|FG002|Consolidation and Randomization|Progression/relapse|298|||
38047856|NCT00002651|69735664|FG000|Consolidation and Randomization|Death|0|||
38047857|NCT00002651|69735665|FG001|Consolidation and Randomization|Death|38|||
38047858|NCT00002651|69735666|FG002|Consolidation and Randomization|Death|48|||
38047859|NCT00002651|69735664|FG000|Consolidation and Randomization|Other|0|||
38047860|NCT00002651|69735665|FG001|Consolidation and Randomization|Other|314|||
38047861|NCT00002651|69735666|FG002|Consolidation and Randomization|Other|313|||
38047862|NCT00002651|69735664|FG000|Consolidation and Randomization|not eligible|0|||
38047863|NCT00002651|69735665|FG001|Consolidation and Randomization|not eligible|102|||
38047864|NCT00002651|69735666|FG002|Consolidation and Randomization|not eligible|112|||
38047865|NCT00002597|69735676|FG000|Overall Study|Protocol Violation|19|||
38047866|NCT00002597|69735677|FG001|Overall Study|Protocol Violation|17|||
38047867|NCT00002597|69735676|FG000|Overall Study|Withdrawal by Subject|7|||
38047868|NCT00002597|69735677|FG001|Overall Study|Withdrawal by Subject|6|||
38047869|NCT03435081|69735686|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
38047870|NCT03435081|69735687|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
38047871|NCT03435081|69735688|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
38047872|NCT03435081|69735686|FG000|Week 0 to Week 16|Adverse Event|2|||
38047873|NCT03435081|69735687|FG001|Week 0 to Week 16|Adverse Event|2|||
38047874|NCT03435081|69735688|FG002|Week 0 to Week 16|Adverse Event|2|||
38047875|NCT03435081|69735686|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
38047876|NCT03435081|69735687|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
38047877|NCT03435081|69735688|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
38047878|NCT03435081|69735686|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
38047879|NCT03435081|69735687|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
38047880|NCT03435081|69735688|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
38047881|NCT03435081|69735686|FG000|Week 0 to Week 16|Pregnancy|1|||
38047882|NCT03435081|69735687|FG001|Week 0 to Week 16|Pregnancy|0|||
38047883|NCT03435081|69735688|FG002|Week 0 to Week 16|Pregnancy|0|||
38047884|NCT03435081|69735686|FG000|Week 0 to Week 16|Non-compliance|1|||
38047885|NCT03435081|69735687|FG001|Week 0 to Week 16|Non-compliance|0|||
38047886|NCT03435081|69735688|FG002|Week 0 to Week 16|Non-compliance|2|||
38047887|NCT03435081|69735686|FG000|Week 0 to Week 16|Inadequate Response|0|||
38047888|NCT03435081|69735687|FG001|Week 0 to Week 16|Inadequate Response|1|||
38047889|NCT03435081|69735688|FG002|Week 0 to Week 16|Inadequate Response|0|||
38047890|NCT03435081|69735686|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
38047891|NCT03435081|69735687|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
38047892|NCT03435081|69735688|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
38047893|NCT03435081|69735686|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
38047894|NCT03435081|69735687|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
38047895|NCT03435081|69735688|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
38047896|NCT03435081|69735686|FG000|Week 16 to Week 104|Adverse Event|1|||
37680318|NCT02586493|69155878|FG000|Overall Study|Adverse Event|4|||
38047897|NCT03435081|69735687|FG001|Week 16 to Week 104|Adverse Event|0|||
38047898|NCT03435081|69735688|FG002|Week 16 to Week 104|Adverse Event|2|||
38047899|NCT03435081|69735686|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
38047900|NCT03435081|69735687|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
38047901|NCT03435081|69735688|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
38047902|NCT03435081|69735686|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
38047903|NCT03435081|69735687|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
38047904|NCT03435081|69735688|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
38047905|NCT03435081|69735686|FG000|Week 16 to Week 104|Non--Compliance|0|||
38047906|NCT03435081|69735687|FG001|Week 16 to Week 104|Non--Compliance|0|||
38047907|NCT03435081|69735688|FG002|Week 16 to Week 104|Non--Compliance|1|||
38047908|NCT02738008|69735703|FG000|Overall Study|Study Terminated by Sponsor|1|||
38047909|NCT02738008|69735704|FG001|Overall Study|Study Terminated by Sponsor|5|||
38047910|NCT02738008|69735705|FG002|Overall Study|Study Terminated by Sponsor|3|||
38047911|NCT02738008|69735703|FG000|Overall Study|Adverse Event|0|||
38047912|NCT02738008|69735704|FG001|Overall Study|Adverse Event|1|||
38047913|NCT02738008|69735705|FG002|Overall Study|Adverse Event|2|||
38047914|NCT03489369|69735717|FG000|Overall Study|Documented Progressive Disease|3|||
38047915|NCT03489369|69735718|FG001|Overall Study|Documented Progressive Disease|2|||
38047916|NCT03489369|69735719|FG002|Overall Study|Documented Progressive Disease|3|||
38047917|NCT03489369|69735720|FG003|Overall Study|Documented Progressive Disease|6|||
38047918|NCT03489369|69735717|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
38047919|NCT03489369|69735718|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
38047920|NCT03489369|69735719|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
38047921|NCT03489369|69735720|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
38047922|NCT03257254|69735730|FG000|Overall Study|Withdrawal by Subject|7|||
38047923|NCT03257254|69735730|FG000|Overall Study|Lost to Follow-up|9|||
38047924|NCT03257254|69735730|FG000|Overall Study|Study discontinued by sponsor|5|||
38047925|NCT03738475|69735736|FG000|Overall Study|Participant Non-Compliance|1|||
38047926|NCT03738475|69735737|FG001|Overall Study|Participant Non-Compliance|0|||
38047927|NCT03084718|69735748|FG000|Overall Study|Withdrawal by Subject|4|||
38047928|NCT03084718|69735749|FG001|Overall Study|Withdrawal by Subject|3|||
38047929|NCT03084718|69735750|FG002|Overall Study|Withdrawal by Subject|4|||
38047930|NCT03084718|69735751|FG003|Overall Study|Withdrawal by Subject|0|||
38047931|NCT03084718|69735752|FG004|Overall Study|Withdrawal by Subject|0|||
38047932|NCT03084718|69735748|FG000|Overall Study|Physician Decision|1|||
38047933|NCT03084718|69735749|FG001|Overall Study|Physician Decision|0|||
38047934|NCT03084718|69735750|FG002|Overall Study|Physician Decision|0|||
38047935|NCT03084718|69735751|FG003|Overall Study|Physician Decision|0|||
38047936|NCT03084718|69735752|FG004|Overall Study|Physician Decision|0|||
38047937|NCT03084718|69735748|FG000|Overall Study|Adverse Event|3|||
38047938|NCT03084718|69735749|FG001|Overall Study|Adverse Event|5|||
38047939|NCT03084718|69735750|FG002|Overall Study|Adverse Event|5|||
38047940|NCT03084718|69735751|FG003|Overall Study|Adverse Event|8|||
38047941|NCT03084718|69735752|FG004|Overall Study|Adverse Event|2|||
38047942|NCT03084718|69735748|FG000|Overall Study|Lack of Efficacy|2|||
38047943|NCT03084718|69735749|FG001|Overall Study|Lack of Efficacy|0|||
38047944|NCT03084718|69735750|FG002|Overall Study|Lack of Efficacy|1|||
38047945|NCT03084718|69735751|FG003|Overall Study|Lack of Efficacy|4|||
38047946|NCT03084718|69735752|FG004|Overall Study|Lack of Efficacy|0|||
38047947|NCT03084718|69735748|FG000|Overall Study|Lost to Follow-up|0|||
38047948|NCT03084718|69735749|FG001|Overall Study|Lost to Follow-up|1|||
38047949|NCT03084718|69735750|FG002|Overall Study|Lost to Follow-up|0|||
38047950|NCT03084718|69735751|FG003|Overall Study|Lost to Follow-up|0|||
38047951|NCT03084718|69735752|FG004|Overall Study|Lost to Follow-up|2|||
38047952|NCT03084718|69735748|FG000|Overall Study|Protocol Violation|0|||
38047953|NCT03084718|69735749|FG001|Overall Study|Protocol Violation|0|||
38047954|NCT03084718|69735750|FG002|Overall Study|Protocol Violation|1|||
38047955|NCT03084718|69735751|FG003|Overall Study|Protocol Violation|0|||
38047956|NCT03084718|69735752|FG004|Overall Study|Protocol Violation|0|||
38047957|NCT03084718|69735748|FG000|Overall Study|Death|0|||
38047958|NCT03084718|69735749|FG001|Overall Study|Death|1|||
38047959|NCT03084718|69735750|FG002|Overall Study|Death|0|||
38047960|NCT03084718|69735751|FG003|Overall Study|Death|0|||
38047961|NCT03084718|69735752|FG004|Overall Study|Death|0|||
38047962|NCT03084718|69735748|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
38047963|NCT03084718|69735749|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
38047964|NCT03084718|69735750|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
38047965|NCT03084718|69735751|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
38047966|NCT03084718|69735752|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
38047967|NCT04321252|69735776|FG000|Overall Study|Withdrawal by Subject|0|||
38047968|NCT04321252|69735777|FG001|Overall Study|Withdrawal by Subject|0|||
38047969|NCT04321252|69735778|FG002|Overall Study|Withdrawal by Subject|0|||
38047970|NCT04321252|69735779|FG003|Overall Study|Withdrawal by Subject|0|||
38047971|NCT04321252|69735780|FG004|Overall Study|Withdrawal by Subject|0|||
38047972|NCT04321252|69735781|FG005|Overall Study|Withdrawal by Subject|1|||
38047973|NCT04321252|69735782|FG006|Overall Study|Withdrawal by Subject|0|||
38047974|NCT04321252|69735783|FG007|Overall Study|Withdrawal by Subject|0|||
38047975|NCT04321252|69735784|FG008|Overall Study|Withdrawal by Subject|0|||
38047976|NCT03433677|69735816|FG000|Period 1|Protocol Violation|1|||
38047977|NCT03433677|69735817|FG001|Period 1|Protocol Violation|0|||
38047978|NCT03433677|69735816|FG000|Period 2|Withdrawal by Subject|1|||
38047979|NCT03433677|69735817|FG001|Period 2|Withdrawal by Subject|1|||
38047980|NCT02492711|69735827|FG000|Overall Study|Adverse Event|9|||
38047981|NCT02492711|69735828|FG001|Overall Study|Adverse Event|9|||
38047982|NCT02492711|69735829|FG002|Overall Study|Adverse Event|2|||
38047983|NCT02492711|69735827|FG000|Overall Study|Death|3|||
38047984|NCT02492711|69735828|FG001|Overall Study|Death|3|||
38047985|NCT02492711|69735829|FG002|Overall Study|Death|0|||
38047986|NCT02492711|69735827|FG000|Overall Study|Withdrawal by Subject|10|||
38047987|NCT02492711|69735828|FG001|Overall Study|Withdrawal by Subject|16|||
38047988|NCT02492711|69735829|FG002|Overall Study|Withdrawal by Subject|5|||
38047989|NCT02492711|69735827|FG000|Overall Study|Physician Decision|10|||
38047990|NCT02492711|69735828|FG001|Overall Study|Physician Decision|6|||
38047991|NCT02492711|69735829|FG002|Overall Study|Physician Decision|4|||
38047992|NCT02492711|69735827|FG000|Overall Study|Lost to Follow-up|0|||
38047993|NCT02492711|69735828|FG001|Overall Study|Lost to Follow-up|0|||
38047994|NCT02492711|69735829|FG002|Overall Study|Lost to Follow-up|1|||
38047995|NCT02492711|69735827|FG000|Overall Study|study treatment delay|2|||
38047996|NCT02492711|69735828|FG001|Overall Study|study treatment delay|1|||
38047997|NCT02492711|69735829|FG002|Overall Study|study treatment delay|0|||
38047998|NCT02492711|69735827|FG000|Overall Study|change in chemotherapy|0|||
38047999|NCT02492711|69735828|FG001|Overall Study|change in chemotherapy|1|||
38048000|NCT02492711|69735829|FG002|Overall Study|change in chemotherapy|0|||
38048001|NCT02492711|69735827|FG000|Overall Study|never treated|2|||
38048002|NCT02492711|69735828|FG001|Overall Study|never treated|4|||
38048003|NCT02492711|69735829|FG002|Overall Study|never treated|0|||
38048004|NCT02492711|69735827|FG000|Overall Study|Other|0|||
38048005|NCT02492711|69735828|FG001|Overall Study|Other|0|||
38048006|NCT02492711|69735829|FG002|Overall Study|Other|1|||
38048007|NCT01147822|69735844|FG000|Overall Study|Death|66|||
38048008|NCT01147822|69735845|FG001|Overall Study|Death|59|||
38048009|NCT01147822|69735844|FG000|Overall Study|Protocol Violation|0|||
38048010|NCT01147822|69735845|FG001|Overall Study|Protocol Violation|1|||
38048011|NCT01147822|69735844|FG000|Overall Study|Lost to Follow-up|3|||
38048012|NCT01147822|69735845|FG001|Overall Study|Lost to Follow-up|2|||
38048013|NCT01147822|69735844|FG000|Overall Study|Physician Decision|0|||
38048014|NCT01147822|69735845|FG001|Overall Study|Physician Decision|2|||
38048015|NCT01147822|69735844|FG000|Overall Study|Withdrawal by Subject|8|||
38048016|NCT01147822|69735845|FG001|Overall Study|Withdrawal by Subject|13|||
38048017|NCT01147822|69735844|FG000|Overall Study|Not Completed/Ongoing|111|||
38048018|NCT01147822|69735845|FG001|Overall Study|Not Completed/Ongoing|102|||
38048019|NCT03431337|69735853|FG000|Overall Study|Lost to Follow-up|21|||
38048020|NCT03431337|69735854|FG001|Overall Study|Lost to Follow-up|19|||
38048021|NCT03431337|69735853|FG000|Overall Study|Withdrawal by Subject|8|||
38048022|NCT03431337|69735854|FG001|Overall Study|Withdrawal by Subject|3|||
38048023|NCT03738241|69735874|FG000|Overall Study|Withdrawal by Subject|0|||
38048024|NCT03738241|69735875|FG001|Overall Study|Withdrawal by Subject|0|||
38048025|NCT03738241|69735876|FG002|Overall Study|Withdrawal by Subject|0|||
38048026|NCT03738241|69735877|FG003|Overall Study|Withdrawal by Subject|0|||
38048027|NCT03738241|69735878|FG004|Overall Study|Withdrawal by Subject|0|||
38048028|NCT03738241|69735879|FG005|Overall Study|Withdrawal by Subject|0|||
37953737|NCT00485134|69640653|FG001|Overall Study|Lost to Follow-up|0|||
37953738|NCT00485134|69640654|FG002|Overall Study|Lost to Follow-up|0|||
37953739|NCT00485134|69640655|FG003|Overall Study|Lost to Follow-up|0|||
37953740|NCT00485134|69640656|FG004|Overall Study|Lost to Follow-up|0|||
37953741|NCT00485134|69640657|FG005|Overall Study|Lost to Follow-up|0|||
37953742|NCT00485134|69640658|FG006|Overall Study|Lost to Follow-up|0|||
37953743|NCT00485134|69640659|FG007|Overall Study|Lost to Follow-up|0|||
37953744|NCT00485134|69640652|FG000|Overall Study|Withdrawal by Subject|0|||
37953745|NCT00485134|69640653|FG001|Overall Study|Withdrawal by Subject|1|||
37953746|NCT00485134|69640654|FG002|Overall Study|Withdrawal by Subject|0|||
37953747|NCT00485134|69640655|FG003|Overall Study|Withdrawal by Subject|0|||
37953748|NCT00485134|69640656|FG004|Overall Study|Withdrawal by Subject|0|||
37953749|NCT00485134|69640657|FG005|Overall Study|Withdrawal by Subject|0|||
37953750|NCT00485134|69640658|FG006|Overall Study|Withdrawal by Subject|0|||
37953751|NCT00485134|69640659|FG007|Overall Study|Withdrawal by Subject|0|||
37953752|NCT00485134|69640652|FG000|Overall Study|Change in health status|0|||
38048029|NCT03738241|69735880|FG006|Overall Study|Withdrawal by Subject|0|||
38048030|NCT03738241|69735881|FG007|Overall Study|Withdrawal by Subject|0|||
38048031|NCT03738241|69735882|FG008|Overall Study|Withdrawal by Subject|0|||
38048032|NCT03738241|69735883|FG009|Overall Study|Withdrawal by Subject|1|||
38048033|NCT03738241|69735874|FG000|Overall Study|Physician Decision|0|||
38048034|NCT03738241|69735875|FG001|Overall Study|Physician Decision|0|||
38048035|NCT03738241|69735876|FG002|Overall Study|Physician Decision|0|||
38048036|NCT03738241|69735877|FG003|Overall Study|Physician Decision|0|||
38048037|NCT03738241|69735878|FG004|Overall Study|Physician Decision|0|||
38048038|NCT03738241|69735879|FG005|Overall Study|Physician Decision|0|||
38048039|NCT03738241|69735880|FG006|Overall Study|Physician Decision|0|||
38048040|NCT03738241|69735881|FG007|Overall Study|Physician Decision|0|||
38048041|NCT03738241|69735882|FG008|Overall Study|Physician Decision|1|||
38048042|NCT03738241|69735883|FG009|Overall Study|Physician Decision|0|||
38048043|NCT03738241|69735874|FG000|Overall Study|Adverse Event|1|||
38048044|NCT03738241|69735875|FG001|Overall Study|Adverse Event|0|||
38048045|NCT03738241|69735876|FG002|Overall Study|Adverse Event|0|||
38048046|NCT03738241|69735877|FG003|Overall Study|Adverse Event|0|||
38048047|NCT03738241|69735878|FG004|Overall Study|Adverse Event|0|||
38048048|NCT03738241|69735879|FG005|Overall Study|Adverse Event|0|||
38048049|NCT03738241|69735880|FG006|Overall Study|Adverse Event|0|||
38048050|NCT03738241|69735881|FG007|Overall Study|Adverse Event|0|||
38048051|NCT03738241|69735882|FG008|Overall Study|Adverse Event|0|||
38048052|NCT03738241|69735883|FG009|Overall Study|Adverse Event|0|||
38048053|NCT03430245|69735905|FG000|Overall Study|Withdrawal by Subject|6|||
38048054|NCT03430245|69735905|FG000|Overall Study|Lost to Follow-up|1|||
38048055|NCT03461289|69735909|FG000|Overall Study|Death|1|||
38048056|NCT03452943|69735915|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
38048057|NCT03452943|69735916|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
38048058|NCT03452943|69735915|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
38048059|NCT03452943|69735916|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
38048060|NCT03452943|69735915|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
38048061|NCT03452943|69735916|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
38048062|NCT03452943|69735915|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
38048063|NCT03452943|69735916|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
38048064|NCT03452943|69735915|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
38048065|NCT03452943|69735916|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
38048066|NCT03452943|69735915|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
38048067|NCT03452943|69735916|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
38048068|NCT03481725|69735924|FG000|Overall Study|Withdrawal by Subject|1|||
38048069|NCT03481725|69735925|FG001|Overall Study|Withdrawal by Subject|0|||
38048070|NCT03480243|69735933|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
38048071|NCT03480243|69735933|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
38048072|NCT03426345|69735948|FG000|Overall Study|Adverse Event|4|||
38048073|NCT03426345|69735949|FG001|Overall Study|Adverse Event|4|||
38048074|NCT03426345|69735948|FG000|Overall Study|Lack of Efficacy|1|||
38048075|NCT03426345|69735949|FG001|Overall Study|Lack of Efficacy|0|||
38048076|NCT03426345|69735948|FG000|Overall Study|Withdrawal by Subject|5|||
38048077|NCT03426345|69735949|FG001|Overall Study|Withdrawal by Subject|6|||
38048078|NCT03426345|69735948|FG000|Overall Study|Lost to Follow-up|3|||
38048079|NCT03426345|69735949|FG001|Overall Study|Lost to Follow-up|1|||
38048080|NCT03426345|69735948|FG000|Overall Study|Protocol Deviation|3|||
38048081|NCT03426345|69735949|FG001|Overall Study|Protocol Deviation|4|||
38048082|NCT03426345|69735948|FG000|Overall Study|Reason Not Specified|1|||
38048083|NCT03426345|69735949|FG001|Overall Study|Reason Not Specified|2|||
38048084|NCT03426345|69735948|FG000|Overall Study|Missing Completion Status|1|||
38048085|NCT03426345|69735949|FG001|Overall Study|Missing Completion Status|0|||
38048086|NCT03426267|69735958|FG000|Overall Study|Physician Decision|1|||
38048087|NCT03426267|69735959|FG001|Overall Study|Physician Decision|4|||
38048088|NCT03426267|69735958|FG000|Overall Study|Lost to Follow-up|1|||
38048089|NCT03426267|69735959|FG001|Overall Study|Lost to Follow-up|0|||
38048090|NCT03426267|69735958|FG000|Overall Study|Withdrawal by Subject|4|||
38048091|NCT03426267|69735959|FG001|Overall Study|Withdrawal by Subject|10|||
38048092|NCT03426267|69735958|FG000|Overall Study|Protocol Violation|1|||
38048093|NCT03426267|69735959|FG001|Overall Study|Protocol Violation|3|||
38048094|NCT03426267|69735958|FG000|Overall Study|Adverse Event|9|||
38048095|NCT03426267|69735959|FG001|Overall Study|Adverse Event|27|||
38048096|NCT03426267|69735958|FG000|Overall Study|Prohibited Treatment Intake|2|||
38048097|NCT03426267|69735959|FG001|Overall Study|Prohibited Treatment Intake|3|||
38048098|NCT03426267|69735958|FG000|Overall Study|Lack of Efficacy|0|||
38048099|NCT03426267|69735959|FG001|Overall Study|Lack of Efficacy|25|||
38048100|NCT03426267|69735958|FG000|Overall Study|other|3|||
38048101|NCT03426267|69735959|FG001|Overall Study|other|0|||
38048102|NCT03412929|69735965|FG000|Overall Study|Protocol Violation|3|||
38048103|NCT03451773|69735971|FG000|Overall Study|Death on study|1|||
38048104|NCT03451773|69735972|FG001|Overall Study|Death on study|5|||
38048105|NCT03451773|69735971|FG000|Overall Study|Death during follow-up period|0|||
38048106|NCT03451773|69735972|FG001|Overall Study|Death during follow-up period|1|||
38048107|NCT03425253|69735979|FG000|Overall Study|Adverse Event|2|||
38048108|NCT03425253|69735979|FG000|Overall Study|Lost to Follow-up|3|||
38048109|NCT03425253|69735979|FG000|Overall Study|Withdrew Consent|6|||
38048110|NCT03425253|69735979|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
38048111|NCT03424239|69735984|FG000|Overall Study|Withdrawal by Subject|2|||
38048112|NCT03451071|69735988|FG000|First Vaccine|Withdrawal by Subject|1|||
38048113|NCT03451071|69735988|FG000|Second Vaccine|Lost to Follow-up|19|||
38048114|NCT03451071|69735988|FG000|Third Vaccine|Lost to Follow-up|22|||
38048115|NCT03451071|69735988|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
38048116|NCT03449979|69735996|FG000|Overall Study|Technical difficulty|0|||
38048117|NCT03449979|69735997|FG001|Overall Study|Technical difficulty|0|||
38048118|NCT03449979|69735998|FG002|Overall Study|Technical difficulty|0|||
38048119|NCT03449979|69735999|FG003|Overall Study|Technical difficulty|1|||
38048120|NCT03449199|69736012|FG000|Overall Study|Lost to Follow-up|1|||
38048121|NCT03449199|69736013|FG001|Overall Study|Lost to Follow-up|1|||
38048122|NCT03449199|69736014|FG002|Overall Study|Lost to Follow-up|0|||
38048123|NCT03449199|69736012|FG000|Overall Study|Protocol Deviation|0|||
38048124|NCT03449199|69736013|FG001|Overall Study|Protocol Deviation|0|||
38048125|NCT03449199|69736014|FG002|Overall Study|Protocol Deviation|1|||
38048126|NCT03449199|69736012|FG000|Overall Study|Withdrawal by Subject|0|||
38048127|NCT03449199|69736013|FG001|Overall Study|Withdrawal by Subject|0|||
38048128|NCT03449199|69736014|FG002|Overall Study|Withdrawal by Subject|1|||
38048129|NCT03421431|69736028|FG000|Overall Study|Adverse Event|2|||
38048130|NCT03421431|69736029|FG001|Overall Study|Adverse Event|1|||
38048131|NCT03421431|69736030|FG002|Overall Study|Adverse Event|12|||
38048132|NCT03421431|69736028|FG000|Overall Study|Lost to Follow-up|1|||
38048133|NCT03421431|69736029|FG001|Overall Study|Lost to Follow-up|1|||
38048134|NCT03421431|69736030|FG002|Overall Study|Lost to Follow-up|1|||
38048135|NCT03421431|69736028|FG000|Overall Study|Withdrawal by Subject|3|||
38048136|NCT03421431|69736029|FG001|Overall Study|Withdrawal by Subject|2|||
38048137|NCT03421431|69736030|FG002|Overall Study|Withdrawal by Subject|1|||
38048138|NCT03421431|69736028|FG000|Overall Study|Protocol Violation|0|||
38048139|NCT03421431|69736029|FG001|Overall Study|Protocol Violation|1|||
38048140|NCT03421431|69736030|FG002|Overall Study|Protocol Violation|0|||
38048141|NCT03421431|69736028|FG000|Overall Study|Participant met Stopping Rules|0|||
38048142|NCT03421431|69736029|FG001|Overall Study|Participant met Stopping Rules|1|||
38048143|NCT03421431|69736030|FG002|Overall Study|Participant met Stopping Rules|0|||
38048144|NCT03448419|69736042|FG000|Overall Study|Adverse Event|10|||
38048145|NCT03448419|69736043|FG001|Overall Study|Adverse Event|9|||
38048146|NCT03448419|69736042|FG000|Overall Study|Lost to Follow-up|0|||
38048147|NCT03448419|69736043|FG001|Overall Study|Lost to Follow-up|2|||
38048148|NCT03448419|69736042|FG000|Overall Study|Withdrawal by Subject|3|||
38048149|NCT03448419|69736043|FG001|Overall Study|Withdrawal by Subject|1|||
38048150|NCT03448419|69736042|FG000|Overall Study|Not treated|0|||
38048151|NCT03448419|69736043|FG001|Overall Study|Not treated|1|||
38048152|NCT03448419|69736042|FG000|Overall Study|Patient did not attend all visits|0|||
38048153|NCT03448419|69736043|FG001|Overall Study|Patient did not attend all visits|2|||
38048154|NCT03448419|69736042|FG000|Overall Study|Withdrawn by Sponsor|0|||
38048155|NCT03448419|69736043|FG001|Overall Study|Withdrawn by Sponsor|1|||
38048156|NCT04816214|69736060|FG000|Overall Study|Progressive Disease|4|||
38048157|NCT04816214|69736061|FG001|Overall Study|Progressive Disease|0|||
38048158|NCT04816214|69736062|FG002|Overall Study|Progressive Disease|0|||
38048159|NCT04816214|69736060|FG000|Overall Study|Death|1|||
38048160|NCT04816214|69736061|FG001|Overall Study|Death|0|||
38048161|NCT04816214|69736062|FG002|Overall Study|Death|0|||
38048162|NCT04816214|69736060|FG000|Overall Study|Study Terminated by Sponsor|1|||
38048163|NCT04816214|69736061|FG001|Overall Study|Study Terminated by Sponsor|0|||
38048164|NCT04816214|69736062|FG002|Overall Study|Study Terminated by Sponsor|0|||
38048165|NCT04350827|69736107|FG000|Overall Study|Lost to Follow-up|1|||
38048166|NCT04350827|69736108|FG001|Overall Study|Lost to Follow-up|2|||
38048167|NCT04303000|69736116|FG000|Opioid Use Questionnaire|Withdrawal by Subject|15|||
38048168|NCT04303000|69736117|FG001|Opioid Use Questionnaire|Withdrawal by Subject|0|||
38048169|NCT04303000|69736118|FG002|Opioid Use Questionnaire|Withdrawal by Subject|0|||
38048170|NCT04212650|69736139|FG000|Overall Study|Withdrawal by Subject|1|||
38048171|NCT04212650|69736140|FG001|Overall Study|Withdrawal by Subject|0|||
38048172|NCT03992196|69736161|FG000|Enrollment|lost to follow-up prior dosing|1|||
38048173|NCT03992196|69736162|FG001|Enrollment|lost to follow-up prior dosing|0|||
38048174|NCT03992196|69736163|FG002|Enrollment|lost to follow-up prior dosing|0|||
38048175|NCT03992196|69736161|FG000|Treatment|Protocol Violation|0|||
38048176|NCT03992196|69736162|FG001|Treatment|Protocol Violation|0|||
38048177|NCT03992196|69736163|FG002|Treatment|Protocol Violation|1|||
38048178|NCT03992196|69736161|FG000|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
38048179|NCT03992196|69736162|FG001|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
38048180|NCT03992196|69736163|FG002|Treatment|Poor drug compliance withdrawn by team and sponsor|1|||
38048181|NCT03992196|69736161|FG000|Treatment|Withdrawal due to non-compliance|0|||
38048182|NCT03992196|69736162|FG001|Treatment|Withdrawal due to non-compliance|0|||
38048183|NCT03992196|69736163|FG002|Treatment|Withdrawal due to non-compliance|1|||
38048184|NCT03992196|69736161|FG000|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
38048185|NCT03992196|69736162|FG001|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
38048186|NCT03992196|69736163|FG002|Treatment|PI's decision due to investigational medicinal product non-compliance|1|||
38048187|NCT03992196|69736161|FG000|Treatment|Withdrawal by parent/guardian|0|||
38048188|NCT03992196|69736162|FG001|Treatment|Withdrawal by parent/guardian|0|||
38048189|NCT03992196|69736163|FG002|Treatment|Withdrawal by parent/guardian|2|||
38048190|NCT03970200|69736172|FG000|Overall Study|Death|2|||
38048191|NCT03970200|69736173|FG001|Overall Study|Death|2|||
38048192|NCT03970200|69736174|FG002|Overall Study|Death|1|||
38048193|NCT03970200|69736172|FG000|Overall Study|Subject re-enrolled into Upper GI|0|||
38048194|NCT03970200|69736173|FG001|Overall Study|Subject re-enrolled into Upper GI|0|||
38048195|NCT03970200|69736174|FG002|Overall Study|Subject re-enrolled into Upper GI|1|||
38048196|NCT03840200|69736186|FG000|Overall Study|Death|6|||
38048197|NCT03840200|69736187|FG001|Overall Study|Death|3|||
38048198|NCT03840200|69736188|FG002|Overall Study|Death|6|||
38048199|NCT03840200|69736189|FG003|Overall Study|Death|10|||
38048200|NCT03840200|69736186|FG000|Overall Study|Reason Not Specified|2|||
38048201|NCT03840200|69736187|FG001|Overall Study|Reason Not Specified|2|||
38048202|NCT03840200|69736188|FG002|Overall Study|Reason Not Specified|1|||
38048203|NCT03840200|69736189|FG003|Overall Study|Reason Not Specified|15|||
38048204|NCT03840200|69736186|FG000|Overall Study|Physician Decision|0|||
38048205|NCT03840200|69736187|FG001|Overall Study|Physician Decision|0|||
38048206|NCT03840200|69736188|FG002|Overall Study|Physician Decision|0|||
38048207|NCT03840200|69736189|FG003|Overall Study|Physician Decision|2|||
38048208|NCT03840200|69736186|FG000|Overall Study|Progressive Disease|0|||
38048209|NCT03840200|69736187|FG001|Overall Study|Progressive Disease|0|||
38048210|NCT03840200|69736188|FG002|Overall Study|Progressive Disease|0|||
38048211|NCT03840200|69736189|FG003|Overall Study|Progressive Disease|1|||
38048212|NCT03840200|69736186|FG000|Overall Study|Withdrawal by Subject|0|||
38048213|NCT03840200|69736187|FG001|Overall Study|Withdrawal by Subject|1|||
38048214|NCT03840200|69736188|FG002|Overall Study|Withdrawal by Subject|0|||
38048215|NCT03840200|69736189|FG003|Overall Study|Withdrawal by Subject|2|||
38048216|NCT03518086|69736211|FG000|Overall Study|Adverse Event|23|||
38048217|NCT03518086|69736212|FG001|Overall Study|Adverse Event|15|||
38048218|NCT03518086|69736213|FG002|Overall Study|Adverse Event|0|||
38048219|NCT03518086|69736214|FG003|Overall Study|Adverse Event|0|||
38048220|NCT03518086|69736211|FG000|Overall Study|Withdrawal by Subject|8|||
38048221|NCT03518086|69736212|FG001|Overall Study|Withdrawal by Subject|5|||
38048222|NCT03518086|69736213|FG002|Overall Study|Withdrawal by Subject|0|||
38048223|NCT03518086|69736214|FG003|Overall Study|Withdrawal by Subject|0|||
38048224|NCT03518086|69736211|FG000|Overall Study|Lack of Efficacy|5|||
38048225|NCT03518086|69736212|FG001|Overall Study|Lack of Efficacy|5|||
38048226|NCT03518086|69736213|FG002|Overall Study|Lack of Efficacy|0|||
38048227|NCT03518086|69736214|FG003|Overall Study|Lack of Efficacy|0|||
38048228|NCT03518086|69736211|FG000|Overall Study|Protocol Violation|1|||
38048229|NCT03518086|69736212|FG001|Overall Study|Protocol Violation|5|||
38048230|NCT03518086|69736213|FG002|Overall Study|Protocol Violation|0|||
38048231|NCT03518086|69736214|FG003|Overall Study|Protocol Violation|0|||
38048232|NCT03518086|69736211|FG000|Overall Study|Lost to Follow-up|0|||
38048233|NCT03518086|69736212|FG001|Overall Study|Lost to Follow-up|3|||
38048234|NCT03518086|69736213|FG002|Overall Study|Lost to Follow-up|0|||
38048235|NCT03518086|69736214|FG003|Overall Study|Lost to Follow-up|0|||
38048236|NCT03518086|69736211|FG000|Overall Study|Insufficient Diary Data|0|||
38048237|NCT03518086|69736212|FG001|Overall Study|Insufficient Diary Data|2|||
38048238|NCT03518086|69736213|FG002|Overall Study|Insufficient Diary Data|0|||
38048239|NCT03518086|69736214|FG003|Overall Study|Insufficient Diary Data|0|||
38048240|NCT03518086|69736211|FG000|Overall Study|Non- compliance to Protocol|0|||
38048241|NCT03518086|69736212|FG001|Overall Study|Non- compliance to Protocol|1|||
37953753|NCT00485134|69640653|FG001|Overall Study|Change in health status|1|||
37953754|NCT00485134|69640654|FG002|Overall Study|Change in health status|2|||
37953755|NCT00485134|69640655|FG003|Overall Study|Change in health status|1|||
37953756|NCT00485134|69640656|FG004|Overall Study|Change in health status|0|||
37953757|NCT00485134|69640657|FG005|Overall Study|Change in health status|1|||
37953758|NCT00485134|69640658|FG006|Overall Study|Change in health status|0|||
37953759|NCT00485134|69640659|FG007|Overall Study|Change in health status|0|||
38048242|NCT03518086|69736213|FG002|Overall Study|Non- compliance to Protocol|0|||
38048243|NCT03518086|69736214|FG003|Overall Study|Non- compliance to Protocol|0|||
38048244|NCT03518086|69736211|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
38048245|NCT03518086|69736212|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
38048246|NCT03518086|69736213|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
38048247|NCT03518086|69736214|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
37953760|NCT00485134|69640652|FG000|Overall Study|Withdrew for adverse event|0|||
38048248|NCT03518086|69736211|FG000|Overall Study|Site Terminated by Sponsor|0|||
38048249|NCT03518086|69736212|FG001|Overall Study|Site Terminated by Sponsor|1|||
38048250|NCT03518086|69736213|FG002|Overall Study|Site Terminated by Sponsor|0|||
38048251|NCT03518086|69736214|FG003|Overall Study|Site Terminated by Sponsor|0|||
37953761|NCT00485134|69640653|FG001|Overall Study|Withdrew for adverse event|0|||
37953762|NCT00485134|69640654|FG002|Overall Study|Withdrew for adverse event|1|||
38048252|NCT03334851|69736234|FG000|Overall Study|Other|0|||
38048253|NCT03334851|69736235|FG001|Overall Study|Other|0|||
38048254|NCT03334851|69736236|FG002|Overall Study|Other|0|||
38048255|NCT03334851|69736237|FG003|Overall Study|Other|0|||
38048256|NCT03334851|69736238|FG004|Overall Study|Other|0|||
38048257|NCT03334851|69736239|FG005|Overall Study|Other|0|||
38048258|NCT03334851|69736240|FG006|Overall Study|Other|0|||
38048259|NCT03334851|69736241|FG007|Overall Study|Other|1|||
38048260|NCT03334851|69736242|FG008|Overall Study|Other|0|||
38048261|NCT03334851|69736243|FG009|Overall Study|Other|0|||
38048262|NCT03334851|69736244|FG010|Overall Study|Other|0|||
38048263|NCT03334851|69736245|FG011|Overall Study|Other|0|||
38048264|NCT03334851|69736246|FG012|Overall Study|Other|0|||
38048265|NCT03334851|69736234|FG000|Overall Study|Adverse Event|0|||
38048266|NCT03334851|69736235|FG001|Overall Study|Adverse Event|0|||
38048267|NCT03334851|69736236|FG002|Overall Study|Adverse Event|0|||
38048268|NCT03334851|69736237|FG003|Overall Study|Adverse Event|0|||
38048269|NCT03334851|69736238|FG004|Overall Study|Adverse Event|0|||
38048270|NCT03334851|69736239|FG005|Overall Study|Adverse Event|0|||
38048271|NCT03334851|69736240|FG006|Overall Study|Adverse Event|0|||
38048272|NCT03334851|69736241|FG007|Overall Study|Adverse Event|1|||
38048273|NCT03334851|69736242|FG008|Overall Study|Adverse Event|0|||
38048274|NCT03334851|69736243|FG009|Overall Study|Adverse Event|0|||
38048275|NCT03334851|69736244|FG010|Overall Study|Adverse Event|0|||
38048276|NCT03334851|69736245|FG011|Overall Study|Adverse Event|0|||
38048277|NCT03334851|69736246|FG012|Overall Study|Adverse Event|0|||
38048278|NCT03334851|69736234|FG000|Overall Study|Withdrawal by Subject|0|||
38048279|NCT03334851|69736235|FG001|Overall Study|Withdrawal by Subject|0|||
38048280|NCT03334851|69736236|FG002|Overall Study|Withdrawal by Subject|0|||
38048281|NCT03334851|69736237|FG003|Overall Study|Withdrawal by Subject|0|||
38048282|NCT03334851|69736238|FG004|Overall Study|Withdrawal by Subject|0|||
38048283|NCT03334851|69736239|FG005|Overall Study|Withdrawal by Subject|0|||
38048284|NCT03334851|69736240|FG006|Overall Study|Withdrawal by Subject|0|||
38048285|NCT03334851|69736241|FG007|Overall Study|Withdrawal by Subject|0|||
38048286|NCT03334851|69736242|FG008|Overall Study|Withdrawal by Subject|0|||
38048287|NCT03334851|69736243|FG009|Overall Study|Withdrawal by Subject|0|||
38048288|NCT03334851|69736244|FG010|Overall Study|Withdrawal by Subject|1|||
38048289|NCT03334851|69736245|FG011|Overall Study|Withdrawal by Subject|0|||
38048290|NCT03334851|69736246|FG012|Overall Study|Withdrawal by Subject|1|||
38048291|NCT03334851|69736234|FG000|Overall Study|Lost to Follow-up|0|||
38048292|NCT03334851|69736235|FG001|Overall Study|Lost to Follow-up|0|||
38048293|NCT03334851|69736236|FG002|Overall Study|Lost to Follow-up|0|||
38048294|NCT03334851|69736237|FG003|Overall Study|Lost to Follow-up|0|||
38048295|NCT03334851|69736238|FG004|Overall Study|Lost to Follow-up|0|||
38048296|NCT03334851|69736239|FG005|Overall Study|Lost to Follow-up|0|||
38048297|NCT03334851|69736240|FG006|Overall Study|Lost to Follow-up|0|||
38048298|NCT03334851|69736241|FG007|Overall Study|Lost to Follow-up|0|||
38048299|NCT03334851|69736242|FG008|Overall Study|Lost to Follow-up|0|||
38048300|NCT03334851|69736243|FG009|Overall Study|Lost to Follow-up|0|||
38048301|NCT03334851|69736244|FG010|Overall Study|Lost to Follow-up|2|||
38048302|NCT03334851|69736245|FG011|Overall Study|Lost to Follow-up|1|||
38048303|NCT03334851|69736246|FG012|Overall Study|Lost to Follow-up|0|||
38048304|NCT02967692|69736293|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|3|||
38048305|NCT02967692|69736294|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|1|||
38048306|NCT02967692|69736295|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|86|||
38048307|NCT02967692|69736296|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|82|||
38048308|NCT02967692|69736293|FG000|Overall Study|Progressive disease|3|||
38048309|NCT02967692|69736294|FG001|Overall Study|Progressive disease|15|||
38048310|NCT02967692|69736295|FG002|Overall Study|Progressive disease|99|||
38048311|NCT02967692|69736296|FG003|Overall Study|Progressive disease|128|||
38048312|NCT02967692|69736293|FG000|Overall Study|Subject/guardian decision|1|||
38048313|NCT02967692|69736294|FG001|Overall Study|Subject/guardian decision|1|||
38048314|NCT02967692|69736295|FG002|Overall Study|Subject/guardian decision|6|||
38048315|NCT02967692|69736296|FG003|Overall Study|Subject/guardian decision|13|||
38048316|NCT02967692|69736293|FG000|Overall Study|Death|0|||
38048317|NCT02967692|69736294|FG001|Overall Study|Death|1|||
38048318|NCT02967692|69736295|FG002|Overall Study|Death|10|||
38048319|NCT02967692|69736296|FG003|Overall Study|Death|9|||
38048320|NCT02967692|69736293|FG000|Overall Study|Protocol deviation|1|||
38048321|NCT02967692|69736294|FG001|Overall Study|Protocol deviation|0|||
38048322|NCT02967692|69736295|FG002|Overall Study|Protocol deviation|1|||
38048323|NCT02967692|69736296|FG003|Overall Study|Protocol deviation|1|||
38048324|NCT02967692|69736293|FG000|Overall Study|Lost to Follow-up|0|||
38048325|NCT02967692|69736294|FG001|Overall Study|Lost to Follow-up|0|||
38048326|NCT02967692|69736295|FG002|Overall Study|Lost to Follow-up|1|||
38048327|NCT02967692|69736296|FG003|Overall Study|Lost to Follow-up|0|||
38048328|NCT02967692|69736293|FG000|Overall Study|Physician Decision|0|||
38048329|NCT02967692|69736294|FG001|Overall Study|Physician Decision|0|||
38048330|NCT02967692|69736295|FG002|Overall Study|Physician Decision|13|||
38048331|NCT02967692|69736296|FG003|Overall Study|Physician Decision|9|||
38048332|NCT02967692|69736293|FG000|Overall Study|Adverse Event|1|||
38048333|NCT02967692|69736294|FG001|Overall Study|Adverse Event|9|||
38048334|NCT02967692|69736295|FG002|Overall Study|Adverse Event|51|||
38048335|NCT02967692|69736296|FG003|Overall Study|Adverse Event|23|||
38048336|NCT02744612|69736333|FG000|Overall Study|Withdrawal by Subject|0|||
38048337|NCT02744612|69736334|FG001|Overall Study|Withdrawal by Subject|2|||
38048338|NCT02717507|69736342|FG000|Overall Study|Lost to Follow-up|5|||
38048339|NCT02717507|69736343|FG001|Overall Study|Lost to Follow-up|8|||
38048340|NCT02717507|69736342|FG000|Overall Study|Pregnancy|1|||
38048341|NCT02717507|69736343|FG001|Overall Study|Pregnancy|1|||
38048342|NCT02717507|69736342|FG000|Overall Study|Protocol Violation|2|||
38048343|NCT02717507|69736343|FG001|Overall Study|Protocol Violation|2|||
38048344|NCT02717507|69736342|FG000|Overall Study|Withdrawal by Subject|20|||
38048345|NCT02717507|69736343|FG001|Overall Study|Withdrawal by Subject|20|||
38048346|NCT02717507|69736342|FG000|Overall Study|Relapse|1|||
38048347|NCT02717507|69736343|FG001|Overall Study|Relapse|1|||
38048348|NCT02717507|69736342|FG000|Overall Study|Cardiac Event|2|||
38048349|NCT02717507|69736343|FG001|Overall Study|Cardiac Event|6|||
38048350|NCT02576509|69736361|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
38048351|NCT02576509|69736362|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
38048352|NCT02576509|69736361|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
38048353|NCT02576509|69736362|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
38048354|NCT02576509|69736361|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
38048355|NCT02576509|69736362|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
38048356|NCT02576509|69736361|FG000|Treatment Period|Disease progression|245|||
38048357|NCT02576509|69736362|FG001|Treatment Period|Disease progression|240|||
38048358|NCT02576509|69736361|FG000|Treatment Period|Study drug toxicity|32|||
38048359|NCT02576509|69736362|FG001|Treatment Period|Study drug toxicity|41|||
38048360|NCT02576509|69736361|FG000|Treatment Period|Death|1|||
38048361|NCT02576509|69736362|FG001|Treatment Period|Death|1|||
38048362|NCT02576509|69736361|FG000|Treatment Period|Adverse event unrelated to study drug|37|||
38048363|NCT02576509|69736362|FG001|Treatment Period|Adverse event unrelated to study drug|40|||
38048364|NCT02576509|69736361|FG000|Treatment Period|Participant request to stop treatment|8|||
38048365|NCT02576509|69736362|FG001|Treatment Period|Participant request to stop treatment|17|||
38048366|NCT02576509|69736361|FG000|Treatment Period|Participant withdrew consent|2|||
38048367|NCT02576509|69736362|FG001|Treatment Period|Participant withdrew consent|7|||
38048368|NCT02576509|69736361|FG000|Treatment Period|Lost to Follow-up|0|||
38048369|NCT02576509|69736362|FG001|Treatment Period|Lost to Follow-up|1|||
38048370|NCT02576509|69736361|FG000|Treatment Period|Maximum clinical benefit|1|||
38048371|NCT02576509|69736362|FG001|Treatment Period|Maximum clinical benefit|0|||
38048372|NCT02576509|69736361|FG000|Treatment Period|Poor/non-compliance|0|||
38048373|NCT02576509|69736362|FG001|Treatment Period|Poor/non-compliance|1|||
38048374|NCT02576509|69736361|FG000|Treatment Period|Participant no longer meets criteria|1|||
38048375|NCT02576509|69736362|FG001|Treatment Period|Participant no longer meets criteria|0|||
38048376|NCT02576509|69736361|FG000|Treatment Period|Other reason|2|||
38048377|NCT02576509|69736362|FG001|Treatment Period|Other reason|7|||
38048378|NCT02576509|69736361|FG000|Follow-up Period|Death|41|||
38048379|NCT02576509|69736362|FG001|Follow-up Period|Death|35|||
38048380|NCT02576509|69736361|FG000|Follow-up Period|Participant withdrew consent|7|||
38048381|NCT02576509|69736362|FG001|Follow-up Period|Participant withdrew consent|14|||
38048382|NCT02576509|69736361|FG000|Follow-up Period|Lost to Follow-up|0|||
38048383|NCT02576509|69736362|FG001|Follow-up Period|Lost to Follow-up|1|||
38048384|NCT02576509|69736361|FG000|Follow-up Period|Other reason|1|||
38048385|NCT02576509|69736362|FG001|Follow-up Period|Other reason|2|||
38048386|NCT02470585|69736375|FG000|Overall Study|Death|82|||
38048387|NCT02470585|69736376|FG001|Overall Study|Death|87|||
38048388|NCT02470585|69736377|FG002|Overall Study|Death|86|||
38048389|NCT02470585|69736375|FG000|Overall Study|Withdrawal by Subject|19|||
38048390|NCT02470585|69736376|FG001|Overall Study|Withdrawal by Subject|21|||
38048391|NCT02470585|69736377|FG002|Overall Study|Withdrawal by Subject|29|||
38048392|NCT02470585|69736375|FG000|Overall Study|Lost to Follow-up|2|||
38048393|NCT02470585|69736376|FG001|Overall Study|Lost to Follow-up|5|||
38048394|NCT02470585|69736377|FG002|Overall Study|Lost to Follow-up|4|||
38048395|NCT02470585|69736375|FG000|Overall Study|Other|4|||
38048396|NCT02470585|69736376|FG001|Overall Study|Other|4|||
38048397|NCT02470585|69736377|FG002|Overall Study|Other|6|||
38048398|NCT02199080|69736419|FG000|Overall Study|Protocol Violation|12|||
38048399|NCT02173379|69736427|FG000|Overall Study|Lost to Follow-up|89|||
38048400|NCT02173379|69736428|FG001|Overall Study|Lost to Follow-up|81|||
38048401|NCT02173379|69736427|FG000|Overall Study|Withdrawal by Subject|24|||
38048402|NCT02173379|69736428|FG001|Overall Study|Withdrawal by Subject|29|||
38048403|NCT02173379|69736427|FG000|Overall Study|Physician Decision|8|||
38048404|NCT02173379|69736428|FG001|Overall Study|Physician Decision|8|||
38048405|NCT02173379|69736427|FG000|Overall Study|Death|75|||
38048406|NCT02173379|69736428|FG001|Overall Study|Death|72|||
38048407|NCT02173379|69736427|FG000|Overall Study|Other Reason|1|||
38048408|NCT02173379|69736428|FG001|Overall Study|Other Reason|0|||
38048409|NCT02134925|69736439|FG000|Overall Study|Withdrawal by Subject|1|||
38048410|NCT02134925|69736440|FG001|Overall Study|Withdrawal by Subject|0|||
38048411|NCT02134925|69736439|FG000|Overall Study|Cancel|1|||
38048412|NCT02134925|69736440|FG001|Overall Study|Cancel|6|||
38048413|NCT02032823|69736448|FG000|Overall Study|Death|75|||
38048414|NCT02032823|69736449|FG001|Overall Study|Death|109|||
38048415|NCT02032823|69736448|FG000|Overall Study|Lost to Follow-up|18|||
38048416|NCT02032823|69736449|FG001|Overall Study|Lost to Follow-up|17|||
38048417|NCT02032823|69736448|FG000|Overall Study|Withdrawal by Subject|70|||
38048418|NCT02032823|69736449|FG001|Overall Study|Withdrawal by Subject|53|||
38048419|NCT02032823|69736448|FG000|Overall Study|Ongoing study at data cut-off|755|||
38048420|NCT02032823|69736449|FG001|Overall Study|Ongoing study at data cut-off|731|||
38048421|NCT02032823|69736448|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
38048422|NCT02032823|69736449|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
38048423|NCT01849874|69736457|FG000|Overall Study|Death|89|||
38048424|NCT01849874|69736458|FG001|Overall Study|Death|42|||
38048425|NCT01849874|69736457|FG000|Overall Study|Withdrawal by Subject|17|||
38048426|NCT01849874|69736458|FG001|Overall Study|Withdrawal by Subject|16|||
38048427|NCT01849874|69736457|FG000|Overall Study|Lost to Follow-up|3|||
38048428|NCT01849874|69736458|FG001|Overall Study|Lost to Follow-up|2|||
38048429|NCT01849874|69736457|FG000|Overall Study|Study Termination By Sponsor|93|||
38048430|NCT01849874|69736458|FG001|Overall Study|Study Termination By Sponsor|48|||
38048431|NCT01849874|69736457|FG000|Overall Study|Completed as per protocol amendment 6|3|||
38048432|NCT01849874|69736458|FG001|Overall Study|Completed as per protocol amendment 6|0|||
38048433|NCT01849874|69736457|FG000|Overall Study|Physician Decision|7|||
38048434|NCT01849874|69736458|FG001|Overall Study|Physician Decision|1|||
38048435|NCT01849874|69736457|FG000|Overall Study|Other|16|||
38048436|NCT01849874|69736458|FG001|Overall Study|Other|4|||
38048437|NCT01771107|69736471|FG000|Overall Study|Adverse Event|1|||
38048438|NCT01771107|69736472|FG001|Overall Study|Adverse Event|3|||
38048439|NCT01771107|69736471|FG000|Overall Study|Withdrawal by Subject|0|||
38048440|NCT01771107|69736472|FG001|Overall Study|Withdrawal by Subject|2|||
38048441|NCT01771107|69736471|FG000|Overall Study|Lost to Follow-up|0|||
38048442|NCT01771107|69736472|FG001|Overall Study|Lost to Follow-up|1|||
38048443|NCT01771107|69736471|FG000|Overall Study|participant moved|0|||
38048444|NCT01771107|69736472|FG001|Overall Study|participant moved|1|||
38048445|NCT01771107|69736471|FG000|Overall Study|Other|0|||
38048446|NCT01771107|69736472|FG001|Overall Study|Other|1|||
38048447|NCT01375114|69736483|FG000|Overall Study|Lost to Follow-up|1|||
38048448|NCT01375114|69736484|FG001|Overall Study|Lost to Follow-up|0|||
38048449|NCT01375114|69736485|FG002|Overall Study|Lost to Follow-up|1|||
38048450|NCT01375114|69736483|FG000|Overall Study|Disease Progression|3|||
38048451|NCT01375114|69736484|FG001|Overall Study|Disease Progression|2|||
38048452|NCT01375114|69736485|FG002|Overall Study|Disease Progression|2|||
38048453|NCT01375114|69736483|FG000|Overall Study|Patient Changed Mind|0|||
38048454|NCT01375114|69736484|FG001|Overall Study|Patient Changed Mind|0|||
38048455|NCT01375114|69736485|FG002|Overall Study|Patient Changed Mind|2|||
38048456|NCT01375114|69736483|FG000|Overall Study|Pruritus|0|||
38048457|NCT01375114|69736484|FG001|Overall Study|Pruritus|0|||
38048458|NCT01375114|69736485|FG002|Overall Study|Pruritus|1|||
38048459|NCT01375114|69736483|FG000|Overall Study|Restlessness|0|||
38048460|NCT01375114|69736484|FG001|Overall Study|Restlessness|0|||
38048461|NCT01375114|69736485|FG002|Overall Study|Restlessness|1|||
38048462|NCT01375114|69736483|FG000|Overall Study|Diarrhea|0|||
38048463|NCT01375114|69736484|FG001|Overall Study|Diarrhea|0|||
38048464|NCT01375114|69736485|FG002|Overall Study|Diarrhea|1|||
38048465|NCT01375114|69736483|FG000|Overall Study|Pt enrolled in another clinical trial|0|||
38048466|NCT01375114|69736484|FG001|Overall Study|Pt enrolled in another clinical trial|1|||
38048467|NCT01375114|69736485|FG002|Overall Study|Pt enrolled in another clinical trial|0|||
38048468|NCT01375114|69736483|FG000|Overall Study|Nausea|0|||
38048469|NCT01375114|69736484|FG001|Overall Study|Nausea|1|||
38048470|NCT01375114|69736485|FG002|Overall Study|Nausea|0|||
38048471|NCT01375114|69736483|FG000|Overall Study|Increased AST/ALT|0|||
38048472|NCT01375114|69736484|FG001|Overall Study|Increased AST/ALT|1|||
38048473|NCT01375114|69736485|FG002|Overall Study|Increased AST/ALT|0|||
38048474|NCT01375114|69736483|FG000|Overall Study|Vaginal Hemorrhage|0|||
38048475|NCT01375114|69736484|FG001|Overall Study|Vaginal Hemorrhage|1|||
38048476|NCT01375114|69736485|FG002|Overall Study|Vaginal Hemorrhage|0|||
37861765|NCT00931801|69545455|FG001|Overall Study|Withdrawal by Subject|0|||
37861766|NCT00931801|69545456|FG002|Overall Study|Withdrawal by Subject|0|||
37861767|NCT00931801|69545454|FG000|Overall Study|Confirmed Virologic Failure|0|||
37861768|NCT00931801|69545455|FG001|Overall Study|Confirmed Virologic Failure|0|||
38048477|NCT01375114|69736483|FG000|Overall Study|Family problem|0|||
38048478|NCT01375114|69736484|FG001|Overall Study|Family problem|1|||
38048479|NCT01375114|69736485|FG002|Overall Study|Family problem|0|||
38048480|NCT01375114|69736483|FG000|Overall Study|Protocol Violation|2|||
38048481|NCT01375114|69736484|FG001|Overall Study|Protocol Violation|0|||
38048482|NCT01375114|69736485|FG002|Overall Study|Protocol Violation|0|||
38048483|NCT01009645|69736499|FG000|Overall Study|Lost to Follow-up|2|||
38048484|NCT01009645|69736500|FG001|Overall Study|Lost to Follow-up|8|||
38048485|NCT01009645|69736501|FG002|Overall Study|Lost to Follow-up|4|||
37861769|NCT00931801|69545456|FG002|Overall Study|Confirmed Virologic Failure|3|||
37861770|NCT00931723|69545470|FG000|Overall Study|Withdrawal by Subject|11|||
37861771|NCT00931723|69545471|FG001|Overall Study|Withdrawal by Subject|13|||
37861772|NCT00931723|69545470|FG000|Overall Study|Adverse Event|6|||
37861773|NCT00931723|69545471|FG001|Overall Study|Adverse Event|13|||
37861774|NCT00931723|69545470|FG000|Overall Study|Lithium found in blood|0|||
37861775|NCT00931723|69545471|FG001|Overall Study|Lithium found in blood|1|||
37861776|NCT00931723|69545470|FG000|Overall Study|Condition under investigation worsened|1|||
37861777|NCT00931723|69545471|FG001|Overall Study|Condition under investigation worsened|2|||
37861778|NCT00931723|69545470|FG000|Overall Study|Lost to Follow-up|1|||
37861779|NCT00931723|69545471|FG001|Overall Study|Lost to Follow-up|2|||
37861780|NCT00931723|69545470|FG000|Overall Study|Study-specific discontinuation criteria|1|||
37861781|NCT00931723|69545471|FG001|Overall Study|Study-specific discontinuation criteria|1|||
37861782|NCT00931723|69545470|FG000|Overall Study|Severe non-compliance to protocol|2|||
37861783|NCT00931723|69545471|FG001|Overall Study|Severe non-compliance to protocol|0|||
37861784|NCT00931723|69545470|FG000|Overall Study|Safety reasons|0|||
37861785|NCT00931723|69545471|FG001|Overall Study|Safety reasons|1|||
37861786|NCT00931723|69545470|FG000|Overall Study|Took prohibited concomitant medication|0|||
37861787|NCT00931723|69545471|FG001|Overall Study|Took prohibited concomitant medication|1|||
37861788|NCT00931723|69545470|FG000|Overall Study|Lack or insufficient theraputic response|2|||
37861789|NCT00931723|69545471|FG001|Overall Study|Lack or insufficient theraputic response|5|||
37861790|NCT00931723|69545470|FG000|Overall Study|Sponsor decision|1|||
37861791|NCT00931723|69545471|FG001|Overall Study|Sponsor decision|0|||
37861792|NCT00931723|69545470|FG000|Overall Study|Late hospital discharge|1|||
37861793|NCT00931723|69545471|FG001|Overall Study|Late hospital discharge|0|||
37861794|NCT00931411|69545479|FG000|First Intervention - 42 Days|Adverse Event|2|||
37861795|NCT00931411|69545480|FG001|First Intervention - 42 Days|Adverse Event|3|||
37861796|NCT00931411|69545479|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
37861797|NCT00931411|69545480|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
37861798|NCT00931411|69545479|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
37861799|NCT00931411|69545480|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
37861800|NCT00931255|69545492|FG000|Overall Study|Follow up biopsy not done|2|||
37861801|NCT00931255|69545493|FG001|Overall Study|Follow up biopsy not done|3|||
37861802|NCT00930553|69545499|FG000|Overall Study|Adverse Event|1|||
37861803|NCT00930553|69545499|FG000|Overall Study|Lack of Efficacy|7|||
37861804|NCT00930553|69545499|FG000|Overall Study|Physician Decision|39|||
37861805|NCT00930553|69545499|FG000|Overall Study|Protocol Violation|1|||
37861806|NCT00930553|69545499|FG000|Overall Study|Pregnancy|1|||
37861807|NCT00930553|69545499|FG000|Overall Study|Withdrawal by Subject|88|||
37861808|NCT00930553|69545499|FG000|Overall Study|Lost to Follow-up|25|||
38048486|NCT01009645|69736502|FG003|Overall Study|Lost to Follow-up|5|||
38048487|NCT00950846|69736512|FG000|Overall Study|Death|6|||
38048488|NCT00950846|69736512|FG000|Overall Study|Lost to Follow-up|3|||
38048489|NCT00950846|69736512|FG000|Overall Study|Possible undiagnosed AML at study entry|1|||
38048490|NCT03419403|69736523|FG000|Overall Study|Withdrawal by Subject|5|||
38048491|NCT03419403|69736524|FG001|Overall Study|Withdrawal by Subject|2|||
38048492|NCT03419403|69736525|FG002|Overall Study|Withdrawal by Subject|5|||
38048493|NCT03419403|69736526|FG003|Overall Study|Withdrawal by Subject|1|||
38048494|NCT03419403|69736523|FG000|Overall Study|Progressive disease (per protocol)|0|||
38048495|NCT03419403|69736524|FG001|Overall Study|Progressive disease (per protocol)|2|||
38048496|NCT03419403|69736525|FG002|Overall Study|Progressive disease (per protocol)|2|||
38048497|NCT03419403|69736526|FG003|Overall Study|Progressive disease (per protocol)|0|||
38048498|NCT03419403|69736523|FG000|Overall Study|Other, not specified|6|||
38048499|NCT03419403|69736524|FG001|Overall Study|Other, not specified|4|||
38048500|NCT03419403|69736525|FG002|Overall Study|Other, not specified|5|||
38048501|NCT03419403|69736526|FG003|Overall Study|Other, not specified|1|||
38048502|NCT03419403|69736523|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
38048503|NCT03419403|69736524|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
38048504|NCT03419403|69736525|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
38048505|NCT03419403|69736526|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
38048506|NCT03447249|69736536|FG000|Overall Study|Adverse Event|1|||
38048507|NCT03447249|69736537|FG001|Overall Study|Adverse Event|0|||
38048508|NCT03447249|69736536|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
37861809|NCT00930553|69545499|FG000|Overall Study|Death|9|||
37861810|NCT00930553|69545499|FG000|Overall Study|Study terminated by sponsor|24|||
37861811|NCT00930553|69545499|FG000|Overall Study|Other than specified above|28|||
37861812|NCT00929695|69545523|FG000|Overall Study|Death|2|||
37861813|NCT00929695|69545524|FG001|Overall Study|Death|1|||
37861814|NCT00929695|69545523|FG000|Overall Study|Withdrawal by Subject|0|||
37861815|NCT00929695|69545524|FG001|Overall Study|Withdrawal by Subject|2|||
37861816|NCT00929695|69545523|FG000|Overall Study|discharge home|4|||
37861817|NCT00929695|69545524|FG001|Overall Study|discharge home|3|||
38048509|NCT03447249|69736537|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
38048510|NCT03447249|69736536|FG000|Overall Study|Other|3|||
38048511|NCT03447249|69736537|FG001|Overall Study|Other|0|||
38048512|NCT03418545|69736547|FG000|Overall Study|Withdrawal by Participant|2|||
38048513|NCT03418545|69736548|FG001|Overall Study|Withdrawal by Participant|4|||
38048514|NCT03418545|69736547|FG000|Overall Study|Lost to Follow-up|3|||
38048515|NCT03418545|69736548|FG001|Overall Study|Lost to Follow-up|5|||
38048516|NCT03418545|69736547|FG000|Overall Study|Reason Not Specified|0|||
38048517|NCT03418545|69736548|FG001|Overall Study|Reason Not Specified|1|||
38048518|NCT03418545|69736547|FG000|Overall Study|Missing Completion Status|0|||
38048519|NCT03418545|69736548|FG001|Overall Study|Missing Completion Status|1|||
38048520|NCT03446781|69736559|FG000|Overall Study|Lost to Follow-up|11|||
38048521|NCT03446781|69736560|FG001|Overall Study|Lost to Follow-up|5|||
38048522|NCT03446781|69736559|FG000|Overall Study|Withdrawal by Subject|9|||
38048523|NCT03446781|69736560|FG001|Overall Study|Withdrawal by Subject|7|||
38048524|NCT03446781|69736559|FG000|Overall Study|Adverse Event|8|||
38048525|NCT03446781|69736560|FG001|Overall Study|Adverse Event|2|||
38048526|NCT03446781|69736559|FG000|Overall Study|Protocol Violation|0|||
38048527|NCT03446781|69736560|FG001|Overall Study|Protocol Violation|3|||
38048528|NCT03445065|69736592|FG000|Overall Study|Withdrawal by Subject|3|||
38048529|NCT03445065|69736593|FG001|Overall Study|Withdrawal by Subject|6|||
38048530|NCT03445065|69736594|FG002|Overall Study|Withdrawal by Subject|2|||
38048531|NCT03445065|69736595|FG003|Overall Study|Withdrawal by Subject|2|||
38048532|NCT03445065|69736592|FG000|Overall Study|Other|4|||
38048533|NCT03445065|69736593|FG001|Overall Study|Other|3|||
38048534|NCT03445065|69736594|FG002|Overall Study|Other|3|||
38048535|NCT03445065|69736595|FG003|Overall Study|Other|1|||
38048536|NCT01224106|69736620|FG000|Double-Blind Treatment Phase|Death|3|||
38048537|NCT01224106|69736621|FG001|Double-Blind Treatment Phase|Death|0|||
38048538|NCT01224106|69736622|FG002|Double-Blind Treatment Phase|Death|0|||
38048539|NCT01224106|69736623|FG003|Double-Blind Treatment Phase|Death|0|||
38048540|NCT01224106|69736624|FG004|Double-Blind Treatment Phase|Death|0|||
38048541|NCT01224106|69736620|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
38048542|NCT01224106|69736621|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
38048543|NCT01224106|69736622|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
38048544|NCT01224106|69736623|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
38048545|NCT01224106|69736624|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
38048546|NCT01224106|69736620|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
38048547|NCT01224106|69736621|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
38048548|NCT01224106|69736622|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
38048549|NCT01224106|69736623|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
38048550|NCT01224106|69736624|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
38048551|NCT01224106|69736620|FG000|Double-Blind Treatment Phase|Other|0|||
38048552|NCT01224106|69736621|FG001|Double-Blind Treatment Phase|Other|0|||
38048553|NCT01224106|69736622|FG002|Double-Blind Treatment Phase|Other|1|||
38048554|NCT01224106|69736623|FG003|Double-Blind Treatment Phase|Other|0|||
38048555|NCT01224106|69736624|FG004|Double-Blind Treatment Phase|Other|0|||
38048556|NCT01224106|69736620|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
38048557|NCT01224106|69736621|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
38048558|NCT01224106|69736622|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
38048559|NCT01224106|69736623|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
38048560|NCT01224106|69736624|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
38048561|NCT01224106|69736620|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
38048562|NCT01224106|69736621|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
38048563|NCT01224106|69736622|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
38048564|NCT01224106|69736623|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
38048565|NCT01224106|69736624|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
37953763|NCT00485134|69640655|FG003|Overall Study|Withdrew for adverse event|0|||
37953764|NCT00485134|69640656|FG004|Overall Study|Withdrew for adverse event|0|||
37953765|NCT00485134|69640657|FG005|Overall Study|Withdrew for adverse event|0|||
37953766|NCT00485134|69640658|FG006|Overall Study|Withdrew for adverse event|0|||
37953767|NCT00485134|69640659|FG007|Overall Study|Withdrew for adverse event|0|||
37953768|NCT00485134|69640652|FG000|Overall Study|Positive drug test|0|||
37953769|NCT00485134|69640653|FG001|Overall Study|Positive drug test|0|||
37953770|NCT00485134|69640654|FG002|Overall Study|Positive drug test|0|||
37953771|NCT00485134|69640655|FG003|Overall Study|Positive drug test|0|||
38048566|NCT01224106|69736620|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
38048567|NCT01224106|69736621|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
38048568|NCT01224106|69736622|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
38048569|NCT01224106|69736623|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
38048570|NCT01224106|69736624|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
38048571|NCT01224106|69736620|FG000|Open-Label Extension (OLE) Phase|Death|0|||
38048572|NCT01224106|69736621|FG001|Open-Label Extension (OLE) Phase|Death|0|||
38048573|NCT01224106|69736622|FG002|Open-Label Extension (OLE) Phase|Death|0|||
37953772|NCT00485134|69640656|FG004|Overall Study|Positive drug test|2|||
37953773|NCT00485134|69640657|FG005|Overall Study|Positive drug test|1|||
37953774|NCT00485134|69640658|FG006|Overall Study|Positive drug test|0|||
37953775|NCT00485134|69640659|FG007|Overall Study|Positive drug test|0|||
37953776|NCT00485134|69640652|FG000|Overall Study|Non-compliance|0|||
37953777|NCT00485134|69640653|FG001|Overall Study|Non-compliance|0|||
37953778|NCT00485134|69640654|FG002|Overall Study|Non-compliance|0|||
37953779|NCT00485134|69640655|FG003|Overall Study|Non-compliance|0|||
37953780|NCT00485134|69640656|FG004|Overall Study|Non-compliance|1|||
37953781|NCT00485134|69640657|FG005|Overall Study|Non-compliance|2|||
37953782|NCT00485134|69640658|FG006|Overall Study|Non-compliance|2|||
37953783|NCT00485134|69640659|FG007|Overall Study|Non-compliance|0|||
37953784|NCT00485134|69640652|FG000|Overall Study|Unable to comply with study schedule|0|||
37953785|NCT00485134|69640653|FG001|Overall Study|Unable to comply with study schedule|0|||
37953786|NCT00485134|69640654|FG002|Overall Study|Unable to comply with study schedule|0|||
37953787|NCT00485134|69640655|FG003|Overall Study|Unable to comply with study schedule|0|||
38048574|NCT01224106|69736623|FG003|Open-Label Extension (OLE) Phase|Death|1|||
38048575|NCT01224106|69736624|FG004|Open-Label Extension (OLE) Phase|Death|3|||
38048576|NCT01224106|69736620|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
38048577|NCT01224106|69736621|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
38048578|NCT01224106|69736622|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
38048579|NCT01224106|69736623|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
38048580|NCT01224106|69736624|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
38048581|NCT01224106|69736620|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
38048582|NCT01224106|69736621|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
38048583|NCT01224106|69736622|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
38048584|NCT01224106|69736623|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
38048585|NCT01224106|69736624|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
38048586|NCT01224106|69736620|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
38048587|NCT01224106|69736621|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
38048588|NCT01224106|69736622|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
38048589|NCT01224106|69736623|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
38048590|NCT01224106|69736624|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
38048591|NCT01224106|69736620|FG000|Open-Label Extension (OLE) Phase|Other|0|||
38048592|NCT01224106|69736621|FG001|Open-Label Extension (OLE) Phase|Other|0|||
38048593|NCT01224106|69736622|FG002|Open-Label Extension (OLE) Phase|Other|0|||
38048594|NCT01224106|69736623|FG003|Open-Label Extension (OLE) Phase|Other|5|||
38048595|NCT01224106|69736624|FG004|Open-Label Extension (OLE) Phase|Other|3|||
38048596|NCT03409107|69736644|FG000|Overall Study|Withdrawal by Subject|4|||
38048597|NCT03409107|69736645|FG001|Overall Study|Withdrawal by Subject|2|||
38048598|NCT03409107|69736644|FG000|Overall Study|Physician Decision|1|||
38048599|NCT03409107|69736645|FG001|Overall Study|Physician Decision|0|||
38048600|NCT03409107|69736644|FG000|Overall Study|Lost to Follow-up|7|||
38048601|NCT03409107|69736645|FG001|Overall Study|Lost to Follow-up|2|||
38048602|NCT03409107|69736644|FG000|Overall Study|Adverse Event|5|||
38048603|NCT03409107|69736645|FG001|Overall Study|Adverse Event|3|||
38048604|NCT03408873|69736659|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
38048605|NCT03408873|69736659|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
38048606|NCT03408873|69736659|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
38048607|NCT03408873|69736659|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
38048608|NCT03408873|69736659|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
38048609|NCT03408873|69736659|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
38048610|NCT03780959|69736666|FG000|Part 1|Adverse Event|1|||
38048611|NCT03780959|69736667|FG001|Part 1|Adverse Event|0|||
38048612|NCT03780959|69736668|FG002|Part 1|Adverse Event|0|||
38048613|NCT03780959|69736666|FG000|Part 1|Withdrawal by Subject|1|||
38048614|NCT03780959|69736667|FG001|Part 1|Withdrawal by Subject|0|||
37953788|NCT00485134|69640656|FG004|Overall Study|Unable to comply with study schedule|0|||
37953789|NCT00485134|69640657|FG005|Overall Study|Unable to comply with study schedule|0|||
37953790|NCT00485134|69640658|FG006|Overall Study|Unable to comply with study schedule|0|||
37953791|NCT00485134|69640659|FG007|Overall Study|Unable to comply with study schedule|1|||
37953792|NCT00485134|69640652|FG000|Overall Study|Pregnancy|0|||
37953793|NCT00485134|69640653|FG001|Overall Study|Pregnancy|0|||
38048615|NCT03780959|69736668|FG002|Part 1|Withdrawal by Subject|0|||
38048616|NCT03780959|69736666|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
38048617|NCT03780959|69736667|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
38048618|NCT03780959|69736668|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
38048619|NCT03780959|69736666|FG000|Part 1|Response Status|2|||
38048620|NCT03780959|69736667|FG001|Part 1|Response Status|0|||
38048621|NCT03780959|69736668|FG002|Part 1|Response Status|0|||
38048622|NCT03780959|69736666|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
38048623|NCT03780959|69736667|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
38048624|NCT03780959|69736668|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
38048625|NCT03780959|69736666|FG000|Part 2|Response Status|0|||
38048626|NCT03780959|69736667|FG001|Part 2|Response Status|18|||
38048627|NCT03780959|69736668|FG002|Part 2|Response Status|6|||
38048628|NCT03408639|69736680|FG000|Overall Study|Death|5|||
38048629|NCT03408639|69736681|FG001|Overall Study|Death|5|||
38048630|NCT03408639|69736680|FG000|Overall Study|Lost to Follow-up|1|||
38048631|NCT03408639|69736681|FG001|Overall Study|Lost to Follow-up|4|||
38048632|NCT03408639|69736680|FG000|Overall Study|Withdrawal by Subject|2|||
38048633|NCT03408639|69736681|FG001|Overall Study|Withdrawal by Subject|7|||
38048634|NCT03408639|69736680|FG000|Overall Study|Physician Decision|3|||
38048635|NCT03408639|69736681|FG001|Overall Study|Physician Decision|6|||
38048636|NCT03810235|69736689|FG000|Overall Study|Withdrawal by Subject|2|||
38048637|NCT03810235|69736690|FG001|Overall Study|Withdrawal by Subject|0|||
38048638|NCT03408483|69736699|FG000|Overall Study|Physician Decision|3|||
38048639|NCT03408483|69736700|FG001|Overall Study|Physician Decision|3|||
38048640|NCT03408483|69736699|FG000|Overall Study|Lost to Follow-up|3|||
38048641|NCT03408483|69736700|FG001|Overall Study|Lost to Follow-up|0|||
38048642|NCT03777059|69736710|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
38048643|NCT03777059|69736711|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
38048644|NCT03777059|69736712|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
38048645|NCT03777059|69736713|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
38048646|NCT03777059|69736710|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
38048647|NCT03777059|69736711|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
38048648|NCT03777059|69736712|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
38048649|NCT03777059|69736713|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
38048650|NCT03777059|69736710|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
38048651|NCT03777059|69736711|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
38048652|NCT03777059|69736712|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
38048653|NCT03777059|69736713|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
38048654|NCT03777059|69736710|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
38048655|NCT03777059|69736711|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
38048656|NCT03777059|69736712|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
38048657|NCT03777059|69736713|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
38048658|NCT03777059|69736710|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
38048659|NCT03777059|69736711|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
38048660|NCT03777059|69736712|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
38048661|NCT03777059|69736713|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
38048662|NCT03777059|69736710|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
38048663|NCT03777059|69736711|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
38048664|NCT03777059|69736712|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
38048665|NCT03777059|69736713|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
38048666|NCT03777059|69736710|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
38048667|NCT03777059|69736711|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
38048668|NCT03777059|69736712|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
38048669|NCT03777059|69736713|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
38048670|NCT03777059|69736710|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
38048671|NCT03777059|69736711|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
38048672|NCT03777059|69736712|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
38048673|NCT03777059|69736713|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
38048674|NCT03777059|69736710|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
38048675|NCT03777059|69736711|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
38048676|NCT03777059|69736712|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
38048677|NCT03777059|69736713|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
38048678|NCT03777059|69736710|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
38048679|NCT03777059|69736711|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
38048680|NCT03777059|69736712|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
38048681|NCT03777059|69736713|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
38048682|NCT03777059|69736710|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
38048683|NCT03777059|69736711|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
38048684|NCT03777059|69736712|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
38048685|NCT03777059|69736713|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
38048686|NCT03100058|69736732|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
38048687|NCT03100058|69736733|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
38048688|NCT03100058|69736734|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
38048689|NCT03100058|69736735|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
38048690|NCT03100058|69736736|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
38048691|NCT03100058|69736737|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
38048692|NCT03100058|69736738|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
38048693|NCT03100058|69736739|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
38048694|NCT03100058|69736740|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
38048695|NCT03100058|69736741|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
38048696|NCT03100058|69736742|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
38048697|NCT03100058|69736743|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
38048698|NCT03100058|69736744|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
38048699|NCT03100058|69736732|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
38048700|NCT03100058|69736733|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
38048701|NCT03100058|69736734|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
38048702|NCT03100058|69736735|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
38048703|NCT03100058|69736736|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
38048704|NCT03100058|69736737|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
38048705|NCT03100058|69736738|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
38048706|NCT03100058|69736739|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
38048707|NCT03100058|69736740|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
38048708|NCT03100058|69736741|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
38048709|NCT03100058|69736742|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
38048710|NCT03100058|69736743|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
38048711|NCT03100058|69736744|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
38048712|NCT03100058|69736732|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
38048713|NCT03100058|69736733|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
38048714|NCT03100058|69736734|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
38048715|NCT03100058|69736735|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
38048716|NCT03100058|69736736|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
38048717|NCT03100058|69736737|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
38048718|NCT03100058|69736738|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
38048719|NCT03100058|69736739|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
38048720|NCT03100058|69736740|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
38048721|NCT03100058|69736741|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
38048722|NCT03100058|69736742|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
38048723|NCT03100058|69736743|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
38048724|NCT03100058|69736744|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
38048725|NCT03100058|69736732|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
38048726|NCT03100058|69736733|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
38048727|NCT03100058|69736734|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
38048728|NCT03100058|69736735|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
38048729|NCT03100058|69736736|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
38048730|NCT03100058|69736737|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
38048731|NCT03100058|69736738|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
38048732|NCT03100058|69736739|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
38048733|NCT03100058|69736740|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
38048734|NCT03100058|69736741|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
38048735|NCT03100058|69736742|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
38048736|NCT03100058|69736743|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
38048737|NCT03100058|69736744|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
38048738|NCT03100058|69736732|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
38048739|NCT03100058|69736733|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
38048740|NCT03100058|69736734|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
38048741|NCT03100058|69736735|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
38048742|NCT03100058|69736736|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
38048743|NCT03100058|69736737|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
38048744|NCT03100058|69736738|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
38048745|NCT03100058|69736739|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
38048746|NCT03100058|69736740|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
38048747|NCT03100058|69736741|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
38048748|NCT03100058|69736742|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
38048749|NCT03100058|69736743|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
38048750|NCT03100058|69736744|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
38048751|NCT03100058|69736732|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
38048752|NCT03100058|69736733|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
38048753|NCT03100058|69736734|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
38048754|NCT03100058|69736735|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
38048755|NCT03100058|69736736|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
38048756|NCT03100058|69736737|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
38048757|NCT03100058|69736738|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
38048758|NCT03100058|69736739|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
38048759|NCT03100058|69736740|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
38048760|NCT03100058|69736741|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
38048761|NCT03100058|69736742|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
38048762|NCT03100058|69736743|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
38048763|NCT03100058|69736744|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
38048764|NCT03100058|69736732|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
38048765|NCT03100058|69736733|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
38048766|NCT03100058|69736734|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
38048767|NCT03100058|69736735|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
38048768|NCT03100058|69736736|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
38048769|NCT03100058|69736737|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
38048770|NCT03100058|69736738|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
38048771|NCT03100058|69736739|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
38048772|NCT03100058|69736740|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
38048773|NCT03100058|69736741|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
38048774|NCT03100058|69736742|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
38048775|NCT03100058|69736743|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
38048776|NCT03100058|69736744|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
38048777|NCT03100058|69736732|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
38048778|NCT03100058|69736733|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
38048779|NCT03100058|69736734|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
38048780|NCT03100058|69736735|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
38048781|NCT03100058|69736736|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
38048782|NCT03100058|69736737|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
38048783|NCT03100058|69736738|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
38048784|NCT03100058|69736739|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
38048785|NCT03100058|69736740|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
38048786|NCT03100058|69736741|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
38048787|NCT03100058|69736742|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
38048788|NCT03100058|69736743|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
38048789|NCT03100058|69736744|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
38048790|NCT03100058|69736732|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
38048791|NCT03100058|69736733|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
38048792|NCT03100058|69736734|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
38048793|NCT03100058|69736735|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
38048794|NCT03100058|69736736|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
38048795|NCT03100058|69736737|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
38048796|NCT03100058|69736738|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
38048797|NCT03100058|69736739|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
38048798|NCT03100058|69736740|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
38048799|NCT03100058|69736741|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
38048800|NCT03100058|69736742|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
38048801|NCT03100058|69736743|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
38048802|NCT03100058|69736744|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
38048803|NCT03100058|69736732|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
38048804|NCT03100058|69736733|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
38048805|NCT03100058|69736734|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
38048806|NCT03100058|69736735|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
38048807|NCT03100058|69736736|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
38048808|NCT03100058|69736737|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
38048809|NCT03100058|69736738|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
38048810|NCT03100058|69736739|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
38048811|NCT03100058|69736740|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
38048812|NCT03100058|69736741|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
38048813|NCT03100058|69736742|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
38048814|NCT03100058|69736743|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
38048815|NCT03100058|69736744|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
38048816|NCT03100058|69736732|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
38048817|NCT03100058|69736733|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
38048818|NCT03100058|69736734|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
38048819|NCT03100058|69736735|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
38048820|NCT03100058|69736736|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
38048821|NCT03100058|69736737|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
38048822|NCT03100058|69736738|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
38048823|NCT03100058|69736739|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
38048824|NCT03100058|69736740|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
38048825|NCT03100058|69736741|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
38048826|NCT03100058|69736742|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
38048827|NCT03100058|69736743|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
38048828|NCT03100058|69736744|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
38048829|NCT03100058|69736732|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
38048830|NCT03100058|69736733|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
38048831|NCT03100058|69736734|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
38048832|NCT03100058|69736735|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
38048833|NCT03100058|69736736|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
38048834|NCT03100058|69736737|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
38048835|NCT03100058|69736738|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
38048836|NCT03100058|69736739|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
38048837|NCT03100058|69736740|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
38048838|NCT03100058|69736741|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
38048839|NCT03100058|69736742|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
38048840|NCT03100058|69736743|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
38048841|NCT03100058|69736744|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
38048842|NCT03100058|69736732|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
38048843|NCT03100058|69736733|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
38048844|NCT03100058|69736734|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
38048845|NCT03100058|69736735|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
38048846|NCT03100058|69736736|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
38048847|NCT03100058|69736737|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
38048848|NCT03100058|69736738|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
38048849|NCT03100058|69736739|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
38048850|NCT03100058|69736740|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
38048851|NCT03100058|69736741|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
38048852|NCT03100058|69736742|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
38048853|NCT03100058|69736743|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
38048854|NCT03100058|69736744|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
38048855|NCT03100058|69736732|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
38048856|NCT03100058|69736733|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
38048857|NCT03100058|69736734|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
38048858|NCT03100058|69736735|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
38048859|NCT03100058|69736736|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
38048860|NCT03100058|69736737|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
38048861|NCT03100058|69736738|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
38048862|NCT03100058|69736739|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
38048863|NCT03100058|69736740|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
38048864|NCT03100058|69736741|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
38048865|NCT03100058|69736742|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
38048866|NCT03100058|69736743|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
38048867|NCT03100058|69736744|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
38048868|NCT03100058|69736732|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
38048869|NCT03100058|69736733|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
38048870|NCT03100058|69736734|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
38048871|NCT03100058|69736735|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
38048872|NCT03100058|69736736|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
38048873|NCT03100058|69736737|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
38048874|NCT03100058|69736738|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
38048875|NCT03100058|69736739|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
38048876|NCT03100058|69736740|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
38048877|NCT03100058|69736741|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
38048878|NCT03100058|69736742|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
38048879|NCT03100058|69736743|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
38048880|NCT03100058|69736744|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
38048881|NCT02871778|69736790|FG000|Part A: Treatment Period 1|Adverse Event|1|||
38048882|NCT02871778|69736791|FG001|Part A: Treatment Period 1|Adverse Event|1|||
38048883|NCT02871778|69736792|FG002|Part A: Treatment Period 1|Adverse Event|1|||
38048884|NCT02871778|69736793|FG003|Part A: Treatment Period 1|Adverse Event|0|||
38048885|NCT02871778|69736794|FG004|Part A: Treatment Period 1|Adverse Event|0|||
38048886|NCT02871778|69736795|FG005|Part A: Treatment Period 1|Adverse Event|0|||
38048887|NCT02871778|69736796|FG006|Part A: Treatment Period 1|Adverse Event|0|||
37953794|NCT00485134|69640654|FG002|Overall Study|Pregnancy|0|||
38048888|NCT02871778|69736797|FG007|Part A: Treatment Period 1|Adverse Event|0|||
38048889|NCT02871778|69736790|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
38048890|NCT02871778|69736791|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
38048891|NCT02871778|69736792|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
38048892|NCT02871778|69736793|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
38048893|NCT02871778|69736794|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
38048894|NCT02871778|69736795|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
38048895|NCT02871778|69736796|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
38048896|NCT02871778|69736797|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
38048897|NCT02871778|69736790|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
38048898|NCT02871778|69736791|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
38048899|NCT02871778|69736792|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
38048900|NCT02871778|69736793|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
38048901|NCT02871778|69736794|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
38048902|NCT02871778|69736795|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
38048903|NCT02871778|69736796|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
38048904|NCT02871778|69736797|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
38048905|NCT02871778|69736790|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
38048906|NCT02871778|69736791|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
38048907|NCT02871778|69736792|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
38048908|NCT02871778|69736793|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
38048909|NCT02871778|69736794|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
38048910|NCT02871778|69736795|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
38048911|NCT02871778|69736796|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
38048912|NCT02871778|69736797|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
38048913|NCT02871778|69736790|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
38048914|NCT02871778|69736791|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
38048915|NCT02871778|69736792|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
38048916|NCT02871778|69736793|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
38048917|NCT02871778|69736794|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
38048918|NCT02871778|69736795|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
38048919|NCT02871778|69736796|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
38048920|NCT02871778|69736797|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
38048921|NCT02871778|69736790|FG000|Part A: Treatment Period 2|Adverse Event|2|||
38048922|NCT02871778|69736791|FG001|Part A: Treatment Period 2|Adverse Event|2|||
38048923|NCT02871778|69736792|FG002|Part A: Treatment Period 2|Adverse Event|0|||
38048924|NCT02871778|69736793|FG003|Part A: Treatment Period 2|Adverse Event|0|||
38048925|NCT02871778|69736794|FG004|Part A: Treatment Period 2|Adverse Event|0|||
38048926|NCT02871778|69736795|FG005|Part A: Treatment Period 2|Adverse Event|0|||
38048927|NCT02871778|69736796|FG006|Part A: Treatment Period 2|Adverse Event|0|||
38048928|NCT02871778|69736797|FG007|Part A: Treatment Period 2|Adverse Event|0|||
38048929|NCT02871778|69736790|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
38048930|NCT02871778|69736791|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
38048931|NCT02871778|69736792|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
38048932|NCT02871778|69736793|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
38048933|NCT02871778|69736794|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
38048934|NCT02871778|69736795|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
38048935|NCT02871778|69736796|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
38048936|NCT02871778|69736797|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
38048937|NCT02871778|69736790|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
38048938|NCT02871778|69736791|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
38048939|NCT02871778|69736792|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
38048940|NCT02871778|69736793|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
38048941|NCT02871778|69736794|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
38048942|NCT02871778|69736795|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
38048943|NCT02871778|69736796|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
38048944|NCT02871778|69736797|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
38048945|NCT02871778|69736790|FG000|Part B: Treatment Period 3|Adverse Event|0|||
38048946|NCT02871778|69736791|FG001|Part B: Treatment Period 3|Adverse Event|0|||
38048947|NCT02871778|69736792|FG002|Part B: Treatment Period 3|Adverse Event|0|||
38048948|NCT02871778|69736793|FG003|Part B: Treatment Period 3|Adverse Event|0|||
38048949|NCT02871778|69736794|FG004|Part B: Treatment Period 3|Adverse Event|1|||
38048950|NCT02871778|69736795|FG005|Part B: Treatment Period 3|Adverse Event|1|||
38048951|NCT02871778|69736796|FG006|Part B: Treatment Period 3|Adverse Event|1|||
38048952|NCT02871778|69736797|FG007|Part B: Treatment Period 3|Adverse Event|0|||
38048953|NCT01471444|69736830|FG000|Overall Study|Physician Decision|3|||
38048954|NCT01471444|69736831|FG001|Overall Study|Physician Decision|2|||
38048955|NCT01471444|69736830|FG000|Overall Study|Withdrawal by Subject|0|||
38048956|NCT01471444|69736831|FG001|Overall Study|Withdrawal by Subject|1|||
38048957|NCT03443427|69736849|FG000|Overall Study|Adverse Event|2|||
38048958|NCT03443427|69736850|FG001|Overall Study|Adverse Event|3|||
38048959|NCT03443427|69736849|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
38048960|NCT03443427|69736850|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
38048961|NCT03443427|69736849|FG000|Overall Study|Other|4|||
38048962|NCT03443427|69736850|FG001|Overall Study|Other|6|||
38048963|NCT03417219|69736858|FG000|Overall Study|Lost to Follow-up|0|||
38048964|NCT03417219|69736859|FG001|Overall Study|Lost to Follow-up|3|||
38048965|NCT02953821|69736867|FG000|Overall Study|Adverse Event|0|||
38048966|NCT02953821|69736868|FG001|Overall Study|Adverse Event|4|||
38048967|NCT02953821|69736867|FG000|Overall Study|Death|1|||
38048968|NCT02953821|69736868|FG001|Overall Study|Death|0|||
38048969|NCT02953821|69736867|FG000|Overall Study|Progressive Disease|5|||
38048970|NCT02953821|69736868|FG001|Overall Study|Progressive Disease|1|||
38048971|NCT02953821|69736867|FG000|Overall Study|Lost to Follow-up|2|||
38048972|NCT02953821|69736868|FG001|Overall Study|Lost to Follow-up|0|||
38048973|NCT02953821|69736867|FG000|Overall Study|Physician Decision|1|||
38048974|NCT02953821|69736868|FG001|Overall Study|Physician Decision|1|||
38048975|NCT02953821|69736867|FG000|Overall Study|Withdrawal by Subject|3|||
38048976|NCT02953821|69736868|FG001|Overall Study|Withdrawal by Subject|3|||
38048977|NCT02953821|69736867|FG000|Overall Study|Change of address|0|||
38048978|NCT02953821|69736868|FG001|Overall Study|Change of address|1|||
38048979|NCT02953821|69736867|FG000|Overall Study|Lack of Efficacy|1|||
38048980|NCT02953821|69736868|FG001|Overall Study|Lack of Efficacy|0|||
38048981|NCT02953821|69736867|FG000|Overall Study|Out of state for indeterminate time|0|||
38048982|NCT02953821|69736868|FG001|Overall Study|Out of state for indeterminate time|1|||
38048983|NCT02953821|69736867|FG000|Overall Study|No improvement|0|||
38048984|NCT02953821|69736868|FG001|Overall Study|No improvement|1|||
38048985|NCT02953821|69736867|FG000|Overall Study|Refused follow-up visit|2|||
38048986|NCT02953821|69736868|FG001|Overall Study|Refused follow-up visit|1|||
38048987|NCT03783923|69736878|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
38048988|NCT03783923|69736879|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
38048989|NCT03783923|69736878|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
38048990|NCT03783923|69736879|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
38048991|NCT03783923|69736878|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
38048992|NCT03783923|69736879|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
38048993|NCT03783923|69736878|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
38048994|NCT03783923|69736879|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
38048995|NCT03783923|69736878|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
38048996|NCT03783923|69736879|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
38048997|NCT03417141|69736883|FG000|Overall Study|Withdrawal by Subject|1|||
38048998|NCT03417141|69736883|FG000|Overall Study|Protocol Violation|3|||
38048999|NCT03724981|69736891|FG000|First Device|Protocol Violation|1|||
38049000|NCT03724981|69736892|FG001|First Device|Protocol Violation|1|||
38049001|NCT01347879|69736902|FG000|Overall Study|Adverse Event|0|||
38049002|NCT01347879|69736903|FG001|Overall Study|Adverse Event|12|||
38049003|NCT01347879|69736902|FG000|Overall Study|Lost to Follow-up|2|||
38049004|NCT01347879|69736903|FG001|Overall Study|Lost to Follow-up|0|||
38049005|NCT01347879|69736902|FG000|Overall Study|Withdrawal by Subject|3|||
38049006|NCT01347879|69736903|FG001|Overall Study|Withdrawal by Subject|2|||
38049007|NCT01347879|69736902|FG000|Overall Study|Other|2|||
38049008|NCT01347879|69736903|FG001|Overall Study|Other|3|||
38049009|NCT03441789|69736920|FG000|Overall Study|Withdrawal by Subject|1|||
38049010|NCT03441789|69736921|FG001|Overall Study|Withdrawal by Subject|1|||
38049011|NCT03441789|69736920|FG000|Overall Study|Adverse Event|0|||
38049012|NCT03441789|69736921|FG001|Overall Study|Adverse Event|1|||
38049013|NCT03441789|69736920|FG000|Overall Study|Protocol Violation|0|||
38049014|NCT03441789|69736921|FG001|Overall Study|Protocol Violation|1|||
38049015|NCT03441789|69736920|FG000|Overall Study|Lost to Follow-up|0|||
38049016|NCT03441789|69736921|FG001|Overall Study|Lost to Follow-up|1|||
38049017|NCT03387735|69736933|FG000|Overall Study|Lost to Follow-up|4|||
38049018|NCT03387735|69736934|FG001|Overall Study|Lost to Follow-up|8|||
38049019|NCT03387735|69736933|FG000|Overall Study|Death|4|||
38049020|NCT03387735|69736934|FG001|Overall Study|Death|8|||
38049021|NCT03439137|69736942|FG000|Overall Study|Adverse Event|16|||
38049022|NCT03439137|69736943|FG001|Overall Study|Adverse Event|12|||
38049023|NCT03439137|69736942|FG000|Overall Study|Physician Decision|0|||
38049024|NCT03439137|69736943|FG001|Overall Study|Physician Decision|5|||
38049025|NCT03439137|69736942|FG000|Overall Study|Withdrawal by Subject|14|||
38049026|NCT03439137|69736943|FG001|Overall Study|Withdrawal by Subject|4|||
38049027|NCT03439137|69736942|FG000|Overall Study|Conducting rescue therapy|2|||
38049028|NCT03439137|69736943|FG001|Overall Study|Conducting rescue therapy|1|||
38049029|NCT03439137|69736942|FG000|Overall Study|Difficult to control Hb|10|||
38049030|NCT03439137|69736943|FG001|Overall Study|Difficult to control Hb|2|||
38049031|NCT03439137|69736942|FG000|Overall Study|Initiation of a renal transplant|0|||
38049032|NCT03439137|69736943|FG001|Overall Study|Initiation of a renal transplant|2|||
38049033|NCT04055090|69736951|FG000|Overall Study|screen failure|1|||
38049034|NCT04055090|69736952|FG001|Overall Study|screen failure|0|||
38049035|NCT04055090|69736951|FG000|Overall Study|Withdrawal by Subject|1|||
38049036|NCT04055090|69736952|FG001|Overall Study|Withdrawal by Subject|0|||
38049037|NCT03403413|69736975|FG000|Overall Study|Lack of Efficacy|2|||
38049038|NCT03721705|69736992|FG000|Overall Study|Adverse Event|2|||
38049039|NCT03721705|69736993|FG001|Overall Study|Adverse Event|0|||
38049040|NCT03721705|69736992|FG000|Overall Study|Withdrawal by Subject|4|||
38049041|NCT03721705|69736993|FG001|Overall Study|Withdrawal by Subject|10|||
38049042|NCT03721705|69736992|FG000|Overall Study|No Suitable Study Partner|1|||
38049043|NCT03721705|69736993|FG001|Overall Study|No Suitable Study Partner|0|||
38049044|NCT03721705|69736992|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
38049045|NCT03721705|69736993|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
38049046|NCT03721705|69736992|FG000|Overall Study|Death|0|||
38049047|NCT03721705|69736993|FG001|Overall Study|Death|1|||
38049048|NCT03720847|69736999|FG000|Washout|Physician Decision|1|||
38049049|NCT03720847|69737000|FG001|Washout|Physician Decision|2|||
38049050|NCT02631070|69737009|FG000|Overall Study|Withdrawal by Subject|35|||
38049051|NCT02631070|69737010|FG001|Overall Study|Withdrawal by Subject|13|||
38049052|NCT02631070|69737009|FG000|Overall Study|Death|45|||
38049053|NCT02631070|69737010|FG001|Overall Study|Death|24|||
38049054|NCT02631070|69737009|FG000|Overall Study|Lost to Follow-up|5|||
38049055|NCT02631070|69737010|FG001|Overall Study|Lost to Follow-up|1|||
38049056|NCT02631070|69737009|FG000|Overall Study|Transition to rollover protocol|52|||
38049057|NCT02631070|69737010|FG001|Overall Study|Transition to rollover protocol|21|||
38049058|NCT02631070|69737009|FG000|Overall Study|Other reasons|12|||
38049059|NCT02631070|69737010|FG001|Overall Study|Other reasons|5|||
38049060|NCT00741988|69737018|FG000|Overall Study|Adverse Event|2|||
38049061|NCT00741988|69737019|FG001|Overall Study|Adverse Event|4|||
38049062|NCT00741988|69737018|FG000|Overall Study|Lack of Efficacy|2|||
38049063|NCT00741988|69737019|FG001|Overall Study|Lack of Efficacy|0|||
38049064|NCT03354429|69737027|FG000|Overall Study|Withdrawal by Subject|8|||
38049065|NCT03354429|69737028|FG001|Overall Study|Withdrawal by Subject|7|||
38049066|NCT03354429|69737027|FG000|Overall Study|Lost to Follow-up|1|||
38049067|NCT03354429|69737028|FG001|Overall Study|Lost to Follow-up|0|||
38049068|NCT03352713|69737034|FG000|Overall Study|Lost to Follow-up|8|||
38049069|NCT03352713|69737034|FG000|Overall Study|Withdrawn by investigator|5|||
38049070|NCT03352713|69737034|FG000|Overall Study|Completed 0 EMAs|8|||
38049071|NCT03352713|69737034|FG000|Overall Study|Device incompatible/stolen|5|||
38049072|NCT03901144|69737038|FG000|Overall Study|Lost to Follow-up|1|||
38049073|NCT03901144|69737039|FG001|Overall Study|Lost to Follow-up|1|||
38049074|NCT03901144|69737040|FG002|Overall Study|Lost to Follow-up|1|||
38049075|NCT03901144|69737041|FG003|Overall Study|Lost to Follow-up|1|||
38049076|NCT02952261|69737053|FG000|Overall Study|Withdrawal by Subject|4|||
38049077|NCT02952261|69737054|FG001|Overall Study|Withdrawal by Subject|5|||
38049078|NCT02952261|69737053|FG000|Overall Study|Protocol Violation|1|||
38049079|NCT02952261|69737054|FG001|Overall Study|Protocol Violation|0|||
38049080|NCT03384693|69737060|FG000|Overall Study|Adverse Event|3|||
38049081|NCT03718429|69737072|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
38049082|NCT03718429|69737073|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
38049083|NCT03718429|69737074|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
38049084|NCT03718429|69737075|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
38049085|NCT01285102|69737095|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
38049086|NCT03382899|69737129|FG000|Overall Study|Ineligibility Determined|0|||
38049087|NCT03382899|69737130|FG001|Overall Study|Ineligibility Determined|1|||
38049088|NCT03382899|69737129|FG000|Overall Study|Lost to Follow-up|0|||
38049089|NCT03382899|69737130|FG001|Overall Study|Lost to Follow-up|1|||
38049090|NCT03382899|69737129|FG000|Overall Study|Sponsor's decision|31|||
38049091|NCT03382899|69737130|FG001|Overall Study|Sponsor's decision|28|||
38049092|NCT03382899|69737129|FG000|Overall Study|Withdrawal by Subject|0|||
38049093|NCT03382899|69737130|FG001|Overall Study|Withdrawal by Subject|5|||
38049094|NCT00709852|69737136|FG000|Period 1|Adverse Event|2|||
38049095|NCT00709852|69737137|FG001|Period 1|Adverse Event|0|||
38049096|NCT00709852|69737136|FG000|Period 1|Withdrawal by Subject|4|||
38049097|NCT00709852|69737137|FG001|Period 1|Withdrawal by Subject|2|||
38049098|NCT00709852|69737136|FG000|Period 1|Protocol Violation|1|||
38049099|NCT00709852|69737137|FG001|Period 1|Protocol Violation|0|||
38049100|NCT00709852|69737136|FG000|Period 1|Defective scanner|0|||
38049101|NCT00709852|69737137|FG001|Period 1|Defective scanner|1|||
38049102|NCT00709852|69737136|FG000|Period 1|Lost to Follow-up|1|||
38049103|NCT00709852|69737137|FG001|Period 1|Lost to Follow-up|0|||
38049104|NCT00709852|69737136|FG000|Period 2|Protocol Violation|4|||
38049105|NCT00709852|69737137|FG001|Period 2|Protocol Violation|1|||
38049106|NCT00709852|69737136|FG000|Period 2|Adverse Event|1|||
38049107|NCT00709852|69737137|FG001|Period 2|Adverse Event|1|||
38049108|NCT00709852|69737136|FG000|Period 2|Lost to Follow-up|1|||
38049109|NCT00709852|69737137|FG001|Period 2|Lost to Follow-up|0|||
38049110|NCT00709852|69737136|FG000|Period 2|No 72-hour follow-up|3|||
38049111|NCT00709852|69737137|FG001|Period 2|No 72-hour follow-up|0|||
38049112|NCT03382041|69737154|FG000|Overall Study|Consent Form Lost|2|||
38049113|NCT03382041|69737155|FG001|Overall Study|Consent Form Lost|1|||
38049114|NCT03382041|69737154|FG000|Overall Study|Withdrawal by Subject|1|||
38049115|NCT03382041|69737155|FG001|Overall Study|Withdrawal by Subject|4|||
38049116|NCT03382041|69737154|FG000|Overall Study|Lost to Follow-up|1|||
38049117|NCT03382041|69737155|FG001|Overall Study|Lost to Follow-up|4|||
38049118|NCT03351231|69737161|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
38049119|NCT03351231|69737161|FG000|Combination Therapy Period|Disease progression|2|||
38049120|NCT03351231|69737161|FG000|Combination Therapy Period|Study drug toxicity|1|||
38049121|NCT03351231|69737161|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
38049122|NCT03351231|69737161|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
38049123|NCT03351231|69737161|FG000|Safety Follow-Up Period|Other reason|2|||
38049124|NCT03381339|69737167|FG000|Overall Study|Protocol Violation|4|||
38049125|NCT03381339|69737168|FG001|Overall Study|Protocol Violation|3|||
38049126|NCT03381339|69737167|FG000|Overall Study|Lost to Follow-up|0|||
38049127|NCT03381339|69737168|FG001|Overall Study|Lost to Follow-up|1|||
38049128|NCT03401229|69737176|FG000|Overall Study|Lost to Follow-up|2|||
38049129|NCT03401229|69737177|FG001|Overall Study|Lost to Follow-up|1|||
38049130|NCT03401229|69737176|FG000|Overall Study|Other|1|||
38049131|NCT03401229|69737177|FG001|Overall Study|Other|3|||
38049132|NCT03401229|69737176|FG000|Overall Study|Adverse Event|8|||
38049133|NCT03401229|69737177|FG001|Overall Study|Adverse Event|6|||
38049134|NCT03401229|69737176|FG000|Overall Study|Withdrawal by Subject|29|||
38049135|NCT03401229|69737177|FG001|Overall Study|Withdrawal by Subject|26|||
38049136|NCT03401229|69737176|FG000|Overall Study|COVID-19|0|||
38049137|NCT03401229|69737177|FG001|Overall Study|COVID-19|1|||
38049138|NCT03349515|69737185|FG000|Overall Study|Lack of Efficacy|2|||
38049139|NCT03349515|69737186|FG001|Overall Study|Lack of Efficacy|0|||
38049140|NCT03349515|69737185|FG000|Overall Study|Physician Decision|3|||
38049141|NCT03349515|69737186|FG001|Overall Study|Physician Decision|1|||
38049142|NCT03349437|69737192|FG000|Screening|Screen Fail|4|||
38049143|NCT03349437|69737193|FG001|Screening|Screen Fail|0|||
38049144|NCT03349437|69737194|FG002|Screening|Screen Fail|0|||
38049145|NCT03349437|69737192|FG000|Screening|Withdrawn|1|||
38049146|NCT03349437|69737193|FG001|Screening|Withdrawn|0|||
38049147|NCT03349437|69737194|FG002|Screening|Withdrawn|0|||
38049148|NCT03380091|69737203|FG000|Overall Study|Withdrawal by Subject|2|||
38049149|NCT03380091|69737204|FG001|Overall Study|Withdrawal by Subject|1|||
38049150|NCT03379233|69737214|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
38049151|NCT03379233|69737215|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
38049152|NCT01377922|69737223|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
38049153|NCT01377922|69737224|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
38049154|NCT03372603|69737230|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
38049155|NCT03372603|69737231|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
38049156|NCT03372603|69737230|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
38049157|NCT03372603|69737231|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
38049158|NCT01377844|69737239|FG000|Overall Study|Withdrawal by Subject|25|||
38049159|NCT01377844|69737240|FG001|Overall Study|Withdrawal by Subject|28|||
38049160|NCT01377844|69737239|FG000|Overall Study|Protocol Violation|2|||
38049161|NCT01377844|69737240|FG001|Overall Study|Protocol Violation|3|||
38049162|NCT01377844|69737239|FG000|Overall Study|Adverse Event|3|||
38049163|NCT01377844|69737240|FG001|Overall Study|Adverse Event|0|||
38049164|NCT01377844|69737239|FG000|Overall Study|Physician Decision|6|||
38049165|NCT01377844|69737240|FG001|Overall Study|Physician Decision|3|||
38049166|NCT01377844|69737239|FG000|Overall Study|Study terminated by Sponsor|0|||
38049167|NCT01377844|69737240|FG001|Overall Study|Study terminated by Sponsor|1|||
38049168|NCT03372369|69737249|FG000|Qualification Period|Withdrawal by Subject|16|||
38049169|NCT03372369|69737250|FG001|Qualification Period|Withdrawal by Subject|13|||
38049170|NCT03372369|69737249|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
38049171|NCT03372369|69737250|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
38049172|NCT03372369|69737249|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
38049173|NCT03372369|69737250|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
38049174|NCT03371355|69737260|FG000|Overall Study|Investigator judgment|0|||
38049175|NCT03371355|69737261|FG001|Overall Study|Investigator judgment|0|||
38049176|NCT03371355|69737262|FG002|Overall Study|Investigator judgment|1|||
38049177|NCT03371355|69737263|FG003|Overall Study|Investigator judgment|1|||
38049178|NCT03371355|69737260|FG000|Overall Study|Voluntary withdrawal|1|||
38049179|NCT03371355|69737261|FG001|Overall Study|Voluntary withdrawal|0|||
38049180|NCT03371355|69737262|FG002|Overall Study|Voluntary withdrawal|1|||
38049181|NCT03371355|69737263|FG003|Overall Study|Voluntary withdrawal|2|||
38049182|NCT03371355|69737260|FG000|Overall Study|Adverse Event|0|||
38049183|NCT03371355|69737261|FG001|Overall Study|Adverse Event|1|||
38049184|NCT03371355|69737262|FG002|Overall Study|Adverse Event|2|||
38049185|NCT03371355|69737263|FG003|Overall Study|Adverse Event|3|||
38049186|NCT03371355|69737260|FG000|Overall Study|Reason not Specified|0|||
38049187|NCT03371355|69737261|FG001|Overall Study|Reason not Specified|1|||
38049188|NCT03371355|69737262|FG002|Overall Study|Reason not Specified|0|||
38049189|NCT03371355|69737263|FG003|Overall Study|Reason not Specified|1|||
38049190|NCT03370419|69737277|FG000|Overall Study|Lost to Follow-up|16|||
38049191|NCT03369951|69737285|FG000|Overall Study|Withdrawal by Subject|3|||
38049192|NCT03369951|69737285|FG000|Overall Study|Death|1|||
38049193|NCT03369951|69737285|FG000|Overall Study|Lost to Follow-up|1|||
38049194|NCT03369951|69737285|FG000|Overall Study|Protocol Violation|1|||
38049195|NCT04040192|69737289|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
38049196|NCT04040192|69737290|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
38049197|NCT04040192|69737291|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
38049198|NCT04040192|69737289|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
38049199|NCT04040192|69737290|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
38049200|NCT04040192|69737291|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
38049201|NCT04040192|69737289|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
38049202|NCT04040192|69737290|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
38049203|NCT04040192|69737291|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
38049204|NCT04040192|69737289|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
38049205|NCT04040192|69737290|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
38049206|NCT04040192|69737291|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
38049207|NCT04040192|69737289|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
38049208|NCT04040192|69737290|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
38049209|NCT04040192|69737291|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
38049210|NCT04040192|69737289|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
38049211|NCT04040192|69737290|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
38049212|NCT04040192|69737291|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
38049213|NCT04040192|69737289|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
38049214|NCT04040192|69737290|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
38049215|NCT04040192|69737291|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
38049216|NCT04040192|69737289|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
38049217|NCT04040192|69737290|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
38049218|NCT04040192|69737291|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
38049219|NCT04040192|69737289|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
38049220|NCT04040192|69737290|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
38049221|NCT04040192|69737291|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
38049222|NCT04040192|69737289|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
38049223|NCT04040192|69737290|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
38049224|NCT04040192|69737291|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
38049225|NCT04040192|69737289|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
38049226|NCT04040192|69737290|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
38049227|NCT04040192|69737291|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
38049228|NCT04040192|69737289|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
38049229|NCT04040192|69737290|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
38049230|NCT04040192|69737291|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
38049231|NCT04040192|69737289|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
38049232|NCT04040192|69737290|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
38049233|NCT04040192|69737291|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
38049234|NCT04040192|69737289|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
38049235|NCT04040192|69737290|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
38049236|NCT04040192|69737291|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
38049237|NCT04040192|69737289|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
38049238|NCT04040192|69737290|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
38049239|NCT04040192|69737291|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
38049240|NCT04040192|69737289|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
38049241|NCT04040192|69737290|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
38049242|NCT04040192|69737291|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
38049243|NCT04040192|69737289|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
38049244|NCT04040192|69737290|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
38049245|NCT04040192|69737291|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
38049246|NCT03368859|69737315|FG000|Overall Study|Withdrew Consent|5|||
38049247|NCT03368859|69737316|FG001|Overall Study|Withdrew Consent|4|||
38049248|NCT03368859|69737315|FG000|Overall Study|Death|12|||
38049249|NCT03368859|69737316|FG001|Overall Study|Death|6|||
38049250|NCT03368859|69737315|FG000|Overall Study|Study terminated by Sponsor|18|||
38049251|NCT03368859|69737316|FG001|Overall Study|Study terminated by Sponsor|23|||
38049252|NCT03368859|69737315|FG000|Overall Study|Other|1|||
38049253|NCT03368859|69737316|FG001|Overall Study|Other|1|||
38049254|NCT03096314|69737330|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
37861818|NCT00929695|69545523|FG000|Overall Study|incorrect stratification|2|||
38049255|NCT03096314|69737331|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
38049256|NCT03335163|69737337|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
38049257|NCT03335163|69737337|FG000|Overall Study|Withdrawal by Subject|18|||
38049258|NCT03364335|69737363|FG000|Overall Study|Adverse Event|3|||
38049259|NCT03364335|69737364|FG001|Overall Study|Adverse Event|4|||
38049260|NCT03364335|69737365|FG002|Overall Study|Adverse Event|1|||
38049261|NCT03364335|69737366|FG003|Overall Study|Adverse Event|2|||
38049262|NCT03364335|69737367|FG004|Overall Study|Adverse Event|0|||
38049263|NCT03364335|69737363|FG000|Overall Study|Lost to Follow-up|7|||
38049264|NCT03364335|69737364|FG001|Overall Study|Lost to Follow-up|7|||
38049265|NCT03364335|69737365|FG002|Overall Study|Lost to Follow-up|10|||
38049266|NCT03364335|69737366|FG003|Overall Study|Lost to Follow-up|11|||
38049267|NCT03364335|69737367|FG004|Overall Study|Lost to Follow-up|11|||
38049268|NCT03334695|69737390|FG000|Overall Study|Lost to Follow-up|3|||
38049269|NCT03334695|69737391|FG001|Overall Study|Lost to Follow-up|3|||
38049270|NCT03334695|69737390|FG000|Overall Study|Physician Decision|1|||
37953795|NCT00485134|69640655|FG003|Overall Study|Pregnancy|0|||
37953796|NCT00485134|69640656|FG004|Overall Study|Pregnancy|0|||
37953797|NCT00485134|69640657|FG005|Overall Study|Pregnancy|0|||
37953798|NCT00485134|69640658|FG006|Overall Study|Pregnancy|1|||
37953799|NCT00485134|69640659|FG007|Overall Study|Pregnancy|0|||
37953800|NCT00583115|69640671|FG000|Overall Study|Death|1|||
37953801|NCT00532779|69640678|FG000|Overall Study|Adverse Event|122|||
37953802|NCT00532779|69640679|FG001|Overall Study|Adverse Event|112|||
37953803|NCT00532779|69640680|FG002|Overall Study|Adverse Event|56|||
37953804|NCT00532779|69640678|FG000|Overall Study|Lost to Follow-up|76|||
37953805|NCT00532779|69640679|FG001|Overall Study|Lost to Follow-up|65|||
37953806|NCT00532779|69640680|FG002|Overall Study|Lost to Follow-up|66|||
37953807|NCT00532779|69640678|FG000|Overall Study|Withdrawal by Subject|63|||
37953808|NCT00532779|69640679|FG001|Overall Study|Withdrawal by Subject|60|||
37953809|NCT00532779|69640680|FG002|Overall Study|Withdrawal by Subject|90|||
37953810|NCT00532779|69640678|FG000|Overall Study|Lack of Efficacy|12|||
37953811|NCT00532779|69640679|FG001|Overall Study|Lack of Efficacy|12|||
37953812|NCT00532779|69640680|FG002|Overall Study|Lack of Efficacy|40|||
37953813|NCT00532779|69640678|FG000|Overall Study|Protocol Violation|5|||
38049271|NCT03334695|69737391|FG001|Overall Study|Physician Decision|2|||
38049272|NCT03334695|69737390|FG000|Overall Study|Protocol Violation|0|||
38049273|NCT03334695|69737391|FG001|Overall Study|Protocol Violation|1|||
38049274|NCT03364023|69737399|FG000|Overall Study|Lost to Follow-up|3|||
38049275|NCT03364023|69737399|FG000|Overall Study|Death|14|||
38049276|NCT03764813|69737423|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
38049277|NCT03764813|69737424|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
38049278|NCT03764813|69737425|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
38049279|NCT03764813|69737426|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
38049280|NCT03363321|69737447|FG000|Overall Study|Withdrawal by Subject|0|||
38049281|NCT03363321|69737448|FG001|Overall Study|Withdrawal by Subject|1|||
38049282|NCT03363321|69737449|FG002|Overall Study|Withdrawal by Subject|0|||
38049283|NCT03363321|69737450|FG003|Overall Study|Withdrawal by Subject|1|||
38049284|NCT03363321|69737451|FG004|Overall Study|Withdrawal by Subject|0|||
38049285|NCT03361605|69737464|FG000|Overall Study|Analyzable data not available|3|||
38049286|NCT03829046|69737470|FG000|Overall Study|Withdrawal by Subject|1|||
38049287|NCT03829046|69737471|FG001|Overall Study|Withdrawal by Subject|0|||
38049288|NCT03361293|69737479|FG000|Overall Study|Lost to Follow-up|0|||
38049289|NCT03361293|69737480|FG001|Overall Study|Lost to Follow-up|2|||
38049290|NCT03361293|69737479|FG000|Overall Study|Withdrawal by Subject|1|||
38049291|NCT03361293|69737480|FG001|Overall Study|Withdrawal by Subject|3|||
38049292|NCT03361137|69737491|FG000|Overall Study|Reason not specified|1|||
38049293|NCT03361137|69737492|FG001|Overall Study|Reason not specified|0|||
38049294|NCT03361137|69737493|FG002|Overall Study|Reason not specified|0|||
38049295|NCT03361137|69737494|FG003|Overall Study|Reason not specified|0|||
38049296|NCT03361137|69737495|FG004|Overall Study|Reason not specified|0|||
38049297|NCT03360747|69737509|FG000|Overall Study|Voluntary Withdrawal|1|||
38049298|NCT03359811|69737515|FG000|Overall Study|Protocol Violation|2|||
38049299|NCT03359811|69737516|FG001|Overall Study|Protocol Violation|0|||
38049300|NCT03728426|69737523|FG000|Overall Study|Death|3|||
38049301|NCT02095678|69737529|FG000|Overall Study|Withdrawal by Subject|0|||
38049302|NCT02095678|69737530|FG001|Overall Study|Withdrawal by Subject|1|||
38049303|NCT02095678|69737529|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
38049304|NCT02095678|69737530|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
38049305|NCT02095678|69737529|FG000|Overall Study|lesion impacted by previous treatment|1|||
37953814|NCT00532779|69640679|FG001|Overall Study|Protocol Violation|9|||
37953815|NCT00532779|69640680|FG002|Overall Study|Protocol Violation|7|||
37953816|NCT00532779|69640678|FG000|Overall Study|Pregnancy|2|||
38049306|NCT02095678|69737530|FG001|Overall Study|lesion impacted by previous treatment|1|||
38049307|NCT02095678|69737529|FG000|Overall Study|No Confirmed Diagnosis|0|||
38049308|NCT02095678|69737530|FG001|Overall Study|No Confirmed Diagnosis|3|||
38049309|NCT02095678|69737529|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
38049310|NCT02095678|69737530|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
38049311|NCT02095678|69737529|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
38049312|NCT02095678|69737530|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
38049313|NCT03763877|69737543|FG000|Overall Study|Withdrawal by Subject|3|||
38049314|NCT03763877|69737544|FG001|Overall Study|Withdrawal by Subject|1|||
38049315|NCT03763877|69737545|FG002|Overall Study|Withdrawal by Subject|3|||
38049316|NCT03763877|69737546|FG003|Overall Study|Withdrawal by Subject|4|||
38049317|NCT03763877|69737543|FG000|Overall Study|Adverse Event|1|||
38049318|NCT03763877|69737544|FG001|Overall Study|Adverse Event|1|||
38049319|NCT03763877|69737545|FG002|Overall Study|Adverse Event|3|||
38049320|NCT03763877|69737546|FG003|Overall Study|Adverse Event|1|||
38049321|NCT03763877|69737543|FG000|Overall Study|Protocol Violation|1|||
38049322|NCT03763877|69737544|FG001|Overall Study|Protocol Violation|1|||
38049323|NCT03763877|69737545|FG002|Overall Study|Protocol Violation|0|||
38049324|NCT03763877|69737546|FG003|Overall Study|Protocol Violation|0|||
38049325|NCT03763877|69737543|FG000|Overall Study|Lost to Follow-up|0|||
38049326|NCT03763877|69737544|FG001|Overall Study|Lost to Follow-up|1|||
38049327|NCT03763877|69737545|FG002|Overall Study|Lost to Follow-up|1|||
38049328|NCT03763877|69737546|FG003|Overall Study|Lost to Follow-up|0|||
38049329|NCT03358407|69737579|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
38049330|NCT03358407|69737580|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
38049331|NCT03358407|69737581|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
38049332|NCT03358407|69737582|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
38049333|NCT03358407|69737583|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
38049334|NCT03358407|69737584|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
38049335|NCT03358407|69737585|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
38049336|NCT03358407|69737586|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
38049337|NCT03358407|69737587|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
38049338|NCT03358407|69737588|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
38049339|NCT03358407|69737579|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
38049340|NCT03358407|69737580|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
38049341|NCT03358407|69737581|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
38049342|NCT03358407|69737582|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
38049343|NCT03358407|69737583|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
38049344|NCT03358407|69737584|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
38049345|NCT03358407|69737585|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
38049346|NCT03358407|69737586|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
38049347|NCT03358407|69737587|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
38049348|NCT03358407|69737588|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
38049349|NCT03358407|69737579|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
38049350|NCT03358407|69737580|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
38049351|NCT03358407|69737581|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
38049352|NCT03358407|69737582|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
38049353|NCT03358407|69737583|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
38049354|NCT03358407|69737584|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
38049355|NCT03358407|69737585|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
38049356|NCT03358407|69737586|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
38049357|NCT03358407|69737587|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
38049358|NCT03358407|69737588|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
38049359|NCT03358407|69737579|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
38049360|NCT03358407|69737580|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
38049361|NCT03358407|69737581|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
38049362|NCT03358407|69737582|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
38049363|NCT03358407|69737583|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
38049364|NCT03358407|69737584|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
38049365|NCT03358407|69737585|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
38049366|NCT03358407|69737586|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
38049367|NCT03358407|69737587|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
38049368|NCT03358407|69737588|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
38049369|NCT03358407|69737579|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
38049370|NCT03358407|69737580|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
38049371|NCT03358407|69737581|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
38049372|NCT03358407|69737582|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
38049373|NCT03358407|69737583|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
38049374|NCT03358407|69737584|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
38049375|NCT03358407|69737585|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
38049376|NCT03358407|69737586|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
38049377|NCT03358407|69737587|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
38049378|NCT03358407|69737588|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
38049379|NCT03358407|69737579|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
38049380|NCT03358407|69737580|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
38049381|NCT03358407|69737581|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
38049382|NCT03358407|69737582|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
38049383|NCT03358407|69737583|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
38049384|NCT03358407|69737584|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
38049385|NCT03358407|69737585|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
38049386|NCT03358407|69737586|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
38049387|NCT03358407|69737587|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
38049388|NCT03358407|69737588|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
38049389|NCT02950545|69737630|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
38049390|NCT02950545|69737631|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
38049391|NCT02950545|69737632|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
38049392|NCT02950545|69737633|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
38049393|NCT02950545|69737634|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
38049394|NCT02950545|69737635|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
38049395|NCT02950545|69737630|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
38049396|NCT02950545|69737631|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
38049397|NCT02950545|69737632|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
38049398|NCT02950545|69737633|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
38049399|NCT02950545|69737634|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
38049400|NCT02950545|69737635|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
38049401|NCT02950545|69737630|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
38049402|NCT02950545|69737631|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
38049403|NCT02950545|69737632|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
38049404|NCT02950545|69737633|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
38049405|NCT02950545|69737634|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
38049406|NCT02950545|69737635|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
38049407|NCT02950545|69737630|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
38049408|NCT02950545|69737631|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
38049409|NCT02950545|69737632|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
38049410|NCT02950545|69737633|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
38049411|NCT02950545|69737634|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
38049412|NCT02950545|69737635|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
38049413|NCT02950545|69737630|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
38049414|NCT02950545|69737631|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
38049415|NCT02950545|69737632|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
38049416|NCT02950545|69737633|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
38049417|NCT02950545|69737634|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
38049418|NCT02950545|69737635|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
38049419|NCT03358329|69737641|FG000|Overall Study|Lost to Follow-up|2|||
38049420|NCT03358329|69737641|FG000|Overall Study|Withdrawal by Subject|2|||
38049421|NCT03357471|69737657|FG000|Overall Study|Adverse Event|1|||
38049422|NCT03357471|69737658|FG001|Overall Study|Adverse Event|0|||
38049423|NCT03357471|69737657|FG000|Overall Study|Lost to Follow-up|1|||
38049424|NCT03357471|69737658|FG001|Overall Study|Lost to Follow-up|0|||
38049425|NCT03356145|69737666|FG000|Overall Study|Withdrawal by Subject|2|||
38049426|NCT03356145|69737667|FG001|Overall Study|Withdrawal by Subject|1|||
38049427|NCT03356145|69737666|FG000|Overall Study|Did not meet inclusion criteria|1|||
38049428|NCT03356145|69737667|FG001|Overall Study|Did not meet inclusion criteria|0|||
38049429|NCT03342963|69737677|FG000|Overall Study|Adverse Event|1|||
38049430|NCT03342963|69737678|FG001|Overall Study|Adverse Event|2|||
38049431|NCT03342963|69737679|FG002|Overall Study|Adverse Event|0|||
38049432|NCT03342963|69737680|FG003|Overall Study|Adverse Event|0|||
38049433|NCT03342963|69737677|FG000|Overall Study|Withdrawal by Subject|1|||
38049434|NCT03342963|69737678|FG001|Overall Study|Withdrawal by Subject|0|||
38049435|NCT03342963|69737679|FG002|Overall Study|Withdrawal by Subject|0|||
38049436|NCT03342963|69737680|FG003|Overall Study|Withdrawal by Subject|0|||
38049437|NCT03361956|69737695|FG000|Overall Study|Adverse Event|1|||
38049438|NCT03361956|69737696|FG001|Overall Study|Adverse Event|0|||
38049439|NCT03361956|69737697|FG002|Overall Study|Adverse Event|1|||
38049440|NCT03361956|69737698|FG003|Overall Study|Adverse Event|1|||
38049441|NCT03361956|69737699|FG004|Overall Study|Adverse Event|0|||
38049442|NCT03361956|69737695|FG000|Overall Study|Other|0|||
38049443|NCT03361956|69737696|FG001|Overall Study|Other|0|||
38049444|NCT03361956|69737697|FG002|Overall Study|Other|0|||
38049445|NCT03361956|69737698|FG003|Overall Study|Other|1|||
38049446|NCT03361956|69737699|FG004|Overall Study|Other|0|||
38049447|NCT03361956|69737695|FG000|Overall Study|Withdrawal by Subject|2|||
38049448|NCT03361956|69737696|FG001|Overall Study|Withdrawal by Subject|2|||
38049449|NCT03361956|69737697|FG002|Overall Study|Withdrawal by Subject|2|||
38049450|NCT03361956|69737698|FG003|Overall Study|Withdrawal by Subject|0|||
38049451|NCT03361956|69737699|FG004|Overall Study|Withdrawal by Subject|3|||
38049452|NCT03361956|69737695|FG000|Overall Study|Disease Relapse|0|||
38049453|NCT03361956|69737696|FG001|Overall Study|Disease Relapse|0|||
38049454|NCT03361956|69737697|FG002|Overall Study|Disease Relapse|1|||
38049455|NCT03361956|69737698|FG003|Overall Study|Disease Relapse|0|||
38049456|NCT03361956|69737699|FG004|Overall Study|Disease Relapse|0|||
38049457|NCT03361956|69737695|FG000|Overall Study|Physician Decision|0|||
38049458|NCT03361956|69737696|FG001|Overall Study|Physician Decision|2|||
38049459|NCT03361956|69737697|FG002|Overall Study|Physician Decision|0|||
38049460|NCT03361956|69737698|FG003|Overall Study|Physician Decision|1|||
38049461|NCT03361956|69737699|FG004|Overall Study|Physician Decision|0|||
38049462|NCT03361956|69737695|FG000|Overall Study|Lost to Follow-up|0|||
38049463|NCT03361956|69737696|FG001|Overall Study|Lost to Follow-up|0|||
38049464|NCT03361956|69737697|FG002|Overall Study|Lost to Follow-up|1|||
38049465|NCT03361956|69737698|FG003|Overall Study|Lost to Follow-up|1|||
38049466|NCT03361956|69737699|FG004|Overall Study|Lost to Follow-up|2|||
38049467|NCT03361176|69737770|FG000|Overall Study|Lost to Follow-up|1|||
38049468|NCT03361176|69737771|FG001|Overall Study|Lost to Follow-up|2|||
38049469|NCT03361176|69737770|FG000|Overall Study|Adverse Event|0|||
38049470|NCT03361176|69737771|FG001|Overall Study|Adverse Event|2|||
38049471|NCT03361176|69737770|FG000|Overall Study|Withdrawal by Subject|0|||
38049472|NCT03361176|69737771|FG001|Overall Study|Withdrawal by Subject|1|||
38049473|NCT05283499|69737779|FG000|Overall Study|Did not receive intervention|1|||
38049474|NCT05283499|69737780|FG001|Overall Study|Did not receive intervention|2|||
38049475|NCT05271175|69737789|FG000|One Week Follow up|Lost to Follow-up|10|||
38049476|NCT05271175|69737790|FG001|One Week Follow up|Lost to Follow-up|7|||
38049477|NCT05271175|69737791|FG002|One Week Follow up|Lost to Follow-up|5|||
38049478|NCT05271175|69737789|FG000|One Month Follow up|Lost to Follow-up|12|||
38049479|NCT05271175|69737790|FG001|One Month Follow up|Lost to Follow-up|7|||
38049480|NCT05271175|69737791|FG002|One Month Follow up|Lost to Follow-up|9|||
38049481|NCT05271175|69737789|FG000|Six Months Follow up|Lost to Follow-up|8|||
38049482|NCT05271175|69737790|FG001|Six Months Follow up|Lost to Follow-up|2|||
38049483|NCT05271175|69737791|FG002|Six Months Follow up|Lost to Follow-up|2|||
38049484|NCT03098030|69737803|FG000|Overall Study|Death|10|||
38049485|NCT03098030|69737804|FG001|Overall Study|Death|156|||
38049486|NCT03098030|69737805|FG002|Overall Study|Death|156|||
38049487|NCT03098030|69737806|FG003|Overall Study|Death|82|||
38049488|NCT03098030|69737803|FG000|Overall Study|Withdrawal by Subject|0|||
38049489|NCT03098030|69737804|FG001|Overall Study|Withdrawal by Subject|7|||
38049490|NCT03098030|69737805|FG002|Overall Study|Withdrawal by Subject|8|||
38049491|NCT03098030|69737806|FG003|Overall Study|Withdrawal by Subject|2|||
38049492|NCT03098030|69737803|FG000|Overall Study|Lost to Follow-up|0|||
38049493|NCT03098030|69737804|FG001|Overall Study|Lost to Follow-up|0|||
38049494|NCT03098030|69737805|FG002|Overall Study|Lost to Follow-up|2|||
38049495|NCT03098030|69737806|FG003|Overall Study|Lost to Follow-up|1|||
38049496|NCT03341637|69737817|FG000|Overall Study|Lost to Follow-up|1|||
38049497|NCT03341637|69737818|FG001|Overall Study|Lost to Follow-up|0|||
38049498|NCT03341637|69737817|FG000|Overall Study|Withdrawal by Subject|3|||
38049499|NCT03341637|69737818|FG001|Overall Study|Withdrawal by Subject|3|||
38049500|NCT03341637|69737817|FG000|Overall Study|Reason not Specified|1|||
38049501|NCT03341637|69737818|FG001|Overall Study|Reason not Specified|1|||
38049502|NCT01378858|69737826|FG000|Overall Study|Withdrawal by Subject|4|||
38049503|NCT01378858|69737827|FG001|Overall Study|Withdrawal by Subject|4|||
38049504|NCT02891850|69737835|FG000|Overall Study|Adverse Event|3|||
38049505|NCT02891850|69737836|FG001|Overall Study|Adverse Event|0|||
38049506|NCT02891850|69737835|FG000|Overall Study|Death|0|||
38049507|NCT02891850|69737836|FG001|Overall Study|Death|4|||
38049508|NCT02891850|69737835|FG000|Overall Study|Physician Decision|1|||
38049509|NCT02891850|69737836|FG001|Overall Study|Physician Decision|0|||
38049510|NCT02891850|69737835|FG000|Overall Study|Pregnancy|1|||
38049511|NCT02891850|69737836|FG001|Overall Study|Pregnancy|0|||
38049512|NCT02891850|69737835|FG000|Overall Study|Withdrawal by Subject|2|||
38049513|NCT02891850|69737836|FG001|Overall Study|Withdrawal by Subject|3|||
38049514|NCT05594173|69737842|FG000|Overall Study|Adverse Event|1|||
38049515|NCT05594173|69737842|FG000|Overall Study|COVID-19 Pandemic|2|||
38049516|NCT03339999|69737855|FG000|Overall Study|Adverse Event|1|||
38049517|NCT03339999|69737856|FG001|Overall Study|Adverse Event|2|||
38049518|NCT03339999|69737857|FG002|Overall Study|Adverse Event|2|||
38049519|NCT03339999|69737858|FG003|Overall Study|Adverse Event|1|||
38049520|NCT03339999|69737855|FG000|Overall Study|Lack of Efficacy|0|||
38049521|NCT03339999|69737856|FG001|Overall Study|Lack of Efficacy|1|||
38049522|NCT03339999|69737857|FG002|Overall Study|Lack of Efficacy|0|||
38049523|NCT03339999|69737858|FG003|Overall Study|Lack of Efficacy|0|||
38049524|NCT03339999|69737855|FG000|Overall Study|Lost to Follow-up|0|||
38049525|NCT03339999|69737856|FG001|Overall Study|Lost to Follow-up|0|||
38049526|NCT03339999|69737857|FG002|Overall Study|Lost to Follow-up|0|||
38049527|NCT03339999|69737858|FG003|Overall Study|Lost to Follow-up|1|||
38049528|NCT03339999|69737855|FG000|Overall Study|Study Terminated by Sponsor|6|||
38049529|NCT03339999|69737856|FG001|Overall Study|Study Terminated by Sponsor|3|||
38049530|NCT03339999|69737857|FG002|Overall Study|Study Terminated by Sponsor|4|||
38049531|NCT03339999|69737858|FG003|Overall Study|Study Terminated by Sponsor|3|||
38049532|NCT03339453|69737871|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
38049533|NCT03339453|69737872|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
38049534|NCT03359850|69737916|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
38049535|NCT03359850|69737917|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
38049536|NCT03359850|69737916|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
38049537|NCT03359850|69737917|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
38049538|NCT03359850|69737916|FG000|Extension Phase (Up to 28 Months)|Death|2|||
38049539|NCT03359850|69737917|FG001|Extension Phase (Up to 28 Months)|Death|4|||
38049540|NCT03359850|69737916|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
38049541|NCT03359850|69737917|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
38049542|NCT03359850|69737916|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
38049543|NCT03359850|69737917|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
38049544|NCT00114140|69737936|FG000|Overall Study|Protocol Violation|7|||
38049545|NCT03712345|69737950|FG000|Overall Study|Failure to meet randomization criteria|0|||
38049546|NCT03712345|69737951|FG001|Overall Study|Failure to meet randomization criteria|0|||
38049547|NCT03712345|69737952|FG002|Overall Study|Failure to meet randomization criteria|1|||
38049548|NCT03358290|69737965|FG000|Overall Study|Study discontinued by Sponsor|0|||
38049549|NCT03358290|69737966|FG001|Overall Study|Study discontinued by Sponsor|1|||
38049550|NCT03358290|69737967|FG002|Overall Study|Study discontinued by Sponsor|1|||
38049551|NCT03358290|69737968|FG003|Overall Study|Study discontinued by Sponsor|0|||
38049552|NCT03358290|69737969|FG004|Overall Study|Study discontinued by Sponsor|0|||
38049553|NCT03358290|69737965|FG000|Overall Study|Adverse Event|0|||
38049554|NCT03358290|69737966|FG001|Overall Study|Adverse Event|0|||
38049555|NCT03358290|69737967|FG002|Overall Study|Adverse Event|1|||
38049556|NCT03358290|69737968|FG003|Overall Study|Adverse Event|2|||
38049557|NCT03358290|69737969|FG004|Overall Study|Adverse Event|0|||
38049558|NCT03358290|69737965|FG000|Overall Study|Withdrawal by Subject|0|||
38049559|NCT03358290|69737966|FG001|Overall Study|Withdrawal by Subject|0|||
38049560|NCT03358290|69737967|FG002|Overall Study|Withdrawal by Subject|0|||
38049561|NCT03358290|69737968|FG003|Overall Study|Withdrawal by Subject|0|||
38049562|NCT03358290|69737969|FG004|Overall Study|Withdrawal by Subject|1|||
38049563|NCT03089216|69737985|FG000|Overall Study|Adverse Event|0|||
38049564|NCT03089216|69737986|FG001|Overall Study|Adverse Event|0|||
38049565|NCT03089216|69737987|FG002|Overall Study|Adverse Event|0|||
38049566|NCT03089216|69737988|FG003|Overall Study|Adverse Event|1|||
38049567|NCT03339726|69738005|FG000|Overall Study|Withdrawal by Subject|1|||
38049568|NCT03339726|69738006|FG001|Overall Study|Withdrawal by Subject|0|||
38049569|NCT03339726|69738007|FG002|Overall Study|Withdrawal by Subject|0|||
38049570|NCT03339726|69738005|FG000|Overall Study|Lost to Follow-up|0|||
38049571|NCT03339726|69738006|FG001|Overall Study|Lost to Follow-up|1|||
38049572|NCT03339726|69738007|FG002|Overall Study|Lost to Follow-up|0|||
38049573|NCT03339297|69738017|FG000|Overall Study|Relapse of Hematologic Disease|1|||
38049574|NCT03339297|69738018|FG001|Overall Study|Relapse of Hematologic Disease|0|||
38049575|NCT03339297|69738017|FG000|Overall Study|Death|10|||
38049576|NCT03339297|69738018|FG001|Overall Study|Death|7|||
38049577|NCT03339297|69738017|FG000|Overall Study|Hepatic Candidosis|1|||
38049578|NCT03339297|69738018|FG001|Overall Study|Hepatic Candidosis|0|||
38049579|NCT03339297|69738017|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
38049580|NCT03339297|69738018|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
38049581|NCT03339297|69738017|FG000|Overall Study|Consent Withdrawn by Participant|3|||
38049582|NCT03339297|69738018|FG001|Overall Study|Consent Withdrawn by Participant|3|||
38049583|NCT03339297|69738017|FG000|Overall Study|Disease Relapse|2|||
38049584|NCT03339297|69738018|FG001|Overall Study|Disease Relapse|0|||
38049585|NCT03339297|69738017|FG000|Overall Study|Physician Decision|1|||
38049586|NCT03339297|69738018|FG001|Overall Study|Physician Decision|1|||
38049587|NCT03339297|69738017|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
38049588|NCT03339297|69738018|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
38049589|NCT03339297|69738017|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
38049590|NCT03339297|69738018|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
38049591|NCT03339297|69738017|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
38049592|NCT03339297|69738018|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
38049593|NCT03339297|69738017|FG000|Overall Study|Adverse Event, Non-fatal|1|||
38049594|NCT03339297|69738018|FG001|Overall Study|Adverse Event, Non-fatal|0|||
38049595|NCT03339297|69738017|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
38049596|NCT03339297|69738018|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
38049597|NCT03339297|69738017|FG000|Overall Study|Patient Was Not Eligible|1|||
38049598|NCT03339297|69738018|FG001|Overall Study|Patient Was Not Eligible|0|||
38049599|NCT03713281|69738044|FG000|Overall Study|Lens handling difficuluties|2|||
38049600|NCT03713281|69738044|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
38049601|NCT03339219|69738048|FG000|Overall Study|Death|12|||
38049602|NCT03339219|69738048|FG000|Overall Study|Site Terminated by Sponsor|22|||
38049603|NCT03339219|69738048|FG000|Overall Study|Withdrawal by Subject|1|||
38049604|NCT03338673|69738054|FG000|Overall Study|Lost to Follow-up|1|||
38049605|NCT03338673|69738055|FG001|Overall Study|Lost to Follow-up|1|||
38049606|NCT02949024|69738063|FG000|Overall Study|Withdrawal by Subject|0|||
38049607|NCT02949024|69738064|FG001|Overall Study|Withdrawal by Subject|1|||
38049608|NCT03093428|69738074|FG000|Overall Study|Not eligible for treatment|2|||
38049609|NCT03093428|69738075|FG001|Overall Study|Not eligible for treatment|1|||
38049610|NCT03093428|69738074|FG000|Overall Study|Progression|14|||
38049611|NCT03093428|69738075|FG001|Overall Study|Progression|4|||
38049612|NCT03093428|69738074|FG000|Overall Study|Death|1|||
38049613|NCT03093428|69738075|FG001|Overall Study|Death|0|||
38049614|NCT03093428|69738074|FG000|Overall Study|Adverse Event|1|||
38049615|NCT03093428|69738075|FG001|Overall Study|Adverse Event|0|||
38049616|NCT03093428|69738074|FG000|Overall Study|Withdrawal by Subject|1|||
38049617|NCT03093428|69738075|FG001|Overall Study|Withdrawal by Subject|1|||
38049618|NCT02735980|69738084|FG000|Overall Study|Adverse Event|0|||
38049619|NCT02735980|69738085|FG001|Overall Study|Adverse Event|4|||
38049620|NCT02735980|69738086|FG002|Overall Study|Adverse Event|1|||
38049621|NCT02735980|69738084|FG000|Overall Study|Death|5|||
38049622|NCT02735980|69738085|FG001|Overall Study|Death|4|||
38049623|NCT02735980|69738086|FG002|Overall Study|Death|0|||
38049624|NCT02735980|69738084|FG000|Overall Study|Physician Decision|3|||
38049625|NCT02735980|69738085|FG001|Overall Study|Physician Decision|1|||
38049626|NCT02735980|69738086|FG002|Overall Study|Physician Decision|0|||
38049627|NCT02735980|69738084|FG000|Overall Study|Screen failure|1|||
38049628|NCT02735980|69738085|FG001|Overall Study|Screen failure|0|||
38049629|NCT02735980|69738086|FG002|Overall Study|Screen failure|0|||
38049630|NCT02735980|69738084|FG000|Overall Study|Withdrawal by Subject|1|||
38049631|NCT02735980|69738085|FG001|Overall Study|Withdrawal by Subject|2|||
38049632|NCT02735980|69738086|FG002|Overall Study|Withdrawal by Subject|0|||
38049633|NCT03338400|69738101|FG000|Overall Study|Lost to Follow-up|1|||
38049634|NCT03338400|69738102|FG001|Overall Study|Lost to Follow-up|2|||
38049635|NCT03337113|69738120|FG000|Overall Study|Adverse Event|1|||
38049636|NCT03337113|69738121|FG001|Overall Study|Adverse Event|1|||
38049637|NCT03337113|69738122|FG002|Overall Study|Adverse Event|0|||
38049638|NCT03337113|69738123|FG003|Overall Study|Adverse Event|1|||
38049639|NCT03337113|69738120|FG000|Overall Study|Physician Decision|0|||
38049640|NCT03337113|69738121|FG001|Overall Study|Physician Decision|2|||
38049641|NCT03337113|69738122|FG002|Overall Study|Physician Decision|0|||
38049642|NCT03337113|69738123|FG003|Overall Study|Physician Decision|1|||
38049643|NCT03337113|69738120|FG000|Overall Study|Withdrawal by Subject|0|||
38049644|NCT03337113|69738121|FG001|Overall Study|Withdrawal by Subject|0|||
38049645|NCT03337113|69738122|FG002|Overall Study|Withdrawal by Subject|1|||
38049646|NCT03337113|69738123|FG003|Overall Study|Withdrawal by Subject|0|||
38049647|NCT03092726|69738135|FG000|Overall Study|Adverse Event|3|||
38049648|NCT03092726|69738136|FG001|Overall Study|Adverse Event|10|||
38049649|NCT03092726|69738135|FG000|Overall Study|Lack of Efficacy|0|||
38049650|NCT03092726|69738136|FG001|Overall Study|Lack of Efficacy|1|||
38049651|NCT03092726|69738135|FG000|Overall Study|Lost to Follow-up|1|||
38049652|NCT03092726|69738136|FG001|Overall Study|Lost to Follow-up|0|||
38049653|NCT03092726|69738135|FG000|Overall Study|Withdrawal by Subject|5|||
38049654|NCT03092726|69738136|FG001|Overall Study|Withdrawal by Subject|3|||
37953817|NCT00532779|69640679|FG001|Overall Study|Pregnancy|5|||
37953818|NCT00532779|69640680|FG002|Overall Study|Pregnancy|3|||
37953819|NCT00532779|69640678|FG000|Overall Study|Death|0|||
37953820|NCT00532779|69640679|FG001|Overall Study|Death|1|||
38049655|NCT03338010|69738144|FG000|Overall Study|Withdrawal by Subject|14|||
38049656|NCT03338010|69738145|FG001|Overall Study|Withdrawal by Subject|8|||
38049657|NCT03338010|69738144|FG000|Overall Study|Lost to Follow-up|4|||
38049658|NCT03338010|69738145|FG001|Overall Study|Lost to Follow-up|2|||
38049659|NCT03338010|69738144|FG000|Overall Study|Adverse Event|3|||
38049660|NCT03338010|69738145|FG001|Overall Study|Adverse Event|2|||
38049661|NCT03338010|69738144|FG000|Overall Study|Physician Decision|2|||
38049662|NCT03338010|69738145|FG001|Overall Study|Physician Decision|2|||
38049663|NCT03338010|69738144|FG000|Overall Study|Non-Compliance with Study Drug|0|||
38049664|NCT03338010|69738145|FG001|Overall Study|Non-Compliance with Study Drug|3|||
38049665|NCT03338010|69738144|FG000|Overall Study|Protocol Violation|0|||
38049666|NCT03338010|69738145|FG001|Overall Study|Protocol Violation|1|||
38049667|NCT03337542|69738151|FG000|Overall Study|Withdrew Consent|17|||
37953821|NCT00532779|69640680|FG002|Overall Study|Death|0|||
38049668|NCT03337542|69738151|FG000|Overall Study|Allergic Adverse Event|1|||
38049669|NCT03337542|69738151|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
38049670|NCT03337542|69738151|FG000|Overall Study|Lost to Follow-up|1|||
38049671|NCT03337542|69738151|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
38049672|NCT01328548|69738158|FG000|Overall Study|Death|3|||
38049673|NCT01328548|69738159|FG001|Overall Study|Death|0|||
38049674|NCT01328548|69738158|FG000|Overall Study|Protocol Violation|1|||
38049675|NCT01328548|69738159|FG001|Overall Study|Protocol Violation|0|||
38049676|NCT03337308|69738197|FG000|Overall Study|Adverse Event|2|||
38049677|NCT03337308|69738198|FG001|Overall Study|Adverse Event|3|||
38049678|NCT03337308|69738199|FG002|Overall Study|Adverse Event|3|||
38049679|NCT03337308|69738200|FG003|Overall Study|Adverse Event|1|||
38049680|NCT03337308|69738197|FG000|Overall Study|Lost to Follow-up|1|||
38049681|NCT03337308|69738198|FG001|Overall Study|Lost to Follow-up|2|||
38049682|NCT03337308|69738199|FG002|Overall Study|Lost to Follow-up|0|||
38049683|NCT03337308|69738200|FG003|Overall Study|Lost to Follow-up|0|||
38049684|NCT03337308|69738197|FG000|Overall Study|Withdrawal by Subject|2|||
38049685|NCT03337308|69738198|FG001|Overall Study|Withdrawal by Subject|1|||
38049686|NCT03337308|69738199|FG002|Overall Study|Withdrawal by Subject|2|||
38049687|NCT03337308|69738200|FG003|Overall Study|Withdrawal by Subject|1|||
38049688|NCT03337308|69738197|FG000|Overall Study|Protocol Violation|0|||
38049689|NCT03337308|69738198|FG001|Overall Study|Protocol Violation|1|||
38049690|NCT03337308|69738199|FG002|Overall Study|Protocol Violation|0|||
38049691|NCT03337308|69738200|FG003|Overall Study|Protocol Violation|0|||
38049692|NCT03337152|69738212|FG000|Overall Study|Physician Decision|1|||
38049693|NCT03337152|69738213|FG001|Overall Study|Physician Decision|0|||
38049694|NCT03337152|69738212|FG000|Overall Study|Lost to Follow-up|1|||
38049695|NCT03337152|69738213|FG001|Overall Study|Lost to Follow-up|3|||
38049696|NCT03337152|69738212|FG000|Overall Study|Adverse Event|3|||
38049697|NCT03337152|69738213|FG001|Overall Study|Adverse Event|1|||
38049698|NCT03337152|69738212|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
38049699|NCT03337152|69738213|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
38049700|NCT03091400|69738227|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
38049701|NCT03091400|69738228|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
38049702|NCT01318993|69738234|FG000|Overall Study|Adverse Event|53|||
38049703|NCT01318993|69738234|FG000|Overall Study|Lack of Efficacy|121|||
38049704|NCT01318993|69738234|FG000|Overall Study|Protocol Violation|3|||
38049705|NCT01318993|69738234|FG000|Overall Study|Protocol based stopping criteria|6|||
38049706|NCT01318993|69738234|FG000|Overall Study|Study closed or terminated|174|||
38049707|NCT01318993|69738234|FG000|Overall Study|Lost to Follow-up|4|||
38049708|NCT01318993|69738234|FG000|Overall Study|Physician Decision|13|||
38049709|NCT01318993|69738234|FG000|Overall Study|Withdrawal by Subject|24|||
38049710|NCT03090152|69738241|FG000|Overall Study|Withdrawal by Subject|0|||
38049711|NCT03090152|69738242|FG001|Overall Study|Withdrawal by Subject|2|||
38049712|NCT03090152|69738243|FG002|Overall Study|Withdrawal by Subject|1|||
38049713|NCT03090152|69738241|FG000|Overall Study|Surgery Canceled|1|||
38049714|NCT03090152|69738242|FG001|Overall Study|Surgery Canceled|0|||
38049715|NCT03090152|69738243|FG002|Overall Study|Surgery Canceled|0|||
38049716|NCT03090152|69738241|FG000|Overall Study|Epidural catheter could not be placed|0|||
38049717|NCT03090152|69738242|FG001|Overall Study|Epidural catheter could not be placed|2|||
38049718|NCT03090152|69738243|FG002|Overall Study|Epidural catheter could not be placed|0|||
38049719|NCT04252287|69738253|FG000|Overall Study|Death|5|||
38049720|NCT04252287|69738254|FG001|Overall Study|Death|3|||
38049721|NCT04252287|69738253|FG000|Overall Study|Lost to Follow-up|4|||
38049722|NCT04252287|69738254|FG001|Overall Study|Lost to Follow-up|6|||
38049723|NCT04252287|69738253|FG000|Overall Study|Withdrawal by Subject|19|||
38049724|NCT04252287|69738254|FG001|Overall Study|Withdrawal by Subject|16|||
38049725|NCT04252287|69738253|FG000|Overall Study|Protocol Violation|3|||
38049726|NCT04252287|69738254|FG001|Overall Study|Protocol Violation|4|||
38049727|NCT02735200|69738266|FG000|Overall Study|Lost to Follow-up|0|||
38049728|NCT02735200|69738267|FG001|Overall Study|Lost to Follow-up|5|||
38049729|NCT02735200|69738266|FG000|Overall Study|Withdrawal by Subject|8|||
38049730|NCT02735200|69738267|FG001|Overall Study|Withdrawal by Subject|0|||
38049731|NCT02946918|69738275|FG000|Overall Study|Patient unblinded himself|1|||
38049732|NCT02946918|69738276|FG001|Overall Study|Patient unblinded himself|0|||
38049733|NCT02946918|69738275|FG000|Overall Study|Physician Decision|0|||
38049734|NCT02946918|69738276|FG001|Overall Study|Physician Decision|2|||
38049735|NCT02946918|69738275|FG000|Overall Study|Ran out of study medication|0|||
38049736|NCT02946918|69738276|FG001|Overall Study|Ran out of study medication|1|||
38049737|NCT02734810|69738297|FG000|Overall Study|Adverse Event|1|||
38049738|NCT02734810|69738298|FG001|Overall Study|Adverse Event|0|||
37953822|NCT00532779|69640678|FG000|Overall Study|Drug noncompliance, moved, other|14|||
38049739|NCT02734810|69738297|FG000|Overall Study|Lack of Efficacy|1|||
38049740|NCT02734810|69738298|FG001|Overall Study|Lack of Efficacy|0|||
38049741|NCT03656068|69738323|FG000|Overall Study|Withdrawal by Subject|4|||
38049742|NCT03656068|69738323|FG000|Overall Study|Adverse Event|1|||
38049743|NCT02944383|69738330|FG000|Overall Study|Lost to Follow-up|0|||
38049744|NCT02944383|69738331|FG001|Overall Study|Lost to Follow-up|0|||
38049745|NCT02944383|69738332|FG002|Overall Study|Lost to Follow-up|1|||
38049746|NCT02944383|69738330|FG000|Overall Study|Withdrawal by Subject|1|||
38049747|NCT02944383|69738331|FG001|Overall Study|Withdrawal by Subject|0|||
38049748|NCT02944383|69738332|FG002|Overall Study|Withdrawal by Subject|0|||
38049749|NCT03768089|69738360|FG000|Part A|Lost to Follow-up|0|||
38049750|NCT03768089|69738361|FG001|Part A|Lost to Follow-up|0|||
38049751|NCT03768089|69738362|FG002|Part A|Lost to Follow-up|0|||
38049752|NCT03768089|69738363|FG003|Part A|Lost to Follow-up|0|||
38049753|NCT03768089|69738364|FG004|Part A|Lost to Follow-up|1|||
38049754|NCT03768089|69738365|FG005|Part A|Lost to Follow-up|0|||
38049755|NCT03768089|69738366|FG006|Part A|Lost to Follow-up|0|||
38049756|NCT03768089|69738367|FG007|Part A|Lost to Follow-up|0|||
38049757|NCT03768089|69738368|FG008|Part A|Lost to Follow-up|0|||
38049758|NCT03768089|69738369|FG009|Part A|Lost to Follow-up|0|||
38049759|NCT03768089|69738370|FG010|Part A|Lost to Follow-up|0|||
38049760|NCT03768089|69738371|FG011|Part A|Lost to Follow-up|0|||
38049761|NCT03768089|69738372|FG012|Part A|Lost to Follow-up|0|||
38049762|NCT03768089|69738373|FG013|Part A|Lost to Follow-up|0|||
38049763|NCT03768089|69738374|FG014|Part A|Lost to Follow-up|0|||
38049764|NCT03768089|69738375|FG015|Part A|Lost to Follow-up|0|||
38049765|NCT03768089|69738376|FG016|Part A|Lost to Follow-up|0|||
38049766|NCT03768089|69738377|FG017|Part A|Lost to Follow-up|0|||
38049767|NCT03768089|69738360|FG000|Part C|Randomized, Never Dosed|0|||
38049768|NCT03768089|69738361|FG001|Part C|Randomized, Never Dosed|0|||
38049769|NCT03768089|69738362|FG002|Part C|Randomized, Never Dosed|0|||
38049770|NCT03768089|69738363|FG003|Part C|Randomized, Never Dosed|0|||
38049771|NCT03768089|69738364|FG004|Part C|Randomized, Never Dosed|0|||
38049772|NCT03768089|69738365|FG005|Part C|Randomized, Never Dosed|0|||
38049773|NCT03768089|69738366|FG006|Part C|Randomized, Never Dosed|0|||
38049774|NCT03768089|69738367|FG007|Part C|Randomized, Never Dosed|0|||
38049775|NCT03768089|69738368|FG008|Part C|Randomized, Never Dosed|0|||
38049776|NCT03768089|69738369|FG009|Part C|Randomized, Never Dosed|0|||
38049777|NCT03768089|69738370|FG010|Part C|Randomized, Never Dosed|0|||
38049778|NCT03768089|69738371|FG011|Part C|Randomized, Never Dosed|0|||
38049779|NCT03768089|69738372|FG012|Part C|Randomized, Never Dosed|0|||
38049780|NCT03768089|69738373|FG013|Part C|Randomized, Never Dosed|0|||
38049781|NCT03768089|69738374|FG014|Part C|Randomized, Never Dosed|1|||
38049782|NCT03768089|69738375|FG015|Part C|Randomized, Never Dosed|0|||
38049783|NCT03768089|69738376|FG016|Part C|Randomized, Never Dosed|0|||
38049784|NCT03768089|69738377|FG017|Part C|Randomized, Never Dosed|0|||
38049785|NCT03548584|69738435|FG000|Overall Study|Lost to Follow-up|0|||
38049786|NCT03548584|69738436|FG001|Overall Study|Lost to Follow-up|0|||
38049787|NCT03548584|69738437|FG002|Overall Study|Lost to Follow-up|1|||
38049788|NCT03548584|69738435|FG000|Overall Study|Adverse Event|1|||
38049789|NCT03548584|69738436|FG001|Overall Study|Adverse Event|11|||
38049790|NCT03548584|69738437|FG002|Overall Study|Adverse Event|5|||
38049791|NCT03548584|69738435|FG000|Overall Study|Site Terminated by Sponsor|1|||
38049792|NCT03548584|69738436|FG001|Overall Study|Site Terminated by Sponsor|3|||
38049793|NCT03548584|69738437|FG002|Overall Study|Site Terminated by Sponsor|2|||
38049794|NCT03548584|69738435|FG000|Overall Study|Subject Withdrew Consent to Participate|5|||
38049795|NCT03548584|69738436|FG001|Overall Study|Subject Withdrew Consent to Participate|5|||
38049796|NCT03548584|69738437|FG002|Overall Study|Subject Withdrew Consent to Participate|3|||
38049797|NCT03548584|69738435|FG000|Overall Study|Lack of Efficacy|0|||
38049798|NCT03548584|69738436|FG001|Overall Study|Lack of Efficacy|1|||
38049799|NCT03548584|69738437|FG002|Overall Study|Lack of Efficacy|0|||
38049800|NCT03548584|69738435|FG000|Overall Study|Non-compliance with Study Drug|0|||
38049801|NCT03548584|69738436|FG001|Overall Study|Non-compliance with Study Drug|1|||
38049802|NCT03548584|69738437|FG002|Overall Study|Non-compliance with Study Drug|0|||
38049803|NCT03548584|69738435|FG000|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|0|||
38049804|NCT03548584|69738436|FG001|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
38049805|NCT03548584|69738437|FG002|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
38049806|NCT03086330|69738450|FG000|Overall Study|Withdrawal by Subject|3|||
38049807|NCT03086330|69738451|FG001|Overall Study|Withdrawal by Subject|2|||
38049808|NCT03086330|69738450|FG000|Overall Study|Lost to Follow-up|1|||
38049809|NCT03086330|69738451|FG001|Overall Study|Lost to Follow-up|2|||
38049810|NCT02943993|69738483|FG000|Overall Study|Withdrawal by Subject|52|||
38049811|NCT02943993|69738483|FG000|Overall Study|Transfer to another institution|6|||
38049812|NCT02943993|69738483|FG000|Overall Study|Lost to Follow-up|135|||
38049813|NCT02943993|69738483|FG000|Overall Study|Death|98|||
38049814|NCT02943993|69738483|FG000|Overall Study|Other reason for premature termination|32|||
38049815|NCT02943993|69738483|FG000|Overall Study|Missing reason for termination|7|||
38049816|NCT02943447|69738507|FG000|Blinded Study Phase|Withdrew Consent|1|||
38049817|NCT02943447|69738508|FG001|Blinded Study Phase|Withdrew Consent|2|||
38049818|NCT02943447|69738509|FG002|Blinded Study Phase|Withdrew Consent|1|||
38049819|NCT02943447|69738507|FG000|Blinded Study Phase|Adverse Event|3|||
38049820|NCT02943447|69738508|FG001|Blinded Study Phase|Adverse Event|0|||
38049821|NCT02943447|69738509|FG002|Blinded Study Phase|Adverse Event|0|||
38049822|NCT02943447|69738507|FG000|Blinded Study Phase|Investigator's discretion|1|||
38049823|NCT02943447|69738508|FG001|Blinded Study Phase|Investigator's discretion|0|||
38049824|NCT02943447|69738509|FG002|Blinded Study Phase|Investigator's discretion|0|||
38049825|NCT02943447|69738507|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
38049826|NCT02943447|69738508|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
38049827|NCT02943447|69738509|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
38049828|NCT02943447|69738507|FG000|Open-Label Extension Phase|Adverse Event|4|||
38049829|NCT02943447|69738508|FG001|Open-Label Extension Phase|Adverse Event|7|||
38049830|NCT02943447|69738509|FG002|Open-Label Extension Phase|Adverse Event|3|||
38049831|NCT02943447|69738507|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
38049832|NCT02943447|69738508|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
38049833|NCT02943447|69738509|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
38049834|NCT02943447|69738507|FG000|Open-Label Extension Phase|Withdrew consent|1|||
38049835|NCT02943447|69738508|FG001|Open-Label Extension Phase|Withdrew consent|1|||
38049836|NCT02943447|69738509|FG002|Open-Label Extension Phase|Withdrew consent|1|||
38049837|NCT02943447|69738507|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
38049838|NCT02943447|69738508|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
38049839|NCT02943447|69738509|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
38049840|NCT02844777|69738538|FG000|Overall Study|Withdrawal by Subject|2|||
38049841|NCT02844777|69738539|FG001|Overall Study|Withdrawal by Subject|0|||
38049842|NCT02844777|69738540|FG002|Overall Study|Withdrawal by Subject|0|||
38049843|NCT02612337|69738550|FG000|Overall Study|Lack of Efficacy|1|||
38049844|NCT02612337|69738551|FG001|Overall Study|Lack of Efficacy|0|||
38049845|NCT02612337|69738550|FG000|Overall Study|Withdrawal by Subject|2|||
38049846|NCT02612337|69738551|FG001|Overall Study|Withdrawal by Subject|2|||
38049847|NCT02612337|69738550|FG000|Overall Study|Did not receive study drug|0|||
38049848|NCT02612337|69738551|FG001|Overall Study|Did not receive study drug|1|||
38049849|NCT03532451|69738565|FG000|Overall Study|Withdrawal by Subject|0|||
38049850|NCT03532451|69738566|FG001|Overall Study|Withdrawal by Subject|1|||
38049851|NCT03532451|69738565|FG000|Overall Study|Progression prior to the surgery|1|||
38049852|NCT03532451|69738566|FG001|Overall Study|Progression prior to the surgery|0|||
38049853|NCT03085238|69738572|FG000|Overall Study|Adverse Event|2|||
38049854|NCT03085238|69738572|FG000|Overall Study|Death|2|||
38049855|NCT03383666|69738585|FG000|Overall Study|Withdrawal by Subject|2|||
38049856|NCT03383666|69738585|FG000|Overall Study|Lost to Follow-up|2|||
38049857|NCT03086018|69738589|FG000|Final Testing for End of Trial|Adverse Event|1|||
38049858|NCT03086018|69738589|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
38049859|NCT03319953|69738599|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
38049860|NCT03319953|69738600|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
38049861|NCT03319953|69738601|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
38049862|NCT03319953|69738602|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
38049863|NCT03319953|69738599|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
38049864|NCT03319953|69738600|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
38049865|NCT03319953|69738601|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
38049866|NCT03319953|69738602|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
38049867|NCT02927834|69738613|FG000|Overall Study|Lost to Follow-up|1|||
38049868|NCT02927834|69738614|FG001|Overall Study|Lost to Follow-up|2|||
38049869|NCT02927834|69738615|FG002|Overall Study|Lost to Follow-up|2|||
38049870|NCT01964547|69738629|FG000|Overall Study|Adverse Event|8|||
38049871|NCT01964547|69738630|FG001|Overall Study|Adverse Event|2|||
38049872|NCT01964547|69738629|FG000|Overall Study|Withdrawal by Subject|4|||
38049873|NCT01964547|69738630|FG001|Overall Study|Withdrawal by Subject|7|||
38049874|NCT01964547|69738629|FG000|Overall Study|Lost to Follow-up|0|||
38049875|NCT01964547|69738630|FG001|Overall Study|Lost to Follow-up|1|||
38049876|NCT01964547|69738629|FG000|Overall Study|Withdrawal by Investigator|0|||
38049877|NCT01964547|69738630|FG001|Overall Study|Withdrawal by Investigator|1|||
38049878|NCT03319719|69738636|FG000|Overall Study|Lost to Follow-up|1|||
38049879|NCT03318783|69738644|FG000|Overall Study|Withdrawal by Subject|0|||
38049880|NCT03318783|69738645|FG001|Overall Study|Withdrawal by Subject|1|||
38049881|NCT03318783|69738644|FG000|Overall Study|Death|0|||
38049882|NCT03318783|69738645|FG001|Overall Study|Death|1|||
38049883|NCT01313689|69738656|FG000|24-Week Randomization 1|Adverse Event|10|||
38049884|NCT01313689|69738657|FG001|24-Week Randomization 1|Adverse Event|5|||
38049885|NCT01313689|69738658|FG002|24-Week Randomization 1|Adverse Event|0|||
38049886|NCT01313689|69738659|FG003|24-Week Randomization 1|Adverse Event|0|||
38049887|NCT01313689|69738660|FG004|24-Week Randomization 1|Adverse Event|0|||
38049888|NCT01313689|69738656|FG000|24-Week Randomization 1|Physician Decision|4|||
38049889|NCT01313689|69738657|FG001|24-Week Randomization 1|Physician Decision|5|||
38049890|NCT01313689|69738658|FG002|24-Week Randomization 1|Physician Decision|0|||
38049891|NCT01313689|69738659|FG003|24-Week Randomization 1|Physician Decision|0|||
38049892|NCT01313689|69738660|FG004|24-Week Randomization 1|Physician Decision|0|||
38049893|NCT01313689|69738656|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
38049894|NCT01313689|69738657|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
38049895|NCT01313689|69738658|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
38049896|NCT01313689|69738659|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
38049897|NCT01313689|69738660|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
38049898|NCT01313689|69738656|FG000|24-Week Randomization 2|Adverse Event|0|||
38049899|NCT01313689|69738657|FG001|24-Week Randomization 2|Adverse Event|0|||
38049900|NCT01313689|69738658|FG002|24-Week Randomization 2|Adverse Event|2|||
38049901|NCT01313689|69738659|FG003|24-Week Randomization 2|Adverse Event|0|||
38049902|NCT01313689|69738660|FG004|24-Week Randomization 2|Adverse Event|8|||
38049903|NCT01313689|69738656|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
38049904|NCT01313689|69738657|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
38049905|NCT01313689|69738658|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
38049906|NCT01313689|69738659|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
38049907|NCT01313689|69738660|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
38049908|NCT01313689|69738656|FG000|24-Week Randomization 2|Physician Decision|0|||
38049909|NCT01313689|69738657|FG001|24-Week Randomization 2|Physician Decision|0|||
38049910|NCT01313689|69738658|FG002|24-Week Randomization 2|Physician Decision|0|||
38049911|NCT01313689|69738659|FG003|24-Week Randomization 2|Physician Decision|0|||
38049912|NCT01313689|69738660|FG004|24-Week Randomization 2|Physician Decision|4|||
38049913|NCT03318315|69738682|FG000|Overall Study|Lost to Follow-up|3|||
38049914|NCT03318315|69738683|FG001|Overall Study|Lost to Follow-up|2|||
38049915|NCT03318315|69738684|FG002|Overall Study|Lost to Follow-up|1|||
38049916|NCT03318315|69738682|FG000|Overall Study|Protocol Violation|1|||
38049917|NCT03318315|69738683|FG001|Overall Study|Protocol Violation|1|||
38049918|NCT03318315|69738684|FG002|Overall Study|Protocol Violation|1|||
38049919|NCT03318315|69738682|FG000|Overall Study|Withdrawal by Subject|0|||
37953823|NCT00532779|69640679|FG001|Overall Study|Drug noncompliance, moved, other|23|||
37953824|NCT00532779|69640680|FG002|Overall Study|Drug noncompliance, moved, other|29|||
38049920|NCT03318315|69738683|FG001|Overall Study|Withdrawal by Subject|0|||
38049921|NCT03318315|69738684|FG002|Overall Study|Withdrawal by Subject|2|||
38049922|NCT04460183|69738695|FG000|Overall Study|Lost to Follow-up|3|||
38049923|NCT04460183|69738696|FG001|Overall Study|Lost to Follow-up|1|||
38049924|NCT04460183|69738695|FG000|Overall Study|Withdrawal by Subject|1|||
38049925|NCT04460183|69738696|FG001|Overall Study|Withdrawal by Subject|0|||
38049926|NCT03710083|69738702|FG000|Overall Study|Withdrawal by Subject|2|||
38049927|NCT03710083|69738702|FG000|Overall Study|Unsuccessful Procedure|1|||
38049928|NCT03318003|69738708|FG000|Overall Study|Withdrawal by Subject|1|||
38049929|NCT03318003|69738709|FG001|Overall Study|Withdrawal by Subject|1|||
38049930|NCT03318003|69738708|FG000|Overall Study|fetal loss|0|||
38049931|NCT03318003|69738709|FG001|Overall Study|fetal loss|1|||
38049932|NCT03317379|69738718|FG000|Overall Study|Lost to Follow-up|0|||
38049933|NCT03317379|69738719|FG001|Overall Study|Lost to Follow-up|3|||
38049934|NCT03317379|69738720|FG002|Overall Study|Lost to Follow-up|2|||
38049935|NCT03316911|69738730|FG000|Overall Study|Lost to Follow-up|33|||
38049936|NCT03316911|69738731|FG001|Overall Study|Lost to Follow-up|29|||
38049937|NCT01106391|69738737|FG000|Overall Study|Death|12|||
38049938|NCT01106391|69738737|FG000|Overall Study|Withdrawal by Subject|7|||
38049939|NCT03316131|69738741|FG000|Treatment Period 2|Protocol deviation|1|||
38049940|NCT03316131|69738742|FG001|Treatment Period 2|Protocol deviation|0|||
38049941|NCT03301415|69738748|FG000|Overall Study|Lost to Follow-up|2|||
38049942|NCT03301415|69738748|FG000|Overall Study|Unable to comply with visit schedule|2|||
38049943|NCT02732938|69738754|FG000|Overall Study|Death|0|||
38049944|NCT02732938|69738755|FG001|Overall Study|Death|11|||
38049945|NCT02732938|69738756|FG002|Overall Study|Death|0|||
38049946|NCT02732938|69738754|FG000|Overall Study|Randomized but did not receive treatment|0|||
38049947|NCT02732938|69738755|FG001|Overall Study|Randomized but did not receive treatment|1|||
38049948|NCT02732938|69738756|FG002|Overall Study|Randomized but did not receive treatment|0|||
38049949|NCT02732938|69738754|FG000|Overall Study|Refused further follow-up|1|||
38049950|NCT02732938|69738755|FG001|Overall Study|Refused further follow-up|0|||
38049951|NCT02732938|69738756|FG002|Overall Study|Refused further follow-up|0|||
38049952|NCT02732938|69738754|FG000|Overall Study|Study terminated by sponsor|3|||
38049953|NCT02732938|69738755|FG001|Overall Study|Study terminated by sponsor|6|||
38049954|NCT02732938|69738756|FG002|Overall Study|Study terminated by sponsor|0|||
38049955|NCT04647721|69738764|FG000|Overall Study|Withdrawal by Subject|0|||
38049956|NCT04647721|69738765|FG001|Overall Study|Withdrawal by Subject|2|||
38049957|NCT04647721|69738764|FG000|Overall Study|Lost to Follow-up|2|||
38049958|NCT04647721|69738765|FG001|Overall Study|Lost to Follow-up|0|||
38049959|NCT03718000|69738786|FG000|Overall Study|Relocation|2|||
38049960|NCT03718000|69738787|FG001|Overall Study|Relocation|4|||
38049961|NCT03718000|69738786|FG000|Overall Study|Pregnancy|0|||
38049962|NCT03718000|69738787|FG001|Overall Study|Pregnancy|1|||
38049963|NCT03063203|69738794|FG000|Overall Study|Chose alternative therapy|3|||
38049964|NCT03063203|69738794|FG000|Overall Study|Death|2|||
38049965|NCT03063203|69738794|FG000|Overall Study|Disease progression|4|||
38049966|NCT03063203|69738794|FG000|Overall Study|Physician Decision|5|||
38049967|NCT02891226|69738813|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
38049968|NCT02891226|69738814|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
38049969|NCT02891226|69738815|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
38049970|NCT02891226|69738816|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
38049971|NCT02891226|69738817|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
38049972|NCT02891226|69738818|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
38049973|NCT02891226|69738819|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
38049974|NCT02891226|69738820|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
38049975|NCT02891226|69738821|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
38049976|NCT02891226|69738822|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
38049977|NCT02891226|69738823|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
38049978|NCT02891226|69738824|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
38049979|NCT02891226|69738825|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
38049980|NCT02891226|69738826|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
38049981|NCT02891226|69738827|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
38049982|NCT02891226|69738828|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
38049983|NCT02891226|69738813|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
38049984|NCT02891226|69738814|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
38049985|NCT02891226|69738815|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
38049986|NCT02891226|69738816|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
38049987|NCT02891226|69738817|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
38049988|NCT02891226|69738818|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
38049989|NCT02891226|69738819|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
38049990|NCT02891226|69738820|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
38049991|NCT02891226|69738821|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
38049992|NCT02891226|69738822|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
38049993|NCT02891226|69738823|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
38049994|NCT02891226|69738824|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
38049995|NCT02891226|69738825|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
38049996|NCT02891226|69738826|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
38049997|NCT02891226|69738827|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
38049998|NCT02891226|69738828|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
38049999|NCT02891226|69738813|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
38050000|NCT02891226|69738814|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
38050001|NCT02891226|69738815|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
38050002|NCT02891226|69738816|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
38050003|NCT02891226|69738817|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
38050004|NCT02891226|69738818|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
38050005|NCT02891226|69738819|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
38050006|NCT02891226|69738820|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
38050007|NCT02891226|69738821|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
38050008|NCT02891226|69738822|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
38050009|NCT02891226|69738823|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
38050010|NCT02891226|69738824|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
38050011|NCT02891226|69738825|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
38050012|NCT02891226|69738826|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
38050013|NCT02891226|69738827|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
38050014|NCT02891226|69738828|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
38050015|NCT02891226|69738813|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
38050016|NCT02891226|69738814|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
38050017|NCT02891226|69738815|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
38050018|NCT02891226|69738816|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
38050019|NCT02891226|69738817|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
38050020|NCT02891226|69738818|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
38050021|NCT02891226|69738819|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
38050022|NCT02891226|69738820|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
38050023|NCT02891226|69738821|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
38050024|NCT02891226|69738822|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
38050025|NCT02891226|69738823|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
38050026|NCT02891226|69738824|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
38050027|NCT02891226|69738825|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
38050028|NCT02891226|69738826|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
38050029|NCT02891226|69738827|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
38050030|NCT02891226|69738828|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
38050031|NCT02891226|69738813|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
38050032|NCT02891226|69738814|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
38050033|NCT02891226|69738815|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
38050034|NCT02891226|69738816|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
38050035|NCT02891226|69738817|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
38050036|NCT02891226|69738818|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
38050037|NCT02891226|69738819|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
38050038|NCT02891226|69738820|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
38050039|NCT02891226|69738821|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
38050040|NCT02891226|69738822|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
38050041|NCT02891226|69738823|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
38050042|NCT02891226|69738824|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
38050043|NCT02891226|69738825|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
38050044|NCT02891226|69738826|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
38050045|NCT02891226|69738827|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
38050046|NCT02891226|69738828|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
38050047|NCT02891226|69738813|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
38050048|NCT02891226|69738814|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
38050049|NCT02891226|69738815|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
38050050|NCT02891226|69738816|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
38050051|NCT02891226|69738817|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
38050052|NCT02891226|69738818|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
38050053|NCT02891226|69738819|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
38050054|NCT02891226|69738820|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
38050055|NCT02891226|69738821|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
38050056|NCT02891226|69738822|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
38050057|NCT02891226|69738823|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
38050058|NCT02891226|69738824|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
38050059|NCT02891226|69738825|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
38050060|NCT02891226|69738826|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
38050061|NCT02891226|69738827|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
38050062|NCT02891226|69738828|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
38050063|NCT02891226|69738813|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
38050064|NCT02891226|69738814|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
38050065|NCT02891226|69738815|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
38050066|NCT02891226|69738816|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
38050067|NCT02891226|69738817|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
38050068|NCT02891226|69738818|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
38050069|NCT02891226|69738819|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
38050070|NCT02891226|69738820|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
38050071|NCT02891226|69738821|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
38050072|NCT02891226|69738822|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
38050073|NCT02891226|69738823|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
38050074|NCT02891226|69738824|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
38050075|NCT02891226|69738825|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
38050076|NCT02891226|69738826|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
38050077|NCT02891226|69738827|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
38050078|NCT02891226|69738828|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
38050079|NCT02891226|69738813|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
38050080|NCT02891226|69738814|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
38050081|NCT02891226|69738815|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
38050082|NCT02891226|69738816|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
38050083|NCT02891226|69738817|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
38050084|NCT02891226|69738818|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
38050085|NCT02891226|69738819|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
38050086|NCT02891226|69738820|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
38050087|NCT02891226|69738821|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
38050088|NCT02891226|69738822|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
38050089|NCT02891226|69738823|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
38050090|NCT02891226|69738824|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
38050091|NCT02891226|69738825|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
38050092|NCT02891226|69738826|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
38050093|NCT02891226|69738827|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
38050094|NCT02891226|69738828|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
38050095|NCT02891226|69738813|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
38050096|NCT02891226|69738814|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
38050097|NCT02891226|69738815|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
38050098|NCT02891226|69738816|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
38050099|NCT02891226|69738817|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
38050100|NCT02891226|69738818|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
38050101|NCT02891226|69738819|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
38050102|NCT02891226|69738820|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
38050103|NCT02891226|69738821|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
38050104|NCT02891226|69738822|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
38050105|NCT02891226|69738823|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
38050106|NCT02891226|69738824|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
38050107|NCT02891226|69738825|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
38050108|NCT02891226|69738826|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
38050109|NCT02891226|69738827|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
38050110|NCT02891226|69738828|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
38050111|NCT02891226|69738813|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
38050112|NCT02891226|69738814|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
38050113|NCT02891226|69738815|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
38050114|NCT02891226|69738816|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
38050115|NCT02891226|69738817|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
38050116|NCT02891226|69738818|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
38050117|NCT02891226|69738819|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
38050118|NCT02891226|69738820|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
38050119|NCT02891226|69738821|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
38050120|NCT02891226|69738822|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
38050121|NCT02891226|69738823|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
38050122|NCT02891226|69738824|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
38050123|NCT02891226|69738825|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
38050124|NCT02891226|69738826|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
38050125|NCT02891226|69738827|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
38050126|NCT02891226|69738828|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
38050127|NCT02891226|69738813|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
38050128|NCT02891226|69738814|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
38050129|NCT02891226|69738815|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
38050130|NCT02891226|69738816|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
38050131|NCT02891226|69738817|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
38050132|NCT02891226|69738818|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
38050133|NCT02891226|69738819|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
38050134|NCT02891226|69738820|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
38050135|NCT02891226|69738821|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
38050136|NCT02891226|69738822|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
38050137|NCT02891226|69738823|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
38050138|NCT02891226|69738824|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
38050139|NCT02891226|69738825|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
38050140|NCT02891226|69738826|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
38050141|NCT02891226|69738827|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
38050142|NCT02891226|69738828|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
38050143|NCT02891226|69738813|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
38050144|NCT02891226|69738814|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
38050145|NCT02891226|69738815|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
38050146|NCT02891226|69738816|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
38050147|NCT02891226|69738817|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
38050148|NCT02891226|69738818|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
38050149|NCT02891226|69738819|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
38050150|NCT02891226|69738820|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
38050151|NCT02891226|69738821|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
38050152|NCT02891226|69738822|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
38050153|NCT02891226|69738823|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
38050154|NCT02891226|69738824|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
38050155|NCT02891226|69738825|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
38050156|NCT02891226|69738826|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
38050157|NCT02891226|69738827|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
38050158|NCT02891226|69738828|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
38050159|NCT02891226|69738813|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
38050160|NCT02891226|69738814|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
38050161|NCT02891226|69738815|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
38050162|NCT02891226|69738816|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
38050163|NCT02891226|69738817|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
38050164|NCT02891226|69738818|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
38050165|NCT02891226|69738819|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
38050166|NCT02891226|69738820|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
38050167|NCT02891226|69738821|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
38050168|NCT02891226|69738822|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
38050169|NCT02891226|69738823|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
38050170|NCT02891226|69738824|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
38050171|NCT02891226|69738825|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
38050172|NCT02891226|69738826|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
38050173|NCT02891226|69738827|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
38050174|NCT02891226|69738828|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
38050175|NCT02891226|69738813|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
38050176|NCT02891226|69738814|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
38050177|NCT02891226|69738815|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
38050178|NCT02891226|69738816|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
38050179|NCT02891226|69738817|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
38050180|NCT02891226|69738818|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
38050181|NCT02891226|69738819|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
38050182|NCT02891226|69738820|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
38050183|NCT02891226|69738821|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
38050184|NCT02891226|69738822|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
38050185|NCT02891226|69738823|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
38050186|NCT02891226|69738824|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
38050187|NCT02891226|69738825|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
38050188|NCT02891226|69738826|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
38050189|NCT02891226|69738827|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
38050190|NCT02891226|69738828|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
38050191|NCT02891226|69738813|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
38050192|NCT02891226|69738814|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
38050193|NCT02891226|69738815|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
38050194|NCT02891226|69738816|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
38050195|NCT02891226|69738817|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
38050196|NCT02891226|69738818|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
38050197|NCT02891226|69738819|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
38050198|NCT02891226|69738820|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
38050199|NCT02891226|69738821|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
38050200|NCT02891226|69738822|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
38050201|NCT02891226|69738823|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
38050202|NCT02891226|69738824|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
38050203|NCT02891226|69738825|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
38050204|NCT02891226|69738826|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
38050205|NCT02891226|69738827|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
38050206|NCT02891226|69738828|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
38050207|NCT02891226|69738813|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
38050208|NCT02891226|69738814|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
38050209|NCT02891226|69738815|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
38050210|NCT02891226|69738816|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
38050211|NCT02891226|69738817|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
38050212|NCT02891226|69738818|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
38050213|NCT02891226|69738819|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
38050214|NCT02891226|69738820|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
38050215|NCT02891226|69738821|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
38050216|NCT02891226|69738822|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
38050217|NCT02891226|69738823|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
38050218|NCT02891226|69738824|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
38050219|NCT02891226|69738825|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
38050220|NCT02891226|69738826|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
38050221|NCT02891226|69738827|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
38050222|NCT02891226|69738828|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
38050223|NCT02891226|69738813|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
38050224|NCT02891226|69738814|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
37953825|NCT00500266|69640688|FG000|Overall Study|Death|3|||
37953826|NCT00500266|69640688|FG000|Overall Study|Lost to Follow-up|3|||
38050225|NCT02891226|69738815|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
38050226|NCT02891226|69738816|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
38050227|NCT02891226|69738817|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
38050228|NCT02891226|69738818|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
38050229|NCT02891226|69738819|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
38050230|NCT02891226|69738820|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
38050231|NCT02891226|69738821|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
38050232|NCT02891226|69738822|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
38050233|NCT02891226|69738823|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
38050234|NCT02891226|69738824|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
38050235|NCT02891226|69738825|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
38050236|NCT02891226|69738826|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
38050237|NCT02891226|69738827|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
38050238|NCT02891226|69738828|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
38050239|NCT02891226|69738813|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
38050240|NCT02891226|69738814|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
38050241|NCT02891226|69738815|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
38050242|NCT02891226|69738816|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
38050243|NCT02891226|69738817|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
38050244|NCT02891226|69738818|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
38050245|NCT02891226|69738819|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
38050246|NCT02891226|69738820|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
38050247|NCT02891226|69738821|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
38050248|NCT02891226|69738822|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
38050249|NCT02891226|69738823|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
38050250|NCT02891226|69738824|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
38050251|NCT02891226|69738825|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
38050252|NCT02891226|69738826|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
38050253|NCT02891226|69738827|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
38050254|NCT02891226|69738828|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
38050255|NCT02891226|69738813|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
38050256|NCT02891226|69738814|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
38050257|NCT02891226|69738815|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
38050258|NCT02891226|69738816|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
38050259|NCT02891226|69738817|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
38050260|NCT02891226|69738818|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
38050261|NCT02891226|69738819|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
38050262|NCT02891226|69738820|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
38050263|NCT02891226|69738821|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
38050264|NCT02891226|69738822|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
38050265|NCT02891226|69738823|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
38050266|NCT02891226|69738824|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
38050267|NCT02891226|69738825|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
38050268|NCT02891226|69738826|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
38050269|NCT02891226|69738827|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
38050270|NCT02891226|69738828|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
38050271|NCT02891226|69738813|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
38050272|NCT02891226|69738814|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
38050273|NCT02891226|69738815|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
38050274|NCT02891226|69738816|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
38050275|NCT02891226|69738817|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
38050276|NCT02891226|69738818|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
38050277|NCT02891226|69738819|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
38050278|NCT02891226|69738820|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
38050279|NCT02891226|69738821|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
38050280|NCT02891226|69738822|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
37861819|NCT00929695|69545524|FG001|Overall Study|incorrect stratification|0|||
37861820|NCT00927355|69545537|FG000|Overall Study|Adverse Event|1|||
38050281|NCT02891226|69738823|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
38050282|NCT02891226|69738824|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
38050283|NCT02891226|69738825|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
38050284|NCT02891226|69738826|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
38050285|NCT02891226|69738827|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
38050286|NCT02891226|69738828|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
38050287|NCT02891226|69738813|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
38050288|NCT02891226|69738814|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
38050289|NCT02891226|69738815|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
38050290|NCT02891226|69738816|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
38050291|NCT02891226|69738817|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
38050292|NCT02891226|69738818|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
38050293|NCT02891226|69738819|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
38050294|NCT02891226|69738820|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
38050295|NCT02891226|69738821|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
38050296|NCT02891226|69738822|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
38050297|NCT02891226|69738823|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
38050298|NCT02891226|69738824|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
38050299|NCT02891226|69738825|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
38050300|NCT02891226|69738826|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
38050301|NCT02891226|69738827|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
38050302|NCT02891226|69738828|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
38050303|NCT02891226|69738813|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
38050304|NCT02891226|69738814|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
38050305|NCT02891226|69738815|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
38050306|NCT02891226|69738816|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
38050307|NCT02891226|69738817|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
38050308|NCT02891226|69738818|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
38050309|NCT02891226|69738819|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
38050310|NCT02891226|69738820|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
38050311|NCT02891226|69738821|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
38050312|NCT02891226|69738822|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
38050313|NCT02891226|69738823|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
38050314|NCT02891226|69738824|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
38050315|NCT02891226|69738825|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
38050316|NCT02891226|69738826|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
38050317|NCT02891226|69738827|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
38050318|NCT02891226|69738828|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
38050319|NCT02891226|69738813|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
38050320|NCT02891226|69738814|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
38050321|NCT02891226|69738815|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
38050322|NCT02891226|69738816|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
38050323|NCT02891226|69738817|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
38050324|NCT02891226|69738818|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
38050325|NCT02891226|69738819|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
38050326|NCT02891226|69738820|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
38050327|NCT02891226|69738821|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
38050328|NCT02891226|69738822|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
38050329|NCT02891226|69738823|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
38050330|NCT02891226|69738824|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
38050331|NCT02891226|69738825|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
38050332|NCT02891226|69738826|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
38050333|NCT02891226|69738827|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
38050334|NCT02891226|69738828|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
38050335|NCT02891226|69738813|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
38050336|NCT02891226|69738814|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
37861821|NCT00927355|69545538|FG001|Overall Study|Adverse Event|1|||
37861822|NCT00923845|69545558|FG000|Induction Therapy|Poor performance status|0|||
37861823|NCT00923845|69545559|FG001|Induction Therapy|Poor performance status|2|||
38050337|NCT02891226|69738815|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
38050338|NCT02891226|69738816|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
38050339|NCT02891226|69738817|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
38050340|NCT02891226|69738818|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
38050341|NCT02891226|69738819|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
38050342|NCT02891226|69738820|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
38050343|NCT02891226|69738821|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
38050344|NCT02891226|69738822|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
38050345|NCT02891226|69738823|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
38050346|NCT02891226|69738824|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
38050347|NCT02891226|69738825|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
38050348|NCT02891226|69738826|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
38050349|NCT02891226|69738827|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
38050350|NCT02891226|69738828|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
38050351|NCT02891226|69738813|FG000|Follow-up Period|Withdrawal by Subject|0|||
38050352|NCT02891226|69738814|FG001|Follow-up Period|Withdrawal by Subject|0|||
38050353|NCT02891226|69738815|FG002|Follow-up Period|Withdrawal by Subject|0|||
38050354|NCT02891226|69738816|FG003|Follow-up Period|Withdrawal by Subject|0|||
38050355|NCT02891226|69738817|FG004|Follow-up Period|Withdrawal by Subject|0|||
38050356|NCT02891226|69738818|FG005|Follow-up Period|Withdrawal by Subject|0|||
38050357|NCT02891226|69738819|FG006|Follow-up Period|Withdrawal by Subject|0|||
37953827|NCT00500266|69640688|FG000|Overall Study|Withdrawal by Subject|3|||
37953828|NCT00500266|69640688|FG000|Overall Study|Assigned, not treated|4|||
37953829|NCT00500110|69640693|FG000|Overall Study|Withdrawal by Subject|3|||
37953830|NCT00534495|69640699|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
37953831|NCT00534495|69640700|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
37953832|NCT00534495|69640701|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
37953833|NCT00534495|69640699|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
38050358|NCT02891226|69738820|FG007|Follow-up Period|Withdrawal by Subject|0|||
38050359|NCT02891226|69738821|FG008|Follow-up Period|Withdrawal by Subject|0|||
38050360|NCT02891226|69738822|FG009|Follow-up Period|Withdrawal by Subject|0|||
38050361|NCT02891226|69738823|FG010|Follow-up Period|Withdrawal by Subject|0|||
38050362|NCT02891226|69738824|FG011|Follow-up Period|Withdrawal by Subject|1|||
38050363|NCT02891226|69738825|FG012|Follow-up Period|Withdrawal by Subject|0|||
38050364|NCT02891226|69738826|FG013|Follow-up Period|Withdrawal by Subject|0|||
38050365|NCT02891226|69738827|FG014|Follow-up Period|Withdrawal by Subject|1|||
38050366|NCT02891226|69738828|FG015|Follow-up Period|Withdrawal by Subject|1|||
38050367|NCT03612856|69738855|FG000|Pre-dose Period|Physician Decision|0|||
38050368|NCT03612856|69738856|FG001|Pre-dose Period|Physician Decision|1|||
38050369|NCT03612856|69738857|FG002|Pre-dose Period|Physician Decision|1|||
38050370|NCT03612856|69738855|FG000|Pre-dose Period|Withdrawal by Subject|0|||
38050371|NCT03612856|69738856|FG001|Pre-dose Period|Withdrawal by Subject|1|||
38050372|NCT03612856|69738857|FG002|Pre-dose Period|Withdrawal by Subject|0|||
38050373|NCT03333837|69738870|FG000|Overall Study|Adverse Event|2|||
38050374|NCT03333837|69738871|FG001|Overall Study|Adverse Event|1|||
38050375|NCT03333837|69738872|FG002|Overall Study|Adverse Event|1|||
38050376|NCT03333837|69738873|FG003|Overall Study|Adverse Event|1|||
38050377|NCT03333837|69738874|FG004|Overall Study|Adverse Event|0|||
38050378|NCT03333837|69738870|FG000|Overall Study|Caregiver withdrew|0|||
38050379|NCT03333837|69738871|FG001|Overall Study|Caregiver withdrew|2|||
38050380|NCT03333837|69738872|FG002|Overall Study|Caregiver withdrew|1|||
38050381|NCT03333837|69738873|FG003|Overall Study|Caregiver withdrew|0|||
38050382|NCT03333837|69738874|FG004|Overall Study|Caregiver withdrew|0|||
38050383|NCT03333837|69738870|FG000|Overall Study|Withdrawal by Subject|0|||
38050384|NCT03333837|69738871|FG001|Overall Study|Withdrawal by Subject|0|||
37953834|NCT00534495|69640700|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
37953835|NCT00534495|69640701|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
37953836|NCT00534495|69640699|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
37953837|NCT00534495|69640700|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
37953838|NCT00534495|69640701|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
37953839|NCT00534495|69640699|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
37953840|NCT00534495|69640700|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
37953841|NCT00534495|69640701|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
37953842|NCT00534495|69640699|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
37953843|NCT00534495|69640700|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
37953844|NCT00534495|69640701|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
38050385|NCT03333837|69738872|FG002|Overall Study|Withdrawal by Subject|1|||
38050386|NCT03333837|69738873|FG003|Overall Study|Withdrawal by Subject|1|||
38050387|NCT03333837|69738874|FG004|Overall Study|Withdrawal by Subject|3|||
38050388|NCT03333837|69738870|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
38050389|NCT03333837|69738871|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
38050390|NCT03333837|69738872|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
38050391|NCT03333837|69738873|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
38050392|NCT03333837|69738874|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
38050393|NCT03708211|69738892|FG000|Overall Study|Progressive Disease|10|||
38050394|NCT03708211|69738893|FG001|Overall Study|Progressive Disease|7|||
38050395|NCT03708211|69738892|FG000|Overall Study|Withdrawal by Subject|0|||
38050396|NCT03708211|69738893|FG001|Overall Study|Withdrawal by Subject|1|||
38050397|NCT03708211|69738892|FG000|Overall Study|Other|2|||
38050398|NCT03708211|69738893|FG001|Overall Study|Other|0|||
38050399|NCT02948634|69738903|FG000|Overall Study|Lack of efficacy and study suspended|10|||
38050400|NCT02948634|69738904|FG001|Overall Study|Lack of efficacy and study suspended|2|||
38050401|NCT02945046|69738913|FG000|Overall Study|Adverse Event|1|||
38050402|NCT02945046|69738914|FG001|Overall Study|Adverse Event|0|||
38050403|NCT02945046|69738915|FG002|Overall Study|Adverse Event|2|||
38050404|NCT02945046|69738913|FG000|Overall Study|Withdrawal by Subject|3|||
38050405|NCT02945046|69738914|FG001|Overall Study|Withdrawal by Subject|3|||
38050406|NCT02945046|69738915|FG002|Overall Study|Withdrawal by Subject|3|||
38050407|NCT02945046|69738913|FG000|Overall Study|Protocol Violation|2|||
38050408|NCT02945046|69738914|FG001|Overall Study|Protocol Violation|3|||
38050409|NCT02945046|69738915|FG002|Overall Study|Protocol Violation|2|||
38050410|NCT02945046|69738913|FG000|Overall Study|Lost to Follow-up|1|||
38050411|NCT02945046|69738914|FG001|Overall Study|Lost to Follow-up|1|||
38050412|NCT02945046|69738915|FG002|Overall Study|Lost to Follow-up|0|||
38050413|NCT02945046|69738913|FG000|Overall Study|Lack of Efficacy|1|||
38050414|NCT02945046|69738914|FG001|Overall Study|Lack of Efficacy|2|||
38050415|NCT02945046|69738915|FG002|Overall Study|Lack of Efficacy|1|||
38050416|NCT02945046|69738913|FG000|Overall Study|Other than specified|5|||
38050417|NCT02945046|69738914|FG001|Overall Study|Other than specified|4|||
38050418|NCT02945046|69738915|FG002|Overall Study|Other than specified|7|||
38050419|NCT03705793|69738925|FG000|Overall Study|Lost to Follow-up|3|||
38050420|NCT03705793|69738926|FG001|Overall Study|Lost to Follow-up|4|||
38050421|NCT03705793|69738925|FG000|Overall Study|Withdrawal by Subject|2|||
38050422|NCT03705793|69738926|FG001|Overall Study|Withdrawal by Subject|1|||
38050423|NCT02944968|69738945|FG000|Overall Study|Subject excluded before study procedure|1|||
38050424|NCT02944968|69738945|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
38050425|NCT03761797|69738949|FG000|Overall Study|Changing hospital|11|||
38050426|NCT03761797|69738949|FG000|Overall Study|Improvement/remission|6|||
38050427|NCT03761797|69738949|FG000|Overall Study|Withdrawal by Subject|19|||
38050428|NCT03761797|69738949|FG000|Overall Study|Lost to Follow-up|33|||
38050429|NCT03761797|69738949|FG000|Overall Study|Adverse Event|37|||
38050430|NCT03761797|69738949|FG000|Overall Study|Case report form (CRF) not collected|5|||
38050431|NCT03761797|69738949|FG000|Overall Study|No patient visit after entry|13|||
38050432|NCT03761797|69738949|FG000|Overall Study|Switch to other diabetes medication|10|||
38050433|NCT03761797|69738949|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
38050434|NCT03761797|69738949|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
38050435|NCT03761797|69738949|FG000|Overall Study|Insufficient effectives|2|||
38050436|NCT03761797|69738949|FG000|Overall Study|Excessive alcohol intake|1|||
38050437|NCT02944656|69738955|FG000|Overall Study|No longer eligible|3|||
38050438|NCT02944656|69738956|FG001|Overall Study|No longer eligible|0|||
38050439|NCT02944656|69738955|FG000|Overall Study|Lost to Follow-up|7|||
38050440|NCT02944656|69738956|FG001|Overall Study|Lost to Follow-up|10|||
38050441|NCT02713529|69738969|FG000|Overall Study|Withdrawal by Subject|3|||
38050442|NCT02713529|69738970|FG001|Overall Study|Withdrawal by Subject|1|||
38050443|NCT02713529|69738971|FG002|Overall Study|Withdrawal by Subject|4|||
38050444|NCT02713529|69738972|FG003|Overall Study|Withdrawal by Subject|2|||
38050445|NCT02713529|69738973|FG004|Overall Study|Withdrawal by Subject|0|||
38050446|NCT02713529|69738974|FG005|Overall Study|Withdrawal by Subject|1|||
38050447|NCT02713529|69738975|FG006|Overall Study|Withdrawal by Subject|1|||
38050448|NCT02713529|69738969|FG000|Overall Study|Lost to Follow-up|1|||
38050449|NCT02713529|69738970|FG001|Overall Study|Lost to Follow-up|0|||
38050450|NCT02713529|69738971|FG002|Overall Study|Lost to Follow-up|1|||
38050451|NCT02713529|69738972|FG003|Overall Study|Lost to Follow-up|0|||
38050452|NCT02713529|69738973|FG004|Overall Study|Lost to Follow-up|0|||
37953845|NCT00534495|69640699|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
37953846|NCT00534495|69640700|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
38050453|NCT02713529|69738974|FG005|Overall Study|Lost to Follow-up|0|||
38050454|NCT02713529|69738975|FG006|Overall Study|Lost to Follow-up|0|||
37953847|NCT00534495|69640701|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
38050455|NCT02713529|69738969|FG000|Overall Study|Death|3|||
38050456|NCT02713529|69738970|FG001|Overall Study|Death|3|||
38050457|NCT02713529|69738971|FG002|Overall Study|Death|26|||
38050458|NCT02713529|69738972|FG003|Overall Study|Death|27|||
38050459|NCT02713529|69738973|FG004|Overall Study|Death|3|||
38050460|NCT02713529|69738974|FG005|Overall Study|Death|13|||
38050461|NCT02713529|69738975|FG006|Overall Study|Death|3|||
38050462|NCT03707821|69739001|FG000|Overall Study|Protocol Violation|0|||
38050463|NCT03707821|69739002|FG001|Overall Study|Protocol Violation|1|||
38050464|NCT03707821|69739001|FG000|Overall Study|Unsatisfactory Visual Response|1|||
38050465|NCT03707821|69739002|FG001|Overall Study|Unsatisfactory Visual Response|0|||
38050466|NCT03707821|69739001|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
38050467|NCT03707821|69739002|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
38050468|NCT04546581|69739010|FG000|Overall Study|Adverse Event|9|||
38050469|NCT04546581|69739011|FG001|Overall Study|Adverse Event|3|||
38050470|NCT04546581|69739010|FG000|Overall Study|Physician Decision|0|||
38050471|NCT04546581|69739011|FG001|Overall Study|Physician Decision|1|||
38050472|NCT04546581|69739010|FG000|Overall Study|Protocol Violation|1|||
38050473|NCT04546581|69739011|FG001|Overall Study|Protocol Violation|2|||
38050474|NCT04546581|69739010|FG000|Overall Study|Withdrawal by Subject|3|||
38050475|NCT04546581|69739011|FG001|Overall Study|Withdrawal by Subject|7|||
38050476|NCT03707587|69739019|FG000|Overall Study|Death|0|||
38050477|NCT03707587|69739020|FG001|Overall Study|Death|1|||
38050478|NCT03312933|69739030|FG000|Overall Study|Protocol Violation|15|||
38050479|NCT03312933|69739030|FG000|Overall Study|Lost to Follow-up|36|||
38050480|NCT03312933|69739030|FG000|Overall Study|Withdrawal by Subject|3|||
38050481|NCT03312543|69739036|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
38050482|NCT03312543|69739037|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
38050483|NCT03312543|69739036|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
38050484|NCT03312543|69739037|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
38050485|NCT03312543|69739036|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
38050486|NCT03312543|69739037|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
38050487|NCT03312543|69739036|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
38050488|NCT03312543|69739037|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
38050489|NCT03312543|69739036|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
38050490|NCT03312543|69739037|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
38050491|NCT03312543|69739036|FG000|Regression (Week 12 to Week 24)|Death|0|||
38050492|NCT03312543|69739037|FG001|Regression (Week 12 to Week 24)|Death|1|||
38050493|NCT02392559|69739066|FG000|Overall Study|Withdrawal by Subject|0|||
38050494|NCT02392559|69739067|FG001|Overall Study|Withdrawal by Subject|1|||
38050495|NCT03332589|69739081|FG000|Overall Study|Lack of Efficacy|2|||
38050496|NCT03332589|69739082|FG001|Overall Study|Lack of Efficacy|0|||
38050497|NCT03332589|69739083|FG002|Overall Study|Lack of Efficacy|0|||
38050498|NCT03332589|69739081|FG000|Overall Study|Adverse Event|1|||
38050499|NCT03332589|69739082|FG001|Overall Study|Adverse Event|0|||
38050500|NCT03332589|69739083|FG002|Overall Study|Adverse Event|0|||
38050501|NCT03332589|69739081|FG000|Overall Study|Death|1|||
38050502|NCT03332589|69739082|FG001|Overall Study|Death|0|||
38050503|NCT03332589|69739083|FG002|Overall Study|Death|0|||
38050504|NCT00458003|69739093|FG000|Overall Study|Non protocol spinal anesthesia|1|||
38050505|NCT00458003|69739094|FG001|Overall Study|Non protocol spinal anesthesia|1|||
38050506|NCT02061293|69739104|FG000|Overall Study|Elevated Blood Pressure|1|||
38050507|NCT02061293|69739105|FG001|Overall Study|Elevated Blood Pressure|1|||
38050508|NCT02913612|69739115|FG000|Overall Study|Lost to Follow-up|6|||
38050509|NCT02913612|69739116|FG001|Overall Study|Lost to Follow-up|5|||
38050510|NCT02913612|69739117|FG002|Overall Study|Lost to Follow-up|2|||
38050511|NCT02913612|69739118|FG003|Overall Study|Lost to Follow-up|0|||
38050512|NCT02913612|69739115|FG000|Overall Study|Physician Decision|1|||
38050513|NCT02913612|69739116|FG001|Overall Study|Physician Decision|4|||
38050514|NCT02913612|69739117|FG002|Overall Study|Physician Decision|1|||
38050515|NCT02913612|69739118|FG003|Overall Study|Physician Decision|0|||
38050516|NCT02913612|69739115|FG000|Overall Study|Withdrawal by Subject|2|||
38050517|NCT02913612|69739116|FG001|Overall Study|Withdrawal by Subject|4|||
38050518|NCT02913612|69739117|FG002|Overall Study|Withdrawal by Subject|0|||
38050519|NCT02913612|69739118|FG003|Overall Study|Withdrawal by Subject|0|||
38050520|NCT02913612|69739115|FG000|Overall Study|Hemangioma resolved|1|||
38050521|NCT02913612|69739116|FG001|Overall Study|Hemangioma resolved|0|||
38050522|NCT02913612|69739117|FG002|Overall Study|Hemangioma resolved|0|||
38050523|NCT02913612|69739118|FG003|Overall Study|Hemangioma resolved|0|||
38050524|NCT02913612|69739115|FG000|Overall Study|Local IRB decision|1|||
38050525|NCT02913612|69739116|FG001|Overall Study|Local IRB decision|0|||
38050526|NCT02913612|69739117|FG002|Overall Study|Local IRB decision|0|||
38050527|NCT02913612|69739118|FG003|Overall Study|Local IRB decision|0|||
38050528|NCT02913612|69739115|FG000|Overall Study|Study drug non-compliance|1|||
38050529|NCT02913612|69739116|FG001|Overall Study|Study drug non-compliance|1|||
38050530|NCT02913612|69739117|FG002|Overall Study|Study drug non-compliance|0|||
38050531|NCT02913612|69739118|FG003|Overall Study|Study drug non-compliance|0|||
38050532|NCT02913612|69739115|FG000|Overall Study|Insurance issues|0|||
38050533|NCT02913612|69739116|FG001|Overall Study|Insurance issues|1|||
38050534|NCT02913612|69739117|FG002|Overall Study|Insurance issues|0|||
38050535|NCT02913612|69739118|FG003|Overall Study|Insurance issues|0|||
38050536|NCT02913612|69739115|FG000|Overall Study|Needed to treat second hemangioma|0|||
38050537|NCT02913612|69739116|FG001|Overall Study|Needed to treat second hemangioma|1|||
38050538|NCT02913612|69739117|FG002|Overall Study|Needed to treat second hemangioma|0|||
38050539|NCT02913612|69739118|FG003|Overall Study|Needed to treat second hemangioma|0|||
38050540|NCT02913612|69739115|FG000|Overall Study|Study completion criteria not met|0|||
38050541|NCT02913612|69739116|FG001|Overall Study|Study completion criteria not met|1|||
38050542|NCT02913612|69739117|FG002|Overall Study|Study completion criteria not met|0|||
38050543|NCT02913612|69739118|FG003|Overall Study|Study completion criteria not met|0|||
38050544|NCT02913612|69739115|FG000|Overall Study|Ineligible|0|||
38050545|NCT02913612|69739116|FG001|Overall Study|Ineligible|1|||
38050546|NCT02913612|69739117|FG002|Overall Study|Ineligible|0|||
38050547|NCT02913612|69739118|FG003|Overall Study|Ineligible|0|||
38050548|NCT03323736|69739130|FG000|Overall Study|Screen Failure|14|||
38050549|NCT03323736|69739131|FG001|Overall Study|Screen Failure|9|||
38050550|NCT03323736|69739132|FG002|Overall Study|Screen Failure|1|||
38050551|NCT03323736|69739130|FG000|Overall Study|Withdrawal Before Treatment|3|||
38050552|NCT03323736|69739131|FG001|Overall Study|Withdrawal Before Treatment|1|||
38050553|NCT03323736|69739132|FG002|Overall Study|Withdrawal Before Treatment|1|||
38050554|NCT03323736|69739130|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
38050555|NCT03323736|69739131|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
38050556|NCT03323736|69739132|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
38050557|NCT03311841|69739147|FG000|14-day Wash-out|Adverse Event|0|||
38050558|NCT03311841|69739148|FG001|14-day Wash-out|Adverse Event|1|||
38050559|NCT03311841|69739149|FG002|14-day Wash-out|Adverse Event|0|||
38050560|NCT03311841|69739150|FG003|14-day Wash-out|Adverse Event|0|||
38050561|NCT03311841|69739151|FG004|14-day Wash-out|Adverse Event|0|||
38050562|NCT03311841|69739147|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
38050563|NCT03311841|69739148|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
38050564|NCT03311841|69739149|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
38050565|NCT03311841|69739150|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
38050566|NCT03311841|69739151|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
38050567|NCT03311373|69739184|FG000|Overall Study|Adverse Event|1|||
38050568|NCT03311373|69739184|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
38050569|NCT03311373|69739184|FG000|Overall Study|Lost to Follow-up|1|||
38050570|NCT03311373|69739184|FG000|Overall Study|Physician Decision|1|||
38050571|NCT03311373|69739184|FG000|Overall Study|Withdrawal by Subject|3|||
38050572|NCT01155375|69739196|FG000|Overall Study|Adverse Event|1|||
38050573|NCT01155375|69739197|FG001|Overall Study|Adverse Event|0|||
38050574|NCT00628095|69739215|FG000|Overall Study|Adverse Event|5|||
38050575|NCT00628095|69739216|FG001|Overall Study|Adverse Event|3|||
38050576|NCT00628095|69739215|FG000|Overall Study|Lack of Efficacy|0|||
38050577|NCT00628095|69739216|FG001|Overall Study|Lack of Efficacy|3|||
38050578|NCT00628095|69739215|FG000|Overall Study|Withdrawal by Subject|2|||
38050579|NCT00628095|69739216|FG001|Overall Study|Withdrawal by Subject|0|||
38050580|NCT00628095|69739215|FG000|Overall Study|Other|0|||
38050581|NCT00628095|69739216|FG001|Overall Study|Other|1|||
38050582|NCT02889861|69739224|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
38050583|NCT03325881|69739235|FG000|Overall Study|Protocol Violation|0|||
38050584|NCT03325881|69739236|FG001|Overall Study|Protocol Violation|1|||
38050585|NCT03325881|69739235|FG000|Overall Study|Withdrawal by Subject|0|||
38050586|NCT03325881|69739236|FG001|Overall Study|Withdrawal by Subject|2|||
38050587|NCT03325881|69739235|FG000|Overall Study|Lack of Efficacy|2|||
38050588|NCT03325881|69739236|FG001|Overall Study|Lack of Efficacy|0|||
38050589|NCT03325881|69739235|FG000|Overall Study|Not treated|1|||
38050590|NCT03325881|69739236|FG001|Overall Study|Not treated|0|||
38050591|NCT02887989|69739246|FG000|Overall Study|Withdrawal by Subject|8|||
37861824|NCT00922987|69545566|FG000|Overall Study|Insufficient clinical response|1|||
37861825|NCT00922987|69545566|FG000|Overall Study|Protocol Violation|2|||
37861826|NCT00922987|69545566|FG000|Overall Study|Adverse Event|1|||
37861827|NCT00928135|69545572|FG000|Overall Study|Withdrawal by Subject|1|||
37861828|NCT00928135|69545573|FG001|Overall Study|Withdrawal by Subject|0|||
37861829|NCT00928057|69545581|FG000|Overall Study|Adverse Event|1|||
37861830|NCT00928057|69545582|FG001|Overall Study|Adverse Event|2|||
37861831|NCT00928057|69545581|FG000|Overall Study|Withdrawal by Subject|1|||
37861832|NCT00928057|69545582|FG001|Overall Study|Withdrawal by Subject|0|||
37861833|NCT00928057|69545581|FG000|Overall Study|Lost to Follow-up|0|||
37861834|NCT00928057|69545582|FG001|Overall Study|Lost to Follow-up|1|||
37861835|NCT00928057|69545581|FG000|Overall Study|Protocol Violation|0|||
37861836|NCT00928057|69545582|FG001|Overall Study|Protocol Violation|1|||
37861837|NCT00927901|69545598|FG000|Treatment Period 1|Subject withdrew consent|0|||
37861838|NCT00927901|69545599|FG001|Treatment Period 1|Subject withdrew consent|0|||
37861839|NCT00927901|69545600|FG002|Treatment Period 1|Subject withdrew consent|1|||
37861840|NCT00927901|69545601|FG003|Treatment Period 1|Subject withdrew consent|0|||
37861841|NCT00927901|69545598|FG000|Treatment Period 4|Adverse Event|0|||
37861842|NCT00927901|69545599|FG001|Treatment Period 4|Adverse Event|0|||
37861843|NCT00927901|69545600|FG002|Treatment Period 4|Adverse Event|0|||
37861844|NCT00927901|69545601|FG003|Treatment Period 4|Adverse Event|1|||
37953848|NCT00534495|69640699|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
37953849|NCT00534495|69640700|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
37953850|NCT00534495|69640701|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
37953851|NCT00534495|69640699|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
37953852|NCT00534495|69640700|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
37953853|NCT00534495|69640701|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
37953854|NCT00534495|69640699|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
37953855|NCT00534495|69640700|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
37953856|NCT00534495|69640701|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
37953857|NCT00484198|69640725|FG000|Overall Study|Participant Withdrew Consent|12|||
37953858|NCT00484198|69640726|FG001|Overall Study|Participant Withdrew Consent|21|||
37953859|NCT00484198|69640727|FG002|Overall Study|Participant Withdrew Consent|47|||
37953860|NCT00484198|69640728|FG003|Overall Study|Participant Withdrew Consent|59|||
37953861|NCT00484198|69640725|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
37953862|NCT00484198|69640726|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
37953863|NCT00484198|69640727|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
37953864|NCT00484198|69640728|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
38050592|NCT02887989|69739247|FG001|Overall Study|Withdrawal by Subject|11|||
38050593|NCT02887989|69739246|FG000|Overall Study|Death|1|||
38050594|NCT02887989|69739247|FG001|Overall Study|Death|0|||
38050595|NCT02887521|69739255|FG000|Overall Study|Withdrawal by Subject|0|||
38050596|NCT02887521|69739256|FG001|Overall Study|Withdrawal by Subject|3|||
38050597|NCT03305055|69739264|FG000|Overall Study|Withdrawal by Subject|0|||
38050598|NCT03305055|69739265|FG001|Overall Study|Withdrawal by Subject|1|||
38050599|NCT03305055|69739264|FG000|Overall Study|Adverse Event|1|||
38050600|NCT03305055|69739265|FG001|Overall Study|Adverse Event|1|||
38050601|NCT02763189|69739273|FG000|Overall Study|Device failure|0|||
38050602|NCT02763189|69739274|FG001|Overall Study|Device failure|2|||
38050603|NCT03273387|69739282|FG000|Overall Study|Death|2|||
38050604|NCT03273387|69739283|FG001|Overall Study|Death|2|||
38050605|NCT03273387|69739282|FG000|Overall Study|Withdrawal by Subject|1|||
38050606|NCT03273387|69739283|FG001|Overall Study|Withdrawal by Subject|1|||
38050607|NCT01328080|69739289|FG000|Overall Study|Lost to Follow-up|5|||
38050608|NCT02649946|69739308|FG000|Overall Study|Withdrawal by Subject|1|||
38050609|NCT02649946|69739309|FG001|Overall Study|Withdrawal by Subject|1|||
38050610|NCT02649946|69739308|FG000|Overall Study|Death|7|||
38050611|NCT02649946|69739309|FG001|Overall Study|Death|9|||
38050612|NCT02649946|69739308|FG000|Overall Study|Physician Decision|1|||
38050613|NCT02649946|69739309|FG001|Overall Study|Physician Decision|0|||
38050614|NCT02649946|69739308|FG000|Overall Study|Lost to Follow-up|2|||
38050615|NCT02649946|69739309|FG001|Overall Study|Lost to Follow-up|1|||
38050616|NCT02649946|69739308|FG000|Overall Study|Erroneously enrolled|1|||
38050617|NCT02649946|69739309|FG001|Overall Study|Erroneously enrolled|0|||
38050618|NCT02649946|69739308|FG000|Overall Study|Missed 6-month follow-up visit|0|||
38050619|NCT02649946|69739309|FG001|Overall Study|Missed 6-month follow-up visit|4|||
38050620|NCT03273153|69739317|FG000|Overall Study|Adverse Event|1|||
38050621|NCT03273153|69739318|FG001|Overall Study|Adverse Event|2|||
38050622|NCT03273153|69739317|FG000|Overall Study|Missing|0|||
38050623|NCT03273153|69739318|FG001|Overall Study|Missing|2|||
38050624|NCT03273153|69739317|FG000|Overall Study|Other|3|||
38050625|NCT03273153|69739318|FG001|Overall Study|Other|2|||
38050626|NCT03273153|69739317|FG000|Overall Study|Symptomatic Deterioration|0|||
38050627|NCT03273153|69739318|FG001|Overall Study|Symptomatic Deterioration|1|||
37953865|NCT00484198|69640725|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
37953866|NCT00484198|69640726|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
37953867|NCT00484198|69640727|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
37953868|NCT00484198|69640728|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
37953869|NCT00484198|69640725|FG000|Overall Study|Adverse Event|3|||
37953870|NCT00484198|69640726|FG001|Overall Study|Adverse Event|11|||
37953871|NCT00484198|69640727|FG002|Overall Study|Adverse Event|32|||
37953872|NCT00484198|69640728|FG003|Overall Study|Adverse Event|31|||
38050628|NCT03273153|69739317|FG000|Overall Study|Progressive Disease|6|||
38050629|NCT03273153|69739318|FG001|Overall Study|Progressive Disease|5|||
38050630|NCT03273153|69739317|FG000|Overall Study|Physician Decision|1|||
38050631|NCT03273153|69739318|FG001|Overall Study|Physician Decision|3|||
38050632|NCT03273153|69739317|FG000|Overall Study|Study Terminated by Sponsor|112|||
38050633|NCT03273153|69739318|FG001|Overall Study|Study Terminated by Sponsor|102|||
38050634|NCT03273153|69739317|FG000|Overall Study|Withdrawal by Subject|26|||
38050635|NCT03273153|69739318|FG001|Overall Study|Withdrawal by Subject|25|||
38050636|NCT03273153|69739317|FG000|Overall Study|Protocol Deviation|3|||
38050637|NCT03273153|69739318|FG001|Overall Study|Protocol Deviation|0|||
38050638|NCT03273153|69739317|FG000|Overall Study|Lost to Follow-up|6|||
38050639|NCT03273153|69739318|FG001|Overall Study|Lost to Follow-up|11|||
38050640|NCT03273153|69739317|FG000|Overall Study|Death|66|||
38050641|NCT03273153|69739318|FG001|Overall Study|Death|69|||
37953873|NCT00484198|69640725|FG000|Overall Study|Protocol Violation|0|||
37953874|NCT00484198|69640726|FG001|Overall Study|Protocol Violation|5|||
37953875|NCT00484198|69640727|FG002|Overall Study|Protocol Violation|6|||
37953876|NCT00484198|69640728|FG003|Overall Study|Protocol Violation|8|||
37953877|NCT00484198|69640725|FG000|Overall Study|Other|7|||
37953878|NCT00484198|69640726|FG001|Overall Study|Other|10|||
37953879|NCT00484198|69640727|FG002|Overall Study|Other|31|||
37953880|NCT00484198|69640728|FG003|Overall Study|Other|28|||
37953881|NCT00499486|69640743|FG000|Overall Study|Withdrawal by Subject|16|||
37953882|NCT00499252|69640747|FG000|Overall Study|Adverse Event|3|||
37953883|NCT00499252|69640747|FG000|Overall Study|Refused further treatment|2|||
37953884|NCT00499252|69640747|FG000|Overall Study|Ineligible|4|||
37953885|NCT00499252|69640747|FG000|Overall Study|<no further label>|3|||
37953886|NCT00499174|69640757|FG000|Overall Study|Physician Decision|78|||
37953887|NCT00499174|69640758|FG001|Overall Study|Physician Decision|9|||
37953888|NCT03775421|69640766|FG000|Overall Study|Lost to Follow-up|2|||
37953889|NCT03775421|69640766|FG000|Overall Study|Withdrawal by Subject|10|||
37953890|NCT03775421|69640766|FG000|Overall Study|Physician Decision|3|||
37953891|NCT03775421|69640766|FG000|Overall Study|Death|1|||
37953892|NCT03775421|69640766|FG000|Overall Study|Study Terminated by Sponsor|94|||
37953893|NCT00532155|69640772|FG000|Overall Study|Adverse Event|66|||
37953894|NCT00532155|69640773|FG001|Overall Study|Adverse Event|123|||
37953895|NCT00532155|69640772|FG000|Overall Study|Lack of Efficacy|332|||
37953896|NCT00532155|69640773|FG001|Overall Study|Lack of Efficacy|255|||
37953897|NCT00532155|69640772|FG000|Overall Study|Protocol Violation|1|||
37953898|NCT00532155|69640773|FG001|Overall Study|Protocol Violation|3|||
37953899|NCT00532155|69640772|FG000|Overall Study|Lost to Follow-up|2|||
37953900|NCT00532155|69640773|FG001|Overall Study|Lost to Follow-up|0|||
37953901|NCT00532155|69640772|FG000|Overall Study|Physician Decision|16|||
37953902|NCT00532155|69640773|FG001|Overall Study|Physician Decision|15|||
37953903|NCT00532155|69640772|FG000|Overall Study|Withdrawal by Subject|23|||
37953904|NCT00532155|69640773|FG001|Overall Study|Withdrawal by Subject|44|||
37953905|NCT00532155|69640772|FG000|Overall Study|Consent withdrawn|5|||
37953906|NCT00532155|69640773|FG001|Overall Study|Consent withdrawn|7|||
37953907|NCT00532155|69640772|FG000|Overall Study|Moved|1|||
37953908|NCT00532155|69640773|FG001|Overall Study|Moved|0|||
37953909|NCT00532155|69640772|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
37953910|NCT00532155|69640773|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
37953911|NCT00532155|69640772|FG000|Overall Study|Occurence of a second cancer|0|||
37953912|NCT00532155|69640773|FG001|Overall Study|Occurence of a second cancer|1|||
37953913|NCT00532155|69640772|FG000|Overall Study|Occurence of a secondary cancer|0|||
37953914|NCT00532155|69640773|FG001|Overall Study|Occurence of a secondary cancer|1|||
37953915|NCT00532155|69640772|FG000|Overall Study|Promotor ended study|1|||
37953916|NCT00532155|69640773|FG001|Overall Study|Promotor ended study|0|||
37953917|NCT00532155|69640772|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
37953918|NCT00532155|69640773|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
37953919|NCT00532155|69640772|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
37953920|NCT00532155|69640773|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
37953921|NCT00532155|69640772|FG000|Overall Study|Study stopped|1|||
37953922|NCT00532155|69640773|FG001|Overall Study|Study stopped|0|||
37953923|NCT00532155|69640772|FG000|Overall Study|Study terminated by sponsor|1|||
37953924|NCT00532155|69640773|FG001|Overall Study|Study terminated by sponsor|0|||
37953925|NCT00532155|69640772|FG000|Overall Study|Study termination stop further treatment|4|||
37953926|NCT00532155|69640773|FG001|Overall Study|Study termination stop further treatment|0|||
37953927|NCT00532155|69640772|FG000|Overall Study|Did not receive study medication|2|||
37953928|NCT00532155|69640773|FG001|Overall Study|Did not receive study medication|6|||
37953929|NCT00205777|69640783|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
37953930|NCT00205777|69640784|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
37953931|NCT00205777|69640785|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
37953932|NCT00205777|69640786|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
37953933|NCT00205777|69640787|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
37953934|NCT00205777|69640788|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
37953935|NCT00205777|69640783|FG000|Core Study (Up to 3 Years)|Death|9|||
37953936|NCT00205777|69640784|FG001|Core Study (Up to 3 Years)|Death|7|||
37953937|NCT00205777|69640785|FG002|Core Study (Up to 3 Years)|Death|14|||
37953938|NCT00205777|69640786|FG003|Core Study (Up to 3 Years)|Death|7|||
37953939|NCT00205777|69640787|FG004|Core Study (Up to 3 Years)|Death|0|||
37953940|NCT00205777|69640788|FG005|Core Study (Up to 3 Years)|Death|0|||
37953941|NCT00205777|69640783|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
37953942|NCT00205777|69640784|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
37953943|NCT00205777|69640785|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
37953944|NCT00205777|69640786|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
37953945|NCT00205777|69640787|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
37953946|NCT00205777|69640788|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
37953947|NCT00205777|69640783|FG000|Core Study (Up to 3 Years)|Other Event|49|||
37953948|NCT00205777|69640784|FG001|Core Study (Up to 3 Years)|Other Event|52|||
37953949|NCT00205777|69640785|FG002|Core Study (Up to 3 Years)|Other Event|41|||
37953950|NCT00205777|69640786|FG003|Core Study (Up to 3 Years)|Other Event|58|||
37953951|NCT00205777|69640787|FG004|Core Study (Up to 3 Years)|Other Event|0|||
37953952|NCT00205777|69640788|FG005|Core Study (Up to 3 Years)|Other Event|0|||
38050642|NCT03270657|69739343|FG000|Overall Study|Withdrawal by Subject|1|||
37953953|NCT00205777|69640783|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
37953954|NCT00205777|69640784|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
37953955|NCT00205777|69640785|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
37953956|NCT00205777|69640786|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
37953957|NCT00205777|69640787|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
37953958|NCT00205777|69640788|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
37953959|NCT00205777|69640783|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
37953960|NCT00205777|69640784|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
38050643|NCT03303417|69739347|FG000|Overall Study|Withdrawal by Subject|1|||
38050644|NCT03303417|69739348|FG001|Overall Study|Withdrawal by Subject|1|||
38050645|NCT02943564|69739366|FG000|Overall Study|Miscellaneous Reasons|0|||
38050646|NCT02943564|69739367|FG001|Overall Study|Miscellaneous Reasons|0|||
38050647|NCT02943564|69739368|FG002|Overall Study|Miscellaneous Reasons|3|||
38050648|NCT02943564|69739366|FG000|Overall Study|Site terminated by sponsor|0|||
37953961|NCT00205777|69640785|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
37953962|NCT00205777|69640786|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
37953963|NCT00205777|69640787|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
37953964|NCT00205777|69640788|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
37953965|NCT00205777|69640783|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
37953966|NCT00205777|69640784|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
37953967|NCT00205777|69640785|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
37953968|NCT00205777|69640786|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
37953969|NCT00205777|69640787|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
37953970|NCT00205777|69640788|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
37953971|NCT00205777|69640783|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
37953972|NCT00205777|69640784|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
37953973|NCT00205777|69640785|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
37953974|NCT00205777|69640786|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
37953975|NCT00205777|69640787|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
37953976|NCT00205777|69640788|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
37953977|NCT00205777|69640783|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
37953978|NCT00205777|69640784|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
37953979|NCT00205777|69640785|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
37953980|NCT00205777|69640786|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
37953981|NCT00205777|69640787|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
37953982|NCT00205777|69640788|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
37953983|NCT00205777|69640783|FG000|Completed Core Study, Entered SE I|Other Event|52|||
37953984|NCT00205777|69640784|FG001|Completed Core Study, Entered SE I|Other Event|46|||
37953985|NCT00205777|69640785|FG002|Completed Core Study, Entered SE I|Other Event|47|||
37953986|NCT00205777|69640786|FG003|Completed Core Study, Entered SE I|Other Event|50|||
37953987|NCT00205777|69640787|FG004|Completed Core Study, Entered SE I|Other Event|0|||
37953988|NCT00205777|69640788|FG005|Completed Core Study, Entered SE I|Other Event|0|||
37953989|NCT00205777|69640783|FG000|Study Extension I|Adverse Event|57|||
37953990|NCT00205777|69640784|FG001|Study Extension I|Adverse Event|0|||
37953991|NCT00205777|69640785|FG002|Study Extension I|Adverse Event|0|||
37953992|NCT00205777|69640786|FG003|Study Extension I|Adverse Event|61|||
37953993|NCT00205777|69640787|FG004|Study Extension I|Adverse Event|58|||
37953994|NCT00205777|69640788|FG005|Study Extension I|Adverse Event|0|||
37953995|NCT00205777|69640783|FG000|Study Extension I|Death|5|||
37953996|NCT00205777|69640784|FG001|Study Extension I|Death|0|||
37953997|NCT00205777|69640785|FG002|Study Extension I|Death|0|||
37953998|NCT00205777|69640786|FG003|Study Extension I|Death|1|||
37953999|NCT00205777|69640787|FG004|Study Extension I|Death|2|||
37954000|NCT00205777|69640788|FG005|Study Extension I|Death|0|||
37680319|NCT02586493|69155878|FG000|Overall Study|Protocol Violation|6|||
37680320|NCT02586493|69155878|FG000|Overall Study|Lost to Follow-up|1|||
38050649|NCT02943564|69739367|FG001|Overall Study|Site terminated by sponsor|1|||
38050650|NCT02943564|69739368|FG002|Overall Study|Site terminated by sponsor|0|||
38050651|NCT02943564|69739366|FG000|Overall Study|Non-compliance with study drug|0|||
37861845|NCT00927901|69545598|FG000|Treatment Period 4|Subject withdrew consent|0|||
37954001|NCT00205777|69640783|FG000|Study Extension I|Withdrawal by Subject|99|||
37954002|NCT00205777|69640784|FG001|Study Extension I|Withdrawal by Subject|0|||
37954003|NCT00205777|69640785|FG002|Study Extension I|Withdrawal by Subject|0|||
37954004|NCT00205777|69640786|FG003|Study Extension I|Withdrawal by Subject|106|||
37954005|NCT00205777|69640787|FG004|Study Extension I|Withdrawal by Subject|89|||
38050652|NCT02943564|69739367|FG001|Overall Study|Non-compliance with study drug|1|||
37954006|NCT00205777|69640788|FG005|Study Extension I|Withdrawal by Subject|0|||
37954007|NCT00205777|69640783|FG000|Study Extension I|Protocol Violation|4|||
37954008|NCT00205777|69640784|FG001|Study Extension I|Protocol Violation|0|||
37954009|NCT00205777|69640785|FG002|Study Extension I|Protocol Violation|0|||
37954010|NCT00205777|69640786|FG003|Study Extension I|Protocol Violation|8|||
37954011|NCT00205777|69640787|FG004|Study Extension I|Protocol Violation|8|||
37954012|NCT00205777|69640788|FG005|Study Extension I|Protocol Violation|0|||
37954013|NCT00205777|69640783|FG000|Study Extension I|Lack of Efficacy|0|||
37954014|NCT00205777|69640784|FG001|Study Extension I|Lack of Efficacy|0|||
37954015|NCT00205777|69640785|FG002|Study Extension I|Lack of Efficacy|0|||
37954016|NCT00205777|69640786|FG003|Study Extension I|Lack of Efficacy|1|||
37954017|NCT00205777|69640787|FG004|Study Extension I|Lack of Efficacy|2|||
37954018|NCT00205777|69640788|FG005|Study Extension I|Lack of Efficacy|0|||
37954019|NCT00205777|69640783|FG000|Study Extension I|Failed to return|15|||
37954020|NCT00205777|69640784|FG001|Study Extension I|Failed to return|0|||
37954021|NCT00205777|69640785|FG002|Study Extension I|Failed to return|0|||
37954022|NCT00205777|69640786|FG003|Study Extension I|Failed to return|17|||
37954023|NCT00205777|69640787|FG004|Study Extension I|Failed to return|13|||
37954024|NCT00205777|69640788|FG005|Study Extension I|Failed to return|0|||
37954025|NCT00205777|69640783|FG000|Study Extension I|Other Event|34|||
37954026|NCT00205777|69640784|FG001|Study Extension I|Other Event|0|||
37954027|NCT00205777|69640785|FG002|Study Extension I|Other Event|0|||
37954028|NCT00205777|69640786|FG003|Study Extension I|Other Event|34|||
37954029|NCT00205777|69640787|FG004|Study Extension I|Other Event|29|||
37954030|NCT00205777|69640788|FG005|Study Extension I|Other Event|0|||
37954031|NCT00205777|69640783|FG000|Study Extension I|Withdrawn as per protocol|0|||
37954032|NCT00205777|69640784|FG001|Study Extension I|Withdrawn as per protocol|0|||
37954033|NCT00205777|69640785|FG002|Study Extension I|Withdrawn as per protocol|1070|||
37954034|NCT00205777|69640786|FG003|Study Extension I|Withdrawn as per protocol|0|||
37954035|NCT00205777|69640787|FG004|Study Extension I|Withdrawn as per protocol|0|||
37954036|NCT00205777|69640788|FG005|Study Extension I|Withdrawn as per protocol|0|||
37954037|NCT00205777|69640783|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
37954038|NCT00205777|69640784|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
37954039|NCT00205777|69640785|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
37954040|NCT00205777|69640786|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
37954041|NCT00205777|69640787|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
37954042|NCT00205777|69640788|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
37954043|NCT00205777|69640783|FG000|Study Extension II|Adverse Event|0|||
37954044|NCT00205777|69640784|FG001|Study Extension II|Adverse Event|0|||
37954045|NCT00205777|69640785|FG002|Study Extension II|Adverse Event|0|||
37954046|NCT00205777|69640786|FG003|Study Extension II|Adverse Event|14|||
37954047|NCT00205777|69640787|FG004|Study Extension II|Adverse Event|0|||
37954048|NCT00205777|69640788|FG005|Study Extension II|Adverse Event|30|||
37954049|NCT00205777|69640783|FG000|Study Extension II|Death|0|||
37954050|NCT00205777|69640784|FG001|Study Extension II|Death|0|||
37954051|NCT00205777|69640785|FG002|Study Extension II|Death|0|||
37954052|NCT00205777|69640786|FG003|Study Extension II|Death|2|||
37954053|NCT00205777|69640787|FG004|Study Extension II|Death|0|||
37954054|NCT00205777|69640788|FG005|Study Extension II|Death|5|||
37954055|NCT00205777|69640783|FG000|Study Extension II|Withdrawal by Subject|0|||
37954056|NCT00205777|69640784|FG001|Study Extension II|Withdrawal by Subject|0|||
37954057|NCT00205777|69640785|FG002|Study Extension II|Withdrawal by Subject|0|||
37954058|NCT00205777|69640786|FG003|Study Extension II|Withdrawal by Subject|35|||
38050653|NCT02943564|69739368|FG002|Overall Study|Non-compliance with study drug|0|||
38050654|NCT02943564|69739366|FG000|Overall Study|Pregnancy|0|||
38050655|NCT02943564|69739367|FG001|Overall Study|Pregnancy|1|||
38050656|NCT02943564|69739368|FG002|Overall Study|Pregnancy|1|||
37954059|NCT00205777|69640787|FG004|Study Extension II|Withdrawal by Subject|0|||
37954060|NCT00205777|69640788|FG005|Study Extension II|Withdrawal by Subject|59|||
37954061|NCT00205777|69640783|FG000|Study Extension II|Protocol Violation|0|||
37954062|NCT00205777|69640784|FG001|Study Extension II|Protocol Violation|0|||
38050657|NCT02943564|69739366|FG000|Overall Study|Protocol Violation|2|||
38050658|NCT02943564|69739367|FG001|Overall Study|Protocol Violation|2|||
37954063|NCT00205777|69640785|FG002|Study Extension II|Protocol Violation|0|||
37954064|NCT00205777|69640786|FG003|Study Extension II|Protocol Violation|1|||
37954065|NCT00205777|69640787|FG004|Study Extension II|Protocol Violation|0|||
37954066|NCT00205777|69640788|FG005|Study Extension II|Protocol Violation|10|||
37954067|NCT00205777|69640783|FG000|Study Extension II|Lack of Efficacy|0|||
37954068|NCT00205777|69640784|FG001|Study Extension II|Lack of Efficacy|0|||
37954069|NCT00205777|69640785|FG002|Study Extension II|Lack of Efficacy|0|||
37954070|NCT00205777|69640786|FG003|Study Extension II|Lack of Efficacy|0|||
37954071|NCT00205777|69640787|FG004|Study Extension II|Lack of Efficacy|0|||
37954072|NCT00205777|69640788|FG005|Study Extension II|Lack of Efficacy|1|||
37954073|NCT00205777|69640783|FG000|Study Extension II|Failed to return|0|||
37954074|NCT00205777|69640784|FG001|Study Extension II|Failed to return|0|||
38050659|NCT02943564|69739368|FG002|Overall Study|Protocol Violation|2|||
38050660|NCT02943564|69739366|FG000|Overall Study|Lost to Follow-up|1|||
37954075|NCT00205777|69640785|FG002|Study Extension II|Failed to return|0|||
37954076|NCT00205777|69640786|FG003|Study Extension II|Failed to return|14|||
37954077|NCT00205777|69640787|FG004|Study Extension II|Failed to return|0|||
37954078|NCT00205777|69640788|FG005|Study Extension II|Failed to return|26|||
37954079|NCT00205777|69640783|FG000|Study Extension II|Other Event|0|||
37954080|NCT00205777|69640784|FG001|Study Extension II|Other Event|0|||
37954081|NCT00205777|69640785|FG002|Study Extension II|Other Event|0|||
37954082|NCT00205777|69640786|FG003|Study Extension II|Other Event|12|||
37954083|NCT00205777|69640787|FG004|Study Extension II|Other Event|0|||
37954084|NCT00205777|69640788|FG005|Study Extension II|Other Event|20|||
37954085|NCT00205777|69640783|FG000|Study Extension II|Enrolled but not treated|0|||
37954086|NCT00205777|69640784|FG001|Study Extension II|Enrolled but not treated|0|||
37954087|NCT00205777|69640785|FG002|Study Extension II|Enrolled but not treated|0|||
37954088|NCT00205777|69640786|FG003|Study Extension II|Enrolled but not treated|71|||
37954089|NCT00205777|69640787|FG004|Study Extension II|Enrolled but not treated|0|||
37954090|NCT00205777|69640788|FG005|Study Extension II|Enrolled but not treated|131|||
37954091|NCT00483652|69640805|FG000|Double-blind Treatment Period|Protocol Violation|2|||
37954092|NCT00483652|69640806|FG001|Double-blind Treatment Period|Protocol Violation|1|||
37954093|NCT00483652|69640805|FG000|Double-blind Treatment Period|Adverse Event|3|||
37954094|NCT00483652|69640806|FG001|Double-blind Treatment Period|Adverse Event|4|||
37954095|NCT00483652|69640805|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
38050661|NCT02943564|69739367|FG001|Overall Study|Lost to Follow-up|0|||
38050662|NCT02943564|69739368|FG002|Overall Study|Lost to Follow-up|0|||
38050663|NCT02943564|69739366|FG000|Overall Study|Withdrawal by Subject|6|||
38050664|NCT02943564|69739367|FG001|Overall Study|Withdrawal by Subject|5|||
38050665|NCT02943564|69739368|FG002|Overall Study|Withdrawal by Subject|2|||
37954096|NCT00483652|69640806|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
38050666|NCT02943564|69739366|FG000|Overall Study|Adverse Event|1|||
38050667|NCT02943564|69739367|FG001|Overall Study|Adverse Event|2|||
37954097|NCT00483652|69640805|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
37954098|NCT00483652|69640806|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
37954099|NCT00483574|69640814|FG000|Overall Study|Adverse Event|6|||
37954100|NCT00483574|69640815|FG001|Overall Study|Adverse Event|0|||
37954101|NCT00483574|69640814|FG000|Overall Study|Protocol Violation|28|||
37954102|NCT00483574|69640815|FG001|Overall Study|Protocol Violation|9|||
37954103|NCT00483574|69640814|FG000|Overall Study|Lost to Follow-up|16|||
37954104|NCT00483574|69640815|FG001|Overall Study|Lost to Follow-up|4|||
37954105|NCT00483574|69640814|FG000|Overall Study|Withdrawal by Subject|52|||
37954106|NCT00483574|69640815|FG001|Overall Study|Withdrawal by Subject|0|||
37954107|NCT00483184|69640826|FG000|Overall Study|Withdrawal by Subject|2|||
37954108|NCT00483184|69640827|FG001|Overall Study|Withdrawal by Subject|2|||
37954109|NCT00483184|69640828|FG002|Overall Study|Withdrawal by Subject|0|||
37954110|NCT00483184|69640826|FG000|Overall Study|Lost to Follow-up|1|||
37954111|NCT00483184|69640827|FG001|Overall Study|Lost to Follow-up|0|||
37954112|NCT00483184|69640828|FG002|Overall Study|Lost to Follow-up|0|||
37954113|NCT00483184|69640826|FG000|Overall Study|Adverse Event|1|||
37954114|NCT00483184|69640827|FG001|Overall Study|Adverse Event|2|||
37954115|NCT00483184|69640828|FG002|Overall Study|Adverse Event|2|||
37954116|NCT00483184|69640826|FG000|Overall Study|Protocol Violation|1|||
37954117|NCT00483184|69640827|FG001|Overall Study|Protocol Violation|0|||
37954118|NCT00483184|69640828|FG002|Overall Study|Protocol Violation|1|||
37954119|NCT00482170|69640838|FG000|Overall Study|Adverse Event|5|||
37954120|NCT00482170|69640839|FG001|Overall Study|Adverse Event|14|||
37954121|NCT00482170|69640838|FG000|Overall Study|Withdrawal by Subject|6|||
37954122|NCT00482170|69640839|FG001|Overall Study|Withdrawal by Subject|1|||
37954123|NCT00482170|69640838|FG000|Overall Study|Protocol Violation|2|||
37954124|NCT00482170|69640839|FG001|Overall Study|Protocol Violation|3|||
37954125|NCT00482170|69640838|FG000|Overall Study|Lost to Follow-up|2|||
37954126|NCT00482170|69640839|FG001|Overall Study|Lost to Follow-up|0|||
37954127|NCT00482170|69640838|FG000|Overall Study|Unspecified reason|0|||
37954128|NCT00482170|69640839|FG001|Overall Study|Unspecified reason|2|||
37954129|NCT03883113|69640847|FG000|Overall Study|Physician Decision|4|||
37954130|NCT03883113|69640848|FG001|Overall Study|Physician Decision|2|||
37954131|NCT03883113|69640847|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
37954132|NCT03883113|69640848|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
37954133|NCT03883113|69640847|FG000|Overall Study|Pregnancy|1|||
37954134|NCT03883113|69640848|FG001|Overall Study|Pregnancy|0|||
37954135|NCT03883113|69640847|FG000|Overall Study|Adverse Event|0|||
37954136|NCT03883113|69640848|FG001|Overall Study|Adverse Event|1|||
37954137|NCT03883113|69640847|FG000|Overall Study|Withdrawal by Subject|1|||
37954138|NCT03883113|69640848|FG001|Overall Study|Withdrawal by Subject|2|||
37954139|NCT03883113|69640847|FG000|Overall Study|Lost to Follow-up|1|||
37954140|NCT03883113|69640848|FG001|Overall Study|Lost to Follow-up|0|||
37954141|NCT04218695|69640870|FG000|Overall Study|Adverse Event|1|||
37954142|NCT04218695|69640871|FG001|Overall Study|Adverse Event|0|||
37954143|NCT00490282|69640877|FG000|Overall Study|Withdrawal by Subject|3|||
37954144|NCT00615056|69640886|FG000|Overall Study|Death|31|||
37954145|NCT00615056|69640887|FG001|Overall Study|Death|31|||
37954146|NCT00615056|69640888|FG002|Overall Study|Death|21|||
37954147|NCT00615056|69640889|FG003|Overall Study|Death|23|||
37954148|NCT00615056|69640886|FG000|Overall Study|Lost to Follow-up|1|||
37954149|NCT00615056|69640887|FG001|Overall Study|Lost to Follow-up|2|||
37954150|NCT00615056|69640888|FG002|Overall Study|Lost to Follow-up|4|||
37954151|NCT00615056|69640889|FG003|Overall Study|Lost to Follow-up|5|||
37954152|NCT00615056|69640886|FG000|Overall Study|Other|13|||
37954153|NCT00615056|69640887|FG001|Overall Study|Other|15|||
37954154|NCT00615056|69640888|FG002|Overall Study|Other|10|||
37954155|NCT00615056|69640889|FG003|Overall Study|Other|7|||
37954156|NCT00615056|69640886|FG000|Overall Study|Objective progression or relapse|0|||
37954157|NCT00615056|69640887|FG001|Overall Study|Objective progression or relapse|2|||
37954158|NCT00615056|69640888|FG002|Overall Study|Objective progression or relapse|0|||
37954159|NCT00615056|69640889|FG003|Overall Study|Objective progression or relapse|0|||
37954160|NCT00615056|69640886|FG000|Overall Study|Withdrawal by Subject|0|||
37954161|NCT00615056|69640887|FG001|Overall Study|Withdrawal by Subject|1|||
37954162|NCT00615056|69640888|FG002|Overall Study|Withdrawal by Subject|1|||
37954163|NCT00615056|69640889|FG003|Overall Study|Withdrawal by Subject|0|||
37954164|NCT00615056|69640886|FG000|Overall Study|Discontinued by Sponsor|1|||
37954165|NCT00615056|69640887|FG001|Overall Study|Discontinued by Sponsor|0|||
37954166|NCT00615056|69640888|FG002|Overall Study|Discontinued by Sponsor|0|||
37954167|NCT00615056|69640889|FG003|Overall Study|Discontinued by Sponsor|0|||
37954168|NCT00615056|69640886|FG000|Overall Study|Randomized but not treated|3|||
37954169|NCT00615056|69640887|FG001|Overall Study|Randomized but not treated|0|||
37954170|NCT00615056|69640888|FG002|Overall Study|Randomized but not treated|0|||
37954171|NCT00615056|69640889|FG003|Overall Study|Randomized but not treated|0|||
37954172|NCT00482014|69640903|FG000|Overall Study|Withdrawal by Subject|1|||
37954173|NCT00482014|69640904|FG001|Overall Study|Withdrawal by Subject|2|||
37954174|NCT00482014|69640905|FG002|Overall Study|Withdrawal by Subject|3|||
37954175|NCT00482014|69640906|FG003|Overall Study|Withdrawal by Subject|4|||
37954176|NCT00482014|69640903|FG000|Overall Study|Adverse Event|3|||
37954177|NCT00482014|69640904|FG001|Overall Study|Adverse Event|0|||
37954178|NCT00482014|69640905|FG002|Overall Study|Adverse Event|2|||
37954179|NCT00482014|69640906|FG003|Overall Study|Adverse Event|8|||
37954180|NCT00482014|69640903|FG000|Overall Study|Death|1|||
37954181|NCT00482014|69640904|FG001|Overall Study|Death|2|||
37954182|NCT00482014|69640905|FG002|Overall Study|Death|1|||
37954183|NCT00482014|69640906|FG003|Overall Study|Death|4|||
37954184|NCT00482014|69640903|FG000|Overall Study|Lack of Efficacy|1|||
37954185|NCT00482014|69640904|FG001|Overall Study|Lack of Efficacy|0|||
37954186|NCT00482014|69640905|FG002|Overall Study|Lack of Efficacy|4|||
37954187|NCT00482014|69640906|FG003|Overall Study|Lack of Efficacy|6|||
37954188|NCT00482014|69640903|FG000|Overall Study|Sponsor Decision|1|||
37954189|NCT00482014|69640904|FG001|Overall Study|Sponsor Decision|2|||
37954190|NCT00482014|69640905|FG002|Overall Study|Sponsor Decision|1|||
37954191|NCT00482014|69640906|FG003|Overall Study|Sponsor Decision|1|||
37954192|NCT03595553|69640920|FG000|Overall Study|Withdrawal by Subject|20|||
37954193|NCT03595553|69640921|FG001|Overall Study|Withdrawal by Subject|8|||
37954194|NCT03595553|69640920|FG000|Overall Study|Physician Decision|3|||
37954195|NCT03595553|69640921|FG001|Overall Study|Physician Decision|2|||
37954196|NCT03595553|69640920|FG000|Overall Study|Adverse Event|2|||
37954197|NCT03595553|69640921|FG001|Overall Study|Adverse Event|5|||
37954198|NCT03595553|69640920|FG000|Overall Study|Death|24|||
37954199|NCT03595553|69640921|FG001|Overall Study|Death|22|||
37954200|NCT03595553|69640920|FG000|Overall Study|Lost to Follow-up|6|||
37954201|NCT03595553|69640921|FG001|Overall Study|Lost to Follow-up|7|||
37954202|NCT03595553|69640920|FG000|Overall Study|Other as indicated in CSR|3|||
37954203|NCT03595553|69640921|FG001|Overall Study|Other as indicated in CSR|3|||
37954204|NCT03595553|69640920|FG000|Overall Study|Sponsor Decision|0|||
38050668|NCT02943564|69739368|FG002|Overall Study|Adverse Event|1|||
38050669|NCT02943564|69739366|FG000|Overall Study|Lack of Efficacy|0|||
38050670|NCT02943564|69739367|FG001|Overall Study|Lack of Efficacy|1|||
37954205|NCT03595553|69640921|FG001|Overall Study|Sponsor Decision|1|||
37954206|NCT00614822|69640927|FG000|Overall Study|Adverse Event|3|||
37954207|NCT00529659|69640934|FG000|Overall Study|Adverse Event|8|||
37954208|NCT00529659|69640935|FG001|Overall Study|Adverse Event|7|||
37954209|NCT00529659|69640934|FG000|Overall Study|Lost to Follow-up|0|||
38050671|NCT02943564|69739368|FG002|Overall Study|Lack of Efficacy|0|||
37954210|NCT00529659|69640935|FG001|Overall Study|Lost to Follow-up|2|||
37954211|NCT00529659|69640934|FG000|Overall Study|Physician Decision|0|||
37954212|NCT00529659|69640935|FG001|Overall Study|Physician Decision|2|||
37954213|NCT00529659|69640934|FG000|Overall Study|Protocol Violation|2|||
37954214|NCT00529659|69640935|FG001|Overall Study|Protocol Violation|6|||
37954215|NCT00529659|69640934|FG000|Overall Study|Withdrawal by Subject|1|||
37954216|NCT00529659|69640935|FG001|Overall Study|Withdrawal by Subject|6|||
37954217|NCT00143455|69640945|FG000|Cohort 1|Adverse Event|8|||
37954218|NCT00143455|69640946|FG001|Cohort 1|Adverse Event|4|||
37954219|NCT00143455|69640947|FG002|Cohort 1|Adverse Event|0|||
38050672|NCT03268941|69739380|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
38050673|NCT03268941|69739381|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
38050674|NCT03268941|69739382|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
38050675|NCT03268941|69739383|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
38050676|NCT03268941|69739384|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
38050677|NCT03268941|69739385|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
38050678|NCT03268941|69739386|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
38050679|NCT03268941|69739380|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
38050680|NCT03268941|69739381|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
38050681|NCT03268941|69739382|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
38050682|NCT03268941|69739383|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
38050683|NCT03268941|69739384|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
38050684|NCT03268941|69739385|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
38050685|NCT03268941|69739386|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
38050686|NCT03268941|69739380|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
38050687|NCT03268941|69739381|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
38050688|NCT03268941|69739382|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
38050689|NCT03268941|69739383|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
38050690|NCT03268941|69739384|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
38050691|NCT03268941|69739385|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
38050692|NCT03268941|69739386|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
38050693|NCT03268941|69739380|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
38050694|NCT03268941|69739381|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
38050695|NCT03268941|69739382|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
37954220|NCT00143455|69640948|FG003|Cohort 1|Adverse Event|0|||
37954221|NCT00143455|69640945|FG000|Cohort 1|Death|5|||
37954222|NCT00143455|69640946|FG001|Cohort 1|Death|2|||
37954223|NCT00143455|69640947|FG002|Cohort 1|Death|0|||
37954224|NCT00143455|69640948|FG003|Cohort 1|Death|0|||
37954225|NCT00143455|69640945|FG000|Cohort 1|Progressive Disease|0|||
37954226|NCT00143455|69640946|FG001|Cohort 1|Progressive Disease|6|||
37954227|NCT00143455|69640947|FG002|Cohort 1|Progressive Disease|0|||
37954228|NCT00143455|69640948|FG003|Cohort 1|Progressive Disease|0|||
37954229|NCT00143455|69640945|FG000|Cohort 1|Withdrawal by Subject|1|||
37954230|NCT00143455|69640946|FG001|Cohort 1|Withdrawal by Subject|4|||
37954231|NCT00143455|69640947|FG002|Cohort 1|Withdrawal by Subject|0|||
37954232|NCT00143455|69640948|FG003|Cohort 1|Withdrawal by Subject|0|||
37954233|NCT00143455|69640945|FG000|Cohort 1|Randomized But Not Treated|0|||
37954234|NCT00143455|69640946|FG001|Cohort 1|Randomized But Not Treated|1|||
37954235|NCT00143455|69640947|FG002|Cohort 1|Randomized But Not Treated|0|||
37954236|NCT00143455|69640948|FG003|Cohort 1|Randomized But Not Treated|0|||
37954237|NCT00143455|69640945|FG000|Cohort 2|Adverse Event|0|||
37954238|NCT00143455|69640946|FG001|Cohort 2|Adverse Event|0|||
37954239|NCT00143455|69640947|FG002|Cohort 2|Adverse Event|42|||
37954240|NCT00143455|69640948|FG003|Cohort 2|Adverse Event|30|||
38050696|NCT03268941|69739383|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
38050697|NCT03268941|69739384|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
38050698|NCT03268941|69739385|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
38050699|NCT03268941|69739386|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
38050700|NCT03268941|69739380|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
38050701|NCT03268941|69739381|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
38050702|NCT03268941|69739382|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
38050703|NCT03268941|69739383|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
38050704|NCT03268941|69739384|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
38050705|NCT03268941|69739385|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
38050706|NCT03268941|69739386|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
38050707|NCT03245619|69739463|FG000|Part A (Up to Day 22)|Physician Decision|4|||
38050708|NCT03245619|69739464|FG001|Part A (Up to Day 22)|Physician Decision|6|||
38050709|NCT03245619|69739465|FG002|Part A (Up to Day 22)|Physician Decision|6|||
37954241|NCT00143455|69640945|FG000|Cohort 2|No Longer Required Study Treatment|0|||
37954242|NCT00143455|69640946|FG001|Cohort 2|No Longer Required Study Treatment|0|||
38050710|NCT03245619|69739466|FG003|Part A (Up to Day 22)|Physician Decision|0|||
38050711|NCT03245619|69739467|FG004|Part A (Up to Day 22)|Physician Decision|0|||
38050712|NCT03245619|69739468|FG005|Part A (Up to Day 22)|Physician Decision|0|||
38050713|NCT03245619|69739469|FG006|Part A (Up to Day 22)|Physician Decision|0|||
37954243|NCT00143455|69640947|FG002|Cohort 2|No Longer Required Study Treatment|1|||
38050714|NCT03245619|69739470|FG007|Part A (Up to Day 22)|Physician Decision|0|||
38050715|NCT03245619|69739471|FG008|Part A (Up to Day 22)|Physician Decision|0|||
38050716|NCT03245619|69739472|FG009|Part A (Up to Day 22)|Physician Decision|0|||
37954244|NCT00143455|69640948|FG003|Cohort 2|No Longer Required Study Treatment|0|||
37954245|NCT00143455|69640945|FG000|Cohort 2|Protocol Violation|0|||
37954246|NCT00143455|69640946|FG001|Cohort 2|Protocol Violation|0|||
38050717|NCT03245619|69739473|FG010|Part A (Up to Day 22)|Physician Decision|0|||
38050718|NCT03245619|69739474|FG011|Part A (Up to Day 22)|Physician Decision|0|||
37954247|NCT00143455|69640947|FG002|Cohort 2|Protocol Violation|1|||
37954248|NCT00143455|69640948|FG003|Cohort 2|Protocol Violation|1|||
38050719|NCT03245619|69739475|FG012|Part A (Up to Day 22)|Physician Decision|0|||
38050720|NCT03245619|69739476|FG013|Part A (Up to Day 22)|Physician Decision|0|||
38050721|NCT03245619|69739477|FG014|Part A (Up to Day 22)|Physician Decision|0|||
38050722|NCT03245619|69739478|FG015|Part A (Up to Day 22)|Physician Decision|0|||
38050723|NCT03245619|69739479|FG016|Part A (Up to Day 22)|Physician Decision|0|||
38050724|NCT04472650|69739540|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
38050725|NCT04472650|69739541|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
38050726|NCT02606461|69739553|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
38050727|NCT02606461|69739554|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
38050728|NCT02606461|69739555|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
38050729|NCT02606461|69739556|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
38050730|NCT02606461|69739557|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
38050731|NCT02606461|69739558|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
38050732|NCT03321396|69739573|FG000|Overall Study|Physician Decision|1|||
38050733|NCT03244917|69739579|FG000|Overall Study|Lost to Follow-up|2|||
38050734|NCT03244917|69739580|FG001|Overall Study|Lost to Follow-up|2|||
37954249|NCT00143455|69640945|FG000|Cohort 2|Lost to Follow-up|0|||
37954250|NCT00143455|69640946|FG001|Cohort 2|Lost to Follow-up|0|||
37954251|NCT00143455|69640947|FG002|Cohort 2|Lost to Follow-up|1|||
37954252|NCT00143455|69640948|FG003|Cohort 2|Lost to Follow-up|4|||
37954253|NCT00143455|69640945|FG000|Cohort 2|Death|0|||
37954254|NCT00143455|69640946|FG001|Cohort 2|Death|0|||
37954255|NCT00143455|69640947|FG002|Cohort 2|Death|20|||
37954256|NCT00143455|69640948|FG003|Cohort 2|Death|12|||
37861846|NCT00927901|69545599|FG001|Treatment Period 4|Subject withdrew consent|0|||
37861847|NCT00927901|69545600|FG002|Treatment Period 4|Subject withdrew consent|1|||
37861848|NCT00927901|69545601|FG003|Treatment Period 4|Subject withdrew consent|0|||
37861849|NCT01218204|69545616|FG000|Part B Washout|Adverse Event|0|||
37861850|NCT01218204|69545617|FG001|Part B Washout|Adverse Event|1|||
37954257|NCT00143455|69640945|FG000|Cohort 2|Progressive Disease|0|||
37954258|NCT00143455|69640946|FG001|Cohort 2|Progressive Disease|0|||
37954259|NCT00143455|69640947|FG002|Cohort 2|Progressive Disease|20|||
37954260|NCT00143455|69640948|FG003|Cohort 2|Progressive Disease|27|||
37954261|NCT00143455|69640945|FG000|Cohort 2|Withdrawal by Subject|0|||
37954262|NCT00143455|69640946|FG001|Cohort 2|Withdrawal by Subject|0|||
37954263|NCT00143455|69640947|FG002|Cohort 2|Withdrawal by Subject|13|||
37954264|NCT00143455|69640948|FG003|Cohort 2|Withdrawal by Subject|12|||
37954265|NCT00143455|69640945|FG000|Cohort 2|Other|0|||
37954266|NCT00143455|69640946|FG001|Cohort 2|Other|0|||
37954267|NCT00143455|69640947|FG002|Cohort 2|Other|7|||
37954268|NCT00143455|69640948|FG003|Cohort 2|Other|6|||
37954269|NCT00143455|69640945|FG000|Cohort 2|Randomized But Not Treated|0|||
37954270|NCT00143455|69640946|FG001|Cohort 2|Randomized But Not Treated|0|||
37954271|NCT00143455|69640947|FG002|Cohort 2|Randomized But Not Treated|1|||
37954272|NCT00143455|69640948|FG003|Cohort 2|Randomized But Not Treated|1|||
37954273|NCT03529955|69640960|FG000|Overall Study|Adverse Event|1|||
37954274|NCT03529955|69640960|FG000|Overall Study|Lack of Efficacy|1|||
37954275|NCT00142909|69640976|FG000|Randomization|Various Reasons|7|||
37954276|NCT00142909|69640977|FG001|Randomization|Various Reasons|10|||
37954277|NCT00142909|69640976|FG000|Medications Begin|Protocol Violation|2|||
38050735|NCT03321006|69739588|FG000|Overall Study|Death|1|||
38050736|NCT03321006|69739589|FG001|Overall Study|Death|0|||
38050737|NCT03321006|69739588|FG000|Overall Study|Lack of Efficacy|1|||
38050738|NCT03321006|69739589|FG001|Overall Study|Lack of Efficacy|0|||
38050739|NCT02593123|69739606|FG000|Overall Study|Physician Decision|2|||
38050740|NCT02593123|69739607|FG001|Overall Study|Physician Decision|1|||
38050741|NCT02593123|69739606|FG000|Overall Study|Relapse|1|||
38050742|NCT02593123|69739607|FG001|Overall Study|Relapse|1|||
38050743|NCT03302559|69739615|FG000|Overall Study|Adverse Event|2|||
38050744|NCT03302559|69739615|FG000|Overall Study|Lost to Follow-up|1|||
38050745|NCT03302559|69739615|FG000|Overall Study|Withdrew Consent|3|||
38050746|NCT03302247|69739619|FG000|Overall Study|the study has closed prematurely|2|||
38050747|NCT03302247|69739619|FG000|Overall Study|Death|1|||
38050748|NCT04993339|69739625|FG000|Overall Study|Lost to Follow-up|0|||
38050749|NCT04993339|69739626|FG001|Overall Study|Lost to Follow-up|1|||
38050750|NCT04993339|69739625|FG000|Overall Study|no MRI scan|3|||
37954278|NCT00142909|69640977|FG001|Medications Begin|Protocol Violation|0|||
37954279|NCT00142909|69640976|FG000|Medications Begin|Withdrawal by Subject|5|||
38050751|NCT04993339|69739626|FG001|Overall Study|no MRI scan|1|||
37954280|NCT00142909|69640977|FG001|Medications Begin|Withdrawal by Subject|3|||
37954281|NCT00142909|69640976|FG000|Medications Begin|Withdrawal by Subject|2|||
38050752|NCT04974697|69739634|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
37954282|NCT00142909|69640977|FG001|Medications Begin|Withdrawal by Subject|0|||
37954283|NCT00205699|69640986|FG000|Overall Study|Lost to Follow-up|1|||
38050753|NCT04974697|69739634|FG000|Overall Study|Lens discomfort|1|||
38050754|NCT03265119|69739642|FG000|Overall Study|Adverse Event|2|||
38050755|NCT03265119|69739643|FG001|Overall Study|Adverse Event|1|||
38050756|NCT03265119|69739642|FG000|Overall Study|Lack of Efficacy|3|||
38050757|NCT03265119|69739643|FG001|Overall Study|Lack of Efficacy|0|||
37954284|NCT00205699|69640987|FG001|Overall Study|Lost to Follow-up|3|||
37954285|NCT00205699|69640988|FG002|Overall Study|Lost to Follow-up|5|||
37954286|NCT00205699|69640986|FG000|Overall Study|Adverse Event|1|||
37954287|NCT00205699|69640987|FG001|Overall Study|Adverse Event|0|||
37954288|NCT00205699|69640988|FG002|Overall Study|Adverse Event|0|||
37954289|NCT00205699|69640986|FG000|Overall Study|Withdrawal by Subject|1|||
37954290|NCT00205699|69640987|FG001|Overall Study|Withdrawal by Subject|2|||
37954291|NCT00205699|69640988|FG002|Overall Study|Withdrawal by Subject|1|||
37954292|NCT00205699|69640986|FG000|Overall Study|Lack of Efficacy|0|||
37954293|NCT00205699|69640987|FG001|Overall Study|Lack of Efficacy|1|||
38050758|NCT03265119|69739642|FG000|Overall Study|Protocol Violation|1|||
38050759|NCT03265119|69739643|FG001|Overall Study|Protocol Violation|2|||
38050760|NCT03265119|69739642|FG000|Overall Study|Withdrawal by Subject|2|||
38050761|NCT03265119|69739643|FG001|Overall Study|Withdrawal by Subject|4|||
38050762|NCT03265119|69739642|FG000|Overall Study|Lost to Follow-up|1|||
38050763|NCT03265119|69739643|FG001|Overall Study|Lost to Follow-up|0|||
38050764|NCT03265119|69739642|FG000|Overall Study|Lack of Compliance|1|||
38050765|NCT03265119|69739643|FG001|Overall Study|Lack of Compliance|0|||
38050766|NCT04952701|69739649|FG000|Control Lens|Physician Decision|4|||
38050767|NCT04952701|69739649|FG000|Test Lens|Physician Decision|1|||
38050768|NCT04723173|69739655|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
38050769|NCT04919161|69739669|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
38050770|NCT04919161|69739670|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
38050771|NCT04919161|69739669|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
38050772|NCT04919161|69739670|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
38050773|NCT04919161|69739669|FG000|Overall Study|Acute ankle sprain after session 1|0|||
38050774|NCT04919161|69739670|FG001|Overall Study|Acute ankle sprain after session 1|1|||
38050775|NCT03262389|69739698|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
38050776|NCT03262389|69739698|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
38050777|NCT03262389|69739698|FG000|Overall Study|opted out of PET/MR|1|||
38050778|NCT03262233|69739706|FG000|Overall Study|Withdrawal by Subject|12|||
38050779|NCT03262233|69739707|FG001|Overall Study|Withdrawal by Subject|8|||
38050780|NCT03262233|69739708|FG002|Overall Study|Withdrawal by Subject|21|||
38050781|NCT03262233|69739709|FG003|Overall Study|Withdrawal by Subject|13|||
38050782|NCT03262233|69739706|FG000|Overall Study|Declined due to shock|1|||
38050783|NCT03262233|69739707|FG001|Overall Study|Declined due to shock|2|||
38050784|NCT03262233|69739708|FG002|Overall Study|Declined due to shock|2|||
38050785|NCT03262233|69739709|FG003|Overall Study|Declined due to shock|3|||
38050786|NCT03262233|69739706|FG000|Overall Study|Protocol Violation|5|||
38050787|NCT03262233|69739707|FG001|Overall Study|Protocol Violation|10|||
38050788|NCT03262233|69739708|FG002|Overall Study|Protocol Violation|2|||
38050789|NCT03262233|69739709|FG003|Overall Study|Protocol Violation|13|||
38050790|NCT03262233|69739706|FG000|Overall Study|data collection artifact|0|||
38050791|NCT03262233|69739707|FG001|Overall Study|data collection artifact|1|||
38050792|NCT03262233|69739708|FG002|Overall Study|data collection artifact|0|||
37954294|NCT00205699|69640988|FG002|Overall Study|Lack of Efficacy|0|||
37954295|NCT03882801|69641001|FG000|Period 1|Adverse Event|0|||
37954296|NCT03882801|69641002|FG001|Period 1|Adverse Event|1|||
37954297|NCT03882801|69641001|FG000|Period 1|Non-compliance with study drug|1|||
37954298|NCT03882801|69641002|FG001|Period 1|Non-compliance with study drug|1|||
37954299|NCT03882801|69641001|FG000|Period 1|Never treated with study drug|1|||
37954300|NCT03882801|69641002|FG001|Period 1|Never treated with study drug|0|||
37954301|NCT03882801|69641001|FG000|Washout Period|Physician Decision|0|||
37954302|NCT03882801|69641002|FG001|Washout Period|Physician Decision|1|||
37954303|NCT03882801|69641001|FG000|Period 2|Non-compliance with study drug|0|||
37954304|NCT03882801|69641002|FG001|Period 2|Non-compliance with study drug|1|||
37954305|NCT03880227|69641012|FG000|First Visit|Withdrawal by Subject|1|||
37954306|NCT03880227|69641013|FG001|First Visit|Withdrawal by Subject|0|||
37954307|NCT03880227|69641014|FG002|First Visit|Withdrawal by Subject|0|||
37954308|NCT03880227|69641015|FG003|First Visit|Withdrawal by Subject|0|||
37954309|NCT03880227|69641012|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
37954310|NCT03880227|69641013|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
37954311|NCT03880227|69641014|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
37954312|NCT03880227|69641015|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
37954313|NCT03880227|69641012|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
37954314|NCT03880227|69641013|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
37954315|NCT03880227|69641014|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
37954316|NCT03880227|69641015|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
37954317|NCT03880227|69641012|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
37954318|NCT03880227|69641013|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
37954319|NCT03880227|69641014|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
38050793|NCT03262233|69739709|FG003|Overall Study|data collection artifact|0|||
38050794|NCT03261531|69739720|FG000|Overall Study|Withdrawal by Subject|4|||
37954320|NCT03880227|69641015|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
37954321|NCT00530439|69641039|FG000|Overall Study|GDM|9|||
37954322|NCT00530439|69641040|FG001|Overall Study|GDM|3|||
37954323|NCT00530439|69641039|FG000|Overall Study|Withdraw|18|||
37954324|NCT00530439|69641040|FG001|Overall Study|Withdraw|14|||
37954325|NCT00530439|69641039|FG000|Overall Study|Missed abortion|1|||
37954326|NCT00530439|69641040|FG001|Overall Study|Missed abortion|4|||
37954327|NCT00530439|69641039|FG000|Overall Study|Misclassification|2|||
37954328|NCT00530439|69641040|FG001|Overall Study|Misclassification|0|||
37954329|NCT00530439|69641039|FG000|Overall Study|Twin pregnancy|0|||
37954330|NCT00530439|69641040|FG001|Overall Study|Twin pregnancy|2|||
37954331|NCT00530439|69641039|FG000|Overall Study|Severe malformation/abortion|0|||
37954332|NCT00530439|69641040|FG001|Overall Study|Severe malformation/abortion|3|||
37954333|NCT00497146|69641048|FG000|Treatment Period|Adverse Event|6|||
37954334|NCT00497146|69641049|FG001|Treatment Period|Adverse Event|2|||
37954335|NCT00497146|69641048|FG000|Treatment Period|Withdrawal by Subject|5|||
37954336|NCT00497146|69641049|FG001|Treatment Period|Withdrawal by Subject|9|||
37954337|NCT00497146|69641048|FG000|Treatment Period|Lost to Follow-up|1|||
37954338|NCT00497146|69641049|FG001|Treatment Period|Lost to Follow-up|3|||
37954339|NCT00497146|69641048|FG000|Treatment Period|Required dialysis|4|||
37954340|NCT00497146|69641049|FG001|Treatment Period|Required dialysis|1|||
37954341|NCT00497146|69641048|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
37954342|NCT00497146|69641049|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
37954343|NCT00497146|69641048|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
37954344|NCT00497146|69641049|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
38050795|NCT04151290|69739724|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
38050796|NCT03260205|69739743|FG000|Overall Study|Adverse Event|2|||
38050797|NCT03260205|69739744|FG001|Overall Study|Adverse Event|0|||
38050798|NCT03260205|69739745|FG002|Overall Study|Adverse Event|2|||
38050799|NCT03260205|69739746|FG003|Overall Study|Adverse Event|2|||
38050800|NCT03260205|69739747|FG004|Overall Study|Adverse Event|4|||
38050801|NCT03260205|69739743|FG000|Overall Study|Lost to Follow-up|2|||
38050802|NCT03260205|69739744|FG001|Overall Study|Lost to Follow-up|2|||
38050803|NCT03260205|69739745|FG002|Overall Study|Lost to Follow-up|1|||
38050804|NCT03260205|69739746|FG003|Overall Study|Lost to Follow-up|1|||
38050805|NCT03260205|69739747|FG004|Overall Study|Lost to Follow-up|5|||
38050806|NCT03260205|69739743|FG000|Overall Study|Protocol Violation|0|||
38050807|NCT03260205|69739744|FG001|Overall Study|Protocol Violation|0|||
38050808|NCT03260205|69739745|FG002|Overall Study|Protocol Violation|2|||
38050809|NCT03260205|69739746|FG003|Overall Study|Protocol Violation|0|||
38050810|NCT03260205|69739747|FG004|Overall Study|Protocol Violation|1|||
38050811|NCT03260205|69739743|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
38050812|NCT03260205|69739744|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
38050813|NCT03260205|69739745|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
38050814|NCT03260205|69739746|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
38050815|NCT03260205|69739747|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
38050816|NCT03260205|69739743|FG000|Overall Study|Other: Unspecified|0|||
38050817|NCT03260205|69739744|FG001|Overall Study|Other: Unspecified|0|||
38050818|NCT03260205|69739745|FG002|Overall Study|Other: Unspecified|3|||
38050819|NCT03260205|69739746|FG003|Overall Study|Other: Unspecified|1|||
38050820|NCT03260205|69739747|FG004|Overall Study|Other: Unspecified|1|||
37954345|NCT00497146|69641048|FG000|Treatment Period|Other Reason|2|||
37954346|NCT00497146|69641049|FG001|Treatment Period|Other Reason|3|||
37954347|NCT00497146|69641048|FG000|Long-term Follow-up Period|Adverse Event|2|||
37954348|NCT00497146|69641049|FG001|Long-term Follow-up Period|Adverse Event|2|||
37954349|NCT00497146|69641048|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
37954350|NCT00497146|69641049|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
37954351|NCT00497146|69641048|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
37954352|NCT00497146|69641049|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
37954353|NCT00497146|69641048|FG000|Long-term Follow-up Period|Other|0|||
37954354|NCT00497146|69641049|FG001|Long-term Follow-up Period|Other|1|||
37954355|NCT00489970|69641060|FG000|Persistence Year 9|Lost to Follow-up|2|||
37954356|NCT00489970|69641061|FG001|Persistence Year 9|Lost to Follow-up|2|||
37954357|NCT00489970|69641062|FG002|Persistence Year 9|Lost to Follow-up|3|||
37954358|NCT00489970|69641060|FG000|Persistence Year 9|Other|1|||
37954359|NCT00489970|69641061|FG001|Persistence Year 9|Other|0|||
37954360|NCT00489970|69641062|FG002|Persistence Year 9|Other|2|||
37954361|NCT02798471|69641075|FG000|Overall Study|Adverse Event|7|||
37954362|NCT02798471|69641076|FG001|Overall Study|Adverse Event|2|||
37954363|NCT02798471|69641075|FG000|Overall Study|Physician Decision|3|||
38050821|NCT03260205|69739743|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
37954364|NCT02798471|69641076|FG001|Overall Study|Physician Decision|7|||
38050822|NCT03260205|69739744|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
38050823|NCT03260205|69739745|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
38050824|NCT03260205|69739746|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
37954365|NCT02798471|69641075|FG000|Overall Study|Death|2|||
37954366|NCT02798471|69641076|FG001|Overall Study|Death|3|||
37954367|NCT02798471|69641075|FG000|Overall Study|Lost to Follow-up|0|||
37954368|NCT02798471|69641076|FG001|Overall Study|Lost to Follow-up|1|||
37954369|NCT02798471|69641075|FG000|Overall Study|Other|5|||
37954370|NCT02798471|69641076|FG001|Overall Study|Other|3|||
37954371|NCT02798471|69641075|FG000|Overall Study|Subject withdrew consent|0|||
37954372|NCT02798471|69641076|FG001|Overall Study|Subject withdrew consent|6|||
37954373|NCT02798471|69641075|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
37954374|NCT02798471|69641076|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
37954375|NCT02798471|69641075|FG000|Overall Study|Randomized, but not treated|0|||
37954376|NCT02798471|69641076|FG001|Overall Study|Randomized, but not treated|2|||
37954377|NCT00489736|69641084|FG000|Overall Study|Lack of Efficacy|53|||
37954378|NCT00489736|69641085|FG001|Overall Study|Lack of Efficacy|14|||
37954379|NCT00489736|69641084|FG000|Overall Study|Adverse Event|32|||
37954380|NCT00489736|69641085|FG001|Overall Study|Adverse Event|45|||
37954381|NCT00489736|69641084|FG000|Overall Study|Poor compliance|6|||
37954382|NCT00489736|69641085|FG001|Overall Study|Poor compliance|2|||
37954383|NCT00489736|69641084|FG000|Overall Study|Not coded/ Not pre-specified|5|||
37954384|NCT00489736|69641085|FG001|Overall Study|Not coded/ Not pre-specified|8|||
37954385|NCT00617084|69641093|FG000|Overall Study|Withdrawal by Subject|5|||
37954386|NCT00617084|69641094|FG001|Overall Study|Withdrawal by Subject|7|||
37954387|NCT00617084|69641093|FG000|Overall Study|Missed 12 Months visit|16|||
37954388|NCT00617084|69641094|FG001|Overall Study|Missed 12 Months visit|19|||
37954389|NCT00489424|69641103|FG000|Overall Study|Adverse Event|3|||
37954390|NCT00489424|69641104|FG001|Overall Study|Adverse Event|3|||
37954391|NCT00489424|69641105|FG002|Overall Study|Adverse Event|4|||
37954392|NCT00489424|69641103|FG000|Overall Study|Lack of Efficacy|1|||
37954393|NCT00489424|69641104|FG001|Overall Study|Lack of Efficacy|0|||
37954394|NCT00489424|69641105|FG002|Overall Study|Lack of Efficacy|0|||
37954395|NCT00489424|69641103|FG000|Overall Study|Administrative problems|0|||
37954396|NCT00489424|69641104|FG001|Overall Study|Administrative problems|2|||
37954397|NCT00489424|69641105|FG002|Overall Study|Administrative problems|1|||
37954398|NCT00614744|69641115|FG000|Overall Study|Lost to Follow-up|5|||
37954399|NCT00614744|69641116|FG001|Overall Study|Lost to Follow-up|4|||
37954400|NCT00614744|69641115|FG000|Overall Study|Incomplete for Behavior Issues|0|||
37954401|NCT00614744|69641116|FG001|Overall Study|Incomplete for Behavior Issues|2|||
37954402|NCT00565812|69641125|FG000|Overall Study|Death|2|||
37954403|NCT00565812|69641126|FG001|Overall Study|Death|1|||
37954404|NCT00565812|69641127|FG002|Overall Study|Death|3|||
37954405|NCT00565812|69641125|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
37954406|NCT00565812|69641126|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
37954407|NCT00565812|69641127|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
37954408|NCT00565812|69641125|FG000|Overall Study|Lost to Follow-up|10|||
37954409|NCT00565812|69641126|FG001|Overall Study|Lost to Follow-up|8|||
37954410|NCT00565812|69641127|FG002|Overall Study|Lost to Follow-up|8|||
37954411|NCT00565812|69641125|FG000|Overall Study|Withdrawal by Subject|58|||
37954412|NCT00565812|69641126|FG001|Overall Study|Withdrawal by Subject|47|||
37954413|NCT00565812|69641127|FG002|Overall Study|Withdrawal by Subject|48|||
37954414|NCT00565812|69641125|FG000|Overall Study|Work Schedule|5|||
37954415|NCT00565812|69641126|FG001|Overall Study|Work Schedule|3|||
37954416|NCT00565812|69641127|FG002|Overall Study|Work Schedule|1|||
37954417|NCT00565812|69641125|FG000|Overall Study|Protocol Violation|2|||
37954418|NCT00565812|69641126|FG001|Overall Study|Protocol Violation|6|||
37954419|NCT00565812|69641127|FG002|Overall Study|Protocol Violation|4|||
37954420|NCT00565812|69641125|FG000|Overall Study|Adverse Event|41|||
37954421|NCT00565812|69641126|FG001|Overall Study|Adverse Event|54|||
37954422|NCT00565812|69641127|FG002|Overall Study|Adverse Event|40|||
37954423|NCT00565812|69641125|FG000|Overall Study|Jury Duty|1|||
37954424|NCT00565812|69641126|FG001|Overall Study|Jury Duty|0|||
37954425|NCT00565812|69641127|FG002|Overall Study|Jury Duty|0|||
37954426|NCT00565812|69641125|FG000|Overall Study|Relocated Out of Area|5|||
37861851|NCT01218204|69545618|FG002|Part B Washout|Adverse Event|0|||
37861852|NCT01218204|69545619|FG003|Part B Washout|Adverse Event|0|||
37954427|NCT00565812|69641126|FG001|Overall Study|Relocated Out of Area|8|||
37954428|NCT00565812|69641127|FG002|Overall Study|Relocated Out of Area|9|||
37954429|NCT00565812|69641125|FG000|Overall Study|Sponsor Decision|1|||
37954430|NCT00565812|69641126|FG001|Overall Study|Sponsor Decision|5|||
37954431|NCT00565812|69641127|FG002|Overall Study|Sponsor Decision|1|||
37954432|NCT00565812|69641125|FG000|Overall Study|Domestic Reasons|7|||
37954433|NCT00565812|69641126|FG001|Overall Study|Domestic Reasons|1|||
37954434|NCT00565812|69641127|FG002|Overall Study|Domestic Reasons|3|||
37954435|NCT00565812|69641125|FG000|Overall Study|Research Site Closure|6|||
37954436|NCT00565812|69641126|FG001|Overall Study|Research Site Closure|1|||
37954437|NCT00565812|69641127|FG002|Overall Study|Research Site Closure|8|||
37954438|NCT00565812|69641125|FG000|Overall Study|Surgical Intervention|0|||
37954439|NCT00565812|69641126|FG001|Overall Study|Surgical Intervention|1|||
37954440|NCT00565812|69641127|FG002|Overall Study|Surgical Intervention|2|||
37954441|NCT00565812|69641125|FG000|Overall Study|Low Compliance|1|||
37954442|NCT00565812|69641126|FG001|Overall Study|Low Compliance|0|||
37954443|NCT00565812|69641127|FG002|Overall Study|Low Compliance|1|||
37954444|NCT00565812|69641125|FG000|Overall Study|Follow-up Visit Not Completed|2|||
37954445|NCT00565812|69641126|FG001|Overall Study|Follow-up Visit Not Completed|0|||
37954446|NCT00565812|69641127|FG002|Overall Study|Follow-up Visit Not Completed|1|||
37954447|NCT00565812|69641125|FG000|Overall Study|Physician Decision|2|||
37954448|NCT00565812|69641126|FG001|Overall Study|Physician Decision|0|||
37954449|NCT00565812|69641127|FG002|Overall Study|Physician Decision|0|||
37954450|NCT03974334|69641135|FG000|Overall Study|Lost to Follow-up|1|||
37954451|NCT03970824|69641142|FG000|Overall Study|Withdrawal by Subject|1|||
37954452|NCT03970824|69641143|FG001|Overall Study|Withdrawal by Subject|1|||
37954453|NCT03970824|69641144|FG002|Overall Study|Withdrawal by Subject|3|||
37954454|NCT03970824|69641142|FG000|Overall Study|Lost to Follow-up|0|||
37954455|NCT03970824|69641143|FG001|Overall Study|Lost to Follow-up|2|||
37954456|NCT03970824|69641144|FG002|Overall Study|Lost to Follow-up|1|||
37954457|NCT03970824|69641142|FG000|Overall Study|Adverse Event|1|||
37954458|NCT03970824|69641143|FG001|Overall Study|Adverse Event|0|||
37954459|NCT03970824|69641144|FG002|Overall Study|Adverse Event|0|||
37954460|NCT00564486|69641155|FG000|Overall Study|Adverse Event|0|||
37954461|NCT00564486|69641156|FG001|Overall Study|Adverse Event|1|||
37954462|NCT00564486|69641157|FG002|Overall Study|Adverse Event|0|||
37954463|NCT00564486|69641158|FG003|Overall Study|Adverse Event|0|||
37954464|NCT00564486|69641155|FG000|Overall Study|Withdrawal by Subject|4|||
37954465|NCT00564486|69641156|FG001|Overall Study|Withdrawal by Subject|0|||
37954466|NCT00564486|69641157|FG002|Overall Study|Withdrawal by Subject|0|||
37954467|NCT00564486|69641158|FG003|Overall Study|Withdrawal by Subject|5|||
37954468|NCT00564486|69641155|FG000|Overall Study|Subject refused to have blood drawn|0|||
37954469|NCT00564486|69641156|FG001|Overall Study|Subject refused to have blood drawn|0|||
37954470|NCT00564486|69641157|FG002|Overall Study|Subject refused to have blood drawn|1|||
37954471|NCT00564486|69641158|FG003|Overall Study|Subject refused to have blood drawn|0|||
37954472|NCT00564486|69641155|FG000|Overall Study|Lost to Follow-up|3|||
37954473|NCT00564486|69641156|FG001|Overall Study|Lost to Follow-up|0|||
37954474|NCT00564486|69641157|FG002|Overall Study|Lost to Follow-up|2|||
37954475|NCT00564486|69641158|FG003|Overall Study|Lost to Follow-up|2|||
37954476|NCT00481078|69641174|FG000|Overall Study|Progression of disease|11|||
37954477|NCT00481078|69641175|FG001|Overall Study|Progression of disease|11|||
37954478|NCT00481078|69641174|FG000|Overall Study|Adverse Event|15|||
37954479|NCT00481078|69641175|FG001|Overall Study|Adverse Event|3|||
37954480|NCT00481078|69641174|FG000|Overall Study|Death|5|||
37954481|NCT00481078|69641175|FG001|Overall Study|Death|3|||
37954482|NCT00481078|69641174|FG000|Overall Study|Intercurrent illness|1|||
37954483|NCT00481078|69641175|FG001|Overall Study|Intercurrent illness|0|||
37954484|NCT00481078|69641174|FG000|Overall Study|Withdrawal by Subject|7|||
37954485|NCT00481078|69641175|FG001|Overall Study|Withdrawal by Subject|1|||
37954486|NCT00481078|69641174|FG000|Overall Study|Information not available|1|||
37954487|NCT00481078|69641175|FG001|Overall Study|Information not available|0|||
37954488|NCT00481078|69641174|FG000|Overall Study|Received other treatment|2|||
37954489|NCT00481078|69641175|FG001|Overall Study|Received other treatment|1|||
37954490|NCT00481078|69641174|FG000|Overall Study|Brain metastasis|0|||
37954491|NCT00481078|69641175|FG001|Overall Study|Brain metastasis|1|||
37954492|NCT00480532|69641185|FG000|Overall Study|Withdrawal by Subject|2|||
37954493|NCT00480532|69641186|FG001|Overall Study|Withdrawal by Subject|4|||
37954494|NCT00480532|69641187|FG002|Overall Study|Withdrawal by Subject|3|||
37954495|NCT00480532|69641188|FG003|Overall Study|Withdrawal by Subject|1|||
37954496|NCT00480532|69641185|FG000|Overall Study|Protocol Violation|0|||
37954497|NCT00480532|69641186|FG001|Overall Study|Protocol Violation|0|||
37954498|NCT00480532|69641187|FG002|Overall Study|Protocol Violation|1|||
37954499|NCT00480532|69641188|FG003|Overall Study|Protocol Violation|0|||
37954500|NCT00496366|69641198|FG000|Overall Study|Death|1|||
37954501|NCT00488644|69641202|FG000|Overall Study|Not Eligible|1|||
37954502|NCT00488644|69641202|FG000|Overall Study|Not Evaluable|1|||
37954503|NCT00564018|69641209|FG000|Overall Study|Withdrawal by Subject|2|||
37954504|NCT00564018|69641210|FG001|Overall Study|Withdrawal by Subject|3|||
37954505|NCT00564018|69641211|FG002|Overall Study|Withdrawal by Subject|1|||
37954506|NCT03381287|69641223|FG000|Overall Study|Withdrawal by Subject|0|||
37954507|NCT03381287|69641224|FG001|Overall Study|Withdrawal by Subject|1|||
37954508|NCT03381287|69641225|FG002|Overall Study|Withdrawal by Subject|0|||
37954509|NCT03381287|69641226|FG003|Overall Study|Withdrawal by Subject|0|||
38050825|NCT03260205|69739747|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
38050826|NCT04666441|69739772|FG000|Overall Study|Lost to Follow-up|1|||
37954510|NCT03381287|69641223|FG000|Overall Study|Adverse Event|0|||
37954511|NCT03381287|69641224|FG001|Overall Study|Adverse Event|0|||
37954512|NCT03381287|69641225|FG002|Overall Study|Adverse Event|0|||
37954513|NCT03381287|69641226|FG003|Overall Study|Adverse Event|1|||
37954514|NCT03381287|69641223|FG000|Overall Study|Physician Decision|0|||
37954515|NCT03381287|69641224|FG001|Overall Study|Physician Decision|0|||
37954516|NCT03381287|69641225|FG002|Overall Study|Physician Decision|0|||
37954517|NCT03381287|69641226|FG003|Overall Study|Physician Decision|1|||
37954518|NCT00616928|69641250|FG000|Overall Study|Adverse Event|6|||
37954519|NCT00616928|69641251|FG001|Overall Study|Adverse Event|3|||
37954520|NCT00616928|69641252|FG002|Overall Study|Adverse Event|2|||
37954521|NCT00616928|69641253|FG003|Overall Study|Adverse Event|2|||
37954522|NCT00616928|69641250|FG000|Overall Study|Other|51|||
37954523|NCT00616928|69641251|FG001|Overall Study|Other|8|||
37954524|NCT00616928|69641252|FG002|Overall Study|Other|15|||
37954525|NCT00616928|69641253|FG003|Overall Study|Other|5|||
37954526|NCT00616928|69641250|FG000|Overall Study|Lost to Follow-up|5|||
37954527|NCT00616928|69641251|FG001|Overall Study|Lost to Follow-up|7|||
37954528|NCT00616928|69641252|FG002|Overall Study|Lost to Follow-up|0|||
37954529|NCT00616928|69641253|FG003|Overall Study|Lost to Follow-up|0|||
37954530|NCT00563784|69641275|FG000|Overall Study|Withdrawal by Subject|2|||
37954531|NCT00563784|69641275|FG000|Overall Study|Screen Failures|20|||
37954532|NCT00203047|69641290|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
37954533|NCT00203047|69641291|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
37954534|NCT00203047|69641290|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
37954535|NCT00203047|69641291|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
37954536|NCT00203047|69641290|FG000|Overall Study|Withdrawal by Subject|13|||
37954537|NCT00203047|69641291|FG001|Overall Study|Withdrawal by Subject|47|||
37954538|NCT00203047|69641290|FG000|Overall Study|Teva requested participant withdrawal|1|||
37954539|NCT00203047|69641291|FG001|Overall Study|Teva requested participant withdrawal|1|||
37954540|NCT00203047|69641290|FG000|Overall Study|Physician Decision|8|||
37954541|NCT00203047|69641291|FG001|Overall Study|Physician Decision|7|||
37954542|NCT00203047|69641290|FG000|Overall Study|Non-compliance|4|||
37954543|NCT00203047|69641291|FG001|Overall Study|Non-compliance|8|||
37954544|NCT00203047|69641290|FG000|Overall Study|Protocol Violation|1|||
37954545|NCT00203047|69641291|FG001|Overall Study|Protocol Violation|0|||
37954546|NCT00203047|69641290|FG000|Overall Study|Lost to Follow-up|11|||
37954547|NCT00203047|69641291|FG001|Overall Study|Lost to Follow-up|5|||
37954548|NCT00203047|69641290|FG000|Overall Study|Adverse Event|8|||
37954549|NCT00203047|69641291|FG001|Overall Study|Adverse Event|18|||
37954550|NCT00203047|69641290|FG000|Overall Study|Death|1|||
37954551|NCT00203047|69641291|FG001|Overall Study|Death|2|||
37954552|NCT00203047|69641290|FG000|Overall Study|Pregnancy|3|||
37954553|NCT00203047|69641291|FG001|Overall Study|Pregnancy|0|||
37954554|NCT00203047|69641290|FG000|Overall Study|Other|5|||
37954555|NCT00203047|69641291|FG001|Overall Study|Other|5|||
37954556|NCT00142519|69641299|FG000|Overall Study|Not Treated|7|||
37954557|NCT00142519|69641300|FG001|Overall Study|Not Treated|9|||
37954558|NCT00142519|69641299|FG000|Overall Study|Protocol Violation|1|||
37954559|NCT00142519|69641300|FG001|Overall Study|Protocol Violation|0|||
37954560|NCT00142519|69641299|FG000|Overall Study|Withdrawal by Subject|10|||
37954561|NCT00142519|69641300|FG001|Overall Study|Withdrawal by Subject|7|||
37954562|NCT00141817|69641319|FG000|Overall Study|Protocol Violation|0|||
37954563|NCT00141817|69641320|FG001|Overall Study|Protocol Violation|0|||
37954564|NCT00141817|69641321|FG002|Overall Study|Protocol Violation|1|||
37954565|NCT00141817|69641322|FG003|Overall Study|Protocol Violation|0|||
37954566|NCT00141817|69641319|FG000|Overall Study|Parent request|1|||
37954567|NCT00141817|69641320|FG001|Overall Study|Parent request|0|||
37954568|NCT00141817|69641321|FG002|Overall Study|Parent request|0|||
37954569|NCT00141817|69641322|FG003|Overall Study|Parent request|0|||
37954570|NCT00573170|69641332|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
37954571|NCT00573170|69641333|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
37954572|NCT00573170|69641334|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
37954573|NCT00573170|69641335|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
37954574|NCT00573170|69641336|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
37954575|NCT00573170|69641337|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
37954576|NCT00573170|69641332|FG000|First Washout Period|Adverse Event|1|||
37954577|NCT00573170|69641333|FG001|First Washout Period|Adverse Event|1|||
37954578|NCT00573170|69641334|FG002|First Washout Period|Adverse Event|0|||
37954579|NCT00573170|69641335|FG003|First Washout Period|Adverse Event|0|||
37954580|NCT00573170|69641336|FG004|First Washout Period|Adverse Event|0|||
37954581|NCT00573170|69641337|FG005|First Washout Period|Adverse Event|1|||
37954582|NCT00573170|69641332|FG000|First Washout Period|Lack of Efficacy|0|||
37954583|NCT00573170|69641333|FG001|First Washout Period|Lack of Efficacy|0|||
37954584|NCT00573170|69641334|FG002|First Washout Period|Lack of Efficacy|0|||
37954585|NCT00573170|69641335|FG003|First Washout Period|Lack of Efficacy|0|||
37954586|NCT00573170|69641336|FG004|First Washout Period|Lack of Efficacy|0|||
37954587|NCT00573170|69641337|FG005|First Washout Period|Lack of Efficacy|1|||
37954588|NCT00573170|69641332|FG000|First Washout Period|Lost to Follow-up|1|||
37954589|NCT00573170|69641333|FG001|First Washout Period|Lost to Follow-up|1|||
37954590|NCT00573170|69641334|FG002|First Washout Period|Lost to Follow-up|0|||
37954591|NCT00573170|69641335|FG003|First Washout Period|Lost to Follow-up|2|||
37954592|NCT00573170|69641336|FG004|First Washout Period|Lost to Follow-up|0|||
37954593|NCT00573170|69641337|FG005|First Washout Period|Lost to Follow-up|2|||
37954594|NCT00573170|69641332|FG000|First Washout Period|Withdrawal by Subject|2|||
37954595|NCT00573170|69641333|FG001|First Washout Period|Withdrawal by Subject|0|||
37954596|NCT00573170|69641334|FG002|First Washout Period|Withdrawal by Subject|0|||
37954597|NCT00573170|69641335|FG003|First Washout Period|Withdrawal by Subject|2|||
37954598|NCT00573170|69641336|FG004|First Washout Period|Withdrawal by Subject|3|||
37954599|NCT00573170|69641337|FG005|First Washout Period|Withdrawal by Subject|3|||
37954600|NCT00573170|69641332|FG000|First Washout Period|Other|4|||
37954601|NCT00573170|69641333|FG001|First Washout Period|Other|0|||
37954602|NCT00573170|69641334|FG002|First Washout Period|Other|1|||
37954603|NCT00573170|69641335|FG003|First Washout Period|Other|1|||
37954604|NCT00573170|69641336|FG004|First Washout Period|Other|0|||
37954605|NCT00573170|69641337|FG005|First Washout Period|Other|0|||
37954606|NCT00573170|69641332|FG000|Second Washout Period|Adverse Event|1|||
37954607|NCT00573170|69641333|FG001|Second Washout Period|Adverse Event|0|||
37954608|NCT00573170|69641334|FG002|Second Washout Period|Adverse Event|0|||
37954609|NCT00573170|69641335|FG003|Second Washout Period|Adverse Event|0|||
37954610|NCT00573170|69641336|FG004|Second Washout Period|Adverse Event|1|||
37954611|NCT00573170|69641337|FG005|Second Washout Period|Adverse Event|0|||
37954612|NCT00573170|69641332|FG000|Second Washout Period|Protocol Violation|2|||
37954613|NCT00573170|69641333|FG001|Second Washout Period|Protocol Violation|1|||
37954614|NCT00573170|69641334|FG002|Second Washout Period|Protocol Violation|1|||
37954615|NCT00573170|69641335|FG003|Second Washout Period|Protocol Violation|0|||
37954616|NCT00573170|69641336|FG004|Second Washout Period|Protocol Violation|0|||
37954617|NCT00573170|69641337|FG005|Second Washout Period|Protocol Violation|0|||
37954618|NCT00573170|69641332|FG000|Second Washout Period|Withdrawal by Subject|1|||
37954619|NCT00573170|69641333|FG001|Second Washout Period|Withdrawal by Subject|1|||
37954620|NCT00573170|69641334|FG002|Second Washout Period|Withdrawal by Subject|2|||
37954621|NCT00573170|69641335|FG003|Second Washout Period|Withdrawal by Subject|0|||
37954622|NCT00573170|69641336|FG004|Second Washout Period|Withdrawal by Subject|1|||
37954623|NCT00573170|69641337|FG005|Second Washout Period|Withdrawal by Subject|0|||
37954624|NCT00573170|69641332|FG000|Second Washout Period|Lost to Follow-up|0|||
37954625|NCT00573170|69641333|FG001|Second Washout Period|Lost to Follow-up|0|||
37954626|NCT00573170|69641334|FG002|Second Washout Period|Lost to Follow-up|0|||
37954627|NCT00573170|69641335|FG003|Second Washout Period|Lost to Follow-up|1|||
37954628|NCT00573170|69641336|FG004|Second Washout Period|Lost to Follow-up|0|||
37954629|NCT00573170|69641337|FG005|Second Washout Period|Lost to Follow-up|0|||
37954630|NCT00573170|69641332|FG000|Second Washout Period|Other|1|||
37954631|NCT00573170|69641333|FG001|Second Washout Period|Other|2|||
37954632|NCT00573170|69641334|FG002|Second Washout Period|Other|1|||
37954633|NCT00573170|69641335|FG003|Second Washout Period|Other|4|||
37954634|NCT00573170|69641336|FG004|Second Washout Period|Other|6|||
37954635|NCT00573170|69641337|FG005|Second Washout Period|Other|2|||
37954636|NCT00573170|69641332|FG000|Third Treatment Period|Withdrawal by Subject|1|||
37954637|NCT00573170|69641333|FG001|Third Treatment Period|Withdrawal by Subject|0|||
37954638|NCT00573170|69641334|FG002|Third Treatment Period|Withdrawal by Subject|0|||
37954639|NCT00573170|69641335|FG003|Third Treatment Period|Withdrawal by Subject|0|||
37954640|NCT00573170|69641336|FG004|Third Treatment Period|Withdrawal by Subject|0|||
37954641|NCT00573170|69641337|FG005|Third Treatment Period|Withdrawal by Subject|0|||
37954642|NCT00573170|69641332|FG000|Third Treatment Period|Lost to Follow-up|0|||
37954643|NCT00573170|69641333|FG001|Third Treatment Period|Lost to Follow-up|0|||
37954644|NCT00573170|69641334|FG002|Third Treatment Period|Lost to Follow-up|0|||
37954645|NCT00573170|69641335|FG003|Third Treatment Period|Lost to Follow-up|0|||
37954646|NCT00573170|69641336|FG004|Third Treatment Period|Lost to Follow-up|0|||
37954647|NCT00573170|69641337|FG005|Third Treatment Period|Lost to Follow-up|2|||
37954648|NCT00201643|69641356|FG000|Overall Study|Withdrawal by Subject|5|||
37954649|NCT00201643|69641357|FG001|Overall Study|Withdrawal by Subject|4|||
37954650|NCT00130039|69641365|FG000|Overall Study|Withdrawal by Subject|15|||
37954651|NCT00130039|69641366|FG001|Overall Study|Withdrawal by Subject|11|||
37954652|NCT00130039|69641365|FG000|Overall Study|Lost to Follow-up|3|||
37954653|NCT00130039|69641366|FG001|Overall Study|Lost to Follow-up|1|||
37954654|NCT00130039|69641365|FG000|Overall Study|Adverse Event|4|||
37954655|NCT00130039|69641366|FG001|Overall Study|Adverse Event|2|||
37954656|NCT00130039|69641365|FG000|Overall Study|Physician Decision|3|||
37954657|NCT00130039|69641366|FG001|Overall Study|Physician Decision|0|||
37954658|NCT00130039|69641365|FG000|Overall Study|clinical events without follow up MRI|5|||
37954659|NCT00130039|69641366|FG001|Overall Study|clinical events without follow up MRI|4|||
37954660|NCT00475852|69641374|FG000|Overall Study|Death|444|||
37954661|NCT00475852|69641375|FG001|Overall Study|Death|456|||
37954662|NCT00475852|69641374|FG000|Overall Study|Withdrawal by Subject|19|||
37954663|NCT00475852|69641375|FG001|Overall Study|Withdrawal by Subject|24|||
37954664|NCT00475852|69641374|FG000|Overall Study|Lost to Follow-up|54|||
37954665|NCT00475852|69641375|FG001|Overall Study|Lost to Follow-up|68|||
37954666|NCT00141271|69641384|FG000|Overall Study|Adverse Event|31|||
37954667|NCT00141271|69641385|FG001|Overall Study|Adverse Event|19|||
37954668|NCT00141271|69641386|FG002|Overall Study|Adverse Event|17|||
37954669|NCT00141271|69641384|FG000|Overall Study|Laboratory Abnormality|2|||
37954670|NCT00141271|69641385|FG001|Overall Study|Laboratory Abnormality|1|||
37954671|NCT00141271|69641386|FG002|Overall Study|Laboratory Abnormality|1|||
37954672|NCT00141271|69641384|FG000|Overall Study|Lack of Efficacy|7|||
37954673|NCT00141271|69641385|FG001|Overall Study|Lack of Efficacy|7|||
37954674|NCT00141271|69641386|FG002|Overall Study|Lack of Efficacy|3|||
37954675|NCT00141271|69641384|FG000|Overall Study|Lost to Follow-up|15|||
37954676|NCT00141271|69641385|FG001|Overall Study|Lost to Follow-up|15|||
37954677|NCT00141271|69641386|FG002|Overall Study|Lost to Follow-up|21|||
37954678|NCT00141271|69641384|FG000|Overall Study|Withdrawal by Subject|14|||
37954679|NCT00141271|69641385|FG001|Overall Study|Withdrawal by Subject|9|||
37954680|NCT00141271|69641386|FG002|Overall Study|Withdrawal by Subject|10|||
37954681|NCT00141271|69641384|FG000|Overall Study|Other|11|||
37954682|NCT00141271|69641385|FG001|Overall Study|Other|12|||
37954683|NCT00141271|69641386|FG002|Overall Study|Other|5|||
37954684|NCT00614120|69641398|FG000|Overall Study|Adverse Event|9|||
37954685|NCT00614120|69641399|FG001|Overall Study|Adverse Event|22|||
37954686|NCT00614120|69641400|FG002|Overall Study|Adverse Event|30|||
37954687|NCT00614120|69641401|FG003|Overall Study|Adverse Event|3|||
37954688|NCT00614120|69641398|FG000|Overall Study|Lack of Efficacy|3|||
37954689|NCT00614120|69641399|FG001|Overall Study|Lack of Efficacy|3|||
37954690|NCT00614120|69641400|FG002|Overall Study|Lack of Efficacy|2|||
37954691|NCT00614120|69641401|FG003|Overall Study|Lack of Efficacy|2|||
37954692|NCT00614120|69641398|FG000|Overall Study|Protocol Violation|2|||
37954693|NCT00614120|69641399|FG001|Overall Study|Protocol Violation|5|||
37954694|NCT00614120|69641400|FG002|Overall Study|Protocol Violation|3|||
37954695|NCT00614120|69641401|FG003|Overall Study|Protocol Violation|1|||
37954696|NCT00614120|69641398|FG000|Overall Study|Withdrawal criteria|1|||
37954697|NCT00614120|69641399|FG001|Overall Study|Withdrawal criteria|0|||
37954698|NCT00614120|69641400|FG002|Overall Study|Withdrawal criteria|0|||
37954699|NCT00614120|69641401|FG003|Overall Study|Withdrawal criteria|0|||
37954700|NCT00614120|69641398|FG000|Overall Study|Withdrawal by Subject|9|||
37954701|NCT00614120|69641399|FG001|Overall Study|Withdrawal by Subject|10|||
37954702|NCT00614120|69641400|FG002|Overall Study|Withdrawal by Subject|16|||
37954703|NCT00614120|69641401|FG003|Overall Study|Withdrawal by Subject|3|||
37954704|NCT00614120|69641398|FG000|Overall Study|Did not meet trial criteria|0|||
37954705|NCT00614120|69641399|FG001|Overall Study|Did not meet trial criteria|1|||
37954706|NCT00614120|69641400|FG002|Overall Study|Did not meet trial criteria|1|||
37954707|NCT00614120|69641401|FG003|Overall Study|Did not meet trial criteria|1|||
37954708|NCT00614120|69641398|FG000|Overall Study|hCG positive (not pregnant)|0|||
37954709|NCT00614120|69641399|FG001|Overall Study|hCG positive (not pregnant)|0|||
37954710|NCT00614120|69641400|FG002|Overall Study|hCG positive (not pregnant)|1|||
37954711|NCT00614120|69641401|FG003|Overall Study|hCG positive (not pregnant)|0|||
37954712|NCT00614120|69641398|FG000|Overall Study|Hypoglycaemia|0|||
37954713|NCT00614120|69641399|FG001|Overall Study|Hypoglycaemia|0|||
37954714|NCT00614120|69641400|FG002|Overall Study|Hypoglycaemia|0|||
37954715|NCT00614120|69641401|FG003|Overall Study|Hypoglycaemia|1|||
37954716|NCT00614120|69641398|FG000|Overall Study|Lack of trial product|3|||
37954717|NCT00614120|69641399|FG001|Overall Study|Lack of trial product|3|||
37954718|NCT00614120|69641400|FG002|Overall Study|Lack of trial product|2|||
37954719|NCT00614120|69641401|FG003|Overall Study|Lack of trial product|0|||
37954720|NCT00614120|69641398|FG000|Overall Study|Late syphilis, latent|1|||
37954721|NCT00614120|69641399|FG001|Overall Study|Late syphilis, latent|0|||
37954722|NCT00614120|69641400|FG002|Overall Study|Late syphilis, latent|0|||
37954723|NCT00614120|69641401|FG003|Overall Study|Late syphilis, latent|0|||
37954724|NCT00614120|69641398|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
37954725|NCT00614120|69641399|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
37954726|NCT00614120|69641400|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
37954727|NCT00614120|69641401|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
37954728|NCT00614120|69641398|FG000|Overall Study|Lost to Follow-up|1|||
37954729|NCT00614120|69641399|FG001|Overall Study|Lost to Follow-up|2|||
37954730|NCT00614120|69641400|FG002|Overall Study|Lost to Follow-up|3|||
37954731|NCT00614120|69641401|FG003|Overall Study|Lost to Follow-up|4|||
37954732|NCT00496054|69641411|FG000|Overall Study|Adverse Event|1|||
37954733|NCT00496054|69641411|FG000|Overall Study|Lost to Follow-up|7|||
37954734|NCT00495820|69641417|FG000|Overall Study|Adverse Event|1|||
37954735|NCT00495820|69641418|FG001|Overall Study|Adverse Event|1|||
37954736|NCT00495586|69641426|FG000|Overall Study|Withdrawal by Subject|4|||
37954737|NCT00495586|69641427|FG001|Overall Study|Withdrawal by Subject|4|||
37954738|NCT00613730|69641435|FG000|Overall Study|Disease progression|2|||
37954739|NCT00613730|69641435|FG000|Overall Study|Administrative decision|1|||
37954740|NCT00613574|69641439|FG000|Overall Study|Adverse Event|3|||
37954741|NCT00613574|69641439|FG000|Overall Study|Lost to Follow-up|2|||
37954742|NCT00613574|69641439|FG000|Overall Study|Other|1|||
37954743|NCT00613106|69641445|FG000|Overall Study|Adverse Event|3|||
37954744|NCT00613106|69641446|FG001|Overall Study|Adverse Event|1|||
37954745|NCT00613106|69641445|FG000|Overall Study|Withdrawal by Subject|6|||
37954746|NCT00613106|69641446|FG001|Overall Study|Withdrawal by Subject|3|||
37954747|NCT00613106|69641445|FG000|Overall Study|Lost to Follow-up|7|||
37954748|NCT00613106|69641446|FG001|Overall Study|Lost to Follow-up|2|||
37954749|NCT00613106|69641445|FG000|Overall Study|misc|4|||
37954750|NCT00613106|69641446|FG001|Overall Study|misc|3|||
37954751|NCT00141037|69641454|FG000|Overall Study|Physician Decision|1|||
37954752|NCT00141037|69641455|FG001|Overall Study|Physician Decision|2|||
37954753|NCT00141037|69641454|FG000|Overall Study|Lost to Follow-up|3|||
37954754|NCT00141037|69641455|FG001|Overall Study|Lost to Follow-up|1|||
37954755|NCT00141037|69641454|FG000|Overall Study|Protocol Violation|0|||
37954756|NCT00141037|69641455|FG001|Overall Study|Protocol Violation|2|||
37954757|NCT00141037|69641454|FG000|Overall Study|Withdrawal by Subject|2|||
37954758|NCT00141037|69641455|FG001|Overall Study|Withdrawal by Subject|1|||
37954759|NCT00141037|69641454|FG000|Overall Study|Other|0|||
37954760|NCT00141037|69641455|FG001|Overall Study|Other|1|||
37954761|NCT00141037|69641454|FG000|Overall Study|Moved from area|1|||
37954762|NCT00141037|69641455|FG001|Overall Study|Moved from area|7|||
37954763|NCT00141037|69641454|FG000|Overall Study|Graft Failure|3|||
37954764|NCT00141037|69641455|FG001|Overall Study|Graft Failure|4|||
37954765|NCT00140413|69641464|FG000|Overall Study|Lost to Follow-up|1|||
37954766|NCT00140413|69641465|FG001|Overall Study|Lost to Follow-up|0|||
37954767|NCT00140413|69641464|FG000|Overall Study|Withdrawal by Subject|2|||
37954768|NCT00140413|69641465|FG001|Overall Study|Withdrawal by Subject|0|||
37954769|NCT00563706|69641481|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
37954770|NCT00563706|69641482|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
37954771|NCT00563706|69641483|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
37954772|NCT00563706|69641484|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
37954773|NCT00563706|69641485|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
37954774|NCT00563706|69641486|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
37954775|NCT00563706|69641487|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
37954776|NCT00563706|69641488|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
37954777|NCT00563706|69641489|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
37954778|NCT00563706|69641481|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
37954779|NCT00563706|69641482|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
37954780|NCT00563706|69641483|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
37954781|NCT00563706|69641484|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
37954782|NCT00563706|69641485|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
37954783|NCT00563706|69641486|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
37954784|NCT00563706|69641487|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
37954785|NCT00563706|69641488|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
37954786|NCT00563706|69641489|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
37954787|NCT00563706|69641481|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
37954788|NCT00563706|69641482|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
37954789|NCT00563706|69641483|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
37954790|NCT00563706|69641484|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
37954791|NCT00563706|69641485|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
37954792|NCT00563706|69641486|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
37954793|NCT00563706|69641487|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
37954794|NCT00563706|69641488|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
37954795|NCT00563706|69641489|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
37954796|NCT00563706|69641481|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
37954797|NCT00563706|69641482|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
37954798|NCT00563706|69641483|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
37954799|NCT00563706|69641484|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
37954800|NCT00563706|69641485|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
37954801|NCT00563706|69641486|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
37954802|NCT00563706|69641487|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
37954803|NCT00563706|69641488|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
37954804|NCT00563706|69641489|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
37954805|NCT00563706|69641481|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
37954806|NCT00563706|69641482|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
38050827|NCT04666441|69739773|FG001|Overall Study|Lost to Follow-up|4|||
37954807|NCT00563706|69641483|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
37954808|NCT00563706|69641484|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
38050828|NCT04666441|69739774|FG002|Overall Study|Lost to Follow-up|1|||
38050829|NCT04666441|69739775|FG003|Overall Study|Lost to Follow-up|3|||
38050830|NCT04666441|69739776|FG004|Overall Study|Lost to Follow-up|0|||
37954809|NCT00563706|69641485|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
37954810|NCT00563706|69641486|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
37954811|NCT00563706|69641487|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
37954812|NCT00563706|69641488|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
37954813|NCT00563706|69641489|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
37954814|NCT00129961|69641511|FG000|Overall Study|Adverse Event|1|||
37954815|NCT00129961|69641512|FG001|Overall Study|Adverse Event|0|||
37954816|NCT00129961|69641511|FG000|Overall Study|Death|1|||
37954817|NCT00129961|69641512|FG001|Overall Study|Death|1|||
37954818|NCT00129961|69641511|FG000|Overall Study|Withdrawal by Sponsor|14|||
37954819|NCT00129961|69641512|FG001|Overall Study|Withdrawal by Sponsor|20|||
37954820|NCT00129961|69641511|FG000|Overall Study|Physician Decision|1|||
37954821|NCT00129961|69641512|FG001|Overall Study|Physician Decision|0|||
37954822|NCT00129961|69641511|FG000|Overall Study|Withdrawal by Subject|2|||
37954823|NCT00129961|69641512|FG001|Overall Study|Withdrawal by Subject|1|||
37954824|NCT00129961|69641511|FG000|Overall Study|Missing Record|0|||
37954825|NCT00129961|69641512|FG001|Overall Study|Missing Record|1|||
37954826|NCT00528567|69641520|FG000|Overall Study|Death|4|||
37954827|NCT00528567|69641521|FG001|Overall Study|Death|5|||
37954828|NCT00528567|69641520|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
37954829|NCT00528567|69641521|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
37954830|NCT00528567|69641520|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
37954831|NCT00528567|69641521|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
37954832|NCT00528567|69641520|FG000|Overall Study|Violation Criteria at Entry|3|||
37954833|NCT00528567|69641521|FG001|Overall Study|Violation Criteria at Entry|17|||
37954834|NCT00528567|69641520|FG000|Overall Study|Withdrew Consent|59|||
37954835|NCT00528567|69641521|FG001|Overall Study|Withdrew Consent|55|||
37954836|NCT00528567|69641520|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
37954837|NCT00528567|69641521|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
37954838|NCT00528567|69641520|FG000|Overall Study|Failure to Return|1|||
37954839|NCT00528567|69641521|FG001|Overall Study|Failure to Return|4|||
37954840|NCT00528567|69641520|FG000|Overall Study|Other Protocol Violation|5|||
37954841|NCT00528567|69641521|FG001|Overall Study|Other Protocol Violation|21|||
37954842|NCT00528567|69641520|FG000|Overall Study|Administrative/Other|22|||
37954843|NCT00528567|69641521|FG001|Overall Study|Administrative/Other|75|||
37954844|NCT00138151|69641534|FG000|Overall Study|Withdrawal by Subject|3|||
37954845|NCT00138151|69641534|FG000|Overall Study|Physician Decision|1|||
37954846|NCT00138073|69641538|FG000|Overall Study|lack of resources|55|||
37954847|NCT02581631|69641547|FG000|Overall Study|Disease progression|29|||
37954848|NCT02581631|69641548|FG001|Overall Study|Disease progression|19|||
37954849|NCT02581631|69641549|FG002|Overall Study|Disease progression|13|||
37954850|NCT02581631|69641550|FG003|Overall Study|Disease progression|5|||
37954851|NCT02581631|69641551|FG004|Overall Study|Disease progression|8|||
37954852|NCT02581631|69641547|FG000|Overall Study|Study drug toxicity|4|||
37954853|NCT02581631|69641548|FG001|Overall Study|Study drug toxicity|6|||
37954854|NCT02581631|69641549|FG002|Overall Study|Study drug toxicity|7|||
37954855|NCT02581631|69641550|FG003|Overall Study|Study drug toxicity|0|||
37954856|NCT02581631|69641551|FG004|Overall Study|Study drug toxicity|3|||
37954857|NCT02581631|69641547|FG000|Overall Study|AE unrelated to study drug|3|||
37954858|NCT02581631|69641548|FG001|Overall Study|AE unrelated to study drug|1|||
37954859|NCT02581631|69641549|FG002|Overall Study|AE unrelated to study drug|1|||
37954860|NCT02581631|69641550|FG003|Overall Study|AE unrelated to study drug|0|||
37954861|NCT02581631|69641551|FG004|Overall Study|AE unrelated to study drug|2|||
37954862|NCT02581631|69641547|FG000|Overall Study|Request to discontinue|1|||
37954863|NCT02581631|69641548|FG001|Overall Study|Request to discontinue|0|||
37954864|NCT02581631|69641549|FG002|Overall Study|Request to discontinue|3|||
37954865|NCT02581631|69641550|FG003|Overall Study|Request to discontinue|0|||
37954866|NCT02581631|69641551|FG004|Overall Study|Request to discontinue|1|||
37954867|NCT02581631|69641547|FG000|Overall Study|participant withdrew consent|3|||
37954868|NCT02581631|69641548|FG001|Overall Study|participant withdrew consent|0|||
37954869|NCT02581631|69641549|FG002|Overall Study|participant withdrew consent|1|||
37954870|NCT02581631|69641550|FG003|Overall Study|participant withdrew consent|0|||
37954871|NCT02581631|69641551|FG004|Overall Study|participant withdrew consent|0|||
37954872|NCT02581631|69641547|FG000|Overall Study|Maximum clinical benefit|1|||
37954873|NCT02581631|69641548|FG001|Overall Study|Maximum clinical benefit|7|||
37954874|NCT02581631|69641549|FG002|Overall Study|Maximum clinical benefit|1|||
37954875|NCT02581631|69641550|FG003|Overall Study|Maximum clinical benefit|3|||
37954876|NCT02581631|69641551|FG004|Overall Study|Maximum clinical benefit|13|||
37954877|NCT02581631|69641547|FG000|Overall Study|Other Reasons|1|||
37954878|NCT02581631|69641548|FG001|Overall Study|Other Reasons|0|||
37954879|NCT02581631|69641549|FG002|Overall Study|Other Reasons|2|||
37954880|NCT02581631|69641550|FG003|Overall Study|Other Reasons|2|||
37954881|NCT02581631|69641551|FG004|Overall Study|Other Reasons|3|||
37954882|NCT02581631|69641547|FG000|Overall Study|Poor/Non-Compliance|0|||
37954883|NCT02581631|69641548|FG001|Overall Study|Poor/Non-Compliance|0|||
37954884|NCT02581631|69641549|FG002|Overall Study|Poor/Non-Compliance|1|||
37954885|NCT02581631|69641550|FG003|Overall Study|Poor/Non-Compliance|0|||
37954886|NCT02581631|69641551|FG004|Overall Study|Poor/Non-Compliance|0|||
37954887|NCT00529035|69641563|FG000|Overall Study|Withdrawal by Subject|1|||
37954888|NCT00609674|69641576|FG000|Overall Study|Adverse Event|1|||
37954889|NCT00609674|69641577|FG001|Overall Study|Adverse Event|1|||
37954890|NCT00609674|69641576|FG000|Overall Study|Protocol Violation|3|||
37954891|NCT00609674|69641577|FG001|Overall Study|Protocol Violation|5|||
37954892|NCT00609674|69641576|FG000|Overall Study|Lost to Follow-up|1|||
37954893|NCT00609674|69641577|FG001|Overall Study|Lost to Follow-up|0|||
37954894|NCT00609674|69641576|FG000|Overall Study|Withdrew consent|2|||
37954895|NCT00609674|69641577|FG001|Overall Study|Withdrew consent|1|||
37954896|NCT00137839|69641583|FG000|Overall Study|Adverse Event|7|||
37954897|NCT00137839|69641583|FG000|Overall Study|Physician Decision|7|||
37954898|NCT00137839|69641583|FG000|Overall Study|Death|8|||
37954899|NCT00137839|69641583|FG000|Overall Study|Disease Progression|60|||
37954900|NCT00137839|69641583|FG000|Overall Study|Not Start Treatment|1|||
37954901|NCT00137839|69641583|FG000|Overall Study|Prolonged Treatment Delay|1|||
37954902|NCT00563316|69641590|FG000|Overall Study|Adverse Event|2|||
37954903|NCT00563316|69641590|FG000|Overall Study|Physician Decision|1|||
37954904|NCT00563316|69641590|FG000|Overall Study|Lost to Follow-up|2|||
37954905|NCT00563316|69641590|FG000|Overall Study|Death|1|||
37954906|NCT00563316|69641590|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
37954907|NCT00563316|69641590|FG000|Overall Study|Other|1|||
37954908|NCT03178487|69641600|FG000|Period 1|Adverse Event|1|||
37954909|NCT03178487|69641601|FG001|Period 1|Adverse Event|2|||
37954910|NCT03178487|69641600|FG000|Period 1|Withdrawal by Subject|2|||
37954911|NCT03178487|69641601|FG001|Period 1|Withdrawal by Subject|1|||
37954912|NCT03178487|69641600|FG000|Period 1|Lost to Follow-up|1|||
37954913|NCT03178487|69641601|FG001|Period 1|Lost to Follow-up|0|||
37954914|NCT03178487|69641600|FG000|Period 1|Other|0|||
37954915|NCT03178487|69641601|FG001|Period 1|Other|1|||
37954916|NCT03178487|69641600|FG000|Period 2|Adverse Event|4|||
37954917|NCT03178487|69641601|FG001|Period 2|Adverse Event|4|||
37954918|NCT03178487|69641600|FG000|Period 2|Withdrawal by Subject|6|||
37954919|NCT03178487|69641601|FG001|Period 2|Withdrawal by Subject|6|||
37954920|NCT03178487|69641600|FG000|Period 2|Lost to Follow-up|2|||
38050831|NCT04666441|69739777|FG005|Overall Study|Lost to Follow-up|2|||
38050832|NCT04666441|69739778|FG006|Overall Study|Lost to Follow-up|2|||
38050833|NCT04666441|69739779|FG007|Overall Study|Lost to Follow-up|2|||
38050834|NCT04666441|69739772|FG000|Overall Study|Subject Decision|1|||
38050835|NCT04666441|69739773|FG001|Overall Study|Subject Decision|1|||
38050836|NCT04666441|69739774|FG002|Overall Study|Subject Decision|3|||
38050837|NCT04666441|69739775|FG003|Overall Study|Subject Decision|1|||
38050838|NCT04666441|69739776|FG004|Overall Study|Subject Decision|0|||
37954921|NCT03178487|69641601|FG001|Period 2|Lost to Follow-up|2|||
37954922|NCT03178487|69641600|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
37954923|NCT03178487|69641601|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
37954924|NCT03178487|69641600|FG000|Period 2|Other|8|||
37954925|NCT03178487|69641601|FG001|Period 2|Other|7|||
37954926|NCT00528957|69641610|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
37954927|NCT00528957|69641611|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
37954928|NCT00528957|69641610|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
37954929|NCT00528957|69641611|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
37954930|NCT00528957|69641610|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
37954931|NCT00528957|69641611|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
37954932|NCT00528957|69641610|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
37954933|NCT00528957|69641611|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
37954934|NCT00528957|69641610|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
37954935|NCT00528957|69641611|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
37954936|NCT00528957|69641610|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
37954937|NCT00528957|69641611|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
37954938|NCT00528957|69641610|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
37954939|NCT00528957|69641611|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
37954940|NCT00528957|69641610|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
37954941|NCT00528957|69641611|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
37954942|NCT00528957|69641610|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
37954943|NCT00528957|69641611|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
38050839|NCT04666441|69739777|FG005|Overall Study|Subject Decision|1|||
37954944|NCT00528957|69641610|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
37954945|NCT00528957|69641611|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
37954946|NCT00528957|69641610|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
37954947|NCT00528957|69641611|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
38050840|NCT04666441|69739778|FG006|Overall Study|Subject Decision|3|||
38050841|NCT04666441|69739779|FG007|Overall Study|Subject Decision|2|||
37954948|NCT00528957|69641610|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
37954949|NCT00528957|69641611|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
37954950|NCT00528957|69641610|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
37954951|NCT00528957|69641611|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
37954952|NCT00528957|69641610|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
37954953|NCT00528957|69641611|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
37954954|NCT00528957|69641610|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
37954955|NCT00528957|69641611|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
37954956|NCT00528957|69641610|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
37954957|NCT00528957|69641611|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
37954958|NCT00560508|69641629|FG000|12 Week Double-blind Period|Adverse Event|3|||
37954959|NCT00560508|69641630|FG001|12 Week Double-blind Period|Adverse Event|2|||
37954960|NCT00560508|69641629|FG000|12 Week Double-blind Period|Protocol Violation|1|||
37954961|NCT00560508|69641630|FG001|12 Week Double-blind Period|Protocol Violation|0|||
37954962|NCT00560508|69641629|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
37954963|NCT00560508|69641630|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
37954964|NCT00560508|69641629|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
37954965|NCT00560508|69641630|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
37954966|NCT00560508|69641629|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
37954967|NCT00560508|69641630|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
37954968|NCT00560508|69641629|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
37954969|NCT00560508|69641630|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
37954970|NCT00560508|69641629|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
37954971|NCT00560508|69641630|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
37954972|NCT03962790|69641641|FG000|Period 1|Adverse Event|0|||
37954973|NCT03962790|69641642|FG001|Period 1|Adverse Event|1|||
37954974|NCT03962790|69641641|FG000|Period 1|Failed to meet all eligibility criteria|1|||
37954975|NCT03962790|69641642|FG001|Period 1|Failed to meet all eligibility criteria|1|||
37954976|NCT03962790|69641641|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
37954977|NCT03962790|69641642|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
37954978|NCT03962790|69641641|FG000|Period 1|Withdrawal by Subject|1|||
37954979|NCT03962790|69641642|FG001|Period 1|Withdrawal by Subject|0|||
37954980|NCT00609518|69641650|FG000|Overall Study|Death from Study Disease|32|||
37954981|NCT00609518|69641651|FG001|Overall Study|Death from Study Disease|32|||
37954982|NCT00609518|69641650|FG000|Overall Study|Withdrawal by Subject|5|||
37954983|NCT00609518|69641651|FG001|Overall Study|Withdrawal by Subject|3|||
37954984|NCT00609518|69641650|FG000|Overall Study|Lost to Follow-up|3|||
37954985|NCT00609518|69641651|FG001|Overall Study|Lost to Follow-up|0|||
37954986|NCT00609518|69641650|FG000|Overall Study|Physician Decision|1|||
37954987|NCT00609518|69641651|FG001|Overall Study|Physician Decision|3|||
37954988|NCT00609518|69641650|FG000|Overall Study|Death from Adverse Event|2|||
37954989|NCT00609518|69641651|FG001|Overall Study|Death from Adverse Event|2|||
37954990|NCT00609362|69641659|FG000|Overall Study|Withdrawal by Subject|2|||
37954991|NCT00609362|69641660|FG001|Overall Study|Withdrawal by Subject|1|||
37954992|NCT00609362|69641659|FG000|Overall Study|Adverse Event|1|||
37954993|NCT00609362|69641660|FG001|Overall Study|Adverse Event|0|||
37954994|NCT00611858|69641666|FG000|Overall Study|Adverse Event|2|||
37954995|NCT00611858|69641666|FG000|Overall Study|Withdrawal by Subject|2|||
37954996|NCT00137449|69641674|FG000|Overall Study|Disease Progression|8|||
37954997|NCT00137449|69641675|FG001|Overall Study|Disease Progression|13|||
37954998|NCT00137449|69641674|FG000|Overall Study|Death|4|||
37954999|NCT00137449|69641675|FG001|Overall Study|Death|3|||
37955000|NCT00137449|69641674|FG000|Overall Study|Adverse Event|3|||
37955001|NCT00137449|69641675|FG001|Overall Study|Adverse Event|1|||
37955002|NCT00137449|69641674|FG000|Overall Study|Withdrawal by Subject|1|||
37955003|NCT00137449|69641675|FG001|Overall Study|Withdrawal by Subject|1|||
37955004|NCT00528879|69641686|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
37955005|NCT00528879|69641687|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
37955006|NCT00528879|69641688|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
37955007|NCT00528879|69641689|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
37955008|NCT00528879|69641686|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
37955009|NCT00528879|69641687|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
37955010|NCT00528879|69641688|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
37955011|NCT00528879|69641689|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
37955012|NCT00528879|69641686|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
37955013|NCT00528879|69641687|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
37955014|NCT00528879|69641688|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
37955015|NCT00528879|69641689|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
37955016|NCT00528879|69641686|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
37955017|NCT00528879|69641687|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
37955018|NCT00528879|69641688|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
37955019|NCT00528879|69641689|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
37955020|NCT00528879|69641686|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
37955021|NCT00528879|69641687|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
37955022|NCT00528879|69641688|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
37955023|NCT00528879|69641689|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
37955024|NCT00528879|69641686|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
37955025|NCT00528879|69641687|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
37955026|NCT00528879|69641688|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
37955027|NCT00528879|69641689|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
37955028|NCT00528879|69641686|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
37955029|NCT00528879|69641687|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
37955030|NCT00528879|69641688|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
37955031|NCT00528879|69641689|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
37955032|NCT00528879|69641686|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
37955033|NCT00528879|69641687|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
37955034|NCT00528879|69641688|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
37955035|NCT00528879|69641689|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
37955036|NCT00528879|69641686|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
37955037|NCT00528879|69641687|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
37955038|NCT00528879|69641688|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
37955039|NCT00528879|69641689|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
37955040|NCT00528879|69641686|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
37955041|NCT00528879|69641687|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
37955042|NCT00528879|69641688|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
37955043|NCT00528879|69641689|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
37955044|NCT00528879|69641686|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
37955045|NCT00528879|69641687|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
37955046|NCT00528879|69641688|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
37955047|NCT00528879|69641689|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
37955048|NCT00528879|69641686|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
37955049|NCT00528879|69641687|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
37955050|NCT00528879|69641688|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
37955051|NCT00528879|69641689|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
37955052|NCT00528879|69641686|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
37955053|NCT00528879|69641687|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
37955054|NCT00528879|69641688|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
37955055|NCT00528879|69641689|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
37955056|NCT00528879|69641686|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
37955057|NCT00528879|69641687|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
37955058|NCT00528879|69641688|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
37955059|NCT00528879|69641689|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
37955060|NCT00528879|69641686|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
37955061|NCT00528879|69641687|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
37955062|NCT00528879|69641688|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
37955063|NCT00528879|69641689|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
37955064|NCT00528879|69641686|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
37955065|NCT00528879|69641687|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
37955066|NCT00528879|69641688|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
37955067|NCT00528879|69641689|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
37955068|NCT00608894|69641701|FG000|Overall Study|Withdrawal by Subject|0|||
37955069|NCT00608894|69641702|FG001|Overall Study|Withdrawal by Subject|2|||
37955070|NCT00557856|69641710|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
37955071|NCT00557856|69641711|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
37955072|NCT00557856|69641712|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
37955073|NCT00557856|69641713|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
37955074|NCT00557856|69641714|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
37955075|NCT00557856|69641715|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
37955076|NCT00557856|69641716|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
37955077|NCT00557856|69641717|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
37955078|NCT00557856|69641718|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
37955079|NCT00557856|69641710|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
37955080|NCT00557856|69641711|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
37955081|NCT00557856|69641712|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
37955082|NCT00557856|69641713|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
37955083|NCT00557856|69641714|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
37955084|NCT00557856|69641715|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
37955085|NCT00557856|69641716|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
37955086|NCT00557856|69641717|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
37955087|NCT00557856|69641718|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
37955088|NCT00557856|69641710|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
37955089|NCT00557856|69641711|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
37955090|NCT00557856|69641712|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
37955091|NCT00557856|69641713|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
37955092|NCT00557856|69641714|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
37955093|NCT00557856|69641715|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
37955094|NCT00557856|69641716|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
37955095|NCT00557856|69641717|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
37955096|NCT00557856|69641718|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
37955097|NCT00557856|69641710|FG000|Part 1: Dose Escalation Phase|Other|0|||
37955098|NCT00557856|69641711|FG001|Part 1: Dose Escalation Phase|Other|0|||
37955099|NCT00557856|69641712|FG002|Part 1: Dose Escalation Phase|Other|1|||
37955100|NCT00557856|69641713|FG003|Part 1: Dose Escalation Phase|Other|1|||
37955101|NCT00557856|69641714|FG004|Part 1: Dose Escalation Phase|Other|0|||
37955102|NCT00557856|69641715|FG005|Part 1: Dose Escalation Phase|Other|0|||
37955103|NCT00557856|69641716|FG006|Part 1: Dose Escalation Phase|Other|0|||
37955104|NCT00557856|69641717|FG007|Part 1: Dose Escalation Phase|Other|1|||
37955105|NCT00557856|69641718|FG008|Part 1: Dose Escalation Phase|Other|0|||
37955106|NCT00557856|69641710|FG000|Part 1: Dose Escalation Phase|Death|0|||
37955107|NCT00557856|69641711|FG001|Part 1: Dose Escalation Phase|Death|0|||
37955108|NCT00557856|69641712|FG002|Part 1: Dose Escalation Phase|Death|0|||
37955109|NCT00557856|69641713|FG003|Part 1: Dose Escalation Phase|Death|0|||
37955110|NCT00557856|69641714|FG004|Part 1: Dose Escalation Phase|Death|0|||
37955111|NCT00557856|69641715|FG005|Part 1: Dose Escalation Phase|Death|1|||
37955112|NCT00557856|69641716|FG006|Part 1: Dose Escalation Phase|Death|0|||
37955113|NCT00557856|69641717|FG007|Part 1: Dose Escalation Phase|Death|0|||
37955114|NCT00557856|69641718|FG008|Part 1: Dose Escalation Phase|Death|0|||
37955115|NCT00557856|69641710|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
37955116|NCT00557856|69641711|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
37955117|NCT00557856|69641712|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
37955118|NCT00557856|69641713|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
37955119|NCT00557856|69641714|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
37955120|NCT00557856|69641715|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
37955121|NCT00557856|69641716|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
37955122|NCT00557856|69641717|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
37955123|NCT00557856|69641718|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
37955124|NCT00557856|69641710|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
37955125|NCT00557856|69641711|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
37955126|NCT00557856|69641712|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
37955127|NCT00557856|69641713|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
37955128|NCT00557856|69641714|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
37955129|NCT00557856|69641715|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
37955130|NCT00557856|69641716|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
37955131|NCT00557856|69641717|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
37955132|NCT00557856|69641718|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
37955133|NCT00557856|69641710|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
37955134|NCT00557856|69641711|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
37955135|NCT00557856|69641712|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
37955136|NCT00557856|69641713|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
37955137|NCT00557856|69641714|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
37955138|NCT00557856|69641715|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
37955139|NCT00557856|69641716|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
37955140|NCT00557856|69641717|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
37955141|NCT00557856|69641718|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
37955142|NCT00557856|69641710|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
37955143|NCT00557856|69641711|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
37955144|NCT00557856|69641712|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
37955145|NCT00557856|69641713|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
37955146|NCT00557856|69641714|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
37955147|NCT00557856|69641715|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
37955148|NCT00557856|69641716|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
37955149|NCT00557856|69641717|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
37955150|NCT00557856|69641718|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
37955151|NCT00557856|69641710|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
37955152|NCT00557856|69641711|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
37955153|NCT00557856|69641712|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
37955154|NCT00557856|69641713|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
37955155|NCT00557856|69641714|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
37955156|NCT00557856|69641715|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
37955157|NCT00557856|69641716|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
37955158|NCT00557856|69641717|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
37955159|NCT00557856|69641718|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
37955160|NCT00557856|69641710|FG000|Part 2: Exploratory Phase|Other|0|||
37955161|NCT00557856|69641711|FG001|Part 2: Exploratory Phase|Other|0|||
37955162|NCT00557856|69641712|FG002|Part 2: Exploratory Phase|Other|0|||
37955163|NCT00557856|69641713|FG003|Part 2: Exploratory Phase|Other|0|||
37955164|NCT00557856|69641714|FG004|Part 2: Exploratory Phase|Other|0|||
37955165|NCT00557856|69641715|FG005|Part 2: Exploratory Phase|Other|0|||
37955166|NCT00557856|69641716|FG006|Part 2: Exploratory Phase|Other|0|||
37955167|NCT00557856|69641717|FG007|Part 2: Exploratory Phase|Other|0|||
37955168|NCT00557856|69641718|FG008|Part 2: Exploratory Phase|Other|1|||
37955169|NCT00557856|69641710|FG000|Part 2: Exploratory Phase|Death|0|||
37955170|NCT00557856|69641711|FG001|Part 2: Exploratory Phase|Death|0|||
37955171|NCT00557856|69641712|FG002|Part 2: Exploratory Phase|Death|0|||
37955172|NCT00557856|69641713|FG003|Part 2: Exploratory Phase|Death|0|||
37955173|NCT00557856|69641714|FG004|Part 2: Exploratory Phase|Death|0|||
37955174|NCT00557856|69641715|FG005|Part 2: Exploratory Phase|Death|0|||
37955175|NCT00557856|69641716|FG006|Part 2: Exploratory Phase|Death|0|||
37955176|NCT00557856|69641717|FG007|Part 2: Exploratory Phase|Death|0|||
37955177|NCT00557856|69641718|FG008|Part 2: Exploratory Phase|Death|2|||
37955178|NCT00557856|69641710|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
37955179|NCT00557856|69641711|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
37955180|NCT00557856|69641712|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
37955181|NCT00557856|69641713|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
37955182|NCT00557856|69641714|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
37955183|NCT00557856|69641715|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
37955184|NCT00557856|69641716|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
37955185|NCT00557856|69641717|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
37955186|NCT00557856|69641718|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
37955187|NCT00191113|69641735|FG000|Core Study|Withdrawal by Subject|25|||
37955188|NCT00191113|69641736|FG001|Core Study|Withdrawal by Subject|9|||
37955189|NCT00191113|69641735|FG000|Core Study|Protocol Violation|6|||
37955190|NCT00191113|69641736|FG001|Core Study|Protocol Violation|2|||
37955191|NCT00191113|69641735|FG000|Core Study|Lost to Follow-up|3|||
37955192|NCT00191113|69641736|FG001|Core Study|Lost to Follow-up|0|||
37955193|NCT00191113|69641735|FG000|Core Study|Adverse Event|0|||
37955194|NCT00191113|69641736|FG001|Core Study|Adverse Event|2|||
37955195|NCT00191113|69641735|FG000|Core Study|Lack of Efficacy|0|||
37955196|NCT00191113|69641736|FG001|Core Study|Lack of Efficacy|2|||
37955197|NCT00191113|69641735|FG000|Core Study|Death|1|||
37955198|NCT00191113|69641736|FG001|Core Study|Death|0|||
37955199|NCT00608582|69641750|FG000|Overall Study|Lost to Follow-up|2|||
37955200|NCT00608582|69641751|FG001|Overall Study|Lost to Follow-up|0|||
37955201|NCT00608582|69641750|FG000|Overall Study|No Best Response in Phase 1 located|1|||
37955202|NCT00608582|69641751|FG001|Overall Study|No Best Response in Phase 1 located|1|||
37955203|NCT00608582|69641750|FG000|Overall Study|Illicit Drug Use|1|||
37955204|NCT00608582|69641751|FG001|Overall Study|Illicit Drug Use|0|||
37955205|NCT00608582|69641750|FG000|Overall Study|Early stage Design Change|0|||
37955206|NCT00608582|69641751|FG001|Overall Study|Early stage Design Change|3|||
37955207|NCT03965052|69641761|FG000|Overall Study|Protocol Violation|1|||
37955208|NCT03965052|69641762|FG001|Overall Study|Protocol Violation|0|||
37955209|NCT03964974|69641770|FG000|Overall Study|Lost to Follow-up|3|||
37955210|NCT03964974|69641771|FG001|Overall Study|Lost to Follow-up|2|||
37955211|NCT03964974|69641770|FG000|Overall Study|Withdrawal by Subject|0|||
37955212|NCT03964974|69641771|FG001|Overall Study|Withdrawal by Subject|3|||
37861853|NCT01218204|69545616|FG000|Part B Washout|Lost to Follow-up|0|||
37955213|NCT00606320|69641777|FG000|Overall Study|Adverse Event|3|||
37955214|NCT00606320|69641777|FG000|Overall Study|Lack of Efficacy|5|||
37955215|NCT00606320|69641777|FG000|Overall Study|Physician Decision|7|||
37955216|NCT00606320|69641777|FG000|Overall Study|Protocol Violation|8|||
37955217|NCT00606320|69641777|FG000|Overall Study|Withdrawal by Subject|10|||
37955218|NCT00606320|69641777|FG000|Overall Study|Progression to depressive phase|4|||
37955219|NCT00528411|69641784|FG000|Overall Study|Adverse Event|4|||
37955220|NCT00528411|69641785|FG001|Overall Study|Adverse Event|0|||
37955221|NCT00528411|69641786|FG002|Overall Study|Adverse Event|1|||
37955222|NCT00528411|69641784|FG000|Overall Study|Incorrect Enrolment|1|||
37955223|NCT00528411|69641785|FG001|Overall Study|Incorrect Enrolment|1|||
37955224|NCT00528411|69641786|FG002|Overall Study|Incorrect Enrolment|0|||
37955225|NCT00528411|69641784|FG000|Overall Study|Severe non-compliance to protocol|0|||
37955226|NCT00528411|69641785|FG001|Overall Study|Severe non-compliance to protocol|1|||
37955227|NCT00528411|69641786|FG002|Overall Study|Severe non-compliance to protocol|0|||
37955228|NCT00528411|69641784|FG000|Overall Study|Prior commitment medication|0|||
37955229|NCT00528411|69641785|FG001|Overall Study|Prior commitment medication|1|||
37955230|NCT00528411|69641786|FG002|Overall Study|Prior commitment medication|0|||
37955231|NCT00136357|69641796|FG000|Overall Study|Withdrawal by Subject|3|||
37955232|NCT00136357|69641797|FG001|Overall Study|Withdrawal by Subject|2|||
37955233|NCT00129649|69641805|FG000|Overall Study|Withdrawal by Subject|76|||
37955234|NCT00129649|69641806|FG001|Overall Study|Withdrawal by Subject|65|||
37955235|NCT00187135|69641818|FG000|Visit One|Withdrawal by Subject|1|||
37955236|NCT00187135|69641819|FG001|Visit One|Withdrawal by Subject|0|||
37955237|NCT00187135|69641820|FG002|Visit One|Withdrawal by Subject|0|||
37955238|NCT00187135|69641821|FG003|Visit One|Withdrawal by Subject|0|||
37955239|NCT00187135|69641822|FG004|Visit One|Withdrawal by Subject|0|||
37955240|NCT00187135|69641823|FG005|Visit One|Withdrawal by Subject|1|||
37955241|NCT00187135|69641818|FG000|Visit One|Physician Decision|3|||
37955242|NCT00187135|69641819|FG001|Visit One|Physician Decision|1|||
37955243|NCT00187135|69641820|FG002|Visit One|Physician Decision|0|||
37955244|NCT00187135|69641821|FG003|Visit One|Physician Decision|0|||
37955245|NCT00187135|69641822|FG004|Visit One|Physician Decision|0|||
37955246|NCT00187135|69641823|FG005|Visit One|Physician Decision|1|||
37955247|NCT00187135|69641818|FG000|Visit Two|Death|0|||
37955248|NCT00187135|69641819|FG001|Visit Two|Death|0|||
37955249|NCT00187135|69641820|FG002|Visit Two|Death|0|||
37955250|NCT00187135|69641821|FG003|Visit Two|Death|1|||
37955251|NCT00187135|69641822|FG004|Visit Two|Death|0|||
37955252|NCT00187135|69641823|FG005|Visit Two|Death|1|||
37955253|NCT00187135|69641818|FG000|Visit Two|Physician Decision|1|||
37955254|NCT00187135|69641819|FG001|Visit Two|Physician Decision|0|||
37955255|NCT00187135|69641820|FG002|Visit Two|Physician Decision|0|||
37955256|NCT00187135|69641821|FG003|Visit Two|Physician Decision|0|||
37955257|NCT00187135|69641822|FG004|Visit Two|Physician Decision|0|||
37955258|NCT00187135|69641823|FG005|Visit Two|Physician Decision|0|||
37955259|NCT00187135|69641818|FG000|Visit Two|Withdrawal by Subject|1|||
37955260|NCT00187135|69641819|FG001|Visit Two|Withdrawal by Subject|1|||
37955261|NCT00187135|69641820|FG002|Visit Two|Withdrawal by Subject|1|||
37955262|NCT00187135|69641821|FG003|Visit Two|Withdrawal by Subject|0|||
37955263|NCT00187135|69641822|FG004|Visit Two|Withdrawal by Subject|1|||
37955264|NCT00187135|69641823|FG005|Visit Two|Withdrawal by Subject|1|||
37955265|NCT00187135|69641818|FG000|Visit Two|Study Discontinued|3|||
37955266|NCT00187135|69641819|FG001|Visit Two|Study Discontinued|2|||
37955267|NCT00187135|69641820|FG002|Visit Two|Study Discontinued|1|||
37955268|NCT00187135|69641821|FG003|Visit Two|Study Discontinued|7|||
37955269|NCT00187135|69641822|FG004|Visit Two|Study Discontinued|5|||
37955270|NCT00187135|69641823|FG005|Visit Two|Study Discontinued|6|||
37955271|NCT00187135|69641818|FG000|Visit Three|Death|0|||
37955272|NCT00187135|69641819|FG001|Visit Three|Death|0|||
37955273|NCT00187135|69641820|FG002|Visit Three|Death|1|||
37955274|NCT00187135|69641821|FG003|Visit Three|Death|0|||
37955275|NCT00187135|69641822|FG004|Visit Three|Death|1|||
37955276|NCT00187135|69641823|FG005|Visit Three|Death|0|||
37955277|NCT00187135|69641818|FG000|Visit Three|Withdrawal by Subject|0|||
37955278|NCT00187135|69641819|FG001|Visit Three|Withdrawal by Subject|1|||
37955279|NCT00187135|69641820|FG002|Visit Three|Withdrawal by Subject|1|||
37955280|NCT00187135|69641821|FG003|Visit Three|Withdrawal by Subject|2|||
37955281|NCT00187135|69641822|FG004|Visit Three|Withdrawal by Subject|0|||
37955282|NCT00187135|69641823|FG005|Visit Three|Withdrawal by Subject|0|||
37955283|NCT00187135|69641818|FG000|Visit Three|Study Discontinued|7|||
37955284|NCT00187135|69641819|FG001|Visit Three|Study Discontinued|6|||
37955285|NCT00187135|69641820|FG002|Visit Three|Study Discontinued|7|||
37955286|NCT00187135|69641821|FG003|Visit Three|Study Discontinued|7|||
38050842|NCT03320850|69739816|FG000|Overall Study|Lost to Follow-up|0|||
38050843|NCT03320850|69739817|FG001|Overall Study|Lost to Follow-up|0|||
38050844|NCT03320850|69739818|FG002|Overall Study|Lost to Follow-up|0|||
37955287|NCT00187135|69641822|FG004|Visit Three|Study Discontinued|7|||
37955288|NCT00187135|69641823|FG005|Visit Three|Study Discontinued|6|||
37955289|NCT00528021|69641839|FG000|Overall Study|Lack of Efficacy|17|||
37955290|NCT00528021|69641840|FG001|Overall Study|Lack of Efficacy|13|||
37955291|NCT00528021|69641841|FG002|Overall Study|Lack of Efficacy|7|||
37955292|NCT00528021|69641842|FG003|Overall Study|Lack of Efficacy|9|||
37955293|NCT00560352|69641855|FG000|Overall Study|Adverse event unrelated to study drug|2|||
37955294|NCT00560352|69641856|FG001|Overall Study|Adverse event unrelated to study drug|1|||
37955295|NCT00560352|69641857|FG002|Overall Study|Adverse event unrelated to study drug|1|||
37955296|NCT00560352|69641855|FG000|Overall Study|Study drug toxicity|3|||
37955297|NCT00560352|69641856|FG001|Overall Study|Study drug toxicity|0|||
37955298|NCT00560352|69641857|FG002|Overall Study|Study drug toxicity|1|||
37955299|NCT00560352|69641855|FG000|Overall Study|Disease progression|0|||
37955300|NCT00560352|69641856|FG001|Overall Study|Disease progression|1|||
38050845|NCT03320850|69739819|FG003|Overall Study|Lost to Follow-up|0|||
37955301|NCT00560352|69641857|FG002|Overall Study|Disease progression|1|||
37955302|NCT00560352|69641855|FG000|Overall Study|Withdrawal by Subject|1|||
37955303|NCT00560352|69641856|FG001|Overall Study|Withdrawal by Subject|1|||
37955304|NCT00560352|69641857|FG002|Overall Study|Withdrawal by Subject|1|||
37955305|NCT00560352|69641855|FG000|Overall Study|Maximum clinical benefit|1|||
37955306|NCT00560352|69641856|FG001|Overall Study|Maximum clinical benefit|0|||
37955307|NCT00560352|69641857|FG002|Overall Study|Maximum clinical benefit|0|||
37955308|NCT00527787|69641871|FG000|Overall Study|Adverse Event|14|||
37955309|NCT00527787|69641872|FG001|Overall Study|Adverse Event|24|||
37955310|NCT00527787|69641871|FG000|Overall Study|Withdrawal by Subject|13|||
37955311|NCT00527787|69641872|FG001|Overall Study|Withdrawal by Subject|25|||
37955312|NCT00527787|69641871|FG000|Overall Study|Lost to Follow-up|5|||
37955313|NCT00527787|69641872|FG001|Overall Study|Lost to Follow-up|2|||
37955314|NCT00527787|69641871|FG000|Overall Study|Duodenal Ulcer|1|||
37955315|NCT00527787|69641872|FG001|Overall Study|Duodenal Ulcer|10|||
37955316|NCT00527787|69641871|FG000|Overall Study|misc|5|||
37955317|NCT00527787|69641872|FG001|Overall Study|misc|2|||
37955318|NCT00608426|69641880|FG000|Overall Study|Death|32|||
37955319|NCT00608426|69641881|FG001|Overall Study|Death|36|||
37955320|NCT00608426|69641880|FG000|Overall Study|Lost to Follow-up|485|||
37955321|NCT00608426|69641881|FG001|Overall Study|Lost to Follow-up|521|||
37955322|NCT00608426|69641880|FG000|Overall Study|refused, health issues, wrong address|319|||
37955323|NCT00608426|69641881|FG001|Overall Study|refused, health issues, wrong address|348|||
37955324|NCT00557076|69641889|FG000|Overall Study|Unblinding|0|||
37955325|NCT00557076|69641890|FG001|Overall Study|Unblinding|1|||
37955326|NCT00129259|69641898|FG000|Overall Study|Lost to Follow-up|1|||
37955327|NCT00129259|69641899|FG001|Overall Study|Lost to Follow-up|1|||
37955328|NCT00129259|69641898|FG000|Overall Study|Withdrawal by Subject|2|||
37955329|NCT00129259|69641899|FG001|Overall Study|Withdrawal by Subject|1|||
37955330|NCT00129259|69641898|FG000|Overall Study|Only available minimal phone assessments|0|||
37955331|NCT00129259|69641899|FG001|Overall Study|Only available minimal phone assessments|1|||
37955332|NCT00186901|69641908|FG000|Overall Study|Pregnancy|6|||
37955333|NCT00186901|69641909|FG001|Overall Study|Pregnancy|3|||
37955334|NCT00186901|69641910|FG002|Overall Study|Pregnancy|0|||
37955335|NCT00186901|69641908|FG000|Overall Study|Lost to Follow-up|6|||
37955336|NCT00186901|69641909|FG001|Overall Study|Lost to Follow-up|3|||
37955337|NCT00186901|69641910|FG002|Overall Study|Lost to Follow-up|0|||
37955338|NCT00186901|69641908|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
37955339|NCT00186901|69641909|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
37955340|NCT00186901|69641910|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
37955341|NCT00186901|69641908|FG000|Overall Study|ALL relapse or second malignancy|1|||
37955342|NCT00186901|69641909|FG001|Overall Study|ALL relapse or second malignancy|2|||
37955343|NCT00186901|69641910|FG002|Overall Study|ALL relapse or second malignancy|0|||
37955344|NCT00186901|69641908|FG000|Overall Study|Withdrawal by Subject|4|||
37955345|NCT00186901|69641909|FG001|Overall Study|Withdrawal by Subject|5|||
37955346|NCT00186901|69641910|FG002|Overall Study|Withdrawal by Subject|0|||
37955347|NCT00186901|69641908|FG000|Overall Study|Open label|3|||
37955348|NCT00186901|69641909|FG001|Overall Study|Open label|2|||
37955349|NCT00186901|69641910|FG002|Overall Study|Open label|0|||
37955350|NCT00186901|69641908|FG000|Overall Study|Limited adherence to study requirements|20|||
37955351|NCT00186901|69641909|FG001|Overall Study|Limited adherence to study requirements|23|||
37955352|NCT00186901|69641910|FG002|Overall Study|Limited adherence to study requirements|0|||
37955353|NCT00186901|69641908|FG000|Overall Study|Bone Mineral Density > 0|0|||
37955354|NCT00186901|69641909|FG001|Overall Study|Bone Mineral Density > 0|0|||
37955355|NCT00186901|69641910|FG002|Overall Study|Bone Mineral Density > 0|149|||
37955356|NCT00186121|69641947|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
37955357|NCT00186121|69641947|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
37955358|NCT00186121|69641947|FG000|Overall Study|Not eligible (no treatment)|1|||
37955359|NCT00186043|69641953|FG000|Overall Study|Lack of Efficacy|1|||
37955360|NCT00186043|69641954|FG001|Overall Study|Lack of Efficacy|3|||
37955361|NCT00186043|69641953|FG000|Overall Study|Lost to Follow-up|4|||
37955362|NCT00186043|69641954|FG001|Overall Study|Lost to Follow-up|6|||
37955363|NCT00186043|69641953|FG000|Overall Study|Withdrawal by Subject|1|||
37955364|NCT00186043|69641954|FG001|Overall Study|Withdrawal by Subject|0|||
37955365|NCT00186043|69641953|FG000|Overall Study|Adverse Event|7|||
37955366|NCT00186043|69641954|FG001|Overall Study|Adverse Event|3|||
37955367|NCT00186043|69641953|FG000|Overall Study|Protocol Violation|2|||
37955368|NCT00186043|69641954|FG001|Overall Study|Protocol Violation|1|||
37955369|NCT00185965|69641962|FG000|Overall Study|Adverse Event|0|||
37955370|NCT00185965|69641963|FG001|Overall Study|Adverse Event|1|||
37955371|NCT00607880|69641971|FG000|Overall Study|Unable to place port due to occlusion|1|||
37955372|NCT00607880|69641972|FG001|Overall Study|Unable to place port due to occlusion|0|||
37955373|NCT00127933|69641980|FG000|Overall Study|Randomized but not dosed|1|||
37955374|NCT00127933|69641981|FG001|Overall Study|Randomized but not dosed|0|||
37955375|NCT03875313|69641992|FG000|Overall Study|Withdrawal by Subject|1|||
37955376|NCT03875313|69641993|FG001|Overall Study|Withdrawal by Subject|3|||
37955377|NCT03875313|69641994|FG002|Overall Study|Withdrawal by Subject|0|||
37955378|NCT03875313|69641995|FG003|Overall Study|Withdrawal by Subject|0|||
37955379|NCT03875313|69641996|FG004|Overall Study|Withdrawal by Subject|0|||
37955380|NCT03875313|69641992|FG000|Overall Study|Death|0|||
37955381|NCT03875313|69641993|FG001|Overall Study|Death|0|||
37955382|NCT03875313|69641994|FG002|Overall Study|Death|0|||
37955383|NCT03875313|69641995|FG003|Overall Study|Death|0|||
37955384|NCT03875313|69641996|FG004|Overall Study|Death|1|||
37955385|NCT03875313|69641992|FG000|Overall Study|Lost to Follow-up|0|||
37955386|NCT03875313|69641993|FG001|Overall Study|Lost to Follow-up|0|||
37955387|NCT03875313|69641994|FG002|Overall Study|Lost to Follow-up|0|||
37955388|NCT03875313|69641995|FG003|Overall Study|Lost to Follow-up|0|||
37955389|NCT03875313|69641996|FG004|Overall Study|Lost to Follow-up|1|||
37955390|NCT03875313|69641992|FG000|Overall Study|Study Termination by Sponsor|0|||
37955391|NCT03875313|69641993|FG001|Overall Study|Study Termination by Sponsor|1|||
37955392|NCT03875313|69641994|FG002|Overall Study|Study Termination by Sponsor|1|||
37955393|NCT03875313|69641995|FG003|Overall Study|Study Termination by Sponsor|0|||
37955394|NCT03875313|69641996|FG004|Overall Study|Study Termination by Sponsor|1|||
37955395|NCT03875313|69641992|FG000|Overall Study|New Anticancer Treatment|0|||
37955396|NCT03875313|69641993|FG001|Overall Study|New Anticancer Treatment|1|||
37955397|NCT03875313|69641994|FG002|Overall Study|New Anticancer Treatment|2|||
37955398|NCT03875313|69641995|FG003|Overall Study|New Anticancer Treatment|1|||
37955399|NCT03875313|69641996|FG004|Overall Study|New Anticancer Treatment|0|||
37955400|NCT03875313|69641992|FG000|Overall Study|Other, Not Specified|2|||
37955401|NCT03875313|69641993|FG001|Overall Study|Other, Not Specified|11|||
37955402|NCT03875313|69641994|FG002|Overall Study|Other, Not Specified|3|||
37955403|NCT03875313|69641995|FG003|Overall Study|Other, Not Specified|3|||
37955404|NCT03875313|69641996|FG004|Overall Study|Other, Not Specified|1|||
37955405|NCT04796415|69642039|FG000|Overall Study|not interested|12|||
37955406|NCT04796415|69642039|FG000|Overall Study|health issue|8|||
37955407|NCT04796415|69642039|FG000|Overall Study|Other|4|||
37955408|NCT04796415|69642039|FG000|Overall Study|discharged from home health service|3|||
37955409|NCT04796415|69642039|FG000|Overall Study|re-hospitalization|2|||
37955410|NCT04796415|69642039|FG000|Overall Study|moving to nursing home|1|||
37955411|NCT04796415|69642039|FG000|Overall Study|lost contact|1|||
37955412|NCT04678557|69642046|FG000|Overall Study|Withdrawal by Subject|1|||
37955413|NCT04678557|69642047|FG001|Overall Study|Withdrawal by Subject|0|||
37955414|NCT04678557|69642046|FG000|Overall Study|Lack of Efficacy|0|||
37955415|NCT04678557|69642047|FG001|Overall Study|Lack of Efficacy|13|||
37955416|NCT04678557|69642046|FG000|Overall Study|Safety Evaluation|0|||
37955417|NCT04678557|69642047|FG001|Overall Study|Safety Evaluation|1|||
37955418|NCT04230980|69642068|FG000|Overall Study|Lost to Follow-up|1|||
37955419|NCT04230980|69642069|FG001|Overall Study|Lost to Follow-up|2|||
37955420|NCT04230980|69642068|FG000|Overall Study|Adverse Event|0|||
37955421|NCT04230980|69642069|FG001|Overall Study|Adverse Event|1|||
37955422|NCT03997383|69642095|FG000|Double-blind Treatment Period|Adverse Event|4|||
37955423|NCT03997383|69642096|FG001|Double-blind Treatment Period|Adverse Event|3|||
37955424|NCT03997383|69642095|FG000|Double-blind Treatment Period|Death|4|||
37955425|NCT03997383|69642096|FG001|Double-blind Treatment Period|Death|4|||
37955426|NCT03997383|69642095|FG000|Double-blind Treatment Period|Physician Decision|2|||
37955427|NCT03997383|69642096|FG001|Double-blind Treatment Period|Physician Decision|0|||
37955428|NCT03997383|69642095|FG000|Double-blind Treatment Period|Withdrawal by Subject|3|||
37955429|NCT03997383|69642096|FG001|Double-blind Treatment Period|Withdrawal by Subject|6|||
37955430|NCT03997383|69642095|FG000|Open-label Extension Period|Ongoing|148|||
37955431|NCT03997383|69642096|FG001|Open-label Extension Period|Ongoing|151|||
37955432|NCT03997383|69642095|FG000|Open-label Extension Period|Adverse Event|4|||
37955433|NCT03997383|69642096|FG001|Open-label Extension Period|Adverse Event|1|||
37955434|NCT03997383|69642095|FG000|Open-label Extension Period|Death|8|||
38050846|NCT03320850|69739820|FG004|Overall Study|Lost to Follow-up|1|||
38050847|NCT03320850|69739821|FG005|Overall Study|Lost to Follow-up|2|||
38050848|NCT03320850|69739822|FG006|Overall Study|Lost to Follow-up|2|||
38050849|NCT03320850|69739823|FG007|Overall Study|Lost to Follow-up|0|||
37955435|NCT03997383|69642096|FG001|Open-label Extension Period|Death|9|||
37955436|NCT03997383|69642095|FG000|Open-label Extension Period|Physician Decision|1|||
37955437|NCT03997383|69642096|FG001|Open-label Extension Period|Physician Decision|1|||
37955438|NCT03997383|69642095|FG000|Open-label Extension Period|Subject Stopped Participation in the Study|3|||
37955439|NCT03997383|69642096|FG001|Open-label Extension Period|Subject Stopped Participation in the Study|6|||
37955440|NCT03997383|69642095|FG000|Open-label Extension Period|Reason Not Specified|2|||
37955441|NCT03997383|69642096|FG001|Open-label Extension Period|Reason Not Specified|0|||
37955442|NCT03880019|69642108|FG000|Overall Study|Competing disease|1|||
37955443|NCT03697720|69642142|FG000|Overall Study|Lost to Follow-up|7|||
37955444|NCT03635983|69642148|FG000|Pre-Treatment Period|Not yet treated at the time of database lock|1|||
37955445|NCT03635983|69642149|FG001|Pre-Treatment Period|Not yet treated at the time of database lock|0|||
38050850|NCT03320850|69739824|FG008|Overall Study|Lost to Follow-up|6|||
38050851|NCT03320850|69739825|FG009|Overall Study|Lost to Follow-up|4|||
38050852|NCT03320850|69739816|FG000|Overall Study|Withdrawal by Subject|0|||
38050853|NCT03320850|69739817|FG001|Overall Study|Withdrawal by Subject|0|||
37955446|NCT03635983|69642148|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
37955447|NCT03635983|69642149|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
37955448|NCT03635983|69642148|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
37955449|NCT03635983|69642149|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
37955450|NCT03635983|69642148|FG000|Pre-Treatment Period|Other reasons|1|||
37955451|NCT03635983|69642149|FG001|Pre-Treatment Period|Other reasons|2|||
37955452|NCT03635983|69642148|FG000|Pre-Treatment Period|Disease Progression|0|||
37955453|NCT03635983|69642149|FG001|Pre-Treatment Period|Disease Progression|1|||
37955454|NCT03635983|69642148|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
37955455|NCT03635983|69642149|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|0|||
37955456|NCT03635983|69642148|FG000|Treatment Period|Completed treatment period|13|||
37955457|NCT03635983|69642149|FG001|Treatment Period|Completed treatment period|20|||
37955458|NCT03635983|69642148|FG000|Treatment Period|Participant request to discontinue Study treatment|5|||
37955459|NCT03635983|69642149|FG001|Treatment Period|Participant request to discontinue Study treatment|5|||
37955460|NCT03635983|69642148|FG000|Treatment Period|Withdrawal by Subject|2|||
37955461|NCT03635983|69642149|FG001|Treatment Period|Withdrawal by Subject|4|||
37955462|NCT03635983|69642148|FG000|Treatment Period|Death|3|||
37955463|NCT03635983|69642149|FG001|Treatment Period|Death|4|||
37955464|NCT03635983|69642148|FG000|Treatment Period|Poor/Non-compliance|1|||
37955465|NCT03635983|69642149|FG001|Treatment Period|Poor/Non-compliance|0|||
37955466|NCT03635983|69642148|FG000|Treatment Period|Participant no longer meets Study criteria|0|||
37955467|NCT03635983|69642149|FG001|Treatment Period|Participant no longer meets Study criteria|2|||
37955468|NCT03635983|69642148|FG000|Treatment Period|Other reasons|5|||
37955469|NCT03635983|69642149|FG001|Treatment Period|Other reasons|2|||
37955470|NCT03635983|69642148|FG000|Treatment Period|Disease progression|184|||
37955471|NCT03635983|69642149|FG001|Treatment Period|Disease progression|168|||
37955472|NCT03635983|69642148|FG000|Treatment Period|Study drug toxicity|26|||
37955473|NCT03635983|69642149|FG001|Treatment Period|Study drug toxicity|29|||
37955474|NCT03635983|69642148|FG000|Treatment Period|Adverse event unrelated to Study drug|10|||
37955475|NCT03635983|69642149|FG001|Treatment Period|Adverse event unrelated to Study drug|11|||
37955476|NCT03635983|69642148|FG000|Treatment Period|Maximum clinical benefit|3|||
37955477|NCT03635983|69642149|FG001|Treatment Period|Maximum clinical benefit|2|||
37955478|NCT03551496|69642166|FG000|Overall Study|Death|11|||
37955479|NCT03551496|69642167|FG001|Overall Study|Death|7|||
37955480|NCT03551496|69642166|FG000|Overall Study|Withdrawal by Subject|4|||
37955481|NCT03551496|69642167|FG001|Overall Study|Withdrawal by Subject|3|||
37955482|NCT03551496|69642166|FG000|Overall Study|Other Reasons|1|||
37955483|NCT03551496|69642167|FG001|Overall Study|Other Reasons|0|||
37955484|NCT03517449|69642175|FG000|Overall Study|Death|184|||
37955485|NCT03517449|69642176|FG001|Overall Study|Death|236|||
37955486|NCT03517449|69642175|FG000|Overall Study|Lost to Follow-up|0|||
37955487|NCT03517449|69642176|FG001|Overall Study|Lost to Follow-up|2|||
37955488|NCT03517449|69642175|FG000|Overall Study|Withdrawal by Subject|7|||
37955489|NCT03517449|69642176|FG001|Overall Study|Withdrawal by Subject|26|||
37955490|NCT03517449|69642175|FG000|Overall Study|Participants Ongoing|220|||
37955491|NCT03517449|69642176|FG001|Overall Study|Participants Ongoing|152|||
38050854|NCT03320850|69739818|FG002|Overall Study|Withdrawal by Subject|0|||
38050855|NCT03320850|69739819|FG003|Overall Study|Withdrawal by Subject|0|||
37955494|NCT03257631|69642203|FG000|Overall Study|Death|8|||
37955495|NCT03257631|69642204|FG001|Overall Study|Death|5|||
37955496|NCT03257631|69642205|FG002|Overall Study|Death|13|||
37955497|NCT03257631|69642206|FG003|Overall Study|Death|5|||
37955498|NCT03257631|69642203|FG000|Overall Study|Progressive Disease|0|||
37955499|NCT03257631|69642204|FG001|Overall Study|Progressive Disease|0|||
37955500|NCT03257631|69642205|FG002|Overall Study|Progressive Disease|1|||
37955501|NCT03257631|69642206|FG003|Overall Study|Progressive Disease|0|||
37955502|NCT03257631|69642203|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
37955503|NCT03257631|69642204|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
37955504|NCT03257631|69642205|FG002|Overall Study|Withdrawal by Parent/Guardian|4|||
37955505|NCT03257631|69642206|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
37955506|NCT03257631|69642203|FG000|Overall Study|Lost to Follow-up|0|||
37955507|NCT03257631|69642204|FG001|Overall Study|Lost to Follow-up|0|||
37955508|NCT03257631|69642205|FG002|Overall Study|Lost to Follow-up|1|||
37955509|NCT03257631|69642206|FG003|Overall Study|Lost to Follow-up|0|||
37955510|NCT03257631|69642203|FG000|Overall Study|Still on Study|3|||
37955511|NCT03257631|69642204|FG001|Overall Study|Still on Study|2|||
37955512|NCT03257631|69642205|FG002|Overall Study|Still on Study|4|||
37955513|NCT03257631|69642206|FG003|Overall Study|Still on Study|4|||
37955514|NCT03055767|69642218|FG000|Open-Label Period|Lost to Follow-up|0|||
37955515|NCT03055767|69642219|FG001|Open-Label Period|Lost to Follow-up|0|||
37955516|NCT03055767|69642220|FG002|Open-Label Period|Lost to Follow-up|2|||
37955517|NCT03055767|69642221|FG003|Open-Label Period|Lost to Follow-up|0|||
37955518|NCT03055767|69642218|FG000|Open-Label Period|Withdrawal by Subject|0|||
37955519|NCT03055767|69642219|FG001|Open-Label Period|Withdrawal by Subject|0|||
37955520|NCT03055767|69642220|FG002|Open-Label Period|Withdrawal by Subject|0|||
37955521|NCT03055767|69642221|FG003|Open-Label Period|Withdrawal by Subject|1|||
37955522|NCT02702414|69642238|FG000|Overall Study|Death|77|||
37955523|NCT02702414|69642239|FG001|Overall Study|Death|34|||
37955524|NCT02702414|69642238|FG000|Overall Study|Lost to Follow-up|0|||
37955525|NCT02702414|69642239|FG001|Overall Study|Lost to Follow-up|1|||
37955526|NCT02702414|69642238|FG000|Overall Study|Withdrawal by Subject|0|||
37955527|NCT02702414|69642239|FG001|Overall Study|Withdrawal by Subject|1|||
37955528|NCT02702414|69642238|FG000|Overall Study|Participants Ongoing in Study|27|||
37955529|NCT02702414|69642239|FG001|Overall Study|Participants Ongoing in Study|15|||
37955530|NCT02702414|69642238|FG000|Overall Study|Not Treated|1|||
37955531|NCT02702414|69642239|FG001|Overall Study|Not Treated|0|||
37955532|NCT02143414|69642258|FG000|Induction|Adverse Event|1|||
37955533|NCT02143414|69642259|FG001|Induction|Adverse Event|2|||
37955534|NCT02143414|69642258|FG000|Induction|Death|1|||
37955535|NCT02143414|69642259|FG001|Induction|Death|2|||
37955536|NCT02143414|69642258|FG000|Induction|Patient refusal|1|||
37955537|NCT02143414|69642259|FG001|Induction|Patient refusal|1|||
37955538|NCT02143414|69642258|FG000|Induction|Refractory|1|||
37955539|NCT02143414|69642259|FG001|Induction|Refractory|0|||
37955540|NCT02143414|69642258|FG000|Induction|Began alternative treatment|1|||
37955541|NCT02143414|69642259|FG001|Induction|Began alternative treatment|0|||
37955542|NCT02143414|69642258|FG000|Induction|Ineligible for postremission|5|||
37955543|NCT02143414|69642259|FG001|Induction|Ineligible for postremission|1|||
37955544|NCT02143414|69642258|FG000|Post-remission|Adverse Event|0|||
37955545|NCT02143414|69642259|FG001|Post-remission|Adverse Event|2|||
37955546|NCT02143414|69642258|FG000|Post-remission|Disease progression/relapse|5|||
37955547|NCT02143414|69642259|FG001|Post-remission|Disease progression/relapse|0|||
37955548|NCT02143414|69642258|FG000|Maintenance|Adverse Event|4|||
37955549|NCT02143414|69642259|FG001|Maintenance|Adverse Event|6|||
37955550|NCT02143414|69642258|FG000|Maintenance|Disease progression/relapse|3|||
37955551|NCT02143414|69642259|FG001|Maintenance|Disease progression/relapse|2|||
37955552|NCT02143414|69642258|FG000|Maintenance|Patient refusal|2|||
37955553|NCT02143414|69642259|FG001|Maintenance|Patient refusal|1|||
37955554|NCT02143414|69642258|FG000|Maintenance|Physician Decision|1|||
37955555|NCT02143414|69642259|FG001|Maintenance|Physician Decision|0|||
37955556|NCT02143414|69642258|FG000|Maintenance|Death|0|||
37955557|NCT02143414|69642259|FG001|Maintenance|Death|1|||
37955558|NCT02143414|69642258|FG000|Maintenance|On protocol treatment|0|||
37955559|NCT02143414|69642259|FG001|Maintenance|On protocol treatment|6|||
37955560|NCT01064479|69642289|FG000|Overall Study|Death|10|||
37955561|NCT01064479|69642290|FG001|Overall Study|Death|11|||
37955562|NCT01064479|69642289|FG000|Overall Study|Withdrawal by Subject|2|||
37955563|NCT01064479|69642290|FG001|Overall Study|Withdrawal by Subject|2|||
37955564|NCT01064479|69642289|FG000|Overall Study|Disease progression|1|||
37955565|NCT01064479|69642290|FG001|Overall Study|Disease progression|1|||
37955566|NCT01064479|69642289|FG000|Overall Study|Toxicity|1|||
37955567|NCT01064479|69642290|FG001|Overall Study|Toxicity|1|||
37955568|NCT01064479|69642289|FG000|Overall Study|Other|1|||
37955569|NCT01064479|69642290|FG001|Overall Study|Other|2|||
37955570|NCT00556998|69642304|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
37955571|NCT00556998|69642304|FG000|Voriconazole Intravenous (IV)|Other|4|||
37955572|NCT00556998|69642304|FG000|Voriconazole Oral|Adverse Event|1|||
37955573|NCT00556998|69642304|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
37955574|NCT00528801|69642314|FG000|Overall Study|Withdrawal by Subject|1|||
37955575|NCT00528801|69642315|FG001|Overall Study|Withdrawal by Subject|1|||
37955576|NCT00528801|69642314|FG000|Overall Study|Protocol Violation|11|||
37955577|NCT00528801|69642315|FG001|Overall Study|Protocol Violation|5|||
37955578|NCT00528801|69642314|FG000|Overall Study|Lost to Follow-up|15|||
37955579|NCT00528801|69642315|FG001|Overall Study|Lost to Follow-up|4|||
37955580|NCT00528801|69642314|FG000|Overall Study|Administrative Reasons|0|||
37955581|NCT00528801|69642315|FG001|Overall Study|Administrative Reasons|1|||
37955582|NCT00527397|69642321|FG000|Overall Study|Adverse Event|3|||
37955583|NCT00527397|69642321|FG000|Overall Study|Lack of Efficacy|1|||
37955584|NCT00527397|69642321|FG000|Overall Study|Protocol Violation|1|||
37955585|NCT00527397|69642321|FG000|Overall Study|Withdrawal by Subject|6|||
37955586|NCT00527397|69642321|FG000|Overall Study|Study terminated by sponsor|13|||
37955587|NCT00527319|69642331|FG000|Overall Study|Withdrawal by Subject|5|||
37955588|NCT00527319|69642332|FG001|Overall Study|Withdrawal by Subject|0|||
37955589|NCT00527319|69642333|FG002|Overall Study|Withdrawal by Subject|1|||
37955590|NCT00527319|69642331|FG000|Overall Study|Lost to Follow-up|1|||
37955591|NCT00527319|69642332|FG001|Overall Study|Lost to Follow-up|0|||
37955592|NCT00527319|69642333|FG002|Overall Study|Lost to Follow-up|0|||
37955593|NCT00527319|69642331|FG000|Overall Study|Death|0|||
37955594|NCT00527319|69642332|FG001|Overall Study|Death|3|||
37955595|NCT00527319|69642333|FG002|Overall Study|Death|1|||
37955596|NCT00527319|69642331|FG000|Overall Study|Intercurrent Medical Illness|0|||
37955597|NCT00527319|69642332|FG001|Overall Study|Intercurrent Medical Illness|1|||
37955598|NCT00527319|69642333|FG002|Overall Study|Intercurrent Medical Illness|3|||
37955599|NCT00527319|69642331|FG000|Overall Study|Adverse Event|0|||
37955600|NCT00527319|69642332|FG001|Overall Study|Adverse Event|0|||
37955601|NCT00527319|69642333|FG002|Overall Study|Adverse Event|1|||
37955602|NCT00562302|69642343|FG000|Overall Study|Lost to Follow-up|3|||
37955603|NCT00562302|69642344|FG001|Overall Study|Lost to Follow-up|3|||
37955604|NCT00562302|69642343|FG000|Overall Study|Adverse Event|0|||
37955605|NCT00562302|69642344|FG001|Overall Study|Adverse Event|6|||
37955606|NCT00562302|69642343|FG000|Overall Study|Non-compliance|1|||
37955607|NCT00562302|69642344|FG001|Overall Study|Non-compliance|2|||
37955608|NCT00562302|69642343|FG000|Overall Study|Withdrawal by Subject|7|||
37955609|NCT00562302|69642344|FG001|Overall Study|Withdrawal by Subject|8|||
37955610|NCT00562302|69642343|FG000|Overall Study|Death|1|||
37955611|NCT00562302|69642344|FG001|Overall Study|Death|2|||
37955612|NCT00562302|69642343|FG000|Overall Study|Lung resection prior to study completion|7|||
37955613|NCT00562302|69642344|FG001|Overall Study|Lung resection prior to study completion|7|||
37955614|NCT00562302|69642343|FG000|Overall Study|Not stated|1|||
37955615|NCT00562302|69642344|FG001|Overall Study|Not stated|4|||
37955616|NCT00134719|69642353|FG000|Primary Vaccination Phase|Adverse Event|4|||
37955617|NCT00134719|69642354|FG001|Primary Vaccination Phase|Adverse Event|0|||
37955618|NCT00134719|69642355|FG002|Primary Vaccination Phase|Adverse Event|0|||
37955619|NCT00134719|69642353|FG000|Primary Vaccination Phase|Protocol Violation|1|||
37955620|NCT00134719|69642354|FG001|Primary Vaccination Phase|Protocol Violation|0|||
37955621|NCT00134719|69642355|FG002|Primary Vaccination Phase|Protocol Violation|0|||
37955622|NCT00134719|69642353|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
37955623|NCT00134719|69642354|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
37955624|NCT00134719|69642355|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
37955625|NCT00134719|69642353|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
37955626|NCT00134719|69642354|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
37955627|NCT00134719|69642355|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
37955628|NCT00134719|69642353|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
38050856|NCT03320850|69739820|FG004|Overall Study|Withdrawal by Subject|1|||
38050857|NCT03320850|69739821|FG005|Overall Study|Withdrawal by Subject|2|||
38050858|NCT03320850|69739822|FG006|Overall Study|Withdrawal by Subject|4|||
38050859|NCT03320850|69739823|FG007|Overall Study|Withdrawal by Subject|5|||
38050860|NCT03320850|69739824|FG008|Overall Study|Withdrawal by Subject|2|||
38050861|NCT03320850|69739825|FG009|Overall Study|Withdrawal by Subject|1|||
38050862|NCT03320850|69739816|FG000|Overall Study|Lack of Efficacy|0|||
37955629|NCT00134719|69642354|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
38050863|NCT03320850|69739817|FG001|Overall Study|Lack of Efficacy|0|||
37955630|NCT00134719|69642355|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
38050864|NCT03320850|69739818|FG002|Overall Study|Lack of Efficacy|0|||
38050865|NCT03320850|69739819|FG003|Overall Study|Lack of Efficacy|1|||
38050866|NCT03320850|69739820|FG004|Overall Study|Lack of Efficacy|0|||
38050867|NCT03320850|69739821|FG005|Overall Study|Lack of Efficacy|1|||
38050868|NCT03320850|69739822|FG006|Overall Study|Lack of Efficacy|0|||
38050869|NCT03320850|69739823|FG007|Overall Study|Lack of Efficacy|2|||
38050870|NCT03320850|69739824|FG008|Overall Study|Lack of Efficacy|0|||
38050871|NCT03320850|69739825|FG009|Overall Study|Lack of Efficacy|3|||
38050872|NCT03320850|69739816|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
38050873|NCT03320850|69739817|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
38050874|NCT03320850|69739818|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
38050875|NCT03320850|69739819|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
38050876|NCT03320850|69739820|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
38050877|NCT03320850|69739821|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
38050878|NCT03320850|69739822|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
38050879|NCT03320850|69739823|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
38050880|NCT03320850|69739824|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
38050881|NCT03320850|69739825|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
38050882|NCT03320850|69739816|FG000|Overall Study|Adverse Event|0|||
38050883|NCT03320850|69739817|FG001|Overall Study|Adverse Event|0|||
37955631|NCT00134719|69642353|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
37955632|NCT00134719|69642354|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
38050884|NCT03320850|69739818|FG002|Overall Study|Adverse Event|0|||
37861854|NCT01218204|69545617|FG001|Part B Washout|Lost to Follow-up|2|||
37861855|NCT01218204|69545618|FG002|Part B Washout|Lost to Follow-up|0|||
37861856|NCT01218204|69545619|FG003|Part B Washout|Lost to Follow-up|0|||
37955633|NCT00134719|69642355|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
37955634|NCT00526071|69642363|FG000|Overall Study|Adverse Event|1|||
37955635|NCT00526071|69642363|FG000|Overall Study|Withdrawal by Subject|1|||
38050885|NCT03320850|69739819|FG003|Overall Study|Adverse Event|0|||
38050886|NCT03320850|69739820|FG004|Overall Study|Adverse Event|0|||
38050887|NCT03320850|69739821|FG005|Overall Study|Adverse Event|2|||
37955636|NCT00526071|69642363|FG000|Overall Study|Lack of Response to Study Drug|4|||
38050888|NCT03320850|69739822|FG006|Overall Study|Adverse Event|1|||
37955637|NCT00525915|69642373|FG000|Overall Study|Non-Compliance|0|||
37955638|NCT00525915|69642374|FG001|Overall Study|Non-Compliance|1|||
37955639|NCT00525915|69642373|FG000|Overall Study|Disease Progression|5|||
37955640|NCT00525915|69642374|FG001|Overall Study|Disease Progression|6|||
37955641|NCT00525915|69642373|FG000|Overall Study|Withdrawal by Subject|1|||
37955642|NCT00525915|69642374|FG001|Overall Study|Withdrawal by Subject|0|||
37955643|NCT00525915|69642373|FG000|Overall Study|Refused Surgery|1|||
37955644|NCT00525915|69642374|FG001|Overall Study|Refused Surgery|2|||
37955645|NCT00525915|69642373|FG000|Overall Study|Unrelated illness|1|||
37955646|NCT00525915|69642374|FG001|Overall Study|Unrelated illness|0|||
37955647|NCT00521079|69642382|FG000|Overall Study|Adverse Event|7|||
37955648|NCT00521079|69642383|FG001|Overall Study|Adverse Event|1|||
37955649|NCT00521079|69642382|FG000|Overall Study|Lost to Follow-up|2|||
37955650|NCT00521079|69642383|FG001|Overall Study|Lost to Follow-up|1|||
37955651|NCT00521079|69642382|FG000|Overall Study|Withdrawal by Subject|5|||
37955652|NCT00521079|69642383|FG001|Overall Study|Withdrawal by Subject|3|||
37955653|NCT00521001|69642389|FG000|Overall Study|Ineligible|1|||
37955654|NCT00134563|69642396|FG000|Overall Study|Not treated due to protocol violation|0|||
37955655|NCT00134563|69642397|FG001|Overall Study|Not treated due to protocol violation|1|||
37955656|NCT00134563|69642398|FG002|Overall Study|Not treated due to protocol violation|1|||
37955657|NCT00134563|69642396|FG000|Overall Study|Adverse Event|29|||
37955658|NCT00134563|69642397|FG001|Overall Study|Adverse Event|37|||
37955659|NCT00134563|69642398|FG002|Overall Study|Adverse Event|38|||
37955660|NCT00134563|69642396|FG000|Overall Study|Lack of Efficacy|24|||
37955661|NCT00134563|69642397|FG001|Overall Study|Lack of Efficacy|14|||
37955662|NCT00134563|69642398|FG002|Overall Study|Lack of Efficacy|17|||
37955663|NCT00134563|69642396|FG000|Overall Study|Protocol Violation|3|||
37955664|NCT00134563|69642397|FG001|Overall Study|Protocol Violation|2|||
37955665|NCT00134563|69642398|FG002|Overall Study|Protocol Violation|5|||
37955666|NCT00134563|69642396|FG000|Overall Study|Lost to Follow-up|4|||
37955667|NCT00134563|69642397|FG001|Overall Study|Lost to Follow-up|0|||
37955668|NCT00134563|69642398|FG002|Overall Study|Lost to Follow-up|2|||
37955669|NCT00134563|69642396|FG000|Overall Study|progressive disease|11|||
37955670|NCT00134563|69642397|FG001|Overall Study|progressive disease|4|||
37955671|NCT00134563|69642398|FG002|Overall Study|progressive disease|2|||
37955672|NCT00134563|69642396|FG000|Overall Study|did not wish to continue|33|||
37955673|NCT00134563|69642397|FG001|Overall Study|did not wish to continue|32|||
37955674|NCT00134563|69642398|FG002|Overall Study|did not wish to continue|26|||
37955675|NCT00134563|69642396|FG000|Overall Study|Reason other than above|0|||
37955676|NCT00134563|69642397|FG001|Overall Study|Reason other than above|2|||
37955677|NCT00134563|69642398|FG002|Overall Study|Reason other than above|5|||
37955678|NCT00520845|69642406|FG000|Overall Study|Death|3|||
37955679|NCT00520845|69642406|FG000|Overall Study|Adverse Event|4|||
37955680|NCT00520845|69642406|FG000|Overall Study|Disease Progression, relapse|13|||
37955681|NCT00520845|69642406|FG000|Overall Study|Withdrawal by Subject|1|||
37955682|NCT00520845|69642406|FG000|Overall Study|Alternative Therapy|1|||
37955683|NCT00185731|69642410|FG000|Overall Study|Withdrawal by Subject|1|||
37955684|NCT00185731|69642410|FG000|Overall Study|Not Eligible|1|||
37955685|NCT00582491|69642418|FG000|Overall Study|Withdrawal by Subject|1|||
37955686|NCT00582491|69642419|FG001|Overall Study|Withdrawal by Subject|0|||
37955687|NCT00520767|69642425|FG000|Overall Study|Death|2|||
37955688|NCT04679051|69642431|FG000|Overall Study|felt tired after restricted time in bed|3|||
37955689|NCT04679051|69642432|FG001|Overall Study|felt tired after restricted time in bed|0|||
37955690|NCT04679051|69642431|FG000|Overall Study|discomfort with blood pressure cuff|2|||
37955691|NCT04679051|69642432|FG001|Overall Study|discomfort with blood pressure cuff|0|||
37955692|NCT04679051|69642431|FG000|Overall Study|scheduling conflict|1|||
38050889|NCT03320850|69739823|FG007|Overall Study|Adverse Event|0|||
38050890|NCT03320850|69739824|FG008|Overall Study|Adverse Event|2|||
38050891|NCT03320850|69739825|FG009|Overall Study|Adverse Event|0|||
38050892|NCT03320850|69739816|FG000|Overall Study|Reason Not Specified|0|||
38050893|NCT03320850|69739817|FG001|Overall Study|Reason Not Specified|0|||
38050894|NCT03320850|69739818|FG002|Overall Study|Reason Not Specified|0|||
38050895|NCT03320850|69739819|FG003|Overall Study|Reason Not Specified|0|||
37955693|NCT04679051|69642432|FG001|Overall Study|scheduling conflict|1|||
37955694|NCT04679051|69642431|FG000|Overall Study|Protocol Violation|0|||
38050896|NCT03320850|69739820|FG004|Overall Study|Reason Not Specified|0|||
37861857|NCT01218204|69545616|FG000|Part B Washout|Physician Decision|0|||
37955695|NCT04679051|69642432|FG001|Overall Study|Protocol Violation|4|||
37955696|NCT03873987|69642443|FG000|Overall Study|Adverse Event|1|||
37955697|NCT03873987|69642444|FG001|Overall Study|Adverse Event|0|||
37955698|NCT03873987|69642443|FG000|Overall Study|staff was unable to start a new IV line|1|||
37955699|NCT03873987|69642444|FG001|Overall Study|staff was unable to start a new IV line|0|||
37955700|NCT03873987|69642443|FG000|Overall Study|Lost to Follow-up|0|||
37955701|NCT03873987|69642444|FG001|Overall Study|Lost to Follow-up|1|||
37955702|NCT00474760|69642462|FG000|Overall Study|Death|0|||
37955703|NCT00474760|69642463|FG001|Overall Study|Death|0|||
37955704|NCT00474760|69642464|FG002|Overall Study|Death|0|||
37955705|NCT00474760|69642465|FG003|Overall Study|Death|0|||
37955706|NCT00474760|69642466|FG004|Overall Study|Death|2|||
37955707|NCT00474760|69642467|FG005|Overall Study|Death|0|||
37955708|NCT00474760|69642468|FG006|Overall Study|Death|0|||
37955709|NCT00474760|69642462|FG000|Overall Study|Adverse Event|0|||
37955710|NCT00474760|69642463|FG001|Overall Study|Adverse Event|0|||
37955711|NCT00474760|69642464|FG002|Overall Study|Adverse Event|0|||
37955712|NCT00474760|69642465|FG003|Overall Study|Adverse Event|0|||
37955713|NCT00474760|69642466|FG004|Overall Study|Adverse Event|1|||
37955714|NCT00474760|69642467|FG005|Overall Study|Adverse Event|7|||
37955715|NCT00474760|69642468|FG006|Overall Study|Adverse Event|0|||
37955716|NCT00474760|69642462|FG000|Overall Study|Laboratory abnormality|0|||
37955717|NCT00474760|69642463|FG001|Overall Study|Laboratory abnormality|0|||
37955718|NCT00474760|69642464|FG002|Overall Study|Laboratory abnormality|0|||
37955719|NCT00474760|69642465|FG003|Overall Study|Laboratory abnormality|0|||
37955720|NCT00474760|69642466|FG004|Overall Study|Laboratory abnormality|0|||
37955721|NCT00474760|69642467|FG005|Overall Study|Laboratory abnormality|1|||
37955722|NCT00474760|69642468|FG006|Overall Study|Laboratory abnormality|0|||
37955723|NCT00474760|69642462|FG000|Overall Study|Withdrawal by Subject|0|||
37955724|NCT00474760|69642463|FG001|Overall Study|Withdrawal by Subject|0|||
37955725|NCT00474760|69642464|FG002|Overall Study|Withdrawal by Subject|0|||
37955726|NCT00474760|69642465|FG003|Overall Study|Withdrawal by Subject|1|||
37955727|NCT00474760|69642466|FG004|Overall Study|Withdrawal by Subject|0|||
37955728|NCT00474760|69642467|FG005|Overall Study|Withdrawal by Subject|1|||
37955729|NCT00474760|69642468|FG006|Overall Study|Withdrawal by Subject|1|||
37955730|NCT00474760|69642462|FG000|Overall Study|Other|0|||
37955731|NCT00474760|69642463|FG001|Overall Study|Other|1|||
37955732|NCT00474760|69642464|FG002|Overall Study|Other|0|||
37955733|NCT00474760|69642465|FG003|Overall Study|Other|0|||
37955734|NCT00474760|69642466|FG004|Overall Study|Other|1|||
37955735|NCT00474760|69642467|FG005|Overall Study|Other|0|||
37955736|NCT00474760|69642468|FG006|Overall Study|Other|0|||
37955737|NCT00474760|69642462|FG000|Overall Study|Progressive disease|3|||
37955738|NCT00474760|69642463|FG001|Overall Study|Progressive disease|2|||
37955739|NCT00474760|69642464|FG002|Overall Study|Progressive disease|3|||
37955740|NCT00474760|69642465|FG003|Overall Study|Progressive disease|2|||
37955741|NCT00474760|69642466|FG004|Overall Study|Progressive disease|8|||
37955742|NCT00474760|69642467|FG005|Overall Study|Progressive disease|20|||
37955743|NCT00474760|69642468|FG006|Overall Study|Progressive disease|7|||
37955744|NCT00474760|69642462|FG000|Overall Study|Terminated by sponsor|0|||
37955745|NCT00474760|69642463|FG001|Overall Study|Terminated by sponsor|0|||
37955746|NCT00474760|69642464|FG002|Overall Study|Terminated by sponsor|0|||
37955747|NCT00474760|69642465|FG003|Overall Study|Terminated by sponsor|0|||
37955748|NCT00474760|69642466|FG004|Overall Study|Terminated by sponsor|0|||
37955749|NCT00474760|69642467|FG005|Overall Study|Terminated by sponsor|0|||
37955750|NCT00474760|69642468|FG006|Overall Study|Terminated by sponsor|2|||
37955751|NCT00528645|69642491|FG000|Overall Study|Adverse Event|3|||
38021485|NCT03657043|69704603|FG000|Overall Study|Withdrawal - declined follow-up|0|||
38021486|NCT03657043|69704604|FG001|Overall Study|Withdrawal - declined follow-up|0|||
38021487|NCT03657043|69704605|FG002|Overall Study|Withdrawal - declined follow-up|0|||
38021488|NCT03657043|69704606|FG003|Overall Study|Withdrawal - declined follow-up|0|||
38021489|NCT03657043|69704607|FG004|Overall Study|Withdrawal - declined follow-up|1|||
38021490|NCT03646669|69704617|FG000|Overall Study|Withdrawal by Subject|5|||
38021491|NCT03646669|69704618|FG001|Overall Study|Withdrawal by Subject|0|||
38021492|NCT03619876|69704626|FG000|Overall Study|Withdrawal by Subject|1|||
38021493|NCT03619876|69704627|FG001|Overall Study|Withdrawal by Subject|2|||
38021494|NCT03619876|69704626|FG000|Overall Study|Withdrawal due to incidental finding|0|||
38021495|NCT03619876|69704627|FG001|Overall Study|Withdrawal due to incidental finding|2|||
37861858|NCT01218204|69545617|FG001|Part B Washout|Physician Decision|14|||
37861859|NCT01218204|69545618|FG002|Part B Washout|Physician Decision|0|||
37861860|NCT01218204|69545619|FG003|Part B Washout|Physician Decision|0|||
37861861|NCT01218204|69545616|FG000|Part B Washout|Withdrawal by Subject|0|||
37861862|NCT01218204|69545617|FG001|Part B Washout|Withdrawal by Subject|14|||
37861863|NCT01218204|69545618|FG002|Part B Washout|Withdrawal by Subject|0|||
37861864|NCT01218204|69545619|FG003|Part B Washout|Withdrawal by Subject|0|||
37861865|NCT01218204|69545616|FG000|Part B Washout|Reached defined stopping criteria|0|||
37861866|NCT01218204|69545617|FG001|Part B Washout|Reached defined stopping criteria|2|||
37861867|NCT01218204|69545618|FG002|Part B Washout|Reached defined stopping criteria|0|||
37861868|NCT01218204|69545619|FG003|Part B Washout|Reached defined stopping criteria|0|||
38021496|NCT03526861|69704649|FG000|Initial Treatment Period|Not dosed|1|||
38021497|NCT03526861|69704650|FG001|Initial Treatment Period|Not dosed|1|||
38021498|NCT03526861|69704651|FG002|Initial Treatment Period|Not dosed|1|||
38021499|NCT03526861|69704652|FG003|Initial Treatment Period|Not dosed|0|||
38021500|NCT03526861|69704653|FG004|Initial Treatment Period|Not dosed|0|||
38021501|NCT03526861|69704654|FG005|Initial Treatment Period|Not dosed|0|||
37861869|NCT01218204|69545616|FG000|Part B Washout|Did not meet continuation criteria|0|||
38021502|NCT03526861|69704655|FG006|Initial Treatment Period|Not dosed|0|||
38021503|NCT03526861|69704656|FG007|Initial Treatment Period|Not dosed|0|||
38021504|NCT03526861|69704657|FG008|Initial Treatment Period|Not dosed|0|||
38021505|NCT03526861|69704649|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
37955752|NCT00524745|69642500|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
37955753|NCT00524745|69642501|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
37955754|NCT00524745|69642502|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
37955755|NCT00524745|69642503|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
37955756|NCT00495040|69642513|FG000|Overall Study|Withdrawal by Subject|3|||
37955757|NCT00494026|69642521|FG000|Overall Study|Sponsor Decision|4|||
37955758|NCT00524589|69642525|FG000|Overall Study|Withdrawal by Subject|2|||
37955759|NCT00524589|69642525|FG000|Overall Study|Disease Progression|16|||
37955760|NCT00472030|69642531|FG000|Overall Study|Physician Decision|1|||
37955761|NCT00472030|69642532|FG001|Overall Study|Physician Decision|0|||
37955762|NCT00127855|69642547|FG000|Primary Vaccination Course|Adverse Event|0|||
37955763|NCT00127855|69642548|FG001|Primary Vaccination Course|Adverse Event|0|||
37955764|NCT00127855|69642549|FG002|Primary Vaccination Course|Adverse Event|1|||
37955765|NCT00127855|69642550|FG003|Primary Vaccination Course|Adverse Event|0|||
37955766|NCT00127855|69642551|FG004|Primary Vaccination Course|Adverse Event|0|||
37955767|NCT00127855|69642547|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
37955768|NCT00127855|69642548|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
37955769|NCT00127855|69642549|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
37861870|NCT01218204|69545617|FG001|Part B Washout|Did not meet continuation criteria|112|||
37861871|NCT01218204|69545618|FG002|Part B Washout|Did not meet continuation criteria|0|||
37861872|NCT01218204|69545619|FG003|Part B Washout|Did not meet continuation criteria|0|||
37861873|NCT01218204|69545616|FG000|Part B Run-in|Adverse Event|0|||
37861874|NCT01218204|69545617|FG001|Part B Run-in|Adverse Event|0|||
37861875|NCT01218204|69545618|FG002|Part B Run-in|Adverse Event|1|||
37861876|NCT01218204|69545619|FG003|Part B Run-in|Adverse Event|0|||
37861877|NCT01218204|69545616|FG000|Part B Run-in|Protocol Violation|0|||
37861878|NCT01218204|69545617|FG001|Part B Run-in|Protocol Violation|0|||
37861879|NCT01218204|69545618|FG002|Part B Run-in|Protocol Violation|2|||
37861880|NCT01218204|69545619|FG003|Part B Run-in|Protocol Violation|0|||
37861881|NCT01218204|69545616|FG000|Part B Run-in|Withdrawal by Subject|0|||
37861882|NCT01218204|69545617|FG001|Part B Run-in|Withdrawal by Subject|0|||
37861883|NCT01218204|69545618|FG002|Part B Run-in|Withdrawal by Subject|3|||
37861884|NCT01218204|69545619|FG003|Part B Run-in|Withdrawal by Subject|0|||
37861885|NCT01218204|69545616|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
37861886|NCT01218204|69545617|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
37861887|NCT01218204|69545618|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
37861888|NCT01218204|69545619|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
37861889|NCT01218204|69545616|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
37861890|NCT01218204|69545617|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
37861891|NCT01218204|69545618|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
37861892|NCT01218204|69545619|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
37861893|NCT00926575|69545668|FG000|Overall Study|Adverse Event|1|||
37955770|NCT00127855|69642550|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
37955771|NCT00127855|69642551|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
37955772|NCT00127855|69642547|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
37861894|NCT00926575|69545669|FG001|Overall Study|Adverse Event|1|||
37861895|NCT00926575|69545668|FG000|Overall Study|Death|4|||
37861896|NCT00926575|69545669|FG001|Overall Study|Death|4|||
37861897|NCT00926575|69545668|FG000|Overall Study|Lost to Follow-up|1|||
37861898|NCT00926575|69545669|FG001|Overall Study|Lost to Follow-up|1|||
37861899|NCT00926575|69545668|FG000|Overall Study|Physician Decision|1|||
37861900|NCT00926575|69545669|FG001|Overall Study|Physician Decision|2|||
37861901|NCT00926575|69545668|FG000|Overall Study|Protocol Violation|1|||
37861902|NCT00926575|69545669|FG001|Overall Study|Protocol Violation|0|||
37861903|NCT00926575|69545668|FG000|Overall Study|Withdrawal by Subject|8|||
37861904|NCT00926575|69545669|FG001|Overall Study|Withdrawal by Subject|9|||
37861905|NCT01218126|69545679|FG000|Overall Study|Adverse Event|8|||
37861906|NCT01218126|69545680|FG001|Overall Study|Adverse Event|10|||
37861907|NCT01218126|69545681|FG002|Overall Study|Adverse Event|12|||
37861908|NCT01218126|69545682|FG003|Overall Study|Adverse Event|16|||
37861909|NCT01218126|69545679|FG000|Overall Study|Lack of Efficacy|7|||
37861910|NCT01218126|69545680|FG001|Overall Study|Lack of Efficacy|2|||
37861911|NCT01218126|69545681|FG002|Overall Study|Lack of Efficacy|2|||
37861912|NCT01218126|69545682|FG003|Overall Study|Lack of Efficacy|6|||
37861913|NCT01218126|69545679|FG000|Overall Study|Protocol Violation|5|||
37861914|NCT01218126|69545680|FG001|Overall Study|Protocol Violation|2|||
37861915|NCT01218126|69545681|FG002|Overall Study|Protocol Violation|2|||
38050897|NCT03320850|69739821|FG005|Overall Study|Reason Not Specified|1|||
38050898|NCT03320850|69739822|FG006|Overall Study|Reason Not Specified|0|||
38050899|NCT03320850|69739823|FG007|Overall Study|Reason Not Specified|0|||
38050900|NCT03320850|69739824|FG008|Overall Study|Reason Not Specified|0|||
38050901|NCT03320850|69739825|FG009|Overall Study|Reason Not Specified|1|||
38050902|NCT03301623|69739854|FG000|Overall Study|Death|3|||
38050903|NCT03301623|69739855|FG001|Overall Study|Death|1|||
38050904|NCT03301623|69739854|FG000|Overall Study|Withdrawal by Subject|11|||
38050905|NCT03301623|69739855|FG001|Overall Study|Withdrawal by Subject|13|||
38050906|NCT03301623|69739854|FG000|Overall Study|Lost to Follow-up|3|||
38050907|NCT03301623|69739855|FG001|Overall Study|Lost to Follow-up|1|||
38050908|NCT03319212|69739863|FG000|Overall Study|Discontinued as moving out of local area|0|||
38050909|NCT03319212|69739864|FG001|Overall Study|Discontinued as moving out of local area|1|||
38050910|NCT03319212|69739863|FG000|Overall Study|Adverse Event|2|||
38050911|NCT03319212|69739864|FG001|Overall Study|Adverse Event|2|||
38050912|NCT03319212|69739863|FG000|Overall Study|Withdrawal by Subject|0|||
38050913|NCT03319212|69739864|FG001|Overall Study|Withdrawal by Subject|1|||
38050914|NCT03319212|69739863|FG000|Overall Study|Lost to Follow-up|0|||
38050915|NCT03319212|69739864|FG001|Overall Study|Lost to Follow-up|1|||
38050916|NCT03319212|69739863|FG000|Overall Study|Physician Decision|1|||
38050917|NCT03319212|69739864|FG001|Overall Study|Physician Decision|0|||
38050918|NCT04656691|69739869|FG000|Overall Study|Adverse Event|1|||
38050919|NCT03301155|69739875|FG000|Overall Study|Сompliance with exclusion criteria|8|||
38050920|NCT03301155|69739876|FG001|Overall Study|Сompliance with exclusion criteria|7|||
38050921|NCT01952730|69739882|FG000|Overall Study|FDA shut down core lab used by study|1|||
38050922|NCT03316170|69739888|FG000|Overall Study|Death|1|||
38050923|NCT03316170|69739889|FG001|Overall Study|Death|0|||
38050924|NCT03316170|69739888|FG000|Overall Study|Lost to Follow-up|6|||
38050925|NCT03316170|69739889|FG001|Overall Study|Lost to Follow-up|7|||
38050926|NCT03257865|69739898|FG000|Overall Study|Adverse Event|4|||
38050927|NCT03257865|69739899|FG001|Overall Study|Adverse Event|8|||
38050928|NCT03257865|69739898|FG000|Overall Study|Lack of Efficacy|1|||
37861916|NCT01218126|69545682|FG003|Overall Study|Protocol Violation|3|||
37861917|NCT01218126|69545679|FG000|Overall Study|Protocol-defined stopping criteria|1|||
37861918|NCT01218126|69545680|FG001|Overall Study|Protocol-defined stopping criteria|1|||
37861919|NCT01218126|69545681|FG002|Overall Study|Protocol-defined stopping criteria|0|||
37861920|NCT01218126|69545682|FG003|Overall Study|Protocol-defined stopping criteria|0|||
37861921|NCT01218126|69545679|FG000|Overall Study|Lost to Follow-up|0|||
37861922|NCT01218126|69545680|FG001|Overall Study|Lost to Follow-up|0|||
37861923|NCT01218126|69545681|FG002|Overall Study|Lost to Follow-up|0|||
37861924|NCT01218126|69545682|FG003|Overall Study|Lost to Follow-up|2|||
37861925|NCT01218126|69545679|FG000|Overall Study|Physician Decision|1|||
37861926|NCT01218126|69545680|FG001|Overall Study|Physician Decision|2|||
37861927|NCT01218126|69545681|FG002|Overall Study|Physician Decision|4|||
37861928|NCT01218126|69545682|FG003|Overall Study|Physician Decision|2|||
37861929|NCT01218126|69545679|FG000|Overall Study|Withdrawal by Subject|2|||
37861930|NCT01218126|69545680|FG001|Overall Study|Withdrawal by Subject|5|||
38050929|NCT03257865|69739899|FG001|Overall Study|Lack of Efficacy|2|||
38050930|NCT03257865|69739898|FG000|Overall Study|Non-compliance with Study Drug|0|||
38050931|NCT03257865|69739899|FG001|Overall Study|Non-compliance with Study Drug|2|||
38050932|NCT03257865|69739898|FG000|Overall Study|Withdrawal by Subject|23|||
38050933|NCT03257865|69739899|FG001|Overall Study|Withdrawal by Subject|17|||
37861931|NCT01218126|69545681|FG002|Overall Study|Withdrawal by Subject|4|||
37861932|NCT01218126|69545682|FG003|Overall Study|Withdrawal by Subject|6|||
37861933|NCT01217892|69545696|FG000|Overall Study|Adverse Event|1|||
38050934|NCT03257865|69739898|FG000|Overall Study|Physician Decision|3|||
37861934|NCT01217892|69545697|FG001|Overall Study|Adverse Event|1|||
37861935|NCT01217892|69545698|FG002|Overall Study|Adverse Event|1|||
37861936|NCT01217892|69545699|FG003|Overall Study|Adverse Event|0|||
37861937|NCT01217892|69545696|FG000|Overall Study|Withdrawal by Subject|0|||
37861938|NCT01217892|69545697|FG001|Overall Study|Withdrawal by Subject|2|||
37861939|NCT01217892|69545698|FG002|Overall Study|Withdrawal by Subject|1|||
37861940|NCT01217892|69545699|FG003|Overall Study|Withdrawal by Subject|0|||
37861941|NCT01217892|69545696|FG000|Overall Study|Lab value|1|||
37861942|NCT01217892|69545697|FG001|Overall Study|Lab value|0|||
37861943|NCT01217892|69545698|FG002|Overall Study|Lab value|1|||
37861944|NCT01217892|69545699|FG003|Overall Study|Lab value|0|||
37861945|NCT01217892|69545696|FG000|Overall Study|Subject no longer meets study criteria|5|||
37861946|NCT01217892|69545697|FG001|Overall Study|Subject no longer meets study criteria|2|||
37861947|NCT01217892|69545698|FG002|Overall Study|Subject no longer meets study criteria|4|||
37861948|NCT01217892|69545699|FG003|Overall Study|Subject no longer meets study criteria|8|||
37861949|NCT01217892|69545696|FG000|Overall Study|Incorrect enrollment|0|||
37861950|NCT01217892|69545697|FG001|Overall Study|Incorrect enrollment|1|||
37861951|NCT01217892|69545698|FG002|Overall Study|Incorrect enrollment|1|||
37861952|NCT01217892|69545699|FG003|Overall Study|Incorrect enrollment|0|||
37861953|NCT01217892|69545696|FG000|Overall Study|Poor/Non-Compliance|0|||
37861954|NCT01217892|69545697|FG001|Overall Study|Poor/Non-Compliance|0|||
37861955|NCT01217892|69545698|FG002|Overall Study|Poor/Non-Compliance|1|||
37861956|NCT01217892|69545699|FG003|Overall Study|Poor/Non-Compliance|0|||
37861957|NCT01217814|69545712|FG000|Overall Study|Adverse Event|1|||
37861958|NCT01217814|69545713|FG001|Overall Study|Adverse Event|1|||
37861959|NCT01217814|69545714|FG002|Overall Study|Adverse Event|0|||
37861960|NCT01217814|69545712|FG000|Overall Study|Lack of Efficacy|0|||
37861961|NCT01217814|69545713|FG001|Overall Study|Lack of Efficacy|0|||
37955773|NCT00127855|69642548|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
37955774|NCT00127855|69642549|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
37955775|NCT00127855|69642550|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
37955776|NCT00127855|69642551|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
37955777|NCT00127855|69642547|FG000|Primary Vaccination Course|Other|0|||
37955778|NCT00127855|69642548|FG001|Primary Vaccination Course|Other|0|||
37955779|NCT00127855|69642549|FG002|Primary Vaccination Course|Other|0|||
37955780|NCT00127855|69642550|FG003|Primary Vaccination Course|Other|0|||
37955781|NCT00127855|69642551|FG004|Primary Vaccination Course|Other|1|||
37955782|NCT00493636|69642565|FG000|Overall Study|Withdrawal by Subject|1|||
37955783|NCT00493636|69642566|FG001|Overall Study|Withdrawal by Subject|0|||
37955784|NCT00493636|69642565|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
37955785|NCT00493636|69642566|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
37955786|NCT00493636|69642565|FG000|Overall Study|Mis-randomization|1|||
37955787|NCT00493636|69642566|FG001|Overall Study|Mis-randomization|1|||
37955788|NCT00524121|69642572|FG000|Overall Study|Disease progression|6|||
37955789|NCT00524121|69642572|FG000|Overall Study|Adverse Event|4|||
37955790|NCT00524121|69642572|FG000|Overall Study|Patient refused|2|||
37955791|NCT00524121|69642572|FG000|Overall Study|Other|1|||
37955792|NCT00524121|69642572|FG000|Overall Study|Death|1|||
37955793|NCT00524121|69642572|FG000|Overall Study|Not treated (became ineligible)|4|||
37955794|NCT00524121|69642572|FG000|Overall Study|Not treated (changed mind)|1|||
37955795|NCT00470626|69642587|FG000|Overall Study|Lost to Follow-up|10|||
37955796|NCT00470626|69642587|FG000|Overall Study|Withdrawal by Subject|7|||
37955797|NCT00132769|69642593|FG000|Overall Study|Withdrawal by Subject|1|||
37955798|NCT00132769|69642594|FG001|Overall Study|Withdrawal by Subject|3|||
37955799|NCT00132769|69642593|FG000|Overall Study|Lack of Efficacy|7|||
37955800|NCT00132769|69642594|FG001|Overall Study|Lack of Efficacy|6|||
37955801|NCT00132769|69642593|FG000|Overall Study|Adverse Event|2|||
37955802|NCT00132769|69642594|FG001|Overall Study|Adverse Event|1|||
37955803|NCT00132769|69642593|FG000|Overall Study|Protocol Violation|1|||
38050935|NCT03257865|69739899|FG001|Overall Study|Physician Decision|1|||
38050936|NCT03257865|69739898|FG000|Overall Study|Other|0|||
38050937|NCT03257865|69739899|FG001|Overall Study|Other|1|||
38050938|NCT03257865|69739898|FG000|Overall Study|Lost to Follow-up|4|||
37861962|NCT01217814|69545714|FG002|Overall Study|Lack of Efficacy|1|||
37861963|NCT01217190|69545725|FG000|Second Dosing|Withdrawal by Subject|0|||
37861964|NCT01217190|69545726|FG001|Second Dosing|Withdrawal by Subject|2|||
37861965|NCT01136733|69545742|FG000|Phase 1b|Adverse Event|0|||
37955804|NCT00132769|69642594|FG001|Overall Study|Protocol Violation|1|||
37955805|NCT00520299|69642603|FG000|Overall Study|Withdrawal by Subject|0|||
37955806|NCT00520299|69642604|FG001|Overall Study|Withdrawal by Subject|0|||
38050939|NCT03257865|69739899|FG001|Overall Study|Lost to Follow-up|4|||
37955807|NCT00520299|69642605|FG002|Overall Study|Withdrawal by Subject|2|||
37861966|NCT01136733|69545743|FG001|Phase 1b|Adverse Event|3|||
37861967|NCT01136733|69545744|FG002|Phase 1b|Adverse Event|1|||
37955808|NCT00520299|69642603|FG000|Overall Study|Progressive disease|0|||
37955809|NCT00520299|69642604|FG001|Overall Study|Progressive disease|3|||
37955810|NCT00520299|69642605|FG002|Overall Study|Progressive disease|4|||
37955811|NCT02478255|69642615|FG000|Overall Study|Physician Decision|6|||
37955812|NCT02478255|69642616|FG001|Overall Study|Physician Decision|0|||
37955813|NCT02478255|69642615|FG000|Overall Study|Withdrawal by Subject|2|||
37955814|NCT02478255|69642616|FG001|Overall Study|Withdrawal by Subject|0|||
37955815|NCT00132691|69642624|FG000|Overall Study|Lost to Follow-up|5|||
37955816|NCT00132691|69642625|FG001|Overall Study|Lost to Follow-up|8|||
37955817|NCT00132691|69642624|FG000|Overall Study|Missed 2-year visit|4|||
37955818|NCT00132691|69642625|FG001|Overall Study|Missed 2-year visit|4|||
37955819|NCT00132691|69642624|FG000|Overall Study|Death|2|||
37955820|NCT00132691|69642625|FG001|Overall Study|Death|0|||
37955821|NCT00125359|69642636|FG000|Overall Study|Death|4|||
37955822|NCT00125359|69642636|FG000|Overall Study|Adverse Event|5|||
37955823|NCT00125359|69642636|FG000|Overall Study|Physician Decision|14|||
37955824|NCT00524043|69642643|FG000|Overall Study|Lack of Efficacy|15|||
37955825|NCT00524043|69642644|FG001|Overall Study|Lack of Efficacy|13|||
37955826|NCT00524043|69642645|FG002|Overall Study|Lack of Efficacy|14|||
37955827|NCT00524043|69642643|FG000|Overall Study|Withdrawal by Subject|5|||
37955828|NCT00524043|69642644|FG001|Overall Study|Withdrawal by Subject|7|||
37955829|NCT00524043|69642645|FG002|Overall Study|Withdrawal by Subject|7|||
37955830|NCT00524043|69642643|FG000|Overall Study|Adverse Event|5|||
37955831|NCT00524043|69642644|FG001|Overall Study|Adverse Event|2|||
37955832|NCT00524043|69642645|FG002|Overall Study|Adverse Event|7|||
37955833|NCT00524043|69642643|FG000|Overall Study|Lost to Follow-up|3|||
37955834|NCT00524043|69642644|FG001|Overall Study|Lost to Follow-up|5|||
37955835|NCT00524043|69642645|FG002|Overall Study|Lost to Follow-up|3|||
37955836|NCT00524043|69642643|FG000|Overall Study|Various (eg, incarceration)|2|||
37955837|NCT00524043|69642644|FG001|Overall Study|Various (eg, incarceration)|1|||
37955838|NCT00524043|69642645|FG002|Overall Study|Various (eg, incarceration)|0|||
37955839|NCT00523419|69642653|FG000|Overall Study|Adverse Event|1|||
37955840|NCT00523419|69642653|FG000|Overall Study|Withdrawal by Subject|1|||
37955841|NCT00523419|69642653|FG000|Overall Study|Physician Decision|2|||
37955842|NCT00523419|69642653|FG000|Overall Study|Progressive Disease|22|||
37955843|NCT00523419|69642653|FG000|Overall Study|Death due to Study Disease|4|||
37955844|NCT00523419|69642653|FG000|Overall Study|Death due to Adverse Event|2|||
37955845|NCT03868059|69642657|FG000|Overall Study|Adverse Event|3|||
37955846|NCT03868059|69642657|FG000|Overall Study|Lost to Follow-up|3|||
37955847|NCT03868059|69642657|FG000|Overall Study|Withdrawal by Subject|6|||
37955848|NCT00522951|69642661|FG000|Period 1|body motion|0|||
37955849|NCT00522951|69642662|FG001|Period 1|body motion|1|||
37955850|NCT00522951|69642661|FG000|Washout Period|Adverse Event|0|||
37955851|NCT00522951|69642662|FG001|Washout Period|Adverse Event|1|||
37955852|NCT00522951|69642661|FG000|Washout Period|Death|0|||
37955853|NCT00522951|69642662|FG001|Washout Period|Death|1|||
37955854|NCT00522951|69642661|FG000|Period 2|Withdrawal by Subject|1|||
37955855|NCT00522951|69642662|FG001|Period 2|Withdrawal by Subject|0|||
37955856|NCT00522951|69642661|FG000|Period 2|residual contrast medium|1|||
37955857|NCT00522951|69642662|FG001|Period 2|residual contrast medium|1|||
37955858|NCT03865953|69642674|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
37955859|NCT03865953|69642675|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
37955860|NCT03865953|69642674|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
37955861|NCT03865953|69642675|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
37955862|NCT03865953|69642674|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
37955863|NCT03865953|69642675|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
37955864|NCT05439941|69642684|FG000|Overall Study|Lack of Efficacy|8|||
37955865|NCT05439941|69642685|FG001|Overall Study|Lack of Efficacy|5|||
37955866|NCT05439941|69642686|FG002|Overall Study|Lack of Efficacy|3|||
37955867|NCT05439941|69642684|FG000|Overall Study|Treatment Failure|0|||
37955868|NCT05439941|69642685|FG001|Overall Study|Treatment Failure|1|||
37955869|NCT05439941|69642686|FG002|Overall Study|Treatment Failure|0|||
37955870|NCT05439941|69642684|FG000|Overall Study|Adverse Event|1|||
37955871|NCT05439941|69642685|FG001|Overall Study|Adverse Event|3|||
37955872|NCT05439941|69642686|FG002|Overall Study|Adverse Event|0|||
37955873|NCT05439941|69642684|FG000|Overall Study|Adverse Event - Parent Study|1|||
37955874|NCT05439941|69642685|FG001|Overall Study|Adverse Event - Parent Study|0|||
37955875|NCT05439941|69642686|FG002|Overall Study|Adverse Event - Parent Study|0|||
37955876|NCT05439941|69642684|FG000|Overall Study|Pregnancy|1|||
37955877|NCT05439941|69642685|FG001|Overall Study|Pregnancy|0|||
37955878|NCT05439941|69642686|FG002|Overall Study|Pregnancy|0|||
37955879|NCT05439941|69642684|FG000|Overall Study|Withdrawal by Subject|9|||
37955880|NCT05439941|69642685|FG001|Overall Study|Withdrawal by Subject|6|||
37955881|NCT05439941|69642686|FG002|Overall Study|Withdrawal by Subject|10|||
37955882|NCT05439941|69642684|FG000|Overall Study|Non-Compliance|1|||
37955883|NCT05439941|69642685|FG001|Overall Study|Non-Compliance|1|||
37955884|NCT05439941|69642686|FG002|Overall Study|Non-Compliance|1|||
37955885|NCT05439941|69642684|FG000|Overall Study|Lost to Follow-up|2|||
37955886|NCT05439941|69642685|FG001|Overall Study|Lost to Follow-up|2|||
37955887|NCT05439941|69642686|FG002|Overall Study|Lost to Follow-up|0|||
37955888|NCT05439941|69642684|FG000|Overall Study|Physician Decision|1|||
37955889|NCT05439941|69642685|FG001|Overall Study|Physician Decision|0|||
37955890|NCT05439941|69642686|FG002|Overall Study|Physician Decision|0|||
37955891|NCT05439941|69642684|FG000|Overall Study|Trial Termination by Sponsor|78|||
37955892|NCT05439941|69642685|FG001|Overall Study|Trial Termination by Sponsor|83|||
37955893|NCT05439941|69642686|FG002|Overall Study|Trial Termination by Sponsor|65|||
37955894|NCT05439941|69642684|FG000|Overall Study|Other than Reasons Listed|2|||
37955895|NCT05439941|69642685|FG001|Overall Study|Other than Reasons Listed|1|||
37955896|NCT05439941|69642686|FG002|Overall Study|Other than Reasons Listed|0|||
37955897|NCT05091918|69642694|FG000|Overall Study|Adverse Event|1|||
37955898|NCT05091918|69642694|FG000|Overall Study|Withdrawal by Subject|81|||
37955899|NCT04912895|69642701|FG000|Overall Study|Unable to provide specimen|2|||
37955900|NCT04912895|69642702|FG001|Overall Study|Unable to provide specimen|0|||
37955901|NCT04912895|69642703|FG002|Overall Study|Unable to provide specimen|0|||
37955902|NCT04776720|69642711|FG000|Overall Study|COVID Related|4|||
37955903|NCT04776720|69642712|FG001|Overall Study|COVID Related|2|||
37955904|NCT04776720|69642711|FG000|Overall Study|Adverse Event|2|||
37955905|NCT04776720|69642712|FG001|Overall Study|Adverse Event|0|||
37955906|NCT04776720|69642711|FG000|Overall Study|Serious Adverse Event|0|||
37955907|NCT04776720|69642712|FG001|Overall Study|Serious Adverse Event|1|||
37955908|NCT04776720|69642711|FG000|Overall Study|Too Busy|3|||
37955909|NCT04776720|69642712|FG001|Overall Study|Too Busy|1|||
37955910|NCT04776720|69642711|FG000|Overall Study|Lost to Follow-up|1|||
37955911|NCT04776720|69642712|FG001|Overall Study|Lost to Follow-up|2|||
37955912|NCT04776720|69642711|FG000|Overall Study|Family|2|||
37955913|NCT04776720|69642712|FG001|Overall Study|Family|2|||
37955914|NCT04776720|69642711|FG000|Overall Study|No remote technology access|0|||
37955915|NCT04776720|69642712|FG001|Overall Study|No remote technology access|1|||
37955916|NCT04776720|69642711|FG000|Overall Study|Withdrawal by Subject|1|||
37955917|NCT04776720|69642712|FG001|Overall Study|Withdrawal by Subject|0|||
37955918|NCT04776720|69642711|FG000|Overall Study|Cannot tolerate intervention|1|||
37955919|NCT04776720|69642712|FG001|Overall Study|Cannot tolerate intervention|0|||
37955920|NCT04776720|69642711|FG000|Overall Study|Incomplete outcome data|6|||
37955921|NCT04776720|69642712|FG001|Overall Study|Incomplete outcome data|1|||
37955922|NCT04675151|69642731|FG000|Overall Study|Protocol Violation|1|||
37955923|NCT04675151|69642732|FG001|Overall Study|Protocol Violation|0|||
37955924|NCT04675151|69642733|FG002|Overall Study|Protocol Violation|0|||
37955925|NCT04675151|69642734|FG003|Overall Study|Protocol Violation|1|||
37955926|NCT04599907|69642747|FG000|Overall Study|Withdrawal by Subject|1|||
37955927|NCT04599907|69642748|FG001|Overall Study|Withdrawal by Subject|7|||
37955928|NCT04599907|69642749|FG002|Overall Study|Withdrawal by Subject|6|||
37955929|NCT04599907|69642747|FG000|Overall Study|Lost to Follow-up|0|||
37955930|NCT04599907|69642748|FG001|Overall Study|Lost to Follow-up|1|||
37955931|NCT04599907|69642749|FG002|Overall Study|Lost to Follow-up|0|||
37955932|NCT04503096|69642772|FG000|Overall Study|Withdrawal by Subject|3|||
37955933|NCT04270760|69642781|FG000|Overall Study|Withdrawal by Subject|0|||
37955934|NCT04270760|69642782|FG001|Overall Study|Withdrawal by Subject|1|||
37955935|NCT04270760|69642783|FG002|Overall Study|Withdrawal by Subject|3|||
37955936|NCT04270760|69642784|FG003|Overall Study|Withdrawal by Subject|0|||
37955937|NCT04270760|69642785|FG004|Overall Study|Withdrawal by Subject|0|||
37955938|NCT04270760|69642781|FG000|Overall Study|Lost to Follow-up|1|||
37955939|NCT04270760|69642782|FG001|Overall Study|Lost to Follow-up|2|||
37955940|NCT04270760|69642783|FG002|Overall Study|Lost to Follow-up|1|||
37955941|NCT04270760|69642784|FG003|Overall Study|Lost to Follow-up|0|||
37955942|NCT04270760|69642785|FG004|Overall Study|Lost to Follow-up|0|||
37955943|NCT04270760|69642781|FG000|Overall Study|Death|0|||
37955944|NCT04270760|69642782|FG001|Overall Study|Death|0|||
37955945|NCT04270760|69642783|FG002|Overall Study|Death|0|||
37955946|NCT04270760|69642784|FG003|Overall Study|Death|0|||
37955947|NCT04270760|69642785|FG004|Overall Study|Death|1|||
37955948|NCT04198363|69642804|FG000|Overall Study|Adverse Event|1|||
37955949|NCT04198363|69642805|FG001|Overall Study|Adverse Event|1|||
37955950|NCT04198363|69642804|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
37955951|NCT04198363|69642805|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
37955952|NCT04198363|69642804|FG000|Overall Study|Reason not Specified|1|||
37955953|NCT04198363|69642805|FG001|Overall Study|Reason not Specified|0|||
37955954|NCT04173247|69642813|FG000|Overall Study|Withdrawal by Subject|0|||
37955955|NCT04173247|69642814|FG001|Overall Study|Withdrawal by Subject|2|||
37955956|NCT04173247|69642813|FG000|Overall Study|Death|1|||
37955957|NCT04173247|69642814|FG001|Overall Study|Death|0|||
37955958|NCT04173247|69642813|FG000|Overall Study|Physician Decision|1|||
37955959|NCT04173247|69642814|FG001|Overall Study|Physician Decision|0|||
37955960|NCT03943446|69642827|FG000|Overall Study|Lost to Follow-up|0|||
37955961|NCT03943446|69642828|FG001|Overall Study|Lost to Follow-up|0|||
37955962|NCT03943446|69642829|FG002|Overall Study|Lost to Follow-up|1|||
37955963|NCT03943446|69642827|FG000|Overall Study|Withdrawal by Subject|1|||
37955964|NCT03943446|69642828|FG001|Overall Study|Withdrawal by Subject|1|||
37955965|NCT03943446|69642829|FG002|Overall Study|Withdrawal by Subject|2|||
37955966|NCT03943446|69642827|FG000|Overall Study|Study Terminated by Sponsor|1|||
37955967|NCT03943446|69642828|FG001|Overall Study|Study Terminated by Sponsor|2|||
37955968|NCT03943446|69642829|FG002|Overall Study|Study Terminated by Sponsor|1|||
37955969|NCT03943446|69642827|FG000|Overall Study|Reason not Specified|5|||
37955970|NCT03943446|69642828|FG001|Overall Study|Reason not Specified|1|||
37955971|NCT03943446|69642829|FG002|Overall Study|Reason not Specified|3|||
37955980|NCT03710161|69642907|FG000|Overall Study|Study halted due to COVID pandemic|3|||
37955981|NCT03710161|69642908|FG001|Overall Study|Study halted due to COVID pandemic|2|||
37955982|NCT03632993|69642924|FG000|Overall Study|Withdrawal by Subject|1|||
37955983|NCT03632993|69642925|FG001|Overall Study|Withdrawal by Subject|0|||
37955984|NCT03632993|69642926|FG002|Overall Study|Withdrawal by Subject|0|||
37955985|NCT03632993|69642927|FG003|Overall Study|Withdrawal by Subject|0|||
37955986|NCT03632993|69642928|FG004|Overall Study|Withdrawal by Subject|0|||
37955987|NCT03632993|69642929|FG005|Overall Study|Withdrawal by Subject|0|||
37955988|NCT03632993|69642930|FG006|Overall Study|Withdrawal by Subject|0|||
37955989|NCT03632993|69642931|FG007|Overall Study|Withdrawal by Subject|0|||
37955990|NCT03632993|69642932|FG008|Overall Study|Withdrawal by Subject|0|||
37955991|NCT03632993|69642933|FG009|Overall Study|Withdrawal by Subject|1|||
37955992|NCT03632993|69642924|FG000|Overall Study|Protocol Non-compliance|0|||
37955993|NCT03632993|69642925|FG001|Overall Study|Protocol Non-compliance|1|||
37955994|NCT03632993|69642926|FG002|Overall Study|Protocol Non-compliance|0|||
37955995|NCT03632993|69642927|FG003|Overall Study|Protocol Non-compliance|0|||
37955996|NCT03632993|69642928|FG004|Overall Study|Protocol Non-compliance|0|||
37955997|NCT03632993|69642929|FG005|Overall Study|Protocol Non-compliance|0|||
37955998|NCT03632993|69642930|FG006|Overall Study|Protocol Non-compliance|0|||
37955999|NCT03632993|69642931|FG007|Overall Study|Protocol Non-compliance|0|||
37956000|NCT03632993|69642932|FG008|Overall Study|Protocol Non-compliance|0|||
37956001|NCT03632993|69642933|FG009|Overall Study|Protocol Non-compliance|0|||
37956002|NCT03632993|69642924|FG000|Overall Study|Lost to Follow-up|0|||
37956003|NCT03632993|69642925|FG001|Overall Study|Lost to Follow-up|0|||
37956004|NCT03632993|69642926|FG002|Overall Study|Lost to Follow-up|0|||
37956005|NCT03632993|69642927|FG003|Overall Study|Lost to Follow-up|0|||
37956006|NCT03632993|69642928|FG004|Overall Study|Lost to Follow-up|0|||
37956007|NCT03632993|69642929|FG005|Overall Study|Lost to Follow-up|1|||
37956008|NCT03632993|69642930|FG006|Overall Study|Lost to Follow-up|0|||
37956009|NCT03632993|69642931|FG007|Overall Study|Lost to Follow-up|1|||
37956010|NCT03632993|69642932|FG008|Overall Study|Lost to Follow-up|0|||
37956011|NCT03632993|69642933|FG009|Overall Study|Lost to Follow-up|0|||
37956012|NCT03632993|69642924|FG000|Overall Study|Adverse Event|0|||
37956013|NCT03632993|69642925|FG001|Overall Study|Adverse Event|0|||
37956014|NCT03632993|69642926|FG002|Overall Study|Adverse Event|0|||
37956015|NCT03632993|69642927|FG003|Overall Study|Adverse Event|0|||
37956016|NCT03632993|69642928|FG004|Overall Study|Adverse Event|0|||
37956017|NCT03632993|69642929|FG005|Overall Study|Adverse Event|1|||
37956018|NCT03632993|69642930|FG006|Overall Study|Adverse Event|0|||
37956019|NCT03632993|69642931|FG007|Overall Study|Adverse Event|1|||
37956020|NCT03632993|69642932|FG008|Overall Study|Adverse Event|0|||
37956021|NCT03632993|69642933|FG009|Overall Study|Adverse Event|0|||
37956022|NCT03568461|69642955|FG000|Overall Study|Death|7|||
37956023|NCT03568461|69642955|FG000|Overall Study|Physician Decision|5|||
37956024|NCT03568461|69642955|FG000|Overall Study|Subject decision|5|||
37956025|NCT03568461|69642955|FG000|Overall Study|Lost to Follow-up|1|||
37956026|NCT03493282|69642962|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
37956027|NCT03493282|69642963|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
37956028|NCT03493282|69642964|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
37956029|NCT03493282|69642962|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
37956030|NCT03493282|69642963|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
37956031|NCT03493282|69642964|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
37956032|NCT02998203|69643017|FG000|First Period (40 Days)|Withdrawal by Subject|24|||
37956033|NCT02998203|69643018|FG001|First Period (40 Days)|Withdrawal by Subject|0|||
37956034|NCT02998203|69643017|FG000|Second Period (40 Days)|Withdrawal by Subject|0|||
37956035|NCT02998203|69643018|FG001|Second Period (40 Days)|Withdrawal by Subject|18|||
37956036|NCT02994927|69643043|FG000|Overall Study|Withdrawal by parent/guardian|0|||
37956037|NCT02994927|69643044|FG001|Overall Study|Withdrawal by parent/guardian|1|||
37956038|NCT02994927|69643043|FG000|Overall Study|Did not meet eligibility criteria|0|||
37956039|NCT02994927|69643044|FG001|Overall Study|Did not meet eligibility criteria|1|||
37956040|NCT02994927|69643043|FG000|Overall Study|Physician Decision|4|||
37956041|NCT02994927|69643044|FG001|Overall Study|Physician Decision|3|||
37956042|NCT02994927|69643043|FG000|Overall Study|Death|4|||
37956043|NCT02994927|69643044|FG001|Overall Study|Death|2|||
37956044|NCT02994927|69643043|FG000|Overall Study|Adverse Event|2|||
37956045|NCT02994927|69643044|FG001|Overall Study|Adverse Event|1|||
37956046|NCT02994927|69643043|FG000|Overall Study|Withdrawal by Subject|3|||
37956047|NCT02994927|69643044|FG001|Overall Study|Withdrawal by Subject|6|||
37956048|NCT02994927|69643043|FG000|Overall Study|Lost to Follow-up|2|||
37956049|NCT02994927|69643044|FG001|Overall Study|Lost to Follow-up|1|||
37956050|NCT02873338|69643053|FG000|Overall Study|Adverse Event|0|||
37956051|NCT02873338|69643054|FG001|Overall Study|Adverse Event|2|||
37956052|NCT02873338|69643055|FG002|Overall Study|Adverse Event|1|||
37956053|NCT02873338|69643053|FG000|Overall Study|Death|2|||
37956054|NCT02873338|69643054|FG001|Overall Study|Death|1|||
37956055|NCT02873338|69643055|FG002|Overall Study|Death|1|||
37956056|NCT02873338|69643053|FG000|Overall Study|Withdrawal by Subject|2|||
37956057|NCT02873338|69643054|FG001|Overall Study|Withdrawal by Subject|1|||
37956058|NCT02873338|69643055|FG002|Overall Study|Withdrawal by Subject|3|||
37956059|NCT02873338|69643053|FG000|Overall Study|Lack of Efficacy|0|||
37956060|NCT02873338|69643054|FG001|Overall Study|Lack of Efficacy|2|||
37956061|NCT02873338|69643055|FG002|Overall Study|Lack of Efficacy|0|||
37956062|NCT02873338|69643053|FG000|Overall Study|Other or Missing|14|||
37956063|NCT02873338|69643054|FG001|Overall Study|Other or Missing|15|||
37956064|NCT02873338|69643055|FG002|Overall Study|Other or Missing|13|||
37956065|NCT02725567|69643079|FG000|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|0|||
37956066|NCT02725567|69643080|FG001|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|1|||
37956067|NCT02725567|69643079|FG000|Part B + A/B ( Up to 24 Weeks)|Physician Decision|0|||
37956068|NCT02725567|69643080|FG001|Part B + A/B ( Up to 24 Weeks)|Physician Decision|1|||
37956069|NCT02725567|69643079|FG000|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|0|||
37956070|NCT02725567|69643080|FG001|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|1|||
37956071|NCT02108964|69643112|FG000|Overall Study|Progressive disease|12|||
37956072|NCT02108964|69643113|FG001|Overall Study|Progressive disease|25|||
37956073|NCT02108964|69643114|FG002|Overall Study|Progressive disease|50|||
37956074|NCT02108964|69643115|FG003|Overall Study|Progressive disease|6|||
37956075|NCT02108964|69643116|FG004|Overall Study|Progressive disease|18|||
37956076|NCT02108964|69643117|FG005|Overall Study|Progressive disease|5|||
37956077|NCT02108964|69643118|FG006|Overall Study|Progressive disease|7|||
37956078|NCT02108964|69643119|FG007|Overall Study|Progressive disease|9|||
37956079|NCT02108964|69643112|FG000|Overall Study|Physician Decision|1|||
37956080|NCT02108964|69643113|FG001|Overall Study|Physician Decision|5|||
37956081|NCT02108964|69643114|FG002|Overall Study|Physician Decision|6|||
37956082|NCT02108964|69643115|FG003|Overall Study|Physician Decision|0|||
37956083|NCT02108964|69643116|FG004|Overall Study|Physician Decision|1|||
37956084|NCT02108964|69643117|FG005|Overall Study|Physician Decision|0|||
37956085|NCT02108964|69643118|FG006|Overall Study|Physician Decision|0|||
37956086|NCT02108964|69643119|FG007|Overall Study|Physician Decision|0|||
37956087|NCT02108964|69643112|FG000|Overall Study|Adverse Event|0|||
37956088|NCT02108964|69643113|FG001|Overall Study|Adverse Event|0|||
37956089|NCT02108964|69643114|FG002|Overall Study|Adverse Event|4|||
37956090|NCT02108964|69643115|FG003|Overall Study|Adverse Event|0|||
37956091|NCT02108964|69643116|FG004|Overall Study|Adverse Event|1|||
37956092|NCT02108964|69643117|FG005|Overall Study|Adverse Event|0|||
37956093|NCT02108964|69643118|FG006|Overall Study|Adverse Event|3|||
37956094|NCT02108964|69643119|FG007|Overall Study|Adverse Event|1|||
37956095|NCT02108964|69643112|FG000|Overall Study|Death|1|||
37956096|NCT02108964|69643113|FG001|Overall Study|Death|1|||
37956097|NCT02108964|69643114|FG002|Overall Study|Death|2|||
37956098|NCT02108964|69643115|FG003|Overall Study|Death|0|||
37956099|NCT02108964|69643116|FG004|Overall Study|Death|3|||
37956100|NCT02108964|69643117|FG005|Overall Study|Death|0|||
37956101|NCT02108964|69643118|FG006|Overall Study|Death|0|||
37956102|NCT02108964|69643119|FG007|Overall Study|Death|1|||
37956103|NCT02108964|69643112|FG000|Overall Study|Subject/Guardian decision|0|||
37956104|NCT02108964|69643113|FG001|Overall Study|Subject/Guardian decision|1|||
37956105|NCT02108964|69643114|FG002|Overall Study|Subject/Guardian decision|3|||
37956106|NCT02108964|69643115|FG003|Overall Study|Subject/Guardian decision|0|||
37956107|NCT02108964|69643116|FG004|Overall Study|Subject/Guardian decision|2|||
38050940|NCT04617847|69739907|FG000|Overall Study|Withdrawal by Subject|1|||
37956108|NCT02108964|69643117|FG005|Overall Study|Subject/Guardian decision|0|||
37956109|NCT02108964|69643118|FG006|Overall Study|Subject/Guardian decision|1|||
37956110|NCT02108964|69643119|FG007|Overall Study|Subject/Guardian decision|1|||
37956111|NCT01909453|69643143|FG000|Overall Study|Ongoing|118|||
37956112|NCT01909453|69643144|FG001|Overall Study|Ongoing|103|||
38050941|NCT04617847|69739908|FG001|Overall Study|Withdrawal by Subject|0|||
37956113|NCT01909453|69643145|FG002|Overall Study|Ongoing|83|||
37956114|NCT01909453|69643146|FG003|Overall Study|Ongoing|164|||
37956115|NCT01909453|69643147|FG004|Overall Study|Ongoing|50|||
37956116|NCT01909453|69643143|FG000|Overall Study|Death|69|||
37956117|NCT01909453|69643144|FG001|Overall Study|Death|74|||
37956118|NCT01909453|69643145|FG002|Overall Study|Death|88|||
37956119|NCT01909453|69643146|FG003|Overall Study|Death|86|||
37956120|NCT01909453|69643147|FG004|Overall Study|Death|29|||
37956121|NCT01909453|69643143|FG000|Overall Study|Lost to Follow-up|3|||
37956122|NCT01909453|69643144|FG001|Overall Study|Lost to Follow-up|4|||
37956123|NCT01909453|69643145|FG002|Overall Study|Lost to Follow-up|4|||
37956124|NCT01909453|69643146|FG003|Overall Study|Lost to Follow-up|3|||
37956125|NCT01909453|69643147|FG004|Overall Study|Lost to Follow-up|3|||
37956126|NCT01909453|69643143|FG000|Overall Study|Withdrawal by Subject|2|||
37956127|NCT01909453|69643144|FG001|Overall Study|Withdrawal by Subject|13|||
37956128|NCT01909453|69643145|FG002|Overall Study|Withdrawal by Subject|16|||
37956129|NCT01909453|69643146|FG003|Overall Study|Withdrawal by Subject|5|||
37956130|NCT01909453|69643147|FG004|Overall Study|Withdrawal by Subject|4|||
37956131|NCT01882803|69643165|FG000|Overall Study|Disease Progression|1|||
37956132|NCT01882803|69643165|FG000|Overall Study|Withdrawal by Subject|9|||
37956133|NCT01882803|69643165|FG000|Overall Study|Death|68|||
37956134|NCT01882803|69643165|FG000|Overall Study|Physician Decision|3|||
37956135|NCT01882803|69643165|FG000|Overall Study|Lost to Follow-up|3|||
37956136|NCT01882803|69643165|FG000|Overall Study|Follow-up Completed|39|||
37956137|NCT01882803|69643165|FG000|Overall Study|Study Terminated by the Sponsor|6|||
38050942|NCT04617847|69739907|FG000|Overall Study|Adverse Event|0|||
38050943|NCT04617847|69739908|FG001|Overall Study|Adverse Event|2|||
38050944|NCT04617847|69739907|FG000|Overall Study|Death|0|||
38050945|NCT04617847|69739908|FG001|Overall Study|Death|1|||
38050946|NCT04617847|69739907|FG000|Overall Study|Termination of Study by Sponsor|2|||
38050947|NCT04617847|69739908|FG001|Overall Study|Termination of Study by Sponsor|21|||
38050948|NCT04615507|69739918|FG000|Period 1|Covid-19 exposure|2|||
38050949|NCT04615507|69739919|FG001|Period 1|Covid-19 exposure|1|||
38050950|NCT04615507|69739918|FG000|Period 2|Covid-19 exposure|0|||
38050951|NCT04615507|69739919|FG001|Period 2|Covid-19 exposure|1|||
37956148|NCT01196390|69643189|FG000|Overall Study|Protocol Violation|4|||
37956149|NCT01196390|69643190|FG001|Overall Study|Protocol Violation|5|||
37956150|NCT00659126|69643213|FG000|Overall Study|Adverse Event|2|||
37956151|NCT00659126|69643214|FG001|Overall Study|Adverse Event|2|||
37956152|NCT00659126|69643213|FG000|Overall Study|Screen failure|1|||
37956153|NCT00659126|69643214|FG001|Overall Study|Screen failure|1|||
37956154|NCT00659126|69643213|FG000|Overall Study|Technical problems with MRI|0|||
37956155|NCT00659126|69643214|FG001|Overall Study|Technical problems with MRI|1|||
37956156|NCT00152503|69643245|FG000|Overall Study|Adverse Event|4|||
37956157|NCT03865407|69643251|FG000|Overall Study|Adverse Event|1|||
37956158|NCT03865407|69643252|FG001|Overall Study|Adverse Event|0|||
37956159|NCT03865407|69643251|FG000|Overall Study|Withdrawal by Subject|1|||
37956160|NCT03865407|69643252|FG001|Overall Study|Withdrawal by Subject|0|||
37956161|NCT03865407|69643251|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
37956162|NCT03865407|69643252|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
37956163|NCT00487942|69643262|FG000|Overall Study|Adverse Event|1|||
37956164|NCT00487942|69643263|FG001|Overall Study|Adverse Event|1|||
37956165|NCT00487942|69643264|FG002|Overall Study|Adverse Event|1|||
37956166|NCT00487942|69643265|FG003|Overall Study|Adverse Event|1|||
37956167|NCT00487942|69643262|FG000|Overall Study|Lost to Follow-up|1|||
37956168|NCT00487942|69643263|FG001|Overall Study|Lost to Follow-up|0|||
37956169|NCT00487942|69643264|FG002|Overall Study|Lost to Follow-up|0|||
37956170|NCT00487942|69643265|FG003|Overall Study|Lost to Follow-up|1|||
37956171|NCT00487942|69643262|FG000|Overall Study|Protocol Violation|1|||
38050952|NCT04615507|69739918|FG000|Period 2|Protocol Violation|1|||
38050953|NCT04615507|69739919|FG001|Period 2|Protocol Violation|0|||
38050954|NCT04615507|69739918|FG000|Period 2|Withdrawal by Subject|1|||
38050955|NCT04615507|69739919|FG001|Period 2|Withdrawal by Subject|0|||
38050956|NCT04615507|69739918|FG000|Period 2|Adverse Event|0|||
38050957|NCT04615507|69739919|FG001|Period 2|Adverse Event|1|||
38050958|NCT04615507|69739918|FG000|Period 3|Covid-19 exposure|0|||
38050959|NCT04615507|69739919|FG001|Period 3|Covid-19 exposure|1|||
38050960|NCT04120233|69739931|FG000|Overall Study|Adverse Event|0|||
38050961|NCT04120233|69739932|FG001|Overall Study|Adverse Event|0|||
38050962|NCT04120233|69739933|FG002|Overall Study|Adverse Event|0|||
38050963|NCT04120233|69739934|FG003|Overall Study|Adverse Event|0|||
38050964|NCT04120233|69739935|FG004|Overall Study|Adverse Event|1|||
37956172|NCT00487942|69643263|FG001|Overall Study|Protocol Violation|1|||
37956173|NCT00487942|69643264|FG002|Overall Study|Protocol Violation|0|||
37956174|NCT00487942|69643265|FG003|Overall Study|Protocol Violation|0|||
37956175|NCT00487942|69643262|FG000|Overall Study|Withdrawal by Subject|0|||
37956176|NCT00487942|69643263|FG001|Overall Study|Withdrawal by Subject|1|||
38050965|NCT04120233|69739936|FG005|Overall Study|Adverse Event|0|||
38050966|NCT01610700|69739952|FG000|Overall Study|Adverse Event|3|||
38050967|NCT01610700|69739953|FG001|Overall Study|Adverse Event|1|||
38050968|NCT01610700|69739952|FG000|Overall Study|Withdrawal by Subject|0|||
37956177|NCT00487942|69643264|FG002|Overall Study|Withdrawal by Subject|2|||
37956178|NCT00487942|69643265|FG003|Overall Study|Withdrawal by Subject|0|||
37956179|NCT00132301|69643277|FG000|Overall Study|Death|7|||
38050969|NCT01610700|69739953|FG001|Overall Study|Withdrawal by Subject|1|||
38050970|NCT01610700|69739952|FG000|Overall Study|subject took one dose of street cannabis|0|||
37956180|NCT00132301|69643278|FG001|Overall Study|Death|6|||
37956181|NCT00132301|69643277|FG000|Overall Study|Withdrawal by Subject|5|||
37956182|NCT00132301|69643278|FG001|Overall Study|Withdrawal by Subject|2|||
37956183|NCT00132301|69643277|FG000|Overall Study|Physician Decision|1|||
37956184|NCT00132301|69643278|FG001|Overall Study|Physician Decision|1|||
37956185|NCT00132301|69643277|FG000|Overall Study|Lost to Follow-up|5|||
37956186|NCT00132301|69643278|FG001|Overall Study|Lost to Follow-up|3|||
37956187|NCT00132301|69643277|FG000|Overall Study|Other|1|||
37956188|NCT00132301|69643278|FG001|Overall Study|Other|1|||
37956189|NCT00132301|69643277|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
37956190|NCT00132301|69643278|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
37956191|NCT00522873|69643286|FG000|Overall Study|Adverse Event|41|||
37956192|NCT00522873|69643287|FG001|Overall Study|Adverse Event|26|||
37956193|NCT00522873|69643286|FG000|Overall Study|Withdrawal by Subject|20|||
37956194|NCT00522873|69643287|FG001|Overall Study|Withdrawal by Subject|9|||
37956195|NCT00522873|69643286|FG000|Overall Study|Protocol Violation|14|||
37956196|NCT00522873|69643287|FG001|Overall Study|Protocol Violation|4|||
37956197|NCT00522873|69643286|FG000|Overall Study|Lost to Follow-up|11|||
37956198|NCT00522873|69643287|FG001|Overall Study|Lost to Follow-up|3|||
37956199|NCT00522873|69643286|FG000|Overall Study|Personal Reasons|8|||
37956200|NCT00522873|69643287|FG001|Overall Study|Personal Reasons|1|||
37956201|NCT00522873|69643286|FG000|Overall Study|Medication Errors|1|||
37956202|NCT00522873|69643287|FG001|Overall Study|Medication Errors|1|||
37956203|NCT00522873|69643286|FG000|Overall Study|Never Received Medication|1|||
37956204|NCT00522873|69643287|FG001|Overall Study|Never Received Medication|0|||
37956205|NCT03684057|69643295|FG000|Overall Study|Withdrawal by Subject|4|||
37956206|NCT03684057|69643296|FG001|Overall Study|Withdrawal by Subject|5|||
37956207|NCT03864627|69643305|FG000|Overall Study|Adverse Event|0|||
37956208|NCT03864627|69643306|FG001|Overall Study|Adverse Event|1|||
37956209|NCT03864627|69643305|FG000|Overall Study|Lack of Efficacy|0|||
37956210|NCT03864627|69643306|FG001|Overall Study|Lack of Efficacy|1|||
37956211|NCT03864627|69643305|FG000|Overall Study|Lost to Follow-up|0|||
38050971|NCT01610700|69739953|FG001|Overall Study|subject took one dose of street cannabis|1|||
38050972|NCT03256851|69739962|FG000|Overall Study|Withdrawal by Subject|1|||
38050973|NCT03256851|69739963|FG001|Overall Study|Withdrawal by Subject|0|||
38050974|NCT04837807|69739969|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
38050975|NCT04837807|69739970|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
38050976|NCT03256695|69739976|FG000|Overall Study|Adverse Event|8|||
38050977|NCT03256695|69739976|FG000|Overall Study|Death|2|||
38050978|NCT03256695|69739976|FG000|Overall Study|Withdrawal by Subject|14|||
38050979|NCT03256695|69739976|FG000|Overall Study|Non-compliance with study drug|1|||
38050980|NCT03256695|69739976|FG000|Overall Study|Lost to Follow-up|3|||
38050981|NCT03256695|69739976|FG000|Overall Study|Lack of Efficacy|3|||
38050982|NCT03256695|69739976|FG000|Overall Study|Protocol Violation|5|||
38050983|NCT03256695|69739976|FG000|Overall Study|Other than specified|3|||
38050984|NCT03305016|69739980|FG000|Overall Study|Withdrawal by Subject|2|||
38050985|NCT03297021|69739987|FG000|Overall Study|Incomplete/illegible data sheet|4|||
38050986|NCT03297021|69739988|FG001|Overall Study|Incomplete/illegible data sheet|2|||
37956212|NCT03864627|69643306|FG001|Overall Study|Lost to Follow-up|1|||
37956213|NCT03864627|69643305|FG000|Overall Study|Withdrawal by Subject|4|||
37956214|NCT03864627|69643306|FG001|Overall Study|Withdrawal by Subject|8|||
37956215|NCT03864627|69643305|FG000|Overall Study|Study terminated by sponsor|0|||
37956216|NCT03864627|69643306|FG001|Overall Study|Study terminated by sponsor|1|||
37956217|NCT00519831|69643313|FG000|Overall Study|Adverse Event|3|||
37956218|NCT00131911|69643323|FG000|Overall Study|Withdrawal by Subject|1|||
37956219|NCT00131911|69643324|FG001|Overall Study|Withdrawal by Subject|0|||
37956220|NCT00184093|69643329|FG000|Overall Study|Adverse Event|3|||
37956221|NCT00184093|69643329|FG000|Overall Study|Lost to Follow-up|3|||
37956222|NCT00184093|69643329|FG000|Overall Study|Physician Decision|1|||
37956223|NCT00184093|69643329|FG000|Overall Study|Withdrawal by Subject|2|||
38050987|NCT03297021|69739989|FG002|Overall Study|Incomplete/illegible data sheet|3|||
38050988|NCT03297021|69739987|FG000|Overall Study|Missing Post-Op Data|1|||
37861968|NCT01136733|69545745|FG003|Phase 1b|Adverse Event|0|||
37861969|NCT01136733|69545746|FG004|Phase 1b|Adverse Event|0|||
37956224|NCT00183625|69643335|FG000|Overall Study|Withdrawal by Subject|18|||
37956225|NCT00183625|69643336|FG001|Overall Study|Withdrawal by Subject|18|||
37956226|NCT00183625|69643337|FG002|Overall Study|Withdrawal by Subject|19|||
37956227|NCT00183625|69643338|FG003|Overall Study|Withdrawal by Subject|14|||
37956228|NCT00511875|69643348|FG000|Overall Study|Lost to Follow-up|4|||
37956229|NCT00511875|69643349|FG001|Overall Study|Lost to Follow-up|0|||
37956230|NCT00511875|69643348|FG000|Overall Study|Missing variables|1|||
37956231|NCT00511875|69643349|FG001|Overall Study|Missing variables|0|||
37956232|NCT00183391|69643357|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
37956233|NCT00183391|69643358|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
37956234|NCT00183391|69643357|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
37956235|NCT00183391|69643358|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
37956236|NCT00493246|69643374|FG000|Overall Study|Withdrawal by Subject|0|||
37956237|NCT00493246|69643375|FG001|Overall Study|Withdrawal by Subject|0|||
37956238|NCT00493246|69643376|FG002|Overall Study|Withdrawal by Subject|0|||
37956239|NCT00493246|69643377|FG003|Overall Study|Withdrawal by Subject|0|||
37956240|NCT00493246|69643378|FG004|Overall Study|Withdrawal by Subject|1|||
37956241|NCT00493246|69643379|FG005|Overall Study|Withdrawal by Subject|0|||
37956242|NCT00493246|69643380|FG006|Overall Study|Withdrawal by Subject|0|||
37956243|NCT00493246|69643381|FG007|Overall Study|Withdrawal by Subject|0|||
37956244|NCT00493246|69643374|FG000|Overall Study|No access to draw blood|0|||
37956245|NCT00493246|69643375|FG001|Overall Study|No access to draw blood|0|||
37956246|NCT00493246|69643376|FG002|Overall Study|No access to draw blood|0|||
37956247|NCT00493246|69643377|FG003|Overall Study|No access to draw blood|0|||
37956248|NCT00493246|69643378|FG004|Overall Study|No access to draw blood|0|||
37956249|NCT00493246|69643379|FG005|Overall Study|No access to draw blood|1|||
37956250|NCT00493246|69643380|FG006|Overall Study|No access to draw blood|0|||
37956251|NCT00493246|69643381|FG007|Overall Study|No access to draw blood|0|||
37956252|NCT00493246|69643374|FG000|Overall Study|Lost to Follow-up|0|||
37956253|NCT00493246|69643375|FG001|Overall Study|Lost to Follow-up|0|||
37956254|NCT00493246|69643376|FG002|Overall Study|Lost to Follow-up|0|||
37956255|NCT00493246|69643377|FG003|Overall Study|Lost to Follow-up|0|||
37956256|NCT00493246|69643378|FG004|Overall Study|Lost to Follow-up|0|||
37956257|NCT00493246|69643379|FG005|Overall Study|Lost to Follow-up|0|||
37956258|NCT00493246|69643380|FG006|Overall Study|Lost to Follow-up|1|||
37956259|NCT00493246|69643381|FG007|Overall Study|Lost to Follow-up|0|||
37956260|NCT02281955|69643399|FG000|Overall Study|Death|1|||
37956261|NCT00511797|69643407|FG000|Overall Study|Adverse Event|1|||
37956262|NCT00511797|69643408|FG001|Overall Study|Adverse Event|2|||
37956263|NCT00511797|69643409|FG002|Overall Study|Adverse Event|2|||
37956264|NCT00511797|69643410|FG003|Overall Study|Adverse Event|2|||
37956265|NCT00511797|69643407|FG000|Overall Study|Lost to Follow-up|1|||
37956266|NCT00511797|69643408|FG001|Overall Study|Lost to Follow-up|0|||
37956267|NCT00511797|69643409|FG002|Overall Study|Lost to Follow-up|0|||
37956268|NCT00511797|69643410|FG003|Overall Study|Lost to Follow-up|1|||
37956269|NCT00511797|69643407|FG000|Overall Study|Pregnancy|0|||
37956270|NCT00511797|69643408|FG001|Overall Study|Pregnancy|0|||
37956271|NCT00511797|69643409|FG002|Overall Study|Pregnancy|0|||
37956272|NCT00511797|69643410|FG003|Overall Study|Pregnancy|1|||
37956273|NCT00511797|69643407|FG000|Overall Study|Protocol Violation|0|||
37956274|NCT00511797|69643408|FG001|Overall Study|Protocol Violation|2|||
37956275|NCT00511797|69643409|FG002|Overall Study|Protocol Violation|2|||
37956276|NCT00511797|69643410|FG003|Overall Study|Protocol Violation|3|||
37956277|NCT00511797|69643407|FG000|Overall Study|Withdrawal by Subject|3|||
37956278|NCT00511797|69643408|FG001|Overall Study|Withdrawal by Subject|3|||
37956279|NCT00511797|69643409|FG002|Overall Study|Withdrawal by Subject|4|||
37956280|NCT00511797|69643410|FG003|Overall Study|Withdrawal by Subject|2|||
37956281|NCT00511797|69643407|FG000|Overall Study|Never dispensed|1|||
37956282|NCT00511797|69643408|FG001|Overall Study|Never dispensed|0|||
37956283|NCT00511797|69643409|FG002|Overall Study|Never dispensed|1|||
37956284|NCT00511797|69643410|FG003|Overall Study|Never dispensed|3|||
37956285|NCT00511797|69643407|FG000|Overall Study|Study drug not taken|0|||
37956286|NCT00511797|69643408|FG001|Overall Study|Study drug not taken|1|||
37956287|NCT00511797|69643409|FG002|Overall Study|Study drug not taken|0|||
37956288|NCT00511797|69643410|FG003|Overall Study|Study drug not taken|1|||
37956289|NCT00511797|69643407|FG000|Overall Study|Partially missing diary|0|||
38050989|NCT03297021|69739988|FG001|Overall Study|Missing Post-Op Data|2|||
38050990|NCT03297021|69739989|FG002|Overall Study|Missing Post-Op Data|1|||
38050991|NCT04820491|69739999|FG000|Overall Study|Withdrawal by Subject|1|||
38050992|NCT04820491|69740000|FG001|Overall Study|Withdrawal by Subject|0|||
37956290|NCT00511797|69643408|FG001|Overall Study|Partially missing diary|0|||
37956291|NCT00511797|69643409|FG002|Overall Study|Partially missing diary|1|||
37956292|NCT00511797|69643410|FG003|Overall Study|Partially missing diary|0|||
37956293|NCT00511797|69643407|FG000|Overall Study|Other (moving etc)|1|||
37956294|NCT00511797|69643408|FG001|Overall Study|Other (moving etc)|0|||
37956295|NCT00511797|69643409|FG002|Overall Study|Other (moving etc)|1|||
37956296|NCT00511797|69643410|FG003|Overall Study|Other (moving etc)|2|||
37956297|NCT00487552|69643420|FG000|Overall Study|Unsuccessful magnet placements|3|||
37956298|NCT00487552|69643420|FG000|Overall Study|Death due to progressive malignancy|2|||
37956299|NCT00487552|69643420|FG000|Overall Study|Stent not placed|1|||
37956300|NCT00182689|69643427|FG000|Overall Study|Adverse Event|8|||
37956301|NCT00182689|69643428|FG001|Overall Study|Adverse Event|11|||
37956302|NCT00182689|69643427|FG000|Overall Study|Withdrawal by Subject|2|||
37956303|NCT00182689|69643428|FG001|Overall Study|Withdrawal by Subject|2|||
37956304|NCT00182689|69643427|FG000|Overall Study|Progression|27|||
37956305|NCT00182689|69643428|FG001|Overall Study|Progression|29|||
37956306|NCT00182689|69643427|FG000|Overall Study|Death|1|||
37956307|NCT00182689|69643428|FG001|Overall Study|Death|0|||
37956308|NCT00182689|69643427|FG000|Overall Study|not protocol specified|0|||
37956309|NCT00182689|69643428|FG001|Overall Study|not protocol specified|3|||
37956310|NCT00182689|69643427|FG000|Overall Study|Ineligible|1|||
37956311|NCT00182689|69643428|FG001|Overall Study|Ineligible|4|||
37956312|NCT00182689|69643427|FG000|Overall Study|Never received treatment|1|||
37956313|NCT00182689|69643428|FG001|Overall Study|Never received treatment|0|||
37956314|NCT03860259|69643440|FG000|Overall Study|Lost to Follow-up|5|||
37956315|NCT03860259|69643441|FG001|Overall Study|Lost to Follow-up|5|||
37956316|NCT03860259|69643440|FG000|Overall Study|Protocol Violation|1|||
37956317|NCT03860259|69643441|FG001|Overall Study|Protocol Violation|0|||
37956318|NCT00131365|69643447|FG000|Overall Study|Withdrawal by Subject|1|||
37956319|NCT00131365|69643447|FG000|Overall Study|Alternative treatment|3|||
37956320|NCT00487240|69643454|FG000|Overall Study|Withdrawal by Subject|12|||
37956321|NCT00487240|69643455|FG001|Overall Study|Withdrawal by Subject|6|||
37956322|NCT00487240|69643454|FG000|Overall Study|Lost to Follow-up|7|||
37956323|NCT00487240|69643455|FG001|Overall Study|Lost to Follow-up|6|||
37956324|NCT00487240|69643454|FG000|Overall Study|Adverse Event|0|||
37956325|NCT00487240|69643455|FG001|Overall Study|Adverse Event|4|||
37956326|NCT00487240|69643454|FG000|Overall Study|Protocol Violation|5|||
37956327|NCT00487240|69643455|FG001|Overall Study|Protocol Violation|5|||
37956328|NCT00487240|69643454|FG000|Overall Study|Entry Criteria Not Met|3|||
37956329|NCT00487240|69643455|FG001|Overall Study|Entry Criteria Not Met|4|||
37956330|NCT00487240|69643454|FG000|Overall Study|Sponsor Decision|2|||
37956331|NCT00487240|69643455|FG001|Overall Study|Sponsor Decision|1|||
37956332|NCT00487240|69643454|FG000|Overall Study|Physician Decision|2|||
37956333|NCT00487240|69643455|FG001|Overall Study|Physician Decision|0|||
37956334|NCT02224391|69643463|FG000|Overall Study|Lost to Follow-up|26|||
37956335|NCT02224391|69643464|FG001|Overall Study|Lost to Follow-up|19|||
37956336|NCT02224391|69643463|FG000|Overall Study|Withdrawal by Subject|6|||
37956337|NCT02224391|69643464|FG001|Overall Study|Withdrawal by Subject|5|||
37956338|NCT00487162|69643472|FG000|Overall Study|Adverse Event|0|||
37956339|NCT00487162|69643473|FG001|Overall Study|Adverse Event|1|||
37956340|NCT00487162|69643472|FG000|Overall Study|Physician Decision|0|||
37956341|NCT00487162|69643473|FG001|Overall Study|Physician Decision|1|||
37956342|NCT00487162|69643472|FG000|Overall Study|Withdrawal by Subject|2|||
37956343|NCT00487162|69643473|FG001|Overall Study|Withdrawal by Subject|3|||
37956344|NCT00487084|69643482|FG000|Overall Study|Did not receive intervention|4|||
37956345|NCT00487084|69643483|FG001|Overall Study|Did not receive intervention|3|||
37956346|NCT00487084|69643484|FG002|Overall Study|Did not receive intervention|5|||
37956347|NCT00466726|69643492|FG000|Overall Study|Not evaluable for response|14|||
37956348|NCT01721291|69643498|FG000|Overall Study|Withdrawal by Subject|1|||
37956349|NCT01721291|69643499|FG001|Overall Study|Withdrawal by Subject|0|||
37956350|NCT01721291|69643498|FG000|Overall Study|did not like the treatment|1|||
37956351|NCT01721291|69643499|FG001|Overall Study|did not like the treatment|0|||
37956352|NCT00486226|69643525|FG000|Overall Study|Death|3|||
37956353|NCT00486226|69643525|FG000|Overall Study|Adverse Event|1|||
37956354|NCT00486226|69643525|FG000|Overall Study|Withdrawal by Subject|1|||
37956355|NCT00486226|69643525|FG000|Overall Study|Lost to Follow-up|8|||
37956356|NCT00485758|69643534|FG000|Overall Study|Adverse Event|102|||
37956357|NCT00485758|69643535|FG001|Overall Study|Adverse Event|31|||
37956358|NCT00485758|69643534|FG000|Overall Study|Death|0|||
37956359|NCT00485758|69643535|FG001|Overall Study|Death|1|||
37956360|NCT00485758|69643534|FG000|Overall Study|Lost to Follow-up|5|||
37956361|NCT00485758|69643535|FG001|Overall Study|Lost to Follow-up|1|||
37956362|NCT00485758|69643534|FG000|Overall Study|Physician Decision|3|||
37956363|NCT00485758|69643535|FG001|Overall Study|Physician Decision|3|||
37956364|NCT00485758|69643534|FG000|Overall Study|Protocol Violation|11|||
37956365|NCT00485758|69643535|FG001|Overall Study|Protocol Violation|2|||
37956366|NCT00485758|69643534|FG000|Overall Study|Withdrawal by Subject|32|||
37956367|NCT00485758|69643535|FG001|Overall Study|Withdrawal by Subject|27|||
37956368|NCT00485758|69643534|FG000|Overall Study|Study Terminated by Sponsor|3|||
37956369|NCT00485758|69643535|FG001|Overall Study|Study Terminated by Sponsor|0|||
37956370|NCT00469612|69643543|FG000|Overall Study|Study terminated before data collected|2|||
37956371|NCT00469612|69643544|FG001|Overall Study|Study terminated before data collected|0|||
37956372|NCT00469456|69643552|FG000|Overall Study|Adverse Event|4|||
37956373|NCT00469456|69643553|FG001|Overall Study|Adverse Event|3|||
37956374|NCT00469456|69643552|FG000|Overall Study|Protocol Violation|1|||
37956375|NCT00469456|69643553|FG001|Overall Study|Protocol Violation|0|||
37956376|NCT00469456|69643552|FG000|Overall Study|Withdrawal by Subject|4|||
37956377|NCT00469456|69643553|FG001|Overall Study|Withdrawal by Subject|1|||
37956378|NCT00581555|69643561|FG000|Overall Study|Adverse Event|4|||
38050993|NCT01988571|69740008|FG000|Overall Study|Death|3|||
37956379|NCT00581555|69643562|FG001|Overall Study|Adverse Event|3|||
37956380|NCT00581555|69643561|FG000|Overall Study|Physician Decision|3|||
37956381|NCT00581555|69643562|FG001|Overall Study|Physician Decision|2|||
37956382|NCT00581555|69643561|FG000|Overall Study|Withdrawal by Subject|18|||
37956383|NCT00581555|69643562|FG001|Overall Study|Withdrawal by Subject|9|||
37956384|NCT00581555|69643561|FG000|Overall Study|Lost to Follow-up|2|||
37956385|NCT00581555|69643562|FG001|Overall Study|Lost to Follow-up|2|||
37956386|NCT00581555|69643561|FG000|Overall Study|Other reasons|16|||
37956387|NCT00581555|69643562|FG001|Overall Study|Other reasons|4|||
37956388|NCT00469144|69643570|FG000|Overall Study|Death|0|||
37956389|NCT00469144|69643571|FG001|Overall Study|Death|1|||
37956390|NCT00469144|69643570|FG000|Overall Study|No Response|5|||
37956391|NCT00469144|69643571|FG001|Overall Study|No Response|5|||
37956392|NCT00469144|69643570|FG000|Overall Study|Progressive Disease|1|||
37956393|NCT00469144|69643571|FG001|Overall Study|Progressive Disease|0|||
37956394|NCT00468910|69643583|FG000|Overall Study|Lost to Follow-up|2|||
37956395|NCT00468910|69643584|FG001|Overall Study|Lost to Follow-up|1|||
37956396|NCT00468910|69643583|FG000|Overall Study|Withdrawal by Subject|2|||
37956397|NCT00468910|69643584|FG001|Overall Study|Withdrawal by Subject|1|||
37956398|NCT00468910|69643583|FG000|Overall Study|Medical Contraindication|0|||
37956399|NCT00468910|69643584|FG001|Overall Study|Medical Contraindication|1|||
37956400|NCT01412333|69643593|FG000|Overall Study|Death|1|||
37956401|NCT01412333|69643594|FG001|Overall Study|Death|1|||
37956402|NCT01412333|69643593|FG000|Overall Study|Physician Decision|0|||
37956403|NCT01412333|69643594|FG001|Overall Study|Physician Decision|1|||
37956404|NCT01412333|69643593|FG000|Overall Study|Reason not specified|16|||
37956405|NCT01412333|69643594|FG001|Overall Study|Reason not specified|10|||
37956406|NCT01412333|69643593|FG000|Overall Study|Non-compliance with study drug|1|||
37956407|NCT01412333|69643594|FG001|Overall Study|Non-compliance with study drug|1|||
37956408|NCT01412333|69643593|FG000|Overall Study|Protocol Violation|1|||
37956409|NCT01412333|69643594|FG001|Overall Study|Protocol Violation|1|||
37956410|NCT01412333|69643593|FG000|Overall Study|Non-compliance|1|||
37956411|NCT01412333|69643594|FG001|Overall Study|Non-compliance|3|||
37956412|NCT01412333|69643593|FG000|Overall Study|Lack of Efficacy|15|||
37956413|NCT01412333|69643594|FG001|Overall Study|Lack of Efficacy|6|||
37956414|NCT01412333|69643593|FG000|Overall Study|Pregnancy|3|||
37956415|NCT01412333|69643594|FG001|Overall Study|Pregnancy|0|||
37956416|NCT01412333|69643593|FG000|Overall Study|Consent withdrawn by participant|25|||
37956417|NCT01412333|69643594|FG001|Overall Study|Consent withdrawn by participant|12|||
37956418|NCT01412333|69643593|FG000|Overall Study|Adverse Event|25|||
37956419|NCT01412333|69643594|FG001|Overall Study|Adverse Event|16|||
37956420|NCT01412333|69643593|FG000|Overall Study|Lost to Follow-up|10|||
37956421|NCT01412333|69643594|FG001|Overall Study|Lost to Follow-up|6|||
37956422|NCT00519285|69643603|FG000|Overall Study|Adverse Event|127|||
37956423|NCT00519285|69643604|FG001|Overall Study|Adverse Event|266|||
37956424|NCT00519285|69643603|FG000|Overall Study|Disease progression|334|||
37956425|NCT00519285|69643604|FG001|Overall Study|Disease progression|186|||
37956426|NCT00519285|69643603|FG000|Overall Study|Physician Decision|75|||
37956427|NCT00519285|69643604|FG001|Overall Study|Physician Decision|47|||
37956428|NCT00519285|69643603|FG000|Overall Study|Participant's request|53|||
37956429|NCT00519285|69643604|FG001|Overall Study|Participant's request|84|||
37956430|NCT00519285|69643603|FG000|Overall Study|Consent withdrawn|4|||
37956431|NCT00519285|69643604|FG001|Overall Study|Consent withdrawn|5|||
37956432|NCT00519285|69643603|FG000|Overall Study|Poor compliance to protocol|5|||
37956433|NCT00519285|69643604|FG001|Overall Study|Poor compliance to protocol|7|||
37956434|NCT00519285|69643603|FG000|Overall Study|Reason unspecified|5|||
37956435|NCT00519285|69643604|FG001|Overall Study|Reason unspecified|8|||
37956436|NCT00519285|69643603|FG000|Overall Study|Not treated|8|||
37956437|NCT00519285|69643604|FG001|Overall Study|Not treated|7|||
37956438|NCT00519285|69643603|FG000|Overall Study|Treatment ongoing|1|||
37956439|NCT00519285|69643604|FG001|Overall Study|Treatment ongoing|2|||
37956440|NCT00464620|69643610|FG000|Overall Study|Physician Decision|1|||
37956441|NCT00464620|69643611|FG001|Overall Study|Physician Decision|0|||
37956442|NCT00464620|69643612|FG002|Overall Study|Physician Decision|0|||
37956443|NCT00464620|69643610|FG000|Overall Study|Withdrawal by Subject|1|||
37956444|NCT00464620|69643611|FG001|Overall Study|Withdrawal by Subject|0|||
37956445|NCT00464620|69643612|FG002|Overall Study|Withdrawal by Subject|3|||
37956446|NCT00464620|69643610|FG000|Overall Study|Ineligible sarcoma subtype|0|||
37956447|NCT00464620|69643611|FG001|Overall Study|Ineligible sarcoma subtype|2|||
37956448|NCT00464620|69643612|FG002|Overall Study|Ineligible sarcoma subtype|2|||
37956449|NCT00464620|69643610|FG000|Overall Study|Use of prohibited concomitant medication|0|||
37956450|NCT00464620|69643611|FG001|Overall Study|Use of prohibited concomitant medication|0|||
37956451|NCT00464620|69643612|FG002|Overall Study|Use of prohibited concomitant medication|2|||
37956452|NCT00464542|69643625|FG000|Pre-treatment|Withdrawal by Subject|2|||
37956453|NCT00468676|69643631|FG000|Overall Study|Lost to Follow-up|14|||
37956454|NCT00468676|69643632|FG001|Overall Study|Lost to Follow-up|11|||
37956455|NCT00468676|69643631|FG000|Overall Study|Death|2|||
37956456|NCT00468676|69643632|FG001|Overall Study|Death|1|||
37956457|NCT00464308|69643643|FG000|Overall Study|Adverse Event|22|||
37956458|NCT00464308|69643644|FG001|Overall Study|Adverse Event|27|||
37956459|NCT00464308|69643645|FG002|Overall Study|Adverse Event|16|||
37956460|NCT00464308|69643643|FG000|Overall Study|Lost to Follow-up|29|||
37956461|NCT00464308|69643644|FG001|Overall Study|Lost to Follow-up|19|||
37956462|NCT00464308|69643645|FG002|Overall Study|Lost to Follow-up|20|||
37956463|NCT00464308|69643643|FG000|Overall Study|Patient discontinued and other reasons|17|||
37956464|NCT00464308|69643644|FG001|Overall Study|Patient discontinued and other reasons|17|||
37956465|NCT00464308|69643645|FG002|Overall Study|Patient discontinued and other reasons|23|||
37956466|NCT00464308|69643643|FG000|Overall Study|Physician Decision|1|||
37956467|NCT00464308|69643644|FG001|Overall Study|Physician Decision|0|||
37956468|NCT00464308|69643645|FG002|Overall Study|Physician Decision|0|||
37956469|NCT00468286|69643655|FG000|Overall Study|Adverse Event|1|||
37956470|NCT00468286|69643656|FG001|Overall Study|Adverse Event|6|||
37956471|NCT00468286|69643655|FG000|Overall Study|Protocol Violation|2|||
37956472|NCT00468286|69643656|FG001|Overall Study|Protocol Violation|2|||
37956473|NCT00468286|69643655|FG000|Overall Study|Withdrawal by Subject|4|||
37956474|NCT00468286|69643656|FG001|Overall Study|Withdrawal by Subject|3|||
37956475|NCT00468286|69643655|FG000|Overall Study|Physician Decision|0|||
37956476|NCT00468286|69643656|FG001|Overall Study|Physician Decision|1|||
37956477|NCT00463840|69643662|FG000|Overall Study|Disease progression|7|||
37956478|NCT00463840|69643662|FG000|Overall Study|Withdrawal by Subject|2|||
37956479|NCT00463840|69643662|FG000|Overall Study|Adverse Event|3|||
37956480|NCT00129389|69643668|FG000|Overall Study|Adverse Event|19|||
37956481|NCT00129389|69643669|FG001|Overall Study|Adverse Event|87|||
37956482|NCT00129389|69643668|FG000|Overall Study|Death|0|||
37956483|NCT00129389|69643669|FG001|Overall Study|Death|1|||
37956484|NCT00129389|69643668|FG000|Overall Study|Lost to Follow-up|2|||
37956485|NCT00129389|69643669|FG001|Overall Study|Lost to Follow-up|1|||
37956486|NCT00129389|69643668|FG000|Overall Study|Physician Decision|0|||
37956487|NCT00129389|69643669|FG001|Overall Study|Physician Decision|4|||
37956488|NCT00129389|69643668|FG000|Overall Study|Protocol Violation|0|||
37956489|NCT00129389|69643669|FG001|Overall Study|Protocol Violation|6|||
37956490|NCT00129389|69643668|FG000|Overall Study|Withdrawal by Subject|9|||
37956491|NCT00129389|69643669|FG001|Overall Study|Withdrawal by Subject|23|||
37956492|NCT00129389|69643668|FG000|Overall Study|Relapse|1|||
37956493|NCT00129389|69643669|FG001|Overall Study|Relapse|0|||
37956494|NCT00129389|69643668|FG000|Overall Study|Not eligible|1|||
37956495|NCT00129389|69643669|FG001|Overall Study|Not eligible|2|||
37956496|NCT00129389|69643668|FG000|Overall Study|Crossed to the other arm|1|||
37956497|NCT00129389|69643669|FG001|Overall Study|Crossed to the other arm|16|||
37956498|NCT00468052|69643677|FG000|Overall Study|Protocol Violation|7|||
37956499|NCT00468052|69643678|FG001|Overall Study|Protocol Violation|8|||
37956500|NCT00453310|69643686|FG000|Overall Study|Progression of Disease|10|||
37956501|NCT00124657|69643693|FG000|Overall Study|Toxicity|0|||
37956502|NCT00124657|69643694|FG001|Overall Study|Toxicity|0|||
37956503|NCT00124657|69643695|FG002|Overall Study|Toxicity|1|||
37956504|NCT00124657|69643693|FG000|Overall Study|Non-compliance|1|||
37956505|NCT00124657|69643694|FG001|Overall Study|Non-compliance|0|||
37956506|NCT00124657|69643695|FG002|Overall Study|Non-compliance|4|||
37956507|NCT00124657|69643693|FG000|Overall Study|Progressive disease|14|||
37956508|NCT00124657|69643694|FG001|Overall Study|Progressive disease|5|||
37956509|NCT00124657|69643695|FG002|Overall Study|Progressive disease|27|||
37956510|NCT00124657|69643693|FG000|Overall Study|Intercurrent illness|1|||
37956511|NCT00124657|69643694|FG001|Overall Study|Intercurrent illness|0|||
37956512|NCT00124657|69643695|FG002|Overall Study|Intercurrent illness|0|||
37956513|NCT00581945|69643718|FG000|Overall Study|Adverse Event|4|||
37956514|NCT00581945|69643719|FG001|Overall Study|Adverse Event|4|||
37956515|NCT00581945|69643718|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
37956516|NCT00581945|69643719|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
37956517|NCT00581945|69643718|FG000|Overall Study|Withdrawal by Subject|2|||
37956518|NCT00581945|69643719|FG001|Overall Study|Withdrawal by Subject|6|||
37956519|NCT00581945|69643718|FG000|Overall Study|Death|1|||
37956520|NCT00581945|69643719|FG001|Overall Study|Death|0|||
37956521|NCT00555906|69643728|FG000|Phase 1|Objective Progression or Relapse|3|||
37956522|NCT00555906|69643729|FG001|Phase 1|Objective Progression or Relapse|5|||
37956523|NCT00555906|69643730|FG002|Phase 1|Objective Progression or Relapse|3|||
37956524|NCT00555906|69643731|FG003|Phase 1|Objective Progression or Relapse|1|||
37956525|NCT00555906|69643732|FG004|Phase 1|Objective Progression or Relapse|0|||
37956526|NCT00555906|69643728|FG000|Phase 1|Global Deterioration of Health Status|0|||
37956527|NCT00555906|69643729|FG001|Phase 1|Global Deterioration of Health Status|1|||
37956528|NCT00555906|69643730|FG002|Phase 1|Global Deterioration of Health Status|1|||
37956529|NCT00555906|69643731|FG003|Phase 1|Global Deterioration of Health Status|1|||
37956530|NCT00555906|69643732|FG004|Phase 1|Global Deterioration of Health Status|0|||
37956531|NCT00555906|69643728|FG000|Phase 1|Adverse Event|0|||
37956532|NCT00555906|69643729|FG001|Phase 1|Adverse Event|0|||
37956533|NCT00555906|69643730|FG002|Phase 1|Adverse Event|3|||
37956534|NCT00555906|69643731|FG003|Phase 1|Adverse Event|2|||
37956535|NCT00555906|69643732|FG004|Phase 1|Adverse Event|0|||
37956536|NCT00555906|69643728|FG000|Phase 1|Withdrawal by Subject|0|||
37956537|NCT00555906|69643729|FG001|Phase 1|Withdrawal by Subject|0|||
37956538|NCT00555906|69643730|FG002|Phase 1|Withdrawal by Subject|0|||
37956539|NCT00555906|69643731|FG003|Phase 1|Withdrawal by Subject|1|||
37956540|NCT00555906|69643732|FG004|Phase 1|Withdrawal by Subject|0|||
37956541|NCT00555906|69643728|FG000|Phase 2|Adverse Event|0|||
37956542|NCT00555906|69643729|FG001|Phase 2|Adverse Event|0|||
37956543|NCT00555906|69643730|FG002|Phase 2|Adverse Event|0|||
37956544|NCT00555906|69643731|FG003|Phase 2|Adverse Event|0|||
37956545|NCT00555906|69643732|FG004|Phase 2|Adverse Event|4|||
37956546|NCT00555906|69643728|FG000|Phase 2|Global Deterioration of Health Status|0|||
37956547|NCT00555906|69643729|FG001|Phase 2|Global Deterioration of Health Status|0|||
37956548|NCT00555906|69643730|FG002|Phase 2|Global Deterioration of Health Status|0|||
37956549|NCT00555906|69643731|FG003|Phase 2|Global Deterioration of Health Status|0|||
37956550|NCT00555906|69643732|FG004|Phase 2|Global Deterioration of Health Status|2|||
37956551|NCT00555906|69643728|FG000|Phase 2|Objective Progression or Relapse|0|||
37956552|NCT00555906|69643729|FG001|Phase 2|Objective Progression or Relapse|0|||
37956553|NCT00555906|69643730|FG002|Phase 2|Objective Progression or Relapse|0|||
37956554|NCT00555906|69643731|FG003|Phase 2|Objective Progression or Relapse|0|||
37956555|NCT00555906|69643732|FG004|Phase 2|Objective Progression or Relapse|16|||
37956556|NCT00555906|69643728|FG000|Phase 2|Withdrawal by Subject|0|||
37956557|NCT00555906|69643729|FG001|Phase 2|Withdrawal by Subject|0|||
37956558|NCT00555906|69643730|FG002|Phase 2|Withdrawal by Subject|0|||
37956559|NCT00555906|69643731|FG003|Phase 2|Withdrawal by Subject|0|||
37956560|NCT00555906|69643732|FG004|Phase 2|Withdrawal by Subject|2|||
37956561|NCT00555906|69643728|FG000|Phase 2|Other|0|||
37956562|NCT00555906|69643729|FG001|Phase 2|Other|0|||
37956563|NCT00555906|69643730|FG002|Phase 2|Other|0|||
37956564|NCT00555906|69643731|FG003|Phase 2|Other|0|||
37956565|NCT00555906|69643732|FG004|Phase 2|Other|6|||
37956566|NCT00555906|69643728|FG000|Phase 2|Randomized but not Treated|0|||
37956567|NCT00555906|69643729|FG001|Phase 2|Randomized but not Treated|0|||
37956568|NCT00555906|69643730|FG002|Phase 2|Randomized but not Treated|0|||
37956569|NCT00555906|69643731|FG003|Phase 2|Randomized but not Treated|0|||
37956570|NCT00555906|69643732|FG004|Phase 2|Randomized but not Treated|2|||
37956571|NCT03817879|69643749|FG000|Overall Study|Drop out|5|||
37956572|NCT03817879|69643750|FG001|Overall Study|Drop out|12|||
37956573|NCT03817879|69643749|FG000|Overall Study|Withdrawal by Subject|0|||
37956574|NCT03817879|69643750|FG001|Overall Study|Withdrawal by Subject|1|||
37956575|NCT00555672|69643758|FG000|Overall Study|Death|0|||
37956576|NCT00555672|69643759|FG001|Overall Study|Death|2|||
37956577|NCT00555672|69643758|FG000|Overall Study|Adverse Event|8|||
37956578|NCT00555672|69643759|FG001|Overall Study|Adverse Event|2|||
37956579|NCT00555672|69643758|FG000|Overall Study|Objective progression or relapse|11|||
37956580|NCT00555672|69643759|FG001|Overall Study|Objective progression or relapse|5|||
37956581|NCT00555672|69643758|FG000|Overall Study|Other|3|||
37956582|NCT00555672|69643759|FG001|Overall Study|Other|1|||
37956583|NCT00555672|69643758|FG000|Overall Study|Participant refused|2|||
37956584|NCT00555672|69643759|FG001|Overall Study|Participant refused|0|||
37956585|NCT03958656|69643769|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
37956586|NCT03958656|69643770|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
37956587|NCT03958656|69643771|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
37956588|NCT03958656|69643772|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
37956589|NCT03958656|69643769|FG000|Overall Study|No longer meets eligibility criteria|0|||
37956590|NCT03958656|69643770|FG001|Overall Study|No longer meets eligibility criteria|0|||
37956591|NCT03958656|69643771|FG002|Overall Study|No longer meets eligibility criteria|1|||
37956592|NCT03958656|69643772|FG003|Overall Study|No longer meets eligibility criteria|0|||
37956593|NCT03958656|69643769|FG000|Overall Study|Started anti-cancer treatment|0|||
37956594|NCT03958656|69643770|FG001|Overall Study|Started anti-cancer treatment|0|||
37956595|NCT03958656|69643771|FG002|Overall Study|Started anti-cancer treatment|1|||
37956596|NCT03958656|69643772|FG003|Overall Study|Started anti-cancer treatment|0|||
37956597|NCT00561912|69643782|FG000|Overall Study|ineligible|1|||
37956598|NCT00561678|69643788|FG000|Overall Study|Withdrawal by Subject|4|||
37956599|NCT00561678|69643789|FG001|Overall Study|Withdrawal by Subject|3|||
37956600|NCT00561678|69643788|FG000|Overall Study|surgery cancelled|1|||
37956601|NCT00561678|69643789|FG001|Overall Study|surgery cancelled|1|||
37956602|NCT00561678|69643788|FG000|Overall Study|surgery rescheduled to different site|2|||
37956603|NCT00561678|69643789|FG001|Overall Study|surgery rescheduled to different site|2|||
37956604|NCT00561678|69643788|FG000|Overall Study|anesthesia provider refusal|1|||
37956605|NCT00561678|69643789|FG001|Overall Study|anesthesia provider refusal|0|||
37956606|NCT00463684|69643795|FG000|Overall Study|Withdrawal by Subject|1|||
37956607|NCT00463684|69643795|FG000|Overall Study|Lost to Follow-up|3|||
38050994|NCT01988571|69740009|FG001|Overall Study|Death|1|||
37956608|NCT00463606|69643802|FG000|Overall Study|Adverse Event|21|||
37956609|NCT00463606|69643803|FG001|Overall Study|Adverse Event|18|||
37956610|NCT00463606|69643804|FG002|Overall Study|Adverse Event|11|||
37956611|NCT00463606|69643802|FG000|Overall Study|Withdrawal by Subject|11|||
37956612|NCT00463606|69643803|FG001|Overall Study|Withdrawal by Subject|11|||
37956613|NCT00463606|69643804|FG002|Overall Study|Withdrawal by Subject|5|||
37956614|NCT00463606|69643802|FG000|Overall Study|Lost to Follow-up|2|||
37956615|NCT00463606|69643803|FG001|Overall Study|Lost to Follow-up|2|||
37956616|NCT00463606|69643804|FG002|Overall Study|Lost to Follow-up|3|||
37956617|NCT00463606|69643802|FG000|Overall Study|Subject noncompliance|1|||
37956618|NCT00463606|69643803|FG001|Overall Study|Subject noncompliance|1|||
37956619|NCT00463606|69643804|FG002|Overall Study|Subject noncompliance|0|||
38050995|NCT01988571|69740008|FG000|Overall Study|Physician Decision|2|||
37956620|NCT00463606|69643802|FG000|Overall Study|Subject moved out of town|1|||
38050996|NCT01988571|69740009|FG001|Overall Study|Physician Decision|1|||
38050997|NCT01988571|69740008|FG000|Overall Study|Lost to Follow-up|3|||
38050998|NCT01988571|69740009|FG001|Overall Study|Lost to Follow-up|0|||
37956621|NCT00463606|69643803|FG001|Overall Study|Subject moved out of town|0|||
37956622|NCT00463606|69643804|FG002|Overall Study|Subject moved out of town|0|||
37956623|NCT00463606|69643802|FG000|Overall Study|Physician Decision|0|||
37956624|NCT00463606|69643803|FG001|Overall Study|Physician Decision|1|||
37956625|NCT00463606|69643804|FG002|Overall Study|Physician Decision|0|||
37956626|NCT00463606|69643802|FG000|Overall Study|Sponsor request|0|||
37956627|NCT00463606|69643803|FG001|Overall Study|Sponsor request|1|||
37956628|NCT00463606|69643804|FG002|Overall Study|Sponsor request|0|||
37956629|NCT00463606|69643802|FG000|Overall Study|Exclusion criteria violation|2|||
37956630|NCT00463606|69643803|FG001|Overall Study|Exclusion criteria violation|0|||
37956631|NCT00463606|69643804|FG002|Overall Study|Exclusion criteria violation|0|||
37956632|NCT00463606|69643802|FG000|Overall Study|Coordinator error|1|||
37956633|NCT00463606|69643803|FG001|Overall Study|Coordinator error|0|||
37956634|NCT00463606|69643804|FG002|Overall Study|Coordinator error|0|||
37956635|NCT00463606|69643802|FG000|Overall Study|Patient randomized in error|1|||
37956636|NCT00463606|69643803|FG001|Overall Study|Patient randomized in error|0|||
37956637|NCT00463606|69643804|FG002|Overall Study|Patient randomized in error|0|||
37956638|NCT00463606|69643802|FG000|Overall Study|Participation in another ABT-335 trial|1|||
37956639|NCT00463606|69643803|FG001|Overall Study|Participation in another ABT-335 trial|0|||
37956640|NCT00463606|69643804|FG002|Overall Study|Participation in another ABT-335 trial|0|||
37956641|NCT00463606|69643802|FG000|Overall Study|Protocol Violation|0|||
37956642|NCT00463606|69643803|FG001|Overall Study|Protocol Violation|0|||
37956643|NCT00463606|69643804|FG002|Overall Study|Protocol Violation|1|||
37956644|NCT03961308|69643814|FG000|Overall Study|Withdrawal by Subject|1|||
37956645|NCT03961308|69643815|FG001|Overall Study|Withdrawal by Subject|0|||
37956646|NCT03961308|69643814|FG000|Overall Study|Other|1|||
37956647|NCT03961308|69643815|FG001|Overall Study|Other|0|||
37956648|NCT03961308|69643814|FG000|Overall Study|Lost to Follow-up|0|||
37956649|NCT03961308|69643815|FG001|Overall Study|Lost to Follow-up|1|||
37956650|NCT03961308|69643814|FG000|Overall Study|Adverse Event|0|||
37956651|NCT03961308|69643815|FG001|Overall Study|Adverse Event|1|||
37956652|NCT00174187|69643823|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
37956653|NCT00174187|69643824|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
37956654|NCT00174187|69643825|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
37956655|NCT00174187|69643823|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
37956656|NCT00174187|69643824|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
37956657|NCT00174187|69643825|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
37956658|NCT00174187|69643823|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
37956659|NCT00174187|69643824|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
37956660|NCT00174187|69643825|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
37956661|NCT00174187|69643823|FG000|Period 1 (up to 3 Years)|Other|0|||
37956662|NCT00174187|69643824|FG001|Period 1 (up to 3 Years)|Other|1|||
37956663|NCT00174187|69643825|FG002|Period 1 (up to 3 Years)|Other|0|||
37956664|NCT00174187|69643823|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
37956665|NCT00174187|69643824|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
37956666|NCT00174187|69643825|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
37956667|NCT00174187|69643823|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
37956668|NCT00174187|69643824|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
37956669|NCT00174187|69643825|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
37956670|NCT00174187|69643823|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
37956671|NCT00174187|69643824|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
37956672|NCT00174187|69643825|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
37956673|NCT00174187|69643823|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
37956674|NCT00174187|69643824|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
37956675|NCT00174187|69643825|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
37956676|NCT00174187|69643823|FG000|Period 2 (After 3 Years)|Other|0|||
37956677|NCT00174187|69643824|FG001|Period 2 (After 3 Years)|Other|0|||
37956678|NCT00174187|69643825|FG002|Period 2 (After 3 Years)|Other|5|||
37956679|NCT01011335|69643837|FG000|Overall Study|Lost to Follow-up|0|||
37956680|NCT01011335|69643838|FG001|Overall Study|Lost to Follow-up|0|||
37956681|NCT01011335|69643839|FG002|Overall Study|Lost to Follow-up|1|||
37956682|NCT01011335|69643840|FG003|Overall Study|Lost to Follow-up|1|||
37956683|NCT01011335|69643841|FG004|Overall Study|Lost to Follow-up|1|||
38050999|NCT01988571|69740008|FG000|Overall Study|Withdrawal by Subject|31|||
38051000|NCT01988571|69740009|FG001|Overall Study|Withdrawal by Subject|33|||
37956684|NCT01011335|69643842|FG005|Overall Study|Lost to Follow-up|1|||
37956685|NCT01011335|69643843|FG006|Overall Study|Lost to Follow-up|2|||
37956686|NCT01011335|69643844|FG007|Overall Study|Lost to Follow-up|2|||
37956687|NCT01011335|69643845|FG008|Overall Study|Lost to Follow-up|1|||
37956688|NCT01011335|69643846|FG009|Overall Study|Lost to Follow-up|0|||
37956689|NCT01011335|69643847|FG010|Overall Study|Lost to Follow-up|0|||
37956690|NCT01011335|69643848|FG011|Overall Study|Lost to Follow-up|1|||
37956691|NCT01011335|69643849|FG012|Overall Study|Lost to Follow-up|2|||
37956692|NCT01011335|69643837|FG000|Overall Study|Protocol Violation|0|||
37956693|NCT01011335|69643838|FG001|Overall Study|Protocol Violation|1|||
37956694|NCT01011335|69643839|FG002|Overall Study|Protocol Violation|0|||
37956695|NCT01011335|69643840|FG003|Overall Study|Protocol Violation|0|||
37956696|NCT01011335|69643841|FG004|Overall Study|Protocol Violation|0|||
37956697|NCT01011335|69643842|FG005|Overall Study|Protocol Violation|0|||
37956698|NCT01011335|69643843|FG006|Overall Study|Protocol Violation|0|||
37956699|NCT01011335|69643844|FG007|Overall Study|Protocol Violation|0|||
37956700|NCT01011335|69643845|FG008|Overall Study|Protocol Violation|0|||
37956701|NCT01011335|69643846|FG009|Overall Study|Protocol Violation|0|||
37956702|NCT01011335|69643847|FG010|Overall Study|Protocol Violation|0|||
37956703|NCT01011335|69643848|FG011|Overall Study|Protocol Violation|0|||
37956704|NCT01011335|69643849|FG012|Overall Study|Protocol Violation|0|||
37956705|NCT01011335|69643837|FG000|Overall Study|Moved/deployed or no booster|1|||
37956706|NCT01011335|69643838|FG001|Overall Study|Moved/deployed or no booster|0|||
37956707|NCT01011335|69643839|FG002|Overall Study|Moved/deployed or no booster|0|||
37956708|NCT01011335|69643840|FG003|Overall Study|Moved/deployed or no booster|1|||
37956709|NCT01011335|69643841|FG004|Overall Study|Moved/deployed or no booster|0|||
37956710|NCT01011335|69643842|FG005|Overall Study|Moved/deployed or no booster|0|||
37956711|NCT01011335|69643843|FG006|Overall Study|Moved/deployed or no booster|1|||
37861970|NCT01136733|69545747|FG005|Phase 1b|Adverse Event|0|||
37861971|NCT01136733|69545748|FG006|Phase 1b|Adverse Event|0|||
37861972|NCT01136733|69545742|FG000|Phase 1b|Participant Choice|0|||
37861973|NCT01136733|69545743|FG001|Phase 1b|Participant Choice|0|||
37956712|NCT01011335|69643844|FG007|Overall Study|Moved/deployed or no booster|0|||
37956713|NCT01011335|69643845|FG008|Overall Study|Moved/deployed or no booster|1|||
37956714|NCT01011335|69643846|FG009|Overall Study|Moved/deployed or no booster|0|||
37956715|NCT01011335|69643847|FG010|Overall Study|Moved/deployed or no booster|2|||
37956716|NCT01011335|69643848|FG011|Overall Study|Moved/deployed or no booster|0|||
37956717|NCT01011335|69643849|FG012|Overall Study|Moved/deployed or no booster|0|||
37956718|NCT01011335|69643837|FG000|Overall Study|Adverse Event|0|||
37956719|NCT01011335|69643838|FG001|Overall Study|Adverse Event|0|||
37956720|NCT01011335|69643839|FG002|Overall Study|Adverse Event|0|||
37956721|NCT01011335|69643840|FG003|Overall Study|Adverse Event|0|||
37956722|NCT01011335|69643841|FG004|Overall Study|Adverse Event|0|||
37956723|NCT01011335|69643842|FG005|Overall Study|Adverse Event|0|||
37956724|NCT01011335|69643843|FG006|Overall Study|Adverse Event|0|||
37956725|NCT01011335|69643844|FG007|Overall Study|Adverse Event|0|||
37956726|NCT01011335|69643845|FG008|Overall Study|Adverse Event|0|||
37956727|NCT01011335|69643846|FG009|Overall Study|Adverse Event|0|||
37956728|NCT01011335|69643847|FG010|Overall Study|Adverse Event|4|||
37956729|NCT01011335|69643848|FG011|Overall Study|Adverse Event|0|||
37956730|NCT01011335|69643849|FG012|Overall Study|Adverse Event|1|||
37956731|NCT00467896|69643886|FG000|Overall Study|Consent Withdrawal|18|||
37956732|NCT00467896|69643886|FG000|Overall Study|Adverse Event|7|||
37956733|NCT00467896|69643886|FG000|Overall Study|Serious Adverse Event|13|||
37956734|NCT00467896|69643886|FG000|Overall Study|Non-compliance|3|||
37956735|NCT00467896|69643886|FG000|Overall Study|Changed therapy|2|||
37956736|NCT00467896|69643886|FG000|Overall Study|Patient received transplant|2|||
37956737|NCT00467896|69643886|FG000|Overall Study|Patient had atrial septostomy|1|||
37956738|NCT00467896|69643886|FG000|Overall Study|Patient weaned off iloprost|1|||
37956739|NCT00467896|69643886|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
37956740|NCT00467896|69643886|FG000|Overall Study|Started intravenous prostacyclin|1|||
37956741|NCT00467896|69643886|FG000|Overall Study|Started inhaled Remodulin|1|||
37956742|NCT00467896|69643886|FG000|Overall Study|Patient had no improvement|1|||
37956743|NCT00579059|69643894|FG000|Overall Study|Study Canceled at 1 Year|21|||
37956744|NCT00579059|69643895|FG001|Overall Study|Study Canceled at 1 Year|10|||
37956745|NCT00467818|69643903|FG000|Overall Study|Adverse Event|1|||
37956746|NCT00467818|69643904|FG001|Overall Study|Adverse Event|0|||
37956747|NCT00467818|69643903|FG000|Overall Study|Lost to Follow-up|2|||
37956748|NCT00467818|69643904|FG001|Overall Study|Lost to Follow-up|2|||
37956749|NCT00467740|69643917|FG000|Overall Study|Adverse Event|0|||
37956750|NCT00467740|69643918|FG001|Overall Study|Adverse Event|0|||
37956751|NCT00467740|69643919|FG002|Overall Study|Adverse Event|1|||
37956752|NCT00467740|69643920|FG003|Overall Study|Adverse Event|0|||
37956753|NCT00467740|69643921|FG004|Overall Study|Adverse Event|0|||
37956754|NCT00467740|69643917|FG000|Overall Study|Protocol Violation|0|||
37956755|NCT00467740|69643918|FG001|Overall Study|Protocol Violation|0|||
37956756|NCT00467740|69643919|FG002|Overall Study|Protocol Violation|1|||
37956757|NCT00467740|69643920|FG003|Overall Study|Protocol Violation|0|||
37956758|NCT00467740|69643921|FG004|Overall Study|Protocol Violation|0|||
37956759|NCT00467740|69643917|FG000|Overall Study|Lost to Follow-up|0|||
37956760|NCT00467740|69643918|FG001|Overall Study|Lost to Follow-up|1|||
37956761|NCT00467740|69643919|FG002|Overall Study|Lost to Follow-up|0|||
37956762|NCT00467740|69643920|FG003|Overall Study|Lost to Follow-up|0|||
37861974|NCT01136733|69545744|FG002|Phase 1b|Participant Choice|1|||
37861975|NCT01136733|69545745|FG003|Phase 1b|Participant Choice|0|||
37861976|NCT01136733|69545746|FG004|Phase 1b|Participant Choice|0|||
37956763|NCT00467740|69643921|FG004|Overall Study|Lost to Follow-up|0|||
37956764|NCT00467740|69643917|FG000|Overall Study|Withdrawal by Subject|1|||
37956765|NCT00467740|69643918|FG001|Overall Study|Withdrawal by Subject|1|||
37956766|NCT00467740|69643919|FG002|Overall Study|Withdrawal by Subject|0|||
37956767|NCT00467740|69643920|FG003|Overall Study|Withdrawal by Subject|1|||
37956768|NCT00467740|69643921|FG004|Overall Study|Withdrawal by Subject|0|||
37956769|NCT00467740|69643917|FG000|Overall Study|Lack of Efficacy|0|||
37956770|NCT00467740|69643918|FG001|Overall Study|Lack of Efficacy|1|||
37956771|NCT00467740|69643919|FG002|Overall Study|Lack of Efficacy|0|||
37956772|NCT00467740|69643920|FG003|Overall Study|Lack of Efficacy|0|||
37956773|NCT00467740|69643921|FG004|Overall Study|Lack of Efficacy|0|||
37956774|NCT00553254|69643935|FG000|Overall Study|Death|3|||
37956775|NCT00553254|69643936|FG001|Overall Study|Death|6|||
37956776|NCT00553254|69643937|FG002|Overall Study|Death|25|||
37956777|NCT00553254|69643935|FG000|Overall Study|Lost to Follow-up|0|||
37956778|NCT00553254|69643936|FG001|Overall Study|Lost to Follow-up|0|||
37956779|NCT00553254|69643937|FG002|Overall Study|Lost to Follow-up|2|||
37956780|NCT00553254|69643935|FG000|Overall Study|Withdrawal by Subject|2|||
37956781|NCT00553254|69643936|FG001|Overall Study|Withdrawal by Subject|0|||
37956782|NCT00553254|69643937|FG002|Overall Study|Withdrawal by Subject|2|||
37956783|NCT00553254|69643935|FG000|Overall Study|Study terminated by Sponsor|0|||
37956784|NCT00553254|69643936|FG001|Overall Study|Study terminated by Sponsor|0|||
37956785|NCT00553254|69643937|FG002|Overall Study|Study terminated by Sponsor|1|||
37956786|NCT00553254|69643935|FG000|Overall Study|Other|1|||
37956787|NCT00553254|69643936|FG001|Overall Study|Other|0|||
37956788|NCT00553254|69643937|FG002|Overall Study|Other|13|||
37956789|NCT00168805|69643952|FG000|Overall Study|Adverse Event|7|||
37956790|NCT00168805|69643953|FG001|Overall Study|Adverse Event|11|||
37956791|NCT00168805|69643954|FG002|Overall Study|Adverse Event|16|||
37956792|NCT00168805|69643952|FG000|Overall Study|Protocol Violation|12|||
37956793|NCT00168805|69643953|FG001|Overall Study|Protocol Violation|11|||
37956794|NCT00168805|69643954|FG002|Overall Study|Protocol Violation|8|||
37956795|NCT00168805|69643952|FG000|Overall Study|Lost to Follow-up|12|||
37956796|NCT00168805|69643953|FG001|Overall Study|Lost to Follow-up|17|||
37956797|NCT00168805|69643954|FG002|Overall Study|Lost to Follow-up|11|||
37956798|NCT00168805|69643952|FG000|Overall Study|Withdrawal by Subject|16|||
37956799|NCT00168805|69643953|FG001|Overall Study|Withdrawal by Subject|18|||
37956800|NCT00168805|69643954|FG002|Overall Study|Withdrawal by Subject|21|||
37956801|NCT00168805|69643952|FG000|Overall Study|Other|24|||
37956802|NCT00168805|69643953|FG001|Overall Study|Other|21|||
37956803|NCT00168805|69643954|FG002|Overall Study|Other|22|||
37956804|NCT00168805|69643952|FG000|Treatment|Adverse Event|25|||
37956805|NCT00168805|69643953|FG001|Treatment|Adverse Event|26|||
37956806|NCT00168805|69643954|FG002|Treatment|Adverse Event|32|||
37956807|NCT00168805|69643952|FG000|Treatment|Protocol Violation|3|||
37956808|NCT00168805|69643953|FG001|Treatment|Protocol Violation|5|||
37956809|NCT00168805|69643954|FG002|Treatment|Protocol Violation|5|||
37956810|NCT00168805|69643952|FG000|Treatment|Withdrawal by Subject|3|||
37956811|NCT00168805|69643953|FG001|Treatment|Withdrawal by Subject|7|||
37956812|NCT00168805|69643954|FG002|Treatment|Withdrawal by Subject|8|||
37956813|NCT00168805|69643952|FG000|Treatment|Other|18|||
37956814|NCT00168805|69643953|FG001|Treatment|Other|18|||
37956815|NCT00168805|69643954|FG002|Treatment|Other|17|||
37956816|NCT00467584|69643965|FG000|Overall Study|Withdrawal by Subject|4|||
37956817|NCT00467584|69643966|FG001|Overall Study|Withdrawal by Subject|5|||
37956818|NCT00467584|69643967|FG002|Overall Study|Withdrawal by Subject|1|||
37956819|NCT03839212|69643975|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
37956820|NCT00168103|69643982|FG000|Overall Study|Withdrawal by Subject|1|||
37956821|NCT00168103|69643983|FG001|Overall Study|Withdrawal by Subject|2|||
37956822|NCT00168103|69643984|FG002|Overall Study|Withdrawal by Subject|1|||
37956823|NCT00168103|69643985|FG003|Overall Study|Withdrawal by Subject|0|||
37956824|NCT00168103|69643982|FG000|Overall Study|Lost to Follow-up|1|||
37956825|NCT00168103|69643983|FG001|Overall Study|Lost to Follow-up|3|||
37956826|NCT00168103|69643984|FG002|Overall Study|Lost to Follow-up|0|||
37956827|NCT00168103|69643985|FG003|Overall Study|Lost to Follow-up|0|||
37956828|NCT00463060|69643995|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
37956829|NCT00463060|69643995|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
37956830|NCT00462982|69644004|FG000|Overall Study|Adverse Event|1|||
37956831|NCT00462982|69644004|FG000|Overall Study|Patient Not Treated|2|||
37956832|NCT00462904|69644025|FG000|Overall Study|Lost to Follow-up|1|||
37956833|NCT00467272|69644029|FG000|Overall Study|Pneumonia|2|||
37956834|NCT00467272|69644029|FG000|Overall Study|Thrombophlebitis|1|||
37956835|NCT00462826|69644033|FG000|Overall Study|Ineligible - second primary|1|||
37956836|NCT00462826|69644033|FG000|Overall Study|Ineligible - wrong cell type|1|||
37956837|NCT00462826|69644033|FG000|Overall Study|Ineligible - wrong primary|2|||
37956838|NCT00462826|69644033|FG000|Overall Study|Never treated|1|||
37956839|NCT00551616|69644045|FG000|Overall Study|Lost to Follow-up|48|||
37956840|NCT00551616|69644046|FG001|Overall Study|Lost to Follow-up|40|||
37956841|NCT00452530|69644054|FG000|Overall Study|Death|1|||
37956842|NCT00452530|69644055|FG001|Overall Study|Death|0|||
37956843|NCT00452530|69644054|FG000|Overall Study|Adverse Event|40|||
37956844|NCT00452530|69644055|FG001|Overall Study|Adverse Event|44|||
37956845|NCT00452530|69644054|FG000|Overall Study|Withdrawal by Subject|68|||
37956846|NCT00452530|69644055|FG001|Overall Study|Withdrawal by Subject|57|||
37956847|NCT00452530|69644054|FG000|Overall Study|Lost to Follow-up|1|||
37956848|NCT00452530|69644055|FG001|Overall Study|Lost to Follow-up|0|||
37956849|NCT00452530|69644054|FG000|Overall Study|Poor compliance/noncompliance|1|||
37956850|NCT00452530|69644055|FG001|Overall Study|Poor compliance/noncompliance|2|||
37956851|NCT00452530|69644054|FG000|Overall Study|No longer met study criteria|18|||
37956852|NCT00452530|69644055|FG001|Overall Study|No longer met study criteria|22|||
37956853|NCT00452530|69644054|FG000|Overall Study|Other|7|||
37956854|NCT00452530|69644055|FG001|Overall Study|Other|11|||
37956855|NCT00549198|69644067|FG000|Overall Study|Adverse Event|28|||
37956856|NCT00549198|69644068|FG001|Overall Study|Adverse Event|26|||
37956857|NCT00549198|69644067|FG000|Overall Study|Insufficient Viral Load Response|4|||
37956858|NCT00549198|69644068|FG001|Overall Study|Insufficient Viral Load Response|2|||
37956859|NCT00549198|69644067|FG000|Overall Study|Protocol-defined Virological Failure|7|||
37956860|NCT00549198|69644068|FG001|Overall Study|Protocol-defined Virological Failure|0|||
37956861|NCT00549198|69644067|FG000|Overall Study|Non-compliance|2|||
37956862|NCT00549198|69644068|FG001|Overall Study|Non-compliance|4|||
37956863|NCT00549198|69644067|FG000|Overall Study|Lost to Follow-up|7|||
37956864|NCT00549198|69644068|FG001|Overall Study|Lost to Follow-up|8|||
37956865|NCT00549198|69644067|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
37956866|NCT00549198|69644068|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
37956867|NCT00549198|69644067|FG000|Overall Study|Protocol Violation|7|||
37956868|NCT00549198|69644068|FG001|Overall Study|Protocol Violation|2|||
37956869|NCT00549198|69644067|FG000|Overall Study|Investigator Decision|4|||
37956870|NCT00549198|69644068|FG001|Overall Study|Investigator Decision|3|||
37956871|NCT00549198|69644067|FG000|Overall Study|Withdrawal by Subject|7|||
37956872|NCT00549198|69644068|FG001|Overall Study|Withdrawal by Subject|7|||
37956873|NCT00549198|69644067|FG000|Overall Study|Disease Progression|1|||
37956874|NCT00549198|69644068|FG001|Overall Study|Disease Progression|0|||
37956875|NCT00549198|69644067|FG000|Overall Study|Participant Moved|2|||
37956876|NCT00549198|69644068|FG001|Overall Study|Participant Moved|0|||
37956877|NCT00549198|69644067|FG000|Overall Study|Participant not able to perform Week 96|1|||
37956878|NCT00549198|69644068|FG001|Overall Study|Participant not able to perform Week 96|0|||
37956879|NCT00549198|69644067|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
37956880|NCT00549198|69644068|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
37956881|NCT00549198|69644067|FG000|Overall Study|Prohibited Medication|1|||
37956882|NCT00549198|69644068|FG001|Overall Study|Prohibited Medication|2|||
37956883|NCT00549198|69644067|FG000|Overall Study|Participant planning pregnancy|1|||
37956884|NCT00549198|69644068|FG001|Overall Study|Participant planning pregnancy|0|||
37956885|NCT00549198|69644067|FG000|Overall Study|Participant overweight, no scan possible|1|||
37956886|NCT00549198|69644068|FG001|Overall Study|Participant overweight, no scan possible|0|||
37956887|NCT00549198|69644067|FG000|Overall Study|No scan facilities|0|||
37956888|NCT00549198|69644068|FG001|Overall Study|No scan facilities|2|||
37956889|NCT00549198|69644067|FG000|Overall Study|Pregnancy|0|||
37956890|NCT00549198|69644068|FG001|Overall Study|Pregnancy|3|||
37956891|NCT00549198|69644067|FG000|Overall Study|Not Exposed to Study Drug|3|||
37956892|NCT00549198|69644068|FG001|Overall Study|Not Exposed to Study Drug|4|||
37956893|NCT00607724|69644081|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
37956894|NCT00607724|69644082|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
37956895|NCT00607724|69644083|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
37956896|NCT00607724|69644084|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
37956897|NCT00607724|69644085|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
37956898|NCT00607724|69644086|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
37956899|NCT00607724|69644087|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
37956900|NCT00607724|69644081|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
37956901|NCT00607724|69644082|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
37956902|NCT00607724|69644083|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
37956903|NCT00607724|69644084|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
37956904|NCT00607724|69644085|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
37956905|NCT00607724|69644086|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
37956906|NCT00607724|69644087|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
37956907|NCT00607724|69644081|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
37956908|NCT00607724|69644082|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
37956909|NCT00607724|69644083|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
37956910|NCT00607724|69644084|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
37956911|NCT00607724|69644085|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
37956912|NCT00607724|69644086|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
37956913|NCT00607724|69644087|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
37956914|NCT00607724|69644081|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
37956915|NCT00607724|69644082|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
37956916|NCT00607724|69644083|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
37956917|NCT00607724|69644084|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
37956918|NCT00607724|69644085|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
37956919|NCT00607724|69644086|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
37956920|NCT00607724|69644087|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
37956921|NCT00607724|69644081|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
37956922|NCT00607724|69644082|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
37956923|NCT00607724|69644083|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
37956924|NCT00607724|69644084|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
37956925|NCT00607724|69644085|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
37956926|NCT00607724|69644086|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
37956927|NCT00607724|69644087|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
37956928|NCT00506415|69644111|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
37956929|NCT00506415|69644112|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
37956930|NCT00506415|69644113|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
37956931|NCT00506415|69644114|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
37956932|NCT00506415|69644111|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
37956933|NCT00506415|69644112|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
37956934|NCT00506415|69644113|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
37956935|NCT00506415|69644114|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
37956936|NCT00506415|69644111|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
37956937|NCT00506415|69644112|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
37956938|NCT00506415|69644113|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
37956939|NCT00506415|69644114|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
37956940|NCT00506415|69644111|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
37956941|NCT00506415|69644112|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
37956942|NCT00506415|69644113|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
37956943|NCT00506415|69644114|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
37956944|NCT00506415|69644111|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
37956945|NCT00506415|69644112|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
37956946|NCT00506415|69644113|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
37956947|NCT00506415|69644114|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
37956948|NCT00506415|69644111|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
37956949|NCT00506415|69644112|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
37956950|NCT00506415|69644113|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
37956951|NCT00506415|69644114|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
37956952|NCT00506415|69644111|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
37956953|NCT00506415|69644112|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
37956954|NCT00506415|69644113|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
37956955|NCT00506415|69644114|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
37956956|NCT00506415|69644111|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
37956957|NCT00506415|69644112|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
37956958|NCT00506415|69644113|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
37956959|NCT00506415|69644114|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
37956960|NCT00506415|69644111|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
37956961|NCT00506415|69644112|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
37956962|NCT00506415|69644113|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
37956963|NCT00506415|69644114|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
37956964|NCT00506415|69644111|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
37956965|NCT00506415|69644112|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
37956966|NCT00506415|69644113|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
37956967|NCT00506415|69644114|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
37956968|NCT00506415|69644111|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
37861977|NCT01136733|69545747|FG005|Phase 1b|Participant Choice|0|||
37861978|NCT01136733|69545748|FG006|Phase 1b|Participant Choice|0|||
37861979|NCT01136733|69545742|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
37861980|NCT01136733|69545743|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
37861981|NCT01136733|69545744|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
37861982|NCT01136733|69545745|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
37861983|NCT01136733|69545746|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
37861984|NCT01136733|69545747|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
37861985|NCT01136733|69545748|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
37861986|NCT01136733|69545742|FG000|Phase 1b|Clinical Progression|1|||
37861987|NCT01136733|69545743|FG001|Phase 1b|Clinical Progression|1|||
37956969|NCT00506415|69644112|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
37956970|NCT00506415|69644113|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
37956971|NCT00506415|69644114|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
37956972|NCT00506415|69644111|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
37956973|NCT00506415|69644112|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
37956974|NCT00506415|69644113|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
37956975|NCT00506415|69644114|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
37956976|NCT00506415|69644111|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
37956977|NCT00506415|69644112|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
37956978|NCT00506415|69644113|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
37956979|NCT00506415|69644114|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
37956980|NCT00506415|69644111|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
37956981|NCT00506415|69644112|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
37956982|NCT00506415|69644113|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
37956983|NCT00506415|69644114|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
37956984|NCT00506415|69644111|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
37956985|NCT00506415|69644112|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
37956986|NCT00506415|69644113|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
37956987|NCT00506415|69644114|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
37956988|NCT00506415|69644111|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
37956989|NCT00506415|69644112|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
37956990|NCT00506415|69644113|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
37956991|NCT00506415|69644114|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
37956992|NCT00506415|69644111|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
37956993|NCT00506415|69644112|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
37956994|NCT00506415|69644113|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
37956995|NCT00506415|69644114|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
37956996|NCT00506415|69644111|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
37956997|NCT00506415|69644112|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
37956998|NCT00506415|69644113|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
37956999|NCT00506415|69644114|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
37957000|NCT00506415|69644111|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
37957001|NCT00506415|69644112|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
37957002|NCT00506415|69644113|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
37957003|NCT00506415|69644114|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
37957004|NCT00506415|69644111|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
37957005|NCT00506415|69644112|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
37957006|NCT00506415|69644113|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
37957007|NCT00506415|69644114|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
37957008|NCT00506415|69644111|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
37957009|NCT00506415|69644112|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
37957010|NCT00506415|69644113|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
37957011|NCT00506415|69644114|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
37957012|NCT00506415|69644111|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
37957013|NCT00506415|69644112|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
37957014|NCT00506415|69644113|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
37957015|NCT00506415|69644114|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
37957016|NCT00506415|69644111|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
37957017|NCT00506415|69644112|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
37957018|NCT00506415|69644113|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
37957019|NCT00506415|69644114|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
37957020|NCT00506415|69644111|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
37957021|NCT00506415|69644112|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
37957022|NCT00506415|69644113|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
37957023|NCT00506415|69644114|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
37957024|NCT00452452|69644130|FG000|Overall Study|Protocol Violation|0|||
37957025|NCT00452452|69644131|FG001|Overall Study|Protocol Violation|0|||
37957026|NCT00452452|69644132|FG002|Overall Study|Protocol Violation|1|||
37957027|NCT00452452|69644130|FG000|Overall Study|Withdrawal by Subject|1|||
37957028|NCT00452452|69644131|FG001|Overall Study|Withdrawal by Subject|0|||
37957029|NCT00452452|69644132|FG002|Overall Study|Withdrawal by Subject|0|||
37957030|NCT00452452|69644130|FG000|Overall Study|Lost to Follow-up|1|||
37957031|NCT00452452|69644131|FG001|Overall Study|Lost to Follow-up|0|||
37957032|NCT00452452|69644132|FG002|Overall Study|Lost to Follow-up|0|||
37957033|NCT00510783|69644148|FG000|Overall Study|Lost to Follow-up|29|||
37957034|NCT00510783|69644149|FG001|Overall Study|Lost to Follow-up|25|||
37957035|NCT00510783|69644148|FG000|Overall Study|Withdrawal by Subject|2|||
37957036|NCT00510783|69644149|FG001|Overall Study|Withdrawal by Subject|3|||
37957037|NCT00510783|69644148|FG000|Overall Study|Protocol Violation|0|||
37957038|NCT00510783|69644149|FG001|Overall Study|Protocol Violation|1|||
37957039|NCT00518973|69644157|FG000|Overall Study|Withdrawal by Subject|3|||
37957040|NCT00518973|69644158|FG001|Overall Study|Withdrawal by Subject|2|||
37957041|NCT00462670|69644166|FG000|Overall Study|Adverse Event|3|||
37957042|NCT00462670|69644167|FG001|Overall Study|Adverse Event|5|||
37957043|NCT00462670|69644166|FG000|Overall Study|Lack of Efficacy|1|||
37957044|NCT00462670|69644167|FG001|Overall Study|Lack of Efficacy|0|||
37957045|NCT00462670|69644166|FG000|Overall Study|Protocol Violation|1|||
38051001|NCT04794751|69740015|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
38051002|NCT04794751|69740016|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
37957046|NCT00462670|69644167|FG001|Overall Study|Protocol Violation|0|||
37957047|NCT00462670|69644166|FG000|Overall Study|Resolution of signs and symptoms|0|||
37957048|NCT00462670|69644167|FG001|Overall Study|Resolution of signs and symptoms|2|||
37957049|NCT00606086|69644175|FG000|Overall Study|Adverse Event|1|||
37957050|NCT00606086|69644176|FG001|Overall Study|Adverse Event|1|||
37957051|NCT00606086|69644175|FG000|Overall Study|Lost to Follow-up|4|||
37957052|NCT00606086|69644176|FG001|Overall Study|Lost to Follow-up|8|||
37957053|NCT00606086|69644175|FG000|Overall Study|Protocol Violation|1|||
37957054|NCT00606086|69644176|FG001|Overall Study|Protocol Violation|0|||
37957055|NCT00606086|69644175|FG000|Overall Study|Withdrawal by Subject|5|||
37957056|NCT00606086|69644176|FG001|Overall Study|Withdrawal by Subject|3|||
37957057|NCT00606086|69644175|FG000|Overall Study|Non-compliance|0|||
37957058|NCT00606086|69644176|FG001|Overall Study|Non-compliance|1|||
37957059|NCT00606086|69644175|FG000|Overall Study|Randomized, not treated|1|||
37957060|NCT00606086|69644176|FG001|Overall Study|Randomized, not treated|2|||
37957061|NCT00609986|69644184|FG000|Overall Study|Did not receive transplant or treatment|8|||
37957062|NCT00609986|69644185|FG001|Overall Study|Did not receive transplant or treatment|3|||
37957063|NCT00451906|69644191|FG000|Overall Study|Adverse Event|515|||
37957064|NCT00451906|69644191|FG000|Overall Study|Lost to Follow-up|31|||
37957065|NCT00451906|69644191|FG000|Overall Study|Withdrawal by Subject|111|||
37957066|NCT00451906|69644191|FG000|Overall Study|Protocol Violation|21|||
37957067|NCT00451906|69644191|FG000|Overall Study|Progressive disease|1328|||
37957068|NCT00451906|69644191|FG000|Overall Study|Termination of the study|108|||
37957069|NCT00451906|69644191|FG000|Overall Study|Other Reasons|121|||
37957070|NCT00451906|69644191|FG000|Overall Study|Did not complete final visit|4|||
37957071|NCT00451282|69644197|FG000|Overall Study|Lost to Follow-up|6|||
37957072|NCT00451282|69644198|FG001|Overall Study|Lost to Follow-up|5|||
37957073|NCT03838198|69644206|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
37957074|NCT03838198|69644207|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
37957075|NCT03838198|69644208|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
37957076|NCT03838198|69644209|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
37957077|NCT03838198|69644206|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
38043593|NCT02603146|69731777|FG000|Overall Study|Withdrawal by Subject|8|||
38043594|NCT02603146|69731778|FG001|Overall Study|Withdrawal by Subject|10|||
38043595|NCT02603146|69731777|FG000|Overall Study|Withdrawn by Investigator or NIAID|15|||
38043596|NCT02603146|69731778|FG001|Overall Study|Withdrawn by Investigator or NIAID|18|||
38043597|NCT02603146|69731777|FG000|Overall Study|Participant moved|2|||
38043598|NCT02603146|69731778|FG001|Overall Study|Participant moved|0|||
38043599|NCT02603146|69731777|FG000|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|1|||
38043600|NCT02603146|69731778|FG001|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|0|||
38043601|NCT02348112|69731786|FG000|Overall Study|Withdrawal by Subject|32|||
38043602|NCT02348112|69731787|FG001|Overall Study|Withdrawal by Subject|29|||
38043603|NCT02348112|69731786|FG000|Overall Study|Lost to Follow-up|24|||
38043604|NCT02348112|69731787|FG001|Overall Study|Lost to Follow-up|20|||
38043605|NCT02348112|69731786|FG000|Overall Study|Physician Decision|17|||
38043606|NCT02348112|69731787|FG001|Overall Study|Physician Decision|15|||
38043607|NCT02348112|69731786|FG000|Overall Study|Site closed due to PI leaving|0|||
38043608|NCT02348112|69731787|FG001|Overall Study|Site closed due to PI leaving|30|||
38043609|NCT02348112|69731786|FG000|Overall Study|Sponsor withdrawal|0|||
38043610|NCT02348112|69731787|FG001|Overall Study|Sponsor withdrawal|7|||
38043611|NCT02348112|69731786|FG000|Overall Study|Death|0|||
38043612|NCT02348112|69731787|FG001|Overall Study|Death|1|||
38043613|NCT02255149|69731793|FG000|Overall Study|Lost to Follow-up|2|||
38043614|NCT02255149|69731793|FG000|Overall Study|Withdrawal by Subject|1|||
38043615|NCT02255149|69731793|FG000|Overall Study|Withdrawal by PI|1|||
38043616|NCT02255149|69731793|FG000|Overall Study|Implant Failure|1|||
38043617|NCT02180867|69731804|FG000|Overall Study|Adverse Event|3|||
38043618|NCT02180867|69731805|FG001|Overall Study|Adverse Event|4|||
38043619|NCT02180867|69731806|FG002|Overall Study|Adverse Event|1|||
38043620|NCT02180867|69731807|FG003|Overall Study|Adverse Event|5|||
38043621|NCT02180867|69731808|FG004|Overall Study|Adverse Event|0|||
38043622|NCT02180867|69731809|FG005|Overall Study|Adverse Event|0|||
38043623|NCT02180867|69731810|FG006|Overall Study|Adverse Event|0|||
38051003|NCT04794751|69740015|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
38051004|NCT04794751|69740016|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
38051005|NCT04794751|69740015|FG000|Period 1|Protocol Violation|0|||
38051006|NCT04794751|69740016|FG001|Period 1|Protocol Violation|2|||
38051007|NCT04794751|69740015|FG000|Period 1|Withdrawal by Subject|0|||
38051008|NCT04794751|69740016|FG001|Period 1|Withdrawal by Subject|1|||
38051009|NCT04794751|69740015|FG000|Period 2|Withdrawal by Subject|0|||
38051010|NCT04794751|69740016|FG001|Period 2|Withdrawal by Subject|1|||
38051011|NCT04794751|69740015|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
38051012|NCT04794751|69740016|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
38051013|NCT04794751|69740015|FG000|Period 2|Protocol Violation|1|||
38051014|NCT04794751|69740016|FG001|Period 2|Protocol Violation|0|||
38051015|NCT04578457|69740022|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
38051016|NCT04578457|69740022|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
38051017|NCT04578457|69740022|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
38051018|NCT04578457|69740022|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
38051019|NCT03334188|69740032|FG000|Overall Study|Withdrawal by Subject|0|||
38051020|NCT03334188|69740033|FG001|Overall Study|Withdrawal by Subject|1|||
38051021|NCT03334188|69740032|FG000|Overall Study|Death|1|||
38051022|NCT03334188|69740033|FG001|Overall Study|Death|0|||
38051023|NCT03334188|69740032|FG000|Overall Study|Never had qualifying clinic visit|7|||
38051024|NCT03334188|69740033|FG001|Overall Study|Never had qualifying clinic visit|7|||
37861988|NCT01136733|69545744|FG002|Phase 1b|Clinical Progression|0|||
37861989|NCT01136733|69545745|FG003|Phase 1b|Clinical Progression|0|||
37861990|NCT01136733|69545746|FG004|Phase 1b|Clinical Progression|0|||
37957078|NCT03838198|69644207|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
37957079|NCT03838198|69644208|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
37957080|NCT03838198|69644209|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
37957081|NCT00115765|69644224|FG000|Overall Study|Withdrawal by Subject|22|||
37957082|NCT00115765|69644225|FG001|Overall Study|Withdrawal by Subject|53|||
37957083|NCT00115765|69644226|FG002|Overall Study|Withdrawal by Subject|76|||
37957084|NCT00115765|69644227|FG003|Overall Study|Withdrawal by Subject|15|||
37957085|NCT00115765|69644224|FG000|Overall Study|Physician Decision|4|||
37957086|NCT00115765|69644225|FG001|Overall Study|Physician Decision|15|||
37957087|NCT00115765|69644226|FG002|Overall Study|Physician Decision|18|||
37957088|NCT00115765|69644227|FG003|Overall Study|Physician Decision|13|||
37957089|NCT00115765|69644224|FG000|Overall Study|Lost to Follow-up|3|||
37957090|NCT00115765|69644225|FG001|Overall Study|Lost to Follow-up|20|||
37957091|NCT00115765|69644226|FG002|Overall Study|Lost to Follow-up|18|||
37957092|NCT00115765|69644227|FG003|Overall Study|Lost to Follow-up|1|||
37957093|NCT00115765|69644224|FG000|Overall Study|Other|6|||
37957094|NCT00115765|69644225|FG001|Overall Study|Other|12|||
37957095|NCT00115765|69644226|FG002|Overall Study|Other|9|||
37957096|NCT00115765|69644227|FG003|Overall Study|Other|2|||
37957097|NCT00606008|69644235|FG000|Overall Study|Adverse Event|1|||
37957098|NCT00606008|69644235|FG000|Overall Study|Withdrawal by Subject|4|||
37957099|NCT00461812|69644247|FG000|Overall Study|study terminated|10|||
37957100|NCT00123955|69644254|FG000|Overall Study|Adverse Event|1|||
37957101|NCT00123955|69644255|FG001|Overall Study|Adverse Event|0|||
37957102|NCT00123955|69644254|FG000|Overall Study|Withdrawal by Subject|4|||
37957103|NCT00123955|69644255|FG001|Overall Study|Withdrawal by Subject|3|||
37957104|NCT00123955|69644254|FG000|Overall Study|Death|0|||
37957105|NCT00123955|69644255|FG001|Overall Study|Death|1|||
37957106|NCT03837028|69644265|FG000|Overall Study|Lost to Follow-up|4|||
37957107|NCT03837028|69644266|FG001|Overall Study|Lost to Follow-up|0|||
37957108|NCT03837028|69644267|FG002|Overall Study|Lost to Follow-up|2|||
37957109|NCT03837028|69644268|FG003|Overall Study|Lost to Follow-up|0|||
37957110|NCT03837028|69644265|FG000|Overall Study|Withdrawal by Subject|12|||
37957111|NCT03837028|69644266|FG001|Overall Study|Withdrawal by Subject|11|||
37957112|NCT03837028|69644267|FG002|Overall Study|Withdrawal by Subject|11|||
37957113|NCT03837028|69644268|FG003|Overall Study|Withdrawal by Subject|7|||
37957114|NCT00115063|69644280|FG000|Overall Study|Lost to Follow-up|98|||
37957115|NCT00115063|69644281|FG001|Overall Study|Lost to Follow-up|104|||
37957116|NCT00115063|69644280|FG000|Overall Study|Death|1|||
37957117|NCT00115063|69644281|FG001|Overall Study|Death|0|||
37957118|NCT00461500|69644289|FG000|Overall Study|Adverse Event|1|||
37957119|NCT00461500|69644290|FG001|Overall Study|Adverse Event|0|||
37957120|NCT00461500|69644289|FG000|Overall Study|Lack of Efficacy|0|||
37957121|NCT00461500|69644290|FG001|Overall Study|Lack of Efficacy|1|||
37957122|NCT00461500|69644289|FG000|Overall Study|Expired Drug Treatment|1|||
37957123|NCT00461500|69644290|FG001|Overall Study|Expired Drug Treatment|1|||
37957124|NCT00461500|69644289|FG000|Overall Study|Study Stopped|1|||
37957125|NCT00461500|69644290|FG001|Overall Study|Study Stopped|2|||
37957126|NCT00461500|69644289|FG000|Overall Study|Drug Treatment Misuse|1|||
38051025|NCT03333876|69740042|FG000|Screening Period|Screen Failure|4|||
38051026|NCT03333876|69740042|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
37957127|NCT00461500|69644290|FG001|Overall Study|Drug Treatment Misuse|0|||
37957128|NCT00461500|69644289|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
37957129|NCT00461500|69644290|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
37957130|NCT00461500|69644289|FG000|Overall Study|Lost to Follow-up|2|||
37957131|NCT00461500|69644290|FG001|Overall Study|Lost to Follow-up|2|||
37957132|NCT00167245|69644298|FG000|Overall Study|Lost to Follow-up|20|||
37957133|NCT00167245|69644299|FG001|Overall Study|Lost to Follow-up|31|||
37957134|NCT00167245|69644298|FG000|Overall Study|Withdrawal by Subject|5|||
37957135|NCT00167245|69644299|FG001|Overall Study|Withdrawal by Subject|8|||
37957136|NCT00167245|69644298|FG000|Overall Study|Incarcerated|3|||
37957137|NCT00167245|69644299|FG001|Overall Study|Incarcerated|2|||
37957138|NCT00167245|69644298|FG000|Overall Study|Drowsy|1|||
37957139|NCT00167245|69644299|FG001|Overall Study|Drowsy|0|||
37957140|NCT00443560|69644310|FG000|Overall Study|No intrathecal dose|58|||
37957141|NCT00443560|69644311|FG001|Overall Study|No intrathecal dose|26|||
37957142|NCT00443560|69644310|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
37957143|NCT00443560|69644311|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
37957144|NCT00451204|69644319|FG000|Overall Study|Adverse Event|4|||
37957145|NCT00451204|69644320|FG001|Overall Study|Adverse Event|6|||
37957146|NCT00451204|69644319|FG000|Overall Study|Lack of Efficacy|4|||
37957147|NCT00451204|69644320|FG001|Overall Study|Lack of Efficacy|4|||
37957148|NCT00451204|69644319|FG000|Overall Study|Lost to Follow-up|4|||
37957149|NCT00451204|69644320|FG001|Overall Study|Lost to Follow-up|4|||
37957150|NCT00451204|69644319|FG000|Overall Study|Protocol Violation|1|||
37957151|NCT00451204|69644320|FG001|Overall Study|Protocol Violation|0|||
37957152|NCT00451204|69644319|FG000|Overall Study|Patient refusal|8|||
37957153|NCT00451204|69644320|FG001|Overall Study|Patient refusal|4|||
37957154|NCT00451204|69644319|FG000|Overall Study|Other|1|||
37957155|NCT00451204|69644320|FG001|Overall Study|Other|2|||
37957156|NCT00605540|69644329|FG000|Overall Study|Death|15|||
37957157|NCT00605540|69644329|FG000|Overall Study|Lost to Follow-up|23|||
37957158|NCT00605306|69644335|FG000|Overall Study|Adverse Event|0|||
37957159|NCT00605306|69644336|FG001|Overall Study|Adverse Event|1|||
37957160|NCT00607022|69644345|FG000|Overall Study|Withdrawal by Subject|1|||
37957161|NCT00607022|69644346|FG001|Overall Study|Withdrawal by Subject|0|||
37957162|NCT00607022|69644347|FG002|Overall Study|Withdrawal by Subject|0|||
37957163|NCT00606632|69644355|FG000|Overall Study|Withdrawal by Subject|13|||
37957164|NCT00606632|69644355|FG000|Overall Study|Miscellaneous reasons|9|||
37957165|NCT00450814|69644374|FG000|Overall Study|Failed to complete the initial therapy|0|||
37957166|NCT00450814|69644375|FG001|Overall Study|Failed to complete the initial therapy|0|||
37957167|NCT00450814|69644376|FG002|Overall Study|Failed to complete the initial therapy|0|||
37957168|NCT00450814|69644377|FG003|Overall Study|Failed to complete the initial therapy|1|||
37957169|NCT00450814|69644378|FG004|Overall Study|Failed to complete the initial therapy|1|||
37957170|NCT00450814|69644379|FG005|Overall Study|Failed to complete the initial therapy|1|||
38051027|NCT03333876|69740042|FG000|Mandibular Advancement|Adverse Event|2|||
38051028|NCT03333876|69740042|FG000|Mandibular Advancement|Product Damage|2|||
38051029|NCT03294681|69740055|FG000|Overall Study|Withdrawal by Subject|1|||
38051030|NCT01140867|69740059|FG000|Overall Study|Adverse Event|22|||
38051031|NCT01140867|69740059|FG000|Overall Study|Lack of Efficacy|3|||
38051032|NCT01140867|69740059|FG000|Overall Study|Lost to Follow-up|2|||
38051033|NCT01140867|69740059|FG000|Overall Study|Withdrawal by Subject|1|||
38051034|NCT01140867|69740059|FG000|Overall Study|Protocol Violation|1|||
38051035|NCT01140867|69740059|FG000|Overall Study|Uncooperative patient|2|||
38051036|NCT01140867|69740059|FG000|Overall Study|Medication Noncompliance|2|||
38051037|NCT04572997|69740063|FG000|Overall Study|Adverse Event|1|||
38051038|NCT02943096|69740073|FG000|Overall Study|Lack of Efficacy|0|||
38051039|NCT02943096|69740074|FG001|Overall Study|Lack of Efficacy|1|||
38051040|NCT04571515|69740085|FG000|Overall Study|Physician Decision|0|||
38051041|NCT04571515|69740086|FG001|Overall Study|Physician Decision|0|||
38051042|NCT04571515|69740087|FG002|Overall Study|Physician Decision|0|||
38051043|NCT04571515|69740088|FG003|Overall Study|Physician Decision|0|||
38051044|NCT04571515|69740089|FG004|Overall Study|Physician Decision|1|||
38051045|NCT04571515|69740085|FG000|Overall Study|Withdrawal by Subject|0|||
38051046|NCT04571515|69740086|FG001|Overall Study|Withdrawal by Subject|0|||
37957171|NCT00450814|69644380|FG006|Overall Study|Failed to complete the initial therapy|0|||
38051047|NCT04571515|69740087|FG002|Overall Study|Withdrawal by Subject|0|||
38051048|NCT04571515|69740088|FG003|Overall Study|Withdrawal by Subject|0|||
38051049|NCT04571515|69740089|FG004|Overall Study|Withdrawal by Subject|1|||
38051050|NCT04571515|69740085|FG000|Overall Study|insufficient pain|1|||
37957172|NCT00450814|69644381|FG007|Overall Study|Failed to complete the initial therapy|0|||
37957173|NCT00450814|69644382|FG008|Overall Study|Failed to complete the initial therapy|0|||
37957174|NCT00450814|69644383|FG009|Overall Study|Failed to complete the initial therapy|0|||
37957175|NCT00450814|69644384|FG010|Overall Study|Failed to complete the initial therapy|0|||
37957176|NCT00450814|69644374|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
38051051|NCT04571515|69740086|FG001|Overall Study|insufficient pain|0|||
38051052|NCT04571515|69740087|FG002|Overall Study|insufficient pain|0|||
37957177|NCT00450814|69644375|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
37957178|NCT00450814|69644376|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
37957179|NCT00450814|69644377|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
37957180|NCT00450814|69644378|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
37957181|NCT00450814|69644379|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
37957182|NCT00450814|69644380|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
37957183|NCT00450814|69644381|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
37957184|NCT00450814|69644382|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
37957185|NCT00450814|69644383|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
37957186|NCT00450814|69644384|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
37957187|NCT00518115|69644419|FG000|Overall Study|Adverse Event|6|||
37957188|NCT00518115|69644420|FG001|Overall Study|Adverse Event|1|||
37957189|NCT00518115|69644421|FG002|Overall Study|Adverse Event|5|||
37957190|NCT00518115|69644422|FG003|Overall Study|Adverse Event|6|||
37957191|NCT00518115|69644423|FG004|Overall Study|Adverse Event|5|||
37957192|NCT00518115|69644424|FG005|Overall Study|Adverse Event|5|||
37957193|NCT00518115|69644425|FG006|Overall Study|Adverse Event|5|||
37957194|NCT00518115|69644426|FG007|Overall Study|Adverse Event|10|||
37957195|NCT00518115|69644427|FG008|Overall Study|Adverse Event|2|||
37957196|NCT00518115|69644428|FG009|Overall Study|Adverse Event|9|||
37957197|NCT00518115|69644419|FG000|Overall Study|Lost to Follow-up|0|||
37957198|NCT00518115|69644420|FG001|Overall Study|Lost to Follow-up|0|||
37957199|NCT00518115|69644421|FG002|Overall Study|Lost to Follow-up|2|||
37957200|NCT00518115|69644422|FG003|Overall Study|Lost to Follow-up|3|||
37957201|NCT00518115|69644423|FG004|Overall Study|Lost to Follow-up|1|||
37957202|NCT00518115|69644424|FG005|Overall Study|Lost to Follow-up|3|||
37957203|NCT00518115|69644425|FG006|Overall Study|Lost to Follow-up|0|||
37957204|NCT00518115|69644426|FG007|Overall Study|Lost to Follow-up|1|||
37957205|NCT00518115|69644427|FG008|Overall Study|Lost to Follow-up|1|||
37957206|NCT00518115|69644428|FG009|Overall Study|Lost to Follow-up|1|||
37957207|NCT00518115|69644419|FG000|Overall Study|Protocol Violation|1|||
37957208|NCT00518115|69644420|FG001|Overall Study|Protocol Violation|3|||
37957209|NCT00518115|69644421|FG002|Overall Study|Protocol Violation|1|||
37957210|NCT00518115|69644422|FG003|Overall Study|Protocol Violation|0|||
37957211|NCT00518115|69644423|FG004|Overall Study|Protocol Violation|0|||
37957212|NCT00518115|69644424|FG005|Overall Study|Protocol Violation|0|||
37957213|NCT00518115|69644425|FG006|Overall Study|Protocol Violation|0|||
37957214|NCT00518115|69644426|FG007|Overall Study|Protocol Violation|0|||
37957215|NCT00518115|69644427|FG008|Overall Study|Protocol Violation|0|||
37957216|NCT00518115|69644428|FG009|Overall Study|Protocol Violation|0|||
37861991|NCT01136733|69545747|FG005|Phase 1b|Clinical Progression|0|||
37861992|NCT01136733|69545748|FG006|Phase 1b|Clinical Progression|0|||
37861993|NCT01136733|69545742|FG000|Phase 2|Disease Progression|0|||
37861994|NCT01136733|69545743|FG001|Phase 2|Disease Progression|0|||
37861995|NCT01136733|69545744|FG002|Phase 2|Disease Progression|0|||
37957217|NCT00518115|69644419|FG000|Overall Study|Withdrawal by Subject|1|||
37957218|NCT00518115|69644420|FG001|Overall Study|Withdrawal by Subject|1|||
37957219|NCT00518115|69644421|FG002|Overall Study|Withdrawal by Subject|5|||
37957220|NCT00518115|69644422|FG003|Overall Study|Withdrawal by Subject|0|||
37957221|NCT00518115|69644423|FG004|Overall Study|Withdrawal by Subject|2|||
37957222|NCT00518115|69644424|FG005|Overall Study|Withdrawal by Subject|1|||
37957223|NCT00518115|69644425|FG006|Overall Study|Withdrawal by Subject|0|||
37957224|NCT00518115|69644426|FG007|Overall Study|Withdrawal by Subject|2|||
37957225|NCT00518115|69644427|FG008|Overall Study|Withdrawal by Subject|1|||
37957226|NCT00518115|69644428|FG009|Overall Study|Withdrawal by Subject|3|||
37957227|NCT00518115|69644419|FG000|Overall Study|Lack of Efficacy|1|||
37957228|NCT00518115|69644420|FG001|Overall Study|Lack of Efficacy|0|||
37957229|NCT00518115|69644421|FG002|Overall Study|Lack of Efficacy|1|||
37957230|NCT00518115|69644422|FG003|Overall Study|Lack of Efficacy|1|||
37957231|NCT00518115|69644423|FG004|Overall Study|Lack of Efficacy|0|||
38051053|NCT04571515|69740088|FG003|Overall Study|insufficient pain|0|||
38051054|NCT04571515|69740089|FG004|Overall Study|insufficient pain|1|||
38051055|NCT03292653|69740104|FG000|Overall Study|Adverse Event|0|||
38051056|NCT03292653|69740105|FG001|Overall Study|Adverse Event|0|||
37957232|NCT00518115|69644424|FG005|Overall Study|Lack of Efficacy|0|||
37957233|NCT00518115|69644425|FG006|Overall Study|Lack of Efficacy|0|||
37957234|NCT00518115|69644426|FG007|Overall Study|Lack of Efficacy|1|||
37957235|NCT00518115|69644427|FG008|Overall Study|Lack of Efficacy|0|||
37957236|NCT00518115|69644428|FG009|Overall Study|Lack of Efficacy|0|||
37957237|NCT00518115|69644419|FG000|Overall Study|Non-Compliance|1|||
37957238|NCT00518115|69644420|FG001|Overall Study|Non-Compliance|0|||
37957239|NCT00518115|69644421|FG002|Overall Study|Non-Compliance|1|||
37957240|NCT00518115|69644422|FG003|Overall Study|Non-Compliance|0|||
37957241|NCT00518115|69644423|FG004|Overall Study|Non-Compliance|1|||
37957242|NCT00518115|69644424|FG005|Overall Study|Non-Compliance|1|||
37957243|NCT00518115|69644425|FG006|Overall Study|Non-Compliance|1|||
37957244|NCT00518115|69644426|FG007|Overall Study|Non-Compliance|1|||
38051057|NCT03292653|69740106|FG002|Overall Study|Adverse Event|1|||
37957245|NCT00518115|69644427|FG008|Overall Study|Non-Compliance|0|||
37957246|NCT00518115|69644428|FG009|Overall Study|Non-Compliance|1|||
37957247|NCT00518115|69644419|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
37957248|NCT00518115|69644420|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
37957249|NCT00518115|69644421|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
37957250|NCT00518115|69644422|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
37957251|NCT00518115|69644423|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
37957252|NCT00518115|69644424|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
37957253|NCT00518115|69644425|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
37957254|NCT00518115|69644426|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
37957255|NCT00518115|69644427|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
37957256|NCT00518115|69644428|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
37957257|NCT00518115|69644419|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
37957258|NCT00518115|69644420|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
37957259|NCT00518115|69644421|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
37957260|NCT00518115|69644422|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
37957261|NCT00518115|69644423|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
37957262|NCT00518115|69644424|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
37957263|NCT00518115|69644425|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
37957264|NCT00518115|69644426|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
37957265|NCT00518115|69644427|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
37957266|NCT00518115|69644428|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
37957267|NCT00518115|69644419|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
37957268|NCT00518115|69644420|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
37957269|NCT00518115|69644421|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
37957270|NCT00518115|69644422|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
37957271|NCT00518115|69644423|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
37957272|NCT00518115|69644424|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
37957273|NCT00518115|69644425|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
37957274|NCT00518115|69644426|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
37957275|NCT00518115|69644427|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
37957276|NCT00518115|69644428|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
37957277|NCT00518115|69644419|FG000|Overall Study|Wrong Monotherapy Administered|0|||
37957278|NCT00518115|69644420|FG001|Overall Study|Wrong Monotherapy Administered|0|||
37957279|NCT00518115|69644421|FG002|Overall Study|Wrong Monotherapy Administered|1|||
37957280|NCT00518115|69644422|FG003|Overall Study|Wrong Monotherapy Administered|0|||
37957281|NCT00518115|69644423|FG004|Overall Study|Wrong Monotherapy Administered|0|||
37957282|NCT00518115|69644424|FG005|Overall Study|Wrong Monotherapy Administered|0|||
37957283|NCT00518115|69644425|FG006|Overall Study|Wrong Monotherapy Administered|1|||
37957284|NCT00518115|69644426|FG007|Overall Study|Wrong Monotherapy Administered|0|||
37957285|NCT00518115|69644427|FG008|Overall Study|Wrong Monotherapy Administered|0|||
37957286|NCT00518115|69644428|FG009|Overall Study|Wrong Monotherapy Administered|0|||
37957287|NCT00518115|69644419|FG000|Overall Study|Violation of Exclusion Criteria|0|||
37957288|NCT00518115|69644420|FG001|Overall Study|Violation of Exclusion Criteria|0|||
37957289|NCT00518115|69644421|FG002|Overall Study|Violation of Exclusion Criteria|0|||
37957290|NCT00518115|69644422|FG003|Overall Study|Violation of Exclusion Criteria|1|||
37957291|NCT00518115|69644423|FG004|Overall Study|Violation of Exclusion Criteria|0|||
37957292|NCT00518115|69644424|FG005|Overall Study|Violation of Exclusion Criteria|0|||
37957293|NCT00518115|69644425|FG006|Overall Study|Violation of Exclusion Criteria|1|||
37957294|NCT00518115|69644426|FG007|Overall Study|Violation of Exclusion Criteria|0|||
37957295|NCT00518115|69644427|FG008|Overall Study|Violation of Exclusion Criteria|0|||
37957296|NCT00518115|69644428|FG009|Overall Study|Violation of Exclusion Criteria|0|||
37957297|NCT00518115|69644419|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
37957298|NCT00518115|69644420|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
37957299|NCT00518115|69644421|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
37957300|NCT00518115|69644422|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
37957301|NCT00518115|69644423|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
37957302|NCT00518115|69644424|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
37957303|NCT00518115|69644425|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
37957304|NCT00518115|69644426|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
37957305|NCT00518115|69644427|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
37957306|NCT00518115|69644428|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
37957307|NCT00518115|69644419|FG000|Overall Study|Withdrew Consent|0|||
37957308|NCT00518115|69644420|FG001|Overall Study|Withdrew Consent|0|||
37957309|NCT00518115|69644421|FG002|Overall Study|Withdrew Consent|0|||
37957310|NCT00518115|69644422|FG003|Overall Study|Withdrew Consent|0|||
37957311|NCT00518115|69644423|FG004|Overall Study|Withdrew Consent|0|||
38051058|NCT03292653|69740104|FG000|Overall Study|Did not Receive Treatment|1|||
37861996|NCT01136733|69545745|FG003|Phase 2|Disease Progression|0|||
37957312|NCT00518115|69644424|FG005|Overall Study|Withdrew Consent|1|||
37957313|NCT00518115|69644425|FG006|Overall Study|Withdrew Consent|0|||
37957314|NCT00518115|69644426|FG007|Overall Study|Withdrew Consent|0|||
37957315|NCT00518115|69644427|FG008|Overall Study|Withdrew Consent|0|||
37957316|NCT00518115|69644428|FG009|Overall Study|Withdrew Consent|0|||
37957317|NCT00518115|69644419|FG000|Overall Study|Moved Out of State|0|||
37957318|NCT00518115|69644420|FG001|Overall Study|Moved Out of State|0|||
37957319|NCT00518115|69644421|FG002|Overall Study|Moved Out of State|0|||
37957320|NCT00518115|69644422|FG003|Overall Study|Moved Out of State|0|||
37957321|NCT00518115|69644423|FG004|Overall Study|Moved Out of State|0|||
37957322|NCT00518115|69644424|FG005|Overall Study|Moved Out of State|0|||
37957323|NCT00518115|69644425|FG006|Overall Study|Moved Out of State|0|||
37957324|NCT00518115|69644426|FG007|Overall Study|Moved Out of State|0|||
37957325|NCT00518115|69644427|FG008|Overall Study|Moved Out of State|0|||
37957326|NCT00518115|69644428|FG009|Overall Study|Moved Out of State|1|||
37957327|NCT00450658|69644453|FG000|Overall Study|Adverse Event|24|||
37957328|NCT00450658|69644454|FG001|Overall Study|Adverse Event|15|||
37957329|NCT00450658|69644453|FG000|Overall Study|Withdrawal by Subject|43|||
37957330|NCT00450658|69644454|FG001|Overall Study|Withdrawal by Subject|26|||
37957331|NCT00450658|69644453|FG000|Overall Study|Lost to Follow-up|22|||
37957332|NCT00450658|69644454|FG001|Overall Study|Lost to Follow-up|5|||
37957333|NCT00450658|69644453|FG000|Overall Study|UGI ulcer|33|||
37957334|NCT00450658|69644454|FG001|Overall Study|UGI ulcer|34|||
37957335|NCT00450658|69644453|FG000|Overall Study|misc|21|||
37957336|NCT00450658|69644454|FG001|Overall Study|misc|10|||
37957337|NCT00517881|69644460|FG000|Overall Study|Protocol Violation|2|||
37957338|NCT00517881|69644460|FG000|Overall Study|Adverse Event|1|||
38051059|NCT03292653|69740105|FG001|Overall Study|Did not Receive Treatment|0|||
38051060|NCT03292653|69740106|FG002|Overall Study|Did not Receive Treatment|0|||
37957339|NCT00517881|69644460|FG000|Overall Study|Renal transplantation|2|||
37957340|NCT00517413|69644481|FG000|Overall Study|Adverse Event|7|||
37957341|NCT00517413|69644481|FG000|Overall Study|Death|13|||
37957342|NCT00517413|69644481|FG000|Overall Study|Protocol Violation|15|||
37957343|NCT00517413|69644481|FG000|Overall Study|Withdrawal by Subject|2|||
37957344|NCT00517413|69644481|FG000|Overall Study|Failure to return|1|||
37957345|NCT00517413|69644481|FG000|Overall Study|Other-Reasons|23|||
37957346|NCT00604214|69644495|FG000|Baseline to Day 28|Death|223|||
37957347|NCT00604214|69644496|FG001|Baseline to Day 28|Death|202|||
37957348|NCT00604214|69644495|FG000|Baseline to Day 28|Lost to Follow-up|2|||
37957349|NCT00604214|69644496|FG001|Baseline to Day 28|Lost to Follow-up|4|||
37957350|NCT00604214|69644495|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
37957351|NCT00604214|69644496|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
37957352|NCT00604214|69644495|FG000|Day 29 to Day 90|Death|64|||
37957353|NCT00604214|69644496|FG001|Day 29 to Day 90|Death|67|||
37957354|NCT00604214|69644495|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
37957355|NCT00604214|69644496|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
37957356|NCT00604214|69644495|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
37957357|NCT00604214|69644496|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
37957358|NCT00604214|69644495|FG000|Day 91 to Day 180|Death|19|||
37957359|NCT00604214|69644496|FG001|Day 91 to Day 180|Death|23|||
37957360|NCT00604214|69644495|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
37957361|NCT00604214|69644496|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
37957362|NCT00604214|69644495|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
37957363|NCT00604214|69644496|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
37957364|NCT00450580|69644504|FG000|Overall Study|Adverse Event|5|||
37957365|NCT00450580|69644505|FG001|Overall Study|Adverse Event|7|||
38051061|NCT03858634|69740117|FG000|Overall Study|Withdrawal by Subject|1|||
38051062|NCT03858634|69740118|FG001|Overall Study|Withdrawal by Subject|0|||
38051063|NCT03858634|69740117|FG000|Overall Study|Adverse Event|1|||
38051064|NCT03858634|69740118|FG001|Overall Study|Adverse Event|0|||
37957366|NCT00450580|69644504|FG000|Overall Study|Lost to Follow-up|4|||
37957367|NCT00450580|69644505|FG001|Overall Study|Lost to Follow-up|5|||
37957368|NCT00450580|69644504|FG000|Overall Study|Withdrawal by Subject|2|||
37957369|NCT00450580|69644505|FG001|Overall Study|Withdrawal by Subject|2|||
37957370|NCT00450580|69644504|FG000|Overall Study|Protocol Violation|1|||
37957371|NCT00450580|69644505|FG001|Overall Study|Protocol Violation|1|||
37957372|NCT00450580|69644504|FG000|Overall Study|Protocol-defined virologic failure|1|||
37957373|NCT00450580|69644505|FG001|Overall Study|Protocol-defined virologic failure|0|||
37957374|NCT00450580|69644504|FG000|Overall Study|Could not comply with scheduled visits|1|||
37957375|NCT00450580|69644505|FG001|Overall Study|Could not comply with scheduled visits|0|||
37957376|NCT00450580|69644504|FG000|Overall Study|Patient went to Brazil|1|||
38051065|NCT03858634|69740117|FG000|Overall Study|Lost to Follow-up|0|||
37957377|NCT00450580|69644505|FG001|Overall Study|Patient went to Brazil|0|||
37957378|NCT00450580|69644504|FG000|Overall Study|Patient could not swallow Norvir|1|||
37957379|NCT00450580|69644505|FG001|Overall Study|Patient could not swallow Norvir|0|||
37957380|NCT00450580|69644504|FG000|Overall Study|Withdrawal due to pregnancy|0|||
37957381|NCT00450580|69644505|FG001|Overall Study|Withdrawal due to pregnancy|1|||
37957382|NCT00123487|69644513|FG000|Randomized|Death prior to starting treatment|0|||
38051066|NCT03858634|69740118|FG001|Overall Study|Lost to Follow-up|1|||
37957383|NCT00123487|69644514|FG001|Randomized|Death prior to starting treatment|1|||
37957384|NCT00123487|69644513|FG000|Randomized|SAE prior to starting treatment|1|||
37957385|NCT00123487|69644514|FG001|Randomized|SAE prior to starting treatment|0|||
37861997|NCT01136733|69545746|FG004|Phase 2|Disease Progression|30|||
37861998|NCT01136733|69545747|FG005|Phase 2|Disease Progression|32|||
37957386|NCT00123487|69644513|FG000|Treated With Study Drug|Adverse Event|23|||
37957387|NCT00123487|69644514|FG001|Treated With Study Drug|Adverse Event|22|||
37957388|NCT00123487|69644513|FG000|Treated With Study Drug|Disease Progression|141|||
37957389|NCT00123487|69644514|FG001|Treated With Study Drug|Disease Progression|122|||
37957390|NCT00123487|69644513|FG000|Treated With Study Drug|Physician Decision|8|||
37957391|NCT00123487|69644514|FG001|Treated With Study Drug|Physician Decision|9|||
37957392|NCT00123487|69644513|FG000|Treated With Study Drug|Other|59|||
38051067|NCT03858634|69740117|FG000|Overall Study|Other, Not Specified|1|||
38051068|NCT03858634|69740118|FG001|Overall Study|Other, Not Specified|1|||
37957393|NCT00123487|69644514|FG001|Treated With Study Drug|Other|58|||
37957394|NCT00123487|69644513|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
37957395|NCT00123487|69644514|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
37957396|NCT00123487|69644513|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
37957397|NCT00123487|69644514|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
37957398|NCT00123487|69644513|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
37957399|NCT00123487|69644514|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
37957400|NCT00509925|69644521|FG000|Overall Study|Personal reasons|0|||
37957401|NCT00509925|69644522|FG001|Overall Study|Personal reasons|1|||
37957402|NCT00504777|69644530|FG000|Overall Study|Adverse Event|1|||
37957403|NCT00509769|69644534|FG000|Overall Study|Progressive disease|77|||
37957404|NCT00509769|69644534|FG000|Overall Study|Adverse Event|4|||
37957405|NCT00509769|69644534|FG000|Overall Study|Patient's decision|1|||
37957406|NCT00509769|69644534|FG000|Overall Study|Physician Decision|8|||
37957407|NCT00509769|69644534|FG000|Overall Study|Use of prohibited therapies during study|1|||
37957408|NCT00114127|69644540|FG000|Overall Study|Adverse Event|2|||
37957409|NCT00114127|69644541|FG001|Overall Study|Adverse Event|1|||
37957410|NCT00114127|69644540|FG000|Overall Study|Lost to Follow-up|1|||
37957411|NCT00114127|69644541|FG001|Overall Study|Lost to Follow-up|0|||
37957412|NCT00114127|69644540|FG000|Overall Study|Withdrawal by Subject|1|||
37957413|NCT00114127|69644541|FG001|Overall Study|Withdrawal by Subject|3|||
37957414|NCT00572624|69644549|FG000|Overall Study|Lost to Follow-up|10|||
37957415|NCT00572624|69644550|FG001|Overall Study|Lost to Follow-up|4|||
37957416|NCT00572624|69644549|FG000|Overall Study|Wanted to do a different diet program|1|||
37957417|NCT00572624|69644550|FG001|Overall Study|Wanted to do a different diet program|0|||
37957418|NCT00572624|69644549|FG000|Overall Study|Medication change|1|||
37957419|NCT00572624|69644550|FG001|Overall Study|Medication change|0|||
37957420|NCT00572624|69644549|FG000|Overall Study|Started a new job-- no time for study|1|||
37957421|NCT00572624|69644550|FG001|Overall Study|Started a new job-- no time for study|0|||
37957422|NCT00572624|69644549|FG000|Overall Study|Admitted to being a smoker|1|||
37957423|NCT00572624|69644550|FG001|Overall Study|Admitted to being a smoker|0|||
37957424|NCT00572624|69644549|FG000|Overall Study|Refused to do the stress test|1|||
37957425|NCT00572624|69644550|FG001|Overall Study|Refused to do the stress test|0|||
37957426|NCT00572624|69644549|FG000|Overall Study|Problem with vascular access|1|||
37957427|NCT00572624|69644550|FG001|Overall Study|Problem with vascular access|0|||
37957428|NCT00572624|69644549|FG000|Overall Study|Health issues unrelated to the study|1|||
37957429|NCT00572624|69644550|FG001|Overall Study|Health issues unrelated to the study|0|||
37957430|NCT00122317|69644556|FG000|Overall Study|Death|3|||
37957431|NCT00122317|69644556|FG000|Overall Study|Adverse Event|4|||
37957432|NCT00122317|69644556|FG000|Overall Study|Physician Decision|2|||
37957433|NCT00122317|69644556|FG000|Overall Study|patient non-compliance|1|||
37957434|NCT00122317|69644556|FG000|Overall Study|Withdrawal by Subject|1|||
37957435|NCT03870555|69644563|FG000|Period 3 (2 Days)|Adverse Event|1|||
37957436|NCT03870555|69644564|FG001|Period 3 (2 Days)|Adverse Event|0|||
37957437|NCT03870555|69644565|FG002|Period 3 (2 Days)|Adverse Event|0|||
37957438|NCT03870477|69644576|FG000|Overall Study|Early Study Termination|1|||
37957439|NCT00165841|69644582|FG000|Overall Study|Adverse Event|2|||
37957440|NCT00165841|69644583|FG001|Overall Study|Adverse Event|3|||
37957441|NCT00165841|69644582|FG000|Overall Study|Lack of Efficacy|6|||
38051069|NCT02891070|69740134|FG000|Overall Study|Adverse Event|1|||
37957442|NCT00165841|69644583|FG001|Overall Study|Lack of Efficacy|33|||
38051070|NCT02891070|69740135|FG001|Overall Study|Adverse Event|0|||
38051071|NCT02891070|69740134|FG000|Overall Study|Physician Decision|0|||
38051072|NCT02891070|69740135|FG001|Overall Study|Physician Decision|1|||
38051073|NCT02891070|69740134|FG000|Overall Study|Lost to Follow-up|4|||
38051074|NCT02891070|69740135|FG001|Overall Study|Lost to Follow-up|4|||
37957443|NCT00165841|69644582|FG000|Overall Study|Lost to Follow-up|4|||
38051075|NCT02891070|69740134|FG000|Overall Study|Other|1|||
38051076|NCT02891070|69740135|FG001|Overall Study|Other|0|||
37957444|NCT00165841|69644583|FG001|Overall Study|Lost to Follow-up|4|||
37957445|NCT00165841|69644582|FG000|Overall Study|Withdrawal by Subject|7|||
37957446|NCT00165841|69644583|FG001|Overall Study|Withdrawal by Subject|8|||
37957447|NCT00165841|69644582|FG000|Overall Study|Physician Decision|1|||
37957448|NCT00165841|69644583|FG001|Overall Study|Physician Decision|0|||
37957449|NCT00165841|69644582|FG000|Overall Study|Protocol Violation|6|||
37957450|NCT00165841|69644583|FG001|Overall Study|Protocol Violation|8|||
37957451|NCT00165841|69644582|FG000|Overall Study|Other|3|||
37957452|NCT00165841|69644583|FG001|Overall Study|Other|5|||
37957453|NCT00165841|69644582|FG000|Overall Study|Medication Noncompliance|1|||
37957454|NCT00165841|69644583|FG001|Overall Study|Medication Noncompliance|1|||
37957455|NCT00509223|69644591|FG000|Overall Study|Lost to Follow-up|1|||
37957456|NCT00509223|69644592|FG001|Overall Study|Lost to Follow-up|1|||
37957457|NCT00509223|69644591|FG000|Overall Study|Adverse Event|1|||
37957458|NCT00509223|69644592|FG001|Overall Study|Adverse Event|1|||
37957459|NCT00509223|69644591|FG000|Overall Study|Withdrawal by Subject|25|||
37957460|NCT00509223|69644592|FG001|Overall Study|Withdrawal by Subject|6|||
37957461|NCT00509223|69644591|FG000|Overall Study|Including: subject change of address|5|||
38051077|NCT02891070|69740134|FG000|Overall Study|Protocol Violation|0|||
38051078|NCT02891070|69740135|FG001|Overall Study|Protocol Violation|1|||
38051079|NCT02891070|69740134|FG000|Overall Study|Withdrawal by Subject|1|||
38051080|NCT02891070|69740135|FG001|Overall Study|Withdrawal by Subject|2|||
38051081|NCT02891070|69740134|FG000|Overall Study|Death|3|||
38051082|NCT02891070|69740135|FG001|Overall Study|Death|0|||
38051083|NCT03255291|69740147|FG000|Overall Study|Determined to be ineligible|10|||
38051084|NCT03255291|69740148|FG001|Overall Study|Determined to be ineligible|12|||
38051085|NCT03255291|69740149|FG002|Overall Study|Determined to be ineligible|6|||
38051086|NCT03255291|69740150|FG003|Overall Study|Determined to be ineligible|6|||
38051087|NCT03255291|69740151|FG004|Overall Study|Determined to be ineligible|5|||
38051088|NCT03255291|69740152|FG005|Overall Study|Determined to be ineligible|10|||
38051089|NCT03255291|69740147|FG000|Overall Study|Baseline data collection issues|3|||
38051090|NCT03255291|69740148|FG001|Overall Study|Baseline data collection issues|0|||
38051091|NCT03255291|69740149|FG002|Overall Study|Baseline data collection issues|0|||
38051092|NCT03255291|69740150|FG003|Overall Study|Baseline data collection issues|0|||
38051093|NCT03255291|69740151|FG004|Overall Study|Baseline data collection issues|2|||
38051094|NCT03255291|69740152|FG005|Overall Study|Baseline data collection issues|0|||
38051095|NCT00381381|69740170|FG000|Overall Study|Adverse Event|3|||
38051096|NCT00381381|69740170|FG000|Overall Study|Lost to Follow-up|52|||
37861999|NCT01136733|69545748|FG006|Phase 2|Disease Progression|38|||
37862000|NCT01136733|69545742|FG000|Phase 2|Adverse Event|0|||
37862001|NCT01136733|69545743|FG001|Phase 2|Adverse Event|0|||
37862002|NCT01136733|69545744|FG002|Phase 2|Adverse Event|0|||
37862003|NCT01136733|69545745|FG003|Phase 2|Adverse Event|0|||
37862004|NCT01136733|69545746|FG004|Phase 2|Adverse Event|11|||
37862005|NCT01136733|69545747|FG005|Phase 2|Adverse Event|13|||
37862006|NCT01136733|69545748|FG006|Phase 2|Adverse Event|5|||
37862007|NCT01136733|69545742|FG000|Phase 2|Participant Choice|0|||
37862008|NCT01136733|69545743|FG001|Phase 2|Participant Choice|0|||
37862009|NCT01136733|69545744|FG002|Phase 2|Participant Choice|0|||
37862010|NCT01136733|69545745|FG003|Phase 2|Participant Choice|0|||
37862011|NCT01136733|69545746|FG004|Phase 2|Participant Choice|3|||
37862012|NCT01136733|69545747|FG005|Phase 2|Participant Choice|0|||
37862013|NCT01136733|69545748|FG006|Phase 2|Participant Choice|1|||
37862014|NCT01136733|69545742|FG000|Phase 2|Administrative-Withdrew Consent|0|||
37862015|NCT01136733|69545743|FG001|Phase 2|Administrative-Withdrew Consent|0|||
37862016|NCT01136733|69545744|FG002|Phase 2|Administrative-Withdrew Consent|0|||
37862017|NCT01136733|69545745|FG003|Phase 2|Administrative-Withdrew Consent|0|||
37862018|NCT01136733|69545746|FG004|Phase 2|Administrative-Withdrew Consent|1|||
37862019|NCT01136733|69545747|FG005|Phase 2|Administrative-Withdrew Consent|0|||
37862020|NCT01136733|69545748|FG006|Phase 2|Administrative-Withdrew Consent|0|||
37862021|NCT01136733|69545742|FG000|Phase 2|Other|0|||
37862022|NCT01136733|69545743|FG001|Phase 2|Other|0|||
37862023|NCT01136733|69545744|FG002|Phase 2|Other|0|||
37862024|NCT01136733|69545745|FG003|Phase 2|Other|0|||
37862025|NCT01136733|69545746|FG004|Phase 2|Other|6|||
37862026|NCT01136733|69545747|FG005|Phase 2|Other|7|||
37862027|NCT01136733|69545748|FG006|Phase 2|Other|6|||
37862028|NCT01136655|69545778|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
37862029|NCT01136655|69545778|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
37862030|NCT01136655|69545778|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
37862031|NCT01136655|69545778|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
37957462|NCT00509223|69644592|FG001|Overall Study|Including: subject change of address|2|||
37957463|NCT00509223|69644591|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
37957464|NCT00509223|69644592|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
37957465|NCT00460798|69644598|FG000|Overall Study|Death|59|||
38051097|NCT00381381|69740170|FG000|Overall Study|Withdrawal by Subject|9|||
38051098|NCT02939937|69740176|FG000|Overall Study|Adverse Event|5|||
38051099|NCT02939937|69740177|FG001|Overall Study|Adverse Event|0|||
37957466|NCT00460798|69644598|FG000|Overall Study|Adverse Event|27|||
37957467|NCT00460798|69644598|FG000|Overall Study|Lost to Follow-up|19|||
37957468|NCT00460798|69644598|FG000|Overall Study|Progressive Disease|99|||
37957469|NCT00460798|69644598|FG000|Overall Study|Other|27|||
37957470|NCT00460798|69644598|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
37957471|NCT00460798|69644598|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
37957472|NCT00603980|69644602|FG000|Study Qualification|Protocol Violation|3|||
37957473|NCT00603980|69644602|FG000|Study Qualification|Inconsistent data reporting|13|||
37957474|NCT00603980|69644602|FG000|Main Study|14th subject completed trial|1|||
37957475|NCT00450190|69644622|FG000|Overall Study|Withdrawal by Subject|2|||
37957476|NCT00450112|69644628|FG000|Overall Study|Other Treatment Required|5|||
37957477|NCT00450112|69644629|FG001|Overall Study|Other Treatment Required|1|||
37957478|NCT00450112|69644628|FG000|Overall Study|Withdrawal by Subject|4|||
37957479|NCT00450112|69644629|FG001|Overall Study|Withdrawal by Subject|1|||
37957480|NCT00450112|69644628|FG000|Overall Study|Lost to Follow-up|2|||
37957481|NCT00450112|69644629|FG001|Overall Study|Lost to Follow-up|1|||
37957482|NCT00450112|69644628|FG000|Overall Study|Others|2|||
37957483|NCT00450112|69644629|FG001|Overall Study|Others|3|||
37957484|NCT00449956|69644638|FG000|Overall Study|Adverse Event|7|||
37957485|NCT00449956|69644639|FG001|Overall Study|Adverse Event|1|||
37957486|NCT00449956|69644640|FG002|Overall Study|Adverse Event|6|||
37957487|NCT00449956|69644638|FG000|Overall Study|Lack of Efficacy|0|||
37957488|NCT00449956|69644639|FG001|Overall Study|Lack of Efficacy|0|||
37957489|NCT00449956|69644640|FG002|Overall Study|Lack of Efficacy|1|||
37957490|NCT00449956|69644638|FG000|Overall Study|Protocol Violation|1|||
37957491|NCT00449956|69644639|FG001|Overall Study|Protocol Violation|1|||
37957492|NCT00449956|69644640|FG002|Overall Study|Protocol Violation|1|||
37957493|NCT00449956|69644638|FG000|Overall Study|Withdrawal by Subject|0|||
37957494|NCT00449956|69644639|FG001|Overall Study|Withdrawal by Subject|1|||
37957495|NCT00449956|69644640|FG002|Overall Study|Withdrawal by Subject|0|||
37957496|NCT00449956|69644638|FG000|Overall Study|Physician Decision|2|||
37957497|NCT00449956|69644639|FG001|Overall Study|Physician Decision|1|||
37957498|NCT00449956|69644640|FG002|Overall Study|Physician Decision|1|||
37957499|NCT00509145|69644650|FG000|Overall Study|Death|0|||
37957500|NCT00509145|69644651|FG001|Overall Study|Death|2|||
37957501|NCT00509145|69644650|FG000|Overall Study|Adverse Event|42|||
37957502|NCT00509145|69644651|FG001|Overall Study|Adverse Event|28|||
37957503|NCT00509145|69644650|FG000|Overall Study|Withdrawal by Subject|32|||
37957504|NCT00509145|69644651|FG001|Overall Study|Withdrawal by Subject|38|||
37957505|NCT00509145|69644650|FG000|Overall Study|Physician Decision|11|||
37957506|NCT00509145|69644651|FG001|Overall Study|Physician Decision|14|||
37957507|NCT00509145|69644650|FG000|Overall Study|Protocol Violation|1|||
37957508|NCT00509145|69644651|FG001|Overall Study|Protocol Violation|6|||
37957509|NCT00509145|69644650|FG000|Overall Study|Pregnancy|3|||
37957510|NCT00509145|69644651|FG001|Overall Study|Pregnancy|8|||
37957511|NCT00509145|69644650|FG000|Overall Study|Lost to Follow-up|6|||
37957512|NCT00509145|69644651|FG001|Overall Study|Lost to Follow-up|5|||
37957513|NCT00509145|69644650|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
37957514|NCT00509145|69644651|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
37957515|NCT00509145|69644650|FG000|Overall Study|Other|6|||
37957516|NCT00509145|69644651|FG001|Overall Study|Other|6|||
37957517|NCT00509067|69644659|FG000|Overall Study|Lost to Follow-up|1|||
37957518|NCT00509067|69644660|FG001|Overall Study|Lost to Follow-up|1|||
37957519|NCT00509067|69644659|FG000|Overall Study|Adverse Event|3|||
37957520|NCT00509067|69644660|FG001|Overall Study|Adverse Event|1|||
37957521|NCT00509067|69644659|FG000|Overall Study|Protocol Violation|0|||
37957522|NCT00509067|69644660|FG001|Overall Study|Protocol Violation|3|||
37957523|NCT00504309|69644676|FG000|Overall Study|Death|0|||
37957524|NCT00504309|69644677|FG001|Overall Study|Death|0|||
37957525|NCT00504309|69644678|FG002|Overall Study|Death|0|||
37957526|NCT00504309|69644679|FG003|Overall Study|Death|0|||
37957527|NCT00504309|69644680|FG004|Overall Study|Death|1|||
37957528|NCT00504309|69644681|FG005|Overall Study|Death|0|||
37957529|NCT00504309|69644676|FG000|Overall Study|Withdrawal by Subject|0|||
37957530|NCT00504309|69644677|FG001|Overall Study|Withdrawal by Subject|0|||
37957531|NCT00504309|69644678|FG002|Overall Study|Withdrawal by Subject|1|||
37957532|NCT00504309|69644679|FG003|Overall Study|Withdrawal by Subject|0|||
37957533|NCT00504309|69644680|FG004|Overall Study|Withdrawal by Subject|0|||
37957534|NCT00504309|69644681|FG005|Overall Study|Withdrawal by Subject|0|||
37957535|NCT00508755|69644693|FG000|Overall Study|Withdrawal by Subject|1|||
37957536|NCT00504231|69644703|FG000|Overall Study|Discrepant chart documentation re route|0|||
37957537|NCT00504231|69644704|FG001|Overall Study|Discrepant chart documentation re route|0|||
37957538|NCT00504231|69644705|FG002|Overall Study|Discrepant chart documentation re route|1|||
37957539|NCT00504231|69644706|FG003|Overall Study|Discrepant chart documentation re route|0|||
37957540|NCT00568178|69644758|FG000|Double Blind Base Study|Adverse Event|0|||
37957541|NCT00568178|69644759|FG001|Double Blind Base Study|Adverse Event|2|||
37957542|NCT00568178|69644760|FG002|Double Blind Base Study|Adverse Event|1|||
38051100|NCT02939937|69740176|FG000|Overall Study|Lost to Follow-up|1|||
37957543|NCT00568178|69644761|FG003|Double Blind Base Study|Adverse Event|2|||
37957544|NCT00568178|69644762|FG004|Double Blind Base Study|Adverse Event|0|||
37957545|NCT00568178|69644763|FG005|Double Blind Base Study|Adverse Event|0|||
37957546|NCT00568178|69644758|FG000|Double Blind Base Study|Lost to Follow-up|1|||
37957547|NCT00568178|69644759|FG001|Double Blind Base Study|Lost to Follow-up|0|||
37957548|NCT00568178|69644760|FG002|Double Blind Base Study|Lost to Follow-up|0|||
37957549|NCT00568178|69644761|FG003|Double Blind Base Study|Lost to Follow-up|1|||
37957550|NCT00568178|69644762|FG004|Double Blind Base Study|Lost to Follow-up|0|||
37957551|NCT00568178|69644763|FG005|Double Blind Base Study|Lost to Follow-up|0|||
38051101|NCT02939937|69740177|FG001|Overall Study|Lost to Follow-up|3|||
38051102|NCT02939079|69740185|FG000|Overall Study|Adverse Event|2|||
38051103|NCT02939079|69740186|FG001|Overall Study|Adverse Event|1|||
38051104|NCT02939079|69740185|FG000|Overall Study|Lost to Follow-up|0|||
38051105|NCT02939079|69740186|FG001|Overall Study|Lost to Follow-up|2|||
38051106|NCT02939079|69740185|FG000|Overall Study|Protocol Violation|1|||
38051107|NCT02939079|69740186|FG001|Overall Study|Protocol Violation|0|||
38051108|NCT02939079|69740185|FG000|Overall Study|Withdrawal by Subject|0|||
38051109|NCT02939079|69740186|FG001|Overall Study|Withdrawal by Subject|1|||
38051110|NCT02939079|69740185|FG000|Overall Study|relapse during the study|1|||
38051111|NCT02939079|69740186|FG001|Overall Study|relapse during the study|1|||
38051112|NCT04562155|69740196|FG000|Overall Study|COVID-19 pandemic|0|||
38051113|NCT04562155|69740197|FG001|Overall Study|COVID-19 pandemic|0|||
38051114|NCT04562155|69740198|FG002|Overall Study|COVID-19 pandemic|0|||
38051115|NCT04562155|69740199|FG003|Overall Study|COVID-19 pandemic|1|||
38051116|NCT04562155|69740196|FG000|Overall Study|Adverse Event|7|||
38051117|NCT04562155|69740197|FG001|Overall Study|Adverse Event|3|||
38051118|NCT04562155|69740198|FG002|Overall Study|Adverse Event|8|||
38051119|NCT04562155|69740199|FG003|Overall Study|Adverse Event|1|||
38051120|NCT04562155|69740196|FG000|Overall Study|Withdrawal by Subject|3|||
38051121|NCT04562155|69740197|FG001|Overall Study|Withdrawal by Subject|6|||
38051122|NCT04562155|69740198|FG002|Overall Study|Withdrawal by Subject|3|||
38051123|NCT04562155|69740199|FG003|Overall Study|Withdrawal by Subject|3|||
38051124|NCT04562155|69740196|FG000|Overall Study|Participant personal reason|1|||
38051125|NCT04562155|69740197|FG001|Overall Study|Participant personal reason|0|||
38051126|NCT04562155|69740198|FG002|Overall Study|Participant personal reason|2|||
37957552|NCT00568178|69644758|FG000|Double Blind Base Study|Physician Decision|1|||
38051127|NCT04562155|69740199|FG003|Overall Study|Participant personal reason|1|||
38051128|NCT03313050|69740213|FG000|Stage 2: 12 Months|Adverse Event|0|||
38051129|NCT03313050|69740214|FG001|Stage 2: 12 Months|Adverse Event|0|||
38051130|NCT03313050|69740215|FG002|Stage 2: 12 Months|Adverse Event|0|||
38051131|NCT03313050|69740216|FG003|Stage 2: 12 Months|Adverse Event|1|||
38051132|NCT03313050|69740213|FG000|Stage 2: 12 Months|Death|0|||
38051133|NCT03313050|69740214|FG001|Stage 2: 12 Months|Death|0|||
38051134|NCT03313050|69740215|FG002|Stage 2: 12 Months|Death|3|||
38051135|NCT03313050|69740216|FG003|Stage 2: 12 Months|Death|0|||
38051136|NCT03313050|69740213|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
38051137|NCT03313050|69740214|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
38051138|NCT03313050|69740215|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
38051139|NCT03313050|69740216|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
38051140|NCT03313050|69740213|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
38051141|NCT03313050|69740214|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
37957553|NCT00568178|69644759|FG001|Double Blind Base Study|Physician Decision|1|||
38051142|NCT03313050|69740215|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
38051143|NCT03313050|69740216|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
38051144|NCT03313050|69740213|FG000|Stage 2: 12 Months|Protocol deviation|0|||
38051145|NCT03313050|69740214|FG001|Stage 2: 12 Months|Protocol deviation|0|||
38051146|NCT03313050|69740215|FG002|Stage 2: 12 Months|Protocol deviation|7|||
38051147|NCT03313050|69740216|FG003|Stage 2: 12 Months|Protocol deviation|7|||
38051148|NCT03313050|69740213|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
37862032|NCT01135017|69545793|FG000|Overall Study|Adverse Event|3|||
38051149|NCT03313050|69740214|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
38051150|NCT03313050|69740215|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
38051151|NCT03313050|69740216|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
38051152|NCT03313050|69740213|FG000|Stage 2: 12 Months|Other|0|||
38051153|NCT03313050|69740214|FG001|Stage 2: 12 Months|Other|0|||
38051154|NCT03313050|69740215|FG002|Stage 2: 12 Months|Other|0|||
38051155|NCT03313050|69740216|FG003|Stage 2: 12 Months|Other|1|||
38051156|NCT04755595|69740235|FG000|Overall Study|Lost to Follow-up|1|||
38051157|NCT04749745|69740240|FG000|Overall Study|Withdrawal by Subject|1|||
38051158|NCT04749745|69740241|FG001|Overall Study|Withdrawal by Subject|0|||
38051159|NCT03257436|69740247|FG000|Overall Study|Withdrawal by Subject|76|||
38051160|NCT03257436|69740247|FG000|Overall Study|Death|19|||
38051161|NCT04748341|69740253|FG000|Overall Study|Lost to Follow-up|1|||
38051162|NCT04748341|69740254|FG001|Overall Study|Lost to Follow-up|1|||
38051163|NCT01328002|69740260|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
38051164|NCT01328002|69740261|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
38051165|NCT01328002|69740260|FG000|Open-Label Period|Adverse Event|8|||
37957554|NCT00568178|69644760|FG002|Double Blind Base Study|Physician Decision|0|||
37957555|NCT00568178|69644761|FG003|Double Blind Base Study|Physician Decision|1|||
37957556|NCT00568178|69644762|FG004|Double Blind Base Study|Physician Decision|0|||
37957557|NCT00568178|69644763|FG005|Double Blind Base Study|Physician Decision|0|||
37957558|NCT00568178|69644758|FG000|Double Blind Base Study|Protocol Violation|3|||
37957559|NCT00568178|69644759|FG001|Double Blind Base Study|Protocol Violation|2|||
37957560|NCT00568178|69644760|FG002|Double Blind Base Study|Protocol Violation|0|||
37957561|NCT00568178|69644761|FG003|Double Blind Base Study|Protocol Violation|0|||
37957562|NCT00568178|69644762|FG004|Double Blind Base Study|Protocol Violation|0|||
37957563|NCT00568178|69644763|FG005|Double Blind Base Study|Protocol Violation|0|||
37957564|NCT00568178|69644758|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
37957565|NCT00568178|69644759|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
37957566|NCT00568178|69644760|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
37957567|NCT00568178|69644761|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
37957568|NCT00568178|69644762|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
37957569|NCT00568178|69644763|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
37957570|NCT00568178|69644758|FG000|Double Blind Base Study|Progressive Disease|0|||
37957571|NCT00568178|69644759|FG001|Double Blind Base Study|Progressive Disease|0|||
37957572|NCT00568178|69644760|FG002|Double Blind Base Study|Progressive Disease|0|||
37957573|NCT00568178|69644761|FG003|Double Blind Base Study|Progressive Disease|1|||
37957574|NCT00568178|69644762|FG004|Double Blind Base Study|Progressive Disease|0|||
37957575|NCT00568178|69644763|FG005|Double Blind Base Study|Progressive Disease|0|||
37957576|NCT00568178|69644758|FG000|Open Label Extension|Adverse Event|0|||
37957577|NCT00568178|69644759|FG001|Open Label Extension|Adverse Event|0|||
37957578|NCT00568178|69644760|FG002|Open Label Extension|Adverse Event|0|||
37957579|NCT00568178|69644761|FG003|Open Label Extension|Adverse Event|0|||
37957580|NCT00568178|69644762|FG004|Open Label Extension|Adverse Event|11|||
37957581|NCT00568178|69644763|FG005|Open Label Extension|Adverse Event|8|||
37957582|NCT00568178|69644758|FG000|Open Label Extension|Protocol Violation|0|||
37957583|NCT00568178|69644759|FG001|Open Label Extension|Protocol Violation|0|||
37957584|NCT00568178|69644760|FG002|Open Label Extension|Protocol Violation|0|||
37957585|NCT00568178|69644761|FG003|Open Label Extension|Protocol Violation|0|||
37957586|NCT00568178|69644762|FG004|Open Label Extension|Protocol Violation|1|||
37957587|NCT00568178|69644763|FG005|Open Label Extension|Protocol Violation|0|||
37957588|NCT00568178|69644758|FG000|Open Label Extension|Lost to Follow-up|0|||
37957589|NCT00568178|69644759|FG001|Open Label Extension|Lost to Follow-up|0|||
37957590|NCT00568178|69644760|FG002|Open Label Extension|Lost to Follow-up|0|||
37957591|NCT00568178|69644761|FG003|Open Label Extension|Lost to Follow-up|0|||
37957592|NCT00568178|69644762|FG004|Open Label Extension|Lost to Follow-up|6|||
37957593|NCT00568178|69644763|FG005|Open Label Extension|Lost to Follow-up|11|||
37957594|NCT00568178|69644758|FG000|Open Label Extension|Physician Decision|0|||
37957595|NCT00568178|69644759|FG001|Open Label Extension|Physician Decision|0|||
37957596|NCT00568178|69644760|FG002|Open Label Extension|Physician Decision|0|||
37957597|NCT00568178|69644761|FG003|Open Label Extension|Physician Decision|0|||
38051166|NCT01328002|69740261|FG001|Open-Label Period|Adverse Event|0|||
38051167|NCT01328002|69740260|FG000|Open-Label Period|Lack of Efficacy|3|||
37957598|NCT00568178|69644762|FG004|Open Label Extension|Physician Decision|9|||
37957599|NCT00568178|69644763|FG005|Open Label Extension|Physician Decision|8|||
37957600|NCT00568178|69644758|FG000|Open Label Extension|Pregnancy|0|||
37957601|NCT00568178|69644759|FG001|Open Label Extension|Pregnancy|0|||
37957602|NCT00568178|69644760|FG002|Open Label Extension|Pregnancy|0|||
37957603|NCT00568178|69644761|FG003|Open Label Extension|Pregnancy|0|||
37957604|NCT00568178|69644762|FG004|Open Label Extension|Pregnancy|0|||
37957605|NCT00568178|69644763|FG005|Open Label Extension|Pregnancy|1|||
37957606|NCT00568178|69644758|FG000|Open Label Extension|Progressive Disease|0|||
37957607|NCT00568178|69644759|FG001|Open Label Extension|Progressive Disease|0|||
37957608|NCT00568178|69644760|FG002|Open Label Extension|Progressive Disease|0|||
37957609|NCT00568178|69644761|FG003|Open Label Extension|Progressive Disease|0|||
37957610|NCT00568178|69644762|FG004|Open Label Extension|Progressive Disease|3|||
37957611|NCT00568178|69644763|FG005|Open Label Extension|Progressive Disease|1|||
37957612|NCT00568178|69644758|FG000|Open Label Extension|Termination of Trial|0|||
37957613|NCT00568178|69644759|FG001|Open Label Extension|Termination of Trial|0|||
37957614|NCT00568178|69644760|FG002|Open Label Extension|Termination of Trial|0|||
37957615|NCT00568178|69644761|FG003|Open Label Extension|Termination of Trial|0|||
38051168|NCT01328002|69740261|FG001|Open-Label Period|Lack of Efficacy|0|||
37957616|NCT00568178|69644762|FG004|Open Label Extension|Termination of Trial|45|||
38051169|NCT01328002|69740260|FG000|Open-Label Period|Protocol Violation|2|||
38051170|NCT01328002|69740261|FG001|Open-Label Period|Protocol Violation|0|||
38051171|NCT01328002|69740260|FG000|Open-Label Period|Withdrawal by Subject|9|||
38051172|NCT01328002|69740261|FG001|Open-Label Period|Withdrawal by Subject|0|||
38051173|NCT01328002|69740260|FG000|Open-Label Period|Lost to Follow-up|6|||
38051174|NCT01328002|69740261|FG001|Open-Label Period|Lost to Follow-up|0|||
38051175|NCT01328002|69740260|FG000|Open-Label Period|Other Reason|2|||
38051176|NCT01328002|69740261|FG001|Open-Label Period|Other Reason|0|||
37957617|NCT00568178|69644763|FG005|Open Label Extension|Termination of Trial|47|||
37957618|NCT00568178|69644758|FG000|Open Label Extension|Withdrawal by Subject|0|||
37957619|NCT00568178|69644759|FG001|Open Label Extension|Withdrawal by Subject|0|||
37957620|NCT00568178|69644760|FG002|Open Label Extension|Withdrawal by Subject|0|||
37957621|NCT00568178|69644761|FG003|Open Label Extension|Withdrawal by Subject|0|||
37957622|NCT00568178|69644762|FG004|Open Label Extension|Withdrawal by Subject|4|||
37957623|NCT00568178|69644763|FG005|Open Label Extension|Withdrawal by Subject|4|||
37957624|NCT00577889|69644780|FG000|Overall Study|Withdrawal by Subject|1|||
37957625|NCT00577889|69644781|FG001|Overall Study|Withdrawal by Subject|0|||
37957626|NCT00577889|69644782|FG002|Overall Study|Withdrawal by Subject|0|||
37957627|NCT00460564|69644794|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
37957628|NCT00460564|69644795|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
37957629|NCT00460564|69644796|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
37957630|NCT00460564|69644797|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
37957631|NCT00460564|69644798|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
37957632|NCT00460564|69644799|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
37957633|NCT00460564|69644800|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
37957634|NCT00460564|69644801|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
37957635|NCT00460564|69644794|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
37957636|NCT00460564|69644795|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
37957637|NCT00460564|69644796|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
37957638|NCT00460564|69644797|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
37957639|NCT00460564|69644798|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
37957640|NCT00460564|69644799|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
37957641|NCT00460564|69644800|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
37957642|NCT00460564|69644801|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
37957643|NCT00460564|69644794|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
37957644|NCT00460564|69644795|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
37957645|NCT00460564|69644796|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
37957646|NCT00460564|69644797|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
37957647|NCT00460564|69644798|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
37957648|NCT00460564|69644799|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
37957649|NCT00460564|69644800|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
37957650|NCT00460564|69644801|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
37957651|NCT00460564|69644794|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
37957652|NCT00460564|69644795|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
37957653|NCT00460564|69644796|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
37957654|NCT00460564|69644797|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
37957655|NCT00460564|69644798|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
37957656|NCT00460564|69644799|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
37957657|NCT00460564|69644800|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
37957658|NCT00460564|69644801|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
37957659|NCT00460564|69644794|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
37957660|NCT00460564|69644795|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
37957661|NCT00460564|69644796|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
37957662|NCT00460564|69644797|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
37957663|NCT00460564|69644798|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
37957664|NCT00460564|69644799|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
37957665|NCT00460564|69644800|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
37957666|NCT00460564|69644801|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
37957667|NCT00567476|69644823|FG000|Overall Study|Adverse Event|2|||
37957668|NCT00567476|69644824|FG001|Overall Study|Adverse Event|0|||
37957669|NCT00567476|69644823|FG000|Overall Study|Pregnancy|1|||
37957670|NCT00567476|69644824|FG001|Overall Study|Pregnancy|0|||
37957671|NCT00567476|69644823|FG000|Overall Study|Protocol Violation|4|||
37957672|NCT00567476|69644824|FG001|Overall Study|Protocol Violation|1|||
37957673|NCT00567476|69644823|FG000|Overall Study|Lost to Follow-up|0|||
37957674|NCT00567476|69644824|FG001|Overall Study|Lost to Follow-up|1|||
38051177|NCT01328002|69740260|FG000|Double-Blind Period|Adverse Event|1|||
38051178|NCT01328002|69740261|FG001|Double-Blind Period|Adverse Event|0|||
38051179|NCT01328002|69740260|FG000|Double-Blind Period|Lack of Efficacy|1|||
38051180|NCT01328002|69740261|FG001|Double-Blind Period|Lack of Efficacy|0|||
37957675|NCT00567476|69644823|FG000|Overall Study|Administrative issues|1|||
37957676|NCT00567476|69644824|FG001|Overall Study|Administrative issues|0|||
37957677|NCT00567476|69644823|FG000|Overall Study|Medical Decision|0|||
37957678|NCT00567476|69644824|FG001|Overall Study|Medical Decision|1|||
37957679|NCT00567476|69644823|FG000|Overall Study|Non-adherence to protocol|0|||
38051181|NCT02579265|69740270|FG000|Overall Study|Weaned off earlier than 28 days|44|||
38051182|NCT02579265|69740271|FG001|Overall Study|Weaned off earlier than 28 days|43|||
38051183|NCT02579265|69740270|FG000|Overall Study|Adverse Event|2|||
38051184|NCT02579265|69740271|FG001|Overall Study|Adverse Event|0|||
38051185|NCT02579265|69740270|FG000|Overall Study|Any other reason not specified|0|||
37957680|NCT00567476|69644824|FG001|Overall Study|Non-adherence to protocol|1|||
37957681|NCT00516321|69644832|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
37957682|NCT00516321|69644833|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
37957683|NCT00516321|69644834|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
37957684|NCT00516321|69644832|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
37957685|NCT00516321|69644833|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
37957686|NCT00516321|69644834|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
37957687|NCT00516321|69644832|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
37957688|NCT00516321|69644833|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
37957689|NCT00516321|69644834|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
37957690|NCT00516321|69644832|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
37957691|NCT00516321|69644833|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
37957692|NCT00516321|69644834|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
37957693|NCT00516321|69644832|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
37957694|NCT00516321|69644833|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
37957695|NCT00516321|69644834|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
37957696|NCT00516321|69644832|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
37957697|NCT00516321|69644833|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
37957698|NCT00516321|69644834|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
37957699|NCT00516321|69644832|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
37957700|NCT00516321|69644833|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
37957701|NCT00516321|69644834|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
37957702|NCT00516321|69644832|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
37957703|NCT00516321|69644833|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
37957704|NCT00516321|69644834|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
37957705|NCT00516321|69644832|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
37957706|NCT00516321|69644833|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
37957707|NCT00516321|69644834|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
37957708|NCT00516321|69644832|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
37957709|NCT00516321|69644833|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
37957710|NCT00516321|69644834|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
37957711|NCT00516321|69644832|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
37957712|NCT00516321|69644833|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
37957713|NCT00516321|69644834|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
37957714|NCT00460408|69644846|FG000|Overall Study|Adverse Event|1|||
37957715|NCT00460408|69644847|FG001|Overall Study|Adverse Event|0|||
37957716|NCT00460408|69644848|FG002|Overall Study|Adverse Event|0|||
37957717|NCT00460408|69644849|FG003|Overall Study|Adverse Event|0|||
37957718|NCT00460408|69644846|FG000|Overall Study|Death|7|||
37957719|NCT00460408|69644847|FG001|Overall Study|Death|0|||
37957720|NCT00460408|69644848|FG002|Overall Study|Death|0|||
38051186|NCT02579265|69740271|FG001|Overall Study|Any other reason not specified|2|||
38051187|NCT02579265|69740270|FG000|Overall Study|Withdrawal by Subject|2|||
38051188|NCT02579265|69740271|FG001|Overall Study|Withdrawal by Subject|0|||
38051189|NCT02579265|69740270|FG000|Overall Study|Physician Decision|1|||
38051190|NCT02579265|69740271|FG001|Overall Study|Physician Decision|0|||
38051191|NCT02579265|69740270|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
38051192|NCT02579265|69740271|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
38051193|NCT03289533|69740277|FG000|Overall Study|Death|12|||
38051194|NCT03289533|69740277|FG000|Overall Study|Terminated from study by sponsor|10|||
38051195|NCT04727749|69740283|FG000|Overall Study|Lost to Follow-up|10|||
38051196|NCT04727749|69740284|FG001|Overall Study|Lost to Follow-up|3|||
38051197|NCT04547023|69740294|FG000|Overall Study|Did Not Receive Intervention|3|||
38051198|NCT04547023|69740295|FG001|Overall Study|Did Not Receive Intervention|2|||
38051199|NCT04547023|69740294|FG000|Overall Study|Lost to Follow-up|1|||
38051200|NCT04547023|69740295|FG001|Overall Study|Lost to Follow-up|1|||
38051201|NCT03697993|69740305|FG000|Overall Study|Became Ineligible after Enrollment|1|||
38051202|NCT03697993|69740306|FG001|Overall Study|Became Ineligible after Enrollment|3|||
38051203|NCT03697993|69740305|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
37957721|NCT00460408|69644849|FG003|Overall Study|Death|0|||
37957722|NCT00460408|69644846|FG000|Overall Study|Lost to Follow-up|11|||
37957723|NCT00460408|69644847|FG001|Overall Study|Lost to Follow-up|0|||
37957724|NCT00460408|69644848|FG002|Overall Study|Lost to Follow-up|1|||
37957725|NCT00460408|69644849|FG003|Overall Study|Lost to Follow-up|0|||
37957726|NCT00460408|69644846|FG000|Overall Study|Withdrawal by Subject|31|||
37957727|NCT00460408|69644847|FG001|Overall Study|Withdrawal by Subject|0|||
38051204|NCT03697993|69740306|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
38051205|NCT03697993|69740305|FG000|Overall Study|Lost to Follow-up|3|||
38051206|NCT03697993|69740306|FG001|Overall Study|Lost to Follow-up|0|||
38051207|NCT03697993|69740305|FG000|Overall Study|Physician Decision|4|||
38051208|NCT03697993|69740306|FG001|Overall Study|Physician Decision|0|||
38051209|NCT03697993|69740305|FG000|Overall Study|Initial Urine Culture Negative|0|||
38051210|NCT03697993|69740306|FG001|Overall Study|Initial Urine Culture Negative|1|||
38051211|NCT03289455|69740316|FG000|Overall Study|Death|1|||
38051212|NCT03289455|69740317|FG001|Overall Study|Death|0|||
38051213|NCT03289455|69740318|FG002|Overall Study|Death|0|||
37957728|NCT00460408|69644848|FG002|Overall Study|Withdrawal by Subject|0|||
37957729|NCT00460408|69644849|FG003|Overall Study|Withdrawal by Subject|0|||
37957730|NCT00460408|69644846|FG000|Overall Study|Insufficient clinical response|5|||
37957731|NCT00460408|69644847|FG001|Overall Study|Insufficient clinical response|1|||
37957732|NCT00460408|69644848|FG002|Overall Study|Insufficient clinical response|5|||
37957733|NCT00460408|69644849|FG003|Overall Study|Insufficient clinical response|0|||
37957734|NCT00460408|69644846|FG000|Overall Study|Other|12|||
37957735|NCT00460408|69644847|FG001|Overall Study|Other|2|||
37957736|NCT00460408|69644848|FG002|Overall Study|Other|0|||
37957737|NCT00460408|69644849|FG003|Overall Study|Other|0|||
37957738|NCT00507819|69644859|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
37957739|NCT00507819|69644860|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
37957740|NCT00442936|69644890|FG000|Overall Study|Protocol Violation|1|||
37957741|NCT00442936|69644891|FG001|Overall Study|Protocol Violation|0|||
37957742|NCT00442936|69644892|FG002|Overall Study|Protocol Violation|1|||
37957743|NCT00442936|69644893|FG003|Overall Study|Protocol Violation|1|||
37957744|NCT00577655|69644905|FG000|Overall Study|Patient Request|0|||
37957745|NCT00577655|69644906|FG001|Overall Study|Patient Request|2|||
37957746|NCT00577655|69644905|FG000|Overall Study|Protocol Violation|0|||
37957747|NCT00577655|69644906|FG001|Overall Study|Protocol Violation|1|||
37957748|NCT00577655|69644905|FG000|Overall Study|Lost to Follow-up|1|||
37957749|NCT00577655|69644906|FG001|Overall Study|Lost to Follow-up|1|||
37957750|NCT00113269|69644917|FG000|Overall Study|Not transplanted, donor issues|4|||
37957751|NCT00113269|69644918|FG001|Overall Study|Not transplanted, donor issues|0|||
37957752|NCT00113269|69644919|FG002|Overall Study|Not transplanted, donor issues|2|||
37680321|NCT02586493|69155878|FG000|Overall Study|Withdrawal by Subject|1|||
37957753|NCT00113269|69644920|FG003|Overall Study|Not transplanted, donor issues|2|||
37957754|NCT00113269|69644917|FG000|Overall Study|Not transplanted, recipient issues|2|||
37957755|NCT00113269|69644918|FG001|Overall Study|Not transplanted, recipient issues|1|||
37957756|NCT00113269|69644919|FG002|Overall Study|Not transplanted, recipient issues|7|||
37957757|NCT00113269|69644920|FG003|Overall Study|Not transplanted, recipient issues|4|||
37957758|NCT00113269|69644917|FG000|Overall Study|Early graft loss, technical|0|||
37957759|NCT00113269|69644918|FG001|Overall Study|Early graft loss, technical|0|||
37957760|NCT00113269|69644919|FG002|Overall Study|Early graft loss, technical|2|||
37957761|NCT00113269|69644920|FG003|Overall Study|Early graft loss, technical|0|||
37957762|NCT00113269|69644917|FG000|Overall Study|Death in operating room|0|||
37957763|NCT00113269|69644918|FG001|Overall Study|Death in operating room|0|||
37957764|NCT00113269|69644919|FG002|Overall Study|Death in operating room|0|||
37957765|NCT00113269|69644920|FG003|Overall Study|Death in operating room|1|||
37957766|NCT00113269|69644917|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
37957767|NCT00113269|69644918|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
37957768|NCT00113269|69644919|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
37957769|NCT00113269|69644920|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
37957770|NCT00113269|69644917|FG000|Overall Study|Adverse Event|2|||
37957771|NCT00113269|69644918|FG001|Overall Study|Adverse Event|7|||
37957772|NCT00113269|69644919|FG002|Overall Study|Adverse Event|11|||
37957773|NCT00113269|69644920|FG003|Overall Study|Adverse Event|7|||
37957774|NCT00113269|69644917|FG000|Overall Study|Withdrawal by Subject|4|||
37957775|NCT00113269|69644918|FG001|Overall Study|Withdrawal by Subject|3|||
37957776|NCT00113269|69644919|FG002|Overall Study|Withdrawal by Subject|4|||
37957777|NCT00113269|69644920|FG003|Overall Study|Withdrawal by Subject|2|||
37957778|NCT00113269|69644917|FG000|Overall Study|Graft loss|6|||
37957779|NCT00113269|69644918|FG001|Overall Study|Graft loss|6|||
37957780|NCT00113269|69644919|FG002|Overall Study|Graft loss|4|||
37957781|NCT00113269|69644920|FG003|Overall Study|Graft loss|9|||
37957782|NCT00113269|69644917|FG000|Overall Study|Protocol Violation|1|||
37957783|NCT00113269|69644918|FG001|Overall Study|Protocol Violation|0|||
37957784|NCT00113269|69644919|FG002|Overall Study|Protocol Violation|4|||
37957785|NCT00113269|69644920|FG003|Overall Study|Protocol Violation|2|||
37957786|NCT00113269|69644917|FG000|Overall Study|Lost to Follow-up|2|||
37957787|NCT00113269|69644918|FG001|Overall Study|Lost to Follow-up|3|||
37957788|NCT00113269|69644919|FG002|Overall Study|Lost to Follow-up|6|||
37957789|NCT00113269|69644920|FG003|Overall Study|Lost to Follow-up|3|||
37957790|NCT00113269|69644917|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
37957791|NCT00113269|69644918|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
38051214|NCT03289455|69740316|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
37957792|NCT00113269|69644919|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
37957793|NCT00113269|69644920|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
37957794|NCT00113269|69644917|FG000|Overall Study|Discontinued due to rejection|0|||
37957795|NCT00113269|69644918|FG001|Overall Study|Discontinued due to rejection|0|||
37957796|NCT00113269|69644919|FG002|Overall Study|Discontinued due to rejection|1|||
37957797|NCT00113269|69644920|FG003|Overall Study|Discontinued due to rejection|0|||
37957798|NCT00113269|69644917|FG000|Overall Study|Moved|0|||
37957799|NCT00113269|69644918|FG001|Overall Study|Moved|1|||
37957800|NCT00113269|69644919|FG002|Overall Study|Moved|0|||
37957801|NCT00113269|69644920|FG003|Overall Study|Moved|3|||
37957802|NCT00113269|69644917|FG000|Overall Study|Received pancreas transplant|0|||
37957803|NCT00113269|69644918|FG001|Overall Study|Received pancreas transplant|0|||
37957804|NCT00113269|69644919|FG002|Overall Study|Received pancreas transplant|0|||
37957805|NCT00113269|69644920|FG003|Overall Study|Received pancreas transplant|2|||
37957806|NCT00113269|69644917|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
37957807|NCT00113269|69644918|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
37957808|NCT00113269|69644919|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
37957809|NCT00113269|69644920|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
37957810|NCT00113269|69644917|FG000|Overall Study|Did not meet eligibility criteria|1|||
37957811|NCT00113269|69644918|FG001|Overall Study|Did not meet eligibility criteria|0|||
37957812|NCT00113269|69644919|FG002|Overall Study|Did not meet eligibility criteria|0|||
37957813|NCT00113269|69644920|FG003|Overall Study|Did not meet eligibility criteria|1|||
37957814|NCT00113269|69644917|FG000|Overall Study|Unable to return for follow up|2|||
37957815|NCT00113269|69644918|FG001|Overall Study|Unable to return for follow up|1|||
37957816|NCT00113269|69644919|FG002|Overall Study|Unable to return for follow up|0|||
37957817|NCT00113269|69644920|FG003|Overall Study|Unable to return for follow up|0|||
37957818|NCT00515619|69644930|FG000|Overall Study|Adverse Event|34|||
37957819|NCT00515619|69644930|FG000|Overall Study|Lack of Efficacy|92|||
37957820|NCT00515619|69644930|FG000|Overall Study|Withdrawal by Subject|66|||
37957821|NCT00515619|69644930|FG000|Overall Study|Protocol Violation|3|||
37957822|NCT00515619|69644930|FG000|Overall Study|Lost to Follow-up|4|||
37957823|NCT00515619|69644930|FG000|Overall Study|Unsatisfactory compliance|6|||
37957824|NCT00515619|69644930|FG000|Overall Study|Other: Site discontinuing trials|2|||
37957825|NCT00515619|69644930|FG000|Overall Study|Other: Subject cannot attend visits|2|||
37957826|NCT00515619|69644930|FG000|Overall Study|Other: Subject required surgery|1|||
37957827|NCT00515619|69644930|FG000|Overall Study|Other: Subject moved to another country|1|||
37957828|NCT00515619|69644930|FG000|Overall Study|Other: Investigator decision|1|||
37957829|NCT00515619|69644930|FG000|Overall Study|Other: Subject became pregnant|1|||
37957830|NCT00515619|69644930|FG000|Overall Study|Other: Request from sponsor|1|||
37957831|NCT00515619|69644930|FG000|Overall Study|Other: Drug available on license|1|||
37957832|NCT00515619|69644930|FG000|Overall Study|Other: Subject interested in other AED|1|||
37957833|NCT00449644|69644938|FG000|Overall Study|Adverse Event|0|||
37957834|NCT00449644|69644939|FG001|Overall Study|Adverse Event|0|||
37957835|NCT00449644|69644940|FG002|Overall Study|Adverse Event|3|||
37957836|NCT00449644|69644941|FG003|Overall Study|Adverse Event|5|||
37957837|NCT00449644|69644938|FG000|Overall Study|Death|1|||
37957838|NCT00449644|69644939|FG001|Overall Study|Death|0|||
37957839|NCT00449644|69644940|FG002|Overall Study|Death|6|||
37957840|NCT00449644|69644941|FG003|Overall Study|Death|1|||
37957841|NCT00449644|69644938|FG000|Overall Study|Lost to Follow-up|1|||
37957842|NCT00449644|69644939|FG001|Overall Study|Lost to Follow-up|1|||
37957843|NCT00449644|69644940|FG002|Overall Study|Lost to Follow-up|5|||
37957844|NCT00449644|69644941|FG003|Overall Study|Lost to Follow-up|3|||
37957845|NCT00449644|69644938|FG000|Overall Study|Pregnancy|0|||
37957846|NCT00449644|69644939|FG001|Overall Study|Pregnancy|0|||
37957847|NCT00449644|69644940|FG002|Overall Study|Pregnancy|3|||
37957848|NCT00449644|69644941|FG003|Overall Study|Pregnancy|2|||
37957849|NCT00449644|69644938|FG000|Overall Study|Protocol Violation|4|||
37957850|NCT00449644|69644939|FG001|Overall Study|Protocol Violation|4|||
37957851|NCT00449644|69644940|FG002|Overall Study|Protocol Violation|3|||
37957852|NCT00449644|69644941|FG003|Overall Study|Protocol Violation|7|||
37957853|NCT00449644|69644938|FG000|Overall Study|Withdrawal by Subject|3|||
37957854|NCT00449644|69644939|FG001|Overall Study|Withdrawal by Subject|4|||
37957855|NCT00449644|69644940|FG002|Overall Study|Withdrawal by Subject|6|||
37957856|NCT00449644|69644941|FG003|Overall Study|Withdrawal by Subject|7|||
37957857|NCT00449644|69644938|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
37957858|NCT00449644|69644939|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
37957859|NCT00449644|69644940|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
37957860|NCT00449644|69644941|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
37957861|NCT00449644|69644938|FG000|Overall Study|Other|1|||
37957862|NCT00449644|69644939|FG001|Overall Study|Other|4|||
37957863|NCT00449644|69644940|FG002|Overall Study|Other|1|||
37957864|NCT00449644|69644941|FG003|Overall Study|Other|0|||
37957865|NCT00449644|69644938|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
37957866|NCT00449644|69644939|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
37957867|NCT00449644|69644940|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
37957868|NCT00449644|69644941|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
37957869|NCT00515541|69644958|FG000|Overall Study|Physician Decision|0|||
37957870|NCT00515541|69644959|FG001|Overall Study|Physician Decision|2|||
37957871|NCT00515541|69644960|FG002|Overall Study|Physician Decision|0|||
37957872|NCT00515541|69644961|FG003|Overall Study|Physician Decision|1|||
37957873|NCT00515541|69644958|FG000|Overall Study|No show for appointments|0|||
37957874|NCT00515541|69644959|FG001|Overall Study|No show for appointments|1|||
37957875|NCT00515541|69644960|FG002|Overall Study|No show for appointments|0|||
37957876|NCT00515541|69644961|FG003|Overall Study|No show for appointments|2|||
37957877|NCT00515541|69644958|FG000|Overall Study|Withdrawal by Subject|0|||
37957878|NCT00515541|69644959|FG001|Overall Study|Withdrawal by Subject|2|||
37957879|NCT00515541|69644960|FG002|Overall Study|Withdrawal by Subject|0|||
37957880|NCT00515541|69644961|FG003|Overall Study|Withdrawal by Subject|2|||
37957881|NCT00112489|69644971|FG000|Overall Study|Refused further treatment|8|||
37957882|NCT00112489|69644971|FG000|Overall Study|Adverse Event|12|||
37957883|NCT00112489|69644971|FG000|Overall Study|Death|2|||
37957884|NCT00112489|69644971|FG000|Overall Study|Other, Not Specified|9|||
37957885|NCT00112489|69644971|FG000|Overall Study|Patient never treated|2|||
37957886|NCT00112489|69644971|FG000|Overall Study|Ineligible|7|||
37957887|NCT00711971|69644984|FG000|Overall Study|Lost to Follow-up|3|||
37957888|NCT00711971|69644985|FG001|Overall Study|Lost to Follow-up|4|||
37957889|NCT00711971|69644986|FG002|Overall Study|Lost to Follow-up|1|||
37957890|NCT00515463|69645000|FG000|Overall Study|Physician Decision|4|||
37957891|NCT00515463|69645001|FG001|Overall Study|Physician Decision|2|||
37957892|NCT00515463|69645000|FG000|Overall Study|Adverse Event|1|||
37957893|NCT00515463|69645001|FG001|Overall Study|Adverse Event|2|||
37957894|NCT00515463|69645000|FG000|Overall Study|Withdrawal by Subject|3|||
37957895|NCT00515463|69645001|FG001|Overall Study|Withdrawal by Subject|4|||
37957896|NCT00515463|69645000|FG000|Overall Study|Lost to Follow-up|6|||
37957897|NCT00515463|69645001|FG001|Overall Study|Lost to Follow-up|5|||
37957898|NCT00515463|69645000|FG000|Overall Study|Other|0|||
37957899|NCT00515463|69645001|FG001|Overall Study|Other|1|||
37957900|NCT00507507|69645010|FG000|Treatment Period|Lost to Follow-up|0|||
37957901|NCT00507507|69645011|FG001|Treatment Period|Lost to Follow-up|2|||
37957902|NCT00507507|69645010|FG000|Treatment Period|Physician Decision|4|||
37957903|NCT00507507|69645011|FG001|Treatment Period|Physician Decision|1|||
37957904|NCT00507507|69645010|FG000|Treatment Period|Protocol Violation|1|||
37957905|NCT00507507|69645011|FG001|Treatment Period|Protocol Violation|2|||
37957906|NCT00507507|69645010|FG000|Treatment Period|Adverse Event|1|||
37957907|NCT00507507|69645011|FG001|Treatment Period|Adverse Event|1|||
37957908|NCT00507507|69645010|FG000|Treatment Period|Withdrawal by Subject|46|||
37957909|NCT00507507|69645011|FG001|Treatment Period|Withdrawal by Subject|47|||
37957910|NCT00507507|69645010|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
37957911|NCT00507507|69645011|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
37957912|NCT00507507|69645010|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
37957913|NCT00507507|69645011|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
37957914|NCT00507507|69645010|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
37957915|NCT00507507|69645011|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
37957916|NCT00459706|69645021|FG000|Overall Study|Adverse Event|19|||
37957917|NCT00459706|69645022|FG001|Overall Study|Adverse Event|13|||
37957918|NCT00459706|69645021|FG000|Overall Study|Withdrawal by Subject|1|||
37957919|NCT00459706|69645022|FG001|Overall Study|Withdrawal by Subject|6|||
37957920|NCT00459706|69645021|FG000|Overall Study|Physician Decision|2|||
37957921|NCT00459706|69645022|FG001|Overall Study|Physician Decision|0|||
37957922|NCT00459706|69645021|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
37957923|NCT00459706|69645022|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
37957924|NCT00459706|69645021|FG000|Overall Study|Protocol Violation|2|||
37957925|NCT00459706|69645022|FG001|Overall Study|Protocol Violation|1|||
37957926|NCT00459706|69645021|FG000|Overall Study|Failed to Return|1|||
37957927|NCT00459706|69645022|FG001|Overall Study|Failed to Return|0|||
37957928|NCT00459706|69645021|FG000|Overall Study|Other|0|||
37957929|NCT00459706|69645022|FG001|Overall Study|Other|1|||
37957930|NCT00507429|69645030|FG000|Treatment Phase|Disease Progression|12|||
37957931|NCT00507429|69645031|FG001|Treatment Phase|Disease Progression|5|||
37957932|NCT00507429|69645030|FG000|Treatment Phase|Adverse Event|12|||
37957933|NCT00507429|69645031|FG001|Treatment Phase|Adverse Event|5|||
37957934|NCT00507429|69645030|FG000|Treatment Phase|Withdrawal by Subject|3|||
37957935|NCT00507429|69645031|FG001|Treatment Phase|Withdrawal by Subject|3|||
37957936|NCT00507429|69645030|FG000|Treatment Phase|Physician Decision|4|||
37957937|NCT00507429|69645031|FG001|Treatment Phase|Physician Decision|2|||
37957938|NCT00507429|69645030|FG000|Treatment Phase|Other|6|||
37957939|NCT00507429|69645031|FG001|Treatment Phase|Other|3|||
37957940|NCT00507429|69645030|FG000|Maintenance Phase|Progressive Disease|14|||
37957941|NCT00507429|69645031|FG001|Maintenance Phase|Progressive Disease|0|||
37957942|NCT00449176|69645042|FG000|Overall Study|Withdrawal by Subject|39|||
37957943|NCT00449176|69645043|FG001|Overall Study|Withdrawal by Subject|43|||
38051215|NCT03289455|69740317|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
37957944|NCT00449176|69645044|FG002|Overall Study|Withdrawal by Subject|59|||
37957945|NCT00449176|69645042|FG000|Overall Study|Lost to Follow-up|13|||
37957946|NCT00449176|69645043|FG001|Overall Study|Lost to Follow-up|8|||
37957947|NCT00449176|69645044|FG002|Overall Study|Lost to Follow-up|12|||
37957948|NCT00449176|69645042|FG000|Overall Study|Adverse Event|51|||
37957949|NCT00449176|69645043|FG001|Overall Study|Adverse Event|107|||
37957950|NCT00449176|69645044|FG002|Overall Study|Adverse Event|15|||
37957951|NCT00449176|69645042|FG000|Overall Study|Lack of Efficacy|13|||
37957952|NCT00449176|69645043|FG001|Overall Study|Lack of Efficacy|7|||
37957953|NCT00449176|69645044|FG002|Overall Study|Lack of Efficacy|50|||
37957954|NCT00449176|69645042|FG000|Overall Study|Study drug non-compliant|14|||
37957955|NCT00449176|69645043|FG001|Overall Study|Study drug non-compliant|11|||
37957956|NCT00449176|69645044|FG002|Overall Study|Study drug non-compliant|11|||
37957957|NCT00449176|69645042|FG000|Overall Study|all other|22|||
37957958|NCT00449176|69645043|FG001|Overall Study|all other|19|||
37957959|NCT00449176|69645044|FG002|Overall Study|all other|20|||
37957960|NCT00515073|69645052|FG000|Overall Study|Withdrawal by Subject|1|||
37957961|NCT00515073|69645052|FG000|Overall Study|Physician Decision|1|||
37957962|NCT00710021|69645059|FG000|Overall Study|Lost to Follow-up|1|||
37957963|NCT00710021|69645060|FG001|Overall Study|Lost to Follow-up|0|||
37957964|NCT00710021|69645061|FG002|Overall Study|Lost to Follow-up|0|||
37957965|NCT00710021|69645059|FG000|Overall Study|Subject's Decision|0|||
37957966|NCT00710021|69645060|FG001|Overall Study|Subject's Decision|1|||
37957967|NCT00710021|69645061|FG002|Overall Study|Subject's Decision|0|||
37957968|NCT00710021|69645059|FG000|Overall Study|Subject misrandomized|0|||
37957969|NCT00710021|69645060|FG001|Overall Study|Subject misrandomized|1|||
37957970|NCT00710021|69645061|FG002|Overall Study|Subject misrandomized|1|||
37957971|NCT00710021|69645059|FG000|Overall Study|Physician Decision|0|||
37957972|NCT00710021|69645060|FG001|Overall Study|Physician Decision|1|||
37957973|NCT00710021|69645061|FG002|Overall Study|Physician Decision|0|||
37957974|NCT00504153|69645070|FG000|Overall Study|Withdrawal by Subject|1|||
37957975|NCT00504153|69645070|FG000|Overall Study|Adverse Event|4|||
37957976|NCT00504153|69645070|FG000|Overall Study|Death|1|||
37957977|NCT00442702|69645076|FG000|Titration Period|Adverse Event|2|||
37957978|NCT00442702|69645077|FG001|Titration Period|Adverse Event|0|||
37957979|NCT00442702|69645076|FG000|Titration Period|Death|3|||
37957980|NCT00442702|69645077|FG001|Titration Period|Death|2|||
37957981|NCT00442702|69645076|FG000|Titration Period|Insufficient Therapeutic Response|1|||
37957982|NCT00442702|69645077|FG001|Titration Period|Insufficient Therapeutic Response|0|||
37957983|NCT00442702|69645076|FG000|Titration Period|Refused Treatment|4|||
37957984|NCT00442702|69645077|FG001|Titration Period|Refused Treatment|1|||
37957985|NCT00442702|69645076|FG000|Titration Period|Failure to return|1|||
37957986|NCT00442702|69645077|FG001|Titration Period|Failure to return|0|||
37957987|NCT00442702|69645076|FG000|Titration Period|Hospitalized in another hospital|1|||
37957988|NCT00442702|69645077|FG001|Titration Period|Hospitalized in another hospital|0|||
37957989|NCT00442702|69645076|FG000|Evaluation Period|Adverse Event|1|||
37957990|NCT00442702|69645077|FG001|Evaluation Period|Adverse Event|0|||
37957991|NCT00442702|69645076|FG000|Evaluation Period|Death|1|||
37957992|NCT00442702|69645077|FG001|Evaluation Period|Death|1|||
37957993|NCT00442702|69645076|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
37957994|NCT00442702|69645077|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
37957995|NCT00442702|69645076|FG000|Evaluation Period|Refused treatment|1|||
37957996|NCT00442702|69645077|FG001|Evaluation Period|Refused treatment|1|||
37957997|NCT00442702|69645076|FG000|Evaluation Period|Renal transplant|0|||
37957998|NCT00442702|69645077|FG001|Evaluation Period|Renal transplant|1|||
37957999|NCT00442702|69645076|FG000|Evaluation Period|Failure to return|1|||
37958000|NCT00442702|69645077|FG001|Evaluation Period|Failure to return|0|||
37958001|NCT00442702|69645076|FG000|Evaluation Period|Site closure|0|||
37958002|NCT00442702|69645077|FG001|Evaluation Period|Site closure|1|||
37958003|NCT00514917|69645085|FG000|Overall Study|Death|4|||
37958004|NCT00514917|69645086|FG001|Overall Study|Death|10|||
37958005|NCT00514917|69645085|FG000|Overall Study|Protocol Violation|1|||
37958006|NCT00514917|69645086|FG001|Overall Study|Protocol Violation|0|||
37958007|NCT00514917|69645085|FG000|Overall Study|Lost to Follow-up|4|||
37958008|NCT00514917|69645086|FG001|Overall Study|Lost to Follow-up|3|||
37958009|NCT00514917|69645085|FG000|Overall Study|Withdrawal by Subject|18|||
37958010|NCT00514917|69645086|FG001|Overall Study|Withdrawal by Subject|16|||
37958011|NCT00514917|69645085|FG000|Overall Study|Discontinued due to study closure|88|||
37958012|NCT00514917|69645086|FG001|Overall Study|Discontinued due to study closure|81|||
37958013|NCT00514917|69645085|FG000|Overall Study|Undefined|11|||
37958014|NCT00514917|69645086|FG001|Overall Study|Undefined|5|||
37958015|NCT00711425|69645094|FG000|Overall Study|Protocol Violation|1|||
37958016|NCT00711425|69645094|FG000|Overall Study|Death|2|||
37958017|NCT00711425|69645094|FG000|Overall Study|Lost to Follow-up|1|||
37958018|NCT00504075|69645098|FG000|Overall Study|Adverse Event|1|||
37958019|NCT00504075|69645098|FG000|Overall Study|Lost to Follow-up|5|||
37958020|NCT00504075|69645098|FG000|Overall Study|Withdrawal by Subject|1|||
37958021|NCT00504075|69645098|FG000|Overall Study|Required other therapeutic intervention|1|||
37958022|NCT00503997|69645103|FG000|Overall Study|disease progression|1|||
37958023|NCT00503997|69645103|FG000|Overall Study|Adverse Event|5|||
37958024|NCT00503997|69645103|FG000|Overall Study|Death|1|||
37958025|NCT00503997|69645103|FG000|Overall Study|Withdrawal by Subject|1|||
37958026|NCT00096265|69645110|FG000|Overall Study|Ineligible|1|||
37958027|NCT00096265|69645111|FG001|Overall Study|Ineligible|0|||
37958028|NCT00096265|69645112|FG002|Overall Study|Ineligible|0|||
37958029|NCT00711191|69645124|FG000|Overall Study|Adverse Event|1|||
37958030|NCT00711191|69645125|FG001|Overall Study|Adverse Event|1|||
37958031|NCT00711191|69645126|FG002|Overall Study|Adverse Event|2|||
37958032|NCT00711191|69645124|FG000|Overall Study|Objective progression or relapse|2|||
37958033|NCT00711191|69645125|FG001|Overall Study|Objective progression or relapse|3|||
37958034|NCT00711191|69645126|FG002|Overall Study|Objective progression or relapse|7|||
37958035|NCT00711191|69645124|FG000|Overall Study|Withdrawal by Subject|0|||
37958036|NCT00711191|69645125|FG001|Overall Study|Withdrawal by Subject|1|||
37958037|NCT00711191|69645126|FG002|Overall Study|Withdrawal by Subject|3|||
37958038|NCT00706511|69645141|FG000|Overall Study|Withdrawal by Subject|1|||
37958039|NCT00706511|69645142|FG001|Overall Study|Withdrawal by Subject|0|||
37958040|NCT00706511|69645143|FG002|Overall Study|Withdrawal by Subject|0|||
37958041|NCT00706511|69645144|FG003|Overall Study|Withdrawal by Subject|0|||
37958042|NCT00448864|69645155|FG000|Overall Study|Death|1|||
37958043|NCT00448864|69645156|FG001|Overall Study|Death|0|||
37958044|NCT00448864|69645157|FG002|Overall Study|Death|0|||
37958045|NCT00448864|69645155|FG000|Overall Study|Lost to Follow-up|3|||
37958046|NCT00448864|69645156|FG001|Overall Study|Lost to Follow-up|1|||
37958047|NCT00448864|69645157|FG002|Overall Study|Lost to Follow-up|0|||
37958048|NCT00448864|69645155|FG000|Overall Study|Physician Decision|1|||
37958049|NCT00448864|69645156|FG001|Overall Study|Physician Decision|0|||
37958050|NCT00448864|69645157|FG002|Overall Study|Physician Decision|1|||
37958051|NCT00448864|69645155|FG000|Overall Study|Withdrawal by Subject|0|||
37958052|NCT00448864|69645156|FG001|Overall Study|Withdrawal by Subject|2|||
37958053|NCT00448864|69645157|FG002|Overall Study|Withdrawal by Subject|0|||
37958054|NCT00448864|69645155|FG000|Overall Study|Protocol Violation|0|||
37958055|NCT00448864|69645156|FG001|Overall Study|Protocol Violation|2|||
37958056|NCT00448864|69645157|FG002|Overall Study|Protocol Violation|0|||
37958057|NCT00567398|69645169|FG000|Overall Study|Adverse Event|6|||
37958058|NCT00567398|69645170|FG001|Overall Study|Adverse Event|14|||
37958059|NCT00567398|69645169|FG000|Overall Study|Physician Decision|0|||
37958060|NCT00567398|69645170|FG001|Overall Study|Physician Decision|4|||
37958061|NCT00567398|69645169|FG000|Overall Study|Withdrawal by Subject|0|||
37958062|NCT00567398|69645170|FG001|Overall Study|Withdrawal by Subject|2|||
37958063|NCT00567398|69645169|FG000|Overall Study|Renal Transplantation|0|||
37958064|NCT00567398|69645170|FG001|Overall Study|Renal Transplantation|3|||
37958065|NCT00567398|69645169|FG000|Overall Study|Other|1|||
37958066|NCT00567398|69645170|FG001|Overall Study|Other|0|||
37958067|NCT00448708|69645178|FG000|Overall Study|Death|21|||
37958068|NCT00448708|69645179|FG001|Overall Study|Death|17|||
37958069|NCT00448708|69645178|FG000|Overall Study|Withdrawal by Subject|8|||
37958070|NCT00448708|69645179|FG001|Overall Study|Withdrawal by Subject|4|||
37958071|NCT00448708|69645178|FG000|Overall Study|Lost to Follow-up|6|||
37958072|NCT00448708|69645179|FG001|Overall Study|Lost to Follow-up|8|||
37958073|NCT00448708|69645178|FG000|Overall Study|not listed|0|||
37958074|NCT00448708|69645179|FG001|Overall Study|not listed|2|||
37958075|NCT00706355|69645189|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
37958076|NCT00706355|69645190|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
37958077|NCT00706355|69645191|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
37958078|NCT00706355|69645192|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
37958079|NCT00706355|69645189|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
37958080|NCT00706355|69645190|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
37958081|NCT00706355|69645191|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
37958082|NCT00706355|69645192|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
37958083|NCT00706355|69645189|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
37958084|NCT00706355|69645190|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
37958085|NCT00706355|69645191|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
37958086|NCT00706355|69645192|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
37958087|NCT00706355|69645189|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
37958088|NCT00706355|69645190|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
37958089|NCT00706355|69645191|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
37958090|NCT00706355|69645192|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
37958091|NCT00706355|69645189|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
37958092|NCT00706355|69645190|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
37958093|NCT00706355|69645191|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
37958094|NCT00706355|69645192|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
37958095|NCT00706355|69645189|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
37958096|NCT00706355|69645190|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
37958097|NCT00706355|69645191|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
37958098|NCT00706355|69645192|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
37958099|NCT00706355|69645189|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
37958100|NCT00706355|69645190|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
37958101|NCT00706355|69645191|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
37958102|NCT00706355|69645192|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
37958103|NCT00706355|69645189|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
37958104|NCT00706355|69645190|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
37958105|NCT00706355|69645191|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
37958106|NCT00706355|69645192|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
37958107|NCT00706355|69645189|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
37958108|NCT00706355|69645190|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
37958109|NCT00706355|69645191|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
37958110|NCT00706355|69645192|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
37958111|NCT00711113|69645204|FG000|Overall Study|Lost to Follow-up|9|||
37958112|NCT00711113|69645204|FG000|Overall Study|Implant lost|2|||
37958113|NCT00710879|69645214|FG000|Overall Study|Lost to Follow-up|2|||
37958114|NCT00710879|69645215|FG001|Overall Study|Lost to Follow-up|1|||
37958115|NCT00710879|69645214|FG000|Overall Study|Protocol Violation|0|||
37958116|NCT00710879|69645215|FG001|Overall Study|Protocol Violation|3|||
37958117|NCT03979274|69645221|FG000|Treatment Period 2|Withdrawal by Subject|0|||
37958118|NCT03979274|69645222|FG001|Treatment Period 2|Withdrawal by Subject|1|||
37958119|NCT00459316|69645232|FG000|Steps 1 & 2|Other eligibility failure|1|||
37958120|NCT00459316|69645233|FG001|Steps 1 & 2|Other eligibility failure|1|||
37958121|NCT00459316|69645234|FG002|Steps 1 & 2|Other eligibility failure|0|||
37958122|NCT00459316|69645232|FG000|Steps 1 & 2|Death|1|||
37958123|NCT00459316|69645233|FG001|Steps 1 & 2|Death|1|||
37958124|NCT00459316|69645234|FG002|Steps 1 & 2|Death|0|||
37958125|NCT00459316|69645232|FG000|Steps 1 & 2|Not able to get to clinic|7|||
37958126|NCT00459316|69645233|FG001|Steps 1 & 2|Not able to get to clinic|4|||
37958127|NCT00459316|69645234|FG002|Steps 1 & 2|Not able to get to clinic|0|||
37958128|NCT00459316|69645232|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
37958129|NCT00459316|69645233|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
37958130|NCT00459316|69645234|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
37958131|NCT00459316|69645232|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
37958132|NCT00459316|69645233|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
37958133|NCT00459316|69645234|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
37958134|NCT00459316|69645232|FG000|Steps 1 & 2|Lost to Follow-up|5|||
37958135|NCT00459316|69645233|FG001|Steps 1 & 2|Lost to Follow-up|0|||
37958136|NCT00459316|69645234|FG002|Steps 1 & 2|Lost to Follow-up|2|||
37958137|NCT00459316|69645232|FG000|Step 3|Withdrawal by Subject|3|||
37958138|NCT00459316|69645233|FG001|Step 3|Withdrawal by Subject|0|||
37958139|NCT00459316|69645234|FG002|Step 3|Withdrawal by Subject|1|||
37958140|NCT05445557|69645266|FG000|Double Blind Part|Lost to Follow-up|1|||
37958141|NCT05299892|69645285|FG000|Overall Study|Withdrawal by Subject|2|||
37958142|NCT05074498|69645305|FG000|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
37958143|NCT05074498|69645306|FG001|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
37958144|NCT05074498|69645307|FG002|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
38051216|NCT03289455|69740318|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
38051217|NCT03289455|69740316|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
38051218|NCT03289455|69740317|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
38051219|NCT03289455|69740318|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
38051220|NCT03289455|69740316|FG000|Overall Study|Progressive disease|3|||
38051221|NCT03289455|69740317|FG001|Overall Study|Progressive disease|4|||
38051222|NCT03289455|69740318|FG002|Overall Study|Progressive disease|5|||
38051223|NCT04484857|69740327|FG000|Overall Study|Adverse Event|2|||
38051224|NCT04484857|69740327|FG000|Overall Study|Death|10|||
38051225|NCT04484857|69740327|FG000|Overall Study|Withdrawal by Subject|3|||
38051226|NCT04484857|69740327|FG000|Overall Study|Transferred/Relocation|5|||
38051227|NCT04484857|69740327|FG000|Overall Study|Kidney Transplant|7|||
38051228|NCT04484857|69740327|FG000|Overall Study|Other than specified|4|||
38051229|NCT04484857|69740327|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
38051230|NCT04095793|69740331|FG000|Overall Study|Adverse Event|3|||
38051231|NCT04095793|69740331|FG000|Overall Study|Study Terminated by Sponsor|103|||
38051232|NCT04095793|69740331|FG000|Overall Study|Withdrawal by Subject|4|||
38051233|NCT04482439|69740335|FG000|Overall Study|Lost to Follow-up|1|||
38051234|NCT04482439|69740335|FG000|Overall Study|Unrelated illness|1|||
38051235|NCT04535947|69740342|FG000|Overall Study|Adverse Event|1|||
38051236|NCT04535947|69740343|FG001|Overall Study|Adverse Event|4|||
37958145|NCT05074498|69645308|FG003|Part 1 (Upto Day 104)|Lost to Follow-up|1|||
37958146|NCT05074498|69645309|FG004|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
37958147|NCT05074498|69645310|FG005|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
37958148|NCT05074498|69645305|FG000|Part 1 (Upto Day 104)|Other|1|||
37958149|NCT05074498|69645306|FG001|Part 1 (Upto Day 104)|Other|0|||
37958150|NCT05074498|69645307|FG002|Part 1 (Upto Day 104)|Other|0|||
37958151|NCT05074498|69645308|FG003|Part 1 (Upto Day 104)|Other|0|||
37958152|NCT05074498|69645309|FG004|Part 1 (Upto Day 104)|Other|0|||
37958153|NCT05074498|69645310|FG005|Part 1 (Upto Day 104)|Other|0|||
37958154|NCT05074498|69645305|FG000|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
37958155|NCT05074498|69645306|FG001|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
37958156|NCT05074498|69645307|FG002|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
37958157|NCT05074498|69645308|FG003|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
37958158|NCT05074498|69645309|FG004|Part 2 (Upto Day 104)|Withdrawal by Subject|2|||
37958159|NCT05074498|69645310|FG005|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
37958160|NCT05074498|69645305|FG000|Part 2 (Upto Day 104)|Death|0|||
37958161|NCT05074498|69645306|FG001|Part 2 (Upto Day 104)|Death|0|||
37958162|NCT05074498|69645307|FG002|Part 2 (Upto Day 104)|Death|0|||
37958163|NCT05074498|69645308|FG003|Part 2 (Upto Day 104)|Death|0|||
37958164|NCT05074498|69645309|FG004|Part 2 (Upto Day 104)|Death|1|||
37958165|NCT05074498|69645310|FG005|Part 2 (Upto Day 104)|Death|0|||
37958166|NCT05074498|69645305|FG000|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
37958167|NCT05074498|69645306|FG001|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
37958168|NCT05074498|69645307|FG002|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
37958169|NCT05074498|69645308|FG003|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
37958170|NCT05074498|69645309|FG004|Part 2 (Upto Day 104)|Lost to Follow-up|1|||
37958171|NCT05074498|69645310|FG005|Part 2 (Upto Day 104)|Lost to Follow-up|2|||
37958172|NCT05074498|69645305|FG000|Part 2 (Upto Day 104)|Other|0|||
37958173|NCT05074498|69645306|FG001|Part 2 (Upto Day 104)|Other|0|||
38051237|NCT04535947|69740342|FG000|Overall Study|Other reasons not specified|2|||
38051238|NCT04535947|69740343|FG001|Overall Study|Other reasons not specified|0|||
38051239|NCT04535947|69740342|FG000|Overall Study|Withdrawal by Subject|1|||
38051240|NCT04535947|69740343|FG001|Overall Study|Withdrawal by Subject|1|||
38051241|NCT04474405|69740355|FG000|Overall Study|Withdrawal by Subject|0|||
38051242|NCT04474405|69740356|FG001|Overall Study|Withdrawal by Subject|0|||
38051243|NCT04474405|69740357|FG002|Overall Study|Withdrawal by Subject|1|||
38051244|NCT04474405|69740358|FG003|Overall Study|Withdrawal by Subject|0|||
38051245|NCT04474405|69740359|FG004|Overall Study|Withdrawal by Subject|1|||
38051246|NCT04474405|69740360|FG005|Overall Study|Withdrawal by Subject|0|||
38051247|NCT04474405|69740355|FG000|Overall Study|Other|0|||
38051248|NCT04474405|69740356|FG001|Overall Study|Other|0|||
38051249|NCT04474405|69740357|FG002|Overall Study|Other|0|||
38051250|NCT04474405|69740358|FG003|Overall Study|Other|0|||
38051251|NCT04474405|69740359|FG004|Overall Study|Other|3|||
38051252|NCT04474405|69740360|FG005|Overall Study|Other|0|||
38051253|NCT04531813|69740374|FG000|Overall Study|Protocol Violation|1|||
38051254|NCT04531813|69740374|FG000|Overall Study|Withdrawal by Subject|1|||
38051255|NCT03538444|69740380|FG000|Overall Study|opioid withdrawal|1|||
38051256|NCT03538444|69740381|FG001|Overall Study|opioid withdrawal|0|||
37958174|NCT05074498|69645307|FG002|Part 2 (Upto Day 104)|Other|0|||
37958175|NCT05074498|69645308|FG003|Part 2 (Upto Day 104)|Other|0|||
37958176|NCT05074498|69645309|FG004|Part 2 (Upto Day 104)|Other|1|||
37958177|NCT05074498|69645310|FG005|Part 2 (Upto Day 104)|Other|0|||
37958178|NCT04871113|69645360|FG000|SOC Follow-up (SOC Day 1 to 27 Months)|Ongoing|0|||
37958179|NCT04871113|69645361|FG001|SOC Follow-up (SOC Day 1 to 27 Months)|Ongoing|0|||
37958180|NCT04871113|69645362|FG002|SOC Follow-up (SOC Day 1 to 27 Months)|Ongoing|0|||
37958181|NCT04871113|69645363|FG003|SOC Follow-up (SOC Day 1 to 27 Months)|Ongoing|0|||
37958182|NCT04871113|69645364|FG004|SOC Follow-up (SOC Day 1 to 27 Months)|Ongoing|0|||
37958183|NCT04871113|69645365|FG005|SOC Follow-up (SOC Day 1 to 27 Months)|Ongoing|7|||
37958184|NCT04871113|69645366|FG006|SOC Follow-up (SOC Day 1 to 27 Months)|Ongoing|5|||
37958185|NCT04871113|69645367|FG007|SOC Follow-up (SOC Day 1 to 27 Months)|Ongoing|16|||
37958186|NCT04871113|69645368|FG008|SOC Follow-up (SOC Day 1 to 27 Months)|Ongoing|16|||
37958187|NCT04871113|69645369|FG009|SOC Follow-up (SOC Day 1 to 27 Months)|Ongoing|16|||
37958188|NCT04871113|69645360|FG000|SOC Follow-up (SOC Day 1 to 27 Months)|Withdrawal by Subject|0|||
37958189|NCT04871113|69645361|FG001|SOC Follow-up (SOC Day 1 to 27 Months)|Withdrawal by Subject|0|||
37958190|NCT04871113|69645362|FG002|SOC Follow-up (SOC Day 1 to 27 Months)|Withdrawal by Subject|0|||
37958191|NCT04871113|69645363|FG003|SOC Follow-up (SOC Day 1 to 27 Months)|Withdrawal by Subject|0|||
37958192|NCT04871113|69645364|FG004|SOC Follow-up (SOC Day 1 to 27 Months)|Withdrawal by Subject|0|||
37958193|NCT04871113|69645365|FG005|SOC Follow-up (SOC Day 1 to 27 Months)|Withdrawal by Subject|0|||
37958194|NCT04871113|69645366|FG006|SOC Follow-up (SOC Day 1 to 27 Months)|Withdrawal by Subject|1|||
37958195|NCT04871113|69645367|FG007|SOC Follow-up (SOC Day 1 to 27 Months)|Withdrawal by Subject|0|||
38051257|NCT01199302|69740391|FG000|Overall Study|Adverse Event|1|||
38051258|NCT01199302|69740392|FG001|Overall Study|Adverse Event|1|||
38051259|NCT01199302|69740393|FG002|Overall Study|Adverse Event|2|||
38051260|NCT01199302|69740394|FG003|Overall Study|Adverse Event|0|||
38051261|NCT01199302|69740391|FG000|Overall Study|Withdrawal by Subject|2|||
38051262|NCT01199302|69740392|FG001|Overall Study|Withdrawal by Subject|2|||
38051263|NCT01199302|69740393|FG002|Overall Study|Withdrawal by Subject|3|||
38051264|NCT01199302|69740394|FG003|Overall Study|Withdrawal by Subject|0|||
37958196|NCT04871113|69645368|FG008|SOC Follow-up (SOC Day 1 to 27 Months)|Withdrawal by Subject|0|||
37958197|NCT04871113|69645369|FG009|SOC Follow-up (SOC Day 1 to 27 Months)|Withdrawal by Subject|0|||
37958198|NCT04715230|69645393|FG000|Overall Study|Withdrawal by Subject|1|||
37958199|NCT04715230|69645394|FG001|Overall Study|Withdrawal by Subject|0|||
37958200|NCT04715230|69645395|FG002|Overall Study|Withdrawal by Subject|0|||
37958201|NCT04715230|69645393|FG000|Overall Study|Lost to Follow-up|0|||
37958202|NCT04715230|69645394|FG001|Overall Study|Lost to Follow-up|5|||
37958203|NCT04715230|69645395|FG002|Overall Study|Lost to Follow-up|1|||
37958204|NCT04710368|69645403|FG000|Overall Study|Withdrawal by Subject|9|||
37958205|NCT04710368|69645403|FG000|Overall Study|Lost to Follow-up|4|||
37958206|NCT04710368|69645403|FG000|Overall Study|Death|2|||
37958207|NCT04710368|69645403|FG000|Overall Study|Patient preference|11|||
37958208|NCT04710368|69645403|FG000|Overall Study|Treatment discontinuation|1|||
37958209|NCT04590963|69645435|FG000|Overall Study|Death|118|||
37958210|NCT04590963|69645436|FG001|Overall Study|Death|59|||
37958211|NCT04590963|69645435|FG000|Overall Study|Lost to Follow-up|1|||
37958212|NCT04590963|69645436|FG001|Overall Study|Lost to Follow-up|1|||
37958213|NCT04590963|69645435|FG000|Overall Study|Progressive disease|0|||
37958214|NCT04590963|69645436|FG001|Overall Study|Progressive disease|1|||
37958215|NCT04590963|69645435|FG000|Overall Study|Study terminated by sponsor|103|||
37958216|NCT04590963|69645436|FG001|Overall Study|Study terminated by sponsor|50|||
37958217|NCT04590963|69645435|FG000|Overall Study|Withdrawal by Subject|15|||
37958218|NCT04590963|69645436|FG001|Overall Study|Withdrawal by Subject|8|||
37958219|NCT04590963|69645435|FG000|Overall Study|Ongoing at data cut-off|9|||
37958220|NCT04590963|69645436|FG001|Overall Study|Ongoing at data cut-off|4|||
37958221|NCT04590963|69645435|FG000|Overall Study|Screen failure|1|||
37958222|NCT04590963|69645436|FG001|Overall Study|Screen failure|0|||
37958223|NCT04493216|69645446|FG000|Overall Study|Adverse Event|1|||
37958224|NCT04493216|69645447|FG001|Overall Study|Adverse Event|4|||
37958225|NCT04493216|69645448|FG002|Overall Study|Adverse Event|5|||
37958226|NCT04493216|69645449|FG003|Overall Study|Adverse Event|2|||
37958227|NCT04493216|69645446|FG000|Overall Study|Lost to Follow-up|1|||
37958228|NCT04493216|69645447|FG001|Overall Study|Lost to Follow-up|1|||
37958229|NCT04493216|69645448|FG002|Overall Study|Lost to Follow-up|0|||
37958230|NCT04493216|69645449|FG003|Overall Study|Lost to Follow-up|1|||
37958231|NCT04493216|69645446|FG000|Overall Study|Physician Decision|0|||
37958232|NCT04493216|69645447|FG001|Overall Study|Physician Decision|0|||
37958233|NCT04493216|69645448|FG002|Overall Study|Physician Decision|1|||
37958234|NCT04493216|69645449|FG003|Overall Study|Physician Decision|0|||
37958235|NCT04493216|69645446|FG000|Overall Study|Withdrawal by Subject|1|||
37958236|NCT04493216|69645447|FG001|Overall Study|Withdrawal by Subject|1|||
37958237|NCT04493216|69645448|FG002|Overall Study|Withdrawal by Subject|1|||
37958238|NCT04493216|69645449|FG003|Overall Study|Withdrawal by Subject|2|||
37958239|NCT04493216|69645446|FG000|Overall Study|Ongoing|18|||
37958240|NCT04493216|69645447|FG001|Overall Study|Ongoing|18|||
37958241|NCT04493216|69645448|FG002|Overall Study|Ongoing|16|||
37958242|NCT04493216|69645449|FG003|Overall Study|Ongoing|16|||
37958243|NCT04493216|69645446|FG000|Overall Study|Site closed|14|||
37958244|NCT04493216|69645447|FG001|Overall Study|Site closed|15|||
37958245|NCT04493216|69645448|FG002|Overall Study|Site closed|11|||
37958246|NCT04493216|69645449|FG003|Overall Study|Site closed|11|||
37958247|NCT04493216|69645446|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|4|||
37958248|NCT04493216|69645447|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|2|||
37958249|NCT04493216|69645448|FG002|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|8|||
37958250|NCT04493216|69645449|FG003|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|2|||
37958251|NCT04493216|69645446|FG000|Overall Study|Protocol Deviation|1|||
37958252|NCT04493216|69645447|FG001|Overall Study|Protocol Deviation|2|||
37958253|NCT04493216|69645448|FG002|Overall Study|Protocol Deviation|0|||
37958254|NCT04493216|69645449|FG003|Overall Study|Protocol Deviation|2|||
37958255|NCT04329949|69645480|FG000|Overall Study|Death|36|||
37958256|NCT04329949|69645480|FG000|Overall Study|Withdrawal by Subject|4|||
37862033|NCT01135017|69545794|FG001|Overall Study|Adverse Event|8|||
37958257|NCT04329949|69645480|FG000|Overall Study|Termination of study by sponsor|3|||
37958258|NCT04290624|69645486|FG000|Overall Study|Adverse Event|1|||
37958259|NCT04290624|69645487|FG001|Overall Study|Adverse Event|0|||
37958260|NCT04288115|69645495|FG000|Overall Study|Withdrawal by Subject|0|||
37958261|NCT04288115|69645496|FG001|Overall Study|Withdrawal by Subject|1|||
37958262|NCT04288115|69645495|FG000|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|3|||
37958263|NCT04288115|69645496|FG001|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|2|||
38051265|NCT01199302|69740391|FG000|Overall Study|Disease Progression|3|||
37958264|NCT04287868|69645507|FG000|Overall Study|Screening fail|1|||
37958265|NCT04287868|69645508|FG001|Overall Study|Screening fail|0|||
37958266|NCT04276935|69645519|FG000|Overall Study|Lost to Follow-up|3|||
37958267|NCT04191096|69645525|FG000|Overall Study|Death|102|||
37958268|NCT04191096|69645526|FG001|Overall Study|Death|89|||
37958269|NCT04191096|69645525|FG000|Overall Study|Lost to Follow-up|1|||
37958270|NCT04191096|69645526|FG001|Overall Study|Lost to Follow-up|1|||
37958271|NCT04191096|69645525|FG000|Overall Study|Withdrawal by Subject|5|||
37958272|NCT04191096|69645526|FG001|Overall Study|Withdrawal by Subject|5|||
37958273|NCT04191096|69645525|FG000|Overall Study|Participants Ongoing|518|||
37958274|NCT04191096|69645526|FG001|Overall Study|Participants Ongoing|530|||
37958275|NCT04152200|69645534|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
37958276|NCT04152200|69645535|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
37958277|NCT04145531|69645547|FG000|Part A|Adverse Event|2|||
37958278|NCT04145531|69645548|FG001|Part A|Adverse Event|12|||
37958279|NCT04145531|69645549|FG002|Part A|Adverse Event|6|||
37958280|NCT04145531|69645550|FG003|Part A|Adverse Event|0|||
37958281|NCT04145531|69645547|FG000|Part A|Death|1|||
37958282|NCT04145531|69645548|FG001|Part A|Death|2|||
37958283|NCT04145531|69645549|FG002|Part A|Death|0|||
37958284|NCT04145531|69645550|FG003|Part A|Death|0|||
37958285|NCT04145531|69645547|FG000|Part A|Physician Decision|2|||
37958286|NCT04145531|69645548|FG001|Part A|Physician Decision|5|||
37958287|NCT04145531|69645549|FG002|Part A|Physician Decision|2|||
37958288|NCT04145531|69645550|FG003|Part A|Physician Decision|0|||
37958289|NCT04145531|69645547|FG000|Part A|Progressive disease|0|||
37958290|NCT04145531|69645548|FG001|Part A|Progressive disease|2|||
37958291|NCT04145531|69645549|FG002|Part A|Progressive disease|1|||
37958292|NCT04145531|69645550|FG003|Part A|Progressive disease|0|||
37958293|NCT04145531|69645547|FG000|Part A|Protocol deviation|0|||
37958294|NCT04145531|69645548|FG001|Part A|Protocol deviation|0|||
37958295|NCT04145531|69645549|FG002|Part A|Protocol deviation|1|||
37958296|NCT04145531|69645550|FG003|Part A|Protocol deviation|0|||
37958297|NCT04145531|69645547|FG000|Part A|Withdrawal by parent or guardian|1|||
37958298|NCT04145531|69645548|FG001|Part A|Withdrawal by parent or guardian|0|||
37958299|NCT04145531|69645549|FG002|Part A|Withdrawal by parent or guardian|0|||
37958300|NCT04145531|69645550|FG003|Part A|Withdrawal by parent or guardian|0|||
37958301|NCT04145531|69645547|FG000|Part A|Withdrawal by participant|0|||
37958302|NCT04145531|69645548|FG001|Part A|Withdrawal by participant|0|||
37958303|NCT04145531|69645549|FG002|Part A|Withdrawal by participant|1|||
37958304|NCT04145531|69645550|FG003|Part A|Withdrawal by participant|0|||
37958305|NCT04145531|69645547|FG000|Part A|Other|0|||
37958306|NCT04145531|69645548|FG001|Part A|Other|0|||
37958307|NCT04145531|69645549|FG002|Part A|Other|1|||
37958308|NCT04145531|69645550|FG003|Part A|Other|0|||
37958309|NCT04145531|69645547|FG000|Part B|Adverse Event|0|||
37958310|NCT04145531|69645548|FG001|Part B|Adverse Event|0|||
37958311|NCT04145531|69645549|FG002|Part B|Adverse Event|0|||
37958312|NCT04145531|69645550|FG003|Part B|Adverse Event|21|||
37958313|NCT04145531|69645547|FG000|Part B|Physician Decision|0|||
37958314|NCT04145531|69645548|FG001|Part B|Physician Decision|0|||
37958315|NCT04145531|69645549|FG002|Part B|Physician Decision|0|||
37958316|NCT04145531|69645550|FG003|Part B|Physician Decision|7|||
37958317|NCT04145531|69645547|FG000|Part B|Progressive disease|0|||
37958318|NCT04145531|69645548|FG001|Part B|Progressive disease|0|||
37958319|NCT04145531|69645549|FG002|Part B|Progressive disease|0|||
37958320|NCT04145531|69645550|FG003|Part B|Progressive disease|1|||
37958321|NCT04145531|69645547|FG000|Part B|Recurrent disease|0|||
37958322|NCT04145531|69645548|FG001|Part B|Recurrent disease|0|||
37958323|NCT04145531|69645549|FG002|Part B|Recurrent disease|0|||
37958324|NCT04145531|69645550|FG003|Part B|Recurrent disease|1|||
37958325|NCT04145531|69645547|FG000|Part B|Withdrawal by parent or guardian|0|||
37958326|NCT04145531|69645548|FG001|Part B|Withdrawal by parent or guardian|0|||
37958327|NCT04145531|69645549|FG002|Part B|Withdrawal by parent or guardian|0|||
37958328|NCT04145531|69645550|FG003|Part B|Withdrawal by parent or guardian|3|||
37958329|NCT04145531|69645547|FG000|Part B|Withdrawal by participant|0|||
37958330|NCT04145531|69645548|FG001|Part B|Withdrawal by participant|0|||
37958331|NCT04145531|69645549|FG002|Part B|Withdrawal by participant|0|||
37958332|NCT04145531|69645550|FG003|Part B|Withdrawal by participant|1|||
37958333|NCT04145531|69645547|FG000|Part B|Other|0|||
37958334|NCT04145531|69645548|FG001|Part B|Other|0|||
37958335|NCT04145531|69645549|FG002|Part B|Other|0|||
37958336|NCT04145531|69645550|FG003|Part B|Other|1|||
37958337|NCT04124692|69645562|FG000|Overall Study|Medical reason|0|||
37958338|NCT04124692|69645563|FG001|Overall Study|Medical reason|1|||
37958339|NCT04124692|69645562|FG000|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|2|||
37958340|NCT04124692|69645563|FG001|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|1|||
37958341|NCT04124692|69645562|FG000|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|1|||
37958342|NCT04124692|69645563|FG001|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|3|||
37958343|NCT04124692|69645562|FG000|Overall Study|Lost to Follow-up|2|||
37958344|NCT04124692|69645563|FG001|Overall Study|Lost to Follow-up|4|||
37958345|NCT04124692|69645562|FG000|Overall Study|Screen failure due to previous use of Radiesse|1|||
37958346|NCT04124692|69645563|FG001|Overall Study|Screen failure due to previous use of Radiesse|0|||
37958347|NCT04102098|69645574|FG000|Main Study Period|Ongoing in study|302|||
37958348|NCT04102098|69645575|FG001|Main Study Period|Ongoing in study|291|||
37958349|NCT04102098|69645574|FG000|Main Study Period|Death|20|||
37958350|NCT04102098|69645575|FG001|Main Study Period|Death|27|||
37958351|NCT04102098|69645574|FG000|Main Study Period|Lost to Follow-up|1|||
37958352|NCT04102098|69645575|FG001|Main Study Period|Lost to Follow-up|1|||
37958353|NCT04102098|69645574|FG000|Main Study Period|Physician Decision|0|||
37958354|NCT04102098|69645575|FG001|Main Study Period|Physician Decision|1|||
37958355|NCT04102098|69645574|FG000|Main Study Period|Withdrawal by Subject|11|||
37958356|NCT04102098|69645575|FG001|Main Study Period|Withdrawal by Subject|14|||
37958357|NCT04102098|69645574|FG000|Crossover: AS Who Crossed Over|Withdrawal by Subject|1|||
37958358|NCT04102098|69645575|FG001|Crossover: AS Who Crossed Over|Withdrawal by Subject|0|||
37958359|NCT04102098|69645574|FG000|Crossover: AS Who Crossed Over|Death|11|||
37958360|NCT04102098|69645575|FG001|Crossover: AS Who Crossed Over|Death|0|||
37958361|NCT04102098|69645574|FG000|Crossover: AS Who Crossed Over|Ongoing in study|69|||
37958362|NCT04102098|69645575|FG001|Crossover: AS Who Crossed Over|Ongoing in study|0|||
37958363|NCT04018066|69645596|FG000|Overall Study|participants started taking medications during the study period|3|||
37958364|NCT04018066|69645596|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
37958365|NCT03905694|69645601|FG000|Long-term Extension Period|Remained in this Period at Time of Data Cut|18|||
37958366|NCT03811249|69645605|FG000|Overall Study|Withdrawal by Subject|44|||
37958367|NCT03811249|69645605|FG000|Overall Study|Missed Visit|24|||
37958368|NCT03759379|69645613|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
37958369|NCT03759379|69645614|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
37958370|NCT03759379|69645613|FG000|Treatment Period|Death|2|||
37958371|NCT03759379|69645614|FG001|Treatment Period|Death|3|||
37958372|NCT03759379|69645613|FG000|Treatment Period|Lost to Follow-up|1|||
37958373|NCT03759379|69645614|FG001|Treatment Period|Lost to Follow-up|0|||
37958374|NCT03759379|69645613|FG000|Treatment Period|Physician Decision|0|||
37958375|NCT03759379|69645614|FG001|Treatment Period|Physician Decision|1|||
37958376|NCT03681184|69645622|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
37958377|NCT03681184|69645623|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
37958378|NCT03681184|69645622|FG000|3-Month Blinded Extension Period|Remained in this Period at Time of Data Cut|12|||
37958379|NCT03681184|69645623|FG001|3-Month Blinded Extension Period|Remained in this Period at Time of Data Cut|23|||
37958380|NCT03681184|69645622|FG000|Open-Label Extension Period|Remained in this Period at Time of Data Cut|1|||
37958381|NCT03681184|69645623|FG001|Open-Label Extension Period|Remained in this Period at Time of Data Cut|1|||
37958382|NCT03678688|69645638|FG000|Overall Study|Reason not Specified|0|||
37958383|NCT03678688|69645639|FG001|Overall Study|Reason not Specified|0|||
37958384|NCT03678688|69645640|FG002|Overall Study|Reason not Specified|3|||
37958385|NCT03678688|69645641|FG003|Overall Study|Reason not Specified|0|||
37958386|NCT03678688|69645642|FG004|Overall Study|Reason not Specified|1|||
37958387|NCT03678688|69645643|FG005|Overall Study|Reason not Specified|0|||
37958388|NCT03678688|69645644|FG006|Overall Study|Reason not Specified|0|||
37958389|NCT03678688|69645645|FG007|Overall Study|Reason not Specified|0|||
37958390|NCT03678688|69645646|FG008|Overall Study|Reason not Specified|0|||
37958391|NCT03678688|69645638|FG000|Overall Study|Non-Covid Related Adverse Event|0|||
37958392|NCT03678688|69645639|FG001|Overall Study|Non-Covid Related Adverse Event|0|||
37958393|NCT03678688|69645640|FG002|Overall Study|Non-Covid Related Adverse Event|0|||
37958394|NCT03678688|69645641|FG003|Overall Study|Non-Covid Related Adverse Event|1|||
37958395|NCT03678688|69645642|FG004|Overall Study|Non-Covid Related Adverse Event|0|||
37958396|NCT03678688|69645643|FG005|Overall Study|Non-Covid Related Adverse Event|0|||
37958397|NCT03678688|69645644|FG006|Overall Study|Non-Covid Related Adverse Event|2|||
37958398|NCT03678688|69645645|FG007|Overall Study|Non-Covid Related Adverse Event|1|||
37958399|NCT03678688|69645646|FG008|Overall Study|Non-Covid Related Adverse Event|0|||
37958400|NCT03678688|69645638|FG000|Overall Study|Covid Related Adverse Event|0|||
37958401|NCT03678688|69645639|FG001|Overall Study|Covid Related Adverse Event|0|||
37958402|NCT03678688|69645640|FG002|Overall Study|Covid Related Adverse Event|0|||
37958403|NCT03678688|69645641|FG003|Overall Study|Covid Related Adverse Event|0|||
37958404|NCT03678688|69645642|FG004|Overall Study|Covid Related Adverse Event|0|||
37958405|NCT03678688|69645643|FG005|Overall Study|Covid Related Adverse Event|3|||
37958406|NCT03678688|69645644|FG006|Overall Study|Covid Related Adverse Event|1|||
37958407|NCT03678688|69645645|FG007|Overall Study|Covid Related Adverse Event|1|||
37958408|NCT03678688|69645646|FG008|Overall Study|Covid Related Adverse Event|0|||
37958409|NCT03678688|69645638|FG000|Overall Study|Physician Decision|0|||
37958410|NCT03678688|69645639|FG001|Overall Study|Physician Decision|0|||
37958411|NCT03678688|69645640|FG002|Overall Study|Physician Decision|0|||
37958412|NCT03678688|69645641|FG003|Overall Study|Physician Decision|0|||
37958413|NCT03678688|69645642|FG004|Overall Study|Physician Decision|0|||
37958414|NCT03678688|69645643|FG005|Overall Study|Physician Decision|1|||
37958415|NCT03678688|69645644|FG006|Overall Study|Physician Decision|0|||
37958416|NCT03678688|69645645|FG007|Overall Study|Physician Decision|0|||
37958417|NCT03678688|69645646|FG008|Overall Study|Physician Decision|0|||
37958418|NCT03678688|69645638|FG000|Overall Study|Withdrawal by Subject|0|||
37958419|NCT03678688|69645639|FG001|Overall Study|Withdrawal by Subject|0|||
37958420|NCT03678688|69645640|FG002|Overall Study|Withdrawal by Subject|0|||
37958421|NCT03678688|69645641|FG003|Overall Study|Withdrawal by Subject|0|||
37958422|NCT03678688|69645642|FG004|Overall Study|Withdrawal by Subject|0|||
37958423|NCT03678688|69645643|FG005|Overall Study|Withdrawal by Subject|0|||
37958424|NCT03678688|69645644|FG006|Overall Study|Withdrawal by Subject|2|||
37958425|NCT03678688|69645645|FG007|Overall Study|Withdrawal by Subject|1|||
37958426|NCT03678688|69645646|FG008|Overall Study|Withdrawal by Subject|0|||
37958427|NCT03624036|69645693|FG000|Overall Study|Death|2|||
37958428|NCT03624036|69645694|FG001|Overall Study|Death|3|||
37958429|NCT03624036|69645695|FG002|Overall Study|Death|0|||
37958430|NCT03624036|69645696|FG003|Overall Study|Death|1|||
37958431|NCT03624036|69645693|FG000|Overall Study|Withdrawal by Subject|1|||
37958432|NCT03624036|69645694|FG001|Overall Study|Withdrawal by Subject|0|||
37958433|NCT03624036|69645695|FG002|Overall Study|Withdrawal by Subject|1|||
37958434|NCT03624036|69645696|FG003|Overall Study|Withdrawal by Subject|0|||
37958435|NCT03624036|69645693|FG000|Overall Study|Enrolled but Never Treated|1|||
37958436|NCT03624036|69645694|FG001|Overall Study|Enrolled but Never Treated|0|||
37958437|NCT03624036|69645695|FG002|Overall Study|Enrolled but Never Treated|0|||
37958438|NCT03624036|69645696|FG003|Overall Study|Enrolled but Never Treated|0|||
37958439|NCT03624036|69645693|FG000|Overall Study|Reason not Specified|3|||
37958440|NCT03624036|69645694|FG001|Overall Study|Reason not Specified|0|||
37958441|NCT03624036|69645695|FG002|Overall Study|Reason not Specified|2|||
37958442|NCT03624036|69645696|FG003|Overall Study|Reason not Specified|2|||
37958443|NCT03569891|69645741|FG000|Lead-in|Ineligible during lead-in|8|||
37958444|NCT03569891|69645741|FG000|Lead-in|Withdrawal by Subject|3|||
37958445|NCT03569891|69645741|FG000|Lead-in|Risks related to COVID-19|2|||
37958446|NCT03569891|69645741|FG000|AMT-061|Adverse Event|1|||
37958447|NCT03442569|69645754|FG000|Overall Study|Subject was ineligible after enrollment|1|||
37958448|NCT03431350|69645770|FG000|Overall Study|ONGOING|0|||
37958449|NCT03431350|69645771|FG001|Overall Study|ONGOING|0|||
37958450|NCT03431350|69645772|FG002|Overall Study|ONGOING|2|||
37958451|NCT03431350|69645773|FG003|Overall Study|ONGOING|0|||
37958452|NCT03431350|69645774|FG004|Overall Study|ONGOING|1|||
37958453|NCT03431350|69645775|FG005|Overall Study|ONGOING|3|||
37958454|NCT03431350|69645776|FG006|Overall Study|ONGOING|0|||
37958455|NCT03431350|69645777|FG007|Overall Study|ONGOING|1|||
37958456|NCT03431350|69645778|FG008|Overall Study|ONGOING|3|||
37958457|NCT03431350|69645779|FG009|Overall Study|ONGOING|4|||
37958458|NCT03431350|69645780|FG010|Overall Study|ONGOING|2|||
37958459|NCT03431350|69645781|FG011|Overall Study|ONGOING|1|||
37958460|NCT03431350|69645770|FG000|Overall Study|Death|6|||
37958461|NCT03431350|69645771|FG001|Overall Study|Death|5|||
37958462|NCT03431350|69645772|FG002|Overall Study|Death|18|||
37958463|NCT03431350|69645773|FG003|Overall Study|Death|7|||
37958464|NCT03431350|69645774|FG004|Overall Study|Death|4|||
37958465|NCT03431350|69645775|FG005|Overall Study|Death|3|||
37958466|NCT03431350|69645776|FG006|Overall Study|Death|2|||
37958467|NCT03431350|69645777|FG007|Overall Study|Death|0|||
37958468|NCT03431350|69645778|FG008|Overall Study|Death|0|||
37958469|NCT03431350|69645779|FG009|Overall Study|Death|0|||
37958470|NCT03431350|69645780|FG010|Overall Study|Death|4|||
37958471|NCT03431350|69645781|FG011|Overall Study|Death|0|||
37958472|NCT03431350|69645770|FG000|Overall Study|Lost to Follow-up|0|||
37958473|NCT03431350|69645771|FG001|Overall Study|Lost to Follow-up|1|||
37958474|NCT03431350|69645772|FG002|Overall Study|Lost to Follow-up|0|||
37958475|NCT03431350|69645773|FG003|Overall Study|Lost to Follow-up|0|||
37958476|NCT03431350|69645774|FG004|Overall Study|Lost to Follow-up|0|||
37958477|NCT03431350|69645775|FG005|Overall Study|Lost to Follow-up|0|||
37958478|NCT03431350|69645776|FG006|Overall Study|Lost to Follow-up|0|||
37958479|NCT03431350|69645777|FG007|Overall Study|Lost to Follow-up|0|||
37958480|NCT03431350|69645778|FG008|Overall Study|Lost to Follow-up|0|||
37958481|NCT03431350|69645779|FG009|Overall Study|Lost to Follow-up|0|||
37958482|NCT03431350|69645780|FG010|Overall Study|Lost to Follow-up|0|||
37958483|NCT03431350|69645781|FG011|Overall Study|Lost to Follow-up|0|||
38051266|NCT01199302|69740392|FG001|Overall Study|Disease Progression|4|||
38051267|NCT01199302|69740393|FG002|Overall Study|Disease Progression|4|||
37680322|NCT02400333|69155886|FG000|Overall Study|Withdrawal by Subject|0|||
37958484|NCT03431350|69645770|FG000|Overall Study|Withdrawal by Subject|0|||
37958485|NCT03431350|69645771|FG001|Overall Study|Withdrawal by Subject|0|||
37958486|NCT03431350|69645772|FG002|Overall Study|Withdrawal by Subject|0|||
38051268|NCT01199302|69740394|FG003|Overall Study|Disease Progression|2|||
37958487|NCT03431350|69645773|FG003|Overall Study|Withdrawal by Subject|1|||
37958488|NCT03431350|69645774|FG004|Overall Study|Withdrawal by Subject|1|||
37958489|NCT03431350|69645775|FG005|Overall Study|Withdrawal by Subject|1|||
37958490|NCT03431350|69645776|FG006|Overall Study|Withdrawal by Subject|0|||
37958491|NCT03431350|69645777|FG007|Overall Study|Withdrawal by Subject|0|||
37958492|NCT03431350|69645778|FG008|Overall Study|Withdrawal by Subject|0|||
37958493|NCT03431350|69645779|FG009|Overall Study|Withdrawal by Subject|2|||
37958494|NCT03431350|69645780|FG010|Overall Study|Withdrawal by Subject|0|||
37958495|NCT03431350|69645781|FG011|Overall Study|Withdrawal by Subject|1|||
37958496|NCT03431350|69645770|FG000|Overall Study|Other|0|||
37958497|NCT03431350|69645771|FG001|Overall Study|Other|0|||
37958498|NCT03431350|69645772|FG002|Overall Study|Other|1|||
37958499|NCT03431350|69645773|FG003|Overall Study|Other|3|||
37958500|NCT03431350|69645774|FG004|Overall Study|Other|2|||
37958501|NCT03431350|69645775|FG005|Overall Study|Other|2|||
38051269|NCT01199302|69740391|FG000|Overall Study|Study Termination|13|||
37958502|NCT03431350|69645776|FG006|Overall Study|Other|4|||
37958503|NCT03431350|69645777|FG007|Overall Study|Other|0|||
37958504|NCT03431350|69645778|FG008|Overall Study|Other|14|||
37958505|NCT03431350|69645779|FG009|Overall Study|Other|11|||
37958506|NCT03431350|69645780|FG010|Overall Study|Other|11|||
37958507|NCT03431350|69645781|FG011|Overall Study|Other|15|||
37958508|NCT03250273|69645808|FG000|Overall Study|Disease Progression|2|||
37958509|NCT03250273|69645809|FG001|Overall Study|Disease Progression|11|||
37958510|NCT03250273|69645808|FG000|Overall Study|Death|0|||
37958511|NCT03250273|69645809|FG001|Overall Study|Death|1|||
37958512|NCT03235544|69645819|FG000|Overall Study|Participants Still Ongoing in the Study|1|||
37958513|NCT03235544|69645820|FG001|Overall Study|Participants Still Ongoing in the Study|13|||
37958514|NCT03235544|69645821|FG002|Overall Study|Participants Still Ongoing in the Study|19|||
37958515|NCT03235544|69645822|FG003|Overall Study|Participants Still Ongoing in the Study|55|||
37958516|NCT03235544|69645819|FG000|Overall Study|Death|11|||
37958517|NCT03235544|69645820|FG001|Overall Study|Death|23|||
37958518|NCT03235544|69645821|FG002|Overall Study|Death|11|||
37958519|NCT03235544|69645822|FG003|Overall Study|Death|20|||
37958520|NCT03235544|69645819|FG000|Overall Study|Lost to Follow-up|0|||
37958521|NCT03235544|69645820|FG001|Overall Study|Lost to Follow-up|1|||
37958522|NCT03235544|69645821|FG002|Overall Study|Lost to Follow-up|0|||
37958523|NCT03235544|69645822|FG003|Overall Study|Lost to Follow-up|1|||
37958524|NCT03235544|69645819|FG000|Overall Study|Withdrawal by Participant|0|||
37958525|NCT03235544|69645820|FG001|Overall Study|Withdrawal by Participant|0|||
37958526|NCT03235544|69645821|FG002|Overall Study|Withdrawal by Participant|1|||
37958527|NCT03235544|69645822|FG003|Overall Study|Withdrawal by Participant|0|||
37958528|NCT03235544|69645819|FG000|Overall Study|Reason not Specified|0|||
37958529|NCT03235544|69645820|FG001|Overall Study|Reason not Specified|4|||
37958530|NCT03235544|69645821|FG002|Overall Study|Reason not Specified|0|||
37958531|NCT03235544|69645822|FG003|Overall Study|Reason not Specified|1|||
37958532|NCT03187353|69645835|FG000|First Intervention (6 Weeks)|Adverse Event|3|||
37958533|NCT03187353|69645836|FG001|First Intervention (6 Weeks)|Adverse Event|2|||
37958534|NCT03187353|69645835|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
37958535|NCT03187353|69645836|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
37958536|NCT03187353|69645835|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
37958537|NCT03187353|69645836|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
37958538|NCT03187353|69645835|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
37958539|NCT03187353|69645836|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
37958540|NCT03187353|69645835|FG000|Washout (2 Weeks)|Adverse Event|2|||
37958541|NCT03187353|69645836|FG001|Washout (2 Weeks)|Adverse Event|0|||
37958542|NCT03187353|69645835|FG000|Second Intervention (6 Weeks)|Adverse Event|1|||
37958543|NCT03187353|69645836|FG001|Second Intervention (6 Weeks)|Adverse Event|0|||
37958544|NCT03056001|69645872|FG000|Overall Study|Death|24|||
37958545|NCT02998918|69645882|FG000|Overall Study|Withdrawal by Subject|1|||
37958546|NCT02998918|69645883|FG001|Overall Study|Withdrawal by Subject|0|||
37958547|NCT02990338|69645891|FG000|Overall Study|Ongoing|30|||
37958548|NCT02990338|69645892|FG001|Overall Study|Ongoing|36|||
37958549|NCT02913482|69645904|FG000|Overall Study|Death|0|||
37958550|NCT02913482|69645905|FG001|Overall Study|Death|2|||
37958551|NCT02913482|69645906|FG002|Overall Study|Death|2|||
37958552|NCT02913482|69645904|FG000|Overall Study|Progressive Disease|1|||
37958553|NCT02913482|69645905|FG001|Overall Study|Progressive Disease|1|||
37958554|NCT02913482|69645906|FG002|Overall Study|Progressive Disease|1|||
37958555|NCT02742246|69645932|FG000|Overall Study|Never initiated treatment|5|||
37958556|NCT02742246|69645933|FG001|Overall Study|Never initiated treatment|3|||
37958557|NCT02742246|69645934|FG002|Overall Study|Never initiated treatment|1|||
37958558|NCT02742246|69645932|FG000|Overall Study|dropped out during treatment|7|||
37958559|NCT02742246|69645933|FG001|Overall Study|dropped out during treatment|13|||
37958560|NCT02742246|69645934|FG002|Overall Study|dropped out during treatment|10|||
37958561|NCT02742246|69645932|FG000|Overall Study|Death|1|||
37958562|NCT02742246|69645933|FG001|Overall Study|Death|0|||
37958563|NCT02742246|69645934|FG002|Overall Study|Death|0|||
37958564|NCT02733042|69645961|FG000|Overall Study|Adverse Event|1|||
37958565|NCT02733042|69645962|FG001|Overall Study|Adverse Event|0|||
37958566|NCT02733042|69645963|FG002|Overall Study|Adverse Event|1|||
37958567|NCT02733042|69645964|FG003|Overall Study|Adverse Event|1|||
37958568|NCT02733042|69645965|FG004|Overall Study|Adverse Event|0|||
37958569|NCT02733042|69645966|FG005|Overall Study|Adverse Event|0|||
37958570|NCT02733042|69645967|FG006|Overall Study|Adverse Event|0|||
37958571|NCT02733042|69645968|FG007|Overall Study|Adverse Event|0|||
37958572|NCT02733042|69645969|FG008|Overall Study|Adverse Event|0|||
37958573|NCT02733042|69645970|FG009|Overall Study|Adverse Event|0|||
37958574|NCT02733042|69645971|FG010|Overall Study|Adverse Event|2|||
37958575|NCT02733042|69645972|FG011|Overall Study|Adverse Event|2|||
37958576|NCT02733042|69645973|FG012|Overall Study|Adverse Event|0|||
37958577|NCT02733042|69645974|FG013|Overall Study|Adverse Event|2|||
37958578|NCT02733042|69645975|FG014|Overall Study|Adverse Event|0|||
37958579|NCT02733042|69645976|FG015|Overall Study|Adverse Event|0|||
37958580|NCT02733042|69645977|FG016|Overall Study|Adverse Event|0|||
37958581|NCT02733042|69645978|FG017|Overall Study|Adverse Event|1|||
37958582|NCT02733042|69645979|FG018|Overall Study|Adverse Event|0|||
37958583|NCT02733042|69645961|FG000|Overall Study|Progressive Disease|2|||
37958584|NCT02733042|69645962|FG001|Overall Study|Progressive Disease|1|||
37958585|NCT02733042|69645963|FG002|Overall Study|Progressive Disease|3|||
37958586|NCT02733042|69645964|FG003|Overall Study|Progressive Disease|1|||
37958587|NCT02733042|69645965|FG004|Overall Study|Progressive Disease|2|||
37958588|NCT02733042|69645966|FG005|Overall Study|Progressive Disease|3|||
37958589|NCT02733042|69645967|FG006|Overall Study|Progressive Disease|0|||
37958590|NCT02733042|69645968|FG007|Overall Study|Progressive Disease|3|||
37958591|NCT02733042|69645969|FG008|Overall Study|Progressive Disease|3|||
37958592|NCT02733042|69645970|FG009|Overall Study|Progressive Disease|2|||
37958593|NCT02733042|69645971|FG010|Overall Study|Progressive Disease|2|||
37958594|NCT02733042|69645972|FG011|Overall Study|Progressive Disease|2|||
37958595|NCT02733042|69645973|FG012|Overall Study|Progressive Disease|8|||
37958596|NCT02733042|69645974|FG013|Overall Study|Progressive Disease|1|||
37958597|NCT02733042|69645975|FG014|Overall Study|Progressive Disease|4|||
37958598|NCT02733042|69645976|FG015|Overall Study|Progressive Disease|7|||
37958599|NCT02733042|69645977|FG016|Overall Study|Progressive Disease|2|||
37958600|NCT02733042|69645978|FG017|Overall Study|Progressive Disease|3|||
37958601|NCT02733042|69645979|FG018|Overall Study|Progressive Disease|4|||
37958602|NCT02733042|69645961|FG000|Overall Study|Withdrawal by Subject|0|||
37958603|NCT02733042|69645962|FG001|Overall Study|Withdrawal by Subject|1|||
37958604|NCT02733042|69645963|FG002|Overall Study|Withdrawal by Subject|2|||
37958605|NCT02733042|69645964|FG003|Overall Study|Withdrawal by Subject|1|||
37958606|NCT02733042|69645965|FG004|Overall Study|Withdrawal by Subject|1|||
37958607|NCT02733042|69645966|FG005|Overall Study|Withdrawal by Subject|0|||
37958608|NCT02733042|69645967|FG006|Overall Study|Withdrawal by Subject|0|||
37958609|NCT02733042|69645968|FG007|Overall Study|Withdrawal by Subject|0|||
37958610|NCT02733042|69645969|FG008|Overall Study|Withdrawal by Subject|1|||
37958611|NCT02733042|69645970|FG009|Overall Study|Withdrawal by Subject|1|||
37958612|NCT02733042|69645971|FG010|Overall Study|Withdrawal by Subject|0|||
37958613|NCT02733042|69645972|FG011|Overall Study|Withdrawal by Subject|2|||
37958614|NCT02733042|69645973|FG012|Overall Study|Withdrawal by Subject|1|||
37958615|NCT02733042|69645974|FG013|Overall Study|Withdrawal by Subject|1|||
37958616|NCT02733042|69645975|FG014|Overall Study|Withdrawal by Subject|0|||
37958617|NCT02733042|69645976|FG015|Overall Study|Withdrawal by Subject|0|||
37958618|NCT02733042|69645977|FG016|Overall Study|Withdrawal by Subject|0|||
37958619|NCT02733042|69645978|FG017|Overall Study|Withdrawal by Subject|0|||
37958620|NCT02733042|69645979|FG018|Overall Study|Withdrawal by Subject|0|||
37958621|NCT02733042|69645961|FG000|Overall Study|Other Reasons|0|||
37958622|NCT02733042|69645962|FG001|Overall Study|Other Reasons|0|||
37958623|NCT02733042|69645963|FG002|Overall Study|Other Reasons|1|||
37958624|NCT02733042|69645964|FG003|Overall Study|Other Reasons|0|||
37958625|NCT02733042|69645965|FG004|Overall Study|Other Reasons|0|||
37958626|NCT02733042|69645966|FG005|Overall Study|Other Reasons|0|||
37958627|NCT02733042|69645967|FG006|Overall Study|Other Reasons|0|||
37958628|NCT02733042|69645968|FG007|Overall Study|Other Reasons|0|||
37958629|NCT02733042|69645969|FG008|Overall Study|Other Reasons|0|||
37958630|NCT02733042|69645970|FG009|Overall Study|Other Reasons|1|||
37958631|NCT02733042|69645971|FG010|Overall Study|Other Reasons|1|||
37958632|NCT02733042|69645972|FG011|Overall Study|Other Reasons|0|||
37958633|NCT02733042|69645973|FG012|Overall Study|Other Reasons|0|||
37958634|NCT02733042|69645974|FG013|Overall Study|Other Reasons|0|||
37958635|NCT02733042|69645975|FG014|Overall Study|Other Reasons|0|||
37958636|NCT02733042|69645976|FG015|Overall Study|Other Reasons|1|||
37958637|NCT02733042|69645977|FG016|Overall Study|Other Reasons|0|||
37958638|NCT02733042|69645978|FG017|Overall Study|Other Reasons|1|||
37958639|NCT02733042|69645979|FG018|Overall Study|Other Reasons|0|||
37958640|NCT02733042|69645961|FG000|Overall Study|Death|0|||
37958641|NCT02733042|69645962|FG001|Overall Study|Death|0|||
37958642|NCT02733042|69645963|FG002|Overall Study|Death|0|||
37958643|NCT02733042|69645964|FG003|Overall Study|Death|0|||
37958644|NCT02733042|69645965|FG004|Overall Study|Death|0|||
37958645|NCT02733042|69645966|FG005|Overall Study|Death|0|||
37958646|NCT02733042|69645967|FG006|Overall Study|Death|1|||
37958647|NCT02733042|69645968|FG007|Overall Study|Death|0|||
37958648|NCT02733042|69645969|FG008|Overall Study|Death|1|||
37958649|NCT02733042|69645970|FG009|Overall Study|Death|0|||
37958650|NCT02733042|69645971|FG010|Overall Study|Death|1|||
37958651|NCT02733042|69645972|FG011|Overall Study|Death|0|||
37862034|NCT01135017|69545793|FG000|Overall Study|Other than above|3|||
37958652|NCT02733042|69645973|FG012|Overall Study|Death|0|||
37958653|NCT02733042|69645974|FG013|Overall Study|Death|0|||
37958654|NCT02733042|69645975|FG014|Overall Study|Death|1|||
37958655|NCT02733042|69645976|FG015|Overall Study|Death|2|||
37958656|NCT02733042|69645977|FG016|Overall Study|Death|0|||
37958657|NCT02733042|69645978|FG017|Overall Study|Death|0|||
37958658|NCT02733042|69645979|FG018|Overall Study|Death|0|||
37958659|NCT02614066|69646036|FG000|Overall Study|Initiated KTE-X19 and Died|5|||
37958660|NCT02614066|69646037|FG001|Overall Study|Initiated KTE-X19 and Died|12|||
37958661|NCT02614066|69646038|FG002|Overall Study|Initiated KTE-X19 and Died|11|||
37958662|NCT02614066|69646039|FG003|Overall Study|Initiated KTE-X19 and Died|20|||
37958663|NCT02614066|69646036|FG000|Overall Study|Full Consent Withdrawn|0|||
37958664|NCT02614066|69646037|FG001|Overall Study|Full Consent Withdrawn|1|||
37958665|NCT02614066|69646038|FG002|Overall Study|Full Consent Withdrawn|0|||
37958666|NCT02614066|69646039|FG003|Overall Study|Full Consent Withdrawn|3|||
37958667|NCT02614066|69646036|FG000|Overall Study|Lost to Follow-up|0|||
37958668|NCT02614066|69646037|FG001|Overall Study|Lost to Follow-up|1|||
37958669|NCT02614066|69646038|FG002|Overall Study|Lost to Follow-up|0|||
37958670|NCT02614066|69646039|FG003|Overall Study|Lost to Follow-up|0|||
37958671|NCT02614066|69646036|FG000|Overall Study|Still on-study|1|||
37958672|NCT02614066|69646037|FG001|Overall Study|Still on-study|9|||
37958673|NCT02614066|69646038|FG002|Overall Study|Still on-study|5|||
37958674|NCT02614066|69646039|FG003|Overall Study|Still on-study|32|||
37958675|NCT02614066|69646036|FG000|Overall Study|Enrolled But Did Not Initiate KTE-X19|0|||
37958676|NCT02614066|69646037|FG001|Overall Study|Enrolled But Did Not Initiate KTE-X19|5|||
37958677|NCT02614066|69646038|FG002|Overall Study|Enrolled But Did Not Initiate KTE-X19|4|||
37958678|NCT02614066|69646039|FG003|Overall Study|Enrolled But Did Not Initiate KTE-X19|16|||
37958679|NCT02609503|69646047|FG000|Overall Study|Adverse Event|1|||
37958680|NCT02609503|69646047|FG000|Overall Study|Death|1|||
37958681|NCT02609503|69646047|FG000|Overall Study|Withdrawal by Subject|1|||
37958682|NCT02609503|69646047|FG000|Overall Study|Disease progression|1|||
37958683|NCT02504866|69646110|FG000|6-Month Follow up (CON Group Only)|Adverse Event|1|||
37958684|NCT02504866|69646111|FG001|6-Month Follow up (CON Group Only)|Adverse Event|0|||
37958685|NCT02504866|69646112|FG002|6-Month Follow up (CON Group Only)|Adverse Event|0|||
37958686|NCT02459769|69646124|FG000|Overall Study|Withdrawal by Subject|7|||
37958687|NCT02459769|69646125|FG001|Overall Study|Withdrawal by Subject|4|||
37958688|NCT02459769|69646126|FG002|Overall Study|Withdrawal by Subject|8|||
37958689|NCT02459769|69646127|FG003|Overall Study|Withdrawal by Subject|5|||
37958690|NCT02459769|69646124|FG000|Overall Study|Lost to Follow-up|1|||
37958691|NCT02459769|69646125|FG001|Overall Study|Lost to Follow-up|0|||
37958692|NCT02459769|69646126|FG002|Overall Study|Lost to Follow-up|1|||
37958693|NCT02459769|69646127|FG003|Overall Study|Lost to Follow-up|0|||
37958694|NCT02369016|69646139|FG000|Overall Study|AE associated with clinical disease progression|2|||
37958695|NCT02369016|69646140|FG001|Overall Study|AE associated with clinical disease progression|1|||
37958696|NCT02369016|69646139|FG000|Overall Study|AE not associated with clinical diseaseprogression|4|||
37958697|NCT02369016|69646140|FG001|Overall Study|AE not associated with clinical diseaseprogression|1|||
37958698|NCT02369016|69646139|FG000|Overall Study|Progressive disease - clinical progression|1|||
37958699|NCT02369016|69646140|FG001|Overall Study|Progressive disease - clinical progression|4|||
37958700|NCT02369016|69646139|FG000|Overall Study|withdrawal by patient|4|||
37958701|NCT02369016|69646140|FG001|Overall Study|withdrawal by patient|0|||
37958702|NCT02369016|69646139|FG000|Overall Study|Progressive disease - radiological progression|6|||
37958703|NCT02369016|69646140|FG001|Overall Study|Progressive disease - radiological progression|2|||
37958704|NCT02363959|69646153|FG000|Overall Study|Medical instability|1|||
37958705|NCT02363959|69646154|FG001|Overall Study|Medical instability|0|||
37958706|NCT02337829|69646174|FG000|Overall Study|Death|0|||
37958707|NCT02337829|69646175|FG001|Overall Study|Death|1|||
38051270|NCT01199302|69740392|FG001|Overall Study|Study Termination|8|||
38051271|NCT01199302|69740393|FG002|Overall Study|Study Termination|11|||
38051272|NCT01199302|69740394|FG003|Overall Study|Study Termination|9|||
38051273|NCT01199302|69740391|FG000|Overall Study|Lost to Follow-up|0|||
38051274|NCT01199302|69740392|FG001|Overall Study|Lost to Follow-up|1|||
38051275|NCT01199302|69740393|FG002|Overall Study|Lost to Follow-up|0|||
38051276|NCT01199302|69740394|FG003|Overall Study|Lost to Follow-up|0|||
38051277|NCT01199302|69740391|FG000|Overall Study|Other|1|||
38051278|NCT01199302|69740392|FG001|Overall Study|Other|0|||
38051279|NCT01199302|69740393|FG002|Overall Study|Other|0|||
38051280|NCT01199302|69740394|FG003|Overall Study|Other|0|||
37958708|NCT02337829|69646176|FG002|Overall Study|Death|0|||
37958709|NCT02337829|69646177|FG003|Overall Study|Death|0|||
37958710|NCT02337829|69646174|FG000|Overall Study|Study terminated by sponsor|12|||
37958711|NCT02337829|69646175|FG001|Overall Study|Study terminated by sponsor|10|||
37958712|NCT02337829|69646176|FG002|Overall Study|Study terminated by sponsor|5|||
37958713|NCT02337829|69646177|FG003|Overall Study|Study terminated by sponsor|6|||
37958714|NCT02337829|69646174|FG000|Overall Study|discontinued for other reasons|6|||
37958715|NCT02337829|69646175|FG001|Overall Study|discontinued for other reasons|3|||
38051281|NCT03332784|69740421|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
38051282|NCT03332784|69740422|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
38051283|NCT03332784|69740423|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
38051284|NCT03332784|69740424|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
38051285|NCT03332784|69740425|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
37958716|NCT02337829|69646176|FG002|Overall Study|discontinued for other reasons|1|||
37958717|NCT02337829|69646177|FG003|Overall Study|discontinued for other reasons|4|||
37958718|NCT02043678|69646191|FG000|Overall Study|Never treated|11|||
37958719|NCT02043678|69646192|FG001|Overall Study|Never treated|9|||
37958720|NCT02043678|69646191|FG000|Overall Study|AE with clinical progressive disease(PD)|18|||
37958721|NCT02043678|69646192|FG001|Overall Study|AE with clinical progressive disease(PD)|18|||
37958722|NCT02043678|69646191|FG000|Overall Study|AE without clinical PD|51|||
37958723|NCT02043678|69646192|FG001|Overall Study|AE without clinical PD|34|||
37958724|NCT02043678|69646191|FG000|Overall Study|Lost to Follow-up|1|||
37958725|NCT02043678|69646192|FG001|Overall Study|Lost to Follow-up|1|||
37958726|NCT02043678|69646191|FG000|Overall Study|Other|19|||
37958727|NCT02043678|69646192|FG001|Overall Study|Other|16|||
37958728|NCT02043678|69646191|FG000|Overall Study|Clinical PD|108|||
37958729|NCT02043678|69646192|FG001|Overall Study|Clinical PD|138|||
37958730|NCT02043678|69646191|FG000|Overall Study|Radiological PD|91|||
37958731|NCT02043678|69646192|FG001|Overall Study|Radiological PD|80|||
37958732|NCT02043678|69646191|FG000|Overall Study|Protocol-driven decision point|56|||
37958733|NCT02043678|69646192|FG001|Overall Study|Protocol-driven decision point|56|||
37958734|NCT02043678|69646191|FG000|Overall Study|Withdrawal by Subject|12|||
37958735|NCT02043678|69646192|FG001|Overall Study|Withdrawal by Subject|15|||
37958736|NCT02043678|69646191|FG000|Overall Study|Ongoing with treatment|34|||
37958737|NCT02043678|69646192|FG001|Overall Study|Ongoing with treatment|38|||
37958738|NCT01824875|69646218|FG000|Overall Study|Disease progression|22|||
37958739|NCT01824875|69646219|FG001|Overall Study|Disease progression|15|||
37958740|NCT01824875|69646218|FG000|Overall Study|Withdrawal by Subject|5|||
37958741|NCT01824875|69646219|FG001|Overall Study|Withdrawal by Subject|4|||
37958742|NCT01824875|69646218|FG000|Overall Study|Adverse Event|4|||
37958743|NCT01824875|69646219|FG001|Overall Study|Adverse Event|10|||
37958744|NCT01824875|69646218|FG000|Overall Study|Alternative therapy|3|||
37958745|NCT01824875|69646219|FG001|Overall Study|Alternative therapy|0|||
37958746|NCT01824875|69646218|FG000|Overall Study|Complicating disease|1|||
37958747|NCT01824875|69646219|FG001|Overall Study|Complicating disease|0|||
37958748|NCT01824875|69646218|FG000|Overall Study|Physician Decision|0|||
37958749|NCT01824875|69646219|FG001|Overall Study|Physician Decision|1|||
37958750|NCT01824875|69646218|FG000|Overall Study|Non-compliance|1|||
37958751|NCT01824875|69646219|FG001|Overall Study|Non-compliance|1|||
37958752|NCT01824875|69646218|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
37958753|NCT01824875|69646219|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
37958754|NCT01824875|69646218|FG000|Overall Study|Administrative issues|0|||
37958755|NCT01824875|69646219|FG001|Overall Study|Administrative issues|2|||
37958756|NCT01824875|69646218|FG000|Overall Study|Ineligible or never started treatment|9|||
37958757|NCT01824875|69646219|FG001|Overall Study|Ineligible or never started treatment|5|||
37958758|NCT01824875|69646218|FG000|Overall Study|Other|0|||
37958759|NCT01824875|69646219|FG001|Overall Study|Other|2|||
38051286|NCT03332784|69740426|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
38051287|NCT03332784|69740427|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
38051288|NCT03332784|69740428|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
38051289|NCT03332784|69740429|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
38051290|NCT03332784|69740430|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
38051291|NCT03332784|69740431|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
37958760|NCT01756040|69646238|FG000|IP in Preterm Infants: Cohort 1|Death|1|||
37958761|NCT01756040|69646238|FG000|IP in Preterm Infants: Cohort 2|Death|1|||
37958762|NCT01756040|69646238|FG000|IP in Preterm Infants: Cohort 2|did not receive sugar probe dose|8|||
37958763|NCT01566695|69646247|FG000|Overall Study|Lack of Efficacy|18|||
37958764|NCT01566695|69646248|FG001|Overall Study|Lack of Efficacy|45|||
37958765|NCT01566695|69646247|FG000|Overall Study|Adverse Event|28|||
37958766|NCT01566695|69646248|FG001|Overall Study|Adverse Event|27|||
37958767|NCT01566695|69646247|FG000|Overall Study|Death|20|||
37958768|NCT01566695|69646248|FG001|Overall Study|Death|8|||
37958769|NCT01566695|69646247|FG000|Overall Study|Withdrawal by Subject|14|||
37958770|NCT01566695|69646248|FG001|Overall Study|Withdrawal by Subject|7|||
38051292|NCT03332784|69740432|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
38051293|NCT03332784|69740433|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
38051294|NCT03332784|69740434|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
38051295|NCT03332784|69740435|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
37958771|NCT01566695|69646247|FG000|Overall Study|Progressive Disease|11|||
37958772|NCT01566695|69646248|FG001|Overall Study|Progressive Disease|6|||
37958773|NCT01566695|69646247|FG000|Overall Study|Miscellaneous|4|||
37958774|NCT01566695|69646248|FG001|Overall Study|Miscellaneous|6|||
37958775|NCT00567164|69646266|FG000|Overall Study|Withdrawal by Subject|171|||
37958776|NCT00567164|69646267|FG001|Overall Study|Withdrawal by Subject|21|||
37958777|NCT00567164|69646268|FG002|Overall Study|Withdrawal by Subject|17|||
37958778|NCT00567164|69646266|FG000|Overall Study|Protocol Violation|23|||
38051296|NCT03332784|69740436|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
38051297|NCT03332784|69740437|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
38051298|NCT03332784|69740438|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
38051299|NCT03332784|69740439|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
37958779|NCT00567164|69646267|FG001|Overall Study|Protocol Violation|4|||
37958780|NCT00567164|69646268|FG002|Overall Study|Protocol Violation|2|||
37958781|NCT00567164|69646266|FG000|Overall Study|Adverse Event|92|||
37958782|NCT00567164|69646267|FG001|Overall Study|Adverse Event|13|||
37958783|NCT00567164|69646268|FG002|Overall Study|Adverse Event|9|||
37958784|NCT00567164|69646266|FG000|Overall Study|Death|0|||
37958785|NCT00567164|69646267|FG001|Overall Study|Death|0|||
37958786|NCT00567164|69646268|FG002|Overall Study|Death|1|||
37958787|NCT00567164|69646266|FG000|Overall Study|Lost to Follow-up|202|||
37958788|NCT00567164|69646267|FG001|Overall Study|Lost to Follow-up|23|||
37958789|NCT00567164|69646268|FG002|Overall Study|Lost to Follow-up|21|||
37958790|NCT00567164|69646266|FG000|Overall Study|Pregnancy|20|||
37958791|NCT00567164|69646267|FG001|Overall Study|Pregnancy|4|||
37958792|NCT00567164|69646268|FG002|Overall Study|Pregnancy|6|||
37958793|NCT00567164|69646266|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
37958794|NCT00567164|69646267|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
37958795|NCT00567164|69646268|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
37958796|NCT00567164|69646266|FG000|Overall Study|Missing|1|||
37958797|NCT00567164|69646267|FG001|Overall Study|Missing|0|||
37958798|NCT00567164|69646268|FG002|Overall Study|Missing|0|||
37958799|NCT00713219|69646280|FG000|Overall Study|Death|1|||
37958800|NCT00713219|69646280|FG000|Overall Study|Protocol Violation|1|||
37958801|NCT00712985|69646284|FG000|Overall Study|1 withdrew prior to start of drug|1|||
37958802|NCT00712985|69646284|FG000|Overall Study|1 patient moved out of state|1|||
37958803|NCT00712985|69646284|FG000|Overall Study|Lack of Efficacy|3|||
37958804|NCT00700115|69646290|FG000|Overall Study|Withdrawal by Subject|1|||
37958805|NCT00700115|69646291|FG001|Overall Study|Withdrawal by Subject|0|||
37958806|NCT00700115|69646290|FG000|Overall Study|Lost to Follow-up|0|||
37958807|NCT00700115|69646291|FG001|Overall Study|Lost to Follow-up|1|||
37958808|NCT00566852|69646299|FG000|Overall Study|Protocol Violation|22|||
37958809|NCT00566852|69646300|FG001|Overall Study|Protocol Violation|24|||
37958810|NCT00566852|69646299|FG000|Overall Study|Death|95|||
37958811|NCT00566852|69646300|FG001|Overall Study|Death|78|||
37958812|NCT00566852|69646299|FG000|Overall Study|Withdrawal by Subject|30|||
37958813|NCT00566852|69646300|FG001|Overall Study|Withdrawal by Subject|25|||
37958814|NCT00566852|69646299|FG000|Overall Study|Patient refusal|37|||
37958815|NCT00566852|69646300|FG001|Overall Study|Patient refusal|37|||
37958816|NCT00566852|69646299|FG000|Overall Study|Not tested due to disability|6|||
37958817|NCT00566852|69646300|FG001|Overall Study|Not tested due to disability|12|||
37958818|NCT00566852|69646299|FG000|Overall Study|Missing reason not specified|1|||
37958819|NCT00566852|69646300|FG001|Overall Study|Missing reason not specified|2|||
37958820|NCT00566852|69646299|FG000|Overall Study|Missing reason not reported|16|||
37958821|NCT00566852|69646300|FG001|Overall Study|Missing reason not reported|20|||
37958822|NCT00442546|69646309|FG000|Overall Study|Adverse Event|11|||
37958823|NCT00442546|69646310|FG001|Overall Study|Adverse Event|17|||
37958824|NCT00442546|69646311|FG002|Overall Study|Adverse Event|13|||
37958825|NCT00442546|69646309|FG000|Overall Study|Lost to Follow-up|1|||
37958826|NCT00442546|69646310|FG001|Overall Study|Lost to Follow-up|2|||
37958827|NCT00442546|69646311|FG002|Overall Study|Lost to Follow-up|1|||
37958828|NCT00442546|69646309|FG000|Overall Study|Other|4|||
37958829|NCT00442546|69646310|FG001|Overall Study|Other|9|||
37958830|NCT00442546|69646311|FG002|Overall Study|Other|6|||
37958831|NCT00442546|69646309|FG000|Overall Study|Withdrawal by Subject|5|||
37958832|NCT00442546|69646310|FG001|Overall Study|Withdrawal by Subject|5|||
38051300|NCT03332784|69740440|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
37958833|NCT00442546|69646311|FG002|Overall Study|Withdrawal by Subject|7|||
37958834|NCT00442546|69646309|FG000|Overall Study|Randomized But Not Treated|5|||
37958835|NCT00442546|69646310|FG001|Overall Study|Randomized But Not Treated|4|||
37958836|NCT00442546|69646311|FG002|Overall Study|Randomized But Not Treated|6|||
37958837|NCT00514683|69646326|FG000|Overall Study|Not treated|2|||
37958838|NCT00514683|69646327|FG001|Overall Study|Not treated|1|||
37958839|NCT00514683|69646328|FG002|Overall Study|Not treated|0|||
37958840|NCT00514683|69646329|FG003|Overall Study|Not treated|0|||
37958841|NCT00514683|69646330|FG004|Overall Study|Not treated|1|||
37958842|NCT00514683|69646326|FG000|Overall Study|Adverse Event|21|||
37958843|NCT00514683|69646327|FG001|Overall Study|Adverse Event|20|||
37958844|NCT00514683|69646328|FG002|Overall Study|Adverse Event|15|||
37958845|NCT00514683|69646329|FG003|Overall Study|Adverse Event|13|||
37958846|NCT00514683|69646330|FG004|Overall Study|Adverse Event|27|||
38051301|NCT04465357|69740504|FG000|Overall Study|Adverse Event|2|||
37958847|NCT00514683|69646326|FG000|Overall Study|Protocol Violation|1|||
37958848|NCT00514683|69646327|FG001|Overall Study|Protocol Violation|1|||
37958849|NCT00514683|69646328|FG002|Overall Study|Protocol Violation|0|||
37958850|NCT00514683|69646329|FG003|Overall Study|Protocol Violation|1|||
37958851|NCT00514683|69646330|FG004|Overall Study|Protocol Violation|0|||
37958852|NCT00514683|69646326|FG000|Overall Study|Withdrawal by Subject|2|||
37958853|NCT00514683|69646327|FG001|Overall Study|Withdrawal by Subject|2|||
37958854|NCT00514683|69646328|FG002|Overall Study|Withdrawal by Subject|1|||
37958855|NCT00514683|69646329|FG003|Overall Study|Withdrawal by Subject|0|||
37958856|NCT00514683|69646330|FG004|Overall Study|Withdrawal by Subject|4|||
37958857|NCT00514683|69646326|FG000|Overall Study|Reason other than listed above|0|||
38051302|NCT04465357|69740504|FG000|Overall Study|Lack of Efficacy|1|||
37958858|NCT00514683|69646327|FG001|Overall Study|Reason other than listed above|1|||
37958859|NCT00514683|69646328|FG002|Overall Study|Reason other than listed above|2|||
37958860|NCT00514683|69646329|FG003|Overall Study|Reason other than listed above|0|||
37958861|NCT00514683|69646330|FG004|Overall Study|Reason other than listed above|1|||
37958862|NCT00566696|69646346|FG000|Overall Study|Met Exclusion Criteria|2|||
37958863|NCT00566696|69646346|FG000|Overall Study|Muromonab not available|1|||
37958864|NCT00566696|69646346|FG000|Overall Study|Health Status Change|1|||
37958865|NCT00566696|69646346|FG000|Overall Study|Physician Decision|1|||
37958866|NCT00566696|69646346|FG000|Overall Study|Non-Patient Donors|37|||
37958867|NCT00503841|69646350|FG000|Overall Study|All screen failures|44|||
37958868|NCT00442468|69646356|FG000|Overall Study|Adverse Event|4|||
37958869|NCT00442468|69646356|FG000|Overall Study|Withdrawal by Subject|91|||
37958870|NCT00442468|69646356|FG000|Overall Study|Did not complete all study procedures|88|||
37958871|NCT00506883|69646363|FG000|Overall Study|Lost to Follow-up|1|||
37958872|NCT00506883|69646364|FG001|Overall Study|Lost to Follow-up|1|||
37958873|NCT00506883|69646365|FG002|Overall Study|Lost to Follow-up|1|||
37958874|NCT00506883|69646363|FG000|Overall Study|Withdrawal by Subject|1|||
37958875|NCT00506883|69646364|FG001|Overall Study|Withdrawal by Subject|0|||
37958876|NCT00506883|69646365|FG002|Overall Study|Withdrawal by Subject|1|||
37958877|NCT00506883|69646363|FG000|Overall Study|Lack of Efficacy|0|||
37958878|NCT00506883|69646364|FG001|Overall Study|Lack of Efficacy|1|||
37958879|NCT00506883|69646365|FG002|Overall Study|Lack of Efficacy|1|||
37958880|NCT00506883|69646363|FG000|Overall Study|Other|5|||
37958881|NCT00506883|69646364|FG001|Overall Study|Other|1|||
37958882|NCT00506883|69646365|FG002|Overall Study|Other|1|||
37958883|NCT00503685|69646376|FG000|Overall Study|Adverse Event|0|||
37958884|NCT00503685|69646377|FG001|Overall Study|Adverse Event|0|||
37958885|NCT00503685|69646378|FG002|Overall Study|Adverse Event|2|||
37958886|NCT00503685|69646376|FG000|Overall Study|Withdrawal by Subject|0|||
37958887|NCT00503685|69646377|FG001|Overall Study|Withdrawal by Subject|1|||
37958888|NCT00503685|69646378|FG002|Overall Study|Withdrawal by Subject|0|||
37958889|NCT00503685|69646376|FG000|Overall Study|Protocol Violation|0|||
37958890|NCT00503685|69646377|FG001|Overall Study|Protocol Violation|1|||
37958891|NCT00503685|69646378|FG002|Overall Study|Protocol Violation|0|||
37958892|NCT00503685|69646376|FG000|Overall Study|Eligibility Criteria Not Met|0|||
37958893|NCT00503685|69646377|FG001|Overall Study|Eligibility Criteria Not Met|1|||
37958894|NCT00503685|69646378|FG002|Overall Study|Eligibility Criteria Not Met|0|||
37958895|NCT00712673|69646390|FG000|Overall Study|Adverse Event|3|||
37958896|NCT00712673|69646391|FG001|Overall Study|Adverse Event|3|||
37958897|NCT00712673|69646392|FG002|Overall Study|Adverse Event|21|||
37958898|NCT00712673|69646393|FG003|Overall Study|Adverse Event|26|||
37958899|NCT00712673|69646390|FG000|Overall Study|Lack of Efficacy|2|||
37958900|NCT00712673|69646391|FG001|Overall Study|Lack of Efficacy|8|||
37958901|NCT00712673|69646392|FG002|Overall Study|Lack of Efficacy|8|||
37958902|NCT00712673|69646393|FG003|Overall Study|Lack of Efficacy|6|||
37958903|NCT00712673|69646390|FG000|Overall Study|Poor Compliance to Protocol|3|||
37958904|NCT00712673|69646391|FG001|Overall Study|Poor Compliance to Protocol|3|||
37958905|NCT00712673|69646392|FG002|Overall Study|Poor Compliance to Protocol|4|||
37958906|NCT00712673|69646393|FG003|Overall Study|Poor Compliance to Protocol|16|||
37958907|NCT00712673|69646390|FG000|Overall Study|Lost to Follow-up|1|||
37958908|NCT00712673|69646391|FG001|Overall Study|Lost to Follow-up|0|||
37958909|NCT00712673|69646392|FG002|Overall Study|Lost to Follow-up|2|||
37958910|NCT00712673|69646393|FG003|Overall Study|Lost to Follow-up|0|||
37958911|NCT00712673|69646390|FG000|Overall Study|Withdrawal by Subject|6|||
37958912|NCT00712673|69646391|FG001|Overall Study|Withdrawal by Subject|7|||
37958913|NCT00712673|69646392|FG002|Overall Study|Withdrawal by Subject|15|||
37958914|NCT00712673|69646393|FG003|Overall Study|Withdrawal by Subject|20|||
37958915|NCT00712673|69646390|FG000|Overall Study|Familial and Personal Reasons|5|||
37958916|NCT00712673|69646391|FG001|Overall Study|Familial and Personal Reasons|0|||
37958917|NCT00712673|69646392|FG002|Overall Study|Familial and Personal Reasons|5|||
37958918|NCT00712673|69646393|FG003|Overall Study|Familial and Personal Reasons|2|||
37958919|NCT00712673|69646390|FG000|Overall Study|Investigator's Decision|1|||
37958920|NCT00712673|69646391|FG001|Overall Study|Investigator's Decision|0|||
37958921|NCT00712673|69646392|FG002|Overall Study|Investigator's Decision|0|||
37958922|NCT00712673|69646393|FG003|Overall Study|Investigator's Decision|0|||
37958923|NCT00712673|69646390|FG000|Overall Study|Protocol Violation|0|||
37958924|NCT00712673|69646391|FG001|Overall Study|Protocol Violation|0|||
37958925|NCT00712673|69646392|FG002|Overall Study|Protocol Violation|2|||
37958926|NCT00712673|69646393|FG003|Overall Study|Protocol Violation|0|||
37958927|NCT03976466|69646414|FG000|Overall Study|Lost to Follow-up|1|||
37958928|NCT03976466|69646415|FG001|Overall Study|Lost to Follow-up|3|||
37958929|NCT02536755|69646423|FG000|Overall Study|Adverse Event|4|||
37958930|NCT03303105|69646432|FG000|Overall Study|Adverse Event|0|||
37958931|NCT03303105|69646433|FG001|Overall Study|Adverse Event|2|||
37958932|NCT03303105|69646432|FG000|Overall Study|Lack of Efficacy|1|||
37958933|NCT03303105|69646433|FG001|Overall Study|Lack of Efficacy|0|||
37958934|NCT03303105|69646432|FG000|Overall Study|Protocol Violation|1|||
37958935|NCT03303105|69646433|FG001|Overall Study|Protocol Violation|0|||
37958936|NCT03303105|69646432|FG000|Overall Study|Withdrawal by Subject|0|||
37958937|NCT03303105|69646433|FG001|Overall Study|Withdrawal by Subject|2|||
37958938|NCT00447694|69646439|FG000|Overall Study|Adverse Event|2|||
37958939|NCT00447694|69646439|FG000|Overall Study|Abnormal laboratory value|1|||
37958940|NCT00447694|69646439|FG000|Overall Study|Abnormal test procedure result|1|||
37958941|NCT00447694|69646439|FG000|Overall Study|Withdrawal by Subject|2|||
37958942|NCT00564278|69646445|FG000|Overall Study|Lost to Follow-up|35|||
37958943|NCT00564278|69646446|FG001|Overall Study|Lost to Follow-up|33|||
37958944|NCT00564278|69646445|FG000|Overall Study|Physician Decision|1|||
37958945|NCT00564278|69646446|FG001|Overall Study|Physician Decision|2|||
37958946|NCT00564278|69646445|FG000|Overall Study|Withdrawal by Subject|11|||
37958947|NCT00564278|69646446|FG001|Overall Study|Withdrawal by Subject|7|||
37958948|NCT00565604|69646452|FG000|Overall Study|Failure to treat|2|||
37958949|NCT00565604|69646452|FG000|Overall Study|Lost to Follow-up|2|||
37958950|NCT00447382|69646458|FG000|Overall Study|Adverse Event|1|||
37958951|NCT00447382|69646459|FG001|Overall Study|Adverse Event|1|||
37958952|NCT00447382|69646458|FG000|Overall Study|Lack of Efficacy|1|||
37958953|NCT00447382|69646459|FG001|Overall Study|Lack of Efficacy|0|||
37958954|NCT00447382|69646458|FG000|Overall Study|Protocol Violation|2|||
37958955|NCT00447382|69646459|FG001|Overall Study|Protocol Violation|0|||
37958956|NCT00447382|69646458|FG000|Overall Study|Unclassified|2|||
37958957|NCT00447382|69646459|FG001|Overall Study|Unclassified|5|||
37958958|NCT00447226|69646465|FG000|12-Week Open-label Phase|Adverse Event|0|||
37958959|NCT00447226|69646466|FG001|12-Week Open-label Phase|Adverse Event|3|||
37958960|NCT00447226|69646465|FG000|12-Week Open-label Phase|Protocol Violation|0|||
37958961|NCT00447226|69646466|FG001|12-Week Open-label Phase|Protocol Violation|1|||
37958962|NCT00447226|69646465|FG000|12-Week Open-label Phase|Disease Progression|0|||
37958963|NCT00447226|69646466|FG001|12-Week Open-label Phase|Disease Progression|20|||
37958964|NCT00447226|69646465|FG000|12-Week Open-label Phase|Physician Decision|0|||
37958965|NCT00447226|69646466|FG001|12-Week Open-label Phase|Physician Decision|1|||
37958966|NCT00447226|69646465|FG000|Double-blind Phase|Disease Progression|4|||
37958967|NCT00447226|69646466|FG001|Double-blind Phase|Disease Progression|3|||
37958968|NCT00446992|69646481|FG000|Overall Study|Adverse Event|11|||
37958969|NCT00446992|69646481|FG000|Overall Study|Lost to Follow-up|5|||
37958970|NCT00503139|69646485|FG000|Overall Study|Case Report Forms were not collected|4|||
37958971|NCT00503139|69646485|FG000|Overall Study|Protocol Violation|4|||
37958972|NCT00577031|69646489|FG000|Overall Study|Adverse Event|52|||
37958973|NCT00577031|69646489|FG000|Overall Study|Progression of disease|93|||
37958974|NCT00577031|69646489|FG000|Overall Study|Protocol Violation|5|||
37958975|NCT00577031|69646489|FG000|Overall Study|Participant withdrew consent|13|||
37958976|NCT00577031|69646489|FG000|Overall Study|Participant non-compliance|5|||
37958977|NCT00577031|69646489|FG000|Overall Study|Need for surgery|17|||
37958978|NCT00577031|69646489|FG000|Overall Study|Medical decision|14|||
37958979|NCT00577031|69646489|FG000|Overall Study|Death|6|||
37958980|NCT00565448|69646498|FG000|Overall Study|Adverse Event|1|||
37958981|NCT00565448|69646499|FG001|Overall Study|Adverse Event|2|||
37958982|NCT00565448|69646498|FG000|Overall Study|Disease progression|1|||
37958983|NCT00565448|69646499|FG001|Overall Study|Disease progression|0|||
37958984|NCT00565448|69646498|FG000|Overall Study|Withdrawal by Subject|1|||
37958985|NCT00565448|69646499|FG001|Overall Study|Withdrawal by Subject|0|||
37958986|NCT00446446|69646508|FG000|Overall Study|Death|10|||
37958987|NCT00446446|69646508|FG000|Overall Study|Withdrawal by Subject|6|||
37958988|NCT00446446|69646508|FG000|Overall Study|Other|4|||
37958989|NCT00446446|69646508|FG000|Overall Study|Disease Progession|2|||
37958990|NCT00446446|69646508|FG000|Overall Study|Adverse Event|1|||
37958991|NCT00446446|69646508|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
37958994|NCT00514449|69646520|FG000|Overall Study|Withdrawal by Subject|1|||
37958995|NCT00514449|69646521|FG001|Overall Study|Withdrawal by Subject|2|||
37958996|NCT00514449|69646520|FG000|Overall Study|Protocol Violation|1|||
37958997|NCT00514449|69646521|FG001|Overall Study|Protocol Violation|2|||
37958998|NCT00514449|69646520|FG000|Overall Study|Lost to Follow-up|1|||
37958999|NCT00514449|69646521|FG001|Overall Study|Lost to Follow-up|0|||
37959000|NCT00565136|69646530|FG000|Overall Study|Lost to Follow-up|1|||
37959001|NCT00565136|69646530|FG000|Overall Study|Withdrawal by Subject|1|||
37959002|NCT00565136|69646530|FG000|Overall Study|Protocol Violation|1|||
37959003|NCT00492921|69646534|FG000|Overall Study|Death|1|||
37959004|NCT00492921|69646535|FG001|Overall Study|Death|0|||
37959005|NCT00492921|69646536|FG002|Overall Study|Death|1|||
37959006|NCT00502671|69646544|FG000|Overall Study|Disease Progression|13|||
37959007|NCT00502671|69646544|FG000|Overall Study|Personal Reasons|22|||
37959008|NCT00502671|69646544|FG000|Overall Study|Lost to Follow-up|7|||
37959009|NCT00502671|69646544|FG000|Overall Study|Protocol Violation|16|||
37959010|NCT00502671|69646544|FG000|Overall Study|Adverse Event|19|||
37959011|NCT00697463|69646548|FG000|Overall Study|Withdrawal by Subject|1|||
37959012|NCT00492531|69646554|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
37959013|NCT00492531|69646555|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
37959014|NCT00111475|69646571|FG000|Overall Study|Lost to Follow-up|0|||
37959015|NCT00111475|69646572|FG001|Overall Study|Lost to Follow-up|0|||
37959016|NCT00111475|69646573|FG002|Overall Study|Lost to Follow-up|0|||
37959017|NCT00111475|69646574|FG003|Overall Study|Lost to Follow-up|0|||
37959018|NCT00111475|69646575|FG004|Overall Study|Lost to Follow-up|0|||
37959019|NCT00111475|69646576|FG005|Overall Study|Lost to Follow-up|1|||
37959020|NCT00111475|69646577|FG006|Overall Study|Lost to Follow-up|0|||
37959021|NCT00111475|69646578|FG007|Overall Study|Lost to Follow-up|0|||
37959022|NCT00111475|69646579|FG008|Overall Study|Lost to Follow-up|0|||
37959023|NCT00111475|69646580|FG009|Overall Study|Lost to Follow-up|0|||
37959024|NCT00111241|69646609|FG000|Overall Study|Lost to Follow-up|1|||
37959025|NCT00111241|69646610|FG001|Overall Study|Lost to Follow-up|0|||
37959026|NCT00111241|69646609|FG000|Overall Study|Withdrawal by Subject|4|||
37959027|NCT00111241|69646610|FG001|Overall Study|Withdrawal by Subject|0|||
37959028|NCT00111241|69646609|FG000|Overall Study|Protocol Violation|9|||
37959029|NCT00111241|69646610|FG001|Overall Study|Protocol Violation|8|||
37959030|NCT00111241|69646609|FG000|Overall Study|Adverse Event|1|||
37959031|NCT00111241|69646610|FG001|Overall Study|Adverse Event|0|||
37959032|NCT00492297|69646618|FG000|Treatment|Death|2|||
37959033|NCT00492297|69646618|FG000|Treatment|Study terminated by sponsor|3|||
37959034|NCT00492297|69646618|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
37959035|NCT00492297|69646618|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
37959036|NCT00492297|69646618|FG000|Survival Only Follow-up|Death|46|||
37959037|NCT00492297|69646618|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
37959038|NCT00492297|69646618|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
37959039|NCT00565058|69646624|FG000|Overall Study|Adverse Event|1|||
37959040|NCT00565058|69646625|FG001|Overall Study|Adverse Event|0|||
37959041|NCT00564902|69646634|FG000|Overall Study|Withdrawal by Subject|0|||
37959042|NCT00564902|69646635|FG001|Overall Study|Withdrawal by Subject|3|||
37959043|NCT00564902|69646636|FG002|Overall Study|Withdrawal by Subject|4|||
37959044|NCT00564902|69646634|FG000|Overall Study|Death|1|||
37959045|NCT00564902|69646635|FG001|Overall Study|Death|1|||
37959046|NCT00564902|69646636|FG002|Overall Study|Death|0|||
37959047|NCT00446134|69646648|FG000|Overall Study|Adverse Event|7|||
37959048|NCT00446134|69646649|FG001|Overall Study|Adverse Event|17|||
37959049|NCT00446134|69646650|FG002|Overall Study|Adverse Event|13|||
37959050|NCT00446134|69646651|FG003|Overall Study|Adverse Event|18|||
37959051|NCT00446134|69646648|FG000|Overall Study|Lack of Efficacy|19|||
37959052|NCT00446134|69646649|FG001|Overall Study|Lack of Efficacy|19|||
37959053|NCT00446134|69646650|FG002|Overall Study|Lack of Efficacy|24|||
37959054|NCT00446134|69646651|FG003|Overall Study|Lack of Efficacy|19|||
37959055|NCT00446134|69646648|FG000|Overall Study|Protocol Violation|0|||
37959056|NCT00446134|69646649|FG001|Overall Study|Protocol Violation|2|||
37959057|NCT00446134|69646650|FG002|Overall Study|Protocol Violation|1|||
37959058|NCT00446134|69646651|FG003|Overall Study|Protocol Violation|0|||
37959059|NCT00446134|69646648|FG000|Overall Study|Lost to Follow-up|1|||
37959060|NCT00446134|69646649|FG001|Overall Study|Lost to Follow-up|3|||
37959061|NCT00446134|69646650|FG002|Overall Study|Lost to Follow-up|1|||
37959062|NCT00446134|69646651|FG003|Overall Study|Lost to Follow-up|1|||
37959063|NCT00446134|69646648|FG000|Overall Study|Withdrawal by Subject|3|||
37959064|NCT00446134|69646649|FG001|Overall Study|Withdrawal by Subject|3|||
37959065|NCT00446134|69646650|FG002|Overall Study|Withdrawal by Subject|1|||
37959066|NCT00446134|69646651|FG003|Overall Study|Withdrawal by Subject|3|||
37959067|NCT00446134|69646648|FG000|Overall Study|Physician Decision|0|||
37959068|NCT00446134|69646649|FG001|Overall Study|Physician Decision|0|||
37959069|NCT00446134|69646650|FG002|Overall Study|Physician Decision|0|||
37959070|NCT00446134|69646651|FG003|Overall Study|Physician Decision|2|||
37959071|NCT00446134|69646648|FG000|Overall Study|Adverse Event-Diarrhea|1|||
37959072|NCT00446134|69646649|FG001|Overall Study|Adverse Event-Diarrhea|1|||
37959073|NCT00446134|69646650|FG002|Overall Study|Adverse Event-Diarrhea|2|||
37959074|NCT00446134|69646651|FG003|Overall Study|Adverse Event-Diarrhea|0|||
37959075|NCT00446134|69646648|FG000|Overall Study|Reason Not Completed|3|||
37959076|NCT00446134|69646649|FG001|Overall Study|Reason Not Completed|0|||
37959077|NCT00446134|69646650|FG002|Overall Study|Reason Not Completed|1|||
37959078|NCT00446134|69646651|FG003|Overall Study|Reason Not Completed|2|||
37959079|NCT00563186|69646663|FG000|Overall Study|LOS<48 hours|97|||
37959080|NCT00563186|69646664|FG001|Overall Study|LOS<48 hours|74|||
37959081|NCT00563186|69646663|FG000|Overall Study|Incomplete data|1|||
37959082|NCT00563186|69646664|FG001|Overall Study|Incomplete data|1|||
37959083|NCT00699413|69646675|FG000|Overall Study|Withdrawal by Subject|0|||
37959084|NCT00699413|69646676|FG001|Overall Study|Withdrawal by Subject|2|||
37959085|NCT00699413|69646675|FG000|Overall Study|Study terminated by sponsor|4|||
37959086|NCT00699413|69646676|FG001|Overall Study|Study terminated by sponsor|2|||
37959087|NCT04808609|69646684|FG000|Overall Study|Lost to Follow-up|0|||
37959088|NCT04808609|69646685|FG001|Overall Study|Lost to Follow-up|2|||
37959089|NCT04808609|69646684|FG000|Overall Study|Administrative Withdrawal|0|||
37959090|NCT04808609|69646685|FG001|Overall Study|Administrative Withdrawal|1|||
37959091|NCT00111007|69646693|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
37959092|NCT00111007|69646694|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
37959093|NCT00111007|69646693|FG000|Double-blind (DB) Treatment|Death|5|||
37959094|NCT00111007|69646694|FG001|Double-blind (DB) Treatment|Death|2|||
37959095|NCT00111007|69646693|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
37959096|NCT00111007|69646694|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
37959097|NCT00111007|69646693|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
37959098|NCT00111007|69646694|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
37959099|NCT00111007|69646693|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
37959100|NCT00111007|69646694|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
37959101|NCT00111007|69646693|FG000|Double-blind (DB) Treatment|Relapse|1|||
37959102|NCT00111007|69646694|FG001|Double-blind (DB) Treatment|Relapse|0|||
37959103|NCT00111007|69646693|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
37959104|NCT00111007|69646694|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
37959105|NCT00111007|69646693|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
37959106|NCT00111007|69646694|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
37959107|NCT00111007|69646693|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
37959108|NCT00111007|69646694|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
37959109|NCT00111007|69646693|FG000|Active Follow-up|Adverse Event|1|||
37959110|NCT00111007|69646694|FG001|Active Follow-up|Adverse Event|0|||
37959111|NCT00111007|69646693|FG000|Active Follow-up|Death|2|||
37959112|NCT00111007|69646694|FG001|Active Follow-up|Death|0|||
37959113|NCT00111007|69646693|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
37959114|NCT00111007|69646694|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
37959115|NCT00111007|69646693|FG000|Long Term Follow-up|Death|34|||
37959116|NCT00111007|69646694|FG001|Long Term Follow-up|Death|39|||
37959117|NCT00111007|69646693|FG000|Long Term Follow-up|Lost to Follow-up|1|||
37959118|NCT00111007|69646694|FG001|Long Term Follow-up|Lost to Follow-up|1|||
37959119|NCT00111007|69646693|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
37959120|NCT00111007|69646694|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
37959121|NCT00111007|69646693|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
37959122|NCT00111007|69646694|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
37959123|NCT00111007|69646693|FG000|Long Term Follow-up|Missing|10|||
37959124|NCT00111007|69646694|FG001|Long Term Follow-up|Missing|3|||
37959125|NCT03975920|69646702|FG000|Overall Study|Lost to Follow-up|1|||
37959126|NCT03975920|69646703|FG001|Overall Study|Lost to Follow-up|2|||
37959127|NCT03975920|69646702|FG000|Overall Study|Protocol Violation|1|||
37959128|NCT03975920|69646703|FG001|Overall Study|Protocol Violation|1|||
37959129|NCT03975920|69646702|FG000|Overall Study|Did not complete survey|2|||
37959130|NCT03975920|69646703|FG001|Overall Study|Did not complete survey|1|||
37959131|NCT00699335|69646709|FG000|Overall Study|Combination of multiple reasons|176|||
37959132|NCT00699335|69646709|FG000|Overall Study|Missing data|52|||
37959133|NCT00445978|69646716|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
37959134|NCT00445978|69646716|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
37959135|NCT00445978|69646716|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
37959136|NCT00445978|69646716|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
37959137|NCT00445978|69646716|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
37959138|NCT00445978|69646716|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
37959139|NCT00445978|69646716|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
37959140|NCT00445978|69646716|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
37959141|NCT00445978|69646716|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
37959142|NCT00566228|69646729|FG000|Overall Study|Withdrawal by Subject|1|||
37959143|NCT00566228|69646730|FG001|Overall Study|Withdrawal by Subject|0|||
37959144|NCT00566228|69646729|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
37959145|NCT00566228|69646730|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
37959146|NCT00566228|69646729|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
37959147|NCT00566228|69646730|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
37959148|NCT00566228|69646729|FG000|Overall Study|progressed before infusion could occur|0|||
37959149|NCT00566228|69646730|FG001|Overall Study|progressed before infusion could occur|1|||
37959150|NCT00698009|69646736|FG000|Overall Study|Withdrawal by Subject|1|||
37959151|NCT03968978|69646742|FG000|Overall Study|Adverse Event|1|||
37959152|NCT03968978|69646743|FG001|Overall Study|Adverse Event|0|||
37959153|NCT00562718|69646749|FG000|Overall Study|Death|1|||
37959154|NCT00562718|69646749|FG000|Overall Study|Withdrawal by Subject|3|||
37959155|NCT00562718|69646749|FG000|Overall Study|Adverse Event|4|||
37959156|NCT00562718|69646749|FG000|Overall Study|Lack of Efficacy|2|||
37959157|NCT00562718|69646749|FG000|Overall Study|not stated|1|||
37959158|NCT00697619|69646755|FG000|Overall Study|Lack of Efficacy|2|||
37959159|NCT00697619|69646756|FG001|Overall Study|Lack of Efficacy|2|||
37959160|NCT00697619|69646755|FG000|Overall Study|Adverse Event|4|||
37959161|NCT00697619|69646756|FG001|Overall Study|Adverse Event|6|||
37959162|NCT00445432|69646765|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
37959163|NCT00445432|69646766|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
37959164|NCT00445432|69646767|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
37959165|NCT00445432|69646768|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
37959166|NCT00445432|69646765|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
37959167|NCT00445432|69646766|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
37959168|NCT00445432|69646767|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
37959169|NCT00445432|69646768|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
37959170|NCT00445432|69646765|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
37959171|NCT00445432|69646766|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
37959172|NCT00445432|69646767|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
37959173|NCT00445432|69646768|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
37959174|NCT00445432|69646765|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
37959175|NCT00445432|69646766|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
37959176|NCT00445432|69646767|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
37959177|NCT00445432|69646768|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
37959178|NCT00445432|69646765|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
37959179|NCT00445432|69646766|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
37959180|NCT00445432|69646767|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
37959181|NCT00445432|69646768|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
37959182|NCT00445432|69646765|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
37959183|NCT00445432|69646766|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
37959184|NCT00445432|69646767|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
37959185|NCT00445432|69646768|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
37959186|NCT00445432|69646765|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
37959187|NCT00445432|69646766|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
37959188|NCT00445432|69646767|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
37959189|NCT00445432|69646768|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
37959190|NCT03370133|69646782|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
37959191|NCT03370133|69646783|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
37959192|NCT03370133|69646784|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
37959193|NCT03370133|69646785|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
37959194|NCT03370133|69646786|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
37959195|NCT03370133|69646787|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
37959196|NCT03370133|69646782|FG000|Initial Treatment Period (WK 16)|Death|1|||
37959197|NCT03370133|69646783|FG001|Initial Treatment Period (WK 16)|Death|1|||
37959198|NCT03370133|69646784|FG002|Initial Treatment Period (WK 16)|Death|1|||
37959199|NCT03370133|69646785|FG003|Initial Treatment Period (WK 16)|Death|0|||
37959200|NCT03370133|69646786|FG004|Initial Treatment Period (WK 16)|Death|0|||
37959201|NCT03370133|69646787|FG005|Initial Treatment Period (WK 16)|Death|0|||
37959202|NCT03370133|69646782|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
37959203|NCT03370133|69646783|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
37959204|NCT03370133|69646784|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
37959205|NCT03370133|69646785|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
37959206|NCT03370133|69646786|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
37959207|NCT03370133|69646787|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
37959208|NCT03370133|69646782|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
37959209|NCT03370133|69646783|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
37959210|NCT03370133|69646784|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
37959211|NCT03370133|69646785|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
37959212|NCT03370133|69646786|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
37959213|NCT03370133|69646787|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
37959214|NCT03370133|69646782|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
37959215|NCT03370133|69646783|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
37959216|NCT03370133|69646784|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
38051303|NCT04465357|69740504|FG000|Overall Study|Lost to Follow-up|2|||
38051304|NCT04465357|69740504|FG000|Overall Study|Withdrawal by Subject|6|||
38051305|NCT04465357|69740504|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
38051306|NCT03332628|69740508|FG000|Overall Study|Physician Decision|2|||
38051307|NCT04516759|69740515|FG000|Overall Study|Withdrawal by Subject|1|||
38051308|NCT04516759|69740516|FG001|Overall Study|Withdrawal by Subject|1|||
38051309|NCT04516759|69740515|FG000|Overall Study|Other|0|||
37959217|NCT03370133|69646785|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
37959218|NCT03370133|69646786|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
38051310|NCT04516759|69740516|FG001|Overall Study|Other|1|||
38051311|NCT03332160|69740524|FG000|Overall Study|Withdrawal by Subject|1|||
38051312|NCT03332160|69740525|FG001|Overall Study|Withdrawal by Subject|1|||
38051313|NCT03332160|69740524|FG000|Overall Study|Adverse Event|0|||
38051314|NCT03332160|69740525|FG001|Overall Study|Adverse Event|1|||
38051315|NCT03332160|69740524|FG000|Overall Study|Developed Exclusion Criteria|0|||
38051316|NCT03332160|69740525|FG001|Overall Study|Developed Exclusion Criteria|1|||
38051317|NCT03332160|69740524|FG000|Overall Study|Non-adherence to treatment|0|||
37959219|NCT03370133|69646787|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
37959220|NCT03370133|69646782|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
37959221|NCT03370133|69646783|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
37959222|NCT03370133|69646784|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
37959223|NCT03370133|69646785|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
37959224|NCT03370133|69646786|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
37959225|NCT03370133|69646787|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
37959226|NCT03370133|69646782|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
37959227|NCT03370133|69646783|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
37959228|NCT03370133|69646784|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
37959229|NCT03370133|69646785|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
37959230|NCT03370133|69646786|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
37959231|NCT03370133|69646787|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
37959232|NCT03370133|69646782|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
37959233|NCT03370133|69646783|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
37959234|NCT03370133|69646784|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
37959235|NCT03370133|69646785|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
37959236|NCT03370133|69646786|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
37959237|NCT03370133|69646787|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
37959238|NCT03370133|69646782|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
37959239|NCT03370133|69646783|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
37959240|NCT03370133|69646784|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
37959241|NCT03370133|69646785|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
37959242|NCT03370133|69646786|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
37959243|NCT03370133|69646787|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
37959244|NCT03370133|69646782|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
37959245|NCT03370133|69646783|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
37959246|NCT03370133|69646784|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
37959247|NCT03370133|69646785|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
37959248|NCT03370133|69646786|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
37959249|NCT03370133|69646787|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
37959250|NCT03370133|69646782|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
37959251|NCT03370133|69646783|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
37959252|NCT03370133|69646784|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
37959253|NCT03370133|69646785|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
37959254|NCT03370133|69646786|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
37959255|NCT03370133|69646787|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
37959256|NCT03370133|69646782|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
37959257|NCT03370133|69646783|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
37959258|NCT03370133|69646784|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
37959259|NCT03370133|69646785|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
37959260|NCT03370133|69646786|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
37959261|NCT03370133|69646787|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
37959262|NCT03370133|69646782|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
37959263|NCT03370133|69646783|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
37959264|NCT03370133|69646784|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
37959265|NCT03370133|69646785|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
37959266|NCT03370133|69646786|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
37959267|NCT03370133|69646787|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
37959268|NCT03370133|69646782|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
37959269|NCT03370133|69646783|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
37959270|NCT03370133|69646784|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
37959271|NCT03370133|69646785|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
37959272|NCT03370133|69646786|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
37959273|NCT03370133|69646787|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
37959274|NCT03370133|69646782|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
37959275|NCT03370133|69646783|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
38051318|NCT03332160|69740525|FG001|Overall Study|Non-adherence to treatment|2|||
38051319|NCT03312114|69740532|FG000|Overall Study|All the five enrolled dropped out of the|5|||
38051320|NCT03694327|69740539|FG000|Overall Study|Lost to Follow-up|13|||
38051321|NCT03694327|69740540|FG001|Overall Study|Lost to Follow-up|23|||
38051322|NCT03330288|69740548|FG000|Overall Study|Other reason|1|||
38051323|NCT03330288|69740549|FG001|Overall Study|Other reason|1|||
37959276|NCT03370133|69646784|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
37959277|NCT03370133|69646785|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
37959278|NCT03370133|69646786|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
37959279|NCT03370133|69646787|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
37959280|NCT00696137|69646805|FG000|Overall Study|Withdrawal by Subject|2|||
37959281|NCT00441142|69646813|FG000|Overall Study|Adverse Event|2|||
37959282|NCT00441142|69646814|FG001|Overall Study|Adverse Event|3|||
37959283|NCT00441142|69646815|FG002|Overall Study|Adverse Event|3|||
37959284|NCT00441142|69646816|FG003|Overall Study|Adverse Event|22|||
37959285|NCT00441142|69646813|FG000|Overall Study|Lack of Efficacy|3|||
37959286|NCT00441142|69646814|FG001|Overall Study|Lack of Efficacy|3|||
37959287|NCT00441142|69646815|FG002|Overall Study|Lack of Efficacy|17|||
37959288|NCT00441142|69646816|FG003|Overall Study|Lack of Efficacy|32|||
37959289|NCT00441142|69646813|FG000|Overall Study|Withdrawal by Subject|0|||
37959290|NCT00441142|69646814|FG001|Overall Study|Withdrawal by Subject|0|||
37959291|NCT00441142|69646815|FG002|Overall Study|Withdrawal by Subject|2|||
37959292|NCT00441142|69646816|FG003|Overall Study|Withdrawal by Subject|10|||
37959293|NCT00441142|69646813|FG000|Overall Study|Patient still receiving active study tx|1|||
37959294|NCT00441142|69646814|FG001|Overall Study|Patient still receiving active study tx|0|||
37959295|NCT00441142|69646815|FG002|Overall Study|Patient still receiving active study tx|0|||
37959296|NCT00441142|69646816|FG003|Overall Study|Patient still receiving active study tx|2|||
37959297|NCT00441142|69646813|FG000|Overall Study|Physician Decision|0|||
37959298|NCT00441142|69646814|FG001|Overall Study|Physician Decision|1|||
37959299|NCT00441142|69646815|FG002|Overall Study|Physician Decision|0|||
37959300|NCT00441142|69646816|FG003|Overall Study|Physician Decision|1|||
37959301|NCT00441142|69646813|FG000|Overall Study|Death|0|||
37959302|NCT00441142|69646814|FG001|Overall Study|Death|0|||
37959303|NCT00441142|69646815|FG002|Overall Study|Death|0|||
37959304|NCT00441142|69646816|FG003|Overall Study|Death|1|||
37959305|NCT04025021|69646830|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
37959306|NCT04025021|69646831|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
37959307|NCT03848416|69646841|FG000|Overall Study|Withdrawal by Subject|1|||
37959308|NCT03848416|69646842|FG001|Overall Study|Withdrawal by Subject|0|||
37959309|NCT03848416|69646843|FG002|Overall Study|Withdrawal by Subject|0|||
37959310|NCT03848416|69646841|FG000|Overall Study|Death|0|||
37959311|NCT03848416|69646842|FG001|Overall Study|Death|0|||
37959312|NCT03848416|69646843|FG002|Overall Study|Death|1|||
37959313|NCT00458302|69646853|FG000|Overall Study|Adverse Event|4|||
37959314|NCT00458302|69646854|FG001|Overall Study|Adverse Event|14|||
37959315|NCT00458302|69646853|FG000|Overall Study|Pregnancy|2|||
37959316|NCT00458302|69646854|FG001|Overall Study|Pregnancy|1|||
37959317|NCT00458302|69646853|FG000|Overall Study|Protocol Violation|0|||
37959318|NCT00458302|69646854|FG001|Overall Study|Protocol Violation|2|||
37959319|NCT00458302|69646853|FG000|Overall Study|Withdrawal by Subject|6|||
37959320|NCT00458302|69646854|FG001|Overall Study|Withdrawal by Subject|4|||
37959321|NCT00458302|69646853|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
37959322|NCT00458302|69646854|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
37959323|NCT00458302|69646853|FG000|Overall Study|Study Termination By Sponsor|1|||
37959324|NCT00458302|69646854|FG001|Overall Study|Study Termination By Sponsor|0|||
37959325|NCT00458302|69646853|FG000|Overall Study|Lost to Follow-up|2|||
37959326|NCT00458302|69646854|FG001|Overall Study|Lost to Follow-up|0|||
37959327|NCT00458302|69646853|FG000|Overall Study|Other|4|||
37959328|NCT00458302|69646854|FG001|Overall Study|Other|2|||
37959329|NCT00444106|69646864|FG000|Overall Study|Lost to Follow-up|2|||
37959330|NCT00444106|69646865|FG001|Overall Study|Lost to Follow-up|1|||
37959331|NCT00444106|69646866|FG002|Overall Study|Lost to Follow-up|0|||
37959332|NCT00444106|69646864|FG000|Overall Study|Abnormal Test Procedure Results|0|||
37959333|NCT00444106|69646865|FG001|Overall Study|Abnormal Test Procedure Results|0|||
37959334|NCT00444106|69646866|FG002|Overall Study|Abnormal Test Procedure Results|1|||
37959335|NCT00561470|69646879|FG000|Overall Study|Adverse Event|74|||
37959336|NCT00561470|69646880|FG001|Overall Study|Adverse Event|163|||
37959337|NCT00561470|69646879|FG000|Overall Study|Disease progression|437|||
37959338|NCT00561470|69646880|FG001|Overall Study|Disease progression|305|||
37959339|NCT00561470|69646879|FG000|Overall Study|poor compliance to protocol|4|||
37959340|NCT00561470|69646880|FG001|Overall Study|poor compliance to protocol|4|||
37959341|NCT00561470|69646879|FG000|Overall Study|Lost to Follow-up|2|||
37959342|NCT00561470|69646880|FG001|Overall Study|Lost to Follow-up|0|||
37959343|NCT00561470|69646879|FG000|Overall Study|Physician Decision|21|||
37959344|NCT00561470|69646880|FG001|Overall Study|Physician Decision|20|||
37959345|NCT00561470|69646879|FG000|Overall Study|Consent Withdrawn|2|||
37959346|NCT00561470|69646880|FG001|Overall Study|Consent Withdrawn|6|||
37959347|NCT00561470|69646879|FG000|Overall Study|Subject request|43|||
37959348|NCT00561470|69646880|FG001|Overall Study|Subject request|77|||
37959349|NCT00561470|69646879|FG000|Overall Study|Metastatic surgery|10|||
37959350|NCT00561470|69646880|FG001|Overall Study|Metastatic surgery|12|||
37959351|NCT00561470|69646879|FG000|Overall Study|Unauthorized procedure|3|||
37959352|NCT00561470|69646880|FG001|Overall Study|Unauthorized procedure|1|||
37959353|NCT00561470|69646879|FG000|Overall Study|Randomized but not treated|5|||
37959354|NCT00561470|69646880|FG001|Overall Study|Randomized but not treated|5|||
37959355|NCT00561470|69646879|FG000|Overall Study|Missed visit window|1|||
37959356|NCT00561470|69646880|FG001|Overall Study|Missed visit window|4|||
37959357|NCT00561470|69646879|FG000|Overall Study|Planning surgery|1|||
37959358|NCT00561470|69646880|FG001|Overall Study|Planning surgery|1|||
37959359|NCT00561470|69646879|FG000|Overall Study|Ongoing Treatment|11|||
37959360|NCT00561470|69646880|FG001|Overall Study|Ongoing Treatment|14|||
37959361|NCT00443872|69646888|FG000|Overall Study|Protocol Violation|7|||
37959362|NCT00443872|69646888|FG000|Overall Study|Lost to Follow-up|2|||
37959363|NCT00443872|69646888|FG000|Overall Study|Adverse Event|8|||
37959364|NCT00441064|69646903|FG000|Overall Study|Adverse Event|1|||
37959365|NCT00441064|69646904|FG001|Overall Study|Adverse Event|0|||
37959366|NCT00441064|69646903|FG000|Overall Study|Abnormal laboratory values|0|||
37959367|NCT00441064|69646904|FG001|Overall Study|Abnormal laboratory values|2|||
37959368|NCT00441064|69646903|FG000|Overall Study|Abnormal test procedure results|0|||
37959369|NCT00441064|69646904|FG001|Overall Study|Abnormal test procedure results|1|||
37959370|NCT00441064|69646903|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
37959371|NCT00441064|69646904|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
37959372|NCT00441064|69646903|FG000|Overall Study|Protocol Deviation|3|||
37959373|NCT00441064|69646904|FG001|Overall Study|Protocol Deviation|2|||
37959374|NCT00441064|69646903|FG000|Overall Study|Patient withdrew consent|5|||
37959375|NCT00441064|69646904|FG001|Overall Study|Patient withdrew consent|2|||
37959376|NCT03962738|69646914|FG000|Overall Study|Protocol Deviation|3|||
37959377|NCT03962738|69646915|FG001|Overall Study|Protocol Deviation|0|||
37959378|NCT03962738|69646916|FG002|Overall Study|Protocol Deviation|1|||
37959379|NCT03962738|69646917|FG003|Overall Study|Protocol Deviation|1|||
37959380|NCT03962738|69646914|FG000|Overall Study|Withdrawal by Subject|4|||
37959381|NCT03962738|69646915|FG001|Overall Study|Withdrawal by Subject|0|||
37959382|NCT03962738|69646916|FG002|Overall Study|Withdrawal by Subject|0|||
37959383|NCT03962738|69646917|FG003|Overall Study|Withdrawal by Subject|0|||
37959384|NCT03962738|69646914|FG000|Overall Study|Lost to Follow-up|0|||
37959385|NCT03962738|69646915|FG001|Overall Study|Lost to Follow-up|0|||
37959386|NCT03962738|69646916|FG002|Overall Study|Lost to Follow-up|1|||
37959387|NCT03962738|69646917|FG003|Overall Study|Lost to Follow-up|0|||
37959388|NCT00561392|69646935|FG000|Overall Study|Adverse Event|38|||
37959389|NCT00561392|69646935|FG000|Overall Study|Lack of Efficacy|2|||
37959390|NCT00561392|69646935|FG000|Overall Study|Protocol Violation|1|||
37959391|NCT00561392|69646935|FG000|Overall Study|Withdrawal by Subject|8|||
37959392|NCT00561392|69646935|FG000|Overall Study|Administrative problems|4|||
37959393|NCT00694109|69646939|FG000|Overall Study|Physician Decision|3|||
37959394|NCT00694109|69646939|FG000|Overall Study|Adverse Event|74|||
37959395|NCT00694109|69646939|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
37959396|NCT00694109|69646939|FG000|Overall Study|Lack of Efficacy|2|||
37959397|NCT00694109|69646939|FG000|Overall Study|Withdrawal by Subject|13|||
37959398|NCT00694109|69646939|FG000|Overall Study|Pregnancy|1|||
37959399|NCT00694109|69646939|FG000|Overall Study|Enrolled but not treated|1|||
37959400|NCT00694109|69646939|FG000|Overall Study|Other|2|||
37959401|NCT00694109|69646939|FG000|Overall Study|Consented but no additional treatment|3|||
37959402|NCT00562484|69646950|FG000|Overall Study|Adverse Event|6|||
37959403|NCT00562484|69646951|FG001|Overall Study|Adverse Event|1|||
37959404|NCT00562484|69646950|FG000|Overall Study|Protocol Violation|11|||
37959405|NCT00562484|69646951|FG001|Overall Study|Protocol Violation|2|||
37959406|NCT00562484|69646950|FG000|Overall Study|Withdrawal by Subject|12|||
37959407|NCT00562484|69646951|FG001|Overall Study|Withdrawal by Subject|9|||
37959408|NCT00562484|69646950|FG000|Overall Study|Moved away from the study area|20|||
37959409|NCT00562484|69646951|FG001|Overall Study|Moved away from the study area|9|||
37959410|NCT00562484|69646950|FG000|Overall Study|Lost to Follow-up|132|||
37959411|NCT00562484|69646951|FG001|Overall Study|Lost to Follow-up|71|||
37959412|NCT00562484|69646950|FG000|Overall Study|Reason not provided or not specified|25|||
37959413|NCT00562484|69646951|FG001|Overall Study|Reason not provided or not specified|12|||
37959414|NCT00561080|69646960|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
38051324|NCT03330288|69740548|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
38051325|NCT03330288|69740549|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
38051326|NCT03330288|69740548|FG000|Overall Study|Adverse Event|1|||
37959415|NCT00561080|69646961|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
37959416|NCT00561080|69646962|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
37959417|NCT00561080|69646960|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
37959418|NCT00561080|69646961|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
37959419|NCT00561080|69646962|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
37959420|NCT00561080|69646960|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
37959421|NCT00561080|69646961|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
37959422|NCT00561080|69646962|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
37959423|NCT00561080|69646960|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
37959424|NCT00561080|69646961|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
37959425|NCT00561080|69646962|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
37959426|NCT00561080|69646960|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
37959427|NCT00561080|69646961|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
37959428|NCT00561080|69646962|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
37959429|NCT00561080|69646960|FG000|Vaccination Period (up to Month 4)|Other|0|||
37959430|NCT00561080|69646961|FG001|Vaccination Period (up to Month 4)|Other|2|||
37959431|NCT00561080|69646962|FG002|Vaccination Period (up to Month 4)|Other|1|||
37959432|NCT00561080|69646960|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
37959433|NCT00561080|69646961|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
37959434|NCT00561080|69646962|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
37959435|NCT00561080|69646960|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
37959436|NCT00561080|69646961|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
37959437|NCT00561080|69646962|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
37959438|NCT00561080|69646960|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
37959439|NCT00561080|69646961|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
37959440|NCT00561080|69646962|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
37959441|NCT00561080|69646960|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
37959442|NCT00561080|69646961|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
37959443|NCT00561080|69646962|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
37959444|NCT00562094|69646972|FG000|Overall Study|Lost to Follow-up|62|||
37959445|NCT03817853|69646980|FG000|Induction Phase|Adverse Event|5|||
37959446|NCT03817853|69646981|FG001|Induction Phase|Adverse Event|0|||
37959447|NCT03817853|69646982|FG002|Induction Phase|Adverse Event|0|||
37959448|NCT03817853|69646980|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
37959449|NCT03817853|69646981|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
37959450|NCT03817853|69646982|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
37959451|NCT03817853|69646980|FG000|Induction Phase|Physician Decision|2|||
37959452|NCT03817853|69646981|FG001|Induction Phase|Physician Decision|0|||
37959453|NCT03817853|69646982|FG002|Induction Phase|Physician Decision|0|||
37959454|NCT03817853|69646980|FG000|Induction Phase|Progressive Disease|4|||
37959455|NCT03817853|69646981|FG001|Induction Phase|Progressive Disease|0|||
37959456|NCT03817853|69646982|FG002|Induction Phase|Progressive Disease|0|||
37959457|NCT03817853|69646980|FG000|Induction Phase|Withdrawal by Subject|3|||
37959458|NCT03817853|69646981|FG001|Induction Phase|Withdrawal by Subject|0|||
37959459|NCT03817853|69646982|FG002|Induction Phase|Withdrawal by Subject|0|||
37959460|NCT03817853|69646980|FG000|Induction Phase|Continuing on Study|34|||
37959461|NCT03817853|69646981|FG001|Induction Phase|Continuing on Study|0|||
37959462|NCT03817853|69646982|FG002|Induction Phase|Continuing on Study|0|||
37959463|NCT03817853|69646980|FG000|Maintenance/ Follow-up Phase|Adverse Event|0|||
37959464|NCT03817853|69646981|FG001|Maintenance/ Follow-up Phase|Adverse Event|1|||
37959465|NCT03817853|69646982|FG002|Maintenance/ Follow-up Phase|Adverse Event|0|||
37959466|NCT03817853|69646980|FG000|Maintenance/ Follow-up Phase|Death|0|||
37959467|NCT03817853|69646981|FG001|Maintenance/ Follow-up Phase|Death|1|||
37959468|NCT03817853|69646982|FG002|Maintenance/ Follow-up Phase|Death|1|||
37959469|NCT03817853|69646980|FG000|Maintenance/ Follow-up Phase|Progressive Disease|0|||
37959470|NCT03817853|69646981|FG001|Maintenance/ Follow-up Phase|Progressive Disease|1|||
37959471|NCT03817853|69646982|FG002|Maintenance/ Follow-up Phase|Progressive Disease|3|||
37959472|NCT03817853|69646980|FG000|Maintenance/ Follow-up Phase|Withdrawal by Subject|0|||
37959473|NCT03817853|69646981|FG001|Maintenance/ Follow-up Phase|Withdrawal by Subject|1|||
37959474|NCT03817853|69646982|FG002|Maintenance/ Follow-up Phase|Withdrawal by Subject|0|||
37959475|NCT03817853|69646980|FG000|Maintenance/ Follow-up Phase|Continuing on Study|0|||
37959476|NCT03817853|69646981|FG001|Maintenance/ Follow-up Phase|Continuing on Study|52|||
37959477|NCT03817853|69646982|FG002|Maintenance/ Follow-up Phase|Continuing on Study|2|||
37959478|NCT00439270|69646995|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
37959479|NCT00439270|69646996|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
37959480|NCT00439270|69646997|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
37959481|NCT00439270|69646998|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
37959482|NCT00439270|69646999|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
37959483|NCT00439270|69646995|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
37680323|NCT02400333|69155887|FG001|Overall Study|Withdrawal by Subject|1|||
37680324|NCT02400333|69155888|FG002|Overall Study|Withdrawal by Subject|0|||
37680325|NCT02400333|69155889|FG003|Overall Study|Withdrawal by Subject|1|||
37680326|NCT02400333|69155886|FG000|Overall Study|Protocol Violation|1|||
37959484|NCT00439270|69646996|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
37959485|NCT00439270|69646997|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
37959486|NCT00439270|69646998|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
37959487|NCT00439270|69646999|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
37959488|NCT00439270|69646995|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
37959489|NCT00439270|69646996|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
37959490|NCT00439270|69646997|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
37959491|NCT00439270|69646998|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
37959492|NCT00439270|69646999|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
37959493|NCT00439270|69646995|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
37959494|NCT00439270|69646996|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
37959495|NCT00439270|69646997|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
37959496|NCT00439270|69646998|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
37959497|NCT00439270|69646999|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
37959498|NCT00439270|69646995|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
37959499|NCT00439270|69646996|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
37959500|NCT00439270|69646997|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
37959501|NCT00439270|69646998|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
37959502|NCT00439270|69646999|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
37959503|NCT00439270|69646995|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
37959504|NCT00439270|69646996|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
37959505|NCT00439270|69646997|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
37959506|NCT00439270|69646998|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
37959507|NCT00439270|69646999|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
37959508|NCT00439270|69646995|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
37959509|NCT00439270|69646996|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
37959510|NCT00439270|69646997|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
37959511|NCT00439270|69646998|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
37959512|NCT00439270|69646999|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
37959513|NCT00439270|69646995|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
37959514|NCT00439270|69646996|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
37959515|NCT00439270|69646997|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
37959516|NCT00439270|69646998|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
37959517|NCT00439270|69646999|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
37959518|NCT00439270|69646995|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
37959519|NCT00439270|69646996|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
37959520|NCT00439270|69646997|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
37959521|NCT00439270|69646998|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
37959522|NCT00439270|69646999|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
37959523|NCT00439270|69646995|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
37959524|NCT00439270|69646996|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
37959525|NCT00439270|69646997|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
37959526|NCT00439270|69646998|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
37959527|NCT00439270|69646999|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
37959528|NCT00553280|69647018|FG000|Overall Study|Adverse Event|19|||
37959529|NCT00553280|69647018|FG000|Overall Study|Lack of Efficacy|3|||
37959530|NCT00553280|69647018|FG000|Overall Study|Withdrawal by Subject|3|||
37959531|NCT00553280|69647018|FG000|Overall Study|Physician Decision|1|||
37959532|NCT00440518|69647025|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
37959533|NCT00440518|69647026|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
37959534|NCT00440518|69647027|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
37959535|NCT00440518|69647025|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
37959536|NCT00440518|69647026|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
37959537|NCT00440518|69647027|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
37959538|NCT00440518|69647025|FG000|Randomized /Titration Period|Protocol Deviation|1|||
37959539|NCT00440518|69647026|FG001|Randomized /Titration Period|Protocol Deviation|0|||
37959540|NCT00440518|69647027|FG002|Randomized /Titration Period|Protocol Deviation|0|||
37959541|NCT00440518|69647025|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
37959542|NCT00440518|69647026|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
37959543|NCT00440518|69647027|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
37959544|NCT00440518|69647025|FG000|Randomized /Titration Period|Other|1|||
37959545|NCT00440518|69647026|FG001|Randomized /Titration Period|Other|0|||
37959546|NCT00440518|69647027|FG002|Randomized /Titration Period|Other|0|||
37959547|NCT00440518|69647025|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
38051327|NCT03330288|69740549|FG001|Overall Study|Adverse Event|0|||
38051328|NCT03330288|69740548|FG000|Overall Study|Withdrawal by Subject|1|||
38051329|NCT03330288|69740549|FG001|Overall Study|Withdrawal by Subject|0|||
38051330|NCT03330288|69740548|FG000|Overall Study|Lost to Follow-up|26|||
37959548|NCT00440518|69647026|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
37959549|NCT00440518|69647027|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
37959550|NCT00440518|69647025|FG000|Randomized /Titration Period|Adverse Event|2|||
38051331|NCT03330288|69740549|FG001|Overall Study|Lost to Follow-up|7|||
38051332|NCT03084536|69740558|FG000|Overall Study|Determined to be ineligible|0|||
37680327|NCT02400333|69155887|FG001|Overall Study|Protocol Violation|0|||
37959551|NCT00440518|69647026|FG001|Randomized /Titration Period|Adverse Event|3|||
37959552|NCT00440518|69647027|FG002|Randomized /Titration Period|Adverse Event|0|||
37959553|NCT00440518|69647025|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
37959554|NCT00440518|69647026|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
37959555|NCT00440518|69647027|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
37959556|NCT00440518|69647025|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
37959557|NCT00440518|69647026|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
37959558|NCT00440518|69647027|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
37959559|NCT00440518|69647025|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
37959560|NCT00440518|69647026|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
37959561|NCT00440518|69647027|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
37959562|NCT00440518|69647025|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
37959563|NCT00440518|69647026|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
37959564|NCT00440518|69647027|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
37959565|NCT00440518|69647025|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
37959566|NCT00440518|69647026|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
37959567|NCT00440518|69647027|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
37959568|NCT00440518|69647025|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
37959569|NCT00440518|69647026|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
37959570|NCT00440518|69647027|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
37959571|NCT00438256|69647035|FG000|Overall Study|Ineligible for Resection|2|||
37959572|NCT00438256|69647036|FG001|Overall Study|Ineligible for Resection|1|||
37959573|NCT00438256|69647037|FG002|Overall Study|Ineligible for Resection|1|||
37959574|NCT00438256|69647038|FG003|Overall Study|Ineligible for Resection|7|||
37959575|NCT00438256|69647035|FG000|Overall Study|Excluded final Diagnosis|0|||
37959576|NCT00438256|69647036|FG001|Overall Study|Excluded final Diagnosis|0|||
37959577|NCT00438256|69647037|FG002|Overall Study|Excluded final Diagnosis|0|||
37959578|NCT00438256|69647038|FG003|Overall Study|Excluded final Diagnosis|2|||
37959579|NCT00436852|69647057|FG000|Overall Study|Death|23|||
37959580|NCT00436852|69647058|FG001|Overall Study|Death|34|||
37959581|NCT00436852|69647057|FG000|Overall Study|Lack of Efficacy|9|||
37959582|NCT00436852|69647058|FG001|Overall Study|Lack of Efficacy|7|||
37959583|NCT00436852|69647057|FG000|Overall Study|Withdrawal by Subject|2|||
37959584|NCT00436852|69647058|FG001|Overall Study|Withdrawal by Subject|4|||
37959585|NCT00436852|69647057|FG000|Overall Study|Ineligible|1|||
37959586|NCT00436852|69647058|FG001|Overall Study|Ineligible|0|||
37959587|NCT00120289|69647069|FG000|Overall Study|Death|96|||
37959588|NCT00120289|69647070|FG001|Overall Study|Death|82|||
37959589|NCT00120289|69647069|FG000|Overall Study|Lost to Follow-up|11|||
37959590|NCT00120289|69647070|FG001|Overall Study|Lost to Follow-up|14|||
37959591|NCT00120289|69647069|FG000|Overall Study|Withdrawal by Subject|14|||
37959592|NCT00120289|69647070|FG001|Overall Study|Withdrawal by Subject|13|||
37959593|NCT00550446|69647083|FG000|Up To Week 12|Adverse Event|2|||
37959594|NCT00550446|69647084|FG001|Up To Week 12|Adverse Event|2|||
37959595|NCT00550446|69647085|FG002|Up To Week 12|Adverse Event|0|||
37959596|NCT00550446|69647086|FG003|Up To Week 12|Adverse Event|0|||
37959597|NCT00550446|69647087|FG004|Up To Week 12|Adverse Event|2|||
37959598|NCT00550446|69647088|FG005|Up To Week 12|Adverse Event|2|||
37959599|NCT00550446|69647089|FG006|Up To Week 12|Adverse Event|1|||
37959600|NCT00550446|69647090|FG007|Up To Week 12|Adverse Event|0|||
37959601|NCT00550446|69647091|FG008|Up To Week 12|Adverse Event|0|||
37959602|NCT00550446|69647092|FG009|Up To Week 12|Adverse Event|0|||
37959603|NCT00550446|69647093|FG010|Up To Week 12|Adverse Event|0|||
37959604|NCT00550446|69647083|FG000|Up To Week 12|Lack of Efficacy|3|||
37959605|NCT00550446|69647084|FG001|Up To Week 12|Lack of Efficacy|1|||
37959606|NCT00550446|69647085|FG002|Up To Week 12|Lack of Efficacy|0|||
37959607|NCT00550446|69647086|FG003|Up To Week 12|Lack of Efficacy|1|||
37959608|NCT00550446|69647087|FG004|Up To Week 12|Lack of Efficacy|0|||
37959609|NCT00550446|69647088|FG005|Up To Week 12|Lack of Efficacy|3|||
37959610|NCT00550446|69647089|FG006|Up To Week 12|Lack of Efficacy|3|||
37959611|NCT00550446|69647090|FG007|Up To Week 12|Lack of Efficacy|0|||
37959612|NCT00550446|69647091|FG008|Up To Week 12|Lack of Efficacy|0|||
37959613|NCT00550446|69647092|FG009|Up To Week 12|Lack of Efficacy|0|||
37959614|NCT00550446|69647093|FG010|Up To Week 12|Lack of Efficacy|0|||
37959615|NCT00550446|69647083|FG000|Up To Week 12|Lost to Follow-up|0|||
37959616|NCT00550446|69647084|FG001|Up To Week 12|Lost to Follow-up|1|||
37959617|NCT00550446|69647085|FG002|Up To Week 12|Lost to Follow-up|0|||
37959618|NCT00550446|69647086|FG003|Up To Week 12|Lost to Follow-up|0|||
37959619|NCT00550446|69647087|FG004|Up To Week 12|Lost to Follow-up|1|||
37959620|NCT00550446|69647088|FG005|Up To Week 12|Lost to Follow-up|1|||
37959621|NCT00550446|69647089|FG006|Up To Week 12|Lost to Follow-up|2|||
37959622|NCT00550446|69647090|FG007|Up To Week 12|Lost to Follow-up|0|||
37959623|NCT00550446|69647091|FG008|Up To Week 12|Lost to Follow-up|0|||
37959624|NCT00550446|69647092|FG009|Up To Week 12|Lost to Follow-up|0|||
37959625|NCT00550446|69647093|FG010|Up To Week 12|Lost to Follow-up|0|||
37959626|NCT00550446|69647083|FG000|Up To Week 12|Withdrawal by Subject|2|||
37959627|NCT00550446|69647084|FG001|Up To Week 12|Withdrawal by Subject|0|||
37959628|NCT00550446|69647085|FG002|Up To Week 12|Withdrawal by Subject|3|||
37959629|NCT00550446|69647086|FG003|Up To Week 12|Withdrawal by Subject|2|||
37959630|NCT00550446|69647087|FG004|Up To Week 12|Withdrawal by Subject|0|||
37959631|NCT00550446|69647088|FG005|Up To Week 12|Withdrawal by Subject|1|||
37959632|NCT00550446|69647089|FG006|Up To Week 12|Withdrawal by Subject|3|||
37959633|NCT00550446|69647090|FG007|Up To Week 12|Withdrawal by Subject|0|||
37959634|NCT00550446|69647091|FG008|Up To Week 12|Withdrawal by Subject|0|||
37959635|NCT00550446|69647092|FG009|Up To Week 12|Withdrawal by Subject|0|||
37959636|NCT00550446|69647093|FG010|Up To Week 12|Withdrawal by Subject|0|||
37959637|NCT00550446|69647083|FG000|Up To Week 12|Other|3|||
37959638|NCT00550446|69647084|FG001|Up To Week 12|Other|0|||
37959639|NCT00550446|69647085|FG002|Up To Week 12|Other|0|||
37959640|NCT00550446|69647086|FG003|Up To Week 12|Other|0|||
37959641|NCT00550446|69647087|FG004|Up To Week 12|Other|0|||
37959642|NCT00550446|69647088|FG005|Up To Week 12|Other|1|||
37959643|NCT00550446|69647089|FG006|Up To Week 12|Other|4|||
37959644|NCT00550446|69647090|FG007|Up To Week 12|Other|0|||
37959645|NCT00550446|69647091|FG008|Up To Week 12|Other|0|||
37959646|NCT00550446|69647092|FG009|Up To Week 12|Other|0|||
37959647|NCT00550446|69647093|FG010|Up To Week 12|Other|0|||
37959648|NCT00550446|69647083|FG000|Up To Week 12|Randomized not treated|0|||
37959649|NCT00550446|69647084|FG001|Up To Week 12|Randomized not treated|1|||
37959650|NCT00550446|69647085|FG002|Up To Week 12|Randomized not treated|1|||
38051333|NCT03084536|69740559|FG001|Overall Study|Determined to be ineligible|0|||
38051334|NCT03084536|69740560|FG002|Overall Study|Determined to be ineligible|16|||
38051335|NCT03084536|69740558|FG000|Overall Study|Withdrawal by Subject|0|||
38051336|NCT03084536|69740559|FG001|Overall Study|Withdrawal by Subject|0|||
38051337|NCT03084536|69740560|FG002|Overall Study|Withdrawal by Subject|4|||
38051338|NCT03084536|69740558|FG000|Overall Study|Physician Decision|0|||
38051339|NCT03084536|69740559|FG001|Overall Study|Physician Decision|0|||
38051340|NCT03084536|69740560|FG002|Overall Study|Physician Decision|3|||
38051341|NCT03084536|69740558|FG000|Overall Study|Death|0|||
38051342|NCT03084536|69740559|FG001|Overall Study|Death|0|||
38051343|NCT03084536|69740560|FG002|Overall Study|Death|1|||
38051344|NCT03084536|69740558|FG000|Overall Study|Lost to Follow-up|0|||
38051345|NCT03084536|69740559|FG001|Overall Study|Lost to Follow-up|0|||
38051346|NCT03084536|69740560|FG002|Overall Study|Lost to Follow-up|1|||
38051347|NCT03084536|69740558|FG000|Overall Study|Protocol Violation|0|||
38051348|NCT03084536|69740559|FG001|Overall Study|Protocol Violation|0|||
38051349|NCT03084536|69740560|FG002|Overall Study|Protocol Violation|1|||
38051350|NCT03084536|69740558|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
38051351|NCT03084536|69740559|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
38051352|NCT03084536|69740560|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
38051353|NCT05291936|69740567|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
38051354|NCT05291936|69740568|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
38051355|NCT05291936|69740567|FG000|Period 1|Withdrew Consent during study|1|||
38051356|NCT05291936|69740568|FG001|Period 1|Withdrew Consent during study|0|||
38051357|NCT05291936|69740567|FG000|Period 2|Adverse Event|0|||
38051358|NCT05291936|69740568|FG001|Period 2|Adverse Event|1|||
38051359|NCT05291936|69740567|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
38051360|NCT05291936|69740568|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
37959651|NCT00550446|69647086|FG003|Up To Week 12|Randomized not treated|0|||
37959652|NCT00550446|69647087|FG004|Up To Week 12|Randomized not treated|0|||
37959653|NCT00550446|69647088|FG005|Up To Week 12|Randomized not treated|0|||
37959654|NCT00550446|69647089|FG006|Up To Week 12|Randomized not treated|0|||
37959655|NCT00550446|69647090|FG007|Up To Week 12|Randomized not treated|0|||
37959656|NCT00550446|69647091|FG008|Up To Week 12|Randomized not treated|0|||
37959657|NCT00550446|69647092|FG009|Up To Week 12|Randomized not treated|0|||
37959658|NCT00550446|69647093|FG010|Up To Week 12|Randomized not treated|0|||
38051361|NCT03289143|69740578|FG000|Overall Study|Caregiver Unavailability|1|||
37959659|NCT00550446|69647083|FG000|Post Week 12|Adverse Event|2|||
37959660|NCT00550446|69647084|FG001|Post Week 12|Adverse Event|1|||
37959661|NCT00550446|69647085|FG002|Post Week 12|Adverse Event|1|||
37959662|NCT00550446|69647086|FG003|Post Week 12|Adverse Event|1|||
37959663|NCT00550446|69647087|FG004|Post Week 12|Adverse Event|1|||
37959664|NCT00550446|69647088|FG005|Post Week 12|Adverse Event|1|||
38051362|NCT03289143|69740579|FG001|Overall Study|Caregiver Unavailability|1|||
38051363|NCT03289143|69740580|FG002|Overall Study|Caregiver Unavailability|0|||
37959665|NCT00550446|69647089|FG006|Post Week 12|Adverse Event|0|||
38051364|NCT03289143|69740581|FG003|Overall Study|Caregiver Unavailability|0|||
38051365|NCT03289143|69740578|FG000|Overall Study|Research Department Closure|0|||
38051366|NCT03289143|69740579|FG001|Overall Study|Research Department Closure|0|||
37959666|NCT00550446|69647090|FG007|Post Week 12|Adverse Event|0|||
37959667|NCT00550446|69647091|FG008|Post Week 12|Adverse Event|0|||
37959668|NCT00550446|69647092|FG009|Post Week 12|Adverse Event|4|||
37959669|NCT00550446|69647093|FG010|Post Week 12|Adverse Event|0|||
37959670|NCT00550446|69647083|FG000|Post Week 12|Lack of Efficacy|0|||
37959671|NCT00550446|69647084|FG001|Post Week 12|Lack of Efficacy|0|||
37959672|NCT00550446|69647085|FG002|Post Week 12|Lack of Efficacy|1|||
37959673|NCT00550446|69647086|FG003|Post Week 12|Lack of Efficacy|0|||
37959674|NCT00550446|69647087|FG004|Post Week 12|Lack of Efficacy|0|||
37959675|NCT00550446|69647088|FG005|Post Week 12|Lack of Efficacy|0|||
37959676|NCT00550446|69647089|FG006|Post Week 12|Lack of Efficacy|0|||
37959677|NCT00550446|69647090|FG007|Post Week 12|Lack of Efficacy|1|||
37959678|NCT00550446|69647091|FG008|Post Week 12|Lack of Efficacy|1|||
37959679|NCT00550446|69647092|FG009|Post Week 12|Lack of Efficacy|2|||
37959680|NCT00550446|69647093|FG010|Post Week 12|Lack of Efficacy|1|||
37959681|NCT00550446|69647083|FG000|Post Week 12|Lost to Follow-up|0|||
37959682|NCT00550446|69647084|FG001|Post Week 12|Lost to Follow-up|0|||
37959683|NCT00550446|69647085|FG002|Post Week 12|Lost to Follow-up|1|||
37959684|NCT00550446|69647086|FG003|Post Week 12|Lost to Follow-up|1|||
37959685|NCT00550446|69647087|FG004|Post Week 12|Lost to Follow-up|0|||
37959686|NCT00550446|69647088|FG005|Post Week 12|Lost to Follow-up|0|||
37959687|NCT00550446|69647089|FG006|Post Week 12|Lost to Follow-up|1|||
37959688|NCT00550446|69647090|FG007|Post Week 12|Lost to Follow-up|0|||
37959689|NCT00550446|69647091|FG008|Post Week 12|Lost to Follow-up|0|||
37959690|NCT00550446|69647092|FG009|Post Week 12|Lost to Follow-up|0|||
37959691|NCT00550446|69647093|FG010|Post Week 12|Lost to Follow-up|0|||
37959692|NCT00550446|69647083|FG000|Post Week 12|Withdrawal by Subject|0|||
37959693|NCT00550446|69647084|FG001|Post Week 12|Withdrawal by Subject|0|||
37959694|NCT00550446|69647085|FG002|Post Week 12|Withdrawal by Subject|0|||
37959695|NCT00550446|69647086|FG003|Post Week 12|Withdrawal by Subject|0|||
37959696|NCT00550446|69647087|FG004|Post Week 12|Withdrawal by Subject|1|||
37959697|NCT00550446|69647088|FG005|Post Week 12|Withdrawal by Subject|0|||
37959698|NCT00550446|69647089|FG006|Post Week 12|Withdrawal by Subject|0|||
37959699|NCT00550446|69647090|FG007|Post Week 12|Withdrawal by Subject|0|||
37959700|NCT00550446|69647091|FG008|Post Week 12|Withdrawal by Subject|0|||
37959701|NCT00550446|69647092|FG009|Post Week 12|Withdrawal by Subject|0|||
37959702|NCT00550446|69647093|FG010|Post Week 12|Withdrawal by Subject|0|||
37959703|NCT00550446|69647083|FG000|Post Week 12|Other|1|||
37959704|NCT00550446|69647084|FG001|Post Week 12|Other|1|||
37959705|NCT00550446|69647085|FG002|Post Week 12|Other|0|||
37959706|NCT00550446|69647086|FG003|Post Week 12|Other|1|||
37959707|NCT00550446|69647087|FG004|Post Week 12|Other|0|||
37959708|NCT00550446|69647088|FG005|Post Week 12|Other|0|||
37959709|NCT00550446|69647089|FG006|Post Week 12|Other|1|||
37959710|NCT00550446|69647090|FG007|Post Week 12|Other|0|||
37959711|NCT00550446|69647091|FG008|Post Week 12|Other|1|||
37959712|NCT00550446|69647092|FG009|Post Week 12|Other|1|||
37959713|NCT00550446|69647093|FG010|Post Week 12|Other|0|||
37959714|NCT00436618|69647134|FG000|Overall Study|Withdrawal by Subject|5|||
37959715|NCT00436618|69647135|FG001|Overall Study|Withdrawal by Subject|8|||
37959716|NCT00436618|69647136|FG002|Overall Study|Withdrawal by Subject|11|||
37959717|NCT00436618|69647134|FG000|Overall Study|Adverse Event|8|||
37959718|NCT00436618|69647135|FG001|Overall Study|Adverse Event|8|||
37959719|NCT00436618|69647136|FG002|Overall Study|Adverse Event|9|||
37959720|NCT00436618|69647134|FG000|Overall Study|Alternate Treatment|3|||
37959721|NCT00436618|69647135|FG001|Overall Study|Alternate Treatment|4|||
37959722|NCT00436618|69647136|FG002|Overall Study|Alternate Treatment|12|||
37959723|NCT00436618|69647134|FG000|Overall Study|Other Medical Problems|3|||
37959724|NCT00436618|69647135|FG001|Overall Study|Other Medical Problems|1|||
37959725|NCT00436618|69647136|FG002|Overall Study|Other Medical Problems|7|||
37959726|NCT00436618|69647134|FG000|Overall Study|Death|4|||
37959727|NCT00436618|69647135|FG001|Overall Study|Death|2|||
37959728|NCT00436618|69647136|FG002|Overall Study|Death|3|||
37959729|NCT00436618|69647134|FG000|Overall Study|New Primary or Other Reasons|6|||
37959730|NCT00436618|69647135|FG001|Overall Study|New Primary or Other Reasons|2|||
37959731|NCT00436618|69647136|FG002|Overall Study|New Primary or Other Reasons|12|||
37680328|NCT02400333|69155888|FG002|Overall Study|Protocol Violation|2|||
37680329|NCT02400333|69155889|FG003|Overall Study|Protocol Violation|1|||
37959732|NCT00436618|69647134|FG000|Overall Study|Still on treatment|1|||
37959733|NCT00436618|69647135|FG001|Overall Study|Still on treatment|2|||
37959734|NCT00436618|69647136|FG002|Overall Study|Still on treatment|7|||
37959735|NCT00548808|69647173|FG000|Overall Study|Lost to Follow-up|9|||
37959736|NCT00548808|69647174|FG001|Overall Study|Lost to Follow-up|3|||
37959737|NCT00548808|69647173|FG000|Overall Study|Protocol Violation|8|||
37959738|NCT00548808|69647174|FG001|Overall Study|Protocol Violation|8|||
37959739|NCT00548808|69647173|FG000|Overall Study|Withdrawal by Subject|8|||
37959740|NCT00548808|69647174|FG001|Overall Study|Withdrawal by Subject|4|||
37959741|NCT00548808|69647173|FG000|Overall Study|Physician Decision|6|||
37959742|NCT00548808|69647174|FG001|Overall Study|Physician Decision|3|||
37959743|NCT00548808|69647173|FG000|Overall Study|Adverse Event|4|||
37959744|NCT00548808|69647174|FG001|Overall Study|Adverse Event|5|||
37959745|NCT00548808|69647173|FG000|Overall Study|Death|2|||
37959746|NCT00548808|69647174|FG001|Overall Study|Death|0|||
37959747|NCT00548808|69647173|FG000|Overall Study|Entry Criteria Not Met|2|||
37959748|NCT00548808|69647174|FG001|Overall Study|Entry Criteria Not Met|2|||
37959749|NCT00548808|69647173|FG000|Overall Study|Lack of Efficacy|2|||
37959750|NCT00548808|69647174|FG001|Overall Study|Lack of Efficacy|0|||
37959751|NCT00548808|69647173|FG000|Overall Study|Sponsor Decision|1|||
37959752|NCT00548808|69647174|FG001|Overall Study|Sponsor Decision|1|||
37959753|NCT00110617|69647182|FG000|Overall Study|Adverse Event|2|||
37959754|NCT00110617|69647183|FG001|Overall Study|Adverse Event|4|||
37959755|NCT00110617|69647182|FG000|Overall Study|Abnormal Laboratory Value|4|||
37959756|NCT00110617|69647183|FG001|Overall Study|Abnormal Laboratory Value|2|||
37959757|NCT00110617|69647182|FG000|Overall Study|Lack of Efficacy|1|||
37959758|NCT00110617|69647183|FG001|Overall Study|Lack of Efficacy|0|||
37959759|NCT00110617|69647182|FG000|Overall Study|Patient no longer requires study drug|1|||
37959760|NCT00110617|69647183|FG001|Overall Study|Patient no longer requires study drug|0|||
37959761|NCT00110617|69647182|FG000|Overall Study|Protocol Violation|5|||
37959762|NCT00110617|69647183|FG001|Overall Study|Protocol Violation|0|||
37959763|NCT00110617|69647182|FG000|Overall Study|Withdrawal by Subject|10|||
37959764|NCT00110617|69647183|FG001|Overall Study|Withdrawal by Subject|4|||
37959765|NCT00110617|69647182|FG000|Overall Study|Lost to Follow-up|9|||
37959766|NCT00110617|69647183|FG001|Overall Study|Lost to Follow-up|1|||
37959767|NCT00110617|69647182|FG000|Overall Study|Administrative problems|6|||
37959768|NCT00110617|69647183|FG001|Overall Study|Administrative problems|5|||
37959769|NCT00110617|69647182|FG000|Overall Study|Death|1|||
37959770|NCT00110617|69647183|FG001|Overall Study|Death|1|||
37959771|NCT00110617|69647182|FG000|Overall Study|Did not receive study drug|0|||
37959772|NCT00110617|69647183|FG001|Overall Study|Did not receive study drug|12|||
37959773|NCT03956862|69647193|FG000|Overall Study|Lost to Follow-up|1|||
37959774|NCT03956862|69647194|FG001|Overall Study|Lost to Follow-up|1|||
37959775|NCT03956862|69647193|FG000|Overall Study|Withdrawal by Subject|1|||
37959776|NCT03956862|69647194|FG001|Overall Study|Withdrawal by Subject|1|||
37959777|NCT00550238|69647200|FG000|Overall Study|Adverse Event|88|||
37959778|NCT00550238|69647200|FG000|Overall Study|Death|34|||
37959779|NCT00550238|69647200|FG000|Overall Study|Disease progression|46|||
37959780|NCT00550238|69647200|FG000|Overall Study|Withdrawal by Subject|167|||
37959781|NCT00550238|69647200|FG000|Overall Study|Physician Decision|31|||
37959782|NCT00550238|69647200|FG000|Overall Study|Patient noncompliance|25|||
37959783|NCT00550238|69647200|FG000|Overall Study|Lost to Follow-up|13|||
37959784|NCT00550238|69647200|FG000|Overall Study|Sponsor decision|55|||
37959785|NCT03956550|69647207|FG000|Overall Study|Sponsor decision|65|||
37959786|NCT03956550|69647208|FG001|Overall Study|Sponsor decision|66|||
37959787|NCT03956550|69647209|FG002|Overall Study|Sponsor decision|64|||
37959788|NCT03956550|69647207|FG000|Overall Study|Adverse Event|0|||
37959789|NCT03956550|69647208|FG001|Overall Study|Adverse Event|1|||
37959790|NCT03956550|69647209|FG002|Overall Study|Adverse Event|0|||
37959791|NCT03956550|69647207|FG000|Overall Study|Withdrawal by Subject|5|||
37959792|NCT03956550|69647208|FG001|Overall Study|Withdrawal by Subject|5|||
37959793|NCT03956550|69647209|FG002|Overall Study|Withdrawal by Subject|6|||
37959794|NCT00110305|69647221|FG000|Overall Study|Adverse Event|46|||
37959795|NCT00110305|69647222|FG001|Overall Study|Adverse Event|13|||
37959796|NCT00110305|69647221|FG000|Overall Study|Sponsors Decision|1|||
37959797|NCT00110305|69647222|FG001|Overall Study|Sponsors Decision|0|||
37959798|NCT00110305|69647221|FG000|Overall Study|Subject Non-Compliant|9|||
37959799|NCT00110305|69647222|FG001|Overall Study|Subject Non-Compliant|2|||
37959800|NCT00110305|69647221|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
37959801|NCT00110305|69647222|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
37959802|NCT00110305|69647221|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
37959803|NCT00110305|69647222|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
37959804|NCT00110305|69647221|FG000|Overall Study|Protocol Violation|0|||
37959805|NCT00110305|69647222|FG001|Overall Study|Protocol Violation|1|||
37959806|NCT00110305|69647221|FG000|Overall Study|Withdrawal by Subject|7|||
37959807|NCT00110305|69647222|FG001|Overall Study|Withdrawal by Subject|7|||
37959808|NCT00110305|69647221|FG000|Overall Study|Lost to Follow-up|20|||
37959809|NCT00110305|69647222|FG001|Overall Study|Lost to Follow-up|3|||
37959810|NCT00110305|69647221|FG000|Overall Study|Other|8|||
37959811|NCT00110305|69647222|FG001|Overall Study|Other|2|||
37959812|NCT00428116|69647241|FG000|Overall Study|Death|1|||
37959813|NCT00428116|69647242|FG001|Overall Study|Death|0|||
37959814|NCT00428116|69647241|FG000|Overall Study|Withdrawal by Subject|1|||
37959815|NCT00428116|69647242|FG001|Overall Study|Withdrawal by Subject|0|||
37959816|NCT00428116|69647241|FG000|Overall Study|Lost to Follow-up|1|||
37959817|NCT00428116|69647242|FG001|Overall Study|Lost to Follow-up|0|||
37959818|NCT00560066|69647251|FG000|Overall Study|Death|2|||
37959819|NCT00560066|69647252|FG001|Overall Study|Death|1|||
37959820|NCT00560066|69647251|FG000|Overall Study|Withdrawal by Subject|0|||
37959821|NCT00560066|69647252|FG001|Overall Study|Withdrawal by Subject|3|||
37959822|NCT00560066|69647251|FG000|Overall Study|Lost to Follow-up|4|||
37959823|NCT00560066|69647252|FG001|Overall Study|Lost to Follow-up|10|||
37959824|NCT00560066|69647251|FG000|Overall Study|Protocol Violation|0|||
37959825|NCT00560066|69647252|FG001|Overall Study|Protocol Violation|1|||
37959826|NCT00560066|69647251|FG000|Overall Study|Administrative reason|0|||
37959827|NCT00560066|69647252|FG001|Overall Study|Administrative reason|5|||
37959828|NCT00560066|69647251|FG000|Overall Study|Missing primary reason|0|||
37959829|NCT00560066|69647252|FG001|Overall Study|Missing primary reason|2|||
37959830|NCT00549900|69647263|FG000|Overall Study|Adverse Event|1|||
37959831|NCT00435994|69647270|FG000|Overall Study|Lost to Follow-up|7|||
37959832|NCT00435994|69647271|FG001|Overall Study|Lost to Follow-up|0|||
37959833|NCT00435994|69647272|FG002|Overall Study|Lost to Follow-up|0|||
37959834|NCT00435370|69647283|FG000|Overall Study|Adverse Event|8|||
37959835|NCT00435370|69647284|FG001|Overall Study|Adverse Event|8|||
37959836|NCT00435370|69647283|FG000|Overall Study|Withdrawal by Subject|10|||
37959837|NCT00435370|69647284|FG001|Overall Study|Withdrawal by Subject|10|||
37959838|NCT00435370|69647283|FG000|Overall Study|Antipsychotic medication changed|4|||
37959839|NCT00435370|69647284|FG001|Overall Study|Antipsychotic medication changed|2|||
37959840|NCT00096031|69647290|FG000|Overall Study|Adverse Event|3|||
37959841|NCT00096031|69647290|FG000|Overall Study|Lack of Efficacy|42|||
37959842|NCT00096031|69647290|FG000|Overall Study|Death|4|||
37959843|NCT00096031|69647290|FG000|Overall Study|Withdrawal by Subject|1|||
37959844|NCT00096031|69647290|FG000|Overall Study|Ineligible|8|||
37959845|NCT00096031|69647290|FG000|Overall Study|Not protocol specified|5|||
37959846|NCT00118417|69647294|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
37959847|NCT00118417|69647295|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
37959848|NCT00118417|69647294|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
37959849|NCT00118417|69647295|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
37959850|NCT00118417|69647294|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
37959851|NCT00118417|69647295|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
37959852|NCT00118417|69647294|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
37959853|NCT00118417|69647295|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
37959854|NCT00118417|69647294|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
37959855|NCT00118417|69647295|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
37959856|NCT00549848|69647308|FG000|Overall Study|Death|1|||
37959857|NCT00549848|69647309|FG001|Overall Study|Death|4|||
37959858|NCT00549848|69647310|FG002|Overall Study|Death|13|||
37959859|NCT00549848|69647308|FG000|Overall Study|Physician Decision|0|||
37959860|NCT00549848|69647309|FG001|Overall Study|Physician Decision|0|||
37959861|NCT00549848|69647310|FG002|Overall Study|Physician Decision|4|||
37959862|NCT00549848|69647308|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
37959863|NCT00549848|69647309|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
37959864|NCT00549848|69647310|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
37959865|NCT00549848|69647308|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
37959866|NCT00549848|69647309|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
37959867|NCT00549848|69647310|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
37959868|NCT00549848|69647308|FG000|Overall Study|Participant/Family Withdraw|2|||
37959869|NCT00549848|69647309|FG001|Overall Study|Participant/Family Withdraw|3|||
37959870|NCT00549848|69647310|FG002|Overall Study|Participant/Family Withdraw|5|||
37959871|NCT00549848|69647308|FG000|Overall Study|Second Malignancy|1|||
37959872|NCT00549848|69647309|FG001|Overall Study|Second Malignancy|0|||
37959873|NCT00549848|69647310|FG002|Overall Study|Second Malignancy|0|||
37959874|NCT00549848|69647308|FG000|Overall Study|Transplant|3|||
37959875|NCT00549848|69647309|FG001|Overall Study|Transplant|3|||
37959876|NCT00549848|69647310|FG002|Overall Study|Transplant|18|||
37959877|NCT00549848|69647308|FG000|Overall Study|Unacceptable Toxicity|1|||
37959878|NCT00549848|69647309|FG001|Overall Study|Unacceptable Toxicity|6|||
37959879|NCT00549848|69647310|FG002|Overall Study|Unacceptable Toxicity|6|||
38051367|NCT03289143|69740580|FG002|Overall Study|Research Department Closure|1|||
38051368|NCT03289143|69740581|FG003|Overall Study|Research Department Closure|0|||
37959880|NCT00549770|69647334|FG000|Overall Study|Protocol deviation|1|||
37959881|NCT00549770|69647335|FG001|Overall Study|Protocol deviation|1|||
37959882|NCT00549770|69647336|FG002|Overall Study|Protocol deviation|1|||
37959883|NCT00549770|69647337|FG003|Overall Study|Protocol deviation|2|||
37959884|NCT00549770|69647338|FG004|Overall Study|Protocol deviation|2|||
37959885|NCT00549770|69647339|FG005|Overall Study|Protocol deviation|2|||
37959886|NCT00549770|69647340|FG006|Overall Study|Protocol deviation|1|||
37959887|NCT00549770|69647341|FG007|Overall Study|Protocol deviation|2|||
37959888|NCT00549770|69647334|FG000|Overall Study|Administrative problems|0|||
37959889|NCT00549770|69647335|FG001|Overall Study|Administrative problems|1|||
37959890|NCT00549770|69647336|FG002|Overall Study|Administrative problems|0|||
37959891|NCT00549770|69647337|FG003|Overall Study|Administrative problems|0|||
37959892|NCT00549770|69647338|FG004|Overall Study|Administrative problems|0|||
37959893|NCT00549770|69647339|FG005|Overall Study|Administrative problems|0|||
37959894|NCT00549770|69647340|FG006|Overall Study|Administrative problems|0|||
37959895|NCT00549770|69647341|FG007|Overall Study|Administrative problems|1|||
37959896|NCT00549770|69647334|FG000|Overall Study|Lost to Follow-up|0|||
37959897|NCT00549770|69647335|FG001|Overall Study|Lost to Follow-up|0|||
37959898|NCT00549770|69647336|FG002|Overall Study|Lost to Follow-up|2|||
38051369|NCT03289143|69740578|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
37959899|NCT00549770|69647337|FG003|Overall Study|Lost to Follow-up|2|||
37959900|NCT00549770|69647338|FG004|Overall Study|Lost to Follow-up|3|||
37959901|NCT00549770|69647339|FG005|Overall Study|Lost to Follow-up|2|||
37959902|NCT00549770|69647340|FG006|Overall Study|Lost to Follow-up|0|||
37959903|NCT00549770|69647341|FG007|Overall Study|Lost to Follow-up|0|||
37959904|NCT00549770|69647334|FG000|Overall Study|Withdrawal by Subject|4|||
37959905|NCT00549770|69647335|FG001|Overall Study|Withdrawal by Subject|6|||
37959906|NCT00549770|69647336|FG002|Overall Study|Withdrawal by Subject|4|||
37959907|NCT00549770|69647337|FG003|Overall Study|Withdrawal by Subject|5|||
37959908|NCT00549770|69647338|FG004|Overall Study|Withdrawal by Subject|6|||
37959909|NCT00549770|69647339|FG005|Overall Study|Withdrawal by Subject|6|||
37959910|NCT00549770|69647340|FG006|Overall Study|Withdrawal by Subject|4|||
37959911|NCT00549770|69647341|FG007|Overall Study|Withdrawal by Subject|9|||
37959912|NCT00549770|69647334|FG000|Overall Study|Lack of Efficacy|1|||
37959913|NCT00549770|69647335|FG001|Overall Study|Lack of Efficacy|0|||
37959914|NCT00549770|69647336|FG002|Overall Study|Lack of Efficacy|2|||
37959915|NCT00549770|69647337|FG003|Overall Study|Lack of Efficacy|3|||
37959916|NCT00549770|69647338|FG004|Overall Study|Lack of Efficacy|5|||
37959917|NCT00549770|69647339|FG005|Overall Study|Lack of Efficacy|1|||
37959918|NCT00549770|69647340|FG006|Overall Study|Lack of Efficacy|3|||
37959919|NCT00549770|69647341|FG007|Overall Study|Lack of Efficacy|8|||
37959920|NCT00549770|69647334|FG000|Overall Study|Abnormal test procedure results|0|||
37959921|NCT00549770|69647335|FG001|Overall Study|Abnormal test procedure results|0|||
37959922|NCT00549770|69647336|FG002|Overall Study|Abnormal test procedure results|0|||
37959923|NCT00549770|69647337|FG003|Overall Study|Abnormal test procedure results|2|||
37959924|NCT00549770|69647338|FG004|Overall Study|Abnormal test procedure results|0|||
37959925|NCT00549770|69647339|FG005|Overall Study|Abnormal test procedure results|1|||
37959926|NCT00549770|69647340|FG006|Overall Study|Abnormal test procedure results|1|||
37959927|NCT00549770|69647341|FG007|Overall Study|Abnormal test procedure results|1|||
37959928|NCT00549770|69647334|FG000|Overall Study|Abnormal laboratory values|0|||
37959929|NCT00549770|69647335|FG001|Overall Study|Abnormal laboratory values|0|||
37959930|NCT00549770|69647336|FG002|Overall Study|Abnormal laboratory values|0|||
37959931|NCT00549770|69647337|FG003|Overall Study|Abnormal laboratory values|0|||
37959932|NCT00549770|69647338|FG004|Overall Study|Abnormal laboratory values|0|||
37959933|NCT00549770|69647339|FG005|Overall Study|Abnormal laboratory values|1|||
37959934|NCT00549770|69647340|FG006|Overall Study|Abnormal laboratory values|0|||
37959935|NCT00549770|69647341|FG007|Overall Study|Abnormal laboratory values|0|||
37959936|NCT00549770|69647334|FG000|Overall Study|Adverse Event|1|||
37959937|NCT00549770|69647335|FG001|Overall Study|Adverse Event|3|||
37959938|NCT00549770|69647336|FG002|Overall Study|Adverse Event|1|||
37959939|NCT00549770|69647337|FG003|Overall Study|Adverse Event|2|||
37959940|NCT00549770|69647338|FG004|Overall Study|Adverse Event|1|||
37959941|NCT00549770|69647339|FG005|Overall Study|Adverse Event|0|||
37959942|NCT00549770|69647340|FG006|Overall Study|Adverse Event|5|||
37959943|NCT00549770|69647341|FG007|Overall Study|Adverse Event|4|||
37959944|NCT00548184|69647359|FG000|Overall Study|Adverse Event|3|||
37959945|NCT00548184|69647359|FG000|Overall Study|took other drug|1|||
37959946|NCT00548184|69647359|FG000|Overall Study|Found Her2 negative|1|||
37959947|NCT00454636|69647367|FG000|Overall Study|Adverse Event|10|||
37959948|NCT00454636|69647368|FG001|Overall Study|Adverse Event|6|||
37959949|NCT00454636|69647369|FG002|Overall Study|Adverse Event|9|||
37959950|NCT00454636|69647370|FG003|Overall Study|Adverse Event|15|||
37959951|NCT00454636|69647367|FG000|Overall Study|Disease Progression|11|||
37959952|NCT00454636|69647368|FG001|Overall Study|Disease Progression|12|||
37959953|NCT00454636|69647369|FG002|Overall Study|Disease Progression|4|||
37959954|NCT00454636|69647370|FG003|Overall Study|Disease Progression|11|||
37959955|NCT00454636|69647367|FG000|Overall Study|Protocol Violation|3|||
37959956|NCT00454636|69647368|FG001|Overall Study|Protocol Violation|2|||
37959957|NCT00454636|69647369|FG002|Overall Study|Protocol Violation|3|||
37959958|NCT00454636|69647370|FG003|Overall Study|Protocol Violation|3|||
37680330|NCT02399475|69155902|FG000|Overall Study|Physician Decision|1|||
37680331|NCT02399475|69155903|FG001|Overall Study|Physician Decision|0|||
37959959|NCT00454636|69647367|FG000|Overall Study|Death|6|||
37959960|NCT00454636|69647368|FG001|Overall Study|Death|1|||
37959961|NCT00454636|69647369|FG002|Overall Study|Death|1|||
37959962|NCT00454636|69647370|FG003|Overall Study|Death|1|||
37959963|NCT00454636|69647367|FG000|Overall Study|Patient refusal|1|||
37959964|NCT00454636|69647368|FG001|Overall Study|Patient refusal|1|||
37959965|NCT00454636|69647369|FG002|Overall Study|Patient refusal|3|||
37959966|NCT00454636|69647370|FG003|Overall Study|Patient refusal|2|||
37959967|NCT00454636|69647367|FG000|Overall Study|Lost to Follow-up|0|||
37959968|NCT00454636|69647368|FG001|Overall Study|Lost to Follow-up|1|||
37959969|NCT00454636|69647369|FG002|Overall Study|Lost to Follow-up|0|||
37959970|NCT00454636|69647370|FG003|Overall Study|Lost to Follow-up|0|||
37959971|NCT00427960|69647382|FG000|Overall Study|Adverse Event|2|||
37959972|NCT00427960|69647383|FG001|Overall Study|Adverse Event|0|||
37959973|NCT00427960|69647382|FG000|Overall Study|Withdrawal by Subject|0|||
37959974|NCT00427960|69647383|FG001|Overall Study|Withdrawal by Subject|3|||
37959975|NCT00427960|69647382|FG000|Overall Study|Other|0|||
37959976|NCT00427960|69647383|FG001|Overall Study|Other|1|||
37959977|NCT00548340|69647392|FG000|Overall Study|Protocol Violation|2|||
37959978|NCT00548340|69647393|FG001|Overall Study|Protocol Violation|3|||
37959979|NCT00548340|69647394|FG002|Overall Study|Protocol Violation|3|||
37959980|NCT00548340|69647392|FG000|Overall Study|Adverse Event|2|||
37959981|NCT00548340|69647393|FG001|Overall Study|Adverse Event|2|||
37959982|NCT00548340|69647394|FG002|Overall Study|Adverse Event|2|||
37959983|NCT00548340|69647392|FG000|Overall Study|Lost to Follow-up|1|||
37959984|NCT00548340|69647393|FG001|Overall Study|Lost to Follow-up|1|||
37959985|NCT00548340|69647394|FG002|Overall Study|Lost to Follow-up|0|||
37959986|NCT00548340|69647392|FG000|Overall Study|Withdrawal by Subject|2|||
37959987|NCT00548340|69647393|FG001|Overall Study|Withdrawal by Subject|4|||
37959988|NCT00548340|69647394|FG002|Overall Study|Withdrawal by Subject|3|||
37959989|NCT00548340|69647392|FG000|Overall Study|Other|1|||
37959990|NCT00548340|69647393|FG001|Overall Study|Other|1|||
37959991|NCT00548340|69647394|FG002|Overall Study|Other|1|||
37959992|NCT00454246|69647405|FG000|Overall Study|Adverse Event|2|||
37959993|NCT00454246|69647406|FG001|Overall Study|Adverse Event|2|||
37959994|NCT00454246|69647407|FG002|Overall Study|Adverse Event|0|||
37959995|NCT00454246|69647405|FG000|Overall Study|Violation of selection criteria at entry|6|||
37959996|NCT00454246|69647406|FG001|Overall Study|Violation of selection criteria at entry|0|||
37959997|NCT00454246|69647407|FG002|Overall Study|Violation of selection criteria at entry|0|||
37959998|NCT00454246|69647405|FG000|Overall Study|Protocol Violation|1|||
37959999|NCT00454246|69647406|FG001|Overall Study|Protocol Violation|0|||
37960000|NCT00454246|69647407|FG002|Overall Study|Protocol Violation|0|||
37960001|NCT00454246|69647405|FG000|Overall Study|Refused Treatment|1|||
37960002|NCT00454246|69647406|FG001|Overall Study|Refused Treatment|1|||
37960003|NCT00454246|69647407|FG002|Overall Study|Refused Treatment|0|||
37960004|NCT00454246|69647405|FG000|Overall Study|Failure to return|1|||
37960005|NCT00454246|69647406|FG001|Overall Study|Failure to return|0|||
37960006|NCT00454246|69647407|FG002|Overall Study|Failure to return|0|||
37960007|NCT00454246|69647405|FG000|Overall Study|Early termination of study|62|||
37960008|NCT00454246|69647406|FG001|Overall Study|Early termination of study|26|||
37960009|NCT00454246|69647407|FG002|Overall Study|Early termination of study|9|||
37960010|NCT00434590|69647417|FG000|Overall Study|Administrative problems|5|||
37960011|NCT00434590|69647418|FG001|Overall Study|Administrative problems|5|||
37960012|NCT02891837|69647426|FG000|Overall Study|Lost to Follow-up|2|||
37960013|NCT02891837|69647427|FG001|Overall Study|Lost to Follow-up|0|||
37960014|NCT02891837|69647426|FG000|Overall Study|Withdrawal by Subject|1|||
37960015|NCT02891837|69647427|FG001|Overall Study|Withdrawal by Subject|0|||
37960016|NCT00695903|69647451|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
37960017|NCT00695903|69647452|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
37960018|NCT00695903|69647451|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
37960019|NCT00695903|69647452|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
37960020|NCT00695903|69647451|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
37960021|NCT00695903|69647452|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
37960022|NCT00695903|69647451|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
37960023|NCT00695903|69647452|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
37960024|NCT00695903|69647451|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
37960025|NCT00695903|69647452|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
37960026|NCT00695903|69647451|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
37960027|NCT00695903|69647452|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
37960028|NCT00695903|69647451|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
37960029|NCT00695903|69647452|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
37960030|NCT00695903|69647451|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
37960031|NCT00695903|69647452|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
37960032|NCT00695903|69647451|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
37960033|NCT00695903|69647452|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
37960034|NCT00548262|69647458|FG000|Overall Study|Death|21|||
37960035|NCT00548262|69647458|FG000|Overall Study|Adverse Event|2|||
37960036|NCT00548262|69647458|FG000|Overall Study|Lack of Efficacy|4|||
37960037|NCT00548262|69647458|FG000|Overall Study|Lost to Follow-up|1|||
37960038|NCT00548262|69647458|FG000|Overall Study|Other|3|||
37960039|NCT00548262|69647458|FG000|Overall Study|Withdrawal by Subject|1|||
37960040|NCT00095173|69647462|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
37960041|NCT00095173|69647463|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
37960042|NCT00095173|69647464|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
37960043|NCT00095173|69647465|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
37960044|NCT00095173|69647466|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
37960045|NCT00095173|69647467|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
37960046|NCT00095173|69647462|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
37960047|NCT00095173|69647463|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
37960048|NCT00095173|69647464|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
37960049|NCT00095173|69647465|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
37960050|NCT00095173|69647466|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
37960051|NCT00095173|69647467|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
37960052|NCT00095173|69647462|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
37960053|NCT00095173|69647463|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
37960054|NCT00095173|69647464|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
37960055|NCT00095173|69647465|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
37960056|NCT00095173|69647466|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
37960057|NCT00095173|69647467|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
37960058|NCT00095173|69647462|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
37960059|NCT00095173|69647463|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
37960060|NCT00095173|69647464|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
37960061|NCT00095173|69647465|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
37960062|NCT00095173|69647466|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
37960063|NCT00095173|69647467|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
37960064|NCT00095173|69647462|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
37960065|NCT00095173|69647463|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
37960066|NCT00095173|69647464|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
37960067|NCT00095173|69647465|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
37960068|NCT00095173|69647466|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
37960069|NCT00095173|69647467|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
37960070|NCT00095173|69647462|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
37960071|NCT00095173|69647463|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
37960072|NCT00095173|69647464|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
37960073|NCT00095173|69647465|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
37960074|NCT00095173|69647466|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
37960075|NCT00095173|69647467|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
37960076|NCT00095173|69647462|FG000|Open-Label Extension Phase (Period C)|Death|0|||
37960077|NCT00095173|69647463|FG001|Open-Label Extension Phase (Period C)|Death|0|||
37960078|NCT00095173|69647464|FG002|Open-Label Extension Phase (Period C)|Death|0|||
37960079|NCT00095173|69647465|FG003|Open-Label Extension Phase (Period C)|Death|0|||
37960080|NCT00095173|69647466|FG004|Open-Label Extension Phase (Period C)|Death|0|||
37960081|NCT00095173|69647467|FG005|Open-Label Extension Phase (Period C)|Death|1|||
37960082|NCT00095173|69647462|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
37960083|NCT00095173|69647463|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
38051370|NCT03289143|69740579|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
38051371|NCT03289143|69740580|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
38051372|NCT03289143|69740581|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
38051373|NCT03289143|69740578|FG000|Overall Study|Medical Monitor Decision|1|||
38051374|NCT03289143|69740579|FG001|Overall Study|Medical Monitor Decision|0|||
38051375|NCT03289143|69740580|FG002|Overall Study|Medical Monitor Decision|0|||
38051376|NCT03289143|69740581|FG003|Overall Study|Medical Monitor Decision|0|||
38051377|NCT03289143|69740578|FG000|Overall Study|Participant Non-Compliance|0|||
38051378|NCT03289143|69740579|FG001|Overall Study|Participant Non-Compliance|0|||
38051379|NCT03289143|69740580|FG002|Overall Study|Participant Non-Compliance|1|||
37960084|NCT00095173|69647464|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
37960085|NCT00095173|69647465|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
37960086|NCT00095173|69647466|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
37960087|NCT00095173|69647467|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
37960088|NCT00095173|69647462|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
37960089|NCT00095173|69647463|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
37960090|NCT00095173|69647464|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
37960091|NCT00095173|69647465|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
37960092|NCT00095173|69647466|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
37960093|NCT00095173|69647467|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
37960094|NCT00095173|69647462|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
37960095|NCT00095173|69647463|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
37960096|NCT00095173|69647464|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
37960097|NCT00095173|69647465|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
37960098|NCT00095173|69647466|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
37960099|NCT00095173|69647467|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
37960100|NCT00095173|69647462|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
37960101|NCT00095173|69647463|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
37960102|NCT00095173|69647464|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
38051380|NCT03289143|69740581|FG003|Overall Study|Participant Non-Compliance|0|||
37960103|NCT00095173|69647465|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
37960104|NCT00095173|69647466|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
38051381|NCT03289143|69740578|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
37960105|NCT00095173|69647467|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
37960106|NCT00095173|69647462|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
37960107|NCT00095173|69647463|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
37960108|NCT00095173|69647464|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
37960109|NCT00095173|69647465|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
37960110|NCT00095173|69647466|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
37960111|NCT00095173|69647467|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
37960112|NCT00095173|69647462|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
37960113|NCT00095173|69647463|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
37960114|NCT00095173|69647464|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
37960115|NCT00095173|69647465|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
37960116|NCT00095173|69647466|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
37960117|NCT00095173|69647467|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
37960118|NCT00095173|69647462|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
37960119|NCT00095173|69647463|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
37960120|NCT00095173|69647464|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
37960121|NCT00095173|69647465|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
37960122|NCT00095173|69647466|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
37960123|NCT00095173|69647467|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
37960124|NCT00095173|69647462|FG000|Open-Label Extension Phase (Period C)|Other|0|||
37960125|NCT00095173|69647463|FG001|Open-Label Extension Phase (Period C)|Other|0|||
37960126|NCT00095173|69647464|FG002|Open-Label Extension Phase (Period C)|Other|0|||
37960127|NCT00095173|69647465|FG003|Open-Label Extension Phase (Period C)|Other|4|||
37960128|NCT00095173|69647466|FG004|Open-Label Extension Phase (Period C)|Other|6|||
37960129|NCT00095173|69647467|FG005|Open-Label Extension Phase (Period C)|Other|8|||
37960130|NCT00690443|69647483|FG000|Overall Study|Adverse Event|1|||
37960131|NCT00690443|69647484|FG001|Overall Study|Adverse Event|2|||
37960132|NCT03954834|69647494|FG000|Overall Study|Adverse Event|1|||
37960133|NCT03954834|69647495|FG001|Overall Study|Adverse Event|3|||
37960134|NCT03954834|69647496|FG002|Overall Study|Adverse Event|1|||
37960135|NCT03954834|69647497|FG003|Overall Study|Adverse Event|1|||
37960136|NCT03954834|69647494|FG000|Overall Study|Death|0|||
37960137|NCT03954834|69647495|FG001|Overall Study|Death|0|||
37960138|NCT03954834|69647496|FG002|Overall Study|Death|0|||
37960139|NCT03954834|69647497|FG003|Overall Study|Death|1|||
37960140|NCT03954834|69647494|FG000|Overall Study|Physician Decision|0|||
37960141|NCT03954834|69647495|FG001|Overall Study|Physician Decision|1|||
37960142|NCT03954834|69647496|FG002|Overall Study|Physician Decision|0|||
37960143|NCT03954834|69647497|FG003|Overall Study|Physician Decision|2|||
37960144|NCT03954834|69647494|FG000|Overall Study|Protocol Violation|1|||
37960145|NCT03954834|69647495|FG001|Overall Study|Protocol Violation|0|||
37960146|NCT03954834|69647496|FG002|Overall Study|Protocol Violation|0|||
37960147|NCT03954834|69647497|FG003|Overall Study|Protocol Violation|1|||
37960148|NCT03954834|69647494|FG000|Overall Study|Withdrawal by Subject|2|||
37960149|NCT03954834|69647495|FG001|Overall Study|Withdrawal by Subject|3|||
37960150|NCT03954834|69647496|FG002|Overall Study|Withdrawal by Subject|13|||
37960151|NCT03954834|69647497|FG003|Overall Study|Withdrawal by Subject|6|||
37960152|NCT03954834|69647494|FG000|Overall Study|Participant left the country|0|||
37960153|NCT03954834|69647495|FG001|Overall Study|Participant left the country|0|||
37960154|NCT03954834|69647496|FG002|Overall Study|Participant left the country|1|||
37960155|NCT03954834|69647497|FG003|Overall Study|Participant left the country|0|||
37960156|NCT03954834|69647494|FG000|Overall Study|Lost to Follow-up|3|||
37960157|NCT03954834|69647495|FG001|Overall Study|Lost to Follow-up|2|||
37960158|NCT03954834|69647496|FG002|Overall Study|Lost to Follow-up|3|||
37960159|NCT03954834|69647497|FG003|Overall Study|Lost to Follow-up|5|||
37960160|NCT00693017|69647509|FG000|Overall Study|Sponsor Decision|2|||
37960161|NCT00693017|69647510|FG001|Overall Study|Sponsor Decision|1|||
37960162|NCT00693017|69647509|FG000|Overall Study|Death|0|||
37960163|NCT00693017|69647510|FG001|Overall Study|Death|1|||
37960164|NCT00692237|69647518|FG000|Overall Study|Withdrawal by Subject|1|||
37960165|NCT00692237|69647519|FG001|Overall Study|Withdrawal by Subject|3|||
37960166|NCT00692237|69647518|FG000|Overall Study|Adverse Event|0|||
37960167|NCT00692237|69647519|FG001|Overall Study|Adverse Event|1|||
37960168|NCT00110149|69647525|FG000|Overall Study|Physician Decision|3|||
37960169|NCT03954444|69647533|FG000|Overall Study|Withdrawal by Subject|5|||
37960170|NCT03954444|69647534|FG001|Overall Study|Withdrawal by Subject|5|||
37960171|NCT03954444|69647535|FG002|Overall Study|Withdrawal by Subject|5|||
37960172|NCT03954444|69647533|FG000|Overall Study|Adverse Event|1|||
37960173|NCT03954444|69647534|FG001|Overall Study|Adverse Event|3|||
37960174|NCT03954444|69647535|FG002|Overall Study|Adverse Event|2|||
37960175|NCT03954444|69647533|FG000|Overall Study|Protocol Violation|0|||
37960176|NCT03954444|69647534|FG001|Overall Study|Protocol Violation|3|||
37960177|NCT03954444|69647535|FG002|Overall Study|Protocol Violation|5|||
37960178|NCT03954444|69647533|FG000|Overall Study|Use of prohibited therapy|1|||
37960179|NCT03954444|69647534|FG001|Overall Study|Use of prohibited therapy|1|||
37960180|NCT03954444|69647535|FG002|Overall Study|Use of prohibited therapy|2|||
37960181|NCT03954444|69647533|FG000|Overall Study|Lost to Follow-up|1|||
37960182|NCT03954444|69647534|FG001|Overall Study|Lost to Follow-up|0|||
37960183|NCT03954444|69647535|FG002|Overall Study|Lost to Follow-up|1|||
37960184|NCT03954444|69647533|FG000|Overall Study|Non-compliant with study drug application|2|||
37960185|NCT03954444|69647534|FG001|Overall Study|Non-compliant with study drug application|2|||
37960186|NCT03954444|69647535|FG002|Overall Study|Non-compliant with study drug application|0|||
37960187|NCT03954444|69647533|FG000|Overall Study|Administrative reasons|0|||
37960188|NCT03954444|69647534|FG001|Overall Study|Administrative reasons|0|||
37960189|NCT03954444|69647535|FG002|Overall Study|Administrative reasons|1|||
37960190|NCT03954444|69647533|FG000|Overall Study|Miscellaneous|3|||
37960191|NCT03954444|69647534|FG001|Overall Study|Miscellaneous|2|||
37960192|NCT03954444|69647535|FG002|Overall Study|Miscellaneous|1|||
37960193|NCT03953820|69647543|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
37960194|NCT03953820|69647544|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
37960195|NCT03953820|69647545|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
37960196|NCT03953820|69647543|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
37960197|NCT03953820|69647544|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
37960198|NCT03953820|69647545|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
37960199|NCT00117949|69647562|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
37960200|NCT00117949|69647563|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
37960201|NCT00117949|69647564|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
38051382|NCT03289143|69740579|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
38051383|NCT03289143|69740580|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
38051384|NCT03289143|69740581|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
38051385|NCT03289143|69740578|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
38051386|NCT03289143|69740579|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
38051387|NCT03289143|69740580|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
38051388|NCT03289143|69740581|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
38051389|NCT03289143|69740578|FG000|Overall Study|Caregiver Passed Away|1|||
38051390|NCT03289143|69740579|FG001|Overall Study|Caregiver Passed Away|0|||
38051391|NCT03289143|69740580|FG002|Overall Study|Caregiver Passed Away|0|||
38051392|NCT03289143|69740581|FG003|Overall Study|Caregiver Passed Away|0|||
38051393|NCT03289143|69740578|FG000|Overall Study|Physician Decision|0|||
38051394|NCT03289143|69740579|FG001|Overall Study|Physician Decision|2|||
38051395|NCT03289143|69740580|FG002|Overall Study|Physician Decision|2|||
38051396|NCT03289143|69740581|FG003|Overall Study|Physician Decision|2|||
38051397|NCT03289143|69740578|FG000|Overall Study|Protocol Deviation|2|||
38051398|NCT03289143|69740579|FG001|Overall Study|Protocol Deviation|1|||
38051399|NCT03289143|69740580|FG002|Overall Study|Protocol Deviation|3|||
38051400|NCT03289143|69740581|FG003|Overall Study|Protocol Deviation|1|||
38051401|NCT03289143|69740578|FG000|Overall Study|Study Terminated By Sponsor|101|||
38051402|NCT03289143|69740579|FG001|Overall Study|Study Terminated By Sponsor|75|||
38051403|NCT03289143|69740580|FG002|Overall Study|Study Terminated By Sponsor|100|||
38051404|NCT03289143|69740581|FG003|Overall Study|Study Terminated By Sponsor|69|||
38051405|NCT03289143|69740578|FG000|Overall Study|Withdrawal by Subject|14|||
38051406|NCT03289143|69740579|FG001|Overall Study|Withdrawal by Subject|6|||
38051407|NCT03289143|69740580|FG002|Overall Study|Withdrawal by Subject|14|||
38051408|NCT03289143|69740581|FG003|Overall Study|Withdrawal by Subject|12|||
38051409|NCT03289143|69740578|FG000|Overall Study|Adverse Event|10|||
38051410|NCT03289143|69740579|FG001|Overall Study|Adverse Event|7|||
38051411|NCT03289143|69740580|FG002|Overall Study|Adverse Event|6|||
38051412|NCT03289143|69740581|FG003|Overall Study|Adverse Event|5|||
38051413|NCT03289143|69740578|FG000|Overall Study|Death|2|||
38051414|NCT03289143|69740579|FG001|Overall Study|Death|0|||
38051415|NCT03289143|69740580|FG002|Overall Study|Death|2|||
38051416|NCT03289143|69740581|FG003|Overall Study|Death|1|||
38051417|NCT03289143|69740578|FG000|Overall Study|Lost to Follow-up|2|||
38051418|NCT03289143|69740579|FG001|Overall Study|Lost to Follow-up|1|||
38051419|NCT03289143|69740580|FG002|Overall Study|Lost to Follow-up|1|||
38051420|NCT03289143|69740581|FG003|Overall Study|Lost to Follow-up|0|||
38051421|NCT03289143|69740578|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
38051422|NCT03289143|69740579|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
37960202|NCT00117949|69647565|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
37960203|NCT00117949|69647562|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
37960204|NCT00117949|69647563|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
37960205|NCT00117949|69647564|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
38051423|NCT03289143|69740580|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
38051424|NCT03289143|69740581|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
38051425|NCT03289143|69740578|FG000|Overall Study|Withdrawal by Caregiver|0|||
37960206|NCT00117949|69647565|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
37960207|NCT00117949|69647562|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
38051426|NCT03289143|69740579|FG001|Overall Study|Withdrawal by Caregiver|1|||
38051427|NCT03289143|69740580|FG002|Overall Study|Withdrawal by Caregiver|0|||
38051428|NCT03289143|69740581|FG003|Overall Study|Withdrawal by Caregiver|0|||
38051429|NCT03289143|69740578|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
38051430|NCT03289143|69740579|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
38051431|NCT03289143|69740580|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
38051432|NCT03289143|69740581|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
38051433|NCT03289143|69740578|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
38051434|NCT03289143|69740579|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
38051435|NCT03289143|69740580|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
38051436|NCT03289143|69740581|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
38051437|NCT03311724|69740600|FG000|Overall Study|Physician Decision|0|||
38051438|NCT03311724|69740601|FG001|Overall Study|Physician Decision|0|||
38051439|NCT03311724|69740602|FG002|Overall Study|Physician Decision|0|||
38051440|NCT03311724|69740603|FG003|Overall Study|Physician Decision|1|||
38051441|NCT03311724|69740600|FG000|Overall Study|Protocol Violation|1|||
38051442|NCT03311724|69740601|FG001|Overall Study|Protocol Violation|0|||
38051443|NCT03311724|69740602|FG002|Overall Study|Protocol Violation|1|||
38051444|NCT03311724|69740603|FG003|Overall Study|Protocol Violation|0|||
38051445|NCT03311724|69740600|FG000|Overall Study|Withdrawal by Subject|1|||
38051446|NCT03311724|69740601|FG001|Overall Study|Withdrawal by Subject|1|||
38051447|NCT03311724|69740602|FG002|Overall Study|Withdrawal by Subject|0|||
38051448|NCT03311724|69740603|FG003|Overall Study|Withdrawal by Subject|0|||
37960208|NCT00117949|69647563|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
37960209|NCT00117949|69647564|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
37960210|NCT00117949|69647565|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
37960211|NCT00117949|69647562|FG000|Overall Study|PSA increase >=10ng/mL|0|||
37960212|NCT00117949|69647563|FG001|Overall Study|PSA increase >=10ng/mL|1|||
37960213|NCT00117949|69647564|FG002|Overall Study|PSA increase >=10ng/mL|1|||
37960214|NCT00117949|69647565|FG003|Overall Study|PSA increase >=10ng/mL|0|||
37960215|NCT00117949|69647562|FG000|Overall Study|PSA reduction <=50%|0|||
37960216|NCT00117949|69647563|FG001|Overall Study|PSA reduction <=50%|2|||
37960217|NCT00117949|69647564|FG002|Overall Study|PSA reduction <=50%|2|||
37960218|NCT00117949|69647565|FG003|Overall Study|PSA reduction <=50%|4|||
37960219|NCT00117949|69647562|FG000|Overall Study|Hepatic abnormalities|0|||
37960220|NCT00117949|69647563|FG001|Overall Study|Hepatic abnormalities|1|||
37960221|NCT00117949|69647564|FG002|Overall Study|Hepatic abnormalities|0|||
37960222|NCT00117949|69647565|FG003|Overall Study|Hepatic abnormalities|1|||
37960223|NCT02611037|69647575|FG000|Overall Study|Withdrawal prior to treatment|2|||
37960224|NCT02611037|69647576|FG001|Overall Study|Withdrawal prior to treatment|0|||
37960225|NCT00117793|69647581|FG000|Overall Study|Withdrawal by Subject|12|||
37960226|NCT00695669|69647590|FG000|Overall Study|Adverse Event|0|||
37960227|NCT00695669|69647591|FG001|Overall Study|Adverse Event|0|||
37960228|NCT00695669|69647592|FG002|Overall Study|Adverse Event|2|||
37960229|NCT00695669|69647593|FG003|Overall Study|Adverse Event|0|||
37960230|NCT00695669|69647590|FG000|Overall Study|Lost to Follow-up|4|||
37960231|NCT00695669|69647591|FG001|Overall Study|Lost to Follow-up|4|||
37960232|NCT00695669|69647592|FG002|Overall Study|Lost to Follow-up|1|||
37960233|NCT00695669|69647593|FG003|Overall Study|Lost to Follow-up|4|||
37960234|NCT03671369|69647606|FG000|Overall Study|Other|1|||
37960235|NCT03671369|69647606|FG000|Overall Study|Withdrawal by Subject|289|||
37960236|NCT03671369|69647606|FG000|Overall Study|Not willing to be vaccinated|1|||
37960237|NCT00692003|69647612|FG000|Overall Study|Sponsor Decision|5|||
37960238|NCT00692003|69647613|FG001|Overall Study|Sponsor Decision|1|||
37960239|NCT00434512|69647625|FG000|Overall Study|Migrated/moved from study area|0|||
37960240|NCT00434512|69647626|FG001|Overall Study|Migrated/moved from study area|0|||
37960241|NCT00434512|69647627|FG002|Overall Study|Migrated/moved from study area|0|||
37960242|NCT00434512|69647628|FG003|Overall Study|Migrated/moved from study area|1|||
37960243|NCT00434512|69647629|FG004|Overall Study|Migrated/moved from study area|1|||
37960244|NCT00434512|69647630|FG005|Overall Study|Migrated/moved from study area|1|||
37960245|NCT00434512|69647625|FG000|Overall Study|Other|0|||
38051449|NCT03311724|69740600|FG000|Overall Study|Lost to Follow-up|1|||
38051450|NCT03311724|69740601|FG001|Overall Study|Lost to Follow-up|0|||
38051451|NCT03311724|69740602|FG002|Overall Study|Lost to Follow-up|0|||
38051452|NCT03311724|69740603|FG003|Overall Study|Lost to Follow-up|0|||
38051453|NCT03311724|69740600|FG000|Overall Study|Sponsor Decision|0|||
38051454|NCT03311724|69740601|FG001|Overall Study|Sponsor Decision|0|||
38051455|NCT03311724|69740602|FG002|Overall Study|Sponsor Decision|1|||
38051456|NCT03311724|69740603|FG003|Overall Study|Sponsor Decision|0|||
37960246|NCT00434512|69647626|FG001|Overall Study|Other|1|||
38051457|NCT03311646|69740625|FG000|Overall Study|Physician Decision|1|||
37960247|NCT00434512|69647627|FG002|Overall Study|Other|0|||
37960248|NCT00434512|69647628|FG003|Overall Study|Other|0|||
37960249|NCT00434512|69647629|FG004|Overall Study|Other|0|||
37960250|NCT00434512|69647630|FG005|Overall Study|Other|0|||
37960251|NCT00427648|69647650|FG000|Overall Study|Protocol Violation|1|||
37960252|NCT00427648|69647651|FG001|Overall Study|Protocol Violation|2|||
37960253|NCT00427648|69647650|FG000|Overall Study|Adverse Event|0|||
37960254|NCT00427648|69647651|FG001|Overall Study|Adverse Event|1|||
37960255|NCT00416884|69647659|FG000|Overall Study|Study terminated due to low accrual|1|||
37960256|NCT00434122|69647665|FG000|Overall Study|Non-compliance with protocol|0|||
37960257|NCT00434122|69647666|FG001|Overall Study|Non-compliance with protocol|1|||
37960258|NCT00434122|69647665|FG000|Overall Study|loss of subject contact|1|||
37960259|NCT00434122|69647666|FG001|Overall Study|loss of subject contact|1|||
37960260|NCT00434122|69647665|FG000|Overall Study|Personal reasons|1|||
37960261|NCT00434122|69647666|FG001|Overall Study|Personal reasons|1|||
37960262|NCT00434122|69647665|FG000|Overall Study|Large follicle size|2|||
37960263|NCT00434122|69647666|FG001|Overall Study|Large follicle size|2|||
37960264|NCT00434122|69647665|FG000|Overall Study|Low follicular response.|1|||
37960265|NCT00434122|69647666|FG001|Overall Study|Low follicular response.|2|||
37960266|NCT00434122|69647665|FG000|Overall Study|Travelling of subject.|1|||
37960267|NCT00434122|69647666|FG001|Overall Study|Travelling of subject.|0|||
37960268|NCT00555620|69647680|FG000|Overall Study|Death|0|||
37960269|NCT00555620|69647681|FG001|Overall Study|Death|1|||
37960270|NCT00555620|69647682|FG002|Overall Study|Death|0|||
37960271|NCT00555620|69647683|FG003|Overall Study|Death|0|||
37960272|NCT00555620|69647684|FG004|Overall Study|Death|0|||
37960273|NCT00555620|69647685|FG005|Overall Study|Death|1|||
37960274|NCT00555620|69647680|FG000|Overall Study|Study terminated by sponsor|0|||
37960275|NCT00555620|69647681|FG001|Overall Study|Study terminated by sponsor|0|||
37960276|NCT00555620|69647682|FG002|Overall Study|Study terminated by sponsor|1|||
37960277|NCT00555620|69647683|FG003|Overall Study|Study terminated by sponsor|0|||
37960278|NCT00555620|69647684|FG004|Overall Study|Study terminated by sponsor|0|||
37960279|NCT00555620|69647685|FG005|Overall Study|Study terminated by sponsor|0|||
37960280|NCT00555620|69647680|FG000|Overall Study|Adverse Event|0|||
37960281|NCT00555620|69647681|FG001|Overall Study|Adverse Event|0|||
37960282|NCT00555620|69647682|FG002|Overall Study|Adverse Event|1|||
37960283|NCT00555620|69647683|FG003|Overall Study|Adverse Event|5|||
37960284|NCT00555620|69647684|FG004|Overall Study|Adverse Event|0|||
37960285|NCT00555620|69647685|FG005|Overall Study|Adverse Event|1|||
37960286|NCT00555620|69647680|FG000|Overall Study|Objective progression or relapse|6|||
37960287|NCT00555620|69647681|FG001|Overall Study|Objective progression or relapse|5|||
37960288|NCT00555620|69647682|FG002|Overall Study|Objective progression or relapse|12|||
37960289|NCT00555620|69647683|FG003|Overall Study|Objective progression or relapse|17|||
37960290|NCT00555620|69647684|FG004|Overall Study|Objective progression or relapse|3|||
37960291|NCT00555620|69647685|FG005|Overall Study|Objective progression or relapse|16|||
37960292|NCT00555620|69647680|FG000|Overall Study|Participant refused treatment|0|||
37960293|NCT00555620|69647681|FG001|Overall Study|Participant refused treatment|1|||
37960294|NCT00555620|69647682|FG002|Overall Study|Participant refused treatment|1|||
37960295|NCT00555620|69647683|FG003|Overall Study|Participant refused treatment|0|||
37960296|NCT00555620|69647684|FG004|Overall Study|Participant refused treatment|0|||
37960297|NCT00555620|69647685|FG005|Overall Study|Participant refused treatment|1|||
37960298|NCT00555620|69647680|FG000|Overall Study|Other|0|||
37960299|NCT00555620|69647681|FG001|Overall Study|Other|0|||
37960300|NCT00555620|69647682|FG002|Overall Study|Other|0|||
37960301|NCT00555620|69647683|FG003|Overall Study|Other|1|||
37960302|NCT00555620|69647684|FG004|Overall Study|Other|0|||
37960303|NCT00555620|69647685|FG005|Overall Study|Other|3|||
37960304|NCT00433966|69647705|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
37960305|NCT00433966|69647706|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
37960306|NCT00433966|69647707|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
37960307|NCT00433966|69647708|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
37960308|NCT00433966|69647705|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
37960309|NCT00433966|69647706|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
37960310|NCT00433966|69647707|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
37960311|NCT00433966|69647708|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
37960312|NCT00433966|69647705|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
37960313|NCT00433966|69647706|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
37960314|NCT00433966|69647707|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
37960315|NCT00433966|69647708|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
37960316|NCT00433966|69647705|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
37960317|NCT00433966|69647706|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
37960318|NCT00433966|69647707|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
37960319|NCT00433966|69647708|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
37960320|NCT00433966|69647705|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
37960321|NCT00433966|69647706|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
37960322|NCT00433966|69647707|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
37960323|NCT00433966|69647708|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
37960324|NCT03952650|69647725|FG000|Overall Study|TRAVEL|0|||
37960325|NCT03952650|69647726|FG001|Overall Study|TRAVEL|4|||
37960326|NCT03952650|69647727|FG002|Overall Study|TRAVEL|0|||
37960327|NCT03952650|69647728|FG003|Overall Study|TRAVEL|4|||
37960328|NCT03952650|69647729|FG004|Overall Study|TRAVEL|0|||
37960329|NCT03952650|69647730|FG005|Overall Study|TRAVEL|3|||
37960330|NCT03952650|69647731|FG006|Overall Study|TRAVEL|2|||
37960331|NCT03952650|69647725|FG000|Overall Study|Withdrawal by Subject|0|||
37960332|NCT03952650|69647726|FG001|Overall Study|Withdrawal by Subject|2|||
37960333|NCT03952650|69647727|FG002|Overall Study|Withdrawal by Subject|0|||
37960334|NCT03952650|69647728|FG003|Overall Study|Withdrawal by Subject|3|||
37960335|NCT03952650|69647729|FG004|Overall Study|Withdrawal by Subject|0|||
37960336|NCT03952650|69647730|FG005|Overall Study|Withdrawal by Subject|1|||
37960337|NCT03952650|69647731|FG006|Overall Study|Withdrawal by Subject|1|||
37960338|NCT03952650|69647725|FG000|Overall Study|Lost to Follow-up|0|||
37960339|NCT03952650|69647726|FG001|Overall Study|Lost to Follow-up|1|||
37960340|NCT03952650|69647727|FG002|Overall Study|Lost to Follow-up|0|||
37960341|NCT03952650|69647728|FG003|Overall Study|Lost to Follow-up|0|||
37960342|NCT03952650|69647729|FG004|Overall Study|Lost to Follow-up|0|||
37960343|NCT03952650|69647730|FG005|Overall Study|Lost to Follow-up|1|||
37960344|NCT03952650|69647731|FG006|Overall Study|Lost to Follow-up|1|||
37960345|NCT03952650|69647725|FG000|Overall Study|Received wrong vaccine and travelled|0|||
37960346|NCT03952650|69647726|FG001|Overall Study|Received wrong vaccine and travelled|0|||
37960347|NCT03952650|69647727|FG002|Overall Study|Received wrong vaccine and travelled|0|||
37960348|NCT03952650|69647728|FG003|Overall Study|Received wrong vaccine and travelled|0|||
37960349|NCT03952650|69647729|FG004|Overall Study|Received wrong vaccine and travelled|0|||
37960350|NCT03952650|69647730|FG005|Overall Study|Received wrong vaccine and travelled|1|||
37960351|NCT03952650|69647731|FG006|Overall Study|Received wrong vaccine and travelled|0|||
37960352|NCT03952650|69647725|FG000|Overall Study|Unable to make study visit|0|||
37960353|NCT03952650|69647726|FG001|Overall Study|Unable to make study visit|0|||
37960354|NCT03952650|69647727|FG002|Overall Study|Unable to make study visit|0|||
37960355|NCT03952650|69647728|FG003|Overall Study|Unable to make study visit|0|||
37960356|NCT03952650|69647729|FG004|Overall Study|Unable to make study visit|0|||
37960357|NCT03952650|69647730|FG005|Overall Study|Unable to make study visit|1|||
37960358|NCT03952650|69647731|FG006|Overall Study|Unable to make study visit|0|||
37960359|NCT00691301|69647747|FG000|Overall Study|Adverse Event|10|||
37960360|NCT00691301|69647747|FG000|Overall Study|Death|2|||
37960361|NCT00691301|69647747|FG000|Overall Study|Lack of Efficacy|32|||
37960362|NCT00691301|69647747|FG000|Overall Study|Withdrawal by Subject|4|||
37960363|NCT00691301|69647747|FG000|Overall Study|Concurrent illness|2|||
37960364|NCT00691301|69647747|FG000|Overall Study|other reason|3|||
37960365|NCT00691301|69647747|FG000|Overall Study|Did not initiate study treatment|1|||
37960366|NCT00927563|69647757|FG000|Overall Study|Lost to Follow-up|1|||
37960367|NCT00927563|69647757|FG000|Overall Study|Withdrawal by Subject|1|||
37960368|NCT00653159|69647772|FG000|Overall Study|Adverse Event|4|||
37960369|NCT00653159|69647773|FG001|Overall Study|Adverse Event|1|||
37960370|NCT00653159|69647772|FG000|Overall Study|Lost to Follow-up|1|||
37960371|NCT00653159|69647773|FG001|Overall Study|Lost to Follow-up|2|||
37960372|NCT00117637|69647781|FG000|First Intervention (Period 1)|Adverse Event|11|||
37960373|NCT00117637|69647782|FG001|First Intervention (Period 1)|Adverse Event|16|||
37960374|NCT00117637|69647781|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
37960375|NCT00117637|69647782|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
37960376|NCT00117637|69647781|FG000|First Intervention (Period 1)|Protocol Violation|1|||
37960377|NCT00117637|69647782|FG001|First Intervention (Period 1)|Protocol Violation|0|||
37960378|NCT00117637|69647781|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
37960379|NCT00117637|69647782|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
37960380|NCT00117637|69647781|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
37960381|NCT00117637|69647782|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
37960382|NCT00117637|69647781|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
37960383|NCT00117637|69647782|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
38051458|NCT03311646|69740625|FG000|Overall Study|Withdrawal by Subject|5|||
37960384|NCT00117637|69647781|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
37960385|NCT00117637|69647782|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
37960386|NCT00117637|69647781|FG000|First Intervention (Period 1)|reason not reported|0|||
37960387|NCT00117637|69647782|FG001|First Intervention (Period 1)|reason not reported|1|||
37960388|NCT00117637|69647781|FG000|Second Intervention (Period 2)|Adverse Event|0|||
38051459|NCT03311646|69740625|FG000|Overall Study|Lost to Follow-up|5|||
38051460|NCT03311646|69740625|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
38051461|NCT01672892|69740632|FG000|Overall Study|Protocol Violation|7|||
37960389|NCT00117637|69647782|FG001|Second Intervention (Period 2)|Adverse Event|9|||
37960390|NCT00117637|69647781|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
37960391|NCT00117637|69647782|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
37960392|NCT00117637|69647781|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
37960393|NCT00117637|69647782|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
37960394|NCT00117637|69647781|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
37960395|NCT00117637|69647782|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
37960396|NCT00117637|69647781|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
37960397|NCT00117637|69647782|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
37960398|NCT00117637|69647781|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
37960399|NCT00117637|69647782|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
37960400|NCT00117637|69647781|FG000|Second Intervention (Period 2)|reason not reported|1|||
37960401|NCT00117637|69647782|FG001|Second Intervention (Period 2)|reason not reported|0|||
37960402|NCT00690755|69647802|FG000|Overall Study|Physician Decision|2|||
37960403|NCT00690755|69647803|FG001|Overall Study|Physician Decision|0|||
37960404|NCT00690755|69647804|FG002|Overall Study|Physician Decision|46|||
37960405|NCT00690755|69647805|FG003|Overall Study|Physician Decision|5|||
37960406|NCT00690755|69647806|FG004|Overall Study|Physician Decision|0|||
37960407|NCT00690755|69647807|FG005|Overall Study|Physician Decision|4|||
37960408|NCT00690755|69647808|FG006|Overall Study|Physician Decision|0|||
37960409|NCT00549302|69647826|FG000|Double-Blind|Death|2|||
37960410|NCT00549302|69647827|FG001|Double-Blind|Death|9|||
37960411|NCT00549302|69647828|FG002|Double-Blind|Death|0|||
37960412|NCT00549302|69647826|FG000|Double-Blind|Adverse Event|3|||
37960413|NCT00549302|69647827|FG001|Double-Blind|Adverse Event|16|||
37960414|NCT00549302|69647828|FG002|Double-Blind|Adverse Event|0|||
37960415|NCT00549302|69647826|FG000|Double-Blind|Withdrawal by Subject|3|||
37960416|NCT00549302|69647827|FG001|Double-Blind|Withdrawal by Subject|8|||
37960417|NCT00549302|69647828|FG002|Double-Blind|Withdrawal by Subject|0|||
37960418|NCT00549302|69647826|FG000|Double-Blind|Investigator Decision|1|||
37960419|NCT00549302|69647827|FG001|Double-Blind|Investigator Decision|5|||
37960420|NCT00549302|69647828|FG002|Double-Blind|Investigator Decision|0|||
37960421|NCT00549302|69647826|FG000|Double-Blind|Sponsor Decision|0|||
37960422|NCT00549302|69647827|FG001|Double-Blind|Sponsor Decision|1|||
37960423|NCT00549302|69647828|FG002|Double-Blind|Sponsor Decision|0|||
37960424|NCT00549302|69647826|FG000|Double-Blind|Lost to Follow-up|1|||
37960425|NCT00549302|69647827|FG001|Double-Blind|Lost to Follow-up|2|||
37960426|NCT00549302|69647828|FG002|Double-Blind|Lost to Follow-up|0|||
37960427|NCT00549302|69647826|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
37960428|NCT00549302|69647827|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
37960429|NCT00549302|69647828|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
37960430|NCT00549302|69647826|FG000|Double-Blind|New condition or starts new therapy|0|||
37960431|NCT00549302|69647827|FG001|Double-Blind|New condition or starts new therapy|2|||
37960432|NCT00549302|69647828|FG002|Double-Blind|New condition or starts new therapy|0|||
37960433|NCT00549302|69647826|FG000|Open-Label|Adverse Event|0|||
37960434|NCT00549302|69647827|FG001|Open-Label|Adverse Event|0|||
37960435|NCT00549302|69647828|FG002|Open-Label|Adverse Event|11|||
37960436|NCT00549302|69647826|FG000|Open-Label|Death|0|||
37960437|NCT00549302|69647827|FG001|Open-Label|Death|0|||
37960438|NCT00549302|69647828|FG002|Open-Label|Death|40|||
37960439|NCT00549302|69647826|FG000|Open-Label|Investigator Decision|0|||
37960440|NCT00549302|69647827|FG001|Open-Label|Investigator Decision|0|||
37960441|NCT00549302|69647828|FG002|Open-Label|Investigator Decision|5|||
37960442|NCT00549302|69647826|FG000|Open-Label|Lost to Follow-up|0|||
37960443|NCT00549302|69647827|FG001|Open-Label|Lost to Follow-up|0|||
37960444|NCT00549302|69647828|FG002|Open-Label|Lost to Follow-up|2|||
37960445|NCT00549302|69647826|FG000|Open-Label|Other|0|||
37960446|NCT00549302|69647827|FG001|Open-Label|Other|0|||
37960447|NCT00549302|69647828|FG002|Open-Label|Other|3|||
37960448|NCT00549302|69647826|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
37960449|NCT00549302|69647827|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
37960450|NCT00549302|69647828|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
37960451|NCT00549302|69647826|FG000|Open-Label|Withdrawal by Subject|0|||
37960452|NCT00549302|69647827|FG001|Open-Label|Withdrawal by Subject|0|||
37960453|NCT00549302|69647828|FG002|Open-Label|Withdrawal by Subject|6|||
37960454|NCT00117325|69647838|FG000|Overall Study|Adverse Event|3|||
37960455|NCT00117325|69647839|FG001|Overall Study|Adverse Event|3|||
37960456|NCT00117325|69647838|FG000|Overall Study|Lost to Follow-up|1|||
37960457|NCT00117325|69647839|FG001|Overall Study|Lost to Follow-up|1|||
37960458|NCT00117325|69647838|FG000|Overall Study|Protocol Violation|2|||
37960459|NCT00117325|69647839|FG001|Overall Study|Protocol Violation|3|||
37960460|NCT00117325|69647838|FG000|Overall Study|Withdrawal by Subject|3|||
37960461|NCT00117325|69647839|FG001|Overall Study|Withdrawal by Subject|2|||
37960462|NCT00117325|69647838|FG000|Overall Study|Lack of Efficacy|1|||
37960463|NCT00117325|69647839|FG001|Overall Study|Lack of Efficacy|0|||
37680332|NCT02399163|69155909|FG000|Overall Study|Adverse Event|2|||
37960464|NCT00117325|69647838|FG000|Overall Study|Use of prohibited medicine|1|||
37960465|NCT00117325|69647839|FG001|Overall Study|Use of prohibited medicine|2|||
37960466|NCT00117325|69647838|FG000|Overall Study|Early termination|1|||
37960467|NCT00117325|69647839|FG001|Overall Study|Early termination|1|||
37960468|NCT00117325|69647838|FG000|Overall Study|Admisnitrative|1|||
37960469|NCT00117325|69647839|FG001|Overall Study|Admisnitrative|0|||
37960470|NCT00108433|69647848|FG000|Overall Study|Lack of Efficacy|1|||
37960471|NCT00108433|69647849|FG001|Overall Study|Lack of Efficacy|2|||
37960472|NCT00108433|69647848|FG000|Overall Study|Death|3|||
37960473|NCT00108433|69647849|FG001|Overall Study|Death|0|||
37960474|NCT00108433|69647848|FG000|Overall Study|Adverse Event|3|||
37960475|NCT00108433|69647849|FG001|Overall Study|Adverse Event|1|||
37960476|NCT00108433|69647848|FG000|Overall Study|Other|14|||
37960477|NCT00108433|69647849|FG001|Overall Study|Other|14|||
37960478|NCT00116779|69647857|FG000|Overall Study|Adverse Event|4|||
37960479|NCT00116779|69647858|FG001|Overall Study|Adverse Event|2|||
37960480|NCT00116779|69647857|FG000|Overall Study|Protocol Violation|1|||
37960481|NCT00116779|69647858|FG001|Overall Study|Protocol Violation|4|||
37960482|NCT00116779|69647857|FG000|Overall Study|Withdrawal by Subject|4|||
37960483|NCT00116779|69647858|FG001|Overall Study|Withdrawal by Subject|1|||
37960484|NCT00116779|69647857|FG000|Overall Study|Inadequate testosterone suppression|7|||
37960485|NCT00116779|69647858|FG001|Overall Study|Inadequate testosterone suppression|9|||
37960486|NCT00116779|69647857|FG000|Overall Study|Physician Decision|3|||
37960487|NCT00116779|69647858|FG001|Overall Study|Physician Decision|1|||
37960488|NCT00116779|69647857|FG000|Overall Study|Elevated PSA levels|2|||
37960489|NCT00116779|69647858|FG001|Overall Study|Elevated PSA levels|2|||
37960490|NCT03943290|69647873|FG000|Overall Study|Sponsor Terminated Study|6|||
37960491|NCT03943290|69647874|FG001|Overall Study|Sponsor Terminated Study|1|||
37960492|NCT03943290|69647875|FG002|Overall Study|Sponsor Terminated Study|11|||
37960493|NCT03943290|69647876|FG003|Overall Study|Sponsor Terminated Study|6|||
37960494|NCT03943290|69647877|FG004|Overall Study|Sponsor Terminated Study|7|||
37960495|NCT03943290|69647878|FG005|Overall Study|Sponsor Terminated Study|6|||
37960496|NCT03943290|69647879|FG006|Overall Study|Sponsor Terminated Study|6|||
37960497|NCT03943290|69647880|FG007|Overall Study|Sponsor Terminated Study|7|||
37960498|NCT03943290|69647881|FG008|Overall Study|Sponsor Terminated Study|8|||
37960499|NCT03943290|69647873|FG000|Overall Study|Lost to Follow-up|1|||
37960500|NCT03943290|69647874|FG001|Overall Study|Lost to Follow-up|0|||
37960501|NCT03943290|69647875|FG002|Overall Study|Lost to Follow-up|1|||
37960502|NCT03943290|69647876|FG003|Overall Study|Lost to Follow-up|0|||
37960503|NCT03943290|69647877|FG004|Overall Study|Lost to Follow-up|0|||
37960504|NCT03943290|69647878|FG005|Overall Study|Lost to Follow-up|0|||
37960505|NCT03943290|69647879|FG006|Overall Study|Lost to Follow-up|0|||
37960506|NCT03943290|69647880|FG007|Overall Study|Lost to Follow-up|1|||
37960507|NCT03943290|69647881|FG008|Overall Study|Lost to Follow-up|0|||
37960508|NCT03943290|69647873|FG000|Overall Study|Withdrawal by Subject|0|||
37960509|NCT03943290|69647874|FG001|Overall Study|Withdrawal by Subject|0|||
37960510|NCT03943290|69647875|FG002|Overall Study|Withdrawal by Subject|1|||
37960511|NCT03943290|69647876|FG003|Overall Study|Withdrawal by Subject|0|||
37960512|NCT03943290|69647877|FG004|Overall Study|Withdrawal by Subject|0|||
37960513|NCT03943290|69647878|FG005|Overall Study|Withdrawal by Subject|0|||
37960514|NCT03943290|69647879|FG006|Overall Study|Withdrawal by Subject|0|||
37960515|NCT03943290|69647880|FG007|Overall Study|Withdrawal by Subject|0|||
37960516|NCT03943290|69647881|FG008|Overall Study|Withdrawal by Subject|0|||
37960517|NCT00108355|69647916|FG000|Overall Study|Peritonitis at index paracentesis|1|||
37960518|NCT00108355|69647917|FG001|Overall Study|Peritonitis at index paracentesis|1|||
37960519|NCT00108355|69647916|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
37960520|NCT00108355|69647917|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
37960521|NCT00094861|69647938|FG000|Overall Study|Adverse Event|5|||
37960522|NCT00094861|69647939|FG001|Overall Study|Adverse Event|2|||
37960523|NCT00094861|69647938|FG000|Overall Study|Withdrawal by Subject|5|||
37960524|NCT00094861|69647939|FG001|Overall Study|Withdrawal by Subject|3|||
37960525|NCT00094861|69647938|FG000|Overall Study|Physician Decision|1|||
37960526|NCT00094861|69647939|FG001|Overall Study|Physician Decision|1|||
37960527|NCT00094861|69647938|FG000|Overall Study|Lost to Follow-up|0|||
37960528|NCT00094861|69647939|FG001|Overall Study|Lost to Follow-up|1|||
37960529|NCT00094861|69647938|FG000|Overall Study|Death|4|||
37960530|NCT00094861|69647939|FG001|Overall Study|Death|2|||
37960531|NCT00094861|69647938|FG000|Overall Study|Other|3|||
37960532|NCT00094861|69647939|FG001|Overall Study|Other|0|||
38051462|NCT01672892|69740633|FG001|Overall Study|Protocol Violation|3|||
38051463|NCT03288987|69740644|FG000|Overall Study|Protocol Violation|10|||
38051464|NCT03288987|69740645|FG001|Overall Study|Protocol Violation|4|||
38051465|NCT02939781|69740651|FG000|Overall Study|Protocol Violation|8|||
37960533|NCT00426556|69647949|FG000|Phase I - Core Phase|Disease Progression|0|||
37960534|NCT00426556|69647950|FG001|Phase I - Core Phase|Disease Progression|6|||
37960535|NCT00426556|69647951|FG002|Phase I - Core Phase|Disease Progression|2|||
37960536|NCT00426556|69647952|FG003|Phase I - Core Phase|Disease Progression|0|||
37960537|NCT00426556|69647949|FG000|Phase I - Core Phase|Adverse Event|1|||
37960538|NCT00426556|69647950|FG001|Phase I - Core Phase|Adverse Event|3|||
37960539|NCT00426556|69647951|FG002|Phase I - Core Phase|Adverse Event|1|||
37960540|NCT00426556|69647952|FG003|Phase I - Core Phase|Adverse Event|0|||
38051466|NCT02939781|69740651|FG000|Overall Study|Withdrawal by Subject|1|||
37960541|NCT00426556|69647949|FG000|Phase I - Core Phase|Death|0|||
37960542|NCT00426556|69647950|FG001|Phase I - Core Phase|Death|1|||
37960543|NCT00426556|69647951|FG002|Phase I - Core Phase|Death|0|||
37960544|NCT00426556|69647952|FG003|Phase I - Core Phase|Death|0|||
37960545|NCT00426556|69647949|FG000|Phase I - Extension Phase|Adverse Event|0|||
37960546|NCT00426556|69647950|FG001|Phase I - Extension Phase|Adverse Event|1|||
37960547|NCT00426556|69647951|FG002|Phase I - Extension Phase|Adverse Event|1|||
37960548|NCT00426556|69647952|FG003|Phase I - Extension Phase|Adverse Event|0|||
37960549|NCT00426556|69647949|FG000|Phase I - Extension Phase|Disease Progression|5|||
37960550|NCT00426556|69647950|FG001|Phase I - Extension Phase|Disease Progression|5|||
37960551|NCT00426556|69647951|FG002|Phase I - Extension Phase|Disease Progression|6|||
37960552|NCT00426556|69647952|FG003|Phase I - Extension Phase|Disease Progression|0|||
37960553|NCT00426556|69647949|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
37960554|NCT00426556|69647950|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
37960555|NCT00426556|69647951|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
37960556|NCT00426556|69647952|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
37960557|NCT00426556|69647949|FG000|Phase II - Core Phase|Disease Progression|0|||
37960558|NCT00426556|69647950|FG001|Phase II - Core Phase|Disease Progression|0|||
37960559|NCT00426556|69647951|FG002|Phase II - Core Phase|Disease Progression|0|||
37960560|NCT00426556|69647952|FG003|Phase II - Core Phase|Disease Progression|16|||
37960561|NCT00426556|69647949|FG000|Phase II - Core Phase|Adverse Event|0|||
37960562|NCT00426556|69647950|FG001|Phase II - Core Phase|Adverse Event|0|||
37960563|NCT00426556|69647951|FG002|Phase II - Core Phase|Adverse Event|0|||
37960564|NCT00426556|69647952|FG003|Phase II - Core Phase|Adverse Event|8|||
37960565|NCT00426556|69647949|FG000|Phase II - Extension Phase|Disease Progression|0|||
37960566|NCT00426556|69647950|FG001|Phase II - Extension Phase|Disease Progression|0|||
37960567|NCT00426556|69647951|FG002|Phase II - Extension Phase|Disease Progression|0|||
37960568|NCT00426556|69647952|FG003|Phase II - Extension Phase|Disease Progression|21|||
37960569|NCT00426556|69647949|FG000|Phase II - Extension Phase|Adverse Event|0|||
37960570|NCT00426556|69647950|FG001|Phase II - Extension Phase|Adverse Event|0|||
37960571|NCT00426556|69647951|FG002|Phase II - Extension Phase|Adverse Event|0|||
37960572|NCT00426556|69647952|FG003|Phase II - Extension Phase|Adverse Event|2|||
37960573|NCT00107653|69647964|FG000|Overall Study|Adverse Event|24|||
37960574|NCT00107653|69647965|FG001|Overall Study|Adverse Event|43|||
37960575|NCT00107653|69647964|FG000|Overall Study|Insufficient Therapeutic Response|25|||
37960576|NCT00107653|69647965|FG001|Overall Study|Insufficient Therapeutic Response|11|||
37960577|NCT00107653|69647964|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
37960578|NCT00107653|69647965|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
37960579|NCT00107653|69647964|FG000|Overall Study|Protocol Violation|1|||
37960580|NCT00107653|69647965|FG001|Overall Study|Protocol Violation|0|||
37960581|NCT00107653|69647964|FG000|Overall Study|Withdrawal by Subject|12|||
37960582|NCT00107653|69647965|FG001|Overall Study|Withdrawal by Subject|13|||
37960583|NCT00107653|69647964|FG000|Overall Study|Lost to Follow-up|13|||
37960584|NCT00107653|69647965|FG001|Overall Study|Lost to Follow-up|5|||
37960585|NCT00107653|69647964|FG000|Overall Study|Administrative Reasons|3|||
37960586|NCT00107653|69647965|FG001|Overall Study|Administrative Reasons|3|||
37960587|NCT03950856|69647975|FG000|Overall Study|Death|1|||
37960588|NCT03950856|69647976|FG001|Overall Study|Death|2|||
37960589|NCT03950856|69647977|FG002|Overall Study|Death|0|||
37960590|NCT03950856|69647978|FG003|Overall Study|Death|0|||
37960591|NCT03950856|69647975|FG000|Overall Study|Lost to Follow-up|5|||
37960592|NCT03950856|69647976|FG001|Overall Study|Lost to Follow-up|6|||
37960593|NCT03950856|69647977|FG002|Overall Study|Lost to Follow-up|8|||
37960594|NCT03950856|69647978|FG003|Overall Study|Lost to Follow-up|2|||
37960595|NCT03950856|69647975|FG000|Overall Study|Protocol Violation|2|||
38051467|NCT03083990|69740667|FG000|Overall Study|Adverse Event|1|||
38051468|NCT03083990|69740668|FG001|Overall Study|Adverse Event|0|||
38051469|NCT03252015|69740686|FG000|Overall Study|Withdrawal by Subject|0|||
38051470|NCT03252015|69740687|FG001|Overall Study|Withdrawal by Subject|1|||
38051471|NCT03252015|69740688|FG002|Overall Study|Withdrawal by Subject|1|||
38051472|NCT03252015|69740689|FG003|Overall Study|Withdrawal by Subject|0|||
38051473|NCT03252015|69740686|FG000|Overall Study|Adverse Event|1|||
38051474|NCT03252015|69740687|FG001|Overall Study|Adverse Event|0|||
38051475|NCT03252015|69740688|FG002|Overall Study|Adverse Event|0|||
38051476|NCT03252015|69740689|FG003|Overall Study|Adverse Event|1|||
38051477|NCT03083132|69740715|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
38051478|NCT03083132|69740716|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
37960596|NCT03950856|69647976|FG001|Overall Study|Protocol Violation|0|||
38051479|NCT03083132|69740715|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
38051480|NCT03083132|69740716|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
38051481|NCT03083132|69740715|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
37960597|NCT03950856|69647977|FG002|Overall Study|Protocol Violation|0|||
37960598|NCT03950856|69647978|FG003|Overall Study|Protocol Violation|1|||
37960599|NCT03950856|69647975|FG000|Overall Study|Withdrawal by Subject|4|||
37960600|NCT03950856|69647976|FG001|Overall Study|Withdrawal by Subject|1|||
38051482|NCT03083132|69740716|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
38051483|NCT03683823|69740724|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
38051484|NCT03683823|69740725|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
37960601|NCT03950856|69647977|FG002|Overall Study|Withdrawal by Subject|3|||
37960602|NCT03950856|69647978|FG003|Overall Study|Withdrawal by Subject|1|||
37960603|NCT03950856|69647975|FG000|Overall Study|Unable to phone|7|||
37960604|NCT03950856|69647976|FG001|Overall Study|Unable to phone|6|||
37960605|NCT03950856|69647977|FG002|Overall Study|Unable to phone|7|||
37960606|NCT03950856|69647978|FG003|Overall Study|Unable to phone|2|||
37960607|NCT00433654|69647992|FG000|Overall Study|Death|4|||
37960608|NCT00433654|69647993|FG001|Overall Study|Death|0|||
37960609|NCT00433654|69647992|FG000|Overall Study|Missed visit|6|||
37960610|NCT00433654|69647993|FG001|Overall Study|Missed visit|3|||
37960611|NCT00433654|69647992|FG000|Overall Study|Subject not yet due for visit|4|||
37960612|NCT00433654|69647993|FG001|Overall Study|Subject not yet due for visit|0|||
37960613|NCT00433654|69647992|FG000|Overall Study|Withdrawal by Subject|1|||
37960614|NCT00433654|69647993|FG001|Overall Study|Withdrawal by Subject|2|||
37960615|NCT00689351|69648007|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
37960616|NCT00689351|69648008|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
37960617|NCT00689351|69648007|FG000|Infant Series of Dosing|Adverse Event|1|||
37960618|NCT00689351|69648008|FG001|Infant Series of Dosing|Adverse Event|0|||
37960619|NCT00689351|69648007|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
37960620|NCT00689351|69648008|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
37960621|NCT00689351|69648007|FG000|After Infant Series|Parent/legal guardian request|1|||
37960622|NCT00689351|69648008|FG001|After Infant Series|Parent/legal guardian request|0|||
37960623|NCT03950622|69648020|FG000|Overall Study|Withdrawal by Subject|1|||
37960624|NCT03950622|69648021|FG001|Overall Study|Withdrawal by Subject|0|||
37960625|NCT03950622|69648020|FG000|Overall Study|Protocol Deviation|0|||
37960626|NCT03950622|69648021|FG001|Overall Study|Protocol Deviation|1|||
37960627|NCT03950622|69648020|FG000|Overall Study|Physician Decision|1|||
37960628|NCT03950622|69648021|FG001|Overall Study|Physician Decision|0|||
37960629|NCT03950622|69648020|FG000|Overall Study|Lost to Follow-up|5|||
37960630|NCT03950622|69648021|FG001|Overall Study|Lost to Follow-up|5|||
37960631|NCT03950622|69648020|FG000|Overall Study|Death|1|||
37960632|NCT03950622|69648021|FG001|Overall Study|Death|1|||
37960633|NCT03937908|69648027|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
37960634|NCT03937908|69648028|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
37960635|NCT00689273|69648036|FG000|Overall Study|Adverse Event|3|||
37960636|NCT00689273|69648037|FG001|Overall Study|Adverse Event|1|||
37960637|NCT00689273|69648036|FG000|Overall Study|Lack of Efficacy|3|||
37960638|NCT00689273|69648037|FG001|Overall Study|Lack of Efficacy|0|||
37960639|NCT00689273|69648036|FG000|Overall Study|Lost to Follow-up|0|||
37960640|NCT00689273|69648037|FG001|Overall Study|Lost to Follow-up|2|||
37960641|NCT00689273|69648036|FG000|Overall Study|Other|6|||
37960642|NCT00689273|69648037|FG001|Overall Study|Other|2|||
37960643|NCT00689273|69648036|FG000|Overall Study|Randomized but not Treated|1|||
37960644|NCT00689273|69648037|FG001|Overall Study|Randomized but not Treated|0|||
37960645|NCT00553358|69648046|FG000|Overall Study|Randomized but did not receive treatment|3|||
37960646|NCT00553358|69648047|FG001|Overall Study|Randomized but did not receive treatment|3|||
37960647|NCT00553358|69648048|FG002|Overall Study|Randomized but did not receive treatment|1|||
37960648|NCT00553358|69648046|FG000|Overall Study|Lost to Follow-up|22|||
37960649|NCT00553358|69648047|FG001|Overall Study|Lost to Follow-up|26|||
37960650|NCT00553358|69648048|FG002|Overall Study|Lost to Follow-up|18|||
37960651|NCT00553358|69648046|FG000|Overall Study|Withdrew completely|23|||
37960652|NCT00553358|69648047|FG001|Overall Study|Withdrew completely|33|||
37960653|NCT00553358|69648048|FG002|Overall Study|Withdrew completely|34|||
37960654|NCT00553358|69648046|FG000|Overall Study|Died during clinical follow-up|25|||
37960655|NCT00553358|69648047|FG001|Overall Study|Died during clinical follow-up|29|||
37960656|NCT00553358|69648048|FG002|Overall Study|Died during clinical follow-up|32|||
37960657|NCT00553358|69648046|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
37960658|NCT00553358|69648047|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
37960659|NCT00553358|69648048|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
37960660|NCT00553358|69648046|FG000|Overall Study|Died after clinical follow-up ended|1|||
37960661|NCT00553358|69648047|FG001|Overall Study|Died after clinical follow-up ended|2|||
37960662|NCT00553358|69648048|FG002|Overall Study|Died after clinical follow-up ended|0|||
37960663|NCT00553358|69648046|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
37960664|NCT00553358|69648047|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
37960665|NCT00553358|69648048|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
37960666|NCT00688259|69648064|FG000|Overall Study|Lost to Follow-up|2|||
37960667|NCT00688259|69648065|FG001|Overall Study|Lost to Follow-up|4|||
37960668|NCT00688259|69648064|FG000|Overall Study|Physician Decision|1|||
37960669|NCT00688259|69648065|FG001|Overall Study|Physician Decision|0|||
37960670|NCT00688259|69648064|FG000|Overall Study|Withdrawal by Subject|2|||
37960671|NCT00688259|69648065|FG001|Overall Study|Withdrawal by Subject|0|||
37960672|NCT00688259|69648064|FG000|Overall Study|Declined Interview|2|||
37960673|NCT00688259|69648065|FG001|Overall Study|Declined Interview|3|||
37960674|NCT00688259|69648064|FG000|Overall Study|Hospitalized at Follow-up|0|||
37960675|NCT00688259|69648065|FG001|Overall Study|Hospitalized at Follow-up|1|||
37960676|NCT00688181|69648071|FG000|Overall Study|Lost to Follow-up|17|||
37960677|NCT00688181|69648071|FG000|Overall Study|Unknown Reason|4|||
37960678|NCT00688181|69648071|FG000|Overall Study|Non-clinical Reason|2|||
37960679|NCT00689117|69648090|FG000|Overall Study|Adverse Event|6|||
37960680|NCT00689117|69648091|FG001|Overall Study|Adverse Event|0|||
37960681|NCT00689117|69648092|FG002|Overall Study|Adverse Event|5|||
37960682|NCT00689117|69648093|FG003|Overall Study|Adverse Event|0|||
37960683|NCT00689117|69648090|FG000|Overall Study|Lost to Follow-up|26|||
37960684|NCT00689117|69648091|FG001|Overall Study|Lost to Follow-up|19|||
37960685|NCT00689117|69648092|FG002|Overall Study|Lost to Follow-up|17|||
37960686|NCT00689117|69648093|FG003|Overall Study|Lost to Follow-up|11|||
37960687|NCT00689117|69648090|FG000|Overall Study|Lack of Efficacy|1|||
37960688|NCT00689117|69648091|FG001|Overall Study|Lack of Efficacy|2|||
37960689|NCT00689117|69648092|FG002|Overall Study|Lack of Efficacy|2|||
37960690|NCT00689117|69648093|FG003|Overall Study|Lack of Efficacy|2|||
37960691|NCT00689117|69648090|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
37960692|NCT00689117|69648091|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
37960693|NCT00689117|69648092|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
37960694|NCT00689117|69648093|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
37960695|NCT00689117|69648090|FG000|Overall Study|Withdrawal by Subject|19|||
37960696|NCT00689117|69648091|FG001|Overall Study|Withdrawal by Subject|18|||
37960697|NCT00689117|69648092|FG002|Overall Study|Withdrawal by Subject|26|||
37960698|NCT00689117|69648093|FG003|Overall Study|Withdrawal by Subject|13|||
37960699|NCT00689117|69648090|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
37960700|NCT00689117|69648091|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
37960701|NCT00689117|69648092|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
37960702|NCT00689117|69648093|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
37960703|NCT00689117|69648090|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
37960704|NCT00689117|69648091|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
37960705|NCT00689117|69648092|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
37960706|NCT00689117|69648093|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
37960707|NCT00689117|69648090|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
37960708|NCT00689117|69648091|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
37960709|NCT00689117|69648092|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
37960710|NCT00689117|69648093|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
37960711|NCT00689117|69648090|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
37960712|NCT00689117|69648091|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
37960713|NCT00689117|69648092|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
37960714|NCT00689117|69648093|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
37960715|NCT00689117|69648090|FG000|Overall Study|Use of Prohibitive Medication|2|||
37960716|NCT00689117|69648091|FG001|Overall Study|Use of Prohibitive Medication|1|||
37960717|NCT00689117|69648092|FG002|Overall Study|Use of Prohibitive Medication|3|||
37960718|NCT00689117|69648093|FG003|Overall Study|Use of Prohibitive Medication|0|||
37960719|NCT00689117|69648090|FG000|Overall Study|Pregnancy|0|||
37960720|NCT00689117|69648091|FG001|Overall Study|Pregnancy|2|||
37960721|NCT00689117|69648092|FG002|Overall Study|Pregnancy|0|||
37960722|NCT00689117|69648093|FG003|Overall Study|Pregnancy|2|||
37960723|NCT00689117|69648090|FG000|Overall Study|Incarceration|2|||
37960724|NCT00689117|69648091|FG001|Overall Study|Incarceration|0|||
37960725|NCT00689117|69648092|FG002|Overall Study|Incarceration|0|||
37960726|NCT00689117|69648093|FG003|Overall Study|Incarceration|0|||
37960727|NCT00689117|69648090|FG000|Overall Study|Fear of Birth Defects|0|||
37960728|NCT00689117|69648091|FG001|Overall Study|Fear of Birth Defects|0|||
37960729|NCT00689117|69648092|FG002|Overall Study|Fear of Birth Defects|1|||
37960730|NCT00689117|69648093|FG003|Overall Study|Fear of Birth Defects|0|||
37960731|NCT00689117|69648090|FG000|Overall Study|Transportation|1|||
37960732|NCT00689117|69648091|FG001|Overall Study|Transportation|0|||
37960733|NCT00689117|69648092|FG002|Overall Study|Transportation|0|||
37960734|NCT00689117|69648093|FG003|Overall Study|Transportation|0|||
37960735|NCT00689117|69648090|FG000|Overall Study|Patient Withdrew from Study|0|||
37960736|NCT00689117|69648091|FG001|Overall Study|Patient Withdrew from Study|0|||
37960737|NCT00689117|69648092|FG002|Overall Study|Patient Withdrew from Study|0|||
37960738|NCT00689117|69648093|FG003|Overall Study|Patient Withdrew from Study|1|||
37960739|NCT00689117|69648090|FG000|Overall Study|Personal Reason|0|||
37960740|NCT00689117|69648091|FG001|Overall Study|Personal Reason|1|||
37960741|NCT00689117|69648092|FG002|Overall Study|Personal Reason|0|||
37960742|NCT00689117|69648093|FG003|Overall Study|Personal Reason|0|||
37960743|NCT00689117|69648090|FG000|Overall Study|Dispensing Error|0|||
37960744|NCT00689117|69648091|FG001|Overall Study|Dispensing Error|1|||
37960745|NCT00689117|69648092|FG002|Overall Study|Dispensing Error|0|||
37960746|NCT00689117|69648093|FG003|Overall Study|Dispensing Error|0|||
37960747|NCT00547248|69648107|FG000|Overall Study|Protocol Violation|0|||
37960748|NCT00547248|69648108|FG001|Overall Study|Protocol Violation|0|||
37960749|NCT00547248|69648109|FG002|Overall Study|Protocol Violation|1|||
37960750|NCT00547248|69648110|FG003|Overall Study|Protocol Violation|1|||
37960751|NCT00547248|69648107|FG000|Overall Study|Migrated/moved from study area|0|||
37960752|NCT00547248|69648108|FG001|Overall Study|Migrated/moved from study area|0|||
37960753|NCT00547248|69648109|FG002|Overall Study|Migrated/moved from study area|2|||
37960754|NCT00547248|69648110|FG003|Overall Study|Migrated/moved from study area|0|||
37960755|NCT00547248|69648107|FG000|Overall Study|Withdrawal by Subject|0|||
37960756|NCT00547248|69648108|FG001|Overall Study|Withdrawal by Subject|0|||
37960757|NCT00547248|69648109|FG002|Overall Study|Withdrawal by Subject|7|||
37960758|NCT00547248|69648110|FG003|Overall Study|Withdrawal by Subject|1|||
37960759|NCT00688103|69648125|FG000|Overall Study|Adverse Event|4|||
37960760|NCT00688103|69648126|FG001|Overall Study|Adverse Event|1|||
37960761|NCT00688103|69648125|FG000|Overall Study|Lack of Efficacy|11|||
37960762|NCT00688103|69648126|FG001|Overall Study|Lack of Efficacy|1|||
37960763|NCT00688103|69648125|FG000|Overall Study|Withdrawal by Subject|4|||
37960764|NCT00688103|69648126|FG001|Overall Study|Withdrawal by Subject|2|||
37960765|NCT00688103|69648125|FG000|Overall Study|complex reasons|11|||
37960766|NCT00688103|69648126|FG001|Overall Study|complex reasons|9|||
37960767|NCT00686855|69648136|FG000|Overall Study|Lost to Follow-up|1|||
37960768|NCT00686855|69648137|FG001|Overall Study|Lost to Follow-up|0|||
37960769|NCT00686855|69648136|FG000|Overall Study|Progressive GVHD|0|||
37960770|NCT00686855|69648137|FG001|Overall Study|Progressive GVHD|1|||
37960771|NCT00686777|69648143|FG000|Overall Study|Adverse Event|2|||
37960772|NCT00686777|69648143|FG000|Overall Study|Pregnancy|1|||
37960773|NCT00686777|69648143|FG000|Overall Study|Withdrawal by Subject|2|||
37960774|NCT00686777|69648143|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
37960775|NCT00686777|69648143|FG000|Overall Study|No Visit|1|||
37960776|NCT00686699|69648149|FG000|Treatment Period 1|Adverse Event|0|||
37960777|NCT00686699|69648150|FG001|Treatment Period 1|Adverse Event|2|||
37960778|NCT00106639|69648159|FG000|Overall Study|Adverse Event|3|||
37960779|NCT00106639|69648160|FG001|Overall Study|Adverse Event|4|||
37960780|NCT00106639|69648161|FG002|Overall Study|Adverse Event|1|||
37960781|NCT00106639|69648159|FG000|Overall Study|Protocol Violation|0|||
37960782|NCT00106639|69648160|FG001|Overall Study|Protocol Violation|1|||
37960783|NCT00106639|69648161|FG002|Overall Study|Protocol Violation|0|||
37960784|NCT00106639|69648159|FG000|Overall Study|Withdrawal by Subject|0|||
37960785|NCT00106639|69648160|FG001|Overall Study|Withdrawal by Subject|1|||
37960786|NCT00106639|69648161|FG002|Overall Study|Withdrawal by Subject|0|||
37960787|NCT00106639|69648159|FG000|Overall Study|Participant defaulted|0|||
37960788|NCT00106639|69648160|FG001|Overall Study|Participant defaulted|1|||
37960789|NCT00106639|69648161|FG002|Overall Study|Participant defaulted|1|||
37960790|NCT00106249|69648172|FG000|Overall Study|Lost to Follow-up|3|||
37960791|NCT00106249|69648173|FG001|Overall Study|Lost to Follow-up|2|||
37960792|NCT00105469|69648181|FG000|Overall Study|Adverse Event|9|||
37960793|NCT00105469|69648182|FG001|Overall Study|Adverse Event|8|||
37960794|NCT00105469|69648181|FG000|Overall Study|Protocol Violation|4|||
37960795|NCT00105469|69648182|FG001|Overall Study|Protocol Violation|0|||
37960796|NCT00105469|69648181|FG000|Overall Study|Withdrawal by Subject|2|||
37960797|NCT00105469|69648182|FG001|Overall Study|Withdrawal by Subject|3|||
37960798|NCT00105469|69648181|FG000|Overall Study|Lost to Follow-up|1|||
37960799|NCT00105469|69648182|FG001|Overall Study|Lost to Follow-up|0|||
37960800|NCT00105469|69648181|FG000|Overall Study|Lack of Efficacy|2|||
37960801|NCT00105469|69648182|FG001|Overall Study|Lack of Efficacy|0|||
37960802|NCT00105469|69648181|FG000|Overall Study|Other Reason|4|||
37960803|NCT00105469|69648182|FG001|Overall Study|Other Reason|0|||
37960804|NCT00105235|69648188|FG000|Overall Study|Death|4|||
37960805|NCT00105235|69648188|FG000|Overall Study|Physician Decision|1|||
37960806|NCT00105235|69648188|FG000|Overall Study|Withdrawal by Subject|2|||
37960807|NCT00547118|69648198|FG000|Overall Study|Did not qualify prior to starting drug|1|||
37960808|NCT00547118|69648199|FG001|Overall Study|Did not qualify prior to starting drug|1|||
37960809|NCT00547118|69648198|FG000|Overall Study|Study suspended|7|||
37960810|NCT00547118|69648199|FG001|Overall Study|Study suspended|8|||
37960811|NCT00502593|69648219|FG000|Overall Study|Withdrawn unspecified reason|1|||
37960812|NCT00502593|69648220|FG001|Overall Study|Withdrawn unspecified reason|1|||
37960813|NCT00502593|69648221|FG002|Overall Study|Withdrawn unspecified reason|3|||
37960814|NCT00502593|69648222|FG003|Overall Study|Withdrawn unspecified reason|1|||
37960815|NCT00502593|69648223|FG004|Overall Study|Withdrawn unspecified reason|2|||
37960816|NCT00502593|69648224|FG005|Overall Study|Withdrawn unspecified reason|0|||
37960817|NCT00502593|69648225|FG006|Overall Study|Withdrawn unspecified reason|2|||
37960818|NCT00502593|69648226|FG007|Overall Study|Withdrawn unspecified reason|0|||
37960819|NCT00502593|69648227|FG008|Overall Study|Withdrawn unspecified reason|0|||
37960820|NCT00502593|69648228|FG009|Overall Study|Withdrawn unspecified reason|0|||
37960821|NCT00502593|69648229|FG010|Overall Study|Withdrawn unspecified reason|0|||
37960822|NCT00502593|69648230|FG011|Overall Study|Withdrawn unspecified reason|0|||
37960823|NCT00502593|69648219|FG000|Overall Study|Withdrawal by Subject|0|||
37960824|NCT00502593|69648220|FG001|Overall Study|Withdrawal by Subject|0|||
37960825|NCT00502593|69648221|FG002|Overall Study|Withdrawal by Subject|6|||
37960826|NCT00502593|69648222|FG003|Overall Study|Withdrawal by Subject|2|||
37960827|NCT00502593|69648223|FG004|Overall Study|Withdrawal by Subject|2|||
37960828|NCT00502593|69648224|FG005|Overall Study|Withdrawal by Subject|0|||
37960829|NCT00502593|69648225|FG006|Overall Study|Withdrawal by Subject|3|||
37960830|NCT00502593|69648226|FG007|Overall Study|Withdrawal by Subject|0|||
37960831|NCT00502593|69648227|FG008|Overall Study|Withdrawal by Subject|3|||
37960832|NCT00502593|69648228|FG009|Overall Study|Withdrawal by Subject|0|||
37960833|NCT00502593|69648229|FG010|Overall Study|Withdrawal by Subject|1|||
37960834|NCT00502593|69648230|FG011|Overall Study|Withdrawal by Subject|0|||
37960835|NCT00502593|69648219|FG000|Overall Study|Lost to Follow-up|2|||
37960836|NCT00502593|69648220|FG001|Overall Study|Lost to Follow-up|1|||
37960837|NCT00502593|69648221|FG002|Overall Study|Lost to Follow-up|1|||
37960838|NCT00502593|69648222|FG003|Overall Study|Lost to Follow-up|1|||
37960839|NCT00502593|69648223|FG004|Overall Study|Lost to Follow-up|0|||
37960840|NCT00502593|69648224|FG005|Overall Study|Lost to Follow-up|0|||
37960841|NCT00502593|69648225|FG006|Overall Study|Lost to Follow-up|0|||
37960842|NCT00502593|69648226|FG007|Overall Study|Lost to Follow-up|0|||
37960843|NCT00502593|69648227|FG008|Overall Study|Lost to Follow-up|3|||
37960844|NCT00502593|69648228|FG009|Overall Study|Lost to Follow-up|0|||
37960845|NCT00502593|69648229|FG010|Overall Study|Lost to Follow-up|1|||
37960846|NCT00502593|69648230|FG011|Overall Study|Lost to Follow-up|0|||
37960847|NCT00686543|69648283|FG000|Overall Study|Adverse Event|9|||
37960848|NCT00686543|69648284|FG001|Overall Study|Adverse Event|1|||
37960849|NCT00686543|69648285|FG002|Overall Study|Adverse Event|3|||
37960850|NCT00686543|69648286|FG003|Overall Study|Adverse Event|2|||
37960851|NCT00686543|69648283|FG000|Overall Study|Withdrawal by Subject|2|||
37960852|NCT00686543|69648284|FG001|Overall Study|Withdrawal by Subject|0|||
37960853|NCT00686543|69648285|FG002|Overall Study|Withdrawal by Subject|0|||
37960854|NCT00686543|69648286|FG003|Overall Study|Withdrawal by Subject|0|||
37960855|NCT00686543|69648283|FG000|Overall Study|Protocol Violation|3|||
37960856|NCT00686543|69648284|FG001|Overall Study|Protocol Violation|0|||
37960857|NCT00686543|69648285|FG002|Overall Study|Protocol Violation|2|||
37960858|NCT00686543|69648286|FG003|Overall Study|Protocol Violation|1|||
37960859|NCT00545688|69648300|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
37960860|NCT00545688|69648301|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
37960861|NCT00545688|69648302|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
37960862|NCT00545688|69648303|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
37960863|NCT00545688|69648300|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
37960864|NCT00545688|69648301|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
37960865|NCT00545688|69648302|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
37960866|NCT00545688|69648303|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
37960867|NCT00545688|69648300|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
37960868|NCT00545688|69648301|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
37960869|NCT00545688|69648302|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
37960870|NCT00545688|69648303|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
37960871|NCT00545688|69648300|FG000|Neo-Adjuvant Treatment Period|Death|0|||
37960872|NCT00545688|69648301|FG001|Neo-Adjuvant Treatment Period|Death|1|||
37960873|NCT00545688|69648302|FG002|Neo-Adjuvant Treatment Period|Death|0|||
37960874|NCT00545688|69648303|FG003|Neo-Adjuvant Treatment Period|Death|0|||
37960875|NCT00545688|69648300|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
37960876|NCT00545688|69648301|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
37960877|NCT00545688|69648302|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
37960878|NCT00545688|69648303|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
37960879|NCT00545688|69648300|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
37960880|NCT00545688|69648301|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
37960881|NCT00545688|69648302|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
37960882|NCT00545688|69648303|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
37960883|NCT00545688|69648300|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
37960884|NCT00545688|69648301|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
37960885|NCT00545688|69648302|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
37960886|NCT00545688|69648303|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
37960887|NCT00545688|69648300|FG000|Adjuvant Treatment Period|Disease Progression|3|||
37960888|NCT00545688|69648301|FG001|Adjuvant Treatment Period|Disease Progression|3|||
37960889|NCT00545688|69648302|FG002|Adjuvant Treatment Period|Disease Progression|0|||
37960890|NCT00545688|69648303|FG003|Adjuvant Treatment Period|Disease Progression|7|||
37960891|NCT00545688|69648300|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
37960892|NCT00545688|69648301|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
37960893|NCT00545688|69648302|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
37960894|NCT00545688|69648303|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
37960895|NCT00545688|69648300|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
37960896|NCT00545688|69648301|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
37960897|NCT00545688|69648302|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
37960898|NCT00545688|69648303|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
37960899|NCT00545688|69648300|FG000|Adjuvant Treatment Period|Adverse Event|0|||
37960900|NCT00545688|69648301|FG001|Adjuvant Treatment Period|Adverse Event|3|||
37960901|NCT00545688|69648302|FG002|Adjuvant Treatment Period|Adverse Event|2|||
37960902|NCT00545688|69648303|FG003|Adjuvant Treatment Period|Adverse Event|2|||
37960903|NCT00545688|69648300|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
37960904|NCT00545688|69648301|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
37960905|NCT00545688|69648302|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
37960906|NCT00545688|69648303|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
37960907|NCT00545688|69648300|FG000|Follow-Up Period|Death|4|||
37960908|NCT00545688|69648301|FG001|Follow-Up Period|Death|2|||
37960909|NCT00545688|69648302|FG002|Follow-Up Period|Death|2|||
37960910|NCT00545688|69648303|FG003|Follow-Up Period|Death|6|||
37960911|NCT00545688|69648300|FG000|Follow-Up Period|Disease Progression|6|||
37960912|NCT00545688|69648301|FG001|Follow-Up Period|Disease Progression|5|||
37960913|NCT00545688|69648302|FG002|Follow-Up Period|Disease Progression|9|||
37960914|NCT00545688|69648303|FG003|Follow-Up Period|Disease Progression|9|||
37960915|NCT00545688|69648300|FG000|Follow-Up Period|Refused Treatment|6|||
38051485|NCT03683823|69740724|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
37960916|NCT00545688|69648301|FG001|Follow-Up Period|Refused Treatment|2|||
37960917|NCT00545688|69648302|FG002|Follow-Up Period|Refused Treatment|0|||
37960918|NCT00545688|69648303|FG003|Follow-Up Period|Refused Treatment|2|||
37960919|NCT00545688|69648300|FG000|Follow-Up Period|Lost to Follow-up|3|||
37960920|NCT00545688|69648301|FG001|Follow-Up Period|Lost to Follow-up|3|||
37960921|NCT00545688|69648302|FG002|Follow-Up Period|Lost to Follow-up|3|||
37960922|NCT00545688|69648303|FG003|Follow-Up Period|Lost to Follow-up|1|||
37960923|NCT00545688|69648300|FG000|Follow-Up Period|Unspecified Reason|2|||
37960924|NCT00545688|69648301|FG001|Follow-Up Period|Unspecified Reason|5|||
37960925|NCT00545688|69648302|FG002|Follow-Up Period|Unspecified Reason|6|||
37960926|NCT00545688|69648303|FG003|Follow-Up Period|Unspecified Reason|8|||
37960927|NCT00545688|69648300|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
37960928|NCT00545688|69648301|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
37960929|NCT00545688|69648302|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
37960930|NCT00545688|69648303|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
37960931|NCT00502203|69648316|FG000|Overall Study|Inevaluable|1|||
37960932|NCT00546078|69648322|FG000|Overall Study|Lost to Follow-up|1|||
37960933|NCT00546078|69648323|FG001|Overall Study|Lost to Follow-up|3|||
37960934|NCT00546078|69648322|FG000|Overall Study|Withdrawal by Subject|2|||
37960935|NCT00546078|69648323|FG001|Overall Study|Withdrawal by Subject|3|||
37960936|NCT00546078|69648322|FG000|Overall Study|Other reason|1|||
37960937|NCT00546078|69648323|FG001|Overall Study|Other reason|1|||
37960938|NCT00546000|69648329|FG000|Overall Study|Adverse Event|1|||
37960939|NCT00546000|69648329|FG000|Overall Study|Lost to Follow-up|1|||
37960940|NCT00546000|69648329|FG000|Overall Study|Baseline HPA Axis Supression|2|||
37960941|NCT00501969|69648333|FG000|Overall Study|Major Protocol Violation|4|||
37960942|NCT00501969|69648333|FG000|Overall Study|Lack of Efficacy|29|||
37960943|NCT00501969|69648333|FG000|Overall Study|Adverse Event|76|||
37960944|NCT00501969|69648333|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
37960945|NCT00501969|69648333|FG000|Overall Study|Subject withdrew consent|51|||
37960946|NCT00501969|69648333|FG000|Overall Study|Lost to Follow-up|4|||
37960947|NCT00501969|69648333|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
37960948|NCT00501969|69648333|FG000|Overall Study|Other: Sponsors Request|10|||
37960949|NCT00501969|69648333|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
37960950|NCT00501969|69648333|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
37960951|NCT00501969|69648333|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
37960952|NCT00501969|69648333|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
37960953|NCT00501969|69648333|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
37960954|NCT00501969|69648333|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
37960955|NCT00501969|69648333|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
37960956|NCT00501969|69648333|FG000|Overall Study|Other: As Required by Local EC|2|||
37960957|NCT00501969|69648333|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
37960958|NCT00501969|69648333|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
38051486|NCT03683823|69740725|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
38051487|NCT03683823|69740724|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
38051488|NCT03683823|69740725|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
38051489|NCT03285711|69740733|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
38051490|NCT03285711|69740734|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
38051491|NCT03285711|69740735|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
38051492|NCT03285711|69740736|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
37680333|NCT02399163|69155909|FG000|Overall Study|Protocol Deviation|2|||
37680334|NCT02399163|69155909|FG000|Overall Study|Withdrawal by Participant|5|||
37960959|NCT03942042|69648339|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
37960960|NCT03942042|69648340|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
37960961|NCT03942042|69648339|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
37960962|NCT03942042|69648340|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
37960963|NCT00104299|69648352|FG000|Overall Study|Adverse Event|3|||
37960964|NCT00104299|69648353|FG001|Overall Study|Adverse Event|1|||
37960965|NCT00104299|69648352|FG000|Overall Study|Death|2|||
37960966|NCT00104299|69648353|FG001|Overall Study|Death|2|||
37960967|NCT00104299|69648352|FG000|Overall Study|Withdrawal by Subject|2|||
37960968|NCT00104299|69648353|FG001|Overall Study|Withdrawal by Subject|6|||
37960969|NCT00104299|69648352|FG000|Overall Study|Physician Decision|1|||
37960970|NCT00104299|69648353|FG001|Overall Study|Physician Decision|1|||
37960971|NCT00104299|69648352|FG000|Overall Study|To have renal transplant|1|||
37960972|NCT00104299|69648353|FG001|Overall Study|To have renal transplant|0|||
37960973|NCT03939312|69648359|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
37960974|NCT03939312|69648359|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
37960975|NCT03939312|69648359|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
37960976|NCT03939312|69648359|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
37960977|NCT03939312|69648359|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
37960978|NCT03939312|69648359|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
37960979|NCT03939312|69648359|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
37960980|NCT03939312|69648359|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
37960981|NCT03939312|69648359|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
37960982|NCT03939312|69648359|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
37960983|NCT03939312|69648359|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
37960984|NCT03939312|69648359|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
37960985|NCT00082381|69648367|FG000|Overall Study|Adverse Event|27|||
37960986|NCT00082381|69648368|FG001|Overall Study|Adverse Event|2|||
37960987|NCT00082381|69648367|FG000|Overall Study|Lost to Follow-up|5|||
37960988|NCT00082381|69648368|FG001|Overall Study|Lost to Follow-up|7|||
37960989|NCT00082381|69648367|FG000|Overall Study|Patient Decision|8|||
37960990|NCT00082381|69648368|FG001|Overall Study|Patient Decision|4|||
37960991|NCT00082381|69648367|FG000|Overall Study|Physician Decision|1|||
37960992|NCT00082381|69648368|FG001|Overall Study|Physician Decision|2|||
37960993|NCT00082381|69648367|FG000|Overall Study|Protocol Violation|10|||
37960994|NCT00082381|69648368|FG001|Overall Study|Protocol Violation|11|||
37960995|NCT00082381|69648367|FG000|Overall Study|Loss of Glucose Control|4|||
37960996|NCT00082381|69648368|FG001|Overall Study|Loss of Glucose Control|0|||
37960997|NCT00545844|69648374|FG000|Overall Study|Lost to Follow-up|9|||
37960998|NCT00545844|69648374|FG000|Overall Study|Protocol Violation|1|||
37960999|NCT00545844|69648374|FG000|Overall Study|Withdrawal by Subject|2|||
37961000|NCT00492063|69648384|FG000|Overall Study|Death|0|||
37961001|NCT00492063|69648385|FG001|Overall Study|Death|0|||
37961002|NCT00492063|69648386|FG002|Overall Study|Death|1|||
37961003|NCT00492063|69648387|FG003|Overall Study|Death|2|||
37961004|NCT00492063|69648384|FG000|Overall Study|Withdrawal by Subject|4|||
37961005|NCT00492063|69648385|FG001|Overall Study|Withdrawal by Subject|3|||
37961006|NCT00492063|69648386|FG002|Overall Study|Withdrawal by Subject|5|||
37961007|NCT00492063|69648387|FG003|Overall Study|Withdrawal by Subject|4|||
37961008|NCT00492063|69648384|FG000|Overall Study|Lost to Follow-up|6|||
37961009|NCT00492063|69648385|FG001|Overall Study|Lost to Follow-up|11|||
37961010|NCT00492063|69648386|FG002|Overall Study|Lost to Follow-up|5|||
37961011|NCT00492063|69648387|FG003|Overall Study|Lost to Follow-up|3|||
37961012|NCT00492063|69648384|FG000|Overall Study|Protocol Violation|0|||
37961013|NCT00492063|69648385|FG001|Overall Study|Protocol Violation|0|||
37961014|NCT00492063|69648386|FG002|Overall Study|Protocol Violation|0|||
37961015|NCT00492063|69648387|FG003|Overall Study|Protocol Violation|1|||
37961016|NCT00093145|69648397|FG000|Overall Study|Unacceptable Toxicity Only|2|||
37961017|NCT00093145|69648397|FG000|Overall Study|Physician Decision|5|||
37961018|NCT00093145|69648397|FG000|Overall Study|Withdrawal by Subject|9|||
37961019|NCT00093145|69648397|FG000|Overall Study|Other|1|||
37961020|NCT00513357|69648403|FG000|Overall Study|did not receive allocated placebo|2|||
37961021|NCT00513357|69648404|FG001|Overall Study|did not receive allocated placebo|3|||
37961022|NCT00513357|69648403|FG000|Overall Study|Adverse Event|4|||
37961023|NCT00513357|69648404|FG001|Overall Study|Adverse Event|2|||
37961024|NCT00513357|69648403|FG000|Overall Study|Death|2|||
37961025|NCT00513357|69648404|FG001|Overall Study|Death|0|||
37961026|NCT00513357|69648403|FG000|Overall Study|Withdrawal by Subject|5|||
37961027|NCT00513357|69648404|FG001|Overall Study|Withdrawal by Subject|4|||
37961028|NCT00513357|69648403|FG000|Overall Study|Disease Progression|2|||
37961029|NCT00513357|69648404|FG001|Overall Study|Disease Progression|1|||
37961030|NCT03933462|69648410|FG000|Overall Study|Adverse Event|2|||
37961031|NCT03933462|69648411|FG001|Overall Study|Adverse Event|0|||
37961032|NCT03929562|69648419|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
37961033|NCT03929562|69648420|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
37961034|NCT03929562|69648419|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
37961035|NCT03929562|69648420|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
37961036|NCT03929562|69648419|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
37961037|NCT03929562|69648420|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
37961038|NCT00415636|69648434|FG000|Overall Study|Symptomatic deterioration|1|||
38051493|NCT03285711|69740733|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
37961039|NCT00415636|69648435|FG001|Overall Study|Symptomatic deterioration|0|||
37961040|NCT00415636|69648436|FG002|Overall Study|Symptomatic deterioration|1|||
37961041|NCT00415636|69648437|FG003|Overall Study|Symptomatic deterioration|2|||
37961042|NCT00415636|69648438|FG004|Overall Study|Symptomatic deterioration|0|||
37961043|NCT00415636|69648439|FG005|Overall Study|Symptomatic deterioration|1|||
37961044|NCT00415636|69648434|FG000|Overall Study|Adverse Event|0|||
37961045|NCT00415636|69648435|FG001|Overall Study|Adverse Event|0|||
37961046|NCT00415636|69648436|FG002|Overall Study|Adverse Event|0|||
37961047|NCT00415636|69648437|FG003|Overall Study|Adverse Event|1|||
37961048|NCT00415636|69648438|FG004|Overall Study|Adverse Event|1|||
37961049|NCT00415636|69648439|FG005|Overall Study|Adverse Event|0|||
37961050|NCT00415636|69648434|FG000|Overall Study|Withdrawal by Subject|0|||
37961051|NCT00415636|69648435|FG001|Overall Study|Withdrawal by Subject|0|||
37961052|NCT00415636|69648436|FG002|Overall Study|Withdrawal by Subject|0|||
37961053|NCT00415636|69648437|FG003|Overall Study|Withdrawal by Subject|0|||
37961054|NCT00415636|69648438|FG004|Overall Study|Withdrawal by Subject|1|||
37961055|NCT00415636|69648439|FG005|Overall Study|Withdrawal by Subject|0|||
37961056|NCT00415636|69648434|FG000|Overall Study|Disease progression|0|||
37961057|NCT00415636|69648435|FG001|Overall Study|Disease progression|0|||
37961058|NCT00415636|69648436|FG002|Overall Study|Disease progression|0|||
37961059|NCT00415636|69648437|FG003|Overall Study|Disease progression|3|||
37961060|NCT00415636|69648438|FG004|Overall Study|Disease progression|0|||
37961061|NCT00415636|69648439|FG005|Overall Study|Disease progression|1|||
37961062|NCT00425854|69648463|FG000|Overall Study|Progressive Disease|19|||
37961063|NCT00425854|69648464|FG001|Overall Study|Progressive Disease|12|||
37961064|NCT00425854|69648463|FG000|Overall Study|Dose reduction toxicity AE|8|||
37961065|NCT00425854|69648464|FG001|Overall Study|Dose reduction toxicity AE|7|||
37961066|NCT00425854|69648463|FG000|Overall Study|Other Adverse Event|2|||
37961067|NCT00425854|69648464|FG001|Overall Study|Other Adverse Event|2|||
37961068|NCT00425698|69648473|FG000|Overall Study|Adverse Event|3|||
37961069|NCT00425698|69648474|FG001|Overall Study|Adverse Event|1|||
37961070|NCT00425698|69648473|FG000|Overall Study|Withdrawal by Subject|0|||
37961071|NCT00425698|69648474|FG001|Overall Study|Withdrawal by Subject|1|||
37961072|NCT00425308|69648482|FG000|Overall Study|Adverse Event|2|||
37961073|NCT00425308|69648483|FG001|Overall Study|Adverse Event|1|||
37961074|NCT00425308|69648482|FG000|Overall Study|Withdrawal by Subject|1|||
37961075|NCT00425308|69648483|FG001|Overall Study|Withdrawal by Subject|0|||
37961076|NCT00425308|69648482|FG000|Overall Study|Death|1|||
37961077|NCT00425308|69648483|FG001|Overall Study|Death|0|||
37961078|NCT00545064|69648489|FG000|Overall Study|Lost to Follow-up|3|||
37961079|NCT00545064|69648489|FG000|Overall Study|Withdrawal by Subject|2|||
37961080|NCT00545064|69648489|FG000|Overall Study|did not complete course of treatment|1|||
37961081|NCT00545064|69648489|FG000|Overall Study|cancel all appointments, no rebooking|1|||
37961082|NCT00545064|69648489|FG000|Overall Study|inclement weather|1|||
37961083|NCT00432562|69648497|FG000|Overall Study|Death|3|||
37961084|NCT00432562|69648498|FG001|Overall Study|Death|0|||
37961085|NCT00432172|69648508|FG000|Overall Study|Physician Decision|0|||
37961086|NCT00432172|69648509|FG001|Overall Study|Physician Decision|0|||
37961087|NCT00432172|69648510|FG002|Overall Study|Physician Decision|2|||
37961088|NCT00432172|69648511|FG003|Overall Study|Physician Decision|0|||
37961089|NCT00432172|69648508|FG000|Overall Study|Adverse Event|4|||
37961090|NCT00432172|69648509|FG001|Overall Study|Adverse Event|2|||
37961091|NCT00432172|69648510|FG002|Overall Study|Adverse Event|4|||
37961092|NCT00432172|69648511|FG003|Overall Study|Adverse Event|3|||
37961093|NCT00432172|69648508|FG000|Overall Study|Disease progression|0|||
37961094|NCT00432172|69648509|FG001|Overall Study|Disease progression|2|||
37961095|NCT00432172|69648510|FG002|Overall Study|Disease progression|5|||
37961096|NCT00432172|69648511|FG003|Overall Study|Disease progression|1|||
37961097|NCT00432172|69648508|FG000|Overall Study|Withdrawal by Subject|0|||
37961098|NCT00432172|69648509|FG001|Overall Study|Withdrawal by Subject|1|||
37961099|NCT00432172|69648510|FG002|Overall Study|Withdrawal by Subject|0|||
37961100|NCT00432172|69648511|FG003|Overall Study|Withdrawal by Subject|2|||
37961101|NCT00432172|69648508|FG000|Overall Study|No treatment received|2|||
37961102|NCT00432172|69648509|FG001|Overall Study|No treatment received|2|||
37961103|NCT00432172|69648510|FG002|Overall Study|No treatment received|0|||
37961104|NCT00432172|69648511|FG003|Overall Study|No treatment received|1|||
37961105|NCT00415168|69648523|FG000|Overall Study|Death|26|||
37961106|NCT00415168|69648523|FG000|Overall Study|Lost to Follow-up|3|||
37961107|NCT00415168|69648523|FG000|Overall Study|Physician Decision|13|||
37961108|NCT00415168|69648523|FG000|Overall Study|Sponsor Decision|4|||
37961109|NCT00415168|69648523|FG000|Overall Study|Withdrawal by Subject|6|||
37961110|NCT00424762|69648529|FG000|Overall Study|Withdrawal by Subject|18|||
37961111|NCT00424762|69648530|FG001|Overall Study|Withdrawal by Subject|19|||
37961112|NCT00424762|69648529|FG000|Overall Study|Lost to Follow-up|2|||
37961113|NCT00424762|69648530|FG001|Overall Study|Lost to Follow-up|3|||
37961114|NCT00414544|69648536|FG000|Overall Study|Lost to Follow-up|14|||
37961115|NCT00414466|69648546|FG000|Overall Study|Adverse Event|0|||
37961116|NCT00414466|69648547|FG001|Overall Study|Adverse Event|0|||
37961117|NCT00414466|69648548|FG002|Overall Study|Adverse Event|1|||
37961118|NCT00414466|69648549|FG003|Overall Study|Adverse Event|1|||
37961119|NCT00414466|69648546|FG000|Overall Study|Lack of Efficacy|1|||
37961120|NCT00414466|69648547|FG001|Overall Study|Lack of Efficacy|0|||
37961121|NCT00414466|69648548|FG002|Overall Study|Lack of Efficacy|0|||
37961122|NCT00414466|69648549|FG003|Overall Study|Lack of Efficacy|0|||
37961123|NCT00414466|69648546|FG000|Overall Study|Withdrawn by Sponsor|1|||
37961124|NCT00414466|69648547|FG001|Overall Study|Withdrawn by Sponsor|0|||
37961125|NCT00414466|69648548|FG002|Overall Study|Withdrawn by Sponsor|0|||
37961126|NCT00414466|69648549|FG003|Overall Study|Withdrawn by Sponsor|0|||
37961127|NCT00424528|69648565|FG000|Overall Study|Adverse Event|2|||
37961128|NCT00424528|69648566|FG001|Overall Study|Adverse Event|1|||
37961129|NCT00424528|69648567|FG002|Overall Study|Adverse Event|2|||
37961130|NCT00424528|69648565|FG000|Overall Study|Protocol Violation|1|||
37961131|NCT00424528|69648566|FG001|Overall Study|Protocol Violation|1|||
37961132|NCT00424528|69648567|FG002|Overall Study|Protocol Violation|0|||
37961133|NCT00424528|69648565|FG000|Overall Study|Lost to Follow-up|0|||
37961134|NCT00424528|69648566|FG001|Overall Study|Lost to Follow-up|1|||
37961135|NCT00424528|69648567|FG002|Overall Study|Lost to Follow-up|0|||
37961136|NCT00424528|69648565|FG000|Overall Study|noncompliance with study requirements|2|||
37961137|NCT00424528|69648566|FG001|Overall Study|noncompliance with study requirements|1|||
37961138|NCT00424528|69648567|FG002|Overall Study|noncompliance with study requirements|2|||
37961139|NCT00545532|69648577|FG000|Overall Study|Withdrawal by Subject|1|||
37961140|NCT00545532|69648578|FG001|Overall Study|Withdrawal by Subject|3|||
37961141|NCT00545532|69648577|FG000|Overall Study|Lost to Follow-up|5|||
37961142|NCT00545532|69648578|FG001|Overall Study|Lost to Follow-up|6|||
37961143|NCT00545532|69648577|FG000|Overall Study|Death|0|||
37961144|NCT00545532|69648578|FG001|Overall Study|Death|1|||
37961145|NCT00544440|69648586|FG000|Overall Study|Other|1|||
37961146|NCT00544440|69648586|FG000|Overall Study|Adverse Event|1|||
37961147|NCT00544440|69648586|FG000|Overall Study|Withdrawal by Subject|2|||
37961148|NCT00544440|69648586|FG000|Overall Study|Subject Non-compliance|1|||
37961149|NCT00544440|69648586|FG000|Overall Study|Progressive Disease|47|||
37961150|NCT00544440|69648586|FG000|Overall Study|Other|5|||
37961151|NCT03920670|69648592|FG000|Overall Study|Protocol Violation|2|||
37961152|NCT03920670|69648593|FG001|Overall Study|Protocol Violation|2|||
37961153|NCT03920670|69648592|FG000|Overall Study|Adverse Event|1|||
37961154|NCT03920670|69648593|FG001|Overall Study|Adverse Event|0|||
37961155|NCT00430300|69648603|FG000|Overall Study|Adverse Event|0|||
37961156|NCT00430300|69648604|FG001|Overall Study|Adverse Event|2|||
37961157|NCT00430300|69648605|FG002|Overall Study|Adverse Event|1|||
37961158|NCT00430300|69648606|FG003|Overall Study|Adverse Event|1|||
37961159|NCT00430300|69648603|FG000|Overall Study|Withdrawal by Subject|1|||
37961160|NCT00430300|69648604|FG001|Overall Study|Withdrawal by Subject|0|||
37961161|NCT00430300|69648605|FG002|Overall Study|Withdrawal by Subject|5|||
37961162|NCT00430300|69648606|FG003|Overall Study|Withdrawal by Subject|0|||
37961163|NCT00430300|69648603|FG000|Overall Study|Laboratory abnormality|1|||
37961164|NCT00430300|69648604|FG001|Overall Study|Laboratory abnormality|0|||
37961165|NCT00430300|69648605|FG002|Overall Study|Laboratory abnormality|0|||
37961166|NCT00430300|69648606|FG003|Overall Study|Laboratory abnormality|0|||
37961167|NCT00430300|69648603|FG000|Overall Study|Other|0|||
37961168|NCT00430300|69648604|FG001|Overall Study|Other|0|||
37961169|NCT00430300|69648605|FG002|Overall Study|Other|0|||
37961170|NCT00430300|69648606|FG003|Overall Study|Other|1|||
37961171|NCT03927846|69648618|FG000|Overall Study|Lost to Follow-up|10|||
37961172|NCT03927846|69648619|FG001|Overall Study|Lost to Follow-up|11|||
37961173|NCT00545298|69648628|FG000|Overall Study|Issues with Standard of Care|2|||
37961174|NCT00545298|69648629|FG001|Overall Study|Issues with Standard of Care|0|||
37961175|NCT00545298|69648630|FG002|Overall Study|Issues with Standard of Care|1|||
37961176|NCT00429364|69648643|FG000|Overall Study|Withdrawal by Subject|11|||
37961177|NCT00429364|69648644|FG001|Overall Study|Withdrawal by Subject|5|||
37961178|NCT00429364|69648643|FG000|Overall Study|Physician Decision|4|||
37961179|NCT00429364|69648644|FG001|Overall Study|Physician Decision|2|||
37961180|NCT00429364|69648643|FG000|Overall Study|Lost to Follow-up|7|||
37961181|NCT00429364|69648644|FG001|Overall Study|Lost to Follow-up|6|||
37961182|NCT00429364|69648643|FG000|Overall Study|Death|0|||
37961183|NCT00429364|69648644|FG001|Overall Study|Death|1|||
37961184|NCT00429364|69648643|FG000|Overall Study|Underwent aortic root surgery|10|||
37961185|NCT00429364|69648644|FG001|Overall Study|Underwent aortic root surgery|18|||
37961186|NCT00429364|69648643|FG000|Overall Study|Pregnancy|0|||
37961187|NCT00429364|69648644|FG001|Overall Study|Pregnancy|1|||
37961188|NCT00414388|69648650|FG000|Overall Study|Adverse Event|1|||
37961189|NCT03920280|69648657|FG000|Overall Study|Adverse Event|2|||
37961190|NCT03920280|69648658|FG001|Overall Study|Adverse Event|3|||
37961191|NCT03920280|69648657|FG000|Overall Study|Lost to Follow-up|0|||
37961192|NCT03920280|69648658|FG001|Overall Study|Lost to Follow-up|1|||
37961193|NCT03920280|69648657|FG000|Overall Study|Withdrawal by Subject|1|||
37961194|NCT03920280|69648658|FG001|Overall Study|Withdrawal by Subject|1|||
37961195|NCT03920280|69648657|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
37961196|NCT03920280|69648658|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
37961197|NCT00424372|69648667|FG000|Overall Study|Death|1|||
37961198|NCT00424372|69648667|FG000|Overall Study|Adverse Event|18|||
37961199|NCT00424372|69648667|FG000|Overall Study|Lack of Efficacy|6|||
37961200|NCT00424372|69648667|FG000|Overall Study|Withdrawal by Subject|4|||
37961201|NCT00424372|69648667|FG000|Overall Study|Protocol Violation|1|||
37961202|NCT00424372|69648667|FG000|Overall Study|Health deterioration|1|||
37961203|NCT00414310|69648673|FG000|Overall Study|Not treated|1|||
37961204|NCT00414310|69648674|FG001|Overall Study|Not treated|0|||
37961205|NCT00542880|69648684|FG000|Period 1|Eligibility criteria not fulfilled|2|||
37961206|NCT00542880|69648685|FG001|Period 1|Eligibility criteria not fulfilled|6|||
37961207|NCT00542880|69648684|FG000|Period 1|Adverse Event|2|||
37961208|NCT00542880|69648685|FG001|Period 1|Adverse Event|2|||
37961209|NCT00542880|69648684|FG000|Period 1|Development of study-specific criteria|1|||
37961210|NCT00542880|69648685|FG001|Period 1|Development of study-specific criteria|2|||
37961211|NCT00542880|69648684|FG000|Period 1|Withdrawal by Subject|1|||
37961212|NCT00542880|69648685|FG001|Period 1|Withdrawal by Subject|1|||
37961213|NCT00542880|69648684|FG000|Period 1|Protocol Violation|0|||
37961214|NCT00542880|69648685|FG001|Period 1|Protocol Violation|1|||
37961215|NCT00542880|69648684|FG000|Period 2|Adverse Event|5|||
37961216|NCT00542880|69648685|FG001|Period 2|Adverse Event|7|||
37961217|NCT00542880|69648684|FG000|Period 2|Eligibility not fulfilled|0|||
37961218|NCT00542880|69648685|FG001|Period 2|Eligibility not fulfilled|1|||
37961219|NCT00542880|69648684|FG000|Period 2|Discontinuation criteria|2|||
37961220|NCT00542880|69648685|FG001|Period 2|Discontinuation criteria|0|||
37961221|NCT00542880|69648684|FG000|Period 2|Severe non-compliance|0|||
37961222|NCT00542880|69648685|FG001|Period 2|Severe non-compliance|1|||
37961223|NCT00542880|69648684|FG000|Period 2|Other|0|||
37961224|NCT00542880|69648685|FG001|Period 2|Other|1|||
37961225|NCT00542880|69648684|FG000|Period 3|Adverse Event|0|||
37961226|NCT00542880|69648685|FG001|Period 3|Adverse Event|2|||
37961227|NCT00414076|69648694|FG000|Overall Study|Progression|1|||
37961228|NCT00414076|69648695|FG001|Overall Study|Progression|2|||
37961229|NCT00414076|69648694|FG000|Overall Study|Withdrawal by Subject|1|||
37961230|NCT00414076|69648695|FG001|Overall Study|Withdrawal by Subject|3|||
37961231|NCT00414076|69648694|FG000|Overall Study|Adverse Event|1|||
37961232|NCT00414076|69648695|FG001|Overall Study|Adverse Event|0|||
37961233|NCT00092677|69648703|FG000|Overall Study|Lost to Follow-up|0|||
37961234|NCT00092677|69648704|FG001|Overall Study|Lost to Follow-up|2|||
37961235|NCT00092677|69648703|FG000|Overall Study|Adminstrative|5|||
37961236|NCT00092677|69648704|FG001|Overall Study|Adminstrative|9|||
37961237|NCT00542178|69648716|FG000|Overall Study|did not complete year 4 follow-up|75|||
37961238|NCT00542178|69648717|FG001|Overall Study|did not complete year 4 follow-up|80|||
37961239|NCT00542178|69648718|FG002|Overall Study|did not complete year 4 follow-up|74|||
37961240|NCT00542178|69648719|FG003|Overall Study|did not complete year 4 follow-up|62|||
37961241|NCT00542178|69648720|FG004|Overall Study|did not complete year 4 follow-up|64|||
37961242|NCT00542178|69648721|FG005|Overall Study|did not complete year 4 follow-up|89|||
37961243|NCT00542178|69648722|FG006|Overall Study|did not complete year 4 follow-up|87|||
37961244|NCT00542178|69648723|FG007|Overall Study|did not complete year 4 follow-up|85|||
37961245|NCT00424294|69648739|FG000|Overall Study|Adverse Event|4|||
37961246|NCT00424294|69648740|FG001|Overall Study|Adverse Event|10|||
37961247|NCT00424294|69648739|FG000|Overall Study|Lack of Efficacy|2|||
37961248|NCT00424294|69648740|FG001|Overall Study|Lack of Efficacy|1|||
37961249|NCT00424294|69648739|FG000|Overall Study|Withdrawal by Subject|1|||
37961250|NCT00424294|69648740|FG001|Overall Study|Withdrawal by Subject|2|||
37961251|NCT00424294|69648739|FG000|Overall Study|Other|0|||
37961252|NCT00424294|69648740|FG001|Overall Study|Other|2|||
37961253|NCT00424294|69648739|FG000|Overall Study|Randomized but not Treated|1|||
37961254|NCT00424294|69648740|FG001|Overall Study|Randomized but not Treated|0|||
37961255|NCT00092521|69648749|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
37961256|NCT00092521|69648750|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
37961257|NCT00092521|69648751|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
37961258|NCT00092521|69648752|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
37961259|NCT00092521|69648749|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
37961260|NCT00092521|69648750|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
37961261|NCT00092521|69648751|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
37961262|NCT00092521|69648752|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
37961263|NCT00092521|69648749|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
37961264|NCT00092521|69648750|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
37961265|NCT00092521|69648751|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
37961266|NCT00092521|69648752|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
37961267|NCT00092521|69648749|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
37961268|NCT00092521|69648750|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
37961269|NCT00092521|69648751|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
37961270|NCT00092521|69648752|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
37961271|NCT00092521|69648749|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
38051494|NCT03285711|69740734|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
37961272|NCT00092521|69648750|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
37961273|NCT00092521|69648751|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
37961274|NCT00092521|69648752|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
37961275|NCT00092521|69648749|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
37961276|NCT00092521|69648750|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
37961277|NCT00092521|69648751|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
37961278|NCT00092521|69648752|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
37961279|NCT00092521|69648749|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
37961280|NCT00092521|69648750|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
37961281|NCT00092521|69648751|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
37961282|NCT00092521|69648752|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
37961283|NCT00092521|69648749|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
37961284|NCT00092521|69648750|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
37961285|NCT00092521|69648751|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
38051495|NCT03285711|69740735|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
38051496|NCT03285711|69740736|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
38051497|NCT03285711|69740733|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
38051498|NCT03285711|69740734|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
38051499|NCT03285711|69740735|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
38051500|NCT03285711|69740736|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
38051501|NCT03285711|69740733|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
38051502|NCT03285711|69740734|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
38051503|NCT03285711|69740735|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
38051504|NCT03285711|69740736|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
38051505|NCT02927366|69740748|FG000|Overall Study|Adverse Event|1|||
38051506|NCT02927366|69740749|FG001|Overall Study|Adverse Event|0|||
38051507|NCT02927366|69740748|FG000|Overall Study|Patient schedule|1|||
38051508|NCT02927366|69740749|FG001|Overall Study|Patient schedule|0|||
38051509|NCT03249909|69740758|FG000|Overall Study|Withdrawal by Subject|3|||
38051510|NCT03249909|69740759|FG001|Overall Study|Withdrawal by Subject|0|||
38051511|NCT03249909|69740760|FG002|Overall Study|Withdrawal by Subject|0|||
38051512|NCT03249909|69740758|FG000|Overall Study|Adverse Event|3|||
38051513|NCT03249909|69740759|FG001|Overall Study|Adverse Event|0|||
38051514|NCT03249909|69740760|FG002|Overall Study|Adverse Event|0|||
38051515|NCT03249909|69740758|FG000|Overall Study|Lost to Follow-up|0|||
37961286|NCT00092521|69648752|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
38051516|NCT03249909|69740759|FG001|Overall Study|Lost to Follow-up|1|||
38051517|NCT03249909|69740760|FG002|Overall Study|Lost to Follow-up|0|||
38051518|NCT03081884|69740771|FG000|Overall Study|deferred prostate cancer treatment|1|||
38051519|NCT03081884|69740771|FG000|Overall Study|metastasis managed with systemic therapy|3|||
38051520|NCT03077438|69740778|FG000|Overall Study|Protocol Violation|3|||
38051521|NCT03077438|69740779|FG001|Overall Study|Protocol Violation|5|||
38051522|NCT03077438|69740778|FG000|Overall Study|Withdrawal by Subject|3|||
38051523|NCT03077438|69740779|FG001|Overall Study|Withdrawal by Subject|6|||
38051524|NCT03077438|69740778|FG000|Overall Study|Lost to Follow-up|6|||
38051525|NCT03077438|69740779|FG001|Overall Study|Lost to Follow-up|3|||
38051526|NCT03076970|69740789|FG000|Washout Period 2|Adverse Event|0|||
38051527|NCT03076970|69740790|FG001|Washout Period 2|Adverse Event|0|||
38051528|NCT03076970|69740791|FG002|Washout Period 2|Adverse Event|0|||
38051529|NCT03076970|69740792|FG003|Washout Period 2|Adverse Event|0|||
38051530|NCT03076970|69740793|FG004|Washout Period 2|Adverse Event|1|||
38051531|NCT03076970|69740794|FG005|Washout Period 2|Adverse Event|0|||
38051532|NCT03076970|69740789|FG000|Period 3|Withdrawal by Subject|0|||
38051533|NCT03076970|69740790|FG001|Period 3|Withdrawal by Subject|0|||
38051534|NCT03076970|69740791|FG002|Period 3|Withdrawal by Subject|0|||
38051535|NCT03076970|69740792|FG003|Period 3|Withdrawal by Subject|0|||
38051536|NCT03076970|69740793|FG004|Period 3|Withdrawal by Subject|0|||
38051537|NCT03076970|69740794|FG005|Period 3|Withdrawal by Subject|1|||
38051538|NCT03076970|69740789|FG000|Period 3|Failure to meet I/E criteria|0|||
38051539|NCT03076970|69740790|FG001|Period 3|Failure to meet I/E criteria|0|||
38051540|NCT03076970|69740791|FG002|Period 3|Failure to meet I/E criteria|0|||
38051541|NCT03076970|69740792|FG003|Period 3|Failure to meet I/E criteria|0|||
38051542|NCT03076970|69740793|FG004|Period 3|Failure to meet I/E criteria|1|||
38051543|NCT03076970|69740794|FG005|Period 3|Failure to meet I/E criteria|0|||
38051544|NCT00726596|69740807|FG000|Overall Study|Adverse Event|2|||
38051545|NCT00726596|69740808|FG001|Overall Study|Adverse Event|1|||
38051546|NCT00726596|69740807|FG000|Overall Study|Withdrawal by Subject|3|||
38051547|NCT00726596|69740808|FG001|Overall Study|Withdrawal by Subject|3|||
38051548|NCT02890992|69740831|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
38051549|NCT02890992|69740832|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
38051550|NCT02890992|69740833|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
38051551|NCT02890992|69740834|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
38051552|NCT02890992|69740835|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
38051553|NCT02890992|69740836|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
38051554|NCT02890992|69740837|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
38051555|NCT02890992|69740838|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
38051556|NCT02890992|69740831|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
38051557|NCT02890992|69740832|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
38051558|NCT02890992|69740833|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
37961287|NCT00092521|69648749|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
37961288|NCT00092521|69648750|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
37961289|NCT00092521|69648751|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
37961290|NCT00092521|69648752|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
37961291|NCT00092521|69648749|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
37961292|NCT00092521|69648750|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
37961293|NCT00092521|69648751|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
37961294|NCT00092521|69648752|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
37961295|NCT00092521|69648749|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
37961296|NCT00092521|69648750|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
37961297|NCT00092521|69648751|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
37961298|NCT00092521|69648752|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
37961299|NCT00092521|69648749|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
37961300|NCT00092521|69648750|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
37961301|NCT00092521|69648751|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
37961302|NCT00092521|69648752|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
37961303|NCT00092521|69648749|FG000|Follow-Up (After Month 7)|Death|2|||
37961304|NCT00092521|69648750|FG001|Follow-Up (After Month 7)|Death|0|||
37961305|NCT00092521|69648751|FG002|Follow-Up (After Month 7)|Death|1|||
37961306|NCT00092521|69648752|FG003|Follow-Up (After Month 7)|Death|0|||
37961307|NCT00092521|69648749|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
37961308|NCT00092521|69648750|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
38051559|NCT02890992|69740834|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
38051560|NCT02890992|69740835|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
38051561|NCT02890992|69740836|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
38051562|NCT02890992|69740837|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
38051563|NCT02890992|69740838|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
38051564|NCT02890992|69740831|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
38051565|NCT02890992|69740832|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
38051566|NCT02890992|69740833|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
38051567|NCT02890992|69740834|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
37961309|NCT00092521|69648751|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
37961310|NCT00092521|69648752|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
37961311|NCT00092521|69648749|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
37961312|NCT00092521|69648750|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
37961313|NCT00092521|69648751|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
37961314|NCT00092521|69648752|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
37961315|NCT00092521|69648749|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
37961316|NCT00092521|69648750|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
37961317|NCT00092521|69648751|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
37961318|NCT00092521|69648752|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
37961319|NCT00092521|69648749|FG000|Follow-Up (After Month 7)|Moved|32|||
37961320|NCT00092521|69648750|FG001|Follow-Up (After Month 7)|Moved|2|||
37961321|NCT00092521|69648751|FG002|Follow-Up (After Month 7)|Moved|28|||
37961322|NCT00092521|69648752|FG003|Follow-Up (After Month 7)|Moved|0|||
37961323|NCT00092521|69648749|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
37961324|NCT00092521|69648750|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
37961325|NCT00092521|69648751|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
37961326|NCT00092521|69648752|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
37961327|NCT00092521|69648749|FG000|Follow-Up (After Month 7)|Travel|2|||
37961328|NCT00092521|69648750|FG001|Follow-Up (After Month 7)|Travel|0|||
37961329|NCT00092521|69648751|FG002|Follow-Up (After Month 7)|Travel|0|||
37961330|NCT00092521|69648752|FG003|Follow-Up (After Month 7)|Travel|0|||
37961331|NCT00092521|69648749|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
37961332|NCT00092521|69648750|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
37961333|NCT00092521|69648751|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
37961334|NCT00092521|69648752|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
37961335|NCT00092521|69648749|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
37961336|NCT00092521|69648750|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
37961337|NCT00092521|69648751|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
37961338|NCT00092521|69648752|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
37961339|NCT00092521|69648749|FG000|Extension Study (Group 4)|Adverse Event|0|||
37961340|NCT00092521|69648750|FG001|Extension Study (Group 4)|Adverse Event|0|||
37961341|NCT00092521|69648751|FG002|Extension Study (Group 4)|Adverse Event|0|||
37961342|NCT00092521|69648752|FG003|Extension Study (Group 4)|Adverse Event|2|||
37961343|NCT00092521|69648749|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
37961344|NCT00092521|69648750|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
37961345|NCT00092521|69648751|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
37961346|NCT00092521|69648752|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
37961347|NCT00092521|69648749|FG000|Extension Study (Group 4)|Pregnancy|0|||
37961348|NCT00092521|69648750|FG001|Extension Study (Group 4)|Pregnancy|0|||
37961349|NCT00092521|69648751|FG002|Extension Study (Group 4)|Pregnancy|0|||
37961350|NCT00092521|69648752|FG003|Extension Study (Group 4)|Pregnancy|4|||
37961351|NCT00092521|69648749|FG000|Extension Study (Group 4)|Protocol Violation|0|||
37961352|NCT00092521|69648750|FG001|Extension Study (Group 4)|Protocol Violation|0|||
37961353|NCT00092521|69648751|FG002|Extension Study (Group 4)|Protocol Violation|0|||
37961354|NCT00092521|69648752|FG003|Extension Study (Group 4)|Protocol Violation|2|||
37961355|NCT00092521|69648749|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
37961356|NCT00092521|69648750|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
37961357|NCT00092521|69648751|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
37961358|NCT00092521|69648752|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
37961359|NCT00092521|69648749|FG000|Extension Study (Group 4)|Moved|0|||
37961360|NCT00092521|69648750|FG001|Extension Study (Group 4)|Moved|0|||
37961361|NCT00092521|69648751|FG002|Extension Study (Group 4)|Moved|0|||
37961362|NCT00092521|69648752|FG003|Extension Study (Group 4)|Moved|16|||
37961363|NCT00092521|69648749|FG000|Extension Study (Group 4)|Site Terminated|0|||
37961364|NCT00092521|69648750|FG001|Extension Study (Group 4)|Site Terminated|0|||
37961365|NCT00092521|69648751|FG002|Extension Study (Group 4)|Site Terminated|0|||
37961366|NCT00092521|69648752|FG003|Extension Study (Group 4)|Site Terminated|4|||
37961367|NCT00092521|69648749|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
38051568|NCT02890992|69740835|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
38051569|NCT02890992|69740836|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
37961368|NCT00092521|69648750|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
37961369|NCT00092521|69648751|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
38051570|NCT02890992|69740837|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
38051571|NCT02890992|69740838|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
38051572|NCT03076190|69740883|FG000|Overall Study|Lost to Follow-up|9|||
38051573|NCT03076190|69740884|FG001|Overall Study|Lost to Follow-up|34|||
37961370|NCT00092521|69648752|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
37961371|NCT03908970|69648762|FG000|Overall Study|Adverse Event|7|||
37961372|NCT03908970|69648763|FG001|Overall Study|Adverse Event|21|||
37961373|NCT03908970|69648762|FG000|Overall Study|Physician Decision|1|||
37961374|NCT03908970|69648763|FG001|Overall Study|Physician Decision|4|||
38051574|NCT03076190|69740883|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
38051575|NCT03076190|69740884|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
38051576|NCT03329196|69740895|FG000|Overall Study|Adverse Event|10|||
38051577|NCT03329196|69740896|FG001|Overall Study|Adverse Event|5|||
38051578|NCT03329196|69740895|FG000|Overall Study|Physician Decision|2|||
38051579|NCT03329196|69740896|FG001|Overall Study|Physician Decision|2|||
38051580|NCT03329196|69740895|FG000|Overall Study|Withdrawal by Subject|11|||
38051581|NCT03329196|69740896|FG001|Overall Study|Withdrawal by Subject|3|||
38051582|NCT03329196|69740895|FG000|Overall Study|Hepatic function abnormalities|0|||
38051583|NCT03329196|69740896|FG001|Overall Study|Hepatic function abnormalities|1|||
38051584|NCT03329196|69740895|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
38051585|NCT03329196|69740896|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
38051586|NCT03329196|69740895|FG000|Overall Study|Difficult to control Hb|2|||
38051587|NCT03329196|69740896|FG001|Overall Study|Difficult to control Hb|3|||
38051588|NCT03329196|69740895|FG000|Overall Study|Dialysis or renal transplant|13|||
38051589|NCT03329196|69740896|FG001|Overall Study|Dialysis or renal transplant|15|||
38051590|NCT03328182|69740902|FG000|Overall Study|Withdrawal by Subject|1|||
38051591|NCT03328182|69740902|FG000|Overall Study|Protocol Violation|2|||
38051592|NCT03328182|69740902|FG000|Overall Study|No Product Evaluated|1|||
38051593|NCT03327402|69740906|FG000|Overall Study|Withdrawal by Subject|1|||
38051594|NCT03327402|69740906|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
37961375|NCT03908970|69648762|FG000|Overall Study|Withdrawal by Subject|9|||
37961376|NCT03908970|69648763|FG001|Overall Study|Withdrawal by Subject|22|||
37961377|NCT00092443|69648771|FG000|Overall Study|Adverse Event|9|||
37961378|NCT00092443|69648772|FG001|Overall Study|Adverse Event|13|||
37961379|NCT00092443|69648771|FG000|Overall Study|Lost to Follow-up|7|||
37961380|NCT00092443|69648772|FG001|Overall Study|Lost to Follow-up|3|||
37961381|NCT00092443|69648771|FG000|Overall Study|Protocol Violation|11|||
37961382|NCT00092443|69648772|FG001|Overall Study|Protocol Violation|9|||
37961383|NCT00092443|69648771|FG000|Overall Study|Withdrawal by Subject|9|||
37961384|NCT00092443|69648772|FG001|Overall Study|Withdrawal by Subject|11|||
37961385|NCT00092443|69648771|FG000|Overall Study|Moved|5|||
37961386|NCT00092443|69648772|FG001|Overall Study|Moved|5|||
37961387|NCT00092443|69648771|FG000|Overall Study|Other|17|||
37961388|NCT00092443|69648772|FG001|Overall Study|Other|13|||
37961389|NCT00413920|69648790|FG000|Overall Study|Adverse Event|9|||
37961390|NCT00413920|69648791|FG001|Overall Study|Adverse Event|11|||
37961391|NCT00413920|69648790|FG000|Overall Study|Lack of Efficacy|11|||
37961392|NCT00413920|69648791|FG001|Overall Study|Lack of Efficacy|9|||
37961393|NCT00413920|69648790|FG000|Overall Study|Death|3|||
37961394|NCT00413920|69648791|FG001|Overall Study|Death|5|||
37961395|NCT00413920|69648790|FG000|Overall Study|Graft Loss|5|||
37961396|NCT00413920|69648791|FG001|Overall Study|Graft Loss|3|||
37961397|NCT00091819|69648799|FG000|Overall Study|Adverse Event|1|||
37961398|NCT00091819|69648800|FG001|Overall Study|Adverse Event|1|||
37961399|NCT00091819|69648799|FG000|Overall Study|Death|4|||
37961400|NCT00091819|69648800|FG001|Overall Study|Death|5|||
37961401|NCT00091819|69648799|FG000|Overall Study|Lost to Follow-up|26|||
37961402|NCT00091819|69648800|FG001|Overall Study|Lost to Follow-up|23|||
37961403|NCT00091819|69648799|FG000|Overall Study|Withdrawal by Subject|5|||
37961404|NCT00091819|69648800|FG001|Overall Study|Withdrawal by Subject|8|||
37961405|NCT00091819|69648799|FG000|Overall Study|Protocol Violation|1|||
37961406|NCT00091819|69648800|FG001|Overall Study|Protocol Violation|2|||
37961407|NCT00091819|69648799|FG000|Overall Study|Other|2|||
37961408|NCT00091819|69648800|FG001|Overall Study|Other|3|||
37961409|NCT00091819|69648799|FG000|Overall Study|Never received study treatment|3|||
37961410|NCT00091819|69648800|FG001|Overall Study|Never received study treatment|4|||
37961411|NCT00540228|69648811|FG000|Overall Study|Adverse Event|2|||
37961412|NCT00540228|69648812|FG001|Overall Study|Adverse Event|0|||
38051595|NCT03075878|69740910|FG000|Overall Study|Physician Decision|1|||
38051596|NCT03326856|69740919|FG000|Overall Study|Lost to Follow-up|1|||
38051597|NCT03326856|69740920|FG001|Overall Study|Lost to Follow-up|1|||
37961413|NCT00540228|69648813|FG002|Overall Study|Adverse Event|0|||
38051598|NCT03326856|69740921|FG002|Overall Study|Lost to Follow-up|0|||
38051599|NCT03326856|69740922|FG003|Overall Study|Lost to Follow-up|0|||
37961414|NCT00540228|69648814|FG003|Overall Study|Adverse Event|0|||
37961415|NCT00540228|69648815|FG004|Overall Study|Adverse Event|0|||
37961416|NCT00540228|69648811|FG000|Overall Study|Lost to Follow-up|1|||
37961417|NCT00540228|69648812|FG001|Overall Study|Lost to Follow-up|1|||
37961418|NCT00540228|69648813|FG002|Overall Study|Lost to Follow-up|0|||
37961419|NCT00540228|69648814|FG003|Overall Study|Lost to Follow-up|0|||
37961420|NCT00540228|69648815|FG004|Overall Study|Lost to Follow-up|0|||
37961421|NCT05013385|69648840|FG000|Overall Study|Sponsor's decision to terminate the trial|5|||
37961422|NCT04250636|69648863|FG000|Overall Study|Lost to Follow-up|2|||
37961423|NCT03989115|69648875|FG000|Overall Study|Withdrawal by Subject|2|||
37961424|NCT03989115|69648876|FG001|Overall Study|Withdrawal by Subject|1|||
37961425|NCT03989115|69648877|FG002|Overall Study|Withdrawal by Subject|3|||
38051600|NCT03326856|69740923|FG004|Overall Study|Lost to Follow-up|0|||
37961426|NCT03989115|69648878|FG003|Overall Study|Withdrawal by Subject|0|||
37961427|NCT03989115|69648879|FG004|Overall Study|Withdrawal by Subject|17|||
37961428|NCT03989115|69648880|FG005|Overall Study|Withdrawal by Subject|1|||
37961429|NCT03989115|69648881|FG006|Overall Study|Withdrawal by Subject|0|||
37961430|NCT03989115|69648882|FG007|Overall Study|Withdrawal by Subject|0|||
37961431|NCT03989115|69648875|FG000|Overall Study|Sponsor decision to terminate the study|1|||
37961432|NCT03989115|69648876|FG001|Overall Study|Sponsor decision to terminate the study|1|||
37961433|NCT03989115|69648877|FG002|Overall Study|Sponsor decision to terminate the study|0|||
37961434|NCT03989115|69648878|FG003|Overall Study|Sponsor decision to terminate the study|1|||
37961435|NCT03989115|69648879|FG004|Overall Study|Sponsor decision to terminate the study|11|||
37961436|NCT03989115|69648880|FG005|Overall Study|Sponsor decision to terminate the study|0|||
37961437|NCT03989115|69648881|FG006|Overall Study|Sponsor decision to terminate the study|2|||
37961438|NCT03989115|69648882|FG007|Overall Study|Sponsor decision to terminate the study|1|||
37961439|NCT03989115|69648875|FG000|Overall Study|Lost to Follow-up|2|||
37961440|NCT03989115|69648876|FG001|Overall Study|Lost to Follow-up|0|||
37961441|NCT03989115|69648877|FG002|Overall Study|Lost to Follow-up|0|||
37961442|NCT03989115|69648878|FG003|Overall Study|Lost to Follow-up|0|||
37961443|NCT03989115|69648879|FG004|Overall Study|Lost to Follow-up|1|||
37961444|NCT03989115|69648880|FG005|Overall Study|Lost to Follow-up|0|||
37961445|NCT03989115|69648881|FG006|Overall Study|Lost to Follow-up|0|||
37961446|NCT03989115|69648882|FG007|Overall Study|Lost to Follow-up|0|||
37961447|NCT03989115|69648875|FG000|Overall Study|Death|2|||
37961448|NCT03989115|69648876|FG001|Overall Study|Death|2|||
37961449|NCT03989115|69648877|FG002|Overall Study|Death|9|||
37961450|NCT03989115|69648878|FG003|Overall Study|Death|6|||
37961451|NCT03989115|69648879|FG004|Overall Study|Death|31|||
37961452|NCT03989115|69648880|FG005|Overall Study|Death|6|||
37961453|NCT03989115|69648881|FG006|Overall Study|Death|2|||
37961454|NCT03989115|69648882|FG007|Overall Study|Death|3|||
37961455|NCT03989115|69648875|FG000|Overall Study|Other|1|||
37961456|NCT03989115|69648876|FG001|Overall Study|Other|2|||
37961457|NCT03989115|69648877|FG002|Overall Study|Other|0|||
37961458|NCT03989115|69648878|FG003|Overall Study|Other|0|||
37961459|NCT03989115|69648879|FG004|Overall Study|Other|5|||
37961460|NCT03989115|69648880|FG005|Overall Study|Other|0|||
37961461|NCT03989115|69648881|FG006|Overall Study|Other|0|||
37961462|NCT03989115|69648882|FG007|Overall Study|Other|0|||
37961463|NCT03971071|69648908|FG000|Overall Study|Sponsor decision|0|||
37961464|NCT03971071|69648909|FG001|Overall Study|Sponsor decision|1|||
37961465|NCT03971071|69648910|FG002|Overall Study|Sponsor decision|0|||
37961466|NCT03971071|69648908|FG000|Overall Study|Withdrawal by Subject|7|||
37961467|NCT03971071|69648909|FG001|Overall Study|Withdrawal by Subject|11|||
37961468|NCT03971071|69648910|FG002|Overall Study|Withdrawal by Subject|6|||
37961469|NCT03971071|69648908|FG000|Overall Study|Other|2|||
37961470|NCT03971071|69648909|FG001|Overall Study|Other|2|||
37961471|NCT03971071|69648910|FG002|Overall Study|Other|0|||
37961472|NCT03797898|69648924|FG000|Overall Study|Lost to Follow-up|60|||
37961473|NCT03797898|69648925|FG001|Overall Study|Lost to Follow-up|69|||
37961474|NCT03797898|69648924|FG000|Overall Study|Withdrawal by Subject|9|||
37961475|NCT03797898|69648925|FG001|Overall Study|Withdrawal by Subject|7|||
37961476|NCT03797898|69648924|FG000|Overall Study|Became ineligible|5|||
37961477|NCT03797898|69648925|FG001|Overall Study|Became ineligible|2|||
37961478|NCT03559192|69648947|FG000|Lead-in Period (3 Weeks)|Protocol Violation|1|||
37961479|NCT03559192|69648948|FG001|Lead-in Period (3 Weeks)|Protocol Violation|0|||
37961480|NCT03559192|69648949|FG002|Lead-in Period (3 Weeks)|Protocol Violation|0|||
37961481|NCT03559192|69648947|FG000|Lead-in Period (3 Weeks)|Withdrawal by Subject|6|||
37961482|NCT03559192|69648948|FG001|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
37961483|NCT03559192|69648949|FG002|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
37961484|NCT03559192|69648947|FG000|Lead-in Period (3 Weeks)|Adverse Event|5|||
37961485|NCT03559192|69648948|FG001|Lead-in Period (3 Weeks)|Adverse Event|0|||
37961486|NCT03559192|69648949|FG002|Lead-in Period (3 Weeks)|Adverse Event|0|||
37961487|NCT03559192|69648947|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
37961488|NCT03559192|69648948|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
37961489|NCT03559192|69648949|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|1|||
37961490|NCT03559192|69648947|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
37961491|NCT03559192|69648948|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|1|||
37961492|NCT03559192|69648949|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
37961493|NCT03559192|69648947|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
37961494|NCT03559192|69648948|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
37961495|NCT03559192|69648949|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|2|||
37961496|NCT03559192|69648947|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|0|||
37961497|NCT03559192|69648948|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
37961498|NCT03559192|69648949|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
37961499|NCT03559192|69648947|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
37961500|NCT03559192|69648948|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
37961501|NCT03559192|69648949|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|1|||
37961502|NCT03559192|69648947|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|0|||
37961503|NCT03559192|69648948|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
37961504|NCT03559192|69648949|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
37961505|NCT03523585|69648960|FG000|Overall Study|Progressive Disease|174|||
37961506|NCT03523585|69648961|FG001|Overall Study|Progressive Disease|64|||
37961507|NCT03523585|69648962|FG002|Overall Study|Progressive Disease|77|||
37961508|NCT03523585|69648960|FG000|Overall Study|Adverse Event|74|||
37961509|NCT03523585|69648961|FG001|Overall Study|Adverse Event|5|||
37961510|NCT03523585|69648962|FG002|Overall Study|Adverse Event|9|||
37961511|NCT03523585|69648960|FG000|Overall Study|Withdrawal by Subject|30|||
37961512|NCT03523585|69648961|FG001|Overall Study|Withdrawal by Subject|11|||
37961513|NCT03523585|69648962|FG002|Overall Study|Withdrawal by Subject|6|||
37961514|NCT03523585|69648960|FG000|Overall Study|Clinical Progression|23|||
37961515|NCT03523585|69648961|FG001|Overall Study|Clinical Progression|5|||
37961516|NCT03523585|69648962|FG002|Overall Study|Clinical Progression|10|||
37961517|NCT03523585|69648960|FG000|Overall Study|Death|4|||
37961518|NCT03523585|69648961|FG001|Overall Study|Death|0|||
37961519|NCT03523585|69648962|FG002|Overall Study|Death|1|||
37961520|NCT03523585|69648960|FG000|Overall Study|Physician Decision|2|||
37961521|NCT03523585|69648961|FG001|Overall Study|Physician Decision|1|||
37961522|NCT03523585|69648962|FG002|Overall Study|Physician Decision|0|||
37961523|NCT03523585|69648960|FG000|Overall Study|Lost to Follow-up|1|||
37961524|NCT03523585|69648961|FG001|Overall Study|Lost to Follow-up|0|||
37961525|NCT03523585|69648962|FG002|Overall Study|Lost to Follow-up|0|||
37961526|NCT03523585|69648960|FG000|Overall Study|Miscellaneous|1|||
37961527|NCT03523585|69648961|FG001|Overall Study|Miscellaneous|0|||
37961528|NCT03523585|69648962|FG002|Overall Study|Miscellaneous|0|||
37961529|NCT03523585|69648960|FG000|Overall Study|Protocol Deviation|1|||
37961530|NCT03523585|69648961|FG001|Overall Study|Protocol Deviation|0|||
37961531|NCT03523585|69648962|FG002|Overall Study|Protocol Deviation|1|||
37961532|NCT03523585|69648960|FG000|Overall Study|Randomized But Not Treated|2|||
37961533|NCT03523585|69648961|FG001|Overall Study|Randomized But Not Treated|4|||
37961534|NCT03523585|69648962|FG002|Overall Study|Randomized But Not Treated|3|||
37961535|NCT03485911|69648972|FG000|Part 1|Perceived lack of efficacy|1|||
37961536|NCT03485911|69648973|FG001|Part 1|Perceived lack of efficacy|1|||
37961537|NCT03485911|69648974|FG002|Part 1|Perceived lack of efficacy|2|||
37961538|NCT03485911|69648975|FG003|Part 1|Perceived lack of efficacy|0|||
37961539|NCT03485911|69648972|FG000|Part 1|Subject withdrew consent|0|||
37961540|NCT03485911|69648973|FG001|Part 1|Subject withdrew consent|1|||
37961541|NCT03485911|69648974|FG002|Part 1|Subject withdrew consent|0|||
37961542|NCT03485911|69648975|FG003|Part 1|Subject withdrew consent|1|||
37961543|NCT03485911|69648972|FG000|Part 1|Lab abnormalities/AEs|3|||
37961544|NCT03485911|69648973|FG001|Part 1|Lab abnormalities/AEs|1|||
37961545|NCT03485911|69648974|FG002|Part 1|Lab abnormalities/AEs|1|||
37961546|NCT03485911|69648975|FG003|Part 1|Lab abnormalities/AEs|0|||
37961547|NCT03485911|69648972|FG000|Part 1|Withdrew Consent prior to dosing|0|||
37961548|NCT03485911|69648973|FG001|Part 1|Withdrew Consent prior to dosing|0|||
37961549|NCT03485911|69648974|FG002|Part 1|Withdrew Consent prior to dosing|0|||
37961550|NCT03485911|69648975|FG003|Part 1|Withdrew Consent prior to dosing|1|||
37961551|NCT03485911|69648972|FG000|Part 1|Other NOS|0|||
37961552|NCT03485911|69648973|FG001|Part 1|Other NOS|0|||
37961553|NCT03485911|69648974|FG002|Part 1|Other NOS|0|||
37961554|NCT03485911|69648975|FG003|Part 1|Other NOS|1|||
37961555|NCT03485911|69648972|FG000|Part 2|Perceived lack of efficacy|5|||
37961556|NCT03485911|69648973|FG001|Part 2|Perceived lack of efficacy|3|||
37961557|NCT03485911|69648974|FG002|Part 2|Perceived lack of efficacy|0|||
37961558|NCT03485911|69648975|FG003|Part 2|Perceived lack of efficacy|2|||
37961559|NCT03485911|69648972|FG000|Part 2|Subject withdrew consent|1|||
37961560|NCT03485911|69648973|FG001|Part 2|Subject withdrew consent|0|||
37961561|NCT03485911|69648974|FG002|Part 2|Subject withdrew consent|2|||
37961562|NCT03485911|69648975|FG003|Part 2|Subject withdrew consent|1|||
37961563|NCT03485911|69648972|FG000|Part 2|Lab abnormalities/AEs|1|||
37961564|NCT03485911|69648973|FG001|Part 2|Lab abnormalities/AEs|2|||
37961565|NCT03485911|69648974|FG002|Part 2|Lab abnormalities/AEs|0|||
37961566|NCT03485911|69648975|FG003|Part 2|Lab abnormalities/AEs|0|||
37961567|NCT03485911|69648972|FG000|Part 2|Other NOS|0|||
37961568|NCT03485911|69648973|FG001|Part 2|Other NOS|1|||
37961569|NCT03485911|69648974|FG002|Part 2|Other NOS|0|||
37961570|NCT03485911|69648975|FG003|Part 2|Other NOS|0|||
37961571|NCT03485911|69648972|FG000|Part 2|Intercurrent illness/new medical condition|1|||
37961572|NCT03485911|69648973|FG001|Part 2|Intercurrent illness/new medical condition|0|||
37961573|NCT03485911|69648974|FG002|Part 2|Intercurrent illness/new medical condition|0|||
37961574|NCT03485911|69648975|FG003|Part 2|Intercurrent illness/new medical condition|0|||
37961575|NCT03485911|69648972|FG000|Part 2|Investigator judgement|1|||
37961576|NCT03485911|69648973|FG001|Part 2|Investigator judgement|0|||
37961577|NCT03485911|69648974|FG002|Part 2|Investigator judgement|0|||
37961578|NCT03485911|69648975|FG003|Part 2|Investigator judgement|0|||
37961579|NCT03485911|69648972|FG000|Part 3|Perceived lack of efficacy|2|||
37961580|NCT03485911|69648973|FG001|Part 3|Perceived lack of efficacy|2|||
37961581|NCT03485911|69648974|FG002|Part 3|Perceived lack of efficacy|2|||
37961582|NCT03485911|69648975|FG003|Part 3|Perceived lack of efficacy|0|||
37961583|NCT03485911|69648972|FG000|Part 3|Subject withdrew consent|1|||
37961584|NCT03485911|69648973|FG001|Part 3|Subject withdrew consent|4|||
37961585|NCT03485911|69648974|FG002|Part 3|Subject withdrew consent|0|||
37961586|NCT03485911|69648975|FG003|Part 3|Subject withdrew consent|1|||
37961587|NCT03485911|69648972|FG000|Part 3|Lab abnormalities/AEs|1|||
37961588|NCT03485911|69648973|FG001|Part 3|Lab abnormalities/AEs|1|||
37961589|NCT03485911|69648974|FG002|Part 3|Lab abnormalities/AEs|0|||
37961590|NCT03485911|69648975|FG003|Part 3|Lab abnormalities/AEs|2|||
37961591|NCT03485911|69648972|FG000|Part 3|Other NOS|1|||
37961592|NCT03485911|69648973|FG001|Part 3|Other NOS|1|||
37961593|NCT03485911|69648974|FG002|Part 3|Other NOS|0|||
37961594|NCT03485911|69648975|FG003|Part 3|Other NOS|0|||
37961595|NCT03485911|69648972|FG000|Part 3|Intercurrent illness/new medical condition|0|||
37961596|NCT03485911|69648973|FG001|Part 3|Intercurrent illness/new medical condition|1|||
37961597|NCT03485911|69648974|FG002|Part 3|Intercurrent illness/new medical condition|1|||
37961598|NCT03485911|69648975|FG003|Part 3|Intercurrent illness/new medical condition|0|||
37961599|NCT03485911|69648972|FG000|Part 3|Sponsor discontinuation|1|||
37961600|NCT03485911|69648973|FG001|Part 3|Sponsor discontinuation|0|||
37961601|NCT03485911|69648974|FG002|Part 3|Sponsor discontinuation|0|||
37961602|NCT03485911|69648975|FG003|Part 3|Sponsor discontinuation|0|||
37961603|NCT03485911|69648972|FG000|Part 3|Berotralstat provided by alternative means|13|||
37961604|NCT03485911|69648973|FG001|Part 3|Berotralstat provided by alternative means|13|||
37961605|NCT03485911|69648974|FG002|Part 3|Berotralstat provided by alternative means|7|||
37961606|NCT03485911|69648975|FG003|Part 3|Berotralstat provided by alternative means|7|||
37961607|NCT02886936|69649050|FG000|Overall Study|Lost to Follow-up|4|||
37961608|NCT02886936|69649051|FG001|Overall Study|Lost to Follow-up|3|||
37961609|NCT02886936|69649052|FG002|Overall Study|Lost to Follow-up|0|||
37961610|NCT02162511|69649087|FG000|Overall Study|Lack of Efficacy|0|||
37961611|NCT02162511|69649088|FG001|Overall Study|Lack of Efficacy|0|||
37961612|NCT02162511|69649089|FG002|Overall Study|Lack of Efficacy|2|||
37961613|NCT00539994|69649134|FG000|Overall Study|Lost to Follow-up|2|||
37961614|NCT00539994|69649135|FG001|Overall Study|Lost to Follow-up|1|||
37961615|NCT00539994|69649136|FG002|Overall Study|Lost to Follow-up|0|||
37961616|NCT00539994|69649134|FG000|Overall Study|Withdrawal by Subject|1|||
37961617|NCT00539994|69649135|FG001|Overall Study|Withdrawal by Subject|0|||
37961618|NCT00539994|69649136|FG002|Overall Study|Withdrawal by Subject|1|||
37961619|NCT00539994|69649134|FG000|Overall Study|Physician Decision|0|||
37961620|NCT00539994|69649135|FG001|Overall Study|Physician Decision|0|||
37961621|NCT00539994|69649136|FG002|Overall Study|Physician Decision|1|||
37961622|NCT00098839|69649153|FG000|Overall Study|Adverse Event|5|||
37961623|NCT00098839|69649154|FG001|Overall Study|Adverse Event|2|||
37961624|NCT00098839|69649153|FG000|Overall Study|Death|1|||
37961625|NCT00098839|69649154|FG001|Overall Study|Death|2|||
37961626|NCT00098839|69649153|FG000|Overall Study|Physician Decision|4|||
37961627|NCT00098839|69649154|FG001|Overall Study|Physician Decision|14|||
37961628|NCT00098839|69649153|FG000|Overall Study|Withdrawal by Subject|1|||
37961629|NCT00098839|69649154|FG001|Overall Study|Withdrawal by Subject|0|||
37961630|NCT00098839|69649153|FG000|Overall Study|Refusal of further protocol therapy|3|||
37961631|NCT00098839|69649154|FG001|Overall Study|Refusal of further protocol therapy|1|||
37961632|NCT00098839|69649153|FG000|Overall Study|Relapse|6|||
37961633|NCT00098839|69649154|FG001|Overall Study|Relapse|3|||
37961634|NCT00098839|69649153|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
37961635|NCT00098839|69649154|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
37961636|NCT00098839|69649153|FG000|Overall Study|Ineligible|2|||
37961637|NCT00098839|69649154|FG001|Overall Study|Ineligible|0|||
37961638|NCT03811093|69649163|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
37961639|NCT03811093|69649164|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
37961640|NCT03811093|69649163|FG000|Overall Study|Unable to measure body fat percentage|2|||
37961641|NCT03811093|69649164|FG001|Overall Study|Unable to measure body fat percentage|0|||
37961642|NCT00485589|69649176|FG000|Overall Study|Death|2|||
37961643|NCT00485589|69649177|FG001|Overall Study|Death|2|||
37961644|NCT00485589|69649178|FG002|Overall Study|Death|0|||
37961645|NCT00485589|69649176|FG000|Overall Study|Failure to return|6|||
37961646|NCT00485589|69649177|FG001|Overall Study|Failure to return|5|||
37961647|NCT00485589|69649178|FG002|Overall Study|Failure to return|1|||
37961648|NCT00485589|69649176|FG000|Overall Study|Protocol Violation|1|||
37961649|NCT00485589|69649177|FG001|Overall Study|Protocol Violation|0|||
37961650|NCT00485589|69649178|FG002|Overall Study|Protocol Violation|0|||
37961651|NCT00485589|69649176|FG000|Overall Study|Violation of selection criteria at entry|0|||
37961652|NCT00485589|69649177|FG001|Overall Study|Violation of selection criteria at entry|3|||
37961653|NCT00485589|69649178|FG002|Overall Study|Violation of selection criteria at entry|1|||
37961654|NCT00485589|69649176|FG000|Overall Study|Administrative/Other|1|||
37961655|NCT00485589|69649177|FG001|Overall Study|Administrative/Other|2|||
37961656|NCT00485589|69649178|FG002|Overall Study|Administrative/Other|1|||
37961657|NCT00485589|69649176|FG000|Overall Study|Insufficient therapeutic response|10|||
37961658|NCT00485589|69649177|FG001|Overall Study|Insufficient therapeutic response|3|||
37961659|NCT00485589|69649178|FG002|Overall Study|Insufficient therapeutic response|1|||
37961660|NCT00485589|69649176|FG000|Overall Study|Refused treatment/did not cooperate|1|||
37961661|NCT00485589|69649177|FG001|Overall Study|Refused treatment/did not cooperate|0|||
37961662|NCT00485589|69649178|FG002|Overall Study|Refused treatment/did not cooperate|2|||
37961663|NCT00485589|69649176|FG000|Overall Study|Withdrawal by Subject|3|||
37961664|NCT00485589|69649177|FG001|Overall Study|Withdrawal by Subject|2|||
37961665|NCT00485589|69649178|FG002|Overall Study|Withdrawal by Subject|2|||
37961666|NCT00485589|69649176|FG000|Overall Study|Adverse Event|3|||
37961667|NCT00485589|69649177|FG001|Overall Study|Adverse Event|3|||
37961668|NCT00485589|69649178|FG002|Overall Study|Adverse Event|10|||
37961669|NCT00490971|69649197|FG000|Acute/Continuation|Adverse Event|62|||
37961670|NCT00490971|69649198|FG001|Acute/Continuation|Adverse Event|13|||
37961671|NCT00490971|69649199|FG002|Acute/Continuation|Adverse Event|0|||
37961672|NCT00490971|69649200|FG003|Acute/Continuation|Adverse Event|0|||
37961673|NCT00490971|69649201|FG004|Acute/Continuation|Adverse Event|0|||
37961674|NCT00490971|69649197|FG000|Acute/Continuation|Death|2|||
37961675|NCT00490971|69649198|FG001|Acute/Continuation|Death|0|||
37961676|NCT00490971|69649199|FG002|Acute/Continuation|Death|0|||
37961677|NCT00490971|69649200|FG003|Acute/Continuation|Death|0|||
37961678|NCT00490971|69649201|FG004|Acute/Continuation|Death|0|||
37961679|NCT00490971|69649197|FG000|Acute/Continuation|Lack of Efficacy|106|||
37961680|NCT00490971|69649198|FG001|Acute/Continuation|Lack of Efficacy|12|||
37961681|NCT00490971|69649199|FG002|Acute/Continuation|Lack of Efficacy|0|||
37961682|NCT00490971|69649200|FG003|Acute/Continuation|Lack of Efficacy|0|||
37961683|NCT00490971|69649201|FG004|Acute/Continuation|Lack of Efficacy|0|||
37961684|NCT00490971|69649197|FG000|Acute/Continuation|Lost to Follow-up|23|||
37961685|NCT00490971|69649198|FG001|Acute/Continuation|Lost to Follow-up|7|||
37961686|NCT00490971|69649199|FG002|Acute/Continuation|Lost to Follow-up|0|||
37961687|NCT00490971|69649200|FG003|Acute/Continuation|Lost to Follow-up|0|||
37961688|NCT00490971|69649201|FG004|Acute/Continuation|Lost to Follow-up|0|||
37961689|NCT00490971|69649197|FG000|Acute/Continuation|Protocol Violation|10|||
37961690|NCT00490971|69649198|FG001|Acute/Continuation|Protocol Violation|2|||
37961691|NCT00490971|69649199|FG002|Acute/Continuation|Protocol Violation|0|||
37961692|NCT00490971|69649200|FG003|Acute/Continuation|Protocol Violation|0|||
37961693|NCT00490971|69649201|FG004|Acute/Continuation|Protocol Violation|0|||
37961694|NCT00490971|69649197|FG000|Acute/Continuation|Withdrawal by Subject|92|||
37961695|NCT00490971|69649198|FG001|Acute/Continuation|Withdrawal by Subject|24|||
37961696|NCT00490971|69649199|FG002|Acute/Continuation|Withdrawal by Subject|0|||
37961697|NCT00490971|69649200|FG003|Acute/Continuation|Withdrawal by Subject|0|||
37961698|NCT00490971|69649201|FG004|Acute/Continuation|Withdrawal by Subject|0|||
37961699|NCT00490971|69649197|FG000|Acute/Continuation|Other|11|||
37961700|NCT00490971|69649198|FG001|Acute/Continuation|Other|4|||
37961701|NCT00490971|69649199|FG002|Acute/Continuation|Other|0|||
37961702|NCT00490971|69649200|FG003|Acute/Continuation|Other|0|||
37961703|NCT00490971|69649201|FG004|Acute/Continuation|Other|0|||
37961704|NCT00490971|69649197|FG000|Maintenance|Adverse Event|0|||
37961705|NCT00490971|69649198|FG001|Maintenance|Adverse Event|0|||
37961706|NCT00490971|69649199|FG002|Maintenance|Adverse Event|4|||
37961707|NCT00490971|69649200|FG003|Maintenance|Adverse Event|5|||
37961708|NCT00490971|69649201|FG004|Maintenance|Adverse Event|7|||
37961709|NCT00490971|69649197|FG000|Maintenance|Death|0|||
37961710|NCT00490971|69649198|FG001|Maintenance|Death|0|||
37961711|NCT00490971|69649199|FG002|Maintenance|Death|0|||
37961712|NCT00490971|69649200|FG003|Maintenance|Death|2|||
37961713|NCT00490971|69649201|FG004|Maintenance|Death|0|||
37961714|NCT00490971|69649197|FG000|Maintenance|Lost to Follow-up|0|||
37961715|NCT00490971|69649198|FG001|Maintenance|Lost to Follow-up|0|||
37961716|NCT00490971|69649199|FG002|Maintenance|Lost to Follow-up|5|||
37961717|NCT00490971|69649200|FG003|Maintenance|Lost to Follow-up|8|||
37961718|NCT00490971|69649201|FG004|Maintenance|Lost to Follow-up|10|||
37961719|NCT00490971|69649197|FG000|Maintenance|Pregnancy|0|||
37961720|NCT00490971|69649198|FG001|Maintenance|Pregnancy|0|||
37961721|NCT00490971|69649199|FG002|Maintenance|Pregnancy|1|||
38051601|NCT03309696|69740937|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
38051602|NCT03309696|69740938|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
37961722|NCT00490971|69649200|FG003|Maintenance|Pregnancy|0|||
37961723|NCT00490971|69649201|FG004|Maintenance|Pregnancy|0|||
37961724|NCT00490971|69649197|FG000|Maintenance|Protocol Violation|0|||
37961725|NCT00490971|69649198|FG001|Maintenance|Protocol Violation|0|||
37961726|NCT00490971|69649199|FG002|Maintenance|Protocol Violation|4|||
37961727|NCT00490971|69649200|FG003|Maintenance|Protocol Violation|1|||
37961728|NCT00490971|69649201|FG004|Maintenance|Protocol Violation|1|||
37961729|NCT00490971|69649197|FG000|Maintenance|Withdrawal by Subject|0|||
37961730|NCT00490971|69649198|FG001|Maintenance|Withdrawal by Subject|0|||
37961731|NCT00490971|69649199|FG002|Maintenance|Withdrawal by Subject|26|||
37961732|NCT00490971|69649200|FG003|Maintenance|Withdrawal by Subject|28|||
37961733|NCT00490971|69649201|FG004|Maintenance|Withdrawal by Subject|18|||
37961734|NCT00490971|69649197|FG000|Maintenance|Other|0|||
37961735|NCT00490971|69649198|FG001|Maintenance|Other|0|||
37961736|NCT00490971|69649199|FG002|Maintenance|Other|11|||
37961737|NCT00490971|69649200|FG003|Maintenance|Other|9|||
37961738|NCT00490971|69649201|FG004|Maintenance|Other|3|||
37961739|NCT00686075|69649223|FG000|Overall Study|Withdrawal by Subject|4|||
37961740|NCT00686075|69649224|FG001|Overall Study|Withdrawal by Subject|3|||
37961741|NCT00686075|69649225|FG002|Overall Study|Withdrawal by Subject|3|||
37961742|NCT00686075|69649226|FG003|Overall Study|Withdrawal by Subject|7|||
37961743|NCT00686075|69649227|FG004|Overall Study|Withdrawal by Subject|1|||
37961744|NCT00686075|69649228|FG005|Overall Study|Withdrawal by Subject|0|||
37961745|NCT00686075|69649229|FG006|Overall Study|Withdrawal by Subject|0|||
37961746|NCT00686075|69649230|FG007|Overall Study|Withdrawal by Subject|2|||
37961747|NCT00686075|69649231|FG008|Overall Study|Withdrawal by Subject|4|||
37961748|NCT00686075|69649232|FG009|Overall Study|Withdrawal by Subject|6|||
37961749|NCT00686075|69649223|FG000|Overall Study|Lost to Follow-up|3|||
37961750|NCT00686075|69649224|FG001|Overall Study|Lost to Follow-up|6|||
37961751|NCT00686075|69649225|FG002|Overall Study|Lost to Follow-up|3|||
37961752|NCT00686075|69649226|FG003|Overall Study|Lost to Follow-up|2|||
37961753|NCT00686075|69649227|FG004|Overall Study|Lost to Follow-up|3|||
37961754|NCT00686075|69649228|FG005|Overall Study|Lost to Follow-up|3|||
37961755|NCT00686075|69649229|FG006|Overall Study|Lost to Follow-up|0|||
37961756|NCT00686075|69649230|FG007|Overall Study|Lost to Follow-up|0|||
37961757|NCT00686075|69649231|FG008|Overall Study|Lost to Follow-up|2|||
37961758|NCT00686075|69649232|FG009|Overall Study|Lost to Follow-up|3|||
37961759|NCT00686075|69649223|FG000|Overall Study|Other|1|||
37961760|NCT00686075|69649224|FG001|Overall Study|Other|1|||
37961761|NCT00686075|69649225|FG002|Overall Study|Other|0|||
37961762|NCT00686075|69649226|FG003|Overall Study|Other|0|||
37961763|NCT00686075|69649227|FG004|Overall Study|Other|0|||
37961764|NCT00686075|69649228|FG005|Overall Study|Other|0|||
37961765|NCT00686075|69649229|FG006|Overall Study|Other|0|||
37961766|NCT00686075|69649230|FG007|Overall Study|Other|0|||
37961767|NCT00686075|69649231|FG008|Overall Study|Other|0|||
37961768|NCT00686075|69649232|FG009|Overall Study|Other|1|||
37961769|NCT00685763|69649254|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
37961770|NCT00685763|69649254|FG000|Overall Study|Protocol Violation|1|||
37961771|NCT00098293|69649261|FG000|Double-blind (DB) Phase|Adverse Event|14|||
37961772|NCT00098293|69649262|FG001|Double-blind (DB) Phase|Adverse Event|27|||
37961773|NCT00098293|69649263|FG002|Double-blind (DB) Phase|Adverse Event|60|||
37961774|NCT00098293|69649264|FG003|Double-blind (DB) Phase|Adverse Event|0|||
37961775|NCT00098293|69649265|FG004|Double-blind (DB) Phase|Adverse Event|0|||
37961776|NCT00098293|69649261|FG000|Double-blind (DB) Phase|Pregnancy|0|||
37961777|NCT00098293|69649262|FG001|Double-blind (DB) Phase|Pregnancy|7|||
37961778|NCT00098293|69649263|FG002|Double-blind (DB) Phase|Pregnancy|9|||
37961779|NCT00098293|69649264|FG003|Double-blind (DB) Phase|Pregnancy|0|||
37961780|NCT00098293|69649265|FG004|Double-blind (DB) Phase|Pregnancy|0|||
37961781|NCT00098293|69649261|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
37961782|NCT00098293|69649262|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
37961783|NCT00098293|69649263|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
37961784|NCT00098293|69649264|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
37961785|NCT00098293|69649265|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
37961786|NCT00098293|69649261|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
37961787|NCT00098293|69649262|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
37961788|NCT00098293|69649263|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
37961789|NCT00098293|69649264|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
37961790|NCT00098293|69649265|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
37961791|NCT00098293|69649261|FG000|Double-blind (DB) Phase|Death|1|||
37961792|NCT00098293|69649262|FG001|Double-blind (DB) Phase|Death|2|||
37961793|NCT00098293|69649263|FG002|Double-blind (DB) Phase|Death|2|||
37961794|NCT00098293|69649264|FG003|Double-blind (DB) Phase|Death|0|||
37961795|NCT00098293|69649265|FG004|Double-blind (DB) Phase|Death|0|||
37961796|NCT00098293|69649261|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
37961797|NCT00098293|69649262|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
37961798|NCT00098293|69649263|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
37961799|NCT00098293|69649264|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
37961800|NCT00098293|69649265|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
37961801|NCT00098293|69649261|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
37961802|NCT00098293|69649262|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
37961803|NCT00098293|69649263|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
38051603|NCT03309696|69740939|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
37961804|NCT00098293|69649264|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
37961805|NCT00098293|69649265|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
37961806|NCT00098293|69649261|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
38051604|NCT03309696|69740940|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
37961807|NCT00098293|69649262|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
37961808|NCT00098293|69649263|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
37961809|NCT00098293|69649264|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
37961810|NCT00098293|69649265|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
37961811|NCT00098293|69649261|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
37961812|NCT00098293|69649262|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
37961813|NCT00098293|69649263|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
37961814|NCT00098293|69649264|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
37961815|NCT00098293|69649265|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
37961816|NCT00098293|69649261|FG000|Open-label (OL) Phase|Adverse Event|0|||
37961817|NCT00098293|69649262|FG001|Open-label (OL) Phase|Adverse Event|3|||
37961818|NCT00098293|69649263|FG002|Open-label (OL) Phase|Adverse Event|7|||
37961819|NCT00098293|69649264|FG003|Open-label (OL) Phase|Adverse Event|6|||
37961820|NCT00098293|69649265|FG004|Open-label (OL) Phase|Adverse Event|0|||
37961821|NCT00098293|69649261|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
37961822|NCT00098293|69649262|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
37961823|NCT00098293|69649263|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
38051605|NCT03075644|69740954|FG000|Overall Study|Withdrawal by Subject|1|||
38051606|NCT03075644|69740955|FG001|Overall Study|Withdrawal by Subject|1|||
38051607|NCT03075410|69740971|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
38051608|NCT03075410|69740972|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
37961824|NCT00098293|69649264|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
37961825|NCT00098293|69649265|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
37961826|NCT00098293|69649261|FG000|Open-label (OL) Phase|Pregnancy|0|||
37961827|NCT00098293|69649262|FG001|Open-label (OL) Phase|Pregnancy|1|||
37961828|NCT00098293|69649263|FG002|Open-label (OL) Phase|Pregnancy|0|||
37961829|NCT00098293|69649264|FG003|Open-label (OL) Phase|Pregnancy|3|||
37961830|NCT00098293|69649265|FG004|Open-label (OL) Phase|Pregnancy|0|||
37961831|NCT00098293|69649261|FG000|Open-label (OL) Phase|Protocol Violation|0|||
37961832|NCT00098293|69649262|FG001|Open-label (OL) Phase|Protocol Violation|6|||
37961833|NCT00098293|69649263|FG002|Open-label (OL) Phase|Protocol Violation|13|||
37961834|NCT00098293|69649264|FG003|Open-label (OL) Phase|Protocol Violation|16|||
37961835|NCT00098293|69649265|FG004|Open-label (OL) Phase|Protocol Violation|0|||
37961836|NCT00098293|69649261|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
37961837|NCT00098293|69649262|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
37961838|NCT00098293|69649263|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
37961839|NCT00098293|69649264|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
37961840|NCT00098293|69649265|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
37961841|NCT00098293|69649261|FG000|Open-label (OL) Phase|Death|0|||
37961842|NCT00098293|69649262|FG001|Open-label (OL) Phase|Death|2|||
37961843|NCT00098293|69649263|FG002|Open-label (OL) Phase|Death|3|||
37961844|NCT00098293|69649264|FG003|Open-label (OL) Phase|Death|0|||
37961845|NCT00098293|69649265|FG004|Open-label (OL) Phase|Death|0|||
37961846|NCT00098293|69649261|FG000|Supplemental Phase (SP)|Death|0|||
37961847|NCT00098293|69649262|FG001|Supplemental Phase (SP)|Death|0|||
37961848|NCT00098293|69649263|FG002|Supplemental Phase (SP)|Death|0|||
37961849|NCT00098293|69649264|FG003|Supplemental Phase (SP)|Death|0|||
37961850|NCT00098293|69649265|FG004|Supplemental Phase (SP)|Death|1|||
37961851|NCT00098293|69649261|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
37961852|NCT00098293|69649262|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
37961853|NCT00098293|69649263|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
37961854|NCT00098293|69649264|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
37961855|NCT00098293|69649265|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
37961856|NCT00098293|69649261|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
37961857|NCT00098293|69649262|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
37961858|NCT00098293|69649263|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
37961859|NCT00098293|69649264|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
37961860|NCT00098293|69649265|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
37961861|NCT00098293|69649261|FG000|Supplemental Phase (SP)|Other|0|||
37961862|NCT00098293|69649262|FG001|Supplemental Phase (SP)|Other|0|||
37961863|NCT00098293|69649263|FG002|Supplemental Phase (SP)|Other|0|||
37961864|NCT00098293|69649264|FG003|Supplemental Phase (SP)|Other|0|||
37961865|NCT00098293|69649265|FG004|Supplemental Phase (SP)|Other|22|||
37961866|NCT00685685|69649276|FG000|Washout Period of 7 Days|Adverse Event|2|||
37961867|NCT00685685|69649277|FG001|Washout Period of 7 Days|Adverse Event|0|||
37961868|NCT00685685|69649276|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
37961869|NCT00685685|69649277|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
37961870|NCT00684671|69649286|FG000|Overall Study|Adverse Event|1|||
37961871|NCT00684671|69649287|FG001|Overall Study|Adverse Event|0|||
37961872|NCT00684671|69649288|FG002|Overall Study|Adverse Event|0|||
37961873|NCT00684671|69649286|FG000|Overall Study|Lost to Follow-up|1|||
37961874|NCT00684671|69649287|FG001|Overall Study|Lost to Follow-up|0|||
37961875|NCT00684671|69649288|FG002|Overall Study|Lost to Follow-up|0|||
37961876|NCT00684671|69649286|FG000|Overall Study|Alcoholic dependance|1|||
37961877|NCT00684671|69649287|FG001|Overall Study|Alcoholic dependance|0|||
37961878|NCT00684671|69649288|FG002|Overall Study|Alcoholic dependance|0|||
37961879|NCT03859323|69649309|FG000|Overall Study|Lost to Follow-up|0|||
38051609|NCT03075410|69740973|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
38051610|NCT03075410|69740974|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
38051611|NCT03075410|69740975|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
37961880|NCT03859323|69649310|FG001|Overall Study|Lost to Follow-up|0|||
37961881|NCT03859323|69649311|FG002|Overall Study|Lost to Follow-up|0|||
37961882|NCT03859323|69649312|FG003|Overall Study|Lost to Follow-up|0|||
37961883|NCT03859323|69649313|FG004|Overall Study|Lost to Follow-up|0|||
37961884|NCT03859323|69649314|FG005|Overall Study|Lost to Follow-up|0|||
37961885|NCT03859323|69649315|FG006|Overall Study|Lost to Follow-up|1|||
37961886|NCT03859323|69649316|FG007|Overall Study|Lost to Follow-up|0|||
37961887|NCT03859323|69649317|FG008|Overall Study|Lost to Follow-up|0|||
37961888|NCT03859323|69649318|FG009|Overall Study|Lost to Follow-up|0|||
37961889|NCT03859323|69649319|FG010|Overall Study|Lost to Follow-up|0|||
37961890|NCT03859323|69649320|FG011|Overall Study|Lost to Follow-up|0|||
37961891|NCT03859323|69649321|FG012|Overall Study|Lost to Follow-up|0|||
37961892|NCT03859323|69649309|FG000|Overall Study|Withdrawal by Subject|0|||
37961893|NCT03859323|69649310|FG001|Overall Study|Withdrawal by Subject|0|||
37961894|NCT03859323|69649311|FG002|Overall Study|Withdrawal by Subject|1|||
37961895|NCT03859323|69649312|FG003|Overall Study|Withdrawal by Subject|0|||
37961896|NCT03859323|69649313|FG004|Overall Study|Withdrawal by Subject|0|||
37961897|NCT03859323|69649314|FG005|Overall Study|Withdrawal by Subject|1|||
37961898|NCT03859323|69649315|FG006|Overall Study|Withdrawal by Subject|0|||
37961899|NCT03859323|69649316|FG007|Overall Study|Withdrawal by Subject|0|||
37961900|NCT03859323|69649317|FG008|Overall Study|Withdrawal by Subject|0|||
37961901|NCT03859323|69649318|FG009|Overall Study|Withdrawal by Subject|1|||
37961902|NCT03859323|69649319|FG010|Overall Study|Withdrawal by Subject|1|||
37961903|NCT03859323|69649320|FG011|Overall Study|Withdrawal by Subject|2|||
37961904|NCT03859323|69649321|FG012|Overall Study|Withdrawal by Subject|1|||
37961905|NCT03859323|69649309|FG000|Overall Study|Pregnancy|0|||
37961906|NCT03859323|69649310|FG001|Overall Study|Pregnancy|0|||
37961907|NCT03859323|69649311|FG002|Overall Study|Pregnancy|0|||
37961908|NCT03859323|69649312|FG003|Overall Study|Pregnancy|0|||
37961909|NCT03859323|69649313|FG004|Overall Study|Pregnancy|0|||
37961910|NCT03859323|69649314|FG005|Overall Study|Pregnancy|0|||
37961911|NCT03859323|69649315|FG006|Overall Study|Pregnancy|0|||
37961912|NCT03859323|69649316|FG007|Overall Study|Pregnancy|0|||
37961913|NCT03859323|69649317|FG008|Overall Study|Pregnancy|0|||
37961914|NCT03859323|69649318|FG009|Overall Study|Pregnancy|1|||
37961915|NCT03859323|69649319|FG010|Overall Study|Pregnancy|0|||
37961916|NCT03859323|69649320|FG011|Overall Study|Pregnancy|0|||
37961917|NCT03859323|69649321|FG012|Overall Study|Pregnancy|0|||
37961918|NCT03857841|69649364|FG000|Overall Study|Death|1|||
37961919|NCT03857841|69649365|FG001|Overall Study|Death|0|||
37961920|NCT03857841|69649366|FG002|Overall Study|Death|0|||
37961921|NCT03857841|69649367|FG003|Overall Study|Death|0|||
37961922|NCT03857841|69649364|FG000|Overall Study|Study Terminated by Sponsor|1|||
37961923|NCT03857841|69649365|FG001|Overall Study|Study Terminated by Sponsor|0|||
37961924|NCT03857841|69649366|FG002|Overall Study|Study Terminated by Sponsor|0|||
37961925|NCT03857841|69649367|FG003|Overall Study|Study Terminated by Sponsor|0|||
37961926|NCT00500331|69649384|FG000|Overall Study|Adverse Event|0|||
37961927|NCT00500331|69649385|FG001|Overall Study|Adverse Event|2|||
37961928|NCT00500331|69649386|FG002|Overall Study|Adverse Event|0|||
37961929|NCT00500331|69649387|FG003|Overall Study|Adverse Event|1|||
37961930|NCT00500331|69649388|FG004|Overall Study|Adverse Event|2|||
37961931|NCT00500331|69649389|FG005|Overall Study|Adverse Event|2|||
37961932|NCT00500331|69649390|FG006|Overall Study|Adverse Event|0|||
37961933|NCT00500331|69649384|FG000|Overall Study|Lost to Follow-up|1|||
37961934|NCT00500331|69649385|FG001|Overall Study|Lost to Follow-up|1|||
37961935|NCT00500331|69649386|FG002|Overall Study|Lost to Follow-up|1|||
37961936|NCT00500331|69649387|FG003|Overall Study|Lost to Follow-up|2|||
37961937|NCT00500331|69649388|FG004|Overall Study|Lost to Follow-up|1|||
37961938|NCT00500331|69649389|FG005|Overall Study|Lost to Follow-up|0|||
37961939|NCT00500331|69649390|FG006|Overall Study|Lost to Follow-up|0|||
37961940|NCT00500331|69649384|FG000|Overall Study|Protocol Violation|3|||
37961941|NCT00500331|69649385|FG001|Overall Study|Protocol Violation|1|||
37961942|NCT00500331|69649386|FG002|Overall Study|Protocol Violation|1|||
37961943|NCT00500331|69649387|FG003|Overall Study|Protocol Violation|0|||
37961944|NCT00500331|69649388|FG004|Overall Study|Protocol Violation|1|||
37961945|NCT00500331|69649389|FG005|Overall Study|Protocol Violation|1|||
37961946|NCT00500331|69649390|FG006|Overall Study|Protocol Violation|1|||
37961947|NCT00500331|69649384|FG000|Overall Study|Withdrawal by Subject|4|||
37961948|NCT00500331|69649385|FG001|Overall Study|Withdrawal by Subject|0|||
38051612|NCT03075410|69740976|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
38051613|NCT03075410|69740977|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
38051614|NCT03075410|69740978|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
37961949|NCT00500331|69649386|FG002|Overall Study|Withdrawal by Subject|1|||
37961950|NCT00500331|69649387|FG003|Overall Study|Withdrawal by Subject|5|||
37961951|NCT00500331|69649388|FG004|Overall Study|Withdrawal by Subject|0|||
37961952|NCT00500331|69649389|FG005|Overall Study|Withdrawal by Subject|1|||
37961953|NCT00500331|69649390|FG006|Overall Study|Withdrawal by Subject|1|||
37961954|NCT00500331|69649384|FG000|Overall Study|Lack of Efficacy|3|||
37961955|NCT00500331|69649385|FG001|Overall Study|Lack of Efficacy|1|||
37961956|NCT00500331|69649386|FG002|Overall Study|Lack of Efficacy|0|||
37961957|NCT00500331|69649387|FG003|Overall Study|Lack of Efficacy|0|||
37961958|NCT00500331|69649388|FG004|Overall Study|Lack of Efficacy|0|||
37961959|NCT00500331|69649389|FG005|Overall Study|Lack of Efficacy|0|||
37961960|NCT00500331|69649390|FG006|Overall Study|Lack of Efficacy|0|||
37961961|NCT00500331|69649384|FG000|Overall Study|Liver function test abnormality|0|||
37961962|NCT00500331|69649385|FG001|Overall Study|Liver function test abnormality|0|||
37961963|NCT00500331|69649386|FG002|Overall Study|Liver function test abnormality|1|||
37961964|NCT00500331|69649387|FG003|Overall Study|Liver function test abnormality|0|||
37961965|NCT00500331|69649388|FG004|Overall Study|Liver function test abnormality|0|||
37961966|NCT00500331|69649389|FG005|Overall Study|Liver function test abnormality|0|||
37961967|NCT00500331|69649390|FG006|Overall Study|Liver function test abnormality|0|||
37961968|NCT00500331|69649384|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
37961969|NCT00500331|69649385|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
37961970|NCT00500331|69649386|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
37961971|NCT00500331|69649387|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
37961972|NCT00500331|69649388|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
37961973|NCT00500331|69649389|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
37961974|NCT00500331|69649390|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
37961975|NCT00500331|69649384|FG000|Overall Study|Didn't return for continuation of study|1|||
37961976|NCT00500331|69649385|FG001|Overall Study|Didn't return for continuation of study|0|||
37961977|NCT00500331|69649386|FG002|Overall Study|Didn't return for continuation of study|0|||
37961978|NCT00500331|69649387|FG003|Overall Study|Didn't return for continuation of study|0|||
37961979|NCT00500331|69649388|FG004|Overall Study|Didn't return for continuation of study|0|||
37961980|NCT00500331|69649389|FG005|Overall Study|Didn't return for continuation of study|0|||
37961981|NCT00500331|69649390|FG006|Overall Study|Didn't return for continuation of study|0|||
37961982|NCT00500331|69649384|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
37961983|NCT00500331|69649385|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
37961984|NCT00500331|69649386|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
37961985|NCT00500331|69649387|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
37961986|NCT00500331|69649388|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
37961987|NCT00500331|69649389|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
37961988|NCT00500331|69649390|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
37961989|NCT00500331|69649384|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
37961990|NCT00500331|69649385|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
37961991|NCT00500331|69649386|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
37961992|NCT00500331|69649387|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
37961993|NCT00500331|69649388|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
37961994|NCT00500331|69649389|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
37961995|NCT00500331|69649390|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
37961996|NCT00500331|69649384|FG000|Overall Study|Participant was randomized by mistake|1|||
37961997|NCT00500331|69649385|FG001|Overall Study|Participant was randomized by mistake|0|||
37961998|NCT00500331|69649386|FG002|Overall Study|Participant was randomized by mistake|0|||
37961999|NCT00500331|69649387|FG003|Overall Study|Participant was randomized by mistake|0|||
37962000|NCT00500331|69649388|FG004|Overall Study|Participant was randomized by mistake|0|||
37962001|NCT00500331|69649389|FG005|Overall Study|Participant was randomized by mistake|0|||
37962002|NCT00500331|69649390|FG006|Overall Study|Participant was randomized by mistake|0|||
37962003|NCT00500331|69649384|FG000|Overall Study|Diabetologist nurse in the study|0|||
37962004|NCT00500331|69649385|FG001|Overall Study|Diabetologist nurse in the study|0|||
37962005|NCT00500331|69649386|FG002|Overall Study|Diabetologist nurse in the study|1|||
37962006|NCT00500331|69649387|FG003|Overall Study|Diabetologist nurse in the study|0|||
37962007|NCT00500331|69649388|FG004|Overall Study|Diabetologist nurse in the study|0|||
37962008|NCT00500331|69649389|FG005|Overall Study|Diabetologist nurse in the study|0|||
37962009|NCT00500331|69649390|FG006|Overall Study|Diabetologist nurse in the study|0|||
37962010|NCT00500331|69649384|FG000|Overall Study|State ban of biological samples export|0|||
37962011|NCT00500331|69649385|FG001|Overall Study|State ban of biological samples export|0|||
37962012|NCT00500331|69649386|FG002|Overall Study|State ban of biological samples export|0|||
37962013|NCT00500331|69649387|FG003|Overall Study|State ban of biological samples export|1|||
37962014|NCT00500331|69649388|FG004|Overall Study|State ban of biological samples export|0|||
37962015|NCT00500331|69649389|FG005|Overall Study|State ban of biological samples export|0|||
37962016|NCT00500331|69649390|FG006|Overall Study|State ban of biological samples export|0|||
37962017|NCT00500331|69649384|FG000|Overall Study|Protocol violated|0|||
37962018|NCT00500331|69649385|FG001|Overall Study|Protocol violated|0|||
37962019|NCT00500331|69649386|FG002|Overall Study|Protocol violated|0|||
37962020|NCT00500331|69649387|FG003|Overall Study|Protocol violated|1|||
37962021|NCT00500331|69649388|FG004|Overall Study|Protocol violated|0|||
38051615|NCT03075410|69740979|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
38051616|NCT03075410|69740971|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
38051617|NCT03075410|69740972|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
37962022|NCT00500331|69649389|FG005|Overall Study|Protocol violated|0|||
37962023|NCT00500331|69649390|FG006|Overall Study|Protocol violated|0|||
37962024|NCT00499863|69649409|FG000|Overall Study|Lack of Efficacy|21|||
37962025|NCT00499863|69649410|FG001|Overall Study|Lack of Efficacy|27|||
37962026|NCT00499863|69649409|FG000|Overall Study|Protocol Violation|12|||
37962027|NCT00499863|69649410|FG001|Overall Study|Protocol Violation|7|||
37962028|NCT00499863|69649409|FG000|Overall Study|Withdrawal by Subject|6|||
37962029|NCT00499863|69649410|FG001|Overall Study|Withdrawal by Subject|4|||
37962030|NCT00499863|69649409|FG000|Overall Study|Adverse Event|8|||
37962031|NCT00499863|69649410|FG001|Overall Study|Adverse Event|2|||
37962032|NCT00499863|69649409|FG000|Overall Study|Sponsor decision|2|||
37962033|NCT00499863|69649410|FG001|Overall Study|Sponsor decision|2|||
37962034|NCT00499863|69649409|FG000|Overall Study|Lost to Follow-up|1|||
37962035|NCT00499863|69649410|FG001|Overall Study|Lost to Follow-up|1|||
37962036|NCT00484185|69649416|FG000|Overall Study|Lost to Follow-up|44|||
37962037|NCT00484185|69649416|FG000|Overall Study|Other|20|||
37962038|NCT00484185|69649416|FG000|Overall Study|Randomized but not treated|5|||
37962039|NCT00484185|69649416|FG000|Overall Study|Death|2|||
37962040|NCT00097981|69649422|FG000|Overall Study|Adverse Event|31|||
37962041|NCT00097981|69649423|FG001|Overall Study|Adverse Event|44|||
37962042|NCT00097981|69649422|FG000|Overall Study|Withdrawal by Subject|10|||
37962043|NCT00097981|69649423|FG001|Overall Study|Withdrawal by Subject|8|||
37962044|NCT00097981|69649422|FG000|Overall Study|Protocol Violation|1|||
37962045|NCT00097981|69649423|FG001|Overall Study|Protocol Violation|1|||
37962046|NCT00097981|69649422|FG000|Overall Study|Death|2|||
37962047|NCT00097981|69649423|FG001|Overall Study|Death|4|||
37962048|NCT00097981|69649422|FG000|Overall Study|Physician Decision|7|||
37962049|NCT00097981|69649423|FG001|Overall Study|Physician Decision|1|||
37962050|NCT00097981|69649422|FG000|Overall Study|Disease Progression|8|||
37962051|NCT00097981|69649423|FG001|Overall Study|Disease Progression|2|||
37962052|NCT00097981|69649422|FG000|Overall Study|Transplant planned|28|||
37962053|NCT00097981|69649423|FG001|Overall Study|Transplant planned|27|||
38051618|NCT03075410|69740973|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
38051619|NCT03075410|69740974|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
37962054|NCT00097981|69649422|FG000|Overall Study|Other|19|||
37962055|NCT00097981|69649423|FG001|Overall Study|Other|13|||
37962056|NCT00572195|69649429|FG000|Overall Study|Withdrawal by Subject|50|||
37962057|NCT00572195|69649429|FG000|Overall Study|Death|9|||
37962058|NCT00572195|69649429|FG000|Overall Study|Adverse Event|4|||
37962059|NCT00572195|69649429|FG000|Overall Study|Lost to Follow-up|5|||
37962060|NCT00572039|69649435|FG000|Overall Study|Withdrawal by Subject|9|||
37962061|NCT00572039|69649436|FG001|Overall Study|Withdrawal by Subject|6|||
37962062|NCT00572039|69649435|FG000|Overall Study|Death|2|||
37962063|NCT00572039|69649436|FG001|Overall Study|Death|3|||
37962064|NCT00572039|69649435|FG000|Overall Study|Ill|5|||
37962065|NCT00572039|69649436|FG001|Overall Study|Ill|1|||
37962066|NCT00684593|69649446|FG000|Overall Study|Adverse Event|0|||
37962067|NCT00684593|69649447|FG001|Overall Study|Adverse Event|2|||
37962068|NCT00685373|69649453|FG000|Overall Study|Adverse Event|3|||
37962069|NCT00685373|69649453|FG000|Overall Study|Withdrawal by Subject|5|||
37962070|NCT00685373|69649453|FG000|Overall Study|Lack of Efficacy|3|||
37962071|NCT00685373|69649453|FG000|Overall Study|Condition no longer requires study drug|1|||
37962072|NCT00685373|69649453|FG000|Overall Study|Lost to Follow-up|2|||
38051620|NCT03075410|69740975|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
38051621|NCT03075410|69740976|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
38051622|NCT03075410|69740977|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
38051623|NCT03075410|69740978|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
38051624|NCT03075410|69740979|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
38051625|NCT03071276|69741021|FG000|Overall Study|Adverse Event|1|||
38051626|NCT03071276|69741021|FG000|Overall Study|Lack of Efficacy|14|||
38051627|NCT03074162|69741031|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
38051628|NCT03074162|69741032|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
38051629|NCT03074162|69741033|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
37962073|NCT00685373|69649453|FG000|Overall Study|Protocol Violation|1|||
37962074|NCT00684515|69649460|FG000|Overall Study|Adverse Event|3|||
37962075|NCT00684515|69649461|FG001|Overall Study|Adverse Event|3|||
37962076|NCT00684515|69649462|FG002|Overall Study|Adverse Event|1|||
37962077|NCT00684515|69649460|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
37962078|NCT00684515|69649461|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
37962079|NCT00684515|69649462|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
37962080|NCT00490815|69649472|FG000|Overall Study|Adverse Event|2|||
37962081|NCT00490815|69649473|FG001|Overall Study|Adverse Event|3|||
37962082|NCT00490815|69649472|FG000|Overall Study|Withdrawal by Subject|4|||
37962083|NCT00490815|69649473|FG001|Overall Study|Withdrawal by Subject|0|||
37962084|NCT00490815|69649472|FG000|Overall Study|Lost to Follow-up|1|||
37962085|NCT00490815|69649473|FG001|Overall Study|Lost to Follow-up|3|||
37962086|NCT00490815|69649472|FG000|Overall Study|Death|1|||
37962087|NCT00490815|69649473|FG001|Overall Study|Death|3|||
37962088|NCT03855189|69649482|FG000|Overall Study|Adverse Event|5|||
37962089|NCT03855189|69649483|FG001|Overall Study|Adverse Event|2|||
37962090|NCT03855189|69649484|FG002|Overall Study|Adverse Event|4|||
37962091|NCT03855189|69649482|FG000|Overall Study|Treatment Failure|1|||
37962092|NCT03855189|69649483|FG001|Overall Study|Treatment Failure|1|||
37962093|NCT03855189|69649484|FG002|Overall Study|Treatment Failure|2|||
37962094|NCT03855189|69649482|FG000|Overall Study|Noncompliance with Protocol|0|||
37962095|NCT03855189|69649483|FG001|Overall Study|Noncompliance with Protocol|1|||
37962096|NCT03855189|69649484|FG002|Overall Study|Noncompliance with Protocol|0|||
37962097|NCT03855189|69649482|FG000|Overall Study|Did Not Return|4|||
37962098|NCT03855189|69649483|FG001|Overall Study|Did Not Return|3|||
37962099|NCT03855189|69649484|FG002|Overall Study|Did Not Return|0|||
37962100|NCT03853551|69649492|FG000|Overall Study|Death|2|||
37962101|NCT03853551|69649492|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
37962102|NCT00423670|69649503|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
37962103|NCT00423670|69649504|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
37962104|NCT00423670|69649505|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
37962105|NCT00423670|69649506|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
37962106|NCT00423670|69649507|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
37962107|NCT00423670|69649508|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
37962108|NCT00423670|69649509|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
37962109|NCT00423670|69649510|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
37962110|NCT00423670|69649503|FG000|Treatment Period|Adverse Event|8|||
37962111|NCT00423670|69649504|FG001|Treatment Period|Adverse Event|12|||
37962112|NCT00423670|69649505|FG002|Treatment Period|Adverse Event|15|||
37962113|NCT00423670|69649506|FG003|Treatment Period|Adverse Event|20|||
37962114|NCT00423670|69649507|FG004|Treatment Period|Adverse Event|9|||
37962115|NCT00423670|69649508|FG005|Treatment Period|Adverse Event|4|||
37962116|NCT00423670|69649509|FG006|Treatment Period|Adverse Event|7|||
37962117|NCT00423670|69649510|FG007|Treatment Period|Adverse Event|2|||
37962118|NCT00423670|69649503|FG000|Treatment Period|Protocol-defined clinical event|0|||
37962119|NCT00423670|69649504|FG001|Treatment Period|Protocol-defined clinical event|7|||
37962120|NCT00423670|69649505|FG002|Treatment Period|Protocol-defined clinical event|4|||
37962121|NCT00423670|69649506|FG003|Treatment Period|Protocol-defined clinical event|12|||
37962122|NCT00423670|69649507|FG004|Treatment Period|Protocol-defined clinical event|5|||
37962123|NCT00423670|69649508|FG005|Treatment Period|Protocol-defined clinical event|4|||
37962124|NCT00423670|69649509|FG006|Treatment Period|Protocol-defined clinical event|16|||
37962125|NCT00423670|69649510|FG007|Treatment Period|Protocol-defined clinical event|15|||
37962126|NCT00423670|69649503|FG000|Treatment Period|Lost to Follow-up|2|||
37962127|NCT00423670|69649504|FG001|Treatment Period|Lost to Follow-up|1|||
37962128|NCT00423670|69649505|FG002|Treatment Period|Lost to Follow-up|3|||
37962129|NCT00423670|69649506|FG003|Treatment Period|Lost to Follow-up|1|||
37962130|NCT00423670|69649507|FG004|Treatment Period|Lost to Follow-up|6|||
37962131|NCT00423670|69649508|FG005|Treatment Period|Lost to Follow-up|0|||
37962132|NCT00423670|69649509|FG006|Treatment Period|Lost to Follow-up|3|||
37962133|NCT00423670|69649510|FG007|Treatment Period|Lost to Follow-up|1|||
37962134|NCT00423670|69649503|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
38051630|NCT03074162|69741034|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
38051631|NCT03074162|69741035|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
38051632|NCT03074162|69741036|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
38051633|NCT03074162|69741031|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
38051634|NCT03074162|69741032|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
37962135|NCT00423670|69649504|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
37962136|NCT00423670|69649505|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
37962137|NCT00423670|69649506|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
37962138|NCT00423670|69649507|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
37962139|NCT00423670|69649508|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
37962140|NCT00423670|69649509|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
37962141|NCT00423670|69649510|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
37962142|NCT00423670|69649503|FG000|Treatment Period|Investigator decision|0|||
37962143|NCT00423670|69649504|FG001|Treatment Period|Investigator decision|0|||
37962144|NCT00423670|69649505|FG002|Treatment Period|Investigator decision|0|||
38051635|NCT03074162|69741033|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
38051636|NCT03074162|69741034|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
37962145|NCT00423670|69649506|FG003|Treatment Period|Investigator decision|0|||
37962146|NCT00423670|69649507|FG004|Treatment Period|Investigator decision|0|||
37962147|NCT00423670|69649508|FG005|Treatment Period|Investigator decision|0|||
37962148|NCT00423670|69649509|FG006|Treatment Period|Investigator decision|0|||
37962149|NCT00423670|69649510|FG007|Treatment Period|Investigator decision|1|||
37962150|NCT00423670|69649503|FG000|Treatment Period|Non-compliance with protocol|3|||
37962151|NCT00423670|69649504|FG001|Treatment Period|Non-compliance with protocol|1|||
37962152|NCT00423670|69649505|FG002|Treatment Period|Non-compliance with protocol|1|||
37962153|NCT00423670|69649506|FG003|Treatment Period|Non-compliance with protocol|3|||
37962154|NCT00423670|69649507|FG004|Treatment Period|Non-compliance with protocol|2|||
37862035|NCT01135017|69545794|FG001|Overall Study|Other than above|4|||
37862036|NCT01134939|69545808|FG000|Overall Study|Adverse Event|9|||
37862037|NCT01134939|69545809|FG001|Overall Study|Adverse Event|3|||
37962155|NCT00423670|69649508|FG005|Treatment Period|Non-compliance with protocol|0|||
37962156|NCT00423670|69649509|FG006|Treatment Period|Non-compliance with protocol|2|||
37962157|NCT00423670|69649510|FG007|Treatment Period|Non-compliance with protocol|2|||
37962158|NCT00423670|69649503|FG000|Follow-up Period|Lost to Follow-up|0|||
37962159|NCT00423670|69649504|FG001|Follow-up Period|Lost to Follow-up|12|||
37962160|NCT00423670|69649505|FG002|Follow-up Period|Lost to Follow-up|8|||
37962161|NCT00423670|69649506|FG003|Follow-up Period|Lost to Follow-up|3|||
37962162|NCT00423670|69649507|FG004|Follow-up Period|Lost to Follow-up|1|||
37962163|NCT00423670|69649508|FG005|Follow-up Period|Lost to Follow-up|0|||
37962164|NCT00423670|69649509|FG006|Follow-up Period|Lost to Follow-up|5|||
37962165|NCT00423670|69649510|FG007|Follow-up Period|Lost to Follow-up|0|||
37962166|NCT00423670|69649503|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
37962167|NCT00423670|69649504|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
37962168|NCT00423670|69649505|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
37962169|NCT00423670|69649506|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
37962170|NCT00423670|69649507|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
37962171|NCT00423670|69649508|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
37962172|NCT00423670|69649509|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
37962173|NCT00423670|69649510|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
37962174|NCT00423670|69649503|FG000|Follow-up Period|Non-compliance with protocol|2|||
37962175|NCT00423670|69649504|FG001|Follow-up Period|Non-compliance with protocol|0|||
37962176|NCT00423670|69649505|FG002|Follow-up Period|Non-compliance with protocol|1|||
37962177|NCT00423670|69649506|FG003|Follow-up Period|Non-compliance with protocol|1|||
37962178|NCT00423670|69649507|FG004|Follow-up Period|Non-compliance with protocol|0|||
37962179|NCT00423670|69649508|FG005|Follow-up Period|Non-compliance with protocol|0|||
37962180|NCT00423670|69649509|FG006|Follow-up Period|Non-compliance with protocol|3|||
37962181|NCT00423670|69649510|FG007|Follow-up Period|Non-compliance with protocol|2|||
37962182|NCT00483717|69649533|FG000|Overall Study|Protocol Violation|5|||
37962183|NCT00483717|69649534|FG001|Overall Study|Protocol Violation|7|||
37962184|NCT00483717|69649533|FG000|Overall Study|Time of dosing missing|1|||
37962185|NCT00483717|69649534|FG001|Overall Study|Time of dosing missing|1|||
37962186|NCT00483717|69649533|FG000|Overall Study|No treatment for migraine|16|||
37962187|NCT00483717|69649534|FG001|Overall Study|No treatment for migraine|13|||
37962188|NCT00483717|69649533|FG000|Overall Study|Lost to Follow-up|1|||
37962189|NCT00483717|69649534|FG001|Overall Study|Lost to Follow-up|0|||
37962190|NCT00483717|69649533|FG000|Overall Study|Withdrawal by Subject|1|||
37962191|NCT00483717|69649534|FG001|Overall Study|Withdrawal by Subject|0|||
37962192|NCT00406354|69649543|FG000|All Randomized Patients|Protocol Violation|0|||
37962193|NCT00406354|69649544|FG001|All Randomized Patients|Protocol Violation|0|||
37962194|NCT00406354|69649545|FG002|All Randomized Patients|Protocol Violation|1|||
37962195|NCT00406354|69649543|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
37962196|NCT00406354|69649544|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
37962197|NCT00406354|69649545|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
37962198|NCT00406354|69649543|FG000|All Randomized and Treated Patients|Adverse Event|6|||
38051637|NCT03074162|69741035|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
38051638|NCT03074162|69741036|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
37862038|NCT01134939|69545810|FG002|Overall Study|Adverse Event|4|||
37862039|NCT01134939|69545811|FG003|Overall Study|Adverse Event|5|||
37862040|NCT01134939|69545812|FG004|Overall Study|Adverse Event|5|||
37862041|NCT01134939|69545813|FG005|Overall Study|Adverse Event|5|||
37962199|NCT00406354|69649544|FG001|All Randomized and Treated Patients|Adverse Event|2|||
37962200|NCT00406354|69649545|FG002|All Randomized and Treated Patients|Adverse Event|1|||
37962201|NCT00406354|69649543|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
37962202|NCT00406354|69649544|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
37862042|NCT01134939|69545814|FG006|Overall Study|Adverse Event|1|||
37862043|NCT01134939|69545815|FG007|Overall Study|Adverse Event|0|||
37862044|NCT01134939|69545808|FG000|Overall Study|Lack of Efficacy|2|||
37862045|NCT01134939|69545809|FG001|Overall Study|Lack of Efficacy|5|||
37962203|NCT00406354|69649545|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
37962204|NCT00406354|69649543|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
37962205|NCT00406354|69649544|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
37962206|NCT00406354|69649545|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
37962207|NCT00406354|69649543|FG000|All Randomized and Treated Patients|Physician Decision|0|||
37962208|NCT00406354|69649544|FG001|All Randomized and Treated Patients|Physician Decision|0|||
37962209|NCT00406354|69649545|FG002|All Randomized and Treated Patients|Physician Decision|1|||
37962210|NCT00483405|69649553|FG000|Overall Study|Adverse Event|8|||
37962211|NCT00483405|69649553|FG000|Overall Study|Lack of Efficacy|14|||
37962212|NCT00483405|69649553|FG000|Overall Study|Death|3|||
37962213|NCT00483405|69649553|FG000|Overall Study|Withdrawal by Subject|2|||
37962214|NCT00483405|69649553|FG000|Overall Study|Other complicating disease|1|||
37962215|NCT00483327|69649561|FG000|Overall Study|Adverse Event|1|||
37962216|NCT00483327|69649561|FG000|Overall Study|Withdrawal by Subject|3|||
37962217|NCT00483327|69649561|FG000|Overall Study|Lost to Follow-up|4|||
37962218|NCT00483327|69649561|FG000|Overall Study|Patient Non Compliance|2|||
37962219|NCT00684203|69649573|FG000|Overall Study|Adverse Event|6|||
37962220|NCT00684203|69649574|FG001|Overall Study|Adverse Event|4|||
37962221|NCT00684203|69649575|FG002|Overall Study|Adverse Event|8|||
37962222|NCT00684203|69649576|FG003|Overall Study|Adverse Event|0|||
37962223|NCT00684203|69649577|FG004|Overall Study|Adverse Event|0|||
37962224|NCT00684203|69649578|FG005|Overall Study|Adverse Event|0|||
37962225|NCT00684203|69649573|FG000|Overall Study|Protocol-defined clinical event|3|||
37962226|NCT00684203|69649574|FG001|Overall Study|Protocol-defined clinical event|1|||
37962227|NCT00684203|69649575|FG002|Overall Study|Protocol-defined clinical event|0|||
37962228|NCT00684203|69649576|FG003|Overall Study|Protocol-defined clinical event|0|||
37962229|NCT00684203|69649577|FG004|Overall Study|Protocol-defined clinical event|0|||
37962230|NCT00684203|69649578|FG005|Overall Study|Protocol-defined clinical event|0|||
37962231|NCT00684203|69649573|FG000|Overall Study|Withdrawal by Subject|0|||
37962232|NCT00684203|69649574|FG001|Overall Study|Withdrawal by Subject|2|||
37962233|NCT00684203|69649575|FG002|Overall Study|Withdrawal by Subject|1|||
37962234|NCT00684203|69649576|FG003|Overall Study|Withdrawal by Subject|0|||
37962235|NCT00684203|69649577|FG004|Overall Study|Withdrawal by Subject|0|||
37962236|NCT00684203|69649578|FG005|Overall Study|Withdrawal by Subject|0|||
37962237|NCT00684203|69649573|FG000|Overall Study|Did not meet protocol eligibility|0|||
37962238|NCT00684203|69649574|FG001|Overall Study|Did not meet protocol eligibility|1|||
37962239|NCT00684203|69649575|FG002|Overall Study|Did not meet protocol eligibility|0|||
37962240|NCT00684203|69649576|FG003|Overall Study|Did not meet protocol eligibility|0|||
37962241|NCT00684203|69649577|FG004|Overall Study|Did not meet protocol eligibility|0|||
37962242|NCT00684203|69649578|FG005|Overall Study|Did not meet protocol eligibility|0|||
37962243|NCT00423592|69649599|FG000|Overall Study|Adverse Event (through Week 12)|2|||
37962244|NCT00423592|69649599|FG000|Overall Study|Adverse Event (post Week 12)|5|||
37962245|NCT00683657|69649605|FG000|Overall Study|Adverse Event|0|||
37962246|NCT00683657|69649606|FG001|Overall Study|Adverse Event|1|||
37962247|NCT00683657|69649605|FG000|Overall Study|Subject Withdrew Consent|1|||
37962248|NCT00683657|69649606|FG001|Overall Study|Subject Withdrew Consent|0|||
37962249|NCT00680771|69649614|FG000|Overall Study|Withdrawal by Subject|1|||
37962250|NCT00680771|69649615|FG001|Overall Study|Withdrawal by Subject|0|||
37962251|NCT00680771|69649614|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
37962252|NCT00680771|69649615|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
37962253|NCT00680771|69649614|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
37962254|NCT00680771|69649615|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
37962255|NCT00482703|69649623|FG000|Overall Study|Poor compliance|1|||
37962256|NCT00482703|69649624|FG001|Overall Study|Poor compliance|0|||
37962257|NCT00482391|69649637|FG000|Overall Study|Withdrawal by Subject|1|||
37962258|NCT00482391|69649637|FG000|Overall Study|Adverse Event|1|||
37962259|NCT00482391|69649637|FG000|Overall Study|Death|1|||
37962260|NCT00423046|69649644|FG000|Overall Study|Other|340|||
37962261|NCT00423046|69649645|FG001|Overall Study|Other|345|||
37962262|NCT00496587|69649653|FG000|Overall Study|Adverse Event|2|||
37962263|NCT00496587|69649653|FG000|Overall Study|Progressive Disease|24|||
37962264|NCT00496587|69649653|FG000|Overall Study|Withdrawal by Subject|2|||
37962265|NCT00496587|69649653|FG000|Overall Study|Death|1|||
38051639|NCT03074162|69741031|FG000|Period 3|Withdrawal by Subject|1|||
37962266|NCT00496587|69649653|FG000|Overall Study|Complications unrelated|2|||
37962267|NCT00405652|69649657|FG000|Overall Study|Adverse Event|4|||
37962268|NCT00422734|69649663|FG000|Overall Study|Physician Decision|1|||
37962269|NCT00422734|69649664|FG001|Overall Study|Physician Decision|1|||
37962270|NCT00422734|69649663|FG000|Overall Study|Protocol Violation|1|||
37962271|NCT00422734|69649664|FG001|Overall Study|Protocol Violation|6|||
37962272|NCT00422734|69649663|FG000|Overall Study|Withdrawal by Subject|12|||
37962273|NCT00422734|69649664|FG001|Overall Study|Withdrawal by Subject|8|||
37962274|NCT00422734|69649663|FG000|Overall Study|Adverse Event|0|||
37962275|NCT00422734|69649664|FG001|Overall Study|Adverse Event|3|||
37962276|NCT00422734|69649663|FG000|Overall Study|Partner Decision|0|||
37962277|NCT00422734|69649664|FG001|Overall Study|Partner Decision|3|||
37962278|NCT00422422|69649670|FG000|Overall Study|Lack of Efficacy|1|||
37962279|NCT00422422|69649670|FG000|Overall Study|Protocol Violation|1|||
37962280|NCT00422422|69649670|FG000|Overall Study|Withdrawal by Subject|2|||
37962281|NCT00422422|69649670|FG000|Overall Study|SAE, non-fatal|1|||
37962282|NCT00422422|69649670|FG000|Overall Study|AE, non-serious non-fatal|5|||
37962283|NCT00413374|69649678|FG000|Overall Study|Ineligible due to screening criteria.|3|||
37962284|NCT00413374|69649679|FG001|Overall Study|Ineligible due to screening criteria.|0|||
37962285|NCT00413374|69649678|FG000|Overall Study|Adverse Event|1|||
37962286|NCT00413374|69649679|FG001|Overall Study|Adverse Event|0|||
37962287|NCT00413374|69649678|FG000|Overall Study|Lost to Follow-up|1|||
37962288|NCT00413374|69649679|FG001|Overall Study|Lost to Follow-up|0|||
37962289|NCT00413374|69649678|FG000|Overall Study|Surgery|1|||
37962290|NCT00413374|69649679|FG001|Overall Study|Surgery|0|||
37962291|NCT00682643|69649690|FG000|Overall Study|Adverse Event|12|||
37962292|NCT00682643|69649691|FG001|Overall Study|Adverse Event|23|||
37962293|NCT00682643|69649690|FG000|Overall Study|Lack of Efficacy|2|||
37962294|NCT00682643|69649691|FG001|Overall Study|Lack of Efficacy|0|||
37962295|NCT00682643|69649690|FG000|Overall Study|Protocol Violation|38|||
37962296|NCT00682643|69649691|FG001|Overall Study|Protocol Violation|76|||
37962297|NCT00682643|69649690|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
37962298|NCT00682643|69649691|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
37962299|NCT00682643|69649690|FG000|Overall Study|Lost to Follow-up|1|||
37962300|NCT00682643|69649691|FG001|Overall Study|Lost to Follow-up|6|||
37962301|NCT00682643|69649690|FG000|Overall Study|Physician Decision|2|||
37962302|NCT00682643|69649691|FG001|Overall Study|Physician Decision|6|||
37962303|NCT00682643|69649690|FG000|Overall Study|Withdrawal by Subject|19|||
37962304|NCT00682643|69649691|FG001|Overall Study|Withdrawal by Subject|53|||
37962305|NCT00682643|69649690|FG000|Overall Study|Did Not Receive Study Drug|1|||
37962306|NCT00682643|69649691|FG001|Overall Study|Did Not Receive Study Drug|1|||
37962307|NCT00421408|69649700|FG000|Overall Study|Lost to Follow-up|30|||
37962308|NCT00421408|69649701|FG001|Overall Study|Lost to Follow-up|20|||
37962309|NCT00421408|69649700|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
37962310|NCT00421408|69649701|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
37962311|NCT00679913|69649709|FG000|Overall Study|Protocol Violation|18|||
37962312|NCT00679913|69649710|FG001|Overall Study|Protocol Violation|13|||
37962313|NCT00482001|69649719|FG000|Overall Study|Protocol Violation|1|||
37962314|NCT00482001|69649720|FG001|Overall Study|Protocol Violation|1|||
37962315|NCT00490035|69649732|FG000|Overall Study|AE, non-serious non-fatal|3|||
37962316|NCT00490035|69649733|FG001|Overall Study|AE, non-serious non-fatal|4|||
37962317|NCT00490035|69649734|FG002|Overall Study|AE, non-serious non-fatal|4|||
37962318|NCT00490035|69649735|FG003|Overall Study|AE, non-serious non-fatal|5|||
37962319|NCT00490035|69649732|FG000|Overall Study|Lost to Follow-up|2|||
37962320|NCT00490035|69649733|FG001|Overall Study|Lost to Follow-up|0|||
37962321|NCT00490035|69649734|FG002|Overall Study|Lost to Follow-up|1|||
37962322|NCT00490035|69649735|FG003|Overall Study|Lost to Follow-up|0|||
37962323|NCT00490035|69649732|FG000|Overall Study|Withdrawal by Subject|2|||
37962324|NCT00490035|69649733|FG001|Overall Study|Withdrawal by Subject|1|||
37962325|NCT00490035|69649734|FG002|Overall Study|Withdrawal by Subject|1|||
37962326|NCT00490035|69649735|FG003|Overall Study|Withdrawal by Subject|0|||
37962327|NCT00490035|69649732|FG000|Overall Study|Other reason|0|||
37962328|NCT00490035|69649733|FG001|Overall Study|Other reason|1|||
37962329|NCT00490035|69649734|FG002|Overall Study|Other reason|3|||
37962330|NCT00490035|69649735|FG003|Overall Study|Other reason|1|||
37962331|NCT00490035|69649732|FG000|Overall Study|AE, serious fatal|1|||
37962332|NCT00490035|69649733|FG001|Overall Study|AE, serious fatal|0|||
37962333|NCT00490035|69649734|FG002|Overall Study|AE, serious fatal|0|||
37962334|NCT00490035|69649735|FG003|Overall Study|AE, serious fatal|0|||
37962335|NCT00490035|69649732|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
37962336|NCT00490035|69649733|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
37962337|NCT00490035|69649734|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
37962338|NCT00490035|69649735|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
37962339|NCT00490035|69649732|FG000|Overall Study|AE of unknown type|0|||
37962340|NCT00490035|69649733|FG001|Overall Study|AE of unknown type|0|||
37962341|NCT00490035|69649734|FG002|Overall Study|AE of unknown type|2|||
37962342|NCT00490035|69649735|FG003|Overall Study|AE of unknown type|0|||
37962343|NCT00404248|69649748|FG000|Overall Study|pts declining status|0|||
37962344|NCT00404248|69649749|FG001|Overall Study|pts declining status|1|||
37962345|NCT00404248|69649750|FG002|Overall Study|pts declining status|0|||
37962346|NCT00404248|69649751|FG003|Overall Study|pts declining status|0|||
37962347|NCT00404248|69649752|FG004|Overall Study|pts declining status|0|||
37962348|NCT00404248|69649753|FG005|Overall Study|pts declining status|0|||
37962349|NCT00404248|69649754|FG006|Overall Study|pts declining status|0|||
37962350|NCT00404248|69649755|FG007|Overall Study|pts declining status|0|||
37962351|NCT00404248|69649756|FG008|Overall Study|pts declining status|0|||
37962352|NCT00421174|69649784|FG000|Overall Study|Withdrawal by Subject|0|||
37962353|NCT00421174|69649785|FG001|Overall Study|Withdrawal by Subject|1|||
37962354|NCT00421174|69649784|FG000|Overall Study|Ineligible due to infection|2|||
37962355|NCT00421174|69649785|FG001|Overall Study|Ineligible due to infection|0|||
37962356|NCT00496197|69649791|FG000|Overall Study|Discontinued study due to death|43|||
37962357|NCT00496197|69649791|FG000|Overall Study|Adverse Event|13|||
37962358|NCT00496197|69649791|FG000|Overall Study|Does not meet entrance criteria|5|||
37962359|NCT00496197|69649791|FG000|Overall Study|Insufficient clinical response|3|||
37962360|NCT00496197|69649791|FG000|Overall Study|Insufficient bacteriological response|10|||
37962361|NCT00496197|69649791|FG000|Overall Study|Lost to Follow-up|11|||
37962362|NCT00496197|69649791|FG000|Overall Study|Withdrawal by Subject|11|||
37962363|NCT00496197|69649791|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
37962364|NCT00496197|69649791|FG000|Overall Study|Other|14|||
37962365|NCT00496197|69649791|FG000|Overall Study|Protocol Violation|8|||
37962366|NCT00495495|69649795|FG000|Overall Study|Protocol Violation|99|||
37962367|NCT00404092|69649804|FG000|Overall Study|Death|1|||
37962368|NCT00404092|69649805|FG001|Overall Study|Death|0|||
37962369|NCT00404092|69649806|FG002|Overall Study|Death|0|||
37962370|NCT00404092|69649807|FG003|Overall Study|Death|0|||
37962371|NCT00404092|69649804|FG000|Overall Study|Adverse Event|0|||
37962372|NCT00404092|69649805|FG001|Overall Study|Adverse Event|0|||
37962373|NCT00404092|69649806|FG002|Overall Study|Adverse Event|1|||
37962374|NCT00404092|69649807|FG003|Overall Study|Adverse Event|0|||
37962375|NCT00481767|69649819|FG000|Overall Study|Withdrawal by Subject|16|||
37962376|NCT00481767|69649820|FG001|Overall Study|Withdrawal by Subject|11|||
37962377|NCT00481767|69649819|FG000|Overall Study|Lost to Follow-up|16|||
37962378|NCT00481767|69649820|FG001|Overall Study|Lost to Follow-up|10|||
37962379|NCT00489489|69649829|FG000|Overall Study|Not treated due to protocol violation|0|||
37962380|NCT00489489|69649830|FG001|Overall Study|Not treated due to protocol violation|1|||
37962381|NCT00489489|69649831|FG002|Overall Study|Not treated due to protocol violation|1|||
37962382|NCT00489489|69649829|FG000|Overall Study|Adverse Event|1|||
37962383|NCT00489489|69649830|FG001|Overall Study|Adverse Event|1|||
37962384|NCT00489489|69649831|FG002|Overall Study|Adverse Event|1|||
37962385|NCT00489489|69649829|FG000|Overall Study|Protocol Violation|1|||
37962386|NCT00489489|69649830|FG001|Overall Study|Protocol Violation|0|||
37962387|NCT00489489|69649831|FG002|Overall Study|Protocol Violation|1|||
37962388|NCT00489489|69649829|FG000|Overall Study|Progressive disease|0|||
37962389|NCT00489489|69649830|FG001|Overall Study|Progressive disease|1|||
37962390|NCT00489489|69649831|FG002|Overall Study|Progressive disease|0|||
37962391|NCT00489489|69649829|FG000|Overall Study|Participant did not wish to continue|1|||
37962392|NCT00489489|69649830|FG001|Overall Study|Participant did not wish to continue|1|||
37962393|NCT00489489|69649831|FG002|Overall Study|Participant did not wish to continue|0|||
37962394|NCT00489489|69649829|FG000|Overall Study|Other than above|0|||
37962395|NCT00489489|69649830|FG001|Overall Study|Other than above|1|||
37962396|NCT00489489|69649831|FG002|Overall Study|Other than above|0|||
37962397|NCT00489411|69649843|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
37962398|NCT00489411|69649844|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
37962399|NCT00489411|69649843|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
37962400|NCT00489411|69649844|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
37962401|NCT00489411|69649843|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
37962402|NCT00489411|69649844|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
37962403|NCT00489411|69649843|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
37962404|NCT00489411|69649844|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
37962405|NCT00489411|69649843|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
37962406|NCT00489411|69649844|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
37962407|NCT00420784|69649854|FG000|Overall Study|Adverse Event|11|||
37962408|NCT00420784|69649855|FG001|Overall Study|Adverse Event|29|||
37962409|NCT00420784|69649856|FG002|Overall Study|Adverse Event|10|||
37962410|NCT00420784|69649857|FG003|Overall Study|Adverse Event|5|||
37962411|NCT00420784|69649854|FG000|Overall Study|Withdrawal by Subject|0|||
37962412|NCT00420784|69649855|FG001|Overall Study|Withdrawal by Subject|1|||
37962413|NCT00420784|69649856|FG002|Overall Study|Withdrawal by Subject|0|||
37962414|NCT00420784|69649857|FG003|Overall Study|Withdrawal by Subject|0|||
37962415|NCT00420784|69649854|FG000|Overall Study|Lost to Follow-up|0|||
37962416|NCT00420784|69649855|FG001|Overall Study|Lost to Follow-up|0|||
37962417|NCT00420784|69649856|FG002|Overall Study|Lost to Follow-up|2|||
37962418|NCT00420784|69649857|FG003|Overall Study|Lost to Follow-up|1|||
37680335|NCT02398227|69155923|FG000|Overall Study|Lost to Follow-up|21|||
37962419|NCT00420784|69649854|FG000|Overall Study|Virologic Stopping Rule|17|||
37962420|NCT00420784|69649855|FG001|Overall Study|Virologic Stopping Rule|26|||
37962421|NCT00420784|69649856|FG002|Overall Study|Virologic Stopping Rule|41|||
37962422|NCT00420784|69649857|FG003|Overall Study|Virologic Stopping Rule|67|||
37962423|NCT00420784|69649854|FG000|Overall Study|Other|1|||
37962424|NCT00420784|69649855|FG001|Overall Study|Other|2|||
37962425|NCT00420784|69649856|FG002|Overall Study|Other|0|||
37962426|NCT00420784|69649857|FG003|Overall Study|Other|5|||
37962427|NCT00420628|69649870|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
37962428|NCT00420628|69649871|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
37962429|NCT00420628|69649870|FG000|Overall Study|Lost to Follow-up|3|||
37962430|NCT00420628|69649871|FG001|Overall Study|Lost to Follow-up|2|||
37962431|NCT00420628|69649870|FG000|Overall Study|Adverse Event|1|||
37962432|NCT00420628|69649871|FG001|Overall Study|Adverse Event|0|||
37962433|NCT00489255|69649879|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
37962434|NCT00489255|69649880|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
37962435|NCT00489255|69649879|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
37962436|NCT00489255|69649880|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
37962437|NCT00489255|69649879|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
37962438|NCT00489255|69649880|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
37962439|NCT00489255|69649879|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
37962440|NCT00489255|69649880|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
37962441|NCT00489255|69649879|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
37962442|NCT00489255|69649880|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
37962443|NCT00489255|69649879|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
37962444|NCT00489255|69649880|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
37962445|NCT00489255|69649879|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
37962446|NCT00489255|69649880|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
37962447|NCT00489255|69649879|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
37962448|NCT00489255|69649880|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
37962449|NCT00489255|69649879|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
37962450|NCT00489255|69649880|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
37962451|NCT00489255|69649879|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
37962452|NCT00489255|69649880|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
37962453|NCT00413218|69649888|FG000|Overall Study|Randomized but didn't receive study drug|2|||
37962454|NCT00413218|69649889|FG001|Overall Study|Randomized but didn't receive study drug|8|||
37962455|NCT00413218|69649888|FG000|Overall Study|Death|57|||
37962456|NCT00413218|69649889|FG001|Overall Study|Death|56|||
37962457|NCT00413218|69649888|FG000|Overall Study|Lost to Follow-up|14|||
37962458|NCT00413218|69649889|FG001|Overall Study|Lost to Follow-up|17|||
37962459|NCT00413218|69649888|FG000|Overall Study|Admin|20|||
37962460|NCT00413218|69649889|FG001|Overall Study|Admin|14|||
37962461|NCT00413218|69649888|FG000|Overall Study|Missing|1|||
37962462|NCT00413218|69649889|FG001|Overall Study|Missing|0|||
37962463|NCT00413218|69649888|FG000|Overall Study|Withdrawal by Subject|9|||
37962464|NCT00413218|69649889|FG001|Overall Study|Withdrawal by Subject|1|||
37962465|NCT00420316|69649898|FG000|Overall Study|Withdrawal by Subject|0|||
37962466|NCT00420316|69649899|FG001|Overall Study|Withdrawal by Subject|1|||
37962467|NCT00420316|69649898|FG000|Overall Study|Lost to Follow-up|12|||
37962468|NCT00420316|69649899|FG001|Overall Study|Lost to Follow-up|8|||
37962469|NCT00494871|69649907|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
37962470|NCT00494871|69649908|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
37962471|NCT00494871|69649907|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
37962472|NCT00494871|69649908|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
37962473|NCT00494871|69649907|FG000|Double-blind (DB) Treatment Period|Death|8|||
37962474|NCT00494871|69649908|FG001|Double-blind (DB) Treatment Period|Death|3|||
37962475|NCT00494871|69649907|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
37962476|NCT00494871|69649908|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
37962477|NCT00494871|69649907|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
37962478|NCT00494871|69649908|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
37962479|NCT00494871|69649907|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
37962480|NCT00494871|69649908|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
37962481|NCT00494871|69649907|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
37962482|NCT00494871|69649908|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
37962483|NCT00494871|69649907|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
37962484|NCT00494871|69649908|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
37962485|NCT00494871|69649907|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
37962486|NCT00494871|69649908|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
37962487|NCT00494871|69649907|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
37962488|NCT00494871|69649908|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
37962489|NCT00494871|69649907|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
37962490|NCT00494871|69649908|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
37962491|NCT00494871|69649907|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
37962492|NCT00494871|69649908|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
37962493|NCT00494871|69649907|FG000|Follow-up (FU) Period|Adverse Event|1|||
37962494|NCT00494871|69649908|FG001|Follow-up (FU) Period|Adverse Event|1|||
37962495|NCT00494871|69649907|FG000|Follow-up (FU) Period|Death|13|||
37962496|NCT00494871|69649908|FG001|Follow-up (FU) Period|Death|12|||
37962497|NCT00494871|69649907|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
37962498|NCT00494871|69649908|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
37962499|NCT00494871|69649907|FG000|Follow-up (FU) Period|Physician Decision|0|||
37962500|NCT00494871|69649908|FG001|Follow-up (FU) Period|Physician Decision|1|||
37962501|NCT00494871|69649907|FG000|Follow-up (FU) Period|Protocol Violation|1|||
37962502|NCT00494871|69649908|FG001|Follow-up (FU) Period|Protocol Violation|0|||
37962503|NCT00494871|69649907|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
37962504|NCT00494871|69649908|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
37962505|NCT00494871|69649907|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
37962506|NCT00494871|69649908|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
37962507|NCT00420238|69649918|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
37962508|NCT00420238|69649919|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
37962509|NCT00420238|69649918|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
37962510|NCT00420238|69649919|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
37962511|NCT00420238|69649918|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
37962512|NCT00420238|69649919|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
37962513|NCT00420238|69649918|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
37962514|NCT00420238|69649919|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
37962515|NCT00420238|69649918|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
37962516|NCT00420238|69649919|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
37962517|NCT00420238|69649918|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
37962518|NCT00420238|69649919|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
37962519|NCT00420004|69649934|FG000|Overall Study|Adverse Event|4|||
37962520|NCT00420004|69649935|FG001|Overall Study|Adverse Event|1|||
37962521|NCT00420004|69649936|FG002|Overall Study|Adverse Event|1|||
37962522|NCT00420004|69649934|FG000|Overall Study|Lack of Efficacy|5|||
37962523|NCT00420004|69649935|FG001|Overall Study|Lack of Efficacy|4|||
37962524|NCT00420004|69649936|FG002|Overall Study|Lack of Efficacy|1|||
37962525|NCT00420004|69649934|FG000|Overall Study|Lost to Follow-up|31|||
37962526|NCT00420004|69649935|FG001|Overall Study|Lost to Follow-up|12|||
37962527|NCT00420004|69649936|FG002|Overall Study|Lost to Follow-up|10|||
37962528|NCT00420004|69649934|FG000|Overall Study|Entry Criteria Not Met|0|||
37962529|NCT00420004|69649935|FG001|Overall Study|Entry Criteria Not Met|1|||
37962530|NCT00420004|69649936|FG002|Overall Study|Entry Criteria Not Met|0|||
37962531|NCT00420004|69649934|FG000|Overall Study|Physician Decision|14|||
37962532|NCT00420004|69649935|FG001|Overall Study|Physician Decision|4|||
37962533|NCT00420004|69649936|FG002|Overall Study|Physician Decision|2|||
37962534|NCT00420004|69649934|FG000|Overall Study|Protocol Violation|5|||
37962535|NCT00420004|69649935|FG001|Overall Study|Protocol Violation|4|||
37962536|NCT00420004|69649936|FG002|Overall Study|Protocol Violation|3|||
37962537|NCT00420004|69649934|FG000|Overall Study|Withdrawal by Subject|67|||
37962538|NCT00420004|69649935|FG001|Overall Study|Withdrawal by Subject|42|||
37962539|NCT00420004|69649936|FG002|Overall Study|Withdrawal by Subject|14|||
37962540|NCT00420004|69649934|FG000|Overall Study|Sponsor Decision|3|||
37962541|NCT00420004|69649935|FG001|Overall Study|Sponsor Decision|3|||
37962542|NCT00420004|69649936|FG002|Overall Study|Sponsor Decision|1|||
37962543|NCT00494481|69649950|FG000|Overall Study|Condition under investigation worsened|11|||
37962544|NCT00494481|69649951|FG001|Overall Study|Condition under investigation worsened|13|||
37962545|NCT00494481|69649950|FG000|Overall Study|Adverse Event|15|||
37962546|NCT00494481|69649951|FG001|Overall Study|Adverse Event|11|||
37962547|NCT00494481|69649950|FG000|Overall Study|Other|1|||
37962548|NCT00494481|69649951|FG001|Overall Study|Other|0|||
37962549|NCT00494481|69649950|FG000|Overall Study|Never received IP|2|||
37962550|NCT00494481|69649951|FG001|Overall Study|Never received IP|0|||
37962551|NCT00097591|69649959|FG000|Overall Study|Withdrawal of consent|342|||
37962552|NCT00097591|69649960|FG001|Overall Study|Withdrawal of consent|323|||
37962553|NCT00097591|69649959|FG000|Overall Study|Less than 6 months on study drug|9|||
37962554|NCT00097591|69649960|FG001|Overall Study|Less than 6 months on study drug|7|||
37962555|NCT00097591|69649959|FG000|Overall Study|Unable to attend termination visit|53|||
37862046|NCT01134939|69545810|FG002|Overall Study|Lack of Efficacy|1|||
37962556|NCT00097591|69649960|FG001|Overall Study|Unable to attend termination visit|51|||
37962557|NCT00097591|69649959|FG000|Overall Study|Lost to follow up|6|||
37962558|NCT00097591|69649960|FG001|Overall Study|Lost to follow up|10|||
37962559|NCT00097591|69649959|FG000|Overall Study|Other|0|||
37962560|NCT00097591|69649960|FG001|Overall Study|Other|3|||
37962561|NCT00419926|69649968|FG000|Overall Study|Withdrawal by Subject|7|||
37962562|NCT00419926|69649969|FG001|Overall Study|Withdrawal by Subject|3|||
37962563|NCT00419926|69649968|FG000|Overall Study|Administrative Problem|4|||
37962564|NCT00419926|69649969|FG001|Overall Study|Administrative Problem|4|||
37962565|NCT00419926|69649968|FG000|Overall Study|Lost to Follow-up|1|||
37962566|NCT00419926|69649969|FG001|Overall Study|Lost to Follow-up|2|||
37962567|NCT00419926|69649968|FG000|Overall Study|Death|2|||
37962568|NCT00419926|69649969|FG001|Overall Study|Death|1|||
37962569|NCT00080119|69649979|FG000|Overall Study|Discontinued because of study closure|0|||
37962570|NCT00080119|69649980|FG001|Overall Study|Discontinued because of study closure|0|||
37962571|NCT00080119|69649981|FG002|Overall Study|Discontinued because of study closure|130|||
37962572|NCT00080119|69649982|FG003|Overall Study|Discontinued because of study closure|141|||
37962573|NCT00080119|69649979|FG000|Overall Study|Unable to get to clinic|24|||
37962574|NCT00080119|69649980|FG001|Overall Study|Unable to get to clinic|24|||
37962575|NCT00080119|69649981|FG002|Overall Study|Unable to get to clinic|7|||
37962576|NCT00080119|69649982|FG003|Overall Study|Unable to get to clinic|1|||
37962577|NCT00080119|69649979|FG000|Overall Study|Consent withdrawn|13|||
37962578|NCT00080119|69649980|FG001|Overall Study|Consent withdrawn|17|||
37962579|NCT00080119|69649981|FG002|Overall Study|Consent withdrawn|4|||
37962580|NCT00080119|69649982|FG003|Overall Study|Consent withdrawn|6|||
37962581|NCT00080119|69649979|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
37962582|NCT00080119|69649980|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
37962583|NCT00080119|69649981|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
37962584|NCT00080119|69649982|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
37962585|NCT00080119|69649979|FG000|Overall Study|Lost to Follow-up|16|||
37962586|NCT00080119|69649980|FG001|Overall Study|Lost to Follow-up|19|||
37962587|NCT00080119|69649981|FG002|Overall Study|Lost to Follow-up|19|||
37962588|NCT00080119|69649982|FG003|Overall Study|Lost to Follow-up|14|||
37962589|NCT00419380|69649996|FG000|Overall Study|Lack of Efficacy|1|||
37962590|NCT00419380|69649997|FG001|Overall Study|Lack of Efficacy|7|||
37962591|NCT00419380|69649996|FG000|Overall Study|Physician Decision|0|||
37962592|NCT00419380|69649997|FG001|Overall Study|Physician Decision|1|||
37962593|NCT00419380|69649996|FG000|Overall Study|Lost to Follow-up|0|||
37962594|NCT00419380|69649997|FG001|Overall Study|Lost to Follow-up|1|||
37962595|NCT00419380|69649996|FG000|Overall Study|Withdrawal by Subject|0|||
37962596|NCT00419380|69649997|FG001|Overall Study|Withdrawal by Subject|1|||
37962597|NCT00413062|69650005|FG000|Overall Study|Adverse event/serious adverse event|289|||
37962598|NCT00413062|69650006|FG001|Overall Study|Adverse event/serious adverse event|56|||
37962599|NCT00413062|69650005|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
37962600|NCT00413062|69650006|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
37962601|NCT00413062|69650005|FG000|Overall Study|Withdrawal of informed consent|111|||
37962602|NCT00413062|69650006|FG001|Overall Study|Withdrawal of informed consent|36|||
37962603|NCT00413062|69650005|FG000|Overall Study|Pregnancy|15|||
37962604|NCT00413062|69650006|FG001|Overall Study|Pregnancy|5|||
37962605|NCT00413062|69650005|FG000|Overall Study|Pregnancy wish|17|||
37962606|NCT00413062|69650006|FG001|Overall Study|Pregnancy wish|6|||
37962607|NCT00413062|69650005|FG000|Overall Study|Lost to Follow-up|175|||
37962608|NCT00413062|69650006|FG001|Overall Study|Lost to Follow-up|73|||
37962609|NCT00413062|69650005|FG000|Overall Study|Other reason|70|||
37962610|NCT00413062|69650006|FG001|Overall Study|Other reason|34|||
37962611|NCT00494091|69650016|FG000|Overall Study|Death|5|||
37962612|NCT00494091|69650017|FG001|Overall Study|Death|54|||
37962613|NCT00494091|69650016|FG000|Overall Study|Lost to Follow-up|0|||
37962614|NCT00494091|69650017|FG001|Overall Study|Lost to Follow-up|4|||
37962615|NCT00494091|69650016|FG000|Overall Study|Other|1|||
37962616|NCT00494091|69650017|FG001|Overall Study|Other|11|||
37962617|NCT00494091|69650016|FG000|Overall Study|Withdrawal by Subject|0|||
37962618|NCT00494091|69650017|FG001|Overall Study|Withdrawal by Subject|7|||
37962619|NCT00494013|69650026|FG000|Overall Study|Adverse Event|0|||
37962620|NCT00494013|69650027|FG001|Overall Study|Adverse Event|1|||
37962621|NCT00494013|69650026|FG000|Overall Study|Entry Criteria Not Met|1|||
37962622|NCT00494013|69650027|FG001|Overall Study|Entry Criteria Not Met|4|||
37962623|NCT00494013|69650026|FG000|Overall Study|Lost to Follow-up|5|||
37962624|NCT00494013|69650027|FG001|Overall Study|Lost to Follow-up|6|||
37962625|NCT00494013|69650026|FG000|Overall Study|Physician Decision|3|||
37962626|NCT00494013|69650027|FG001|Overall Study|Physician Decision|5|||
37962627|NCT00494013|69650026|FG000|Overall Study|Protocol Violation|8|||
37680336|NCT02398227|69155924|FG001|Overall Study|Lost to Follow-up|12|||
37962628|NCT00494013|69650027|FG001|Overall Study|Protocol Violation|5|||
37962629|NCT00494013|69650026|FG000|Overall Study|Withdrawal by Subject|13|||
37962630|NCT00494013|69650027|FG001|Overall Study|Withdrawal by Subject|14|||
38051640|NCT03074162|69741032|FG001|Period 3|Withdrawal by Subject|0|||
38051641|NCT03074162|69741033|FG002|Period 3|Withdrawal by Subject|0|||
37962631|NCT00494013|69650026|FG000|Overall Study|Sponsor Decision|0|||
37962632|NCT00494013|69650027|FG001|Overall Study|Sponsor Decision|1|||
37962633|NCT00079339|69650036|FG000|Overall Study|Adverse Event|1|||
38051642|NCT03074162|69741034|FG003|Period 3|Withdrawal by Subject|0|||
37962634|NCT00079339|69650037|FG001|Overall Study|Adverse Event|7|||
37962635|NCT00079339|69650038|FG002|Overall Study|Adverse Event|2|||
37962636|NCT00079339|69650036|FG000|Overall Study|Death|1|||
37962637|NCT00079339|69650037|FG001|Overall Study|Death|0|||
37962638|NCT00079339|69650038|FG002|Overall Study|Death|0|||
38051643|NCT03074162|69741035|FG004|Period 3|Withdrawal by Subject|1|||
37962639|NCT00079339|69650036|FG000|Overall Study|Non-compliance|0|||
37962640|NCT00079339|69650037|FG001|Overall Study|Non-compliance|0|||
37962641|NCT00079339|69650038|FG002|Overall Study|Non-compliance|1|||
37962642|NCT00079339|69650036|FG000|Overall Study|Withdrawal by Subject|0|||
37962643|NCT00079339|69650037|FG001|Overall Study|Withdrawal by Subject|4|||
37962644|NCT00079339|69650038|FG002|Overall Study|Withdrawal by Subject|1|||
37962645|NCT00079339|69650036|FG000|Overall Study|Disease progression|3|||
37962646|NCT00079339|69650037|FG001|Overall Study|Disease progression|28|||
37962647|NCT00079339|69650038|FG002|Overall Study|Disease progression|2|||
37962648|NCT00493779|69650051|FG000|Overall Study|Logistical issue at site|1|||
37962649|NCT00541866|69650061|FG000|Overall Study|Adverse Event|3|||
37962650|NCT00541866|69650062|FG001|Overall Study|Adverse Event|0|||
37962651|NCT00541866|69650063|FG002|Overall Study|Adverse Event|0|||
37962652|NCT00541866|69650064|FG003|Overall Study|Adverse Event|0|||
37962653|NCT00541866|69650065|FG004|Overall Study|Adverse Event|0|||
37962654|NCT00541866|69650061|FG000|Overall Study|Death|1|||
37962655|NCT00541866|69650062|FG001|Overall Study|Death|0|||
37962656|NCT00541866|69650063|FG002|Overall Study|Death|0|||
37962657|NCT00541866|69650064|FG003|Overall Study|Death|0|||
37962658|NCT00541866|69650065|FG004|Overall Study|Death|0|||
37962659|NCT00541866|69650061|FG000|Overall Study|Lack of Efficacy|19|||
37962660|NCT00541866|69650062|FG001|Overall Study|Lack of Efficacy|15|||
37962661|NCT00541866|69650063|FG002|Overall Study|Lack of Efficacy|10|||
37962662|NCT00541866|69650064|FG003|Overall Study|Lack of Efficacy|12|||
37962663|NCT00541866|69650065|FG004|Overall Study|Lack of Efficacy|14|||
37962664|NCT00541866|69650061|FG000|Overall Study|Not Reported or Other|11|||
37962665|NCT00541866|69650062|FG001|Overall Study|Not Reported or Other|3|||
37962666|NCT00541866|69650063|FG002|Overall Study|Not Reported or Other|3|||
37962667|NCT00541866|69650064|FG003|Overall Study|Not Reported or Other|3|||
37962668|NCT00541866|69650065|FG004|Overall Study|Not Reported or Other|1|||
37962669|NCT00541866|69650061|FG000|Overall Study|Physician Decision|0|||
37962670|NCT00541866|69650062|FG001|Overall Study|Physician Decision|0|||
37962671|NCT00541866|69650063|FG002|Overall Study|Physician Decision|2|||
37962672|NCT00541866|69650064|FG003|Overall Study|Physician Decision|1|||
37962673|NCT00541866|69650065|FG004|Overall Study|Physician Decision|0|||
37962674|NCT00493467|69650093|FG000|Overall Study|Death|1|||
37962675|NCT00090493|69650097|FG000|Overall Study|Physician Decision|2|||
37962676|NCT04329702|69650104|FG000|Overall Study|illness|3|||
37962677|NCT04329702|69650105|FG001|Overall Study|illness|4|||
37962678|NCT04329702|69650106|FG002|Overall Study|illness|0|||
37962679|NCT04329702|69650104|FG000|Overall Study|Lost to Follow-up|0|||
37962680|NCT04329702|69650105|FG001|Overall Study|Lost to Follow-up|0|||
37962681|NCT04329702|69650106|FG002|Overall Study|Lost to Follow-up|2|||
37962682|NCT04329702|69650104|FG000|Overall Study|Death|0|||
37962683|NCT04329702|69650105|FG001|Overall Study|Death|2|||
37962684|NCT04329702|69650106|FG002|Overall Study|Death|0|||
37962685|NCT00481065|69650127|FG000|Overall Study|Adverse event or death|1|||
37962686|NCT00481065|69650128|FG001|Overall Study|Adverse event or death|1|||
37962687|NCT00481065|69650129|FG002|Overall Study|Adverse event or death|3|||
37962688|NCT00481065|69650130|FG003|Overall Study|Adverse event or death|0|||
37962689|NCT00481065|69650131|FG004|Overall Study|Adverse event or death|2|||
37962690|NCT00481065|69650132|FG005|Overall Study|Adverse event or death|0|||
37962691|NCT00481065|69650133|FG006|Overall Study|Adverse event or death|1|||
37962692|NCT00481065|69650134|FG007|Overall Study|Adverse event or death|1|||
37962693|NCT00481065|69650127|FG000|Overall Study|Withdrawal by Subject|11|||
37962694|NCT00481065|69650128|FG001|Overall Study|Withdrawal by Subject|12|||
37962695|NCT00481065|69650129|FG002|Overall Study|Withdrawal by Subject|7|||
38051644|NCT03074162|69741036|FG005|Period 3|Withdrawal by Subject|0|||
37962696|NCT00481065|69650130|FG003|Overall Study|Withdrawal by Subject|11|||
37962697|NCT00481065|69650131|FG004|Overall Study|Withdrawal by Subject|13|||
37962698|NCT00481065|69650132|FG005|Overall Study|Withdrawal by Subject|12|||
37962699|NCT00481065|69650133|FG006|Overall Study|Withdrawal by Subject|9|||
37962700|NCT00481065|69650134|FG007|Overall Study|Withdrawal by Subject|10|||
37962701|NCT00481065|69650127|FG000|Overall Study|Lost to Follow-up|4|||
37962702|NCT00481065|69650128|FG001|Overall Study|Lost to Follow-up|2|||
37962703|NCT00481065|69650129|FG002|Overall Study|Lost to Follow-up|4|||
37962704|NCT00481065|69650130|FG003|Overall Study|Lost to Follow-up|3|||
38051645|NCT03070964|69741044|FG000|Overall Study|Progressive disease|8|||
38051646|NCT03070964|69741044|FG000|Overall Study|Treatment-unrelated adverse event|2|||
38051647|NCT03070964|69741044|FG000|Overall Study|Never treated|1|||
37962705|NCT00481065|69650131|FG004|Overall Study|Lost to Follow-up|3|||
38051648|NCT03070964|69741044|FG000|Overall Study|Physician Decision|1|||
38051649|NCT03070964|69741044|FG000|Overall Study|Withdrawal by Subject|1|||
37862047|NCT01134939|69545811|FG003|Overall Study|Lack of Efficacy|0|||
37962706|NCT00481065|69650132|FG005|Overall Study|Lost to Follow-up|3|||
37962707|NCT00481065|69650133|FG006|Overall Study|Lost to Follow-up|2|||
37962708|NCT00481065|69650134|FG007|Overall Study|Lost to Follow-up|5|||
37962709|NCT00481065|69650127|FG000|Overall Study|Inappropriate enrollment|4|||
37962710|NCT00481065|69650128|FG001|Overall Study|Inappropriate enrollment|0|||
38051650|NCT03070964|69741044|FG000|Overall Study|Adverse Event|1|||
37962711|NCT00481065|69650129|FG002|Overall Study|Inappropriate enrollment|2|||
37962712|NCT00481065|69650130|FG003|Overall Study|Inappropriate enrollment|0|||
37962713|NCT00481065|69650131|FG004|Overall Study|Inappropriate enrollment|2|||
37962714|NCT00481065|69650132|FG005|Overall Study|Inappropriate enrollment|1|||
37962715|NCT00481065|69650133|FG006|Overall Study|Inappropriate enrollment|0|||
37962716|NCT00481065|69650134|FG007|Overall Study|Inappropriate enrollment|1|||
37962717|NCT00481065|69650127|FG000|Overall Study|Administrative reason|0|||
37962718|NCT00481065|69650128|FG001|Overall Study|Administrative reason|0|||
37962719|NCT00481065|69650129|FG002|Overall Study|Administrative reason|0|||
37962720|NCT00481065|69650130|FG003|Overall Study|Administrative reason|0|||
37962721|NCT00481065|69650131|FG004|Overall Study|Administrative reason|0|||
37962722|NCT00481065|69650132|FG005|Overall Study|Administrative reason|2|||
37962723|NCT00481065|69650133|FG006|Overall Study|Administrative reason|1|||
37962724|NCT00481065|69650134|FG007|Overall Study|Administrative reason|0|||
37962725|NCT00481065|69650127|FG000|Overall Study|Protocol Violation|2|||
37962726|NCT00481065|69650128|FG001|Overall Study|Protocol Violation|1|||
37962727|NCT00481065|69650129|FG002|Overall Study|Protocol Violation|1|||
37962728|NCT00481065|69650130|FG003|Overall Study|Protocol Violation|1|||
37962729|NCT00481065|69650131|FG004|Overall Study|Protocol Violation|2|||
37962730|NCT00481065|69650132|FG005|Overall Study|Protocol Violation|6|||
37962731|NCT00481065|69650133|FG006|Overall Study|Protocol Violation|3|||
37962732|NCT00481065|69650134|FG007|Overall Study|Protocol Violation|2|||
37962733|NCT00481065|69650127|FG000|Overall Study|Unable to classify|0|||
37962734|NCT00481065|69650128|FG001|Overall Study|Unable to classify|1|||
37962735|NCT00481065|69650129|FG002|Overall Study|Unable to classify|2|||
37962736|NCT00481065|69650130|FG003|Overall Study|Unable to classify|0|||
37962737|NCT00481065|69650131|FG004|Overall Study|Unable to classify|1|||
37962738|NCT00481065|69650132|FG005|Overall Study|Unable to classify|0|||
37962739|NCT00481065|69650133|FG006|Overall Study|Unable to classify|0|||
37962740|NCT00481065|69650134|FG007|Overall Study|Unable to classify|0|||
37962741|NCT00493311|69650156|FG000|Overall Study|Need for rescue medication|2|||
37962742|NCT00493311|69650157|FG001|Overall Study|Need for rescue medication|2|||
37962743|NCT00571649|69650165|FG000|Treatment Period|Adverse Event|438|||
37962744|NCT00571649|69650166|FG001|Treatment Period|Adverse Event|385|||
37962745|NCT00571649|69650165|FG000|Treatment Period|Clinical endpoint reached|50|||
37962746|NCT00571649|69650166|FG001|Treatment Period|Clinical endpoint reached|56|||
37962747|NCT00571649|69650165|FG000|Treatment Period|Withdrawal by Subject|285|||
37962748|NCT00571649|69650166|FG001|Treatment Period|Withdrawal by Subject|255|||
37962749|NCT00571649|69650165|FG000|Treatment Period|Death|76|||
37962750|NCT00571649|69650166|FG001|Treatment Period|Death|59|||
37962751|NCT00571649|69650165|FG000|Treatment Period|Physician Decision|8|||
37962752|NCT00571649|69650166|FG001|Treatment Period|Physician Decision|9|||
37962753|NCT00571649|69650165|FG000|Treatment Period|Lost to Follow-up|43|||
37962754|NCT00571649|69650166|FG001|Treatment Period|Lost to Follow-up|41|||
37962755|NCT00571649|69650165|FG000|Treatment Period|Non-compliant with study medication|88|||
37962756|NCT00571649|69650166|FG001|Treatment Period|Non-compliant with study medication|89|||
37962757|NCT00571649|69650165|FG000|Treatment Period|Patient convenience|11|||
37962758|NCT00571649|69650166|FG001|Treatment Period|Patient convenience|13|||
37962759|NCT00571649|69650165|FG000|Treatment Period|Protocol Violation|90|||
37962760|NCT00571649|69650166|FG001|Treatment Period|Protocol Violation|92|||
37962761|NCT00571649|69650165|FG000|Treatment Period|Technical problems|3|||
37962762|NCT00571649|69650166|FG001|Treatment Period|Technical problems|5|||
37962763|NCT00571649|69650165|FG000|Follow-up Period|Adverse Event|46|||
37962764|NCT00571649|69650166|FG001|Follow-up Period|Adverse Event|40|||
37962765|NCT00571649|69650165|FG000|Follow-up Period|Clinical endpoint reached|5|||
37962766|NCT00571649|69650166|FG001|Follow-up Period|Clinical endpoint reached|2|||
37962767|NCT00571649|69650165|FG000|Follow-up Period|Withdrawal by Subject|119|||
37962768|NCT00571649|69650166|FG001|Follow-up Period|Withdrawal by Subject|115|||
37962769|NCT00571649|69650165|FG000|Follow-up Period|Death|132|||
37962770|NCT00571649|69650166|FG001|Follow-up Period|Death|133|||
37962771|NCT00571649|69650165|FG000|Follow-up Period|Physician Decision|7|||
37962772|NCT00571649|69650166|FG001|Follow-up Period|Physician Decision|13|||
37962773|NCT00571649|69650165|FG000|Follow-up Period|Lost to Follow-up|95|||
37680337|NCT02398227|69155923|FG000|Overall Study|Withdrawal by Subject|5|||
37680338|NCT02398227|69155924|FG001|Overall Study|Withdrawal by Subject|6|||
37962774|NCT00571649|69650166|FG001|Follow-up Period|Lost to Follow-up|92|||
37962775|NCT00571649|69650165|FG000|Follow-up Period|Patient convenience|136|||
37962776|NCT00571649|69650166|FG001|Follow-up Period|Patient convenience|121|||
37962777|NCT00571649|69650165|FG000|Follow-up Period|Protocol Violation|5|||
37962778|NCT00571649|69650166|FG001|Follow-up Period|Protocol Violation|12|||
37962779|NCT00546572|69650174|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
37962780|NCT00546572|69650175|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
37862048|NCT01134939|69545812|FG004|Overall Study|Lack of Efficacy|3|||
38051651|NCT04065074|69741048|FG000|Overall Study|Adverse Event|1|||
37962781|NCT00546572|69650174|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
37962782|NCT00546572|69650175|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
37962783|NCT00546572|69650174|FG000|Vax 1 / Year 0|Protocol Violation|3|||
37962784|NCT00546572|69650175|FG001|Vax 1 / Year 0|Protocol Violation|4|||
37962785|NCT00546572|69650174|FG000|Vax 1 / Year 0|Death|2|||
37962786|NCT00546572|69650175|FG001|Vax 1 / Year 0|Death|2|||
37962787|NCT00546572|69650174|FG000|Vax 1 / Year 0|Adverse Event|0|||
37962788|NCT00546572|69650175|FG001|Vax 1 / Year 0|Adverse Event|1|||
37962789|NCT00546572|69650174|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
37962790|NCT00546572|69650175|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
37962791|NCT00546572|69650174|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
37862049|NCT01134939|69545813|FG005|Overall Study|Lack of Efficacy|0|||
37962792|NCT00546572|69650175|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
37962793|NCT00546572|69650174|FG000|Vax 2 / Year 1|Other|1|||
37962794|NCT00546572|69650175|FG001|Vax 2 / Year 1|Other|1|||
37962795|NCT00546572|69650174|FG000|Vax 2 / Year 1|Adverse Event|1|||
37962796|NCT00546572|69650175|FG001|Vax 2 / Year 1|Adverse Event|0|||
37962797|NCT00546572|69650174|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
37962798|NCT00546572|69650175|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
37962799|NCT03917472|69650194|FG000|Overall Study|Physician Decision|4|||
37962800|NCT03917472|69650195|FG001|Overall Study|Physician Decision|0|||
37962801|NCT03917472|69650194|FG000|Overall Study|Adverse Event|3|||
37962802|NCT03917472|69650195|FG001|Overall Study|Adverse Event|1|||
37962803|NCT03917472|69650194|FG000|Overall Study|Death|7|||
37962804|NCT03917472|69650195|FG001|Overall Study|Death|5|||
37962805|NCT03917472|69650194|FG000|Overall Study|Withdrawal by Subject|11|||
37962806|NCT03917472|69650195|FG001|Overall Study|Withdrawal by Subject|4|||
37962807|NCT03917472|69650194|FG000|Overall Study|Lost to Follow-up|10|||
37962808|NCT03917472|69650195|FG001|Overall Study|Lost to Follow-up|5|||
37962809|NCT00681863|69650202|FG000|Overall Study|Adverse Event|1|||
37962810|NCT00681863|69650202|FG000|Overall Study|Lost to Follow-up|2|||
37962811|NCT00681863|69650202|FG000|Overall Study|Lack of Efficacy|2|||
37962812|NCT00681863|69650202|FG000|Overall Study|Other|18|||
37962813|NCT00681629|69650208|FG000|Overall Study|Study termination|4|||
37962814|NCT00681629|69650209|FG001|Overall Study|Study termination|2|||
37962815|NCT00681629|69650208|FG000|Overall Study|Adverse Event|1|||
37962816|NCT00681629|69650209|FG001|Overall Study|Adverse Event|0|||
37962817|NCT00679367|69650215|FG000|Overall Study|Adverse Event|7|||
37962818|NCT00679367|69650215|FG000|Overall Study|inability to swallow oral drugs|1|||
37962819|NCT00679367|69650215|FG000|Overall Study|Lack of Efficacy|3|||
37962820|NCT00679367|69650215|FG000|Overall Study|Withdrawal by Subject|1|||
37962821|NCT03937778|69650220|FG000|Overall Study|Withdrawal by Subject|1|||
37962822|NCT03937778|69650220|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
37962823|NCT03935126|69650224|FG000|Overall Study|Study termination by sponsor|3|||
37962824|NCT00545714|69650228|FG000|Induction Phase (6 Months)|Physician Decision|3|||
37962825|NCT00545714|69650228|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
37962826|NCT00545714|69650228|FG000|Induction Phase (6 Months)|Disease Progression|1|||
37962827|NCT00545714|69650228|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
37962828|NCT00545714|69650228|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
37962829|NCT00545714|69650228|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
37962830|NCT00545714|69650228|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
37962831|NCT00545714|69650228|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
37962832|NCT00545714|69650228|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
37962833|NCT00545714|69650228|FG000|Maintenance Phase (36 Months)|Death|2|||
37962834|NCT00539838|69650235|FG000|Overall Study|Fail to return|2|||
37962835|NCT00539838|69650236|FG001|Overall Study|Fail to return|0|||
37962836|NCT00539838|69650237|FG002|Overall Study|Fail to return|0|||
37962837|NCT00539838|69650235|FG000|Overall Study|Withdrawal by Subject|0|||
37962838|NCT00539838|69650236|FG001|Overall Study|Withdrawal by Subject|4|||
37962839|NCT00539838|69650237|FG002|Overall Study|Withdrawal by Subject|0|||
37962840|NCT00539838|69650235|FG000|Overall Study|Death|0|||
37962841|NCT00539838|69650236|FG001|Overall Study|Death|2|||
37962842|NCT00539838|69650237|FG002|Overall Study|Death|0|||
37962843|NCT00539838|69650235|FG000|Overall Study|Did not cooperate|1|||
37962844|NCT00539838|69650236|FG001|Overall Study|Did not cooperate|0|||
37962845|NCT00539838|69650237|FG002|Overall Study|Did not cooperate|1|||
37962846|NCT00539838|69650235|FG000|Overall Study|Administrative|4|||
37962847|NCT00539838|69650236|FG001|Overall Study|Administrative|0|||
37962848|NCT00539838|69650237|FG002|Overall Study|Administrative|8|||
37962849|NCT00679289|69650250|FG000|Overall Study|Progressive disease|4|||
37962850|NCT00679289|69650251|FG001|Overall Study|Progressive disease|5|||
37962851|NCT00679289|69650252|FG002|Overall Study|Progressive disease|18|||
37962852|NCT00679289|69650250|FG000|Overall Study|Withdrawal by Subject|0|||
37962853|NCT00679289|69650251|FG001|Overall Study|Withdrawal by Subject|1|||
37962854|NCT00679289|69650252|FG002|Overall Study|Withdrawal by Subject|1|||
37962855|NCT00679289|69650250|FG000|Overall Study|Adverse Event|0|||
37962856|NCT00679289|69650251|FG001|Overall Study|Adverse Event|0|||
37962857|NCT00679289|69650252|FG002|Overall Study|Adverse Event|3|||
37962858|NCT00679289|69650250|FG000|Overall Study|Physician Decision|1|||
37962859|NCT00679289|69650251|FG001|Overall Study|Physician Decision|0|||
37962860|NCT00679289|69650252|FG002|Overall Study|Physician Decision|1|||
37962861|NCT00679211|69650262|FG000|Overall Study|Progressive disease|82|||
37962862|NCT00679211|69650262|FG000|Overall Study|Adverse Event|7|||
37962863|NCT00679211|69650262|FG000|Overall Study|Withdrawal by Subject|2|||
37962864|NCT00679211|69650262|FG000|Overall Study|Physician Decision|5|||
37962865|NCT00679211|69650262|FG000|Overall Study|Refused to undergo protocol procedures|1|||
37962866|NCT00679211|69650262|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
37962867|NCT00679211|69650262|FG000|Overall Study|Other|1|||
37962868|NCT00545948|69650271|FG000|Overall Study|Not Treated|1|||
37962869|NCT00545948|69650272|FG001|Overall Study|Not Treated|1|||
37962870|NCT00545948|69650273|FG002|Overall Study|Not Treated|7|||
37962871|NCT00679055|69650284|FG000|Overall Study|Adverse Event|0|||
37962872|NCT00679055|69650285|FG001|Overall Study|Adverse Event|1|||
37962873|NCT00679055|69650284|FG000|Overall Study|Other|0|||
37962874|NCT00679055|69650285|FG001|Overall Study|Other|3|||
37962875|NCT00679055|69650284|FG000|Overall Study|Study Terminated|2|||
37962876|NCT00679055|69650285|FG001|Overall Study|Study Terminated|1|||
37962877|NCT03927950|69650291|FG000|Overall Study|Adverse Event|9|||
37962878|NCT00678899|69650296|FG000|Overall Study|Adverse Event|1|||
37962879|NCT00678587|69650303|FG000|Overall Study|Adverse Event|3|||
37962880|NCT00678587|69650304|FG001|Overall Study|Adverse Event|3|||
37962881|NCT00678587|69650303|FG000|Overall Study|Lack of Efficacy|1|||
37962882|NCT00678587|69650304|FG001|Overall Study|Lack of Efficacy|0|||
37962883|NCT00678587|69650303|FG000|Overall Study|Protocol Violation|2|||
38051652|NCT04065074|69741048|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
38051653|NCT02888106|69741058|FG000|Overall Study|Withdrawal by Subject|1|||
38051654|NCT02888106|69741059|FG001|Overall Study|Withdrawal by Subject|2|||
38051655|NCT02888106|69741060|FG002|Overall Study|Withdrawal by Subject|0|||
38051656|NCT02888106|69741061|FG003|Overall Study|Withdrawal by Subject|1|||
38051657|NCT02888106|69741062|FG004|Overall Study|Withdrawal by Subject|0|||
38051658|NCT02888106|69741063|FG005|Overall Study|Withdrawal by Subject|0|||
38051659|NCT02888106|69741058|FG000|Overall Study|Lost to Follow-up|1|||
38051660|NCT02888106|69741059|FG001|Overall Study|Lost to Follow-up|0|||
38051661|NCT02888106|69741060|FG002|Overall Study|Lost to Follow-up|0|||
38051662|NCT02888106|69741061|FG003|Overall Study|Lost to Follow-up|1|||
38051663|NCT02888106|69741062|FG004|Overall Study|Lost to Follow-up|0|||
38051664|NCT02888106|69741063|FG005|Overall Study|Lost to Follow-up|1|||
38051665|NCT02888106|69741058|FG000|Overall Study|Adverse Event|2|||
38051666|NCT02888106|69741059|FG001|Overall Study|Adverse Event|0|||
38051667|NCT02888106|69741060|FG002|Overall Study|Adverse Event|0|||
37962884|NCT00678587|69650304|FG001|Overall Study|Protocol Violation|1|||
37962885|NCT00678587|69650303|FG000|Overall Study|Study Closed/Terminated|1|||
37962886|NCT00678587|69650304|FG001|Overall Study|Study Closed/Terminated|0|||
37962887|NCT00678587|69650303|FG000|Overall Study|Lost to Follow-up|3|||
37962888|NCT00678587|69650304|FG001|Overall Study|Lost to Follow-up|5|||
37962889|NCT00678587|69650303|FG000|Overall Study|Investigator Discretion|2|||
37962890|NCT00678587|69650304|FG001|Overall Study|Investigator Discretion|6|||
37962891|NCT00678587|69650303|FG000|Overall Study|Withdrew Consent|8|||
38051668|NCT02888106|69741061|FG003|Overall Study|Adverse Event|0|||
38051669|NCT02888106|69741062|FG004|Overall Study|Adverse Event|0|||
38051670|NCT02888106|69741063|FG005|Overall Study|Adverse Event|0|||
38051671|NCT02888106|69741058|FG000|Overall Study|Withdrawal of consent|0|||
38051672|NCT02888106|69741059|FG001|Overall Study|Withdrawal of consent|0|||
37962892|NCT00678587|69650304|FG001|Overall Study|Withdrew Consent|3|||
37962893|NCT03523728|69650316|FG000|Stage 1 (24 Months)|Adverse Event|2|||
37962894|NCT03523728|69650317|FG001|Stage 1 (24 Months)|Adverse Event|2|||
37962895|NCT03523728|69650318|FG002|Stage 1 (24 Months)|Adverse Event|4|||
37962896|NCT03523728|69650319|FG003|Stage 1 (24 Months)|Adverse Event|0|||
37962897|NCT03523728|69650320|FG004|Stage 1 (24 Months)|Adverse Event|0|||
37962898|NCT03523728|69650316|FG000|Stage 1 (24 Months)|Progressive disease|0|||
37962899|NCT03523728|69650317|FG001|Stage 1 (24 Months)|Progressive disease|0|||
37962900|NCT03523728|69650318|FG002|Stage 1 (24 Months)|Progressive disease|1|||
37962901|NCT03523728|69650319|FG003|Stage 1 (24 Months)|Progressive disease|0|||
37962902|NCT03523728|69650320|FG004|Stage 1 (24 Months)|Progressive disease|0|||
37962903|NCT03523728|69650316|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
37962904|NCT03523728|69650317|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
37962905|NCT03523728|69650318|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
37962906|NCT03523728|69650319|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
37962907|NCT03523728|69650320|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
37962908|NCT03523728|69650316|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
37962909|NCT03523728|69650317|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
37962910|NCT03523728|69650318|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
37962911|NCT03523728|69650319|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
37962912|NCT03523728|69650320|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
37962913|NCT03523728|69650316|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
37962914|NCT03523728|69650317|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
37962915|NCT03523728|69650318|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
37962916|NCT03523728|69650319|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
37962917|NCT03523728|69650320|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
37962918|NCT03523728|69650316|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
37962919|NCT03523728|69650317|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
37962920|NCT03523728|69650318|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
37962921|NCT03523728|69650319|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
37962922|NCT03523728|69650320|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
37962923|NCT03523728|69650316|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
37962924|NCT03523728|69650317|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
37962925|NCT03523728|69650318|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
37962926|NCT03523728|69650319|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
37962927|NCT03523728|69650320|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
37962928|NCT03523728|69650316|FG000|Stage 2 (24 Months)|Adverse Event|0|||
37962929|NCT03523728|69650317|FG001|Stage 2 (24 Months)|Adverse Event|0|||
37962930|NCT03523728|69650318|FG002|Stage 2 (24 Months)|Adverse Event|0|||
37962931|NCT03523728|69650319|FG003|Stage 2 (24 Months)|Adverse Event|1|||
37962932|NCT03523728|69650320|FG004|Stage 2 (24 Months)|Adverse Event|2|||
37962933|NCT03523728|69650316|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
37962934|NCT03523728|69650317|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
37962935|NCT03523728|69650318|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
37962936|NCT03523728|69650319|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
37962937|NCT03523728|69650320|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
37962938|NCT03523728|69650316|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
37962939|NCT03523728|69650317|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
37962940|NCT03523728|69650318|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
37962941|NCT03523728|69650319|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
37962942|NCT03523728|69650320|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
37962943|NCT03523728|69650316|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
37962944|NCT03523728|69650317|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
37962945|NCT03523728|69650318|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
37962946|NCT03523728|69650319|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
37962947|NCT03523728|69650320|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
37962948|NCT03523728|69650316|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
37962949|NCT03523728|69650317|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
37962950|NCT03523728|69650318|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
37962951|NCT03523728|69650319|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
37962952|NCT03523728|69650320|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
37962953|NCT00538590|69650339|FG000|Overall Study|Death|1|||
37962954|NCT00538590|69650340|FG001|Overall Study|Death|0|||
37962955|NCT00466947|69650348|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
37962956|NCT00466947|69650349|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
37962957|NCT00466947|69650348|FG000|Study End Analysis Period|Adverse Event|35|||
37962958|NCT00466947|69650349|FG001|Study End Analysis Period|Adverse Event|43|||
37962959|NCT00466947|69650348|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
37962960|NCT00466947|69650349|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
37962961|NCT00466947|69650348|FG000|Study End Analysis Period|Physician Decision|29|||
37962962|NCT00466947|69650349|FG001|Study End Analysis Period|Physician Decision|29|||
37962963|NCT00466947|69650348|FG000|Study End Analysis Period|Protocol Violation|9|||
37962964|NCT00466947|69650349|FG001|Study End Analysis Period|Protocol Violation|17|||
37962965|NCT00466947|69650348|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
37962966|NCT00466947|69650349|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
37962967|NCT00466947|69650348|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
37962968|NCT00466947|69650349|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
37962969|NCT00466947|69650348|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
37962970|NCT00466947|69650349|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
37962971|NCT00466947|69650348|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
37962972|NCT00466947|69650349|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
37962973|NCT00537810|69650360|FG000|Overall Study|Withdrawal by Subject|4|||
37962974|NCT00537810|69650361|FG001|Overall Study|Withdrawal by Subject|11|||
37962975|NCT00537810|69650362|FG002|Overall Study|Withdrawal by Subject|4|||
37962976|NCT00537810|69650363|FG003|Overall Study|Withdrawal by Subject|3|||
37962977|NCT00537810|69650360|FG000|Overall Study|Medically withdrawn|2|||
37962978|NCT00537810|69650361|FG001|Overall Study|Medically withdrawn|2|||
37962979|NCT00537810|69650362|FG002|Overall Study|Medically withdrawn|0|||
37962980|NCT00537810|69650363|FG003|Overall Study|Medically withdrawn|1|||
37962981|NCT01287936|69650376|FG000|Overall Study|Lost to Follow-up|0|||
37962982|NCT01287936|69650377|FG001|Overall Study|Lost to Follow-up|1|||
37962983|NCT01287936|69650378|FG002|Overall Study|Lost to Follow-up|1|||
37962984|NCT00090259|69650388|FG000|Overall Study|Lost to Follow-up|30|||
37962985|NCT00090259|69650389|FG001|Overall Study|Lost to Follow-up|26|||
37962986|NCT00090259|69650388|FG000|Overall Study|Withdrawal by Subject|21|||
37962987|NCT00090259|69650389|FG001|Overall Study|Withdrawal by Subject|15|||
37962988|NCT00090259|69650388|FG000|Overall Study|Investigator site closed|11|||
37962989|NCT00090259|69650389|FG001|Overall Study|Investigator site closed|7|||
37962990|NCT00079183|69650395|FG000|Overall Study|Withdrawal by Subject|4|||
37962991|NCT00079183|69650395|FG000|Overall Study|Study medication non-compliance|2|||
37962992|NCT00079183|69650395|FG000|Overall Study|Specimen collection non-compliance|1|||
37962993|NCT00676403|69650406|FG000|Overall Study|Adverse Event|1|||
37962994|NCT00676403|69650407|FG001|Overall Study|Adverse Event|2|||
37962995|NCT00676403|69650408|FG002|Overall Study|Adverse Event|0|||
37962996|NCT00676403|69650409|FG003|Overall Study|Adverse Event|5|||
37962997|NCT00676403|69650410|FG004|Overall Study|Adverse Event|1|||
37962998|NCT00676403|69650411|FG005|Overall Study|Adverse Event|2|||
37962999|NCT00676403|69650406|FG000|Overall Study|Lost to Follow-up|0|||
37963000|NCT00676403|69650407|FG001|Overall Study|Lost to Follow-up|0|||
37963001|NCT00676403|69650408|FG002|Overall Study|Lost to Follow-up|0|||
37963002|NCT00676403|69650409|FG003|Overall Study|Lost to Follow-up|0|||
37963003|NCT00676403|69650410|FG004|Overall Study|Lost to Follow-up|0|||
37963004|NCT00676403|69650411|FG005|Overall Study|Lost to Follow-up|1|||
37963005|NCT00676403|69650406|FG000|Overall Study|Reason Unspecified|1|||
37963006|NCT00676403|69650407|FG001|Overall Study|Reason Unspecified|0|||
37963007|NCT00676403|69650408|FG002|Overall Study|Reason Unspecified|1|||
37963008|NCT00676403|69650409|FG003|Overall Study|Reason Unspecified|0|||
37963009|NCT00676403|69650410|FG004|Overall Study|Reason Unspecified|0|||
37963010|NCT00676403|69650411|FG005|Overall Study|Reason Unspecified|1|||
37963011|NCT00676403|69650406|FG000|Overall Study|Withdrawal by Subject|0|||
37963012|NCT00676403|69650407|FG001|Overall Study|Withdrawal by Subject|0|||
37963013|NCT00676403|69650408|FG002|Overall Study|Withdrawal by Subject|0|||
37963014|NCT00676403|69650409|FG003|Overall Study|Withdrawal by Subject|0|||
37963015|NCT00676403|69650410|FG004|Overall Study|Withdrawal by Subject|0|||
37963016|NCT00676403|69650411|FG005|Overall Study|Withdrawal by Subject|1|||
37963017|NCT00078325|69650434|FG000|Overall Study|Adverse Event|15|||
37963018|NCT00078325|69650435|FG001|Overall Study|Adverse Event|10|||
37963019|NCT00078325|69650436|FG002|Overall Study|Adverse Event|5|||
37963020|NCT00078325|69650434|FG000|Overall Study|Protocol Violation|2|||
37963021|NCT00078325|69650435|FG001|Overall Study|Protocol Violation|2|||
37963022|NCT00078325|69650436|FG002|Overall Study|Protocol Violation|0|||
37963023|NCT00078325|69650434|FG000|Overall Study|Withdrawal by Subject|1|||
37963024|NCT00078325|69650435|FG001|Overall Study|Withdrawal by Subject|5|||
37963025|NCT00078325|69650436|FG002|Overall Study|Withdrawal by Subject|3|||
37963026|NCT00078325|69650434|FG000|Overall Study|Lost to Follow-up|0|||
37963027|NCT00078325|69650435|FG001|Overall Study|Lost to Follow-up|1|||
37963028|NCT00078325|69650436|FG002|Overall Study|Lost to Follow-up|1|||
37862050|NCT01134939|69545814|FG006|Overall Study|Lack of Efficacy|1|||
37963029|NCT00078325|69650434|FG000|Overall Study|Physician Decision|2|||
37963030|NCT00078325|69650435|FG001|Overall Study|Physician Decision|0|||
37963031|NCT00078325|69650436|FG002|Overall Study|Physician Decision|1|||
37963032|NCT00078325|69650434|FG000|Overall Study|Miscellaneous|1|||
37963033|NCT00078325|69650435|FG001|Overall Study|Miscellaneous|1|||
37963034|NCT00078325|69650436|FG002|Overall Study|Miscellaneous|1|||
37963035|NCT00077857|69650446|FG000|Overall Study|Adverse Event|30|||
37963036|NCT00077857|69650447|FG001|Overall Study|Adverse Event|32|||
37963037|NCT00077857|69650446|FG000|Overall Study|Death|7|||
37963038|NCT00077857|69650447|FG001|Overall Study|Death|3|||
37963039|NCT00077857|69650446|FG000|Overall Study|Insufficient therapeutic response|112|||
37963040|NCT00077857|69650447|FG001|Overall Study|Insufficient therapeutic response|128|||
37963041|NCT00077857|69650446|FG000|Overall Study|Violation of selection criteria at entry|3|||
37963042|NCT00077857|69650447|FG001|Overall Study|Violation of selection criteria at entry|1|||
37963043|NCT00077857|69650446|FG000|Overall Study|Other protocol violation|0|||
37963044|NCT00077857|69650447|FG001|Overall Study|Other protocol violation|1|||
37963045|NCT00077857|69650446|FG000|Overall Study|Refused treatment|29|||
37963046|NCT00077857|69650447|FG001|Overall Study|Refused treatment|21|||
37963047|NCT00077857|69650446|FG000|Overall Study|Failure to return|5|||
37963048|NCT00077857|69650447|FG001|Overall Study|Failure to return|5|||
37963049|NCT00077857|69650446|FG000|Overall Study|Other|15|||
37963050|NCT00077857|69650447|FG001|Overall Study|Other|13|||
37963051|NCT00545402|69650455|FG000|Overall Study|Discontinuation of treatment|17|||
37963052|NCT00545402|69650456|FG001|Overall Study|Discontinuation of treatment|9|||
37963053|NCT00545402|69650455|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
37963054|NCT00545402|69650456|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
37963055|NCT00545402|69650455|FG000|Overall Study|Death|5|||
37963056|NCT00545402|69650456|FG001|Overall Study|Death|7|||
37963057|NCT00545402|69650455|FG000|Overall Study|Graft loss|2|||
37963058|NCT00545402|69650456|FG001|Overall Study|Graft loss|4|||
37963059|NCT00545402|69650455|FG000|Overall Study|Withdrawal by Subject|0|||
37963060|NCT00545402|69650456|FG001|Overall Study|Withdrawal by Subject|1|||
37963061|NCT00545402|69650455|FG000|Overall Study|Protocol Violation|1|||
37963062|NCT00545402|69650456|FG001|Overall Study|Protocol Violation|0|||
37963063|NCT00545402|69650455|FG000|Overall Study|Reason not specified|1|||
37963064|NCT00545402|69650456|FG001|Overall Study|Reason not specified|1|||
37963065|NCT00545792|69650462|FG000|Overall Study|Withdrawal by Subject|1|||
37963066|NCT00545168|69650469|FG000|Overall Study|Lost to Follow-up|5|||
37963067|NCT00545168|69650470|FG001|Overall Study|Lost to Follow-up|5|||
37963068|NCT00545168|69650471|FG002|Overall Study|Lost to Follow-up|5|||
37963069|NCT00545168|69650469|FG000|Overall Study|Withdrawal by Subject|9|||
37963070|NCT00545168|69650470|FG001|Overall Study|Withdrawal by Subject|0|||
37963071|NCT00545168|69650471|FG002|Overall Study|Withdrawal by Subject|13|||
37963072|NCT00545168|69650469|FG000|Overall Study|Protocol Violation|1|||
37963073|NCT00545168|69650470|FG001|Overall Study|Protocol Violation|0|||
37963074|NCT00545168|69650471|FG002|Overall Study|Protocol Violation|1|||
37963075|NCT00545168|69650469|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
37963076|NCT00545168|69650470|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
37963077|NCT00545168|69650471|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
37963078|NCT00544544|69650480|FG000|Overall Study|Withdrawal by Subject|1|||
37963079|NCT00544544|69650480|FG000|Overall Study|Adverse Event|1|||
37963080|NCT00544544|69650480|FG000|Overall Study|Lost to Follow-up|1|||
37963081|NCT00541346|69650484|FG000|Follow-up|Adverse Event|1|||
37963082|NCT00077623|69650491|FG000|Overall Study|Adverse Event|1|||
37963083|NCT00077623|69650492|FG001|Overall Study|Adverse Event|0|||
37963084|NCT00077623|69650493|FG002|Overall Study|Adverse Event|1|||
37963085|NCT00077623|69650491|FG000|Overall Study|Withdrawal by Subject|2|||
37963086|NCT00077623|69650492|FG001|Overall Study|Withdrawal by Subject|10|||
37963087|NCT00077623|69650493|FG002|Overall Study|Withdrawal by Subject|1|||
37963088|NCT00077623|69650491|FG000|Overall Study|Other-Non safety reason|18|||
37963089|NCT00077623|69650492|FG001|Overall Study|Other-Non safety reason|15|||
37963090|NCT00077623|69650493|FG002|Overall Study|Other-Non safety reason|19|||
37963091|NCT00077623|69650491|FG000|Overall Study|Insufficient therapeutic response|2|||
37963092|NCT00077623|69650492|FG001|Overall Study|Insufficient therapeutic response|0|||
37963093|NCT00077623|69650493|FG002|Overall Study|Insufficient therapeutic response|0|||
37963094|NCT00077623|69650491|FG000|Overall Study|Death|12|||
37963095|NCT00077623|69650492|FG001|Overall Study|Death|18|||
37963096|NCT00077623|69650493|FG002|Overall Study|Death|11|||
37963097|NCT00077623|69650491|FG000|Overall Study|Failure to return|1|||
37963098|NCT00077623|69650492|FG001|Overall Study|Failure to return|0|||
37963099|NCT00077623|69650493|FG002|Overall Study|Failure to return|0|||
37963100|NCT00541034|69650501|FG000|Overall Study|Non-Compliance|3|||
37963101|NCT00540644|69650507|FG000|Overall Study|Adverse Event|3|||
37963102|NCT00540644|69650508|FG001|Overall Study|Adverse Event|1|||
37963103|NCT00540644|69650507|FG000|Overall Study|Disease Progression|3|||
37862051|NCT01134939|69545815|FG007|Overall Study|Lack of Efficacy|0|||
37963104|NCT00540644|69650508|FG001|Overall Study|Disease Progression|1|||
37963105|NCT00540644|69650507|FG000|Overall Study|Physician Decision|0|||
37963106|NCT00540644|69650508|FG001|Overall Study|Physician Decision|5|||
37963107|NCT00540644|69650507|FG000|Overall Study|Withdrawal by Subject|2|||
37963108|NCT00540644|69650508|FG001|Overall Study|Withdrawal by Subject|2|||
37963109|NCT00540644|69650507|FG000|Overall Study|Noncomplilance|1|||
37963110|NCT00540644|69650508|FG001|Overall Study|Noncomplilance|0|||
37963111|NCT00543296|69650514|FG000|Overall Study|Physician Decision|7|||
37963112|NCT00543140|69650518|FG000|Overall Study|Lost to Follow-up|33|||
37963113|NCT00543140|69650518|FG000|Overall Study|Withdrawal by Subject|13|||
37963114|NCT00543140|69650518|FG000|Overall Study|Protocol Violation|10|||
37963115|NCT00543140|69650518|FG000|Overall Study|Insufficient weight loss|10|||
37963116|NCT00543140|69650518|FG000|Overall Study|SAE leading to explant of SAGB|3|||
37963117|NCT00543140|69650518|FG000|Overall Study|Death|1|||
37963118|NCT00543140|69650518|FG000|Overall Study|Subject moved|1|||
37963119|NCT00543140|69650518|FG000|Overall Study|Conversion to different procedure|1|||
37963120|NCT00543062|69650522|FG000|Overall Study|Withdrawal by Subject|1|||
37963121|NCT00543062|69650523|FG001|Overall Study|Withdrawal by Subject|0|||
37963122|NCT00543062|69650524|FG002|Overall Study|Withdrawal by Subject|2|||
37963123|NCT00543062|69650525|FG003|Overall Study|Withdrawal by Subject|0|||
37963124|NCT00543062|69650522|FG000|Overall Study|Adverse Event|0|||
37963125|NCT00543062|69650523|FG001|Overall Study|Adverse Event|1|||
37963126|NCT00543062|69650524|FG002|Overall Study|Adverse Event|1|||
37963127|NCT00543062|69650525|FG003|Overall Study|Adverse Event|1|||
37963128|NCT00543062|69650522|FG000|Overall Study|Protocol Violation|1|||
37963129|NCT00543062|69650523|FG001|Overall Study|Protocol Violation|0|||
37963130|NCT00543062|69650524|FG002|Overall Study|Protocol Violation|0|||
37963131|NCT00543062|69650525|FG003|Overall Study|Protocol Violation|0|||
37963132|NCT03911960|69650545|FG000|Overall Study|Lost to Follow-up|5|||
37963133|NCT03911960|69650546|FG001|Overall Study|Lost to Follow-up|3|||
37963134|NCT00676091|69650555|FG000|Infant Series|Parent or legal guardian request|10|||
37963135|NCT00676091|69650556|FG001|Infant Series|Parent or legal guardian request|8|||
37963136|NCT00676091|69650555|FG000|Infant Series|Protocol Violation|6|||
37963137|NCT00676091|69650556|FG001|Infant Series|Protocol Violation|3|||
37963138|NCT00676091|69650555|FG000|Infant Series|Adverse Event|2|||
37963139|NCT00676091|69650556|FG001|Infant Series|Adverse Event|3|||
37963140|NCT00676091|69650555|FG000|Infant Series|Failed to return|1|||
37963141|NCT00676091|69650556|FG001|Infant Series|Failed to return|3|||
37963142|NCT00676091|69650555|FG000|Infant Series|Lost to Follow-up|1|||
37963143|NCT00676091|69650556|FG001|Infant Series|Lost to Follow-up|0|||
37963144|NCT00676091|69650555|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
37963145|NCT00676091|69650556|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
37963146|NCT00676091|69650555|FG000|After Infant Series|Adverse Event|0|||
37963147|NCT00676091|69650556|FG001|After Infant Series|Adverse Event|1|||
37963148|NCT00676091|69650555|FG000|After Infant Series|Protocol Violation|0|||
37963149|NCT00676091|69650556|FG001|After Infant Series|Protocol Violation|1|||
37963150|NCT00676091|69650555|FG000|After Infant Series|Failed to return|1|||
37963151|NCT00676091|69650556|FG001|After Infant Series|Failed to return|1|||
37963152|NCT00676091|69650555|FG000|Toddler Dose|Failed to return|2|||
37963153|NCT00676091|69650556|FG001|Toddler Dose|Failed to return|0|||
37963154|NCT00676091|69650555|FG000|Toddler Dose|Parent or legal guardian request|1|||
37963155|NCT00676091|69650556|FG001|Toddler Dose|Parent or legal guardian request|0|||
37963156|NCT00678041|69650568|FG000|Overall Study|Physician Decision|5|||
37963157|NCT00678041|69650569|FG001|Overall Study|Physician Decision|5|||
37963158|NCT03903822|69650584|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
37963159|NCT03903822|69650585|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
37963160|NCT03903822|69650586|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
37963161|NCT03903822|69650587|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
37963162|NCT03903822|69650588|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
37963163|NCT03903822|69650589|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
37963164|NCT03903822|69650590|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
37963165|NCT03903822|69650591|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
37963166|NCT03903822|69650584|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
37963167|NCT03903822|69650585|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
37963168|NCT03903822|69650586|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
37963169|NCT03903822|69650587|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
37963170|NCT03903822|69650588|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
37963171|NCT03903822|69650589|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
37963172|NCT03903822|69650590|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
37963173|NCT03903822|69650591|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
37963174|NCT03903822|69650584|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
37963175|NCT03903822|69650585|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
37963176|NCT03903822|69650586|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
37963177|NCT03903822|69650587|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
37963178|NCT03903822|69650588|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
37963179|NCT03903822|69650589|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
37963180|NCT03903822|69650590|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
37963181|NCT03903822|69650591|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
37963182|NCT03903822|69650584|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
37963183|NCT03903822|69650585|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
37963184|NCT03903822|69650586|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
37963185|NCT03903822|69650587|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
37963186|NCT03903822|69650588|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
37963187|NCT03903822|69650589|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
37963188|NCT03903822|69650590|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
37963189|NCT03903822|69650591|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
37963190|NCT03903822|69650584|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
37963191|NCT03903822|69650585|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
37963192|NCT03903822|69650586|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
37963193|NCT03903822|69650587|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
37963194|NCT03903822|69650588|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
37963195|NCT03903822|69650589|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
37963196|NCT03903822|69650590|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
37963197|NCT03903822|69650591|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
37963198|NCT03903822|69650584|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
37963199|NCT03903822|69650585|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
37963200|NCT03903822|69650586|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
37963201|NCT03903822|69650587|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
37963202|NCT03903822|69650588|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
37963203|NCT03903822|69650589|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
37963204|NCT03903822|69650590|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
37963205|NCT03903822|69650591|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
37963206|NCT03903822|69650584|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
37963207|NCT03903822|69650585|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
37963208|NCT03903822|69650586|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
37963209|NCT03903822|69650587|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
37963210|NCT03903822|69650588|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
37963211|NCT03903822|69650589|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
37963212|NCT03903822|69650590|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
37963213|NCT03903822|69650591|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
37963214|NCT03903822|69650584|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
37963215|NCT03903822|69650585|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
37963216|NCT03903822|69650586|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
37963217|NCT03903822|69650587|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
37963218|NCT03903822|69650588|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
37963219|NCT03903822|69650589|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
37963220|NCT03903822|69650590|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
37963221|NCT03903822|69650591|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
37963222|NCT03903822|69650584|FG000|Treatment Phase (6 Weeks)|Other|2|||
37963223|NCT03903822|69650585|FG001|Treatment Phase (6 Weeks)|Other|1|||
37963224|NCT03903822|69650586|FG002|Treatment Phase (6 Weeks)|Other|0|||
37963225|NCT03903822|69650587|FG003|Treatment Phase (6 Weeks)|Other|0|||
37963226|NCT03903822|69650588|FG004|Treatment Phase (6 Weeks)|Other|1|||
37963227|NCT03903822|69650589|FG005|Treatment Phase (6 Weeks)|Other|1|||
37963228|NCT03903822|69650590|FG006|Treatment Phase (6 Weeks)|Other|0|||
37963229|NCT03903822|69650591|FG007|Treatment Phase (6 Weeks)|Other|0|||
37963230|NCT03903822|69650584|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
37963231|NCT03903822|69650585|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
37963232|NCT03903822|69650586|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
37963233|NCT03903822|69650587|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
37963234|NCT03903822|69650588|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
37963235|NCT03903822|69650589|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
37963236|NCT03903822|69650590|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
37963237|NCT03903822|69650591|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
37963238|NCT03903822|69650584|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
37963239|NCT03903822|69650585|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
37963240|NCT03903822|69650586|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
37963241|NCT03903822|69650587|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
37963242|NCT03903822|69650588|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
37963243|NCT03903822|69650589|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
37963244|NCT03903822|69650590|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
37963245|NCT03903822|69650591|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
37963246|NCT03903822|69650584|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
37963247|NCT03903822|69650585|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
37963248|NCT03903822|69650586|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
37963249|NCT03903822|69650587|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
37963250|NCT03903822|69650588|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
37963251|NCT03903822|69650589|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
37963252|NCT03903822|69650590|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
37963253|NCT03903822|69650591|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
37963254|NCT03903822|69650584|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
37963255|NCT03903822|69650585|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
37963256|NCT03903822|69650586|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
37963257|NCT03903822|69650587|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
37963258|NCT03903822|69650588|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
37963259|NCT03903822|69650589|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
37963260|NCT03903822|69650590|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
37963261|NCT03903822|69650591|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
37963262|NCT03903822|69650584|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
37963263|NCT03903822|69650585|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
37963264|NCT03903822|69650586|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
37963265|NCT03903822|69650587|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
37963266|NCT03903822|69650588|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
37963267|NCT03903822|69650589|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
37963268|NCT03903822|69650590|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
37963269|NCT03903822|69650591|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
37963270|NCT03903822|69650584|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
37963271|NCT03903822|69650585|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
37963272|NCT03903822|69650586|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
37963273|NCT03903822|69650587|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
37963274|NCT03903822|69650588|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
37963275|NCT03903822|69650589|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
37963276|NCT03903822|69650590|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
37963277|NCT03903822|69650591|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
37963278|NCT03903822|69650584|FG000|Follow up Phase (4 Weeks)|Other|1|||
37963279|NCT03903822|69650585|FG001|Follow up Phase (4 Weeks)|Other|1|||
37963280|NCT03903822|69650586|FG002|Follow up Phase (4 Weeks)|Other|0|||
37963281|NCT03903822|69650587|FG003|Follow up Phase (4 Weeks)|Other|0|||
37963282|NCT03903822|69650588|FG004|Follow up Phase (4 Weeks)|Other|0|||
37963283|NCT03903822|69650589|FG005|Follow up Phase (4 Weeks)|Other|0|||
37963284|NCT03903822|69650590|FG006|Follow up Phase (4 Weeks)|Other|0|||
37963285|NCT03903822|69650591|FG007|Follow up Phase (4 Weeks)|Other|0|||
37963286|NCT00677807|69650612|FG000|Overall Study|Adverse Event|4|||
37963287|NCT00677807|69650613|FG001|Overall Study|Adverse Event|1|||
37963288|NCT00677807|69650614|FG002|Overall Study|Adverse Event|6|||
37963289|NCT00677807|69650612|FG000|Overall Study|Lack of Efficacy|0|||
37963290|NCT00677807|69650613|FG001|Overall Study|Lack of Efficacy|0|||
37963291|NCT00677807|69650614|FG002|Overall Study|Lack of Efficacy|2|||
37963292|NCT00677807|69650612|FG000|Overall Study|Participant no longer needs study drug|0|||
37963293|NCT00677807|69650613|FG001|Overall Study|Participant no longer needs study drug|0|||
37963294|NCT00677807|69650614|FG002|Overall Study|Participant no longer needs study drug|1|||
37963295|NCT00677807|69650612|FG000|Overall Study|Withdrawal by Subject|10|||
37963296|NCT00677807|69650613|FG001|Overall Study|Withdrawal by Subject|3|||
37963297|NCT00677807|69650614|FG002|Overall Study|Withdrawal by Subject|6|||
37963298|NCT00677807|69650612|FG000|Overall Study|Lost to Follow-up|2|||
37963299|NCT00677807|69650613|FG001|Overall Study|Lost to Follow-up|2|||
37963300|NCT00677807|69650614|FG002|Overall Study|Lost to Follow-up|2|||
37963301|NCT00677807|69650612|FG000|Overall Study|Administrative problems|1|||
37963302|NCT00677807|69650613|FG001|Overall Study|Administrative problems|1|||
37963303|NCT00677807|69650614|FG002|Overall Study|Administrative problems|2|||
37963304|NCT00677807|69650612|FG000|Overall Study|Death|0|||
37963305|NCT00677807|69650613|FG001|Overall Study|Death|1|||
37963306|NCT00677807|69650614|FG002|Overall Study|Death|1|||
37963307|NCT00677807|69650612|FG000|Overall Study|Protocol Deviation|1|||
37963308|NCT00677807|69650613|FG001|Overall Study|Protocol Deviation|3|||
37963309|NCT00677807|69650614|FG002|Overall Study|Protocol Deviation|0|||
37963310|NCT00687401|69650622|FG000|Overall Study|Protocol Violation|7|||
37963311|NCT00687401|69650622|FG000|Overall Study|Adverse Event|6|||
37963312|NCT00687401|69650622|FG000|Overall Study|Lack of Efficacy|6|||
37963313|NCT00687401|69650622|FG000|Overall Study|Withdrawal by Subject|4|||
37963314|NCT00687401|69650622|FG000|Overall Study|Did not return for visit|3|||
37963315|NCT00687401|69650622|FG000|Overall Study|For reasons different from those above|4|||
37963316|NCT00538902|69650642|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
37680339|NCT02398227|69155923|FG000|Overall Study|Removed from treatment and dropped out|1|||
37680340|NCT02398227|69155924|FG001|Overall Study|Removed from treatment and dropped out|0|||
37680341|NCT02397915|69155930|FG000|Period 1|Protocol Violation|0|||
37680342|NCT02397915|69155931|FG001|Period 1|Protocol Violation|1|||
37680343|NCT02397915|69155932|FG002|Period 1|Protocol Violation|0|||
37680344|NCT02397915|69155933|FG003|Period 1|Protocol Violation|0|||
37680345|NCT02397915|69155930|FG000|Period 1|Physician Decision|1|||
37680346|NCT02397915|69155931|FG001|Period 1|Physician Decision|0|||
37680347|NCT02397915|69155932|FG002|Period 1|Physician Decision|0|||
37680348|NCT02397915|69155933|FG003|Period 1|Physician Decision|0|||
37680349|NCT02397837|69155943|FG000|Overall Study|Withdrawal by Subject|6|||
37680350|NCT02397837|69155944|FG001|Overall Study|Withdrawal by Subject|5|||
37680351|NCT02397837|69155943|FG000|Overall Study|Physician Decision|1|||
37680352|NCT02397837|69155944|FG001|Overall Study|Physician Decision|1|||
37680353|NCT02586415|69155952|FG000|Overall Study|Death|13|||
37963317|NCT00538902|69650643|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
37963318|NCT00538902|69650644|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
37963319|NCT00538902|69650642|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
37963320|NCT00538902|69650643|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
37963321|NCT00538902|69650644|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
37963322|NCT00538902|69650642|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
37963323|NCT00538902|69650643|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
37963324|NCT00538902|69650644|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
37963325|NCT00538902|69650642|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
37963326|NCT00538902|69650643|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
37963327|NCT00538902|69650644|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
37963328|NCT00538902|69650642|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
37963329|NCT00538902|69650643|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
37963330|NCT00538902|69650644|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
37963331|NCT00538902|69650642|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
37963332|NCT00538902|69650643|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
37963333|NCT00538902|69650644|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
37963334|NCT00538902|69650642|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
37963335|NCT00538902|69650643|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
37963336|NCT00538902|69650644|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
37963337|NCT00538902|69650642|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
37963338|NCT00538902|69650643|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
37963339|NCT00538902|69650644|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
37963340|NCT00541970|69650658|FG000|Month 7|Protocol Violation|9|||
37963341|NCT00541970|69650659|FG001|Month 7|Protocol Violation|13|||
37963342|NCT00541970|69650660|FG002|Month 7|Protocol Violation|11|||
37963343|NCT00541970|69650661|FG003|Month 7|Protocol Violation|5|||
37963344|NCT00541970|69650658|FG000|Month 12|Adverse Event|0|||
37963345|NCT00541970|69650659|FG001|Month 12|Adverse Event|1|||
37963346|NCT00541970|69650660|FG002|Month 12|Adverse Event|1|||
37963347|NCT00541970|69650661|FG003|Month 12|Adverse Event|1|||
37963348|NCT00541970|69650658|FG000|Month 12|Protocol Violation|12|||
37963349|NCT00541970|69650659|FG001|Month 12|Protocol Violation|21|||
37963350|NCT00541970|69650660|FG002|Month 12|Protocol Violation|20|||
37963351|NCT00541970|69650661|FG003|Month 12|Protocol Violation|15|||
37963352|NCT00541970|69650658|FG000|Month 18|Adverse Event|0|||
37963353|NCT00541970|69650659|FG001|Month 18|Adverse Event|1|||
37963354|NCT00541970|69650660|FG002|Month 18|Adverse Event|1|||
37963355|NCT00541970|69650661|FG003|Month 18|Adverse Event|1|||
37963356|NCT00541970|69650658|FG000|Month 18|Protocol Violation|14|||
37963357|NCT00541970|69650659|FG001|Month 18|Protocol Violation|23|||
37963358|NCT00541970|69650660|FG002|Month 18|Protocol Violation|24|||
37963359|NCT00541970|69650661|FG003|Month 18|Protocol Violation|16|||
37963360|NCT00541970|69650658|FG000|Month 24|Adverse Event|0|||
37963361|NCT00541970|69650659|FG001|Month 24|Adverse Event|1|||
37963362|NCT00541970|69650660|FG002|Month 24|Adverse Event|1|||
37963363|NCT00541970|69650661|FG003|Month 24|Adverse Event|1|||
37963364|NCT00541970|69650658|FG000|Month 24|Protocol Violation|29|||
37963365|NCT00541970|69650659|FG001|Month 24|Protocol Violation|31|||
37963366|NCT00541970|69650660|FG002|Month 24|Protocol Violation|31|||
37963367|NCT00541970|69650661|FG003|Month 24|Protocol Violation|21|||
37963368|NCT00541970|69650658|FG000|Month 36|Protocol Violation|61|||
37963369|NCT00541970|69650659|FG001|Month 36|Protocol Violation|66|||
37963370|NCT00541970|69650660|FG002|Month 36|Protocol Violation|66|||
37963371|NCT00541970|69650661|FG003|Month 36|Protocol Violation|60|||
37963372|NCT00541970|69650658|FG000|Month 48|Withdrawal by Subject|2|||
37963373|NCT00541970|69650659|FG001|Month 48|Withdrawal by Subject|4|||
37963374|NCT00541970|69650660|FG002|Month 48|Withdrawal by Subject|4|||
37963375|NCT00541970|69650661|FG003|Month 48|Withdrawal by Subject|2|||
37963376|NCT00541970|69650658|FG000|Month 48|Other|3|||
37963377|NCT00541970|69650659|FG001|Month 48|Other|1|||
37963378|NCT00541970|69650660|FG002|Month 48|Other|1|||
37963379|NCT00541970|69650661|FG003|Month 48|Other|0|||
37963380|NCT00541970|69650658|FG000|Month 48|Lost to Follow-up|66|||
37963381|NCT00541970|69650659|FG001|Month 48|Lost to Follow-up|68|||
37963382|NCT00541970|69650660|FG002|Month 48|Lost to Follow-up|68|||
37963383|NCT00541970|69650661|FG003|Month 48|Lost to Follow-up|73|||
37963384|NCT00541970|69650658|FG000|Month 60|Protocol Violation|78|||
37963385|NCT00541970|69650659|FG001|Month 60|Protocol Violation|77|||
37963386|NCT00541970|69650660|FG002|Month 60|Protocol Violation|82|||
37963387|NCT00541970|69650661|FG003|Month 60|Protocol Violation|72|||
37963388|NCT00687323|69650671|FG000|Overall Study|Death|25|||
37963389|NCT00687323|69650671|FG000|Overall Study|Withdrawal by Subject|1|||
37963390|NCT00687323|69650671|FG000|Overall Study|Excluded from efficacy evaluations|6|||
37963391|NCT00687323|69650671|FG000|Overall Study|Screen failure|148|||
37963392|NCT03899064|69650688|FG000|Overall Study|Lost to Follow-up|1|||
37963393|NCT03899064|69650688|FG000|Overall Study|Protocol Violation|2|||
37963394|NCT03899064|69650688|FG000|Overall Study|Withdrawal by Subject|2|||
37963395|NCT03899064|69650688|FG000|Overall Study|Other|2|||
37963396|NCT03902574|69650695|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
37963397|NCT03902574|69650696|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
37963398|NCT03902574|69650697|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
37963399|NCT00542828|69650709|FG000|Overall Study|Physician Decision|1|||
37963400|NCT00542828|69650709|FG000|Overall Study|Need for Prohibited Treatment|3|||
37963401|NCT00542828|69650709|FG000|Overall Study|Study Prematurely Discontinued|7|||
37963402|NCT00542828|69650709|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
37963403|NCT00090103|69650716|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
37963404|NCT00090103|69650717|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
37963405|NCT00090103|69650718|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
37963406|NCT00090103|69650716|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
37963407|NCT00090103|69650717|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
37963408|NCT00090103|69650718|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
37963409|NCT00090103|69650716|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
37963410|NCT00090103|69650717|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
37963411|NCT00090103|69650718|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
37963412|NCT00090103|69650716|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
37963413|NCT00090103|69650717|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
37963414|NCT00090103|69650718|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
37963415|NCT00090103|69650716|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
37963416|NCT00090103|69650717|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
37963417|NCT00090103|69650718|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
37963418|NCT00090103|69650716|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
37963419|NCT00090103|69650717|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
37963420|NCT00090103|69650718|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
37963421|NCT00090103|69650716|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
37963422|NCT00090103|69650717|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
37963423|NCT00090103|69650718|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
37963424|NCT00090103|69650716|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
37963425|NCT00090103|69650717|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
37963426|NCT00090103|69650718|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
37963427|NCT00090103|69650716|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
37963428|NCT00090103|69650717|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
37963429|NCT00090103|69650718|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
37963430|NCT00090103|69650716|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
37963431|NCT00090103|69650717|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
37963432|NCT00090103|69650718|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
37963433|NCT00090103|69650716|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
37963434|NCT00090103|69650717|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
37963435|NCT00090103|69650718|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
37963436|NCT00090103|69650716|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
37963437|NCT00090103|69650717|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
37963438|NCT00090103|69650718|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
37963439|NCT00090103|69650716|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
37963440|NCT00090103|69650717|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
37963441|NCT00090103|69650718|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
37963442|NCT00090103|69650716|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
37963443|NCT00090103|69650717|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
37963444|NCT00090103|69650718|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
37963445|NCT00090103|69650716|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
37963446|NCT00090103|69650717|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
37963447|NCT00090103|69650718|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
37963448|NCT00090103|69650716|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
37963449|NCT00090103|69650717|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
37963450|NCT00090103|69650718|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
37963451|NCT00090103|69650716|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
37963452|NCT00090103|69650717|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
37963453|NCT00090103|69650718|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
37963454|NCT00090103|69650716|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
37963455|NCT00090103|69650717|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
37963456|NCT00090103|69650718|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
37963457|NCT00090103|69650716|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
37963458|NCT00090103|69650717|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
37963459|NCT00090103|69650718|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
37963460|NCT00090103|69650716|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
37963461|NCT00090103|69650717|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
37963462|NCT00090103|69650718|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
37963463|NCT00090103|69650716|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
37963464|NCT00090103|69650717|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
37963465|NCT00090103|69650718|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
37963466|NCT00090103|69650716|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
37963467|NCT00090103|69650717|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
37963468|NCT00090103|69650718|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
37963469|NCT00090103|69650716|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
37963470|NCT00090103|69650717|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
37963471|NCT00090103|69650718|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
37963472|NCT00090103|69650716|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
37963473|NCT00090103|69650717|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
37963474|NCT00090103|69650718|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
37963475|NCT00090103|69650716|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
37963476|NCT00090103|69650717|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
37963477|NCT00090103|69650718|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
37963478|NCT00090103|69650716|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
37963479|NCT00090103|69650717|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
37963480|NCT00090103|69650718|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
37963481|NCT00090103|69650716|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
37963482|NCT00090103|69650717|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
37963483|NCT00090103|69650718|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
37963484|NCT00090103|69650716|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
37963485|NCT00090103|69650717|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
37963486|NCT00090103|69650718|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
37963487|NCT00090103|69650716|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
37963488|NCT00090103|69650717|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
37963489|NCT00090103|69650718|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
37963490|NCT00090103|69650716|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
37963491|NCT00090103|69650717|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
37963492|NCT00090103|69650718|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
37963493|NCT00090103|69650716|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
37963494|NCT00090103|69650717|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
37963495|NCT00090103|69650718|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
37963496|NCT00090103|69650716|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
37963497|NCT00090103|69650717|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
37963498|NCT00090103|69650718|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
37963499|NCT00090103|69650716|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
37963500|NCT00090103|69650717|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
37963501|NCT00090103|69650718|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
37963502|NCT00090103|69650716|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
38051673|NCT02888106|69741060|FG002|Overall Study|Withdrawal of consent|0|||
38051674|NCT02888106|69741061|FG003|Overall Study|Withdrawal of consent|0|||
38051675|NCT02888106|69741062|FG004|Overall Study|Withdrawal of consent|1|||
38051676|NCT02888106|69741063|FG005|Overall Study|Withdrawal of consent|0|||
38051677|NCT02888106|69741058|FG000|Overall Study|Pregnancy|1|||
38051678|NCT02888106|69741059|FG001|Overall Study|Pregnancy|0|||
38051679|NCT02888106|69741060|FG002|Overall Study|Pregnancy|0|||
38051680|NCT02888106|69741061|FG003|Overall Study|Pregnancy|0|||
38051681|NCT02888106|69741062|FG004|Overall Study|Pregnancy|0|||
38051682|NCT02888106|69741063|FG005|Overall Study|Pregnancy|0|||
38051683|NCT03793010|69741085|FG000|Overall Study|Withdrawal by Subject|5|||
38051684|NCT03793010|69741086|FG001|Overall Study|Withdrawal by Subject|7|||
37963503|NCT00090103|69650717|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
37963504|NCT00090103|69650718|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
37963505|NCT00090103|69650716|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
37963506|NCT00090103|69650717|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
37963507|NCT00090103|69650718|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
37963508|NCT00090103|69650716|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
37963509|NCT00090103|69650717|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
37963510|NCT00090103|69650718|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
37963511|NCT00090103|69650716|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
37963512|NCT00090103|69650717|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
37963513|NCT00090103|69650718|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
37963514|NCT00090103|69650716|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
37963515|NCT00090103|69650717|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
37963516|NCT00090103|69650718|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
37963517|NCT00090103|69650716|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
37963518|NCT00090103|69650717|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
37963519|NCT00090103|69650718|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
37963520|NCT00090103|69650716|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
37963521|NCT00090103|69650717|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
37963522|NCT00090103|69650718|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
37963523|NCT00090103|69650716|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
37963524|NCT00090103|69650717|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
37963525|NCT00090103|69650718|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
37963526|NCT00090103|69650716|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
37963527|NCT00090103|69650717|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
37963528|NCT00090103|69650718|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
37963529|NCT00090103|69650716|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
37963530|NCT00090103|69650717|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
37963531|NCT00090103|69650718|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
37963532|NCT00090103|69650716|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
37963533|NCT00090103|69650717|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
37963534|NCT00090103|69650718|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
37963535|NCT00090103|69650716|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
37963536|NCT00090103|69650717|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
37963537|NCT00090103|69650718|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
37963538|NCT00090103|69650716|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
37963539|NCT00090103|69650717|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
37963540|NCT00090103|69650718|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
37963541|NCT00090103|69650716|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
37963542|NCT00090103|69650717|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
37963543|NCT00090103|69650718|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
37963544|NCT00090103|69650716|FG000|16-Week Safety Follow-up Period|Death|1|||
37963545|NCT00090103|69650717|FG001|16-Week Safety Follow-up Period|Death|0|||
37963546|NCT00090103|69650718|FG002|16-Week Safety Follow-up Period|Death|1|||
37963547|NCT00090103|69650716|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
37963548|NCT00090103|69650717|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
37963549|NCT00090103|69650718|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
37862052|NCT01134939|69545808|FG000|Overall Study|Lost to Follow-up|2|||
37963550|NCT00090103|69650716|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
37963551|NCT00090103|69650717|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
37963552|NCT00090103|69650718|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
37862053|NCT01134939|69545809|FG001|Overall Study|Lost to Follow-up|3|||
37862054|NCT01134939|69545810|FG002|Overall Study|Lost to Follow-up|0|||
37862055|NCT01134939|69545811|FG003|Overall Study|Lost to Follow-up|1|||
37862056|NCT01134939|69545812|FG004|Overall Study|Lost to Follow-up|2|||
37862057|NCT01134939|69545813|FG005|Overall Study|Lost to Follow-up|1|||
37862058|NCT01134939|69545814|FG006|Overall Study|Lost to Follow-up|0|||
37862059|NCT01134939|69545815|FG007|Overall Study|Lost to Follow-up|0|||
37862060|NCT01134939|69545808|FG000|Overall Study|Death|0|||
37862061|NCT01134939|69545809|FG001|Overall Study|Death|1|||
37862062|NCT01134939|69545810|FG002|Overall Study|Death|0|||
37862063|NCT01134939|69545811|FG003|Overall Study|Death|0|||
37862064|NCT01134939|69545812|FG004|Overall Study|Death|0|||
37862065|NCT01134939|69545813|FG005|Overall Study|Death|0|||
37963553|NCT00090103|69650716|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
37963554|NCT00090103|69650717|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
37963555|NCT00090103|69650718|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
37963556|NCT00090103|69650716|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
37963557|NCT00090103|69650717|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
37963558|NCT00090103|69650718|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
37963559|NCT00090103|69650716|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
37963560|NCT00090103|69650717|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
37963561|NCT00090103|69650718|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
37963562|NCT00090103|69650716|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
37963563|NCT00090103|69650717|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
37963564|NCT00090103|69650718|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
37963565|NCT00090103|69650716|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
37963566|NCT00090103|69650717|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
37963567|NCT00090103|69650718|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
37963568|NCT00090103|69650716|FG000|16-Week Safety Follow-up Period|Depression|0|||
37963569|NCT00090103|69650717|FG001|16-Week Safety Follow-up Period|Depression|1|||
37963570|NCT00090103|69650718|FG002|16-Week Safety Follow-up Period|Depression|0|||
37963571|NCT00090103|69650716|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
37963572|NCT00090103|69650717|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
37963573|NCT00090103|69650718|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
37963574|NCT00090103|69650716|FG000|16-Week Safety Follow-up Period|Jailed|0|||
37963575|NCT00090103|69650717|FG001|16-Week Safety Follow-up Period|Jailed|1|||
37963576|NCT00090103|69650718|FG002|16-Week Safety Follow-up Period|Jailed|0|||
37963577|NCT00090103|69650716|FG000|16-Week Safety Follow-up Period|Other|0|||
37963578|NCT00090103|69650717|FG001|16-Week Safety Follow-up Period|Other|1|||
37963579|NCT00090103|69650718|FG002|16-Week Safety Follow-up Period|Other|0|||
37963580|NCT00087607|69650728|FG000|Overall Study|Adverse Event|14|||
37963581|NCT00087607|69650729|FG001|Overall Study|Adverse Event|24|||
37963582|NCT00087607|69650728|FG000|Overall Study|Death|0|||
37963583|NCT00087607|69650729|FG001|Overall Study|Death|1|||
37963584|NCT00087607|69650728|FG000|Overall Study|Insufficient Therapeutic Response|53|||
37963585|NCT00087607|69650729|FG001|Overall Study|Insufficient Therapeutic Response|42|||
37963586|NCT00087607|69650728|FG000|Overall Study|Failure to return|21|||
37963587|NCT00087607|69650729|FG001|Overall Study|Failure to return|17|||
37963588|NCT00087607|69650728|FG000|Overall Study|Withdrew Consent|12|||
37963589|NCT00087607|69650729|FG001|Overall Study|Withdrew Consent|16|||
37963590|NCT00087607|69650728|FG000|Overall Study|Administrative|12|||
37963591|NCT00087607|69650729|FG001|Overall Study|Administrative|12|||
37963592|NCT00087607|69650728|FG000|Overall Study|Refused Treatment|5|||
37963593|NCT00087607|69650729|FG001|Overall Study|Refused Treatment|7|||
37963594|NCT00087607|69650728|FG000|Overall Study|Other Protocol Violation|5|||
37963595|NCT00087607|69650729|FG001|Overall Study|Other Protocol Violation|2|||
37963596|NCT00087607|69650728|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
37963597|NCT00087607|69650729|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
37963598|NCT00069823|69650741|FG000|Overall Study|Did not have follow-up diary cards|6|||
37963599|NCT00069823|69650742|FG001|Overall Study|Did not have follow-up diary cards|3|||
37963600|NCT00086515|69650754|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
37963601|NCT00086515|69650755|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
37963602|NCT00086515|69650754|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
37963603|NCT00086515|69650755|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
37963604|NCT00086515|69650754|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
37963605|NCT00086515|69650755|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
37963606|NCT00086515|69650754|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
37963607|NCT00086515|69650755|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
37963608|NCT00086515|69650754|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
37963609|NCT00086515|69650755|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
37963610|NCT00086515|69650754|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
37963611|NCT00086515|69650755|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
37963612|NCT00086515|69650754|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
37963613|NCT00086515|69650755|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
37963614|NCT00086515|69650754|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
37963615|NCT00086515|69650755|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
37963616|NCT00086515|69650754|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
37963617|NCT00086515|69650755|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
37963618|NCT00086515|69650754|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
37963619|NCT00086515|69650755|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
37963620|NCT00086515|69650754|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
38051685|NCT03793010|69741085|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
38051686|NCT03793010|69741086|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
38051687|NCT03793010|69741085|FG000|Overall Study|Lost to Follow-up|1|||
38051688|NCT03793010|69741086|FG001|Overall Study|Lost to Follow-up|2|||
37963621|NCT00086515|69650755|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
37963622|NCT00086515|69650754|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
37963623|NCT00086515|69650755|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
37963624|NCT00086515|69650754|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
37963625|NCT00086515|69650755|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
37963626|NCT00086515|69650754|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
37963627|NCT00086515|69650755|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
37963628|NCT00086515|69650754|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
37963629|NCT00086515|69650755|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
37963630|NCT00086515|69650754|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
37963631|NCT00086515|69650755|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
37963632|NCT00086515|69650754|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
37963633|NCT00086515|69650755|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
37963634|NCT00086515|69650754|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
37963635|NCT00086515|69650755|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
37963636|NCT00086515|69650754|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
37963637|NCT00086515|69650755|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
37963638|NCT00086515|69650754|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
37963639|NCT00086515|69650755|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
37963640|NCT00086515|69650754|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
37963641|NCT00086515|69650755|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
37963642|NCT00086515|69650754|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
37963643|NCT00086515|69650755|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
37963644|NCT00086515|69650754|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
37963645|NCT00086515|69650755|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
37963646|NCT00086515|69650754|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
37963647|NCT00086515|69650755|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
37963648|NCT00086515|69650754|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
37963649|NCT00086515|69650755|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
37963650|NCT00086515|69650754|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
37963651|NCT00086515|69650755|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
37963652|NCT00086515|69650754|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
37963653|NCT00086515|69650755|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
37963654|NCT00086515|69650754|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
37963655|NCT00086515|69650755|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
37963656|NCT00086515|69650754|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
37963657|NCT00086515|69650755|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
37963658|NCT00086515|69650754|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
37963659|NCT00086515|69650755|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
37963660|NCT00086515|69650754|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
37963661|NCT00086515|69650755|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
37963662|NCT00541658|69650764|FG000|Overall Study|Adverse Event|28|||
37963663|NCT00541658|69650765|FG001|Overall Study|Adverse Event|37|||
37963664|NCT00541658|69650766|FG002|Overall Study|Adverse Event|25|||
37963665|NCT00541658|69650764|FG000|Overall Study|Physician Decision|0|||
37963666|NCT00541658|69650765|FG001|Overall Study|Physician Decision|0|||
37963667|NCT00541658|69650766|FG002|Overall Study|Physician Decision|4|||
37963668|NCT00541658|69650764|FG000|Overall Study|Lost to Follow-up|3|||
37963669|NCT00541658|69650765|FG001|Overall Study|Lost to Follow-up|3|||
37963670|NCT00541658|69650766|FG002|Overall Study|Lost to Follow-up|6|||
37963671|NCT00541658|69650764|FG000|Overall Study|Protocol Violation|0|||
37963672|NCT00541658|69650765|FG001|Overall Study|Protocol Violation|1|||
37963673|NCT00541658|69650766|FG002|Overall Study|Protocol Violation|1|||
37963674|NCT00541658|69650764|FG000|Overall Study|Withdrawal by Subject|28|||
37963675|NCT00541658|69650765|FG001|Overall Study|Withdrawal by Subject|32|||
37963676|NCT00541658|69650766|FG002|Overall Study|Withdrawal by Subject|32|||
37963677|NCT00541658|69650764|FG000|Overall Study|Took No Study Drug|1|||
37963678|NCT00541658|69650765|FG001|Overall Study|Took No Study Drug|0|||
37963679|NCT00541658|69650766|FG002|Overall Study|Took No Study Drug|0|||
37963680|NCT03907280|69650790|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
37963681|NCT03907280|69650791|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
37963682|NCT03907280|69650792|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
37963683|NCT04120376|69650804|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
37963684|NCT04120376|69650805|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
37963685|NCT03905642|69650812|FG000|Overall Study|Withdrawal by Subject|3|||
37963686|NCT03905642|69650812|FG000|Overall Study|Pregnancy|1|||
37963687|NCT03905642|69650812|FG000|Overall Study|Adverse Event|1|||
37963688|NCT03905642|69650812|FG000|Overall Study|Lack of Efficacy|1|||
37963689|NCT03905642|69650812|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
37963690|NCT00412984|69650852|FG000|Overall Study|Death|331|||
37963691|NCT00412984|69650853|FG001|Overall Study|Death|349|||
37963692|NCT00412984|69650852|FG000|Overall Study|Adverse Event|679|||
37963693|NCT00412984|69650853|FG001|Overall Study|Adverse Event|738|||
37963694|NCT00412984|69650852|FG000|Overall Study|Withdrawal by Subject|921|||
37963695|NCT00412984|69650853|FG001|Overall Study|Withdrawal by Subject|989|||
37963696|NCT00412984|69650852|FG000|Overall Study|Lost to Follow-up|51|||
37963697|NCT00412984|69650853|FG001|Overall Study|Lost to Follow-up|39|||
37963698|NCT00412984|69650852|FG000|Overall Study|Poor/Noncompliance|57|||
37963699|NCT00412984|69650853|FG001|Overall Study|Poor/Noncompliance|77|||
37963700|NCT00412984|69650852|FG000|Overall Study|Pregnancy|1|||
37963701|NCT00412984|69650853|FG001|Overall Study|Pregnancy|0|||
37963702|NCT00412984|69650852|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
37963703|NCT00412984|69650853|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
37963704|NCT00412984|69650852|FG000|Overall Study|Administrative Reason by Sponsor|11|||
37963705|NCT00412984|69650853|FG001|Overall Study|Administrative Reason by Sponsor|8|||
37963706|NCT00412984|69650852|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
37963707|NCT00412984|69650853|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
37963708|NCT00412984|69650852|FG000|Overall Study|Other Reason|80|||
37963709|NCT00412984|69650853|FG001|Overall Study|Other Reason|92|||
37963710|NCT00412984|69650852|FG000|Overall Study|Not Reported|11|||
37963711|NCT00412984|69650853|FG001|Overall Study|Not Reported|12|||
37963712|NCT00539864|69650861|FG000|Overall Study|Lost to Follow-up|0|||
37963713|NCT00539864|69650862|FG001|Overall Study|Lost to Follow-up|1|||
37963714|NCT00539864|69650861|FG000|Overall Study|Withdrawal by Subject|1|||
37963715|NCT00539864|69650862|FG001|Overall Study|Withdrawal by Subject|1|||
37963716|NCT00673049|69650870|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
37963717|NCT00673049|69650871|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
37963718|NCT00673049|69650872|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
37963719|NCT00673049|69650873|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
37963720|NCT00673049|69650870|FG000|Before Progression on Erlotinib|Death|235|||
37963721|NCT00673049|69650871|FG001|Before Progression on Erlotinib|Death|167|||
37963722|NCT00673049|69650872|FG002|Before Progression on Erlotinib|Death|1|||
37963723|NCT00673049|69650873|FG003|Before Progression on Erlotinib|Death|0|||
37963724|NCT00673049|69650870|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
37963725|NCT00673049|69650871|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
37963726|NCT00673049|69650872|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
37963727|NCT00673049|69650873|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
37963728|NCT00673049|69650870|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
37963729|NCT00673049|69650871|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
37963730|NCT00673049|69650872|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
37963731|NCT00673049|69650873|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
37963732|NCT00673049|69650870|FG000|Before Progression on Erlotinib|Other|1|||
37963733|NCT00673049|69650871|FG001|Before Progression on Erlotinib|Other|2|||
37963734|NCT00673049|69650872|FG002|Before Progression on Erlotinib|Other|0|||
37963735|NCT00673049|69650873|FG003|Before Progression on Erlotinib|Other|0|||
37963736|NCT00673049|69650870|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
37963737|NCT00673049|69650871|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
37963738|NCT00673049|69650872|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
37963739|NCT00673049|69650873|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
37963740|NCT00673049|69650870|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
37963741|NCT00673049|69650871|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
37963742|NCT00673049|69650872|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
37963743|NCT00673049|69650873|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
37963744|NCT00673049|69650870|FG000|After Progression on Erlotinib|Death|0|||
37963745|NCT00673049|69650871|FG001|After Progression on Erlotinib|Death|0|||
37963746|NCT00673049|69650872|FG002|After Progression on Erlotinib|Death|0|||
37963747|NCT00673049|69650873|FG003|After Progression on Erlotinib|Death|71|||
37963748|NCT00673049|69650870|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
37963749|NCT00673049|69650871|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
37963750|NCT00673049|69650872|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
37963751|NCT00673049|69650873|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
37963752|NCT00673049|69650870|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
37963753|NCT00673049|69650871|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
37963754|NCT00673049|69650872|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
37963755|NCT00673049|69650873|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
37963756|NCT00673049|69650870|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
37963757|NCT00673049|69650871|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
37963758|NCT00673049|69650872|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
37963759|NCT00673049|69650873|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
37963760|NCT00412750|69650884|FG000|Overall Study|Abnormal laboratory value(s)|1|||
37963761|NCT00412750|69650885|FG001|Overall Study|Abnormal laboratory value(s)|0|||
37963762|NCT00412750|69650886|FG002|Overall Study|Abnormal laboratory value(s)|0|||
37963763|NCT00412750|69650884|FG000|Overall Study|Administrative problems|21|||
37963764|NCT00412750|69650885|FG001|Overall Study|Administrative problems|17|||
37963765|NCT00412750|69650886|FG002|Overall Study|Administrative problems|14|||
37963766|NCT00412750|69650884|FG000|Overall Study|Adverse Event|8|||
37963767|NCT00412750|69650885|FG001|Overall Study|Adverse Event|3|||
37963768|NCT00412750|69650886|FG002|Overall Study|Adverse Event|3|||
37963769|NCT00412750|69650884|FG000|Overall Study|Lost to Follow-up|1|||
37963770|NCT00412750|69650885|FG001|Overall Study|Lost to Follow-up|0|||
37963771|NCT00412750|69650886|FG002|Overall Study|Lost to Follow-up|1|||
37963772|NCT00412750|69650884|FG000|Overall Study|Withdrawal by Subject|0|||
37963773|NCT00412750|69650885|FG001|Overall Study|Withdrawal by Subject|1|||
37963774|NCT00412750|69650886|FG002|Overall Study|Withdrawal by Subject|2|||
37963775|NCT00412750|69650884|FG000|Overall Study|Lack of Efficacy|0|||
37963776|NCT00412750|69650885|FG001|Overall Study|Lack of Efficacy|0|||
37963777|NCT00412750|69650886|FG002|Overall Study|Lack of Efficacy|3|||
37963778|NCT00076999|69650900|FG000|Overall Study|Adverse Event|2|||
37963779|NCT00076999|69650901|FG001|Overall Study|Adverse Event|8|||
37963780|NCT00076999|69650902|FG002|Overall Study|Adverse Event|6|||
37963781|NCT00076999|69650903|FG003|Overall Study|Adverse Event|0|||
37963782|NCT00076999|69650904|FG004|Overall Study|Adverse Event|2|||
37963783|NCT00076999|69650900|FG000|Overall Study|Protocol Violation|0|||
37963784|NCT00076999|69650901|FG001|Overall Study|Protocol Violation|3|||
37963785|NCT00076999|69650902|FG002|Overall Study|Protocol Violation|4|||
37963786|NCT00076999|69650903|FG003|Overall Study|Protocol Violation|0|||
37963787|NCT00076999|69650904|FG004|Overall Study|Protocol Violation|9|||
37963788|NCT00076999|69650900|FG000|Overall Study|Lost to Follow-up|2|||
37963789|NCT00076999|69650901|FG001|Overall Study|Lost to Follow-up|1|||
37963790|NCT00076999|69650902|FG002|Overall Study|Lost to Follow-up|0|||
37963791|NCT00076999|69650903|FG003|Overall Study|Lost to Follow-up|0|||
37963792|NCT00076999|69650904|FG004|Overall Study|Lost to Follow-up|0|||
37963793|NCT00076999|69650900|FG000|Overall Study|Withdrawal by Subject|0|||
37963794|NCT00076999|69650901|FG001|Overall Study|Withdrawal by Subject|4|||
37963795|NCT00076999|69650902|FG002|Overall Study|Withdrawal by Subject|3|||
37963796|NCT00076999|69650903|FG003|Overall Study|Withdrawal by Subject|0|||
37963797|NCT00076999|69650904|FG004|Overall Study|Withdrawal by Subject|1|||
37963798|NCT00076999|69650900|FG000|Overall Study|Other reason (not specified)|8|||
37963799|NCT00076999|69650901|FG001|Overall Study|Other reason (not specified)|8|||
37963800|NCT00076999|69650902|FG002|Overall Study|Other reason (not specified)|4|||
37963801|NCT00076999|69650903|FG003|Overall Study|Other reason (not specified)|1|||
37963802|NCT00076999|69650904|FG004|Overall Study|Other reason (not specified)|13|||
37963803|NCT03905096|69650919|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
37963804|NCT03905096|69650920|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
37963805|NCT00412360|69650935|FG000|Overall Study|Lost to Follow-up|0|||
37963806|NCT00412360|69650936|FG001|Overall Study|Lost to Follow-up|1|||
37963807|NCT00412360|69650935|FG000|Overall Study|Not Transplanted|1|||
37963808|NCT00412360|69650936|FG001|Overall Study|Not Transplanted|2|||
37963809|NCT00571103|69650942|FG000|Overall Study|Withdrawal by Subject|1|||
37963810|NCT00571103|69650942|FG000|Overall Study|Lost to Follow-up|1|||
37963811|NCT00069277|69650946|FG000|Overall Study|Adverse Event|3|||
37963812|NCT00069277|69650946|FG000|Overall Study|Withdrawal by Subject|1|||
37963813|NCT00069277|69650946|FG000|Overall Study|Progressive Disease|15|||
37963814|NCT00069277|69650946|FG000|Overall Study|Physician Decision|2|||
37963815|NCT00418522|69650952|FG000|Overall Study|Adverse Event|7|||
37963816|NCT00418522|69650953|FG001|Overall Study|Adverse Event|1|||
37963817|NCT00418522|69650952|FG000|Overall Study|Lack of Efficacy|1|||
37963818|NCT00418522|69650953|FG001|Overall Study|Lack of Efficacy|3|||
37963819|NCT00418522|69650952|FG000|Overall Study|Lost to Follow-up|10|||
37963820|NCT00418522|69650953|FG001|Overall Study|Lost to Follow-up|4|||
37963821|NCT00418522|69650952|FG000|Overall Study|Withdrawal by Subject|31|||
38051689|NCT03793010|69741085|FG000|Overall Study|Patient couldn't sit still for injection|1|||
37963822|NCT00418522|69650953|FG001|Overall Study|Withdrawal by Subject|7|||
38051690|NCT03793010|69741086|FG001|Overall Study|Patient couldn't sit still for injection|0|||
38051691|NCT03793010|69741085|FG000|Overall Study|Withdrew to pursue other treatment|1|||
37963823|NCT00418522|69650952|FG000|Overall Study|Other|27|||
37963824|NCT00418522|69650953|FG001|Overall Study|Other|23|||
37963825|NCT00418522|69650952|FG000|Overall Study|Randomized but did not receive treatment|7|||
37963826|NCT00418522|69650953|FG001|Overall Study|Randomized but did not receive treatment|4|||
38051692|NCT03793010|69741086|FG001|Overall Study|Withdrew to pursue other treatment|0|||
37963827|NCT00403546|69650961|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
37963828|NCT00403546|69650962|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
37963829|NCT00403546|69650963|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
37963830|NCT00403546|69650961|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
37963831|NCT00403546|69650962|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
37963832|NCT00403546|69650963|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
37963833|NCT00403546|69650961|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
37963834|NCT00403546|69650962|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
37963835|NCT00403546|69650963|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
37963836|NCT00403546|69650961|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
37963837|NCT00403546|69650962|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
37963838|NCT00403546|69650963|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
37963839|NCT00403546|69650961|FG000|Screening Phase|Screening Failure|22|||
37963840|NCT00403546|69650962|FG001|Screening Phase|Screening Failure|0|||
37963841|NCT00403546|69650963|FG002|Screening Phase|Screening Failure|0|||
37963842|NCT00403546|69650961|FG000|Screening Phase|Adverse Event|1|||
37963843|NCT00403546|69650962|FG001|Screening Phase|Adverse Event|0|||
37963844|NCT00403546|69650963|FG002|Screening Phase|Adverse Event|0|||
37963845|NCT00403546|69650961|FG000|Screening Phase|Terminated Prior to Randomization|5|||
37963846|NCT00403546|69650962|FG001|Screening Phase|Terminated Prior to Randomization|0|||
37963847|NCT00403546|69650963|FG002|Screening Phase|Terminated Prior to Randomization|0|||
37963848|NCT00403546|69650961|FG000|Randomized Trial|Early Terminations|0|||
37963849|NCT00403546|69650962|FG001|Randomized Trial|Early Terminations|17|||
37963850|NCT00403546|69650963|FG002|Randomized Trial|Early Terminations|16|||
37963851|NCT00403390|69650974|FG000|Overall Study|Withdrawal by Subject|1|||
37963852|NCT00403390|69650975|FG001|Overall Study|Withdrawal by Subject|0|||
37963853|NCT00403390|69650974|FG000|Overall Study|samples lost|1|||
37963854|NCT00403390|69650975|FG001|Overall Study|samples lost|0|||
37963855|NCT00403390|69650974|FG000|Overall Study|non-compliant|1|||
37963856|NCT00403390|69650975|FG001|Overall Study|non-compliant|0|||
37963857|NCT00403234|69650985|FG000|Overall Study|Withdrawal by Subject|0|||
37963858|NCT00403234|69650986|FG001|Overall Study|Withdrawal by Subject|1|||
37963859|NCT00403234|69650987|FG002|Overall Study|Withdrawal by Subject|0|||
37963860|NCT00403234|69650988|FG003|Overall Study|Withdrawal by Subject|0|||
37963861|NCT00403234|69650985|FG000|Overall Study|Adverse Event|1|||
37963862|NCT00403234|69650986|FG001|Overall Study|Adverse Event|0|||
37963863|NCT00403234|69650987|FG002|Overall Study|Adverse Event|1|||
37963864|NCT00403234|69650988|FG003|Overall Study|Adverse Event|0|||
37963865|NCT00402688|69651001|FG000|Overall Study|Adverse Event|12|||
37963866|NCT00402688|69651002|FG001|Overall Study|Adverse Event|9|||
37963867|NCT00402688|69651003|FG002|Overall Study|Adverse Event|3|||
37963868|NCT00402688|69651001|FG000|Overall Study|Withdrawal by Subject|3|||
37963869|NCT00402688|69651002|FG001|Overall Study|Withdrawal by Subject|1|||
37963870|NCT00402688|69651003|FG002|Overall Study|Withdrawal by Subject|1|||
37963871|NCT00402688|69651001|FG000|Overall Study|Physician Decision|0|||
37963872|NCT00402688|69651002|FG001|Overall Study|Physician Decision|0|||
37963873|NCT00402688|69651003|FG002|Overall Study|Physician Decision|1|||
37963874|NCT00402688|69651001|FG000|Overall Study|Lack of Efficacy|4|||
37963875|NCT00402688|69651002|FG001|Overall Study|Lack of Efficacy|4|||
37963876|NCT00402688|69651003|FG002|Overall Study|Lack of Efficacy|5|||
37963877|NCT00402688|69651001|FG000|Overall Study|Protocol Violation|1|||
37963878|NCT00402688|69651002|FG001|Overall Study|Protocol Violation|1|||
37963879|NCT00402688|69651003|FG002|Overall Study|Protocol Violation|1|||
37963880|NCT00402688|69651001|FG000|Overall Study|Lost to Follow-up|1|||
37963881|NCT00402688|69651002|FG001|Overall Study|Lost to Follow-up|0|||
37963882|NCT00402688|69651003|FG002|Overall Study|Lost to Follow-up|2|||
37963883|NCT00402688|69651001|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
37963884|NCT00402688|69651002|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
37963885|NCT00402688|69651003|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
37963886|NCT00402688|69651001|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
37963887|NCT00402688|69651002|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
37963888|NCT00402688|69651003|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
37963889|NCT00402688|69651001|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
37963890|NCT00402688|69651002|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
37963891|NCT00402688|69651003|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
37963892|NCT00671879|69651014|FG000|Overall Study|Withdrawal by Subject|0|||
37963893|NCT00671879|69651015|FG001|Overall Study|Withdrawal by Subject|4|||
37963894|NCT00671879|69651016|FG002|Overall Study|Withdrawal by Subject|6|||
37963895|NCT00402298|69651027|FG000|Overall Study|Withdrawal by Subject|1|||
37963896|NCT00402298|69651028|FG001|Overall Study|Withdrawal by Subject|0|||
38051693|NCT03793010|69741085|FG000|Overall Study|Did not meet eligibility criteria|1|||
37963897|NCT00401830|69651036|FG000|Overall Study|Adverse Event|10|||
37963898|NCT00401830|69651037|FG001|Overall Study|Adverse Event|18|||
37963899|NCT00401830|69651036|FG000|Overall Study|Lack of Efficacy|11|||
37963900|NCT00401830|69651037|FG001|Overall Study|Lack of Efficacy|5|||
37963901|NCT00401830|69651036|FG000|Overall Study|Withdrawal by Subject|4|||
37963902|NCT00401830|69651037|FG001|Overall Study|Withdrawal by Subject|3|||
37963903|NCT00401830|69651036|FG000|Overall Study|Protocol Violation|3|||
37963904|NCT00401830|69651037|FG001|Overall Study|Protocol Violation|3|||
37963905|NCT00401830|69651036|FG000|Overall Study|Non-compliance with drug study|1|||
37963906|NCT00401830|69651037|FG001|Overall Study|Non-compliance with drug study|0|||
37963907|NCT00401830|69651036|FG000|Overall Study|Lost to Follow-up|1|||
37963908|NCT00401830|69651037|FG001|Overall Study|Lost to Follow-up|3|||
37963909|NCT00401830|69651036|FG000|Overall Study|Other: Personal / Family problems|1|||
37963910|NCT00401830|69651037|FG001|Overall Study|Other: Personal / Family problems|0|||
37963911|NCT00401752|69651045|FG000|Overall Study|Adverse Event|2|||
37963912|NCT00401752|69651046|FG001|Overall Study|Adverse Event|5|||
37963913|NCT00401752|69651045|FG000|Overall Study|Withdrawal by Subject|2|||
37963914|NCT00401752|69651046|FG001|Overall Study|Withdrawal by Subject|6|||
37963915|NCT00401752|69651045|FG000|Overall Study|Lost to Follow-up|1|||
37963916|NCT00401752|69651046|FG001|Overall Study|Lost to Follow-up|4|||
37963917|NCT00401752|69651045|FG000|Overall Study|Development of any exclusion criteria|4|||
37963918|NCT00401752|69651046|FG001|Overall Study|Development of any exclusion criteria|2|||
37963919|NCT00401752|69651045|FG000|Overall Study|Physician Decision|1|||
38051694|NCT03793010|69741086|FG001|Overall Study|Did not meet eligibility criteria|0|||
37862066|NCT01134939|69545814|FG006|Overall Study|Death|0|||
37862067|NCT01134939|69545815|FG007|Overall Study|Death|0|||
37862068|NCT01134939|69545808|FG000|Overall Study|Termination page not available|4|||
37862069|NCT01134939|69545809|FG001|Overall Study|Termination page not available|6|||
37862070|NCT01134939|69545810|FG002|Overall Study|Termination page not available|5|||
37862071|NCT01134939|69545811|FG003|Overall Study|Termination page not available|8|||
37862072|NCT01134939|69545812|FG004|Overall Study|Termination page not available|0|||
37862073|NCT01134939|69545813|FG005|Overall Study|Termination page not available|3|||
37862074|NCT01134939|69545814|FG006|Overall Study|Termination page not available|7|||
37862075|NCT01134939|69545815|FG007|Overall Study|Termination page not available|0|||
37862076|NCT01134783|69545831|FG000|Overall Study|Pregnancy|16|||
37862077|NCT01134783|69545832|FG001|Overall Study|Pregnancy|8|||
37862078|NCT01134783|69545831|FG000|Overall Study|Withdrawal by Subject|15|||
37963920|NCT00401752|69651046|FG001|Overall Study|Physician Decision|1|||
37963921|NCT00539240|69651055|FG000|Overall Study|Withdrawal by Subject|0|||
38051695|NCT03304626|69741094|FG000|Overall Study|Adverse Event|1|||
38051696|NCT03304626|69741095|FG001|Overall Study|Adverse Event|0|||
38051697|NCT03304626|69741094|FG000|Overall Study|Lack of Efficacy|1|||
38051698|NCT03304626|69741095|FG001|Overall Study|Lack of Efficacy|1|||
38051699|NCT03274986|69741104|FG000|Overall Study|Withdrawal by Subject|0|||
38051700|NCT03274986|69741105|FG001|Overall Study|Withdrawal by Subject|1|||
38051701|NCT03274986|69741104|FG000|Overall Study|Lost to Follow-up|0|||
38051702|NCT03274986|69741105|FG001|Overall Study|Lost to Follow-up|1|||
38051703|NCT02919306|69741120|FG000|Overall Study|Withdrawal by Subject|1|||
38051704|NCT02919306|69741121|FG001|Overall Study|Withdrawal by Subject|0|||
38051705|NCT02919306|69741120|FG000|Overall Study|Protocol Violation|1|||
38051706|NCT02919306|69741121|FG001|Overall Study|Protocol Violation|0|||
38051707|NCT03274440|69741127|FG000|Overall Study|Time commitment too great|1|||
38051708|NCT03274440|69741128|FG001|Overall Study|Time commitment too great|0|||
38051709|NCT03274440|69741129|FG002|Overall Study|Time commitment too great|0|||
38051710|NCT03274440|69741130|FG003|Overall Study|Time commitment too great|1|||
38051711|NCT03274440|69741131|FG004|Overall Study|Time commitment too great|0|||
38051712|NCT03274440|69741132|FG005|Overall Study|Time commitment too great|0|||
38051713|NCT03268746|69741140|FG000|Overall Study|Withdrawal by Subject|1|||
38051714|NCT03268590|69741151|FG000|Overall Study|Previously unknown exclusion criteria|1|||
38051715|NCT03267576|69741160|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
38051716|NCT03267576|69741161|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
38051717|NCT03267576|69741160|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
38051718|NCT03267576|69741161|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
38051719|NCT03267264|69741171|FG000|Overall Study|Withdrawal by Subject|1|||
38051720|NCT03267264|69741172|FG001|Overall Study|Withdrawal by Subject|0|||
38051721|NCT03267264|69741173|FG002|Overall Study|Withdrawal by Subject|2|||
38051722|NCT03267264|69741174|FG003|Overall Study|Withdrawal by Subject|4|||
38051723|NCT03244800|69741191|FG000|Overall Study|Adverse Event|0|||
38051724|NCT03244800|69741192|FG001|Overall Study|Adverse Event|1|||
38051725|NCT03244800|69741193|FG002|Overall Study|Adverse Event|0|||
38051726|NCT03244800|69741194|FG003|Overall Study|Adverse Event|1|||
38051727|NCT03244800|69741191|FG000|Overall Study|Withdrew treatment|0|||
38051728|NCT03244800|69741192|FG001|Overall Study|Withdrew treatment|0|||
38051729|NCT03244800|69741193|FG002|Overall Study|Withdrew treatment|0|||
38051730|NCT03244800|69741194|FG003|Overall Study|Withdrew treatment|1|||
38051731|NCT04516291|69741215|FG000|Treatment Period (24 Weeks)|Other|1|||
37963922|NCT00539240|69651056|FG001|Overall Study|Withdrawal by Subject|2|||
37862079|NCT01134783|69545832|FG001|Overall Study|Withdrawal by Subject|9|||
37862080|NCT01134783|69545831|FG000|Overall Study|Lost to Follow-up|5|||
38051732|NCT04516291|69741216|FG001|Treatment Period (24 Weeks)|Other|0|||
38051733|NCT04516291|69741217|FG002|Treatment Period (24 Weeks)|Other|0|||
38051734|NCT04516291|69741218|FG003|Treatment Period (24 Weeks)|Other|2|||
38051735|NCT04516291|69741219|FG004|Treatment Period (24 Weeks)|Other|2|||
38051736|NCT04516291|69741220|FG005|Treatment Period (24 Weeks)|Other|4|||
38051737|NCT04516291|69741221|FG006|Treatment Period (24 Weeks)|Other|2|||
38051738|NCT04516291|69741222|FG007|Treatment Period (24 Weeks)|Other|0|||
38051739|NCT04516291|69741215|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
38051740|NCT04516291|69741216|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
38051741|NCT04516291|69741217|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
38051742|NCT04516291|69741218|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
38051743|NCT04516291|69741219|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
38051744|NCT04516291|69741220|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
38051745|NCT04516291|69741221|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
38051746|NCT04516291|69741222|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
38051747|NCT04516291|69741215|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
38051748|NCT04516291|69741216|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
38051749|NCT04516291|69741217|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
38051750|NCT04516291|69741218|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
38051751|NCT04516291|69741219|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
38051752|NCT04516291|69741220|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
38051753|NCT04516291|69741221|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
38051754|NCT04516291|69741222|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
38051755|NCT04516291|69741215|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
38051756|NCT04516291|69741216|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
38051757|NCT04516291|69741217|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
38051758|NCT04516291|69741218|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
38051759|NCT04516291|69741219|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
38051760|NCT04516291|69741220|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
38051761|NCT04516291|69741221|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
38051762|NCT04516291|69741222|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
38051763|NCT04516291|69741215|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
38051764|NCT04516291|69741216|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
38051765|NCT04516291|69741217|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
38051766|NCT04516291|69741218|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
38051767|NCT04516291|69741219|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
38051768|NCT04516291|69741220|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
38051769|NCT04516291|69741221|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
38051770|NCT04516291|69741222|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
38051771|NCT04516291|69741215|FG000|Follow-up Period (12 Weeks)|Other|0|||
38051772|NCT04516291|69741216|FG001|Follow-up Period (12 Weeks)|Other|1|||
38051773|NCT04516291|69741217|FG002|Follow-up Period (12 Weeks)|Other|0|||
38051774|NCT04516291|69741218|FG003|Follow-up Period (12 Weeks)|Other|2|||
38051775|NCT04516291|69741219|FG004|Follow-up Period (12 Weeks)|Other|0|||
38051776|NCT04516291|69741220|FG005|Follow-up Period (12 Weeks)|Other|0|||
38051777|NCT04516291|69741221|FG006|Follow-up Period (12 Weeks)|Other|0|||
38051778|NCT04516291|69741222|FG007|Follow-up Period (12 Weeks)|Other|0|||
38051779|NCT04516291|69741215|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
38051780|NCT04516291|69741216|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
38051781|NCT04516291|69741217|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
38051782|NCT04516291|69741218|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
38051783|NCT04516291|69741219|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
37963923|NCT00539240|69651057|FG002|Overall Study|Withdrawal by Subject|0|||
37963924|NCT00539240|69651055|FG000|Overall Study|Protocol Violation|1|||
37963925|NCT00539240|69651056|FG001|Overall Study|Protocol Violation|1|||
37963926|NCT00539240|69651057|FG002|Overall Study|Protocol Violation|4|||
37963927|NCT00539240|69651055|FG000|Overall Study|Lost to Follow-up|2|||
37963928|NCT00539240|69651056|FG001|Overall Study|Lost to Follow-up|3|||
37963929|NCT00539240|69651057|FG002|Overall Study|Lost to Follow-up|1|||
37963930|NCT00539240|69651055|FG000|Overall Study|Adverse Event|3|||
37963931|NCT00539240|69651056|FG001|Overall Study|Adverse Event|1|||
37963932|NCT00539240|69651057|FG002|Overall Study|Adverse Event|10|||
38051784|NCT04516291|69741220|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
38051785|NCT04516291|69741221|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
38051786|NCT04516291|69741222|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
38051787|NCT04516291|69741215|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
38051788|NCT04516291|69741216|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
38051789|NCT04516291|69741217|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
38051790|NCT04516291|69741218|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
37963933|NCT00417976|69651065|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
37963934|NCT00417976|69651065|FG000|Overall Study|Treatment -related toxicity|2|||
37963935|NCT00673673|69651070|FG000|Overall Study|Progressive disease|27|||
38051791|NCT04516291|69741219|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
37680354|NCT02586415|69155953|FG001|Overall Study|Death|23|||
38051792|NCT04516291|69741220|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
38051793|NCT04516291|69741221|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
38051794|NCT04516291|69741222|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
38051795|NCT03243630|69741240|FG000|Overall Study|Protocol Violation|1|||
38051796|NCT03243630|69741240|FG000|Overall Study|Physician Decision|1|||
38051797|NCT04450381|69741248|FG000|Overall Study|Protocol Violation|4|||
38051798|NCT04450381|69741248|FG000|Overall Study|Wrong device setting|2|||
38051799|NCT03068468|69741254|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
38051800|NCT03068468|69741255|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
38051801|NCT03068468|69741256|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
38051802|NCT03068468|69741257|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
38051803|NCT03068468|69741254|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
38051804|NCT03068468|69741255|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
38051805|NCT03068468|69741256|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
38051806|NCT03068468|69741257|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
38051807|NCT03068468|69741254|FG000|Placebo-Controlled Period|Adverse Event|16|||
38051808|NCT03068468|69741255|FG001|Placebo-Controlled Period|Adverse Event|21|||
38051809|NCT03068468|69741256|FG002|Placebo-Controlled Period|Adverse Event|0|||
38051810|NCT03068468|69741257|FG003|Placebo-Controlled Period|Adverse Event|0|||
38051811|NCT03068468|69741254|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
38051812|NCT03068468|69741255|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
38051813|NCT03068468|69741256|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
38051814|NCT03068468|69741257|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
38051815|NCT03068468|69741254|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
38051816|NCT03068468|69741255|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
38051817|NCT03068468|69741256|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
38051818|NCT03068468|69741257|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
38051819|NCT03068468|69741254|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
38051820|NCT03068468|69741255|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
38051821|NCT03068468|69741256|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
38051822|NCT03068468|69741257|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
38051823|NCT03068468|69741254|FG000|Placebo-Controlled Period|Death|0|||
38051824|NCT03068468|69741255|FG001|Placebo-Controlled Period|Death|1|||
38051825|NCT03068468|69741256|FG002|Placebo-Controlled Period|Death|0|||
38051826|NCT03068468|69741257|FG003|Placebo-Controlled Period|Death|0|||
38051827|NCT03068468|69741254|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
38051828|NCT03068468|69741255|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
37862081|NCT01134783|69545832|FG001|Overall Study|Lost to Follow-up|20|||
37862082|NCT01134705|69545844|FG000|Overall Study|Adverse Event|1|||
37963936|NCT00673673|69651070|FG000|Overall Study|Adverse Event|4|||
37963937|NCT00673673|69651070|FG000|Overall Study|Withdrawal by Subject|3|||
37963938|NCT00673673|69651070|FG000|Overall Study|Investigators' discretion|2|||
37963939|NCT00069121|69651076|FG000|Overall Study|Death|286|||
37963940|NCT00069121|69651077|FG001|Overall Study|Death|242|||
37963941|NCT00069121|69651076|FG000|Overall Study|Withdrawal by Subject|18|||
37963942|NCT00069121|69651077|FG001|Overall Study|Withdrawal by Subject|20|||
37963943|NCT00069121|69651076|FG000|Overall Study|Lost to Follow-up|63|||
37963944|NCT00069121|69651077|FG001|Overall Study|Lost to Follow-up|63|||
37963945|NCT00399802|69651089|FG000|Overall Study|Adverse Event|0|||
37963946|NCT00399802|69651090|FG001|Overall Study|Adverse Event|2|||
37963947|NCT00399802|69651089|FG000|Overall Study|Participant discontinued by mistake|0|||
37963948|NCT00399802|69651090|FG001|Overall Study|Participant discontinued by mistake|1|||
37963949|NCT00399568|69651098|FG000|Overall Study|Adverse Event|1|||
37963950|NCT00399568|69651099|FG001|Overall Study|Adverse Event|2|||
37963951|NCT00399568|69651098|FG000|Overall Study|Withdrawal by Subject|7|||
37963952|NCT00399568|69651099|FG001|Overall Study|Withdrawal by Subject|3|||
37963953|NCT00399568|69651098|FG000|Overall Study|Protocol non-compliance|2|||
37963954|NCT00399568|69651099|FG001|Overall Study|Protocol non-compliance|2|||
37963955|NCT00399568|69651098|FG000|Overall Study|Lost to Follow-up|2|||
37963956|NCT00399568|69651099|FG001|Overall Study|Lost to Follow-up|2|||
37963957|NCT03900728|69651110|FG000|Overall Study|No text responses|0|||
37963958|NCT03900728|69651111|FG001|Overall Study|No text responses|0|||
37963959|NCT03900728|69651112|FG002|Overall Study|No text responses|4|||
37963960|NCT00068419|69651120|FG000|Overall Study|Adverse Event|3|||
37963961|NCT00068419|69651120|FG000|Overall Study|Lack of Efficacy|24|||
37963962|NCT00068419|69651120|FG000|Overall Study|Lost to Follow-up|1|||
37963963|NCT00068419|69651120|FG000|Overall Study|Physician Decision|7|||
37963964|NCT00068419|69651120|FG000|Overall Study|Withdrawal by Subject|14|||
37963965|NCT00068419|69651120|FG000|Overall Study|Ineligible|11|||
37963966|NCT00068107|69651124|FG000|Overall Study|end-stage renal disease|6|||
37963967|NCT00068107|69651124|FG000|Overall Study|Death|2|||
37963968|NCT00068107|69651124|FG000|Overall Study|Withdrawal by Subject|1|||
37963969|NCT00394654|69651133|FG000|Overall Study|Lost to Follow-up|1|||
37963970|NCT00394654|69651134|FG001|Overall Study|Lost to Follow-up|0|||
37862083|NCT01134705|69545845|FG001|Overall Study|Adverse Event|7|||
38051829|NCT03068468|69741256|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
38051830|NCT03068468|69741257|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
38051831|NCT03068468|69741254|FG000|Open-Label Extension Period|Adverse Event|0|||
38051832|NCT03068468|69741255|FG001|Open-Label Extension Period|Adverse Event|0|||
38051833|NCT03068468|69741256|FG002|Open-Label Extension Period|Adverse Event|13|||
38051834|NCT03068468|69741257|FG003|Open-Label Extension Period|Adverse Event|17|||
38051835|NCT03068468|69741254|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
38051836|NCT03068468|69741255|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
38051837|NCT03068468|69741256|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
38051838|NCT03068468|69741257|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
38051839|NCT03068468|69741254|FG000|Open-Label Extension Period|Death|0|||
38051840|NCT03068468|69741255|FG001|Open-Label Extension Period|Death|0|||
38051841|NCT03068468|69741256|FG002|Open-Label Extension Period|Death|0|||
38051842|NCT03068468|69741257|FG003|Open-Label Extension Period|Death|1|||
38051843|NCT03068468|69741254|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
38051844|NCT03068468|69741255|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
38051845|NCT03068468|69741256|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
38051846|NCT03068468|69741257|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
38051847|NCT03068468|69741254|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
38051848|NCT03068468|69741255|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
38051849|NCT03068468|69741256|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
38051850|NCT03068468|69741257|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
38051851|NCT03068468|69741254|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
38051852|NCT03068468|69741255|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
38051853|NCT03068468|69741256|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
38051854|NCT03068468|69741257|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
38051855|NCT03068468|69741254|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
38051856|NCT03068468|69741255|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
38051857|NCT03068468|69741256|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
38051858|NCT03068468|69741257|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
38051859|NCT03068468|69741254|FG000|Open-Label Extension Period|Reason not Specified|0|||
38051860|NCT03068468|69741255|FG001|Open-Label Extension Period|Reason not Specified|0|||
38051861|NCT03068468|69741256|FG002|Open-Label Extension Period|Reason not Specified|1|||
38051862|NCT03068468|69741257|FG003|Open-Label Extension Period|Reason not Specified|4|||
38051863|NCT04512001|69741267|FG000|Week 0 to Week 24|Adverse Event|14|||
38051864|NCT04512001|69741268|FG001|Week 0 to Week 24|Adverse Event|10|||
38051865|NCT04512001|69741269|FG002|Week 0 to Week 24|Adverse Event|0|||
38051866|NCT04512001|69741270|FG003|Week 0 to Week 24|Adverse Event|0|||
38051867|NCT04512001|69741271|FG004|Week 0 to Week 24|Adverse Event|0|||
38051868|NCT04512001|69741267|FG000|Week 0 to Week 24|Death|0|||
38051869|NCT04512001|69741268|FG001|Week 0 to Week 24|Death|2|||
38051870|NCT04512001|69741269|FG002|Week 0 to Week 24|Death|0|||
38051871|NCT04512001|69741270|FG003|Week 0 to Week 24|Death|0|||
38051872|NCT04512001|69741271|FG004|Week 0 to Week 24|Death|0|||
38051873|NCT04512001|69741267|FG000|Week 0 to Week 24|Withdrawal by Subject|16|||
38051874|NCT04512001|69741268|FG001|Week 0 to Week 24|Withdrawal by Subject|9|||
38051875|NCT04512001|69741269|FG002|Week 0 to Week 24|Withdrawal by Subject|0|||
38051876|NCT04512001|69741270|FG003|Week 0 to Week 24|Withdrawal by Subject|0|||
38051877|NCT04512001|69741271|FG004|Week 0 to Week 24|Withdrawal by Subject|0|||
38051878|NCT04512001|69741267|FG000|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
38051879|NCT04512001|69741268|FG001|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
38051880|NCT04512001|69741269|FG002|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
38051881|NCT04512001|69741270|FG003|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
38051882|NCT04512001|69741271|FG004|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
38051883|NCT04512001|69741267|FG000|Week 0 to Week 24|Withdrawal By Sponsor's Decision|1|||
38051884|NCT04512001|69741268|FG001|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
38051885|NCT04512001|69741269|FG002|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
38051886|NCT04512001|69741270|FG003|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
38051887|NCT04512001|69741271|FG004|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
38051888|NCT04512001|69741267|FG000|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
38051889|NCT04512001|69741268|FG001|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|1|||
38051890|NCT04512001|69741269|FG002|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
38051891|NCT04512001|69741270|FG003|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
38051892|NCT04512001|69741271|FG004|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
38051893|NCT04512001|69741267|FG000|Week 24 to Week 63|Adverse Event|0|||
38051894|NCT04512001|69741268|FG001|Week 24 to Week 63|Adverse Event|0|||
38051895|NCT04512001|69741269|FG002|Week 24 to Week 63|Adverse Event|13|||
38051896|NCT04512001|69741270|FG003|Week 24 to Week 63|Adverse Event|8|||
38051897|NCT04512001|69741271|FG004|Week 24 to Week 63|Adverse Event|6|||
38051898|NCT04512001|69741267|FG000|Week 24 to Week 63|Lost to Follow-up|0|||
38051899|NCT04512001|69741268|FG001|Week 24 to Week 63|Lost to Follow-up|0|||
38051900|NCT04512001|69741269|FG002|Week 24 to Week 63|Lost to Follow-up|1|||
38051901|NCT04512001|69741270|FG003|Week 24 to Week 63|Lost to Follow-up|1|||
38051902|NCT04512001|69741271|FG004|Week 24 to Week 63|Lost to Follow-up|1|||
38051903|NCT04512001|69741267|FG000|Week 24 to Week 63|Death|0|||
38051904|NCT04512001|69741268|FG001|Week 24 to Week 63|Death|0|||
38051905|NCT04512001|69741269|FG002|Week 24 to Week 63|Death|0|||
38051906|NCT04512001|69741270|FG003|Week 24 to Week 63|Death|1|||
38051907|NCT04512001|69741271|FG004|Week 24 to Week 63|Death|1|||
38051908|NCT04512001|69741267|FG000|Week 24 to Week 63|Withdrawal by Subject|0|||
38051909|NCT04512001|69741268|FG001|Week 24 to Week 63|Withdrawal by Subject|0|||
38051910|NCT04512001|69741269|FG002|Week 24 to Week 63|Withdrawal by Subject|6|||
38051911|NCT04512001|69741270|FG003|Week 24 to Week 63|Withdrawal by Subject|4|||
38051912|NCT04512001|69741271|FG004|Week 24 to Week 63|Withdrawal by Subject|6|||
38051913|NCT04512001|69741267|FG000|Week 24 to Week 63|Miscellaneous|0|||
38051914|NCT04512001|69741268|FG001|Week 24 to Week 63|Miscellaneous|0|||
38051915|NCT04512001|69741269|FG002|Week 24 to Week 63|Miscellaneous|3|||
38051916|NCT04512001|69741270|FG003|Week 24 to Week 63|Miscellaneous|2|||
38051917|NCT04512001|69741271|FG004|Week 24 to Week 63|Miscellaneous|1|||
38051918|NCT04447417|69741286|FG000|Overall Study|Withdrawal by Subject|1|||
38051919|NCT04447417|69741287|FG001|Overall Study|Withdrawal by Subject|0|||
38051920|NCT04447417|69741286|FG000|Overall Study|Failure to meet inclusion criteria|1|||
38051921|NCT04447417|69741287|FG001|Overall Study|Failure to meet inclusion criteria|0|||
38051922|NCT04447417|69741286|FG000|Overall Study|Lost to Follow-up|1|||
38051923|NCT04447417|69741287|FG001|Overall Study|Lost to Follow-up|0|||
38051924|NCT02787044|69741295|FG000|Overall Study|Lost to Follow-up|15|||
38051925|NCT02787044|69741296|FG001|Overall Study|Lost to Follow-up|19|||
38051926|NCT01345019|69741308|FG000|Blinded Treatment Phase|Death|147|||
38051927|NCT01345019|69741309|FG001|Blinded Treatment Phase|Death|137|||
38051928|NCT01345019|69741308|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
38051929|NCT01345019|69741309|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
38051930|NCT01345019|69741308|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
38051931|NCT01345019|69741309|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
38051932|NCT01345019|69741308|FG000|Blinded Treatment Phase|Disease Progression|12|||
38051933|NCT01345019|69741309|FG001|Blinded Treatment Phase|Disease Progression|10|||
38051934|NCT01345019|69741308|FG000|Blinded Treatment Phase|Adverse Event|6|||
38051935|NCT01345019|69741309|FG001|Blinded Treatment Phase|Adverse Event|13|||
38051936|NCT01345019|69741308|FG000|Blinded Treatment Phase|Administrative Decision|10|||
38051937|NCT01345019|69741309|FG001|Blinded Treatment Phase|Administrative Decision|8|||
38051938|NCT01345019|69741308|FG000|Blinded Treatment Phase|Noncompliance|5|||
38051939|NCT01345019|69741309|FG001|Blinded Treatment Phase|Noncompliance|3|||
38051940|NCT01345019|69741308|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
38051941|NCT01345019|69741309|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
38051942|NCT01345019|69741308|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
38051943|NCT01345019|69741309|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
38051944|NCT01345019|69741308|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
38051945|NCT01345019|69741309|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
38051946|NCT01345019|69741308|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
38051947|NCT01345019|69741309|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
38051948|NCT01345019|69741308|FG000|Open Label Treatment Phase|Death|49|||
38051949|NCT01345019|69741309|FG001|Open Label Treatment Phase|Death|48|||
37680355|NCT02586415|69155952|FG000|Overall Study|Lost to Follow-up|1|||
37963971|NCT00394654|69651133|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
37963972|NCT00394654|69651134|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
37963973|NCT03900416|69651142|FG000|Six Week Follow-up|Lost to Follow-up|1|||
37963974|NCT03900416|69651143|FG001|Six Week Follow-up|Lost to Follow-up|0|||
37963975|NCT03900416|69651142|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
37963976|NCT03900416|69651143|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
37963977|NCT03900416|69651142|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
37963978|NCT03900416|69651143|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
37963979|NCT03900416|69651142|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
37963980|NCT03900416|69651143|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
37963981|NCT03900416|69651142|FG000|Twelve Week Follow-up|Adverse Event|1|||
37963982|NCT03900416|69651143|FG001|Twelve Week Follow-up|Adverse Event|1|||
38051950|NCT01345019|69741308|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
38051951|NCT01345019|69741309|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
38051952|NCT01345019|69741308|FG000|Open Label Treatment Phase|Adverse Event|30|||
38051953|NCT01345019|69741309|FG001|Open Label Treatment Phase|Adverse Event|51|||
38051954|NCT01345019|69741308|FG000|Open Label Treatment Phase|Administrative Decision|30|||
38051955|NCT01345019|69741309|FG001|Open Label Treatment Phase|Administrative Decision|15|||
38051956|NCT01345019|69741308|FG000|Open Label Treatment Phase|Disease Progression|17|||
38051957|NCT01345019|69741309|FG001|Open Label Treatment Phase|Disease Progression|18|||
38051958|NCT01345019|69741308|FG000|Open Label Treatment Phase|Noncompliance|5|||
38051959|NCT01345019|69741309|FG001|Open Label Treatment Phase|Noncompliance|4|||
38051960|NCT01345019|69741308|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
38051961|NCT01345019|69741309|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
38051962|NCT01345019|69741308|FG000|Open Label Treatment Phase|Pregnancy|1|||
38051963|NCT01345019|69741309|FG001|Open Label Treatment Phase|Pregnancy|0|||
38051964|NCT01345019|69741308|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
38051965|NCT01345019|69741309|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
38051966|NCT01345019|69741308|FG000|Open Label Treatment Phase|Protocol Violation|0|||
38051967|NCT01345019|69741309|FG001|Open Label Treatment Phase|Protocol Violation|1|||
38051968|NCT04507867|69741319|FG000|Overall Study|Death|7|||
38051969|NCT04507867|69741320|FG001|Overall Study|Death|1|||
38051970|NCT03069716|69741344|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
38051971|NCT03069716|69741345|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
38051972|NCT03069716|69741346|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
38051973|NCT03069716|69741344|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
38051974|NCT03069716|69741345|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
38051975|NCT03069716|69741346|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
38051976|NCT03069716|69741344|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
38051977|NCT03069716|69741345|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
38051978|NCT03069716|69741346|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
38051979|NCT03069716|69741344|FG000|Randomized Treatment|Withdrawal by Subject|0|||
38051980|NCT03069716|69741345|FG001|Randomized Treatment|Withdrawal by Subject|2|||
38051981|NCT03069716|69741346|FG002|Randomized Treatment|Withdrawal by Subject|0|||
38051982|NCT03693625|69741359|FG000|Overall Study|Adverse Event|2|||
38051983|NCT03693625|69741360|FG001|Overall Study|Adverse Event|0|||
38051984|NCT03693625|69741359|FG000|Overall Study|Study Terminated By Sponsor|20|||
38051985|NCT03693625|69741360|FG001|Overall Study|Study Terminated By Sponsor|7|||
38051986|NCT03693625|69741359|FG000|Overall Study|Withdrawal by Subject|1|||
38051987|NCT03693625|69741360|FG001|Overall Study|Withdrawal by Subject|1|||
38051988|NCT01265537|69741368|FG000|Overall Study|Adverse Event|2|||
38051989|NCT01265537|69741369|FG001|Overall Study|Adverse Event|1|||
38051990|NCT01265537|69741368|FG000|Overall Study|Physician Decision|0|||
38051991|NCT01265537|69741369|FG001|Overall Study|Physician Decision|1|||
38051992|NCT04396639|69741375|FG000|Overall Study|Withdrawal by Subject|1|||
38051993|NCT04396639|69741375|FG000|Overall Study|Other|1|||
38051994|NCT04432298|69741381|FG000|Overall Study|Other than specified|1|||
38051995|NCT04432298|69741382|FG001|Overall Study|Other than specified|0|||
38051996|NCT04432298|69741381|FG000|Overall Study|Lost to Follow-up|0|||
38051997|NCT04432298|69741382|FG001|Overall Study|Lost to Follow-up|1|||
38051998|NCT04432298|69741381|FG000|Overall Study|Death|3|||
38051999|NCT04432298|69741382|FG001|Overall Study|Death|2|||
38052000|NCT04432298|69741381|FG000|Overall Study|Withdrawal by Subject|2|||
38052001|NCT04432298|69741382|FG001|Overall Study|Withdrawal by Subject|0|||
38052002|NCT04167085|69741390|FG000|Baseline|Withdrawal by Subject|2|||
38052003|NCT04167085|69741391|FG001|Baseline|Withdrawal by Subject|1|||
38052004|NCT04167085|69741390|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
38052005|NCT04167085|69741391|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
38052006|NCT04162795|69741397|FG000|Overall Study|Other|16|||
38052007|NCT04162795|69741397|FG000|Overall Study|Screen failures|10|||
38052008|NCT03069482|69741403|FG000|Overall Study|Lost to Follow-up|0|||
38052009|NCT03069482|69741404|FG001|Overall Study|Lost to Follow-up|1|||
38052010|NCT03069482|69741403|FG000|Overall Study|Physician Decision|1|||
38052011|NCT03069482|69741404|FG001|Overall Study|Physician Decision|0|||
38052012|NCT03266172|69741416|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
38052013|NCT03266172|69741417|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
38052014|NCT03266172|69741418|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
38052015|NCT03266172|69741416|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
38052016|NCT03266172|69741417|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
38052017|NCT03266172|69741418|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
38052018|NCT03266172|69741416|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
38052019|NCT03266172|69741417|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
38052020|NCT03266172|69741418|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
38052021|NCT03266172|69741416|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
38052022|NCT03266172|69741417|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
38052023|NCT03266172|69741418|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
38052024|NCT03266172|69741416|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
38052025|NCT03266172|69741417|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
38052026|NCT03266172|69741418|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
38052027|NCT03266172|69741416|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
38052028|NCT03266172|69741417|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
38052029|NCT03266172|69741418|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
38052030|NCT04356937|69741470|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
38052031|NCT04356937|69741471|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
38052032|NCT03301740|69741483|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
38052033|NCT03301740|69741484|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
38052034|NCT03301740|69741483|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
38052035|NCT03301740|69741484|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
38052036|NCT04355767|69741492|FG000|Overall Study|Withdrawal by Subject|2|||
38052037|NCT04355767|69741493|FG001|Overall Study|Withdrawal by Subject|2|||
38052038|NCT04355767|69741492|FG000|Overall Study|Death|5|||
38052039|NCT04355767|69741493|FG001|Overall Study|Death|1|||
38052040|NCT00882050|69741502|FG000|Overall Study|Physician Decision|1|||
38052041|NCT00882050|69741503|FG001|Overall Study|Physician Decision|0|||
38052042|NCT00882050|69741504|FG002|Overall Study|Physician Decision|0|||
38052043|NCT03266094|69741512|FG000|Overall Study|Lost to Follow-up|1|||
38052044|NCT03266094|69741512|FG000|Overall Study|Withdrawal by Subject|1|||
38052045|NCT04161079|69741518|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
38052046|NCT03243084|69741528|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
38052047|NCT03243084|69741529|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
38052048|NCT04353817|69741538|FG000|Overall Study|Adverse Event|0|||
38052049|NCT04353817|69741539|FG001|Overall Study|Adverse Event|1|||
38052050|NCT00159588|69741548|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
38052051|NCT00159588|69741549|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
38052052|NCT00159588|69741550|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
38052053|NCT03265938|69741561|FG000|Overall Study|Withdrawal by Subject|1|||
38052054|NCT03265938|69741561|FG000|Overall Study|Physician Decision|1|||
38052055|NCT03265938|69741561|FG000|Overall Study|friable mass|6|||
38052056|NCT04353037|69741570|FG000|Overall Study|Lost to Follow-up|0|||
38052057|NCT04353037|69741571|FG001|Overall Study|Lost to Follow-up|1|||
38052058|NCT04353037|69741572|FG002|Overall Study|Lost to Follow-up|2|||
38052059|NCT04353037|69741573|FG003|Overall Study|Lost to Follow-up|3|||
38052060|NCT04353037|69741570|FG000|Overall Study|Withdrawal by Subject|0|||
38052061|NCT04353037|69741571|FG001|Overall Study|Withdrawal by Subject|2|||
38052062|NCT04353037|69741572|FG002|Overall Study|Withdrawal by Subject|3|||
38052063|NCT04353037|69741573|FG003|Overall Study|Withdrawal by Subject|5|||
38052064|NCT04353037|69741570|FG000|Overall Study|Adverse Event|0|||
38052065|NCT04353037|69741571|FG001|Overall Study|Adverse Event|0|||
38052066|NCT04353037|69741572|FG002|Overall Study|Adverse Event|2|||
38052067|NCT04353037|69741573|FG003|Overall Study|Adverse Event|0|||
38052068|NCT04353037|69741570|FG000|Overall Study|Exposure Change|0|||
38052069|NCT04353037|69741571|FG001|Overall Study|Exposure Change|0|||
38052070|NCT04353037|69741572|FG002|Overall Study|Exposure Change|0|||
38052071|NCT04353037|69741573|FG003|Overall Study|Exposure Change|2|||
38052072|NCT04349917|69741587|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
38052073|NCT04349917|69741588|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
38052074|NCT04349917|69741587|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
38052075|NCT04349917|69741588|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
38052076|NCT04156399|69741595|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
38052077|NCT04156399|69741595|FG000|Overall Study|study suspension due to COVID pandemic|3|||
38052078|NCT03300570|69741601|FG000|Overall Study|Adverse Event|0|||
38052079|NCT03300570|69741602|FG001|Overall Study|Adverse Event|1|||
38052080|NCT03300570|69741601|FG000|Overall Study|Withdrawal by Subject|1|||
38052081|NCT03300570|69741602|FG001|Overall Study|Withdrawal by Subject|0|||
38052082|NCT03300570|69741601|FG000|Overall Study|Inadequate bowel prep|1|||
38052083|NCT03300570|69741602|FG001|Overall Study|Inadequate bowel prep|0|||
38052084|NCT04154605|69741611|FG000|Overall Study|Procedure Canceled|1|||
38052085|NCT04154605|69741612|FG001|Overall Study|Procedure Canceled|1|||
38052086|NCT04154605|69741611|FG000|Overall Study|Missed follow up|1|||
38052087|NCT04154605|69741612|FG001|Overall Study|Missed follow up|1|||
38052088|NCT04154605|69741611|FG000|Overall Study|Withdrawal by Subject|1|||
38052089|NCT04154605|69741612|FG001|Overall Study|Withdrawal by Subject|0|||
38052090|NCT03264456|69741618|FG000|Overall Study|Withdrawal by Subject|3|||
38052091|NCT03264456|69741618|FG000|Overall Study|Lost to Follow-up|1|||
38052092|NCT03853694|69741625|FG000|Overall Study|Protocol Violation|3|||
38052093|NCT03853694|69741626|FG001|Overall Study|Protocol Violation|5|||
38052094|NCT03853694|69741627|FG002|Overall Study|Protocol Violation|3|||
38052095|NCT03853694|69741625|FG000|Overall Study|Delivered early|0|||
38052096|NCT03853694|69741626|FG001|Overall Study|Delivered early|1|||
38052097|NCT03853694|69741627|FG002|Overall Study|Delivered early|0|||
38052098|NCT03853694|69741625|FG000|Overall Study|not suitable to proceed|0|||
38052099|NCT03853694|69741626|FG001|Overall Study|not suitable to proceed|1|||
38052100|NCT03853694|69741627|FG002|Overall Study|not suitable to proceed|0|||
38052101|NCT03853694|69741625|FG000|Overall Study|difficult surgery|0|||
38052102|NCT03853694|69741626|FG001|Overall Study|difficult surgery|0|||
38052103|NCT03853694|69741627|FG002|Overall Study|difficult surgery|1|||
38052104|NCT03853694|69741625|FG000|Overall Study|Lost to Follow-up|0|||
38052105|NCT03853694|69741626|FG001|Overall Study|Lost to Follow-up|1|||
38052106|NCT03853694|69741627|FG002|Overall Study|Lost to Follow-up|0|||
38052107|NCT03853694|69741625|FG000|Overall Study|Withdrawal by Subject|0|||
38052108|NCT03853694|69741626|FG001|Overall Study|Withdrawal by Subject|1|||
38052109|NCT03853694|69741627|FG002|Overall Study|Withdrawal by Subject|0|||
38052110|NCT04154293|69741638|FG000|Overall Study|Withdrawal by Subject|2|||
38052111|NCT04154293|69741639|FG001|Overall Study|Withdrawal by Subject|3|||
38052112|NCT04154293|69741640|FG002|Overall Study|Withdrawal by Subject|1|||
38052113|NCT04154293|69741638|FG000|Overall Study|Physician Decision|0|||
38052114|NCT04154293|69741639|FG001|Overall Study|Physician Decision|0|||
38052115|NCT04154293|69741640|FG002|Overall Study|Physician Decision|1|||
38052116|NCT04342897|69741650|FG000|Overall Study|Death|7|||
38052117|NCT04342897|69741651|FG001|Overall Study|Death|4|||
38052118|NCT04342897|69741650|FG000|Overall Study|Lost to Follow-up|6|||
38052119|NCT04342897|69741651|FG001|Overall Study|Lost to Follow-up|6|||
38052120|NCT04342897|69741650|FG000|Overall Study|Withdrawal by Subject|1|||
38052121|NCT04342897|69741651|FG001|Overall Study|Withdrawal by Subject|2|||
38052122|NCT04340557|69741659|FG000|Overall Study|Transferred to ICU and/or death|1|||
38052123|NCT04340557|69741660|FG001|Overall Study|Transferred to ICU and/or death|2|||
38052124|NCT04382053|69741668|FG000|Overall Study|Death|6|||
38052125|NCT04382053|69741669|FG001|Overall Study|Death|8|||
38052126|NCT04382053|69741668|FG000|Overall Study|Lost to Follow-up|0|||
38052127|NCT04382053|69741669|FG001|Overall Study|Lost to Follow-up|2|||
38052128|NCT04382053|69741668|FG000|Overall Study|Protocol Deviation|1|||
38052129|NCT04382053|69741669|FG001|Overall Study|Protocol Deviation|2|||
38052130|NCT04382053|69741668|FG000|Overall Study|Withdrawal by Subject|2|||
38052131|NCT04382053|69741669|FG001|Overall Study|Withdrawal by Subject|1|||
38052132|NCT03066830|69741678|FG000|Overall Study|At the Participant's own Request|16|||
38052133|NCT03066830|69741679|FG001|Overall Study|At the Participant's own Request|17|||
38052134|NCT03066830|69741678|FG000|Overall Study|Other|3|||
38052135|NCT03066830|69741679|FG001|Overall Study|Other|0|||
38052136|NCT03066830|69741678|FG000|Overall Study|Poor Compliance to Protocol|1|||
38052137|NCT03066830|69741679|FG001|Overall Study|Poor Compliance to Protocol|0|||
38052138|NCT03066830|69741678|FG000|Overall Study|Adverse Event|2|||
38052139|NCT03066830|69741679|FG001|Overall Study|Adverse Event|2|||
38052140|NCT03066830|69741678|FG000|Overall Study|Lost to Follow-up|11|||
38052141|NCT03066830|69741679|FG001|Overall Study|Lost to Follow-up|3|||
38052142|NCT04380961|69741688|FG000|Overall Study|Lost to Follow-up|17|||
38052143|NCT04380961|69741689|FG001|Overall Study|Lost to Follow-up|11|||
38052144|NCT04380961|69741688|FG000|Overall Study|Withdrawal by Subject|3|||
38052145|NCT04380961|69741689|FG001|Overall Study|Withdrawal by Subject|0|||
38052146|NCT04380961|69741688|FG000|Overall Study|Death|22|||
38052147|NCT04380961|69741689|FG001|Overall Study|Death|16|||
38052148|NCT04380961|69741688|FG000|Overall Study|Other|1|||
38052149|NCT04380961|69741689|FG001|Overall Study|Other|0|||
38052150|NCT04380961|69741688|FG000|Overall Study|Randomized but Not Treated|1|||
38052151|NCT04380961|69741689|FG001|Overall Study|Randomized but Not Treated|2|||
38052152|NCT04331899|69741699|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
38052153|NCT04331899|69741700|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
38052154|NCT04328467|69741709|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
38052155|NCT04328467|69741710|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
38052156|NCT04328467|69741711|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
38052157|NCT04328077|69741723|FG000|Overall Study|Lost to Follow-up|0|||
38052158|NCT04328077|69741724|FG001|Overall Study|Lost to Follow-up|1|||
38052159|NCT04328077|69741725|FG002|Overall Study|Lost to Follow-up|0|||
38052160|NCT04328077|69741726|FG003|Overall Study|Lost to Follow-up|0|||
38052161|NCT04328077|69741723|FG000|Overall Study|Withdrawal by Subject|0|||
38052162|NCT04328077|69741724|FG001|Overall Study|Withdrawal by Subject|1|||
38052163|NCT04328077|69741725|FG002|Overall Study|Withdrawal by Subject|1|||
38052164|NCT04328077|69741726|FG003|Overall Study|Withdrawal by Subject|3|||
38052165|NCT03691831|69741744|FG000|Overall Study|Lost to Follow-up|16|||
38052166|NCT03691831|69741745|FG001|Overall Study|Lost to Follow-up|12|||
38052167|NCT03691831|69741744|FG000|Overall Study|Withdrawal by Subject|9|||
38052168|NCT03691831|69741745|FG001|Overall Study|Withdrawal by Subject|17|||
38052169|NCT03691831|69741744|FG000|Overall Study|Investigator Decision|2|||
38052170|NCT03691831|69741745|FG001|Overall Study|Investigator Decision|2|||
38052171|NCT04320745|69741762|FG000|Overall Study|Adverse Event|26|||
38052172|NCT04320745|69741762|FG000|Overall Study|Withdrawal by Subject|4|||
38052173|NCT04320745|69741762|FG000|Overall Study|Lost to Follow-up|12|||
38052174|NCT04320745|69741762|FG000|Overall Study|Protocol Deviation|2|||
38052175|NCT04320745|69741762|FG000|Overall Study|Non-compliance With Study Drug|2|||
38052176|NCT04320745|69741762|FG000|Overall Study|Reason Not Specified|1|||
38052177|NCT03063086|69741766|FG000|Overall Study|technical problems|1|||
38052178|NCT03063086|69741767|FG001|Overall Study|technical problems|0|||
38052179|NCT03063086|69741768|FG002|Overall Study|technical problems|0|||
38052180|NCT03063086|69741769|FG003|Overall Study|technical problems|0|||
38052181|NCT03063086|69741770|FG004|Overall Study|technical problems|0|||
38052182|NCT03063086|69741771|FG005|Overall Study|technical problems|0|||
38052183|NCT03063086|69741766|FG000|Overall Study|Adverse Event|1|||
38052184|NCT03063086|69741767|FG001|Overall Study|Adverse Event|1|||
38052185|NCT03063086|69741768|FG002|Overall Study|Adverse Event|1|||
38052186|NCT03063086|69741769|FG003|Overall Study|Adverse Event|1|||
38052187|NCT03063086|69741770|FG004|Overall Study|Adverse Event|0|||
38052188|NCT03063086|69741771|FG005|Overall Study|Adverse Event|0|||
38052189|NCT03063086|69741766|FG000|Overall Study|subject/guardian decision|1|||
38052190|NCT03063086|69741767|FG001|Overall Study|subject/guardian decision|0|||
38052191|NCT03063086|69741768|FG002|Overall Study|subject/guardian decision|0|||
38052192|NCT03063086|69741769|FG003|Overall Study|subject/guardian decision|0|||
38052193|NCT03063086|69741770|FG004|Overall Study|subject/guardian decision|0|||
38052194|NCT03063086|69741771|FG005|Overall Study|subject/guardian decision|0|||
38052195|NCT03063086|69741766|FG000|Overall Study|Non-compliance with study treatment|0|||
38052196|NCT03063086|69741767|FG001|Overall Study|Non-compliance with study treatment|0|||
38052197|NCT03063086|69741768|FG002|Overall Study|Non-compliance with study treatment|0|||
38052198|NCT03063086|69741769|FG003|Overall Study|Non-compliance with study treatment|1|||
38052199|NCT03063086|69741770|FG004|Overall Study|Non-compliance with study treatment|0|||
38052200|NCT03063086|69741771|FG005|Overall Study|Non-compliance with study treatment|1|||
38052201|NCT03063086|69741766|FG000|Overall Study|Physician Decision|0|||
38052202|NCT03063086|69741767|FG001|Overall Study|Physician Decision|0|||
38052203|NCT03063086|69741768|FG002|Overall Study|Physician Decision|0|||
38052204|NCT03063086|69741769|FG003|Overall Study|Physician Decision|1|||
38052205|NCT03063086|69741770|FG004|Overall Study|Physician Decision|0|||
38052206|NCT03063086|69741771|FG005|Overall Study|Physician Decision|0|||
38052207|NCT04128007|69741782|FG000|Overall Study|Withdrawal by Subject|9|||
38052208|NCT04128007|69741783|FG001|Overall Study|Withdrawal by Subject|6|||
38052209|NCT04128007|69741782|FG000|Overall Study|Protocol Violation|1|||
38052210|NCT04128007|69741783|FG001|Overall Study|Protocol Violation|0|||
38052211|NCT04128007|69741782|FG000|Overall Study|Lost to Follow-up|8|||
38052212|NCT04128007|69741783|FG001|Overall Study|Lost to Follow-up|7|||
38052213|NCT04128007|69741782|FG000|Overall Study|Adverse Event|5|||
38052214|NCT04128007|69741783|FG001|Overall Study|Adverse Event|2|||
38052215|NCT04128007|69741782|FG000|Overall Study|Not reported|0|||
38052216|NCT04128007|69741783|FG001|Overall Study|Not reported|2|||
38052217|NCT04318093|69741791|FG000|Overall Study|Adverse Event|2|||
38052218|NCT04318093|69741792|FG001|Overall Study|Adverse Event|2|||
38052219|NCT04318093|69741791|FG000|Overall Study|Participant withdrew consent|1|||
38052220|NCT04318093|69741792|FG001|Overall Study|Participant withdrew consent|0|||
38052221|NCT04318093|69741791|FG000|Overall Study|Other reasons|0|||
38052222|NCT04318093|69741792|FG001|Overall Study|Other reasons|1|||
38052223|NCT04123405|69741803|FG000|Overall Study|Adverse Event|1|||
38052224|NCT04123405|69741804|FG001|Overall Study|Adverse Event|2|||
38052225|NCT04123405|69741805|FG002|Overall Study|Adverse Event|3|||
38052226|NCT04123405|69741806|FG003|Overall Study|Adverse Event|3|||
38052227|NCT04123405|69741803|FG000|Overall Study|Exclusion criteria met|1|||
38052228|NCT04123405|69741804|FG001|Overall Study|Exclusion criteria met|2|||
38052229|NCT04123405|69741805|FG002|Overall Study|Exclusion criteria met|0|||
37963983|NCT03900416|69651142|FG000|Six Month Follow-up|Lost to Follow-up|4|||
37963984|NCT03900416|69651143|FG001|Six Month Follow-up|Lost to Follow-up|3|||
37963985|NCT03900416|69651142|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
37963986|NCT03900416|69651143|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
37963987|NCT00399490|69651149|FG000|Overall Study|Adverse Event|19|||
37963988|NCT00399490|69651149|FG000|Overall Study|Lack of Efficacy|31|||
37963989|NCT00399490|69651149|FG000|Overall Study|Lost to Follow-up|5|||
37963990|NCT00399490|69651149|FG000|Overall Study|Withdrawal by Subject|18|||
37963991|NCT00399490|69651149|FG000|Overall Study|Other|25|||
38052230|NCT04123405|69741806|FG003|Overall Study|Exclusion criteria met|2|||
38052231|NCT04123405|69741803|FG000|Overall Study|Withdrawal by Subject|1|||
38052232|NCT04123405|69741804|FG001|Overall Study|Withdrawal by Subject|3|||
38052233|NCT04123405|69741805|FG002|Overall Study|Withdrawal by Subject|0|||
38052234|NCT04123405|69741806|FG003|Overall Study|Withdrawal by Subject|2|||
38052235|NCT04123405|69741803|FG000|Overall Study|Contact to subject lost|0|||
38052236|NCT04123405|69741804|FG001|Overall Study|Contact to subject lost|0|||
38052237|NCT04123405|69741805|FG002|Overall Study|Contact to subject lost|0|||
38052238|NCT04123405|69741806|FG003|Overall Study|Contact to subject lost|1|||
38052239|NCT04123405|69741803|FG000|Overall Study|screening failure|1|||
38052240|NCT04123405|69741804|FG001|Overall Study|screening failure|0|||
38052241|NCT04123405|69741805|FG002|Overall Study|screening failure|0|||
38052242|NCT04123405|69741806|FG003|Overall Study|screening failure|0|||
38052243|NCT04314037|69741835|FG000|Treatment Period 2|Adverse Event|1|||
38052244|NCT04314037|69741836|FG001|Treatment Period 2|Adverse Event|0|||
38052245|NCT04314037|69741835|FG000|Treatment Period 3|Protocol Violation|1|||
38052246|NCT04314037|69741836|FG001|Treatment Period 3|Protocol Violation|0|||
37680356|NCT02586415|69155953|FG001|Overall Study|Lost to Follow-up|2|||
37963992|NCT00398866|69651158|FG000|Overall Study|Adverse Event|1|||
37963993|NCT00398866|69651159|FG001|Overall Study|Adverse Event|0|||
37963994|NCT00398866|69651160|FG002|Overall Study|Adverse Event|0|||
37963995|NCT00398866|69651158|FG000|Overall Study|Lack of Efficacy|0|||
37963996|NCT00398866|69651159|FG001|Overall Study|Lack of Efficacy|0|||
37963997|NCT00398866|69651160|FG002|Overall Study|Lack of Efficacy|1|||
37963998|NCT00398866|69651158|FG000|Overall Study|Lost to Follow-up|7|||
37963999|NCT00398866|69651159|FG001|Overall Study|Lost to Follow-up|6|||
37964000|NCT00398866|69651160|FG002|Overall Study|Lost to Follow-up|4|||
37964001|NCT00398866|69651158|FG000|Overall Study|Withdrawal by Subject|5|||
37964002|NCT00398866|69651159|FG001|Overall Study|Withdrawal by Subject|1|||
37964003|NCT00398866|69651160|FG002|Overall Study|Withdrawal by Subject|2|||
37964004|NCT00398866|69651158|FG000|Overall Study|Unable to complete requirements of study|1|||
37964005|NCT00398866|69651159|FG001|Overall Study|Unable to complete requirements of study|1|||
37964006|NCT00398866|69651160|FG002|Overall Study|Unable to complete requirements of study|1|||
37964007|NCT00398632|69651169|FG000|Overall Study|Withdrawal by Subject|1|||
37964008|NCT00398632|69651169|FG000|Overall Study|Lack of Efficacy|1|||
37964009|NCT00673361|69651174|FG000|Overall Study|Screen Failure|2|||
37964010|NCT00393718|69651180|FG000|Overall Study|Adverse Event|20|||
37964011|NCT00393718|69651181|FG001|Overall Study|Adverse Event|8|||
37964012|NCT00393718|69651180|FG000|Overall Study|Protocol Violation|1|||
37964013|NCT00393718|69651181|FG001|Overall Study|Protocol Violation|2|||
37964014|NCT00393718|69651180|FG000|Overall Study|Lack of Efficacy|10|||
37964015|NCT00393718|69651181|FG001|Overall Study|Lack of Efficacy|9|||
37964016|NCT00393718|69651180|FG000|Overall Study|Hypoglycaemia|3|||
37964017|NCT00393718|69651181|FG001|Overall Study|Hypoglycaemia|2|||
37964018|NCT00393718|69651180|FG000|Overall Study|Subject decision|5|||
37964019|NCT00393718|69651181|FG001|Overall Study|Subject decision|0|||
37964020|NCT00393718|69651180|FG000|Overall Study|Withdrawal of consent|2|||
37964021|NCT00393718|69651181|FG001|Overall Study|Withdrawal of consent|1|||
37964022|NCT00393718|69651180|FG000|Overall Study|Missed measurement|1|||
37964023|NCT00393718|69651181|FG001|Overall Study|Missed measurement|0|||
37964024|NCT00393718|69651180|FG000|Overall Study|Move|1|||
37964025|NCT00393718|69651181|FG001|Overall Study|Move|0|||
37964026|NCT00669071|69651187|FG000|Overall Study|Lost to Follow-up|3|||
37964027|NCT00669071|69651187|FG000|Overall Study|Final visit 40 days out of window|1|||
37964028|NCT00398320|69651193|FG000|Overall Study|Death|1|||
37964029|NCT00398320|69651193|FG000|Overall Study|Adverse Event|4|||
37964030|NCT00398320|69651193|FG000|Overall Study|Physician Decision|1|||
37964031|NCT00670007|69651197|FG000|Overall Study|Drug abuse|1|||
37964032|NCT00670007|69651197|FG000|Overall Study|Lung transplant|1|||
37964033|NCT00670007|69651197|FG000|Overall Study|Travel/Vacation|1|||
37964034|NCT00670007|69651197|FG000|Overall Study|Adverse event, serious fatal|1|||
37964035|NCT00670007|69651197|FG000|Overall Study|Adverse Event|1|||
37964036|NCT00670007|69651197|FG000|Overall Study|Withdrawal by Subject|4|||
37964037|NCT00535496|69651204|FG000|Overall Study|Lost to Follow-up|0|||
37964038|NCT00535496|69651205|FG001|Overall Study|Lost to Follow-up|1|||
37964039|NCT00535496|69651206|FG002|Overall Study|Lost to Follow-up|0|||
37964040|NCT00535496|69651207|FG003|Overall Study|Lost to Follow-up|0|||
37964041|NCT00535496|69651204|FG000|Overall Study|Not treated with sugammadex|0|||
37964042|NCT00535496|69651205|FG001|Overall Study|Not treated with sugammadex|1|||
37964043|NCT00535496|69651206|FG002|Overall Study|Not treated with sugammadex|0|||
37964044|NCT00535496|69651207|FG003|Overall Study|Not treated with sugammadex|0|||
37964045|NCT00539006|69651218|FG000|Pre-treatment|Other|0|||
37964046|NCT00539006|69651219|FG001|Pre-treatment|Other|1|||
37964047|NCT00539006|69651220|FG002|Pre-treatment|Other|0|||
37964048|NCT00539006|69651221|FG003|Pre-treatment|Other|0|||
37964049|NCT00539006|69651218|FG000|Treatment Period 1|Lost to Follow-up|0|||
37964050|NCT00539006|69651219|FG001|Treatment Period 1|Lost to Follow-up|0|||
37964051|NCT00539006|69651220|FG002|Treatment Period 1|Lost to Follow-up|1|||
37964052|NCT00539006|69651221|FG003|Treatment Period 1|Lost to Follow-up|0|||
37964053|NCT00539006|69651218|FG000|Treatment Period 1|Protocol Violation|0|||
37964054|NCT00539006|69651219|FG001|Treatment Period 1|Protocol Violation|0|||
38052247|NCT04314037|69741835|FG000|Treatment Period 3|Adverse Event|0|||
38052248|NCT04314037|69741836|FG001|Treatment Period 3|Adverse Event|1|||
38052249|NCT03056300|69741852|FG000|Overall Study|Surgical reason per study protocol|3|||
38052250|NCT03061214|69741859|FG000|Overall Study|Withdrawal by Subject|21|||
38052251|NCT03061214|69741860|FG001|Overall Study|Withdrawal by Subject|26|||
38052252|NCT03061214|69741861|FG002|Overall Study|Withdrawal by Subject|9|||
38052253|NCT03061214|69741859|FG000|Overall Study|Lost to Follow-up|3|||
38052254|NCT03061214|69741860|FG001|Overall Study|Lost to Follow-up|1|||
38052255|NCT03061214|69741861|FG002|Overall Study|Lost to Follow-up|1|||
38052256|NCT03061214|69741859|FG000|Overall Study|Death|1|||
38052257|NCT03061214|69741860|FG001|Overall Study|Death|1|||
38052258|NCT03061214|69741861|FG002|Overall Study|Death|0|||
38052259|NCT04115839|69741872|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
38052260|NCT04115839|69741873|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
38052261|NCT04115839|69741874|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
38052262|NCT04115839|69741875|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
38052263|NCT04115839|69741876|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
38052264|NCT04115839|69741877|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
38052265|NCT04115839|69741878|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
38052266|NCT04115839|69741872|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
38052267|NCT04115839|69741873|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
38052268|NCT04115839|69741874|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
38052269|NCT04115839|69741875|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
38052270|NCT04115839|69741876|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
38052271|NCT04115839|69741877|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
38052272|NCT04115839|69741878|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
38052273|NCT04115839|69741872|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
38052274|NCT04115839|69741873|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
38052275|NCT04115839|69741874|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
38052276|NCT04115839|69741875|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
38052277|NCT04115839|69741876|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
38052278|NCT04115839|69741877|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
38052279|NCT04115839|69741878|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
38052280|NCT04115839|69741872|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
38052281|NCT04115839|69741873|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
38052282|NCT04115839|69741874|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
38052283|NCT04115839|69741875|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
38052284|NCT04115839|69741876|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
38052285|NCT04115839|69741877|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
38052286|NCT04115839|69741878|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
38052287|NCT04115839|69741872|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
38052288|NCT04115839|69741873|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
38052289|NCT04115839|69741874|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
38052290|NCT04115839|69741875|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
38052291|NCT04115839|69741876|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
38052292|NCT04115839|69741877|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
38052293|NCT04115839|69741878|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
38052294|NCT04115839|69741872|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
38052295|NCT04115839|69741873|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
38052296|NCT04115839|69741874|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
38052297|NCT04115839|69741875|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
38052298|NCT04115839|69741876|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
38052299|NCT04115839|69741877|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
38052300|NCT04115839|69741878|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
38052301|NCT01561430|69741907|FG000|Overall Study|Adverse Event|0|||
38052302|NCT01561430|69741908|FG001|Overall Study|Adverse Event|0|||
38052303|NCT01561430|69741909|FG002|Overall Study|Adverse Event|3|||
38052304|NCT01561430|69741910|FG003|Overall Study|Adverse Event|1|||
38052305|NCT01561430|69741907|FG000|Overall Study|Withdrawal by Subject|0|||
38052306|NCT01561430|69741908|FG001|Overall Study|Withdrawal by Subject|0|||
38052307|NCT01561430|69741909|FG002|Overall Study|Withdrawal by Subject|1|||
38052308|NCT01561430|69741910|FG003|Overall Study|Withdrawal by Subject|0|||
38052309|NCT01561430|69741907|FG000|Overall Study|Physician Decision|0|||
38052310|NCT01561430|69741908|FG001|Overall Study|Physician Decision|1|||
38052311|NCT01561430|69741909|FG002|Overall Study|Physician Decision|0|||
38052312|NCT01561430|69741910|FG003|Overall Study|Physician Decision|0|||
38052313|NCT01561430|69741907|FG000|Overall Study|Sponsor Decision|1|||
38052314|NCT01561430|69741908|FG001|Overall Study|Sponsor Decision|14|||
38052315|NCT01561430|69741909|FG002|Overall Study|Sponsor Decision|13|||
38052316|NCT01561430|69741910|FG003|Overall Study|Sponsor Decision|12|||
38052317|NCT03060512|69741945|FG000|Overall Study|Adverse Event|4|||
38052318|NCT03060512|69741946|FG001|Overall Study|Adverse Event|6|||
38052319|NCT03060512|69741945|FG000|Overall Study|Lost to Follow-up|1|||
38052320|NCT03060512|69741946|FG001|Overall Study|Lost to Follow-up|1|||
38052321|NCT03060512|69741945|FG000|Overall Study|Withdrawal by Subject|1|||
38052322|NCT03060512|69741946|FG001|Overall Study|Withdrawal by Subject|0|||
38052323|NCT03060512|69741945|FG000|Overall Study|Non-compliance with study medication|1|||
38052324|NCT03060512|69741946|FG001|Overall Study|Non-compliance with study medication|2|||
38052325|NCT02539160|69742034|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
38052326|NCT02539160|69742035|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
38052327|NCT02539160|69742036|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
38052328|NCT02539160|69742037|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
38052329|NCT02539160|69742034|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
38052330|NCT02539160|69742035|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
38052331|NCT02539160|69742036|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
38052332|NCT02539160|69742037|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
38052333|NCT02539160|69742034|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
38052334|NCT02539160|69742035|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
38052335|NCT02539160|69742036|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
38052336|NCT02539160|69742037|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
38052337|NCT04292899|69742051|FG000|Overall Study|Death|21|||
38052338|NCT04292899|69742052|FG001|Overall Study|Death|28|||
38052339|NCT04292899|69742053|FG002|Overall Study|Death|188|||
38052340|NCT04292899|69742054|FG003|Overall Study|Death|371|||
38052341|NCT04292899|69742051|FG000|Overall Study|Lost to Follow-up|8|||
38052342|NCT04292899|69742052|FG001|Overall Study|Lost to Follow-up|4|||
38052343|NCT04292899|69742053|FG002|Overall Study|Lost to Follow-up|22|||
38052344|NCT04292899|69742054|FG003|Overall Study|Lost to Follow-up|235|||
38052345|NCT04292899|69742051|FG000|Overall Study|Withdrew consent|1|||
38052346|NCT04292899|69742052|FG001|Overall Study|Withdrew consent|0|||
38052347|NCT04292899|69742053|FG002|Overall Study|Withdrew consent|11|||
38052348|NCT04292899|69742054|FG003|Overall Study|Withdrew consent|32|||
38052349|NCT04292899|69742051|FG000|Overall Study|Adverse Event|2|||
38052350|NCT04292899|69742052|FG001|Overall Study|Adverse Event|1|||
38052351|NCT04292899|69742053|FG002|Overall Study|Adverse Event|2|||
38052352|NCT04292899|69742054|FG003|Overall Study|Adverse Event|2|||
38052353|NCT04292899|69742051|FG000|Overall Study|Investigator's Discretion|0|||
38052354|NCT04292899|69742052|FG001|Overall Study|Investigator's Discretion|0|||
37964055|NCT00539006|69651220|FG002|Treatment Period 1|Protocol Violation|1|||
37964056|NCT00539006|69651221|FG003|Treatment Period 1|Protocol Violation|0|||
37964057|NCT00539006|69651218|FG000|Treatment Period 1|Lack of Efficacy|0|||
37964058|NCT00539006|69651219|FG001|Treatment Period 1|Lack of Efficacy|0|||
37964059|NCT00539006|69651220|FG002|Treatment Period 1|Lack of Efficacy|0|||
37964060|NCT00539006|69651221|FG003|Treatment Period 1|Lack of Efficacy|1|||
37964061|NCT00539006|69651218|FG000|Washout|Adverse Event|2|||
37964062|NCT00539006|69651219|FG001|Washout|Adverse Event|1|||
37964063|NCT00539006|69651220|FG002|Washout|Adverse Event|0|||
37964064|NCT00539006|69651221|FG003|Washout|Adverse Event|0|||
37964065|NCT00539006|69651218|FG000|Washout|Protocol Violation|1|||
37964066|NCT00539006|69651219|FG001|Washout|Protocol Violation|1|||
37964067|NCT00539006|69651220|FG002|Washout|Protocol Violation|0|||
37964068|NCT00539006|69651221|FG003|Washout|Protocol Violation|0|||
37964069|NCT00539006|69651218|FG000|Washout|Withdrawal by Subject|0|||
37964070|NCT00539006|69651219|FG001|Washout|Withdrawal by Subject|2|||
37964071|NCT00539006|69651220|FG002|Washout|Withdrawal by Subject|0|||
37964072|NCT00539006|69651221|FG003|Washout|Withdrawal by Subject|0|||
37964073|NCT00539006|69651218|FG000|Washout|Failed to meet continuation criteria|16|||
38052355|NCT04292899|69742053|FG002|Overall Study|Investigator's Discretion|0|||
38052356|NCT04292899|69742054|FG003|Overall Study|Investigator's Discretion|3|||
38052357|NCT04292899|69742051|FG000|Overall Study|Non-compliance With Study Drug|0|||
38052358|NCT04292899|69742052|FG001|Overall Study|Non-compliance With Study Drug|0|||
38052359|NCT04292899|69742053|FG002|Overall Study|Non-compliance With Study Drug|0|||
38052360|NCT04292899|69742054|FG003|Overall Study|Non-compliance With Study Drug|1|||
38052361|NCT04292899|69742051|FG000|Overall Study|Protocol Violation|0|||
38052362|NCT04292899|69742052|FG001|Overall Study|Protocol Violation|0|||
38052363|NCT04292899|69742053|FG002|Overall Study|Protocol Violation|0|||
37964074|NCT00539006|69651219|FG001|Washout|Failed to meet continuation criteria|5|||
37964075|NCT00539006|69651220|FG002|Washout|Failed to meet continuation criteria|14|||
37964076|NCT00539006|69651221|FG003|Washout|Failed to meet continuation criteria|6|||
37964077|NCT00539006|69651218|FG000|Washout|Other|1|||
37964078|NCT00539006|69651219|FG001|Washout|Other|1|||
37964079|NCT00539006|69651220|FG002|Washout|Other|2|||
38052364|NCT04292899|69742054|FG003|Overall Study|Protocol Violation|1|||
38052365|NCT03241173|69742073|FG000|Overall Study|Death|3|||
38052366|NCT03241173|69742074|FG001|Overall Study|Death|2|||
38052367|NCT03241173|69742075|FG002|Overall Study|Death|4|||
38052368|NCT03241173|69742076|FG003|Overall Study|Death|4|||
38052369|NCT03241173|69742077|FG004|Overall Study|Death|2|||
38052370|NCT03241173|69742078|FG005|Overall Study|Death|2|||
38052371|NCT03241173|69742079|FG006|Overall Study|Death|3|||
38052372|NCT03241173|69742080|FG007|Overall Study|Death|1|||
38052373|NCT03241173|69742081|FG008|Overall Study|Death|0|||
38052374|NCT03241173|69742082|FG009|Overall Study|Death|5|||
38052375|NCT03241173|69742083|FG010|Overall Study|Death|4|||
38052376|NCT03241173|69742084|FG011|Overall Study|Death|3|||
38052377|NCT03241173|69742085|FG012|Overall Study|Death|0|||
38052378|NCT03241173|69742086|FG013|Overall Study|Death|0|||
38052379|NCT03241173|69742087|FG014|Overall Study|Death|0|||
38052380|NCT03241173|69742073|FG000|Overall Study|Withdrawal by Subject|0|||
38052381|NCT03241173|69742074|FG001|Overall Study|Withdrawal by Subject|0|||
38052382|NCT03241173|69742075|FG002|Overall Study|Withdrawal by Subject|1|||
38052383|NCT03241173|69742076|FG003|Overall Study|Withdrawal by Subject|0|||
38052384|NCT03241173|69742077|FG004|Overall Study|Withdrawal by Subject|0|||
38052385|NCT03241173|69742078|FG005|Overall Study|Withdrawal by Subject|1|||
38052386|NCT03241173|69742079|FG006|Overall Study|Withdrawal by Subject|0|||
38052387|NCT03241173|69742080|FG007|Overall Study|Withdrawal by Subject|0|||
38052388|NCT03241173|69742081|FG008|Overall Study|Withdrawal by Subject|0|||
38052389|NCT03241173|69742082|FG009|Overall Study|Withdrawal by Subject|0|||
38052390|NCT03241173|69742083|FG010|Overall Study|Withdrawal by Subject|0|||
38052391|NCT03241173|69742084|FG011|Overall Study|Withdrawal by Subject|0|||
38052392|NCT03241173|69742085|FG012|Overall Study|Withdrawal by Subject|0|||
38052393|NCT03241173|69742086|FG013|Overall Study|Withdrawal by Subject|0|||
38052394|NCT03241173|69742087|FG014|Overall Study|Withdrawal by Subject|0|||
38052395|NCT03241173|69742073|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
38052396|NCT03241173|69742074|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
38052397|NCT03241173|69742075|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
38052398|NCT03241173|69742076|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
38052399|NCT03241173|69742077|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
38052400|NCT03241173|69742078|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
38052401|NCT03241173|69742079|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
38052402|NCT03241173|69742080|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
38052403|NCT03241173|69742081|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
38052404|NCT03241173|69742082|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
38052405|NCT03241173|69742083|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
38052406|NCT03241173|69742084|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
38052407|NCT03241173|69742085|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
38052408|NCT03241173|69742086|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
38052409|NCT03241173|69742087|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
38052410|NCT03241173|69742073|FG000|Overall Study|Lost to Follow-up|0|||
38052411|NCT03241173|69742074|FG001|Overall Study|Lost to Follow-up|0|||
38052412|NCT03241173|69742075|FG002|Overall Study|Lost to Follow-up|0|||
38052413|NCT03241173|69742076|FG003|Overall Study|Lost to Follow-up|0|||
38052414|NCT03241173|69742077|FG004|Overall Study|Lost to Follow-up|1|||
38052415|NCT03241173|69742078|FG005|Overall Study|Lost to Follow-up|0|||
38052416|NCT03241173|69742079|FG006|Overall Study|Lost to Follow-up|0|||
38052417|NCT03241173|69742080|FG007|Overall Study|Lost to Follow-up|0|||
38052418|NCT03241173|69742081|FG008|Overall Study|Lost to Follow-up|0|||
38052419|NCT03241173|69742082|FG009|Overall Study|Lost to Follow-up|1|||
38052420|NCT03241173|69742083|FG010|Overall Study|Lost to Follow-up|0|||
38052421|NCT03241173|69742084|FG011|Overall Study|Lost to Follow-up|0|||
38052422|NCT03241173|69742085|FG012|Overall Study|Lost to Follow-up|0|||
38052423|NCT03241173|69742086|FG013|Overall Study|Lost to Follow-up|0|||
38052424|NCT03241173|69742087|FG014|Overall Study|Lost to Follow-up|0|||
38052425|NCT03264066|69742121|FG000|Overall Study|Adverse Event|1|||
38052426|NCT03264066|69742122|FG001|Overall Study|Adverse Event|1|||
38052427|NCT03264066|69742123|FG002|Overall Study|Adverse Event|0|||
38052428|NCT03264066|69742124|FG003|Overall Study|Adverse Event|0|||
38052429|NCT03264066|69742125|FG004|Overall Study|Adverse Event|0|||
38052430|NCT03264066|69742126|FG005|Overall Study|Adverse Event|0|||
38052431|NCT03264066|69742121|FG000|Overall Study|Death|12|||
38052432|NCT03264066|69742122|FG001|Overall Study|Death|12|||
38052433|NCT03264066|69742123|FG002|Overall Study|Death|8|||
38052434|NCT03264066|69742124|FG003|Overall Study|Death|10|||
38052435|NCT03264066|69742125|FG004|Overall Study|Death|6|||
38052436|NCT03264066|69742126|FG005|Overall Study|Death|1|||
38052437|NCT03264066|69742121|FG000|Overall Study|Lost to Follow-up|1|||
38052438|NCT03264066|69742122|FG001|Overall Study|Lost to Follow-up|0|||
38052439|NCT03264066|69742123|FG002|Overall Study|Lost to Follow-up|0|||
38052440|NCT03264066|69742124|FG003|Overall Study|Lost to Follow-up|0|||
38052441|NCT03264066|69742125|FG004|Overall Study|Lost to Follow-up|0|||
38052442|NCT03264066|69742126|FG005|Overall Study|Lost to Follow-up|0|||
38052443|NCT03264066|69742121|FG000|Overall Study|Progressive Disease|0|||
38052444|NCT03264066|69742122|FG001|Overall Study|Progressive Disease|2|||
38052445|NCT03264066|69742123|FG002|Overall Study|Progressive Disease|1|||
38052446|NCT03264066|69742124|FG003|Overall Study|Progressive Disease|0|||
38052447|NCT03264066|69742125|FG004|Overall Study|Progressive Disease|0|||
38052448|NCT03264066|69742126|FG005|Overall Study|Progressive Disease|0|||
38052449|NCT03264066|69742121|FG000|Overall Study|Study Terminated by Sponsor|5|||
38052450|NCT03264066|69742122|FG001|Overall Study|Study Terminated by Sponsor|5|||
38052451|NCT03264066|69742123|FG002|Overall Study|Study Terminated by Sponsor|8|||
38052452|NCT03264066|69742124|FG003|Overall Study|Study Terminated by Sponsor|5|||
38052453|NCT03264066|69742125|FG004|Overall Study|Study Terminated by Sponsor|1|||
38052454|NCT03264066|69742126|FG005|Overall Study|Study Terminated by Sponsor|2|||
38052455|NCT03264066|69742121|FG000|Overall Study|Withdrawal by Subject|1|||
38052456|NCT03264066|69742122|FG001|Overall Study|Withdrawal by Subject|0|||
38052457|NCT03264066|69742123|FG002|Overall Study|Withdrawal by Subject|0|||
38052458|NCT03264066|69742124|FG003|Overall Study|Withdrawal by Subject|5|||
38052459|NCT03264066|69742125|FG004|Overall Study|Withdrawal by Subject|0|||
38052460|NCT03264066|69742126|FG005|Overall Study|Withdrawal by Subject|0|||
38052461|NCT03759041|69742144|FG000|Overall Study|Withdrawal by Subject|4|||
38052462|NCT03759041|69742145|FG001|Overall Study|Withdrawal by Subject|10|||
38052463|NCT03759041|69742146|FG002|Overall Study|Withdrawal by Subject|10|||
38052464|NCT03759041|69742144|FG000|Overall Study|Adverse Event|1|||
38052465|NCT03759041|69742145|FG001|Overall Study|Adverse Event|3|||
38052466|NCT03759041|69742146|FG002|Overall Study|Adverse Event|4|||
38052467|NCT03759041|69742144|FG000|Overall Study|Lack of Efficacy|0|||
38052468|NCT03759041|69742145|FG001|Overall Study|Lack of Efficacy|0|||
38052469|NCT03759041|69742146|FG002|Overall Study|Lack of Efficacy|1|||
38052470|NCT03759041|69742144|FG000|Overall Study|Study Terminated by Sponsor|15|||
38052471|NCT03759041|69742145|FG001|Overall Study|Study Terminated by Sponsor|16|||
38052472|NCT03759041|69742146|FG002|Overall Study|Study Terminated by Sponsor|10|||
38052473|NCT03759041|69742144|FG000|Overall Study|Other reason for discontinuation|0|||
38052474|NCT03759041|69742145|FG001|Overall Study|Other reason for discontinuation|2|||
38052475|NCT03759041|69742146|FG002|Overall Study|Other reason for discontinuation|1|||
38052476|NCT03759041|69742144|FG000|Overall Study|Lost to Follow-up|7|||
38052477|NCT03759041|69742145|FG001|Overall Study|Lost to Follow-up|2|||
38052478|NCT03759041|69742146|FG002|Overall Study|Lost to Follow-up|2|||
38052479|NCT03759041|69742144|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
38052480|NCT03759041|69742145|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
38052481|NCT03759041|69742146|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
38052482|NCT04110145|69742159|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
38052483|NCT04110145|69742160|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
38052484|NCT04110145|69742161|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
38052485|NCT04110145|69742162|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
38052486|NCT04110145|69742163|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
38052487|NCT02477618|69742177|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
38052488|NCT02477618|69742178|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
38052489|NCT02477618|69742177|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
38052490|NCT02477618|69742178|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
38052491|NCT02477618|69742177|FG000|Overall Study|Adverse Event|1|||
38052492|NCT02477618|69742178|FG001|Overall Study|Adverse Event|1|||
38052493|NCT02477618|69742177|FG000|Overall Study|Transferred Away from Study Site|1|||
38052494|NCT02477618|69742178|FG001|Overall Study|Transferred Away from Study Site|0|||
38052495|NCT02477618|69742177|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
38052496|NCT02477618|69742178|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
38052497|NCT04102501|69742186|FG000|Overall Study|Withdrawal by Subject|7|||
38052498|NCT04102501|69742187|FG001|Overall Study|Withdrawal by Subject|9|||
38052499|NCT04102501|69742186|FG000|Overall Study|Adverse Event|1|||
38052500|NCT04102501|69742187|FG001|Overall Study|Adverse Event|3|||
38052501|NCT03285477|69742197|FG000|Treatment and Response Assessment Period|Death|1|||
38052502|NCT03285477|69742198|FG001|Treatment and Response Assessment Period|Death|0|||
38052503|NCT03285477|69742197|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
38052504|NCT03285477|69742198|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
38052505|NCT03285477|69742197|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
38052506|NCT03285477|69742198|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
38052507|NCT03285477|69742197|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
38052508|NCT03285477|69742198|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
38052509|NCT03285477|69742197|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
38052510|NCT03285477|69742198|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
38052511|NCT04289623|69742215|FG000|Wave 1 Emails|Email was not delivered|268|||
38052512|NCT04289623|69742216|FG001|Wave 1 Emails|Email was not delivered|257|||
38052513|NCT04289623|69742217|FG002|Wave 1 Emails|Email was not delivered|0|||
38052514|NCT04289623|69742218|FG003|Wave 1 Emails|Email was not delivered|0|||
38052515|NCT04289623|69742219|FG004|Wave 1 Emails|Email was not delivered|0|||
38052516|NCT04289623|69742220|FG005|Wave 1 Emails|Email was not delivered|0|||
38052517|NCT03248037|69742236|FG000|Overall Study|Withdrawal by Subject|6|||
38052518|NCT03248037|69742237|FG001|Overall Study|Withdrawal by Subject|9|||
38052519|NCT03248037|69742236|FG000|Overall Study|Adverse Event|15|||
38052520|NCT03248037|69742237|FG001|Overall Study|Adverse Event|0|||
38052521|NCT04287517|69742252|FG000|Overall Study|Withdrawal by Subject|1|||
38052522|NCT04287517|69742253|FG001|Overall Study|Withdrawal by Subject|1|||
38052523|NCT03284229|69742259|FG000|Overall Study|Lost to Follow-up|3|||
38052524|NCT03242928|69742266|FG000|Overall Study|Adverse Event|2|||
38052525|NCT03242928|69742267|FG001|Overall Study|Adverse Event|1|||
38052526|NCT03242928|69742266|FG000|Overall Study|Lost to Follow-up|2|||
38052527|NCT03242928|69742267|FG001|Overall Study|Lost to Follow-up|0|||
38052528|NCT03242928|69742266|FG000|Overall Study|Physician Decision|0|||
38052529|NCT03242928|69742267|FG001|Overall Study|Physician Decision|1|||
38052530|NCT03242928|69742266|FG000|Overall Study|Withdrawal by Subject|5|||
38052531|NCT03242928|69742267|FG001|Overall Study|Withdrawal by Subject|3|||
38052532|NCT03300024|69742275|FG000|Overall Study|Physician Decision|4|||
38052533|NCT03300024|69742276|FG001|Overall Study|Physician Decision|6|||
38052534|NCT04276207|69742284|FG000|Period 1|Withdrawal by Subject|0|||
38052535|NCT04276207|69742285|FG001|Period 1|Withdrawal by Subject|1|||
38052536|NCT03282357|69742291|FG000|Overall Study|Lost to Follow-up|3|||
37964080|NCT00539006|69651221|FG003|Washout|Other|3|||
37964081|NCT00539006|69651218|FG000|Treatment Period 2|Protocol Violation|1|||
37964082|NCT00539006|69651219|FG001|Treatment Period 2|Protocol Violation|0|||
37964083|NCT00539006|69651220|FG002|Treatment Period 2|Protocol Violation|0|||
37964084|NCT00539006|69651221|FG003|Treatment Period 2|Protocol Violation|0|||
37964085|NCT00539006|69651218|FG000|Treatment Period 2|Other|0|||
37964086|NCT00539006|69651219|FG001|Treatment Period 2|Other|1|||
37964087|NCT00539006|69651220|FG002|Treatment Period 2|Other|0|||
37964088|NCT00539006|69651221|FG003|Treatment Period 2|Other|0|||
37964089|NCT00537056|69651237|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
37964090|NCT00535262|69651243|FG000|Overall Study|No funding|3|||
38052537|NCT03282357|69742291|FG000|Overall Study|Withdrawal by Subject|4|||
38052538|NCT03282357|69742291|FG000|Overall Study|Adverse Event|1|||
38052539|NCT03282357|69742291|FG000|Overall Study|Other|9|||
38052540|NCT04272775|69742298|FG000|Overall Study|Study Terminated by Sponsor|1|||
38052541|NCT04272775|69742299|FG001|Overall Study|Study Terminated by Sponsor|0|||
38052542|NCT04272775|69742298|FG000|Overall Study|Protocol Violation|0|||
37964091|NCT00074581|69651249|FG000|Overall Study|Death|15|||
37964092|NCT00074581|69651250|FG001|Overall Study|Death|16|||
37964093|NCT00074581|69651249|FG000|Overall Study|Withdrawal by Subject|50|||
38052543|NCT04272775|69742299|FG001|Overall Study|Protocol Violation|1|||
38052544|NCT04272775|69742298|FG000|Overall Study|Symptomatic Deterioration|1|||
38052545|NCT04272775|69742299|FG001|Overall Study|Symptomatic Deterioration|1|||
38052546|NCT04272775|69742298|FG000|Overall Study|Withdrawal by Subject|1|||
38052547|NCT04272775|69742299|FG001|Overall Study|Withdrawal by Subject|2|||
38052548|NCT04272775|69742298|FG000|Overall Study|Adverse Event|1|||
38052549|NCT04272775|69742299|FG001|Overall Study|Adverse Event|2|||
38052550|NCT04272775|69742298|FG000|Overall Study|Progressive Disease|3|||
38052551|NCT04272775|69742299|FG001|Overall Study|Progressive Disease|1|||
38052552|NCT03232983|69742305|FG000|Period 1|Physician Decision|0|||
38052553|NCT03232983|69742306|FG001|Period 1|Physician Decision|0|||
38052554|NCT03232983|69742307|FG002|Period 1|Physician Decision|1|||
38052555|NCT03232983|69742308|FG003|Period 1|Physician Decision|0|||
38052556|NCT03232983|69742305|FG000|Washout Period 2|Physician Decision|0|||
38052557|NCT03232983|69742306|FG001|Washout Period 2|Physician Decision|0|||
38052558|NCT03232983|69742307|FG002|Washout Period 2|Physician Decision|1|||
38052559|NCT03232983|69742308|FG003|Washout Period 2|Physician Decision|0|||
38052560|NCT03232983|69742305|FG000|Washout Period 2|Withdrawal by Subject|0|||
38052561|NCT03232983|69742306|FG001|Washout Period 2|Withdrawal by Subject|0|||
38052562|NCT03232983|69742307|FG002|Washout Period 2|Withdrawal by Subject|0|||
38052563|NCT03232983|69742308|FG003|Washout Period 2|Withdrawal by Subject|1|||
38052564|NCT03232983|69742305|FG000|Period 4|Withdrawal by Subject|1|||
38052565|NCT03232983|69742306|FG001|Period 4|Withdrawal by Subject|0|||
38052566|NCT03232983|69742307|FG002|Period 4|Withdrawal by Subject|0|||
38052567|NCT03232983|69742308|FG003|Period 4|Withdrawal by Subject|0|||
38052568|NCT04102345|69742322|FG000|Overall Study|Withdrawal by Subject|1|||
38052569|NCT04102345|69742323|FG001|Overall Study|Withdrawal by Subject|0|||
38052570|NCT04271605|69742329|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
38052571|NCT03299244|69742335|FG000|Overall Study|Withdrawal by Subject|34|||
38052572|NCT03299244|69742336|FG001|Overall Study|Withdrawal by Subject|29|||
38052573|NCT03299244|69742335|FG000|Overall Study|Decision by Sponsor|4|||
38052574|NCT03299244|69742336|FG001|Overall Study|Decision by Sponsor|5|||
38052575|NCT03299244|69742335|FG000|Overall Study|Death|9|||
38052576|NCT03299244|69742336|FG001|Overall Study|Death|4|||
38052577|NCT03757715|69742345|FG000|Overall Study|Lost to Follow-up|4|||
38052578|NCT03757715|69742346|FG001|Overall Study|Lost to Follow-up|9|||
38052579|NCT03757715|69742345|FG000|Overall Study|Withdrawal by Subject|1|||
38052580|NCT03757715|69742346|FG001|Overall Study|Withdrawal by Subject|1|||
38052581|NCT03281577|69742356|FG000|Overall Study|Adverse Event|0|||
38052582|NCT03281577|69742357|FG001|Overall Study|Adverse Event|0|||
38052583|NCT03281577|69742358|FG002|Overall Study|Adverse Event|0|||
38052584|NCT03281577|69742359|FG003|Overall Study|Adverse Event|1|||
38052585|NCT03281577|69742356|FG000|Overall Study|Withdrawal by Subject|1|||
38052586|NCT03281577|69742357|FG001|Overall Study|Withdrawal by Subject|0|||
38052587|NCT03281577|69742358|FG002|Overall Study|Withdrawal by Subject|0|||
38052588|NCT03281577|69742359|FG003|Overall Study|Withdrawal by Subject|0|||
38052589|NCT04098367|69742375|FG000|Overall Study|Adverse Event|0|||
38052590|NCT04098367|69742376|FG001|Overall Study|Adverse Event|0|||
38052591|NCT04098367|69742377|FG002|Overall Study|Adverse Event|1|||
38052592|NCT04098367|69742375|FG000|Overall Study|Lost to Follow-up|1|||
38052593|NCT04098367|69742376|FG001|Overall Study|Lost to Follow-up|5|||
38052594|NCT04098367|69742377|FG002|Overall Study|Lost to Follow-up|2|||
38052595|NCT04098367|69742375|FG000|Overall Study|Withdrawal by Subject|0|||
38052596|NCT04098367|69742376|FG001|Overall Study|Withdrawal by Subject|0|||
38052597|NCT04098367|69742377|FG002|Overall Study|Withdrawal by Subject|1|||
38052598|NCT04098367|69742375|FG000|Overall Study|Sick . Could not attend visit|1|||
38052599|NCT04098367|69742376|FG001|Overall Study|Sick . Could not attend visit|0|||
38052600|NCT04098367|69742377|FG002|Overall Study|Sick . Could not attend visit|0|||
38052601|NCT03759587|69742392|FG000|Overall Study|Ongoing|19|||
38052602|NCT04091659|69742398|FG000|Overall Study|Protocol Violation|3|||
38052603|NCT04091659|69742399|FG001|Overall Study|Protocol Violation|0|||
38052604|NCT04091659|69742398|FG000|Overall Study|Lost to Follow-up|0|||
38052605|NCT04091659|69742399|FG001|Overall Study|Lost to Follow-up|1|||
38052606|NCT04256785|69742436|FG000|Overall Study|Adverse Event|8|||
38052607|NCT04256785|69742437|FG001|Overall Study|Adverse Event|6|||
38052608|NCT04256785|69742436|FG000|Overall Study|Lack of Efficacy|3|||
38052609|NCT04256785|69742437|FG001|Overall Study|Lack of Efficacy|4|||
38052610|NCT04256785|69742436|FG000|Overall Study|Lost to Follow-up|7|||
38052611|NCT04256785|69742437|FG001|Overall Study|Lost to Follow-up|7|||
38052612|NCT04256785|69742436|FG000|Overall Study|Protocol Violation|1|||
38052613|NCT04256785|69742437|FG001|Overall Study|Protocol Violation|0|||
38052614|NCT04256785|69742436|FG000|Overall Study|Withdrawal by Subject|4|||
38052615|NCT04256785|69742437|FG001|Overall Study|Withdrawal by Subject|1|||
38052616|NCT04256785|69742436|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
38052617|NCT04256785|69742437|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
38052618|NCT02959918|69742459|FG000|Overall Study|Adverse Event|1|||
38052619|NCT02959918|69742460|FG001|Overall Study|Adverse Event|1|||
38052620|NCT02959918|69742461|FG002|Overall Study|Adverse Event|2|||
38052621|NCT02959918|69742462|FG003|Overall Study|Adverse Event|0|||
38052622|NCT02959918|69742463|FG004|Overall Study|Adverse Event|0|||
38052623|NCT02959918|69742464|FG005|Overall Study|Adverse Event|2|||
38052624|NCT02959918|69742465|FG006|Overall Study|Adverse Event|2|||
38052625|NCT02959918|69742466|FG007|Overall Study|Adverse Event|1|||
38052626|NCT02959918|69742467|FG008|Overall Study|Adverse Event|2|||
38052627|NCT02959918|69742468|FG009|Overall Study|Adverse Event|1|||
38052628|NCT02959918|69742469|FG010|Overall Study|Adverse Event|1|||
38052629|NCT02959918|69742470|FG011|Overall Study|Adverse Event|3|||
38052630|NCT02959918|69742471|FG012|Overall Study|Adverse Event|2|||
38052631|NCT02959918|69742472|FG013|Overall Study|Adverse Event|4|||
38052632|NCT02959918|69742459|FG000|Overall Study|Lost to Follow-up|0|||
38052633|NCT02959918|69742460|FG001|Overall Study|Lost to Follow-up|0|||
38052634|NCT02959918|69742461|FG002|Overall Study|Lost to Follow-up|0|||
38052635|NCT02959918|69742462|FG003|Overall Study|Lost to Follow-up|0|||
38052636|NCT02959918|69742463|FG004|Overall Study|Lost to Follow-up|0|||
38052637|NCT02959918|69742464|FG005|Overall Study|Lost to Follow-up|0|||
38052638|NCT02959918|69742465|FG006|Overall Study|Lost to Follow-up|0|||
38052639|NCT02959918|69742466|FG007|Overall Study|Lost to Follow-up|0|||
38052640|NCT02959918|69742467|FG008|Overall Study|Lost to Follow-up|0|||
38052641|NCT02959918|69742468|FG009|Overall Study|Lost to Follow-up|1|||
38052642|NCT02959918|69742469|FG010|Overall Study|Lost to Follow-up|0|||
38052643|NCT02959918|69742470|FG011|Overall Study|Lost to Follow-up|0|||
38052644|NCT02959918|69742471|FG012|Overall Study|Lost to Follow-up|1|||
38052645|NCT02959918|69742472|FG013|Overall Study|Lost to Follow-up|0|||
38052646|NCT02959918|69742459|FG000|Overall Study|Withdrawal by Subject|0|||
38052647|NCT02959918|69742460|FG001|Overall Study|Withdrawal by Subject|0|||
38052648|NCT02959918|69742461|FG002|Overall Study|Withdrawal by Subject|1|||
38052649|NCT02959918|69742462|FG003|Overall Study|Withdrawal by Subject|2|||
38052650|NCT02959918|69742463|FG004|Overall Study|Withdrawal by Subject|0|||
38052651|NCT02959918|69742464|FG005|Overall Study|Withdrawal by Subject|0|||
38052652|NCT02959918|69742465|FG006|Overall Study|Withdrawal by Subject|1|||
38052653|NCT02959918|69742466|FG007|Overall Study|Withdrawal by Subject|0|||
38052654|NCT02959918|69742467|FG008|Overall Study|Withdrawal by Subject|1|||
38052655|NCT02959918|69742468|FG009|Overall Study|Withdrawal by Subject|1|||
38052656|NCT02959918|69742469|FG010|Overall Study|Withdrawal by Subject|2|||
38052657|NCT02959918|69742470|FG011|Overall Study|Withdrawal by Subject|3|||
38052658|NCT02959918|69742471|FG012|Overall Study|Withdrawal by Subject|1|||
38052659|NCT02959918|69742472|FG013|Overall Study|Withdrawal by Subject|1|||
37964094|NCT00074581|69651250|FG001|Overall Study|Withdrawal by Subject|49|||
37964095|NCT00074581|69651249|FG000|Overall Study|Unable to adhere to visit schedule|13|||
37964096|NCT00074581|69651250|FG001|Overall Study|Unable to adhere to visit schedule|14|||
37964097|NCT00074581|69651249|FG000|Overall Study|Relocated|14|||
37964098|NCT00074581|69651250|FG001|Overall Study|Relocated|9|||
37964099|NCT00074581|69651249|FG000|Overall Study|Were withdrawn by investigator|5|||
37964100|NCT00074581|69651250|FG001|Overall Study|Were withdrawn by investigator|2|||
37964101|NCT00074581|69651249|FG000|Overall Study|Lost to Follow-up|16|||
37964102|NCT00074581|69651250|FG001|Overall Study|Lost to Follow-up|11|||
37964103|NCT00074581|69651249|FG000|Overall Study|Ended relationship w. index participant|117|||
37964104|NCT00074581|69651250|FG001|Overall Study|Ended relationship w. index participant|106|||
37964105|NCT00074581|69651249|FG000|Overall Study|Other|14|||
38052660|NCT02959918|69742459|FG000|Overall Study|Protocol Violation|0|||
38052661|NCT02959918|69742460|FG001|Overall Study|Protocol Violation|0|||
38052662|NCT02959918|69742461|FG002|Overall Study|Protocol Violation|1|||
38052663|NCT02959918|69742462|FG003|Overall Study|Protocol Violation|0|||
38052664|NCT02959918|69742463|FG004|Overall Study|Protocol Violation|0|||
38052665|NCT02959918|69742464|FG005|Overall Study|Protocol Violation|1|||
38052666|NCT02959918|69742465|FG006|Overall Study|Protocol Violation|0|||
37964106|NCT00074581|69651250|FG001|Overall Study|Other|19|||
37964107|NCT03895034|69651256|FG000|Overall Study|Lost to Follow-up|2|||
38052667|NCT02959918|69742466|FG007|Overall Study|Protocol Violation|0|||
38052668|NCT02959918|69742467|FG008|Overall Study|Protocol Violation|2|||
38052669|NCT02959918|69742468|FG009|Overall Study|Protocol Violation|1|||
38052670|NCT02959918|69742469|FG010|Overall Study|Protocol Violation|0|||
38052671|NCT02959918|69742470|FG011|Overall Study|Protocol Violation|1|||
38052672|NCT02959918|69742471|FG012|Overall Study|Protocol Violation|1|||
38052673|NCT02959918|69742472|FG013|Overall Study|Protocol Violation|0|||
38052674|NCT02959918|69742459|FG000|Overall Study|Stopping Rule Met|1|||
38052675|NCT02959918|69742460|FG001|Overall Study|Stopping Rule Met|0|||
38052676|NCT02959918|69742461|FG002|Overall Study|Stopping Rule Met|3|||
38052677|NCT02959918|69742462|FG003|Overall Study|Stopping Rule Met|4|||
38052678|NCT02959918|69742463|FG004|Overall Study|Stopping Rule Met|5|||
38052679|NCT02959918|69742464|FG005|Overall Study|Stopping Rule Met|3|||
38052680|NCT02959918|69742465|FG006|Overall Study|Stopping Rule Met|2|||
38052681|NCT02959918|69742466|FG007|Overall Study|Stopping Rule Met|4|||
38052682|NCT02959918|69742467|FG008|Overall Study|Stopping Rule Met|1|||
38052683|NCT02959918|69742468|FG009|Overall Study|Stopping Rule Met|1|||
38052684|NCT02959918|69742469|FG010|Overall Study|Stopping Rule Met|3|||
38052685|NCT02959918|69742470|FG011|Overall Study|Stopping Rule Met|5|||
38052686|NCT02959918|69742471|FG012|Overall Study|Stopping Rule Met|2|||
38052687|NCT02959918|69742472|FG013|Overall Study|Stopping Rule Met|1|||
38052688|NCT02959918|69742459|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
38052689|NCT02959918|69742460|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
38052690|NCT02959918|69742461|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
38052691|NCT02959918|69742462|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
38052692|NCT02959918|69742463|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
38052693|NCT02959918|69742464|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
38052694|NCT02959918|69742465|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
38052695|NCT02959918|69742466|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
38052696|NCT02959918|69742467|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
38052697|NCT02959918|69742468|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
38052698|NCT02959918|69742469|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
38052699|NCT02959918|69742470|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
38052700|NCT02959918|69742471|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
37964108|NCT00536978|69651260|FG000|Overall Study|Not eligible for Adback Infusion|22|||
38052701|NCT02959918|69742472|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
38052702|NCT02959918|69742459|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
38052703|NCT02959918|69742460|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
38052704|NCT02959918|69742461|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
38052705|NCT02959918|69742462|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
38052706|NCT02959918|69742463|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
38052707|NCT02959918|69742464|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
38052708|NCT02959918|69742465|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
38052709|NCT02959918|69742466|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
38052710|NCT02959918|69742467|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
38052711|NCT02959918|69742468|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
38052712|NCT02959918|69742469|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
37964109|NCT03809611|69651266|FG000|Overall Study|Withdrawal by Subject|1|||
37964110|NCT03809611|69651267|FG001|Overall Study|Withdrawal by Subject|1|||
37964111|NCT03807739|69651278|FG000|Overall Study|Adverse Event|1|||
37964112|NCT03807739|69651279|FG001|Overall Study|Adverse Event|0|||
37964113|NCT03807739|69651280|FG002|Overall Study|Adverse Event|0|||
37964114|NCT03807739|69651281|FG003|Overall Study|Adverse Event|0|||
37964115|NCT03807739|69651278|FG000|Overall Study|Withdrawal by Subject|1|||
37964116|NCT03807739|69651279|FG001|Overall Study|Withdrawal by Subject|0|||
37964117|NCT03807739|69651280|FG002|Overall Study|Withdrawal by Subject|0|||
37964118|NCT03807739|69651281|FG003|Overall Study|Withdrawal by Subject|0|||
37964119|NCT00536744|69651293|FG000|Overall Study|Adverse Event|13|||
37964120|NCT00536744|69651294|FG001|Overall Study|Adverse Event|10|||
37964121|NCT00536744|69651293|FG000|Overall Study|Death|2|||
37964122|NCT00536744|69651294|FG001|Overall Study|Death|1|||
37964123|NCT00536744|69651293|FG000|Overall Study|Physician Decision|3|||
37964124|NCT00536744|69651294|FG001|Overall Study|Physician Decision|1|||
37964125|NCT00536744|69651293|FG000|Overall Study|Lost to Follow-up|3|||
37964126|NCT00536744|69651294|FG001|Overall Study|Lost to Follow-up|5|||
37964127|NCT00536744|69651293|FG000|Overall Study|Withdrawal by Subject|7|||
37964128|NCT00536744|69651294|FG001|Overall Study|Withdrawal by Subject|8|||
37964129|NCT00536744|69651293|FG000|Overall Study|PI tried alternative treatment|1|||
37964130|NCT00536744|69651294|FG001|Overall Study|PI tried alternative treatment|3|||
37964131|NCT00536510|69651311|FG000|Overall Study|Adverse Event|27|||
38052713|NCT02959918|69742470|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
38052714|NCT02959918|69742471|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
38052715|NCT02959918|69742472|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
37964132|NCT00536510|69651312|FG001|Overall Study|Adverse Event|4|||
38052716|NCT02959918|69742459|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
38052717|NCT02959918|69742460|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
38052718|NCT02959918|69742461|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
38052719|NCT02959918|69742462|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
38052720|NCT02959918|69742463|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
38052721|NCT02959918|69742464|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
38052722|NCT02959918|69742465|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
38052723|NCT02959918|69742466|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
38052724|NCT02959918|69742467|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
38052725|NCT02959918|69742468|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
38052726|NCT02959918|69742469|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
38052727|NCT02959918|69742470|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
38052728|NCT02959918|69742471|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
38052729|NCT02959918|69742472|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
38052730|NCT02959918|69742459|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
38052731|NCT02959918|69742460|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
38052732|NCT02959918|69742461|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
38052733|NCT02959918|69742462|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
38052734|NCT02959918|69742463|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
38052735|NCT02959918|69742464|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
38052736|NCT02959918|69742465|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
38052737|NCT02959918|69742466|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
38052738|NCT02959918|69742467|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
38052739|NCT02959918|69742468|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
38052740|NCT02959918|69742469|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
38052741|NCT02959918|69742470|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
38052742|NCT02959918|69742471|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
38052743|NCT02959918|69742472|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
38052744|NCT03263442|69742507|FG000|Inpatient Phase|Death|1|||
38052745|NCT03263442|69742508|FG001|Inpatient Phase|Death|0|||
38052746|NCT03263442|69742507|FG000|Inpatient Phase|Withdrawal by Subject|1|||
38052747|NCT03263442|69742508|FG001|Inpatient Phase|Withdrawal by Subject|0|||
38052748|NCT03263442|69742507|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
38052749|NCT03263442|69742508|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
38052750|NCT03263442|69742507|FG000|1-month Follow-Up|Lost to Follow-up|1|||
38052751|NCT03263442|69742508|FG001|1-month Follow-Up|Lost to Follow-up|0|||
38052752|NCT03263442|69742507|FG000|3-month Follow-Up|Lost to Follow-up|1|||
38052753|NCT03263442|69742508|FG001|3-month Follow-Up|Lost to Follow-up|3|||
38052754|NCT03263442|69742507|FG000|6-month Follow-Up|Lost to Follow-up|2|||
38052755|NCT03263442|69742508|FG001|6-month Follow-Up|Lost to Follow-up|2|||
38052756|NCT04245709|69742516|FG000|Overall Study|Adverse Event|13|||
38052757|NCT04245709|69742516|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
38052758|NCT04091581|69742522|FG000|Overall Study|Lost to Follow-up|0|||
38052759|NCT04091581|69742523|FG001|Overall Study|Lost to Follow-up|1|||
38052760|NCT02940522|69742531|FG000|Overall Study|Lost to Follow-up|1|||
38052761|NCT02940522|69742532|FG001|Overall Study|Lost to Follow-up|2|||
38052762|NCT02940522|69742531|FG000|Overall Study|Withdrawal by Subject|1|||
38052763|NCT02940522|69742532|FG001|Overall Study|Withdrawal by Subject|0|||
38052764|NCT03262038|69742540|FG000|Overall Study|Withdrawal by Subject|0|||
38052765|NCT03262038|69742541|FG001|Overall Study|Withdrawal by Subject|1|||
38052766|NCT02472964|69742549|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
38052767|NCT02472964|69742550|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
38052768|NCT02472964|69742549|FG000|Part 1 (up to Week 24)|disease progression|58|||
38052769|NCT02472964|69742550|FG001|Part 1 (up to Week 24)|disease progression|47|||
38052770|NCT02472964|69742549|FG000|Part 1 (up to Week 24)|Death|3|||
38052771|NCT02472964|69742550|FG001|Part 1 (up to Week 24)|Death|6|||
38052772|NCT02472964|69742549|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
37964133|NCT00536510|69651311|FG000|Overall Study|Lost to Follow-up|11|||
37964134|NCT00536510|69651312|FG001|Overall Study|Lost to Follow-up|8|||
37964135|NCT00536510|69651311|FG000|Overall Study|Protocol Violation|4|||
37964136|NCT00536510|69651312|FG001|Overall Study|Protocol Violation|5|||
37964137|NCT00536510|69651311|FG000|Overall Study|Withdrawal by Subject|16|||
37964138|NCT00536510|69651312|FG001|Overall Study|Withdrawal by Subject|9|||
37964139|NCT00536510|69651311|FG000|Overall Study|Flushing with Product|20|||
37964140|NCT00536510|69651312|FG001|Overall Study|Flushing with Product|0|||
37964141|NCT00536510|69651311|FG000|Overall Study|Laboratory Adverse Event|2|||
37964142|NCT00536510|69651312|FG001|Overall Study|Laboratory Adverse Event|1|||
37964143|NCT00536510|69651311|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
38052773|NCT02472964|69742550|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
38052774|NCT02472964|69742549|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
38052775|NCT02472964|69742550|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
38052776|NCT02472964|69742549|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
38052777|NCT02472964|69742550|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
38052778|NCT02472964|69742549|FG000|Part 1 (up to Week 24)|Other|2|||
38052779|NCT02472964|69742550|FG001|Part 1 (up to Week 24)|Other|1|||
38052780|NCT02472964|69742549|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
38052781|NCT02472964|69742550|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
38052782|NCT02472964|69742549|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
38052783|NCT02472964|69742550|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
38052784|NCT02472964|69742549|FG000|Part 2 (Week 24-week 48)|Death|0|||
38052785|NCT02472964|69742550|FG001|Part 2 (Week 24-week 48)|Death|1|||
38052786|NCT02472964|69742549|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
38052787|NCT02472964|69742550|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
38052788|NCT02472964|69742549|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
38052789|NCT02472964|69742550|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
38052790|NCT02472964|69742549|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
38052791|NCT02472964|69742550|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
38052792|NCT02472964|69742549|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
38052793|NCT02472964|69742550|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
38052794|NCT04079803|69742563|FG000|Overall Study|Withdrawal by Subject|0|||
38052795|NCT04079803|69742564|FG001|Overall Study|Withdrawal by Subject|0|||
38052796|NCT04079803|69742565|FG002|Overall Study|Withdrawal by Subject|1|||
38052797|NCT03278613|69742593|FG000|Overall Study|Lost to Follow-up|3|||
38052798|NCT03278613|69742594|FG001|Overall Study|Lost to Follow-up|1|||
38052799|NCT03761147|69742602|FG000|Overall Study|Withdrawal by Subject|6|||
38052800|NCT03761147|69742603|FG001|Overall Study|Withdrawal by Subject|1|||
38052801|NCT03761147|69742602|FG000|Overall Study|Adverse Event|1|||
38052802|NCT03761147|69742603|FG001|Overall Study|Adverse Event|3|||
38052803|NCT04076917|69742609|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
38052804|NCT04076917|69742609|FG000|Overall Study|Study closure|13|||
38052805|NCT04076917|69742609|FG000|Overall Study|Physician Decision|3|||
38052806|NCT04076917|69742609|FG000|Overall Study|Death|1|||
38052807|NCT04076917|69742609|FG000|Overall Study|Lost to Follow-up|1|||
38052808|NCT04076917|69742609|FG000|Overall Study|Withdrawal by Subject|1|||
38052809|NCT04076917|69742609|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
38052810|NCT04222699|69742613|FG000|Overall Study|Lost to Follow-up|2|||
38052811|NCT02731690|69742626|FG000|Overall Study|Adverse Event|1|||
38052812|NCT02731690|69742626|FG000|Overall Study|Withdrawal by Subject|3|||
38052813|NCT02731690|69742626|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
38052814|NCT04075513|69742632|FG000|Overall Study|Withdrawal by Subject|2|||
38052815|NCT04075513|69742633|FG001|Overall Study|Withdrawal by Subject|2|||
37964144|NCT00536510|69651312|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
37964145|NCT00398086|69651321|FG000|Overall Study|Unacceptable Toxicity|2|||
37964146|NCT00398086|69651322|FG001|Overall Study|Unacceptable Toxicity|8|||
37964147|NCT00398086|69651323|FG002|Overall Study|Unacceptable Toxicity|2|||
37964148|NCT00398086|69651321|FG000|Overall Study|Adverse Event|1|||
37964149|NCT00398086|69651322|FG001|Overall Study|Adverse Event|4|||
37964150|NCT00398086|69651323|FG002|Overall Study|Adverse Event|0|||
37964151|NCT00398086|69651321|FG000|Overall Study|Physician Decision|1|||
37964152|NCT00398086|69651322|FG001|Overall Study|Physician Decision|4|||
37964153|NCT00398086|69651323|FG002|Overall Study|Physician Decision|0|||
37964154|NCT00398086|69651321|FG000|Overall Study|Withdrawal by Subject|5|||
37964155|NCT00398086|69651322|FG001|Overall Study|Withdrawal by Subject|7|||
38052816|NCT04075513|69742632|FG000|Overall Study|Lack of Efficacy|1|||
38052817|NCT04075513|69742633|FG001|Overall Study|Lack of Efficacy|0|||
38052818|NCT04075513|69742632|FG000|Overall Study|Lost to Follow-up|4|||
38052819|NCT04075513|69742633|FG001|Overall Study|Lost to Follow-up|2|||
38052820|NCT04075513|69742632|FG000|Overall Study|Switch to insulin pump|1|||
38052821|NCT04075513|69742633|FG001|Overall Study|Switch to insulin pump|0|||
38052822|NCT04073407|69742641|FG000|Part 1|Withdrawal by Subject|1|||
38052823|NCT04073407|69742642|FG001|Part 1|Withdrawal by Subject|0|||
38052824|NCT04073407|69742641|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
38052825|NCT04073407|69742642|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
38052826|NCT04073407|69742641|FG000|Part 2|Withdrawal by Subject|0|||
38052827|NCT04073407|69742642|FG001|Part 2|Withdrawal by Subject|1|||
38052828|NCT02778204|69742652|FG000|Overall Study|Adverse Event|1|||
38052829|NCT02778204|69742653|FG001|Overall Study|Adverse Event|0|||
37964156|NCT00398086|69651323|FG002|Overall Study|Withdrawal by Subject|0|||
37964157|NCT00536198|69651333|FG000|Overall Study|Lost to Follow-up|15|||
38052830|NCT02778204|69742654|FG002|Overall Study|Adverse Event|0|||
38052831|NCT02778204|69742655|FG003|Overall Study|Adverse Event|0|||
38052832|NCT02778204|69742652|FG000|Overall Study|Withdrawal by Subject|0|||
38052833|NCT02778204|69742653|FG001|Overall Study|Withdrawal by Subject|0|||
38052834|NCT02778204|69742654|FG002|Overall Study|Withdrawal by Subject|1|||
38052835|NCT02778204|69742655|FG003|Overall Study|Withdrawal by Subject|2|||
38052836|NCT02778204|69742652|FG000|Overall Study|Lost to Follow-up|1|||
38052837|NCT02778204|69742653|FG001|Overall Study|Lost to Follow-up|0|||
38052838|NCT02778204|69742654|FG002|Overall Study|Lost to Follow-up|2|||
38052839|NCT02778204|69742655|FG003|Overall Study|Lost to Follow-up|1|||
38052840|NCT02778204|69742652|FG000|Overall Study|Protocol Violation|0|||
38052841|NCT02778204|69742653|FG001|Overall Study|Protocol Violation|0|||
38052842|NCT02778204|69742654|FG002|Overall Study|Protocol Violation|1|||
38052843|NCT02778204|69742655|FG003|Overall Study|Protocol Violation|0|||
38052844|NCT02778204|69742652|FG000|Overall Study|Eligibility Violation|0|||
38052845|NCT02778204|69742653|FG001|Overall Study|Eligibility Violation|0|||
37964158|NCT00536198|69651334|FG001|Overall Study|Lost to Follow-up|14|||
37964159|NCT00536198|69651333|FG000|Overall Study|Withdrawal by Subject|16|||
37964160|NCT00536198|69651334|FG001|Overall Study|Withdrawal by Subject|12|||
37964161|NCT00536198|69651333|FG000|Overall Study|Adverse Event|2|||
37964162|NCT00536198|69651334|FG001|Overall Study|Adverse Event|2|||
37964163|NCT00536198|69651333|FG000|Overall Study|Rescue|3|||
37964164|NCT00536198|69651334|FG001|Overall Study|Rescue|9|||
37964165|NCT00536198|69651333|FG000|Overall Study|Pregnancy|1|||
37964166|NCT00536198|69651334|FG001|Overall Study|Pregnancy|1|||
37964167|NCT00536198|69651333|FG000|Overall Study|Protocol Violation|0|||
37964168|NCT00536198|69651334|FG001|Overall Study|Protocol Violation|1|||
37964169|NCT00393484|69651344|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
37964170|NCT00393484|69651345|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
37964171|NCT00393484|69651344|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
37964172|NCT00393484|69651345|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
37964173|NCT00393484|69651344|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
37964174|NCT00393484|69651345|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
37964175|NCT00393484|69651344|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
37964176|NCT00393484|69651345|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
37964177|NCT00393484|69651344|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
37964178|NCT00393484|69651345|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
37964179|NCT00393484|69651344|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
37964180|NCT00393484|69651345|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
37964181|NCT00393484|69651344|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
37964182|NCT00393484|69651345|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
37964183|NCT00393484|69651344|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
37964184|NCT00393484|69651345|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
37964185|NCT00393484|69651344|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
37964186|NCT00393484|69651345|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
37964187|NCT00393484|69651344|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
37964188|NCT00393484|69651345|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
37964189|NCT00667823|69651353|FG000|Overall Study|Lost to Follow-up|5|||
37964190|NCT00667823|69651353|FG000|Overall Study|Adverse Event|7|||
37964191|NCT00667823|69651353|FG000|Overall Study|Death|182|||
37964192|NCT00667823|69651353|FG000|Overall Study|Withdrawal by Subject|12|||
37964193|NCT00667823|69651353|FG000|Overall Study|Other|8|||
37964194|NCT00667823|69651353|FG000|Overall Study|Missing (completion page missing)|2|||
37964195|NCT00397930|69651359|FG000|Overall Study|Personal reasons|14|||
37964196|NCT00397930|69651360|FG001|Overall Study|Personal reasons|8|||
37964197|NCT00397930|69651359|FG000|Overall Study|Other medical|9|||
37964198|NCT00397930|69651360|FG001|Overall Study|Other medical|4|||
37964199|NCT00397930|69651359|FG000|Overall Study|Unknown reasons|9|||
37964200|NCT00397930|69651360|FG001|Overall Study|Unknown reasons|14|||
37680357|NCT02383017|69155962|FG000|Overall Study|Injury Sustained Outside Study|1|||
37680358|NCT02383017|69155963|FG001|Overall Study|Injury Sustained Outside Study|0|||
37680359|NCT02383017|69155962|FG000|Overall Study|Compliance|3|||
37964201|NCT00397930|69651359|FG000|Overall Study|Noncompliant|3|||
37964202|NCT00397930|69651360|FG001|Overall Study|Noncompliant|2|||
37964203|NCT00397930|69651359|FG000|Overall Study|Too time-consuming|2|||
37964204|NCT00397930|69651360|FG001|Overall Study|Too time-consuming|9|||
37964205|NCT00397930|69651359|FG000|Overall Study|Started own yoga program|1|||
37964206|NCT00397930|69651360|FG001|Overall Study|Started own yoga program|1|||
38052846|NCT02778204|69742654|FG002|Overall Study|Eligibility Violation|0|||
38052847|NCT02778204|69742655|FG003|Overall Study|Eligibility Violation|1|||
38052848|NCT04072159|69742669|FG000|Overall Study|Lost to Follow-up|6|||
38052849|NCT04072159|69742670|FG001|Overall Study|Lost to Follow-up|6|||
38052850|NCT04072159|69742669|FG000|Overall Study|Withdrawal by Subject|2|||
38052851|NCT04072159|69742670|FG001|Overall Study|Withdrawal by Subject|0|||
38052852|NCT03232281|69742680|FG000|Overall Study|Adverse Event|1|||
38052853|NCT03232281|69742681|FG001|Overall Study|Adverse Event|1|||
38052854|NCT03232281|69742680|FG000|Overall Study|Withdrawal by Subject|5|||
38052855|NCT03232281|69742681|FG001|Overall Study|Withdrawal by Subject|4|||
38052856|NCT03232281|69742680|FG000|Overall Study|Protocol Deviation|1|||
38052857|NCT03232281|69742681|FG001|Overall Study|Protocol Deviation|1|||
38052858|NCT04071301|69742687|FG000|Overall Study|Withdrawal by Subject|6|||
38052859|NCT04071301|69742687|FG000|Overall Study|Death|1|||
38052860|NCT03261336|69742691|FG000|Overall Study|Adverse Event|1|||
38052861|NCT00462748|69742698|FG000|Overall Study|Adverse Event|7|||
38052862|NCT00462748|69742699|FG001|Overall Study|Adverse Event|5|||
38052863|NCT00462748|69742700|FG002|Overall Study|Adverse Event|9|||
38052864|NCT00462748|69742698|FG000|Overall Study|Protocol Violation|0|||
38052865|NCT00462748|69742699|FG001|Overall Study|Protocol Violation|2|||
38052866|NCT00462748|69742700|FG002|Overall Study|Protocol Violation|1|||
38052867|NCT00462748|69742698|FG000|Overall Study|Withdrew consent|3|||
38052868|NCT00462748|69742699|FG001|Overall Study|Withdrew consent|3|||
38052869|NCT00462748|69742700|FG002|Overall Study|Withdrew consent|0|||
38052870|NCT00462748|69742698|FG000|Overall Study|Lost to Follow-up|1|||
38052871|NCT00462748|69742699|FG001|Overall Study|Lost to Follow-up|1|||
38052872|NCT00462748|69742700|FG002|Overall Study|Lost to Follow-up|1|||
38052873|NCT00462748|69742698|FG000|Overall Study|Discontinued after 41 days Rx|1|||
38052874|NCT00462748|69742699|FG001|Overall Study|Discontinued after 41 days Rx|0|||
38052875|NCT00462748|69742700|FG002|Overall Study|Discontinued after 41 days Rx|0|||
38052876|NCT04206085|69742711|FG000|Overall Study|Lost to Follow-up|0|||
38052877|NCT04206085|69742712|FG001|Overall Study|Lost to Follow-up|1|||
38052878|NCT04206085|69742713|FG002|Overall Study|Lost to Follow-up|0|||
38052879|NCT04206085|69742711|FG000|Overall Study|Lost to Follow-up|0|||
38052880|NCT04206085|69742712|FG001|Overall Study|Lost to Follow-up|0|||
38052881|NCT04206085|69742713|FG002|Overall Study|Lost to Follow-up|1|||
38052882|NCT04202497|69742721|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
38052883|NCT04202497|69742722|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
38052884|NCT04202497|69742723|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
38052885|NCT04202497|69742724|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
38052886|NCT03297294|69742740|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
38052887|NCT03297294|69742741|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
38052888|NCT03297294|69742742|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
38052889|NCT03297294|69742743|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
38052890|NCT03297294|69742744|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
38052891|NCT03297294|69742740|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
38052892|NCT03297294|69742741|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
38052893|NCT03297294|69742742|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
38052894|NCT03297294|69742743|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
38052895|NCT03297294|69742744|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
38052896|NCT03297294|69742740|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
38052897|NCT03297294|69742741|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
38052898|NCT03297294|69742742|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
38052899|NCT03297294|69742743|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
38052900|NCT03297294|69742744|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
38052901|NCT03297294|69742740|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
38052902|NCT03297294|69742741|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
38052903|NCT03297294|69742742|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
38052904|NCT03297294|69742743|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
37964207|NCT00397930|69651359|FG000|Overall Study|Did not want to be in control group|0|||
37964208|NCT00397930|69651360|FG001|Overall Study|Did not want to be in control group|1|||
37964209|NCT00397930|69651359|FG000|Overall Study|Withdrawal by Subject|0|||
37964210|NCT00397930|69651360|FG001|Overall Study|Withdrawal by Subject|8|||
37964211|NCT00397930|69651359|FG000|Overall Study|Missing data|0|||
37964212|NCT00397930|69651360|FG001|Overall Study|Missing data|4|||
37964213|NCT00397540|69651368|FG000|Overall Study|short follow-up duration < 12 months|1|||
37964214|NCT00397540|69651369|FG001|Overall Study|short follow-up duration < 12 months|0|||
37964215|NCT00536120|69651378|FG000|Overall Study|Lost to Follow-up|1|||
37964216|NCT00536120|69651379|FG001|Overall Study|Lost to Follow-up|0|||
37964217|NCT00536120|69651378|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
37964218|NCT00536120|69651379|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
37964219|NCT00536120|69651378|FG000|Overall Study|Non-compliance|1|||
37964220|NCT00536120|69651379|FG001|Overall Study|Non-compliance|0|||
37964221|NCT00536120|69651378|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
37680360|NCT02383017|69155963|FG001|Overall Study|Compliance|2|||
38052905|NCT03297294|69742744|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
38052906|NCT03297294|69742740|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
38052907|NCT03297294|69742741|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
38052908|NCT03297294|69742742|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
38052909|NCT03297294|69742743|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
38052910|NCT03297294|69742744|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
38052911|NCT03238911|69742758|FG000|Overall Study|Withdrawal by Subject|1|||
38052912|NCT03238911|69742759|FG001|Overall Study|Withdrawal by Subject|2|||
38052913|NCT03238911|69742758|FG000|Overall Study|Lost to Follow-up|2|||
38052914|NCT03238911|69742759|FG001|Overall Study|Lost to Follow-up|1|||
38052915|NCT00418834|69742768|FG000|Overall Study|Adverse Event|16|||
38052916|NCT00418834|69742769|FG001|Overall Study|Adverse Event|9|||
38052917|NCT00418834|69742768|FG000|Overall Study|Lost to Follow-up|0|||
38052918|NCT00418834|69742769|FG001|Overall Study|Lost to Follow-up|1|||
38052919|NCT00418834|69742768|FG000|Overall Study|Protocol Violation|4|||
38052920|NCT00418834|69742769|FG001|Overall Study|Protocol Violation|3|||
38052921|NCT00418834|69742768|FG000|Overall Study|Withdrawal by Subject|3|||
38052922|NCT00418834|69742769|FG001|Overall Study|Withdrawal by Subject|7|||
38052923|NCT03276975|69742777|FG000|Overall Study|Withdrawal by Subject|1|||
38052924|NCT03276975|69742778|FG001|Overall Study|Withdrawal by Subject|0|||
38052925|NCT03297216|69742786|FG000|Overall Study|Death|0|||
38052926|NCT03297216|69742787|FG001|Overall Study|Death|1|||
38052927|NCT03297216|69742786|FG000|Overall Study|Miscarriage|0|||
38052928|NCT03297216|69742787|FG001|Overall Study|Miscarriage|2|||
38052929|NCT03297216|69742786|FG000|Overall Study|Lost to Follow-up|3|||
38052930|NCT03297216|69742787|FG001|Overall Study|Lost to Follow-up|2|||
38052931|NCT03260868|69742802|FG000|Overall Study|Poor Compliance to Protocol|0|||
38052932|NCT03260868|69742803|FG001|Overall Study|Poor Compliance to Protocol|2|||
38052933|NCT03260868|69742802|FG000|Overall Study|Study Terminated By Sponsor|2|||
38052934|NCT03260868|69742803|FG001|Overall Study|Study Terminated By Sponsor|1|||
38052935|NCT03260868|69742802|FG000|Overall Study|Other than specified above|1|||
38052936|NCT03260868|69742803|FG001|Overall Study|Other than specified above|0|||
38052937|NCT03293394|69742811|FG000|Follow-up (6 Months)|Adverse Event|4|||
38052938|NCT03293394|69742812|FG001|Follow-up (6 Months)|Adverse Event|2|||
38052939|NCT03259308|69742821|FG000|Overall Study|Adverse Event|5|||
38052940|NCT03259308|69742822|FG001|Overall Study|Adverse Event|4|||
38052941|NCT03259308|69742823|FG002|Overall Study|Adverse Event|1|||
38052942|NCT03259308|69742821|FG000|Overall Study|Withdrawal by Subject|2|||
38052943|NCT03259308|69742822|FG001|Overall Study|Withdrawal by Subject|1|||
38052944|NCT03259308|69742823|FG002|Overall Study|Withdrawal by Subject|3|||
38052945|NCT03259308|69742821|FG000|Overall Study|Lost to Follow-up|0|||
38052946|NCT03259308|69742822|FG001|Overall Study|Lost to Follow-up|0|||
38052947|NCT03259308|69742823|FG002|Overall Study|Lost to Follow-up|1|||
38052948|NCT03259308|69742821|FG000|Overall Study|Pregnancy|0|||
38052949|NCT03259308|69742822|FG001|Overall Study|Pregnancy|0|||
38052950|NCT03259308|69742823|FG002|Overall Study|Pregnancy|1|||
38052951|NCT03259308|69742821|FG000|Overall Study|Protocol Deviation|0|||
38052952|NCT03259308|69742822|FG001|Overall Study|Protocol Deviation|3|||
38052953|NCT03259308|69742823|FG002|Overall Study|Protocol Deviation|0|||
38052954|NCT03259308|69742821|FG000|Overall Study|Lack of Efficacy|0|||
38052955|NCT03259308|69742822|FG001|Overall Study|Lack of Efficacy|0|||
38052956|NCT03259308|69742823|FG002|Overall Study|Lack of Efficacy|1|||
38052957|NCT03258762|69742833|FG000|Overall Study|Lost to Follow-up|0|||
38052958|NCT03258762|69742834|FG001|Overall Study|Lost to Follow-up|1|||
38052959|NCT04502589|69742843|FG000|Overall Study|Physician Decision|1|||
38052960|NCT04502589|69742844|FG001|Overall Study|Physician Decision|0|||
38052961|NCT03291288|69742850|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
38052962|NCT03291288|69742851|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
38052963|NCT03291288|69742850|FG000|Drug-drug Interaction Phase|Disease progression|1|||
38052964|NCT03291288|69742851|FG001|Drug-drug Interaction Phase|Disease progression|0|||
38052965|NCT03291288|69742850|FG000|Drug-drug Interaction Phase|Other|3|||
38052966|NCT03291288|69742851|FG001|Drug-drug Interaction Phase|Other|0|||
38052967|NCT03291288|69742850|FG000|Pexidartinib Only|Ongoing|0|||
38052968|NCT03291288|69742851|FG001|Pexidartinib Only|Ongoing|2|||
38052969|NCT03257358|69742876|FG000|Overall Study|Adverse Event|25|||
38052970|NCT03257358|69742877|FG001|Overall Study|Adverse Event|12|||
38052971|NCT03257358|69742876|FG000|Overall Study|Lack of Efficacy|1|||
38052972|NCT03257358|69742877|FG001|Overall Study|Lack of Efficacy|1|||
38052973|NCT03257358|69742876|FG000|Overall Study|Lost to Follow-up|12|||
38052974|NCT03257358|69742877|FG001|Overall Study|Lost to Follow-up|4|||
38052975|NCT03257358|69742876|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
38052976|NCT03257358|69742877|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
38052977|NCT03257358|69742876|FG000|Overall Study|Physician Decision|2|||
38052978|NCT03257358|69742877|FG001|Overall Study|Physician Decision|2|||
38052979|NCT03257358|69742876|FG000|Overall Study|Protocol Violation|5|||
38052980|NCT03257358|69742877|FG001|Overall Study|Protocol Violation|3|||
38052981|NCT03257358|69742876|FG000|Overall Study|Technical problems|4|||
38052982|NCT03257358|69742877|FG001|Overall Study|Technical problems|1|||
38052983|NCT03257358|69742876|FG000|Overall Study|Withdrawal by Subject|8|||
38052984|NCT03257358|69742877|FG001|Overall Study|Withdrawal by Subject|3|||
38052985|NCT03257358|69742876|FG000|Overall Study|Withdrawal of informed consent|9|||
38052986|NCT03257358|69742877|FG001|Overall Study|Withdrawal of informed consent|5|||
38052987|NCT03257358|69742876|FG000|Overall Study|New therapy for study indication|1|||
38052988|NCT03257358|69742877|FG001|Overall Study|New therapy for study indication|0|||
38052989|NCT03257358|69742876|FG000|Overall Study|No longer requires treatment|0|||
38052990|NCT03257358|69742877|FG001|Overall Study|No longer requires treatment|1|||
37964222|NCT00536120|69651379|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
37964223|NCT00536120|69651378|FG000|Overall Study|Steroid Use|0|||
37964224|NCT00536120|69651379|FG001|Overall Study|Steroid Use|2|||
37964225|NCT00536120|69651378|FG000|Overall Study|Missed Study Visit|0|||
37964226|NCT00536120|69651379|FG001|Overall Study|Missed Study Visit|1|||
37964227|NCT00057811|69651387|FG000|Overall Study|Lack of Efficacy|1|||
37964228|NCT00057811|69651388|FG001|Overall Study|Lack of Efficacy|4|||
37964229|NCT00057811|69651387|FG000|Overall Study|Physician Decision|1|||
37964230|NCT00057811|69651388|FG001|Overall Study|Physician Decision|0|||
37964231|NCT00057811|69651387|FG000|Overall Study|Withdrawal by Subject|3|||
37964232|NCT00057811|69651388|FG001|Overall Study|Withdrawal by Subject|4|||
37964233|NCT00057811|69651387|FG000|Overall Study|Ineligible|4|||
37964234|NCT00057811|69651388|FG001|Overall Study|Ineligible|2|||
37964235|NCT00057811|69651387|FG000|Overall Study|Inevaluable|1|||
37964236|NCT00057811|69651388|FG001|Overall Study|Inevaluable|2|||
37964237|NCT02866682|69651401|FG000|Overall Study|Death|0|||
37964238|NCT02866682|69651402|FG001|Overall Study|Death|1|||
37964239|NCT02866682|69651401|FG000|Overall Study|Lost to Follow-up|0|||
37964240|NCT02866682|69651402|FG001|Overall Study|Lost to Follow-up|4|||
37964241|NCT02866682|69651401|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
37964242|NCT02866682|69651402|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
37964243|NCT02866682|69651401|FG000|Overall Study|Other|0|||
37964244|NCT02866682|69651402|FG001|Overall Study|Other|1|||
37964245|NCT00570713|69651419|FG000|Overall Study|Adverse Event|16|||
37964246|NCT00570713|69651420|FG001|Overall Study|Adverse Event|9|||
37964247|NCT00570713|69651419|FG000|Overall Study|Death|7|||
37964248|NCT00570713|69651420|FG001|Overall Study|Death|7|||
37964249|NCT00570713|69651419|FG000|Overall Study|Lack of Efficacy|40|||
37964250|NCT00570713|69651420|FG001|Overall Study|Lack of Efficacy|49|||
37964251|NCT00570713|69651419|FG000|Overall Study|Physician Decision|2|||
37964252|NCT00570713|69651420|FG001|Overall Study|Physician Decision|2|||
37964253|NCT00570713|69651419|FG000|Overall Study|Withdrawal by Subject|3|||
37964254|NCT00570713|69651420|FG001|Overall Study|Withdrawal by Subject|3|||
37964255|NCT00570713|69651419|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
37964256|NCT00570713|69651420|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
37964257|NCT00669617|69651430|FG000|Period 1|Withdrawal by Subject|0|||
37964258|NCT00669617|69651431|FG001|Period 1|Withdrawal by Subject|0|||
37964259|NCT00669617|69651432|FG002|Period 1|Withdrawal by Subject|1|||
37964260|NCT00669617|69651433|FG003|Period 1|Withdrawal by Subject|0|||
37964261|NCT00669617|69651434|FG004|Period 1|Withdrawal by Subject|0|||
37964262|NCT00669617|69651430|FG000|Period 1|Protocol Deviation|0|||
37964263|NCT00669617|69651431|FG001|Period 1|Protocol Deviation|0|||
37964264|NCT00669617|69651432|FG002|Period 1|Protocol Deviation|0|||
37964265|NCT00669617|69651433|FG003|Period 1|Protocol Deviation|0|||
37964266|NCT00669617|69651434|FG004|Period 1|Protocol Deviation|1|||
37964267|NCT00669617|69651430|FG000|Period 3|Lost to Follow-up|1|||
37964268|NCT00669617|69651431|FG001|Period 3|Lost to Follow-up|0|||
37964269|NCT00669617|69651432|FG002|Period 3|Lost to Follow-up|0|||
37964270|NCT00669617|69651433|FG003|Period 3|Lost to Follow-up|0|||
37964271|NCT00669617|69651434|FG004|Period 3|Lost to Follow-up|0|||
37964272|NCT00535730|69651448|FG000|Overall Study|Adverse Event|1|||
38052991|NCT02936037|69742885|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
38052992|NCT02936037|69742886|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
38052993|NCT02936037|69742885|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
38052994|NCT02936037|69742886|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
38052995|NCT02936037|69742885|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
37964273|NCT00535730|69651449|FG001|Overall Study|Adverse Event|1|||
37964274|NCT00535730|69651448|FG000|Overall Study|Lost to Follow-up|0|||
37964275|NCT00535730|69651449|FG001|Overall Study|Lost to Follow-up|1|||
37964276|NCT00535730|69651448|FG000|Overall Study|Physician Decision|0|||
37964277|NCT00535730|69651449|FG001|Overall Study|Physician Decision|1|||
37964278|NCT00535730|69651448|FG000|Overall Study|Protocol Violation|1|||
37964279|NCT00535730|69651449|FG001|Overall Study|Protocol Violation|0|||
37964280|NCT00535730|69651448|FG000|Overall Study|Withdrawal by Subject|0|||
37964281|NCT00535730|69651449|FG001|Overall Study|Withdrawal by Subject|4|||
37964282|NCT00666965|69651460|FG000|Overall Study|Adverse Event|0|||
37964283|NCT00666965|69651461|FG001|Overall Study|Adverse Event|2|||
38052996|NCT02936037|69742886|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
38052997|NCT02936037|69742885|FG000|Double-Blind Treatment Period|Death|0|||
38052998|NCT02936037|69742886|FG001|Double-Blind Treatment Period|Death|1|||
38052999|NCT02936037|69742885|FG000|Double-Blind Treatment Period|Adverse Event|11|||
38053000|NCT02936037|69742886|FG001|Double-Blind Treatment Period|Adverse Event|11|||
38053001|NCT02936037|69742885|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
38053002|NCT02936037|69742886|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
38053003|NCT02936037|69742885|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
38053004|NCT02936037|69742886|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
38053005|NCT02936037|69742885|FG000|Open Label Extension|Adverse Event|0|||
38053006|NCT02936037|69742886|FG001|Open Label Extension|Adverse Event|3|||
38053007|NCT02936037|69742885|FG000|Open Label Extension|Other|0|||
38053008|NCT02936037|69742886|FG001|Open Label Extension|Other|3|||
38053009|NCT02936037|69742885|FG000|Open Label Extension|Withdrawal by Subject|0|||
38053010|NCT02936037|69742886|FG001|Open Label Extension|Withdrawal by Subject|4|||
38053011|NCT03288714|69742894|FG000|Overall Study|Lost to Follow-up|2|||
38053012|NCT03288714|69742895|FG001|Overall Study|Lost to Follow-up|1|||
38053013|NCT03288714|69742894|FG000|Overall Study|Non-compliance with study schedule|2|||
38053014|NCT03288714|69742895|FG001|Overall Study|Non-compliance with study schedule|0|||
38053015|NCT03288714|69742894|FG000|Overall Study|Withdrawal by Subject|3|||
38053016|NCT03288714|69742895|FG001|Overall Study|Withdrawal by Subject|1|||
38053017|NCT03288714|69742894|FG000|Overall Study|Clinical Worsening|2|||
38053018|NCT03288714|69742895|FG001|Overall Study|Clinical Worsening|1|||
38053019|NCT03288714|69742894|FG000|Overall Study|Adverse Event|1|||
38053020|NCT03288714|69742895|FG001|Overall Study|Adverse Event|0|||
38053021|NCT03256578|69742905|FG000|Overall Study|Excluded Post Randomization|66|||
38053022|NCT03256578|69742906|FG001|Overall Study|Excluded Post Randomization|56|||
38053023|NCT03227445|69742912|FG000|Period 1 (28 Days)|Adverse Event|1|||
38053024|NCT03227445|69742913|FG001|Period 1 (28 Days)|Adverse Event|2|||
38053025|NCT03227445|69742914|FG002|Period 1 (28 Days)|Adverse Event|0|||
38053026|NCT03227445|69742915|FG003|Period 1 (28 Days)|Adverse Event|1|||
38053027|NCT03227445|69742912|FG000|Period 1 (28 Days)|Protocol Violation|1|||
38053028|NCT03227445|69742913|FG001|Period 1 (28 Days)|Protocol Violation|0|||
38053029|NCT03227445|69742914|FG002|Period 1 (28 Days)|Protocol Violation|0|||
38053030|NCT03227445|69742915|FG003|Period 1 (28 Days)|Protocol Violation|0|||
38053031|NCT03227445|69742912|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
38053032|NCT03227445|69742913|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
38053033|NCT03227445|69742914|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
38053034|NCT03227445|69742915|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
38053035|NCT03227445|69742912|FG000|Period 2 (28 Days)|Adverse Event|1|||
38053036|NCT03227445|69742913|FG001|Period 2 (28 Days)|Adverse Event|0|||
38053037|NCT03227445|69742914|FG002|Period 2 (28 Days)|Adverse Event|2|||
38053038|NCT03227445|69742915|FG003|Period 2 (28 Days)|Adverse Event|1|||
38053039|NCT03227445|69742912|FG000|Period 2 (28 Days)|Protocol Violation|0|||
38053040|NCT03227445|69742913|FG001|Period 2 (28 Days)|Protocol Violation|0|||
38053041|NCT03227445|69742914|FG002|Period 2 (28 Days)|Protocol Violation|0|||
38053042|NCT03227445|69742915|FG003|Period 2 (28 Days)|Protocol Violation|1|||
38053043|NCT03227445|69742912|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
38053044|NCT03227445|69742913|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
38053045|NCT03227445|69742914|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
38053046|NCT03227445|69742915|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
38053047|NCT04067401|69742926|FG000|Overall Study|Withdrawal by Subject|7|||
38053048|NCT04067401|69742927|FG001|Overall Study|Withdrawal by Subject|0|||
38053049|NCT04067401|69742926|FG000|Overall Study|no data provided|1|||
38053050|NCT04067401|69742927|FG001|Overall Study|no data provided|0|||
38053051|NCT04194151|69742939|FG000|Overall Study|Physician Decision|1|||
38053052|NCT04194151|69742940|FG001|Overall Study|Physician Decision|1|||
38053053|NCT04194151|69742941|FG002|Overall Study|Physician Decision|1|||
38053054|NCT04194151|69742942|FG003|Overall Study|Physician Decision|1|||
38053055|NCT04194151|69742943|FG004|Overall Study|Physician Decision|0|||
38053056|NCT04194151|69742944|FG005|Overall Study|Physician Decision|1|||
38053057|NCT04194151|69742939|FG000|Overall Study|Monitorization problem|0|||
38053058|NCT04194151|69742940|FG001|Overall Study|Monitorization problem|1|||
38053059|NCT04194151|69742941|FG002|Overall Study|Monitorization problem|0|||
38053060|NCT04194151|69742942|FG003|Overall Study|Monitorization problem|0|||
38053061|NCT04194151|69742943|FG004|Overall Study|Monitorization problem|0|||
37964284|NCT00666965|69651462|FG002|Overall Study|Adverse Event|1|||
37964285|NCT00666965|69651463|FG003|Overall Study|Adverse Event|9|||
37964286|NCT00666965|69651460|FG000|Overall Study|Lack of Efficacy|1|||
37964287|NCT00666965|69651461|FG001|Overall Study|Lack of Efficacy|1|||
37964288|NCT00666965|69651462|FG002|Overall Study|Lack of Efficacy|0|||
37964289|NCT00666965|69651463|FG003|Overall Study|Lack of Efficacy|0|||
37964290|NCT00666965|69651460|FG000|Overall Study|Protocol Violation|0|||
38053062|NCT04194151|69742944|FG005|Overall Study|Monitorization problem|0|||
38053063|NCT03820323|69742960|FG000|Overall Study|Lost to Follow-up|2|||
38053064|NCT03820323|69742961|FG001|Overall Study|Lost to Follow-up|1|||
38053065|NCT03820323|69742960|FG000|Overall Study|Missed 12-month visit|22|||
38053066|NCT03820323|69742961|FG001|Overall Study|Missed 12-month visit|14|||
38053067|NCT03820323|69742960|FG000|Overall Study|Death|2|||
38053068|NCT03820323|69742961|FG001|Overall Study|Death|1|||
38053069|NCT03820323|69742960|FG000|Overall Study|Transferred out|13|||
38053070|NCT03820323|69742961|FG001|Overall Study|Transferred out|11|||
38053071|NCT03820323|69742960|FG000|Overall Study|Terminated|0|||
38053072|NCT03820323|69742961|FG001|Overall Study|Terminated|3|||
38053073|NCT03820323|69742960|FG000|Overall Study|Withdrawal by Subject|1|||
38053074|NCT03820323|69742961|FG001|Overall Study|Withdrawal by Subject|6|||
38053075|NCT03287622|69742976|FG000|Overall Study|Withdrawal by Subject|1|||
38053076|NCT03287622|69742977|FG001|Overall Study|Withdrawal by Subject|0|||
38053077|NCT03287622|69742976|FG000|Overall Study|Lost to Follow-up|27|||
38053078|NCT03287622|69742977|FG001|Overall Study|Lost to Follow-up|15|||
38053079|NCT03287622|69742976|FG000|Overall Study|No prescripion after surgery|28|||
38053080|NCT03287622|69742977|FG001|Overall Study|No prescripion after surgery|31|||
38053081|NCT03287622|69742976|FG000|Overall Study|prolonged Length of stay|2|||
38053082|NCT03287622|69742977|FG001|Overall Study|prolonged Length of stay|0|||
38053083|NCT03287622|69742976|FG000|Overall Study|surgery related|0|||
38053084|NCT03287622|69742977|FG001|Overall Study|surgery related|2|||
38053085|NCT04063657|69742992|FG000|Overall Study|Lost to Follow-up|1|||
38053086|NCT04063657|69742993|FG001|Overall Study|Lost to Follow-up|0|||
38053087|NCT04058353|69743010|FG000|Overall Study|Adverse Event|2|||
38053088|NCT04058353|69743011|FG001|Overall Study|Adverse Event|1|||
38053089|NCT04058353|69743010|FG000|Overall Study|Physician Decision|1|||
38053090|NCT04058353|69743011|FG001|Overall Study|Physician Decision|0|||
38053091|NCT04058353|69743010|FG000|Overall Study|Other|1|||
38053092|NCT04058353|69743011|FG001|Overall Study|Other|0|||
38053093|NCT03226353|69743018|FG000|Overall Study|Withdrawal by Subject|1|||
38053094|NCT03226353|69743018|FG000|Overall Study|Screen Failure|5|||
38053095|NCT02730598|69743027|FG000|Overall Study|Withdrawal by Subject|3|||
38053096|NCT02730598|69743028|FG001|Overall Study|Withdrawal by Subject|3|||
38053097|NCT02730598|69743027|FG000|Overall Study|Protocol Violation|0|||
38053098|NCT02730598|69743028|FG001|Overall Study|Protocol Violation|1|||
38053099|NCT02730598|69743027|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
38053100|NCT02730598|69743028|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
38053101|NCT03226275|69743038|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
38053102|NCT03226275|69743039|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
38053103|NCT03226275|69743040|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
38053104|NCT03226275|69743041|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
38053105|NCT03226275|69743038|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
37964291|NCT00666965|69651461|FG001|Overall Study|Protocol Violation|0|||
38053106|NCT03226275|69743039|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
38053107|NCT03226275|69743040|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
38053108|NCT03226275|69743041|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
38053109|NCT04189081|69743054|FG000|Overall Study|Lost to Follow-up|1|||
38053110|NCT04189081|69743055|FG001|Overall Study|Lost to Follow-up|0|||
38053111|NCT04189081|69743056|FG002|Overall Study|Lost to Follow-up|0|||
38053112|NCT04189081|69743054|FG000|Overall Study|Withdrawal by Subject|0|||
38053113|NCT04189081|69743055|FG001|Overall Study|Withdrawal by Subject|0|||
38053114|NCT04189081|69743056|FG002|Overall Study|Withdrawal by Subject|1|||
37964292|NCT00666965|69651462|FG002|Overall Study|Protocol Violation|0|||
37964293|NCT00666965|69651463|FG003|Overall Study|Protocol Violation|2|||
37964294|NCT00666965|69651460|FG000|Overall Study|Discontinuation criteria|2|||
37964295|NCT00666965|69651461|FG001|Overall Study|Discontinuation criteria|1|||
37964296|NCT00666965|69651462|FG002|Overall Study|Discontinuation criteria|1|||
37964297|NCT00666965|69651463|FG003|Overall Study|Discontinuation criteria|2|||
37964298|NCT00666965|69651460|FG000|Overall Study|Withdrawal by Subject|0|||
37964299|NCT00666965|69651461|FG001|Overall Study|Withdrawal by Subject|0|||
38053115|NCT04187989|69743066|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
38053116|NCT04187989|69743067|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
38053117|NCT04187989|69743066|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
38053118|NCT04187989|69743067|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
38053119|NCT01150890|69743077|FG000|Overall Study|Other|0|||
38053120|NCT01150890|69743078|FG001|Overall Study|Other|1|||
38053121|NCT01150890|69743079|FG002|Overall Study|Other|0|||
37964300|NCT00666965|69651462|FG002|Overall Study|Withdrawal by Subject|0|||
38053122|NCT01150890|69743080|FG003|Overall Study|Other|2|||
38053123|NCT01150890|69743077|FG000|Overall Study|Pregnancy|0|||
38053124|NCT01150890|69743078|FG001|Overall Study|Pregnancy|0|||
38053125|NCT01150890|69743079|FG002|Overall Study|Pregnancy|0|||
38053126|NCT01150890|69743080|FG003|Overall Study|Pregnancy|1|||
37964301|NCT00666965|69651463|FG003|Overall Study|Withdrawal by Subject|2|||
38053127|NCT01150890|69743077|FG000|Overall Study|Administrative Decision|4|||
38053128|NCT01150890|69743078|FG001|Overall Study|Administrative Decision|4|||
38053129|NCT01150890|69743079|FG002|Overall Study|Administrative Decision|5|||
38053130|NCT01150890|69743080|FG003|Overall Study|Administrative Decision|6|||
38053131|NCT01150890|69743077|FG000|Overall Study|Ineligibility determined|0|||
38053132|NCT01150890|69743078|FG001|Overall Study|Ineligibility determined|1|||
38053133|NCT01150890|69743079|FG002|Overall Study|Ineligibility determined|0|||
38053134|NCT01150890|69743080|FG003|Overall Study|Ineligibility determined|0|||
38053135|NCT01150890|69743077|FG000|Overall Study|Adverse Event|0|||
38053136|NCT01150890|69743078|FG001|Overall Study|Adverse Event|0|||
38053137|NCT01150890|69743079|FG002|Overall Study|Adverse Event|2|||
38053138|NCT01150890|69743080|FG003|Overall Study|Adverse Event|0|||
38053139|NCT01150890|69743077|FG000|Overall Study|Withdrawal by Subject|0|||
38053140|NCT01150890|69743078|FG001|Overall Study|Withdrawal by Subject|0|||
38053141|NCT01150890|69743079|FG002|Overall Study|Withdrawal by Subject|2|||
38053142|NCT01150890|69743080|FG003|Overall Study|Withdrawal by Subject|1|||
38053143|NCT01150890|69743077|FG000|Overall Study|Disease progression|0|||
38053144|NCT01150890|69743078|FG001|Overall Study|Disease progression|7|||
38053145|NCT01150890|69743079|FG002|Overall Study|Disease progression|3|||
38053146|NCT01150890|69743080|FG003|Overall Study|Disease progression|7|||
38053147|NCT04057573|69743095|FG000|24-Week Double-Blind Period|Adverse Event|2|||
38053148|NCT04057573|69743096|FG001|24-Week Double-Blind Period|Adverse Event|0|||
38053149|NCT04057573|69743097|FG002|24-Week Double-Blind Period|Adverse Event|0|||
38053150|NCT04057573|69743098|FG003|24-Week Double-Blind Period|Adverse Event|0|||
38053151|NCT04057573|69743095|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
38053152|NCT04057573|69743096|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
38053153|NCT04057573|69743097|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
38053154|NCT04057573|69743098|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
38053155|NCT04057573|69743095|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
38053156|NCT04057573|69743096|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
38053157|NCT04057573|69743097|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
38053158|NCT04057573|69743098|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
38053159|NCT04057573|69743095|FG000|24-Week Double-Blind Period|Physician Decision|1|||
38053160|NCT04057573|69743096|FG001|24-Week Double-Blind Period|Physician Decision|0|||
38053161|NCT04057573|69743097|FG002|24-Week Double-Blind Period|Physician Decision|0|||
38053162|NCT04057573|69743098|FG003|24-Week Double-Blind Period|Physician Decision|0|||
38053163|NCT04057573|69743095|FG000|24-Week Double-Blind Period|Pregnancy|1|||
38053164|NCT04057573|69743096|FG001|24-Week Double-Blind Period|Pregnancy|0|||
38053165|NCT04057573|69743097|FG002|24-Week Double-Blind Period|Pregnancy|0|||
38053166|NCT04057573|69743098|FG003|24-Week Double-Blind Period|Pregnancy|0|||
38053167|NCT04057573|69743095|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
38053168|NCT04057573|69743096|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
38053169|NCT04057573|69743097|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
38053170|NCT04057573|69743098|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
38053171|NCT04057573|69743095|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
38053172|NCT04057573|69743096|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
38053173|NCT04057573|69743097|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
38053174|NCT04057573|69743098|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
38053175|NCT04057573|69743095|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
38053176|NCT04057573|69743096|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
38053177|NCT04057573|69743097|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
38053178|NCT04057573|69743098|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
38053179|NCT04057573|69743095|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
38053180|NCT04057573|69743096|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
38053181|NCT04057573|69743097|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
38053182|NCT04057573|69743098|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
38053183|NCT04057573|69743095|FG000|24-Week Double-Blind Period|Not Treated|1|||
38053184|NCT04057573|69743096|FG001|24-Week Double-Blind Period|Not Treated|0|||
37862084|NCT01134705|69545844|FG000|Overall Study|Withdrawal by Subject|6|||
38053185|NCT04057573|69743097|FG002|24-Week Double-Blind Period|Not Treated|0|||
38053186|NCT04057573|69743098|FG003|24-Week Double-Blind Period|Not Treated|0|||
38053187|NCT04057573|69743095|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
38053188|NCT04057573|69743096|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
38053189|NCT04057573|69743097|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
38053190|NCT04057573|69743098|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
38053191|NCT04057573|69743095|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
38053192|NCT04057573|69743096|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
38053193|NCT04057573|69743097|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
37862085|NCT01134705|69545845|FG001|Overall Study|Withdrawal by Subject|6|||
37862086|NCT01134705|69545844|FG000|Overall Study|Pregnancy|1|||
38053194|NCT04057573|69743098|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
38053195|NCT04057573|69743095|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
38053196|NCT04057573|69743096|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
38053197|NCT04057573|69743097|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
38053198|NCT04057573|69743098|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
38053199|NCT04057573|69743095|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
38053200|NCT04057573|69743096|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
38053201|NCT04057573|69743097|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
38053202|NCT04057573|69743098|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
38053203|NCT04057573|69743095|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
38053204|NCT04057573|69743096|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
38053205|NCT04057573|69743097|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
38053206|NCT04057573|69743098|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
38053207|NCT04054765|69743111|FG000|Baseline|Withdrawal by Subject|5|||
38053208|NCT04054765|69743112|FG001|Baseline|Withdrawal by Subject|3|||
38053209|NCT04054765|69743111|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
38053210|NCT04054765|69743112|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
38053211|NCT04054765|69743111|FG000|3-month Follow up|Withdrawal by Subject|0|||
38053212|NCT04054765|69743112|FG001|3-month Follow up|Withdrawal by Subject|3|||
38053213|NCT04054765|69743111|FG000|6-month Follow up|Lost to Follow-up|32|||
38053214|NCT04054765|69743112|FG001|6-month Follow up|Lost to Follow-up|32|||
38053215|NCT04179721|69743120|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
38053216|NCT04179721|69743121|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
38053217|NCT04179721|69743120|FG000|Overall Study|Lost to Follow-up|0|||
38053218|NCT04179721|69743121|FG001|Overall Study|Lost to Follow-up|1|||
38053219|NCT03286218|69743127|FG000|Qualification Phase Period 1|Adverse Event|1|||
38053220|NCT03286218|69743128|FG001|Qualification Phase Period 1|Adverse Event|0|||
38053221|NCT03286218|69743129|FG002|Qualification Phase Period 1|Adverse Event|0|||
38053222|NCT03286218|69743130|FG003|Qualification Phase Period 1|Adverse Event|0|||
38053223|NCT03286218|69743131|FG004|Qualification Phase Period 1|Adverse Event|0|||
38053224|NCT03286218|69743132|FG005|Qualification Phase Period 1|Adverse Event|0|||
38053225|NCT03286218|69743133|FG006|Qualification Phase Period 1|Adverse Event|0|||
38053226|NCT03286218|69743134|FG007|Qualification Phase Period 1|Adverse Event|0|||
38053227|NCT03286218|69743135|FG008|Qualification Phase Period 1|Adverse Event|0|||
38053228|NCT03286218|69743136|FG009|Qualification Phase Period 1|Adverse Event|0|||
38053229|NCT03286218|69743137|FG010|Qualification Phase Period 1|Adverse Event|0|||
38053230|NCT03286218|69743138|FG011|Qualification Phase Period 1|Adverse Event|0|||
38053231|NCT03286218|69743127|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
38053232|NCT03286218|69743128|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
38053233|NCT03286218|69743129|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
38053234|NCT03286218|69743130|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
38053235|NCT03286218|69743131|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
38053236|NCT03286218|69743132|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
38053237|NCT03286218|69743133|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
38053238|NCT03286218|69743134|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
37862087|NCT01134705|69545845|FG001|Overall Study|Pregnancy|0|||
37964302|NCT03889886|69651477|FG000|Overall Study|Other|0|||
37964303|NCT03889886|69651478|FG001|Overall Study|Other|1|||
37964304|NCT03889886|69651479|FG002|Overall Study|Other|0|||
37964305|NCT03889886|69651480|FG003|Overall Study|Other|1|||
37964306|NCT03889886|69651477|FG000|Overall Study|Withdrawal by Subject|0|||
37964307|NCT03889886|69651478|FG001|Overall Study|Withdrawal by Subject|0|||
37964308|NCT03889886|69651479|FG002|Overall Study|Withdrawal by Subject|1|||
37964309|NCT03889886|69651480|FG003|Overall Study|Withdrawal by Subject|0|||
37964310|NCT03889886|69651477|FG000|Overall Study|Adverse Event|0|||
37964311|NCT03889886|69651478|FG001|Overall Study|Adverse Event|0|||
37964312|NCT03889886|69651479|FG002|Overall Study|Adverse Event|0|||
37964313|NCT03889886|69651480|FG003|Overall Study|Adverse Event|6|||
37964314|NCT03888482|69651492|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
37964315|NCT03888482|69651493|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
37964316|NCT03888482|69651492|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
37964317|NCT03888482|69651493|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
37964318|NCT00667355|69651501|FG000|Overall Study|Adverse Event|5|||
37964319|NCT00667355|69651501|FG000|Overall Study|Lost to Follow-up|1|||
37964320|NCT00667355|69651501|FG000|Overall Study|Other reason was not specified|5|||
37964321|NCT00532844|69651507|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
37964322|NCT00532844|69651508|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
37964323|NCT00532844|69651507|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
37964324|NCT00532844|69651508|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
37964325|NCT00532844|69651507|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
38053239|NCT03286218|69743135|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
38053240|NCT03286218|69743136|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
38053241|NCT03286218|69743137|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
38053242|NCT03286218|69743138|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
38053243|NCT03286218|69743127|FG000|Qualification Phase Period 2|Adverse Event|0|||
38053244|NCT03286218|69743128|FG001|Qualification Phase Period 2|Adverse Event|1|||
38053245|NCT03286218|69743129|FG002|Qualification Phase Period 2|Adverse Event|0|||
38053246|NCT03286218|69743130|FG003|Qualification Phase Period 2|Adverse Event|0|||
38053247|NCT03286218|69743131|FG004|Qualification Phase Period 2|Adverse Event|0|||
38053248|NCT03286218|69743132|FG005|Qualification Phase Period 2|Adverse Event|0|||
38053249|NCT03286218|69743133|FG006|Qualification Phase Period 2|Adverse Event|0|||
38053250|NCT03286218|69743134|FG007|Qualification Phase Period 2|Adverse Event|0|||
38053251|NCT03286218|69743135|FG008|Qualification Phase Period 2|Adverse Event|0|||
38053252|NCT03286218|69743136|FG009|Qualification Phase Period 2|Adverse Event|0|||
38053253|NCT03286218|69743137|FG010|Qualification Phase Period 2|Adverse Event|0|||
38053254|NCT03286218|69743138|FG011|Qualification Phase Period 2|Adverse Event|0|||
38053255|NCT03286218|69743127|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
38053256|NCT03286218|69743128|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
38053257|NCT03286218|69743129|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
38053258|NCT03286218|69743130|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
38053259|NCT03286218|69743131|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
38053260|NCT03286218|69743132|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
38053261|NCT03286218|69743133|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
38053262|NCT03286218|69743134|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
38053263|NCT03286218|69743135|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
38053264|NCT03286218|69743136|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
38053265|NCT03286218|69743137|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
38053266|NCT03286218|69743138|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
38053267|NCT03286218|69743127|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
38053268|NCT03286218|69743128|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
38053269|NCT03286218|69743129|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
38053270|NCT03286218|69743130|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
38053271|NCT03286218|69743131|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
38053272|NCT03286218|69743132|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
38053273|NCT03286218|69743133|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
38053274|NCT03286218|69743134|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
38053275|NCT03286218|69743135|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
38053276|NCT03286218|69743136|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
38053277|NCT03286218|69743137|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
38053278|NCT03286218|69743138|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
38053279|NCT03286218|69743127|FG000|Qualification Phase Period 2|Protocol Violation|2|||
38053280|NCT03286218|69743128|FG001|Qualification Phase Period 2|Protocol Violation|0|||
38053281|NCT03286218|69743129|FG002|Qualification Phase Period 2|Protocol Violation|0|||
38053282|NCT03286218|69743130|FG003|Qualification Phase Period 2|Protocol Violation|0|||
38053283|NCT03286218|69743131|FG004|Qualification Phase Period 2|Protocol Violation|0|||
38053284|NCT03286218|69743132|FG005|Qualification Phase Period 2|Protocol Violation|0|||
38053285|NCT03286218|69743133|FG006|Qualification Phase Period 2|Protocol Violation|0|||
38053286|NCT03286218|69743134|FG007|Qualification Phase Period 2|Protocol Violation|0|||
38053287|NCT03286218|69743135|FG008|Qualification Phase Period 2|Protocol Violation|0|||
38053288|NCT03286218|69743136|FG009|Qualification Phase Period 2|Protocol Violation|0|||
38053289|NCT03286218|69743137|FG010|Qualification Phase Period 2|Protocol Violation|0|||
38053290|NCT03286218|69743138|FG011|Qualification Phase Period 2|Protocol Violation|0|||
38053291|NCT03286218|69743127|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
38053292|NCT03286218|69743128|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
38053293|NCT03286218|69743129|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
38053294|NCT03286218|69743130|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
38053295|NCT03286218|69743131|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
38053296|NCT03286218|69743132|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
38053297|NCT03286218|69743133|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
38053298|NCT03286218|69743134|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
38053299|NCT03286218|69743135|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
38053300|NCT03286218|69743136|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
38053301|NCT03286218|69743137|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
38053302|NCT03286218|69743138|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
38053303|NCT03286218|69743127|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
38053304|NCT03286218|69743128|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
38053305|NCT03286218|69743129|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
38053306|NCT03286218|69743130|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
38053307|NCT03286218|69743131|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
38053308|NCT03286218|69743132|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
38053309|NCT03286218|69743133|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
38053310|NCT03286218|69743134|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
38053311|NCT03286218|69743135|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
38053312|NCT03286218|69743136|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
38053313|NCT03286218|69743137|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
38053314|NCT03286218|69743138|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
38053315|NCT03286218|69743127|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
38053316|NCT03286218|69743128|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
38053317|NCT03286218|69743129|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
38053318|NCT03286218|69743130|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
38053319|NCT03286218|69743131|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
38053320|NCT03286218|69743132|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
38053321|NCT03286218|69743133|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
38053322|NCT03286218|69743134|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
38053323|NCT03286218|69743135|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
38053324|NCT03286218|69743136|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
38053325|NCT03286218|69743137|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
38053326|NCT03286218|69743138|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
38053327|NCT03224325|69743172|FG000|Overall Study|Adverse Event|1|||
38053328|NCT03224325|69743173|FG001|Overall Study|Adverse Event|0|||
38053329|NCT03224325|69743174|FG002|Overall Study|Adverse Event|0|||
38053330|NCT03224325|69743175|FG003|Overall Study|Adverse Event|0|||
38053331|NCT03224325|69743176|FG004|Overall Study|Adverse Event|0|||
38053332|NCT03224325|69743177|FG005|Overall Study|Adverse Event|0|||
38053333|NCT03224325|69743178|FG006|Overall Study|Adverse Event|1|||
38053334|NCT03224325|69743172|FG000|Overall Study|Withdrawal by Subject|0|||
38053335|NCT03224325|69743173|FG001|Overall Study|Withdrawal by Subject|0|||
38053336|NCT03224325|69743174|FG002|Overall Study|Withdrawal by Subject|0|||
38053337|NCT03224325|69743175|FG003|Overall Study|Withdrawal by Subject|1|||
38053338|NCT03224325|69743176|FG004|Overall Study|Withdrawal by Subject|0|||
38053339|NCT03224325|69743177|FG005|Overall Study|Withdrawal by Subject|0|||
38053340|NCT03224325|69743178|FG006|Overall Study|Withdrawal by Subject|0|||
38053341|NCT04016779|69743202|FG000|Overall Study|Adverse Event|9|||
38053342|NCT04016779|69743203|FG001|Overall Study|Adverse Event|17|||
38053343|NCT04016779|69743202|FG000|Overall Study|Lack of Efficacy|4|||
38053344|NCT04016779|69743203|FG001|Overall Study|Lack of Efficacy|1|||
38053345|NCT04016779|69743202|FG000|Overall Study|Lost to Follow-up|5|||
38053346|NCT04016779|69743203|FG001|Overall Study|Lost to Follow-up|14|||
38053347|NCT04016779|69743202|FG000|Overall Study|Physician Decision|1|||
38053348|NCT04016779|69743203|FG001|Overall Study|Physician Decision|3|||
38053349|NCT04016779|69743202|FG000|Overall Study|Withdrawal by Subject|6|||
38053350|NCT04016779|69743203|FG001|Overall Study|Withdrawal by Subject|8|||
38053351|NCT04016779|69743202|FG000|Overall Study|Non-compliance with Study Drug|2|||
38053352|NCT04016779|69743203|FG001|Overall Study|Non-compliance with Study Drug|3|||
38053353|NCT04016779|69743202|FG000|Overall Study|Other, Multiple categories|17|||
37964326|NCT00532844|69651508|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
37964327|NCT00532844|69651507|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
37964328|NCT00532844|69651508|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
37964329|NCT00532844|69651507|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
37964330|NCT00532844|69651508|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
37964331|NCT00666263|69651536|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
37964332|NCT00666263|69651537|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
37964333|NCT00666263|69651536|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
37964334|NCT00666263|69651537|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
37964335|NCT00666263|69651536|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
37964336|NCT00666263|69651537|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
37964337|NCT00667277|69651582|FG000|Overall Study|Withdrawal by Subject|2|||
38053354|NCT04016779|69743203|FG001|Overall Study|Other, Multiple categories|17|||
38053355|NCT02857426|69743213|FG000|Overall Study|Disease progression|34|||
38053356|NCT02857426|69743214|FG001|Overall Study|Disease progression|13|||
38053357|NCT02857426|69743213|FG000|Overall Study|Study drug toxicity|4|||
38053358|NCT02857426|69743214|FG001|Overall Study|Study drug toxicity|1|||
38053359|NCT02857426|69743213|FG000|Overall Study|Death|1|||
38053360|NCT02857426|69743214|FG001|Overall Study|Death|0|||
38053361|NCT02857426|69743213|FG000|Overall Study|Adverse event unrelated to study drug|6|||
38053362|NCT02857426|69743214|FG001|Overall Study|Adverse event unrelated to study drug|2|||
38053363|NCT02857426|69743213|FG000|Overall Study|Participant withdrew consent|1|||
38053364|NCT02857426|69743214|FG001|Overall Study|Participant withdrew consent|1|||
38053365|NCT02857426|69743213|FG000|Overall Study|Maximum clinical benefit|1|||
38053366|NCT02857426|69743214|FG001|Overall Study|Maximum clinical benefit|0|||
38053367|NCT02857426|69743213|FG000|Overall Study|Completed treatment|0|||
38053368|NCT02857426|69743214|FG001|Overall Study|Completed treatment|2|||
38053369|NCT01127256|69743222|FG000|Overall Study|Adverse Event|13|||
38053370|NCT01127256|69743223|FG001|Overall Study|Adverse Event|13|||
38053371|NCT01127256|69743222|FG000|Overall Study|Lack of Efficacy|4|||
38053372|NCT01127256|69743223|FG001|Overall Study|Lack of Efficacy|0|||
38053373|NCT01127256|69743222|FG000|Overall Study|Lost to Follow-up|16|||
38053374|NCT01127256|69743223|FG001|Overall Study|Lost to Follow-up|17|||
38053375|NCT01127256|69743222|FG000|Overall Study|Withdrawal by Subject|5|||
38053376|NCT01127256|69743223|FG001|Overall Study|Withdrawal by Subject|9|||
38053377|NCT01127256|69743222|FG000|Overall Study|Protocol Violation|1|||
38053378|NCT01127256|69743223|FG001|Overall Study|Protocol Violation|0|||
37964338|NCT00534638|69651588|FG000|Overall Study|Withdrawal by Subject|3|||
37964339|NCT00534638|69651589|FG001|Overall Study|Withdrawal by Subject|4|||
37964340|NCT00534638|69651588|FG000|Overall Study|Migrated/moved from study area|13|||
37964341|NCT00534638|69651589|FG001|Overall Study|Migrated/moved from study area|11|||
37964342|NCT00534638|69651588|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
37964343|NCT00534638|69651589|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
37964344|NCT00534638|69651588|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
37964345|NCT00534638|69651589|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
38053379|NCT04016311|69743231|FG000|Overall Study|Withdrawal by Subject|1|||
38053380|NCT04016311|69743232|FG001|Overall Study|Withdrawal by Subject|0|||
38053381|NCT04052425|69743242|FG000|24-Week Double-blind Period|Adverse Event|0|||
38053382|NCT04052425|69743243|FG001|24-Week Double-blind Period|Adverse Event|1|||
38053383|NCT04052425|69743244|FG002|24-Week Double-blind Period|Adverse Event|0|||
38053384|NCT04052425|69743245|FG003|24-Week Double-blind Period|Adverse Event|0|||
38053385|NCT04052425|69743242|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
38053386|NCT04052425|69743243|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
38053387|NCT04052425|69743244|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
38053388|NCT04052425|69743245|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
38053389|NCT04052425|69743242|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
38053390|NCT04052425|69743243|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
38053391|NCT04052425|69743244|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
38053392|NCT04052425|69743245|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
38053393|NCT04052425|69743242|FG000|24-Week Double-blind Period|Physician Decision|1|||
38053394|NCT04052425|69743243|FG001|24-Week Double-blind Period|Physician Decision|0|||
38053395|NCT04052425|69743244|FG002|24-Week Double-blind Period|Physician Decision|0|||
38053396|NCT04052425|69743245|FG003|24-Week Double-blind Period|Physician Decision|0|||
38053397|NCT04052425|69743242|FG000|24-Week Double-blind Period|Protocol Violation|1|||
38053398|NCT04052425|69743243|FG001|24-Week Double-blind Period|Protocol Violation|0|||
38053399|NCT04052425|69743244|FG002|24-Week Double-blind Period|Protocol Violation|0|||
38053400|NCT04052425|69743245|FG003|24-Week Double-blind Period|Protocol Violation|0|||
38053401|NCT04052425|69743242|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
38053402|NCT04052425|69743243|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
38053403|NCT04052425|69743244|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
37862088|NCT01134705|69545844|FG000|Overall Study|Lost to Follow-up|5|||
37862089|NCT01134705|69545845|FG001|Overall Study|Lost to Follow-up|2|||
37964346|NCT00534638|69651588|FG000|Overall Study|Other|1685|||
37964347|NCT00534638|69651589|FG001|Overall Study|Other|902|||
37964348|NCT00662129|69651600|FG000|Overall Study|Protocol Violation|1|||
37964349|NCT00662129|69651600|FG000|Overall Study|Cancel prior to beginning treatment|1|||
37964350|NCT00662129|69651600|FG000|Overall Study|Ineligible|1|||
37964351|NCT00664859|69651607|FG000|Overall Study|Adverse Event|2|||
37964352|NCT00664859|69651608|FG001|Overall Study|Adverse Event|1|||
37964353|NCT00664859|69651609|FG002|Overall Study|Adverse Event|3|||
37964354|NCT00664859|69651607|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
37964355|NCT00664859|69651608|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
37964356|NCT00664859|69651609|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
37964357|NCT00664859|69651607|FG000|Overall Study|Noncompliance with protocol|1|||
37964358|NCT00664859|69651608|FG001|Overall Study|Noncompliance with protocol|0|||
37964359|NCT00664859|69651609|FG002|Overall Study|Noncompliance with protocol|4|||
37964360|NCT00664859|69651607|FG000|Overall Study|Laboratory abnormality|2|||
37964361|NCT00664859|69651608|FG001|Overall Study|Laboratory abnormality|1|||
37964362|NCT00664859|69651609|FG002|Overall Study|Laboratory abnormality|4|||
37964363|NCT00664859|69651607|FG000|Overall Study|Withdrawal by Subject|4|||
37964364|NCT00664859|69651608|FG001|Overall Study|Withdrawal by Subject|1|||
38053404|NCT04052425|69743245|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
38053405|NCT04052425|69743242|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
38053406|NCT04052425|69743243|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
38053407|NCT04052425|69743244|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
38053408|NCT04052425|69743245|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
38053409|NCT04052425|69743242|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
38053410|NCT04052425|69743243|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
38053411|NCT04052425|69743244|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
38053412|NCT04052425|69743245|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
38053413|NCT04052425|69743242|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
38053414|NCT04052425|69743243|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
38053415|NCT04052425|69743244|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
38053416|NCT04052425|69743245|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
38053417|NCT04052425|69743242|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
38053418|NCT04052425|69743243|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
38053419|NCT04052425|69743244|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
38053420|NCT04052425|69743245|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
38053421|NCT04052425|69743242|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
38053422|NCT04052425|69743243|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
38053423|NCT04052425|69743244|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
38053424|NCT04052425|69743245|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
38053425|NCT04052425|69743242|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
38053426|NCT04052425|69743243|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
38053427|NCT04052425|69743244|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
38053428|NCT04052425|69743245|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
38053429|NCT04052425|69743242|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
38053430|NCT04052425|69743243|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
38053431|NCT04052425|69743244|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
38053432|NCT04052425|69743245|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
38053433|NCT04052425|69743242|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
38053434|NCT04052425|69743243|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
38053435|NCT04052425|69743244|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
38053436|NCT04052425|69743245|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
38053437|NCT03235089|69743255|FG000|Overall Study|Lost to Follow-up|1|||
38053438|NCT03235089|69743256|FG001|Overall Study|Lost to Follow-up|1|||
38053439|NCT03235089|69743255|FG000|Overall Study|Physician Decision|2|||
38053440|NCT03235089|69743256|FG001|Overall Study|Physician Decision|2|||
38053441|NCT04013191|69743265|FG000|Overall Study|Adverse Event|1|||
38053442|NCT04013191|69743266|FG001|Overall Study|Adverse Event|0|||
38053443|NCT03285594|69743279|FG000|Overall Study|At the Participant's Own Request|10|||
38053444|NCT03285594|69743280|FG001|Overall Study|At the Participant's Own Request|5|||
38053445|NCT03285594|69743281|FG002|Overall Study|At the Participant's Own Request|21|||
38053446|NCT03285594|69743279|FG000|Overall Study|Adverse Event|2|||
38053447|NCT03285594|69743280|FG001|Overall Study|Adverse Event|2|||
38053448|NCT03285594|69743281|FG002|Overall Study|Adverse Event|6|||
38053449|NCT03285594|69743279|FG000|Overall Study|Poor Compliance to Protocol|0|||
38053450|NCT03285594|69743280|FG001|Overall Study|Poor Compliance to Protocol|0|||
38053451|NCT03285594|69743281|FG002|Overall Study|Poor Compliance to Protocol|1|||
38053452|NCT03285594|69743279|FG000|Overall Study|Lost to Follow-up|0|||
38053453|NCT03285594|69743280|FG001|Overall Study|Lost to Follow-up|0|||
38053454|NCT03285594|69743281|FG002|Overall Study|Lost to Follow-up|1|||
38053455|NCT03285594|69743279|FG000|Overall Study|Reason Not Specified|3|||
38053456|NCT03285594|69743280|FG001|Overall Study|Reason Not Specified|4|||
38053457|NCT03285594|69743281|FG002|Overall Study|Reason Not Specified|8|||
38053458|NCT03234465|69743292|FG000|Overall Study|Adverse Event|4|||
38053459|NCT03234465|69743293|FG001|Overall Study|Adverse Event|2|||
38053460|NCT03234465|69743292|FG000|Overall Study|Death|0|||
38053461|NCT03234465|69743293|FG001|Overall Study|Death|1|||
38053462|NCT03234465|69743292|FG000|Overall Study|Lost to Follow-up|1|||
38053463|NCT03234465|69743293|FG001|Overall Study|Lost to Follow-up|1|||
38053464|NCT03234465|69743292|FG000|Overall Study|Withdrawal by Subject|12|||
38053465|NCT03234465|69743293|FG001|Overall Study|Withdrawal by Subject|27|||
38053466|NCT03234465|69743292|FG000|Overall Study|Symptomatic deterioration|0|||
38053467|NCT03234465|69743293|FG001|Overall Study|Symptomatic deterioration|1|||
38053468|NCT03234465|69743292|FG000|Overall Study|Non-compliance|2|||
38053469|NCT03234465|69743293|FG001|Overall Study|Non-compliance|0|||
38053470|NCT03234465|69743292|FG000|Overall Study|Other|14|||
38053471|NCT03234465|69743293|FG001|Overall Study|Other|8|||
38053472|NCT03290131|69743302|FG000|Overall Study|Adverse Event|22|||
38053473|NCT03290131|69743303|FG001|Overall Study|Adverse Event|57|||
38053474|NCT03290131|69743304|FG002|Overall Study|Adverse Event|11|||
38053475|NCT03290131|69743302|FG000|Overall Study|Withdrawal by Subject|18|||
38053476|NCT03290131|69743303|FG001|Overall Study|Withdrawal by Subject|13|||
38053477|NCT03290131|69743304|FG002|Overall Study|Withdrawal by Subject|8|||
38053478|NCT03290131|69743302|FG000|Overall Study|MS Relapse|2|||
38053479|NCT03290131|69743303|FG001|Overall Study|MS Relapse|1|||
38053480|NCT03290131|69743304|FG002|Overall Study|MS Relapse|0|||
38053481|NCT03290131|69743302|FG000|Overall Study|Unknown reason|0|||
38053482|NCT03290131|69743303|FG001|Overall Study|Unknown reason|1|||
38053483|NCT03290131|69743304|FG002|Overall Study|Unknown reason|0|||
38053484|NCT04050865|69743315|FG000|Overall Study|Adverse Event|1|||
38053485|NCT04050865|69743316|FG001|Overall Study|Adverse Event|0|||
38053486|NCT04050865|69743315|FG000|Overall Study|no insert|1|||
38053487|NCT04050865|69743316|FG001|Overall Study|no insert|0|||
38053488|NCT04050865|69743315|FG000|Overall Study|Only 1 insert|2|||
38053489|NCT04050865|69743316|FG001|Overall Study|Only 1 insert|3|||
38053490|NCT04050865|69743315|FG000|Overall Study|Physician Decision|0|||
38053491|NCT04050865|69743316|FG001|Overall Study|Physician Decision|1|||
38053492|NCT04050865|69743315|FG000|Overall Study|Withdrawal by Subject|0|||
38053493|NCT04050865|69743316|FG001|Overall Study|Withdrawal by Subject|1|||
38053494|NCT03283566|69743324|FG000|Overall Study|Lost to Follow-up|1|||
38053495|NCT03283566|69743325|FG001|Overall Study|Lost to Follow-up|2|||
38053496|NCT03210519|69743333|FG000|Overall Study|Adverse Event|2|||
38053497|NCT03210519|69743334|FG001|Overall Study|Adverse Event|0|||
38053498|NCT04048681|69743340|FG000|Overall Study|family emergency|0|||
38053499|NCT04048681|69743341|FG001|Overall Study|family emergency|0|||
38053500|NCT04048681|69743342|FG002|Overall Study|family emergency|0|||
38053501|NCT04048681|69743343|FG003|Overall Study|family emergency|1|||
38053502|NCT04048681|69743344|FG004|Overall Study|family emergency|0|||
38053503|NCT04007107|69743352|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
38053504|NCT04007107|69743353|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
38053505|NCT04007107|69743354|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
38053506|NCT04007107|69743355|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
38053507|NCT04046341|69743360|FG000|Overall Study|Lost to Follow-up|2|||
38053508|NCT04046341|69743360|FG000|Overall Study|Withdrawal by Subject|1|||
38053509|NCT03233529|69743364|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
38053510|NCT03233529|69743364|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
38053511|NCT04006171|69743374|FG000|Overall Study|Withdrawal by Subject|8|||
38053512|NCT04006171|69743375|FG001|Overall Study|Withdrawal by Subject|7|||
38053513|NCT04006171|69743374|FG000|Overall Study|missing serum samples|2|||
38053514|NCT04006171|69743375|FG001|Overall Study|missing serum samples|2|||
38053515|NCT04006171|69743374|FG000|Overall Study|insufficient sample volume|2|||
38053516|NCT04006171|69743375|FG001|Overall Study|insufficient sample volume|3|||
38053517|NCT04043143|69743388|FG000|Overall Study|Lost to Follow-up|5|||
38053518|NCT04043143|69743389|FG001|Overall Study|Lost to Follow-up|5|||
38053519|NCT04043143|69743388|FG000|Overall Study|screen failure|1|||
38053520|NCT04043143|69743389|FG001|Overall Study|screen failure|0|||
38053521|NCT03283098|69743397|FG000|Overall Study|Withdrawal by Subject|0|||
38053522|NCT03283098|69743398|FG001|Overall Study|Withdrawal by Subject|1|||
38053523|NCT03655951|69743406|FG000|Overall Study|Lost to Follow-up|39|||
38053524|NCT03655951|69743407|FG001|Overall Study|Lost to Follow-up|20|||
38053525|NCT03655951|69743406|FG000|Overall Study|Withdrawal by Subject|0|||
38053526|NCT03655951|69743407|FG001|Overall Study|Withdrawal by Subject|1|||
38053527|NCT02527798|69743419|FG000|Overall Study|Physician Decision|1|||
38053528|NCT02527798|69743420|FG001|Overall Study|Physician Decision|0|||
38053529|NCT02527798|69743421|FG002|Overall Study|Physician Decision|1|||
38053530|NCT02527798|69743422|FG003|Overall Study|Physician Decision|1|||
38053531|NCT02527798|69743423|FG004|Overall Study|Physician Decision|0|||
38053532|NCT02527798|69743424|FG005|Overall Study|Physician Decision|0|||
38053533|NCT02527798|69743419|FG000|Overall Study|Death|0|||
38053534|NCT02527798|69743420|FG001|Overall Study|Death|0|||
38053535|NCT02527798|69743421|FG002|Overall Study|Death|1|||
38053536|NCT02527798|69743422|FG003|Overall Study|Death|0|||
38053537|NCT02527798|69743423|FG004|Overall Study|Death|0|||
38053538|NCT02527798|69743424|FG005|Overall Study|Death|0|||
38053539|NCT02527798|69743419|FG000|Overall Study|Withdrawal by Subject|0|||
38053540|NCT02527798|69743420|FG001|Overall Study|Withdrawal by Subject|1|||
38053541|NCT02527798|69743421|FG002|Overall Study|Withdrawal by Subject|2|||
38053542|NCT02527798|69743422|FG003|Overall Study|Withdrawal by Subject|0|||
38053543|NCT02527798|69743423|FG004|Overall Study|Withdrawal by Subject|0|||
38053544|NCT02527798|69743424|FG005|Overall Study|Withdrawal by Subject|0|||
38053545|NCT02527798|69743419|FG000|Overall Study|Reason undisclosed|1|||
38053546|NCT02527798|69743420|FG001|Overall Study|Reason undisclosed|0|||
38053547|NCT02527798|69743421|FG002|Overall Study|Reason undisclosed|1|||
38053548|NCT02527798|69743422|FG003|Overall Study|Reason undisclosed|0|||
38053549|NCT02527798|69743423|FG004|Overall Study|Reason undisclosed|0|||
38053550|NCT02527798|69743424|FG005|Overall Study|Reason undisclosed|0|||
38053551|NCT02527798|69743419|FG000|Overall Study|Did not receive intervention|1|||
38053552|NCT02527798|69743420|FG001|Overall Study|Did not receive intervention|1|||
38053553|NCT02527798|69743421|FG002|Overall Study|Did not receive intervention|0|||
38053554|NCT02527798|69743422|FG003|Overall Study|Did not receive intervention|0|||
38053555|NCT02527798|69743423|FG004|Overall Study|Did not receive intervention|0|||
38053556|NCT02527798|69743424|FG005|Overall Study|Did not receive intervention|0|||
38053557|NCT03188991|69743455|FG000|Overall Study|Withdrawal by Subject|0|||
38053558|NCT03188991|69743456|FG001|Overall Study|Withdrawal by Subject|0|||
38053559|NCT03188991|69743457|FG002|Overall Study|Withdrawal by Subject|0|||
38053560|NCT03188991|69743458|FG003|Overall Study|Withdrawal by Subject|1|||
38053561|NCT03857542|69743470|FG000|Overall Study|Adverse Event|1|||
38053562|NCT03857542|69743471|FG001|Overall Study|Adverse Event|3|||
38053563|NCT03857542|69743470|FG000|Overall Study|Withdrawal by Subject|2|||
38053564|NCT03857542|69743471|FG001|Overall Study|Withdrawal by Subject|1|||
38053565|NCT03857542|69743470|FG000|Overall Study|Lost to Follow-up|2|||
38053566|NCT03857542|69743471|FG001|Overall Study|Lost to Follow-up|1|||
38053567|NCT03857542|69743470|FG000|Overall Study|Reason not Specified|1|||
38053568|NCT03857542|69743471|FG001|Overall Study|Reason not Specified|0|||
38053569|NCT03209973|69743478|FG000|Overall Study|Withdrawal by Subject|7|||
38053570|NCT03209973|69743478|FG000|Overall Study|Lost to Follow-up|2|||
38053571|NCT03209973|69743478|FG000|Overall Study|Death|8|||
38053572|NCT03209973|69743478|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
38053573|NCT03209973|69743478|FG000|Overall Study|Sponsor Decision|18|||
38053574|NCT03209973|69743478|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
38053575|NCT03209973|69743478|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
38053576|NCT03751631|69743484|FG000|Overall Study|Withdrawal by Subject|0|||
38053577|NCT03751631|69743485|FG001|Overall Study|Withdrawal by Subject|0|||
38053578|NCT03751631|69743486|FG002|Overall Study|Withdrawal by Subject|1|||
38053579|NCT03751631|69743487|FG003|Overall Study|Withdrawal by Subject|1|||
38053580|NCT03751631|69743488|FG004|Overall Study|Withdrawal by Subject|0|||
38053581|NCT03751631|69743489|FG005|Overall Study|Withdrawal by Subject|0|||
37964365|NCT00664859|69651609|FG002|Overall Study|Withdrawal by Subject|3|||
37964366|NCT00664859|69651607|FG000|Overall Study|Lost to Follow-up|2|||
37964367|NCT00664859|69651608|FG001|Overall Study|Lost to Follow-up|2|||
37964368|NCT00664859|69651609|FG002|Overall Study|Lost to Follow-up|1|||
37964369|NCT00664859|69651607|FG000|Overall Study|Other|0|||
37964370|NCT00664859|69651608|FG001|Overall Study|Other|1|||
37964371|NCT00664859|69651609|FG002|Overall Study|Other|2|||
37964372|NCT00570401|69651617|FG000|Overall Study|Adverse Event|2|||
37964373|NCT00532298|69651627|FG000|Overall Study|Adverse Event|1|||
37964374|NCT00532298|69651628|FG001|Overall Study|Adverse Event|0|||
37964375|NCT00532298|69651629|FG002|Overall Study|Adverse Event|0|||
37964376|NCT00532298|69651630|FG003|Overall Study|Adverse Event|0|||
37964377|NCT00532298|69651631|FG004|Overall Study|Adverse Event|1|||
38053582|NCT03688711|69743502|FG000|Overall Study|Withdrawal by Subject|0|||
38053583|NCT03688711|69743503|FG001|Overall Study|Withdrawal by Subject|1|||
38053584|NCT03188055|69743511|FG000|Overall Study|Unavailable for training|0|||
38053585|NCT03188055|69743512|FG001|Overall Study|Unavailable for training|0|||
38053586|NCT03188055|69743513|FG002|Overall Study|Unavailable for training|19|||
37862090|NCT01134705|69545844|FG000|Overall Study|Protocol Violation|1|||
37862091|NCT01134705|69545845|FG001|Overall Study|Protocol Violation|1|||
37862092|NCT01134705|69545844|FG000|Overall Study|Other|1|||
37862093|NCT01134705|69545845|FG001|Overall Study|Other|6|||
37862094|NCT00927823|69545851|FG000|Continuous Dosing Period|Death|0|||
37862095|NCT00927823|69545852|FG001|Continuous Dosing Period|Death|0|||
37862096|NCT00927823|69545853|FG002|Continuous Dosing Period|Death|6|||
37862097|NCT00927823|69545854|FG003|Continuous Dosing Period|Death|0|||
37862098|NCT00927823|69545851|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
37862099|NCT00927823|69545852|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
37862100|NCT00927823|69545853|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
37862101|NCT00927823|69545854|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
37862102|NCT00927823|69545851|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
37862103|NCT00927823|69545852|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
37862104|NCT00927823|69545853|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
37862105|NCT00927823|69545854|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
37862106|NCT00927823|69545851|FG000|Continuous Dosing Period|Other|1|||
37862107|NCT00927823|69545852|FG001|Continuous Dosing Period|Other|2|||
37862108|NCT00927823|69545853|FG002|Continuous Dosing Period|Other|9|||
37862109|NCT00927823|69545854|FG003|Continuous Dosing Period|Other|3|||
37862110|NCT01134627|69545873|FG000|Overall Study|Adverse Event|47|||
37862111|NCT01134627|69545874|FG001|Overall Study|Adverse Event|31|||
37862112|NCT01134627|69545873|FG000|Overall Study|Lost to Follow-up|1|||
37862113|NCT01134627|69545874|FG001|Overall Study|Lost to Follow-up|2|||
37862114|NCT01134627|69545873|FG000|Overall Study|Protocol Violation|3|||
37964378|NCT00532298|69651632|FG005|Overall Study|Adverse Event|1|||
37862115|NCT01134627|69545874|FG001|Overall Study|Protocol Violation|5|||
38053587|NCT03188055|69743514|FG003|Overall Study|Unavailable for training|0|||
38053588|NCT03188055|69743515|FG004|Overall Study|Unavailable for training|0|||
38053589|NCT03188055|69743516|FG005|Overall Study|Unavailable for training||||
38053590|NCT03188055|69743511|FG000|Overall Study|Lost to Follow-up|0|||
38053591|NCT03188055|69743512|FG001|Overall Study|Lost to Follow-up|18|||
38053592|NCT03188055|69743513|FG002|Overall Study|Lost to Follow-up|0|||
38053593|NCT03188055|69743514|FG003|Overall Study|Lost to Follow-up|11|||
38053594|NCT03188055|69743515|FG004|Overall Study|Lost to Follow-up|0|||
38053595|NCT03188055|69743516|FG005|Overall Study|Lost to Follow-up||||
38053596|NCT03188055|69743511|FG000|Overall Study|Withdrawal by Subject|0|||
38053597|NCT03188055|69743512|FG001|Overall Study|Withdrawal by Subject|1|||
38053598|NCT03188055|69743513|FG002|Overall Study|Withdrawal by Subject|0|||
38053599|NCT03188055|69743514|FG003|Overall Study|Withdrawal by Subject|1|||
38053600|NCT03188055|69743515|FG004|Overall Study|Withdrawal by Subject|0|||
38053601|NCT03188055|69743516|FG005|Overall Study|Withdrawal by Subject||||
38053602|NCT04035577|69743527|FG000|Overall Study|Lost to Follow-up|1|||
38053603|NCT04035577|69743527|FG000|Overall Study|Withdrawal by Subject|1|||
38053604|NCT03655717|69743555|FG000|Overall Study|Withdrawal by Subject|4|||
38053605|NCT03655717|69743556|FG001|Overall Study|Withdrawal by Subject|8|||
38053606|NCT03655717|69743557|FG002|Overall Study|Withdrawal by Subject|1|||
38053607|NCT03655717|69743558|FG003|Overall Study|Withdrawal by Subject|0|||
38053608|NCT03655717|69743559|FG004|Overall Study|Withdrawal by Subject|0|||
38053609|NCT03655717|69743560|FG005|Overall Study|Withdrawal by Subject|1|||
38053610|NCT03655717|69743561|FG006|Overall Study|Withdrawal by Subject|3|||
38053611|NCT03655717|69743562|FG007|Overall Study|Withdrawal by Subject|1|||
38053612|NCT03655717|69743563|FG008|Overall Study|Withdrawal by Subject|2|||
38053613|NCT03655717|69743564|FG009|Overall Study|Withdrawal by Subject|0|||
38053614|NCT03655717|69743565|FG010|Overall Study|Withdrawal by Subject|0|||
38053615|NCT03655717|69743566|FG011|Overall Study|Withdrawal by Subject|1|||
38053616|NCT03655717|69743567|FG012|Overall Study|Withdrawal by Subject|0|||
38053617|NCT03655717|69743568|FG013|Overall Study|Withdrawal by Subject|3|||
38053618|NCT03655717|69743569|FG014|Overall Study|Withdrawal by Subject|0|||
38053619|NCT03655717|69743570|FG015|Overall Study|Withdrawal by Subject|1|||
38053620|NCT03655717|69743571|FG016|Overall Study|Withdrawal by Subject|0|||
38053621|NCT03655717|69743572|FG017|Overall Study|Withdrawal by Subject|0|||
38053622|NCT03655717|69743573|FG018|Overall Study|Withdrawal by Subject|1|||
38053623|NCT03655717|69743574|FG019|Overall Study|Withdrawal by Subject|0|||
38053624|NCT03655717|69743575|FG020|Overall Study|Withdrawal by Subject|0|||
38053625|NCT03655717|69743576|FG021|Overall Study|Withdrawal by Subject|1|||
38053626|NCT03655717|69743577|FG022|Overall Study|Withdrawal by Subject|2|||
38053627|NCT03655717|69743578|FG023|Overall Study|Withdrawal by Subject|1|||
38053628|NCT03655717|69743579|FG024|Overall Study|Withdrawal by Subject|1|||
38053629|NCT03655717|69743580|FG025|Overall Study|Withdrawal by Subject|0|||
38053630|NCT03655717|69743555|FG000|Overall Study|Physician Decision|3|||
38053631|NCT03655717|69743556|FG001|Overall Study|Physician Decision|3|||
38053632|NCT03655717|69743557|FG002|Overall Study|Physician Decision|0|||
38053633|NCT03655717|69743558|FG003|Overall Study|Physician Decision|0|||
38053634|NCT03655717|69743559|FG004|Overall Study|Physician Decision|0|||
38053635|NCT03655717|69743560|FG005|Overall Study|Physician Decision|0|||
38053636|NCT03655717|69743561|FG006|Overall Study|Physician Decision|0|||
38053637|NCT03655717|69743562|FG007|Overall Study|Physician Decision|0|||
38053638|NCT03655717|69743563|FG008|Overall Study|Physician Decision|0|||
38053639|NCT03655717|69743564|FG009|Overall Study|Physician Decision|1|||
38053640|NCT03655717|69743565|FG010|Overall Study|Physician Decision|0|||
38053641|NCT03655717|69743566|FG011|Overall Study|Physician Decision|0|||
38053642|NCT03655717|69743567|FG012|Overall Study|Physician Decision|0|||
38053643|NCT03655717|69743568|FG013|Overall Study|Physician Decision|0|||
38053644|NCT03655717|69743569|FG014|Overall Study|Physician Decision|0|||
38053645|NCT03655717|69743570|FG015|Overall Study|Physician Decision|0|||
38053646|NCT03655717|69743571|FG016|Overall Study|Physician Decision|0|||
38053647|NCT03655717|69743572|FG017|Overall Study|Physician Decision|0|||
38053648|NCT03655717|69743573|FG018|Overall Study|Physician Decision|0|||
38053649|NCT03655717|69743574|FG019|Overall Study|Physician Decision|1|||
38053650|NCT03655717|69743575|FG020|Overall Study|Physician Decision|0|||
38053651|NCT03655717|69743576|FG021|Overall Study|Physician Decision|0|||
38053652|NCT03655717|69743577|FG022|Overall Study|Physician Decision|0|||
38053653|NCT03655717|69743578|FG023|Overall Study|Physician Decision|1|||
38053654|NCT03655717|69743579|FG024|Overall Study|Physician Decision|0|||
38053655|NCT03655717|69743580|FG025|Overall Study|Physician Decision|0|||
38053656|NCT03655717|69743555|FG000|Overall Study|Lost to Follow-up|3|||
37680361|NCT02383017|69155962|FG000|Overall Study|Found to be Hypogonadal|1|||
37680362|NCT02383017|69155963|FG001|Overall Study|Found to be Hypogonadal|0|||
37680363|NCT02382939|69155971|FG000|Overall Study|Adverse Event|1|||
37862116|NCT01134627|69545873|FG000|Overall Study|Lack of Efficacy|2|||
38053657|NCT03655717|69743556|FG001|Overall Study|Lost to Follow-up|1|||
38053658|NCT03655717|69743557|FG002|Overall Study|Lost to Follow-up|0|||
38053659|NCT03655717|69743558|FG003|Overall Study|Lost to Follow-up|1|||
38053660|NCT03655717|69743559|FG004|Overall Study|Lost to Follow-up|0|||
38053661|NCT03655717|69743560|FG005|Overall Study|Lost to Follow-up|1|||
38053662|NCT03655717|69743561|FG006|Overall Study|Lost to Follow-up|0|||
38053663|NCT03655717|69743562|FG007|Overall Study|Lost to Follow-up|0|||
38053664|NCT03655717|69743563|FG008|Overall Study|Lost to Follow-up|0|||
38053665|NCT03655717|69743564|FG009|Overall Study|Lost to Follow-up|0|||
38053666|NCT03655717|69743565|FG010|Overall Study|Lost to Follow-up|0|||
38053667|NCT03655717|69743566|FG011|Overall Study|Lost to Follow-up|1|||
38053668|NCT03655717|69743567|FG012|Overall Study|Lost to Follow-up|0|||
38053669|NCT03655717|69743568|FG013|Overall Study|Lost to Follow-up|0|||
38053670|NCT03655717|69743569|FG014|Overall Study|Lost to Follow-up|0|||
38053671|NCT03655717|69743570|FG015|Overall Study|Lost to Follow-up|0|||
38053672|NCT03655717|69743571|FG016|Overall Study|Lost to Follow-up|0|||
38053673|NCT03655717|69743572|FG017|Overall Study|Lost to Follow-up|0|||
38053674|NCT03655717|69743573|FG018|Overall Study|Lost to Follow-up|0|||
38053675|NCT03655717|69743574|FG019|Overall Study|Lost to Follow-up|0|||
38053676|NCT03655717|69743575|FG020|Overall Study|Lost to Follow-up|0|||
38053677|NCT03655717|69743576|FG021|Overall Study|Lost to Follow-up|0|||
38053678|NCT03655717|69743577|FG022|Overall Study|Lost to Follow-up|0|||
38053679|NCT03655717|69743578|FG023|Overall Study|Lost to Follow-up|0|||
38053680|NCT03655717|69743579|FG024|Overall Study|Lost to Follow-up|0|||
38053681|NCT03655717|69743580|FG025|Overall Study|Lost to Follow-up|0|||
38053682|NCT04032613|69743596|FG000|Overall Study|Did not complete post-program assessment|5|||
38053683|NCT04032613|69743597|FG001|Overall Study|Did not complete post-program assessment|2|||
38053684|NCT04000165|69743603|FG000|Overall Study|Physician Decision|1|||
38053685|NCT04000165|69743603|FG000|Overall Study|Withdrawal by Subject|1|||
38053686|NCT03187197|69743610|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
38053687|NCT03187197|69743611|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
38053688|NCT03187197|69743612|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
38053689|NCT03187197|69743610|FG000|Overall Study|Withdrawal by Subject|8|||
38053690|NCT03187197|69743611|FG001|Overall Study|Withdrawal by Subject|63|||
38053691|NCT03187197|69743612|FG002|Overall Study|Withdrawal by Subject|4|||
38053692|NCT03187197|69743610|FG000|Overall Study|Lost to Follow-up|1|||
38053693|NCT03187197|69743611|FG001|Overall Study|Lost to Follow-up|60|||
38053694|NCT03187197|69743612|FG002|Overall Study|Lost to Follow-up|7|||
38053695|NCT03187197|69743610|FG000|Overall Study|Adverse Event|6|||
38053696|NCT03187197|69743611|FG001|Overall Study|Adverse Event|29|||
38053697|NCT03187197|69743612|FG002|Overall Study|Adverse Event|0|||
38053698|NCT03187197|69743610|FG000|Overall Study|Death|0|||
38053699|NCT03187197|69743611|FG001|Overall Study|Death|11|||
38053700|NCT03187197|69743612|FG002|Overall Study|Death|0|||
38053701|NCT03187197|69743610|FG000|Overall Study|Administrative problem|1|||
38053702|NCT03187197|69743611|FG001|Overall Study|Administrative problem|1|||
38053703|NCT03187197|69743612|FG002|Overall Study|Administrative problem|0|||
38053704|NCT03187197|69743610|FG000|Overall Study|Reason not listed|2|||
38053705|NCT03187197|69743611|FG001|Overall Study|Reason not listed|54|||
38053706|NCT03187197|69743612|FG002|Overall Study|Reason not listed|1|||
38053707|NCT03187197|69743610|FG000|Overall Study|Missing|1|||
38053708|NCT03187197|69743611|FG001|Overall Study|Missing|32|||
38053709|NCT03187197|69743612|FG002|Overall Study|Missing|3|||
38053710|NCT03187197|69743610|FG000|Overall Study|Status missing|2|||
38053711|NCT03187197|69743611|FG001|Overall Study|Status missing|33|||
38053712|NCT03187197|69743612|FG002|Overall Study|Status missing|3|||
38053713|NCT03187197|69743610|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
38053714|NCT03187197|69743611|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
38053715|NCT03187197|69743612|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
38053716|NCT04000009|69743620|FG000|Overall Study|Adverse Event|13|||
38053717|NCT04000009|69743620|FG000|Overall Study|Lack of Efficacy|7|||
38053718|NCT04000009|69743620|FG000|Overall Study|Lost to Follow-up|8|||
38053719|NCT04000009|69743620|FG000|Overall Study|Noncompliance with study drug|4|||
38053720|NCT04000009|69743620|FG000|Overall Study|Physician Decision|1|||
38053721|NCT04000009|69743620|FG000|Overall Study|Use of prohibited medication|3|||
38053722|NCT04000009|69743620|FG000|Overall Study|Pregnancy|1|||
38053723|NCT04000009|69743620|FG000|Overall Study|Withdrawal by Subject|22|||
37680364|NCT02382939|69155972|FG001|Overall Study|Adverse Event|1|||
38053724|NCT04000009|69743620|FG000|Overall Study|Study terminated by sponsor|98|||
38053725|NCT04000009|69743620|FG000|Overall Study|Not further specified|8|||
38053726|NCT03282240|69743627|FG000|Overall Study|Adverse Event|2|||
38053727|NCT03282240|69743628|FG001|Overall Study|Adverse Event|2|||
38053728|NCT03282240|69743629|FG002|Overall Study|Adverse Event|0|||
38053729|NCT03282240|69743627|FG000|Overall Study|Lost to Follow-up|3|||
38053730|NCT03282240|69743628|FG001|Overall Study|Lost to Follow-up|0|||
38053731|NCT03282240|69743629|FG002|Overall Study|Lost to Follow-up|0|||
38053732|NCT03282240|69743627|FG000|Overall Study|Protocol Deviation|4|||
38053733|NCT03282240|69743628|FG001|Overall Study|Protocol Deviation|1|||
38053734|NCT03282240|69743629|FG002|Overall Study|Protocol Deviation|2|||
38053735|NCT03282240|69743627|FG000|Overall Study|Withdrawal by Subject|1|||
38053736|NCT03282240|69743628|FG001|Overall Study|Withdrawal by Subject|0|||
38053737|NCT03282240|69743629|FG002|Overall Study|Withdrawal by Subject|1|||
38053738|NCT03185949|69743642|FG000|ITT Analysis|Withdrawal by Subject|4|||
37964379|NCT00532298|69651627|FG000|Overall Study|Lost to Follow-up|1|||
37964380|NCT00532298|69651628|FG001|Overall Study|Lost to Follow-up|1|||
37964381|NCT00532298|69651629|FG002|Overall Study|Lost to Follow-up|1|||
37964382|NCT00532298|69651630|FG003|Overall Study|Lost to Follow-up|0|||
37964383|NCT00532298|69651631|FG004|Overall Study|Lost to Follow-up|0|||
37964384|NCT00532298|69651632|FG005|Overall Study|Lost to Follow-up|1|||
37964385|NCT00410410|69651652|FG000|Induction Period (IP)|Death|1|||
37964386|NCT00410410|69651653|FG001|Induction Period (IP)|Death|0|||
37964387|NCT00410410|69651654|FG002|Induction Period (IP)|Death|0|||
37964388|NCT00410410|69651655|FG003|Induction Period (IP)|Death|0|||
37964389|NCT00410410|69651656|FG004|Induction Period (IP)|Death|0|||
37964390|NCT00410410|69651657|FG005|Induction Period (IP)|Death|0|||
37964391|NCT00410410|69651658|FG006|Induction Period (IP)|Death|0|||
37964392|NCT00410410|69651659|FG007|Induction Period (IP)|Death|0|||
37964393|NCT00410410|69651660|FG008|Induction Period (IP)|Death|0|||
37964394|NCT00410410|69651652|FG000|Induction Period (IP)|Adverse Event|3|||
37964395|NCT00410410|69651653|FG001|Induction Period (IP)|Adverse Event|4|||
37964396|NCT00410410|69651654|FG002|Induction Period (IP)|Adverse Event|2|||
37964397|NCT00410410|69651655|FG003|Induction Period (IP)|Adverse Event|4|||
37964398|NCT00410410|69651656|FG004|Induction Period (IP)|Adverse Event|1|||
37964399|NCT00410410|69651657|FG005|Induction Period (IP)|Adverse Event|0|||
37964400|NCT00410410|69651658|FG006|Induction Period (IP)|Adverse Event|0|||
37964401|NCT00410410|69651659|FG007|Induction Period (IP)|Adverse Event|0|||
37964402|NCT00410410|69651660|FG008|Induction Period (IP)|Adverse Event|0|||
37964403|NCT00410410|69651652|FG000|Induction Period (IP)|Lack of Efficacy|26|||
37964404|NCT00410410|69651653|FG001|Induction Period (IP)|Lack of Efficacy|24|||
37964405|NCT00410410|69651654|FG002|Induction Period (IP)|Lack of Efficacy|8|||
37964406|NCT00410410|69651655|FG003|Induction Period (IP)|Lack of Efficacy|8|||
37964407|NCT00410410|69651656|FG004|Induction Period (IP)|Lack of Efficacy|7|||
37964408|NCT00410410|69651657|FG005|Induction Period (IP)|Lack of Efficacy|7|||
37964409|NCT00410410|69651658|FG006|Induction Period (IP)|Lack of Efficacy|0|||
37964410|NCT00410410|69651659|FG007|Induction Period (IP)|Lack of Efficacy|0|||
37964411|NCT00410410|69651660|FG008|Induction Period (IP)|Lack of Efficacy|0|||
37964412|NCT00410410|69651652|FG000|Induction Period (IP)|Lost to Follow-up|2|||
37964413|NCT00410410|69651653|FG001|Induction Period (IP)|Lost to Follow-up|2|||
37964414|NCT00410410|69651654|FG002|Induction Period (IP)|Lost to Follow-up|2|||
37964415|NCT00410410|69651655|FG003|Induction Period (IP)|Lost to Follow-up|3|||
37964416|NCT00410410|69651656|FG004|Induction Period (IP)|Lost to Follow-up|0|||
37964417|NCT00410410|69651657|FG005|Induction Period (IP)|Lost to Follow-up|1|||
37964418|NCT00410410|69651658|FG006|Induction Period (IP)|Lost to Follow-up|0|||
37964419|NCT00410410|69651659|FG007|Induction Period (IP)|Lost to Follow-up|0|||
37964420|NCT00410410|69651660|FG008|Induction Period (IP)|Lost to Follow-up|0|||
37964421|NCT00410410|69651652|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
37964422|NCT00410410|69651653|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
37964423|NCT00410410|69651654|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
37964424|NCT00410410|69651655|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
37964425|NCT00410410|69651656|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
37964426|NCT00410410|69651657|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
37964427|NCT00410410|69651658|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
37964428|NCT00410410|69651659|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
37964429|NCT00410410|69651660|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
37964430|NCT00410410|69651652|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
37964431|NCT00410410|69651653|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
37964432|NCT00410410|69651654|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
37964433|NCT00410410|69651655|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
37964434|NCT00410410|69651656|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
37964435|NCT00410410|69651657|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
37964436|NCT00410410|69651658|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
37964437|NCT00410410|69651659|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
37964438|NCT00410410|69651660|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
37964439|NCT00410410|69651652|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
37964440|NCT00410410|69651653|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
37964441|NCT00410410|69651654|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
37964442|NCT00410410|69651655|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
37964443|NCT00410410|69651656|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
37964444|NCT00410410|69651657|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
37964445|NCT00410410|69651658|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
37964446|NCT00410410|69651659|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
37964447|NCT00410410|69651660|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
37964448|NCT00410410|69651652|FG000|Induction Period (IP)|Other|0|||
37964449|NCT00410410|69651653|FG001|Induction Period (IP)|Other|0|||
37964450|NCT00410410|69651654|FG002|Induction Period (IP)|Other|1|||
37964451|NCT00410410|69651655|FG003|Induction Period (IP)|Other|0|||
38053739|NCT03185949|69743643|FG001|ITT Analysis|Withdrawal by Subject|3|||
38053740|NCT03185949|69743642|FG000|PP Analysis|Protocol Violation|2|||
37964452|NCT00410410|69651656|FG004|Induction Period (IP)|Other|0|||
37964453|NCT00410410|69651657|FG005|Induction Period (IP)|Other|0|||
37964454|NCT00410410|69651658|FG006|Induction Period (IP)|Other|0|||
37964455|NCT00410410|69651659|FG007|Induction Period (IP)|Other|0|||
37964456|NCT00410410|69651660|FG008|Induction Period (IP)|Other|0|||
37964457|NCT00410410|69651652|FG000|Maintenance Period (MP)|Death|0|||
37964458|NCT00410410|69651653|FG001|Maintenance Period (MP)|Death|0|||
37964459|NCT00410410|69651654|FG002|Maintenance Period (MP)|Death|0|||
37964460|NCT00410410|69651655|FG003|Maintenance Period (MP)|Death|0|||
37964461|NCT00410410|69651656|FG004|Maintenance Period (MP)|Death|0|||
37964462|NCT00410410|69651657|FG005|Maintenance Period (MP)|Death|0|||
37964463|NCT00410410|69651658|FG006|Maintenance Period (MP)|Death|1|||
37964464|NCT00410410|69651659|FG007|Maintenance Period (MP)|Death|0|||
37964465|NCT00410410|69651660|FG008|Maintenance Period (MP)|Death|0|||
37964466|NCT00410410|69651652|FG000|Maintenance Period (MP)|Adverse Event|0|||
37964467|NCT00410410|69651653|FG001|Maintenance Period (MP)|Adverse Event|0|||
37964468|NCT00410410|69651654|FG002|Maintenance Period (MP)|Adverse Event|0|||
37964469|NCT00410410|69651655|FG003|Maintenance Period (MP)|Adverse Event|0|||
37964470|NCT00410410|69651656|FG004|Maintenance Period (MP)|Adverse Event|0|||
37964471|NCT00410410|69651657|FG005|Maintenance Period (MP)|Adverse Event|0|||
37964472|NCT00410410|69651658|FG006|Maintenance Period (MP)|Adverse Event|1|||
37964473|NCT00410410|69651659|FG007|Maintenance Period (MP)|Adverse Event|3|||
37964474|NCT00410410|69651660|FG008|Maintenance Period (MP)|Adverse Event|0|||
37964475|NCT00410410|69651652|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
37964476|NCT00410410|69651653|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
37964477|NCT00410410|69651654|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
37964478|NCT00410410|69651655|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
37964479|NCT00410410|69651656|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
37964480|NCT00410410|69651657|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
37964481|NCT00410410|69651658|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
37964482|NCT00410410|69651659|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
37964483|NCT00410410|69651660|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
37964484|NCT00410410|69651652|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
37964485|NCT00410410|69651653|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
37964486|NCT00410410|69651654|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
37964487|NCT00410410|69651655|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
37964488|NCT00410410|69651656|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
37964489|NCT00410410|69651657|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
37964490|NCT00410410|69651658|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
37964491|NCT00410410|69651659|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
37964492|NCT00410410|69651660|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
37964493|NCT00410410|69651652|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
37964494|NCT00410410|69651653|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
37964495|NCT00410410|69651654|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
37964496|NCT00410410|69651655|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
37964497|NCT00410410|69651656|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
37964498|NCT00410410|69651657|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
37964499|NCT00410410|69651658|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
37964500|NCT00410410|69651659|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
37964501|NCT00410410|69651660|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
37964502|NCT00410410|69651652|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
37964503|NCT00410410|69651653|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
37964504|NCT00410410|69651654|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
37964505|NCT00410410|69651655|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
37964506|NCT00410410|69651656|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
37964507|NCT00410410|69651657|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
37964508|NCT00410410|69651658|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
37964509|NCT00410410|69651659|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
37964510|NCT00410410|69651660|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
37964511|NCT00410410|69651652|FG000|Open-Label Period (OL)|Death|0|||
37964512|NCT00410410|69651653|FG001|Open-Label Period (OL)|Death|0|||
37964513|NCT00410410|69651654|FG002|Open-Label Period (OL)|Death|0|||
37964514|NCT00410410|69651655|FG003|Open-Label Period (OL)|Death|0|||
37964515|NCT00410410|69651656|FG004|Open-Label Period (OL)|Death|0|||
37964516|NCT00410410|69651657|FG005|Open-Label Period (OL)|Death|0|||
37964517|NCT00410410|69651658|FG006|Open-Label Period (OL)|Death|0|||
38053741|NCT03185949|69743643|FG001|PP Analysis|Protocol Violation|2|||
38053742|NCT03185949|69743642|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
38053743|NCT03185949|69743643|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
38053744|NCT03655405|69743653|FG000|Overall Study|Death after initial data collection|4|||
38053745|NCT03655405|69743654|FG001|Overall Study|Death after initial data collection|2|||
38053746|NCT03655405|69743653|FG000|Overall Study|Died before initial data collection|1|||
38053747|NCT03655405|69743654|FG001|Overall Study|Died before initial data collection|2|||
38053748|NCT03655405|69743653|FG000|Overall Study|Protocol Violation|0|||
38053749|NCT03655405|69743654|FG001|Overall Study|Protocol Violation|1|||
38053750|NCT03510598|69743660|FG000|Overall Study|Withdrawal by Subject|1|||
38053751|NCT03222141|69743664|FG000|Overall Study|Death|15|||
38053752|NCT03222141|69743664|FG000|Overall Study|Lost to Follow-up|3|||
38053753|NCT04029961|69743671|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
38053754|NCT04029961|69743672|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
38053755|NCT04029961|69743671|FG000|Overall Study|Change in Treatment Course|0|||
38053756|NCT04029961|69743672|FG001|Overall Study|Change in Treatment Course|1|||
38053757|NCT03997825|69743678|FG000|Overall Study|Death|3|||
38053758|NCT03997825|69743678|FG000|Overall Study|Lost to Follow-up|10|||
38053759|NCT03997825|69743678|FG000|Overall Study|Withdrawal by Subject|3|||
38053760|NCT03997825|69743678|FG000|Overall Study|Refused participation|1|||
38053761|NCT04024891|69743684|FG000|Overall Study|Pregnancy|0|||
38053762|NCT04024891|69743685|FG001|Overall Study|Pregnancy|1|||
38053763|NCT03250182|69743691|FG000|Overall Study|Withdrawal by Subject|1|||
38053764|NCT03993379|69743699|FG000|Overall Study|The study was terminated early due to business decision.|0|||
38053765|NCT03993379|69743700|FG001|Overall Study|The study was terminated early due to business decision.|2|||
38053766|NCT03993379|69743701|FG002|Overall Study|The study was terminated early due to business decision.|0|||
38053767|NCT03993379|69743702|FG003|Overall Study|The study was terminated early due to business decision.|0|||
38053768|NCT03993379|69743699|FG000|Overall Study|Withdrawal by Subject|0|||
38053769|NCT03993379|69743700|FG001|Overall Study|Withdrawal by Subject|1|||
38053770|NCT03993379|69743701|FG002|Overall Study|Withdrawal by Subject|0|||
38053771|NCT03993379|69743702|FG003|Overall Study|Withdrawal by Subject|0|||
38053772|NCT03370120|69743712|FG000|Overall Study|Adverse event, non-fatal|24|||
38053773|NCT03370120|69743712|FG000|Overall Study|Withdrawal by Subject|6|||
38053774|NCT03370120|69743712|FG000|Overall Study|Lost to Follow-up|1|||
38053775|NCT03370120|69743712|FG000|Overall Study|Lack of Efficacy|37|||
38053776|NCT03370120|69743712|FG000|Overall Study|Per sponsor's instructions|1|||
38053777|NCT03370120|69743712|FG000|Overall Study|Study was terminated by parent company UCB|2|||
38053778|NCT03370120|69743712|FG000|Overall Study|The study was ended by the promoter|3|||
38053779|NCT03370120|69743712|FG000|Overall Study|Discontinuation of drug development|3|||
38053780|NCT03370120|69743712|FG000|Overall Study|End of project|2|||
38053781|NCT03370120|69743712|FG000|Overall Study|Premature study closure|2|||
38053782|NCT03370120|69743712|FG000|Overall Study|Premature program termination|1|||
38053783|NCT03370120|69743712|FG000|Overall Study|Premature study termination|7|||
38053784|NCT03370120|69743712|FG000|Overall Study|Trial terminated by sponsor|2|||
38053785|NCT03370120|69743712|FG000|Overall Study|Trial discontinued by sponsor|2|||
38053786|NCT03370120|69743712|FG000|Overall Study|Study ended|15|||
38053787|NCT03370120|69743712|FG000|Overall Study|Clinical trial has been cancelled|1|||
38053788|NCT03370120|69743712|FG000|Overall Study|End of study per sponsor decision|2|||
38053789|NCT03370120|69743712|FG000|Overall Study|Promoter's decision|2|||
38053790|NCT03370120|69743712|FG000|Overall Study|The trial has been suspended|3|||
38053791|NCT03370120|69743712|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
38053792|NCT03370120|69743712|FG000|Overall Study|Early termination by order of sponsor|2|||
38053793|NCT03370120|69743712|FG000|Overall Study|Discontinuation of the study|5|||
38053794|NCT03370120|69743712|FG000|Overall Study|End of clinical trial discontinuation|1|||
37964518|NCT00410410|69651659|FG007|Open-Label Period (OL)|Death|0|||
37964519|NCT00410410|69651660|FG008|Open-Label Period (OL)|Death|1|||
37964520|NCT00410410|69651652|FG000|Open-Label Period (OL)|Adverse Event|0|||
37964521|NCT00410410|69651653|FG001|Open-Label Period (OL)|Adverse Event|0|||
37964522|NCT00410410|69651654|FG002|Open-Label Period (OL)|Adverse Event|0|||
37964523|NCT00410410|69651655|FG003|Open-Label Period (OL)|Adverse Event|0|||
37964524|NCT00410410|69651656|FG004|Open-Label Period (OL)|Adverse Event|0|||
37964525|NCT00410410|69651657|FG005|Open-Label Period (OL)|Adverse Event|0|||
37964526|NCT00410410|69651658|FG006|Open-Label Period (OL)|Adverse Event|0|||
37964527|NCT00410410|69651659|FG007|Open-Label Period (OL)|Adverse Event|0|||
37964528|NCT00410410|69651660|FG008|Open-Label Period (OL)|Adverse Event|10|||
37964529|NCT00410410|69651652|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
37964530|NCT00410410|69651653|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
37964531|NCT00410410|69651654|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
37964532|NCT00410410|69651655|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
37964533|NCT00410410|69651656|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
37964534|NCT00410410|69651657|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
37964535|NCT00410410|69651658|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
37964536|NCT00410410|69651659|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
37964537|NCT00410410|69651660|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
37964538|NCT00410410|69651652|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
38053795|NCT03370120|69743712|FG000|Overall Study|Because the clinical trial ended halfway|4|||
38053796|NCT03370120|69743712|FG000|Overall Study|Development discontinued|5|||
38053797|NCT03370120|69743712|FG000|Overall Study|Padsenovil program closed|3|||
38053798|NCT03370120|69743712|FG000|Overall Study|End of project|2|||
38053799|NCT03370120|69743712|FG000|Overall Study|Termination of project|1|||
38053800|NCT03370120|69743712|FG000|Overall Study|The study was interrupted by sponsor|4|||
38053801|NCT03370120|69743712|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
38053802|NCT03370120|69743712|FG000|Overall Study|End of sponsor decision|1|||
38053803|NCT03370120|69743712|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
38053804|NCT03370120|69743712|FG000|Overall Study|Early termination of studies|5|||
38053805|NCT03370120|69743712|FG000|Overall Study|This study is ended early|1|||
38053806|NCT03370120|69743712|FG000|Overall Study|End of padsevonil program|2|||
38053807|NCT03370120|69743712|FG000|Overall Study|Decision of sponsor|6|||
38053808|NCT03370120|69743712|FG000|Overall Study|Asked by the sponsor|3|||
38053809|NCT03370120|69743712|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
38053810|NCT03370120|69743712|FG000|Overall Study|PI decision poor compliance from participant|1|||
38053811|NCT03370120|69743712|FG000|Overall Study|Promoter ended the study|3|||
38053812|NCT03370120|69743712|FG000|Overall Study|Premature study close by sponsor's decision|4|||
38053813|NCT03370120|69743712|FG000|Overall Study|Study terminated by sponsor|33|||
38053814|NCT03370120|69743712|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
38053815|NCT03370120|69743712|FG000|Overall Study|Sponsor decision to terminate study|63|||
38053816|NCT03370120|69743712|FG000|Overall Study|Program closure|3|||
38053817|NCT03370120|69743712|FG000|Overall Study|Study ended prematurely|1|||
38053818|NCT03370120|69743712|FG000|Overall Study|Study stopped by sponsor|2|||
38053819|NCT03370120|69743712|FG000|Overall Study|Program termination|55|||
38053820|NCT03370120|69743712|FG000|Overall Study|Sponsor decision|62|||
38053821|NCT03370120|69743712|FG000|Overall Study|Sponsor study closure|10|||
38053822|NCT03247686|69743720|FG000|Overall Study|Withdrawal by Subject|1|||
38053823|NCT03247686|69743721|FG001|Overall Study|Withdrawal by Subject|2|||
38053824|NCT03990649|69743732|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
38053825|NCT03990649|69743733|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
38053826|NCT03990649|69743734|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
38053827|NCT03990649|69743732|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
38053828|NCT03990649|69743733|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
38053829|NCT03990649|69743734|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
38053830|NCT03990649|69743732|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
38053831|NCT03990649|69743733|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
38053832|NCT03990649|69743734|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
38053833|NCT03990649|69743732|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
38053834|NCT03990649|69743733|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
38053835|NCT03990649|69743734|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
38053836|NCT03990649|69743732|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
38053837|NCT03990649|69743733|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
38053838|NCT03990649|69743734|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
38053839|NCT03990649|69743732|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
38053840|NCT03990649|69743733|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
38053841|NCT03990649|69743734|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
38053842|NCT03990649|69743732|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
38053843|NCT03990649|69743733|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
38053844|NCT03990649|69743734|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
38053845|NCT03185481|69743741|FG000|Overall Study|Adverse Event|1|||
38053846|NCT03185481|69743741|FG000|Overall Study|Study Terminated by Sponsor|4|||
38053847|NCT03652675|69743747|FG000|Overall Study|Lost to Follow-up|4|||
38053848|NCT03652675|69743748|FG001|Overall Study|Lost to Follow-up|4|||
38053849|NCT03241368|69743754|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
38053850|NCT03241368|69743754|FG000|Overall Study|Lost to Follow-up|1|||
38053851|NCT03241368|69743754|FG000|Overall Study|Physician Decision|6|||
38053852|NCT03241368|69743754|FG000|Overall Study|Withdrawal by Subject|6|||
38053853|NCT03241368|69743754|FG000|Overall Study|Protocol Violation|1|||
38053854|NCT03220581|69743761|FG000|Overall Study|Withdrawal by Subject|0|||
38053855|NCT03220581|69743762|FG001|Overall Study|Withdrawal by Subject|1|||
38053856|NCT03220581|69743761|FG000|Overall Study|Lost to Follow-up|3|||
38053857|NCT03220581|69743762|FG001|Overall Study|Lost to Follow-up|6|||
38053858|NCT02954575|69743770|FG000|Overall Study|Withdrawal by Subject|2|||
38053859|NCT02954575|69743770|FG000|Overall Study|Adverse Event|1|||
38053860|NCT03184701|69743778|FG000|Overall Study|Death|3|||
38053861|NCT03184701|69743778|FG000|Overall Study|Physician Decision|3|||
38053862|NCT03184701|69743778|FG000|Overall Study|Withdrawal by Subject|6|||
38053863|NCT03184701|69743778|FG000|Overall Study|Lost to Follow-up|5|||
38053864|NCT03247530|69743785|FG000|Overall Study|Withdrawal by caregiver|19|||
38053865|NCT03247530|69743786|FG001|Overall Study|Withdrawal by caregiver|8|||
38053866|NCT03247530|69743787|FG002|Overall Study|Withdrawal by caregiver|10|||
38053867|NCT03247530|69743785|FG000|Overall Study|Lost to Follow-up|3|||
38053868|NCT03247530|69743786|FG001|Overall Study|Lost to Follow-up|9|||
38053869|NCT03247530|69743787|FG002|Overall Study|Lost to Follow-up|6|||
37771408|NCT01360632|69290633|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
37771409|NCT01360632|69290634|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
37771410|NCT01360632|69290630|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
37771411|NCT01360632|69290631|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
37771412|NCT01360632|69290632|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
37771413|NCT01360632|69290633|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
37771414|NCT01360632|69290634|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
37771415|NCT01360632|69290630|FG000|Phase B (6 Weeks)|Adverse Event|0|||
37771416|NCT01360632|69290631|FG001|Phase B (6 Weeks)|Adverse Event|3|||
38053870|NCT03247530|69743785|FG000|Overall Study|Adverse Event|2|||
38053871|NCT03247530|69743786|FG001|Overall Study|Adverse Event|5|||
38053872|NCT03247530|69743787|FG002|Overall Study|Adverse Event|2|||
38053873|NCT03247530|69743785|FG000|Overall Study|Failure to follow procedure|1|||
38053874|NCT03247530|69743786|FG001|Overall Study|Failure to follow procedure|1|||
38053875|NCT03247530|69743787|FG002|Overall Study|Failure to follow procedure|1|||
38053876|NCT03247530|69743785|FG000|Overall Study|Withdrawal by Subject|1|||
38053877|NCT03247530|69743786|FG001|Overall Study|Withdrawal by Subject|1|||
38053878|NCT03247530|69743787|FG002|Overall Study|Withdrawal by Subject|0|||
38053879|NCT03247530|69743785|FG000|Overall Study|Study medication misuse|0|||
38053880|NCT03247530|69743786|FG001|Overall Study|Study medication misuse|1|||
38053881|NCT03247530|69743787|FG002|Overall Study|Study medication misuse|0|||
38053882|NCT03247530|69743785|FG000|Overall Study|Other, multiple categories|1|||
38053883|NCT03247530|69743786|FG001|Overall Study|Other, multiple categories|3|||
38053884|NCT03247530|69743787|FG002|Overall Study|Other, multiple categories|1|||
38053885|NCT03246672|69743798|FG000|Overall Study|Lost to Follow-up|2|||
38053886|NCT03983317|69743802|FG000|Overall Study|Physician Decision|5|||
38053887|NCT03207243|69743808|FG000|Overall Study|Adverse Event|2|||
38053888|NCT03207243|69743809|FG001|Overall Study|Adverse Event|2|||
38053889|NCT03207243|69743808|FG000|Overall Study|Loss of Asthma Control|47|||
38053890|NCT03207243|69743809|FG001|Overall Study|Loss of Asthma Control|31|||
38053891|NCT03207243|69743808|FG000|Overall Study|Withdrawal by Subject|2|||
38053892|NCT03207243|69743809|FG001|Overall Study|Withdrawal by Subject|4|||
38053893|NCT03207243|69743808|FG000|Overall Study|Physician Decision|1|||
38053894|NCT03207243|69743809|FG001|Overall Study|Physician Decision|1|||
38053895|NCT03207243|69743808|FG000|Overall Study|Lost to Follow-up|0|||
38053896|NCT03207243|69743809|FG001|Overall Study|Lost to Follow-up|1|||
38053897|NCT03207243|69743808|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
37771417|NCT01360632|69290632|FG002|Phase B (6 Weeks)|Adverse Event|9|||
37862117|NCT01134627|69545874|FG001|Overall Study|Lack of Efficacy|12|||
38053898|NCT03207243|69743809|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
38053899|NCT03207243|69743808|FG000|Overall Study|Protocol Violation|0|||
38053900|NCT03207243|69743809|FG001|Overall Study|Protocol Violation|3|||
38053901|NCT03982069|69743820|FG000|Overall Study|Lost to Follow-up|5|||
38053902|NCT03982069|69743821|FG001|Overall Study|Lost to Follow-up|5|||
38053903|NCT03982069|69743822|FG002|Overall Study|Lost to Follow-up|3|||
38053904|NCT03982069|69743823|FG003|Overall Study|Lost to Follow-up|5|||
38053905|NCT03982069|69743820|FG000|Overall Study|Physician Decision|0|||
38053906|NCT03982069|69743821|FG001|Overall Study|Physician Decision|1|||
38053907|NCT03982069|69743822|FG002|Overall Study|Physician Decision|0|||
38053908|NCT03982069|69743823|FG003|Overall Study|Physician Decision|0|||
38053909|NCT03982069|69743820|FG000|Overall Study|Withdrawal by Subject|2|||
38053910|NCT03982069|69743821|FG001|Overall Study|Withdrawal by Subject|1|||
38053911|NCT03982069|69743822|FG002|Overall Study|Withdrawal by Subject|5|||
38053912|NCT03982069|69743823|FG003|Overall Study|Withdrawal by Subject|2|||
38053913|NCT03982069|69743820|FG000|Overall Study|Specimen loss|3|||
38053914|NCT03982069|69743821|FG001|Overall Study|Specimen loss|3|||
38053915|NCT03982069|69743822|FG002|Overall Study|Specimen loss|1|||
38053916|NCT03982069|69743823|FG003|Overall Study|Specimen loss|1|||
38053917|NCT02937870|69743831|FG000|Overall Study|Adverse Event|1|||
38053918|NCT02937870|69743831|FG000|Overall Study|Protocol Deviation|2|||
38053919|NCT03629041|69743845|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
38053920|NCT03629041|69743846|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
38053921|NCT03629041|69743847|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
38053922|NCT03629041|69743848|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
38053923|NCT03219723|69743866|FG000|Overall Study|Case Report Forms Uncollected|6|||
38053924|NCT03219723|69743866|FG000|Overall Study|Protocol Deviation|4|||
38053925|NCT03628417|69743870|FG000|Overall Study|Death|1|||
38053926|NCT03628417|69743871|FG001|Overall Study|Death|1|||
38053927|NCT03184077|69743883|FG000|Overall Study|Lost to Follow-up|21|||
38053928|NCT03184077|69743884|FG001|Overall Study|Lost to Follow-up|21|||
38053929|NCT03245736|69743890|FG000|Overall Study|Adverse Event|1|||
38053930|NCT03245736|69743890|FG000|Overall Study|Progressive Disease|4|||
38053931|NCT02954887|69743894|FG000|Overall Study|Withdrawal by Subject|3|||
38053932|NCT02954887|69743894|FG000|Overall Study|Lack of Efficacy|3|||
38053933|NCT02954887|69743894|FG000|Overall Study|Other|1|||
38053934|NCT03183063|69743901|FG000|Overall Study|Withdrawal by Subject|2|||
38053935|NCT03183063|69743902|FG001|Overall Study|Withdrawal by Subject|0|||
38053936|NCT03183063|69743903|FG002|Overall Study|Withdrawal by Subject|0|||
38053937|NCT03183063|69743901|FG000|Overall Study|Physician Decision|3|||
38053938|NCT03183063|69743902|FG001|Overall Study|Physician Decision|4|||
38053939|NCT03183063|69743903|FG002|Overall Study|Physician Decision|4|||
38053940|NCT03182829|69743919|FG000|Overall Study|Protocol Violation|12|||
38053941|NCT03182829|69743920|FG001|Overall Study|Protocol Violation|12|||
38053942|NCT03182829|69743919|FG000|Overall Study|Other|4|||
38053943|NCT03182829|69743920|FG001|Overall Study|Other|3|||
38053944|NCT03278028|69743928|FG000|Overall Study|Lost to Follow-up|1|||
38053945|NCT03278028|69743929|FG001|Overall Study|Lost to Follow-up|0|||
38053946|NCT03278028|69743928|FG000|Overall Study|Withdrawal by Subject|3|||
38053947|NCT03278028|69743929|FG001|Overall Study|Withdrawal by Subject|1|||
38053948|NCT03278028|69743928|FG000|Overall Study|Pregnancy|0|||
38053949|NCT03278028|69743929|FG001|Overall Study|Pregnancy|1|||
38053950|NCT03181503|69743937|FG000|Overall Study|Adverse Event|2|||
38053951|NCT03181503|69743938|FG001|Overall Study|Adverse Event|2|||
38053952|NCT03181503|69743937|FG000|Overall Study|Protocol Violation|1|||
38053953|NCT03181503|69743938|FG001|Overall Study|Protocol Violation|0|||
38053954|NCT03181503|69743937|FG000|Overall Study|Withdrawal by Subject|3|||
38053955|NCT03181503|69743938|FG001|Overall Study|Withdrawal by Subject|0|||
38053956|NCT03181503|69743937|FG000|Overall Study|Lost to Follow-up|1|||
38053957|NCT03181503|69743938|FG001|Overall Study|Lost to Follow-up|1|||
38053958|NCT03277794|69743949|FG000|Overall Study|Lost to Follow-up|2|||
38053959|NCT03277794|69743950|FG001|Overall Study|Lost to Follow-up|4|||
38053960|NCT03277794|69743949|FG000|Overall Study|Withdrew due to high acuity|1|||
38053961|NCT03277794|69743950|FG001|Overall Study|Withdrew due to high acuity|0|||
38053962|NCT03276078|69743957|FG000|Overall Study|Adverse Event|1|||
38053963|NCT03180801|69743964|FG000|Overall Study|Physician Decision|3|||
38053964|NCT03180801|69743965|FG001|Overall Study|Physician Decision|3|||
38053965|NCT03180801|69743966|FG002|Overall Study|Physician Decision|1|||
38053966|NCT03180801|69743964|FG000|Overall Study|Non-compliance|1|||
38053967|NCT03180801|69743965|FG001|Overall Study|Non-compliance|4|||
38053968|NCT03180801|69743966|FG002|Overall Study|Non-compliance|0|||
38053969|NCT03180801|69743964|FG000|Overall Study|Inoculation Target Reached|1|||
38053970|NCT03180801|69743965|FG001|Overall Study|Inoculation Target Reached|1|||
38053971|NCT03180801|69743966|FG002|Overall Study|Inoculation Target Reached|3|||
38053972|NCT03180801|69743964|FG000|Overall Study|Adverse Event|1|||
38053973|NCT03180801|69743965|FG001|Overall Study|Adverse Event|0|||
38053974|NCT03180801|69743966|FG002|Overall Study|Adverse Event|2|||
38053975|NCT03180801|69743964|FG000|Overall Study|Withdrawal by Subject|2|||
38053976|NCT03180801|69743965|FG001|Overall Study|Withdrawal by Subject|2|||
38053977|NCT03180801|69743966|FG002|Overall Study|Withdrawal by Subject|1|||
38053978|NCT03180801|69743964|FG000|Overall Study|Lost to Follow-up|0|||
38053979|NCT03180801|69743965|FG001|Overall Study|Lost to Follow-up|2|||
38053980|NCT03180801|69743966|FG002|Overall Study|Lost to Follow-up|3|||
38053981|NCT03742271|69743977|FG000|Overall Study|Unsatisfactory Visual Response|1|||
38053982|NCT03742271|69743977|FG000|Overall Study|Withdrawal by Subject|3|||
38053983|NCT03742271|69743977|FG000|Overall Study|Lost to Follow-up|4|||
38053984|NCT03742271|69743977|FG000|Overall Study|Failed Insertion & removal|3|||
38053985|NCT03742271|69743977|FG000|Overall Study|Protocol Violation|1|||
38053986|NCT03214224|69743981|FG000|Overall Study|Protocol Violation|1|||
38053987|NCT03214224|69743981|FG000|Overall Study|Withdrawal by Subject|2|||
38053988|NCT03214224|69743981|FG000|Overall Study|Practice controls or therapists|6|||
38053989|NCT03180645|69743988|FG000|Overall Study|Adverse Event|0|||
38053990|NCT03180645|69743989|FG001|Overall Study|Adverse Event|1|||
38053991|NCT03180645|69743990|FG002|Overall Study|Adverse Event|2|||
38053992|NCT03750695|69744002|FG000|Overall Study|Lost to Follow-up|0|||
38053993|NCT03750695|69744003|FG001|Overall Study|Lost to Follow-up|1|||
38053994|NCT03231228|69744016|FG000|Overall Study|Lost to Follow-up|2|||
38053995|NCT03231228|69744017|FG001|Overall Study|Lost to Follow-up|0|||
38053996|NCT03231228|69744016|FG000|Overall Study|Physician Decision|1|||
38053997|NCT03231228|69744017|FG001|Overall Study|Physician Decision|0|||
38053998|NCT03213366|69744025|FG000|Overall Study|Lost to Follow-up|9|||
38053999|NCT03213366|69744026|FG001|Overall Study|Lost to Follow-up|4|||
38054000|NCT03213210|69744032|FG000|Overall Study|Lost to Follow-up|2|||
38054001|NCT03213210|69744032|FG000|Overall Study|Study termination|3|||
38054002|NCT02932878|69744038|FG000|Overall Study|Due to Lab Results|2|||
38054003|NCT02932878|69744039|FG001|Overall Study|Due to Lab Results|1|||
38054004|NCT03230292|69744045|FG000|Overall Study|Adverse Event|1|||
38054005|NCT03230292|69744045|FG000|Overall Study|Protocol Violation|1|||
38054006|NCT03230292|69744045|FG000|Overall Study|Lost to Follow-up|1|||
38054007|NCT03230292|69744045|FG000|Overall Study|Withdrawal by Subject|3|||
38054008|NCT03228420|69744053|FG000|Overall Study|Lost to Follow-up|5|||
38054009|NCT03228420|69744054|FG001|Overall Study|Lost to Follow-up|3|||
38054010|NCT03228420|69744053|FG000|Overall Study|Withdrawal by Subject|10|||
38054011|NCT03228420|69744054|FG001|Overall Study|Withdrawal by Subject|0|||
38054012|NCT03228420|69744053|FG000|Overall Study|Adverse Event|5|||
38054013|NCT03228420|69744054|FG001|Overall Study|Adverse Event|2|||
38054014|NCT03746483|69744062|FG000|Overall Study|Adverse Event|0|||
38054015|NCT03746483|69744063|FG001|Overall Study|Adverse Event|1|||
38054016|NCT03746483|69744062|FG000|Overall Study|Lack of Efficacy|3|||
38054017|NCT03746483|69744063|FG001|Overall Study|Lack of Efficacy|2|||
38054018|NCT03746483|69744062|FG000|Overall Study|Lost to Follow-up|1|||
38054019|NCT03746483|69744063|FG001|Overall Study|Lost to Follow-up|0|||
38054020|NCT03746483|69744062|FG000|Overall Study|Protocol Violation|2|||
38054021|NCT03746483|69744063|FG001|Overall Study|Protocol Violation|0|||
38054022|NCT03746405|69744073|FG000|Overall Study|Withdrawal by Subject|3|||
38054023|NCT03746405|69744074|FG001|Overall Study|Withdrawal by Subject|0|||
38054024|NCT03746405|69744073|FG000|Overall Study|technical difficulties|0|||
38054025|NCT03746405|69744074|FG001|Overall Study|technical difficulties|2|||
38054026|NCT03226392|69744082|FG000|Overall Study|Protocol Deviation|1|||
38054027|NCT03226392|69744083|FG001|Overall Study|Protocol Deviation|0|||
38054028|NCT03226392|69744082|FG000|Overall Study|Physician Decision|1|||
38054029|NCT03226392|69744083|FG001|Overall Study|Physician Decision|0|||
38054030|NCT03226392|69744082|FG000|Overall Study|Lost to Follow-up|1|||
38054031|NCT03226392|69744083|FG001|Overall Study|Lost to Follow-up|0|||
38054032|NCT03226392|69744082|FG000|Overall Study|Adverse Event|1|||
38054033|NCT03226392|69744083|FG001|Overall Study|Adverse Event|0|||
38054034|NCT03226392|69744082|FG000|Overall Study|Technical Problems|0|||
38054035|NCT03226392|69744083|FG001|Overall Study|Technical Problems|2|||
38054036|NCT03226392|69744082|FG000|Overall Study|Subject/Guardian Decision|7|||
38054037|NCT03226392|69744083|FG001|Overall Study|Subject/Guardian Decision|6|||
38054038|NCT03205371|69744101|FG000|Overall Study|Withdrawal by Subject|4|||
38054039|NCT03205371|69744102|FG001|Overall Study|Withdrawal by Subject|1|||
38054040|NCT03205371|69744103|FG002|Overall Study|Withdrawal by Subject|0|||
38054041|NCT03205371|69744104|FG003|Overall Study|Withdrawal by Subject|0|||
38054042|NCT03205371|69744105|FG004|Overall Study|Withdrawal by Subject|0|||
38054043|NCT03205371|69744106|FG005|Overall Study|Withdrawal by Subject|0|||
38054044|NCT03205371|69744107|FG006|Overall Study|Withdrawal by Subject|4|||
38054045|NCT03205371|69744108|FG007|Overall Study|Withdrawal by Subject|0|||
38054046|NCT03205371|69744109|FG008|Overall Study|Withdrawal by Subject|2|||
38054047|NCT03205371|69744110|FG009|Overall Study|Withdrawal by Subject|0|||
38054048|NCT03205371|69744111|FG010|Overall Study|Withdrawal by Subject|0|||
38054049|NCT03205371|69744112|FG011|Overall Study|Withdrawal by Subject|1|||
38054050|NCT03205371|69744101|FG000|Overall Study|Lost to Follow-up|0|||
38054051|NCT03205371|69744102|FG001|Overall Study|Lost to Follow-up|0|||
38054052|NCT03205371|69744103|FG002|Overall Study|Lost to Follow-up|0|||
38054053|NCT03205371|69744104|FG003|Overall Study|Lost to Follow-up|0|||
38054054|NCT03205371|69744105|FG004|Overall Study|Lost to Follow-up|0|||
38054055|NCT03205371|69744106|FG005|Overall Study|Lost to Follow-up|0|||
38054056|NCT03205371|69744107|FG006|Overall Study|Lost to Follow-up|5|||
38054057|NCT03205371|69744108|FG007|Overall Study|Lost to Follow-up|2|||
38054058|NCT03205371|69744109|FG008|Overall Study|Lost to Follow-up|3|||
38054059|NCT03205371|69744110|FG009|Overall Study|Lost to Follow-up|0|||
38054060|NCT03205371|69744111|FG010|Overall Study|Lost to Follow-up|0|||
38054061|NCT03205371|69744112|FG011|Overall Study|Lost to Follow-up|0|||
38054062|NCT03205371|69744101|FG000|Overall Study|Protocol Violation|0|||
38054063|NCT03205371|69744102|FG001|Overall Study|Protocol Violation|0|||
38054064|NCT03205371|69744103|FG002|Overall Study|Protocol Violation|0|||
38054065|NCT03205371|69744104|FG003|Overall Study|Protocol Violation|0|||
38054066|NCT03205371|69744105|FG004|Overall Study|Protocol Violation|0|||
38054067|NCT03205371|69744106|FG005|Overall Study|Protocol Violation|0|||
38054068|NCT03205371|69744107|FG006|Overall Study|Protocol Violation|1|||
37862118|NCT01134627|69545873|FG000|Overall Study|Withdrawal by Subject|4|||
37862119|NCT01134627|69545874|FG001|Overall Study|Withdrawal by Subject|3|||
38054069|NCT03205371|69744108|FG007|Overall Study|Protocol Violation|0|||
38054070|NCT03205371|69744109|FG008|Overall Study|Protocol Violation|0|||
38054071|NCT03205371|69744110|FG009|Overall Study|Protocol Violation|0|||
38054072|NCT03205371|69744111|FG010|Overall Study|Protocol Violation|0|||
38054073|NCT03205371|69744112|FG011|Overall Study|Protocol Violation|0|||
38054074|NCT03205371|69744101|FG000|Overall Study|Adverse Event|0|||
38054075|NCT03205371|69744102|FG001|Overall Study|Adverse Event|0|||
38054076|NCT03205371|69744103|FG002|Overall Study|Adverse Event|0|||
38054077|NCT03205371|69744104|FG003|Overall Study|Adverse Event|0|||
38054078|NCT03205371|69744105|FG004|Overall Study|Adverse Event|0|||
38054079|NCT03205371|69744106|FG005|Overall Study|Adverse Event|0|||
38054080|NCT03205371|69744107|FG006|Overall Study|Adverse Event|0|||
38054081|NCT03205371|69744108|FG007|Overall Study|Adverse Event|1|||
38054082|NCT03205371|69744109|FG008|Overall Study|Adverse Event|0|||
38054083|NCT03205371|69744110|FG009|Overall Study|Adverse Event|0|||
38054084|NCT03205371|69744111|FG010|Overall Study|Adverse Event|0|||
38054085|NCT03205371|69744112|FG011|Overall Study|Adverse Event|0|||
38054086|NCT03367858|69744160|FG000|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
38054087|NCT03367858|69744161|FG001|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
38054088|NCT03367858|69744160|FG000|Intervention + Baseline Scan|Withdrawal by Subject|2|||
38054089|NCT03367858|69744161|FG001|Intervention + Baseline Scan|Withdrawal by Subject|0|||
38054090|NCT03367858|69744160|FG000|3 Month Follow Up|Lost to Follow-up|8|||
38054091|NCT03367858|69744161|FG001|3 Month Follow Up|Lost to Follow-up|3|||
38054092|NCT03367858|69744160|FG000|3 Month Follow Up|Moved out of study area|2|||
38054093|NCT03367858|69744161|FG001|3 Month Follow Up|Moved out of study area|6|||
38054094|NCT03367858|69744160|FG000|3 Month Follow Up|Unable to adhere to session timeline|1|||
38054095|NCT03367858|69744161|FG001|3 Month Follow Up|Unable to adhere to session timeline|3|||
38054096|NCT03367858|69744160|FG000|3 Month Follow Up|MRI contraindication|2|||
38054097|NCT03367858|69744161|FG001|3 Month Follow Up|MRI contraindication|1|||
38054098|NCT03367858|69744160|FG000|3 Month Follow Up|Incarcerated|0|||
38054099|NCT03367858|69744161|FG001|3 Month Follow Up|Incarcerated|1|||
38054100|NCT03367858|69744160|FG000|3 Month Follow Up|Withdrawal by Subject|3|||
38054101|NCT03367858|69744161|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
38054102|NCT03367858|69744160|FG000|6 Month Follow Up|Lost to Follow-up|5|||
38054103|NCT03367858|69744161|FG001|6 Month Follow Up|Lost to Follow-up|2|||
38054104|NCT03367858|69744160|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
38054105|NCT03367858|69744161|FG001|6 Month Follow Up|Withdrawal by Subject|1|||
38054106|NCT03367858|69744160|FG000|12 Month Follow Up|Lost to Follow-up|3|||
38054107|NCT03367858|69744161|FG001|12 Month Follow Up|Lost to Follow-up|3|||
38054108|NCT03367858|69744160|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
38054109|NCT03367858|69744161|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
38054110|NCT03682705|69744173|FG000|Overall Study|Adverse Event|1|||
38054111|NCT03682705|69744174|FG001|Overall Study|Adverse Event|1|||
38054112|NCT03682705|69744175|FG002|Overall Study|Adverse Event|1|||
38054113|NCT03682705|69744176|FG003|Overall Study|Adverse Event|0|||
38054114|NCT03682705|69744177|FG004|Overall Study|Adverse Event|1|||
38054115|NCT03682705|69744178|FG005|Overall Study|Adverse Event|1|||
38054116|NCT03682705|69744173|FG000|Overall Study|Withdrawal by Subject|1|||
38054117|NCT03682705|69744174|FG001|Overall Study|Withdrawal by Subject|3|||
38054118|NCT03682705|69744175|FG002|Overall Study|Withdrawal by Subject|2|||
38054119|NCT03682705|69744176|FG003|Overall Study|Withdrawal by Subject|4|||
38054120|NCT03682705|69744177|FG004|Overall Study|Withdrawal by Subject|0|||
38054121|NCT03682705|69744178|FG005|Overall Study|Withdrawal by Subject|1|||
38054122|NCT03682705|69744173|FG000|Overall Study|Other, not specified|0|||
38054123|NCT03682705|69744174|FG001|Overall Study|Other, not specified|0|||
38054124|NCT03682705|69744175|FG002|Overall Study|Other, not specified|0|||
38054125|NCT03682705|69744176|FG003|Overall Study|Other, not specified|1|||
37862120|NCT01134627|69545873|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
38054126|NCT03682705|69744177|FG004|Overall Study|Other, not specified|2|||
38054127|NCT03682705|69744178|FG005|Overall Study|Other, not specified|0|||
38054128|NCT03682705|69744173|FG000|Overall Study|Lost to Follow-up|0|||
38054129|NCT03682705|69744174|FG001|Overall Study|Lost to Follow-up|0|||
38054130|NCT03682705|69744175|FG002|Overall Study|Lost to Follow-up|0|||
38054131|NCT03682705|69744176|FG003|Overall Study|Lost to Follow-up|0|||
38054132|NCT03682705|69744177|FG004|Overall Study|Lost to Follow-up|3|||
38054133|NCT03682705|69744178|FG005|Overall Study|Lost to Follow-up|0|||
38054134|NCT03179787|69744192|FG000|Overall Study|Lost to Follow-up|15|||
38054135|NCT03179787|69744192|FG000|Overall Study|Case report failures|2|||
38054136|NCT03179787|69744192|FG000|Overall Study|Treatment not administered|1|||
38054137|NCT03745937|69744200|FG000|Overall Study|Withdrawal by Subject|0|||
38054138|NCT03745937|69744201|FG001|Overall Study|Withdrawal by Subject|0|||
38054139|NCT03745937|69744202|FG002|Overall Study|Withdrawal by Subject|0|||
38054140|NCT03745937|69744203|FG003|Overall Study|Withdrawal by Subject|1|||
38054141|NCT03745937|69744200|FG000|Overall Study|Not-specifed|0|||
38054142|NCT03745937|69744201|FG001|Overall Study|Not-specifed|1|||
38054143|NCT03745937|69744202|FG002|Overall Study|Not-specifed|0|||
38054144|NCT03745937|69744203|FG003|Overall Study|Not-specifed|1|||
38054145|NCT02956057|69744220|FG000|Overall Study|Discontinued intervention|14|||
38054146|NCT02956057|69744221|FG001|Overall Study|Discontinued intervention|10|||
38054147|NCT02956057|69744222|FG002|Overall Study|Discontinued intervention|7|||
38054148|NCT02956057|69744223|FG003|Overall Study|Discontinued intervention|14|||
38054149|NCT02956057|69744224|FG004|Overall Study|Discontinued intervention|4|||
38054150|NCT02956057|69744225|FG005|Overall Study|Discontinued intervention|17|||
38054151|NCT02956057|69744220|FG000|Overall Study|Lost to Follow-up|0|||
38054152|NCT02956057|69744221|FG001|Overall Study|Lost to Follow-up|2|||
38054153|NCT02956057|69744222|FG002|Overall Study|Lost to Follow-up|1|||
38054154|NCT02956057|69744223|FG003|Overall Study|Lost to Follow-up|1|||
38054155|NCT02956057|69744224|FG004|Overall Study|Lost to Follow-up|1|||
38054156|NCT02956057|69744225|FG005|Overall Study|Lost to Follow-up|0|||
38054157|NCT03179319|69744241|FG000|Overall Study|Lost to Follow-up|6|||
38054158|NCT03179319|69744242|FG001|Overall Study|Lost to Follow-up|0|||
38054159|NCT03627091|69744251|FG000|Overall Study|Adverse Event|0|||
38054160|NCT03627091|69744252|FG001|Overall Study|Adverse Event|0|||
38054161|NCT03627091|69744253|FG002|Overall Study|Adverse Event|2|||
38054162|NCT03627091|69744251|FG000|Overall Study|Withdrawal by Subject|2|||
38054163|NCT03627091|69744252|FG001|Overall Study|Withdrawal by Subject|0|||
38054164|NCT03627091|69744253|FG002|Overall Study|Withdrawal by Subject|2|||
38054165|NCT03627091|69744251|FG000|Overall Study|Physician Decision|2|||
38054166|NCT03627091|69744252|FG001|Overall Study|Physician Decision|0|||
38054167|NCT03627091|69744253|FG002|Overall Study|Physician Decision|0|||
38054168|NCT03627091|69744251|FG000|Overall Study|Site terminated by sponsor|0|||
38054169|NCT03627091|69744252|FG001|Overall Study|Site terminated by sponsor|1|||
38054170|NCT03627091|69744253|FG002|Overall Study|Site terminated by sponsor|0|||
38054171|NCT03627091|69744251|FG000|Overall Study|Disease relapse|7|||
38054172|NCT03627091|69744252|FG001|Overall Study|Disease relapse|5|||
38054173|NCT03627091|69744253|FG002|Overall Study|Disease relapse|1|||
38054174|NCT03627091|69744251|FG000|Overall Study|Other|1|||
38054175|NCT03627091|69744252|FG001|Overall Study|Other|0|||
38054176|NCT03627091|69744253|FG002|Overall Study|Other|0|||
38054177|NCT04237584|69744266|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
38054178|NCT04237584|69744267|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
38054179|NCT04237584|69744268|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
38054180|NCT04237584|69744269|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
38054181|NCT04237584|69744266|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
38054182|NCT04237584|69744267|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
38054183|NCT04237584|69744268|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
38054184|NCT04237584|69744269|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
38054185|NCT04237584|69744266|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
38054186|NCT04237584|69744267|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
38054187|NCT04237584|69744268|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
38054188|NCT04237584|69744269|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
38054189|NCT04237584|69744266|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
38054190|NCT04237584|69744267|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
38054191|NCT04237584|69744268|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
38054192|NCT04237584|69744269|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
37862121|NCT01134627|69545874|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
37862122|NCT01134627|69545873|FG000|Overall Study|Other|11|||
38054193|NCT04237584|69744266|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
38054194|NCT04237584|69744267|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
38054195|NCT04237584|69744268|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
38054196|NCT04237584|69744269|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
38054197|NCT03224598|69744286|FG000|Overall Study|Lost to Follow-up|0|||
38054198|NCT03224598|69744287|FG001|Overall Study|Lost to Follow-up|2|||
38054199|NCT03224598|69744288|FG002|Overall Study|Lost to Follow-up|0|||
38054200|NCT03224598|69744286|FG000|Overall Study|Other|0|||
38054201|NCT03224598|69744287|FG001|Overall Study|Other|1|||
38054202|NCT03224598|69744288|FG002|Overall Study|Other|0|||
38054203|NCT03681691|69744298|FG000|Overall Study|COVID|1|||
38054204|NCT03681691|69744299|FG001|Overall Study|COVID|0|||
38054205|NCT03681691|69744298|FG000|Overall Study|prolonged bleeding|1|||
38054206|NCT03681691|69744299|FG001|Overall Study|prolonged bleeding|0|||
38054207|NCT03681691|69744298|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
38054208|NCT03681691|69744299|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
38054209|NCT02935842|69744311|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
38054210|NCT02935842|69744312|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
38054211|NCT02935842|69744313|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
38054212|NCT02935842|69744314|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
38054213|NCT02935842|69744311|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
38054214|NCT02935842|69744312|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
38054215|NCT02935842|69744313|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
38054216|NCT02935842|69744314|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
38054217|NCT02935842|69744311|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
38054218|NCT02935842|69744312|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
38054219|NCT02935842|69744313|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
38054220|NCT02935842|69744314|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
38054221|NCT02935842|69744311|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
38054222|NCT02935842|69744312|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
38054223|NCT02935842|69744313|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
38054224|NCT02935842|69744314|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
38054225|NCT02935842|69744311|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
38054226|NCT02935842|69744312|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
38054227|NCT02935842|69744313|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
38054228|NCT02935842|69744314|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
38054229|NCT03680911|69744333|FG000|At Home Treatment|Study Termination|3|||
38054230|NCT03680911|69744334|FG001|At Home Treatment|Study Termination|0|||
38054231|NCT03680911|69744333|FG000|At Home Treatment|Lost to Follow-up|0|||
38054232|NCT03680911|69744334|FG001|At Home Treatment|Lost to Follow-up|1|||
38054233|NCT03680911|69744333|FG000|At Home Treatment|Withdrawal by Subject|0|||
38054234|NCT03680911|69744334|FG001|At Home Treatment|Withdrawal by Subject|2|||
38054235|NCT03680911|69744333|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
38054236|NCT03680911|69744334|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
38054237|NCT03224130|69744342|FG000|Overall Study|consent issue|0|||
38054238|NCT03224130|69744343|FG001|Overall Study|consent issue|1|||
38054239|NCT03679741|69744349|FG000|Period 1|No longer meet eligibility criteria|1|||
38054240|NCT03679741|69744350|FG001|Period 1|No longer meet eligibility criteria|0|||
38054241|NCT03679741|69744349|FG000|Period 1|Lost to Follow-up|0|||
38054242|NCT03679741|69744350|FG001|Period 1|Lost to Follow-up|1|||
38054243|NCT03679741|69744349|FG000|Period 1|Adverse Event|1|||
38054244|NCT03679741|69744350|FG001|Period 1|Adverse Event|1|||
38054245|NCT03679741|69744349|FG000|Period 1|Withdrawal by Subject|0|||
38054246|NCT03679741|69744350|FG001|Period 1|Withdrawal by Subject|1|||
38054247|NCT03679741|69744349|FG000|Period 2|Adverse Event|2|||
38054248|NCT03679741|69744350|FG001|Period 2|Adverse Event|1|||
38054249|NCT03679741|69744349|FG000|Period 2|Withdrawal by Subject|1|||
38054250|NCT03679741|69744350|FG001|Period 2|Withdrawal by Subject|1|||
38054251|NCT03678103|69744356|FG000|Overall Study|Withdrawn prior to completion|4|||
38054252|NCT03649477|69744363|FG000|Overall Study|Adverse Event|2|||
38054253|NCT03649477|69744364|FG001|Overall Study|Adverse Event|0|||
38054254|NCT03649477|69744365|FG002|Overall Study|Adverse Event|0|||
38054255|NCT03677869|69744373|FG000|Overall Study|Withdrawal by Subject|1|||
38054256|NCT03677401|69744379|FG000|Overall Study|Adverse Event|4|||
38054257|NCT03677401|69744380|FG001|Overall Study|Adverse Event|14|||
38054258|NCT03677401|69744379|FG000|Overall Study|Lack of Efficacy|3|||
38054259|NCT03677401|69744380|FG001|Overall Study|Lack of Efficacy|1|||
38054260|NCT03677401|69744379|FG000|Overall Study|Withdrawal by Subject|2|||
38054261|NCT03677401|69744380|FG001|Overall Study|Withdrawal by Subject|2|||
38054262|NCT03677401|69744379|FG000|Overall Study|Sponsor decision|0|||
38054263|NCT03677401|69744380|FG001|Overall Study|Sponsor decision|1|||
38054264|NCT03677401|69744379|FG000|Overall Study|Reason Unspecified|1|||
38054265|NCT03677401|69744380|FG001|Overall Study|Reason Unspecified|0|||
38054266|NCT03218787|69744386|FG000|Overall Study|Lost to Follow-up|12|||
38054267|NCT03218787|69744386|FG000|Overall Study|Withdrawal by Subject|72|||
38054268|NCT03218787|69744386|FG000|Overall Study|Physician Decision|11|||
38054269|NCT03218787|69744386|FG000|Overall Study|Death|111|||
38054270|NCT01348087|69744390|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
38054271|NCT01348087|69744390|FG000|Overall Study|Administrative problems|79|||
38054272|NCT01348087|69744390|FG000|Overall Study|protocol deviation|1|||
38054273|NCT01348087|69744390|FG000|Overall Study|Lost to Follow-up|1|||
38054274|NCT01348087|69744390|FG000|Overall Study|Subject withdrew consent|7|||
38054275|NCT01348087|69744390|FG000|Overall Study|Adverse Event|25|||
37964539|NCT00410410|69651653|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
37964540|NCT00410410|69651654|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
37964541|NCT00410410|69651655|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
37964542|NCT00410410|69651656|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
37964543|NCT00410410|69651657|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
37964544|NCT00410410|69651658|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
37964545|NCT00410410|69651659|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
37964546|NCT00410410|69651660|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
37964547|NCT00410410|69651652|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
37964548|NCT00410410|69651653|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
37964549|NCT00410410|69651654|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
37964550|NCT00410410|69651655|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
37964551|NCT00410410|69651656|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
37964552|NCT00410410|69651657|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
37862123|NCT01134627|69545874|FG001|Overall Study|Other|14|||
37771418|NCT01360632|69290633|FG003|Phase B (6 Weeks)|Adverse Event|3|||
37862124|NCT01134393|69545880|FG000|Overall Study|Adverse Event|18|||
37862125|NCT01134393|69545880|FG000|Overall Study|Lack of Efficacy|2|||
37680365|NCT02382939|69155971|FG000|Overall Study|Withdrawal by Subject|2|||
38054276|NCT01347931|69744404|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
38054277|NCT03645421|69744414|FG000|Overall Study|Adverse Event|0|||
38054278|NCT03645421|69744415|FG001|Overall Study|Adverse Event|0|||
38054279|NCT03645421|69744416|FG002|Overall Study|Adverse Event|4|||
38054280|NCT03645421|69744417|FG003|Overall Study|Adverse Event|1|||
38054281|NCT03645421|69744414|FG000|Overall Study|Withdrawal by patient|0|||
38054282|NCT03645421|69744415|FG001|Overall Study|Withdrawal by patient|0|||
38054283|NCT03645421|69744416|FG002|Overall Study|Withdrawal by patient|0|||
38054284|NCT03645421|69744417|FG003|Overall Study|Withdrawal by patient|3|||
38054285|NCT03645421|69744414|FG000|Overall Study|Study specific withdrawal criteria|0|||
38054286|NCT03645421|69744415|FG001|Overall Study|Study specific withdrawal criteria|0|||
38054287|NCT03645421|69744416|FG002|Overall Study|Study specific withdrawal criteria|1|||
38054288|NCT03645421|69744417|FG003|Overall Study|Study specific withdrawal criteria|0|||
38054289|NCT03207750|69744432|FG000|Overall Study|Adverse Event|3|||
38054290|NCT03207750|69744433|FG001|Overall Study|Adverse Event|2|||
38054291|NCT03207750|69744432|FG000|Overall Study|Lost to Follow-up|21|||
38054292|NCT03207750|69744433|FG001|Overall Study|Lost to Follow-up|29|||
38054293|NCT03207750|69744432|FG000|Overall Study|Protocol Violation|0|||
38054294|NCT03207750|69744433|FG001|Overall Study|Protocol Violation|1|||
38054295|NCT03207750|69744432|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
38054296|NCT03207750|69744433|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
38054297|NCT03207750|69744432|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
38054298|NCT03207750|69744433|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
38054299|NCT03207750|69744432|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
38054300|NCT03207750|69744433|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
38054301|NCT03207750|69744432|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
38054302|NCT03207750|69744433|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
38054303|NCT03207750|69744432|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
38054304|NCT03207750|69744433|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
38054305|NCT03674281|69744442|FG000|Overall Study|screen failure|2|||
38054306|NCT03674281|69744443|FG001|Overall Study|screen failure|0|||
38054307|NCT03674281|69744444|FG002|Overall Study|screen failure|0|||
38054308|NCT03674281|69744442|FG000|Overall Study|Withdrawal by Subject|1|||
38054309|NCT03674281|69744443|FG001|Overall Study|Withdrawal by Subject|3|||
38054310|NCT03674281|69744444|FG002|Overall Study|Withdrawal by Subject|3|||
38054311|NCT03673345|69744468|FG000|Overall Study|Lost to Follow-up|1|||
38054312|NCT03673345|69744469|FG001|Overall Study|Lost to Follow-up|0|||
38054313|NCT03673345|69744470|FG002|Overall Study|Lost to Follow-up|3|||
38054314|NCT03673345|69744471|FG003|Overall Study|Lost to Follow-up|3|||
38054315|NCT03673345|69744472|FG004|Overall Study|Lost to Follow-up|2|||
38054316|NCT03673345|69744473|FG005|Overall Study|Lost to Follow-up|1|||
38054317|NCT03673345|69744474|FG006|Overall Study|Lost to Follow-up|0|||
38054318|NCT03673345|69744475|FG007|Overall Study|Lost to Follow-up|0|||
38054319|NCT03673345|69744468|FG000|Overall Study|Withdrawal by Subject|1|||
38054320|NCT03673345|69744469|FG001|Overall Study|Withdrawal by Subject|0|||
38054321|NCT03673345|69744470|FG002|Overall Study|Withdrawal by Subject|4|||
38054322|NCT03673345|69744471|FG003|Overall Study|Withdrawal by Subject|2|||
38054323|NCT03673345|69744472|FG004|Overall Study|Withdrawal by Subject|0|||
38054324|NCT03673345|69744473|FG005|Overall Study|Withdrawal by Subject|0|||
38054325|NCT03673345|69744474|FG006|Overall Study|Withdrawal by Subject|0|||
38054326|NCT03673345|69744475|FG007|Overall Study|Withdrawal by Subject|0|||
38054327|NCT03673345|69744468|FG000|Overall Study|Physician Decision|0|||
38054328|NCT03673345|69744469|FG001|Overall Study|Physician Decision|0|||
38054329|NCT03673345|69744470|FG002|Overall Study|Physician Decision|2|||
38054330|NCT03673345|69744471|FG003|Overall Study|Physician Decision|0|||
38054331|NCT03673345|69744472|FG004|Overall Study|Physician Decision|0|||
38054332|NCT03673345|69744473|FG005|Overall Study|Physician Decision|0|||
38054333|NCT03673345|69744474|FG006|Overall Study|Physician Decision|0|||
38054334|NCT03673345|69744475|FG007|Overall Study|Physician Decision|0|||
38054335|NCT03223662|69744493|FG000|Overall Study|Physician Decision|1|||
38054336|NCT03223662|69744493|FG000|Overall Study|Study closure|1|||
38054337|NCT03672097|69744497|FG000|Period 1|Withdrawal by Subject|2|||
38054338|NCT03672097|69744497|FG000|Period 1|Adverse Event|1|||
38054339|NCT03672097|69744497|FG000|Period 1|Did not receive treatment|1|||
38054340|NCT03672097|69744497|FG000|Period 2|Withdrawal by Subject|3|||
38054341|NCT03672097|69744497|FG000|Period 2|Other|1|||
38054342|NCT03847896|69744506|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
38054343|NCT03847896|69744507|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
38054344|NCT03847896|69744508|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
38054345|NCT03847896|69744509|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
38054346|NCT03847896|69744510|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
38054347|NCT03847896|69744506|FG000|Overall Study|Withdrawal by Subject|2|||
38054348|NCT03847896|69744507|FG001|Overall Study|Withdrawal by Subject|10|||
38054349|NCT03847896|69744508|FG002|Overall Study|Withdrawal by Subject|5|||
38054350|NCT03847896|69744509|FG003|Overall Study|Withdrawal by Subject|9|||
38054351|NCT03847896|69744510|FG004|Overall Study|Withdrawal by Subject|8|||
38054352|NCT03847896|69744506|FG000|Overall Study|Withdrawal by parent/guardian|0|||
38054353|NCT03847896|69744507|FG001|Overall Study|Withdrawal by parent/guardian|0|||
38054354|NCT03847896|69744508|FG002|Overall Study|Withdrawal by parent/guardian|1|||
38054355|NCT03847896|69744509|FG003|Overall Study|Withdrawal by parent/guardian|0|||
38054356|NCT03847896|69744510|FG004|Overall Study|Withdrawal by parent/guardian|0|||
38054357|NCT03847896|69744506|FG000|Overall Study|Adverse Event|2|||
38054358|NCT03847896|69744507|FG001|Overall Study|Adverse Event|1|||
38054359|NCT03847896|69744508|FG002|Overall Study|Adverse Event|3|||
38054360|NCT03847896|69744509|FG003|Overall Study|Adverse Event|2|||
38054361|NCT03847896|69744510|FG004|Overall Study|Adverse Event|4|||
38054362|NCT03847896|69744506|FG000|Overall Study|A severe exacerbation event|0|||
38054363|NCT03847896|69744507|FG001|Overall Study|A severe exacerbation event|0|||
38054364|NCT03847896|69744508|FG002|Overall Study|A severe exacerbation event|0|||
38054365|NCT03847896|69744509|FG003|Overall Study|A severe exacerbation event|0|||
38054366|NCT03847896|69744510|FG004|Overall Study|A severe exacerbation event|3|||
38054367|NCT03847896|69744506|FG000|Overall Study|Protocol Violation|0|||
38054368|NCT03847896|69744507|FG001|Overall Study|Protocol Violation|2|||
38054369|NCT03847896|69744508|FG002|Overall Study|Protocol Violation|1|||
38054370|NCT03847896|69744509|FG003|Overall Study|Protocol Violation|0|||
37680366|NCT02382939|69155972|FG001|Overall Study|Withdrawal by Subject|2|||
37680367|NCT02587819|69155979|FG000|Overall Study|Adverse Event|1|||
37964553|NCT00410410|69651658|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
37964554|NCT00410410|69651659|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
37964555|NCT00410410|69651660|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
37964556|NCT00410410|69651652|FG000|Open-Label Period (OL)|Pregnancy|0|||
37964557|NCT00410410|69651653|FG001|Open-Label Period (OL)|Pregnancy|0|||
37964558|NCT00410410|69651654|FG002|Open-Label Period (OL)|Pregnancy|0|||
37964559|NCT00410410|69651655|FG003|Open-Label Period (OL)|Pregnancy|0|||
37964560|NCT00410410|69651656|FG004|Open-Label Period (OL)|Pregnancy|0|||
37964561|NCT00410410|69651657|FG005|Open-Label Period (OL)|Pregnancy|0|||
37964562|NCT00410410|69651658|FG006|Open-Label Period (OL)|Pregnancy|0|||
37964563|NCT00410410|69651659|FG007|Open-Label Period (OL)|Pregnancy|0|||
37964564|NCT00410410|69651660|FG008|Open-Label Period (OL)|Pregnancy|1|||
37964565|NCT00410410|69651652|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
37964566|NCT00410410|69651653|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
37964567|NCT00410410|69651654|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
37964568|NCT00410410|69651655|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
37964569|NCT00410410|69651656|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
37964570|NCT00410410|69651657|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
37964571|NCT00410410|69651658|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
37964572|NCT00410410|69651659|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
37964573|NCT00410410|69651660|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
37964574|NCT00410410|69651652|FG000|Open-Label Period (OL)|Other|0|||
37964575|NCT00410410|69651653|FG001|Open-Label Period (OL)|Other|0|||
37964576|NCT00410410|69651654|FG002|Open-Label Period (OL)|Other|0|||
38054371|NCT03847896|69744510|FG004|Overall Study|Protocol Violation|2|||
38054372|NCT03847896|69744506|FG000|Overall Study|Lost to Follow-up|0|||
38054373|NCT03847896|69744507|FG001|Overall Study|Lost to Follow-up|0|||
38054374|NCT03847896|69744508|FG002|Overall Study|Lost to Follow-up|0|||
38054375|NCT03847896|69744509|FG003|Overall Study|Lost to Follow-up|1|||
38054376|NCT03847896|69744510|FG004|Overall Study|Lost to Follow-up|0|||
38054377|NCT03847896|69744506|FG000|Overall Study|Condition under investigation worsened|0|||
38054378|NCT03847896|69744507|FG001|Overall Study|Condition under investigation worsened|0|||
38054379|NCT03847896|69744508|FG002|Overall Study|Condition under investigation worsened|0|||
38054380|NCT03847896|69744509|FG003|Overall Study|Condition under investigation worsened|1|||
38054381|NCT03847896|69744510|FG004|Overall Study|Condition under investigation worsened|1|||
38054382|NCT03847896|69744506|FG000|Overall Study|Lack of Efficacy|0|||
38054383|NCT03847896|69744507|FG001|Overall Study|Lack of Efficacy|0|||
38054384|NCT03847896|69744508|FG002|Overall Study|Lack of Efficacy|0|||
38054385|NCT03847896|69744509|FG003|Overall Study|Lack of Efficacy|2|||
38054386|NCT03847896|69744510|FG004|Overall Study|Lack of Efficacy|2|||
38054387|NCT03847896|69744506|FG000|Overall Study|Other reasons|3|||
38054388|NCT03847896|69744507|FG001|Overall Study|Other reasons|3|||
38054389|NCT03847896|69744508|FG002|Overall Study|Other reasons|1|||
38054390|NCT03847896|69744509|FG003|Overall Study|Other reasons|2|||
38054391|NCT03847896|69744510|FG004|Overall Study|Other reasons|1|||
38054392|NCT03670537|69744522|FG000|Overall Study|Protocol Violation|1|||
38054393|NCT03619837|69744526|FG000|Screening|received organs from HCV-negative donors|47|||
38054394|NCT03619837|69744526|FG000|Screening|died on the wait-list|2|||
38054395|NCT03619837|69744526|FG000|Screening|remained on the wait list|40|||
38054396|NCT03619837|69744526|FG000|Screening|didn't meet eligibility criteria|3|||
38054397|NCT03619837|69744526|FG000|Screening|withdrew consent|2|||
38054398|NCT03619837|69744526|FG000|Screening|never listed for HCV-viremic donor|1|||
38054399|NCT03619837|69744526|FG000|Screening|developed exclusion criteria|2|||
38054400|NCT03619837|69744526|FG000|Screening|excluded by the investigator due to non-compliance|1|||
38054401|NCT03206970|69744530|FG000|Overall Study|Death|21|||
38054402|NCT03206970|69744530|FG000|Overall Study|Withdrawal by Subject|13|||
38054403|NCT03206970|69744530|FG000|Overall Study|Lost to Follow-up|3|||
38054404|NCT03206970|69744530|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
38054405|NCT03644173|69744534|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
38054406|NCT03644173|69744534|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
38054407|NCT03644173|69744534|FG000|Participants at the 1-month Follow up|Death|2|||
38054408|NCT03644173|69744534|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
38054409|NCT03178851|69744542|FG000|Overall Study|Death|48|||
38054410|NCT03178851|69744543|FG001|Overall Study|Death|2|||
38054411|NCT03178851|69744544|FG002|Overall Study|Death|25|||
37964577|NCT00410410|69651655|FG003|Open-Label Period (OL)|Other|0|||
37964578|NCT00410410|69651656|FG004|Open-Label Period (OL)|Other|0|||
37964579|NCT00410410|69651657|FG005|Open-Label Period (OL)|Other|0|||
37964580|NCT00410410|69651658|FG006|Open-Label Period (OL)|Other|0|||
37964581|NCT00410410|69651659|FG007|Open-Label Period (OL)|Other|0|||
37964582|NCT00410410|69651660|FG008|Open-Label Period (OL)|Other|7|||
37964583|NCT00534404|69651698|FG000|Overall Study|Death|0|||
37964584|NCT00534404|69651699|FG001|Overall Study|Death|0|||
37964585|NCT00534404|69651700|FG002|Overall Study|Death|2|||
37964586|NCT00534404|69651698|FG000|Overall Study|Withdrawal by Subject|8|||
37964587|NCT00534404|69651699|FG001|Overall Study|Withdrawal by Subject|2|||
37964588|NCT00534404|69651700|FG002|Overall Study|Withdrawal by Subject|38|||
37964589|NCT00534404|69651698|FG000|Overall Study|Removed by study staff|2|||
37964590|NCT00534404|69651699|FG001|Overall Study|Removed by study staff|3|||
37964591|NCT00534404|69651700|FG002|Overall Study|Removed by study staff|1|||
38054412|NCT03178851|69744542|FG000|Overall Study|Withdrawal by Subject|8|||
38054413|NCT03178851|69744543|FG001|Overall Study|Withdrawal by Subject|0|||
38054414|NCT03178851|69744544|FG002|Overall Study|Withdrawal by Subject|0|||
37964592|NCT00534404|69651698|FG000|Overall Study|Lost to Follow-up|170|||
38054415|NCT03178851|69744542|FG000|Overall Study|Lost to Follow-up|5|||
38054416|NCT03178851|69744543|FG001|Overall Study|Lost to Follow-up|2|||
38054417|NCT03178851|69744544|FG002|Overall Study|Lost to Follow-up|0|||
38054418|NCT03178851|69744542|FG000|Overall Study|Adverse Event|0|||
38054419|NCT03178851|69744543|FG001|Overall Study|Adverse Event|0|||
38054420|NCT03178851|69744544|FG002|Overall Study|Adverse Event|1|||
38054421|NCT03178851|69744542|FG000|Overall Study|Study Termination by Sponsor|31|||
38054422|NCT03178851|69744543|FG001|Overall Study|Study Termination by Sponsor|7|||
38054423|NCT03178851|69744544|FG002|Overall Study|Study Termination by Sponsor|26|||
38054424|NCT03643159|69744555|FG000|Overall Study|Adverse Event|1|||
38054425|NCT03643159|69744555|FG000|Overall Study|Withdrawal by Subject|1|||
38054426|NCT03205566|69744562|FG000|Phase 1|Protocol Violation|1|||
38054427|NCT03205566|69744563|FG001|Phase 1|Protocol Violation|1|||
38054428|NCT02935452|69744575|FG000|Overall Study|work and life commintment|3|||
38054429|NCT02935452|69744576|FG001|Overall Study|work and life commintment|1|||
38054430|NCT03178773|69744584|FG000|Overall Study|Death|0|||
38054431|NCT03178773|69744585|FG001|Overall Study|Death|1|||
38054432|NCT03178773|69744584|FG000|Overall Study|Lost to Follow-up|29|||
38054433|NCT03178773|69744585|FG001|Overall Study|Lost to Follow-up|25|||
38054434|NCT03178773|69744584|FG000|Overall Study|Withdrawal by Subject|10|||
38054435|NCT03178773|69744585|FG001|Overall Study|Withdrawal by Subject|14|||
38054436|NCT03713034|69744594|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
38054437|NCT03713034|69744595|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
38054438|NCT03218397|69744605|FG000|Overall Study|Prior positive blood culture|8|||
38054439|NCT03218397|69744606|FG001|Overall Study|Prior positive blood culture|13|||
38054440|NCT03218397|69744605|FG000|Overall Study|Comfort care|8|||
38054441|NCT03218397|69744606|FG001|Overall Study|Comfort care|5|||
38054442|NCT03218397|69744605|FG000|Overall Study|Comfort care and positive blood culture|1|||
38054443|NCT03218397|69744606|FG001|Overall Study|Comfort care and positive blood culture|0|||
38054444|NCT03218397|69744605|FG000|Overall Study|Comfort care and mixed culture|0|||
38054445|NCT03218397|69744606|FG001|Overall Study|Comfort care and mixed culture|1|||
38054446|NCT03218397|69744605|FG000|Overall Study|Mixed culture|2|||
38054447|NCT03218397|69744606|FG001|Overall Study|Mixed culture|2|||
38054448|NCT03218397|69744605|FG000|Overall Study|Inaccessible hospital records|2|||
38054449|NCT03218397|69744606|FG001|Overall Study|Inaccessible hospital records|5|||
38054450|NCT03218397|69744605|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
38054451|NCT03218397|69744606|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
38054452|NCT03218397|69744605|FG000|Overall Study|Randomized during laboratory off hours|2|||
38054453|NCT03218397|69744606|FG001|Overall Study|Randomized during laboratory off hours|1|||
38054454|NCT03618823|69744614|FG000|Overall Study|Lost to Follow-up|63|||
38054455|NCT03618823|69744615|FG001|Overall Study|Lost to Follow-up|61|||
38054456|NCT03640507|69744627|FG000|Overall Study|Withdrawal by Subject|0|||
38054457|NCT03640507|69744628|FG001|Overall Study|Withdrawal by Subject|0|||
38054458|NCT03640507|69744629|FG002|Overall Study|Withdrawal by Subject|1|||
38054459|NCT02937636|69744639|FG000|Overall Study|Other (Not specified)|3|||
38054460|NCT02937636|69744640|FG001|Overall Study|Other (Not specified)|2|||
38054461|NCT03638635|69744649|FG000|Initial Hospitalization|Study terminated prematurely|0|||
38054462|NCT03638635|69744650|FG001|Initial Hospitalization|Study terminated prematurely|1|||
38054463|NCT03638635|69744649|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
38054464|NCT03638635|69744650|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
38054465|NCT03638635|69744649|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
38054466|NCT03638635|69744650|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
38054467|NCT03204981|69744656|FG000|Overall Study|Physician Decision|2|||
38054468|NCT03204981|69744656|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
38054469|NCT03205488|69744665|FG000|Overall Study|Adverse Event|1|||
38054470|NCT03205488|69744666|FG001|Overall Study|Adverse Event|2|||
38054471|NCT03205488|69744667|FG002|Overall Study|Adverse Event|4|||
38054472|NCT03205488|69744665|FG000|Overall Study|Protocol Violation|0|||
38054473|NCT03205488|69744666|FG001|Overall Study|Protocol Violation|0|||
38054474|NCT03205488|69744667|FG002|Overall Study|Protocol Violation|1|||
38054475|NCT03204279|69744681|FG000|Overall Study|Withdrawal by Subject|0|||
38054476|NCT03204279|69744682|FG001|Overall Study|Withdrawal by Subject|1|||
38054477|NCT03173547|69744691|FG000|Overall Study|Adverse Event|2|||
38054478|NCT03173547|69744692|FG001|Overall Study|Adverse Event|0|||
38054479|NCT03173547|69744691|FG000|Overall Study|Withdrawal by Subject|2|||
38054480|NCT03173547|69744692|FG001|Overall Study|Withdrawal by Subject|2|||
38054481|NCT02954653|69744700|FG000|Overall Study|Death|3|||
37862126|NCT01134393|69545880|FG000|Overall Study|Protocol Violation|12|||
37862127|NCT01134393|69545880|FG000|Overall Study|Lost to Follow-up|3|||
38054482|NCT02954653|69744701|FG001|Overall Study|Death|1|||
38054483|NCT02954653|69744702|FG002|Overall Study|Death|0|||
38054484|NCT02954653|69744703|FG003|Overall Study|Death|0|||
38054485|NCT02954653|69744704|FG004|Overall Study|Death|0|||
38054486|NCT02954653|69744705|FG005|Overall Study|Death|0|||
38054487|NCT02954653|69744706|FG006|Overall Study|Death|0|||
38054488|NCT02954653|69744707|FG007|Overall Study|Death|0|||
38054489|NCT02954653|69744708|FG008|Overall Study|Death|0|||
38054490|NCT02954653|69744700|FG000|Overall Study|Randomized but did not receive treatment|1|||
38054491|NCT02954653|69744701|FG001|Overall Study|Randomized but did not receive treatment|0|||
38054492|NCT02954653|69744702|FG002|Overall Study|Randomized but did not receive treatment|0|||
38054493|NCT02954653|69744703|FG003|Overall Study|Randomized but did not receive treatment|0|||
38054494|NCT02954653|69744704|FG004|Overall Study|Randomized but did not receive treatment|0|||
38054495|NCT02954653|69744705|FG005|Overall Study|Randomized but did not receive treatment|0|||
38054496|NCT02954653|69744706|FG006|Overall Study|Randomized but did not receive treatment|0|||
38054497|NCT02954653|69744707|FG007|Overall Study|Randomized but did not receive treatment|0|||
38054498|NCT02954653|69744708|FG008|Overall Study|Randomized but did not receive treatment|0|||
38054499|NCT02954653|69744700|FG000|Overall Study|Started another anti-cancer therapy|0|||
38054500|NCT02954653|69744701|FG001|Overall Study|Started another anti-cancer therapy|1|||
38054501|NCT02954653|69744702|FG002|Overall Study|Started another anti-cancer therapy|0|||
38054502|NCT02954653|69744703|FG003|Overall Study|Started another anti-cancer therapy|0|||
38054503|NCT02954653|69744704|FG004|Overall Study|Started another anti-cancer therapy|0|||
38054504|NCT02954653|69744705|FG005|Overall Study|Started another anti-cancer therapy|0|||
38054505|NCT02954653|69744706|FG006|Overall Study|Started another anti-cancer therapy|0|||
38054506|NCT02954653|69744707|FG007|Overall Study|Started another anti-cancer therapy|0|||
38054507|NCT02954653|69744708|FG008|Overall Study|Started another anti-cancer therapy|0|||
38054508|NCT02954653|69744700|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
38054509|NCT02954653|69744701|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
38054510|NCT02954653|69744702|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
38054511|NCT02954653|69744703|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
38054512|NCT02954653|69744704|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
38054513|NCT02954653|69744705|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
38054514|NCT02954653|69744706|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
38054515|NCT02954653|69744707|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
38054516|NCT02954653|69744708|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
38054517|NCT03173313|69744722|FG000|Overall Study|Lost to Follow-up|2|||
38054518|NCT03173313|69744723|FG001|Overall Study|Lost to Follow-up|3|||
38054519|NCT03173313|69744722|FG000|Overall Study|Withdrawal by Subject|0|||
38054520|NCT03173313|69744723|FG001|Overall Study|Withdrawal by Subject|1|||
38054521|NCT03173313|69744722|FG000|Overall Study|Death|5|||
38054522|NCT03173313|69744723|FG001|Overall Study|Death|0|||
38054523|NCT03173313|69744722|FG000|Overall Study|Physician Decision|1|||
38054524|NCT03173313|69744723|FG001|Overall Study|Physician Decision|0|||
38054525|NCT03173313|69744722|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
38054526|NCT03173313|69744723|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
38054527|NCT03173313|69744722|FG000|Overall Study|Bone Fracture|1|||
38054528|NCT03173313|69744723|FG001|Overall Study|Bone Fracture|0|||
38054529|NCT03215667|69744729|FG000|Overall Study|Physician Decision|4|||
38054530|NCT03634579|69744733|FG000|Overall Study|study termination|9|||
38054531|NCT02730208|69744739|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
38054532|NCT02730208|69744740|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
38054533|NCT01291511|69744748|FG000|Cross-Titration and Stabilization Phase|Withdrawal by Subject|107|||
38054534|NCT01291511|69744749|FG001|Cross-Titration and Stabilization Phase|Withdrawal by Subject|0|||
38054535|NCT01291511|69744748|FG000|Cross-Titration and Stabilization Phase|Adverse Event|92|||
38054536|NCT01291511|69744749|FG001|Cross-Titration and Stabilization Phase|Adverse Event|0|||
38054537|NCT01291511|69744748|FG000|Cross-Titration and Stabilization Phase|Administrative problems|30|||
38054538|NCT01291511|69744749|FG001|Cross-Titration and Stabilization Phase|Administrative problems|0|||
38054539|NCT01291511|69744748|FG000|Cross-Titration and Stabilization Phase|Lack of Efficacy|28|||
38054540|NCT01291511|69744749|FG001|Cross-Titration and Stabilization Phase|Lack of Efficacy|0|||
38054541|NCT01291511|69744748|FG000|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|25|||
38054542|NCT01291511|69744749|FG001|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|0|||
38054543|NCT01291511|69744748|FG000|Cross-Titration and Stabilization Phase|Lost to Follow-up|24|||
38054544|NCT01291511|69744749|FG001|Cross-Titration and Stabilization Phase|Lost to Follow-up|0|||
38054545|NCT01291511|69744748|FG000|Cross-Titration and Stabilization Phase|Protocol Violation|13|||
38054546|NCT01291511|69744749|FG001|Cross-Titration and Stabilization Phase|Protocol Violation|0|||
38054547|NCT01291511|69744748|FG000|Cross-Titration and Stabilization Phase|Abnormal test|6|||
38054548|NCT01291511|69744749|FG001|Cross-Titration and Stabilization Phase|Abnormal test|0|||
38054549|NCT01291511|69744748|FG000|Cross-Titration and Stabilization Phase|Death|1|||
38054550|NCT01291511|69744749|FG001|Cross-Titration and Stabilization Phase|Death|0|||
38054551|NCT01291511|69744748|FG000|Double-blind Relapse Prevention Phase|Administrative problems|45|||
38054552|NCT01291511|69744749|FG001|Double-blind Relapse Prevention Phase|Administrative problems|29|||
38054553|NCT01291511|69744748|FG000|Double-blind Relapse Prevention Phase|Withdrawal by Subject|14|||
38054554|NCT01291511|69744749|FG001|Double-blind Relapse Prevention Phase|Withdrawal by Subject|10|||
38054555|NCT01291511|69744748|FG000|Double-blind Relapse Prevention Phase|Lost to Follow-up|6|||
38054556|NCT01291511|69744749|FG001|Double-blind Relapse Prevention Phase|Lost to Follow-up|4|||
38054557|NCT01291511|69744748|FG000|Double-blind Relapse Prevention Phase|Adverse Event|5|||
38054558|NCT01291511|69744749|FG001|Double-blind Relapse Prevention Phase|Adverse Event|0|||
38054559|NCT01291511|69744748|FG000|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|4|||
38054560|NCT01291511|69744749|FG001|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|2|||
38054561|NCT01291511|69744748|FG000|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
38054562|NCT01291511|69744749|FG001|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
38054563|NCT01291511|69744748|FG000|Double-blind Relapse Prevention Phase|Lack of Efficacy|0|||
38054564|NCT01291511|69744749|FG001|Double-blind Relapse Prevention Phase|Lack of Efficacy|2|||
38054565|NCT01291511|69744748|FG000|Double-blind Relapse Prevention Phase|Abnormal test|1|||
38054566|NCT01291511|69744749|FG001|Double-blind Relapse Prevention Phase|Abnormal test|0|||
38054567|NCT01291511|69744748|FG000|Double-blind Relapse Prevention Phase|Death|1|||
38054568|NCT01291511|69744749|FG001|Double-blind Relapse Prevention Phase|Death|0|||
38054569|NCT03201900|69744756|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
38054570|NCT03201900|69744756|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
38054571|NCT03201900|69744756|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
38054572|NCT03201900|69744756|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
38054573|NCT03201900|69744756|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
38054574|NCT03201900|69744756|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
38054575|NCT03201900|69744756|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
38054576|NCT03201900|69744756|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
38054577|NCT03201900|69744756|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
38054578|NCT03201900|69744756|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
38054579|NCT03201900|69744756|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
38054580|NCT03201900|69744756|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
38054581|NCT03201900|69744756|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
38054582|NCT03170271|69744771|FG000|Overall Study|Adverse Event|7|||
38054583|NCT03170271|69744772|FG001|Overall Study|Adverse Event|2|||
38054584|NCT03170271|69744771|FG000|Overall Study|Lost to Follow-up|0|||
38054585|NCT03170271|69744772|FG001|Overall Study|Lost to Follow-up|1|||
38054586|NCT03170271|69744771|FG000|Overall Study|Physician Decision|1|||
38054587|NCT03170271|69744772|FG001|Overall Study|Physician Decision|0|||
38054588|NCT03170271|69744771|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
38054589|NCT03170271|69744772|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
37964593|NCT00534404|69651699|FG001|Overall Study|Lost to Follow-up|138|||
37964594|NCT00534404|69651700|FG002|Overall Study|Lost to Follow-up|201|||
37964595|NCT00393094|69651708|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
37964596|NCT00393094|69651708|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
37964597|NCT00409786|69651714|FG000|Overall Study|Withdrawal by Subject|3|||
37964598|NCT00409708|69651720|FG000|Treatment|Abnormal test procedure result(s)|1|||
37964599|NCT00409708|69651721|FG001|Treatment|Abnormal test procedure result(s)|0|||
37964600|NCT00409708|69651720|FG000|Treatment|Lack of Efficacy|0|||
37964601|NCT00409708|69651721|FG001|Treatment|Lack of Efficacy|1|||
37964602|NCT00409708|69651720|FG000|Treatment|Protocol Violation|6|||
37964603|NCT00409708|69651721|FG001|Treatment|Protocol Violation|2|||
37964604|NCT00409708|69651720|FG000|Treatment|Withdrawal by Subject|3|||
37964605|NCT00409708|69651721|FG001|Treatment|Withdrawal by Subject|8|||
37964606|NCT00409708|69651720|FG000|Treatment|Lost to Follow-up|0|||
37964607|NCT00409708|69651721|FG001|Treatment|Lost to Follow-up|6|||
37964608|NCT00409708|69651720|FG000|Treatment|Administrative problems|5|||
37964609|NCT00409708|69651721|FG001|Treatment|Administrative problems|0|||
38054590|NCT03170271|69744771|FG000|Overall Study|Withdrawal by Subject|17|||
37964610|NCT00409708|69651720|FG000|Washout|Lack of Efficacy|9|||
37964611|NCT00409708|69651721|FG001|Washout|Lack of Efficacy|1|||
37964612|NCT00409708|69651720|FG000|Washout|Protocol Violation|0|||
37964613|NCT00409708|69651721|FG001|Washout|Protocol Violation|1|||
37964614|NCT00409708|69651720|FG000|Washout|Withdrawal by Subject|11|||
38054591|NCT03170271|69744772|FG001|Overall Study|Withdrawal by Subject|5|||
38054592|NCT03170271|69744771|FG000|Overall Study|Other|2|||
38054593|NCT03170271|69744772|FG001|Overall Study|Other|2|||
38054594|NCT03170271|69744771|FG000|Overall Study|Randomized in error|4|||
38054595|NCT03170271|69744772|FG001|Overall Study|Randomized in error|0|||
38054596|NCT03613129|69744782|FG000|Pre-treatment Assessment|Protocol Violation|2|||
38054597|NCT03613129|69744783|FG001|Pre-treatment Assessment|Protocol Violation|0|||
38054598|NCT03613129|69744784|FG002|Pre-treatment Assessment|Protocol Violation|0|||
38054599|NCT03613129|69744785|FG003|Pre-treatment Assessment|Protocol Violation|0|||
38054600|NCT03613129|69744786|FG004|Pre-treatment Assessment|Protocol Violation|0|||
38054601|NCT03613129|69744782|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
38054602|NCT03613129|69744783|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
38054603|NCT03613129|69744784|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
38054604|NCT03613129|69744785|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
38054605|NCT03613129|69744786|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
38054606|NCT03235284|69744801|FG000|Overall Study|Adverse Event|1|||
38054607|NCT03235284|69744802|FG001|Overall Study|Adverse Event|2|||
38054608|NCT03235284|69744803|FG002|Overall Study|Adverse Event|1|||
38054609|NCT03170193|69744818|FG000|Overall Study|Withdrawal by Subject|0|||
38054610|NCT03170193|69744819|FG001|Overall Study|Withdrawal by Subject|0|||
38054611|NCT03170193|69744820|FG002|Overall Study|Withdrawal by Subject|0|||
38054612|NCT03170193|69744821|FG003|Overall Study|Withdrawal by Subject|1|||
38054613|NCT03170193|69744822|FG004|Overall Study|Withdrawal by Subject|0|||
38054614|NCT03170193|69744823|FG005|Overall Study|Withdrawal by Subject|0|||
38054615|NCT03170193|69744824|FG006|Overall Study|Withdrawal by Subject|0|||
38054616|NCT03170193|69744818|FG000|Overall Study|Lost to Follow-up|1|||
38054617|NCT03170193|69744819|FG001|Overall Study|Lost to Follow-up|1|||
38054618|NCT03170193|69744820|FG002|Overall Study|Lost to Follow-up|0|||
38054619|NCT03170193|69744821|FG003|Overall Study|Lost to Follow-up|0|||
38054620|NCT03170193|69744822|FG004|Overall Study|Lost to Follow-up|0|||
38054621|NCT03170193|69744823|FG005|Overall Study|Lost to Follow-up|0|||
38054622|NCT03170193|69744824|FG006|Overall Study|Lost to Follow-up|0|||
38054623|NCT03633331|69744846|FG000|Overall Study|Withdrawal by Subject|1|||
38054624|NCT03201003|69744852|FG000|Overall Study|Adverse Event|14|||
38054625|NCT03201003|69744853|FG001|Overall Study|Adverse Event|1|||
38054626|NCT03201003|69744852|FG000|Overall Study|Other reasons|5|||
38054627|NCT03201003|69744853|FG001|Overall Study|Other reasons|1|||
38054628|NCT03201003|69744852|FG000|Overall Study|Withdrawal by Subject|4|||
38054629|NCT03201003|69744853|FG001|Overall Study|Withdrawal by Subject|1|||
38054630|NCT03201003|69744852|FG000|Overall Study|Lost to Follow-up|2|||
38054631|NCT03201003|69744853|FG001|Overall Study|Lost to Follow-up|0|||
38054632|NCT03201003|69744852|FG000|Overall Study|Protocol Violation|1|||
38054633|NCT03201003|69744853|FG001|Overall Study|Protocol Violation|0|||
38054634|NCT03166215|69744861|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
38054635|NCT03166215|69744862|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
38054636|NCT03166215|69744863|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
38054637|NCT03166215|69744861|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
38054638|NCT03166215|69744862|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
38054639|NCT03166215|69744863|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
38054640|NCT03168711|69744885|FG000|Overall Study|Adverse Event|2|||
38054641|NCT03168711|69744886|FG001|Overall Study|Adverse Event|0|||
38054642|NCT03168711|69744885|FG000|Overall Study|Withdrawal by Subject|0|||
38054643|NCT03168711|69744886|FG001|Overall Study|Withdrawal by Subject|1|||
38054644|NCT03168711|69744885|FG000|Overall Study|Death|0|||
38054645|NCT03168711|69744886|FG001|Overall Study|Death|1|||
38054646|NCT03738215|69744895|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
38054647|NCT03738215|69744896|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
38054648|NCT03738215|69744897|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
38054649|NCT03738215|69744895|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
38054650|NCT03738215|69744896|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
38054651|NCT03738215|69744897|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
38054652|NCT03738215|69744895|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
37964615|NCT00409708|69651721|FG001|Washout|Withdrawal by Subject|5|||
38054653|NCT03738215|69744896|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
38054654|NCT03738215|69744897|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
38054655|NCT03738215|69744895|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
38054656|NCT03738215|69744896|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
38054657|NCT03738215|69744897|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
38054658|NCT03738215|69744895|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
38054659|NCT03738215|69744896|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
38054660|NCT03738215|69744897|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
38054661|NCT03738215|69744895|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
38054662|NCT03738215|69744896|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
38054663|NCT03738215|69744897|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
38054664|NCT03738215|69744895|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
38054665|NCT03738215|69744896|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
38054666|NCT03738215|69744897|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
38054667|NCT03738215|69744895|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
38054668|NCT03738215|69744896|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
38054669|NCT03738215|69744897|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
38054670|NCT03738215|69744895|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
38054671|NCT03738215|69744896|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
38054672|NCT03738215|69744897|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
38054673|NCT03738215|69744895|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
38054674|NCT03738215|69744896|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
38054675|NCT03738215|69744897|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
38054676|NCT03199911|69744907|FG000|Overall Study|Lost to Follow-up|5|||
38054677|NCT03199911|69744908|FG001|Overall Study|Lost to Follow-up|5|||
38054678|NCT03199911|69744907|FG000|Overall Study|Did not proceed with surgery|2|||
38054679|NCT03199911|69744908|FG001|Overall Study|Did not proceed with surgery|1|||
38054680|NCT03736967|69744918|FG000|Overall Study|Withdrawal by Subject|26|||
38054681|NCT03736967|69744919|FG001|Overall Study|Withdrawal by Subject|25|||
38054682|NCT03736967|69744920|FG002|Overall Study|Withdrawal by Subject|23|||
38054683|NCT03736967|69744921|FG003|Overall Study|Withdrawal by Subject|26|||
38054684|NCT03736967|69744918|FG000|Overall Study|Lost to Follow-up|3|||
38054685|NCT03736967|69744919|FG001|Overall Study|Lost to Follow-up|2|||
38054686|NCT03736967|69744920|FG002|Overall Study|Lost to Follow-up|1|||
38054687|NCT03736967|69744921|FG003|Overall Study|Lost to Follow-up|1|||
38054688|NCT03736967|69744918|FG000|Overall Study|Physician Decision|1|||
38054689|NCT03736967|69744919|FG001|Overall Study|Physician Decision|0|||
38054690|NCT03736967|69744920|FG002|Overall Study|Physician Decision|0|||
38054691|NCT03736967|69744921|FG003|Overall Study|Physician Decision|1|||
38054692|NCT03736967|69744918|FG000|Overall Study|Adverse Event|0|||
38054693|NCT03736967|69744919|FG001|Overall Study|Adverse Event|1|||
38054694|NCT03736967|69744920|FG002|Overall Study|Adverse Event|0|||
38054695|NCT03736967|69744921|FG003|Overall Study|Adverse Event|1|||
38054696|NCT03736967|69744918|FG000|Overall Study|Death|0|||
38054697|NCT03736967|69744919|FG001|Overall Study|Death|0|||
38054698|NCT03736967|69744920|FG002|Overall Study|Death|0|||
38054699|NCT03736967|69744921|FG003|Overall Study|Death|1|||
38054700|NCT03736967|69744918|FG000|Overall Study|Randomized but never treated|1|||
38054701|NCT03736967|69744919|FG001|Overall Study|Randomized but never treated|0|||
38054702|NCT03736967|69744920|FG002|Overall Study|Randomized but never treated|0|||
38054703|NCT03736967|69744921|FG003|Overall Study|Randomized but never treated|0|||
38054704|NCT03168555|69744934|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
38054705|NCT03168555|69744934|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
38054706|NCT03168555|69744934|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
38054707|NCT03168555|69744934|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
38054708|NCT03235050|69744946|FG000|Overall Study|Adverse Event|0|||
38054709|NCT03235050|69744947|FG001|Overall Study|Adverse Event|0|||
38054710|NCT03235050|69744948|FG002|Overall Study|Adverse Event|1|||
38054711|NCT03235050|69744949|FG003|Overall Study|Adverse Event|4|||
38054712|NCT03235050|69744950|FG004|Overall Study|Adverse Event|1|||
38054713|NCT03235050|69744946|FG000|Overall Study|Death|0|||
38054714|NCT03235050|69744947|FG001|Overall Study|Death|0|||
38054715|NCT03235050|69744948|FG002|Overall Study|Death|0|||
38054716|NCT03235050|69744949|FG003|Overall Study|Death|2|||
38054717|NCT03235050|69744950|FG004|Overall Study|Death|1|||
38054718|NCT03235050|69744946|FG000|Overall Study|Lost to Follow-up|1|||
38054719|NCT03235050|69744947|FG001|Overall Study|Lost to Follow-up|2|||
38054720|NCT03235050|69744948|FG002|Overall Study|Lost to Follow-up|1|||
38054721|NCT03235050|69744949|FG003|Overall Study|Lost to Follow-up|2|||
38054722|NCT03235050|69744950|FG004|Overall Study|Lost to Follow-up|0|||
38054723|NCT03235050|69744946|FG000|Overall Study|Withdrawal by Subject|3|||
38054724|NCT03235050|69744947|FG001|Overall Study|Withdrawal by Subject|2|||
38054725|NCT03235050|69744948|FG002|Overall Study|Withdrawal by Subject|2|||
38054726|NCT03235050|69744949|FG003|Overall Study|Withdrawal by Subject|5|||
38054727|NCT03235050|69744950|FG004|Overall Study|Withdrawal by Subject|7|||
38054728|NCT03235050|69744946|FG000|Overall Study|Other reasons|0|||
38054729|NCT03235050|69744947|FG001|Overall Study|Other reasons|1|||
38054730|NCT03235050|69744948|FG002|Overall Study|Other reasons|0|||
38054731|NCT03235050|69744949|FG003|Overall Study|Other reasons|1|||
38054732|NCT03235050|69744950|FG004|Overall Study|Other reasons|2|||
38054733|NCT04502212|69744979|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
38054734|NCT04502212|69744979|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
38054735|NCT03167619|69744986|FG000|Overall Study|Death|11|||
38054736|NCT03167619|69744987|FG001|Overall Study|Death|8|||
38054737|NCT03167619|69744986|FG000|Overall Study|Withdrawal by Subject|1|||
38054738|NCT03167619|69744987|FG001|Overall Study|Withdrawal by Subject|2|||
38054739|NCT03167619|69744986|FG000|Overall Study|Physician Decision|0|||
38054740|NCT03167619|69744987|FG001|Overall Study|Physician Decision|1|||
38054741|NCT03578809|69744997|FG000|Overall Study|Death|0|||
38054742|NCT03578809|69744998|FG001|Overall Study|Death|2|||
38054743|NCT03578809|69744999|FG002|Overall Study|Death|0|||
38054744|NCT03578809|69745000|FG003|Overall Study|Death|1|||
38054745|NCT03578809|69744997|FG000|Overall Study|Lost to Follow-up|0|||
38054746|NCT03578809|69744998|FG001|Overall Study|Lost to Follow-up|1|||
38054747|NCT03578809|69744999|FG002|Overall Study|Lost to Follow-up|0|||
38054748|NCT03578809|69745000|FG003|Overall Study|Lost to Follow-up|0|||
38054749|NCT03578809|69744997|FG000|Overall Study|Withdrawal by Subject|3|||
38054750|NCT03578809|69744998|FG001|Overall Study|Withdrawal by Subject|5|||
38054751|NCT03578809|69744999|FG002|Overall Study|Withdrawal by Subject|2|||
38054752|NCT03578809|69745000|FG003|Overall Study|Withdrawal by Subject|0|||
38054753|NCT03578809|69744997|FG000|Overall Study|Other|3|||
38054754|NCT03578809|69744998|FG001|Overall Study|Other|6|||
38054755|NCT03578809|69744999|FG002|Overall Study|Other|2|||
38054756|NCT03578809|69745000|FG003|Overall Study|Other|8|||
38054757|NCT03198507|69745015|FG000|Overall Study|Withdrawal by Subject|1|||
38054758|NCT03198507|69745016|FG001|Overall Study|Withdrawal by Subject|0|||
38054759|NCT03610165|69745024|FG000|Overall Study|Device didn't work|0|||
38054760|NCT03610165|69745025|FG001|Overall Study|Device didn't work|1|||
38054761|NCT03609619|69745033|FG000|Overall Study|Adverse Event|1|||
38054762|NCT03609619|69745034|FG001|Overall Study|Adverse Event|0|||
38054763|NCT03609619|69745033|FG000|Overall Study|Lack of Efficacy|1|||
38054764|NCT03609619|69745034|FG001|Overall Study|Lack of Efficacy|2|||
38054765|NCT03609619|69745033|FG000|Overall Study|Protocol Violation|5|||
38054766|NCT03609619|69745034|FG001|Overall Study|Protocol Violation|0|||
38054767|NCT03609619|69745033|FG000|Overall Study|Withdrawal by Subject|2|||
38054768|NCT03609619|69745034|FG001|Overall Study|Withdrawal by Subject|3|||
38054769|NCT03609619|69745033|FG000|Overall Study|Lost to Follow-up|1|||
38054770|NCT03609619|69745034|FG001|Overall Study|Lost to Follow-up|1|||
38054771|NCT03167151|69745043|FG000|Overall Study|Withdrawal by Subject|1|||
38054772|NCT03167151|69745044|FG001|Overall Study|Withdrawal by Subject|0|||
38054773|NCT03167151|69745045|FG002|Overall Study|Withdrawal by Subject|0|||
38054774|NCT03167151|69745043|FG000|Overall Study|No evidence of tumour at surgery|0|||
38054775|NCT03167151|69745044|FG001|Overall Study|No evidence of tumour at surgery|1|||
38054776|NCT03167151|69745045|FG002|Overall Study|No evidence of tumour at surgery|1|||
38054777|NCT03660943|69745055|FG000|Overall Study|Adverse Event|5|||
38054778|NCT03660943|69745056|FG001|Overall Study|Adverse Event|3|||
38054779|NCT03660943|69745055|FG000|Overall Study|Death|0|||
38054780|NCT03660943|69745056|FG001|Overall Study|Death|2|||
38054781|NCT03660943|69745055|FG000|Overall Study|Lost to Follow-up|7|||
38054782|NCT03660943|69745056|FG001|Overall Study|Lost to Follow-up|3|||
38054783|NCT03660943|69745055|FG000|Overall Study|Protocol Violation|3|||
38054784|NCT03660943|69745056|FG001|Overall Study|Protocol Violation|5|||
38054785|NCT03660943|69745055|FG000|Overall Study|Withdrawal by Subject|8|||
38054786|NCT03660943|69745056|FG001|Overall Study|Withdrawal by Subject|15|||
38054787|NCT03660943|69745055|FG000|Overall Study|Lack of Efficacy|9|||
38054788|NCT03660943|69745056|FG001|Overall Study|Lack of Efficacy|12|||
38054789|NCT03660943|69745055|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
38054790|NCT03660943|69745056|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
38054791|NCT03167073|69745064|FG000|Overall Study|Stillbirth|1|||
38054792|NCT03167073|69745065|FG001|Overall Study|Stillbirth|0|||
38054793|NCT03657277|69745071|FG000|Overall Study|Physician Decision|2|||
38054794|NCT03657277|69745071|FG000|Overall Study|Lost to Follow-up|1|||
38054795|NCT03657277|69745071|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
38054796|NCT03197883|69745077|FG000|Overall Study|Adverse Event|1|||
38054797|NCT03197883|69745078|FG001|Overall Study|Adverse Event|1|||
38054798|NCT03197883|69745077|FG000|Overall Study|Lost to Follow-up|1|||
38054799|NCT03197883|69745078|FG001|Overall Study|Lost to Follow-up|0|||
38054800|NCT03197883|69745077|FG000|Overall Study|Protocol Violation|1|||
37964616|NCT00409708|69651720|FG000|Washout|Lost to Follow-up|1|||
37964617|NCT00409708|69651721|FG001|Washout|Lost to Follow-up|3|||
37964618|NCT00391846|69651738|FG000|Overall Study|Adverse Event|4|||
37964619|NCT00391846|69651739|FG001|Overall Study|Adverse Event|1|||
37964620|NCT00391846|69651738|FG000|Overall Study|Did not meet the required elig. crit|2|||
37964621|NCT00391846|69651739|FG001|Overall Study|Did not meet the required elig. crit|2|||
37964622|NCT00391846|69651738|FG000|Overall Study|Withdrawal by Subject|2|||
37964623|NCT00391846|69651739|FG001|Overall Study|Withdrawal by Subject|3|||
37964624|NCT00391846|69651738|FG000|Overall Study|Developed study specific DC criteria|0|||
37964625|NCT00391846|69651739|FG001|Overall Study|Developed study specific DC criteria|1|||
37964626|NCT00534248|69651764|FG000|Overall Study|Adverse Event|19|||
37964627|NCT00534248|69651765|FG001|Overall Study|Adverse Event|29|||
37964628|NCT00534248|69651764|FG000|Overall Study|Lost to Follow-up|353|||
37964629|NCT00534248|69651765|FG001|Overall Study|Lost to Follow-up|375|||
37964630|NCT00534248|69651764|FG000|Overall Study|Other protocol specified criteria|13|||
37964631|NCT00534248|69651765|FG001|Overall Study|Other protocol specified criteria|3|||
37964632|NCT00534248|69651764|FG000|Overall Study|Physician Decision|10|||
37964633|NCT00534248|69651765|FG001|Overall Study|Physician Decision|7|||
37964634|NCT00534248|69651764|FG000|Overall Study|Protocol Violation|3|||
37964635|NCT00534248|69651765|FG001|Overall Study|Protocol Violation|4|||
37964636|NCT00534248|69651764|FG000|Overall Study|Withdrawal by Subject|263|||
37964637|NCT00534248|69651765|FG001|Overall Study|Withdrawal by Subject|255|||
37964638|NCT00391768|69651778|FG000|Overall Study|Withdrawal by Subject|0|||
37964639|NCT00391768|69651779|FG001|Overall Study|Withdrawal by Subject|0|||
37964640|NCT00391768|69651780|FG002|Overall Study|Withdrawal by Subject|1|||
37964641|NCT00391768|69651781|FG003|Overall Study|Withdrawal by Subject|0|||
37964642|NCT00391768|69651782|FG004|Overall Study|Withdrawal by Subject|0|||
37964643|NCT00391768|69651783|FG005|Overall Study|Withdrawal by Subject|1|||
37964644|NCT00391768|69651784|FG006|Overall Study|Withdrawal by Subject|1|||
37964645|NCT00391768|69651778|FG000|Overall Study|Lost to Follow-up|0|||
37964646|NCT00391768|69651779|FG001|Overall Study|Lost to Follow-up|0|||
37964647|NCT00391768|69651780|FG002|Overall Study|Lost to Follow-up|0|||
37964648|NCT00391768|69651781|FG003|Overall Study|Lost to Follow-up|1|||
37964649|NCT00391768|69651782|FG004|Overall Study|Lost to Follow-up|2|||
37964650|NCT00391768|69651783|FG005|Overall Study|Lost to Follow-up|2|||
37964651|NCT00391768|69651784|FG006|Overall Study|Lost to Follow-up|3|||
37964652|NCT00391222|69651821|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
37964653|NCT00391222|69651822|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
37964654|NCT00391222|69651823|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
37964655|NCT00391222|69651824|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
37964656|NCT00391222|69651821|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
37964657|NCT00391222|69651822|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
37964658|NCT00391222|69651823|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
37964659|NCT00391222|69651824|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
37964660|NCT00391222|69651821|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
37964661|NCT00391222|69651822|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
37964662|NCT00391222|69651823|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
37964663|NCT00391222|69651824|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
37964664|NCT00391222|69651821|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
37964665|NCT00391222|69651822|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
37964666|NCT00391222|69651823|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
37964667|NCT00391222|69651824|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
37964668|NCT00391222|69651821|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
37964669|NCT00391222|69651822|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
37964670|NCT00391222|69651823|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
37964671|NCT00391222|69651824|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
37964672|NCT00391222|69651821|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
37964673|NCT00391222|69651822|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
37964674|NCT00391222|69651823|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
37964675|NCT00391222|69651824|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
37964676|NCT00391222|69651821|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
37964677|NCT00391222|69651822|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
37964678|NCT00391222|69651823|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
38054801|NCT03197883|69745078|FG001|Overall Study|Protocol Violation|0|||
37964679|NCT00391222|69651824|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
37964680|NCT00391222|69651821|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
38054802|NCT03197883|69745077|FG000|Overall Study|Other (Not Specified)|0|||
38054803|NCT03197883|69745078|FG001|Overall Study|Other (Not Specified)|5|||
38054804|NCT03234036|69745087|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
38054805|NCT03234036|69745088|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
38054806|NCT03234036|69745089|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
38054807|NCT03234036|69745090|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
38054808|NCT03606109|69745108|FG000|Overall Study|Lost to Follow-up|2|||
38054809|NCT03606109|69745109|FG001|Overall Study|Lost to Follow-up|1|||
38054810|NCT02729896|69745118|FG000|Overall Study|Death|0|||
38054811|NCT02729896|69745119|FG001|Overall Study|Death|2|||
38054812|NCT02729896|69745120|FG002|Overall Study|Death|13|||
38054813|NCT02729896|69745118|FG000|Overall Study|Lost to Follow-up|0|||
38054814|NCT02729896|69745119|FG001|Overall Study|Lost to Follow-up|2|||
38054815|NCT02729896|69745120|FG002|Overall Study|Lost to Follow-up|3|||
38054816|NCT02729896|69745118|FG000|Overall Study|Other|0|||
38054817|NCT02729896|69745119|FG001|Overall Study|Other|2|||
38054818|NCT02729896|69745120|FG002|Overall Study|Other|0|||
38054819|NCT02729896|69745118|FG000|Overall Study|Physician Decision|1|||
38054820|NCT02729896|69745119|FG001|Overall Study|Physician Decision|2|||
38054821|NCT02729896|69745120|FG002|Overall Study|Physician Decision|3|||
38054822|NCT02729896|69745118|FG000|Overall Study|Progressive Disease|0|||
38054823|NCT02729896|69745119|FG001|Overall Study|Progressive Disease|1|||
38054824|NCT02729896|69745120|FG002|Overall Study|Progressive Disease|0|||
38054825|NCT02729896|69745118|FG000|Overall Study|Withdrawal by Subject|1|||
38054826|NCT02729896|69745119|FG001|Overall Study|Withdrawal by Subject|0|||
38054827|NCT02729896|69745120|FG002|Overall Study|Withdrawal by Subject|3|||
38054828|NCT03575065|69745131|FG000|Overall Study|Death|31|||
38054829|NCT03575065|69745132|FG001|Overall Study|Death|12|||
38054830|NCT03575065|69745131|FG000|Overall Study|Sponsor's Decision|28|||
38054831|NCT03575065|69745132|FG001|Overall Study|Sponsor's Decision|13|||
38054832|NCT03575065|69745131|FG000|Overall Study|Withdrawal by Subject|2|||
38054833|NCT03575065|69745132|FG001|Overall Study|Withdrawal by Subject|1|||
38054834|NCT03575065|69745131|FG000|Overall Study|Lost to Follow-up|1|||
38054835|NCT03575065|69745132|FG001|Overall Study|Lost to Follow-up|0|||
38054836|NCT03514134|69745141|FG000|Overall Study|Lost to Follow-up|0|||
38054837|NCT03514134|69745142|FG001|Overall Study|Lost to Follow-up|1|||
38054838|NCT03188718|69745148|FG000|Overall Study|Participant noncompliance|4|||
38054839|NCT03188718|69745148|FG000|Overall Study|Withdrawal by Subject|1|||
38054840|NCT03188718|69745148|FG000|Overall Study|Device failure|3|||
38054841|NCT03574753|69745152|FG000|Overall Study|Adverse Event|3|||
38054842|NCT03574753|69745152|FG000|Overall Study|Progression/relapse|19|||
38054843|NCT03574753|69745152|FG000|Overall Study|Death|1|||
38054844|NCT03573505|69745159|FG000|Overall Study|Adverse Event|1|||
38054845|NCT03573505|69745160|FG001|Overall Study|Adverse Event|1|||
38054846|NCT03573505|69745159|FG000|Overall Study|Consent withdrawn|0|||
38054847|NCT03573505|69745160|FG001|Overall Study|Consent withdrawn|1|||
38054848|NCT03573505|69745159|FG000|Overall Study|Disease progression|0|||
38054849|NCT03573505|69745160|FG001|Overall Study|Disease progression|1|||
38054850|NCT03573505|69745159|FG000|Overall Study|Site Terminated by Sponsor|1|||
38054851|NCT03573505|69745160|FG001|Overall Study|Site Terminated by Sponsor|1|||
38054852|NCT03573505|69745159|FG000|Overall Study|Study terminated by sponsor|50|||
38054853|NCT03573505|69745160|FG001|Overall Study|Study terminated by sponsor|45|||
38054854|NCT03573505|69745159|FG000|Overall Study|Reason not specified|0|||
38054855|NCT03573505|69745160|FG001|Overall Study|Reason not specified|1|||
38054856|NCT03573505|69745159|FG000|Overall Study|Death|0|||
38054857|NCT03573505|69745160|FG001|Overall Study|Death|4|||
38054858|NCT01376908|69745169|FG000|Overall Study|Protocol Violation|1|||
38054859|NCT01376908|69745170|FG001|Overall Study|Protocol Violation|1|||
38054860|NCT01376908|69745169|FG000|Overall Study|Withdrawal by Subject|1|||
38054861|NCT01376908|69745170|FG001|Overall Study|Withdrawal by Subject|2|||
38054862|NCT03736031|69745185|FG000|Overall Study|Death|2|||
38054863|NCT03736031|69745186|FG001|Overall Study|Death|4|||
38054864|NCT03736031|69745185|FG000|Overall Study|Lost to Follow-up|21|||
38054865|NCT03736031|69745186|FG001|Overall Study|Lost to Follow-up|2|||
38054866|NCT03736031|69745185|FG000|Overall Study|Withdrawal by Subject|9|||
38054867|NCT03736031|69745186|FG001|Overall Study|Withdrawal by Subject|0|||
38054868|NCT03602053|69745195|FG000|Overall Study|Withdrawal by Subject|7|||
38054869|NCT03602053|69745196|FG001|Overall Study|Withdrawal by Subject|9|||
38054870|NCT03602053|69745197|FG002|Overall Study|Withdrawal by Subject|7|||
38054871|NCT03602053|69745195|FG000|Overall Study|Lost to Follow-up|5|||
38054872|NCT03602053|69745196|FG001|Overall Study|Lost to Follow-up|6|||
38054873|NCT03602053|69745197|FG002|Overall Study|Lost to Follow-up|0|||
38054874|NCT03602053|69745195|FG000|Overall Study|Protocol Violation|3|||
38054875|NCT03602053|69745196|FG001|Overall Study|Protocol Violation|0|||
38054876|NCT03602053|69745197|FG002|Overall Study|Protocol Violation|4|||
38054877|NCT03602053|69745195|FG000|Overall Study|Physician Decision|1|||
38054878|NCT03602053|69745196|FG001|Overall Study|Physician Decision|0|||
38054879|NCT03602053|69745197|FG002|Overall Study|Physician Decision|0|||
38054880|NCT03602053|69745195|FG000|Overall Study|migration|2|||
38054881|NCT03602053|69745196|FG001|Overall Study|migration|3|||
37964681|NCT00391222|69651822|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
37964682|NCT00391222|69651823|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
37964683|NCT00391222|69651824|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
37964684|NCT00391222|69651821|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
37964685|NCT00391222|69651822|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
37964686|NCT00391222|69651823|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
37964687|NCT00391222|69651824|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
37964688|NCT00391222|69651821|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
37964689|NCT00391222|69651822|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
37964690|NCT00391222|69651823|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
37964691|NCT00391222|69651824|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
37964692|NCT00391222|69651821|FG000|Period III (Double-Blind Treatment)|Other|6|||
37964693|NCT00391222|69651822|FG001|Period III (Double-Blind Treatment)|Other|1|||
37964694|NCT00391222|69651823|FG002|Period III (Double-Blind Treatment)|Other|6|||
37964695|NCT00391222|69651824|FG003|Period III (Double-Blind Treatment)|Other|0|||
37964696|NCT00409006|69651836|FG000|Overall Study|Death|15|||
37964697|NCT00409006|69651837|FG001|Overall Study|Death|6|||
37964698|NCT00409006|69651836|FG000|Overall Study|Lost to Follow-up|1|||
37964699|NCT00409006|69651837|FG001|Overall Study|Lost to Follow-up|2|||
37964700|NCT00409006|69651836|FG000|Overall Study|Withdrawal by Subject|3|||
37964701|NCT00409006|69651837|FG001|Overall Study|Withdrawal by Subject|2|||
37964702|NCT00409006|69651836|FG000|Overall Study|Physician Decision|1|||
37964703|NCT00409006|69651837|FG001|Overall Study|Physician Decision|2|||
37964704|NCT00534092|69651845|FG000|Overall Study|Lost to Follow-up|1|||
37964705|NCT00534092|69651846|FG001|Overall Study|Lost to Follow-up|0|||
37964706|NCT00534092|69651845|FG000|Overall Study|personal reasons/family concerns|1|||
37964707|NCT00534092|69651846|FG001|Overall Study|personal reasons/family concerns|0|||
37964708|NCT00408928|69651854|FG000|Overall Study|Withdrawal by Subject|1|||
37964709|NCT00408928|69651854|FG000|Overall Study|Death|1|||
37964710|NCT00408928|69651854|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
37964711|NCT00390910|69651861|FG000|Overall Study|Adverse Event|1|||
37964712|NCT00390910|69651862|FG001|Overall Study|Adverse Event|0|||
37964713|NCT00390910|69651863|FG002|Overall Study|Adverse Event|0|||
37964714|NCT00390910|69651861|FG000|Overall Study|Lost to Follow-up|0|||
37964715|NCT00390910|69651862|FG001|Overall Study|Lost to Follow-up|1|||
37964716|NCT00390910|69651863|FG002|Overall Study|Lost to Follow-up|5|||
37964717|NCT00390910|69651861|FG000|Overall Study|Withdrawal by Subject|1|||
37964718|NCT00390910|69651862|FG001|Overall Study|Withdrawal by Subject|3|||
37964719|NCT00390910|69651863|FG002|Overall Study|Withdrawal by Subject|2|||
37964720|NCT00390910|69651861|FG000|Overall Study|Migrated/moved from study area|0|||
37964721|NCT00390910|69651862|FG001|Overall Study|Migrated/moved from study area|0|||
37964722|NCT00390910|69651863|FG002|Overall Study|Migrated/moved from study area|3|||
37964723|NCT00533702|69651875|FG000|Overall Study|Withdrawal by Subject|3|||
37964724|NCT00533702|69651876|FG001|Overall Study|Withdrawal by Subject|1|||
37964725|NCT00533702|69651875|FG000|Overall Study|Found ineligible after randomization|2|||
37964726|NCT00533702|69651876|FG001|Overall Study|Found ineligible after randomization|1|||
37964727|NCT00408694|69651882|FG000|Overall Study|Ineligible|1|||
37964728|NCT00408694|69651882|FG000|Overall Study|No protocol treatment|1|||
37964729|NCT00396136|69651886|FG000|Overall Study|Death|43|||
37964730|NCT00396136|69651886|FG000|Overall Study|Withdrawal by Subject|59|||
37964731|NCT00396136|69651886|FG000|Overall Study|Lost to Follow-up|15|||
37964732|NCT00396136|69651886|FG000|Overall Study|Study device explanted|8|||
37964733|NCT00530894|69651894|FG000|Overall Study|Death|84|||
37964734|NCT00530894|69651895|FG001|Overall Study|Death|89|||
37964735|NCT00530894|69651896|FG002|Overall Study|Death|55|||
37964736|NCT00530894|69651897|FG003|Overall Study|Death|89|||
37964737|NCT00530894|69651894|FG000|Overall Study|Lost to Follow-up|1|||
37964738|NCT00530894|69651895|FG001|Overall Study|Lost to Follow-up|3|||
37964739|NCT00530894|69651896|FG002|Overall Study|Lost to Follow-up|0|||
37964740|NCT00530894|69651897|FG003|Overall Study|Lost to Follow-up|0|||
37964741|NCT00530894|69651894|FG000|Overall Study|Withdrawal by Subject|1|||
37964742|NCT00530894|69651895|FG001|Overall Study|Withdrawal by Subject|23|||
37964743|NCT00530894|69651896|FG002|Overall Study|Withdrawal by Subject|0|||
37964744|NCT00530894|69651897|FG003|Overall Study|Withdrawal by Subject|5|||
37964745|NCT00530894|69651894|FG000|Overall Study|Alive and censored prior to 1 year|2|||
37964746|NCT00530894|69651895|FG001|Overall Study|Alive and censored prior to 1 year|0|||
37964747|NCT00530894|69651896|FG002|Overall Study|Alive and censored prior to 1 year|0|||
37964748|NCT00530894|69651897|FG003|Overall Study|Alive and censored prior to 1 year|0|||
37964749|NCT00056407|69651911|FG000|Overall Study|Adverse Event|282|||
37964750|NCT00056407|69651912|FG001|Overall Study|Adverse Event|364|||
37964751|NCT00056407|69651911|FG000|Overall Study|Withdrawal by Subject|377|||
37964752|NCT00056407|69651912|FG001|Overall Study|Withdrawal by Subject|361|||
37964753|NCT00056407|69651911|FG000|Overall Study|Lost to Follow-up|123|||
37964754|NCT00056407|69651912|FG001|Overall Study|Lost to Follow-up|113|||
38054882|NCT03602053|69745197|FG002|Overall Study|migration|0|||
38054883|NCT03602053|69745195|FG000|Overall Study|Other|1|||
38054884|NCT03602053|69745196|FG001|Overall Study|Other|0|||
38054885|NCT03602053|69745197|FG002|Overall Study|Other|0|||
38054886|NCT04831515|69745209|FG000|First Intervention|Adverse Event|0|||
38054887|NCT04831515|69745210|FG001|First Intervention|Adverse Event|1|||
38054888|NCT03554629|69745216|FG000|Overall Study|Inadequate data|6|||
38054889|NCT03196791|69745246|FG000|Overall Study|Protocol Violation|7|||
38054890|NCT03196791|69745247|FG001|Overall Study|Protocol Violation|3|||
38054891|NCT03196791|69745246|FG000|Overall Study|Withdrawal by Subject|3|||
38054892|NCT03196791|69745247|FG001|Overall Study|Withdrawal by Subject|2|||
38054893|NCT03196635|69745253|FG000|Overall Study|Withdrawal by Subject|1|||
38054894|NCT03194217|69745275|FG000|Overall Study|Adverse Event|0|||
38054895|NCT03194217|69745276|FG001|Overall Study|Adverse Event|2|||
38054896|NCT03194217|69745277|FG002|Overall Study|Adverse Event|3|||
38054897|NCT03194217|69745278|FG003|Overall Study|Adverse Event|3|||
38054898|NCT03194217|69745275|FG000|Overall Study|Failure to meet randomisation criteria|0|||
38054899|NCT03194217|69745276|FG001|Overall Study|Failure to meet randomisation criteria|0|||
38054900|NCT03194217|69745277|FG002|Overall Study|Failure to meet randomisation criteria|0|||
38054901|NCT03194217|69745278|FG003|Overall Study|Failure to meet randomisation criteria|1|||
38054902|NCT03194217|69745275|FG000|Overall Study|Other|0|||
38054903|NCT03194217|69745276|FG001|Overall Study|Other|1|||
38054904|NCT03194217|69745277|FG002|Overall Study|Other|1|||
38054905|NCT03194217|69745278|FG003|Overall Study|Other|0|||
38054906|NCT00709618|69745288|FG000|Overall Study|Withdrawal by Subject|4|||
38054907|NCT00709618|69745288|FG000|Overall Study|Lost to Follow-up|1|||
38054908|NCT00709618|69745288|FG000|Overall Study|Study Closed/Terminated|25|||
38054909|NCT03193047|69745294|FG000|Overall Study|Physician Decision|1|||
38054910|NCT03193047|69745295|FG001|Overall Study|Physician Decision|0|||
38054911|NCT03193047|69745294|FG000|Overall Study|Participant Left State|1|||
38054912|NCT03193047|69745295|FG001|Overall Study|Participant Left State|0|||
38054913|NCT02918019|69745307|FG000|Overall Study|Death|0|||
38054914|NCT02918019|69745308|FG001|Overall Study|Death|0|||
38054915|NCT02918019|69745309|FG002|Overall Study|Death|1|||
38054916|NCT02918019|69745310|FG003|Overall Study|Death|0|||
38054917|NCT02918019|69745307|FG000|Overall Study|Lost to Follow-up|1|||
38054918|NCT02918019|69745308|FG001|Overall Study|Lost to Follow-up|1|||
38054919|NCT02918019|69745309|FG002|Overall Study|Lost to Follow-up|0|||
38054920|NCT02918019|69745310|FG003|Overall Study|Lost to Follow-up|1|||
38054921|NCT02918019|69745307|FG000|Overall Study|Principal investigator request|0|||
38054922|NCT02918019|69745308|FG001|Overall Study|Principal investigator request|0|||
38054923|NCT02918019|69745309|FG002|Overall Study|Principal investigator request|0|||
38054924|NCT02918019|69745310|FG003|Overall Study|Principal investigator request|1|||
38054925|NCT02918019|69745307|FG000|Overall Study|Physician Decision|1|||
38054926|NCT02918019|69745308|FG001|Overall Study|Physician Decision|3|||
38054927|NCT02918019|69745309|FG002|Overall Study|Physician Decision|2|||
38054928|NCT02918019|69745310|FG003|Overall Study|Physician Decision|0|||
38054929|NCT02918019|69745307|FG000|Overall Study|Protocol deviation|1|||
38054930|NCT02918019|69745308|FG001|Overall Study|Protocol deviation|1|||
37964755|NCT00056407|69651911|FG000|Overall Study|Protocol Violation|104|||
37964756|NCT00056407|69651912|FG001|Overall Study|Protocol Violation|95|||
37964757|NCT00056407|69651911|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
37964758|NCT00056407|69651912|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
37964759|NCT00056407|69651911|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
37964760|NCT00056407|69651912|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
37964761|NCT00056407|69651911|FG000|Overall Study|Missing|25|||
37964762|NCT00056407|69651912|FG001|Overall Study|Missing|34|||
37964763|NCT00388726|69651920|FG000|Overall Study|Adverse Event|50|||
37964764|NCT00388726|69651921|FG001|Overall Study|Adverse Event|24|||
37964765|NCT00388726|69651920|FG000|Overall Study|Progressive Disease|336|||
37964766|NCT00388726|69651921|FG001|Overall Study|Progressive Disease|153|||
37964767|NCT00388726|69651920|FG000|Overall Study|Clinical Progression|61|||
37964768|NCT00388726|69651921|FG001|Overall Study|Clinical Progression|36|||
37964769|NCT00388726|69651920|FG000|Overall Study|Withdrawal by Subject|10|||
37964770|NCT00388726|69651921|FG001|Overall Study|Withdrawal by Subject|7|||
38054931|NCT02918019|69745309|FG002|Overall Study|Protocol deviation|0|||
38054932|NCT02918019|69745310|FG003|Overall Study|Protocol deviation|2|||
38054933|NCT02918019|69745307|FG000|Overall Study|Withdrawal by Subject|3|||
38054934|NCT02918019|69745308|FG001|Overall Study|Withdrawal by Subject|4|||
38054935|NCT02918019|69745309|FG002|Overall Study|Withdrawal by Subject|6|||
38054936|NCT02918019|69745310|FG003|Overall Study|Withdrawal by Subject|4|||
38054937|NCT02918019|69745307|FG000|Overall Study|Adverse Event|0|||
38054938|NCT02918019|69745308|FG001|Overall Study|Adverse Event|1|||
38054939|NCT02918019|69745309|FG002|Overall Study|Adverse Event|0|||
38054940|NCT02918019|69745310|FG003|Overall Study|Adverse Event|1|||
38054941|NCT03055988|69745328|FG000|Period 1|Adverse Event|0|||
38054942|NCT03055988|69745329|FG001|Period 1|Adverse Event|1|||
38054943|NCT03055988|69745328|FG000|Period 1|Lost to Follow-up|1|||
38054944|NCT03055988|69745329|FG001|Period 1|Lost to Follow-up|0|||
38054945|NCT03055988|69745328|FG000|Period 1|Withdrawal by Subject|0|||
38054946|NCT03055988|69745329|FG001|Period 1|Withdrawal by Subject|4|||
38054947|NCT03055988|69745328|FG000|Period 2|Adverse Event|0|||
38054948|NCT03055988|69745329|FG001|Period 2|Adverse Event|1|||
38054949|NCT03055988|69745328|FG000|Period 2|Other than listed|1|||
38054950|NCT03055988|69745329|FG001|Period 2|Other than listed|1|||
38054951|NCT01250912|69745335|FG000|Overall Study|Lost to Follow-up|1|||
38054952|NCT03733301|69745345|FG000|Overall Study|Screen Fail|1|||
38054953|NCT03733301|69745346|FG001|Overall Study|Screen Fail|0|||
38054954|NCT03733301|69745347|FG002|Overall Study|Screen Fail|0|||
38054955|NCT03733301|69745345|FG000|Overall Study|Non-compliance|1|||
38054956|NCT03733301|69745346|FG001|Overall Study|Non-compliance|0|||
38054957|NCT03733301|69745347|FG002|Overall Study|Non-compliance|0|||
38054958|NCT03733301|69745345|FG000|Overall Study|Lack of Efficacy|2|||
38054959|NCT03733301|69745346|FG001|Overall Study|Lack of Efficacy|3|||
38054960|NCT03733301|69745347|FG002|Overall Study|Lack of Efficacy|0|||
38054961|NCT03733301|69745345|FG000|Overall Study|Adverse Event|0|||
38054962|NCT03733301|69745346|FG001|Overall Study|Adverse Event|1|||
38054963|NCT03733301|69745347|FG002|Overall Study|Adverse Event|3|||
38054964|NCT03733301|69745345|FG000|Overall Study|Withdrawal by Subject|3|||
38054965|NCT03733301|69745346|FG001|Overall Study|Withdrawal by Subject|5|||
38054966|NCT03733301|69745347|FG002|Overall Study|Withdrawal by Subject|1|||
38054967|NCT02871297|69745356|FG000|Overall Study|Adverse Event|34|||
38054968|NCT02871297|69745356|FG000|Overall Study|Lack of Efficacy|10|||
38054969|NCT02871297|69745356|FG000|Overall Study|Non-compliance with study drug|15|||
38054970|NCT02871297|69745356|FG000|Overall Study|Protocol Violation|3|||
38054971|NCT02871297|69745356|FG000|Overall Study|Withdrawal by Subject|20|||
38054972|NCT02871297|69745356|FG000|Overall Study|Lost to Follow-up|13|||
38054973|NCT02871297|69745356|FG000|Overall Study|Rolled over to 13546A|2|||
38054974|NCT02871297|69745356|FG000|Overall Study|Other than specified|39|||
38054975|NCT03554005|69745366|FG000|Overall Study|Not in participant's best interest|0|||
38054976|NCT03554005|69745367|FG001|Overall Study|Not in participant's best interest|0|||
38054977|NCT03554005|69745368|FG002|Overall Study|Not in participant's best interest|0|||
38054978|NCT03554005|69745369|FG003|Overall Study|Not in participant's best interest|0|||
38054979|NCT03554005|69745370|FG004|Overall Study|Not in participant's best interest|0|||
38054980|NCT03554005|69745371|FG005|Overall Study|Not in participant's best interest|1|||
38054981|NCT03554005|69745366|FG000|Overall Study|Disease Progression|1|||
38054982|NCT03554005|69745367|FG001|Overall Study|Disease Progression|1|||
38054983|NCT03554005|69745368|FG002|Overall Study|Disease Progression|1|||
38054984|NCT03554005|69745369|FG003|Overall Study|Disease Progression|1|||
38054985|NCT03554005|69745370|FG004|Overall Study|Disease Progression|5|||
37862128|NCT01134393|69545880|FG000|Overall Study|Withdrawal by Subject|11|||
37862129|NCT01134393|69545880|FG000|Overall Study|Other|6|||
37862130|NCT00922441|69545888|FG000|Overall Study|Protocol Violation|0|||
37964771|NCT00388726|69651920|FG000|Overall Study|Administrative|6|||
37964772|NCT00388726|69651921|FG001|Overall Study|Administrative|9|||
37964773|NCT00388726|69651920|FG000|Overall Study|Physician Decision|18|||
37964774|NCT00388726|69651921|FG001|Overall Study|Physician Decision|13|||
37964775|NCT00388726|69651920|FG000|Overall Study|Death|3|||
37964776|NCT00388726|69651921|FG001|Overall Study|Death|2|||
37964777|NCT00387790|69651927|FG000|Overall Study|Adverse Event|5|||
37964778|NCT00387790|69651927|FG000|Overall Study|Lack of Efficacy|2|||
37964779|NCT00387790|69651927|FG000|Overall Study|Physician Decision|2|||
37964780|NCT00387790|69651927|FG000|Overall Study|Withdrawal by Subject|3|||
37964781|NCT00387790|69651927|FG000|Overall Study|Ineligible for study|2|||
37964782|NCT00073021|69651933|FG000|Overall Study|Protocol Violation|2|||
37964783|NCT00073021|69651934|FG001|Overall Study|Protocol Violation|1|||
37964784|NCT00073021|69651933|FG000|Overall Study|Adverse Event|4|||
37964785|NCT00073021|69651934|FG001|Overall Study|Adverse Event|4|||
37964786|NCT00073021|69651933|FG000|Overall Study|Withdrawal by Subject|6|||
37964787|NCT00073021|69651934|FG001|Overall Study|Withdrawal by Subject|5|||
37964788|NCT00073021|69651933|FG000|Overall Study|Physician Decision|3|||
37964789|NCT00073021|69651934|FG001|Overall Study|Physician Decision|1|||
38054986|NCT03554005|69745371|FG005|Overall Study|Disease Progression|6|||
37862131|NCT00922441|69545889|FG001|Overall Study|Protocol Violation|0|||
37964790|NCT00073021|69651933|FG000|Overall Study|Lack of Efficacy|11|||
37964791|NCT00073021|69651934|FG001|Overall Study|Lack of Efficacy|5|||
37964792|NCT00407758|69651940|FG000|Overall Study|ineligible -improper prior treatment|1|||
38054987|NCT03554005|69745366|FG000|Overall Study|Adverse Event|0|||
38054988|NCT03554005|69745367|FG001|Overall Study|Adverse Event|0|||
38054989|NCT03554005|69745368|FG002|Overall Study|Adverse Event|0|||
38054990|NCT03554005|69745369|FG003|Overall Study|Adverse Event|0|||
38054991|NCT03554005|69745370|FG004|Overall Study|Adverse Event|0|||
38054992|NCT03554005|69745371|FG005|Overall Study|Adverse Event|3|||
38054993|NCT03554005|69745366|FG000|Overall Study|Physician Decision|0|||
38054994|NCT03554005|69745367|FG001|Overall Study|Physician Decision|0|||
38054995|NCT03554005|69745368|FG002|Overall Study|Physician Decision|0|||
38054996|NCT03554005|69745369|FG003|Overall Study|Physician Decision|0|||
38054997|NCT03554005|69745370|FG004|Overall Study|Physician Decision|1|||
38054998|NCT03554005|69745371|FG005|Overall Study|Physician Decision|0|||
38054999|NCT03554005|69745366|FG000|Overall Study|Other|0|||
38055000|NCT03554005|69745367|FG001|Overall Study|Other|0|||
38055001|NCT03554005|69745368|FG002|Overall Study|Other|0|||
38055002|NCT03554005|69745369|FG003|Overall Study|Other|0|||
38055003|NCT03554005|69745370|FG004|Overall Study|Other|0|||
38055004|NCT03554005|69745371|FG005|Overall Study|Other|1|||
38055005|NCT00709228|69745385|FG000|Overall Study|Not treated|14|||
38055006|NCT00709228|69745385|FG000|Overall Study|Eligibility criteria not met|281|||
38055007|NCT00709228|69745385|FG000|Overall Study|Adverse events|2|||
38055008|NCT00709228|69745385|FG000|Overall Study|Discontinued treatment|14|||
38055009|NCT00709228|69745385|FG000|Overall Study|Did not enter follow-up|4|||
38055010|NCT00709228|69745385|FG000|Overall Study|Discontinued follow-up|5|||
38055011|NCT00709228|69745385|FG000|Overall Study|Disease progression|1|||
38055012|NCT00709228|69745385|FG000|Overall Study|Lost to Follow-up|6|||
38055013|NCT00709228|69745385|FG000|Overall Study|Non-compliance|5|||
38055014|NCT03219372|69745391|FG000|Overall Study|Withdrawal by Subject|1|||
38055015|NCT03219372|69745392|FG001|Overall Study|Withdrawal by Subject|0|||
38055016|NCT03056690|69745407|FG000|Overall Study|Adverse Event|3|||
38055017|NCT03056690|69745408|FG001|Overall Study|Adverse Event|2|||
38055018|NCT03056690|69745407|FG000|Overall Study|Lack of Efficacy|1|||
38055019|NCT03056690|69745408|FG001|Overall Study|Lack of Efficacy|2|||
38055020|NCT03056690|69745407|FG000|Overall Study|Lost to Follow-up|3|||
38055021|NCT03056690|69745408|FG001|Overall Study|Lost to Follow-up|2|||
38055022|NCT03056690|69745407|FG000|Overall Study|Protocol Violation|2|||
38055023|NCT03056690|69745408|FG001|Overall Study|Protocol Violation|2|||
38055024|NCT03056690|69745407|FG000|Overall Study|Withdrawal by Subject|3|||
38055025|NCT03056690|69745408|FG001|Overall Study|Withdrawal by Subject|6|||
38055026|NCT03056690|69745407|FG000|Overall Study|Non-compliance with Study Drug|1|||
38055027|NCT03056690|69745408|FG001|Overall Study|Non-compliance with Study Drug|0|||
38055028|NCT03056690|69745407|FG000|Overall Study|Miscellaneous|1|||
38055029|NCT03056690|69745408|FG001|Overall Study|Miscellaneous|2|||
38055030|NCT03191799|69745414|FG000|Overall Study|Withdrawal by Subject|4|||
38055031|NCT03191799|69745414|FG000|Overall Study|Physician Decision|2|||
38055032|NCT03191799|69745414|FG000|Overall Study|Lost to Follow-up|1|||
38055033|NCT03191799|69745414|FG000|Overall Study|Death|2|||
38055034|NCT00708916|69745418|FG000|Overall Study|Subject Noncompliance|2|||
38055035|NCT00708916|69745418|FG000|Overall Study|Adverse Event|2|||
38055036|NCT02352753|69745423|FG000|6-Month Dosing Period|Decision by sponsor|2|||
38055037|NCT02352753|69745423|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
38055038|NCT02352753|69745423|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
38055039|NCT02352753|69745423|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
38055040|NCT02352753|69745423|FG000|3-Month Dosing Period|Decision by sponsor|14|||
38055041|NCT02352753|69745423|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
38055042|NCT04532294|69745434|FG000|Overall Study|Withdrawal by Subject|0|||
38055043|NCT04532294|69745435|FG001|Overall Study|Withdrawal by Subject|0|||
38055044|NCT04532294|69745436|FG002|Overall Study|Withdrawal by Subject|1|||
38055045|NCT04532294|69745434|FG000|Overall Study|Participants Not Dosed|0|||
38055046|NCT04532294|69745435|FG001|Overall Study|Participants Not Dosed|0|||
38055047|NCT04532294|69745436|FG002|Overall Study|Participants Not Dosed|2|||
38055048|NCT03197766|69745448|FG000|Overall Study|Withdrawal by Subject|2|||
38055049|NCT03197766|69745449|FG001|Overall Study|Withdrawal by Subject|0|||
38055050|NCT03738332|69745455|FG000|Overall Study|Withdrawal by Subject|1|||
38055051|NCT03173456|69745465|FG000|Baseline|Medication dispensing system malfunction'|0|||
38055052|NCT03173456|69745466|FG001|Baseline|Medication dispensing system malfunction'|1|||
38055053|NCT03173456|69745467|FG002|Baseline|Medication dispensing system malfunction'|0|||
38055054|NCT03173456|69745468|FG003|Baseline|Medication dispensing system malfunction'|0|||
38055055|NCT03173456|69745469|FG004|Baseline|Medication dispensing system malfunction'|2|||
38055056|NCT03173456|69745465|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
38055057|NCT03173456|69745466|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
38055058|NCT03173456|69745467|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
38055059|NCT03173456|69745468|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
38055060|NCT03173456|69745469|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
38055061|NCT03197376|69745492|FG000|Primary and Booster Phase|Adverse Event|0|||
38055062|NCT03197376|69745493|FG001|Primary and Booster Phase|Adverse Event|0|||
38055063|NCT03197376|69745494|FG002|Primary and Booster Phase|Adverse Event|0|||
38055064|NCT03197376|69745495|FG003|Primary and Booster Phase|Adverse Event|1|||
38055065|NCT03197376|69745492|FG000|Primary and Booster Phase|Death|1|||
38055066|NCT03197376|69745493|FG001|Primary and Booster Phase|Death|0|||
38055067|NCT03197376|69745494|FG002|Primary and Booster Phase|Death|0|||
38055068|NCT03197376|69745495|FG003|Primary and Booster Phase|Death|2|||
38055069|NCT03197376|69745492|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
38055070|NCT03197376|69745493|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
38055071|NCT03197376|69745494|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
38055072|NCT03197376|69745495|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
38055073|NCT03197376|69745492|FG000|Primary and Booster Phase|Physician Decision|1|||
38055074|NCT03197376|69745493|FG001|Primary and Booster Phase|Physician Decision|0|||
38055075|NCT03197376|69745494|FG002|Primary and Booster Phase|Physician Decision|1|||
38055076|NCT03197376|69745495|FG003|Primary and Booster Phase|Physician Decision|3|||
38055077|NCT03197376|69745492|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
38055078|NCT03197376|69745493|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
38055079|NCT03197376|69745494|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
38055080|NCT03197376|69745495|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
38055081|NCT03197376|69745492|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
38055082|NCT03197376|69745493|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
38055083|NCT03197376|69745494|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
38055084|NCT03197376|69745495|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
38055085|NCT03197376|69745492|FG000|Primary and Booster Phase|Not vaccine related|1|||
38055086|NCT03197376|69745493|FG001|Primary and Booster Phase|Not vaccine related|2|||
38055087|NCT03197376|69745494|FG002|Primary and Booster Phase|Not vaccine related|0|||
38055088|NCT03197376|69745495|FG003|Primary and Booster Phase|Not vaccine related|6|||
38055089|NCT03197376|69745492|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
38055090|NCT03197376|69745493|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
38055091|NCT03197376|69745494|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
38055092|NCT03197376|69745495|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
38055093|NCT03197376|69745492|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
38055094|NCT03197376|69745493|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
38055095|NCT03197376|69745494|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
38055096|NCT03197376|69745495|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
38055097|NCT03197376|69745492|FG000|Immune Persistence Phase|Not vaccine related|1|||
38055098|NCT03197376|69745493|FG001|Immune Persistence Phase|Not vaccine related|0|||
38055099|NCT03197376|69745494|FG002|Immune Persistence Phase|Not vaccine related|1|||
38055100|NCT03197376|69745495|FG003|Immune Persistence Phase|Not vaccine related|1|||
38055101|NCT03600805|69745532|FG000|Overall Study|Adverse Event|2|||
38055102|NCT03600805|69745533|FG001|Overall Study|Adverse Event|1|||
38055103|NCT03600805|69745534|FG002|Overall Study|Adverse Event|1|||
38055104|NCT03600805|69745535|FG003|Overall Study|Adverse Event|7|||
38055105|NCT03600805|69745532|FG000|Overall Study|Lack of Efficacy|2|||
38055106|NCT03600805|69745533|FG001|Overall Study|Lack of Efficacy|1|||
38055107|NCT03600805|69745534|FG002|Overall Study|Lack of Efficacy|0|||
38055108|NCT03600805|69745535|FG003|Overall Study|Lack of Efficacy|0|||
38055109|NCT03600805|69745532|FG000|Overall Study|Withdrawal by Subject|1|||
38055110|NCT03600805|69745533|FG001|Overall Study|Withdrawal by Subject|0|||
38055111|NCT03600805|69745534|FG002|Overall Study|Withdrawal by Subject|0|||
38055112|NCT03600805|69745535|FG003|Overall Study|Withdrawal by Subject|1|||
38055113|NCT03600805|69745532|FG000|Overall Study|Other unspecified|14|||
38055114|NCT03600805|69745533|FG001|Overall Study|Other unspecified|6|||
38055115|NCT03600805|69745534|FG002|Overall Study|Other unspecified|7|||
38055116|NCT03600805|69745535|FG003|Overall Study|Other unspecified|11|||
38055117|NCT02729740|69745547|FG000|Overall Study|Early Termination|130|||
38055118|NCT02729740|69745547|FG000|Overall Study|Other|1|||
38055119|NCT03196284|69745557|FG000|Main Part|Withdrawal by Subject|0|||
38055120|NCT03196284|69745558|FG001|Main Part|Withdrawal by Subject|1|||
38055121|NCT03196284|69745559|FG002|Main Part|Withdrawal by Subject|0|||
38055122|NCT03196284|69745557|FG000|Extension Part|Lack of Efficacy|0|||
38055123|NCT03196284|69745558|FG001|Extension Part|Lack of Efficacy|0|||
38055124|NCT03196284|69745559|FG002|Extension Part|Lack of Efficacy|1|||
38055125|NCT03196284|69745557|FG000|Extension Part|Withdrawal by Subject|0|||
38055126|NCT03196284|69745558|FG001|Extension Part|Withdrawal by Subject|0|||
38055127|NCT03196284|69745559|FG002|Extension Part|Withdrawal by Subject|1|||
38055128|NCT03196284|69745557|FG000|Extension Part|Physician Decision|0|||
38055129|NCT03196284|69745558|FG001|Extension Part|Physician Decision|0|||
38055130|NCT03196284|69745559|FG002|Extension Part|Physician Decision|1|||
38055131|NCT03730961|69745581|FG000|Overall Study|Adverse Event|0|||
38055132|NCT03730961|69745582|FG001|Overall Study|Adverse Event|1|||
38055133|NCT01078454|69745590|FG000|Overall Study|Adverse Event|1|||
38055134|NCT01078454|69745591|FG001|Overall Study|Adverse Event|1|||
38055135|NCT01078454|69745590|FG000|Overall Study|Death|0|||
38055136|NCT01078454|69745591|FG001|Overall Study|Death|1|||
38055137|NCT03345004|69745608|FG000|Overall Study|Physician Decision|1|||
38055138|NCT03345004|69745609|FG001|Overall Study|Physician Decision|0|||
38055139|NCT03345004|69745608|FG000|Overall Study|Withdrawal by Subject|0|||
38055140|NCT03345004|69745609|FG001|Overall Study|Withdrawal by Subject|1|||
38055141|NCT03552757|69745620|FG000|Overall Study|Withdrawal by Subject|10|||
38055142|NCT03552757|69745621|FG001|Overall Study|Withdrawal by Subject|5|||
38055143|NCT03552757|69745622|FG002|Overall Study|Withdrawal by Subject|12|||
38055144|NCT03552757|69745620|FG000|Overall Study|Lost to Follow-up|2|||
38055145|NCT03552757|69745621|FG001|Overall Study|Lost to Follow-up|7|||
38055146|NCT03552757|69745622|FG002|Overall Study|Lost to Follow-up|7|||
38055147|NCT03552757|69745620|FG000|Overall Study|Death|1|||
38055148|NCT03552757|69745621|FG001|Overall Study|Death|1|||
38055149|NCT03552757|69745622|FG002|Overall Study|Death|1|||
38055150|NCT03730103|69745635|FG000|Overall Study|Did not meet inclusion criteria|0|||
38055151|NCT03730103|69745636|FG001|Overall Study|Did not meet inclusion criteria|5|||
38055152|NCT03727841|69745644|FG000|Overall Study|Physician Decision|3|||
38055153|NCT03727841|69745645|FG001|Overall Study|Physician Decision|1|||
38055154|NCT03552523|69745651|FG000|Overall Study|Withdrawal by Subject|1|||
38055155|NCT03552523|69745652|FG001|Overall Study|Withdrawal by Subject|1|||
38055156|NCT03345550|69745660|FG000|Overall Study|Withdrawal by Subject|1|||
38055157|NCT03345550|69745661|FG001|Overall Study|Withdrawal by Subject|0|||
38055158|NCT03345550|69745660|FG000|Overall Study|Lost to Follow-up|4|||
38055159|NCT03345550|69745661|FG001|Overall Study|Lost to Follow-up|5|||
38055160|NCT03186378|69745669|FG000|Overall Study|Lost to Follow-up|1|||
38055161|NCT03186378|69745670|FG001|Overall Study|Lost to Follow-up|0|||
38055162|NCT00687596|69745678|FG000|Overall Study|Adverse Event (AE)|10|||
38055163|NCT00687596|69745679|FG001|Overall Study|Adverse Event (AE)|3|||
38055164|NCT00687596|69745678|FG000|Overall Study|Radiological Disease Progression|6|||
38055165|NCT00687596|69745679|FG001|Overall Study|Radiological Disease Progression|2|||
38055166|NCT00687596|69745678|FG000|Overall Study|Clinical Disease Progression|1|||
38055167|NCT00687596|69745679|FG001|Overall Study|Clinical Disease Progression|3|||
38055168|NCT00687596|69745678|FG000|Overall Study|Investigator Discretion|3|||
38055169|NCT00687596|69745679|FG001|Overall Study|Investigator Discretion|1|||
38055170|NCT00687596|69745678|FG000|Overall Study|Sponsor Terminated Study|6|||
38055171|NCT00687596|69745679|FG001|Overall Study|Sponsor Terminated Study|17|||
38055172|NCT02892409|69745687|FG000|Overall Study|Adverse Event|1|||
38055173|NCT02892409|69745688|FG001|Overall Study|Adverse Event|0|||
38055174|NCT02892409|69745687|FG000|Overall Study|Withdrawal by Subject|2|||
38055175|NCT02892409|69745688|FG001|Overall Study|Withdrawal by Subject|1|||
38055176|NCT03219216|69745696|FG000|Overall Study|Lost to Follow-up|0|||
38055177|NCT03219216|69745697|FG001|Overall Study|Lost to Follow-up|1|||
38055178|NCT03195660|69745711|FG000|Overall Study|The study was terminated|2|||
38055179|NCT03194490|69745717|FG000|Overall Study|Lost to Follow-up|1|||
38055180|NCT03194490|69745718|FG001|Overall Study|Lost to Follow-up|3|||
38055181|NCT03194490|69745717|FG000|Overall Study|participant developed specific neck pain|1|||
38055182|NCT03194490|69745718|FG001|Overall Study|participant developed specific neck pain|0|||
38055183|NCT03217968|69745725|FG000|Overall Study|Withdrawal by Subject|4|||
38055184|NCT03217968|69745725|FG000|Overall Study|Lost to Follow-up|1|||
38055185|NCT03217968|69745725|FG000|Overall Study|Protocol Violation|6|||
38055186|NCT03192306|69745731|FG000|Overall Study|Did not treat cold sore during study|149|||
38055187|NCT03192306|69745732|FG001|Overall Study|Did not treat cold sore during study|143|||
38055188|NCT03192306|69745731|FG000|Overall Study|Withdrawal by Subject|1|||
38055189|NCT03192306|69745732|FG001|Overall Study|Withdrawal by Subject|1|||
38055190|NCT03192306|69745731|FG000|Overall Study|Lost to Follow-up|1|||
38055191|NCT03192306|69745732|FG001|Overall Study|Lost to Follow-up|0|||
38055192|NCT03192306|69745731|FG000|Overall Study|Protocol Violation|1|||
38055193|NCT03192306|69745732|FG001|Overall Study|Protocol Violation|1|||
38055194|NCT03216954|69745755|FG000|Overall Study|Adverse Event|0|||
38055195|NCT03216954|69745756|FG001|Overall Study|Adverse Event|0|||
38055196|NCT03216954|69745757|FG002|Overall Study|Adverse Event|1|||
38055197|NCT03216954|69745758|FG003|Overall Study|Adverse Event|0|||
38055198|NCT03216954|69745759|FG004|Overall Study|Adverse Event|1|||
38055199|NCT03216954|69745755|FG000|Overall Study|Withdrawal by Subject|2|||
38055200|NCT03216954|69745756|FG001|Overall Study|Withdrawal by Subject|0|||
38055201|NCT03216954|69745757|FG002|Overall Study|Withdrawal by Subject|0|||
38055202|NCT03216954|69745758|FG003|Overall Study|Withdrawal by Subject|0|||
38055203|NCT03216954|69745759|FG004|Overall Study|Withdrawal by Subject|0|||
38055204|NCT03216954|69745755|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
38055205|NCT03216954|69745756|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
38055206|NCT03216954|69745757|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
38055207|NCT03216954|69745758|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
38055208|NCT03216954|69745759|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
38055209|NCT03599089|69745771|FG000|Overall Study|Lost to Follow-up|1|||
38055210|NCT03599089|69745772|FG001|Overall Study|Lost to Follow-up|0|||
38055211|NCT03599089|69745773|FG002|Overall Study|Lost to Follow-up|0|||
38055212|NCT03599089|69745774|FG003|Overall Study|Lost to Follow-up|0|||
37964793|NCT00531752|69651948|FG000|First Double-blind Intervention Period|Adverse Event|2|||
37964794|NCT00531752|69651949|FG001|First Double-blind Intervention Period|Adverse Event|0|||
37964795|NCT00531752|69651950|FG002|First Double-blind Intervention Period|Adverse Event|1|||
37964796|NCT00531752|69651951|FG003|First Double-blind Intervention Period|Adverse Event|1|||
37964797|NCT00531752|69651948|FG000|First Double-blind Intervention Period|Other|1|||
37964798|NCT00531752|69651949|FG001|First Double-blind Intervention Period|Other|4|||
37964799|NCT00531752|69651950|FG002|First Double-blind Intervention Period|Other|4|||
38055213|NCT03599089|69745771|FG000|Overall Study|Withdrawal by Subject|2|||
37964800|NCT00531752|69651951|FG003|First Double-blind Intervention Period|Other|0|||
38055214|NCT03599089|69745772|FG001|Overall Study|Withdrawal by Subject|1|||
38055215|NCT03599089|69745773|FG002|Overall Study|Withdrawal by Subject|0|||
38055216|NCT03599089|69745774|FG003|Overall Study|Withdrawal by Subject|0|||
38055217|NCT03599089|69745771|FG000|Overall Study|Lack of Efficacy|0|||
38055218|NCT03599089|69745772|FG001|Overall Study|Lack of Efficacy|0|||
38055219|NCT03599089|69745773|FG002|Overall Study|Lack of Efficacy|1|||
38055220|NCT03599089|69745774|FG003|Overall Study|Lack of Efficacy|2|||
38055221|NCT03192150|69745786|FG000|Overall Study|Adverse Event|14|||
38055222|NCT03192150|69745787|FG001|Overall Study|Adverse Event|12|||
38055223|NCT03192150|69745786|FG000|Overall Study|Lack of Efficacy|23|||
38055224|NCT03192150|69745787|FG001|Overall Study|Lack of Efficacy|30|||
38055225|NCT03192150|69745786|FG000|Overall Study|Lost to Follow-up|1|||
38055226|NCT03192150|69745787|FG001|Overall Study|Lost to Follow-up|1|||
38055227|NCT03192150|69745786|FG000|Overall Study|Withdrawal by Subject|4|||
38055228|NCT03192150|69745787|FG001|Overall Study|Withdrawal by Subject|2|||
38055229|NCT03192150|69745786|FG000|Overall Study|Protocol Violation|5|||
38055230|NCT03192150|69745787|FG001|Overall Study|Protocol Violation|2|||
38055231|NCT03192150|69745786|FG000|Overall Study|Surgery Canceled|6|||
38055232|NCT03192150|69745787|FG001|Overall Study|Surgery Canceled|2|||
38055233|NCT03192150|69745786|FG000|Overall Study|Other-Various Administrative Reasons|2|||
38055234|NCT03192150|69745787|FG001|Overall Study|Other-Various Administrative Reasons|5|||
38055235|NCT03597529|69745795|FG000|Overall Study|Lost to Follow-up|10|||
38055236|NCT03597529|69745796|FG001|Overall Study|Lost to Follow-up|12|||
38055237|NCT03597529|69745795|FG000|Overall Study|Physician Decision|3|||
38055238|NCT03597529|69745796|FG001|Overall Study|Physician Decision|1|||
38055239|NCT03597529|69745795|FG000|Overall Study|Withdrawal by Subject|6|||
38055240|NCT03597529|69745796|FG001|Overall Study|Withdrawal by Subject|3|||
38055241|NCT03597529|69745795|FG000|Overall Study|Non-compliant with study activities|1|||
38055242|NCT03597529|69745796|FG001|Overall Study|Non-compliant with study activities|2|||
38055243|NCT03180528|69745802|FG000|Overall Study|Adverse Event|1|||
38055244|NCT03180528|69745802|FG000|Overall Study|Withdrawal by Subject|1|||
38055245|NCT03180528|69745802|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
38055246|NCT03597295|69745806|FG000|Overall Study|Death|70|||
38055247|NCT03597295|69745806|FG000|Overall Study|Lost to Follow-up|7|||
38055248|NCT03180138|69745813|FG000|Overall Study|Mobile-phone could not be verified|2|||
38055249|NCT03180138|69745814|FG001|Overall Study|Mobile-phone could not be verified|13|||
38055250|NCT03180138|69745815|FG002|Overall Study|Mobile-phone could not be verified|15|||
38055251|NCT03180138|69745813|FG000|Overall Study|No prior immunization records|17|||
38055252|NCT03180138|69745814|FG001|Overall Study|No prior immunization records|0|||
38055253|NCT03180138|69745815|FG002|Overall Study|No prior immunization records|6|||
38055254|NCT03180138|69745813|FG000|Overall Study|Found to be >24 mon after randomization|3|||
38055255|NCT03180138|69745814|FG001|Overall Study|Found to be >24 mon after randomization|0|||
38055256|NCT03180138|69745815|FG002|Overall Study|Found to be >24 mon after randomization|3|||
38055257|NCT03597139|69745825|FG000|Overall Study|Adverse Event|3|||
38055258|NCT03597139|69745826|FG001|Overall Study|Adverse Event|0|||
38055259|NCT03597139|69745825|FG000|Overall Study|Protocol Non-compliance|1|||
38055260|NCT03597139|69745826|FG001|Overall Study|Protocol Non-compliance|0|||
38055261|NCT03179202|69745832|FG000|Overall Study|Screen Failure|67|||
38055262|NCT03179202|69745832|FG000|Overall Study|Subject Lost to Follow Up|12|||
38055263|NCT03179202|69745832|FG000|Overall Study|Withdrawal by Subject|7|||
38055264|NCT03179202|69745832|FG000|Overall Study|Adverse Event|3|||
38055265|NCT03179202|69745832|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
38055266|NCT03179202|69745832|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
38055267|NCT00708214|69745841|FG000|Overall Study|Other Adverse Event|3|||
38055268|NCT00708214|69745842|FG001|Overall Study|Other Adverse Event|6|||
38055269|NCT00708214|69745843|FG002|Overall Study|Other Adverse Event|2|||
38055270|NCT00708214|69745841|FG000|Overall Study|Other|0|||
38055271|NCT00708214|69745842|FG001|Overall Study|Other|1|||
38055272|NCT00708214|69745843|FG002|Overall Study|Other|1|||
38055273|NCT00708214|69745841|FG000|Overall Study|Progressive Disease|4|||
38055274|NCT00708214|69745842|FG001|Overall Study|Progressive Disease|6|||
38055275|NCT00708214|69745843|FG002|Overall Study|Progressive Disease|5|||
38055276|NCT03570697|69745858|FG000|Overall Study|Lost to Follow-up|0|||
38055277|NCT03570697|69745859|FG001|Overall Study|Lost to Follow-up|1|||
38055278|NCT03570697|69745858|FG000|Overall Study|Death|2|||
38055279|NCT03570697|69745859|FG001|Overall Study|Death|0|||
38055280|NCT03570697|69745858|FG000|Overall Study|Withdrawal by Subject|4|||
38055281|NCT03570697|69745859|FG001|Overall Study|Withdrawal by Subject|2|||
38055282|NCT03569371|69745876|FG000|Overall Study|Lack of Efficacy|1|||
38055283|NCT03569371|69745876|FG000|Overall Study|Lost to Follow-up|1|||
38055284|NCT03569371|69745876|FG000|Overall Study|Adverse Event|1|||
38055285|NCT01318070|69745883|FG000|Overall Study|Adverse Event|1|||
38055286|NCT01318070|69745884|FG001|Overall Study|Adverse Event|1|||
38055287|NCT01318070|69745885|FG002|Overall Study|Adverse Event|5|||
38055288|NCT01318070|69745883|FG000|Overall Study|Withdrawal by Subject|0|||
38055289|NCT01318070|69745884|FG001|Overall Study|Withdrawal by Subject|1|||
38055290|NCT01318070|69745885|FG002|Overall Study|Withdrawal by Subject|1|||
38055291|NCT01318070|69745883|FG000|Overall Study|Lack of Efficacy|0|||
37862132|NCT00922441|69545890|FG002|Overall Study|Protocol Violation|2|||
37862133|NCT00922441|69545888|FG000|Overall Study|Withdrawal by Subject|0|||
37862134|NCT00922441|69545889|FG001|Overall Study|Withdrawal by Subject|0|||
37862135|NCT00922441|69545890|FG002|Overall Study|Withdrawal by Subject|1|||
37862136|NCT01217112|69545903|FG000|Overall Study|Adverse Event|0|||
37862137|NCT01217112|69545904|FG001|Overall Study|Adverse Event|2|||
37862138|NCT01217112|69545905|FG002|Overall Study|Adverse Event|0|||
37862139|NCT01217112|69545906|FG003|Overall Study|Adverse Event|2|||
37862140|NCT01217112|69545907|FG004|Overall Study|Adverse Event|0|||
37862141|NCT01217112|69545903|FG000|Overall Study|Withdrawal by Subject|0|||
37964801|NCT00531752|69651948|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
37964802|NCT00531752|69651949|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
37964803|NCT00531752|69651950|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
37964804|NCT00531752|69651951|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
37964805|NCT00531752|69651948|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
37964806|NCT00531752|69651949|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
37964807|NCT00531752|69651950|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
37964808|NCT00531752|69651951|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
37964809|NCT00531752|69651948|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
37964810|NCT00531752|69651949|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
37964811|NCT00531752|69651950|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
37964812|NCT00531752|69651951|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
37964813|NCT00531752|69651948|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
37964814|NCT00531752|69651949|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
37964815|NCT00531752|69651950|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
37964816|NCT00531752|69651951|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
37964817|NCT00531752|69651948|FG000|Second Double-blind Intervention Period|Other|1|||
37964818|NCT00531752|69651949|FG001|Second Double-blind Intervention Period|Other|1|||
37964819|NCT00531752|69651950|FG002|Second Double-blind Intervention Period|Other|0|||
37964820|NCT00531752|69651951|FG003|Second Double-blind Intervention Period|Other|0|||
37964821|NCT00531752|69651948|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
37964822|NCT00531752|69651949|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
37964823|NCT00531752|69651950|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
37964824|NCT00531752|69651951|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
37964825|NCT00531752|69651948|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
37964826|NCT00531752|69651949|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
37964827|NCT00531752|69651950|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
37964828|NCT00531752|69651951|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
37964829|NCT00395746|69651962|FG000|Overall Study|Adverse Event|5|||
37964830|NCT00395746|69651963|FG001|Overall Study|Adverse Event|2|||
37964831|NCT00395746|69651964|FG002|Overall Study|Adverse Event|2|||
37964832|NCT00395746|69651962|FG000|Overall Study|Protocol Violation|0|||
37964833|NCT00395746|69651963|FG001|Overall Study|Protocol Violation|1|||
37964834|NCT00395746|69651964|FG002|Overall Study|Protocol Violation|0|||
37964835|NCT00395746|69651962|FG000|Overall Study|Lack of Efficacy|2|||
37964836|NCT00395746|69651963|FG001|Overall Study|Lack of Efficacy|0|||
37964837|NCT00395746|69651964|FG002|Overall Study|Lack of Efficacy|17|||
37964838|NCT00395746|69651962|FG000|Overall Study|Hypoglycaemia|2|||
37964839|NCT00395746|69651963|FG001|Overall Study|Hypoglycaemia|1|||
37964840|NCT00395746|69651964|FG002|Overall Study|Hypoglycaemia|0|||
37964841|NCT00395746|69651962|FG000|Overall Study|Subject decision|0|||
37964842|NCT00395746|69651963|FG001|Overall Study|Subject decision|0|||
37964843|NCT00395746|69651964|FG002|Overall Study|Subject decision|1|||
37964844|NCT00395746|69651962|FG000|Overall Study|Withdrawal of consent|0|||
37964845|NCT00395746|69651963|FG001|Overall Study|Withdrawal of consent|0|||
37964846|NCT00395746|69651964|FG002|Overall Study|Withdrawal of consent|1|||
37964847|NCT00395746|69651962|FG000|Overall Study|Difficultulty in use of device|0|||
37862142|NCT01217112|69545904|FG001|Overall Study|Withdrawal by Subject|0|||
37862143|NCT01217112|69545905|FG002|Overall Study|Withdrawal by Subject|1|||
37862144|NCT01217112|69545906|FG003|Overall Study|Withdrawal by Subject|0|||
37862145|NCT01217112|69545907|FG004|Overall Study|Withdrawal by Subject|0|||
37862146|NCT01217112|69545903|FG000|Overall Study|Physician Decision|0|||
37862147|NCT01217112|69545904|FG001|Overall Study|Physician Decision|0|||
37862148|NCT01217112|69545905|FG002|Overall Study|Physician Decision|0|||
37862149|NCT01217112|69545906|FG003|Overall Study|Physician Decision|0|||
37862150|NCT01217112|69545907|FG004|Overall Study|Physician Decision|1|||
37862151|NCT01216332|69545921|FG000|Overall Study|Withdrawal by Subject|4|||
37862152|NCT01216332|69545922|FG001|Overall Study|Withdrawal by Subject|0|||
37862153|NCT00922207|69545931|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
37862154|NCT00922207|69545932|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
37862155|NCT00922207|69545933|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
37862156|NCT00922207|69545931|FG000|Overall Study|Insufficient Therapeutic Response|0|||
38055292|NCT01318070|69745884|FG001|Overall Study|Lack of Efficacy|0|||
38055293|NCT01318070|69745885|FG002|Overall Study|Lack of Efficacy|1|||
38055294|NCT01318070|69745883|FG000|Overall Study|Principal Investigator Discretion|1|||
38055295|NCT01318070|69745884|FG001|Overall Study|Principal Investigator Discretion|0|||
38055296|NCT01318070|69745885|FG002|Overall Study|Principal Investigator Discretion|0|||
38055297|NCT02895295|69745896|FG000|Overall Study|Survey Non-response|71|||
38055298|NCT02895295|69745897|FG001|Overall Study|Survey Non-response|94|||
38055299|NCT02895295|69745898|FG002|Overall Study|Survey Non-response|92|||
38055300|NCT00245960|69745908|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
38055301|NCT00245960|69745909|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
38055302|NCT00245960|69745908|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
38055303|NCT00245960|69745909|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
38055304|NCT00245960|69745908|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
38055305|NCT00245960|69745909|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
38055306|NCT00245960|69745908|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
38055307|NCT00245960|69745909|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
38055308|NCT00245960|69745908|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
38055309|NCT00245960|69745909|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
38055310|NCT00245960|69745908|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
38055311|NCT00245960|69745909|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
38055312|NCT00245960|69745908|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
38055313|NCT00245960|69745909|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
38055314|NCT00245960|69745908|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
38055315|NCT00245960|69745909|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
38055316|NCT00245960|69745908|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
38055317|NCT00245960|69745909|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
38055318|NCT00245960|69745908|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
38055319|NCT00245960|69745909|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
38055320|NCT00245960|69745908|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
38055321|NCT00245960|69745909|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
38055322|NCT00245960|69745908|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
38055323|NCT00245960|69745909|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
38055324|NCT02729194|69745915|FG000|Overall Study|Withdrawal by Subject|3|||
37862157|NCT00922207|69545932|FG001|Overall Study|Insufficient Therapeutic Response|0|||
37964848|NCT00395746|69651963|FG001|Overall Study|Difficultulty in use of device|0|||
37964849|NCT00395746|69651964|FG002|Overall Study|Difficultulty in use of device|1|||
37964850|NCT00395746|69651962|FG000|Overall Study|Unable to visit site on schedule|1|||
37964851|NCT00395746|69651963|FG001|Overall Study|Unable to visit site on schedule|0|||
37964852|NCT00395746|69651964|FG002|Overall Study|Unable to visit site on schedule|0|||
37964853|NCT00055471|69651975|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
37964854|NCT00055471|69651976|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
37964855|NCT00055471|69651977|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
37964856|NCT00055471|69651975|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
37964857|NCT00055471|69651976|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
37964858|NCT00055471|69651977|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
37964859|NCT00055471|69651975|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
37964860|NCT00055471|69651976|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
37964861|NCT00055471|69651977|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
37964862|NCT00395512|69651989|FG000|Overall Study|Adverse Event|3|||
37964863|NCT00395512|69651990|FG001|Overall Study|Adverse Event|8|||
37964864|NCT00395512|69651991|FG002|Overall Study|Adverse Event|6|||
37964865|NCT00395512|69651992|FG003|Overall Study|Adverse Event|6|||
37964866|NCT00395512|69651989|FG000|Overall Study|Protocol Violation|2|||
37964867|NCT00395512|69651990|FG001|Overall Study|Protocol Violation|3|||
37964868|NCT00395512|69651991|FG002|Overall Study|Protocol Violation|6|||
37964869|NCT00395512|69651992|FG003|Overall Study|Protocol Violation|7|||
37964870|NCT00395512|69651989|FG000|Overall Study|Lost to Follow-up|2|||
37964871|NCT00395512|69651990|FG001|Overall Study|Lost to Follow-up|6|||
37964872|NCT00395512|69651991|FG002|Overall Study|Lost to Follow-up|5|||
37964873|NCT00395512|69651992|FG003|Overall Study|Lost to Follow-up|5|||
37964874|NCT00395512|69651989|FG000|Overall Study|Withdrawal by Subject|6|||
37964875|NCT00395512|69651990|FG001|Overall Study|Withdrawal by Subject|5|||
37964876|NCT00395512|69651991|FG002|Overall Study|Withdrawal by Subject|5|||
37964877|NCT00395512|69651992|FG003|Overall Study|Withdrawal by Subject|12|||
38055325|NCT03178266|69745921|FG000|Overall Study|Death|0|||
38055326|NCT03178266|69745922|FG001|Overall Study|Death|1|||
38055327|NCT03178266|69745921|FG000|Overall Study|Disont. Early|0|||
38055328|NCT03178266|69745922|FG001|Overall Study|Disont. Early|1|||
38055329|NCT03178266|69745921|FG000|Overall Study|Withdrawal by Subject|0|||
38055330|NCT03178266|69745922|FG001|Overall Study|Withdrawal by Subject|2|||
38055331|NCT03548935|69745930|FG000|Overall Study|Withdrawal by Subject|26|||
38055332|NCT03548935|69745931|FG001|Overall Study|Withdrawal by Subject|17|||
38055333|NCT03548935|69745930|FG000|Overall Study|Lost to Follow-up|39|||
38055334|NCT03548935|69745931|FG001|Overall Study|Lost to Follow-up|28|||
38055335|NCT03548935|69745930|FG000|Overall Study|Death|1|||
38055336|NCT03548935|69745931|FG001|Overall Study|Death|1|||
38055337|NCT03547687|69745937|FG000|Overall Study|Withdrawal by Subject|1|||
38055338|NCT03547687|69745937|FG000|Overall Study|Death|1|||
38055339|NCT03547531|69745943|FG000|Overall Study|not coming in data collection : sick|2|||
38055340|NCT03547531|69745944|FG001|Overall Study|not coming in data collection : sick|2|||
38055341|NCT03547531|69745943|FG000|Overall Study|having family occasion|0|||
38055342|NCT03547531|69745944|FG001|Overall Study|having family occasion|2|||
38055343|NCT03566485|69745952|FG000|Overall Study|Disease progression|5|||
38055344|NCT03566485|69745953|FG001|Overall Study|Disease progression|4|||
38055345|NCT03566485|69745952|FG000|Overall Study|Clinical progression|0|||
38055346|NCT03566485|69745953|FG001|Overall Study|Clinical progression|1|||
38055347|NCT03566485|69745952|FG000|Overall Study|Toxicity|0|||
38055348|NCT03566485|69745953|FG001|Overall Study|Toxicity|2|||
38055349|NCT03176238|69745961|FG000|Overall Study|Unacceptable AEs|15|||
38055350|NCT03176238|69745962|FG001|Overall Study|Unacceptable AEs|8|||
38055351|NCT03176238|69745961|FG000|Overall Study|Abnormal lab value(s)|2|||
38055352|NCT03176238|69745962|FG001|Overall Study|Abnormal lab value(s)|0|||
38055353|NCT03176238|69745961|FG000|Overall Study|Inter-current illness|0|||
38055354|NCT03176238|69745962|FG001|Overall Study|Inter-current illness|1|||
38055355|NCT03176238|69745961|FG000|Overall Study|Consent withdrawal|14|||
38055356|NCT03176238|69745962|FG001|Overall Study|Consent withdrawal|2|||
38055357|NCT03176238|69745961|FG000|Overall Study|Lost to Follow-up|3|||
37964878|NCT00395512|69651989|FG000|Overall Study|Physician Decision|6|||
37964879|NCT00395512|69651990|FG001|Overall Study|Physician Decision|4|||
38055358|NCT03176238|69745962|FG001|Overall Study|Lost to Follow-up|0|||
38055359|NCT03176238|69745961|FG000|Overall Study|Administrative problems|1|||
38055360|NCT03176238|69745962|FG001|Overall Study|Administrative problems|0|||
38055361|NCT03176238|69745961|FG000|Overall Study|Death|3|||
37964880|NCT00395512|69651991|FG002|Overall Study|Physician Decision|2|||
37964881|NCT00395512|69651992|FG003|Overall Study|Physician Decision|2|||
37964882|NCT00395512|69651989|FG000|Overall Study|Other|1|||
37964883|NCT00395512|69651990|FG001|Overall Study|Other|1|||
37964884|NCT00395512|69651991|FG002|Overall Study|Other|0|||
37964885|NCT00395512|69651992|FG003|Overall Study|Other|0|||
38055362|NCT03176238|69745962|FG001|Overall Study|Death|0|||
38055363|NCT03176238|69745961|FG000|Overall Study|Disease Progression|133|||
38055364|NCT03176238|69745962|FG001|Overall Study|Disease Progression|22|||
38055365|NCT03176238|69745961|FG000|Overall Study|Tx duration completed per EAP|0|||
37964886|NCT00395512|69651989|FG000|Overall Study|Hyperglycemic Rescue|18|||
38055366|NCT03176238|69745962|FG001|Overall Study|Tx duration completed per EAP|1|||
37964887|NCT00395512|69651990|FG001|Overall Study|Hyperglycemic Rescue|10|||
38055367|NCT03176238|69745961|FG000|Overall Study|Patient is switched to commercial drug|16|||
38055368|NCT03176238|69745962|FG001|Overall Study|Patient is switched to commercial drug|1|||
38055369|NCT03176238|69745961|FG000|Overall Study|Protocol Violation|1|||
38055370|NCT03176238|69745962|FG001|Overall Study|Protocol Violation|0|||
38055371|NCT03176238|69745961|FG000|Overall Study|Changes in the patient's condition|2|||
38055372|NCT03176238|69745962|FG001|Overall Study|Changes in the patient's condition|1|||
38055373|NCT03176238|69745961|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
38055374|NCT03176238|69745962|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
38055375|NCT03565315|69745976|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
38055376|NCT03565315|69745977|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
38055377|NCT03565315|69745978|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
38055378|NCT03565315|69745979|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
38055379|NCT03565237|69746002|FG000|Overall Study|Non-compliance of Investigational Product|1|||
38055380|NCT03565237|69746002|FG000|Overall Study|Physician Decision|1|||
38055381|NCT01345682|69746008|FG000|Overall Study|Progressive disease per RECIST|226|||
38055382|NCT01345682|69746009|FG001|Overall Study|Progressive disease per RECIST|93|||
38055383|NCT01345682|69746008|FG000|Overall Study|Worsening of underlying cancer disease|23|||
38055384|NCT01345682|69746009|FG001|Overall Study|Worsening of underlying cancer disease|12|||
38055385|NCT01345682|69746008|FG000|Overall Study|Adverse Event|51|||
38055386|NCT01345682|69746009|FG001|Overall Study|Adverse Event|41|||
38055387|NCT01345682|69746008|FG000|Overall Study|Non-compliance with protocol|0|||
38055388|NCT01345682|69746009|FG001|Overall Study|Non-compliance with protocol|1|||
38055389|NCT01345682|69746008|FG000|Overall Study|Lost to Follow-up|0|||
38055390|NCT01345682|69746009|FG001|Overall Study|Lost to Follow-up|1|||
38055391|NCT01345682|69746008|FG000|Overall Study|Refused to continue trial medication|16|||
38055392|NCT01345682|69746009|FG001|Overall Study|Refused to continue trial medication|9|||
38055393|NCT01345682|69746008|FG000|Overall Study|Not treated|2|||
38055394|NCT01345682|69746009|FG001|Overall Study|Not treated|1|||
38055395|NCT01345682|69746008|FG000|Overall Study|Reason other than those specified above|4|||
38055396|NCT01345682|69746009|FG001|Overall Study|Reason other than those specified above|3|||
38055397|NCT03562117|69746018|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
38055398|NCT03562117|69746019|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
38055399|NCT03562117|69746020|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
38055400|NCT03561883|69746030|FG000|Overall Study|Adverse Event|10|||
38055401|NCT03561883|69746031|FG001|Overall Study|Adverse Event|13|||
38055402|NCT03561883|69746030|FG000|Overall Study|Non-Compliance With Study Drug|1|||
38055403|NCT03561883|69746031|FG001|Overall Study|Non-Compliance With Study Drug|2|||
38055404|NCT03561883|69746030|FG000|Overall Study|Protocol Violation|2|||
38055405|NCT03561883|69746031|FG001|Overall Study|Protocol Violation|3|||
38055406|NCT03561883|69746030|FG000|Overall Study|Withdrawal by Subject|14|||
38055407|NCT03561883|69746031|FG001|Overall Study|Withdrawal by Subject|6|||
38055408|NCT03561883|69746030|FG000|Overall Study|Lost to Follow-up|2|||
38055409|NCT03561883|69746031|FG001|Overall Study|Lost to Follow-up|6|||
38055410|NCT03561883|69746030|FG000|Overall Study|Study Terminated by Sponsor|12|||
38055411|NCT03561883|69746031|FG001|Overall Study|Study Terminated by Sponsor|11|||
38055412|NCT03561883|69746030|FG000|Overall Study|Physician Decision|1|||
38055413|NCT03561883|69746031|FG001|Overall Study|Physician Decision|0|||
38055414|NCT03561883|69746030|FG000|Overall Study|Randomized by Mistake|1|||
38055415|NCT03561883|69746031|FG001|Overall Study|Randomized by Mistake|0|||
38055416|NCT03561883|69746030|FG000|Overall Study|Other, Not Specified|3|||
38055417|NCT03561883|69746031|FG001|Overall Study|Other, Not Specified|2|||
38055418|NCT03546907|69746039|FG000|Overall Study|Lack of Efficacy|1|||
38055419|NCT03546907|69746040|FG001|Overall Study|Lack of Efficacy|1|||
38055420|NCT03546907|69746039|FG000|Overall Study|Withdrawal by Subject|8|||
38055421|NCT03546907|69746040|FG001|Overall Study|Withdrawal by Subject|9|||
38055422|NCT03546907|69746039|FG000|Overall Study|Adverse events (AEs)|7|||
38055423|NCT03546907|69746040|FG001|Overall Study|Adverse events (AEs)|10|||
38055424|NCT03546907|69746039|FG000|Overall Study|Other-unspecified|1|||
38055425|NCT03546907|69746040|FG001|Overall Study|Other-unspecified|1|||
38055426|NCT01318382|69746046|FG000|Overall Study|Physician Decision|2|||
38055427|NCT01318382|69746046|FG000|Overall Study|Device Malfunction|10|||
38055428|NCT01318382|69746046|FG000|Overall Study|Protocol Violation|1|||
38055429|NCT03053180|69746064|FG000|Overall Study|Failure to Return|1|||
38055430|NCT03560869|69746068|FG000|Overall Study|Withdrawal by Subject|3|||
38055431|NCT03560869|69746069|FG001|Overall Study|Withdrawal by Subject|4|||
38055432|NCT03560869|69746068|FG000|Overall Study|Screening failure|4|||
38055433|NCT03560869|69746069|FG001|Overall Study|Screening failure|4|||
37964888|NCT00395512|69651991|FG002|Overall Study|Hyperglycemic Rescue|4|||
37964889|NCT00395512|69651992|FG003|Overall Study|Hyperglycemic Rescue|6|||
37964890|NCT00054691|69652002|FG000|Overall Study|Unmeasurable Disease|2|||
37964891|NCT00054691|69652002|FG000|Overall Study|Noncompliant|1|||
37964892|NCT00387712|69652008|FG000|Overall Study|Physician Decision|6|||
37964893|NCT00387712|69652009|FG001|Overall Study|Physician Decision|4|||
37964894|NCT00387712|69652008|FG000|Overall Study|Lost to Follow-up|17|||
37964895|NCT00387712|69652009|FG001|Overall Study|Lost to Follow-up|20|||
37964896|NCT00387712|69652008|FG000|Overall Study|Withdrawal by Subject|6|||
37964897|NCT00387712|69652009|FG001|Overall Study|Withdrawal by Subject|12|||
37964898|NCT00066703|69652017|FG000|Overall Study|Adverse Event|80|||
37964899|NCT00066703|69652018|FG001|Overall Study|Adverse Event|111|||
37964900|NCT00066703|69652017|FG000|Overall Study|Death|3|||
37964901|NCT00066703|69652018|FG001|Overall Study|Death|0|||
37964902|NCT00066703|69652017|FG000|Overall Study|Lack of Efficacy|114|||
37964903|NCT00066703|69652018|FG001|Overall Study|Lack of Efficacy|69|||
37964904|NCT00066703|69652017|FG000|Overall Study|Lost to Follow-up|31|||
37964905|NCT00066703|69652018|FG001|Overall Study|Lost to Follow-up|28|||
37964906|NCT00066703|69652017|FG000|Overall Study|Withdrawal by Subject|38|||
37964907|NCT00066703|69652018|FG001|Overall Study|Withdrawal by Subject|63|||
37964908|NCT00066703|69652017|FG000|Overall Study|Treatment ongoing|346|||
37964909|NCT00066703|69652018|FG001|Overall Study|Treatment ongoing|311|||
37964910|NCT00072475|69652024|FG000|Overall Study|Adverse Event|44|||
37964911|NCT00072475|69652024|FG000|Overall Study|Death|3|||
37964912|NCT00072475|69652024|FG000|Overall Study|Withdrawal by Subject|46|||
37964913|NCT00072475|69652024|FG000|Overall Study|Patient/Investigator Decision|4|||
37964914|NCT00066469|69652028|FG000|Overall Study|Death|3|||
37964915|NCT00066469|69652028|FG000|Overall Study|Lack of Efficacy|9|||
37964916|NCT00066469|69652028|FG000|Overall Study|Lost to Follow-up|1|||
37964917|NCT00066469|69652028|FG000|Overall Study|Physician Decision|1|||
37964918|NCT00066469|69652028|FG000|Overall Study|Withdrawal by Subject|1|||
37964919|NCT00066469|69652028|FG000|Overall Study|ineligible|1|||
37964920|NCT00387088|69652034|FG000|Overall Study|Adverse Event|143|||
37964921|NCT00387088|69652035|FG001|Overall Study|Adverse Event|156|||
37964922|NCT00387088|69652034|FG000|Overall Study|Protocol Violation|47|||
37964923|NCT00387088|69652035|FG001|Overall Study|Protocol Violation|35|||
37964924|NCT00387088|69652034|FG000|Overall Study|Withdrawal by Subject|20|||
37964925|NCT00387088|69652035|FG001|Overall Study|Withdrawal by Subject|35|||
37964926|NCT00387088|69652034|FG000|Overall Study|Lack of Efficacy|28|||
37964927|NCT00387088|69652035|FG001|Overall Study|Lack of Efficacy|67|||
37964928|NCT00387088|69652034|FG000|Overall Study|Lost to Follow-up|22|||
37964929|NCT00387088|69652035|FG001|Overall Study|Lost to Follow-up|28|||
37964930|NCT00387088|69652034|FG000|Overall Study|Other|58|||
37964931|NCT00387088|69652035|FG001|Overall Study|Other|52|||
37964932|NCT00053365|69652041|FG000|Overall Study|Incorrect cell type|1|||
37964933|NCT00053365|69652041|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
37964934|NCT00053365|69652041|FG000|Overall Study|Never treated|4|||
37964935|NCT00387010|69652047|FG000|Dose Titration Period|Adverse Event|12|||
37964936|NCT00387010|69652047|FG000|Dose Titration Period|Lack of Efficacy|5|||
37964937|NCT00387010|69652047|FG000|Dose Titration Period|Withdrawal by Subject|3|||
37964938|NCT00387010|69652047|FG000|Dose Titration Period|Protocol Violation|1|||
37964939|NCT00387010|69652047|FG000|Dose Titration Period|Lost to Follow-up|2|||
37964940|NCT00387010|69652047|FG000|Dose Titration Period|Noncompliance with study medication|8|||
37964941|NCT00387010|69652047|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
37964942|NCT00387010|69652047|FG000|Treatment Period|Adverse Event|4|||
37964943|NCT00387010|69652047|FG000|Treatment Period|Withdrawal by Subject|1|||
37964944|NCT00387010|69652047|FG000|Treatment Period|Noncompliance with study medication|2|||
37964945|NCT00387010|69652047|FG000|Treatment Period|Noncompliance with study procedures|3|||
37964946|NCT00387010|69652047|FG000|Treatment Period|Participant reported study drug stolen|1|||
37964947|NCT00386776|69652051|FG000|Overall Study|Withdrawal by Subject|8|||
37964948|NCT00065065|69652059|FG000|Overall Study|Adverse Event|3|||
37964949|NCT00065065|69652060|FG001|Overall Study|Adverse Event|2|||
37964950|NCT00065065|69652059|FG000|Overall Study|Withdrawal by Subject|1|||
37964951|NCT00065065|69652060|FG001|Overall Study|Withdrawal by Subject|5|||
37964952|NCT00065065|69652059|FG000|Overall Study|Lack of Efficacy|4|||
37964953|NCT00065065|69652060|FG001|Overall Study|Lack of Efficacy|11|||
37964954|NCT00065065|69652059|FG000|Overall Study|Other|2|||
37964955|NCT00065065|69652060|FG001|Overall Study|Other|2|||
37964956|NCT00386308|69652070|FG000|Overall Study|Adverse Event|3|||
37964957|NCT00386308|69652071|FG001|Overall Study|Adverse Event|3|||
37964958|NCT00386308|69652070|FG000|Overall Study|Protocol Violation|2|||
37964959|NCT00386308|69652071|FG001|Overall Study|Protocol Violation|5|||
37964960|NCT00386308|69652070|FG000|Overall Study|Lack of Efficacy|0|||
37964961|NCT00386308|69652071|FG001|Overall Study|Lack of Efficacy|2|||
37964962|NCT00386308|69652070|FG000|Overall Study|Lost to Follow-up|10|||
37964963|NCT00386308|69652071|FG001|Overall Study|Lost to Follow-up|6|||
37964964|NCT00386308|69652070|FG000|Overall Study|Withdrawal by Subject|6|||
37964965|NCT00386308|69652071|FG001|Overall Study|Withdrawal by Subject|2|||
37964966|NCT00386308|69652070|FG000|Overall Study|Other Event|8|||
37964967|NCT00386308|69652071|FG001|Overall Study|Other Event|1|||
37964968|NCT00064987|69652079|FG000|Overall Study|Physician Decision|3|||
37964969|NCT00064987|69652080|FG001|Overall Study|Physician Decision|0|||
37964970|NCT00374452|69652088|FG000|Overall Study|Left clinic before intervention started|4|||
37964971|NCT00374452|69652089|FG001|Overall Study|Left clinic before intervention started|1|||
37964972|NCT00374452|69652088|FG000|Overall Study|Change in job role before intervention|0|||
37964973|NCT00374452|69652089|FG001|Overall Study|Change in job role before intervention|1|||
37964974|NCT00374452|69652088|FG000|Overall Study|Left clinic after intervention started|1|||
37964975|NCT00374452|69652089|FG001|Overall Study|Left clinic after intervention started|1|||
38055434|NCT03560869|69746068|FG000|Overall Study|Withdrawal by PI|0|||
38055435|NCT03560869|69746069|FG001|Overall Study|Withdrawal by PI|1|||
38055436|NCT03590743|69746077|FG000|Overall Study|Withdrawal by Subject|0|||
38055437|NCT03590743|69746078|FG001|Overall Study|Withdrawal by Subject|1|||
38055438|NCT03053102|69746084|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
38055439|NCT03053102|69746084|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
38055440|NCT03589885|69746092|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
38055441|NCT03589885|69746093|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
38055442|NCT03589885|69746094|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
38055443|NCT03589885|69746095|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
38055444|NCT03589885|69746096|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
38055445|NCT03589885|69746092|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
38055446|NCT03589885|69746093|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
38055447|NCT03589885|69746094|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
38055448|NCT03589885|69746095|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
38055449|NCT03589885|69746096|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
38055450|NCT03589885|69746092|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
38055451|NCT03589885|69746093|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
38055452|NCT03589885|69746094|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
38055453|NCT03589885|69746095|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
38055454|NCT03589885|69746096|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
38055455|NCT03589885|69746092|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
38055456|NCT03589885|69746093|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
38055457|NCT03589885|69746094|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
38055458|NCT03589885|69746095|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
38055459|NCT03589885|69746096|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
38055460|NCT03589885|69746092|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
38055461|NCT03589885|69746093|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
38055462|NCT03589885|69746094|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
38055463|NCT03589885|69746095|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
38055464|NCT03589885|69746096|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
38055465|NCT03589885|69746092|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
38055466|NCT03589885|69746093|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
38055467|NCT03589885|69746094|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
38055468|NCT03589885|69746095|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
38055469|NCT03589885|69746096|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
38055470|NCT03589885|69746092|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
38055471|NCT03589885|69746093|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
38055472|NCT03589885|69746094|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
38055473|NCT03589885|69746095|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
38055474|NCT03589885|69746096|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
38055475|NCT03589885|69746092|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
38055476|NCT03589885|69746093|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
38055477|NCT03589885|69746094|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
38055478|NCT03589885|69746095|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
38055479|NCT03589885|69746096|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
38055480|NCT03545503|69746116|FG000|Overall Study|Protocol Violation|14|||
38055481|NCT03545503|69746117|FG001|Overall Study|Protocol Violation|16|||
38055482|NCT03545113|69746125|FG000|Overall Study|Surgery Cancelled|1|||
38055483|NCT03545113|69746126|FG001|Overall Study|Surgery Cancelled|0|||
38055484|NCT03545113|69746125|FG000|Overall Study|Death|1|||
38055485|NCT03545113|69746126|FG001|Overall Study|Death|0|||
38055486|NCT03545113|69746125|FG000|Overall Study|Adverse Event|2|||
38055487|NCT03545113|69746126|FG001|Overall Study|Adverse Event|0|||
38055488|NCT03545113|69746125|FG000|Overall Study|Received different surgery|1|||
38055489|NCT03545113|69746126|FG001|Overall Study|Received different surgery|0|||
38055490|NCT03214380|69746138|FG000|Lead-in|Adverse Event|3|||
37964976|NCT00374452|69652088|FG000|Overall Study|Withdrawal by Subject|0|||
37964977|NCT00374452|69652089|FG001|Overall Study|Withdrawal by Subject|2|||
37964978|NCT00064753|69652097|FG000|Overall Study|Death|251|||
37964979|NCT00064753|69652098|FG001|Overall Study|Death|242|||
37964980|NCT00064753|69652097|FG000|Overall Study|Withdrawal by Subject|198|||
37964981|NCT00064753|69652098|FG001|Overall Study|Withdrawal by Subject|171|||
37964982|NCT00064753|69652097|FG000|Overall Study|Lost to Follow-up|225|||
37964983|NCT00064753|69652098|FG001|Overall Study|Lost to Follow-up|235|||
37964984|NCT00374140|69652104|FG000|Overall Study|Lost to Follow-up|1|||
37964985|NCT00374140|69652104|FG000|Overall Study|Protocol Violation|1|||
37964986|NCT00665561|69652110|FG000|Overall Study|Death recorded on subject summary pages|75|||
38055491|NCT03214380|69746139|FG001|Lead-in|Adverse Event|0|||
38055492|NCT03214380|69746140|FG002|Lead-in|Adverse Event|0|||
38055493|NCT03214380|69746141|FG003|Lead-in|Adverse Event|1|||
38055494|NCT03214380|69746142|FG004|Lead-in|Adverse Event|0|||
38055495|NCT03214380|69746143|FG005|Lead-in|Adverse Event|0|||
38055496|NCT03214380|69746138|FG000|Lead-in|Lost to Follow-up|4|||
38055497|NCT03214380|69746139|FG001|Lead-in|Lost to Follow-up|0|||
38055498|NCT03214380|69746140|FG002|Lead-in|Lost to Follow-up|0|||
38055499|NCT03214380|69746141|FG003|Lead-in|Lost to Follow-up|1|||
38055500|NCT03214380|69746142|FG004|Lead-in|Lost to Follow-up|0|||
38055501|NCT03214380|69746143|FG005|Lead-in|Lost to Follow-up|0|||
38055502|NCT03214380|69746138|FG000|Lead-in|Eligibility Criteria|3|||
38055503|NCT03214380|69746139|FG001|Lead-in|Eligibility Criteria|0|||
38055504|NCT03214380|69746140|FG002|Lead-in|Eligibility Criteria|0|||
38055505|NCT03214380|69746141|FG003|Lead-in|Eligibility Criteria|0|||
38055506|NCT03214380|69746142|FG004|Lead-in|Eligibility Criteria|0|||
38055507|NCT03214380|69746143|FG005|Lead-in|Eligibility Criteria|0|||
38055508|NCT03214380|69746138|FG000|Lead-in|Physician Decision|6|||
38055509|NCT03214380|69746139|FG001|Lead-in|Physician Decision|0|||
38055510|NCT03214380|69746140|FG002|Lead-in|Physician Decision|0|||
38055511|NCT03214380|69746141|FG003|Lead-in|Physician Decision|0|||
38055512|NCT03214380|69746142|FG004|Lead-in|Physician Decision|0|||
38055513|NCT03214380|69746143|FG005|Lead-in|Physician Decision|0|||
38055514|NCT03214380|69746138|FG000|Lead-in|Protocol Deviation|7|||
38055515|NCT03214380|69746139|FG001|Lead-in|Protocol Deviation|0|||
38055516|NCT03214380|69746140|FG002|Lead-in|Protocol Deviation|0|||
38055517|NCT03214380|69746141|FG003|Lead-in|Protocol Deviation|3|||
38055518|NCT03214380|69746142|FG004|Lead-in|Protocol Deviation|0|||
38055519|NCT03214380|69746143|FG005|Lead-in|Protocol Deviation|0|||
38055520|NCT03214380|69746138|FG000|Lead-in|Withdrawal by Subject|41|||
38055521|NCT03214380|69746139|FG001|Lead-in|Withdrawal by Subject|0|||
38055522|NCT03214380|69746140|FG002|Lead-in|Withdrawal by Subject|0|||
38055523|NCT03214380|69746141|FG003|Lead-in|Withdrawal by Subject|14|||
38055524|NCT03214380|69746142|FG004|Lead-in|Withdrawal by Subject|0|||
38055525|NCT03214380|69746143|FG005|Lead-in|Withdrawal by Subject|0|||
38055526|NCT03214380|69746138|FG000|Lead-in|Family Emergency|1|||
38055527|NCT03214380|69746139|FG001|Lead-in|Family Emergency|0|||
38055528|NCT03214380|69746140|FG002|Lead-in|Family Emergency|0|||
38055529|NCT03214380|69746141|FG003|Lead-in|Family Emergency|0|||
38055530|NCT03214380|69746142|FG004|Lead-in|Family Emergency|0|||
38055531|NCT03214380|69746143|FG005|Lead-in|Family Emergency|0|||
38055532|NCT03214380|69746138|FG000|Lead-in|Natural Disaster|9|||
38055533|NCT03214380|69746139|FG001|Lead-in|Natural Disaster|0|||
38055534|NCT03214380|69746140|FG002|Lead-in|Natural Disaster|0|||
38055535|NCT03214380|69746141|FG003|Lead-in|Natural Disaster|0|||
38055536|NCT03214380|69746142|FG004|Lead-in|Natural Disaster|0|||
38055537|NCT03214380|69746143|FG005|Lead-in|Natural Disaster|0|||
38055538|NCT03214380|69746138|FG000|Lead-in|Non Compliance|1|||
38055539|NCT03214380|69746139|FG001|Lead-in|Non Compliance|0|||
38055540|NCT03214380|69746140|FG002|Lead-in|Non Compliance|0|||
38055541|NCT03214380|69746141|FG003|Lead-in|Non Compliance|0|||
38055542|NCT03214380|69746142|FG004|Lead-in|Non Compliance|0|||
38055543|NCT03214380|69746143|FG005|Lead-in|Non Compliance|0|||
38055544|NCT03214380|69746138|FG000|Lead-in|Participant Schedule|2|||
38055545|NCT03214380|69746139|FG001|Lead-in|Participant Schedule|0|||
38055546|NCT03214380|69746140|FG002|Lead-in|Participant Schedule|0|||
38055547|NCT03214380|69746141|FG003|Lead-in|Participant Schedule|0|||
38055548|NCT03214380|69746142|FG004|Lead-in|Participant Schedule|0|||
38055549|NCT03214380|69746143|FG005|Lead-in|Participant Schedule|0|||
38055550|NCT03214380|69746138|FG000|Treatment Period|Adverse Event|0|||
38055551|NCT03214380|69746139|FG001|Treatment Period|Adverse Event|1|||
38055552|NCT03214380|69746140|FG002|Treatment Period|Adverse Event|1|||
38055553|NCT03214380|69746141|FG003|Treatment Period|Adverse Event|0|||
38055554|NCT03214380|69746142|FG004|Treatment Period|Adverse Event|1|||
38055555|NCT03214380|69746143|FG005|Treatment Period|Adverse Event|0|||
38055556|NCT03214380|69746138|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
38055557|NCT03214380|69746139|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
38055558|NCT03214380|69746140|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
38055559|NCT03214380|69746141|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
38055560|NCT03214380|69746142|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
38055561|NCT03214380|69746143|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
38055562|NCT03214380|69746138|FG000|Treatment Period|Withdrawal by Subject|0|||
38055563|NCT03214380|69746139|FG001|Treatment Period|Withdrawal by Subject|10|||
38055564|NCT03214380|69746140|FG002|Treatment Period|Withdrawal by Subject|8|||
38055565|NCT03214380|69746141|FG003|Treatment Period|Withdrawal by Subject|0|||
38055566|NCT03214380|69746142|FG004|Treatment Period|Withdrawal by Subject|7|||
38055567|NCT03214380|69746143|FG005|Treatment Period|Withdrawal by Subject|11|||
38055568|NCT03214380|69746138|FG000|Treatment Period|Death|0|||
38055569|NCT03214380|69746139|FG001|Treatment Period|Death|1|||
38055570|NCT03214380|69746140|FG002|Treatment Period|Death|2|||
38055571|NCT03214380|69746141|FG003|Treatment Period|Death|0|||
38055572|NCT03214380|69746142|FG004|Treatment Period|Death|0|||
38055573|NCT03214380|69746143|FG005|Treatment Period|Death|0|||
38055574|NCT03214380|69746138|FG000|Treatment Period|Lost to Follow-up|0|||
38055575|NCT03214380|69746139|FG001|Treatment Period|Lost to Follow-up|6|||
38055576|NCT03214380|69746140|FG002|Treatment Period|Lost to Follow-up|3|||
38055577|NCT03214380|69746141|FG003|Treatment Period|Lost to Follow-up|0|||
38055578|NCT03214380|69746142|FG004|Treatment Period|Lost to Follow-up|0|||
38055579|NCT03214380|69746143|FG005|Treatment Period|Lost to Follow-up|0|||
38055580|NCT03214380|69746138|FG000|Treatment Period|Participant schedule|0|||
38055581|NCT03214380|69746139|FG001|Treatment Period|Participant schedule|0|||
38055582|NCT03214380|69746140|FG002|Treatment Period|Participant schedule|1|||
38055583|NCT03214380|69746141|FG003|Treatment Period|Participant schedule|0|||
38055584|NCT03214380|69746142|FG004|Treatment Period|Participant schedule|0|||
38055585|NCT03214380|69746143|FG005|Treatment Period|Participant schedule|0|||
38055586|NCT03214380|69746138|FG000|Treatment Period|Treatment Interruption|0|||
38055587|NCT03214380|69746139|FG001|Treatment Period|Treatment Interruption|0|||
38055588|NCT03214380|69746140|FG002|Treatment Period|Treatment Interruption|1|||
38055589|NCT03214380|69746141|FG003|Treatment Period|Treatment Interruption|0|||
38055590|NCT03214380|69746142|FG004|Treatment Period|Treatment Interruption|0|||
38055591|NCT03214380|69746143|FG005|Treatment Period|Treatment Interruption|0|||
38055592|NCT02674464|69746157|FG000|Overall Study|Death|10|||
38055593|NCT02674464|69746158|FG001|Overall Study|Death|21|||
38055594|NCT02674464|69746157|FG000|Overall Study|Withdrawal by Subject|24|||
38055595|NCT02674464|69746158|FG001|Overall Study|Withdrawal by Subject|44|||
38055596|NCT02674464|69746157|FG000|Overall Study|Lost to Follow-up|97|||
38055597|NCT02674464|69746158|FG001|Overall Study|Lost to Follow-up|92|||
38055598|NCT02674464|69746157|FG000|Overall Study|Outside survey window|6|||
38055599|NCT02674464|69746158|FG001|Overall Study|Outside survey window|3|||
38055600|NCT03172026|69746166|FG000|Overall Study|Withdrawal by Subject|1|||
38055601|NCT03172026|69746167|FG001|Overall Study|Withdrawal by Subject|0|||
38055602|NCT03172026|69746166|FG000|Overall Study|COVID restrictions|1|||
38055603|NCT03172026|69746167|FG001|Overall Study|COVID restrictions|0|||
38055604|NCT01343888|69746177|FG000|Overall Study|Adverse Event|12|||
38055605|NCT01343888|69746178|FG001|Overall Study|Adverse Event|22|||
38055606|NCT01343888|69746179|FG002|Overall Study|Adverse Event|5|||
38055607|NCT01343888|69746177|FG000|Overall Study|Lack of Efficacy|9|||
38055608|NCT01343888|69746178|FG001|Overall Study|Lack of Efficacy|9|||
38055609|NCT01343888|69746179|FG002|Overall Study|Lack of Efficacy|13|||
38055610|NCT01343888|69746177|FG000|Overall Study|Lost to Follow-up|0|||
38055611|NCT01343888|69746178|FG001|Overall Study|Lost to Follow-up|2|||
38055612|NCT01343888|69746179|FG002|Overall Study|Lost to Follow-up|1|||
38055613|NCT01343888|69746177|FG000|Overall Study|Protocol Violation|0|||
38055614|NCT01343888|69746178|FG001|Overall Study|Protocol Violation|2|||
38055615|NCT01343888|69746179|FG002|Overall Study|Protocol Violation|0|||
38055616|NCT01343888|69746177|FG000|Overall Study|Withdrawal by Subject|4|||
38055617|NCT01343888|69746178|FG001|Overall Study|Withdrawal by Subject|4|||
38055618|NCT01343888|69746179|FG002|Overall Study|Withdrawal by Subject|2|||
38055619|NCT01343888|69746177|FG000|Overall Study|other than stated above|0|||
38055620|NCT01343888|69746178|FG001|Overall Study|other than stated above|0|||
38055621|NCT01343888|69746179|FG002|Overall Study|other than stated above|1|||
38055622|NCT03589807|69746193|FG000|Overall Study|Lost to Follow-up|0|||
38055623|NCT03589807|69746194|FG001|Overall Study|Lost to Follow-up|2|||
38055624|NCT03589807|69746195|FG002|Overall Study|Lost to Follow-up|2|||
38055625|NCT03589807|69746196|FG003|Overall Study|Lost to Follow-up|3|||
38055626|NCT03589807|69746197|FG004|Overall Study|Lost to Follow-up|1|||
38055627|NCT03589807|69746198|FG005|Overall Study|Lost to Follow-up|1|||
38055628|NCT03589807|69746193|FG000|Overall Study|Withdrawal by Subject|0|||
38055629|NCT03589807|69746194|FG001|Overall Study|Withdrawal by Subject|5|||
38055630|NCT03589807|69746195|FG002|Overall Study|Withdrawal by Subject|0|||
38055631|NCT03589807|69746196|FG003|Overall Study|Withdrawal by Subject|0|||
38055632|NCT03589807|69746197|FG004|Overall Study|Withdrawal by Subject|0|||
38055633|NCT03589807|69746198|FG005|Overall Study|Withdrawal by Subject|0|||
38055634|NCT03589807|69746193|FG000|Overall Study|Protocol Violation|0|||
38055635|NCT03589807|69746194|FG001|Overall Study|Protocol Violation|0|||
38055636|NCT03589807|69746195|FG002|Overall Study|Protocol Violation|0|||
38055637|NCT03589807|69746196|FG003|Overall Study|Protocol Violation|1|||
38055638|NCT03589807|69746197|FG004|Overall Study|Protocol Violation|0|||
38055639|NCT03589807|69746198|FG005|Overall Study|Protocol Violation|0|||
38055640|NCT03589807|69746193|FG000|Overall Study|Enrolled but treatment not administered|0|||
38055641|NCT03589807|69746194|FG001|Overall Study|Enrolled but treatment not administered|0|||
38055642|NCT03589807|69746195|FG002|Overall Study|Enrolled but treatment not administered|0|||
38055643|NCT03589807|69746196|FG003|Overall Study|Enrolled but treatment not administered|0|||
38055644|NCT03589807|69746197|FG004|Overall Study|Enrolled but treatment not administered|1|||
38055645|NCT03589807|69746198|FG005|Overall Study|Enrolled but treatment not administered|0|||
37964987|NCT00665561|69652111|FG001|Overall Study|Death recorded on subject summary pages|75|||
37964988|NCT00665561|69652110|FG000|Overall Study|Does not meet entrance criteria|19|||
37964989|NCT00665561|69652111|FG001|Overall Study|Does not meet entrance criteria|21|||
37964990|NCT00665561|69652110|FG000|Overall Study|Lost to Follow-up|203|||
37964991|NCT00665561|69652111|FG001|Overall Study|Lost to Follow-up|264|||
37964992|NCT00665561|69652110|FG000|Overall Study|Withdrawal by Subject|74|||
37964993|NCT00665561|69652111|FG001|Overall Study|Withdrawal by Subject|65|||
37964994|NCT00665561|69652110|FG000|Overall Study|Other|123|||
37964995|NCT00665561|69652111|FG001|Overall Study|Other|108|||
37964996|NCT00665561|69652110|FG000|Overall Study|Site closed|8|||
37964997|NCT00665561|69652111|FG001|Overall Study|Site closed|0|||
37964998|NCT00665561|69652110|FG000|Overall Study|Withdrawn due to pregnancy|0|||
37964999|NCT00665561|69652111|FG001|Overall Study|Withdrawn due to pregnancy|1|||
37965000|NCT00663923|69652117|FG000|Overall Study|Lost to Follow-up|2|||
37965001|NCT00386152|69652126|FG000|Overall Study|Adverse Event|6|||
37965002|NCT00386152|69652127|FG001|Overall Study|Adverse Event|5|||
37965003|NCT00386152|69652128|FG002|Overall Study|Adverse Event|4|||
37965004|NCT00386152|69652126|FG000|Overall Study|Chang from original chemo stratification|4|||
37965005|NCT00386152|69652127|FG001|Overall Study|Chang from original chemo stratification|5|||
37965006|NCT00386152|69652128|FG002|Overall Study|Chang from original chemo stratification|6|||
37965007|NCT00386152|69652126|FG000|Overall Study|Death|3|||
37965008|NCT00386152|69652127|FG001|Overall Study|Death|0|||
37965009|NCT00386152|69652128|FG002|Overall Study|Death|1|||
37965010|NCT00386152|69652126|FG000|Overall Study|Disease progression|7|||
37965011|NCT00386152|69652127|FG001|Overall Study|Disease progression|4|||
37965012|NCT00386152|69652128|FG002|Overall Study|Disease progression|5|||
37965013|NCT00386152|69652126|FG000|Overall Study|Physician Decision|13|||
37965014|NCT00386152|69652127|FG001|Overall Study|Physician Decision|10|||
37965015|NCT00386152|69652128|FG002|Overall Study|Physician Decision|4|||
37965016|NCT00386152|69652126|FG000|Overall Study|Lost to Follow-up|1|||
37965017|NCT00386152|69652127|FG001|Overall Study|Lost to Follow-up|0|||
37965018|NCT00386152|69652128|FG002|Overall Study|Lost to Follow-up|0|||
37965019|NCT00386152|69652126|FG000|Overall Study|Completed chemotherapy|4|||
37965020|NCT00386152|69652127|FG001|Overall Study|Completed chemotherapy|5|||
37965021|NCT00386152|69652128|FG002|Overall Study|Completed chemotherapy|1|||
37965022|NCT00386152|69652126|FG000|Overall Study|Protocol Violation|3|||
37965023|NCT00386152|69652127|FG001|Overall Study|Protocol Violation|5|||
37965024|NCT00386152|69652128|FG002|Overall Study|Protocol Violation|2|||
37965025|NCT00386152|69652126|FG000|Overall Study|Withdrawal by Subject|3|||
37965026|NCT00386152|69652127|FG001|Overall Study|Withdrawal by Subject|6|||
37965027|NCT00386152|69652128|FG002|Overall Study|Withdrawal by Subject|10|||
37965028|NCT00385918|69652138|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
37965029|NCT00385918|69652139|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
37965030|NCT00385918|69652140|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
37965031|NCT00385918|69652138|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
37965032|NCT00385918|69652139|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
37965033|NCT00385918|69652140|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
37965034|NCT00385918|69652138|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
37965035|NCT00385918|69652139|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
37965036|NCT00385918|69652140|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
37965037|NCT00385918|69652138|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
37965038|NCT00385918|69652139|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
37965039|NCT00385918|69652140|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
37965040|NCT00385918|69652138|FG000|Intervention Phase After Randomization|Physician Decision|1|||
37965041|NCT00385918|69652139|FG001|Intervention Phase After Randomization|Physician Decision|0|||
37965042|NCT00385918|69652140|FG002|Intervention Phase After Randomization|Physician Decision|0|||
37965043|NCT00385918|69652138|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
37965044|NCT00385918|69652139|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
37965045|NCT00385918|69652140|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
37965046|NCT00385840|69652149|FG000|Overall Study|Adverse Event|1|||
37965047|NCT00385840|69652150|FG001|Overall Study|Adverse Event|1|||
37965048|NCT00385840|69652149|FG000|Overall Study|Lost to Follow-up|3|||
38055646|NCT03544333|69746217|FG000|Overall Study|Withdrawal by Subject|1|||
37965049|NCT00385840|69652150|FG001|Overall Study|Lost to Follow-up|13|||
37965050|NCT00385762|69652156|FG000|Overall Study|Adverse Event|1|||
37965051|NCT00385762|69652156|FG000|Overall Study|Lost to Follow-up|1|||
37965052|NCT00385684|69652160|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
37965053|NCT00385684|69652161|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
37965054|NCT00385684|69652160|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
38055647|NCT03544333|69746218|FG001|Overall Study|Withdrawal by Subject|0|||
38055648|NCT03560245|69746226|FG000|Overall Study|Withdrawal by Subject|3|||
38055649|NCT03560245|69746227|FG001|Overall Study|Withdrawal by Subject|2|||
38055650|NCT03560245|69746226|FG000|Overall Study|Adverse Event|1|||
38055651|NCT03560245|69746227|FG001|Overall Study|Adverse Event|1|||
38055652|NCT03560245|69746226|FG000|Overall Study|Protocol Violation|1|||
38055653|NCT03560245|69746227|FG001|Overall Study|Protocol Violation|0|||
38055654|NCT03560245|69746226|FG000|Overall Study|Death|0|||
38055655|NCT03560245|69746227|FG001|Overall Study|Death|1|||
38055656|NCT03560245|69746226|FG000|Overall Study|Lost to Follow-up|0|||
38055657|NCT03560245|69746227|FG001|Overall Study|Lost to Follow-up|1|||
38055658|NCT03560245|69746226|FG000|Overall Study|Physician Decision|0|||
38055659|NCT03560245|69746227|FG001|Overall Study|Physician Decision|1|||
38055660|NCT03560245|69746226|FG000|Overall Study|Other|0|||
38055661|NCT03560245|69746227|FG001|Overall Study|Other|1|||
38055662|NCT00707434|69746235|FG000|Overall Study|Adverse Event|1|||
38055663|NCT03054428|69746242|FG000|Overall Study|Physician Decision|0|||
38055664|NCT03054428|69746243|FG001|Overall Study|Physician Decision|1|||
38055665|NCT03054428|69746244|FG002|Overall Study|Physician Decision|1|||
38055666|NCT03054428|69746242|FG000|Overall Study|Lack of Efficacy|3|||
38055667|NCT03054428|69746243|FG001|Overall Study|Lack of Efficacy|1|||
38055668|NCT03054428|69746244|FG002|Overall Study|Lack of Efficacy|0|||
38055669|NCT03054428|69746242|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
38055670|NCT03054428|69746243|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
38055671|NCT03054428|69746244|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
38055672|NCT03054428|69746242|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
38055673|NCT03054428|69746243|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
38055674|NCT03054428|69746244|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
38055675|NCT03054428|69746242|FG000|Overall Study|Transitioned to OLE study|76|||
38055676|NCT03054428|69746243|FG001|Overall Study|Transitioned to OLE study|76|||
38055677|NCT03054428|69746244|FG002|Overall Study|Transitioned to OLE study|73|||
38055678|NCT03054428|69746242|FG000|Overall Study|Withdrawal by Subject|3|||
38055679|NCT03054428|69746243|FG001|Overall Study|Withdrawal by Subject|2|||
38055680|NCT03054428|69746244|FG002|Overall Study|Withdrawal by Subject|3|||
38055681|NCT03054428|69746242|FG000|Overall Study|Lost to Follow-up|0|||
38055682|NCT03054428|69746243|FG001|Overall Study|Lost to Follow-up|0|||
38055683|NCT03054428|69746244|FG002|Overall Study|Lost to Follow-up|1|||
38055684|NCT03558997|69746256|FG000|Overall Study|Adverse Event|0|||
38055685|NCT03558997|69746257|FG001|Overall Study|Adverse Event|2|||
38055686|NCT03558997|69746258|FG002|Overall Study|Adverse Event|5|||
38055687|NCT03558997|69746259|FG003|Overall Study|Adverse Event|1|||
38055688|NCT03558997|69746256|FG000|Overall Study|Physician Decision|0|||
38055689|NCT03558997|69746257|FG001|Overall Study|Physician Decision|0|||
38055690|NCT03558997|69746258|FG002|Overall Study|Physician Decision|1|||
38055691|NCT03558997|69746259|FG003|Overall Study|Physician Decision|0|||
38055692|NCT03558997|69746256|FG000|Overall Study|Withdrawal by Subject|1|||
38055693|NCT03558997|69746257|FG001|Overall Study|Withdrawal by Subject|0|||
38055694|NCT03558997|69746258|FG002|Overall Study|Withdrawal by Subject|1|||
38055695|NCT03558997|69746259|FG003|Overall Study|Withdrawal by Subject|1|||
38055696|NCT03558997|69746256|FG000|Overall Study|Lost to Follow-up|0|||
38055697|NCT03558997|69746257|FG001|Overall Study|Lost to Follow-up|0|||
38055698|NCT03558997|69746258|FG002|Overall Study|Lost to Follow-up|1|||
38055699|NCT03558997|69746259|FG003|Overall Study|Lost to Follow-up|0|||
38055700|NCT03052400|69746274|FG000|Overall Study|Lost to Follow-up|1|||
38055701|NCT03052400|69746275|FG001|Overall Study|Lost to Follow-up|0|||
38055702|NCT03052400|69746274|FG000|Overall Study|Withdrawal by Subject|0|||
38055703|NCT03052400|69746275|FG001|Overall Study|Withdrawal by Subject|1|||
38055704|NCT03538951|69746283|FG000|Overall Study|Withdrawal by Subject|1|||
38055705|NCT03538951|69746284|FG001|Overall Study|Withdrawal by Subject|2|||
38055706|NCT03052322|69746292|FG000|Overall Study|Other un-specified|1|||
38055707|NCT03052322|69746293|FG001|Overall Study|Other un-specified|2|||
38055708|NCT03052322|69746292|FG000|Overall Study|Withdrawal by Subject|10|||
38055709|NCT03052322|69746293|FG001|Overall Study|Withdrawal by Subject|9|||
37862158|NCT00922207|69545933|FG002|Overall Study|Insufficient Therapeutic Response|1|||
38055710|NCT03052322|69746292|FG000|Overall Study|Death|0|||
38055711|NCT03052322|69746293|FG001|Overall Study|Death|2|||
38055712|NCT03052322|69746292|FG000|Overall Study|Lack of Efficacy|1|||
38055713|NCT03052322|69746293|FG001|Overall Study|Lack of Efficacy|2|||
38055714|NCT03052322|69746292|FG000|Overall Study|Protocol Violation|1|||
38055715|NCT03052322|69746293|FG001|Overall Study|Protocol Violation|0|||
38055716|NCT03052322|69746292|FG000|Overall Study|Lost to Follow-up|2|||
38055717|NCT03052322|69746293|FG001|Overall Study|Lost to Follow-up|4|||
38055718|NCT03052322|69746292|FG000|Overall Study|Adverse Event|6|||
38055719|NCT03052322|69746293|FG001|Overall Study|Adverse Event|13|||
38055720|NCT03521791|69746301|FG000|Overall Study|Protocol Violation|7|||
38055721|NCT03521791|69746302|FG001|Overall Study|Protocol Violation|17|||
37965055|NCT00385684|69652161|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
37965056|NCT00385684|69652160|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
37965057|NCT00385684|69652161|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
37965058|NCT00661661|69652169|FG000|Overall Study|Adverse Event|99|||
37965059|NCT00661661|69652170|FG001|Overall Study|Adverse Event|24|||
37965060|NCT00661661|69652169|FG000|Overall Study|Lack of Efficacy|3|||
37965061|NCT00661661|69652170|FG001|Overall Study|Lack of Efficacy|2|||
37965062|NCT00661661|69652169|FG000|Overall Study|Lost to Follow-up|0|||
37965063|NCT00661661|69652170|FG001|Overall Study|Lost to Follow-up|1|||
37965064|NCT00661661|69652169|FG000|Overall Study|Withdrawal by Subject|15|||
37965065|NCT00661661|69652170|FG001|Overall Study|Withdrawal by Subject|5|||
37965066|NCT00661661|69652169|FG000|Overall Study|Other|22|||
37965067|NCT00661661|69652170|FG001|Overall Study|Other|7|||
37965068|NCT00661661|69652169|FG000|Overall Study|Not assigned treatment|1|||
37965069|NCT00661661|69652170|FG001|Overall Study|Not assigned treatment|0|||
37965070|NCT00038467|69652180|FG000|Overall Study|Adverse Event|170|||
37965071|NCT00038467|69652181|FG001|Overall Study|Adverse Event|145|||
37965072|NCT00038467|69652180|FG000|Overall Study|Withdrawal by Subject|150|||
37965073|NCT00038467|69652181|FG001|Overall Study|Withdrawal by Subject|107|||
37965074|NCT00038467|69652180|FG000|Overall Study|Protocol Violation|19|||
37965075|NCT00038467|69652181|FG001|Overall Study|Protocol Violation|22|||
37965076|NCT00038467|69652180|FG000|Overall Study|Death|22|||
37965077|NCT00038467|69652181|FG001|Overall Study|Death|16|||
37965078|NCT00038467|69652180|FG000|Overall Study|Lost to Follow-up|15|||
37965079|NCT00038467|69652181|FG001|Overall Study|Lost to Follow-up|10|||
37965080|NCT00038467|69652180|FG000|Overall Study|Recurrence|109|||
37965081|NCT00038467|69652181|FG001|Overall Study|Recurrence|179|||
37965082|NCT00038467|69652180|FG000|Overall Study|Randomized, but not treated|31|||
37965083|NCT00038467|69652181|FG001|Overall Study|Randomized, but not treated|35|||
37965084|NCT00038467|69652180|FG000|Overall Study|Other|26|||
37965085|NCT00038467|69652181|FG001|Overall Study|Other|28|||
37965086|NCT00051025|69652189|FG000|Overall Study|Progressive Disease|1|||
37965087|NCT00051025|69652190|FG001|Overall Study|Progressive Disease|1|||
37965088|NCT00051025|69652189|FG000|Overall Study|Adverse Event|1|||
37965089|NCT00051025|69652190|FG001|Overall Study|Adverse Event|1|||
37965090|NCT00051025|69652189|FG000|Overall Study|Withdrawal by Subject|0|||
37965091|NCT00051025|69652190|FG001|Overall Study|Withdrawal by Subject|1|||
37965092|NCT00051025|69652189|FG000|Overall Study|Death|0|||
37965093|NCT00051025|69652190|FG001|Overall Study|Death|1|||
37965094|NCT00660179|69652199|FG000|Overall Study|Death|44|||
37965095|NCT00660179|69652200|FG001|Overall Study|Death|47|||
37965096|NCT00660179|69652201|FG002|Overall Study|Death|34|||
37965097|NCT00660179|69652199|FG000|Overall Study|Withdrawal of consent|4|||
37965098|NCT00660179|69652200|FG001|Overall Study|Withdrawal of consent|6|||
37965099|NCT00660179|69652201|FG002|Overall Study|Withdrawal of consent|4|||
37965100|NCT00660179|69652199|FG000|Overall Study|Lost to Follow-up|7|||
37965101|NCT00660179|69652200|FG001|Overall Study|Lost to Follow-up|5|||
37965102|NCT00660179|69652201|FG002|Overall Study|Lost to Follow-up|2|||
37965103|NCT00660179|69652199|FG000|Overall Study|Administrative reason|0|||
37965104|NCT00660179|69652200|FG001|Overall Study|Administrative reason|0|||
37965105|NCT00660179|69652201|FG002|Overall Study|Administrative reason|1|||
37965106|NCT00660179|69652199|FG000|Overall Study|Incorrect randomization|1|||
37965107|NCT00660179|69652200|FG001|Overall Study|Incorrect randomization|0|||
37965108|NCT00660179|69652201|FG002|Overall Study|Incorrect randomization|0|||
37965109|NCT00050167|69652211|FG000|Overall Study|not eligible not invasive|1|||
37965110|NCT00050167|69652212|FG001|Overall Study|not eligible not invasive|1|||
37965111|NCT00660023|69652218|FG000|Overall Study|Adverse Event|2|||
37965112|NCT00660023|69652218|FG000|Overall Study|Death|8|||
37965113|NCT00660023|69652218|FG000|Overall Study|Blood Transfusion|5|||
37965114|NCT00660023|69652218|FG000|Overall Study|Renal Transplantation|3|||
37965115|NCT00660023|69652218|FG000|Overall Study|Withdrawal by Subject|1|||
37965116|NCT00660023|69652218|FG000|Overall Study|Missed Pregnancy Test|1|||
37965117|NCT00660023|69652218|FG000|Overall Study|Other Screening Failure|9|||
37965118|NCT00062647|69652224|FG000|Overall Study|Death|2|||
37965119|NCT00062647|69652225|FG001|Overall Study|Death|2|||
37965120|NCT00062647|69652224|FG000|Overall Study|Adverse Event|1|||
37965121|NCT00062647|69652225|FG001|Overall Study|Adverse Event|1|||
37965122|NCT00062647|69652224|FG000|Overall Study|Withdrawal by Subject|2|||
37965123|NCT00062647|69652225|FG001|Overall Study|Withdrawal by Subject|1|||
37965124|NCT00062647|69652224|FG000|Overall Study|Protocol Violation|1|||
37965125|NCT00062647|69652225|FG001|Overall Study|Protocol Violation|0|||
37965126|NCT00062647|69652224|FG000|Overall Study|Lost to Follow-up|1|||
37965127|NCT00062647|69652225|FG001|Overall Study|Lost to Follow-up|2|||
37965128|NCT00062647|69652224|FG000|Overall Study|Failed continuation criteria|4|||
37965129|NCT00062647|69652225|FG001|Overall Study|Failed continuation criteria|2|||
37965130|NCT00062647|69652224|FG000|Overall Study|Other|4|||
37965131|NCT00062647|69652225|FG001|Overall Study|Other|4|||
37965132|NCT00062647|69652224|FG000|Overall Study|Never received study treatment|1|||
37965133|NCT00062647|69652225|FG001|Overall Study|Never received study treatment|1|||
38055722|NCT03521635|69746310|FG000|Overall Study|Adverse Event|1|||
38055723|NCT03521635|69746311|FG001|Overall Study|Adverse Event|1|||
38055724|NCT03521635|69746310|FG000|Overall Study|Refused to complete study visit|1|||
38055725|NCT03521635|69746311|FG001|Overall Study|Refused to complete study visit|0|||
38055726|NCT03521635|69746310|FG000|Overall Study|Refused to continue trial medication|2|||
38055727|NCT03521635|69746311|FG001|Overall Study|Refused to continue trial medication|2|||
38055728|NCT03521635|69746310|FG000|Overall Study|Lost to Follow-up|0|||
38055729|NCT03521635|69746311|FG001|Overall Study|Lost to Follow-up|1|||
38055730|NCT03521635|69746310|FG000|Overall Study|Meet exclusion criteria|0|||
38055731|NCT03521635|69746311|FG001|Overall Study|Meet exclusion criteria|1|||
38055732|NCT03521635|69746310|FG000|Overall Study|Patient not taken study medicine|0|||
38055733|NCT03521635|69746311|FG001|Overall Study|Patient not taken study medicine|1|||
38055734|NCT03170544|69746329|FG000|Part 1|Lost to Follow-up|1|||
38055735|NCT03170544|69746330|FG001|Part 1|Lost to Follow-up|0|||
38055736|NCT03170544|69746331|FG002|Part 1|Lost to Follow-up|0|||
38055737|NCT03170544|69746332|FG003|Part 1|Lost to Follow-up|0|||
38055738|NCT03170544|69746333|FG004|Part 1|Lost to Follow-up|0|||
38055739|NCT03170544|69746334|FG005|Part 1|Lost to Follow-up|0|||
38055740|NCT03170544|69746335|FG006|Part 1|Lost to Follow-up|0|||
38055741|NCT03170544|69746336|FG007|Part 1|Lost to Follow-up|0|||
38055742|NCT03170544|69746337|FG008|Part 1|Lost to Follow-up|0|||
38055743|NCT03170544|69746338|FG009|Part 1|Lost to Follow-up|0|||
38055744|NCT03170544|69746339|FG010|Part 1|Lost to Follow-up|0|||
38055745|NCT03170544|69746340|FG011|Part 1|Lost to Follow-up|0|||
38055746|NCT03170544|69746329|FG000|Part 1|Not treated|0|||
38055747|NCT03170544|69746330|FG001|Part 1|Not treated|0|||
38055748|NCT03170544|69746331|FG002|Part 1|Not treated|0|||
38055749|NCT03170544|69746332|FG003|Part 1|Not treated|1|||
38055750|NCT03170544|69746333|FG004|Part 1|Not treated|0|||
38055751|NCT03170544|69746334|FG005|Part 1|Not treated|0|||
38055752|NCT03170544|69746335|FG006|Part 1|Not treated|0|||
38055753|NCT03170544|69746336|FG007|Part 1|Not treated|0|||
38055754|NCT03170544|69746337|FG008|Part 1|Not treated|0|||
38055755|NCT03170544|69746338|FG009|Part 1|Not treated|0|||
38055756|NCT03170544|69746339|FG010|Part 1|Not treated|0|||
38055757|NCT03170544|69746340|FG011|Part 1|Not treated|0|||
38055758|NCT03582943|69746425|FG000|Allocated to Groups|Withdrawal by Subject|1|||
38055759|NCT03582943|69746426|FG001|Allocated to Groups|Withdrawal by Subject|1|||
38055760|NCT03582943|69746425|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
38055761|NCT03582943|69746426|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
38055762|NCT03582943|69746425|FG000|Analyzed|Protocol Violation|4|||
38055763|NCT03582943|69746426|FG001|Analyzed|Protocol Violation|1|||
38055764|NCT03532009|69746434|FG000|Overall Study|Other|1|||
38055765|NCT03532009|69746435|FG001|Overall Study|Other|1|||
38055766|NCT03532009|69746434|FG000|Overall Study|Death|1|||
38055767|NCT03532009|69746435|FG001|Overall Study|Death|1|||
38055768|NCT03532009|69746434|FG000|Overall Study|Withdrawal by Patient|0|||
38055769|NCT03532009|69746435|FG001|Overall Study|Withdrawal by Patient|2|||
38055770|NCT03520387|69746446|FG000|Pre-Randomization|Withdrawal by Subject|1|||
38055771|NCT03520387|69746447|FG001|Pre-Randomization|Withdrawal by Subject|0|||
38055772|NCT03520387|69746448|FG002|Pre-Randomization|Withdrawal by Subject|0|||
38055773|NCT03520387|69746449|FG003|Pre-Randomization|Withdrawal by Subject|0|||
38055774|NCT03520387|69746450|FG004|Pre-Randomization|Withdrawal by Subject|0|||
38055775|NCT03520387|69746446|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
38055776|NCT03520387|69746447|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
38055777|NCT03520387|69746448|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
38055778|NCT03520387|69746449|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
38055779|NCT03520387|69746450|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
38055780|NCT03170232|69746463|FG000|Overall Study|Adverse Event|0|||
38055781|NCT03170232|69746464|FG001|Overall Study|Adverse Event|1|||
38055782|NCT03170232|69746463|FG000|Overall Study|Protocol Violation|0|||
38055783|NCT03170232|69746464|FG001|Overall Study|Protocol Violation|1|||
38055784|NCT03170232|69746463|FG000|Overall Study|Lack of Efficacy|0|||
38055785|NCT03170232|69746464|FG001|Overall Study|Lack of Efficacy|1|||
38055786|NCT03170232|69746463|FG000|Overall Study|Study closed/terminated|26|||
38055787|NCT03170232|69746464|FG001|Overall Study|Study closed/terminated|23|||
38055788|NCT03170232|69746463|FG000|Overall Study|Lost to Follow-up|1|||
38055789|NCT03170232|69746464|FG001|Overall Study|Lost to Follow-up|0|||
38055790|NCT03170232|69746463|FG000|Overall Study|Withdrawal by Subject|0|||
38055791|NCT03170232|69746464|FG001|Overall Study|Withdrawal by Subject|1|||
38055792|NCT03519919|69746470|FG000|Overall Study|Withdrawal by Subject|1|||
38055793|NCT03519919|69746470|FG000|Overall Study|Lack of Efficacy|1|||
38055794|NCT03519919|69746470|FG000|Overall Study|Screen Failure|1|||
38055795|NCT03478969|69746503|FG000|Overall Study|Withdrawal by Subject|4|||
38055796|NCT03478969|69746504|FG001|Overall Study|Withdrawal by Subject|7|||
38055797|NCT03478969|69746505|FG002|Overall Study|Withdrawal by Subject|6|||
38055798|NCT03478969|69746503|FG000|Overall Study|Adverse Event|2|||
38055799|NCT03478969|69746504|FG001|Overall Study|Adverse Event|0|||
38055800|NCT03478969|69746505|FG002|Overall Study|Adverse Event|1|||
38055801|NCT03478969|69746503|FG000|Overall Study|Pregnancy|1|||
38055802|NCT03478969|69746504|FG001|Overall Study|Pregnancy|0|||
38055803|NCT03478969|69746505|FG002|Overall Study|Pregnancy|0|||
38055804|NCT03478969|69746503|FG000|Overall Study|Personal Reasons|1|||
38055805|NCT03478969|69746504|FG001|Overall Study|Personal Reasons|0|||
38055806|NCT03478969|69746505|FG002|Overall Study|Personal Reasons|1|||
38055807|NCT03478969|69746503|FG000|Overall Study|Covid-19|1|||
38055808|NCT03478969|69746504|FG001|Overall Study|Covid-19|4|||
38055809|NCT03478969|69746505|FG002|Overall Study|Covid-19|3|||
38055810|NCT03478969|69746503|FG000|Overall Study|Multiple Reasons|0|||
38055811|NCT03478969|69746504|FG001|Overall Study|Multiple Reasons|1|||
38055812|NCT03478969|69746505|FG002|Overall Study|Multiple Reasons|1|||
38055813|NCT03478969|69746503|FG000|Overall Study|Eligibility Criteria|0|||
38055814|NCT03478969|69746504|FG001|Overall Study|Eligibility Criteria|0|||
38055815|NCT03478969|69746505|FG002|Overall Study|Eligibility Criteria|5|||
38055816|NCT03478969|69746503|FG000|Overall Study|Lost to Follow-up|0|||
38055817|NCT03478969|69746504|FG001|Overall Study|Lost to Follow-up|0|||
38055818|NCT03478969|69746505|FG002|Overall Study|Lost to Follow-up|1|||
38055819|NCT04823949|69746536|FG000|Overall Study|Withdrawal by Subject|0|||
38055820|NCT04823949|69746537|FG001|Overall Study|Withdrawal by Subject|4|||
38055821|NCT04823949|69746536|FG000|Overall Study|Physician Decision|0|||
38055822|NCT04823949|69746537|FG001|Overall Study|Physician Decision|1|||
38055823|NCT04499482|69746552|FG000|Foods Containing 10 g Soy Flour|One subject dropped from the study at Day 3 as the subject could not meet the demands of the study|1|||
38055824|NCT04408794|69746571|FG000|Overall Study|Adverse Event|43|||
38055825|NCT04408794|69746571|FG000|Overall Study|Infrequent study drug usage|43|||
38055826|NCT04408794|69746571|FG000|Overall Study|Lack of Efficacy|61|||
38055827|NCT04408794|69746571|FG000|Overall Study|Lost to Follow-up|33|||
38055828|NCT04408794|69746571|FG000|Overall Study|Non-compliance|6|||
38055829|NCT04408794|69746571|FG000|Overall Study|Physician Decision|1|||
38055830|NCT04408794|69746571|FG000|Overall Study|Pregnancy|6|||
38055831|NCT04408794|69746571|FG000|Overall Study|Protocol Deviation|9|||
38055832|NCT04408794|69746571|FG000|Overall Study|Sheehan-STS Result|1|||
38055833|NCT04408794|69746571|FG000|Overall Study|Withdrawal by Subject|57|||
38055834|NCT04408794|69746571|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
38055835|NCT04408794|69746571|FG000|Overall Study|Never Treated Migraine|5|||
38055836|NCT04354168|69746604|FG000|Overall Study|Lost to Follow-up|22|||
38055837|NCT04305405|69746610|FG000|Overall Study|Withdrawal by parent/guardian|0|||
38055838|NCT04305405|69746611|FG001|Overall Study|Withdrawal by parent/guardian|1|||
38055839|NCT03543410|69746629|FG000|Overall Study|Adverse Event|10|||
38055840|NCT03543410|69746630|FG001|Overall Study|Adverse Event|8|||
38055841|NCT03543410|69746631|FG002|Overall Study|Adverse Event|2|||
38055842|NCT03543410|69746629|FG000|Overall Study|Lack of Efficacy|0|||
38055843|NCT03543410|69746630|FG001|Overall Study|Lack of Efficacy|1|||
38055844|NCT03543410|69746631|FG002|Overall Study|Lack of Efficacy|0|||
38055845|NCT03543410|69746629|FG000|Overall Study|Lost to Follow-up|0|||
38055846|NCT03543410|69746630|FG001|Overall Study|Lost to Follow-up|1|||
38055847|NCT03543410|69746631|FG002|Overall Study|Lost to Follow-up|0|||
38055848|NCT03543410|69746629|FG000|Overall Study|Withdrawal by Subject|5|||
38055849|NCT03543410|69746630|FG001|Overall Study|Withdrawal by Subject|2|||
38055850|NCT03543410|69746631|FG002|Overall Study|Withdrawal by Subject|8|||
38055851|NCT03543410|69746629|FG000|Overall Study|Protocol Violation|0|||
38055852|NCT03543410|69746630|FG001|Overall Study|Protocol Violation|1|||
38055853|NCT03543410|69746631|FG002|Overall Study|Protocol Violation|0|||
38055854|NCT03543410|69746629|FG000|Overall Study|Due to COVID-19|4|||
38055855|NCT03543410|69746630|FG001|Overall Study|Due to COVID-19|0|||
38055856|NCT03543410|69746631|FG002|Overall Study|Due to COVID-19|2|||
38055857|NCT03543410|69746629|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
38055858|NCT03543410|69746630|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
38055859|NCT03543410|69746631|FG002|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|2|||
38055860|NCT03543410|69746629|FG000|Overall Study|Not Due to COVID-19|2|||
38055861|NCT03543410|69746630|FG001|Overall Study|Not Due to COVID-19|0|||
38055862|NCT03543410|69746631|FG002|Overall Study|Not Due to COVID-19|1|||
38055863|NCT02908074|69746645|FG000|Overall Study|sponsor/ICON decision|0|||
38055864|NCT02908074|69746646|FG001|Overall Study|sponsor/ICON decision|0|||
38055865|NCT02908074|69746647|FG002|Overall Study|sponsor/ICON decision|1|||
38055866|NCT02908074|69746648|FG003|Overall Study|sponsor/ICON decision|0|||
38055867|NCT02908074|69746649|FG004|Overall Study|sponsor/ICON decision|0|||
38055868|NCT02908074|69746650|FG005|Overall Study|sponsor/ICON decision|0|||
38055869|NCT02908074|69746645|FG000|Overall Study|Protocol Violation|0|||
38055870|NCT02908074|69746646|FG001|Overall Study|Protocol Violation|1|||
38055871|NCT02908074|69746647|FG002|Overall Study|Protocol Violation|0|||
38055872|NCT02908074|69746648|FG003|Overall Study|Protocol Violation|0|||
38055873|NCT02908074|69746649|FG004|Overall Study|Protocol Violation|0|||
38055874|NCT02908074|69746650|FG005|Overall Study|Protocol Violation|0|||
38055875|NCT02908074|69746645|FG000|Overall Study|Adverse Event|5|||
38055876|NCT02908074|69746646|FG001|Overall Study|Adverse Event|2|||
38055877|NCT02908074|69746647|FG002|Overall Study|Adverse Event|0|||
38055878|NCT02908074|69746648|FG003|Overall Study|Adverse Event|0|||
38055879|NCT02908074|69746649|FG004|Overall Study|Adverse Event|1|||
38055880|NCT02908074|69746650|FG005|Overall Study|Adverse Event|0|||
38055881|NCT02908074|69746645|FG000|Overall Study|AESI|1|||
38055882|NCT02908074|69746646|FG001|Overall Study|AESI|0|||
38055883|NCT02908074|69746647|FG002|Overall Study|AESI|1|||
38055884|NCT02908074|69746648|FG003|Overall Study|AESI|0|||
38055885|NCT02908074|69746649|FG004|Overall Study|AESI|1|||
38055886|NCT02908074|69746650|FG005|Overall Study|AESI|0|||
38055887|NCT02908074|69746645|FG000|Overall Study|Discontinuation criteria per protocol|0|||
38055888|NCT02908074|69746646|FG001|Overall Study|Discontinuation criteria per protocol|0|||
38055889|NCT02908074|69746647|FG002|Overall Study|Discontinuation criteria per protocol|1|||
38055890|NCT02908074|69746648|FG003|Overall Study|Discontinuation criteria per protocol|0|||
38055891|NCT02908074|69746649|FG004|Overall Study|Discontinuation criteria per protocol|0|||
38055892|NCT02908074|69746650|FG005|Overall Study|Discontinuation criteria per protocol|1|||
38055893|NCT02908074|69746645|FG000|Overall Study|Withdrawal by Subject|3|||
38055894|NCT02908074|69746646|FG001|Overall Study|Withdrawal by Subject|2|||
38055895|NCT02908074|69746647|FG002|Overall Study|Withdrawal by Subject|2|||
38055896|NCT02908074|69746648|FG003|Overall Study|Withdrawal by Subject|2|||
38055897|NCT02908074|69746649|FG004|Overall Study|Withdrawal by Subject|2|||
38055898|NCT02908074|69746650|FG005|Overall Study|Withdrawal by Subject|2|||
38055899|NCT02908074|69746645|FG000|Overall Study|Lost to Follow-up|0|||
38055900|NCT02908074|69746646|FG001|Overall Study|Lost to Follow-up|1|||
38055901|NCT02908074|69746647|FG002|Overall Study|Lost to Follow-up|1|||
38055902|NCT02908074|69746648|FG003|Overall Study|Lost to Follow-up|1|||
38055903|NCT02908074|69746649|FG004|Overall Study|Lost to Follow-up|0|||
38055904|NCT02908074|69746650|FG005|Overall Study|Lost to Follow-up|1|||
38055905|NCT02907359|69746669|FG000|Overall Study|Death|234|||
38055906|NCT02907359|69746670|FG001|Overall Study|Death|117|||
38055907|NCT02907359|69746669|FG000|Overall Study|Withdrawal by Subject|6|||
38055908|NCT02907359|69746670|FG001|Overall Study|Withdrawal by Subject|11|||
38055909|NCT02907359|69746669|FG000|Overall Study|Lost to Follow-up|1|||
38055910|NCT02907359|69746670|FG001|Overall Study|Lost to Follow-up|0|||
38055911|NCT02714205|69746678|FG000|Overall Study|Cannot tolerate medication|1|||
38055912|NCT02714205|69746679|FG001|Overall Study|Cannot tolerate medication|0|||
38055913|NCT02714205|69746678|FG000|Overall Study|Adverse Event|2|||
38055914|NCT02714205|69746679|FG001|Overall Study|Adverse Event|0|||
38055915|NCT02714205|69746678|FG000|Overall Study|Too busy|1|||
38055916|NCT02714205|69746679|FG001|Overall Study|Too busy|0|||
38055917|NCT02714205|69746678|FG000|Overall Study|Incomplete outcome data|0|||
38055918|NCT02714205|69746679|FG001|Overall Study|Incomplete outcome data|1|||
38055919|NCT00583752|69746703|FG000|Overall Study|Lost to Follow-up|5|||
38055920|NCT00583752|69746704|FG001|Overall Study|Lost to Follow-up|5|||
38055921|NCT02318784|69746711|FG000|Overall Study|Adverse Event|13|||
38055922|NCT02318784|69746711|FG000|Overall Study|Death|2|||
38055923|NCT02318784|69746711|FG000|Overall Study|Progressive Disease|37|||
38055924|NCT02318784|69746711|FG000|Overall Study|Withdrawal by Subject|10|||
38055925|NCT03170154|69746726|FG000|Overall Study|Lost to Follow-up|4|||
38055926|NCT03170154|69746726|FG000|Overall Study|Death|2|||
38055927|NCT03170154|69746726|FG000|Overall Study|Withdrawal by Subject|2|||
38055928|NCT03518125|69746741|FG000|Overall Study|Lost to Follow-up|0|||
38055929|NCT03518125|69746742|FG001|Overall Study|Lost to Follow-up|2|||
38055930|NCT03518125|69746743|FG002|Overall Study|Lost to Follow-up|0|||
38055931|NCT03518125|69746744|FG003|Overall Study|Lost to Follow-up|0|||
38055932|NCT03518125|69746745|FG004|Overall Study|Lost to Follow-up|3|||
38055933|NCT03518125|69746746|FG005|Overall Study|Lost to Follow-up|5|||
38055934|NCT03518125|69746741|FG000|Overall Study|Physician Decision|0|||
38055935|NCT03518125|69746742|FG001|Overall Study|Physician Decision|1|||
38055936|NCT03518125|69746743|FG002|Overall Study|Physician Decision|0|||
38055937|NCT03518125|69746744|FG003|Overall Study|Physician Decision|0|||
38055938|NCT03518125|69746745|FG004|Overall Study|Physician Decision|0|||
38055939|NCT03518125|69746746|FG005|Overall Study|Physician Decision|0|||
38055940|NCT03518125|69746741|FG000|Overall Study|Withdrawal by Subject|1|||
38055941|NCT03518125|69746742|FG001|Overall Study|Withdrawal by Subject|1|||
38055942|NCT03518125|69746743|FG002|Overall Study|Withdrawal by Subject|0|||
38055943|NCT03518125|69746744|FG003|Overall Study|Withdrawal by Subject|1|||
38055944|NCT03518125|69746745|FG004|Overall Study|Withdrawal by Subject|1|||
38055945|NCT03518125|69746746|FG005|Overall Study|Withdrawal by Subject|3|||
38055946|NCT03518125|69746741|FG000|Overall Study|Missed Day 394 Visit|1|||
38055947|NCT03518125|69746742|FG001|Overall Study|Missed Day 394 Visit|0|||
38055948|NCT03518125|69746743|FG002|Overall Study|Missed Day 394 Visit|0|||
38055949|NCT03518125|69746744|FG003|Overall Study|Missed Day 394 Visit|0|||
38055950|NCT03518125|69746745|FG004|Overall Study|Missed Day 394 Visit|0|||
38055951|NCT03518125|69746746|FG005|Overall Study|Missed Day 394 Visit|0|||
38055952|NCT03169530|69746763|FG000|Overall Study|Study ended by NIH|15|||
38055953|NCT03169530|69746764|FG001|Overall Study|Study ended by NIH|17|||
38055954|NCT03478891|69746782|FG000|Overall Study|Enrolled, but product never administered|0|||
38055955|NCT03478891|69746783|FG001|Overall Study|Enrolled, but product never administered|0|||
38055956|NCT03478891|69746784|FG002|Overall Study|Enrolled, but product never administered|1|||
38055957|NCT03478891|69746782|FG000|Overall Study|Moved from area|0|||
38055958|NCT03478891|69746783|FG001|Overall Study|Moved from area|0|||
38055959|NCT03478891|69746784|FG002|Overall Study|Moved from area|1|||
38055960|NCT03478891|69746782|FG000|Overall Study|Lost to Follow-up|1|||
38055961|NCT03478891|69746783|FG001|Overall Study|Lost to Follow-up|0|||
38055962|NCT03478891|69746784|FG002|Overall Study|Lost to Follow-up|1|||
38055963|NCT01585103|69746796|FG000|Overall Study|Unable to swallow Cytosponge|6|||
38055964|NCT03168906|69746802|FG000|Overall Study|Lack of Efficacy|6|||
38055965|NCT03168906|69746803|FG001|Overall Study|Lack of Efficacy|6|||
38055966|NCT00706966|69746810|FG000|Overall Study|Adverse Event|1|||
38055967|NCT03478657|69746844|FG000|Overall Study|Withdrawal by Subject|0|||
38055968|NCT03478657|69746845|FG001|Overall Study|Withdrawal by Subject|1|||
38055969|NCT03515941|69746853|FG000|Overall Study|Adverse Event|1|||
38055970|NCT03515941|69746854|FG001|Overall Study|Adverse Event|0|||
38055971|NCT03011034|69746862|FG000|Overall Study|Adverse Event|1|||
38055972|NCT03011034|69746863|FG001|Overall Study|Adverse Event|0|||
38055973|NCT03515629|69746871|FG000|Overall Study|Death|0|||
38055974|NCT03515629|69746872|FG001|Overall Study|Death|1|||
38055975|NCT03515629|69746873|FG002|Overall Study|Death|1|||
38055976|NCT03515629|69746871|FG000|Overall Study|Progressive disease|0|||
38055977|NCT03515629|69746872|FG001|Overall Study|Progressive disease|1|||
38055978|NCT03515629|69746873|FG002|Overall Study|Progressive disease|0|||
38055979|NCT03512353|69746882|FG000|Overall Study|Sponsor Decision|3|||
38055980|NCT03512353|69746882|FG000|Overall Study|Death|1|||
38055981|NCT03512275|69746890|FG000|Overall Study|Withdrawal by Subject|1|||
38055982|NCT03512275|69746891|FG001|Overall Study|Withdrawal by Subject|3|||
38055983|NCT03512275|69746890|FG000|Overall Study|Physician Decision|0|||
38055984|NCT03512275|69746891|FG001|Overall Study|Physician Decision|1|||
38055985|NCT03512275|69746890|FG000|Overall Study|Lost to Follow-up|0|||
38055986|NCT03512275|69746891|FG001|Overall Study|Lost to Follow-up|3|||
38055987|NCT03512275|69746890|FG000|Overall Study|Other|1|||
38055988|NCT03512275|69746891|FG001|Overall Study|Other|0|||
38055989|NCT03473197|69746897|FG000|Overall Study|Adverse Event|4|||
38055990|NCT03473197|69746897|FG000|Overall Study|Lost to Follow-up|1|||
38055991|NCT03473197|69746897|FG000|Overall Study|Withdrawal by Subject|5|||
38055992|NCT03511105|69746903|FG000|Overall Study|Adverse Event|1|||
38055993|NCT03511105|69746904|FG001|Overall Study|Adverse Event|0|||
38055994|NCT03511105|69746903|FG000|Overall Study|Withdrew consent|1|||
38055995|NCT03511105|69746904|FG001|Overall Study|Withdrew consent|0|||
38055996|NCT03510715|69746924|FG000|Overall Study|Adverse Event|1|||
38055997|NCT03510715|69746925|FG001|Overall Study|Adverse Event|0|||
38055998|NCT03508843|69746932|FG000|Overall Study|Withdrawal by Subject|1|||
38055999|NCT03508843|69746932|FG000|Overall Study|technical difficulties|2|||
38056000|NCT03508609|69746936|FG000|Overall Study|Withdrawal by Subject|1|||
38056001|NCT03054350|69746946|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
38056002|NCT03054350|69746947|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
38056003|NCT03054350|69746948|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
38056004|NCT03054350|69746949|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
38056005|NCT03054350|69746950|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
38056006|NCT03054350|69746951|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
38056007|NCT03054350|69746946|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
38056008|NCT03054350|69746947|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
38056009|NCT03054350|69746948|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
38056010|NCT03054350|69746949|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
38056011|NCT03054350|69746950|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
38056012|NCT03054350|69746951|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
38056013|NCT03054350|69746946|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
38056014|NCT03054350|69746947|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
38056015|NCT03054350|69746948|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
38056016|NCT03054350|69746949|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
38056017|NCT03054350|69746950|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
38056018|NCT03054350|69746951|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
38056019|NCT03054350|69746946|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
38056020|NCT03054350|69746947|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
38056021|NCT03054350|69746948|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
38056022|NCT03054350|69746949|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
38056023|NCT03054350|69746950|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
38056024|NCT03054350|69746951|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
38056025|NCT03528577|69746982|FG000|Sequence 1|Failed Spirometry|1|||
38056026|NCT03528577|69746982|FG000|Sequence 1|Restricted medication|1|||
38056027|NCT03528577|69746982|FG000|Sequence 2|Adverse Event|1|||
38056028|NCT03528577|69746982|FG000|Sequence 2|Withdrawal by Subject|1|||
38056029|NCT03528577|69746982|FG000|Sequence 2|Failed Spirometry|1|||
38056030|NCT03528577|69746982|FG000|Sequence 3|Failed Spirometry|1|||
38056031|NCT03528577|69746982|FG000|Sequence 4|Failed Spirometry|2|||
38056032|NCT03528577|69746982|FG000|Sequence 4|Adverse Event|1|||
38056033|NCT00706654|69746992|FG000|Conversion Phase|Lost to Follow-up|4|||
38056034|NCT00706654|69746993|FG001|Conversion Phase|Lost to Follow-up|0|||
38056035|NCT00706654|69746994|FG002|Conversion Phase|Lost to Follow-up|0|||
38056036|NCT00706654|69746995|FG003|Conversion Phase|Lost to Follow-up|0|||
38056037|NCT00706654|69746992|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
38056038|NCT00706654|69746993|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
38056039|NCT00706654|69746994|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
38056040|NCT00706654|69746995|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
38056041|NCT00706654|69746992|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
38056042|NCT00706654|69746993|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
38056043|NCT00706654|69746994|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
38056044|NCT00706654|69746995|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
38056045|NCT00706654|69746992|FG000|Conversion Phase|Withdrawn by Investigator|14|||
38056046|NCT00706654|69746993|FG001|Conversion Phase|Withdrawn by Investigator|0|||
38056047|NCT00706654|69746994|FG002|Conversion Phase|Withdrawn by Investigator|0|||
38056048|NCT00706654|69746995|FG003|Conversion Phase|Withdrawn by Investigator|0|||
38056049|NCT00706654|69746992|FG000|Conversion Phase|Withdrew Consent|38|||
38056050|NCT00706654|69746993|FG001|Conversion Phase|Withdrew Consent|0|||
38056051|NCT00706654|69746994|FG002|Conversion Phase|Withdrew Consent|0|||
38056052|NCT00706654|69746995|FG003|Conversion Phase|Withdrew Consent|0|||
38056053|NCT00706654|69746992|FG000|Conversion Phase|Adverse Event|18|||
38056054|NCT00706654|69746993|FG001|Conversion Phase|Adverse Event|0|||
38056055|NCT00706654|69746994|FG002|Conversion Phase|Adverse Event|0|||
38056056|NCT00706654|69746995|FG003|Conversion Phase|Adverse Event|0|||
38056057|NCT00706654|69746992|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
38056058|NCT00706654|69746993|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
38056059|NCT00706654|69746994|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
38056060|NCT00706654|69746995|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
38056061|NCT00706654|69746992|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
38056062|NCT00706654|69746993|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
38056063|NCT00706654|69746994|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
38056064|NCT00706654|69746995|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
38056065|NCT00706654|69746992|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
38056066|NCT00706654|69746993|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
38056067|NCT00706654|69746994|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
38056068|NCT00706654|69746995|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
38056069|NCT00706654|69746992|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
38056070|NCT00706654|69746993|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
38056071|NCT00706654|69746994|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
37965134|NCT00570323|69652233|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
37965135|NCT00570323|69652234|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
37965136|NCT00570323|69652233|FG000|Started Treatment After Randomization|Protocol Violation|1|||
37965137|NCT00570323|69652234|FG001|Started Treatment After Randomization|Protocol Violation|0|||
37965138|NCT00570323|69652233|FG000|Started Treatment After Randomization|Physician Decision|1|||
37965139|NCT00570323|69652234|FG001|Started Treatment After Randomization|Physician Decision|0|||
37965140|NCT00570323|69652233|FG000|Complete Study After Start|Lost to Follow-up|0|||
37965141|NCT00570323|69652234|FG001|Complete Study After Start|Lost to Follow-up|1|||
37965142|NCT00570323|69652233|FG000|Complete Study After Start|Withdrawal by Subject|2|||
37965143|NCT00570323|69652234|FG001|Complete Study After Start|Withdrawal by Subject|0|||
38056072|NCT00706654|69746995|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
38056073|NCT00706654|69746992|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
38056074|NCT00706654|69746993|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
38056075|NCT00706654|69746994|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
38056076|NCT00706654|69746995|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
38056077|NCT00706654|69746992|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
38056078|NCT00706654|69746993|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
38056079|NCT00706654|69746994|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
38056080|NCT00706654|69746995|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
38056081|NCT00706654|69746992|FG000|Oral Stabilization Phase|Withdrew consent|55|||
38056082|NCT00706654|69746993|FG001|Oral Stabilization Phase|Withdrew consent|0|||
38056083|NCT00706654|69746994|FG002|Oral Stabilization Phase|Withdrew consent|0|||
38056084|NCT00706654|69746995|FG003|Oral Stabilization Phase|Withdrew consent|0|||
38056085|NCT00706654|69746992|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
38056086|NCT00706654|69746993|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
38056087|NCT00706654|69746994|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
38056088|NCT00706654|69746995|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
38056089|NCT00706654|69746992|FG000|Oral Stabilization Phase|Adverse Event|21|||
38056090|NCT00706654|69746993|FG001|Oral Stabilization Phase|Adverse Event|0|||
38056091|NCT00706654|69746994|FG002|Oral Stabilization Phase|Adverse Event|0|||
38056092|NCT00706654|69746995|FG003|Oral Stabilization Phase|Adverse Event|0|||
38056093|NCT00706654|69746992|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
38056094|NCT00706654|69746993|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
38056095|NCT00706654|69746994|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
38056096|NCT00706654|69746995|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
38056097|NCT00706654|69746992|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
38056098|NCT00706654|69746993|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
38056099|NCT00706654|69746994|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
38056100|NCT00706654|69746995|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
38056101|NCT00706654|69746992|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
38056102|NCT00706654|69746993|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
38056103|NCT00706654|69746994|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
38056104|NCT00706654|69746995|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
38056105|NCT00706654|69746992|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
38056106|NCT00706654|69746993|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
38056107|NCT00706654|69746994|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
38056108|NCT00706654|69746995|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
38056109|NCT00706654|69746992|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
38056110|NCT00706654|69746993|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
38056111|NCT00706654|69746994|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
38056112|NCT00706654|69746995|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
38056113|NCT00706654|69746992|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
38056114|NCT00706654|69746993|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
38056115|NCT00706654|69746994|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
38056116|NCT00706654|69746995|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
38056117|NCT00706654|69746992|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
38056118|NCT00706654|69746993|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
38056119|NCT00706654|69746994|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
38056120|NCT00706654|69746995|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
38056121|NCT00706654|69746992|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
38056122|NCT00706654|69746993|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
38056123|NCT00706654|69746994|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
38056124|NCT00706654|69746995|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
38056125|NCT00706654|69746992|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
38056126|NCT00706654|69746993|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
38056127|NCT00706654|69746994|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
38056128|NCT00706654|69746995|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
38056129|NCT00706654|69746992|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
38056130|NCT00706654|69746993|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
38056131|NCT00706654|69746994|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
38056132|NCT00706654|69746995|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
38056133|NCT03471871|69747007|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
38056134|NCT03471871|69747008|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
38056135|NCT03471871|69747009|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
38056136|NCT03471871|69747010|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
38056137|NCT03471871|69747011|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
38056138|NCT03471871|69747007|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
38056139|NCT03471871|69747008|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
38056140|NCT03471871|69747009|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
38056141|NCT03471871|69747010|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
38056142|NCT03471871|69747011|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
38056143|NCT03471871|69747007|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
38056144|NCT03471871|69747008|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
38056145|NCT03471871|69747009|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
38056146|NCT03471871|69747010|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
38056147|NCT03471871|69747011|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
38056148|NCT03471871|69747007|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
38056149|NCT03471871|69747008|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
38056150|NCT03471871|69747009|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
38056151|NCT03471871|69747010|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
38056152|NCT03471871|69747011|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
38056153|NCT03471871|69747007|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
38056154|NCT03471871|69747008|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
38056155|NCT03471871|69747009|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
38056156|NCT03471871|69747010|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
38056157|NCT03471871|69747011|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
38056158|NCT01957176|69747029|FG000|Overall Study|Adverse Event|2|||
38056159|NCT01957176|69747030|FG001|Overall Study|Adverse Event|0|||
38056160|NCT01957176|69747029|FG000|Overall Study|Physician Decision|2|||
38056161|NCT01957176|69747030|FG001|Overall Study|Physician Decision|1|||
38056162|NCT01957176|69747029|FG000|Overall Study|Withdrawal by Subject|1|||
38056163|NCT01957176|69747030|FG001|Overall Study|Withdrawal by Subject|0|||
38056164|NCT03527173|69747039|FG000|Overall Study|Lost to Follow-up|4|||
38056165|NCT03527173|69747040|FG001|Overall Study|Lost to Follow-up|2|||
38056166|NCT03527173|69747039|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
38056167|NCT03527173|69747040|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
38056168|NCT03527173|69747039|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
38056169|NCT03527173|69747040|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
38056170|NCT03527173|69747039|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
38056171|NCT03527173|69747040|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
38056172|NCT00707980|69747046|FG000|Overall Study|Adverse Event|49|||
38056173|NCT00707980|69747046|FG000|Overall Study|Lack of Efficacy|35|||
38056174|NCT00707980|69747046|FG000|Overall Study|Non-Compliance with Study Drug|28|||
38056175|NCT00707980|69747046|FG000|Overall Study|Protocol Deviations|19|||
38056176|NCT00707980|69747046|FG000|Overall Study|Withdrawal of Consent|81|||
38056177|NCT00707980|69747046|FG000|Overall Study|Lost to Follow-up|59|||
38056178|NCT00707980|69747046|FG000|Overall Study|Other|39|||
38056179|NCT03506425|69747053|FG000|Overall Study|Adverse Event|1|||
38056180|NCT03506425|69747054|FG001|Overall Study|Adverse Event|3|||
38056181|NCT03506425|69747055|FG002|Overall Study|Adverse Event|0|||
38056182|NCT03506425|69747053|FG000|Overall Study|Death|1|||
38056183|NCT03506425|69747054|FG001|Overall Study|Death|0|||
38056184|NCT03506425|69747055|FG002|Overall Study|Death|0|||
38056185|NCT03506425|69747053|FG000|Overall Study|Withdrawal by Subject|0|||
38056186|NCT03506425|69747054|FG001|Overall Study|Withdrawal by Subject|0|||
38056187|NCT03506425|69747055|FG002|Overall Study|Withdrawal by Subject|1|||
38056188|NCT03051620|69747064|FG000|Overall Study|Lost to Follow-up|6|||
38056189|NCT03051620|69747064|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
38056190|NCT03053492|69747070|FG000|Overall Study|Adverse Event|1|||
38056191|NCT03053492|69747071|FG001|Overall Study|Adverse Event|1|||
38056192|NCT03053492|69747070|FG000|Overall Study|Withdrawal by Subject|7|||
38056193|NCT03053492|69747071|FG001|Overall Study|Withdrawal by Subject|5|||
38056194|NCT03801707|69747077|FG000|Overall Study|Removed from study due to reaching the study target of 30 transplant from hepatitis C viremic donors|6|||
38056195|NCT04239872|69747081|FG000|Overall Study|Lost to Follow-up|0|||
38056196|NCT04239872|69747082|FG001|Overall Study|Lost to Follow-up|1|||
38056197|NCT03164772|69747090|FG000|Overall Study|Death|4|||
38056198|NCT03164772|69747091|FG001|Overall Study|Death|2|||
38056199|NCT03164772|69747090|FG000|Overall Study|Adverse Event|1|||
38056200|NCT03164772|69747091|FG001|Overall Study|Adverse Event|4|||
38056201|NCT03164772|69747090|FG000|Overall Study|Progressive Disease|11|||
38056202|NCT03164772|69747091|FG001|Overall Study|Progressive Disease|21|||
38056203|NCT03164772|69747090|FG000|Overall Study|Physician Decision|2|||
38056204|NCT03164772|69747091|FG001|Overall Study|Physician Decision|0|||
38056205|NCT03164772|69747090|FG000|Overall Study|Withdrawal by Subject|0|||
38056206|NCT03164772|69747091|FG001|Overall Study|Withdrawal by Subject|4|||
38056207|NCT03050450|69747114|FG000|Overall Study|Physician Decision|1|||
38056208|NCT03050450|69747115|FG001|Overall Study|Physician Decision|0|||
38056209|NCT03050450|69747116|FG002|Overall Study|Physician Decision|0|||
38056210|NCT03050450|69747117|FG003|Overall Study|Physician Decision|0|||
38056211|NCT03050450|69747118|FG004|Overall Study|Physician Decision|0|||
38056212|NCT03505021|69747132|FG000|Overall Study|Protocol Violation|1|||
38056213|NCT03505021|69747133|FG001|Overall Study|Protocol Violation|0|||
38056214|NCT03505021|69747132|FG000|Overall Study|Death|9|||
38056215|NCT03505021|69747133|FG001|Overall Study|Death|8|||
38056216|NCT03505021|69747132|FG000|Overall Study|Consent withdrawn by subject|6|||
38056217|NCT03505021|69747133|FG001|Overall Study|Consent withdrawn by subject|1|||
38056218|NCT03505021|69747132|FG000|Overall Study|Lost to Follow-up|5|||
38056219|NCT03505021|69747133|FG001|Overall Study|Lost to Follow-up|3|||
38056220|NCT03505021|69747132|FG000|Overall Study|Adverse Event|26|||
38056221|NCT03505021|69747133|FG001|Overall Study|Adverse Event|9|||
38056222|NCT03505021|69747132|FG000|Overall Study|Disease progression|33|||
38056223|NCT03505021|69747133|FG001|Overall Study|Disease progression|17|||
38056224|NCT03505021|69747132|FG000|Overall Study|Other|11|||
38056225|NCT03505021|69747133|FG001|Overall Study|Other|5|||
38056226|NCT03505021|69747132|FG000|Overall Study|Personal reason|21|||
38056227|NCT03505021|69747133|FG001|Overall Study|Personal reason|12|||
38056228|NCT03050372|69747139|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
38056229|NCT03050372|69747140|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
38056230|NCT03050372|69747139|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
38056231|NCT03050372|69747140|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
38056232|NCT03470545|69747147|FG000|Overall Study|Death|0|||
38056233|NCT03470545|69747148|FG001|Overall Study|Death|1|||
38056234|NCT03470545|69747147|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
38056235|NCT03470545|69747148|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
38056236|NCT03470545|69747147|FG000|Overall Study|Adverse Event|2|||
38056237|NCT03470545|69747148|FG001|Overall Study|Adverse Event|0|||
38056238|NCT03470545|69747147|FG000|Overall Study|Withdrawal by Subject|1|||
38056239|NCT03470545|69747148|FG001|Overall Study|Withdrawal by Subject|1|||
38056240|NCT03470545|69747147|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
38056241|NCT03470545|69747148|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
38056242|NCT03163446|69747157|FG000|Overall Study|Unable to return for Day 180 visit|2|||
38056243|NCT03163446|69747158|FG001|Overall Study|Unable to return for Day 180 visit|0|||
38056244|NCT03163446|69747157|FG000|Overall Study|Withdrawal by Subject|2|||
38056245|NCT03163446|69747158|FG001|Overall Study|Withdrawal by Subject|6|||
38056246|NCT03163446|69747157|FG000|Overall Study|Death|16|||
38056247|NCT03163446|69747158|FG001|Overall Study|Death|5|||
37965144|NCT00570323|69652233|FG000|Complete Study After Start|Physician Decision|1|||
37965145|NCT00570323|69652234|FG001|Complete Study After Start|Physician Decision|0|||
37965146|NCT00661505|69652242|FG000|Overall Study|Adverse Event|3|||
37965147|NCT00661505|69652242|FG000|Overall Study|Protocol Violation|14|||
37965148|NCT00661505|69652242|FG000|Overall Study|Withdrawal by Subject|8|||
37965149|NCT00661505|69652242|FG000|Overall Study|Lost to Follow-up|3|||
37965150|NCT00661505|69652242|FG000|Overall Study|Other|2|||
37965151|NCT00662909|69652250|FG000|Overall Study|Adverse Event|17|||
38056248|NCT03163446|69747157|FG000|Overall Study|Lost to Follow-up|6|||
38056249|NCT03163446|69747158|FG001|Overall Study|Lost to Follow-up|5|||
38056250|NCT03163446|69747157|FG000|Overall Study|Physician Decision|1|||
38056251|NCT03163446|69747158|FG001|Overall Study|Physician Decision|1|||
38056252|NCT03163446|69747157|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
38056253|NCT03163446|69747158|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
38056254|NCT03722485|69747172|FG000|Overall Study|Withdrawal by Subject|1|||
38056255|NCT03722485|69747173|FG001|Overall Study|Withdrawal by Subject|0|||
38056256|NCT03722485|69747172|FG000|Overall Study|Adverse Event|0|||
38056257|NCT03722485|69747173|FG001|Overall Study|Adverse Event|2|||
38056258|NCT03722485|69747172|FG000|Overall Study|subject discharged prior to study completion|1|||
38056259|NCT03722485|69747173|FG001|Overall Study|subject discharged prior to study completion|5|||
38056260|NCT03722485|69747172|FG000|Overall Study|eligibility criteria not met|2|||
38056261|NCT03722485|69747173|FG001|Overall Study|eligibility criteria not met|0|||
38056262|NCT03047720|69747207|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
38056263|NCT03047720|69747208|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
38056264|NCT03626168|69747233|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
38056265|NCT03626168|69747234|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
38056266|NCT03626168|69747233|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
38056267|NCT03626168|69747234|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
38056268|NCT03626168|69747233|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
38056269|NCT03626168|69747234|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
38056270|NCT02966873|69747242|FG000|Overall Study|Lost to Follow-up|16|||
38056271|NCT02966873|69747243|FG001|Overall Study|Lost to Follow-up|15|||
38056272|NCT01389024|69747251|FG000|Overall Study|Withdrawal by Subject|0|||
38056273|NCT01389024|69747252|FG001|Overall Study|Withdrawal by Subject|1|||
38056274|NCT01389024|69747251|FG000|Overall Study|Lost to Follow-up|1|||
38056275|NCT01389024|69747252|FG001|Overall Study|Lost to Follow-up|0|||
38056276|NCT03050060|69747262|FG000|Overall Study|Adverse Event|7|||
38056277|NCT03050060|69747262|FG000|Overall Study|Withdrawal by Subject|1|||
38056278|NCT03050060|69747262|FG000|Overall Study|Progression|7|||
38056279|NCT00706342|69747275|FG000|Overall Study|Adverse Event|3|||
38056280|NCT00706342|69747275|FG000|Overall Study|Not responding to treatment|2|||
38056281|NCT00706342|69747275|FG000|Overall Study|Withdrawn due to failure to respond|1|||
38056282|NCT00706342|69747275|FG000|Overall Study|Death|1|||
37680368|NCT02587819|69155979|FG000|Overall Study|Lost to Follow-up|1|||
37680369|NCT01666951|69155986|FG000|Overall Study|Not dosed|1|||
38056283|NCT00706342|69747275|FG000|Overall Study|Withdrew from the study on his own.|1|||
38056284|NCT00706342|69747275|FG000|Overall Study|Investigator discretion|2|||
38056285|NCT00706342|69747275|FG000|Overall Study|Non-responder Week 12|1|||
38056286|NCT00706342|69747275|FG000|Overall Study|Ongoing|6|||
38056287|NCT00706342|69747275|FG000|Overall Study|WIthdrawal of consent|1|||
38056288|NCT03049748|69747281|FG000|Overall Study|Lost to Follow-up|1|||
38056289|NCT03049748|69747282|FG001|Overall Study|Lost to Follow-up|0|||
38056290|NCT03049748|69747281|FG000|Overall Study|Death|3|||
38056291|NCT03049748|69747282|FG001|Overall Study|Death|0|||
38056292|NCT03049748|69747281|FG000|Overall Study|Withdrawal by Subject|0|||
38056293|NCT03049748|69747282|FG001|Overall Study|Withdrawal by Subject|3|||
38056294|NCT03049748|69747281|FG000|Overall Study|Protocol Violation|0|||
38056295|NCT03049748|69747282|FG001|Overall Study|Protocol Violation|2|||
38056296|NCT03049748|69747281|FG000|Overall Study|Moved out of state (relocation)|0|||
38056297|NCT03049748|69747282|FG001|Overall Study|Moved out of state (relocation)|1|||
38056298|NCT03501277|69747296|FG000|Intervention Period 1 (4 Days)|Other|0|||
38056299|NCT03501277|69747297|FG001|Intervention Period 1 (4 Days)|Other|0|||
38056300|NCT03501277|69747298|FG002|Intervention Period 1 (4 Days)|Other|1|||
38056301|NCT03501277|69747299|FG003|Intervention Period 1 (4 Days)|Other|0|||
38056302|NCT03501277|69747296|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
38056303|NCT03501277|69747297|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
38056304|NCT03501277|69747298|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
38056305|NCT03501277|69747299|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
38056306|NCT03501277|69747296|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
38056307|NCT03501277|69747297|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
38056308|NCT03501277|69747298|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
38056309|NCT03501277|69747299|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
38056310|NCT03501277|69747296|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
38056311|NCT03501277|69747297|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
38056312|NCT03501277|69747298|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
38056313|NCT03501277|69747299|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
38056314|NCT03500419|69747311|FG000|Overall Study|Withdrawal by Subject|2|||
38056315|NCT03500419|69747312|FG001|Overall Study|Withdrawal by Subject|25|||
38056316|NCT03500341|69747318|FG000|Overall Study|Withdrawn prior to Completion|2|||
38056317|NCT01316900|69747339|FG000|Overall Study|Adverse Event|10|||
38056318|NCT01316900|69747340|FG001|Overall Study|Adverse Event|10|||
38056319|NCT01316900|69747341|FG002|Overall Study|Adverse Event|15|||
38056320|NCT01316900|69747342|FG003|Overall Study|Adverse Event|9|||
38056321|NCT01316900|69747339|FG000|Overall Study|Lack of Efficacy|17|||
38056322|NCT01316900|69747340|FG001|Overall Study|Lack of Efficacy|9|||
38056323|NCT01316900|69747341|FG002|Overall Study|Lack of Efficacy|5|||
38056324|NCT01316900|69747342|FG003|Overall Study|Lack of Efficacy|7|||
38056325|NCT01316900|69747339|FG000|Overall Study|Protocol Violation|7|||
38056326|NCT01316900|69747340|FG001|Overall Study|Protocol Violation|1|||
38056327|NCT01316900|69747341|FG002|Overall Study|Protocol Violation|4|||
38056328|NCT01316900|69747342|FG003|Overall Study|Protocol Violation|0|||
38056329|NCT01316900|69747339|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
38056330|NCT01316900|69747340|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
38056331|NCT01316900|69747341|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
38056332|NCT01316900|69747342|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
38056333|NCT01316900|69747339|FG000|Overall Study|Lost to Follow-up|1|||
38056334|NCT01316900|69747340|FG001|Overall Study|Lost to Follow-up|0|||
38056335|NCT01316900|69747341|FG002|Overall Study|Lost to Follow-up|1|||
38056336|NCT01316900|69747342|FG003|Overall Study|Lost to Follow-up|1|||
38056337|NCT01316900|69747339|FG000|Overall Study|Withdrawal by Subject|7|||
38056338|NCT01316900|69747340|FG001|Overall Study|Withdrawal by Subject|8|||
38056339|NCT01316900|69747341|FG002|Overall Study|Withdrawal by Subject|6|||
38056340|NCT01316900|69747342|FG003|Overall Study|Withdrawal by Subject|9|||
38056341|NCT03499873|69747355|FG000|Overall Study|Withdrawal by Subject|4|||
38056342|NCT03499873|69747356|FG001|Overall Study|Withdrawal by Subject|6|||
38056343|NCT03499873|69747357|FG002|Overall Study|Withdrawal by Subject|1|||
38056344|NCT03499873|69747355|FG000|Overall Study|Subjects condition worsened|0|||
38056345|NCT03499873|69747356|FG001|Overall Study|Subjects condition worsened|3|||
38056346|NCT03499873|69747357|FG002|Overall Study|Subjects condition worsened|11|||
38056347|NCT03499873|69747355|FG000|Overall Study|Adverse Event|8|||
38056348|NCT03499873|69747356|FG001|Overall Study|Adverse Event|3|||
38056349|NCT03499873|69747357|FG002|Overall Study|Adverse Event|6|||
38056350|NCT03499873|69747355|FG000|Overall Study|Physician Decision|1|||
38056351|NCT03499873|69747356|FG001|Overall Study|Physician Decision|0|||
38056352|NCT03499873|69747357|FG002|Overall Study|Physician Decision|0|||
38056353|NCT03499873|69747355|FG000|Overall Study|Administrative reasons|0|||
38056354|NCT03499873|69747356|FG001|Overall Study|Administrative reasons|1|||
38056355|NCT03499873|69747357|FG002|Overall Study|Administrative reasons|0|||
38056356|NCT03499873|69747355|FG000|Overall Study|Concomitant therapy|5|||
38056357|NCT03499873|69747356|FG001|Overall Study|Concomitant therapy|4|||
38056358|NCT03499873|69747357|FG002|Overall Study|Concomitant therapy|7|||
38056359|NCT03499873|69747355|FG000|Overall Study|Miscellaneous|1|||
38056360|NCT03499873|69747356|FG001|Overall Study|Miscellaneous|2|||
38056361|NCT03499873|69747357|FG002|Overall Study|Miscellaneous|2|||
38056362|NCT03499873|69747355|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
38056363|NCT03499873|69747356|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
38056364|NCT03499873|69747357|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
38056365|NCT03467971|69747367|FG000|Treatment Period 2|Withdrawal by Subject|0|||
38056366|NCT03467971|69747368|FG001|Treatment Period 2|Withdrawal by Subject|1|||
38056367|NCT03049280|69747384|FG000|Overall Study|Physician Decision|1|||
38056368|NCT03048500|69747390|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
38056369|NCT03048500|69747390|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
38056370|NCT03048500|69747390|FG000|Reached 1st Response/Continued Treatment|Death|1|||
38056371|NCT03048500|69747390|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
38056372|NCT03048500|69747390|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
38056373|NCT03048500|69747390|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
38056374|NCT03048500|69747390|FG000|Follow up for 3 Years|Death|12|||
38056375|NCT00908076|69747396|FG000|Overall Study|Lack of Efficacy|1|||
38056376|NCT00908076|69747397|FG001|Overall Study|Lack of Efficacy|1|||
38056377|NCT03467425|69747405|FG000|Overall Study|Adverse Event|9|||
38056378|NCT03467425|69747406|FG001|Overall Study|Adverse Event|9|||
38056379|NCT03467425|69747405|FG000|Overall Study|Lack of Efficacy|3|||
38056380|NCT03467425|69747406|FG001|Overall Study|Lack of Efficacy|1|||
38056381|NCT03467425|69747405|FG000|Overall Study|Protocol Violation|0|||
38056382|NCT03467425|69747406|FG001|Overall Study|Protocol Violation|1|||
38056383|NCT03467425|69747405|FG000|Overall Study|Lost to Follow-up|18|||
38056384|NCT03467425|69747406|FG001|Overall Study|Lost to Follow-up|25|||
38056385|NCT03467425|69747405|FG000|Overall Study|Physician Decision|2|||
38056386|NCT03467425|69747406|FG001|Overall Study|Physician Decision|1|||
38056387|NCT03467425|69747405|FG000|Overall Study|Withdrawal by Subject|15|||
38056388|NCT03467425|69747406|FG001|Overall Study|Withdrawal by Subject|17|||
38056389|NCT02886702|69747415|FG000|Overall Study|Other|4|||
38056390|NCT02886702|69747416|FG001|Overall Study|Other|3|||
38056391|NCT02886702|69747417|FG002|Overall Study|Other|9|||
38056392|NCT02886702|69747415|FG000|Overall Study|Withdrawal by Subject|24|||
38056393|NCT02886702|69747416|FG001|Overall Study|Withdrawal by Subject|18|||
38056394|NCT02886702|69747417|FG002|Overall Study|Withdrawal by Subject|22|||
38056395|NCT02886702|69747415|FG000|Overall Study|Significant Worsening of Condition|0|||
38056396|NCT02886702|69747416|FG001|Overall Study|Significant Worsening of Condition|1|||
38056397|NCT02886702|69747417|FG002|Overall Study|Significant Worsening of Condition|0|||
38056398|NCT02886702|69747415|FG000|Overall Study|Protocol Violation|2|||
38056399|NCT02886702|69747416|FG001|Overall Study|Protocol Violation|2|||
38056400|NCT02886702|69747417|FG002|Overall Study|Protocol Violation|1|||
38056401|NCT02886702|69747415|FG000|Overall Study|Non-Compliance With Study Drug|0|||
38056402|NCT02886702|69747416|FG001|Overall Study|Non-Compliance With Study Drug|1|||
38056403|NCT02886702|69747417|FG002|Overall Study|Non-Compliance With Study Drug|4|||
38056404|NCT02886702|69747415|FG000|Overall Study|Lost to Follow-up|11|||
38056405|NCT02886702|69747416|FG001|Overall Study|Lost to Follow-up|13|||
38056406|NCT02886702|69747417|FG002|Overall Study|Lost to Follow-up|8|||
38056407|NCT02886702|69747415|FG000|Overall Study|Lack of Efficacy|3|||
38056408|NCT02886702|69747416|FG001|Overall Study|Lack of Efficacy|4|||
38056409|NCT02886702|69747417|FG002|Overall Study|Lack of Efficacy|5|||
38056410|NCT02886702|69747415|FG000|Overall Study|Adverse Event|4|||
38056411|NCT02886702|69747416|FG001|Overall Study|Adverse Event|9|||
38056412|NCT02886702|69747417|FG002|Overall Study|Adverse Event|3|||
38056413|NCT02886702|69747415|FG000|Overall Study|Administrative Reasons|0|||
38056414|NCT02886702|69747416|FG001|Overall Study|Administrative Reasons|0|||
38056415|NCT02886702|69747417|FG002|Overall Study|Administrative Reasons|1|||
38056416|NCT03498313|69747431|FG000|Experimental Period 1|Adverse Event|1|||
38056417|NCT03498313|69747432|FG001|Experimental Period 1|Adverse Event|0|||
38056418|NCT03498313|69747433|FG002|Experimental Period 1|Adverse Event|0|||
38056419|NCT03498313|69747434|FG003|Experimental Period 1|Adverse Event|1|||
38056420|NCT03498313|69747435|FG004|Experimental Period 1|Adverse Event|0|||
38056421|NCT03498313|69747436|FG005|Experimental Period 1|Adverse Event|0|||
38056422|NCT03498313|69747431|FG000|Experimental Period 1|Withdrawal by Subject|0|||
38056423|NCT03498313|69747432|FG001|Experimental Period 1|Withdrawal by Subject|1|||
38056424|NCT03498313|69747433|FG002|Experimental Period 1|Withdrawal by Subject|0|||
38056425|NCT03498313|69747434|FG003|Experimental Period 1|Withdrawal by Subject|0|||
38056426|NCT03498313|69747435|FG004|Experimental Period 1|Withdrawal by Subject|0|||
38056427|NCT03498313|69747436|FG005|Experimental Period 1|Withdrawal by Subject|0|||
38056428|NCT03498313|69747431|FG000|Washout Period 1|Anovulation|1|||
38056429|NCT03498313|69747432|FG001|Washout Period 1|Anovulation|0|||
38056430|NCT03498313|69747433|FG002|Washout Period 1|Anovulation|0|||
38056431|NCT03498313|69747434|FG003|Washout Period 1|Anovulation|0|||
38056432|NCT03498313|69747435|FG004|Washout Period 1|Anovulation|0|||
38056433|NCT03498313|69747436|FG005|Washout Period 1|Anovulation|0|||
38056434|NCT03498313|69747431|FG000|Washout Period 1|Withdrawal by Subject|0|||
38056435|NCT03498313|69747432|FG001|Washout Period 1|Withdrawal by Subject|3|||
38056436|NCT03498313|69747433|FG002|Washout Period 1|Withdrawal by Subject|0|||
37862159|NCT00922207|69545931|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
38056437|NCT03498313|69747434|FG003|Washout Period 1|Withdrawal by Subject|1|||
38056438|NCT03498313|69747435|FG004|Washout Period 1|Withdrawal by Subject|0|||
38056439|NCT03498313|69747436|FG005|Washout Period 1|Withdrawal by Subject|1|||
38056440|NCT03498313|69747431|FG000|Experimental Period 2|Adverse Event|0|||
38056441|NCT03498313|69747432|FG001|Experimental Period 2|Adverse Event|0|||
38056442|NCT03498313|69747433|FG002|Experimental Period 2|Adverse Event|0|||
38056443|NCT03498313|69747434|FG003|Experimental Period 2|Adverse Event|0|||
38056444|NCT03498313|69747435|FG004|Experimental Period 2|Adverse Event|1|||
37862160|NCT00922207|69545932|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
38056445|NCT03498313|69747436|FG005|Experimental Period 2|Adverse Event|2|||
38056446|NCT03498313|69747431|FG000|Washout Period 2|Physician Decision|1|||
38056447|NCT03498313|69747432|FG001|Washout Period 2|Physician Decision|0|||
38056448|NCT03498313|69747433|FG002|Washout Period 2|Physician Decision|0|||
38056449|NCT03498313|69747434|FG003|Washout Period 2|Physician Decision|1|||
38056450|NCT03498313|69747435|FG004|Washout Period 2|Physician Decision|0|||
38056451|NCT03498313|69747436|FG005|Washout Period 2|Physician Decision|1|||
38056452|NCT03498313|69747431|FG000|Washout Period 2|Withdrawal by Subject|3|||
38056453|NCT03498313|69747432|FG001|Washout Period 2|Withdrawal by Subject|2|||
38056454|NCT03498313|69747433|FG002|Washout Period 2|Withdrawal by Subject|0|||
38056455|NCT03498313|69747434|FG003|Washout Period 2|Withdrawal by Subject|0|||
38056456|NCT03498313|69747435|FG004|Washout Period 2|Withdrawal by Subject|2|||
38056457|NCT03498313|69747436|FG005|Washout Period 2|Withdrawal by Subject|0|||
38056458|NCT03498313|69747431|FG000|Washout Period 2|Anovulation|0|||
38056459|NCT03498313|69747432|FG001|Washout Period 2|Anovulation|0|||
38056460|NCT03498313|69747433|FG002|Washout Period 2|Anovulation|0|||
38056461|NCT03498313|69747434|FG003|Washout Period 2|Anovulation|0|||
38056462|NCT03498313|69747435|FG004|Washout Period 2|Anovulation|0|||
38056463|NCT03498313|69747436|FG005|Washout Period 2|Anovulation|1|||
38056464|NCT02601014|69747446|FG000|Overall Study|Adverse Event|3|||
38056465|NCT02601014|69747447|FG001|Overall Study|Adverse Event|3|||
38056466|NCT02601014|69747446|FG000|Overall Study|Death|3|||
38056467|NCT02601014|69747447|FG001|Overall Study|Death|1|||
38056468|NCT02601014|69747446|FG000|Overall Study|Disease progression|4|||
38056469|NCT02601014|69747447|FG001|Overall Study|Disease progression|8|||
38056470|NCT01307046|69747455|FG000|Overall Study|Adverse Event|3|||
38056471|NCT01307046|69747456|FG001|Overall Study|Adverse Event|3|||
38056472|NCT01307046|69747455|FG000|Overall Study|Lack of Efficacy|0|||
38056473|NCT01307046|69747456|FG001|Overall Study|Lack of Efficacy|2|||
38056474|NCT01307046|69747455|FG000|Overall Study|Physician Decision|2|||
38056475|NCT01307046|69747456|FG001|Overall Study|Physician Decision|0|||
38056476|NCT01307046|69747455|FG000|Overall Study|Withdrawal by Subject|1|||
38056477|NCT01307046|69747456|FG001|Overall Study|Withdrawal by Subject|1|||
38056478|NCT01307046|69747455|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
38056479|NCT01307046|69747456|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
38056480|NCT01307046|69747455|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
38056481|NCT01307046|69747456|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
38056482|NCT03495817|69747462|FG000|26 Week Open Label|Adverse Event|3|||
38056483|NCT03495817|69747462|FG000|26 Week Open Label|Withdrawal by Subject|4|||
38056484|NCT03495817|69747462|FG000|26 Week Open Label|Lost to Follow-up|1|||
38056485|NCT03495817|69747462|FG000|26 Week Extension|Lost to Follow-up|2|||
38056486|NCT02886624|69747466|FG000|12-week Post Treatment Follow-up|Death|1|||
38056487|NCT02886624|69747466|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
38056488|NCT02963766|69747473|FG000|Double-Blind Period|Adverse Event|1|||
38056489|NCT02963766|69747474|FG001|Double-Blind Period|Adverse Event|0|||
38056490|NCT02963766|69747475|FG002|Double-Blind Period|Adverse Event|1|||
37965152|NCT00662909|69652251|FG001|Overall Study|Adverse Event|18|||
37965153|NCT00662909|69652252|FG002|Overall Study|Adverse Event|19|||
37965154|NCT00662909|69652250|FG000|Overall Study|Lack of Efficacy|9|||
37965155|NCT00662909|69652251|FG001|Overall Study|Lack of Efficacy|1|||
37965156|NCT00662909|69652252|FG002|Overall Study|Lack of Efficacy|5|||
37965157|NCT00662909|69652250|FG000|Overall Study|Withdrawal by Subject|29|||
37965158|NCT00662909|69652251|FG001|Overall Study|Withdrawal by Subject|22|||
37965159|NCT00662909|69652252|FG002|Overall Study|Withdrawal by Subject|16|||
37965160|NCT00662909|69652250|FG000|Overall Study|Lost to Follow-up|2|||
37965161|NCT00662909|69652251|FG001|Overall Study|Lost to Follow-up|9|||
37965162|NCT00662909|69652252|FG002|Overall Study|Lost to Follow-up|3|||
37965163|NCT00662909|69652250|FG000|Overall Study|Protocol Violation|7|||
37965164|NCT00662909|69652251|FG001|Overall Study|Protocol Violation|4|||
37965165|NCT00662909|69652252|FG002|Overall Study|Protocol Violation|5|||
37965166|NCT00662909|69652250|FG000|Overall Study|Randomized- never received study drug|1|||
37965167|NCT00662909|69652251|FG001|Overall Study|Randomized- never received study drug|0|||
37965168|NCT00662909|69652252|FG002|Overall Study|Randomized- never received study drug|0|||
37965169|NCT00662909|69652250|FG000|Overall Study|Non-compliance with study procedures|3|||
37965170|NCT00662909|69652251|FG001|Overall Study|Non-compliance with study procedures|3|||
38056491|NCT02963766|69747473|FG000|Double-Blind Period|Physician Decision|1|||
38056492|NCT02963766|69747474|FG001|Double-Blind Period|Physician Decision|0|||
38056493|NCT02963766|69747475|FG002|Double-Blind Period|Physician Decision|0|||
38056494|NCT02963766|69747473|FG000|Double-Blind Period|Withdrawal by Subject|1|||
37965171|NCT00662909|69652252|FG002|Overall Study|Non-compliance with study procedures|2|||
37965172|NCT00662909|69652250|FG000|Overall Study|Physician Decision|1|||
37965173|NCT00662909|69652251|FG001|Overall Study|Physician Decision|1|||
38056495|NCT02963766|69747474|FG001|Double-Blind Period|Withdrawal by Subject|1|||
37965174|NCT00662909|69652252|FG002|Overall Study|Physician Decision|2|||
38056496|NCT02963766|69747475|FG002|Double-Blind Period|Withdrawal by Subject|0|||
38056497|NCT02963766|69747473|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
38056498|NCT02963766|69747474|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
38056499|NCT02963766|69747475|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
38056500|NCT02963766|69747473|FG000|Double-Blind Period|Protocol Violation|1|||
38056501|NCT02963766|69747474|FG001|Double-Blind Period|Protocol Violation|0|||
38056502|NCT02963766|69747475|FG002|Double-Blind Period|Protocol Violation|0|||
38056503|NCT02963766|69747473|FG000|Double-Blind Period|Lost to Follow-up|0|||
38056504|NCT02963766|69747474|FG001|Double-Blind Period|Lost to Follow-up|1|||
38056505|NCT02963766|69747475|FG002|Double-Blind Period|Lost to Follow-up|0|||
38056506|NCT02963766|69747473|FG000|Open Label Extension (OLE)|Physician Decision|1|||
38056507|NCT02963766|69747474|FG001|Open Label Extension (OLE)|Physician Decision|2|||
38056508|NCT02963766|69747475|FG002|Open Label Extension (OLE)|Physician Decision|2|||
38056509|NCT02963766|69747473|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
38056510|NCT02963766|69747474|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
38056511|NCT02963766|69747475|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
38056512|NCT04839965|69747495|FG000|Overall Study|Death|6|||
38056513|NCT04839965|69747496|FG001|Overall Study|Death|6|||
38056514|NCT04839965|69747495|FG000|Overall Study|Lost to Follow-up|1|||
38056515|NCT04839965|69747496|FG001|Overall Study|Lost to Follow-up|0|||
38056516|NCT03466099|69747505|FG000|Overall Study|Adverse Event|1|||
38056517|NCT03466099|69747506|FG001|Overall Study|Adverse Event|1|||
38056518|NCT03466099|69747507|FG002|Overall Study|Adverse Event|1|||
38056519|NCT03466099|69747505|FG000|Overall Study|Withdrawal by Subject|2|||
38056520|NCT03466099|69747506|FG001|Overall Study|Withdrawal by Subject|3|||
38056521|NCT03466099|69747507|FG002|Overall Study|Withdrawal by Subject|1|||
38056522|NCT03466099|69747505|FG000|Overall Study|Use of rescue medication|8|||
38056523|NCT03466099|69747506|FG001|Overall Study|Use of rescue medication|9|||
38056524|NCT03466099|69747507|FG002|Overall Study|Use of rescue medication|13|||
38056525|NCT03466099|69747505|FG000|Overall Study|Rescued without meeting criteria|4|||
38056526|NCT03466099|69747506|FG001|Overall Study|Rescued without meeting criteria|1|||
38056527|NCT03466099|69747507|FG002|Overall Study|Rescued without meeting criteria|1|||
38056528|NCT03466099|69747505|FG000|Overall Study|Subject compliance|2|||
38056529|NCT03466099|69747506|FG001|Overall Study|Subject compliance|0|||
38056530|NCT03466099|69747507|FG002|Overall Study|Subject compliance|0|||
38056531|NCT03466099|69747505|FG000|Overall Study|Worsening disease|0|||
38056532|NCT03466099|69747506|FG001|Overall Study|Worsening disease|0|||
38056533|NCT03466099|69747507|FG002|Overall Study|Worsening disease|1|||
38056534|NCT00739674|69747517|FG000|Overall Study|Screening failures|19|||
38056535|NCT00739674|69747518|FG001|Overall Study|Screening failures|17|||
38056536|NCT00739674|69747517|FG000|Overall Study|Site 212 removal|19|||
38056537|NCT00739674|69747518|FG001|Overall Study|Site 212 removal|13|||
38056538|NCT00739674|69747517|FG000|Overall Study|No follow-up data|33|||
38056539|NCT00739674|69747518|FG001|Overall Study|No follow-up data|18|||
38056540|NCT00739674|69747517|FG000|Overall Study|Dietician consultation >30 days|1|||
38056541|NCT00739674|69747518|FG001|Overall Study|Dietician consultation >30 days|9|||
38056542|NCT00739674|69747517|FG000|Overall Study|Adverse Event|22|||
38056543|NCT00739674|69747518|FG001|Overall Study|Adverse Event|13|||
38056544|NCT00739674|69747517|FG000|Overall Study|Death|1|||
38056545|NCT00739674|69747518|FG001|Overall Study|Death|0|||
38056546|NCT00739674|69747517|FG000|Overall Study|Lack of Efficacy|1|||
38056547|NCT00739674|69747518|FG001|Overall Study|Lack of Efficacy|0|||
38056548|NCT00739674|69747517|FG000|Overall Study|Lost to Follow-up|52|||
38056549|NCT00739674|69747518|FG001|Overall Study|Lost to Follow-up|30|||
38056550|NCT00739674|69747517|FG000|Overall Study|Protocol Violation|5|||
38056551|NCT00739674|69747518|FG001|Overall Study|Protocol Violation|5|||
38056552|NCT00739674|69747517|FG000|Overall Study|Withdrawal by Subject|9|||
38056553|NCT00739674|69747518|FG001|Overall Study|Withdrawal by Subject|9|||
38056554|NCT00739674|69747517|FG000|Overall Study|Reason missing|2|||
38056555|NCT00739674|69747518|FG001|Overall Study|Reason missing|0|||
38056556|NCT00739674|69747517|FG000|Overall Study|Clinic closed|6|||
38056557|NCT00739674|69747518|FG001|Overall Study|Clinic closed|4|||
38056558|NCT00739674|69747517|FG000|Overall Study|Patient moved|3|||
38056559|NCT00739674|69747518|FG001|Overall Study|Patient moved|2|||
38056560|NCT00739674|69747517|FG000|Overall Study|Non compliant|4|||
38056561|NCT00739674|69747518|FG001|Overall Study|Non compliant|0|||
38056562|NCT00739674|69747517|FG000|Overall Study|Unable to attend visit|3|||
38056563|NCT00739674|69747518|FG001|Overall Study|Unable to attend visit|1|||
38056564|NCT00739674|69747517|FG000|Overall Study|Home monitoring off meds|1|||
38056565|NCT00739674|69747518|FG001|Overall Study|Home monitoring off meds|0|||
38056566|NCT00739674|69747517|FG000|Overall Study|Erectile dysfunction|0|||
38056567|NCT00739674|69747518|FG001|Overall Study|Erectile dysfunction|1|||
38056568|NCT03494725|69747526|FG000|Overall Study|Withdrawal by Subject|0|||
38056569|NCT03494725|69747527|FG001|Overall Study|Withdrawal by Subject|2|||
38056570|NCT03494725|69747526|FG000|Overall Study|Antibiotic use|1|||
38056571|NCT03494725|69747527|FG001|Overall Study|Antibiotic use|0|||
38056572|NCT00705718|69747541|FG000|Overall Study|Death|6|||
38056573|NCT00705718|69747542|FG001|Overall Study|Death|6|||
38056574|NCT00705718|69747541|FG000|Overall Study|Not due for Visit|0|||
38056575|NCT00705718|69747542|FG001|Overall Study|Not due for Visit|12|||
38056576|NCT00705718|69747541|FG000|Overall Study|Follow up not done|1|||
38056577|NCT00705718|69747542|FG001|Overall Study|Follow up not done|4|||
38056578|NCT03435211|69747557|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
38056579|NCT03465709|69747570|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
38056580|NCT03465709|69747570|FG000|Overall Study|Withdrawal by Subject|3|||
38056581|NCT03435055|69747576|FG000|Screening|Physician Decision|2|||
38056582|NCT03435055|69747576|FG000|Received Intervention|Did not complete nitrous administration|3|||
38056583|NCT03434977|69747589|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
38056584|NCT03434977|69747590|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
38056585|NCT03434119|69747598|FG000|Overall Study|Randomized but not treated|1|||
38056586|NCT03434119|69747599|FG001|Overall Study|Randomized but not treated|0|||
38056587|NCT03434119|69747598|FG000|Overall Study|Adverse Event|1|||
38056588|NCT03434119|69747599|FG001|Overall Study|Adverse Event|0|||
38056589|NCT03434119|69747598|FG000|Overall Study|Poor Compliance to Protocol|0|||
38056590|NCT03434119|69747599|FG001|Overall Study|Poor Compliance to Protocol|1|||
38056591|NCT03434119|69747598|FG000|Overall Study|Study Terminated by Sponsor|91|||
38056592|NCT03434119|69747599|FG001|Overall Study|Study Terminated by Sponsor|102|||
38056593|NCT03434119|69747598|FG000|Overall Study|Withdrawal by Subject|7|||
38056594|NCT03434119|69747599|FG001|Overall Study|Withdrawal by Subject|5|||
38056595|NCT03434119|69747598|FG000|Overall Study|Other than specified|7|||
38056596|NCT03434119|69747599|FG001|Overall Study|Other than specified|5|||
38056597|NCT00378378|69747608|FG000|Overall Study|Withdrawal by Subject|0|||
38056598|NCT00378378|69747609|FG001|Overall Study|Withdrawal by Subject|1|||
38056599|NCT00378378|69747610|FG002|Overall Study|Withdrawal by Subject|0|||
38056600|NCT00378378|69747608|FG000|Overall Study|Treatment Failure|0|||
38056601|NCT00378378|69747609|FG001|Overall Study|Treatment Failure|0|||
38056602|NCT00378378|69747610|FG002|Overall Study|Treatment Failure|1|||
38056603|NCT00378378|69747608|FG000|Overall Study|Non-compliance with protocol|0|||
38056604|NCT00378378|69747609|FG001|Overall Study|Non-compliance with protocol|0|||
38056605|NCT00378378|69747610|FG002|Overall Study|Non-compliance with protocol|1|||
38056606|NCT03490981|69747620|FG000|Overall Study|Lost to Follow-up|1|||
38056607|NCT03490981|69747621|FG001|Overall Study|Lost to Follow-up|2|||
38056608|NCT03160716|69747627|FG000|Overall Study|Lost to Follow-up|1|||
38056609|NCT03713021|69747631|FG000|Overall Study|Did not have CT sim scan available|6|||
38056610|NCT03713021|69747631|FG000|Overall Study|Not eligible|4|||
38056611|NCT03713021|69747631|FG000|Overall Study|Issues with TraceIT markers|5|||
38056612|NCT03160560|69747639|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
38056613|NCT03160560|69747640|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
38056614|NCT03160560|69747641|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
38056615|NCT03160560|69747642|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
38056616|NCT03160560|69747639|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
38056617|NCT03160560|69747640|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
38056618|NCT03160560|69747641|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
38056619|NCT03160560|69747642|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
38056620|NCT03489343|69747659|FG000|Overall Study|Documented progressive disease|1|||
38056621|NCT03489343|69747660|FG001|Overall Study|Documented progressive disease|0|||
38056622|NCT03489343|69747661|FG002|Overall Study|Documented progressive disease|3|||
38056623|NCT03489343|69747662|FG003|Overall Study|Documented progressive disease|1|||
38056624|NCT03489343|69747663|FG004|Overall Study|Documented progressive disease|3|||
38056625|NCT03489343|69747664|FG005|Overall Study|Documented progressive disease|5|||
38056626|NCT03489343|69747665|FG006|Overall Study|Documented progressive disease|4|||
38056627|NCT03489343|69747659|FG000|Overall Study|Adverse Event|0|||
38056628|NCT03489343|69747660|FG001|Overall Study|Adverse Event|1|||
38056629|NCT03489343|69747661|FG002|Overall Study|Adverse Event|0|||
38056630|NCT03489343|69747662|FG003|Overall Study|Adverse Event|0|||
38056631|NCT03489343|69747663|FG004|Overall Study|Adverse Event|0|||
38056632|NCT03489343|69747664|FG005|Overall Study|Adverse Event|1|||
38056633|NCT03489343|69747665|FG006|Overall Study|Adverse Event|0|||
38056634|NCT03489343|69747659|FG000|Overall Study|Withdrawal by Subject|0|||
38056635|NCT03489343|69747660|FG001|Overall Study|Withdrawal by Subject|0|||
38056636|NCT03489343|69747661|FG002|Overall Study|Withdrawal by Subject|0|||
38056637|NCT03489343|69747662|FG003|Overall Study|Withdrawal by Subject|1|||
38056638|NCT03489343|69747663|FG004|Overall Study|Withdrawal by Subject|0|||
38056639|NCT03489343|69747664|FG005|Overall Study|Withdrawal by Subject|1|||
38056640|NCT03489343|69747665|FG006|Overall Study|Withdrawal by Subject|1|||
38056641|NCT03489343|69747659|FG000|Overall Study|Clinical progression|0|||
38056642|NCT03489343|69747660|FG001|Overall Study|Clinical progression|0|||
38056643|NCT03489343|69747661|FG002|Overall Study|Clinical progression|0|||
38056644|NCT03489343|69747662|FG003|Overall Study|Clinical progression|1|||
38056645|NCT03489343|69747663|FG004|Overall Study|Clinical progression|0|||
38056646|NCT03489343|69747664|FG005|Overall Study|Clinical progression|0|||
38056647|NCT03489343|69747665|FG006|Overall Study|Clinical progression|1|||
38056648|NCT03489109|69747683|FG000|Overall Study|Lost to Follow-up|1|||
38056649|NCT03489109|69747684|FG001|Overall Study|Lost to Follow-up|2|||
38056650|NCT03709823|69747696|FG000|Overall Study|Adverse Event|0|||
38056651|NCT03709823|69747697|FG001|Overall Study|Adverse Event|0|||
38056652|NCT03709823|69747698|FG002|Overall Study|Adverse Event|1|||
38056653|NCT03709823|69747699|FG003|Overall Study|Adverse Event|0|||
38056654|NCT03709823|69747700|FG004|Overall Study|Adverse Event|0|||
38056655|NCT03709823|69747701|FG005|Overall Study|Adverse Event|0|||
38056656|NCT03709823|69747696|FG000|Overall Study|Lost to Follow-up|2|||
38056657|NCT03709823|69747697|FG001|Overall Study|Lost to Follow-up|2|||
38056658|NCT03709823|69747698|FG002|Overall Study|Lost to Follow-up|2|||
38056659|NCT03709823|69747699|FG003|Overall Study|Lost to Follow-up|1|||
38056660|NCT03709823|69747700|FG004|Overall Study|Lost to Follow-up|1|||
38056661|NCT03709823|69747701|FG005|Overall Study|Lost to Follow-up|0|||
38056662|NCT03709823|69747696|FG000|Overall Study|Withdrawal by Subject|1|||
38056663|NCT03709823|69747697|FG001|Overall Study|Withdrawal by Subject|3|||
38056664|NCT03709823|69747698|FG002|Overall Study|Withdrawal by Subject|0|||
38056665|NCT03709823|69747699|FG003|Overall Study|Withdrawal by Subject|0|||
38056666|NCT03709823|69747700|FG004|Overall Study|Withdrawal by Subject|0|||
38056667|NCT03709823|69747701|FG005|Overall Study|Withdrawal by Subject|0|||
38056668|NCT03709823|69747696|FG000|Overall Study|Other, Not Specified|0|||
38056669|NCT03709823|69747697|FG001|Overall Study|Other, Not Specified|0|||
38056670|NCT03709823|69747698|FG002|Overall Study|Other, Not Specified|0|||
38056671|NCT03709823|69747699|FG003|Overall Study|Other, Not Specified|1|||
38056672|NCT03709823|69747700|FG004|Overall Study|Other, Not Specified|0|||
38056673|NCT03709823|69747701|FG005|Overall Study|Other, Not Specified|0|||
38056674|NCT03488563|69747721|FG000|Overall Study|Lost to Follow-up|7|||
38056675|NCT03488563|69747722|FG001|Overall Study|Lost to Follow-up|6|||
38056676|NCT03488563|69747723|FG002|Overall Study|Lost to Follow-up|7|||
38056677|NCT03488563|69747721|FG000|Overall Study|Withdrawal by Subject|8|||
38056678|NCT03488563|69747722|FG001|Overall Study|Withdrawal by Subject|7|||
38056679|NCT03488563|69747723|FG002|Overall Study|Withdrawal by Subject|7|||
38056680|NCT03488563|69747721|FG000|Overall Study|Physician Decision|0|||
38056681|NCT03488563|69747722|FG001|Overall Study|Physician Decision|0|||
38056682|NCT03488563|69747723|FG002|Overall Study|Physician Decision|1|||
38056683|NCT03488563|69747721|FG000|Overall Study|Protocol Violation|3|||
38056684|NCT03488563|69747722|FG001|Overall Study|Protocol Violation|2|||
38056685|NCT03488563|69747723|FG002|Overall Study|Protocol Violation|6|||
38056686|NCT03488563|69747721|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
38056687|NCT03488563|69747722|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
38056688|NCT03488563|69747723|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
38056689|NCT03488563|69747721|FG000|Overall Study|Use of prohibited medication|2|||
38056690|NCT03488563|69747722|FG001|Overall Study|Use of prohibited medication|0|||
38056691|NCT03488563|69747723|FG002|Overall Study|Use of prohibited medication|0|||
38056692|NCT03488563|69747721|FG000|Overall Study|Adverse Event|1|||
38056693|NCT03488563|69747722|FG001|Overall Study|Adverse Event|0|||
38056694|NCT03488563|69747723|FG002|Overall Study|Adverse Event|1|||
38056695|NCT03488563|69747721|FG000|Overall Study|Subject returned for ET visit|0|||
38056696|NCT03488563|69747722|FG001|Overall Study|Subject returned for ET visit|1|||
38056697|NCT03488563|69747723|FG002|Overall Study|Subject returned for ET visit|0|||
38056698|NCT03488563|69747721|FG000|Overall Study|Sponsor's decision|0|||
38056699|NCT03488563|69747722|FG001|Overall Study|Sponsor's decision|0|||
38056700|NCT03488563|69747723|FG002|Overall Study|Sponsor's decision|1|||
38056701|NCT00706030|69747737|FG000|Overall Study|Disease Progression|4|||
38056702|NCT00706030|69747738|FG001|Overall Study|Disease Progression|6|||
38056703|NCT00706030|69747739|FG002|Overall Study|Disease Progression|46|||
38056704|NCT00706030|69747740|FG003|Overall Study|Disease Progression|12|||
38056705|NCT00706030|69747737|FG000|Overall Study|Adverse Event|1|||
38056706|NCT00706030|69747738|FG001|Overall Study|Adverse Event|0|||
38056707|NCT00706030|69747739|FG002|Overall Study|Adverse Event|4|||
38056708|NCT00706030|69747740|FG003|Overall Study|Adverse Event|2|||
38056709|NCT00706030|69747737|FG000|Overall Study|Withdrawal by Subject|1|||
38056710|NCT00706030|69747738|FG001|Overall Study|Withdrawal by Subject|0|||
38056711|NCT00706030|69747739|FG002|Overall Study|Withdrawal by Subject|2|||
38056712|NCT00706030|69747740|FG003|Overall Study|Withdrawal by Subject|0|||
38056713|NCT00706030|69747737|FG000|Overall Study|Physician Decision|0|||
38056714|NCT00706030|69747738|FG001|Overall Study|Physician Decision|0|||
38056715|NCT00706030|69747739|FG002|Overall Study|Physician Decision|2|||
38056716|NCT00706030|69747740|FG003|Overall Study|Physician Decision|0|||
38056717|NCT00706030|69747737|FG000|Overall Study|Not recorded|0|||
38056718|NCT00706030|69747738|FG001|Overall Study|Not recorded|0|||
38056719|NCT00706030|69747739|FG002|Overall Study|Not recorded|2|||
38056720|NCT00706030|69747740|FG003|Overall Study|Not recorded|0|||
38056721|NCT00706030|69747737|FG000|Overall Study|Protocol Violation|0|||
38056722|NCT00706030|69747738|FG001|Overall Study|Protocol Violation|0|||
38056723|NCT00706030|69747739|FG002|Overall Study|Protocol Violation|1|||
38056724|NCT00706030|69747740|FG003|Overall Study|Protocol Violation|1|||
38056725|NCT00706030|69747737|FG000|Overall Study|Failed to return|0|||
38056726|NCT00706030|69747738|FG001|Overall Study|Failed to return|0|||
38056727|NCT00706030|69747739|FG002|Overall Study|Failed to return|1|||
38056728|NCT00706030|69747740|FG003|Overall Study|Failed to return|0|||
38056729|NCT00706030|69747737|FG000|Overall Study|Symptomatic Deterioration|0|||
38056730|NCT00706030|69747738|FG001|Overall Study|Symptomatic Deterioration|0|||
38056731|NCT00706030|69747739|FG002|Overall Study|Symptomatic Deterioration|1|||
38056732|NCT00706030|69747740|FG003|Overall Study|Symptomatic Deterioration|0|||
38056733|NCT00706030|69747737|FG000|Overall Study|No treatment received|0|||
38056734|NCT00706030|69747738|FG001|Overall Study|No treatment received|0|||
38056735|NCT00706030|69747739|FG002|Overall Study|No treatment received|0|||
38056736|NCT00706030|69747740|FG003|Overall Study|No treatment received|1|||
38056737|NCT00706030|69747737|FG000|Overall Study|Death|0|||
38056738|NCT00706030|69747738|FG001|Overall Study|Death|0|||
38056739|NCT00706030|69747739|FG002|Overall Study|Death|1|||
38056740|NCT00706030|69747740|FG003|Overall Study|Death|0|||
38056741|NCT03488251|69747755|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
38056742|NCT03488251|69747756|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
38056743|NCT03488251|69747757|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
38056744|NCT03488251|69747758|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
38056745|NCT03488251|69747755|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
38056746|NCT03488251|69747756|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
38056747|NCT03488251|69747757|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
38056748|NCT03488251|69747758|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
38056749|NCT03488251|69747755|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
38056750|NCT03488251|69747756|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
38056751|NCT03488251|69747757|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
38056752|NCT03488251|69747758|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
38056753|NCT03488251|69747755|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
38056754|NCT03488251|69747756|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
38056755|NCT03488251|69747757|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
38056756|NCT03488251|69747758|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
38056757|NCT03488251|69747755|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
38056758|NCT03488251|69747756|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
38056759|NCT03488251|69747757|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
38056760|NCT03488251|69747758|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
38056761|NCT02727322|69747771|FG000|Overall Study|Withdrawal by Subject|1|||
38056762|NCT02727322|69747772|FG001|Overall Study|Withdrawal by Subject|1|||
38056763|NCT02727322|69747771|FG000|Overall Study|Protocol Violation|1|||
38056764|NCT02727322|69747772|FG001|Overall Study|Protocol Violation|0|||
38056765|NCT03431857|69747782|FG000|Overall Study|Death|6|||
38056766|NCT03431857|69747782|FG000|Overall Study|Lost to Follow-up|41|||
38056767|NCT03431857|69747782|FG000|Overall Study|Adverse Event|6|||
38056768|NCT03431857|69747782|FG000|Overall Study|Withdrawal by Subject|1|||
38056769|NCT03487549|69747788|FG000|Overall Study|Protocol Violation|0|||
38056770|NCT03487549|69747789|FG001|Overall Study|Protocol Violation|1|||
38056771|NCT03487549|69747788|FG000|Overall Study|Lost to Follow-up|2|||
38056772|NCT03487549|69747789|FG001|Overall Study|Lost to Follow-up|1|||
38056773|NCT03487549|69747788|FG000|Overall Study|Withdrawal by Subject|2|||
38056774|NCT03487549|69747789|FG001|Overall Study|Withdrawal by Subject|0|||
38056775|NCT03464383|69747798|FG000|Overall Study|Lost to Follow-up|1|||
38056776|NCT03464383|69747799|FG001|Overall Study|Lost to Follow-up|0|||
38056777|NCT03464383|69747800|FG002|Overall Study|Lost to Follow-up|0|||
38056778|NCT03464383|69747798|FG000|Overall Study|Withdrawal by Subject|0|||
38056779|NCT03464383|69747799|FG001|Overall Study|Withdrawal by Subject|1|||
38056780|NCT03464383|69747800|FG002|Overall Study|Withdrawal by Subject|0|||
38056781|NCT01444092|69747809|FG000|Overall Study|Adverse Event|8|||
38056782|NCT01444092|69747809|FG000|Overall Study|Protocol Violation|1|||
38056783|NCT01444092|69747809|FG000|Overall Study|Withdrawal by Subject|1|||
38056784|NCT01444092|69747809|FG000|Overall Study|Other Eligibility criteria|7|||
38056785|NCT01265784|69747816|FG000|Overall Study|Lost to Follow-up|5|||
38056786|NCT01265784|69747817|FG001|Overall Study|Lost to Follow-up|3|||
38056787|NCT01265784|69747818|FG002|Overall Study|Lost to Follow-up|2|||
38056788|NCT01265784|69747816|FG000|Overall Study|Withdrawal by Subject|0|||
38056789|NCT01265784|69747817|FG001|Overall Study|Withdrawal by Subject|5|||
38056790|NCT01265784|69747818|FG002|Overall Study|Withdrawal by Subject|0|||
38056791|NCT01265784|69747816|FG000|Overall Study|Physician Decision|1|||
38056792|NCT01265784|69747817|FG001|Overall Study|Physician Decision|0|||
38056793|NCT01265784|69747818|FG002|Overall Study|Physician Decision|1|||
38056794|NCT01265784|69747816|FG000|Overall Study|Adverse Event|1|||
38056795|NCT01265784|69747817|FG001|Overall Study|Adverse Event|0|||
38056796|NCT01265784|69747818|FG002|Overall Study|Adverse Event|0|||
38056797|NCT01265784|69747816|FG000|Overall Study|Death|3|||
38056798|NCT01265784|69747817|FG001|Overall Study|Death|0|||
38056799|NCT01265784|69747818|FG002|Overall Study|Death|0|||
38056800|NCT01265784|69747816|FG000|Overall Study|Protocol Violation|2|||
38056801|NCT01265784|69747817|FG001|Overall Study|Protocol Violation|0|||
38056802|NCT01265784|69747818|FG002|Overall Study|Protocol Violation|0|||
38056803|NCT01265784|69747816|FG000|Overall Study|Incorrectly Randomized|0|||
38056804|NCT01265784|69747817|FG001|Overall Study|Incorrectly Randomized|0|||
38056805|NCT01265784|69747818|FG002|Overall Study|Incorrectly Randomized|1|||
38056806|NCT03156504|69747826|FG000|Overall Study|Withdrawal by Subject|1|||
38056807|NCT03159468|69747836|FG000|Overall Study|Withdrawal by Subject|0|||
38056808|NCT03159468|69747837|FG001|Overall Study|Withdrawal by Subject|0|||
38056809|NCT03159468|69747838|FG002|Overall Study|Withdrawal by Subject|3|||
38056810|NCT03159468|69747839|FG003|Overall Study|Withdrawal by Subject|0|||
38056811|NCT03159468|69747840|FG004|Overall Study|Withdrawal by Subject|0|||
38056812|NCT03159468|69747841|FG005|Overall Study|Withdrawal by Subject|0|||
38056813|NCT03430063|69747858|FG000|Overall Study|Adverse Event|0|||
38056814|NCT03430063|69747859|FG001|Overall Study|Adverse Event|1|||
38056815|NCT03430063|69747860|FG002|Overall Study|Adverse Event|0|||
38056816|NCT03430063|69747858|FG000|Overall Study|Death|3|||
38056817|NCT03430063|69747859|FG001|Overall Study|Death|2|||
38056818|NCT03430063|69747860|FG002|Overall Study|Death|3|||
38056819|NCT03430063|69747858|FG000|Overall Study|Lost to Follow-up|0|||
38056820|NCT03430063|69747859|FG001|Overall Study|Lost to Follow-up|1|||
38056821|NCT03430063|69747860|FG002|Overall Study|Lost to Follow-up|0|||
38056822|NCT03430063|69747858|FG000|Overall Study|Withdrawal by Subject|0|||
38056823|NCT03430063|69747859|FG001|Overall Study|Withdrawal by Subject|0|||
38056824|NCT03430063|69747860|FG002|Overall Study|Withdrawal by Subject|1|||
38056825|NCT03430063|69747858|FG000|Overall Study|Withdrawal of consent|3|||
38056826|NCT03430063|69747859|FG001|Overall Study|Withdrawal of consent|1|||
38056827|NCT03430063|69747860|FG002|Overall Study|Withdrawal of consent|2|||
38056828|NCT03430063|69747858|FG000|Overall Study|Progressive disease|1|||
38056829|NCT03430063|69747859|FG001|Overall Study|Progressive disease|2|||
38056830|NCT03430063|69747860|FG002|Overall Study|Progressive disease|1|||
38056831|NCT03430063|69747858|FG000|Overall Study|Other un-specified|1|||
38056832|NCT03430063|69747859|FG001|Overall Study|Other un-specified|1|||
38056833|NCT03430063|69747860|FG002|Overall Study|Other un-specified|0|||
38056834|NCT03430063|69747858|FG000|Overall Study|Randomized, but never treated|0|||
38056835|NCT03430063|69747859|FG001|Overall Study|Randomized, but never treated|0|||
38056836|NCT03430063|69747860|FG002|Overall Study|Randomized, but never treated|1|||
38056837|NCT03158220|69747871|FG000|Overall Study|Screen Failure|0|||
38056838|NCT03158220|69747872|FG001|Overall Study|Screen Failure|1|||
38056839|NCT03158220|69747871|FG000|Overall Study|Withdrawal by Subject|8|||
38056840|NCT03158220|69747872|FG001|Overall Study|Withdrawal by Subject|9|||
37680370|NCT01666951|69155987|FG001|Overall Study|Not dosed|1|||
37862161|NCT00922207|69545933|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
37965175|NCT00662909|69652250|FG000|Overall Study|Eligibility criterion not met|0|||
37965176|NCT00662909|69652251|FG001|Overall Study|Eligibility criterion not met|1|||
37965177|NCT00662909|69652252|FG002|Overall Study|Eligibility criterion not met|1|||
37965178|NCT00050011|69652262|FG000|Overall Study|Adverse Event|41|||
37965179|NCT00050011|69652263|FG001|Overall Study|Adverse Event|46|||
37965180|NCT00050011|69652262|FG000|Overall Study|Abnormal laboratory value(s)|1|||
37965181|NCT00050011|69652263|FG001|Overall Study|Abnormal laboratory value(s)|1|||
37965182|NCT00050011|69652262|FG000|Overall Study|Abnormal test procedure results|0|||
37965183|NCT00050011|69652263|FG001|Overall Study|Abnormal test procedure results|1|||
37965184|NCT00050011|69652262|FG000|Overall Study|Lack of Efficacy|16|||
37965185|NCT00050011|69652263|FG001|Overall Study|Lack of Efficacy|21|||
37965186|NCT00050011|69652262|FG000|Overall Study|Participant condition no longer required|1|||
37965187|NCT00050011|69652263|FG001|Overall Study|Participant condition no longer required|0|||
37965188|NCT00050011|69652262|FG000|Overall Study|Protocol Violation|4|||
37965189|NCT00050011|69652263|FG001|Overall Study|Protocol Violation|10|||
38056841|NCT03158220|69747871|FG000|Overall Study|Status unknown|0|||
38056842|NCT03158220|69747872|FG001|Overall Study|Status unknown|1|||
38056843|NCT03158220|69747871|FG000|Overall Study|Lost to Follow-up|8|||
38056844|NCT03158220|69747872|FG001|Overall Study|Lost to Follow-up|5|||
38056845|NCT03158220|69747871|FG000|Overall Study|Physician Decision|1|||
38056846|NCT03158220|69747872|FG001|Overall Study|Physician Decision|0|||
38056847|NCT03156270|69747878|FG000|Overall Study|Failed pre-treatment screening|1|||
38056848|NCT03156270|69747878|FG000|Overall Study|Lost to Follow-up|1|||
38056849|NCT03429049|69747886|FG000|Overall Study|Adverse Event|2|||
38056850|NCT03429049|69747887|FG001|Overall Study|Adverse Event|3|||
38056851|NCT03429049|69747886|FG000|Overall Study|Death|0|||
38056852|NCT03429049|69747887|FG001|Overall Study|Death|1|||
38056853|NCT03429049|69747886|FG000|Overall Study|Lack of Efficacy|4|||
38056854|NCT03429049|69747887|FG001|Overall Study|Lack of Efficacy|2|||
38056855|NCT03429049|69747886|FG000|Overall Study|Lost to Follow-up|9|||
38056856|NCT03429049|69747887|FG001|Overall Study|Lost to Follow-up|8|||
38056857|NCT03429049|69747886|FG000|Overall Study|Physician Decision|1|||
38056858|NCT03429049|69747887|FG001|Overall Study|Physician Decision|0|||
38056859|NCT03429049|69747886|FG000|Overall Study|Protocol Violation|3|||
38056860|NCT03429049|69747887|FG001|Overall Study|Protocol Violation|0|||
38056861|NCT03429049|69747886|FG000|Overall Study|Sponsor Decision|2|||
38056862|NCT03429049|69747887|FG001|Overall Study|Sponsor Decision|0|||
38056863|NCT03429049|69747886|FG000|Overall Study|Withdrawal by Subject|4|||
38056864|NCT03429049|69747887|FG001|Overall Study|Withdrawal by Subject|20|||
38056865|NCT03429049|69747886|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
38056866|NCT03429049|69747887|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
38056867|NCT03428815|69747895|FG000|Overall Study|Lost to Follow-up|2|||
38056868|NCT03428815|69747896|FG001|Overall Study|Lost to Follow-up|2|||
38056869|NCT03428815|69747895|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
38056870|NCT03428815|69747896|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
38056871|NCT03428815|69747895|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
38056872|NCT03428815|69747896|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
38056873|NCT03155724|69747902|FG000|Overall Study|Death|3|||
38056874|NCT03155724|69747902|FG000|Overall Study|Physician Decision|1|||
38056875|NCT03155724|69747902|FG000|Overall Study|Study closure|7|||
38056876|NCT03426787|69747906|FG000|Overall Study|Withdrawal by Subject|6|||
38056877|NCT03426787|69747906|FG000|Overall Study|Lost to Follow-up|7|||
38056878|NCT03426787|69747906|FG000|Overall Study|Unrelated to intervention death|1|||
38056879|NCT03426631|69747916|FG000|Overall Study|Lost to Follow-up|0|||
38056880|NCT03426631|69747917|FG001|Overall Study|Lost to Follow-up|1|||
38056881|NCT03484429|69747925|FG000|Overall Study|Withdrawal by Subject|1|||
38056882|NCT03484429|69747926|FG001|Overall Study|Withdrawal by Subject|0|||
38056883|NCT03484429|69747925|FG000|Overall Study|Adverse Event|2|||
38056884|NCT03484429|69747926|FG001|Overall Study|Adverse Event|0|||
38056885|NCT03484273|69747932|FG000|Overall Study|Equipment Malfunction|1|||
38056886|NCT03484273|69747932|FG000|Overall Study|Data excluded from analysis|1|||
38056887|NCT02724592|69747946|FG000|Overall Study|Lost to Follow-up|4|||
38056888|NCT02724592|69747947|FG001|Overall Study|Lost to Follow-up|1|||
38056889|NCT03154476|69747955|FG000|Overall Study|Lost to Follow-up|4|||
38056890|NCT03154476|69747956|FG001|Overall Study|Lost to Follow-up|4|||
38056891|NCT02726074|69747962|FG000|Overall Study|Withdrawal by Subject|4|||
38056892|NCT02726074|69747962|FG000|Overall Study|Adverse Event|14|||
38056893|NCT02726074|69747962|FG000|Overall Study|Protocol Violation|3|||
38056894|NCT02726074|69747962|FG000|Overall Study|Lost to Follow-up|2|||
38056895|NCT02726074|69747962|FG000|Overall Study|Others|3|||
38056896|NCT03482635|69747970|FG000|Overall Study|Lack of Efficacy|0|||
38056897|NCT03482635|69747971|FG001|Overall Study|Lack of Efficacy|0|||
38056898|NCT03482635|69747972|FG002|Overall Study|Lack of Efficacy|1|||
38056899|NCT03482635|69747973|FG003|Overall Study|Lack of Efficacy|3|||
38056900|NCT03482635|69747970|FG000|Overall Study|Adverse Event|2|||
38056901|NCT03482635|69747971|FG001|Overall Study|Adverse Event|2|||
38056902|NCT03482635|69747972|FG002|Overall Study|Adverse Event|0|||
38056903|NCT03482635|69747973|FG003|Overall Study|Adverse Event|3|||
38056904|NCT03482635|69747970|FG000|Overall Study|Withdrawal by Subject|2|||
38056905|NCT03482635|69747971|FG001|Overall Study|Withdrawal by Subject|1|||
38056906|NCT03482635|69747972|FG002|Overall Study|Withdrawal by Subject|0|||
38056907|NCT03482635|69747973|FG003|Overall Study|Withdrawal by Subject|1|||
38056908|NCT03482635|69747970|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
38056909|NCT03482635|69747971|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
38056910|NCT03482635|69747972|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
38056911|NCT03482635|69747973|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
38056912|NCT03482635|69747970|FG000|Overall Study|Not treated|0|||
38056913|NCT03482635|69747971|FG001|Overall Study|Not treated|0|||
38056914|NCT03482635|69747972|FG002|Overall Study|Not treated|0|||
38056915|NCT03482635|69747973|FG003|Overall Study|Not treated|1|||
38056916|NCT03712787|69747987|FG000|Overall Study|Adverse Event|2|||
38056917|NCT03712787|69747988|FG001|Overall Study|Adverse Event|3|||
38056918|NCT03712787|69747989|FG002|Overall Study|Adverse Event|0|||
38056919|NCT03712787|69747990|FG003|Overall Study|Adverse Event|4|||
38056920|NCT03712787|69747987|FG000|Overall Study|Withdrawal by Subject|4|||
38056921|NCT03712787|69747988|FG001|Overall Study|Withdrawal by Subject|14|||
38056922|NCT03712787|69747989|FG002|Overall Study|Withdrawal by Subject|12|||
38056923|NCT03712787|69747990|FG003|Overall Study|Withdrawal by Subject|8|||
38056924|NCT03712787|69747987|FG000|Overall Study|Lost to Follow-up|1|||
38056925|NCT03712787|69747988|FG001|Overall Study|Lost to Follow-up|1|||
38056926|NCT03712787|69747989|FG002|Overall Study|Lost to Follow-up|2|||
38056927|NCT03712787|69747990|FG003|Overall Study|Lost to Follow-up|1|||
38056928|NCT03712787|69747987|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
38056929|NCT03712787|69747988|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
38056930|NCT03712787|69747989|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
38056931|NCT03712787|69747990|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
38056932|NCT03712787|69747987|FG000|Overall Study|COVID-19 Infection|0|||
38056933|NCT03712787|69747988|FG001|Overall Study|COVID-19 Infection|1|||
38056934|NCT03712787|69747989|FG002|Overall Study|COVID-19 Infection|0|||
38056935|NCT03712787|69747990|FG003|Overall Study|COVID-19 Infection|0|||
38056936|NCT03712787|69747987|FG000|Overall Study|Other, Not Specified|79|||
38056937|NCT03712787|69747988|FG001|Overall Study|Other, Not Specified|77|||
38056938|NCT03712787|69747989|FG002|Overall Study|Other, Not Specified|74|||
38056939|NCT03712787|69747990|FG003|Overall Study|Other, Not Specified|78|||
38056940|NCT03048422|69748022|FG000|Overall Study|Death|1|||
38056941|NCT03048422|69748023|FG001|Overall Study|Death|0|||
38056942|NCT03048422|69748024|FG002|Overall Study|Death|0|||
38056943|NCT03048422|69748022|FG000|Overall Study|Lost to Follow-up|5|||
38056944|NCT03048422|69748023|FG001|Overall Study|Lost to Follow-up|0|||
38056945|NCT03048422|69748024|FG002|Overall Study|Lost to Follow-up|1|||
38056946|NCT03048422|69748022|FG000|Overall Study|Withdrawal by Subject|5|||
38056947|NCT03048422|69748023|FG001|Overall Study|Withdrawal by Subject|7|||
38056948|NCT03048422|69748024|FG002|Overall Study|Withdrawal by Subject|4|||
38056949|NCT03048422|69748022|FG000|Overall Study|Moved|3|||
38056950|NCT03048422|69748023|FG001|Overall Study|Moved|2|||
38056951|NCT03048422|69748024|FG002|Overall Study|Moved|2|||
38056952|NCT03048422|69748022|FG000|Overall Study|Noncompliant with Study Requirements|2|||
38056953|NCT03048422|69748023|FG001|Overall Study|Noncompliant with Study Requirements|1|||
38056954|NCT03048422|69748024|FG002|Overall Study|Noncompliant with Study Requirements|2|||
38056955|NCT03048422|69748022|FG000|Overall Study|Not Able to Get to Clinic|1|||
38056956|NCT03048422|69748023|FG001|Overall Study|Not Able to Get to Clinic|0|||
38056957|NCT03048422|69748024|FG002|Overall Study|Not Able to Get to Clinic|0|||
38056958|NCT04664855|69748044|FG000|Overall Study|Withdrawal by Subject|0|||
38056959|NCT04664855|69748045|FG001|Overall Study|Withdrawal by Subject|2|||
38056960|NCT04664153|69748055|FG000|Overall Study|Lack of Efficacy|0|||
38056961|NCT04664153|69748056|FG001|Overall Study|Lack of Efficacy|0|||
38056962|NCT04664153|69748057|FG002|Overall Study|Lack of Efficacy|1|||
38056963|NCT04664153|69748058|FG003|Overall Study|Lack of Efficacy|0|||
38056964|NCT04664153|69748055|FG000|Overall Study|Physician Decision|0|||
38056965|NCT04664153|69748056|FG001|Overall Study|Physician Decision|0|||
38056966|NCT04664153|69748057|FG002|Overall Study|Physician Decision|1|||
38056967|NCT04664153|69748058|FG003|Overall Study|Physician Decision|0|||
38056968|NCT04664153|69748055|FG000|Overall Study|Withdrawal by Subject|3|||
38056969|NCT04664153|69748056|FG001|Overall Study|Withdrawal by Subject|2|||
38056970|NCT04664153|69748057|FG002|Overall Study|Withdrawal by Subject|1|||
38056971|NCT04664153|69748058|FG003|Overall Study|Withdrawal by Subject|2|||
38056972|NCT04664153|69748055|FG000|Overall Study|Other|0|||
38056973|NCT04664153|69748056|FG001|Overall Study|Other|1|||
38056974|NCT04664153|69748057|FG002|Overall Study|Other|0|||
38056975|NCT04664153|69748058|FG003|Overall Study|Other|0|||
38056976|NCT04664153|69748055|FG000|Overall Study|Adverse Event|4|||
38056977|NCT04664153|69748056|FG001|Overall Study|Adverse Event|0|||
38056978|NCT04664153|69748057|FG002|Overall Study|Adverse Event|1|||
38056979|NCT04664153|69748058|FG003|Overall Study|Adverse Event|0|||
38056980|NCT04663295|69748070|FG000|Run-in Period|Withdrawal by Subject|3|||
38056981|NCT04663295|69748070|FG000|Overall Study Period|Pregnancy|1|||
38056982|NCT04663295|69748070|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
38056983|NCT04228445|69748081|FG000|Overall Study|Lost to Follow-up|1|||
38056984|NCT04228445|69748082|FG001|Overall Study|Lost to Follow-up|1|||
38056985|NCT04228445|69748081|FG000|Overall Study|Physician Decision|1|||
38056986|NCT04228445|69748082|FG001|Overall Study|Physician Decision|2|||
38056987|NCT04228445|69748081|FG000|Overall Study|Withdrawal by Subject|0|||
38056988|NCT04228445|69748082|FG001|Overall Study|Withdrawal by Subject|1|||
38056989|NCT04228445|69748081|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
38056990|NCT04228445|69748082|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
38056991|NCT04641299|69748094|FG000|Overall Study|Adverse Event|0|||
38056992|NCT04641299|69748095|FG001|Overall Study|Adverse Event|0|||
38056993|NCT04641299|69748096|FG002|Overall Study|Adverse Event|2|||
38056994|NCT04641299|69748097|FG003|Overall Study|Adverse Event|0|||
38056995|NCT04641299|69748094|FG000|Overall Study|Lost to Follow-up|0|||
38056996|NCT04641299|69748095|FG001|Overall Study|Lost to Follow-up|1|||
38056997|NCT04641299|69748096|FG002|Overall Study|Lost to Follow-up|0|||
38056998|NCT04641299|69748097|FG003|Overall Study|Lost to Follow-up|0|||
38056999|NCT04641299|69748094|FG000|Overall Study|Withdrawal by Subject|1|||
38057000|NCT04641299|69748095|FG001|Overall Study|Withdrawal by Subject|0|||
38057001|NCT04641299|69748096|FG002|Overall Study|Withdrawal by Subject|0|||
38057002|NCT04641299|69748097|FG003|Overall Study|Withdrawal by Subject|0|||
38057003|NCT04641299|69748094|FG000|Overall Study|Reason not given|1|||
38057004|NCT04641299|69748095|FG001|Overall Study|Reason not given|0|||
38057005|NCT04641299|69748096|FG002|Overall Study|Reason not given|0|||
38057006|NCT04641299|69748097|FG003|Overall Study|Reason not given|0|||
38057007|NCT03703817|69748113|FG000|Overall Study|Not meeting eligibility criteria|7|||
38057008|NCT03703817|69748114|FG001|Overall Study|Not meeting eligibility criteria|4|||
38057009|NCT03698591|69748122|FG000|Overall Study|Withdrawal by Subject|2|||
38057010|NCT03698591|69748123|FG001|Overall Study|Withdrawal by Subject|2|||
38057011|NCT03698591|69748122|FG000|Overall Study|Failed drug screen|1|||
38057012|NCT03698591|69748123|FG001|Overall Study|Failed drug screen|1|||
38057013|NCT03698591|69748122|FG000|Overall Study|Failed health screen|0|||
38057014|NCT03698591|69748123|FG001|Overall Study|Failed health screen|1|||
38057015|NCT03698591|69748122|FG000|Overall Study|Ineligible for financial compensation|1|||
38057016|NCT03698591|69748123|FG001|Overall Study|Ineligible for financial compensation|0|||
38057017|NCT03698591|69748122|FG000|Overall Study|Equipment Error|1|||
38057018|NCT03698591|69748123|FG001|Overall Study|Equipment Error|0|||
38057019|NCT03698591|69748122|FG000|Overall Study|Could not establish TMS dosage|0|||
38057020|NCT03698591|69748123|FG001|Overall Study|Could not establish TMS dosage|1|||
38057021|NCT04606199|69748129|FG000|Overall Study|Withdrawal by Subject|2|||
38057022|NCT05085665|69748135|FG000|Overall Study|Physician Decision|2|||
38057023|NCT05017493|69748141|FG000|Overall Study|Withdrawal by Subject|26|||
38057024|NCT05017493|69748142|FG001|Overall Study|Withdrawal by Subject|0|||
38057025|NCT05017493|69748141|FG000|Overall Study|Physician Decision|15|||
38057026|NCT05017493|69748142|FG001|Overall Study|Physician Decision|0|||
38057027|NCT05017493|69748141|FG000|Overall Study|Protocol Violation|81|||
38057028|NCT05017493|69748142|FG001|Overall Study|Protocol Violation|0|||
38057029|NCT04599803|69748148|FG000|Overall Study|Withdrawal by Subject|5|||
38057030|NCT04599803|69748148|FG000|Overall Study|Lost to Follow-up|26|||
38057031|NCT05002985|69748152|FG000|Overall Study|Withdrawal by Subject|1|||
38057032|NCT04580303|69748158|FG000|Overall Study|Adverse Event|0|||
38057033|NCT04580303|69748159|FG001|Overall Study|Adverse Event|1|||
38057034|NCT04580303|69748160|FG002|Overall Study|Adverse Event|0|||
38057035|NCT04580303|69748161|FG003|Overall Study|Adverse Event|0|||
38057036|NCT04580303|69748158|FG000|Overall Study|Withdrawal by Subject|0|||
38057037|NCT04580303|69748159|FG001|Overall Study|Withdrawal by Subject|0|||
38057038|NCT04580303|69748160|FG002|Overall Study|Withdrawal by Subject|1|||
38057039|NCT04580303|69748161|FG003|Overall Study|Withdrawal by Subject|0|||
38057040|NCT04577183|69748171|FG000|Overall Study|Death|1|||
38057041|NCT04577183|69748171|FG000|Overall Study|Withdrawal by Subject|3|||
38057042|NCT04577183|69748171|FG000|Overall Study|Early termination|2|||
38057043|NCT04574999|69748177|FG000|Overall Study|Adverse Event|1|||
38057044|NCT04574999|69748178|FG001|Overall Study|Adverse Event|0|||
38057045|NCT04574999|69748177|FG000|Overall Study|Lack of Efficacy|2|||
38057046|NCT04574999|69748178|FG001|Overall Study|Lack of Efficacy|3|||
38057047|NCT04574999|69748177|FG000|Overall Study|Protocol Violation|1|||
38057048|NCT04574999|69748178|FG001|Overall Study|Protocol Violation|0|||
38057049|NCT04574999|69748177|FG000|Overall Study|Withdrawal by Subject|2|||
38057050|NCT04574999|69748178|FG001|Overall Study|Withdrawal by Subject|2|||
38057051|NCT04574999|69748177|FG000|Overall Study|Lost to Follow-up|1|||
38057052|NCT04574999|69748178|FG001|Overall Study|Lost to Follow-up|0|||
38057053|NCT04574999|69748177|FG000|Overall Study|Personal problems|1|||
38057054|NCT04574999|69748178|FG001|Overall Study|Personal problems|0|||
38057055|NCT04574999|69748177|FG000|Overall Study|Previous planned surgery|1|||
38057056|NCT04574999|69748178|FG001|Overall Study|Previous planned surgery|0|||
38057057|NCT04565249|69748188|FG000|Overall Study|Death|0|||
38057058|NCT04565249|69748189|FG001|Overall Study|Death|0|||
38057059|NCT04565249|69748190|FG002|Overall Study|Death|0|||
38057060|NCT04565249|69748191|FG003|Overall Study|Death|1|||
38057061|NCT04942925|69748203|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
38057062|NCT04942925|69748204|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
38057063|NCT04942925|69748203|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
38057064|NCT04942925|69748204|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
38057065|NCT04854707|69748216|FG000|Overall Study|Lack of Efficacy|78|||
38057066|NCT04854707|69748217|FG001|Overall Study|Lack of Efficacy|59|||
38057067|NCT04854707|69748218|FG002|Overall Study|Lack of Efficacy|30|||
38057068|NCT04557371|69748233|FG000|Overall Study|Covid-19-related|0|||
38057069|NCT04557371|69748234|FG001|Overall Study|Covid-19-related|1|||
38057070|NCT04557371|69748235|FG002|Overall Study|Covid-19-related|0|||
38057071|NCT04557371|69748233|FG000|Overall Study|Withdrawal by Subject|0|||
38057072|NCT04557371|69748234|FG001|Overall Study|Withdrawal by Subject|1|||
38057073|NCT04557371|69748235|FG002|Overall Study|Withdrawal by Subject|0|||
38057074|NCT04557371|69748233|FG000|Overall Study|Adverse Event|1|||
38057075|NCT04557371|69748234|FG001|Overall Study|Adverse Event|0|||
38057076|NCT04557371|69748235|FG002|Overall Study|Adverse Event|0|||
38057077|NCT04821245|69748243|FG000|Overall Study|Withdrawal by Subject|3|||
38057078|NCT04821245|69748243|FG000|Overall Study|Physician Decision|1|||
38057079|NCT04821245|69748243|FG000|Overall Study|Protocol Violation|5|||
37771419|NCT01360632|69290634|FG004|Phase B (6 Weeks)|Adverse Event|0|||
38057080|NCT04539275|69748251|FG000|Overall Study|Death|2|||
38057081|NCT04539275|69748252|FG001|Overall Study|Death|4|||
38057082|NCT04539275|69748251|FG000|Overall Study|Lost to Follow-up|1|||
38057083|NCT04539275|69748252|FG001|Overall Study|Lost to Follow-up|1|||
38057084|NCT04539275|69748251|FG000|Overall Study|Withdrawal by Subject|3|||
38057085|NCT04539275|69748252|FG001|Overall Study|Withdrawal by Subject|0|||
38057086|NCT04784897|69748261|FG000|Overall Study|Death|4|||
38057087|NCT04784897|69748262|FG001|Overall Study|Death|2|||
38057088|NCT04784897|69748263|FG002|Overall Study|Death|1|||
38057089|NCT04784897|69748261|FG000|Overall Study|Withdrawal by Subject|0|||
38057090|NCT04784897|69748262|FG001|Overall Study|Withdrawal by Subject|0|||
38057091|NCT04784897|69748263|FG002|Overall Study|Withdrawal by Subject|1|||
38057092|NCT04537949|69748282|FG000|Overall Study|personal reasons not related to the IMP|1|||
38057093|NCT04537949|69748283|FG001|Overall Study|personal reasons not related to the IMP|0|||
38057094|NCT04537949|69748284|FG002|Overall Study|personal reasons not related to the IMP|0|||
38057095|NCT04537949|69748285|FG003|Overall Study|personal reasons not related to the IMP|0|||
38057096|NCT04537949|69748286|FG004|Overall Study|personal reasons not related to the IMP|0|||
38057097|NCT04537949|69748287|FG005|Overall Study|personal reasons not related to the IMP|0|||
38057098|NCT04537949|69748288|FG006|Overall Study|personal reasons not related to the IMP|0|||
38057099|NCT04537949|69748289|FG007|Overall Study|personal reasons not related to the IMP|0|||
38057100|NCT04532099|69748310|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
38057101|NCT04532099|69748311|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
38057102|NCT04532099|69748312|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
38057103|NCT03041792|69748326|FG000|Overall Study|Adverse Event|4|||
38057104|NCT03041792|69748327|FG001|Overall Study|Adverse Event|0|||
38057105|NCT03041792|69748326|FG000|Overall Study|Death in the family|0|||
38057106|NCT03041792|69748327|FG001|Overall Study|Death in the family|2|||
38057107|NCT03041792|69748326|FG000|Overall Study|Randomized but not treated|0|||
38057108|NCT03041792|69748327|FG001|Overall Study|Randomized but not treated|1|||
38057109|NCT04507763|69748333|FG000|Overall Study|Participants did not meet entrance criteria|201|||
38057110|NCT03045302|69748340|FG000|Overall Study|Pre-treatment adverse event|1|||
38057111|NCT00705484|69748346|FG000|Overall Study|Adverse Event|28|||
38057112|NCT00705484|69748347|FG001|Overall Study|Adverse Event|27|||
38057113|NCT00705484|69748346|FG000|Overall Study|Lost to Follow-up|169|||
38057114|NCT00705484|69748347|FG001|Overall Study|Lost to Follow-up|250|||
38057115|NCT00705484|69748346|FG000|Overall Study|Withdrawal by Subject|96|||
38057116|NCT00705484|69748347|FG001|Overall Study|Withdrawal by Subject|72|||
38057117|NCT00705484|69748346|FG000|Overall Study|Administrative|89|||
38057118|NCT00705484|69748347|FG001|Overall Study|Administrative|59|||
38057119|NCT04523831|69748357|FG000|Overall Study|Lost to Follow-up|15|||
38057120|NCT04523831|69748358|FG001|Overall Study|Lost to Follow-up|17|||
38057121|NCT04523831|69748357|FG000|Overall Study|Death|0|||
38057122|NCT04523831|69748358|FG001|Overall Study|Death|3|||
38057123|NCT04523831|69748357|FG000|Overall Study|Adverse Event|2|||
38057124|NCT04523831|69748358|FG001|Overall Study|Adverse Event|0|||
38057125|NCT04707664|69748369|FG000|Overall Study|Adverse Event|2|||
38057126|NCT04707664|69748370|FG001|Overall Study|Adverse Event|0|||
38057127|NCT04707664|69748369|FG000|Overall Study|Death|1|||
38057128|NCT04707664|69748370|FG001|Overall Study|Death|2|||
38057129|NCT04707664|69748369|FG000|Overall Study|Withdrawal by Subject|13|||
38057130|NCT04707664|69748370|FG001|Overall Study|Withdrawal by Subject|21|||
38057131|NCT04707664|69748369|FG000|Overall Study|Lost to Follow-up|11|||
38057132|NCT04707664|69748370|FG001|Overall Study|Lost to Follow-up|13|||
38057133|NCT04707664|69748369|FG000|Overall Study|Not treated|2|||
38057134|NCT04707664|69748370|FG001|Overall Study|Not treated|0|||
38057135|NCT01316276|69748376|FG000|Overall Study|Death|1|||
38057136|NCT01316276|69748376|FG000|Overall Study|Adverse Event|19|||
38057137|NCT01316276|69748376|FG000|Overall Study|Withdrawal of consent|24|||
38057138|NCT01316276|69748376|FG000|Overall Study|Lost to Follow-up|1|||
38057139|NCT01316276|69748376|FG000|Overall Study|Other|22|||
38057140|NCT04668989|69748381|FG000|First Intervention|Covid-19 related self-isolation|0|||
38057141|NCT04668989|69748382|FG001|First Intervention|Covid-19 related self-isolation|1|||
38057142|NCT04668989|69748381|FG000|Second Intervention|Adverse Event|0|||
38057143|NCT04668989|69748382|FG001|Second Intervention|Adverse Event|1|||
38057144|NCT03700385|69748388|FG000|Overall Study|Lost to Follow-up|1|||
38057145|NCT04498403|69748394|FG000|Overall Study|Adverse Event|1|||
38057146|NCT04498403|69748395|FG001|Overall Study|Adverse Event|0|||
38057147|NCT04498403|69748394|FG000|Overall Study|Study Terminated By Sponsor|29|||
38057148|NCT04498403|69748395|FG001|Overall Study|Study Terminated By Sponsor|10|||
38057149|NCT04362137|69748403|FG000|Overall Study|Death|9|||
38057150|NCT04362137|69748404|FG001|Overall Study|Death|3|||
38057151|NCT04362137|69748403|FG000|Overall Study|Patient decision|6|||
38057152|NCT04362137|69748404|FG001|Overall Study|Patient decision|3|||
38057153|NCT04362137|69748403|FG000|Overall Study|Adverse Event|1|||
38057154|NCT04362137|69748404|FG001|Overall Study|Adverse Event|0|||
38057155|NCT04362137|69748403|FG000|Overall Study|Lost to Follow-up|1|||
38057156|NCT04362137|69748404|FG001|Overall Study|Lost to Follow-up|0|||
38057157|NCT04362137|69748403|FG000|Overall Study|Protocol deviation|1|||
38057158|NCT04362137|69748404|FG001|Overall Study|Protocol deviation|0|||
38057159|NCT05099380|69748412|FG000|Overall Study|Subject enrolled in error|1|||
38057160|NCT05099380|69748413|FG001|Overall Study|Subject enrolled in error|0|||
38057161|NCT05099380|69748412|FG000|Overall Study|Study Procedure|1|||
38057162|NCT05099380|69748413|FG001|Overall Study|Study Procedure|0|||
38057163|NCT05099380|69748412|FG000|Overall Study|Protocol Violation|1|||
38057164|NCT05099380|69748413|FG001|Overall Study|Protocol Violation|0|||
38057165|NCT05099380|69748412|FG000|Overall Study|Adverse Event|1|||
38057166|NCT05099380|69748413|FG001|Overall Study|Adverse Event|1|||
38057167|NCT05099380|69748412|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
38057168|NCT05099380|69748413|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
38057169|NCT03614728|69748423|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
38057170|NCT03614728|69748424|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
38057171|NCT03614728|69748425|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
38057172|NCT03614728|69748426|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
38057173|NCT03614728|69748423|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
38057174|NCT03614728|69748424|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
38057175|NCT03614728|69748425|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
38057176|NCT03614728|69748426|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
38057177|NCT03154086|69748449|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
38057178|NCT03154086|69748450|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
38057179|NCT03154086|69748451|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
38057180|NCT03154086|69748452|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
38057181|NCT03154086|69748453|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
38057182|NCT03154086|69748454|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
38057183|NCT03154086|69748455|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
38057184|NCT03154086|69748456|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
38057185|NCT03154086|69748457|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
38057186|NCT03154086|69748458|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
38057187|NCT03154086|69748459|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
38057188|NCT03154086|69748460|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
38057189|NCT03154086|69748461|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
38057190|NCT03154086|69748462|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
38057191|NCT03154086|69748463|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
38057192|NCT03154086|69748449|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
38057193|NCT03154086|69748450|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
38057194|NCT03154086|69748451|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
38057195|NCT03154086|69748452|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
38057196|NCT03154086|69748453|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
38057197|NCT03154086|69748454|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
38057198|NCT03154086|69748455|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
37965190|NCT00050011|69652262|FG000|Overall Study|Withdrawal by Subject|34|||
37965191|NCT00050011|69652263|FG001|Overall Study|Withdrawal by Subject|26|||
37965192|NCT00050011|69652262|FG000|Overall Study|Lost to Follow-up|7|||
37965193|NCT00050011|69652263|FG001|Overall Study|Lost to Follow-up|9|||
37965194|NCT00050011|69652262|FG000|Overall Study|Administrative problems|10|||
37965195|NCT00050011|69652263|FG001|Overall Study|Administrative problems|6|||
37965196|NCT00050011|69652262|FG000|Overall Study|Death|7|||
37965197|NCT00050011|69652263|FG001|Overall Study|Death|4|||
37965198|NCT00050011|69652262|FG000|Overall Study|Unknown - Reason is missing|0|||
37965199|NCT00050011|69652263|FG001|Overall Study|Unknown - Reason is missing|2|||
37965200|NCT00661427|69652272|FG000|Overall Study|Adverse Event|5|||
37862162|NCT00922207|69545931|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
37862163|NCT00922207|69545932|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
37862164|NCT00922207|69545933|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
37862165|NCT00922207|69545931|FG000|Overall Study|Withdrew Consent|2|||
37862166|NCT00922207|69545932|FG001|Overall Study|Withdrew Consent|5|||
37862167|NCT00922207|69545933|FG002|Overall Study|Withdrew Consent|2|||
37862168|NCT00922207|69545931|FG000|Overall Study|Abnormality of Laboratory Test|0|||
37862169|NCT00922207|69545932|FG001|Overall Study|Abnormality of Laboratory Test|1|||
37862170|NCT00922207|69545933|FG002|Overall Study|Abnormality of Laboratory Test|1|||
37862171|NCT01134315|69545943|FG000|Overall Study|Adverse Event|1|||
37862172|NCT01134315|69545944|FG001|Overall Study|Adverse Event|2|||
37862173|NCT01134315|69545943|FG000|Overall Study|Other Reason|8|||
37862174|NCT01134315|69545944|FG001|Overall Study|Other Reason|17|||
37862175|NCT01216176|69545953|FG000|Overall Study|Adverse Event|0|||
37862176|NCT01216176|69545954|FG001|Overall Study|Adverse Event|8|||
37862177|NCT01216176|69545955|FG002|Overall Study|Adverse Event|0|||
37862178|NCT01216176|69545953|FG000|Overall Study|Physician Decision|0|||
37862179|NCT01216176|69545954|FG001|Overall Study|Physician Decision|0|||
37965201|NCT00661427|69652273|FG001|Overall Study|Adverse Event|5|||
37965202|NCT00661427|69652272|FG000|Overall Study|Patient not treated|0|||
37965203|NCT00661427|69652273|FG001|Overall Study|Patient not treated|2|||
38057199|NCT03154086|69748456|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
38057200|NCT03154086|69748457|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
38057201|NCT03154086|69748458|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
38057202|NCT03154086|69748459|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
38057203|NCT03154086|69748460|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
38057204|NCT03154086|69748461|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
38057205|NCT03154086|69748462|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
38057206|NCT03154086|69748463|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
38057207|NCT03154086|69748449|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
38057208|NCT03154086|69748450|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
38057209|NCT03154086|69748451|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
38057210|NCT03154086|69748452|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
38057211|NCT03154086|69748453|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
38057212|NCT03154086|69748454|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
38057213|NCT03154086|69748455|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
38057214|NCT03154086|69748456|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
38057215|NCT03154086|69748457|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
38057216|NCT03154086|69748458|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
38057217|NCT03154086|69748459|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
38057218|NCT03154086|69748460|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
38057219|NCT03154086|69748461|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
38057220|NCT03154086|69748462|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
38057221|NCT03154086|69748463|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
38057222|NCT03154086|69748449|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
38057223|NCT03154086|69748450|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
38057224|NCT03154086|69748451|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
38057225|NCT03154086|69748452|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
38057226|NCT03154086|69748453|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
38057227|NCT03154086|69748454|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
38057228|NCT03154086|69748455|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
38057229|NCT03154086|69748456|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
38057230|NCT03154086|69748457|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
38057231|NCT03154086|69748458|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
38057232|NCT03154086|69748459|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
38057233|NCT03154086|69748460|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
38057234|NCT03154086|69748461|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
38057235|NCT03154086|69748462|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
38057236|NCT03154086|69748463|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
38057237|NCT03154086|69748449|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
38057238|NCT03154086|69748450|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
38057239|NCT03154086|69748451|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
38057240|NCT03154086|69748452|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
38057241|NCT03154086|69748453|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
38057242|NCT03154086|69748454|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
38057243|NCT03154086|69748455|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
38057244|NCT03154086|69748456|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
38057245|NCT03154086|69748457|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
38057246|NCT03154086|69748458|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
38057247|NCT03154086|69748459|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
38057248|NCT03154086|69748460|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
38057249|NCT03154086|69748461|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
38057250|NCT03154086|69748462|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
38057251|NCT03154086|69748463|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
38057252|NCT03154086|69748449|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
38057253|NCT03154086|69748450|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
38057254|NCT03154086|69748451|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
38057255|NCT03154086|69748452|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
38057256|NCT03154086|69748453|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
38057257|NCT03154086|69748454|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
38057258|NCT03154086|69748455|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
38057259|NCT03154086|69748456|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
38057260|NCT03154086|69748457|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
38057261|NCT03154086|69748458|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
38057262|NCT03154086|69748459|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
38057263|NCT03154086|69748460|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
38057264|NCT03154086|69748461|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
38057265|NCT03154086|69748462|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
38057266|NCT03154086|69748463|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
38057267|NCT03154086|69748449|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
38057268|NCT03154086|69748450|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
38057269|NCT03154086|69748451|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
38057270|NCT03154086|69748452|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
38057271|NCT03154086|69748453|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
38057272|NCT03154086|69748454|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
38057273|NCT03154086|69748455|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
38057274|NCT03154086|69748456|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
38057275|NCT03154086|69748457|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
38057276|NCT03154086|69748458|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
38057277|NCT03154086|69748459|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
38057278|NCT03154086|69748460|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
38057279|NCT03154086|69748461|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
38057280|NCT03154086|69748462|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
38057281|NCT03154086|69748463|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
38057282|NCT02723344|69748521|FG000|Overall Study|Lost to Follow-up|0|||
38057283|NCT02723344|69748522|FG001|Overall Study|Lost to Follow-up|4|||
38057284|NCT02723188|69748531|FG000|Overall Study|Withdrawal by Subject|1|||
38057285|NCT02723188|69748532|FG001|Overall Study|Withdrawal by Subject|0|||
38057286|NCT02723188|69748533|FG002|Overall Study|Withdrawal by Subject|0|||
38057287|NCT00705406|69748543|FG000|Overall Study|Lost to Follow-up|3|||
38057288|NCT00705406|69748544|FG001|Overall Study|Lost to Follow-up|3|||
38057289|NCT00705406|69748543|FG000|Overall Study|Did not receive study drug|1|||
38057290|NCT00705406|69748544|FG001|Overall Study|Did not receive study drug|2|||
38057291|NCT03155178|69748555|FG000|Overall Study|Did not meet treatment day baseline|7|||
38057292|NCT03155178|69748556|FG001|Overall Study|Did not meet treatment day baseline|7|||
38057293|NCT03155178|69748557|FG002|Overall Study|Did not meet treatment day baseline|7|||
38057294|NCT03155178|69748558|FG003|Overall Study|Did not meet treatment day baseline|7|||
38057295|NCT00705250|69748582|FG000|Overall Study|Withdrawal by Subject|1|||
38057296|NCT00705250|69748582|FG000|Overall Study|Patient died in car accident|1|||
37965204|NCT00049543|69652281|FG000|Overall Study|still on treatment|2|||
37965205|NCT00049543|69652282|FG001|Overall Study|still on treatment|9|||
37965206|NCT00048997|69652290|FG000|Overall Study|Protocol Violation|7|||
37965207|NCT00048997|69652291|FG001|Overall Study|Protocol Violation|2|||
37965208|NCT00048997|69652290|FG000|Overall Study|Withdrawal by Subject|6|||
37965209|NCT00048997|69652291|FG001|Overall Study|Withdrawal by Subject|1|||
37965210|NCT00035815|69652298|FG000|Overall Study|Withdrawal by Subject|17|||
37965211|NCT00035815|69652299|FG001|Overall Study|Withdrawal by Subject|11|||
37965212|NCT00662831|69652307|FG000|Overall Study|Death|4|||
37965213|NCT00662831|69652308|FG001|Overall Study|Death|1|||
37965214|NCT00662831|69652307|FG000|Overall Study|Lack of Efficacy|6|||
37965215|NCT00662831|69652308|FG001|Overall Study|Lack of Efficacy|6|||
37965216|NCT00662831|69652307|FG000|Overall Study|Lost to Follow-up|1|||
37965217|NCT00662831|69652308|FG001|Overall Study|Lost to Follow-up|0|||
37965218|NCT00662831|69652307|FG000|Overall Study|Withdrawal by Subject|2|||
37965219|NCT00662831|69652308|FG001|Overall Study|Withdrawal by Subject|1|||
37965220|NCT00662831|69652307|FG000|Overall Study|Other|62|||
37965221|NCT00662831|69652308|FG001|Overall Study|Other|31|||
37965222|NCT00662831|69652307|FG000|Overall Study|Protocol Violation|8|||
37965223|NCT00662831|69652308|FG001|Overall Study|Protocol Violation|4|||
37965224|NCT00662831|69652307|FG000|Overall Study|Adverse Event|23|||
37965225|NCT00662831|69652308|FG001|Overall Study|Adverse Event|16|||
37965226|NCT00662363|69652316|FG000|Overall Study|Withdrawal by Subject|6|||
37965227|NCT00662363|69652317|FG001|Overall Study|Withdrawal by Subject|5|||
37965228|NCT00662363|69652316|FG000|Overall Study|Adverse Event|0|||
37965229|NCT00662363|69652317|FG001|Overall Study|Adverse Event|3|||
37965230|NCT00662363|69652316|FG000|Overall Study|Discharged early from rehab|4|||
37965231|NCT00662363|69652317|FG001|Overall Study|Discharged early from rehab|1|||
37965232|NCT00662363|69652316|FG000|Overall Study|Protocol Violation|1|||
37965233|NCT00662363|69652317|FG001|Overall Study|Protocol Violation|1|||
37965234|NCT00661271|69652327|FG000|Overall Study|Lost to Follow-up|28|||
37965235|NCT00661271|69652328|FG001|Overall Study|Lost to Follow-up|25|||
38057297|NCT03078192|69748588|FG000|Overall Study|Withdrawal by Subject|2|||
38057298|NCT03078192|69748589|FG001|Overall Study|Withdrawal by Subject|1|||
38057299|NCT03078192|69748588|FG000|Overall Study|screen failure|0|||
38057300|NCT03078192|69748589|FG001|Overall Study|screen failure|3|||
37965236|NCT00661193|69652336|FG000|Overall Study|Adverse Event|2|||
37965237|NCT00661193|69652337|FG001|Overall Study|Adverse Event|1|||
37965238|NCT00661193|69652336|FG000|Overall Study|Withdrawal by Subject|3|||
37965239|NCT00661193|69652337|FG001|Overall Study|Withdrawal by Subject|1|||
37965240|NCT00661193|69652336|FG000|Overall Study|Progression|27|||
37965241|NCT00661193|69652337|FG001|Overall Study|Progression|24|||
38057301|NCT00703846|69748595|FG000|Overall Study|Adverse Event|8|||
37862180|NCT01216176|69545955|FG002|Overall Study|Physician Decision|1|||
38057302|NCT00703846|69748595|FG000|Overall Study|Lost to Follow-up|55|||
38057303|NCT00703846|69748595|FG000|Overall Study|Lack of Efficacy|15|||
38057304|NCT00703846|69748595|FG000|Overall Study|Noncompliance with Study Treatment|2|||
38057305|NCT00703846|69748595|FG000|Overall Study|Withdrawal by Subject|40|||
38057306|NCT00703846|69748595|FG000|Overall Study|Death|1|||
38057307|NCT00703846|69748595|FG000|Overall Study|Other|14|||
38057308|NCT00703846|69748595|FG000|Overall Study|Did Not Receive Study Drug|2|||
38057309|NCT05372575|69748605|FG000|Overall Study|Protocol Violation|7|||
38057310|NCT05372575|69748606|FG001|Overall Study|Protocol Violation|16|||
38057311|NCT05132127|69748617|FG000|Overall Study|Adverse Event|1|||
38057312|NCT04969276|69748644|FG000|Overall Study|Protocol Deviation|0|||
38057313|NCT04969276|69748645|FG001|Overall Study|Protocol Deviation|1|||
38057314|NCT04969276|69748646|FG002|Overall Study|Protocol Deviation|0|||
38057315|NCT04969276|69748644|FG000|Overall Study|Withdrawal by Subject|1|||
38057316|NCT04969276|69748645|FG001|Overall Study|Withdrawal by Subject|10|||
38057317|NCT04969276|69748646|FG002|Overall Study|Withdrawal by Subject|0|||
38057318|NCT04969276|69748644|FG000|Overall Study|Lost to Follow-up|0|||
38057319|NCT04969276|69748645|FG001|Overall Study|Lost to Follow-up|1|||
37862181|NCT01133847|69545967|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
37862182|NCT01133847|69545968|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
37862183|NCT01133847|69545969|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
37862184|NCT01133847|69545967|FG000|Follow-Up Phase|Lost to Follow-up|1|||
37862185|NCT01133847|69545968|FG001|Follow-Up Phase|Lost to Follow-up|3|||
37965242|NCT00661193|69652336|FG000|Overall Study|Not protocol specified|1|||
37862186|NCT01133847|69545969|FG002|Follow-Up Phase|Lost to Follow-up|7|||
37862187|NCT01133379|69545981|FG000|Overall Study|Withdrawal by Subject|0|||
37862188|NCT01133379|69545982|FG001|Overall Study|Withdrawal by Subject|1|||
37862189|NCT01133379|69545983|FG002|Overall Study|Withdrawal by Subject|1|||
37862190|NCT01133379|69545981|FG000|Overall Study|Lost to Follow-up|1|||
37862191|NCT01133379|69545982|FG001|Overall Study|Lost to Follow-up|1|||
37862192|NCT01133379|69545983|FG002|Overall Study|Lost to Follow-up|1|||
37862193|NCT01133067|69545991|FG000|Overall Study|Death|136|||
37862194|NCT01133067|69545991|FG000|Overall Study|Lost to Follow-up|3|||
37862195|NCT01132755|69545995|FG000|Overall Study|Procedure not done due to medical reason|23|||
37862196|NCT01132755|69545995|FG000|Overall Study|Protocol Violation|15|||
37862197|NCT01132755|69545995|FG000|Overall Study|Withdrawal by Subject|4|||
37862198|NCT00919711|69546001|FG000|Overall Study|Withdrawal by Subject|15|||
37862199|NCT00919711|69546002|FG001|Overall Study|Withdrawal by Subject|7|||
37862200|NCT00919711|69546001|FG000|Overall Study|Adverse Event|13|||
37862201|NCT00919711|69546002|FG001|Overall Study|Adverse Event|3|||
37862202|NCT00919711|69546001|FG000|Overall Study|Other|1|||
37862203|NCT00919711|69546002|FG001|Overall Study|Other|2|||
37862204|NCT00919711|69546001|FG000|Overall Study|Administrative Decision|0|||
37862205|NCT00919711|69546002|FG001|Overall Study|Administrative Decision|1|||
37862206|NCT00919711|69546001|FG000|Overall Study|Lost to Follow-up|2|||
37965243|NCT00661193|69652337|FG001|Overall Study|Not protocol specified|0|||
37965244|NCT00658541|69652343|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
37965245|NCT00658541|69652344|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
37965246|NCT00658541|69652343|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
37965247|NCT00658541|69652344|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
37965248|NCT00048061|69652354|FG000|Overall Study|Adverse Event|41|||
38057320|NCT04969276|69748646|FG002|Overall Study|Lost to Follow-up|0|||
38057321|NCT04969224|69748654|FG000|Overall Study|Adverse Event|1|||
38057322|NCT04969224|69748654|FG000|Overall Study|Enrolled but never dosed|1|||
38057323|NCT04507126|69748680|FG000|Overall Study|Withdrawal by Subject|1|||
38057324|NCT04507126|69748680|FG000|Overall Study|Protocol Violation|2|||
38057325|NCT04507126|69748680|FG000|Overall Study|Physician Decision|1|||
38057326|NCT04498832|69748687|FG000|Overall Study|Adverse Event|1|||
38057327|NCT04498832|69748688|FG001|Overall Study|Adverse Event|3|||
38057328|NCT04498832|69748687|FG000|Overall Study|Withdrawal by Subject|0|||
37965249|NCT00048061|69652355|FG001|Overall Study|Adverse Event|32|||
37965250|NCT00048061|69652356|FG002|Overall Study|Adverse Event|44|||
37965251|NCT00048061|69652357|FG003|Overall Study|Adverse Event|37|||
37965252|NCT00048061|69652354|FG000|Overall Study|Lost to Follow-up|3|||
37965253|NCT00048061|69652355|FG001|Overall Study|Lost to Follow-up|2|||
38057329|NCT04498832|69748688|FG001|Overall Study|Withdrawal by Subject|1|||
38057330|NCT04490018|69748697|FG000|Overall Study|Protocol Violation|0|||
38057331|NCT04490018|69748698|FG001|Overall Study|Protocol Violation|2|||
38057332|NCT04490018|69748699|FG002|Overall Study|Protocol Violation|1|||
38057333|NCT04490018|69748697|FG000|Overall Study|Lost to Follow-up|2|||
38057334|NCT04490018|69748698|FG001|Overall Study|Lost to Follow-up|2|||
38057335|NCT04490018|69748699|FG002|Overall Study|Lost to Follow-up|0|||
37862207|NCT00919711|69546002|FG001|Overall Study|Lost to Follow-up|0|||
37862208|NCT00919711|69546001|FG000|Overall Study|Death|1|||
37862209|NCT00919711|69546002|FG001|Overall Study|Death|0|||
37862210|NCT00919711|69546001|FG000|Overall Study|Noncompliance|1|||
38057336|NCT04490018|69748697|FG000|Overall Study|Withdrawal by Subject|2|||
38057337|NCT04490018|69748698|FG001|Overall Study|Withdrawal by Subject|1|||
38057338|NCT04490018|69748699|FG002|Overall Study|Withdrawal by Subject|0|||
38057339|NCT04490018|69748697|FG000|Overall Study|Withdrawal by parent/guardian|2|||
38057340|NCT04490018|69748698|FG001|Overall Study|Withdrawal by parent/guardian|3|||
38057341|NCT04490018|69748699|FG002|Overall Study|Withdrawal by parent/guardian|0|||
38057342|NCT04453202|69748720|FG000|Overall Study|Adverse Event|0|||
38057343|NCT04453202|69748721|FG001|Overall Study|Adverse Event|0|||
38057344|NCT04453202|69748722|FG002|Overall Study|Adverse Event|0|||
38057345|NCT04453202|69748723|FG003|Overall Study|Adverse Event|0|||
38057346|NCT04453202|69748724|FG004|Overall Study|Adverse Event|0|||
38057347|NCT04453202|69748725|FG005|Overall Study|Adverse Event|0|||
38057348|NCT04453202|69748726|FG006|Overall Study|Adverse Event|1|||
38057349|NCT04453202|69748727|FG007|Overall Study|Adverse Event|0|||
38057350|NCT04453202|69748728|FG008|Overall Study|Adverse Event|0|||
38057351|NCT04453202|69748729|FG009|Overall Study|Adverse Event|0|||
38057352|NCT04453202|69748730|FG010|Overall Study|Adverse Event|0|||
38057353|NCT04453202|69748720|FG000|Overall Study|Death|0|||
38057354|NCT04453202|69748721|FG001|Overall Study|Death|0|||
38057355|NCT04453202|69748722|FG002|Overall Study|Death|0|||
38057356|NCT04453202|69748723|FG003|Overall Study|Death|0|||
38057357|NCT04453202|69748724|FG004|Overall Study|Death|0|||
38057358|NCT04453202|69748725|FG005|Overall Study|Death|0|||
38057359|NCT04453202|69748726|FG006|Overall Study|Death|0|||
38057360|NCT04453202|69748727|FG007|Overall Study|Death|0|||
38057361|NCT04453202|69748728|FG008|Overall Study|Death|0|||
38057362|NCT04453202|69748729|FG009|Overall Study|Death|1|||
38057363|NCT04453202|69748730|FG010|Overall Study|Death|0|||
38057364|NCT04453202|69748720|FG000|Overall Study|Lost to Follow-up|0|||
38057365|NCT04453202|69748721|FG001|Overall Study|Lost to Follow-up|1|||
38057366|NCT04453202|69748722|FG002|Overall Study|Lost to Follow-up|0|||
38057367|NCT04453202|69748723|FG003|Overall Study|Lost to Follow-up|1|||
38057368|NCT04453202|69748724|FG004|Overall Study|Lost to Follow-up|0|||
38057369|NCT04453202|69748725|FG005|Overall Study|Lost to Follow-up|0|||
38057370|NCT04453202|69748726|FG006|Overall Study|Lost to Follow-up|0|||
38057371|NCT04453202|69748727|FG007|Overall Study|Lost to Follow-up|0|||
38057372|NCT04453202|69748728|FG008|Overall Study|Lost to Follow-up|0|||
38057373|NCT04453202|69748729|FG009|Overall Study|Lost to Follow-up|1|||
38057374|NCT04453202|69748730|FG010|Overall Study|Lost to Follow-up|1|||
38057375|NCT04453202|69748720|FG000|Overall Study|Withdrawal by Subject|1|||
38057376|NCT04453202|69748721|FG001|Overall Study|Withdrawal by Subject|2|||
38057377|NCT04453202|69748722|FG002|Overall Study|Withdrawal by Subject|1|||
38057378|NCT04453202|69748723|FG003|Overall Study|Withdrawal by Subject|2|||
38057379|NCT04453202|69748724|FG004|Overall Study|Withdrawal by Subject|1|||
38057380|NCT04453202|69748725|FG005|Overall Study|Withdrawal by Subject|1|||
38057381|NCT04453202|69748726|FG006|Overall Study|Withdrawal by Subject|0|||
38057382|NCT04453202|69748727|FG007|Overall Study|Withdrawal by Subject|0|||
38057383|NCT04453202|69748728|FG008|Overall Study|Withdrawal by Subject|0|||
38057384|NCT04453202|69748729|FG009|Overall Study|Withdrawal by Subject|1|||
38057385|NCT04453202|69748730|FG010|Overall Study|Withdrawal by Subject|0|||
38057386|NCT04453202|69748720|FG000|Overall Study|Adverse Event|0|||
38057387|NCT04453202|69748721|FG001|Overall Study|Adverse Event|0|||
38057388|NCT04453202|69748722|FG002|Overall Study|Adverse Event|0|||
38057389|NCT04453202|69748723|FG003|Overall Study|Adverse Event|0|||
38057390|NCT04453202|69748724|FG004|Overall Study|Adverse Event|0|||
38057391|NCT04453202|69748725|FG005|Overall Study|Adverse Event|1|||
38057392|NCT04453202|69748726|FG006|Overall Study|Adverse Event|0|||
38057393|NCT04453202|69748727|FG007|Overall Study|Adverse Event|0|||
38057394|NCT04453202|69748728|FG008|Overall Study|Adverse Event|0|||
38057395|NCT04453202|69748729|FG009|Overall Study|Adverse Event|0|||
38057396|NCT04453202|69748730|FG010|Overall Study|Adverse Event|0|||
38057397|NCT03807778|69748787|FG000|Overall Study|Adverse Event|0|||
38057398|NCT03807778|69748788|FG001|Overall Study|Adverse Event|0|||
38057399|NCT03807778|69748789|FG002|Overall Study|Adverse Event|3|||
38057400|NCT03807778|69748790|FG003|Overall Study|Adverse Event|5|||
38057401|NCT03807778|69748787|FG000|Overall Study|Progressive Disease|4|||
38057402|NCT03807778|69748788|FG001|Overall Study|Progressive Disease|2|||
38057403|NCT03807778|69748789|FG002|Overall Study|Progressive Disease|8|||
38057404|NCT03807778|69748790|FG003|Overall Study|Progressive Disease|15|||
38057405|NCT03807778|69748787|FG000|Overall Study|Symptomatic Deterioration|0|||
38057406|NCT03807778|69748788|FG001|Overall Study|Symptomatic Deterioration|1|||
38057407|NCT03807778|69748789|FG002|Overall Study|Symptomatic Deterioration|0|||
38057408|NCT03807778|69748790|FG003|Overall Study|Symptomatic Deterioration|1|||
38057409|NCT03807778|69748787|FG000|Overall Study|Withdrawal by Subject|0|||
38057410|NCT03807778|69748788|FG001|Overall Study|Withdrawal by Subject|1|||
38057411|NCT03807778|69748789|FG002|Overall Study|Withdrawal by Subject|0|||
38057412|NCT03807778|69748790|FG003|Overall Study|Withdrawal by Subject|1|||
38057413|NCT03807778|69748787|FG000|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
38057414|NCT03807778|69748788|FG001|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
38057415|NCT03807778|69748789|FG002|Overall Study|Ongoing at data cut- off date (08 November 2021)|1|||
38057416|NCT03807778|69748790|FG003|Overall Study|Ongoing at data cut- off date (08 November 2021)|11|||
38057417|NCT03672461|69748815|FG000|Overall Study|COVID Related|4|||
38057418|NCT03672461|69748816|FG001|Overall Study|COVID Related|2|||
38057419|NCT03672461|69748815|FG000|Overall Study|Adverse Event|2|||
38057420|NCT03672461|69748816|FG001|Overall Study|Adverse Event|0|||
38057421|NCT03672461|69748815|FG000|Overall Study|Serious Adverse Event|0|||
38057422|NCT03672461|69748816|FG001|Overall Study|Serious Adverse Event|1|||
38057423|NCT03672461|69748815|FG000|Overall Study|Too Busy|3|||
38057424|NCT03672461|69748816|FG001|Overall Study|Too Busy|1|||
38057425|NCT03672461|69748815|FG000|Overall Study|Lost to Follow-up|1|||
38057426|NCT03672461|69748816|FG001|Overall Study|Lost to Follow-up|2|||
38057427|NCT03672461|69748815|FG000|Overall Study|Family|2|||
38057428|NCT03672461|69748816|FG001|Overall Study|Family|2|||
38057429|NCT03672461|69748815|FG000|Overall Study|No remote technology access|0|||
38057430|NCT03672461|69748816|FG001|Overall Study|No remote technology access|1|||
38057431|NCT03672461|69748815|FG000|Overall Study|Withdrawal by Subject|1|||
38057432|NCT03672461|69748816|FG001|Overall Study|Withdrawal by Subject|0|||
38057433|NCT03672461|69748815|FG000|Overall Study|Cannot tolerate intervention|1|||
38057434|NCT03672461|69748816|FG001|Overall Study|Cannot tolerate intervention|0|||
38057435|NCT03672461|69748815|FG000|Overall Study|Incomplete outcome data|6|||
38057436|NCT03672461|69748816|FG001|Overall Study|Incomplete outcome data|1|||
38057437|NCT03611556|69748829|FG000|Overall Study|Death|7|||
38057438|NCT03611556|69748830|FG001|Overall Study|Death|7|||
38057439|NCT03611556|69748831|FG002|Overall Study|Death|3|||
38057440|NCT03611556|69748832|FG003|Overall Study|Death|8|||
38057441|NCT03611556|69748833|FG004|Overall Study|Death|47|||
38057442|NCT03611556|69748834|FG005|Overall Study|Death|32|||
38057443|NCT03611556|69748835|FG006|Overall Study|Death|53|||
38057444|NCT03611556|69748829|FG000|Overall Study|Withdrawal by Subject|0|||
37965254|NCT00048061|69652356|FG002|Overall Study|Lost to Follow-up|4|||
37965255|NCT00048061|69652357|FG003|Overall Study|Lost to Follow-up|5|||
37965256|NCT00048061|69652354|FG000|Overall Study|Withdrawal by Subject|20|||
37965257|NCT00048061|69652355|FG001|Overall Study|Withdrawal by Subject|29|||
37965258|NCT00048061|69652356|FG002|Overall Study|Withdrawal by Subject|29|||
37965259|NCT00048061|69652357|FG003|Overall Study|Withdrawal by Subject|32|||
37965260|NCT00048061|69652354|FG000|Overall Study|Did not follow-up|5|||
37965261|NCT00048061|69652355|FG001|Overall Study|Did not follow-up|5|||
37965262|NCT00048061|69652356|FG002|Overall Study|Did not follow-up|4|||
37965263|NCT00048061|69652357|FG003|Overall Study|Did not follow-up|5|||
37965264|NCT00048061|69652354|FG000|Overall Study|Early improvement|6|||
37965265|NCT00048061|69652355|FG001|Overall Study|Early improvement|5|||
37965266|NCT00048061|69652356|FG002|Overall Study|Early improvement|3|||
37965267|NCT00048061|69652357|FG003|Overall Study|Early improvement|0|||
37965268|NCT00656513|69652370|FG000|Overall Study|Protocol Violation|1|||
37965269|NCT00656513|69652371|FG001|Overall Study|Protocol Violation|0|||
37965270|NCT00656513|69652372|FG002|Overall Study|Protocol Violation|2|||
37965271|NCT00656513|69652370|FG000|Overall Study|Withdrawal by Subject|0|||
37965272|NCT00656513|69652371|FG001|Overall Study|Withdrawal by Subject|11|||
37965273|NCT00656513|69652372|FG002|Overall Study|Withdrawal by Subject|4|||
37965274|NCT00656513|69652370|FG000|Overall Study|Death|0|||
37965275|NCT00656513|69652371|FG001|Overall Study|Death|0|||
37965276|NCT00656513|69652372|FG002|Overall Study|Death|1|||
37965277|NCT00656513|69652370|FG000|Overall Study|Missing data|0|||
37965278|NCT00656513|69652371|FG001|Overall Study|Missing data|11|||
37965279|NCT00656513|69652372|FG002|Overall Study|Missing data|9|||
37965280|NCT00656513|69652370|FG000|Overall Study|Incomplete treatment|3|||
37965281|NCT00656513|69652371|FG001|Overall Study|Incomplete treatment|0|||
37965282|NCT00656513|69652372|FG002|Overall Study|Incomplete treatment|0|||
37965283|NCT00656513|69652370|FG000|Overall Study|Treatment completed outside of timeframe|0|||
37965284|NCT00656513|69652371|FG001|Overall Study|Treatment completed outside of timeframe|3|||
37965285|NCT00656513|69652372|FG002|Overall Study|Treatment completed outside of timeframe|1|||
37965286|NCT00656513|69652370|FG000|Overall Study|Missing baseline form|0|||
37965287|NCT00656513|69652371|FG001|Overall Study|Missing baseline form|5|||
37965288|NCT00656513|69652372|FG002|Overall Study|Missing baseline form|5|||
37965289|NCT00655889|69652380|FG000|Overall Study|Inadequate cell growth|1|||
37965290|NCT00655889|69652380|FG000|Overall Study|Protocol Violation|1|||
37965291|NCT00655733|69652386|FG000|Overall Study|Lost to Follow-up|2|||
37965292|NCT00655733|69652387|FG001|Overall Study|Lost to Follow-up|2|||
38057445|NCT03611556|69748830|FG001|Overall Study|Withdrawal by Subject|0|||
38057446|NCT03611556|69748831|FG002|Overall Study|Withdrawal by Subject|0|||
38057447|NCT03611556|69748832|FG003|Overall Study|Withdrawal by Subject|0|||
38057448|NCT03611556|69748833|FG004|Overall Study|Withdrawal by Subject|4|||
38057449|NCT03611556|69748834|FG005|Overall Study|Withdrawal by Subject|2|||
38057450|NCT03611556|69748835|FG006|Overall Study|Withdrawal by Subject|4|||
37965293|NCT00655733|69652386|FG000|Overall Study|Adverse Event|2|||
38057451|NCT03611556|69748829|FG000|Overall Study|Sponsor decision|0|||
38057452|NCT03611556|69748830|FG001|Overall Study|Sponsor decision|0|||
37965294|NCT00655733|69652387|FG001|Overall Study|Adverse Event|2|||
37965295|NCT00655733|69652386|FG000|Overall Study|Withdrawal by Subject|3|||
37965296|NCT00655733|69652387|FG001|Overall Study|Withdrawal by Subject|3|||
37965297|NCT00655733|69652386|FG000|Overall Study|Physician Decision|0|||
37965298|NCT00655733|69652387|FG001|Overall Study|Physician Decision|1|||
37965299|NCT00657371|69652395|FG000|Overall Study|Poor bowel preparation|15|||
37965300|NCT00657371|69652395|FG000|Overall Study|Unable to intubate the cecum|5|||
37965301|NCT00657371|69652395|FG000|Overall Study|Protocol Violation|2|||
37965302|NCT00657371|69652395|FG000|Overall Study|Device- related reasons|13|||
37965303|NCT00657371|69652395|FG000|Overall Study|Pre-existing medical condition|4|||
37965304|NCT00658775|69652401|FG000|Overall Study|Adverse Event|4|||
37965305|NCT00658775|69652402|FG001|Overall Study|Adverse Event|6|||
37965306|NCT00658775|69652401|FG000|Overall Study|Lost to Follow-up|17|||
37965307|NCT00658775|69652402|FG001|Overall Study|Lost to Follow-up|18|||
37965308|NCT00658775|69652401|FG000|Overall Study|Withdrawal by Subject|6|||
37965309|NCT00658775|69652402|FG001|Overall Study|Withdrawal by Subject|4|||
37965310|NCT00658775|69652401|FG000|Overall Study|Withdrawal of consent|8|||
37965311|NCT00658775|69652402|FG001|Overall Study|Withdrawal of consent|7|||
37965312|NCT00658775|69652401|FG000|Overall Study|Other|7|||
37965313|NCT00658775|69652402|FG001|Overall Study|Other|8|||
37965314|NCT00488631|69652414|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
37965315|NCT00488631|69652415|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
37965316|NCT00488631|69652416|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
37965317|NCT00488631|69652417|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
37965318|NCT00488631|69652418|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
37965319|NCT00488631|69652419|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
37965320|NCT00488631|69652420|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
37965321|NCT00488631|69652421|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
37965322|NCT00488631|69652422|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
37965323|NCT00488631|69652423|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
37965324|NCT00488631|69652414|FG000|Double Blind Period (Week 0-54)|Death|0|||
37965325|NCT00488631|69652415|FG001|Double Blind Period (Week 0-54)|Death|0|||
37965326|NCT00488631|69652416|FG002|Double Blind Period (Week 0-54)|Death|0|||
37965327|NCT00488631|69652417|FG003|Double Blind Period (Week 0-54)|Death|0|||
37965328|NCT00488631|69652418|FG004|Double Blind Period (Week 0-54)|Death|0|||
37965329|NCT00488631|69652419|FG005|Double Blind Period (Week 0-54)|Death|1|||
37965330|NCT00488631|69652420|FG006|Double Blind Period (Week 0-54)|Death|0|||
37965331|NCT00488631|69652421|FG007|Double Blind Period (Week 0-54)|Death|0|||
37965332|NCT00488631|69652422|FG008|Double Blind Period (Week 0-54)|Death|0|||
37965333|NCT00488631|69652423|FG009|Double Blind Period (Week 0-54)|Death|0|||
37965334|NCT00488631|69652414|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
37965335|NCT00488631|69652415|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
37965336|NCT00488631|69652416|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
37965337|NCT00488631|69652417|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
37965338|NCT00488631|69652418|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
37965339|NCT00488631|69652419|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
37965340|NCT00488631|69652420|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
38057453|NCT03611556|69748831|FG002|Overall Study|Sponsor decision|0|||
38057454|NCT03611556|69748832|FG003|Overall Study|Sponsor decision|0|||
38057455|NCT03611556|69748833|FG004|Overall Study|Sponsor decision|9|||
38057456|NCT03611556|69748834|FG005|Overall Study|Sponsor decision|4|||
38057457|NCT03611556|69748835|FG006|Overall Study|Sponsor decision|12|||
38057458|NCT03611556|69748829|FG000|Overall Study|Reasons|0|||
38057459|NCT03611556|69748830|FG001|Overall Study|Reasons|0|||
38057460|NCT03611556|69748831|FG002|Overall Study|Reasons|0|||
38057461|NCT03611556|69748832|FG003|Overall Study|Reasons|0|||
38057462|NCT03611556|69748833|FG004|Overall Study|Reasons|2|||
38057463|NCT03611556|69748834|FG005|Overall Study|Reasons|0|||
38057464|NCT03611556|69748835|FG006|Overall Study|Reasons|1|||
38057465|NCT03554317|69748870|FG000|Overall Study|Withdrawal by Subject|1|||
38057466|NCT03554317|69748870|FG000|Overall Study|PSA Progression|3|||
37965341|NCT00488631|69652421|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
37965342|NCT00488631|69652422|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
38057467|NCT03554317|69748870|FG000|Overall Study|Radiographic Progression|4|||
38057468|NCT03309813|69748890|FG000|Main Randomized Study|Withdrawal by Subject|1|||
38057469|NCT03309813|69748891|FG001|Main Randomized Study|Withdrawal by Subject|0|||
37965343|NCT00488631|69652423|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
37965344|NCT00488631|69652414|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
37965345|NCT00488631|69652415|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
37965346|NCT00488631|69652416|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
38057470|NCT02273388|69748944|FG000|Overall Study|Adverse Event|0|||
38057471|NCT02273388|69748945|FG001|Overall Study|Adverse Event|0|||
38057472|NCT02273388|69748946|FG002|Overall Study|Adverse Event|0|||
38057473|NCT02273388|69748947|FG003|Overall Study|Adverse Event|0|||
38057474|NCT02273388|69748948|FG004|Overall Study|Adverse Event|0|||
38057475|NCT02273388|69748949|FG005|Overall Study|Adverse Event|0|||
38057476|NCT02273388|69748950|FG006|Overall Study|Adverse Event|1|||
38057477|NCT02273388|69748951|FG007|Overall Study|Adverse Event|2|||
38057478|NCT02273388|69748952|FG008|Overall Study|Adverse Event|0|||
38057479|NCT02273388|69748953|FG009|Overall Study|Adverse Event|0|||
38057480|NCT02273388|69748954|FG010|Overall Study|Adverse Event|0|||
38057481|NCT02273388|69748955|FG011|Overall Study|Adverse Event|0|||
38057482|NCT02273388|69748944|FG000|Overall Study|Adverse Event study disease worse|4|||
38057483|NCT02273388|69748945|FG001|Overall Study|Adverse Event study disease worse|3|||
38057484|NCT02273388|69748946|FG002|Overall Study|Adverse Event study disease worse|3|||
38057485|NCT02273388|69748947|FG003|Overall Study|Adverse Event study disease worse|2|||
38057486|NCT02273388|69748948|FG004|Overall Study|Adverse Event study disease worse|4|||
38057487|NCT02273388|69748949|FG005|Overall Study|Adverse Event study disease worse|3|||
38057488|NCT02273388|69748950|FG006|Overall Study|Adverse Event study disease worse|14|||
38057489|NCT02273388|69748951|FG007|Overall Study|Adverse Event study disease worse|6|||
38057490|NCT02273388|69748952|FG008|Overall Study|Adverse Event study disease worse|6|||
38057491|NCT02273388|69748953|FG009|Overall Study|Adverse Event study disease worse|5|||
38057492|NCT02273388|69748954|FG010|Overall Study|Adverse Event study disease worse|10|||
38057493|NCT02273388|69748955|FG011|Overall Study|Adverse Event study disease worse|1|||
38057494|NCT02273388|69748944|FG000|Overall Study|Sponsor decision|0|||
38057495|NCT02273388|69748945|FG001|Overall Study|Sponsor decision|0|||
38057496|NCT02273388|69748946|FG002|Overall Study|Sponsor decision|0|||
38057497|NCT02273388|69748947|FG003|Overall Study|Sponsor decision|0|||
38057498|NCT02273388|69748948|FG004|Overall Study|Sponsor decision|0|||
38057499|NCT02273388|69748949|FG005|Overall Study|Sponsor decision|0|||
38057500|NCT02273388|69748950|FG006|Overall Study|Sponsor decision|0|||
38057501|NCT02273388|69748951|FG007|Overall Study|Sponsor decision|0|||
38057502|NCT02273388|69748952|FG008|Overall Study|Sponsor decision|0|||
38057503|NCT02273388|69748953|FG009|Overall Study|Sponsor decision|0|||
38057504|NCT02273388|69748954|FG010|Overall Study|Sponsor decision|0|||
38057505|NCT02273388|69748955|FG011|Overall Study|Sponsor decision|1|||
38057506|NCT02272790|69748990|FG000|Overall Study|Physician Decision|0|||
38057507|NCT02272790|69748991|FG001|Overall Study|Physician Decision|1|||
38057508|NCT02272790|69748992|FG002|Overall Study|Physician Decision|0|||
38057509|NCT02272790|69748993|FG003|Overall Study|Physician Decision|0|||
38057510|NCT02272790|69748994|FG004|Overall Study|Physician Decision|0|||
38057511|NCT02272790|69748995|FG005|Overall Study|Physician Decision|0|||
38057512|NCT02100956|69749017|FG000|At Least One Week Between Injections|Adverse Event|0|||
38057513|NCT02100956|69749018|FG001|At Least One Week Between Injections|Adverse Event|1|||
38057514|NCT01438411|69749034|FG000|Overall Study|Adverse Event|8|||
38057515|NCT01438411|69749034|FG000|Overall Study|Lost to Follow-up|1|||
38057516|NCT01438411|69749034|FG000|Overall Study|Lack of Efficacy|1|||
38057517|NCT01438411|69749034|FG000|Overall Study|Withdrawal by Subject|3|||
38057518|NCT01302834|69749040|FG000|Overall Study|Protocol Violation|17|||
38057519|NCT01302834|69749041|FG001|Overall Study|Protocol Violation|23|||
38057520|NCT01302834|69749040|FG000|Overall Study|HIV positive|1|||
38057521|NCT01302834|69749041|FG001|Overall Study|HIV positive|3|||
38057522|NCT01153698|69749047|FG000|Overall Study|Adverse Event|12|||
38057523|NCT01153698|69749047|FG000|Overall Study|Lost to Follow-up|4|||
38057524|NCT01153698|69749047|FG000|Overall Study|Withdrawal by Subject|2|||
37680371|NCT02586805|69155997|FG000|Overall Study|Withdrawal by Subject|3|||
38057525|NCT01153698|69749047|FG000|Overall Study|Switch to other anticoagulants|4|||
38057526|NCT01153698|69749047|FG000|Overall Study|Other|2|||
38057527|NCT01153698|69749047|FG000|Overall Study|Not treated with Pradaxa|5|||
38057528|NCT01012817|69749079|FG000|Overall Study|Withdrawal by Subject|0|||
38057529|NCT01012817|69749080|FG001|Overall Study|Withdrawal by Subject|0|||
38057530|NCT01012817|69749081|FG002|Overall Study|Withdrawal by Subject|0|||
38057531|NCT01012817|69749082|FG003|Overall Study|Withdrawal by Subject|1|||
38057532|NCT01012817|69749083|FG004|Overall Study|Withdrawal by Subject|0|||
38057533|NCT01012817|69749084|FG005|Overall Study|Withdrawal by Subject|0|||
38057534|NCT01012817|69749085|FG006|Overall Study|Withdrawal by Subject|0|||
38057535|NCT01012817|69749086|FG007|Overall Study|Withdrawal by Subject|1|||
38057536|NCT01012817|69749087|FG008|Overall Study|Withdrawal by Subject|0|||
38057537|NCT01012817|69749088|FG009|Overall Study|Withdrawal by Subject|0|||
38057538|NCT01012817|69749089|FG010|Overall Study|Withdrawal by Subject|1|||
38057539|NCT01012817|69749090|FG011|Overall Study|Withdrawal by Subject|1|||
38057540|NCT01012817|69749091|FG012|Overall Study|Withdrawal by Subject|0|||
38057541|NCT01012817|69749092|FG013|Overall Study|Withdrawal by Subject|1|||
38057542|NCT01012817|69749079|FG000|Overall Study|Adverse Event|0|||
38057543|NCT01012817|69749080|FG001|Overall Study|Adverse Event|0|||
38057544|NCT01012817|69749081|FG002|Overall Study|Adverse Event|0|||
38057545|NCT01012817|69749082|FG003|Overall Study|Adverse Event|0|||
38057546|NCT01012817|69749083|FG004|Overall Study|Adverse Event|0|||
38057547|NCT01012817|69749084|FG005|Overall Study|Adverse Event|1|||
38057548|NCT01012817|69749085|FG006|Overall Study|Adverse Event|0|||
38057549|NCT01012817|69749086|FG007|Overall Study|Adverse Event|0|||
38057550|NCT01012817|69749087|FG008|Overall Study|Adverse Event|0|||
38057551|NCT01012817|69749088|FG009|Overall Study|Adverse Event|0|||
38057552|NCT01012817|69749089|FG010|Overall Study|Adverse Event|1|||
38057553|NCT01012817|69749090|FG011|Overall Study|Adverse Event|0|||
38057554|NCT01012817|69749091|FG012|Overall Study|Adverse Event|0|||
38057555|NCT01012817|69749092|FG013|Overall Study|Adverse Event|1|||
38057556|NCT00804856|69749137|FG000|Overall Study|Progressive Disease|3|||
38057557|NCT00804856|69749138|FG001|Overall Study|Progressive Disease|2|||
38057558|NCT00804856|69749139|FG002|Overall Study|Progressive Disease|4|||
38057559|NCT00804856|69749140|FG003|Overall Study|Progressive Disease|6|||
38057560|NCT00804856|69749141|FG004|Overall Study|Progressive Disease|4|||
38057561|NCT00804856|69749142|FG005|Overall Study|Progressive Disease|1|||
38057562|NCT00804856|69749143|FG006|Overall Study|Progressive Disease|8|||
38057563|NCT00804856|69749144|FG007|Overall Study|Progressive Disease|2|||
38057564|NCT00804856|69749145|FG008|Overall Study|Progressive Disease|4|||
38057565|NCT00804856|69749146|FG009|Overall Study|Progressive Disease|5|||
38057566|NCT00804856|69749147|FG010|Overall Study|Progressive Disease|12|||
38057567|NCT00804856|69749148|FG011|Overall Study|Progressive Disease|2|||
38057568|NCT00804856|69749149|FG012|Overall Study|Progressive Disease|2|||
38057569|NCT00804856|69749150|FG013|Overall Study|Progressive Disease|26|||
38057570|NCT00804856|69749151|FG014|Overall Study|Progressive Disease|20|||
38057571|NCT00804856|69749137|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
38057572|NCT00804856|69749138|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
38057573|NCT00804856|69749139|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
38057574|NCT00804856|69749140|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
38057575|NCT00804856|69749141|FG004|Overall Study|Dose Limiting Toxicity (DLT)|1|||
38057576|NCT00804856|69749142|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
38057577|NCT00804856|69749143|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
38057578|NCT00804856|69749144|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
38057579|NCT00804856|69749145|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
38057580|NCT00804856|69749146|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
38057581|NCT00804856|69749147|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
38057582|NCT00804856|69749148|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
38057583|NCT00804856|69749149|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
38057584|NCT00804856|69749150|FG013|Overall Study|Dose Limiting Toxicity (DLT)|0|||
38057585|NCT00804856|69749151|FG014|Overall Study|Dose Limiting Toxicity (DLT)|1|||
38057586|NCT00804856|69749137|FG000|Overall Study|Other Adverse Event|1|||
38057587|NCT00804856|69749138|FG001|Overall Study|Other Adverse Event|1|||
38057588|NCT00804856|69749139|FG002|Overall Study|Other Adverse Event|1|||
38057589|NCT00804856|69749140|FG003|Overall Study|Other Adverse Event|2|||
38057590|NCT00804856|69749141|FG004|Overall Study|Other Adverse Event|2|||
38057591|NCT00804856|69749142|FG005|Overall Study|Other Adverse Event|1|||
38057592|NCT00804856|69749143|FG006|Overall Study|Other Adverse Event|3|||
38057593|NCT00804856|69749144|FG007|Overall Study|Other Adverse Event|0|||
38057594|NCT00804856|69749145|FG008|Overall Study|Other Adverse Event|0|||
38057595|NCT00804856|69749146|FG009|Overall Study|Other Adverse Event|1|||
38057596|NCT00804856|69749147|FG010|Overall Study|Other Adverse Event|5|||
38057597|NCT00804856|69749148|FG011|Overall Study|Other Adverse Event|2|||
38057598|NCT00804856|69749149|FG012|Overall Study|Other Adverse Event|0|||
37965347|NCT00488631|69652417|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
37965348|NCT00488631|69652418|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
37965349|NCT00488631|69652419|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
37965350|NCT00488631|69652420|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
37965351|NCT00488631|69652421|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
37965352|NCT00488631|69652422|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
37965353|NCT00488631|69652423|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
37965354|NCT00488631|69652414|FG000|Double Blind Period (Week 0-54)|Other|6|||
37965355|NCT00488631|69652415|FG001|Double Blind Period (Week 0-54)|Other|12|||
37965356|NCT00488631|69652416|FG002|Double Blind Period (Week 0-54)|Other|10|||
37965357|NCT00488631|69652417|FG003|Double Blind Period (Week 0-54)|Other|11|||
37965358|NCT00488631|69652418|FG004|Double Blind Period (Week 0-54)|Other|14|||
37965359|NCT00488631|69652419|FG005|Double Blind Period (Week 0-54)|Other|34|||
37965360|NCT00488631|69652420|FG006|Double Blind Period (Week 0-54)|Other|0|||
38057599|NCT00804856|69749150|FG013|Overall Study|Other Adverse Event|6|||
38057600|NCT00804856|69749151|FG014|Overall Study|Other Adverse Event|13|||
38057601|NCT00804856|69749137|FG000|Overall Study|Non compliance with protocol|0|||
38057602|NCT00804856|69749138|FG001|Overall Study|Non compliance with protocol|0|||
38057603|NCT00804856|69749139|FG002|Overall Study|Non compliance with protocol|0|||
38057604|NCT00804856|69749140|FG003|Overall Study|Non compliance with protocol|0|||
38057605|NCT00804856|69749141|FG004|Overall Study|Non compliance with protocol|0|||
38057606|NCT00804856|69749142|FG005|Overall Study|Non compliance with protocol|0|||
38057607|NCT00804856|69749143|FG006|Overall Study|Non compliance with protocol|0|||
38057608|NCT00804856|69749144|FG007|Overall Study|Non compliance with protocol|0|||
38057609|NCT00804856|69749145|FG008|Overall Study|Non compliance with protocol|0|||
38057610|NCT00804856|69749146|FG009|Overall Study|Non compliance with protocol|0|||
38057611|NCT00804856|69749147|FG010|Overall Study|Non compliance with protocol|0|||
38057612|NCT00804856|69749148|FG011|Overall Study|Non compliance with protocol|0|||
38057613|NCT00804856|69749149|FG012|Overall Study|Non compliance with protocol|0|||
38057614|NCT00804856|69749150|FG013|Overall Study|Non compliance with protocol|2|||
38057615|NCT00804856|69749151|FG014|Overall Study|Non compliance with protocol|0|||
38057616|NCT00804856|69749137|FG000|Overall Study|Refused to continue medication|0|||
38057617|NCT00804856|69749138|FG001|Overall Study|Refused to continue medication|0|||
38057618|NCT00804856|69749139|FG002|Overall Study|Refused to continue medication|0|||
38057619|NCT00804856|69749140|FG003|Overall Study|Refused to continue medication|1|||
38057620|NCT00804856|69749141|FG004|Overall Study|Refused to continue medication|1|||
38057621|NCT00804856|69749142|FG005|Overall Study|Refused to continue medication|0|||
38057622|NCT00804856|69749143|FG006|Overall Study|Refused to continue medication|0|||
38057623|NCT00804856|69749144|FG007|Overall Study|Refused to continue medication|0|||
38057624|NCT00804856|69749145|FG008|Overall Study|Refused to continue medication|0|||
38057625|NCT00804856|69749146|FG009|Overall Study|Refused to continue medication|0|||
38057626|NCT00804856|69749147|FG010|Overall Study|Refused to continue medication|3|||
38057627|NCT00804856|69749148|FG011|Overall Study|Refused to continue medication|0|||
38057628|NCT00804856|69749149|FG012|Overall Study|Refused to continue medication|1|||
38057629|NCT00804856|69749150|FG013|Overall Study|Refused to continue medication|1|||
38057630|NCT00804856|69749151|FG014|Overall Study|Refused to continue medication|5|||
38057631|NCT00804856|69749137|FG000|Overall Study|Other reason than listed above|0|||
38057632|NCT00804856|69749138|FG001|Overall Study|Other reason than listed above|0|||
38057633|NCT00804856|69749139|FG002|Overall Study|Other reason than listed above|0|||
38057634|NCT00804856|69749140|FG003|Overall Study|Other reason than listed above|0|||
38057635|NCT00804856|69749141|FG004|Overall Study|Other reason than listed above|0|||
38057636|NCT00804856|69749142|FG005|Overall Study|Other reason than listed above|1|||
38057637|NCT00804856|69749143|FG006|Overall Study|Other reason than listed above|0|||
38057638|NCT00804856|69749144|FG007|Overall Study|Other reason than listed above|0|||
38057639|NCT00804856|69749145|FG008|Overall Study|Other reason than listed above|1|||
38057640|NCT00804856|69749146|FG009|Overall Study|Other reason than listed above|0|||
38057641|NCT00804856|69749147|FG010|Overall Study|Other reason than listed above|3|||
38057642|NCT00804856|69749148|FG011|Overall Study|Other reason than listed above|1|||
38057643|NCT00804856|69749149|FG012|Overall Study|Other reason than listed above|1|||
38057644|NCT00804856|69749150|FG013|Overall Study|Other reason than listed above|10|||
38057645|NCT00804856|69749151|FG014|Overall Study|Other reason than listed above|3|||
38057646|NCT01314872|69749239|FG000|Treatment Period 1|Protocol Violation|2|||
38057647|NCT01314872|69749240|FG001|Treatment Period 1|Protocol Violation|1|||
38057648|NCT01314872|69749241|FG002|Treatment Period 1|Protocol Violation|1|||
38057649|NCT01314872|69749242|FG003|Treatment Period 1|Protocol Violation|0|||
38057650|NCT01314872|69749243|FG004|Treatment Period 1|Protocol Violation|1|||
38057651|NCT01314872|69749244|FG005|Treatment Period 1|Protocol Violation|0|||
38057652|NCT01314872|69749245|FG006|Treatment Period 1|Protocol Violation|0|||
38057653|NCT01314872|69749246|FG007|Treatment Period 1|Protocol Violation|0|||
38057654|NCT01314872|69749247|FG008|Treatment Period 1|Protocol Violation|0|||
38057655|NCT01314872|69749248|FG009|Treatment Period 1|Protocol Violation|1|||
38057656|NCT01314872|69749249|FG010|Treatment Period 1|Protocol Violation|1|||
38057657|NCT01314872|69749250|FG011|Treatment Period 1|Protocol Violation|0|||
38057658|NCT01314872|69749251|FG012|Treatment Period 1|Protocol Violation|0|||
38057659|NCT01314872|69749252|FG013|Treatment Period 1|Protocol Violation|0|||
38057660|NCT01314872|69749253|FG014|Treatment Period 1|Protocol Violation|0|||
38057661|NCT01314872|69749239|FG000|Treatment Period 1|Physician Decision|0|||
38057662|NCT01314872|69749240|FG001|Treatment Period 1|Physician Decision|1|||
38057663|NCT01314872|69749241|FG002|Treatment Period 1|Physician Decision|0|||
38057664|NCT01314872|69749242|FG003|Treatment Period 1|Physician Decision|1|||
38057665|NCT01314872|69749243|FG004|Treatment Period 1|Physician Decision|0|||
38057666|NCT01314872|69749244|FG005|Treatment Period 1|Physician Decision|0|||
38057667|NCT01314872|69749245|FG006|Treatment Period 1|Physician Decision|0|||
38057668|NCT01314872|69749246|FG007|Treatment Period 1|Physician Decision|0|||
38057669|NCT01314872|69749247|FG008|Treatment Period 1|Physician Decision|0|||
38057670|NCT01314872|69749248|FG009|Treatment Period 1|Physician Decision|1|||
38057671|NCT01314872|69749249|FG010|Treatment Period 1|Physician Decision|0|||
38057672|NCT01314872|69749250|FG011|Treatment Period 1|Physician Decision|0|||
38057673|NCT01314872|69749251|FG012|Treatment Period 1|Physician Decision|0|||
38057674|NCT01314872|69749252|FG013|Treatment Period 1|Physician Decision|0|||
38057675|NCT01314872|69749253|FG014|Treatment Period 1|Physician Decision|0|||
38057676|NCT01314872|69749239|FG000|Treatment Period 1|Lack of Efficacy|1|||
38057677|NCT01314872|69749240|FG001|Treatment Period 1|Lack of Efficacy|0|||
38057678|NCT01314872|69749241|FG002|Treatment Period 1|Lack of Efficacy|0|||
38057679|NCT01314872|69749242|FG003|Treatment Period 1|Lack of Efficacy|0|||
38057680|NCT01314872|69749243|FG004|Treatment Period 1|Lack of Efficacy|0|||
38057681|NCT01314872|69749244|FG005|Treatment Period 1|Lack of Efficacy|1|||
38057682|NCT01314872|69749245|FG006|Treatment Period 1|Lack of Efficacy|0|||
38057683|NCT01314872|69749246|FG007|Treatment Period 1|Lack of Efficacy|2|||
38057684|NCT01314872|69749247|FG008|Treatment Period 1|Lack of Efficacy|0|||
38057685|NCT01314872|69749248|FG009|Treatment Period 1|Lack of Efficacy|0|||
38057686|NCT01314872|69749249|FG010|Treatment Period 1|Lack of Efficacy|0|||
38057687|NCT01314872|69749250|FG011|Treatment Period 1|Lack of Efficacy|0|||
38057688|NCT01314872|69749251|FG012|Treatment Period 1|Lack of Efficacy|0|||
38057689|NCT01314872|69749252|FG013|Treatment Period 1|Lack of Efficacy|0|||
38057690|NCT01314872|69749253|FG014|Treatment Period 1|Lack of Efficacy|0|||
38057691|NCT01314872|69749239|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
38057692|NCT01314872|69749240|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
38057693|NCT01314872|69749241|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
38057694|NCT01314872|69749242|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
38057695|NCT01314872|69749243|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
38057696|NCT01314872|69749244|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
38057697|NCT01314872|69749245|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
38057698|NCT01314872|69749246|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
38057699|NCT01314872|69749247|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
38057700|NCT01314872|69749248|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
38057701|NCT01314872|69749249|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
38057702|NCT01314872|69749250|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
38057703|NCT01314872|69749251|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
38057704|NCT01314872|69749252|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
38057705|NCT01314872|69749253|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
38057706|NCT01314872|69749239|FG000|Treatment Period 1|Withdrawal by Subject|3|||
38057707|NCT01314872|69749240|FG001|Treatment Period 1|Withdrawal by Subject|1|||
38057708|NCT01314872|69749241|FG002|Treatment Period 1|Withdrawal by Subject|0|||
38057709|NCT01314872|69749242|FG003|Treatment Period 1|Withdrawal by Subject|2|||
38057710|NCT01314872|69749243|FG004|Treatment Period 1|Withdrawal by Subject|3|||
38057711|NCT01314872|69749244|FG005|Treatment Period 1|Withdrawal by Subject|1|||
38057712|NCT01314872|69749245|FG006|Treatment Period 1|Withdrawal by Subject|3|||
38057713|NCT01314872|69749246|FG007|Treatment Period 1|Withdrawal by Subject|2|||
38057714|NCT01314872|69749247|FG008|Treatment Period 1|Withdrawal by Subject|2|||
38057715|NCT01314872|69749248|FG009|Treatment Period 1|Withdrawal by Subject|2|||
38057716|NCT01314872|69749249|FG010|Treatment Period 1|Withdrawal by Subject|1|||
38057717|NCT01314872|69749250|FG011|Treatment Period 1|Withdrawal by Subject|0|||
38057718|NCT01314872|69749251|FG012|Treatment Period 1|Withdrawal by Subject|0|||
38057719|NCT01314872|69749252|FG013|Treatment Period 1|Withdrawal by Subject|0|||
38057720|NCT01314872|69749253|FG014|Treatment Period 1|Withdrawal by Subject|0|||
38057721|NCT01314872|69749239|FG000|Treatment Period 1|Lost to Follow-up|0|||
38057722|NCT01314872|69749240|FG001|Treatment Period 1|Lost to Follow-up|1|||
38057723|NCT01314872|69749241|FG002|Treatment Period 1|Lost to Follow-up|2|||
38057724|NCT01314872|69749242|FG003|Treatment Period 1|Lost to Follow-up|2|||
38057725|NCT01314872|69749243|FG004|Treatment Period 1|Lost to Follow-up|1|||
38057726|NCT01314872|69749244|FG005|Treatment Period 1|Lost to Follow-up|1|||
38057727|NCT01314872|69749245|FG006|Treatment Period 1|Lost to Follow-up|1|||
38057728|NCT01314872|69749246|FG007|Treatment Period 1|Lost to Follow-up|1|||
38057729|NCT01314872|69749247|FG008|Treatment Period 1|Lost to Follow-up|1|||
38057730|NCT01314872|69749248|FG009|Treatment Period 1|Lost to Follow-up|0|||
38057731|NCT01314872|69749249|FG010|Treatment Period 1|Lost to Follow-up|0|||
38057732|NCT01314872|69749250|FG011|Treatment Period 1|Lost to Follow-up|0|||
38057733|NCT01314872|69749251|FG012|Treatment Period 1|Lost to Follow-up|0|||
38057734|NCT01314872|69749252|FG013|Treatment Period 1|Lost to Follow-up|0|||
38057735|NCT01314872|69749253|FG014|Treatment Period 1|Lost to Follow-up|0|||
38057736|NCT01314872|69749239|FG000|Period 2|Protocol Violation|0|||
38057737|NCT01314872|69749240|FG001|Period 2|Protocol Violation|0|||
38057738|NCT01314872|69749241|FG002|Period 2|Protocol Violation|0|||
38057739|NCT01314872|69749242|FG003|Period 2|Protocol Violation|0|||
38057740|NCT01314872|69749243|FG004|Period 2|Protocol Violation|0|||
38057741|NCT01314872|69749244|FG005|Period 2|Protocol Violation|0|||
38057742|NCT01314872|69749245|FG006|Period 2|Protocol Violation|0|||
38057743|NCT01314872|69749246|FG007|Period 2|Protocol Violation|0|||
38057744|NCT01314872|69749247|FG008|Period 2|Protocol Violation|0|||
38057745|NCT01314872|69749248|FG009|Period 2|Protocol Violation|0|||
38057746|NCT01314872|69749249|FG010|Period 2|Protocol Violation|0|||
38057747|NCT01314872|69749250|FG011|Period 2|Protocol Violation|3|||
38057748|NCT01314872|69749251|FG012|Period 2|Protocol Violation|3|||
38057749|NCT01314872|69749252|FG013|Period 2|Protocol Violation|2|||
38057750|NCT01314872|69749253|FG014|Period 2|Protocol Violation|0|||
38057751|NCT01314872|69749239|FG000|Period 2|Non-compliance with study drug|0|||
38057752|NCT01314872|69749240|FG001|Period 2|Non-compliance with study drug|0|||
38057753|NCT01314872|69749241|FG002|Period 2|Non-compliance with study drug|0|||
38057754|NCT01314872|69749242|FG003|Period 2|Non-compliance with study drug|0|||
38057755|NCT01314872|69749243|FG004|Period 2|Non-compliance with study drug|0|||
38057756|NCT01314872|69749244|FG005|Period 2|Non-compliance with study drug|0|||
38057757|NCT01314872|69749245|FG006|Period 2|Non-compliance with study drug|0|||
38057758|NCT01314872|69749246|FG007|Period 2|Non-compliance with study drug|0|||
38057759|NCT01314872|69749247|FG008|Period 2|Non-compliance with study drug|0|||
38057760|NCT01314872|69749248|FG009|Period 2|Non-compliance with study drug|0|||
38057761|NCT01314872|69749249|FG010|Period 2|Non-compliance with study drug|0|||
38057762|NCT01314872|69749250|FG011|Period 2|Non-compliance with study drug|3|||
38057763|NCT01314872|69749251|FG012|Period 2|Non-compliance with study drug|3|||
38057764|NCT01314872|69749252|FG013|Period 2|Non-compliance with study drug|1|||
38057765|NCT01314872|69749253|FG014|Period 2|Non-compliance with study drug|2|||
38057766|NCT01314872|69749239|FG000|Period 2|Lack of Efficacy|0|||
38057767|NCT01314872|69749240|FG001|Period 2|Lack of Efficacy|0|||
38057768|NCT01314872|69749241|FG002|Period 2|Lack of Efficacy|0|||
38057769|NCT01314872|69749242|FG003|Period 2|Lack of Efficacy|0|||
38057770|NCT01314872|69749243|FG004|Period 2|Lack of Efficacy|0|||
38057771|NCT01314872|69749244|FG005|Period 2|Lack of Efficacy|0|||
38057772|NCT01314872|69749245|FG006|Period 2|Lack of Efficacy|0|||
38057773|NCT01314872|69749246|FG007|Period 2|Lack of Efficacy|0|||
38057774|NCT01314872|69749247|FG008|Period 2|Lack of Efficacy|0|||
38057775|NCT01314872|69749248|FG009|Period 2|Lack of Efficacy|0|||
38057776|NCT01314872|69749249|FG010|Period 2|Lack of Efficacy|0|||
38057777|NCT01314872|69749250|FG011|Period 2|Lack of Efficacy|7|||
38057778|NCT01314872|69749251|FG012|Period 2|Lack of Efficacy|12|||
38057779|NCT01314872|69749252|FG013|Period 2|Lack of Efficacy|9|||
38057780|NCT01314872|69749253|FG014|Period 2|Lack of Efficacy|2|||
38057781|NCT01314872|69749239|FG000|Period 2|Pregnancy|0|||
38057782|NCT01314872|69749240|FG001|Period 2|Pregnancy|0|||
38057783|NCT01314872|69749241|FG002|Period 2|Pregnancy|0|||
38057784|NCT01314872|69749242|FG003|Period 2|Pregnancy|0|||
38057785|NCT01314872|69749243|FG004|Period 2|Pregnancy|0|||
38057786|NCT01314872|69749244|FG005|Period 2|Pregnancy|0|||
38057787|NCT01314872|69749245|FG006|Period 2|Pregnancy|0|||
37965361|NCT00488631|69652421|FG007|Double Blind Period (Week 0-54)|Other|0|||
37965362|NCT00488631|69652422|FG008|Double Blind Period (Week 0-54)|Other|0|||
37965363|NCT00488631|69652423|FG009|Double Blind Period (Week 0-54)|Other|0|||
37965364|NCT00488631|69652414|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
37965365|NCT00488631|69652415|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
37965366|NCT00488631|69652416|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
37965367|NCT00488631|69652417|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
37965368|NCT00488631|69652418|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
37965369|NCT00488631|69652419|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
37965370|NCT00488631|69652420|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
38057788|NCT01314872|69749246|FG007|Period 2|Pregnancy|0|||
38057789|NCT01314872|69749247|FG008|Period 2|Pregnancy|0|||
38057790|NCT01314872|69749248|FG009|Period 2|Pregnancy|0|||
38057791|NCT01314872|69749249|FG010|Period 2|Pregnancy|0|||
38057792|NCT01314872|69749250|FG011|Period 2|Pregnancy|0|||
38057793|NCT01314872|69749251|FG012|Period 2|Pregnancy|0|||
38057794|NCT01314872|69749252|FG013|Period 2|Pregnancy|0|||
38057795|NCT01314872|69749253|FG014|Period 2|Pregnancy|1|||
38057796|NCT01314872|69749239|FG000|Period 2|Study terminated by Sponsor|0|||
38057797|NCT01314872|69749240|FG001|Period 2|Study terminated by Sponsor|0|||
38057798|NCT01314872|69749241|FG002|Period 2|Study terminated by Sponsor|0|||
38057799|NCT01314872|69749242|FG003|Period 2|Study terminated by Sponsor|0|||
38057800|NCT01314872|69749243|FG004|Period 2|Study terminated by Sponsor|0|||
38057801|NCT01314872|69749244|FG005|Period 2|Study terminated by Sponsor|0|||
38057802|NCT01314872|69749245|FG006|Period 2|Study terminated by Sponsor|0|||
38057803|NCT01314872|69749246|FG007|Period 2|Study terminated by Sponsor|0|||
38057804|NCT01314872|69749247|FG008|Period 2|Study terminated by Sponsor|0|||
38057805|NCT01314872|69749248|FG009|Period 2|Study terminated by Sponsor|0|||
38057806|NCT01314872|69749249|FG010|Period 2|Study terminated by Sponsor|0|||
38057807|NCT01314872|69749250|FG011|Period 2|Study terminated by Sponsor|2|||
38057808|NCT01314872|69749251|FG012|Period 2|Study terminated by Sponsor|2|||
38057809|NCT01314872|69749252|FG013|Period 2|Study terminated by Sponsor|3|||
38057810|NCT01314872|69749253|FG014|Period 2|Study terminated by Sponsor|0|||
38057811|NCT01314872|69749239|FG000|Period 2|Adverse event, non-fatal|0|||
38057812|NCT01314872|69749240|FG001|Period 2|Adverse event, non-fatal|0|||
38057813|NCT01314872|69749241|FG002|Period 2|Adverse event, non-fatal|0|||
38057814|NCT01314872|69749242|FG003|Period 2|Adverse event, non-fatal|0|||
38057815|NCT01314872|69749243|FG004|Period 2|Adverse event, non-fatal|0|||
38057816|NCT01314872|69749244|FG005|Period 2|Adverse event, non-fatal|0|||
38057817|NCT01314872|69749245|FG006|Period 2|Adverse event, non-fatal|0|||
38057818|NCT01314872|69749246|FG007|Period 2|Adverse event, non-fatal|0|||
38057819|NCT01314872|69749247|FG008|Period 2|Adverse event, non-fatal|0|||
38057820|NCT01314872|69749248|FG009|Period 2|Adverse event, non-fatal|0|||
38057821|NCT01314872|69749249|FG010|Period 2|Adverse event, non-fatal|0|||
38057822|NCT01314872|69749250|FG011|Period 2|Adverse event, non-fatal|13|||
38057823|NCT01314872|69749251|FG012|Period 2|Adverse event, non-fatal|16|||
38057824|NCT01314872|69749252|FG013|Period 2|Adverse event, non-fatal|24|||
38057825|NCT01314872|69749253|FG014|Period 2|Adverse event, non-fatal|9|||
38057826|NCT01314872|69749239|FG000|Period 2|Withdrawal by Subject|0|||
38057827|NCT01314872|69749240|FG001|Period 2|Withdrawal by Subject|0|||
38057828|NCT01314872|69749241|FG002|Period 2|Withdrawal by Subject|0|||
38057829|NCT01314872|69749242|FG003|Period 2|Withdrawal by Subject|0|||
38057830|NCT01314872|69749243|FG004|Period 2|Withdrawal by Subject|0|||
38057831|NCT01314872|69749244|FG005|Period 2|Withdrawal by Subject|0|||
38057832|NCT01314872|69749245|FG006|Period 2|Withdrawal by Subject|0|||
38057833|NCT01314872|69749246|FG007|Period 2|Withdrawal by Subject|0|||
38057834|NCT01314872|69749247|FG008|Period 2|Withdrawal by Subject|0|||
38057835|NCT01314872|69749248|FG009|Period 2|Withdrawal by Subject|0|||
38057836|NCT01314872|69749249|FG010|Period 2|Withdrawal by Subject|0|||
38057837|NCT01314872|69749250|FG011|Period 2|Withdrawal by Subject|14|||
38057838|NCT01314872|69749251|FG012|Period 2|Withdrawal by Subject|17|||
38057839|NCT01314872|69749252|FG013|Period 2|Withdrawal by Subject|12|||
38057840|NCT01314872|69749253|FG014|Period 2|Withdrawal by Subject|4|||
38057841|NCT01314872|69749239|FG000|Period 2|Lost to Follow-up|0|||
38057842|NCT01314872|69749240|FG001|Period 2|Lost to Follow-up|0|||
38057843|NCT01314872|69749241|FG002|Period 2|Lost to Follow-up|0|||
38057844|NCT01314872|69749242|FG003|Period 2|Lost to Follow-up|0|||
38057845|NCT01314872|69749243|FG004|Period 2|Lost to Follow-up|0|||
38057846|NCT01314872|69749244|FG005|Period 2|Lost to Follow-up|0|||
38057847|NCT01314872|69749245|FG006|Period 2|Lost to Follow-up|0|||
38057848|NCT01314872|69749246|FG007|Period 2|Lost to Follow-up|0|||
38057849|NCT01314872|69749247|FG008|Period 2|Lost to Follow-up|0|||
38057850|NCT01314872|69749248|FG009|Period 2|Lost to Follow-up|0|||
38057851|NCT01314872|69749249|FG010|Period 2|Lost to Follow-up|0|||
38057852|NCT01314872|69749250|FG011|Period 2|Lost to Follow-up|6|||
38057853|NCT01314872|69749251|FG012|Period 2|Lost to Follow-up|7|||
38057854|NCT01314872|69749252|FG013|Period 2|Lost to Follow-up|2|||
38057855|NCT01314872|69749253|FG014|Period 2|Lost to Follow-up|6|||
38057856|NCT00703924|69749287|FG000|Overall Study|Withdrawal by Subject|1|||
38057857|NCT00703924|69749288|FG001|Overall Study|Withdrawal by Subject|1|||
38057858|NCT03152526|69749300|FG000|Overall Study|Withdrawal by Subject|0|||
38057859|NCT03152526|69749301|FG001|Overall Study|Withdrawal by Subject|1|||
38057860|NCT03149328|69749309|FG000|Overall Study|Withdrawal by Subject|30|||
38057861|NCT03149328|69749310|FG001|Overall Study|Withdrawal by Subject|26|||
38057862|NCT03149328|69749309|FG000|Overall Study|Changed Dialysis Modality|18|||
38057863|NCT03149328|69749310|FG001|Overall Study|Changed Dialysis Modality|1|||
38057864|NCT03149328|69749309|FG000|Overall Study|Transplant|9|||
38057865|NCT03149328|69749310|FG001|Overall Study|Transplant|1|||
38057866|NCT03149328|69749309|FG000|Overall Study|Lost to Follow-up|25|||
38057867|NCT03149328|69749310|FG001|Overall Study|Lost to Follow-up|16|||
38057868|NCT03149328|69749309|FG000|Overall Study|Left Study Site|1|||
38057869|NCT03149328|69749310|FG001|Overall Study|Left Study Site|2|||
37965371|NCT00488631|69652421|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
37965372|NCT00488631|69652422|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
37965373|NCT00488631|69652423|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
37965374|NCT00488631|69652414|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
37965375|NCT00488631|69652415|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
37965376|NCT00488631|69652416|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
37965377|NCT00488631|69652417|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
37965378|NCT00488631|69652418|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
37965379|NCT00488631|69652419|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
37965380|NCT00488631|69652420|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
37965381|NCT00488631|69652421|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
37965382|NCT00488631|69652422|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
37965383|NCT00488631|69652423|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
37965384|NCT00488631|69652414|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
37965385|NCT00488631|69652415|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
37965386|NCT00488631|69652416|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
38057870|NCT03149328|69749309|FG000|Overall Study|Language Barrier|1|||
38057871|NCT03149328|69749310|FG001|Overall Study|Language Barrier|0|||
38057872|NCT04296942|69749359|FG000|Overall Study|Study closure by sponsor|1|||
38057873|NCT04296942|69749360|FG001|Overall Study|Study closure by sponsor|0|||
38057874|NCT04296942|69749361|FG002|Overall Study|Study closure by sponsor|0|||
38057875|NCT01315028|69749417|FG000|Overall Study|Lost to Follow-up|1|||
38057876|NCT01315028|69749418|FG001|Overall Study|Lost to Follow-up|0|||
38057877|NCT01315028|69749417|FG000|Overall Study|Death|0|||
38057878|NCT01315028|69749418|FG001|Overall Study|Death|1|||
38057879|NCT02720536|69749424|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
38057880|NCT02720536|69749424|FG000|Overall Study|PR - pregnancy|2|||
38057881|NCT02720536|69749424|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
38057882|NCT02720536|69749424|FG000|Overall Study|PR - death|1|||
38057883|NCT02720536|69749424|FG000|Overall Study|PR - adverse event|1|||
38057884|NCT02720536|69749424|FG000|Overall Study|PR - abnormal lab value(s)|1|||
38057885|NCT02720536|69749424|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
38057886|NCT03168438|69749436|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
38057887|NCT03168438|69749437|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
38057888|NCT03137784|69749444|FG000|Overall Study|Adverse Event|1|||
38057889|NCT03137784|69749445|FG001|Overall Study|Adverse Event|1|||
38057890|NCT03137784|69749446|FG002|Overall Study|Adverse Event|0|||
38057891|NCT03137784|69749447|FG003|Overall Study|Adverse Event|0|||
38057892|NCT03137784|69749448|FG004|Overall Study|Adverse Event|0|||
38057893|NCT03137784|69749449|FG005|Overall Study|Adverse Event|0|||
38057894|NCT03137784|69749444|FG000|Overall Study|Subject/guardian decision|1|||
38057895|NCT03137784|69749445|FG001|Overall Study|Subject/guardian decision|0|||
38057896|NCT03137784|69749446|FG002|Overall Study|Subject/guardian decision|0|||
38057897|NCT03137784|69749447|FG003|Overall Study|Subject/guardian decision|0|||
38057898|NCT03137784|69749448|FG004|Overall Study|Subject/guardian decision|0|||
38057899|NCT03137784|69749449|FG005|Overall Study|Subject/guardian decision|0|||
38057900|NCT03137784|69749444|FG000|Overall Study|Non-compliance with study treatment|0|||
38057901|NCT03137784|69749445|FG001|Overall Study|Non-compliance with study treatment|0|||
38057902|NCT03137784|69749446|FG002|Overall Study|Non-compliance with study treatment|0|||
38057903|NCT03137784|69749447|FG003|Overall Study|Non-compliance with study treatment|0|||
38057904|NCT03137784|69749448|FG004|Overall Study|Non-compliance with study treatment|1|||
38057905|NCT03137784|69749449|FG005|Overall Study|Non-compliance with study treatment|0|||
38057906|NCT01314716|69749459|FG000|Double-Blind Phase|Randomized but not treated|1|||
38057907|NCT01314716|69749460|FG001|Double-Blind Phase|Randomized but not treated|1|||
38057908|NCT01314716|69749459|FG000|Double-Blind Phase|Adverse Event|10|||
38057909|NCT01314716|69749460|FG001|Double-Blind Phase|Adverse Event|4|||
38057910|NCT01314716|69749459|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
38057911|NCT01314716|69749460|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
38057912|NCT01314716|69749459|FG000|Double-Blind Phase|Lost to Follow-up|0|||
38057913|NCT01314716|69749460|FG001|Double-Blind Phase|Lost to Follow-up|1|||
38057914|NCT01314716|69749459|FG000|Double-Blind Phase|Sponsor request|1|||
38057915|NCT01314716|69749460|FG001|Double-Blind Phase|Sponsor request|2|||
38057916|NCT01314716|69749459|FG000|Double-Blind Phase|Physician Decision|0|||
38057917|NCT01314716|69749460|FG001|Double-Blind Phase|Physician Decision|1|||
38057918|NCT01314716|69749459|FG000|Open-Label Phase|Adverse Event|4|||
38057919|NCT01314716|69749460|FG001|Open-Label Phase|Adverse Event|6|||
38057920|NCT01314716|69749459|FG000|Open-Label Phase|Withdrawal by Subject|1|||
38057921|NCT01314716|69749460|FG001|Open-Label Phase|Withdrawal by Subject|2|||
38057922|NCT01314716|69749459|FG000|Open-Label Phase|Physician Decision|5|||
38057923|NCT01314716|69749460|FG001|Open-Label Phase|Physician Decision|4|||
38057924|NCT03144180|69749470|FG000|Overall Study|STAT Delivery|1|||
38057925|NCT03144180|69749471|FG001|Overall Study|STAT Delivery|1|||
38057926|NCT03144180|69749470|FG000|Overall Study|Provider forgot to fill out forms|1|||
38057927|NCT03144180|69749471|FG001|Overall Study|Provider forgot to fill out forms|3|||
38057928|NCT03144180|69749470|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
38057929|NCT03144180|69749471|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
38057930|NCT03144180|69749470|FG000|Overall Study|Scrub tech removed tube cap|0|||
38057931|NCT03144180|69749471|FG001|Overall Study|Scrub tech removed tube cap|1|||
38057932|NCT01465334|69749481|FG000|Overall Study|Disease Progression|1|||
38057933|NCT01465334|69749482|FG001|Overall Study|Disease Progression|0|||
38057934|NCT01465334|69749481|FG000|Overall Study|Adverse Event|1|||
38057935|NCT01465334|69749482|FG001|Overall Study|Adverse Event|0|||
38057936|NCT01465334|69749481|FG000|Overall Study|Richter's transformation|0|||
38057937|NCT01465334|69749482|FG001|Overall Study|Richter's transformation|3|||
38057938|NCT01465334|69749481|FG000|Overall Study|Refractory Disease|0|||
38057939|NCT01465334|69749482|FG001|Overall Study|Refractory Disease|3|||
38057940|NCT00702208|69749488|FG000|Overall Study|Lost to Follow-up|28|||
38057941|NCT00702208|69749488|FG000|Overall Study|Did not self-lavage|1|||
38057942|NCT00702208|69749488|FG000|Overall Study|Unsatisfactory colposcopy|2|||
38057943|NCT02718898|69749505|FG000|Blinded Treatment Period|Adverse Event|5|||
38057944|NCT02718898|69749506|FG001|Blinded Treatment Period|Adverse Event|1|||
38057945|NCT02718898|69749507|FG002|Blinded Treatment Period|Adverse Event|0|||
38057946|NCT02718898|69749508|FG003|Blinded Treatment Period|Adverse Event|0|||
38057947|NCT02718898|69749509|FG004|Blinded Treatment Period|Adverse Event|0|||
38057948|NCT02718898|69749510|FG005|Blinded Treatment Period|Adverse Event|0|||
38057949|NCT02718898|69749511|FG006|Blinded Treatment Period|Adverse Event|0|||
38057950|NCT02718898|69749505|FG000|Blinded Treatment Period|Physician Decision|1|||
38057951|NCT02718898|69749506|FG001|Blinded Treatment Period|Physician Decision|0|||
38057952|NCT02718898|69749507|FG002|Blinded Treatment Period|Physician Decision|0|||
38057953|NCT02718898|69749508|FG003|Blinded Treatment Period|Physician Decision|0|||
38057954|NCT02718898|69749509|FG004|Blinded Treatment Period|Physician Decision|0|||
38057955|NCT02718898|69749510|FG005|Blinded Treatment Period|Physician Decision|0|||
38057956|NCT02718898|69749511|FG006|Blinded Treatment Period|Physician Decision|0|||
38057957|NCT02718898|69749505|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
38057958|NCT02718898|69749506|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
38057959|NCT02718898|69749507|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
38057960|NCT02718898|69749508|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
38057961|NCT02718898|69749509|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
38057962|NCT02718898|69749510|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
38057963|NCT02718898|69749511|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
38057964|NCT02718898|69749505|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
38057965|NCT02718898|69749506|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
38057966|NCT02718898|69749507|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
38057967|NCT02718898|69749508|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
38057968|NCT02718898|69749509|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
38057969|NCT02718898|69749510|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
38057970|NCT02718898|69749511|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
38057971|NCT02718898|69749505|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
38057972|NCT02718898|69749506|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
38057973|NCT02718898|69749507|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
38057974|NCT02718898|69749508|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
38057975|NCT02718898|69749509|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
38057976|NCT02718898|69749510|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
38057977|NCT02718898|69749511|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
38057978|NCT02718898|69749505|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
38057979|NCT02718898|69749506|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
38057980|NCT02718898|69749507|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
38057981|NCT02718898|69749508|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
38057982|NCT02718898|69749509|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
38057983|NCT02718898|69749510|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
38057984|NCT02718898|69749511|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
38057985|NCT02718898|69749505|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
38057986|NCT02718898|69749506|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
38057987|NCT02718898|69749507|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
38057988|NCT02718898|69749508|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
38057989|NCT02718898|69749509|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
38057990|NCT02718898|69749510|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
38057991|NCT02718898|69749511|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
38057992|NCT02718898|69749505|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
38057993|NCT02718898|69749506|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
38057994|NCT02718898|69749507|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
38057995|NCT02718898|69749508|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
38057996|NCT02718898|69749509|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
38057997|NCT02718898|69749510|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
38057998|NCT02718898|69749511|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
38057999|NCT02718898|69749505|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
38058000|NCT02718898|69749506|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
38058001|NCT02718898|69749507|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
38058002|NCT02718898|69749508|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
37965387|NCT00488631|69652417|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
37965388|NCT00488631|69652418|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
37965389|NCT00488631|69652419|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
37965390|NCT00488631|69652420|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
37965391|NCT00488631|69652421|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
37965392|NCT00488631|69652422|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
37965393|NCT00488631|69652423|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
38058003|NCT02718898|69749509|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
38058004|NCT02718898|69749510|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
38058005|NCT02718898|69749511|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
38058006|NCT02718898|69749505|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
37965394|NCT00488631|69652414|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
37965395|NCT00488631|69652415|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
37965396|NCT00488631|69652416|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
38058007|NCT02718898|69749506|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
38058008|NCT02718898|69749507|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
38058009|NCT02718898|69749508|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
38058010|NCT02718898|69749509|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
38058011|NCT02718898|69749510|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
38058012|NCT02718898|69749511|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
38058013|NCT02718898|69749505|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
38058014|NCT02718898|69749506|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
38058015|NCT02718898|69749507|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
38058016|NCT02718898|69749508|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
38058017|NCT02718898|69749509|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
38058018|NCT02718898|69749510|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
38058019|NCT02718898|69749511|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
38058020|NCT02718898|69749505|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
38058021|NCT02718898|69749506|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
38058022|NCT02718898|69749507|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
38058023|NCT02718898|69749508|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
38058024|NCT02718898|69749509|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
38058025|NCT02718898|69749510|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
38058026|NCT02718898|69749511|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
38058027|NCT02718898|69749505|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
38058028|NCT02718898|69749506|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
38058029|NCT02718898|69749507|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
38058030|NCT02718898|69749508|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
38058031|NCT02718898|69749509|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
38058032|NCT02718898|69749510|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
38058033|NCT02718898|69749511|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
38058034|NCT03143166|69749528|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
38058035|NCT02879994|69749534|FG000|Overall Study|off treatment early|7|||
38058036|NCT02879994|69749534|FG000|Overall Study|Adverse Event|2|||
38058037|NCT02879994|69749534|FG000|Overall Study|Death|2|||
38058038|NCT03142932|69749540|FG000|Overall Study|Lost to Follow-up|2|||
38058039|NCT03142932|69749541|FG001|Overall Study|Lost to Follow-up|11|||
38058040|NCT00702052|69749547|FG000|Overall Study|Adverse Event|23|||
38058041|NCT00702052|69749547|FG000|Overall Study|Disease Progression|30|||
38058042|NCT00702052|69749547|FG000|Overall Study|Withdrawal by Subject|5|||
38058043|NCT03140280|69749551|FG000|Overall Study|Physician Decision|5|||
38058044|NCT03136380|69749557|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
38058045|NCT03136380|69749558|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
38058046|NCT03136380|69749559|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
38058047|NCT03136380|69749560|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
38058048|NCT03136380|69749561|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
38058049|NCT03136068|69749581|FG000|Overall Study|Lost to Follow-up|1|||
38058050|NCT03136068|69749582|FG001|Overall Study|Lost to Follow-up|1|||
38058051|NCT03136068|69749581|FG000|Overall Study|Protocol Violation|1|||
38058052|NCT03136068|69749582|FG001|Overall Study|Protocol Violation|0|||
38058053|NCT02585232|69749590|FG000|Overall Study|Lost to Follow-up|8|||
38058054|NCT02585232|69749591|FG001|Overall Study|Lost to Follow-up|8|||
38058055|NCT02585232|69749590|FG000|Overall Study|Withdrawal by Subject|4|||
38058056|NCT02585232|69749591|FG001|Overall Study|Withdrawal by Subject|8|||
38058057|NCT03377790|69749620|FG000|Overall Study|Withdrawal by Subject|1|||
38058058|NCT03377790|69749621|FG001|Overall Study|Withdrawal by Subject|0|||
38058059|NCT03377790|69749620|FG000|Overall Study|Adverse Event|1|||
38058060|NCT03377790|69749621|FG001|Overall Study|Adverse Event|0|||
38058061|NCT03377790|69749620|FG000|Overall Study|Lost to Follow-up|0|||
38058062|NCT03377790|69749621|FG001|Overall Study|Lost to Follow-up|2|||
38058063|NCT03377790|69749620|FG000|Overall Study|Randomized but not treated|1|||
37965397|NCT00488631|69652417|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
37965398|NCT00488631|69652418|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
37965399|NCT00488631|69652419|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
37965400|NCT00488631|69652420|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
37965401|NCT00488631|69652421|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
37965402|NCT00488631|69652422|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
37965403|NCT00488631|69652423|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
37965404|NCT00488631|69652414|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
38058064|NCT03377790|69749621|FG001|Overall Study|Randomized but not treated|0|||
38058065|NCT03377790|69749620|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
38058066|NCT03377790|69749621|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
38058067|NCT02717494|69749630|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
38058068|NCT02717494|69749631|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
38058069|NCT02717494|69749632|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
38058070|NCT02717494|69749630|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
38058071|NCT02717494|69749631|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
38058072|NCT02717494|69749632|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
38058073|NCT02717494|69749630|FG000|First Intervention (Step 1)|Death|0|||
38058074|NCT02717494|69749631|FG001|First Intervention (Step 1)|Death|0|||
38058075|NCT02717494|69749632|FG002|First Intervention (Step 1)|Death|1|||
38058076|NCT02717494|69749630|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
38058077|NCT02717494|69749631|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
38058078|NCT02717494|69749632|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
38058079|NCT01844856|69749660|FG000|Overall Study|Lost to Follow-up|15|||
38058080|NCT01844856|69749661|FG001|Overall Study|Lost to Follow-up|3|||
38058081|NCT01844856|69749660|FG000|Overall Study|Adverse Event|3|||
38058082|NCT01844856|69749661|FG001|Overall Study|Adverse Event|6|||
38058083|NCT01844856|69749660|FG000|Overall Study|Withdrawal by Subject|3|||
38058084|NCT01844856|69749661|FG001|Overall Study|Withdrawal by Subject|2|||
38058085|NCT01844856|69749660|FG000|Overall Study|Noncompliance|2|||
38058086|NCT01844856|69749661|FG001|Overall Study|Noncompliance|3|||
38058087|NCT01844856|69749660|FG000|Overall Study|Enterococcus Resistant|0|||
38058088|NCT01844856|69749661|FG001|Overall Study|Enterococcus Resistant|1|||
38058089|NCT01844856|69749660|FG000|Overall Study|Inadvertently Not Scheduled|1|||
38058090|NCT01844856|69749661|FG001|Overall Study|Inadvertently Not Scheduled|0|||
38058091|NCT01844856|69749660|FG000|Overall Study|Randomized but was a Screen Failure|0|||
38058092|NCT01844856|69749661|FG001|Overall Study|Randomized but was a Screen Failure|1|||
38058093|NCT03135210|69749697|FG000|Overall Study|Death|0|||
38058094|NCT03135210|69749698|FG001|Overall Study|Death|1|||
38058095|NCT00701662|69749704|FG000|Overall Study|Lack of Efficacy|1|||
38058096|NCT02878590|69749708|FG000|Overall Study|Withdrawal by Subject|2|||
38058097|NCT04634409|69749739|FG000|Overall Study|Death|0|||
38058098|NCT04634409|69749740|FG001|Overall Study|Death|0|||
38058099|NCT04634409|69749741|FG002|Overall Study|Death|0|||
38058100|NCT04634409|69749742|FG003|Overall Study|Death|0|||
38058101|NCT04634409|69749743|FG004|Overall Study|Death|0|||
38058102|NCT04634409|69749744|FG005|Overall Study|Death|0|||
38058103|NCT04634409|69749745|FG006|Overall Study|Death|0|||
38058104|NCT04634409|69749746|FG007|Overall Study|Death|0|||
38058105|NCT04634409|69749747|FG008|Overall Study|Death|0|||
38058106|NCT04634409|69749748|FG009|Overall Study|Death|0|||
38058107|NCT04634409|69749749|FG010|Overall Study|Death|1|||
38058108|NCT04634409|69749750|FG011|Overall Study|Death|0|||
38058109|NCT04634409|69749751|FG012|Overall Study|Death|1|||
38058110|NCT04634409|69749752|FG013|Overall Study|Death|0|||
38058111|NCT04634409|69749753|FG014|Overall Study|Death|0|||
38058112|NCT04634409|69749754|FG015|Overall Study|Death|0|||
38058113|NCT04634409|69749755|FG016|Overall Study|Death|0|||
38058114|NCT04634409|69749756|FG017|Overall Study|Death|0|||
38058115|NCT04634409|69749757|FG018|Overall Study|Death|0|||
38058116|NCT04634409|69749758|FG019|Overall Study|Death|0|||
38058117|NCT04634409|69749759|FG020|Overall Study|Death|0|||
37965405|NCT00488631|69652415|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
37965406|NCT00488631|69652416|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
37965407|NCT00488631|69652417|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
37965408|NCT00488631|69652418|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
37965409|NCT00488631|69652419|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
37965410|NCT00488631|69652420|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
37965411|NCT00488631|69652421|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
37965412|NCT00488631|69652422|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
37965413|NCT00488631|69652423|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
37965414|NCT00655499|69652446|FG000|Overall Study|not eligible|4|||
37965415|NCT00654875|69652453|FG000|Overall Study|Adverse Event|5|||
37965416|NCT00654875|69652454|FG001|Overall Study|Adverse Event|5|||
37965417|NCT00654875|69652453|FG000|Overall Study|Withdrawal by Subject|4|||
37965418|NCT00654875|69652454|FG001|Overall Study|Withdrawal by Subject|4|||
37965419|NCT00654875|69652453|FG000|Overall Study|Protocol Violation|3|||
37965420|NCT00654875|69652454|FG001|Overall Study|Protocol Violation|3|||
38058118|NCT04634409|69749760|FG021|Overall Study|Death|0|||
38058119|NCT04634409|69749761|FG022|Overall Study|Death|0|||
38058120|NCT04634409|69749762|FG023|Overall Study|Death|0|||
38058121|NCT04634409|69749763|FG024|Overall Study|Death|0|||
37965421|NCT00654875|69652453|FG000|Overall Study|Lack of Efficacy|2|||
38058122|NCT04634409|69749764|FG025|Overall Study|Death|0|||
38058123|NCT04634409|69749765|FG026|Overall Study|Death|0|||
38058124|NCT04634409|69749739|FG000|Overall Study|Adverse Event|0|||
38058125|NCT04634409|69749740|FG001|Overall Study|Adverse Event|0|||
38058126|NCT04634409|69749741|FG002|Overall Study|Adverse Event|1|||
38058127|NCT04634409|69749742|FG003|Overall Study|Adverse Event|0|||
38058128|NCT04634409|69749743|FG004|Overall Study|Adverse Event|0|||
38058129|NCT04634409|69749744|FG005|Overall Study|Adverse Event|1|||
38058130|NCT04634409|69749745|FG006|Overall Study|Adverse Event|0|||
38058131|NCT04634409|69749746|FG007|Overall Study|Adverse Event|0|||
38058132|NCT04634409|69749747|FG008|Overall Study|Adverse Event|0|||
38058133|NCT04634409|69749748|FG009|Overall Study|Adverse Event|0|||
38058134|NCT04634409|69749749|FG010|Overall Study|Adverse Event|0|||
38058135|NCT04634409|69749750|FG011|Overall Study|Adverse Event|0|||
38058136|NCT04634409|69749751|FG012|Overall Study|Adverse Event|0|||
38058137|NCT04634409|69749752|FG013|Overall Study|Adverse Event|0|||
38058138|NCT04634409|69749753|FG014|Overall Study|Adverse Event|0|||
38058139|NCT04634409|69749754|FG015|Overall Study|Adverse Event|0|||
38058140|NCT04634409|69749755|FG016|Overall Study|Adverse Event|0|||
38058141|NCT04634409|69749756|FG017|Overall Study|Adverse Event|0|||
38058142|NCT04634409|69749757|FG018|Overall Study|Adverse Event|0|||
38058143|NCT04634409|69749758|FG019|Overall Study|Adverse Event|0|||
38058144|NCT04634409|69749759|FG020|Overall Study|Adverse Event|0|||
38058145|NCT04634409|69749760|FG021|Overall Study|Adverse Event|0|||
38058146|NCT04634409|69749761|FG022|Overall Study|Adverse Event|0|||
38058147|NCT04634409|69749762|FG023|Overall Study|Adverse Event|0|||
38058148|NCT04634409|69749763|FG024|Overall Study|Adverse Event|0|||
38058149|NCT04634409|69749764|FG025|Overall Study|Adverse Event|0|||
38058150|NCT04634409|69749765|FG026|Overall Study|Adverse Event|0|||
38058151|NCT04634409|69749739|FG000|Overall Study|Lost to Follow-up|3|||
38058152|NCT04634409|69749740|FG001|Overall Study|Lost to Follow-up|1|||
38058153|NCT04634409|69749741|FG002|Overall Study|Lost to Follow-up|1|||
38058154|NCT04634409|69749742|FG003|Overall Study|Lost to Follow-up|3|||
38058155|NCT04634409|69749743|FG004|Overall Study|Lost to Follow-up|1|||
38058156|NCT04634409|69749744|FG005|Overall Study|Lost to Follow-up|1|||
38058157|NCT04634409|69749745|FG006|Overall Study|Lost to Follow-up|1|||
38058158|NCT04634409|69749746|FG007|Overall Study|Lost to Follow-up|3|||
38058159|NCT04634409|69749747|FG008|Overall Study|Lost to Follow-up|3|||
38058160|NCT04634409|69749748|FG009|Overall Study|Lost to Follow-up|11|||
38058161|NCT04634409|69749749|FG010|Overall Study|Lost to Follow-up|8|||
38058162|NCT04634409|69749750|FG011|Overall Study|Lost to Follow-up|15|||
38058163|NCT04634409|69749751|FG012|Overall Study|Lost to Follow-up|3|||
38058164|NCT04634409|69749752|FG013|Overall Study|Lost to Follow-up|2|||
38058165|NCT04634409|69749753|FG014|Overall Study|Lost to Follow-up|7|||
38058166|NCT04634409|69749754|FG015|Overall Study|Lost to Follow-up|0|||
38058167|NCT04634409|69749755|FG016|Overall Study|Lost to Follow-up|0|||
38058168|NCT04634409|69749756|FG017|Overall Study|Lost to Follow-up|0|||
38058169|NCT04634409|69749757|FG018|Overall Study|Lost to Follow-up|0|||
38058170|NCT04634409|69749758|FG019|Overall Study|Lost to Follow-up|0|||
38058171|NCT04634409|69749759|FG020|Overall Study|Lost to Follow-up|0|||
38058172|NCT04634409|69749760|FG021|Overall Study|Lost to Follow-up|0|||
38058173|NCT04634409|69749761|FG022|Overall Study|Lost to Follow-up|0|||
38058174|NCT04634409|69749762|FG023|Overall Study|Lost to Follow-up|0|||
38058175|NCT04634409|69749763|FG024|Overall Study|Lost to Follow-up|0|||
38058176|NCT04634409|69749764|FG025|Overall Study|Lost to Follow-up|0|||
38058177|NCT04634409|69749765|FG026|Overall Study|Lost to Follow-up|0|||
38058178|NCT04634409|69749739|FG000|Overall Study|Withdrawal by Subject|3|||
38058179|NCT04634409|69749740|FG001|Overall Study|Withdrawal by Subject|1|||
38058180|NCT04634409|69749741|FG002|Overall Study|Withdrawal by Subject|6|||
38058181|NCT04634409|69749742|FG003|Overall Study|Withdrawal by Subject|4|||
38058182|NCT04634409|69749743|FG004|Overall Study|Withdrawal by Subject|2|||
38058183|NCT04634409|69749744|FG005|Overall Study|Withdrawal by Subject|0|||
38058184|NCT04634409|69749745|FG006|Overall Study|Withdrawal by Subject|0|||
38058185|NCT04634409|69749746|FG007|Overall Study|Withdrawal by Subject|2|||
38058186|NCT04634409|69749747|FG008|Overall Study|Withdrawal by Subject|3|||
38058187|NCT04634409|69749748|FG009|Overall Study|Withdrawal by Subject|2|||
38058188|NCT04634409|69749749|FG010|Overall Study|Withdrawal by Subject|3|||
38058189|NCT04634409|69749750|FG011|Overall Study|Withdrawal by Subject|2|||
38058190|NCT04634409|69749751|FG012|Overall Study|Withdrawal by Subject|2|||
38058191|NCT04634409|69749752|FG013|Overall Study|Withdrawal by Subject|1|||
38058192|NCT04634409|69749753|FG014|Overall Study|Withdrawal by Subject|5|||
38058193|NCT04634409|69749754|FG015|Overall Study|Withdrawal by Subject|0|||
38058194|NCT04634409|69749755|FG016|Overall Study|Withdrawal by Subject|0|||
38058195|NCT04634409|69749756|FG017|Overall Study|Withdrawal by Subject|1|||
38058196|NCT04634409|69749757|FG018|Overall Study|Withdrawal by Subject|0|||
38058197|NCT04634409|69749758|FG019|Overall Study|Withdrawal by Subject|0|||
38058198|NCT04634409|69749759|FG020|Overall Study|Withdrawal by Subject|0|||
38058199|NCT04634409|69749760|FG021|Overall Study|Withdrawal by Subject|0|||
38058200|NCT04634409|69749761|FG022|Overall Study|Withdrawal by Subject|0|||
38058201|NCT04634409|69749762|FG023|Overall Study|Withdrawal by Subject|1|||
38058202|NCT04634409|69749763|FG024|Overall Study|Withdrawal by Subject|0|||
38058203|NCT04634409|69749764|FG025|Overall Study|Withdrawal by Subject|0|||
38058204|NCT04634409|69749765|FG026|Overall Study|Withdrawal by Subject|0|||
38058205|NCT04634409|69749739|FG000|Overall Study|Other - As reported by Investigator|1|||
38058206|NCT04634409|69749740|FG001|Overall Study|Other - As reported by Investigator|0|||
38058207|NCT04634409|69749741|FG002|Overall Study|Other - As reported by Investigator|0|||
38058208|NCT04634409|69749742|FG003|Overall Study|Other - As reported by Investigator|0|||
38058209|NCT04634409|69749743|FG004|Overall Study|Other - As reported by Investigator|0|||
38058210|NCT04634409|69749744|FG005|Overall Study|Other - As reported by Investigator|0|||
38058211|NCT04634409|69749745|FG006|Overall Study|Other - As reported by Investigator|0|||
38058212|NCT04634409|69749746|FG007|Overall Study|Other - As reported by Investigator|6|||
38058213|NCT04634409|69749747|FG008|Overall Study|Other - As reported by Investigator|4|||
38058214|NCT04634409|69749748|FG009|Overall Study|Other - As reported by Investigator|0|||
38058215|NCT04634409|69749749|FG010|Overall Study|Other - As reported by Investigator|1|||
38058216|NCT04634409|69749750|FG011|Overall Study|Other - As reported by Investigator|2|||
38058217|NCT04634409|69749751|FG012|Overall Study|Other - As reported by Investigator|2|||
38058218|NCT04634409|69749752|FG013|Overall Study|Other - As reported by Investigator|1|||
38058219|NCT04634409|69749753|FG014|Overall Study|Other - As reported by Investigator|0|||
38058220|NCT04634409|69749754|FG015|Overall Study|Other - As reported by Investigator|0|||
38058221|NCT04634409|69749755|FG016|Overall Study|Other - As reported by Investigator|0|||
38058222|NCT04634409|69749756|FG017|Overall Study|Other - As reported by Investigator|0|||
38058223|NCT04634409|69749757|FG018|Overall Study|Other - As reported by Investigator|0|||
38058224|NCT04634409|69749758|FG019|Overall Study|Other - As reported by Investigator|0|||
38058225|NCT04634409|69749759|FG020|Overall Study|Other - As reported by Investigator|0|||
38058226|NCT04634409|69749760|FG021|Overall Study|Other - As reported by Investigator|0|||
38058227|NCT04634409|69749761|FG022|Overall Study|Other - As reported by Investigator|0|||
38058228|NCT04634409|69749762|FG023|Overall Study|Other - As reported by Investigator|0|||
38058229|NCT04634409|69749763|FG024|Overall Study|Other - As reported by Investigator|0|||
38058230|NCT04634409|69749764|FG025|Overall Study|Other - As reported by Investigator|0|||
38058231|NCT04634409|69749765|FG026|Overall Study|Other - As reported by Investigator|0|||
38058232|NCT00005780|69749843|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
38058233|NCT01978938|69749852|FG000|Overall Study|Lost to Follow-up|12|||
38058234|NCT01978938|69749853|FG001|Overall Study|Lost to Follow-up|6|||
38058235|NCT01978938|69749852|FG000|Overall Study|Withdrawal by Subject|8|||
38058236|NCT01978938|69749853|FG001|Overall Study|Withdrawal by Subject|4|||
38058237|NCT01978938|69749852|FG000|Overall Study|Adverse Event, non-fatal|2|||
38058238|NCT01978938|69749853|FG001|Overall Study|Adverse Event, non-fatal|1|||
38058239|NCT01978938|69749852|FG000|Overall Study|Participant noncompliance|1|||
38058240|NCT01978938|69749853|FG001|Overall Study|Participant noncompliance|1|||
38058241|NCT01978938|69749852|FG000|Overall Study|Did not meet inclusion criteria|0|||
38058242|NCT01978938|69749853|FG001|Overall Study|Did not meet inclusion criteria|1|||
38058243|NCT01978938|69749852|FG000|Overall Study|Previously scheduled procedure|0|||
38058244|NCT01978938|69749853|FG001|Overall Study|Previously scheduled procedure|1|||
38058245|NCT03041090|69749861|FG000|Overall Study|technical error|0|||
38058246|NCT03041090|69749862|FG001|Overall Study|technical error|3|||
38058247|NCT00116142|69749870|FG000|Overall Study|Adverse Event|8|||
38058248|NCT00116142|69749871|FG001|Overall Study|Adverse Event|7|||
38058249|NCT00116142|69749870|FG000|Overall Study|Protocol Violation|2|||
38058250|NCT00116142|69749871|FG001|Overall Study|Protocol Violation|1|||
38058251|NCT00116142|69749870|FG000|Overall Study|Withdrawal by Subject|5|||
38058252|NCT00116142|69749871|FG001|Overall Study|Withdrawal by Subject|5|||
38058253|NCT00116142|69749870|FG000|Overall Study|Physician Decision|3|||
38058254|NCT00116142|69749871|FG001|Overall Study|Physician Decision|1|||
38058255|NCT00116142|69749870|FG000|Overall Study|Delayed Radiation Therapy|1|||
38058256|NCT00116142|69749871|FG001|Overall Study|Delayed Radiation Therapy|0|||
38058257|NCT00116142|69749870|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
38058258|NCT00116142|69749871|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
38058259|NCT00116142|69749870|FG000|Overall Study|Patient stopped due to depression|0|||
38058260|NCT00116142|69749871|FG001|Overall Study|Patient stopped due to depression|1|||
38058261|NCT00116142|69749870|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
38058262|NCT00116142|69749871|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
38058263|NCT00116142|69749870|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
38058264|NCT00116142|69749871|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
38058265|NCT00116142|69749870|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
38058266|NCT00116142|69749871|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
38058267|NCT03135522|69749882|FG000|Overall Study|Adverse Event|1|||
38058268|NCT03135522|69749883|FG001|Overall Study|Adverse Event|0|||
38058269|NCT02875080|69749906|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
38058270|NCT02875080|69749907|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
38058271|NCT02875080|69749908|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
38058272|NCT03129360|69749919|FG000|Overall Study|Did not meet entry criteria|0|||
38058273|NCT03129360|69749920|FG001|Overall Study|Did not meet entry criteria|2|||
38058274|NCT03129360|69749921|FG002|Overall Study|Did not meet entry criteria|1|||
38058275|NCT03129360|69749919|FG000|Overall Study|Excluded due to motion in scanner|1|||
38058276|NCT03129360|69749920|FG001|Overall Study|Excluded due to motion in scanner|0|||
38058277|NCT03129360|69749921|FG002|Overall Study|Excluded due to motion in scanner|0|||
38058278|NCT03165045|69749929|FG000|Visit 1|No registration after visit 1|9|||
38058279|NCT03165045|69749929|FG000|Visit 1|No treatment documented|10|||
38058280|NCT03165045|69749929|FG000|Visit 1|No visit 1|10|||
38058281|NCT03165045|69749929|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
38058282|NCT03165045|69749929|FG000|Visit 2|No available total CCQ score at all|29|||
38058283|NCT03165045|69749929|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
38058284|NCT01928199|69749937|FG000|Overall Study|Lost to Follow-up|2|||
38058285|NCT01928199|69749938|FG001|Overall Study|Lost to Follow-up|1|||
38058286|NCT01928199|69749937|FG000|Overall Study|Withdrawal by Subject|3|||
38058287|NCT01928199|69749938|FG001|Overall Study|Withdrawal by Subject|5|||
38058288|NCT03128892|69749944|FG000|Overall Study|Withdrawal by Subject|2|||
38058289|NCT03128892|69749944|FG000|Overall Study|Physician Decision|1|||
38058290|NCT03039686|69749960|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
38058291|NCT03039686|69749961|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
38058292|NCT03039686|69749962|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
38058293|NCT03039686|69749960|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
38058294|NCT03039686|69749961|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
38058295|NCT03039686|69749962|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
38058296|NCT03039686|69749960|FG000|Double-blind Period|Withdrawal by Subject|2|||
38058297|NCT03039686|69749961|FG001|Double-blind Period|Withdrawal by Subject|2|||
38058298|NCT03039686|69749962|FG002|Double-blind Period|Withdrawal by Subject|1|||
38058299|NCT03039686|69749960|FG000|Double-blind Period|Death|0|||
38058300|NCT03039686|69749961|FG001|Double-blind Period|Death|0|||
38058301|NCT03039686|69749962|FG002|Double-blind Period|Death|1|||
38058302|NCT03039686|69749960|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
38058303|NCT03039686|69749961|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
38058304|NCT03039686|69749962|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
38058305|NCT03039686|69749960|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
38058306|NCT03039686|69749961|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
38058307|NCT03039686|69749962|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
38058308|NCT03039686|69749960|FG000|Open Label Period|Withdrawal by Subject|0|||
38058309|NCT03039686|69749961|FG001|Open Label Period|Withdrawal by Subject|3|||
38058310|NCT03039686|69749962|FG002|Open Label Period|Withdrawal by Subject|1|||
38058311|NCT01822275|69749980|FG000|Overall Study|Withdrawal by Subject|3|||
38058312|NCT01822275|69749980|FG000|Overall Study|Adverse Event|3|||
38058313|NCT01822275|69749980|FG000|Overall Study|Progression|14|||
38058314|NCT01822275|69749980|FG000|Overall Study|Physician Decision|2|||
38058315|NCT01656434|69749992|FG000|Overall Study|Adverse Event|199|||
38058316|NCT01656434|69749993|FG001|Overall Study|Adverse Event|63|||
38058317|NCT01656434|69749992|FG000|Overall Study|Enrollment terminated at trial site|2|||
38058318|NCT01656434|69749993|FG001|Overall Study|Enrollment terminated at trial site|0|||
38058319|NCT01656434|69749992|FG000|Overall Study|Lost to Follow-up|309|||
38058320|NCT01656434|69749993|FG001|Overall Study|Lost to Follow-up|76|||
38058321|NCT01656434|69749992|FG000|Overall Study|Site discontinued study participation|24|||
38058322|NCT01656434|69749993|FG001|Overall Study|Site discontinued study participation|9|||
38058323|NCT01656434|69749992|FG000|Overall Study|Screen failure|2|||
38058324|NCT01656434|69749993|FG001|Overall Study|Screen failure|0|||
38058325|NCT01656434|69749992|FG000|Overall Study|Protocol Violation|7|||
38058326|NCT01656434|69749993|FG001|Overall Study|Protocol Violation|0|||
38058327|NCT01656434|69749992|FG000|Overall Study|Pregnancy wish|18|||
38058328|NCT01656434|69749993|FG001|Overall Study|Pregnancy wish|6|||
38058329|NCT01656434|69749992|FG000|Overall Study|Pregnancy|45|||
38058330|NCT01656434|69749993|FG001|Overall Study|Pregnancy|10|||
38058331|NCT01656434|69749992|FG000|Overall Study|Physician Decision|7|||
38058332|NCT01656434|69749993|FG001|Overall Study|Physician Decision|2|||
38058333|NCT01656434|69749992|FG000|Overall Study|Non-compliance with study drug|48|||
38058334|NCT01656434|69749993|FG001|Overall Study|Non-compliance with study drug|9|||
38058335|NCT01656434|69749992|FG000|Overall Study|Study terminated by sponsor|1501|||
37965422|NCT00654875|69652454|FG001|Overall Study|Lack of Efficacy|2|||
37965423|NCT00654875|69652453|FG000|Overall Study|Lost to Follow-up|1|||
37965424|NCT00654875|69652454|FG001|Overall Study|Lost to Follow-up|3|||
37965425|NCT00654875|69652453|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
37965426|NCT00654875|69652454|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
37965427|NCT00654875|69652453|FG000|Overall Study|Administrative Problems|1|||
37965428|NCT00654875|69652454|FG001|Overall Study|Administrative Problems|0|||
38058336|NCT01656434|69749993|FG001|Overall Study|Study terminated by sponsor|348|||
38058337|NCT01656434|69749992|FG000|Overall Study|Participant discontinued; drug related|13|||
37965429|NCT00651755|69652460|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
38058338|NCT01656434|69749993|FG001|Overall Study|Participant discontinued; drug related|4|||
38058339|NCT01656434|69749992|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
38058340|NCT01656434|69749993|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
38058341|NCT01656434|69749992|FG000|Overall Study|Non-compliance with protocol|39|||
38058342|NCT01656434|69749993|FG001|Overall Study|Non-compliance with protocol|15|||
38058343|NCT01656434|69749992|FG000|Overall Study|Participant moved|40|||
38058344|NCT01656434|69749993|FG001|Overall Study|Participant moved|12|||
38058345|NCT01656434|69749992|FG000|Overall Study|Participant withdrew consent|28|||
38058346|NCT01656434|69749993|FG001|Overall Study|Participant withdrew consent|9|||
38058347|NCT01656434|69749992|FG000|Overall Study|Withdrawal by Subject|64|||
38058348|NCT01656434|69749993|FG001|Overall Study|Withdrawal by Subject|7|||
38058349|NCT02931396|69750001|FG000|Overall Study|Lost to Follow-up|3|||
38058350|NCT02931396|69750002|FG001|Overall Study|Lost to Follow-up|0|||
38058351|NCT02931396|69750001|FG000|Overall Study|Withdrawal by Subject|2|||
38058352|NCT02931396|69750002|FG001|Overall Study|Withdrawal by Subject|0|||
38058353|NCT03037580|69750010|FG000|Overall Study|Withdrawal by Subject|3|||
38058354|NCT03037580|69750011|FG001|Overall Study|Withdrawal by Subject|0|||
38058355|NCT03037580|69750010|FG000|Overall Study|Adverse Event|1|||
38058356|NCT03037580|69750011|FG001|Overall Study|Adverse Event|0|||
38058357|NCT03037580|69750010|FG000|Overall Study|Study Terminated by Sponsor|12|||
38058358|NCT03037580|69750011|FG001|Overall Study|Study Terminated by Sponsor|15|||
38058359|NCT03037580|69750010|FG000|Overall Study|Death|0|||
38058360|NCT03037580|69750011|FG001|Overall Study|Death|1|||
38058361|NCT01755195|69750017|FG000|Overall Study|Participant noncompliance|2|||
38058362|NCT01755195|69750017|FG000|Overall Study|Switched to alternative treatment|4|||
38058363|NCT01755195|69750017|FG000|Overall Study|Withdrawal by Subject|1|||
38058364|NCT01755195|69750017|FG000|Overall Study|Participant refused to start treatment|1|||
38058365|NCT01755195|69750017|FG000|Overall Study|Participant has been consented for another trial|1|||
38058366|NCT01755195|69750017|FG000|Overall Study|Refused further treatment|3|||
38058367|NCT01755195|69750017|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
38058368|NCT00897104|69750024|FG000|Overall Study|Lost to Follow-up|12|||
38058369|NCT00897104|69750025|FG001|Overall Study|Lost to Follow-up|17|||
38058370|NCT00897104|69750026|FG002|Overall Study|Lost to Follow-up|2|||
38058371|NCT00897104|69750024|FG000|Overall Study|Pregnancy|0|||
38058372|NCT00897104|69750025|FG001|Overall Study|Pregnancy|1|||
38058373|NCT00897104|69750026|FG002|Overall Study|Pregnancy|0|||
38058374|NCT00897104|69750024|FG000|Overall Study|Protocol Violation|0|||
38058375|NCT00897104|69750025|FG001|Overall Study|Protocol Violation|1|||
38058376|NCT00897104|69750026|FG002|Overall Study|Protocol Violation|0|||
38058377|NCT00897104|69750024|FG000|Overall Study|Withdrawal by Subject|23|||
38058378|NCT00897104|69750025|FG001|Overall Study|Withdrawal by Subject|27|||
38058379|NCT00897104|69750026|FG002|Overall Study|Withdrawal by Subject|3|||
38058380|NCT00897104|69750024|FG000|Overall Study|Abnormal Prestudy Labs|2|||
38058381|NCT00897104|69750025|FG001|Overall Study|Abnormal Prestudy Labs|0|||
38058382|NCT00897104|69750026|FG002|Overall Study|Abnormal Prestudy Labs|0|||
38058383|NCT00897104|69750024|FG000|Overall Study|Abnormal Baseline ECG|2|||
38058384|NCT00897104|69750025|FG001|Overall Study|Abnormal Baseline ECG|2|||
38058385|NCT00897104|69750026|FG002|Overall Study|Abnormal Baseline ECG|0|||
38058386|NCT00897104|69750024|FG000|Overall Study|Need for Concom. Med.|0|||
38058387|NCT00897104|69750025|FG001|Overall Study|Need for Concom. Med.|1|||
38058388|NCT00897104|69750026|FG002|Overall Study|Need for Concom. Med.|1|||
38058389|NCT00897104|69750024|FG000|Overall Study|Lack of Migraine Attack|20|||
38058390|NCT00897104|69750025|FG001|Overall Study|Lack of Migraine Attack|22|||
38058391|NCT00897104|69750026|FG002|Overall Study|Lack of Migraine Attack|1|||
38058392|NCT00897104|69750024|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
37965430|NCT00651755|69652461|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
37965431|NCT00651755|69652460|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
37965432|NCT00651755|69652461|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
37965433|NCT00654641|69652470|FG000|Overall Study|Lost to Follow-up|2|||
37965434|NCT00654641|69652471|FG001|Overall Study|Lost to Follow-up|3|||
37965435|NCT00569777|69652479|FG000|Overall Study|Withdrawal by Subject|4|||
37965436|NCT00569777|69652480|FG001|Overall Study|Withdrawal by Subject|0|||
37965437|NCT00569777|69652479|FG000|Overall Study|Adverse Event|3|||
37965438|NCT00569777|69652480|FG001|Overall Study|Adverse Event|0|||
37965439|NCT00569777|69652479|FG000|Overall Study|Lost to Follow-up|1|||
37965440|NCT00569777|69652480|FG001|Overall Study|Lost to Follow-up|0|||
37965441|NCT00569777|69652479|FG000|Overall Study|scheduled eye surgery|0|||
37965442|NCT00569777|69652480|FG001|Overall Study|scheduled eye surgery|1|||
37965443|NCT00569777|69652479|FG000|Overall Study|did not meet exclusion criteria|1|||
38058393|NCT00897104|69750025|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
38058394|NCT00897104|69750026|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
38058395|NCT00897104|69750024|FG000|Overall Study|Other|3|||
38058396|NCT00897104|69750025|FG001|Overall Study|Other|0|||
38058397|NCT00897104|69750026|FG002|Overall Study|Other|0|||
38058398|NCT00897104|69750024|FG000|Overall Study|Protocol Violation|1|||
38058399|NCT00897104|69750025|FG001|Overall Study|Protocol Violation|0|||
38058400|NCT00897104|69750026|FG002|Overall Study|Protocol Violation|0|||
38058401|NCT00897104|69750024|FG000|Overall Study|Withdrawal by Subject|0|||
38058402|NCT00897104|69750025|FG001|Overall Study|Withdrawal by Subject|0|||
38058403|NCT00897104|69750026|FG002|Overall Study|Withdrawal by Subject|1|||
38058404|NCT01339689|69750036|FG000|Overall Study|Adverse Event|1|||
38058405|NCT01339689|69750037|FG001|Overall Study|Adverse Event|2|||
38058406|NCT01339689|69750036|FG000|Overall Study|Lost to Follow-up|9|||
38058407|NCT01339689|69750037|FG001|Overall Study|Lost to Follow-up|3|||
38058408|NCT01339689|69750036|FG000|Overall Study|Withdrawal by Subject|3|||
38058409|NCT01339689|69750037|FG001|Overall Study|Withdrawal by Subject|0|||
38058410|NCT01339689|69750036|FG000|Overall Study|Noncompliance|1|||
38058411|NCT01339689|69750037|FG001|Overall Study|Noncompliance|0|||
38058412|NCT01339689|69750036|FG000|Overall Study|Relocated out of area|0|||
38058413|NCT01339689|69750037|FG001|Overall Study|Relocated out of area|1|||
38058414|NCT01339689|69750036|FG000|Overall Study|Other|2|||
38058415|NCT01339689|69750037|FG001|Overall Study|Other|2|||
38058416|NCT01339689|69750036|FG000|Overall Study|multiple reasons|1|||
38058417|NCT01339689|69750037|FG001|Overall Study|multiple reasons|1|||
38058418|NCT03038126|69750045|FG000|Overall Study|Death|1|||
38058419|NCT03038126|69750046|FG001|Overall Study|Death|1|||
38058420|NCT03038126|69750045|FG000|Overall Study|Withdrawal by Subject|5|||
38058421|NCT03038126|69750046|FG001|Overall Study|Withdrawal by Subject|0|||
38058422|NCT03038126|69750045|FG000|Overall Study|Lost to Follow-up|0|||
38058423|NCT03038126|69750046|FG001|Overall Study|Lost to Follow-up|1|||
38058424|NCT03038126|69750045|FG000|Overall Study|Long Term Hospitalization|2|||
38058425|NCT03038126|69750046|FG001|Overall Study|Long Term Hospitalization|0|||
38058426|NCT03038126|69750045|FG000|Overall Study|Too Ill to Participate|1|||
38058427|NCT03038126|69750046|FG001|Overall Study|Too Ill to Participate|2|||
38058428|NCT00696878|69750064|FG000|Overall Study|Adverse Event|8|||
38058429|NCT00696878|69750064|FG000|Overall Study|Withdrawal by Subject|87|||
38058430|NCT00696878|69750064|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
38058431|NCT00696878|69750064|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
38058432|NCT00696878|69750064|FG000|Overall Study|Trial stopped|32|||
38058433|NCT00696878|69750064|FG000|Overall Study|Other reason (not specified)|55|||
38058434|NCT00696800|69750070|FG000|Overall Study|Adverse Event|16|||
38058435|NCT00696800|69750071|FG001|Overall Study|Adverse Event|3|||
38058436|NCT00696800|69750070|FG000|Overall Study|Insufficient compliance with medication|2|||
38058437|NCT00696800|69750071|FG001|Overall Study|Insufficient compliance with medication|1|||
38058438|NCT00696800|69750070|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
38058439|NCT00696800|69750071|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
38058440|NCT00696800|69750070|FG000|Overall Study|Insufficient ovarian response|4|||
38058441|NCT00696800|69750071|FG001|Overall Study|Insufficient ovarian response|1|||
38058442|NCT00696800|69750070|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
38058443|NCT00696800|69750071|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
38058444|NCT00696800|69750070|FG000|Overall Study|Too high ovarian response|6|||
38058445|NCT00696800|69750071|FG001|Overall Study|Too high ovarian response|1|||
38058446|NCT00696800|69750070|FG000|Overall Study|No/too few/bad quality oocytes|4|||
38058447|NCT00696800|69750071|FG001|Overall Study|No/too few/bad quality oocytes|3|||
38058448|NCT00696800|69750070|FG000|Overall Study|No/abnormal fertilization|11|||
38058449|NCT00696800|69750071|FG001|Overall Study|No/abnormal fertilization|13|||
38058450|NCT00696800|69750070|FG000|Overall Study|No/too few/bad quality embryos|24|||
38058451|NCT00696800|69750071|FG001|Overall Study|No/too few/bad quality embryos|18|||
38058452|NCT00696800|69750070|FG000|Overall Study|Other Reasons|5|||
38058453|NCT00696800|69750071|FG001|Overall Study|Other Reasons|3|||
38058454|NCT00696800|69750070|FG000|Overall Study|Not treated|1|||
38058455|NCT00696800|69750071|FG001|Overall Study|Not treated|2|||
38058456|NCT00289874|69750079|FG000|Overall Study|Adverse Event|1|||
38058457|NCT00289874|69750080|FG001|Overall Study|Adverse Event|5|||
38058458|NCT00289874|69750079|FG000|Overall Study|Lost to Follow-up|1|||
38058459|NCT00289874|69750080|FG001|Overall Study|Lost to Follow-up|1|||
38058460|NCT00289874|69750079|FG000|Overall Study|Protocol Violation|3|||
38058461|NCT00289874|69750080|FG001|Overall Study|Protocol Violation|2|||
38058462|NCT00289874|69750079|FG000|Overall Study|Did not meet eligibility|1|||
38058463|NCT00289874|69750080|FG001|Overall Study|Did not meet eligibility|0|||
38058464|NCT00245570|69750086|FG000|Washout Between Periods III and IV|Adverse Event|0|||
37862211|NCT00919711|69546002|FG001|Overall Study|Noncompliance|0|||
38058465|NCT00245570|69750087|FG001|Washout Between Periods III and IV|Adverse Event|1|||
38058466|NCT00245570|69750088|FG002|Washout Between Periods III and IV|Adverse Event|0|||
38058467|NCT00245570|69750089|FG003|Washout Between Periods III and IV|Adverse Event|0|||
38058468|NCT00245570|69750090|FG004|Washout Between Periods III and IV|Adverse Event|0|||
38058469|NCT00245570|69750091|FG005|Washout Between Periods III and IV|Adverse Event|0|||
38058470|NCT04638660|69750137|FG000|Overall Study|Withdrawal by Subject|2|||
38058471|NCT04638660|69750138|FG001|Overall Study|Withdrawal by Subject|0|||
38058472|NCT04638660|69750137|FG000|Overall Study|Lost to Follow-up|1|||
38058473|NCT04638660|69750138|FG001|Overall Study|Lost to Follow-up|0|||
38058474|NCT04367480|69750147|FG000|Overall Study|Adverse Event|1|||
38058475|NCT04367480|69750148|FG001|Overall Study|Adverse Event|1|||
38058476|NCT04367480|69750147|FG000|Overall Study|Death|1|||
38058477|NCT04367480|69750148|FG001|Overall Study|Death|0|||
38058478|NCT04367480|69750147|FG000|Overall Study|Lost to Follow-up|1|||
38058479|NCT04367480|69750148|FG001|Overall Study|Lost to Follow-up|1|||
38058480|NCT04367480|69750147|FG000|Overall Study|Withdrawal by Subject|0|||
38058481|NCT04367480|69750148|FG001|Overall Study|Withdrawal by Subject|3|||
38058482|NCT04367480|69750147|FG000|Overall Study|App glitch during the study|1|||
38058483|NCT04367480|69750148|FG001|Overall Study|App glitch during the study|0|||
38058484|NCT04367480|69750147|FG000|Overall Study|Device Distribution Error|0|||
38058485|NCT04367480|69750148|FG001|Overall Study|Device Distribution Error|2|||
38058486|NCT04367480|69750147|FG000|Overall Study|Ineligible after Randomization|0|||
38058487|NCT04367480|69750148|FG001|Overall Study|Ineligible after Randomization|1|||
38058488|NCT04367480|69750147|FG000|Overall Study|Other Medical Reasons|0|||
38058489|NCT04367480|69750148|FG001|Overall Study|Other Medical Reasons|2|||
38058490|NCT04137731|69750171|FG000|Overall Study|Surgery Cancellation|1|||
38058491|NCT04137731|69750172|FG001|Overall Study|Surgery Cancellation|2|||
38058492|NCT04137731|69750171|FG000|Overall Study|Withdrawal by Subject|2|||
38058493|NCT04137731|69750172|FG001|Overall Study|Withdrawal by Subject|0|||
38058494|NCT04137731|69750171|FG000|Overall Study|Protocol Violation|0|||
38058495|NCT04137731|69750172|FG001|Overall Study|Protocol Violation|1|||
38058496|NCT04088760|69750187|FG000|Overall Study|Physician Decision|1|||
38058497|NCT03813238|69750206|FG000|Overall Study|Adverse Event|0|||
38058498|NCT03813238|69750207|FG001|Overall Study|Adverse Event|6|||
38058499|NCT03813238|69750206|FG000|Overall Study|Withdrawal by parent/guardian|0|||
38058500|NCT03813238|69750207|FG001|Overall Study|Withdrawal by parent/guardian|2|||
38058501|NCT03813238|69750206|FG000|Overall Study|Lost to Follow-up|0|||
38058502|NCT03813238|69750207|FG001|Overall Study|Lost to Follow-up|1|||
38058503|NCT03813238|69750206|FG000|Overall Study|Other than specified|1|||
38058504|NCT03813238|69750207|FG001|Overall Study|Other than specified|2|||
38058505|NCT03737240|69750215|FG000|Overall Study|Lost to Follow-up|16|||
38058506|NCT03737240|69750216|FG001|Overall Study|Lost to Follow-up|15|||
38058507|NCT03532178|69750224|FG000|First Period|Withdrawal by Subject|1|||
38058508|NCT03532178|69750225|FG001|First Period|Withdrawal by Subject|3|||
38058509|NCT03532178|69750224|FG000|First Period|technical issues in data collection Technical issues|0|||
38058510|NCT03532178|69750225|FG001|First Period|technical issues in data collection Technical issues|1|||
38058511|NCT03532178|69750224|FG000|Second Period|Withdrawal by Subject|1|||
38058512|NCT03532178|69750225|FG001|Second Period|Withdrawal by Subject|1|||
38058513|NCT03532178|69750224|FG000|Second Period|Technical issues|0|||
38058514|NCT03532178|69750225|FG001|Second Period|Technical issues|1|||
38058515|NCT03526549|69750233|FG000|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|0|||
38058516|NCT03526549|69750234|FG001|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|238|||
38058517|NCT03526549|69750233|FG000|180 Days Observational Phase|Withdrawal by Subject|40|||
38058518|NCT03526549|69750234|FG001|180 Days Observational Phase|Withdrawal by Subject|2|||
38058519|NCT03526549|69750233|FG000|180 Days Observational Phase|Lost to Follow-up|1|||
38058520|NCT03526549|69750234|FG001|180 Days Observational Phase|Lost to Follow-up|0|||
37965444|NCT00569777|69652480|FG001|Overall Study|did not meet exclusion criteria|2|||
37965445|NCT00569777|69652479|FG000|Overall Study|pregnant|1|||
37965446|NCT00569777|69652480|FG001|Overall Study|pregnant|0|||
37965447|NCT00569231|69652486|FG000|Overall Study|Study unrelated surgery|1|||
37965448|NCT00569231|69652486|FG000|Overall Study|Airfare expense|2|||
37965449|NCT00569231|69652486|FG000|Overall Study|Withdrawal by Subject|1|||
37965450|NCT00569231|69652486|FG000|Overall Study|Car accident injury|1|||
37965451|NCT00569231|69652486|FG000|Overall Study|Non-compliance|2|||
37965452|NCT00654095|69652490|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
37965453|NCT00654095|69652490|FG000|Overall Study|Elevated triglyceride level (2)|1|||
37965454|NCT00654095|69652490|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
37965455|NCT00654095|69652490|FG000|Overall Study|Adverse Event|11|||
37965456|NCT00654095|69652490|FG000|Overall Study|Withdrawal by Subject|5|||
37965457|NCT00654095|69652490|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
37965458|NCT00654095|69652490|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
37965459|NCT00654095|69652490|FG000|Overall Study|Did not meet inclusion criteria|1|||
37965460|NCT00650585|69652496|FG000|Overall Study|Lost to Follow-up|505|||
37965461|NCT00650585|69652497|FG001|Overall Study|Lost to Follow-up|482|||
37965462|NCT00650585|69652496|FG000|Overall Study|No parental consent|935|||
37965463|NCT00650585|69652497|FG001|Overall Study|No parental consent|866|||
37965464|NCT00650585|69652496|FG000|Overall Study|Excluded/ruled ineligible|357|||
37965465|NCT00650585|69652497|FG001|Overall Study|Excluded/ruled ineligible|129|||
37965466|NCT00653939|69652505|FG000|Overall Study|Adverse Event|1|||
38058521|NCT03526549|69750233|FG000|Open-label Phase|Adverse Event|4|||
38058522|NCT03526549|69750234|FG001|Open-label Phase|Adverse Event|0|||
38058523|NCT03526549|69750233|FG000|Open-label Phase|Withdrawal by Subject|54|||
38058524|NCT03526549|69750234|FG001|Open-label Phase|Withdrawal by Subject|0|||
38058525|NCT03526549|69750233|FG000|Open-label Phase|Lost to Follow-up|35|||
38058526|NCT03526549|69750234|FG001|Open-label Phase|Lost to Follow-up|0|||
38058527|NCT03526549|69750233|FG000|Open-label Phase|Other than Specified|5|||
38058528|NCT03526549|69750234|FG001|Open-label Phase|Other than Specified|0|||
38058529|NCT03449901|69750248|FG000|Overall Study|Progression|57|||
38058530|NCT03449901|69750249|FG001|Overall Study|Progression|12|||
38058531|NCT03449901|69750248|FG000|Overall Study|Adverse Event|3|||
38058532|NCT03449901|69750249|FG001|Overall Study|Adverse Event|0|||
38058533|NCT03449901|69750248|FG000|Overall Study|Death|6|||
38058534|NCT03449901|69750249|FG001|Overall Study|Death|2|||
38058535|NCT03449901|69750248|FG000|Overall Study|Withdrawal by Subject|12|||
38058536|NCT03449901|69750249|FG001|Overall Study|Withdrawal by Subject|1|||
38058537|NCT03449901|69750248|FG000|Overall Study|Physician Decision|1|||
38058538|NCT03449901|69750249|FG001|Overall Study|Physician Decision|0|||
38058539|NCT03449901|69750248|FG000|Overall Study|Patient elected for surgical intervention|1|||
38058540|NCT03449901|69750249|FG001|Overall Study|Patient elected for surgical intervention|0|||
38058541|NCT03449901|69750248|FG000|Overall Study|Patient off for other complicating disease|1|||
38058542|NCT03449901|69750249|FG001|Overall Study|Patient off for other complicating disease|0|||
38058543|NCT03435380|69750264|FG000|Overall Study|Death|1|||
38058544|NCT03435380|69750265|FG001|Overall Study|Death|2|||
38058545|NCT03435380|69750266|FG002|Overall Study|Death|1|||
38058546|NCT03435380|69750264|FG000|Overall Study|Lost to Follow-up|12|||
38058547|NCT03435380|69750265|FG001|Overall Study|Lost to Follow-up|8|||
38058548|NCT03435380|69750266|FG002|Overall Study|Lost to Follow-up|6|||
38058549|NCT03435380|69750264|FG000|Overall Study|Physician Decision|1|||
38058550|NCT03435380|69750265|FG001|Overall Study|Physician Decision|0|||
38058551|NCT03435380|69750266|FG002|Overall Study|Physician Decision|0|||
38058552|NCT03435380|69750264|FG000|Overall Study|Withdrawal by Subject|0|||
38058553|NCT03435380|69750265|FG001|Overall Study|Withdrawal by Subject|1|||
38058554|NCT03435380|69750266|FG002|Overall Study|Withdrawal by Subject|1|||
38058555|NCT03435380|69750264|FG000|Overall Study|Ineligible|0|||
38058556|NCT03435380|69750265|FG001|Overall Study|Ineligible|1|||
38058557|NCT03435380|69750266|FG002|Overall Study|Ineligible|1|||
38058558|NCT03363659|69750274|FG000|Overall Study|Adverse Event|1|||
38058559|NCT03363659|69750274|FG000|Overall Study|Screen fail|1|||
38058560|NCT03363659|69750274|FG000|Overall Study|Withdrawal by Subject|1|||
38058561|NCT03299166|69750280|FG000|Overall Study|Adverse Event|9|||
38058562|NCT03299166|69750281|FG001|Overall Study|Adverse Event|4|||
38058563|NCT03299166|69750280|FG000|Overall Study|Withdrawal by Subject|6|||
38058564|NCT03299166|69750281|FG001|Overall Study|Withdrawal by Subject|5|||
38058565|NCT03299166|69750280|FG000|Overall Study|Physician Decision|1|||
38058566|NCT03299166|69750281|FG001|Overall Study|Physician Decision|1|||
38058567|NCT03299166|69750280|FG000|Overall Study|Sponsor Decision|3|||
38058568|NCT03299166|69750281|FG001|Overall Study|Sponsor Decision|0|||
38058569|NCT03299166|69750280|FG000|Overall Study|Lost to Follow-up|2|||
38058570|NCT03299166|69750281|FG001|Overall Study|Lost to Follow-up|4|||
37965467|NCT00653939|69652506|FG001|Overall Study|Adverse Event|3|||
37965468|NCT00653939|69652505|FG000|Overall Study|Withdrawal by Subject|3|||
37965469|NCT00653939|69652506|FG001|Overall Study|Withdrawal by Subject|3|||
37965470|NCT00653939|69652505|FG000|Overall Study|Physician Decision|4|||
37965471|NCT00653939|69652506|FG001|Overall Study|Physician Decision|0|||
37965472|NCT00653939|69652505|FG000|Overall Study|Disease Progression|2|||
37965473|NCT00653939|69652506|FG001|Overall Study|Disease Progression|3|||
37965474|NCT00653939|69652505|FG000|Overall Study|Other|2|||
37965475|NCT00653939|69652506|FG001|Overall Study|Other|6|||
37965476|NCT00646451|69652514|FG000|Overall Study|Adverse Event|3|||
37965477|NCT00646451|69652515|FG001|Overall Study|Adverse Event|0|||
37965478|NCT00646451|69652514|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
37965479|NCT00646451|69652515|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
37965480|NCT00642707|69652527|FG000|Overall Study|Adverse Event|0|||
37965481|NCT00642707|69652528|FG001|Overall Study|Adverse Event|0|||
37965482|NCT00642707|69652529|FG002|Overall Study|Adverse Event|0|||
37965483|NCT00642707|69652530|FG003|Overall Study|Adverse Event|2|||
37965484|NCT00642707|69652527|FG000|Overall Study|Withdrawal by Subject|1|||
37965485|NCT00642707|69652528|FG001|Overall Study|Withdrawal by Subject|0|||
37965486|NCT00642707|69652529|FG002|Overall Study|Withdrawal by Subject|0|||
37965487|NCT00642707|69652530|FG003|Overall Study|Withdrawal by Subject|0|||
37965488|NCT00568685|69652543|FG000|Overall Study|Adverse Event|2|||
37965489|NCT00568685|69652544|FG001|Overall Study|Adverse Event|3|||
38058571|NCT03299166|69750280|FG000|Overall Study|Randomization Error|0|||
38058572|NCT03299166|69750281|FG001|Overall Study|Randomization Error|1|||
38058573|NCT03299166|69750280|FG000|Overall Study|Subject unable to return due to COVID|1|||
38058574|NCT03299166|69750281|FG001|Overall Study|Subject unable to return due to COVID|0|||
38058575|NCT03299166|69750280|FG000|Overall Study|Unable to complete Week 12 visit at site|1|||
38058576|NCT03299166|69750281|FG001|Overall Study|Unable to complete Week 12 visit at site|0|||
38058577|NCT03204812|69750287|FG000|Overall Study|Adverse Event|3|||
37965490|NCT00568685|69652545|FG002|Overall Study|Adverse Event|3|||
38058578|NCT03201250|69750294|FG000|Overall Study|screen failures|3|||
38058579|NCT03201250|69750295|FG001|Overall Study|screen failures|0|||
38058580|NCT03201250|69750296|FG002|Overall Study|screen failures|0|||
38058581|NCT03164616|69750308|FG000|Overall Study|Death|250|||
38058582|NCT03164616|69750309|FG001|Overall Study|Death|264|||
38058583|NCT03164616|69750310|FG002|Overall Study|Death|279|||
38058584|NCT03164616|69750308|FG000|Overall Study|Lost to Follow-up|2|||
38058585|NCT03164616|69750309|FG001|Overall Study|Lost to Follow-up|2|||
38058586|NCT03164616|69750310|FG002|Overall Study|Lost to Follow-up|2|||
38058587|NCT03164616|69750308|FG000|Overall Study|Withdrawal by Subject|6|||
38058588|NCT03164616|69750309|FG001|Overall Study|Withdrawal by Subject|7|||
38058589|NCT03164616|69750310|FG002|Overall Study|Withdrawal by Subject|16|||
38058590|NCT03149029|69750322|FG000|Overall Study|Adverse Event|2|||
38058591|NCT03149029|69750323|FG001|Overall Study|Adverse Event|0|||
38058592|NCT02853305|69750333|FG000|Overall Study|Death|287|||
38058593|NCT02853305|69750334|FG001|Overall Study|Death|249|||
38058594|NCT02853305|69750335|FG002|Overall Study|Death|300|||
38058595|NCT02853305|69750333|FG000|Overall Study|Withdrawal by Subject|2|||
38058596|NCT02853305|69750334|FG001|Overall Study|Withdrawal by Subject|8|||
38058597|NCT02853305|69750335|FG002|Overall Study|Withdrawal by Subject|3|||
38058598|NCT02853305|69750333|FG000|Overall Study|Transferred to Extension Study|46|||
38058599|NCT02853305|69750334|FG001|Overall Study|Transferred to Extension Study|30|||
38058600|NCT02853305|69750335|FG002|Overall Study|Transferred to Extension Study|25|||
38058601|NCT02853305|69750333|FG000|Overall Study|Did Not Continue on Extension Study|16|||
38058602|NCT02853305|69750334|FG001|Overall Study|Did Not Continue on Extension Study|20|||
38058603|NCT02853305|69750335|FG002|Overall Study|Did Not Continue on Extension Study|24|||
38058604|NCT02524275|69750345|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
38058605|NCT02499120|69750351|FG000|Overall Study|Death|52|||
38058606|NCT02499120|69750352|FG001|Overall Study|Death|43|||
38058607|NCT02499120|69750351|FG000|Overall Study|Lost to Follow-up|1|||
38058608|NCT02499120|69750352|FG001|Overall Study|Lost to Follow-up|2|||
38058609|NCT02499120|69750351|FG000|Overall Study|Participant refused further follow-up|1|||
38058610|NCT02499120|69750352|FG001|Overall Study|Participant refused further follow-up|0|||
38058611|NCT02499120|69750351|FG000|Overall Study|Withdrawal by Subject|2|||
38058612|NCT02499120|69750352|FG001|Overall Study|Withdrawal by Subject|5|||
38058613|NCT02499120|69750351|FG000|Overall Study|Other|9|||
38058614|NCT02499120|69750352|FG001|Overall Study|Other|10|||
38058615|NCT02227992|69750360|FG000|Overall Study|Lost to Follow-up|1|||
38058616|NCT02227992|69750361|FG001|Overall Study|Lost to Follow-up|1|||
38058617|NCT01027143|69750373|FG000|Overall Study|Lost to Follow-up|9|||
38058618|NCT01027143|69750374|FG001|Overall Study|Lost to Follow-up|4|||
38058619|NCT00981656|69750380|FG000|Overall Study|Protocol Violation|1|||
38058620|NCT00981656|69750380|FG000|Overall Study|Did not start protocol treatment|2|||
38058621|NCT00895622|69750387|FG000|Overall Study|Protocol Violation|5|||
38058622|NCT00895622|69750388|FG001|Overall Study|Protocol Violation|4|||
38058623|NCT00895622|69750389|FG002|Overall Study|Protocol Violation|4|||
38058624|NCT00847535|69750405|FG000|Overall Study|Withdrawal by Subject|2|||
38058625|NCT00847535|69750406|FG001|Overall Study|Withdrawal by Subject|1|||
38058626|NCT00847535|69750407|FG002|Overall Study|Withdrawal by Subject|1|||
38058627|NCT00847535|69750405|FG000|Overall Study|Lost to Follow-up|0|||
38058628|NCT00847535|69750406|FG001|Overall Study|Lost to Follow-up|1|||
38058629|NCT00847535|69750407|FG002|Overall Study|Lost to Follow-up|0|||
38058630|NCT00539591|69750419|FG000|Overall Study|Toxicity|3|||
38058631|NCT00539591|69750420|FG001|Overall Study|Toxicity|0|||
38058632|NCT00539591|69750421|FG002|Overall Study|Toxicity|0|||
38058633|NCT00539591|69750419|FG000|Overall Study|Disease progression|2|||
37965491|NCT00568685|69652543|FG000|Overall Study|Withdrawal by Subject|7|||
37965492|NCT00568685|69652544|FG001|Overall Study|Withdrawal by Subject|2|||
37965493|NCT00568685|69652545|FG002|Overall Study|Withdrawal by Subject|2|||
37965494|NCT00568685|69652543|FG000|Overall Study|Protocol Violation|1|||
37965495|NCT00568685|69652544|FG001|Overall Study|Protocol Violation|0|||
37965496|NCT00568685|69652545|FG002|Overall Study|Protocol Violation|0|||
37965497|NCT00061945|69652559|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
37965498|NCT00061945|69652560|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
37965499|NCT00061945|69652559|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
37965500|NCT00061945|69652560|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
37965501|NCT00061945|69652559|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
38058634|NCT00539591|69750420|FG001|Overall Study|Disease progression|2|||
38058635|NCT00539591|69750421|FG002|Overall Study|Disease progression|3|||
38058636|NCT03512210|69750461|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
38058637|NCT03512210|69750461|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
38058638|NCT03512210|69750461|FG000|Step 2:Post-MINMON|Death|2|||
38058639|NCT03512210|69750461|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
38058640|NCT03512210|69750461|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
38058641|NCT00383721|69750470|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
38058642|NCT00383721|69750471|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
38058643|NCT00383721|69750472|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
38058644|NCT00383721|69750473|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
37862212|NCT01131585|69546010|FG000|Overall Study|Adverse Event|0|||
38058645|NCT00383721|69750474|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
38058646|NCT00383721|69750470|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
38058647|NCT00383721|69750471|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
38058648|NCT00383721|69750472|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
38058649|NCT00383721|69750473|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
38058650|NCT00383721|69750474|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
38058651|NCT00383721|69750470|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
38058652|NCT00383721|69750471|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
38058653|NCT00383721|69750472|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
38058654|NCT00383721|69750473|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
38058655|NCT00383721|69750474|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
38058656|NCT00383721|69750470|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
38058657|NCT00383721|69750471|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
38058658|NCT00383721|69750472|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
38058659|NCT00383721|69750473|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
38058660|NCT00383721|69750474|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
38058661|NCT00383721|69750470|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
38058662|NCT00383721|69750471|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
38058663|NCT00383721|69750472|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
38058664|NCT00383721|69750473|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
38058665|NCT00383721|69750474|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
38058666|NCT00383721|69750470|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
38058667|NCT00383721|69750471|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
38058668|NCT00383721|69750472|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
38058669|NCT00383721|69750473|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
38058670|NCT00383721|69750474|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
38058671|NCT00383721|69750470|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
38058672|NCT00383721|69750471|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
38058673|NCT00383721|69750472|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
38058674|NCT00383721|69750473|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
38058675|NCT00383721|69750474|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
38058676|NCT00383721|69750470|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
38058677|NCT00383721|69750471|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
38058678|NCT00383721|69750472|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
38058679|NCT00383721|69750473|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
38058680|NCT00383721|69750474|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
38058681|NCT00383721|69750470|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
38058682|NCT00383721|69750471|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
38058683|NCT00383721|69750472|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
38058684|NCT00383721|69750473|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
38058685|NCT00383721|69750474|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
38058686|NCT00383721|69750470|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
38058687|NCT00383721|69750471|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
38058688|NCT00383721|69750472|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
38058689|NCT00383721|69750473|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
38058690|NCT00383721|69750474|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
38058691|NCT00383721|69750470|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
38058692|NCT00383721|69750471|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
38058693|NCT00383721|69750472|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
38058694|NCT00383721|69750473|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
38058695|NCT00383721|69750474|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
38058696|NCT00383721|69750470|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
38058697|NCT00383721|69750471|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
38058698|NCT00383721|69750472|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
38058699|NCT00383721|69750473|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
38058700|NCT00383721|69750474|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
38058701|NCT00383721|69750470|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
37680372|NCT02586805|69155998|FG001|Overall Study|Withdrawal by Subject|1|||
37680373|NCT02586805|69155999|FG002|Overall Study|Withdrawal by Subject|1|||
37680374|NCT02586805|69156000|FG003|Overall Study|Withdrawal by Subject|2|||
38058702|NCT00383721|69750471|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
38058703|NCT00383721|69750472|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
38058704|NCT00383721|69750473|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
38058705|NCT00383721|69750474|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
37680375|NCT02586805|69155997|FG000|Overall Study|Adverse Event|2|||
38058706|NCT00383721|69750470|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
38058707|NCT00383721|69750471|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
38058708|NCT00383721|69750472|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
38058709|NCT00383721|69750473|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
38058710|NCT00383721|69750474|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
38058711|NCT00383721|69750470|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
38058712|NCT00383721|69750471|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
38058713|NCT00383721|69750472|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
38058714|NCT00383721|69750473|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
38058715|NCT00383721|69750474|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
38058716|NCT00383721|69750470|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
38058717|NCT00383721|69750471|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
38058718|NCT00383721|69750472|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
38058719|NCT00383721|69750473|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
38058720|NCT00383721|69750474|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
38058721|NCT00383721|69750470|FG000|26-Week Treatment Safety Extension|Administrative|1|||
38058722|NCT00383721|69750471|FG001|26-Week Treatment Safety Extension|Administrative|2|||
38058723|NCT00383721|69750472|FG002|26-Week Treatment Safety Extension|Administrative|3|||
38058724|NCT00383721|69750473|FG003|26-Week Treatment Safety Extension|Administrative|1|||
38058725|NCT00383721|69750474|FG004|26-Week Treatment Safety Extension|Administrative|0|||
38058726|NCT03035942|69750502|FG000|Overall Study|Adverse Event|8|||
38058727|NCT03035942|69750503|FG001|Overall Study|Adverse Event|4|||
38058728|NCT03035942|69750504|FG002|Overall Study|Adverse Event|5|||
38058729|NCT02616146|69750516|FG000|Overall Study|Adverse Event|64|||
38058730|NCT02616146|69750517|FG001|Overall Study|Adverse Event|24|||
38058731|NCT02616146|69750516|FG000|Overall Study|Lost to Follow-up|23|||
38058732|NCT02616146|69750517|FG001|Overall Study|Lost to Follow-up|13|||
38058733|NCT02616146|69750516|FG000|Overall Study|Non-compliance with study protocol|2|||
38058734|NCT02616146|69750517|FG001|Overall Study|Non-compliance with study protocol|0|||
38058735|NCT02616146|69750516|FG000|Overall Study|Non-compliance with study drug|4|||
38058736|NCT02616146|69750517|FG001|Overall Study|Non-compliance with study drug|2|||
38058737|NCT02616146|69750516|FG000|Overall Study|Pregnancy|2|||
38058738|NCT02616146|69750517|FG001|Overall Study|Pregnancy|2|||
38058739|NCT02616146|69750516|FG000|Overall Study|Pregnancy wish|3|||
38058740|NCT02616146|69750517|FG001|Overall Study|Pregnancy wish|0|||
38058741|NCT02616146|69750516|FG000|Overall Study|Protocol Violation|6|||
38058742|NCT02616146|69750517|FG001|Overall Study|Protocol Violation|3|||
38058743|NCT02616146|69750516|FG000|Overall Study|Study terminated by sponsor|1372|||
38058744|NCT02616146|69750517|FG001|Overall Study|Study terminated by sponsor|432|||
38058745|NCT02616146|69750516|FG000|Overall Study|Participant moved|4|||
38058746|NCT02616146|69750517|FG001|Overall Study|Participant moved|3|||
38058747|NCT02616146|69750516|FG000|Overall Study|Withdrawal by Subject|30|||
38058748|NCT02616146|69750517|FG001|Overall Study|Withdrawal by Subject|24|||
38058749|NCT02616146|69750516|FG000|Overall Study|Physician Decision|2|||
38058750|NCT02616146|69750517|FG001|Overall Study|Physician Decision|1|||
38058751|NCT04850313|69750525|FG000|Overall Study|Withdrawal by Subject|0|||
38058752|NCT04850313|69750526|FG001|Overall Study|Withdrawal by Subject|1|||
38058753|NCT03035864|69750534|FG000|Treatment Period|Adverse Event|1|||
38058754|NCT03035864|69750535|FG001|Treatment Period|Adverse Event|0|||
38058755|NCT03035864|69750534|FG000|Treatment Period|Other|3|||
38058756|NCT03035864|69750535|FG001|Treatment Period|Other|1|||
38058757|NCT03035864|69750534|FG000|Follow-up Period|Adverse Event|1|||
38058758|NCT03035864|69750535|FG001|Follow-up Period|Adverse Event|0|||
38058759|NCT03035864|69750534|FG000|Follow-up Period|Lost to Follow-up|6|||
38058760|NCT03035864|69750535|FG001|Follow-up Period|Lost to Follow-up|2|||
37965502|NCT00061945|69652560|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
37965503|NCT00061945|69652559|FG000|Course IV: Alemtuzumab|Early exits|6|||
38058761|NCT03035864|69750534|FG000|Follow-up Period|Physician Decision|1|||
38058762|NCT03035864|69750535|FG001|Follow-up Period|Physician Decision|0|||
38058763|NCT03035864|69750534|FG000|Follow-up Period|Other|3|||
38058764|NCT03035864|69750535|FG001|Follow-up Period|Other|2|||
38058765|NCT02885181|69750553|FG000|Overall Study|Investigator's Discretion|0|||
38058766|NCT02885181|69750554|FG001|Overall Study|Investigator's Discretion|1|||
38058767|NCT02885181|69750555|FG002|Overall Study|Investigator's Discretion|0|||
38058768|NCT02885181|69750556|FG003|Overall Study|Investigator's Discretion|1|||
38058769|NCT02885181|69750553|FG000|Overall Study|Adverse Event|0|||
38058770|NCT02885181|69750554|FG001|Overall Study|Adverse Event|0|||
38058771|NCT02885181|69750555|FG002|Overall Study|Adverse Event|0|||
38058772|NCT02885181|69750556|FG003|Overall Study|Adverse Event|1|||
38058773|NCT02885181|69750553|FG000|Overall Study|Withdrawal by Subject|0|||
38058774|NCT02885181|69750554|FG001|Overall Study|Withdrawal by Subject|0|||
38058775|NCT02885181|69750555|FG002|Overall Study|Withdrawal by Subject|0|||
38058776|NCT02885181|69750556|FG003|Overall Study|Withdrawal by Subject|1|||
38058777|NCT02884089|69750570|FG000|Period 1|Dosing error|2|||
38058778|NCT02884089|69750571|FG001|Period 1|Dosing error|2|||
38058779|NCT02884089|69750572|FG002|Period 1|Dosing error|0|||
38058780|NCT02884089|69750573|FG003|Period 1|Dosing error|0|||
38058781|NCT02884089|69750570|FG000|Washout Period 1|Lost to Follow-up|0|||
38058782|NCT02884089|69750571|FG001|Washout Period 1|Lost to Follow-up|1|||
38058783|NCT02884089|69750572|FG002|Washout Period 1|Lost to Follow-up|0|||
38058784|NCT02884089|69750573|FG003|Washout Period 1|Lost to Follow-up|1|||
38058785|NCT02884089|69750570|FG000|Washout Period 1|Withdrawal by Subject|0|||
38058786|NCT02884089|69750571|FG001|Washout Period 1|Withdrawal by Subject|1|||
38058787|NCT02884089|69750572|FG002|Washout Period 1|Withdrawal by Subject|0|||
38058788|NCT02884089|69750573|FG003|Washout Period 1|Withdrawal by Subject|0|||
38058789|NCT02884089|69750570|FG000|Period 2|Adverse Event|1|||
38058790|NCT02884089|69750571|FG001|Period 2|Adverse Event|0|||
38058791|NCT02884089|69750572|FG002|Period 2|Adverse Event|0|||
38058792|NCT02884089|69750573|FG003|Period 2|Adverse Event|0|||
38058793|NCT02884089|69750570|FG000|Period 3|Withdrawal by Subject|0|||
38058794|NCT02884089|69750571|FG001|Period 3|Withdrawal by Subject|0|||
38058795|NCT02884089|69750572|FG002|Period 3|Withdrawal by Subject|1|||
38058796|NCT02884089|69750573|FG003|Period 3|Withdrawal by Subject|0|||
38058797|NCT02884089|69750570|FG000|Washout Period 3|Withdrawal by Subject|0|||
38058798|NCT02884089|69750571|FG001|Washout Period 3|Withdrawal by Subject|0|||
38058799|NCT02884089|69750572|FG002|Washout Period 3|Withdrawal by Subject|1|||
38058800|NCT02884089|69750573|FG003|Washout Period 3|Withdrawal by Subject|0|||
38058801|NCT02884089|69750570|FG000|Washout Period 3|Lost to Follow-up|0|||
38058802|NCT02884089|69750571|FG001|Washout Period 3|Lost to Follow-up|0|||
38058803|NCT02884089|69750572|FG002|Washout Period 3|Lost to Follow-up|0|||
38058804|NCT02884089|69750573|FG003|Washout Period 3|Lost to Follow-up|1|||
38058805|NCT02884089|69750570|FG000|Period 4|Withdrawal by Subject|0|||
38058806|NCT02884089|69750571|FG001|Period 4|Withdrawal by Subject|1|||
38058807|NCT02884089|69750572|FG002|Period 4|Withdrawal by Subject|0|||
38058808|NCT02884089|69750573|FG003|Period 4|Withdrawal by Subject|0|||
38058809|NCT02884089|69750570|FG000|Period 4|Lost to Follow-up|1|||
38058810|NCT02884089|69750571|FG001|Period 4|Lost to Follow-up|0|||
38058811|NCT02884089|69750572|FG002|Period 4|Lost to Follow-up|0|||
38058812|NCT02884089|69750573|FG003|Period 4|Lost to Follow-up|0|||
38058813|NCT02884089|69750570|FG000|Follow-up Visit|Withdrawal by Subject|1|||
38058814|NCT02884089|69750571|FG001|Follow-up Visit|Withdrawal by Subject|0|||
38058815|NCT02884089|69750572|FG002|Follow-up Visit|Withdrawal by Subject|0|||
38058816|NCT02884089|69750573|FG003|Follow-up Visit|Withdrawal by Subject|1|||
38058817|NCT02809677|69750583|FG000|Overall Study|Withdrawal by Subject|8|||
38058818|NCT02881047|69750588|FG000|Overall Study|Adverse Event|1|||
38058819|NCT02881047|69750588|FG000|Overall Study|Withdrawal by Subject|1|||
38058820|NCT03157089|69750594|FG000|Overall Study|Treated only with pembrolizumab|1|||
38058821|NCT03157089|69750595|FG001|Overall Study|Treated only with pembrolizumab|0|||
38058822|NCT03157089|69750594|FG000|Overall Study|Adverse Event|5|||
38058823|NCT03157089|69750595|FG001|Overall Study|Adverse Event|4|||
38058824|NCT03157089|69750594|FG000|Overall Study|Progressive disease|6|||
38058825|NCT03157089|69750595|FG001|Overall Study|Progressive disease|8|||
38058826|NCT03158727|69750604|FG000|Overall Study|Withdrawal by Subject|2|||
38058827|NCT03158727|69750605|FG001|Overall Study|Withdrawal by Subject|6|||
38058828|NCT03158727|69750604|FG000|Overall Study|Death|11|||
38058829|NCT03158727|69750605|FG001|Overall Study|Death|12|||
37680376|NCT02586805|69155998|FG001|Overall Study|Adverse Event|0|||
37680377|NCT02586805|69155999|FG002|Overall Study|Adverse Event|1|||
38058830|NCT03158727|69750604|FG000|Overall Study|Lost to Follow-up|1|||
38058831|NCT03158727|69750605|FG001|Overall Study|Lost to Follow-up|0|||
38058832|NCT03158727|69750604|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
38058833|NCT03158727|69750605|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
38058834|NCT03158727|69750604|FG000|Overall Study|Visit 11 not done by mistake|0|||
38058835|NCT03158727|69750605|FG001|Overall Study|Visit 11 not done by mistake|1|||
38058836|NCT03158727|69750604|FG000|Overall Study|Enrolled, not treated|1|||
38058837|NCT03158727|69750605|FG001|Overall Study|Enrolled, not treated|0|||
38058838|NCT00089895|69750613|FG000|Overall Study|Consent Withdrawn|11|||
38058839|NCT00089895|69750614|FG001|Overall Study|Consent Withdrawn|14|||
38058840|NCT00089895|69750613|FG000|Overall Study|Technical reason|7|||
38058841|NCT00089895|69750614|FG001|Overall Study|Technical reason|2|||
38058842|NCT00089895|69750613|FG000|Overall Study|Surgery|0|||
38058843|NCT00089895|69750614|FG001|Overall Study|Surgery|1|||
38058844|NCT00089895|69750613|FG000|Overall Study|Bleeding|0|||
38058845|NCT00089895|69750614|FG001|Overall Study|Bleeding|2|||
38058846|NCT00089895|69750613|FG000|Overall Study|Physician Decision|3|||
38058847|NCT00089895|69750614|FG001|Overall Study|Physician Decision|7|||
38058848|NCT00089895|69750613|FG000|Overall Study|Exclusion criteria met|6|||
38058849|NCT00089895|69750614|FG001|Overall Study|Exclusion criteria met|6|||
38058850|NCT00089895|69750613|FG000|Overall Study|Not otherwise specified|4|||
38058851|NCT00089895|69750614|FG001|Overall Study|Not otherwise specified|8|||
38058852|NCT00089895|69750613|FG000|Overall Study|Missing|4|||
38058853|NCT00089895|69750614|FG001|Overall Study|Missing|2|||
38058854|NCT02714218|69750623|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
38058855|NCT02714218|69750624|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
38058856|NCT02714218|69750625|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
38058857|NCT02714218|69750623|FG000|Pre-Treatment Period|Other reasons|0|||
38058858|NCT02714218|69750624|FG001|Pre-Treatment Period|Other reasons|1|||
38058859|NCT02714218|69750625|FG002|Pre-Treatment Period|Other reasons|0|||
38058860|NCT02714218|69750623|FG000|Treatment Period|Disease Progression|55|||
38058861|NCT02714218|69750624|FG001|Treatment Period|Disease Progression|52|||
38058862|NCT02714218|69750625|FG002|Treatment Period|Disease Progression|14|||
38058863|NCT02714218|69750623|FG000|Treatment Period|Study drug toxicity|46|||
38058864|NCT02714218|69750624|FG001|Treatment Period|Study drug toxicity|70|||
38058865|NCT02714218|69750625|FG002|Treatment Period|Study drug toxicity|6|||
38058866|NCT02714218|69750623|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
38058867|NCT02714218|69750624|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
38058868|NCT02714218|69750625|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
38058869|NCT02714218|69750623|FG000|Treatment Period|Request to discontinue treatment|1|||
38058870|NCT02714218|69750624|FG001|Treatment Period|Request to discontinue treatment|4|||
38058871|NCT02714218|69750625|FG002|Treatment Period|Request to discontinue treatment|1|||
38058872|NCT02714218|69750623|FG000|Treatment Period|Participant withdrew consent|2|||
38058873|NCT02714218|69750624|FG001|Treatment Period|Participant withdrew consent|2|||
38058874|NCT02714218|69750625|FG002|Treatment Period|Participant withdrew consent|0|||
38058875|NCT02714218|69750623|FG000|Treatment Period|Maximum clinical benefit|4|||
38058876|NCT02714218|69750624|FG001|Treatment Period|Maximum clinical benefit|2|||
38058877|NCT02714218|69750625|FG002|Treatment Period|Maximum clinical benefit|0|||
37965504|NCT00061945|69652560|FG001|Course IV: Alemtuzumab|Early exits|15|||
37965505|NCT00642473|69652571|FG000|Overall Study|Withdrawal by Subject|0|||
37965506|NCT00642473|69652572|FG001|Overall Study|Withdrawal by Subject|5|||
37965507|NCT00642473|69652571|FG000|Overall Study|Progression or death|2|||
37965508|NCT00642473|69652572|FG001|Overall Study|Progression or death|4|||
37965509|NCT00642473|69652571|FG000|Overall Study|Other|2|||
37965510|NCT00642473|69652572|FG001|Overall Study|Other|2|||
37965511|NCT00645671|69652583|FG000|Overall Study|Protocol Violation|1|||
37965512|NCT00645671|69652584|FG001|Overall Study|Protocol Violation|0|||
37965513|NCT00645671|69652583|FG000|Overall Study|Withdrawal by Subject|0|||
37965514|NCT00645671|69652584|FG001|Overall Study|Withdrawal by Subject|4|||
37965515|NCT00645671|69652583|FG000|Overall Study|Adverse Event|0|||
37965516|NCT00645671|69652584|FG001|Overall Study|Adverse Event|1|||
37965517|NCT00645671|69652583|FG000|Overall Study|Physician Decision|0|||
37965518|NCT00645671|69652584|FG001|Overall Study|Physician Decision|1|||
37965519|NCT00366340|69652592|FG000|Infant Series|Protocol Violation|3|||
37965520|NCT00366340|69652593|FG001|Infant Series|Protocol Violation|4|||
37965521|NCT00366340|69652592|FG000|Infant Series|Withdrawal by Subject|3|||
37965522|NCT00366340|69652593|FG001|Infant Series|Withdrawal by Subject|3|||
37965523|NCT00366340|69652592|FG000|Infant Series|Adverse Event|0|||
37965524|NCT00366340|69652593|FG001|Infant Series|Adverse Event|2|||
37965525|NCT00366340|69652592|FG000|Infant Series|Lost to Follow-up|1|||
37965526|NCT00366340|69652593|FG001|Infant Series|Lost to Follow-up|1|||
37965527|NCT00366340|69652592|FG000|Infant Series|Failure to return|1|||
37965528|NCT00366340|69652593|FG001|Infant Series|Failure to return|0|||
37965529|NCT00366340|69652592|FG000|After the Infant Series|Parent/legal guardian request|1|||
37965530|NCT00366340|69652593|FG001|After the Infant Series|Parent/legal guardian request|1|||
37965531|NCT00366340|69652592|FG000|After the Infant Series|Failed to return|0|||
37965532|NCT00366340|69652593|FG001|After the Infant Series|Failed to return|1|||
37965533|NCT00366340|69652592|FG000|After the Infant Series|Protocol Violation|2|||
37965534|NCT00366340|69652593|FG001|After the Infant Series|Protocol Violation|2|||
37965535|NCT00366340|69652592|FG000|After the Infant Series|Adverse Event|0|||
37965536|NCT00366340|69652593|FG001|After the Infant Series|Adverse Event|1|||
37965537|NCT00366340|69652592|FG000|After the Infant Series|Lost to Follow-up|0|||
37965538|NCT00366340|69652593|FG001|After the Infant Series|Lost to Follow-up|1|||
37965539|NCT00366340|69652592|FG000|Toddler Dose|Failed to return|1|||
37965540|NCT00366340|69652593|FG001|Toddler Dose|Failed to return|0|||
37965541|NCT00366340|69652592|FG000|Toddler Dose|Parent/legal guardian request|0|||
37965542|NCT00366340|69652593|FG001|Toddler Dose|Parent/legal guardian request|1|||
37965543|NCT00061633|69652625|FG000|Overall Study|Adverse Event|1|||
37965544|NCT00061633|69652626|FG001|Overall Study|Adverse Event|2|||
37965545|NCT00061633|69652625|FG000|Overall Study|Withdrawal by Subject|2|||
37965546|NCT00061633|69652626|FG001|Overall Study|Withdrawal by Subject|2|||
38058878|NCT02714218|69750623|FG000|Treatment Period|Administrative reason by sponsor|2|||
38058879|NCT02714218|69750624|FG001|Treatment Period|Administrative reason by sponsor|1|||
37965547|NCT00061633|69652625|FG000|Overall Study|Lost to Follow-up|1|||
38058880|NCT02714218|69750625|FG002|Treatment Period|Administrative reason by sponsor|0|||
38058881|NCT02714218|69750623|FG000|Treatment Period|Other reasons|6|||
38058882|NCT02714218|69750624|FG001|Treatment Period|Other reasons|6|||
38058883|NCT02714218|69750625|FG002|Treatment Period|Other reasons|0|||
38058884|NCT02714218|69750623|FG000|Treatment Period|Completed treatment as per protocol|36|||
38058885|NCT02714218|69750624|FG001|Treatment Period|Completed treatment as per protocol|27|||
38058886|NCT02714218|69750625|FG002|Treatment Period|Completed treatment as per protocol|3|||
38058887|NCT02714218|69750623|FG000|Treatment Period|Not reported|9|||
38058888|NCT02714218|69750624|FG001|Treatment Period|Not reported|6|||
38058889|NCT02714218|69750625|FG002|Treatment Period|Not reported|0|||
38058890|NCT03154047|69750632|FG000|Overall Study|Death|1|||
38058891|NCT03154047|69750632|FG000|Overall Study|Study terminated by sponsor|76|||
38058892|NCT03154047|69750632|FG000|Overall Study|Withdrawal by Subject|3|||
38058893|NCT03156621|69750638|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
38058894|NCT03156621|69750639|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
38058895|NCT03156621|69750638|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
38058896|NCT03156621|69750639|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
38058897|NCT03156543|69750650|FG000|Overall Study|Withdrawal by Subject|1|||
38058898|NCT03156543|69750651|FG001|Overall Study|Withdrawal by Subject|0|||
38058899|NCT02713594|69750659|FG000|Overall Study|Withdrawal by Subject|32|||
38058900|NCT02713594|69750660|FG001|Overall Study|Withdrawal by Subject|22|||
38058901|NCT02713594|69750659|FG000|Overall Study|Lost to Follow-up|358|||
38058902|NCT02713594|69750660|FG001|Overall Study|Lost to Follow-up|374|||
38058903|NCT03152019|69750670|FG000|Overall Study|Adverse Event|0|||
38058904|NCT03152019|69750671|FG001|Overall Study|Adverse Event|1|||
38058905|NCT02714062|69750684|FG000|Overall Study|Adverse Event|0|||
38058906|NCT02714062|69750685|FG001|Overall Study|Adverse Event|0|||
38058907|NCT02714062|69750686|FG002|Overall Study|Adverse Event|2|||
38058908|NCT02714062|69750684|FG000|Overall Study|Withdrawal by Subject|1|||
38058909|NCT02714062|69750685|FG001|Overall Study|Withdrawal by Subject|0|||
38058910|NCT02714062|69750686|FG002|Overall Study|Withdrawal by Subject|1|||
38058911|NCT02714062|69750684|FG000|Overall Study|Protocol Violation|0|||
38058912|NCT02714062|69750685|FG001|Overall Study|Protocol Violation|1|||
38058913|NCT02714062|69750686|FG002|Overall Study|Protocol Violation|0|||
38058914|NCT03151395|69750696|FG000|Overall Study|Adverse Event|2|||
38058915|NCT03151395|69750696|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
38058916|NCT03151395|69750696|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
38058917|NCT03151395|69750696|FG000|Overall Study|Unspecified reason|4|||
38058918|NCT02713828|69750702|FG000|Overall Study|Death|2|||
38058919|NCT02713828|69750703|FG001|Overall Study|Death|0|||
38058920|NCT02713828|69750702|FG000|Overall Study|Withdrawal by Subject|1|||
38058921|NCT02713828|69750703|FG001|Overall Study|Withdrawal by Subject|0|||
38058922|NCT02713828|69750702|FG000|Overall Study|study terminated but patient allowed to|2|||
38058923|NCT02713828|69750703|FG001|Overall Study|study terminated but patient allowed to|0|||
38058924|NCT02876328|69750732|FG000|Overall Study|Death|2|||
38058925|NCT02876328|69750733|FG001|Overall Study|Death|1|||
38058926|NCT02876328|69750734|FG002|Overall Study|Death|3|||
38058927|NCT02876328|69750735|FG003|Overall Study|Death|0|||
38058928|NCT02876328|69750736|FG004|Overall Study|Death|0|||
38058929|NCT02876328|69750737|FG005|Overall Study|Death|0|||
38058930|NCT02876328|69750738|FG006|Overall Study|Death|1|||
38058931|NCT02876328|69750739|FG007|Overall Study|Death|3|||
38058932|NCT02876328|69750740|FG008|Overall Study|Death|0|||
38058933|NCT02876328|69750741|FG009|Overall Study|Death|1|||
38058934|NCT02876328|69750742|FG010|Overall Study|Death|1|||
38058935|NCT02876328|69750743|FG011|Overall Study|Death|0|||
38058936|NCT02876328|69750744|FG012|Overall Study|Death|0|||
38058937|NCT02876328|69750745|FG013|Overall Study|Death|0|||
38058938|NCT02876328|69750746|FG014|Overall Study|Death|0|||
38058939|NCT02876328|69750747|FG015|Overall Study|Death|0|||
38058940|NCT02876328|69750748|FG016|Overall Study|Death|1|||
38058941|NCT02876328|69750749|FG017|Overall Study|Death|1|||
38058942|NCT02876328|69750750|FG018|Overall Study|Death|0|||
38058943|NCT02876328|69750751|FG019|Overall Study|Death|0|||
38058944|NCT02876328|69750752|FG020|Overall Study|Death|0|||
38058945|NCT02876328|69750753|FG021|Overall Study|Death|1|||
37965548|NCT00061633|69652626|FG001|Overall Study|Lost to Follow-up|4|||
38058946|NCT02876328|69750754|FG022|Overall Study|Death|0|||
38058947|NCT02876328|69750755|FG023|Overall Study|Death|0|||
38058948|NCT02876328|69750732|FG000|Overall Study|Withdrawal by Subject|0|||
38058949|NCT02876328|69750733|FG001|Overall Study|Withdrawal by Subject|2|||
38058950|NCT02876328|69750734|FG002|Overall Study|Withdrawal by Subject|3|||
38058951|NCT02876328|69750735|FG003|Overall Study|Withdrawal by Subject|3|||
38058952|NCT02876328|69750736|FG004|Overall Study|Withdrawal by Subject|0|||
38058953|NCT02876328|69750737|FG005|Overall Study|Withdrawal by Subject|1|||
38058954|NCT02876328|69750738|FG006|Overall Study|Withdrawal by Subject|0|||
38058955|NCT02876328|69750739|FG007|Overall Study|Withdrawal by Subject|1|||
38058956|NCT02876328|69750740|FG008|Overall Study|Withdrawal by Subject|1|||
38058957|NCT02876328|69750741|FG009|Overall Study|Withdrawal by Subject|2|||
37680378|NCT02586805|69156000|FG003|Overall Study|Adverse Event|0|||
38058958|NCT02876328|69750742|FG010|Overall Study|Withdrawal by Subject|0|||
38058959|NCT02876328|69750743|FG011|Overall Study|Withdrawal by Subject|0|||
38058960|NCT02876328|69750744|FG012|Overall Study|Withdrawal by Subject|0|||
38058961|NCT02876328|69750745|FG013|Overall Study|Withdrawal by Subject|0|||
38058962|NCT02876328|69750746|FG014|Overall Study|Withdrawal by Subject|0|||
38058963|NCT02876328|69750747|FG015|Overall Study|Withdrawal by Subject|0|||
38058964|NCT02876328|69750748|FG016|Overall Study|Withdrawal by Subject|1|||
38058965|NCT02876328|69750749|FG017|Overall Study|Withdrawal by Subject|3|||
38058966|NCT02876328|69750750|FG018|Overall Study|Withdrawal by Subject|0|||
38058967|NCT02876328|69750751|FG019|Overall Study|Withdrawal by Subject|0|||
38058968|NCT02876328|69750752|FG020|Overall Study|Withdrawal by Subject|1|||
38058969|NCT02876328|69750753|FG021|Overall Study|Withdrawal by Subject|0|||
38058970|NCT02876328|69750754|FG022|Overall Study|Withdrawal by Subject|0|||
38058971|NCT02876328|69750755|FG023|Overall Study|Withdrawal by Subject|0|||
38058972|NCT02876328|69750732|FG000|Overall Study|Missed 12 Month Visit|15|||
38058973|NCT02876328|69750733|FG001|Overall Study|Missed 12 Month Visit|10|||
38058974|NCT02876328|69750734|FG002|Overall Study|Missed 12 Month Visit|11|||
38058975|NCT02876328|69750735|FG003|Overall Study|Missed 12 Month Visit|6|||
38058976|NCT02876328|69750736|FG004|Overall Study|Missed 12 Month Visit|10|||
38058977|NCT02876328|69750737|FG005|Overall Study|Missed 12 Month Visit|14|||
38058978|NCT02876328|69750738|FG006|Overall Study|Missed 12 Month Visit|3|||
38058979|NCT02876328|69750739|FG007|Overall Study|Missed 12 Month Visit|8|||
38058980|NCT02876328|69750740|FG008|Overall Study|Missed 12 Month Visit|9|||
38058981|NCT02876328|69750741|FG009|Overall Study|Missed 12 Month Visit|5|||
38058982|NCT02876328|69750742|FG010|Overall Study|Missed 12 Month Visit|4|||
38058983|NCT02876328|69750743|FG011|Overall Study|Missed 12 Month Visit|1|||
38058984|NCT02876328|69750744|FG012|Overall Study|Missed 12 Month Visit|5|||
38058985|NCT02876328|69750745|FG013|Overall Study|Missed 12 Month Visit|4|||
38058986|NCT02876328|69750746|FG014|Overall Study|Missed 12 Month Visit|4|||
38058987|NCT02876328|69750747|FG015|Overall Study|Missed 12 Month Visit|4|||
38058988|NCT02876328|69750748|FG016|Overall Study|Missed 12 Month Visit|3|||
38058989|NCT02876328|69750749|FG017|Overall Study|Missed 12 Month Visit|6|||
38058990|NCT02876328|69750750|FG018|Overall Study|Missed 12 Month Visit|2|||
38058991|NCT02876328|69750751|FG019|Overall Study|Missed 12 Month Visit|2|||
38058992|NCT02876328|69750752|FG020|Overall Study|Missed 12 Month Visit|11|||
38058993|NCT02876328|69750753|FG021|Overall Study|Missed 12 Month Visit|7|||
38058994|NCT02876328|69750754|FG022|Overall Study|Missed 12 Month Visit|1|||
38058995|NCT02876328|69750755|FG023|Overall Study|Missed 12 Month Visit|0|||
38058996|NCT02875860|69750783|FG000|Overall Study|Withdrawal by Subject|0|||
38058997|NCT02875860|69750784|FG001|Overall Study|Withdrawal by Subject|1|||
38058998|NCT02875392|69750792|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
38058999|NCT02875392|69750793|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
38059000|NCT03127644|69750802|FG000|Overall Study|Study-specific withdrawal criteria|0|||
38059001|NCT03127644|69750803|FG001|Overall Study|Study-specific withdrawal criteria|0|||
38059002|NCT03127644|69750804|FG002|Overall Study|Study-specific withdrawal criteria|2|||
38059003|NCT03965962|69750818|FG000|Overall Study|Adverse Event|1|||
38059004|NCT03965962|69750819|FG001|Overall Study|Adverse Event|0|||
38059005|NCT03965962|69750820|FG002|Overall Study|Adverse Event|0|||
38059006|NCT03965962|69750821|FG003|Overall Study|Adverse Event|0|||
38059007|NCT03965962|69750818|FG000|Overall Study|Protocol Violation|21|||
38059008|NCT03965962|69750819|FG001|Overall Study|Protocol Violation|4|||
38059009|NCT03965962|69750820|FG002|Overall Study|Protocol Violation|10|||
38059010|NCT03965962|69750821|FG003|Overall Study|Protocol Violation|5|||
38059011|NCT03965962|69750818|FG000|Overall Study|Lost to Follow-up|0|||
37965549|NCT00061633|69652625|FG000|Overall Study|Other|1|||
38059012|NCT03965962|69750819|FG001|Overall Study|Lost to Follow-up|1|||
38059013|NCT03965962|69750820|FG002|Overall Study|Lost to Follow-up|0|||
38059014|NCT03965962|69750821|FG003|Overall Study|Lost to Follow-up|0|||
38059015|NCT03965962|69750818|FG000|Overall Study|Withdrawal by Subject|3|||
38059016|NCT03965962|69750819|FG001|Overall Study|Withdrawal by Subject|0|||
38059017|NCT03965962|69750820|FG002|Overall Study|Withdrawal by Subject|0|||
38059018|NCT03965962|69750821|FG003|Overall Study|Withdrawal by Subject|1|||
38059019|NCT03151551|69750833|FG000|Open-Label Treatment Period|Adverse Event|0|||
38059020|NCT03151551|69750834|FG001|Open-Label Treatment Period|Adverse Event|2|||
38059021|NCT03151551|69750833|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
38059022|NCT03151551|69750834|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
38059023|NCT03151551|69750833|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
38059024|NCT03151551|69750834|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
38059025|NCT03151551|69750833|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
38059026|NCT03151551|69750834|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
38059027|NCT03151551|69750833|FG000|Open-Label Treatment Period|Physician Decision|3|||
38059028|NCT03151551|69750834|FG001|Open-Label Treatment Period|Physician Decision|0|||
38059029|NCT03151551|69750833|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
38059030|NCT03151551|69750834|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
38059031|NCT03151551|69750833|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
38059032|NCT03151551|69750834|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
38059033|NCT03151551|69750833|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
38059034|NCT03151551|69750834|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
38059035|NCT03151551|69750833|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
38059036|NCT03151551|69750834|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
38059037|NCT03151551|69750833|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
38059038|NCT03151551|69750834|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
38059039|NCT03147495|69750844|FG000|Overall Study|Physician Decision|0|||
38059040|NCT03147495|69750845|FG001|Overall Study|Physician Decision|6|||
38059041|NCT03126786|69750853|FG000|Overall Study|Adverse Event|3|||
38059042|NCT03126786|69750854|FG001|Overall Study|Adverse Event|0|||
38059043|NCT03126786|69750853|FG000|Overall Study|Lost to Follow-up|0|||
38059044|NCT03126786|69750854|FG001|Overall Study|Lost to Follow-up|1|||
38059045|NCT03126786|69750853|FG000|Overall Study|Withdrawal by Subject|3|||
38059046|NCT03126786|69750854|FG001|Overall Study|Withdrawal by Subject|1|||
38059047|NCT03146403|69750862|FG000|Overall Study|Withdrawal by Subject|0|||
38059048|NCT03146403|69750863|FG001|Overall Study|Withdrawal by Subject|3|||
38059049|NCT03146403|69750862|FG000|Overall Study|Lost to Follow-up|2|||
38059050|NCT03146403|69750863|FG001|Overall Study|Lost to Follow-up|0|||
38059051|NCT02713204|69750872|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
38059052|NCT02713204|69750873|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
38059053|NCT02713204|69750874|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
38059054|NCT02713204|69750875|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
38059055|NCT02713204|69750876|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
38059056|NCT02713204|69750877|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
38059057|NCT02713204|69750878|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
38059058|NCT02713204|69750879|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
38059059|NCT02713204|69750872|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
38059060|NCT02713204|69750873|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
38059061|NCT02713204|69750874|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
38059062|NCT02713204|69750875|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
38059063|NCT02713204|69750876|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
38059064|NCT02713204|69750877|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
38059065|NCT02713204|69750878|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
38059066|NCT02713204|69750879|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
38059067|NCT02713204|69750872|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
38059068|NCT02713204|69750873|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
38059069|NCT02713204|69750874|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
38059070|NCT02713204|69750875|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
38059071|NCT02713204|69750876|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
38059072|NCT02713204|69750877|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
38059073|NCT02713204|69750878|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
38059074|NCT02713204|69750879|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
38059075|NCT02713204|69750872|FG000|From Week 12 up to Week 36|Adverse Event|1|||
38059076|NCT02713204|69750873|FG001|From Week 12 up to Week 36|Adverse Event|0|||
38059077|NCT02713204|69750874|FG002|From Week 12 up to Week 36|Adverse Event|0|||
38059078|NCT02713204|69750875|FG003|From Week 12 up to Week 36|Adverse Event|1|||
38059079|NCT02713204|69750876|FG004|From Week 12 up to Week 36|Adverse Event|1|||
38059080|NCT02713204|69750877|FG005|From Week 12 up to Week 36|Adverse Event|0|||
38059081|NCT02713204|69750878|FG006|From Week 12 up to Week 36|Adverse Event|2|||
38059082|NCT02713204|69750879|FG007|From Week 12 up to Week 36|Adverse Event|1|||
38059083|NCT02713204|69750872|FG000|From Week 12 up to Week 36|Death|0|||
38059084|NCT02713204|69750873|FG001|From Week 12 up to Week 36|Death|0|||
38059085|NCT02713204|69750874|FG002|From Week 12 up to Week 36|Death|0|||
38059086|NCT02713204|69750875|FG003|From Week 12 up to Week 36|Death|1|||
38059087|NCT02713204|69750876|FG004|From Week 12 up to Week 36|Death|0|||
38059088|NCT02713204|69750877|FG005|From Week 12 up to Week 36|Death|1|||
38059089|NCT02713204|69750878|FG006|From Week 12 up to Week 36|Death|0|||
38059090|NCT02713204|69750879|FG007|From Week 12 up to Week 36|Death|3|||
38059091|NCT02713204|69750872|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
38059092|NCT02713204|69750873|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
37965550|NCT00061633|69652626|FG001|Overall Study|Other|1|||
37965551|NCT00061633|69652625|FG000|Overall Study|Never received study treatment|0|||
38059093|NCT02713204|69750874|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
38059094|NCT02713204|69750875|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
38059095|NCT02713204|69750876|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
38059096|NCT02713204|69750877|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
38059097|NCT02713204|69750878|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
38059098|NCT02713204|69750879|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
38059099|NCT02713204|69750872|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
38059100|NCT02713204|69750873|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
38059101|NCT02713204|69750874|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
38059102|NCT02713204|69750875|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
38059103|NCT02713204|69750876|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
38059104|NCT02713204|69750877|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
38059105|NCT02713204|69750878|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
38059106|NCT02713204|69750879|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
38059107|NCT03695172|69750899|FG000|Overall Study|Withdrawal by Subject|1|||
38059108|NCT03695172|69750900|FG001|Overall Study|Withdrawal by Subject|1|||
38059109|NCT03695172|69750901|FG002|Overall Study|Withdrawal by Subject|0|||
38059110|NCT03721107|69750913|FG000|Overall Study|Adverse Event|1|||
38059111|NCT03721107|69750914|FG001|Overall Study|Adverse Event|1|||
38059112|NCT03721107|69750915|FG002|Overall Study|Adverse Event|6|||
38059113|NCT03721107|69750916|FG003|Overall Study|Adverse Event|5|||
38059114|NCT03721107|69750913|FG000|Overall Study|Lost to Follow-up|2|||
38059115|NCT03721107|69750914|FG001|Overall Study|Lost to Follow-up|0|||
38059116|NCT03721107|69750915|FG002|Overall Study|Lost to Follow-up|3|||
38059117|NCT03721107|69750916|FG003|Overall Study|Lost to Follow-up|0|||
38059118|NCT03721107|69750913|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
38059119|NCT03721107|69750914|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
38059120|NCT03721107|69750915|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
38059121|NCT03721107|69750916|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
38059122|NCT03721107|69750913|FG000|Overall Study|Physician Decision|0|||
38059123|NCT03721107|69750914|FG001|Overall Study|Physician Decision|1|||
38059124|NCT03721107|69750915|FG002|Overall Study|Physician Decision|0|||
38059125|NCT03721107|69750916|FG003|Overall Study|Physician Decision|0|||
38059126|NCT03721107|69750913|FG000|Overall Study|Pregnancy|0|||
38059127|NCT03721107|69750914|FG001|Overall Study|Pregnancy|0|||
38059128|NCT03721107|69750915|FG002|Overall Study|Pregnancy|1|||
38059129|NCT03721107|69750916|FG003|Overall Study|Pregnancy|0|||
38059130|NCT03721107|69750913|FG000|Overall Study|Withdrawal by Subject|1|||
38059131|NCT03721107|69750914|FG001|Overall Study|Withdrawal by Subject|1|||
38059132|NCT03721107|69750915|FG002|Overall Study|Withdrawal by Subject|5|||
38059133|NCT03721107|69750916|FG003|Overall Study|Withdrawal by Subject|5|||
38059134|NCT03721107|69750913|FG000|Overall Study|Other|1|||
38059135|NCT03721107|69750914|FG001|Overall Study|Other|0|||
38059136|NCT03721107|69750915|FG002|Overall Study|Other|0|||
38059137|NCT03721107|69750916|FG003|Overall Study|Other|1|||
38059138|NCT03052920|69750935|FG000|Overall Study|Withdrawal by Subject|1|||
38059139|NCT02930226|69750945|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
38059140|NCT02930226|69750946|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
38059141|NCT02930226|69750947|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
38059142|NCT02930226|69750948|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
38059143|NCT02930226|69750949|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
38059144|NCT02930226|69750950|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
38059145|NCT02722434|69750987|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
38059146|NCT02722434|69750988|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
38059147|NCT02722434|69750987|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
38059148|NCT02722434|69750988|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
38059149|NCT03539601|69750998|FG000|Overall Study|Withdraw by parent/guardian|1|||
38059150|NCT03539601|69750999|FG001|Overall Study|Withdraw by parent/guardian|0|||
38059151|NCT03539601|69751000|FG002|Overall Study|Withdraw by parent/guardian|1|||
38059152|NCT03539601|69751001|FG003|Overall Study|Withdraw by parent/guardian|0|||
38059153|NCT03539601|69750998|FG000|Overall Study|Adverse Event|0|||
38059154|NCT03539601|69750999|FG001|Overall Study|Adverse Event|2|||
38059155|NCT03539601|69751000|FG002|Overall Study|Adverse Event|0|||
38059156|NCT03539601|69751001|FG003|Overall Study|Adverse Event|0|||
38059157|NCT03539601|69750998|FG000|Overall Study|Lost to Follow-up|2|||
38059158|NCT03539601|69750999|FG001|Overall Study|Lost to Follow-up|4|||
38059159|NCT03539601|69751000|FG002|Overall Study|Lost to Follow-up|5|||
38059160|NCT03539601|69751001|FG003|Overall Study|Lost to Follow-up|0|||
38059161|NCT03539601|69750998|FG000|Overall Study|Withdrawal by Subject|2|||
38059162|NCT03539601|69750999|FG001|Overall Study|Withdrawal by Subject|0|||
38059163|NCT03539601|69751000|FG002|Overall Study|Withdrawal by Subject|0|||
38059164|NCT03539601|69751001|FG003|Overall Study|Withdrawal by Subject|1|||
38059165|NCT03539601|69750998|FG000|Overall Study|Randomized but not treated|1|||
38059166|NCT03539601|69750999|FG001|Overall Study|Randomized but not treated|1|||
38059167|NCT03539601|69751000|FG002|Overall Study|Randomized but not treated|0|||
38059168|NCT03539601|69751001|FG003|Overall Study|Randomized but not treated|0|||
38059169|NCT00700804|69751021|FG000|Overall Study|Withdrawal by Subject|1|||
38059170|NCT00700804|69751022|FG001|Overall Study|Withdrawal by Subject|2|||
38059171|NCT00700804|69751021|FG000|Overall Study|Protocol Violation|1|||
38059172|NCT00700804|69751022|FG001|Overall Study|Protocol Violation|1|||
38059173|NCT00700804|69751021|FG000|Overall Study|Loose Stools|1|||
38059174|NCT00700804|69751022|FG001|Overall Study|Loose Stools|1|||
38059175|NCT02903823|69751028|FG000|Overall Study|Physician Decision|5|||
38059176|NCT02903823|69751028|FG000|Overall Study|Could not advance catheter|1|||
38059177|NCT02903823|69751028|FG000|Overall Study|Catheter dislodgement|1|||
38059178|NCT00832455|69751057|FG000|Overall Study|Adverse Event|13|||
38059179|NCT00832455|69751057|FG000|Overall Study|Lost to Follow-up|26|||
38059180|NCT00832455|69751057|FG000|Overall Study|Protocol Violation|4|||
38059181|NCT00832455|69751057|FG000|Overall Study|Withdrawal by Subject|17|||
38059182|NCT00832455|69751057|FG000|Overall Study|Screening Failure|2|||
38059183|NCT00832455|69751057|FG000|Overall Study|Stopped Medication|4|||
38059184|NCT00832455|69751057|FG000|Overall Study|Parent misunderstood study|1|||
38059185|NCT00832455|69751057|FG000|Overall Study|Parent dissatisfied|1|||
38059186|NCT00832455|69751057|FG000|Overall Study|No improvement|3|||
38059187|NCT00832455|69751057|FG000|Overall Study|Patient moved|1|||
38059188|NCT00687531|69751070|FG000|Overall Study|Did not meet protocol eligibility|104|||
38059189|NCT00687531|69751070|FG000|Overall Study|Adverse Event|5|||
38059190|NCT00687531|69751070|FG000|Overall Study|Lost to Follow-up|26|||
38059191|NCT00423579|69751076|FG000|Overall Study|Lost to Follow-up|3|||
38059192|NCT00423579|69751077|FG001|Overall Study|Lost to Follow-up|0|||
38059193|NCT00423579|69751076|FG000|Overall Study|Protocol Violation|1|||
38059194|NCT00423579|69751077|FG001|Overall Study|Protocol Violation|3|||
38059195|NCT00423579|69751076|FG000|Overall Study|Diagnosis of diabetes|0|||
38059196|NCT00423579|69751077|FG001|Overall Study|Diagnosis of diabetes|1|||
38059197|NCT03268005|69751085|FG000|Overall Study|Death|2|||
38059198|NCT03268005|69751086|FG001|Overall Study|Death|1|||
38059199|NCT03268005|69751085|FG000|Overall Study|Lost to Follow-up|2|||
38059200|NCT03268005|69751086|FG001|Overall Study|Lost to Follow-up|2|||
38059201|NCT03268005|69751085|FG000|Overall Study|Withdrawal by Subject|11|||
38059202|NCT03268005|69751086|FG001|Overall Study|Withdrawal by Subject|11|||
38059203|NCT03149055|69751092|FG000|Overall Study|Not treated|4|||
38059204|NCT03137121|69751107|FG000|Overall Study|Withdrawal by Subject|0|||
38059205|NCT03137121|69751108|FG001|Overall Study|Withdrawal by Subject|1|||
38059206|NCT00700570|69751151|FG000|Overall Study|Adverse Event|2|||
38059207|NCT00700570|69751152|FG001|Overall Study|Adverse Event|6|||
38059208|NCT00700570|69751151|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
38059209|NCT00700570|69751152|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
38059210|NCT00700570|69751151|FG000|Overall Study|Disease Progression|8|||
38059211|NCT00700570|69751152|FG001|Overall Study|Disease Progression|11|||
38059212|NCT00700570|69751151|FG000|Overall Study|Withdrawal by Subject|1|||
38059213|NCT00700570|69751152|FG001|Overall Study|Withdrawal by Subject|6|||
38059214|NCT02874924|69751170|FG000|Overall Study|Adverse Event|2|||
38059215|NCT02874924|69751171|FG001|Overall Study|Adverse Event|0|||
38059216|NCT02874924|69751172|FG002|Overall Study|Adverse Event|0|||
38059217|NCT02874924|69751170|FG000|Overall Study|Withdrawal by Subject|1|||
38059218|NCT02874924|69751171|FG001|Overall Study|Withdrawal by Subject|0|||
38059219|NCT02874924|69751172|FG002|Overall Study|Withdrawal by Subject|0|||
38059220|NCT04425863|69751183|FG000|Overall Study|Death|0|||
38059221|NCT04425863|69751184|FG001|Overall Study|Death|0|||
38059222|NCT04425863|69751185|FG002|Overall Study|Death|1|||
38059223|NCT04360187|69751207|FG000|Double-Blind Treatment|Adverse Event|9|||
38059224|NCT04360187|69751208|FG001|Double-Blind Treatment|Adverse Event|11|||
38059225|NCT04360187|69751207|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
38059226|NCT04360187|69751208|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
38059227|NCT04360187|69751207|FG000|Double-Blind Treatment|Physician Decision|1|||
38059228|NCT04360187|69751208|FG001|Double-Blind Treatment|Physician Decision|0|||
38059229|NCT04360187|69751207|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
38059230|NCT04360187|69751208|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
38059231|NCT04360187|69751207|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
38059232|NCT04360187|69751208|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
38059233|NCT04360187|69751207|FG000|Follow-Up|Lost to Follow-up|1|||
38059234|NCT04360187|69751208|FG001|Follow-Up|Lost to Follow-up|0|||
38059235|NCT04498169|69751216|FG000|Study Completion|Adverse Event|1|||
38059236|NCT04498169|69751217|FG001|Study Completion|Adverse Event|1|||
38059237|NCT03695393|69751225|FG000|Overall Study|Death|3|||
38059238|NCT03695393|69751226|FG001|Overall Study|Death|1|||
38059239|NCT03695393|69751225|FG000|Overall Study|Lost to Follow-up|0|||
38059240|NCT03695393|69751226|FG001|Overall Study|Lost to Follow-up|1|||
38059241|NCT03694925|69751235|FG000|Overall Study|Inadequate laboratory testing|0|||
38059242|NCT03694925|69751236|FG001|Overall Study|Inadequate laboratory testing|3|||
38059243|NCT03694925|69751237|FG002|Overall Study|Inadequate laboratory testing|0|||
38059244|NCT04258020|69751249|FG000|Overall Study|Withdrawal by Subject|1|||
38059245|NCT04258020|69751250|FG001|Overall Study|Withdrawal by Subject|0|||
38059246|NCT04495283|69751259|FG000|Overall Study|Physician Decision|0|||
38059247|NCT04495283|69751260|FG001|Overall Study|Physician Decision|0|||
38059248|NCT04495283|69751261|FG002|Overall Study|Physician Decision|1|||
38059249|NCT04495283|69751259|FG000|Overall Study|Withdrawal by Subject|0|||
38059250|NCT04495283|69751260|FG001|Overall Study|Withdrawal by Subject|1|||
38059251|NCT04495283|69751261|FG002|Overall Study|Withdrawal by Subject|1|||
38059252|NCT04495283|69751259|FG000|Overall Study|Other|1|||
38059253|NCT04495283|69751260|FG001|Overall Study|Other|0|||
38059254|NCT04495283|69751261|FG002|Overall Study|Other|1|||
38059255|NCT03117738|69751274|FG000|Overall Study|Withdrawal by Subject|3|||
38059256|NCT03117738|69751275|FG001|Overall Study|Withdrawal by Subject|1|||
38059257|NCT03117738|69751274|FG000|Overall Study|Lost to Follow-up|1|||
38059258|NCT03117738|69751275|FG001|Overall Study|Lost to Follow-up|4|||
38059259|NCT04234464|69751283|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
38059260|NCT04234464|69751284|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
38059261|NCT03123588|69751292|FG000|Overall Study|Study Terminated by Sponsor|2|||
38059262|NCT03123588|69751293|FG001|Overall Study|Study Terminated by Sponsor|5|||
38059263|NCT03123588|69751292|FG000|Overall Study|Withdrawal by Subject|1|||
38059264|NCT03123588|69751293|FG001|Overall Study|Withdrawal by Subject|0|||
38059265|NCT03123588|69751292|FG000|Overall Study|Adverse Event|1|||
38059266|NCT03123588|69751293|FG001|Overall Study|Adverse Event|0|||
38059267|NCT03123588|69751292|FG000|Overall Study|Physician Decision|2|||
38059268|NCT03123588|69751293|FG001|Overall Study|Physician Decision|1|||
38059269|NCT03123354|69751300|FG000|Overall Study|Physician Decision|6|||
38059270|NCT04421027|69751306|FG000|Treatment Period|Adverse Event|5|||
38059271|NCT04421027|69751307|FG001|Treatment Period|Adverse Event|3|||
38059272|NCT04421027|69751308|FG002|Treatment Period|Adverse Event|0|||
38059273|NCT04421027|69751309|FG003|Treatment Period|Adverse Event|0|||
38059274|NCT04421027|69751306|FG000|Treatment Period|Death|98|||
38059275|NCT04421027|69751307|FG001|Treatment Period|Death|61|||
38059276|NCT04421027|69751308|FG002|Treatment Period|Death|0|||
38059277|NCT04421027|69751309|FG003|Treatment Period|Death|0|||
38059278|NCT04421027|69751306|FG000|Treatment Period|Lost to Follow-up|22|||
38059279|NCT04421027|69751307|FG001|Treatment Period|Lost to Follow-up|20|||
38059280|NCT04421027|69751308|FG002|Treatment Period|Lost to Follow-up|0|||
38059281|NCT04421027|69751309|FG003|Treatment Period|Lost to Follow-up|0|||
38059282|NCT04421027|69751306|FG000|Treatment Period|Other-Unknown|15|||
38059283|NCT04421027|69751307|FG001|Treatment Period|Other-Unknown|9|||
38059284|NCT04421027|69751308|FG002|Treatment Period|Other-Unknown|0|||
38059285|NCT04421027|69751309|FG003|Treatment Period|Other-Unknown|0|||
38059286|NCT04421027|69751306|FG000|Treatment Period|Physician Decision|1|||
38059287|NCT04421027|69751307|FG001|Treatment Period|Physician Decision|1|||
38059288|NCT04421027|69751308|FG002|Treatment Period|Physician Decision|0|||
38059289|NCT04421027|69751309|FG003|Treatment Period|Physician Decision|0|||
38059290|NCT04421027|69751306|FG000|Treatment Period|Withdrawal by Subject|7|||
38059291|NCT04421027|69751307|FG001|Treatment Period|Withdrawal by Subject|12|||
38059292|NCT04421027|69751308|FG002|Treatment Period|Withdrawal by Subject|0|||
38059293|NCT04421027|69751309|FG003|Treatment Period|Withdrawal by Subject|0|||
38059294|NCT04421027|69751306|FG000|Treatment Period|Randomized Not Dosed|9|||
38059295|NCT04421027|69751307|FG001|Treatment Period|Randomized Not Dosed|14|||
38059296|NCT04421027|69751308|FG002|Treatment Period|Randomized Not Dosed|0|||
38059297|NCT04421027|69751309|FG003|Treatment Period|Randomized Not Dosed|0|||
38059298|NCT04421027|69751306|FG000|Follow-Up Period|Adverse Event|0|||
38059299|NCT04421027|69751307|FG001|Follow-Up Period|Adverse Event|0|||
38059300|NCT04421027|69751308|FG002|Follow-Up Period|Adverse Event|0|||
38059301|NCT04421027|69751309|FG003|Follow-Up Period|Adverse Event|3|||
38059302|NCT04421027|69751306|FG000|Follow-Up Period|Death|0|||
38059303|NCT04421027|69751307|FG001|Follow-Up Period|Death|0|||
38059304|NCT04421027|69751308|FG002|Follow-Up Period|Death|16|||
38059305|NCT04421027|69751309|FG003|Follow-Up Period|Death|17|||
38059306|NCT04421027|69751306|FG000|Follow-Up Period|Lost to Follow-up|0|||
38059307|NCT04421027|69751307|FG001|Follow-Up Period|Lost to Follow-up|0|||
38059308|NCT04421027|69751308|FG002|Follow-Up Period|Lost to Follow-up|7|||
38059309|NCT04421027|69751309|FG003|Follow-Up Period|Lost to Follow-up|7|||
38059310|NCT04421027|69751306|FG000|Follow-Up Period|Protocol Deviation|0|||
38059311|NCT04421027|69751307|FG001|Follow-Up Period|Protocol Deviation|0|||
38059312|NCT04421027|69751308|FG002|Follow-Up Period|Protocol Deviation|1|||
38059313|NCT04421027|69751309|FG003|Follow-Up Period|Protocol Deviation|0|||
38059314|NCT04421027|69751306|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
38059315|NCT04421027|69751307|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
38059316|NCT04421027|69751308|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
38059317|NCT04421027|69751309|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
38059318|NCT04421027|69751306|FG000|Follow-Up Period|Left message, participant did not call back|0|||
38059319|NCT04421027|69751307|FG001|Follow-Up Period|Left message, participant did not call back|0|||
38059320|NCT04421027|69751308|FG002|Follow-Up Period|Left message, participant did not call back|0|||
38059321|NCT04421027|69751309|FG003|Follow-Up Period|Left message, participant did not call back|1|||
38059322|NCT04421027|69751306|FG000|Follow-Up Period|Participant died|0|||
38059323|NCT04421027|69751307|FG001|Follow-Up Period|Participant died|0|||
38059324|NCT04421027|69751308|FG002|Follow-Up Period|Participant died|0|||
38059325|NCT04421027|69751309|FG003|Follow-Up Period|Participant died|1|||
38059326|NCT04421027|69751306|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
38059327|NCT04421027|69751307|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
38059328|NCT04421027|69751308|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
38059329|NCT04421027|69751309|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
38059330|NCT04419311|69751319|FG000|Overall Study|Lost to Follow-up|1|||
38059331|NCT04419311|69751320|FG001|Overall Study|Lost to Follow-up|0|||
38059332|NCT04411667|69751330|FG000|Overall Study|Physician Decision|1|||
38059333|NCT04411667|69751331|FG001|Overall Study|Physician Decision|0|||
38059334|NCT04358549|69751339|FG000|Overall Study|Adverse Event|0|||
38059335|NCT04358549|69751340|FG001|Overall Study|Adverse Event|1|||
38059336|NCT04358549|69751339|FG000|Overall Study|Death|1|||
38059337|NCT04358549|69751340|FG001|Overall Study|Death|0|||
38059338|NCT04358549|69751339|FG000|Overall Study|Lost to Follow-up|2|||
38059339|NCT04358549|69751340|FG001|Overall Study|Lost to Follow-up|1|||
38059340|NCT04358549|69751339|FG000|Overall Study|Withdrawal by Subject|6|||
38059341|NCT04358549|69751340|FG001|Overall Study|Withdrawal by Subject|6|||
38059342|NCT04358549|69751339|FG000|Overall Study|Start remdesivir|1|||
38059343|NCT04358549|69751340|FG001|Overall Study|Start remdesivir|0|||
38059344|NCT00700180|69751348|FG000|Overall Study|Death|99|||
38059345|NCT00700180|69751349|FG001|Overall Study|Death|114|||
38059346|NCT00700180|69751348|FG000|Overall Study|Alive on treatment|5|||
38059347|NCT00700180|69751349|FG001|Overall Study|Alive on treatment|3|||
38059348|NCT00700180|69751348|FG000|Overall Study|Alive in follow-up|46|||
38059349|NCT00700180|69751349|FG001|Overall Study|Alive in follow-up|27|||
38059350|NCT00700180|69751348|FG000|Overall Study|Lost to Follow-up|4|||
38059351|NCT00700180|69751349|FG001|Overall Study|Lost to Follow-up|5|||
38059352|NCT00238420|69751357|FG000|Overall Study|Protocol Violation|1|||
38059353|NCT00238420|69751358|FG001|Overall Study|Protocol Violation|1|||
38059354|NCT04492475|69751366|FG000|Overall Study|Enrolled but not treated|8|||
38059355|NCT04492475|69751367|FG001|Overall Study|Enrolled but not treated|8|||
38059356|NCT04492475|69751366|FG000|Overall Study|Withdrawal by Subject|4|||
38059357|NCT04492475|69751367|FG001|Overall Study|Withdrawal by Subject|0|||
38059358|NCT04492475|69751366|FG000|Overall Study|Became ineligible after enrollment|2|||
38059359|NCT04492475|69751367|FG001|Overall Study|Became ineligible after enrollment|0|||
38059360|NCT04486235|69751382|FG000|Overall Study|Pregnancy|1|||
38059361|NCT04486235|69751383|FG001|Overall Study|Pregnancy|0|||
38059362|NCT04486235|69751382|FG000|Overall Study|Lost to Follow-up|1|||
38059363|NCT04486235|69751383|FG001|Overall Study|Lost to Follow-up|0|||
38059364|NCT04358081|69751393|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
38059365|NCT04358081|69751394|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
38059366|NCT04358081|69751395|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
38059367|NCT04358081|69751393|FG000|Treatment Phase of Study|Adverse Event|1|||
38059368|NCT04358081|69751394|FG001|Treatment Phase of Study|Adverse Event|0|||
38059369|NCT04358081|69751395|FG002|Treatment Phase of Study|Adverse Event|1|||
38059370|NCT04358081|69751393|FG000|Treatment Phase of Study|Physician Decision|2|||
38059371|NCT04358081|69751394|FG001|Treatment Phase of Study|Physician Decision|0|||
37965552|NCT00061633|69652626|FG001|Overall Study|Never received study treatment|2|||
37965553|NCT00645593|69652634|FG000|Overall Study|Later found to be ineligible|1|||
37965554|NCT00645593|69652635|FG001|Overall Study|Later found to be ineligible|0|||
37965555|NCT03832738|69652644|FG000|Overall Study|Withdrawal by Subject|6|||
37965556|NCT03832738|69652645|FG001|Overall Study|Withdrawal by Subject|7|||
37965557|NCT03832738|69652646|FG002|Overall Study|Withdrawal by Subject|16|||
37965558|NCT03832738|69652644|FG000|Overall Study|Physician Decision|0|||
37965559|NCT03832738|69652645|FG001|Overall Study|Physician Decision|1|||
37965560|NCT03832738|69652646|FG002|Overall Study|Physician Decision|2|||
37965561|NCT03832738|69652644|FG000|Overall Study|Adverse Event|2|||
37965562|NCT03832738|69652645|FG001|Overall Study|Adverse Event|3|||
37965563|NCT03832738|69652646|FG002|Overall Study|Adverse Event|1|||
37965564|NCT03832738|69652644|FG000|Overall Study|Pregnancy|0|||
37965565|NCT03832738|69652645|FG001|Overall Study|Pregnancy|1|||
37965566|NCT03832738|69652646|FG002|Overall Study|Pregnancy|0|||
37965567|NCT00046891|69652656|FG000|Overall Study|Cancels|5|||
37965568|NCT00046891|69652657|FG001|Overall Study|Cancels|9|||
37965569|NCT00046891|69652656|FG000|Overall Study|Ineligible|1|||
38059372|NCT04358081|69751395|FG002|Treatment Phase of Study|Physician Decision|1|||
38059373|NCT04358081|69751393|FG000|Treatment Phase of Study|Protocol Violation|1|||
38059374|NCT04358081|69751394|FG001|Treatment Phase of Study|Protocol Violation|0|||
37965570|NCT00046891|69652657|FG001|Overall Study|Ineligible|1|||
38059375|NCT04358081|69751395|FG002|Treatment Phase of Study|Protocol Violation|0|||
38059376|NCT04358081|69751393|FG000|Study Completion Phase|Death|0|||
38059377|NCT04358081|69751394|FG001|Study Completion Phase|Death|0|||
38059378|NCT04358081|69751395|FG002|Study Completion Phase|Death|1|||
38059379|NCT04358081|69751393|FG000|Study Completion Phase|Lost to Follow-up|1|||
37965571|NCT00046891|69652656|FG000|Overall Study|Withdrawal by Subject|18|||
38059380|NCT04358081|69751394|FG001|Study Completion Phase|Lost to Follow-up|0|||
38059381|NCT04358081|69751395|FG002|Study Completion Phase|Lost to Follow-up|1|||
38059382|NCT04355663|69751408|FG000|Overall Study|Physician Decision|2|||
38059383|NCT04355663|69751409|FG001|Overall Study|Physician Decision|7|||
38059384|NCT04355663|69751410|FG002|Overall Study|Physician Decision|0|||
37965572|NCT00046891|69652657|FG001|Overall Study|Withdrawal by Subject|15|||
38059385|NCT04355663|69751408|FG000|Overall Study|Adverse Event|0|||
38059386|NCT04355663|69751409|FG001|Overall Study|Adverse Event|0|||
38059387|NCT04355663|69751410|FG002|Overall Study|Adverse Event|1|||
38059388|NCT04355663|69751408|FG000|Overall Study|Withdrawal by Subject|0|||
38059389|NCT04355663|69751409|FG001|Overall Study|Withdrawal by Subject|8|||
38059390|NCT04355663|69751410|FG002|Overall Study|Withdrawal by Subject|3|||
38059391|NCT04345367|69751420|FG000|Overall Study|Other|3|||
38059392|NCT04345367|69751421|FG001|Overall Study|Other|4|||
38059393|NCT04345367|69751420|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
38059394|NCT04345367|69751421|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
38059395|NCT04345367|69751420|FG000|Overall Study|Withdrawal by Subject|11|||
38059396|NCT04345367|69751421|FG001|Overall Study|Withdrawal by Subject|11|||
38059397|NCT04345367|69751420|FG000|Overall Study|Protocol Violation|4|||
38059398|NCT04345367|69751421|FG001|Overall Study|Protocol Violation|3|||
38059399|NCT04345367|69751420|FG000|Overall Study|Lost to Follow-up|2|||
38059400|NCT04345367|69751421|FG001|Overall Study|Lost to Follow-up|4|||
38059401|NCT04345367|69751420|FG000|Overall Study|Lack of Efficacy|2|||
38059402|NCT04345367|69751421|FG001|Overall Study|Lack of Efficacy|0|||
38059403|NCT04345367|69751420|FG000|Overall Study|Death|2|||
38059404|NCT04345367|69751421|FG001|Overall Study|Death|0|||
38059405|NCT04345367|69751420|FG000|Overall Study|Adverse Event|10|||
38059406|NCT04345367|69751421|FG001|Overall Study|Adverse Event|9|||
38059407|NCT04404725|69751427|FG000|First Intervention|Withdrawal by Subject|0|||
38059408|NCT04404725|69751428|FG001|First Intervention|Withdrawal by Subject|2|||
38059409|NCT04404725|69751427|FG000|Second Intervention|Adverse Event|1|||
38059410|NCT04404725|69751428|FG001|Second Intervention|Adverse Event|1|||
38059411|NCT04404725|69751427|FG000|Second Intervention|Withdrawal by Subject|0|||
38059412|NCT04404725|69751428|FG001|Second Intervention|Withdrawal by Subject|1|||
38059413|NCT04343261|69751434|FG000|Overall Study|Adverse Event|1|||
38059414|NCT04343261|69751434|FG000|Overall Study|received inadequate amount of antibodies|7|||
38059415|NCT04336475|69751440|FG000|Overall Study|pain|1|||
38059416|NCT04336475|69751441|FG001|Overall Study|pain|0|||
38059417|NCT04336475|69751440|FG000|Overall Study|upper respiratory infection|1|||
37965573|NCT00046891|69652656|FG000|Overall Study|Adverse Event|5|||
38059418|NCT04336475|69751441|FG001|Overall Study|upper respiratory infection|0|||
38059419|NCT04336475|69751440|FG000|Overall Study|Lost to Follow-up|0|||
38059420|NCT04336475|69751441|FG001|Overall Study|Lost to Follow-up|2|||
38059421|NCT04335929|69751447|FG000|Overall Study|Lost to Follow-up|10|||
38059422|NCT04333199|69751454|FG000|Evaluated Patients|Lost to Follow-up|0|||
38059423|NCT04333199|69751455|FG001|Evaluated Patients|Lost to Follow-up|1|||
38059424|NCT04333199|69751456|FG002|Evaluated Patients|Lost to Follow-up|2|||
38059425|NCT04332419|69751465|FG000|Overall Study|Withdrawal by Subject|1|||
38059426|NCT04330157|69751469|FG000|Overall Study|Protocol Violation|4|||
38059427|NCT04330157|69751469|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
38059428|NCT04329923|69751484|FG000|Overall Study|Withdrawal by Subject|1|||
38059429|NCT04329923|69751485|FG001|Overall Study|Withdrawal by Subject|4|||
38059430|NCT04329923|69751486|FG002|Overall Study|Withdrawal by Subject|1|||
38059431|NCT04329923|69751487|FG003|Overall Study|Withdrawal by Subject|1|||
38059432|NCT04329923|69751488|FG004|Overall Study|Withdrawal by Subject|1|||
38059433|NCT04329923|69751489|FG005|Overall Study|Withdrawal by Subject|1|||
38059434|NCT04329923|69751484|FG000|Overall Study|early termination of study|0|||
38059435|NCT04329923|69751485|FG001|Overall Study|early termination of study|0|||
38059436|NCT04329923|69751486|FG002|Overall Study|early termination of study|0|||
38059437|NCT04329923|69751487|FG003|Overall Study|early termination of study|0|||
38059438|NCT04329923|69751488|FG004|Overall Study|early termination of study|1|||
38059439|NCT04329923|69751489|FG005|Overall Study|early termination of study|2|||
38059440|NCT04329923|69751484|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
38059441|NCT04329923|69751485|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
38059442|NCT04329923|69751486|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
38059443|NCT04329923|69751487|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
38059444|NCT04329923|69751488|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
38059445|NCT04329923|69751489|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
38059446|NCT04403399|69751505|FG000|Period 2|Physician Decision|0|||
38059447|NCT04403399|69751506|FG001|Period 2|Physician Decision|1|||
38059448|NCT04401293|69751514|FG000|Overall Study|Withdrawal by Subject|1|||
38059449|NCT04401293|69751515|FG001|Overall Study|Withdrawal by Subject|3|||
38059450|NCT04319159|69751523|FG000|Overall Study|Screening failure|13|||
37965574|NCT00046891|69652657|FG001|Overall Study|Adverse Event|5|||
38059451|NCT04319159|69751523|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
38059452|NCT04319159|69751523|FG000|Overall Study|Withdrawal by Subject|1|||
38059453|NCT04318535|69751529|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
38059454|NCT04318535|69751530|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
38059455|NCT04318535|69751531|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
38059456|NCT04454567|69751542|FG000|Overall Study|Study Terminated by Sponsor|1|||
38059457|NCT04454567|69751543|FG001|Overall Study|Study Terminated by Sponsor|1|||
38059458|NCT04449341|69751551|FG000|Overall Study|Protocol Violation|1|||
38059459|NCT04449341|69751552|FG001|Overall Study|Protocol Violation|0|||
38059460|NCT04448561|69751560|FG000|Overall Study|Noncompliance|1|||
38059461|NCT04448561|69751561|FG001|Overall Study|Noncompliance|0|||
38059462|NCT04308239|69751577|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
38059463|NCT04308239|69751578|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
38059464|NCT04308239|69751577|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
38059465|NCT04308239|69751578|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
38059466|NCT04308239|69751577|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
38059467|NCT04308239|69751578|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
38059468|NCT04308239|69751577|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
38059469|NCT04308239|69751578|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
38059470|NCT04302545|69751590|FG000|Overall Study|Lost to Follow-up|3|||
38059471|NCT04302545|69751591|FG001|Overall Study|Lost to Follow-up|4|||
38059472|NCT04297241|69751608|FG000|Overall Study|Withdrawal by Subject|1|||
38059473|NCT04297241|69751608|FG000|Overall Study|Adverse Event|1|||
38059474|NCT04297241|69751608|FG000|Overall Study|Physician Decision|3|||
38059475|NCT04292171|69751624|FG000|Overall Study|Pharmacy error|2|||
38059476|NCT04292171|69751625|FG001|Overall Study|Pharmacy error|0|||
38059477|NCT04292171|69751624|FG000|Overall Study|Delivered prior to procedure|0|||
38059478|NCT04292171|69751625|FG001|Overall Study|Delivered prior to procedure|1|||
38059479|NCT04393493|69751633|FG000|First 4 Days of Intervention|Early improvement|5|||
38059480|NCT04393493|69751634|FG001|First 4 Days of Intervention|Early improvement|7|||
38059481|NCT04280705|69751644|FG000|Overall Study|Enrolled but not treated|4|||
38059482|NCT04280705|69751645|FG001|Overall Study|Enrolled but not treated|10|||
38059483|NCT04280705|69751644|FG000|Overall Study|Physician Decision|1|||
38059484|NCT04280705|69751645|FG001|Overall Study|Physician Decision|0|||
38059485|NCT04280705|69751644|FG000|Overall Study|Withdrawal by Subject|7|||
38059486|NCT04280705|69751645|FG001|Overall Study|Withdrawal by Subject|9|||
38059487|NCT04280705|69751644|FG000|Overall Study|Adverse Event|0|||
38059488|NCT04280705|69751645|FG001|Overall Study|Adverse Event|4|||
38059489|NCT04280705|69751644|FG000|Overall Study|Transferred to another hospital|1|||
38059490|NCT04280705|69751645|FG001|Overall Study|Transferred to another hospital|1|||
38059491|NCT02077166|69751658|FG000|Overall Study|Death|6|||
38059492|NCT02077166|69751659|FG001|Overall Study|Death|7|||
38059493|NCT02077166|69751660|FG002|Overall Study|Death|5|||
38059494|NCT02077166|69751661|FG003|Overall Study|Death|6|||
38059495|NCT02077166|69751662|FG004|Overall Study|Death|4|||
38059496|NCT02077166|69751663|FG005|Overall Study|Death|32|||
38059497|NCT02077166|69751664|FG006|Overall Study|Death|22|||
38059498|NCT02077166|69751658|FG000|Overall Study|Study Closure by Sponsor|3|||
38059499|NCT02077166|69751659|FG001|Overall Study|Study Closure by Sponsor|0|||
38059500|NCT02077166|69751660|FG002|Overall Study|Study Closure by Sponsor|2|||
38059501|NCT02077166|69751661|FG003|Overall Study|Study Closure by Sponsor|2|||
38059502|NCT02077166|69751662|FG004|Overall Study|Study Closure by Sponsor|2|||
38059503|NCT02077166|69751663|FG005|Overall Study|Study Closure by Sponsor|12|||
38059504|NCT02077166|69751664|FG006|Overall Study|Study Closure by Sponsor|4|||
38059505|NCT02077166|69751658|FG000|Overall Study|Lost to Follow-up|0|||
38059506|NCT02077166|69751659|FG001|Overall Study|Lost to Follow-up|0|||
38059507|NCT02077166|69751660|FG002|Overall Study|Lost to Follow-up|0|||
38059508|NCT02077166|69751661|FG003|Overall Study|Lost to Follow-up|0|||
38059509|NCT02077166|69751662|FG004|Overall Study|Lost to Follow-up|0|||
38059510|NCT02077166|69751663|FG005|Overall Study|Lost to Follow-up|1|||
38059511|NCT02077166|69751664|FG006|Overall Study|Lost to Follow-up|0|||
38059512|NCT02077166|69751658|FG000|Overall Study|Withdrawal by Subject|3|||
38059513|NCT02077166|69751659|FG001|Overall Study|Withdrawal by Subject|0|||
38059514|NCT02077166|69751660|FG002|Overall Study|Withdrawal by Subject|1|||
38059515|NCT02077166|69751661|FG003|Overall Study|Withdrawal by Subject|1|||
38059516|NCT02077166|69751662|FG004|Overall Study|Withdrawal by Subject|1|||
38059517|NCT02077166|69751663|FG005|Overall Study|Withdrawal by Subject|3|||
38059518|NCT02077166|69751664|FG006|Overall Study|Withdrawal by Subject|0|||
38059519|NCT02077166|69751658|FG000|Overall Study|Other, Not Specified|0|||
38059520|NCT02077166|69751659|FG001|Overall Study|Other, Not Specified|0|||
38059521|NCT02077166|69751660|FG002|Overall Study|Other, Not Specified|1|||
38059522|NCT02077166|69751661|FG003|Overall Study|Other, Not Specified|0|||
38059523|NCT02077166|69751662|FG004|Overall Study|Other, Not Specified|1|||
38059524|NCT02077166|69751663|FG005|Overall Study|Other, Not Specified|7|||
38059525|NCT02077166|69751664|FG006|Overall Study|Other, Not Specified|8|||
38059526|NCT04273217|69751691|FG000|Overall Study|Lost to Follow-up|0|||
38059527|NCT04273217|69751692|FG001|Overall Study|Lost to Follow-up|0|||
38059528|NCT04273217|69751693|FG002|Overall Study|Lost to Follow-up|0|||
38059529|NCT04273217|69751694|FG003|Overall Study|Lost to Follow-up|0|||
38059530|NCT04273217|69751695|FG004|Overall Study|Lost to Follow-up|0|||
38059531|NCT04273217|69751696|FG005|Overall Study|Lost to Follow-up|1|||
38059532|NCT04273217|69751691|FG000|Overall Study|Participant non-compliance|0|||
38059533|NCT04273217|69751692|FG001|Overall Study|Participant non-compliance|0|||
38059534|NCT04273217|69751693|FG002|Overall Study|Participant non-compliance|0|||
38059535|NCT04273217|69751694|FG003|Overall Study|Participant non-compliance|0|||
38059536|NCT04273217|69751695|FG004|Overall Study|Participant non-compliance|1|||
38059537|NCT04273217|69751696|FG005|Overall Study|Participant non-compliance|0|||
38059538|NCT04273217|69751691|FG000|Overall Study|Positive urine drug screen|1|||
38059539|NCT04273217|69751692|FG001|Overall Study|Positive urine drug screen|0|||
38059540|NCT04273217|69751693|FG002|Overall Study|Positive urine drug screen|1|||
38059541|NCT04273217|69751694|FG003|Overall Study|Positive urine drug screen|0|||
38059542|NCT04273217|69751695|FG004|Overall Study|Positive urine drug screen|0|||
38059543|NCT04273217|69751696|FG005|Overall Study|Positive urine drug screen|1|||
38059544|NCT04384523|69751716|FG000|Overall Study|Lost to Follow-up|0|||
38059545|NCT04384523|69751717|FG001|Overall Study|Lost to Follow-up|0|||
38059546|NCT04384523|69751718|FG002|Overall Study|Lost to Follow-up|0|||
38059547|NCT04384523|69751719|FG003|Overall Study|Lost to Follow-up|0|||
38059548|NCT04384523|69751720|FG004|Overall Study|Lost to Follow-up|0|||
38059549|NCT04384523|69751721|FG005|Overall Study|Lost to Follow-up|1|||
38059550|NCT04384523|69751716|FG000|Overall Study|Protocol Violation|0|||
38059551|NCT04384523|69751717|FG001|Overall Study|Protocol Violation|1|||
38059552|NCT04384523|69751718|FG002|Overall Study|Protocol Violation|0|||
38059553|NCT04384523|69751719|FG003|Overall Study|Protocol Violation|0|||
38059554|NCT04384523|69751720|FG004|Overall Study|Protocol Violation|0|||
38059555|NCT04384523|69751721|FG005|Overall Study|Protocol Violation|0|||
38059556|NCT04384523|69751716|FG000|Overall Study|Withdrawal by Subject|1|||
38059557|NCT04384523|69751717|FG001|Overall Study|Withdrawal by Subject|0|||
38059558|NCT04384523|69751718|FG002|Overall Study|Withdrawal by Subject|0|||
38059559|NCT04384523|69751719|FG003|Overall Study|Withdrawal by Subject|0|||
38059560|NCT04384523|69751720|FG004|Overall Study|Withdrawal by Subject|0|||
38059561|NCT04384523|69751721|FG005|Overall Study|Withdrawal by Subject|0|||
38059562|NCT04382651|69751756|FG000|Overall Study|Death|26|||
38059563|NCT04382651|69751757|FG001|Overall Study|Death|23|||
38059564|NCT04382651|69751756|FG000|Overall Study|Lost to Follow-up|3|||
38059565|NCT04382651|69751757|FG001|Overall Study|Lost to Follow-up|4|||
38059566|NCT04382651|69751756|FG000|Overall Study|Withdrawal by Subject|2|||
38059567|NCT04382651|69751757|FG001|Overall Study|Withdrawal by Subject|0|||
38059568|NCT04382651|69751756|FG000|Overall Study|Physician Decision|0|||
38059569|NCT04382651|69751757|FG001|Overall Study|Physician Decision|1|||
38059570|NCT03442088|69751769|FG000|Overall Study|Adverse Event|1|||
38059571|NCT03442088|69751769|FG000|Overall Study|Lack of Efficacy|2|||
38059572|NCT03442088|69751769|FG000|Overall Study|Lost to Follow-up|2|||
38059573|NCT04223687|69751775|FG000|Overall Study|Missing primary outcome|1|||
38059574|NCT04223687|69751776|FG001|Overall Study|Missing primary outcome|0|||
38059575|NCT03722576|69751782|FG000|Overall Study|Withdrawal by Subject|3|||
38059576|NCT03722576|69751782|FG000|Overall Study|Adverse Event|2|||
38059577|NCT03722576|69751782|FG000|Overall Study|Physician Decision|1|||
38059578|NCT03722576|69751782|FG000|Overall Study|Lost to Follow-up|1|||
38059579|NCT03693989|69751788|FG000|Overall Study|Protocol Violation|3|||
38059580|NCT03693989|69751789|FG001|Overall Study|Protocol Violation|4|||
38059581|NCT04206293|69751795|FG000|Overall Study|Consent withdrawal|1|||
38059582|NCT02727998|69751802|FG000|Overall Study|Lost to Follow-up|3|||
38059583|NCT02727998|69751803|FG001|Overall Study|Lost to Follow-up|3|||
38059584|NCT02727998|69751802|FG000|Overall Study|Withdrawal by Subject|0|||
38059585|NCT02727998|69751803|FG001|Overall Study|Withdrawal by Subject|1|||
38059586|NCT04366349|69751815|FG000|Overall Study|Withdrawal by Subject|1|||
38059587|NCT04366349|69751816|FG001|Overall Study|Withdrawal by Subject|0|||
38059588|NCT04366349|69751817|FG002|Overall Study|Withdrawal by Subject|0|||
38059589|NCT04366349|69751818|FG003|Overall Study|Withdrawal by Subject|0|||
38059590|NCT04366349|69751819|FG004|Overall Study|Withdrawal by Subject|0|||
38059591|NCT04366349|69751820|FG005|Overall Study|Withdrawal by Subject|0|||
38059592|NCT04179461|69751838|FG000|Overall Study|Lost to Follow-up|4|||
38059593|NCT04017611|69751842|FG000|Overall Study|Withdrawn prior to completion|1|||
38059594|NCT04172831|69751857|FG000|Overall Study|Adverse Event|21|||
38059595|NCT04172831|69751858|FG001|Overall Study|Adverse Event|9|||
38059596|NCT04172831|69751857|FG000|Overall Study|Lack of Efficacy|2|||
38059597|NCT04172831|69751858|FG001|Overall Study|Lack of Efficacy|8|||
38059598|NCT04172831|69751857|FG000|Overall Study|Physician Decision|0|||
38059599|NCT04172831|69751858|FG001|Overall Study|Physician Decision|1|||
38059600|NCT04172831|69751857|FG000|Overall Study|Withdrawal by Subject|12|||
38059601|NCT04172831|69751858|FG001|Overall Study|Withdrawal by Subject|11|||
38059602|NCT04172831|69751857|FG000|Overall Study|Lost to Follow-up|4|||
38059603|NCT04172831|69751858|FG001|Overall Study|Lost to Follow-up|9|||
38059604|NCT04172831|69751857|FG000|Overall Study|COVID-19 related crisis|3|||
38059605|NCT04172831|69751858|FG001|Overall Study|COVID-19 related crisis|3|||
38059606|NCT04172831|69751857|FG000|Overall Study|Subject non-compliance|1|||
37680379|NCT02586805|69155997|FG000|Overall Study|Lost to Follow-up|0|||
38059607|NCT04172831|69751858|FG001|Overall Study|Subject non-compliance|1|||
38059608|NCT04172831|69751857|FG000|Overall Study|Family emergency|1|||
38059609|NCT04172831|69751858|FG001|Overall Study|Family emergency|0|||
38059610|NCT04165031|69751875|FG000|Overall Study|Adverse Event|1|||
38059611|NCT04165031|69751876|FG001|Overall Study|Adverse Event|1|||
38059612|NCT04165031|69751877|FG002|Overall Study|Adverse Event|0|||
38059613|NCT04165031|69751878|FG003|Overall Study|Adverse Event|0|||
38059614|NCT04165031|69751879|FG004|Overall Study|Adverse Event|0|||
38059615|NCT04165031|69751880|FG005|Overall Study|Adverse Event|0|||
38059616|NCT04165031|69751875|FG000|Overall Study|Withdrawal by Subject|0|||
38059617|NCT04165031|69751876|FG001|Overall Study|Withdrawal by Subject|0|||
38059618|NCT04165031|69751877|FG002|Overall Study|Withdrawal by Subject|1|||
38059619|NCT04165031|69751878|FG003|Overall Study|Withdrawal by Subject|0|||
38059620|NCT04165031|69751879|FG004|Overall Study|Withdrawal by Subject|0|||
38059621|NCT04165031|69751880|FG005|Overall Study|Withdrawal by Subject|0|||
38059622|NCT02712424|69751897|FG000|Overall Study|Lost to Follow-up|34|||
38059623|NCT02712424|69751898|FG001|Overall Study|Lost to Follow-up|32|||
38059624|NCT02968004|69751906|FG000|Overall Study|Adverse Event|1|||
38059625|NCT02968004|69751907|FG001|Overall Study|Adverse Event|0|||
38059626|NCT02968004|69751906|FG000|Overall Study|Withdrawal by Subject|0|||
38059627|NCT02968004|69751907|FG001|Overall Study|Withdrawal by Subject|1|||
37862213|NCT01131585|69546011|FG001|Overall Study|Adverse Event|2|||
37965575|NCT00365794|69652671|FG000|Overall Study|Withdrawal by Subject|2|||
37965576|NCT00383500|69652679|FG000|Overall Study|Withdrawal by Subject|8|||
38059628|NCT03034772|69751915|FG000|Overall Study|Adverse Event|0|||
38059629|NCT03034772|69751916|FG001|Overall Study|Adverse Event|1|||
38059630|NCT03034772|69751915|FG000|Overall Study|Withdrawal by Subject|0|||
38059631|NCT03034772|69751916|FG001|Overall Study|Withdrawal by Subject|1|||
38059632|NCT03032198|69751922|FG000|Overall Study|Screen Fail|1|||
38059633|NCT02431364|69751931|FG000|Overall Study|Adverse Event|0|||
38059634|NCT02431364|69751932|FG001|Overall Study|Adverse Event|1|||
38059635|NCT02431364|69751933|FG002|Overall Study|Adverse Event|0|||
38059636|NCT02431364|69751934|FG003|Overall Study|Adverse Event|0|||
38059637|NCT02431364|69751935|FG004|Overall Study|Adverse Event|0|||
38059638|NCT02431364|69751931|FG000|Overall Study|Randomized but never treated|0|||
38059639|NCT02431364|69751932|FG001|Overall Study|Randomized but never treated|0|||
38059640|NCT02431364|69751933|FG002|Overall Study|Randomized but never treated|0|||
38059641|NCT02431364|69751934|FG003|Overall Study|Randomized but never treated|1|||
38059642|NCT02431364|69751935|FG004|Overall Study|Randomized but never treated|0|||
38059643|NCT03034460|69751953|FG000|Overall Study|Adverse Event|0|||
38059644|NCT03034460|69751954|FG001|Overall Study|Adverse Event|1|||
38059645|NCT03034460|69751953|FG000|Overall Study|Withdrawal by Subject|2|||
38059646|NCT03034460|69751954|FG001|Overall Study|Withdrawal by Subject|2|||
38059647|NCT03034460|69751953|FG000|Overall Study|Personal Reasons|1|||
38059648|NCT03034460|69751954|FG001|Overall Study|Personal Reasons|0|||
38059649|NCT04162769|69751967|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
38059650|NCT04162769|69751968|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
38059651|NCT04162769|69751969|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
38059652|NCT04162769|69751970|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
38059653|NCT04162769|69751967|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
38059654|NCT04162769|69751968|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
38059655|NCT04162769|69751969|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
38059656|NCT04162769|69751970|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
38059657|NCT04162769|69751967|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
38059658|NCT04162769|69751968|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
38059659|NCT04162769|69751969|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
38059660|NCT04162769|69751970|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
38059661|NCT04162769|69751967|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
38059662|NCT04162769|69751968|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
38059663|NCT04162769|69751969|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
38059664|NCT04162769|69751970|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
38059665|NCT04162769|69751967|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
38059666|NCT04162769|69751968|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
38059667|NCT04162769|69751969|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
38059668|NCT04162769|69751970|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
38059669|NCT04162769|69751967|FG000|Double-blind Treatment (12-Week)|Other|0|||
38059670|NCT04162769|69751968|FG001|Double-blind Treatment (12-Week)|Other|1|||
38059671|NCT04162769|69751969|FG002|Double-blind Treatment (12-Week)|Other|1|||
38059672|NCT04162769|69751970|FG003|Double-blind Treatment (12-Week)|Other|0|||
38059673|NCT04162769|69751967|FG000|OLE Period (52-Week)|Adverse Event|0|||
38059674|NCT04162769|69751968|FG001|OLE Period (52-Week)|Adverse Event|0|||
38059675|NCT04162769|69751969|FG002|OLE Period (52-Week)|Adverse Event|0|||
38059676|NCT04162769|69751970|FG003|OLE Period (52-Week)|Adverse Event|5|||
38059677|NCT04162769|69751967|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
38059678|NCT04162769|69751968|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
38059679|NCT04162769|69751969|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
38059680|NCT04162769|69751970|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
38059681|NCT04162769|69751967|FG000|OLE Period (52-Week)|Physician Decision|0|||
38059682|NCT04162769|69751968|FG001|OLE Period (52-Week)|Physician Decision|0|||
38059683|NCT04162769|69751969|FG002|OLE Period (52-Week)|Physician Decision|0|||
38059684|NCT04162769|69751970|FG003|OLE Period (52-Week)|Physician Decision|1|||
38059685|NCT04162769|69751967|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
38059686|NCT04162769|69751968|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
38059687|NCT04162769|69751969|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
38059688|NCT04162769|69751970|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
38059689|NCT04162769|69751967|FG000|OLE Period (52-Week)|Protocol deviation|0|||
38059690|NCT04162769|69751968|FG001|OLE Period (52-Week)|Protocol deviation|0|||
38059691|NCT04162769|69751969|FG002|OLE Period (52-Week)|Protocol deviation|0|||
38059692|NCT04162769|69751970|FG003|OLE Period (52-Week)|Protocol deviation|2|||
38059693|NCT04161131|69751981|FG000|Overall Study|Ineligible|2|||
38059694|NCT04161131|69751981|FG000|Overall Study|Lost to Follow-up|4|||
38059695|NCT04155047|69751987|FG000|Overall Study|Adverse Event|1|||
38059696|NCT04155047|69751988|FG001|Overall Study|Adverse Event|0|||
38059697|NCT04155047|69751987|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
38059698|NCT04155047|69751988|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
38059699|NCT04152083|69751996|FG000|Overall Study|Lost to Follow-up|2|||
38059700|NCT04152083|69751997|FG001|Overall Study|Lost to Follow-up|1|||
38059701|NCT04152083|69751996|FG000|Overall Study|Adverse Event|1|||
38059702|NCT04152083|69751997|FG001|Overall Study|Adverse Event|0|||
38059703|NCT04152083|69751996|FG000|Overall Study|Randomized but not treated|3|||
38059704|NCT04152083|69751997|FG001|Overall Study|Randomized but not treated|2|||
38059705|NCT02711956|69752018|FG000|Overall Study|Adverse Event|0|||
38059706|NCT02711956|69752019|FG001|Overall Study|Adverse Event|0|||
38059707|NCT02711956|69752020|FG002|Overall Study|Adverse Event|0|||
38059708|NCT02711956|69752021|FG003|Overall Study|Adverse Event|1|||
38059709|NCT02711956|69752022|FG004|Overall Study|Adverse Event|2|||
38059710|NCT02711956|69752023|FG005|Overall Study|Adverse Event|0|||
38059711|NCT02711956|69752024|FG006|Overall Study|Adverse Event|0|||
38059712|NCT02711956|69752025|FG007|Overall Study|Adverse Event|1|||
38059713|NCT02711956|69752026|FG008|Overall Study|Adverse Event|1|||
38059714|NCT02711956|69752027|FG009|Overall Study|Adverse Event|1|||
38059715|NCT02711956|69752028|FG010|Overall Study|Adverse Event|1|||
38059716|NCT02711956|69752029|FG011|Overall Study|Adverse Event|0|||
38059717|NCT02711956|69752030|FG012|Overall Study|Adverse Event|0|||
38059718|NCT02711956|69752031|FG013|Overall Study|Adverse Event|0|||
38059719|NCT02711956|69752032|FG014|Overall Study|Adverse Event|2|||
38059720|NCT02711956|69752018|FG000|Overall Study|Physician Decision|0|||
38059721|NCT02711956|69752019|FG001|Overall Study|Physician Decision|0|||
38059722|NCT02711956|69752020|FG002|Overall Study|Physician Decision|0|||
38059723|NCT02711956|69752021|FG003|Overall Study|Physician Decision|2|||
38059724|NCT02711956|69752022|FG004|Overall Study|Physician Decision|0|||
38059725|NCT02711956|69752023|FG005|Overall Study|Physician Decision|0|||
38059726|NCT02711956|69752024|FG006|Overall Study|Physician Decision|0|||
38059727|NCT02711956|69752025|FG007|Overall Study|Physician Decision|0|||
38059728|NCT02711956|69752026|FG008|Overall Study|Physician Decision|0|||
38059729|NCT02711956|69752027|FG009|Overall Study|Physician Decision|0|||
38059730|NCT02711956|69752028|FG010|Overall Study|Physician Decision|0|||
38059731|NCT02711956|69752029|FG011|Overall Study|Physician Decision|0|||
38059732|NCT02711956|69752030|FG012|Overall Study|Physician Decision|0|||
38059733|NCT02711956|69752031|FG013|Overall Study|Physician Decision|0|||
38059734|NCT02711956|69752032|FG014|Overall Study|Physician Decision|0|||
38059735|NCT02711956|69752018|FG000|Overall Study|Withdrawal by Subject|0|||
38059736|NCT02711956|69752019|FG001|Overall Study|Withdrawal by Subject|0|||
38059737|NCT02711956|69752020|FG002|Overall Study|Withdrawal by Subject|0|||
38059738|NCT02711956|69752021|FG003|Overall Study|Withdrawal by Subject|0|||
38059739|NCT02711956|69752022|FG004|Overall Study|Withdrawal by Subject|0|||
38059740|NCT02711956|69752023|FG005|Overall Study|Withdrawal by Subject|0|||
38059741|NCT02711956|69752024|FG006|Overall Study|Withdrawal by Subject|1|||
38059742|NCT02711956|69752025|FG007|Overall Study|Withdrawal by Subject|0|||
38059743|NCT02711956|69752026|FG008|Overall Study|Withdrawal by Subject|0|||
38059744|NCT02711956|69752027|FG009|Overall Study|Withdrawal by Subject|0|||
38059745|NCT02711956|69752028|FG010|Overall Study|Withdrawal by Subject|0|||
38059746|NCT02711956|69752029|FG011|Overall Study|Withdrawal by Subject|1|||
37862214|NCT01131585|69546010|FG000|Overall Study|Abnormal laboratory value|1|||
37862215|NCT01131585|69546011|FG001|Overall Study|Abnormal laboratory value|0|||
38059747|NCT02711956|69752030|FG012|Overall Study|Withdrawal by Subject|6|||
38059748|NCT02711956|69752031|FG013|Overall Study|Withdrawal by Subject|0|||
37862216|NCT01131585|69546010|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
38059749|NCT02711956|69752032|FG014|Overall Study|Withdrawal by Subject|1|||
38059750|NCT02711956|69752018|FG000|Overall Study|Clinical progression|1|||
38059751|NCT02711956|69752019|FG001|Overall Study|Clinical progression|0|||
38059752|NCT02711956|69752020|FG002|Overall Study|Clinical progression|0|||
38059753|NCT02711956|69752021|FG003|Overall Study|Clinical progression|0|||
38059754|NCT02711956|69752022|FG004|Overall Study|Clinical progression|0|||
38059755|NCT02711956|69752023|FG005|Overall Study|Clinical progression|0|||
38059756|NCT02711956|69752024|FG006|Overall Study|Clinical progression|1|||
38059757|NCT02711956|69752025|FG007|Overall Study|Clinical progression|0|||
38059758|NCT02711956|69752026|FG008|Overall Study|Clinical progression|1|||
38059759|NCT02711956|69752027|FG009|Overall Study|Clinical progression|0|||
38059760|NCT02711956|69752028|FG010|Overall Study|Clinical progression|0|||
38059761|NCT02711956|69752029|FG011|Overall Study|Clinical progression|2|||
38059762|NCT02711956|69752030|FG012|Overall Study|Clinical progression|4|||
38059763|NCT02711956|69752031|FG013|Overall Study|Clinical progression|1|||
38059764|NCT02711956|69752032|FG014|Overall Study|Clinical progression|1|||
38059765|NCT02711956|69752018|FG000|Overall Study|Radiographic progression|1|||
38059766|NCT02711956|69752019|FG001|Overall Study|Radiographic progression|1|||
38059767|NCT02711956|69752020|FG002|Overall Study|Radiographic progression|2|||
38059768|NCT02711956|69752021|FG003|Overall Study|Radiographic progression|0|||
38059769|NCT02711956|69752022|FG004|Overall Study|Radiographic progression|1|||
38059770|NCT02711956|69752023|FG005|Overall Study|Radiographic progression|0|||
38059771|NCT02711956|69752024|FG006|Overall Study|Radiographic progression|0|||
38059772|NCT02711956|69752025|FG007|Overall Study|Radiographic progression|0|||
38059773|NCT02711956|69752026|FG008|Overall Study|Radiographic progression|2|||
38059774|NCT02711956|69752027|FG009|Overall Study|Radiographic progression|1|||
38059775|NCT02711956|69752028|FG010|Overall Study|Radiographic progression|0|||
38059776|NCT02711956|69752029|FG011|Overall Study|Radiographic progression|5|||
38059777|NCT02711956|69752030|FG012|Overall Study|Radiographic progression|3|||
38059778|NCT02711956|69752031|FG013|Overall Study|Radiographic progression|0|||
38059779|NCT02711956|69752032|FG014|Overall Study|Radiographic progression|1|||
38059780|NCT02711956|69752018|FG000|Overall Study|PSA progression with clinical progression|0|||
38059781|NCT02711956|69752019|FG001|Overall Study|PSA progression with clinical progression|0|||
38059782|NCT02711956|69752020|FG002|Overall Study|PSA progression with clinical progression|0|||
38059783|NCT02711956|69752021|FG003|Overall Study|PSA progression with clinical progression|0|||
38059784|NCT02711956|69752022|FG004|Overall Study|PSA progression with clinical progression|1|||
38059785|NCT02711956|69752023|FG005|Overall Study|PSA progression with clinical progression|0|||
38059786|NCT02711956|69752024|FG006|Overall Study|PSA progression with clinical progression|0|||
38059787|NCT02711956|69752025|FG007|Overall Study|PSA progression with clinical progression|0|||
38059788|NCT02711956|69752026|FG008|Overall Study|PSA progression with clinical progression|0|||
38059789|NCT02711956|69752027|FG009|Overall Study|PSA progression with clinical progression|0|||
38059790|NCT02711956|69752028|FG010|Overall Study|PSA progression with clinical progression|0|||
38059791|NCT02711956|69752029|FG011|Overall Study|PSA progression with clinical progression|0|||
38059792|NCT02711956|69752030|FG012|Overall Study|PSA progression with clinical progression|1|||
38059793|NCT02711956|69752031|FG013|Overall Study|PSA progression with clinical progression|1|||
38059794|NCT02711956|69752032|FG014|Overall Study|PSA progression with clinical progression|0|||
38059795|NCT02711956|69752018|FG000|Overall Study|PSA progression with radiographic progression|0|||
38059796|NCT02711956|69752019|FG001|Overall Study|PSA progression with radiographic progression|1|||
38059797|NCT02711956|69752020|FG002|Overall Study|PSA progression with radiographic progression|0|||
37862217|NCT01131585|69546011|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
37965577|NCT00383500|69652680|FG001|Overall Study|Withdrawal by Subject|3|||
38059798|NCT02711956|69752021|FG003|Overall Study|PSA progression with radiographic progression|0|||
38059799|NCT02711956|69752022|FG004|Overall Study|PSA progression with radiographic progression|0|||
38059800|NCT02711956|69752023|FG005|Overall Study|PSA progression with radiographic progression|2|||
38059801|NCT02711956|69752024|FG006|Overall Study|PSA progression with radiographic progression|2|||
38059802|NCT02711956|69752025|FG007|Overall Study|PSA progression with radiographic progression|1|||
38059803|NCT02711956|69752026|FG008|Overall Study|PSA progression with radiographic progression|0|||
38059804|NCT02711956|69752027|FG009|Overall Study|PSA progression with radiographic progression|1|||
38059805|NCT02711956|69752028|FG010|Overall Study|PSA progression with radiographic progression|0|||
38059806|NCT02711956|69752029|FG011|Overall Study|PSA progression with radiographic progression|1|||
38059807|NCT02711956|69752030|FG012|Overall Study|PSA progression with radiographic progression|2|||
38059808|NCT02711956|69752031|FG013|Overall Study|PSA progression with radiographic progression|3|||
38059809|NCT02711956|69752032|FG014|Overall Study|PSA progression with radiographic progression|3|||
38059810|NCT04149353|69752073|FG000|Overall Study|Study terminated|1|||
38059811|NCT02711800|69752078|FG000|Overall Study|Lost to Follow-up|1|||
38059812|NCT02711800|69752078|FG000|Overall Study|Withdrawal by Subject|1|||
37965578|NCT00383500|69652681|FG002|Overall Study|Withdrawal by Subject|0|||
37965579|NCT00383500|69652679|FG000|Overall Study|Lost to Follow-up|0|||
37965580|NCT00383500|69652680|FG001|Overall Study|Lost to Follow-up|0|||
37965581|NCT00383500|69652681|FG002|Overall Study|Lost to Follow-up|2|||
37965582|NCT00365716|69652695|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
37965583|NCT00365716|69652696|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
37965584|NCT00365716|69652697|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
37965585|NCT00365716|69652698|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
37965586|NCT00365716|69652699|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
38059813|NCT03031496|69752082|FG000|Period 1|Adverse Event|2|||
38059814|NCT03031496|69752083|FG001|Period 1|Adverse Event|0|||
38059815|NCT03031496|69752082|FG000|Period 1|Withdrawal by Subject|0|||
38059816|NCT03031496|69752083|FG001|Period 1|Withdrawal by Subject|2|||
38059817|NCT02659020|69752096|FG000|Overall Study|Adverse Event|0|||
38059818|NCT02659020|69752097|FG001|Overall Study|Adverse Event|0|||
38059819|NCT02659020|69752098|FG002|Overall Study|Adverse Event|0|||
38059820|NCT02659020|69752099|FG003|Overall Study|Adverse Event|2|||
38059821|NCT02659020|69752100|FG004|Overall Study|Adverse Event|0|||
38059822|NCT02659020|69752101|FG005|Overall Study|Adverse Event|0|||
38059823|NCT02659020|69752102|FG006|Overall Study|Adverse Event|2|||
38059824|NCT02659020|69752096|FG000|Overall Study|Lost to Follow-up|1|||
38059825|NCT02659020|69752097|FG001|Overall Study|Lost to Follow-up|2|||
38059826|NCT02659020|69752098|FG002|Overall Study|Lost to Follow-up|1|||
38059827|NCT02659020|69752099|FG003|Overall Study|Lost to Follow-up|6|||
38059828|NCT02659020|69752100|FG004|Overall Study|Lost to Follow-up|1|||
38059829|NCT02659020|69752101|FG005|Overall Study|Lost to Follow-up|5|||
38059830|NCT02659020|69752102|FG006|Overall Study|Lost to Follow-up|0|||
38059831|NCT02659020|69752096|FG000|Overall Study|Physician Decision|0|||
38059832|NCT02659020|69752097|FG001|Overall Study|Physician Decision|0|||
38059833|NCT02659020|69752098|FG002|Overall Study|Physician Decision|0|||
38059834|NCT02659020|69752099|FG003|Overall Study|Physician Decision|1|||
38059835|NCT02659020|69752100|FG004|Overall Study|Physician Decision|1|||
38059836|NCT02659020|69752101|FG005|Overall Study|Physician Decision|0|||
38059837|NCT02659020|69752102|FG006|Overall Study|Physician Decision|1|||
38059838|NCT02659020|69752096|FG000|Overall Study|Withdrawal by Subject|2|||
38059839|NCT02659020|69752097|FG001|Overall Study|Withdrawal by Subject|1|||
38059840|NCT02659020|69752098|FG002|Overall Study|Withdrawal by Subject|0|||
38059841|NCT02659020|69752099|FG003|Overall Study|Withdrawal by Subject|3|||
38059842|NCT02659020|69752100|FG004|Overall Study|Withdrawal by Subject|3|||
38059843|NCT02659020|69752101|FG005|Overall Study|Withdrawal by Subject|6|||
38059844|NCT02659020|69752102|FG006|Overall Study|Withdrawal by Subject|3|||
38059845|NCT02659020|69752096|FG000|Overall Study|Progressive Disease|0|||
38059846|NCT02659020|69752097|FG001|Overall Study|Progressive Disease|0|||
38059847|NCT02659020|69752098|FG002|Overall Study|Progressive Disease|0|||
38059848|NCT02659020|69752099|FG003|Overall Study|Progressive Disease|4|||
38059849|NCT02659020|69752100|FG004|Overall Study|Progressive Disease|1|||
38059850|NCT02659020|69752101|FG005|Overall Study|Progressive Disease|0|||
38059851|NCT02659020|69752102|FG006|Overall Study|Progressive Disease|2|||
38059852|NCT03482011|69752127|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
38059853|NCT03482011|69752128|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
38059854|NCT03482011|69752129|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
38059855|NCT03482011|69752130|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
38059856|NCT03482011|69752131|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
38059857|NCT03482011|69752132|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
38059858|NCT03482011|69752133|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
38059859|NCT03482011|69752134|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
38059860|NCT03482011|69752127|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
38059861|NCT03482011|69752128|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
38059862|NCT03482011|69752129|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
38059863|NCT03482011|69752130|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
38059864|NCT03482011|69752131|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
38059865|NCT03482011|69752132|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
38059866|NCT03482011|69752133|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
38059867|NCT03482011|69752134|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
38059868|NCT03482011|69752127|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
38059869|NCT03482011|69752128|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
38059870|NCT03482011|69752129|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
38059871|NCT03482011|69752130|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
38059872|NCT03482011|69752131|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
38059873|NCT03482011|69752132|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
38059874|NCT03482011|69752133|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
38059875|NCT03482011|69752134|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
38059876|NCT03482011|69752127|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
38059877|NCT03482011|69752128|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
38059878|NCT03482011|69752129|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
38059879|NCT03482011|69752130|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
38059880|NCT03482011|69752131|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
38059881|NCT03482011|69752132|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
37680380|NCT02586805|69155998|FG001|Overall Study|Lost to Follow-up|0|||
38059882|NCT03482011|69752133|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
38059883|NCT03482011|69752134|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
38059884|NCT03482011|69752127|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
38059885|NCT03482011|69752128|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
38059886|NCT03482011|69752129|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
38059887|NCT03482011|69752130|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
38059888|NCT03482011|69752131|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
38059889|NCT03482011|69752132|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
38059890|NCT03482011|69752133|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
38059891|NCT03482011|69752134|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
38059892|NCT03482011|69752127|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
38059893|NCT03482011|69752128|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
38059894|NCT03482011|69752129|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
38059895|NCT03482011|69752130|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
38059896|NCT03482011|69752131|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
38059897|NCT03482011|69752132|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
38059898|NCT03482011|69752133|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
38059899|NCT03482011|69752134|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
38059900|NCT03482011|69752127|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
38059901|NCT03482011|69752128|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
38059902|NCT03482011|69752129|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
38059903|NCT03482011|69752130|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
38059904|NCT03482011|69752131|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
38059905|NCT03482011|69752132|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
38059906|NCT03482011|69752133|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
38059907|NCT03482011|69752134|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
38059908|NCT03482011|69752127|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
38059909|NCT03482011|69752128|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
38059910|NCT03482011|69752129|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
38059911|NCT03482011|69752130|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
38059912|NCT03482011|69752131|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
38059913|NCT03482011|69752132|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
38059914|NCT03482011|69752133|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
38059915|NCT03482011|69752134|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
38059916|NCT03482011|69752127|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
38059917|NCT03482011|69752128|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
38059918|NCT03482011|69752129|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
38059919|NCT03482011|69752130|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
38059920|NCT03482011|69752131|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
38059921|NCT03482011|69752132|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
38059922|NCT03482011|69752133|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
38059923|NCT03482011|69752134|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
38059924|NCT03482011|69752127|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
38059925|NCT03482011|69752128|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
38059926|NCT03482011|69752129|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
38059927|NCT03482011|69752130|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
38059928|NCT03482011|69752131|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
38059929|NCT03482011|69752132|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
38059930|NCT03482011|69752133|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
38059931|NCT03482011|69752134|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
38059932|NCT03482011|69752127|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
38059933|NCT03482011|69752128|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
38059934|NCT03482011|69752129|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
38059935|NCT03482011|69752130|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
38059936|NCT03482011|69752131|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
38059937|NCT03482011|69752132|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
38059938|NCT03482011|69752133|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
38059939|NCT03482011|69752134|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
38059940|NCT03482011|69752127|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
38059941|NCT03482011|69752128|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
38059942|NCT03482011|69752129|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
38059943|NCT03482011|69752130|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
38059944|NCT03482011|69752131|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
38059945|NCT03482011|69752132|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
38059946|NCT03482011|69752133|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
38059947|NCT03482011|69752134|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
38059948|NCT03482011|69752127|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
38059949|NCT03482011|69752128|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
38059950|NCT03482011|69752129|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
38059951|NCT03482011|69752130|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
38059952|NCT03482011|69752131|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
37965587|NCT00365716|69652700|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
37965588|NCT00365716|69652701|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
37965589|NCT00365716|69652695|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
37965590|NCT00365716|69652696|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
37965591|NCT00365716|69652697|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
37965592|NCT00365716|69652698|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
37965593|NCT00365716|69652699|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
37965594|NCT00365716|69652700|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
37965595|NCT00365716|69652701|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
37965596|NCT00365716|69652695|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
38059953|NCT03482011|69752132|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
38059954|NCT03482011|69752133|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
38059955|NCT03482011|69752134|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
38059956|NCT03482011|69752127|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
38059957|NCT03482011|69752128|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
38059958|NCT03482011|69752129|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
38059959|NCT03482011|69752130|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
38059960|NCT03482011|69752131|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
38059961|NCT03482011|69752132|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
38059962|NCT03482011|69752133|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
38059963|NCT03482011|69752134|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
38059964|NCT03482011|69752127|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
38059965|NCT03482011|69752128|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
38059966|NCT03482011|69752129|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
38059967|NCT03482011|69752130|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
38059968|NCT03482011|69752131|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
38059969|NCT03482011|69752132|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
38059970|NCT03482011|69752133|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
38059971|NCT03482011|69752134|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
38059972|NCT03481309|69752165|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
38059973|NCT03481309|69752166|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
38059974|NCT03481309|69752167|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
38059975|NCT03481309|69752168|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
38059976|NCT03481309|69752169|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
38059977|NCT03481309|69752170|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
38059978|NCT03480841|69752178|FG000|Overall Study|Lost to Follow-up|2|||
38059979|NCT02709538|69752185|FG000|Overall Study|Adverse Event|13|||
38059980|NCT02709538|69752186|FG001|Overall Study|Adverse Event|2|||
38059981|NCT02709538|69752187|FG002|Overall Study|Adverse Event|3|||
38059982|NCT02709538|69752185|FG000|Overall Study|Lack of Efficacy|1|||
38059983|NCT02709538|69752186|FG001|Overall Study|Lack of Efficacy|0|||
38059984|NCT02709538|69752187|FG002|Overall Study|Lack of Efficacy|0|||
38059985|NCT02709538|69752185|FG000|Overall Study|Lost to Follow-up|24|||
38059986|NCT02709538|69752186|FG001|Overall Study|Lost to Follow-up|8|||
38059987|NCT02709538|69752187|FG002|Overall Study|Lost to Follow-up|4|||
38059988|NCT02709538|69752185|FG000|Overall Study|Physician Decision|1|||
38059989|NCT02709538|69752186|FG001|Overall Study|Physician Decision|0|||
38059990|NCT02709538|69752187|FG002|Overall Study|Physician Decision|0|||
38059991|NCT02709538|69752185|FG000|Overall Study|Withdrawal by Subject|40|||
38059992|NCT02709538|69752186|FG001|Overall Study|Withdrawal by Subject|7|||
38059993|NCT02709538|69752187|FG002|Overall Study|Withdrawal by Subject|4|||
38059994|NCT02709538|69752185|FG000|Overall Study|Non-compliance with study procedures|5|||
38059995|NCT02709538|69752186|FG001|Overall Study|Non-compliance with study procedures|0|||
38059996|NCT02709538|69752187|FG002|Overall Study|Non-compliance with study procedures|0|||
38059997|NCT02709538|69752185|FG000|Overall Study|Non-compliance with study drug|2|||
38059998|NCT02709538|69752186|FG001|Overall Study|Non-compliance with study drug|0|||
38059999|NCT02709538|69752187|FG002|Overall Study|Non-compliance with study drug|0|||
38060000|NCT02709538|69752185|FG000|Overall Study|Protocol deviation|10|||
38060001|NCT02709538|69752186|FG001|Overall Study|Protocol deviation|4|||
38060002|NCT02709538|69752187|FG002|Overall Study|Protocol deviation|4|||
38060003|NCT02709538|69752185|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
38060004|NCT02709538|69752186|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
38060005|NCT02709538|69752187|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
38060006|NCT02709538|69752185|FG000|Overall Study|Other|16|||
38060007|NCT02709538|69752186|FG001|Overall Study|Other|7|||
38060008|NCT02709538|69752187|FG002|Overall Study|Other|5|||
38060009|NCT03789318|69752200|FG000|Overall Study|Adverse Event|0|||
37965597|NCT00365716|69652696|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
38060010|NCT03789318|69752201|FG001|Overall Study|Adverse Event|0|||
38060011|NCT03789318|69752202|FG002|Overall Study|Adverse Event|1|||
38060012|NCT03789318|69752203|FG003|Overall Study|Adverse Event|1|||
38060013|NCT03789318|69752204|FG004|Overall Study|Adverse Event|0|||
38060014|NCT03789318|69752200|FG000|Overall Study|Lost to Follow-up|0|||
38060015|NCT03789318|69752201|FG001|Overall Study|Lost to Follow-up|0|||
38060016|NCT03789318|69752202|FG002|Overall Study|Lost to Follow-up|1|||
38060017|NCT03789318|69752203|FG003|Overall Study|Lost to Follow-up|0|||
38060018|NCT03789318|69752204|FG004|Overall Study|Lost to Follow-up|0|||
38060019|NCT03789318|69752200|FG000|Overall Study|Withdrawal by Subject|0|||
38060020|NCT03789318|69752201|FG001|Overall Study|Withdrawal by Subject|0|||
38060021|NCT03789318|69752202|FG002|Overall Study|Withdrawal by Subject|1|||
38060022|NCT03789318|69752203|FG003|Overall Study|Withdrawal by Subject|0|||
38060023|NCT03789318|69752204|FG004|Overall Study|Withdrawal by Subject|0|||
38060024|NCT00511134|69752222|FG000|Overall Study|Withdrawal by Subject|0|||
38060025|NCT00511134|69752223|FG001|Overall Study|Withdrawal by Subject|2|||
38060026|NCT01372384|69752229|FG000|Overall Study|Progression of disease|3|||
38060027|NCT03115476|69752236|FG000|LP0084-1369|Death|1|||
38060028|NCT03115476|69752237|FG001|LP0084-1369|Death|0|||
38060029|NCT03115476|69752238|FG002|LP0084-1369|Death|2|||
38060030|NCT03115476|69752236|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
38060031|NCT03115476|69752237|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
38060032|NCT03115476|69752238|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
38060033|NCT03480763|69752248|FG000|Overall Study|Withdrawal by Subject|18|||
38060034|NCT03480763|69752249|FG001|Overall Study|Withdrawal by Subject|10|||
38060035|NCT03480763|69752248|FG000|Overall Study|Lost to Follow-up|4|||
38060036|NCT03480763|69752249|FG001|Overall Study|Lost to Follow-up|7|||
38060037|NCT03480763|69752248|FG000|Overall Study|non-study pneumococcal vaccine|1|||
38060038|NCT03480763|69752249|FG001|Overall Study|non-study pneumococcal vaccine|0|||
38060039|NCT03480763|69752248|FG000|Overall Study|oncological treatment|0|||
38060040|NCT03480763|69752249|FG001|Overall Study|oncological treatment|2|||
38060041|NCT03480763|69752248|FG000|Overall Study|pain with vaccination|1|||
38060042|NCT03480763|69752249|FG001|Overall Study|pain with vaccination|0|||
38060043|NCT03123120|69752263|FG000|Overall Study|Lost to Follow-up|0|||
38060044|NCT03123120|69752264|FG001|Overall Study|Lost to Follow-up|1|||
38060045|NCT03123120|69752263|FG000|Overall Study|Withdrawal by Subject|0|||
38060046|NCT03123120|69752264|FG001|Overall Study|Withdrawal by Subject|1|||
38060047|NCT01319994|69752274|FG000|Overall Study|Protocol Violation|7|||
38060048|NCT01319994|69752275|FG001|Overall Study|Protocol Violation|6|||
38060049|NCT03453151|69752285|FG000|Overall Study|Withdrawal by Subject|1|||
38060050|NCT03453151|69752285|FG000|Overall Study|Physician Decision|3|||
38060051|NCT02887248|69752289|FG000|Overall Study|Withdrawal by Subject|1|||
38060052|NCT02887248|69752289|FG000|Overall Study|Adverse Event|1|||
38060053|NCT02887248|69752289|FG000|Overall Study|Progressive Disease|1|||
38060054|NCT03452527|69752295|FG000|Overall Study|Withdrawal by Subject|1|||
38060055|NCT03452527|69752296|FG001|Overall Study|Withdrawal by Subject|1|||
38060056|NCT03452527|69752295|FG000|Overall Study|Study Terminated|2|||
38060057|NCT03452527|69752296|FG001|Overall Study|Study Terminated|3|||
38060058|NCT03028142|69752302|FG000|Overall Study|Adverse Event|1|||
38060059|NCT03028142|69752303|FG001|Overall Study|Adverse Event|1|||
38060060|NCT03028142|69752304|FG002|Overall Study|Adverse Event|0|||
38060061|NCT03028142|69752305|FG003|Overall Study|Adverse Event|0|||
38060062|NCT03028142|69752306|FG004|Overall Study|Adverse Event|0|||
38060063|NCT03028142|69752307|FG005|Overall Study|Adverse Event|1|||
38060064|NCT03028142|69752302|FG000|Overall Study|Withdrawal by Subject|0|||
38060065|NCT03028142|69752303|FG001|Overall Study|Withdrawal by Subject|0|||
38060066|NCT03028142|69752304|FG002|Overall Study|Withdrawal by Subject|0|||
38060067|NCT03028142|69752305|FG003|Overall Study|Withdrawal by Subject|0|||
38060068|NCT03028142|69752306|FG004|Overall Study|Withdrawal by Subject|1|||
38060069|NCT03028142|69752307|FG005|Overall Study|Withdrawal by Subject|0|||
38060070|NCT02708524|69752320|FG000|Overall Study|Adverse Event|0|||
38060071|NCT02708524|69752321|FG001|Overall Study|Adverse Event|1|||
38060072|NCT02708524|69752322|FG002|Overall Study|Adverse Event|0|||
38060073|NCT02708524|69752323|FG003|Overall Study|Adverse Event|0|||
38060074|NCT02708524|69752320|FG000|Overall Study|Lens Discomfort|1|||
38060075|NCT02708524|69752321|FG001|Overall Study|Lens Discomfort|0|||
38060076|NCT02708524|69752322|FG002|Overall Study|Lens Discomfort|1|||
38060077|NCT02708524|69752323|FG003|Overall Study|Lens Discomfort|0|||
38060078|NCT02708524|69752320|FG000|Overall Study|Lost to Follow-up|1|||
38060079|NCT02708524|69752321|FG001|Overall Study|Lost to Follow-up|1|||
38060080|NCT02708524|69752322|FG002|Overall Study|Lost to Follow-up|1|||
38060081|NCT02708524|69752323|FG003|Overall Study|Lost to Follow-up|0|||
38060082|NCT02708524|69752320|FG000|Overall Study|Protocol Violation|0|||
38060083|NCT02708524|69752321|FG001|Overall Study|Protocol Violation|1|||
38060084|NCT02708524|69752322|FG002|Overall Study|Protocol Violation|0|||
38060085|NCT02708524|69752323|FG003|Overall Study|Protocol Violation|0|||
38060086|NCT02708524|69752320|FG000|Overall Study|Withdrawal by Subject|1|||
38060087|NCT02708524|69752321|FG001|Overall Study|Withdrawal by Subject|1|||
38060088|NCT02708524|69752322|FG002|Overall Study|Withdrawal by Subject|0|||
38060089|NCT02708524|69752323|FG003|Overall Study|Withdrawal by Subject|0|||
38060090|NCT02708524|69752320|FG000|Overall Study|Dispensed incorrect study lens|0|||
38060091|NCT02708524|69752321|FG001|Overall Study|Dispensed incorrect study lens|1|||
38060092|NCT02708524|69752322|FG002|Overall Study|Dispensed incorrect study lens|1|||
38060093|NCT02708524|69752323|FG003|Overall Study|Dispensed incorrect study lens|0|||
38060094|NCT02708524|69752320|FG000|Overall Study|Did not wear lens at final visit|0|||
38060095|NCT02708524|69752321|FG001|Overall Study|Did not wear lens at final visit|1|||
38060096|NCT02708524|69752322|FG002|Overall Study|Did not wear lens at final visit|0|||
38060097|NCT02708524|69752323|FG003|Overall Study|Did not wear lens at final visit|0|||
38060098|NCT02708524|69752320|FG000|Overall Study|Subject lost study lens|1|||
38060099|NCT02708524|69752321|FG001|Overall Study|Subject lost study lens|0|||
38060100|NCT02708524|69752322|FG002|Overall Study|Subject lost study lens|0|||
38060101|NCT02708524|69752323|FG003|Overall Study|Subject lost study lens|0|||
38060102|NCT03418675|69752335|FG000|Overall Study|Lost to Follow-up|13|||
38060103|NCT03418675|69752336|FG001|Overall Study|Lost to Follow-up|10|||
38060104|NCT03418675|69752335|FG000|Overall Study|Adverse Event|2|||
38060105|NCT03418675|69752336|FG001|Overall Study|Adverse Event|0|||
38060106|NCT03417505|69752353|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
38060107|NCT03417505|69752354|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
38060108|NCT02953639|69752363|FG000|Overall Study|Adverse Event|2|||
38060109|NCT02953639|69752364|FG001|Overall Study|Adverse Event|0|||
38060110|NCT02953639|69752365|FG002|Overall Study|Adverse Event|1|||
38060111|NCT02953639|69752363|FG000|Overall Study|Lost to Follow-up|8|||
38060112|NCT02953639|69752364|FG001|Overall Study|Lost to Follow-up|4|||
38060113|NCT02953639|69752365|FG002|Overall Study|Lost to Follow-up|3|||
38060114|NCT02953639|69752363|FG000|Overall Study|Non-Compliance With Study Drug|0|||
38060115|NCT02953639|69752364|FG001|Overall Study|Non-Compliance With Study Drug|2|||
38060116|NCT02953639|69752365|FG002|Overall Study|Non-Compliance With Study Drug|1|||
38060117|NCT02953639|69752363|FG000|Overall Study|Multiple Reasons|1|||
38060118|NCT02953639|69752364|FG001|Overall Study|Multiple Reasons|0|||
38060119|NCT02953639|69752365|FG002|Overall Study|Multiple Reasons|1|||
38060120|NCT02953639|69752363|FG000|Overall Study|Physician Decision|1|||
38060121|NCT02953639|69752364|FG001|Overall Study|Physician Decision|0|||
38060122|NCT02953639|69752365|FG002|Overall Study|Physician Decision|0|||
38060123|NCT02953639|69752363|FG000|Overall Study|Withdrawal by Subject|7|||
38060124|NCT02953639|69752364|FG001|Overall Study|Withdrawal by Subject|8|||
38060125|NCT02953639|69752365|FG002|Overall Study|Withdrawal by Subject|10|||
38060126|NCT02953639|69752363|FG000|Overall Study|Completed or Discontinued information is missing|1|||
38060127|NCT02953639|69752364|FG001|Overall Study|Completed or Discontinued information is missing|0|||
38060128|NCT02953639|69752365|FG002|Overall Study|Completed or Discontinued information is missing|0|||
38060129|NCT04147715|69752387|FG000|Overall Study|Adverse Event|0|||
38060130|NCT04147715|69752388|FG001|Overall Study|Adverse Event|0|||
38060131|NCT04147715|69752389|FG002|Overall Study|Adverse Event|0|||
38060132|NCT04147715|69752390|FG003|Overall Study|Adverse Event|0|||
38060133|NCT04147715|69752391|FG004|Overall Study|Adverse Event|0|||
38060134|NCT04147715|69752392|FG005|Overall Study|Adverse Event|0|||
38060135|NCT04147715|69752393|FG006|Overall Study|Adverse Event|0|||
38060136|NCT04147715|69752394|FG007|Overall Study|Adverse Event|2|||
38060137|NCT04147715|69752395|FG008|Overall Study|Adverse Event|1|||
38060138|NCT04147715|69752396|FG009|Overall Study|Adverse Event|0|||
38060139|NCT04147715|69752397|FG010|Overall Study|Adverse Event|0|||
38060140|NCT04147715|69752398|FG011|Overall Study|Adverse Event|0|||
38060141|NCT02452554|69752485|FG000|Overall Study|Death|2|||
38060142|NCT02452554|69752486|FG001|Overall Study|Death|1|||
38060143|NCT02452554|69752487|FG002|Overall Study|Death|0|||
38060144|NCT02452554|69752488|FG003|Overall Study|Death|0|||
38060145|NCT02452554|69752489|FG004|Overall Study|Death|0|||
38060146|NCT02452554|69752490|FG005|Overall Study|Death|0|||
38060147|NCT02452554|69752485|FG000|Overall Study|Lack of Efficacy|13|||
38060148|NCT02452554|69752486|FG001|Overall Study|Lack of Efficacy|14|||
38060149|NCT02452554|69752487|FG002|Overall Study|Lack of Efficacy|9|||
38060150|NCT02452554|69752488|FG003|Overall Study|Lack of Efficacy|1|||
38060151|NCT02452554|69752489|FG004|Overall Study|Lack of Efficacy|5|||
38060152|NCT02452554|69752490|FG005|Overall Study|Lack of Efficacy|8|||
38060153|NCT02452554|69752485|FG000|Overall Study|Physician Decision|0|||
38060154|NCT02452554|69752486|FG001|Overall Study|Physician Decision|1|||
38060155|NCT02452554|69752487|FG002|Overall Study|Physician Decision|0|||
38060156|NCT02452554|69752488|FG003|Overall Study|Physician Decision|0|||
38060157|NCT02452554|69752489|FG004|Overall Study|Physician Decision|0|||
38060158|NCT02452554|69752490|FG005|Overall Study|Physician Decision|0|||
38060159|NCT02452554|69752485|FG000|Overall Study|Withdrawal by Subject|1|||
38060160|NCT02452554|69752486|FG001|Overall Study|Withdrawal by Subject|0|||
38060161|NCT02452554|69752487|FG002|Overall Study|Withdrawal by Subject|2|||
38060162|NCT02452554|69752488|FG003|Overall Study|Withdrawal by Subject|0|||
38060163|NCT02452554|69752489|FG004|Overall Study|Withdrawal by Subject|0|||
38060164|NCT02452554|69752490|FG005|Overall Study|Withdrawal by Subject|1|||
38060165|NCT02452554|69752485|FG000|Overall Study|Ineligible|0|||
38060166|NCT02452554|69752486|FG001|Overall Study|Ineligible|1|||
38060167|NCT02452554|69752487|FG002|Overall Study|Ineligible|0|||
38060168|NCT02452554|69752488|FG003|Overall Study|Ineligible|0|||
38060169|NCT02452554|69752489|FG004|Overall Study|Ineligible|0|||
38060170|NCT02452554|69752490|FG005|Overall Study|Ineligible|0|||
38060171|NCT02452554|69752485|FG000|Overall Study|Never Received Treatment|1|||
38060172|NCT02452554|69752486|FG001|Overall Study|Never Received Treatment|0|||
38060173|NCT02452554|69752487|FG002|Overall Study|Never Received Treatment|0|||
38060174|NCT02452554|69752488|FG003|Overall Study|Never Received Treatment|0|||
38060175|NCT02452554|69752489|FG004|Overall Study|Never Received Treatment|0|||
38060176|NCT02452554|69752490|FG005|Overall Study|Never Received Treatment|0|||
38060177|NCT04009577|69752509|FG000|Core Study|Adverse Event|1|||
38060178|NCT04009577|69752510|FG001|Core Study|Adverse Event|0|||
38060179|NCT04009577|69752511|FG002|Core Study|Adverse Event|2|||
38060180|NCT04009577|69752512|FG003|Core Study|Adverse Event|4|||
38060181|NCT04009577|69752509|FG000|Core Study|Withdrawal by Subject|0|||
38060182|NCT04009577|69752510|FG001|Core Study|Withdrawal by Subject|0|||
38060183|NCT04009577|69752511|FG002|Core Study|Withdrawal by Subject|2|||
38060184|NCT04009577|69752512|FG003|Core Study|Withdrawal by Subject|0|||
38060185|NCT04009577|69752509|FG000|Core Study|Other|0|||
38060186|NCT04009577|69752510|FG001|Core Study|Other|0|||
38060187|NCT04009577|69752511|FG002|Core Study|Other|0|||
38060188|NCT04009577|69752512|FG003|Core Study|Other|1|||
38060189|NCT04009577|69752509|FG000|Extension Phase|Adverse Event|0|||
38060190|NCT04009577|69752510|FG001|Extension Phase|Adverse Event|0|||
38060191|NCT04009577|69752511|FG002|Extension Phase|Adverse Event|0|||
38060192|NCT04009577|69752512|FG003|Extension Phase|Adverse Event|1|||
38060193|NCT04009577|69752509|FG000|Extension Phase|Inadequate therapeutic effect|0|||
38060194|NCT04009577|69752510|FG001|Extension Phase|Inadequate therapeutic effect|0|||
38060195|NCT04009577|69752511|FG002|Extension Phase|Inadequate therapeutic effect|1|||
38060196|NCT04009577|69752512|FG003|Extension Phase|Inadequate therapeutic effect|0|||
38060197|NCT04009577|69752509|FG000|Extension Phase|Withdrawal by Subject|0|||
38060198|NCT04009577|69752510|FG001|Extension Phase|Withdrawal by Subject|0|||
38060199|NCT04009577|69752511|FG002|Extension Phase|Withdrawal by Subject|1|||
38060200|NCT04009577|69752512|FG003|Extension Phase|Withdrawal by Subject|0|||
38060201|NCT04009577|69752509|FG000|Extension Phase|Not Treated|0|||
38060202|NCT04009577|69752510|FG001|Extension Phase|Not Treated|0|||
38060203|NCT04009577|69752511|FG002|Extension Phase|Not Treated|2|||
38060204|NCT04009577|69752512|FG003|Extension Phase|Not Treated|0|||
38060205|NCT04146467|69752540|FG000|Overall Study|Adverse Event|0|||
38060206|NCT04146467|69752541|FG001|Overall Study|Adverse Event|1|||
38060207|NCT04146467|69752540|FG000|Overall Study|Lost to Follow-up|0|||
38060208|NCT04146467|69752541|FG001|Overall Study|Lost to Follow-up|2|||
38060209|NCT02705716|69752552|FG000|Overall Study|Adverse Event|0|||
38060210|NCT02705716|69752553|FG001|Overall Study|Adverse Event|1|||
38060211|NCT02705716|69752552|FG000|Overall Study|Protocol Violation|3|||
38060212|NCT02705716|69752553|FG001|Overall Study|Protocol Violation|0|||
38060213|NCT02705716|69752552|FG000|Overall Study|Withdrawal of Consent|1|||
38060214|NCT02705716|69752553|FG001|Overall Study|Withdrawal of Consent|1|||
38060215|NCT04138043|69752561|FG000|Overall Study|Withdrawal by Subject|0|||
38060216|NCT04138043|69752562|FG001|Overall Study|Withdrawal by Subject|1|||
38060217|NCT03443713|69752581|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
38060218|NCT03443713|69752582|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
38060219|NCT03443713|69752583|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
38060220|NCT04133519|69752597|FG000|Overall Study|Withdrawal by Subject|5|||
38060221|NCT04133519|69752598|FG001|Overall Study|Withdrawal by Subject|4|||
38060222|NCT04133519|69752597|FG000|Overall Study|Protocol Violation|0|||
38060223|NCT04133519|69752598|FG001|Overall Study|Protocol Violation|1|||
38060224|NCT04133519|69752597|FG000|Overall Study|Never started treatment|1|||
38060225|NCT04133519|69752598|FG001|Overall Study|Never started treatment|1|||
38060226|NCT04007159|69752604|FG000|Induction Phase|(missed study visits)|16|||
38060227|NCT04007159|69752604|FG000|Induction Phase|Withdrawal by Subject|4|||
38060228|NCT04007159|69752604|FG000|Induction Phase|Adverse Event|2|||
38060229|NCT04007159|69752604|FG000|Challenge Phase|missed study visits|3|||
38060230|NCT03119688|69752615|FG000|Overall Study|Adverse Event|4|||
38060231|NCT03389893|69752634|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
38060232|NCT03389893|69752635|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
38060233|NCT03389893|69752636|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
38060234|NCT03389893|69752637|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
38060235|NCT03389893|69752634|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
38060236|NCT03389893|69752635|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
38060237|NCT03389893|69752636|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
38060238|NCT03389893|69752637|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
38060239|NCT03389893|69752634|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
38060240|NCT03389893|69752635|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
38060241|NCT03389893|69752636|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
38060242|NCT03389893|69752637|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
38060243|NCT03389893|69752634|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
38060244|NCT03389893|69752635|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
38060245|NCT03389893|69752636|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
38060246|NCT03389893|69752637|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
38060247|NCT04128293|69752647|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
37862218|NCT01131585|69546010|FG000|Overall Study|Protocol Violation|2|||
38060248|NCT04128293|69752648|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
38060249|NCT04128293|69752649|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
38060250|NCT04128293|69752650|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
38060251|NCT00787176|69752669|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
38060252|NCT00787176|69752670|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
38060253|NCT00787176|69752671|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
38060254|NCT00787176|69752672|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
38060255|NCT03691571|69752685|FG000|Overall Study|Withdrawal by Subject|9|||
37862219|NCT01131585|69546011|FG001|Overall Study|Protocol Violation|1|||
37862220|NCT01131585|69546010|FG000|Overall Study|Withdrawal by Subject|3|||
38060256|NCT03691571|69752686|FG001|Overall Study|Withdrawal by Subject|2|||
38060257|NCT03113916|69752695|FG000|Overall Study|Withdrawal by Subject|9|||
38060258|NCT03113916|69752696|FG001|Overall Study|Withdrawal by Subject|7|||
38060259|NCT03113916|69752695|FG000|Overall Study|Pregnancy|1|||
38060260|NCT03113916|69752696|FG001|Overall Study|Pregnancy|3|||
38060261|NCT03113916|69752695|FG000|Overall Study|Lost to Follow-up|1|||
38060262|NCT03113916|69752696|FG001|Overall Study|Lost to Follow-up|2|||
38060263|NCT02925494|69752711|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
38060264|NCT02925494|69752712|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
38060265|NCT02925494|69752713|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
38060266|NCT02925494|69752714|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
38060267|NCT02925494|69752711|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
38060268|NCT02925494|69752712|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
38060269|NCT02925494|69752713|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
38060270|NCT02925494|69752714|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
38060271|NCT02925494|69752711|FG000|Post-Treatment Follow-Up Period|Other|1|||
38060272|NCT02925494|69752712|FG001|Post-Treatment Follow-Up Period|Other|4|||
38060273|NCT02925494|69752713|FG002|Post-Treatment Follow-Up Period|Other|3|||
38060274|NCT02925494|69752714|FG003|Post-Treatment Follow-Up Period|Other|6|||
38060275|NCT02925494|69752711|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
38060276|NCT02925494|69752712|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
38060277|NCT02925494|69752713|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
38060278|NCT02925494|69752714|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
38060279|NCT02925494|69752711|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
38060280|NCT02925494|69752712|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
38060281|NCT02925494|69752713|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
38060282|NCT02925494|69752714|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
38060283|NCT02925494|69752711|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
38060284|NCT02925494|69752712|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
38060285|NCT02925494|69752713|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
37862221|NCT01131585|69546011|FG001|Overall Study|Withdrawal by Subject|3|||
38060286|NCT02925494|69752714|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
38060287|NCT02925494|69752711|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
38060288|NCT02925494|69752712|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
38060289|NCT02925494|69752713|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
38060290|NCT02925494|69752714|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
37680381|NCT02586805|69155999|FG002|Overall Study|Lost to Follow-up|1|||
37862222|NCT01131585|69546010|FG000|Overall Study|Lost to Follow-up|0|||
38060291|NCT04006145|69752727|FG000|Overall Study|Lost to Follow-up|0|||
38060292|NCT04006145|69752728|FG001|Overall Study|Lost to Follow-up|1|||
38060293|NCT04006145|69752727|FG000|Overall Study|Other|1|||
38060294|NCT04006145|69752728|FG001|Overall Study|Other|2|||
38060295|NCT03386773|69752736|FG000|Overall Study|Lost to Follow-up|24|||
38060296|NCT03386773|69752737|FG001|Overall Study|Lost to Follow-up|33|||
38060297|NCT03386773|69752736|FG000|Overall Study|Withdrawal by Subject|3|||
38060298|NCT03386773|69752737|FG001|Overall Study|Withdrawal by Subject|2|||
38060299|NCT04126343|69752749|FG000|Overall Study|Adverse Event|0|||
38060300|NCT04126343|69752750|FG001|Overall Study|Adverse Event|0|||
38060301|NCT04126343|69752751|FG002|Overall Study|Adverse Event|0|||
38060302|NCT04126343|69752752|FG003|Overall Study|Adverse Event|0|||
38060303|NCT04126343|69752753|FG004|Overall Study|Adverse Event|0|||
38060304|NCT04126343|69752754|FG005|Overall Study|Adverse Event|1|||
38060305|NCT04126343|69752749|FG000|Overall Study|Withdrawal by Subject|0|||
38060306|NCT04126343|69752750|FG001|Overall Study|Withdrawal by Subject|0|||
38060307|NCT04126343|69752751|FG002|Overall Study|Withdrawal by Subject|0|||
38060308|NCT04126343|69752752|FG003|Overall Study|Withdrawal by Subject|1|||
38060309|NCT04126343|69752753|FG004|Overall Study|Withdrawal by Subject|0|||
38060310|NCT04126343|69752754|FG005|Overall Study|Withdrawal by Subject|0|||
38060311|NCT04126343|69752749|FG000|Overall Study|Related to COVID-19 pandemic|3|||
38060312|NCT04126343|69752750|FG001|Overall Study|Related to COVID-19 pandemic|4|||
38060313|NCT04126343|69752751|FG002|Overall Study|Related to COVID-19 pandemic|3|||
38060314|NCT04126343|69752752|FG003|Overall Study|Related to COVID-19 pandemic|3|||
38060315|NCT04126343|69752753|FG004|Overall Study|Related to COVID-19 pandemic|3|||
38060316|NCT04126343|69752754|FG005|Overall Study|Related to COVID-19 pandemic|3|||
38060317|NCT02952313|69752769|FG000|Primary Endpoint|Lost to Follow-up|4|||
38060318|NCT02952313|69752769|FG000|Primary Endpoint|Withdrawal by Subject|1|||
38060319|NCT02952313|69752769|FG000|Primary Endpoint|Lack of Efficacy|1|||
38060320|NCT02952313|69752769|FG000|Primary Endpoint|Missed visit|1|||
38060321|NCT02952313|69752769|FG000|Long-term Follow-up|Lost to Follow-up|12|||
38060322|NCT02952313|69752769|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
38060323|NCT02952313|69752769|FG000|Long-term Follow-up|Lack of Efficacy|6|||
38060324|NCT02952313|69752769|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
38060325|NCT02952313|69752769|FG000|Long-term Follow-up|Physician Decision|1|||
38060326|NCT02952313|69752769|FG000|Long-term Follow-up|Death|1|||
38060327|NCT03119610|69752776|FG000|Overall Study|Adverse Event|1|||
38060328|NCT03119610|69752777|FG001|Overall Study|Adverse Event|0|||
38060329|NCT03119610|69752776|FG000|Overall Study|Lost to Follow-up|0|||
38060330|NCT03119610|69752777|FG001|Overall Study|Lost to Follow-up|1|||
38060331|NCT04005755|69752783|FG000|Overall Study|Adverse Event|6|||
38060332|NCT04005755|69752783|FG000|Overall Study|Physician Decision|3|||
38060333|NCT04005755|69752783|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
38060334|NCT04005755|69752783|FG000|Overall Study|Withdrawal by Subject|3|||
38060335|NCT04005755|69752783|FG000|Overall Study|Lost to Follow-up|1|||
38060336|NCT03442777|69752790|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
38060337|NCT03442777|69752791|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
38060338|NCT03442777|69752792|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
38060339|NCT03401749|69752801|FG000|Overall Study|Lost to Follow-up|20|||
38060340|NCT03401749|69752802|FG001|Overall Study|Lost to Follow-up|16|||
38060341|NCT03401749|69752803|FG002|Overall Study|Lost to Follow-up|26|||
38060342|NCT03029624|69752811|FG000|Overall Study|Adverse Event|1|||
38060343|NCT03029624|69752811|FG000|Overall Study|Withdrawal by Subject|1|||
38060344|NCT03029624|69752811|FG000|Overall Study|Lack of Efficacy|1|||
38060345|NCT03029624|69752811|FG000|Overall Study|MRI need|2|||
38060346|NCT02952001|69752819|FG000|Overall Study|Adverse Event|3|||
38060347|NCT02952001|69752820|FG001|Overall Study|Adverse Event|0|||
38060348|NCT02952001|69752819|FG000|Overall Study|Prohibited therapy|10|||
38060349|NCT02952001|69752820|FG001|Overall Study|Prohibited therapy|3|||
38060350|NCT02952001|69752819|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
38060351|NCT02952001|69752820|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
37680382|NCT02586805|69156000|FG003|Overall Study|Lost to Follow-up|0|||
38060352|NCT04123067|69752829|FG000|Overall Study|Lost to Follow-up|0|||
38060353|NCT04123067|69752830|FG001|Overall Study|Lost to Follow-up|1|||
38060354|NCT04117607|69752839|FG000|Overall Study|Early Termination|0|||
38060355|NCT04117607|69752840|FG001|Overall Study|Early Termination|1|||
38060356|NCT04117607|69752841|FG002|Overall Study|Early Termination|0|||
38060357|NCT04117607|69752842|FG003|Overall Study|Early Termination|0|||
38060358|NCT04117607|69752843|FG004|Overall Study|Early Termination|0|||
38060359|NCT04117607|69752844|FG005|Overall Study|Early Termination|0|||
38060360|NCT04117607|69752845|FG006|Overall Study|Early Termination|1|||
38060361|NCT04117607|69752846|FG007|Overall Study|Early Termination|0|||
38060362|NCT04117607|69752847|FG008|Overall Study|Early Termination|0|||
38060363|NCT04117607|69752848|FG009|Overall Study|Early Termination|0|||
38060364|NCT04117607|69752849|FG010|Overall Study|Early Termination|0|||
38060365|NCT04117607|69752850|FG011|Overall Study|Early Termination|0|||
38060366|NCT04117607|69752851|FG012|Overall Study|Early Termination|0|||
38060367|NCT04117607|69752852|FG013|Overall Study|Early Termination|0|||
38060368|NCT04112303|69752868|FG000|Overall Study|Death|1|||
38060369|NCT03998189|69752874|FG000|Overall Study|Lack of Efficacy|0|||
38060370|NCT03998189|69752875|FG001|Overall Study|Lack of Efficacy|1|||
38060371|NCT04099277|69752881|FG000|Overall Study|Physician Decision|1|||
38060372|NCT04099277|69752881|FG000|Overall Study|Withdrawal by Subject|1|||
38060373|NCT03990389|69752887|FG000|Overall Study|Lost to Follow-up|3|||
38060374|NCT03990389|69752888|FG001|Overall Study|Lost to Follow-up|0|||
38060375|NCT03988907|69752896|FG000|Overall Study|Unable to complete visit|0|||
38060376|NCT03988907|69752897|FG001|Overall Study|Unable to complete visit|1|||
38060377|NCT03987191|69752911|FG000|Overall Study|COVID-19 related research disruption|0|||
38060378|NCT03987191|69752912|FG001|Overall Study|COVID-19 related research disruption|2|||
38060379|NCT04098809|69752920|FG000|Overall Study|Withdrawal by Subject|1|||
38060380|NCT04098809|69752921|FG001|Overall Study|Withdrawal by Subject|3|||
38060381|NCT04098809|69752920|FG000|Overall Study|Physician Decision|2|||
38060382|NCT04098809|69752921|FG001|Overall Study|Physician Decision|1|||
38060383|NCT03122184|69752929|FG000|Overall Study|Lost to Follow-up|4|||
38060384|NCT03122184|69752930|FG001|Overall Study|Lost to Follow-up|6|||
38060385|NCT03122184|69752929|FG000|Overall Study|Withdrawal by Subject|3|||
38060386|NCT03122184|69752930|FG001|Overall Study|Withdrawal by Subject|0|||
38060387|NCT03122184|69752929|FG000|Overall Study|Terminated due to cognitive problem|1|||
38060388|NCT03122184|69752930|FG001|Overall Study|Terminated due to cognitive problem|0|||
38060389|NCT04091087|69752955|FG000|Overall Study|Not treated|1|||
38060390|NCT04091087|69752956|FG001|Overall Study|Not treated|0|||
38060391|NCT04091087|69752955|FG000|Overall Study|Adverse Event|4|||
38060392|NCT04091087|69752956|FG001|Overall Study|Adverse Event|4|||
38060393|NCT04091087|69752955|FG000|Overall Study|Protocol Violation|0|||
38060394|NCT04091087|69752956|FG001|Overall Study|Protocol Violation|1|||
38060395|NCT04091087|69752955|FG000|Overall Study|Withdrawal by Subject|5|||
38060396|NCT04091087|69752956|FG001|Overall Study|Withdrawal by Subject|2|||
38060397|NCT03400033|69752974|FG000|Overall Study|Withdrawal by Subject|1|||
38060398|NCT03400033|69752975|FG001|Overall Study|Withdrawal by Subject|2|||
38060399|NCT04089761|69752990|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
38060400|NCT04089761|69752990|FG000|"Run In Phase"|Lost to Follow-up|1|||
38060401|NCT04089761|69752990|FG000|"Treatment Phase"|No evaluable data|5|||
38060402|NCT04089761|69752990|FG000|"Treatment Phase"|Lost to Follow-up|1|||
38060403|NCT03118518|69752996|FG000|Overall Study|Early Exit after treatment|2|||
38060404|NCT03118518|69752997|FG001|Overall Study|Early Exit after treatment|8|||
38060405|NCT03118518|69752996|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
38060406|NCT03118518|69752997|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
38060407|NCT03984305|69753005|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
38060408|NCT03984305|69753006|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
38060409|NCT03984305|69753005|FG000|Overall Study|Withdrawal by Subject|3|||
38060410|NCT03984305|69753006|FG001|Overall Study|Withdrawal by Subject|3|||
38060411|NCT03984305|69753005|FG000|Overall Study|Lost to Follow-up|1|||
38060412|NCT03984305|69753006|FG001|Overall Study|Lost to Follow-up|0|||
38060413|NCT03397771|69753014|FG000|Overall Study|2 erroneously randomized, never treated|3|||
38060414|NCT03397771|69753015|FG001|Overall Study|2 erroneously randomized, never treated|1|||
38060415|NCT03397771|69753014|FG000|Overall Study|Withdrawal by Subject|1|||
38060416|NCT03397771|69753015|FG001|Overall Study|Withdrawal by Subject|3|||
37965598|NCT00365716|69652697|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
38060417|NCT03397771|69753014|FG000|Overall Study|Protocol Violation|2|||
38060418|NCT03397771|69753015|FG001|Overall Study|Protocol Violation|2|||
38060419|NCT03397771|69753014|FG000|Overall Study|Adverse Event|2|||
38060420|NCT03397771|69753015|FG001|Overall Study|Adverse Event|1|||
38060421|NCT02876835|69753023|FG000|Treatment Period (51.1 Month)|Other|1|||
38060422|NCT02876835|69753024|FG001|Treatment Period (51.1 Month)|Other|0|||
38060423|NCT02876835|69753023|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
38060424|NCT02876835|69753024|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
38060425|NCT02876835|69753023|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
38060426|NCT02876835|69753024|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
38060427|NCT02876835|69753023|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
38060428|NCT02876835|69753024|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
38060429|NCT04086641|69753033|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
38060430|NCT04086641|69753034|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
38060431|NCT03503318|69753043|FG000|Overall Study|Death|1|||
38060432|NCT03503318|69753044|FG001|Overall Study|Death|0|||
38060433|NCT03503318|69753045|FG002|Overall Study|Death|4|||
38060434|NCT03503318|69753043|FG000|Overall Study|Adverse Event|3|||
38060435|NCT03503318|69753044|FG001|Overall Study|Adverse Event|4|||
38060436|NCT03503318|69753045|FG002|Overall Study|Adverse Event|2|||
37862223|NCT01131585|69546011|FG001|Overall Study|Lost to Follow-up|1|||
38060437|NCT03503318|69753043|FG000|Overall Study|Withdrawal by Subject|12|||
38060438|NCT03503318|69753044|FG001|Overall Study|Withdrawal by Subject|17|||
38060439|NCT03503318|69753045|FG002|Overall Study|Withdrawal by Subject|16|||
38060440|NCT03503318|69753043|FG000|Overall Study|Protocol Violation|5|||
38060441|NCT03503318|69753044|FG001|Overall Study|Protocol Violation|0|||
38060442|NCT03503318|69753045|FG002|Overall Study|Protocol Violation|3|||
38060443|NCT03503318|69753043|FG000|Overall Study|Lost to Follow-up|17|||
38060444|NCT03503318|69753044|FG001|Overall Study|Lost to Follow-up|15|||
38060445|NCT03503318|69753045|FG002|Overall Study|Lost to Follow-up|12|||
38060446|NCT03503318|69753043|FG000|Overall Study|Other than specified|1|||
38060447|NCT03503318|69753044|FG001|Overall Study|Other than specified|3|||
38060448|NCT03503318|69753045|FG002|Overall Study|Other than specified|3|||
38060449|NCT03396913|69753055|FG000|Overall Study|Lost to Follow-up|0|||
38060450|NCT03396913|69753056|FG001|Overall Study|Lost to Follow-up|6|||
38060451|NCT03982433|69753062|FG000|Overall Study|Lost to Follow-up|1|||
38060452|NCT03396835|69753066|FG000|Overall Study|Withdrawn prior to completion|1|||
38060453|NCT03396835|69753066|FG000|Overall Study|Did not meet criteria for data analysis|1|||
38060454|NCT03121950|69753072|FG000|Overall Study|Withdrawal by Subject|11|||
38060455|NCT03121950|69753073|FG001|Overall Study|Withdrawal by Subject|2|||
38060456|NCT03395353|69753081|FG000|Overall Study|Adverse Event|20|||
38060457|NCT03395353|69753081|FG000|Overall Study|Protocol Violation|1|||
38060458|NCT03395353|69753081|FG000|Overall Study|Lack of Efficacy|3|||
38060459|NCT03395353|69753081|FG000|Overall Study|Withdrawal by Subject|24|||
38060460|NCT03395353|69753081|FG000|Overall Study|Discontinued visit|1|||
38060461|NCT03395353|69753081|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
38060462|NCT03395353|69753081|FG000|Overall Study|Physician Decision|4|||
38060463|NCT03395353|69753081|FG000|Overall Study|Early termination of overall study|33|||
38060464|NCT04082663|69753089|FG000|Overall Study|Adverse Event|6|||
38060465|NCT04082663|69753089|FG000|Overall Study|Lost to Follow-up|1|||
38060466|NCT03682367|69753095|FG000|Overall Study|Protocol Violation|2|||
38060467|NCT03682367|69753096|FG001|Overall Study|Protocol Violation|1|||
38060468|NCT03682367|69753095|FG000|Overall Study|Closed Study Early|0|||
38060469|NCT03682367|69753096|FG001|Overall Study|Closed Study Early|3|||
38060470|NCT03681353|69753102|FG000|Overall Study|Lost to Follow-up|2|||
38060471|NCT03681353|69753102|FG000|Overall Study|Withdrawal by Subject|3|||
38060472|NCT03681353|69753102|FG000|Overall Study|withdrawn by PI|2|||
38060473|NCT03394885|69753106|FG000|Overall Study|Adverse Event|4|||
38060474|NCT03394885|69753106|FG000|Overall Study|Lack of Efficacy|1|||
38060475|NCT03394885|69753106|FG000|Overall Study|Physician Decision|1|||
38060476|NCT03394885|69753106|FG000|Overall Study|Withdrawal by Subject|8|||
38060477|NCT03394885|69753106|FG000|Overall Study|Alternative Therapy|1|||
38060478|NCT02877927|69753112|FG000|Overall Study|Adverse Event|1|||
38060479|NCT02877927|69753113|FG001|Overall Study|Adverse Event|0|||
38060480|NCT02877927|69753112|FG000|Overall Study|Lost to Follow-up|37|||
37862224|NCT01131585|69546010|FG000|Overall Study|Administrative problems|1|||
37862225|NCT01131585|69546011|FG001|Overall Study|Administrative problems|1|||
37862226|NCT01131585|69546010|FG000|Overall Study|Study termination|78|||
38060481|NCT02877927|69753113|FG001|Overall Study|Lost to Follow-up|38|||
38060482|NCT02877927|69753112|FG000|Overall Study|Withdrawal by Subject|11|||
38060483|NCT02877927|69753113|FG001|Overall Study|Withdrawal by Subject|12|||
38060484|NCT02877927|69753112|FG000|Overall Study|Physician Decision|0|||
38060485|NCT02877927|69753113|FG001|Overall Study|Physician Decision|1|||
38060486|NCT02877927|69753112|FG000|Overall Study|Missed EOT/PTE Visit|5|||
38060487|NCT02877927|69753113|FG001|Overall Study|Missed EOT/PTE Visit|6|||
38060488|NCT02706886|69753128|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
38060489|NCT02706886|69753129|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
38060490|NCT02706886|69753130|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
38060491|NCT02706886|69753131|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
38060492|NCT02706886|69753132|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
38060493|NCT02706886|69753133|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
38060494|NCT02706886|69753134|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
38060495|NCT02706886|69753135|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
38060496|NCT02706886|69753136|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
38060497|NCT04069715|69753190|FG000|Overall Study|Lost to Follow-up|1|||
38060498|NCT04069715|69753191|FG001|Overall Study|Lost to Follow-up|1|||
37862227|NCT01131585|69546011|FG001|Overall Study|Study termination|32|||
38060499|NCT04069715|69753190|FG000|Overall Study|Physician Decision|1|||
38060500|NCT04069715|69753191|FG001|Overall Study|Physician Decision|1|||
38060501|NCT04069715|69753190|FG000|Overall Study|Withdrawal by Subject|3|||
38060502|NCT04069715|69753191|FG001|Overall Study|Withdrawal by Subject|3|||
38060503|NCT03681119|69753199|FG000|Overall Study|No specific reason|4|||
38060504|NCT03681119|69753200|FG001|Overall Study|No specific reason|0|||
38060505|NCT03681119|69753199|FG000|Overall Study|Sickness|2|||
38060506|NCT03681119|69753200|FG001|Overall Study|Sickness|0|||
38060507|NCT03111108|69753206|FG000|Overall Study|Death|0|||
38060508|NCT03111108|69753207|FG001|Overall Study|Death|1|||
38060509|NCT03111108|69753206|FG000|Overall Study|Withdrawal by Subject|1|||
38060510|NCT03111108|69753207|FG001|Overall Study|Withdrawal by Subject|0|||
38060511|NCT03677375|69753213|FG000|Overall Study|Incomplete procedure|8|||
38060512|NCT03677375|69753213|FG000|Overall Study|Adverse Event|3|||
38060513|NCT03677375|69753213|FG000|Overall Study|Physician Decision|1|||
38060514|NCT00702520|69753219|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
38060515|NCT00702520|69753220|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
38060516|NCT00702520|69753221|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
38060517|NCT00702520|69753222|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
38060518|NCT00702520|69753219|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
38060519|NCT00702520|69753220|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
38060520|NCT00702520|69753221|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
38060521|NCT00702520|69753222|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
38060522|NCT00702520|69753219|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
38060523|NCT00702520|69753220|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
38060524|NCT00702520|69753221|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
38060525|NCT00702520|69753222|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
38060526|NCT04067141|69753232|FG000|First Intervention|Withdrawal by Subject|0|||
38060527|NCT04067141|69753233|FG001|First Intervention|Withdrawal by Subject|1|||
38060528|NCT04067141|69753232|FG000|Second Intervention|Adverse Event|0|||
38060529|NCT04067141|69753233|FG001|Second Intervention|Adverse Event|2|||
38060530|NCT02876601|69753243|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
38060531|NCT02876601|69753244|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
38060532|NCT02876601|69753245|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
38060533|NCT02876601|69753246|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
38060534|NCT04054193|69753291|FG000|Cycle 1|Physician Decision|1|||
38060535|NCT04054193|69753291|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
38060536|NCT04054193|69753291|FG000|Cycle 1|Allocated but not treated|3|||
38060537|NCT04054193|69753291|FG000|Cycles 2-3|Physician Decision|2|||
38060538|NCT04054193|69753291|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
38060539|NCT04054193|69753291|FG000|Cycles 2-3|Various reasons|17|||
38060540|NCT03394027|69753299|FG000|Overall Study|Ineligible|3|||
38060541|NCT03394027|69753300|FG001|Overall Study|Ineligible|1|||
38060542|NCT03394027|69753301|FG002|Overall Study|Ineligible|3|||
38060543|NCT03394027|69753299|FG000|Overall Study|Participant declined to participate before treatment started|0|||
38060544|NCT03394027|69753300|FG001|Overall Study|Participant declined to participate before treatment started|0|||
38060545|NCT03394027|69753301|FG002|Overall Study|Participant declined to participate before treatment started|1|||
38060546|NCT03136107|69753327|FG000|Overall Study|Other (Not specified)|1|||
38060547|NCT02916056|69753335|FG000|Overall Study|Adverse Event|6|||
38060548|NCT02916056|69753335|FG000|Overall Study|Lost to Follow-up|1|||
38060549|NCT02916056|69753335|FG000|Overall Study|Other|12|||
38060550|NCT02916056|69753335|FG000|Overall Study|Protocol Violation|1|||
38060551|NCT02916056|69753335|FG000|Overall Study|Withdrawal by Subject|8|||
38060552|NCT02916056|69753335|FG000|Overall Study|Study Terminated by Sponsor|269|||
38060553|NCT04854642|69753339|FG000|Overall Study|Adverse Event|1|||
38060554|NCT04854642|69753340|FG001|Overall Study|Adverse Event|2|||
38060555|NCT04854642|69753339|FG000|Overall Study|Withdrawal by Subject|0|||
38060556|NCT04854642|69753340|FG001|Overall Study|Withdrawal by Subject|1|||
38060557|NCT03384745|69753354|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
38060558|NCT03384745|69753355|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
38060559|NCT03384745|69753356|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
38060560|NCT03384745|69753357|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
38060561|NCT03384745|69753358|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
38060562|NCT03384745|69753359|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
38060563|NCT03384745|69753354|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
38060564|NCT03384745|69753355|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
38060565|NCT03384745|69753356|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
38060566|NCT03384745|69753357|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
38060567|NCT03384745|69753358|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
38060568|NCT03384745|69753359|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
38060569|NCT03384745|69753354|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
38060570|NCT03384745|69753355|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
38060571|NCT03384745|69753356|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
38060572|NCT03384745|69753357|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
38060573|NCT03384745|69753358|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
38060574|NCT03384745|69753359|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
38060575|NCT03384745|69753354|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
38060576|NCT03384745|69753355|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
38060577|NCT03384745|69753356|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
38060578|NCT03384745|69753357|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
38060579|NCT03384745|69753358|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
38060580|NCT03384745|69753359|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
38060581|NCT03384745|69753354|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
38060582|NCT03384745|69753355|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
38060583|NCT03384745|69753356|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
38060584|NCT03384745|69753357|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
38060585|NCT03384745|69753358|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
38060586|NCT03384745|69753359|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
38060587|NCT03384745|69753354|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
38060588|NCT03384745|69753355|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
38060589|NCT03384745|69753356|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
38060590|NCT03384745|69753357|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
38060591|NCT03384745|69753358|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
38060592|NCT03384745|69753359|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
38060593|NCT03384745|69753354|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
38060594|NCT03384745|69753355|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
38060595|NCT03384745|69753356|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
38060596|NCT03384745|69753357|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
38060597|NCT03384745|69753358|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
38060598|NCT03384745|69753359|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
38060599|NCT03384745|69753354|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
38060600|NCT03384745|69753355|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
38060601|NCT03384745|69753356|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
38060602|NCT03384745|69753357|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
38060603|NCT03384745|69753358|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
38060604|NCT03384745|69753359|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
38060605|NCT03384745|69753354|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
38060606|NCT03384745|69753355|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
38060607|NCT03384745|69753356|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
38060608|NCT03384745|69753357|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
38060609|NCT03384745|69753358|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
38060610|NCT03384745|69753359|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
38060611|NCT03384745|69753354|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
38060612|NCT03384745|69753355|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
38060613|NCT03384745|69753356|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
38060614|NCT03384745|69753357|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
38060615|NCT03384745|69753358|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
38060616|NCT03384745|69753359|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
38060617|NCT03384745|69753354|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
38060618|NCT03384745|69753355|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
38060619|NCT03384745|69753356|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
38060620|NCT03384745|69753357|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
38060621|NCT03384745|69753358|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
38060622|NCT03384745|69753359|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
38060623|NCT03383887|69753379|FG000|Overall Study|Lost to Follow-up|0|||
38060624|NCT03383887|69753380|FG001|Overall Study|Lost to Follow-up|1|||
38060625|NCT03379753|69753388|FG000|Overall Study|Withdrawal by Subject|2|||
38060626|NCT03379753|69753389|FG001|Overall Study|Withdrawal by Subject|1|||
38060627|NCT03379753|69753388|FG000|Overall Study|not having correct procedure|1|||
38060628|NCT03379753|69753389|FG001|Overall Study|not having correct procedure|2|||
38060629|NCT03379753|69753388|FG000|Overall Study|No primary outcome|12|||
38060630|NCT03379753|69753389|FG001|Overall Study|No primary outcome|22|||
38060631|NCT03379675|69753398|FG000|Overall Study|Lost to Follow-up|0|||
38060632|NCT03379675|69753399|FG001|Overall Study|Lost to Follow-up|1|||
38060633|NCT03379675|69753400|FG002|Overall Study|Lost to Follow-up|0|||
38060634|NCT03379675|69753398|FG000|Overall Study|Adverse Event|2|||
38060635|NCT03379675|69753399|FG001|Overall Study|Adverse Event|0|||
38060636|NCT03379675|69753400|FG002|Overall Study|Adverse Event|0|||
38060637|NCT03379675|69753398|FG000|Overall Study|Withdrawal by Subject|2|||
38060638|NCT03379675|69753399|FG001|Overall Study|Withdrawal by Subject|1|||
38060639|NCT03379675|69753400|FG002|Overall Study|Withdrawal by Subject|2|||
38060640|NCT02930889|69753408|FG000|Overall Study|Lost to Follow-up|2|||
38060641|NCT02930889|69753408|FG000|Overall Study|Withdrawal by Subject|6|||
38060642|NCT02930889|69753408|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
38060643|NCT02875977|69753414|FG000|Overall Study|Lost to Follow-up|42|||
38060644|NCT02875977|69753415|FG001|Overall Study|Lost to Follow-up|29|||
38060645|NCT02703532|69753434|FG000|Overall Study|Withdrawal by Subject|0|||
38060646|NCT02703532|69753435|FG001|Overall Study|Withdrawal by Subject|1|||
38060647|NCT02703532|69753436|FG002|Overall Study|Withdrawal by Subject|0|||
38060648|NCT02703532|69753437|FG003|Overall Study|Withdrawal by Subject|1|||
38060649|NCT02703532|69753434|FG000|Overall Study|Lost to Follow-up|2|||
38060650|NCT02703532|69753435|FG001|Overall Study|Lost to Follow-up|0|||
38060651|NCT02703532|69753436|FG002|Overall Study|Lost to Follow-up|2|||
38060652|NCT02703532|69753437|FG003|Overall Study|Lost to Follow-up|0|||
38060653|NCT02930343|69753470|FG000|Overall Study|Lost to Follow-up|9|||
38060654|NCT02930343|69753471|FG001|Overall Study|Lost to Follow-up|7|||
38060655|NCT02703454|69753479|FG000|Overall Study|Not treated|1|||
38060656|NCT02703454|69753480|FG001|Overall Study|Not treated|3|||
38060657|NCT02703454|69753479|FG000|Overall Study|Withdrawal by Subject|4|||
38060658|NCT02703454|69753480|FG001|Overall Study|Withdrawal by Subject|3|||
38060659|NCT02703454|69753479|FG000|Overall Study|Lost to Follow-up|1|||
38060660|NCT02703454|69753480|FG001|Overall Study|Lost to Follow-up|2|||
38060661|NCT02703454|69753479|FG000|Overall Study|Study discontinuation|5|||
38060662|NCT02703454|69753480|FG001|Overall Study|Study discontinuation|8|||
38060663|NCT03103542|69753486|FG000|Overall Study|Physician Decision|2|||
38060664|NCT03103542|69753486|FG000|Overall Study|Adverse Event|2|||
38060665|NCT03103542|69753486|FG000|Overall Study|Other|2|||
38060666|NCT03103542|69753486|FG000|Overall Study|Withdrawal by Subject|1|||
38060667|NCT03376321|69753513|FG000|Overall Study|Other|5|||
38060668|NCT03376321|69753514|FG001|Overall Study|Other|1|||
38060669|NCT03376321|69753513|FG000|Overall Study|Withdrawal by Subject|8|||
38060670|NCT03376321|69753514|FG001|Overall Study|Withdrawal by Subject|14|||
38060671|NCT03376321|69753513|FG000|Overall Study|Lost to Follow-up|1|||
38060672|NCT03376321|69753514|FG001|Overall Study|Lost to Follow-up|7|||
38060673|NCT03376321|69753513|FG000|Overall Study|Death|4|||
38060674|NCT03376321|69753514|FG001|Overall Study|Death|0|||
38060675|NCT03376321|69753513|FG000|Overall Study|Randomized, not treated|5|||
38060676|NCT03376321|69753514|FG001|Overall Study|Randomized, not treated|3|||
38060677|NCT03374995|69753522|FG000|Overall Study|Withdrawal by Subject|0|||
38060678|NCT03374995|69753523|FG001|Overall Study|Withdrawal by Subject|1|||
38060679|NCT02828982|69753529|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
38060680|NCT02828982|69753530|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
38060681|NCT03133767|69753540|FG000|Overall Study|Lost to Follow-up|38|||
38060682|NCT03133767|69753541|FG001|Overall Study|Lost to Follow-up|24|||
38060683|NCT03133767|69753540|FG000|Overall Study|Protocol Violation|0|||
38060684|NCT03133767|69753541|FG001|Overall Study|Protocol Violation|1|||
38060685|NCT03391765|69753551|FG000|Overall Study|Adverse Event|2|||
37862228|NCT01131507|69546017|FG000|Overall Study|Adverse Event|1|||
37965599|NCT00365716|69652698|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
37965600|NCT00365716|69652699|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
37965601|NCT00365716|69652700|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
37965602|NCT00365716|69652701|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
37965603|NCT00365716|69652695|FG000|Base Study (Day 1 to Month 7)|Other|0|||
37965604|NCT00365716|69652696|FG001|Base Study (Day 1 to Month 7)|Other|1|||
37965605|NCT00365716|69652697|FG002|Base Study (Day 1 to Month 7)|Other|0|||
37965606|NCT00365716|69652698|FG003|Base Study (Day 1 to Month 7)|Other|0|||
37965607|NCT00365716|69652699|FG004|Base Study (Day 1 to Month 7)|Other|0|||
37965608|NCT00365716|69652700|FG005|Base Study (Day 1 to Month 7)|Other|0|||
37965609|NCT00365716|69652701|FG006|Base Study (Day 1 to Month 7)|Other|0|||
37965610|NCT00365716|69652695|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
37965611|NCT00365716|69652696|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
37965612|NCT00365716|69652697|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
37965613|NCT00365716|69652698|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
38060686|NCT03391765|69753552|FG001|Overall Study|Adverse Event|0|||
38060687|NCT03391765|69753553|FG002|Overall Study|Adverse Event|0|||
38060688|NCT03391765|69753554|FG003|Overall Study|Adverse Event|2|||
38060689|NCT03391765|69753551|FG000|Overall Study|Withdrew consent|5|||
38060690|NCT03391765|69753552|FG001|Overall Study|Withdrew consent|7|||
38060691|NCT03391765|69753553|FG002|Overall Study|Withdrew consent|2|||
38060692|NCT03391765|69753554|FG003|Overall Study|Withdrew consent|5|||
38060693|NCT03391765|69753551|FG000|Overall Study|Other, not specified|44|||
38060694|NCT03391765|69753552|FG001|Overall Study|Other, not specified|38|||
38060695|NCT03391765|69753553|FG002|Overall Study|Other, not specified|21|||
38060696|NCT03391765|69753554|FG003|Overall Study|Other, not specified|16|||
38060697|NCT02802228|69753566|FG000|Overall Study|Withdrawal by Subject|2|||
38060698|NCT02802228|69753567|FG001|Overall Study|Withdrawal by Subject|0|||
38060699|NCT02802228|69753566|FG000|Overall Study|Lost to Follow-up|1|||
38060700|NCT02802228|69753567|FG001|Overall Study|Lost to Follow-up|0|||
38060701|NCT02802228|69753566|FG000|Overall Study|Adverse Event|1|||
38060702|NCT02802228|69753567|FG001|Overall Study|Adverse Event|0|||
38060703|NCT02802228|69753566|FG000|Overall Study|Physician Decision|1|||
38060704|NCT02802228|69753567|FG001|Overall Study|Physician Decision|0|||
38060705|NCT03130257|69753576|FG000|Overall Study|Withdrawal by Subject|1|||
38060706|NCT03130257|69753577|FG001|Overall Study|Withdrawal by Subject|0|||
38060707|NCT03130257|69753578|FG002|Overall Study|Withdrawal by Subject|2|||
38060708|NCT03674177|69753590|FG000|Overall Study|Lost to Follow-up|2|||
38060709|NCT03674177|69753591|FG001|Overall Study|Lost to Follow-up|1|||
38060710|NCT03674177|69753592|FG002|Overall Study|Lost to Follow-up|0|||
38060711|NCT03674177|69753593|FG003|Overall Study|Lost to Follow-up|2|||
38060712|NCT03354637|69753619|FG000|Double-blind Period|Protocol Violation|2|||
38060713|NCT03354637|69753620|FG001|Double-blind Period|Protocol Violation|0|||
38060714|NCT03354637|69753621|FG002|Double-blind Period|Protocol Violation|0|||
38060715|NCT03354637|69753619|FG000|Double-blind Period|Adverse Event|1|||
38060716|NCT03354637|69753620|FG001|Double-blind Period|Adverse Event|2|||
38060717|NCT03354637|69753621|FG002|Double-blind Period|Adverse Event|0|||
38060718|NCT03354637|69753619|FG000|Double-blind Period|Lost to Follow-up|3|||
38060719|NCT03354637|69753620|FG001|Double-blind Period|Lost to Follow-up|4|||
38060720|NCT03354637|69753621|FG002|Double-blind Period|Lost to Follow-up|3|||
38060721|NCT03354637|69753619|FG000|Double-blind Period|Withdrawal by Subject|10|||
38060722|NCT03354637|69753620|FG001|Double-blind Period|Withdrawal by Subject|6|||
38060723|NCT03354637|69753621|FG002|Double-blind Period|Withdrawal by Subject|4|||
38060724|NCT03354637|69753619|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
38060725|NCT03354637|69753620|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
38060726|NCT03354637|69753621|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
38060727|NCT03354637|69753619|FG000|Open Label Extension|Adverse Event|0|||
38060728|NCT03354637|69753620|FG001|Open Label Extension|Adverse Event|0|||
38060729|NCT03354637|69753621|FG002|Open Label Extension|Adverse Event|1|||
38060730|NCT03354637|69753619|FG000|Open Label Extension|Lost to Follow-up|0|||
38060731|NCT03354637|69753620|FG001|Open Label Extension|Lost to Follow-up|0|||
38060732|NCT03354637|69753621|FG002|Open Label Extension|Lost to Follow-up|2|||
38060733|NCT03354637|69753619|FG000|Open Label Extension|Withdrawal by Subject|0|||
38060734|NCT03354637|69753620|FG001|Open Label Extension|Withdrawal by Subject|0|||
38060735|NCT03354637|69753621|FG002|Open Label Extension|Withdrawal by Subject|5|||
38060736|NCT03354637|69753619|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
38060737|NCT03354637|69753620|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
38060738|NCT03354637|69753621|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
38060739|NCT03354637|69753619|FG000|Open Label Extension|Subject Noncompliance|0|||
38060740|NCT03354637|69753620|FG001|Open Label Extension|Subject Noncompliance|0|||
38060741|NCT03354637|69753621|FG002|Open Label Extension|Subject Noncompliance|1|||
38060742|NCT03354637|69753619|FG000|Open Label Extension|Lack of Efficacy|0|||
38060743|NCT03354637|69753620|FG001|Open Label Extension|Lack of Efficacy|0|||
38060744|NCT03354637|69753621|FG002|Open Label Extension|Lack of Efficacy|1|||
38060745|NCT03354637|69753619|FG000|Open Label Extension|Physician Decision|0|||
38060746|NCT03354637|69753620|FG001|Open Label Extension|Physician Decision|0|||
38060747|NCT03354637|69753621|FG002|Open Label Extension|Physician Decision|1|||
38060748|NCT04053023|69753632|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
38060749|NCT04053023|69753633|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
38060750|NCT03352453|69753645|FG000|Overall Study|Miscellaneous Reasons|1|||
38060751|NCT03352453|69753646|FG001|Overall Study|Miscellaneous Reasons|2|||
38060752|NCT03352453|69753645|FG000|Overall Study|Lack of Efficacy|1|||
38060753|NCT03352453|69753646|FG001|Overall Study|Lack of Efficacy|0|||
38060754|NCT03352453|69753645|FG000|Overall Study|Withdrawal by Subject|8|||
38060755|NCT03352453|69753646|FG001|Overall Study|Withdrawal by Subject|14|||
38060756|NCT03352453|69753645|FG000|Overall Study|Study Terminated by Sponsor|2|||
38060757|NCT03352453|69753646|FG001|Overall Study|Study Terminated by Sponsor|1|||
38060758|NCT03352453|69753645|FG000|Overall Study|Protocol Deviation|1|||
38060759|NCT03352453|69753646|FG001|Overall Study|Protocol Deviation|0|||
38060760|NCT03352453|69753645|FG000|Overall Study|Lost to Follow-up|7|||
38060761|NCT03352453|69753646|FG001|Overall Study|Lost to Follow-up|6|||
38060762|NCT03352453|69753645|FG000|Overall Study|Adverse Event|2|||
38060763|NCT03352453|69753646|FG001|Overall Study|Adverse Event|9|||
38060764|NCT03128931|69753652|FG000|Overall Study|Physician Decision|1|||
38060765|NCT03128931|69753652|FG000|Overall Study|Equipment Issues|3|||
38060766|NCT03107052|69753659|FG000|Overall Study|Adverse Event|6|||
38060767|NCT03107052|69753660|FG001|Overall Study|Adverse Event|1|||
38060768|NCT03107052|69753661|FG002|Overall Study|Adverse Event|2|||
38060769|NCT03107052|69753659|FG000|Overall Study|Withdrawal by Subject|9|||
38060770|NCT03107052|69753660|FG001|Overall Study|Withdrawal by Subject|5|||
38060771|NCT03107052|69753661|FG002|Overall Study|Withdrawal by Subject|8|||
38060772|NCT03107052|69753659|FG000|Overall Study|Protocol Violation|6|||
38060773|NCT03107052|69753660|FG001|Overall Study|Protocol Violation|0|||
38060774|NCT03107052|69753661|FG002|Overall Study|Protocol Violation|3|||
38060775|NCT03107052|69753659|FG000|Overall Study|Lost to Follow-up|4|||
38060776|NCT03107052|69753660|FG001|Overall Study|Lost to Follow-up|0|||
38060777|NCT03107052|69753661|FG002|Overall Study|Lost to Follow-up|1|||
38060778|NCT03107052|69753659|FG000|Overall Study|Lack of Efficacy|23|||
38060779|NCT03107052|69753660|FG001|Overall Study|Lack of Efficacy|7|||
38060780|NCT03107052|69753661|FG002|Overall Study|Lack of Efficacy|4|||
38060781|NCT03107052|69753659|FG000|Overall Study|Other than specified|4|||
38060782|NCT03107052|69753660|FG001|Overall Study|Other than specified|2|||
38060783|NCT03107052|69753661|FG002|Overall Study|Other than specified|0|||
38060784|NCT03107052|69753659|FG000|Overall Study|Study terminated due to futility|67|||
38060785|NCT03107052|69753660|FG001|Overall Study|Study terminated due to futility|31|||
38060786|NCT03107052|69753661|FG002|Overall Study|Study terminated due to futility|23|||
38060787|NCT04050371|69753671|FG000|Overall Study|Withdrawal by Subject|1|||
38060788|NCT04050371|69753672|FG001|Overall Study|Withdrawal by Subject|0|||
38060789|NCT04447287|69753681|FG000|Period 1: Run-in Period|Adverse Event|3|||
38060790|NCT04447287|69753682|FG001|Period 1: Run-in Period|Adverse Event|0|||
38060791|NCT04447287|69753683|FG002|Period 1: Run-in Period|Adverse Event|0|||
38060792|NCT04447287|69753681|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
38060793|NCT04447287|69753682|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
38060794|NCT04447287|69753683|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
38060795|NCT04447287|69753681|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
38060796|NCT04447287|69753682|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
38060797|NCT04447287|69753683|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
38060798|NCT01879319|69753704|FG000|Overall Study|Withdrawal by Subject|1|||
38060799|NCT01879319|69753705|FG001|Overall Study|Withdrawal by Subject|0|||
38060800|NCT01879319|69753704|FG000|Overall Study|Lost to Follow-up|1|||
38060801|NCT01879319|69753705|FG001|Overall Study|Lost to Follow-up|5|||
38060802|NCT03102918|69753713|FG000|Overall Study|Protocol Violation|1|||
38060803|NCT03102918|69753714|FG001|Overall Study|Protocol Violation|0|||
38060804|NCT03128307|69753720|FG000|Overall Study|Lost to Follow-up|29|||
38060805|NCT03128307|69753720|FG000|Overall Study|Withdrawal by Subject|5|||
38060806|NCT03102762|69753726|FG000|Overall Study|Lost to Follow-up|1|||
38060807|NCT03102762|69753727|FG001|Overall Study|Lost to Follow-up|0|||
38060808|NCT01346475|69753740|FG000|First Intervention|Lost to Follow-up|4|||
38060809|NCT01346475|69753741|FG001|First Intervention|Lost to Follow-up|3|||
38060810|NCT01338636|69753747|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
38060811|NCT00322218|69753753|FG000|Overall Study|Death|3|||
38060812|NCT00322218|69753754|FG001|Overall Study|Death|6|||
38060813|NCT02873754|69753760|FG000|Overall Study|Lost to Follow-up|5|||
38060814|NCT02873754|69753760|FG000|Overall Study|Couldn't complete study procedures|1|||
38060815|NCT03287414|69753766|FG000|Treatment Epoch|Adverse Event|0|||
38060816|NCT03287414|69753767|FG001|Treatment Epoch|Adverse Event|1|||
38060817|NCT03287414|69753766|FG000|Treatment Epoch|Study terminated by sponsor|2|||
38060818|NCT03287414|69753767|FG001|Treatment Epoch|Study terminated by sponsor|2|||
38060819|NCT03287414|69753766|FG000|Treatment Epoch|Subject/Guardian decision|4|||
38060820|NCT03287414|69753767|FG001|Treatment Epoch|Subject/Guardian decision|0|||
38060821|NCT03287414|69753766|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
38060822|NCT03287414|69753767|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
38060823|NCT03287414|69753766|FG000|Treatment Epoch|Withdrawal by Subject|1|||
38060824|NCT03287414|69753767|FG001|Treatment Epoch|Withdrawal by Subject|0|||
38060825|NCT03287414|69753766|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
38060826|NCT03287414|69753767|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
38060827|NCT03287414|69753766|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
38060828|NCT03287414|69753767|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
38060829|NCT03101592|69753797|FG000|Overall Study|participant files could not be located|111|||
38060830|NCT03101592|69753798|FG001|Overall Study|participant files could not be located|170|||
38060831|NCT03101592|69753799|FG002|Overall Study|participant files could not be located|118|||
38060832|NCT04046939|69753817|FG000|Primary Assessment Period|Adverse Event|1|||
38060833|NCT04046939|69753818|FG001|Primary Assessment Period|Adverse Event|0|||
38060834|NCT04046939|69753819|FG002|Primary Assessment Period|Adverse Event|0|||
38060835|NCT04046939|69753820|FG003|Primary Assessment Period|Adverse Event|0|||
38060836|NCT04046939|69753817|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
38060837|NCT04046939|69753818|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
38060838|NCT04046939|69753819|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
38060839|NCT04046939|69753820|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
38060840|NCT04046939|69753817|FG000|Primary Assessment Period|Physician Decision|0|||
38060841|NCT04046939|69753818|FG001|Primary Assessment Period|Physician Decision|0|||
37680383|NCT02586805|69155997|FG000|Overall Study|Physician Decision|1|||
37862229|NCT01131507|69546017|FG000|Overall Study|Lost to Follow-up|1|||
38060842|NCT04046939|69753819|FG002|Primary Assessment Period|Physician Decision|1|||
38060843|NCT04046939|69753820|FG003|Primary Assessment Period|Physician Decision|0|||
38060844|NCT04046939|69753817|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
38060845|NCT04046939|69753818|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
38060846|NCT04046939|69753819|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
38060847|NCT04046939|69753820|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
38060848|NCT04042103|69753836|FG000|Overall Study|Lost to Follow-up|1|||
38060849|NCT04042103|69753836|FG000|Overall Study|Withdrawal by Subject|1|||
38060850|NCT02955797|69753844|FG000|Overall Study|Protocol Violation|1|||
38060851|NCT02955797|69753845|FG001|Overall Study|Protocol Violation|0|||
38060852|NCT02955797|69753846|FG002|Overall Study|Protocol Violation|0|||
38060853|NCT02955797|69753847|FG003|Overall Study|Protocol Violation|1|||
38060854|NCT02955797|69753844|FG000|Overall Study|Withdrawal by Subject|2|||
38060855|NCT02955797|69753845|FG001|Overall Study|Withdrawal by Subject|2|||
38060856|NCT02955797|69753846|FG002|Overall Study|Withdrawal by Subject|0|||
38060857|NCT02955797|69753847|FG003|Overall Study|Withdrawal by Subject|1|||
38060858|NCT02955797|69753844|FG000|Overall Study|Lost to Follow-up|0|||
38060859|NCT02955797|69753845|FG001|Overall Study|Lost to Follow-up|1|||
38060860|NCT02955797|69753846|FG002|Overall Study|Lost to Follow-up|0|||
38060861|NCT02955797|69753847|FG003|Overall Study|Lost to Follow-up|0|||
38060862|NCT03101514|69753860|FG000|Overall Study|Withdrawal by Subject|4|||
38060863|NCT03101514|69753860|FG000|Overall Study|Protocol Violation|2|||
38060864|NCT03101514|69753860|FG000|Overall Study|patient's information was incomplete|1|||
38060865|NCT02702518|69753866|FG000|Overall Study|Lost to Follow-up|3|||
38060866|NCT02702518|69753867|FG001|Overall Study|Lost to Follow-up|4|||
38060867|NCT04039503|69753877|FG000|Overall Study|Adverse Event|3|||
38060868|NCT04039503|69753878|FG001|Overall Study|Adverse Event|0|||
38060869|NCT04039503|69753879|FG002|Overall Study|Adverse Event|2|||
38060870|NCT04039503|69753880|FG003|Overall Study|Adverse Event|0|||
38060871|NCT04039503|69753877|FG000|Overall Study|Lost to Follow-up|0|||
38060872|NCT04039503|69753878|FG001|Overall Study|Lost to Follow-up|0|||
38060873|NCT04039503|69753879|FG002|Overall Study|Lost to Follow-up|1|||
38060874|NCT04039503|69753880|FG003|Overall Study|Lost to Follow-up|0|||
37965614|NCT00365716|69652699|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
37965615|NCT00365716|69652700|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
37965616|NCT00365716|69652701|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
37965617|NCT00365716|69652695|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
37965618|NCT00365716|69652696|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
37965619|NCT00365716|69652697|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
37965620|NCT00365716|69652698|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
37965621|NCT00365716|69652699|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
37965622|NCT00365716|69652700|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
37965623|NCT00365716|69652701|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
37965624|NCT00365716|69652695|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
37965625|NCT00365716|69652696|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
37965626|NCT00365716|69652697|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
37965627|NCT00365716|69652698|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
37965628|NCT00365716|69652699|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
37965629|NCT00365716|69652700|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
37965630|NCT00365716|69652701|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
37965631|NCT00365716|69652695|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
37965632|NCT00365716|69652696|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
37965633|NCT00365716|69652697|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
37965634|NCT00365716|69652698|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
37965635|NCT00365716|69652699|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
37965636|NCT00365716|69652700|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
37965637|NCT00365716|69652701|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
37965638|NCT00365716|69652695|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
37965639|NCT00365716|69652696|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
37965640|NCT00365716|69652697|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
37965641|NCT00365716|69652698|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
38060875|NCT04039503|69753877|FG000|Overall Study|Protocol Violation|0|||
38060876|NCT04039503|69753878|FG001|Overall Study|Protocol Violation|1|||
37965642|NCT00365716|69652699|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
37965643|NCT00365716|69652700|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
37965644|NCT00365716|69652701|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
38060877|NCT04039503|69753879|FG002|Overall Study|Protocol Violation|2|||
38060878|NCT04039503|69753880|FG003|Overall Study|Protocol Violation|1|||
38060879|NCT04039503|69753877|FG000|Overall Study|Withdrawal by Subject|4|||
38060880|NCT04039503|69753878|FG001|Overall Study|Withdrawal by Subject|3|||
38060881|NCT04039503|69753879|FG002|Overall Study|Withdrawal by Subject|5|||
37965645|NCT00365716|69652695|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
37965646|NCT00365716|69652696|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
37965647|NCT00365716|69652697|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
37965648|NCT00365716|69652698|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
37965649|NCT00365716|69652699|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
37965650|NCT00365716|69652700|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
37965651|NCT00365716|69652701|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
37965652|NCT00365716|69652695|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
37965653|NCT00365716|69652696|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
37965654|NCT00365716|69652697|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
37965655|NCT00365716|69652698|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
37965656|NCT00365716|69652699|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
37965657|NCT00365716|69652700|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
37965658|NCT00365716|69652701|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
37965659|NCT00365716|69652695|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
37965660|NCT00365716|69652696|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
37965661|NCT00365716|69652697|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
37965662|NCT00365716|69652698|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
37965663|NCT00365716|69652699|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
37965664|NCT00365716|69652700|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
37965665|NCT00365716|69652701|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
37965666|NCT00365716|69652695|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
37965667|NCT00365716|69652696|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
37965668|NCT00365716|69652697|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
37965669|NCT00365716|69652698|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
37965670|NCT00365716|69652699|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
37965671|NCT00365716|69652700|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
37965672|NCT00365716|69652701|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
37965673|NCT00365716|69652695|FG000|Extension 1|Lost to Follow-up|0|||
37965674|NCT00365716|69652696|FG001|Extension 1|Lost to Follow-up|0|||
37965675|NCT00365716|69652697|FG002|Extension 1|Lost to Follow-up|0|||
37965676|NCT00365716|69652698|FG003|Extension 1|Lost to Follow-up|0|||
37965677|NCT00365716|69652699|FG004|Extension 1|Lost to Follow-up|0|||
37965678|NCT00365716|69652700|FG005|Extension 1|Lost to Follow-up|1|||
37965679|NCT00365716|69652701|FG006|Extension 1|Lost to Follow-up|0|||
37965680|NCT00365716|69652695|FG000|Extension 1|Other|0|||
37965681|NCT00365716|69652696|FG001|Extension 1|Other|0|||
37965682|NCT00365716|69652697|FG002|Extension 1|Other|0|||
37965683|NCT00365716|69652698|FG003|Extension 1|Other|0|||
37965684|NCT00365716|69652699|FG004|Extension 1|Other|0|||
37965685|NCT00365716|69652700|FG005|Extension 1|Other|9|||
37965686|NCT00365716|69652701|FG006|Extension 1|Other|0|||
37965687|NCT00365716|69652695|FG000|Extension 1|Moved|0|||
37965688|NCT00365716|69652696|FG001|Extension 1|Moved|0|||
37965689|NCT00365716|69652697|FG002|Extension 1|Moved|0|||
37965690|NCT00365716|69652698|FG003|Extension 1|Moved|0|||
37965691|NCT00365716|69652699|FG004|Extension 1|Moved|0|||
37965692|NCT00365716|69652700|FG005|Extension 1|Moved|4|||
37965693|NCT00365716|69652701|FG006|Extension 1|Moved|0|||
37965694|NCT00365716|69652695|FG000|Extension 1|Withdrawal by Subject|0|||
38060882|NCT04039503|69753880|FG003|Overall Study|Withdrawal by Subject|2|||
38060883|NCT03131895|69753917|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
38060884|NCT03131895|69753918|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
38060885|NCT03131895|69753919|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
38060886|NCT03131895|69753920|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
38060887|NCT03131895|69753917|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
38060888|NCT03131895|69753918|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
38060889|NCT03131895|69753919|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
38060890|NCT03131895|69753920|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
38060891|NCT03131895|69753917|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
38060892|NCT03131895|69753918|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
37965695|NCT00365716|69652696|FG001|Extension 1|Withdrawal by Subject|0|||
37965696|NCT00365716|69652697|FG002|Extension 1|Withdrawal by Subject|0|||
37965697|NCT00365716|69652698|FG003|Extension 1|Withdrawal by Subject|0|||
37965698|NCT00365716|69652699|FG004|Extension 1|Withdrawal by Subject|0|||
37965699|NCT00365716|69652700|FG005|Extension 1|Withdrawal by Subject|3|||
37965700|NCT00365716|69652701|FG006|Extension 1|Withdrawal by Subject|0|||
37965701|NCT00365716|69652695|FG000|Extension 1|Pregnancy|0|||
37965702|NCT00365716|69652696|FG001|Extension 1|Pregnancy|0|||
37965703|NCT00365716|69652697|FG002|Extension 1|Pregnancy|0|||
37965704|NCT00365716|69652698|FG003|Extension 1|Pregnancy|0|||
37965705|NCT00365716|69652699|FG004|Extension 1|Pregnancy|0|||
37680384|NCT02586805|69155998|FG001|Overall Study|Physician Decision|0|||
37862230|NCT01131507|69546017|FG000|Overall Study|Withdrawal by Subject|1|||
38060893|NCT03131895|69753919|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
38060894|NCT03131895|69753920|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
38060895|NCT03131895|69753917|FG000|Washout Period (at Least 5 Days)|Other|0|||
38060896|NCT03131895|69753918|FG001|Washout Period (at Least 5 Days)|Other|0|||
38060897|NCT03131895|69753919|FG002|Washout Period (at Least 5 Days)|Other|2|||
38060898|NCT03131895|69753920|FG003|Washout Period (at Least 5 Days)|Other|0|||
38060899|NCT03131895|69753917|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
38060900|NCT03131895|69753918|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
38060901|NCT03131895|69753919|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
38060902|NCT03131895|69753920|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
38060903|NCT03131895|69753917|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
38060904|NCT03131895|69753918|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
38060905|NCT03131895|69753919|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
38060906|NCT03131895|69753920|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
38060907|NCT04039919|69753935|FG000|Treatment Period 1|Withdrawal by Subject|1|||
38060908|NCT04039919|69753936|FG001|Treatment Period 1|Withdrawal by Subject|0|||
38060909|NCT04039919|69753937|FG002|Treatment Period 1|Withdrawal by Subject|0|||
38060910|NCT04039919|69753938|FG003|Treatment Period 1|Withdrawal by Subject|0|||
38060911|NCT04039919|69753939|FG004|Treatment Period 1|Withdrawal by Subject|0|||
38060912|NCT04039919|69753935|FG000|Treatment Period 1|Sponsor's decision|0|||
38060913|NCT04039919|69753936|FG001|Treatment Period 1|Sponsor's decision|0|||
38060914|NCT04039919|69753937|FG002|Treatment Period 1|Sponsor's decision|0|||
38060915|NCT04039919|69753938|FG003|Treatment Period 1|Sponsor's decision|0|||
38060916|NCT04039919|69753939|FG004|Treatment Period 1|Sponsor's decision|16|||
38060917|NCT04039919|69753935|FG000|Treatment Period 5|Withdrawal by Subject|1|||
38060918|NCT04039919|69753936|FG001|Treatment Period 5|Withdrawal by Subject|0|||
38060919|NCT04039919|69753937|FG002|Treatment Period 5|Withdrawal by Subject|0|||
38060920|NCT04039919|69753938|FG003|Treatment Period 5|Withdrawal by Subject|0|||
38060921|NCT04039919|69753939|FG004|Treatment Period 5|Withdrawal by Subject|0|||
38060922|NCT04035473|69753975|FG000|Screening/Baseline|Death|0|||
38060923|NCT04035473|69753976|FG001|Screening/Baseline|Death|1|||
38060924|NCT04035473|69753975|FG000|Screening/Baseline|Adverse Event|0|||
38060925|NCT04035473|69753976|FG001|Screening/Baseline|Adverse Event|1|||
38060926|NCT04035473|69753975|FG000|Follow-up Period|Adverse Event|2|||
38060927|NCT04035473|69753976|FG001|Follow-up Period|Adverse Event|0|||
38060928|NCT04032977|69753984|FG000|Overall Study|Withdrawal by Subject|6|||
38060929|NCT04032977|69753985|FG001|Overall Study|Withdrawal by Subject|1|||
38060930|NCT04032977|69753984|FG000|Overall Study|Lost to Follow-up|2|||
38060931|NCT04032977|69753985|FG001|Overall Study|Lost to Follow-up|7|||
38060932|NCT04032977|69753984|FG000|Overall Study|Pregnancy|1|||
38060933|NCT04032977|69753985|FG001|Overall Study|Pregnancy|0|||
38060934|NCT04030247|69753991|FG000|Overall Study|Withdrawal by Subject|4|||
38060935|NCT04030247|69753991|FG000|Overall Study|Lost to Follow-up|13|||
38060936|NCT02915978|69753998|FG000|Overall Study|Adverse Event|2|||
38060937|NCT02915978|69753999|FG001|Overall Study|Adverse Event|1|||
38060938|NCT02915978|69754000|FG002|Overall Study|Adverse Event|0|||
38060939|NCT02701192|69754008|FG000|Overall Study|Protocol Violation|2|||
38060940|NCT02701192|69754008|FG000|Overall Study|Lost to Follow-up|4|||
38060941|NCT03101358|69754016|FG000|Overall Study|Non-compliance with study schedule|1|||
38060942|NCT03101358|69754017|FG001|Overall Study|Non-compliance with study schedule|0|||
38060943|NCT03101358|69754018|FG002|Overall Study|Non-compliance with study schedule|0|||
38060944|NCT03101358|69754019|FG003|Overall Study|Non-compliance with study schedule|1|||
38060945|NCT03101358|69754016|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
38060946|NCT03101358|69754017|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
38060947|NCT03101358|69754018|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
38060948|NCT03101358|69754019|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
38060949|NCT03101358|69754016|FG000|Overall Study|Physician Decision|1|||
38060950|NCT03101358|69754017|FG001|Overall Study|Physician Decision|0|||
38060951|NCT03101358|69754018|FG002|Overall Study|Physician Decision|0|||
38060952|NCT03101358|69754019|FG003|Overall Study|Physician Decision|3|||
38060953|NCT03101358|69754016|FG000|Overall Study|Adverse Event|0|||
38060954|NCT03101358|69754017|FG001|Overall Study|Adverse Event|0|||
38060955|NCT03101358|69754018|FG002|Overall Study|Adverse Event|1|||
38060956|NCT03101358|69754019|FG003|Overall Study|Adverse Event|0|||
38060957|NCT03101358|69754016|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
38060958|NCT03101358|69754017|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
38060959|NCT03101358|69754018|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
38060960|NCT03101358|69754019|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
38060961|NCT03101358|69754016|FG000|Overall Study|Lost to Follow-up|1|||
38060962|NCT03101358|69754017|FG001|Overall Study|Lost to Follow-up|0|||
38060963|NCT03101358|69754018|FG002|Overall Study|Lost to Follow-up|0|||
38060964|NCT03101358|69754019|FG003|Overall Study|Lost to Follow-up|1|||
38060965|NCT03657095|69754032|FG000|Overall Study|Withdrawal by Subject|1|||
38060966|NCT03657095|69754033|FG001|Overall Study|Withdrawal by Subject|1|||
38060967|NCT03657095|69754032|FG000|Overall Study|Adverse Event|0|||
38060968|NCT03657095|69754033|FG001|Overall Study|Adverse Event|3|||
38060969|NCT03657095|69754032|FG000|Overall Study|Study Terminated by Sponsor|58|||
38060970|NCT03657095|69754033|FG001|Overall Study|Study Terminated by Sponsor|49|||
38060971|NCT03100344|69754043|FG000|Overall Study|Adverse Event|0|||
38060972|NCT03100344|69754044|FG001|Overall Study|Adverse Event|3|||
38060973|NCT03100344|69754045|FG002|Overall Study|Adverse Event|2|||
38060974|NCT03100344|69754046|FG003|Overall Study|Adverse Event|3|||
38060975|NCT03100344|69754043|FG000|Overall Study|Lack of Efficacy|2|||
38060976|NCT03100344|69754044|FG001|Overall Study|Lack of Efficacy|0|||
38060977|NCT03100344|69754045|FG002|Overall Study|Lack of Efficacy|0|||
38060978|NCT03100344|69754046|FG003|Overall Study|Lack of Efficacy|0|||
38060979|NCT03100344|69754043|FG000|Overall Study|Protocol Violation|1|||
38060980|NCT03100344|69754044|FG001|Overall Study|Protocol Violation|0|||
38060981|NCT03100344|69754045|FG002|Overall Study|Protocol Violation|0|||
38060982|NCT03100344|69754046|FG003|Overall Study|Protocol Violation|0|||
38060983|NCT03100344|69754043|FG000|Overall Study|Withdrawal by Subject|10|||
38060984|NCT03100344|69754044|FG001|Overall Study|Withdrawal by Subject|7|||
38060985|NCT03100344|69754045|FG002|Overall Study|Withdrawal by Subject|4|||
38060986|NCT03100344|69754046|FG003|Overall Study|Withdrawal by Subject|8|||
38060987|NCT03100344|69754043|FG000|Overall Study|Lost to Follow-up|1|||
38060988|NCT03100344|69754044|FG001|Overall Study|Lost to Follow-up|1|||
38060989|NCT03100344|69754045|FG002|Overall Study|Lost to Follow-up|1|||
38060990|NCT03100344|69754046|FG003|Overall Study|Lost to Follow-up|1|||
38060991|NCT02951533|69754059|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
38060992|NCT02951533|69754060|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
38060993|NCT02951533|69754061|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
38060994|NCT02951533|69754059|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
38060995|NCT02951533|69754060|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
38060996|NCT02951533|69754061|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
38060997|NCT02951533|69754059|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
38060998|NCT02951533|69754060|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
38060999|NCT02951533|69754061|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
38061000|NCT02951533|69754059|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
38061001|NCT02951533|69754060|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
38061002|NCT02951533|69754061|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
38061003|NCT02951533|69754059|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
38061004|NCT02951533|69754060|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
38061005|NCT02951533|69754061|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
38061006|NCT02951533|69754059|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
38061007|NCT02951533|69754060|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
38061008|NCT02951533|69754061|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
38061009|NCT02951533|69754059|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
38061010|NCT02951533|69754060|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
38061011|NCT02951533|69754061|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
38061012|NCT02951533|69754059|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
38061013|NCT02951533|69754060|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
38061014|NCT02951533|69754061|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
38061015|NCT02951533|69754059|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
38061016|NCT02951533|69754060|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
38061017|NCT02951533|69754061|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
38061018|NCT02951533|69754059|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
38061019|NCT02951533|69754060|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
38061020|NCT02951533|69754061|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
38061021|NCT02951533|69754059|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
38061022|NCT02951533|69754060|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
38061023|NCT02951533|69754061|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
38061024|NCT02700412|69754078|FG000|Overall Study|Adverse Event|6|||
38061025|NCT02700412|69754078|FG000|Overall Study|Death|1|||
38061026|NCT02700412|69754078|FG000|Overall Study|Lack of Efficacy|19|||
38061027|NCT02700412|69754078|FG000|Overall Study|Protocol Violation|5|||
38061028|NCT02700412|69754078|FG000|Overall Study|Withdrawal by Subject|2|||
38061029|NCT03665441|69754084|FG000|Overall Study|survival follow up ongoing|23|||
38061030|NCT03665441|69754085|FG001|Overall Study|survival follow up ongoing|0|||
38061031|NCT03665441|69754084|FG000|Overall Study|Patients ongoing on treatment|9|||
38061032|NCT03665441|69754085|FG001|Overall Study|Patients ongoing on treatment|6|||
38061033|NCT03665441|69754084|FG000|Overall Study|Randomized but not treated|7|||
38061034|NCT03665441|69754085|FG001|Overall Study|Randomized but not treated|11|||
38061035|NCT02699866|69754091|FG000|Overall Study|Withdrawal by Subject|3|||
38061036|NCT02699866|69754091|FG000|Overall Study|Physician Decision|2|||
38061037|NCT02699866|69754091|FG000|Overall Study|Adverse Event|3|||
38061038|NCT03663569|69754095|FG000|Overall Study|Discontinuation of study|11|||
38061039|NCT03663569|69754095|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
38061040|NCT03663569|69754095|FG000|Overall Study|Deceased patient|6|||
38061041|NCT03663569|69754095|FG000|Overall Study|Lost to Follow-up|18|||
38061042|NCT03663569|69754095|FG000|Overall Study|Withdrawal of consent|5|||
38061043|NCT03663569|69754095|FG000|Overall Study|Patient's request|11|||
38061044|NCT03663569|69754095|FG000|Overall Study|Adverse Event|4|||
38061045|NCT03663569|69754095|FG000|Overall Study|Not come to second visit|3|||
38061046|NCT03663569|69754095|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
38061047|NCT03663569|69754095|FG000|Overall Study|Serious adverse event|1|||
38061048|NCT03596762|69754104|FG000|Overall Study|Protocol Violation|0|||
38061049|NCT03596762|69754105|FG001|Overall Study|Protocol Violation|0|||
38061050|NCT03596762|69754106|FG002|Overall Study|Protocol Violation|0|||
38061051|NCT03596762|69754107|FG003|Overall Study|Protocol Violation|0|||
38061052|NCT03596762|69754108|FG004|Overall Study|Protocol Violation|1|||
38061053|NCT03596762|69754104|FG000|Overall Study|Adverse Event|2|||
38061054|NCT03596762|69754105|FG001|Overall Study|Adverse Event|0|||
38061055|NCT03596762|69754106|FG002|Overall Study|Adverse Event|1|||
38061056|NCT03596762|69754107|FG003|Overall Study|Adverse Event|0|||
38061057|NCT03596762|69754108|FG004|Overall Study|Adverse Event|5|||
38061058|NCT03596762|69754104|FG000|Overall Study|Withdrawal by Subject|2|||
38061059|NCT03596762|69754105|FG001|Overall Study|Withdrawal by Subject|1|||
38061060|NCT03596762|69754106|FG002|Overall Study|Withdrawal by Subject|0|||
38061061|NCT03596762|69754107|FG003|Overall Study|Withdrawal by Subject|1|||
38061062|NCT03596762|69754108|FG004|Overall Study|Withdrawal by Subject|1|||
38061063|NCT03663179|69754126|FG000|Overall Study|Withdrawal by Subject|2|||
38061064|NCT03663179|69754127|FG001|Overall Study|Withdrawal by Subject|0|||
38061065|NCT03663179|69754126|FG000|Overall Study|Lost to Follow-up|1|||
38061066|NCT03663179|69754127|FG001|Overall Study|Lost to Follow-up|1|||
38061067|NCT03663179|69754126|FG000|Overall Study|Revealed exclusionary condition|1|||
38061068|NCT03663179|69754127|FG001|Overall Study|Revealed exclusionary condition|0|||
38061069|NCT03662789|69754135|FG000|Overall Study|Lost to Follow-up|1|||
38061070|NCT03662789|69754136|FG001|Overall Study|Lost to Follow-up|2|||
38061071|NCT03662789|69754135|FG000|Overall Study|Could not perform treadmill test|4|||
38061072|NCT03662789|69754136|FG001|Overall Study|Could not perform treadmill test|4|||
38061073|NCT03662789|69754135|FG000|Overall Study|Death|0|||
38061074|NCT03662789|69754136|FG001|Overall Study|Death|1|||
38061075|NCT03658889|69754144|FG000|Overall Study|Protocol Violation|2|||
38061076|NCT03658889|69754145|FG001|Overall Study|Protocol Violation|0|||
38061077|NCT03655691|69754153|FG000|Overall Study|Adverse Event|0|||
38061078|NCT03655691|69754154|FG001|Overall Study|Adverse Event|0|||
38061079|NCT03655691|69754155|FG002|Overall Study|Adverse Event|1|||
38061080|NCT03655691|69754153|FG000|Overall Study|Lost to Follow-up|1|||
38061081|NCT03655691|69754154|FG001|Overall Study|Lost to Follow-up|1|||
38061082|NCT03655691|69754155|FG002|Overall Study|Lost to Follow-up|2|||
38061083|NCT03655691|69754153|FG000|Overall Study|Protocol Violation|0|||
38061084|NCT03655691|69754154|FG001|Overall Study|Protocol Violation|1|||
38061085|NCT03655691|69754155|FG002|Overall Study|Protocol Violation|0|||
38061086|NCT03655691|69754153|FG000|Overall Study|Withdrawal by Subject|1|||
38061087|NCT03655691|69754154|FG001|Overall Study|Withdrawal by Subject|1|||
38061088|NCT03655691|69754155|FG002|Overall Study|Withdrawal by Subject|0|||
38061089|NCT03658811|69754163|FG000|Overall Study|Lost to Follow-up|3|||
38061090|NCT03631355|69754173|FG000|Overall Study|Lost to Follow-up|1|||
38061091|NCT03631355|69754174|FG001|Overall Study|Lost to Follow-up|2|||
38061092|NCT03629249|69754183|FG000|Overall Study|Study terminated by sponsor|197|||
38061093|NCT03629249|69754184|FG001|Overall Study|Study terminated by sponsor|197|||
38061094|NCT03629249|69754185|FG002|Overall Study|Study terminated by sponsor|194|||
38061095|NCT03629249|69754183|FG000|Overall Study|Protocol deviation|0|||
38061096|NCT03629249|69754184|FG001|Overall Study|Protocol deviation|2|||
38061097|NCT03629249|69754185|FG002|Overall Study|Protocol deviation|5|||
38061098|NCT03629249|69754183|FG000|Overall Study|Subject decision|1|||
38061099|NCT03629249|69754184|FG001|Overall Study|Subject decision|1|||
38061100|NCT03629249|69754185|FG002|Overall Study|Subject decision|3|||
38061101|NCT03629249|69754183|FG000|Overall Study|Adverse Event|1|||
38061102|NCT03629249|69754184|FG001|Overall Study|Adverse Event|1|||
38061103|NCT03629249|69754185|FG002|Overall Study|Adverse Event|0|||
38061104|NCT03629249|69754183|FG000|Overall Study|Death|1|||
38061105|NCT03629249|69754184|FG001|Overall Study|Death|0|||
38061106|NCT03629249|69754185|FG002|Overall Study|Death|0|||
38061107|NCT03629249|69754183|FG000|Overall Study|Physician Decision|1|||
38061108|NCT03629249|69754184|FG001|Overall Study|Physician Decision|0|||
38061109|NCT03629249|69754185|FG002|Overall Study|Physician Decision|0|||
38061110|NCT03628781|69754195|FG000|Overall Study|Lost to Follow-up|16|||
38061111|NCT03628781|69754196|FG001|Overall Study|Lost to Follow-up|8|||
38061112|NCT03628781|69754195|FG000|Overall Study|Withdrawal by Subject|16|||
37862231|NCT01131351|69546023|FG000|Overall Study|Adverse Event|0|||
38061113|NCT03628781|69754196|FG001|Overall Study|Withdrawal by Subject|1|||
38061114|NCT03371251|69754208|FG000|Overall Study|Withdrawal by Subject|1|||
38061115|NCT03371251|69754209|FG001|Overall Study|Withdrawal by Subject|0|||
38061116|NCT03371251|69754210|FG002|Overall Study|Withdrawal by Subject|1|||
38061117|NCT03371251|69754211|FG003|Overall Study|Withdrawal by Subject|0|||
37862232|NCT01131351|69546024|FG001|Overall Study|Adverse Event|2|||
38061118|NCT03371251|69754212|FG004|Overall Study|Withdrawal by Subject|2|||
38061119|NCT03371251|69754213|FG005|Overall Study|Withdrawal by Subject|2|||
38061120|NCT03371251|69754208|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
38061121|NCT03371251|69754209|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
38061122|NCT03371251|69754210|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
38061123|NCT03371251|69754211|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
38061124|NCT03371251|69754212|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
38061125|NCT03371251|69754213|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
38061126|NCT03371251|69754208|FG000|Overall Study|Adverse Event|0|||
38061127|NCT03371251|69754209|FG001|Overall Study|Adverse Event|0|||
38061128|NCT03371251|69754210|FG002|Overall Study|Adverse Event|0|||
38061129|NCT03371251|69754211|FG003|Overall Study|Adverse Event|0|||
38061130|NCT03371251|69754212|FG004|Overall Study|Adverse Event|1|||
38061131|NCT03371251|69754213|FG005|Overall Study|Adverse Event|0|||
38061132|NCT03371251|69754208|FG000|Overall Study|Decision by Sponsor|0|||
38061133|NCT03371251|69754209|FG001|Overall Study|Decision by Sponsor|0|||
37862233|NCT01131351|69546023|FG000|Overall Study|Protocol Deviation|0|||
37862234|NCT01131351|69546024|FG001|Overall Study|Protocol Deviation|1|||
37862235|NCT00919633|69546034|FG000|Overall Study|Adverse Event|1|||
38061134|NCT03371251|69754210|FG002|Overall Study|Decision by Sponsor|0|||
38061135|NCT03371251|69754211|FG003|Overall Study|Decision by Sponsor|0|||
38061136|NCT03371251|69754212|FG004|Overall Study|Decision by Sponsor|2|||
38061137|NCT03371251|69754213|FG005|Overall Study|Decision by Sponsor|0|||
38061138|NCT03370471|69754232|FG000|Overall Study|Withdrawal by Subject|6|||
38061139|NCT03370471|69754233|FG001|Overall Study|Withdrawal by Subject|1|||
38061140|NCT03370471|69754232|FG000|Overall Study|Unable to access veins for blood draw|0|||
38061141|NCT03370471|69754233|FG001|Overall Study|Unable to access veins for blood draw|1|||
38061142|NCT03370471|69754232|FG000|Overall Study|Screen fail|1|||
38061143|NCT03370471|69754233|FG001|Overall Study|Screen fail|0|||
38061144|NCT03349645|69754241|FG000|Overall Study|Sponsor Terminated Study|75|||
38061145|NCT03349645|69754241|FG000|Overall Study|Withdrawal by Subject|4|||
38061146|NCT03349645|69754241|FG000|Overall Study|Protocol Violation|1|||
38061147|NCT03349645|69754241|FG000|Overall Study|Other|2|||
38061148|NCT03349333|69754245|FG000|Overall Study|Progression of Disease|36|||
38061149|NCT03349333|69754245|FG000|Overall Study|Adverse Event|11|||
38061150|NCT03349333|69754245|FG000|Overall Study|Other|6|||
38061151|NCT03349333|69754245|FG000|Overall Study|Withdrawal by Subject|5|||
38061152|NCT03349333|69754245|FG000|Overall Study|Conditions interfere with participation|2|||
38061153|NCT03349333|69754245|FG000|Overall Study|Physician Decision|2|||
38061154|NCT03349333|69754245|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
38061155|NCT03349333|69754245|FG000|Overall Study|Patients in treatment less than 24 month|8|||
38061156|NCT03349099|69754251|FG000|Overall Study|Physician Decision|3|||
38061157|NCT03349099|69754252|FG001|Overall Study|Physician Decision|4|||
38061158|NCT03349099|69754251|FG000|Overall Study|Stone migrated from the kidney|1|||
38061159|NCT03349099|69754252|FG001|Overall Study|Stone migrated from the kidney|0|||
38061160|NCT03348163|69754260|FG000|Overall Study|Withdrawal by Subject|2|||
38061161|NCT03348163|69754261|FG001|Overall Study|Withdrawal by Subject|0|||
38061162|NCT03347695|69754269|FG000|Overall Study|Death|0|||
38061163|NCT03347695|69754270|FG001|Overall Study|Death|4|||
38061164|NCT03347695|69754269|FG000|Overall Study|Lost to Follow-up|0|||
38061165|NCT03347695|69754270|FG001|Overall Study|Lost to Follow-up|1|||
38061166|NCT02892019|69754280|FG000|Overall Study|randomized but not treated|0|||
38061167|NCT02892019|69754281|FG001|Overall Study|randomized but not treated|1|||
38061168|NCT02892019|69754280|FG000|Overall Study|Withdrawal by Subject|0|||
38061169|NCT02892019|69754281|FG001|Overall Study|Withdrawal by Subject|1|||
38061170|NCT02892019|69754280|FG000|Overall Study|Adverse Event|1|||
38061171|NCT02892019|69754281|FG001|Overall Study|Adverse Event|1|||
38061172|NCT03365791|69754287|FG000|Overall Study|Adverse Event|5|||
38061173|NCT03365791|69754287|FG000|Overall Study|Death|1|||
38061174|NCT03365791|69754287|FG000|Overall Study|Lost to Follow-up|1|||
38061175|NCT03365791|69754287|FG000|Overall Study|Physician Decision|9|||
38061176|NCT03365791|69754287|FG000|Overall Study|Progressive disease|51|||
38061177|NCT03365791|69754287|FG000|Overall Study|Subject/guardian decision|5|||
38061178|NCT03365011|69754294|FG000|Overall Study|Withdrawal by Subject|1|||
38061179|NCT03365011|69754295|FG001|Overall Study|Withdrawal by Subject|2|||
38061180|NCT03627767|69754304|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
38061181|NCT03627767|69754305|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
38061182|NCT03627767|69754306|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
38061183|NCT03627767|69754307|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
38061184|NCT03627767|69754308|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
38061185|NCT03627767|69754304|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
38061186|NCT03627767|69754305|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
38061187|NCT03627767|69754306|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
38061188|NCT03627767|69754307|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
38061189|NCT03627767|69754308|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
37862236|NCT00919633|69546035|FG001|Overall Study|Adverse Event|9|||
38061190|NCT03627767|69754304|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
38061191|NCT03627767|69754305|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
38061192|NCT03627767|69754306|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
38061193|NCT03627767|69754307|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
38061194|NCT03627767|69754308|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
38061195|NCT03627767|69754304|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
38061196|NCT03627767|69754305|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
38061197|NCT03627767|69754306|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
38061198|NCT03627767|69754307|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
38061199|NCT03627767|69754308|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
38061200|NCT03627767|69754304|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
38061201|NCT03627767|69754305|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
38061202|NCT03627767|69754306|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
38061203|NCT03627767|69754307|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
38061204|NCT03627767|69754308|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
38061205|NCT03627767|69754304|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
38061206|NCT03627767|69754305|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
38061207|NCT03627767|69754306|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
38061208|NCT03627767|69754307|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
38061209|NCT03627767|69754308|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
38061210|NCT03627767|69754304|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
38061211|NCT03627767|69754305|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
38061212|NCT03627767|69754306|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
38061213|NCT03627767|69754307|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
38061214|NCT03627767|69754308|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
38061215|NCT03627767|69754304|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
38061216|NCT03627767|69754305|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
38061217|NCT03627767|69754306|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
38061218|NCT03627767|69754307|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
38061219|NCT03627767|69754308|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
38061220|NCT03627767|69754304|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
38061221|NCT03627767|69754305|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
38061222|NCT03627767|69754306|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
38061223|NCT03627767|69754307|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
38061224|NCT03627767|69754308|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
38061225|NCT03627767|69754304|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
38061226|NCT03627767|69754305|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
38061227|NCT03627767|69754306|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
38061228|NCT03627767|69754307|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
38061229|NCT03627767|69754308|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
38061230|NCT03627767|69754304|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
38061231|NCT03627767|69754305|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
38061232|NCT03627767|69754306|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
38061233|NCT03627767|69754307|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
38061234|NCT03627767|69754308|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
38061235|NCT03627767|69754304|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
38061236|NCT03627767|69754305|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
38061237|NCT03627767|69754306|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
38061238|NCT03627767|69754307|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
38061239|NCT03627767|69754308|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
38061240|NCT03627767|69754304|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
38061241|NCT03627767|69754305|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
38061242|NCT03627767|69754306|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
38061243|NCT03627767|69754307|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
38061244|NCT03627767|69754308|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
38061245|NCT03627767|69754304|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
38061246|NCT03627767|69754305|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
38061247|NCT03627767|69754306|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
38061248|NCT03627767|69754307|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
38061249|NCT03627767|69754308|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
38061250|NCT03627767|69754304|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
38061251|NCT03627767|69754305|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
38061252|NCT03627767|69754306|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
38061253|NCT03627767|69754307|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
38061254|NCT03627767|69754308|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
38061255|NCT03627767|69754304|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
38061256|NCT03627767|69754305|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
38061257|NCT03627767|69754306|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
38061258|NCT03627767|69754307|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
38061259|NCT03627767|69754308|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
38061260|NCT03627767|69754304|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
38061261|NCT03627767|69754305|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
38061262|NCT03627767|69754306|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
38061263|NCT03627767|69754307|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
38061264|NCT03627767|69754308|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
38061265|NCT03627767|69754304|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
38061266|NCT03627767|69754305|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
38061267|NCT03627767|69754306|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
38061268|NCT03627767|69754307|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
38061269|NCT03627767|69754308|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
38061270|NCT03627767|69754304|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
38061271|NCT03627767|69754305|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
38061272|NCT03627767|69754306|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
38061273|NCT03627767|69754307|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
38061274|NCT03627767|69754308|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
38061275|NCT03627767|69754304|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
38061276|NCT03627767|69754305|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
38061277|NCT03627767|69754306|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
38061278|NCT03627767|69754307|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
38061279|NCT03627767|69754308|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
38061280|NCT03627065|69754319|FG000|Overall Study|Study Terminated by sponsor|1|||
38061281|NCT03627065|69754319|FG000|Overall Study|Withdrawal by Subject|2|||
38061282|NCT02142738|69754325|FG000|Overall Study|Adverse Event|13|||
38061283|NCT02142738|69754326|FG001|Overall Study|Adverse Event|9|||
38061284|NCT02142738|69754325|FG000|Overall Study|Death|92|||
38061285|NCT02142738|69754326|FG001|Overall Study|Death|112|||
38061286|NCT02142738|69754325|FG000|Overall Study|Lost to Follow-up|0|||
38061287|NCT02142738|69754326|FG001|Overall Study|Lost to Follow-up|3|||
38061288|NCT02142738|69754325|FG000|Overall Study|Withdrawal by Subject|6|||
38061289|NCT02142738|69754326|FG001|Overall Study|Withdrawal by Subject|7|||
38061290|NCT02142738|69754325|FG000|Overall Study|Follow up ended by sponsor|43|||
38061291|NCT02142738|69754326|FG001|Overall Study|Follow up ended by sponsor|20|||
38061292|NCT03617861|69754337|FG000|Second Intervention (1 Day)|Adverse Event|0|||
38061293|NCT03617861|69754338|FG001|Second Intervention (1 Day)|Adverse Event|0|||
38061294|NCT03617861|69754339|FG002|Second Intervention (1 Day)|Adverse Event|1|||
38061295|NCT03617861|69754340|FG003|Second Intervention (1 Day)|Adverse Event|0|||
38061296|NCT03614975|69754352|FG000|Overall Study|Physician Decision|7|||
38061297|NCT03614975|69754353|FG001|Overall Study|Physician Decision|5|||
38061298|NCT03614975|69754352|FG000|Overall Study|Withdrawal by Subject|2|||
38061299|NCT03614975|69754353|FG001|Overall Study|Withdrawal by Subject|2|||
38061300|NCT03614975|69754352|FG000|Overall Study|Specimens not in lab batch shipment|1|||
38061301|NCT03614975|69754353|FG001|Overall Study|Specimens not in lab batch shipment|1|||
38061302|NCT03613649|69754371|FG000|Second Treatment|Lost to Follow-up|0|||
38061303|NCT03613649|69754372|FG001|Second Treatment|Lost to Follow-up|0|||
38061304|NCT03613649|69754373|FG002|Second Treatment|Lost to Follow-up|1|||
38061305|NCT03613649|69754374|FG003|Second Treatment|Lost to Follow-up|0|||
38061306|NCT03613649|69754375|FG004|Second Treatment|Lost to Follow-up|0|||
38061307|NCT03613649|69754376|FG005|Second Treatment|Lost to Follow-up|0|||
38061308|NCT03613649|69754377|FG006|Second Treatment|Lost to Follow-up|0|||
38061309|NCT03613649|69754378|FG007|Second Treatment|Lost to Follow-up|0|||
38061310|NCT03613649|69754379|FG008|Second Treatment|Lost to Follow-up|0|||
38061311|NCT03613649|69754380|FG009|Second Treatment|Lost to Follow-up|0|||
38061312|NCT03613649|69754381|FG010|Second Treatment|Lost to Follow-up|0|||
38061313|NCT03613649|69754382|FG011|Second Treatment|Lost to Follow-up|0|||
38061314|NCT03613649|69754371|FG000|Second Treatment|Withdrawal by Subject|0|||
38061315|NCT03613649|69754372|FG001|Second Treatment|Withdrawal by Subject|0|||
38061316|NCT03613649|69754373|FG002|Second Treatment|Withdrawal by Subject|0|||
38061317|NCT03613649|69754374|FG003|Second Treatment|Withdrawal by Subject|0|||
38061318|NCT03613649|69754375|FG004|Second Treatment|Withdrawal by Subject|1|||
38061319|NCT03613649|69754376|FG005|Second Treatment|Withdrawal by Subject|0|||
38061320|NCT03613649|69754377|FG006|Second Treatment|Withdrawal by Subject|0|||
38061321|NCT03613649|69754378|FG007|Second Treatment|Withdrawal by Subject|0|||
38061322|NCT03613649|69754379|FG008|Second Treatment|Withdrawal by Subject|0|||
38061323|NCT03613649|69754380|FG009|Second Treatment|Withdrawal by Subject|0|||
38061324|NCT03613649|69754381|FG010|Second Treatment|Withdrawal by Subject|0|||
38061325|NCT03613649|69754382|FG011|Second Treatment|Withdrawal by Subject|0|||
38061326|NCT03613649|69754371|FG000|Third Treatment|Lost to Follow-up|0|||
38061327|NCT03613649|69754372|FG001|Third Treatment|Lost to Follow-up|0|||
38061328|NCT03613649|69754373|FG002|Third Treatment|Lost to Follow-up|0|||
38061329|NCT03613649|69754374|FG003|Third Treatment|Lost to Follow-up|0|||
38061330|NCT03613649|69754375|FG004|Third Treatment|Lost to Follow-up|1|||
38061331|NCT03613649|69754376|FG005|Third Treatment|Lost to Follow-up|0|||
38061332|NCT03613649|69754377|FG006|Third Treatment|Lost to Follow-up|0|||
38061333|NCT03613649|69754378|FG007|Third Treatment|Lost to Follow-up|0|||
38061334|NCT03613649|69754379|FG008|Third Treatment|Lost to Follow-up|0|||
38061335|NCT03613649|69754380|FG009|Third Treatment|Lost to Follow-up|0|||
38061336|NCT03613649|69754381|FG010|Third Treatment|Lost to Follow-up|0|||
38061337|NCT03613649|69754382|FG011|Third Treatment|Lost to Follow-up|1|||
38061338|NCT03613649|69754371|FG000|Third Treatment|Protocol Violation|0|||
38061339|NCT03613649|69754372|FG001|Third Treatment|Protocol Violation|0|||
38061340|NCT03613649|69754373|FG002|Third Treatment|Protocol Violation|0|||
38061341|NCT03613649|69754374|FG003|Third Treatment|Protocol Violation|0|||
38061342|NCT03613649|69754375|FG004|Third Treatment|Protocol Violation|0|||
38061343|NCT03613649|69754376|FG005|Third Treatment|Protocol Violation|0|||
38061344|NCT03613649|69754377|FG006|Third Treatment|Protocol Violation|1|||
38061345|NCT03613649|69754378|FG007|Third Treatment|Protocol Violation|0|||
38061346|NCT03613649|69754379|FG008|Third Treatment|Protocol Violation|0|||
38061347|NCT03613649|69754380|FG009|Third Treatment|Protocol Violation|0|||
38061348|NCT03613649|69754381|FG010|Third Treatment|Protocol Violation|0|||
38061349|NCT03613649|69754382|FG011|Third Treatment|Protocol Violation|1|||
38061350|NCT03613649|69754371|FG000|Fourth Treatment|Protocol Violation|1|||
38061351|NCT03613649|69754372|FG001|Fourth Treatment|Protocol Violation|0|||
38061352|NCT03613649|69754373|FG002|Fourth Treatment|Protocol Violation|0|||
38061353|NCT03613649|69754374|FG003|Fourth Treatment|Protocol Violation|0|||
38061354|NCT03613649|69754375|FG004|Fourth Treatment|Protocol Violation|1|||
38061355|NCT03613649|69754376|FG005|Fourth Treatment|Protocol Violation|0|||
38061356|NCT03613649|69754377|FG006|Fourth Treatment|Protocol Violation|0|||
38061357|NCT03613649|69754378|FG007|Fourth Treatment|Protocol Violation|0|||
38061358|NCT03613649|69754379|FG008|Fourth Treatment|Protocol Violation|0|||
38061359|NCT03613649|69754380|FG009|Fourth Treatment|Protocol Violation|0|||
38061360|NCT03613649|69754381|FG010|Fourth Treatment|Protocol Violation|0|||
38061361|NCT03613649|69754382|FG011|Fourth Treatment|Protocol Violation|0|||
38061362|NCT03613649|69754371|FG000|Fourth Treatment|Physician Decision|0|||
38061363|NCT03613649|69754372|FG001|Fourth Treatment|Physician Decision|0|||
38061364|NCT03613649|69754373|FG002|Fourth Treatment|Physician Decision|0|||
38061365|NCT03613649|69754374|FG003|Fourth Treatment|Physician Decision|0|||
38061366|NCT03613649|69754375|FG004|Fourth Treatment|Physician Decision|0|||
38061367|NCT03613649|69754376|FG005|Fourth Treatment|Physician Decision|0|||
38061368|NCT03613649|69754377|FG006|Fourth Treatment|Physician Decision|1|||
38061369|NCT03613649|69754378|FG007|Fourth Treatment|Physician Decision|0|||
38061370|NCT03613649|69754379|FG008|Fourth Treatment|Physician Decision|0|||
38061371|NCT03613649|69754380|FG009|Fourth Treatment|Physician Decision|0|||
38061372|NCT03613649|69754381|FG010|Fourth Treatment|Physician Decision|0|||
38061373|NCT03613649|69754382|FG011|Fourth Treatment|Physician Decision|0|||
38061374|NCT03096288|69754404|FG000|Overall Study|Withdrawal by Subject|0|||
38061375|NCT03096288|69754405|FG001|Overall Study|Withdrawal by Subject|1|||
38061376|NCT03096288|69754406|FG002|Overall Study|Withdrawal by Subject|0|||
38061377|NCT03096288|69754407|FG003|Overall Study|Withdrawal by Subject|1|||
38061378|NCT03611075|69754426|FG000|Overall Study|Physician Decision|0|||
38061379|NCT03611075|69754427|FG001|Overall Study|Physician Decision|1|||
38061380|NCT03611075|69754428|FG002|Overall Study|Physician Decision|1|||
37862237|NCT00919633|69546036|FG002|Overall Study|Adverse Event|12|||
37862238|NCT00919633|69546037|FG003|Overall Study|Adverse Event|10|||
38061381|NCT03611075|69754429|FG003|Overall Study|Physician Decision|0|||
38061382|NCT03611075|69754430|FG004|Overall Study|Physician Decision|0|||
38061383|NCT03611075|69754431|FG005|Overall Study|Physician Decision|0|||
38061384|NCT03611075|69754432|FG006|Overall Study|Physician Decision|0|||
38061385|NCT03611075|69754433|FG007|Overall Study|Physician Decision|0|||
38061386|NCT03611075|69754434|FG008|Overall Study|Physician Decision|0|||
38061387|NCT03611075|69754426|FG000|Overall Study|Lost to Follow-up|1|||
38061388|NCT03611075|69754427|FG001|Overall Study|Lost to Follow-up|0|||
38061389|NCT03611075|69754428|FG002|Overall Study|Lost to Follow-up|0|||
38061390|NCT03611075|69754429|FG003|Overall Study|Lost to Follow-up|2|||
38061391|NCT03611075|69754430|FG004|Overall Study|Lost to Follow-up|0|||
38061392|NCT03611075|69754431|FG005|Overall Study|Lost to Follow-up|0|||
38061393|NCT03611075|69754432|FG006|Overall Study|Lost to Follow-up|0|||
37862239|NCT00919633|69546034|FG000|Overall Study|Death|0|||
38061394|NCT03611075|69754433|FG007|Overall Study|Lost to Follow-up|0|||
38061395|NCT03611075|69754434|FG008|Overall Study|Lost to Follow-up|0|||
38061396|NCT03611075|69754426|FG000|Overall Study|Withdrawal by Subject|0|||
38061397|NCT03611075|69754427|FG001|Overall Study|Withdrawal by Subject|1|||
38061398|NCT03611075|69754428|FG002|Overall Study|Withdrawal by Subject|1|||
38061399|NCT03611075|69754429|FG003|Overall Study|Withdrawal by Subject|1|||
38061400|NCT03611075|69754430|FG004|Overall Study|Withdrawal by Subject|0|||
38061401|NCT03611075|69754431|FG005|Overall Study|Withdrawal by Subject|0|||
38061402|NCT03611075|69754432|FG006|Overall Study|Withdrawal by Subject|1|||
38061403|NCT03611075|69754433|FG007|Overall Study|Withdrawal by Subject|0|||
38061404|NCT03611075|69754434|FG008|Overall Study|Withdrawal by Subject|0|||
38061405|NCT03611075|69754426|FG000|Overall Study|Reason unknown|0|||
38061406|NCT03611075|69754427|FG001|Overall Study|Reason unknown|0|||
37862240|NCT00919633|69546035|FG001|Overall Study|Death|0|||
37862241|NCT00919633|69546036|FG002|Overall Study|Death|2|||
37862242|NCT00919633|69546037|FG003|Overall Study|Death|0|||
37862243|NCT00919633|69546034|FG000|Overall Study|Lack of Efficacy|17|||
37862244|NCT00919633|69546035|FG001|Overall Study|Lack of Efficacy|3|||
37862245|NCT00919633|69546036|FG002|Overall Study|Lack of Efficacy|2|||
37862246|NCT00919633|69546037|FG003|Overall Study|Lack of Efficacy|3|||
37862247|NCT00919633|69546034|FG000|Overall Study|Withdrawal by Subject|1|||
38061407|NCT03611075|69754428|FG002|Overall Study|Reason unknown|0|||
38061408|NCT03611075|69754429|FG003|Overall Study|Reason unknown|1|||
38061409|NCT03611075|69754430|FG004|Overall Study|Reason unknown|0|||
38061410|NCT03611075|69754431|FG005|Overall Study|Reason unknown|0|||
38061411|NCT03611075|69754432|FG006|Overall Study|Reason unknown|1|||
38061412|NCT03611075|69754433|FG007|Overall Study|Reason unknown|0|||
38061413|NCT03611075|69754434|FG008|Overall Study|Reason unknown|0|||
38061414|NCT03095508|69754479|FG000|Overall Study|Adverse Event|0|||
38061415|NCT03095508|69754480|FG001|Overall Study|Adverse Event|1|||
38061416|NCT03607487|69754490|FG000|Overall Study|Withdrawal by Subject|2|||
38061417|NCT03607487|69754491|FG001|Overall Study|Withdrawal by Subject|0|||
38061418|NCT03607487|69754492|FG002|Overall Study|Withdrawal by Subject|0|||
38061419|NCT03607487|69754493|FG003|Overall Study|Withdrawal by Subject|1|||
38061420|NCT03605693|69754507|FG000|Overall Study|Lost to Follow-up|4|||
38061421|NCT03605693|69754508|FG001|Overall Study|Lost to Follow-up|0|||
38061422|NCT03605693|69754507|FG000|Overall Study|Physician Decision|1|||
38061423|NCT03605693|69754508|FG001|Overall Study|Physician Decision|0|||
38061424|NCT03605303|69754514|FG000|Period 1|Study Terminated|2|||
38061425|NCT03605303|69754515|FG001|Period 1|Study Terminated|1|||
38061426|NCT03604523|69754523|FG000|Overall Study|Physician Decision|1|||
38061427|NCT03604523|69754524|FG001|Overall Study|Physician Decision|0|||
38061428|NCT03602339|69754530|FG000|Overall Study|Withdrawal by Subject|9|||
38061429|NCT03602339|69754530|FG000|Overall Study|Physician Decision|2|||
38061430|NCT03602339|69754530|FG000|Overall Study|Other reason|4|||
38061431|NCT03653429|69754539|FG000|Overall Study|Physician Decision|4|||
38061432|NCT03653429|69754540|FG001|Overall Study|Physician Decision|10|||
38061433|NCT03601715|69754549|FG000|Second Intervention|Lost to Follow-up|1|||
38061434|NCT03601715|69754550|FG001|Second Intervention|Lost to Follow-up|1|||
38061435|NCT03601715|69754551|FG002|Second Intervention|Lost to Follow-up|0|||
38061436|NCT03594227|69754567|FG000|Overall Study|Adverse Event|2|||
38061437|NCT03594227|69754568|FG001|Overall Study|Adverse Event|1|||
38061438|NCT03594227|69754569|FG002|Overall Study|Adverse Event|0|||
38061439|NCT03594227|69754570|FG003|Overall Study|Adverse Event|2|||
38061440|NCT03594227|69754567|FG000|Overall Study|Lost to Follow-up|1|||
38061441|NCT03594227|69754568|FG001|Overall Study|Lost to Follow-up|1|||
38061442|NCT03594227|69754569|FG002|Overall Study|Lost to Follow-up|1|||
38061443|NCT03594227|69754570|FG003|Overall Study|Lost to Follow-up|0|||
38061444|NCT03594227|69754567|FG000|Overall Study|Withdrawal by Subject|1|||
38061445|NCT03594227|69754568|FG001|Overall Study|Withdrawal by Subject|1|||
38061446|NCT03594227|69754569|FG002|Overall Study|Withdrawal by Subject|1|||
38061447|NCT03594227|69754570|FG003|Overall Study|Withdrawal by Subject|1|||
38061448|NCT03594227|69754567|FG000|Overall Study|Pregnancy|0|||
38061449|NCT03594227|69754568|FG001|Overall Study|Pregnancy|1|||
38061450|NCT03594227|69754569|FG002|Overall Study|Pregnancy|0|||
38061451|NCT03594227|69754570|FG003|Overall Study|Pregnancy|0|||
38061452|NCT03594227|69754567|FG000|Overall Study|Sponsor Decision|0|||
38061453|NCT03594227|69754568|FG001|Overall Study|Sponsor Decision|0|||
38061454|NCT03594227|69754569|FG002|Overall Study|Sponsor Decision|0|||
37862248|NCT00919633|69546035|FG001|Overall Study|Withdrawal by Subject|2|||
37862249|NCT00919633|69546036|FG002|Overall Study|Withdrawal by Subject|4|||
38061455|NCT03594227|69754570|FG003|Overall Study|Sponsor Decision|1|||
38061456|NCT03594227|69754567|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
38061457|NCT03594227|69754568|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
38061458|NCT03594227|69754569|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
38061459|NCT03594227|69754570|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
38061460|NCT03098550|69754594|FG000|Overall Study|Disease Progression|30|||
38061461|NCT03098550|69754595|FG001|Overall Study|Disease Progression|19|||
38061462|NCT03098550|69754596|FG002|Overall Study|Disease Progression|41|||
38061463|NCT03098550|69754594|FG000|Overall Study|Study Drug Toxicity|2|||
38061464|NCT03098550|69754595|FG001|Overall Study|Study Drug Toxicity|1|||
38061465|NCT03098550|69754596|FG002|Overall Study|Study Drug Toxicity|0|||
38061466|NCT03098550|69754594|FG000|Overall Study|Death|1|||
38061467|NCT03098550|69754595|FG001|Overall Study|Death|0|||
38061468|NCT03098550|69754596|FG002|Overall Study|Death|0|||
38061469|NCT03098550|69754594|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
38061470|NCT03098550|69754595|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
38061471|NCT03098550|69754596|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
38061472|NCT03098550|69754594|FG000|Overall Study|Administrative reason by sponsor|0|||
38061473|NCT03098550|69754595|FG001|Overall Study|Administrative reason by sponsor|0|||
38061474|NCT03098550|69754596|FG002|Overall Study|Administrative reason by sponsor|1|||
38061475|NCT03098550|69754594|FG000|Overall Study|Other reasons|2|||
38061476|NCT03098550|69754595|FG001|Overall Study|Other reasons|0|||
38061477|NCT03098550|69754596|FG002|Overall Study|Other reasons|0|||
38061478|NCT03095118|69754608|FG000|Overall Study|Adverse Event|1|||
38061479|NCT03095118|69754608|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
38061480|NCT03594071|69754612|FG000|Overall Study|Re-operation|3|||
38061481|NCT03594071|69754612|FG000|Overall Study|Missed visit|2|||
38061482|NCT02696902|69754619|FG000|Overall Study|Lost to Follow-up|0|||
38061483|NCT02696902|69754620|FG001|Overall Study|Lost to Follow-up|1|||
38061484|NCT02696902|69754621|FG002|Overall Study|Lost to Follow-up|1|||
38061485|NCT02696902|69754619|FG000|Overall Study|Withdrawal by Subject|0|||
38061486|NCT02696902|69754620|FG001|Overall Study|Withdrawal by Subject|0|||
38061487|NCT02696902|69754621|FG002|Overall Study|Withdrawal by Subject|1|||
38061488|NCT02696902|69754619|FG000|Overall Study|Death|19|||
38061489|NCT02696902|69754620|FG001|Overall Study|Death|3|||
38061490|NCT02696902|69754621|FG002|Overall Study|Death|24|||
38061491|NCT02696902|69754619|FG000|Overall Study|Participant not fit post-randomization|0|||
38061492|NCT02696902|69754620|FG001|Overall Study|Participant not fit post-randomization|0|||
38061493|NCT02696902|69754621|FG002|Overall Study|Participant not fit post-randomization|1|||
38061494|NCT02696902|69754619|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
38061495|NCT02696902|69754620|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
38061496|NCT02696902|69754621|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
38061497|NCT02696902|69754619|FG000|Overall Study|Principal investigator's decision|1|||
38061498|NCT02696902|69754620|FG001|Overall Study|Principal investigator's decision|0|||
38061499|NCT02696902|69754621|FG002|Overall Study|Principal investigator's decision|0|||
38061500|NCT02696902|69754619|FG000|Overall Study|Sponsor's decision|1|||
38061501|NCT02696902|69754620|FG001|Overall Study|Sponsor's decision|0|||
38061502|NCT02696902|69754621|FG002|Overall Study|Sponsor's decision|0|||
38061503|NCT02696902|69754619|FG000|Overall Study|Transferred to other hospital|1|||
38061504|NCT02696902|69754620|FG001|Overall Study|Transferred to other hospital|0|||
38061505|NCT02696902|69754621|FG002|Overall Study|Transferred to other hospital|0|||
38061506|NCT02694562|69754631|FG000|Overall Study|Death|8|||
38061507|NCT02694562|69754631|FG000|Overall Study|Protocol Violation|4|||
38061508|NCT02694562|69754631|FG000|Overall Study|Lost to Follow-up|3|||
38061509|NCT02694562|69754631|FG000|Overall Study|Screen Failure|2|||
38061510|NCT02694562|69754631|FG000|Overall Study|Physician Decision|1|||
38061511|NCT02874534|69754637|FG000|Overall Study|Withdrawal by Subject|5|||
38061512|NCT02874534|69754638|FG001|Overall Study|Withdrawal by Subject|8|||
38061513|NCT02874534|69754637|FG000|Overall Study|Lost to Follow-up|2|||
38061514|NCT02874534|69754638|FG001|Overall Study|Lost to Follow-up|2|||
38061515|NCT02874534|69754637|FG000|Overall Study|Ongoing in study|1|||
38061516|NCT02874534|69754638|FG001|Overall Study|Ongoing in study|1|||
38061517|NCT03097614|69754644|FG000|Overall Study|Adverse Event|3|||
38061518|NCT03364309|69754651|FG000|Induction Period|Adverse Event|4|||
38061519|NCT03364309|69754652|FG001|Induction Period|Adverse Event|0|||
38061520|NCT03364309|69754653|FG002|Induction Period|Adverse Event|1|||
38061521|NCT03364309|69754654|FG003|Induction Period|Adverse Event|0|||
38061522|NCT03364309|69754655|FG004|Induction Period|Adverse Event|0|||
38061523|NCT03364309|69754656|FG005|Induction Period|Adverse Event|0|||
38061524|NCT03364309|69754657|FG006|Induction Period|Adverse Event|0|||
38061525|NCT03364309|69754658|FG007|Induction Period|Adverse Event|0|||
38061526|NCT03364309|69754659|FG008|Induction Period|Adverse Event|0|||
38061527|NCT03364309|69754660|FG009|Induction Period|Adverse Event|0|||
38061528|NCT03364309|69754661|FG010|Induction Period|Adverse Event|0|||
38061529|NCT03364309|69754662|FG011|Induction Period|Adverse Event|0|||
38061530|NCT03364309|69754663|FG012|Induction Period|Adverse Event|0|||
38061531|NCT03364309|69754664|FG013|Induction Period|Adverse Event|0|||
38061532|NCT03364309|69754665|FG014|Induction Period|Adverse Event|0|||
38061533|NCT03364309|69754666|FG015|Induction Period|Adverse Event|0|||
38061534|NCT03364309|69754667|FG016|Induction Period|Adverse Event|0|||
38061535|NCT03364309|69754668|FG017|Induction Period|Adverse Event|0|||
38061536|NCT03364309|69754669|FG018|Induction Period|Adverse Event|0|||
38061537|NCT03364309|69754651|FG000|Induction Period|Withdrawal by Subject|1|||
38061538|NCT03364309|69754652|FG001|Induction Period|Withdrawal by Subject|3|||
38061539|NCT03364309|69754653|FG002|Induction Period|Withdrawal by Subject|0|||
38061540|NCT03364309|69754654|FG003|Induction Period|Withdrawal by Subject|0|||
38061541|NCT03364309|69754655|FG004|Induction Period|Withdrawal by Subject|0|||
38061542|NCT03364309|69754656|FG005|Induction Period|Withdrawal by Subject|0|||
38061543|NCT03364309|69754657|FG006|Induction Period|Withdrawal by Subject|0|||
38061544|NCT03364309|69754658|FG007|Induction Period|Withdrawal by Subject|0|||
38061545|NCT03364309|69754659|FG008|Induction Period|Withdrawal by Subject|0|||
38061546|NCT03364309|69754660|FG009|Induction Period|Withdrawal by Subject|0|||
38061547|NCT03364309|69754661|FG010|Induction Period|Withdrawal by Subject|0|||
38061548|NCT03364309|69754662|FG011|Induction Period|Withdrawal by Subject|0|||
38061549|NCT03364309|69754663|FG012|Induction Period|Withdrawal by Subject|0|||
38061550|NCT03364309|69754664|FG013|Induction Period|Withdrawal by Subject|0|||
38061551|NCT03364309|69754665|FG014|Induction Period|Withdrawal by Subject|0|||
38061552|NCT03364309|69754666|FG015|Induction Period|Withdrawal by Subject|0|||
38061553|NCT03364309|69754667|FG016|Induction Period|Withdrawal by Subject|0|||
38061554|NCT03364309|69754668|FG017|Induction Period|Withdrawal by Subject|0|||
38061555|NCT03364309|69754669|FG018|Induction Period|Withdrawal by Subject|0|||
38061556|NCT03364309|69754651|FG000|Induction Period|Lost to Follow-up|1|||
38061557|NCT03364309|69754652|FG001|Induction Period|Lost to Follow-up|0|||
38061558|NCT03364309|69754653|FG002|Induction Period|Lost to Follow-up|0|||
38061559|NCT03364309|69754654|FG003|Induction Period|Lost to Follow-up|0|||
38061560|NCT03364309|69754655|FG004|Induction Period|Lost to Follow-up|0|||
38061561|NCT03364309|69754656|FG005|Induction Period|Lost to Follow-up|0|||
38061562|NCT03364309|69754657|FG006|Induction Period|Lost to Follow-up|0|||
38061563|NCT03364309|69754658|FG007|Induction Period|Lost to Follow-up|0|||
38061564|NCT03364309|69754659|FG008|Induction Period|Lost to Follow-up|0|||
38061565|NCT03364309|69754660|FG009|Induction Period|Lost to Follow-up|0|||
38061566|NCT03364309|69754661|FG010|Induction Period|Lost to Follow-up|0|||
38061567|NCT03364309|69754662|FG011|Induction Period|Lost to Follow-up|0|||
38061568|NCT03364309|69754663|FG012|Induction Period|Lost to Follow-up|0|||
38061569|NCT03364309|69754664|FG013|Induction Period|Lost to Follow-up|0|||
38061570|NCT03364309|69754665|FG014|Induction Period|Lost to Follow-up|0|||
38061571|NCT03364309|69754666|FG015|Induction Period|Lost to Follow-up|0|||
38061572|NCT03364309|69754667|FG016|Induction Period|Lost to Follow-up|0|||
38061573|NCT03364309|69754668|FG017|Induction Period|Lost to Follow-up|0|||
38061574|NCT03364309|69754669|FG018|Induction Period|Lost to Follow-up|0|||
38061575|NCT03364309|69754651|FG000|Induction Period|Physician Decision|0|||
38061576|NCT03364309|69754652|FG001|Induction Period|Physician Decision|1|||
38061577|NCT03364309|69754653|FG002|Induction Period|Physician Decision|0|||
38061578|NCT03364309|69754654|FG003|Induction Period|Physician Decision|0|||
38061579|NCT03364309|69754655|FG004|Induction Period|Physician Decision|0|||
38061580|NCT03364309|69754656|FG005|Induction Period|Physician Decision|0|||
38061581|NCT03364309|69754657|FG006|Induction Period|Physician Decision|0|||
38061582|NCT03364309|69754658|FG007|Induction Period|Physician Decision|0|||
38061583|NCT03364309|69754659|FG008|Induction Period|Physician Decision|0|||
38061584|NCT03364309|69754660|FG009|Induction Period|Physician Decision|0|||
38061585|NCT03364309|69754661|FG010|Induction Period|Physician Decision|0|||
38061586|NCT03364309|69754662|FG011|Induction Period|Physician Decision|0|||
38061587|NCT03364309|69754663|FG012|Induction Period|Physician Decision|0|||
38061588|NCT03364309|69754664|FG013|Induction Period|Physician Decision|0|||
38061589|NCT03364309|69754665|FG014|Induction Period|Physician Decision|0|||
38061590|NCT03364309|69754666|FG015|Induction Period|Physician Decision|0|||
38061591|NCT03364309|69754667|FG016|Induction Period|Physician Decision|0|||
38061592|NCT03364309|69754668|FG017|Induction Period|Physician Decision|0|||
38061593|NCT03364309|69754669|FG018|Induction Period|Physician Decision|0|||
38061594|NCT03364309|69754651|FG000|Maintenance Period|Withdrawal by Subject|0|||
38061595|NCT03364309|69754652|FG001|Maintenance Period|Withdrawal by Subject|0|||
38061596|NCT03364309|69754653|FG002|Maintenance Period|Withdrawal by Subject|0|||
38061597|NCT03364309|69754654|FG003|Maintenance Period|Withdrawal by Subject|1|||
38061598|NCT03364309|69754655|FG004|Maintenance Period|Withdrawal by Subject|3|||
38061599|NCT03364309|69754656|FG005|Maintenance Period|Withdrawal by Subject|1|||
38061600|NCT03364309|69754657|FG006|Maintenance Period|Withdrawal by Subject|3|||
38061601|NCT03364309|69754658|FG007|Maintenance Period|Withdrawal by Subject|0|||
38061602|NCT03364309|69754659|FG008|Maintenance Period|Withdrawal by Subject|1|||
38061603|NCT03364309|69754660|FG009|Maintenance Period|Withdrawal by Subject|1|||
38061604|NCT03364309|69754661|FG010|Maintenance Period|Withdrawal by Subject|2|||
38061605|NCT03364309|69754662|FG011|Maintenance Period|Withdrawal by Subject|0|||
38061606|NCT03364309|69754663|FG012|Maintenance Period|Withdrawal by Subject|0|||
38061607|NCT03364309|69754664|FG013|Maintenance Period|Withdrawal by Subject|0|||
38061608|NCT03364309|69754665|FG014|Maintenance Period|Withdrawal by Subject|0|||
38061609|NCT03364309|69754666|FG015|Maintenance Period|Withdrawal by Subject|0|||
38061610|NCT03364309|69754667|FG016|Maintenance Period|Withdrawal by Subject|0|||
38061611|NCT03364309|69754668|FG017|Maintenance Period|Withdrawal by Subject|0|||
38061612|NCT03364309|69754669|FG018|Maintenance Period|Withdrawal by Subject|0|||
38061613|NCT03364309|69754651|FG000|Maintenance Period|Adverse Event|0|||
38061614|NCT03364309|69754652|FG001|Maintenance Period|Adverse Event|0|||
38061615|NCT03364309|69754653|FG002|Maintenance Period|Adverse Event|0|||
38061616|NCT03364309|69754654|FG003|Maintenance Period|Adverse Event|0|||
38061617|NCT03364309|69754655|FG004|Maintenance Period|Adverse Event|2|||
38061618|NCT03364309|69754656|FG005|Maintenance Period|Adverse Event|0|||
38061619|NCT03364309|69754657|FG006|Maintenance Period|Adverse Event|3|||
38061620|NCT03364309|69754658|FG007|Maintenance Period|Adverse Event|0|||
38061621|NCT03364309|69754659|FG008|Maintenance Period|Adverse Event|1|||
38061622|NCT03364309|69754660|FG009|Maintenance Period|Adverse Event|0|||
38061623|NCT03364309|69754661|FG010|Maintenance Period|Adverse Event|2|||
38061624|NCT03364309|69754662|FG011|Maintenance Period|Adverse Event|0|||
38061625|NCT03364309|69754663|FG012|Maintenance Period|Adverse Event|0|||
38061626|NCT03364309|69754664|FG013|Maintenance Period|Adverse Event|0|||
38061627|NCT03364309|69754665|FG014|Maintenance Period|Adverse Event|0|||
38061628|NCT03364309|69754666|FG015|Maintenance Period|Adverse Event|0|||
38061629|NCT03364309|69754667|FG016|Maintenance Period|Adverse Event|0|||
38061630|NCT03364309|69754668|FG017|Maintenance Period|Adverse Event|0|||
38061631|NCT03364309|69754669|FG018|Maintenance Period|Adverse Event|0|||
38061632|NCT03364309|69754651|FG000|Maintenance Period|Relapsed|0|||
38061633|NCT03364309|69754652|FG001|Maintenance Period|Relapsed|0|||
38061634|NCT03364309|69754653|FG002|Maintenance Period|Relapsed|0|||
38061635|NCT03364309|69754654|FG003|Maintenance Period|Relapsed|43|||
38061636|NCT03364309|69754655|FG004|Maintenance Period|Relapsed|7|||
38061637|NCT03364309|69754656|FG005|Maintenance Period|Relapsed|45|||
38061638|NCT03364309|69754657|FG006|Maintenance Period|Relapsed|10|||
38061639|NCT03364309|69754658|FG007|Maintenance Period|Relapsed|2|||
38061640|NCT03364309|69754659|FG008|Maintenance Period|Relapsed|0|||
38061641|NCT03364309|69754660|FG009|Maintenance Period|Relapsed|0|||
38061642|NCT03364309|69754661|FG010|Maintenance Period|Relapsed|0|||
38061643|NCT03364309|69754662|FG011|Maintenance Period|Relapsed|0|||
38061644|NCT03364309|69754663|FG012|Maintenance Period|Relapsed|0|||
38061645|NCT03364309|69754664|FG013|Maintenance Period|Relapsed|0|||
38061646|NCT03364309|69754665|FG014|Maintenance Period|Relapsed|0|||
38061647|NCT03364309|69754666|FG015|Maintenance Period|Relapsed|0|||
38061648|NCT03364309|69754667|FG016|Maintenance Period|Relapsed|0|||
38061649|NCT03364309|69754668|FG017|Maintenance Period|Relapsed|0|||
38061650|NCT03364309|69754669|FG018|Maintenance Period|Relapsed|0|||
38061651|NCT03364309|69754651|FG000|Maintenance Period|Lack of Efficacy|0|||
38061652|NCT03364309|69754652|FG001|Maintenance Period|Lack of Efficacy|0|||
38061653|NCT03364309|69754653|FG002|Maintenance Period|Lack of Efficacy|0|||
38061654|NCT03364309|69754654|FG003|Maintenance Period|Lack of Efficacy|0|||
38061655|NCT03364309|69754655|FG004|Maintenance Period|Lack of Efficacy|0|||
38061656|NCT03364309|69754656|FG005|Maintenance Period|Lack of Efficacy|0|||
38061657|NCT03364309|69754657|FG006|Maintenance Period|Lack of Efficacy|0|||
38061658|NCT03364309|69754658|FG007|Maintenance Period|Lack of Efficacy|0|||
38061659|NCT03364309|69754659|FG008|Maintenance Period|Lack of Efficacy|1|||
38061660|NCT03364309|69754660|FG009|Maintenance Period|Lack of Efficacy|3|||
38061661|NCT03364309|69754661|FG010|Maintenance Period|Lack of Efficacy|2|||
38061662|NCT03364309|69754662|FG011|Maintenance Period|Lack of Efficacy|0|||
38061663|NCT03364309|69754663|FG012|Maintenance Period|Lack of Efficacy|0|||
38061664|NCT03364309|69754664|FG013|Maintenance Period|Lack of Efficacy|0|||
38061665|NCT03364309|69754665|FG014|Maintenance Period|Lack of Efficacy|0|||
38061666|NCT03364309|69754666|FG015|Maintenance Period|Lack of Efficacy|0|||
38061667|NCT03364309|69754667|FG016|Maintenance Period|Lack of Efficacy|0|||
38061668|NCT03364309|69754668|FG017|Maintenance Period|Lack of Efficacy|0|||
38061669|NCT03364309|69754669|FG018|Maintenance Period|Lack of Efficacy|0|||
38061670|NCT03364309|69754651|FG000|Maintenance Period|Death|0|||
38061671|NCT03364309|69754652|FG001|Maintenance Period|Death|0|||
38061672|NCT03364309|69754653|FG002|Maintenance Period|Death|0|||
38061673|NCT03364309|69754654|FG003|Maintenance Period|Death|0|||
38061674|NCT03364309|69754655|FG004|Maintenance Period|Death|0|||
38061675|NCT03364309|69754656|FG005|Maintenance Period|Death|0|||
38061676|NCT03364309|69754657|FG006|Maintenance Period|Death|0|||
38061677|NCT03364309|69754658|FG007|Maintenance Period|Death|0|||
38061678|NCT03364309|69754659|FG008|Maintenance Period|Death|1|||
38061679|NCT03364309|69754660|FG009|Maintenance Period|Death|0|||
38061680|NCT03364309|69754661|FG010|Maintenance Period|Death|0|||
38061681|NCT03364309|69754662|FG011|Maintenance Period|Death|0|||
38061682|NCT03364309|69754663|FG012|Maintenance Period|Death|0|||
38061683|NCT03364309|69754664|FG013|Maintenance Period|Death|0|||
38061684|NCT03364309|69754665|FG014|Maintenance Period|Death|0|||
38061685|NCT03364309|69754666|FG015|Maintenance Period|Death|0|||
38061686|NCT03364309|69754667|FG016|Maintenance Period|Death|0|||
38061687|NCT03364309|69754668|FG017|Maintenance Period|Death|0|||
38061688|NCT03364309|69754669|FG018|Maintenance Period|Death|0|||
38061689|NCT03364309|69754651|FG000|Maintenance Period|Lost to Follow-up|0|||
38061690|NCT03364309|69754652|FG001|Maintenance Period|Lost to Follow-up|0|||
38061691|NCT03364309|69754653|FG002|Maintenance Period|Lost to Follow-up|0|||
38061692|NCT03364309|69754654|FG003|Maintenance Period|Lost to Follow-up|0|||
38061693|NCT03364309|69754655|FG004|Maintenance Period|Lost to Follow-up|0|||
38061694|NCT03364309|69754656|FG005|Maintenance Period|Lost to Follow-up|0|||
38061695|NCT03364309|69754657|FG006|Maintenance Period|Lost to Follow-up|0|||
38061696|NCT03364309|69754658|FG007|Maintenance Period|Lost to Follow-up|0|||
38061697|NCT03364309|69754659|FG008|Maintenance Period|Lost to Follow-up|1|||
38061698|NCT03364309|69754660|FG009|Maintenance Period|Lost to Follow-up|0|||
38061699|NCT03364309|69754661|FG010|Maintenance Period|Lost to Follow-up|0|||
38061700|NCT03364309|69754662|FG011|Maintenance Period|Lost to Follow-up|0|||
38061701|NCT03364309|69754663|FG012|Maintenance Period|Lost to Follow-up|0|||
38061702|NCT03364309|69754664|FG013|Maintenance Period|Lost to Follow-up|0|||
38061703|NCT03364309|69754665|FG014|Maintenance Period|Lost to Follow-up|0|||
38061704|NCT03364309|69754666|FG015|Maintenance Period|Lost to Follow-up|0|||
38061705|NCT03364309|69754667|FG016|Maintenance Period|Lost to Follow-up|0|||
38061706|NCT03364309|69754668|FG017|Maintenance Period|Lost to Follow-up|0|||
38061707|NCT03364309|69754669|FG018|Maintenance Period|Lost to Follow-up|0|||
38061708|NCT03364309|69754651|FG000|Maintenance Period|Miscellaneous|0|||
38061709|NCT03364309|69754652|FG001|Maintenance Period|Miscellaneous|0|||
38061710|NCT03364309|69754653|FG002|Maintenance Period|Miscellaneous|0|||
38061711|NCT03364309|69754654|FG003|Maintenance Period|Miscellaneous|0|||
38061712|NCT03364309|69754655|FG004|Maintenance Period|Miscellaneous|0|||
38061713|NCT03364309|69754656|FG005|Maintenance Period|Miscellaneous|0|||
38061714|NCT03364309|69754657|FG006|Maintenance Period|Miscellaneous|0|||
38061715|NCT03364309|69754658|FG007|Maintenance Period|Miscellaneous|0|||
38061716|NCT03364309|69754659|FG008|Maintenance Period|Miscellaneous|1|||
38061717|NCT03364309|69754660|FG009|Maintenance Period|Miscellaneous|0|||
38061718|NCT03364309|69754661|FG010|Maintenance Period|Miscellaneous|0|||
38061719|NCT03364309|69754662|FG011|Maintenance Period|Miscellaneous|0|||
38061720|NCT03364309|69754663|FG012|Maintenance Period|Miscellaneous|0|||
38061721|NCT03364309|69754664|FG013|Maintenance Period|Miscellaneous|0|||
38061722|NCT03364309|69754665|FG014|Maintenance Period|Miscellaneous|0|||
38061723|NCT03364309|69754666|FG015|Maintenance Period|Miscellaneous|0|||
38061724|NCT03364309|69754667|FG016|Maintenance Period|Miscellaneous|0|||
38061725|NCT03364309|69754668|FG017|Maintenance Period|Miscellaneous|0|||
38061726|NCT03364309|69754669|FG018|Maintenance Period|Miscellaneous|0|||
38061727|NCT03364309|69754651|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
38061728|NCT03364309|69754652|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
38061729|NCT03364309|69754653|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
38061730|NCT03364309|69754654|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
38061731|NCT03364309|69754655|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
38061732|NCT03364309|69754656|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
38061733|NCT03364309|69754657|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
38061734|NCT03364309|69754658|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
38061735|NCT03364309|69754659|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
38061736|NCT03364309|69754660|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
38061737|NCT03364309|69754661|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
38061738|NCT03364309|69754662|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
38061739|NCT03364309|69754663|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
38061740|NCT03364309|69754664|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
38061741|NCT03364309|69754665|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
38061742|NCT03364309|69754666|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
38061743|NCT03364309|69754667|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
38061744|NCT03364309|69754668|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
38061745|NCT03364309|69754669|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
38061746|NCT03364309|69754651|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
38061747|NCT03364309|69754652|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
38061748|NCT03364309|69754653|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
38061749|NCT03364309|69754654|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
38061750|NCT03364309|69754655|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
38061751|NCT03364309|69754656|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
38061752|NCT03364309|69754657|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
38061753|NCT03364309|69754658|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
38061754|NCT03364309|69754659|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
38061755|NCT03364309|69754660|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
38061756|NCT03364309|69754661|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
38061757|NCT03364309|69754662|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
38061758|NCT03364309|69754663|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
38061759|NCT03364309|69754664|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
38061760|NCT03364309|69754665|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
38061761|NCT03364309|69754666|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
38061762|NCT03364309|69754667|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
38061763|NCT03364309|69754668|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
38061764|NCT03364309|69754669|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
38061765|NCT03364309|69754651|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
38061766|NCT03364309|69754652|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
38061767|NCT03364309|69754653|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
38061768|NCT03364309|69754654|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
38061769|NCT03364309|69754655|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
38061770|NCT03364309|69754656|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
38061771|NCT03364309|69754657|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
38061772|NCT03364309|69754658|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
38061773|NCT03364309|69754659|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
38061774|NCT03364309|69754660|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
38061775|NCT03364309|69754661|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
38061776|NCT03364309|69754662|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
38061777|NCT03364309|69754663|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
38061778|NCT03364309|69754664|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
38061779|NCT03364309|69754665|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
38061780|NCT03364309|69754666|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
38061781|NCT03364309|69754667|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
38061782|NCT03364309|69754668|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
38061783|NCT03364309|69754669|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
38061784|NCT03364309|69754651|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
38061785|NCT03364309|69754652|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
38061786|NCT03364309|69754653|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
38061787|NCT03364309|69754654|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
38061788|NCT03364309|69754655|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
38061789|NCT03364309|69754656|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
38061790|NCT03364309|69754657|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
38061791|NCT03364309|69754658|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
38061792|NCT03364309|69754659|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
38061793|NCT03364309|69754660|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
38061794|NCT03364309|69754661|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
38061795|NCT03364309|69754662|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
38061796|NCT03364309|69754663|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
38061797|NCT03364309|69754664|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
38061798|NCT03364309|69754665|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
38061799|NCT03364309|69754666|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
38061800|NCT03364309|69754667|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
38061801|NCT03364309|69754668|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
38061802|NCT03364309|69754669|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
38061803|NCT03364309|69754651|FG000|Post-Treatment Followup Period|Adverse Event|0|||
38061804|NCT03364309|69754652|FG001|Post-Treatment Followup Period|Adverse Event|0|||
38061805|NCT03364309|69754653|FG002|Post-Treatment Followup Period|Adverse Event|0|||
38061806|NCT03364309|69754654|FG003|Post-Treatment Followup Period|Adverse Event|0|||
38061807|NCT03364309|69754655|FG004|Post-Treatment Followup Period|Adverse Event|0|||
38061808|NCT03364309|69754656|FG005|Post-Treatment Followup Period|Adverse Event|0|||
38061809|NCT03364309|69754657|FG006|Post-Treatment Followup Period|Adverse Event|0|||
38061810|NCT03364309|69754658|FG007|Post-Treatment Followup Period|Adverse Event|0|||
38061811|NCT03364309|69754659|FG008|Post-Treatment Followup Period|Adverse Event|0|||
38061812|NCT03364309|69754660|FG009|Post-Treatment Followup Period|Adverse Event|0|||
38061813|NCT03364309|69754661|FG010|Post-Treatment Followup Period|Adverse Event|0|||
38061814|NCT03364309|69754662|FG011|Post-Treatment Followup Period|Adverse Event|0|||
38061815|NCT03364309|69754663|FG012|Post-Treatment Followup Period|Adverse Event|0|||
38061816|NCT03364309|69754664|FG013|Post-Treatment Followup Period|Adverse Event|0|||
38061817|NCT03364309|69754665|FG014|Post-Treatment Followup Period|Adverse Event|0|||
38061818|NCT03364309|69754666|FG015|Post-Treatment Followup Period|Adverse Event|0|||
38061819|NCT03364309|69754667|FG016|Post-Treatment Followup Period|Adverse Event|2|||
38061820|NCT03364309|69754668|FG017|Post-Treatment Followup Period|Adverse Event|6|||
38061821|NCT03364309|69754669|FG018|Post-Treatment Followup Period|Adverse Event|1|||
38061822|NCT03364309|69754651|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
38061823|NCT03364309|69754652|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
38061824|NCT03364309|69754653|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
38061825|NCT03364309|69754654|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
38061826|NCT03364309|69754655|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
38061827|NCT03364309|69754656|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
38061828|NCT03364309|69754657|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
38061829|NCT03364309|69754658|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
38061830|NCT03364309|69754659|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
38061831|NCT03364309|69754660|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
38061832|NCT03364309|69754661|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
38061833|NCT03364309|69754662|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
38061834|NCT03364309|69754663|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
38061835|NCT03364309|69754664|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
38061836|NCT03364309|69754665|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
38061837|NCT03364309|69754666|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
38061838|NCT03364309|69754667|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
38061839|NCT03364309|69754668|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
38061840|NCT03364309|69754669|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
38061841|NCT03364309|69754651|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
38061842|NCT03364309|69754652|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
38061843|NCT03364309|69754653|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
38061844|NCT03364309|69754654|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
38061845|NCT03364309|69754655|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
38061846|NCT03364309|69754656|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
38061847|NCT03364309|69754657|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
38061848|NCT03364309|69754658|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
38061849|NCT03364309|69754659|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
38061850|NCT03364309|69754660|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
38061851|NCT03364309|69754661|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
38061852|NCT03364309|69754662|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
38061853|NCT03364309|69754663|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
38061854|NCT03364309|69754664|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
38061855|NCT03364309|69754665|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
38061856|NCT03364309|69754666|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
38061857|NCT03364309|69754667|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
38061858|NCT03364309|69754668|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
38061859|NCT03364309|69754669|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
38061860|NCT03334903|69754695|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
38061861|NCT03334903|69754696|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
38061862|NCT03334903|69754695|FG000|Overall Study|Protocol Violation|1|||
38061863|NCT03334903|69754696|FG001|Overall Study|Protocol Violation|3|||
38061864|NCT03334903|69754695|FG000|Overall Study|Surgery postponed|1|||
38061865|NCT03334903|69754696|FG001|Overall Study|Surgery postponed|0|||
38061866|NCT03334903|69754695|FG000|Overall Study|Adverse Event|1|||
38061867|NCT03334903|69754696|FG001|Overall Study|Adverse Event|1|||
38061868|NCT03334903|69754695|FG000|Overall Study|Withdrawal by Subject|0|||
38061869|NCT03334903|69754696|FG001|Overall Study|Withdrawal by Subject|1|||
38061870|NCT01353664|69754702|FG000|Overall Study|Other|3|||
38061871|NCT01353664|69754702|FG000|Overall Study|Disease Progression|16|||
38061872|NCT02694328|69754708|FG000|Overall Study|Adverse Event|27|||
38061873|NCT02694328|69754709|FG001|Overall Study|Adverse Event|33|||
38061874|NCT02694328|69754708|FG000|Overall Study|Withdrawal by Subject|27|||
37862250|NCT00919633|69546037|FG003|Overall Study|Withdrawal by Subject|3|||
38061875|NCT02694328|69754709|FG001|Overall Study|Withdrawal by Subject|23|||
38061876|NCT02694328|69754708|FG000|Overall Study|Lost to Follow-up|26|||
38061877|NCT02694328|69754709|FG001|Overall Study|Lost to Follow-up|22|||
38061878|NCT02694328|69754708|FG000|Overall Study|Noncompliant with study drug|11|||
38061879|NCT02694328|69754709|FG001|Overall Study|Noncompliant with study drug|8|||
38061880|NCT02694328|69754708|FG000|Overall Study|Incarceration|1|||
38061881|NCT02694328|69754709|FG001|Overall Study|Incarceration|1|||
38061882|NCT02694328|69754708|FG000|Overall Study|Lack of Efficacy|1|||
38061883|NCT02694328|69754709|FG001|Overall Study|Lack of Efficacy|2|||
38061884|NCT02694328|69754708|FG000|Overall Study|Pregnancy|1|||
38061885|NCT02694328|69754709|FG001|Overall Study|Pregnancy|1|||
38061886|NCT02694328|69754708|FG000|Overall Study|Protocol Violation|6|||
38061887|NCT02694328|69754709|FG001|Overall Study|Protocol Violation|5|||
38061888|NCT02694328|69754708|FG000|Overall Study|Abnormal Laboratory Value|0|||
38061889|NCT02694328|69754709|FG001|Overall Study|Abnormal Laboratory Value|3|||
38061890|NCT03334747|69754724|FG000|Treatment Phase|Technical problems|0|||
38061891|NCT03334747|69754725|FG001|Treatment Phase|Technical problems|0|||
38061892|NCT03334747|69754726|FG002|Treatment Phase|Technical problems|0|||
38061893|NCT03334747|69754727|FG003|Treatment Phase|Technical problems|0|||
38061894|NCT03334747|69754728|FG004|Treatment Phase|Technical problems|1|||
38061895|NCT03334747|69754729|FG005|Treatment Phase|Technical problems|0|||
38061896|NCT03334747|69754730|FG006|Treatment Phase|Technical problems|0|||
38061897|NCT03334747|69754731|FG007|Treatment Phase|Technical problems|0|||
38061898|NCT03334747|69754732|FG008|Treatment Phase|Technical problems|0|||
38061899|NCT03334747|69754724|FG000|Treatment Phase|Subject/guardian decision|1|||
38061900|NCT03334747|69754725|FG001|Treatment Phase|Subject/guardian decision|0|||
38061901|NCT03334747|69754726|FG002|Treatment Phase|Subject/guardian decision|0|||
38061902|NCT03334747|69754727|FG003|Treatment Phase|Subject/guardian decision|0|||
38061903|NCT03334747|69754728|FG004|Treatment Phase|Subject/guardian decision|0|||
38061904|NCT03334747|69754729|FG005|Treatment Phase|Subject/guardian decision|1|||
38061905|NCT03334747|69754730|FG006|Treatment Phase|Subject/guardian decision|0|||
38061906|NCT03334747|69754731|FG007|Treatment Phase|Subject/guardian decision|0|||
38061907|NCT03334747|69754732|FG008|Treatment Phase|Subject/guardian decision|0|||
38061908|NCT03334747|69754724|FG000|Follow-Up Phase|Subject/guardian decision|0|||
38061909|NCT03334747|69754725|FG001|Follow-Up Phase|Subject/guardian decision|0|||
38061910|NCT03334747|69754726|FG002|Follow-Up Phase|Subject/guardian decision|0|||
38061911|NCT03334747|69754727|FG003|Follow-Up Phase|Subject/guardian decision|0|||
38061912|NCT03334747|69754728|FG004|Follow-Up Phase|Subject/guardian decision|0|||
38061913|NCT03334747|69754729|FG005|Follow-Up Phase|Subject/guardian decision|0|||
38061914|NCT03334747|69754730|FG006|Follow-Up Phase|Subject/guardian decision|1|||
38061915|NCT03334747|69754731|FG007|Follow-Up Phase|Subject/guardian decision|0|||
38061916|NCT03334747|69754732|FG008|Follow-Up Phase|Subject/guardian decision|1|||
38061917|NCT03346759|69754754|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
38061918|NCT03346759|69754755|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
38061919|NCT03346759|69754754|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
38061920|NCT03346759|69754755|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
38061921|NCT03346759|69754754|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
38061922|NCT03346759|69754755|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
38061923|NCT03361423|69754764|FG000|Overall Study|Withdrawal by Subject|4|||
38061924|NCT03361423|69754765|FG001|Overall Study|Withdrawal by Subject|3|||
38061925|NCT03361423|69754764|FG000|Overall Study|Did not treat|19|||
38061926|NCT03361423|69754765|FG001|Overall Study|Did not treat|18|||
38061927|NCT03361423|69754764|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
38061928|NCT03361423|69754765|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
38061929|NCT03361423|69754764|FG000|Overall Study|Missing data|4|||
38061930|NCT03361423|69754765|FG001|Overall Study|Missing data|1|||
38061931|NCT02693002|69754773|FG000|Overall Study|Withdrawal by Subject|1|||
38061932|NCT02693002|69754774|FG001|Overall Study|Withdrawal by Subject|0|||
38061933|NCT03093870|69754783|FG000|Overall Study|Withdrawal by Subject|2|||
38061934|NCT03093870|69754784|FG001|Overall Study|Withdrawal by Subject|6|||
38061935|NCT03093870|69754785|FG002|Overall Study|Withdrawal by Subject|5|||
38061936|NCT03093870|69754783|FG000|Overall Study|Death|1|||
38061937|NCT03093870|69754784|FG001|Overall Study|Death|35|||
38061938|NCT03093870|69754785|FG002|Overall Study|Death|35|||
38061939|NCT03093870|69754783|FG000|Overall Study|Radiographic disease progression|10|||
38061940|NCT03093870|69754784|FG001|Overall Study|Radiographic disease progression|0|||
38061941|NCT03093870|69754785|FG002|Overall Study|Radiographic disease progression|0|||
38061942|NCT03093870|69754783|FG000|Overall Study|Clinical disease progression|1|||
38061943|NCT03093870|69754784|FG001|Overall Study|Clinical disease progression|0|||
38061944|NCT03093870|69754785|FG002|Overall Study|Clinical disease progression|0|||
38061945|NCT03093870|69754783|FG000|Overall Study|Physician Decision|2|||
38061946|NCT03093870|69754784|FG001|Overall Study|Physician Decision|0|||
38061947|NCT03093870|69754785|FG002|Overall Study|Physician Decision|0|||
37862251|NCT00919633|69546034|FG000|Overall Study|Lost to Follow-up|3|||
37862252|NCT00919633|69546035|FG001|Overall Study|Lost to Follow-up|1|||
37862253|NCT00919633|69546036|FG002|Overall Study|Lost to Follow-up|0|||
37862254|NCT00919633|69546037|FG003|Overall Study|Lost to Follow-up|2|||
37862255|NCT00919633|69546034|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
37862256|NCT00919633|69546035|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
38061948|NCT03093870|69754783|FG000|Overall Study|Adverse Event|7|||
38061949|NCT03093870|69754784|FG001|Overall Study|Adverse Event|0|||
38061950|NCT03093870|69754785|FG002|Overall Study|Adverse Event|0|||
38061951|NCT03093870|69754783|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
38061952|NCT03093870|69754784|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
38061953|NCT03093870|69754785|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
38061954|NCT03093870|69754783|FG000|Overall Study|Lost to Follow-up|0|||
38061955|NCT03093870|69754784|FG001|Overall Study|Lost to Follow-up|0|||
38061956|NCT03093870|69754785|FG002|Overall Study|Lost to Follow-up|1|||
38061957|NCT03346057|69754808|FG000|Overall Study|Death|1|||
38061958|NCT03346057|69754809|FG001|Overall Study|Death|2|||
38061959|NCT03346057|69754810|FG002|Overall Study|Death|0|||
38061960|NCT03346057|69754811|FG003|Overall Study|Death|0|||
38061961|NCT03346057|69754808|FG000|Overall Study|Lost to Follow-up|0|||
38061962|NCT03346057|69754809|FG001|Overall Study|Lost to Follow-up|2|||
38061963|NCT03346057|69754810|FG002|Overall Study|Lost to Follow-up|1|||
38061964|NCT03346057|69754811|FG003|Overall Study|Lost to Follow-up|0|||
38061965|NCT03346057|69754808|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
38061966|NCT03346057|69754809|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
38061967|NCT03346057|69754810|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
38061968|NCT03346057|69754811|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
38061969|NCT03346057|69754808|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
38061970|NCT03346057|69754809|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
38061971|NCT03346057|69754810|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
38061972|NCT03346057|69754811|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
38061973|NCT03346057|69754808|FG000|Overall Study|Physician Decision|3|||
38061974|NCT03346057|69754809|FG001|Overall Study|Physician Decision|2|||
38061975|NCT03346057|69754810|FG002|Overall Study|Physician Decision|0|||
38061976|NCT03346057|69754811|FG003|Overall Study|Physician Decision|2|||
38061977|NCT03346057|69754808|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
38061978|NCT03346057|69754809|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
38061979|NCT03346057|69754810|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
38061980|NCT03346057|69754811|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
38061981|NCT03346057|69754808|FG000|Overall Study|Withdrawal by Subject|1|||
38061982|NCT03346057|69754809|FG001|Overall Study|Withdrawal by Subject|0|||
38061983|NCT03346057|69754810|FG002|Overall Study|Withdrawal by Subject|0|||
38061984|NCT03346057|69754811|FG003|Overall Study|Withdrawal by Subject|0|||
38061985|NCT03345979|69754823|FG000|Overall Study|Withdrawal by Subject|20|||
38061986|NCT03345979|69754824|FG001|Overall Study|Withdrawal by Subject|31|||
38061987|NCT03345979|69754823|FG000|Overall Study|Adverse Event|10|||
38061988|NCT03345979|69754824|FG001|Overall Study|Adverse Event|11|||
38061989|NCT03345979|69754823|FG000|Overall Study|Lost to Follow-up|8|||
38061990|NCT03345979|69754824|FG001|Overall Study|Lost to Follow-up|9|||
38061991|NCT03345979|69754823|FG000|Overall Study|Lack of Efficacy|4|||
38061992|NCT03345979|69754824|FG001|Overall Study|Lack of Efficacy|2|||
38061993|NCT03345979|69754823|FG000|Overall Study|Protocol Violation|1|||
38061994|NCT03345979|69754824|FG001|Overall Study|Protocol Violation|3|||
38061995|NCT03345979|69754823|FG000|Overall Study|Physician Decision|0|||
38061996|NCT03345979|69754824|FG001|Overall Study|Physician Decision|2|||
38061997|NCT02696434|69754832|FG000|Overall Study|Adverse Event|3|||
38061998|NCT02696434|69754833|FG001|Overall Study|Adverse Event|1|||
38061999|NCT02696434|69754832|FG000|Overall Study|Lost to Follow-up|5|||
38062000|NCT02696434|69754833|FG001|Overall Study|Lost to Follow-up|4|||
38062001|NCT02696434|69754832|FG000|Overall Study|Withdrawal by Subject|14|||
38062002|NCT02696434|69754833|FG001|Overall Study|Withdrawal by Subject|12|||
38062003|NCT02696434|69754832|FG000|Overall Study|Physician Decision|0|||
38062004|NCT02696434|69754833|FG001|Overall Study|Physician Decision|1|||
38062005|NCT03345901|69754839|FG000|Overall Study|The study was terminated|18|||
38062006|NCT02950831|69754844|FG000|Overall Study|Lost to Follow-up|1|||
38062007|NCT02950831|69754844|FG000|Overall Study|Withdrawal by Subject|3|||
38062008|NCT02950831|69754844|FG000|Overall Study|stimulation trail failure|5|||
38062009|NCT03593681|69754848|FG000|Overall Study|Inadequate sample collected|12|||
38062010|NCT03593681|69754848|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
38062011|NCT03593681|69754848|FG000|Overall Study|Protocol Violation|3|||
38062012|NCT03593681|69754848|FG000|Overall Study|Withdrawal by Subject|3|||
38062013|NCT03593681|69754848|FG000|Overall Study|Procedure not attempted|3|||
38062014|NCT03593681|69754848|FG000|Overall Study|Adverse Event|2|||
38062015|NCT03593681|69754848|FG000|Overall Study|Physician Decision|1|||
38062016|NCT03592745|69754871|FG000|Overall Study|Adverse Event|0|||
38062017|NCT03592745|69754872|FG001|Overall Study|Adverse Event|2|||
38062018|NCT03592745|69754871|FG000|Overall Study|Lost to Follow-up|2|||
38062019|NCT03592745|69754872|FG001|Overall Study|Lost to Follow-up|0|||
38062020|NCT03592745|69754871|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
38062021|NCT03592745|69754872|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
38062022|NCT03592277|69754880|FG000|Overall Study|Withdrawal by Subject|6|||
38062023|NCT03592277|69754881|FG001|Overall Study|Withdrawal by Subject|8|||
38062024|NCT03401112|69754892|FG000|Overall Study|Adverse Event|1|||
38062025|NCT03401112|69754893|FG001|Overall Study|Adverse Event|2|||
38062026|NCT03401112|69754894|FG002|Overall Study|Adverse Event|3|||
38062027|NCT03401112|69754895|FG003|Overall Study|Adverse Event|2|||
38062028|NCT03401112|69754896|FG004|Overall Study|Adverse Event|0|||
38062029|NCT03401112|69754892|FG000|Overall Study|Lost to Follow-up|1|||
38062030|NCT03401112|69754893|FG001|Overall Study|Lost to Follow-up|0|||
38062031|NCT03401112|69754894|FG002|Overall Study|Lost to Follow-up|0|||
38062032|NCT03401112|69754895|FG003|Overall Study|Lost to Follow-up|0|||
38062033|NCT03401112|69754896|FG004|Overall Study|Lost to Follow-up|0|||
38062034|NCT03401112|69754892|FG000|Overall Study|Noncompliance|1|||
38062035|NCT03401112|69754893|FG001|Overall Study|Noncompliance|2|||
38062036|NCT03401112|69754894|FG002|Overall Study|Noncompliance|3|||
38062037|NCT03401112|69754895|FG003|Overall Study|Noncompliance|0|||
38062038|NCT03401112|69754896|FG004|Overall Study|Noncompliance|0|||
38062039|NCT03401112|69754892|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
38062040|NCT03401112|69754893|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
38062041|NCT03401112|69754894|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
38062042|NCT03401112|69754895|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
38062043|NCT03401112|69754896|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
38062044|NCT03401112|69754892|FG000|Overall Study|Withdrawal by Subject|0|||
38062045|NCT03401112|69754893|FG001|Overall Study|Withdrawal by Subject|3|||
38062046|NCT03401112|69754894|FG002|Overall Study|Withdrawal by Subject|2|||
38062047|NCT03401112|69754895|FG003|Overall Study|Withdrawal by Subject|1|||
38062048|NCT03401112|69754896|FG004|Overall Study|Withdrawal by Subject|0|||
38062049|NCT03401112|69754892|FG000|Overall Study|Physician Decision|0|||
38062050|NCT03401112|69754893|FG001|Overall Study|Physician Decision|0|||
38062051|NCT03401112|69754894|FG002|Overall Study|Physician Decision|0|||
38062052|NCT03401112|69754895|FG003|Overall Study|Physician Decision|2|||
38062053|NCT03401112|69754896|FG004|Overall Study|Physician Decision|0|||
38062054|NCT03401112|69754892|FG000|Overall Study|Study was Terminated by Sponsor|0|||
38062055|NCT03401112|69754893|FG001|Overall Study|Study was Terminated by Sponsor|0|||
38062056|NCT03401112|69754894|FG002|Overall Study|Study was Terminated by Sponsor|0|||
38062057|NCT03401112|69754895|FG003|Overall Study|Study was Terminated by Sponsor|1|||
38062058|NCT03401112|69754896|FG004|Overall Study|Study was Terminated by Sponsor|0|||
38062059|NCT03401112|69754892|FG000|Overall Study|Day 1 Assessment not Done|1|||
38062060|NCT03401112|69754893|FG001|Overall Study|Day 1 Assessment not Done|0|||
38062061|NCT03401112|69754894|FG002|Overall Study|Day 1 Assessment not Done|0|||
38062062|NCT03401112|69754895|FG003|Overall Study|Day 1 Assessment not Done|0|||
38062063|NCT03401112|69754896|FG004|Overall Study|Day 1 Assessment not Done|0|||
38062064|NCT03401112|69754892|FG000|Overall Study|Not Dosed|0|||
38062065|NCT03401112|69754893|FG001|Overall Study|Not Dosed|0|||
38062066|NCT03401112|69754894|FG002|Overall Study|Not Dosed|1|||
38062067|NCT03401112|69754895|FG003|Overall Study|Not Dosed|0|||
38062068|NCT03401112|69754896|FG004|Overall Study|Not Dosed|0|||
38062069|NCT03401112|69754892|FG000|Overall Study|Missed Clinical Visit|0|||
38062070|NCT03401112|69754893|FG001|Overall Study|Missed Clinical Visit|0|||
38062071|NCT03401112|69754894|FG002|Overall Study|Missed Clinical Visit|1|||
38062072|NCT03401112|69754895|FG003|Overall Study|Missed Clinical Visit|0|||
38062073|NCT03401112|69754896|FG004|Overall Study|Missed Clinical Visit|0|||
38062074|NCT03401112|69754892|FG000|Overall Study|Missed Doses|0|||
38062075|NCT03401112|69754893|FG001|Overall Study|Missed Doses|0|||
38062076|NCT03401112|69754894|FG002|Overall Study|Missed Doses|1|||
38062077|NCT03401112|69754895|FG003|Overall Study|Missed Doses|0|||
38062078|NCT03401112|69754896|FG004|Overall Study|Missed Doses|0|||
38062079|NCT02697916|69754925|FG000|Overall Study|Death|357|||
38062080|NCT02697916|69754926|FG001|Overall Study|Death|315|||
38062081|NCT02697916|69754925|FG000|Overall Study|Withdrawal by Subject|221|||
38062082|NCT02697916|69754926|FG001|Overall Study|Withdrawal by Subject|393|||
38062083|NCT03650387|69754932|FG000|Overall Study|Withdrawal by Subject|13|||
38062084|NCT03650387|69754932|FG000|Overall Study|Lost to Follow-up|12|||
38062085|NCT03650387|69754932|FG000|Overall Study|Adverse Event (Not related)|1|||
38062086|NCT03650387|69754932|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
38062087|NCT03359473|69754958|FG000|Overall Study|Adverse Event|0|||
38062088|NCT03359473|69754959|FG001|Overall Study|Adverse Event|2|||
38062089|NCT03359473|69754960|FG002|Overall Study|Adverse Event|5|||
37680385|NCT02586805|69155999|FG002|Overall Study|Physician Decision|0|||
38062090|NCT03359473|69754961|FG003|Overall Study|Adverse Event|3|||
38062091|NCT03359473|69754958|FG000|Overall Study|Lost to Follow-up|0|||
38062092|NCT03359473|69754959|FG001|Overall Study|Lost to Follow-up|1|||
38062093|NCT03359473|69754960|FG002|Overall Study|Lost to Follow-up|0|||
38062094|NCT03359473|69754961|FG003|Overall Study|Lost to Follow-up|0|||
38062095|NCT03359473|69754958|FG000|Overall Study|Physician Decision|0|||
38062096|NCT03359473|69754959|FG001|Overall Study|Physician Decision|1|||
38062097|NCT03359473|69754960|FG002|Overall Study|Physician Decision|0|||
38062098|NCT03359473|69754961|FG003|Overall Study|Physician Decision|1|||
38062099|NCT03359473|69754958|FG000|Overall Study|Withdrawal by Subject|1|||
38062100|NCT03359473|69754959|FG001|Overall Study|Withdrawal by Subject|2|||
38062101|NCT03359473|69754960|FG002|Overall Study|Withdrawal by Subject|1|||
38062102|NCT03359473|69754961|FG003|Overall Study|Withdrawal by Subject|0|||
38062103|NCT03359473|69754958|FG000|Overall Study|Protocol-defined stopping criteria|1|||
38062104|NCT03359473|69754959|FG001|Overall Study|Protocol-defined stopping criteria|0|||
38062105|NCT03359473|69754960|FG002|Overall Study|Protocol-defined stopping criteria|0|||
38062106|NCT03359473|69754961|FG003|Overall Study|Protocol-defined stopping criteria|1|||
38062107|NCT03589469|69754974|FG000|Overall Study|Withdrawal by Subject|8|||
38062108|NCT03589469|69754974|FG000|Overall Study|Physician Decision|20|||
38062109|NCT03589469|69754974|FG000|Overall Study|Death|97|||
38062110|NCT03589469|69754974|FG000|Overall Study|Lost to Follow-up|8|||
38062111|NCT03589469|69754974|FG000|Overall Study|Miscellaneous|1|||
38062112|NCT03359395|69754980|FG000|First Intervention A / B|Withdrawal by Subject|1|||
38062113|NCT03359395|69754981|FG001|First Intervention A / B|Withdrawal by Subject|0|||
38062114|NCT03359395|69754980|FG000|First Intervention A / B|Lost to Follow-up|2|||
38062115|NCT03359395|69754981|FG001|First Intervention A / B|Lost to Follow-up|3|||
38062116|NCT03359395|69754980|FG000|Second Intervention B/A|Exclusion criteria|0|||
38062117|NCT03359395|69754981|FG001|Second Intervention B/A|Exclusion criteria|1|||
38062118|NCT03359395|69754980|FG000|Second Intervention B/A|Lost to Follow-up|3|||
38062119|NCT03359395|69754981|FG001|Second Intervention B/A|Lost to Follow-up|2|||
38062120|NCT03586427|69754992|FG000|Overall Study|Lost to Follow-up|0|||
38062121|NCT03586427|69754993|FG001|Overall Study|Lost to Follow-up|3|||
38062122|NCT03586427|69754994|FG002|Overall Study|Lost to Follow-up|1|||
38062123|NCT03586427|69754995|FG003|Overall Study|Lost to Follow-up|3|||
38062124|NCT03586427|69754996|FG004|Overall Study|Lost to Follow-up|3|||
38062125|NCT03586427|69754992|FG000|Overall Study|Withdrawal by Subject|0|||
38062126|NCT03586427|69754993|FG001|Overall Study|Withdrawal by Subject|1|||
38062127|NCT03586427|69754994|FG002|Overall Study|Withdrawal by Subject|2|||
38062128|NCT03586427|69754995|FG003|Overall Study|Withdrawal by Subject|1|||
38062129|NCT03586427|69754996|FG004|Overall Study|Withdrawal by Subject|1|||
38062130|NCT03586427|69754992|FG000|Overall Study|Adverse Event|0|||
38062131|NCT03586427|69754993|FG001|Overall Study|Adverse Event|0|||
38062132|NCT03586427|69754994|FG002|Overall Study|Adverse Event|1|||
38062133|NCT03586427|69754995|FG003|Overall Study|Adverse Event|0|||
38062134|NCT03586427|69754996|FG004|Overall Study|Adverse Event|0|||
38062135|NCT03586427|69754992|FG000|Overall Study|Protocol Violation|0|||
38062136|NCT03586427|69754993|FG001|Overall Study|Protocol Violation|0|||
38062137|NCT03586427|69754994|FG002|Overall Study|Protocol Violation|1|||
38062138|NCT03586427|69754995|FG003|Overall Study|Protocol Violation|0|||
38062139|NCT03586427|69754996|FG004|Overall Study|Protocol Violation|1|||
38062140|NCT03586427|69754992|FG000|Overall Study|Noncompliance with study drug|0|||
38062141|NCT03586427|69754993|FG001|Overall Study|Noncompliance with study drug|0|||
38062142|NCT03586427|69754994|FG002|Overall Study|Noncompliance with study drug|1|||
38062143|NCT03586427|69754995|FG003|Overall Study|Noncompliance with study drug|0|||
38062144|NCT03586427|69754996|FG004|Overall Study|Noncompliance with study drug|0|||
38062145|NCT03648983|69755013|FG000|Overall Study|Study was terminated due to PI departure|95|||
38062146|NCT02695420|69755022|FG000|Overall Study|Death|0|||
38062147|NCT02695420|69755023|FG001|Overall Study|Death|1|||
38062148|NCT02695420|69755024|FG002|Overall Study|Death|0|||
38062149|NCT02695420|69755025|FG003|Overall Study|Death|0|||
38062150|NCT03358147|69755043|FG000|Overall Study|Withdrawal by Subject|13|||
38062151|NCT03358147|69755044|FG001|Overall Study|Withdrawal by Subject|19|||
38062152|NCT03358147|69755045|FG002|Overall Study|Withdrawal by Subject|16|||
38062153|NCT03358147|69755046|FG003|Overall Study|Withdrawal by Subject|10|||
38062154|NCT03358147|69755047|FG004|Overall Study|Withdrawal by Subject|5|||
38062155|NCT03358147|69755043|FG000|Overall Study|Adverse Event|3|||
38062156|NCT03358147|69755044|FG001|Overall Study|Adverse Event|9|||
38062157|NCT03358147|69755045|FG002|Overall Study|Adverse Event|7|||
38062158|NCT03358147|69755046|FG003|Overall Study|Adverse Event|5|||
38062159|NCT03358147|69755047|FG004|Overall Study|Adverse Event|2|||
37680386|NCT02586805|69156000|FG003|Overall Study|Physician Decision|0|||
38062160|NCT03358147|69755043|FG000|Overall Study|Lost to Follow-up|4|||
38062161|NCT03358147|69755044|FG001|Overall Study|Lost to Follow-up|3|||
38062162|NCT03358147|69755045|FG002|Overall Study|Lost to Follow-up|7|||
38062163|NCT03358147|69755046|FG003|Overall Study|Lost to Follow-up|6|||
38062164|NCT03358147|69755047|FG004|Overall Study|Lost to Follow-up|4|||
38062165|NCT03358147|69755043|FG000|Overall Study|Major Protocol Deviation|11|||
38062166|NCT03358147|69755044|FG001|Overall Study|Major Protocol Deviation|3|||
38062167|NCT03358147|69755045|FG002|Overall Study|Major Protocol Deviation|2|||
38062168|NCT03358147|69755046|FG003|Overall Study|Major Protocol Deviation|3|||
38062169|NCT03358147|69755047|FG004|Overall Study|Major Protocol Deviation|1|||
38062170|NCT03358147|69755043|FG000|Overall Study|Protocol specified criteria|2|||
38062171|NCT03358147|69755044|FG001|Overall Study|Protocol specified criteria|3|||
38062172|NCT03358147|69755045|FG002|Overall Study|Protocol specified criteria|0|||
38062173|NCT03358147|69755046|FG003|Overall Study|Protocol specified criteria|3|||
38062174|NCT03358147|69755047|FG004|Overall Study|Protocol specified criteria|1|||
38062175|NCT03358147|69755043|FG000|Overall Study|Physician Decision|1|||
38062176|NCT03358147|69755044|FG001|Overall Study|Physician Decision|0|||
38062177|NCT03358147|69755045|FG002|Overall Study|Physician Decision|1|||
38062178|NCT03358147|69755046|FG003|Overall Study|Physician Decision|6|||
38062179|NCT03358147|69755047|FG004|Overall Study|Physician Decision|1|||
38062180|NCT03358147|69755043|FG000|Overall Study|Administrative reasons|0|||
38062181|NCT03358147|69755044|FG001|Overall Study|Administrative reasons|1|||
38062182|NCT03358147|69755045|FG002|Overall Study|Administrative reasons|0|||
38062183|NCT03358147|69755046|FG003|Overall Study|Administrative reasons|3|||
38062184|NCT03358147|69755047|FG004|Overall Study|Administrative reasons|0|||
38062185|NCT03358147|69755043|FG000|Overall Study|Lack of Efficacy|0|||
38062186|NCT03358147|69755044|FG001|Overall Study|Lack of Efficacy|1|||
38062187|NCT03358147|69755045|FG002|Overall Study|Lack of Efficacy|1|||
38062188|NCT03358147|69755046|FG003|Overall Study|Lack of Efficacy|0|||
38062189|NCT03358147|69755047|FG004|Overall Study|Lack of Efficacy|0|||
38062190|NCT03093402|69755063|FG000|Overall Study|Lost to Follow-up|1|||
38062191|NCT03093402|69755064|FG001|Overall Study|Lost to Follow-up|0|||
38062192|NCT03093402|69755065|FG002|Overall Study|Lost to Follow-up|0|||
38062193|NCT03093402|69755066|FG003|Overall Study|Lost to Follow-up|0|||
38062194|NCT03093402|69755063|FG000|Overall Study|Withdrawal by Subject|3|||
38062195|NCT03093402|69755064|FG001|Overall Study|Withdrawal by Subject|3|||
38062196|NCT03093402|69755065|FG002|Overall Study|Withdrawal by Subject|0|||
38062197|NCT03093402|69755066|FG003|Overall Study|Withdrawal by Subject|1|||
38062198|NCT03093402|69755063|FG000|Overall Study|Withdrew prior to dosing|2|||
38062199|NCT03093402|69755064|FG001|Overall Study|Withdrew prior to dosing|1|||
38062200|NCT03093402|69755065|FG002|Overall Study|Withdrew prior to dosing|2|||
38062201|NCT03093402|69755066|FG003|Overall Study|Withdrew prior to dosing|3|||
38062202|NCT03093402|69755063|FG000|Overall Study|Ineligible for study|1|||
38062203|NCT03093402|69755064|FG001|Overall Study|Ineligible for study|0|||
38062204|NCT03093402|69755065|FG002|Overall Study|Ineligible for study|0|||
38062205|NCT03093402|69755066|FG003|Overall Study|Ineligible for study|0|||
38062206|NCT03093402|69755063|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
38062207|NCT03093402|69755064|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
38062208|NCT03093402|69755065|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
38062209|NCT03093402|69755066|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
38062210|NCT03585959|69755076|FG000|Overall Study|Physician Decision|1|||
38062211|NCT03585959|69755076|FG000|Overall Study|Unsuccessful Procedure|2|||
38062212|NCT03584789|69755085|FG000|Overall Study|refused EHR permission|19|||
38062213|NCT03584789|69755086|FG001|Overall Study|refused EHR permission|28|||
38062214|NCT03584789|69755087|FG002|Overall Study|refused EHR permission|23|||
38062215|NCT03584789|69755085|FG000|Overall Study|patients tied to a provider who retired|0|||
38062216|NCT03584789|69755086|FG001|Overall Study|patients tied to a provider who retired|0|||
38062217|NCT03584789|69755087|FG002|Overall Study|patients tied to a provider who retired|3|||
38062218|NCT03343639|69755097|FG000|Overall Study|Withdrawal by Subject|10|||
38062219|NCT03343639|69755098|FG001|Overall Study|Withdrawal by Subject|6|||
38062220|NCT03343639|69755097|FG000|Overall Study|Lost to Follow-up|4|||
38062221|NCT03343639|69755098|FG001|Overall Study|Lost to Follow-up|5|||
38062222|NCT03343639|69755097|FG000|Overall Study|Protocol Violation|0|||
38062223|NCT03343639|69755098|FG001|Overall Study|Protocol Violation|1|||
38062224|NCT03647267|69755106|FG000|Overall Study|Lost to Follow-up|1|||
38062225|NCT03647267|69755107|FG001|Overall Study|Lost to Follow-up|0|||
38062226|NCT03356977|69755115|FG000|Overall Study|Lost to Follow-up|3|||
38062227|NCT03356977|69755115|FG000|Overall Study|Withdrawal by parent/guardian|2|||
38062228|NCT02690974|69755119|FG000|Overall Study|Adverse Event|16|||
38062229|NCT02690974|69755119|FG000|Overall Study|Death|9|||
38062230|NCT02690974|69755119|FG000|Overall Study|Subject/guardian decision|4|||
38062231|NCT02690974|69755119|FG000|Overall Study|Lost to Follow-up|3|||
38062232|NCT02690974|69755119|FG000|Overall Study|Withdrawal of Informed Consent|3|||
38062233|NCT02690974|69755119|FG000|Overall Study|Physician Decision|2|||
38062234|NCT02690974|69755119|FG000|Overall Study|Non-compliance with study treatment|1|||
38062235|NCT02690974|69755119|FG000|Overall Study|Protocol-defined stopping criteria|1|||
38062236|NCT02690974|69755119|FG000|Overall Study|Protocol Deviation|1|||
38062237|NCT03093324|69755125|FG000|Overall Study|Adverse Event|4|||
38062238|NCT03093324|69755126|FG001|Overall Study|Adverse Event|15|||
38062239|NCT03093324|69755125|FG000|Overall Study|Lost to Follow-up|1|||
38062240|NCT03093324|69755126|FG001|Overall Study|Lost to Follow-up|0|||
38062241|NCT03093324|69755125|FG000|Overall Study|Protocol Deviation|2|||
38062242|NCT03093324|69755126|FG001|Overall Study|Protocol Deviation|2|||
38062243|NCT03093324|69755125|FG000|Overall Study|Withdrawal by Subject|2|||
38062244|NCT03093324|69755126|FG001|Overall Study|Withdrawal by Subject|2|||
38062245|NCT03584009|69755134|FG000|Overall Study|Death|25|||
38062246|NCT03584009|69755135|FG001|Overall Study|Death|18|||
38062247|NCT03584009|69755134|FG000|Overall Study|Lost to Follow-up|0|||
38062248|NCT03584009|69755135|FG001|Overall Study|Lost to Follow-up|1|||
38062249|NCT03584009|69755134|FG000|Overall Study|Physician Decision|1|||
38062250|NCT03584009|69755135|FG001|Overall Study|Physician Decision|1|||
38062251|NCT03584009|69755134|FG000|Overall Study|Study Terminated by Sponsor|22|||
38062252|NCT03584009|69755135|FG001|Overall Study|Study Terminated by Sponsor|30|||
38062253|NCT03584009|69755134|FG000|Overall Study|Withdrawal by Subject|3|||
38062254|NCT03584009|69755135|FG001|Overall Study|Withdrawal by Subject|2|||
38062255|NCT04167462|69755146|FG000|Overall Study|Other reasons|3|||
38062256|NCT04167462|69755147|FG001|Overall Study|Other reasons|2|||
38062257|NCT04167462|69755146|FG000|Overall Study|Withdrawal by Subject|6|||
38062258|NCT04167462|69755147|FG001|Overall Study|Withdrawal by Subject|7|||
38062259|NCT04167462|69755146|FG000|Overall Study|Adverse Event|4|||
38062260|NCT04167462|69755147|FG001|Overall Study|Adverse Event|0|||
38062261|NCT04167462|69755146|FG000|Overall Study|Pregnancy|1|||
38062262|NCT04167462|69755147|FG001|Overall Study|Pregnancy|0|||
38062263|NCT04167462|69755146|FG000|Overall Study|Lack of Efficacy|0|||
38062264|NCT04167462|69755147|FG001|Overall Study|Lack of Efficacy|1|||
38062265|NCT03583385|69755154|FG000|Treatment Period 1|Withdrawal by Subject|1|||
38062266|NCT03583385|69755155|FG001|Treatment Period 1|Withdrawal by Subject|1|||
38062267|NCT03583385|69755154|FG000|Treatment Period 2|Adverse Event|1|||
38062268|NCT03583385|69755155|FG001|Treatment Period 2|Adverse Event|0|||
38062269|NCT04350372|69755161|FG000|Overall Study|Death|1|||
38062270|NCT02949973|69755165|FG000|Overall Study|Physician Decision|1|||
38062271|NCT02948959|69755171|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
38062272|NCT02948959|69755172|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
38062273|NCT02948959|69755171|FG000|52 Weeks Treatment Period|Adverse Event|2|||
38062274|NCT02948959|69755172|FG001|52 Weeks Treatment Period|Adverse Event|5|||
38062275|NCT02948959|69755171|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
38062276|NCT02948959|69755172|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
38062277|NCT02948959|69755171|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
38062278|NCT02948959|69755172|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
38062279|NCT02948959|69755171|FG000|52 Weeks Treatment Period|Randomized by error|0|||
38062280|NCT02948959|69755172|FG001|52 Weeks Treatment Period|Randomized by error|5|||
38062281|NCT02948959|69755171|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
38062282|NCT02948959|69755172|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
38062283|NCT02948959|69755171|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
38062284|NCT02948959|69755172|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
38062285|NCT02948959|69755171|FG000|52 Weeks Treatment Period|Change of residence location|0|||
38062286|NCT02948959|69755172|FG001|52 Weeks Treatment Period|Change of residence location|1|||
38062287|NCT02948959|69755171|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
38062288|NCT02948959|69755172|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
38062289|NCT02948959|69755171|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
38062290|NCT02948959|69755172|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
38062291|NCT02948959|69755171|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
38062292|NCT02948959|69755172|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
38062293|NCT02948959|69755171|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
38062294|NCT02948959|69755172|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
38062295|NCT02948959|69755171|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
38062296|NCT02948959|69755172|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
38062297|NCT02948959|69755171|FG000|12 Weeks Follow-up Period|Study site closure|1|||
38062298|NCT02948959|69755172|FG001|12 Weeks Follow-up Period|Study site closure|0|||
38062299|NCT03582215|69755194|FG000|Overall Study|Adverse Event|1|||
38062300|NCT03582215|69755195|FG001|Overall Study|Adverse Event|0|||
38062301|NCT03582215|69755196|FG002|Overall Study|Adverse Event|0|||
38062302|NCT03582215|69755197|FG003|Overall Study|Adverse Event|0|||
38062303|NCT03582215|69755198|FG004|Overall Study|Adverse Event|0|||
38062304|NCT03582215|69755199|FG005|Overall Study|Adverse Event|0|||
38062305|NCT03582215|69755200|FG006|Overall Study|Adverse Event|2|||
38062306|NCT03582215|69755201|FG007|Overall Study|Adverse Event|2|||
38062307|NCT03089580|69755230|FG000|Overall Study|Lost to Follow-up|2|||
38062308|NCT03645395|69755240|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
38062309|NCT03645395|69755241|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
38062310|NCT03645395|69755242|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
38062311|NCT03645395|69755243|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
38062312|NCT03645395|69755240|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
38062313|NCT03645395|69755241|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
38062314|NCT03645395|69755242|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
38062315|NCT03645395|69755243|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
38062316|NCT03645395|69755240|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
38062317|NCT03645395|69755241|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
38062318|NCT03645395|69755242|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
38062319|NCT03645395|69755243|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
38062320|NCT03645395|69755240|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
38062321|NCT03645395|69755241|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
38062322|NCT03645395|69755242|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
38062323|NCT03645395|69755243|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
38062324|NCT03342469|69755256|FG000|Overall Study|Withdrawal by Subject|0|||
38062325|NCT03342469|69755257|FG001|Overall Study|Withdrawal by Subject|1|||
38062326|NCT03342469|69755258|FG002|Overall Study|Withdrawal by Subject|0|||
38062327|NCT03342469|69755259|FG003|Overall Study|Withdrawal by Subject|0|||
38062328|NCT03581825|69755270|FG000|Period 1|Lens Discomfort|1|||
38062329|NCT03581825|69755271|FG001|Period 1|Lens Discomfort|0|||
38062330|NCT03581825|69755270|FG000|Period 2|Unsatisfactory Vision to Test|0|||
38062331|NCT03581825|69755271|FG001|Period 2|Unsatisfactory Vision to Test|1|||
38062332|NCT03342001|69755277|FG000|Overall Study|Adverse Event|1|||
38062333|NCT03342001|69755277|FG000|Overall Study|Lost to Follow-up|1|||
38062334|NCT03341923|69755281|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
38062335|NCT03341923|69755282|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
38062336|NCT03579719|69755290|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
38062337|NCT03341533|69755296|FG000|Overall Study|Withdrawal by Subject|1|||
38062338|NCT03341533|69755297|FG001|Overall Study|Withdrawal by Subject|1|||
38062339|NCT03341533|69755296|FG000|Overall Study|Not eligible after randomization|2|||
38062340|NCT03341533|69755297|FG001|Overall Study|Not eligible after randomization|1|||
38062341|NCT02688088|69755303|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
38062342|NCT02688088|69755304|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
38062343|NCT02688088|69755305|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
38062344|NCT02688088|69755306|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
38062345|NCT02688088|69755307|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
38062346|NCT02688088|69755303|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
38062347|NCT02688088|69755304|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
38062348|NCT02688088|69755305|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
38062349|NCT02688088|69755306|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
38062350|NCT02688088|69755307|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
38062351|NCT02688088|69755303|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
38062352|NCT02688088|69755304|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
38062353|NCT02688088|69755305|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
38062354|NCT02688088|69755306|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
38062355|NCT02688088|69755307|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
38062356|NCT02688088|69755303|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
38062357|NCT02688088|69755304|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
38062358|NCT02688088|69755305|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
38062359|NCT02688088|69755306|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
38062360|NCT02688088|69755307|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
38062361|NCT02688088|69755303|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
38062362|NCT02688088|69755304|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
38062363|NCT02688088|69755305|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
38062364|NCT02688088|69755306|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
38062365|NCT02688088|69755307|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
38062366|NCT02688088|69755303|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
38062367|NCT02688088|69755304|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
38062368|NCT02688088|69755305|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
38062369|NCT02688088|69755306|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
38062370|NCT02688088|69755307|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
38062371|NCT02688088|69755303|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
38062372|NCT02688088|69755304|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
38062373|NCT02688088|69755305|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
38062374|NCT02688088|69755306|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
38062375|NCT02688088|69755307|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
38062376|NCT02688088|69755303|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
38062377|NCT02688088|69755304|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
38062378|NCT02688088|69755305|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
38062379|NCT02688088|69755306|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
38062380|NCT02688088|69755307|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
38062381|NCT02688088|69755303|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
38062382|NCT02688088|69755304|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
38062383|NCT02688088|69755305|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
38062384|NCT02688088|69755306|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
38062385|NCT02688088|69755307|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
38062386|NCT03641651|69755332|FG000|Overall Study|organizational issues at one study site|1|||
38062387|NCT03341299|69755336|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
38062388|NCT03341299|69755337|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
38062389|NCT03341299|69755338|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
38062390|NCT03341299|69755339|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
38062391|NCT02949271|69755353|FG000|Overall Study|Lack of Efficacy|5|||
38062392|NCT02949271|69755354|FG001|Overall Study|Lack of Efficacy|4|||
38062393|NCT02949271|69755353|FG000|Overall Study|Lost to Follow-up|3|||
38062394|NCT02949271|69755354|FG001|Overall Study|Lost to Follow-up|6|||
38062395|NCT02949271|69755353|FG000|Overall Study|Physician Decision|5|||
38062396|NCT02949271|69755354|FG001|Overall Study|Physician Decision|5|||
38062397|NCT02949271|69755353|FG000|Overall Study|Protocol Violation|6|||
38062398|NCT02949271|69755354|FG001|Overall Study|Protocol Violation|3|||
38062399|NCT02949271|69755353|FG000|Overall Study|Withdrawal by Subject|1|||
38062400|NCT02949271|69755354|FG001|Overall Study|Withdrawal by Subject|0|||
38062401|NCT02949271|69755353|FG000|Overall Study|Delivered prior to intervention|7|||
38062402|NCT02949271|69755354|FG001|Overall Study|Delivered prior to intervention|9|||
38062403|NCT02949271|69755353|FG000|Overall Study|Outside the window for cervical dilation|2|||
38062404|NCT02949271|69755354|FG001|Overall Study|Outside the window for cervical dilation|3|||
38062405|NCT03640559|69755362|FG000|Overall Study|Physician Decision|1|||
38062406|NCT03640559|69755363|FG001|Overall Study|Physician Decision|1|||
38062407|NCT03640559|69755362|FG000|Overall Study|Withdrawal by Subject|1|||
38062408|NCT03640559|69755363|FG001|Overall Study|Withdrawal by Subject|0|||
38062409|NCT03339583|69755371|FG000|First Intervention (14 Days)|Adverse Event|1|||
38062410|NCT03339583|69755372|FG001|First Intervention (14 Days)|Adverse Event|0|||
38062411|NCT03339583|69755371|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
38062412|NCT03339583|69755372|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
38062413|NCT03339583|69755371|FG000|Second Intervention (14 Days)|Adverse Event|0|||
38062414|NCT03339583|69755372|FG001|Second Intervention (14 Days)|Adverse Event|1|||
38062415|NCT03339583|69755371|FG000|Follow-up (14 Days)|Physician Decision|6|||
38062416|NCT03339583|69755372|FG001|Follow-up (14 Days)|Physician Decision|3|||
38062417|NCT03639779|69755380|FG000|Overall Study|Lost to Follow-up|1|||
38062418|NCT03575975|69755389|FG000|Overall Study|Lost to Follow-up|1|||
38062419|NCT03575975|69755390|FG001|Overall Study|Lost to Follow-up|0|||
38062420|NCT03575975|69755391|FG002|Overall Study|Lost to Follow-up|0|||
38062421|NCT03636893|69755399|FG000|Overall Study|Death|0|||
38062422|NCT03636893|69755400|FG001|Overall Study|Death|1|||
38062423|NCT03636893|69755399|FG000|Overall Study|Protocol Violation|0|||
38062424|NCT03636893|69755400|FG001|Overall Study|Protocol Violation|3|||
38062425|NCT03636893|69755399|FG000|Overall Study|Withdrawal by Subject|1|||
38062426|NCT03636893|69755400|FG001|Overall Study|Withdrawal by Subject|2|||
38062427|NCT03636893|69755399|FG000|Overall Study|Refusal to surgery|4|||
38062428|NCT03636893|69755400|FG001|Overall Study|Refusal to surgery|3|||
38062429|NCT03636893|69755399|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
38062430|NCT03636893|69755400|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
38062431|NCT03636893|69755399|FG000|Overall Study|Adverse Event|1|||
38062432|NCT03636893|69755400|FG001|Overall Study|Adverse Event|1|||
38062433|NCT01353586|69755408|FG000|Overall Study|Procedure terminated prior to ablation|3|||
38062434|NCT01353586|69755409|FG001|Overall Study|Procedure terminated prior to ablation|0|||
38062435|NCT01353586|69755408|FG000|Overall Study|Never had insertion of study catheter|4|||
38062436|NCT01353586|69755409|FG001|Overall Study|Never had insertion of study catheter|1|||
38062437|NCT01353586|69755408|FG000|Overall Study|Neurological exam not done|0|||
38062438|NCT01353586|69755409|FG001|Overall Study|Neurological exam not done|1|||
38062439|NCT03091920|69755421|FG000|Overall Study|Adverse Event|0|||
38062440|NCT03091920|69755422|FG001|Overall Study|Adverse Event|1|||
38062441|NCT03091920|69755423|FG002|Overall Study|Adverse Event|0|||
38062442|NCT03338569|69755439|FG000|Overall Study|Physician Decision|8|||
38062443|NCT03338569|69755440|FG001|Overall Study|Physician Decision|3|||
38062444|NCT03338569|69755439|FG000|Overall Study|Withdrawal by Subject|0|||
38062445|NCT03338569|69755440|FG001|Overall Study|Withdrawal by Subject|1|||
38062446|NCT03338569|69755439|FG000|Overall Study|Lost to Follow-up|0|||
38062447|NCT03338569|69755440|FG001|Overall Study|Lost to Follow-up|1|||
38062448|NCT03338023|69755448|FG000|Overall Study|Withdrawal by Subject|3|||
38062449|NCT03338023|69755449|FG001|Overall Study|Withdrawal by Subject|4|||
38062450|NCT03338023|69755448|FG000|Overall Study|Protocol Violation|3|||
38062451|NCT03338023|69755449|FG001|Overall Study|Protocol Violation|3|||
38062452|NCT03338023|69755448|FG000|Overall Study|Lost to Follow-up|2|||
38062453|NCT03338023|69755449|FG001|Overall Study|Lost to Follow-up|1|||
38062454|NCT03338023|69755448|FG000|Overall Study|Physician Decision|1|||
38062455|NCT03338023|69755449|FG001|Overall Study|Physician Decision|2|||
38062456|NCT03337477|69755457|FG000|Overall Study|not categorized into the listed ones|11|||
38062457|NCT03337477|69755458|FG001|Overall Study|not categorized into the listed ones|9|||
38062458|NCT03337477|69755457|FG000|Overall Study|Withdrawal by Subject|0|||
38062459|NCT03337477|69755458|FG001|Overall Study|Withdrawal by Subject|1|||
38062460|NCT03337477|69755457|FG000|Overall Study|Death|0|||
38062461|NCT03337477|69755458|FG001|Overall Study|Death|1|||
38062462|NCT03337477|69755457|FG000|Overall Study|Lost to Follow-up|0|||
38062463|NCT03337477|69755458|FG001|Overall Study|Lost to Follow-up|2|||
38062464|NCT02687542|69755471|FG000|Overall Study|Medication error without associated AEs|0|||
38062465|NCT02687542|69755472|FG001|Overall Study|Medication error without associated AEs|0|||
38062466|NCT02687542|69755473|FG002|Overall Study|Medication error without associated AEs|0|||
38062467|NCT02687542|69755474|FG003|Overall Study|Medication error without associated AEs|0|||
38062468|NCT02687542|69755475|FG004|Overall Study|Medication error without associated AEs|1|||
38062469|NCT02687542|69755471|FG000|Overall Study|Lost to Follow-up|0|||
38062470|NCT02687542|69755472|FG001|Overall Study|Lost to Follow-up|0|||
38062471|NCT02687542|69755473|FG002|Overall Study|Lost to Follow-up|0|||
38062472|NCT02687542|69755474|FG003|Overall Study|Lost to Follow-up|0|||
38062473|NCT02687542|69755475|FG004|Overall Study|Lost to Follow-up|1|||
38062474|NCT02687542|69755471|FG000|Overall Study|Protocol Violation|0|||
38062475|NCT02687542|69755472|FG001|Overall Study|Protocol Violation|1|||
38062476|NCT02687542|69755473|FG002|Overall Study|Protocol Violation|0|||
38062477|NCT02687542|69755474|FG003|Overall Study|Protocol Violation|0|||
38062478|NCT02687542|69755475|FG004|Overall Study|Protocol Violation|0|||
38062479|NCT02687542|69755471|FG000|Overall Study|Other|5|||
38062480|NCT02687542|69755472|FG001|Overall Study|Other|9|||
38062481|NCT02687542|69755473|FG002|Overall Study|Other|10|||
38062482|NCT02687542|69755474|FG003|Overall Study|Other|6|||
38062483|NCT02687542|69755475|FG004|Overall Study|Other|5|||
38062484|NCT02687542|69755471|FG000|Overall Study|Adverse Event|3|||
38062485|NCT02687542|69755472|FG001|Overall Study|Adverse Event|1|||
38062486|NCT02687542|69755473|FG002|Overall Study|Adverse Event|3|||
38062487|NCT02687542|69755474|FG003|Overall Study|Adverse Event|2|||
38062488|NCT02687542|69755475|FG004|Overall Study|Adverse Event|9|||
38062489|NCT02687542|69755471|FG000|Overall Study|Withdrawal by Subject|0|||
38062490|NCT02687542|69755472|FG001|Overall Study|Withdrawal by Subject|1|||
38062491|NCT02687542|69755473|FG002|Overall Study|Withdrawal by Subject|1|||
38062492|NCT02687542|69755474|FG003|Overall Study|Withdrawal by Subject|2|||
38062493|NCT02687542|69755475|FG004|Overall Study|Withdrawal by Subject|4|||
38062494|NCT03336619|69755489|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
38062495|NCT03336619|69755490|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
38062496|NCT03336619|69755489|FG000|Overall Study|Withdrawal by Subject|17|||
38062497|NCT03336619|69755490|FG001|Overall Study|Withdrawal by Subject|16|||
38062498|NCT03336619|69755489|FG000|Overall Study|Adverse Event|2|||
38062499|NCT03336619|69755490|FG001|Overall Study|Adverse Event|5|||
38062500|NCT03336619|69755489|FG000|Overall Study|Physician Decision|3|||
38062501|NCT03336619|69755490|FG001|Overall Study|Physician Decision|0|||
38062502|NCT01353508|69755512|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
38062503|NCT01353508|69755513|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
38062504|NCT01353508|69755514|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
38062505|NCT01353508|69755515|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
38062506|NCT01353508|69755512|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
38062507|NCT01353508|69755513|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
38062508|NCT01353508|69755514|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
38062509|NCT01353508|69755515|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
38062510|NCT03636269|69755527|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
38062511|NCT03636269|69755528|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
38062512|NCT03636269|69755529|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
38062513|NCT03636269|69755527|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
38062514|NCT03636269|69755528|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
38062515|NCT03636269|69755529|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
38062516|NCT03636269|69755527|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
38062517|NCT03636269|69755528|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
38062518|NCT03636269|69755529|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
38062519|NCT03636269|69755527|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
38062520|NCT03636269|69755528|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
38062521|NCT03636269|69755529|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
38062522|NCT03636269|69755527|FG000|Period 1: Double-blind Phase|Other|6|||
38062523|NCT03636269|69755528|FG001|Period 1: Double-blind Phase|Other|3|||
38062524|NCT03636269|69755529|FG002|Period 1: Double-blind Phase|Other|0|||
38062525|NCT03636269|69755527|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
38062526|NCT03636269|69755528|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
37862257|NCT00919633|69546036|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
38062527|NCT03636269|69755529|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
38062528|NCT03636269|69755527|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
38062529|NCT03636269|69755528|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
38062530|NCT03636269|69755529|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
38062531|NCT03636269|69755527|FG000|Period 2: Open-label Phase|Adverse Event|0|||
38062532|NCT03636269|69755528|FG001|Period 2: Open-label Phase|Adverse Event|0|||
38062533|NCT03636269|69755529|FG002|Period 2: Open-label Phase|Adverse Event|21|||
38062534|NCT03636269|69755527|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
38062535|NCT03636269|69755528|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
38062536|NCT03636269|69755529|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
38062537|NCT03636269|69755527|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
38062538|NCT03636269|69755528|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
38062539|NCT03636269|69755529|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
38062540|NCT03636269|69755527|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
38062541|NCT03636269|69755528|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
38062542|NCT03636269|69755529|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
38062543|NCT03636269|69755527|FG000|Period 2: Open-label Phase|Administrative|0|||
38062544|NCT03636269|69755528|FG001|Period 2: Open-label Phase|Administrative|0|||
38062545|NCT03636269|69755529|FG002|Period 2: Open-label Phase|Administrative|36|||
38062546|NCT03636269|69755527|FG000|Period 2: Open-label Phase|Other|0|||
38062547|NCT03636269|69755528|FG001|Period 2: Open-label Phase|Other|0|||
38062548|NCT03636269|69755529|FG002|Period 2: Open-label Phase|Other|9|||
38062549|NCT03636269|69755527|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
38062550|NCT03636269|69755528|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
38062551|NCT03636269|69755529|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
38062552|NCT02685202|69755538|FG000|Overall Study|Lost to Follow-up|9|||
38062553|NCT03087786|69755544|FG000|Overall Study|Withdrawal by Subject|2|||
38062554|NCT03087786|69755545|FG001|Overall Study|Withdrawal by Subject|0|||
38062555|NCT03635957|69755551|FG000|Run-In Period|Lost to Follow-up|1|||
38062556|NCT03635957|69755551|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
38062557|NCT01353274|69755556|FG000|Overall Study|No case report form (CRF) collected|28|||
38062558|NCT02690194|69755563|FG000|Overall Study|Withdrawal by Subject|1|||
38062559|NCT02690194|69755564|FG001|Overall Study|Withdrawal by Subject|4|||
38062560|NCT02690194|69755565|FG002|Overall Study|Withdrawal by Subject|0|||
38062561|NCT02684344|69755575|FG000|Overall Study|Withdrawal by Subject|0|||
38062562|NCT02684344|69755576|FG001|Overall Study|Withdrawal by Subject|1|||
38062563|NCT02683876|69755584|FG000|Overall Study|samples damaged during shipping|2|||
38062564|NCT02683876|69755585|FG001|Overall Study|samples damaged during shipping|0|||
38062565|NCT03974100|69755595|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
38062566|NCT03974100|69755596|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
38062567|NCT03974100|69755597|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
38062568|NCT03974100|69755598|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
38062569|NCT03974100|69755599|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
38062570|NCT03974100|69755595|FG000|TP1 - Day 1 to Week 52|Death|1|||
38062571|NCT03974100|69755596|FG001|TP1 - Day 1 to Week 52|Death|0|||
38062572|NCT03974100|69755597|FG002|TP1 - Day 1 to Week 52|Death|0|||
38062573|NCT03974100|69755598|FG003|TP1 - Day 1 to Week 52|Death|0|||
38062574|NCT03974100|69755599|FG004|TP1 - Day 1 to Week 52|Death|0|||
38062575|NCT03974100|69755595|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
38062576|NCT03974100|69755596|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
38062577|NCT03974100|69755597|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
38062578|NCT03974100|69755598|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
38062579|NCT03974100|69755599|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
38062580|NCT03974100|69755595|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
38062581|NCT03974100|69755596|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
38062582|NCT03974100|69755597|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
38062583|NCT03974100|69755598|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
38062584|NCT03974100|69755599|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
38062585|NCT03974100|69755595|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
38062586|NCT03974100|69755596|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
38062587|NCT03974100|69755597|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
38062588|NCT03974100|69755598|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
38062589|NCT03974100|69755599|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
38062590|NCT03974100|69755595|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
38062591|NCT03974100|69755596|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
38062592|NCT03974100|69755597|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
38062593|NCT03974100|69755598|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
38062594|NCT03974100|69755599|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
38062595|NCT03974100|69755595|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
38062596|NCT03974100|69755596|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
38062597|NCT03974100|69755597|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
38062598|NCT03974100|69755598|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
38062599|NCT03974100|69755599|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
38062600|NCT02689804|69755613|FG000|Overall Study|Withdrawal by Subject|2|||
38062601|NCT02689804|69755614|FG001|Overall Study|Withdrawal by Subject|0|||
38062602|NCT02946931|69755623|FG000|Overall Study|Did not require collection of CRFs|588|||
38062603|NCT02946931|69755623|FG000|Overall Study|Other than listed|37|||
38062604|NCT02946931|69755623|FG000|Overall Study|Discharge from hospital|118|||
38062605|NCT02946931|69755623|FG000|Overall Study|Adverse Event|81|||
38062606|NCT02946931|69755623|FG000|Overall Study|CRFs not valid|1|||
38062607|NCT02946931|69755623|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
38062608|NCT02689492|69755627|FG000|Overall Study|Lost to Follow-up|61|||
38062609|NCT02689492|69755627|FG000|Overall Study|Withdrawal by Subject|11|||
38062610|NCT02689492|69755627|FG000|Overall Study|Death|9|||
38062611|NCT02689492|69755627|FG000|Overall Study|Physician Decision|2|||
38062612|NCT02689492|69755627|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
38062613|NCT02689492|69755627|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
38062614|NCT02689492|69755627|FG000|Overall Study|Other than listed|1|||
38062615|NCT01374568|69755645|FG000|Overall Study|Lab unable to analyze BTM|0|||
38062616|NCT01374568|69755646|FG001|Overall Study|Lab unable to analyze BTM|2|||
38062617|NCT02682784|69755656|FG000|Overall Study|Withdrawal by Subject|0|||
38062618|NCT02682784|69755657|FG001|Overall Study|Withdrawal by Subject|2|||
38062619|NCT02682784|69755658|FG002|Overall Study|Withdrawal by Subject|1|||
38062620|NCT02682784|69755659|FG003|Overall Study|Withdrawal by Subject|2|||
38062621|NCT02682784|69755656|FG000|Overall Study|Physician Decision|1|||
38062622|NCT02682784|69755657|FG001|Overall Study|Physician Decision|0|||
38062623|NCT02682784|69755658|FG002|Overall Study|Physician Decision|1|||
38062624|NCT02682784|69755659|FG003|Overall Study|Physician Decision|1|||
38062625|NCT03387852|69755673|FG000|Overall Study|Adverse event (AE)|3|||
38062626|NCT03387852|69755674|FG001|Overall Study|Adverse event (AE)|0|||
38062627|NCT03387852|69755675|FG002|Overall Study|Adverse event (AE)|2|||
38062628|NCT03387852|69755676|FG003|Overall Study|Adverse event (AE)|0|||
38062629|NCT03387852|69755673|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
38062630|NCT03387852|69755674|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
38062631|NCT03387852|69755675|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
38062632|NCT03387852|69755676|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
38062633|NCT03387852|69755673|FG000|Overall Study|Withdrawal by participant|1|||
38062634|NCT03387852|69755674|FG001|Overall Study|Withdrawal by participant|1|||
38062635|NCT03387852|69755675|FG002|Overall Study|Withdrawal by participant|3|||
38062636|NCT03387852|69755676|FG003|Overall Study|Withdrawal by participant|2|||
38062637|NCT03387852|69755673|FG000|Overall Study|Other- Unspecified|1|||
38062638|NCT03387852|69755674|FG001|Overall Study|Other- Unspecified|1|||
38062639|NCT03387852|69755675|FG002|Overall Study|Other- Unspecified|2|||
38062640|NCT03387852|69755676|FG003|Overall Study|Other- Unspecified|1|||
38062641|NCT03387852|69755673|FG000|Overall Study|Poor compliance to protocol|0|||
38062642|NCT03387852|69755674|FG001|Overall Study|Poor compliance to protocol|0|||
38062643|NCT03387852|69755675|FG002|Overall Study|Poor compliance to protocol|0|||
38062644|NCT03387852|69755676|FG003|Overall Study|Poor compliance to protocol|1|||
38062645|NCT03387852|69755673|FG000|Overall Study|Randomized and not treated|0|||
38062646|NCT03387852|69755674|FG001|Overall Study|Randomized and not treated|0|||
38062647|NCT03387852|69755675|FG002|Overall Study|Randomized and not treated|0|||
38062648|NCT03387852|69755676|FG003|Overall Study|Randomized and not treated|1|||
38062649|NCT02679274|69755689|FG000|Overall Study|Withdrawal by Subject|1|||
38062650|NCT02679274|69755690|FG001|Overall Study|Withdrawal by Subject|0|||
38062651|NCT04969861|69755698|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
38062652|NCT04969861|69755699|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
38062653|NCT02678416|69755707|FG000|Part 1|Withdrawal by Subject|1|||
38062654|NCT02678416|69755707|FG000|Part 2|Adverse Event|2|||
38062655|NCT02678416|69755707|FG000|Part 2|Withdrawal by Subject|1|||
38062656|NCT02680834|69755727|FG000|Overall Study|Physician Decision|5|||
38062657|NCT02680834|69755728|FG001|Overall Study|Physician Decision|2|||
38062658|NCT02680834|69755727|FG000|Overall Study|Withdrawal by Subject|6|||
38062659|NCT02680834|69755728|FG001|Overall Study|Withdrawal by Subject|0|||
38062660|NCT02680834|69755727|FG000|Overall Study|Lost to Follow-up|0|||
38062661|NCT02680834|69755728|FG001|Overall Study|Lost to Follow-up|1|||
38062662|NCT03343704|69755736|FG000|Overall Study|Refused to complete follow up|0|||
38062663|NCT03343704|69755737|FG001|Overall Study|Refused to complete follow up|1|||
38062664|NCT03343704|69755736|FG000|Overall Study|Death|0|||
38062665|NCT03343704|69755737|FG001|Overall Study|Death|1|||
38062666|NCT03343704|69755736|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
38062667|NCT03343704|69755737|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
38062668|NCT02680756|69755747|FG000|Overall Study|Adverse Event|10|||
38062669|NCT02680756|69755748|FG001|Overall Study|Adverse Event|2|||
38062670|NCT02680756|69755747|FG000|Overall Study|Lost to Follow-up|7|||
38062671|NCT02680756|69755748|FG001|Overall Study|Lost to Follow-up|6|||
38062672|NCT02680756|69755747|FG000|Overall Study|Withdrawal by Subject|5|||
38062673|NCT02680756|69755748|FG001|Overall Study|Withdrawal by Subject|5|||
38062674|NCT02680756|69755747|FG000|Overall Study|Physician Decision|4|||
38062675|NCT02680756|69755748|FG001|Overall Study|Physician Decision|1|||
38062676|NCT02680756|69755747|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
38062677|NCT02680756|69755748|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
38062678|NCT02680756|69755747|FG000|Overall Study|Blood transfusion for any reason|0|||
38062679|NCT02680756|69755748|FG001|Overall Study|Blood transfusion for any reason|1|||
38062680|NCT02680756|69755747|FG000|Overall Study|Death|1|||
38062681|NCT02680756|69755748|FG001|Overall Study|Death|0|||
38062682|NCT02680756|69755747|FG000|Overall Study|Protocol Violation|1|||
38062683|NCT02680756|69755748|FG001|Overall Study|Protocol Violation|0|||
38062684|NCT02680756|69755747|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
38062685|NCT02680756|69755748|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
38062686|NCT02680756|69755747|FG000|Overall Study|None of above or not recorded|3|||
38062687|NCT02680756|69755748|FG001|Overall Study|None of above or not recorded|2|||
38062688|NCT03086460|69755754|FG000|Study Participants|Lost to Follow-up|2|||
38062689|NCT03086460|69755754|FG000|Study Participants|Protocol Violation|1|||
38062690|NCT03086460|69755754|FG000|Study Participants|Withdrawal by Subject|6|||
38062691|NCT03086460|69755754|FG000|Treatment A|Lost to Follow-up|1|||
38062692|NCT03086460|69755754|FG000|Treatment A|Protocol Violation|1|||
38062693|NCT03086460|69755754|FG000|Treatment A|Withdrawal by Subject|2|||
38062694|NCT03086460|69755754|FG000|Treatment C|Withdrawal by Subject|2|||
38062695|NCT03086460|69755754|FG000|Treatment E|Lost to Follow-up|1|||
38062696|NCT03086460|69755754|FG000|Treatment E|Withdrawal by Subject|3|||
38062697|NCT02677714|69755780|FG000|Overall Study|Withdrawal by Subject|2|||
38062698|NCT02677714|69755781|FG001|Overall Study|Withdrawal by Subject|0|||
38062699|NCT02677324|69755787|FG000|Overall Study|Disease Progression|6|||
38062700|NCT02677324|69755787|FG000|Overall Study|Inability to Swallow pills|1|||
38062701|NCT02677324|69755787|FG000|Overall Study|Non-compliance|1|||
38062702|NCT02677324|69755787|FG000|Overall Study|Lack of Efficacy|1|||
38062703|NCT02677324|69755787|FG000|Overall Study|Medical insurance coverage|1|||
38062704|NCT02677324|69755787|FG000|Overall Study|Adverse Event|1|||
38062705|NCT02677324|69755787|FG000|Overall Study|IgM Myeloma diagnosis|1|||
38062706|NCT01971008|69755795|FG000|Overall Study|Protocol Violation|2|||
38062707|NCT01971008|69755796|FG001|Overall Study|Protocol Violation|1|||
38062708|NCT01374178|69755805|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
38062709|NCT01374178|69755806|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
38062710|NCT01374178|69755805|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
38062711|NCT01374178|69755806|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
38062712|NCT03025542|69755814|FG000|Overall Study|Adverse Event|0|||
38062713|NCT03025542|69755815|FG001|Overall Study|Adverse Event|2|||
38062714|NCT03025542|69755814|FG000|Overall Study|Lost to Follow-up|1|||
38062715|NCT03025542|69755815|FG001|Overall Study|Lost to Follow-up|0|||
38062716|NCT03025542|69755814|FG000|Overall Study|Withdrawal by Subject|1|||
38062717|NCT03025542|69755815|FG001|Overall Study|Withdrawal by Subject|0|||
38062718|NCT03022370|69755829|FG000|Overall Study|Death|6|||
38062719|NCT03022370|69755830|FG001|Overall Study|Death|12|||
38062720|NCT03022370|69755829|FG000|Overall Study|Lost to Follow-up|174|||
38062721|NCT03022370|69755830|FG001|Overall Study|Lost to Follow-up|109|||
38062722|NCT03021668|69755842|FG000|Overall Study|Physician Decision|0|||
38062723|NCT03021668|69755843|FG001|Overall Study|Physician Decision|1|||
38062724|NCT03020888|69755849|FG000|Overall Study|Physician Decision|4|||
38062725|NCT03020888|69755849|FG000|Overall Study|Withdrawal by Subject|6|||
38062726|NCT03020888|69755849|FG000|Overall Study|Insurance coverage|2|||
38062727|NCT03020888|69755849|FG000|Overall Study|Lost to Follow-up|1|||
38062728|NCT02250300|69755857|FG000|Expansion Phase|Death|6|||
38062729|NCT02250300|69755858|FG001|Expansion Phase|Death|7|||
38062730|NCT02250300|69755859|FG002|Expansion Phase|Death|0|||
38062731|NCT02250300|69755860|FG003|Expansion Phase|Death|0|||
38062732|NCT03020966|69755873|FG000|Overall Study|Withdrawal by Subject|2|||
38062733|NCT03020966|69755874|FG001|Overall Study|Withdrawal by Subject|0|||
38062734|NCT03020576|69755882|FG000|Overall Study|Withdrawal by Subject|1|||
38062735|NCT03020576|69755883|FG001|Overall Study|Withdrawal by Subject|2|||
38062736|NCT03017612|69755889|FG000|Overall Study|Adverse Event|2|||
38062737|NCT03635099|69755901|FG000|Period 1|Adverse Event|1|||
38062738|NCT03635099|69755902|FG001|Period 1|Adverse Event|0|||
38062739|NCT03635099|69755903|FG002|Period 1|Adverse Event|0|||
38062740|NCT03635099|69755904|FG003|Period 1|Adverse Event|1|||
38062741|NCT03635099|69755905|FG004|Period 1|Adverse Event|0|||
38062742|NCT03635099|69755906|FG005|Period 1|Adverse Event|0|||
38062743|NCT03635099|69755907|FG006|Period 1|Adverse Event|0|||
38062744|NCT03635099|69755908|FG007|Period 1|Adverse Event|0|||
38062745|NCT03635099|69755901|FG000|Period 1|Protocol Violation|0|||
38062746|NCT03635099|69755902|FG001|Period 1|Protocol Violation|0|||
38062747|NCT03635099|69755903|FG002|Period 1|Protocol Violation|1|||
38062748|NCT03635099|69755904|FG003|Period 1|Protocol Violation|0|||
38062749|NCT03635099|69755905|FG004|Period 1|Protocol Violation|0|||
38062750|NCT03635099|69755906|FG005|Period 1|Protocol Violation|0|||
38062751|NCT03635099|69755907|FG006|Period 1|Protocol Violation|0|||
38062752|NCT03635099|69755908|FG007|Period 1|Protocol Violation|0|||
38062753|NCT03635099|69755901|FG000|Period 1|Lost to Follow-up|0|||
38062754|NCT03635099|69755902|FG001|Period 1|Lost to Follow-up|0|||
38062755|NCT03635099|69755903|FG002|Period 1|Lost to Follow-up|1|||
38062756|NCT03635099|69755904|FG003|Period 1|Lost to Follow-up|2|||
38062757|NCT03635099|69755905|FG004|Period 1|Lost to Follow-up|1|||
38062758|NCT03635099|69755906|FG005|Period 1|Lost to Follow-up|0|||
38062759|NCT03635099|69755907|FG006|Period 1|Lost to Follow-up|1|||
38062760|NCT03635099|69755908|FG007|Period 1|Lost to Follow-up|2|||
38062761|NCT03635099|69755901|FG000|Period 1|Withdrawal by Subject|3|||
38062762|NCT03635099|69755902|FG001|Period 1|Withdrawal by Subject|3|||
38062763|NCT03635099|69755903|FG002|Period 1|Withdrawal by Subject|5|||
38062764|NCT03635099|69755904|FG003|Period 1|Withdrawal by Subject|2|||
38062765|NCT03635099|69755905|FG004|Period 1|Withdrawal by Subject|2|||
38062766|NCT03635099|69755906|FG005|Period 1|Withdrawal by Subject|0|||
38062767|NCT03635099|69755907|FG006|Period 1|Withdrawal by Subject|3|||
38062768|NCT03635099|69755908|FG007|Period 1|Withdrawal by Subject|0|||
38062769|NCT03635099|69755901|FG000|Period 1|History of suicidal ideation|0|||
38062770|NCT03635099|69755902|FG001|Period 1|History of suicidal ideation|0|||
38062771|NCT03635099|69755903|FG002|Period 1|History of suicidal ideation|1|||
38062772|NCT03635099|69755904|FG003|Period 1|History of suicidal ideation|0|||
38062773|NCT03635099|69755905|FG004|Period 1|History of suicidal ideation|0|||
38062774|NCT03635099|69755906|FG005|Period 1|History of suicidal ideation|0|||
38062775|NCT03635099|69755907|FG006|Period 1|History of suicidal ideation|0|||
38062776|NCT03635099|69755908|FG007|Period 1|History of suicidal ideation|0|||
38062777|NCT03635099|69755901|FG000|Period 1|pursue other treatment options|0|||
38062778|NCT03635099|69755902|FG001|Period 1|pursue other treatment options|0|||
38062779|NCT03635099|69755903|FG002|Period 1|pursue other treatment options|0|||
38062780|NCT03635099|69755904|FG003|Period 1|pursue other treatment options|0|||
38062781|NCT03635099|69755905|FG004|Period 1|pursue other treatment options|0|||
38062782|NCT03635099|69755906|FG005|Period 1|pursue other treatment options|1|||
38062783|NCT03635099|69755907|FG006|Period 1|pursue other treatment options|0|||
38062784|NCT03635099|69755908|FG007|Period 1|pursue other treatment options|0|||
38062785|NCT03635099|69755901|FG000|Not Eligible for Period 2|Pregnancy|0|||
38062786|NCT03635099|69755902|FG001|Not Eligible for Period 2|Pregnancy|0|||
38062787|NCT03635099|69755903|FG002|Not Eligible for Period 2|Pregnancy|0|||
38062788|NCT03635099|69755904|FG003|Not Eligible for Period 2|Pregnancy|1|||
38062789|NCT03635099|69755905|FG004|Not Eligible for Period 2|Pregnancy|0|||
38062790|NCT03635099|69755906|FG005|Not Eligible for Period 2|Pregnancy|0|||
38062791|NCT03635099|69755907|FG006|Not Eligible for Period 2|Pregnancy|0|||
38062792|NCT03635099|69755908|FG007|Not Eligible for Period 2|Pregnancy|0|||
38062793|NCT03635099|69755901|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
38062794|NCT03635099|69755902|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
38062795|NCT03635099|69755903|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
38062796|NCT03635099|69755904|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
38062797|NCT03635099|69755905|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
38062798|NCT03635099|69755906|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
38062799|NCT03635099|69755907|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
38062800|NCT03635099|69755908|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
38062801|NCT03635099|69755901|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
38062802|NCT03635099|69755902|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
38062803|NCT03635099|69755903|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
38062804|NCT03635099|69755904|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
38062805|NCT03635099|69755905|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
38062806|NCT03635099|69755906|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
38062807|NCT03635099|69755907|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
38062808|NCT03635099|69755908|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
38062809|NCT03635099|69755901|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
38062810|NCT03635099|69755902|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
38062811|NCT03635099|69755903|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
38062812|NCT03635099|69755904|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
38062813|NCT03635099|69755905|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
38062814|NCT03635099|69755906|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
38062815|NCT03635099|69755907|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
38062816|NCT03635099|69755908|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
38062817|NCT03635099|69755901|FG000|Period 2|Adverse Event|0|||
38062818|NCT03635099|69755902|FG001|Period 2|Adverse Event|0|||
38062819|NCT03635099|69755903|FG002|Period 2|Adverse Event|1|||
38062820|NCT03635099|69755904|FG003|Period 2|Adverse Event|0|||
38062821|NCT03635099|69755905|FG004|Period 2|Adverse Event|1|||
38062822|NCT03635099|69755906|FG005|Period 2|Adverse Event|0|||
38062823|NCT03635099|69755907|FG006|Period 2|Adverse Event|0|||
38062824|NCT03635099|69755908|FG007|Period 2|Adverse Event|0|||
38062825|NCT03635099|69755901|FG000|Period 2|Lost to Follow-up|0|||
38062826|NCT03635099|69755902|FG001|Period 2|Lost to Follow-up|0|||
38062827|NCT03635099|69755903|FG002|Period 2|Lost to Follow-up|1|||
38062828|NCT03635099|69755904|FG003|Period 2|Lost to Follow-up|0|||
38062829|NCT03635099|69755905|FG004|Period 2|Lost to Follow-up|4|||
38062830|NCT03635099|69755906|FG005|Period 2|Lost to Follow-up|0|||
38062831|NCT03635099|69755907|FG006|Period 2|Lost to Follow-up|0|||
38062832|NCT03635099|69755908|FG007|Period 2|Lost to Follow-up|0|||
38062833|NCT03635099|69755901|FG000|Period 2|Withdrawal by Subject|0|||
38062834|NCT03635099|69755902|FG001|Period 2|Withdrawal by Subject|0|||
38062835|NCT03635099|69755903|FG002|Period 2|Withdrawal by Subject|7|||
38062836|NCT03635099|69755904|FG003|Period 2|Withdrawal by Subject|4|||
38062837|NCT03635099|69755905|FG004|Period 2|Withdrawal by Subject|7|||
38062838|NCT03635099|69755906|FG005|Period 2|Withdrawal by Subject|0|||
38062839|NCT03635099|69755907|FG006|Period 2|Withdrawal by Subject|0|||
38062840|NCT03635099|69755908|FG007|Period 2|Withdrawal by Subject|0|||
38062841|NCT02108652|69755934|FG000|Overall Study|Death|226|||
38062842|NCT02108652|69755934|FG000|Overall Study|Lost to Follow-up|2|||
38062843|NCT02108652|69755934|FG000|Overall Study|Withdrawal by Subject|8|||
38062844|NCT02108652|69755934|FG000|Overall Study|Ongoing at data cutoff 04 July 2016|74|||
38062845|NCT03634085|69755940|FG000|Overall Study|Adverse Event|1|||
38062846|NCT03634085|69755941|FG001|Overall Study|Adverse Event|0|||
38062847|NCT03634085|69755940|FG000|Overall Study|Withdrawal by Subject|0|||
38062848|NCT03634085|69755941|FG001|Overall Study|Withdrawal by Subject|2|||
38062849|NCT02676778|69755957|FG000|Overall Study|Disease Progression|7|||
38062850|NCT02676778|69755958|FG001|Overall Study|Disease Progression|3|||
38062851|NCT02676778|69755959|FG002|Overall Study|Disease Progression|1|||
38062852|NCT02676778|69755957|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
38062853|NCT02676778|69755958|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
38062854|NCT02676778|69755959|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
38062855|NCT02676778|69755957|FG000|Overall Study|Withdrawal by Subject|3|||
38062856|NCT02676778|69755958|FG001|Overall Study|Withdrawal by Subject|2|||
38062857|NCT02676778|69755959|FG002|Overall Study|Withdrawal by Subject|0|||
38062858|NCT02676778|69755957|FG000|Overall Study|Other|4|||
38062859|NCT02676778|69755958|FG001|Overall Study|Other|3|||
38062860|NCT02676778|69755959|FG002|Overall Study|Other|0|||
38062861|NCT02676778|69755957|FG000|Overall Study|Adverse Event|2|||
38062862|NCT02676778|69755958|FG001|Overall Study|Adverse Event|3|||
38062863|NCT02676778|69755959|FG002|Overall Study|Adverse Event|0|||
38062864|NCT02946385|69755974|FG000|Overall Study|Lost to Follow-up|0|||
38062865|NCT02946385|69755975|FG001|Overall Study|Lost to Follow-up|0|||
38062866|NCT02946385|69755976|FG002|Overall Study|Lost to Follow-up|3|||
38062867|NCT02946385|69755977|FG003|Overall Study|Lost to Follow-up|0|||
38062868|NCT02946385|69755978|FG004|Overall Study|Lost to Follow-up|2|||
38062869|NCT02946385|69755979|FG005|Overall Study|Lost to Follow-up|1|||
38062870|NCT02694718|69755999|FG000|Overall Study|Death|1|||
38062871|NCT02694718|69755999|FG000|Overall Study|Withdrawal by Subject|1|||
38062872|NCT02944513|69756005|FG000|Overall Study|Withdrawal by Subject|4|||
38062873|NCT02944513|69756006|FG001|Overall Study|Withdrawal by Subject|1|||
38062874|NCT03018938|69756034|FG000|Overall Study|Death|0|||
38062875|NCT03018938|69756035|FG001|Overall Study|Death|1|||
38062876|NCT03018938|69756034|FG000|Overall Study|Lost to Follow-up|21|||
38062877|NCT03018938|69756035|FG001|Overall Study|Lost to Follow-up|32|||
38062878|NCT03018938|69756034|FG000|Overall Study|Withdrawal by Subject|38|||
38062879|NCT03018938|69756035|FG001|Overall Study|Withdrawal by Subject|45|||
38062880|NCT03018938|69756034|FG000|Overall Study|Physician Decision|3|||
38062881|NCT03018938|69756035|FG001|Overall Study|Physician Decision|2|||
38062882|NCT03018938|69756034|FG000|Overall Study|Sponsor Decision|0|||
38062883|NCT03018938|69756035|FG001|Overall Study|Sponsor Decision|1|||
38062884|NCT03018938|69756034|FG000|Overall Study|Screen failure-After randomization|4|||
38062885|NCT03018938|69756035|FG001|Overall Study|Screen failure-After randomization|2|||
38062886|NCT03018938|69756034|FG000|Overall Study|Not recorded|0|||
38062887|NCT03018938|69756035|FG001|Overall Study|Not recorded|2|||
38062888|NCT02943577|69756043|FG000|Overall Study|Protocol Violation|0|||
38062889|NCT02943577|69756044|FG001|Overall Study|Protocol Violation|1|||
38062890|NCT02943577|69756043|FG000|Overall Study|Adverse Event|3|||
38062891|NCT02943577|69756044|FG001|Overall Study|Adverse Event|2|||
38062892|NCT02943577|69756043|FG000|Overall Study|Lost to Follow-up|0|||
38062893|NCT02943577|69756044|FG001|Overall Study|Lost to Follow-up|1|||
38062894|NCT02943577|69756043|FG000|Overall Study|Withdrawal by Subject|1|||
38062895|NCT02943577|69756044|FG001|Overall Study|Withdrawal by Subject|1|||
38062896|NCT02943577|69756043|FG000|Overall Study|Pregnancy|1|||
38062897|NCT02943577|69756044|FG001|Overall Study|Pregnancy|0|||
38062898|NCT03016598|69756052|FG000|Overall Study|Lost to Follow-up|0|||
38062899|NCT03016598|69756053|FG001|Overall Study|Lost to Follow-up|2|||
38062900|NCT03017846|69756059|FG000|Overall Study|Lost to Follow-up|3|||
38062901|NCT03017846|69756059|FG000|Overall Study|Adverse Event|2|||
38062902|NCT03014180|69756065|FG000|Overall Study|Protocol Violation|2|||
38062903|NCT03011840|69756075|FG000|Overall Study|Not received PIL in post PIL phase|0|||
38062904|NCT03011840|69756076|FG001|Overall Study|Not received PIL in post PIL phase|21|||
38062905|NCT02942485|69756084|FG000|Overall Study|Lost to Follow-up|1|||
38062906|NCT02942485|69756085|FG001|Overall Study|Lost to Follow-up|0|||
38062907|NCT02942407|69756093|FG000|Overall Study|Lost to Follow-up|3|||
38062908|NCT02942407|69756094|FG001|Overall Study|Lost to Follow-up|2|||
38062909|NCT02942407|69756093|FG000|Overall Study|Withdrawal by Subject|7|||
38062910|NCT02942407|69756094|FG001|Overall Study|Withdrawal by Subject|9|||
38062911|NCT02942407|69756093|FG000|Overall Study|Death|16|||
38062912|NCT02942407|69756094|FG001|Overall Study|Death|13|||
38062913|NCT03009344|69756108|FG000|Overall Study|Lack of Efficacy|5|||
38062914|NCT03009344|69756108|FG000|Overall Study|Withdrawal by Subject|1|||
38062915|NCT03009344|69756108|FG000|Overall Study|Adverse Event|1|||
38062916|NCT03322423|69756112|FG000|Period 1|Subject no longer eligible|0|||
38062917|NCT03322423|69756113|FG001|Period 1|Subject no longer eligible|1|||
38062918|NCT03322423|69756112|FG000|Period 1|Withdrawal by Subject|0|||
38062919|NCT03322423|69756113|FG001|Period 1|Withdrawal by Subject|1|||
38062920|NCT03322423|69756112|FG000|Period 1|Incorrect Lens Dispensed|1|||
38062921|NCT03322423|69756113|FG001|Period 1|Incorrect Lens Dispensed|0|||
38062922|NCT03322423|69756112|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
38062923|NCT03322423|69756113|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
38062924|NCT03322423|69756112|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
38062925|NCT03322423|69756113|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
38062926|NCT03322423|69756112|FG000|Period 2|Protocol Violation|1|||
38062927|NCT03322423|69756113|FG001|Period 2|Protocol Violation|0|||
38062928|NCT03322423|69756112|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
38062929|NCT03322423|69756113|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
38062930|NCT03007472|69756119|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
38062931|NCT03007472|69756119|FG000|Overall Study|Death|2|||
38062932|NCT03007472|69756119|FG000|Overall Study|Loss to Follow Up|1|||
38062933|NCT03321721|69756126|FG000|Overall Study|Lost to Follow-up|4|||
38062934|NCT03321721|69756127|FG001|Overall Study|Lost to Follow-up|8|||
38062935|NCT03321721|69756128|FG002|Overall Study|Lost to Follow-up|11|||
38062936|NCT03015116|69756140|FG000|Overall Study|Lost to Follow-up|3|||
38062937|NCT03015116|69756141|FG001|Overall Study|Lost to Follow-up|0|||
38062938|NCT03015116|69756142|FG002|Overall Study|Lost to Follow-up|2|||
38062939|NCT03015116|69756140|FG000|Overall Study|Withdrawal by Subject|3|||
38062940|NCT03015116|69756141|FG001|Overall Study|Withdrawal by Subject|1|||
38062941|NCT03015116|69756142|FG002|Overall Study|Withdrawal by Subject|0|||
38062942|NCT03015116|69756140|FG000|Overall Study|Subject has New Medical Status|1|||
38062943|NCT03015116|69756141|FG001|Overall Study|Subject has New Medical Status|0|||
38062944|NCT03015116|69756142|FG002|Overall Study|Subject has New Medical Status|0|||
38062945|NCT03015116|69756140|FG000|Overall Study|Physician Decision|0|||
38062946|NCT03015116|69756141|FG001|Overall Study|Physician Decision|1|||
38062947|NCT03015116|69756142|FG002|Overall Study|Physician Decision|0|||
38062948|NCT03006458|69756152|FG000|First Intervention|Unsatisfied Vision|0|||
38062949|NCT03006458|69756153|FG001|First Intervention|Unsatisfied Vision|3|||
38062950|NCT03320941|69756164|FG000|Overall Study|subject/guardian decision|0|||
38062951|NCT03320941|69756165|FG001|Overall Study|subject/guardian decision|0|||
38062952|NCT03320941|69756166|FG002|Overall Study|subject/guardian decision|0|||
38062953|NCT03320941|69756167|FG003|Overall Study|subject/guardian decision|1|||
38062954|NCT03320941|69756168|FG004|Overall Study|subject/guardian decision|0|||
38062955|NCT03005288|69756182|FG000|Overall Study|Withdrawal by Subject|7|||
38062956|NCT03005288|69756183|FG001|Overall Study|Withdrawal by Subject|5|||
38062957|NCT03005288|69756182|FG000|Overall Study|Lost to Follow-up|0|||
38062958|NCT03005288|69756183|FG001|Overall Study|Lost to Follow-up|1|||
38062959|NCT03005288|69756182|FG000|Overall Study|Adverse Event|5|||
38062960|NCT03005288|69756183|FG001|Overall Study|Adverse Event|0|||
38062961|NCT03005288|69756182|FG000|Overall Study|Protocol deviation|0|||
38062962|NCT03005288|69756183|FG001|Overall Study|Protocol deviation|1|||
38062963|NCT03005288|69756182|FG000|Overall Study|Physician Decision|0|||
38062964|NCT03005288|69756183|FG001|Overall Study|Physician Decision|1|||
38062965|NCT03003494|69756189|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
38062966|NCT03559699|69756193|FG000|Overall Study|Withdrawal by Subject|6|||
38062967|NCT03559699|69756193|FG000|Overall Study|Lost to Follow-up|1|||
38062968|NCT03085758|69756200|FG000|Overall Study|Death|26|||
38062969|NCT03085758|69756201|FG001|Overall Study|Death|24|||
38062970|NCT03085758|69756202|FG002|Overall Study|Death|53|||
38062971|NCT03085758|69756200|FG000|Overall Study|Lost to Follow-up|1|||
38062972|NCT03085758|69756201|FG001|Overall Study|Lost to Follow-up|1|||
38062973|NCT03085758|69756202|FG002|Overall Study|Lost to Follow-up|1|||
38062974|NCT03085758|69756200|FG000|Overall Study|Withdrawal by Subject|2|||
38062975|NCT03085758|69756201|FG001|Overall Study|Withdrawal by Subject|2|||
38062976|NCT03085758|69756202|FG002|Overall Study|Withdrawal by Subject|1|||
38062977|NCT03085758|69756200|FG000|Overall Study|Refusal to recall it up to day 90|0|||
38062978|NCT03085758|69756201|FG001|Overall Study|Refusal to recall it up to day 90|0|||
38062979|NCT03085758|69756202|FG002|Overall Study|Refusal to recall it up to day 90|1|||
38062980|NCT03085758|69756200|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
38062981|NCT03085758|69756201|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
38062982|NCT03085758|69756202|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
38062983|NCT03935880|69756226|FG000|Overall Study|Lost to Follow-up|0|||
38062984|NCT03935880|69756227|FG001|Overall Study|Lost to Follow-up|1|||
38062985|NCT03315793|69756235|FG000|Overall Study|Adverse Event|4|||
38062986|NCT03315793|69756236|FG001|Overall Study|Adverse Event|2|||
38062987|NCT03315793|69756235|FG000|Overall Study|Protocol Deviation|1|||
38062988|NCT03315793|69756236|FG001|Overall Study|Protocol Deviation|0|||
38062989|NCT03315793|69756235|FG000|Overall Study|Difficult for regular visit|0|||
38062990|NCT03315793|69756236|FG001|Overall Study|Difficult for regular visit|1|||
38062991|NCT02676466|69756252|FG000|Overall Study|Death|0|||
38062992|NCT02676466|69756253|FG001|Overall Study|Death|2|||
38062993|NCT02676466|69756254|FG002|Overall Study|Death|1|||
38062994|NCT02676466|69756255|FG003|Overall Study|Death|0|||
38062995|NCT02676466|69756256|FG004|Overall Study|Death|0|||
38062996|NCT02676466|69756257|FG005|Overall Study|Death|0|||
38062997|NCT02676466|69756258|FG006|Overall Study|Death|0|||
38062998|NCT02676466|69756259|FG007|Overall Study|Death|0|||
38062999|NCT02676466|69756252|FG000|Overall Study|Withdrawal by Subject|4|||
38063000|NCT02676466|69756253|FG001|Overall Study|Withdrawal by Subject|3|||
38063001|NCT02676466|69756254|FG002|Overall Study|Withdrawal by Subject|1|||
38063002|NCT02676466|69756255|FG003|Overall Study|Withdrawal by Subject|0|||
38063003|NCT02676466|69756256|FG004|Overall Study|Withdrawal by Subject|3|||
38063004|NCT02676466|69756257|FG005|Overall Study|Withdrawal by Subject|1|||
38063005|NCT02676466|69756258|FG006|Overall Study|Withdrawal by Subject|1|||
38063006|NCT02676466|69756259|FG007|Overall Study|Withdrawal by Subject|1|||
38063007|NCT03633695|69756283|FG000|Overall Study|Lost to Follow-up|4|||
38063008|NCT03633695|69756284|FG001|Overall Study|Lost to Follow-up|5|||
38063009|NCT03633695|69756283|FG000|Overall Study|Discontinued|8|||
38063010|NCT03633695|69756284|FG001|Overall Study|Discontinued|4|||
38063011|NCT03314233|69756306|FG000|Overall Study|No longer eligible at time of delivery|1|||
38063012|NCT02675998|69756314|FG000|8-Week Treatment Period|Adverse Event|6|||
38063013|NCT02675998|69756315|FG001|8-Week Treatment Period|Adverse Event|5|||
38063014|NCT02675998|69756316|FG002|8-Week Treatment Period|Adverse Event|6|||
38063015|NCT02675998|69756317|FG003|8-Week Treatment Period|Adverse Event|0|||
38063016|NCT02675998|69756314|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
38063017|NCT02675998|69756315|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
38063018|NCT02675998|69756316|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
38063019|NCT02675998|69756317|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
38063020|NCT02675998|69756314|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
38063021|NCT02675998|69756315|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
38063022|NCT02675998|69756316|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
38063023|NCT02675998|69756317|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
38063024|NCT02675998|69756314|FG000|8-Week Treatment Period|Physician Decision|1|||
38063025|NCT02675998|69756315|FG001|8-Week Treatment Period|Physician Decision|0|||
38063026|NCT02675998|69756316|FG002|8-Week Treatment Period|Physician Decision|2|||
38063027|NCT02675998|69756317|FG003|8-Week Treatment Period|Physician Decision|0|||
38063028|NCT02675998|69756314|FG000|8-Week Treatment Period|GI side Effects|1|||
38063029|NCT02675998|69756315|FG001|8-Week Treatment Period|GI side Effects|4|||
38063030|NCT02675998|69756316|FG002|8-Week Treatment Period|GI side Effects|2|||
38063031|NCT02675998|69756317|FG003|8-Week Treatment Period|GI side Effects|0|||
38063032|NCT02675998|69756314|FG000|8-Week Treatment Period|Protocol Violation|1|||
38063033|NCT02675998|69756315|FG001|8-Week Treatment Period|Protocol Violation|1|||
38063034|NCT02675998|69756316|FG002|8-Week Treatment Period|Protocol Violation|1|||
38063035|NCT02675998|69756317|FG003|8-Week Treatment Period|Protocol Violation|0|||
38063036|NCT02675998|69756314|FG000|8-Week Treatment Period|Other|3|||
38063037|NCT02675998|69756315|FG001|8-Week Treatment Period|Other|1|||
38063038|NCT02675998|69756316|FG002|8-Week Treatment Period|Other|2|||
38063039|NCT02675998|69756317|FG003|8-Week Treatment Period|Other|0|||
38063040|NCT02675998|69756314|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
38063041|NCT02675998|69756315|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
38063042|NCT02675998|69756316|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
38063043|NCT02675998|69756317|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
38063044|NCT02675998|69756314|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
38063045|NCT02675998|69756315|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
38063046|NCT02675998|69756316|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
38063047|NCT02675998|69756317|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
38063048|NCT02675998|69756314|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
38063049|NCT02675998|69756315|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
38063050|NCT02675998|69756316|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
38063051|NCT02675998|69756317|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
38063052|NCT02675998|69756314|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
38063053|NCT02675998|69756315|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
38063054|NCT02675998|69756316|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
38063055|NCT02675998|69756317|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
38063056|NCT02675998|69756314|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
38063057|NCT02675998|69756315|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
38063058|NCT02675998|69756316|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
38063059|NCT02675998|69756317|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
38063060|NCT02674204|69756333|FG000|Overall Study|Adverse Event|1|||
38063061|NCT02674204|69756334|FG001|Overall Study|Adverse Event|0|||
38063062|NCT02941627|69756340|FG000|Overall Study|Death|1|||
38063063|NCT02941627|69756340|FG000|Overall Study|Surgical failure|1|||
38063064|NCT02941627|69756340|FG000|Overall Study|cholesteatoma prevented implantation|1|||
38063065|NCT03521934|69756352|FG000|Overall Study|Death|65|||
38063066|NCT03521934|69756353|FG001|Overall Study|Death|73|||
38063067|NCT03521934|69756352|FG000|Overall Study|Withdrawal by Subject|18|||
38063068|NCT03521934|69756353|FG001|Overall Study|Withdrawal by Subject|23|||
38063069|NCT03521934|69756352|FG000|Overall Study|Site Terminated by Sponsor|39|||
38063070|NCT03521934|69756353|FG001|Overall Study|Site Terminated by Sponsor|35|||
38063071|NCT03521934|69756352|FG000|Overall Study|Study Terminated by Sponsor|483|||
38063072|NCT03521934|69756353|FG001|Overall Study|Study Terminated by Sponsor|477|||
38063073|NCT03521934|69756352|FG000|Overall Study|Reason not Specified|3|||
38063074|NCT03521934|69756353|FG001|Overall Study|Reason not Specified|6|||
38063075|NCT03434353|69756364|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
38063076|NCT03434353|69756365|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
38063077|NCT03434353|69756366|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
38063078|NCT03434353|69756367|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
38063079|NCT03434353|69756368|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
38063080|NCT03434353|69756364|FG000|Overall Study|Withdrew consent|1|||
38063081|NCT03434353|69756365|FG001|Overall Study|Withdrew consent|0|||
38063082|NCT03434353|69756366|FG002|Overall Study|Withdrew consent|3|||
38063083|NCT03434353|69756367|FG003|Overall Study|Withdrew consent|0|||
38063084|NCT03434353|69756368|FG004|Overall Study|Withdrew consent|0|||
37862258|NCT00919633|69546037|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
37862259|NCT00919633|69546034|FG000|Overall Study|Protocol Violation|0|||
38063085|NCT03434353|69756364|FG000|Overall Study|Adverse Event|1|||
38063086|NCT03434353|69756365|FG001|Overall Study|Adverse Event|0|||
38063087|NCT03434353|69756366|FG002|Overall Study|Adverse Event|0|||
38063088|NCT03434353|69756367|FG003|Overall Study|Adverse Event|0|||
38063089|NCT03434353|69756368|FG004|Overall Study|Adverse Event|1|||
38063090|NCT03434353|69756364|FG000|Overall Study|Lost to Follow-up|2|||
38063091|NCT03434353|69756365|FG001|Overall Study|Lost to Follow-up|0|||
38063092|NCT03434353|69756366|FG002|Overall Study|Lost to Follow-up|0|||
38063093|NCT03434353|69756367|FG003|Overall Study|Lost to Follow-up|0|||
38063094|NCT03434353|69756368|FG004|Overall Study|Lost to Follow-up|0|||
38063095|NCT02914184|69756384|FG000|Overall Study|Lost to Follow-up|7|||
38063096|NCT02914184|69756385|FG001|Overall Study|Lost to Follow-up|10|||
38063097|NCT02914184|69756386|FG002|Overall Study|Lost to Follow-up|8|||
38063098|NCT02914184|69756387|FG003|Overall Study|Lost to Follow-up|7|||
38063099|NCT02914184|69756384|FG000|Overall Study|Withdrawal by Subject|4|||
38063100|NCT02914184|69756385|FG001|Overall Study|Withdrawal by Subject|2|||
38063101|NCT02914184|69756386|FG002|Overall Study|Withdrawal by Subject|7|||
38063102|NCT02914184|69756387|FG003|Overall Study|Withdrawal by Subject|3|||
38063103|NCT02914184|69756384|FG000|Overall Study|Other|1|||
38063104|NCT02914184|69756385|FG001|Overall Study|Other|0|||
38063105|NCT02914184|69756386|FG002|Overall Study|Other|0|||
38063106|NCT02914184|69756387|FG003|Overall Study|Other|0|||
38063107|NCT02914184|69756384|FG000|Overall Study|Migrated/moved from the study area|2|||
38063108|NCT02914184|69756385|FG001|Overall Study|Migrated/moved from the study area|1|||
38063109|NCT02914184|69756386|FG002|Overall Study|Migrated/moved from the study area|2|||
38063110|NCT02914184|69756387|FG003|Overall Study|Migrated/moved from the study area|1|||
38063111|NCT03633227|69756401|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
38063112|NCT03633227|69756402|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
38063113|NCT03633227|69756401|FG000|Double Blind (DB), up to Week 48|Death|2|||
38063114|NCT03633227|69756402|FG001|Double Blind (DB), up to Week 48|Death|1|||
38063115|NCT03633227|69756401|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
38063116|NCT03633227|69756402|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
38063117|NCT03633227|69756401|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
38063118|NCT03633227|69756402|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
38063119|NCT03633227|69756401|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
38063120|NCT03633227|69756402|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
38063121|NCT03633227|69756401|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
38063122|NCT03633227|69756402|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
38063123|NCT03633227|69756401|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
38063124|NCT03633227|69756402|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
38063125|NCT03633227|69756401|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
38063126|NCT03633227|69756402|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
38063127|NCT03633227|69756401|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
38063128|NCT03633227|69756402|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
38063129|NCT03633227|69756401|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
38063130|NCT03633227|69756402|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
38063131|NCT03633227|69756401|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
38063132|NCT03633227|69756402|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
38063133|NCT03633227|69756401|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
38063134|NCT03633227|69756402|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
38063135|NCT02913326|69756415|FG000|Overall Study|Reason not listed|0|||
38063136|NCT02913326|69756416|FG001|Overall Study|Reason not listed|1|||
38063137|NCT02913326|69756415|FG000|Overall Study|Lost to Follow-up|0|||
38063138|NCT02913326|69756416|FG001|Overall Study|Lost to Follow-up|1|||
38063139|NCT02913326|69756415|FG000|Overall Study|Adverse Event|1|||
38063140|NCT02913326|69756416|FG001|Overall Study|Adverse Event|0|||
38063141|NCT02912468|69756424|FG000|Overall Study|Adverse Event|3|||
38063142|NCT02912468|69756425|FG001|Overall Study|Adverse Event|2|||
38063143|NCT02912468|69756424|FG000|Overall Study|Withdrawal by Subject|6|||
38063144|NCT02912468|69756425|FG001|Overall Study|Withdrawal by Subject|2|||
38063145|NCT02912468|69756424|FG000|Overall Study|Randomized and not treated|0|||
38063146|NCT02912468|69756425|FG001|Overall Study|Randomized and not treated|1|||
38063147|NCT04438499|69756432|FG000|Overall Study|Lack of Efficacy|2|||
38063148|NCT00002874|69756438|FG000|Overall Study|Withdrawal by Subject|1|||
38063149|NCT00002874|69756439|FG001|Overall Study|Withdrawal by Subject|1|||
38063150|NCT00002874|69756438|FG000|Overall Study|Protocol Violation|44|||
38063151|NCT00002874|69756439|FG001|Overall Study|Protocol Violation|34|||
38063152|NCT03001076|69756447|FG000|Overall Study|Withdrawal by patient|2|||
38063153|NCT03001076|69756448|FG001|Overall Study|Withdrawal by patient|0|||
38063154|NCT03001076|69756447|FG000|Overall Study|Other|1|||
37862260|NCT00919633|69546035|FG001|Overall Study|Protocol Violation|0|||
38063155|NCT03001076|69756448|FG001|Overall Study|Other|0|||
38063156|NCT03001076|69756447|FG000|Overall Study|Adverse Event|3|||
38063157|NCT03001076|69756448|FG001|Overall Study|Adverse Event|3|||
38063158|NCT03001076|69756447|FG000|Overall Study|Sponsor decision|1|||
38063159|NCT03001076|69756448|FG001|Overall Study|Sponsor decision|0|||
38063160|NCT03001076|69756447|FG000|Overall Study|Lost to Follow-up|0|||
38063161|NCT03001076|69756448|FG001|Overall Study|Lost to Follow-up|2|||
38063162|NCT03555305|69756454|FG000|Period 1|Physician Decision|0|||
38063163|NCT03555305|69756455|FG001|Period 1|Physician Decision|1|||
38063164|NCT03555305|69756454|FG000|Period 1|Adverse Event|0|||
38063165|NCT03555305|69756455|FG001|Period 1|Adverse Event|1|||
38063166|NCT03553823|69756463|FG000|Overall Study|Physician Decision|0|||
38063167|NCT03553823|69756464|FG001|Overall Study|Physician Decision|1|||
38063168|NCT03000686|69756472|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
38063169|NCT03000686|69756473|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
38063170|NCT03000686|69756474|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
38063171|NCT03000686|69756475|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
38063172|NCT02493660|69756493|FG000|Overall Study|Physician Decision|0|||
38063173|NCT02493660|69756494|FG001|Overall Study|Physician Decision|1|||
38063174|NCT02493660|69756493|FG000|Overall Study|Adverse Event|4|||
38063175|NCT02493660|69756494|FG001|Overall Study|Adverse Event|2|||
38063176|NCT02493660|69756493|FG000|Overall Study|Withdrawal by Subject|2|||
38063177|NCT02493660|69756494|FG001|Overall Study|Withdrawal by Subject|3|||
38063178|NCT02493660|69756493|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
38063179|NCT02493660|69756494|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
38063180|NCT02493660|69756493|FG000|Overall Study|Protocol Violation|0|||
38063181|NCT02493660|69756494|FG001|Overall Study|Protocol Violation|1|||
38063182|NCT02493660|69756493|FG000|Overall Study|Death|0|||
38063183|NCT02493660|69756494|FG001|Overall Study|Death|1|||
38063184|NCT02493660|69756493|FG000|Overall Study|Lost to Follow-up|2|||
38063185|NCT02493660|69756494|FG001|Overall Study|Lost to Follow-up|4|||
38063186|NCT03552029|69756504|FG000|Overall Study|Death|3|||
38063187|NCT03552029|69756505|FG001|Overall Study|Death|0|||
38063188|NCT03552029|69756504|FG000|Overall Study|Adverse Event|1|||
38063189|NCT03552029|69756505|FG001|Overall Study|Adverse Event|0|||
38063190|NCT03552029|69756504|FG000|Overall Study|Lack of Efficacy|0|||
38063191|NCT03552029|69756505|FG001|Overall Study|Lack of Efficacy|2|||
38063192|NCT03552029|69756504|FG000|Overall Study|Physician Decision|0|||
38063193|NCT03552029|69756505|FG001|Overall Study|Physician Decision|1|||
38063194|NCT03552029|69756504|FG000|Overall Study|Study terminated by Sponsor|0|||
38063195|NCT03552029|69756505|FG001|Overall Study|Study terminated by Sponsor|1|||
38063196|NCT03552029|69756504|FG000|Overall Study|Other|0|||
38063197|NCT03552029|69756505|FG001|Overall Study|Other|2|||
38063198|NCT03521141|69756514|FG000|Overall Study|Death|1|||
38063199|NCT03521141|69756515|FG001|Overall Study|Death|0|||
38063200|NCT03521141|69756516|FG002|Overall Study|Death|1|||
38063201|NCT02997176|69756528|FG000|Overall Study|Adverse Event|0|||
38063202|NCT02997176|69756529|FG001|Overall Study|Adverse Event|0|||
38063203|NCT02997176|69756530|FG002|Overall Study|Adverse Event|0|||
38063204|NCT02997176|69756531|FG003|Overall Study|Adverse Event|8|||
38063205|NCT02997176|69756528|FG000|Overall Study|Progressive Disease|1|||
38063206|NCT02997176|69756529|FG001|Overall Study|Progressive Disease|0|||
38063207|NCT02997176|69756530|FG002|Overall Study|Progressive Disease|1|||
38063208|NCT02997176|69756531|FG003|Overall Study|Progressive Disease|1|||
37965706|NCT00365716|69652700|FG005|Extension 1|Pregnancy|4|||
37965707|NCT00365716|69652701|FG006|Extension 1|Pregnancy|0|||
37965708|NCT00365716|69652695|FG000|Extension 1|Protocol Violation|0|||
37965709|NCT00365716|69652696|FG001|Extension 1|Protocol Violation|0|||
37965710|NCT00365716|69652697|FG002|Extension 1|Protocol Violation|0|||
37965711|NCT00365716|69652698|FG003|Extension 1|Protocol Violation|0|||
38063209|NCT02997176|69756528|FG000|Overall Study|Death|0|||
38063210|NCT02997176|69756529|FG001|Overall Study|Death|0|||
38063211|NCT02997176|69756530|FG002|Overall Study|Death|1|||
38063212|NCT02997176|69756531|FG003|Overall Study|Death|1|||
38063213|NCT02997176|69756528|FG000|Overall Study|Withdrawal by Subject|0|||
38063214|NCT02997176|69756529|FG001|Overall Study|Withdrawal by Subject|2|||
38063215|NCT02997176|69756530|FG002|Overall Study|Withdrawal by Subject|0|||
38063216|NCT02997176|69756531|FG003|Overall Study|Withdrawal by Subject|1|||
38063217|NCT03000452|69756541|FG000|Treatment Period|Death|1|||
38063218|NCT03000452|69756541|FG000|Treatment Period|Progressive Disease (PD)|14|||
38063219|NCT03000452|69756541|FG000|Treatment Period|Physician Decision|1|||
38063220|NCT03000452|69756541|FG000|Treatment Period|Miscellaneous|2|||
38063221|NCT03000452|69756541|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
38063222|NCT03000452|69756541|FG000|Follow-Up Period|Death|3|||
38063223|NCT03000452|69756541|FG000|Follow-Up Period|Withdrawal by Subject|3|||
38063224|NCT01373164|69756550|FG000|Overall Study|Lost to Follow-up|0|||
38063225|NCT01373164|69756551|FG001|Overall Study|Lost to Follow-up|0|||
38063226|NCT01373164|69756552|FG002|Overall Study|Lost to Follow-up|1|||
38063227|NCT01373164|69756553|FG003|Overall Study|Lost to Follow-up|2|||
38063228|NCT01373164|69756554|FG004|Overall Study|Lost to Follow-up|0|||
38063229|NCT01373164|69756550|FG000|Overall Study|Withdrawal by Subject|0|||
38063230|NCT01373164|69756551|FG001|Overall Study|Withdrawal by Subject|1|||
38063231|NCT01373164|69756552|FG002|Overall Study|Withdrawal by Subject|0|||
38063232|NCT01373164|69756553|FG003|Overall Study|Withdrawal by Subject|10|||
38063233|NCT01373164|69756554|FG004|Overall Study|Withdrawal by Subject|2|||
38063234|NCT02999984|69756569|FG000|Overall Study|Treatment Failure|1|||
38063235|NCT03550313|69756576|FG000|Overall Study|Adverse Event|0|||
38063236|NCT03550313|69756577|FG001|Overall Study|Adverse Event|1|||
38063237|NCT03550313|69756578|FG002|Overall Study|Adverse Event|0|||
38063238|NCT03550313|69756576|FG000|Overall Study|Lost to Follow-up|5|||
38063239|NCT03550313|69756577|FG001|Overall Study|Lost to Follow-up|7|||
38063240|NCT03550313|69756578|FG002|Overall Study|Lost to Follow-up|12|||
38063241|NCT03550313|69756576|FG000|Overall Study|Study terminated by sponsor|44|||
38063242|NCT03550313|69756577|FG001|Overall Study|Study terminated by sponsor|37|||
38063243|NCT03550313|69756578|FG002|Overall Study|Study terminated by sponsor|48|||
37965712|NCT00365716|69652699|FG004|Extension 1|Protocol Violation|0|||
37965713|NCT00365716|69652700|FG005|Extension 1|Protocol Violation|1|||
37965714|NCT00365716|69652701|FG006|Extension 1|Protocol Violation|0|||
38063244|NCT03550313|69756576|FG000|Overall Study|No longer met eligibility criteria|3|||
38063245|NCT03550313|69756577|FG001|Overall Study|No longer met eligibility criteria|5|||
38063246|NCT03550313|69756578|FG002|Overall Study|No longer met eligibility criteria|6|||
38063247|NCT03550313|69756576|FG000|Overall Study|Withdrawal by parent/guardian|20|||
38063248|NCT03550313|69756577|FG001|Overall Study|Withdrawal by parent/guardian|18|||
38063249|NCT03550313|69756578|FG002|Overall Study|Withdrawal by parent/guardian|26|||
38063250|NCT03550313|69756576|FG000|Overall Study|Other|4|||
38063251|NCT03550313|69756577|FG001|Overall Study|Other|2|||
38063252|NCT03550313|69756578|FG002|Overall Study|Other|2|||
38063253|NCT03550313|69756576|FG000|Overall Study|Randomized but not vaccinated|3|||
38063254|NCT03550313|69756577|FG001|Overall Study|Randomized but not vaccinated|23|||
38063255|NCT03550313|69756578|FG002|Overall Study|Randomized but not vaccinated|2|||
38063256|NCT03550313|69756576|FG000|Overall Study|Sites terminated due to quality issues|18|||
38063257|NCT03550313|69756577|FG001|Overall Study|Sites terminated due to quality issues|17|||
38063258|NCT03550313|69756578|FG002|Overall Study|Sites terminated due to quality issues|18|||
38063259|NCT03312907|69756590|FG000|Overall Study|Adverse Event|1|||
38063260|NCT03312907|69756591|FG001|Overall Study|Adverse Event|6|||
38063261|NCT03312907|69756592|FG002|Overall Study|Adverse Event|1|||
38063262|NCT03312907|69756590|FG000|Overall Study|Protocol Violation|2|||
38063263|NCT03312907|69756591|FG001|Overall Study|Protocol Violation|3|||
38063264|NCT03312907|69756592|FG002|Overall Study|Protocol Violation|4|||
38063265|NCT03312907|69756590|FG000|Overall Study|Lost to Follow-up|2|||
38063266|NCT03312907|69756591|FG001|Overall Study|Lost to Follow-up|3|||
38063267|NCT03312907|69756592|FG002|Overall Study|Lost to Follow-up|2|||
38063268|NCT03312907|69756590|FG000|Overall Study|Physician Decision|3|||
38063269|NCT03312907|69756591|FG001|Overall Study|Physician Decision|4|||
38063270|NCT03312907|69756592|FG002|Overall Study|Physician Decision|2|||
38063271|NCT03312907|69756590|FG000|Overall Study|Withdrawal by Subject|9|||
38063272|NCT03312907|69756591|FG001|Overall Study|Withdrawal by Subject|14|||
38063273|NCT03312907|69756592|FG002|Overall Study|Withdrawal by Subject|10|||
38063274|NCT02999672|69756602|FG000|Overall Study|Death|0|||
38063275|NCT02999672|69756603|FG001|Overall Study|Death|1|||
38063276|NCT02999672|69756602|FG000|Overall Study|Study Terminated by Sponsor|0|||
38063277|NCT02999672|69756603|FG001|Overall Study|Study Terminated by Sponsor|1|||
38063278|NCT02999672|69756602|FG000|Overall Study|Progressive Disease|9|||
38063279|NCT02999672|69756603|FG001|Overall Study|Progressive Disease|5|||
38063280|NCT02999672|69756602|FG000|Overall Study|Adverse Event|4|||
38063281|NCT02999672|69756603|FG001|Overall Study|Adverse Event|0|||
38063282|NCT01911676|69756613|FG000|Period 1 of Study|Withdrawal by Subject|4|||
38063283|NCT01911676|69756614|FG001|Period 1 of Study|Withdrawal by Subject|2|||
38063284|NCT01911676|69756615|FG002|Period 1 of Study|Withdrawal by Subject|1|||
38063285|NCT01911676|69756616|FG003|Period 1 of Study|Withdrawal by Subject|2|||
38063286|NCT01911676|69756613|FG000|Period 1 of Study|Physician Decision|2|||
38063287|NCT01911676|69756614|FG001|Period 1 of Study|Physician Decision|0|||
38063288|NCT01911676|69756615|FG002|Period 1 of Study|Physician Decision|0|||
38063289|NCT01911676|69756616|FG003|Period 1 of Study|Physician Decision|1|||
38063290|NCT01911676|69756613|FG000|Period 2 of Study|Physician Decision|2|||
38063291|NCT01911676|69756614|FG001|Period 2 of Study|Physician Decision|0|||
38063292|NCT01911676|69756615|FG002|Period 2 of Study|Physician Decision|0|||
38063293|NCT01911676|69756616|FG003|Period 2 of Study|Physician Decision|1|||
38063294|NCT01911676|69756613|FG000|Period 2 of Study|Lost to Follow-up|0|||
38063295|NCT01911676|69756614|FG001|Period 2 of Study|Lost to Follow-up|0|||
38063296|NCT01911676|69756615|FG002|Period 2 of Study|Lost to Follow-up|0|||
38063297|NCT01911676|69756616|FG003|Period 2 of Study|Lost to Follow-up|1|||
38063298|NCT03573323|69756633|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
38063299|NCT03573323|69756634|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
38063300|NCT03573323|69756633|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
38063301|NCT03573323|69756634|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
38063302|NCT03573323|69756633|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
38063303|NCT03573323|69756634|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
38063304|NCT03573323|69756633|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
38063305|NCT03573323|69756634|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
38063306|NCT03573323|69756633|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
38063307|NCT03573323|69756634|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
38063308|NCT03573323|69756633|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
38063309|NCT03573323|69756634|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
38063310|NCT03573323|69756633|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
38063311|NCT03573323|69756634|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
38063312|NCT03573323|69756633|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
38063313|NCT03573323|69756634|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
38063314|NCT03573323|69756633|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
38063315|NCT03573323|69756634|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
38063316|NCT03573323|69756633|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
38063317|NCT03573323|69756634|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
38063318|NCT03573323|69756633|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
38063319|NCT03573323|69756634|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
38063320|NCT03573323|69756633|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
38063321|NCT03573323|69756634|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
38063322|NCT03573323|69756633|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
38063323|NCT03573323|69756634|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
38063324|NCT03573323|69756633|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
38063325|NCT03573323|69756634|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
38063326|NCT03573323|69756633|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
38063327|NCT03573323|69756634|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
38063328|NCT03573323|69756633|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
38063329|NCT03573323|69756634|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
38063330|NCT03573323|69756633|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
38063331|NCT03573323|69756634|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
38063332|NCT03573323|69756633|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
38063333|NCT03573323|69756634|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
38063334|NCT03573323|69756633|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
38063335|NCT03573323|69756634|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
38063336|NCT03306043|69756660|FG000|Overall Study|Adverse Event|1|||
38063337|NCT03306043|69756660|FG000|Overall Study|Lost to Follow-up|1|||
38063338|NCT03306043|69756660|FG000|Overall Study|Withdrawal by Subject|2|||
38063339|NCT01069172|69756664|FG000|Overall Study|Withdrawal by Subject|1|||
38063340|NCT01069172|69756665|FG001|Overall Study|Withdrawal by Subject|0|||
38063341|NCT02911688|69756674|FG000|Washout|Lost to Follow-up|1|||
38063342|NCT02911688|69756675|FG001|Washout|Lost to Follow-up|1|||
38063343|NCT02911688|69756674|FG000|Washout|Withdrawal by Subject|0|||
38063344|NCT02911688|69756675|FG001|Washout|Withdrawal by Subject|1|||
38063345|NCT02670928|69756685|FG000|Overall Study|Adverse Event|3|||
38063346|NCT02670928|69756686|FG001|Overall Study|Adverse Event|1|||
38063347|NCT02670928|69756685|FG000|Overall Study|Withdrawal by Subject|4|||
38063348|NCT02670928|69756686|FG001|Overall Study|Withdrawal by Subject|0|||
38063349|NCT02670928|69756685|FG000|Overall Study|Lost to Follow-up|1|||
38063350|NCT02670928|69756686|FG001|Overall Study|Lost to Follow-up|0|||
38063351|NCT02670928|69756685|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
38063352|NCT02670928|69756686|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
38063353|NCT03305809|69756696|FG000|Overall Study|Adverse Event|2|||
38063354|NCT03305809|69756697|FG001|Overall Study|Adverse Event|2|||
38063355|NCT03305809|69756698|FG002|Overall Study|Adverse Event|6|||
38063356|NCT03305809|69756699|FG003|Overall Study|Adverse Event|6|||
38063357|NCT03305809|69756696|FG000|Overall Study|Death|0|||
38063358|NCT03305809|69756697|FG001|Overall Study|Death|0|||
38063359|NCT03305809|69756698|FG002|Overall Study|Death|1|||
38063360|NCT03305809|69756699|FG003|Overall Study|Death|1|||
38063361|NCT03305809|69756696|FG000|Overall Study|Lost to Follow-up|1|||
38063362|NCT03305809|69756697|FG001|Overall Study|Lost to Follow-up|2|||
38063363|NCT03305809|69756698|FG002|Overall Study|Lost to Follow-up|0|||
38063364|NCT03305809|69756699|FG003|Overall Study|Lost to Follow-up|0|||
38063365|NCT03305809|69756696|FG000|Overall Study|Sponsor Decision|1|||
38063366|NCT03305809|69756697|FG001|Overall Study|Sponsor Decision|0|||
38063367|NCT03305809|69756698|FG002|Overall Study|Sponsor Decision|1|||
38063368|NCT03305809|69756699|FG003|Overall Study|Sponsor Decision|8|||
38063369|NCT03305809|69756696|FG000|Overall Study|Physician Decision|0|||
38063370|NCT03305809|69756697|FG001|Overall Study|Physician Decision|0|||
38063371|NCT03305809|69756698|FG002|Overall Study|Physician Decision|2|||
38063372|NCT03305809|69756699|FG003|Overall Study|Physician Decision|4|||
38063373|NCT03305809|69756696|FG000|Overall Study|Progressive Disease|0|||
38063374|NCT03305809|69756697|FG001|Overall Study|Progressive Disease|0|||
38063375|NCT03305809|69756698|FG002|Overall Study|Progressive Disease|1|||
38063376|NCT03305809|69756699|FG003|Overall Study|Progressive Disease|0|||
38063377|NCT03305809|69756696|FG000|Overall Study|Protocol Violation|1|||
38063378|NCT03305809|69756697|FG001|Overall Study|Protocol Violation|0|||
38063379|NCT03305809|69756698|FG002|Overall Study|Protocol Violation|2|||
38063380|NCT03305809|69756699|FG003|Overall Study|Protocol Violation|3|||
38063381|NCT03305809|69756696|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
38063382|NCT03305809|69756697|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
38063383|NCT03305809|69756698|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
38063384|NCT03305809|69756699|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
38063385|NCT03305809|69756696|FG000|Overall Study|Withdrawal by Subject|2|||
38063386|NCT03305809|69756697|FG001|Overall Study|Withdrawal by Subject|4|||
38063387|NCT03305809|69756698|FG002|Overall Study|Withdrawal by Subject|5|||
38063388|NCT03305809|69756699|FG003|Overall Study|Withdrawal by Subject|2|||
38063389|NCT03305809|69756696|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
38063390|NCT03305809|69756697|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
38063391|NCT03305809|69756698|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
38063392|NCT03305809|69756699|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
38063393|NCT02994056|69756712|FG000|Overall Study|Death|8|||
38063394|NCT02994056|69756712|FG000|Overall Study|Withdrew Consent|1|||
38063395|NCT03548051|69756731|FG000|Overall Study|Death|1|||
38063396|NCT03548051|69756732|FG001|Overall Study|Death|1|||
38063397|NCT03548051|69756731|FG000|Overall Study|Withdrawal by Subject|1|||
38063398|NCT03548051|69756732|FG001|Overall Study|Withdrawal by Subject|0|||
38063399|NCT03305731|69756738|FG000|Overall Study|Protocol Violation|1|||
38063400|NCT03305575|69756744|FG000|Overall Study|Physician Decision|1|||
38063401|NCT03305575|69756745|FG001|Overall Study|Physician Decision|0|||
38063402|NCT02993822|69756755|FG000|Overall Study|Lack of Efficacy|1|||
38063403|NCT02993822|69756756|FG001|Overall Study|Lack of Efficacy|1|||
38063404|NCT02993822|69756757|FG002|Overall Study|Lack of Efficacy|0|||
38063405|NCT02993822|69756758|FG003|Overall Study|Lack of Efficacy|0|||
38063406|NCT02993822|69756755|FG000|Overall Study|Protocol Violation|1|||
38063407|NCT02993822|69756756|FG001|Overall Study|Protocol Violation|0|||
38063408|NCT02993822|69756757|FG002|Overall Study|Protocol Violation|0|||
38063409|NCT02993822|69756758|FG003|Overall Study|Protocol Violation|0|||
38063410|NCT02993822|69756755|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
38063411|NCT02993822|69756756|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
38063412|NCT02993822|69756757|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
38063413|NCT02993822|69756758|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
38063414|NCT02993822|69756755|FG000|Overall Study|Adverse Event|3|||
38063415|NCT02993822|69756756|FG001|Overall Study|Adverse Event|1|||
38063416|NCT02993822|69756757|FG002|Overall Study|Adverse Event|7|||
38063417|NCT02993822|69756758|FG003|Overall Study|Adverse Event|0|||
38063418|NCT02993822|69756755|FG000|Overall Study|Withdrawal by Subject|4|||
38063419|NCT02993822|69756756|FG001|Overall Study|Withdrawal by Subject|2|||
38063420|NCT02993822|69756757|FG002|Overall Study|Withdrawal by Subject|2|||
38063421|NCT02993822|69756758|FG003|Overall Study|Withdrawal by Subject|3|||
38063422|NCT02993822|69756755|FG000|Overall Study|Lost to Follow-up|1|||
38063423|NCT02993822|69756756|FG001|Overall Study|Lost to Follow-up|0|||
38063424|NCT02993822|69756757|FG002|Overall Study|Lost to Follow-up|1|||
38063425|NCT02993822|69756758|FG003|Overall Study|Lost to Follow-up|0|||
38063426|NCT01068860|69756778|FG000|Overall Study|Withdrawal by Subject|0|||
38063427|NCT01068860|69756779|FG001|Overall Study|Withdrawal by Subject|0|||
38063428|NCT01068860|69756780|FG002|Overall Study|Withdrawal by Subject|0|||
38063429|NCT01068860|69756781|FG003|Overall Study|Withdrawal by Subject|0|||
38063430|NCT01068860|69756782|FG004|Overall Study|Withdrawal by Subject|0|||
38063431|NCT01068860|69756783|FG005|Overall Study|Withdrawal by Subject|2|||
38063432|NCT01068860|69756784|FG006|Overall Study|Withdrawal by Subject|0|||
38063433|NCT01068860|69756785|FG007|Overall Study|Withdrawal by Subject|0|||
38063434|NCT01068860|69756786|FG008|Overall Study|Withdrawal by Subject|0|||
38063435|NCT01068860|69756787|FG009|Overall Study|Withdrawal by Subject|3|||
38063436|NCT01068860|69756778|FG000|Overall Study|Administrative problems; misrandomized|0|||
38063437|NCT01068860|69756779|FG001|Overall Study|Administrative problems; misrandomized|0|||
38063438|NCT01068860|69756780|FG002|Overall Study|Administrative problems; misrandomized|0|||
38063439|NCT01068860|69756781|FG003|Overall Study|Administrative problems; misrandomized|1|||
38063440|NCT01068860|69756782|FG004|Overall Study|Administrative problems; misrandomized|0|||
38063441|NCT01068860|69756783|FG005|Overall Study|Administrative problems; misrandomized|0|||
38063442|NCT01068860|69756784|FG006|Overall Study|Administrative problems; misrandomized|0|||
38063443|NCT01068860|69756785|FG007|Overall Study|Administrative problems; misrandomized|0|||
38063444|NCT01068860|69756786|FG008|Overall Study|Administrative problems; misrandomized|0|||
38063445|NCT01068860|69756787|FG009|Overall Study|Administrative problems; misrandomized|1|||
38063446|NCT01068860|69756778|FG000|Overall Study|Lost to Follow-up|0|||
38063447|NCT01068860|69756779|FG001|Overall Study|Lost to Follow-up|1|||
38063448|NCT01068860|69756780|FG002|Overall Study|Lost to Follow-up|0|||
38063449|NCT01068860|69756781|FG003|Overall Study|Lost to Follow-up|0|||
38063450|NCT01068860|69756782|FG004|Overall Study|Lost to Follow-up|0|||
38063451|NCT01068860|69756783|FG005|Overall Study|Lost to Follow-up|0|||
38063452|NCT01068860|69756784|FG006|Overall Study|Lost to Follow-up|0|||
38063453|NCT01068860|69756785|FG007|Overall Study|Lost to Follow-up|0|||
38063454|NCT01068860|69756786|FG008|Overall Study|Lost to Follow-up|0|||
38063455|NCT01068860|69756787|FG009|Overall Study|Lost to Follow-up|0|||
38063456|NCT02989610|69756809|FG000|Overall Study|Withdrawal/Other reasons|39|||
38063457|NCT01372774|69756815|FG000|Overall Study|Withdrawal prior to treatment|4|||
38063458|NCT01372774|69756816|FG001|Overall Study|Withdrawal prior to treatment|5|||
38063459|NCT02670538|69756827|FG000|Overall Study|Withdrawal of Consent|8|||
38063460|NCT02670538|69756828|FG001|Overall Study|Withdrawal of Consent|6|||
38063461|NCT02670538|69756829|FG002|Overall Study|Withdrawal of Consent|5|||
38063462|NCT02670538|69756827|FG000|Overall Study|Lost to Follow-up|8|||
38063463|NCT02670538|69756828|FG001|Overall Study|Lost to Follow-up|12|||
38063464|NCT02670538|69756829|FG002|Overall Study|Lost to Follow-up|7|||
38063465|NCT02670538|69756827|FG000|Overall Study|Adverse Event|5|||
38063466|NCT02670538|69756828|FG001|Overall Study|Adverse Event|5|||
38063467|NCT02670538|69756829|FG002|Overall Study|Adverse Event|11|||
38063468|NCT02670538|69756827|FG000|Overall Study|Lack of Efficacy|7|||
38063469|NCT02670538|69756828|FG001|Overall Study|Lack of Efficacy|1|||
38063470|NCT02670538|69756829|FG002|Overall Study|Lack of Efficacy|2|||
38063471|NCT02670538|69756827|FG000|Overall Study|Protocol Violation|3|||
38063472|NCT02670538|69756828|FG001|Overall Study|Protocol Violation|4|||
38063473|NCT02670538|69756829|FG002|Overall Study|Protocol Violation|1|||
38063474|NCT02670538|69756827|FG000|Overall Study|Noncompliance with Study Drug|1|||
38063475|NCT02670538|69756828|FG001|Overall Study|Noncompliance with Study Drug|3|||
38063476|NCT02670538|69756829|FG002|Overall Study|Noncompliance with Study Drug|2|||
38063477|NCT02670538|69756827|FG000|Overall Study|Other Miscellaneous Reasons|0|||
38063478|NCT02670538|69756828|FG001|Overall Study|Other Miscellaneous Reasons|1|||
38063479|NCT02670538|69756829|FG002|Overall Study|Other Miscellaneous Reasons|2|||
38063480|NCT03547583|69756840|FG000|Overall Study|Adverse Event|16|||
38063481|NCT03547583|69756841|FG001|Overall Study|Adverse Event|11|||
38063482|NCT03547583|69756842|FG002|Overall Study|Adverse Event|10|||
38063483|NCT03547583|69756840|FG000|Overall Study|Death|11|||
38063484|NCT03547583|69756841|FG001|Overall Study|Death|7|||
38063485|NCT03547583|69756842|FG002|Overall Study|Death|4|||
38063486|NCT03547583|69756840|FG000|Overall Study|Lost to Follow-up|1|||
38063487|NCT03547583|69756841|FG001|Overall Study|Lost to Follow-up|0|||
38063488|NCT03547583|69756842|FG002|Overall Study|Lost to Follow-up|0|||
38063489|NCT03547583|69756840|FG000|Overall Study|Non-compliance with study drug|0|||
38063490|NCT03547583|69756841|FG001|Overall Study|Non-compliance with study drug|0|||
38063491|NCT03547583|69756842|FG002|Overall Study|Non-compliance with study drug|1|||
38063492|NCT03547583|69756840|FG000|Overall Study|Physician Decision|1|||
38063493|NCT03547583|69756841|FG001|Overall Study|Physician Decision|0|||
38063494|NCT03547583|69756842|FG002|Overall Study|Physician Decision|3|||
38063495|NCT03547583|69756840|FG000|Overall Study|Protocol Violation|2|||
38063496|NCT03547583|69756841|FG001|Overall Study|Protocol Violation|1|||
38063497|NCT03547583|69756842|FG002|Overall Study|Protocol Violation|1|||
38063498|NCT03547583|69756840|FG000|Overall Study|Withdrawal by Subject|12|||
38063499|NCT03547583|69756841|FG001|Overall Study|Withdrawal by Subject|19|||
38063500|NCT03547583|69756842|FG002|Overall Study|Withdrawal by Subject|10|||
38063501|NCT03547583|69756840|FG000|Overall Study|Other|2|||
38063502|NCT03547583|69756841|FG001|Overall Study|Other|2|||
38063503|NCT03547583|69756842|FG002|Overall Study|Other|3|||
38063504|NCT02670382|69756853|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
38063505|NCT02670382|69756854|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
38063506|NCT02991482|69756864|FG000|Overall Study|Disease progression|56|||
38063507|NCT02991482|69756865|FG001|Overall Study|Disease progression|47|||
38063508|NCT02991482|69756864|FG000|Overall Study|Death|4|||
38063509|NCT02991482|69756865|FG001|Overall Study|Death|4|||
38063510|NCT02991482|69756864|FG000|Overall Study|Adverse Event|1|||
38063511|NCT02991482|69756865|FG001|Overall Study|Adverse Event|6|||
38063512|NCT02991482|69756864|FG000|Overall Study|Patient decision|1|||
38063513|NCT02991482|69756865|FG001|Overall Study|Patient decision|1|||
38063514|NCT02991482|69756864|FG000|Overall Study|Physician Decision|0|||
38063515|NCT02991482|69756865|FG001|Overall Study|Physician Decision|6|||
38063516|NCT02991482|69756864|FG000|Overall Study|Clinical deterioration|1|||
38063517|NCT02991482|69756865|FG001|Overall Study|Clinical deterioration|0|||
38063518|NCT02991482|69756864|FG000|Overall Study|Patient feeling too unwell|1|||
38063519|NCT02991482|69756865|FG001|Overall Study|Patient feeling too unwell|0|||
38063520|NCT02991482|69756864|FG000|Overall Study|Worsening of performance status|0|||
38063521|NCT02991482|69756865|FG001|Overall Study|Worsening of performance status|1|||
38063522|NCT02991482|69756864|FG000|Overall Study|Death prior to study drug initiation|1|||
38063523|NCT02991482|69756865|FG001|Overall Study|Death prior to study drug initiation|0|||
38063524|NCT02991482|69756864|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
38063525|NCT02991482|69756865|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
38063526|NCT02674750|69756874|FG000|Overall Study|Death|4|||
38063527|NCT02674750|69756875|FG001|Overall Study|Death|5|||
38063528|NCT02674750|69756876|FG002|Overall Study|Death|8|||
38063529|NCT02674750|69756874|FG000|Overall Study|Lost to Follow-up|0|||
38063530|NCT02674750|69756875|FG001|Overall Study|Lost to Follow-up|8|||
38063531|NCT02674750|69756876|FG002|Overall Study|Lost to Follow-up|0|||
38063532|NCT02674750|69756874|FG000|Overall Study|Lack of Efficacy|1|||
38063533|NCT02674750|69756875|FG001|Overall Study|Lack of Efficacy|17|||
38063534|NCT02674750|69756876|FG002|Overall Study|Lack of Efficacy|3|||
38063535|NCT02674750|69756874|FG000|Overall Study|Withdrawal by Subject|0|||
38063536|NCT02674750|69756875|FG001|Overall Study|Withdrawal by Subject|7|||
38063537|NCT02674750|69756876|FG002|Overall Study|Withdrawal by Subject|1|||
38063538|NCT02674750|69756874|FG000|Overall Study|Other|0|||
38063539|NCT02674750|69756875|FG001|Overall Study|Other|8|||
38063540|NCT02674750|69756876|FG002|Overall Study|Other|0|||
38063541|NCT02987972|69756905|FG000|Overall Study|Adverse Event|1|||
38063542|NCT02987972|69756906|FG001|Overall Study|Adverse Event|1|||
38063543|NCT02987972|69756907|FG002|Overall Study|Adverse Event|0|||
38063544|NCT02987972|69756905|FG000|Overall Study|Death|1|||
38063545|NCT02987972|69756906|FG001|Overall Study|Death|0|||
38063546|NCT02987972|69756907|FG002|Overall Study|Death|0|||
38063547|NCT02987972|69756905|FG000|Overall Study|Lack of Efficacy|9|||
38063548|NCT02987972|69756906|FG001|Overall Study|Lack of Efficacy|12|||
38063549|NCT02987972|69756907|FG002|Overall Study|Lack of Efficacy|12|||
38063550|NCT02987972|69756905|FG000|Overall Study|Lost to Follow-up|7|||
38063551|NCT02987972|69756906|FG001|Overall Study|Lost to Follow-up|8|||
38063552|NCT02987972|69756907|FG002|Overall Study|Lost to Follow-up|4|||
38063553|NCT02987972|69756905|FG000|Overall Study|Physician Decision|1|||
38063554|NCT02987972|69756906|FG001|Overall Study|Physician Decision|6|||
38063555|NCT02987972|69756907|FG002|Overall Study|Physician Decision|0|||
38063556|NCT02987972|69756905|FG000|Overall Study|Protocol Violation|2|||
38063557|NCT02987972|69756906|FG001|Overall Study|Protocol Violation|1|||
38063558|NCT02987972|69756907|FG002|Overall Study|Protocol Violation|5|||
38063559|NCT02987972|69756905|FG000|Overall Study|Withdrawal by Subject|22|||
38063560|NCT02987972|69756906|FG001|Overall Study|Withdrawal by Subject|17|||
38063561|NCT02987972|69756907|FG002|Overall Study|Withdrawal by Subject|21|||
38063562|NCT01372618|69756915|FG000|Overall Study|PI Died. Study Terminated|9|||
38063563|NCT03304873|69756921|FG000|Overall Study|Lost to Follow-up|1|||
38063564|NCT03304873|69756922|FG001|Overall Study|Lost to Follow-up|8|||
38063565|NCT02669758|69756928|FG000|Overall Study|Withdrawal by Subject|43|||
38063566|NCT02669758|69756928|FG000|Overall Study|Lost to Follow-up|19|||
38063567|NCT02669758|69756928|FG000|Overall Study|Adverse Event|16|||
38063568|NCT02669758|69756928|FG000|Overall Study|Non-Compliance with Study Drug|8|||
38063569|NCT02669758|69756928|FG000|Overall Study|Lack of Efficacy|5|||
38063570|NCT02669758|69756928|FG000|Overall Study|Pregnancy|1|||
38063571|NCT02669758|69756928|FG000|Overall Study|Study noncompliance|1|||
38063572|NCT02669758|69756928|FG000|Overall Study|Protocol Violation|1|||
38063573|NCT02987660|69756934|FG000|Overall Study|Study terminated by sponsor|10|||
38063574|NCT02987660|69756935|FG001|Overall Study|Study terminated by sponsor|10|||
38063575|NCT04528069|69756941|FG000|Overall Study|Adverse Event|1|||
38063576|NCT04528069|69756941|FG000|Overall Study|Lost to Follow-up|1|||
38063577|NCT04528069|69756941|FG000|Overall Study|Patient Unable to Come|1|||
38063578|NCT04528069|69756941|FG000|Overall Study|Patient Unable to Attend|1|||
38063579|NCT03303469|69756957|FG000|Overall Study|Lost to Follow-up|2|||
38063580|NCT02990000|69756963|FG000|Overall Study|Failed to provide data beyond baseline|36|||
38063581|NCT02990000|69756964|FG001|Overall Study|Failed to provide data beyond baseline|34|||
38063582|NCT01068626|69756972|FG000|Overall Study|Adverse Event|3|||
38063583|NCT01068626|69756973|FG001|Overall Study|Adverse Event|0|||
38063584|NCT01068626|69756972|FG000|Overall Study|Withdrawal by Subject|0|||
38063585|NCT01068626|69756973|FG001|Overall Study|Withdrawal by Subject|2|||
38063586|NCT02921750|69756981|FG000|Overall Study|Adverse Event|1|||
38063587|NCT02921750|69756982|FG001|Overall Study|Adverse Event|2|||
38063588|NCT02921750|69756981|FG000|Overall Study|Withdrawal by Subject|1|||
38063589|NCT02921750|69756982|FG001|Overall Study|Withdrawal by Subject|1|||
38063590|NCT02921750|69756981|FG000|Overall Study|Lost to Follow-up|3|||
38063591|NCT02921750|69756982|FG001|Overall Study|Lost to Follow-up|3|||
38063592|NCT02921750|69756981|FG000|Overall Study|Wound healed|3|||
38063593|NCT02921750|69756982|FG001|Overall Study|Wound healed|3|||
38063594|NCT02921750|69756981|FG000|Overall Study|Serious Adverse Event|1|||
38063595|NCT02921750|69756982|FG001|Overall Study|Serious Adverse Event|2|||
38063596|NCT02920970|69756991|FG000|First Intervention|Protocol Violation|0|||
38063597|NCT02920970|69756992|FG001|First Intervention|Protocol Violation|1|||
38063598|NCT02920970|69756991|FG000|First Intervention|Adverse Event|0|||
38063599|NCT02920970|69756992|FG001|First Intervention|Adverse Event|1|||
38063600|NCT02920970|69756991|FG000|Second Intervention|Poor Lens Fit|1|||
38063601|NCT02920970|69756992|FG001|Second Intervention|Poor Lens Fit|0|||
38063602|NCT01068158|69757002|FG000|Overall Study|Withdrawal by Subject|1|||
38063603|NCT01068158|69757003|FG001|Overall Study|Withdrawal by Subject|2|||
38063604|NCT01068158|69757002|FG000|Overall Study|Lost to Follow-up|7|||
38063605|NCT01068158|69757003|FG001|Overall Study|Lost to Follow-up|0|||
38063606|NCT01068158|69757002|FG000|Overall Study|Protocol Violation|0|||
38063607|NCT01068158|69757003|FG001|Overall Study|Protocol Violation|2|||
38063608|NCT03303079|69757012|FG000|Overall Study|Adverse Event|0|||
38063609|NCT03303079|69757013|FG001|Overall Study|Adverse Event|1|||
38063610|NCT03303079|69757014|FG002|Overall Study|Adverse Event|3|||
38063611|NCT03303079|69757012|FG000|Overall Study|Protocol Violation|5|||
38063612|NCT03303079|69757013|FG001|Overall Study|Protocol Violation|4|||
38063613|NCT03303079|69757014|FG002|Overall Study|Protocol Violation|7|||
38063614|NCT03303079|69757012|FG000|Overall Study|Withdrawal by Subject|2|||
38063615|NCT03303079|69757013|FG001|Overall Study|Withdrawal by Subject|4|||
38063616|NCT03303079|69757014|FG002|Overall Study|Withdrawal by Subject|2|||
38063617|NCT03303079|69757012|FG000|Overall Study|Other than specified|0|||
38063618|NCT03303079|69757013|FG001|Overall Study|Other than specified|2|||
37862261|NCT00919633|69546036|FG002|Overall Study|Protocol Violation|0|||
38063619|NCT03303079|69757014|FG002|Overall Study|Other than specified|0|||
38063620|NCT01067846|69757024|FG000|Overall Study|Lost to Follow-up|17|||
38063621|NCT01067846|69757025|FG001|Overall Study|Lost to Follow-up|19|||
37862262|NCT00919633|69546037|FG003|Overall Study|Protocol Violation|1|||
38063622|NCT01067846|69757024|FG000|Overall Study|Withdrawal by Subject|1|||
38063623|NCT01067846|69757025|FG001|Overall Study|Withdrawal by Subject|0|||
38063624|NCT01067846|69757024|FG000|Overall Study|participation in other tx study|1|||
38063625|NCT01067846|69757025|FG001|Overall Study|participation in other tx study|0|||
38063626|NCT03311659|69757031|FG000|Overall Study|Protocol Violation|1|||
38063627|NCT03874234|69757048|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
38063628|NCT03874234|69757049|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
38063629|NCT03874234|69757050|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
38063630|NCT03874234|69757051|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
38063631|NCT03874234|69757052|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
38063632|NCT03874234|69757053|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
38063633|NCT03874234|69757054|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
38063634|NCT03874234|69757055|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
38063635|NCT03874234|69757056|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
38063636|NCT03874234|69757057|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
38063637|NCT03874234|69757058|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
38063638|NCT03874234|69757059|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
38063639|NCT03874234|69757060|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
38063640|NCT03874234|69757048|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
38063641|NCT03874234|69757049|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
38063642|NCT03874234|69757050|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
38063643|NCT03874234|69757051|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
38063644|NCT03874234|69757052|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
38063645|NCT03874234|69757053|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
38063646|NCT03874234|69757054|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
38063647|NCT03874234|69757055|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
38063648|NCT03874234|69757056|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
38063649|NCT03874234|69757057|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
38063650|NCT03874234|69757058|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
38063651|NCT03874234|69757059|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
38063652|NCT03874234|69757060|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
38063653|NCT03874234|69757048|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
38063654|NCT03874234|69757049|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
38063655|NCT03874234|69757050|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
38063656|NCT03874234|69757051|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
38063657|NCT03874234|69757052|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
38063658|NCT03874234|69757053|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
38063659|NCT03874234|69757054|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
38063660|NCT03874234|69757055|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
38063661|NCT03874234|69757056|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
38063662|NCT03874234|69757057|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
38063663|NCT03874234|69757058|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
38063664|NCT03874234|69757059|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
38063665|NCT03874234|69757060|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
38063666|NCT03874234|69757048|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
38063667|NCT03874234|69757049|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
38063668|NCT03874234|69757050|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
38063669|NCT03874234|69757051|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
38063670|NCT03874234|69757052|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
38063671|NCT03874234|69757053|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
38063672|NCT03874234|69757054|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
38063673|NCT03874234|69757055|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
38063674|NCT03874234|69757056|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
38063675|NCT03874234|69757057|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
38063676|NCT03874234|69757058|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
38063677|NCT03874234|69757059|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
38063678|NCT03874234|69757060|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
38063679|NCT03874234|69757048|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
38063680|NCT03874234|69757049|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
38063681|NCT03874234|69757050|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
38063682|NCT03874234|69757051|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
38063683|NCT03874234|69757052|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
38063684|NCT03874234|69757053|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
38063685|NCT03874234|69757054|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
38063686|NCT03874234|69757055|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
38063687|NCT03874234|69757056|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
38063688|NCT03874234|69757057|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
38063689|NCT03874234|69757058|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
38063690|NCT03874234|69757059|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
38063691|NCT03874234|69757060|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
38063692|NCT03874234|69757048|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
38063693|NCT03874234|69757049|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
38063694|NCT03874234|69757050|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
38063695|NCT03874234|69757051|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
38063696|NCT03874234|69757052|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
38063697|NCT03874234|69757053|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
38063698|NCT03874234|69757054|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
38063699|NCT03874234|69757055|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
38063700|NCT03874234|69757056|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
38063701|NCT03874234|69757057|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
38063702|NCT03874234|69757058|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
38063703|NCT03874234|69757059|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
38063704|NCT03874234|69757060|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
38063705|NCT03874234|69757048|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
38063706|NCT03874234|69757049|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
38063707|NCT03874234|69757050|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
38063708|NCT03874234|69757051|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
38063709|NCT03874234|69757052|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
38063710|NCT03874234|69757053|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
38063711|NCT03874234|69757054|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
38063712|NCT03874234|69757055|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
38063713|NCT03874234|69757056|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
38063714|NCT03874234|69757057|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
38063715|NCT03874234|69757058|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
38063716|NCT03874234|69757059|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
38063717|NCT03874234|69757060|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
38063718|NCT03874234|69757048|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
38063719|NCT03874234|69757049|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
38063720|NCT03874234|69757050|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
38063721|NCT03874234|69757051|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
38063722|NCT03874234|69757052|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
38063723|NCT03874234|69757053|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
38063724|NCT03874234|69757054|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
38063725|NCT03874234|69757055|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
38063726|NCT03874234|69757056|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
38063727|NCT03874234|69757057|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
38063728|NCT03874234|69757058|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
38063729|NCT03874234|69757059|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
38063730|NCT03874234|69757060|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
38063731|NCT02985398|69757096|FG000|Overall Study|Adverse Event|1|||
38063732|NCT02985398|69757096|FG000|Overall Study|Lost to Follow-up|4|||
38063733|NCT02985398|69757096|FG000|Overall Study|Withdrawal by Subject|8|||
38063734|NCT02985398|69757096|FG000|Overall Study|Study Burden|9|||
38063735|NCT03310723|69757102|FG000|Overall Study|Withdrawal by Subject|0|||
38063736|NCT03310723|69757103|FG001|Overall Study|Withdrawal by Subject|1|||
38063737|NCT03310723|69757102|FG000|Overall Study|Protocol Violation|0|||
38063738|NCT03310723|69757103|FG001|Overall Study|Protocol Violation|2|||
38063739|NCT02663674|69757111|FG000|Overall Study|Lost to Follow-up|5|||
38063740|NCT02663674|69757112|FG001|Overall Study|Lost to Follow-up|4|||
38063741|NCT02663674|69757111|FG000|Overall Study|Withdrawal by Subject|1|||
38063742|NCT02663674|69757112|FG001|Overall Study|Withdrawal by Subject|4|||
38063743|NCT02663674|69757111|FG000|Overall Study|Physician Decision|1|||
38063744|NCT02663674|69757112|FG001|Overall Study|Physician Decision|1|||
38063745|NCT02663674|69757111|FG000|Overall Study|Other Event (Health Related)|0|||
38063746|NCT02663674|69757112|FG001|Overall Study|Other Event (Health Related)|1|||
38063747|NCT02908880|69757118|FG000|Overall Study|Lost to Follow-up|4|||
38063748|NCT02908880|69757118|FG000|Overall Study|Explantation of the device|1|||
38063749|NCT02908880|69757118|FG000|Overall Study|Withdrawal by Subject|17|||
38063750|NCT02908880|69757118|FG000|Overall Study|Death|5|||
38063751|NCT03310411|69757122|FG000|Period 1|Adverse Event|0|||
38063752|NCT03310411|69757123|FG001|Period 1|Adverse Event|0|||
38063753|NCT03310411|69757124|FG002|Period 1|Adverse Event|0|||
38063754|NCT03310411|69757125|FG003|Period 1|Adverse Event|1|||
38063755|NCT03301831|69757143|FG000|Overall Study|Lost to Follow-up|5|||
38063756|NCT03301831|69757144|FG001|Overall Study|Lost to Follow-up|3|||
38063757|NCT03301831|69757143|FG000|Overall Study|Protocol Violation|4|||
38063758|NCT03301831|69757144|FG001|Overall Study|Protocol Violation|0|||
38063759|NCT03301831|69757143|FG000|Overall Study|Withdrawal by Subject|11|||
38063760|NCT03301831|69757144|FG001|Overall Study|Withdrawal by Subject|0|||
38063761|NCT02909504|69757150|FG000|Overall Study|Adverse Event|2|||
38063762|NCT02909504|69757150|FG000|Overall Study|Lack of Efficacy|3|||
38063763|NCT02909504|69757150|FG000|Overall Study|Withdrawal by Subject|4|||
38063764|NCT02909504|69757150|FG000|Overall Study|Pregnancy|1|||
38063765|NCT02909504|69757150|FG000|Overall Study|Subject moved|1|||
38063766|NCT02909504|69757150|FG000|Overall Study|Lost to Follow-up|1|||
38063767|NCT02199691|69757159|FG000|Overall Study|Protocol Violation|3|||
38063768|NCT02199691|69757160|FG001|Overall Study|Protocol Violation|3|||
38063769|NCT02199691|69757161|FG002|Overall Study|Protocol Violation|6|||
38063770|NCT02199691|69757162|FG003|Overall Study|Protocol Violation|7|||
38063771|NCT02199691|69757159|FG000|Overall Study|Withdrawal by Subject|5|||
38063772|NCT02199691|69757160|FG001|Overall Study|Withdrawal by Subject|3|||
38063773|NCT02199691|69757161|FG002|Overall Study|Withdrawal by Subject|12|||
38063774|NCT02199691|69757162|FG003|Overall Study|Withdrawal by Subject|13|||
38063775|NCT02199691|69757159|FG000|Overall Study|Lost to Follow-up|2|||
38063776|NCT02199691|69757160|FG001|Overall Study|Lost to Follow-up|1|||
38063777|NCT02199691|69757161|FG002|Overall Study|Lost to Follow-up|9|||
38063778|NCT02199691|69757162|FG003|Overall Study|Lost to Follow-up|10|||
38063779|NCT03299881|69757176|FG000|Overall Study|Study Termination|17|||
38063780|NCT03299881|69757177|FG001|Overall Study|Study Termination|13|||
38063781|NCT03299101|69757183|FG000|Overall Study|Lost to Follow-up|1|||
38063782|NCT03299101|69757183|FG000|Overall Study|Withdrawal by Subject|5|||
38063783|NCT03299101|69757183|FG000|Overall Study|Surgery was changed|3|||
38063784|NCT03299101|69757183|FG000|Overall Study|Not enough time to complete prehab|1|||
38063785|NCT02663128|69757189|FG000|Period 2|Physician Decision|0|||
38063786|NCT02663128|69757190|FG001|Period 2|Physician Decision|0|||
38063787|NCT02663128|69757191|FG002|Period 2|Physician Decision|0|||
38063788|NCT02663128|69757192|FG003|Period 2|Physician Decision|0|||
38063789|NCT02663128|69757193|FG004|Period 2|Physician Decision|1|||
38063790|NCT02663128|69757194|FG005|Period 2|Physician Decision|0|||
38063791|NCT03298867|69757205|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
38063792|NCT03298867|69757206|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
38063793|NCT03298867|69757205|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
38063794|NCT03298867|69757206|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
38063795|NCT03298867|69757205|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
38063796|NCT03298867|69757206|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
38063797|NCT03298867|69757205|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
38063798|NCT03298867|69757206|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
38063799|NCT03298867|69757205|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
38063800|NCT03298867|69757206|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
38063801|NCT03298867|69757205|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
38063802|NCT03298867|69757206|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
38063803|NCT03298867|69757205|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
38063804|NCT03298867|69757206|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
38063805|NCT03298867|69757205|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
38063806|NCT03298867|69757206|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
38063807|NCT03298867|69757205|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
38063808|NCT03298867|69757206|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
38063809|NCT02906930|69757216|FG000|Overall Study|Withdrawal by Subject|0|||
38063810|NCT02906930|69757217|FG001|Overall Study|Withdrawal by Subject|5|||
38063811|NCT02906930|69757218|FG002|Overall Study|Withdrawal by Subject|5|||
38063812|NCT02906930|69757219|FG003|Overall Study|Withdrawal by Subject|4|||
38063813|NCT02906930|69757216|FG000|Overall Study|Lost to Follow-up|5|||
38063814|NCT02906930|69757217|FG001|Overall Study|Lost to Follow-up|7|||
38063815|NCT02906930|69757218|FG002|Overall Study|Lost to Follow-up|5|||
38063816|NCT02906930|69757219|FG003|Overall Study|Lost to Follow-up|2|||
38063817|NCT02906930|69757216|FG000|Overall Study|Death|0|||
38063818|NCT02906930|69757217|FG001|Overall Study|Death|0|||
38063819|NCT02906930|69757218|FG002|Overall Study|Death|1|||
38063820|NCT02906930|69757219|FG003|Overall Study|Death|0|||
38063821|NCT02906930|69757216|FG000|Overall Study|Other|1|||
38063822|NCT02906930|69757217|FG001|Overall Study|Other|2|||
38063823|NCT02906930|69757218|FG002|Overall Study|Other|1|||
38063824|NCT02906930|69757219|FG003|Overall Study|Other|2|||
38063825|NCT02983604|69757233|FG000|Overall Study|Enrolled but not Treated|0|||
38063826|NCT02983604|69757234|FG001|Overall Study|Enrolled but not Treated|0|||
38063827|NCT02983604|69757235|FG002|Overall Study|Enrolled but not Treated|1|||
38063828|NCT02983604|69757236|FG003|Overall Study|Enrolled but not Treated|0|||
38063829|NCT02662582|69757248|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
38063830|NCT02662582|69757249|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
38063831|NCT02662582|69757248|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
38063832|NCT02662582|69757249|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
38063833|NCT02662582|69757248|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
38063834|NCT02662582|69757249|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
38063835|NCT02662582|69757248|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
38063836|NCT02662582|69757249|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
38063837|NCT02908100|69757259|FG000|Overall Study|Adverse Event|7|||
38063838|NCT02908100|69757260|FG001|Overall Study|Adverse Event|6|||
38063839|NCT02908100|69757261|FG002|Overall Study|Adverse Event|9|||
38063840|NCT02908100|69757259|FG000|Overall Study|Death|2|||
38063841|NCT02908100|69757260|FG001|Overall Study|Death|0|||
38063842|NCT02908100|69757261|FG002|Overall Study|Death|0|||
38063843|NCT02908100|69757259|FG000|Overall Study|Lack of Efficacy|2|||
38063844|NCT02908100|69757260|FG001|Overall Study|Lack of Efficacy|3|||
38063845|NCT02908100|69757261|FG002|Overall Study|Lack of Efficacy|3|||
38063846|NCT02908100|69757259|FG000|Overall Study|Lost to Follow-up|0|||
38063847|NCT02908100|69757260|FG001|Overall Study|Lost to Follow-up|1|||
38063848|NCT02908100|69757261|FG002|Overall Study|Lost to Follow-up|2|||
38063849|NCT02908100|69757259|FG000|Overall Study|Non-Compliance With Study Drug|1|||
38063850|NCT02908100|69757260|FG001|Overall Study|Non-Compliance With Study Drug|1|||
38063851|NCT02908100|69757261|FG002|Overall Study|Non-Compliance With Study Drug|2|||
38063852|NCT02908100|69757259|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
38063853|NCT02908100|69757260|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
38063854|NCT02908100|69757261|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
38063855|NCT02908100|69757259|FG000|Overall Study|Physician Decision|0|||
38063856|NCT02908100|69757260|FG001|Overall Study|Physician Decision|1|||
38063857|NCT02908100|69757261|FG002|Overall Study|Physician Decision|0|||
38063858|NCT02908100|69757259|FG000|Overall Study|Pregnancy|1|||
38063859|NCT02908100|69757260|FG001|Overall Study|Pregnancy|2|||
38063860|NCT02908100|69757261|FG002|Overall Study|Pregnancy|0|||
38063861|NCT02908100|69757259|FG000|Overall Study|Withdrawal by Subject|8|||
38063862|NCT02908100|69757260|FG001|Overall Study|Withdrawal by Subject|7|||
38063863|NCT02908100|69757261|FG002|Overall Study|Withdrawal by Subject|5|||
38063864|NCT02908100|69757259|FG000|Overall Study|Randomised in Error|1|||
38063865|NCT02908100|69757260|FG001|Overall Study|Randomised in Error|0|||
38063866|NCT02908100|69757261|FG002|Overall Study|Randomised in Error|0|||
38063867|NCT02982590|69757285|FG000|Overall Study|Lost to Follow-up|0|||
38063868|NCT02982590|69757286|FG001|Overall Study|Lost to Follow-up|1|||
38063869|NCT02982590|69757285|FG000|Overall Study|Death|4|||
38063870|NCT02982590|69757286|FG001|Overall Study|Death|0|||
38063871|NCT03310021|69757312|FG000|Overall Study|Withdrawal by Subject|0|||
38063872|NCT03310021|69757313|FG001|Overall Study|Withdrawal by Subject|0|||
38063873|NCT03310021|69757314|FG002|Overall Study|Withdrawal by Subject|0|||
38063874|NCT03310021|69757315|FG003|Overall Study|Withdrawal by Subject|0|||
38063875|NCT03310021|69757316|FG004|Overall Study|Withdrawal by Subject|0|||
38063876|NCT03310021|69757317|FG005|Overall Study|Withdrawal by Subject|0|||
38063877|NCT03310021|69757318|FG006|Overall Study|Withdrawal by Subject|1|||
38063878|NCT03310021|69757319|FG007|Overall Study|Withdrawal by Subject|0|||
38063879|NCT03310021|69757320|FG008|Overall Study|Withdrawal by Subject|0|||
38063880|NCT03310021|69757321|FG009|Overall Study|Withdrawal by Subject|0|||
38063881|NCT03310021|69757322|FG010|Overall Study|Withdrawal by Subject|0|||
38063882|NCT03310021|69757323|FG011|Overall Study|Withdrawal by Subject|0|||
38063883|NCT03310021|69757324|FG012|Overall Study|Withdrawal by Subject|0|||
38063884|NCT03310021|69757325|FG013|Overall Study|Withdrawal by Subject|0|||
38063885|NCT03310021|69757326|FG014|Overall Study|Withdrawal by Subject|0|||
38063886|NCT03310021|69757327|FG015|Overall Study|Withdrawal by Subject|0|||
38063887|NCT03310021|69757328|FG016|Overall Study|Withdrawal by Subject|0|||
38063888|NCT03310021|69757329|FG017|Overall Study|Withdrawal by Subject|0|||
38063889|NCT03310021|69757330|FG018|Overall Study|Withdrawal by Subject|0|||
38063890|NCT03310021|69757331|FG019|Overall Study|Withdrawal by Subject|0|||
38063891|NCT03310021|69757312|FG000|Overall Study|Lost to Follow-up|0|||
38063892|NCT03310021|69757313|FG001|Overall Study|Lost to Follow-up|0|||
38063893|NCT03310021|69757314|FG002|Overall Study|Lost to Follow-up|0|||
38063894|NCT03310021|69757315|FG003|Overall Study|Lost to Follow-up|0|||
38063895|NCT03310021|69757316|FG004|Overall Study|Lost to Follow-up|0|||
38063896|NCT03310021|69757317|FG005|Overall Study|Lost to Follow-up|0|||
38063897|NCT03310021|69757318|FG006|Overall Study|Lost to Follow-up|0|||
38063898|NCT03310021|69757319|FG007|Overall Study|Lost to Follow-up|0|||
38063899|NCT03310021|69757320|FG008|Overall Study|Lost to Follow-up|0|||
38063900|NCT03310021|69757321|FG009|Overall Study|Lost to Follow-up|0|||
38063901|NCT03310021|69757322|FG010|Overall Study|Lost to Follow-up|1|||
38063902|NCT03310021|69757323|FG011|Overall Study|Lost to Follow-up|0|||
38063903|NCT03310021|69757324|FG012|Overall Study|Lost to Follow-up|0|||
38063904|NCT03310021|69757325|FG013|Overall Study|Lost to Follow-up|0|||
38063905|NCT03310021|69757326|FG014|Overall Study|Lost to Follow-up|0|||
38063906|NCT03310021|69757327|FG015|Overall Study|Lost to Follow-up|0|||
38063907|NCT03310021|69757328|FG016|Overall Study|Lost to Follow-up|0|||
38063908|NCT03310021|69757329|FG017|Overall Study|Lost to Follow-up|0|||
38063909|NCT03310021|69757330|FG018|Overall Study|Lost to Follow-up|0|||
38063910|NCT03310021|69757331|FG019|Overall Study|Lost to Follow-up|0|||
38063911|NCT03333109|69757376|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
38063912|NCT03333109|69757377|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
38063913|NCT03333109|69757378|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
38063914|NCT03333109|69757376|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
38063915|NCT03333109|69757377|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
38063916|NCT03333109|69757378|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
38063917|NCT03333109|69757376|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
38063918|NCT03333109|69757377|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
38063919|NCT03333109|69757378|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
38063920|NCT03333109|69757376|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
38063921|NCT03333109|69757377|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
38063922|NCT03333109|69757378|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
38063923|NCT03333109|69757376|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
38063924|NCT03333109|69757377|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
38063925|NCT03333109|69757378|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
38063926|NCT03333109|69757376|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
38063927|NCT03333109|69757377|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
38063928|NCT03333109|69757378|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
38063929|NCT03333109|69757376|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
38063930|NCT03333109|69757377|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
38063931|NCT03333109|69757378|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
38063932|NCT03333109|69757376|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
38063933|NCT03333109|69757377|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
38063934|NCT03333109|69757378|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
38063935|NCT02940223|69757388|FG000|Overall Study|Failed Requirement|2|||
38063936|NCT02940223|69757389|FG001|Overall Study|Failed Requirement|0|||
38063937|NCT03295201|69757397|FG000|Overall Study|Lost to Follow-up|1|||
38063938|NCT03295201|69757398|FG001|Overall Study|Lost to Follow-up|1|||
38063939|NCT03295201|69757397|FG000|Overall Study|Hospital admission|0|||
38063940|NCT03295201|69757398|FG001|Overall Study|Hospital admission|1|||
38063941|NCT03293485|69757404|FG000|Overall Study|Death|1|||
38063942|NCT03293485|69757404|FG000|Overall Study|Screen Failure|2|||
38063943|NCT03293485|69757404|FG000|Overall Study|Withdrawal by Subject|2|||
38063944|NCT03309943|69757412|FG000|Overall Study|Withdrawal by Subject|0|||
38063945|NCT03309943|69757413|FG001|Overall Study|Withdrawal by Subject|1|||
38063946|NCT03309943|69757412|FG000|Overall Study|Inappropriate behavior towards staff|0|||
38063947|NCT03309943|69757413|FG001|Overall Study|Inappropriate behavior towards staff|1|||
38063948|NCT01732627|69757421|FG000|Overall Study|Withdrawal by Subject|1|||
38063949|NCT01732627|69757422|FG001|Overall Study|Withdrawal by Subject|0|||
38063950|NCT03307837|69757434|FG000|Overall Study|Withdrawal by Subject|0|||
38063951|NCT03307837|69757435|FG001|Overall Study|Withdrawal by Subject|0|||
38063952|NCT03307837|69757436|FG002|Overall Study|Withdrawal by Subject|1|||
38063953|NCT03307837|69757437|FG003|Overall Study|Withdrawal by Subject|0|||
38063954|NCT03307837|69757438|FG004|Overall Study|Withdrawal by Subject|0|||
38063955|NCT03307837|69757439|FG005|Overall Study|Withdrawal by Subject|1|||
38063956|NCT03307837|69757434|FG000|Overall Study|Lost to Follow-up|1|||
38063957|NCT03307837|69757435|FG001|Overall Study|Lost to Follow-up|1|||
38063958|NCT03307837|69757436|FG002|Overall Study|Lost to Follow-up|0|||
38063959|NCT03307837|69757437|FG003|Overall Study|Lost to Follow-up|0|||
38063960|NCT03307837|69757438|FG004|Overall Study|Lost to Follow-up|0|||
37862263|NCT00919633|69546034|FG000|Overall Study|Physician Decision|0|||
37862264|NCT00919633|69546035|FG001|Overall Study|Physician Decision|0|||
38063961|NCT03307837|69757439|FG005|Overall Study|Lost to Follow-up|1|||
38063962|NCT03331315|69757460|FG000|Overall Study|Physician Decision|18|||
38063963|NCT03331315|69757461|FG001|Overall Study|Physician Decision|14|||
38063964|NCT03329989|69757469|FG000|Overall Study|Withdrawal by Subject|9|||
38063965|NCT03329989|69757469|FG000|Overall Study|Lost to Follow-up|8|||
38063966|NCT03329989|69757469|FG000|Overall Study|Adverse Event|5|||
38063967|NCT03329989|69757469|FG000|Overall Study|Protocol Violation|1|||
38063968|NCT03287869|69757475|FG000|Overall Study|Adverse Event|14|||
38063969|NCT03287869|69757476|FG001|Overall Study|Adverse Event|12|||
38063970|NCT03287869|69757475|FG000|Overall Study|Lack of Efficacy|1|||
38063971|NCT03287869|69757476|FG001|Overall Study|Lack of Efficacy|0|||
38063972|NCT03287869|69757475|FG000|Overall Study|Lost to Follow-up|13|||
38063973|NCT03287869|69757476|FG001|Overall Study|Lost to Follow-up|19|||
38063974|NCT03287869|69757475|FG000|Overall Study|Non-Compliance With Study Drug|5|||
38063975|NCT03287869|69757476|FG001|Overall Study|Non-Compliance With Study Drug|9|||
38063976|NCT03287869|69757475|FG000|Overall Study|Progressive Disease|1|||
38063977|NCT03287869|69757476|FG001|Overall Study|Progressive Disease|0|||
38063978|NCT03287869|69757475|FG000|Overall Study|Protocol Deviation|2|||
38063979|NCT03287869|69757476|FG001|Overall Study|Protocol Deviation|1|||
38063980|NCT03287869|69757475|FG000|Overall Study|Withdrawal by Subject|36|||
38063981|NCT03287869|69757476|FG001|Overall Study|Withdrawal by Subject|43|||
38063982|NCT03287869|69757475|FG000|Overall Study|Early Closure of the Site|0|||
38063983|NCT03287869|69757476|FG001|Overall Study|Early Closure of the Site|1|||
38063984|NCT03287869|69757475|FG000|Overall Study|Physician Decision|5|||
38063985|NCT03287869|69757476|FG001|Overall Study|Physician Decision|5|||
38063986|NCT03287869|69757475|FG000|Overall Study|Reason not Specified|6|||
38063987|NCT03287869|69757476|FG001|Overall Study|Reason not Specified|3|||
38063988|NCT02661490|69757487|FG000|Overall Study|Lost to Follow-up|0|||
38063989|NCT02661490|69757488|FG001|Overall Study|Lost to Follow-up|1|||
38063990|NCT02661490|69757489|FG002|Overall Study|Lost to Follow-up|0|||
38063991|NCT02661490|69757490|FG003|Overall Study|Lost to Follow-up|0|||
38063992|NCT02661490|69757491|FG004|Overall Study|Lost to Follow-up|2|||
38063993|NCT02661490|69757487|FG000|Overall Study|Withdrawal by Subject|2|||
38063994|NCT02661490|69757488|FG001|Overall Study|Withdrawal by Subject|0|||
38063995|NCT02661490|69757489|FG002|Overall Study|Withdrawal by Subject|2|||
38063996|NCT02661490|69757490|FG003|Overall Study|Withdrawal by Subject|0|||
38063997|NCT02661490|69757491|FG004|Overall Study|Withdrawal by Subject|0|||
38063998|NCT02661490|69757487|FG000|Overall Study|Death|1|||
38063999|NCT02661490|69757488|FG001|Overall Study|Death|1|||
38064000|NCT02661490|69757489|FG002|Overall Study|Death|0|||
38064001|NCT02661490|69757490|FG003|Overall Study|Death|1|||
38064002|NCT02661490|69757491|FG004|Overall Study|Death|0|||
38064003|NCT02661490|69757487|FG000|Overall Study|Reason not Specified|0|||
38064004|NCT02661490|69757488|FG001|Overall Study|Reason not Specified|0|||
38064005|NCT02661490|69757489|FG002|Overall Study|Reason not Specified|0|||
38064006|NCT02661490|69757490|FG003|Overall Study|Reason not Specified|0|||
38064007|NCT02661490|69757491|FG004|Overall Study|Reason not Specified|1|||
38064008|NCT03287791|69757506|FG000|Overall Study|Insufficient Therapeutic Response|0|||
38064009|NCT03287791|69757507|FG001|Overall Study|Insufficient Therapeutic Response|0|||
38064010|NCT03287791|69757508|FG002|Overall Study|Insufficient Therapeutic Response|1|||
38064011|NCT03287791|69757506|FG000|Overall Study|Adverse Event|0|||
38064012|NCT03287791|69757507|FG001|Overall Study|Adverse Event|4|||
38064013|NCT03287791|69757508|FG002|Overall Study|Adverse Event|3|||
38064014|NCT03287791|69757506|FG000|Overall Study|Withdrawal by Subject|12|||
38064015|NCT03287791|69757507|FG001|Overall Study|Withdrawal by Subject|12|||
38064016|NCT03287791|69757508|FG002|Overall Study|Withdrawal by Subject|17|||
38064017|NCT03287791|69757506|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
38064018|NCT03287791|69757507|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
38064019|NCT03287791|69757508|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
38064020|NCT03287791|69757506|FG000|Overall Study|Lost to Follow-up|8|||
38064021|NCT03287791|69757507|FG001|Overall Study|Lost to Follow-up|14|||
38064022|NCT03287791|69757508|FG002|Overall Study|Lost to Follow-up|11|||
38064023|NCT03287791|69757506|FG000|Overall Study|Protocol Violation|7|||
38064024|NCT03287791|69757507|FG001|Overall Study|Protocol Violation|2|||
38064025|NCT03287791|69757508|FG002|Overall Study|Protocol Violation|1|||
38064026|NCT03287791|69757506|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
38064027|NCT03287791|69757507|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
38064028|NCT03287791|69757508|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
38064029|NCT03287791|69757506|FG000|Overall Study|Too much time between 2 visits|0|||
38064030|NCT03287791|69757507|FG001|Overall Study|Too much time between 2 visits|1|||
38064031|NCT03287791|69757508|FG002|Overall Study|Too much time between 2 visits|0|||
38064032|NCT03287791|69757506|FG000|Overall Study|Non-compliance|0|||
38064033|NCT03287791|69757507|FG001|Overall Study|Non-compliance|1|||
38064034|NCT03287791|69757508|FG002|Overall Study|Non-compliance|0|||
38064035|NCT03287791|69757506|FG000|Overall Study|Did not meet inclusion criteria|1|||
38064036|NCT03287791|69757507|FG001|Overall Study|Did not meet inclusion criteria|0|||
38064037|NCT03287791|69757508|FG002|Overall Study|Did not meet inclusion criteria|0|||
38064038|NCT03287635|69757516|FG000|Overall Study|Lost to Follow-up|5|||
38064039|NCT03287635|69757516|FG000|Overall Study|Withdrawal by Subject|1|||
38064040|NCT03287635|69757516|FG000|Overall Study|Physician Decision|1|||
38064041|NCT03287089|69757522|FG000|Overall Study|Lost to Follow-up|0|||
38064042|NCT03287089|69757523|FG001|Overall Study|Lost to Follow-up|2|||
38064043|NCT03287089|69757522|FG000|Overall Study|Physician Decision|0|||
38064044|NCT03287089|69757523|FG001|Overall Study|Physician Decision|2|||
38064045|NCT03287089|69757522|FG000|Overall Study|Withdrawal by Subject|0|||
38064046|NCT03287089|69757523|FG001|Overall Study|Withdrawal by Subject|2|||
38064047|NCT03286543|69757531|FG000|Consented|Screen failure before randomization|2|||
38064048|NCT03286543|69757532|FG001|Consented|Screen failure before randomization|0|||
38064049|NCT03286543|69757533|FG002|Consented|Screen failure before randomization|0|||
38064050|NCT03286543|69757531|FG000|Consented|Screen failure before enrollment|4|||
38064051|NCT03286543|69757532|FG001|Consented|Screen failure before enrollment|0|||
38064052|NCT03286543|69757533|FG002|Consented|Screen failure before enrollment|0|||
38064053|NCT03286543|69757531|FG000|Consented|TKA cancelled after enrollment|1|||
38064054|NCT03286543|69757532|FG001|Consented|TKA cancelled after enrollment|0|||
38064055|NCT03286543|69757533|FG002|Consented|TKA cancelled after enrollment|0|||
38064056|NCT03286543|69757531|FG000|Consented|Withdrawn from study|12|||
38064057|NCT03286543|69757532|FG001|Consented|Withdrawn from study|0|||
38064058|NCT03286543|69757533|FG002|Consented|Withdrawn from study|0|||
38064059|NCT03286543|69757531|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
38064060|NCT03286543|69757532|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
38064061|NCT03286543|69757533|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
38064062|NCT03286543|69757531|FG000|Study Enrollment|Withdrawn from study|0|||
38064063|NCT03286543|69757532|FG001|Study Enrollment|Withdrawn from study|6|||
38064064|NCT03286543|69757533|FG002|Study Enrollment|Withdrawn from study|6|||
38064065|NCT03306433|69757539|FG000|Overall Study|Lost to Follow-up|3|||
38064066|NCT03306433|69757539|FG000|Overall Study|Patient did not have teeth extracted|1|||
38064067|NCT03306433|69757539|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
38064068|NCT02940691|69757547|FG000|Overall Study|Lost to Follow-up|5|||
38064069|NCT02940691|69757547|FG000|Overall Study|Incarceration|1|||
38064070|NCT03306277|69757585|FG000|Overall Study|Death|1|||
38064071|NCT03306277|69757585|FG000|Overall Study|Adverse Event|1|||
38064072|NCT03306277|69757585|FG000|Overall Study|Withdrawal by Subject|1|||
38064073|NCT03130959|69757599|FG000|Overall Study|Disease progression|19|||
38064074|NCT03130959|69757600|FG001|Overall Study|Disease progression|7|||
38064075|NCT03130959|69757601|FG002|Overall Study|Disease progression|12|||
38064076|NCT03130959|69757602|FG003|Overall Study|Disease progression|7|||
38064077|NCT03130959|69757603|FG004|Overall Study|Disease progression|12|||
38064078|NCT03130959|69757604|FG005|Overall Study|Disease progression|3|||
38064079|NCT03130959|69757605|FG006|Overall Study|Disease progression|6|||
38064080|NCT03130959|69757606|FG007|Overall Study|Disease progression|3|||
38064081|NCT03130959|69757607|FG008|Overall Study|Disease progression|15|||
38064082|NCT03130959|69757608|FG009|Overall Study|Disease progression|8|||
38064083|NCT03130959|69757599|FG000|Overall Study|Study drug toxicity|2|||
38064084|NCT03130959|69757600|FG001|Overall Study|Study drug toxicity|2|||
38064085|NCT03130959|69757601|FG002|Overall Study|Study drug toxicity|1|||
38064086|NCT03130959|69757602|FG003|Overall Study|Study drug toxicity|2|||
38064087|NCT03130959|69757603|FG004|Overall Study|Study drug toxicity|1|||
38064088|NCT03130959|69757604|FG005|Overall Study|Study drug toxicity|1|||
38064089|NCT03130959|69757605|FG006|Overall Study|Study drug toxicity|3|||
38064090|NCT03130959|69757606|FG007|Overall Study|Study drug toxicity|0|||
38064091|NCT03130959|69757607|FG008|Overall Study|Study drug toxicity|3|||
38064092|NCT03130959|69757608|FG009|Overall Study|Study drug toxicity|3|||
38064093|NCT03130959|69757599|FG000|Overall Study|Other reasons|0|||
38064094|NCT03130959|69757600|FG001|Overall Study|Other reasons|0|||
38064095|NCT03130959|69757601|FG002|Overall Study|Other reasons|0|||
38064096|NCT03130959|69757602|FG003|Overall Study|Other reasons|0|||
38064097|NCT03130959|69757603|FG004|Overall Study|Other reasons|0|||
38064098|NCT03130959|69757604|FG005|Overall Study|Other reasons|1|||
38064099|NCT03130959|69757605|FG006|Overall Study|Other reasons|1|||
38064100|NCT03130959|69757606|FG007|Overall Study|Other reasons|0|||
38064101|NCT03130959|69757607|FG008|Overall Study|Other reasons|0|||
38064102|NCT03130959|69757608|FG009|Overall Study|Other reasons|0|||
38064103|NCT03130959|69757599|FG000|Overall Study|Subject request to discontinue therapy|0|||
38064104|NCT03130959|69757600|FG001|Overall Study|Subject request to discontinue therapy|0|||
38064105|NCT03130959|69757601|FG002|Overall Study|Subject request to discontinue therapy|1|||
38064106|NCT03130959|69757602|FG003|Overall Study|Subject request to discontinue therapy|1|||
38064107|NCT03130959|69757603|FG004|Overall Study|Subject request to discontinue therapy|0|||
38064108|NCT03130959|69757604|FG005|Overall Study|Subject request to discontinue therapy|0|||
38064109|NCT03130959|69757605|FG006|Overall Study|Subject request to discontinue therapy|1|||
38064110|NCT03130959|69757606|FG007|Overall Study|Subject request to discontinue therapy|1|||
38064111|NCT03130959|69757607|FG008|Overall Study|Subject request to discontinue therapy|0|||
38064112|NCT03130959|69757608|FG009|Overall Study|Subject request to discontinue therapy|0|||
38064113|NCT03130959|69757599|FG000|Overall Study|Not reported|0|||
38064114|NCT03130959|69757600|FG001|Overall Study|Not reported|0|||
38064115|NCT03130959|69757601|FG002|Overall Study|Not reported|0|||
38064116|NCT03130959|69757602|FG003|Overall Study|Not reported|1|||
38064117|NCT03130959|69757603|FG004|Overall Study|Not reported|0|||
38064118|NCT03130959|69757604|FG005|Overall Study|Not reported|1|||
38064119|NCT03130959|69757605|FG006|Overall Study|Not reported|0|||
38064120|NCT03130959|69757606|FG007|Overall Study|Not reported|0|||
38064121|NCT03130959|69757607|FG008|Overall Study|Not reported|0|||
38064122|NCT03130959|69757608|FG009|Overall Study|Not reported|1|||
38064123|NCT03130959|69757599|FG000|Overall Study|Adverse Event unrelated to drug|0|||
38064124|NCT03130959|69757600|FG001|Overall Study|Adverse Event unrelated to drug|0|||
38064125|NCT03130959|69757601|FG002|Overall Study|Adverse Event unrelated to drug|1|||
38064126|NCT03130959|69757602|FG003|Overall Study|Adverse Event unrelated to drug|1|||
38064127|NCT03130959|69757603|FG004|Overall Study|Adverse Event unrelated to drug|1|||
38064128|NCT03130959|69757604|FG005|Overall Study|Adverse Event unrelated to drug|0|||
38064129|NCT03130959|69757605|FG006|Overall Study|Adverse Event unrelated to drug|1|||
38064130|NCT03130959|69757606|FG007|Overall Study|Adverse Event unrelated to drug|0|||
38064131|NCT03130959|69757607|FG008|Overall Study|Adverse Event unrelated to drug|1|||
38064132|NCT03130959|69757608|FG009|Overall Study|Adverse Event unrelated to drug|1|||
38064133|NCT03130959|69757599|FG000|Overall Study|Participant withdrew consent|0|||
38064134|NCT03130959|69757600|FG001|Overall Study|Participant withdrew consent|1|||
38064135|NCT03130959|69757601|FG002|Overall Study|Participant withdrew consent|0|||
38064136|NCT03130959|69757602|FG003|Overall Study|Participant withdrew consent|2|||
38064137|NCT03130959|69757603|FG004|Overall Study|Participant withdrew consent|1|||
38064138|NCT03130959|69757604|FG005|Overall Study|Participant withdrew consent|0|||
38064139|NCT03130959|69757605|FG006|Overall Study|Participant withdrew consent|0|||
38064140|NCT03130959|69757606|FG007|Overall Study|Participant withdrew consent|0|||
38064141|NCT03130959|69757607|FG008|Overall Study|Participant withdrew consent|0|||
38064142|NCT03130959|69757608|FG009|Overall Study|Participant withdrew consent|2|||
38064143|NCT03130959|69757599|FG000|Overall Study|Administrative reason by sponsor|1|||
38064144|NCT03130959|69757600|FG001|Overall Study|Administrative reason by sponsor|0|||
38064145|NCT03130959|69757601|FG002|Overall Study|Administrative reason by sponsor|1|||
38064146|NCT03130959|69757602|FG003|Overall Study|Administrative reason by sponsor|0|||
38064147|NCT03130959|69757603|FG004|Overall Study|Administrative reason by sponsor|0|||
38064148|NCT03130959|69757604|FG005|Overall Study|Administrative reason by sponsor|0|||
38064149|NCT03130959|69757605|FG006|Overall Study|Administrative reason by sponsor|0|||
38064150|NCT03130959|69757606|FG007|Overall Study|Administrative reason by sponsor|0|||
38064151|NCT03130959|69757607|FG008|Overall Study|Administrative reason by sponsor|0|||
38064152|NCT03130959|69757608|FG009|Overall Study|Administrative reason by sponsor|0|||
38064153|NCT03130959|69757599|FG000|Overall Study|Lost to Follow-up|1|||
38064154|NCT03130959|69757600|FG001|Overall Study|Lost to Follow-up|0|||
38064155|NCT03130959|69757601|FG002|Overall Study|Lost to Follow-up|0|||
38064156|NCT03130959|69757602|FG003|Overall Study|Lost to Follow-up|0|||
38064157|NCT03130959|69757603|FG004|Overall Study|Lost to Follow-up|0|||
38064158|NCT03130959|69757604|FG005|Overall Study|Lost to Follow-up|0|||
38064159|NCT03130959|69757605|FG006|Overall Study|Lost to Follow-up|0|||
38064160|NCT03130959|69757606|FG007|Overall Study|Lost to Follow-up|0|||
38064161|NCT03130959|69757607|FG008|Overall Study|Lost to Follow-up|0|||
38064162|NCT03130959|69757608|FG009|Overall Study|Lost to Follow-up|0|||
38064163|NCT03124407|69757647|FG000|Overall Study|Lost to Follow-up|1|||
38064164|NCT03124407|69757648|FG001|Overall Study|Lost to Follow-up|0|||
38064165|NCT03124407|69757649|FG002|Overall Study|Lost to Follow-up|0|||
38064166|NCT03124407|69757650|FG003|Overall Study|Lost to Follow-up|0|||
38064167|NCT03124407|69757647|FG000|Overall Study|Adverse Event|0|||
38064168|NCT03124407|69757648|FG001|Overall Study|Adverse Event|0|||
38064169|NCT03124407|69757649|FG002|Overall Study|Adverse Event|1|||
38064170|NCT03124407|69757650|FG003|Overall Study|Adverse Event|0|||
38064171|NCT02929407|69757664|FG000|Overall Study|Adverse Event|1|||
38064172|NCT03123939|69757668|FG000|Overall Study|Lack of Efficacy|6|||
38064173|NCT03123939|69757668|FG000|Overall Study|Death|5|||
38064174|NCT03123939|69757668|FG000|Overall Study|Physician Decision|2|||
38064175|NCT03123939|69757668|FG000|Overall Study|Subject/guardian decision|2|||
38064176|NCT03123939|69757668|FG000|Overall Study|Lost to Follow-up|1|||
38064177|NCT03123939|69757668|FG000|Overall Study|New therapy for study indication|1|||
38064178|NCT03123939|69757668|FG000|Overall Study|Protocol deviation|1|||
38064179|NCT03123939|69757668|FG000|Overall Study|Progressive disease|18|||
38064180|NCT03123939|69757668|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
38064181|NCT03123939|69757668|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
38064182|NCT03123861|69757683|FG000|Overall Study|Protocol Violation|1|||
38064183|NCT03123861|69757684|FG001|Overall Study|Protocol Violation|1|||
38064184|NCT03123861|69757683|FG000|Overall Study|Withdrawal by Subject|2|||
38064185|NCT03123861|69757684|FG001|Overall Study|Withdrawal by Subject|2|||
38064186|NCT03123471|69757692|FG000|Placebo-controlled Phase|Adverse Event|3|||
38064187|NCT03123471|69757693|FG001|Placebo-controlled Phase|Adverse Event|8|||
38064188|NCT03123471|69757692|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
38064189|NCT03123471|69757693|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
38064190|NCT03123471|69757692|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
38064191|NCT03123471|69757693|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
38064192|NCT03123471|69757692|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
38064193|NCT03123471|69757693|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
38064194|NCT03123471|69757692|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
38064195|NCT03123471|69757693|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
38064196|NCT03123471|69757692|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
38064197|NCT03123471|69757693|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
38064198|NCT03123471|69757692|FG000|Placebo-controlled Phase|Miscellaneous|0|||
38064199|NCT03123471|69757693|FG001|Placebo-controlled Phase|Miscellaneous|1|||
38064200|NCT03123471|69757692|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
38064201|NCT03123471|69757693|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
38064202|NCT03123471|69757692|FG000|Apremilast Extension Phase|Adverse Event|1|||
38064203|NCT03123471|69757693|FG001|Apremilast Extension Phase|Adverse Event|5|||
38064204|NCT03123471|69757692|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
38064205|NCT03123471|69757693|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
38064206|NCT03123471|69757692|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
38064207|NCT03123471|69757693|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
38064208|NCT02661178|69757720|FG000|Part 1|Protocol Violation|1|||
38064209|NCT02661178|69757721|FG001|Part 1|Protocol Violation|0|||
38064210|NCT02661178|69757722|FG002|Part 1|Protocol Violation|0|||
38064211|NCT02661178|69757723|FG003|Part 1|Protocol Violation|0|||
38064212|NCT02661178|69757724|FG004|Part 1|Protocol Violation|0|||
38064213|NCT02661178|69757725|FG005|Part 1|Protocol Violation|0|||
38064214|NCT02661178|69757726|FG006|Part 1|Protocol Violation|0|||
38064215|NCT02661178|69757727|FG007|Part 1|Protocol Violation|0|||
38064216|NCT02661178|69757728|FG008|Part 1|Protocol Violation|0|||
38064217|NCT02661178|69757729|FG009|Part 1|Protocol Violation|0|||
38064218|NCT02661178|69757730|FG010|Part 1|Protocol Violation|0|||
38064219|NCT02661178|69757731|FG011|Part 1|Protocol Violation|0|||
38064220|NCT02661178|69757732|FG012|Part 1|Protocol Violation|0|||
38064221|NCT02661178|69757733|FG013|Part 1|Protocol Violation|0|||
38064222|NCT02661178|69757734|FG014|Part 1|Protocol Violation|0|||
38064223|NCT02660944|69757786|FG000|Overall Study|Adverse Event|3|||
38064224|NCT02660944|69757787|FG001|Overall Study|Adverse Event|4|||
38064225|NCT02660944|69757786|FG000|Overall Study|Physician Decision|3|||
38064226|NCT02660944|69757787|FG001|Overall Study|Physician Decision|1|||
38064227|NCT02660944|69757786|FG000|Overall Study|Withdrawal by Subject|5|||
38064228|NCT02660944|69757787|FG001|Overall Study|Withdrawal by Subject|3|||
38064229|NCT02660944|69757786|FG000|Overall Study|Lost to Follow-up|4|||
38064230|NCT02660944|69757787|FG001|Overall Study|Lost to Follow-up|1|||
38064231|NCT02660944|69757786|FG000|Overall Study|Subject schedule|0|||
38064232|NCT02660944|69757787|FG001|Overall Study|Subject schedule|1|||
38064233|NCT02660944|69757786|FG000|Overall Study|Exclusion criteria met|2|||
38064234|NCT02660944|69757787|FG001|Overall Study|Exclusion criteria met|0|||
38064235|NCT02975336|69757797|FG000|DBPC (52 Weeks)|Adverse Event|16|||
38064236|NCT02975336|69757798|FG001|DBPC (52 Weeks)|Adverse Event|17|||
38064237|NCT02975336|69757799|FG002|DBPC (52 Weeks)|Adverse Event|13|||
38064238|NCT02975336|69757800|FG003|DBPC (52 Weeks)|Adverse Event|18|||
38064239|NCT02975336|69757801|FG004|DBPC (52 Weeks)|Adverse Event|0|||
38064240|NCT02975336|69757802|FG005|DBPC (52 Weeks)|Adverse Event|0|||
38064241|NCT02975336|69757803|FG006|DBPC (52 Weeks)|Adverse Event|0|||
38064242|NCT02975336|69757804|FG007|DBPC (52 Weeks)|Adverse Event|0|||
38064243|NCT02975336|69757797|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
38064244|NCT02975336|69757798|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
38064245|NCT02975336|69757799|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
38064246|NCT02975336|69757800|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
38064247|NCT02975336|69757801|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
38064248|NCT02975336|69757802|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
38064249|NCT02975336|69757803|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
38064250|NCT02975336|69757804|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
38064251|NCT02975336|69757797|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
38064252|NCT02975336|69757798|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
38064253|NCT02975336|69757799|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
38064254|NCT02975336|69757800|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
38064255|NCT02975336|69757801|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
38064256|NCT02975336|69757802|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
38064257|NCT02975336|69757803|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
38064258|NCT02975336|69757804|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
38064259|NCT02975336|69757797|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
38064260|NCT02975336|69757798|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
38064261|NCT02975336|69757799|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
38064262|NCT02975336|69757800|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
38064263|NCT02975336|69757801|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
38064264|NCT02975336|69757802|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
38064265|NCT02975336|69757803|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
38064266|NCT02975336|69757804|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
38064267|NCT02975336|69757797|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
38064268|NCT02975336|69757798|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
38064269|NCT02975336|69757799|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
38064270|NCT02975336|69757800|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
38064271|NCT02975336|69757801|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
38064272|NCT02975336|69757802|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
38064273|NCT02975336|69757803|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
38064274|NCT02975336|69757804|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
38064275|NCT02975336|69757797|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
38064276|NCT02975336|69757798|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
38064277|NCT02975336|69757799|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
38064278|NCT02975336|69757800|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
38064279|NCT02975336|69757801|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
38064280|NCT02975336|69757802|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
38064281|NCT02975336|69757803|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
38064282|NCT02975336|69757804|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
38064283|NCT02975336|69757797|FG000|LTE (104 Weeks)|Adverse Event|0|||
37965715|NCT00365716|69652695|FG000|Extension 2|Lost to Follow-up|0|||
37965716|NCT00365716|69652696|FG001|Extension 2|Lost to Follow-up|0|||
37965717|NCT00365716|69652697|FG002|Extension 2|Lost to Follow-up|0|||
37965718|NCT00365716|69652698|FG003|Extension 2|Lost to Follow-up|0|||
37965719|NCT00365716|69652699|FG004|Extension 2|Lost to Follow-up|0|||
37965720|NCT00365716|69652700|FG005|Extension 2|Lost to Follow-up|0|||
37965721|NCT00365716|69652701|FG006|Extension 2|Lost to Follow-up|2|||
37965722|NCT00365716|69652695|FG000|Extension 2|Other|0|||
37965723|NCT00365716|69652696|FG001|Extension 2|Other|0|||
37965724|NCT00365716|69652697|FG002|Extension 2|Other|0|||
37965725|NCT00365716|69652698|FG003|Extension 2|Other|0|||
37965726|NCT00365716|69652699|FG004|Extension 2|Other|0|||
37965727|NCT00365716|69652700|FG005|Extension 2|Other|0|||
37965728|NCT00365716|69652701|FG006|Extension 2|Other|3|||
37965729|NCT00365716|69652695|FG000|Extension 2|Withdrawal by Subject|0|||
37965730|NCT00365716|69652696|FG001|Extension 2|Withdrawal by Subject|0|||
37965731|NCT00365716|69652697|FG002|Extension 2|Withdrawal by Subject|0|||
37965732|NCT00365716|69652698|FG003|Extension 2|Withdrawal by Subject|0|||
37965733|NCT00365716|69652699|FG004|Extension 2|Withdrawal by Subject|0|||
37965734|NCT00365716|69652700|FG005|Extension 2|Withdrawal by Subject|0|||
38064284|NCT02975336|69757798|FG001|LTE (104 Weeks)|Adverse Event|0|||
38064285|NCT02975336|69757799|FG002|LTE (104 Weeks)|Adverse Event|0|||
38064286|NCT02975336|69757800|FG003|LTE (104 Weeks)|Adverse Event|0|||
37862265|NCT00919633|69546036|FG002|Overall Study|Physician Decision|0|||
38064287|NCT02975336|69757801|FG004|LTE (104 Weeks)|Adverse Event|7|||
37862266|NCT00919633|69546037|FG003|Overall Study|Physician Decision|1|||
37965735|NCT00365716|69652701|FG006|Extension 2|Withdrawal by Subject|5|||
37965736|NCT00059839|69652717|FG000|Overall Study|Death|1|||
37965737|NCT00059839|69652718|FG001|Overall Study|Death|1|||
37965738|NCT00059839|69652717|FG000|Overall Study|Lack of Efficacy|6|||
37965739|NCT00059839|69652718|FG001|Overall Study|Lack of Efficacy|5|||
38064288|NCT02975336|69757802|FG005|LTE (104 Weeks)|Adverse Event|4|||
38064289|NCT02975336|69757803|FG006|LTE (104 Weeks)|Adverse Event|2|||
38064290|NCT02975336|69757804|FG007|LTE (104 Weeks)|Adverse Event|0|||
38064291|NCT02975336|69757797|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
38064292|NCT02975336|69757798|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
38064293|NCT02975336|69757799|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
38064294|NCT02975336|69757800|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
38064295|NCT02975336|69757801|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
38064296|NCT02975336|69757802|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
38064297|NCT02975336|69757803|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
38064298|NCT02975336|69757804|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
38064299|NCT02975336|69757797|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
38064300|NCT02975336|69757798|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
38064301|NCT02975336|69757799|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
38064302|NCT02975336|69757800|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
38064303|NCT02975336|69757801|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
38064304|NCT02975336|69757802|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
38064305|NCT02975336|69757803|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
38064306|NCT02975336|69757804|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
38064307|NCT02975336|69757797|FG000|LTE (104 Weeks)|Other|0|||
38064308|NCT02975336|69757798|FG001|LTE (104 Weeks)|Other|0|||
38064309|NCT02975336|69757799|FG002|LTE (104 Weeks)|Other|0|||
38064310|NCT02975336|69757800|FG003|LTE (104 Weeks)|Other|0|||
38064311|NCT02975336|69757801|FG004|LTE (104 Weeks)|Other|55|||
38064312|NCT02975336|69757802|FG005|LTE (104 Weeks)|Other|63|||
38064313|NCT02975336|69757803|FG006|LTE (104 Weeks)|Other|76|||
38064314|NCT02975336|69757804|FG007|LTE (104 Weeks)|Other|72|||
38064315|NCT03124563|69757820|FG000|Overall Study|Lost to Follow-up|1|||
38064316|NCT03124563|69757821|FG001|Overall Study|Lost to Follow-up|1|||
38064317|NCT03124563|69757820|FG000|Overall Study|Withdrawal by Subject|1|||
38064318|NCT03124563|69757821|FG001|Overall Study|Withdrawal by Subject|1|||
38064319|NCT03079869|69757829|FG000|Overall Study|Adverse Event|6|||
38064320|NCT03079869|69757830|FG001|Overall Study|Adverse Event|8|||
38064321|NCT03079869|69757829|FG000|Overall Study|Withdrawal by Subject|4|||
38064322|NCT03079869|69757830|FG001|Overall Study|Withdrawal by Subject|1|||
38064323|NCT03079869|69757829|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
38064324|NCT03079869|69757830|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
38064325|NCT03085914|69757843|FG000|Overall Study|Death|6|||
38064326|NCT03085914|69757844|FG001|Overall Study|Death|6|||
38064327|NCT03085914|69757845|FG002|Overall Study|Death|4|||
38064328|NCT03085914|69757846|FG003|Overall Study|Death|1|||
38064329|NCT03085914|69757847|FG004|Overall Study|Death|5|||
38064330|NCT03085914|69757848|FG005|Overall Study|Death|2|||
38064331|NCT03085914|69757849|FG006|Overall Study|Death|2|||
38064332|NCT03085914|69757843|FG000|Overall Study|Withdrawal by Subject|1|||
38064333|NCT03085914|69757844|FG001|Overall Study|Withdrawal by Subject|1|||
38064334|NCT03085914|69757845|FG002|Overall Study|Withdrawal by Subject|2|||
38064335|NCT03085914|69757846|FG003|Overall Study|Withdrawal by Subject|2|||
38064336|NCT03085914|69757847|FG004|Overall Study|Withdrawal by Subject|2|||
38064337|NCT03085914|69757848|FG005|Overall Study|Withdrawal by Subject|0|||
38064338|NCT03085914|69757849|FG006|Overall Study|Withdrawal by Subject|1|||
38064339|NCT03085914|69757843|FG000|Overall Study|Lost to Follow-up|0|||
38064340|NCT03085914|69757844|FG001|Overall Study|Lost to Follow-up|0|||
38064341|NCT03085914|69757845|FG002|Overall Study|Lost to Follow-up|1|||
38064342|NCT03085914|69757846|FG003|Overall Study|Lost to Follow-up|0|||
38064343|NCT03085914|69757847|FG004|Overall Study|Lost to Follow-up|0|||
38064344|NCT03085914|69757848|FG005|Overall Study|Lost to Follow-up|1|||
38064345|NCT03085914|69757849|FG006|Overall Study|Lost to Follow-up|1|||
38064346|NCT03085914|69757843|FG000|Overall Study|Reason was not specified,|2|||
38064347|NCT03085914|69757844|FG001|Overall Study|Reason was not specified,|2|||
38064348|NCT03085914|69757845|FG002|Overall Study|Reason was not specified,|2|||
38064349|NCT03085914|69757846|FG003|Overall Study|Reason was not specified,|3|||
38064350|NCT03085914|69757847|FG004|Overall Study|Reason was not specified,|3|||
38064351|NCT03085914|69757848|FG005|Overall Study|Reason was not specified,|3|||
38064352|NCT03085914|69757849|FG006|Overall Study|Reason was not specified,|6|||
38064353|NCT03085914|69757843|FG000|Overall Study|Progressive Disease|0|||
38064354|NCT03085914|69757844|FG001|Overall Study|Progressive Disease|0|||
38064355|NCT03085914|69757845|FG002|Overall Study|Progressive Disease|2|||
38064356|NCT03085914|69757846|FG003|Overall Study|Progressive Disease|2|||
38064357|NCT03085914|69757847|FG004|Overall Study|Progressive Disease|1|||
38064358|NCT03085914|69757848|FG005|Overall Study|Progressive Disease|1|||
38064359|NCT03085914|69757849|FG006|Overall Study|Progressive Disease|1|||
38064360|NCT03085914|69757843|FG000|Overall Study|Study Terminated by the Sponsor|0|||
38064361|NCT03085914|69757844|FG001|Overall Study|Study Terminated by the Sponsor|0|||
38064362|NCT03085914|69757845|FG002|Overall Study|Study Terminated by the Sponsor|0|||
38064363|NCT03085914|69757846|FG003|Overall Study|Study Terminated by the Sponsor|1|||
38064364|NCT03085914|69757847|FG004|Overall Study|Study Terminated by the Sponsor|2|||
38064365|NCT03085914|69757848|FG005|Overall Study|Study Terminated by the Sponsor|1|||
38064366|NCT03085914|69757849|FG006|Overall Study|Study Terminated by the Sponsor|0|||
38064367|NCT03078582|69757877|FG000|Overall Study|Adverse Event|0|||
38064368|NCT03078582|69757878|FG001|Overall Study|Adverse Event|8|||
38064369|NCT03077724|69757886|FG000|Overall Study|Lost to Follow-up|5|||
38064370|NCT03077724|69757887|FG001|Overall Study|Lost to Follow-up|1|||
38064371|NCT03077724|69757886|FG000|Overall Study|Withdrawal by Subject|3|||
38064372|NCT03077724|69757887|FG001|Overall Study|Withdrawal by Subject|1|||
38064373|NCT00979212|69757895|FG000|Overall Study|Protocol Violation|1|||
38064374|NCT00979212|69757896|FG001|Overall Study|Protocol Violation|8|||
38064375|NCT00979212|69757895|FG000|Overall Study|No protocol therapy received|1|||
38064376|NCT00979212|69757896|FG001|Overall Study|No protocol therapy received|0|||
38064377|NCT03080454|69757902|FG000|Baseline|Adverse Event|2|||
38064378|NCT03080454|69757902|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
38064379|NCT03080454|69757902|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
38064380|NCT02981342|69757926|FG000|Overall Study|Adverse Event|0|||
38064381|NCT02981342|69757927|FG001|Overall Study|Adverse Event|0|||
38064382|NCT02981342|69757928|FG002|Overall Study|Adverse Event|0|||
38064383|NCT02981342|69757929|FG003|Overall Study|Adverse Event|1|||
38064384|NCT02981342|69757926|FG000|Overall Study|Death|0|||
38064385|NCT02981342|69757927|FG001|Overall Study|Death|9|||
38064386|NCT02981342|69757928|FG002|Overall Study|Death|9|||
38064387|NCT02981342|69757929|FG003|Overall Study|Death|4|||
38064388|NCT02981342|69757926|FG000|Overall Study|Withdrawal by Subject|0|||
38064389|NCT02981342|69757927|FG001|Overall Study|Withdrawal by Subject|0|||
38064390|NCT02981342|69757928|FG002|Overall Study|Withdrawal by Subject|3|||
38064391|NCT02981342|69757929|FG003|Overall Study|Withdrawal by Subject|1|||
38064392|NCT02981342|69757926|FG000|Overall Study|Study closed by sponsor|0|||
38064393|NCT02981342|69757927|FG001|Overall Study|Study closed by sponsor|0|||
38064394|NCT02981342|69757928|FG002|Overall Study|Study closed by sponsor|1|||
38064395|NCT02981342|69757929|FG003|Overall Study|Study closed by sponsor|1|||
38064396|NCT02981342|69757926|FG000|Overall Study|Randomized, Never Treated|0|||
38064397|NCT02981342|69757927|FG001|Overall Study|Randomized, Never Treated|1|||
38064398|NCT02981342|69757928|FG002|Overall Study|Randomized, Never Treated|0|||
38064399|NCT02981342|69757929|FG003|Overall Study|Randomized, Never Treated|7|||
38064400|NCT02981342|69757926|FG000|Overall Study|Lost to Follow-up|0|||
38064401|NCT02981342|69757927|FG001|Overall Study|Lost to Follow-up|1|||
38064402|NCT02981342|69757928|FG002|Overall Study|Lost to Follow-up|0|||
38064403|NCT02981342|69757929|FG003|Overall Study|Lost to Follow-up|0|||
38064404|NCT02794246|69757941|FG000|Overall Study|Withdrawal by Subject|2|||
38064405|NCT02794246|69757941|FG000|Overall Study|Physician Decision|4|||
38064406|NCT03428100|69757949|FG000|Overall Study|Adverse Event|1|||
38064407|NCT03428100|69757950|FG001|Overall Study|Adverse Event|0|||
38064408|NCT03428100|69757951|FG002|Overall Study|Adverse Event|3|||
38064409|NCT03428100|69757952|FG003|Overall Study|Adverse Event|1|||
38064410|NCT03428100|69757949|FG000|Overall Study|Lack of Efficacy|16|||
38064411|NCT03428100|69757950|FG001|Overall Study|Lack of Efficacy|10|||
38064412|NCT03428100|69757951|FG002|Overall Study|Lack of Efficacy|7|||
38064413|NCT03428100|69757952|FG003|Overall Study|Lack of Efficacy|6|||
38064414|NCT03428100|69757949|FG000|Overall Study|Protocol Deviation|0|||
38064415|NCT03428100|69757950|FG001|Overall Study|Protocol Deviation|2|||
38064416|NCT03428100|69757951|FG002|Overall Study|Protocol Deviation|2|||
38064417|NCT03428100|69757952|FG003|Overall Study|Protocol Deviation|0|||
38064418|NCT03428100|69757949|FG000|Overall Study|Withdrawal by Subject|4|||
38064419|NCT03428100|69757950|FG001|Overall Study|Withdrawal by Subject|0|||
38064420|NCT03428100|69757951|FG002|Overall Study|Withdrawal by Subject|0|||
38064421|NCT03428100|69757952|FG003|Overall Study|Withdrawal by Subject|0|||
38064422|NCT03428100|69757949|FG000|Overall Study|Physician Decision|0|||
38064423|NCT03428100|69757950|FG001|Overall Study|Physician Decision|1|||
38064424|NCT03428100|69757951|FG002|Overall Study|Physician Decision|0|||
38064425|NCT03428100|69757952|FG003|Overall Study|Physician Decision|0|||
38064426|NCT02980874|69757974|FG000|Overall Study|Adverse Event|2|||
38064427|NCT02980874|69757975|FG001|Overall Study|Adverse Event|7|||
38064428|NCT02980874|69757974|FG000|Overall Study|Withdrawal by Subject|7|||
38064429|NCT02980874|69757975|FG001|Overall Study|Withdrawal by Subject|2|||
38064430|NCT02980874|69757974|FG000|Overall Study|Lost to Follow-up|5|||
38064431|NCT02980874|69757975|FG001|Overall Study|Lost to Follow-up|5|||
38064432|NCT02980874|69757974|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
38064433|NCT02980874|69757975|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
38064434|NCT02980874|69757974|FG000|Overall Study|Unknown study completion status|1|||
38064435|NCT02980874|69757975|FG001|Overall Study|Unknown study completion status|0|||
38064436|NCT01066052|69757983|FG000|Overall Study|Enrolled But Not Treated|3|||
38064437|NCT01066052|69757984|FG001|Overall Study|Enrolled But Not Treated|0|||
38064438|NCT03077646|69757992|FG000|Overall Study|Lost to Follow-up|29|||
38064439|NCT03077646|69757993|FG001|Overall Study|Lost to Follow-up|30|||
38064440|NCT03077646|69757994|FG002|Overall Study|Lost to Follow-up|31|||
38064441|NCT02892149|69758004|FG000|Overall Study|Death|262|||
38064442|NCT02892149|69758005|FG001|Overall Study|Death|278|||
38064443|NCT02892149|69758004|FG000|Overall Study|Withdrawal by Subject|53|||
38064444|NCT02892149|69758005|FG001|Overall Study|Withdrawal by Subject|47|||
38064445|NCT02892149|69758004|FG000|Overall Study|Lost to Follow-up|37|||
38064446|NCT02892149|69758005|FG001|Overall Study|Lost to Follow-up|31|||
38064447|NCT04187092|69758013|FG000|Overall Study|Lost to Follow-up|1|||
38064448|NCT04187092|69758014|FG001|Overall Study|Lost to Follow-up|1|||
38064449|NCT04187092|69758013|FG000|Overall Study|Withdrawal by Subject|1|||
38064450|NCT04187092|69758014|FG001|Overall Study|Withdrawal by Subject|1|||
38064451|NCT04187092|69758013|FG000|Overall Study|Adverse Event|0|||
38064452|NCT04187092|69758014|FG001|Overall Study|Adverse Event|1|||
38064453|NCT02896127|69758022|FG000|COMPLETED WEEK 52|Adverse Event|9|||
38064454|NCT02896127|69758023|FG001|COMPLETED WEEK 52|Adverse Event|2|||
38064455|NCT02896127|69758022|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
38064456|NCT02896127|69758023|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
38064457|NCT02896127|69758022|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
38064458|NCT02896127|69758023|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
38064459|NCT02896127|69758022|FG000|COMPLETED WEEK 52|Physician Decision|1|||
38064460|NCT02896127|69758023|FG001|COMPLETED WEEK 52|Physician Decision|1|||
38064461|NCT02896127|69758022|FG000|COMPLETED WEEK 52|Pregnancy|2|||
38064462|NCT02896127|69758023|FG001|COMPLETED WEEK 52|Pregnancy|0|||
38064463|NCT02896127|69758022|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
38064464|NCT02896127|69758023|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
38064465|NCT02896127|69758022|FG000|COMPLETED WEEK 52|Technical problems|1|||
38064466|NCT02896127|69758023|FG001|COMPLETED WEEK 52|Technical problems|0|||
38064467|NCT02896127|69758022|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
38064468|NCT02896127|69758023|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
38064469|NCT02896127|69758022|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
38064470|NCT02896127|69758023|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
38064471|NCT02896127|69758022|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
38064472|NCT02896127|69758023|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
38064473|NCT02896127|69758022|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
38064474|NCT02896127|69758023|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
38064475|NCT02896127|69758022|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
38064476|NCT02896127|69758023|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
38064477|NCT03546647|69758029|FG000|Overall Study|Adverse Event|1|||
38064478|NCT03546647|69758030|FG001|Overall Study|Adverse Event|0|||
38064479|NCT03077412|69758039|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
38064480|NCT03077412|69758040|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
38064481|NCT03077412|69758041|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
38064482|NCT03077412|69758039|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
38064483|NCT03077412|69758040|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
38064484|NCT03077412|69758041|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
38064485|NCT03077412|69758039|FG000|Overall Study|Adverse Event|1|||
38064486|NCT03077412|69758040|FG001|Overall Study|Adverse Event|2|||
38064487|NCT03077412|69758041|FG002|Overall Study|Adverse Event|2|||
38064488|NCT03077412|69758039|FG000|Overall Study|Investigator's Discretion|0|||
38064489|NCT03077412|69758040|FG001|Overall Study|Investigator's Discretion|1|||
38064490|NCT03077412|69758041|FG002|Overall Study|Investigator's Discretion|1|||
38064491|NCT03077412|69758039|FG000|Overall Study|Withdrew Consent|0|||
38064492|NCT03077412|69758040|FG001|Overall Study|Withdrew Consent|2|||
38064493|NCT03077412|69758041|FG002|Overall Study|Withdrew Consent|0|||
38064494|NCT03544229|69758053|FG000|Overall Study|Adverse Event|1|||
38064495|NCT03544229|69758054|FG001|Overall Study|Adverse Event|0|||
38064496|NCT03544229|69758055|FG002|Overall Study|Adverse Event|1|||
38064497|NCT03544229|69758056|FG003|Overall Study|Adverse Event|0|||
38064498|NCT03544229|69758053|FG000|Overall Study|Protocol Deviation|0|||
38064499|NCT03544229|69758054|FG001|Overall Study|Protocol Deviation|0|||
38064500|NCT03544229|69758055|FG002|Overall Study|Protocol Deviation|1|||
38064501|NCT03544229|69758056|FG003|Overall Study|Protocol Deviation|0|||
38064502|NCT03544229|69758053|FG000|Overall Study|Lost to Follow-up|3|||
38064503|NCT03544229|69758054|FG001|Overall Study|Lost to Follow-up|0|||
38064504|NCT03544229|69758055|FG002|Overall Study|Lost to Follow-up|0|||
38064505|NCT03544229|69758056|FG003|Overall Study|Lost to Follow-up|2|||
38064506|NCT03544229|69758053|FG000|Overall Study|Voluntary Withdrawal|2|||
38064507|NCT03544229|69758054|FG001|Overall Study|Voluntary Withdrawal|1|||
38064508|NCT03544229|69758055|FG002|Overall Study|Voluntary Withdrawal|3|||
38064509|NCT03544229|69758056|FG003|Overall Study|Voluntary Withdrawal|0|||
38064510|NCT03544229|69758053|FG000|Overall Study|Lack of Efficacy|0|||
38064511|NCT03544229|69758054|FG001|Overall Study|Lack of Efficacy|1|||
38064512|NCT03544229|69758055|FG002|Overall Study|Lack of Efficacy|0|||
38064513|NCT03544229|69758056|FG003|Overall Study|Lack of Efficacy|0|||
38064514|NCT03078816|69758066|FG000|Overall Study|Withdrawal by Subject|1|||
38064515|NCT03510455|69758070|FG000|Overall Study|Physician Decision|1|||
38064516|NCT03509675|69758078|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
38064517|NCT03509675|69758079|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
38064518|NCT03509675|69758078|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
38064519|NCT03509675|69758079|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
38064520|NCT03509675|69758078|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
38064521|NCT03509675|69758079|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
38064522|NCT03509675|69758078|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
38064523|NCT03509675|69758079|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
38064524|NCT03509207|69758085|FG000|Overall Study|Death|2|||
38064525|NCT03543137|69758089|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
38064526|NCT03543137|69758090|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
38064527|NCT03543137|69758089|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
38064528|NCT03543137|69758090|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
38064529|NCT03543137|69758089|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
38064530|NCT03543137|69758090|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
38064531|NCT02895347|69758100|FG000|Overall Study|Withdrawal by Subject|3|||
38064532|NCT02895347|69758101|FG001|Overall Study|Withdrawal by Subject|1|||
38064533|NCT03539549|69758108|FG000|Overall Study|Adverse Event|12|||
38064534|NCT03539549|69758108|FG000|Overall Study|Lost to Follow-up|1|||
38064535|NCT03539549|69758108|FG000|Overall Study|Death|2|||
38064536|NCT03539549|69758108|FG000|Overall Study|Progressive Disease|1|||
38064537|NCT03539549|69758108|FG000|Overall Study|Reason not Specified|1|||
38064538|NCT03506477|69758114|FG000|Overall Study|Withdrawal by Subject|1|||
38064539|NCT03506477|69758115|FG001|Overall Study|Withdrawal by Subject|0|||
38064540|NCT03073980|69758124|FG000|Overall Study|Lost to Follow-up|10|||
38064541|NCT03073980|69758125|FG001|Overall Study|Lost to Follow-up|2|||
38064542|NCT03073980|69758126|FG002|Overall Study|Lost to Follow-up|9|||
38064543|NCT03073980|69758124|FG000|Overall Study|No post-procedure data|0|||
38064544|NCT03073980|69758125|FG001|Overall Study|No post-procedure data|0|||
38064545|NCT03073980|69758126|FG002|Overall Study|No post-procedure data|2|||
38064546|NCT03930186|69758138|FG000|Weeks 0 to 16|Adverse Event|6|||
38064547|NCT03930186|69758138|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
38064548|NCT03930186|69758138|FG000|Weeks 16 to 32|Adverse Event|1|||
38064549|NCT03930186|69758138|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
38064550|NCT03504917|69758144|FG000|Blinded Treatment Period|Protocol Violation|1|||
38064551|NCT03504917|69758145|FG001|Blinded Treatment Period|Protocol Violation|0|||
38064552|NCT03504917|69758144|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
38064553|NCT03504917|69758145|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
38064554|NCT03504917|69758144|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
38064555|NCT03504917|69758145|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
38064556|NCT03504917|69758144|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
38064557|NCT03504917|69758145|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
38064558|NCT03504917|69758144|FG000|Blinded Treatment Period|Adverse Event|4|||
38064559|NCT03504917|69758145|FG001|Blinded Treatment Period|Adverse Event|4|||
38064560|NCT03504917|69758144|FG000|Blinded Treatment Period|Physician Decision|1|||
38064561|NCT03504917|69758145|FG001|Blinded Treatment Period|Physician Decision|0|||
38064562|NCT03504917|69758144|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
38064563|NCT03504917|69758145|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
38064564|NCT03504917|69758144|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
38064565|NCT03504917|69758145|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
38064566|NCT03504917|69758144|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
38064567|NCT03504917|69758145|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
38064568|NCT03504917|69758144|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
38064569|NCT03504917|69758145|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
38064570|NCT03504917|69758144|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
38064571|NCT03504917|69758145|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
38064572|NCT03504917|69758144|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
38064573|NCT03504917|69758145|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
38064574|NCT03504917|69758144|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
38064575|NCT03504917|69758145|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
38064576|NCT03504917|69758144|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
38064577|NCT03504917|69758145|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
38064578|NCT03504917|69758144|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
38064579|NCT03504917|69758145|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
38064580|NCT03504917|69758144|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
38064581|NCT03504917|69758145|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
38064582|NCT03536663|69758157|FG000|Endexo|Protocol Violation|1|||
38064583|NCT03565211|69758166|FG000|Overall Study|Withdrawal by Subject|2|||
38064584|NCT03565211|69758166|FG000|Overall Study|Lost to Follow-up|1|||
38064585|NCT03565211|69758166|FG000|Overall Study|Adverse Event|44|||
38064586|NCT03565211|69758166|FG000|Overall Study|Personal issues|1|||
38064587|NCT03531905|69758173|FG000|Overall Study|Withdrawal by Subject|3|||
38064588|NCT03531905|69758174|FG001|Overall Study|Withdrawal by Subject|3|||
38064589|NCT03531905|69758175|FG002|Overall Study|Withdrawal by Subject|2|||
38064590|NCT03531905|69758173|FG000|Overall Study|Lost to Follow-up|2|||
38064591|NCT03531905|69758174|FG001|Overall Study|Lost to Follow-up|2|||
38064592|NCT03531905|69758175|FG002|Overall Study|Lost to Follow-up|1|||
38064593|NCT03531905|69758173|FG000|Overall Study|Participant was out of town|1|||
38064594|NCT03531905|69758174|FG001|Overall Study|Participant was out of town|0|||
38064595|NCT03531905|69758175|FG002|Overall Study|Participant was out of town|0|||
38064596|NCT03531905|69758173|FG000|Overall Study|Could not speak with the participant|1|||
38064597|NCT03531905|69758174|FG001|Overall Study|Could not speak with the participant|0|||
38064598|NCT03531905|69758175|FG002|Overall Study|Could not speak with the participant|0|||
38064599|NCT03531827|69758185|FG000|Overall Study|Adverse Event|2|||
38064600|NCT03531827|69758186|FG001|Overall Study|Adverse Event|0|||
38064601|NCT03531827|69758185|FG000|Overall Study|Progressive disease|1|||
38064602|NCT03531827|69758186|FG001|Overall Study|Progressive disease|0|||
38064603|NCT03530345|69758215|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
38064604|NCT03530345|69758216|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
38064605|NCT03530345|69758215|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
38064606|NCT03530345|69758216|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
38064607|NCT03530345|69758215|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
38064608|NCT03530345|69758216|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
38064609|NCT03530345|69758215|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
38064610|NCT03530345|69758216|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
38064611|NCT03500159|69758230|FG000|Overall Study|Study Terminated|2|||
38064612|NCT03500159|69758231|FG001|Overall Study|Study Terminated|1|||
38064613|NCT03785340|69758239|FG000|Overall Study|Lost to Follow-up|2|||
38064614|NCT03785340|69758240|FG001|Overall Study|Lost to Follow-up|0|||
38064615|NCT03785340|69758239|FG000|Overall Study|Adverse Event|1|||
38064616|NCT03785340|69758240|FG001|Overall Study|Adverse Event|0|||
38064617|NCT03499067|69758246|FG000|First Intervention|Physician Decision|2|||
38064618|NCT03499067|69758247|FG001|First Intervention|Physician Decision|1|||
38064619|NCT03499067|69758246|FG000|First Intervention|Withdrawal by Subject|3|||
38064620|NCT03499067|69758247|FG001|First Intervention|Withdrawal by Subject|6|||
38064621|NCT03562481|69758255|FG000|First Intervention|Lost to Follow-up|1|||
38064622|NCT03562481|69758256|FG001|First Intervention|Lost to Follow-up|0|||
38064623|NCT03529409|69758282|FG000|Randomized|Lost to Follow-up|0|||
38064624|NCT03529409|69758283|FG001|Randomized|Lost to Follow-up|0|||
38064625|NCT03529409|69758284|FG002|Randomized|Lost to Follow-up|4|||
38064626|NCT03529409|69758282|FG000|Randomized|Excluded|0|||
38064627|NCT03529409|69758283|FG001|Randomized|Excluded|0|||
38064628|NCT03529409|69758284|FG002|Randomized|Excluded|1|||
38064629|NCT03529409|69758282|FG000|Post-treatment Assessment|Death|1|||
38064630|NCT03529409|69758283|FG001|Post-treatment Assessment|Death|0|||
38064631|NCT03529409|69758284|FG002|Post-treatment Assessment|Death|0|||
38064632|NCT03529409|69758282|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
38064633|NCT03529409|69758283|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
38064634|NCT03529409|69758284|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
38064635|NCT03529409|69758282|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
38064636|NCT03529409|69758283|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
38064637|NCT03529409|69758284|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
38064638|NCT03529409|69758282|FG000|Follow-up Assessment|Death|1|||
38064639|NCT03529409|69758283|FG001|Follow-up Assessment|Death|0|||
38064640|NCT03529409|69758284|FG002|Follow-up Assessment|Death|0|||
38064641|NCT03529409|69758282|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
38064642|NCT03529409|69758283|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
38064643|NCT03529409|69758284|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
38064644|NCT03498287|69758293|FG000|Overall Study|Withdrawal by Subject|3|||
38064645|NCT03498287|69758294|FG001|Overall Study|Withdrawal by Subject|0|||
38064646|NCT03498287|69758293|FG000|Overall Study|Protocol Violation|0|||
38064647|NCT03498287|69758294|FG001|Overall Study|Protocol Violation|4|||
38064648|NCT03498287|69758293|FG000|Overall Study|Adverse Event|0|||
38064649|NCT03498287|69758294|FG001|Overall Study|Adverse Event|1|||
38064650|NCT03497429|69758302|FG000|Overall Study|Progressive disease|3|||
38064651|NCT03497429|69758303|FG001|Overall Study|Progressive disease|4|||
38064652|NCT03497429|69758302|FG000|Overall Study|Adverse Event|0|||
38064653|NCT03497429|69758303|FG001|Overall Study|Adverse Event|2|||
38064654|NCT03497039|69758311|FG000|Overall Study|Withdrawal by Subject|1|||
38064655|NCT03497039|69758312|FG001|Overall Study|Withdrawal by Subject|0|||
38064656|NCT03497039|69758311|FG000|Overall Study|Protocol Violation|0|||
38064657|NCT03497039|69758312|FG001|Overall Study|Protocol Violation|1|||
38064658|NCT03495869|69758331|FG000|Overall Study|Lost to Follow-up|4|||
38064659|NCT03495869|69758332|FG001|Overall Study|Lost to Follow-up|17|||
38064660|NCT03495869|69758333|FG002|Overall Study|Lost to Follow-up|8|||
38064661|NCT03495869|69758334|FG003|Overall Study|Lost to Follow-up|14|||
38064662|NCT03495869|69758331|FG000|Overall Study|Withdrawal by Subject|0|||
38064663|NCT03495869|69758332|FG001|Overall Study|Withdrawal by Subject|3|||
38064664|NCT03495869|69758333|FG002|Overall Study|Withdrawal by Subject|0|||
38064665|NCT03495869|69758334|FG003|Overall Study|Withdrawal by Subject|3|||
38064666|NCT03495869|69758331|FG000|Overall Study|Dropped from study|0|||
38064667|NCT03495869|69758332|FG001|Overall Study|Dropped from study|7|||
38064668|NCT03495869|69758333|FG002|Overall Study|Dropped from study|2|||
38064669|NCT03495869|69758334|FG003|Overall Study|Dropped from study|4|||
38064670|NCT03071094|69758355|FG000|Overall Study|Death|1|||
38064671|NCT03071094|69758356|FG001|Overall Study|Death|1|||
38064672|NCT03071094|69758355|FG000|Overall Study|Adverse Event|1|||
38064673|NCT03071094|69758356|FG001|Overall Study|Adverse Event|0|||
38064674|NCT03559517|69758365|FG000|Overall Study|Withdrawal by Subject|1|||
38064675|NCT03559517|69758366|FG001|Overall Study|Withdrawal by Subject|0|||
38064676|NCT03559517|69758367|FG002|Overall Study|Withdrawal by Subject|0|||
38064677|NCT02509494|69758384|FG000|Overall Study|Lost to Follow-up|8|||
38064678|NCT02509494|69758385|FG001|Overall Study|Lost to Follow-up|47|||
38064679|NCT02509494|69758386|FG002|Overall Study|Lost to Follow-up|19|||
38064680|NCT02509494|69758387|FG003|Overall Study|Lost to Follow-up|6|||
38064681|NCT02509494|69758388|FG004|Overall Study|Lost to Follow-up|3|||
38064682|NCT02509494|69758389|FG005|Overall Study|Lost to Follow-up|3|||
38064683|NCT02509494|69758390|FG006|Overall Study|Lost to Follow-up|1|||
38064684|NCT02509494|69758391|FG007|Overall Study|Lost to Follow-up|3|||
38064685|NCT02509494|69758392|FG008|Overall Study|Lost to Follow-up|1|||
38064686|NCT02509494|69758384|FG000|Overall Study|Physician Decision|2|||
38064687|NCT02509494|69758385|FG001|Overall Study|Physician Decision|1|||
38064688|NCT02509494|69758386|FG002|Overall Study|Physician Decision|0|||
38064689|NCT02509494|69758387|FG003|Overall Study|Physician Decision|0|||
38064690|NCT02509494|69758388|FG004|Overall Study|Physician Decision|0|||
38064691|NCT02509494|69758389|FG005|Overall Study|Physician Decision|0|||
38064692|NCT02509494|69758390|FG006|Overall Study|Physician Decision|0|||
38064693|NCT02509494|69758391|FG007|Overall Study|Physician Decision|0|||
38064694|NCT02509494|69758392|FG008|Overall Study|Physician Decision|0|||
38064695|NCT02509494|69758384|FG000|Overall Study|Withdrawal by Subject|4|||
38064696|NCT02509494|69758385|FG001|Overall Study|Withdrawal by Subject|17|||
38064697|NCT02509494|69758386|FG002|Overall Study|Withdrawal by Subject|7|||
38064698|NCT02509494|69758387|FG003|Overall Study|Withdrawal by Subject|5|||
38064699|NCT02509494|69758388|FG004|Overall Study|Withdrawal by Subject|0|||
38064700|NCT02509494|69758389|FG005|Overall Study|Withdrawal by Subject|6|||
38064701|NCT02509494|69758390|FG006|Overall Study|Withdrawal by Subject|1|||
38064702|NCT02509494|69758391|FG007|Overall Study|Withdrawal by Subject|2|||
38064703|NCT02509494|69758392|FG008|Overall Study|Withdrawal by Subject|1|||
38064704|NCT02509494|69758384|FG000|Overall Study|Death|0|||
38064705|NCT02509494|69758385|FG001|Overall Study|Death|1|||
38064706|NCT02509494|69758386|FG002|Overall Study|Death|0|||
38064707|NCT02509494|69758387|FG003|Overall Study|Death|0|||
38064708|NCT02509494|69758388|FG004|Overall Study|Death|1|||
38064709|NCT02509494|69758389|FG005|Overall Study|Death|0|||
38064710|NCT02509494|69758390|FG006|Overall Study|Death|0|||
38064711|NCT02509494|69758391|FG007|Overall Study|Death|1|||
38064712|NCT02509494|69758392|FG008|Overall Study|Death|0|||
38064713|NCT02509494|69758384|FG000|Overall Study|Other|0|||
38064714|NCT02509494|69758385|FG001|Overall Study|Other|4|||
38064715|NCT02509494|69758386|FG002|Overall Study|Other|5|||
38064716|NCT02509494|69758387|FG003|Overall Study|Other|0|||
38064717|NCT02509494|69758388|FG004|Overall Study|Other|0|||
38064718|NCT02509494|69758389|FG005|Overall Study|Other|0|||
38064719|NCT02509494|69758390|FG006|Overall Study|Other|0|||
38064720|NCT02509494|69758391|FG007|Overall Study|Other|0|||
38064721|NCT02509494|69758392|FG008|Overall Study|Other|0|||
38064722|NCT02509494|69758384|FG000|Overall Study|Non-Compliance With Study Drug|1|||
38064723|NCT02509494|69758385|FG001|Overall Study|Non-Compliance With Study Drug|11|||
38064724|NCT02509494|69758386|FG002|Overall Study|Non-Compliance With Study Drug|7|||
38064725|NCT02509494|69758387|FG003|Overall Study|Non-Compliance With Study Drug|0|||
38064726|NCT02509494|69758388|FG004|Overall Study|Non-Compliance With Study Drug|1|||
38064727|NCT02509494|69758389|FG005|Overall Study|Non-Compliance With Study Drug|2|||
38064728|NCT02509494|69758390|FG006|Overall Study|Non-Compliance With Study Drug|1|||
38064729|NCT02509494|69758391|FG007|Overall Study|Non-Compliance With Study Drug|1|||
38064730|NCT02509494|69758392|FG008|Overall Study|Non-Compliance With Study Drug|0|||
38064731|NCT03493451|69758429|FG000|Overall Study|Death|11|||
38064732|NCT03493451|69758430|FG001|Overall Study|Death|26|||
38064733|NCT03493451|69758431|FG002|Overall Study|Death|3|||
38064734|NCT03493451|69758429|FG000|Overall Study|Lost to Follow-up|1|||
38064735|NCT03493451|69758430|FG001|Overall Study|Lost to Follow-up|4|||
38064736|NCT03493451|69758431|FG002|Overall Study|Lost to Follow-up|1|||
38064737|NCT03493451|69758429|FG000|Overall Study|Withdrawal by Subject|1|||
38064738|NCT03493451|69758430|FG001|Overall Study|Withdrawal by Subject|1|||
38064739|NCT03493451|69758431|FG002|Overall Study|Withdrawal by Subject|2|||
38064740|NCT03493451|69758429|FG000|Overall Study|Progressive Disease|1|||
38064741|NCT03493451|69758430|FG001|Overall Study|Progressive Disease|0|||
38064742|NCT03493451|69758431|FG002|Overall Study|Progressive Disease|0|||
38064743|NCT03493451|69758429|FG000|Overall Study|Transferred to long term extension study|8|||
38064744|NCT03493451|69758430|FG001|Overall Study|Transferred to long term extension study|13|||
38064745|NCT03493451|69758431|FG002|Overall Study|Transferred to long term extension study|5|||
38064746|NCT03492281|69758442|FG000|Overall Study|Withdrawal by Subject|21|||
38064747|NCT03492281|69758443|FG001|Overall Study|Withdrawal by Subject|14|||
38064748|NCT03492281|69758444|FG002|Overall Study|Withdrawal by Subject|13|||
38064749|NCT03492281|69758442|FG000|Overall Study|Lost to Follow-up|14|||
38064750|NCT03492281|69758443|FG001|Overall Study|Lost to Follow-up|15|||
38064751|NCT03492281|69758444|FG002|Overall Study|Lost to Follow-up|10|||
38064752|NCT03492281|69758442|FG000|Overall Study|Adverse Event|6|||
38064753|NCT03492281|69758443|FG001|Overall Study|Adverse Event|8|||
38064754|NCT03492281|69758444|FG002|Overall Study|Adverse Event|13|||
38064755|NCT03492281|69758442|FG000|Overall Study|Lack of Efficacy|3|||
38064756|NCT03492281|69758443|FG001|Overall Study|Lack of Efficacy|0|||
38064757|NCT03492281|69758444|FG002|Overall Study|Lack of Efficacy|1|||
38064758|NCT03492281|69758442|FG000|Overall Study|Physician Decision|1|||
38064759|NCT03492281|69758443|FG001|Overall Study|Physician Decision|0|||
38064760|NCT03492281|69758444|FG002|Overall Study|Physician Decision|3|||
38064761|NCT03492281|69758442|FG000|Overall Study|Protocol Violation|0|||
38064762|NCT03492281|69758443|FG001|Overall Study|Protocol Violation|2|||
38064763|NCT03492281|69758444|FG002|Overall Study|Protocol Violation|1|||
38064764|NCT03492281|69758442|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
38064765|NCT03492281|69758443|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
38064766|NCT03492281|69758444|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
38064767|NCT03492281|69758442|FG000|Overall Study|Death|0|||
38064768|NCT03492281|69758443|FG001|Overall Study|Death|0|||
38064769|NCT03492281|69758444|FG002|Overall Study|Death|1|||
38064770|NCT03492281|69758442|FG000|Overall Study|Captured as Other in Database|8|||
38064771|NCT03492281|69758443|FG001|Overall Study|Captured as Other in Database|6|||
38064772|NCT03492281|69758444|FG002|Overall Study|Captured as Other in Database|3|||
38064773|NCT03070782|69758461|FG000|Overall Study|Adverse Event|3|||
38064774|NCT03070782|69758462|FG001|Overall Study|Adverse Event|0|||
38064775|NCT03070782|69758463|FG002|Overall Study|Adverse Event|3|||
38064776|NCT03070782|69758464|FG003|Overall Study|Adverse Event|1|||
38064777|NCT03070782|69758465|FG004|Overall Study|Adverse Event|6|||
38064778|NCT03070782|69758466|FG005|Overall Study|Adverse Event|2|||
38064779|NCT03070782|69758461|FG000|Overall Study|Withdrawal by Subject|2|||
38064780|NCT03070782|69758462|FG001|Overall Study|Withdrawal by Subject|1|||
38064781|NCT03070782|69758463|FG002|Overall Study|Withdrawal by Subject|1|||
38064782|NCT03070782|69758464|FG003|Overall Study|Withdrawal by Subject|0|||
38064783|NCT03070782|69758465|FG004|Overall Study|Withdrawal by Subject|4|||
38064784|NCT03070782|69758466|FG005|Overall Study|Withdrawal by Subject|3|||
38064785|NCT03070782|69758461|FG000|Overall Study|Reason Not Specified|2|||
38064786|NCT03070782|69758462|FG001|Overall Study|Reason Not Specified|0|||
38064787|NCT03070782|69758463|FG002|Overall Study|Reason Not Specified|0|||
38064788|NCT03070782|69758464|FG003|Overall Study|Reason Not Specified|1|||
38064789|NCT03070782|69758465|FG004|Overall Study|Reason Not Specified|2|||
38064790|NCT03070782|69758466|FG005|Overall Study|Reason Not Specified|1|||
38064791|NCT03070782|69758461|FG000|Overall Study|Ineligibility|0|||
37862267|NCT00919633|69546034|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
38064792|NCT03070782|69758462|FG001|Overall Study|Ineligibility|0|||
38064793|NCT03070782|69758463|FG002|Overall Study|Ineligibility|0|||
38064794|NCT03070782|69758464|FG003|Overall Study|Ineligibility|1|||
38064795|NCT03070782|69758465|FG004|Overall Study|Ineligibility|0|||
38064796|NCT03070782|69758466|FG005|Overall Study|Ineligibility|1|||
38064797|NCT03070782|69758461|FG000|Overall Study|Pregnancy|0|||
38064798|NCT03070782|69758462|FG001|Overall Study|Pregnancy|0|||
38064799|NCT03070782|69758463|FG002|Overall Study|Pregnancy|0|||
38064800|NCT03070782|69758464|FG003|Overall Study|Pregnancy|1|||
38064801|NCT03070782|69758465|FG004|Overall Study|Pregnancy|0|||
38064802|NCT03070782|69758466|FG005|Overall Study|Pregnancy|0|||
38064803|NCT03070782|69758461|FG000|Overall Study|Investigator Judgement|0|||
38064804|NCT03070782|69758462|FG001|Overall Study|Investigator Judgement|0|||
38064805|NCT03070782|69758463|FG002|Overall Study|Investigator Judgement|0|||
38064806|NCT03070782|69758464|FG003|Overall Study|Investigator Judgement|1|||
38064807|NCT03070782|69758465|FG004|Overall Study|Investigator Judgement|0|||
38064808|NCT03070782|69758466|FG005|Overall Study|Investigator Judgement|0|||
38064809|NCT03525119|69758502|FG000|Overall Study|Adverse Event|0|||
38064810|NCT03525119|69758503|FG001|Overall Study|Adverse Event|1|||
38064811|NCT03525119|69758504|FG002|Overall Study|Adverse Event|0|||
38064812|NCT03525119|69758502|FG000|Overall Study|Lost to Follow-up|32|||
38064813|NCT03525119|69758503|FG001|Overall Study|Lost to Follow-up|33|||
38064814|NCT03525119|69758504|FG002|Overall Study|Lost to Follow-up|37|||
38064815|NCT03525119|69758502|FG000|Overall Study|Withdrawal by Subject|5|||
38064816|NCT03525119|69758503|FG001|Overall Study|Withdrawal by Subject|4|||
38064817|NCT03525119|69758504|FG002|Overall Study|Withdrawal by Subject|2|||
38064818|NCT03525119|69758502|FG000|Overall Study|Reason not Specified|2|||
38064819|NCT03525119|69758503|FG001|Overall Study|Reason not Specified|1|||
38064820|NCT03525119|69758504|FG002|Overall Study|Reason not Specified|2|||
38064821|NCT03525119|69758502|FG000|Overall Study|Randomized but not Vaccinated|1|||
38064822|NCT03525119|69758503|FG001|Overall Study|Randomized but not Vaccinated|0|||
38064823|NCT03525119|69758504|FG002|Overall Study|Randomized but not Vaccinated|2|||
38064824|NCT03558503|69758512|FG000|Overall Study|Adverse Event|1|||
38064825|NCT03558503|69758512|FG000|Overall Study|Death|1|||
38064826|NCT03558503|69758512|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
38064827|NCT03489863|69758518|FG000|Overall Study|Withdrawal by Subject|0|||
38064828|NCT03489863|69758519|FG001|Overall Study|Withdrawal by Subject|1|||
38064829|NCT03489551|69758525|FG000|Overall Study|Withdrawal by Subject|2|||
38064830|NCT03557801|69758532|FG000|Overall Study|Protocol Violation|1|||
38064831|NCT03557801|69758533|FG001|Overall Study|Protocol Violation|0|||
38064832|NCT03557801|69758534|FG002|Overall Study|Protocol Violation|0|||
38064833|NCT03557801|69758532|FG000|Overall Study|Withdrawal by Subject|1|||
38064834|NCT03557801|69758533|FG001|Overall Study|Withdrawal by Subject|0|||
38064835|NCT03557801|69758534|FG002|Overall Study|Withdrawal by Subject|3|||
38064836|NCT03557801|69758532|FG000|Overall Study|Lost to Follow-up|0|||
38064837|NCT03557801|69758533|FG001|Overall Study|Lost to Follow-up|1|||
38064838|NCT03557801|69758534|FG002|Overall Study|Lost to Follow-up|0|||
38064839|NCT04210180|69758542|FG000|Overall Study|Withdrawal by Subject|2|||
38064840|NCT03523871|69758546|FG000|Overall Study|Death|1|||
38064841|NCT03523715|69758552|FG000|Overall Study|Lost to Follow-up|11|||
38064842|NCT03523715|69758553|FG001|Overall Study|Lost to Follow-up|14|||
38064843|NCT03523715|69758552|FG000|Overall Study|Did not meet inclusion criteria|1|||
38064844|NCT03523715|69758553|FG001|Overall Study|Did not meet inclusion criteria|0|||
38064845|NCT03523715|69758552|FG000|Overall Study|Internally inconsistent reporting|0|||
38064846|NCT03523715|69758553|FG001|Overall Study|Internally inconsistent reporting|2|||
38064847|NCT03980730|69758561|FG000|Overall Study|Study Terminated by Sponsor|0|||
38064848|NCT03980730|69758562|FG001|Overall Study|Study Terminated by Sponsor|3|||
38064849|NCT03980730|69758561|FG000|Overall Study|Adverse Event|2|||
38064850|NCT03980730|69758562|FG001|Overall Study|Adverse Event|0|||
38064851|NCT03980730|69758561|FG000|Overall Study|Sponsor Request|0|||
38064852|NCT03980730|69758562|FG001|Overall Study|Sponsor Request|1|||
38064853|NCT03523091|69758570|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
38064854|NCT03523091|69758571|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
38064855|NCT03523091|69758570|FG000|Overall Study|Withdrawal by Subject|0|||
38064856|NCT03523091|69758571|FG001|Overall Study|Withdrawal by Subject|3|||
38064857|NCT03523091|69758570|FG000|Overall Study|Increase Botox dose|0|||
38064858|NCT03523091|69758571|FG001|Overall Study|Increase Botox dose|1|||
38064859|NCT03438383|69758592|FG000|Overall Study|Protocol Violation|9|||
38064860|NCT03438383|69758593|FG001|Overall Study|Protocol Violation|3|||
38064861|NCT03478787|69758601|FG000|Overall Study|Adverse Event|5|||
38064862|NCT03478787|69758602|FG001|Overall Study|Adverse Event|1|||
38064863|NCT03478787|69758601|FG000|Overall Study|Protocol Violation|3|||
38064864|NCT03478787|69758602|FG001|Overall Study|Protocol Violation|0|||
38064865|NCT03478787|69758601|FG000|Overall Study|Lack of Efficacy|7|||
38064866|NCT03478787|69758602|FG001|Overall Study|Lack of Efficacy|1|||
38064867|NCT03478787|69758601|FG000|Overall Study|Lost to Follow-up|9|||
38064868|NCT03478787|69758602|FG001|Overall Study|Lost to Follow-up|5|||
38064869|NCT03478787|69758601|FG000|Overall Study|Withdrawal by Subject|2|||
38064870|NCT03478787|69758602|FG001|Overall Study|Withdrawal by Subject|6|||
38064871|NCT03478787|69758601|FG000|Overall Study|Other, Not Specified|3|||
38064872|NCT03478787|69758602|FG001|Overall Study|Other, Not Specified|0|||
38064873|NCT03488927|69758611|FG000|Overall Study|Withdrawal by Subject|44|||
38064874|NCT03488927|69758612|FG001|Overall Study|Withdrawal by Subject|118|||
38064875|NCT03488927|69758613|FG002|Overall Study|Withdrawal by Subject|217|||
37965740|NCT00059839|69652717|FG000|Overall Study|Lost to Follow-up|2|||
38064876|NCT03437447|69758624|FG000|Treatment Period 1|Withdrawal by Subject|0|||
38064877|NCT03437447|69758625|FG001|Treatment Period 1|Withdrawal by Subject|0|||
38064878|NCT03437447|69758626|FG002|Treatment Period 1|Withdrawal by Subject|1|||
38064879|NCT03487445|69758649|FG000|Randomization|Not treated for administrative reasons|1|||
38064880|NCT03487445|69758650|FG001|Randomization|Not treated for administrative reasons|0|||
38064881|NCT02109172|69758656|FG000|Overall Study|Withdrawal by Subject|1|||
38064882|NCT02109172|69758657|FG001|Overall Study|Withdrawal by Subject|0|||
38064883|NCT02109172|69758658|FG002|Overall Study|Withdrawal by Subject|0|||
38064884|NCT02109172|69758659|FG003|Overall Study|Withdrawal by Subject|1|||
38064885|NCT02109172|69758660|FG004|Overall Study|Withdrawal by Subject|0|||
38064886|NCT02109172|69758661|FG005|Overall Study|Withdrawal by Subject|0|||
38064887|NCT02109172|69758656|FG000|Overall Study|Adverse Event|0|||
38064888|NCT02109172|69758657|FG001|Overall Study|Adverse Event|0|||
38064889|NCT02109172|69758658|FG002|Overall Study|Adverse Event|1|||
38064890|NCT02109172|69758659|FG003|Overall Study|Adverse Event|0|||
38064891|NCT02109172|69758660|FG004|Overall Study|Adverse Event|0|||
38064892|NCT02109172|69758661|FG005|Overall Study|Adverse Event|1|||
38064893|NCT02109172|69758656|FG000|Overall Study|Death|0|||
38064894|NCT02109172|69758657|FG001|Overall Study|Death|0|||
38064895|NCT02109172|69758658|FG002|Overall Study|Death|0|||
38064896|NCT02109172|69758659|FG003|Overall Study|Death|0|||
38064897|NCT02109172|69758660|FG004|Overall Study|Death|1|||
38064898|NCT02109172|69758661|FG005|Overall Study|Death|0|||
38064899|NCT02974868|69758672|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
38064900|NCT02974868|69758673|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
38064901|NCT02974868|69758674|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
38064902|NCT02974868|69758675|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
38064903|NCT02974868|69758672|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
38064904|NCT02974868|69758673|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
38064905|NCT02974868|69758674|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
38064906|NCT02974868|69758675|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
38064907|NCT02974868|69758672|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
38064908|NCT02974868|69758673|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
38064909|NCT02974868|69758674|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
38064910|NCT02974868|69758675|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
38064911|NCT02974868|69758672|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
38064912|NCT02974868|69758673|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
38064913|NCT02974868|69758674|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
38064914|NCT02974868|69758675|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
38064915|NCT03486899|69758720|FG000|Overall Study|Lost to Follow-up|4|||
38064916|NCT03486899|69758721|FG001|Overall Study|Lost to Follow-up|1|||
38064917|NCT03486899|69758722|FG002|Overall Study|Lost to Follow-up|4|||
38064918|NCT03486899|69758723|FG003|Overall Study|Lost to Follow-up|3|||
38064919|NCT03486899|69758720|FG000|Overall Study|Death|1|||
38064920|NCT03486899|69758721|FG001|Overall Study|Death|0|||
38064921|NCT03486899|69758722|FG002|Overall Study|Death|0|||
38064922|NCT03486899|69758723|FG003|Overall Study|Death|1|||
38064923|NCT03486899|69758720|FG000|Overall Study|Adverse Event|0|||
38064924|NCT03486899|69758721|FG001|Overall Study|Adverse Event|2|||
38064925|NCT03486899|69758722|FG002|Overall Study|Adverse Event|0|||
38064926|NCT03486899|69758723|FG003|Overall Study|Adverse Event|2|||
38064927|NCT03486899|69758720|FG000|Overall Study|Withdrawal by Subject|3|||
38064928|NCT03486899|69758721|FG001|Overall Study|Withdrawal by Subject|7|||
38064929|NCT03486899|69758722|FG002|Overall Study|Withdrawal by Subject|4|||
38064930|NCT03486899|69758723|FG003|Overall Study|Withdrawal by Subject|3|||
38064931|NCT03486899|69758720|FG000|Overall Study|Other Reasons|0|||
38064932|NCT03486899|69758721|FG001|Overall Study|Other Reasons|1|||
38064933|NCT03486899|69758722|FG002|Overall Study|Other Reasons|0|||
38064934|NCT03486899|69758723|FG003|Overall Study|Other Reasons|1|||
38064935|NCT02918552|69758735|FG000|Overall Study|Failed Pharmacokinetics|1|||
38064936|NCT02918552|69758736|FG001|Overall Study|Failed Pharmacokinetics|0|||
38064937|NCT02918552|69758735|FG000|Overall Study|Withdrawal by Subject|0|||
38064938|NCT02918552|69758736|FG001|Overall Study|Withdrawal by Subject|1|||
38064939|NCT02918552|69758735|FG000|Overall Study|Lost to Follow-up|0|||
38064940|NCT02918552|69758736|FG001|Overall Study|Lost to Follow-up|1|||
38064941|NCT03485495|69758744|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
38064942|NCT03485495|69758745|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
38064943|NCT01065818|69758751|FG000|Overall Study|Withdrawal by Subject|1|||
38064944|NCT01065818|69758751|FG000|Overall Study|Not a candidate for surgery|1|||
38064945|NCT03483623|69758755|FG000|Overall Study|43 complete sets achieved|1|||
38064946|NCT02318277|69758767|FG000|Overall Study|Physician Decision|0|||
38064947|NCT02318277|69758768|FG001|Overall Study|Physician Decision|0|||
38064948|NCT02318277|69758769|FG002|Overall Study|Physician Decision|0|||
38064949|NCT02318277|69758770|FG003|Overall Study|Physician Decision|0|||
38064950|NCT02318277|69758771|FG004|Overall Study|Physician Decision|0|||
38064951|NCT02318277|69758772|FG005|Overall Study|Physician Decision|0|||
38064952|NCT02318277|69758773|FG006|Overall Study|Physician Decision|0|||
38064953|NCT02318277|69758774|FG007|Overall Study|Physician Decision|1|||
38064954|NCT02318277|69758767|FG000|Overall Study|Other|0|||
38064955|NCT02318277|69758768|FG001|Overall Study|Other|0|||
38064956|NCT02318277|69758769|FG002|Overall Study|Other|0|||
38064957|NCT02318277|69758770|FG003|Overall Study|Other|0|||
38064958|NCT02318277|69758771|FG004|Overall Study|Other|0|||
38064959|NCT02318277|69758772|FG005|Overall Study|Other|0|||
38064960|NCT02318277|69758773|FG006|Overall Study|Other|1|||
38064961|NCT02318277|69758774|FG007|Overall Study|Other|0|||
38064962|NCT02318277|69758767|FG000|Overall Study|Withdrawal by Subject|0|||
38064963|NCT02318277|69758768|FG001|Overall Study|Withdrawal by Subject|0|||
38064964|NCT02318277|69758769|FG002|Overall Study|Withdrawal by Subject|1|||
38064965|NCT02318277|69758770|FG003|Overall Study|Withdrawal by Subject|0|||
38064966|NCT02318277|69758771|FG004|Overall Study|Withdrawal by Subject|1|||
38064967|NCT02318277|69758772|FG005|Overall Study|Withdrawal by Subject|1|||
38064968|NCT02318277|69758773|FG006|Overall Study|Withdrawal by Subject|6|||
38064969|NCT02318277|69758774|FG007|Overall Study|Withdrawal by Subject|14|||
38064970|NCT02318277|69758767|FG000|Overall Study|Participant trial terminated by sponsor|0|||
38064971|NCT02318277|69758768|FG001|Overall Study|Participant trial terminated by sponsor|0|||
38064972|NCT02318277|69758769|FG002|Overall Study|Participant trial terminated by sponsor|1|||
38064973|NCT02318277|69758770|FG003|Overall Study|Participant trial terminated by sponsor|0|||
38064974|NCT02318277|69758771|FG004|Overall Study|Participant trial terminated by sponsor|1|||
38064975|NCT02318277|69758772|FG005|Overall Study|Participant trial terminated by sponsor|2|||
38064976|NCT02318277|69758773|FG006|Overall Study|Participant trial terminated by sponsor|5|||
38064977|NCT02318277|69758774|FG007|Overall Study|Participant trial terminated by sponsor|16|||
38064978|NCT02318277|69758767|FG000|Overall Study|Lost to Follow-up|1|||
38064979|NCT02318277|69758768|FG001|Overall Study|Lost to Follow-up|0|||
38064980|NCT02318277|69758769|FG002|Overall Study|Lost to Follow-up|1|||
38064981|NCT02318277|69758770|FG003|Overall Study|Lost to Follow-up|0|||
38064982|NCT02318277|69758771|FG004|Overall Study|Lost to Follow-up|0|||
38064983|NCT02318277|69758772|FG005|Overall Study|Lost to Follow-up|0|||
38064984|NCT02318277|69758773|FG006|Overall Study|Lost to Follow-up|3|||
38064985|NCT02318277|69758774|FG007|Overall Study|Lost to Follow-up|4|||
38064986|NCT02318277|69758767|FG000|Overall Study|Death|5|||
38064987|NCT02318277|69758768|FG001|Overall Study|Death|3|||
38064988|NCT02318277|69758769|FG002|Overall Study|Death|1|||
38064989|NCT02318277|69758770|FG003|Overall Study|Death|4|||
38064990|NCT02318277|69758771|FG004|Overall Study|Death|6|||
38064991|NCT02318277|69758772|FG005|Overall Study|Death|5|||
38064992|NCT02318277|69758773|FG006|Overall Study|Death|34|||
38064993|NCT02318277|69758774|FG007|Overall Study|Death|58|||
38064994|NCT02318277|69758767|FG000|Overall Study|Transitioned to Hospice|0|||
38064995|NCT02318277|69758768|FG001|Overall Study|Transitioned to Hospice|0|||
38064996|NCT02318277|69758769|FG002|Overall Study|Transitioned to Hospice|0|||
38064997|NCT02318277|69758770|FG003|Overall Study|Transitioned to Hospice|0|||
38064998|NCT02318277|69758771|FG004|Overall Study|Transitioned to Hospice|0|||
38064999|NCT02318277|69758772|FG005|Overall Study|Transitioned to Hospice|1|||
38065000|NCT02318277|69758773|FG006|Overall Study|Transitioned to Hospice|0|||
38065001|NCT02318277|69758774|FG007|Overall Study|Transitioned to Hospice|0|||
38065002|NCT01063868|69758819|FG000|Overall Study|Adverse Event|9|||
38065003|NCT01063868|69758820|FG001|Overall Study|Adverse Event|7|||
38065004|NCT01063868|69758819|FG000|Overall Study|Withdrawal by Subject|3|||
38065005|NCT01063868|69758820|FG001|Overall Study|Withdrawal by Subject|1|||
38065006|NCT01063868|69758819|FG000|Overall Study|Study Terminated By Sponsor|23|||
38065007|NCT01063868|69758820|FG001|Overall Study|Study Terminated By Sponsor|4|||
38065008|NCT02974088|69758828|FG000|Overall Study|Lost to Follow-up|0|||
38065009|NCT02974088|69758829|FG001|Overall Study|Lost to Follow-up|2|||
38065010|NCT02974088|69758828|FG000|Overall Study|Adverse Event|0|||
38065011|NCT02974088|69758829|FG001|Overall Study|Adverse Event|1|||
38065012|NCT02385045|69758835|FG000|Overall Study|Endoscopy could not be completed|4|||
38065013|NCT02974010|69758843|FG000|Overall Study|Lost to Follow-up|3|||
38065014|NCT02974010|69758844|FG001|Overall Study|Lost to Follow-up|1|||
38065015|NCT02974010|69758845|FG002|Overall Study|Lost to Follow-up|0|||
38065016|NCT02974010|69758846|FG003|Overall Study|Lost to Follow-up|0|||
38065017|NCT02974010|69758843|FG000|Overall Study|Withdrawal by Subject|2|||
38065018|NCT02974010|69758844|FG001|Overall Study|Withdrawal by Subject|1|||
38065019|NCT02974010|69758845|FG002|Overall Study|Withdrawal by Subject|0|||
38065020|NCT02974010|69758846|FG003|Overall Study|Withdrawal by Subject|0|||
38065021|NCT02974010|69758843|FG000|Overall Study|Adverse Event|0|||
38065022|NCT02974010|69758844|FG001|Overall Study|Adverse Event|1|||
38065023|NCT02974010|69758845|FG002|Overall Study|Adverse Event|0|||
38065024|NCT02974010|69758846|FG003|Overall Study|Adverse Event|0|||
38065025|NCT02974010|69758843|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
38065026|NCT02974010|69758844|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
38065027|NCT02974010|69758845|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
38065028|NCT02974010|69758846|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
38065029|NCT02974010|69758843|FG000|Overall Study|Lack of Efficacy|0|||
38065030|NCT02974010|69758844|FG001|Overall Study|Lack of Efficacy|0|||
38065031|NCT02974010|69758845|FG002|Overall Study|Lack of Efficacy|1|||
38065032|NCT02974010|69758846|FG003|Overall Study|Lack of Efficacy|0|||
38065033|NCT02030938|69758856|FG000|Overall Study|Lost to Follow-up|4|||
38065034|NCT02030938|69758856|FG000|Overall Study|Withdrawal by Subject|1|||
38065035|NCT03122535|69758864|FG000|Overall Study|Lost to Follow-up|68|||
38065036|NCT03122535|69758865|FG001|Overall Study|Lost to Follow-up|68|||
38065037|NCT03122535|69758864|FG000|Overall Study|Physician Decision|3|||
38065038|NCT03122535|69758865|FG001|Overall Study|Physician Decision|3|||
38065039|NCT03122535|69758864|FG000|Overall Study|Withdrawal by Subject|2|||
38065040|NCT03122535|69758865|FG001|Overall Study|Withdrawal by Subject|2|||
38065041|NCT01061606|69758871|FG000|Overall Study|Adverse Event|1|||
38065042|NCT01061606|69758871|FG000|Overall Study|Death|1|||
38065043|NCT01061606|69758871|FG000|Overall Study|Disease Progression|4|||
38065044|NCT01061606|69758871|FG000|Overall Study|alternative therapy|2|||
38065045|NCT03122457|69758875|FG000|Overall Study|Withdrawal by Subject|6|||
38065046|NCT03482453|69758891|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
38065047|NCT03482453|69758892|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
38065048|NCT03482453|69758893|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
38065049|NCT03482453|69758894|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
38065050|NCT03482453|69758895|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
38065051|NCT03482453|69758896|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
38065052|NCT03482453|69758897|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
38065053|NCT03482453|69758898|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
38065054|NCT03482453|69758899|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
38065055|NCT03482453|69758900|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
38065056|NCT03482453|69758901|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
38065057|NCT03482453|69758902|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
38065058|NCT03480425|69758938|FG000|Overall Study|Force transducer technical failure|1|||
38065059|NCT03472547|69758942|FG000|Overall Study|Withdrawal by Subject|30|||
38065060|NCT00799396|69758946|FG000|Clopidogrel Treatment|Adverse Event|6|||
38065061|NCT00799396|69758946|FG000|Clopidogrel Treatment|Physician Decision|5|||
38065062|NCT00799396|69758946|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
38065063|NCT00799396|69758946|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
38065064|NCT00799396|69758946|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
38065065|NCT03469349|69758952|FG000|Overall Study|Withdrawal by Subject|1|||
38065066|NCT03469349|69758953|FG001|Overall Study|Withdrawal by Subject|3|||
38065067|NCT03469349|69758952|FG000|Overall Study|Progressive Disease|0|||
38065068|NCT03469349|69758953|FG001|Overall Study|Progressive Disease|1|||
38065069|NCT03469349|69758952|FG000|Overall Study|Lost to Follow-up|2|||
38065070|NCT03469349|69758953|FG001|Overall Study|Lost to Follow-up|2|||
38065071|NCT03469349|69758952|FG000|Overall Study|Adverse Event|2|||
38065072|NCT03469349|69758953|FG001|Overall Study|Adverse Event|4|||
38065073|NCT03467945|69758963|FG000|Treatment Period 2|Withdrawal by Subject|0|||
38065074|NCT03467945|69758964|FG001|Treatment Period 2|Withdrawal by Subject|1|||
38065075|NCT03467945|69758965|FG002|Treatment Period 2|Withdrawal by Subject|0|||
38065076|NCT03467945|69758966|FG003|Treatment Period 2|Withdrawal by Subject|0|||
38065077|NCT03467945|69758963|FG000|Treatment Period 3|Withdrawal by Subject|1|||
38065078|NCT03467945|69758964|FG001|Treatment Period 3|Withdrawal by Subject|0|||
38065079|NCT03467945|69758965|FG002|Treatment Period 3|Withdrawal by Subject|2|||
38065080|NCT03467945|69758966|FG003|Treatment Period 3|Withdrawal by Subject|1|||
38065081|NCT00069238|69758977|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
38065082|NCT00069238|69758978|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
38065083|NCT00069238|69758979|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
38065084|NCT00069238|69758977|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
38065085|NCT00069238|69758978|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
38065086|NCT00069238|69758979|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
38065087|NCT00069238|69758977|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
38065088|NCT00069238|69758978|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
38065089|NCT00069238|69758979|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
38065090|NCT03435497|69758986|FG000|Overall Study|Lost to Follow-up|1|||
38065091|NCT03435497|69758987|FG001|Overall Study|Lost to Follow-up|0|||
38065092|NCT03435497|69758986|FG000|Overall Study|Death|1|||
38065093|NCT03435497|69758987|FG001|Overall Study|Death|0|||
38065094|NCT03435497|69758986|FG000|Overall Study|Withdrawal by Subject|0|||
38065095|NCT03435497|69758987|FG001|Overall Study|Withdrawal by Subject|4|||
38065096|NCT03435497|69758986|FG000|Overall Study|Wrong survey administered|0|||
38065097|NCT03435497|69758987|FG001|Overall Study|Wrong survey administered|2|||
38065098|NCT03073200|69758996|FG000|Double Blind Treatment Period|Protocol Violation|1|||
38065099|NCT03073200|69758997|FG001|Double Blind Treatment Period|Protocol Violation|0|||
38065100|NCT03073200|69758998|FG002|Double Blind Treatment Period|Protocol Violation|0|||
38065101|NCT03073200|69758999|FG003|Double Blind Treatment Period|Protocol Violation|0|||
38065102|NCT03073200|69759000|FG004|Double Blind Treatment Period|Protocol Violation|0|||
38065103|NCT03073200|69759001|FG005|Double Blind Treatment Period|Protocol Violation|0|||
38065104|NCT03073200|69759002|FG006|Double Blind Treatment Period|Protocol Violation|0|||
38065105|NCT03073200|69759003|FG007|Double Blind Treatment Period|Protocol Violation|0|||
38065106|NCT03073200|69759004|FG008|Double Blind Treatment Period|Protocol Violation|0|||
38065107|NCT03073200|69759005|FG009|Double Blind Treatment Period|Protocol Violation|0|||
38065108|NCT03073200|69759006|FG010|Double Blind Treatment Period|Protocol Violation|0|||
38065109|NCT03073200|69759007|FG011|Double Blind Treatment Period|Protocol Violation|0|||
38065110|NCT03073200|69759008|FG012|Double Blind Treatment Period|Protocol Violation|0|||
38065111|NCT03073200|69759009|FG013|Double Blind Treatment Period|Protocol Violation|0|||
38065112|NCT03073200|69759010|FG014|Double Blind Treatment Period|Protocol Violation|0|||
38065113|NCT03073200|69758996|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
38065114|NCT03073200|69758997|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
38065115|NCT03073200|69758998|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
38065116|NCT03073200|69758999|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
38065117|NCT03073200|69759000|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
38065118|NCT03073200|69759001|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
38065119|NCT03073200|69759002|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
38065120|NCT03073200|69759003|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
38065121|NCT03073200|69759004|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
38065122|NCT03073200|69759005|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
38065123|NCT03073200|69759006|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
38065124|NCT03073200|69759007|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
38065125|NCT03073200|69759008|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
38065126|NCT03073200|69759009|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
38065127|NCT03073200|69759010|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
38065128|NCT03073200|69758996|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
38065129|NCT03073200|69758997|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
38065130|NCT03073200|69758998|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
38065131|NCT03073200|69758999|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
38065132|NCT03073200|69759000|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
38065133|NCT03073200|69759001|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
38065134|NCT03073200|69759002|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
38065135|NCT03073200|69759003|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
38065136|NCT03073200|69759004|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
38065137|NCT03073200|69759005|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
38065138|NCT03073200|69759006|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
38065139|NCT03073200|69759007|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
38065140|NCT03073200|69759008|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
38065141|NCT03073200|69759009|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
38065142|NCT03073200|69759010|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
38065143|NCT03073200|69758996|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
38065144|NCT03073200|69758997|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
38065145|NCT03073200|69758998|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
38065146|NCT03073200|69758999|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
38065147|NCT03073200|69759000|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
38065148|NCT03073200|69759001|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
38065149|NCT03073200|69759002|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
38065150|NCT03073200|69759003|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
38065151|NCT03073200|69759004|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
38065152|NCT03073200|69759005|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
38065153|NCT03073200|69759006|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
38065154|NCT03073200|69759007|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
38065155|NCT03073200|69759008|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
38065156|NCT03073200|69759009|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
38065157|NCT03073200|69759010|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
38065158|NCT03073200|69758996|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
38065159|NCT03073200|69758997|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
38065160|NCT03073200|69758998|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
38065161|NCT03073200|69758999|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
38065162|NCT03073200|69759000|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
38065163|NCT03073200|69759001|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
38065164|NCT03073200|69759002|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
38065165|NCT03073200|69759003|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
38065166|NCT03073200|69759004|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
38065167|NCT03073200|69759005|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
37965741|NCT00059839|69652718|FG001|Overall Study|Lost to Follow-up|0|||
38065168|NCT03073200|69759006|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
38065169|NCT03073200|69759007|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
38065170|NCT03073200|69759008|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
38065171|NCT03073200|69759009|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
38065172|NCT03073200|69759010|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
38065173|NCT03073200|69758996|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
38065174|NCT03073200|69758997|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
38065175|NCT03073200|69758998|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
38065176|NCT03073200|69758999|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
37965742|NCT00059839|69652717|FG000|Overall Study|Physician Decision|1|||
37965743|NCT00059839|69652718|FG001|Overall Study|Physician Decision|2|||
37965744|NCT00059839|69652717|FG000|Overall Study|Withdrawal by Subject|1|||
37965745|NCT00059839|69652718|FG001|Overall Study|Withdrawal by Subject|6|||
37965746|NCT00059839|69652717|FG000|Overall Study|Ineligible|1|||
37965747|NCT00059839|69652718|FG001|Overall Study|Ineligible|3|||
37965748|NCT00059215|69652728|FG000|Overall Study|Adverse Event|5|||
37965749|NCT00059215|69652729|FG001|Overall Study|Adverse Event|5|||
37965750|NCT00059215|69652730|FG002|Overall Study|Adverse Event|9|||
37965751|NCT00059215|69652731|FG003|Overall Study|Adverse Event|9|||
37965752|NCT00059215|69652728|FG000|Overall Study|Death|0|||
37965753|NCT00059215|69652729|FG001|Overall Study|Death|0|||
37965754|NCT00059215|69652730|FG002|Overall Study|Death|3|||
37965755|NCT00059215|69652731|FG003|Overall Study|Death|0|||
37965756|NCT00059215|69652728|FG000|Overall Study|Lost to Follow-up|1|||
37965757|NCT00059215|69652729|FG001|Overall Study|Lost to Follow-up|2|||
37965758|NCT00059215|69652730|FG002|Overall Study|Lost to Follow-up|0|||
37965759|NCT00059215|69652731|FG003|Overall Study|Lost to Follow-up|0|||
37965760|NCT00059215|69652728|FG000|Overall Study|Withdrawal by Subject|4|||
37965761|NCT00059215|69652729|FG001|Overall Study|Withdrawal by Subject|4|||
37965762|NCT00059215|69652730|FG002|Overall Study|Withdrawal by Subject|1|||
37965763|NCT00059215|69652731|FG003|Overall Study|Withdrawal by Subject|3|||
38065177|NCT03073200|69759000|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
38065178|NCT03073200|69759001|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
37965764|NCT00059215|69652728|FG000|Overall Study|Protocol Violation|1|||
37965765|NCT00059215|69652729|FG001|Overall Study|Protocol Violation|0|||
37965766|NCT00059215|69652730|FG002|Overall Study|Protocol Violation|1|||
38065179|NCT03073200|69759002|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
38065180|NCT03073200|69759003|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
38065181|NCT03073200|69759004|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
38065182|NCT03073200|69759005|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
38065183|NCT03073200|69759006|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
38065184|NCT03073200|69759007|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
38065185|NCT03073200|69759008|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
38065186|NCT03073200|69759009|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
38065187|NCT03073200|69759010|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
38065188|NCT03073200|69758996|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
38065189|NCT03073200|69758997|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
38065190|NCT03073200|69758998|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
38065191|NCT03073200|69758999|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
38065192|NCT03073200|69759000|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
38065193|NCT03073200|69759001|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
38065194|NCT03073200|69759002|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
38065195|NCT03073200|69759003|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
38065196|NCT03073200|69759004|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
38065197|NCT03073200|69759005|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
38065198|NCT03073200|69759006|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
38065199|NCT03073200|69759007|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
38065200|NCT03073200|69759008|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
38065201|NCT03073200|69759009|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
38065202|NCT03073200|69759010|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
38065203|NCT03073200|69758996|FG000|Extension Period|Lost to Follow-up|0|||
38065204|NCT03073200|69758997|FG001|Extension Period|Lost to Follow-up|0|||
38065205|NCT03073200|69758998|FG002|Extension Period|Lost to Follow-up|0|||
38065206|NCT03073200|69758999|FG003|Extension Period|Lost to Follow-up|0|||
38065207|NCT03073200|69759000|FG004|Extension Period|Lost to Follow-up|0|||
38065208|NCT03073200|69759001|FG005|Extension Period|Lost to Follow-up|0|||
38065209|NCT03073200|69759002|FG006|Extension Period|Lost to Follow-up|1|||
38065210|NCT03073200|69759003|FG007|Extension Period|Lost to Follow-up|1|||
38065211|NCT03073200|69759004|FG008|Extension Period|Lost to Follow-up|0|||
38065212|NCT03073200|69759005|FG009|Extension Period|Lost to Follow-up|0|||
38065213|NCT03073200|69759006|FG010|Extension Period|Lost to Follow-up|0|||
38065214|NCT03073200|69759007|FG011|Extension Period|Lost to Follow-up|0|||
38065215|NCT03073200|69759008|FG012|Extension Period|Lost to Follow-up|0|||
38065216|NCT03073200|69759009|FG013|Extension Period|Lost to Follow-up|0|||
38065217|NCT03073200|69759010|FG014|Extension Period|Lost to Follow-up|0|||
38065218|NCT03073200|69758996|FG000|Extension Period|Sponsor Decision|0|||
38065219|NCT03073200|69758997|FG001|Extension Period|Sponsor Decision|0|||
38065220|NCT03073200|69758998|FG002|Extension Period|Sponsor Decision|0|||
38065221|NCT03073200|69758999|FG003|Extension Period|Sponsor Decision|0|||
38065222|NCT03073200|69759000|FG004|Extension Period|Sponsor Decision|0|||
38065223|NCT03073200|69759001|FG005|Extension Period|Sponsor Decision|0|||
38065224|NCT03073200|69759002|FG006|Extension Period|Sponsor Decision|0|||
38065225|NCT03073200|69759003|FG007|Extension Period|Sponsor Decision|0|||
37965767|NCT00059215|69652731|FG003|Overall Study|Protocol Violation|0|||
38065226|NCT03073200|69759004|FG008|Extension Period|Sponsor Decision|1|||
38065227|NCT03073200|69759005|FG009|Extension Period|Sponsor Decision|0|||
38065228|NCT03073200|69759006|FG010|Extension Period|Sponsor Decision|0|||
38065229|NCT03073200|69759007|FG011|Extension Period|Sponsor Decision|0|||
38065230|NCT03073200|69759008|FG012|Extension Period|Sponsor Decision|0|||
38065231|NCT03073200|69759009|FG013|Extension Period|Sponsor Decision|0|||
38065232|NCT03073200|69759010|FG014|Extension Period|Sponsor Decision|0|||
38065233|NCT03073200|69758996|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
38065234|NCT03073200|69758997|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
38065235|NCT03073200|69758998|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
38065236|NCT03073200|69758999|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
38065237|NCT03073200|69759000|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
38065238|NCT03073200|69759001|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
38065239|NCT03073200|69759002|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
38065240|NCT03073200|69759003|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
38065241|NCT03073200|69759004|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
38065242|NCT03073200|69759005|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
38065243|NCT03073200|69759006|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
38065244|NCT03073200|69759007|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
38065245|NCT03073200|69759008|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
38065246|NCT03073200|69759009|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
38065247|NCT03073200|69759010|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
38065248|NCT03073200|69758996|FG000|Extension Period|Withdrawal by Subject|0|||
38065249|NCT03073200|69758997|FG001|Extension Period|Withdrawal by Subject|0|||
38065250|NCT03073200|69758998|FG002|Extension Period|Withdrawal by Subject|0|||
38065251|NCT03073200|69758999|FG003|Extension Period|Withdrawal by Subject|0|||
38065252|NCT03073200|69759000|FG004|Extension Period|Withdrawal by Subject|0|||
38065253|NCT03073200|69759001|FG005|Extension Period|Withdrawal by Subject|0|||
38065254|NCT03073200|69759002|FG006|Extension Period|Withdrawal by Subject|1|||
38065255|NCT03073200|69759003|FG007|Extension Period|Withdrawal by Subject|2|||
38065256|NCT03073200|69759004|FG008|Extension Period|Withdrawal by Subject|0|||
38065257|NCT03073200|69759005|FG009|Extension Period|Withdrawal by Subject|0|||
38065258|NCT03073200|69759006|FG010|Extension Period|Withdrawal by Subject|0|||
38065259|NCT03073200|69759007|FG011|Extension Period|Withdrawal by Subject|0|||
38065260|NCT03073200|69759008|FG012|Extension Period|Withdrawal by Subject|0|||
38065261|NCT03073200|69759009|FG013|Extension Period|Withdrawal by Subject|0|||
38065262|NCT03073200|69759010|FG014|Extension Period|Withdrawal by Subject|0|||
38065263|NCT03073200|69758996|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
38065264|NCT03073200|69758997|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
38065265|NCT03073200|69758998|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
38065266|NCT03073200|69758999|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
38065267|NCT03073200|69759000|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
38065268|NCT03073200|69759001|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
38065269|NCT03073200|69759002|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
38065270|NCT03073200|69759003|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
38065271|NCT03073200|69759004|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
38065272|NCT03073200|69759005|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
38065273|NCT03073200|69759006|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
38065274|NCT03073200|69759007|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
38065275|NCT03073200|69759008|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
38065276|NCT03073200|69759009|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
38065277|NCT03073200|69759010|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
38065278|NCT03073200|69758996|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
38065279|NCT03073200|69758997|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
38065280|NCT03073200|69758998|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
38065281|NCT03073200|69758999|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
38065282|NCT03073200|69759000|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
38065283|NCT03073200|69759001|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
38065284|NCT03073200|69759002|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
38065285|NCT03073200|69759003|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
38065286|NCT03073200|69759004|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
38065287|NCT03073200|69759005|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
38065288|NCT03073200|69759006|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
38065289|NCT03073200|69759007|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
38065290|NCT03073200|69759008|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
38065291|NCT03073200|69759009|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
38065292|NCT03073200|69759010|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
38065293|NCT03073200|69758996|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
38065294|NCT03073200|69758997|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
38065295|NCT03073200|69758998|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
38065296|NCT03073200|69758999|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
38065297|NCT03073200|69759000|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
38065298|NCT03073200|69759001|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
38065299|NCT03073200|69759002|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
38065300|NCT03073200|69759003|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
38065301|NCT03073200|69759004|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
38065302|NCT03073200|69759005|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
38065303|NCT03073200|69759006|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
38065304|NCT03073200|69759007|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
38065305|NCT03073200|69759008|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
38065306|NCT03073200|69759009|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
38065307|NCT03073200|69759010|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
38065308|NCT03073200|69758996|FG000|Randomized Withdrawal Period|Adverse Event|0|||
38065309|NCT03073200|69758997|FG001|Randomized Withdrawal Period|Adverse Event|0|||
38065310|NCT03073200|69758998|FG002|Randomized Withdrawal Period|Adverse Event|0|||
38065311|NCT03073200|69758999|FG003|Randomized Withdrawal Period|Adverse Event|0|||
38065312|NCT03073200|69759000|FG004|Randomized Withdrawal Period|Adverse Event|0|||
38065313|NCT03073200|69759001|FG005|Randomized Withdrawal Period|Adverse Event|0|||
38065314|NCT03073200|69759002|FG006|Randomized Withdrawal Period|Adverse Event|0|||
38065315|NCT03073200|69759003|FG007|Randomized Withdrawal Period|Adverse Event|0|||
38065316|NCT03073200|69759004|FG008|Randomized Withdrawal Period|Adverse Event|0|||
38065317|NCT03073200|69759005|FG009|Randomized Withdrawal Period|Adverse Event|0|||
38065318|NCT03073200|69759006|FG010|Randomized Withdrawal Period|Adverse Event|1|||
38065319|NCT03073200|69759007|FG011|Randomized Withdrawal Period|Adverse Event|0|||
38065320|NCT03073200|69759008|FG012|Randomized Withdrawal Period|Adverse Event|0|||
38065321|NCT03073200|69759009|FG013|Randomized Withdrawal Period|Adverse Event|0|||
38065322|NCT03073200|69759010|FG014|Randomized Withdrawal Period|Adverse Event|0|||
38065323|NCT03073200|69758996|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
38065324|NCT03073200|69758997|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
38065325|NCT03073200|69758998|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
38065326|NCT03073200|69758999|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
37965768|NCT00059215|69652728|FG000|Overall Study|Protocol entry criteria not met|1|||
37965769|NCT00059215|69652729|FG001|Overall Study|Protocol entry criteria not met|1|||
37965770|NCT00059215|69652730|FG002|Overall Study|Protocol entry criteria not met|0|||
37965771|NCT00059215|69652731|FG003|Overall Study|Protocol entry criteria not met|2|||
37965772|NCT00059215|69652728|FG000|Overall Study|Physician Decision|1|||
37965773|NCT00059215|69652729|FG001|Overall Study|Physician Decision|2|||
37965774|NCT00059215|69652730|FG002|Overall Study|Physician Decision|1|||
37965775|NCT00059215|69652731|FG003|Overall Study|Physician Decision|1|||
37965776|NCT00058825|69652742|FG000|Overall Study|Relapse|9|||
37965777|NCT00058825|69652742|FG000|Overall Study|Progressive Disease|5|||
37965778|NCT00058825|69652742|FG000|Overall Study|Graft Failure|5|||
37965779|NCT00058825|69652742|FG000|Overall Study|Death|3|||
37965780|NCT00364858|69652750|FG000|Overall Study|Adverse Event|1|||
37965781|NCT00364858|69652751|FG001|Overall Study|Adverse Event|5|||
37965782|NCT00364858|69652750|FG000|Overall Study|Withdrawal by Subject|1|||
37965783|NCT00364858|69652751|FG001|Overall Study|Withdrawal by Subject|1|||
37965784|NCT00364858|69652750|FG000|Overall Study|Pregnancy|1|||
37965785|NCT00364858|69652751|FG001|Overall Study|Pregnancy|1|||
37965786|NCT00364858|69652750|FG000|Overall Study|Clinical failure|2|||
37965787|NCT00364858|69652751|FG001|Overall Study|Clinical failure|13|||
37965788|NCT00364858|69652750|FG000|Overall Study|Discontinuation at baseline|1|||
37965789|NCT00364858|69652751|FG001|Overall Study|Discontinuation at baseline|0|||
37965790|NCT00364858|69652750|FG000|Overall Study|Non-compliant|1|||
37965791|NCT00364858|69652751|FG001|Overall Study|Non-compliant|0|||
37965792|NCT00364858|69652750|FG000|Overall Study|Return to Q2 regimen|0|||
37965793|NCT00364858|69652751|FG001|Overall Study|Return to Q2 regimen|1|||
37965794|NCT00364858|69652750|FG000|Overall Study|Clinical baseline issue|0|||
37965795|NCT00364858|69652751|FG001|Overall Study|Clinical baseline issue|1|||
37965796|NCT03803059|69652758|FG000|Overall Study|Protocol Violation|2|||
37965797|NCT03803059|69652758|FG000|Overall Study|Lost to Follow-up|1|||
37965798|NCT00372424|69652763|FG000|Overall Study|Adverse Event|2|||
37965799|NCT00372424|69652763|FG000|Overall Study|Withdrawal by Subject|1|||
37965800|NCT00372424|69652763|FG000|Overall Study|Death|1|||
37965801|NCT00372424|69652763|FG000|Overall Study|Objective Progression or Relapse|14|||
37965802|NCT00372424|69652763|FG000|Overall Study|Other|7|||
38065327|NCT03073200|69759000|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
38065328|NCT03073200|69759001|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
37965803|NCT00372424|69652763|FG000|Overall Study|Enrolled, Not Treated|1|||
37965804|NCT00372190|69652769|FG000|Overall Study|Lost to Follow-up|3|||
37965805|NCT00372190|69652770|FG001|Overall Study|Lost to Follow-up|1|||
37965806|NCT00044083|69652780|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
37965807|NCT00044083|69652781|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
37965808|NCT00044083|69652780|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
37965809|NCT00044083|69652781|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
38065329|NCT03073200|69759002|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
38065330|NCT03073200|69759003|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
38065331|NCT03073200|69759004|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
38065332|NCT03073200|69759005|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
38065333|NCT03073200|69759006|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
38065334|NCT03073200|69759007|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
38065335|NCT03073200|69759008|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
38065336|NCT03073200|69759009|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
38065337|NCT03073200|69759010|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
38065338|NCT03073200|69758996|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
38065339|NCT03073200|69758997|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
38065340|NCT03073200|69758998|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
38065341|NCT03073200|69758999|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
38065342|NCT03073200|69759000|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
38065343|NCT03073200|69759001|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
38065344|NCT03073200|69759002|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
38065345|NCT03073200|69759003|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
38065346|NCT03073200|69759004|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
38065347|NCT03073200|69759005|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
38065348|NCT03073200|69759006|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
38065349|NCT03073200|69759007|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
38065350|NCT03073200|69759008|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
38065351|NCT03073200|69759009|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
38065352|NCT03073200|69759010|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
38065353|NCT03073200|69758996|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
38065354|NCT03073200|69758997|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
38065355|NCT03073200|69758998|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
38065356|NCT03073200|69758999|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
38065357|NCT03073200|69759000|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
38065358|NCT03073200|69759001|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
38065359|NCT03073200|69759002|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
38065360|NCT03073200|69759003|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
38065361|NCT03073200|69759004|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
38065362|NCT03073200|69759005|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
38065363|NCT03073200|69759006|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
38065364|NCT03073200|69759007|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
38065365|NCT03073200|69759008|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
38065366|NCT03073200|69759009|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
38065367|NCT03073200|69759010|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
38065368|NCT03073200|69758996|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
38065369|NCT03073200|69758997|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
38065370|NCT03073200|69758998|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
38065371|NCT03073200|69758999|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
38065372|NCT03073200|69759000|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
38065373|NCT03073200|69759001|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
38065374|NCT03073200|69759002|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
38065375|NCT03073200|69759003|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
38065376|NCT03073200|69759004|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
38065377|NCT03073200|69759005|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
38065378|NCT03073200|69759006|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
38065379|NCT03073200|69759007|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
38065380|NCT03073200|69759008|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
38065381|NCT03073200|69759009|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
38065382|NCT03073200|69759010|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
38065383|NCT03073200|69758996|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
38065384|NCT03073200|69758997|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
38065385|NCT03073200|69758998|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
38065386|NCT03073200|69758999|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
38065387|NCT03073200|69759000|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
38065388|NCT03073200|69759001|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
38065389|NCT03073200|69759002|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
38065390|NCT03073200|69759003|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
38065391|NCT03073200|69759004|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
38065392|NCT03073200|69759005|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
38065393|NCT03073200|69759006|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
38065394|NCT03073200|69759007|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
38065395|NCT03073200|69759008|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
38065396|NCT03073200|69759009|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
38065397|NCT03073200|69759010|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
38065398|NCT03073200|69758996|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
38065399|NCT03073200|69758997|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
38065400|NCT03073200|69758998|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
38065401|NCT03073200|69758999|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
38065402|NCT03073200|69759000|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
38065403|NCT03073200|69759001|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
38065404|NCT03073200|69759002|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
38065405|NCT03073200|69759003|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
38065406|NCT03073200|69759004|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
38065407|NCT03073200|69759005|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
38065408|NCT03073200|69759006|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
38065409|NCT03073200|69759007|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
38065410|NCT03073200|69759008|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
38065411|NCT03073200|69759009|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
38065412|NCT03073200|69759010|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
38065413|NCT03073200|69758996|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
38065414|NCT03073200|69758997|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
38065415|NCT03073200|69758998|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
38065416|NCT03073200|69758999|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
38065417|NCT03073200|69759000|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
38065418|NCT03073200|69759001|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
38065419|NCT03073200|69759002|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
38065420|NCT03073200|69759003|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
38065421|NCT03073200|69759004|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
38065422|NCT03073200|69759005|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
38065423|NCT03073200|69759006|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
38065424|NCT03073200|69759007|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
38065425|NCT03073200|69759008|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
38065426|NCT03073200|69759009|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
38065427|NCT03073200|69759010|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
38065428|NCT03073200|69758996|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
38065429|NCT03073200|69758997|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
38065430|NCT03073200|69758998|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
38065431|NCT03073200|69758999|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
38065432|NCT03073200|69759000|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
38065433|NCT03073200|69759001|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
38065434|NCT03073200|69759002|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
38065435|NCT03073200|69759003|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
38065436|NCT03073200|69759004|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
38065437|NCT03073200|69759005|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
38065438|NCT03073200|69759006|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
38065439|NCT03073200|69759007|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
38065440|NCT03073200|69759008|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
38065441|NCT03073200|69759009|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
38065442|NCT03073200|69759010|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
38065443|NCT03290781|69759039|FG000|Overall Study|Adverse Event|5|||
38065444|NCT03290781|69759040|FG001|Overall Study|Adverse Event|7|||
38065445|NCT03290781|69759041|FG002|Overall Study|Adverse Event|4|||
38065446|NCT03290781|69759042|FG003|Overall Study|Adverse Event|1|||
38065447|NCT03290781|69759043|FG004|Overall Study|Adverse Event|0|||
38065448|NCT03290781|69759044|FG005|Overall Study|Adverse Event|0|||
38065449|NCT03290781|69759045|FG006|Overall Study|Adverse Event|0|||
38065450|NCT03290781|69759039|FG000|Overall Study|Death|0|||
38065451|NCT03290781|69759040|FG001|Overall Study|Death|0|||
38065452|NCT03290781|69759041|FG002|Overall Study|Death|1|||
38065453|NCT03290781|69759042|FG003|Overall Study|Death|0|||
38065454|NCT03290781|69759043|FG004|Overall Study|Death|1|||
38065455|NCT03290781|69759044|FG005|Overall Study|Death|0|||
38065456|NCT03290781|69759045|FG006|Overall Study|Death|0|||
38065457|NCT03290781|69759039|FG000|Overall Study|Withdrawal by Subject|6|||
38065458|NCT03290781|69759040|FG001|Overall Study|Withdrawal by Subject|5|||
38065459|NCT03290781|69759041|FG002|Overall Study|Withdrawal by Subject|9|||
38065460|NCT03290781|69759042|FG003|Overall Study|Withdrawal by Subject|10|||
38065461|NCT03290781|69759043|FG004|Overall Study|Withdrawal by Subject|1|||
38065462|NCT03290781|69759044|FG005|Overall Study|Withdrawal by Subject|2|||
38065463|NCT03290781|69759045|FG006|Overall Study|Withdrawal by Subject|0|||
38065464|NCT03290781|69759039|FG000|Overall Study|Physician Decision|0|||
38065465|NCT03290781|69759040|FG001|Overall Study|Physician Decision|1|||
38065466|NCT03290781|69759041|FG002|Overall Study|Physician Decision|0|||
38065467|NCT03290781|69759042|FG003|Overall Study|Physician Decision|0|||
38065468|NCT03290781|69759043|FG004|Overall Study|Physician Decision|0|||
38065469|NCT03290781|69759044|FG005|Overall Study|Physician Decision|0|||
38065470|NCT03290781|69759045|FG006|Overall Study|Physician Decision|0|||
38065471|NCT03290781|69759039|FG000|Overall Study|Site Terminated by Sponsor|1|||
38065472|NCT03290781|69759040|FG001|Overall Study|Site Terminated by Sponsor|0|||
38065473|NCT03290781|69759041|FG002|Overall Study|Site Terminated by Sponsor|2|||
38065474|NCT03290781|69759042|FG003|Overall Study|Site Terminated by Sponsor|1|||
38065475|NCT03290781|69759043|FG004|Overall Study|Site Terminated by Sponsor|0|||
38065476|NCT03290781|69759044|FG005|Overall Study|Site Terminated by Sponsor|0|||
38065477|NCT03290781|69759045|FG006|Overall Study|Site Terminated by Sponsor|0|||
38065478|NCT03290781|69759039|FG000|Overall Study|Lost to Follow-up|0|||
38065479|NCT03290781|69759040|FG001|Overall Study|Lost to Follow-up|0|||
38065480|NCT03290781|69759041|FG002|Overall Study|Lost to Follow-up|0|||
38065481|NCT03290781|69759042|FG003|Overall Study|Lost to Follow-up|1|||
38065482|NCT03290781|69759043|FG004|Overall Study|Lost to Follow-up|0|||
38065483|NCT03290781|69759044|FG005|Overall Study|Lost to Follow-up|0|||
38065484|NCT03290781|69759045|FG006|Overall Study|Lost to Follow-up|0|||
38065485|NCT03290781|69759039|FG000|Overall Study|Protocol Deviation|2|||
38065486|NCT03290781|69759040|FG001|Overall Study|Protocol Deviation|0|||
38065487|NCT03290781|69759041|FG002|Overall Study|Protocol Deviation|0|||
38065488|NCT03290781|69759042|FG003|Overall Study|Protocol Deviation|1|||
38065489|NCT03290781|69759043|FG004|Overall Study|Protocol Deviation|0|||
38065490|NCT03290781|69759044|FG005|Overall Study|Protocol Deviation|0|||
38065491|NCT03290781|69759045|FG006|Overall Study|Protocol Deviation|0|||
38065492|NCT03290781|69759039|FG000|Overall Study|Disease Relapse|32|||
38065493|NCT03290781|69759040|FG001|Overall Study|Disease Relapse|5|||
38065494|NCT03290781|69759041|FG002|Overall Study|Disease Relapse|38|||
38065495|NCT03290781|69759042|FG003|Overall Study|Disease Relapse|7|||
38065496|NCT03290781|69759043|FG004|Overall Study|Disease Relapse|3|||
38065497|NCT03290781|69759044|FG005|Overall Study|Disease Relapse|1|||
38065498|NCT03290781|69759045|FG006|Overall Study|Disease Relapse|4|||
38065499|NCT03290781|69759039|FG000|Overall Study|Other|3|||
38065500|NCT03290781|69759040|FG001|Overall Study|Other|0|||
38065501|NCT03290781|69759041|FG002|Overall Study|Other|2|||
38065502|NCT03290781|69759042|FG003|Overall Study|Other|2|||
38065503|NCT03290781|69759043|FG004|Overall Study|Other|0|||
38065504|NCT03290781|69759044|FG005|Overall Study|Other|0|||
38065505|NCT03290781|69759045|FG006|Overall Study|Other|0|||
38065506|NCT03466073|69759074|FG000|Overall Study|Death|1|||
38065507|NCT03466073|69759075|FG001|Overall Study|Death|0|||
38065508|NCT03466073|69759076|FG002|Overall Study|Death|0|||
38065509|NCT03466073|69759077|FG003|Overall Study|Death|0|||
38065510|NCT03466073|69759078|FG004|Overall Study|Death|0|||
38065511|NCT03466073|69759079|FG005|Overall Study|Death|1|||
38065512|NCT03412019|69759102|FG000|Overall Study|Withdrawal by Subject|1|||
38065513|NCT03412019|69759103|FG001|Overall Study|Withdrawal by Subject|1|||
38065514|NCT03070002|69759109|FG000|Follow up for 2 Years|Death|1|||
38065515|NCT02918318|69759117|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
38065516|NCT02918318|69759118|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
38065517|NCT02918318|69759119|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
38065518|NCT02918318|69759120|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
38065519|NCT02918318|69759121|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
38065520|NCT02918318|69759117|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
37680387|NCT02580877|69156012|FG000|Overall Study|Withdrawal by Subject|1|||
37680388|NCT02580877|69156013|FG001|Overall Study|Withdrawal by Subject|3|||
38065521|NCT02918318|69759118|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
38065522|NCT02918318|69759119|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
38065523|NCT02918318|69759120|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
38065524|NCT02918318|69759121|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
38065525|NCT02918318|69759117|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
38065526|NCT02918318|69759118|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
38065527|NCT02918318|69759119|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
38065528|NCT02918318|69759120|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
38065529|NCT02918318|69759121|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
38065530|NCT02918318|69759117|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
38065531|NCT02918318|69759118|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
38065532|NCT02918318|69759119|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
38065533|NCT02918318|69759120|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
38065534|NCT02918318|69759121|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
38065535|NCT02918318|69759117|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
38065536|NCT02918318|69759118|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
38065537|NCT02918318|69759119|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
38065538|NCT02918318|69759120|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
38065539|NCT02918318|69759121|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
38065540|NCT02918318|69759117|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
38065541|NCT02918318|69759118|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
38065542|NCT02918318|69759119|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
38065543|NCT02918318|69759120|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
38065544|NCT02918318|69759121|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
38065545|NCT02918318|69759117|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
38065546|NCT02918318|69759118|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
38065547|NCT02918318|69759119|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
38065548|NCT02918318|69759120|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
38065549|NCT02918318|69759121|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
38065550|NCT02918318|69759117|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
38065551|NCT02918318|69759118|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
38065552|NCT02918318|69759119|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
38065553|NCT02918318|69759120|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
38065554|NCT02918318|69759121|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
38065555|NCT02918318|69759117|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
38065556|NCT02918318|69759118|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
38065557|NCT02918318|69759119|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
38065558|NCT02918318|69759120|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
38065559|NCT02918318|69759121|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
38065560|NCT02918318|69759117|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
38065561|NCT02918318|69759118|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
38065562|NCT02918318|69759119|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
38065563|NCT02918318|69759120|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
38065564|NCT02918318|69759121|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
38065565|NCT02918318|69759117|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
38065566|NCT02918318|69759118|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
38065567|NCT02918318|69759119|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
38065568|NCT02918318|69759120|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
38065569|NCT02918318|69759121|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
38065570|NCT02918318|69759117|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
38065571|NCT02918318|69759118|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
38065572|NCT02918318|69759119|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
38065573|NCT02918318|69759120|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
38065574|NCT02918318|69759121|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
38065575|NCT03411863|69759166|FG000|Overall Study|Withdrawal by Subject|3|||
38065576|NCT03411863|69759167|FG001|Overall Study|Withdrawal by Subject|1|||
38065577|NCT03411863|69759166|FG000|Overall Study|Physician Decision|0|||
38065578|NCT03411863|69759167|FG001|Overall Study|Physician Decision|1|||
38065579|NCT01065350|69759176|FG000|Overall Study|Received incorrect drug allocation|0|||
38065580|NCT01065350|69759177|FG001|Overall Study|Received incorrect drug allocation|1|||
38065581|NCT03434249|69759185|FG000|Overall Study|Adverse Event|1|||
38065582|NCT03434249|69759186|FG001|Overall Study|Adverse Event|0|||
38065583|NCT03434249|69759185|FG000|Overall Study|Lost to Follow-up|0|||
38065584|NCT03434249|69759186|FG001|Overall Study|Lost to Follow-up|1|||
38065585|NCT03434249|69759185|FG000|Overall Study|Non-compliance of family|2|||
38065586|NCT03434249|69759186|FG001|Overall Study|Non-compliance of family|1|||
38065587|NCT03434249|69759185|FG000|Overall Study|Difficulties in completing daily diary|2|||
38065588|NCT03434249|69759186|FG001|Overall Study|Difficulties in completing daily diary|1|||
38065589|NCT03114969|69759201|FG000|Overall Study|Lost to Follow-up|0|||
38065590|NCT03114969|69759202|FG001|Overall Study|Lost to Follow-up|0|||
38065591|NCT03114969|69759203|FG002|Overall Study|Lost to Follow-up|3|||
38065592|NCT03114969|69759204|FG003|Overall Study|Lost to Follow-up|2|||
38065593|NCT03114969|69759205|FG004|Overall Study|Lost to Follow-up|0|||
38065594|NCT03114969|69759206|FG005|Overall Study|Lost to Follow-up|0|||
38065595|NCT03114969|69759207|FG006|Overall Study|Lost to Follow-up|0|||
38065596|NCT03114969|69759208|FG007|Overall Study|Lost to Follow-up|0|||
38065597|NCT03114969|69759209|FG008|Overall Study|Lost to Follow-up|0|||
38065598|NCT03114969|69759201|FG000|Overall Study|Adverse Event|0|||
38065599|NCT03114969|69759202|FG001|Overall Study|Adverse Event|0|||
38065600|NCT03114969|69759203|FG002|Overall Study|Adverse Event|1|||
38065601|NCT03114969|69759204|FG003|Overall Study|Adverse Event|0|||
38065602|NCT03114969|69759205|FG004|Overall Study|Adverse Event|0|||
38065603|NCT03114969|69759206|FG005|Overall Study|Adverse Event|1|||
38065604|NCT03114969|69759207|FG006|Overall Study|Adverse Event|1|||
38065605|NCT03114969|69759208|FG007|Overall Study|Adverse Event|0|||
38065606|NCT03114969|69759209|FG008|Overall Study|Adverse Event|2|||
38065607|NCT02046096|69759238|FG000|Overall Study|Death|28|||
38065608|NCT02046096|69759239|FG001|Overall Study|Death|45|||
38065609|NCT02046096|69759238|FG000|Overall Study|Lost to Follow-up|9|||
38065610|NCT02046096|69759239|FG001|Overall Study|Lost to Follow-up|20|||
38065611|NCT02046096|69759238|FG000|Overall Study|Withdrawal by Subject|5|||
38065612|NCT02046096|69759239|FG001|Overall Study|Withdrawal by Subject|17|||
38065613|NCT02046096|69759238|FG000|Overall Study|Other endpoint|2|||
38065614|NCT02046096|69759239|FG001|Overall Study|Other endpoint|19|||
38065615|NCT03463577|69759253|FG000|Overall Study|Lost to Follow-up|238|||
38065616|NCT03463577|69759254|FG001|Overall Study|Lost to Follow-up|435|||
38065617|NCT03463577|69759255|FG002|Overall Study|Lost to Follow-up|0|||
38065618|NCT03463577|69759256|FG003|Overall Study|Lost to Follow-up|0|||
38065619|NCT03463577|69759257|FG004|Overall Study|Lost to Follow-up|0|||
38065620|NCT03463577|69759258|FG005|Overall Study|Lost to Follow-up|0|||
38065621|NCT03463577|69759253|FG000|Overall Study|With unknown pregnancy outcome|0|||
38065622|NCT03463577|69759254|FG001|Overall Study|With unknown pregnancy outcome|5|||
38065623|NCT03463577|69759255|FG002|Overall Study|With unknown pregnancy outcome|0|||
38065624|NCT03463577|69759256|FG003|Overall Study|With unknown pregnancy outcome|0|||
38065625|NCT03463577|69759257|FG004|Overall Study|With unknown pregnancy outcome|0|||
38065626|NCT03463577|69759258|FG005|Overall Study|With unknown pregnancy outcome|0|||
38065627|NCT03463577|69759253|FG000|Overall Study|Maternal death|2|||
38065628|NCT03463577|69759254|FG001|Overall Study|Maternal death|0|||
38065629|NCT03463577|69759255|FG002|Overall Study|Maternal death|0|||
38065630|NCT03463577|69759256|FG003|Overall Study|Maternal death|0|||
38065631|NCT03463577|69759257|FG004|Overall Study|Maternal death|0|||
38065632|NCT03463577|69759258|FG005|Overall Study|Maternal death|0|||
38065633|NCT03463577|69759253|FG000|Overall Study|Neonatal death|0|||
38065634|NCT03463577|69759254|FG001|Overall Study|Neonatal death|0|||
38065635|NCT03463577|69759255|FG002|Overall Study|Neonatal death|0|||
38065636|NCT03463577|69759256|FG003|Overall Study|Neonatal death|15|||
38065637|NCT03463577|69759257|FG004|Overall Study|Neonatal death|17|||
38065638|NCT03463577|69759258|FG005|Overall Study|Neonatal death|0|||
38065639|NCT03122145|69759274|FG000|Overall Study|Concurrent respiratory disease|3|||
38065640|NCT03122145|69759275|FG001|Overall Study|Concurrent respiratory disease|0|||
38065641|NCT03114657|69759283|FG000|Overall Study|Adverse Event|9|||
38065642|NCT03114657|69759284|FG001|Overall Study|Adverse Event|6|||
38065643|NCT03114657|69759283|FG000|Overall Study|Death|4|||
38065644|NCT03114657|69759284|FG001|Overall Study|Death|0|||
38065645|NCT03114657|69759283|FG000|Overall Study|Multiple Reasons|1|||
38065646|NCT03114657|69759284|FG001|Overall Study|Multiple Reasons|2|||
38065647|NCT03114657|69759283|FG000|Overall Study|Physician Decision|2|||
38065648|NCT03114657|69759284|FG001|Overall Study|Physician Decision|2|||
38065649|NCT03114657|69759283|FG000|Overall Study|Study Terminated By Sponsor|355|||
38065650|NCT03114657|69759284|FG001|Overall Study|Study Terminated By Sponsor|374|||
38065651|NCT03114657|69759283|FG000|Overall Study|Symptomatic Deterioration|0|||
38065652|NCT03114657|69759284|FG001|Overall Study|Symptomatic Deterioration|1|||
38065653|NCT03114657|69759283|FG000|Overall Study|Withdrawal by Subject|28|||
38065654|NCT03114657|69759284|FG001|Overall Study|Withdrawal by Subject|22|||
38065655|NCT02926950|69759293|FG000|Overall Study|Adverse Event|4|||
38065656|NCT02926950|69759294|FG001|Overall Study|Adverse Event|6|||
38065657|NCT02926950|69759293|FG000|Overall Study|At the participant's own request|21|||
38065658|NCT02926950|69759294|FG001|Overall Study|At the participant's own request|25|||
38065659|NCT02926950|69759293|FG000|Overall Study|Reason not Specified|17|||
38065660|NCT02926950|69759294|FG001|Overall Study|Reason not Specified|9|||
38065661|NCT02926950|69759293|FG000|Overall Study|Lost to Follow-up|7|||
38065662|NCT02926950|69759294|FG001|Overall Study|Lost to Follow-up|8|||
38065663|NCT03410693|69759303|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
38065664|NCT03410693|69759304|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
38065665|NCT03410693|69759303|FG000|Overall Study|Disc trt: Lost to follow up|0|||
38065666|NCT03410693|69759304|FG001|Overall Study|Disc trt: Lost to follow up|1|||
38065667|NCT03410693|69759303|FG000|Overall Study|Disc trt: radiological progression|58|||
38065668|NCT03410693|69759304|FG001|Overall Study|Disc trt: radiological progression|50|||
38065669|NCT03410693|69759303|FG000|Overall Study|Disc trt: Other|1|||
38065670|NCT03410693|69759304|FG001|Overall Study|Disc trt: Other|0|||
38065671|NCT03410693|69759303|FG000|Overall Study|Study drug never administered|1|||
38065672|NCT03410693|69759304|FG001|Overall Study|Study drug never administered|6|||
38065673|NCT03410693|69759303|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
38065674|NCT03410693|69759304|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
38065675|NCT03410693|69759303|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
38065676|NCT03410693|69759304|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
38065677|NCT03410693|69759303|FG000|Overall Study|Disc trt: Physician decision|0|||
38065678|NCT03410693|69759304|FG001|Overall Study|Disc trt: Physician decision|5|||
38065679|NCT03410693|69759303|FG000|Overall Study|Disc trt: clinical progression|1|||
38065680|NCT03410693|69759304|FG001|Overall Study|Disc trt: clinical progression|5|||
38065681|NCT03410693|69759303|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
38065682|NCT03410693|69759304|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
38065683|NCT01064414|69759319|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
38065684|NCT01064414|69759320|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
38065685|NCT01064414|69759321|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
38065686|NCT01064414|69759319|FG000|Core Period: Baseline to Week 26|Death|0|||
38065687|NCT01064414|69759320|FG001|Core Period: Baseline to Week 26|Death|1|||
38065688|NCT01064414|69759321|FG002|Core Period: Baseline to Week 26|Death|0|||
38065689|NCT01064414|69759319|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
38065690|NCT01064414|69759320|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
38065691|NCT01064414|69759321|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
38065692|NCT01064414|69759319|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
38065693|NCT01064414|69759320|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
38065694|NCT01064414|69759321|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
38065695|NCT01064414|69759319|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
38065696|NCT01064414|69759320|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
38065697|NCT01064414|69759321|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
38065698|NCT01064414|69759319|FG000|Core Period: Baseline to Week 26|Other|4|||
38065699|NCT01064414|69759320|FG001|Core Period: Baseline to Week 26|Other|7|||
38065700|NCT01064414|69759321|FG002|Core Period: Baseline to Week 26|Other|2|||
38065701|NCT01064414|69759319|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
38065702|NCT01064414|69759320|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
38065703|NCT01064414|69759321|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
38065704|NCT01064414|69759319|FG000|Extension Period: Week 26 to Week 52|Death|0|||
38065705|NCT01064414|69759320|FG001|Extension Period: Week 26 to Week 52|Death|1|||
38065706|NCT01064414|69759321|FG002|Extension Period: Week 26 to Week 52|Death|0|||
38065707|NCT01064414|69759319|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
38065708|NCT01064414|69759320|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
38065709|NCT01064414|69759321|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
38065710|NCT01064414|69759319|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
38065711|NCT01064414|69759320|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
38065712|NCT01064414|69759321|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
38065713|NCT01064414|69759319|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
38065714|NCT01064414|69759320|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
38065715|NCT01064414|69759321|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
38065716|NCT01064414|69759319|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
38065717|NCT01064414|69759320|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
38065718|NCT01064414|69759321|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
38065719|NCT01064414|69759319|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
38065720|NCT01064414|69759320|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
38065721|NCT01064414|69759321|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
38065722|NCT01064414|69759319|FG000|Extension Period: Week 26 to Week 52|Other|5|||
37680389|NCT02580877|69156012|FG000|Overall Study|Adverse Event|0|||
38065723|NCT01064414|69759320|FG001|Extension Period: Week 26 to Week 52|Other|2|||
38065724|NCT01064414|69759321|FG002|Extension Period: Week 26 to Week 52|Other|1|||
38065725|NCT03433703|69759332|FG000|Overall Study|Study terminated by Sponsor|2|||
38065726|NCT03463031|69759342|FG000|Overall Study|Withdrawal by Subject|4|||
38065727|NCT03463031|69759343|FG001|Overall Study|Withdrawal by Subject|2|||
38065728|NCT03463031|69759342|FG000|Overall Study|Investigator/Sponsor Decision|0|||
38065729|NCT03463031|69759343|FG001|Overall Study|Investigator/Sponsor Decision|1|||
38065730|NCT03463031|69759342|FG000|Overall Study|Lost to Follow-up|1|||
38065731|NCT03463031|69759343|FG001|Overall Study|Lost to Follow-up|1|||
38065732|NCT03463031|69759342|FG000|Overall Study|Adverse Event|4|||
38065733|NCT03463031|69759343|FG001|Overall Study|Adverse Event|1|||
38065734|NCT03463031|69759342|FG000|Overall Study|Use of prohibited medication by subject|1|||
38065735|NCT03463031|69759343|FG001|Overall Study|Use of prohibited medication by subject|0|||
38065736|NCT03462641|69759351|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
38065737|NCT03462641|69759352|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
38065738|NCT03462641|69759351|FG000|Visit 2|Withdrawal by Subject|0|||
38065739|NCT03462641|69759352|FG001|Visit 2|Withdrawal by Subject|1|||
38065740|NCT02974634|69759362|FG000|Overall Study|Advanced disease|12|||
38065741|NCT02974634|69759363|FG001|Overall Study|Advanced disease|3|||
38065742|NCT02974634|69759362|FG000|Overall Study|Noncompliance|3|||
38065743|NCT02974634|69759363|FG001|Overall Study|Noncompliance|7|||
38065744|NCT02974634|69759362|FG000|Overall Study|intervention technology related issues|5|||
38065745|NCT02974634|69759363|FG001|Overall Study|intervention technology related issues|0|||
38065746|NCT02974634|69759362|FG000|Overall Study|Death|8|||
38065747|NCT02974634|69759363|FG001|Overall Study|Death|11|||
38065748|NCT01060670|69759372|FG000|Run In|screen failure|0|||
38065749|NCT01060670|69759373|FG001|Run In|screen failure|238|||
38065750|NCT02971670|69759385|FG000|Overall Study|Withdrawal by Subject|4|||
38065751|NCT02971670|69759386|FG001|Overall Study|Withdrawal by Subject|1|||
38065752|NCT02971670|69759387|FG002|Overall Study|Withdrawal by Subject|1|||
38065753|NCT02971670|69759388|FG003|Overall Study|Withdrawal by Subject|2|||
38065754|NCT02971202|69759401|FG000|Overall Study|Pregnancy|1|||
38065755|NCT02971202|69759402|FG001|Overall Study|Pregnancy|0|||
38065756|NCT02971202|69759403|FG002|Overall Study|Pregnancy|0|||
38065757|NCT02971202|69759401|FG000|Overall Study|screen fail after consent|1|||
38065758|NCT02971202|69759402|FG001|Overall Study|screen fail after consent|0|||
38065759|NCT02971202|69759403|FG002|Overall Study|screen fail after consent|1|||
38065760|NCT02926638|69759413|FG000|Overall Study|Progression|2|||
38065761|NCT02926638|69759414|FG001|Overall Study|Progression|5|||
38065762|NCT02926638|69759413|FG000|Overall Study|Ineligible|1|||
38065763|NCT02926638|69759414|FG001|Overall Study|Ineligible|0|||
38065764|NCT02926638|69759413|FG000|Overall Study|Not protocol specified|1|||
38065765|NCT02926638|69759414|FG001|Overall Study|Not protocol specified|0|||
38065766|NCT02903030|69759422|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
38065767|NCT02903030|69759423|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
38065768|NCT02969408|69759432|FG000|Overall Study|Adverse Event|2|||
38065769|NCT02969408|69759432|FG000|Overall Study|Withdrawal by Subject|8|||
38065770|NCT02969408|69759432|FG000|Overall Study|Lost to Follow-up|4|||
38065771|NCT02969408|69759432|FG000|Overall Study|Protocol Violation|1|||
38065772|NCT02969408|69759432|FG000|Overall Study|Other than specified|1|||
38065773|NCT03462563|69759438|FG000|Overall Study|Death|1|||
38065774|NCT03462563|69759439|FG001|Overall Study|Death|1|||
38065775|NCT03462563|69759438|FG000|Overall Study|Termination of study|2|||
38065776|NCT03462563|69759439|FG001|Overall Study|Termination of study|1|||
38065777|NCT03462563|69759438|FG000|Overall Study|Adverse Event|1|||
38065778|NCT03462563|69759439|FG001|Overall Study|Adverse Event|3|||
38065779|NCT03462563|69759438|FG000|Overall Study|Unspecified reason|10|||
38065780|NCT03462563|69759439|FG001|Overall Study|Unspecified reason|12|||
38065781|NCT03462563|69759438|FG000|Overall Study|Physician Decision|1|||
38065782|NCT03462563|69759439|FG001|Overall Study|Physician Decision|0|||
38065783|NCT01060124|69759445|FG000|Overall Study|Other|16|||
38065784|NCT01060124|69759445|FG000|Overall Study|Adverse Event|14|||
38065785|NCT01060124|69759445|FG000|Overall Study|Withdrawal by Subject|7|||
38065786|NCT03461003|69759451|FG000|Overall Study|Lost to Follow-up|2|||
38065787|NCT03461003|69759452|FG001|Overall Study|Lost to Follow-up|2|||
38065788|NCT03461003|69759451|FG000|Overall Study|Withdrawal by Subject|3|||
38065789|NCT03461003|69759452|FG001|Overall Study|Withdrawal by Subject|1|||
38065790|NCT02904902|69759458|FG000|Overall Study|Withdrawal by Subject|1|||
38065791|NCT04425720|69759464|FG000|Overall Study|Withdrawal by Subject|0|||
38065792|NCT04425720|69759465|FG001|Overall Study|Withdrawal by Subject|20|||
38065793|NCT02904512|69759474|FG000|Overall Study|Withdrawal by Subject|1|||
38065794|NCT02904512|69759475|FG001|Overall Study|Withdrawal by Subject|0|||
38065795|NCT02904512|69759474|FG000|Overall Study|Transferred to ICU|1|||
38065796|NCT02904512|69759475|FG001|Overall Study|Transferred to ICU|0|||
38065797|NCT02904512|69759474|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
38065798|NCT02904512|69759475|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
38065799|NCT02904200|69759481|FG000|Overall Study|Withdrawal by Subject|1|||
38065800|NCT02904200|69759482|FG001|Overall Study|Withdrawal by Subject|0|||
38065801|NCT03432533|69759488|FG000|Overall Study|Lost to Follow-up|1|||
38065802|NCT03432533|69759489|FG001|Overall Study|Lost to Follow-up|2|||
38065803|NCT03432533|69759488|FG000|Overall Study|Withdrawal by Subject|14|||
38065804|NCT03432533|69759489|FG001|Overall Study|Withdrawal by Subject|9|||
38065805|NCT02901548|69759495|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
38065806|NCT02903966|69759501|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
38065807|NCT02903966|69759502|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
38065808|NCT02903966|69759501|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
38065809|NCT02903966|69759502|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
38065810|NCT02903966|69759501|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
38065811|NCT02903966|69759502|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
38065812|NCT03457727|69759518|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
38065813|NCT03457727|69759519|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
38065814|NCT03457727|69759520|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
38065815|NCT03457727|69759521|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
38065816|NCT03431441|69759553|FG000|Overall Study|Withdrawal by Subject|2|||
38065817|NCT03431441|69759553|FG000|Overall Study|Adverse Event|2|||
38065818|NCT03431441|69759553|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
38065819|NCT03457103|69759559|FG000|Overall Study|illness/hospitalization|4|||
38065820|NCT03457103|69759560|FG001|Overall Study|illness/hospitalization|2|||
38065821|NCT03457103|69759559|FG000|Overall Study|Lost to Follow-up|2|||
38065822|NCT03457103|69759560|FG001|Overall Study|Lost to Follow-up|1|||
38065823|NCT03457103|69759559|FG000|Overall Study|Withdrawal by Subject|1|||
38065824|NCT03457103|69759560|FG001|Overall Study|Withdrawal by Subject|2|||
38065825|NCT03457103|69759559|FG000|Overall Study|financial/ insurance issues|1|||
38065826|NCT03457103|69759560|FG001|Overall Study|financial/ insurance issues|1|||
38065827|NCT03455543|69759568|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
38065828|NCT03455543|69759569|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
38065829|NCT03455543|69759570|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
38065830|NCT03455543|69759568|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
38065831|NCT03455543|69759569|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
38065832|NCT03455543|69759570|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
38065833|NCT03455543|69759568|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
38065834|NCT03455543|69759569|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
38065835|NCT03455543|69759570|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
38065836|NCT03455543|69759568|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
38065837|NCT03455543|69759569|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
38065838|NCT03455543|69759570|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
38065839|NCT03455543|69759568|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
38065840|NCT03455543|69759569|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
38065841|NCT03455543|69759570|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
38065842|NCT03455543|69759568|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
38065843|NCT03455543|69759569|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
38065844|NCT03455543|69759570|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
38065845|NCT03455543|69759568|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
38065846|NCT03455543|69759569|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
38065847|NCT03455543|69759570|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
38065848|NCT03455543|69759568|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
38065849|NCT03455543|69759569|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
38065850|NCT03455543|69759570|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
38065851|NCT03455543|69759568|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
38065852|NCT03455543|69759569|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
38065853|NCT03455543|69759570|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
38065854|NCT03068754|69759580|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
38065855|NCT03068754|69759581|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
38065856|NCT03068754|69759582|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
38065857|NCT03068754|69759583|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
38065858|NCT03068754|69759580|FG000|Randomized Treatment Period (RTP)|Death|2|||
38065859|NCT03068754|69759581|FG001|Randomized Treatment Period (RTP)|Death|2|||
38065860|NCT03068754|69759582|FG002|Randomized Treatment Period (RTP)|Death|0|||
38065861|NCT03068754|69759583|FG003|Randomized Treatment Period (RTP)|Death|0|||
38065862|NCT03068754|69759580|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
38065863|NCT03068754|69759581|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
38065864|NCT03068754|69759582|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
38065865|NCT03068754|69759583|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
38065866|NCT03068754|69759580|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
38065867|NCT03068754|69759581|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
38065868|NCT03068754|69759582|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
38065869|NCT03068754|69759583|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
38065870|NCT03068754|69759580|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
38065871|NCT03068754|69759581|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
38065872|NCT03068754|69759582|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
38065873|NCT03068754|69759583|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
38065874|NCT03068754|69759580|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
38065875|NCT03068754|69759581|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
38065876|NCT03068754|69759582|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
38065877|NCT03068754|69759583|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
38065878|NCT03068754|69759580|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
38065879|NCT03068754|69759581|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
38065880|NCT03068754|69759582|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
38065881|NCT03068754|69759583|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
38065882|NCT03068754|69759580|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
38065883|NCT03068754|69759581|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
38065884|NCT03068754|69759582|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
38065885|NCT03068754|69759583|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
38065886|NCT03068754|69759580|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
38065887|NCT03068754|69759581|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
38065888|NCT03068754|69759582|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
38065889|NCT03068754|69759583|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
38065890|NCT03068754|69759580|FG000|Open Label Extension Period (OLE)|Death|0|||
38065891|NCT03068754|69759581|FG001|Open Label Extension Period (OLE)|Death|0|||
38065892|NCT03068754|69759582|FG002|Open Label Extension Period (OLE)|Death|0|||
38065893|NCT03068754|69759583|FG003|Open Label Extension Period (OLE)|Death|1|||
38065894|NCT03068754|69759580|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
38065895|NCT03068754|69759581|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
38065896|NCT03068754|69759582|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
38065897|NCT03068754|69759583|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
38065898|NCT03068754|69759580|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
38065899|NCT03068754|69759581|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
38065900|NCT03068754|69759582|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
38065901|NCT03068754|69759583|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
38065902|NCT03068754|69759580|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
38065903|NCT03068754|69759581|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
38065904|NCT03068754|69759582|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
38065905|NCT03068754|69759583|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
38065906|NCT03068754|69759580|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
38065907|NCT03068754|69759581|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
38065908|NCT03068754|69759582|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
38065909|NCT03068754|69759583|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
38065910|NCT02965820|69759593|FG000|Period 2, Second 30 Days|Adverse Event|1|||
38065911|NCT02965820|69759594|FG001|Period 2, Second 30 Days|Adverse Event|1|||
38065912|NCT03430895|69759600|FG000|Overall Study|Not Treated|2|||
38065913|NCT03452189|69759604|FG000|First Intervention (3 Months)|Adverse Event|1|||
38065914|NCT03452189|69759605|FG001|First Intervention (3 Months)|Adverse Event|0|||
38065915|NCT03452189|69759604|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
38065916|NCT03452189|69759605|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
38065917|NCT03451721|69759611|FG000|Overall Study|Death|1|||
38065918|NCT00603954|69759617|FG000|Overall Study|Protocol Violation|1|||
38065919|NCT00603954|69759618|FG001|Overall Study|Protocol Violation|2|||
38065920|NCT03427619|69759625|FG000|Overall Study|Physician Decision|3|||
38065921|NCT03427619|69759625|FG000|Overall Study|Withdrawal by Subject|4|||
38065922|NCT03427619|69759625|FG000|Overall Study|Lost to Follow-up|5|||
38065923|NCT03427619|69759625|FG000|Overall Study|Administrative|4|||
38065924|NCT03427619|69759625|FG000|Overall Study|Other|2|||
38065925|NCT03427619|69759625|FG000|Overall Study|Unknown or Missing Completion Status|48|||
38065926|NCT03407729|69759631|FG000|Overall Study|Lost to Follow-up|2|||
38065927|NCT03407729|69759632|FG001|Overall Study|Lost to Follow-up|0|||
38065928|NCT03407729|69759631|FG000|Overall Study|Unable to schedule|0|||
38065929|NCT03407729|69759632|FG001|Overall Study|Unable to schedule|3|||
38065930|NCT02435433|69759643|FG000|Overall Study|Withdrawal by Subject|2|||
38065931|NCT02435433|69759644|FG001|Overall Study|Withdrawal by Subject|3|||
38065932|NCT02435433|69759645|FG002|Overall Study|Withdrawal by Subject|1|||
38065933|NCT02435433|69759646|FG003|Overall Study|Withdrawal by Subject|0|||
38065934|NCT02435433|69759647|FG004|Overall Study|Withdrawal by Subject|0|||
38065935|NCT02435433|69759643|FG000|Overall Study|Lost to Follow-up|2|||
38065936|NCT02435433|69759644|FG001|Overall Study|Lost to Follow-up|2|||
38065937|NCT02435433|69759645|FG002|Overall Study|Lost to Follow-up|4|||
38065938|NCT02435433|69759646|FG003|Overall Study|Lost to Follow-up|1|||
38065939|NCT02435433|69759647|FG004|Overall Study|Lost to Follow-up|0|||
38065940|NCT03120351|69759660|FG000|Overall Study|Physician Decision|1|||
38065941|NCT03120351|69759661|FG001|Overall Study|Physician Decision|1|||
38065942|NCT02354703|69759671|FG000|Overall Study|Withdrawal by Subject|1|||
38065943|NCT02354703|69759672|FG001|Overall Study|Withdrawal by Subject|1|||
38065944|NCT02354703|69759673|FG002|Overall Study|Withdrawal by Subject|1|||
38065945|NCT02354703|69759674|FG003|Overall Study|Withdrawal by Subject|1|||
38065946|NCT02354703|69759671|FG000|Overall Study|Lost to Follow-up|2|||
38065947|NCT02354703|69759672|FG001|Overall Study|Lost to Follow-up|7|||
38065948|NCT02354703|69759673|FG002|Overall Study|Lost to Follow-up|9|||
38065949|NCT02354703|69759674|FG003|Overall Study|Lost to Follow-up|2|||
38065950|NCT02354703|69759671|FG000|Overall Study|Adverse Event|0|||
38065951|NCT02354703|69759672|FG001|Overall Study|Adverse Event|0|||
38065952|NCT02354703|69759673|FG002|Overall Study|Adverse Event|1|||
38065953|NCT02354703|69759674|FG003|Overall Study|Adverse Event|0|||
38065954|NCT00384111|69759690|FG000|Overall Study|Disease Progression|3|||
38065955|NCT00384111|69759690|FG000|Overall Study|Adverse Event|1|||
38065956|NCT00384111|69759690|FG000|Overall Study|Investigator Decision|3|||
38065957|NCT00384111|69759690|FG000|Overall Study|Study Terminated by the Sponsor|19|||
38065958|NCT03113409|69759694|FG000|Overall Study|Withdrawal by Subject|5|||
38065959|NCT03113409|69759695|FG001|Overall Study|Withdrawal by Subject|0|||
38065960|NCT03113409|69759696|FG002|Overall Study|Withdrawal by Subject|0|||
38065961|NCT01319877|69759702|FG000|Overall Study|Lost to Follow-up|100|||
38065962|NCT01319877|69759703|FG001|Overall Study|Lost to Follow-up|37|||
38065963|NCT01319877|69759702|FG000|Overall Study|Physician Decision|2|||
38065964|NCT01319877|69759703|FG001|Overall Study|Physician Decision|0|||
38065965|NCT01319877|69759702|FG000|Overall Study|Disease Progression|2|||
38065966|NCT01319877|69759703|FG001|Overall Study|Disease Progression|2|||
38065967|NCT01319877|69759702|FG000|Overall Study|Withdrawal by Subject|0|||
38065968|NCT01319877|69759703|FG001|Overall Study|Withdrawal by Subject|1|||
38065969|NCT01319877|69759702|FG000|Overall Study|Reason Not Specified|4|||
38065970|NCT01319877|69759703|FG001|Overall Study|Reason Not Specified|5|||
38065971|NCT03427073|69759716|FG000|Overall Study|Disease Progression|1|||
38065972|NCT03427073|69759717|FG001|Overall Study|Disease Progression|1|||
38065973|NCT03427073|69759718|FG002|Overall Study|Disease Progression|1|||
38065974|NCT03427073|69759719|FG003|Overall Study|Disease Progression|3|||
38065975|NCT03427073|69759720|FG004|Overall Study|Disease Progression|3|||
38065976|NCT03427073|69759721|FG005|Overall Study|Disease Progression|4|||
38065977|NCT03427073|69759722|FG006|Overall Study|Disease Progression|2|||
38065978|NCT03427073|69759723|FG007|Overall Study|Disease Progression|3|||
38065979|NCT03427073|69759716|FG000|Overall Study|Physician Decision|0|||
38065980|NCT03427073|69759717|FG001|Overall Study|Physician Decision|0|||
38065981|NCT03427073|69759718|FG002|Overall Study|Physician Decision|0|||
38065982|NCT03427073|69759719|FG003|Overall Study|Physician Decision|0|||
38065983|NCT03427073|69759720|FG004|Overall Study|Physician Decision|0|||
38065984|NCT03427073|69759721|FG005|Overall Study|Physician Decision|0|||
38065985|NCT03427073|69759722|FG006|Overall Study|Physician Decision|1|||
38065986|NCT03427073|69759723|FG007|Overall Study|Physician Decision|1|||
38065987|NCT03066804|69759743|FG000|Overall Study|Physician Decision|0|||
38065988|NCT03066804|69759744|FG001|Overall Study|Physician Decision|4|||
38065989|NCT03066804|69759743|FG000|Overall Study|Death|23|||
38065990|NCT03066804|69759744|FG001|Overall Study|Death|17|||
38065991|NCT03066804|69759743|FG000|Overall Study|Withdrawal by Subject|19|||
38065992|NCT03066804|69759744|FG001|Overall Study|Withdrawal by Subject|25|||
38065993|NCT03066804|69759743|FG000|Overall Study|Lost to Follow-up|2|||
38065994|NCT03066804|69759744|FG001|Overall Study|Lost to Follow-up|0|||
38065995|NCT03066804|69759743|FG000|Overall Study|Adverse Event|2|||
38065996|NCT03066804|69759744|FG001|Overall Study|Adverse Event|3|||
38065997|NCT03066804|69759743|FG000|Overall Study|Technical problems|5|||
38065998|NCT03066804|69759744|FG001|Overall Study|Technical problems|1|||
38065999|NCT02954237|69759751|FG000|Overall Study|Withdrawal by Subject|25|||
38066000|NCT02954237|69759751|FG000|Overall Study|Missed visit|16|||
38066001|NCT02954237|69759751|FG000|Overall Study|Death|2|||
38066002|NCT04250337|69759757|FG000|Overall Study|Adverse Event|0|||
38066003|NCT04250337|69759758|FG001|Overall Study|Adverse Event|3|||
38066004|NCT04250337|69759757|FG000|Overall Study|Lack of Efficacy|1|||
38066005|NCT04250337|69759758|FG001|Overall Study|Lack of Efficacy|3|||
38066006|NCT04250337|69759757|FG000|Overall Study|Physician Decision|1|||
38066007|NCT04250337|69759758|FG001|Overall Study|Physician Decision|0|||
38066008|NCT04250337|69759757|FG000|Overall Study|Protocol Deviation|2|||
38066009|NCT04250337|69759758|FG001|Overall Study|Protocol Deviation|2|||
38066010|NCT04250337|69759757|FG000|Overall Study|Withdrawal by Subject|4|||
38066011|NCT04250337|69759758|FG001|Overall Study|Withdrawal by Subject|3|||
38066012|NCT03118947|69759765|FG000|Overall Study|Adverse Event|7|||
38066013|NCT03118947|69759765|FG000|Overall Study|Death|3|||
38066014|NCT03118947|69759765|FG000|Overall Study|Lack of Efficacy|4|||
38066015|NCT03118947|69759765|FG000|Overall Study|Non-compliance with study drug|1|||
38066016|NCT03118947|69759765|FG000|Overall Study|Protocol Violation|2|||
38066017|NCT03118947|69759765|FG000|Overall Study|Withdrawal by Subject|3|||
38066018|NCT03118947|69759765|FG000|Overall Study|Withdrawal by caregiver|3|||
38066019|NCT03118947|69759765|FG000|Overall Study|Change in patient's living situation|4|||
38066020|NCT03118947|69759765|FG000|Overall Study|Lost to Follow-up|2|||
38066021|NCT03953079|69759772|FG000|Core Study|Withdrawal by Subject|1|||
38066022|NCT03953079|69759773|FG001|Core Study|Withdrawal by Subject|2|||
38066023|NCT03953079|69759774|FG002|Core Study|Withdrawal by Subject|1|||
38066024|NCT03953079|69759772|FG000|Core Study|COVID-19|0|||
38066025|NCT03953079|69759773|FG001|Core Study|COVID-19|1|||
38066026|NCT03953079|69759774|FG002|Core Study|COVID-19|0|||
38066027|NCT03953079|69759772|FG000|Core Study|Difficulties leaving the house|0|||
38066028|NCT03953079|69759773|FG001|Core Study|Difficulties leaving the house|1|||
38066029|NCT03953079|69759774|FG002|Core Study|Difficulties leaving the house|0|||
38066030|NCT03953079|69759772|FG000|Extension Study|Withdrawal by Subject|1|||
38066031|NCT03953079|69759773|FG001|Extension Study|Withdrawal by Subject|0|||
38066032|NCT03953079|69759774|FG002|Extension Study|Withdrawal by Subject|0|||
38066033|NCT03953079|69759772|FG000|Extension Study|Received Rescue Treatment|5|||
38066034|NCT03953079|69759773|FG001|Extension Study|Received Rescue Treatment|6|||
38066035|NCT03953079|69759774|FG002|Extension Study|Received Rescue Treatment|5|||
38066036|NCT03885999|69759787|FG000|Overall Study|Adverse Event|1|||
38066037|NCT03108027|69759801|FG000|Period 1|Subject/Guardian Decision|0|||
38066038|NCT03108027|69759802|FG001|Period 1|Subject/Guardian Decision|0|||
38066039|NCT03108027|69759803|FG002|Period 1|Subject/Guardian Decision|0|||
38066040|NCT03108027|69759804|FG003|Period 1|Subject/Guardian Decision|2|||
38066041|NCT03108027|69759805|FG004|Period 1|Subject/Guardian Decision|0|||
38066042|NCT03108027|69759806|FG005|Period 1|Subject/Guardian Decision|0|||
38066043|NCT03108027|69759801|FG000|Period 3|Adverse Event|0|||
38066044|NCT03108027|69759802|FG001|Period 3|Adverse Event|1|||
38066045|NCT03108027|69759803|FG002|Period 3|Adverse Event|0|||
38066046|NCT03108027|69759804|FG003|Period 3|Adverse Event|0|||
38066047|NCT03108027|69759805|FG004|Period 3|Adverse Event|0|||
38066048|NCT03108027|69759806|FG005|Period 3|Adverse Event|0|||
38066049|NCT03107715|69759822|FG000|Overall Study|did not deliver at the home hospital|4|||
38066050|NCT03107715|69759823|FG001|Overall Study|did not deliver at the home hospital|6|||
38066051|NCT03107715|69759822|FG000|Overall Study|infant stillborn|0|||
38066052|NCT03107715|69759823|FG001|Overall Study|infant stillborn|1|||
38066053|NCT03567057|69759832|FG000|Overall Study|Adverse Event|56|||
38066054|NCT03567057|69759833|FG001|Overall Study|Adverse Event|53|||
38066055|NCT03567057|69759834|FG002|Overall Study|Adverse Event|28|||
38066056|NCT03567057|69759832|FG000|Overall Study|Withdrawal by Subject|22|||
38066057|NCT03567057|69759833|FG001|Overall Study|Withdrawal by Subject|24|||
38066058|NCT03567057|69759834|FG002|Overall Study|Withdrawal by Subject|13|||
38066059|NCT03567057|69759832|FG000|Overall Study|Lost to Follow-up|3|||
38066060|NCT03567057|69759833|FG001|Overall Study|Lost to Follow-up|5|||
38066061|NCT03567057|69759834|FG002|Overall Study|Lost to Follow-up|2|||
38066062|NCT03567057|69759832|FG000|Overall Study|COVID-19 pandemic|4|||
38066063|NCT03567057|69759833|FG001|Overall Study|COVID-19 pandemic|3|||
38066064|NCT03567057|69759834|FG002|Overall Study|COVID-19 pandemic|0|||
38066065|NCT03567057|69759832|FG000|Overall Study|Non-compliance with study drug|4|||
38066066|NCT03567057|69759833|FG001|Overall Study|Non-compliance with study drug|2|||
38066067|NCT03567057|69759834|FG002|Overall Study|Non-compliance with study drug|0|||
38066068|NCT03567057|69759832|FG000|Overall Study|Lack of Efficacy|3|||
38066069|NCT03567057|69759833|FG001|Overall Study|Lack of Efficacy|0|||
38066070|NCT03567057|69759834|FG002|Overall Study|Lack of Efficacy|1|||
38066071|NCT03567057|69759832|FG000|Overall Study|Death|1|||
38066072|NCT03567057|69759833|FG001|Overall Study|Death|0|||
38066073|NCT03567057|69759834|FG002|Overall Study|Death|0|||
38066074|NCT03567057|69759832|FG000|Overall Study|Physician Decision|1|||
38066075|NCT03567057|69759833|FG001|Overall Study|Physician Decision|0|||
38066076|NCT03567057|69759834|FG002|Overall Study|Physician Decision|0|||
38066077|NCT03567057|69759832|FG000|Overall Study|Unstable medical condition|1|||
38066078|NCT03567057|69759833|FG001|Overall Study|Unstable medical condition|0|||
38066079|NCT03567057|69759834|FG002|Overall Study|Unstable medical condition|0|||
38066080|NCT03567057|69759832|FG000|Overall Study|Medical history event|0|||
38066081|NCT03567057|69759833|FG001|Overall Study|Medical history event|0|||
38066082|NCT03567057|69759834|FG002|Overall Study|Medical history event|1|||
38066083|NCT03567057|69759832|FG000|Overall Study|Other|0|||
38066084|NCT03567057|69759833|FG001|Overall Study|Other|0|||
38066085|NCT03567057|69759834|FG002|Overall Study|Other|1|||
38066086|NCT04388787|69759842|FG000|Blinded Period|Patient could not follow instructions|1|||
38066087|NCT04388787|69759842|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
38066088|NCT03057600|69759854|FG000|Overall Study|Adverse Event|0|||
38066089|NCT03057600|69759855|FG001|Overall Study|Adverse Event|0|||
38066090|NCT03057600|69759856|FG002|Overall Study|Adverse Event|4|||
38066091|NCT03057600|69759857|FG003|Overall Study|Adverse Event|0|||
38066092|NCT03057600|69759854|FG000|Overall Study|Radiologic Disease Progression|8|||
38066093|NCT03057600|69759855|FG001|Overall Study|Radiologic Disease Progression|7|||
38066094|NCT03057600|69759856|FG002|Overall Study|Radiologic Disease Progression|13|||
38066095|NCT03057600|69759857|FG003|Overall Study|Radiologic Disease Progression|10|||
38066096|NCT03057600|69759854|FG000|Overall Study|Symptomatic Deterioration|0|||
38066097|NCT03057600|69759855|FG001|Overall Study|Symptomatic Deterioration|1|||
38066098|NCT03057600|69759856|FG002|Overall Study|Symptomatic Deterioration|1|||
38066099|NCT03057600|69759857|FG003|Overall Study|Symptomatic Deterioration|0|||
38066100|NCT03057600|69759854|FG000|Overall Study|Investigator Decision|0|||
38066101|NCT03057600|69759855|FG001|Overall Study|Investigator Decision|0|||
38066102|NCT03057600|69759856|FG002|Overall Study|Investigator Decision|1|||
38066103|NCT03057600|69759857|FG003|Overall Study|Investigator Decision|0|||
38066104|NCT03057600|69759854|FG000|Overall Study|Study Termination by Sponsor|0|||
38066105|NCT03057600|69759855|FG001|Overall Study|Study Termination by Sponsor|0|||
38066106|NCT03057600|69759856|FG002|Overall Study|Study Termination by Sponsor|0|||
38066107|NCT03057600|69759857|FG003|Overall Study|Study Termination by Sponsor|2|||
38066108|NCT03057600|69759854|FG000|Overall Study|Withdrawal by Subject|0|||
38066109|NCT03057600|69759855|FG001|Overall Study|Withdrawal by Subject|1|||
38066110|NCT03057600|69759856|FG002|Overall Study|Withdrawal by Subject|0|||
38066111|NCT03057600|69759857|FG003|Overall Study|Withdrawal by Subject|0|||
38066112|NCT03057600|69759854|FG000|Overall Study|Other, Not Specified|1|||
38066113|NCT03057600|69759855|FG001|Overall Study|Other, Not Specified|1|||
38066114|NCT03057600|69759856|FG002|Overall Study|Other, Not Specified|1|||
38066115|NCT03057600|69759857|FG003|Overall Study|Other, Not Specified|1|||
38066116|NCT03371823|69759887|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
38066117|NCT03371823|69759888|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
38066118|NCT02966301|69759903|FG000|Overall Study|Death|2|||
38066119|NCT02966301|69759903|FG000|Overall Study|Withdrawal by Subject|1|||
38066120|NCT03107091|69759907|FG000|Overall Study|Physician Decision|1|||
38066121|NCT03065400|69759921|FG000|Overall Study|Adverse Event|1|||
38066122|NCT03065400|69759921|FG000|Overall Study|Physician Decision|3|||
38066123|NCT03065400|69759921|FG000|Overall Study|Withdrawal by Subject|1|||
38066124|NCT03065400|69759921|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
38066125|NCT03085095|69759927|FG000|Overall Study|Adverse Event|23|||
38066126|NCT03085095|69759928|FG001|Overall Study|Adverse Event|8|||
38066127|NCT03085095|69759927|FG000|Overall Study|Protocol Violation|0|||
38066128|NCT03085095|69759928|FG001|Overall Study|Protocol Violation|1|||
38066129|NCT03085095|69759927|FG000|Overall Study|Lost to Follow-up|2|||
38066130|NCT03085095|69759928|FG001|Overall Study|Lost to Follow-up|1|||
38066131|NCT03085095|69759927|FG000|Overall Study|Withdrawal by Subject|17|||
38066132|NCT03085095|69759928|FG001|Overall Study|Withdrawal by Subject|6|||
38066133|NCT03085095|69759927|FG000|Overall Study|Physician Decision|9|||
38066134|NCT03085095|69759928|FG001|Overall Study|Physician Decision|3|||
38066135|NCT03085095|69759927|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
38066136|NCT03085095|69759928|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
38066137|NCT03085095|69759927|FG000|Overall Study|Did not Receive Study Drug|2|||
38066138|NCT03085095|69759928|FG001|Overall Study|Did not Receive Study Drug|2|||
38066139|NCT03085095|69759927|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
38066140|NCT03085095|69759928|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
38066141|NCT04097301|69759937|FG000|Overall Study|Death|1|||
38066142|NCT04097301|69759937|FG000|Overall Study|Withdrawal by Subject|1|||
38066143|NCT04097301|69759937|FG000|Overall Study|Screening Failure|5|||
38066144|NCT02276547|69759943|FG000|Overall Study|Death|2|||
38066145|NCT02276547|69759943|FG000|Overall Study|Explant|2|||
38066146|NCT02966834|69759953|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
38066147|NCT02966834|69759954|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
38066148|NCT02966834|69759955|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
38066149|NCT02966834|69759956|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
37680390|NCT02580877|69156013|FG001|Overall Study|Adverse Event|1|||
38066150|NCT02966834|69759957|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
38066151|NCT02966834|69759958|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
38066152|NCT02966834|69759953|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
38066153|NCT02966834|69759954|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
38066154|NCT02966834|69759955|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
38066155|NCT02966834|69759956|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
38066156|NCT02966834|69759957|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
38066157|NCT02966834|69759958|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
38066158|NCT02966834|69759953|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
38066159|NCT02966834|69759954|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
38066160|NCT02966834|69759955|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
38066161|NCT02966834|69759956|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
38066162|NCT02966834|69759957|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
38066163|NCT02966834|69759958|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
38066164|NCT02966834|69759953|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
38066165|NCT02966834|69759954|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
38066166|NCT02966834|69759955|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
38066167|NCT02966834|69759956|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
38066168|NCT02966834|69759957|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
38066169|NCT02966834|69759958|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
38066170|NCT02966834|69759953|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
38066171|NCT02966834|69759954|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
38066172|NCT02966834|69759955|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
38066173|NCT02966834|69759956|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
38066174|NCT02966834|69759957|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
38066175|NCT02966834|69759958|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
38066176|NCT02966834|69759953|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
38066177|NCT02966834|69759954|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
38066178|NCT02966834|69759955|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
38066179|NCT02966834|69759956|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
38066180|NCT02966834|69759957|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
38066181|NCT02966834|69759958|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
38066182|NCT03106077|69760007|FG000|Overall Study|Screen Failure|94|||
38066183|NCT03106077|69760008|FG001|Overall Study|Screen Failure|0|||
38066184|NCT03105297|69760013|FG000|Baseline Phase (Day 1)|Other|21|||
38066185|NCT03105297|69760013|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
38066186|NCT03105297|69760013|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
38066187|NCT03426995|69760043|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
38066188|NCT03426995|69760044|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
38066189|NCT03426995|69760045|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
38066190|NCT03426995|69760046|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
38066191|NCT03426995|69760047|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
38066192|NCT03426995|69760048|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
38066193|NCT03426995|69760049|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
38066194|NCT03426995|69760050|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
38066195|NCT03426995|69760051|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
38066196|NCT03426995|69760052|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
38066197|NCT03426995|69760053|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
38066198|NCT03426995|69760054|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
38066199|NCT03426995|69760055|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
38066200|NCT03426995|69760056|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
38066201|NCT03426995|69760057|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
38066202|NCT03426995|69760058|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
38066203|NCT03426995|69760059|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
38066204|NCT03426995|69760060|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
38066205|NCT03426995|69760061|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
38066206|NCT03426995|69760043|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
38066207|NCT03426995|69760044|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
38066208|NCT03426995|69760045|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
38066209|NCT03426995|69760046|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
38066210|NCT03426995|69760047|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
38066211|NCT03426995|69760048|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
38066212|NCT03426995|69760049|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
38066213|NCT03426995|69760050|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
38066214|NCT03426995|69760051|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
38066215|NCT03426995|69760052|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
38066216|NCT03426995|69760053|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
38066217|NCT03426995|69760054|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
38066218|NCT03426995|69760055|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
38066219|NCT03426995|69760056|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
38066220|NCT03426995|69760057|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
38066221|NCT03426995|69760058|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
38066222|NCT03426995|69760059|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
38066223|NCT03426995|69760060|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
38066224|NCT03426995|69760061|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
38066225|NCT03426995|69760043|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
38066226|NCT03426995|69760044|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
38066227|NCT03426995|69760045|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
38066228|NCT03426995|69760046|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
38066229|NCT03426995|69760047|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
38066230|NCT03426995|69760048|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
38066231|NCT03426995|69760049|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
38066232|NCT03426995|69760050|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
38066233|NCT03426995|69760051|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
38066234|NCT03426995|69760052|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
38066235|NCT03426995|69760053|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
38066236|NCT03426995|69760054|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
38066237|NCT03426995|69760055|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
38066238|NCT03426995|69760056|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
38066239|NCT03426995|69760057|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
38066240|NCT03426995|69760058|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
38066241|NCT03426995|69760059|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
38066242|NCT03426995|69760060|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
38066243|NCT03426995|69760061|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
38066244|NCT03426995|69760043|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
38066245|NCT03426995|69760044|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
38066246|NCT03426995|69760045|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
38066247|NCT03426995|69760046|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
38066248|NCT03426995|69760047|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
38066249|NCT03426995|69760048|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
38066250|NCT03426995|69760049|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
38066251|NCT03426995|69760050|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
38066252|NCT03426995|69760051|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
38066253|NCT03426995|69760052|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
38066254|NCT03426995|69760053|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
38066255|NCT03426995|69760054|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
38066256|NCT03426995|69760055|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
38066257|NCT03426995|69760056|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
38066258|NCT03426995|69760057|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
38066259|NCT03426995|69760058|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
38066260|NCT03426995|69760059|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
38066261|NCT03426995|69760060|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
38066262|NCT03426995|69760061|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
38066263|NCT03426995|69760043|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
38066264|NCT03426995|69760044|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
38066265|NCT03426995|69760045|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
38066266|NCT03426995|69760046|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
38066267|NCT03426995|69760047|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
38066268|NCT03426995|69760048|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
38066269|NCT03426995|69760049|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
38066270|NCT03426995|69760050|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
38066271|NCT03426995|69760051|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
38066272|NCT03426995|69760052|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
38066273|NCT03426995|69760053|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
38066274|NCT03426995|69760054|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
38066275|NCT03426995|69760055|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
38066276|NCT03426995|69760056|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
38066277|NCT03426995|69760057|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
38066278|NCT03426995|69760058|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
38066279|NCT03426995|69760059|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
38066280|NCT03426995|69760060|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
38066281|NCT03426995|69760061|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
38066282|NCT03426995|69760043|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
38066283|NCT03426995|69760044|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
38066284|NCT03426995|69760045|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
38066285|NCT03426995|69760046|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
38066286|NCT03426995|69760047|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
38066287|NCT03426995|69760048|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
38066288|NCT03426995|69760049|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
38066289|NCT03426995|69760050|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
38066290|NCT03426995|69760051|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
38066291|NCT03426995|69760052|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
38066292|NCT03426995|69760053|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
38066293|NCT03426995|69760054|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
38066294|NCT03426995|69760055|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
38066295|NCT03426995|69760056|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
38066296|NCT03426995|69760057|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
38066297|NCT03426995|69760058|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
38066298|NCT03426995|69760059|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
38066299|NCT03426995|69760060|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
38066300|NCT03426995|69760061|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
38066301|NCT03426995|69760043|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
38066302|NCT03426995|69760044|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
38066303|NCT03426995|69760045|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
38066304|NCT03426995|69760046|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
38066305|NCT03426995|69760047|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
38066306|NCT03426995|69760048|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
38066307|NCT03426995|69760049|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
38066308|NCT03426995|69760050|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
38066309|NCT03426995|69760051|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
38066310|NCT03426995|69760052|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
38066311|NCT03426995|69760053|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
38066312|NCT03426995|69760054|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
38066313|NCT03426995|69760055|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
38066314|NCT03426995|69760056|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
38066315|NCT03426995|69760057|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
38066316|NCT03426995|69760058|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
38066317|NCT03426995|69760059|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
38066318|NCT03426995|69760060|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
38066319|NCT03426995|69760061|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
38066320|NCT03424265|69760110|FG000|Overall Study|screening failure|1|||
38066321|NCT03424265|69760111|FG001|Overall Study|screening failure|0|||
38066322|NCT03424265|69760110|FG000|Overall Study|Withdrawal by Subject|0|||
38066323|NCT03424265|69760111|FG001|Overall Study|Withdrawal by Subject|2|||
38066324|NCT03322566|69760120|FG000|Overall Study|Death|34|||
38066325|NCT03322566|69760121|FG001|Overall Study|Death|35|||
38066326|NCT03322566|69760122|FG002|Overall Study|Death|23|||
38066327|NCT03322566|69760120|FG000|Overall Study|Physician Decision|6|||
38066328|NCT03322566|69760121|FG001|Overall Study|Physician Decision|7|||
38066329|NCT03322566|69760122|FG002|Overall Study|Physician Decision|2|||
38066330|NCT03322566|69760120|FG000|Overall Study|Withdrawal by Subject|4|||
38066331|NCT03322566|69760121|FG001|Overall Study|Withdrawal by Subject|3|||
38066332|NCT03322566|69760122|FG002|Overall Study|Withdrawal by Subject|6|||
38066333|NCT03322566|69760120|FG000|Overall Study|Lost to Follow-up|0|||
38066334|NCT03322566|69760121|FG001|Overall Study|Lost to Follow-up|0|||
38066335|NCT03322566|69760122|FG002|Overall Study|Lost to Follow-up|1|||
38066336|NCT03322566|69760120|FG000|Overall Study|Study terminated by sponsor|1|||
38066337|NCT03322566|69760121|FG001|Overall Study|Study terminated by sponsor|0|||
38066338|NCT03322566|69760122|FG002|Overall Study|Study terminated by sponsor|1|||
38066339|NCT02969018|69760138|FG000|Overall Study|Adverse Event|2|||
38066340|NCT02969018|69760139|FG001|Overall Study|Adverse Event|4|||
38066341|NCT02969018|69760140|FG002|Overall Study|Adverse Event|1|||
38066342|NCT02969018|69760141|FG003|Overall Study|Adverse Event|2|||
37680391|NCT02582983|69156029|FG000|Overall Study|Death|3|||
38066343|NCT02969018|69760142|FG004|Overall Study|Adverse Event|0|||
38066344|NCT02969018|69760143|FG005|Overall Study|Adverse Event|1|||
38066345|NCT02969018|69760144|FG006|Overall Study|Adverse Event|2|||
38066346|NCT02969018|69760145|FG007|Overall Study|Adverse Event|0|||
38066347|NCT02969018|69760138|FG000|Overall Study|Lack of Efficacy|0|||
38066348|NCT02969018|69760139|FG001|Overall Study|Lack of Efficacy|1|||
38066349|NCT02969018|69760140|FG002|Overall Study|Lack of Efficacy|0|||
38066350|NCT02969018|69760141|FG003|Overall Study|Lack of Efficacy|0|||
38066351|NCT02969018|69760142|FG004|Overall Study|Lack of Efficacy|1|||
38066352|NCT02969018|69760143|FG005|Overall Study|Lack of Efficacy|1|||
38066353|NCT02969018|69760144|FG006|Overall Study|Lack of Efficacy|1|||
38066354|NCT02969018|69760145|FG007|Overall Study|Lack of Efficacy|1|||
38066355|NCT02969018|69760138|FG000|Overall Study|Lost to Follow-up|1|||
38066356|NCT02969018|69760139|FG001|Overall Study|Lost to Follow-up|2|||
38066357|NCT02969018|69760140|FG002|Overall Study|Lost to Follow-up|2|||
38066358|NCT02969018|69760141|FG003|Overall Study|Lost to Follow-up|0|||
38066359|NCT02969018|69760142|FG004|Overall Study|Lost to Follow-up|1|||
38066360|NCT02969018|69760143|FG005|Overall Study|Lost to Follow-up|1|||
38066361|NCT02969018|69760144|FG006|Overall Study|Lost to Follow-up|0|||
38066362|NCT02969018|69760145|FG007|Overall Study|Lost to Follow-up|1|||
38066363|NCT02969018|69760138|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
38066364|NCT02969018|69760139|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
38066365|NCT02969018|69760140|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
38066366|NCT02969018|69760141|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
38066367|NCT02969018|69760142|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
38066368|NCT02969018|69760143|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
38066369|NCT02969018|69760144|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
38066370|NCT02969018|69760145|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
38066371|NCT02969018|69760138|FG000|Overall Study|Non-Compliance With Study Drug|1|||
38066372|NCT02969018|69760139|FG001|Overall Study|Non-Compliance With Study Drug|0|||
38066373|NCT02969018|69760140|FG002|Overall Study|Non-Compliance With Study Drug|0|||
38066374|NCT02969018|69760141|FG003|Overall Study|Non-Compliance With Study Drug|0|||
38066375|NCT02969018|69760142|FG004|Overall Study|Non-Compliance With Study Drug|0|||
38066376|NCT02969018|69760143|FG005|Overall Study|Non-Compliance With Study Drug|0|||
38066377|NCT02969018|69760144|FG006|Overall Study|Non-Compliance With Study Drug|0|||
38066378|NCT02969018|69760145|FG007|Overall Study|Non-Compliance With Study Drug|0|||
38066379|NCT02969018|69760138|FG000|Overall Study|Other|0|||
38066380|NCT02969018|69760139|FG001|Overall Study|Other|0|||
38066381|NCT02969018|69760140|FG002|Overall Study|Other|0|||
38066382|NCT02969018|69760141|FG003|Overall Study|Other|1|||
38066383|NCT02969018|69760142|FG004|Overall Study|Other|0|||
38066384|NCT02969018|69760143|FG005|Overall Study|Other|0|||
38066385|NCT02969018|69760144|FG006|Overall Study|Other|0|||
38066386|NCT02969018|69760145|FG007|Overall Study|Other|2|||
38066387|NCT02969018|69760138|FG000|Overall Study|Pregnancy|0|||
38066388|NCT02969018|69760139|FG001|Overall Study|Pregnancy|0|||
38066389|NCT02969018|69760140|FG002|Overall Study|Pregnancy|0|||
38066390|NCT02969018|69760141|FG003|Overall Study|Pregnancy|0|||
38066391|NCT02969018|69760142|FG004|Overall Study|Pregnancy|0|||
38066392|NCT02969018|69760143|FG005|Overall Study|Pregnancy|1|||
38066393|NCT02969018|69760144|FG006|Overall Study|Pregnancy|0|||
38066394|NCT02969018|69760145|FG007|Overall Study|Pregnancy|0|||
38066395|NCT02969018|69760138|FG000|Overall Study|Protocol Violation|0|||
38066396|NCT02969018|69760139|FG001|Overall Study|Protocol Violation|0|||
38066397|NCT02969018|69760140|FG002|Overall Study|Protocol Violation|1|||
38066398|NCT02969018|69760141|FG003|Overall Study|Protocol Violation|1|||
38066399|NCT02969018|69760142|FG004|Overall Study|Protocol Violation|0|||
38066400|NCT02969018|69760143|FG005|Overall Study|Protocol Violation|0|||
38066401|NCT02969018|69760144|FG006|Overall Study|Protocol Violation|0|||
38066402|NCT02969018|69760145|FG007|Overall Study|Protocol Violation|0|||
38066403|NCT02969018|69760138|FG000|Overall Study|Withdrawal by Subject|0|||
38066404|NCT02969018|69760139|FG001|Overall Study|Withdrawal by Subject|1|||
38066405|NCT02969018|69760140|FG002|Overall Study|Withdrawal by Subject|2|||
38066406|NCT02969018|69760141|FG003|Overall Study|Withdrawal by Subject|1|||
38066407|NCT02969018|69760142|FG004|Overall Study|Withdrawal by Subject|0|||
38066408|NCT02969018|69760143|FG005|Overall Study|Withdrawal by Subject|4|||
38066409|NCT02969018|69760144|FG006|Overall Study|Withdrawal by Subject|4|||
38066410|NCT02969018|69760145|FG007|Overall Study|Withdrawal by Subject|3|||
38066411|NCT01319721|69760168|FG000|Overall Study|Lost to Follow-up|1|||
38066412|NCT01319721|69760169|FG001|Overall Study|Lost to Follow-up|6|||
38066413|NCT02905032|69760178|FG000|Overall Study|Withdrawal by Subject|2|||
38066414|NCT02905032|69760179|FG001|Overall Study|Withdrawal by Subject|0|||
38066415|NCT02905032|69760180|FG002|Overall Study|Withdrawal by Subject|0|||
38066416|NCT02905032|69760178|FG000|Overall Study|Protocol Violation|6|||
38066417|NCT02905032|69760179|FG001|Overall Study|Protocol Violation|12|||
38066418|NCT02905032|69760180|FG002|Overall Study|Protocol Violation|0|||
38066419|NCT03259425|69760187|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
38066420|NCT03101241|69760193|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
38066421|NCT03101241|69760194|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
38066422|NCT03101241|69760193|FG000|Overall Study|Participant withdrew consent|3|||
38066423|NCT03101241|69760194|FG001|Overall Study|Participant withdrew consent|1|||
38066424|NCT03101241|69760193|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
38066425|NCT03101241|69760194|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
38066426|NCT03101241|69760193|FG000|Overall Study|Lost to Follow-up|2|||
38066427|NCT03101241|69760194|FG001|Overall Study|Lost to Follow-up|0|||
38066428|NCT03101241|69760193|FG000|Overall Study|Lack of Efficacy|0|||
38066429|NCT03101241|69760194|FG001|Overall Study|Lack of Efficacy|1|||
38066430|NCT03101241|69760193|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
38066431|NCT03101241|69760194|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
38066432|NCT03061188|69760204|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
38066433|NCT03061188|69760205|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
38066434|NCT03061188|69760206|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
38066435|NCT03061188|69760207|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
38066436|NCT03061188|69760204|FG000|On Follow-up for 3 Years|Death|0|||
38066437|NCT03061188|69760205|FG001|On Follow-up for 3 Years|Death|3|||
38066438|NCT03061188|69760206|FG002|On Follow-up for 3 Years|Death|5|||
38066439|NCT03061188|69760207|FG003|On Follow-up for 3 Years|Death|2|||
38066440|NCT03061188|69760204|FG000|On Follow-up for 3 Years|Still in follow-up|0|||
38066441|NCT03061188|69760205|FG001|On Follow-up for 3 Years|Still in follow-up|0|||
38066442|NCT03061188|69760206|FG002|On Follow-up for 3 Years|Still in follow-up|0|||
38066443|NCT03061188|69760207|FG003|On Follow-up for 3 Years|Still in follow-up|3|||
38066444|NCT03449147|69760225|FG000|52-week Treatment Period|Death|0|||
38066445|NCT03449147|69760226|FG001|52-week Treatment Period|Death|1|||
38066446|NCT03449147|69760227|FG002|52-week Treatment Period|Death|0|||
38066447|NCT03449147|69760225|FG000|52-week Treatment Period|Lost to Follow-up|6|||
38066448|NCT03449147|69760226|FG001|52-week Treatment Period|Lost to Follow-up|2|||
38066449|NCT03449147|69760227|FG002|52-week Treatment Period|Lost to Follow-up|5|||
38066450|NCT03449147|69760225|FG000|52-week Treatment Period|Other|0|||
38066451|NCT03449147|69760226|FG001|52-week Treatment Period|Other|1|||
38066452|NCT03449147|69760227|FG002|52-week Treatment Period|Other|2|||
38066453|NCT03449147|69760225|FG000|52-week Treatment Period|Physician Decision|1|||
38066454|NCT03449147|69760226|FG001|52-week Treatment Period|Physician Decision|0|||
38066455|NCT03449147|69760227|FG002|52-week Treatment Period|Physician Decision|3|||
38066456|NCT03449147|69760225|FG000|52-week Treatment Period|Screen Failure|1|||
38066457|NCT03449147|69760226|FG001|52-week Treatment Period|Screen Failure|2|||
38066458|NCT03449147|69760227|FG002|52-week Treatment Period|Screen Failure|0|||
38066459|NCT03449147|69760225|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
38066460|NCT03449147|69760226|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
38066461|NCT03449147|69760227|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
38066462|NCT03449147|69760225|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
38066463|NCT03449147|69760226|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
38066464|NCT03449147|69760227|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
38066465|NCT03449147|69760225|FG000|12-Week Off-Treatment Durability Period|Other|0|||
38066466|NCT03449147|69760226|FG001|12-Week Off-Treatment Durability Period|Other|1|||
38066467|NCT03449147|69760227|FG002|12-Week Off-Treatment Durability Period|Other|0|||
38066468|NCT03423173|69760243|FG000|Overall Study|Randomized but not vaccinated|1|||
38066469|NCT03423173|69760244|FG001|Overall Study|Randomized but not vaccinated|0|||
38066470|NCT03423173|69760245|FG002|Overall Study|Randomized but not vaccinated|2|||
38066471|NCT03423173|69760246|FG003|Overall Study|Randomized but not vaccinated|1|||
38066472|NCT03423173|69760243|FG000|Overall Study|Adverse Event|1|||
38066473|NCT03423173|69760244|FG001|Overall Study|Adverse Event|1|||
38066474|NCT03423173|69760245|FG002|Overall Study|Adverse Event|1|||
38066475|NCT03423173|69760246|FG003|Overall Study|Adverse Event|1|||
38066476|NCT03423173|69760243|FG000|Overall Study|Lost to Follow-up|10|||
38066477|NCT03423173|69760244|FG001|Overall Study|Lost to Follow-up|19|||
38066478|NCT03423173|69760245|FG002|Overall Study|Lost to Follow-up|17|||
38066479|NCT03423173|69760246|FG003|Overall Study|Lost to Follow-up|22|||
38066480|NCT03423173|69760243|FG000|Overall Study|Withdrawal of consent|4|||
38066481|NCT03423173|69760244|FG001|Overall Study|Withdrawal of consent|10|||
38066482|NCT03423173|69760245|FG002|Overall Study|Withdrawal of consent|4|||
38066483|NCT03423173|69760246|FG003|Overall Study|Withdrawal of consent|5|||
38066484|NCT03423173|69760243|FG000|Overall Study|Death|1|||
38066485|NCT03423173|69760244|FG001|Overall Study|Death|0|||
38066486|NCT03423173|69760245|FG002|Overall Study|Death|0|||
38066487|NCT03423173|69760246|FG003|Overall Study|Death|0|||
38066488|NCT03423173|69760243|FG000|Overall Study|Reason not Specified|2|||
38066489|NCT03423173|69760244|FG001|Overall Study|Reason not Specified|5|||
38066490|NCT03423173|69760245|FG002|Overall Study|Reason not Specified|3|||
38066491|NCT03423173|69760246|FG003|Overall Study|Reason not Specified|1|||
38066492|NCT03447821|69760259|FG000|Overall Study|Withdrawal by Subject|1|||
38066493|NCT03447821|69760260|FG001|Overall Study|Withdrawal by Subject|1|||
38066494|NCT03447821|69760261|FG002|Overall Study|Withdrawal by Subject|0|||
38066495|NCT03447821|69760259|FG000|Overall Study|Lost to Follow-up|0|||
38066496|NCT03447821|69760260|FG001|Overall Study|Lost to Follow-up|0|||
38066497|NCT03447821|69760261|FG002|Overall Study|Lost to Follow-up|1|||
38066498|NCT03447353|69760275|FG000|Overall Study|Failure at Screening Visit|2|||
38066499|NCT03447353|69760275|FG000|Overall Study|Lost to Follow-up|4|||
38066500|NCT03447353|69760275|FG000|Overall Study|Scheduling Conflicts|3|||
38066501|NCT03447353|69760275|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
38066502|NCT03446885|69760285|FG000|Overall Study|Lost to Follow-up|1|||
38066503|NCT03446885|69760286|FG001|Overall Study|Lost to Follow-up|0|||
38066504|NCT03446885|69760285|FG000|Overall Study|Did not complete entire visit|1|||
38066505|NCT03446885|69760286|FG001|Overall Study|Did not complete entire visit|0|||
38066506|NCT00710970|69760294|FG000|Overall Study|Never took drug|3|||
38066507|NCT03421379|69760300|FG000|Period 1|Withdrawal by Subject|0|||
38066508|NCT03421379|69760301|FG001|Period 1|Withdrawal by Subject|1|||
38066509|NCT03421379|69760300|FG000|Period 1|Physician Decision|1|||
38066510|NCT03421379|69760301|FG001|Period 1|Physician Decision|1|||
38066511|NCT03421379|69760300|FG000|Period 1|Did not receive treatment|1|||
38066512|NCT03421379|69760301|FG001|Period 1|Did not receive treatment|2|||
38066513|NCT02900378|69760309|FG000|Randomization (Visit 2)|Adverse Event|14|||
38066514|NCT02900378|69760310|FG001|Randomization (Visit 2)|Adverse Event|11|||
38066515|NCT02900378|69760309|FG000|Randomization (Visit 2)|Death|1|||
38066516|NCT02900378|69760310|FG001|Randomization (Visit 2)|Death|4|||
38066517|NCT02900378|69760309|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
38066518|NCT02900378|69760310|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
38066519|NCT02900378|69760309|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
38066520|NCT02900378|69760310|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
38066521|NCT02900378|69760309|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
38066522|NCT02900378|69760310|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
38066523|NCT02900378|69760309|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
38066524|NCT02900378|69760310|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
38066525|NCT02900378|69760309|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
38066526|NCT02900378|69760310|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
38066527|NCT03058692|69760318|FG000|Overall Study|Lost to Follow-up|2|||
38066528|NCT03058692|69760319|FG001|Overall Study|Lost to Follow-up|1|||
38066529|NCT03058692|69760318|FG000|Overall Study|Withdrawal by Subject|1|||
38066530|NCT03058692|69760319|FG001|Overall Study|Withdrawal by Subject|1|||
38066531|NCT02964338|69760329|FG000|Overall Study|Sponsor terminated study for futility|12|||
38066532|NCT02964338|69760330|FG001|Overall Study|Sponsor terminated study for futility|15|||
38066533|NCT02964338|69760331|FG002|Overall Study|Sponsor terminated study for futility|14|||
38066534|NCT02964338|69760329|FG000|Overall Study|Lack of Efficacy|0|||
38066535|NCT02964338|69760330|FG001|Overall Study|Lack of Efficacy|3|||
38066536|NCT02964338|69760331|FG002|Overall Study|Lack of Efficacy|0|||
38066537|NCT02964338|69760329|FG000|Overall Study|Lost to Follow-up|1|||
38066538|NCT02964338|69760330|FG001|Overall Study|Lost to Follow-up|0|||
38066539|NCT02964338|69760331|FG002|Overall Study|Lost to Follow-up|3|||
38066540|NCT02964338|69760329|FG000|Overall Study|Protocol Violation|0|||
38066541|NCT02964338|69760330|FG001|Overall Study|Protocol Violation|1|||
38066542|NCT02964338|69760331|FG002|Overall Study|Protocol Violation|0|||
38066543|NCT02964338|69760329|FG000|Overall Study|Withdrawal by Subject|1|||
38066544|NCT02964338|69760330|FG001|Overall Study|Withdrawal by Subject|3|||
38066545|NCT02964338|69760331|FG002|Overall Study|Withdrawal by Subject|1|||
38066546|NCT02964338|69760329|FG000|Overall Study|Adverse Event|2|||
38066547|NCT02964338|69760330|FG001|Overall Study|Adverse Event|1|||
38066548|NCT02964338|69760331|FG002|Overall Study|Adverse Event|1|||
38066549|NCT02964338|69760329|FG000|Overall Study|Non-compliant with e-diary|0|||
38066550|NCT02964338|69760330|FG001|Overall Study|Non-compliant with e-diary|1|||
38066551|NCT02964338|69760331|FG002|Overall Study|Non-compliant with e-diary|0|||
38066552|NCT02964338|69760329|FG000|Overall Study|Did not meet criteria|1|||
38066553|NCT02964338|69760330|FG001|Overall Study|Did not meet criteria|0|||
38066554|NCT02964338|69760331|FG002|Overall Study|Did not meet criteria|0|||
38066555|NCT03056352|69760339|FG000|Overall Study|Lost to Follow-up|1|||
38066556|NCT02898662|69760345|FG000|Overall Study|Adverse Event|1|||
38066557|NCT02898662|69760346|FG001|Overall Study|Adverse Event|0|||
38066558|NCT02898662|69760345|FG000|Overall Study|Loss of asthma control|23|||
38066559|NCT02898662|69760346|FG001|Overall Study|Loss of asthma control|24|||
37965810|NCT00044083|69652780|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
37965811|NCT00044083|69652781|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
37965812|NCT00044083|69652780|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
37965813|NCT00044083|69652781|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
37965814|NCT00044083|69652780|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
37965815|NCT00044083|69652781|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
37965816|NCT00044083|69652780|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
37965817|NCT00044083|69652781|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
37965818|NCT00044083|69652780|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
37965819|NCT00044083|69652781|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
38066560|NCT02898662|69760345|FG000|Overall Study|Withdrawal by Subject|4|||
38066561|NCT02898662|69760346|FG001|Overall Study|Withdrawal by Subject|1|||
38066562|NCT02898662|69760345|FG000|Overall Study|Technical issue|0|||
38066563|NCT02898662|69760346|FG001|Overall Study|Technical issue|1|||
38066564|NCT02898662|69760345|FG000|Overall Study|Randomized in error|0|||
38066565|NCT02898662|69760346|FG001|Overall Study|Randomized in error|1|||
38066566|NCT02898662|69760345|FG000|Overall Study|Subject decision|1|||
38066567|NCT02898662|69760346|FG001|Overall Study|Subject decision|0|||
38066568|NCT02898662|69760345|FG000|Overall Study|Other|0|||
38066569|NCT02898662|69760346|FG001|Overall Study|Other|1|||
38066570|NCT03055338|69760355|FG000|Overall Study|Lost to Follow-up|9|||
38066571|NCT03055338|69760356|FG001|Overall Study|Lost to Follow-up|2|||
38066572|NCT03055338|69760357|FG002|Overall Study|Lost to Follow-up|3|||
38066573|NCT03055338|69760355|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
38066574|NCT03055338|69760356|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
38066575|NCT03055338|69760357|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
38066576|NCT03055338|69760355|FG000|Overall Study|Physician Decision|0|||
38066577|NCT03055338|69760356|FG001|Overall Study|Physician Decision|0|||
38066578|NCT03055338|69760357|FG002|Overall Study|Physician Decision|2|||
38066579|NCT03055338|69760355|FG000|Overall Study|Withdrawal by Subject|9|||
38066580|NCT03055338|69760356|FG001|Overall Study|Withdrawal by Subject|8|||
38066581|NCT03055338|69760357|FG002|Overall Study|Withdrawal by Subject|7|||
38066582|NCT03913130|69760365|FG000|Overall Study|Sponsor Decision|1|||
38066583|NCT03419741|69760371|FG000|Overall Study|Adverse Event|1|||
38066584|NCT03419741|69760372|FG001|Overall Study|Adverse Event|0|||
38066585|NCT03419741|69760371|FG000|Overall Study|Withdrawal by Subject|1|||
38066586|NCT03419741|69760372|FG001|Overall Study|Withdrawal by Subject|2|||
38066587|NCT02896400|69760394|FG000|1 Month Follow-up|Lost to Follow-up|7|||
38066588|NCT02896400|69760395|FG001|1 Month Follow-up|Lost to Follow-up|7|||
38066589|NCT02896400|69760396|FG002|1 Month Follow-up|Lost to Follow-up|5|||
38066590|NCT02896400|69760397|FG003|1 Month Follow-up|Lost to Follow-up|8|||
38066591|NCT02896400|69760398|FG004|1 Month Follow-up|Lost to Follow-up|9|||
38066592|NCT02896400|69760399|FG005|1 Month Follow-up|Lost to Follow-up|6|||
38066593|NCT02896400|69760400|FG006|1 Month Follow-up|Lost to Follow-up|5|||
38066594|NCT02896400|69760401|FG007|1 Month Follow-up|Lost to Follow-up|6|||
38066595|NCT02896400|69760402|FG008|1 Month Follow-up|Lost to Follow-up|4|||
38066596|NCT02896400|69760403|FG009|1 Month Follow-up|Lost to Follow-up|7|||
38066597|NCT02896400|69760404|FG010|1 Month Follow-up|Lost to Follow-up|5|||
38066598|NCT02896400|69760405|FG011|1 Month Follow-up|Lost to Follow-up|5|||
38066599|NCT02896400|69760406|FG012|1 Month Follow-up|Lost to Follow-up|3|||
38066600|NCT02896400|69760407|FG013|1 Month Follow-up|Lost to Follow-up|4|||
38066601|NCT02896400|69760408|FG014|1 Month Follow-up|Lost to Follow-up|1|||
38066602|NCT02896400|69760409|FG015|1 Month Follow-up|Lost to Follow-up|2|||
38066603|NCT02896400|69760394|FG000|1 Month Follow-up|Death|0|||
38066604|NCT02896400|69760395|FG001|1 Month Follow-up|Death|0|||
38066605|NCT02896400|69760396|FG002|1 Month Follow-up|Death|0|||
38066606|NCT02896400|69760397|FG003|1 Month Follow-up|Death|0|||
38066607|NCT02896400|69760398|FG004|1 Month Follow-up|Death|0|||
38066608|NCT02896400|69760399|FG005|1 Month Follow-up|Death|0|||
38066609|NCT02896400|69760400|FG006|1 Month Follow-up|Death|0|||
38066610|NCT02896400|69760401|FG007|1 Month Follow-up|Death|0|||
37965820|NCT00044083|69652780|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
38066611|NCT02896400|69760402|FG008|1 Month Follow-up|Death|0|||
38066612|NCT02896400|69760403|FG009|1 Month Follow-up|Death|0|||
38066613|NCT02896400|69760404|FG010|1 Month Follow-up|Death|0|||
38066614|NCT02896400|69760405|FG011|1 Month Follow-up|Death|0|||
38066615|NCT02896400|69760406|FG012|1 Month Follow-up|Death|0|||
38066616|NCT02896400|69760407|FG013|1 Month Follow-up|Death|0|||
38066617|NCT02896400|69760408|FG014|1 Month Follow-up|Death|0|||
38066618|NCT02896400|69760409|FG015|1 Month Follow-up|Death|1|||
38066619|NCT02896400|69760394|FG000|3 Month Follow-up|Lost to Follow-up|6|||
38066620|NCT02896400|69760395|FG001|3 Month Follow-up|Lost to Follow-up|3|||
38066621|NCT02896400|69760396|FG002|3 Month Follow-up|Lost to Follow-up|6|||
38066622|NCT02896400|69760397|FG003|3 Month Follow-up|Lost to Follow-up|11|||
38066623|NCT02896400|69760398|FG004|3 Month Follow-up|Lost to Follow-up|12|||
38066624|NCT02896400|69760399|FG005|3 Month Follow-up|Lost to Follow-up|6|||
38066625|NCT02896400|69760400|FG006|3 Month Follow-up|Lost to Follow-up|4|||
38066626|NCT02896400|69760401|FG007|3 Month Follow-up|Lost to Follow-up|3|||
38066627|NCT02896400|69760402|FG008|3 Month Follow-up|Lost to Follow-up|6|||
38066628|NCT02896400|69760403|FG009|3 Month Follow-up|Lost to Follow-up|5|||
38066629|NCT02896400|69760404|FG010|3 Month Follow-up|Lost to Follow-up|6|||
38066630|NCT02896400|69760405|FG011|3 Month Follow-up|Lost to Follow-up|6|||
38066631|NCT02896400|69760406|FG012|3 Month Follow-up|Lost to Follow-up|3|||
38066632|NCT02896400|69760407|FG013|3 Month Follow-up|Lost to Follow-up|5|||
38066633|NCT02896400|69760408|FG014|3 Month Follow-up|Lost to Follow-up|3|||
38066634|NCT02896400|69760409|FG015|3 Month Follow-up|Lost to Follow-up|2|||
38066635|NCT02896400|69760394|FG000|3 Month Follow-up|Death|0|||
38066636|NCT02896400|69760395|FG001|3 Month Follow-up|Death|0|||
38066637|NCT02896400|69760396|FG002|3 Month Follow-up|Death|0|||
38066638|NCT02896400|69760397|FG003|3 Month Follow-up|Death|0|||
38066639|NCT02896400|69760398|FG004|3 Month Follow-up|Death|0|||
38066640|NCT02896400|69760399|FG005|3 Month Follow-up|Death|0|||
38066641|NCT02896400|69760400|FG006|3 Month Follow-up|Death|0|||
38066642|NCT02896400|69760401|FG007|3 Month Follow-up|Death|0|||
38066643|NCT02896400|69760402|FG008|3 Month Follow-up|Death|0|||
38066644|NCT02896400|69760403|FG009|3 Month Follow-up|Death|0|||
38066645|NCT02896400|69760404|FG010|3 Month Follow-up|Death|0|||
38066646|NCT02896400|69760405|FG011|3 Month Follow-up|Death|0|||
38066647|NCT02896400|69760406|FG012|3 Month Follow-up|Death|0|||
38066648|NCT02896400|69760407|FG013|3 Month Follow-up|Death|1|||
38066649|NCT02896400|69760408|FG014|3 Month Follow-up|Death|1|||
38066650|NCT02896400|69760409|FG015|3 Month Follow-up|Death|0|||
38066651|NCT02896400|69760394|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
38066652|NCT02896400|69760395|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
38066653|NCT02896400|69760396|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
38066654|NCT02896400|69760397|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
38066655|NCT02896400|69760398|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
38066656|NCT02896400|69760399|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
38066657|NCT02896400|69760400|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
38066658|NCT02896400|69760401|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
38066659|NCT02896400|69760402|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
38066660|NCT02896400|69760403|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
38066661|NCT02896400|69760404|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
38066662|NCT02896400|69760405|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
38066663|NCT02896400|69760406|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
38066664|NCT02896400|69760407|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
38066665|NCT02896400|69760408|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
38066666|NCT02896400|69760409|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
38066667|NCT02896400|69760394|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
38066668|NCT02896400|69760395|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
38066669|NCT02896400|69760396|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
38066670|NCT02896400|69760397|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
38066671|NCT02896400|69760398|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
38066672|NCT02896400|69760399|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
38066673|NCT02896400|69760400|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
38066674|NCT02896400|69760401|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
38066675|NCT02896400|69760402|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
38066676|NCT02896400|69760403|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
38066677|NCT02896400|69760404|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
38066678|NCT02896400|69760405|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
38066679|NCT02896400|69760406|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
38066680|NCT02896400|69760407|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
38066681|NCT02896400|69760408|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
38066682|NCT02896400|69760409|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
38066683|NCT03405935|69760435|FG000|Overall Study|Adverse Event|3|||
38066684|NCT03405935|69760435|FG000|Overall Study|Death|2|||
38066685|NCT03405935|69760435|FG000|Overall Study|Withdrawal by Subject|1|||
38066686|NCT03405935|69760435|FG000|Overall Study|Lost to Follow-up|2|||
38066687|NCT03055260|69760441|FG000|Overall Study|Withdrawal by Subject|1|||
38066688|NCT03055260|69760442|FG001|Overall Study|Withdrawal by Subject|0|||
38066689|NCT03404843|69760450|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
38066690|NCT03404843|69760451|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
38066691|NCT03444155|69760475|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
38066692|NCT03444155|69760476|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
38066693|NCT02898116|69760482|FG000|Overall Study|Adverse Event|1|||
38066694|NCT02898116|69760482|FG000|Overall Study|Progressive disease|1|||
38066695|NCT03658304|69760486|FG000|Overall Study|participants still on follow up|8|||
38066696|NCT03422159|69760492|FG000|Overall Study|Exclusion due to terminal disease|2|||
38066697|NCT03422159|69760493|FG001|Overall Study|Exclusion due to terminal disease|1|||
38066698|NCT03403751|69760503|FG000|Overall Study|Death|5|||
38066699|NCT03403751|69760504|FG001|Overall Study|Death|6|||
38066700|NCT03403751|69760503|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
38066701|NCT03403751|69760504|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
38066702|NCT02297412|69760514|FG000|Overall Study|Canceled|1|||
38066703|NCT02297412|69760515|FG001|Overall Study|Canceled|1|||
38066704|NCT03418727|69760524|FG000|Overall Study|Adverse Event|1|||
38066705|NCT03418727|69760525|FG001|Overall Study|Adverse Event|2|||
38066706|NCT03418727|69760526|FG002|Overall Study|Adverse Event|0|||
38066707|NCT03418727|69760524|FG000|Overall Study|Withdrawal by Subject|0|||
38066708|NCT03418727|69760525|FG001|Overall Study|Withdrawal by Subject|0|||
38066709|NCT03418727|69760526|FG002|Overall Study|Withdrawal by Subject|2|||
38066710|NCT03418571|69760536|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
38066711|NCT03418571|69760537|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
38066712|NCT03402893|69760543|FG000|Overall Study|Withdrawal by Subject|1|||
38066713|NCT03442985|69760551|FG000|Overall Study|Sponsor Request|55|||
38066714|NCT03442985|69760552|FG001|Overall Study|Sponsor Request|60|||
38066715|NCT03442985|69760553|FG002|Overall Study|Sponsor Request|54|||
38066716|NCT03442985|69760551|FG000|Overall Study|Lost to Follow-up|5|||
38066717|NCT03442985|69760552|FG001|Overall Study|Lost to Follow-up|2|||
38066718|NCT03442985|69760553|FG002|Overall Study|Lost to Follow-up|7|||
38066719|NCT03442985|69760551|FG000|Overall Study|Withdrawal by Subject|2|||
38066720|NCT03442985|69760552|FG001|Overall Study|Withdrawal by Subject|3|||
38066721|NCT03442985|69760553|FG002|Overall Study|Withdrawal by Subject|4|||
38066722|NCT03442985|69760551|FG000|Overall Study|Adverse Event|0|||
38066723|NCT03442985|69760552|FG001|Overall Study|Adverse Event|1|||
38066724|NCT03442985|69760553|FG002|Overall Study|Adverse Event|0|||
38066725|NCT01318122|69760565|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
38066726|NCT01318122|69760566|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
38066727|NCT01318122|69760567|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
38066728|NCT01318122|69760568|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
38066729|NCT01318122|69760565|FG000|Enrolled - Long-Term Extension Study|Other|1|||
38066730|NCT01318122|69760566|FG001|Enrolled - Long-Term Extension Study|Other|0|||
38066731|NCT01318122|69760567|FG002|Enrolled - Long-Term Extension Study|Other|0|||
38066732|NCT01318122|69760568|FG003|Enrolled - Long-Term Extension Study|Other|0|||
38066733|NCT01318122|69760565|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
38066734|NCT01318122|69760566|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
38066735|NCT01318122|69760567|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
38066736|NCT01318122|69760568|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
38066737|NCT01318122|69760565|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
38066738|NCT01318122|69760566|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
38066739|NCT01318122|69760567|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
38066740|NCT01318122|69760568|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
38066741|NCT01318122|69760565|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
38066742|NCT01318122|69760566|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
38066743|NCT01318122|69760567|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
38066744|NCT01318122|69760568|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
38066745|NCT01318122|69760565|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
38066746|NCT01318122|69760566|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
38066747|NCT01318122|69760567|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
38066748|NCT01318122|69760568|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
38066749|NCT02954159|69760576|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
38066750|NCT02954159|69760577|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
38066751|NCT02954159|69760576|FG000|Overall Study|Withdrawal by Subject|0|||
38066752|NCT02954159|69760577|FG001|Overall Study|Withdrawal by Subject|1|||
38066753|NCT03442829|69760585|FG000|Overall Study|Scheduling clash|3|||
38066754|NCT03442829|69760586|FG001|Overall Study|Scheduling clash|1|||
38066755|NCT03442829|69760585|FG000|Overall Study|Illness unrelated to study|1|||
38066756|NCT03442829|69760586|FG001|Overall Study|Illness unrelated to study|1|||
38066757|NCT03442595|69760594|FG000|Overall Study|Lost to Follow-up|94|||
38066758|NCT03442595|69760595|FG001|Overall Study|Lost to Follow-up|0|||
38066759|NCT03440411|69760604|FG000|Overall Study|Adverse Event|0|||
38066760|NCT03440411|69760605|FG001|Overall Study|Adverse Event|0|||
38066761|NCT03440411|69760606|FG002|Overall Study|Adverse Event|1|||
38066762|NCT03440411|69760607|FG003|Overall Study|Adverse Event|0|||
38066763|NCT03440411|69760604|FG000|Overall Study|PD|2|||
38066764|NCT03440411|69760605|FG001|Overall Study|PD|1|||
38066765|NCT03440411|69760606|FG002|Overall Study|PD|1|||
38066766|NCT03440411|69760607|FG003|Overall Study|PD|1|||
38066767|NCT03440411|69760604|FG000|Overall Study|Withdrawal by Subject|1|||
38066768|NCT03440411|69760605|FG001|Overall Study|Withdrawal by Subject|0|||
38066769|NCT03440411|69760606|FG002|Overall Study|Withdrawal by Subject|0|||
38066770|NCT03440411|69760607|FG003|Overall Study|Withdrawal by Subject|0|||
38066771|NCT03440411|69760604|FG000|Overall Study|Closed study by sponsor|0|||
38066772|NCT03440411|69760605|FG001|Overall Study|Closed study by sponsor|0|||
38066773|NCT03440411|69760606|FG002|Overall Study|Closed study by sponsor|0|||
38066774|NCT03440411|69760607|FG003|Overall Study|Closed study by sponsor|1|||
38066775|NCT03438539|69760628|FG000|Overall Study|Lost to Follow-up|8|||
38066776|NCT03438539|69760629|FG001|Overall Study|Lost to Follow-up|4|||
38066777|NCT03438539|69760630|FG002|Overall Study|Lost to Follow-up|10|||
38066778|NCT03438539|69760631|FG003|Overall Study|Lost to Follow-up|9|||
38066779|NCT03438539|69760632|FG004|Overall Study|Lost to Follow-up|3|||
38066780|NCT03438539|69760633|FG005|Overall Study|Lost to Follow-up|8|||
38066781|NCT03400787|69760649|FG000|Overall Study|Lost to Follow-up|1|||
38066782|NCT03400787|69760650|FG001|Overall Study|Lost to Follow-up|0|||
38066783|NCT03400787|69760649|FG000|Overall Study|Death|1|||
38066784|NCT03400787|69760650|FG001|Overall Study|Death|0|||
38066785|NCT03400787|69760649|FG000|Overall Study|Protocol Violation|0|||
38066786|NCT03400787|69760650|FG001|Overall Study|Protocol Violation|2|||
38066787|NCT03400787|69760649|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
38066788|NCT03400787|69760650|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
38066789|NCT03417245|69760658|FG000|Overall Study|Adverse Event|1|||
38066790|NCT03417245|69760659|FG001|Overall Study|Adverse Event|0|||
38066791|NCT03417245|69760658|FG000|Overall Study|Protocol Violation|1|||
38066792|NCT03417245|69760659|FG001|Overall Study|Protocol Violation|0|||
38066793|NCT03417245|69760658|FG000|Overall Study|Withdrawal by Subject|1|||
38066794|NCT03417245|69760659|FG001|Overall Study|Withdrawal by Subject|1|||
38066795|NCT03389555|69760667|FG000|Overall Study|Protocol Violation|1|||
38066796|NCT03389555|69760668|FG001|Overall Study|Protocol Violation|3|||
38066797|NCT03389555|69760667|FG000|Overall Study|Death|1|||
38066798|NCT03389555|69760668|FG001|Overall Study|Death|0|||
38066799|NCT03395639|69760676|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
38066800|NCT03395639|69760677|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
38066801|NCT03395639|69760678|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
38066802|NCT03395639|69760676|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
38066803|NCT03395639|69760677|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
38066804|NCT03395639|69760678|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
38066805|NCT03395639|69760676|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
38066806|NCT03395639|69760677|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
38066807|NCT03395639|69760678|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
38066808|NCT03395639|69760676|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
38066809|NCT03395639|69760677|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
38066810|NCT03395639|69760678|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
38066811|NCT03395639|69760676|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
38066812|NCT03395639|69760677|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
38066813|NCT03395639|69760678|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
38066814|NCT03353922|69760685|FG000|Overall Study|Withdrawal by Subject|1|||
38066815|NCT03353922|69760686|FG001|Overall Study|Withdrawal by Subject|0|||
38066816|NCT03353922|69760687|FG002|Overall Study|Withdrawal by Subject|1|||
38066817|NCT03353922|69760688|FG003|Overall Study|Withdrawal by Subject|1|||
38066818|NCT03353922|69760689|FG004|Overall Study|Withdrawal by Subject|0|||
38066819|NCT03353922|69760690|FG005|Overall Study|Withdrawal by Subject|0|||
38066820|NCT03353922|69760685|FG000|Overall Study|Adverse Event|0|||
38066821|NCT03353922|69760686|FG001|Overall Study|Adverse Event|1|||
38066822|NCT03353922|69760687|FG002|Overall Study|Adverse Event|0|||
38066823|NCT03353922|69760688|FG003|Overall Study|Adverse Event|0|||
38066824|NCT03353922|69760689|FG004|Overall Study|Adverse Event|0|||
38066825|NCT03353922|69760690|FG005|Overall Study|Adverse Event|0|||
38066826|NCT03387683|69760703|FG000|Overall Study|In receipt of disallowed medication|1|||
38066827|NCT03387683|69760704|FG001|Overall Study|In receipt of disallowed medication|0|||
38066828|NCT03387683|69760703|FG000|Overall Study|Did not receive treatment|1|||
38066829|NCT03387683|69760704|FG001|Overall Study|Did not receive treatment|0|||
38066830|NCT03387059|69760712|FG000|Overall Study|Study termination|5|||
38066831|NCT03387059|69760713|FG001|Overall Study|Study termination|4|||
38066832|NCT02942004|69760722|FG000|Overall Study|Withdrawal by Subject|0|||
38066833|NCT02942004|69760723|FG001|Overall Study|Withdrawal by Subject|2|||
38066834|NCT02942004|69760724|FG002|Overall Study|Withdrawal by Subject|3|||
38066835|NCT02942004|69760722|FG000|Overall Study|Lost to Follow-up|1|||
38066836|NCT02942004|69760723|FG001|Overall Study|Lost to Follow-up|1|||
38066837|NCT02942004|69760724|FG002|Overall Study|Lost to Follow-up|2|||
38066838|NCT02942004|69760722|FG000|Overall Study|Randomized but not dosed|3|||
38066839|NCT02942004|69760723|FG001|Overall Study|Randomized but not dosed|9|||
38066840|NCT02942004|69760724|FG002|Overall Study|Randomized but not dosed|4|||
38066841|NCT03394391|69760734|FG000|Overall Study|Lost to Follow-up|1|||
38066842|NCT03394391|69760735|FG001|Overall Study|Lost to Follow-up|2|||
38066843|NCT03386435|69760743|FG000|Overall Study|Protocol Violation|5|||
38066844|NCT03386435|69760744|FG001|Overall Study|Protocol Violation|7|||
38066845|NCT02726880|69760752|FG000|Overall Study|Withdrawal by Subject|2|||
38066846|NCT02726880|69760753|FG001|Overall Study|Withdrawal by Subject|0|||
38066847|NCT02726880|69760752|FG000|Overall Study|Lost to Follow-up|1|||
38066848|NCT02726880|69760753|FG001|Overall Study|Lost to Follow-up|3|||
38066849|NCT03275389|69760770|FG000|Overall Study|Lost to Follow-up|10|||
38066850|NCT03275389|69760771|FG001|Overall Study|Lost to Follow-up|10|||
38066851|NCT03275389|69760772|FG002|Overall Study|Lost to Follow-up|19|||
38066852|NCT03275389|69760773|FG003|Overall Study|Lost to Follow-up|12|||
38066853|NCT03275389|69760774|FG004|Overall Study|Lost to Follow-up|11|||
38066854|NCT03275389|69760775|FG005|Overall Study|Lost to Follow-up|12|||
38066855|NCT03275389|69760776|FG006|Overall Study|Lost to Follow-up|21|||
38066856|NCT03275389|69760777|FG007|Overall Study|Lost to Follow-up|15|||
38066857|NCT03275389|69760778|FG008|Overall Study|Lost to Follow-up|12|||
38066858|NCT03275389|69760779|FG009|Overall Study|Lost to Follow-up|14|||
38066859|NCT03275389|69760770|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
38066860|NCT03275389|69760771|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
38066861|NCT03275389|69760772|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
38066862|NCT03275389|69760773|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
38066863|NCT03275389|69760774|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
38066864|NCT03275389|69760775|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
38066865|NCT03275389|69760776|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
38066866|NCT03275389|69760777|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
38066867|NCT03275389|69760778|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
38066868|NCT03275389|69760779|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
38066869|NCT03275389|69760770|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
38066870|NCT03275389|69760771|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
38066871|NCT03275389|69760772|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
38066872|NCT03275389|69760773|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
38066873|NCT03275389|69760774|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
38066874|NCT03275389|69760775|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
38066875|NCT03275389|69760776|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
38066876|NCT03275389|69760777|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
38066877|NCT03275389|69760778|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
38066878|NCT03275389|69760779|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
38066879|NCT03275389|69760770|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
38066880|NCT03275389|69760771|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
38066881|NCT03275389|69760772|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
38066882|NCT03275389|69760773|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
38066883|NCT03275389|69760774|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
38066884|NCT03275389|69760775|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
38066885|NCT03275389|69760776|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
38066886|NCT03275389|69760777|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
38066887|NCT03275389|69760778|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
38066888|NCT03275389|69760779|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
38066889|NCT03275389|69760770|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
38066890|NCT03275389|69760771|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
38066891|NCT03275389|69760772|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
38066892|NCT03275389|69760773|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
38066893|NCT03275389|69760774|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
38066894|NCT03275389|69760775|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
38066895|NCT03275389|69760776|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
38066896|NCT03275389|69760777|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
38066897|NCT03275389|69760778|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
38066898|NCT03275389|69760779|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
38066899|NCT03275389|69760770|FG000|Overall Study|Other|0|||
38066900|NCT03275389|69760771|FG001|Overall Study|Other|4|||
38066901|NCT03275389|69760772|FG002|Overall Study|Other|3|||
38066902|NCT03275389|69760773|FG003|Overall Study|Other|2|||
38066903|NCT03275389|69760774|FG004|Overall Study|Other|2|||
38066904|NCT03275389|69760775|FG005|Overall Study|Other|2|||
38066905|NCT03275389|69760776|FG006|Overall Study|Other|0|||
38066906|NCT03275389|69760777|FG007|Overall Study|Other|0|||
38066907|NCT03275389|69760778|FG008|Overall Study|Other|1|||
38066908|NCT03275389|69760779|FG009|Overall Study|Other|0|||
38066909|NCT03414359|69760803|FG000|Overall Study|Lack of Efficacy|1|||
38066910|NCT03414359|69760804|FG001|Overall Study|Lack of Efficacy|1|||
38066911|NCT03414359|69760803|FG000|Overall Study|Protocol Violation|0|||
38066912|NCT03414359|69760804|FG001|Overall Study|Protocol Violation|1|||
38066913|NCT03285295|69760815|FG000|Alinity s HBsAg|Protocol Violation|11|||
38066914|NCT03285295|69760816|FG001|Alinity s HBsAg|Protocol Violation|0|||
38066915|NCT03285295|69760817|FG002|Alinity s HBsAg|Protocol Violation|0|||
38066916|NCT03285295|69760818|FG003|Alinity s HBsAg|Protocol Violation|0|||
38066917|NCT03285295|69760819|FG004|Alinity s HBsAg|Protocol Violation|0|||
38066918|NCT03285295|69760815|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
38066919|NCT03285295|69760816|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
38066920|NCT03285295|69760817|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
38066921|NCT03285295|69760818|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
38066922|NCT03285295|69760819|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
38066923|NCT03285295|69760815|FG000|Alinity s HBsAg|No Results Generated|74|||
38066924|NCT03285295|69760816|FG001|Alinity s HBsAg|No Results Generated|6|||
38066925|NCT03285295|69760817|FG002|Alinity s HBsAg|No Results Generated|0|||
38066926|NCT03285295|69760818|FG003|Alinity s HBsAg|No Results Generated|0|||
38066927|NCT03285295|69760819|FG004|Alinity s HBsAg|No Results Generated|0|||
38066928|NCT03285295|69760815|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
38066929|NCT03285295|69760816|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
38066930|NCT03285295|69760817|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
38066931|NCT03285295|69760818|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
38066932|NCT03285295|69760819|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
38066933|NCT03285295|69760815|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
38066934|NCT03285295|69760816|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
38066935|NCT03285295|69760817|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
38066936|NCT03285295|69760818|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
38066937|NCT03285295|69760819|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
38066938|NCT03285295|69760815|FG000|Alinity s HTLV I/II|No Results Generated|70|||
38066939|NCT03285295|69760816|FG001|Alinity s HTLV I/II|No Results Generated|0|||
38066940|NCT03285295|69760817|FG002|Alinity s HTLV I/II|No Results Generated|0|||
38066941|NCT03285295|69760818|FG003|Alinity s HTLV I/II|No Results Generated|0|||
38066942|NCT03285295|69760819|FG004|Alinity s HTLV I/II|No Results Generated|0|||
38066943|NCT03285295|69760815|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
38066944|NCT03285295|69760816|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
38066945|NCT03285295|69760817|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
38066946|NCT03285295|69760818|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
38066947|NCT03285295|69760819|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
38066948|NCT03285295|69760815|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
38066949|NCT03285295|69760816|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
38066950|NCT03285295|69760817|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
38066951|NCT03285295|69760818|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
38066952|NCT03285295|69760819|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
38066953|NCT03285295|69760815|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
38066954|NCT03285295|69760816|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
38066955|NCT03285295|69760817|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
38066956|NCT03285295|69760818|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
38066957|NCT03285295|69760819|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
38066958|NCT03285295|69760815|FG000|Alinity s Anti-HCV|No Results Generated|71|||
38066959|NCT03285295|69760816|FG001|Alinity s Anti-HCV|No Results Generated|0|||
38066960|NCT03285295|69760817|FG002|Alinity s Anti-HCV|No Results Generated|0|||
38066961|NCT03285295|69760818|FG003|Alinity s Anti-HCV|No Results Generated|0|||
38066962|NCT03285295|69760819|FG004|Alinity s Anti-HCV|No Results Generated|0|||
38066963|NCT03285295|69760815|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
38066964|NCT03285295|69760816|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
38066965|NCT03285295|69760817|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
38066966|NCT03285295|69760818|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
38066967|NCT03285295|69760819|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
38066968|NCT03285295|69760815|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
38066969|NCT03285295|69760816|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
38066970|NCT03285295|69760817|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
38066971|NCT03285295|69760818|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
38066972|NCT03285295|69760819|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
37862268|NCT00919633|69546035|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
38066973|NCT03285295|69760815|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
38066974|NCT03285295|69760816|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
38066975|NCT03285295|69760817|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
38066976|NCT03285295|69760818|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
38066977|NCT03285295|69760819|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
38066978|NCT03285295|69760815|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
38066979|NCT03285295|69760816|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
38066980|NCT03285295|69760817|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
38066981|NCT03285295|69760818|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
38066982|NCT03285295|69760819|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
38066983|NCT03285295|69760815|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
38066984|NCT03285295|69760816|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
38066985|NCT03285295|69760817|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
38066986|NCT03285295|69760818|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
38066987|NCT03285295|69760819|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
38066988|NCT03285295|69760815|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
38066989|NCT03285295|69760816|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
38066990|NCT03285295|69760817|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
38066991|NCT03285295|69760818|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
38066992|NCT03285295|69760819|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
38066993|NCT03285295|69760815|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
38066994|NCT03285295|69760816|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
38066995|NCT03285295|69760817|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
38066996|NCT03285295|69760818|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
38066997|NCT03285295|69760819|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
38066998|NCT03285295|69760815|FG000|Alinity s Anti-HBc|No Results Generated|70|||
38066999|NCT03285295|69760816|FG001|Alinity s Anti-HBc|No Results Generated|0|||
38067000|NCT03285295|69760817|FG002|Alinity s Anti-HBc|No Results Generated|0|||
38067001|NCT03285295|69760818|FG003|Alinity s Anti-HBc|No Results Generated|0|||
38067002|NCT03285295|69760819|FG004|Alinity s Anti-HBc|No Results Generated|0|||
38067003|NCT03285295|69760815|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
38067004|NCT03285295|69760816|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
38067005|NCT03285295|69760817|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
38067006|NCT03285295|69760818|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
38067007|NCT03285295|69760819|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
38067008|NCT03285295|69760815|FG000|Alinity s Chagas|Protocol Violation|76|||
38067009|NCT03285295|69760816|FG001|Alinity s Chagas|Protocol Violation|0|||
38067010|NCT03285295|69760817|FG002|Alinity s Chagas|Protocol Violation|0|||
38067011|NCT03285295|69760818|FG003|Alinity s Chagas|Protocol Violation|0|||
38067012|NCT03285295|69760819|FG004|Alinity s Chagas|Protocol Violation|0|||
38067013|NCT03285295|69760815|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
38067014|NCT03285295|69760816|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
38067015|NCT03285295|69760817|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
38067016|NCT03285295|69760818|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
38067017|NCT03285295|69760819|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
38067018|NCT03285295|69760815|FG000|Alinity s Chagas|No Results Generated|105|||
38067019|NCT03285295|69760816|FG001|Alinity s Chagas|No Results Generated|0|||
38067020|NCT03285295|69760817|FG002|Alinity s Chagas|No Results Generated|0|||
38067021|NCT03285295|69760818|FG003|Alinity s Chagas|No Results Generated|0|||
38067022|NCT03285295|69760819|FG004|Alinity s Chagas|No Results Generated|0|||
38067023|NCT03285295|69760815|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
38067024|NCT03285295|69760816|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
38067025|NCT03285295|69760817|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
38067026|NCT03285295|69760818|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
38067027|NCT03285295|69760819|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
38067028|NCT02583048|69760851|FG000|Overall Study|Withdrawal by Subject|0|||
38067029|NCT02583048|69760852|FG001|Overall Study|Withdrawal by Subject|1|||
38067030|NCT02583048|69760853|FG002|Overall Study|Withdrawal by Subject|0|||
38067031|NCT02583048|69760851|FG000|Overall Study|Failed to meet eligibility criterion|0|||
38067032|NCT02583048|69760852|FG001|Overall Study|Failed to meet eligibility criterion|0|||
38067033|NCT02583048|69760853|FG002|Overall Study|Failed to meet eligibility criterion|1|||
38067034|NCT02939599|69760866|FG000|Overall Study|Adverse Event|1|||
38067035|NCT02939599|69760867|FG001|Overall Study|Adverse Event|0|||
38067036|NCT02939599|69760866|FG000|Overall Study|Study Terminated By Sponsor|2|||
38067037|NCT02939599|69760867|FG001|Overall Study|Study Terminated By Sponsor|2|||
38067038|NCT01318512|69760874|FG000|Maintenance Period (6 Months)|Death|2|||
38067039|NCT01318512|69760874|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
38067040|NCT03274687|69760895|FG000|Overall Study|Protocol Violation|1|||
38067041|NCT03274687|69760896|FG001|Overall Study|Protocol Violation|1|||
38067042|NCT04651218|69760902|FG000|Overall Study|Withdrawal by Subject|0|||
38067043|NCT04651218|69760903|FG001|Overall Study|Withdrawal by Subject|2|||
38067044|NCT03274453|69760913|FG000|Overall Study|Lost to Follow-up|2|||
38067045|NCT03274453|69760914|FG001|Overall Study|Lost to Follow-up|5|||
38067046|NCT03274453|69760915|FG002|Overall Study|Lost to Follow-up|4|||
38067047|NCT03274453|69760916|FG003|Overall Study|Lost to Follow-up|1|||
38067048|NCT03274453|69760913|FG000|Overall Study|Physician Decision|2|||
38067049|NCT03274453|69760914|FG001|Overall Study|Physician Decision|0|||
38067050|NCT03274453|69760915|FG002|Overall Study|Physician Decision|0|||
38067051|NCT03274453|69760916|FG003|Overall Study|Physician Decision|3|||
38067052|NCT03274453|69760913|FG000|Overall Study|Surgery Cancelled|0|||
38067053|NCT03274453|69760914|FG001|Overall Study|Surgery Cancelled|1|||
38067054|NCT03274453|69760915|FG002|Overall Study|Surgery Cancelled|0|||
38067055|NCT03274453|69760916|FG003|Overall Study|Surgery Cancelled|0|||
38067056|NCT03273907|69760926|FG000|Overall Study|Death|1|||
38067057|NCT03273907|69760926|FG000|Overall Study|Lost to Follow-up|4|||
38067058|NCT03273907|69760926|FG000|Overall Study|Withdrawal by Subject|2|||
38067059|NCT03273907|69760926|FG000|Overall Study|COVID 19|2|||
38067060|NCT00659646|69760948|FG000|Overall Study|Protocol Violation|12|||
38067061|NCT00659646|69760949|FG001|Overall Study|Protocol Violation|8|||
38067062|NCT00659646|69760948|FG000|Overall Study|Adverse Event|1|||
38067063|NCT00659646|69760949|FG001|Overall Study|Adverse Event|0|||
38067064|NCT00659646|69760948|FG000|Overall Study|Lost to Follow-up|1|||
38067065|NCT00659646|69760949|FG001|Overall Study|Lost to Follow-up|0|||
38067066|NCT00659646|69760948|FG000|Overall Study|protocol noncompliance after randomized|1|||
38067067|NCT00659646|69760949|FG001|Overall Study|protocol noncompliance after randomized|0|||
38067068|NCT02236572|69760957|FG000|Overall Study|Withdrawal by Subject|1|||
38067069|NCT02236572|69760957|FG000|Overall Study|Protocol Violation|1|||
38067070|NCT02236572|69760957|FG000|Overall Study|Lost to Follow-up|1|||
38067071|NCT03054870|69760961|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
38067072|NCT03054870|69760961|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
38067073|NCT03414047|69760980|FG000|Overall Study|Adverse Event|0|||
38067074|NCT03414047|69760981|FG001|Overall Study|Adverse Event|0|||
38067075|NCT03414047|69760982|FG002|Overall Study|Adverse Event|1|||
38067076|NCT03414047|69760983|FG003|Overall Study|Adverse Event|1|||
38067077|NCT03414047|69760980|FG000|Overall Study|Physician Decision|1|||
38067078|NCT03414047|69760981|FG001|Overall Study|Physician Decision|0|||
38067079|NCT03414047|69760982|FG002|Overall Study|Physician Decision|0|||
38067080|NCT03414047|69760983|FG003|Overall Study|Physician Decision|1|||
38067081|NCT03414047|69760980|FG000|Overall Study|Withdrawal by Subject|1|||
38067082|NCT03414047|69760981|FG001|Overall Study|Withdrawal by Subject|0|||
38067083|NCT03414047|69760982|FG002|Overall Study|Withdrawal by Subject|2|||
38067084|NCT03414047|69760983|FG003|Overall Study|Withdrawal by Subject|0|||
38067085|NCT03351335|69760997|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
38067086|NCT03351335|69760998|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
38067087|NCT03351335|69760999|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
38067088|NCT03055806|69761011|FG000|Overall Study|Adverse Event|0|||
38067089|NCT03055806|69761012|FG001|Overall Study|Adverse Event|0|||
38067090|NCT03055806|69761013|FG002|Overall Study|Adverse Event|1|||
38067091|NCT03055806|69761014|FG003|Overall Study|Adverse Event|1|||
38067092|NCT03055806|69761011|FG000|Overall Study|Lost to Follow-up|0|||
38067093|NCT03055806|69761012|FG001|Overall Study|Lost to Follow-up|3|||
38067094|NCT03055806|69761013|FG002|Overall Study|Lost to Follow-up|6|||
38067095|NCT03055806|69761014|FG003|Overall Study|Lost to Follow-up|7|||
38067096|NCT03055806|69761011|FG000|Overall Study|Physician Decision|1|||
38067097|NCT03055806|69761012|FG001|Overall Study|Physician Decision|0|||
38067098|NCT03055806|69761013|FG002|Overall Study|Physician Decision|0|||
38067099|NCT03055806|69761014|FG003|Overall Study|Physician Decision|1|||
38067100|NCT03055806|69761011|FG000|Overall Study|Protocol Violation|1|||
38067101|NCT03055806|69761012|FG001|Overall Study|Protocol Violation|0|||
38067102|NCT03055806|69761013|FG002|Overall Study|Protocol Violation|0|||
38067103|NCT03055806|69761014|FG003|Overall Study|Protocol Violation|0|||
38067104|NCT03055806|69761011|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
38067105|NCT03055806|69761012|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
38067106|NCT03055806|69761013|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
38067107|NCT03055806|69761014|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
38067108|NCT03055806|69761011|FG000|Overall Study|Withdrawal of consent to continue study|2|||
38067109|NCT03055806|69761012|FG001|Overall Study|Withdrawal of consent to continue study|3|||
38067110|NCT03055806|69761013|FG002|Overall Study|Withdrawal of consent to continue study|4|||
38067111|NCT03055806|69761014|FG003|Overall Study|Withdrawal of consent to continue study|6|||
38067112|NCT03055806|69761011|FG000|Overall Study|Partner not willing to try intercourse|1|||
38067113|NCT03055806|69761012|FG001|Overall Study|Partner not willing to try intercourse|0|||
38067114|NCT03055806|69761013|FG002|Overall Study|Partner not willing to try intercourse|0|||
38067115|NCT03055806|69761014|FG003|Overall Study|Partner not willing to try intercourse|0|||
38067116|NCT04620798|69761026|FG000|Overall Study|Lost to Follow-up|126|||
38067117|NCT04620798|69761027|FG001|Overall Study|Lost to Follow-up|138|||
38067118|NCT03052764|69761035|FG000|Double-Blind Treatment Period|Adverse Event|2|||
38067119|NCT03052764|69761036|FG001|Double-Blind Treatment Period|Adverse Event|0|||
38067120|NCT03052764|69761035|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
38067121|NCT03052764|69761036|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
38067122|NCT03052764|69761035|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
38067123|NCT03052764|69761036|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
38067124|NCT03052764|69761035|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
38067125|NCT03052764|69761036|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
38067126|NCT03052764|69761035|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
38067127|NCT03052764|69761036|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
38067128|NCT02951819|69761046|FG000|Overall Study|Death|9|||
38067129|NCT02951819|69761047|FG001|Overall Study|Death|7|||
38067130|NCT02951819|69761046|FG000|Overall Study|Withdrawal by Subject|3|||
38067131|NCT02951819|69761047|FG001|Overall Study|Withdrawal by Subject|0|||
38067132|NCT02951819|69761046|FG000|Overall Study|Adverse Event|1|||
38067133|NCT02951819|69761047|FG001|Overall Study|Adverse Event|0|||
38067134|NCT02951819|69761046|FG000|Overall Study|Lack of Efficacy|4|||
38067135|NCT02951819|69761047|FG001|Overall Study|Lack of Efficacy|0|||
38067136|NCT02951819|69761046|FG000|Overall Study|Lost to Follow-up|1|||
38067137|NCT02951819|69761047|FG001|Overall Study|Lost to Follow-up|0|||
38067138|NCT02951819|69761046|FG000|Overall Study|Progressive Disease|1|||
38067139|NCT02951819|69761047|FG001|Overall Study|Progressive Disease|0|||
38067140|NCT02951819|69761046|FG000|Overall Study|Other|9|||
38067141|NCT02951819|69761047|FG001|Overall Study|Other|0|||
38067142|NCT03383783|69761053|FG000|Overall Study|Withdrawal by Subject|2|||
38067143|NCT03334721|69761071|FG000|Overall Study|Withdrawal by Subject|1|||
38067144|NCT03334721|69761072|FG001|Overall Study|Withdrawal by Subject|0|||
38067145|NCT03334721|69761071|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
38067146|NCT03334721|69761072|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
38067147|NCT03515551|69761085|FG000|Overall Study|Death|4|||
38067148|NCT03515551|69761086|FG001|Overall Study|Death|1|||
38067149|NCT03515551|69761087|FG002|Overall Study|Death|2|||
38067150|NCT03515551|69761088|FG003|Overall Study|Death|2|||
38067151|NCT03515551|69761089|FG004|Overall Study|Death|2|||
38067152|NCT03515551|69761090|FG005|Overall Study|Death|4|||
38067153|NCT03515551|69761091|FG006|Overall Study|Death|1|||
38067154|NCT03515551|69761085|FG000|Overall Study|Lost to Follow-up|0|||
38067155|NCT03515551|69761086|FG001|Overall Study|Lost to Follow-up|0|||
38067156|NCT03515551|69761087|FG002|Overall Study|Lost to Follow-up|1|||
38067157|NCT03515551|69761088|FG003|Overall Study|Lost to Follow-up|0|||
38067158|NCT03515551|69761089|FG004|Overall Study|Lost to Follow-up|0|||
38067159|NCT03515551|69761090|FG005|Overall Study|Lost to Follow-up|0|||
38067160|NCT03515551|69761091|FG006|Overall Study|Lost to Follow-up|0|||
38067161|NCT03515551|69761085|FG000|Overall Study|Withdrawal by Subject|0|||
38067162|NCT03515551|69761086|FG001|Overall Study|Withdrawal by Subject|1|||
38067163|NCT03515551|69761087|FG002|Overall Study|Withdrawal by Subject|0|||
38067164|NCT03515551|69761088|FG003|Overall Study|Withdrawal by Subject|0|||
38067165|NCT03515551|69761089|FG004|Overall Study|Withdrawal by Subject|0|||
38067166|NCT03515551|69761090|FG005|Overall Study|Withdrawal by Subject|0|||
38067167|NCT03515551|69761091|FG006|Overall Study|Withdrawal by Subject|1|||
38067168|NCT03515551|69761085|FG000|Overall Study|Study ended by sponsor|0|||
38067169|NCT03515551|69761086|FG001|Overall Study|Study ended by sponsor|0|||
38067170|NCT03515551|69761087|FG002|Overall Study|Study ended by sponsor|2|||
38067171|NCT03515551|69761088|FG003|Overall Study|Study ended by sponsor|1|||
38067172|NCT03515551|69761089|FG004|Overall Study|Study ended by sponsor|3|||
38067173|NCT03515551|69761090|FG005|Overall Study|Study ended by sponsor|0|||
38067174|NCT03515551|69761091|FG006|Overall Study|Study ended by sponsor|3|||
38067175|NCT03515551|69761085|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
38067176|NCT03515551|69761086|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
38067177|NCT03515551|69761087|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
38067178|NCT03515551|69761088|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
38067179|NCT03515551|69761089|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
38067180|NCT03515551|69761090|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
38067181|NCT03515551|69761091|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
38067182|NCT03380429|69761117|FG000|Overall Study|Physician Decision|0|||
38067183|NCT03380429|69761118|FG001|Overall Study|Physician Decision|1|||
38067184|NCT03380429|69761119|FG002|Overall Study|Physician Decision|0|||
38067185|NCT03380429|69761120|FG003|Overall Study|Physician Decision|1|||
38067186|NCT03380429|69761121|FG004|Overall Study|Physician Decision|1|||
38067187|NCT03380429|69761117|FG000|Overall Study|Withdrawal by Subject|3|||
38067188|NCT03380429|69761118|FG001|Overall Study|Withdrawal by Subject|3|||
38067189|NCT03380429|69761119|FG002|Overall Study|Withdrawal by Subject|5|||
38067190|NCT03380429|69761120|FG003|Overall Study|Withdrawal by Subject|2|||
38067191|NCT03380429|69761121|FG004|Overall Study|Withdrawal by Subject|1|||
38067192|NCT03380429|69761117|FG000|Overall Study|Lost to Follow-up|0|||
38067193|NCT03380429|69761118|FG001|Overall Study|Lost to Follow-up|2|||
38067194|NCT03380429|69761119|FG002|Overall Study|Lost to Follow-up|4|||
38067195|NCT03380429|69761120|FG003|Overall Study|Lost to Follow-up|3|||
38067196|NCT03380429|69761121|FG004|Overall Study|Lost to Follow-up|1|||
38067197|NCT03380429|69761117|FG000|Overall Study|Protocol Violation|1|||
38067198|NCT03380429|69761118|FG001|Overall Study|Protocol Violation|0|||
38067199|NCT03380429|69761119|FG002|Overall Study|Protocol Violation|1|||
38067200|NCT03380429|69761120|FG003|Overall Study|Protocol Violation|0|||
38067201|NCT03380429|69761121|FG004|Overall Study|Protocol Violation|1|||
38067202|NCT03380429|69761117|FG000|Overall Study|Lack of Efficacy|0|||
38067203|NCT03380429|69761118|FG001|Overall Study|Lack of Efficacy|0|||
38067204|NCT03380429|69761119|FG002|Overall Study|Lack of Efficacy|0|||
38067205|NCT03380429|69761120|FG003|Overall Study|Lack of Efficacy|2|||
38067206|NCT03380429|69761121|FG004|Overall Study|Lack of Efficacy|1|||
38067207|NCT03380429|69761117|FG000|Overall Study|Adverse Event|1|||
38067208|NCT03380429|69761118|FG001|Overall Study|Adverse Event|1|||
38067209|NCT03380429|69761119|FG002|Overall Study|Adverse Event|1|||
38067210|NCT03380429|69761120|FG003|Overall Study|Adverse Event|2|||
38067211|NCT03380429|69761121|FG004|Overall Study|Adverse Event|0|||
38067212|NCT03280615|69761140|FG000|Overall Study|Lost to Follow-up|1|||
38067213|NCT03280615|69761141|FG001|Overall Study|Lost to Follow-up|2|||
38067214|NCT03280615|69761140|FG000|Overall Study|Adverse Event|1|||
38067215|NCT03280615|69761141|FG001|Overall Study|Adverse Event|1|||
38067216|NCT03280615|69761140|FG000|Overall Study|Withdrawal by Subject|2|||
38067217|NCT03280615|69761141|FG001|Overall Study|Withdrawal by Subject|2|||
38067218|NCT03280537|69761149|FG000|Overall Study|Withdrawal by Subject|2|||
38067219|NCT03280537|69761150|FG001|Overall Study|Withdrawal by Subject|4|||
38067220|NCT03280381|69761158|FG000|Overall Study|Physician Decision|0|||
38067221|NCT03280381|69761159|FG001|Overall Study|Physician Decision|2|||
38067222|NCT03270085|69761168|FG000|Overall Study|Withdrawal by Subject|1|||
38067223|NCT03270085|69761169|FG001|Overall Study|Withdrawal by Subject|0|||
38067224|NCT03267511|69761179|FG000|Overall Study|Lost to Follow-up|0|||
38067225|NCT03267511|69761180|FG001|Overall Study|Lost to Follow-up|0|||
38067226|NCT03267511|69761181|FG002|Overall Study|Lost to Follow-up|0|||
38067227|NCT03267511|69761182|FG003|Overall Study|Lost to Follow-up|1|||
38067228|NCT03379259|69761209|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
38067229|NCT03379259|69761210|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
38067230|NCT03379259|69761211|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
38067231|NCT03379259|69761212|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
38067232|NCT03379259|69761213|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
38067233|NCT03379259|69761214|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
38067234|NCT03379259|69761209|FG000|Overall Study|Death|0|||
38067235|NCT03379259|69761210|FG001|Overall Study|Death|1|||
38067236|NCT03379259|69761211|FG002|Overall Study|Death|2|||
38067237|NCT03379259|69761212|FG003|Overall Study|Death|1|||
38067238|NCT03379259|69761213|FG004|Overall Study|Death|4|||
38067239|NCT03379259|69761214|FG005|Overall Study|Death|2|||
38067240|NCT03379259|69761209|FG000|Overall Study|Withdrawal by Subject|0|||
38067241|NCT03379259|69761210|FG001|Overall Study|Withdrawal by Subject|0|||
38067242|NCT03379259|69761211|FG002|Overall Study|Withdrawal by Subject|1|||
38067243|NCT03379259|69761212|FG003|Overall Study|Withdrawal by Subject|0|||
38067244|NCT03379259|69761213|FG004|Overall Study|Withdrawal by Subject|2|||
38067245|NCT03379259|69761214|FG005|Overall Study|Withdrawal by Subject|0|||
38067246|NCT03379259|69761209|FG000|Overall Study|Study terminated by sponsor|0|||
38067247|NCT03379259|69761210|FG001|Overall Study|Study terminated by sponsor|0|||
38067248|NCT03379259|69761211|FG002|Overall Study|Study terminated by sponsor|0|||
38067249|NCT03379259|69761212|FG003|Overall Study|Study terminated by sponsor|1|||
38067250|NCT03379259|69761213|FG004|Overall Study|Study terminated by sponsor|1|||
37965821|NCT00044083|69652781|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
38067251|NCT03379259|69761214|FG005|Overall Study|Study terminated by sponsor|4|||
38067252|NCT03379259|69761209|FG000|Overall Study|Disease progression|0|||
38067253|NCT03379259|69761210|FG001|Overall Study|Disease progression|0|||
38067254|NCT03379259|69761211|FG002|Overall Study|Disease progression|0|||
38067255|NCT03379259|69761212|FG003|Overall Study|Disease progression|1|||
38067256|NCT03379259|69761213|FG004|Overall Study|Disease progression|0|||
38067257|NCT03379259|69761214|FG005|Overall Study|Disease progression|1|||
38067258|NCT03379259|69761209|FG000|Overall Study|Lost to Follow-up|0|||
38067259|NCT03379259|69761210|FG001|Overall Study|Lost to Follow-up|0|||
38067260|NCT03379259|69761211|FG002|Overall Study|Lost to Follow-up|0|||
38067261|NCT03379259|69761212|FG003|Overall Study|Lost to Follow-up|0|||
38067262|NCT03379259|69761213|FG004|Overall Study|Lost to Follow-up|1|||
38067263|NCT03379259|69761214|FG005|Overall Study|Lost to Follow-up|0|||
38067264|NCT03379259|69761209|FG000|Overall Study|Deteriorating condition|0|||
38067265|NCT03379259|69761210|FG001|Overall Study|Deteriorating condition|0|||
38067266|NCT03379259|69761211|FG002|Overall Study|Deteriorating condition|0|||
38067267|NCT03379259|69761212|FG003|Overall Study|Deteriorating condition|0|||
38067268|NCT03379259|69761213|FG004|Overall Study|Deteriorating condition|1|||
38067269|NCT03379259|69761214|FG005|Overall Study|Deteriorating condition|0|||
38067270|NCT03328897|69761234|FG000|Randomized-treatment Epoch|Adverse Event|4|||
38067271|NCT03328897|69761235|FG001|Randomized-treatment Epoch|Adverse Event|1|||
38067272|NCT03328897|69761236|FG002|Randomized-treatment Epoch|Adverse Event|1|||
38067273|NCT03328897|69761234|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
38067274|NCT03328897|69761235|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
38067275|NCT03328897|69761236|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
38067276|NCT03328897|69761234|FG000|Randomized-treatment Epoch|Pregnancy|3|||
38067277|NCT03328897|69761235|FG001|Randomized-treatment Epoch|Pregnancy|0|||
38067278|NCT03328897|69761236|FG002|Randomized-treatment Epoch|Pregnancy|0|||
38067279|NCT03328897|69761234|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
38067280|NCT03328897|69761235|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
38067281|NCT03328897|69761236|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
38067282|NCT03328897|69761234|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
38067283|NCT03328897|69761235|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
38067284|NCT03328897|69761236|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
38067285|NCT03328897|69761234|FG000|Follow-up Epoch|Adverse Event|4|||
38067286|NCT03328897|69761235|FG001|Follow-up Epoch|Adverse Event|0|||
38067287|NCT03328897|69761236|FG002|Follow-up Epoch|Adverse Event|1|||
38067288|NCT03328897|69761234|FG000|Follow-up Epoch|Lack of Efficacy|1|||
38067289|NCT03328897|69761235|FG001|Follow-up Epoch|Lack of Efficacy|1|||
38067290|NCT03328897|69761236|FG002|Follow-up Epoch|Lack of Efficacy|1|||
38067291|NCT03328897|69761234|FG000|Follow-up Epoch|Lost to Follow-up|0|||
38067292|NCT03328897|69761235|FG001|Follow-up Epoch|Lost to Follow-up|1|||
38067293|NCT03328897|69761236|FG002|Follow-up Epoch|Lost to Follow-up|0|||
38067294|NCT03328897|69761234|FG000|Follow-up Epoch|Pregnancy|1|||
38067295|NCT03328897|69761235|FG001|Follow-up Epoch|Pregnancy|0|||
38067296|NCT03328897|69761236|FG002|Follow-up Epoch|Pregnancy|0|||
38067297|NCT03328897|69761234|FG000|Follow-up Epoch|Patient/guardian decision|2|||
38067298|NCT03328897|69761235|FG001|Follow-up Epoch|Patient/guardian decision|1|||
38067299|NCT03328897|69761236|FG002|Follow-up Epoch|Patient/guardian decision|0|||
38067300|NCT03266107|69761244|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
38067301|NCT03266107|69761244|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
38067302|NCT03266107|69761244|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
38067303|NCT03266107|69761244|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
38067304|NCT03378635|69761253|FG000|Overall Study|Adverse Event|1|||
38067305|NCT03378635|69761254|FG001|Overall Study|Adverse Event|0|||
38067306|NCT03378635|69761255|FG002|Overall Study|Adverse Event|0|||
38067307|NCT03378635|69761253|FG000|Overall Study|Withdrawal by Subject|1|||
38067308|NCT03378635|69761254|FG001|Overall Study|Withdrawal by Subject|0|||
37680392|NCT02582983|69156029|FG000|Overall Study|Withdrawal by Subject|2|||
37680393|NCT02582983|69156029|FG000|Overall Study|Adverse Event|1|||
38067309|NCT03378635|69761255|FG002|Overall Study|Withdrawal by Subject|0|||
38067310|NCT03326869|69761266|FG000|Overall Study|Study data has been lost to natural disa|1|||
38067311|NCT03326869|69761267|FG001|Overall Study|Study data has been lost to natural disa|1|||
37680394|NCT02582749|69156035|FG000|Overall Study|Study terminated by funder|5|||
38067312|NCT03334409|69761279|FG000|Overall Study|Did not meet inclusion criteria|1|||
38067313|NCT03334409|69761280|FG001|Overall Study|Did not meet inclusion criteria|0|||
38067314|NCT02891915|69761288|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
38067315|NCT02891915|69761289|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
38067316|NCT02891915|69761288|FG000|Overall Study|Withdrawal by Subject|3|||
38067317|NCT02891915|69761289|FG001|Overall Study|Withdrawal by Subject|3|||
38067318|NCT02891915|69761288|FG000|Overall Study|Became Ineligible After Enrollment|2|||
38067319|NCT02891915|69761289|FG001|Overall Study|Became Ineligible After Enrollment|1|||
38067320|NCT02891915|69761288|FG000|Overall Study|Lost to Follow-up|1|||
38067321|NCT02891915|69761289|FG001|Overall Study|Lost to Follow-up|4|||
38067322|NCT02891915|69761288|FG000|Overall Study|Physician Decision|1|||
38067323|NCT02891915|69761289|FG001|Overall Study|Physician Decision|0|||
38067324|NCT02891681|69761298|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
38067325|NCT02891681|69761299|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
38067326|NCT02891681|69761300|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
38067327|NCT02891681|69761298|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
38067328|NCT02891681|69761299|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
38067329|NCT02891681|69761300|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
38067330|NCT02891681|69761298|FG000|Overall Study|Taken off study after first imaging appointment|1|||
38067331|NCT02891681|69761299|FG001|Overall Study|Taken off study after first imaging appointment|0|||
38067332|NCT02891681|69761300|FG002|Overall Study|Taken off study after first imaging appointment|0|||
38067333|NCT04671342|69761308|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
38067334|NCT04671342|69761308|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
38067335|NCT04671342|69761308|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
38067336|NCT04671342|69761308|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
38067337|NCT04671342|69761308|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
38067338|NCT04671342|69761308|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
38067339|NCT03046446|69761312|FG000|Overall Study|Lack of Efficacy|7|||
38067340|NCT03046446|69761312|FG000|Overall Study|Adverse Event|6|||
38067341|NCT03046446|69761312|FG000|Overall Study|Lost to Follow-up|3|||
38067342|NCT03046446|69761312|FG000|Overall Study|Withdrawal by Subject|14|||
38067343|NCT03046446|69761312|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
38067344|NCT03046446|69761312|FG000|Overall Study|Disease Progression (see caveats)|25|||
38067345|NCT03046446|69761312|FG000|Overall Study|Non OA related knee surgery|1|||
38067346|NCT03051217|69761319|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
38067347|NCT03051217|69761320|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
38067348|NCT03051217|69761321|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
38067349|NCT03051217|69761322|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
38067350|NCT03051217|69761323|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
38067351|NCT03051217|69761324|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
38067352|NCT03051217|69761325|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
38067353|NCT03051217|69761319|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
38067354|NCT03051217|69761320|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
38067355|NCT03051217|69761321|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
38067356|NCT03051217|69761322|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
38067357|NCT03051217|69761323|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
38067358|NCT03051217|69761324|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
38067359|NCT03051217|69761325|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
38067360|NCT03051217|69761319|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
38067361|NCT03051217|69761320|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
38067362|NCT03051217|69761321|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
38067363|NCT03051217|69761322|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
38067364|NCT03051217|69761323|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
38067365|NCT03051217|69761324|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
38067366|NCT03051217|69761325|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
38067367|NCT03051217|69761319|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
38067368|NCT03051217|69761320|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
38067369|NCT03051217|69761321|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
38067370|NCT03051217|69761322|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
38067371|NCT03051217|69761323|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
38067372|NCT03051217|69761324|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
38067373|NCT03051217|69761325|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
38067374|NCT03051217|69761319|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
38067375|NCT03051217|69761320|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
38067376|NCT03051217|69761321|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
38067377|NCT03051217|69761322|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
38067378|NCT03051217|69761323|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
38067379|NCT03051217|69761324|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
38067380|NCT03051217|69761325|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
38067381|NCT03051217|69761319|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
37965822|NCT00044083|69652780|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
37965823|NCT00044083|69652781|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
37965824|NCT00044083|69652780|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
37965825|NCT00044083|69652781|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
37965826|NCT00058123|69652814|FG000|Overall Study|Wrong histology|9|||
37965827|NCT00058123|69652814|FG000|Overall Study|Received >3 prior treatments|1|||
37965828|NCT00022633|69652821|FG000|Overall Study|Adverse Event|11|||
37965829|NCT00022633|69652822|FG001|Overall Study|Adverse Event|1|||
37965830|NCT00022633|69652821|FG000|Overall Study|Refusal unrelated to adverse event|1|||
37965831|NCT00022633|69652822|FG001|Overall Study|Refusal unrelated to adverse event|0|||
37965832|NCT00022633|69652821|FG000|Overall Study|Progression/relapse|9|||
37965833|NCT00022633|69652822|FG001|Overall Study|Progression/relapse|2|||
37965834|NCT00022633|69652821|FG000|Overall Study|Death|4|||
37965835|NCT00022633|69652822|FG001|Overall Study|Death|0|||
37965836|NCT00022633|69652821|FG000|Overall Study|Other - not protocol specified|3|||
37965837|NCT00022633|69652822|FG001|Overall Study|Other - not protocol specified|2|||
37965838|NCT00022633|69652821|FG000|Overall Study|Ineligible|4|||
37965839|NCT00022633|69652822|FG001|Overall Study|Ineligible|0|||
37965840|NCT00021541|69652829|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
37965841|NCT00021541|69652830|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
37965842|NCT00021541|69652829|FG000|Period 1-First Treatment|Adverse Event|2|||
37965843|NCT00021541|69652830|FG001|Period 1-First Treatment|Adverse Event|1|||
37965844|NCT00021541|69652829|FG000|Period 1-First Treatment|non-adherence|3|||
37965845|NCT00021541|69652830|FG001|Period 1-First Treatment|non-adherence|0|||
37965846|NCT00021541|69652829|FG000|Period 1-First Treatment|Death|1|||
37965847|NCT00021541|69652830|FG001|Period 1-First Treatment|Death|0|||
37965848|NCT00021541|69652829|FG000|Period 1-First Treatment|Pts that did not progress|2|||
37965849|NCT00021541|69652830|FG001|Period 1-First Treatment|Pts that did not progress|2|||
37965850|NCT00021541|69652829|FG000|Period 1-First Treatment|Ineligible|0|||
37965851|NCT00021541|69652830|FG001|Period 1-First Treatment|Ineligible|2|||
37965852|NCT00021541|69652829|FG000|Period 2-crossover|refused phase B|2|||
37965853|NCT00021541|69652830|FG001|Period 2-crossover|refused phase B|2|||
37965854|NCT00021541|69652829|FG000|Period 2-crossover|Withdrawal by Subject|3|||
37965855|NCT00021541|69652830|FG001|Period 2-crossover|Withdrawal by Subject|4|||
37965856|NCT00021541|69652829|FG000|Period 2-crossover|Adverse Event|2|||
37965857|NCT00021541|69652830|FG001|Period 2-crossover|Adverse Event|2|||
37965858|NCT00021541|69652829|FG000|Period 2-crossover|non-adherence|1|||
37965859|NCT00021541|69652830|FG001|Period 2-crossover|non-adherence|0|||
37965860|NCT00021541|69652829|FG000|Period 2-crossover|Pts that did not progress|2|||
37965861|NCT00021541|69652830|FG001|Period 2-crossover|Pts that did not progress|3|||
37965862|NCT00021229|69652841|FG000|Overall Study|Adverse Event|10|||
37965863|NCT00021229|69652842|FG001|Overall Study|Adverse Event|5|||
37965864|NCT00021229|69652843|FG002|Overall Study|Adverse Event|2|||
37965865|NCT00021229|69652841|FG000|Overall Study|Death|0|||
37965866|NCT00021229|69652842|FG001|Overall Study|Death|1|||
38067382|NCT03051217|69761320|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
38067383|NCT03051217|69761321|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
38067384|NCT03051217|69761322|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
38067385|NCT03051217|69761323|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
38067386|NCT03051217|69761324|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
38067387|NCT03051217|69761325|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
38067388|NCT03051217|69761319|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
38067389|NCT03051217|69761320|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
38067390|NCT03051217|69761321|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
38067391|NCT03051217|69761322|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
38067392|NCT03051217|69761323|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
38067393|NCT03051217|69761324|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
38067394|NCT03051217|69761325|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
38067395|NCT03051217|69761319|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
38067396|NCT03051217|69761320|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
38067397|NCT03051217|69761321|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
38067398|NCT03051217|69761322|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
38067399|NCT03051217|69761323|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
38067400|NCT03051217|69761324|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
38067401|NCT03051217|69761325|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
38067402|NCT03046056|69761351|FG000|Overall Study|Non-responder at Week 10|6|||
38067403|NCT03046056|69761352|FG001|Overall Study|Non-responder at Week 10|6|||
38067404|NCT03046056|69761353|FG002|Overall Study|Non-responder at Week 10|4|||
38067405|NCT03046056|69761351|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
38067406|NCT03046056|69761352|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
38067407|NCT03046056|69761353|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
38067408|NCT03046056|69761351|FG000|Overall Study|Adverse Event|1|||
38067409|NCT03046056|69761352|FG001|Overall Study|Adverse Event|5|||
38067410|NCT03046056|69761353|FG002|Overall Study|Adverse Event|0|||
38067411|NCT03046056|69761351|FG000|Overall Study|Non-compliance With Study Drug|0|||
38067412|NCT03046056|69761352|FG001|Overall Study|Non-compliance With Study Drug|0|||
38067413|NCT03046056|69761353|FG002|Overall Study|Non-compliance With Study Drug|2|||
38067414|NCT03046056|69761351|FG000|Overall Study|Protocol Violation|1|||
38067415|NCT03046056|69761352|FG001|Overall Study|Protocol Violation|1|||
38067416|NCT03046056|69761353|FG002|Overall Study|Protocol Violation|0|||
38067417|NCT03046056|69761351|FG000|Overall Study|Investigator's Discretion|0|||
38067418|NCT03046056|69761352|FG001|Overall Study|Investigator's Discretion|1|||
38067419|NCT03046056|69761353|FG002|Overall Study|Investigator's Discretion|0|||
38067420|NCT03046056|69761351|FG000|Overall Study|Withdrew Consent|1|||
38067421|NCT03046056|69761352|FG001|Overall Study|Withdrew Consent|0|||
38067422|NCT03046056|69761353|FG002|Overall Study|Withdrew Consent|0|||
38067423|NCT02849587|69761364|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
38067424|NCT02849587|69761365|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
38067425|NCT02849587|69761366|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
38067426|NCT02849587|69761364|FG000|Overall Study|Withdrawal by Subject|0|||
38067427|NCT02849587|69761365|FG001|Overall Study|Withdrawal by Subject|1|||
38067428|NCT02849587|69761366|FG002|Overall Study|Withdrawal by Subject|0|||
38067429|NCT03347279|69761380|FG000|Overall Study|Withdrawal by Subject|8|||
38067430|NCT03347279|69761381|FG001|Overall Study|Withdrawal by Subject|15|||
38067431|NCT03347279|69761380|FG000|Overall Study|Death|0|||
38067432|NCT03347279|69761381|FG001|Overall Study|Death|2|||
38067433|NCT03347279|69761380|FG000|Overall Study|Lost to Follow-up|5|||
38067434|NCT03347279|69761381|FG001|Overall Study|Lost to Follow-up|2|||
38067435|NCT03347279|69761380|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
38067436|NCT03347279|69761381|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
38067437|NCT03262441|69761387|FG000|Overall Study|Withdrawal by Subject|1|||
38067438|NCT04580394|69761391|FG000|First Intervention|Incorrectly Randomized|1|||
38067439|NCT04580394|69761391|FG000|First Intervention|Physician Decision|1|||
38067440|NCT04580394|69761391|FG000|First Intervention|Lost to Follow-up|1|||
38067441|NCT04580394|69761391|FG000|Washout (One Week)|Withdrawal by Subject|1|||
38067442|NCT04580394|69761391|FG000|Washout (One Week)|Adverse Event|1|||
38067443|NCT04580394|69761391|FG000|Washout (One Week)|Withdrawal by Subject|2|||
38067444|NCT04580394|69761391|FG000|Third Intervention|Adverse Event|1|||
38067445|NCT04580394|69761391|FG000|Third Intervention|Withdrawal by Subject|1|||
38067446|NCT04580394|69761391|FG000|Washout (One Week)|Withdrawal by Subject|2|||
38067447|NCT02781727|69761403|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
38067448|NCT02781727|69761404|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
38067449|NCT02781727|69761403|FG000|Treatment Period|Withdrawal by Subject|1|||
38067450|NCT02781727|69761404|FG001|Treatment Period|Withdrawal by Subject|0|||
38067451|NCT02781727|69761403|FG000|Treatment Period|Lost to Follow-up|0|||
38067452|NCT02781727|69761404|FG001|Treatment Period|Lost to Follow-up|1|||
38067453|NCT01343082|69761410|FG000|The run-in Period|Not meeting criteria|3|||
38067454|NCT01343082|69761411|FG001|The run-in Period|Not meeting criteria|4|||
38067455|NCT01343082|69761412|FG002|The run-in Period|Not meeting criteria|5|||
37862269|NCT00919633|69546036|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
37862270|NCT00919633|69546037|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
37862271|NCT00919633|69546034|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
37862272|NCT00919633|69546035|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
37862273|NCT00919633|69546036|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
37862274|NCT00919633|69546037|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
37862275|NCT01130883|69546047|FG000|Overall Study|Patient Noncompliance|6|||
37862276|NCT01130883|69546047|FG000|Overall Study|Reason Unknown|1|||
37862277|NCT01130883|69546047|FG000|Overall Study|Adverse Event|3|||
37862278|NCT00926029|69546054|FG000|Overall Study|Lost to Follow-up|2|||
37862279|NCT00926029|69546055|FG001|Overall Study|Lost to Follow-up|1|||
37862280|NCT00926029|69546056|FG002|Overall Study|Lost to Follow-up|1|||
37862281|NCT01130493|69546066|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
37862282|NCT01130493|69546067|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
37862283|NCT01130493|69546068|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
37965867|NCT00021229|69652843|FG002|Overall Study|Death|0|||
37965868|NCT00021229|69652841|FG000|Overall Study|Withdrawal by Subject|7|||
37965869|NCT00021229|69652842|FG001|Overall Study|Withdrawal by Subject|7|||
37965870|NCT00021229|69652843|FG002|Overall Study|Withdrawal by Subject|1|||
37965871|NCT00021229|69652841|FG000|Overall Study|Progressive Disease|15|||
37965872|NCT00021229|69652842|FG001|Overall Study|Progressive Disease|19|||
37965873|NCT00021229|69652843|FG002|Overall Study|Progressive Disease|12|||
37862284|NCT01130493|69546066|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
37862285|NCT01130493|69546067|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
37862286|NCT01130493|69546068|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
37862287|NCT01130493|69546066|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
37862288|NCT01130493|69546067|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
37862289|NCT01130493|69546068|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
37862290|NCT01130493|69546066|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
37862291|NCT01130493|69546067|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
37965874|NCT00021229|69652841|FG000|Overall Study|Protocol Violation|1|||
37965875|NCT00021229|69652842|FG001|Overall Study|Protocol Violation|1|||
37965876|NCT00021229|69652843|FG002|Overall Study|Protocol Violation|0|||
38067456|NCT01343082|69761410|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
38067457|NCT01343082|69761411|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
37862292|NCT01130493|69546068|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
37965877|NCT00021229|69652841|FG000|Overall Study|Physician Decision|0|||
38067458|NCT01343082|69761412|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
37862293|NCT01130493|69546066|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
37965878|NCT00021229|69652842|FG001|Overall Study|Physician Decision|0|||
37862294|NCT01130493|69546067|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
37862295|NCT01130493|69546068|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
37862296|NCT01130493|69546066|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
37862297|NCT01130493|69546067|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
37862298|NCT01130493|69546068|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
37862299|NCT01130493|69546066|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
38067459|NCT01343082|69761410|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
38067460|NCT01343082|69761411|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
38067461|NCT01343082|69761412|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
38067462|NCT01343082|69761410|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
38067463|NCT01343082|69761411|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
38067464|NCT01343082|69761412|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
38067465|NCT01343082|69761410|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
38067466|NCT01343082|69761411|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
38067467|NCT01343082|69761412|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
38067468|NCT03374189|69761418|FG000|Overall Study|Lost to Follow-up|1|||
38067469|NCT03374189|69761419|FG001|Overall Study|Lost to Follow-up|0|||
38067470|NCT03261037|69761429|FG000|Overall Study|Withdrawal by Subject|2|||
38067471|NCT03261037|69761430|FG001|Overall Study|Withdrawal by Subject|13|||
38067472|NCT03261037|69761431|FG002|Overall Study|Withdrawal by Subject|0|||
37862300|NCT01130493|69546067|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
37862301|NCT01130493|69546068|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
38067473|NCT03261037|69761432|FG003|Overall Study|Withdrawal by Subject|18|||
38067474|NCT03261037|69761429|FG000|Overall Study|Non-compliance with study procedures|0|||
38067475|NCT03261037|69761430|FG001|Overall Study|Non-compliance with study procedures|2|||
38067476|NCT03261037|69761431|FG002|Overall Study|Non-compliance with study procedures|0|||
38067477|NCT03261037|69761432|FG003|Overall Study|Non-compliance with study procedures|6|||
38067478|NCT03261037|69761429|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
38067479|NCT03261037|69761430|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
38067480|NCT03261037|69761431|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
38067481|NCT03261037|69761432|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
38067482|NCT03261037|69761429|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
38067483|NCT03261037|69761430|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
38067484|NCT03261037|69761431|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
38067485|NCT03261037|69761432|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
38067486|NCT03261037|69761429|FG000|Overall Study|Diagnosed but protocol deviation|1|||
38067487|NCT03261037|69761430|FG001|Overall Study|Diagnosed but protocol deviation|0|||
38067488|NCT03261037|69761431|FG002|Overall Study|Diagnosed but protocol deviation|0|||
38067489|NCT03261037|69761432|FG003|Overall Study|Diagnosed but protocol deviation|0|||
38067490|NCT03261037|69761429|FG000|Overall Study|Participant did not want to continue the study|0|||
38067491|NCT03261037|69761430|FG001|Overall Study|Participant did not want to continue the study|1|||
38067492|NCT03261037|69761431|FG002|Overall Study|Participant did not want to continue the study|0|||
38067493|NCT03261037|69761432|FG003|Overall Study|Participant did not want to continue the study|0|||
38067494|NCT03261037|69761429|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
38067495|NCT03261037|69761430|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
38067496|NCT03261037|69761431|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
38067497|NCT03261037|69761432|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
38067498|NCT03261037|69761429|FG000|Overall Study|Participant presented clinical improvement|0|||
38067499|NCT03261037|69761430|FG001|Overall Study|Participant presented clinical improvement|2|||
38067500|NCT03261037|69761431|FG002|Overall Study|Participant presented clinical improvement|0|||
38067501|NCT03261037|69761432|FG003|Overall Study|Participant presented clinical improvement|0|||
38067502|NCT03261037|69761429|FG000|Overall Study|Technical difficulties|0|||
38067503|NCT03261037|69761430|FG001|Overall Study|Technical difficulties|0|||
38067504|NCT03261037|69761431|FG002|Overall Study|Technical difficulties|0|||
38067505|NCT03261037|69761432|FG003|Overall Study|Technical difficulties|1|||
38067506|NCT03261037|69761429|FG000|Overall Study|Equipment failed to work|0|||
38067507|NCT03261037|69761430|FG001|Overall Study|Equipment failed to work|0|||
38067508|NCT03261037|69761431|FG002|Overall Study|Equipment failed to work|0|||
38067509|NCT03261037|69761432|FG003|Overall Study|Equipment failed to work|1|||
38067510|NCT03261037|69761429|FG000|Overall Study|End of study for participant and no follow up|0|||
37862302|NCT01130493|69546066|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
37862303|NCT01130493|69546067|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
37965879|NCT00021229|69652843|FG002|Overall Study|Physician Decision|1|||
38067511|NCT03261037|69761430|FG001|Overall Study|End of study for participant and no follow up|0|||
38067512|NCT03261037|69761431|FG002|Overall Study|End of study for participant and no follow up|0|||
38067513|NCT03261037|69761432|FG003|Overall Study|End of study for participant and no follow up|1|||
37965880|NCT00021229|69652841|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
37965881|NCT00021229|69652842|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
37965882|NCT00021229|69652843|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
37965883|NCT00372112|69652857|FG000|Overall Study|Adverse Event|0|||
37965884|NCT00372112|69652858|FG001|Overall Study|Adverse Event|1|||
37965885|NCT00372112|69652859|FG002|Overall Study|Adverse Event|1|||
37965886|NCT00372112|69652860|FG003|Overall Study|Adverse Event|1|||
37965887|NCT00372112|69652857|FG000|Overall Study|Withdrawal by Subject|0|||
37965888|NCT00372112|69652858|FG001|Overall Study|Withdrawal by Subject|0|||
37965889|NCT00372112|69652859|FG002|Overall Study|Withdrawal by Subject|2|||
37965890|NCT00372112|69652860|FG003|Overall Study|Withdrawal by Subject|1|||
37965891|NCT00372112|69652857|FG000|Overall Study|Exacerbation|0|||
38067514|NCT03261037|69761429|FG000|Overall Study|Participant was too weak to continue in study|1|||
38067515|NCT03261037|69761430|FG001|Overall Study|Participant was too weak to continue in study|0|||
38067516|NCT03261037|69761431|FG002|Overall Study|Participant was too weak to continue in study|0|||
38067517|NCT03261037|69761432|FG003|Overall Study|Participant was too weak to continue in study|0|||
38067518|NCT03372551|69761443|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
38067519|NCT03372551|69761444|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
38067520|NCT03326323|69761457|FG000|Overall Study|Unable to receive ANH protocol|3|||
38067521|NCT03259789|69761468|FG000|Overall Study|Adverse Event|3|||
38067522|NCT03259789|69761469|FG001|Overall Study|Adverse Event|2|||
38067523|NCT03259789|69761470|FG002|Overall Study|Adverse Event|1|||
38067524|NCT03259789|69761468|FG000|Overall Study|Withdrawal by Subject|9|||
38067525|NCT03259789|69761469|FG001|Overall Study|Withdrawal by Subject|5|||
38067526|NCT03259789|69761470|FG002|Overall Study|Withdrawal by Subject|1|||
38067527|NCT03259789|69761468|FG000|Overall Study|Lost to Follow-up|5|||
38067528|NCT03259789|69761469|FG001|Overall Study|Lost to Follow-up|9|||
38067529|NCT03259789|69761470|FG002|Overall Study|Lost to Follow-up|4|||
38067530|NCT03259789|69761468|FG000|Overall Study|Physician Decision|0|||
38067531|NCT03259789|69761469|FG001|Overall Study|Physician Decision|1|||
38067532|NCT03259789|69761470|FG002|Overall Study|Physician Decision|0|||
38067533|NCT03259555|69761481|FG000|Overall Study|Adverse Event|6|||
38067534|NCT03259555|69761482|FG001|Overall Study|Adverse Event|4|||
38067535|NCT03259555|69761481|FG000|Overall Study|Lack of Efficacy|6|||
38067536|NCT03259555|69761482|FG001|Overall Study|Lack of Efficacy|4|||
38067537|NCT03259555|69761481|FG000|Overall Study|Lost to Follow-up|0|||
38067538|NCT03259555|69761482|FG001|Overall Study|Lost to Follow-up|2|||
38067539|NCT03259555|69761481|FG000|Overall Study|Non-Compliance With Study Drug|1|||
38067540|NCT03259555|69761482|FG001|Overall Study|Non-Compliance With Study Drug|0|||
38067541|NCT03259555|69761481|FG000|Overall Study|Progressive Disease|0|||
38067542|NCT03259555|69761482|FG001|Overall Study|Progressive Disease|2|||
38067543|NCT03259555|69761481|FG000|Overall Study|Withdrawal by Subject|19|||
38067544|NCT03259555|69761482|FG001|Overall Study|Withdrawal by Subject|16|||
38067545|NCT03259555|69761481|FG000|Overall Study|Physician Decision|1|||
38067546|NCT03259555|69761482|FG001|Overall Study|Physician Decision|2|||
38067547|NCT03259555|69761481|FG000|Overall Study|Other|1|||
38067548|NCT03259555|69761482|FG001|Overall Study|Other|0|||
38067549|NCT03259087|69761493|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
38067550|NCT03259087|69761494|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
38067551|NCT03259087|69761495|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
38067552|NCT03259087|69761496|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
38067553|NCT03259087|69761497|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
38067554|NCT03259087|69761493|FG000|Period 2 of Part 2|Adverse Event|0|||
38067555|NCT03259087|69761494|FG001|Period 2 of Part 2|Adverse Event|0|||
38067556|NCT03259087|69761495|FG002|Period 2 of Part 2|Adverse Event|0|||
38067557|NCT03259087|69761496|FG003|Period 2 of Part 2|Adverse Event|0|||
38067558|NCT03259087|69761497|FG004|Period 2 of Part 2|Adverse Event|1|||
38067559|NCT03257995|69761519|FG000|Overall Study|Adverse Event|0|||
38067560|NCT03257995|69761520|FG001|Overall Study|Adverse Event|1|||
38067561|NCT03257995|69761521|FG002|Overall Study|Adverse Event|0|||
38067562|NCT03257995|69761522|FG003|Overall Study|Adverse Event|0|||
38067563|NCT03257995|69761523|FG004|Overall Study|Adverse Event|0|||
38067564|NCT03257995|69761524|FG005|Overall Study|Adverse Event|0|||
38067565|NCT03257995|69761519|FG000|Overall Study|Protocol deviation|0|||
38067566|NCT03257995|69761520|FG001|Overall Study|Protocol deviation|0|||
38067567|NCT03257995|69761521|FG002|Overall Study|Protocol deviation|0|||
38067568|NCT03257995|69761522|FG003|Overall Study|Protocol deviation|0|||
38067569|NCT03257995|69761523|FG004|Overall Study|Protocol deviation|0|||
38067570|NCT03257995|69761524|FG005|Overall Study|Protocol deviation|2|||
38067571|NCT03049488|69761542|FG000|Overall Study|Lost to Follow-up|1|||
38067572|NCT03049488|69761543|FG001|Overall Study|Lost to Follow-up|1|||
38067573|NCT03049488|69761544|FG002|Overall Study|Lost to Follow-up|0|||
38067574|NCT03049488|69761545|FG003|Overall Study|Lost to Follow-up|0|||
38067575|NCT03049488|69761546|FG004|Overall Study|Lost to Follow-up|0|||
38067576|NCT03049488|69761547|FG005|Overall Study|Lost to Follow-up|0|||
38067577|NCT03049488|69761542|FG000|Overall Study|Moved from Area|1|||
38067578|NCT03049488|69761543|FG001|Overall Study|Moved from Area|0|||
38067579|NCT03049488|69761544|FG002|Overall Study|Moved from Area|0|||
38067580|NCT03049488|69761545|FG003|Overall Study|Moved from Area|1|||
38067581|NCT03049488|69761546|FG004|Overall Study|Moved from Area|1|||
38067582|NCT03049488|69761547|FG005|Overall Study|Moved from Area|0|||
38067583|NCT03049488|69761542|FG000|Overall Study|Physician Decision|0|||
38067584|NCT03049488|69761543|FG001|Overall Study|Physician Decision|1|||
38067585|NCT03049488|69761544|FG002|Overall Study|Physician Decision|0|||
38067586|NCT03049488|69761545|FG003|Overall Study|Physician Decision|0|||
38067587|NCT03049488|69761546|FG004|Overall Study|Physician Decision|0|||
38067588|NCT03049488|69761547|FG005|Overall Study|Physician Decision|0|||
38067589|NCT03049488|69761542|FG000|Overall Study|Withdrawal by Subject|0|||
38067590|NCT03049488|69761543|FG001|Overall Study|Withdrawal by Subject|0|||
38067591|NCT03049488|69761544|FG002|Overall Study|Withdrawal by Subject|0|||
38067592|NCT03049488|69761545|FG003|Overall Study|Withdrawal by Subject|1|||
38067593|NCT03049488|69761546|FG004|Overall Study|Withdrawal by Subject|1|||
38067594|NCT03049488|69761547|FG005|Overall Study|Withdrawal by Subject|0|||
38067595|NCT03257371|69761562|FG000|Overall Study|Lost to Follow-up|1|||
38067596|NCT03242863|69761566|FG000|Study Week 1|Withdrawal by Subject|0|||
38067597|NCT03242863|69761567|FG001|Study Week 1|Withdrawal by Subject|1|||
38067598|NCT03242863|69761568|FG002|Study Week 1|Withdrawal by Subject|0|||
38067599|NCT03242863|69761569|FG003|Study Week 1|Withdrawal by Subject|0|||
38067600|NCT03242863|69761570|FG004|Study Week 1|Withdrawal by Subject|3|||
38067601|NCT03242863|69761571|FG005|Study Week 1|Withdrawal by Subject|0|||
38067602|NCT03044106|69761579|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
38067603|NCT03044106|69761580|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
38067604|NCT03043560|69761606|FG000|Overall Study|Discontinued Intervention|1|||
38067605|NCT03043560|69761607|FG001|Overall Study|Discontinued Intervention|2|||
38067606|NCT03043560|69761606|FG000|Overall Study|Lost to Follow-up|0|||
38067607|NCT03043560|69761607|FG001|Overall Study|Lost to Follow-up|1|||
38067608|NCT03255733|69761633|FG000|Overall Study|Lost to Follow-up|4|||
38067609|NCT03255655|69761639|FG000|Overall Study|Lost to Follow-up|7|||
38067610|NCT03255655|69761640|FG001|Overall Study|Lost to Follow-up|4|||
38067611|NCT02899988|69761650|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
38067612|NCT02899988|69761651|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
38067613|NCT02899988|69761652|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
38067614|NCT02899988|69761653|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
38067615|NCT02899988|69761654|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
38067616|NCT02899988|69761655|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
38067617|NCT02899988|69761656|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
38067618|NCT02899988|69761657|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
38067619|NCT02899988|69761658|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
38067620|NCT02899988|69761659|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
38067621|NCT02899988|69761660|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
38067622|NCT02899988|69761650|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
38067623|NCT02899988|69761651|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
38067624|NCT02899988|69761652|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
38067625|NCT02899988|69761653|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
38067626|NCT02899988|69761654|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
38067627|NCT02899988|69761655|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
38067628|NCT02899988|69761656|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
38067629|NCT02899988|69761657|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
38067630|NCT02899988|69761658|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
38067631|NCT02899988|69761659|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
38067632|NCT02899988|69761660|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
38067633|NCT02899988|69761650|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
38067634|NCT02899988|69761651|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
38067635|NCT02899988|69761652|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
37862304|NCT01130493|69546068|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
37862305|NCT01130493|69546066|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
38067636|NCT02899988|69761653|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
38067637|NCT02899988|69761654|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
38067638|NCT02899988|69761655|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
38067639|NCT02899988|69761656|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
38067640|NCT02899988|69761657|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
38067641|NCT02899988|69761658|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
38067642|NCT02899988|69761659|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
37965892|NCT00372112|69652858|FG001|Overall Study|Exacerbation|0|||
38067643|NCT02899988|69761660|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
38067644|NCT02899988|69761650|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
38067645|NCT02899988|69761651|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
38067646|NCT02899988|69761652|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
38067647|NCT02899988|69761653|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
38067648|NCT02899988|69761654|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
38067649|NCT02899988|69761655|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
38067650|NCT02899988|69761656|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
38067651|NCT02899988|69761657|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
38067652|NCT02899988|69761658|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
38067653|NCT02899988|69761659|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
38067654|NCT02899988|69761660|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
38067655|NCT02899988|69761650|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
38067656|NCT02899988|69761651|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
38067657|NCT02899988|69761652|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
38067658|NCT02899988|69761653|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
38067659|NCT02899988|69761654|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
38067660|NCT02899988|69761655|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
38067661|NCT02899988|69761656|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
38067662|NCT02899988|69761657|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
38067663|NCT02899988|69761658|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
38067664|NCT02899988|69761659|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
38067665|NCT02899988|69761660|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
38067666|NCT02899988|69761650|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
38067667|NCT02899988|69761651|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
38067668|NCT02899988|69761652|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
38067669|NCT02899988|69761653|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
38067670|NCT02899988|69761654|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
38067671|NCT02899988|69761655|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
38067672|NCT02899988|69761656|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
38067673|NCT02899988|69761657|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
38067674|NCT02899988|69761658|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
38067675|NCT02899988|69761659|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
38067676|NCT02899988|69761660|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
38067677|NCT02939131|69761694|FG000|Overall Study|Unable to get to clinic|6|||
38067678|NCT02939131|69761695|FG001|Overall Study|Unable to get to clinic|4|||
38067679|NCT02939131|69761694|FG000|Overall Study|Lost to Follow-up|2|||
38067680|NCT02939131|69761695|FG001|Overall Study|Lost to Follow-up|4|||
38067681|NCT02939131|69761694|FG000|Overall Study|severe debilitation|1|||
38067682|NCT02939131|69761695|FG001|Overall Study|severe debilitation|0|||
38067683|NCT02939131|69761694|FG000|Overall Study|Other|0|||
38067684|NCT02939131|69761695|FG001|Overall Study|Other|1|||
38067685|NCT02939131|69761694|FG000|Overall Study|not willing to adhere to protocol|2|||
38067686|NCT02939131|69761695|FG001|Overall Study|not willing to adhere to protocol|0|||
38067687|NCT03345407|69761709|FG000|Overall Study|Withdrawal by Subject|11|||
38067688|NCT03345407|69761710|FG001|Overall Study|Withdrawal by Subject|1|||
38067689|NCT03345407|69761711|FG002|Overall Study|Withdrawal by Subject|5|||
38067690|NCT03345407|69761712|FG003|Overall Study|Withdrawal by Subject|6|||
38067691|NCT03345407|69761713|FG004|Overall Study|Withdrawal by Subject|3|||
38067692|NCT03345407|69761714|FG005|Overall Study|Withdrawal by Subject|6|||
38067693|NCT03345407|69761715|FG006|Overall Study|Withdrawal by Subject|16|||
38067694|NCT03345407|69761709|FG000|Overall Study|Physician Decision|3|||
38067695|NCT03345407|69761710|FG001|Overall Study|Physician Decision|1|||
38067696|NCT03345407|69761711|FG002|Overall Study|Physician Decision|0|||
38067697|NCT03345407|69761712|FG003|Overall Study|Physician Decision|0|||
38067698|NCT03345407|69761713|FG004|Overall Study|Physician Decision|1|||
38067699|NCT03345407|69761714|FG005|Overall Study|Physician Decision|2|||
38067700|NCT03345407|69761715|FG006|Overall Study|Physician Decision|3|||
38067701|NCT03345407|69761709|FG000|Overall Study|Lost to Follow-up|2|||
38067702|NCT03345407|69761710|FG001|Overall Study|Lost to Follow-up|0|||
38067703|NCT03345407|69761711|FG002|Overall Study|Lost to Follow-up|1|||
38067704|NCT03345407|69761712|FG003|Overall Study|Lost to Follow-up|0|||
38067705|NCT03345407|69761713|FG004|Overall Study|Lost to Follow-up|1|||
38067706|NCT03345407|69761714|FG005|Overall Study|Lost to Follow-up|2|||
38067707|NCT03345407|69761715|FG006|Overall Study|Lost to Follow-up|3|||
38067708|NCT03345407|69761709|FG000|Overall Study|Protocol-defined stopping criteria|9|||
38067709|NCT03345407|69761710|FG001|Overall Study|Protocol-defined stopping criteria|0|||
38067710|NCT03345407|69761711|FG002|Overall Study|Protocol-defined stopping criteria|0|||
38067711|NCT03345407|69761712|FG003|Overall Study|Protocol-defined stopping criteria|0|||
38067712|NCT03345407|69761713|FG004|Overall Study|Protocol-defined stopping criteria|2|||
38067713|NCT03345407|69761714|FG005|Overall Study|Protocol-defined stopping criteria|1|||
38067714|NCT03345407|69761715|FG006|Overall Study|Protocol-defined stopping criteria|1|||
38067715|NCT03345407|69761709|FG000|Overall Study|Protocol Violation|2|||
38067716|NCT03345407|69761710|FG001|Overall Study|Protocol Violation|0|||
38067717|NCT03345407|69761711|FG002|Overall Study|Protocol Violation|0|||
38067718|NCT03345407|69761712|FG003|Overall Study|Protocol Violation|0|||
38067719|NCT03345407|69761713|FG004|Overall Study|Protocol Violation|1|||
38067720|NCT03345407|69761714|FG005|Overall Study|Protocol Violation|0|||
38067721|NCT03345407|69761715|FG006|Overall Study|Protocol Violation|3|||
38067722|NCT03345407|69761709|FG000|Overall Study|Lack of Efficacy|1|||
38067723|NCT03345407|69761710|FG001|Overall Study|Lack of Efficacy|1|||
38067724|NCT03345407|69761711|FG002|Overall Study|Lack of Efficacy|1|||
38067725|NCT03345407|69761712|FG003|Overall Study|Lack of Efficacy|1|||
38067726|NCT03345407|69761713|FG004|Overall Study|Lack of Efficacy|1|||
38067727|NCT03345407|69761714|FG005|Overall Study|Lack of Efficacy|0|||
38067728|NCT03345407|69761715|FG006|Overall Study|Lack of Efficacy|3|||
38067729|NCT03345407|69761709|FG000|Overall Study|Adverse Event|4|||
38067730|NCT03345407|69761710|FG001|Overall Study|Adverse Event|0|||
38067731|NCT03345407|69761711|FG002|Overall Study|Adverse Event|5|||
38067732|NCT03345407|69761712|FG003|Overall Study|Adverse Event|4|||
38067733|NCT03345407|69761713|FG004|Overall Study|Adverse Event|6|||
38067734|NCT03345407|69761714|FG005|Overall Study|Adverse Event|5|||
38067735|NCT03345407|69761715|FG006|Overall Study|Adverse Event|16|||
38067736|NCT03255187|69761739|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
38067737|NCT03255187|69761740|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
38067738|NCT03255187|69761739|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
38067739|NCT03255187|69761740|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
38067740|NCT02929329|69761748|FG000|Overall Study|Withdrawal by Subject|24|||
38067741|NCT02929329|69761749|FG001|Overall Study|Withdrawal by Subject|21|||
38067742|NCT02929329|69761748|FG000|Overall Study|Lost to Follow-up|26|||
38067743|NCT02929329|69761749|FG001|Overall Study|Lost to Follow-up|20|||
38067744|NCT02929329|69761748|FG000|Overall Study|Death|1054|||
38067745|NCT02929329|69761749|FG001|Overall Study|Death|1051|||
38067746|NCT03240133|69761762|FG000|Overall Study|Withdrawal by Subject|0|||
38067747|NCT03240133|69761763|FG001|Overall Study|Withdrawal by Subject|1|||
38067748|NCT03240133|69761764|FG002|Overall Study|Withdrawal by Subject|0|||
38067749|NCT03240133|69761762|FG000|Overall Study|Adverse Event|1|||
38067750|NCT03240133|69761763|FG001|Overall Study|Adverse Event|1|||
38067751|NCT03240133|69761764|FG002|Overall Study|Adverse Event|0|||
38067752|NCT03240133|69761762|FG000|Overall Study|Rash|1|||
38067753|NCT03240133|69761763|FG001|Overall Study|Rash|0|||
38067754|NCT03240133|69761764|FG002|Overall Study|Rash|0|||
38067755|NCT03240133|69761762|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
38067756|NCT03240133|69761763|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
38067757|NCT03240133|69761764|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
38067758|NCT03240133|69761762|FG000|Overall Study|Intercurrent illness.|0|||
38067759|NCT03240133|69761763|FG001|Overall Study|Intercurrent illness.|1|||
38067760|NCT03240133|69761764|FG002|Overall Study|Intercurrent illness.|0|||
38067761|NCT03240133|69761762|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
38067762|NCT03240133|69761763|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
38067763|NCT03240133|69761764|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
38067764|NCT03372083|69761788|FG000|Overall Study|Adverse Event|3|||
38067765|NCT03372083|69761788|FG000|Overall Study|Physician Decision|1|||
38067766|NCT03372083|69761788|FG000|Overall Study|Withdrawal by Subject|1|||
38067767|NCT03044886|69761795|FG000|Overall Study|Lost to Follow-up|15|||
38067768|NCT03044886|69761796|FG001|Overall Study|Lost to Follow-up|10|||
38067769|NCT03044886|69761797|FG002|Overall Study|Lost to Follow-up|12|||
38067770|NCT02961764|69761807|FG000|Overall Study|Protocol Violation|0|||
38067771|NCT02961764|69761808|FG001|Overall Study|Protocol Violation|1|||
38067772|NCT02961764|69761807|FG000|Overall Study|Death|2|||
38067773|NCT02961764|69761808|FG001|Overall Study|Death|0|||
38067774|NCT02961764|69761807|FG000|Overall Study|Lost to Follow-up|35|||
38067775|NCT02961764|69761808|FG001|Overall Study|Lost to Follow-up|24|||
38067776|NCT02961764|69761807|FG000|Overall Study|Withdrawal by Subject|2|||
38067777|NCT02961764|69761808|FG001|Overall Study|Withdrawal by Subject|0|||
38067778|NCT03371459|69761814|FG000|Washout|Lost to Follow-up|0|||
38067779|NCT03371459|69761815|FG001|Washout|Lost to Follow-up|1|||
38067780|NCT02961920|69761823|FG000|Overall Study|did not achive stydy protocol schedule|1|||
38067781|NCT02961920|69761824|FG001|Overall Study|did not achive stydy protocol schedule|1|||
38067782|NCT03371381|69761830|FG000|Overall Study|Death|5|||
38067783|NCT03371381|69761830|FG000|Overall Study|Study terminated by sponsor|3|||
38067784|NCT03371381|69761830|FG000|Overall Study|Other|4|||
38067785|NCT03044730|69761834|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
38067786|NCT03044730|69761834|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
38067787|NCT03044730|69761834|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
38067788|NCT03044730|69761834|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
38067789|NCT03044730|69761834|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
38067790|NCT03044730|69761834|FG000|Cycles 4 and Beyond|Adverse Event|1|||
38067791|NCT03044730|69761834|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
38067792|NCT03044730|69761834|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
38067793|NCT03044730|69761834|FG000|On Follow-up for 2 Years|Death|17|||
38067794|NCT02961374|69761839|FG000|Overall Study|Adverse Event|4|||
38067795|NCT02951429|69761845|FG000|Overall Study|Adverse Event|3|||
38067796|NCT02951429|69761846|FG001|Overall Study|Adverse Event|7|||
38067797|NCT02951429|69761845|FG000|Overall Study|Death|28|||
38067798|NCT02951429|69761846|FG001|Overall Study|Death|36|||
38067799|NCT02951429|69761845|FG000|Overall Study|Lack of Efficacy|0|||
38067800|NCT02951429|69761846|FG001|Overall Study|Lack of Efficacy|1|||
38067801|NCT02951429|69761845|FG000|Overall Study|Lost to Follow-up|0|||
38067802|NCT02951429|69761846|FG001|Overall Study|Lost to Follow-up|1|||
38067803|NCT02951429|69761845|FG000|Overall Study|Lung Transplantation|9|||
38067804|NCT02951429|69761846|FG001|Overall Study|Lung Transplantation|6|||
38067805|NCT02951429|69761845|FG000|Overall Study|Other|1|||
38067806|NCT02951429|69761846|FG001|Overall Study|Other|3|||
38067807|NCT02951429|69761845|FG000|Overall Study|Progressive Disease|1|||
38067808|NCT02951429|69761846|FG001|Overall Study|Progressive Disease|1|||
38067809|NCT02951429|69761845|FG000|Overall Study|Withdrawal by Subject|7|||
38067810|NCT02951429|69761846|FG001|Overall Study|Withdrawal by Subject|11|||
38067811|NCT02951429|69761845|FG000|Overall Study|Participant ongoing in the study|23|||
38067812|NCT02951429|69761846|FG001|Overall Study|Participant ongoing in the study|17|||
38067813|NCT03343067|69761859|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
38067814|NCT03343067|69761860|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
38067815|NCT03343067|69761861|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
38067816|NCT03103503|69761869|FG000|Overall Study|Death|64|||
38067817|NCT03103503|69761869|FG000|Overall Study|Physician Decision|57|||
38067818|NCT03103503|69761869|FG000|Overall Study|Withdrawal by Subject|10|||
38067819|NCT03103503|69761869|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
38067820|NCT03103503|69761869|FG000|Overall Study|Lost to Follow-up|3|||
38067821|NCT03103503|69761869|FG000|Overall Study|Study Closure|757|||
38067822|NCT02961218|69761875|FG000|Overall Study|Lost to Follow-up|0|||
38067823|NCT02961218|69761876|FG001|Overall Study|Lost to Follow-up|2|||
38067824|NCT02961218|69761875|FG000|Overall Study|Physician Decision|0|||
38067825|NCT02961218|69761876|FG001|Overall Study|Physician Decision|2|||
38067826|NCT02961218|69761875|FG000|Overall Study|Subject/Guardian Decision|3|||
38067827|NCT02961218|69761876|FG001|Overall Study|Subject/Guardian Decision|1|||
38067828|NCT02949947|69761886|FG000|Overall Study|Non Compliance|0|||
38067829|NCT02949947|69761887|FG001|Overall Study|Non Compliance|1|||
38067830|NCT02949947|69761886|FG000|Overall Study|Insurance change|1|||
38067831|NCT02949947|69761887|FG001|Overall Study|Insurance change|0|||
38067832|NCT03341507|69761893|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
38067833|NCT01345058|69761899|FG000|Overall Study|Withdrawal by Subject|1|||
38067834|NCT01345058|69761900|FG001|Overall Study|Withdrawal by Subject|0|||
38067835|NCT01345058|69761899|FG000|Overall Study|Participant Reported Increase in Events|1|||
38067836|NCT01345058|69761900|FG001|Overall Study|Participant Reported Increase in Events|0|||
38067837|NCT01345058|69761899|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
38067838|NCT01345058|69761900|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
38067839|NCT01345058|69761899|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
38067840|NCT01345058|69761900|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
38067841|NCT01345058|69761899|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
38067842|NCT01345058|69761900|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
38067843|NCT01345292|69761909|FG000|Overall Study|Withdrawal by Subject|2|||
38067844|NCT01345292|69761910|FG001|Overall Study|Withdrawal by Subject|0|||
38067845|NCT01345292|69761911|FG002|Overall Study|Withdrawal by Subject|1|||
38067846|NCT03340961|69761923|FG000|Overall Study|Adverse Event|1|||
38067847|NCT03340961|69761924|FG001|Overall Study|Adverse Event|3|||
38067848|NCT03340961|69761925|FG002|Overall Study|Adverse Event|2|||
38067849|NCT03340961|69761926|FG003|Overall Study|Adverse Event|4|||
38067850|NCT03340961|69761923|FG000|Overall Study|Lost to Follow-up|0|||
38067851|NCT03340961|69761924|FG001|Overall Study|Lost to Follow-up|1|||
38067852|NCT03340961|69761925|FG002|Overall Study|Lost to Follow-up|0|||
38067853|NCT03340961|69761926|FG003|Overall Study|Lost to Follow-up|1|||
37862306|NCT01130493|69546067|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
37862307|NCT01130493|69546068|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
38067854|NCT03340961|69761923|FG000|Overall Study|Withdrawal by Subject|3|||
38067855|NCT03340961|69761924|FG001|Overall Study|Withdrawal by Subject|2|||
38067856|NCT03340961|69761925|FG002|Overall Study|Withdrawal by Subject|4|||
38067857|NCT03340961|69761926|FG003|Overall Study|Withdrawal by Subject|7|||
38067858|NCT03340961|69761923|FG000|Overall Study|Use of prohibited treatment|0|||
38067859|NCT03340961|69761924|FG001|Overall Study|Use of prohibited treatment|3|||
38067860|NCT03340961|69761925|FG002|Overall Study|Use of prohibited treatment|2|||
38067861|NCT03340961|69761926|FG003|Overall Study|Use of prohibited treatment|4|||
38067862|NCT03340961|69761923|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
38067863|NCT03340961|69761924|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
38067864|NCT03340961|69761925|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
38067865|NCT03340961|69761926|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
38067866|NCT03340961|69761923|FG000|Overall Study|Subject developed an exclusion criterion|0|||
38067867|NCT03340961|69761924|FG001|Overall Study|Subject developed an exclusion criterion|1|||
38067868|NCT03340961|69761925|FG002|Overall Study|Subject developed an exclusion criterion|0|||
38067869|NCT03340961|69761926|FG003|Overall Study|Subject developed an exclusion criterion|0|||
38067870|NCT03340961|69761923|FG000|Overall Study|Protocol Violation|1|||
38067871|NCT03340961|69761924|FG001|Overall Study|Protocol Violation|0|||
38067872|NCT03340961|69761925|FG002|Overall Study|Protocol Violation|1|||
38067873|NCT03340961|69761926|FG003|Overall Study|Protocol Violation|0|||
38067874|NCT03340961|69761923|FG000|Overall Study|Adverse Event|1|||
38067875|NCT03340961|69761924|FG001|Overall Study|Adverse Event|1|||
38067876|NCT03340961|69761925|FG002|Overall Study|Adverse Event|0|||
38067877|NCT03340961|69761926|FG003|Overall Study|Adverse Event|0|||
38067878|NCT03340961|69761923|FG000|Overall Study|Lack of Efficacy|0|||
38067879|NCT03340961|69761924|FG001|Overall Study|Lack of Efficacy|0|||
38067880|NCT03340961|69761925|FG002|Overall Study|Lack of Efficacy|0|||
38067881|NCT03340961|69761926|FG003|Overall Study|Lack of Efficacy|1|||
38067882|NCT03340025|69761938|FG000|Overall Study|Lost to Follow-up|2|||
38067883|NCT03340025|69761939|FG001|Overall Study|Lost to Follow-up|2|||
38067884|NCT03339713|69761947|FG000|Overall Study|Lost to Follow-up|2|||
38067885|NCT03339713|69761948|FG001|Overall Study|Lost to Follow-up|1|||
38067886|NCT03339713|69761947|FG000|Overall Study|Protocol Violation|1|||
38067887|NCT03339713|69761948|FG001|Overall Study|Protocol Violation|0|||
38067888|NCT03339713|69761947|FG000|Overall Study|Withdrawal by Subject|1|||
38067889|NCT03339713|69761948|FG001|Overall Study|Withdrawal by Subject|1|||
38067890|NCT03254485|69761960|FG000|Overall Study|Adverse Event|3|||
38067891|NCT03254485|69761961|FG001|Overall Study|Adverse Event|0|||
38067892|NCT03254485|69761962|FG002|Overall Study|Adverse Event|0|||
38067893|NCT03254485|69761963|FG003|Overall Study|Adverse Event|6|||
38067894|NCT03254485|69761960|FG000|Overall Study|Protocol Violation|6|||
38067895|NCT03254485|69761961|FG001|Overall Study|Protocol Violation|0|||
38067896|NCT03254485|69761962|FG002|Overall Study|Protocol Violation|0|||
38067897|NCT03254485|69761963|FG003|Overall Study|Protocol Violation|2|||
38067898|NCT03254485|69761960|FG000|Overall Study|Withdrawal by Subject|1|||
38067899|NCT03254485|69761961|FG001|Overall Study|Withdrawal by Subject|0|||
38067900|NCT03254485|69761962|FG002|Overall Study|Withdrawal by Subject|0|||
38067901|NCT03254485|69761963|FG003|Overall Study|Withdrawal by Subject|4|||
38067902|NCT03254485|69761960|FG000|Overall Study|Death|0|||
38067903|NCT03254485|69761961|FG001|Overall Study|Death|0|||
38067904|NCT03254485|69761962|FG002|Overall Study|Death|0|||
38067905|NCT03254485|69761963|FG003|Overall Study|Death|1|||
37965893|NCT00372112|69652859|FG002|Overall Study|Exacerbation|0|||
37965894|NCT00372112|69652860|FG003|Overall Study|Exacerbation|1|||
37965895|NCT00372112|69652857|FG000|Overall Study|PR >240 at Visit 3|0|||
37965896|NCT00372112|69652858|FG001|Overall Study|PR >240 at Visit 3|0|||
38067906|NCT03254485|69761960|FG000|Overall Study|Lost to Follow-up|1|||
38067907|NCT03254485|69761961|FG001|Overall Study|Lost to Follow-up|0|||
38067908|NCT03254485|69761962|FG002|Overall Study|Lost to Follow-up|0|||
38067909|NCT03254485|69761963|FG003|Overall Study|Lost to Follow-up|0|||
38067910|NCT03254485|69761960|FG000|Overall Study|Other|1|||
38067911|NCT03254485|69761961|FG001|Overall Study|Other|0|||
38067912|NCT03254485|69761962|FG002|Overall Study|Other|0|||
38067913|NCT03254485|69761963|FG003|Overall Study|Other|2|||
38067914|NCT03339401|69761976|FG000|Overall Study|Death|2|||
38067915|NCT03339401|69761977|FG001|Overall Study|Death|1|||
38067916|NCT03339401|69761976|FG000|Overall Study|Withdrawal by Subject|2|||
38067917|NCT03339401|69761977|FG001|Overall Study|Withdrawal by Subject|0|||
38067918|NCT03339401|69761976|FG000|Overall Study|Study terminated|4|||
38067919|NCT03339401|69761977|FG001|Overall Study|Study terminated|3|||
38067920|NCT03339401|69761976|FG000|Overall Study|Investigator Decision|1|||
38067921|NCT03339401|69761977|FG001|Overall Study|Investigator Decision|0|||
38067922|NCT03370289|69761983|FG000|Overall Study|Screen Failure|1|||
38067923|NCT03370289|69761983|FG000|Overall Study|Sample Size Sufficient|4|||
38067924|NCT01344824|69761987|FG000|Overall Study|Adverse Event|15|||
38067925|NCT01344824|69761987|FG000|Overall Study|Withdrawal by Subject|6|||
38067926|NCT01344824|69761987|FG000|Overall Study|Other complicating disease|1|||
38067927|NCT01344824|69761987|FG000|Overall Study|Progression|15|||
38067928|NCT03339245|69761994|FG000|Overall Study|Adverse Event|1|||
38067929|NCT03339245|69761995|FG001|Overall Study|Adverse Event|1|||
38067930|NCT03339245|69761994|FG000|Overall Study|Withdrawal by Subject|1|||
38067931|NCT03339245|69761995|FG001|Overall Study|Withdrawal by Subject|0|||
38067932|NCT03044574|69762003|FG000|Overall Study|Lost to Follow-up|37|||
38067933|NCT03044574|69762004|FG001|Overall Study|Lost to Follow-up|45|||
38067934|NCT02959892|69762012|FG000|Overall Study|PET tracer synthesis failure|1|||
38067935|NCT02959892|69762013|FG001|Overall Study|PET tracer synthesis failure|0|||
38067936|NCT02959892|69762012|FG000|Overall Study|Study termination|0|||
38067937|NCT02959892|69762013|FG001|Overall Study|Study termination|1|||
38067938|NCT03252145|69762021|FG000|Overall Study|Withdrawal by Subject|1|||
38067939|NCT03252145|69762022|FG001|Overall Study|Withdrawal by Subject|0|||
38067940|NCT03252145|69762021|FG000|Overall Study|Complicating Disease|1|||
38067941|NCT03252145|69762022|FG001|Overall Study|Complicating Disease|2|||
38067942|NCT02959814|69762028|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
38067943|NCT02959814|69762028|FG000|Overall Study|Excluded based on anatomical criteria|2|||
38067944|NCT02959814|69762028|FG000|Overall Study|Protocol Violation|7|||
38067945|NCT02959814|69762028|FG000|Overall Study|FFR not measured|2|||
38067946|NCT02959814|69762028|FG000|Overall Study|In-procedure QFR not computed|6|||
38067947|NCT02959814|69762028|FG000|Overall Study|Excluded by FFR core-lab|24|||
38067948|NCT03666624|69762035|FG000|Overall Study|participant grieving over recent death of parent|1|||
38067949|NCT03666624|69762036|FG001|Overall Study|participant grieving over recent death of parent|0|||
38067950|NCT03368807|69762042|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
38067951|NCT03368807|69762042|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
38067952|NCT03368807|69762042|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
38067953|NCT03368807|69762042|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
38067954|NCT03338855|69762050|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
38067955|NCT03338855|69762051|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
38067956|NCT03367793|69762063|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
38067957|NCT03367793|69762064|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
38067958|NCT03367793|69762065|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
38067959|NCT03367793|69762066|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
38067960|NCT03367793|69762067|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
38067961|NCT03367793|69762068|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
38067962|NCT01347307|69762090|FG000|Overall Study|Death|0|||
38067963|NCT01347307|69762091|FG001|Overall Study|Death|4|||
38067964|NCT01347307|69762090|FG000|Overall Study|Physician Decision|0|||
38067965|NCT01347307|69762091|FG001|Overall Study|Physician Decision|1|||
38067966|NCT03247543|69762148|FG000|Overall Study|Adverse Event|3|||
38067967|NCT03247543|69762149|FG001|Overall Study|Adverse Event|6|||
38067968|NCT03247543|69762150|FG002|Overall Study|Adverse Event|4|||
38067969|NCT03247543|69762148|FG000|Overall Study|Lost to Follow-up|10|||
38067970|NCT03247543|69762149|FG001|Overall Study|Lost to Follow-up|7|||
38067971|NCT03247543|69762150|FG002|Overall Study|Lost to Follow-up|8|||
38067972|NCT03247543|69762148|FG000|Overall Study|Consent withdrawn by caregiver|2|||
38067973|NCT03247543|69762149|FG001|Overall Study|Consent withdrawn by caregiver|2|||
38067974|NCT03247543|69762150|FG002|Overall Study|Consent withdrawn by caregiver|9|||
38067975|NCT03247543|69762148|FG000|Overall Study|Withdrawal by Subject|0|||
38067976|NCT03247543|69762149|FG001|Overall Study|Withdrawal by Subject|0|||
38067977|NCT03247543|69762150|FG002|Overall Study|Withdrawal by Subject|1|||
38067978|NCT03247543|69762148|FG000|Overall Study|Failure to Follow study procedures|1|||
38067979|NCT03247543|69762149|FG001|Overall Study|Failure to Follow study procedures|3|||
38067980|NCT03247543|69762150|FG002|Overall Study|Failure to Follow study procedures|1|||
38067981|NCT03247543|69762148|FG000|Overall Study|Lack of Efficacy|1|||
38067982|NCT03247543|69762149|FG001|Overall Study|Lack of Efficacy|0|||
38067983|NCT03247543|69762150|FG002|Overall Study|Lack of Efficacy|0|||
38067984|NCT03247543|69762148|FG000|Overall Study|Non-compliance with study visits|0|||
38067985|NCT03247543|69762149|FG001|Overall Study|Non-compliance with study visits|1|||
38067986|NCT03247543|69762150|FG002|Overall Study|Non-compliance with study visits|0|||
38067987|NCT01347073|69762160|FG000|Overall Study|Adverse Event|1|||
38067988|NCT01347073|69762160|FG000|Overall Study|Liver Transplant|1|||
38067989|NCT01315236|69762172|FG000|Double-blind Phase|Death|1|||
38067990|NCT01315236|69762173|FG001|Double-blind Phase|Death|0|||
38067991|NCT01315236|69762172|FG000|Double-blind Phase|Adverse Event|1|||
38067992|NCT01315236|69762173|FG001|Double-blind Phase|Adverse Event|0|||
38067993|NCT01315236|69762172|FG000|Double-blind Phase|Withdrawal of Consent|1|||
38067994|NCT01315236|69762173|FG001|Double-blind Phase|Withdrawal of Consent|0|||
38067995|NCT01315236|69762172|FG000|Double-blind Phase|Lost to Follow-up|1|||
38067996|NCT01315236|69762173|FG001|Double-blind Phase|Lost to Follow-up|0|||
38067997|NCT01315236|69762172|FG000|Open-label Phase|Death|1|||
38067998|NCT01315236|69762173|FG001|Open-label Phase|Death|0|||
38067999|NCT01315236|69762172|FG000|Open-label Phase|Adverse Event|0|||
38068000|NCT01315236|69762173|FG001|Open-label Phase|Adverse Event|1|||
38068001|NCT01315236|69762172|FG000|Open-label Phase|Other|0|||
38068002|NCT01315236|69762173|FG001|Open-label Phase|Other|1|||
38068003|NCT01315236|69762172|FG000|12-Month Follow-up Period|Death|0|||
38068004|NCT01315236|69762173|FG001|12-Month Follow-up Period|Death|1|||
38068005|NCT01315236|69762172|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
38068006|NCT01315236|69762173|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
38068007|NCT03232567|69762185|FG000|Overall Study|Withdrawal by Subject|0|||
38068008|NCT03232567|69762186|FG001|Overall Study|Withdrawal by Subject|1|||
37680395|NCT02582749|69156036|FG001|Overall Study|Study terminated by funder|10|||
38068009|NCT03232567|69762187|FG002|Overall Study|Withdrawal by Subject|0|||
38068010|NCT03232567|69762188|FG003|Overall Study|Withdrawal by Subject|0|||
38068011|NCT01348490|69762198|FG000|Overall Study|Death|1|||
38068012|NCT01348490|69762198|FG000|Overall Study|Adverse Event|3|||
38068013|NCT01348490|69762198|FG000|Overall Study|Consent withdrawn|7|||
38068014|NCT01348490|69762198|FG000|Overall Study|Disease progression|3|||
38068015|NCT01348490|69762198|FG000|Overall Study|Lost to Follow-up|1|||
38068016|NCT01348490|69762198|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
38068017|NCT01348490|69762198|FG000|Overall Study|Other Unspecified|8|||
38068018|NCT03040674|69762219|FG000|Overall Study|Lost to Follow-up|225|||
38068019|NCT03040674|69762219|FG000|Overall Study|Death|23|||
38068020|NCT03232333|69762224|FG000|Overall Study|Infection or Osteomyelitis|9|||
38068021|NCT03232333|69762224|FG000|Overall Study|Lost to Follow-up|4|||
38068022|NCT03232333|69762224|FG000|Overall Study|Withdrawal by Subject|2|||
38068023|NCT03364049|69762232|FG000|Overall Study|Death|6|||
38068024|NCT03364049|69762233|FG001|Overall Study|Death|4|||
38068025|NCT03364049|69762234|FG002|Overall Study|Death|5|||
38068026|NCT03364049|69762235|FG003|Overall Study|Death|14|||
38068027|NCT03364049|69762232|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
38068028|NCT03364049|69762233|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
38068029|NCT03364049|69762234|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
38068030|NCT03364049|69762235|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
38068031|NCT03364049|69762232|FG000|Overall Study|Withdrawal by Subject|0|||
38068032|NCT03364049|69762233|FG001|Overall Study|Withdrawal by Subject|1|||
38068033|NCT03364049|69762234|FG002|Overall Study|Withdrawal by Subject|1|||
38068034|NCT03364049|69762235|FG003|Overall Study|Withdrawal by Subject|1|||
38068035|NCT03238963|69762247|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
38068036|NCT03238963|69762248|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
38068037|NCT03238963|69762247|FG000|Overall Study|Withdrawal by Subject|1|||
38068038|NCT03238963|69762248|FG001|Overall Study|Withdrawal by Subject|1|||
38068039|NCT03238963|69762247|FG000|Overall Study|Lost to Follow-up|1|||
38068040|NCT03238963|69762248|FG001|Overall Study|Lost to Follow-up|0|||
38068041|NCT03238963|69762247|FG000|Overall Study|Protocol Violation|1|||
38068042|NCT03238963|69762248|FG001|Overall Study|Protocol Violation|1|||
38068043|NCT03238963|69762247|FG000|Overall Study|Adverse Event|1|||
38068044|NCT03238963|69762248|FG001|Overall Study|Adverse Event|0|||
38068045|NCT03337139|69762256|FG000|Phase I|Withdrawal by Subject|10|||
38068046|NCT03337139|69762257|FG001|Phase I|Withdrawal by Subject|0|||
38068047|NCT03042312|69762265|FG000|Overall Study|Administrative Reason|1|||
38068048|NCT03042312|69762266|FG001|Overall Study|Administrative Reason|1|||
38068049|NCT03042312|69762265|FG000|Overall Study|Adverse Event|0|||
38068050|NCT03042312|69762266|FG001|Overall Study|Adverse Event|1|||
38068051|NCT03042312|69762265|FG000|Overall Study|Lost to Follow-up|1|||
38068052|NCT03042312|69762266|FG001|Overall Study|Lost to Follow-up|3|||
38068053|NCT03042312|69762265|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
38068054|NCT03042312|69762266|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
38068055|NCT03042312|69762265|FG000|Overall Study|Withdrawal by Subject|4|||
38068056|NCT03042312|69762266|FG001|Overall Study|Withdrawal by Subject|5|||
38068057|NCT03360071|69762274|FG000|Overall Study|Lost to Follow-up|1|||
38068058|NCT03360071|69762275|FG001|Overall Study|Lost to Follow-up|0|||
38068059|NCT02949011|69762284|FG000|Overall Study|Adverse Event|6|||
38068060|NCT02949011|69762285|FG001|Overall Study|Adverse Event|7|||
38068061|NCT02949011|69762286|FG002|Overall Study|Adverse Event|3|||
38068062|NCT02949011|69762284|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
38068063|NCT02949011|69762285|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
38068064|NCT02949011|69762286|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
38068065|NCT02949011|69762284|FG000|Overall Study|Protocol Deviation|5|||
38068066|NCT02949011|69762285|FG001|Overall Study|Protocol Deviation|3|||
38068067|NCT02949011|69762286|FG002|Overall Study|Protocol Deviation|3|||
38068068|NCT02949011|69762284|FG000|Overall Study|Lack of Efficacy|0|||
38068069|NCT02949011|69762285|FG001|Overall Study|Lack of Efficacy|2|||
38068070|NCT02949011|69762286|FG002|Overall Study|Lack of Efficacy|0|||
38068071|NCT02949011|69762284|FG000|Overall Study|Withdrawal by Subject|13|||
38068072|NCT02949011|69762285|FG001|Overall Study|Withdrawal by Subject|13|||
38068073|NCT02949011|69762286|FG002|Overall Study|Withdrawal by Subject|21|||
38068074|NCT02949011|69762284|FG000|Overall Study|Lost to Follow-up|7|||
38068075|NCT02949011|69762285|FG001|Overall Study|Lost to Follow-up|5|||
38068076|NCT02949011|69762286|FG002|Overall Study|Lost to Follow-up|5|||
38068077|NCT02949011|69762284|FG000|Overall Study|Death|0|||
38068078|NCT02949011|69762285|FG001|Overall Study|Death|0|||
38068079|NCT02949011|69762286|FG002|Overall Study|Death|1|||
38068080|NCT02949011|69762284|FG000|Overall Study|Miscellaneous|2|||
38068081|NCT02949011|69762285|FG001|Overall Study|Miscellaneous|4|||
37965897|NCT00372112|69652859|FG002|Overall Study|PR >240 at Visit 3|0|||
38068082|NCT02949011|69762286|FG002|Overall Study|Miscellaneous|6|||
38068083|NCT03357731|69762298|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
38068084|NCT03357731|69762299|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
38068085|NCT03357731|69762300|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
38068086|NCT03357731|69762301|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
38068087|NCT03357731|69762302|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
38068088|NCT03357731|69762303|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
38068089|NCT03357731|69762298|FG000|Overall Study|Acute bradycardia and hypotension|0|||
38068090|NCT03357731|69762299|FG001|Overall Study|Acute bradycardia and hypotension|0|||
38068091|NCT03357731|69762300|FG002|Overall Study|Acute bradycardia and hypotension|0|||
38068092|NCT03357731|69762301|FG003|Overall Study|Acute bradycardia and hypotension|1|||
38068093|NCT03357731|69762302|FG004|Overall Study|Acute bradycardia and hypotension|0|||
38068094|NCT03357731|69762303|FG005|Overall Study|Acute bradycardia and hypotension|0|||
38068095|NCT03357731|69762298|FG000|Overall Study|Adverse Event|0|||
38068096|NCT03357731|69762299|FG001|Overall Study|Adverse Event|0|||
38068097|NCT03357731|69762300|FG002|Overall Study|Adverse Event|0|||
38068098|NCT03357731|69762301|FG003|Overall Study|Adverse Event|0|||
38068099|NCT03357731|69762302|FG004|Overall Study|Adverse Event|0|||
38068100|NCT03357731|69762303|FG005|Overall Study|Adverse Event|1|||
38068101|NCT03357731|69762298|FG000|Overall Study|Hypotension|0|||
38068102|NCT03357731|69762299|FG001|Overall Study|Hypotension|0|||
38068103|NCT03357731|69762300|FG002|Overall Study|Hypotension|1|||
38068104|NCT03357731|69762301|FG003|Overall Study|Hypotension|1|||
38068105|NCT03357731|69762302|FG004|Overall Study|Hypotension|0|||
38068106|NCT03357731|69762303|FG005|Overall Study|Hypotension|0|||
38068107|NCT03357731|69762298|FG000|Overall Study|Lost to Follow-up|0|||
38068108|NCT03357731|69762299|FG001|Overall Study|Lost to Follow-up|0|||
38068109|NCT03357731|69762300|FG002|Overall Study|Lost to Follow-up|0|||
38068110|NCT03357731|69762301|FG003|Overall Study|Lost to Follow-up|1|||
38068111|NCT03357731|69762302|FG004|Overall Study|Lost to Follow-up|0|||
38068112|NCT03357731|69762303|FG005|Overall Study|Lost to Follow-up|0|||
38068113|NCT03357341|69762313|FG000|Overall Study|Withdrawal by Subject|3|||
38068114|NCT03357341|69762314|FG001|Overall Study|Withdrawal by Subject|6|||
38068115|NCT03357341|69762313|FG000|Overall Study|Lost to Follow-up|4|||
38068116|NCT03357341|69762314|FG001|Overall Study|Lost to Follow-up|5|||
38068117|NCT03357341|69762313|FG000|Overall Study|Death|0|||
38068118|NCT03357341|69762314|FG001|Overall Study|Death|1|||
38068119|NCT03039738|69762323|FG000|Overall Study|Incomplete data sets|54|||
38068120|NCT03039738|69762324|FG001|Overall Study|Incomplete data sets|0|||
38068121|NCT03036852|69762355|FG000|Overall Study|Death|2|||
38068122|NCT03036852|69762355|FG000|Overall Study|Lack of Efficacy|2|||
38068123|NCT03036852|69762355|FG000|Overall Study|Adverse Event|1|||
38068124|NCT03036852|69762355|FG000|Overall Study|Lost to Follow-up|1|||
38068125|NCT02945657|69762366|FG000|Overall Study|Adverse Event|1|||
38068126|NCT02945657|69762366|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
38068127|NCT02948777|69762371|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
38068128|NCT03324581|69762379|FG000|Overall Study|Adverse Event|18|||
38068129|NCT03324581|69762380|FG001|Overall Study|Adverse Event|11|||
38068130|NCT03324581|69762381|FG002|Overall Study|Adverse Event|7|||
38068131|NCT03324581|69762379|FG000|Overall Study|Lack of Efficacy|0|||
38068132|NCT03324581|69762380|FG001|Overall Study|Lack of Efficacy|1|||
38068133|NCT03324581|69762381|FG002|Overall Study|Lack of Efficacy|0|||
38068134|NCT03324581|69762379|FG000|Overall Study|Lost to Follow-up|5|||
38068135|NCT03324581|69762380|FG001|Overall Study|Lost to Follow-up|3|||
38068136|NCT03324581|69762381|FG002|Overall Study|Lost to Follow-up|6|||
38068137|NCT03324581|69762379|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
38068138|NCT03324581|69762380|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
38068139|NCT03324581|69762381|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
38068140|NCT03324581|69762379|FG000|Overall Study|Physician Decision|0|||
38068141|NCT03324581|69762380|FG001|Overall Study|Physician Decision|1|||
38068142|NCT03324581|69762381|FG002|Overall Study|Physician Decision|2|||
38068143|NCT03324581|69762379|FG000|Overall Study|Protocol Deviation|8|||
38068144|NCT03324581|69762380|FG001|Overall Study|Protocol Deviation|9|||
38068145|NCT03324581|69762381|FG002|Overall Study|Protocol Deviation|4|||
38068146|NCT03324581|69762379|FG000|Overall Study|Withdrawal by Subject|6|||
38068147|NCT03324581|69762380|FG001|Overall Study|Withdrawal by Subject|8|||
38068148|NCT03324581|69762381|FG002|Overall Study|Withdrawal by Subject|6|||
38068149|NCT03324581|69762379|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
38068150|NCT03324581|69762380|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
38068151|NCT03324581|69762381|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
38068152|NCT02943473|69762389|FG000|Overall Study|enrolled but not dosed|1|||
38068153|NCT02943473|69762389|FG000|Overall Study|screen failure|1|||
38068154|NCT02943473|69762389|FG000|Overall Study|Physician Decision|4|||
38068155|NCT03320369|69762393|FG000|Overall Study|Adverse Event|1|||
38068156|NCT03320369|69762393|FG000|Overall Study|Withdrawal by Subject|2|||
38068157|NCT02650895|69762403|FG000|Overall Study|Withdrawal by Subject|0|||
38068158|NCT02650895|69762404|FG001|Overall Study|Withdrawal by Subject|1|||
38068159|NCT02650895|69762405|FG002|Overall Study|Withdrawal by Subject|0|||
38068160|NCT02650895|69762406|FG003|Overall Study|Withdrawal by Subject|0|||
38068161|NCT02650895|69762407|FG004|Overall Study|Withdrawal by Subject|0|||
38068162|NCT02650895|69762408|FG005|Overall Study|Withdrawal by Subject|0|||
37680396|NCT02582749|69156035|FG000|Overall Study|Withdrawal by Subject|0|||
38068163|NCT03320057|69762427|FG000|Overall Study|Lost to Follow-up|4|||
38068164|NCT03320057|69762428|FG001|Overall Study|Lost to Follow-up|17|||
38068165|NCT03320057|69762427|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
38068166|NCT03320057|69762428|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
38068167|NCT03316547|69762436|FG000|Overall Study|Death|3|||
38068168|NCT03316547|69762437|FG001|Overall Study|Death|1|||
38068169|NCT03316547|69762436|FG000|Overall Study|Lost to Follow-up|6|||
38068170|NCT03316547|69762437|FG001|Overall Study|Lost to Follow-up|6|||
38068171|NCT03316547|69762436|FG000|Overall Study|Withdrawal by Subject|3|||
38068172|NCT03316547|69762437|FG001|Overall Study|Withdrawal by Subject|2|||
38068173|NCT03316547|69762436|FG000|Overall Study|Transfer to another hospital|6|||
38068174|NCT03316547|69762437|FG001|Overall Study|Transfer to another hospital|4|||
38068175|NCT03315689|69762460|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
38068176|NCT03315689|69762461|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
38068177|NCT03315689|69762460|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
38068178|NCT03315689|69762461|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
38068179|NCT03315689|69762460|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
38068180|NCT03315689|69762461|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
38068181|NCT03314519|69762471|FG000|Overall Study|Protocol Violation|3|||
38068182|NCT03314519|69762472|FG001|Overall Study|Protocol Violation|2|||
38068183|NCT03313037|69762484|FG000|Overall Study|Protocol Violation|4|||
38068184|NCT03313037|69762485|FG001|Overall Study|Protocol Violation|1|||
38068185|NCT03313037|69762484|FG000|Overall Study|Other|1|||
38068186|NCT03313037|69762485|FG001|Overall Study|Other|1|||
38068187|NCT03313037|69762484|FG000|Overall Study|Withdrawal by Subject|4|||
38068188|NCT03313037|69762485|FG001|Overall Study|Withdrawal by Subject|3|||
38068189|NCT03313037|69762484|FG000|Overall Study|No longer meets eligibility criteria|1|||
38068190|NCT03313037|69762485|FG001|Overall Study|No longer meets eligibility criteria|7|||
38068191|NCT03313037|69762484|FG000|Overall Study|Lost to Follow-up|9|||
38068192|NCT03313037|69762485|FG001|Overall Study|Lost to Follow-up|8|||
38068193|NCT03313037|69762484|FG000|Overall Study|Randomized but not treated|1|||
38068194|NCT03313037|69762485|FG001|Overall Study|Randomized but not treated|0|||
38068195|NCT02420795|69762494|FG000|Overall Study|Withdrawal by Subject|1|||
38068196|NCT02420795|69762495|FG001|Overall Study|Withdrawal by Subject|0|||
38068197|NCT02420795|69762496|FG002|Overall Study|Withdrawal by Subject|0|||
38068198|NCT02420795|69762494|FG000|Overall Study|Adverse Event|1|||
38068199|NCT02420795|69762495|FG001|Overall Study|Adverse Event|0|||
38068200|NCT02420795|69762496|FG002|Overall Study|Adverse Event|0|||
38068201|NCT02420795|69762494|FG000|Overall Study|Progressive disease|2|||
38068202|NCT02420795|69762495|FG001|Overall Study|Progressive disease|2|||
38068203|NCT02420795|69762496|FG002|Overall Study|Progressive disease|4|||
38068204|NCT02420795|69762494|FG000|Overall Study|Death|0|||
38068205|NCT02420795|69762495|FG001|Overall Study|Death|0|||
38068206|NCT02420795|69762496|FG002|Overall Study|Death|1|||
38068207|NCT03334175|69762508|FG000|Overall Study|Lost to Follow-up|0|||
38068208|NCT03334175|69762509|FG001|Overall Study|Lost to Follow-up|1|||
38068209|NCT02942771|69762520|FG000|Overall Study|Adverse Event|1|||
38068210|NCT02942771|69762521|FG001|Overall Study|Adverse Event|0|||
38068211|NCT02942771|69762522|FG002|Overall Study|Adverse Event|0|||
38068212|NCT02942771|69762523|FG003|Overall Study|Adverse Event|0|||
38068213|NCT02942771|69762524|FG004|Overall Study|Adverse Event|2|||
38068214|NCT02942771|69762520|FG000|Overall Study|Lost to Follow-up|1|||
38068215|NCT02942771|69762521|FG001|Overall Study|Lost to Follow-up|0|||
38068216|NCT02942771|69762522|FG002|Overall Study|Lost to Follow-up|0|||
38068217|NCT02942771|69762523|FG003|Overall Study|Lost to Follow-up|0|||
38068218|NCT02942771|69762524|FG004|Overall Study|Lost to Follow-up|0|||
38068219|NCT02942771|69762520|FG000|Overall Study|Withdrawal by Subject|1|||
38068220|NCT02942771|69762521|FG001|Overall Study|Withdrawal by Subject|0|||
38068221|NCT02942771|69762522|FG002|Overall Study|Withdrawal by Subject|0|||
38068222|NCT02942771|69762523|FG003|Overall Study|Withdrawal by Subject|0|||
38068223|NCT02942771|69762524|FG004|Overall Study|Withdrawal by Subject|2|||
38068224|NCT03036150|69762538|FG000|Overall Study|Withdrawal by Subject|8|||
38068225|NCT03036150|69762539|FG001|Overall Study|Withdrawal by Subject|3|||
38068226|NCT03036150|69762538|FG000|Overall Study|Lost to Follow-up|2|||
38068227|NCT03036150|69762539|FG001|Overall Study|Lost to Follow-up|2|||
38068228|NCT03332771|69762549|FG000|Overall Study|Adverse Event|6|||
38068229|NCT03332771|69762550|FG001|Overall Study|Adverse Event|4|||
38068230|NCT03332771|69762551|FG002|Overall Study|Adverse Event|1|||
38068231|NCT03332771|69762552|FG003|Overall Study|Adverse Event|3|||
38068232|NCT03332771|69762549|FG000|Overall Study|Poor Compliance to Protocol|0|||
38068233|NCT03332771|69762550|FG001|Overall Study|Poor Compliance to Protocol|1|||
38068234|NCT03332771|69762551|FG002|Overall Study|Poor Compliance to Protocol|0|||
38068235|NCT03332771|69762552|FG003|Overall Study|Poor Compliance to Protocol|1|||
38068236|NCT03332771|69762549|FG000|Overall Study|Lost to Follow-up|2|||
38068237|NCT03332771|69762550|FG001|Overall Study|Lost to Follow-up|2|||
38068238|NCT03332771|69762551|FG002|Overall Study|Lost to Follow-up|1|||
38068239|NCT03332771|69762552|FG003|Overall Study|Lost to Follow-up|2|||
38068240|NCT03332771|69762549|FG000|Overall Study|At the Participant's own request|20|||
38068241|NCT03332771|69762550|FG001|Overall Study|At the Participant's own request|26|||
38068242|NCT03332771|69762551|FG002|Overall Study|At the Participant's own request|14|||
38068243|NCT03332771|69762552|FG003|Overall Study|At the Participant's own request|23|||
38068244|NCT03332771|69762549|FG000|Overall Study|Reason Not Specified|6|||
38068245|NCT03332771|69762550|FG001|Overall Study|Reason Not Specified|18|||
38068246|NCT03332771|69762551|FG002|Overall Study|Reason Not Specified|16|||
38068247|NCT03332771|69762552|FG003|Overall Study|Reason Not Specified|19|||
38068248|NCT03310775|69762564|FG000|Overall Study|Lost to Follow-up|2|||
38068249|NCT03310775|69762565|FG001|Overall Study|Lost to Follow-up|3|||
38068250|NCT03310775|69762564|FG000|Overall Study|aggravation of depression|0|||
38068251|NCT03310775|69762565|FG001|Overall Study|aggravation of depression|1|||
38068252|NCT03330119|69762577|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
38068253|NCT03330119|69762578|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
38068254|NCT03040986|69762586|FG000|Overall Study|Hospice|1|||
38068255|NCT03040986|69762587|FG001|Overall Study|Hospice|0|||
38068256|NCT03040986|69762586|FG000|Overall Study|Adverse Event|2|||
38068257|NCT03040986|69762587|FG001|Overall Study|Adverse Event|1|||
38068258|NCT03040986|69762586|FG000|Overall Study|Disease progression on study|3|||
38068259|NCT03040986|69762587|FG001|Overall Study|Disease progression on study|1|||
38068260|NCT03039192|69762597|FG000|Overall Study|Lost to Follow-up|4|||
38068261|NCT03039192|69762598|FG001|Overall Study|Lost to Follow-up|4|||
38068262|NCT03039192|69762597|FG000|Overall Study|Adverse event, serious fatal|0|||
38068263|NCT03039192|69762598|FG001|Overall Study|Adverse event, serious fatal|1|||
38068264|NCT03039192|69762597|FG000|Overall Study|Adverse event, non-fatal|0|||
38068265|NCT03039192|69762598|FG001|Overall Study|Adverse event, non-fatal|2|||
38068266|NCT03039192|69762597|FG000|Overall Study|Withdrawal by Subject|6|||
38068267|NCT03039192|69762598|FG001|Overall Study|Withdrawal by Subject|9|||
38068268|NCT03039192|69762597|FG000|Overall Study|Discontinued from treatment phase|19|||
38068269|NCT03039192|69762598|FG001|Overall Study|Discontinued from treatment phase|12|||
38068270|NCT03039192|69762597|FG000|Overall Study|Other|3|||
38068271|NCT03039192|69762598|FG001|Overall Study|Other|2|||
38068272|NCT03698279|69762610|FG000|Overall Study|Withdrawal by parent/guardian|1|||
38068273|NCT03698279|69762611|FG001|Overall Study|Withdrawal by parent/guardian|1|||
38068274|NCT03698279|69762612|FG002|Overall Study|Withdrawal by parent/guardian|1|||
38068275|NCT03698279|69762613|FG003|Overall Study|Withdrawal by parent/guardian|1|||
38068276|NCT03698279|69762614|FG004|Overall Study|Withdrawal by parent/guardian|0|||
38068277|NCT03698279|69762615|FG005|Overall Study|Withdrawal by parent/guardian|0|||
38068278|NCT03698279|69762610|FG000|Overall Study|Protocol deviation|1|||
38068279|NCT03698279|69762611|FG001|Overall Study|Protocol deviation|0|||
38068280|NCT03698279|69762612|FG002|Overall Study|Protocol deviation|1|||
38068281|NCT03698279|69762613|FG003|Overall Study|Protocol deviation|0|||
38068282|NCT03698279|69762614|FG004|Overall Study|Protocol deviation|0|||
38068283|NCT03698279|69762615|FG005|Overall Study|Protocol deviation|0|||
38068284|NCT03698279|69762610|FG000|Overall Study|Withdrawal by Subject|0|||
38068285|NCT03698279|69762611|FG001|Overall Study|Withdrawal by Subject|0|||
38068286|NCT03698279|69762612|FG002|Overall Study|Withdrawal by Subject|1|||
38068287|NCT03698279|69762613|FG003|Overall Study|Withdrawal by Subject|0|||
38068288|NCT03698279|69762614|FG004|Overall Study|Withdrawal by Subject|0|||
38068289|NCT03698279|69762615|FG005|Overall Study|Withdrawal by Subject|0|||
38068290|NCT03698279|69762610|FG000|Overall Study|Lost to Follow-up|3|||
38068291|NCT03698279|69762611|FG001|Overall Study|Lost to Follow-up|1|||
38068292|NCT03698279|69762612|FG002|Overall Study|Lost to Follow-up|4|||
38068293|NCT03698279|69762613|FG003|Overall Study|Lost to Follow-up|5|||
38068294|NCT03698279|69762614|FG004|Overall Study|Lost to Follow-up|0|||
38068295|NCT03698279|69762615|FG005|Overall Study|Lost to Follow-up|0|||
38068296|NCT01529034|69762634|FG000|Overall Study|Discontinued prior to study treatment|14|||
38068297|NCT01529034|69762634|FG000|Overall Study|Site closure|62|||
38068298|NCT01529034|69762634|FG000|Overall Study|Study termination|29|||
38068299|NCT01529034|69762634|FG000|Overall Study|Withdrawal by Subject|25|||
38068300|NCT01529034|69762634|FG000|Overall Study|No treated SCs within protocol window|13|||
38068301|NCT01529034|69762634|FG000|Overall Study|Noncompliance|8|||
38068302|NCT01529034|69762634|FG000|Overall Study|Caregiver no longer available|7|||
38068303|NCT01529034|69762634|FG000|Overall Study|Adverse Event|4|||
38068304|NCT01529034|69762634|FG000|Overall Study|Protocol Violation|4|||
37965898|NCT00372112|69652860|FG003|Overall Study|PR >240 at Visit 3|1|||
38068305|NCT01529034|69762634|FG000|Overall Study|Lack of Efficacy|4|||
38068306|NCT01529034|69762634|FG000|Overall Study|Investigator no longer available|2|||
38068307|NCT01529034|69762634|FG000|Overall Study|Study drug not available|2|||
38068308|NCT03036072|69762641|FG000|Overall Study|Death|0|||
38068309|NCT03036072|69762642|FG001|Overall Study|Death|1|||
38068310|NCT03036072|69762641|FG000|Overall Study|Withdrawal by Subject|0|||
38068311|NCT03036072|69762642|FG001|Overall Study|Withdrawal by Subject|1|||
38068312|NCT03036072|69762641|FG000|Overall Study|Physician Decision|0|||
38068313|NCT03036072|69762642|FG001|Overall Study|Physician Decision|1|||
38068314|NCT03038880|69762651|FG000|Overall Study|Death|1|||
38068315|NCT03038880|69762652|FG001|Overall Study|Death|2|||
38068316|NCT03038880|69762653|FG002|Overall Study|Death|0|||
38068317|NCT03038880|69762651|FG000|Overall Study|Physician Decision|2|||
38068318|NCT03038880|69762652|FG001|Overall Study|Physician Decision|1|||
38068319|NCT03038880|69762653|FG002|Overall Study|Physician Decision|0|||
38068320|NCT03035916|69762664|FG000|Overall Study|Puncture failed|0|||
38068321|NCT03035916|69762665|FG001|Overall Study|Puncture failed|2|||
38068322|NCT03035916|69762666|FG002|Overall Study|Puncture failed|0|||
38068323|NCT01702571|69762676|FG000|Overall Study|Death|1067|||
38068324|NCT01702571|69762677|FG001|Overall Study|Death|76|||
38068325|NCT01702571|69762676|FG000|Overall Study|Lost to Follow-up|144|||
38068326|NCT01702571|69762677|FG001|Overall Study|Lost to Follow-up|10|||
38068327|NCT01702571|69762676|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
38068328|NCT01702571|69762677|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
38068329|NCT01702571|69762676|FG000|Overall Study|Investigator Decision|5|||
38068330|NCT01702571|69762677|FG001|Overall Study|Investigator Decision|0|||
38068331|NCT01702571|69762676|FG000|Overall Study|Not Classifiable|1|||
38068332|NCT01702571|69762677|FG001|Overall Study|Not Classifiable|0|||
38068333|NCT01702571|69762676|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
38068334|NCT01702571|69762677|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
38068335|NCT01702571|69762676|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
38068336|NCT01702571|69762677|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
38068337|NCT01702571|69762676|FG000|Overall Study|Progressive Disease|3|||
38068338|NCT01702571|69762677|FG001|Overall Study|Progressive Disease|0|||
38068339|NCT01702571|69762676|FG000|Overall Study|Protocol Violation|2|||
38068340|NCT01702571|69762677|FG001|Overall Study|Protocol Violation|0|||
38068341|NCT01702571|69762676|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
38068342|NCT01702571|69762677|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
38068343|NCT01702571|69762676|FG000|Overall Study|Termination By Sponsor|4|||
38068344|NCT01702571|69762677|FG001|Overall Study|Termination By Sponsor|0|||
38068345|NCT01702571|69762676|FG000|Overall Study|Withdrawal by Subject|177|||
38068346|NCT01702571|69762677|FG001|Overall Study|Withdrawal by Subject|29|||
38068347|NCT03231943|69762700|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
38068348|NCT03231943|69762701|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
38068349|NCT03231943|69762702|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
38068350|NCT03231943|69762703|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
38068351|NCT03231943|69762704|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
38068352|NCT03231943|69762705|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
38068353|NCT03231943|69762706|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
38068354|NCT03231943|69762707|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
38068355|NCT03231943|69762708|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
38068356|NCT03231943|69762709|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
38068357|NCT03231943|69762710|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
38068358|NCT03231943|69762711|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
38068359|NCT03231943|69762712|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
38068360|NCT03231943|69762700|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
38068361|NCT03231943|69762701|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
38068362|NCT03231943|69762702|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
38068363|NCT03231943|69762703|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
38068364|NCT03231943|69762704|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
38068365|NCT03231943|69762705|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
38068366|NCT03231943|69762706|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
38068367|NCT03231943|69762707|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
38068368|NCT03231943|69762708|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
38068369|NCT03231943|69762709|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
38068370|NCT03231943|69762710|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
38068371|NCT03231943|69762711|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
38068372|NCT03231943|69762712|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
38068373|NCT03231943|69762700|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
38068374|NCT03231943|69762701|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
38068375|NCT03231943|69762702|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
38068376|NCT03231943|69762703|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
38068377|NCT03231943|69762704|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
38068378|NCT03231943|69762705|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
38068379|NCT03231943|69762706|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
38068380|NCT03231943|69762707|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
38068381|NCT03231943|69762708|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
38068382|NCT03231943|69762709|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
38068383|NCT03231943|69762710|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
38068384|NCT03231943|69762711|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
38068385|NCT03231943|69762712|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
37965899|NCT00372112|69652857|FG000|Overall Study|Hepatitis B|1|||
38068386|NCT03231943|69762700|FG000|Part 2|Adverse Event|0|||
38068387|NCT03231943|69762701|FG001|Part 2|Adverse Event|0|||
38068388|NCT03231943|69762702|FG002|Part 2|Adverse Event|0|||
38068389|NCT03231943|69762703|FG003|Part 2|Adverse Event|0|||
38068390|NCT03231943|69762704|FG004|Part 2|Adverse Event|0|||
38068391|NCT03231943|69762705|FG005|Part 2|Adverse Event|0|||
38068392|NCT03231943|69762706|FG006|Part 2|Adverse Event|0|||
38068393|NCT03231943|69762707|FG007|Part 2|Adverse Event|0|||
38068394|NCT03231943|69762708|FG008|Part 2|Adverse Event|0|||
38068395|NCT03231943|69762709|FG009|Part 2|Adverse Event|0|||
38068396|NCT03231943|69762710|FG010|Part 2|Adverse Event|1|||
38068397|NCT03231943|69762711|FG011|Part 2|Adverse Event|0|||
38068398|NCT03231943|69762712|FG012|Part 2|Adverse Event|0|||
38068399|NCT03231943|69762700|FG000|Part 2|Withdrawal by Subject|0|||
38068400|NCT03231943|69762701|FG001|Part 2|Withdrawal by Subject|0|||
37965900|NCT00372112|69652858|FG001|Overall Study|Hepatitis B|0|||
38068401|NCT03231943|69762702|FG002|Part 2|Withdrawal by Subject|0|||
38068402|NCT03231943|69762703|FG003|Part 2|Withdrawal by Subject|0|||
38068403|NCT03231943|69762704|FG004|Part 2|Withdrawal by Subject|0|||
38068404|NCT03231943|69762705|FG005|Part 2|Withdrawal by Subject|0|||
38068405|NCT03231943|69762706|FG006|Part 2|Withdrawal by Subject|0|||
38068406|NCT03231943|69762707|FG007|Part 2|Withdrawal by Subject|0|||
38068407|NCT03231943|69762708|FG008|Part 2|Withdrawal by Subject|0|||
38068408|NCT03231943|69762709|FG009|Part 2|Withdrawal by Subject|0|||
38068409|NCT03231943|69762710|FG010|Part 2|Withdrawal by Subject|0|||
38068410|NCT03231943|69762711|FG011|Part 2|Withdrawal by Subject|1|||
38068411|NCT03231943|69762712|FG012|Part 2|Withdrawal by Subject|0|||
38068412|NCT01578239|69762744|FG000|Treatment Period|Progressive Disease|19|||
38068413|NCT01578239|69762745|FG001|Treatment Period|Progressive Disease|64|||
38068414|NCT01578239|69762744|FG000|Treatment Period|Physician Decision|17|||
38068415|NCT01578239|69762745|FG001|Treatment Period|Physician Decision|17|||
38068416|NCT01578239|69762744|FG000|Treatment Period|Adverse Event|13|||
38068417|NCT01578239|69762745|FG001|Treatment Period|Adverse Event|10|||
38068418|NCT01578239|69762744|FG000|Treatment Period|Non-compliance|2|||
38068419|NCT01578239|69762745|FG001|Treatment Period|Non-compliance|0|||
38068420|NCT01578239|69762744|FG000|Treatment Period|Withdrawal by Subject|10|||
38068421|NCT01578239|69762745|FG001|Treatment Period|Withdrawal by Subject|9|||
38068422|NCT01578239|69762744|FG000|Treatment Period|Other|6|||
38068423|NCT01578239|69762745|FG001|Treatment Period|Other|1|||
38068424|NCT01578239|69762744|FG000|Long-term Follow-Up Period|Death|69|||
38068425|NCT01578239|69762745|FG001|Long-term Follow-Up Period|Death|64|||
38068426|NCT01578239|69762744|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
38068427|NCT01578239|69762745|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
38068428|NCT01578239|69762744|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
37965901|NCT00372112|69652859|FG002|Overall Study|Hepatitis B|0|||
37965902|NCT00372112|69652860|FG003|Overall Study|Hepatitis B|0|||
37965903|NCT00372112|69652857|FG000|Overall Study|Other-protocol violation|0|||
37965904|NCT00372112|69652858|FG001|Overall Study|Other-protocol violation|0|||
37965905|NCT00372112|69652859|FG002|Overall Study|Other-protocol violation|1|||
37965906|NCT00372112|69652860|FG003|Overall Study|Other-protocol violation|0|||
37965907|NCT00488475|69652873|FG000|Overall Study|Other|1754|||
37965908|NCT00042991|69652884|FG000|Overall Study|Adverse Event|1|||
37965909|NCT00042991|69652885|FG001|Overall Study|Adverse Event|4|||
37965910|NCT00042991|69652886|FG002|Overall Study|Adverse Event|2|||
37965911|NCT00042991|69652887|FG003|Overall Study|Adverse Event|0|||
38068429|NCT01578239|69762745|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
37862308|NCT01130493|69546066|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
37862309|NCT01130493|69546067|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
37862310|NCT01130493|69546068|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
37862311|NCT01130493|69546066|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
37862312|NCT01130493|69546067|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
37862313|NCT01130493|69546068|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
37965912|NCT00042991|69652888|FG004|Overall Study|Adverse Event|0|||
38068430|NCT01578239|69762744|FG000|Long-term Follow-Up Period|Other|2|||
38068431|NCT01578239|69762745|FG001|Long-term Follow-Up Period|Other|2|||
38068432|NCT03231709|69762753|FG000|Treatment Period 1|Reason not Specified|0|||
38068433|NCT03231709|69762754|FG001|Treatment Period 1|Reason not Specified|1|||
38068434|NCT03231709|69762753|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
38068435|NCT03231709|69762754|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
38068436|NCT03241927|69762764|FG000|Overall Study|study terminated|1|||
38068437|NCT03241927|69762765|FG001|Overall Study|study terminated|0|||
37965913|NCT00042991|69652889|FG005|Overall Study|Adverse Event|1|||
38068438|NCT03329885|69762777|FG000|Overall Study|Sponsor discontinued the study early|0|||
38068439|NCT03329885|69762778|FG001|Overall Study|Sponsor discontinued the study early|0|||
38068440|NCT03329885|69762779|FG002|Overall Study|Sponsor discontinued the study early|0|||
38068441|NCT03329885|69762780|FG003|Overall Study|Sponsor discontinued the study early|0|||
38068442|NCT03329885|69762781|FG004|Overall Study|Sponsor discontinued the study early|0|||
38068443|NCT03329885|69762782|FG005|Overall Study|Sponsor discontinued the study early|0|||
38068444|NCT03329885|69762783|FG006|Overall Study|Sponsor discontinued the study early|1|||
38068445|NCT03329885|69762784|FG007|Overall Study|Sponsor discontinued the study early|1|||
38068446|NCT03329885|69762785|FG008|Overall Study|Sponsor discontinued the study early|0|||
38068447|NCT02941523|69762807|FG000|Monotherapy|Withdrawal by Subject|0|||
38068448|NCT02941523|69762808|FG001|Monotherapy|Withdrawal by Subject|1|||
38068449|NCT02941523|69762807|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
38068450|NCT02941523|69762808|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
38068451|NCT02941523|69762807|FG000|Carboplatin Combination Therapy|Death|1|||
38068452|NCT02941523|69762808|FG001|Carboplatin Combination Therapy|Death|2|||
38068453|NCT02941523|69762807|FG000|Carboplatin Combination Therapy|Disease progression|2|||
38068454|NCT02941523|69762808|FG001|Carboplatin Combination Therapy|Disease progression|0|||
38068455|NCT02941523|69762807|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
38068456|NCT02941523|69762808|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
38068457|NCT02938585|69762826|FG000|Overall Study|Withdrawal by parent or guardian|0|||
38068458|NCT02938585|69762827|FG001|Overall Study|Withdrawal by parent or guardian|1|||
38068459|NCT02938585|69762828|FG002|Overall Study|Withdrawal by parent or guardian|0|||
38068460|NCT02938585|69762829|FG003|Overall Study|Withdrawal by parent or guardian|0|||
38068461|NCT02938585|69762826|FG000|Overall Study|Withdrawal by Subject|0|||
38068462|NCT02938585|69762827|FG001|Overall Study|Withdrawal by Subject|0|||
38068463|NCT02938585|69762828|FG002|Overall Study|Withdrawal by Subject|0|||
38068464|NCT02938585|69762829|FG003|Overall Study|Withdrawal by Subject|5|||
38068465|NCT03229759|69762853|FG000|Overall Study|Screen Failure|30|||
38068466|NCT03228433|69762865|FG000|Overall Study|Lost to Follow-up|1|||
38068467|NCT03228433|69762866|FG001|Overall Study|Lost to Follow-up|0|||
38068468|NCT03228433|69762867|FG002|Overall Study|Lost to Follow-up|0|||
38068469|NCT03228433|69762868|FG003|Overall Study|Lost to Follow-up|0|||
38068470|NCT03228433|69762869|FG004|Overall Study|Lost to Follow-up|0|||
38068471|NCT03228433|69762870|FG005|Overall Study|Lost to Follow-up|0|||
38068472|NCT03228433|69762865|FG000|Overall Study|Positive alcohol test|0|||
38068473|NCT03228433|69762866|FG001|Overall Study|Positive alcohol test|0|||
38068474|NCT03228433|69762867|FG002|Overall Study|Positive alcohol test|0|||
38068475|NCT03228433|69762868|FG003|Overall Study|Positive alcohol test|1|||
38068476|NCT03228433|69762869|FG004|Overall Study|Positive alcohol test|0|||
38068477|NCT03228433|69762870|FG005|Overall Study|Positive alcohol test|0|||
38068478|NCT01496118|69762900|FG000|Overall Study|Disease progression|3|||
38068479|NCT01496118|69762901|FG001|Overall Study|Disease progression|2|||
38068480|NCT01496118|69762902|FG002|Overall Study|Disease progression|3|||
38068481|NCT01496118|69762903|FG003|Overall Study|Disease progression|1|||
38068482|NCT01496118|69762904|FG004|Overall Study|Disease progression|2|||
38068483|NCT01496118|69762905|FG005|Overall Study|Disease progression|2|||
38068484|NCT01496118|69762906|FG006|Overall Study|Disease progression|14|||
38068485|NCT01496118|69762907|FG007|Overall Study|Disease progression|10|||
38068486|NCT01496118|69762900|FG000|Overall Study|Physician Decision|0|||
38068487|NCT01496118|69762901|FG001|Overall Study|Physician Decision|0|||
38068488|NCT01496118|69762902|FG002|Overall Study|Physician Decision|0|||
38068489|NCT01496118|69762903|FG003|Overall Study|Physician Decision|0|||
38068490|NCT01496118|69762904|FG004|Overall Study|Physician Decision|1|||
38068491|NCT01496118|69762905|FG005|Overall Study|Physician Decision|0|||
38068492|NCT01496118|69762906|FG006|Overall Study|Physician Decision|3|||
38068493|NCT01496118|69762907|FG007|Overall Study|Physician Decision|6|||
38068494|NCT01496118|69762900|FG000|Overall Study|Adverse Event|1|||
38068495|NCT01496118|69762901|FG001|Overall Study|Adverse Event|1|||
38068496|NCT01496118|69762902|FG002|Overall Study|Adverse Event|0|||
38068497|NCT01496118|69762903|FG003|Overall Study|Adverse Event|0|||
38068498|NCT01496118|69762904|FG004|Overall Study|Adverse Event|0|||
38068499|NCT01496118|69762905|FG005|Overall Study|Adverse Event|0|||
38068500|NCT01496118|69762906|FG006|Overall Study|Adverse Event|6|||
38068501|NCT01496118|69762907|FG007|Overall Study|Adverse Event|10|||
38068502|NCT01496118|69762900|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
38068503|NCT01496118|69762901|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
38068504|NCT01496118|69762902|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
38068505|NCT01496118|69762903|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
38068506|NCT01496118|69762904|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
38068507|NCT01496118|69762905|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
37862314|NCT01130493|69546066|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
37862315|NCT01130493|69546067|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
38068508|NCT01496118|69762906|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
38068509|NCT01496118|69762907|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
38068510|NCT01496118|69762900|FG000|Overall Study|Death|0|||
38068511|NCT01496118|69762901|FG001|Overall Study|Death|0|||
38068512|NCT01496118|69762902|FG002|Overall Study|Death|0|||
38068513|NCT01496118|69762903|FG003|Overall Study|Death|0|||
38068514|NCT01496118|69762904|FG004|Overall Study|Death|0|||
38068515|NCT01496118|69762905|FG005|Overall Study|Death|0|||
38068516|NCT01496118|69762906|FG006|Overall Study|Death|1|||
38068517|NCT01496118|69762907|FG007|Overall Study|Death|1|||
38068518|NCT01496118|69762900|FG000|Overall Study|Withdrawal by Subject|0|||
38068519|NCT01496118|69762901|FG001|Overall Study|Withdrawal by Subject|0|||
38068520|NCT01496118|69762902|FG002|Overall Study|Withdrawal by Subject|0|||
38068521|NCT01496118|69762903|FG003|Overall Study|Withdrawal by Subject|2|||
38068522|NCT01496118|69762904|FG004|Overall Study|Withdrawal by Subject|0|||
38068523|NCT01496118|69762905|FG005|Overall Study|Withdrawal by Subject|1|||
38068524|NCT01496118|69762906|FG006|Overall Study|Withdrawal by Subject|6|||
38068525|NCT01496118|69762907|FG007|Overall Study|Withdrawal by Subject|3|||
38068526|NCT02936869|69762927|FG000|Overall Study|Lost to Follow-up|1|||
38068527|NCT02936869|69762928|FG001|Overall Study|Lost to Follow-up|3|||
38068528|NCT02936869|69762927|FG000|Overall Study|Death|0|||
38068529|NCT02936869|69762928|FG001|Overall Study|Death|1|||
38068530|NCT02936869|69762927|FG000|Overall Study|Legal Case|0|||
38068531|NCT02936869|69762928|FG001|Overall Study|Legal Case|1|||
38068532|NCT02936869|69762927|FG000|Overall Study|Protocol Violation|1|||
38068533|NCT02936869|69762928|FG001|Overall Study|Protocol Violation|0|||
38068534|NCT03309605|69762943|FG000|Overall Study|Adverse Event|0|||
38068535|NCT03309605|69762944|FG001|Overall Study|Adverse Event|0|||
38068536|NCT03309605|69762945|FG002|Overall Study|Adverse Event|0|||
38068537|NCT03309605|69762946|FG003|Overall Study|Adverse Event|1|||
38068538|NCT03309605|69762947|FG004|Overall Study|Adverse Event|0|||
38068539|NCT03309605|69762948|FG005|Overall Study|Adverse Event|0|||
38068540|NCT03309605|69762949|FG006|Overall Study|Adverse Event|2|||
38068541|NCT03309605|69762950|FG007|Overall Study|Adverse Event|1|||
38068542|NCT03309605|69762943|FG000|Overall Study|Withdrawal by Subject|0|||
38068543|NCT03309605|69762944|FG001|Overall Study|Withdrawal by Subject|0|||
38068544|NCT03309605|69762945|FG002|Overall Study|Withdrawal by Subject|0|||
38068545|NCT03309605|69762946|FG003|Overall Study|Withdrawal by Subject|0|||
38068546|NCT03309605|69762947|FG004|Overall Study|Withdrawal by Subject|1|||
38068547|NCT03309605|69762948|FG005|Overall Study|Withdrawal by Subject|0|||
38068548|NCT03309605|69762949|FG006|Overall Study|Withdrawal by Subject|1|||
38068549|NCT03309605|69762950|FG007|Overall Study|Withdrawal by Subject|1|||
38068550|NCT02936635|69762966|FG000|Overall Study|Adverse Event|43|||
38068551|NCT02936635|69762967|FG001|Overall Study|Adverse Event|25|||
38068552|NCT02936635|69762966|FG000|Overall Study|Progressive Disease|10|||
38068553|NCT02936635|69762967|FG001|Overall Study|Progressive Disease|18|||
38068554|NCT02936635|69762966|FG000|Overall Study|Sponsor Discretion|10|||
38068555|NCT02936635|69762967|FG001|Overall Study|Sponsor Discretion|16|||
38068556|NCT02936635|69762966|FG000|Overall Study|Death|9|||
38068557|NCT02936635|69762967|FG001|Overall Study|Death|15|||
38068558|NCT02936635|69762966|FG000|Overall Study|Withdrawal by Subject|8|||
38068559|NCT02936635|69762967|FG001|Overall Study|Withdrawal by Subject|15|||
38068560|NCT02936635|69762966|FG000|Overall Study|Physician Decision|2|||
38068561|NCT02936635|69762967|FG001|Overall Study|Physician Decision|9|||
38068562|NCT02936635|69762966|FG000|Overall Study|Lost to Follow-up|1|||
38068563|NCT02936635|69762967|FG001|Overall Study|Lost to Follow-up|2|||
38068564|NCT02936635|69762966|FG000|Overall Study|Protocol Violation|1|||
38068565|NCT02936635|69762967|FG001|Overall Study|Protocol Violation|0|||
38068566|NCT02936635|69762966|FG000|Overall Study|Lack of effect/Entry into other study|31|||
38068567|NCT02936635|69762967|FG001|Overall Study|Lack of effect/Entry into other study|65|||
38068568|NCT03227029|69762976|FG000|Overall Study|Child Wheezed (no treatment)|0|||
38068569|NCT03227029|69762977|FG001|Overall Study|Child Wheezed (no treatment)|1|||
38068570|NCT03227029|69762978|FG002|Overall Study|Child Wheezed (no treatment)|0|||
38068571|NCT03227029|69762976|FG000|Overall Study|No post RSV season visit due to COVID|3|||
38068572|NCT03227029|69762977|FG001|Overall Study|No post RSV season visit due to COVID|3|||
38068573|NCT03227029|69762978|FG002|Overall Study|No post RSV season visit due to COVID|2|||
38068574|NCT03227029|69762976|FG000|Overall Study|Not able to get to clinic|0|||
38068575|NCT03227029|69762977|FG001|Overall Study|Not able to get to clinic|0|||
38068576|NCT03227029|69762978|FG002|Overall Study|Not able to get to clinic|1|||
37862316|NCT01130493|69546068|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
37862317|NCT01130493|69546066|FG000|Part 2: OLE|Adverse Event|0|||
37862318|NCT01130493|69546067|FG001|Part 2: OLE|Adverse Event|2|||
37862319|NCT01130493|69546068|FG002|Part 2: OLE|Adverse Event|1|||
38068577|NCT03227029|69762976|FG000|Overall Study|Withdrawal by Subject|1|||
38068578|NCT03227029|69762977|FG001|Overall Study|Withdrawal by Subject|0|||
38068579|NCT03227029|69762978|FG002|Overall Study|Withdrawal by Subject|0|||
38068580|NCT03227029|69762976|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
38068581|NCT03227029|69762977|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
38068582|NCT03227029|69762978|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
38068583|NCT03329573|69762990|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
38068584|NCT03329573|69762991|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
38068585|NCT03329573|69762992|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
38068586|NCT03329573|69762993|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
38068587|NCT03329573|69762990|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
38068588|NCT03329573|69762991|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
38068589|NCT03329573|69762992|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
38068590|NCT03329573|69762993|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
38068591|NCT03329573|69762990|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
38068592|NCT03329573|69762991|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
38068593|NCT03329573|69762992|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
38068594|NCT03329573|69762993|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
38068595|NCT03329573|69762990|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
38068596|NCT03329573|69762991|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
38068597|NCT03329573|69762992|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
38068598|NCT03329573|69762993|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
38068599|NCT03308825|69763024|FG000|Overall Study|Lost to Follow-up|2|||
38068600|NCT03308825|69763025|FG001|Overall Study|Lost to Follow-up|2|||
38068601|NCT03308825|69763026|FG002|Overall Study|Lost to Follow-up|1|||
38068602|NCT03308825|69763027|FG003|Overall Study|Lost to Follow-up|0|||
38068603|NCT03308825|69763024|FG000|Overall Study|Protocol Violation|0|||
38068604|NCT03308825|69763025|FG001|Overall Study|Protocol Violation|2|||
38068605|NCT03308825|69763026|FG002|Overall Study|Protocol Violation|0|||
38068606|NCT03308825|69763027|FG003|Overall Study|Protocol Violation|0|||
38068607|NCT03328325|69763041|FG000|Overall Study|Lost to Follow-up|4|||
38068608|NCT03328325|69763041|FG000|Overall Study|Physician Decision|1|||
38068609|NCT03328325|69763041|FG000|Overall Study|Withdrawal by Subject|3|||
38068610|NCT03328325|69763041|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
38068611|NCT03305081|69763051|FG000|Overall Study|Lost to Follow-up|10|||
38068612|NCT03305081|69763052|FG001|Overall Study|Lost to Follow-up|15|||
38068613|NCT03325673|69763070|FG000|Overall Study|Adverse Event|4|||
38068614|NCT03325673|69763071|FG001|Overall Study|Adverse Event|0|||
38068615|NCT03223909|69763080|FG000|Overall Study|Protocol Violation|48|||
38068616|NCT03223909|69763081|FG001|Overall Study|Protocol Violation|45|||
38068617|NCT03223909|69763082|FG002|Overall Study|Protocol Violation|16|||
38068618|NCT03733925|69763090|FG000|Overall Study|Lost to Follow-up|1|||
38068619|NCT03733925|69763090|FG000|Overall Study|Withdrawal by Subject|2|||
38068620|NCT03733925|69763090|FG000|Overall Study|Adverse Event|2|||
38068621|NCT03733925|69763090|FG000|Overall Study|Non-Compliance with Study Drug|1|||
38068622|NCT03649711|69763097|FG000|Overall Study|Adverse Event|0|||
38068623|NCT03649711|69763098|FG001|Overall Study|Adverse Event|1|||
38068624|NCT03649711|69763099|FG002|Overall Study|Adverse Event|0|||
38068625|NCT03649711|69763097|FG000|Overall Study|Kidney Transplant|1|||
38068626|NCT03649711|69763098|FG001|Overall Study|Kidney Transplant|0|||
38068627|NCT03649711|69763099|FG002|Overall Study|Kidney Transplant|0|||
38068628|NCT03303521|69763109|FG000|Overall Study|Withdrawal by Subject|2|||
38068629|NCT03303521|69763110|FG001|Overall Study|Withdrawal by Subject|0|||
38068630|NCT03303521|69763109|FG000|Overall Study|Death|1|||
38068631|NCT03303521|69763110|FG001|Overall Study|Death|0|||
38068632|NCT03303521|69763109|FG000|Overall Study|Kidney transplantation|0|||
38068633|NCT03303521|69763110|FG001|Overall Study|Kidney transplantation|1|||
38068634|NCT03303521|69763109|FG000|Overall Study|Investigational product discontinuation|0|||
38068635|NCT03303521|69763110|FG001|Overall Study|Investigational product discontinuation|1|||
38068636|NCT03303521|69763109|FG000|Overall Study|Transferred to non-study dialysis center|1|||
38068637|NCT03303521|69763110|FG001|Overall Study|Transferred to non-study dialysis center|0|||
38068638|NCT03303521|69763109|FG000|Overall Study|Non-comliance to study protocol|0|||
38068639|NCT03303521|69763110|FG001|Overall Study|Non-comliance to study protocol|1|||
38068640|NCT03303521|69763109|FG000|Overall Study|Adverse Event|1|||
38068641|NCT03303521|69763110|FG001|Overall Study|Adverse Event|0|||
38068642|NCT03214081|69763116|FG000|Overall Study|Case Report Forms Uncollected|9|||
38068643|NCT03214081|69763116|FG000|Overall Study|Protocol Deviation|54|||
38068644|NCT02888171|69763122|FG000|Overall Study|Lost to Follow-up|2|||
38068645|NCT02888171|69763123|FG001|Overall Study|Lost to Follow-up|1|||
38068646|NCT02888171|69763122|FG000|Overall Study|Withdrawal by Subject|3|||
38068647|NCT02888171|69763123|FG001|Overall Study|Withdrawal by Subject|2|||
38068648|NCT02888171|69763122|FG000|Overall Study|Adverse Event|0|||
38068649|NCT02888171|69763123|FG001|Overall Study|Adverse Event|1|||
38068650|NCT02932891|69763129|FG000|Overall Study|Lost to Follow-up|2|||
38068651|NCT02932891|69763129|FG000|Overall Study|HPA Suppress|2|||
38068652|NCT03302975|69763133|FG000|Overall Study|Lost to Follow-up|4|||
38068653|NCT03212521|69763137|FG000|Overall Study|Adverse Event|1|||
38068654|NCT03212521|69763137|FG000|Overall Study|Lost to Follow-up|4|||
38068655|NCT03212521|69763137|FG000|Overall Study|Withdrawal by Subject|1|||
38068656|NCT03212521|69763137|FG000|Overall Study|Other|1|||
38068657|NCT03212365|69763143|FG000|Overall Study|Discharged prior to Xa level|12|||
38068658|NCT03212365|69763144|FG001|Overall Study|Discharged prior to Xa level|8|||
38068659|NCT03212365|69763143|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
38068660|NCT03212365|69763144|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
38068661|NCT03212365|69763143|FG000|Overall Study|Refused study medication|3|||
38068662|NCT03212365|69763144|FG001|Overall Study|Refused study medication|0|||
38068663|NCT03212365|69763143|FG000|Overall Study|Initiated heparin infusion on floor|1|||
38068664|NCT03212365|69763144|FG001|Overall Study|Initiated heparin infusion on floor|1|||
38068665|NCT03212365|69763143|FG000|Overall Study|Unexpected return to OR|1|||
38068666|NCT03212365|69763144|FG001|Overall Study|Unexpected return to OR|1|||
38068667|NCT03212365|69763143|FG000|Overall Study|Medication distribution error|1|||
38068668|NCT03212365|69763144|FG001|Overall Study|Medication distribution error|0|||
38068669|NCT03212365|69763143|FG000|Overall Study|Required epidural placement|1|||
38068670|NCT03212365|69763144|FG001|Overall Study|Required epidural placement|0|||
38068671|NCT03212365|69763143|FG000|Overall Study|Withdrawal by Subject|0|||
38068672|NCT03212365|69763144|FG001|Overall Study|Withdrawal by Subject|1|||
38068673|NCT03212365|69763143|FG000|Overall Study|developed acute renal failure|0|||
38068674|NCT03212365|69763144|FG001|Overall Study|developed acute renal failure|1|||
38068675|NCT03273257|69763152|FG000|Overall Study|Death|0|||
38068676|NCT03273257|69763153|FG001|Overall Study|Death|1|||
38068677|NCT03273257|69763152|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
38068678|NCT03273257|69763153|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
38068679|NCT03273257|69763152|FG000|Overall Study|Study terminated|3|||
38068680|NCT03273257|69763153|FG001|Overall Study|Study terminated|2|||
38068681|NCT04316741|69763161|FG000|Baseline Enrollment|Lost to Follow-up|1|||
38068682|NCT04316741|69763162|FG001|Baseline Enrollment|Lost to Follow-up|1|||
38068683|NCT04316741|69763161|FG000|Immediate Post-Test|Lost to Follow-up|5|||
38068684|NCT04316741|69763162|FG001|Immediate Post-Test|Lost to Follow-up|1|||
38068685|NCT04316741|69763161|FG000|1-month Post-test|Lost to Follow-up|7|||
38068686|NCT04316741|69763162|FG001|1-month Post-test|Lost to Follow-up|2|||
38068687|NCT04316741|69763161|FG000|3-month Follow-up|Lost to Follow-up|10|||
38068688|NCT04316741|69763162|FG001|3-month Follow-up|Lost to Follow-up|2|||
38068689|NCT03271307|69763172|FG000|Overall Study|Lost to Follow-up|0|||
38068690|NCT03271307|69763173|FG001|Overall Study|Lost to Follow-up|0|||
38068691|NCT03271307|69763174|FG002|Overall Study|Lost to Follow-up|0|||
38068692|NCT03271307|69763175|FG003|Overall Study|Lost to Follow-up|28|||
38068693|NCT03271307|69763176|FG004|Overall Study|Lost to Follow-up|91|||
38068694|NCT03271151|69763193|FG000|Overall Study|Lost to Follow-up|1|||
38068695|NCT03271151|69763194|FG001|Overall Study|Lost to Follow-up|3|||
38068696|NCT03271151|69763193|FG000|Overall Study|Withdrawal by Subject|1|||
38068697|NCT03271151|69763194|FG001|Overall Study|Withdrawal by Subject|0|||
38068698|NCT03245723|69763202|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
38068699|NCT03245723|69763203|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
38068700|NCT03245723|69763202|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
38068701|NCT03245723|69763203|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
38068702|NCT03245723|69763202|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
38068703|NCT03245723|69763203|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
38068704|NCT03245723|69763202|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
38068705|NCT03245723|69763203|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
38068706|NCT03301649|69763212|FG000|Overall Study|Need alternate therapy due to live lice|17|||
38068707|NCT03301649|69763213|FG001|Overall Study|Need alternate therapy due to live lice|25|||
38068708|NCT03301649|69763214|FG002|Overall Study|Need alternate therapy due to live lice|81|||
38068709|NCT03301649|69763212|FG000|Overall Study|Lost to Follow-up|11|||
38068710|NCT03301649|69763213|FG001|Overall Study|Lost to Follow-up|11|||
38068711|NCT03301649|69763214|FG002|Overall Study|Lost to Follow-up|3|||
38068712|NCT03301649|69763212|FG000|Overall Study|Protocol Violation|0|||
38068713|NCT03301649|69763213|FG001|Overall Study|Protocol Violation|1|||
38068714|NCT03301649|69763214|FG002|Overall Study|Protocol Violation|1|||
38068715|NCT03301649|69763212|FG000|Overall Study|Withdrawal by Subject|10|||
38068716|NCT03301649|69763213|FG001|Overall Study|Withdrawal by Subject|4|||
38068717|NCT03301649|69763214|FG002|Overall Study|Withdrawal by Subject|0|||
38068718|NCT03301649|69763212|FG000|Overall Study|Other than specified|5|||
38068719|NCT03301649|69763213|FG001|Overall Study|Other than specified|3|||
38068720|NCT03301649|69763214|FG002|Overall Study|Other than specified|0|||
38068721|NCT03222973|69763224|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
38068722|NCT03222973|69763225|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
38068723|NCT03222973|69763226|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
38068724|NCT03222973|69763227|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
38068725|NCT03222973|69763224|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
38068726|NCT03222973|69763225|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
38068727|NCT03222973|69763226|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
38068728|NCT03222973|69763227|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
38068729|NCT03222973|69763224|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
38068730|NCT03222973|69763225|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
38068731|NCT03222973|69763226|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
38068732|NCT03222973|69763227|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
38068733|NCT03222973|69763224|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
38068734|NCT03222973|69763225|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
38068735|NCT03222973|69763226|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
38068736|NCT03222973|69763227|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
38068737|NCT03222973|69763224|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
38068738|NCT03222973|69763225|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
38068739|NCT03222973|69763226|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
38068740|NCT03222973|69763227|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
38068741|NCT03222973|69763224|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
38068742|NCT03222973|69763225|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
38068743|NCT03222973|69763226|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
38068744|NCT03222973|69763227|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
38068745|NCT03222973|69763224|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
38068746|NCT03222973|69763225|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
38068747|NCT03222973|69763226|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
38068748|NCT03222973|69763227|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
38068749|NCT03222973|69763224|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
38068750|NCT03222973|69763225|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
38068751|NCT03222973|69763226|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
38068752|NCT03222973|69763227|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
38068753|NCT03222973|69763224|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
38068754|NCT03222973|69763225|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
38068755|NCT03222973|69763226|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
38068756|NCT03222973|69763227|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
38068757|NCT03222973|69763224|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
38068758|NCT03222973|69763225|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
38068759|NCT03222973|69763226|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
38068760|NCT03222973|69763227|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
38068761|NCT03222973|69763224|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
38068762|NCT03222973|69763225|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
38068763|NCT03222973|69763226|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
38068764|NCT03222973|69763227|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
38068765|NCT03222973|69763224|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
38068766|NCT03222973|69763225|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
38068767|NCT03222973|69763226|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
38068768|NCT03222973|69763227|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
38068769|NCT01144416|69763239|FG000|Intervention Period|Adverse Event|5|||
38068770|NCT01144416|69763240|FG001|Intervention Period|Adverse Event|6|||
38068771|NCT01144416|69763239|FG000|Intervention Period|Insufficient ovarian response|11|||
38068772|NCT01144416|69763240|FG001|Intervention Period|Insufficient ovarian response|17|||
38068773|NCT01144416|69763239|FG000|Intervention Period|Risk of OHSS|0|||
38068774|NCT01144416|69763240|FG001|Intervention Period|Risk of OHSS|1|||
38068775|NCT01144416|69763239|FG000|Intervention Period|Too high ovarian response|4|||
38068776|NCT01144416|69763240|FG001|Intervention Period|Too high ovarian response|2|||
38068777|NCT01144416|69763239|FG000|Intervention Period|No/too few/bad oocytes|7|||
38068778|NCT01144416|69763240|FG001|Intervention Period|No/too few/bad oocytes|5|||
38068779|NCT01144416|69763239|FG000|Intervention Period|No or abnormal fertilization|25|||
38068780|NCT01144416|69763240|FG001|Intervention Period|No or abnormal fertilization|10|||
38068781|NCT01144416|69763239|FG000|Intervention Period|No/too few/bad quality embryos|3|||
37862320|NCT01130493|69546066|FG000|Part 2: OLE|Withdrawal by Subject|0|||
37862321|NCT01130493|69546067|FG001|Part 2: OLE|Withdrawal by Subject|1|||
37862322|NCT01130493|69546068|FG002|Part 2: OLE|Withdrawal by Subject|4|||
38068782|NCT01144416|69763240|FG001|Intervention Period|No/too few/bad quality embryos|3|||
38068783|NCT01144416|69763239|FG000|Intervention Period|Other|7|||
38068784|NCT01144416|69763240|FG001|Intervention Period|Other|5|||
38068785|NCT00335777|69763250|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
37965914|NCT00042991|69652890|FG006|Overall Study|Adverse Event|0|||
38068786|NCT00335777|69763250|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
38068787|NCT00335777|69763250|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
38068788|NCT00335777|69763250|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
38068789|NCT00335777|69763250|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
38068790|NCT01140048|69763255|FG000|Overall Study|Physician Decision|1|||
38068791|NCT01140048|69763255|FG000|Overall Study|Withdrawal by Subject|13|||
38068792|NCT01140048|69763255|FG000|Overall Study|Lost to Follow-up|31|||
38068793|NCT02889809|69763261|FG000|Overall Study|Withdrawal by Subject|30|||
38068794|NCT02889809|69763262|FG001|Overall Study|Withdrawal by Subject|21|||
38068795|NCT02889809|69763261|FG000|Overall Study|Lost to Follow-up|1|||
38068796|NCT02889809|69763262|FG001|Overall Study|Lost to Follow-up|1|||
38068797|NCT02889809|69763261|FG000|Overall Study|Site Closed|12|||
38068798|NCT02889809|69763262|FG001|Overall Study|Site Closed|11|||
38068799|NCT00972738|69763275|FG000|Overall Study|Adverse Event|7|||
38068800|NCT00972738|69763276|FG001|Overall Study|Adverse Event|1|||
38068801|NCT00972738|69763277|FG002|Overall Study|Adverse Event|8|||
38068802|NCT00972738|69763275|FG000|Overall Study|Protocol Violation|2|||
38068803|NCT00972738|69763276|FG001|Overall Study|Protocol Violation|1|||
38068804|NCT00972738|69763277|FG002|Overall Study|Protocol Violation|3|||
38068805|NCT00972738|69763275|FG000|Overall Study|Lost to Follow-up|1|||
38068806|NCT00972738|69763276|FG001|Overall Study|Lost to Follow-up|0|||
38068807|NCT00972738|69763277|FG002|Overall Study|Lost to Follow-up|1|||
38068808|NCT00972738|69763275|FG000|Overall Study|Lack of Efficacy|5|||
38068809|NCT00972738|69763276|FG001|Overall Study|Lack of Efficacy|1|||
38068810|NCT00972738|69763277|FG002|Overall Study|Lack of Efficacy|11|||
38068811|NCT00972738|69763275|FG000|Overall Study|Withdrawal by Subject|5|||
38068812|NCT00972738|69763276|FG001|Overall Study|Withdrawal by Subject|1|||
38068813|NCT00972738|69763277|FG002|Overall Study|Withdrawal by Subject|4|||
38068814|NCT00972738|69763275|FG000|Overall Study|Moved|0|||
38068815|NCT00972738|69763276|FG001|Overall Study|Moved|0|||
38068816|NCT00972738|69763277|FG002|Overall Study|Moved|1|||
38068817|NCT00972738|69763275|FG000|Overall Study|Other|1|||
38068818|NCT00972738|69763276|FG001|Overall Study|Other|2|||
38068819|NCT00972738|69763277|FG002|Overall Study|Other|1|||
38068820|NCT03243305|69763285|FG000|Overall Study|Lost to Follow-up|250|||
38068821|NCT03243305|69763285|FG000|Overall Study|Withdrawal by Subject|170|||
38068822|NCT03243305|69763285|FG000|Overall Study|Pregnancy|104|||
38068823|NCT03243305|69763285|FG000|Overall Study|Non-Compliance with Study Drug|38|||
38068824|NCT03243305|69763285|FG000|Overall Study|Adverse Event|23|||
38068825|NCT03243305|69763285|FG000|Overall Study|No sexually active|26|||
38068826|NCT03243305|69763285|FG000|Overall Study|Physician Decision|22|||
38068827|NCT03243305|69763285|FG000|Overall Study|Protocol Violation|22|||
38068828|NCT03243305|69763285|FG000|Overall Study|Study method no longer primary method|12|||
38068829|NCT03243305|69763285|FG000|Overall Study|Study Terminated by Sponsor|1|||
38068830|NCT03243305|69763285|FG000|Overall Study|Early terminations|267|||
38068831|NCT03222583|69763291|FG000|Overall Study|Withdrawal by Subject|3|||
38068832|NCT03222583|69763292|FG001|Overall Study|Withdrawal by Subject|3|||
38068833|NCT03222583|69763291|FG000|Overall Study|Lost to Follow-up|1|||
38068834|NCT03222583|69763292|FG001|Overall Study|Lost to Follow-up|0|||
38068835|NCT03222583|69763291|FG000|Overall Study|Other|1|||
38068836|NCT03222583|69763292|FG001|Overall Study|Other|3|||
38068837|NCT03295721|69763301|FG000|Overall Study|Adverse Event|1|||
38068838|NCT03295721|69763302|FG001|Overall Study|Adverse Event|0|||
38068839|NCT03295721|69763303|FG002|Overall Study|Adverse Event|0|||
38068840|NCT03295721|69763301|FG000|Overall Study|Lost to Follow-up|1|||
38068841|NCT03295721|69763302|FG001|Overall Study|Lost to Follow-up|1|||
38068842|NCT03295721|69763303|FG002|Overall Study|Lost to Follow-up|1|||
38068843|NCT03295721|69763301|FG000|Overall Study|Withdrawal by Subject|1|||
38068844|NCT03295721|69763302|FG001|Overall Study|Withdrawal by Subject|0|||
38068845|NCT03295721|69763303|FG002|Overall Study|Withdrawal by Subject|1|||
38068846|NCT03295721|69763301|FG000|Overall Study|Death|0|||
38068847|NCT03295721|69763302|FG001|Overall Study|Death|0|||
38068848|NCT03295721|69763303|FG002|Overall Study|Death|1|||
38068849|NCT00803790|69763314|FG000|Period 1|Adverse Event|0|||
38068850|NCT00803790|69763315|FG001|Period 1|Adverse Event|1|||
38068851|NCT00803790|69763316|FG002|Period 1|Adverse Event|0|||
38068852|NCT00803790|69763317|FG003|Period 1|Adverse Event|0|||
38068853|NCT00803790|69763314|FG000|Period 1|Lost to Follow-up|1|||
38068854|NCT00803790|69763315|FG001|Period 1|Lost to Follow-up|2|||
38068855|NCT00803790|69763316|FG002|Period 1|Lost to Follow-up|0|||
38068856|NCT00803790|69763317|FG003|Period 1|Lost to Follow-up|0|||
38068857|NCT00803790|69763314|FG000|Period 1|Withdrawal by Subject|8|||
38068858|NCT00803790|69763315|FG001|Period 1|Withdrawal by Subject|6|||
38068859|NCT00803790|69763316|FG002|Period 1|Withdrawal by Subject|0|||
38068860|NCT00803790|69763317|FG003|Period 1|Withdrawal by Subject|0|||
38068861|NCT00803790|69763314|FG000|Period 1|positive drug screen or personal reasons|0|||
38068862|NCT00803790|69763315|FG001|Period 1|positive drug screen or personal reasons|3|||
38068863|NCT00803790|69763316|FG002|Period 1|positive drug screen or personal reasons|0|||
38068864|NCT00803790|69763317|FG003|Period 1|positive drug screen or personal reasons|4|||
38068865|NCT00803790|69763314|FG000|Period 1|Protocol Violation|0|||
38068866|NCT00803790|69763315|FG001|Period 1|Protocol Violation|0|||
38068867|NCT00803790|69763316|FG002|Period 1|Protocol Violation|1|||
38068868|NCT00803790|69763317|FG003|Period 1|Protocol Violation|0|||
38068869|NCT00803790|69763314|FG000|Period 2|Adverse Event|0|||
38068870|NCT00803790|69763315|FG001|Period 2|Adverse Event|0|||
38068871|NCT00803790|69763316|FG002|Period 2|Adverse Event|1|||
38068872|NCT00803790|69763317|FG003|Period 2|Adverse Event|1|||
38068873|NCT00803790|69763314|FG000|Period 2|Withdrawal by Subject|1|||
38068874|NCT00803790|69763315|FG001|Period 2|Withdrawal by Subject|0|||
38068875|NCT00803790|69763316|FG002|Period 2|Withdrawal by Subject|0|||
38068876|NCT00803790|69763317|FG003|Period 2|Withdrawal by Subject|0|||
38068877|NCT00803790|69763314|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
38068878|NCT00803790|69763315|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
38068879|NCT00803790|69763316|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
38068880|NCT00803790|69763317|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
38068881|NCT00250458|69763365|FG000|Overall Study|Lost to Follow-up|4|||
38068882|NCT00250458|69763366|FG001|Overall Study|Lost to Follow-up|2|||
38068883|NCT00250458|69763365|FG000|Overall Study|Protocol Violation|0|||
38068884|NCT00250458|69763366|FG001|Overall Study|Protocol Violation|1|||
38068885|NCT00250458|69763365|FG000|Overall Study|Withdrawal by Subject|4|||
38068886|NCT00250458|69763366|FG001|Overall Study|Withdrawal by Subject|2|||
38068887|NCT00250458|69763365|FG000|Overall Study|Lack of Migraine Attack|20|||
38068888|NCT00250458|69763366|FG001|Overall Study|Lack of Migraine Attack|9|||
38068889|NCT00250458|69763365|FG000|Overall Study|Qualifying migraine but did not treat|3|||
38068890|NCT00250458|69763366|FG001|Overall Study|Qualifying migraine but did not treat|3|||
38068891|NCT00250458|69763365|FG000|Overall Study|Other|1|||
38068892|NCT00250458|69763366|FG001|Overall Study|Other|0|||
38068893|NCT01667133|69763384|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
38068894|NCT01667133|69763385|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
38068895|NCT01667133|69763386|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
38068896|NCT01667133|69763387|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
38068897|NCT01667133|69763388|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
38068898|NCT01667133|69763389|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
38068899|NCT01667133|69763390|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
38068900|NCT01667133|69763391|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
38068901|NCT01667133|69763392|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
38068902|NCT01667133|69763393|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
38068903|NCT01667133|69763394|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
38068904|NCT01667133|69763395|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
38068905|NCT01667133|69763384|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
38068906|NCT01667133|69763385|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
38068907|NCT01667133|69763386|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
38068908|NCT01667133|69763387|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
38068909|NCT01667133|69763388|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
38068910|NCT01667133|69763389|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
38068911|NCT01667133|69763390|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
38068912|NCT01667133|69763391|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
38068913|NCT01667133|69763392|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
38068914|NCT01667133|69763393|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
38068915|NCT01667133|69763394|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
38068916|NCT01667133|69763395|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
38068917|NCT01667133|69763384|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
38068918|NCT01667133|69763385|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
38068919|NCT01667133|69763386|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
38068920|NCT01667133|69763387|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
38068921|NCT01667133|69763388|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
38068922|NCT01667133|69763389|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
38068923|NCT01667133|69763390|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
38068924|NCT01667133|69763391|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
38068925|NCT01667133|69763392|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
38068926|NCT01667133|69763393|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
38068927|NCT01667133|69763394|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
38068928|NCT01667133|69763395|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
38068929|NCT01667133|69763384|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
38068930|NCT01667133|69763385|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
38068931|NCT01667133|69763386|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
38068932|NCT01667133|69763387|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
38068933|NCT01667133|69763388|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
38068934|NCT01667133|69763389|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
38068935|NCT01667133|69763390|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
38068936|NCT01667133|69763391|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
38068937|NCT01667133|69763392|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
38068938|NCT01667133|69763393|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
38068939|NCT01667133|69763394|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
38068940|NCT01667133|69763395|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
38068941|NCT01667133|69763384|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
38068942|NCT01667133|69763385|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
38068943|NCT01667133|69763386|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
38068944|NCT01667133|69763387|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
38068945|NCT01667133|69763388|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
38068946|NCT01667133|69763389|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
38068947|NCT01667133|69763390|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
38068948|NCT01667133|69763391|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
38068949|NCT01667133|69763392|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
38068950|NCT01667133|69763393|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
38068951|NCT01667133|69763394|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
38068952|NCT01667133|69763395|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
38068953|NCT01667133|69763384|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
38068954|NCT01667133|69763385|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
38068955|NCT01667133|69763386|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
38068956|NCT01667133|69763387|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
38068957|NCT01667133|69763388|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
38068958|NCT01667133|69763389|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
38068959|NCT01667133|69763390|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
38068960|NCT01667133|69763391|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
38068961|NCT01667133|69763392|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
38068962|NCT01667133|69763393|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
38068963|NCT01667133|69763394|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
38068964|NCT01667133|69763395|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
38068965|NCT01667133|69763384|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
38068966|NCT01667133|69763385|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
38068967|NCT01667133|69763386|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
38068968|NCT01667133|69763387|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
38068969|NCT01667133|69763388|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
38068970|NCT01667133|69763389|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
38068971|NCT01667133|69763390|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
38068972|NCT01667133|69763391|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
38068973|NCT01667133|69763392|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
38068974|NCT01667133|69763393|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
38068975|NCT01667133|69763394|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
38068976|NCT01667133|69763395|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
38068977|NCT01667133|69763384|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
38068978|NCT01667133|69763385|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
38068979|NCT01667133|69763386|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
38068980|NCT01667133|69763387|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
38068981|NCT01667133|69763388|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
38068982|NCT01667133|69763389|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
38068983|NCT01667133|69763390|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
38068984|NCT01667133|69763391|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
38068985|NCT01667133|69763392|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
38068986|NCT01667133|69763393|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
38068987|NCT01667133|69763394|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
38068988|NCT01667133|69763395|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
38068989|NCT01667133|69763384|FG000|Phase 2: Dose-expansion|Death|0|||
38068990|NCT01667133|69763385|FG001|Phase 2: Dose-expansion|Death|0|||
38068991|NCT01667133|69763386|FG002|Phase 2: Dose-expansion|Death|0|||
38068992|NCT01667133|69763387|FG003|Phase 2: Dose-expansion|Death|0|||
38068993|NCT01667133|69763388|FG004|Phase 2: Dose-expansion|Death|0|||
38068994|NCT01667133|69763389|FG005|Phase 2: Dose-expansion|Death|0|||
38068995|NCT01667133|69763390|FG006|Phase 2: Dose-expansion|Death|0|||
38068996|NCT01667133|69763391|FG007|Phase 2: Dose-expansion|Death|0|||
38068997|NCT01667133|69763392|FG008|Phase 2: Dose-expansion|Death|0|||
38068998|NCT01667133|69763393|FG009|Phase 2: Dose-expansion|Death|1|||
38068999|NCT01667133|69763394|FG010|Phase 2: Dose-expansion|Death|0|||
38069000|NCT01667133|69763395|FG011|Phase 2: Dose-expansion|Death|0|||
38069001|NCT01667133|69763384|FG000|Phase 2: Dose-expansion|Other|0|||
38069002|NCT01667133|69763385|FG001|Phase 2: Dose-expansion|Other|0|||
38069003|NCT01667133|69763386|FG002|Phase 2: Dose-expansion|Other|0|||
38069004|NCT01667133|69763387|FG003|Phase 2: Dose-expansion|Other|0|||
38069005|NCT01667133|69763388|FG004|Phase 2: Dose-expansion|Other|0|||
38069006|NCT01667133|69763389|FG005|Phase 2: Dose-expansion|Other|0|||
38069007|NCT01667133|69763390|FG006|Phase 2: Dose-expansion|Other|0|||
38069008|NCT01667133|69763391|FG007|Phase 2: Dose-expansion|Other|0|||
38069009|NCT01667133|69763392|FG008|Phase 2: Dose-expansion|Other|0|||
38069010|NCT01667133|69763393|FG009|Phase 2: Dose-expansion|Other|0|||
38069011|NCT01667133|69763394|FG010|Phase 2: Dose-expansion|Other|0|||
38069012|NCT01667133|69763395|FG011|Phase 2: Dose-expansion|Other|1|||
38069013|NCT01181778|69763456|FG000|Overall Study|Physician Decision|48|||
38069014|NCT00092118|69763464|FG000|Overall Study|Adverse Event|35|||
38069015|NCT00092118|69763465|FG001|Overall Study|Adverse Event|32|||
38069016|NCT00092118|69763464|FG000|Overall Study|Lack of Efficacy|12|||
38069017|NCT00092118|69763465|FG001|Overall Study|Lack of Efficacy|14|||
38069018|NCT00092118|69763464|FG000|Overall Study|Lost to Follow-up|4|||
38069019|NCT00092118|69763465|FG001|Overall Study|Lost to Follow-up|3|||
38069020|NCT00092118|69763464|FG000|Overall Study|Protocol Violation|23|||
38069021|NCT00092118|69763465|FG001|Overall Study|Protocol Violation|25|||
38069022|NCT00092118|69763464|FG000|Overall Study|Withdrawal by Subject|4|||
38069023|NCT00092118|69763465|FG001|Overall Study|Withdrawal by Subject|10|||
38069024|NCT00092118|69763464|FG000|Overall Study|Other|6|||
38069025|NCT00092118|69763465|FG001|Overall Study|Other|5|||
38069026|NCT03261947|69763476|FG000|Overall Study|Death|10|||
38069027|NCT03261947|69763477|FG001|Overall Study|Death|13|||
38069028|NCT03261947|69763478|FG002|Overall Study|Death|17|||
38069029|NCT03261947|69763479|FG003|Overall Study|Death|12|||
38069030|NCT03261947|69763480|FG004|Overall Study|Death|8|||
38069031|NCT03261947|69763476|FG000|Overall Study|Lost to Follow-up|0|||
38069032|NCT03261947|69763477|FG001|Overall Study|Lost to Follow-up|0|||
38069033|NCT03261947|69763478|FG002|Overall Study|Lost to Follow-up|2|||
38069034|NCT03261947|69763479|FG003|Overall Study|Lost to Follow-up|1|||
38069035|NCT03261947|69763480|FG004|Overall Study|Lost to Follow-up|0|||
38069036|NCT03261947|69763476|FG000|Overall Study|Withdrawal by Subject|0|||
38069037|NCT03261947|69763477|FG001|Overall Study|Withdrawal by Subject|0|||
38069038|NCT03261947|69763478|FG002|Overall Study|Withdrawal by Subject|3|||
38069039|NCT03261947|69763479|FG003|Overall Study|Withdrawal by Subject|0|||
38069040|NCT03261947|69763480|FG004|Overall Study|Withdrawal by Subject|1|||
38069041|NCT03261947|69763476|FG000|Overall Study|Site Terminated by Sponsor|0|||
38069042|NCT03261947|69763477|FG001|Overall Study|Site Terminated by Sponsor|0|||
38069043|NCT03261947|69763478|FG002|Overall Study|Site Terminated by Sponsor|4|||
38069044|NCT03261947|69763479|FG003|Overall Study|Site Terminated by Sponsor|7|||
38069045|NCT03261947|69763480|FG004|Overall Study|Site Terminated by Sponsor|5|||
38069046|NCT03261947|69763476|FG000|Overall Study|Reason not Specified|2|||
38069047|NCT03261947|69763477|FG001|Overall Study|Reason not Specified|0|||
38069048|NCT03261947|69763478|FG002|Overall Study|Reason not Specified|4|||
38069049|NCT03261947|69763479|FG003|Overall Study|Reason not Specified|1|||
38069050|NCT03261947|69763480|FG004|Overall Study|Reason not Specified|3|||
38069051|NCT03098979|69763511|FG000|Overall Study|Adverse Event|1|||
38069052|NCT03098979|69763512|FG001|Overall Study|Adverse Event|0|||
38069053|NCT03098979|69763513|FG002|Overall Study|Adverse Event|1|||
38069054|NCT03098979|69763514|FG003|Overall Study|Adverse Event|4|||
38069055|NCT03098979|69763515|FG004|Overall Study|Adverse Event|6|||
38069056|NCT03098979|69763516|FG005|Overall Study|Adverse Event|1|||
38069057|NCT03098979|69763511|FG000|Overall Study|Withdrawal by Subject|2|||
38069058|NCT03098979|69763512|FG001|Overall Study|Withdrawal by Subject|1|||
38069059|NCT03098979|69763513|FG002|Overall Study|Withdrawal by Subject|1|||
38069060|NCT03098979|69763514|FG003|Overall Study|Withdrawal by Subject|1|||
38069061|NCT03098979|69763515|FG004|Overall Study|Withdrawal by Subject|2|||
38069062|NCT03098979|69763516|FG005|Overall Study|Withdrawal by Subject|1|||
38069063|NCT03098979|69763511|FG000|Overall Study|Death|1|||
38069064|NCT03098979|69763512|FG001|Overall Study|Death|0|||
38069065|NCT03098979|69763513|FG002|Overall Study|Death|2|||
38069066|NCT03098979|69763514|FG003|Overall Study|Death|0|||
38069067|NCT03098979|69763515|FG004|Overall Study|Death|1|||
38069068|NCT03098979|69763516|FG005|Overall Study|Death|0|||
38069069|NCT03098979|69763511|FG000|Overall Study|Physician Decision|2|||
38069070|NCT03098979|69763512|FG001|Overall Study|Physician Decision|1|||
38069071|NCT03098979|69763513|FG002|Overall Study|Physician Decision|0|||
38069072|NCT03098979|69763514|FG003|Overall Study|Physician Decision|0|||
38069073|NCT03098979|69763515|FG004|Overall Study|Physician Decision|0|||
38069074|NCT03098979|69763516|FG005|Overall Study|Physician Decision|0|||
38069075|NCT03098979|69763511|FG000|Overall Study|Non-compliance|0|||
38069076|NCT03098979|69763512|FG001|Overall Study|Non-compliance|0|||
38069077|NCT03098979|69763513|FG002|Overall Study|Non-compliance|0|||
38069078|NCT03098979|69763514|FG003|Overall Study|Non-compliance|0|||
38069079|NCT03098979|69763515|FG004|Overall Study|Non-compliance|0|||
38069080|NCT03098979|69763516|FG005|Overall Study|Non-compliance|1|||
38069081|NCT03098979|69763511|FG000|Overall Study|Protocol Violation|0|||
38069082|NCT03098979|69763512|FG001|Overall Study|Protocol Violation|0|||
38069083|NCT03098979|69763513|FG002|Overall Study|Protocol Violation|0|||
38069084|NCT03098979|69763514|FG003|Overall Study|Protocol Violation|0|||
38069085|NCT03098979|69763515|FG004|Overall Study|Protocol Violation|0|||
38069086|NCT03098979|69763516|FG005|Overall Study|Protocol Violation|1|||
38069087|NCT03261167|69763532|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
38069088|NCT03261167|69763533|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
38069089|NCT03261167|69763532|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
38069090|NCT03261167|69763533|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
38069091|NCT03261167|69763532|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
38069092|NCT03261167|69763533|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
38069093|NCT03261167|69763532|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
38069094|NCT03261167|69763533|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
38069095|NCT03261167|69763532|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
38069096|NCT03261167|69763533|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
38069097|NCT03294941|69763547|FG000|Overall Study|Withdrawal by Subject|0|||
38069098|NCT03294941|69763548|FG001|Overall Study|Withdrawal by Subject|2|||
38069099|NCT03098433|69763555|FG000|Overall Study|Withdrawal by Subject|10|||
38069100|NCT03294317|69763560|FG000|Overall Study|Physician Decision|1|||
38069101|NCT03294317|69763560|FG000|Overall Study|Withdrawal by Subject|6|||
38069102|NCT03294317|69763560|FG000|Overall Study|Lost to Follow-up|1|||
38069103|NCT03294317|69763560|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
38069104|NCT03294317|69763560|FG000|Overall Study|Failed HB lead implant|8|||
38069105|NCT03294317|69763560|FG000|Overall Study|Received CRT instead|1|||
38069106|NCT03294317|69763560|FG000|Overall Study|Exited after lead revision|2|||
38069107|NCT03292913|69763566|FG000|Overall Study|Death|9|||
38069108|NCT03292913|69763567|FG001|Overall Study|Death|3|||
38069109|NCT03292913|69763566|FG000|Overall Study|Lost to Follow-up|49|||
38069110|NCT03292913|69763567|FG001|Overall Study|Lost to Follow-up|49|||
38069111|NCT03292913|69763566|FG000|Overall Study|Withdrawal by Subject|2|||
38069112|NCT03292913|69763567|FG001|Overall Study|Withdrawal by Subject|0|||
38069113|NCT03292913|69763566|FG000|Overall Study|Clinic closed due to COVID|22|||
38069114|NCT03292913|69763567|FG001|Overall Study|Clinic closed due to COVID|36|||
38069115|NCT03291587|69763579|FG000|Overall Study|Lost to Follow-up|62|||
38069116|NCT03291587|69763580|FG001|Overall Study|Lost to Follow-up|43|||
38069117|NCT03291587|69763579|FG000|Overall Study|Refused to Answer|5|||
38069118|NCT03291587|69763580|FG001|Overall Study|Refused to Answer|2|||
38069119|NCT03291587|69763579|FG000|Overall Study|Death|2|||
38069120|NCT03291587|69763580|FG001|Overall Study|Death|4|||
38069121|NCT03291587|69763579|FG000|Overall Study|Not interested in participating|8|||
38069122|NCT03291587|69763580|FG001|Overall Study|Not interested in participating|6|||
38069123|NCT03291587|69763579|FG000|Overall Study|Too busy to participate|4|||
38069124|NCT03291587|69763580|FG001|Overall Study|Too busy to participate|2|||
38069125|NCT03210961|69763611|FG000|Overall Study|Adverse Event|0|||
38069126|NCT03210961|69763612|FG001|Overall Study|Adverse Event|0|||
38069127|NCT03210961|69763613|FG002|Overall Study|Adverse Event|0|||
38069128|NCT03210961|69763614|FG003|Overall Study|Adverse Event|0|||
38069129|NCT03210961|69763615|FG004|Overall Study|Adverse Event|0|||
38069130|NCT03210961|69763616|FG005|Overall Study|Adverse Event|0|||
38069131|NCT03210961|69763617|FG006|Overall Study|Adverse Event|0|||
38069132|NCT03210961|69763618|FG007|Overall Study|Adverse Event|0|||
38069133|NCT03210961|69763619|FG008|Overall Study|Adverse Event|0|||
38069134|NCT03210961|69763620|FG009|Overall Study|Adverse Event|0|||
38069135|NCT03210961|69763621|FG010|Overall Study|Adverse Event|0|||
38069136|NCT03210961|69763622|FG011|Overall Study|Adverse Event|0|||
38069137|NCT03210961|69763623|FG012|Overall Study|Adverse Event|0|||
38069138|NCT03210961|69763624|FG013|Overall Study|Adverse Event|1|||
38069139|NCT03210961|69763625|FG014|Overall Study|Adverse Event|0|||
38069140|NCT03210961|69763611|FG000|Overall Study|Lost to Follow-up|0|||
38069141|NCT03210961|69763612|FG001|Overall Study|Lost to Follow-up|0|||
38069142|NCT03210961|69763613|FG002|Overall Study|Lost to Follow-up|0|||
38069143|NCT03210961|69763614|FG003|Overall Study|Lost to Follow-up|0|||
38069144|NCT03210961|69763615|FG004|Overall Study|Lost to Follow-up|0|||
38069145|NCT03210961|69763616|FG005|Overall Study|Lost to Follow-up|0|||
38069146|NCT03210961|69763617|FG006|Overall Study|Lost to Follow-up|0|||
38069147|NCT03210961|69763618|FG007|Overall Study|Lost to Follow-up|0|||
38069148|NCT03210961|69763619|FG008|Overall Study|Lost to Follow-up|0|||
38069149|NCT03210961|69763620|FG009|Overall Study|Lost to Follow-up|0|||
38069150|NCT03210961|69763621|FG010|Overall Study|Lost to Follow-up|0|||
38069151|NCT03210961|69763622|FG011|Overall Study|Lost to Follow-up|0|||
37965915|NCT00042991|69652884|FG000|Overall Study|Withdrawal by Subject|0|||
38069152|NCT03210961|69763623|FG012|Overall Study|Lost to Follow-up|0|||
38069153|NCT03210961|69763624|FG013|Overall Study|Lost to Follow-up|0|||
38069154|NCT03210961|69763625|FG014|Overall Study|Lost to Follow-up|1|||
38069155|NCT03210961|69763611|FG000|Overall Study|Withdrawal by Subject|0|||
38069156|NCT03210961|69763612|FG001|Overall Study|Withdrawal by Subject|0|||
38069157|NCT03210961|69763613|FG002|Overall Study|Withdrawal by Subject|0|||
38069158|NCT03210961|69763614|FG003|Overall Study|Withdrawal by Subject|0|||
38069159|NCT03210961|69763615|FG004|Overall Study|Withdrawal by Subject|0|||
38069160|NCT03210961|69763616|FG005|Overall Study|Withdrawal by Subject|0|||
38069161|NCT03210961|69763617|FG006|Overall Study|Withdrawal by Subject|0|||
38069162|NCT03210961|69763618|FG007|Overall Study|Withdrawal by Subject|0|||
38069163|NCT03210961|69763619|FG008|Overall Study|Withdrawal by Subject|0|||
38069164|NCT03210961|69763620|FG009|Overall Study|Withdrawal by Subject|0|||
38069165|NCT03210961|69763621|FG010|Overall Study|Withdrawal by Subject|0|||
38069166|NCT03210961|69763622|FG011|Overall Study|Withdrawal by Subject|0|||
38069167|NCT03210961|69763623|FG012|Overall Study|Withdrawal by Subject|0|||
38069168|NCT03210961|69763624|FG013|Overall Study|Withdrawal by Subject|0|||
38069169|NCT03210961|69763625|FG014|Overall Study|Withdrawal by Subject|1|||
38069170|NCT03210961|69763611|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
38069171|NCT03210961|69763612|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
38069172|NCT03210961|69763613|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
38069173|NCT03210961|69763614|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
38069174|NCT03210961|69763615|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
38069175|NCT03210961|69763616|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
38069176|NCT03210961|69763617|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
38069177|NCT03210961|69763618|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
38069178|NCT03210961|69763619|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
38069179|NCT03210961|69763620|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
38069180|NCT03210961|69763621|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
38069181|NCT03210961|69763622|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
38069182|NCT03210961|69763623|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
38069183|NCT03210961|69763624|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
38069184|NCT03210961|69763625|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
38069185|NCT03210961|69763611|FG000|Overall Study|Other|0|||
38069186|NCT03210961|69763612|FG001|Overall Study|Other|0|||
38069187|NCT03210961|69763613|FG002|Overall Study|Other|0|||
38069188|NCT03210961|69763614|FG003|Overall Study|Other|1|||
38069189|NCT03210961|69763615|FG004|Overall Study|Other|0|||
38069190|NCT03210961|69763616|FG005|Overall Study|Other|0|||
38069191|NCT03210961|69763617|FG006|Overall Study|Other|1|||
38069192|NCT03210961|69763618|FG007|Overall Study|Other|0|||
38069193|NCT03210961|69763619|FG008|Overall Study|Other|0|||
38069194|NCT03210961|69763620|FG009|Overall Study|Other|0|||
38069195|NCT03210961|69763621|FG010|Overall Study|Other|1|||
38069196|NCT03210961|69763622|FG011|Overall Study|Other|0|||
38069197|NCT03210961|69763623|FG012|Overall Study|Other|2|||
38069198|NCT03210961|69763624|FG013|Overall Study|Other|2|||
38069199|NCT03210961|69763625|FG014|Overall Study|Other|0|||
38069200|NCT03242759|69763678|FG000|Overall Study|Adverse Event|5|||
38069201|NCT03242759|69763679|FG001|Overall Study|Adverse Event|1|||
38069202|NCT03242759|69763678|FG000|Overall Study|Withdrawal by Subject|4|||
38069203|NCT03242759|69763679|FG001|Overall Study|Withdrawal by Subject|3|||
38069204|NCT03242759|69763678|FG000|Overall Study|Lost to Follow-up|3|||
38069205|NCT03242759|69763679|FG001|Overall Study|Lost to Follow-up|1|||
38069206|NCT03242759|69763678|FG000|Overall Study|Administrative problems|1|||
38069207|NCT03242759|69763679|FG001|Overall Study|Administrative problems|1|||
38069208|NCT03242759|69763678|FG000|Overall Study|Death|22|||
38069209|NCT03242759|69763679|FG001|Overall Study|Death|0|||
38069210|NCT03242759|69763678|FG000|Overall Study|Change visit schedule|0|||
38069211|NCT03242759|69763679|FG001|Overall Study|Change visit schedule|1|||
38069212|NCT03097029|69763685|FG000|Overall Study|Withdrawal by Subject|1|||
38069213|NCT03257813|69763691|FG000|Overall Study|Protocol Violation|6|||
38069214|NCT03257813|69763692|FG001|Overall Study|Protocol Violation|3|||
38069215|NCT03210259|69763703|FG000|12-Week Run-in Period|Adverse Event|1|||
38069216|NCT03210259|69763704|FG001|12-Week Run-in Period|Adverse Event|0|||
38069217|NCT03210259|69763705|FG002|12-Week Run-in Period|Adverse Event|0|||
38069218|NCT03210259|69763703|FG000|12-Week Run-in Period|Death|1|||
38069219|NCT03210259|69763704|FG001|12-Week Run-in Period|Death|0|||
38069220|NCT03210259|69763705|FG002|12-Week Run-in Period|Death|0|||
38069221|NCT03210259|69763703|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
38069222|NCT03210259|69763704|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
38069223|NCT03210259|69763705|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
38069224|NCT03210259|69763703|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
38069225|NCT03210259|69763704|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
38069226|NCT03210259|69763705|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
38069227|NCT03210259|69763703|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
38069228|NCT03210259|69763704|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
38069229|NCT03210259|69763705|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
38069230|NCT03210259|69763703|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
38069231|NCT03210259|69763704|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
38069232|NCT03210259|69763705|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
38069233|NCT03210259|69763703|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
38069234|NCT03210259|69763704|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
38069235|NCT03210259|69763705|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
38069236|NCT03210259|69763703|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
38069237|NCT03210259|69763704|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
38069238|NCT03210259|69763705|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
38069239|NCT03210259|69763703|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
38069240|NCT03210259|69763704|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
38069241|NCT03210259|69763705|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
38069242|NCT03210259|69763703|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
38069243|NCT03210259|69763704|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
37965916|NCT00042991|69652885|FG001|Overall Study|Withdrawal by Subject|7|||
37965917|NCT00042991|69652886|FG002|Overall Study|Withdrawal by Subject|2|||
37965918|NCT00042991|69652887|FG003|Overall Study|Withdrawal by Subject|0|||
37965919|NCT00042991|69652888|FG004|Overall Study|Withdrawal by Subject|1|||
37965920|NCT00042991|69652889|FG005|Overall Study|Withdrawal by Subject|0|||
37965921|NCT00042991|69652890|FG006|Overall Study|Withdrawal by Subject|0|||
37965922|NCT00042991|69652884|FG000|Overall Study|Disease Progression|5|||
37965923|NCT00042991|69652885|FG001|Overall Study|Disease Progression|29|||
37965924|NCT00042991|69652886|FG002|Overall Study|Disease Progression|2|||
37965925|NCT00042991|69652887|FG003|Overall Study|Disease Progression|2|||
37965926|NCT00042991|69652888|FG004|Overall Study|Disease Progression|1|||
37965927|NCT00042991|69652889|FG005|Overall Study|Disease Progression|4|||
37965928|NCT00042991|69652890|FG006|Overall Study|Disease Progression|2|||
37965929|NCT00042991|69652884|FG000|Overall Study|Alternative Therapy|0|||
37965930|NCT00042991|69652885|FG001|Overall Study|Alternative Therapy|0|||
37965931|NCT00042991|69652886|FG002|Overall Study|Alternative Therapy|0|||
37965932|NCT00042991|69652887|FG003|Overall Study|Alternative Therapy|0|||
37965933|NCT00042991|69652888|FG004|Overall Study|Alternative Therapy|1|||
37965934|NCT00042991|69652889|FG005|Overall Study|Alternative Therapy|0|||
37965935|NCT00042991|69652890|FG006|Overall Study|Alternative Therapy|0|||
37965936|NCT00466167|69652911|FG000|Overall Study|Adverse Event|8|||
37965937|NCT00466167|69652912|FG001|Overall Study|Adverse Event|8|||
37965938|NCT00466167|69652913|FG002|Overall Study|Adverse Event|7|||
37965939|NCT00466167|69652911|FG000|Overall Study|Lack of Efficacy|2|||
37965940|NCT00466167|69652912|FG001|Overall Study|Lack of Efficacy|0|||
37965941|NCT00466167|69652913|FG002|Overall Study|Lack of Efficacy|3|||
37965942|NCT00466167|69652911|FG000|Overall Study|Protocol Violation|1|||
37965943|NCT00466167|69652912|FG001|Overall Study|Protocol Violation|1|||
37965944|NCT00466167|69652913|FG002|Overall Study|Protocol Violation|2|||
37965945|NCT00466167|69652911|FG000|Overall Study|Lost to Follow-up|3|||
37965946|NCT00466167|69652912|FG001|Overall Study|Lost to Follow-up|2|||
37965947|NCT00466167|69652913|FG002|Overall Study|Lost to Follow-up|2|||
37965948|NCT00466167|69652911|FG000|Overall Study|Withdrawal by Subject|4|||
37965949|NCT00466167|69652912|FG001|Overall Study|Withdrawal by Subject|1|||
37965950|NCT00466167|69652913|FG002|Overall Study|Withdrawal by Subject|6|||
37965951|NCT00466167|69652911|FG000|Overall Study|patient did not meet inclusion criteria|1|||
37965952|NCT00466167|69652912|FG001|Overall Study|patient did not meet inclusion criteria|0|||
37965953|NCT00466167|69652913|FG002|Overall Study|patient did not meet inclusion criteria|1|||
37965954|NCT00466167|69652911|FG000|Overall Study|Not treated|1|||
37965955|NCT00466167|69652912|FG001|Overall Study|Not treated|0|||
37965956|NCT00466167|69652913|FG002|Overall Study|Not treated|0|||
37965957|NCT00480441|69652923|FG000|Screening|Not Eligible|37|||
37965958|NCT00480441|69652924|FG001|Screening|Not Eligible|0|||
37965959|NCT00480441|69652925|FG002|Screening|Not Eligible|0|||
37965960|NCT00480441|69652923|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
37965961|NCT00480441|69652924|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
37965962|NCT00480441|69652925|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
37965963|NCT00480441|69652923|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
37965964|NCT00480441|69652924|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
37965965|NCT00480441|69652925|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
37965966|NCT00480441|69652923|FG000|Baseline Functional MRI|physical contraindication|4|||
37965967|NCT00480441|69652924|FG001|Baseline Functional MRI|physical contraindication|0|||
37965968|NCT00480441|69652925|FG002|Baseline Functional MRI|physical contraindication|0|||
37965969|NCT00480441|69652923|FG000|Randomization|Lost to Follow-up|0|||
37965970|NCT00480441|69652924|FG001|Randomization|Lost to Follow-up|7|||
37965971|NCT00480441|69652925|FG002|Randomization|Lost to Follow-up|2|||
37965972|NCT00488319|69652935|FG000|Overall Study|Adverse Event|1|||
38069244|NCT03210259|69763705|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
38069245|NCT03210259|69763703|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
37965973|NCT00488319|69652936|FG001|Overall Study|Adverse Event|2|||
37965974|NCT00488319|69652937|FG002|Overall Study|Adverse Event|23|||
37965975|NCT00488319|69652935|FG000|Overall Study|Lack of Efficacy|6|||
37965976|NCT00488319|69652936|FG001|Overall Study|Lack of Efficacy|12|||
37965977|NCT00488319|69652937|FG002|Overall Study|Lack of Efficacy|27|||
37965978|NCT00488319|69652935|FG000|Overall Study|Lost to Follow-up|3|||
37965979|NCT00488319|69652936|FG001|Overall Study|Lost to Follow-up|5|||
37965980|NCT00488319|69652937|FG002|Overall Study|Lost to Follow-up|16|||
37965981|NCT00488319|69652935|FG000|Overall Study|Withdrawal by Subject|5|||
37965982|NCT00488319|69652936|FG001|Overall Study|Withdrawal by Subject|20|||
37965983|NCT00488319|69652937|FG002|Overall Study|Withdrawal by Subject|44|||
37965984|NCT00488319|69652935|FG000|Overall Study|Other reasons for withdrawal|0|||
37965985|NCT00488319|69652936|FG001|Overall Study|Other reasons for withdrawal|4|||
37965986|NCT00488319|69652937|FG002|Overall Study|Other reasons for withdrawal|12|||
37965987|NCT00463047|69652946|FG000|Titration Period 1|Adverse Event|10|||
37965988|NCT00463047|69652947|FG001|Titration Period 1|Adverse Event|8|||
37965989|NCT00463047|69652946|FG000|Titration Period 1|Lack of Efficacy|10|||
37965990|NCT00463047|69652947|FG001|Titration Period 1|Lack of Efficacy|4|||
37965991|NCT00463047|69652946|FG000|Titration Period 1|Lost to Follow-up|2|||
37965992|NCT00463047|69652947|FG001|Titration Period 1|Lost to Follow-up|0|||
38069246|NCT03210259|69763704|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
38069247|NCT03210259|69763705|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
38069248|NCT03257657|69763714|FG000|Overall Study|Lost to Follow-up|0|||
38069249|NCT03257657|69763715|FG001|Overall Study|Lost to Follow-up|3|||
38069250|NCT03257657|69763714|FG000|Overall Study|Withdrawn|0|||
38069251|NCT03257657|69763715|FG001|Overall Study|Withdrawn|1|||
38069252|NCT03257657|69763714|FG000|Overall Study|Noted not eligible right after enrolled|0|||
38069253|NCT03257657|69763715|FG001|Overall Study|Noted not eligible right after enrolled|1|||
38069254|NCT02496611|69763724|FG000|Overall Study|Lost to Follow-up|2|||
38069255|NCT02496611|69763725|FG001|Overall Study|Lost to Follow-up|1|||
38069256|NCT02496611|69763724|FG000|Overall Study|Withdrawal by Subject|5|||
38069257|NCT02496611|69763725|FG001|Overall Study|Withdrawal by Subject|2|||
38069258|NCT03237481|69763735|FG000|Overall Study|Lost to Follow-up|1|||
38069259|NCT03237481|69763736|FG001|Overall Study|Lost to Follow-up|0|||
38069260|NCT03237481|69763737|FG002|Overall Study|Lost to Follow-up|0|||
38069261|NCT03237481|69763735|FG000|Overall Study|Protocol Violation|1|||
38069262|NCT03237481|69763736|FG001|Overall Study|Protocol Violation|0|||
38069263|NCT03237481|69763737|FG002|Overall Study|Protocol Violation|0|||
38069264|NCT03237481|69763735|FG000|Overall Study|Withdrawal by Subject|3|||
38069265|NCT03237481|69763736|FG001|Overall Study|Withdrawal by Subject|2|||
38069266|NCT03237481|69763737|FG002|Overall Study|Withdrawal by Subject|1|||
38069267|NCT03222349|69763745|FG000|Overall Study|Treatment B not done|5|||
38069268|NCT03222349|69763746|FG001|Overall Study|Treatment B not done|0|||
38069269|NCT03222349|69763745|FG000|Overall Study|Lost to Follow-up|1|||
38069270|NCT03222349|69763746|FG001|Overall Study|Lost to Follow-up|2|||
38069271|NCT03222349|69763745|FG000|Overall Study|Withdrawal by Subject|1|||
38069272|NCT03222349|69763746|FG001|Overall Study|Withdrawal by Subject|0|||
38069273|NCT03222349|69763745|FG000|Overall Study|Treatment A not done|0|||
38069274|NCT03222349|69763746|FG001|Overall Study|Treatment A not done|5|||
37965993|NCT00463047|69652946|FG000|Titration Period 1|Non-compliance with study medication|3|||
38069275|NCT03222349|69763745|FG000|Overall Study|Study terminated by sponsor|1|||
38069276|NCT03222349|69763746|FG001|Overall Study|Study terminated by sponsor|0|||
38069277|NCT02927925|69763759|FG000|Overall Study|Death|16|||
38069278|NCT02927925|69763759|FG000|Overall Study|Physician Decision|1|||
38069279|NCT02927925|69763759|FG000|Overall Study|Withdrawal by Subject|11|||
38069280|NCT02927925|69763759|FG000|Overall Study|Other|3|||
38069281|NCT02927925|69763759|FG000|Overall Study|Disease progression at clinical cutoff|1|||
38069282|NCT03208933|69763763|FG000|Overall Study|Death|3|||
38069283|NCT03208933|69763763|FG000|Overall Study|Withdrawal by Subject|3|||
38069284|NCT03208933|69763763|FG000|Overall Study|Adverse Event|1|||
37965994|NCT00463047|69652947|FG001|Titration Period 1|Non-compliance with study medication|5|||
38069285|NCT03208933|69763763|FG000|Overall Study|Lost to Follow-up|2|||
38069286|NCT03208933|69763763|FG000|Overall Study|Physician Decision|3|||
38069287|NCT03208933|69763763|FG000|Overall Study|Protocol Violation|1|||
38069288|NCT03207763|69763769|FG000|Overall Study|Lost to Follow-up|1|||
38069289|NCT03207763|69763770|FG001|Overall Study|Lost to Follow-up|0|||
38069290|NCT04766034|69763789|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
38069291|NCT04766034|69763790|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
38069292|NCT04766034|69763791|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
38069293|NCT04766034|69763792|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
38069294|NCT04766034|69763793|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
38069295|NCT04766034|69763789|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
38069296|NCT04766034|69763790|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
38069297|NCT04766034|69763791|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
38069298|NCT04766034|69763792|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
38069299|NCT04766034|69763793|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
38069300|NCT04766034|69763789|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
38069301|NCT04766034|69763790|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
38069302|NCT04766034|69763791|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
38069303|NCT04766034|69763792|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
38069304|NCT04766034|69763793|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
38069305|NCT04766034|69763789|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
38069306|NCT04766034|69763790|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
38069307|NCT04766034|69763791|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
38069308|NCT04766034|69763792|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
38069309|NCT04766034|69763793|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
38069310|NCT03237013|69763808|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
38069311|NCT03237013|69763809|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
38069312|NCT03237013|69763810|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
38069313|NCT03236779|69763820|FG000|Overall Study|Lost to Follow-up|13|||
38069314|NCT03236779|69763821|FG001|Overall Study|Lost to Follow-up|21|||
38069315|NCT03096483|69763829|FG000|Overall Study|Withdrawal by site|1|||
38069316|NCT02932579|69763835|FG000|Overall Study|Withdrawal by Subject|4|||
38069317|NCT02932579|69763836|FG001|Overall Study|Withdrawal by Subject|1|||
38069318|NCT03207451|69763846|FG000|Overall Study|scheduling conflict|1|||
38069319|NCT03207451|69763847|FG001|Overall Study|scheduling conflict|0|||
38069320|NCT03207451|69763848|FG002|Overall Study|scheduling conflict|2|||
38069321|NCT03207451|69763849|FG003|Overall Study|scheduling conflict|2|||
38069322|NCT03207451|69763846|FG000|Overall Study|Adverse Event|0|||
38069323|NCT03207451|69763847|FG001|Overall Study|Adverse Event|0|||
38069324|NCT03207451|69763848|FG002|Overall Study|Adverse Event|0|||
38069325|NCT03207451|69763849|FG003|Overall Study|Adverse Event|1|||
38069326|NCT03350503|69763876|FG000|Overall Study|Adverse Event|5|||
38069327|NCT03350503|69763876|FG000|Overall Study|Withdrawal by Subject|5|||
38069328|NCT03350503|69763876|FG000|Overall Study|Continuation impossible due to move|4|||
38069329|NCT03350503|69763876|FG000|Overall Study|Physician Decision|3|||
38069330|NCT03288779|69763899|FG000|Overall Study|Withdrawal by Subject|3|||
38069331|NCT03206749|69763906|FG000|Overall Study|Withdrawal of consent|5|||
38069332|NCT03206749|69763907|FG001|Overall Study|Withdrawal of consent|3|||
38069333|NCT03206749|69763908|FG002|Overall Study|Withdrawal of consent|6|||
38069334|NCT03206749|69763906|FG000|Overall Study|Lost to Follow-up|0|||
38069335|NCT03206749|69763907|FG001|Overall Study|Lost to Follow-up|0|||
38069336|NCT03206749|69763908|FG002|Overall Study|Lost to Follow-up|1|||
38069337|NCT03255941|69763928|FG000|Overall Study|Not eligible or refused injection|37|||
38069338|NCT03255941|69763929|FG001|Overall Study|Not eligible or refused injection|44|||
38069339|NCT03255941|69763930|FG002|Overall Study|Not eligible or refused injection|5|||
38069340|NCT03255941|69763931|FG003|Overall Study|Not eligible or refused injection|6|||
38069341|NCT03255941|69763928|FG000|Overall Study|Did not complete exit interview|1|||
38069342|NCT03255941|69763929|FG001|Overall Study|Did not complete exit interview|2|||
38069343|NCT03255941|69763930|FG002|Overall Study|Did not complete exit interview|0|||
38069344|NCT03255941|69763931|FG003|Overall Study|Did not complete exit interview|0|||
38069345|NCT03255629|69763953|FG000|Overall Study|Adverse Event|1|||
38069346|NCT03255629|69763954|FG001|Overall Study|Adverse Event|0|||
38069347|NCT03255629|69763953|FG000|Overall Study|did not experience hypoglycemia|2|||
38069348|NCT03255629|69763954|FG001|Overall Study|did not experience hypoglycemia|1|||
38069349|NCT03031938|69763963|FG000|Overall Study|Death|1|||
38069350|NCT03031938|69763964|FG001|Overall Study|Death|0|||
38069351|NCT01137773|69763972|FG000|Overall Study|Death|3|||
38069352|NCT01137773|69763973|FG001|Overall Study|Death|3|||
38069353|NCT01137773|69763972|FG000|Overall Study|Lost to Follow-up|6|||
38069354|NCT01137773|69763973|FG001|Overall Study|Lost to Follow-up|0|||
38069355|NCT03094611|69763981|FG000|Overall Study|Lack of Efficacy|1|||
38069356|NCT03094611|69763981|FG000|Overall Study|Stem Cell Transplant|1|||
38069357|NCT04105725|69764005|FG000|Primary Intervention|Lost to Follow-up|0|||
38069358|NCT04105725|69764006|FG001|Primary Intervention|Lost to Follow-up|2|||
38069359|NCT04105725|69764005|FG000|Primary Intervention|Withdrawal by Subject|0|||
38069360|NCT04105725|69764006|FG001|Primary Intervention|Withdrawal by Subject|1|||
38069361|NCT04066023|69764015|FG000|Overall Study|Adverse Event|0|||
38069362|NCT04066023|69764016|FG001|Overall Study|Adverse Event|0|||
38069363|NCT04066023|69764017|FG002|Overall Study|Adverse Event|1|||
38069364|NCT04066023|69764015|FG000|Overall Study|Sponsor decision|3|||
38069365|NCT04066023|69764016|FG001|Overall Study|Sponsor decision|6|||
38069366|NCT04066023|69764017|FG002|Overall Study|Sponsor decision|2|||
38069367|NCT04066023|69764015|FG000|Overall Study|Physician Decision|0|||
38069368|NCT04066023|69764016|FG001|Overall Study|Physician Decision|0|||
38069369|NCT04066023|69764017|FG002|Overall Study|Physician Decision|1|||
38069370|NCT04066023|69764015|FG000|Overall Study|Lost to Follow-up|0|||
38069371|NCT04066023|69764016|FG001|Overall Study|Lost to Follow-up|1|||
38069372|NCT04066023|69764017|FG002|Overall Study|Lost to Follow-up|1|||
38069373|NCT04066023|69764015|FG000|Overall Study|Noncompliance|0|||
38069374|NCT04066023|69764016|FG001|Overall Study|Noncompliance|1|||
38069375|NCT04066023|69764017|FG002|Overall Study|Noncompliance|1|||
38069376|NCT03106987|69764029|FG000|Overall Study|Death|37|||
38069377|NCT03106987|69764030|FG001|Overall Study|Death|22|||
38069378|NCT03106987|69764031|FG002|Overall Study|Death|12|||
38069379|NCT03106987|69764032|FG003|Overall Study|Death|8|||
38069380|NCT03106987|69764029|FG000|Overall Study|Lost to Follow-up|2|||
38069381|NCT03106987|69764030|FG001|Overall Study|Lost to Follow-up|0|||
38069382|NCT03106987|69764031|FG002|Overall Study|Lost to Follow-up|2|||
38069383|NCT03106987|69764032|FG003|Overall Study|Lost to Follow-up|2|||
38069384|NCT03106987|69764029|FG000|Overall Study|Withdrawal by Subject|5|||
38069385|NCT03106987|69764030|FG001|Overall Study|Withdrawal by Subject|1|||
38069386|NCT03106987|69764031|FG002|Overall Study|Withdrawal by Subject|4|||
38069387|NCT03106987|69764032|FG003|Overall Study|Withdrawal by Subject|1|||
38069388|NCT02932267|69764042|FG000|Overall Study|Withdrawal by Subject|3|||
38069389|NCT02932267|69764042|FG000|Overall Study|Lost to Follow-up|4|||
38069390|NCT02932267|69764042|FG000|Overall Study|Pregnancy|1|||
38069391|NCT03217591|69764049|FG000|Overall Study|Adverse Event|1|||
38069392|NCT03217591|69764050|FG001|Overall Study|Adverse Event|2|||
38069393|NCT03217591|69764051|FG002|Overall Study|Adverse Event|6|||
38069394|NCT03217591|69764049|FG000|Overall Study|Withdrawal by Subject|0|||
38069395|NCT03217591|69764050|FG001|Overall Study|Withdrawal by Subject|1|||
38069396|NCT03217591|69764051|FG002|Overall Study|Withdrawal by Subject|3|||
38069397|NCT03217591|69764049|FG000|Overall Study|Lost to Follow-up|1|||
38069398|NCT03217591|69764050|FG001|Overall Study|Lost to Follow-up|0|||
38069399|NCT03217591|69764051|FG002|Overall Study|Lost to Follow-up|0|||
38069400|NCT03217591|69764049|FG000|Overall Study|Protocol Violation|1|||
38069401|NCT03217591|69764050|FG001|Overall Study|Protocol Violation|0|||
38069402|NCT03217591|69764051|FG002|Overall Study|Protocol Violation|1|||
38069403|NCT03031782|69764060|FG000|Treatment Period 1|Lack of Efficacy|3|||
38069404|NCT03031782|69764061|FG001|Treatment Period 1|Lack of Efficacy|0|||
38069405|NCT03031782|69764062|FG002|Treatment Period 1|Lack of Efficacy|0|||
38069406|NCT03031782|69764063|FG003|Treatment Period 1|Lack of Efficacy|0|||
38069407|NCT03031782|69764064|FG004|Treatment Period 1|Lack of Efficacy|0|||
38069408|NCT03031782|69764060|FG000|Treatment Period 2|Physician Decision|0|||
38069409|NCT03031782|69764061|FG001|Treatment Period 2|Physician Decision|1|||
38069410|NCT03031782|69764062|FG002|Treatment Period 2|Physician Decision|0|||
38069411|NCT03031782|69764063|FG003|Treatment Period 2|Physician Decision|0|||
38069412|NCT03031782|69764064|FG004|Treatment Period 2|Physician Decision|3|||
38069413|NCT03031782|69764060|FG000|Treatment Period 2|Lack of Efficacy|0|||
38069414|NCT03031782|69764061|FG001|Treatment Period 2|Lack of Efficacy|1|||
38069415|NCT03031782|69764062|FG002|Treatment Period 2|Lack of Efficacy|0|||
38069416|NCT03031782|69764063|FG003|Treatment Period 2|Lack of Efficacy|0|||
38069417|NCT03031782|69764064|FG004|Treatment Period 2|Lack of Efficacy|1|||
38069418|NCT03031782|69764060|FG000|Treatment Period 2|Withdrawal by Subject|0|||
38069419|NCT03031782|69764061|FG001|Treatment Period 2|Withdrawal by Subject|3|||
38069420|NCT03031782|69764062|FG002|Treatment Period 2|Withdrawal by Subject|0|||
38069421|NCT03031782|69764063|FG003|Treatment Period 2|Withdrawal by Subject|0|||
38069422|NCT03031782|69764064|FG004|Treatment Period 2|Withdrawal by Subject|1|||
38069423|NCT03031782|69764060|FG000|Treatment Period 2|Adverse Event|0|||
38069424|NCT03031782|69764061|FG001|Treatment Period 2|Adverse Event|1|||
38069425|NCT03031782|69764062|FG002|Treatment Period 2|Adverse Event|2|||
38069426|NCT03031782|69764063|FG003|Treatment Period 2|Adverse Event|0|||
38069427|NCT03031782|69764064|FG004|Treatment Period 2|Adverse Event|0|||
38069428|NCT03031782|69764060|FG000|Treatment Period 3|Withdrawal by Subject|0|||
38069429|NCT03031782|69764061|FG001|Treatment Period 3|Withdrawal by Subject|0|||
38069430|NCT03031782|69764062|FG002|Treatment Period 3|Withdrawal by Subject|0|||
38069431|NCT03031782|69764063|FG003|Treatment Period 3|Withdrawal by Subject|1|||
38069432|NCT03031782|69764064|FG004|Treatment Period 3|Withdrawal by Subject|0|||
38069433|NCT03216265|69764081|FG000|Overall Study|Adverse Event|2|||
38069434|NCT03216265|69764082|FG001|Overall Study|Adverse Event|0|||
38069435|NCT03216265|69764083|FG002|Overall Study|Adverse Event|2|||
38069436|NCT03216265|69764081|FG000|Overall Study|Lost to Follow-up|0|||
38069437|NCT03216265|69764082|FG001|Overall Study|Lost to Follow-up|1|||
38069438|NCT03216265|69764083|FG002|Overall Study|Lost to Follow-up|0|||
38069439|NCT03216265|69764081|FG000|Overall Study|Withdrawal by Subject|0|||
38069440|NCT03216265|69764082|FG001|Overall Study|Withdrawal by Subject|0|||
38069441|NCT03216265|69764083|FG002|Overall Study|Withdrawal by Subject|1|||
38069442|NCT04486950|69764114|FG000|Overall Study|Lost to Follow-up|0|||
38069443|NCT04486950|69764115|FG001|Overall Study|Lost to Follow-up|0|||
38069444|NCT04486950|69764116|FG002|Overall Study|Lost to Follow-up|0|||
38069445|NCT04486950|69764117|FG003|Overall Study|Lost to Follow-up|0|||
38069446|NCT04486950|69764118|FG004|Overall Study|Lost to Follow-up|0|||
38069447|NCT04486950|69764119|FG005|Overall Study|Lost to Follow-up|1|||
38069448|NCT04486950|69764120|FG006|Overall Study|Lost to Follow-up|0|||
38069449|NCT04693416|69764142|FG000|Overall Study|Lost to Follow-up|13|||
38069450|NCT04693416|69764143|FG001|Overall Study|Lost to Follow-up|0|||
38069451|NCT00265941|69764151|FG000|Overall Study|Protocol Violation|22|||
38069452|NCT00265941|69764152|FG001|Overall Study|Protocol Violation|25|||
38069453|NCT00265941|69764151|FG000|Overall Study|Lost to Follow-up|1|||
38069454|NCT00265941|69764152|FG001|Overall Study|Lost to Follow-up|1|||
38069455|NCT03882957|69764166|FG000|Overall Study|Did not complete all three arms|1|||
38069456|NCT03201211|69764178|FG000|Overall Study|Adverse Event|1|||
38069457|NCT03201211|69764179|FG001|Overall Study|Adverse Event|0|||
38069458|NCT03201211|69764180|FG002|Overall Study|Adverse Event|0|||
38069459|NCT03201211|69764178|FG000|Overall Study|Protocol Violation|1|||
38069460|NCT03201211|69764179|FG001|Overall Study|Protocol Violation|0|||
38069461|NCT03201211|69764180|FG002|Overall Study|Protocol Violation|0|||
38069462|NCT03201211|69764178|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
38069463|NCT03201211|69764179|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
38069464|NCT03201211|69764180|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
38069465|NCT03201211|69764178|FG000|Overall Study|OTHER unknown reasons|0|||
38069466|NCT03201211|69764179|FG001|Overall Study|OTHER unknown reasons|1|||
38069467|NCT03201211|69764180|FG002|Overall Study|OTHER unknown reasons|0|||
38069468|NCT04633837|69764190|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
38069469|NCT04633837|69764191|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
38069470|NCT03029832|69764199|FG000|Overall Study|Safety Follow-Up Completed|2|||
38069471|NCT03029832|69764200|FG001|Overall Study|Safety Follow-Up Completed|0|||
38069472|NCT03029832|69764199|FG000|Overall Study|Death due to Disease Progression|1|||
38069473|NCT03029832|69764200|FG001|Overall Study|Death due to Disease Progression|0|||
38069474|NCT03029832|69764199|FG000|Overall Study|Study Terminated By Sponsor|1|||
38069475|NCT03029832|69764200|FG001|Overall Study|Study Terminated By Sponsor|1|||
38069476|NCT03089697|69764208|FG000|Overall Study|Adverse Event|1|||
38069477|NCT03089697|69764209|FG001|Overall Study|Adverse Event|2|||
38069478|NCT03089697|69764208|FG000|Overall Study|Withdrawal by Subject|1|||
38069479|NCT03089697|69764209|FG001|Overall Study|Withdrawal by Subject|0|||
38069480|NCT03199963|69764217|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
38069481|NCT03199963|69764218|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
38069482|NCT03199963|69764217|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
38069483|NCT03199963|69764218|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
38069484|NCT03199963|69764217|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
38069485|NCT03199963|69764218|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
38069486|NCT03199963|69764217|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
38069487|NCT03199963|69764218|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
38069488|NCT03199963|69764217|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
38069489|NCT03199963|69764218|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
38069490|NCT03199963|69764217|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
38069491|NCT03199963|69764218|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
38069492|NCT03883581|69764230|FG000|Overall Study|Withdrawal by Subject|4|||
38069493|NCT03029208|69764236|FG000|Overall Study|Withdrawal by Subject|2|||
38069494|NCT03029208|69764237|FG001|Overall Study|Withdrawal by Subject|3|||
38069495|NCT03029208|69764236|FG000|Overall Study|Lost to Follow-up|0|||
38069496|NCT03029208|69764237|FG001|Overall Study|Lost to Follow-up|1|||
38069497|NCT03198715|69764257|FG000|Overall Study|Death|0|||
38069498|NCT03198715|69764258|FG001|Overall Study|Death|0|||
38069499|NCT03198715|69764259|FG002|Overall Study|Death|1|||
38069500|NCT03198715|69764260|FG003|Overall Study|Death|0|||
38069501|NCT03198715|69764261|FG004|Overall Study|Death|2|||
38069502|NCT03198715|69764257|FG000|Overall Study|Other|0|||
38069503|NCT03198715|69764258|FG001|Overall Study|Other|1|||
38069504|NCT03198715|69764259|FG002|Overall Study|Other|1|||
38069505|NCT03198715|69764260|FG003|Overall Study|Other|0|||
38069506|NCT03198715|69764261|FG004|Overall Study|Other|0|||
38069507|NCT03088917|69764282|FG000|Overall Study|In care/cured elsewhere|15|||
38069508|NCT03088917|69764282|FG000|Overall Study|Refuse re-evaluation|13|||
38069509|NCT03088917|69764282|FG000|Overall Study|Contact not established|13|||
38069510|NCT03088917|69764282|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
38069511|NCT03088917|69764282|FG000|Overall Study|Moved outside study region|50|||
38069512|NCT03087513|69764288|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
38069513|NCT02917629|69764303|FG000|Overall Study|Withdrawal by Subject|0|||
38069514|NCT02917629|69764304|FG001|Overall Study|Withdrawal by Subject|1|||
38069515|NCT02927847|69764313|FG000|Overall Study|Lost to Follow-up|1|||
38069516|NCT02927847|69764314|FG001|Overall Study|Lost to Follow-up|0|||
38069517|NCT02927847|69764313|FG000|Overall Study|Withdrawal by Subject|4|||
38069518|NCT02927847|69764314|FG001|Overall Study|Withdrawal by Subject|2|||
38069519|NCT02927847|69764313|FG000|Overall Study|PI withdrawn due to missed visits|1|||
38069520|NCT02927847|69764314|FG001|Overall Study|PI withdrawn due to missed visits|1|||
38069521|NCT02960438|69764324|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
38069522|NCT02960438|69764325|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
38069523|NCT02960438|69764326|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
38069524|NCT02960438|69764327|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
38069525|NCT02960438|69764324|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
38069526|NCT02960438|69764325|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
38069527|NCT02960438|69764326|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
38069528|NCT02960438|69764327|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
38069529|NCT02960438|69764324|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
38069530|NCT02960438|69764325|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
38069531|NCT02960438|69764326|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
38069532|NCT02960438|69764327|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
38069533|NCT02960438|69764324|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
38069534|NCT02960438|69764325|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
38069535|NCT02960438|69764326|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
38069536|NCT02960438|69764327|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
38069537|NCT02960438|69764324|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
38069538|NCT02960438|69764325|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
38069539|NCT02960438|69764326|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
38069540|NCT02960438|69764327|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
38069541|NCT02960438|69764324|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
38069542|NCT02960438|69764325|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
38069543|NCT02960438|69764326|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
38069544|NCT02960438|69764327|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
38069545|NCT02960438|69764324|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
38069546|NCT02960438|69764325|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
38069547|NCT02960438|69764326|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
38069548|NCT02960438|69764327|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
38069549|NCT02960438|69764324|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
38069550|NCT02960438|69764325|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
38069551|NCT02960438|69764326|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
38069552|NCT02960438|69764327|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
38069553|NCT02960438|69764324|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
38069554|NCT02960438|69764325|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
38069555|NCT02960438|69764326|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
38069556|NCT02960438|69764327|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
38069557|NCT02960438|69764324|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
38069558|NCT02960438|69764325|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
38069559|NCT02960438|69764326|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
38069560|NCT02960438|69764327|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
38069561|NCT02960438|69764324|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
38069562|NCT02960438|69764325|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
38069563|NCT02960438|69764326|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
38069564|NCT02960438|69764327|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
38069565|NCT02960438|69764324|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
38069566|NCT02960438|69764325|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
38069567|NCT02960438|69764326|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
38069568|NCT02960438|69764327|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
38069569|NCT02957942|69764347|FG000|Overall Study|Withdrawal by Subject|0|||
38069570|NCT02957942|69764348|FG001|Overall Study|Withdrawal by Subject|1|||
38069571|NCT02957942|69764347|FG000|Overall Study|Practicing experiment protocol|0|||
38069572|NCT02957942|69764348|FG001|Overall Study|Practicing experiment protocol|6|||
38069573|NCT02959970|69764356|FG000|Overall Study|Adverse Event|1|||
38069574|NCT02959970|69764357|FG001|Overall Study|Adverse Event|0|||
38069575|NCT02959970|69764356|FG000|Overall Study|Withdrawal by Subject|0|||
38069576|NCT02959970|69764357|FG001|Overall Study|Withdrawal by Subject|2|||
38069577|NCT02959970|69764356|FG000|Overall Study|Lost to Follow-up|1|||
38069578|NCT02959970|69764357|FG001|Overall Study|Lost to Follow-up|5|||
38069579|NCT05300763|69764390|FG000|Overall Study|Adverse Event|0|||
38069580|NCT05300763|69764391|FG001|Overall Study|Adverse Event|1|||
38069581|NCT05300763|69764390|FG000|Overall Study|Major Protocol Deviation|1|||
38069582|NCT05300763|69764391|FG001|Overall Study|Major Protocol Deviation|0|||
38069583|NCT05300763|69764390|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
38069584|NCT05300763|69764391|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
38069585|NCT02925312|69764399|FG000|Overall Study|Lost to Follow-up|25|||
38069586|NCT02925312|69764400|FG001|Overall Study|Lost to Follow-up|0|||
38069587|NCT02925312|69764399|FG000|Overall Study|Adverse Event|2|||
38069588|NCT02925312|69764400|FG001|Overall Study|Adverse Event|0|||
38069589|NCT03196297|69764415|FG000|Main Period|Withdrawal by Subject|4|||
38069590|NCT03196297|69764415|FG000|Extension Period|Withdrawal by Subject|1|||
38069591|NCT03196297|69764415|FG000|Extension Period|Lack of Efficacy|2|||
38069592|NCT03192475|69764440|FG000|Overall Study|Death|0|||
38069593|NCT03192475|69764441|FG001|Overall Study|Death|1|||
38069594|NCT03192475|69764440|FG000|Overall Study|Lost to Follow-up|13|||
38069595|NCT03192475|69764441|FG001|Overall Study|Lost to Follow-up|8|||
38069596|NCT03189745|69764450|FG000|Overall Study|Conflict in work schedule of participant|1|||
38069597|NCT03189745|69764451|FG001|Overall Study|Conflict in work schedule of participant|1|||
38069598|NCT03188263|69764459|FG000|Overall Study|Withdrawal by Subject|3|||
38069599|NCT03188263|69764460|FG001|Overall Study|Withdrawal by Subject|0|||
38069600|NCT03188263|69764459|FG000|Overall Study|Physician Decision|1|||
38069601|NCT03188263|69764460|FG001|Overall Study|Physician Decision|0|||
38069602|NCT03188185|69764468|FG000|Stage 1|Adverse Event|4|||
38069603|NCT03188185|69764469|FG001|Stage 1|Adverse Event|12|||
38069604|NCT03188185|69764470|FG002|Stage 1|Adverse Event|0|||
38069605|NCT03188185|69764471|FG003|Stage 1|Adverse Event|0|||
38069606|NCT03188185|69764468|FG000|Stage 1|Lack of Efficacy|0|||
38069607|NCT03188185|69764469|FG001|Stage 1|Lack of Efficacy|2|||
38069608|NCT03188185|69764470|FG002|Stage 1|Lack of Efficacy|0|||
38069609|NCT03188185|69764471|FG003|Stage 1|Lack of Efficacy|0|||
38069610|NCT03188185|69764468|FG000|Stage 1|Lost to Follow-up|6|||
38069611|NCT03188185|69764469|FG001|Stage 1|Lost to Follow-up|1|||
38069612|NCT03188185|69764470|FG002|Stage 1|Lost to Follow-up|0|||
38069613|NCT03188185|69764471|FG003|Stage 1|Lost to Follow-up|0|||
38069614|NCT03188185|69764468|FG000|Stage 1|Withdrawal by Subject|9|||
38069615|NCT03188185|69764469|FG001|Stage 1|Withdrawal by Subject|0|||
38069616|NCT03188185|69764470|FG002|Stage 1|Withdrawal by Subject|0|||
38069617|NCT03188185|69764471|FG003|Stage 1|Withdrawal by Subject|0|||
38069618|NCT03188185|69764468|FG000|Stage 1|Identified as a professional patient|0|||
38069619|NCT03188185|69764469|FG001|Stage 1|Identified as a professional patient|1|||
38069620|NCT03188185|69764470|FG002|Stage 1|Identified as a professional patient|0|||
38069621|NCT03188185|69764471|FG003|Stage 1|Identified as a professional patient|0|||
38069622|NCT03188185|69764468|FG000|Stage 2|Adverse Event|0|||
38069623|NCT03188185|69764469|FG001|Stage 2|Adverse Event|0|||
38069624|NCT03188185|69764470|FG002|Stage 2|Adverse Event|2|||
38069625|NCT03188185|69764471|FG003|Stage 2|Adverse Event|4|||
38069626|NCT03188185|69764468|FG000|Stage 2|Lack of Efficacy|0|||
38069627|NCT03188185|69764469|FG001|Stage 2|Lack of Efficacy|0|||
38069628|NCT03188185|69764470|FG002|Stage 2|Lack of Efficacy|3|||
38069629|NCT03188185|69764471|FG003|Stage 2|Lack of Efficacy|0|||
38069630|NCT03188185|69764468|FG000|Stage 2|Lost to Follow-up|0|||
38069631|NCT03188185|69764469|FG001|Stage 2|Lost to Follow-up|0|||
38069632|NCT03188185|69764470|FG002|Stage 2|Lost to Follow-up|1|||
38069633|NCT03188185|69764471|FG003|Stage 2|Lost to Follow-up|0|||
38069634|NCT03188185|69764468|FG000|Stage 2|Physician Decision|0|||
38069635|NCT03188185|69764469|FG001|Stage 2|Physician Decision|0|||
38069636|NCT03188185|69764470|FG002|Stage 2|Physician Decision|0|||
38069637|NCT03188185|69764471|FG003|Stage 2|Physician Decision|1|||
38069638|NCT03188185|69764468|FG000|Stage 2|Withdrawal by Subject|0|||
38069639|NCT03188185|69764469|FG001|Stage 2|Withdrawal by Subject|0|||
38069640|NCT03188185|69764470|FG002|Stage 2|Withdrawal by Subject|3|||
38069641|NCT03188185|69764471|FG003|Stage 2|Withdrawal by Subject|1|||
38069642|NCT03186781|69764487|FG000|Overall Study|Lost to Follow-up|0|||
38069643|NCT03186781|69764488|FG001|Overall Study|Lost to Follow-up|0|||
38069644|NCT03186781|69764489|FG002|Overall Study|Lost to Follow-up|1|||
38069645|NCT03186781|69764490|FG003|Overall Study|Lost to Follow-up|0|||
38069646|NCT03186781|69764491|FG004|Overall Study|Lost to Follow-up|1|||
38069647|NCT03186781|69764492|FG005|Overall Study|Lost to Follow-up|0|||
38069648|NCT03186781|69764487|FG000|Overall Study|Moved from Area|0|||
38069649|NCT03186781|69764488|FG001|Overall Study|Moved from Area|0|||
38069650|NCT03186781|69764489|FG002|Overall Study|Moved from Area|0|||
38069651|NCT03186781|69764490|FG003|Overall Study|Moved from Area|0|||
38069652|NCT03186781|69764491|FG004|Overall Study|Moved from Area|1|||
38069653|NCT03186781|69764492|FG005|Overall Study|Moved from Area|0|||
38069654|NCT03186781|69764487|FG000|Overall Study|Withdrawal by Subject|0|||
38069655|NCT03186781|69764488|FG001|Overall Study|Withdrawal by Subject|0|||
38069656|NCT03186781|69764489|FG002|Overall Study|Withdrawal by Subject|0|||
38069657|NCT03186781|69764490|FG003|Overall Study|Withdrawal by Subject|0|||
38069658|NCT03186781|69764491|FG004|Overall Study|Withdrawal by Subject|1|||
38069659|NCT03186781|69764492|FG005|Overall Study|Withdrawal by Subject|0|||
38069660|NCT03184987|69764519|FG000|Overall Study|Withdrawal by Subject|0|||
38069661|NCT03184987|69764520|FG001|Overall Study|Withdrawal by Subject|1|||
38069662|NCT03184987|69764521|FG002|Overall Study|Withdrawal by Subject|2|||
38069663|NCT03184987|69764519|FG000|Overall Study|Physician Decision|0|||
38069664|NCT03184987|69764520|FG001|Overall Study|Physician Decision|0|||
38069665|NCT03184987|69764521|FG002|Overall Study|Physician Decision|1|||
38069666|NCT03184987|69764519|FG000|Overall Study|Adverse Event|1|||
38069667|NCT03184987|69764520|FG001|Overall Study|Adverse Event|0|||
38069668|NCT03184987|69764521|FG002|Overall Study|Adverse Event|1|||
38069669|NCT03184519|69764529|FG000|Overall Study|Lost to Follow-up|6|||
38069670|NCT03184519|69764529|FG000|Overall Study|Physician Decision|21|||
38069671|NCT03184441|69764533|FG000|Overall Study|Withdrawal by Subject|1|||
38069672|NCT03026166|69764542|FG000|Overall Study|Death|22|||
38069673|NCT03026166|69764543|FG001|Overall Study|Death|7|||
38069674|NCT03026166|69764542|FG000|Overall Study|Physician Decision|2|||
38069675|NCT03026166|69764543|FG001|Overall Study|Physician Decision|0|||
38069676|NCT03026166|69764542|FG000|Overall Study|Withdrawal by Subject|1|||
38069677|NCT03026166|69764543|FG001|Overall Study|Withdrawal by Subject|2|||
38069678|NCT03026166|69764542|FG000|Overall Study|Lost to Follow-up|1|||
38069679|NCT03026166|69764543|FG001|Overall Study|Lost to Follow-up|0|||
38069680|NCT03026166|69764542|FG000|Overall Study|Study Terminated by Sponsor|3|||
38069681|NCT03026166|69764543|FG001|Overall Study|Study Terminated by Sponsor|3|||
38069682|NCT03026166|69764542|FG000|Overall Study|Other|1|||
38069683|NCT03026166|69764543|FG001|Overall Study|Other|0|||
38069684|NCT03026088|69764549|FG000|Overall Study|Study termination|20|||
38069685|NCT03181789|69764557|FG000|Overall Study|Withdrawal by Subject|0|||
38069686|NCT03181789|69764558|FG001|Overall Study|Withdrawal by Subject|1|||
38069687|NCT03181789|69764559|FG002|Overall Study|Withdrawal by Subject|1|||
38069688|NCT03181789|69764560|FG003|Overall Study|Withdrawal by Subject|0|||
38069689|NCT03181789|69764557|FG000|Overall Study|Lost to Follow-up|7|||
38069690|NCT03181789|69764558|FG001|Overall Study|Lost to Follow-up|1|||
38069691|NCT03181789|69764559|FG002|Overall Study|Lost to Follow-up|0|||
38069692|NCT03181789|69764560|FG003|Overall Study|Lost to Follow-up|0|||
38069693|NCT03181789|69764557|FG000|Overall Study|Participant unable to adhere to visit|0|||
38069694|NCT03181789|69764558|FG001|Overall Study|Participant unable to adhere to visit|1|||
38069695|NCT03181789|69764559|FG002|Overall Study|Participant unable to adhere to visit|0|||
38069696|NCT03181789|69764560|FG003|Overall Study|Participant unable to adhere to visit|0|||
38069697|NCT03024606|69764572|FG000|Overall Study|Withdrawal by Subject|9|||
38069698|NCT03024606|69764573|FG001|Overall Study|Withdrawal by Subject|10|||
38069699|NCT03180619|69764582|FG000|Overall Study|Withdrew Consent|5|||
38069700|NCT03180619|69764583|FG001|Overall Study|Withdrew Consent|0|||
38069701|NCT03180619|69764584|FG002|Overall Study|Withdrew Consent|2|||
38069702|NCT03180619|69764582|FG000|Overall Study|Death|2|||
38069703|NCT03180619|69764583|FG001|Overall Study|Death|1|||
38069704|NCT03180619|69764584|FG002|Overall Study|Death|2|||
38069705|NCT03180619|69764582|FG000|Overall Study|Adverse Event|2|||
38069706|NCT03180619|69764583|FG001|Overall Study|Adverse Event|0|||
38069707|NCT03180619|69764584|FG002|Overall Study|Adverse Event|1|||
38069708|NCT03180619|69764582|FG000|Overall Study|Investigator's discretion|2|||
38069709|NCT03180619|69764583|FG001|Overall Study|Investigator's discretion|0|||
38069710|NCT03180619|69764584|FG002|Overall Study|Investigator's discretion|1|||
38069711|NCT02915874|69764601|FG000|Overall Study|Lost to Follow-up|5|||
38069712|NCT02915874|69764602|FG001|Overall Study|Lost to Follow-up|4|||
38069713|NCT02915874|69764601|FG000|Overall Study|Withdrawal by Subject|1|||
38069714|NCT02915874|69764602|FG001|Overall Study|Withdrawal by Subject|1|||
38069715|NCT02915874|69764601|FG000|Overall Study|Started New Anxiety Medication|0|||
38069716|NCT02915874|69764602|FG001|Overall Study|Started New Anxiety Medication|1|||
38069717|NCT03022578|69764608|FG000|Overall Study|Adverse Event|1|||
38069718|NCT03022578|69764608|FG000|Overall Study|Lack of Efficacy|2|||
38069719|NCT03022578|69764608|FG000|Overall Study|Withdrawal by Subject|1|||
38069720|NCT03022422|69764618|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
38069721|NCT03022422|69764619|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
38069722|NCT03022422|69764620|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
38069723|NCT03022422|69764621|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
38069724|NCT03022422|69764622|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
38069725|NCT03022422|69764623|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
38069726|NCT03023826|69764639|FG000|Period 1|Withdrawal by Subject|0|||
38069727|NCT03023826|69764640|FG001|Period 1|Withdrawal by Subject|0|||
38069728|NCT03023826|69764641|FG002|Period 1|Withdrawal by Subject|0|||
38069729|NCT03023826|69764642|FG003|Period 1|Withdrawal by Subject|0|||
38069730|NCT03023826|69764643|FG004|Period 1|Withdrawal by Subject|1|||
38069731|NCT03023826|69764644|FG005|Period 1|Withdrawal by Subject|0|||
38069732|NCT03166735|69764657|FG000|Overall Study|Not Treated|1|||
38069733|NCT03166735|69764658|FG001|Overall Study|Not Treated|0|||
38069734|NCT03166735|69764659|FG002|Overall Study|Not Treated|0|||
38069735|NCT03166735|69764660|FG003|Overall Study|Not Treated|0|||
38069736|NCT03166735|69764661|FG004|Overall Study|Not Treated|0|||
38069737|NCT03166735|69764657|FG000|Overall Study|follow-up not completed as planned|0|||
38069738|NCT03166735|69764658|FG001|Overall Study|follow-up not completed as planned|1|||
38069739|NCT03166735|69764659|FG002|Overall Study|follow-up not completed as planned|1|||
38069740|NCT03166735|69764660|FG003|Overall Study|follow-up not completed as planned|0|||
38069741|NCT03166735|69764661|FG004|Overall Study|follow-up not completed as planned|1|||
38069742|NCT03166735|69764657|FG000|Overall Study|Withdrawal by Subject|0|||
38069743|NCT03166735|69764658|FG001|Overall Study|Withdrawal by Subject|0|||
38069744|NCT03166735|69764659|FG002|Overall Study|Withdrawal by Subject|1|||
38069745|NCT03166735|69764660|FG003|Overall Study|Withdrawal by Subject|1|||
38069746|NCT03166735|69764661|FG004|Overall Study|Withdrawal by Subject|2|||
38069747|NCT03166735|69764657|FG000|Overall Study|Lost to Follow-up|0|||
38069748|NCT03166735|69764658|FG001|Overall Study|Lost to Follow-up|2|||
38069749|NCT03166735|69764659|FG002|Overall Study|Lost to Follow-up|1|||
38069750|NCT03166735|69764660|FG003|Overall Study|Lost to Follow-up|0|||
38069751|NCT03166735|69764661|FG004|Overall Study|Lost to Follow-up|1|||
38069752|NCT03165955|69764674|FG000|Treatment|Withdrawal by Subject|3|||
38069753|NCT03165955|69764674|FG000|Treatment|Death|1|||
38069754|NCT03165955|69764674|FG000|Treatment|Adverse Event|1|||
38069755|NCT03165955|69764674|FG000|Treatment|Progressive disease|3|||
38069756|NCT03055494|69764680|FG000|Overall Study|Lost to Follow-up|6|||
38069757|NCT03055494|69764681|FG001|Overall Study|Lost to Follow-up|0|||
38069758|NCT03055494|69764680|FG000|Overall Study|Physician Decision|2|||
38069759|NCT03055494|69764681|FG001|Overall Study|Physician Decision|0|||
38069760|NCT03055494|69764680|FG000|Overall Study|Withdrawal by Subject|1|||
38069761|NCT03055494|69764681|FG001|Overall Study|Withdrawal by Subject|0|||
38069762|NCT03055494|69764680|FG000|Overall Study|Adverse Event|0|||
38069763|NCT03055494|69764681|FG001|Overall Study|Adverse Event|1|||
38069764|NCT03055494|69764680|FG000|Overall Study|Non-compliance with study treatment|1|||
38069765|NCT03055494|69764681|FG001|Overall Study|Non-compliance with study treatment|0|||
38069766|NCT02914548|69764691|FG000|Overall Study|Adverse Event|15|||
38069767|NCT02914548|69764692|FG001|Overall Study|Adverse Event|7|||
38069768|NCT02914548|69764693|FG002|Overall Study|Adverse Event|15|||
38069769|NCT02914548|69764691|FG000|Overall Study|Physician Decision|2|||
38069770|NCT02914548|69764692|FG001|Overall Study|Physician Decision|2|||
38069771|NCT02914548|69764693|FG002|Overall Study|Physician Decision|0|||
38069772|NCT02914548|69764691|FG000|Overall Study|Protocol Violation|1|||
38069773|NCT02914548|69764692|FG001|Overall Study|Protocol Violation|0|||
38069774|NCT02914548|69764693|FG002|Overall Study|Protocol Violation|0|||
38069775|NCT02914548|69764691|FG000|Overall Study|Withdrawal by Subject|3|||
38069776|NCT02914548|69764692|FG001|Overall Study|Withdrawal by Subject|4|||
38069777|NCT02914548|69764693|FG002|Overall Study|Withdrawal by Subject|4|||
38069778|NCT02914548|69764691|FG000|Overall Study|>40% of body surface area|0|||
38069779|NCT02914548|69764692|FG001|Overall Study|>40% of body surface area|1|||
38069780|NCT02914548|69764693|FG002|Overall Study|>40% of body surface area|1|||
38069781|NCT03165721|69764704|FG000|Overall Study|Refused further treatment|3|||
38069782|NCT03165721|69764705|FG001|Overall Study|Refused further treatment|0|||
38069783|NCT03165721|69764706|FG002|Overall Study|Refused further treatment|0|||
38069784|NCT03165721|69764704|FG000|Overall Study|Physician Decision|1|||
38069785|NCT03165721|69764705|FG001|Overall Study|Physician Decision|0|||
38069786|NCT03165721|69764706|FG002|Overall Study|Physician Decision|0|||
38069787|NCT02187198|69764722|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
38069788|NCT02187198|69764723|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
38069789|NCT02187198|69764722|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
38069790|NCT02187198|69764723|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
38069791|NCT02642029|69764729|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
38069792|NCT02642029|69764730|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
38069793|NCT02642029|69764731|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
38069794|NCT02642029|69764732|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
38069795|NCT02642029|69764733|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
38069796|NCT02642029|69764734|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
38069797|NCT02642029|69764729|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
38069798|NCT02642029|69764730|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
38069799|NCT02642029|69764731|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
38069800|NCT02642029|69764732|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
38069801|NCT02642029|69764733|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
38069802|NCT02642029|69764734|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
38069803|NCT02642029|69764729|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
38069804|NCT02642029|69764730|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
38069805|NCT02642029|69764731|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
38069806|NCT02642029|69764732|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
38069807|NCT02642029|69764733|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
38069808|NCT02642029|69764734|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
38069809|NCT02642029|69764729|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
38069810|NCT02642029|69764730|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
38069811|NCT02642029|69764731|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
38069812|NCT02642029|69764732|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
38069813|NCT02642029|69764733|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
38069814|NCT02642029|69764734|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
38069815|NCT02642029|69764729|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
38069816|NCT02642029|69764730|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
38069817|NCT02642029|69764731|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
38069818|NCT02642029|69764732|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
38069819|NCT02642029|69764733|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
38069820|NCT02642029|69764734|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
38069821|NCT02642029|69764729|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
38069822|NCT02642029|69764730|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
38069823|NCT02642029|69764731|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
38069824|NCT02642029|69764732|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
38069825|NCT02642029|69764733|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
38069826|NCT02642029|69764734|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
38069827|NCT03178669|69764747|FG000|Overall Study|Adverse Event|4|||
38069828|NCT03178669|69764748|FG001|Overall Study|Adverse Event|1|||
38069829|NCT03178669|69764749|FG002|Overall Study|Adverse Event|4|||
38069830|NCT03178669|69764750|FG003|Overall Study|Adverse Event|2|||
38069831|NCT03178669|69764751|FG004|Overall Study|Adverse Event|2|||
38069832|NCT03178669|69764747|FG000|Overall Study|Lack of Efficacy|0|||
38069833|NCT03178669|69764748|FG001|Overall Study|Lack of Efficacy|0|||
38069834|NCT03178669|69764749|FG002|Overall Study|Lack of Efficacy|2|||
38069835|NCT03178669|69764750|FG003|Overall Study|Lack of Efficacy|0|||
38069836|NCT03178669|69764751|FG004|Overall Study|Lack of Efficacy|1|||
37862323|NCT01130337|69546079|FG000|Overall Study|Withdrawal by Subject|3|||
38069837|NCT03178669|69764747|FG000|Overall Study|Physician Decision|0|||
38069838|NCT03178669|69764748|FG001|Overall Study|Physician Decision|0|||
38069839|NCT03178669|69764749|FG002|Overall Study|Physician Decision|0|||
38069840|NCT03178669|69764750|FG003|Overall Study|Physician Decision|0|||
38069841|NCT03178669|69764751|FG004|Overall Study|Physician Decision|1|||
38069842|NCT03178669|69764747|FG000|Overall Study|Withdrawal by Subject|1|||
38069843|NCT03178669|69764748|FG001|Overall Study|Withdrawal by Subject|0|||
38069844|NCT03178669|69764749|FG002|Overall Study|Withdrawal by Subject|1|||
38069845|NCT03178669|69764750|FG003|Overall Study|Withdrawal by Subject|1|||
38069846|NCT03178669|69764751|FG004|Overall Study|Withdrawal by Subject|0|||
38069847|NCT03178669|69764747|FG000|Overall Study|Lost to Follow-up|0|||
38069848|NCT03178669|69764748|FG001|Overall Study|Lost to Follow-up|0|||
38069849|NCT03178669|69764749|FG002|Overall Study|Lost to Follow-up|0|||
38069850|NCT03178669|69764750|FG003|Overall Study|Lost to Follow-up|1|||
38069851|NCT03178669|69764751|FG004|Overall Study|Lost to Follow-up|0|||
38069852|NCT03178201|69764763|FG000|Overall Study|Off study|5|||
38069853|NCT03021642|69764767|FG000|Washout Period (21 Days)|Adverse Event|1|||
38069854|NCT03021642|69764768|FG001|Washout Period (21 Days)|Adverse Event|1|||
38069855|NCT03021564|69764776|FG000|Overall Study|Death|84|||
38069856|NCT03021564|69764777|FG001|Overall Study|Death|466|||
38069857|NCT03021564|69764776|FG000|Overall Study|Lost to Follow-up|0|||
38069858|NCT03021564|69764777|FG001|Overall Study|Lost to Follow-up|2|||
38069859|NCT03023046|69764787|FG000|Overall Study|Withdrawal by Subject|1|||
37862324|NCT01130337|69546079|FG000|Overall Study|Principal investigator decision|1|||
37862325|NCT01130337|69546079|FG000|Overall Study|Death|1|||
37862326|NCT01130337|69546079|FG000|Overall Study|Disease progression|1|||
37862327|NCT01130337|69546079|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
37862328|NCT01130337|69546079|FG000|Overall Study|Surgical resection (R2)|1|||
37862329|NCT01130103|69546085|FG000|Randomized Treatment|Adverse Event|1|||
37862330|NCT01130103|69546086|FG001|Randomized Treatment|Adverse Event|1|||
37862331|NCT01130103|69546085|FG000|Randomized Treatment|Lost to Follow-up|1|||
37862332|NCT01130103|69546086|FG001|Randomized Treatment|Lost to Follow-up|0|||
37862333|NCT01130103|69546085|FG000|Randomized Treatment|Protocol Violation|3|||
37862334|NCT01130103|69546086|FG001|Randomized Treatment|Protocol Violation|2|||
38069860|NCT03019458|69764795|FG000|Overall Study|Death|0|||
38069861|NCT03019458|69764796|FG001|Overall Study|Death|1|||
38069862|NCT02923830|69764806|FG000|Overall Study|Physician Decision|13|||
38069863|NCT02923830|69764807|FG001|Overall Study|Physician Decision|15|||
38069864|NCT03021018|69764816|FG000|Overall Study|Adverse Event|1|||
38069865|NCT03021018|69764817|FG001|Overall Study|Adverse Event|0|||
38069866|NCT03021018|69764818|FG002|Overall Study|Adverse Event|0|||
38069867|NCT03021018|69764816|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
38069868|NCT03021018|69764817|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
38069869|NCT03021018|69764818|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
38069870|NCT02509507|69764835|FG000|Overall Study|Death|21|||
38069871|NCT02509507|69764836|FG001|Overall Study|Death|3|||
38069872|NCT02509507|69764837|FG002|Overall Study|Death|22|||
38069873|NCT02509507|69764838|FG003|Overall Study|Death|13|||
38069874|NCT02509507|69764839|FG004|Overall Study|Death|6|||
38069875|NCT02509507|69764840|FG005|Overall Study|Death|9|||
38069876|NCT02509507|69764841|FG006|Overall Study|Death|4|||
38069877|NCT02509507|69764842|FG007|Overall Study|Death|3|||
38069878|NCT02509507|69764843|FG008|Overall Study|Death|7|||
38069879|NCT02509507|69764835|FG000|Overall Study|Lost to Follow-up|0|||
38069880|NCT02509507|69764836|FG001|Overall Study|Lost to Follow-up|1|||
38069881|NCT02509507|69764837|FG002|Overall Study|Lost to Follow-up|0|||
38069882|NCT02509507|69764838|FG003|Overall Study|Lost to Follow-up|0|||
38069883|NCT02509507|69764839|FG004|Overall Study|Lost to Follow-up|0|||
38069884|NCT02509507|69764840|FG005|Overall Study|Lost to Follow-up|1|||
38069885|NCT02509507|69764841|FG006|Overall Study|Lost to Follow-up|0|||
38069886|NCT02509507|69764842|FG007|Overall Study|Lost to Follow-up|0|||
38069887|NCT02509507|69764843|FG008|Overall Study|Lost to Follow-up|0|||
38069888|NCT02509507|69764835|FG000|Overall Study|Withdrawal by Subject|2|||
38069889|NCT02509507|69764836|FG001|Overall Study|Withdrawal by Subject|0|||
38069890|NCT02509507|69764837|FG002|Overall Study|Withdrawal by Subject|1|||
38069891|NCT02509507|69764838|FG003|Overall Study|Withdrawal by Subject|4|||
38069892|NCT02509507|69764839|FG004|Overall Study|Withdrawal by Subject|0|||
37862335|NCT01130103|69546085|FG000|Randomized Treatment|Withdrawal by Subject|1|||
38069893|NCT02509507|69764840|FG005|Overall Study|Withdrawal by Subject|3|||
38069894|NCT02509507|69764841|FG006|Overall Study|Withdrawal by Subject|3|||
38069895|NCT02509507|69764842|FG007|Overall Study|Withdrawal by Subject|0|||
38069896|NCT02509507|69764843|FG008|Overall Study|Withdrawal by Subject|0|||
38069897|NCT02509507|69764835|FG000|Overall Study|Continuing Study|0|||
38069898|NCT02509507|69764836|FG001|Overall Study|Continuing Study|1|||
38069899|NCT02509507|69764837|FG002|Overall Study|Continuing Study|1|||
38069900|NCT02509507|69764838|FG003|Overall Study|Continuing Study|5|||
38069901|NCT02509507|69764839|FG004|Overall Study|Continuing Study|4|||
38069902|NCT02509507|69764840|FG005|Overall Study|Continuing Study|5|||
38069903|NCT02509507|69764841|FG006|Overall Study|Continuing Study|3|||
38069904|NCT02509507|69764842|FG007|Overall Study|Continuing Study|2|||
38069905|NCT02509507|69764843|FG008|Overall Study|Continuing Study|3|||
38069906|NCT03176407|69764868|FG000|Overall Study|Protocol Violation|1|||
38069907|NCT03176407|69764868|FG000|Overall Study|human failure|1|||
38069908|NCT03176407|69764868|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
38069909|NCT03175549|69764876|FG000|Overall Study|Lost to Follow-up|2|||
38069910|NCT03175549|69764877|FG001|Overall Study|Lost to Follow-up|2|||
38069911|NCT03175549|69764876|FG000|Overall Study|Medication non-compliance|2|||
38069912|NCT03175549|69764877|FG001|Overall Study|Medication non-compliance|2|||
38069913|NCT03174925|69764885|FG000|Overall Study|Elastographic images not retrievable|2|||
38069914|NCT03174925|69764885|FG000|Overall Study|Elastography image not interpretable|1|||
38069915|NCT02924688|69764895|FG000|Overall Study|Adverse Event|9|||
38069916|NCT02924688|69764896|FG001|Overall Study|Adverse Event|3|||
38069917|NCT02924688|69764897|FG002|Overall Study|Adverse Event|2|||
38069918|NCT02924688|69764898|FG003|Overall Study|Adverse Event|2|||
38069919|NCT02924688|69764899|FG004|Overall Study|Adverse Event|3|||
38069920|NCT02924688|69764900|FG005|Overall Study|Adverse Event|2|||
38069921|NCT02924688|69764895|FG000|Overall Study|Lack of Efficacy|2|||
37862336|NCT01130103|69546086|FG001|Randomized Treatment|Withdrawal by Subject|2|||
38069922|NCT02924688|69764896|FG001|Overall Study|Lack of Efficacy|3|||
38069923|NCT02924688|69764897|FG002|Overall Study|Lack of Efficacy|4|||
38069924|NCT02924688|69764898|FG003|Overall Study|Lack of Efficacy|2|||
38069925|NCT02924688|69764899|FG004|Overall Study|Lack of Efficacy|1|||
38069926|NCT02924688|69764900|FG005|Overall Study|Lack of Efficacy|1|||
38069927|NCT02924688|69764895|FG000|Overall Study|Protocol Violation|3|||
38069928|NCT02924688|69764896|FG001|Overall Study|Protocol Violation|7|||
38069929|NCT02924688|69764897|FG002|Overall Study|Protocol Violation|5|||
38069930|NCT02924688|69764898|FG003|Overall Study|Protocol Violation|6|||
38069931|NCT02924688|69764899|FG004|Overall Study|Protocol Violation|2|||
38069932|NCT02924688|69764900|FG005|Overall Study|Protocol Violation|2|||
38069933|NCT02924688|69764895|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
38069934|NCT02924688|69764896|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
38069935|NCT02924688|69764897|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
38069936|NCT02924688|69764898|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
38069937|NCT02924688|69764899|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
38069938|NCT02924688|69764900|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
38069939|NCT02924688|69764895|FG000|Overall Study|Lost to Follow-up|2|||
38069940|NCT02924688|69764896|FG001|Overall Study|Lost to Follow-up|4|||
38069941|NCT02924688|69764897|FG002|Overall Study|Lost to Follow-up|2|||
38069942|NCT02924688|69764898|FG003|Overall Study|Lost to Follow-up|4|||
38069943|NCT02924688|69764899|FG004|Overall Study|Lost to Follow-up|2|||
38069944|NCT02924688|69764900|FG005|Overall Study|Lost to Follow-up|4|||
38069945|NCT02924688|69764895|FG000|Overall Study|Physician Decision|2|||
38069946|NCT02924688|69764896|FG001|Overall Study|Physician Decision|1|||
38069947|NCT02924688|69764897|FG002|Overall Study|Physician Decision|0|||
38069948|NCT02924688|69764898|FG003|Overall Study|Physician Decision|1|||
38069949|NCT02924688|69764899|FG004|Overall Study|Physician Decision|1|||
38069950|NCT02924688|69764900|FG005|Overall Study|Physician Decision|1|||
38069951|NCT02924688|69764895|FG000|Overall Study|Withdrawal by Subject|14|||
38069952|NCT02924688|69764896|FG001|Overall Study|Withdrawal by Subject|13|||
38069953|NCT02924688|69764897|FG002|Overall Study|Withdrawal by Subject|9|||
38069954|NCT02924688|69764898|FG003|Overall Study|Withdrawal by Subject|12|||
38069955|NCT02924688|69764899|FG004|Overall Study|Withdrawal by Subject|13|||
38069956|NCT02924688|69764900|FG005|Overall Study|Withdrawal by Subject|14|||
38069957|NCT03011892|69764923|FG000|Double Blind (DB) Period|Adverse Event|0|||
38069958|NCT03011892|69764924|FG001|Double Blind (DB) Period|Adverse Event|1|||
38069959|NCT03011892|69764925|FG002|Double Blind (DB) Period|Adverse Event|1|||
38069960|NCT03011892|69764926|FG003|Double Blind (DB) Period|Adverse Event|0|||
38069961|NCT03011892|69764927|FG004|Double Blind (DB) Period|Adverse Event|0|||
38069962|NCT03011892|69764928|FG005|Double Blind (DB) Period|Adverse Event|0|||
38069963|NCT03011892|69764929|FG006|Double Blind (DB) Period|Adverse Event|0|||
38069964|NCT03011892|69764930|FG007|Double Blind (DB) Period|Adverse Event|0|||
38069965|NCT03011892|69764931|FG008|Double Blind (DB) Period|Adverse Event|0|||
38069966|NCT03011892|69764932|FG009|Double Blind (DB) Period|Adverse Event|0|||
38069967|NCT03011892|69764933|FG010|Double Blind (DB) Period|Adverse Event|0|||
38069968|NCT03011892|69764934|FG011|Double Blind (DB) Period|Adverse Event|0|||
38069969|NCT03011892|69764923|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
38069970|NCT03011892|69764924|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
38069971|NCT03011892|69764925|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
38069972|NCT03011892|69764926|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
38069973|NCT03011892|69764927|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
38069974|NCT03011892|69764928|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
38069975|NCT03011892|69764929|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
38069976|NCT03011892|69764930|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
38069977|NCT03011892|69764931|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
38069978|NCT03011892|69764932|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
38069979|NCT03011892|69764933|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
38069980|NCT03011892|69764934|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
37862337|NCT01130103|69546085|FG000|Maintenance Treatment|Lack of Efficacy|0|||
38069981|NCT03011892|69764923|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
38069982|NCT03011892|69764924|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
38069983|NCT03011892|69764925|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
38069984|NCT03011892|69764926|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
38069985|NCT03011892|69764927|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
38069986|NCT03011892|69764928|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
38069987|NCT03011892|69764929|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
38069988|NCT03011892|69764930|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
38069989|NCT03011892|69764931|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
38069990|NCT03011892|69764932|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
38069991|NCT03011892|69764933|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
38069992|NCT03011892|69764934|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
38069993|NCT03011892|69764923|FG000|Double Blind (DB) Period|Other|1|||
38069994|NCT03011892|69764924|FG001|Double Blind (DB) Period|Other|1|||
38069995|NCT03011892|69764925|FG002|Double Blind (DB) Period|Other|1|||
38069996|NCT03011892|69764926|FG003|Double Blind (DB) Period|Other|0|||
38069997|NCT03011892|69764927|FG004|Double Blind (DB) Period|Other|1|||
38069998|NCT03011892|69764928|FG005|Double Blind (DB) Period|Other|0|||
38069999|NCT03011892|69764929|FG006|Double Blind (DB) Period|Other|0|||
38070000|NCT03011892|69764930|FG007|Double Blind (DB) Period|Other|0|||
38070001|NCT03011892|69764931|FG008|Double Blind (DB) Period|Other|0|||
38070002|NCT03011892|69764932|FG009|Double Blind (DB) Period|Other|0|||
38070003|NCT03011892|69764933|FG010|Double Blind (DB) Period|Other|0|||
38070004|NCT03011892|69764934|FG011|Double Blind (DB) Period|Other|0|||
38070005|NCT03011892|69764923|FG000|Double Blind (DB) Period|Physician Decision|1|||
38070006|NCT03011892|69764924|FG001|Double Blind (DB) Period|Physician Decision|0|||
38070007|NCT03011892|69764925|FG002|Double Blind (DB) Period|Physician Decision|1|||
38070008|NCT03011892|69764926|FG003|Double Blind (DB) Period|Physician Decision|0|||
38070009|NCT03011892|69764927|FG004|Double Blind (DB) Period|Physician Decision|0|||
38070010|NCT03011892|69764928|FG005|Double Blind (DB) Period|Physician Decision|0|||
38070011|NCT03011892|69764929|FG006|Double Blind (DB) Period|Physician Decision|0|||
38070012|NCT03011892|69764930|FG007|Double Blind (DB) Period|Physician Decision|0|||
38070013|NCT03011892|69764931|FG008|Double Blind (DB) Period|Physician Decision|0|||
38070014|NCT03011892|69764932|FG009|Double Blind (DB) Period|Physician Decision|0|||
38070015|NCT03011892|69764933|FG010|Double Blind (DB) Period|Physician Decision|0|||
38070016|NCT03011892|69764934|FG011|Double Blind (DB) Period|Physician Decision|0|||
38070017|NCT03011892|69764923|FG000|Double Blind (DB) Period|Pregnancy|0|||
38070018|NCT03011892|69764924|FG001|Double Blind (DB) Period|Pregnancy|0|||
38070019|NCT03011892|69764925|FG002|Double Blind (DB) Period|Pregnancy|0|||
38070020|NCT03011892|69764926|FG003|Double Blind (DB) Period|Pregnancy|0|||
38070021|NCT03011892|69764927|FG004|Double Blind (DB) Period|Pregnancy|1|||
38070022|NCT03011892|69764928|FG005|Double Blind (DB) Period|Pregnancy|0|||
38070023|NCT03011892|69764929|FG006|Double Blind (DB) Period|Pregnancy|0|||
38070024|NCT03011892|69764930|FG007|Double Blind (DB) Period|Pregnancy|0|||
38070025|NCT03011892|69764931|FG008|Double Blind (DB) Period|Pregnancy|0|||
38070026|NCT03011892|69764932|FG009|Double Blind (DB) Period|Pregnancy|0|||
38070027|NCT03011892|69764933|FG010|Double Blind (DB) Period|Pregnancy|0|||
38070028|NCT03011892|69764934|FG011|Double Blind (DB) Period|Pregnancy|0|||
38070029|NCT03011892|69764923|FG000|Double Blind (DB) Period|Protocol Violation|1|||
38070030|NCT03011892|69764924|FG001|Double Blind (DB) Period|Protocol Violation|0|||
38070031|NCT03011892|69764925|FG002|Double Blind (DB) Period|Protocol Violation|0|||
38070032|NCT03011892|69764926|FG003|Double Blind (DB) Period|Protocol Violation|0|||
38070033|NCT03011892|69764927|FG004|Double Blind (DB) Period|Protocol Violation|0|||
38070034|NCT03011892|69764928|FG005|Double Blind (DB) Period|Protocol Violation|0|||
38070035|NCT03011892|69764929|FG006|Double Blind (DB) Period|Protocol Violation|0|||
38070036|NCT03011892|69764930|FG007|Double Blind (DB) Period|Protocol Violation|0|||
38070037|NCT03011892|69764931|FG008|Double Blind (DB) Period|Protocol Violation|0|||
38070038|NCT03011892|69764932|FG009|Double Blind (DB) Period|Protocol Violation|0|||
38070039|NCT03011892|69764933|FG010|Double Blind (DB) Period|Protocol Violation|0|||
38070040|NCT03011892|69764934|FG011|Double Blind (DB) Period|Protocol Violation|0|||
38070041|NCT03011892|69764923|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
38070042|NCT03011892|69764924|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
38070043|NCT03011892|69764925|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
38070044|NCT03011892|69764926|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
38070045|NCT03011892|69764927|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
38070046|NCT03011892|69764928|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
38070047|NCT03011892|69764929|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
38070048|NCT03011892|69764930|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
38070049|NCT03011892|69764931|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
38070050|NCT03011892|69764932|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
38070051|NCT03011892|69764933|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
38070052|NCT03011892|69764934|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
38070053|NCT03011892|69764923|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
38070054|NCT03011892|69764924|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
38070055|NCT03011892|69764925|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
38070056|NCT03011892|69764926|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
38070057|NCT03011892|69764927|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
38070058|NCT03011892|69764928|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
38070059|NCT03011892|69764929|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
38070060|NCT03011892|69764930|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
38070061|NCT03011892|69764931|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
38070062|NCT03011892|69764932|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
38070063|NCT03011892|69764933|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
38070064|NCT03011892|69764934|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
38070065|NCT03011892|69764923|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
38070066|NCT03011892|69764924|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
38070067|NCT03011892|69764925|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
38070068|NCT03011892|69764926|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
38070069|NCT03011892|69764927|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
38070070|NCT03011892|69764928|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
38070071|NCT03011892|69764929|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
38070072|NCT03011892|69764930|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
38070073|NCT03011892|69764931|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
38070074|NCT03011892|69764932|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
38070075|NCT03011892|69764933|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
38070076|NCT03011892|69764934|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
38070077|NCT03011892|69764923|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
38070078|NCT03011892|69764924|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
38070079|NCT03011892|69764925|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
38070080|NCT03011892|69764926|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
38070081|NCT03011892|69764927|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
38070082|NCT03011892|69764928|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
38070083|NCT03011892|69764929|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
38070084|NCT03011892|69764930|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
38070085|NCT03011892|69764931|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
38070086|NCT03011892|69764932|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
38070087|NCT03011892|69764933|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
38070088|NCT03011892|69764934|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
38070089|NCT03011892|69764923|FG000|Open Label (OL) Period|Reason not specified|0|||
38070090|NCT03011892|69764924|FG001|Open Label (OL) Period|Reason not specified|0|||
38070091|NCT03011892|69764925|FG002|Open Label (OL) Period|Reason not specified|0|||
38070092|NCT03011892|69764926|FG003|Open Label (OL) Period|Reason not specified|0|||
38070093|NCT03011892|69764927|FG004|Open Label (OL) Period|Reason not specified|0|||
38070094|NCT03011892|69764928|FG005|Open Label (OL) Period|Reason not specified|0|||
38070095|NCT03011892|69764929|FG006|Open Label (OL) Period|Reason not specified|0|||
38070096|NCT03011892|69764930|FG007|Open Label (OL) Period|Reason not specified|1|||
38070097|NCT03011892|69764931|FG008|Open Label (OL) Period|Reason not specified|0|||
38070098|NCT03011892|69764932|FG009|Open Label (OL) Period|Reason not specified|0|||
38070099|NCT03011892|69764933|FG010|Open Label (OL) Period|Reason not specified|0|||
38070100|NCT03011892|69764934|FG011|Open Label (OL) Period|Reason not specified|0|||
38070101|NCT03017742|69764961|FG000|Overall Study|Protocol Violation|36|||
38070102|NCT03017742|69764961|FG000|Overall Study|Withdrawal by Subject|37|||
38070103|NCT03012828|69764971|FG000|Overall Study|Lost to Follow-up|1|||
38070104|NCT03012828|69764972|FG001|Overall Study|Lost to Follow-up|0|||
38070105|NCT03012828|69764973|FG002|Overall Study|Lost to Follow-up|1|||
38070106|NCT03012828|69764974|FG003|Overall Study|Lost to Follow-up|0|||
38070107|NCT03012828|69764975|FG004|Overall Study|Lost to Follow-up|1|||
38070108|NCT03012828|69764976|FG005|Overall Study|Lost to Follow-up|0|||
38070109|NCT03012828|69764971|FG000|Overall Study|Withdrawal by Subject|0|||
38070110|NCT03012828|69764972|FG001|Overall Study|Withdrawal by Subject|0|||
38070111|NCT03012828|69764973|FG002|Overall Study|Withdrawal by Subject|1|||
38070112|NCT03012828|69764974|FG003|Overall Study|Withdrawal by Subject|0|||
38070113|NCT03012828|69764975|FG004|Overall Study|Withdrawal by Subject|0|||
38070114|NCT03012828|69764976|FG005|Overall Study|Withdrawal by Subject|1|||
38070115|NCT03012828|69764971|FG000|Overall Study|Non-compliance with protocol|0|||
38070116|NCT03012828|69764972|FG001|Overall Study|Non-compliance with protocol|0|||
38070117|NCT03012828|69764973|FG002|Overall Study|Non-compliance with protocol|0|||
38070118|NCT03012828|69764974|FG003|Overall Study|Non-compliance with protocol|0|||
38070119|NCT03012828|69764975|FG004|Overall Study|Non-compliance with protocol|1|||
38070120|NCT03012828|69764976|FG005|Overall Study|Non-compliance with protocol|0|||
38070121|NCT03012828|69764971|FG000|Overall Study|Delay to last visit would delay DBL|0|||
38070122|NCT03012828|69764972|FG001|Overall Study|Delay to last visit would delay DBL|0|||
38070123|NCT03012828|69764973|FG002|Overall Study|Delay to last visit would delay DBL|0|||
38070124|NCT03012828|69764974|FG003|Overall Study|Delay to last visit would delay DBL|0|||
38070125|NCT03012828|69764975|FG004|Overall Study|Delay to last visit would delay DBL|0|||
38070126|NCT03012828|69764976|FG005|Overall Study|Delay to last visit would delay DBL|1|||
38070127|NCT03010254|69764994|FG000|Overall Study|Adverse Event|0|||
38070128|NCT03010254|69764995|FG001|Overall Study|Adverse Event|1|||
38070129|NCT03010254|69764994|FG000|Overall Study|Lost to Follow-up|4|||
38070130|NCT03010254|69764995|FG001|Overall Study|Lost to Follow-up|0|||
38070131|NCT03010254|69764994|FG000|Overall Study|Withdrawal by Subject|1|||
38070132|NCT03010254|69764995|FG001|Overall Study|Withdrawal by Subject|1|||
38070133|NCT03010254|69764994|FG000|Overall Study|Other|2|||
38070134|NCT03010254|69764995|FG001|Overall Study|Other|3|||
38070135|NCT03008460|69765010|FG000|Overall Study|Protocol deviation|0|||
38070136|NCT03008460|69765011|FG001|Overall Study|Protocol deviation|2|||
38070137|NCT03008460|69765010|FG000|Overall Study|Study drug not dispensed|0|||
38070138|NCT03008460|69765011|FG001|Overall Study|Study drug not dispensed|1|||
38070139|NCT03008460|69765010|FG000|Overall Study|Adverse Event|0|||
38070140|NCT03008460|69765011|FG001|Overall Study|Adverse Event|1|||
38070141|NCT03008460|69765010|FG000|Overall Study|Withdrawal by Subject|5|||
38070142|NCT03008460|69765011|FG001|Overall Study|Withdrawal by Subject|6|||
38070143|NCT03008460|69765010|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
38070144|NCT03008460|69765011|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
38070145|NCT03008460|69765010|FG000|Overall Study|End of study visit outside permitted time window|0|||
38070146|NCT03008460|69765011|FG001|Overall Study|End of study visit outside permitted time window|1|||
38070147|NCT03008460|69765010|FG000|Overall Study|Lost to Follow-up|1|||
38070148|NCT03008460|69765011|FG001|Overall Study|Lost to Follow-up|3|||
38070149|NCT02914236|69765017|FG000|Overall Study|Lost to Follow-up|1|||
38070150|NCT03003390|69765023|FG000|Overall Study|Physician Decision|2|||
38070151|NCT03003390|69765024|FG001|Overall Study|Physician Decision|0|||
38070152|NCT03003390|69765023|FG000|Overall Study|Parent refused intervention|2|||
38070153|NCT03003390|69765024|FG001|Overall Study|Parent refused intervention|0|||
38070154|NCT03003000|69765038|FG000|Overall Study|Adverse Event|1|||
38070155|NCT03003000|69765039|FG001|Overall Study|Adverse Event|2|||
38070156|NCT03003000|69765040|FG002|Overall Study|Adverse Event|3|||
38070157|NCT03003000|69765038|FG000|Overall Study|Lack of Efficacy|1|||
38070158|NCT03003000|69765039|FG001|Overall Study|Lack of Efficacy|0|||
38070159|NCT03003000|69765040|FG002|Overall Study|Lack of Efficacy|0|||
38070160|NCT03003000|69765038|FG000|Overall Study|Non-compliant with protocol|0|||
38070161|NCT03003000|69765039|FG001|Overall Study|Non-compliant with protocol|1|||
38070162|NCT03003000|69765040|FG002|Overall Study|Non-compliant with protocol|1|||
38070163|NCT03003000|69765038|FG000|Overall Study|Refused to continue medication|2|||
38070164|NCT03003000|69765039|FG001|Overall Study|Refused to continue medication|0|||
38070165|NCT03003000|69765040|FG002|Overall Study|Refused to continue medication|0|||
38070166|NCT03003000|69765038|FG000|Overall Study|Other than listed|1|||
38070167|NCT03003000|69765039|FG001|Overall Study|Other than listed|1|||
38070168|NCT03003000|69765040|FG002|Overall Study|Other than listed|1|||
38070169|NCT03002610|69765051|FG000|Overall Study|Withdrawal by Subject|6|||
38070170|NCT03002610|69765052|FG001|Overall Study|Withdrawal by Subject|25|||
38070171|NCT03002610|69765053|FG002|Overall Study|Withdrawal by Subject|13|||
38070172|NCT03005106|69765061|FG000|Overall Study|Lost to Follow-up|16|||
38070173|NCT03005106|69765061|FG000|Overall Study|Adverse Event|1|||
38070174|NCT03005106|69765061|FG000|Overall Study|Physician Decision|1|||
38070175|NCT03005106|69765061|FG000|Overall Study|Death|2|||
38070176|NCT01004861|69765078|FG000|Overall Study|Disease progression|3|||
38070177|NCT01004861|69765079|FG001|Overall Study|Disease progression|4|||
38070178|NCT01004861|69765080|FG002|Overall Study|Disease progression|5|||
38070179|NCT01004861|69765081|FG003|Overall Study|Disease progression|4|||
38070180|NCT01004861|69765082|FG004|Overall Study|Disease progression|4|||
38070181|NCT01004861|69765083|FG005|Overall Study|Disease progression|4|||
38070182|NCT01004861|69765084|FG006|Overall Study|Disease progression|5|||
38070183|NCT01004861|69765085|FG007|Overall Study|Disease progression|1|||
38070184|NCT01004861|69765086|FG008|Overall Study|Disease progression|4|||
38070185|NCT01004861|69765087|FG009|Overall Study|Disease progression|7|||
38070186|NCT01004861|69765088|FG010|Overall Study|Disease progression|6|||
38070187|NCT01004861|69765089|FG011|Overall Study|Disease progression|3|||
38070188|NCT01004861|69765090|FG012|Overall Study|Disease progression|8|||
38070189|NCT01004861|69765078|FG000|Overall Study|Physician Decision|0|||
38070190|NCT01004861|69765079|FG001|Overall Study|Physician Decision|2|||
38070191|NCT01004861|69765080|FG002|Overall Study|Physician Decision|1|||
38070192|NCT01004861|69765081|FG003|Overall Study|Physician Decision|1|||
38070193|NCT01004861|69765082|FG004|Overall Study|Physician Decision|1|||
38070194|NCT01004861|69765083|FG005|Overall Study|Physician Decision|0|||
38070195|NCT01004861|69765084|FG006|Overall Study|Physician Decision|0|||
38070196|NCT01004861|69765085|FG007|Overall Study|Physician Decision|1|||
38070197|NCT01004861|69765086|FG008|Overall Study|Physician Decision|0|||
38070198|NCT01004861|69765087|FG009|Overall Study|Physician Decision|0|||
38070199|NCT01004861|69765088|FG010|Overall Study|Physician Decision|0|||
38070200|NCT01004861|69765089|FG011|Overall Study|Physician Decision|0|||
38070201|NCT01004861|69765090|FG012|Overall Study|Physician Decision|3|||
38070202|NCT01004861|69765078|FG000|Overall Study|Adverse Event|0|||
38070203|NCT01004861|69765079|FG001|Overall Study|Adverse Event|0|||
38070204|NCT01004861|69765080|FG002|Overall Study|Adverse Event|0|||
38070205|NCT01004861|69765081|FG003|Overall Study|Adverse Event|1|||
38070206|NCT01004861|69765082|FG004|Overall Study|Adverse Event|0|||
38070207|NCT01004861|69765083|FG005|Overall Study|Adverse Event|2|||
38070208|NCT01004861|69765084|FG006|Overall Study|Adverse Event|1|||
38070209|NCT01004861|69765085|FG007|Overall Study|Adverse Event|1|||
38070210|NCT01004861|69765086|FG008|Overall Study|Adverse Event|13|||
38070211|NCT01004861|69765087|FG009|Overall Study|Adverse Event|1|||
38070212|NCT01004861|69765088|FG010|Overall Study|Adverse Event|1|||
38070213|NCT01004861|69765089|FG011|Overall Study|Adverse Event|0|||
37862338|NCT01130103|69546086|FG001|Maintenance Treatment|Lack of Efficacy|1|||
38070214|NCT01004861|69765090|FG012|Overall Study|Adverse Event|2|||
38070215|NCT01004861|69765078|FG000|Overall Study|Protocol Violation|0|||
38070216|NCT01004861|69765079|FG001|Overall Study|Protocol Violation|0|||
38070217|NCT01004861|69765080|FG002|Overall Study|Protocol Violation|0|||
38070218|NCT01004861|69765081|FG003|Overall Study|Protocol Violation|0|||
38070219|NCT01004861|69765082|FG004|Overall Study|Protocol Violation|1|||
38070220|NCT01004861|69765083|FG005|Overall Study|Protocol Violation|0|||
38070221|NCT01004861|69765084|FG006|Overall Study|Protocol Violation|0|||
38070222|NCT01004861|69765085|FG007|Overall Study|Protocol Violation|0|||
38070223|NCT01004861|69765086|FG008|Overall Study|Protocol Violation|0|||
38070224|NCT01004861|69765087|FG009|Overall Study|Protocol Violation|0|||
38070225|NCT01004861|69765088|FG010|Overall Study|Protocol Violation|0|||
38070226|NCT01004861|69765089|FG011|Overall Study|Protocol Violation|0|||
38070227|NCT01004861|69765090|FG012|Overall Study|Protocol Violation|0|||
38070228|NCT01004861|69765078|FG000|Overall Study|Lost to Follow-up|0|||
38070229|NCT01004861|69765079|FG001|Overall Study|Lost to Follow-up|0|||
38070230|NCT01004861|69765080|FG002|Overall Study|Lost to Follow-up|0|||
38070231|NCT01004861|69765081|FG003|Overall Study|Lost to Follow-up|0|||
38070232|NCT01004861|69765082|FG004|Overall Study|Lost to Follow-up|0|||
38070233|NCT01004861|69765083|FG005|Overall Study|Lost to Follow-up|0|||
38070234|NCT01004861|69765084|FG006|Overall Study|Lost to Follow-up|0|||
38070235|NCT01004861|69765085|FG007|Overall Study|Lost to Follow-up|1|||
38070236|NCT01004861|69765086|FG008|Overall Study|Lost to Follow-up|3|||
38070237|NCT01004861|69765087|FG009|Overall Study|Lost to Follow-up|0|||
38070238|NCT01004861|69765088|FG010|Overall Study|Lost to Follow-up|0|||
38070239|NCT01004861|69765089|FG011|Overall Study|Lost to Follow-up|1|||
38070240|NCT01004861|69765090|FG012|Overall Study|Lost to Follow-up|0|||
38070241|NCT01004861|69765078|FG000|Overall Study|Non-compliance|0|||
38070242|NCT01004861|69765079|FG001|Overall Study|Non-compliance|0|||
38070243|NCT01004861|69765080|FG002|Overall Study|Non-compliance|0|||
38070244|NCT01004861|69765081|FG003|Overall Study|Non-compliance|0|||
38070245|NCT01004861|69765082|FG004|Overall Study|Non-compliance|0|||
38070246|NCT01004861|69765083|FG005|Overall Study|Non-compliance|0|||
38070247|NCT01004861|69765084|FG006|Overall Study|Non-compliance|0|||
38070248|NCT01004861|69765085|FG007|Overall Study|Non-compliance|0|||
38070249|NCT01004861|69765086|FG008|Overall Study|Non-compliance|5|||
38070250|NCT01004861|69765087|FG009|Overall Study|Non-compliance|0|||
38070251|NCT01004861|69765088|FG010|Overall Study|Non-compliance|0|||
38070252|NCT01004861|69765089|FG011|Overall Study|Non-compliance|0|||
38070253|NCT01004861|69765090|FG012|Overall Study|Non-compliance|1|||
38070254|NCT01004861|69765078|FG000|Overall Study|Other|0|||
38070255|NCT01004861|69765079|FG001|Overall Study|Other|0|||
38070256|NCT01004861|69765080|FG002|Overall Study|Other|0|||
38070257|NCT01004861|69765081|FG003|Overall Study|Other|0|||
38070258|NCT01004861|69765082|FG004|Overall Study|Other|0|||
38070259|NCT01004861|69765083|FG005|Overall Study|Other|0|||
38070260|NCT01004861|69765084|FG006|Overall Study|Other|0|||
38070261|NCT01004861|69765085|FG007|Overall Study|Other|0|||
38070262|NCT01004861|69765086|FG008|Overall Study|Other|0|||
38070263|NCT01004861|69765087|FG009|Overall Study|Other|2|||
38070264|NCT01004861|69765088|FG010|Overall Study|Other|1|||
38070265|NCT01004861|69765089|FG011|Overall Study|Other|2|||
38070266|NCT01004861|69765090|FG012|Overall Study|Other|3|||
38070267|NCT01004861|69765078|FG000|Overall Study|Patient decision|0|||
38070268|NCT01004861|69765079|FG001|Overall Study|Patient decision|0|||
38070269|NCT01004861|69765080|FG002|Overall Study|Patient decision|0|||
38070270|NCT01004861|69765081|FG003|Overall Study|Patient decision|0|||
38070271|NCT01004861|69765082|FG004|Overall Study|Patient decision|1|||
38070272|NCT01004861|69765083|FG005|Overall Study|Patient decision|0|||
38070273|NCT01004861|69765084|FG006|Overall Study|Patient decision|1|||
38070274|NCT01004861|69765085|FG007|Overall Study|Patient decision|0|||
38070275|NCT01004861|69765086|FG008|Overall Study|Patient decision|7|||
38070276|NCT01004861|69765087|FG009|Overall Study|Patient decision|1|||
38070277|NCT01004861|69765088|FG010|Overall Study|Patient decision|1|||
38070278|NCT01004861|69765089|FG011|Overall Study|Patient decision|2|||
38070279|NCT01004861|69765090|FG012|Overall Study|Patient decision|3|||
38070280|NCT01004861|69765078|FG000|Overall Study|Transitioned to Phase 4 study|0|||
38070281|NCT01004861|69765079|FG001|Overall Study|Transitioned to Phase 4 study|0|||
38070282|NCT01004861|69765080|FG002|Overall Study|Transitioned to Phase 4 study|0|||
38070283|NCT01004861|69765081|FG003|Overall Study|Transitioned to Phase 4 study|0|||
38070284|NCT01004861|69765082|FG004|Overall Study|Transitioned to Phase 4 study|0|||
38070285|NCT01004861|69765083|FG005|Overall Study|Transitioned to Phase 4 study|0|||
38070286|NCT01004861|69765084|FG006|Overall Study|Transitioned to Phase 4 study|0|||
38070287|NCT01004861|69765085|FG007|Overall Study|Transitioned to Phase 4 study|0|||
38070288|NCT01004861|69765086|FG008|Overall Study|Transitioned to Phase 4 study|2|||
38070289|NCT01004861|69765087|FG009|Overall Study|Transitioned to Phase 4 study|0|||
38070290|NCT01004861|69765088|FG010|Overall Study|Transitioned to Phase 4 study|0|||
38070291|NCT01004861|69765089|FG011|Overall Study|Transitioned to Phase 4 study|0|||
38070292|NCT01004861|69765090|FG012|Overall Study|Transitioned to Phase 4 study|0|||
38070293|NCT01004861|69765078|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
38070294|NCT01004861|69765079|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
38070295|NCT01004861|69765080|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
38070296|NCT01004861|69765081|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
38070297|NCT01004861|69765082|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
38070298|NCT01004861|69765083|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
38070299|NCT01004861|69765084|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
38070300|NCT01004861|69765085|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
38070301|NCT01004861|69765086|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
38070302|NCT01004861|69765087|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
38070303|NCT01004861|69765088|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
38070304|NCT01004861|69765089|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
38070305|NCT01004861|69765090|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
38070306|NCT01004861|69765078|FG000|Overall Study|Patient withdrew|0|||
38070307|NCT01004861|69765079|FG001|Overall Study|Patient withdrew|0|||
38070308|NCT01004861|69765080|FG002|Overall Study|Patient withdrew|0|||
38070309|NCT01004861|69765081|FG003|Overall Study|Patient withdrew|0|||
38070310|NCT01004861|69765082|FG004|Overall Study|Patient withdrew|0|||
38070311|NCT01004861|69765083|FG005|Overall Study|Patient withdrew|0|||
38070312|NCT01004861|69765084|FG006|Overall Study|Patient withdrew|0|||
38070313|NCT01004861|69765085|FG007|Overall Study|Patient withdrew|0|||
38070314|NCT01004861|69765086|FG008|Overall Study|Patient withdrew|1|||
38070315|NCT01004861|69765087|FG009|Overall Study|Patient withdrew|0|||
38070316|NCT01004861|69765088|FG010|Overall Study|Patient withdrew|0|||
38070317|NCT01004861|69765089|FG011|Overall Study|Patient withdrew|0|||
38070318|NCT01004861|69765090|FG012|Overall Study|Patient withdrew|0|||
38070319|NCT01004861|69765078|FG000|Overall Study|Surgical resection|0|||
38070320|NCT01004861|69765079|FG001|Overall Study|Surgical resection|0|||
38070321|NCT01004861|69765080|FG002|Overall Study|Surgical resection|0|||
38070322|NCT01004861|69765081|FG003|Overall Study|Surgical resection|0|||
38070323|NCT01004861|69765082|FG004|Overall Study|Surgical resection|0|||
38070324|NCT01004861|69765083|FG005|Overall Study|Surgical resection|0|||
38070325|NCT01004861|69765084|FG006|Overall Study|Surgical resection|0|||
38070326|NCT01004861|69765085|FG007|Overall Study|Surgical resection|0|||
38070327|NCT01004861|69765086|FG008|Overall Study|Surgical resection|1|||
38070328|NCT01004861|69765087|FG009|Overall Study|Surgical resection|0|||
38070329|NCT01004861|69765088|FG010|Overall Study|Surgical resection|0|||
38070330|NCT01004861|69765089|FG011|Overall Study|Surgical resection|0|||
38070331|NCT01004861|69765090|FG012|Overall Study|Surgical resection|0|||
38070332|NCT01004861|69765078|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
38070333|NCT01004861|69765079|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
38070334|NCT01004861|69765080|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
38070335|NCT01004861|69765081|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
38070336|NCT01004861|69765082|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
38070337|NCT01004861|69765083|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
38070338|NCT01004861|69765084|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
38070339|NCT01004861|69765085|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
38070340|NCT01004861|69765086|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
38070341|NCT01004861|69765087|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
38070342|NCT01004861|69765088|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
38070343|NCT01004861|69765089|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
38070344|NCT01004861|69765090|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
38070345|NCT01004861|69765078|FG000|Overall Study|Study termination by Sponsor|0|||
38070346|NCT01004861|69765079|FG001|Overall Study|Study termination by Sponsor|0|||
38070347|NCT01004861|69765080|FG002|Overall Study|Study termination by Sponsor|0|||
38070348|NCT01004861|69765081|FG003|Overall Study|Study termination by Sponsor|0|||
38070349|NCT01004861|69765082|FG004|Overall Study|Study termination by Sponsor|0|||
38070350|NCT01004861|69765083|FG005|Overall Study|Study termination by Sponsor|0|||
38070351|NCT01004861|69765084|FG006|Overall Study|Study termination by Sponsor|0|||
38070352|NCT01004861|69765085|FG007|Overall Study|Study termination by Sponsor|0|||
38070353|NCT01004861|69765086|FG008|Overall Study|Study termination by Sponsor|1|||
38070354|NCT01004861|69765087|FG009|Overall Study|Study termination by Sponsor|0|||
38070355|NCT01004861|69765088|FG010|Overall Study|Study termination by Sponsor|0|||
38070356|NCT01004861|69765089|FG011|Overall Study|Study termination by Sponsor|0|||
38070357|NCT01004861|69765090|FG012|Overall Study|Study termination by Sponsor|0|||
38070358|NCT03254459|69765137|FG000|Overall Study|Adverse Event|7|||
38070359|NCT03254459|69765138|FG001|Overall Study|Adverse Event|20|||
38070360|NCT03254459|69765137|FG000|Overall Study|Withdrawal by Subject Consent|3|||
38070361|NCT03254459|69765138|FG001|Overall Study|Withdrawal by Subject Consent|1|||
38070362|NCT03254459|69765137|FG000|Overall Study|Lost to Follow-up|0|||
38070363|NCT03254459|69765138|FG001|Overall Study|Lost to Follow-up|1|||
38070364|NCT03254459|69765137|FG000|Overall Study|Miscellaneous|0|||
38070365|NCT03254459|69765138|FG001|Overall Study|Miscellaneous|1|||
38070366|NCT02736617|69765144|FG000|Treatment|Adverse Event|1|||
38070367|NCT02736617|69765144|FG000|Treatment|Lack of Efficacy|1|||
38070368|NCT02736617|69765144|FG000|Treatment|Withdrawal by Subject|1|||
38070369|NCT02736617|69765144|FG000|Maintenance|Lack of Efficacy|4|||
38070370|NCT02736617|69765144|FG000|Maintenance|Physician Decision|1|||
38070371|NCT03251963|69765151|FG000|Overall Study|inappropriate Xa level timing|6|||
38070372|NCT03251963|69765152|FG001|Overall Study|inappropriate Xa level timing|3|||
38070373|NCT03251963|69765151|FG000|Overall Study|no peak Xa level drawn|2|||
38070374|NCT03251963|69765152|FG001|Overall Study|no peak Xa level drawn|0|||
38070375|NCT03251963|69765151|FG000|Overall Study|bled prior to Xa level|1|||
38070376|NCT03251963|69765152|FG001|Overall Study|bled prior to Xa level|2|||
38070377|NCT03287219|69765160|FG000|Overall Study|Protocol Violation|0|||
38070378|NCT03287219|69765161|FG001|Overall Study|Protocol Violation|2|||
38070379|NCT03286751|69765200|FG000|Washout Period 1|Withdrawal by Subject|0|||
38070380|NCT03286751|69765201|FG001|Washout Period 1|Withdrawal by Subject|0|||
38070381|NCT03286751|69765202|FG002|Washout Period 1|Withdrawal by Subject|0|||
38070382|NCT03286751|69765203|FG003|Washout Period 1|Withdrawal by Subject|0|||
38070383|NCT03286751|69765204|FG004|Washout Period 1|Withdrawal by Subject|1|||
38070384|NCT03286751|69765205|FG005|Washout Period 1|Withdrawal by Subject|0|||
38070385|NCT03286751|69765200|FG000|Washout Period 2|Personal Reasons|0|||
38070386|NCT03286751|69765201|FG001|Washout Period 2|Personal Reasons|1|||
38070387|NCT03286751|69765202|FG002|Washout Period 2|Personal Reasons|0|||
38070388|NCT03286751|69765203|FG003|Washout Period 2|Personal Reasons|0|||
38070389|NCT03286751|69765204|FG004|Washout Period 2|Personal Reasons|0|||
38070390|NCT03286751|69765205|FG005|Washout Period 2|Personal Reasons|0|||
38070391|NCT03286751|69765200|FG000|Washout Period 5|Adverse Event|0|||
38070392|NCT03286751|69765201|FG001|Washout Period 5|Adverse Event|0|||
38070393|NCT03286751|69765202|FG002|Washout Period 5|Adverse Event|0|||
38070394|NCT03286751|69765203|FG003|Washout Period 5|Adverse Event|0|||
38070395|NCT03286751|69765204|FG004|Washout Period 5|Adverse Event|1|||
38070396|NCT03286751|69765205|FG005|Washout Period 5|Adverse Event|0|||
38070397|NCT03249935|69765219|FG000|Overall Study|Discharged from facility early|36|||
38070398|NCT03249935|69765219|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
38070399|NCT03249935|69765219|FG000|Overall Study|Protocol Violation|5|||
38070400|NCT03285113|69765225|FG000|Overall Study|Unable to implant leads|2|||
38070401|NCT03000348|69765235|FG000|Overall Study|Adverse Event|1|||
38070402|NCT03000348|69765236|FG001|Overall Study|Adverse Event|1|||
38070403|NCT03000348|69765237|FG002|Overall Study|Adverse Event|1|||
38070404|NCT03000348|69765238|FG003|Overall Study|Adverse Event|1|||
38070405|NCT03000348|69765239|FG004|Overall Study|Adverse Event|1|||
38070406|NCT03000348|69765240|FG005|Overall Study|Adverse Event|1|||
38070407|NCT03000348|69765235|FG000|Overall Study|Lost to Follow-up|0|||
38070408|NCT03000348|69765236|FG001|Overall Study|Lost to Follow-up|0|||
38070409|NCT03000348|69765237|FG002|Overall Study|Lost to Follow-up|1|||
38070410|NCT03000348|69765238|FG003|Overall Study|Lost to Follow-up|0|||
38070411|NCT03000348|69765239|FG004|Overall Study|Lost to Follow-up|0|||
38070412|NCT03000348|69765240|FG005|Overall Study|Lost to Follow-up|0|||
38070413|NCT03000348|69765235|FG000|Overall Study|Withdrawal by Subject|0|||
38070414|NCT03000348|69765236|FG001|Overall Study|Withdrawal by Subject|1|||
38070415|NCT03000348|69765237|FG002|Overall Study|Withdrawal by Subject|0|||
38070416|NCT03000348|69765238|FG003|Overall Study|Withdrawal by Subject|0|||
38070417|NCT03000348|69765239|FG004|Overall Study|Withdrawal by Subject|0|||
38070418|NCT03000348|69765240|FG005|Overall Study|Withdrawal by Subject|0|||
38070419|NCT03000348|69765235|FG000|Overall Study|Consent|0|||
38070420|NCT03000348|69765236|FG001|Overall Study|Consent|0|||
38070421|NCT03000348|69765237|FG002|Overall Study|Consent|0|||
38070422|NCT03000348|69765238|FG003|Overall Study|Consent|0|||
38070423|NCT03000348|69765239|FG004|Overall Study|Consent|1|||
38070424|NCT03000348|69765240|FG005|Overall Study|Consent|0|||
38070425|NCT03000348|69765235|FG000|Overall Study|Failure to expectorate sputum|1|||
38070426|NCT03000348|69765236|FG001|Overall Study|Failure to expectorate sputum|0|||
38070427|NCT03000348|69765237|FG002|Overall Study|Failure to expectorate sputum|1|||
38070428|NCT03000348|69765238|FG003|Overall Study|Failure to expectorate sputum|0|||
38070429|NCT03000348|69765239|FG004|Overall Study|Failure to expectorate sputum|1|||
38070430|NCT03000348|69765240|FG005|Overall Study|Failure to expectorate sputum|0|||
38070431|NCT03000348|69765235|FG000|Overall Study|No gram negative|1|||
38070432|NCT03000348|69765236|FG001|Overall Study|No gram negative|2|||
38070433|NCT03000348|69765237|FG002|Overall Study|No gram negative|1|||
38070434|NCT03000348|69765238|FG003|Overall Study|No gram negative|1|||
38070435|NCT03000348|69765239|FG004|Overall Study|No gram negative|1|||
38070436|NCT03000348|69765240|FG005|Overall Study|No gram negative|1|||
38070437|NCT03000348|69765235|FG000|Overall Study|Patient had no transport|0|||
38070438|NCT03000348|69765236|FG001|Overall Study|Patient had no transport|0|||
38070439|NCT03000348|69765237|FG002|Overall Study|Patient had no transport|0|||
38070440|NCT03000348|69765238|FG003|Overall Study|Patient had no transport|1|||
38070441|NCT03000348|69765239|FG004|Overall Study|Patient had no transport|0|||
38070442|NCT03000348|69765240|FG005|Overall Study|Patient had no transport|0|||
38070443|NCT03000348|69765235|FG000|Overall Study|Dosing|0|||
38070444|NCT03000348|69765236|FG001|Overall Study|Dosing|0|||
38070445|NCT03000348|69765237|FG002|Overall Study|Dosing|0|||
38070446|NCT03000348|69765238|FG003|Overall Study|Dosing|0|||
38070447|NCT03000348|69765239|FG004|Overall Study|Dosing|1|||
38070448|NCT03000348|69765240|FG005|Overall Study|Dosing|0|||
38070449|NCT03283709|69765259|FG000|Overall Study|trial terminated|0|||
38070450|NCT03283709|69765260|FG001|Overall Study|trial terminated|1|||
38070451|NCT03247673|69765269|FG000|Overall Study|Withdrawal by Subject|1|||
38070452|NCT03247673|69765270|FG001|Overall Study|Withdrawal by Subject|0|||
38070453|NCT03247673|69765271|FG002|Overall Study|Withdrawal by Subject|3|||
38070454|NCT03247673|69765269|FG000|Overall Study|Lost to Follow-up|0|||
38070455|NCT03247673|69765270|FG001|Overall Study|Lost to Follow-up|0|||
38070456|NCT03247673|69765271|FG002|Overall Study|Lost to Follow-up|1|||
38070457|NCT03247517|69765282|FG000|Overall Study|Adverse Event|0|||
38070458|NCT03247517|69765283|FG001|Overall Study|Adverse Event|4|||
38070459|NCT03247517|69765284|FG002|Overall Study|Adverse Event|2|||
38070460|NCT03247517|69765282|FG000|Overall Study|Lost to Follow-up|2|||
38070461|NCT03247517|69765283|FG001|Overall Study|Lost to Follow-up|6|||
38070462|NCT03247517|69765284|FG002|Overall Study|Lost to Follow-up|4|||
38070463|NCT03247517|69765282|FG000|Overall Study|Consent withdrawn by caregiver|1|||
38070464|NCT03247517|69765283|FG001|Overall Study|Consent withdrawn by caregiver|4|||
38070465|NCT03247517|69765284|FG002|Overall Study|Consent withdrawn by caregiver|7|||
38070466|NCT03247517|69765282|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
38070467|NCT03247517|69765283|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
38070468|NCT03247517|69765284|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
38070469|NCT03247517|69765282|FG000|Overall Study|Protocol Violation|0|||
38070470|NCT03247517|69765283|FG001|Overall Study|Protocol Violation|2|||
38070471|NCT03247517|69765284|FG002|Overall Study|Protocol Violation|0|||
38070472|NCT03247517|69765282|FG000|Overall Study|Multiple reasons|3|||
38070473|NCT03247517|69765283|FG001|Overall Study|Multiple reasons|1|||
38070474|NCT03247517|69765284|FG002|Overall Study|Multiple reasons|0|||
38070475|NCT03283553|69765294|FG000|Patient Participant Flow|Death|5|||
38070476|NCT03283553|69765295|FG001|Patient Participant Flow|Death|10|||
38070477|NCT03283553|69765294|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
38070478|NCT03283553|69765295|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
38070479|NCT03283553|69765294|FG000|Patient Participant Flow|Lost to Follow-up|1|||
38070480|NCT03283553|69765295|FG001|Patient Participant Flow|Lost to Follow-up|1|||
38070481|NCT03283553|69765294|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
38070482|NCT03283553|69765295|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
38070483|NCT03283553|69765294|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
38070484|NCT03283553|69765295|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
38070485|NCT03283553|69765294|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
38070486|NCT03283553|69765295|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
38070487|NCT03283319|69765309|FG000|Overall Study|Lost to Follow-up|5|||
38070488|NCT03283319|69765310|FG001|Overall Study|Lost to Follow-up|4|||
38070489|NCT03283319|69765311|FG002|Overall Study|Lost to Follow-up|5|||
38070490|NCT03283319|69765312|FG003|Overall Study|Lost to Follow-up|5|||
38070491|NCT03283319|69765313|FG004|Overall Study|Lost to Follow-up|4|||
38070492|NCT03283319|69765314|FG005|Overall Study|Lost to Follow-up|3|||
38070493|NCT03283319|69765309|FG000|Overall Study|Withdrawal by Subject|2|||
38070494|NCT03283319|69765310|FG001|Overall Study|Withdrawal by Subject|2|||
38070495|NCT03283319|69765311|FG002|Overall Study|Withdrawal by Subject|2|||
38070496|NCT03283319|69765312|FG003|Overall Study|Withdrawal by Subject|1|||
38070497|NCT03283319|69765313|FG004|Overall Study|Withdrawal by Subject|0|||
38070498|NCT03283319|69765314|FG005|Overall Study|Withdrawal by Subject|1|||
38070499|NCT03283319|69765309|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
38070500|NCT03283319|69765310|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
38070501|NCT03283319|69765311|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
38070502|NCT03283319|69765312|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
38070503|NCT03283319|69765313|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
38070504|NCT03283319|69765314|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
38070505|NCT03282227|69765328|FG000|Overall Study|Exposure Goals Achieved|60|||
38070506|NCT03282227|69765328|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
38070507|NCT03282227|69765328|FG000|Overall Study|Adverse Event|15|||
38070508|NCT03282227|69765328|FG000|Overall Study|Lost to Follow-up|21|||
38070509|NCT03282227|69765328|FG000|Overall Study|Withdrawal by Subject|20|||
38070510|NCT03282227|69765328|FG000|Overall Study|Lack of Efficacy|12|||
38070511|NCT03282227|69765328|FG000|Overall Study|Sponsor decision|3|||
38070512|NCT03282227|69765328|FG000|Overall Study|Physician Decision|2|||
38070513|NCT03282227|69765328|FG000|Overall Study|Pregnancy|2|||
38070514|NCT03282227|69765328|FG000|Overall Study|Other|1|||
38070515|NCT03240575|69765336|FG000|Overall Study|Adverse Event|0|||
38070516|NCT03240575|69765337|FG001|Overall Study|Adverse Event|2|||
38070517|NCT03240575|69765338|FG002|Overall Study|Adverse Event|0|||
38070518|NCT03240575|69765339|FG003|Overall Study|Adverse Event|1|||
38070519|NCT03240575|69765336|FG000|Overall Study|Withdrawal by Subject|2|||
38070520|NCT03240575|69765337|FG001|Overall Study|Withdrawal by Subject|11|||
38070521|NCT03240575|69765338|FG002|Overall Study|Withdrawal by Subject|0|||
38070522|NCT03240575|69765339|FG003|Overall Study|Withdrawal by Subject|1|||
38070523|NCT03240575|69765336|FG000|Overall Study|Other|0|||
38070524|NCT03240575|69765337|FG001|Overall Study|Other|1|||
38070525|NCT03240575|69765338|FG002|Overall Study|Other|0|||
38070526|NCT03240575|69765339|FG003|Overall Study|Other|0|||
38070527|NCT03385265|69765351|FG000|Overall Study|Withdrawal by Subject|5|||
38070528|NCT03385265|69765352|FG001|Overall Study|Withdrawal by Subject|2|||
38070529|NCT03385265|69765353|FG002|Overall Study|Withdrawal by Subject|5|||
38070530|NCT03385265|69765354|FG003|Overall Study|Withdrawal by Subject|2|||
38070531|NCT03280121|69765366|FG000|Overall Study|Physician Decision|1|||
38070532|NCT03280121|69765366|FG000|Overall Study|Lost to Follow-up|1|||
38070533|NCT03280121|69765366|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
38070534|NCT03233009|69765370|FG000|Overall Study|Lost to Follow-up|1|||
38070535|NCT04034225|69765385|FG000|Overall Study|Death|3|||
38070536|NCT04034225|69765385|FG000|Overall Study|Withdrawal by Subject|2|||
38070537|NCT04034225|69765385|FG000|Overall Study|Study termination by Sponsor|18|||
38070538|NCT04034225|69765385|FG000|Overall Study|Physician Decision|1|||
38070539|NCT04034225|69765385|FG000|Overall Study|Lack of Efficacy|1|||
38070540|NCT02999178|69765393|FG000|Overall Study|Adverse Event|85|||
38070541|NCT02999178|69765394|FG001|Overall Study|Adverse Event|62|||
38070542|NCT02999178|69765393|FG000|Overall Study|Protocol Violation|1|||
38070543|NCT02999178|69765394|FG001|Overall Study|Protocol Violation|2|||
38070544|NCT02999178|69765393|FG000|Overall Study|Lost to Follow-up|0|||
38070545|NCT02999178|69765394|FG001|Overall Study|Lost to Follow-up|2|||
38070546|NCT02999178|69765393|FG000|Overall Study|Withdrawal by Subject|21|||
38070547|NCT02999178|69765394|FG001|Overall Study|Withdrawal by Subject|21|||
38070548|NCT02999178|69765393|FG000|Overall Study|Other reason not defined above|7|||
38070549|NCT02999178|69765394|FG001|Overall Study|Other reason not defined above|13|||
38070550|NCT02959190|69765406|FG000|Open Label|Adverse Event|5|||
38070551|NCT02959190|69765407|FG001|Open Label|Adverse Event|7|||
38070552|NCT02959190|69765408|FG002|Open Label|Adverse Event|3|||
38070553|NCT02959190|69765409|FG003|Open Label|Adverse Event|4|||
38070554|NCT02959190|69765406|FG000|Open Label|Pregnancy|0|||
38070555|NCT02959190|69765407|FG001|Open Label|Pregnancy|1|||
38070556|NCT02959190|69765408|FG002|Open Label|Pregnancy|0|||
38070557|NCT02959190|69765409|FG003|Open Label|Pregnancy|0|||
38070558|NCT02959190|69765406|FG000|Open Label|Withdrawal by Subject|2|||
38070559|NCT02959190|69765407|FG001|Open Label|Withdrawal by Subject|8|||
38070560|NCT02959190|69765408|FG002|Open Label|Withdrawal by Subject|0|||
38070561|NCT02959190|69765409|FG003|Open Label|Withdrawal by Subject|0|||
38070562|NCT02959190|69765406|FG000|Open Label|Physician Decision|0|||
38070563|NCT02959190|69765407|FG001|Open Label|Physician Decision|0|||
38070564|NCT02959190|69765408|FG002|Open Label|Physician Decision|1|||
38070565|NCT02959190|69765409|FG003|Open Label|Physician Decision|0|||
38070566|NCT02959190|69765406|FG000|Open Label|Protocol Violation|0|||
38070567|NCT02959190|69765407|FG001|Open Label|Protocol Violation|0|||
38070568|NCT02959190|69765408|FG002|Open Label|Protocol Violation|0|||
38070569|NCT02959190|69765409|FG003|Open Label|Protocol Violation|2|||
38070570|NCT02959190|69765406|FG000|Post Treatment Follow Up|Adverse Event|1|||
38070571|NCT02959190|69765407|FG001|Post Treatment Follow Up|Adverse Event|1|||
38070572|NCT02959190|69765408|FG002|Post Treatment Follow Up|Adverse Event|0|||
38070573|NCT02959190|69765409|FG003|Post Treatment Follow Up|Adverse Event|0|||
38070574|NCT02959190|69765406|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
38070575|NCT02959190|69765407|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
38070576|NCT02959190|69765408|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
38070577|NCT02959190|69765409|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
38070578|NCT01344356|69765430|FG000|Overall Study|Physician Decision|0|||
38070579|NCT01344356|69765431|FG001|Overall Study|Physician Decision|3|||
38070580|NCT01344356|69765430|FG000|Overall Study|Lost to Follow-up|0|||
38070581|NCT01344356|69765431|FG001|Overall Study|Lost to Follow-up|6|||
38070582|NCT02956460|69765457|FG000|Lens 1|Lost to Follow-up|1|||
38070583|NCT02956460|69765458|FG001|Lens 1|Lost to Follow-up|0|||
38070584|NCT02999100|69765470|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
38070585|NCT02999100|69765471|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
38070586|NCT02999100|69765472|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
38070587|NCT02999100|69765473|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
38070588|NCT02999100|69765474|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
38070589|NCT02999100|69765475|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
38070590|NCT02999100|69765470|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
38070591|NCT02999100|69765471|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
38070592|NCT02999100|69765472|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
38070593|NCT02999100|69765473|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
38070594|NCT02999100|69765474|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
38070595|NCT02999100|69765475|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
38070596|NCT02999100|69765470|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
38070597|NCT02999100|69765471|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
38070598|NCT02999100|69765472|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
38070599|NCT02999100|69765473|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
38070600|NCT02999100|69765474|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
38070601|NCT02999100|69765475|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
38070602|NCT02749370|69765497|FG000|Overall Study|Withdrawal by Subject|11|||
38070603|NCT02749370|69765497|FG000|Overall Study|Lost to Follow-up|3|||
38070604|NCT03607994|69765503|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
38070605|NCT03607994|69765504|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
38070606|NCT02996682|69765512|FG000|Overall Study|Death|0|||
38070607|NCT02996682|69765513|FG001|Overall Study|Death|3|||
38070608|NCT02873702|69765521|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
38070609|NCT02873702|69765522|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
38070610|NCT02873702|69765523|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
38070611|NCT02873702|69765524|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
38070612|NCT02873702|69765521|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
38070613|NCT02873702|69765522|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
38070614|NCT02873702|69765523|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
38070615|NCT02873702|69765524|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
38070616|NCT02873702|69765521|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
38070617|NCT02873702|69765522|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
38070618|NCT02873702|69765523|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
38070619|NCT02873702|69765524|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
38070620|NCT02873702|69765521|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
38070621|NCT02873702|69765522|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
38070622|NCT02873702|69765523|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
38070623|NCT02873702|69765524|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
38070624|NCT02873702|69765521|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
38070625|NCT02873702|69765522|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
38070626|NCT02873702|69765523|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
38070627|NCT02873702|69765524|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
38070628|NCT02911116|69765536|FG000|Overall Study|Insufficient Therapeutic Response|1|||
38070629|NCT02911116|69765537|FG001|Overall Study|Insufficient Therapeutic Response|0|||
38070630|NCT02911116|69765536|FG000|Overall Study|Lost to Follow-up|0|||
38070631|NCT02911116|69765537|FG001|Overall Study|Lost to Follow-up|1|||
38070632|NCT02998554|69765545|FG000|Overall Study|Adverse Event|8|||
38070633|NCT02998554|69765546|FG001|Overall Study|Adverse Event|3|||
38070634|NCT02998554|69765545|FG000|Overall Study|Protocol deviation|1|||
38070635|NCT02998554|69765546|FG001|Overall Study|Protocol deviation|0|||
38070636|NCT02998554|69765545|FG000|Overall Study|Withdrawal by Subject|2|||
38070637|NCT02998554|69765546|FG001|Overall Study|Withdrawal by Subject|6|||
38070638|NCT02998554|69765545|FG000|Overall Study|Lost to Follow-up|0|||
38070639|NCT02998554|69765546|FG001|Overall Study|Lost to Follow-up|1|||
38070640|NCT02998554|69765545|FG000|Overall Study|Lack of Efficacy|0|||
38070641|NCT02998554|69765546|FG001|Overall Study|Lack of Efficacy|1|||
38070642|NCT02996448|69765554|FG000|Overall Study|Study terminated due to adverse effects|3|||
38070643|NCT02995980|69765559|FG000|Overall Study|Lost to Follow-up|14|||
38070644|NCT02872142|69765564|FG000|Overall Study|Adverse Event|2|||
38070645|NCT02872142|69765564|FG000|Overall Study|Death|1|||
38070646|NCT02872142|69765564|FG000|Overall Study|Participant Decision|3|||
38070647|NCT02994654|69765568|FG000|Overall Study|Lost to Follow-up|1|||
38070648|NCT02870972|69765578|FG000|Overall Study|Adverse Event|1|||
38070649|NCT02870972|69765579|FG001|Overall Study|Adverse Event|0|||
38070650|NCT02870972|69765580|FG002|Overall Study|Adverse Event|0|||
38070651|NCT02870972|69765581|FG003|Overall Study|Adverse Event|0|||
38070652|NCT02870972|69765582|FG004|Overall Study|Adverse Event|0|||
37862339|NCT01130103|69546085|FG000|Maintenance Treatment|Lost to Follow-up|1|||
38070653|NCT03214367|69765602|FG000|Lead-in Period|Withdrawal by Subject|50|||
38070654|NCT03214367|69765603|FG001|Lead-in Period|Withdrawal by Subject|0|||
38070655|NCT03214367|69765604|FG002|Lead-in Period|Withdrawal by Subject|0|||
38070656|NCT03214367|69765605|FG003|Lead-in Period|Withdrawal by Subject|0|||
38070657|NCT03214367|69765606|FG004|Lead-in Period|Withdrawal by Subject|2|||
38070658|NCT03214367|69765607|FG005|Lead-in Period|Withdrawal by Subject|0|||
37862340|NCT01130103|69546086|FG001|Maintenance Treatment|Lost to Follow-up|1|||
38070659|NCT03214367|69765608|FG006|Lead-in Period|Withdrawal by Subject|0|||
38070660|NCT03214367|69765609|FG007|Lead-in Period|Withdrawal by Subject|0|||
38070661|NCT03214367|69765602|FG000|Lead-in Period|Adverse Event|3|||
38070662|NCT03214367|69765603|FG001|Lead-in Period|Adverse Event|0|||
38070663|NCT03214367|69765604|FG002|Lead-in Period|Adverse Event|0|||
38070664|NCT03214367|69765605|FG003|Lead-in Period|Adverse Event|0|||
38070665|NCT03214367|69765606|FG004|Lead-in Period|Adverse Event|0|||
38070666|NCT03214367|69765607|FG005|Lead-in Period|Adverse Event|0|||
38070667|NCT03214367|69765608|FG006|Lead-in Period|Adverse Event|0|||
38070668|NCT03214367|69765609|FG007|Lead-in Period|Adverse Event|0|||
38070669|NCT03214367|69765602|FG000|Lead-in Period|Lost to Follow-up|12|||
38070670|NCT03214367|69765603|FG001|Lead-in Period|Lost to Follow-up|0|||
38070671|NCT03214367|69765604|FG002|Lead-in Period|Lost to Follow-up|0|||
38070672|NCT03214367|69765605|FG003|Lead-in Period|Lost to Follow-up|0|||
38070673|NCT03214367|69765606|FG004|Lead-in Period|Lost to Follow-up|0|||
38070674|NCT03214367|69765607|FG005|Lead-in Period|Lost to Follow-up|0|||
38070675|NCT03214367|69765608|FG006|Lead-in Period|Lost to Follow-up|0|||
38070676|NCT03214367|69765609|FG007|Lead-in Period|Lost to Follow-up|0|||
38070677|NCT03214367|69765602|FG000|Lead-in Period|Sponsor Decision|11|||
38070678|NCT03214367|69765603|FG001|Lead-in Period|Sponsor Decision|0|||
38070679|NCT03214367|69765604|FG002|Lead-in Period|Sponsor Decision|0|||
38070680|NCT03214367|69765605|FG003|Lead-in Period|Sponsor Decision|0|||
38070681|NCT03214367|69765606|FG004|Lead-in Period|Sponsor Decision|0|||
38070682|NCT03214367|69765607|FG005|Lead-in Period|Sponsor Decision|0|||
38070683|NCT03214367|69765608|FG006|Lead-in Period|Sponsor Decision|0|||
38070684|NCT03214367|69765609|FG007|Lead-in Period|Sponsor Decision|0|||
38070685|NCT03214367|69765602|FG000|Lead-in Period|Physician Decision|12|||
38070686|NCT03214367|69765603|FG001|Lead-in Period|Physician Decision|0|||
38070687|NCT03214367|69765604|FG002|Lead-in Period|Physician Decision|0|||
38070688|NCT03214367|69765605|FG003|Lead-in Period|Physician Decision|0|||
38070689|NCT03214367|69765606|FG004|Lead-in Period|Physician Decision|0|||
38070690|NCT03214367|69765607|FG005|Lead-in Period|Physician Decision|0|||
38070691|NCT03214367|69765608|FG006|Lead-in Period|Physician Decision|0|||
38070692|NCT03214367|69765609|FG007|Lead-in Period|Physician Decision|0|||
38070693|NCT03214367|69765602|FG000|Lead-in Period|Protocol Violation|5|||
38070694|NCT03214367|69765603|FG001|Lead-in Period|Protocol Violation|0|||
38070695|NCT03214367|69765604|FG002|Lead-in Period|Protocol Violation|0|||
38070696|NCT03214367|69765605|FG003|Lead-in Period|Protocol Violation|0|||
38070697|NCT03214367|69765606|FG004|Lead-in Period|Protocol Violation|0|||
38070698|NCT03214367|69765607|FG005|Lead-in Period|Protocol Violation|0|||
38070699|NCT03214367|69765608|FG006|Lead-in Period|Protocol Violation|0|||
38070700|NCT03214367|69765609|FG007|Lead-in Period|Protocol Violation|0|||
38070701|NCT03214367|69765602|FG000|Lead-in Period|Treatment Interruption|1|||
38070702|NCT03214367|69765603|FG001|Lead-in Period|Treatment Interruption|0|||
38070703|NCT03214367|69765604|FG002|Lead-in Period|Treatment Interruption|0|||
38070704|NCT03214367|69765605|FG003|Lead-in Period|Treatment Interruption|0|||
38070705|NCT03214367|69765606|FG004|Lead-in Period|Treatment Interruption|0|||
38070706|NCT03214367|69765607|FG005|Lead-in Period|Treatment Interruption|0|||
38070707|NCT03214367|69765608|FG006|Lead-in Period|Treatment Interruption|0|||
38070708|NCT03214367|69765609|FG007|Lead-in Period|Treatment Interruption|0|||
38070709|NCT03214367|69765602|FG000|Treatment Period|Adverse Event|0|||
38070710|NCT03214367|69765603|FG001|Treatment Period|Adverse Event|1|||
38070711|NCT03214367|69765604|FG002|Treatment Period|Adverse Event|4|||
38070712|NCT03214367|69765605|FG003|Treatment Period|Adverse Event|2|||
38070713|NCT03214367|69765606|FG004|Treatment Period|Adverse Event|0|||
38070714|NCT03214367|69765607|FG005|Treatment Period|Adverse Event|0|||
38070715|NCT03214367|69765608|FG006|Treatment Period|Adverse Event|0|||
38070716|NCT03214367|69765609|FG007|Treatment Period|Adverse Event|0|||
38070717|NCT03214367|69765602|FG000|Treatment Period|Death|0|||
38070718|NCT03214367|69765603|FG001|Treatment Period|Death|1|||
38070719|NCT03214367|69765604|FG002|Treatment Period|Death|1|||
38070720|NCT03214367|69765605|FG003|Treatment Period|Death|1|||
38070721|NCT03214367|69765606|FG004|Treatment Period|Death|0|||
38070722|NCT03214367|69765607|FG005|Treatment Period|Death|0|||
38070723|NCT03214367|69765608|FG006|Treatment Period|Death|0|||
38070724|NCT03214367|69765609|FG007|Treatment Period|Death|0|||
38070725|NCT03214367|69765602|FG000|Treatment Period|Lost to Follow-up|0|||
38070726|NCT03214367|69765603|FG001|Treatment Period|Lost to Follow-up|5|||
38070727|NCT03214367|69765604|FG002|Treatment Period|Lost to Follow-up|3|||
38070728|NCT03214367|69765605|FG003|Treatment Period|Lost to Follow-up|2|||
38070729|NCT03214367|69765606|FG004|Treatment Period|Lost to Follow-up|0|||
38070730|NCT03214367|69765607|FG005|Treatment Period|Lost to Follow-up|2|||
38070731|NCT03214367|69765608|FG006|Treatment Period|Lost to Follow-up|1|||
38070732|NCT03214367|69765609|FG007|Treatment Period|Lost to Follow-up|0|||
38070733|NCT03214367|69765602|FG000|Treatment Period|Sponsor Decision|0|||
38070734|NCT03214367|69765603|FG001|Treatment Period|Sponsor Decision|3|||
38070735|NCT03214367|69765604|FG002|Treatment Period|Sponsor Decision|0|||
38070736|NCT03214367|69765605|FG003|Treatment Period|Sponsor Decision|0|||
38070737|NCT03214367|69765606|FG004|Treatment Period|Sponsor Decision|0|||
38070738|NCT03214367|69765607|FG005|Treatment Period|Sponsor Decision|0|||
38070739|NCT03214367|69765608|FG006|Treatment Period|Sponsor Decision|0|||
38070740|NCT03214367|69765609|FG007|Treatment Period|Sponsor Decision|0|||
38070741|NCT03214367|69765602|FG000|Treatment Period|Physician Decision|0|||
38070742|NCT03214367|69765603|FG001|Treatment Period|Physician Decision|1|||
38070743|NCT03214367|69765604|FG002|Treatment Period|Physician Decision|2|||
38070744|NCT03214367|69765605|FG003|Treatment Period|Physician Decision|0|||
38070745|NCT03214367|69765606|FG004|Treatment Period|Physician Decision|0|||
38070746|NCT03214367|69765607|FG005|Treatment Period|Physician Decision|0|||
38070747|NCT03214367|69765608|FG006|Treatment Period|Physician Decision|0|||
38070748|NCT03214367|69765609|FG007|Treatment Period|Physician Decision|0|||
38070749|NCT03214367|69765602|FG000|Treatment Period|Protocol Violation|0|||
38070750|NCT03214367|69765603|FG001|Treatment Period|Protocol Violation|3|||
38070751|NCT03214367|69765604|FG002|Treatment Period|Protocol Violation|0|||
38070752|NCT03214367|69765605|FG003|Treatment Period|Protocol Violation|0|||
38070753|NCT03214367|69765606|FG004|Treatment Period|Protocol Violation|0|||
38070754|NCT03214367|69765607|FG005|Treatment Period|Protocol Violation|0|||
38070755|NCT03214367|69765608|FG006|Treatment Period|Protocol Violation|0|||
38070756|NCT03214367|69765609|FG007|Treatment Period|Protocol Violation|0|||
38070757|NCT03214367|69765602|FG000|Treatment Period|Withdrawal by Subject|0|||
38070758|NCT03214367|69765603|FG001|Treatment Period|Withdrawal by Subject|20|||
38070759|NCT03214367|69765604|FG002|Treatment Period|Withdrawal by Subject|23|||
38070760|NCT03214367|69765605|FG003|Treatment Period|Withdrawal by Subject|14|||
38070761|NCT03214367|69765606|FG004|Treatment Period|Withdrawal by Subject|0|||
38070762|NCT03214367|69765607|FG005|Treatment Period|Withdrawal by Subject|1|||
38070763|NCT03214367|69765608|FG006|Treatment Period|Withdrawal by Subject|1|||
38070764|NCT03214367|69765609|FG007|Treatment Period|Withdrawal by Subject|1|||
38070765|NCT02994108|69765625|FG000|Intervention Messages|Withdrawal by Subject|2|||
38070766|NCT02994108|69765626|FG001|Intervention Messages|Withdrawal by Subject|0|||
38070767|NCT02994108|69765625|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
38070768|NCT02994108|69765626|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
38070769|NCT02994108|69765625|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
38070770|NCT02994108|69765626|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
38070771|NCT02994108|69765625|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
38070772|NCT02994108|69765626|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
38070773|NCT03231371|69765633|FG000|Overall Study|Withdrawal by Subject|1|||
38070774|NCT03231371|69765633|FG000|Overall Study|chose or were ineligible to have MRI|12|||
38070775|NCT02870348|69765637|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
38070776|NCT03239873|69765643|FG000|Overall Study|Lost to Follow-up|15|||
38070777|NCT03239873|69765644|FG001|Overall Study|Lost to Follow-up|16|||
38070778|NCT03239873|69765643|FG000|Overall Study|Physician Decision|1|||
38070779|NCT03239873|69765644|FG001|Overall Study|Physician Decision|0|||
38070780|NCT03239873|69765643|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
38070781|NCT03239873|69765644|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
38070782|NCT03239873|69765643|FG000|Overall Study|Withdrawal by Subject|2|||
38070783|NCT03239873|69765644|FG001|Overall Study|Withdrawal by Subject|0|||
38070784|NCT03239873|69765643|FG000|Overall Study|Contraindication to study medication|1|||
38070785|NCT03239873|69765644|FG001|Overall Study|Contraindication to study medication|0|||
38070786|NCT03239873|69765643|FG000|Overall Study|Protocol Violation|1|||
38070787|NCT03239873|69765644|FG001|Overall Study|Protocol Violation|0|||
38070788|NCT03213509|69765652|FG000|Overall Study|Did not consent for verbal autopsy|4|||
38070789|NCT03213509|69765653|FG001|Overall Study|Did not consent for verbal autopsy|5|||
38070790|NCT03239483|69765662|FG000|Overall Study|Lost to Follow-up|1|||
38070791|NCT03239483|69765663|FG001|Overall Study|Lost to Follow-up|0|||
38070792|NCT03239483|69765662|FG000|Overall Study|Withdrawal by Subject|1|||
38070793|NCT03239483|69765663|FG001|Overall Study|Withdrawal by Subject|0|||
38070794|NCT02868554|69765672|FG000|Overall Study|Lost to Follow-up|3|||
38070795|NCT02868554|69765673|FG001|Overall Study|Lost to Follow-up|0|||
38070796|NCT02868554|69765674|FG002|Overall Study|Lost to Follow-up|1|||
38070797|NCT01068912|69765685|FG000|Overall Study|Adverse Event|2|||
38070798|NCT01068912|69765686|FG001|Overall Study|Adverse Event|3|||
37965995|NCT00463047|69652946|FG000|Titration Period 1|Protocol Violation|5|||
38070799|NCT01068912|69765687|FG002|Overall Study|Adverse Event|2|||
38070800|NCT01068912|69765685|FG000|Overall Study|Withdrawal by Subject|5|||
38070801|NCT01068912|69765686|FG001|Overall Study|Withdrawal by Subject|6|||
38070802|NCT01068912|69765687|FG002|Overall Study|Withdrawal by Subject|6|||
38070803|NCT01068912|69765685|FG000|Overall Study|Lost to Follow-up|3|||
38070804|NCT01068912|69765686|FG001|Overall Study|Lost to Follow-up|7|||
38070805|NCT01068912|69765687|FG002|Overall Study|Lost to Follow-up|3|||
38070806|NCT01068912|69765685|FG000|Overall Study|Protocol Violation|0|||
38070807|NCT01068912|69765686|FG001|Overall Study|Protocol Violation|2|||
38070808|NCT01068912|69765687|FG002|Overall Study|Protocol Violation|0|||
38070809|NCT01068912|69765685|FG000|Overall Study|aggravation influenza|1|||
38070810|NCT01068912|69765686|FG001|Overall Study|aggravation influenza|1|||
38070811|NCT01068912|69765687|FG002|Overall Study|aggravation influenza|1|||
38070812|NCT01068912|69765685|FG000|Overall Study|other underlying illness|0|||
38070813|NCT01068912|69765686|FG001|Overall Study|other underlying illness|3|||
37965996|NCT00463047|69652947|FG001|Titration Period 1|Protocol Violation|5|||
38070814|NCT01068912|69765687|FG002|Overall Study|other underlying illness|3|||
38070815|NCT03229109|69765699|FG000|Overall Study|Withdrawal by Subject|0|||
38070816|NCT03229109|69765700|FG001|Overall Study|Withdrawal by Subject|0|||
38070817|NCT03229109|69765701|FG002|Overall Study|Withdrawal by Subject|0|||
38070818|NCT03229109|69765702|FG003|Overall Study|Withdrawal by Subject|1|||
38070819|NCT03212261|69765712|FG000|Overall Study|Became ineligible d/t tech|2|||
38070820|NCT03212261|69765712|FG000|Overall Study|Tech Trouble- No first study visit|1|||
38070821|NCT03212261|69765712|FG000|Overall Study|Lost to Follow-up|7|||
38070822|NCT03212261|69765712|FG000|Overall Study|Family Emergency|1|||
38070823|NCT03212261|69765712|FG000|Overall Study|Too busy/ No time|5|||
38070824|NCT02993250|69765719|FG000|Overall Study|Lost to Follow-up|0|||
38070825|NCT02993250|69765720|FG001|Overall Study|Lost to Follow-up|1|||
38070826|NCT02989194|69765729|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
38070827|NCT02989194|69765730|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
38070828|NCT02989194|69765731|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
38070829|NCT02989194|69765729|FG000|Overall Study|Lost to Follow-up|0|||
38070830|NCT02989194|69765730|FG001|Overall Study|Lost to Follow-up|1|||
38070831|NCT02989194|69765731|FG002|Overall Study|Lost to Follow-up|0|||
38070832|NCT02989194|69765729|FG000|Overall Study|Withdrawal by Subject|0|||
38070833|NCT02989194|69765730|FG001|Overall Study|Withdrawal by Subject|1|||
38070834|NCT02989194|69765731|FG002|Overall Study|Withdrawal by Subject|0|||
38070835|NCT02990910|69765752|FG000|Overall Study|Lack of Efficacy|6|||
38070836|NCT02990910|69765753|FG001|Overall Study|Lack of Efficacy|10|||
38070837|NCT03227861|69765759|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
38070838|NCT03227861|69765759|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
38070839|NCT03227861|69765759|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
38070840|NCT03227861|69765759|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
38070841|NCT03227861|69765759|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
38070842|NCT03227861|69765759|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
38070843|NCT03227861|69765759|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
38070844|NCT03227861|69765759|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
38070845|NCT03227861|69765759|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
38070846|NCT03227861|69765759|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
38070847|NCT01336712|69765765|FG000|Overall Study|Death|2|||
38070848|NCT01336712|69765765|FG000|Overall Study|Lack of Efficacy|1|||
38070849|NCT03208127|69765769|FG000|Overall Study|Death|1|||
38070850|NCT02865122|69765776|FG000|Overall Study|Adverse Event|1|||
38070851|NCT02865122|69765777|FG001|Overall Study|Adverse Event|0|||
38070852|NCT02865122|69765778|FG002|Overall Study|Adverse Event|0|||
38070853|NCT02864498|69765789|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
38070854|NCT02864498|69765790|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
38070855|NCT02864498|69765791|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
38070856|NCT02864498|69765789|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
38070857|NCT02864498|69765790|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
38070858|NCT02864498|69765791|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
38070859|NCT02864498|69765789|FG000|Overall Study|Investigator Discretion|0|||
38070860|NCT02864498|69765790|FG001|Overall Study|Investigator Discretion|2|||
38070861|NCT02864498|69765791|FG002|Overall Study|Investigator Discretion|1|||
38070862|NCT02864498|69765789|FG000|Overall Study|Lost to Follow-up|8|||
38070863|NCT02864498|69765790|FG001|Overall Study|Lost to Follow-up|6|||
38070864|NCT02864498|69765791|FG002|Overall Study|Lost to Follow-up|3|||
38070865|NCT02864498|69765789|FG000|Overall Study|Lack of Efficacy|5|||
38070866|NCT02864498|69765790|FG001|Overall Study|Lack of Efficacy|3|||
38070867|NCT02864498|69765791|FG002|Overall Study|Lack of Efficacy|3|||
38070868|NCT02864498|69765789|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
38070869|NCT02864498|69765790|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
38070870|NCT02864498|69765791|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
38070871|NCT02864498|69765789|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
38070872|NCT02864498|69765790|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
38070873|NCT02864498|69765791|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
38070874|NCT02864498|69765789|FG000|Overall Study|Subject moved out of the country.|0|||
38070875|NCT02864498|69765790|FG001|Overall Study|Subject moved out of the country.|0|||
38070876|NCT02864498|69765791|FG002|Overall Study|Subject moved out of the country.|1|||
38070877|NCT03238781|69765802|FG000|Overall Study|Adverse Event|1|||
38070878|NCT03238781|69765803|FG001|Overall Study|Adverse Event|1|||
37862341|NCT01130103|69546085|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
38070879|NCT03238781|69765804|FG002|Overall Study|Adverse Event|2|||
38070880|NCT03238781|69765802|FG000|Overall Study|Lost to Follow-up|2|||
38070881|NCT03238781|69765803|FG001|Overall Study|Lost to Follow-up|1|||
38070882|NCT03238781|69765804|FG002|Overall Study|Lost to Follow-up|2|||
38070883|NCT03238781|69765802|FG000|Overall Study|Withdrawal by Subject|23|||
38070884|NCT03238781|69765803|FG001|Overall Study|Withdrawal by Subject|14|||
38070885|NCT03238781|69765804|FG002|Overall Study|Withdrawal by Subject|16|||
38070886|NCT03238781|69765802|FG000|Overall Study|Decision by sponsor|0|||
38070887|NCT03238781|69765803|FG001|Overall Study|Decision by sponsor|1|||
38070888|NCT03238781|69765804|FG002|Overall Study|Decision by sponsor|0|||
38070889|NCT02097121|69765815|FG000|Overall Study|Other, not specified|4|||
38070890|NCT02097121|69765816|FG001|Overall Study|Other, not specified|2|||
38070891|NCT02097121|69765817|FG002|Overall Study|Other, not specified|3|||
38070892|NCT02097121|69765815|FG000|Overall Study|Lack of Efficacy|2|||
38070893|NCT02097121|69765816|FG001|Overall Study|Lack of Efficacy|1|||
38070894|NCT02097121|69765817|FG002|Overall Study|Lack of Efficacy|3|||
38070895|NCT02097121|69765815|FG000|Overall Study|Withdrawal by Subject|0|||
38070896|NCT02097121|69765816|FG001|Overall Study|Withdrawal by Subject|1|||
38070897|NCT02097121|69765817|FG002|Overall Study|Withdrawal by Subject|2|||
38070898|NCT02097121|69765815|FG000|Overall Study|Adverse Event|0|||
38070899|NCT02097121|69765816|FG001|Overall Study|Adverse Event|1|||
38070900|NCT02097121|69765817|FG002|Overall Study|Adverse Event|0|||
38070901|NCT02097121|69765815|FG000|Overall Study|Lost to Follow-up|1|||
38070902|NCT02097121|69765816|FG001|Overall Study|Lost to Follow-up|1|||
38070903|NCT02097121|69765817|FG002|Overall Study|Lost to Follow-up|2|||
38070904|NCT02747420|69765846|FG000|Overall Study|Lost to Follow-up|4|||
38070905|NCT02747420|69765847|FG001|Overall Study|Lost to Follow-up|2|||
38070906|NCT02747420|69765846|FG000|Overall Study|Withdrawal by Subject|3|||
38070907|NCT02747420|69765847|FG001|Overall Study|Withdrawal by Subject|2|||
38070908|NCT03238001|69765853|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
38070909|NCT03238001|69765853|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
38070910|NCT03238001|69765853|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
38070911|NCT03238001|69765853|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
38070912|NCT03238001|69765853|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
38070913|NCT03238001|69765853|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
38070914|NCT03238001|69765853|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
38070915|NCT03238001|69765853|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
38070916|NCT02747108|69765867|FG000|Overall Study|Death|2|||
38070917|NCT02747108|69765868|FG001|Overall Study|Death|2|||
38070918|NCT02747108|69765867|FG000|Overall Study|Withdrawal by Subject|1|||
38070919|NCT02747108|69765868|FG001|Overall Study|Withdrawal by Subject|0|||
38070920|NCT02747108|69765867|FG000|Overall Study|Protocol Violation|2|||
38070921|NCT02747108|69765868|FG001|Overall Study|Protocol Violation|0|||
38070922|NCT03226769|69765896|FG000|Overall Study|Withdrawal by Subject|0|||
38070923|NCT03226769|69765897|FG001|Overall Study|Withdrawal by Subject|1|||
38070924|NCT02864342|69765905|FG000|Overall Study|Eligibility Criteria Deviation|2|||
38070925|NCT02864342|69765906|FG001|Overall Study|Eligibility Criteria Deviation|3|||
38070926|NCT02864342|69765905|FG000|Overall Study|Withdrawal by Subject|4|||
38070927|NCT02864342|69765906|FG001|Overall Study|Withdrawal by Subject|2|||
38070928|NCT02864342|69765905|FG000|Overall Study|Device Technology Issue|6|||
38070929|NCT02864342|69765906|FG001|Overall Study|Device Technology Issue|7|||
38070930|NCT02864342|69765905|FG000|Overall Study|Death|0|||
38070931|NCT02864342|69765906|FG001|Overall Study|Death|1|||
38070932|NCT02864342|69765905|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
38070933|NCT02864342|69765906|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
38070934|NCT02864342|69765905|FG000|Overall Study|Lost to Follow-up|1|||
38070935|NCT02864342|69765906|FG001|Overall Study|Lost to Follow-up|5|||
38070936|NCT02864342|69765905|FG000|Overall Study|Lost Device|1|||
38070937|NCT02864342|69765906|FG001|Overall Study|Lost Device|0|||
38070938|NCT02864342|69765905|FG000|Overall Study|Adverse Event|1|||
38070939|NCT02864342|69765906|FG001|Overall Study|Adverse Event|0|||
38070940|NCT03237065|69765915|FG000|Overall Study|Adverse Event|0|||
38070941|NCT03237065|69765916|FG001|Overall Study|Adverse Event|2|||
38070942|NCT03237065|69765915|FG000|Overall Study|Protocol Violation|0|||
38070943|NCT03237065|69765916|FG001|Overall Study|Protocol Violation|1|||
38070944|NCT03237065|69765915|FG000|Overall Study|Withdrawal by Subject|3|||
38070945|NCT03237065|69765916|FG001|Overall Study|Withdrawal by Subject|0|||
38070946|NCT03237065|69765915|FG000|Overall Study|Lost to Follow-up|1|||
38070947|NCT03237065|69765916|FG001|Overall Study|Lost to Follow-up|0|||
38070948|NCT03237065|69765915|FG000|Overall Study|Unable to obtain venous access|0|||
38070949|NCT03237065|69765916|FG001|Overall Study|Unable to obtain venous access|1|||
38070950|NCT03171415|69765927|FG000|Overall Study|Lost to Follow-up|0|||
38070951|NCT03171415|69765928|FG001|Overall Study|Lost to Follow-up|0|||
38070952|NCT03171415|69765929|FG002|Overall Study|Lost to Follow-up|0|||
38070953|NCT03171415|69765930|FG003|Overall Study|Lost to Follow-up|0|||
38070954|NCT03171415|69765931|FG004|Overall Study|Lost to Follow-up|2|||
38070955|NCT03829241|69765956|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
38070956|NCT03829241|69765957|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
38070957|NCT03829241|69765956|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
38070958|NCT03829241|69765957|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
38070959|NCT03829241|69765956|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
38070960|NCT03829241|69765957|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
38070961|NCT03829241|69765956|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
38070962|NCT03829241|69765957|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
38070963|NCT03829241|69765956|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
38070964|NCT03829241|69765957|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
38070965|NCT03829241|69765956|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
38070966|NCT03829241|69765957|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
38070967|NCT03829241|69765956|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
38070968|NCT03829241|69765957|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
38070969|NCT03829241|69765956|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
38070970|NCT03829241|69765957|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
38070971|NCT03829241|69765956|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
38070972|NCT03829241|69765957|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
38070973|NCT03829241|69765956|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
38070974|NCT03829241|69765957|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
38070975|NCT03829241|69765956|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
38070976|NCT03829241|69765957|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
38070977|NCT03829241|69765956|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
38070978|NCT03829241|69765957|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
38070979|NCT03829241|69765956|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
38070980|NCT03829241|69765957|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
38070981|NCT03829241|69765956|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
38070982|NCT03829241|69765957|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
38070983|NCT03164551|69765969|FG000|Overall Study|Imaging discontinued prior completion|8|||
38070984|NCT03164551|69765970|FG001|Overall Study|Imaging discontinued prior completion|0|||
38070985|NCT03164551|69765969|FG000|Overall Study|Participant was non-compliant|1|||
38070986|NCT03164551|69765970|FG001|Overall Study|Participant was non-compliant|0|||
38070987|NCT03164551|69765969|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
38070988|NCT03164551|69765970|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
38070989|NCT03164551|69765969|FG000|Overall Study|Other|8|||
38070990|NCT03164551|69765970|FG001|Overall Study|Other|2|||
38070991|NCT02863328|69765978|FG000|Overall Study|Lost to Follow-up|4|||
38070992|NCT02863328|69765979|FG001|Overall Study|Lost to Follow-up|10|||
38070993|NCT02863328|69765978|FG000|Overall Study|Withdrawal by Subject|7|||
38070994|NCT02863328|69765979|FG001|Overall Study|Withdrawal by Subject|12|||
38070995|NCT02863328|69765978|FG000|Overall Study|Died|0|||
38070996|NCT02863328|69765979|FG001|Overall Study|Died|1|||
38070997|NCT03040141|69765988|FG000|Overall Study|Death|1|||
38070998|NCT03040141|69765989|FG001|Overall Study|Death|2|||
38070999|NCT03040141|69765990|FG002|Overall Study|Death|3|||
38071000|NCT03040141|69765988|FG000|Overall Study|Withdrawal by Subject|3|||
38071001|NCT03040141|69765989|FG001|Overall Study|Withdrawal by Subject|1|||
38071002|NCT03040141|69765990|FG002|Overall Study|Withdrawal by Subject|1|||
38071003|NCT03040141|69765988|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
38071004|NCT03040141|69765989|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
38071005|NCT03040141|69765990|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
38071006|NCT03040141|69765988|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
38071007|NCT03040141|69765989|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
38071008|NCT03040141|69765990|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
38071009|NCT02937701|69766004|FG000|Day 1 to Week 22|Adverse Event|11|||
38071010|NCT02937701|69766005|FG001|Day 1 to Week 22|Adverse Event|14|||
38071011|NCT02937701|69766006|FG002|Day 1 to Week 22|Adverse Event|0|||
38071012|NCT02937701|69766007|FG003|Day 1 to Week 22|Adverse Event|0|||
38071013|NCT02937701|69766008|FG004|Day 1 to Week 22|Adverse Event|0|||
38071014|NCT02937701|69766004|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
38071015|NCT02937701|69766005|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
38071016|NCT02937701|69766006|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
38071017|NCT02937701|69766007|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
38071018|NCT02937701|69766008|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
38071019|NCT02937701|69766004|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
38071020|NCT02937701|69766005|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
38071021|NCT02937701|69766006|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
38071022|NCT02937701|69766007|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
38071023|NCT02937701|69766008|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
38071024|NCT02937701|69766004|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
37965997|NCT00463047|69652946|FG000|Titration Period 1|Withdrawal by Subject|3|||
38071025|NCT02937701|69766005|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
38071026|NCT02937701|69766006|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
38071027|NCT02937701|69766007|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
38071028|NCT02937701|69766008|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
38071029|NCT02937701|69766004|FG000|Day 1 to Week 22|Death|1|||
38071030|NCT02937701|69766005|FG001|Day 1 to Week 22|Death|1|||
38071031|NCT02937701|69766006|FG002|Day 1 to Week 22|Death|0|||
38071032|NCT02937701|69766007|FG003|Day 1 to Week 22|Death|0|||
38071033|NCT02937701|69766008|FG004|Day 1 to Week 22|Death|0|||
38071034|NCT02937701|69766004|FG000|Day 1 to Week 22|Protocol Violation|1|||
38071035|NCT02937701|69766005|FG001|Day 1 to Week 22|Protocol Violation|1|||
38071036|NCT02937701|69766006|FG002|Day 1 to Week 22|Protocol Violation|0|||
38071037|NCT02937701|69766007|FG003|Day 1 to Week 22|Protocol Violation|0|||
38071038|NCT02937701|69766008|FG004|Day 1 to Week 22|Protocol Violation|0|||
38071039|NCT02937701|69766004|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
38071040|NCT02937701|69766005|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
38071041|NCT02937701|69766006|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
38071042|NCT02937701|69766007|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
38071043|NCT02937701|69766008|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
38071044|NCT02937701|69766004|FG000|Day 1 to Week 22|Physician Decision|2|||
38071045|NCT02937701|69766005|FG001|Day 1 to Week 22|Physician Decision|0|||
38071046|NCT02937701|69766006|FG002|Day 1 to Week 22|Physician Decision|0|||
38071047|NCT02937701|69766007|FG003|Day 1 to Week 22|Physician Decision|0|||
38071048|NCT02937701|69766008|FG004|Day 1 to Week 22|Physician Decision|0|||
38071049|NCT02937701|69766004|FG000|Day 1 to Week 22|Other|1|||
38071050|NCT02937701|69766005|FG001|Day 1 to Week 22|Other|0|||
38071051|NCT02937701|69766006|FG002|Day 1 to Week 22|Other|0|||
38071052|NCT02937701|69766007|FG003|Day 1 to Week 22|Other|0|||
38071053|NCT02937701|69766008|FG004|Day 1 to Week 22|Other|0|||
38071054|NCT02937701|69766004|FG000|Week 22 to Week 50|Adverse Event|0|||
38071055|NCT02937701|69766005|FG001|Week 22 to Week 50|Adverse Event|0|||
38071056|NCT02937701|69766006|FG002|Week 22 to Week 50|Adverse Event|10|||
38071057|NCT02937701|69766007|FG003|Week 22 to Week 50|Adverse Event|3|||
38071058|NCT02937701|69766008|FG004|Week 22 to Week 50|Adverse Event|3|||
38071059|NCT02937701|69766004|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
38071060|NCT02937701|69766005|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
38071061|NCT02937701|69766006|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
38071062|NCT02937701|69766007|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
38071063|NCT02937701|69766008|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
38071064|NCT02937701|69766004|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
38071065|NCT02937701|69766005|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
38071066|NCT02937701|69766006|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
38071067|NCT02937701|69766007|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
38071068|NCT02937701|69766008|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
38071069|NCT02937701|69766004|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
38071070|NCT02937701|69766005|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
38071071|NCT02937701|69766006|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
38071072|NCT02937701|69766007|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
38071073|NCT02937701|69766008|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
38071074|NCT02937701|69766004|FG000|Week 22 to Week 50|Physician Decision|0|||
38071075|NCT02937701|69766005|FG001|Week 22 to Week 50|Physician Decision|0|||
38071076|NCT02937701|69766006|FG002|Week 22 to Week 50|Physician Decision|2|||
38071077|NCT02937701|69766007|FG003|Week 22 to Week 50|Physician Decision|0|||
38071078|NCT02937701|69766008|FG004|Week 22 to Week 50|Physician Decision|1|||
38071079|NCT02937701|69766004|FG000|Week 22 to Week 50|Other|0|||
38071080|NCT02937701|69766005|FG001|Week 22 to Week 50|Other|0|||
38071081|NCT02937701|69766006|FG002|Week 22 to Week 50|Other|0|||
38071082|NCT02937701|69766007|FG003|Week 22 to Week 50|Other|0|||
38071083|NCT02937701|69766008|FG004|Week 22 to Week 50|Other|1|||
38071084|NCT03169153|69766020|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
38071085|NCT03169153|69766021|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
38071086|NCT03169153|69766020|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
38071087|NCT03169153|69766021|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
38071088|NCT03169153|69766020|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
38071089|NCT03169153|69766021|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
38071090|NCT03169153|69766020|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
38071091|NCT03169153|69766021|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
38071092|NCT03168919|69766027|FG000|Overall Study|Withdrawal by Subject|2|||
38071093|NCT03205163|69766037|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
38071094|NCT03205163|69766038|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
38071095|NCT01759537|69766053|FG000|Overall Study|Death|1|||
38071096|NCT01759537|69766054|FG001|Overall Study|Death|1|||
38071097|NCT01759537|69766053|FG000|Overall Study|Pregnancy|1|||
38071098|NCT01759537|69766054|FG001|Overall Study|Pregnancy|1|||
38071099|NCT01759537|69766053|FG000|Overall Study|Lost to Follow-up|9|||
38071100|NCT01759537|69766054|FG001|Overall Study|Lost to Follow-up|9|||
38071101|NCT01759537|69766053|FG000|Overall Study|Accident involving jaw fracture|1|||
38071102|NCT01759537|69766054|FG001|Overall Study|Accident involving jaw fracture|1|||
38071103|NCT01759537|69766053|FG000|Overall Study|Subcrestal implant too coronal|1|||
38071104|NCT01759537|69766054|FG001|Overall Study|Subcrestal implant too coronal|1|||
38071105|NCT03204539|69766062|FG000|Overall Study|Loss of funding|0|||
38071106|NCT03204539|69766063|FG001|Overall Study|Loss of funding|1|||
38071107|NCT03502681|69766080|FG000|Overall Study|Adverse Event|1|||
38071108|NCT03502681|69766081|FG001|Overall Study|Adverse Event|1|||
38071109|NCT03502681|69766080|FG000|Overall Study|Disease Progression|2|||
38071110|NCT03502681|69766081|FG001|Overall Study|Disease Progression|1|||
38071111|NCT02860130|69766088|FG000|Overall Study|Adverse Event|2|||
38071112|NCT02860130|69766089|FG001|Overall Study|Adverse Event|3|||
38071113|NCT02860130|69766088|FG000|Overall Study|Protocol Violation|1|||
38071114|NCT02860130|69766089|FG001|Overall Study|Protocol Violation|1|||
38071115|NCT02860130|69766088|FG000|Overall Study|Withdrawal by Subject|0|||
38071116|NCT02860130|69766089|FG001|Overall Study|Withdrawal by Subject|2|||
38071117|NCT02860130|69766088|FG000|Overall Study|Physician Decision|2|||
38071118|NCT02860130|69766089|FG001|Overall Study|Physician Decision|2|||
38071119|NCT02860130|69766088|FG000|Overall Study|Other|2|||
38071120|NCT02860130|69766089|FG001|Overall Study|Other|1|||
38071121|NCT02986854|69766098|FG000|Overall Study|Withdrawal by Subject|0|||
38071122|NCT02986854|69766099|FG001|Overall Study|Withdrawal by Subject|1|||
38071123|NCT02986854|69766100|FG002|Overall Study|Withdrawal by Subject|1|||
38071124|NCT02986854|69766098|FG000|Overall Study|Lost to Follow-up|3|||
38071125|NCT02986854|69766099|FG001|Overall Study|Lost to Follow-up|11|||
38071126|NCT02986854|69766100|FG002|Overall Study|Lost to Follow-up|2|||
38071127|NCT02887183|69766110|FG000|Overall Study|Adverse Event|44|||
38071128|NCT02887183|69766110|FG000|Overall Study|Death|30|||
38071129|NCT02887183|69766110|FG000|Overall Study|Pregnancy|1|||
38071130|NCT02887183|69766110|FG000|Overall Study|Protocol Violation|6|||
38071131|NCT02887183|69766110|FG000|Overall Study|Technical Problems|2|||
38071132|NCT02887183|69766110|FG000|Overall Study|Lost to Follow-up|13|||
38071133|NCT02887183|69766110|FG000|Overall Study|Physician Decision|10|||
38071134|NCT02887183|69766110|FG000|Overall Study|Withdrawal by Subject|35|||
38071135|NCT03167359|69766114|FG000|Overall Study|Physician Decision|1|||
38071136|NCT03167359|69766114|FG000|Overall Study|Lost to Follow-up|1|||
38071137|NCT01068600|69766120|FG000|Overall Study|Withdrawal by Subject|5|||
38071138|NCT01068600|69766121|FG001|Overall Study|Withdrawal by Subject|6|||
38071139|NCT01068600|69766120|FG000|Overall Study|Adverse Event|3|||
38071140|NCT01068600|69766121|FG001|Overall Study|Adverse Event|3|||
38071141|NCT01068600|69766120|FG000|Overall Study|Abnormal laboratory value(s)|1|||
38071142|NCT01068600|69766121|FG001|Overall Study|Abnormal laboratory value(s)|0|||
38071143|NCT01068600|69766120|FG000|Overall Study|Lost to Follow-up|1|||
38071144|NCT01068600|69766121|FG001|Overall Study|Lost to Follow-up|2|||
38071145|NCT01068600|69766120|FG000|Overall Study|Protocol deviation|1|||
38071146|NCT01068600|69766121|FG001|Overall Study|Protocol deviation|1|||
38071147|NCT01068600|69766120|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
38071148|NCT01068600|69766121|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
38071149|NCT01068600|69766120|FG000|Overall Study|Administrative problems|0|||
38071150|NCT01068600|69766121|FG001|Overall Study|Administrative problems|1|||
38071151|NCT01067976|69766127|FG000|Overall Study|Study drug never administered|20|||
38071152|NCT01067976|69766127|FG000|Overall Study|Study prematurely discontinued|2|||
38071153|NCT02858492|69766149|FG000|Overall Study|Withdrawal by Subject|0|||
38071154|NCT02858492|69766150|FG001|Overall Study|Withdrawal by Subject|1|||
38071155|NCT02858492|69766151|FG002|Overall Study|Withdrawal by Subject|0|||
38071156|NCT02858492|69766152|FG003|Overall Study|Withdrawal by Subject|1|||
38071157|NCT02858492|69766149|FG000|Overall Study|Adverse Event|0|||
38071158|NCT02858492|69766150|FG001|Overall Study|Adverse Event|0|||
38071159|NCT02858492|69766151|FG002|Overall Study|Adverse Event|0|||
38071160|NCT02858492|69766152|FG003|Overall Study|Adverse Event|3|||
38071161|NCT02858492|69766149|FG000|Overall Study|Lack of Efficacy|0|||
38071162|NCT02858492|69766150|FG001|Overall Study|Lack of Efficacy|0|||
38071163|NCT02858492|69766151|FG002|Overall Study|Lack of Efficacy|0|||
38071164|NCT02858492|69766152|FG003|Overall Study|Lack of Efficacy|1|||
38071165|NCT02858492|69766149|FG000|Overall Study|Protocol defined stopping criteria|0|||
38071166|NCT02858492|69766150|FG001|Overall Study|Protocol defined stopping criteria|0|||
38071167|NCT02858492|69766151|FG002|Overall Study|Protocol defined stopping criteria|0|||
38071168|NCT02858492|69766152|FG003|Overall Study|Protocol defined stopping criteria|1|||
38071169|NCT01067508|69766166|FG000|Overall Study|Physician Decision|0|||
38071170|NCT01067508|69766167|FG001|Overall Study|Physician Decision|1|||
38071171|NCT01067508|69766166|FG000|Overall Study|Withdrawal by Subject|0|||
38071172|NCT01067508|69766167|FG001|Overall Study|Withdrawal by Subject|1|||
38071173|NCT01067352|69766176|FG000|Overall Study|Withdrawal by Subject|1|||
38071174|NCT01067352|69766177|FG001|Overall Study|Withdrawal by Subject|2|||
38071175|NCT01067352|69766178|FG002|Overall Study|Withdrawal by Subject|1|||
38071176|NCT01067352|69766176|FG000|Overall Study|Physician Decision|0|||
38071177|NCT01067352|69766177|FG001|Overall Study|Physician Decision|1|||
38071178|NCT01067352|69766178|FG002|Overall Study|Physician Decision|0|||
38071179|NCT02986074|69766186|FG000|First Trial Period|Adverse Event|1|||
38071180|NCT02986074|69766187|FG001|First Trial Period|Adverse Event|0|||
38071181|NCT02986074|69766188|FG002|First Trial Period|Adverse Event|0|||
38071182|NCT02986074|69766189|FG003|First Trial Period|Adverse Event|0|||
38071183|NCT02986074|69766186|FG000|Follow up Period|system explant|0|||
38071184|NCT02986074|69766187|FG001|Follow up Period|system explant|0|||
38071185|NCT02986074|69766188|FG002|Follow up Period|system explant|1|||
38071186|NCT02986074|69766189|FG003|Follow up Period|system explant|2|||
38071187|NCT02986074|69766186|FG000|Follow up Period|Physician Decision|0|||
38071188|NCT02986074|69766187|FG001|Follow up Period|Physician Decision|0|||
38071189|NCT02986074|69766188|FG002|Follow up Period|Physician Decision|0|||
38071190|NCT02986074|69766189|FG003|Follow up Period|Physician Decision|1|||
38071191|NCT02920242|69766197|FG000|Overall Study|Withdrawal by Subject|1|||
38071192|NCT02920242|69766198|FG001|Overall Study|Withdrawal by Subject|0|||
38071193|NCT02920242|69766199|FG002|Overall Study|Withdrawal by Subject|1|||
38071194|NCT02920242|69766197|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
38071195|NCT02920242|69766198|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
38071196|NCT02920242|69766199|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
38071197|NCT02985996|69766212|FG000|Overall Study|Withdrawal by Subject|0|||
38071198|NCT02985996|69766213|FG001|Overall Study|Withdrawal by Subject|0|||
38071199|NCT02985996|69766214|FG002|Overall Study|Withdrawal by Subject|1|||
38071200|NCT02985996|69766215|FG003|Overall Study|Withdrawal by Subject|0|||
38071201|NCT02985996|69766216|FG004|Overall Study|Withdrawal by Subject|0|||
38071202|NCT02985996|69766212|FG000|Overall Study|Protocol Violation|0|||
38071203|NCT02985996|69766213|FG001|Overall Study|Protocol Violation|1|||
38071204|NCT02985996|69766214|FG002|Overall Study|Protocol Violation|0|||
38071205|NCT02985996|69766215|FG003|Overall Study|Protocol Violation|0|||
38071206|NCT02985996|69766216|FG004|Overall Study|Protocol Violation|0|||
38071207|NCT03225833|69766238|FG000|Overall Study|Adverse Event|0|||
38071208|NCT03225833|69766239|FG001|Overall Study|Adverse Event|1|||
38071209|NCT03225833|69766240|FG002|Overall Study|Adverse Event|2|||
38071210|NCT03225833|69766241|FG003|Overall Study|Adverse Event|0|||
38071211|NCT03225833|69766242|FG004|Overall Study|Adverse Event|0|||
38071212|NCT03225833|69766243|FG005|Overall Study|Adverse Event|2|||
38071213|NCT03225833|69766238|FG000|Overall Study|Withdrawal by Subject|1|||
38071214|NCT03225833|69766239|FG001|Overall Study|Withdrawal by Subject|0|||
38071215|NCT03225833|69766240|FG002|Overall Study|Withdrawal by Subject|0|||
38071216|NCT03225833|69766241|FG003|Overall Study|Withdrawal by Subject|0|||
38071217|NCT03225833|69766242|FG004|Overall Study|Withdrawal by Subject|1|||
38071218|NCT03225833|69766243|FG005|Overall Study|Withdrawal by Subject|0|||
38071219|NCT03225833|69766238|FG000|Overall Study|Termination of Study by Sponsor|4|||
38071220|NCT03225833|69766239|FG001|Overall Study|Termination of Study by Sponsor|0|||
38071221|NCT03225833|69766240|FG002|Overall Study|Termination of Study by Sponsor|0|||
38071222|NCT03225833|69766241|FG003|Overall Study|Termination of Study by Sponsor|0|||
38071223|NCT03225833|69766242|FG004|Overall Study|Termination of Study by Sponsor|0|||
38071224|NCT03225833|69766243|FG005|Overall Study|Termination of Study by Sponsor|7|||
38071225|NCT03225833|69766238|FG000|Overall Study|Sponsor Decision|0|||
38071226|NCT03225833|69766239|FG001|Overall Study|Sponsor Decision|0|||
38071227|NCT03225833|69766240|FG002|Overall Study|Sponsor Decision|0|||
38071228|NCT03225833|69766241|FG003|Overall Study|Sponsor Decision|0|||
38071229|NCT03225833|69766242|FG004|Overall Study|Sponsor Decision|0|||
38071230|NCT03225833|69766243|FG005|Overall Study|Sponsor Decision|1|||
38071231|NCT03203447|69766264|FG000|Overall Study|Withdrawal by Subject|2|||
38071232|NCT03203447|69766265|FG001|Overall Study|Withdrawal by Subject|1|||
38071233|NCT03203447|69766264|FG000|Overall Study|Lost to Follow-up|1|||
38071234|NCT03203447|69766265|FG001|Overall Study|Lost to Follow-up|10|||
38071235|NCT03203447|69766264|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
38071236|NCT03203447|69766265|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
38071237|NCT02858726|69766275|FG000|Overall Study|Adverse Event|4|||
38071238|NCT02858726|69766276|FG001|Overall Study|Adverse Event|4|||
38071239|NCT02858726|69766277|FG002|Overall Study|Adverse Event|9|||
38071240|NCT02858726|69766278|FG003|Overall Study|Adverse Event|1|||
38071241|NCT02858726|69766275|FG000|Overall Study|Physician Decision|0|||
38071242|NCT02858726|69766276|FG001|Overall Study|Physician Decision|0|||
38071243|NCT02858726|69766277|FG002|Overall Study|Physician Decision|1|||
38071244|NCT02858726|69766278|FG003|Overall Study|Physician Decision|0|||
38071245|NCT02858726|69766275|FG000|Overall Study|Protocol Violation|0|||
38071246|NCT02858726|69766276|FG001|Overall Study|Protocol Violation|0|||
38071247|NCT02858726|69766277|FG002|Overall Study|Protocol Violation|0|||
38071248|NCT02858726|69766278|FG003|Overall Study|Protocol Violation|1|||
38071249|NCT02858726|69766275|FG000|Overall Study|Study Terminated by Sponsor|0|||
38071250|NCT02858726|69766276|FG001|Overall Study|Study Terminated by Sponsor|0|||
38071251|NCT02858726|69766277|FG002|Overall Study|Study Terminated by Sponsor|0|||
38071252|NCT02858726|69766278|FG003|Overall Study|Study Terminated by Sponsor|1|||
38071253|NCT02858726|69766275|FG000|Overall Study|Withdrawal by Subject|1|||
38071254|NCT02858726|69766276|FG001|Overall Study|Withdrawal by Subject|2|||
38071255|NCT02858726|69766277|FG002|Overall Study|Withdrawal by Subject|1|||
38071256|NCT02858726|69766278|FG003|Overall Study|Withdrawal by Subject|0|||
38071257|NCT02858726|69766275|FG000|Overall Study|Noncompliance|0|||
38071258|NCT02858726|69766276|FG001|Overall Study|Noncompliance|1|||
38071259|NCT02858726|69766277|FG002|Overall Study|Noncompliance|0|||
38071260|NCT02858726|69766278|FG003|Overall Study|Noncompliance|0|||
38071261|NCT03203291|69766292|FG000|Overall Study|Withdrawal by Subject|1|||
38071262|NCT01068678|69766298|FG000|Overall Study|Lack of Efficacy|3|||
38071263|NCT01068678|69766299|FG001|Overall Study|Lack of Efficacy|2|||
38071264|NCT01068678|69766298|FG000|Overall Study|Protocol Violation|5|||
38071265|NCT01068678|69766299|FG001|Overall Study|Protocol Violation|1|||
38071266|NCT01068678|69766298|FG000|Overall Study|Withdrawal criteria|12|||
38071267|NCT01068678|69766299|FG001|Overall Study|Withdrawal criteria|6|||
38071268|NCT01068678|69766298|FG000|Overall Study|Unclassified|18|||
38071269|NCT01068678|69766299|FG001|Overall Study|Unclassified|15|||
38071270|NCT03202511|69766305|FG000|Overall Study|Withdrawal by Subject|1|||
38071271|NCT03202511|69766306|FG001|Overall Study|Withdrawal by Subject|0|||
38071272|NCT02919696|69766327|FG000|Overall Study|Adverse Event|1|||
38071273|NCT02919696|69766328|FG001|Overall Study|Adverse Event|2|||
38071274|NCT02919696|69766327|FG000|Overall Study|Withdrawal by Subject|2|||
38071275|NCT02919696|69766328|FG001|Overall Study|Withdrawal by Subject|1|||
38071276|NCT02919696|69766327|FG000|Overall Study|Sponsor Decision|1|||
38071277|NCT02919696|69766328|FG001|Overall Study|Sponsor Decision|1|||
38071278|NCT02919696|69766327|FG000|Overall Study|Never Treated|0|||
38071279|NCT02919696|69766328|FG001|Overall Study|Never Treated|1|||
38071280|NCT02935673|69766343|FG000|Overall Study|Adverse Event|0|||
38071281|NCT02935673|69766344|FG001|Overall Study|Adverse Event|1|||
38071282|NCT02935673|69766345|FG002|Overall Study|Adverse Event|0|||
38071283|NCT02935673|69766343|FG000|Overall Study|Withdrawal by Subject|1|||
38071284|NCT02935673|69766344|FG001|Overall Study|Withdrawal by Subject|2|||
38071285|NCT02935673|69766345|FG002|Overall Study|Withdrawal by Subject|0|||
38071286|NCT03201809|69766357|FG000|Overall Study|Lost to Follow-up|2|||
38071287|NCT03201809|69766358|FG001|Overall Study|Lost to Follow-up|0|||
38071288|NCT02985450|69766369|FG000|Overall Study|Lost to Follow-up|7|||
38071289|NCT02908464|69766378|FG000|Overall Study|Withdrawal by Subject|2|||
38071290|NCT02908464|69766379|FG001|Overall Study|Withdrawal by Subject|1|||
38071291|NCT02908464|69766378|FG000|Overall Study|Found ineligible after randomization|0|||
38071292|NCT02908464|69766379|FG001|Overall Study|Found ineligible after randomization|2|||
38071293|NCT02907216|69766388|FG000|Overall Study|No benefit to be obtained by continuing|0|||
38071294|NCT02907216|69766389|FG001|Overall Study|No benefit to be obtained by continuing|1|||
38071295|NCT02907216|69766388|FG000|Overall Study|Withdrawal by Subject|1|||
38071296|NCT02907216|69766389|FG001|Overall Study|Withdrawal by Subject|0|||
38071297|NCT02984982|69766397|FG000|Overall Study|Adverse Event|2|||
38071298|NCT02984982|69766398|FG001|Overall Study|Adverse Event|5|||
38071299|NCT02984982|69766397|FG000|Overall Study|Poor Compliance to Protocol|4|||
38071300|NCT02984982|69766398|FG001|Overall Study|Poor Compliance to Protocol|4|||
38071301|NCT02984982|69766397|FG000|Overall Study|Withdrawal by Subject|2|||
38071302|NCT02984982|69766398|FG001|Overall Study|Withdrawal by Subject|0|||
38071303|NCT02984982|69766397|FG000|Overall Study|Randomized but not treated|0|||
38071304|NCT02984982|69766398|FG001|Overall Study|Randomized but not treated|1|||
38071305|NCT02981472|69766407|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
38071306|NCT02981472|69766408|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
38071307|NCT02981472|69766407|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
38071308|NCT02981472|69766408|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
38071309|NCT02981472|69766407|FG000|Treatment Period|Adverse Event|6|||
38071310|NCT02981472|69766408|FG001|Treatment Period|Adverse Event|1|||
38071311|NCT02981472|69766407|FG000|Treatment Period|Participant withdrew consent|1|||
38071312|NCT02981472|69766408|FG001|Treatment Period|Participant withdrew consent|0|||
38071313|NCT02981472|69766407|FG000|Treatment Period|Lost to Follow-up|0|||
38071314|NCT02981472|69766408|FG001|Treatment Period|Lost to Follow-up|1|||
38071315|NCT02982720|69766420|FG000|Overall Study|Adverse Event|3|||
38071316|NCT02982720|69766420|FG000|Overall Study|Death|1|||
38071317|NCT00849667|69766427|FG000|Overall Study|Withdrawal by Subject|16|||
38071318|NCT00849667|69766428|FG001|Overall Study|Withdrawal by Subject|33|||
38071319|NCT00849667|69766429|FG002|Overall Study|Withdrawal by Subject|35|||
38071320|NCT00849667|69766427|FG000|Overall Study|Lost to Follow-up|8|||
38071321|NCT00849667|69766428|FG001|Overall Study|Lost to Follow-up|8|||
38071322|NCT00849667|69766429|FG002|Overall Study|Lost to Follow-up|8|||
38071323|NCT00849667|69766427|FG000|Overall Study|Adverse Event|1|||
38071324|NCT00849667|69766428|FG001|Overall Study|Adverse Event|2|||
38071325|NCT00849667|69766429|FG002|Overall Study|Adverse Event|0|||
38071326|NCT00849667|69766427|FG000|Overall Study|Other|18|||
38071327|NCT00849667|69766428|FG001|Overall Study|Other|19|||
38071328|NCT00849667|69766429|FG002|Overall Study|Other|18|||
38071329|NCT00849667|69766427|FG000|Overall Study|Progressive disease|119|||
38071330|NCT00849667|69766428|FG001|Overall Study|Progressive disease|100|||
38071331|NCT00849667|69766429|FG002|Overall Study|Progressive disease|112|||
38071332|NCT00849667|69766427|FG000|Overall Study|Sponsor decision|208|||
38071333|NCT00849667|69766428|FG001|Overall Study|Sponsor decision|204|||
38071334|NCT00849667|69766429|FG002|Overall Study|Sponsor decision|190|||
38071335|NCT00849667|69766427|FG000|Overall Study|Investigator discretion|0|||
38071336|NCT00849667|69766428|FG001|Overall Study|Investigator discretion|0|||
38071337|NCT00849667|69766429|FG002|Overall Study|Investigator discretion|1|||
38071338|NCT03201419|69766448|FG000|Overall Study|Adverse Event|3|||
38071339|NCT03201419|69766449|FG001|Overall Study|Adverse Event|1|||
38071340|NCT03201419|69766450|FG002|Overall Study|Adverse Event|0|||
38071341|NCT03201419|69766451|FG003|Overall Study|Adverse Event|0|||
38071342|NCT03201419|69766452|FG004|Overall Study|Adverse Event|1|||
38071343|NCT03201419|69766453|FG005|Overall Study|Adverse Event|1|||
38071344|NCT03201419|69766454|FG006|Overall Study|Adverse Event|5|||
38071345|NCT03201419|69766455|FG007|Overall Study|Adverse Event|0|||
38071346|NCT03201419|69766456|FG008|Overall Study|Adverse Event|0|||
38071347|NCT03201419|69766448|FG000|Overall Study|Lost to Follow-up|1|||
38071348|NCT03201419|69766449|FG001|Overall Study|Lost to Follow-up|0|||
38071349|NCT03201419|69766450|FG002|Overall Study|Lost to Follow-up|0|||
38071350|NCT03201419|69766451|FG003|Overall Study|Lost to Follow-up|0|||
38071351|NCT03201419|69766452|FG004|Overall Study|Lost to Follow-up|0|||
38071352|NCT03201419|69766453|FG005|Overall Study|Lost to Follow-up|0|||
38071353|NCT03201419|69766454|FG006|Overall Study|Lost to Follow-up|0|||
38071354|NCT03201419|69766455|FG007|Overall Study|Lost to Follow-up|0|||
38071355|NCT03201419|69766456|FG008|Overall Study|Lost to Follow-up|0|||
38071356|NCT03201419|69766448|FG000|Overall Study|Protocol Deviation|0|||
38071357|NCT03201419|69766449|FG001|Overall Study|Protocol Deviation|0|||
38071358|NCT03201419|69766450|FG002|Overall Study|Protocol Deviation|0|||
38071359|NCT03201419|69766451|FG003|Overall Study|Protocol Deviation|0|||
38071360|NCT03201419|69766452|FG004|Overall Study|Protocol Deviation|0|||
38071361|NCT03201419|69766453|FG005|Overall Study|Protocol Deviation|0|||
38071362|NCT03201419|69766454|FG006|Overall Study|Protocol Deviation|1|||
38071363|NCT03201419|69766455|FG007|Overall Study|Protocol Deviation|0|||
38071364|NCT03201419|69766456|FG008|Overall Study|Protocol Deviation|0|||
38071365|NCT03201419|69766448|FG000|Overall Study|Withdrawal by Subject|4|||
38071366|NCT03201419|69766449|FG001|Overall Study|Withdrawal by Subject|2|||
38071367|NCT03201419|69766450|FG002|Overall Study|Withdrawal by Subject|1|||
38071368|NCT03201419|69766451|FG003|Overall Study|Withdrawal by Subject|0|||
38071369|NCT03201419|69766452|FG004|Overall Study|Withdrawal by Subject|0|||
38071370|NCT03201419|69766453|FG005|Overall Study|Withdrawal by Subject|0|||
38071371|NCT03201419|69766454|FG006|Overall Study|Withdrawal by Subject|0|||
38071372|NCT03201419|69766455|FG007|Overall Study|Withdrawal by Subject|1|||
38071373|NCT03201419|69766456|FG008|Overall Study|Withdrawal by Subject|2|||
38071374|NCT03201419|69766448|FG000|Overall Study|Other|0|||
38071375|NCT03201419|69766449|FG001|Overall Study|Other|0|||
38071376|NCT03201419|69766450|FG002|Overall Study|Other|1|||
38071377|NCT03201419|69766451|FG003|Overall Study|Other|0|||
38071378|NCT03201419|69766452|FG004|Overall Study|Other|0|||
38071379|NCT03201419|69766453|FG005|Overall Study|Other|0|||
38071380|NCT03201419|69766454|FG006|Overall Study|Other|0|||
38071381|NCT03201419|69766455|FG007|Overall Study|Other|0|||
38071382|NCT03201419|69766456|FG008|Overall Study|Other|0|||
38071383|NCT01764633|69766492|FG000|Overall Study|Withdrawal by Subject|105|||
38071384|NCT01764633|69766493|FG001|Overall Study|Withdrawal by Subject|88|||
38071385|NCT01764633|69766492|FG000|Overall Study|Lost to Follow-up|13|||
38071386|NCT01764633|69766493|FG001|Overall Study|Lost to Follow-up|5|||
38071387|NCT02924389|69766501|FG000|Overall Study|Lost to Follow-up|1|||
38071388|NCT02924389|69766502|FG001|Overall Study|Lost to Follow-up|0|||
38071389|NCT02924389|69766501|FG000|Overall Study|Physician Decision|2|||
38071390|NCT02924389|69766502|FG001|Overall Study|Physician Decision|0|||
38071391|NCT02924389|69766501|FG000|Overall Study|Withdrawal by Subject|3|||
38071392|NCT02924389|69766502|FG001|Overall Study|Withdrawal by Subject|0|||
38071393|NCT02924389|69766501|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
38071394|NCT02924389|69766502|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
38071395|NCT03235349|69766509|FG000|Overall Study|Adverse Event|1|||
38071396|NCT03235349|69766509|FG000|Overall Study|Other|1|||
38071397|NCT03235115|69766513|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
38071398|NCT03235115|69766514|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
38071399|NCT03235115|69766515|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
38071400|NCT03235115|69766516|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
38071401|NCT03235115|69766517|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
38071402|NCT03235115|69766518|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
38071403|NCT02923531|69766526|FG000|Overall Study|Adverse Event|4|||
38071404|NCT02923531|69766526|FG000|Overall Study|Clinical Deterioration|1|||
38071405|NCT02923531|69766526|FG000|Overall Study|Disease Progression|3|||
38071406|NCT02923531|69766526|FG000|Overall Study|Study Termination|1|||
38071407|NCT02934503|69766531|FG000|Overall Study|progression of disease|3|||
38071408|NCT02934503|69766531|FG000|Overall Study|Withdrawal by Subject|1|||
38071409|NCT02937545|69766537|FG000|Overall Study|Withdrawal by Subject|1|||
38071410|NCT02937545|69766538|FG001|Overall Study|Withdrawal by Subject|2|||
38071411|NCT02937545|69766539|FG002|Overall Study|Withdrawal by Subject|6|||
38071412|NCT02937545|69766540|FG003|Overall Study|Withdrawal by Subject|7|||
38071413|NCT02937545|69766537|FG000|Overall Study|Lost to Follow-up|1|||
38071414|NCT02937545|69766538|FG001|Overall Study|Lost to Follow-up|0|||
38071415|NCT02937545|69766539|FG002|Overall Study|Lost to Follow-up|0|||
38071416|NCT02937545|69766540|FG003|Overall Study|Lost to Follow-up|0|||
38071417|NCT03199391|69766551|FG000|Overall Study|Death|1|||
38071418|NCT03199391|69766551|FG000|Overall Study|Lost to Follow-up|3|||
38071419|NCT03199391|69766551|FG000|Overall Study|Adverse Event|2|||
38071420|NCT03199391|69766551|FG000|Overall Study|Withdrawal by Subject|10|||
38071421|NCT03198767|69766562|FG000|Overall Study|Protocol Violation|0|||
38071422|NCT03198767|69766563|FG001|Overall Study|Protocol Violation|0|||
38071423|NCT03198767|69766564|FG002|Overall Study|Protocol Violation|0|||
38071424|NCT03198767|69766565|FG003|Overall Study|Protocol Violation|6|||
38071425|NCT03198767|69766566|FG004|Overall Study|Protocol Violation|0|||
38071426|NCT03198767|69766567|FG005|Overall Study|Protocol Violation|0|||
38071427|NCT03198767|69766568|FG006|Overall Study|Protocol Violation|0|||
38071428|NCT03162055|69766585|FG000|Overall Study|Adverse Event|6|||
38071429|NCT03162055|69766586|FG001|Overall Study|Adverse Event|5|||
38071430|NCT03162055|69766585|FG000|Overall Study|Death|3|||
38071431|NCT03162055|69766586|FG001|Overall Study|Death|3|||
38071432|NCT03162055|69766585|FG000|Overall Study|Lost to Follow-up|0|||
38071433|NCT03162055|69766586|FG001|Overall Study|Lost to Follow-up|1|||
38071434|NCT03162055|69766585|FG000|Overall Study|Study-specific withdrawal criteria|22|||
38071435|NCT03162055|69766586|FG001|Overall Study|Study-specific withdrawal criteria|14|||
38071436|NCT03162055|69766585|FG000|Overall Study|Withdrawal by Subject|17|||
38071437|NCT03162055|69766586|FG001|Overall Study|Withdrawal by Subject|2|||
38071438|NCT03162055|69766585|FG000|Overall Study|Did not receive treatment|2|||
38071439|NCT03162055|69766586|FG001|Overall Study|Did not receive treatment|0|||
38071440|NCT03162055|69766585|FG000|Overall Study|Incorrect randomization|4|||
38071441|NCT03162055|69766586|FG001|Overall Study|Incorrect randomization|3|||
38071442|NCT03162055|69766585|FG000|Overall Study|Other|8|||
38071443|NCT03162055|69766586|FG001|Overall Study|Other|15|||
38071444|NCT02927145|69766599|FG000|Initial Recruitment|Withdrawal by Subject|0|||
38071445|NCT02927145|69766600|FG001|Initial Recruitment|Withdrawal by Subject|1|||
38071446|NCT02927145|69766601|FG002|Initial Recruitment|Withdrawal by Subject|1|||
38071447|NCT02927145|69766602|FG003|Initial Recruitment|Withdrawal by Subject|4|||
38071448|NCT02927145|69766603|FG004|Initial Recruitment|Withdrawal by Subject|1|||
38071449|NCT02927145|69766604|FG005|Initial Recruitment|Withdrawal by Subject|1|||
38071450|NCT02927145|69766605|FG006|Initial Recruitment|Withdrawal by Subject|0|||
38071451|NCT02927145|69766606|FG007|Initial Recruitment|Withdrawal by Subject|0|||
38071452|NCT02927145|69766607|FG008|Initial Recruitment|Withdrawal by Subject|2|||
38071453|NCT02927145|69766599|FG000|Initial Recruitment|Adverse Event|0|||
38071454|NCT02927145|69766600|FG001|Initial Recruitment|Adverse Event|0|||
38071455|NCT02927145|69766601|FG002|Initial Recruitment|Adverse Event|0|||
38071456|NCT02927145|69766602|FG003|Initial Recruitment|Adverse Event|0|||
38071457|NCT02927145|69766603|FG004|Initial Recruitment|Adverse Event|2|||
38071458|NCT02927145|69766604|FG005|Initial Recruitment|Adverse Event|0|||
38071459|NCT02927145|69766605|FG006|Initial Recruitment|Adverse Event|0|||
38071460|NCT02927145|69766606|FG007|Initial Recruitment|Adverse Event|0|||
38071461|NCT02927145|69766607|FG008|Initial Recruitment|Adverse Event|0|||
38071462|NCT02927145|69766599|FG000|Invitation for Additional Challenge|Pregnancy|0|||
38071463|NCT02927145|69766600|FG001|Invitation for Additional Challenge|Pregnancy|0|||
38071464|NCT02927145|69766601|FG002|Invitation for Additional Challenge|Pregnancy|0|||
38071465|NCT02927145|69766602|FG003|Invitation for Additional Challenge|Pregnancy|0|||
38071466|NCT02927145|69766603|FG004|Invitation for Additional Challenge|Pregnancy|0|||
38071467|NCT02927145|69766604|FG005|Invitation for Additional Challenge|Pregnancy|0|||
37965998|NCT00463047|69652947|FG001|Titration Period 1|Withdrawal by Subject|5|||
37965999|NCT00463047|69652946|FG000|Titration Period 1|Non-compliance procedures|4|||
37966000|NCT00463047|69652947|FG001|Titration Period 1|Non-compliance procedures|10|||
37966001|NCT00463047|69652946|FG000|Titration Period 1|Other|0|||
38071468|NCT02927145|69766605|FG006|Invitation for Additional Challenge|Pregnancy|1|||
38071469|NCT02927145|69766606|FG007|Invitation for Additional Challenge|Pregnancy|0|||
38071470|NCT02927145|69766607|FG008|Invitation for Additional Challenge|Pregnancy|0|||
38071471|NCT03688919|69766630|FG000|Overall Study|Lost to Follow-up|2|||
38071472|NCT03688919|69766631|FG001|Overall Study|Lost to Follow-up|1|||
38071473|NCT03688919|69766630|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
38071474|NCT03688919|69766631|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
38071475|NCT02888119|69766654|FG000|Overall Study|Lost to Follow-up|5|||
38071476|NCT02888119|69766655|FG001|Overall Study|Lost to Follow-up|4|||
38071477|NCT02888119|69766656|FG002|Overall Study|Lost to Follow-up|0|||
38071478|NCT03197129|69766665|FG000|Overall Study|did not answer the VPT: shyness|4|||
38071479|NCT03197129|69766666|FG001|Overall Study|did not answer the VPT: shyness|5|||
38071480|NCT03196973|69766675|FG000|Overall Study|Adverse Event|1|||
38071481|NCT03196973|69766676|FG001|Overall Study|Adverse Event|1|||
37966002|NCT00463047|69652947|FG001|Titration Period 1|Other|2|||
37966003|NCT00463047|69652946|FG000|Titration Period 2|Adverse Event|9|||
37966004|NCT00463047|69652947|FG001|Titration Period 2|Adverse Event|9|||
37966005|NCT00463047|69652946|FG000|Titration Period 2|Lack of Efficacy|6|||
37966006|NCT00463047|69652947|FG001|Titration Period 2|Lack of Efficacy|4|||
37966007|NCT00463047|69652946|FG000|Titration Period 2|Withdrawal by Subject|1|||
37966008|NCT00463047|69652947|FG001|Titration Period 2|Withdrawal by Subject|0|||
37966009|NCT00463047|69652946|FG000|Titration Period 2|Protocol Violation|2|||
37966010|NCT00463047|69652947|FG001|Titration Period 2|Protocol Violation|3|||
37966011|NCT00463047|69652946|FG000|Titration Period 2|Lost to Follow-up|1|||
37966012|NCT00463047|69652947|FG001|Titration Period 2|Lost to Follow-up|2|||
37966013|NCT00463047|69652946|FG000|Titration Period 2|Non-compliance study medication|4|||
37966014|NCT00463047|69652947|FG001|Titration Period 2|Non-compliance study medication|2|||
37966015|NCT00463047|69652946|FG000|Titration Period 2|Non-compliance procedures|4|||
37966016|NCT00463047|69652947|FG001|Titration Period 2|Non-compliance procedures|1|||
37966017|NCT00463047|69652946|FG000|Titration Period 2|Other|3|||
37966018|NCT00463047|69652947|FG001|Titration Period 2|Other|2|||
37966019|NCT00463047|69652946|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
37966020|NCT00463047|69652947|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
37966021|NCT00463047|69652946|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
37966022|NCT00463047|69652947|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
37966023|NCT00463047|69652946|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
37966024|NCT00463047|69652947|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
37966025|NCT00463047|69652946|FG000|Double-Blind Treatment Period 1|Other|1|||
37966026|NCT00463047|69652947|FG001|Double-Blind Treatment Period 1|Other|0|||
37966027|NCT00463047|69652946|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
37966028|NCT00463047|69652947|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
37966029|NCT00463047|69652946|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
37966030|NCT00463047|69652947|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
37966031|NCT00463047|69652946|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
37966032|NCT00463047|69652947|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
37966033|NCT00487695|69652954|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
37966034|NCT00487695|69652955|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
37966035|NCT00487695|69652954|FG000|First Procedure|active wheezing (did not have procedure)|1|||
37966036|NCT00487695|69652955|FG001|First Procedure|active wheezing (did not have procedure)|0|||
37966037|NCT00487695|69652954|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
37966038|NCT00487695|69652955|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
37966039|NCT00487695|69652954|FG000|Second Procedure|active wheezing|0|||
37966040|NCT00487695|69652955|FG001|Second Procedure|active wheezing|1|||
37966041|NCT00487695|69652954|FG000|Second Procedure|Withdrawal by Subject|1|||
37966042|NCT00487695|69652955|FG001|Second Procedure|Withdrawal by Subject|2|||
37966043|NCT00487539|69652965|FG000|Overall Study|Adverse Event|3|||
37966044|NCT00487539|69652966|FG001|Overall Study|Adverse Event|2|||
37966045|NCT00487539|69652967|FG002|Overall Study|Adverse Event|1|||
37966046|NCT00487539|69652968|FG003|Overall Study|Adverse Event|1|||
37966047|NCT00487539|69652965|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
37966048|NCT00487539|69652966|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
37966049|NCT00487539|69652967|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
37966050|NCT00487539|69652968|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
37966051|NCT00487539|69652965|FG000|Overall Study|Other|3|||
37966052|NCT00487539|69652966|FG001|Overall Study|Other|1|||
37966053|NCT00487539|69652967|FG002|Overall Study|Other|2|||
37966054|NCT00487539|69652968|FG003|Overall Study|Other|2|||
38071482|NCT03196973|69766677|FG002|Overall Study|Adverse Event|2|||
38071483|NCT03196973|69766675|FG000|Overall Study|Lack of Efficacy|2|||
38071484|NCT03196973|69766676|FG001|Overall Study|Lack of Efficacy|6|||
38071485|NCT03196973|69766677|FG002|Overall Study|Lack of Efficacy|1|||
38071486|NCT03196973|69766675|FG000|Overall Study|Lost to Follow-up|4|||
38071487|NCT03196973|69766676|FG001|Overall Study|Lost to Follow-up|3|||
38071488|NCT03196973|69766677|FG002|Overall Study|Lost to Follow-up|2|||
38071489|NCT03196973|69766675|FG000|Overall Study|Consent withdrawn|2|||
38071490|NCT03196973|69766676|FG001|Overall Study|Consent withdrawn|1|||
38071491|NCT03196973|69766677|FG002|Overall Study|Consent withdrawn|0|||
38071492|NCT03196973|69766675|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
38071493|NCT03196973|69766676|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
38071494|NCT03196973|69766677|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
38071495|NCT03196505|69766687|FG000|Overall Study|Physician Decision|26|||
38071496|NCT03196505|69766688|FG001|Overall Study|Physician Decision|26|||
38071497|NCT03196349|69766697|FG000|Overall Study|Did not receive study drug|0|||
38071498|NCT03196349|69766698|FG001|Overall Study|Did not receive study drug|1|||
38071499|NCT03196349|69766699|FG002|Overall Study|Did not receive study drug|2|||
38071500|NCT03196349|69766697|FG000|Overall Study|No data entered|2|||
38071501|NCT03196349|69766698|FG001|Overall Study|No data entered|4|||
38071502|NCT03196349|69766699|FG002|Overall Study|No data entered|0|||
37966055|NCT00486837|69652979|FG000|Overall Study|Withdrawal by Subject|1|||
37966056|NCT00486837|69652980|FG001|Overall Study|Withdrawal by Subject|0|||
37966057|NCT00486837|69652979|FG000|Overall Study|Adverse Event|1|||
37966058|NCT00486837|69652980|FG001|Overall Study|Adverse Event|1|||
37966059|NCT00486837|69652979|FG000|Overall Study|Protocol Violation|4|||
37966060|NCT00486837|69652980|FG001|Overall Study|Protocol Violation|2|||
37966061|NCT00486837|69652979|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
37966062|NCT00486837|69652980|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
37966063|NCT00486759|69652990|FG000|Treatment|Adverse event/intercurrent illness|86|||
37966064|NCT00486759|69652991|FG001|Treatment|Adverse event/intercurrent illness|39|||
37966065|NCT00486759|69652990|FG000|Treatment|Insufficient therapeutic response|37|||
37966066|NCT00486759|69652991|FG001|Treatment|Insufficient therapeutic response|39|||
37966067|NCT00486759|69652990|FG000|Treatment|Death|17|||
37966068|NCT00486759|69652991|FG001|Treatment|Death|10|||
37966069|NCT00486759|69652990|FG000|Treatment|Withdrew consent|15|||
37966070|NCT00486759|69652991|FG001|Treatment|Withdrew consent|12|||
37966071|NCT00486759|69652990|FG000|Treatment|Administrative/reason not specified|17|||
37966072|NCT00486759|69652991|FG001|Treatment|Administrative/reason not specified|21|||
37966073|NCT00486759|69652990|FG000|Treatment|Refused treatment|10|||
37966074|NCT00486759|69652991|FG001|Treatment|Refused treatment|7|||
37966075|NCT00486759|69652990|FG000|Treatment|Violation of selection criteria at entry|3|||
37966076|NCT00486759|69652991|FG001|Treatment|Violation of selection criteria at entry|3|||
37966077|NCT00486759|69652990|FG000|Treatment|Other protocol violation|1|||
37966078|NCT00486759|69652991|FG001|Treatment|Other protocol violation|5|||
37966079|NCT00486759|69652990|FG000|Treatment|Failure to return|1|||
37966080|NCT00486759|69652991|FG001|Treatment|Failure to return|1|||
37966081|NCT00486759|69652990|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
37966082|NCT00486759|69652991|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
37966083|NCT00486759|69652990|FG000|Safety Follow-up|Death|40|||
37966084|NCT00486759|69652991|FG001|Safety Follow-up|Death|29|||
37966085|NCT00486759|69652990|FG000|Safety Follow-up|Withdrew consent|32|||
37966086|NCT00486759|69652991|FG001|Safety Follow-up|Withdrew consent|23|||
37966087|NCT00486759|69652990|FG000|Safety Follow-up|Failure to return|9|||
37966088|NCT00486759|69652991|FG001|Safety Follow-up|Failure to return|6|||
37966089|NCT00486759|69652990|FG000|Safety Follow-up|Administrative/not specified|8|||
37966090|NCT00486759|69652991|FG001|Safety Follow-up|Administrative/not specified|6|||
37966091|NCT00486759|69652990|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
38071503|NCT03196349|69766697|FG000|Overall Study|Study Terminated early|15|||
38071504|NCT03196349|69766698|FG001|Overall Study|Study Terminated early|9|||
38071505|NCT03196349|69766699|FG002|Overall Study|Study Terminated early|11|||
38071506|NCT02886715|69766710|FG000|Overall Study|Non-Compliance With Study Drug|0|||
38071507|NCT02886715|69766711|FG001|Overall Study|Non-Compliance With Study Drug|2|||
38071508|NCT02886715|69766712|FG002|Overall Study|Non-Compliance With Study Drug|0|||
38071509|NCT02886715|69766710|FG000|Overall Study|Adverse Event|4|||
38071510|NCT02886715|69766711|FG001|Overall Study|Adverse Event|2|||
38071511|NCT02886715|69766712|FG002|Overall Study|Adverse Event|0|||
38071512|NCT02886715|69766710|FG000|Overall Study|Lack of Efficacy|0|||
38071513|NCT02886715|69766711|FG001|Overall Study|Lack of Efficacy|2|||
38071514|NCT02886715|69766712|FG002|Overall Study|Lack of Efficacy|1|||
38071515|NCT02886715|69766710|FG000|Overall Study|Lost to Follow-up|29|||
38071516|NCT02886715|69766711|FG001|Overall Study|Lost to Follow-up|26|||
38071517|NCT02886715|69766712|FG002|Overall Study|Lost to Follow-up|10|||
38071518|NCT02886715|69766710|FG000|Overall Study|Pregnancy|1|||
38071519|NCT02886715|69766711|FG001|Overall Study|Pregnancy|1|||
38071520|NCT02886715|69766712|FG002|Overall Study|Pregnancy|1|||
38071521|NCT02886715|69766710|FG000|Overall Study|Protocol Violation|3|||
38071522|NCT02886715|69766711|FG001|Overall Study|Protocol Violation|2|||
38071523|NCT02886715|69766712|FG002|Overall Study|Protocol Violation|1|||
38071524|NCT02886715|69766710|FG000|Overall Study|Withdrawal by Subject|20|||
38071525|NCT02886715|69766711|FG001|Overall Study|Withdrawal by Subject|18|||
38071526|NCT02886715|69766712|FG002|Overall Study|Withdrawal by Subject|5|||
38071527|NCT02886715|69766710|FG000|Overall Study|missing|7|||
38071528|NCT02886715|69766711|FG001|Overall Study|missing|2|||
37966092|NCT00486759|69652991|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
37966093|NCT00486759|69652990|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
38071529|NCT02886715|69766712|FG002|Overall Study|missing|2|||
38071530|NCT03085797|69766722|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
38071531|NCT03085797|69766723|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
38071532|NCT03085797|69766722|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
38071533|NCT03085797|69766723|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
38071534|NCT03085797|69766722|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
38071535|NCT03085797|69766723|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
38071536|NCT03157531|69766731|FG000|Overall Study|Death|2|||
37966094|NCT00486759|69652991|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
37966095|NCT00486603|69652999|FG000|Overall Study|Withdrawal by Subject|1|||
38071537|NCT03157531|69766731|FG000|Overall Study|Lost to Follow-up|4|||
38071538|NCT03159091|69766737|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
38071539|NCT03159091|69766738|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
38071540|NCT03159091|69766737|FG000|Overall Study|Patient has taken no dose of study drug|0|||
38071541|NCT03159091|69766738|FG001|Overall Study|Patient has taken no dose of study drug|1|||
38071542|NCT03196193|69766746|FG000|Overall Study|Adverse Event|1|||
38071543|NCT03196193|69766747|FG001|Overall Study|Adverse Event|0|||
38071544|NCT03196193|69766746|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
38071545|NCT03196193|69766747|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
38071546|NCT03621761|69766756|FG000|Overall Study|Lost to Follow-up|1|||
38071547|NCT03621761|69766757|FG001|Overall Study|Lost to Follow-up|1|||
38071548|NCT03621761|69766758|FG002|Overall Study|Lost to Follow-up|2|||
38071549|NCT03621761|69766756|FG000|Overall Study|Withdrawal by Subject|2|||
38071550|NCT03621761|69766757|FG001|Overall Study|Withdrawal by Subject|1|||
38071551|NCT03621761|69766758|FG002|Overall Study|Withdrawal by Subject|1|||
38071552|NCT03621761|69766756|FG000|Overall Study|Became Ineligible|0|||
38071553|NCT03621761|69766757|FG001|Overall Study|Became Ineligible|2|||
38071554|NCT03621761|69766758|FG002|Overall Study|Became Ineligible|0|||
38071555|NCT03221387|69766766|FG000|Overall Study|Lost to Follow-up|1|||
38071556|NCT03221387|69766766|FG000|Overall Study|Lung transplant|1|||
38071557|NCT03318861|69766775|FG000|Overall Study|Death|2|||
38071558|NCT03318861|69766776|FG001|Overall Study|Death|3|||
38071559|NCT03318861|69766777|FG002|Overall Study|Death|3|||
38071560|NCT03318861|69766778|FG003|Overall Study|Death|2|||
38071561|NCT03318861|69766779|FG004|Overall Study|Death|2|||
38071562|NCT03318861|69766775|FG000|Overall Study|Enrolled But Never Treated|0|||
38071563|NCT03318861|69766776|FG001|Overall Study|Enrolled But Never Treated|1|||
38071564|NCT03318861|69766777|FG002|Overall Study|Enrolled But Never Treated|0|||
38071565|NCT03318861|69766778|FG003|Overall Study|Enrolled But Never Treated|1|||
38071566|NCT03318861|69766779|FG004|Overall Study|Enrolled But Never Treated|1|||
38071567|NCT03318861|69766775|FG000|Overall Study|Informed Consent Withdraw|0|||
38071568|NCT03318861|69766776|FG001|Overall Study|Informed Consent Withdraw|0|||
38071569|NCT03318861|69766777|FG002|Overall Study|Informed Consent Withdraw|0|||
38071570|NCT03318861|69766778|FG003|Overall Study|Informed Consent Withdraw|1|||
38071571|NCT03318861|69766779|FG004|Overall Study|Informed Consent Withdraw|0|||
38071572|NCT03318861|69766775|FG000|Overall Study|Withdrawal of Consent From Further Follow-up|1|||
38071573|NCT03318861|69766776|FG001|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
38071574|NCT03318861|69766777|FG002|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
38071575|NCT03318861|69766778|FG003|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
38071576|NCT03318861|69766779|FG004|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
38071577|NCT03084315|69766794|FG000|Overall Study|Lost to Follow-up|8|||
38071578|NCT03084315|69766795|FG001|Overall Study|Lost to Follow-up|7|||
38071579|NCT03084315|69766794|FG000|Overall Study|Withdrawal by Subject|2|||
38071580|NCT03084315|69766795|FG001|Overall Study|Withdrawal by Subject|2|||
38071581|NCT03187301|69766801|FG000|Titration Period|Adverse Event|0|||
38071582|NCT03187301|69766802|FG001|Titration Period|Adverse Event|0|||
38071583|NCT03187301|69766803|FG002|Titration Period|Adverse Event|0|||
38071584|NCT03187301|69766804|FG003|Titration Period|Adverse Event|0|||
38071585|NCT03187301|69766805|FG004|Titration Period|Adverse Event|0|||
38071586|NCT03187301|69766806|FG005|Titration Period|Adverse Event|0|||
38071587|NCT03187301|69766807|FG006|Titration Period|Adverse Event|5|||
38071588|NCT03187301|69766801|FG000|Titration Period|Withdrawal by Subject|0|||
38071589|NCT03187301|69766802|FG001|Titration Period|Withdrawal by Subject|0|||
38071590|NCT03187301|69766803|FG002|Titration Period|Withdrawal by Subject|0|||
38071591|NCT03187301|69766804|FG003|Titration Period|Withdrawal by Subject|0|||
38071592|NCT03187301|69766805|FG004|Titration Period|Withdrawal by Subject|0|||
38071593|NCT03187301|69766806|FG005|Titration Period|Withdrawal by Subject|0|||
38071594|NCT03187301|69766807|FG006|Titration Period|Withdrawal by Subject|1|||
38071595|NCT03187301|69766801|FG000|Titration Period|Exclusion Criteria Met|0|||
38071596|NCT03187301|69766802|FG001|Titration Period|Exclusion Criteria Met|0|||
38071597|NCT03187301|69766803|FG002|Titration Period|Exclusion Criteria Met|0|||
38071598|NCT03187301|69766804|FG003|Titration Period|Exclusion Criteria Met|0|||
38071599|NCT03187301|69766805|FG004|Titration Period|Exclusion Criteria Met|0|||
38071600|NCT03187301|69766806|FG005|Titration Period|Exclusion Criteria Met|0|||
38071601|NCT03187301|69766807|FG006|Titration Period|Exclusion Criteria Met|1|||
38071602|NCT03187301|69766801|FG000|Pre-Intervention|Withdrawal by Subject|1|||
38071603|NCT03187301|69766802|FG001|Pre-Intervention|Withdrawal by Subject|0|||
38071604|NCT03187301|69766803|FG002|Pre-Intervention|Withdrawal by Subject|0|||
38071605|NCT03187301|69766804|FG003|Pre-Intervention|Withdrawal by Subject|0|||
38071606|NCT03187301|69766805|FG004|Pre-Intervention|Withdrawal by Subject|0|||
38071607|NCT03187301|69766806|FG005|Pre-Intervention|Withdrawal by Subject|0|||
38071608|NCT03187301|69766807|FG006|Pre-Intervention|Withdrawal by Subject|0|||
38071609|NCT02946047|69766832|FG000|Overall Study|Adverse Event|1|||
38071610|NCT02946047|69766833|FG001|Overall Study|Adverse Event|0|||
38071611|NCT02946047|69766834|FG002|Overall Study|Adverse Event|0|||
38071612|NCT02946047|69766835|FG003|Overall Study|Adverse Event|0|||
38071613|NCT03077919|69766847|FG000|Overall Study|Lost to Follow-up|4|||
38071614|NCT03077919|69766848|FG001|Overall Study|Lost to Follow-up|1|||
38071615|NCT03220217|69766857|FG000|Overall Study|Withdrawal by Subject|0|||
38071616|NCT03220217|69766858|FG001|Overall Study|Withdrawal by Subject|1|||
38071617|NCT03220217|69766859|FG002|Overall Study|Withdrawal by Subject|0|||
38071618|NCT03220217|69766857|FG000|Overall Study|Subject Missed Procedure|0|||
38071619|NCT03220217|69766858|FG001|Overall Study|Subject Missed Procedure|0|||
38071620|NCT03220217|69766859|FG002|Overall Study|Subject Missed Procedure|1|||
38071621|NCT03192137|69766890|FG000|Overall Study|Adverse Event|10|||
38071622|NCT03192137|69766891|FG001|Overall Study|Adverse Event|11|||
38071623|NCT03192137|69766890|FG000|Overall Study|Physician Decision|1|||
38071624|NCT03192137|69766891|FG001|Overall Study|Physician Decision|0|||
38071625|NCT03192137|69766890|FG000|Overall Study|Lack of Efficacy|20|||
38071626|NCT03192137|69766891|FG001|Overall Study|Lack of Efficacy|37|||
38071627|NCT03192137|69766890|FG000|Overall Study|Withdrawal by Subject|3|||
38071628|NCT03192137|69766891|FG001|Overall Study|Withdrawal by Subject|3|||
38071629|NCT03192137|69766890|FG000|Overall Study|Protocol Violation|4|||
38071630|NCT03192137|69766891|FG001|Overall Study|Protocol Violation|3|||
38071631|NCT03192137|69766890|FG000|Overall Study|Surgery Cancelled|4|||
38071632|NCT03192137|69766891|FG001|Overall Study|Surgery Cancelled|1|||
38071633|NCT03192137|69766890|FG000|Overall Study|Other - Various Administrative Reasons|8|||
38071634|NCT03192137|69766891|FG001|Overall Study|Other - Various Administrative Reasons|3|||
38071635|NCT03881059|69766911|FG000|Treatment Period - Part A|Adverse Event|1|||
38071636|NCT03881059|69766912|FG001|Treatment Period - Part A|Adverse Event|3|||
38071637|NCT03881059|69766913|FG002|Treatment Period - Part A|Adverse Event|4|||
38071638|NCT03881059|69766911|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
38071639|NCT03881059|69766912|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
38071640|NCT03881059|69766913|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
38071641|NCT03881059|69766911|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
38071642|NCT03881059|69766912|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
38071643|NCT03881059|69766913|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
38071644|NCT03881059|69766911|FG000|Treatment Period - Part A|Other reasons|2|||
38071645|NCT03881059|69766912|FG001|Treatment Period - Part A|Other reasons|1|||
38071646|NCT03881059|69766913|FG002|Treatment Period - Part A|Other reasons|0|||
38071647|NCT03881059|69766911|FG000|Treatment Period - Part B|Adverse Event|0|||
38071648|NCT03881059|69766912|FG001|Treatment Period - Part B|Adverse Event|0|||
38071649|NCT03881059|69766913|FG002|Treatment Period - Part B|Adverse Event|3|||
38071650|NCT03881059|69766911|FG000|Treatment Period - Part B|Death|0|||
38071651|NCT03881059|69766912|FG001|Treatment Period - Part B|Death|1|||
38071652|NCT03881059|69766913|FG002|Treatment Period - Part B|Death|1|||
38071653|NCT03881059|69766911|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
38071654|NCT03881059|69766912|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
38071655|NCT03881059|69766913|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
38071656|NCT03881059|69766911|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
38071657|NCT03881059|69766912|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
38071658|NCT03881059|69766913|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
38071659|NCT03881059|69766911|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
38071660|NCT03881059|69766912|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
38071661|NCT03881059|69766913|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
38071662|NCT03881059|69766911|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
38071663|NCT03881059|69766912|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
38071664|NCT03881059|69766913|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
38071665|NCT03881059|69766911|FG000|Treatment Period - Part B|Other reasons|4|||
38071666|NCT03881059|69766912|FG001|Treatment Period - Part B|Other reasons|3|||
38071667|NCT03881059|69766913|FG002|Treatment Period - Part B|Other reasons|3|||
38071668|NCT02861534|69766928|FG000|Overall Study|Death|541|||
38071669|NCT02861534|69766929|FG001|Overall Study|Death|552|||
38071670|NCT02861534|69766928|FG000|Overall Study|Lost to Follow-up|14|||
38071671|NCT02861534|69766929|FG001|Overall Study|Lost to Follow-up|14|||
38071672|NCT02861534|69766928|FG000|Overall Study|Site Terminated by Sponsor|4|||
38071673|NCT02861534|69766929|FG001|Overall Study|Site Terminated by Sponsor|3|||
38071674|NCT02861534|69766928|FG000|Overall Study|Withdrawal by Subject|15|||
38071675|NCT02861534|69766929|FG001|Overall Study|Withdrawal by Subject|18|||
38071676|NCT03083847|69766970|FG000|Main|Physician Decision|0|||
38071677|NCT03083847|69766971|FG001|Main|Physician Decision|0|||
38071678|NCT03083847|69766972|FG002|Main|Physician Decision|0|||
38071679|NCT03083847|69766973|FG003|Main|Physician Decision|0|||
38071680|NCT03083847|69766974|FG004|Main|Physician Decision|0|||
38071681|NCT03083847|69766975|FG005|Main|Physician Decision|1|||
38071682|NCT03083847|69766976|FG006|Main|Physician Decision|0|||
38071683|NCT03083847|69766977|FG007|Main|Physician Decision|0|||
38071684|NCT03083847|69766978|FG008|Main|Physician Decision|0|||
38071685|NCT03083847|69766979|FG009|Main|Physician Decision|0|||
38071686|NCT03083847|69766970|FG000|Main|Pregnancy|0|||
38071687|NCT03083847|69766971|FG001|Main|Pregnancy|0|||
38071688|NCT03083847|69766972|FG002|Main|Pregnancy|0|||
38071689|NCT03083847|69766973|FG003|Main|Pregnancy|0|||
38071690|NCT03083847|69766974|FG004|Main|Pregnancy|0|||
38071691|NCT03083847|69766975|FG005|Main|Pregnancy|0|||
38071692|NCT03083847|69766976|FG006|Main|Pregnancy|0|||
38071693|NCT03083847|69766977|FG007|Main|Pregnancy|1|||
38071694|NCT03083847|69766978|FG008|Main|Pregnancy|0|||
38071695|NCT03083847|69766979|FG009|Main|Pregnancy|0|||
38071696|NCT03083847|69766970|FG000|Main|Adverse Event|0|||
38071697|NCT03083847|69766971|FG001|Main|Adverse Event|0|||
38071698|NCT03083847|69766972|FG002|Main|Adverse Event|0|||
38071699|NCT03083847|69766973|FG003|Main|Adverse Event|0|||
38071700|NCT03083847|69766974|FG004|Main|Adverse Event|0|||
38071701|NCT03083847|69766975|FG005|Main|Adverse Event|0|||
38071702|NCT03083847|69766976|FG006|Main|Adverse Event|0|||
38071703|NCT03083847|69766977|FG007|Main|Adverse Event|2|||
38071704|NCT03083847|69766978|FG008|Main|Adverse Event|0|||
38071705|NCT03083847|69766979|FG009|Main|Adverse Event|0|||
38071706|NCT03083847|69766970|FG000|Main|Withdrawal by Subject|0|||
38071707|NCT03083847|69766971|FG001|Main|Withdrawal by Subject|0|||
38071708|NCT03083847|69766972|FG002|Main|Withdrawal by Subject|0|||
38071709|NCT03083847|69766973|FG003|Main|Withdrawal by Subject|0|||
38071710|NCT03083847|69766974|FG004|Main|Withdrawal by Subject|0|||
38071711|NCT03083847|69766975|FG005|Main|Withdrawal by Subject|0|||
38071712|NCT03083847|69766976|FG006|Main|Withdrawal by Subject|1|||
38071713|NCT03083847|69766977|FG007|Main|Withdrawal by Subject|1|||
38071714|NCT03083847|69766978|FG008|Main|Withdrawal by Subject|0|||
38071715|NCT03083847|69766979|FG009|Main|Withdrawal by Subject|0|||
38071716|NCT03082677|69767007|FG000|Overall Study|Not Treated|2|||
38071717|NCT02858180|69767022|FG000|Overall Study|Lost to Follow-up|0|||
38071718|NCT02858180|69767023|FG001|Overall Study|Lost to Follow-up|2|||
38071719|NCT03082599|69767031|FG000|Overall Study|Lost to Follow-up|1|||
38071720|NCT03082599|69767032|FG001|Overall Study|Lost to Follow-up|0|||
38071721|NCT01346501|69767040|FG000|Overall Study|Initiated Other Biological Agents|3|||
38071722|NCT01346501|69767041|FG001|Overall Study|Initiated Other Biological Agents|1|||
38071723|NCT01346501|69767040|FG000|Overall Study|Other|8|||
38071724|NCT01346501|69767041|FG001|Overall Study|Other|12|||
38071725|NCT03160885|69767051|FG000|Initial Treatment Period|Not dosed|2|||
38071726|NCT03160885|69767052|FG001|Initial Treatment Period|Not dosed|0|||
38071727|NCT03160885|69767053|FG002|Initial Treatment Period|Not dosed|0|||
38071728|NCT03160885|69767054|FG003|Initial Treatment Period|Not dosed|0|||
38071729|NCT03160885|69767055|FG004|Initial Treatment Period|Not dosed|0|||
38071730|NCT03160885|69767056|FG005|Initial Treatment Period|Not dosed|0|||
38071731|NCT03160885|69767057|FG006|Initial Treatment Period|Not dosed|0|||
38071732|NCT03160885|69767051|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
38071733|NCT03160885|69767052|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
38071734|NCT03160885|69767053|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
38071735|NCT03160885|69767054|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
38071736|NCT03160885|69767055|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
38071737|NCT03160885|69767056|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
38071738|NCT03160885|69767057|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
38071739|NCT03160885|69767051|FG000|Open-label Treatment|Not dosed|0|||
38071740|NCT03160885|69767052|FG001|Open-label Treatment|Not dosed|0|||
38071741|NCT03160885|69767053|FG002|Open-label Treatment|Not dosed|0|||
38071742|NCT03160885|69767054|FG003|Open-label Treatment|Not dosed|0|||
38071743|NCT03160885|69767055|FG004|Open-label Treatment|Not dosed|0|||
38071744|NCT03160885|69767056|FG005|Open-label Treatment|Not dosed|0|||
38071745|NCT03160885|69767057|FG006|Open-label Treatment|Not dosed|2|||
38071746|NCT03160885|69767051|FG000|Open-label Treatment|Discontinued IMP|0|||
38071747|NCT03160885|69767052|FG001|Open-label Treatment|Discontinued IMP|0|||
38071748|NCT03160885|69767053|FG002|Open-label Treatment|Discontinued IMP|0|||
38071749|NCT03160885|69767054|FG003|Open-label Treatment|Discontinued IMP|0|||
38071750|NCT03160885|69767055|FG004|Open-label Treatment|Discontinued IMP|0|||
38071751|NCT03160885|69767056|FG005|Open-label Treatment|Discontinued IMP|0|||
38071752|NCT03160885|69767057|FG006|Open-label Treatment|Discontinued IMP|131|||
38071753|NCT03160885|69767051|FG000|Open-label Treatment|Completed Week 50|0|||
38071754|NCT03160885|69767052|FG001|Open-label Treatment|Completed Week 50|0|||
38071755|NCT03160885|69767053|FG002|Open-label Treatment|Completed Week 50|0|||
38071756|NCT03160885|69767054|FG003|Open-label Treatment|Completed Week 50|0|||
38071757|NCT03160885|69767055|FG004|Open-label Treatment|Completed Week 50|0|||
38071758|NCT03160885|69767056|FG005|Open-label Treatment|Completed Week 50|0|||
38071759|NCT03160885|69767057|FG006|Open-label Treatment|Completed Week 50|4|||
38071760|NCT03160885|69767051|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
38071761|NCT03160885|69767052|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
38071762|NCT03160885|69767053|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
38071763|NCT03160885|69767054|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
38071764|NCT03160885|69767055|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
38071765|NCT03160885|69767056|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
38071766|NCT03160885|69767057|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
38071767|NCT03160885|69767051|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
38071768|NCT03160885|69767052|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
38071769|NCT03160885|69767053|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
38071770|NCT03160885|69767054|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
38071771|NCT03160885|69767055|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
38071772|NCT03160885|69767056|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
38071773|NCT03160885|69767057|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
38071774|NCT03160885|69767051|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
38071775|NCT03160885|69767052|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
38071776|NCT03160885|69767053|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
38071777|NCT03160885|69767054|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
38071778|NCT03160885|69767055|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
38071779|NCT03160885|69767056|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
38071780|NCT03160885|69767057|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
38071781|NCT03160885|69767051|FG000|Maintenance Treatment Period|Completed Week 50|0|||
38071782|NCT03160885|69767052|FG001|Maintenance Treatment Period|Completed Week 50|0|||
38071783|NCT03160885|69767053|FG002|Maintenance Treatment Period|Completed Week 50|1|||
38071784|NCT03160885|69767054|FG003|Maintenance Treatment Period|Completed Week 50|0|||
38071785|NCT03160885|69767055|FG004|Maintenance Treatment Period|Completed Week 50|0|||
38071786|NCT03160885|69767056|FG005|Maintenance Treatment Period|Completed Week 50|0|||
38071787|NCT03160885|69767057|FG006|Maintenance Treatment Period|Completed Week 50|0|||
38071788|NCT03181451|69767077|FG000|Overall Study|Adverse Event|0|||
38071789|NCT03181451|69767078|FG001|Overall Study|Adverse Event|1|||
38071790|NCT03181451|69767079|FG002|Overall Study|Adverse Event|0|||
38071791|NCT03181451|69767077|FG000|Overall Study|Withdrawal by Subject|0|||
38071792|NCT03181451|69767078|FG001|Overall Study|Withdrawal by Subject|1|||
38071793|NCT03181451|69767079|FG002|Overall Study|Withdrawal by Subject|0|||
38071794|NCT00406783|69767091|FG000|Overall Study|Adverse Event|4|||
38071795|NCT00406783|69767092|FG001|Overall Study|Adverse Event|4|||
38071796|NCT00406783|69767091|FG000|Overall Study|Treatment Failure|2|||
38071797|NCT00406783|69767092|FG001|Overall Study|Treatment Failure|3|||
38071798|NCT00406783|69767091|FG000|Overall Study|Lost to Follow-up|3|||
38071799|NCT00406783|69767092|FG001|Overall Study|Lost to Follow-up|0|||
38071800|NCT00406783|69767091|FG000|Overall Study|Withdrawal by Subject|1|||
38071801|NCT00406783|69767092|FG001|Overall Study|Withdrawal by Subject|4|||
38071802|NCT00406783|69767091|FG000|Overall Study|Protocol Violation|4|||
38071803|NCT00406783|69767092|FG001|Overall Study|Protocol Violation|4|||
38071804|NCT03179891|69767098|FG000|First Intervention|Withdrawal by Subject|1|||
38071805|NCT03179891|69767099|FG001|First Intervention|Withdrawal by Subject|1|||
38071806|NCT03179891|69767098|FG000|First Intervention|Unspecified reason|1|||
38071807|NCT03179891|69767099|FG001|First Intervention|Unspecified reason|0|||
38071808|NCT03179891|69767098|FG000|First Intervention|Protocol Violation|0|||
38071809|NCT03179891|69767099|FG001|First Intervention|Protocol Violation|1|||
38071810|NCT02973815|69767110|FG000|Post Intervention|Death|1|||
38071811|NCT02973815|69767111|FG001|Post Intervention|Death|0|||
38071812|NCT02973815|69767110|FG000|Post Intervention|Lost to Follow-up|7|||
38071813|NCT02973815|69767111|FG001|Post Intervention|Lost to Follow-up|24|||
38071814|NCT02973815|69767110|FG000|Follow-up|Lost to Follow-up|2|||
38071815|NCT02973815|69767111|FG001|Follow-up|Lost to Follow-up|0|||
38071816|NCT03160573|69767121|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
38071817|NCT03160573|69767122|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
38071818|NCT03160573|69767123|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
38071819|NCT03160573|69767124|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
38071820|NCT02736227|69767137|FG000|Overall Study|Withdrawal by Subject|0|||
38071821|NCT02736227|69767138|FG001|Overall Study|Withdrawal by Subject|0|||
38071822|NCT02736227|69767139|FG002|Overall Study|Withdrawal by Subject|1|||
38071823|NCT02736227|69767137|FG000|Overall Study|Physician Decision|0|||
38071824|NCT02736227|69767138|FG001|Overall Study|Physician Decision|0|||
38071825|NCT02736227|69767139|FG002|Overall Study|Physician Decision|5|||
38071826|NCT02736227|69767137|FG000|Overall Study|Non Compliant|0|||
38071827|NCT02736227|69767138|FG001|Overall Study|Non Compliant|0|||
38071828|NCT02736227|69767139|FG002|Overall Study|Non Compliant|2|||
38071829|NCT03176459|69767148|FG000|Overall Study|Lost to Follow-up|5|||
38071830|NCT03176459|69767149|FG001|Overall Study|Lost to Follow-up|7|||
38071831|NCT03155269|69767157|FG000|Overall Study|Withdrawal by Subject|4|||
38071832|NCT03155269|69767158|FG001|Overall Study|Withdrawal by Subject|5|||
38071833|NCT03155269|69767157|FG000|Overall Study|Lost to Follow-up|1|||
38071834|NCT03155269|69767158|FG001|Overall Study|Lost to Follow-up|2|||
38071835|NCT02906670|69767174|FG000|Cohort 1, QW|Radiological Progression|1|||
38071836|NCT02906670|69767175|FG001|Cohort 1, QW|Radiological Progression|0|||
38071837|NCT02906670|69767176|FG002|Cohort 1, QW|Radiological Progression|0|||
38071838|NCT02906670|69767177|FG003|Cohort 1, QW|Radiological Progression|0|||
38071839|NCT02906670|69767178|FG004|Cohort 1, QW|Radiological Progression|0|||
38071840|NCT02906670|69767179|FG005|Cohort 1, QW|Radiological Progression|0|||
38071841|NCT02906670|69767180|FG006|Cohort 1, QW|Radiological Progression|0|||
38071842|NCT02906670|69767181|FG007|Cohort 1, QW|Radiological Progression|0|||
38071843|NCT02906670|69767182|FG008|Cohort 1, QW|Radiological Progression|0|||
38071844|NCT02906670|69767183|FG009|Cohort 1, QW|Radiological Progression|0|||
38071845|NCT02906670|69767174|FG000|Cohort 2, QW|Radiological Progression|0|||
38071846|NCT02906670|69767175|FG001|Cohort 2, QW|Radiological Progression|1|||
38071847|NCT02906670|69767176|FG002|Cohort 2, QW|Radiological Progression|0|||
38071848|NCT02906670|69767177|FG003|Cohort 2, QW|Radiological Progression|0|||
38071849|NCT02906670|69767178|FG004|Cohort 2, QW|Radiological Progression|0|||
38071850|NCT02906670|69767179|FG005|Cohort 2, QW|Radiological Progression|0|||
38071851|NCT02906670|69767180|FG006|Cohort 2, QW|Radiological Progression|0|||
38071852|NCT02906670|69767181|FG007|Cohort 2, QW|Radiological Progression|0|||
38071853|NCT02906670|69767182|FG008|Cohort 2, QW|Radiological Progression|0|||
38071854|NCT02906670|69767183|FG009|Cohort 2, QW|Radiological Progression|0|||
38071855|NCT02906670|69767174|FG000|Cohort 3, QW|Radiological Progression|0|||
38071856|NCT02906670|69767175|FG001|Cohort 3, QW|Radiological Progression|0|||
38071857|NCT02906670|69767176|FG002|Cohort 3, QW|Radiological Progression|2|||
38071858|NCT02906670|69767177|FG003|Cohort 3, QW|Radiological Progression|0|||
38071859|NCT02906670|69767178|FG004|Cohort 3, QW|Radiological Progression|0|||
38071860|NCT02906670|69767179|FG005|Cohort 3, QW|Radiological Progression|0|||
38071861|NCT02906670|69767180|FG006|Cohort 3, QW|Radiological Progression|0|||
38071862|NCT02906670|69767181|FG007|Cohort 3, QW|Radiological Progression|0|||
38071863|NCT02906670|69767182|FG008|Cohort 3, QW|Radiological Progression|0|||
38071864|NCT02906670|69767183|FG009|Cohort 3, QW|Radiological Progression|0|||
38071865|NCT02906670|69767174|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
38071866|NCT02906670|69767175|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
38071867|NCT02906670|69767176|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
38071868|NCT02906670|69767177|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
38071869|NCT02906670|69767178|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
38071870|NCT02906670|69767179|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
38071871|NCT02906670|69767180|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
38071872|NCT02906670|69767181|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
38071873|NCT02906670|69767182|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
38071874|NCT02906670|69767183|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
38071875|NCT02906670|69767174|FG000|Cohort 4, Q2W|Radiological Progression|0|||
38071876|NCT02906670|69767175|FG001|Cohort 4, Q2W|Radiological Progression|0|||
38071877|NCT02906670|69767176|FG002|Cohort 4, Q2W|Radiological Progression|0|||
38071878|NCT02906670|69767177|FG003|Cohort 4, Q2W|Radiological Progression|0|||
38071879|NCT02906670|69767178|FG004|Cohort 4, Q2W|Radiological Progression|0|||
38071880|NCT02906670|69767179|FG005|Cohort 4, Q2W|Radiological Progression|1|||
38071881|NCT02906670|69767180|FG006|Cohort 4, Q2W|Radiological Progression|0|||
38071882|NCT02906670|69767181|FG007|Cohort 4, Q2W|Radiological Progression|0|||
38071883|NCT02906670|69767182|FG008|Cohort 4, Q2W|Radiological Progression|0|||
38071884|NCT02906670|69767183|FG009|Cohort 4, Q2W|Radiological Progression|0|||
38071885|NCT02906670|69767174|FG000|Cohort 4, Q2W|Clinical Progression|0|||
38071886|NCT02906670|69767175|FG001|Cohort 4, Q2W|Clinical Progression|0|||
38071887|NCT02906670|69767176|FG002|Cohort 4, Q2W|Clinical Progression|0|||
38071888|NCT02906670|69767177|FG003|Cohort 4, Q2W|Clinical Progression|0|||
38071889|NCT02906670|69767178|FG004|Cohort 4, Q2W|Clinical Progression|0|||
38071890|NCT02906670|69767179|FG005|Cohort 4, Q2W|Clinical Progression|2|||
38071891|NCT02906670|69767180|FG006|Cohort 4, Q2W|Clinical Progression|0|||
38071892|NCT02906670|69767181|FG007|Cohort 4, Q2W|Clinical Progression|0|||
38071893|NCT02906670|69767182|FG008|Cohort 4, Q2W|Clinical Progression|0|||
38071894|NCT02906670|69767183|FG009|Cohort 4, Q2W|Clinical Progression|0|||
38071895|NCT02906670|69767174|FG000|Cohort 5, Q2W|Radiological Progression|0|||
38071896|NCT02906670|69767175|FG001|Cohort 5, Q2W|Radiological Progression|0|||
38071897|NCT02906670|69767176|FG002|Cohort 5, Q2W|Radiological Progression|0|||
38071898|NCT02906670|69767177|FG003|Cohort 5, Q2W|Radiological Progression|0|||
38071899|NCT02906670|69767178|FG004|Cohort 5, Q2W|Radiological Progression|0|||
38071900|NCT02906670|69767179|FG005|Cohort 5, Q2W|Radiological Progression|0|||
38071901|NCT02906670|69767180|FG006|Cohort 5, Q2W|Radiological Progression|4|||
38071902|NCT02906670|69767181|FG007|Cohort 5, Q2W|Radiological Progression|0|||
38071903|NCT02906670|69767182|FG008|Cohort 5, Q2W|Radiological Progression|0|||
38071904|NCT02906670|69767183|FG009|Cohort 5, Q2W|Radiological Progression|0|||
38071905|NCT02906670|69767174|FG000|Cohort 5, Q2W|Clinical Progression|0|||
38071906|NCT02906670|69767175|FG001|Cohort 5, Q2W|Clinical Progression|0|||
38071907|NCT02906670|69767176|FG002|Cohort 5, Q2W|Clinical Progression|0|||
38071908|NCT02906670|69767177|FG003|Cohort 5, Q2W|Clinical Progression|0|||
38071909|NCT02906670|69767178|FG004|Cohort 5, Q2W|Clinical Progression|0|||
38071910|NCT02906670|69767179|FG005|Cohort 5, Q2W|Clinical Progression|0|||
38071911|NCT02906670|69767180|FG006|Cohort 5, Q2W|Clinical Progression|1|||
38071912|NCT02906670|69767181|FG007|Cohort 5, Q2W|Clinical Progression|0|||
38071913|NCT02906670|69767182|FG008|Cohort 5, Q2W|Clinical Progression|0|||
38071914|NCT02906670|69767183|FG009|Cohort 5, Q2W|Clinical Progression|0|||
38071915|NCT02906670|69767174|FG000|Cohort 5, Q2W|Adverse Event|0|||
38071916|NCT02906670|69767175|FG001|Cohort 5, Q2W|Adverse Event|0|||
38071917|NCT02906670|69767176|FG002|Cohort 5, Q2W|Adverse Event|0|||
38071918|NCT02906670|69767177|FG003|Cohort 5, Q2W|Adverse Event|0|||
38071919|NCT02906670|69767178|FG004|Cohort 5, Q2W|Adverse Event|0|||
38071920|NCT02906670|69767179|FG005|Cohort 5, Q2W|Adverse Event|0|||
38071921|NCT02906670|69767180|FG006|Cohort 5, Q2W|Adverse Event|1|||
38071922|NCT02906670|69767181|FG007|Cohort 5, Q2W|Adverse Event|0|||
38071923|NCT02906670|69767182|FG008|Cohort 5, Q2W|Adverse Event|0|||
38071924|NCT02906670|69767183|FG009|Cohort 5, Q2W|Adverse Event|0|||
38071925|NCT02906670|69767174|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
38071926|NCT02906670|69767175|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
38071927|NCT02906670|69767176|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
38071928|NCT02906670|69767177|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
38071929|NCT02906670|69767178|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
38071930|NCT02906670|69767179|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
38071931|NCT02906670|69767180|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
38071932|NCT02906670|69767181|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
38071933|NCT02906670|69767182|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
38071934|NCT02906670|69767183|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
38071935|NCT02906670|69767174|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
38071936|NCT02906670|69767175|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
38071937|NCT02906670|69767176|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
38071938|NCT02906670|69767177|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
38071939|NCT02906670|69767178|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
38071940|NCT02906670|69767179|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
38071941|NCT02906670|69767180|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
38071942|NCT02906670|69767181|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
38071943|NCT02906670|69767182|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
38071944|NCT02906670|69767183|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
38071945|NCT02906670|69767174|FG000|Cohort 5P, Q2W|Adverse Event|0|||
38071946|NCT02906670|69767175|FG001|Cohort 5P, Q2W|Adverse Event|0|||
38071947|NCT02906670|69767176|FG002|Cohort 5P, Q2W|Adverse Event|0|||
38071948|NCT02906670|69767177|FG003|Cohort 5P, Q2W|Adverse Event|0|||
38071949|NCT02906670|69767178|FG004|Cohort 5P, Q2W|Adverse Event|0|||
38071950|NCT02906670|69767179|FG005|Cohort 5P, Q2W|Adverse Event|0|||
38071951|NCT02906670|69767180|FG006|Cohort 5P, Q2W|Adverse Event|0|||
38071952|NCT02906670|69767181|FG007|Cohort 5P, Q2W|Adverse Event|1|||
38071953|NCT02906670|69767182|FG008|Cohort 5P, Q2W|Adverse Event|0|||
38071954|NCT02906670|69767183|FG009|Cohort 5P, Q2W|Adverse Event|0|||
38071955|NCT02906670|69767174|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
38071956|NCT02906670|69767175|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
38071957|NCT02906670|69767176|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
38071958|NCT02906670|69767177|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
38071959|NCT02906670|69767178|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
38071960|NCT02906670|69767179|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
38071961|NCT02906670|69767180|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
38071962|NCT02906670|69767181|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
38071963|NCT02906670|69767182|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
38071964|NCT02906670|69767183|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
38071965|NCT02906670|69767174|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
38071966|NCT02906670|69767175|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
38071967|NCT02906670|69767176|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
38071968|NCT02906670|69767177|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
38071969|NCT02906670|69767178|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
38071970|NCT02906670|69767179|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
38071971|NCT02906670|69767180|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
37862342|NCT01130103|69546086|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
38071972|NCT02906670|69767181|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
38071973|NCT02906670|69767182|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
38071974|NCT02906670|69767183|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
38071975|NCT02906670|69767174|FG000|Cohort 4P, QW|Radiological Progression|0|||
37862343|NCT01129557|69546095|FG000|Overall Study|Adverse Event|1|||
38071976|NCT02906670|69767175|FG001|Cohort 4P, QW|Radiological Progression|0|||
38071977|NCT02906670|69767176|FG002|Cohort 4P, QW|Radiological Progression|0|||
38071978|NCT02906670|69767177|FG003|Cohort 4P, QW|Radiological Progression|3|||
38071979|NCT02906670|69767178|FG004|Cohort 4P, QW|Radiological Progression|0|||
38071980|NCT02906670|69767179|FG005|Cohort 4P, QW|Radiological Progression|0|||
38071981|NCT02906670|69767180|FG006|Cohort 4P, QW|Radiological Progression|0|||
38071982|NCT02906670|69767181|FG007|Cohort 4P, QW|Radiological Progression|0|||
38071983|NCT02906670|69767182|FG008|Cohort 4P, QW|Radiological Progression|0|||
38071984|NCT02906670|69767183|FG009|Cohort 4P, QW|Radiological Progression|0|||
38071985|NCT02906670|69767174|FG000|Cohort 7P, Q2W|Adverse Event|0|||
38071986|NCT02906670|69767175|FG001|Cohort 7P, Q2W|Adverse Event|0|||
38071987|NCT02906670|69767176|FG002|Cohort 7P, Q2W|Adverse Event|0|||
38071988|NCT02906670|69767177|FG003|Cohort 7P, Q2W|Adverse Event|0|||
38071989|NCT02906670|69767178|FG004|Cohort 7P, Q2W|Adverse Event|0|||
38071990|NCT02906670|69767179|FG005|Cohort 7P, Q2W|Adverse Event|0|||
38071991|NCT02906670|69767180|FG006|Cohort 7P, Q2W|Adverse Event|0|||
38071992|NCT02906670|69767181|FG007|Cohort 7P, Q2W|Adverse Event|0|||
38071993|NCT02906670|69767182|FG008|Cohort 7P, Q2W|Adverse Event|0|||
38071994|NCT02906670|69767183|FG009|Cohort 7P, Q2W|Adverse Event|1|||
38071995|NCT02906670|69767174|FG000|Cohort 7P, Q2W|Physician Decision|0|||
38071996|NCT02906670|69767175|FG001|Cohort 7P, Q2W|Physician Decision|0|||
38071997|NCT02906670|69767176|FG002|Cohort 7P, Q2W|Physician Decision|0|||
38071998|NCT02906670|69767177|FG003|Cohort 7P, Q2W|Physician Decision|0|||
38071999|NCT02906670|69767178|FG004|Cohort 7P, Q2W|Physician Decision|0|||
38072000|NCT02906670|69767179|FG005|Cohort 7P, Q2W|Physician Decision|0|||
38072001|NCT02906670|69767180|FG006|Cohort 7P, Q2W|Physician Decision|0|||
38072002|NCT02906670|69767181|FG007|Cohort 7P, Q2W|Physician Decision|0|||
38072003|NCT02906670|69767182|FG008|Cohort 7P, Q2W|Physician Decision|0|||
38072004|NCT02906670|69767183|FG009|Cohort 7P, Q2W|Physician Decision|1|||
38072005|NCT02906670|69767174|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
38072006|NCT02906670|69767175|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
38072007|NCT02906670|69767176|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
38072008|NCT02906670|69767177|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
38072009|NCT02906670|69767178|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
38072010|NCT02906670|69767179|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
38072011|NCT02906670|69767180|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
38072012|NCT02906670|69767181|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
38072013|NCT02906670|69767182|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
38072014|NCT02906670|69767183|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
38072015|NCT02906670|69767174|FG000|Cohort 5P, QW|Radiological Progression|0|||
38072016|NCT02906670|69767175|FG001|Cohort 5P, QW|Radiological Progression|0|||
38072017|NCT02906670|69767176|FG002|Cohort 5P, QW|Radiological Progression|0|||
38072018|NCT02906670|69767177|FG003|Cohort 5P, QW|Radiological Progression|0|||
38072019|NCT02906670|69767178|FG004|Cohort 5P, QW|Radiological Progression|3|||
38072020|NCT02906670|69767179|FG005|Cohort 5P, QW|Radiological Progression|0|||
38072021|NCT02906670|69767180|FG006|Cohort 5P, QW|Radiological Progression|0|||
38072022|NCT02906670|69767181|FG007|Cohort 5P, QW|Radiological Progression|0|||
38072023|NCT02906670|69767182|FG008|Cohort 5P, QW|Radiological Progression|0|||
38072024|NCT02906670|69767183|FG009|Cohort 5P, QW|Radiological Progression|0|||
38072025|NCT02906358|69767235|FG000|Overall Study|Withdrawal by Subject|10|||
38072026|NCT02906358|69767236|FG001|Overall Study|Withdrawal by Subject|7|||
38072027|NCT02906358|69767235|FG000|Overall Study|Lost to Follow-up|12|||
38072028|NCT02906358|69767236|FG001|Overall Study|Lost to Follow-up|15|||
38072029|NCT02186834|69767242|FG000|Dose Escalation|Death|0|||
38072030|NCT02186834|69767243|FG001|Dose Escalation|Death|0|||
38072031|NCT02186834|69767244|FG002|Dose Escalation|Death|0|||
38072032|NCT02186834|69767245|FG003|Dose Escalation|Death|1|||
38072033|NCT02186834|69767246|FG004|Dose Escalation|Death|0|||
38072034|NCT02186834|69767247|FG005|Dose Escalation|Death|0|||
38072035|NCT02186834|69767242|FG000|Treatment at RP2D|Died prior to treatment|0|||
38072036|NCT02186834|69767243|FG001|Treatment at RP2D|Died prior to treatment|0|||
38072037|NCT02186834|69767244|FG002|Treatment at RP2D|Died prior to treatment|0|||
38072038|NCT02186834|69767245|FG003|Treatment at RP2D|Died prior to treatment|0|||
38072039|NCT02186834|69767246|FG004|Treatment at RP2D|Died prior to treatment|0|||
38072040|NCT02186834|69767247|FG005|Treatment at RP2D|Died prior to treatment|1|||
38072041|NCT03144687|69767258|FG000|Overall Study|Death|0|||
38072042|NCT03144687|69767259|FG001|Overall Study|Death|2|||
38072043|NCT03144687|69767258|FG000|Overall Study|Lost to Follow-up|0|||
38072044|NCT03144687|69767259|FG001|Overall Study|Lost to Follow-up|1|||
38072045|NCT03144687|69767258|FG000|Overall Study|Physician Decision|0|||
38072046|NCT03144687|69767259|FG001|Overall Study|Physician Decision|1|||
37862344|NCT01129557|69546096|FG001|Overall Study|Adverse Event|2|||
38072047|NCT03144687|69767258|FG000|Overall Study|Withdrawal by Subject|1|||
38072048|NCT03144687|69767259|FG001|Overall Study|Withdrawal by Subject|3|||
38072049|NCT03144687|69767258|FG000|Overall Study|Not Reported|2|||
38072050|NCT03144687|69767259|FG001|Overall Study|Not Reported|0|||
38072051|NCT03080961|69767269|FG000|Overall Study|Withdrawal by Subject|3|||
38072052|NCT02905266|69767293|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
38072053|NCT02905266|69767294|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
38072054|NCT02905266|69767293|FG000|Treatment Phase Part 1|Disease Progression|6|||
38072055|NCT02905266|69767294|FG001|Treatment Phase Part 1|Disease Progression|7|||
38072056|NCT02905266|69767293|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
38072057|NCT02905266|69767294|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
38072058|NCT02905266|69767293|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
38072059|NCT02905266|69767294|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
38072060|NCT02905266|69767293|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
38072061|NCT02905266|69767294|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
38072062|NCT02905266|69767293|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
38072063|NCT02905266|69767294|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
38072064|NCT02905266|69767293|FG000|Transition From Part 1 to Part 2|Death|0|||
38072065|NCT02905266|69767294|FG001|Transition From Part 1 to Part 2|Death|1|||
38072066|NCT02905266|69767293|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
38072067|NCT02905266|69767294|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
38072068|NCT02905266|69767293|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
38072069|NCT02905266|69767294|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
38072070|NCT02905266|69767293|FG000|Maintenance Phase Part 2|Disease Progression|9|||
38072071|NCT02905266|69767294|FG001|Maintenance Phase Part 2|Disease Progression|2|||
38072072|NCT02905266|69767293|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
38072073|NCT02905266|69767294|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
38072074|NCT02905266|69767293|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
38072075|NCT02905266|69767294|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
38072076|NCT02982018|69767302|FG000|Overall Study|Incorrect Lens Dispensed|1|||
38072077|NCT02982018|69767303|FG001|Overall Study|Incorrect Lens Dispensed|0|||
38072078|NCT02982018|69767302|FG000|Overall Study|Protocol Violation|1|||
38072079|NCT02982018|69767303|FG001|Overall Study|Protocol Violation|1|||
38072080|NCT02982018|69767302|FG000|Overall Study|Adverse Event|1|||
37680397|NCT02582749|69156036|FG001|Overall Study|Withdrawal by Subject|1|||
38072081|NCT02982018|69767303|FG001|Overall Study|Adverse Event|1|||
38072082|NCT02982018|69767302|FG000|Overall Study|Lens Discomfort|2|||
38072083|NCT02982018|69767303|FG001|Overall Study|Lens Discomfort|0|||
38072084|NCT02982018|69767302|FG000|Overall Study|Withdrawal by Subject|0|||
38072085|NCT02982018|69767303|FG001|Overall Study|Withdrawal by Subject|1|||
38072086|NCT03080493|69767311|FG000|Overall Study|Did not provide NRS pain results|1|||
38072087|NCT03080493|69767312|FG001|Overall Study|Did not provide NRS pain results|0|||
38072088|NCT03080493|69767311|FG000|Overall Study|Adverse Event|0|||
38072089|NCT03080493|69767312|FG001|Overall Study|Adverse Event|1|||
38072090|NCT03080493|69767311|FG000|Overall Study|Randomization error (parity group)|0|||
38072091|NCT03080493|69767312|FG001|Overall Study|Randomization error (parity group)|1|||
38072092|NCT01339910|69767320|FG000|Overall Study|Withdrawal by Subject|1|||
38072093|NCT01339910|69767321|FG001|Overall Study|Withdrawal by Subject|0|||
38072094|NCT01339910|69767320|FG000|Overall Study|Physician Decision|1|||
38072095|NCT01339910|69767321|FG001|Overall Study|Physician Decision|0|||
38072096|NCT01339910|69767320|FG000|Overall Study|Disease relapse|1|||
38072097|NCT01339910|69767321|FG001|Overall Study|Disease relapse|4|||
38072098|NCT02981082|69767329|FG000|Overall Study|Withdrawal by Subject|2|||
38072099|NCT02981082|69767330|FG001|Overall Study|Withdrawal by Subject|0|||
38072100|NCT02981082|69767329|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
38072101|NCT02981082|69767330|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
38072102|NCT02981082|69767329|FG000|Overall Study|Adverse Event|0|||
38072103|NCT02981082|69767330|FG001|Overall Study|Adverse Event|1|||
38072104|NCT01066104|69767338|FG000|Overall Study|Adverse Event|1|||
38072105|NCT01066104|69767339|FG001|Overall Study|Adverse Event|1|||
38072106|NCT01066104|69767338|FG000|Overall Study|Protocol Violation|1|||
38072107|NCT01066104|69767339|FG001|Overall Study|Protocol Violation|0|||
38072108|NCT02736968|69767350|FG000|Overall Study|Lost to Follow-up|0|||
38072109|NCT02736968|69767351|FG001|Overall Study|Lost to Follow-up|0|||
38072110|NCT02736968|69767352|FG002|Overall Study|Lost to Follow-up|0|||
38072111|NCT02736968|69767353|FG003|Overall Study|Lost to Follow-up|0|||
38072112|NCT02736968|69767354|FG004|Overall Study|Lost to Follow-up|0|||
38072113|NCT02736968|69767355|FG005|Overall Study|Lost to Follow-up|0|||
38072114|NCT02736968|69767356|FG006|Overall Study|Lost to Follow-up|5|||
38072115|NCT02736968|69767357|FG007|Overall Study|Lost to Follow-up|2|||
38072116|NCT02736968|69767350|FG000|Overall Study|COVID-19 Pandemic|0|||
38072117|NCT02736968|69767351|FG001|Overall Study|COVID-19 Pandemic|0|||
38072118|NCT02736968|69767352|FG002|Overall Study|COVID-19 Pandemic|0|||
38072119|NCT02736968|69767353|FG003|Overall Study|COVID-19 Pandemic|0|||
38072120|NCT02736968|69767354|FG004|Overall Study|COVID-19 Pandemic|0|||
38072121|NCT02736968|69767355|FG005|Overall Study|COVID-19 Pandemic|0|||
38072122|NCT02736968|69767356|FG006|Overall Study|COVID-19 Pandemic|2|||
38072123|NCT02736968|69767357|FG007|Overall Study|COVID-19 Pandemic|0|||
38072124|NCT02736968|69767350|FG000|Overall Study|Withdrawal by Subject|0|||
38072125|NCT02736968|69767351|FG001|Overall Study|Withdrawal by Subject|0|||
38072126|NCT02736968|69767352|FG002|Overall Study|Withdrawal by Subject|0|||
38072127|NCT02736968|69767353|FG003|Overall Study|Withdrawal by Subject|0|||
38072128|NCT02736968|69767354|FG004|Overall Study|Withdrawal by Subject|0|||
38072129|NCT02736968|69767355|FG005|Overall Study|Withdrawal by Subject|0|||
38072130|NCT02736968|69767356|FG006|Overall Study|Withdrawal by Subject|1|||
38072131|NCT02736968|69767357|FG007|Overall Study|Withdrawal by Subject|0|||
38072132|NCT02980224|69767370|FG000|Overall Study|Adverse Event|4|||
38072133|NCT02980224|69767371|FG001|Overall Study|Adverse Event|1|||
38072134|NCT02980224|69767370|FG000|Overall Study|Withdrawal by Subject|0|||
38072135|NCT02980224|69767371|FG001|Overall Study|Withdrawal by Subject|2|||
38072136|NCT02591615|69767381|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
38072137|NCT02591615|69767382|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
38072138|NCT02591615|69767383|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
37966096|NCT00486603|69653000|FG001|Overall Study|Withdrawal by Subject|0|||
37966097|NCT00486603|69653001|FG002|Overall Study|Withdrawal by Subject|0|||
37966098|NCT00486603|69653002|FG003|Overall Study|Withdrawal by Subject|0|||
38072139|NCT02591615|69767384|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
38072140|NCT02591615|69767381|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
38072141|NCT02591615|69767382|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
38072142|NCT02591615|69767383|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
38072143|NCT02591615|69767384|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
38072144|NCT02591615|69767381|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
38072145|NCT02591615|69767382|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
38072146|NCT02591615|69767383|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
38072147|NCT02591615|69767384|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
37966099|NCT00486603|69653003|FG004|Overall Study|Withdrawal by Subject|0|||
37966100|NCT00486603|69652999|FG000|Overall Study|Physician Decision|0|||
38072148|NCT02591615|69767381|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
38072149|NCT02591615|69767382|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
38072150|NCT02591615|69767383|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
38072151|NCT02591615|69767384|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
38072152|NCT02591615|69767381|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
38072153|NCT02591615|69767382|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
38072154|NCT02591615|69767383|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
38072155|NCT02591615|69767384|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
38072156|NCT02591615|69767381|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
38072157|NCT02591615|69767382|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
38072158|NCT02591615|69767383|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
38072159|NCT02591615|69767384|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
38072160|NCT02591615|69767381|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
38072161|NCT02591615|69767382|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
38072162|NCT02591615|69767383|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
38072163|NCT02591615|69767384|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
38072164|NCT02591615|69767381|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
38072165|NCT02591615|69767382|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
38072166|NCT02591615|69767383|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
38072167|NCT02591615|69767384|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
38072168|NCT02591615|69767381|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
38072169|NCT02591615|69767382|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
38072170|NCT02591615|69767383|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
38072171|NCT02591615|69767384|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
38072172|NCT02591615|69767381|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
38072173|NCT02591615|69767382|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
38072174|NCT02591615|69767383|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
38072175|NCT02591615|69767384|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
38072176|NCT02591615|69767381|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
38072177|NCT02591615|69767382|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
38072178|NCT02591615|69767383|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
38072179|NCT02591615|69767384|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
38072180|NCT02591615|69767381|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
38072181|NCT02591615|69767382|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
38072182|NCT02591615|69767383|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
38072183|NCT02591615|69767384|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
38072184|NCT02591615|69767381|FG000|Maintenance MK-3475|Adverse Event|0|||
38072185|NCT02591615|69767382|FG001|Maintenance MK-3475|Adverse Event|3|||
38072186|NCT02591615|69767383|FG002|Maintenance MK-3475|Adverse Event|1|||
38072187|NCT02591615|69767384|FG003|Maintenance MK-3475|Adverse Event|2|||
38072188|NCT02591615|69767381|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
38072189|NCT02591615|69767382|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
38072190|NCT02591615|69767383|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
38072191|NCT02591615|69767384|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
38072192|NCT02591615|69767381|FG000|Maintenance MK-3475|Death|0|||
38072193|NCT02591615|69767382|FG001|Maintenance MK-3475|Death|1|||
38072194|NCT02591615|69767383|FG002|Maintenance MK-3475|Death|1|||
38072195|NCT02591615|69767384|FG003|Maintenance MK-3475|Death|0|||
38072196|NCT02591615|69767381|FG000|Maintenance MK-3475|Physician discretion|0|||
38072197|NCT02591615|69767382|FG001|Maintenance MK-3475|Physician discretion|0|||
38072198|NCT02591615|69767383|FG002|Maintenance MK-3475|Physician discretion|1|||
38072199|NCT02591615|69767384|FG003|Maintenance MK-3475|Physician discretion|0|||
38072200|NCT02591615|69767381|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
38072201|NCT02591615|69767382|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
38072202|NCT02591615|69767383|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
38072203|NCT02591615|69767384|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
38072204|NCT02591615|69767381|FG000|Maintenance MK-3475|In active treatment|2|||
38072205|NCT02591615|69767382|FG001|Maintenance MK-3475|In active treatment|0|||
38072206|NCT02591615|69767383|FG002|Maintenance MK-3475|In active treatment|0|||
38072207|NCT02591615|69767384|FG003|Maintenance MK-3475|In active treatment|1|||
38072208|NCT03077607|69767399|FG000|Period 1 (15 Days)|Adverse Event|1|||
38072209|NCT03077607|69767400|FG001|Period 1 (15 Days)|Adverse Event|0|||
38072210|NCT03077607|69767399|FG000|Period 1 (15 Days)|Death|1|||
38072211|NCT03077607|69767400|FG001|Period 1 (15 Days)|Death|0|||
38072212|NCT03077607|69767399|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
38072213|NCT03077607|69767400|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
38072214|NCT03077607|69767399|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
38072215|NCT03077607|69767400|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
38072216|NCT02977572|69767419|FG000|Overall Study|Exclusion criterion|2|||
38072217|NCT02977572|69767420|FG001|Overall Study|Exclusion criterion|2|||
38072218|NCT02746874|69767432|FG000|Overall Study|Withdrawal by Subject|0|||
38072219|NCT02746874|69767433|FG001|Overall Study|Withdrawal by Subject|1|||
38072220|NCT02746874|69767432|FG000|Overall Study|Surgery Date Changed|0|||
38072221|NCT02746874|69767433|FG001|Overall Study|Surgery Date Changed|2|||
38072222|NCT03217175|69767439|FG000|Overall Study|Physician Decision|4|||
38072223|NCT03217175|69767440|FG001|Overall Study|Physician Decision|1|||
38072224|NCT01062126|69767446|FG000|Overall Study|Death|209|||
38072225|NCT01062126|69767446|FG000|Overall Study|All Withdrawals|324|||
38072226|NCT02522429|69767450|FG000|Overall Study|Lost to Follow-up|8|||
38072227|NCT02522429|69767450|FG000|Overall Study|Adverse Event|2|||
38072228|NCT02522429|69767450|FG000|Overall Study|Death|1|||
38072229|NCT02522429|69767450|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
38072230|NCT02974140|69767454|FG000|Overall Study|Adverse Event|2|||
38072231|NCT02974140|69767454|FG000|Overall Study|Lost to Follow-up|1|||
38072232|NCT02974140|69767454|FG000|Overall Study|Study Terminated by Sponsor|36|||
38072233|NCT02974842|69767461|FG000|Overall Study|Withdrawal by Subject|4|||
38072234|NCT02974842|69767461|FG000|Overall Study|Screen failures|4|||
38072235|NCT03172481|69767467|FG000|Double-blind|Withdrawal by Subject|1|||
38072236|NCT03172481|69767468|FG001|Double-blind|Withdrawal by Subject|0|||
38072237|NCT02855450|69767476|FG000|Overall Study|Adverse Event|1|||
38072238|NCT02855450|69767477|FG001|Overall Study|Adverse Event|0|||
38072239|NCT02855450|69767476|FG000|Overall Study|Lost to Follow-up|4|||
38072240|NCT02855450|69767477|FG001|Overall Study|Lost to Follow-up|0|||
38072241|NCT03172325|69767485|FG000|Overall Study|Adverse Event|2|||
38072242|NCT03172325|69767486|FG001|Overall Study|Adverse Event|3|||
38072243|NCT03172325|69767485|FG000|Overall Study|Positive PPD|1|||
38072244|NCT03172325|69767486|FG001|Overall Study|Positive PPD|0|||
38072245|NCT03172325|69767485|FG000|Overall Study|Poor Compliance|1|||
38072246|NCT03172325|69767486|FG001|Overall Study|Poor Compliance|1|||
38072247|NCT03085017|69767494|FG000|Overall Study|Death|0|||
38072248|NCT03085017|69767495|FG001|Overall Study|Death|3|||
38072249|NCT03215771|69767501|FG000|Overall Study|Withdrawal by Subject|2|||
38072250|NCT03215771|69767501|FG000|Overall Study|Physician Decision|1|||
38072251|NCT02745392|69767510|FG000|Overall Study|Lost to Follow-up|0|||
38072252|NCT02745392|69767511|FG001|Overall Study|Lost to Follow-up|1|||
38072253|NCT02745392|69767512|FG002|Overall Study|Lost to Follow-up|0|||
38072254|NCT02745392|69767513|FG003|Overall Study|Lost to Follow-up|0|||
38072255|NCT03076515|69767525|FG000|Overall Study|DMC decision based on interim analysis|25|||
38072256|NCT03076515|69767526|FG001|Overall Study|DMC decision based on interim analysis|29|||
38072257|NCT03170609|69767539|FG000|Overall Study|Death|0|||
38072258|NCT03170609|69767540|FG001|Overall Study|Death|0|||
38072259|NCT03170609|69767541|FG002|Overall Study|Death|1|||
38072260|NCT03170609|69767542|FG003|Overall Study|Death|0|||
38072261|NCT03170609|69767543|FG004|Overall Study|Death|0|||
38072262|NCT03170609|69767544|FG005|Overall Study|Death|0|||
38072263|NCT03170609|69767545|FG006|Overall Study|Death|0|||
38072264|NCT03170609|69767539|FG000|Overall Study|Withdrawal by Subject|1|||
38072265|NCT03170609|69767540|FG001|Overall Study|Withdrawal by Subject|2|||
38072266|NCT03170609|69767541|FG002|Overall Study|Withdrawal by Subject|0|||
38072267|NCT03170609|69767542|FG003|Overall Study|Withdrawal by Subject|0|||
38072268|NCT03170609|69767543|FG004|Overall Study|Withdrawal by Subject|0|||
38072269|NCT03170609|69767544|FG005|Overall Study|Withdrawal by Subject|0|||
38072270|NCT03170609|69767545|FG006|Overall Study|Withdrawal by Subject|1|||
38072271|NCT03170609|69767539|FG000|Overall Study|Lost to Follow-up|1|||
38072272|NCT03170609|69767540|FG001|Overall Study|Lost to Follow-up|0|||
38072273|NCT03170609|69767541|FG002|Overall Study|Lost to Follow-up|5|||
38072274|NCT03170609|69767542|FG003|Overall Study|Lost to Follow-up|2|||
38072275|NCT03170609|69767543|FG004|Overall Study|Lost to Follow-up|1|||
38072276|NCT03170609|69767544|FG005|Overall Study|Lost to Follow-up|1|||
38072277|NCT03170609|69767545|FG006|Overall Study|Lost to Follow-up|0|||
38072278|NCT03170609|69767539|FG000|Overall Study|Other|1|||
38072279|NCT03170609|69767540|FG001|Overall Study|Other|0|||
38072280|NCT03170609|69767541|FG002|Overall Study|Other|0|||
38072281|NCT03170609|69767542|FG003|Overall Study|Other|0|||
38072282|NCT03170609|69767543|FG004|Overall Study|Other|0|||
38072283|NCT03170609|69767544|FG005|Overall Study|Other|1|||
38072284|NCT03170609|69767545|FG006|Overall Study|Other|0|||
38072285|NCT01141712|69767561|FG000|Overall Study|Disease progression|3|||
38072286|NCT03219333|69767571|FG000|Overall Study|Withdrawal by Subject|8|||
38072287|NCT03219333|69767572|FG001|Overall Study|Withdrawal by Subject|3|||
38072288|NCT03219333|69767571|FG000|Overall Study|Lost to Follow-up|1|||
38072289|NCT03219333|69767572|FG001|Overall Study|Lost to Follow-up|0|||
38072290|NCT03219333|69767571|FG000|Overall Study|Death|94|||
38072291|NCT03219333|69767572|FG001|Overall Study|Death|44|||
38072292|NCT03219333|69767571|FG000|Overall Study|Includes 4 participants who were enrolled and never received study treatment.|2|||
38072293|NCT03219333|69767572|FG001|Overall Study|Includes 4 participants who were enrolled and never received study treatment.|2|||
38072294|NCT03168867|69767580|FG000|Overall Study|Withdrawal by Subject|1|||
38072295|NCT03168867|69767581|FG001|Overall Study|Withdrawal by Subject|5|||
38072296|NCT01064622|69767590|FG000|Randomized Phase II|Withdrawal by Subject|2|||
38072297|NCT01064622|69767591|FG001|Randomized Phase II|Withdrawal by Subject|2|||
38072298|NCT01064622|69767590|FG000|Randomized Phase II|Protocol Violation|0|||
38072299|NCT01064622|69767591|FG001|Randomized Phase II|Protocol Violation|1|||
38072300|NCT04163718|69767600|FG000|Overall Study|Study terminated|12|||
38072301|NCT01063764|69767604|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
38072302|NCT01063764|69767604|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
38072303|NCT01063764|69767604|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
38072304|NCT01063764|69767604|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
38072305|NCT01063764|69767604|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
38072306|NCT01063764|69767604|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
38072307|NCT01063764|69767604|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
38072308|NCT03075891|69767614|FG000|Overall Study|Withdrawal by Subject|3|||
38072309|NCT03075891|69767615|FG001|Overall Study|Withdrawal by Subject|6|||
38072310|NCT03075891|69767614|FG000|Overall Study|Lost to Follow-up|1|||
38072311|NCT03075891|69767615|FG001|Overall Study|Lost to Follow-up|0|||
38072312|NCT03075891|69767614|FG000|Overall Study|Pregnancy|3|||
38072313|NCT03075891|69767615|FG001|Overall Study|Pregnancy|1|||
38072314|NCT03075891|69767614|FG000|Overall Study|visits not performed (no time)|1|||
38072315|NCT03075891|69767615|FG001|Overall Study|visits not performed (no time)|0|||
38072316|NCT03075891|69767614|FG000|Overall Study|Drug abuse relapse issue|0|||
38072317|NCT03075891|69767615|FG001|Overall Study|Drug abuse relapse issue|1|||
38072318|NCT03075891|69767614|FG000|Overall Study|Participant requiring study withdrawal|0|||
38072319|NCT03075891|69767615|FG001|Overall Study|Participant requiring study withdrawal|1|||
38072320|NCT03075891|69767614|FG000|Overall Study|Adverse event, non-fatal|1|||
38072321|NCT03075891|69767615|FG001|Overall Study|Adverse event, non-fatal|4|||
38072322|NCT02013167|69767625|FG000|Overall Study|Withdrawal by Subject|15|||
38072323|NCT02013167|69767626|FG001|Overall Study|Withdrawal by Subject|14|||
38072324|NCT02013167|69767625|FG000|Overall Study|Sponsor Decision|1|||
38072325|NCT02013167|69767626|FG001|Overall Study|Sponsor Decision|3|||
38072326|NCT02013167|69767625|FG000|Overall Study|Lost to Follow-up|0|||
38072327|NCT02013167|69767626|FG001|Overall Study|Lost to Follow-up|1|||
38072328|NCT02013167|69767625|FG000|Overall Study|Death|85|||
38072329|NCT02013167|69767626|FG001|Overall Study|Death|160|||
38072330|NCT01063062|69767635|FG000|Overall Study|Patient withdrew consent|0|||
38072331|NCT01063062|69767636|FG001|Overall Study|Patient withdrew consent|1|||
38072332|NCT01063062|69767635|FG000|Overall Study|Adverse Event|2|||
38072333|NCT01063062|69767636|FG001|Overall Study|Adverse Event|4|||
38072334|NCT01063062|69767635|FG000|Overall Study|Protocol Violation|5|||
38072335|NCT01063062|69767636|FG001|Overall Study|Protocol Violation|4|||
38072336|NCT01063062|69767635|FG000|Overall Study|Investigator's request|1|||
38072337|NCT01063062|69767636|FG001|Overall Study|Investigator's request|0|||
38072338|NCT01063062|69767635|FG000|Overall Study|Lost to Follow-up|0|||
38072339|NCT01063062|69767636|FG001|Overall Study|Lost to Follow-up|2|||
38072340|NCT01063062|69767635|FG000|Overall Study|Miscellaneous reason|0|||
38072341|NCT01063062|69767636|FG001|Overall Study|Miscellaneous reason|1|||
38072342|NCT02973048|69767645|FG000|Overall Study|Epidural catheter insertion failure|1|||
38072343|NCT02973048|69767646|FG001|Overall Study|Epidural catheter insertion failure|0|||
38072344|NCT02973048|69767645|FG000|Overall Study|Withdrawal by Subject|0|||
38072345|NCT02973048|69767646|FG001|Overall Study|Withdrawal by Subject|3|||
38072346|NCT02932943|69767654|FG000|Overall Study|Lost to Follow-up|0|||
38072347|NCT02932943|69767655|FG001|Overall Study|Lost to Follow-up|2|||
38072348|NCT02932943|69767654|FG000|Overall Study|Adverse Event|2|||
38072349|NCT02932943|69767655|FG001|Overall Study|Adverse Event|2|||
38072350|NCT02932943|69767654|FG000|Overall Study|Withdrawal by Subject|3|||
38072351|NCT02932943|69767655|FG001|Overall Study|Withdrawal by Subject|3|||
38072352|NCT02972658|69767680|FG000|Overall Study|Adverse Event|0|||
38072353|NCT02972658|69767681|FG001|Overall Study|Adverse Event|3|||
38072354|NCT02972658|69767682|FG002|Overall Study|Adverse Event|0|||
38072355|NCT02972658|69767683|FG003|Overall Study|Adverse Event|2|||
38072356|NCT02972658|69767680|FG000|Overall Study|Other-determined by Investigator|1|||
38072357|NCT02972658|69767681|FG001|Overall Study|Other-determined by Investigator|1|||
38072358|NCT02972658|69767682|FG002|Overall Study|Other-determined by Investigator|0|||
38072359|NCT02972658|69767683|FG003|Overall Study|Other-determined by Investigator|0|||
38072360|NCT02972658|69767680|FG000|Overall Study|Death|0|||
38072361|NCT02972658|69767681|FG001|Overall Study|Death|0|||
38072362|NCT02972658|69767682|FG002|Overall Study|Death|0|||
38072363|NCT02972658|69767683|FG003|Overall Study|Death|1|||
38072364|NCT02972658|69767680|FG000|Overall Study|Lost to Follow-up|0|||
38072365|NCT02972658|69767681|FG001|Overall Study|Lost to Follow-up|1|||
38072366|NCT02972658|69767682|FG002|Overall Study|Lost to Follow-up|1|||
38072367|NCT02972658|69767683|FG003|Overall Study|Lost to Follow-up|2|||
38072368|NCT02972658|69767680|FG000|Overall Study|Progressive Disease|0|||
38072369|NCT02972658|69767681|FG001|Overall Study|Progressive Disease|1|||
38072370|NCT02972658|69767682|FG002|Overall Study|Progressive Disease|0|||
38072371|NCT02972658|69767683|FG003|Overall Study|Progressive Disease|1|||
38072372|NCT02972658|69767680|FG000|Overall Study|Withdrawal by Subject|4|||
38072373|NCT02972658|69767681|FG001|Overall Study|Withdrawal by Subject|4|||
38072374|NCT02972658|69767682|FG002|Overall Study|Withdrawal by Subject|1|||
38072375|NCT02972658|69767683|FG003|Overall Study|Withdrawal by Subject|6|||
38072376|NCT02972658|69767680|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
38072377|NCT02972658|69767681|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
38072378|NCT02972658|69767682|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
38072379|NCT02972658|69767683|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
38072380|NCT02972658|69767680|FG000|Overall Study|Sponsor Decision|70|||
38072381|NCT02972658|69767681|FG001|Overall Study|Sponsor Decision|127|||
38072382|NCT02972658|69767682|FG002|Overall Study|Sponsor Decision|72|||
38072383|NCT02972658|69767683|FG003|Overall Study|Sponsor Decision|119|||
38072384|NCT02853032|69767695|FG000|Overall Study|Adverse Event|4|||
38072385|NCT02853032|69767696|FG001|Overall Study|Adverse Event|0|||
38072386|NCT02853032|69767695|FG000|Overall Study|Withdrawal by Subject|3|||
38072387|NCT02853032|69767696|FG001|Overall Study|Withdrawal by Subject|1|||
38072388|NCT02853032|69767695|FG000|Overall Study|Requested to withdraw from all treatment|2|||
38072389|NCT02853032|69767696|FG001|Overall Study|Requested to withdraw from all treatment|2|||
38072390|NCT02232087|69767704|FG000|Overall Study|Withdrawal by Subject|2|||
38072391|NCT02232087|69767705|FG001|Overall Study|Withdrawal by Subject|0|||
38072392|NCT02232087|69767706|FG002|Overall Study|Withdrawal by Subject|0|||
38072393|NCT02232087|69767707|FG003|Overall Study|Withdrawal by Subject|0|||
38072394|NCT02232087|69767708|FG004|Overall Study|Withdrawal by Subject|0|||
38072395|NCT02232087|69767709|FG005|Overall Study|Withdrawal by Subject|1|||
38072396|NCT02232087|69767704|FG000|Overall Study|poor inhalation technique|0|||
38072397|NCT02232087|69767705|FG001|Overall Study|poor inhalation technique|1|||
38072398|NCT02232087|69767706|FG002|Overall Study|poor inhalation technique|0|||
38072399|NCT02232087|69767707|FG003|Overall Study|poor inhalation technique|0|||
38072400|NCT02232087|69767708|FG004|Overall Study|poor inhalation technique|0|||
38072401|NCT02232087|69767709|FG005|Overall Study|poor inhalation technique|2|||
38072402|NCT02232087|69767704|FG000|Overall Study|protocol stop criteria|0|||
38072403|NCT02232087|69767705|FG001|Overall Study|protocol stop criteria|1|||
38072404|NCT02232087|69767706|FG002|Overall Study|protocol stop criteria|0|||
38072405|NCT02232087|69767707|FG003|Overall Study|protocol stop criteria|1|||
38072406|NCT02232087|69767708|FG004|Overall Study|protocol stop criteria|0|||
38072407|NCT02232087|69767709|FG005|Overall Study|protocol stop criteria|0|||
38072408|NCT02232087|69767704|FG000|Overall Study|Adverse Event|0|||
38072409|NCT02232087|69767705|FG001|Overall Study|Adverse Event|0|||
38072410|NCT02232087|69767706|FG002|Overall Study|Adverse Event|0|||
38072411|NCT02232087|69767707|FG003|Overall Study|Adverse Event|0|||
38072412|NCT02232087|69767708|FG004|Overall Study|Adverse Event|1|||
38072413|NCT02232087|69767709|FG005|Overall Study|Adverse Event|0|||
38072414|NCT03168425|69767730|FG000|Overall Study|Lost to Follow-up|5|||
38072415|NCT03168425|69767731|FG001|Overall Study|Lost to Follow-up|8|||
38072416|NCT03168425|69767730|FG000|Overall Study|unable to confirm post op opioids|2|||
38072417|NCT03168425|69767731|FG001|Overall Study|unable to confirm post op opioids|3|||
38072418|NCT00004445|69767738|FG000|Overall Study|Physician Decision|2|||
38072419|NCT00004445|69767738|FG000|Overall Study|Withdrawal by Subject|1|||
38072420|NCT02972502|69767748|FG000|Overall Study|Lost to Follow-up|3|||
38072421|NCT02972502|69767749|FG001|Overall Study|Lost to Follow-up|1|||
38072422|NCT02972502|69767748|FG000|Overall Study|Withdrawal by Subject|1|||
38072423|NCT02972502|69767749|FG001|Overall Study|Withdrawal by Subject|1|||
38072424|NCT02971800|69767755|FG000|Overall Study|Protocol Violation|1|||
38072425|NCT02971800|69767755|FG000|Overall Study|Withdrawal by Subject|1|||
38072426|NCT02971800|69767755|FG000|Overall Study|Exclusion criteria prior intervention|1|||
38072427|NCT02971800|69767755|FG000|Overall Study|Number evaluable participant already reached|4|||
38072428|NCT03163667|69767761|FG000|Overall Study|Death|15|||
38072429|NCT03163667|69767762|FG001|Overall Study|Death|27|||
38072430|NCT03163667|69767761|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
38072431|NCT03163667|69767762|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
38072432|NCT03167411|69767770|FG000|Overall Study|Adverse Event|0|||
38072433|NCT03167411|69767771|FG001|Overall Study|Adverse Event|1|||
38072434|NCT01952847|69767781|FG000|Overall Study|Ineligible|1|||
38072435|NCT01952847|69767782|FG001|Overall Study|Ineligible|0|||
38072436|NCT01952847|69767783|FG002|Overall Study|Ineligible|0|||
38072437|NCT01952847|69767784|FG003|Overall Study|Ineligible|0|||
37680398|NCT02582671|69156042|FG000|Overall Study|Failure to return|1|||
38072438|NCT01952847|69767781|FG000|Overall Study|Lack of Insurance Coverage|0|||
38072439|NCT01952847|69767782|FG001|Overall Study|Lack of Insurance Coverage|1|||
38072440|NCT01952847|69767783|FG002|Overall Study|Lack of Insurance Coverage|0|||
38072441|NCT01952847|69767784|FG003|Overall Study|Lack of Insurance Coverage|0|||
38072442|NCT01952847|69767781|FG000|Overall Study|Withdrawal by Subject|1|||
38072443|NCT01952847|69767782|FG001|Overall Study|Withdrawal by Subject|1|||
38072444|NCT01952847|69767783|FG002|Overall Study|Withdrawal by Subject|0|||
38072445|NCT01952847|69767784|FG003|Overall Study|Withdrawal by Subject|1|||
38072446|NCT01560585|69767796|FG000|Overall Study|Physician Decision|3|||
38072447|NCT03075501|69767803|FG000|Overall Study|Scheduling difficulties|15|||
38072448|NCT03075501|69767804|FG001|Overall Study|Scheduling difficulties|9|||
38072449|NCT02317991|69767811|FG000|Overall Study|Adverse Event|12|||
38072450|NCT02317991|69767811|FG000|Overall Study|Death|4|||
38072451|NCT02317991|69767811|FG000|Overall Study|Withdrawal by Subject|8|||
38072452|NCT02317991|69767811|FG000|Overall Study|Progressive Disease|41|||
38072453|NCT03075267|69767818|FG000|Overall Study|Protocol Violation|1|||
38072454|NCT03075267|69767819|FG001|Overall Study|Protocol Violation|0|||
38072455|NCT03075267|69767820|FG002|Overall Study|Protocol Violation|0|||
38072456|NCT03074331|69767828|FG000|Overall Study|Enrolled but Not Treated|1|||
38072457|NCT03074331|69767828|FG000|Overall Study|Lost to Follow-up|5|||
38072458|NCT03074331|69767828|FG000|Overall Study|Withdrew Consent|1|||
38072459|NCT02260193|69767835|FG000|Overall Study|Lack of Efficacy|0|||
38072460|NCT02260193|69767836|FG001|Overall Study|Lack of Efficacy|1|||
38072461|NCT02260193|69767837|FG002|Overall Study|Lack of Efficacy|6|||
38072462|NCT02260193|69767835|FG000|Overall Study|Adverse Event|3|||
38072463|NCT02260193|69767836|FG001|Overall Study|Adverse Event|4|||
38072464|NCT02260193|69767837|FG002|Overall Study|Adverse Event|1|||
38072465|NCT02260193|69767835|FG000|Overall Study|Protocol Violation|0|||
38072466|NCT02260193|69767836|FG001|Overall Study|Protocol Violation|4|||
38072467|NCT02260193|69767837|FG002|Overall Study|Protocol Violation|0|||
38072468|NCT02260193|69767835|FG000|Overall Study|Withdrawal by Subject|3|||
38072469|NCT02260193|69767836|FG001|Overall Study|Withdrawal by Subject|0|||
38072470|NCT02260193|69767837|FG002|Overall Study|Withdrawal by Subject|2|||
38072471|NCT02260193|69767835|FG000|Overall Study|Kidney Transplantation|0|||
38072472|NCT02260193|69767836|FG001|Overall Study|Kidney Transplantation|0|||
38072473|NCT02260193|69767837|FG002|Overall Study|Kidney Transplantation|1|||
38072474|NCT02849678|69767847|FG000|Overall Study|Protocol Violation|3|||
38072475|NCT02849678|69767848|FG001|Overall Study|Protocol Violation|6|||
38072476|NCT01596257|69767856|FG000|Overall Study|Inadequate Collection|23|||
38072477|NCT01596257|69767857|FG001|Overall Study|Inadequate Collection|19|||
38072478|NCT04577781|69767867|FG000|Overall Study|Adverse Event|2|||
38072479|NCT04577781|69767868|FG001|Overall Study|Adverse Event|2|||
38072480|NCT04577781|69767867|FG000|Overall Study|Physician Decision|1|||
38072481|NCT04577781|69767868|FG001|Overall Study|Physician Decision|0|||
38072482|NCT02737826|69767875|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
38072483|NCT02737826|69767876|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
38072484|NCT02737826|69767877|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
38072485|NCT03070431|69767904|FG000|Overall Study|Withdrawal by Subject|2|||
38072486|NCT03070431|69767904|FG000|Overall Study|Lost to Follow-up|2|||
38072487|NCT01071395|69767915|FG000|Overall Study|Withdrawal by Subject|2|||
38072488|NCT01071395|69767916|FG001|Overall Study|Withdrawal by Subject|1|||
38072489|NCT01071395|69767915|FG000|Overall Study|Adverse Event|3|||
38072490|NCT01071395|69767916|FG001|Overall Study|Adverse Event|1|||
38072491|NCT02970942|69767926|FG000|Overall Study|Death|0|||
38072492|NCT02970942|69767927|FG001|Overall Study|Death|1|||
38072493|NCT02970942|69767928|FG002|Overall Study|Death|0|||
38072494|NCT02970942|69767929|FG003|Overall Study|Death|0|||
38072495|NCT02970942|69767926|FG000|Overall Study|Lost to Follow-up|1|||
38072496|NCT02970942|69767927|FG001|Overall Study|Lost to Follow-up|0|||
38072497|NCT02970942|69767928|FG002|Overall Study|Lost to Follow-up|2|||
38072498|NCT02970942|69767929|FG003|Overall Study|Lost to Follow-up|1|||
38072499|NCT02970942|69767926|FG000|Overall Study|Withdrawal by Subject|3|||
38072500|NCT02970942|69767927|FG001|Overall Study|Withdrawal by Subject|5|||
38072501|NCT02970942|69767928|FG002|Overall Study|Withdrawal by Subject|3|||
38072502|NCT02970942|69767929|FG003|Overall Study|Withdrawal by Subject|2|||
38072503|NCT03073005|69767943|FG000|Overall Study|Death|6|||
38072504|NCT03073005|69767944|FG001|Overall Study|Death|0|||
38072505|NCT03073005|69767945|FG002|Overall Study|Death|7|||
38072506|NCT03073005|69767946|FG003|Overall Study|Death|0|||
38072507|NCT03073005|69767943|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
38072508|NCT03073005|69767944|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
38072509|NCT03073005|69767945|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
38072510|NCT03073005|69767946|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
38072511|NCT03073005|69767943|FG000|Overall Study|Lost to Follow-up|2|||
38072512|NCT03073005|69767944|FG001|Overall Study|Lost to Follow-up|2|||
38072513|NCT03073005|69767945|FG002|Overall Study|Lost to Follow-up|1|||
38072514|NCT03073005|69767946|FG003|Overall Study|Lost to Follow-up|2|||
38072515|NCT03073005|69767943|FG000|Overall Study|Withdrawal by Subject|0|||
38072516|NCT03073005|69767944|FG001|Overall Study|Withdrawal by Subject|4|||
38072517|NCT03073005|69767945|FG002|Overall Study|Withdrawal by Subject|4|||
38072518|NCT03073005|69767946|FG003|Overall Study|Withdrawal by Subject|4|||
38072519|NCT02849171|69767959|FG000|Overall Study|Withdrawal by Subject|1|||
38072520|NCT02849171|69767959|FG000|Overall Study|Not treated|1|||
38072521|NCT02848664|69767972|FG000|Overall Study|Withdrawal by Subject|2|||
38072522|NCT02848664|69767972|FG000|Overall Study|Adverse Event|1|||
38072523|NCT02848664|69767972|FG000|Overall Study|no assistance for device training|1|||
38072524|NCT02969382|69767982|FG000|Overall Study|Adverse Event|8|||
38072525|NCT02969382|69767983|FG001|Overall Study|Adverse Event|10|||
38072526|NCT02969382|69767982|FG000|Overall Study|Lack of Efficacy|4|||
38072527|NCT02969382|69767983|FG001|Overall Study|Lack of Efficacy|5|||
38072528|NCT02969382|69767982|FG000|Overall Study|Death|0|||
38072529|NCT02969382|69767983|FG001|Overall Study|Death|1|||
38072530|NCT02969382|69767982|FG000|Overall Study|PROTOCOL DEVIATION|0|||
38072531|NCT02969382|69767983|FG001|Overall Study|PROTOCOL DEVIATION|1|||
38072532|NCT02969382|69767982|FG000|Overall Study|Withdrawal by Subject|14|||
38072533|NCT02969382|69767983|FG001|Overall Study|Withdrawal by Subject|9|||
38072534|NCT01989104|69767994|FG000|Overall Study|Withdrawal by Subject|3|||
38072535|NCT01989104|69767995|FG001|Overall Study|Withdrawal by Subject|0|||
38072536|NCT01989104|69767996|FG002|Overall Study|Withdrawal by Subject|0|||
38072537|NCT01989104|69767997|FG003|Overall Study|Withdrawal by Subject|0|||
38072538|NCT01989104|69767998|FG004|Overall Study|Withdrawal by Subject|0|||
38072539|NCT02903238|69768010|FG000|Overall Study|Lost to Follow-up|4|||
38072540|NCT02847260|69768015|FG000|Overall Study|Adverse Event|3|||
38072541|NCT02847260|69768015|FG000|Overall Study|Withdrawal by Subject|2|||
38072542|NCT02847260|69768015|FG000|Overall Study|Clinical Deterioration|1|||
38072543|NCT02847260|69768015|FG000|Overall Study|Physician Decision|1|||
38072544|NCT02968563|69768021|FG000|Overall Study|Adverse Event|0|||
38072545|NCT02968563|69768022|FG001|Overall Study|Adverse Event|6|||
38072546|NCT02968563|69768021|FG000|Overall Study|Death|1|||
38072547|NCT02968563|69768022|FG001|Overall Study|Death|1|||
38072548|NCT02968563|69768021|FG000|Overall Study|Lost to Follow-up|0|||
38072549|NCT02968563|69768022|FG001|Overall Study|Lost to Follow-up|1|||
38072550|NCT02904096|69768030|FG000|Overall Study|Adverse Event|1|||
38072551|NCT02904096|69768031|FG001|Overall Study|Adverse Event|0|||
38072552|NCT02904096|69768030|FG000|Overall Study|Withdrawal by Subject|4|||
38072553|NCT02904096|69768031|FG001|Overall Study|Withdrawal by Subject|3|||
38072554|NCT02904096|69768030|FG000|Overall Study|Lost to Follow-up|10|||
38072555|NCT02904096|69768031|FG001|Overall Study|Lost to Follow-up|17|||
38072556|NCT02904096|69768030|FG000|Overall Study|Non-compliant|3|||
38072557|NCT02904096|69768031|FG001|Overall Study|Non-compliant|1|||
38072558|NCT02904096|69768030|FG000|Overall Study|Sponsor instructed|1|||
38072559|NCT02904096|69768031|FG001|Overall Study|Sponsor instructed|0|||
38072560|NCT03161405|69768041|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
38072561|NCT01813929|69768050|FG000|Overall Study|Withdrawal by Subject|0|||
38072562|NCT01813929|69768051|FG001|Overall Study|Withdrawal by Subject|1|||
38072563|NCT02901054|69768061|FG000|Overall Study|Physician Decision|1|||
38072564|NCT02901054|69768061|FG000|Overall Study|Withdrawal by Subject|3|||
38072565|NCT03068715|69768067|FG000|Overall Study|No longer met inclusion criteria|1|||
38072566|NCT03068715|69768068|FG001|Overall Study|No longer met inclusion criteria|0|||
38072567|NCT02966340|69768076|FG000|Overall Study|Adverse Event|0|||
38072568|NCT02966340|69768077|FG001|Overall Study|Adverse Event|1|||
38072569|NCT02966340|69768076|FG000|Overall Study|Lost to Follow-up|0|||
38072570|NCT02966340|69768077|FG001|Overall Study|Lost to Follow-up|1|||
38072571|NCT02966340|69768076|FG000|Overall Study|Withdrawal by Subject|1|||
38072572|NCT02966340|69768077|FG001|Overall Study|Withdrawal by Subject|0|||
38072573|NCT02966340|69768076|FG000|Overall Study|data acquisition error|1|||
38072574|NCT02966340|69768077|FG001|Overall Study|data acquisition error|0|||
38072575|NCT02966340|69768076|FG000|Overall Study|startle non-responder|1|||
38072576|NCT02966340|69768077|FG001|Overall Study|startle non-responder|1|||
38072577|NCT03067311|69768085|FG000|Overall Study|Lost to Follow-up|1|||
38072578|NCT03067311|69768086|FG001|Overall Study|Lost to Follow-up|1|||
38072579|NCT03067311|69768085|FG000|Overall Study|Moved away|1|||
38072580|NCT03067311|69768086|FG001|Overall Study|Moved away|1|||
38072581|NCT04380519|69768095|FG000|Overall Study|Withdrawal by Subject|4|||
38072582|NCT04380519|69768096|FG001|Overall Study|Withdrawal by Subject|0|||
38072583|NCT04380519|69768097|FG002|Overall Study|Withdrawal by Subject|1|||
38072584|NCT04380519|69768095|FG000|Overall Study|Death|14|||
38072585|NCT04380519|69768096|FG001|Overall Study|Death|9|||
38072586|NCT04380519|69768097|FG002|Overall Study|Death|6|||
38072587|NCT04380519|69768095|FG000|Overall Study|Adverse Event|0|||
38072588|NCT04380519|69768096|FG001|Overall Study|Adverse Event|1|||
38072589|NCT04380519|69768097|FG002|Overall Study|Adverse Event|0|||
38072590|NCT04380519|69768095|FG000|Overall Study|relatives' decision|0|||
38072591|NCT04380519|69768096|FG001|Overall Study|relatives' decision|1|||
38072592|NCT04380519|69768097|FG002|Overall Study|relatives' decision|0|||
38072593|NCT02847182|69768107|FG000|Overall Study|Withdrawal by Subject|0|||
38072594|NCT02847182|69768108|FG001|Overall Study|Withdrawal by Subject|1|||
38072595|NCT02846558|69768124|FG000|Overall Study|Adverse Event|1|||
38072596|NCT02846558|69768125|FG001|Overall Study|Adverse Event|0|||
38072597|NCT02846558|69768126|FG002|Overall Study|Adverse Event|0|||
38072598|NCT02846558|69768127|FG003|Overall Study|Adverse Event|0|||
38072599|NCT02846558|69768124|FG000|Overall Study|Withdrawal by Subject|5|||
38072600|NCT02846558|69768125|FG001|Overall Study|Withdrawal by Subject|4|||
38072601|NCT02846558|69768126|FG002|Overall Study|Withdrawal by Subject|2|||
38072602|NCT02846558|69768127|FG003|Overall Study|Withdrawal by Subject|2|||
38072603|NCT02846558|69768124|FG000|Overall Study|Lost to Follow-up|2|||
38072604|NCT02846558|69768125|FG001|Overall Study|Lost to Follow-up|0|||
38072605|NCT02846558|69768126|FG002|Overall Study|Lost to Follow-up|0|||
38072606|NCT02846558|69768127|FG003|Overall Study|Lost to Follow-up|0|||
38072607|NCT04362813|69768146|FG000|Overall Study|Death|12|||
38072608|NCT04362813|69768147|FG001|Overall Study|Death|16|||
38072609|NCT04362813|69768146|FG000|Overall Study|Withdrawal by Subject|3|||
38072610|NCT04362813|69768147|FG001|Overall Study|Withdrawal by Subject|1|||
38072611|NCT04362813|69768146|FG000|Overall Study|Protocol Violation|0|||
38072612|NCT04362813|69768147|FG001|Overall Study|Protocol Violation|3|||
38072613|NCT04362813|69768146|FG000|Overall Study|Lost to Follow-up|1|||
38072614|NCT04362813|69768147|FG001|Overall Study|Lost to Follow-up|1|||
38072615|NCT04362813|69768146|FG000|Overall Study|Enrolled but did not receive treatment|2|||
38072616|NCT04362813|69768147|FG001|Overall Study|Enrolled but did not receive treatment|4|||
38072617|NCT02966028|69768156|FG000|Overall Study|Adverse Event|7|||
38072618|NCT02966028|69768157|FG001|Overall Study|Adverse Event|13|||
38072619|NCT02966028|69768158|FG002|Overall Study|Adverse Event|10|||
38072620|NCT02966028|69768156|FG000|Overall Study|Physician Decision|1|||
38072621|NCT02966028|69768157|FG001|Overall Study|Physician Decision|0|||
38072622|NCT02966028|69768158|FG002|Overall Study|Physician Decision|2|||
38072623|NCT02966028|69768156|FG000|Overall Study|Withdrawal by Subject|7|||
38072624|NCT02966028|69768157|FG001|Overall Study|Withdrawal by Subject|5|||
38072625|NCT02966028|69768158|FG002|Overall Study|Withdrawal by Subject|5|||
38072626|NCT02966028|69768156|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
38072627|NCT02966028|69768157|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
38072628|NCT02966028|69768158|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
38072629|NCT02925741|69768172|FG000|Overall Study|Withdrawal by Subject|11|||
38072630|NCT02925741|69768173|FG001|Overall Study|Withdrawal by Subject|0|||
38072631|NCT02964312|69768182|FG000|Overall Study|Lost to Follow-up|28|||
38072632|NCT02964312|69768182|FG000|Overall Study|Withdrawal by Subject|11|||
38072633|NCT02964312|69768182|FG000|Overall Study|Lack of Efficacy|10|||
38072634|NCT02964312|69768182|FG000|Overall Study|Did not consent to long-term FU|14|||
38072635|NCT02964312|69768182|FG000|Overall Study|Death|1|||
38072636|NCT02899962|69768206|FG000|Open-label Phase|Adverse Event|2|||
38072637|NCT02899962|69768207|FG001|Open-label Phase|Adverse Event|0|||
38072638|NCT02899962|69768208|FG002|Open-label Phase|Adverse Event|0|||
38072639|NCT02899962|69768206|FG000|Open-label Phase|Lost to Follow-up|9|||
38072640|NCT02899962|69768207|FG001|Open-label Phase|Lost to Follow-up|0|||
38072641|NCT02899962|69768208|FG002|Open-label Phase|Lost to Follow-up|0|||
38072642|NCT02899962|69768206|FG000|Open-label Phase|Other reasons|9|||
38072643|NCT02899962|69768207|FG001|Open-label Phase|Other reasons|0|||
38072644|NCT02899962|69768208|FG002|Open-label Phase|Other reasons|0|||
38072645|NCT02899962|69768206|FG000|Open-label Phase|Withdrawal by Subject|7|||
37680399|NCT02582671|69156042|FG000|Overall Study|Other, not specified|1|||
38072646|NCT02899962|69768207|FG001|Open-label Phase|Withdrawal by Subject|0|||
38072647|NCT02899962|69768208|FG002|Open-label Phase|Withdrawal by Subject|0|||
38072648|NCT02899962|69768206|FG000|Maintenance Phase|Adverse Event|0|||
38072649|NCT02899962|69768207|FG001|Maintenance Phase|Adverse Event|2|||
37680400|NCT02585713|69156049|FG000|Overall Study|Withdrew prior to treatment|2|||
38072650|NCT02899962|69768208|FG002|Maintenance Phase|Adverse Event|1|||
38072651|NCT02899962|69768206|FG000|Maintenance Phase|Death|0|||
38072652|NCT02899962|69768207|FG001|Maintenance Phase|Death|0|||
38072653|NCT02899962|69768208|FG002|Maintenance Phase|Death|1|||
38072654|NCT02899962|69768206|FG000|Maintenance Phase|Lack of Efficacy|0|||
38072655|NCT02899962|69768207|FG001|Maintenance Phase|Lack of Efficacy|20|||
38072656|NCT02899962|69768208|FG002|Maintenance Phase|Lack of Efficacy|16|||
38072657|NCT02899962|69768206|FG000|Maintenance Phase|Lost to Follow-up|0|||
38072658|NCT02899962|69768207|FG001|Maintenance Phase|Lost to Follow-up|12|||
38072659|NCT02899962|69768208|FG002|Maintenance Phase|Lost to Follow-up|14|||
38072660|NCT02899962|69768206|FG000|Maintenance Phase|Other reasons|0|||
38072661|NCT02899962|69768207|FG001|Maintenance Phase|Other reasons|9|||
38072662|NCT02899962|69768208|FG002|Maintenance Phase|Other reasons|13|||
38072663|NCT02899962|69768206|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
38072664|NCT02899962|69768207|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
38072665|NCT02899962|69768208|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
38072666|NCT02899962|69768206|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
38072667|NCT02899962|69768207|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
38072668|NCT02899962|69768208|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
38072669|NCT02899962|69768206|FG000|Maintenance Phase|Withdrawal by Subject|0|||
38072670|NCT02899962|69768207|FG001|Maintenance Phase|Withdrawal by Subject|30|||
38072671|NCT02899962|69768208|FG002|Maintenance Phase|Withdrawal by Subject|36|||
38072672|NCT02899338|69768217|FG000|Overall Study|Adverse Event|1|||
38072673|NCT02899338|69768218|FG001|Overall Study|Adverse Event|2|||
38072674|NCT02899338|69768217|FG000|Overall Study|Withdrawal by Subject|2|||
38072675|NCT02899338|69768218|FG001|Overall Study|Withdrawal by Subject|0|||
38072676|NCT03066609|69768227|FG000|INDUCTION|Pregnancy|0|||
38072677|NCT03066609|69768228|FG001|INDUCTION|Pregnancy|0|||
38072678|NCT03066609|69768229|FG002|INDUCTION|Pregnancy|1|||
38072679|NCT03066609|69768230|FG003|INDUCTION|Pregnancy|0|||
38072680|NCT03066609|69768227|FG000|INDUCTION|Lack of Efficacy|0|||
38072681|NCT03066609|69768228|FG001|INDUCTION|Lack of Efficacy|0|||
38072682|NCT03066609|69768229|FG002|INDUCTION|Lack of Efficacy|1|||
38072683|NCT03066609|69768230|FG003|INDUCTION|Lack of Efficacy|0|||
38072684|NCT03066609|69768227|FG000|INDUCTION|Adverse Event|2|||
38072685|NCT03066609|69768228|FG001|INDUCTION|Adverse Event|2|||
38072686|NCT03066609|69768229|FG002|INDUCTION|Adverse Event|0|||
38072687|NCT03066609|69768230|FG003|INDUCTION|Adverse Event|0|||
38072688|NCT03066609|69768227|FG000|MAINTENANCE|Adverse Event|0|||
38072689|NCT03066609|69768228|FG001|MAINTENANCE|Adverse Event|0|||
38072690|NCT03066609|69768229|FG002|MAINTENANCE|Adverse Event|0|||
38072691|NCT03066609|69768230|FG003|MAINTENANCE|Adverse Event|1|||
38072692|NCT03066609|69768227|FG000|MAINTENANCE|Withdrawal by Subject|4|||
38072693|NCT03066609|69768228|FG001|MAINTENANCE|Withdrawal by Subject|2|||
38072694|NCT03066609|69768229|FG002|MAINTENANCE|Withdrawal by Subject|1|||
38072695|NCT03066609|69768230|FG003|MAINTENANCE|Withdrawal by Subject|1|||
38072696|NCT03066609|69768227|FG000|MAINTENANCE|Lost to Follow-up|0|||
38072697|NCT03066609|69768228|FG001|MAINTENANCE|Lost to Follow-up|1|||
38072698|NCT03066609|69768229|FG002|MAINTENANCE|Lost to Follow-up|1|||
38072699|NCT03066609|69768230|FG003|MAINTENANCE|Lost to Follow-up|0|||
38072700|NCT03066609|69768227|FG000|MAINTENANCE|Pregnancy|1|||
38072701|NCT03066609|69768228|FG001|MAINTENANCE|Pregnancy|0|||
38072702|NCT03066609|69768229|FG002|MAINTENANCE|Pregnancy|0|||
38072703|NCT03066609|69768230|FG003|MAINTENANCE|Pregnancy|0|||
38072704|NCT03066609|69768227|FG000|MAINTENANCE|Lack of Efficacy|2|||
38072705|NCT03066609|69768228|FG001|MAINTENANCE|Lack of Efficacy|1|||
38072706|NCT03066609|69768229|FG002|MAINTENANCE|Lack of Efficacy|0|||
38072707|NCT03066609|69768230|FG003|MAINTENANCE|Lack of Efficacy|1|||
38072708|NCT03066609|69768227|FG000|OVERALL STUDY|Adverse Event|2|||
37966101|NCT00486603|69653000|FG001|Overall Study|Physician Decision|1|||
37966102|NCT00486603|69653001|FG002|Overall Study|Physician Decision|0|||
37966103|NCT00486603|69653002|FG003|Overall Study|Physician Decision|0|||
37966104|NCT00486603|69653003|FG004|Overall Study|Physician Decision|0|||
37966105|NCT00486291|69653020|FG000|Overall Study|Adverse Event|3|||
37966106|NCT00486291|69653021|FG001|Overall Study|Adverse Event|4|||
37966107|NCT00486291|69653020|FG000|Overall Study|Lost to Follow-up|3|||
37966108|NCT00486291|69653021|FG001|Overall Study|Lost to Follow-up|7|||
37966109|NCT00486291|69653020|FG000|Overall Study|protocol non-compliance|10|||
38072709|NCT03066609|69768228|FG001|OVERALL STUDY|Adverse Event|2|||
38072710|NCT03066609|69768229|FG002|OVERALL STUDY|Adverse Event|0|||
38072711|NCT03066609|69768230|FG003|OVERALL STUDY|Adverse Event|1|||
38072712|NCT03066609|69768227|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
38072713|NCT03066609|69768228|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
38072714|NCT03066609|69768229|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
38072715|NCT03066609|69768230|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
38072716|NCT03066609|69768227|FG000|OVERALL STUDY|Lost to Follow-up|1|||
38072717|NCT03066609|69768228|FG001|OVERALL STUDY|Lost to Follow-up|1|||
37966110|NCT00486291|69653021|FG001|Overall Study|protocol non-compliance|15|||
37966111|NCT00486291|69653020|FG000|Overall Study|requirement for restricted medication|0|||
37966112|NCT00486291|69653021|FG001|Overall Study|requirement for restricted medication|3|||
38072718|NCT03066609|69768229|FG002|OVERALL STUDY|Lost to Follow-up|1|||
38072719|NCT03066609|69768230|FG003|OVERALL STUDY|Lost to Follow-up|1|||
38072720|NCT03066609|69768227|FG000|OVERALL STUDY|Pregnancy|1|||
38072721|NCT03066609|69768228|FG001|OVERALL STUDY|Pregnancy|0|||
37966113|NCT00474045|69653029|FG000|Overall Study|Adverse Event|18|||
37966114|NCT00474045|69653030|FG001|Overall Study|Adverse Event|8|||
38072722|NCT03066609|69768229|FG002|OVERALL STUDY|Pregnancy|1|||
38072723|NCT03066609|69768230|FG003|OVERALL STUDY|Pregnancy|0|||
38072724|NCT03066609|69768227|FG000|OVERALL STUDY|Lack of Efficacy|2|||
38072725|NCT03066609|69768228|FG001|OVERALL STUDY|Lack of Efficacy|1|||
38072726|NCT03066609|69768229|FG002|OVERALL STUDY|Lack of Efficacy|1|||
38072727|NCT03066609|69768230|FG003|OVERALL STUDY|Lack of Efficacy|1|||
38072728|NCT03066609|69768227|FG000|OVERALL STUDY|discontinued follow up|0|||
38072729|NCT03066609|69768228|FG001|OVERALL STUDY|discontinued follow up|2|||
38072730|NCT03066609|69768229|FG002|OVERALL STUDY|discontinued follow up|0|||
38072731|NCT03066609|69768230|FG003|OVERALL STUDY|discontinued follow up|0|||
38072732|NCT02964234|69768247|FG000|Overall Study|Lost to Follow-up|22|||
38072733|NCT02964234|69768248|FG001|Overall Study|Lost to Follow-up|13|||
38072734|NCT01345188|69768254|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
38072735|NCT01345188|69768254|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
38072736|NCT03852459|69768263|FG000|Overall Study|Adverse Event|2|||
38072737|NCT03852459|69768264|FG001|Overall Study|Adverse Event|2|||
38072738|NCT03852459|69768263|FG000|Overall Study|Withdrawal by Subject|1|||
38072739|NCT03852459|69768264|FG001|Overall Study|Withdrawal by Subject|1|||
38072740|NCT02896296|69768270|FG000|Overall Study|Adverse Event|1|||
38072741|NCT02896296|69768270|FG000|Overall Study|Lost to Follow-up|19|||
38072742|NCT02896296|69768270|FG000|Overall Study|Pregnancy|1|||
38072743|NCT02896296|69768270|FG000|Overall Study|Physician Decision|2|||
38072744|NCT02896296|69768270|FG000|Overall Study|Withdrawal by Subject|10|||
38072745|NCT02896296|69768270|FG000|Overall Study|Site closing|7|||
38072746|NCT02896296|69768270|FG000|Overall Study|Incarceration|1|||
38072747|NCT02896296|69768270|FG000|Overall Study|Relocation|1|||
38072748|NCT03740919|69768277|FG000|Lead-in Period|Lost to Follow-up|1|||
38072749|NCT03740919|69768278|FG001|Lead-in Period|Lost to Follow-up|0|||
38072750|NCT03740919|69768279|FG002|Lead-in Period|Lost to Follow-up|0|||
38072751|NCT03740919|69768280|FG003|Lead-in Period|Lost to Follow-up|0|||
38072752|NCT03740919|69768277|FG000|Lead-in Period|Physician Decision|2|||
38072753|NCT03740919|69768278|FG001|Lead-in Period|Physician Decision|0|||
38072754|NCT03740919|69768279|FG002|Lead-in Period|Physician Decision|0|||
38072755|NCT03740919|69768280|FG003|Lead-in Period|Physician Decision|0|||
38072756|NCT03740919|69768277|FG000|Lead-in Period|Protocol Violation|1|||
38072757|NCT03740919|69768278|FG001|Lead-in Period|Protocol Violation|0|||
38072758|NCT03740919|69768279|FG002|Lead-in Period|Protocol Violation|0|||
38072759|NCT03740919|69768280|FG003|Lead-in Period|Protocol Violation|0|||
38072760|NCT03740919|69768277|FG000|Lead-in Period|Withdrawal by Subject|10|||
38072761|NCT03740919|69768278|FG001|Lead-in Period|Withdrawal by Subject|0|||
38072762|NCT03740919|69768279|FG002|Lead-in Period|Withdrawal by Subject|0|||
38072763|NCT03740919|69768280|FG003|Lead-in Period|Withdrawal by Subject|0|||
38072764|NCT03740919|69768277|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
38072765|NCT03740919|69768278|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
38072766|NCT03740919|69768279|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
38072767|NCT03740919|69768280|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
38072768|NCT03740919|69768277|FG000|Lead-in Period|Study Task Too Burdensome|1|||
38072769|NCT03740919|69768278|FG001|Lead-in Period|Study Task Too Burdensome|0|||
38072770|NCT03740919|69768279|FG002|Lead-in Period|Study Task Too Burdensome|0|||
38072771|NCT03740919|69768280|FG003|Lead-in Period|Study Task Too Burdensome|0|||
38072772|NCT03740919|69768277|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
38072773|NCT03740919|69768278|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
38072774|NCT03740919|69768279|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
38072775|NCT03740919|69768280|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
38072776|NCT03740919|69768277|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
38072777|NCT03740919|69768278|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
38072778|NCT03740919|69768279|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
38072779|NCT03740919|69768280|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
38072780|NCT03740919|69768277|FG000|Treatment Period|Adverse Event|0|||
38072781|NCT03740919|69768278|FG001|Treatment Period|Adverse Event|0|||
38072782|NCT03740919|69768279|FG002|Treatment Period|Adverse Event|2|||
38072783|NCT03740919|69768280|FG003|Treatment Period|Adverse Event|0|||
38072784|NCT03740919|69768277|FG000|Treatment Period|Protocol Violation|0|||
38072785|NCT03740919|69768278|FG001|Treatment Period|Protocol Violation|1|||
38072786|NCT03740919|69768279|FG002|Treatment Period|Protocol Violation|0|||
38072787|NCT03740919|69768280|FG003|Treatment Period|Protocol Violation|0|||
38072788|NCT03740919|69768277|FG000|Treatment Period|Withdrawal by Subject|0|||
38072789|NCT03740919|69768278|FG001|Treatment Period|Withdrawal by Subject|7|||
38072790|NCT03740919|69768279|FG002|Treatment Period|Withdrawal by Subject|6|||
38072791|NCT03740919|69768280|FG003|Treatment Period|Withdrawal by Subject|2|||
38072792|NCT03740919|69768277|FG000|Treatment Period|Terminated by Sponsor|0|||
38072793|NCT03740919|69768278|FG001|Treatment Period|Terminated by Sponsor|1|||
38072794|NCT03740919|69768279|FG002|Treatment Period|Terminated by Sponsor|0|||
38072795|NCT03740919|69768280|FG003|Treatment Period|Terminated by Sponsor|0|||
38072796|NCT03740919|69768277|FG000|Treatment Period|Issue with Insulin Pump|0|||
38072797|NCT03740919|69768278|FG001|Treatment Period|Issue with Insulin Pump|1|||
38072798|NCT03740919|69768279|FG002|Treatment Period|Issue with Insulin Pump|0|||
38072799|NCT03740919|69768280|FG003|Treatment Period|Issue with Insulin Pump|0|||
38072800|NCT03740919|69768277|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
38072801|NCT03740919|69768278|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
38072802|NCT03740919|69768279|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
38072803|NCT03740919|69768280|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
38072804|NCT03740919|69768277|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
38072805|NCT03740919|69768278|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
38072806|NCT03740919|69768279|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
38072807|NCT03740919|69768280|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
38072808|NCT03740919|69768277|FG000|Treatment Period|Not Completing Diary|0|||
38072809|NCT03740919|69768278|FG001|Treatment Period|Not Completing Diary|0|||
38072810|NCT03740919|69768279|FG002|Treatment Period|Not Completing Diary|1|||
38072811|NCT03740919|69768280|FG003|Treatment Period|Not Completing Diary|0|||
38072812|NCT03740919|69768277|FG000|Treatment Period|Insulin Painful to Participant|0|||
38072813|NCT03740919|69768278|FG001|Treatment Period|Insulin Painful to Participant|0|||
38072814|NCT03740919|69768279|FG002|Treatment Period|Insulin Painful to Participant|1|||
38072815|NCT03740919|69768280|FG003|Treatment Period|Insulin Painful to Participant|0|||
38072816|NCT01335685|69768295|FG000|Overall Study|Study Terminated by Sponsor|2|||
38072817|NCT01335685|69768296|FG001|Overall Study|Study Terminated by Sponsor|1|||
38072818|NCT01335685|69768297|FG002|Overall Study|Study Terminated by Sponsor|1|||
38072819|NCT01335685|69768298|FG003|Overall Study|Study Terminated by Sponsor|10|||
38072820|NCT01335685|69768299|FG004|Overall Study|Study Terminated by Sponsor|0|||
38072821|NCT01335685|69768300|FG005|Overall Study|Study Terminated by Sponsor|4|||
38072822|NCT01335685|69768301|FG006|Overall Study|Study Terminated by Sponsor|2|||
38072823|NCT01335685|69768302|FG007|Overall Study|Study Terminated by Sponsor|3|||
38072824|NCT01335685|69768295|FG000|Overall Study|Withdrawal by Subject|1|||
38072825|NCT01335685|69768296|FG001|Overall Study|Withdrawal by Subject|0|||
38072826|NCT01335685|69768297|FG002|Overall Study|Withdrawal by Subject|0|||
38072827|NCT01335685|69768298|FG003|Overall Study|Withdrawal by Subject|1|||
38072828|NCT01335685|69768299|FG004|Overall Study|Withdrawal by Subject|0|||
38072829|NCT01335685|69768300|FG005|Overall Study|Withdrawal by Subject|0|||
38072830|NCT01335685|69768301|FG006|Overall Study|Withdrawal by Subject|0|||
38072831|NCT01335685|69768302|FG007|Overall Study|Withdrawal by Subject|0|||
38072832|NCT01335685|69768295|FG000|Overall Study|Reason not Specified|0|||
38072833|NCT01335685|69768296|FG001|Overall Study|Reason not Specified|0|||
38072834|NCT01335685|69768297|FG002|Overall Study|Reason not Specified|1|||
38072835|NCT01335685|69768298|FG003|Overall Study|Reason not Specified|0|||
38072836|NCT01335685|69768299|FG004|Overall Study|Reason not Specified|0|||
38072837|NCT01335685|69768300|FG005|Overall Study|Reason not Specified|1|||
38072838|NCT01335685|69768301|FG006|Overall Study|Reason not Specified|0|||
38072839|NCT01335685|69768302|FG007|Overall Study|Reason not Specified|0|||
38072840|NCT02926209|69768325|FG000|Study Cohort|Poor Bowel Preparation|1|||
38072841|NCT02926209|69768326|FG001|Study Cohort|Poor Bowel Preparation|0|||
38072842|NCT03066999|69768335|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
38072843|NCT03066999|69768336|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
38072844|NCT02963922|69768350|FG000|Overall Study|Adverse Event|15|||
38072845|NCT02963922|69768351|FG001|Overall Study|Adverse Event|6|||
38072846|NCT02963922|69768350|FG000|Overall Study|Protocol deviation|6|||
38072847|NCT02963922|69768351|FG001|Overall Study|Protocol deviation|6|||
38072848|NCT02963922|69768350|FG000|Overall Study|Lack of Efficacy|1|||
38072849|NCT02963922|69768351|FG001|Overall Study|Lack of Efficacy|1|||
38072850|NCT02963922|69768350|FG000|Overall Study|Lost to Follow-up|2|||
38072851|NCT02963922|69768351|FG001|Overall Study|Lost to Follow-up|3|||
38072852|NCT02963922|69768350|FG000|Overall Study|Other|8|||
38072853|NCT02963922|69768351|FG001|Overall Study|Other|14|||
38072854|NCT02881567|69768357|FG000|Overall Study|Adverse Event|1|||
38072855|NCT02881567|69768357|FG000|Overall Study|Lost to Follow-up|3|||
38072856|NCT02881567|69768357|FG000|Overall Study|Consent withdrawn|1|||
38072857|NCT02881567|69768357|FG000|Overall Study|Investigator decision|1|||
38072858|NCT02881567|69768357|FG000|Overall Study|Study terminated by sponsor|9|||
38072859|NCT02881567|69768357|FG000|Overall Study|Reason not Specified|3|||
38072860|NCT02962674|69768361|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
38072861|NCT02962908|69768371|FG000|Overall Study|Lost to Follow-up|0|||
38072862|NCT02962908|69768372|FG001|Overall Study|Lost to Follow-up|3|||
37966115|NCT00474045|69653029|FG000|Overall Study|Unclassified|1|||
37966116|NCT00474045|69653030|FG001|Overall Study|Unclassified|3|||
38072863|NCT02962908|69768373|FG002|Overall Study|Lost to Follow-up|0|||
38072864|NCT02962908|69768374|FG003|Overall Study|Lost to Follow-up|1|||
38072865|NCT02962908|69768371|FG000|Overall Study|Withdrawal by Subject|0|||
38072866|NCT02962908|69768372|FG001|Overall Study|Withdrawal by Subject|3|||
38072867|NCT02962908|69768373|FG002|Overall Study|Withdrawal by Subject|0|||
38072868|NCT02962908|69768374|FG003|Overall Study|Withdrawal by Subject|2|||
38072869|NCT02962908|69768371|FG000|Overall Study|Protocol Violation|0|||
38072870|NCT02962908|69768372|FG001|Overall Study|Protocol Violation|1|||
37966117|NCT00474045|69653029|FG000|Overall Study|Lack of Efficacy|0|||
38072871|NCT02962908|69768373|FG002|Overall Study|Protocol Violation|0|||
38072872|NCT02962908|69768374|FG003|Overall Study|Protocol Violation|0|||
38072873|NCT02962908|69768371|FG000|Overall Study|Physician Decision|0|||
38072874|NCT02962908|69768372|FG001|Overall Study|Physician Decision|1|||
38072875|NCT02962908|69768373|FG002|Overall Study|Physician Decision|0|||
38072876|NCT02962908|69768374|FG003|Overall Study|Physician Decision|0|||
38072877|NCT02962284|69768392|FG000|Overall Study|Death|2|||
38072878|NCT02962284|69768393|FG001|Overall Study|Death|0|||
38072879|NCT02962284|69768392|FG000|Overall Study|Progressive disease|2|||
38072880|NCT02962284|69768393|FG001|Overall Study|Progressive disease|3|||
38072881|NCT02962284|69768392|FG000|Overall Study|Withdrawal by Subject|1|||
38072882|NCT02962284|69768393|FG001|Overall Study|Withdrawal by Subject|0|||
38072883|NCT01344876|69768401|FG000|Overall Study|Adverse Event|0|||
38072884|NCT01344876|69768402|FG001|Overall Study|Adverse Event|0|||
38072885|NCT01344876|69768403|FG002|Overall Study|Adverse Event|0|||
38072886|NCT01344876|69768404|FG003|Overall Study|Adverse Event|0|||
38072887|NCT01344876|69768405|FG004|Overall Study|Adverse Event|1|||
38072888|NCT01344876|69768401|FG000|Overall Study|Withdrawal by Subject|0|||
38072889|NCT01344876|69768402|FG001|Overall Study|Withdrawal by Subject|0|||
38072890|NCT01344876|69768403|FG002|Overall Study|Withdrawal by Subject|1|||
38072891|NCT01344876|69768404|FG003|Overall Study|Withdrawal by Subject|0|||
38072892|NCT01344876|69768405|FG004|Overall Study|Withdrawal by Subject|0|||
38072893|NCT01344876|69768401|FG000|Overall Study|Definite progression of primary disease|1|||
38072894|NCT01344876|69768402|FG001|Overall Study|Definite progression of primary disease|0|||
38072895|NCT01344876|69768403|FG002|Overall Study|Definite progression of primary disease|0|||
38072896|NCT01344876|69768404|FG003|Overall Study|Definite progression of primary disease|3|||
38072897|NCT01344876|69768405|FG004|Overall Study|Definite progression of primary disease|0|||
38072898|NCT02846324|69768422|FG000|Overall Study|Other|1|||
38072899|NCT02846324|69768423|FG001|Overall Study|Other|0|||
38072900|NCT02846324|69768424|FG002|Overall Study|Other|0|||
38072901|NCT02846324|69768425|FG003|Overall Study|Other|0|||
38072902|NCT02846324|69768422|FG000|Overall Study|Withdrawal by Subject|1|||
38072903|NCT02846324|69768423|FG001|Overall Study|Withdrawal by Subject|0|||
38072904|NCT02846324|69768424|FG002|Overall Study|Withdrawal by Subject|4|||
38072905|NCT02846324|69768425|FG003|Overall Study|Withdrawal by Subject|0|||
38072906|NCT03161093|69768450|FG000|Overall Study|Protocol Violation|11|||
38072907|NCT03161093|69768451|FG001|Overall Study|Protocol Violation|14|||
38072908|NCT03161093|69768452|FG002|Overall Study|Protocol Violation|6|||
38072909|NCT03161093|69768453|FG003|Overall Study|Protocol Violation|13|||
38072910|NCT03161093|69768454|FG004|Overall Study|Protocol Violation|1|||
38072911|NCT03161093|69768455|FG005|Overall Study|Protocol Violation|0|||
38072912|NCT03161093|69768450|FG000|Overall Study|Adverse Event|5|||
38072913|NCT03161093|69768451|FG001|Overall Study|Adverse Event|21|||
38072914|NCT03161093|69768452|FG002|Overall Study|Adverse Event|16|||
38072915|NCT03161093|69768453|FG003|Overall Study|Adverse Event|35|||
38072916|NCT03161093|69768454|FG004|Overall Study|Adverse Event|2|||
38072917|NCT03161093|69768455|FG005|Overall Study|Adverse Event|1|||
38072918|NCT03161093|69768450|FG000|Overall Study|Lack of Efficacy|9|||
38072919|NCT03161093|69768451|FG001|Overall Study|Lack of Efficacy|13|||
38072920|NCT03161093|69768452|FG002|Overall Study|Lack of Efficacy|9|||
38072921|NCT03161093|69768453|FG003|Overall Study|Lack of Efficacy|24|||
38072922|NCT03161093|69768454|FG004|Overall Study|Lack of Efficacy|4|||
38072923|NCT03161093|69768455|FG005|Overall Study|Lack of Efficacy|1|||
38072924|NCT03161093|69768450|FG000|Overall Study|Physician Decision|0|||
38072925|NCT03161093|69768451|FG001|Overall Study|Physician Decision|1|||
38072926|NCT03161093|69768452|FG002|Overall Study|Physician Decision|0|||
38072927|NCT03161093|69768453|FG003|Overall Study|Physician Decision|2|||
38072928|NCT03161093|69768454|FG004|Overall Study|Physician Decision|17|||
38072929|NCT03161093|69768455|FG005|Overall Study|Physician Decision|15|||
38072930|NCT03161093|69768450|FG000|Overall Study|Withdrawal by Subject|24|||
38072931|NCT03161093|69768451|FG001|Overall Study|Withdrawal by Subject|73|||
38072932|NCT03161093|69768452|FG002|Overall Study|Withdrawal by Subject|44|||
38072933|NCT03161093|69768453|FG003|Overall Study|Withdrawal by Subject|97|||
38072934|NCT03161093|69768454|FG004|Overall Study|Withdrawal by Subject|11|||
38072935|NCT03161093|69768455|FG005|Overall Study|Withdrawal by Subject|10|||
38072936|NCT03161093|69768450|FG000|Overall Study|Lost to Follow-up|3|||
37966118|NCT00474045|69653030|FG001|Overall Study|Lack of Efficacy|9|||
38072937|NCT03161093|69768451|FG001|Overall Study|Lost to Follow-up|12|||
38072938|NCT03161093|69768452|FG002|Overall Study|Lost to Follow-up|4|||
38072939|NCT03161093|69768453|FG003|Overall Study|Lost to Follow-up|7|||
38072940|NCT03161093|69768454|FG004|Overall Study|Lost to Follow-up|8|||
38072941|NCT03161093|69768455|FG005|Overall Study|Lost to Follow-up|13|||
38072942|NCT03161093|69768450|FG000|Overall Study|Death|3|||
38072943|NCT03161093|69768451|FG001|Overall Study|Death|9|||
38072944|NCT03161093|69768452|FG002|Overall Study|Death|7|||
38072945|NCT03161093|69768453|FG003|Overall Study|Death|9|||
38072946|NCT03161093|69768454|FG004|Overall Study|Death|0|||
37862345|NCT01129557|69546097|FG002|Overall Study|Adverse Event|2|||
38072947|NCT03161093|69768455|FG005|Overall Study|Death|0|||
38072948|NCT03161093|69768450|FG000|Overall Study|Unknown - Not reported|0|||
38072949|NCT03161093|69768451|FG001|Overall Study|Unknown - Not reported|1|||
38072950|NCT03161093|69768452|FG002|Overall Study|Unknown - Not reported|0|||
38072951|NCT03161093|69768453|FG003|Overall Study|Unknown - Not reported|0|||
38072952|NCT03161093|69768454|FG004|Overall Study|Unknown - Not reported|0|||
38072953|NCT03161093|69768455|FG005|Overall Study|Unknown - Not reported|1|||
38072954|NCT02847650|69768476|FG000|Overall Study|Adverse Event|2|||
38072955|NCT02847650|69768477|FG001|Overall Study|Adverse Event|4|||
38072956|NCT02847650|69768476|FG000|Overall Study|Lost to Follow-up|1|||
38072957|NCT02847650|69768477|FG001|Overall Study|Lost to Follow-up|0|||
38072958|NCT02847650|69768476|FG000|Overall Study|Protocol Violation|0|||
38072959|NCT02847650|69768477|FG001|Overall Study|Protocol Violation|1|||
38072960|NCT02847650|69768476|FG000|Overall Study|Withdrawal by Subject|1|||
38072961|NCT02847650|69768477|FG001|Overall Study|Withdrawal by Subject|1|||
38072962|NCT02847494|69768485|FG000|Overall Study|Lost to Follow-up|8|||
38072963|NCT02847494|69768486|FG001|Overall Study|Lost to Follow-up|5|||
38072964|NCT02554253|69768494|FG000|Overall Study|ineligible after enrollment|1|||
38072965|NCT02554253|69768495|FG001|Overall Study|ineligible after enrollment|0|||
38072966|NCT02554253|69768494|FG000|Overall Study|converted to transcatheter procedure|0|||
38072967|NCT02554253|69768495|FG001|Overall Study|converted to transcatheter procedure|1|||
38072968|NCT02554253|69768494|FG000|Overall Study|received both drugs|0|||
38072969|NCT02554253|69768495|FG001|Overall Study|received both drugs|1|||
38072970|NCT03157583|69768502|FG000|Overall Study|Other (did not meet study criteria)|1|||
38072971|NCT02842736|69768520|FG000|Overall Study|Lost to Follow-up|13|||
38072972|NCT02842736|69768520|FG000|Overall Study|Intervention for menstrual bleeding|17|||
38072973|NCT02842736|69768520|FG000|Overall Study|Withdrawal by Subject|4|||
38072974|NCT02842736|69768520|FG000|Overall Study|Pregnancy|3|||
38072975|NCT02842736|69768520|FG000|Overall Study|Hysterectomy for fibroids|2|||
38072976|NCT02842736|69768520|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
38072977|NCT02842736|69768520|FG000|Overall Study|IUD: Mirena|1|||
38072978|NCT01307033|69768526|FG000|8-week Double-blind Period|Adverse Event|2|||
38072979|NCT01307033|69768527|FG001|8-week Double-blind Period|Adverse Event|0|||
38072980|NCT01307033|69768528|FG002|8-week Double-blind Period|Adverse Event|0|||
38072981|NCT01307033|69768529|FG003|8-week Double-blind Period|Adverse Event|0|||
38072982|NCT01307033|69768526|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
38072983|NCT01307033|69768527|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
38072984|NCT01307033|69768528|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
38072985|NCT01307033|69768529|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
38072986|NCT01307033|69768526|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
38072987|NCT01307033|69768527|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
38072988|NCT01307033|69768528|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
38072989|NCT01307033|69768529|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
38072990|NCT01307033|69768526|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
38072991|NCT01307033|69768527|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
38072992|NCT01307033|69768528|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
38072993|NCT01307033|69768529|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
38072994|NCT01307033|69768526|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
38072995|NCT01307033|69768527|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
38072996|NCT01307033|69768528|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
38072997|NCT01307033|69768529|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
38072998|NCT01307033|69768526|FG000|44-week Open-label Extension|Adverse Event|0|||
38072999|NCT01307033|69768527|FG001|44-week Open-label Extension|Adverse Event|0|||
38073000|NCT01307033|69768528|FG002|44-week Open-label Extension|Adverse Event|2|||
38073001|NCT01307033|69768529|FG003|44-week Open-label Extension|Adverse Event|1|||
38073002|NCT01307033|69768526|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
38073003|NCT01307033|69768527|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
38073004|NCT01307033|69768528|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
38073005|NCT01307033|69768529|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
38073006|NCT01307033|69768526|FG000|44-week Open-label Extension|Physician Decision|0|||
38073007|NCT01307033|69768527|FG001|44-week Open-label Extension|Physician Decision|0|||
38073008|NCT01307033|69768528|FG002|44-week Open-label Extension|Physician Decision|1|||
38073009|NCT01307033|69768529|FG003|44-week Open-label Extension|Physician Decision|0|||
38073010|NCT01307033|69768526|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
38073011|NCT01307033|69768527|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
38073012|NCT01307033|69768528|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
38073013|NCT01307033|69768529|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
38073014|NCT01307033|69768526|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
38073015|NCT01307033|69768527|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
38073016|NCT01307033|69768528|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
38073017|NCT01307033|69768529|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
37966119|NCT00474045|69653029|FG000|Overall Study|Lost to Follow-up|1|||
38073018|NCT01307033|69768526|FG000|44-week Open-label Extension|Death|0|||
38073019|NCT01307033|69768527|FG001|44-week Open-label Extension|Death|0|||
38073020|NCT01307033|69768528|FG002|44-week Open-label Extension|Death|0|||
38073021|NCT01307033|69768529|FG003|44-week Open-label Extension|Death|1|||
38073022|NCT02844920|69768541|FG000|Overall Study|Lost to Follow-up|2|||
38073023|NCT03158311|69768548|FG000|Overall Study|Subject/Guardian Decision|10|||
38073024|NCT03158311|69768549|FG001|Overall Study|Subject/Guardian Decision|6|||
38073025|NCT03158311|69768550|FG002|Overall Study|Subject/Guardian Decision|11|||
38073026|NCT03158311|69768548|FG000|Overall Study|Adverse Event|5|||
38073027|NCT03158311|69768549|FG001|Overall Study|Adverse Event|3|||
38073028|NCT03158311|69768550|FG002|Overall Study|Adverse Event|3|||
38073029|NCT03158311|69768548|FG000|Overall Study|Techinical Problems|3|||
38073030|NCT03158311|69768549|FG001|Overall Study|Techinical Problems|1|||
38073031|NCT03158311|69768550|FG002|Overall Study|Techinical Problems|5|||
38073032|NCT03158311|69768548|FG000|Overall Study|Physician Decision|2|||
38073033|NCT03158311|69768549|FG001|Overall Study|Physician Decision|3|||
38073034|NCT03158311|69768550|FG002|Overall Study|Physician Decision|7|||
38073035|NCT03158311|69768548|FG000|Overall Study|Lost to Follow-up|1|||
38073036|NCT03158311|69768549|FG001|Overall Study|Lost to Follow-up|1|||
38073037|NCT03158311|69768550|FG002|Overall Study|Lost to Follow-up|1|||
38073038|NCT03158311|69768548|FG000|Overall Study|Sponsor decision|1|||
38073039|NCT03158311|69768549|FG001|Overall Study|Sponsor decision|0|||
38073040|NCT03158311|69768550|FG002|Overall Study|Sponsor decision|0|||
38073041|NCT03158311|69768548|FG000|Overall Study|Pregnancy|0|||
38073042|NCT03158311|69768549|FG001|Overall Study|Pregnancy|2|||
38073043|NCT03158311|69768550|FG002|Overall Study|Pregnancy|0|||
38073044|NCT03158311|69768548|FG000|Overall Study|Randomized in error|0|||
38073045|NCT03158311|69768549|FG001|Overall Study|Randomized in error|0|||
38073046|NCT03158311|69768550|FG002|Overall Study|Randomized in error|1|||
38073047|NCT01336621|69768562|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
38073048|NCT01336621|69768562|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
38073049|NCT01336621|69768562|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
38073050|NCT01336621|69768562|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
38073051|NCT01336621|69768562|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
38073052|NCT01336621|69768562|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
38073053|NCT01336621|69768562|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
38073054|NCT01336621|69768562|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
38073055|NCT01336621|69768562|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
38073056|NCT01336621|69768562|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
38073057|NCT01336621|69768562|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
38073058|NCT01336621|69768562|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
38073059|NCT01336621|69768562|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
38073060|NCT01336621|69768562|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
38073061|NCT00383435|69768574|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
38073062|NCT00383435|69768575|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
38073063|NCT00383435|69768576|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
38073064|NCT00383435|69768577|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
38073065|NCT00383435|69768578|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
38073066|NCT00383435|69768574|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
38073067|NCT00383435|69768575|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
38073068|NCT00383435|69768576|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
38073069|NCT00383435|69768577|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
38073070|NCT00383435|69768578|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
38073071|NCT00383435|69768574|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
38073072|NCT00383435|69768575|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
38073073|NCT00383435|69768576|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
38073074|NCT00383435|69768577|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
38073075|NCT00383435|69768578|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
38073076|NCT00383435|69768574|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
38073077|NCT00383435|69768575|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
38073078|NCT00383435|69768576|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
38073079|NCT00383435|69768577|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
38073080|NCT00383435|69768578|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
38073081|NCT00383435|69768574|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
38073082|NCT00383435|69768575|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
38073083|NCT00383435|69768576|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
38073084|NCT00383435|69768577|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
38073085|NCT00383435|69768578|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
38073086|NCT00383435|69768574|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
38073087|NCT00383435|69768575|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
38073088|NCT00383435|69768576|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
38073089|NCT00383435|69768577|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
38073090|NCT00383435|69768578|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
38073091|NCT00383435|69768574|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
38073092|NCT00383435|69768575|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
38073093|NCT00383435|69768576|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
38073094|NCT00383435|69768577|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
38073095|NCT00383435|69768578|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
38073096|NCT00383435|69768574|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
38073097|NCT00383435|69768575|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
38073098|NCT00383435|69768576|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
38073099|NCT00383435|69768577|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
38073100|NCT00383435|69768578|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
38073101|NCT00383435|69768574|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
38073102|NCT00383435|69768575|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
38073103|NCT00383435|69768576|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
38073104|NCT00383435|69768577|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
38073105|NCT00383435|69768578|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
38073106|NCT00383435|69768574|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
38073107|NCT00383435|69768575|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
38073108|NCT00383435|69768576|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
38073109|NCT00383435|69768577|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
38073110|NCT00383435|69768578|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
38073111|NCT00383435|69768574|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
38073112|NCT00383435|69768575|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
38073113|NCT00383435|69768576|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
38073114|NCT00383435|69768577|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
38073115|NCT00383435|69768578|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
38073116|NCT00383435|69768574|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
38073117|NCT00383435|69768575|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
38073118|NCT00383435|69768576|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
38073119|NCT00383435|69768577|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
38073120|NCT00383435|69768578|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
38073121|NCT00383435|69768574|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
38073122|NCT00383435|69768575|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
38073123|NCT00383435|69768576|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
38073124|NCT00383435|69768577|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
38073125|NCT00383435|69768578|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
38073126|NCT00383435|69768574|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
38073127|NCT00383435|69768575|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
38073128|NCT00383435|69768576|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
38073129|NCT00383435|69768577|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
38073130|NCT00383435|69768578|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
38073131|NCT00383435|69768574|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
38073132|NCT00383435|69768575|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
38073133|NCT00383435|69768576|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
38073134|NCT00383435|69768577|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
38073135|NCT00383435|69768578|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
38073136|NCT00383435|69768574|FG000|26-Week Treatment Safety Extension|Administrative|1|||
38073137|NCT00383435|69768575|FG001|26-Week Treatment Safety Extension|Administrative|1|||
38073138|NCT00383435|69768576|FG002|26-Week Treatment Safety Extension|Administrative|0|||
38073139|NCT00383435|69768577|FG003|26-Week Treatment Safety Extension|Administrative|1|||
38073140|NCT00383435|69768578|FG004|26-Week Treatment Safety Extension|Administrative|0|||
38073141|NCT03157037|69768590|FG000|Overall Study|Death|1|||
38073142|NCT00381485|69768612|FG000|Open-Label Run-In Period|Adverse Event|9|||
38073143|NCT00381485|69768613|FG001|Open-Label Run-In Period|Adverse Event|0|||
38073144|NCT00381485|69768614|FG002|Open-Label Run-In Period|Adverse Event|0|||
38073145|NCT00381485|69768615|FG003|Open-Label Run-In Period|Adverse Event|0|||
38073146|NCT00381485|69768612|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
37966120|NCT00474045|69653030|FG001|Overall Study|Lost to Follow-up|1|||
38073147|NCT00381485|69768613|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
38073148|NCT00381485|69768614|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
38073149|NCT00381485|69768615|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
38073150|NCT00381485|69768612|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
38073151|NCT00381485|69768613|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
38073152|NCT00381485|69768614|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
38073153|NCT00381485|69768615|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
38073154|NCT00381485|69768612|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
38073155|NCT00381485|69768613|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
38073156|NCT00381485|69768614|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
38073157|NCT00381485|69768615|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
38073158|NCT00381485|69768612|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
38073159|NCT00381485|69768613|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
38073160|NCT00381485|69768614|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
38073161|NCT00381485|69768615|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
38073162|NCT00381485|69768612|FG000|Open-Label Run-In Period|Treatment failure|1|||
38073163|NCT00381485|69768613|FG001|Open-Label Run-In Period|Treatment failure|0|||
38073164|NCT00381485|69768614|FG002|Open-Label Run-In Period|Treatment failure|0|||
38073165|NCT00381485|69768615|FG003|Open-Label Run-In Period|Treatment failure|0|||
38073166|NCT00381485|69768612|FG000|Double-Blind Treatment Period|Adverse Event|0|||
38073167|NCT00381485|69768613|FG001|Double-Blind Treatment Period|Adverse Event|2|||
38073168|NCT00381485|69768614|FG002|Double-Blind Treatment Period|Adverse Event|2|||
38073169|NCT00381485|69768615|FG003|Double-Blind Treatment Period|Adverse Event|5|||
38073170|NCT00381485|69768612|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
38073171|NCT00381485|69768613|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
38073172|NCT00381485|69768614|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
38073173|NCT00381485|69768615|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
38073174|NCT00381485|69768612|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
38073175|NCT00381485|69768613|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
38073176|NCT00381485|69768614|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
38073177|NCT00381485|69768615|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
38073178|NCT00381485|69768612|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
38073179|NCT00381485|69768613|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
38073180|NCT00381485|69768614|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
38073181|NCT00381485|69768615|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
38073182|NCT00381485|69768612|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
38073183|NCT00381485|69768613|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
38073184|NCT00381485|69768614|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
38073185|NCT00381485|69768615|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
38073186|NCT00381485|69768612|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
38073187|NCT00381485|69768613|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
38073188|NCT00381485|69768614|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
38073189|NCT00381485|69768615|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
38073190|NCT00381485|69768612|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
38073191|NCT00381485|69768613|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
38073192|NCT00381485|69768614|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
38073193|NCT00381485|69768615|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
38073194|NCT00381485|69768612|FG000|Double-Blind Treatment Period|Administrative|0|||
38073195|NCT00381485|69768613|FG001|Double-Blind Treatment Period|Administrative|1|||
38073196|NCT00381485|69768614|FG002|Double-Blind Treatment Period|Administrative|0|||
38073197|NCT00381485|69768615|FG003|Double-Blind Treatment Period|Administrative|1|||
38073198|NCT02840474|69768626|FG000|Overall Study|Lost to Follow-up|1|||
38073199|NCT02840474|69768627|FG001|Overall Study|Lost to Follow-up|0|||
38073200|NCT03155945|69768635|FG000|Overall Study|Lost to Follow-up|0|||
38073201|NCT03155945|69768636|FG001|Overall Study|Lost to Follow-up|1|||
38073202|NCT03155945|69768635|FG000|Overall Study|Withdrawal by Subject|0|||
38073203|NCT03155945|69768636|FG001|Overall Study|Withdrawal by Subject|1|||
37966121|NCT00474045|69653029|FG000|Overall Study|Protocol Violation|10|||
37966122|NCT00474045|69653030|FG001|Overall Study|Protocol Violation|12|||
38073204|NCT03155945|69768635|FG000|Overall Study|Other Reason|0|||
38073205|NCT03155945|69768636|FG001|Overall Study|Other Reason|1|||
38073206|NCT03160703|69768646|FG000|Overall Study|Withdrawal by Subject|0|||
38073207|NCT03160703|69768647|FG001|Overall Study|Withdrawal by Subject|0|||
38073208|NCT03160703|69768648|FG002|Overall Study|Withdrawal by Subject|0|||
38073209|NCT03160703|69768649|FG003|Overall Study|Withdrawal by Subject|1|||
38073210|NCT03159611|69768661|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
38073211|NCT03159611|69768662|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
38073212|NCT03159611|69768661|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
38073213|NCT03159611|69768662|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
38073214|NCT03159611|69768661|FG000|Overall Study|Protocol Violation|7|||
38073215|NCT03159611|69768662|FG001|Overall Study|Protocol Violation|4|||
38073216|NCT03159611|69768661|FG000|Overall Study|Adverse Event|1|||
38073217|NCT03159611|69768662|FG001|Overall Study|Adverse Event|0|||
38073218|NCT03159611|69768661|FG000|Overall Study|Withdrawal by Subject|1|||
38073219|NCT03159611|69768662|FG001|Overall Study|Withdrawal by Subject|1|||
38073220|NCT03159611|69768661|FG000|Overall Study|Non-compliance with protocol requirement|3|||
38073221|NCT03159611|69768662|FG001|Overall Study|Non-compliance with protocol requirement|2|||
38073222|NCT03159611|69768661|FG000|Overall Study|Inability to perform procedures|1|||
38073223|NCT03159611|69768662|FG001|Overall Study|Inability to perform procedures|0|||
38073224|NCT03159455|69768674|FG000|Overall Study|Adverse Event|0|||
38073225|NCT03159455|69768675|FG001|Overall Study|Adverse Event|0|||
38073226|NCT03159455|69768676|FG002|Overall Study|Adverse Event|0|||
38073227|NCT03159455|69768677|FG003|Overall Study|Adverse Event|0|||
38073228|NCT03159455|69768678|FG004|Overall Study|Adverse Event|0|||
38073229|NCT03159455|69768679|FG005|Overall Study|Adverse Event|1|||
38073230|NCT02838134|69768699|FG000|Overall Study|Lost to Follow-up|1|||
38073231|NCT02838134|69768700|FG001|Overall Study|Lost to Follow-up|2|||
38073232|NCT02838134|69768699|FG000|Overall Study|logistic problems|1|||
38073233|NCT02838134|69768700|FG001|Overall Study|logistic problems|1|||
38073234|NCT03150589|69768708|FG000|Overall Study|Withdrawal by Subject|16|||
38073235|NCT03150589|69768709|FG001|Overall Study|Withdrawal by Subject|9|||
38073236|NCT03150589|69768708|FG000|Overall Study|Adverse Event|7|||
38073237|NCT03150589|69768709|FG001|Overall Study|Adverse Event|6|||
38073238|NCT03150589|69768708|FG000|Overall Study|Protocol Violation|4|||
38073239|NCT03150589|69768709|FG001|Overall Study|Protocol Violation|3|||
38073240|NCT03150589|69768708|FG000|Overall Study|Lost to Follow-up|3|||
38073241|NCT03150589|69768709|FG001|Overall Study|Lost to Follow-up|3|||
38073242|NCT03150589|69768708|FG000|Overall Study|Death|2|||
38073243|NCT03150589|69768709|FG001|Overall Study|Death|3|||
38073244|NCT03150589|69768708|FG000|Overall Study|IP non-compliance and other reasons|12|||
38073245|NCT03150589|69768709|FG001|Overall Study|IP non-compliance and other reasons|3|||
38073246|NCT02835092|69768718|FG000|Overall Study|Withdrawal by Subject|3|||
38073247|NCT02835092|69768719|FG001|Overall Study|Withdrawal by Subject|6|||
38073248|NCT02835092|69768720|FG002|Overall Study|Withdrawal by Subject|3|||
38073249|NCT02835092|69768718|FG000|Overall Study|Lost to Follow-up|0|||
38073250|NCT02835092|69768719|FG001|Overall Study|Lost to Follow-up|2|||
38073251|NCT02835092|69768720|FG002|Overall Study|Lost to Follow-up|0|||
38073252|NCT03145207|69768728|FG000|Overall Study|volunteer started taking allergy shots|1|||
38073253|NCT03145207|69768728|FG000|Overall Study|baseline blood pressure high|1|||
38073254|NCT02836652|69768745|FG000|Overall Study|Death|3|||
38073255|NCT02836652|69768746|FG001|Overall Study|Death|3|||
38073256|NCT02836652|69768745|FG000|Overall Study|Transplant/Explant|3|||
38073257|NCT02836652|69768746|FG001|Overall Study|Transplant/Explant|4|||
38073258|NCT02836652|69768745|FG000|Overall Study|Withdrawn|9|||
38073259|NCT02836652|69768746|FG001|Overall Study|Withdrawn|9|||
38073260|NCT02836652|69768745|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
38073261|NCT02836652|69768746|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
38073262|NCT02836496|69768754|FG000|Overall Study|Adverse Event|2|||
38073263|NCT02836496|69768755|FG001|Overall Study|Adverse Event|1|||
38073264|NCT02836496|69768754|FG000|Overall Study|Withdrawal by Subject|0|||
38073265|NCT02836496|69768755|FG001|Overall Study|Withdrawal by Subject|1|||
38073266|NCT04213807|69768764|FG000|Overall Study|Physician Decision|0|||
38073267|NCT04213807|69768765|FG001|Overall Study|Physician Decision|0|||
38073268|NCT04213807|69768766|FG002|Overall Study|Physician Decision|1|||
38073269|NCT00577577|69768785|FG000|Overall Study|Adverse Event|3|||
38073270|NCT00577577|69768786|FG001|Overall Study|Adverse Event|2|||
38073271|NCT00577577|69768785|FG000|Overall Study|Lost to Follow-up|1|||
38073272|NCT00577577|69768786|FG001|Overall Study|Lost to Follow-up|0|||
38073273|NCT00577577|69768785|FG000|Overall Study|Protocol Violation|0|||
38073274|NCT00577577|69768786|FG001|Overall Study|Protocol Violation|3|||
38073275|NCT00577577|69768785|FG000|Overall Study|Transportation|1|||
38073276|NCT00577577|69768786|FG001|Overall Study|Transportation|0|||
38073277|NCT02833844|69768794|FG000|Double-Blind Period|Withdrawal by Subject|2|||
38073278|NCT02833844|69768795|FG001|Double-Blind Period|Withdrawal by Subject|3|||
38073279|NCT02833844|69768794|FG000|Double-Blind Period|Protocol Violation|0|||
38073280|NCT02833844|69768795|FG001|Double-Blind Period|Protocol Violation|4|||
38073281|NCT02833844|69768794|FG000|Open-Label Period|Death|0|||
38073282|NCT02833844|69768795|FG001|Open-Label Period|Death|2|||
38073283|NCT02833844|69768794|FG000|Open-Label Period|Lost to Follow-up|1|||
38073284|NCT02833844|69768795|FG001|Open-Label Period|Lost to Follow-up|0|||
38073285|NCT02833844|69768794|FG000|Open-Label Period|Withdrawal by Subject|1|||
38073286|NCT02833844|69768795|FG001|Open-Label Period|Withdrawal by Subject|0|||
38073287|NCT01341782|69768805|FG000|Overall Study|Adverse Event|1|||
38073288|NCT01341782|69768806|FG001|Overall Study|Adverse Event|1|||
38073289|NCT01341782|69768805|FG000|Overall Study|Withdrawal by Subject|6|||
38073290|NCT01341782|69768806|FG001|Overall Study|Withdrawal by Subject|5|||
38073291|NCT01341782|69768805|FG000|Overall Study|Missed 3 consecutive doses|0|||
38073292|NCT01341782|69768806|FG001|Overall Study|Missed 3 consecutive doses|4|||
38073293|NCT01341782|69768805|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
38073294|NCT01341782|69768806|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
38073295|NCT01341782|69768805|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
38073296|NCT01341782|69768806|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
38073297|NCT01341782|69768805|FG000|Overall Study|Other|5|||
38073298|NCT01341782|69768806|FG001|Overall Study|Other|0|||
38073299|NCT01341470|69768818|FG000|Overall Study|Sponsor decision|0|||
38073300|NCT01341470|69768819|FG001|Overall Study|Sponsor decision|0|||
38073301|NCT01341470|69768820|FG002|Overall Study|Sponsor decision|1|||
38073302|NCT01341470|69768821|FG003|Overall Study|Sponsor decision|1|||
38073303|NCT01341470|69768822|FG004|Overall Study|Sponsor decision|0|||
38073304|NCT01341470|69768823|FG005|Overall Study|Sponsor decision|1|||
38073305|NCT03143101|69768842|FG000|Overall Study|Withdrawal by Subject|0|||
38073306|NCT03143101|69768843|FG001|Overall Study|Withdrawal by Subject|1|||
38073307|NCT03143101|69768844|FG002|Overall Study|Withdrawal by Subject|0|||
38073308|NCT03143101|69768842|FG000|Overall Study|Lost to Follow-up|2|||
38073309|NCT03143101|69768843|FG001|Overall Study|Lost to Follow-up|2|||
38073310|NCT03143101|69768844|FG002|Overall Study|Lost to Follow-up|0|||
38073311|NCT00871351|69768855|FG000|Overall Study|Withdrawal by Subject|1|||
38073312|NCT00871351|69768856|FG001|Overall Study|Withdrawal by Subject|0|||
38073313|NCT00871351|69768857|FG002|Overall Study|Withdrawal by Subject|0|||
38073314|NCT00871351|69768855|FG000|Overall Study|Adverse Event|3|||
38073315|NCT00871351|69768856|FG001|Overall Study|Adverse Event|1|||
38073316|NCT00871351|69768857|FG002|Overall Study|Adverse Event|0|||
38073317|NCT02745080|69768867|FG000|Overall Study|Adverse Event|13|||
38073318|NCT02745080|69768868|FG001|Overall Study|Adverse Event|21|||
38073319|NCT02745080|69768867|FG000|Overall Study|Lack of Efficacy|11|||
38073320|NCT02745080|69768868|FG001|Overall Study|Lack of Efficacy|23|||
38073321|NCT02745080|69768867|FG000|Overall Study|Lost to Follow-up|3|||
38073322|NCT02745080|69768868|FG001|Overall Study|Lost to Follow-up|3|||
38073323|NCT02745080|69768867|FG000|Overall Study|Physician Decision|3|||
38073324|NCT02745080|69768868|FG001|Overall Study|Physician Decision|0|||
38073325|NCT02745080|69768867|FG000|Overall Study|Protocol Violation|3|||
38073326|NCT02745080|69768868|FG001|Overall Study|Protocol Violation|1|||
38073327|NCT02745080|69768867|FG000|Overall Study|Withdrawal by Subject|22|||
38073328|NCT02745080|69768868|FG001|Overall Study|Withdrawal by Subject|41|||
38073329|NCT00521599|69768878|FG000|Overall Study|Adverse Event|5|||
38073330|NCT00521599|69768879|FG001|Overall Study|Adverse Event|7|||
38073331|NCT00521599|69768880|FG002|Overall Study|Adverse Event|6|||
38073332|NCT00521599|69768878|FG000|Overall Study|Treatment Failure|8|||
38073333|NCT00521599|69768879|FG001|Overall Study|Treatment Failure|9|||
38073334|NCT00521599|69768880|FG002|Overall Study|Treatment Failure|22|||
38073335|NCT00521599|69768878|FG000|Overall Study|Lost to Follow-up|2|||
38073336|NCT00521599|69768879|FG001|Overall Study|Lost to Follow-up|1|||
38073337|NCT00521599|69768880|FG002|Overall Study|Lost to Follow-up|2|||
38073338|NCT00521599|69768878|FG000|Overall Study|Withdrawal by Subject|3|||
38073339|NCT00521599|69768879|FG001|Overall Study|Withdrawal by Subject|5|||
38073340|NCT00521599|69768880|FG002|Overall Study|Withdrawal by Subject|1|||
38073341|NCT00521599|69768878|FG000|Overall Study|Withdrawal by subject treatment related|3|||
38073342|NCT00521599|69768879|FG001|Overall Study|Withdrawal by subject treatment related|1|||
38073343|NCT00521599|69768880|FG002|Overall Study|Withdrawal by subject treatment related|2|||
38073344|NCT00521599|69768878|FG000|Overall Study|Protocol Violation|2|||
38073345|NCT00521599|69768879|FG001|Overall Study|Protocol Violation|4|||
38073346|NCT00521599|69768880|FG002|Overall Study|Protocol Violation|2|||
38073347|NCT00521599|69768878|FG000|Overall Study|Did not meet protocol eligibility|2|||
38073348|NCT00521599|69768879|FG001|Overall Study|Did not meet protocol eligibility|2|||
38073349|NCT00521599|69768880|FG002|Overall Study|Did not meet protocol eligibility|1|||
38073350|NCT00442897|69768891|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
38073351|NCT00442897|69768892|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
38073352|NCT00442897|69768891|FG000|Base Study (12 Week Follow-up)|Death|0|||
38073353|NCT00442897|69768892|FG001|Base Study (12 Week Follow-up)|Death|1|||
38073354|NCT00442897|69768891|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
38073355|NCT00442897|69768892|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
38073356|NCT00442897|69768891|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
38073357|NCT00442897|69768892|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
38073358|NCT00442897|69768891|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
38073359|NCT00442897|69768892|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
38073360|NCT00442897|69768891|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
38073361|NCT00442897|69768892|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
38073362|NCT00442897|69768891|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
38073363|NCT00442897|69768892|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
38073364|NCT00442897|69768891|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
38073365|NCT00442897|69768892|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
38073366|NCT02834390|69768900|FG000|Induction Phase|Progressive disease|0|||
38073367|NCT02834390|69768901|FG001|Induction Phase|Progressive disease|1|||
38073368|NCT02834390|69768900|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
38073369|NCT02834390|69768901|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
38073370|NCT02834390|69768900|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
38073371|NCT02834390|69768901|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
38073372|NCT02834390|69768900|FG000|Consolidation Phase|Physician Decision|1|||
38073373|NCT02834390|69768901|FG001|Consolidation Phase|Physician Decision|1|||
38073374|NCT03141151|69768909|FG000|Overall Study|Lost to Follow-up|3|||
38073375|NCT03141151|69768910|FG001|Overall Study|Lost to Follow-up|2|||
38073376|NCT03141151|69768909|FG000|Overall Study|Withdrawal by Subject|3|||
38073377|NCT03141151|69768910|FG001|Overall Study|Withdrawal by Subject|2|||
38073378|NCT01358708|69768918|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
38073379|NCT01358708|69768919|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
38073380|NCT01358708|69768918|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
38073381|NCT01358708|69768919|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
38073382|NCT01356602|69768932|FG000|Overall Study|Protocol Deviation|0|||
38073383|NCT01356602|69768933|FG001|Overall Study|Protocol Deviation|1|||
38073384|NCT01356602|69768934|FG002|Overall Study|Protocol Deviation|1|||
38073385|NCT01356602|69768932|FG000|Overall Study|Administrative Problems|1|||
38073386|NCT01356602|69768933|FG001|Overall Study|Administrative Problems|4|||
38073387|NCT01356602|69768934|FG002|Overall Study|Administrative Problems|5|||
38073388|NCT01356602|69768932|FG000|Overall Study|Lost to Follow-up|4|||
38073389|NCT01356602|69768933|FG001|Overall Study|Lost to Follow-up|5|||
38073390|NCT01356602|69768934|FG002|Overall Study|Lost to Follow-up|6|||
38073391|NCT01356602|69768932|FG000|Overall Study|Withdrawal by Subject|4|||
38073392|NCT01356602|69768933|FG001|Overall Study|Withdrawal by Subject|3|||
38073393|NCT01356602|69768934|FG002|Overall Study|Withdrawal by Subject|7|||
38073394|NCT01356602|69768932|FG000|Overall Study|Lack of Efficacy|0|||
38073395|NCT01356602|69768933|FG001|Overall Study|Lack of Efficacy|1|||
38073396|NCT01356602|69768934|FG002|Overall Study|Lack of Efficacy|4|||
38073397|NCT01356602|69768932|FG000|Overall Study|Adverse Event|0|||
38073398|NCT01356602|69768933|FG001|Overall Study|Adverse Event|1|||
38073399|NCT01356602|69768934|FG002|Overall Study|Adverse Event|1|||
38073400|NCT02830880|69768942|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
38073401|NCT02830880|69768942|FG000|Overall Study|Death|1|||
38073402|NCT02830880|69768942|FG000|Overall Study|Physician Decision|1|||
38073403|NCT03141307|69768948|FG000|In-Hospital|Withdrawal by Subject|0|||
38073404|NCT03141307|69768949|FG001|In-Hospital|Withdrawal by Subject|2|||
38073405|NCT03141307|69768948|FG000|In-Hospital|Protocol Violation|4|||
38073406|NCT03141307|69768949|FG001|In-Hospital|Protocol Violation|0|||
38073407|NCT03141307|69768948|FG000|Follow-Up|Lost to Follow-up|97|||
38073408|NCT03141307|69768949|FG001|Follow-Up|Lost to Follow-up|54|||
38073409|NCT02825420|69768957|FG000|Overall Study|Death|30|||
38073410|NCT02825420|69768958|FG001|Overall Study|Death|12|||
38073411|NCT02825420|69768957|FG000|Overall Study|Progressive disease|6|||
38073412|NCT02825420|69768958|FG001|Overall Study|Progressive disease|1|||
38073413|NCT02825420|69768957|FG000|Overall Study|Lost to Follow-up|2|||
38073414|NCT02825420|69768958|FG001|Overall Study|Lost to Follow-up|2|||
38073415|NCT02825420|69768957|FG000|Overall Study|Withdrawal by Subject|1|||
38073416|NCT02825420|69768958|FG001|Overall Study|Withdrawal by Subject|1|||
38073417|NCT02825420|69768957|FG000|Overall Study|Protocol amendment not signed|1|||
38073418|NCT02825420|69768958|FG001|Overall Study|Protocol amendment not signed|1|||
38073419|NCT02825420|69768957|FG000|Overall Study|Physician Decision|1|||
38073420|NCT02825420|69768958|FG001|Overall Study|Physician Decision|0|||
38073421|NCT02825420|69768957|FG000|Overall Study|Did not receive PLD|2|||
38073422|NCT02825420|69768958|FG001|Overall Study|Did not receive PLD|0|||
38073423|NCT02829944|69768971|FG000|Overall Study|Physician Decision|0|||
38073424|NCT02829944|69768972|FG001|Overall Study|Physician Decision|1|||
38073425|NCT02829944|69768971|FG000|Overall Study|Screen Failure|2|||
38073426|NCT02829944|69768972|FG001|Overall Study|Screen Failure|2|||
38073427|NCT02829944|69768971|FG000|Overall Study|Inadequate Neuraxial Block|1|||
38073428|NCT02829944|69768972|FG001|Overall Study|Inadequate Neuraxial Block|1|||
38073429|NCT02829944|69768971|FG000|Overall Study|Withdrawal by Subject|2|||
38073430|NCT02829944|69768972|FG001|Overall Study|Withdrawal by Subject|1|||
38073431|NCT02829944|69768971|FG000|Overall Study|Catheter Displacement|1|||
38073432|NCT02829944|69768972|FG001|Overall Study|Catheter Displacement|0|||
38073433|NCT02829944|69768971|FG000|Overall Study|Catheter broke|0|||
38073434|NCT02829944|69768972|FG001|Overall Study|Catheter broke|1|||
38073435|NCT02829944|69768971|FG000|Overall Study|Staff unavailable|0|||
38073436|NCT02829944|69768972|FG001|Overall Study|Staff unavailable|1|||
38073437|NCT02824562|69768980|FG000|Overall Study|Lost to Follow-up|3|||
38073438|NCT02824562|69768981|FG001|Overall Study|Lost to Follow-up|4|||
38073439|NCT02824562|69768980|FG000|Overall Study|Death|0|||
38073440|NCT02824562|69768981|FG001|Overall Study|Death|1|||
38073441|NCT02744066|69768989|FG000|Overall Study|Withdrawal by parent|0|||
38073442|NCT02744066|69768990|FG001|Overall Study|Withdrawal by parent|1|||
38073443|NCT02744066|69768989|FG000|Overall Study|Discharged from NICU prior to completion|0|||
38073444|NCT02744066|69768990|FG001|Overall Study|Discharged from NICU prior to completion|4|||
38073445|NCT01338818|69768998|FG000|Overall Study|Adverse Event|8|||
38073446|NCT01338818|69768998|FG000|Overall Study|Lack of Efficacy|5|||
38073447|NCT01338818|69768998|FG000|Overall Study|no longer require study drug|1|||
38073448|NCT01338818|69768998|FG000|Overall Study|Withdrawal by Subject|11|||
38073449|NCT01338818|69768998|FG000|Overall Study|Lost to Follow-up|4|||
38073450|NCT01338818|69768998|FG000|Overall Study|Administrative problems|3|||
38073451|NCT01338818|69768998|FG000|Overall Study|Protocol Deviation|4|||
38073452|NCT02823470|69769004|FG000|Overall Study|Adverse Event|1|||
38073453|NCT02823470|69769005|FG001|Overall Study|Adverse Event|0|||
38073454|NCT02823470|69769004|FG000|Overall Study|Study terminated by sponsor|8|||
38073455|NCT02823470|69769005|FG001|Overall Study|Study terminated by sponsor|15|||
38073456|NCT01371656|69769016|FG000|Overall Study|Death|7|||
38073457|NCT01371656|69769017|FG001|Overall Study|Death|4|||
38073458|NCT01371656|69769016|FG000|Overall Study|Physician Decision|46|||
38073459|NCT01371656|69769017|FG001|Overall Study|Physician Decision|7|||
38073460|NCT01371656|69769016|FG000|Overall Study|Withdrawal by Subject|7|||
38073461|NCT01371656|69769017|FG001|Overall Study|Withdrawal by Subject|0|||
38073462|NCT01371656|69769016|FG000|Overall Study|Ineligible|4|||
38073463|NCT01371656|69769017|FG001|Overall Study|Ineligible|3|||
38073464|NCT01354106|69769023|FG000|Overall Study|Withdrawal by Subject|2|||
38073465|NCT01354028|69769029|FG000|Overall Study|Physician Decision|0|||
38073466|NCT01354028|69769030|FG001|Overall Study|Physician Decision|2|||
38073467|NCT01354028|69769029|FG000|Overall Study|Discharged before study start|2|||
38073468|NCT01354028|69769030|FG001|Overall Study|Discharged before study start|2|||
38073469|NCT01354028|69769029|FG000|Overall Study|No quiet alert state|0|||
38073470|NCT01354028|69769030|FG001|Overall Study|No quiet alert state|1|||
38073471|NCT01354964|69769044|FG000|Overall Study|Lost to Follow-up|2|||
38073472|NCT01354964|69769045|FG001|Overall Study|Lost to Follow-up|0|||
38073473|NCT01354964|69769044|FG000|Overall Study|IV access issues|1|||
38073474|NCT01354964|69769045|FG001|Overall Study|IV access issues|1|||
38073475|NCT01354964|69769044|FG000|Overall Study|Physician Decision|1|||
38073476|NCT01354964|69769045|FG001|Overall Study|Physician Decision|0|||
38073477|NCT01354496|69769055|FG000|Period 1|Adverse Event|0|||
38073478|NCT01354496|69769056|FG001|Period 1|Adverse Event|0|||
38073479|NCT01354496|69769057|FG002|Period 1|Adverse Event|1|||
38073480|NCT01354496|69769058|FG003|Period 1|Adverse Event|0|||
38073481|NCT01354496|69769059|FG004|Period 1|Adverse Event|0|||
38073482|NCT01354496|69769060|FG005|Period 1|Adverse Event|0|||
38073483|NCT01354496|69769055|FG000|Period 1|Physician Decision|0|||
38073484|NCT01354496|69769056|FG001|Period 1|Physician Decision|0|||
38073485|NCT01354496|69769057|FG002|Period 1|Physician Decision|1|||
38073486|NCT01354496|69769058|FG003|Period 1|Physician Decision|0|||
38073487|NCT01354496|69769059|FG004|Period 1|Physician Decision|0|||
38073488|NCT01354496|69769060|FG005|Period 1|Physician Decision|0|||
38073489|NCT01354496|69769055|FG000|Period 2|Adverse Event|0|||
38073490|NCT01354496|69769056|FG001|Period 2|Adverse Event|0|||
38073491|NCT01354496|69769057|FG002|Period 2|Adverse Event|0|||
38073492|NCT01354496|69769058|FG003|Period 2|Adverse Event|1|||
38073493|NCT01354496|69769059|FG004|Period 2|Adverse Event|0|||
38073494|NCT01354496|69769060|FG005|Period 2|Adverse Event|0|||
38073495|NCT01354496|69769055|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
38073496|NCT01354496|69769056|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
37680401|NCT02585713|69156050|FG001|Overall Study|Withdrew prior to treatment|7|||
38073497|NCT01354496|69769057|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
38073498|NCT01354496|69769058|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
38073499|NCT01354496|69769059|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
38073500|NCT01354496|69769060|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
38073501|NCT02822222|69769083|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
38073502|NCT02822222|69769084|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
38073503|NCT02821910|69769096|FG000|Overall Study|Withdrawal by Subject|0|||
38073504|NCT02821910|69769097|FG001|Overall Study|Withdrawal by Subject|0|||
38073505|NCT02821910|69769098|FG002|Overall Study|Withdrawal by Subject|1|||
38073506|NCT02821910|69769099|FG003|Overall Study|Withdrawal by Subject|0|||
38073507|NCT02821910|69769100|FG004|Overall Study|Withdrawal by Subject|0|||
38073508|NCT02821910|69769101|FG005|Overall Study|Withdrawal by Subject|1|||
38073509|NCT02821910|69769096|FG000|Overall Study|Other than specified|1|||
38073510|NCT02821910|69769097|FG001|Overall Study|Other than specified|0|||
38073511|NCT02821910|69769098|FG002|Overall Study|Other than specified|1|||
38073512|NCT02821910|69769099|FG003|Overall Study|Other than specified|0|||
38073513|NCT02821910|69769100|FG004|Overall Study|Other than specified|0|||
38073514|NCT02821910|69769101|FG005|Overall Study|Other than specified|0|||
38073515|NCT02817776|69769115|FG000|Overall Study|Excluded|33|||
38073516|NCT02817776|69769115|FG000|Overall Study|Lost to Follow-up|20|||
38073517|NCT02817776|69769115|FG000|Overall Study|Withdrawal by Subject|33|||
38073518|NCT02817776|69769115|FG000|Overall Study|Death|2|||
38073519|NCT03138655|69769127|FG000|Overall Study|Adverse Event|2|||
38073520|NCT03138655|69769128|FG001|Overall Study|Adverse Event|1|||
38073521|NCT03138655|69769129|FG002|Overall Study|Adverse Event|2|||
38073522|NCT03138655|69769130|FG003|Overall Study|Adverse Event|1|||
38073523|NCT03138655|69769131|FG004|Overall Study|Adverse Event|1|||
38073524|NCT03138655|69769132|FG005|Overall Study|Adverse Event|4|||
38073525|NCT03138655|69769133|FG006|Overall Study|Adverse Event|2|||
38073526|NCT03138655|69769134|FG007|Overall Study|Adverse Event|2|||
38073527|NCT03138655|69769127|FG000|Overall Study|Withdrawal by Subject|0|||
38073528|NCT03138655|69769128|FG001|Overall Study|Withdrawal by Subject|1|||
38073529|NCT03138655|69769129|FG002|Overall Study|Withdrawal by Subject|0|||
38073530|NCT03138655|69769130|FG003|Overall Study|Withdrawal by Subject|0|||
38073531|NCT03138655|69769131|FG004|Overall Study|Withdrawal by Subject|0|||
38073532|NCT03138655|69769132|FG005|Overall Study|Withdrawal by Subject|0|||
38073533|NCT03138655|69769133|FG006|Overall Study|Withdrawal by Subject|1|||
38073534|NCT03138655|69769134|FG007|Overall Study|Withdrawal by Subject|0|||
38073535|NCT03138655|69769127|FG000|Overall Study|Reason not Specified|1|||
38073536|NCT03138655|69769128|FG001|Overall Study|Reason not Specified|0|||
38073537|NCT03138655|69769129|FG002|Overall Study|Reason not Specified|0|||
38073538|NCT03138655|69769130|FG003|Overall Study|Reason not Specified|2|||
38073539|NCT03138655|69769131|FG004|Overall Study|Reason not Specified|1|||
38073540|NCT03138655|69769132|FG005|Overall Study|Reason not Specified|1|||
38073541|NCT03138655|69769133|FG006|Overall Study|Reason not Specified|0|||
38073542|NCT03138655|69769134|FG007|Overall Study|Reason not Specified|0|||
38073543|NCT02820038|69769160|FG000|Overall Study|Lost to Follow-up|7|||
38073544|NCT02820038|69769161|FG001|Overall Study|Lost to Follow-up|11|||
38073545|NCT02820038|69769162|FG002|Overall Study|Lost to Follow-up|2|||
38073546|NCT02820038|69769163|FG003|Overall Study|Lost to Follow-up|9|||
38073547|NCT02820038|69769160|FG000|Overall Study|Withdrawal by Subject|3|||
38073548|NCT02820038|69769161|FG001|Overall Study|Withdrawal by Subject|14|||
38073549|NCT02820038|69769162|FG002|Overall Study|Withdrawal by Subject|3|||
38073550|NCT02820038|69769163|FG003|Overall Study|Withdrawal by Subject|13|||
38073551|NCT02819804|69769174|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
38073552|NCT02819726|69769181|FG000|Part A (All Participants)|Lost to Follow-up|0|||
38073553|NCT02819726|69769182|FG001|Part A (All Participants)|Lost to Follow-up|1|||
38073554|NCT02819726|69769183|FG002|Part A (All Participants)|Lost to Follow-up|0|||
38073555|NCT02819726|69769184|FG003|Part A (All Participants)|Lost to Follow-up|0|||
38073556|NCT02819726|69769181|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
38073557|NCT02819726|69769182|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
38073558|NCT02819726|69769183|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
38073559|NCT02819726|69769184|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
38073560|NCT02819726|69769181|FG000|Part A (All Participants)|Protocol non-compliance|3|||
38073561|NCT02819726|69769182|FG001|Part A (All Participants)|Protocol non-compliance|4|||
38073562|NCT02819726|69769183|FG002|Part A (All Participants)|Protocol non-compliance|5|||
38073563|NCT02819726|69769184|FG003|Part A (All Participants)|Protocol non-compliance|0|||
38073564|NCT02819726|69769181|FG000|Part B (All Participants)|Lost to Follow-up|1|||
38073565|NCT02819726|69769182|FG001|Part B (All Participants)|Lost to Follow-up|1|||
38073566|NCT02819726|69769183|FG002|Part B (All Participants)|Lost to Follow-up|2|||
38073567|NCT02819726|69769184|FG003|Part B (All Participants)|Lost to Follow-up|2|||
38073568|NCT02819726|69769181|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
38073569|NCT02819726|69769182|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
38073570|NCT02819726|69769183|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
38073571|NCT02819726|69769184|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
38073572|NCT02819726|69769181|FG000|Part B (All Participants)|Protocol non-compliance|0|||
37680402|NCT02585713|69156049|FG000|Overall Study|Other|3|||
38073573|NCT02819726|69769182|FG001|Part B (All Participants)|Protocol non-compliance|0|||
38073574|NCT02819726|69769183|FG002|Part B (All Participants)|Protocol non-compliance|1|||
38073575|NCT02819726|69769184|FG003|Part B (All Participants)|Protocol non-compliance|0|||
38073576|NCT02816138|69769192|FG000|Overall Study|Adverse Event|1|||
38073577|NCT02815670|69769196|FG000|Overall Study|Prematurely discontinued of the trial|1|||
38073578|NCT02809976|69769200|FG000|Overall Study|Lost to Follow-up|1|||
38073579|NCT02809976|69769200|FG000|Overall Study|Withdrawal by Subject|1|||
38073580|NCT02880865|69769206|FG000|Overall Study|Adverse Event|1|||
38073581|NCT02880865|69769207|FG001|Overall Study|Adverse Event|0|||
38073582|NCT02880865|69769206|FG000|Overall Study|Withdrawal by Subject|0|||
38073583|NCT02880865|69769207|FG001|Overall Study|Withdrawal by Subject|2|||
38073584|NCT02880865|69769206|FG000|Overall Study|Physician Decision|0|||
38073585|NCT02880865|69769207|FG001|Overall Study|Physician Decision|1|||
38073586|NCT01854385|69769234|FG000|Pre-Treatment|Withdrawal by Subject|4|||
38073587|NCT01854385|69769234|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
38073588|NCT01854385|69769234|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
38073589|NCT01854385|69769234|FG000|Pre-Treatment|Unable to come for study visits|1|||
38073590|NCT01854385|69769234|FG000|Treatment|Lost to Follow-up|1|||
38073591|NCT02809118|69769241|FG000|Overall Study|Withdrawal by Subject|0|||
38073592|NCT02809118|69769242|FG001|Overall Study|Withdrawal by Subject|1|||
38073593|NCT02809118|69769243|FG002|Overall Study|Withdrawal by Subject|1|||
38073594|NCT03604159|69769253|FG000|Overall Study|Lost to Follow-up|6|||
38073595|NCT03604159|69769254|FG001|Overall Study|Lost to Follow-up|7|||
38073596|NCT02808338|69769260|FG000|Screening|Screen Failure|10|||
38073597|NCT02808338|69769260|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
38073598|NCT02808338|69769260|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
38073599|NCT02807948|69769271|FG000|Overall Study|Physician Decision|1|||
38073600|NCT02807948|69769272|FG001|Overall Study|Physician Decision|0|||
38073601|NCT02879383|69769281|FG000|First 24 Weeks|Physician Decision|0|||
38073602|NCT02879383|69769282|FG001|First 24 Weeks|Physician Decision|1|||
38073603|NCT02879383|69769283|FG002|First 24 Weeks|Physician Decision|0|||
38073604|NCT02879383|69769284|FG003|First 24 Weeks|Physician Decision|0|||
38073605|NCT02049710|69769298|FG000|Overall Study|Lost to Follow-up|319|||
38073606|NCT02049710|69769299|FG001|Overall Study|Lost to Follow-up|324|||
38073607|NCT02806232|69769327|FG000|Overall Study|Lost to Follow-up|1|||
38073608|NCT02806232|69769328|FG001|Overall Study|Lost to Follow-up|2|||
38073609|NCT02806232|69769329|FG002|Overall Study|Lost to Follow-up|1|||
38073610|NCT02806232|69769330|FG003|Overall Study|Lost to Follow-up|0|||
38073611|NCT02806232|69769331|FG004|Overall Study|Lost to Follow-up|0|||
38073612|NCT02806232|69769332|FG005|Overall Study|Lost to Follow-up|1|||
38073613|NCT02806232|69769333|FG006|Overall Study|Lost to Follow-up|0|||
38073614|NCT02806232|69769334|FG007|Overall Study|Lost to Follow-up|0|||
38073615|NCT02806232|69769335|FG008|Overall Study|Lost to Follow-up|0|||
38073616|NCT02806232|69769327|FG000|Overall Study|Withdrawal by Subject|0|||
38073617|NCT02806232|69769328|FG001|Overall Study|Withdrawal by Subject|2|||
38073618|NCT02806232|69769329|FG002|Overall Study|Withdrawal by Subject|0|||
38073619|NCT02806232|69769330|FG003|Overall Study|Withdrawal by Subject|0|||
38073620|NCT02806232|69769331|FG004|Overall Study|Withdrawal by Subject|2|||
38073621|NCT02806232|69769332|FG005|Overall Study|Withdrawal by Subject|1|||
38073622|NCT02806232|69769333|FG006|Overall Study|Withdrawal by Subject|0|||
38073623|NCT02806232|69769334|FG007|Overall Study|Withdrawal by Subject|0|||
38073624|NCT02806232|69769335|FG008|Overall Study|Withdrawal by Subject|0|||
38073625|NCT02807402|69769355|FG000|Overall Study|Failure to Return|1|||
38073626|NCT02807402|69769355|FG000|Overall Study|Death|3|||
38073627|NCT02807402|69769355|FG000|Overall Study|Other|2|||
38073628|NCT00392327|69769375|FG000|Overall Study|Death|1|||
38073629|NCT00392327|69769376|FG001|Overall Study|Death|0|||
38073630|NCT00392327|69769377|FG002|Overall Study|Death|1|||
38073631|NCT00392327|69769378|FG003|Overall Study|Death|0|||
38073632|NCT00392327|69769379|FG004|Overall Study|Death|0|||
38073633|NCT00392327|69769380|FG005|Overall Study|Death|0|||
38073634|NCT00392327|69769381|FG006|Overall Study|Death|0|||
38073635|NCT00392327|69769382|FG007|Overall Study|Death|0|||
38073636|NCT00392327|69769375|FG000|Overall Study|Lack of Efficacy|8|||
38073637|NCT00392327|69769376|FG001|Overall Study|Lack of Efficacy|8|||
38073638|NCT00392327|69769377|FG002|Overall Study|Lack of Efficacy|9|||
38073639|NCT00392327|69769378|FG003|Overall Study|Lack of Efficacy|6|||
38073640|NCT00392327|69769379|FG004|Overall Study|Lack of Efficacy|3|||
38073641|NCT00392327|69769380|FG005|Overall Study|Lack of Efficacy|3|||
38073642|NCT00392327|69769381|FG006|Overall Study|Lack of Efficacy|3|||
38073643|NCT00392327|69769382|FG007|Overall Study|Lack of Efficacy|3|||
38073644|NCT00392327|69769375|FG000|Overall Study|Physician Decision|3|||
38073645|NCT00392327|69769376|FG001|Overall Study|Physician Decision|5|||
38073646|NCT00392327|69769377|FG002|Overall Study|Physician Decision|2|||
38073647|NCT00392327|69769378|FG003|Overall Study|Physician Decision|2|||
38073648|NCT00392327|69769379|FG004|Overall Study|Physician Decision|0|||
38073649|NCT00392327|69769380|FG005|Overall Study|Physician Decision|1|||
38073650|NCT00392327|69769381|FG006|Overall Study|Physician Decision|5|||
38073651|NCT00392327|69769382|FG007|Overall Study|Physician Decision|3|||
38073652|NCT00392327|69769375|FG000|Overall Study|Protocol Violation|0|||
38073653|NCT00392327|69769376|FG001|Overall Study|Protocol Violation|0|||
38073654|NCT00392327|69769377|FG002|Overall Study|Protocol Violation|1|||
38073655|NCT00392327|69769378|FG003|Overall Study|Protocol Violation|0|||
38073656|NCT00392327|69769379|FG004|Overall Study|Protocol Violation|0|||
38073657|NCT00392327|69769380|FG005|Overall Study|Protocol Violation|0|||
38073658|NCT00392327|69769381|FG006|Overall Study|Protocol Violation|0|||
38073659|NCT00392327|69769382|FG007|Overall Study|Protocol Violation|0|||
38073660|NCT00392327|69769375|FG000|Overall Study|Withdrawal by Subject|3|||
38073661|NCT00392327|69769376|FG001|Overall Study|Withdrawal by Subject|2|||
38073662|NCT00392327|69769377|FG002|Overall Study|Withdrawal by Subject|4|||
38073663|NCT00392327|69769378|FG003|Overall Study|Withdrawal by Subject|6|||
38073664|NCT00392327|69769379|FG004|Overall Study|Withdrawal by Subject|0|||
38073665|NCT00392327|69769380|FG005|Overall Study|Withdrawal by Subject|1|||
38073666|NCT00392327|69769381|FG006|Overall Study|Withdrawal by Subject|1|||
38073667|NCT00392327|69769382|FG007|Overall Study|Withdrawal by Subject|5|||
38073668|NCT00392327|69769375|FG000|Overall Study|Ineligible|0|||
38073669|NCT00392327|69769376|FG001|Overall Study|Ineligible|4|||
38073670|NCT00392327|69769377|FG002|Overall Study|Ineligible|3|||
38073671|NCT00392327|69769378|FG003|Overall Study|Ineligible|2|||
38073672|NCT00392327|69769379|FG004|Overall Study|Ineligible|0|||
38073673|NCT00392327|69769380|FG005|Overall Study|Ineligible|0|||
38073674|NCT00392327|69769381|FG006|Overall Study|Ineligible|0|||
38073675|NCT00392327|69769382|FG007|Overall Study|Ineligible|0|||
38073676|NCT02960490|69769402|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
38073677|NCT02960490|69769403|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
38073678|NCT02960490|69769404|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
38073679|NCT02960490|69769405|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
38073680|NCT02960490|69769406|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
38073681|NCT02960490|69769407|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
38073682|NCT02960490|69769408|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
38073683|NCT02960490|69769409|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
38073684|NCT02960490|69769410|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
38073685|NCT02960490|69769411|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
38073686|NCT02960490|69769402|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
38073687|NCT02960490|69769403|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
38073688|NCT02960490|69769404|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
38073689|NCT02960490|69769405|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
38073690|NCT02960490|69769406|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
38073691|NCT02960490|69769407|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
38073692|NCT02960490|69769408|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
38073693|NCT02960490|69769409|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
38073694|NCT02960490|69769410|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
38073695|NCT02960490|69769411|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
38073696|NCT02960490|69769402|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
38073697|NCT02960490|69769403|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
38073698|NCT02960490|69769404|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
38073699|NCT02960490|69769405|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
38073700|NCT02960490|69769406|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
38073701|NCT02960490|69769407|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
38073702|NCT02960490|69769408|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
38073703|NCT02960490|69769409|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
38073704|NCT02960490|69769410|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
38073705|NCT02960490|69769411|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
38073706|NCT02960490|69769402|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
38073707|NCT02960490|69769403|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
38073708|NCT02960490|69769404|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
38073709|NCT02960490|69769405|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
38073710|NCT02960490|69769406|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
38073711|NCT02960490|69769407|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
38073712|NCT02960490|69769408|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
38073713|NCT02960490|69769409|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
38073714|NCT02960490|69769410|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
38073715|NCT02960490|69769411|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
38073716|NCT02960490|69769402|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
38073717|NCT02960490|69769403|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
38073718|NCT02960490|69769404|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
38073719|NCT02960490|69769405|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
38073720|NCT02960490|69769406|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
38073721|NCT02960490|69769407|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
38073722|NCT02960490|69769408|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
38073723|NCT02960490|69769409|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
38073724|NCT02960490|69769410|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
38073725|NCT02960490|69769411|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
38073726|NCT02960490|69769402|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
38073727|NCT02960490|69769403|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
38073728|NCT02960490|69769404|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
38073729|NCT02960490|69769405|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
38073730|NCT02960490|69769406|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
38073731|NCT02960490|69769407|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
38073732|NCT02960490|69769408|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
38073733|NCT02960490|69769409|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
38073734|NCT02960490|69769410|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
38073735|NCT02960490|69769411|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
38073736|NCT02960490|69769402|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
38073737|NCT02960490|69769403|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
38073738|NCT02960490|69769404|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
38073739|NCT02960490|69769405|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
38073740|NCT02960490|69769406|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
38073741|NCT02960490|69769407|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
38073742|NCT02960490|69769408|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
38073743|NCT02960490|69769409|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
38073744|NCT02960490|69769410|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
38073745|NCT02960490|69769411|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
38073746|NCT02960490|69769402|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
38073747|NCT02960490|69769403|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
38073748|NCT02960490|69769404|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
38073749|NCT02960490|69769405|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
38073750|NCT02960490|69769406|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
38073751|NCT02960490|69769407|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
38073752|NCT02960490|69769408|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
38073753|NCT02960490|69769409|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
38073754|NCT02960490|69769410|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
38073755|NCT02960490|69769411|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
38073756|NCT02960490|69769402|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
38073757|NCT02960490|69769403|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
38073758|NCT02960490|69769404|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
38073759|NCT02960490|69769405|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
38073760|NCT02960490|69769406|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
38073761|NCT02960490|69769407|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
38073762|NCT02960490|69769408|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
38073763|NCT02960490|69769409|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
38073764|NCT02960490|69769410|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
38073765|NCT02960490|69769411|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
38073766|NCT02960490|69769402|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
38073767|NCT02960490|69769403|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
38073768|NCT02960490|69769404|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
38073769|NCT02960490|69769405|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
38073770|NCT02960490|69769406|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
38073771|NCT02960490|69769407|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
38073772|NCT02960490|69769408|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
38073773|NCT02960490|69769409|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
38073774|NCT02960490|69769410|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
38073775|NCT02960490|69769411|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
38073776|NCT02960490|69769402|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
38073777|NCT02960490|69769403|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
38073778|NCT02960490|69769404|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
38073779|NCT02960490|69769405|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
38073780|NCT02960490|69769406|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
38073781|NCT02960490|69769407|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
37966123|NCT00474045|69653029|FG000|Overall Study|Withdrawal by Subject|16|||
37966124|NCT00474045|69653030|FG001|Overall Study|Withdrawal by Subject|18|||
38073782|NCT02960490|69769408|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
38073783|NCT02960490|69769409|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
38073784|NCT02960490|69769410|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
38073785|NCT02960490|69769411|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
38073786|NCT02960490|69769402|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
38073787|NCT02960490|69769403|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
38073788|NCT02960490|69769404|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
38073789|NCT02960490|69769405|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
38073790|NCT02960490|69769406|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
38073791|NCT02960490|69769407|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
38073792|NCT02960490|69769408|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
38073793|NCT02960490|69769409|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
38073794|NCT02960490|69769410|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
38073795|NCT02960490|69769411|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
38073796|NCT02804750|69769435|FG000|Period 1|Adverse Event|0|||
38073797|NCT02804750|69769436|FG001|Period 1|Adverse Event|2|||
38073798|NCT02804750|69769435|FG000|Period 1|Withdrawal by Subject|0|||
38073799|NCT02804750|69769436|FG001|Period 1|Withdrawal by Subject|1|||
37966125|NCT00474045|69653029|FG000|Overall Study|Withdrawal criteria|60|||
38073800|NCT02804750|69769435|FG000|Period 2|Adverse Event|1|||
38073801|NCT02804750|69769436|FG001|Period 2|Adverse Event|0|||
38073802|NCT02804750|69769435|FG000|Period 3|Adverse Event|0|||
38073803|NCT02804750|69769436|FG001|Period 3|Adverse Event|2|||
38073804|NCT02804750|69769435|FG000|Period 4|Adverse Event|0|||
38073805|NCT02804750|69769436|FG001|Period 4|Adverse Event|5|||
38073806|NCT02959866|69769444|FG000|Overall Study|Withdrawal by Subject|1|||
38073807|NCT02748512|69769451|FG000|Overall Study|Lost to Follow-up|1|||
38073808|NCT02748512|69769452|FG001|Overall Study|Lost to Follow-up|1|||
38073809|NCT02748356|69769458|FG000|Overall Study|Withdrawal by Subject|1|||
38073810|NCT03439657|69769464|FG000|Overall Study|Adverse Event|2|||
38073811|NCT03439657|69769465|FG001|Overall Study|Adverse Event|3|||
38073812|NCT03439657|69769464|FG000|Overall Study|Lost to Follow-up|1|||
38073813|NCT03439657|69769465|FG001|Overall Study|Lost to Follow-up|0|||
38073814|NCT03439657|69769464|FG000|Overall Study|Protocol Violation|1|||
38073815|NCT03439657|69769465|FG001|Overall Study|Protocol Violation|1|||
38073816|NCT03439657|69769464|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
38073817|NCT03439657|69769465|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
38073818|NCT02803580|69769473|FG000|Overall Study|Death|13|||
38073819|NCT02803580|69769473|FG000|Overall Study|Lost to Follow-up|19|||
38073820|NCT02803580|69769473|FG000|Overall Study|Withdrawal by Subject|3|||
38073821|NCT02803580|69769473|FG000|Overall Study|Inclusion in clinical trial|1|||
38073822|NCT02878213|69769477|FG000|Overall Study|Withdrawal by Subject|2|||
38073823|NCT02878213|69769477|FG000|Overall Study|Adverse Event|1|||
38073824|NCT02802878|69769484|FG000|Overall Study|Withdrawal by Subject|3|||
38073825|NCT02802878|69769485|FG001|Overall Study|Withdrawal by Subject|3|||
38073826|NCT02802878|69769484|FG000|Overall Study|Protocol Violation|1|||
38073827|NCT02802878|69769485|FG001|Overall Study|Protocol Violation|0|||
38073828|NCT02801396|69769491|FG000|Period 1|Withdrawal by Subject|0|||
38073829|NCT02801396|69769492|FG001|Period 1|Withdrawal by Subject|0|||
38073830|NCT02801396|69769493|FG002|Period 1|Withdrawal by Subject|0|||
38073831|NCT02801396|69769494|FG003|Period 1|Withdrawal by Subject|0|||
38073832|NCT02801396|69769495|FG004|Period 1|Withdrawal by Subject|1|||
38073833|NCT02801396|69769496|FG005|Period 1|Withdrawal by Subject|0|||
38073834|NCT02800928|69769504|FG000|Overall Study|Withdrawal by Subject|1|||
38073835|NCT02800928|69769505|FG001|Overall Study|Withdrawal by Subject|1|||
38073836|NCT02800928|69769504|FG000|Overall Study|Protocol Violation|1|||
38073837|NCT02800928|69769505|FG001|Overall Study|Protocol Violation|1|||
38073838|NCT03148691|69769514|FG000|Overall Study|Protocol Violation|1|||
38073839|NCT03148691|69769515|FG001|Overall Study|Protocol Violation|2|||
38073840|NCT03148691|69769516|FG002|Overall Study|Protocol Violation|7|||
38073841|NCT03148691|69769514|FG000|Overall Study|Lost to Follow-up|0|||
37966126|NCT00474045|69653030|FG001|Overall Study|Withdrawal criteria|50|||
38073842|NCT03148691|69769515|FG001|Overall Study|Lost to Follow-up|0|||
38073843|NCT03148691|69769516|FG002|Overall Study|Lost to Follow-up|1|||
38073844|NCT03148691|69769514|FG000|Overall Study|Other|1|||
38073845|NCT03148691|69769515|FG001|Overall Study|Other|0|||
38073846|NCT03148691|69769516|FG002|Overall Study|Other|0|||
38073847|NCT03148691|69769514|FG000|Overall Study|Withdrawal by Subject|1|||
38073848|NCT03148691|69769515|FG001|Overall Study|Withdrawal by Subject|0|||
38073849|NCT03148691|69769516|FG002|Overall Study|Withdrawal by Subject|0|||
38073850|NCT03148067|69769524|FG000|Overall Study|Lost to Follow-up|3|||
38073851|NCT03148067|69769524|FG000|Overall Study|Death|1|||
38073852|NCT03146741|69769538|FG000|Overall Study|Txp with non-HCV+ heart|4|||
38073853|NCT03146741|69769538|FG000|Overall Study|Listeted for MOT|2|||
38073854|NCT03146741|69769538|FG000|Overall Study|Physician Decision|2|||
38073855|NCT03146741|69769538|FG000|Overall Study|Awaiting txp|2|||
38073856|NCT03150719|69769544|FG000|Overall Study|Adverse Event|0|||
38073857|NCT03150719|69769545|FG001|Overall Study|Adverse Event|1|||
38073858|NCT03150719|69769544|FG000|Overall Study|Death|0|||
38073859|NCT03150719|69769545|FG001|Overall Study|Death|1|||
38073860|NCT03150719|69769544|FG000|Overall Study|Other|1|||
38073861|NCT03150719|69769545|FG001|Overall Study|Other|0|||
38073862|NCT04039217|69769551|FG000|Overall Study|Lost to Follow-up|1|||
38073863|NCT00982111|69769561|FG000|Overall Study|Adverse Event|1|||
38073864|NCT00982111|69769562|FG001|Overall Study|Adverse Event|1|||
38073865|NCT00982111|69769561|FG000|Overall Study|Progressive Disease|46|||
38073866|NCT00982111|69769562|FG001|Overall Study|Progressive Disease|39|||
38073867|NCT00982111|69769561|FG000|Overall Study|Lost to Follow-up|9|||
38073868|NCT00982111|69769562|FG001|Overall Study|Lost to Follow-up|6|||
38073869|NCT00982111|69769561|FG000|Overall Study|New Anti-Cancer Therapy|5|||
38073870|NCT00982111|69769562|FG001|Overall Study|New Anti-Cancer Therapy|5|||
38073871|NCT00982111|69769561|FG000|Overall Study|Medical Decision|1|||
38073872|NCT00982111|69769562|FG001|Overall Study|Medical Decision|0|||
38073873|NCT00982111|69769561|FG000|Overall Study|Withdrawal by Subject|17|||
38073874|NCT00982111|69769562|FG001|Overall Study|Withdrawal by Subject|19|||
38073875|NCT00982111|69769561|FG000|Overall Study|Global Study End|0|||
38073876|NCT00982111|69769562|FG001|Overall Study|Global Study End|1|||
38073877|NCT00982111|69769561|FG000|Overall Study|Sponsor's Decision|0|||
38073878|NCT00982111|69769562|FG001|Overall Study|Sponsor's Decision|1|||
38073879|NCT02957682|69769571|FG000|Overall Study|Adverse Event|64|||
38073880|NCT02957682|69769572|FG001|Overall Study|Adverse Event|67|||
38073881|NCT02957682|69769571|FG000|Overall Study|Poor Compliance to Protocol|30|||
38073882|NCT02957682|69769572|FG001|Overall Study|Poor Compliance to Protocol|26|||
38073883|NCT02957682|69769571|FG000|Overall Study|Physician Decision|4|||
38073884|NCT02957682|69769572|FG001|Overall Study|Physician Decision|4|||
38073885|NCT02957682|69769571|FG000|Overall Study|Study Terminated by Sponsor|4|||
38073886|NCT02957682|69769572|FG001|Overall Study|Study Terminated by Sponsor|3|||
38073887|NCT02957682|69769571|FG000|Overall Study|Subject Moved|10|||
38073888|NCT02957682|69769572|FG001|Overall Study|Subject Moved|16|||
38073889|NCT02957682|69769571|FG000|Overall Study|Withdrawal by Subject|64|||
38073890|NCT02957682|69769572|FG001|Overall Study|Withdrawal by Subject|33|||
38073891|NCT02957682|69769571|FG000|Overall Study|Related to IMP Administration|3|||
38073892|NCT02957682|69769572|FG001|Overall Study|Related to IMP Administration|6|||
38073893|NCT02957682|69769571|FG000|Overall Study|Non-disclosed|16|||
38073894|NCT02957682|69769572|FG001|Overall Study|Non-disclosed|12|||
38073895|NCT02957682|69769571|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
38073896|NCT02957682|69769572|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
38073897|NCT03057951|69769580|FG000|Overall Study|Adverse Event|553|||
38073898|NCT03057951|69769581|FG001|Overall Study|Adverse Event|575|||
38073899|NCT03057951|69769580|FG000|Overall Study|Protocol Violation|30|||
38073900|NCT03057951|69769581|FG001|Overall Study|Protocol Violation|24|||
38073901|NCT03057951|69769580|FG000|Overall Study|Lost to Follow-up|6|||
38073902|NCT03057951|69769581|FG001|Overall Study|Lost to Follow-up|16|||
38073903|NCT03057951|69769580|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
38073904|NCT03057951|69769581|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
38073905|NCT03057951|69769580|FG000|Overall Study|Study drug stopped, reason missing|6|||
38073906|NCT03057951|69769581|FG001|Overall Study|Study drug stopped, reason missing|1|||
38073907|NCT03057951|69769580|FG000|Overall Study|Medical advice|6|||
38073908|NCT03057951|69769581|FG001|Overall Study|Medical advice|2|||
38073909|NCT03057951|69769580|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
38073910|NCT03057951|69769581|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
38073911|NCT03057951|69769580|FG000|Overall Study|Investigator decision|2|||
38073912|NCT03057951|69769581|FG001|Overall Study|Investigator decision|0|||
38073913|NCT03057951|69769580|FG000|Overall Study|Patient decision|5|||
38073914|NCT03057951|69769581|FG001|Overall Study|Patient decision|2|||
38073915|NCT03057951|69769580|FG000|Overall Study|Not attending study visits|3|||
38073916|NCT03057951|69769581|FG001|Overall Study|Not attending study visits|0|||
38073917|NCT03057951|69769580|FG000|Overall Study|Patient moved away|3|||
38073918|NCT03057951|69769581|FG001|Overall Study|Patient moved away|4|||
38073919|NCT03057951|69769580|FG000|Overall Study|Other reason than stated above|23|||
38073920|NCT03057951|69769581|FG001|Overall Study|Other reason than stated above|29|||
38073921|NCT03057951|69769580|FG000|Overall Study|Not treated|2|||
38073922|NCT03057951|69769581|FG001|Overall Study|Not treated|1|||
38073923|NCT03146663|69769589|FG000|Overall Study|Did not receive study treatment|1|||
38073924|NCT03146663|69769590|FG001|Overall Study|Did not receive study treatment|1|||
38073925|NCT02956278|69769600|FG000|Overall Study|Withdrawal by Subject|6|||
38073926|NCT02956278|69769601|FG001|Overall Study|Withdrawal by Subject|2|||
38073927|NCT02956278|69769602|FG002|Overall Study|Withdrawal by Subject|0|||
38073928|NCT02957136|69769612|FG000|Overall Study|Withdrawal by Subject|2|||
38073929|NCT02957136|69769613|FG001|Overall Study|Withdrawal by Subject|1|||
38073930|NCT03150485|69769619|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
38073931|NCT03150485|69769620|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
38073932|NCT03150485|69769621|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
38073933|NCT03150485|69769622|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
38073934|NCT03150485|69769623|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
38073935|NCT03150485|69769624|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
38073936|NCT03134911|69769631|FG000|Overall Study|Screen failure|31|||
38073937|NCT03134911|69769631|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
38073938|NCT03134599|69769650|FG000|Week 1|Lost to Follow-up|0|||
38073939|NCT03134599|69769651|FG001|Week 1|Lost to Follow-up|0|||
38073940|NCT03134599|69769652|FG002|Week 1|Lost to Follow-up|0|||
38073941|NCT03134599|69769653|FG003|Week 1|Lost to Follow-up|0|||
38073942|NCT03134599|69769654|FG004|Week 1|Lost to Follow-up|1|||
38073943|NCT03134599|69769655|FG005|Week 1|Lost to Follow-up|0|||
38073944|NCT03134599|69769650|FG000|Week 2|Lost to Follow-up|1|||
38073945|NCT03134599|69769651|FG001|Week 2|Lost to Follow-up|0|||
38073946|NCT03134599|69769652|FG002|Week 2|Lost to Follow-up|0|||
38073947|NCT03134599|69769653|FG003|Week 2|Lost to Follow-up|1|||
38073948|NCT03134599|69769654|FG004|Week 2|Lost to Follow-up|1|||
38073949|NCT03134599|69769655|FG005|Week 2|Lost to Follow-up|0|||
38073950|NCT03134599|69769650|FG000|Week 3|Lost to Follow-up|0|||
38073951|NCT03134599|69769651|FG001|Week 3|Lost to Follow-up|0|||
38073952|NCT03134599|69769652|FG002|Week 3|Lost to Follow-up|0|||
38073953|NCT03134599|69769653|FG003|Week 3|Lost to Follow-up|1|||
38073954|NCT03134599|69769654|FG004|Week 3|Lost to Follow-up|0|||
38073955|NCT03134599|69769655|FG005|Week 3|Lost to Follow-up|1|||
38073956|NCT03153137|69769665|FG000|Overall Study|Lost to Follow-up|1|||
38073957|NCT03153137|69769666|FG001|Overall Study|Lost to Follow-up|0|||
38073958|NCT03153137|69769665|FG000|Overall Study|Withdrawal by Subject|2|||
38073959|NCT03153137|69769666|FG001|Overall Study|Withdrawal by Subject|1|||
38073960|NCT03153137|69769665|FG000|Overall Study|Physician Decision|0|||
38073961|NCT03153137|69769666|FG001|Overall Study|Physician Decision|3|||
38073962|NCT03136861|69769679|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
38073963|NCT03136861|69769680|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
38073964|NCT03136861|69769681|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
38073965|NCT03136861|69769682|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
38073966|NCT03136861|69769683|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
38073967|NCT03136861|69769684|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
38073968|NCT03136861|69769685|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
38073969|NCT03136861|69769679|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
38073970|NCT03136861|69769680|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
38073971|NCT03136861|69769681|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
38073972|NCT03136861|69769682|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
38073973|NCT03136861|69769683|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
38073974|NCT03136861|69769684|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
38073975|NCT03136861|69769685|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
38073976|NCT03136861|69769679|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
38073977|NCT03136861|69769680|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
38073978|NCT03136861|69769681|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
38073979|NCT03136861|69769682|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
38073980|NCT03136861|69769683|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
38073981|NCT03136861|69769684|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
38073982|NCT03136861|69769685|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
38073983|NCT03136861|69769679|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
38073984|NCT03136861|69769680|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
38073985|NCT03136861|69769681|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
38073986|NCT03136861|69769682|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
38073987|NCT03136861|69769683|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
38073988|NCT03136861|69769684|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
38073989|NCT03136861|69769685|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
38073990|NCT03136861|69769679|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
38073991|NCT03136861|69769680|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
38073992|NCT03136861|69769681|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
38073993|NCT03136861|69769682|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
38073994|NCT03136861|69769683|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
38073995|NCT03136861|69769684|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
38073996|NCT03136861|69769685|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
38073997|NCT03136861|69769679|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
38073998|NCT03136861|69769680|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
38073999|NCT03136861|69769681|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
38074000|NCT03136861|69769682|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
38074001|NCT03136861|69769683|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
37966127|NCT00462501|69653036|FG000|Overall Study|Not treated|3|||
37966128|NCT00462501|69653036|FG000|Overall Study|Adverse Event|2|||
38074002|NCT03136861|69769684|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
38074003|NCT03136861|69769685|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
38074004|NCT03136861|69769679|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
38074005|NCT03136861|69769680|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
38074006|NCT03136861|69769681|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
38074007|NCT03136861|69769682|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
38074008|NCT03136861|69769683|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
38074009|NCT03136861|69769684|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
38074010|NCT03136861|69769685|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
38074011|NCT03136861|69769679|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
38074012|NCT03136861|69769680|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
38074013|NCT03136861|69769681|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
38074014|NCT03136861|69769682|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
38074015|NCT03136861|69769683|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
38074016|NCT03136861|69769684|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
38074017|NCT03136861|69769685|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
38074018|NCT03316950|69769713|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
38074019|NCT03316950|69769714|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
38074020|NCT03316950|69769715|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
38074021|NCT03316950|69769716|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
38074022|NCT03316950|69769713|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
38074023|NCT03316950|69769714|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
38074024|NCT03316950|69769715|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
38074025|NCT03316950|69769716|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
38074026|NCT03316950|69769713|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
38074027|NCT03316950|69769714|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
38074028|NCT03316950|69769715|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
38074029|NCT03316950|69769716|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
38074030|NCT03139279|69769730|FG000|Overall Study|Physician Decision|2|||
38074031|NCT03139279|69769731|FG001|Overall Study|Physician Decision|0|||
38074032|NCT03139279|69769730|FG000|Overall Study|Protocol Violation|5|||
38074033|NCT03139279|69769731|FG001|Overall Study|Protocol Violation|4|||
38074034|NCT03139279|69769730|FG000|Overall Study|Withdrawal by Subject|0|||
38074035|NCT03139279|69769731|FG001|Overall Study|Withdrawal by Subject|2|||
38074036|NCT01370642|69769740|FG000|Overall Study|Adverse Event|2|||
38074037|NCT01370642|69769741|FG001|Overall Study|Adverse Event|1|||
38074038|NCT01370642|69769742|FG002|Overall Study|Adverse Event|1|||
38074039|NCT01370642|69769740|FG000|Overall Study|Detectable HCV RNA|0|||
38074040|NCT01370642|69769741|FG001|Overall Study|Detectable HCV RNA|0|||
38074041|NCT01370642|69769742|FG002|Overall Study|Detectable HCV RNA|22|||
38074042|NCT01370642|69769740|FG000|Overall Study|Lost to Follow-up|0|||
38074043|NCT01370642|69769741|FG001|Overall Study|Lost to Follow-up|0|||
38074044|NCT01370642|69769742|FG002|Overall Study|Lost to Follow-up|1|||
38074045|NCT01370642|69769740|FG000|Overall Study|Physician Decision|4|||
38074046|NCT01370642|69769741|FG001|Overall Study|Physician Decision|1|||
38074047|NCT01370642|69769742|FG002|Overall Study|Physician Decision|2|||
38074048|NCT01370642|69769740|FG000|Overall Study|Withdrawal by Subject|2|||
38074049|NCT01370642|69769741|FG001|Overall Study|Withdrawal by Subject|4|||
38074050|NCT01370642|69769742|FG002|Overall Study|Withdrawal by Subject|3|||
38074051|NCT02873208|69769750|FG000|Overall Study|Withdrawal by Subject|36|||
38074052|NCT02873208|69769750|FG000|Overall Study|Lost to Follow-up|22|||
38074053|NCT02873208|69769750|FG000|Overall Study|Adverse Event|15|||
38074054|NCT02873208|69769750|FG000|Overall Study|Non-compliance with study drug|12|||
38074055|NCT02873208|69769750|FG000|Overall Study|Protocol Violation|8|||
38074056|NCT02873208|69769750|FG000|Overall Study|Pregnancy|2|||
38074057|NCT02873208|69769750|FG000|Overall Study|Incarceration|1|||
38074058|NCT02873208|69769750|FG000|Overall Study|Lack of Efficacy|1|||
38074059|NCT02873208|69769750|FG000|Overall Study|Physician Decision|1|||
38074060|NCT03138967|69769756|FG000|Overall Study|Death|0|||
38074061|NCT03138967|69769757|FG001|Overall Study|Death|1|||
38074062|NCT03138967|69769756|FG000|Overall Study|Physician Decision|1|||
38074063|NCT03138967|69769757|FG001|Overall Study|Physician Decision|3|||
38074064|NCT01547117|69769767|FG000|Overall Study|Physician Decision|0|||
37966129|NCT00383188|69653045|FG000|Overall Study|Adverse Event|4|||
38074065|NCT01547117|69769768|FG001|Overall Study|Physician Decision|1|||
38074066|NCT01547117|69769769|FG002|Overall Study|Physician Decision|1|||
38074067|NCT01547117|69769770|FG003|Overall Study|Physician Decision|3|||
37966130|NCT00383188|69653046|FG001|Overall Study|Adverse Event|7|||
37966131|NCT00383188|69653047|FG002|Overall Study|Adverse Event|9|||
37966132|NCT00383188|69653048|FG003|Overall Study|Adverse Event|8|||
37966133|NCT00383188|69653049|FG004|Overall Study|Adverse Event|8|||
38074068|NCT01547117|69769767|FG000|Overall Study|Withdrawal by Subject|1|||
38074069|NCT01547117|69769768|FG001|Overall Study|Withdrawal by Subject|2|||
38074070|NCT01547117|69769769|FG002|Overall Study|Withdrawal by Subject|1|||
38074071|NCT01547117|69769770|FG003|Overall Study|Withdrawal by Subject|2|||
38074072|NCT03136159|69769798|FG000|Overall Study|chorioamnionitis|2|||
38074073|NCT03136159|69769799|FG001|Overall Study|chorioamnionitis|0|||
38074074|NCT03136159|69769798|FG000|Overall Study|vertical skin incision|1|||
38074075|NCT03136159|69769799|FG001|Overall Study|vertical skin incision|0|||
38074076|NCT03136159|69769798|FG000|Overall Study|additional dressing|1|||
38074077|NCT03136159|69769799|FG001|Overall Study|additional dressing|0|||
38074078|NCT03136159|69769798|FG000|Overall Study|never got dressing placed|1|||
38074079|NCT03136159|69769799|FG001|Overall Study|never got dressing placed|0|||
38074080|NCT01986933|69769810|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
38074081|NCT01986933|69769811|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
38074082|NCT01986933|69769812|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
38074083|NCT01986933|69769813|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
38074084|NCT01986933|69769814|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
38074085|NCT01986933|69769810|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
38074086|NCT01986933|69769811|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
38074087|NCT01986933|69769812|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
38074088|NCT01986933|69769813|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
38074089|NCT01986933|69769814|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
38074090|NCT01986933|69769810|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
38074091|NCT01986933|69769811|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
38074092|NCT01986933|69769812|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
38074093|NCT01986933|69769813|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
38074094|NCT01986933|69769814|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
38074095|NCT01986933|69769810|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
38074096|NCT01986933|69769811|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
38074097|NCT01986933|69769812|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
38074098|NCT01986933|69769813|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
38074099|NCT01986933|69769814|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
38074100|NCT01986933|69769810|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
38074101|NCT01986933|69769811|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
38074102|NCT01986933|69769812|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
38074103|NCT01986933|69769813|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
38074104|NCT01986933|69769814|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
38074105|NCT01986933|69769810|FG000|Active-to-active (Part B)|Adverse Event|0|||
38074106|NCT01986933|69769811|FG001|Active-to-active (Part B)|Adverse Event|2|||
38074107|NCT01986933|69769812|FG002|Active-to-active (Part B)|Adverse Event|0|||
38074108|NCT01986933|69769813|FG003|Active-to-active (Part B)|Adverse Event|1|||
38074109|NCT01986933|69769814|FG004|Active-to-active (Part B)|Adverse Event|3|||
38074110|NCT01986933|69769810|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
38074111|NCT01986933|69769811|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
38074112|NCT01986933|69769812|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
38074113|NCT01986933|69769813|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
38074114|NCT01986933|69769814|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
38074115|NCT01986933|69769810|FG000|Active-to-active (Part B)|Pregnancy|0|||
38074116|NCT01986933|69769811|FG001|Active-to-active (Part B)|Pregnancy|0|||
38074117|NCT01986933|69769812|FG002|Active-to-active (Part B)|Pregnancy|0|||
38074118|NCT01986933|69769813|FG003|Active-to-active (Part B)|Pregnancy|0|||
38074119|NCT01986933|69769814|FG004|Active-to-active (Part B)|Pregnancy|1|||
38074120|NCT01986933|69769810|FG000|Active-to-active (Part B)|Physician Decision|0|||
38074121|NCT01986933|69769811|FG001|Active-to-active (Part B)|Physician Decision|0|||
38074122|NCT01986933|69769812|FG002|Active-to-active (Part B)|Physician Decision|1|||
38074123|NCT01986933|69769813|FG003|Active-to-active (Part B)|Physician Decision|1|||
38074124|NCT01986933|69769814|FG004|Active-to-active (Part B)|Physician Decision|0|||
38074125|NCT01986933|69769810|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
38074126|NCT01986933|69769811|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
37966134|NCT00383188|69653045|FG000|Overall Study|Lack of Efficacy|9|||
37966135|NCT00383188|69653046|FG001|Overall Study|Lack of Efficacy|3|||
37966136|NCT00383188|69653047|FG002|Overall Study|Lack of Efficacy|3|||
38074127|NCT01986933|69769812|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
38074128|NCT01986933|69769813|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
38074129|NCT01986933|69769814|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
38074130|NCT01986933|69769810|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
38074131|NCT01986933|69769811|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
38074132|NCT01986933|69769812|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
38074133|NCT01986933|69769813|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
38074134|NCT01986933|69769814|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
38074135|NCT01986933|69769810|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
38074136|NCT01986933|69769811|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
38074137|NCT01986933|69769812|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
38074138|NCT01986933|69769813|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
38074139|NCT01986933|69769814|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
38074140|NCT01986933|69769810|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
38074141|NCT01986933|69769811|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
38074142|NCT01986933|69769812|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
38074143|NCT01986933|69769813|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
38074144|NCT01986933|69769814|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
38074145|NCT01986933|69769810|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
38074146|NCT01986933|69769811|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
38074147|NCT01986933|69769812|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
38074148|NCT01986933|69769813|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
38074149|NCT01986933|69769814|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
38074150|NCT01986933|69769810|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
38074151|NCT01986933|69769811|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
38074152|NCT01986933|69769812|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
38074153|NCT01986933|69769813|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
38074154|NCT01986933|69769814|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
38074155|NCT01986933|69769810|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
38074156|NCT01986933|69769811|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
38074157|NCT01986933|69769812|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
38074158|NCT01986933|69769813|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
38074159|NCT01986933|69769814|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
38074160|NCT01986933|69769810|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
38074161|NCT01986933|69769811|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
38074162|NCT01986933|69769812|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
38074163|NCT01986933|69769813|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
38074164|NCT01986933|69769814|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
38074165|NCT00394355|69769858|FG000|Overall Study|Adverse Event|10|||
37966137|NCT00383188|69653048|FG003|Overall Study|Lack of Efficacy|2|||
37966138|NCT00383188|69653049|FG004|Overall Study|Lack of Efficacy|6|||
37966139|NCT00383188|69653045|FG000|Overall Study|Other|3|||
37966140|NCT00383188|69653046|FG001|Overall Study|Other|1|||
38074166|NCT00394355|69769859|FG001|Overall Study|Adverse Event|6|||
38074167|NCT00394355|69769860|FG002|Overall Study|Adverse Event|7|||
38074168|NCT00394355|69769861|FG003|Overall Study|Adverse Event|8|||
38074169|NCT00394355|69769858|FG000|Overall Study|Did not meet protocol eligibility|1|||
38074170|NCT00394355|69769859|FG001|Overall Study|Did not meet protocol eligibility|5|||
38074171|NCT00394355|69769860|FG002|Overall Study|Did not meet protocol eligibility|4|||
38074172|NCT00394355|69769861|FG003|Overall Study|Did not meet protocol eligibility|2|||
38074173|NCT00394355|69769858|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
38074174|NCT00394355|69769859|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
37680403|NCT02585713|69156050|FG001|Overall Study|Other|1|||
37966141|NCT00383188|69653047|FG002|Overall Study|Other|0|||
37966142|NCT00383188|69653048|FG003|Overall Study|Other|2|||
37966143|NCT00383188|69653049|FG004|Overall Study|Other|6|||
38074175|NCT00394355|69769860|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
38074176|NCT00394355|69769861|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
38074177|NCT00394355|69769858|FG000|Overall Study|Subject withdrawal - related to drug|1|||
38074178|NCT00394355|69769859|FG001|Overall Study|Subject withdrawal - related to drug|0|||
38074179|NCT00394355|69769860|FG002|Overall Study|Subject withdrawal - related to drug|0|||
38074180|NCT00394355|69769861|FG003|Overall Study|Subject withdrawal - related to drug|0|||
38074181|NCT00394355|69769858|FG000|Overall Study|Lost to Follow-up|7|||
38074182|NCT00394355|69769859|FG001|Overall Study|Lost to Follow-up|5|||
38074183|NCT00394355|69769860|FG002|Overall Study|Lost to Follow-up|4|||
38074184|NCT00394355|69769861|FG003|Overall Study|Lost to Follow-up|3|||
38074185|NCT00394355|69769858|FG000|Overall Study|Noncompliance with protocol|4|||
38074186|NCT00394355|69769859|FG001|Overall Study|Noncompliance with protocol|3|||
38074187|NCT00394355|69769860|FG002|Overall Study|Noncompliance with protocol|10|||
38074188|NCT00394355|69769861|FG003|Overall Study|Noncompliance with protocol|8|||
38074189|NCT00394355|69769858|FG000|Overall Study|Administrative|0|||
38074190|NCT00394355|69769859|FG001|Overall Study|Administrative|1|||
38074191|NCT00394355|69769860|FG002|Overall Study|Administrative|1|||
38074192|NCT00394355|69769861|FG003|Overall Study|Administrative|1|||
38074193|NCT00394355|69769858|FG000|Overall Study|Lack of Efficacy|0|||
38074194|NCT00394355|69769859|FG001|Overall Study|Lack of Efficacy|0|||
38074195|NCT00394355|69769860|FG002|Overall Study|Lack of Efficacy|2|||
38074196|NCT00394355|69769861|FG003|Overall Study|Lack of Efficacy|3|||
38074197|NCT02797808|69769873|FG000|Overall Study|Withdrawal by Subject|1|||
38074198|NCT02797808|69769874|FG001|Overall Study|Withdrawal by Subject|1|||
38074199|NCT02797808|69769873|FG000|Overall Study|Physician Decision|6|||
38074200|NCT02797808|69769874|FG001|Overall Study|Physician Decision|2|||
38074201|NCT02796560|69769882|FG000|Overall Study|Adverse Event|2|||
38074202|NCT02796560|69769883|FG001|Overall Study|Adverse Event|0|||
38074203|NCT02796560|69769882|FG000|Overall Study|Withdrawal by Subject|2|||
38074204|NCT02796560|69769883|FG001|Overall Study|Withdrawal by Subject|2|||
38074205|NCT00344487|69769889|FG000|Overall Study|immunologic failure|1|||
38074206|NCT02871492|69769898|FG000|Overall Study|Lost to Follow-up|6|||
38074207|NCT02871492|69769899|FG001|Overall Study|Lost to Follow-up|3|||
38074208|NCT02871492|69769900|FG002|Overall Study|Lost to Follow-up|5|||
38074209|NCT02871492|69769898|FG000|Overall Study|Withdrawal by Subject|0|||
38074210|NCT02871492|69769899|FG001|Overall Study|Withdrawal by Subject|0|||
38074211|NCT02871492|69769900|FG002|Overall Study|Withdrawal by Subject|1|||
38074212|NCT03143855|69769910|FG000|Overall Study|Withdrawal by Subject|4|||
38074213|NCT03143855|69769911|FG001|Overall Study|Withdrawal by Subject|3|||
38074214|NCT03143855|69769910|FG000|Overall Study|Protocol Violation|1|||
38074215|NCT03143855|69769911|FG001|Overall Study|Protocol Violation|0|||
38074216|NCT03143855|69769910|FG000|Overall Study|Participant experienced withdrawal|0|||
38074217|NCT03143855|69769911|FG001|Overall Study|Participant experienced withdrawal|1|||
38074218|NCT02878603|69769919|FG000|Overall Study|Lost to Follow-up|4|||
38074219|NCT02878603|69769920|FG001|Overall Study|Lost to Follow-up|1|||
38074220|NCT02878603|69769919|FG000|Overall Study|Withdrawal by Subject|1|||
38074221|NCT02878603|69769920|FG001|Overall Study|Withdrawal by Subject|1|||
38074222|NCT02878603|69769919|FG000|Overall Study|Death|1|||
38074223|NCT02878603|69769920|FG001|Overall Study|Death|0|||
38074224|NCT02878603|69769919|FG000|Overall Study|Physician Decision|0|||
38074225|NCT02878603|69769920|FG001|Overall Study|Physician Decision|3|||
38074226|NCT01370408|69769926|FG000|Overall Study|treatment failure|9|||
38074227|NCT03294109|69769932|FG000|Overall Study|Withdrawal by Subject|6|||
38074228|NCT03294109|69769933|FG001|Overall Study|Withdrawal by Subject|5|||
38074229|NCT03132805|69769952|FG000|Overall Study|Lost to Follow-up|142|||
38074230|NCT03132805|69769953|FG001|Overall Study|Lost to Follow-up|141|||
38074231|NCT03132805|69769954|FG002|Overall Study|Lost to Follow-up|113|||
38074232|NCT02793128|69769962|FG000|Overall Study|Death|4|||
38074233|NCT02793128|69769962|FG000|Overall Study|Withdrawal by Subject|2|||
38074234|NCT02793128|69769962|FG000|Overall Study|Physician Decision|1|||
38074235|NCT02793128|69769962|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
38074236|NCT02793128|69769962|FG000|Overall Study|Patient elected nephroureterectomy|1|||
38074237|NCT03142451|69769976|FG000|Overall Study|Adverse Event|5|||
38074238|NCT03142451|69769977|FG001|Overall Study|Adverse Event|2|||
37966144|NCT00383188|69653045|FG000|Overall Study|No longer willing to participate|1|||
38074239|NCT03142451|69769976|FG000|Overall Study|Lost to Follow-up|25|||
38074240|NCT03142451|69769977|FG001|Overall Study|Lost to Follow-up|8|||
38074241|NCT03142451|69769976|FG000|Overall Study|Participant request|24|||
38074242|NCT03142451|69769977|FG001|Overall Study|Participant request|12|||
38074243|NCT03142451|69769976|FG000|Overall Study|Protocol Violation|3|||
38074244|NCT03142451|69769977|FG001|Overall Study|Protocol Violation|1|||
38074245|NCT03142451|69769976|FG000|Overall Study|Other|1|||
38074246|NCT03142451|69769977|FG001|Overall Study|Other|1|||
38074247|NCT03141905|69769985|FG000|Overall Study|Death|3|||
38074248|NCT03141905|69769986|FG001|Overall Study|Death|2|||
38074249|NCT03141905|69769985|FG000|Overall Study|Withdrawal by Subject|1|||
38074250|NCT03141905|69769986|FG001|Overall Study|Withdrawal by Subject|0|||
38074251|NCT03141905|69769985|FG000|Overall Study|Lost to Follow-up|3|||
38074252|NCT03141905|69769986|FG001|Overall Study|Lost to Follow-up|7|||
38074253|NCT03141905|69769985|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
38074254|NCT03141905|69769986|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
38074255|NCT01370018|69769993|FG000|Overall Study|Did not meet criteria for analysis|1|||
38074256|NCT04034355|69769999|FG000|Overall Study|Study terminated by Sponsor|10|||
38074257|NCT04034355|69770000|FG001|Overall Study|Study terminated by Sponsor|17|||
38074258|NCT04034355|69769999|FG000|Overall Study|Withdrawal by Subject|12|||
38074259|NCT04034355|69770000|FG001|Overall Study|Withdrawal by Subject|11|||
38074260|NCT04034355|69769999|FG000|Overall Study|Site terminated by Sponsor|4|||
38074261|NCT04034355|69770000|FG001|Overall Study|Site terminated by Sponsor|5|||
38074262|NCT04034355|69769999|FG000|Overall Study|Adverse Event|2|||
38074263|NCT04034355|69770000|FG001|Overall Study|Adverse Event|0|||
38074264|NCT04034355|69769999|FG000|Overall Study|Death|1|||
38074265|NCT04034355|69770000|FG001|Overall Study|Death|1|||
38074266|NCT04034355|69769999|FG000|Overall Study|Not reported|2|||
38074267|NCT04034355|69770000|FG001|Overall Study|Not reported|0|||
38074268|NCT04034355|69769999|FG000|Overall Study|Lost to Follow-up|1|||
38074269|NCT04034355|69770000|FG001|Overall Study|Lost to Follow-up|0|||
38074270|NCT04034355|69769999|FG000|Overall Study|Physician Decision|1|||
38074271|NCT04034355|69770000|FG001|Overall Study|Physician Decision|0|||
38074272|NCT04034355|69769999|FG000|Overall Study|Protocol Violation|0|||
38074273|NCT04034355|69770000|FG001|Overall Study|Protocol Violation|1|||
38074274|NCT04034355|69769999|FG000|Overall Study|Progressive disease|1|||
38074275|NCT04034355|69770000|FG001|Overall Study|Progressive disease|0|||
38074276|NCT01336764|69770017|FG000|Overall Study|Withdrawal by Subject|5|||
38074277|NCT01336764|69770018|FG001|Overall Study|Withdrawal by Subject|5|||
38074278|NCT01336608|69770027|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
38074279|NCT01336608|69770028|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
38074280|NCT01336608|69770029|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
38074281|NCT01336608|69770030|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
38074282|NCT01336608|69770027|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
38074283|NCT01336608|69770028|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
38074284|NCT01336608|69770029|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
38074285|NCT01336608|69770030|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
38074286|NCT01336608|69770027|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
38074287|NCT01336608|69770028|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
38074288|NCT01336608|69770029|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
38074289|NCT01336608|69770030|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
38074290|NCT01336608|69770027|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
38074291|NCT01336608|69770028|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
38074292|NCT01336608|69770029|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
38074293|NCT01336608|69770030|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
38074294|NCT01336608|69770027|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
38074295|NCT01336608|69770028|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
38074296|NCT01336608|69770029|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
38074297|NCT01336608|69770030|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
38074298|NCT01336608|69770027|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
38074299|NCT01336608|69770028|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
38074300|NCT01336608|69770029|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
38074301|NCT01336608|69770030|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
38074302|NCT01336608|69770027|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
38074303|NCT01336608|69770028|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
38074304|NCT01336608|69770029|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
38074305|NCT01336608|69770030|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
38074306|NCT01336608|69770027|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
38074307|NCT01336608|69770028|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
38074308|NCT01336608|69770029|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
38074309|NCT01336608|69770030|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
38074310|NCT01336608|69770027|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
38074311|NCT01336608|69770028|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
38074312|NCT01336608|69770029|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
38074313|NCT01336608|69770030|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
38074314|NCT01336608|69770027|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
38074315|NCT01336608|69770028|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
38074316|NCT01336608|69770029|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
37966145|NCT00383188|69653046|FG001|Overall Study|No longer willing to participate|0|||
38074317|NCT01336608|69770030|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
38074318|NCT01336608|69770027|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
38074319|NCT01336608|69770028|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
38074320|NCT01336608|69770029|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
38074321|NCT01336608|69770030|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
38074322|NCT01336608|69770027|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
38074323|NCT01336608|69770028|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
38074324|NCT01336608|69770029|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
38074325|NCT01336608|69770030|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
38074326|NCT01336608|69770027|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
38074327|NCT01336608|69770028|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
38074328|NCT01336608|69770029|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
38074329|NCT01336608|69770030|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
38074330|NCT01346371|69770049|FG000|Overall Study|Lost to Follow-up|2|||
38074331|NCT01346371|69770050|FG001|Overall Study|Lost to Follow-up|0|||
38074332|NCT03644849|69770068|FG000|Overall Study|Lost to Follow-up|1|||
38074333|NCT03644849|69770069|FG001|Overall Study|Lost to Follow-up|3|||
38074334|NCT03131479|69770080|FG000|Overall Study|Adverse Event|0|||
38074335|NCT03131479|69770081|FG001|Overall Study|Adverse Event|0|||
38074336|NCT03131479|69770082|FG002|Overall Study|Adverse Event|1|||
38074337|NCT03131479|69770083|FG003|Overall Study|Adverse Event|1|||
38074338|NCT03131479|69770084|FG004|Overall Study|Adverse Event|0|||
38074339|NCT03131479|69770080|FG000|Overall Study|Subject/Guardian Decision|0|||
38074340|NCT03131479|69770081|FG001|Overall Study|Subject/Guardian Decision|0|||
38074341|NCT03131479|69770082|FG002|Overall Study|Subject/Guardian Decision|0|||
38074342|NCT03131479|69770083|FG003|Overall Study|Subject/Guardian Decision|1|||
38074343|NCT03131479|69770084|FG004|Overall Study|Subject/Guardian Decision|0|||
38074344|NCT03602885|69770098|FG000|Overall Study|Lost to Follow-up|3|||
38074345|NCT03602885|69770099|FG001|Overall Study|Lost to Follow-up|0|||
38074346|NCT02880761|69770107|FG000|Overall Study|Death|6|||
38074347|NCT02880761|69770108|FG001|Overall Study|Death|8|||
38074348|NCT02880761|69770107|FG000|Overall Study|Withdrawal by Subject|3|||
38074349|NCT02880761|69770108|FG001|Overall Study|Withdrawal by Subject|6|||
38074350|NCT02880761|69770107|FG000|Overall Study|Protocol Violation|4|||
38074351|NCT02880761|69770108|FG001|Overall Study|Protocol Violation|3|||
38074352|NCT02880761|69770107|FG000|Overall Study|Lost to Follow-up|3|||
38074353|NCT02880761|69770108|FG001|Overall Study|Lost to Follow-up|4|||
38074354|NCT02930941|69770116|FG000|Overall Study|Lost to Follow-up|1|||
38074355|NCT02930941|69770117|FG001|Overall Study|Lost to Follow-up|2|||
38074356|NCT03137537|69770129|FG000|Overall Study|Adverse Event|0|||
38074357|NCT03137537|69770130|FG001|Overall Study|Adverse Event|1|||
38074358|NCT03137459|69770138|FG000|2-month Assessment|Withdrawal by Subject|13|||
38074359|NCT03137459|69770139|FG001|2-month Assessment|Withdrawal by Subject|3|||
38074360|NCT03137459|69770138|FG000|2-month Assessment|Unable to reach|42|||
38074361|NCT03137459|69770139|FG001|2-month Assessment|Unable to reach|32|||
38074362|NCT03137459|69770138|FG000|2-month Assessment|Refused assessment|7|||
38074363|NCT03137459|69770139|FG001|2-month Assessment|Refused assessment|5|||
38074364|NCT03137459|69770138|FG000|2-month Assessment|Acutely ill|6|||
38074365|NCT03137459|69770139|FG001|2-month Assessment|Acutely ill|2|||
38074366|NCT03137459|69770138|FG000|4-month Assessment|Death|4|||
38074367|NCT03137459|69770139|FG001|4-month Assessment|Death|2|||
38074368|NCT03137459|69770138|FG000|4-month Assessment|Withdrawal by Subject|4|||
38074369|NCT03137459|69770139|FG001|4-month Assessment|Withdrawal by Subject|2|||
38074370|NCT03137459|69770138|FG000|4-month Assessment|Unable to reach|44|||
38074371|NCT03137459|69770139|FG001|4-month Assessment|Unable to reach|29|||
38074372|NCT03137459|69770138|FG000|4-month Assessment|Refused assessment|24|||
38074373|NCT03137459|69770139|FG001|4-month Assessment|Refused assessment|10|||
38074374|NCT03137459|69770138|FG000|4-month Assessment|Acutely ill|2|||
38074375|NCT03137459|69770139|FG001|4-month Assessment|Acutely ill|3|||
38074376|NCT03137459|69770138|FG000|6-months|Lost to Follow-up|14|||
38074377|NCT03137459|69770139|FG001|6-months|Lost to Follow-up|11|||
38074378|NCT03137459|69770138|FG000|6-months|Death|0|||
38074379|NCT03137459|69770139|FG001|6-months|Death|2|||
38074380|NCT03137459|69770138|FG000|6-months|Refused assessment|6|||
38074381|NCT03137459|69770139|FG001|6-months|Refused assessment|3|||
38074382|NCT03137459|69770138|FG000|6-months|Acutely ill|1|||
38074383|NCT03137459|69770139|FG001|6-months|Acutely ill|1|||
38074384|NCT03131713|69770148|FG000|Overall Study|Lost to Follow-up|5|||
38074385|NCT03131713|69770149|FG001|Overall Study|Lost to Follow-up|0|||
38074386|NCT02930005|69770157|FG000|Overall Study|Lost to Follow-up|1|||
38074387|NCT02930005|69770158|FG001|Overall Study|Lost to Follow-up|5|||
38074388|NCT03637491|69770168|FG000|Overall Study|Death|9|||
38074389|NCT03637491|69770169|FG001|Overall Study|Death|9|||
38074390|NCT03637491|69770170|FG002|Overall Study|Death|5|||
38074391|NCT03637491|69770171|FG003|Overall Study|Death|3|||
38074392|NCT03637491|69770168|FG000|Overall Study|Lost to Follow-up|0|||
38074393|NCT03637491|69770169|FG001|Overall Study|Lost to Follow-up|1|||
38074394|NCT03637491|69770170|FG002|Overall Study|Lost to Follow-up|0|||
38074395|NCT03637491|69770171|FG003|Overall Study|Lost to Follow-up|1|||
38074396|NCT03637491|69770168|FG000|Overall Study|Study Terminated By Sponsor|0|||
38074397|NCT03637491|69770169|FG001|Overall Study|Study Terminated By Sponsor|2|||
38074398|NCT03637491|69770170|FG002|Overall Study|Study Terminated By Sponsor|1|||
38074399|NCT03637491|69770171|FG003|Overall Study|Study Terminated By Sponsor|0|||
38074400|NCT03637491|69770168|FG000|Overall Study|Withdrawal by Subject|1|||
38074401|NCT03637491|69770169|FG001|Overall Study|Withdrawal by Subject|0|||
38074402|NCT03637491|69770170|FG002|Overall Study|Withdrawal by Subject|1|||
38074403|NCT03637491|69770171|FG003|Overall Study|Withdrawal by Subject|2|||
38074404|NCT03334539|69770205|FG000|Overall Study|Adverse Event|3|||
38074405|NCT03334539|69770206|FG001|Overall Study|Adverse Event|5|||
38074406|NCT03334539|69770207|FG002|Overall Study|Adverse Event|0|||
38074407|NCT03334539|69770205|FG000|Overall Study|Withdrawal by Subject|0|||
38074408|NCT03334539|69770206|FG001|Overall Study|Withdrawal by Subject|1|||
38074409|NCT03334539|69770207|FG002|Overall Study|Withdrawal by Subject|1|||
38074410|NCT03334539|69770205|FG000|Overall Study|Administrative Reasons|1|||
38074411|NCT03334539|69770206|FG001|Overall Study|Administrative Reasons|0|||
38074412|NCT03334539|69770207|FG002|Overall Study|Administrative Reasons|0|||
38074413|NCT03334539|69770205|FG000|Overall Study|Hypertension Not Controlled|0|||
38074414|NCT03334539|69770206|FG001|Overall Study|Hypertension Not Controlled|1|||
38074415|NCT03334539|69770207|FG002|Overall Study|Hypertension Not Controlled|0|||
38074416|NCT03137303|69770222|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
38074417|NCT03137303|69770223|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
38074418|NCT03137303|69770222|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
38074419|NCT03137303|69770223|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
38074420|NCT03137303|69770222|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
38074421|NCT03137303|69770223|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
38074422|NCT03137303|69770222|FG000|T3: 9-month Follow-up|Death|1|||
38074423|NCT03137303|69770223|FG001|T3: 9-month Follow-up|Death|0|||
38074424|NCT03137303|69770222|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
38074425|NCT03137303|69770223|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
38074426|NCT03137303|69770222|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
38074427|NCT03137303|69770223|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
38074428|NCT03137303|69770222|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
38074429|NCT03137303|69770223|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
38074430|NCT03296553|69770231|FG000|Overall Study|Withdrawal by Subject|1|||
38074431|NCT03296553|69770232|FG001|Overall Study|Withdrawal by Subject|1|||
38074432|NCT03296553|69770231|FG000|Overall Study|Death|1|||
38074433|NCT03296553|69770232|FG001|Overall Study|Death|0|||
38074434|NCT03131167|69770251|FG000|Overall Study|Other (Unspecified)|0|||
38074435|NCT03131167|69770252|FG001|Overall Study|Other (Unspecified)|0|||
38074436|NCT03131167|69770253|FG002|Overall Study|Other (Unspecified)|0|||
38074437|NCT03131167|69770254|FG003|Overall Study|Other (Unspecified)|0|||
38074438|NCT03131167|69770255|FG004|Overall Study|Other (Unspecified)|0|||
38074439|NCT03131167|69770256|FG005|Overall Study|Other (Unspecified)|1|||
38074440|NCT03131167|69770257|FG006|Overall Study|Other (Unspecified)|0|||
38074441|NCT03131167|69770258|FG007|Overall Study|Other (Unspecified)|0|||
38074442|NCT03131167|69770259|FG008|Overall Study|Other (Unspecified)|0|||
38074443|NCT03131167|69770260|FG009|Overall Study|Other (Unspecified)|0|||
38074444|NCT03131167|69770261|FG010|Overall Study|Other (Unspecified)|0|||
38074445|NCT03131167|69770262|FG011|Overall Study|Other (Unspecified)|0|||
38074446|NCT03131167|69770263|FG012|Overall Study|Other (Unspecified)|0|||
38074447|NCT03060447|69770294|FG000|Overall Study|Withdrawal by Subject|2|||
38074448|NCT03060447|69770295|FG001|Overall Study|Withdrawal by Subject|0|||
38074449|NCT01712789|69770307|FG000|Overall Study|Lack of Efficacy|2|||
38074450|NCT01712789|69770307|FG000|Overall Study|Lost to Follow-up|1|||
38074451|NCT01712789|69770307|FG000|Overall Study|Progressive Disease|504|||
38074452|NCT01712789|69770307|FG000|Overall Study|Death|57|||
38074453|NCT01712789|69770307|FG000|Overall Study|Adverse Event|52|||
38074454|NCT01712789|69770307|FG000|Overall Study|Miscellaneous|31|||
38074455|NCT01712789|69770307|FG000|Overall Study|Withdrawal by Subject|21|||
38074456|NCT01712789|69770307|FG000|Overall Study|Transition to Commercial Treatment|8|||
38074457|NCT01712789|69770307|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
38074458|NCT03074318|69770315|FG000|Overall Study|Adverse Event|0|||
38074459|NCT03074318|69770316|FG001|Overall Study|Adverse Event|1|||
38074460|NCT03074318|69770317|FG002|Overall Study|Adverse Event|1|||
38074461|NCT03074318|69770318|FG003|Overall Study|Adverse Event|1|||
38074462|NCT03074318|69770315|FG000|Overall Study|Death|1|||
38074463|NCT03074318|69770316|FG001|Overall Study|Death|0|||
38074464|NCT03074318|69770317|FG002|Overall Study|Death|0|||
38074465|NCT03074318|69770318|FG003|Overall Study|Death|0|||
38074466|NCT03074318|69770315|FG000|Overall Study|Withdrawal by Subject|1|||
38074467|NCT03074318|69770316|FG001|Overall Study|Withdrawal by Subject|2|||
38074468|NCT03074318|69770317|FG002|Overall Study|Withdrawal by Subject|2|||
38074469|NCT03074318|69770318|FG003|Overall Study|Withdrawal by Subject|4|||
38074470|NCT03074318|69770315|FG000|Overall Study|Trial Closure|2|||
38074471|NCT03074318|69770316|FG001|Overall Study|Trial Closure|2|||
38074472|NCT03074318|69770317|FG002|Overall Study|Trial Closure|3|||
38074473|NCT03074318|69770318|FG003|Overall Study|Trial Closure|11|||
38074474|NCT03135119|69770339|FG000|Overall Study|Lost to Follow-up|2|||
38074475|NCT03135119|69770340|FG001|Overall Study|Lost to Follow-up|0|||
38074476|NCT03135119|69770339|FG000|Overall Study|Physician Decision|1|||
38074477|NCT03135119|69770340|FG001|Overall Study|Physician Decision|1|||
38074478|NCT03135119|69770339|FG000|Overall Study|COVID-19 Shutdown|2|||
38074479|NCT03135119|69770340|FG001|Overall Study|COVID-19 Shutdown|2|||
38074480|NCT01369784|69770346|FG000|Overall Study|Protocol Violation|12|||
38074481|NCT03353675|69770350|FG000|Overall Study|Adverse Event|4|||
38074482|NCT03137069|69770360|FG000|Overall Study|Withdrawal by Subject|1|||
38074483|NCT03137069|69770361|FG001|Overall Study|Withdrawal by Subject|2|||
38074484|NCT03137069|69770362|FG002|Overall Study|Withdrawal by Subject|2|||
38074485|NCT03137069|69770363|FG003|Overall Study|Withdrawal by Subject|2|||
38074486|NCT03137069|69770364|FG004|Overall Study|Withdrawal by Subject|0|||
38074487|NCT03137069|69770365|FG005|Overall Study|Withdrawal by Subject|0|||
38074488|NCT03137069|69770360|FG000|Overall Study|Adverse Event|0|||
38074489|NCT03137069|69770361|FG001|Overall Study|Adverse Event|3|||
38074490|NCT03137069|69770362|FG002|Overall Study|Adverse Event|1|||
38074491|NCT03137069|69770363|FG003|Overall Study|Adverse Event|1|||
38074492|NCT03137069|69770364|FG004|Overall Study|Adverse Event|0|||
38074493|NCT03137069|69770365|FG005|Overall Study|Adverse Event|1|||
38074494|NCT03137069|69770360|FG000|Overall Study|Protocol Violation|0|||
38074495|NCT03137069|69770361|FG001|Overall Study|Protocol Violation|1|||
38074496|NCT03137069|69770362|FG002|Overall Study|Protocol Violation|0|||
38074497|NCT03137069|69770363|FG003|Overall Study|Protocol Violation|1|||
38074498|NCT03137069|69770364|FG004|Overall Study|Protocol Violation|1|||
38074499|NCT03137069|69770365|FG005|Overall Study|Protocol Violation|1|||
38074500|NCT03137069|69770360|FG000|Overall Study|Physician Decision|0|||
38074501|NCT03137069|69770361|FG001|Overall Study|Physician Decision|0|||
38074502|NCT03137069|69770362|FG002|Overall Study|Physician Decision|0|||
38074503|NCT03137069|69770363|FG003|Overall Study|Physician Decision|1|||
38074504|NCT03137069|69770364|FG004|Overall Study|Physician Decision|0|||
38074505|NCT03137069|69770365|FG005|Overall Study|Physician Decision|0|||
38074506|NCT03137069|69770360|FG000|Overall Study|Study Terminated by Sponsor|0|||
38074507|NCT03137069|69770361|FG001|Overall Study|Study Terminated by Sponsor|0|||
38074508|NCT03137069|69770362|FG002|Overall Study|Study Terminated by Sponsor|0|||
38074509|NCT03137069|69770363|FG003|Overall Study|Study Terminated by Sponsor|0|||
38074510|NCT03137069|69770364|FG004|Overall Study|Study Terminated by Sponsor|1|||
38074511|NCT03137069|69770365|FG005|Overall Study|Study Terminated by Sponsor|0|||
38074512|NCT03137069|69770360|FG000|Overall Study|Data Entry Error|0|||
38074513|NCT03137069|69770361|FG001|Overall Study|Data Entry Error|0|||
38074514|NCT03137069|69770362|FG002|Overall Study|Data Entry Error|0|||
38074515|NCT03137069|69770363|FG003|Overall Study|Data Entry Error|1|||
38074516|NCT03137069|69770364|FG004|Overall Study|Data Entry Error|0|||
38074517|NCT03137069|69770365|FG005|Overall Study|Data Entry Error|0|||
38074518|NCT02792504|69770383|FG000|Overall Study|Lost to Follow-up|24|||
38074519|NCT02792504|69770383|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
38074520|NCT03124459|69770393|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
38074521|NCT03124459|69770394|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
37966146|NCT00383188|69653047|FG002|Overall Study|No longer willing to participate|1|||
37966147|NCT00383188|69653048|FG003|Overall Study|No longer willing to participate|0|||
38074522|NCT03124459|69770395|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
38074523|NCT03124459|69770396|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
38074524|NCT03124459|69770397|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
38074525|NCT03124459|69770398|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
38074526|NCT03124459|69770393|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
38074527|NCT03124459|69770394|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
38074528|NCT03124459|69770395|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
38074529|NCT03124459|69770396|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
38074530|NCT03124459|69770397|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
38074531|NCT03124459|69770398|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
38074532|NCT03124459|69770393|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
38074533|NCT03124459|69770394|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
38074534|NCT03124459|69770395|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
38074535|NCT03124459|69770396|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
38074536|NCT03124459|69770397|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
38074537|NCT03124459|69770398|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
38074538|NCT03124459|69770393|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
38074539|NCT03124459|69770394|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
38074540|NCT03124459|69770395|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
38074541|NCT03124459|69770396|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
38074542|NCT03124459|69770397|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
38074543|NCT03124459|69770398|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
38074544|NCT03124459|69770393|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
38074545|NCT03124459|69770394|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
38074546|NCT03124459|69770395|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
38074547|NCT03124459|69770396|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
38074548|NCT03124459|69770397|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
38074549|NCT03124459|69770398|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
38074550|NCT03124459|69770393|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
38074551|NCT03124459|69770394|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
38074552|NCT03124459|69770395|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
38074553|NCT03124459|69770396|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
38074554|NCT03124459|69770397|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
38074555|NCT03124459|69770398|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
38074556|NCT03134183|69770413|FG000|Overall Study|Withdrawal by Subject|1|||
38074557|NCT03134183|69770414|FG001|Overall Study|Withdrawal by Subject|1|||
38074558|NCT03136367|69770423|FG000|T1 Consultation|discontinued mistakenly included|2|||
38074559|NCT03136367|69770424|FG001|T1 Consultation|discontinued mistakenly included|6|||
37966148|NCT00383188|69653049|FG004|Overall Study|No longer willing to participate|2|||
37966149|NCT00383188|69653045|FG000|Overall Study|Lost to Follow-up|0|||
37966150|NCT00383188|69653046|FG001|Overall Study|Lost to Follow-up|0|||
37966151|NCT00383188|69653047|FG002|Overall Study|Lost to Follow-up|0|||
37966152|NCT00383188|69653048|FG003|Overall Study|Lost to Follow-up|0|||
37966153|NCT00383188|69653049|FG004|Overall Study|Lost to Follow-up|1|||
37966154|NCT00462345|69653063|FG000|Overall Study|Withdrawal by Subject|2|||
37966155|NCT00462345|69653063|FG000|Overall Study|Did not complete second course|1|||
37966156|NCT00453999|69653070|FG000|Overall Study|Adverse Event|1|||
37966157|NCT00453999|69653071|FG001|Overall Study|Adverse Event|2|||
37966158|NCT00453999|69653072|FG002|Overall Study|Adverse Event|1|||
37966159|NCT00453999|69653070|FG000|Overall Study|Lost to Follow-up|0|||
37966160|NCT00453999|69653071|FG001|Overall Study|Lost to Follow-up|1|||
37966161|NCT00453999|69653072|FG002|Overall Study|Lost to Follow-up|1|||
37966162|NCT00453999|69653070|FG000|Overall Study|Withdrawal by Subject|2|||
37966163|NCT00453999|69653071|FG001|Overall Study|Withdrawal by Subject|1|||
37966164|NCT00453999|69653072|FG002|Overall Study|Withdrawal by Subject|1|||
37966165|NCT00453999|69653070|FG000|Overall Study|Subject Request|2|||
37966166|NCT00453999|69653071|FG001|Overall Study|Subject Request|1|||
37966167|NCT00453999|69653072|FG002|Overall Study|Subject Request|0|||
37966168|NCT00453921|69653085|FG000|Overall Study|Withdrawal by Subject|1|||
37966169|NCT00453921|69653086|FG001|Overall Study|Withdrawal by Subject|1|||
37966170|NCT00453921|69653087|FG002|Overall Study|Withdrawal by Subject|1|||
37966171|NCT00453921|69653088|FG003|Overall Study|Withdrawal by Subject|1|||
37966172|NCT00453921|69653085|FG000|Overall Study|Lost to Follow-up|0|||
37966173|NCT00453921|69653086|FG001|Overall Study|Lost to Follow-up|0|||
37966174|NCT00453921|69653087|FG002|Overall Study|Lost to Follow-up|1|||
37966175|NCT00453921|69653088|FG003|Overall Study|Lost to Follow-up|0|||
37966176|NCT00382720|69653105|FG000|Overall Study|Adverse Event|21|||
37966177|NCT00382720|69653106|FG001|Overall Study|Adverse Event|23|||
37966178|NCT00382720|69653107|FG002|Overall Study|Adverse Event|15|||
37966179|NCT00382720|69653105|FG000|Overall Study|Protocol Violation|2|||
37966180|NCT00382720|69653106|FG001|Overall Study|Protocol Violation|5|||
37966181|NCT00382720|69653107|FG002|Overall Study|Protocol Violation|1|||
37966182|NCT00382720|69653105|FG000|Overall Study|Death|0|||
37966183|NCT00382720|69653106|FG001|Overall Study|Death|1|||
37966184|NCT00382720|69653107|FG002|Overall Study|Death|2|||
37966185|NCT00382720|69653105|FG000|Overall Study|Progressive disease|37|||
37966186|NCT00382720|69653106|FG001|Overall Study|Progressive disease|28|||
38074560|NCT03136367|69770425|FG002|T1 Consultation|discontinued mistakenly included|1|||
38074561|NCT03136367|69770423|FG000|T1 Consultation|Discontinued other|0|||
37966187|NCT00382720|69653107|FG002|Overall Study|Progressive disease|38|||
37966188|NCT00382720|69653105|FG000|Overall Study|Withdrew consent|1|||
37966189|NCT00382720|69653106|FG001|Overall Study|Withdrew consent|1|||
37966190|NCT00382720|69653107|FG002|Overall Study|Withdrew consent|2|||
37966191|NCT00382720|69653105|FG000|Overall Study|Withdrawal by Subject|11|||
37966192|NCT00382720|69653106|FG001|Overall Study|Withdrawal by Subject|20|||
37966193|NCT00382720|69653107|FG002|Overall Study|Withdrawal by Subject|12|||
37966194|NCT00382720|69653105|FG000|Overall Study|Surgery|1|||
37966195|NCT00382720|69653106|FG001|Overall Study|Surgery|1|||
37966196|NCT00382720|69653107|FG002|Overall Study|Surgery|4|||
37966197|NCT00382720|69653105|FG000|Overall Study|Patient did not receive study medication|1|||
37966198|NCT00382720|69653106|FG001|Overall Study|Patient did not receive study medication|1|||
37966199|NCT00382720|69653107|FG002|Overall Study|Patient did not receive study medication|4|||
37966200|NCT00382720|69653105|FG000|Overall Study|Clinically progressive disease|0|||
37966201|NCT00382720|69653106|FG001|Overall Study|Clinically progressive disease|1|||
37966202|NCT00382720|69653107|FG002|Overall Study|Clinically progressive disease|0|||
37966203|NCT00382720|69653105|FG000|Overall Study|Good prognosis|0|||
37966204|NCT00382720|69653106|FG001|Overall Study|Good prognosis|1|||
37966205|NCT00382720|69653107|FG002|Overall Study|Good prognosis|0|||
37966206|NCT00382720|69653105|FG000|Overall Study|Investigator/Clinical decision|5|||
37966207|NCT00382720|69653106|FG001|Overall Study|Investigator/Clinical decision|6|||
37966208|NCT00382720|69653107|FG002|Overall Study|Investigator/Clinical decision|6|||
37966209|NCT00382720|69653105|FG000|Overall Study|Discontinued at end of study|0|||
37966210|NCT00382720|69653106|FG001|Overall Study|Discontinued at end of study|1|||
37966211|NCT00382720|69653107|FG002|Overall Study|Discontinued at end of study|2|||
37966212|NCT00453063|69653117|FG000|Overall Study|Adverse Event|1|||
37966213|NCT00453063|69653118|FG001|Overall Study|Adverse Event|2|||
37966214|NCT00453063|69653117|FG000|Overall Study|Withdrawal by Subject|1|||
37966215|NCT00453063|69653118|FG001|Overall Study|Withdrawal by Subject|1|||
37966216|NCT00453063|69653117|FG000|Overall Study|Protocol Violation|1|||
37966217|NCT00453063|69653118|FG001|Overall Study|Protocol Violation|0|||
37966218|NCT00371566|69653126|FG000|Treatment Phase|Withdrawal by Subject|0|||
37966219|NCT00371566|69653127|FG001|Treatment Phase|Withdrawal by Subject|1|||
37966220|NCT00371566|69653126|FG000|Treatment Phase|Adverse Event|0|||
37966221|NCT00371566|69653127|FG001|Treatment Phase|Adverse Event|1|||
37966222|NCT00371566|69653126|FG000|Treatment Phase|Protocol Violation|0|||
37966223|NCT00371566|69653127|FG001|Treatment Phase|Protocol Violation|1|||
37966224|NCT00371566|69653126|FG000|Chemoradiation Phase|Physician Decision|2|||
37966225|NCT00371566|69653127|FG001|Chemoradiation Phase|Physician Decision|0|||
37966226|NCT00371566|69653126|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
37966227|NCT00371566|69653127|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
37966228|NCT00371566|69653126|FG000|Chemoradiation Phase|Non compliant|0|||
37966229|NCT00371566|69653127|FG001|Chemoradiation Phase|Non compliant|1|||
37966230|NCT00371566|69653126|FG000|Chemoradiation Phase|Progressive Disease|1|||
37966231|NCT00371566|69653127|FG001|Chemoradiation Phase|Progressive Disease|1|||
37966232|NCT00371566|69653126|FG000|Chemoradiation Phase|Death|2|||
37966233|NCT00371566|69653127|FG001|Chemoradiation Phase|Death|0|||
37966234|NCT00371566|69653126|FG000|Follow Up Phase|Death|0|||
37966235|NCT00371566|69653127|FG001|Follow Up Phase|Death|5|||
37966236|NCT00371566|69653126|FG000|Follow Up Phase|Disease progression|1|||
37966237|NCT00371566|69653127|FG001|Follow Up Phase|Disease progression|0|||
37966238|NCT00371566|69653126|FG000|Follow Up Phase|Withdrawal by Subject|0|||
37966239|NCT00371566|69653127|FG001|Follow Up Phase|Withdrawal by Subject|1|||
37966240|NCT00371566|69653126|FG000|Follow Up Phase|Physician Decision|1|||
37966241|NCT00371566|69653127|FG001|Follow Up Phase|Physician Decision|1|||
37966242|NCT00371566|69653126|FG000|Follow Up Phase|Lost to Follow-up|1|||
37966243|NCT00371566|69653127|FG001|Follow Up Phase|Lost to Follow-up|0|||
37966244|NCT00382408|69653135|FG000|Overall Study|Did not meet protocol requirement|3|||
37966245|NCT00382408|69653136|FG001|Overall Study|Did not meet protocol requirement|3|||
37966246|NCT00382408|69653135|FG000|Overall Study|Protocol Violation|2|||
37966247|NCT00382408|69653136|FG001|Overall Study|Protocol Violation|2|||
37966248|NCT00382408|69653135|FG000|Overall Study|Physician Decision|1|||
37966249|NCT00382408|69653136|FG001|Overall Study|Physician Decision|0|||
37966250|NCT00382408|69653135|FG000|Overall Study|Withdrawal by Subject|17|||
37966251|NCT00382408|69653136|FG001|Overall Study|Withdrawal by Subject|6|||
37966252|NCT00382408|69653135|FG000|Overall Study|Pregnancy|2|||
37966253|NCT00382408|69653136|FG001|Overall Study|Pregnancy|0|||
37966254|NCT00382408|69653135|FG000|Overall Study|Lost to Follow-up|19|||
37966255|NCT00382408|69653136|FG001|Overall Study|Lost to Follow-up|8|||
37966256|NCT00382408|69653135|FG000|Overall Study|Other|100|||
37966257|NCT00382408|69653136|FG001|Overall Study|Other|35|||
37966258|NCT00371254|69653144|FG000|Overall Study|Disease progression|13|||
37966259|NCT00371254|69653145|FG001|Overall Study|Disease progression|13|||
37966260|NCT00371254|69653144|FG000|Overall Study|Study drug toxicity|3|||
37966261|NCT00371254|69653145|FG001|Overall Study|Study drug toxicity|5|||
37966262|NCT00371254|69653144|FG000|Overall Study|Subject request|5|||
37966263|NCT00371254|69653145|FG001|Overall Study|Subject request|0|||
37966264|NCT00371254|69653144|FG000|Overall Study|Investigator Decision|2|||
37966265|NCT00371254|69653145|FG001|Overall Study|Investigator Decision|0|||
37966266|NCT00371254|69653144|FG000|Overall Study|Adverse event unrelated to study drug|0|||
37680404|NCT02579863|69156058|FG000|Overall Study|Final Disposition Unknown|2|||
37680405|NCT02579863|69156059|FG001|Overall Study|Final Disposition Unknown|1|||
37966267|NCT00371254|69653145|FG001|Overall Study|Adverse event unrelated to study drug|1|||
37966268|NCT00371254|69653144|FG000|Overall Study|Lost to Follow-up|0|||
37966269|NCT00371254|69653145|FG001|Overall Study|Lost to Follow-up|1|||
37966270|NCT00371254|69653144|FG000|Overall Study|Withdrawal by Subject|0|||
37966271|NCT00371254|69653145|FG001|Overall Study|Withdrawal by Subject|1|||
37966272|NCT00452673|69653155|FG000|Dose Escalation Period|Disease Progression|6|||
37966273|NCT00452673|69653156|FG001|Dose Escalation Period|Disease Progression|6|||
37966274|NCT00452673|69653157|FG002|Dose Escalation Period|Disease Progression|2|||
37966275|NCT00452673|69653158|FG003|Dose Escalation Period|Disease Progression|6|||
37966276|NCT00452673|69653159|FG004|Dose Escalation Period|Disease Progression|0|||
37966277|NCT00452673|69653155|FG000|Dose Escalation Period|study drug toxicity|1|||
37966278|NCT00452673|69653156|FG001|Dose Escalation Period|study drug toxicity|3|||
37966279|NCT00452673|69653157|FG002|Dose Escalation Period|study drug toxicity|3|||
37966280|NCT00452673|69653158|FG003|Dose Escalation Period|study drug toxicity|1|||
37966281|NCT00452673|69653159|FG004|Dose Escalation Period|study drug toxicity|0|||
37966282|NCT00452673|69653155|FG000|Dose Escalation Period|Other|0|||
37966283|NCT00452673|69653156|FG001|Dose Escalation Period|Other|0|||
37966284|NCT00452673|69653157|FG002|Dose Escalation Period|Other|1|||
37966285|NCT00452673|69653158|FG003|Dose Escalation Period|Other|0|||
37966286|NCT00452673|69653159|FG004|Dose Escalation Period|Other|0|||
37966287|NCT00452673|69653155|FG000|Dose Escalation Period|Adverse Event|0|||
37966288|NCT00452673|69653156|FG001|Dose Escalation Period|Adverse Event|0|||
37966289|NCT00452673|69653157|FG002|Dose Escalation Period|Adverse Event|0|||
37966290|NCT00452673|69653158|FG003|Dose Escalation Period|Adverse Event|1|||
37966291|NCT00452673|69653159|FG004|Dose Escalation Period|Adverse Event|0|||
37966292|NCT00452673|69653155|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
37966293|NCT00452673|69653156|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
37966294|NCT00452673|69653157|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
37966295|NCT00452673|69653158|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
37966296|NCT00452673|69653159|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
37966297|NCT00452673|69653155|FG000|Dose Expansion Period|Disease Progression|0|||
37966298|NCT00452673|69653156|FG001|Dose Expansion Period|Disease Progression|0|||
37966299|NCT00452673|69653157|FG002|Dose Expansion Period|Disease Progression|0|||
37966300|NCT00452673|69653158|FG003|Dose Expansion Period|Disease Progression|0|||
37966301|NCT00452673|69653159|FG004|Dose Expansion Period|Disease Progression|19|||
37966302|NCT00452673|69653155|FG000|Dose Expansion Period|Other|0|||
37966303|NCT00452673|69653156|FG001|Dose Expansion Period|Other|0|||
37966304|NCT00452673|69653157|FG002|Dose Expansion Period|Other|0|||
37966305|NCT00452673|69653158|FG003|Dose Expansion Period|Other|0|||
37966306|NCT00452673|69653159|FG004|Dose Expansion Period|Other|2|||
37966307|NCT00461253|69653172|FG000|Overall Study|Death|985|||
37966308|NCT00461253|69653173|FG001|Overall Study|Death|0|||
37966309|NCT00461253|69653172|FG000|Overall Study|Protocol Violation|613|||
37966310|NCT00461253|69653173|FG001|Overall Study|Protocol Violation|236|||
37966311|NCT00461253|69653172|FG000|Overall Study|no response|2609|||
37966312|NCT00461253|69653173|FG001|Overall Study|no response|11789|||
37966313|NCT00461253|69653172|FG000|Overall Study|administrative|773|||
37966314|NCT00461253|69653173|FG001|Overall Study|administrative|7773|||
37966315|NCT00469833|69653179|FG000|Overall Study|No IV access|2|||
37966316|NCT00382174|69653191|FG000|Overall Study|Lost to Follow-up|1|||
37966317|NCT00382174|69653192|FG001|Overall Study|Lost to Follow-up|4|||
37966318|NCT00382174|69653193|FG002|Overall Study|Lost to Follow-up|5|||
37966319|NCT00382174|69653191|FG000|Overall Study|Adverse Event|1|||
37966320|NCT00382174|69653192|FG001|Overall Study|Adverse Event|4|||
37966321|NCT00382174|69653193|FG002|Overall Study|Adverse Event|5|||
37966322|NCT00382174|69653191|FG000|Overall Study|Withdrawal by Subject|1|||
37966323|NCT00382174|69653192|FG001|Overall Study|Withdrawal by Subject|4|||
37966324|NCT00382174|69653193|FG002|Overall Study|Withdrawal by Subject|5|||
37966325|NCT00382174|69653191|FG000|Overall Study|Non compliance|1|||
37966326|NCT00382174|69653192|FG001|Overall Study|Non compliance|0|||
37966327|NCT00382174|69653193|FG002|Overall Study|Non compliance|1|||
37966328|NCT00382174|69653191|FG000|Overall Study|Physician Decision|0|||
37966329|NCT00382174|69653192|FG001|Overall Study|Physician Decision|2|||
37966330|NCT00382174|69653193|FG002|Overall Study|Physician Decision|2|||
37966331|NCT00382174|69653191|FG000|Overall Study|Failed to meet criteria|0|||
37966332|NCT00382174|69653192|FG001|Overall Study|Failed to meet criteria|1|||
37966333|NCT00382174|69653193|FG002|Overall Study|Failed to meet criteria|1|||
37966334|NCT00382174|69653191|FG000|Overall Study|Wounds merged|0|||
37966335|NCT00382174|69653192|FG001|Overall Study|Wounds merged|2|||
37966336|NCT00382174|69653193|FG002|Overall Study|Wounds merged|2|||
37966337|NCT00641537|69653206|FG000|96-week Period|Adverse Event|0|||
37966338|NCT00641537|69653207|FG001|96-week Period|Adverse Event|1|||
37966339|NCT00641537|69653208|FG002|96-week Period|Adverse Event|3|||
37966340|NCT00641537|69653209|FG003|96-week Period|Adverse Event|0|||
37966341|NCT00641537|69653210|FG004|96-week Period|Adverse Event|2|||
38074562|NCT03136367|69770424|FG001|T1 Consultation|Discontinued other|1|||
38074563|NCT03136367|69770425|FG002|T1 Consultation|Discontinued other|0|||
37966342|NCT00641537|69653211|FG005|96-week Period|Adverse Event|0|||
37966343|NCT00641537|69653212|FG006|96-week Period|Adverse Event|0|||
37966344|NCT00641537|69653213|FG007|96-week Period|Adverse Event|0|||
37966345|NCT00641537|69653206|FG000|96-week Period|Lost to Follow-up|3|||
37966346|NCT00641537|69653207|FG001|96-week Period|Lost to Follow-up|1|||
37966347|NCT00641537|69653208|FG002|96-week Period|Lost to Follow-up|2|||
37966348|NCT00641537|69653209|FG003|96-week Period|Lost to Follow-up|2|||
37966349|NCT00641537|69653210|FG004|96-week Period|Lost to Follow-up|4|||
37966350|NCT00641537|69653211|FG005|96-week Period|Lost to Follow-up|0|||
37966351|NCT00641537|69653212|FG006|96-week Period|Lost to Follow-up|1|||
37966352|NCT00641537|69653213|FG007|96-week Period|Lost to Follow-up|0|||
37966353|NCT00641537|69653206|FG000|96-week Period|Protocol Violation|0|||
37966354|NCT00641537|69653207|FG001|96-week Period|Protocol Violation|1|||
37966355|NCT00641537|69653208|FG002|96-week Period|Protocol Violation|0|||
37966356|NCT00641537|69653209|FG003|96-week Period|Protocol Violation|1|||
37966357|NCT00641537|69653210|FG004|96-week Period|Protocol Violation|0|||
37966358|NCT00641537|69653211|FG005|96-week Period|Protocol Violation|1|||
37966359|NCT00641537|69653212|FG006|96-week Period|Protocol Violation|0|||
37966360|NCT00641537|69653213|FG007|96-week Period|Protocol Violation|0|||
37966361|NCT00641537|69653206|FG000|96-week Period|Death|2|||
37966362|NCT00641537|69653207|FG001|96-week Period|Death|0|||
37966363|NCT00641537|69653208|FG002|96-week Period|Death|1|||
37966364|NCT00641537|69653209|FG003|96-week Period|Death|0|||
37966365|NCT00641537|69653210|FG004|96-week Period|Death|0|||
37966366|NCT00641537|69653211|FG005|96-week Period|Death|0|||
37966367|NCT00641537|69653212|FG006|96-week Period|Death|0|||
37966368|NCT00641537|69653213|FG007|96-week Period|Death|0|||
37966369|NCT00641537|69653206|FG000|96-week Period|Other|4|||
37966370|NCT00641537|69653207|FG001|96-week Period|Other|7|||
37966371|NCT00641537|69653208|FG002|96-week Period|Other|14|||
37966372|NCT00641537|69653209|FG003|96-week Period|Other|9|||
37966373|NCT00641537|69653210|FG004|96-week Period|Other|11|||
37966374|NCT00641537|69653211|FG005|96-week Period|Other|6|||
37966375|NCT00641537|69653212|FG006|96-week Period|Other|4|||
37966376|NCT00641537|69653213|FG007|96-week Period|Other|6|||
37966377|NCT00641537|69653206|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
37966378|NCT00641537|69653207|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
37966379|NCT00641537|69653208|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
37966380|NCT00641537|69653209|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
37966381|NCT00641537|69653210|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
37966382|NCT00641537|69653211|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
37966383|NCT00641537|69653212|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
37966384|NCT00641537|69653213|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
37966385|NCT00641537|69653206|FG000|24-Week Supplemental Follow-up Period|Other|0|||
37966386|NCT00641537|69653207|FG001|24-Week Supplemental Follow-up Period|Other|2|||
37966387|NCT00641537|69653208|FG002|24-Week Supplemental Follow-up Period|Other|2|||
37966388|NCT00641537|69653209|FG003|24-Week Supplemental Follow-up Period|Other|1|||
37966389|NCT00641537|69653210|FG004|24-Week Supplemental Follow-up Period|Other|3|||
37966390|NCT00641537|69653211|FG005|24-Week Supplemental Follow-up Period|Other|0|||
37966391|NCT00641537|69653212|FG006|24-Week Supplemental Follow-up Period|Other|1|||
37966392|NCT00641537|69653213|FG007|24-Week Supplemental Follow-up Period|Other|1|||
37966393|NCT03840135|69653233|FG000|Overall Study|Protocol Violation|6|||
37966394|NCT03840135|69653234|FG001|Overall Study|Protocol Violation|1|||
37966395|NCT03840135|69653233|FG000|Overall Study|Withdrawal by Subject|1|||
37966396|NCT03840135|69653234|FG001|Overall Study|Withdrawal by Subject|0|||
37966397|NCT00461175|69653246|FG000|Overall Study|Protocol Violation|522|||
37966398|NCT00461175|69653247|FG001|Overall Study|Protocol Violation|365|||
37966399|NCT00641147|69653255|FG000|Completed 4 Months.|Physician Decision|1|||
37966400|NCT00641147|69653256|FG001|Completed 4 Months.|Physician Decision|0|||
37966401|NCT00641147|69653255|FG000|Completed 4 Months.|Adverse Event|1|||
37966402|NCT00641147|69653256|FG001|Completed 4 Months.|Adverse Event|0|||
37966403|NCT00641147|69653255|FG000|Completed 8 Months.|Physician Decision|2|||
37966404|NCT00641147|69653256|FG001|Completed 8 Months.|Physician Decision|1|||
37966405|NCT00641147|69653255|FG000|Completed 8 Months.|non compliance|1|||
37966406|NCT00641147|69653256|FG001|Completed 8 Months.|non compliance|0|||
37966407|NCT00641147|69653255|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
37966408|NCT00641147|69653256|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
37966409|NCT00641147|69653255|FG000|Completed 12 Months.|Physician Decision|1|||
37966410|NCT00641147|69653256|FG001|Completed 12 Months.|Physician Decision|1|||
37966411|NCT00641147|69653255|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
37966412|NCT00641147|69653256|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
38074564|NCT03136367|69770423|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
38074565|NCT03136367|69770424|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
38074566|NCT03136367|69770425|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
38074567|NCT03136367|69770423|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
38074568|NCT03136367|69770424|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
38074569|NCT03136367|69770425|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
37966413|NCT00641147|69653255|FG000|Completed 16 Months.|Physician Decision|1|||
37966414|NCT00641147|69653256|FG001|Completed 16 Months.|Physician Decision|0|||
37966415|NCT00641147|69653255|FG000|Completed 16 Months.|Lost to Follow-up|1|||
37966416|NCT00641147|69653256|FG001|Completed 16 Months.|Lost to Follow-up|0|||
37966417|NCT00460239|69653266|FG000|Overall Study|Physician Decision|0|||
37966418|NCT00460239|69653267|FG001|Overall Study|Physician Decision|1|||
37966419|NCT00460239|69653268|FG002|Overall Study|Physician Decision|0|||
37966420|NCT00460239|69653269|FG003|Overall Study|Physician Decision|0|||
37966421|NCT00460239|69653270|FG004|Overall Study|Physician Decision|0|||
37966422|NCT00460239|69653271|FG005|Overall Study|Physician Decision|2|||
37966423|NCT00460239|69653272|FG006|Overall Study|Physician Decision|0|||
38074570|NCT03136367|69770423|FG000|T2 Post-consultation|Discontinued other|0|||
38074571|NCT03136367|69770424|FG001|T2 Post-consultation|Discontinued other|2|||
38074572|NCT03136367|69770425|FG002|T2 Post-consultation|Discontinued other|6|||
38074573|NCT03136367|69770423|FG000|T2 Post-consultation|Discontinued transferred care|0|||
38074574|NCT03136367|69770424|FG001|T2 Post-consultation|Discontinued transferred care|0|||
38074575|NCT03136367|69770425|FG002|T2 Post-consultation|Discontinued transferred care|3|||
38074576|NCT03136367|69770423|FG000|T2 Post-consultation|Discontinued lost contact|0|||
38074577|NCT03136367|69770424|FG001|T2 Post-consultation|Discontinued lost contact|1|||
38074578|NCT03136367|69770425|FG002|T2 Post-consultation|Discontinued lost contact|0|||
38074579|NCT03136367|69770423|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
38074580|NCT03136367|69770424|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
38074581|NCT03136367|69770425|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
38074582|NCT03136367|69770423|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
38074583|NCT03136367|69770424|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
38074584|NCT03136367|69770425|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
38074585|NCT03136367|69770423|FG000|T3 1 Week After Surgery|other discontinued|2|||
38074586|NCT03136367|69770424|FG001|T3 1 Week After Surgery|other discontinued|4|||
38074587|NCT03136367|69770425|FG002|T3 1 Week After Surgery|other discontinued|3|||
38074588|NCT03136367|69770423|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
38074589|NCT03136367|69770424|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
38074590|NCT03136367|69770425|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
38074591|NCT03136367|69770423|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
38074592|NCT03136367|69770424|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
38074593|NCT03136367|69770425|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
38074594|NCT03136367|69770423|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
38074595|NCT03136367|69770424|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
38074596|NCT03136367|69770425|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
38074597|NCT03136367|69770423|FG000|T4 12 Weeks After Surgery|Death|0|||
38074598|NCT03136367|69770424|FG001|T4 12 Weeks After Surgery|Death|1|||
38074599|NCT03136367|69770425|FG002|T4 12 Weeks After Surgery|Death|3|||
38074600|NCT03136367|69770423|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
38074601|NCT03136367|69770424|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
38074602|NCT03136367|69770425|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
38074603|NCT03136367|69770423|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
38074604|NCT03136367|69770424|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
38074605|NCT03136367|69770425|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
38074606|NCT03136367|69770423|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
38074607|NCT03136367|69770424|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
38074608|NCT03136367|69770425|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
38074609|NCT03136367|69770423|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
38074610|NCT03136367|69770424|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
38074611|NCT03136367|69770425|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
38074612|NCT03136367|69770423|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
38074613|NCT03136367|69770424|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
38074614|NCT03136367|69770425|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
38074615|NCT03136367|69770423|FG000|T5 1 Year After Surgery|Death|0|||
38074616|NCT03136367|69770424|FG001|T5 1 Year After Surgery|Death|0|||
38074617|NCT03136367|69770425|FG002|T5 1 Year After Surgery|Death|1|||
38074618|NCT03136367|69770423|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
38074619|NCT03136367|69770424|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
38074620|NCT03136367|69770425|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
38074621|NCT03136367|69770423|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
38074622|NCT03136367|69770424|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
38074623|NCT03136367|69770425|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
38074624|NCT03136367|69770423|FG000|T5 1 Year After Surgery|study ended before due|31|||
38074625|NCT03136367|69770424|FG001|T5 1 Year After Surgery|study ended before due|103|||
38074626|NCT03136367|69770425|FG002|T5 1 Year After Surgery|study ended before due|110|||
38074627|NCT03136367|69770423|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
38074628|NCT03136367|69770424|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
38074629|NCT03136367|69770425|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
38074630|NCT03124381|69770438|FG000|Overall Study|Lost to Follow-up|1|||
38074631|NCT03124381|69770439|FG001|Overall Study|Lost to Follow-up|1|||
38074632|NCT03124381|69770438|FG000|Overall Study|Withdrawal by Subject|6|||
38074633|NCT03124381|69770439|FG001|Overall Study|Withdrawal by Subject|3|||
38074634|NCT03124381|69770438|FG000|Overall Study|Protocol Violation|0|||
37966424|NCT00460239|69653273|FG007|Overall Study|Physician Decision|0|||
38074635|NCT03124381|69770439|FG001|Overall Study|Protocol Violation|1|||
38074636|NCT03124381|69770438|FG000|Overall Study|Adverse Event|1|||
38074637|NCT03124381|69770439|FG001|Overall Study|Adverse Event|1|||
38074638|NCT03124381|69770438|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
38074639|NCT03124381|69770439|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
38074640|NCT03133793|69770449|FG000|Overall Study|Withdrawal by Subject|0|||
38074641|NCT03133793|69770450|FG001|Overall Study|Withdrawal by Subject|4|||
38074642|NCT03133793|69770451|FG002|Overall Study|Withdrawal by Subject|2|||
38074643|NCT03133793|69770452|FG003|Overall Study|Withdrawal by Subject|4|||
38074644|NCT03133793|69770449|FG000|Overall Study|Lost to Follow-up|1|||
38074645|NCT03133793|69770450|FG001|Overall Study|Lost to Follow-up|0|||
38074646|NCT03133793|69770451|FG002|Overall Study|Lost to Follow-up|2|||
38074647|NCT03133793|69770452|FG003|Overall Study|Lost to Follow-up|0|||
38074648|NCT03133793|69770449|FG000|Overall Study|Death|0|||
38074649|NCT03133793|69770450|FG001|Overall Study|Death|0|||
38074650|NCT03133793|69770451|FG002|Overall Study|Death|0|||
38074651|NCT03133793|69770452|FG003|Overall Study|Death|1|||
38074652|NCT02747238|69770468|FG000|Overall Study|Lack of Efficacy|0|||
38074653|NCT02747238|69770469|FG001|Overall Study|Lack of Efficacy|1|||
38074654|NCT02747238|69770468|FG000|Overall Study|Data lost|3|||
38074655|NCT02747238|69770469|FG001|Overall Study|Data lost|5|||
38074656|NCT03133481|69770477|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
38074657|NCT03133481|69770478|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
38074658|NCT02864316|69770486|FG000|Overall Study|Progressive Disease|2|||
38074659|NCT02864316|69770487|FG001|Overall Study|Progressive Disease|1|||
38074660|NCT02864316|69770486|FG000|Overall Study|Adverse Event|0|||
38074661|NCT02864316|69770487|FG001|Overall Study|Adverse Event|1|||
38074662|NCT02862600|69770493|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
38074663|NCT02862600|69770493|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
38074664|NCT02862600|69770493|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
38074665|NCT02862600|69770493|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
38074666|NCT02864082|69770501|FG000|Overall Study|Adverse Event|1|||
38074667|NCT02864082|69770502|FG001|Overall Study|Adverse Event|1|||
38074668|NCT02864082|69770501|FG000|Overall Study|Lost to Follow-up|0|||
38074669|NCT02864082|69770502|FG001|Overall Study|Lost to Follow-up|1|||
38074670|NCT02864082|69770501|FG000|Overall Study|Withdrawal by Subject|2|||
38074671|NCT02864082|69770502|FG001|Overall Study|Withdrawal by Subject|2|||
38074672|NCT02792192|69770526|FG000|Overall Study|Death|1|||
38074673|NCT02792192|69770527|FG001|Overall Study|Death|0|||
38074674|NCT02792192|69770528|FG002|Overall Study|Death|0|||
38074675|NCT02792192|69770529|FG003|Overall Study|Death|0|||
38074676|NCT02792192|69770526|FG000|Overall Study|Informed Consent Withdrawn|4|||
38074677|NCT02792192|69770527|FG001|Overall Study|Informed Consent Withdrawn|0|||
38074678|NCT02792192|69770528|FG002|Overall Study|Informed Consent Withdrawn|0|||
38074679|NCT02792192|69770529|FG003|Overall Study|Informed Consent Withdrawn|0|||
38074680|NCT02792192|69770526|FG000|Overall Study|Physician Decision|1|||
38074681|NCT02792192|69770527|FG001|Overall Study|Physician Decision|0|||
38074682|NCT02792192|69770528|FG002|Overall Study|Physician Decision|0|||
38074683|NCT02792192|69770529|FG003|Overall Study|Physician Decision|0|||
38074684|NCT02792192|69770526|FG000|Overall Study|Progressive Disease|0|||
38074685|NCT02792192|69770527|FG001|Overall Study|Progressive Disease|1|||
38074686|NCT02792192|69770528|FG002|Overall Study|Progressive Disease|0|||
38074687|NCT02792192|69770529|FG003|Overall Study|Progressive Disease|0|||
38074688|NCT02792192|69770526|FG000|Overall Study|Study Terminated By Sponsor|6|||
38074689|NCT02792192|69770527|FG001|Overall Study|Study Terminated By Sponsor|10|||
38074690|NCT02792192|69770528|FG002|Overall Study|Study Terminated By Sponsor|0|||
38074691|NCT02792192|69770529|FG003|Overall Study|Study Terminated By Sponsor|0|||
38074692|NCT02964507|69770548|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
38074693|NCT02964507|69770549|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
38074694|NCT02964507|69770550|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
38074695|NCT02964507|69770551|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
38074696|NCT02964507|69770552|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
38074697|NCT02964507|69770553|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
37966425|NCT00460239|69653274|FG008|Overall Study|Physician Decision|0|||
38074698|NCT02964507|69770554|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
38074699|NCT02964507|69770555|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
38074700|NCT02964507|69770548|FG000|Overall Study|Study terminated by Sponsor|9|||
38074701|NCT02964507|69770549|FG001|Overall Study|Study terminated by Sponsor|1|||
38074702|NCT02964507|69770550|FG002|Overall Study|Study terminated by Sponsor|9|||
38074703|NCT02964507|69770551|FG003|Overall Study|Study terminated by Sponsor|3|||
38074704|NCT02964507|69770552|FG004|Overall Study|Study terminated by Sponsor|3|||
38074705|NCT02964507|69770553|FG005|Overall Study|Study terminated by Sponsor|2|||
38074706|NCT02964507|69770554|FG006|Overall Study|Study terminated by Sponsor|0|||
37966426|NCT00460239|69653266|FG000|Overall Study|Withdrawal by Subject|0|||
38074707|NCT02964507|69770555|FG007|Overall Study|Study terminated by Sponsor|0|||
38074708|NCT02964507|69770548|FG000|Overall Study|Other|3|||
38074709|NCT02964507|69770549|FG001|Overall Study|Other|0|||
38074710|NCT02964507|69770550|FG002|Overall Study|Other|0|||
38074711|NCT02964507|69770551|FG003|Overall Study|Other|0|||
38074712|NCT02964507|69770552|FG004|Overall Study|Other|1|||
38074713|NCT02964507|69770553|FG005|Overall Study|Other|0|||
38074714|NCT02964507|69770554|FG006|Overall Study|Other|0|||
38074715|NCT02964507|69770555|FG007|Overall Study|Other|0|||
38074716|NCT02964507|69770548|FG000|Overall Study|Death|11|||
38074717|NCT02964507|69770549|FG001|Overall Study|Death|9|||
38074718|NCT02964507|69770550|FG002|Overall Study|Death|12|||
38074719|NCT02964507|69770551|FG003|Overall Study|Death|2|||
38074720|NCT02964507|69770552|FG004|Overall Study|Death|10|||
38074721|NCT02964507|69770553|FG005|Overall Study|Death|5|||
38074722|NCT02964507|69770554|FG006|Overall Study|Death|0|||
38074723|NCT02964507|69770555|FG007|Overall Study|Death|0|||
38074724|NCT02964507|69770548|FG000|Overall Study|Withdrawal by Subject|1|||
38074725|NCT02964507|69770549|FG001|Overall Study|Withdrawal by Subject|0|||
38074726|NCT02964507|69770550|FG002|Overall Study|Withdrawal by Subject|1|||
38074727|NCT02964507|69770551|FG003|Overall Study|Withdrawal by Subject|1|||
38074728|NCT02964507|69770552|FG004|Overall Study|Withdrawal by Subject|0|||
38074729|NCT02964507|69770553|FG005|Overall Study|Withdrawal by Subject|1|||
38074730|NCT02964507|69770554|FG006|Overall Study|Withdrawal by Subject|0|||
38074731|NCT02964507|69770555|FG007|Overall Study|Withdrawal by Subject|0|||
38074732|NCT02964507|69770548|FG000|Overall Study|Physician Decision|2|||
38074733|NCT02964507|69770549|FG001|Overall Study|Physician Decision|0|||
38074734|NCT02964507|69770550|FG002|Overall Study|Physician Decision|3|||
38074735|NCT02964507|69770551|FG003|Overall Study|Physician Decision|0|||
38074736|NCT02964507|69770552|FG004|Overall Study|Physician Decision|1|||
38074737|NCT02964507|69770553|FG005|Overall Study|Physician Decision|0|||
38074738|NCT02964507|69770554|FG006|Overall Study|Physician Decision|0|||
38074739|NCT02964507|69770555|FG007|Overall Study|Physician Decision|0|||
38074740|NCT03170869|69770574|FG000|Overall Study|Protocol Violation|5|||
38074741|NCT03170869|69770574|FG000|Overall Study|Early study termination|3|||
38074742|NCT02440464|69770581|FG000|Overall Study|Withdrawal by Subject|3|||
38074743|NCT02440464|69770582|FG001|Overall Study|Withdrawal by Subject|2|||
38074744|NCT03103321|69770593|FG000|Overall Study|Protocol Violation|1|||
38074745|NCT03103321|69770594|FG001|Overall Study|Protocol Violation|1|||
38074746|NCT03103321|69770595|FG002|Overall Study|Protocol Violation|1|||
38074747|NCT03103321|69770596|FG003|Overall Study|Protocol Violation|0|||
38074748|NCT03131453|69770609|FG000|Overall Study|Study terminated by Sponsor|424|||
38074749|NCT03131453|69770610|FG001|Overall Study|Study terminated by Sponsor|222|||
38074750|NCT03131453|69770611|FG002|Overall Study|Study terminated by Sponsor|438|||
38074751|NCT03131453|69770609|FG000|Overall Study|Withdrawal by Subject|18|||
38074752|NCT03131453|69770610|FG001|Overall Study|Withdrawal by Subject|7|||
38074753|NCT03131453|69770611|FG002|Overall Study|Withdrawal by Subject|13|||
38074754|NCT03131453|69770609|FG000|Overall Study|Adverse Event|10|||
38074755|NCT03131453|69770610|FG001|Overall Study|Adverse Event|3|||
38074756|NCT03131453|69770611|FG002|Overall Study|Adverse Event|3|||
38074757|NCT03131453|69770609|FG000|Overall Study|Lost to Follow-up|1|||
38074758|NCT03131453|69770610|FG001|Overall Study|Lost to Follow-up|0|||
38074759|NCT03131453|69770611|FG002|Overall Study|Lost to Follow-up|1|||
38074760|NCT03131453|69770609|FG000|Overall Study|Physician Decision|1|||
38074761|NCT03131453|69770610|FG001|Overall Study|Physician Decision|0|||
38074762|NCT03131453|69770611|FG002|Overall Study|Physician Decision|1|||
38074763|NCT03131453|69770609|FG000|Overall Study|Non-compliance with study treatment|1|||
38074764|NCT03131453|69770610|FG001|Overall Study|Non-compliance with study treatment|0|||
38074765|NCT03131453|69770611|FG002|Overall Study|Non-compliance with study treatment|0|||
38074766|NCT03131453|69770609|FG000|Overall Study|Technical problems|1|||
38074767|NCT03131453|69770610|FG001|Overall Study|Technical problems|0|||
38074768|NCT03131453|69770611|FG002|Overall Study|Technical problems|0|||
38074769|NCT03131453|69770609|FG000|Overall Study|Protocol deviation|0|||
38074770|NCT03131453|69770610|FG001|Overall Study|Protocol deviation|1|||
38074771|NCT03131453|69770611|FG002|Overall Study|Protocol deviation|0|||
38074772|NCT02942277|69770639|FG000|Year 1|Withdrawal by Subject|0|||
38074773|NCT02942277|69770640|FG001|Year 1|Withdrawal by Subject|0|||
38074774|NCT02942277|69770641|FG002|Year 1|Withdrawal by Subject|0|||
38074775|NCT02942277|69770642|FG003|Year 1|Withdrawal by Subject|0|||
38074776|NCT02942277|69770643|FG004|Year 1|Withdrawal by Subject|1|||
38074777|NCT02942277|69770644|FG005|Year 1|Withdrawal by Subject|3|||
38074778|NCT02942277|69770645|FG006|Year 1|Withdrawal by Subject|0|||
38074779|NCT02942277|69770646|FG007|Year 1|Withdrawal by Subject|1|||
38074780|NCT02942277|69770647|FG008|Year 1|Withdrawal by Subject|0|||
38074781|NCT02942277|69770648|FG009|Year 1|Withdrawal by Subject|0|||
38074782|NCT02942277|69770649|FG010|Year 1|Withdrawal by Subject|3|||
38074783|NCT02942277|69770639|FG000|Year 1|Travel|0|||
38074784|NCT02942277|69770640|FG001|Year 1|Travel|1|||
38074785|NCT02942277|69770641|FG002|Year 1|Travel|0|||
38074786|NCT02942277|69770642|FG003|Year 1|Travel|0|||
38074787|NCT02942277|69770643|FG004|Year 1|Travel|4|||
38074788|NCT02942277|69770644|FG005|Year 1|Travel|5|||
38074789|NCT02942277|69770645|FG006|Year 1|Travel|0|||
38074790|NCT02942277|69770646|FG007|Year 1|Travel|0|||
38074791|NCT02942277|69770647|FG008|Year 1|Travel|0|||
38074792|NCT02942277|69770648|FG009|Year 1|Travel|0|||
38074793|NCT02942277|69770649|FG010|Year 1|Travel|8|||
38074794|NCT02942277|69770639|FG000|Year 1|Joined Army|0|||
38074795|NCT02942277|69770640|FG001|Year 1|Joined Army|1|||
38074796|NCT02942277|69770641|FG002|Year 1|Joined Army|0|||
38074797|NCT02942277|69770642|FG003|Year 1|Joined Army|0|||
38074798|NCT02942277|69770643|FG004|Year 1|Joined Army|0|||
38074799|NCT02942277|69770644|FG005|Year 1|Joined Army|0|||
38074800|NCT02942277|69770645|FG006|Year 1|Joined Army|0|||
38074801|NCT02942277|69770646|FG007|Year 1|Joined Army|0|||
38074802|NCT02942277|69770647|FG008|Year 1|Joined Army|0|||
38074803|NCT02942277|69770648|FG009|Year 1|Joined Army|0|||
38074804|NCT02942277|69770649|FG010|Year 1|Joined Army|0|||
38074805|NCT02942277|69770639|FG000|Year 1|Subject met withdrawal criteria|0|||
38074806|NCT02942277|69770640|FG001|Year 1|Subject met withdrawal criteria|0|||
38074807|NCT02942277|69770641|FG002|Year 1|Subject met withdrawal criteria|0|||
38074808|NCT02942277|69770642|FG003|Year 1|Subject met withdrawal criteria|1|||
38074809|NCT02942277|69770643|FG004|Year 1|Subject met withdrawal criteria|0|||
38074810|NCT02942277|69770644|FG005|Year 1|Subject met withdrawal criteria|0|||
38074811|NCT02942277|69770645|FG006|Year 1|Subject met withdrawal criteria|0|||
38074812|NCT02942277|69770646|FG007|Year 1|Subject met withdrawal criteria|0|||
38074813|NCT02942277|69770647|FG008|Year 1|Subject met withdrawal criteria|0|||
38074814|NCT02942277|69770648|FG009|Year 1|Subject met withdrawal criteria|0|||
38074815|NCT02942277|69770649|FG010|Year 1|Subject met withdrawal criteria|0|||
38074816|NCT02942277|69770639|FG000|Year 1|Lost to Follow-up|0|||
38074817|NCT02942277|69770640|FG001|Year 1|Lost to Follow-up|0|||
38074818|NCT02942277|69770641|FG002|Year 1|Lost to Follow-up|0|||
38074819|NCT02942277|69770642|FG003|Year 1|Lost to Follow-up|0|||
38074820|NCT02942277|69770643|FG004|Year 1|Lost to Follow-up|1|||
38074821|NCT02942277|69770644|FG005|Year 1|Lost to Follow-up|0|||
38074822|NCT02942277|69770645|FG006|Year 1|Lost to Follow-up|0|||
38074823|NCT02942277|69770646|FG007|Year 1|Lost to Follow-up|0|||
38074824|NCT02942277|69770647|FG008|Year 1|Lost to Follow-up|0|||
38074825|NCT02942277|69770648|FG009|Year 1|Lost to Follow-up|0|||
38074826|NCT02942277|69770649|FG010|Year 1|Lost to Follow-up|2|||
38074827|NCT02942277|69770639|FG000|Year 1|Protocol Violation|0|||
38074828|NCT02942277|69770640|FG001|Year 1|Protocol Violation|0|||
38074829|NCT02942277|69770641|FG002|Year 1|Protocol Violation|0|||
38074830|NCT02942277|69770642|FG003|Year 1|Protocol Violation|0|||
38074831|NCT02942277|69770643|FG004|Year 1|Protocol Violation|1|||
38074832|NCT02942277|69770644|FG005|Year 1|Protocol Violation|1|||
38074833|NCT02942277|69770645|FG006|Year 1|Protocol Violation|0|||
38074834|NCT02942277|69770646|FG007|Year 1|Protocol Violation|0|||
38074835|NCT02942277|69770647|FG008|Year 1|Protocol Violation|0|||
38074836|NCT02942277|69770648|FG009|Year 1|Protocol Violation|0|||
38074837|NCT02942277|69770649|FG010|Year 1|Protocol Violation|2|||
38074838|NCT02942277|69770639|FG000|Year 1|Pregnancy|0|||
38074839|NCT02942277|69770640|FG001|Year 1|Pregnancy|0|||
38074840|NCT02942277|69770641|FG002|Year 1|Pregnancy|0|||
38074841|NCT02942277|69770642|FG003|Year 1|Pregnancy|0|||
38074842|NCT02942277|69770643|FG004|Year 1|Pregnancy|0|||
38074843|NCT02942277|69770644|FG005|Year 1|Pregnancy|1|||
38074844|NCT02942277|69770645|FG006|Year 1|Pregnancy|0|||
38074845|NCT02942277|69770646|FG007|Year 1|Pregnancy|0|||
38074846|NCT02942277|69770647|FG008|Year 1|Pregnancy|0|||
38074847|NCT02942277|69770648|FG009|Year 1|Pregnancy|0|||
38074848|NCT02942277|69770649|FG010|Year 1|Pregnancy|0|||
38074849|NCT02942277|69770639|FG000|Year 2|Lost to Follow-up|0|||
38074850|NCT02942277|69770640|FG001|Year 2|Lost to Follow-up|0|||
38074851|NCT02942277|69770641|FG002|Year 2|Lost to Follow-up|0|||
38074852|NCT02942277|69770642|FG003|Year 2|Lost to Follow-up|0|||
38074853|NCT02942277|69770643|FG004|Year 2|Lost to Follow-up|2|||
38074854|NCT02942277|69770644|FG005|Year 2|Lost to Follow-up|1|||
38074855|NCT02942277|69770645|FG006|Year 2|Lost to Follow-up|0|||
38074856|NCT02942277|69770646|FG007|Year 2|Lost to Follow-up|0|||
38074857|NCT02942277|69770647|FG008|Year 2|Lost to Follow-up|0|||
38074858|NCT02942277|69770648|FG009|Year 2|Lost to Follow-up|0|||
38074859|NCT02942277|69770649|FG010|Year 2|Lost to Follow-up|0|||
38074860|NCT02942277|69770639|FG000|Year 2|Did not rescreen|0|||
38074861|NCT02942277|69770640|FG001|Year 2|Did not rescreen|0|||
38074862|NCT02942277|69770641|FG002|Year 2|Did not rescreen|1|||
38074863|NCT02942277|69770642|FG003|Year 2|Did not rescreen|1|||
38074864|NCT02942277|69770643|FG004|Year 2|Did not rescreen|9|||
38074865|NCT02942277|69770644|FG005|Year 2|Did not rescreen|6|||
38074866|NCT02942277|69770645|FG006|Year 2|Did not rescreen|0|||
38074867|NCT02942277|69770646|FG007|Year 2|Did not rescreen|1|||
38074868|NCT02942277|69770647|FG008|Year 2|Did not rescreen|0|||
38074869|NCT02942277|69770648|FG009|Year 2|Did not rescreen|0|||
38074870|NCT02942277|69770649|FG010|Year 2|Did not rescreen|21|||
38074871|NCT02942277|69770639|FG000|Year 2|Met withdrawal criteria|0|||
38074872|NCT02942277|69770640|FG001|Year 2|Met withdrawal criteria|0|||
38074873|NCT02942277|69770641|FG002|Year 2|Met withdrawal criteria|0|||
38074874|NCT02942277|69770642|FG003|Year 2|Met withdrawal criteria|0|||
38074875|NCT02942277|69770643|FG004|Year 2|Met withdrawal criteria|1|||
38074876|NCT02942277|69770644|FG005|Year 2|Met withdrawal criteria|2|||
38074877|NCT02942277|69770645|FG006|Year 2|Met withdrawal criteria|0|||
38074878|NCT02942277|69770646|FG007|Year 2|Met withdrawal criteria|0|||
38074879|NCT02942277|69770647|FG008|Year 2|Met withdrawal criteria|0|||
38074880|NCT02942277|69770648|FG009|Year 2|Met withdrawal criteria|0|||
38074881|NCT02942277|69770649|FG010|Year 2|Met withdrawal criteria|1|||
38074882|NCT02942277|69770639|FG000|Year 2|Travel|0|||
38074883|NCT02942277|69770640|FG001|Year 2|Travel|1|||
38074884|NCT02942277|69770641|FG002|Year 2|Travel|0|||
38074885|NCT02942277|69770642|FG003|Year 2|Travel|0|||
38074886|NCT02942277|69770643|FG004|Year 2|Travel|0|||
38074887|NCT02942277|69770644|FG005|Year 2|Travel|1|||
38074888|NCT02942277|69770645|FG006|Year 2|Travel|0|||
38074889|NCT02942277|69770646|FG007|Year 2|Travel|0|||
38074890|NCT02942277|69770647|FG008|Year 2|Travel|0|||
38074891|NCT02942277|69770648|FG009|Year 2|Travel|1|||
38074892|NCT02942277|69770649|FG010|Year 2|Travel|3|||
38074893|NCT02942277|69770639|FG000|Year 2|Non-compliant|0|||
38074894|NCT02942277|69770640|FG001|Year 2|Non-compliant|0|||
38074895|NCT02942277|69770641|FG002|Year 2|Non-compliant|0|||
38074896|NCT02942277|69770642|FG003|Year 2|Non-compliant|0|||
38074897|NCT02942277|69770643|FG004|Year 2|Non-compliant|1|||
38074898|NCT02942277|69770644|FG005|Year 2|Non-compliant|1|||
38074899|NCT02942277|69770645|FG006|Year 2|Non-compliant|0|||
38074900|NCT02942277|69770646|FG007|Year 2|Non-compliant|0|||
38074901|NCT02942277|69770647|FG008|Year 2|Non-compliant|0|||
38074902|NCT02942277|69770648|FG009|Year 2|Non-compliant|0|||
38074903|NCT02942277|69770649|FG010|Year 2|Non-compliant|0|||
38074904|NCT02942277|69770639|FG000|Year 2|Withdrawal by Subject|0|||
38074905|NCT02942277|69770640|FG001|Year 2|Withdrawal by Subject|0|||
38074906|NCT02942277|69770641|FG002|Year 2|Withdrawal by Subject|0|||
38074907|NCT02942277|69770642|FG003|Year 2|Withdrawal by Subject|0|||
38074908|NCT02942277|69770643|FG004|Year 2|Withdrawal by Subject|0|||
38074909|NCT02942277|69770644|FG005|Year 2|Withdrawal by Subject|0|||
38074910|NCT02942277|69770645|FG006|Year 2|Withdrawal by Subject|1|||
38074911|NCT02942277|69770646|FG007|Year 2|Withdrawal by Subject|0|||
38074912|NCT02942277|69770647|FG008|Year 2|Withdrawal by Subject|0|||
38074913|NCT02942277|69770648|FG009|Year 2|Withdrawal by Subject|0|||
38074914|NCT02942277|69770649|FG010|Year 2|Withdrawal by Subject|0|||
38074915|NCT02859324|69770700|FG000|Overall Study|Death|4|||
38074916|NCT02859324|69770701|FG001|Overall Study|Death|6|||
38074917|NCT02859324|69770702|FG002|Overall Study|Death|5|||
38074918|NCT02859324|69770700|FG000|Overall Study|Other reasons|3|||
38074919|NCT02859324|69770701|FG001|Overall Study|Other reasons|3|||
38074920|NCT02859324|69770702|FG002|Overall Study|Other reasons|0|||
38074921|NCT02143063|69770713|FG000|Overall Study|Lost to Follow-up|16|||
38074922|NCT02143063|69770714|FG001|Overall Study|Lost to Follow-up|28|||
38074923|NCT02143063|69770715|FG002|Overall Study|Lost to Follow-up|29|||
38074924|NCT02143063|69770713|FG000|Overall Study|Withdrawal by Subject|0|||
38074925|NCT02143063|69770714|FG001|Overall Study|Withdrawal by Subject|1|||
38074926|NCT02143063|69770715|FG002|Overall Study|Withdrawal by Subject|0|||
38074927|NCT02143063|69770713|FG000|Overall Study|Death|0|||
38074928|NCT02143063|69770714|FG001|Overall Study|Death|1|||
38074929|NCT02143063|69770715|FG002|Overall Study|Death|1|||
38074930|NCT02859246|69770723|FG000|Overall Study|Screen fails|3|||
38074931|NCT02859246|69770723|FG000|Overall Study|Adverse Event|1|||
38074932|NCT02859246|69770723|FG000|Overall Study|Withdrawal by Subject|1|||
38074933|NCT01083433|69770746|FG000|Overall Study|Lost to Follow-up|2|||
38074934|NCT01083433|69770747|FG001|Overall Study|Lost to Follow-up|1|||
38074935|NCT01083433|69770748|FG002|Overall Study|Lost to Follow-up|1|||
38074936|NCT01083433|69770746|FG000|Overall Study|Withdrawal by Subject|0|||
38074937|NCT01083433|69770747|FG001|Overall Study|Withdrawal by Subject|5|||
38074938|NCT01083433|69770748|FG002|Overall Study|Withdrawal by Subject|3|||
38074939|NCT01083433|69770746|FG000|Overall Study|Pregnancy|0|||
38074940|NCT01083433|69770747|FG001|Overall Study|Pregnancy|0|||
38074941|NCT01083433|69770748|FG002|Overall Study|Pregnancy|1|||
38074942|NCT02791490|69770762|FG000|Overall Study|Lost to Follow-up|1|||
38074943|NCT02791490|69770763|FG001|Overall Study|Lost to Follow-up|2|||
38074944|NCT02791490|69770762|FG000|Overall Study|Withdrawal by Subject|2|||
38074945|NCT02791490|69770763|FG001|Overall Study|Withdrawal by Subject|6|||
38074946|NCT02507973|69770778|FG000|Overall Study|Adverse Event|1|||
38074947|NCT02425644|69770786|FG000|Overall Study|Lost to Follow-up|2|||
38074948|NCT02425644|69770787|FG001|Overall Study|Lost to Follow-up|3|||
38074949|NCT02425644|69770786|FG000|Overall Study|Withdrawal by Subject|41|||
38074950|NCT02425644|69770787|FG001|Overall Study|Withdrawal by Subject|36|||
38074951|NCT02425644|69770786|FG000|Overall Study|Lack of Efficacy|3|||
38074952|NCT02425644|69770787|FG001|Overall Study|Lack of Efficacy|10|||
38074953|NCT02425644|69770786|FG000|Overall Study|Adverse Event|13|||
38074954|NCT02425644|69770787|FG001|Overall Study|Adverse Event|3|||
38074955|NCT02425644|69770786|FG000|Overall Study|Death|0|||
38074956|NCT02425644|69770787|FG001|Overall Study|Death|2|||
38074957|NCT02425644|69770786|FG000|Overall Study|Other|18|||
38074958|NCT02425644|69770787|FG001|Overall Study|Other|17|||
38074959|NCT02861664|69770799|FG000|Overall Study|Withdrawal of Consent|0|||
38074960|NCT02861664|69770800|FG001|Overall Study|Withdrawal of Consent|1|||
38074961|NCT01307787|69770808|FG000|Overall Study|Withdrawal by Subject|2|||
38074962|NCT01307787|69770809|FG001|Overall Study|Withdrawal by Subject|0|||
38074963|NCT03284853|69770822|FG000|Overall Study|Adverse Event|40|||
38074964|NCT03284853|69770823|FG001|Overall Study|Adverse Event|4|||
38074965|NCT03284853|69770822|FG000|Overall Study|Withdrawal by Subject|5|||
38074966|NCT03284853|69770823|FG001|Overall Study|Withdrawal by Subject|1|||
38074967|NCT03284853|69770822|FG000|Overall Study|Lost to Follow-up|1|||
38074968|NCT03284853|69770823|FG001|Overall Study|Lost to Follow-up|0|||
38074969|NCT03284853|69770822|FG000|Overall Study|Lack of Efficacy|1|||
38074970|NCT03284853|69770823|FG001|Overall Study|Lack of Efficacy|0|||
38074971|NCT03284853|69770822|FG000|Overall Study|Disallowed Concurrent Medication|1|||
38074972|NCT03284853|69770823|FG001|Overall Study|Disallowed Concurrent Medication|1|||
38074973|NCT03284853|69770822|FG000|Overall Study|Protocol Violation|3|||
38074974|NCT03284853|69770823|FG001|Overall Study|Protocol Violation|3|||
38074975|NCT03284853|69770822|FG000|Overall Study|Death|0|||
38074976|NCT03284853|69770823|FG001|Overall Study|Death|1|||
38074977|NCT03284853|69770822|FG000|Overall Study|Other - Reason not reported in CSR|4|||
38074978|NCT03284853|69770823|FG001|Overall Study|Other - Reason not reported in CSR|3|||
38074979|NCT03055221|69770829|FG000|Overall Study|Adverse Event|2|||
38074980|NCT03055221|69770829|FG000|Overall Study|Withdrawal by Subject|4|||
38074981|NCT03055221|69770829|FG000|Overall Study|Death|6|||
38074982|NCT03055221|69770829|FG000|Overall Study|Physician Decision|1|||
38074983|NCT03055221|69770829|FG000|Overall Study|Study terminated by Sponsor|3|||
38074984|NCT04497415|69770855|FG000|Overall Study|Lost to Follow-up|43|||
38074985|NCT04497415|69770856|FG001|Overall Study|Lost to Follow-up|27|||
38074986|NCT03125941|69770864|FG000|Overall Study|did not receive intervention|1|||
38074987|NCT03125941|69770865|FG001|Overall Study|did not receive intervention|2|||
38074988|NCT02774889|69770873|FG000|Overall Study|Lost to Follow-up|2|||
38074989|NCT02774889|69770874|FG001|Overall Study|Lost to Follow-up|1|||
38074990|NCT03125629|69770882|FG000|Overall Study|Withdrawal by Subject|2|||
38074991|NCT03125629|69770882|FG000|Overall Study|Equipment malfunction|1|||
38074992|NCT03125395|69770894|FG000|Overall Study|Adverse Event|2|||
38074993|NCT03125395|69770894|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
38074994|NCT03125395|69770894|FG000|Overall Study|Physician Decision|2|||
38074995|NCT03125395|69770894|FG000|Overall Study|Commercial drug is available|5|||
38074996|NCT00261807|69770908|FG000|Overall Study|Lost to Follow-up|2|||
38074997|NCT00261807|69770908|FG000|Overall Study|Adverse Event|2|||
38074998|NCT00261807|69770908|FG000|Overall Study|Death|1|||
38074999|NCT00261807|69770908|FG000|Overall Study|Protocol Violation|2|||
38075000|NCT02820753|69770915|FG000|2 Month|Withdrawal by Subject|3|||
38075001|NCT02820753|69770916|FG001|2 Month|Withdrawal by Subject|3|||
38075002|NCT02820753|69770915|FG000|2 Month|Lost to Follow-up|24|||
38075003|NCT02820753|69770916|FG001|2 Month|Lost to Follow-up|26|||
38075004|NCT02820753|69770915|FG000|2 Month|Stopped per NIH Hold|51|||
38075005|NCT02820753|69770916|FG001|2 Month|Stopped per NIH Hold|13|||
38075006|NCT02820753|69770915|FG000|6 Month|Withdrawal by Subject|2|||
38075007|NCT02820753|69770916|FG001|6 Month|Withdrawal by Subject|2|||
38075008|NCT02820753|69770915|FG000|6 Month|Lost to Follow-up|20|||
38075009|NCT02820753|69770916|FG001|6 Month|Lost to Follow-up|27|||
38075010|NCT02820753|69770915|FG000|6 Month|Stopped per NIH Hold|81|||
38075011|NCT02820753|69770916|FG001|6 Month|Stopped per NIH Hold|81|||
38075012|NCT02820753|69770915|FG000|6 Month|Death|0|||
38075013|NCT02820753|69770916|FG001|6 Month|Death|1|||
38075014|NCT02861586|69770930|FG000|Overall Study|Withdrawal by Subject|1|||
38075015|NCT02861586|69770931|FG001|Overall Study|Withdrawal by Subject|2|||
38075016|NCT02861586|69770932|FG002|Overall Study|Withdrawal by Subject|0|||
38075017|NCT02861586|69770933|FG003|Overall Study|Withdrawal by Subject|0|||
38075018|NCT02861586|69770934|FG004|Overall Study|Withdrawal by Subject|0|||
38075019|NCT02861586|69770935|FG005|Overall Study|Withdrawal by Subject|1|||
38075020|NCT02861586|69770936|FG006|Overall Study|Withdrawal by Subject|1|||
38075021|NCT02861586|69770937|FG007|Overall Study|Withdrawal by Subject|0|||
38075022|NCT02861586|69770930|FG000|Overall Study|Lost to Follow-up|3|||
38075023|NCT02861586|69770931|FG001|Overall Study|Lost to Follow-up|1|||
38075024|NCT02861586|69770932|FG002|Overall Study|Lost to Follow-up|1|||
38075025|NCT02861586|69770933|FG003|Overall Study|Lost to Follow-up|0|||
38075026|NCT02861586|69770934|FG004|Overall Study|Lost to Follow-up|0|||
38075027|NCT02861586|69770935|FG005|Overall Study|Lost to Follow-up|3|||
38075028|NCT02861586|69770936|FG006|Overall Study|Lost to Follow-up|0|||
38075029|NCT02861586|69770937|FG007|Overall Study|Lost to Follow-up|0|||
38075030|NCT02861586|69770930|FG000|Overall Study|Adverse Event|0|||
38075031|NCT02861586|69770931|FG001|Overall Study|Adverse Event|0|||
38075032|NCT02861586|69770932|FG002|Overall Study|Adverse Event|0|||
38075033|NCT02861586|69770933|FG003|Overall Study|Adverse Event|0|||
38075034|NCT02861586|69770934|FG004|Overall Study|Adverse Event|0|||
38075035|NCT02861586|69770935|FG005|Overall Study|Adverse Event|1|||
38075036|NCT02861586|69770936|FG006|Overall Study|Adverse Event|0|||
38075037|NCT02861586|69770937|FG007|Overall Study|Adverse Event|0|||
38075038|NCT03124537|69770980|FG000|Overall Study|Lost to Follow-up|3|||
38075039|NCT03124537|69770981|FG001|Overall Study|Lost to Follow-up|5|||
38075040|NCT03124537|69770980|FG000|Overall Study|App Crash, Incomplete Data|7|||
38075041|NCT03124537|69770981|FG001|Overall Study|App Crash, Incomplete Data|8|||
38075042|NCT03118297|69770989|FG000|Overall Study|Lost to Follow-up|0|||
38075043|NCT03118297|69770990|FG001|Overall Study|Lost to Follow-up|2|||
38075044|NCT03117361|69770996|FG000|Overall Study|Progressive disease|5|||
38075045|NCT03117361|69770996|FG000|Overall Study|Death|1|||
38075046|NCT03117361|69770996|FG000|Overall Study|Physician Decision|2|||
38075047|NCT03117361|69770996|FG000|Overall Study|On study treatment at the end of study|1|||
38075048|NCT03117361|69770996|FG000|Overall Study|Treatment-related adverse event|1|||
38075049|NCT01368614|69771000|FG000|Screening Period|Screen Failure|58|||
38075050|NCT01368614|69771001|FG001|Screening Period|Screen Failure|0|||
38075051|NCT01368614|69771002|FG002|Screening Period|Screen Failure|0|||
38075052|NCT01368614|69771003|FG003|Screening Period|Screen Failure|0|||
38075053|NCT01368614|69771000|FG000|Study Period|Withdrawal by Subject|0|||
38075054|NCT01368614|69771001|FG001|Study Period|Withdrawal by Subject|1|||
38075055|NCT01368614|69771002|FG002|Study Period|Withdrawal by Subject|1|||
38075056|NCT01368614|69771003|FG003|Study Period|Withdrawal by Subject|3|||
38075057|NCT01368614|69771000|FG000|Study Period|Lost to Follow-up|0|||
38075058|NCT01368614|69771001|FG001|Study Period|Lost to Follow-up|0|||
38075059|NCT01368614|69771002|FG002|Study Period|Lost to Follow-up|1|||
38075060|NCT01368614|69771003|FG003|Study Period|Lost to Follow-up|0|||
38075061|NCT03053427|69771013|FG000|Overall Study|Adverse Event|4|||
38075062|NCT03053427|69771014|FG001|Overall Study|Adverse Event|4|||
38075063|NCT03053427|69771013|FG000|Overall Study|Lack of Efficacy|1|||
38075064|NCT03053427|69771014|FG001|Overall Study|Lack of Efficacy|3|||
38075065|NCT03053427|69771013|FG000|Overall Study|Lost to Follow-up|2|||
38075066|NCT03053427|69771014|FG001|Overall Study|Lost to Follow-up|2|||
38075067|NCT03053427|69771013|FG000|Overall Study|Worsening of the target disease|0|||
38075068|NCT03053427|69771014|FG001|Overall Study|Worsening of the target disease|1|||
38075069|NCT03053427|69771013|FG000|Overall Study|Protocol Deviation|3|||
38075070|NCT03053427|69771014|FG001|Overall Study|Protocol Deviation|3|||
38075071|NCT03053427|69771013|FG000|Overall Study|Withdrawal by Subject|3|||
38075072|NCT03053427|69771014|FG001|Overall Study|Withdrawal by Subject|2|||
38075073|NCT03053427|69771013|FG000|Overall Study|Miscellaneous|0|||
38075074|NCT03053427|69771014|FG001|Overall Study|Miscellaneous|1|||
38075075|NCT03052959|69771031|FG000|Overall Study|Lost to Follow-up|4|||
38075076|NCT03052959|69771032|FG001|Overall Study|Lost to Follow-up|5|||
38075077|NCT03120013|69771039|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
38075078|NCT03120013|69771040|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
38075079|NCT01845649|69771048|FG000|Overall Study|Adverse Event|7|||
38075080|NCT01845649|69771049|FG001|Overall Study|Adverse Event|10|||
38075081|NCT01845649|69771048|FG000|Overall Study|Lack of Efficacy|1|||
38075082|NCT01845649|69771049|FG001|Overall Study|Lack of Efficacy|1|||
38075083|NCT01845649|69771048|FG000|Overall Study|Lost to Follow-up|2|||
38075084|NCT01845649|69771049|FG001|Overall Study|Lost to Follow-up|2|||
38075085|NCT01845649|69771048|FG000|Overall Study|Withdrew Consent|12|||
38075086|NCT01845649|69771049|FG001|Overall Study|Withdrew Consent|4|||
38075087|NCT01845649|69771048|FG000|Overall Study|Protocol Deviation|7|||
38075088|NCT01845649|69771049|FG001|Overall Study|Protocol Deviation|4|||
38075089|NCT01845649|69771048|FG000|Overall Study|Reason not Specified|2|||
38075090|NCT01845649|69771049|FG001|Overall Study|Reason not Specified|1|||
38075091|NCT01345929|69771057|FG000|Overall Study|Withdrawal by Subject|9|||
38075092|NCT01345929|69771058|FG001|Overall Study|Withdrawal by Subject|8|||
38075093|NCT01345929|69771057|FG000|Overall Study|Lost to Follow-up|9|||
38075094|NCT01345929|69771058|FG001|Overall Study|Lost to Follow-up|9|||
38075095|NCT01345929|69771057|FG000|Overall Study|Adverse Event|0|||
38075096|NCT01345929|69771058|FG001|Overall Study|Adverse Event|1|||
38075097|NCT01345929|69771057|FG000|Overall Study|Didn't meet eligibility criteria|2|||
38075098|NCT01345929|69771058|FG001|Overall Study|Didn't meet eligibility criteria|0|||
38075099|NCT01345929|69771057|FG000|Overall Study|40,000 CFU/ML|1|||
38075100|NCT01345929|69771058|FG001|Overall Study|40,000 CFU/ML|0|||
38075101|NCT01345929|69771057|FG000|Overall Study|Patient withdrawal|0|||
38075102|NCT01345929|69771058|FG001|Overall Study|Patient withdrawal|1|||
38075103|NCT01343901|69771064|FG000|Overall Study|Death|85|||
38075104|NCT01343901|69771064|FG000|Overall Study|Physician Decision|4|||
38075105|NCT01343901|69771064|FG000|Overall Study|Lost to Follow-up|12|||
38075106|NCT01343901|69771064|FG000|Overall Study|Management by another medical team|11|||
38075107|NCT01343901|69771064|FG000|Overall Study|Participant decision|1|||
38075108|NCT03053271|69771068|FG000|Overall Study|Did not meet randomization criteria|3|||
38075109|NCT03053271|69771068|FG000|Overall Study|Withdrawal by Subject|1|||
38075110|NCT01343823|69771076|FG000|Overall Study|Study Terminated|1|||
38075111|NCT01343823|69771077|FG001|Overall Study|Study Terminated|0|||
38075112|NCT01343823|69771078|FG002|Overall Study|Study Terminated|0|||
38075113|NCT01343823|69771079|FG003|Overall Study|Study Terminated|1|||
38075114|NCT01343823|69771076|FG000|Overall Study|Withdrawal by Subject|1|||
38075115|NCT01343823|69771077|FG001|Overall Study|Withdrawal by Subject|0|||
38075116|NCT01343823|69771078|FG002|Overall Study|Withdrawal by Subject|0|||
38075117|NCT01343823|69771079|FG003|Overall Study|Withdrawal by Subject|0|||
38075118|NCT01318083|69771092|FG000|Overall Study|Adverse Event|4|||
38075119|NCT01318083|69771093|FG001|Overall Study|Adverse Event|1|||
38075120|NCT01318083|69771094|FG002|Overall Study|Adverse Event|2|||
38075121|NCT01318083|69771092|FG000|Overall Study|Withdrawal by Subject|1|||
38075122|NCT01318083|69771093|FG001|Overall Study|Withdrawal by Subject|0|||
38075123|NCT01318083|69771094|FG002|Overall Study|Withdrawal by Subject|2|||
38075124|NCT01318083|69771092|FG000|Overall Study|Lack of Efficacy|0|||
38075125|NCT01318083|69771093|FG001|Overall Study|Lack of Efficacy|0|||
38075126|NCT01318083|69771094|FG002|Overall Study|Lack of Efficacy|1|||
38075127|NCT01318083|69771092|FG000|Overall Study|Treatment Complications|1|||
38075128|NCT01318083|69771093|FG001|Overall Study|Treatment Complications|0|||
38075129|NCT01318083|69771094|FG002|Overall Study|Treatment Complications|0|||
38075130|NCT01318083|69771092|FG000|Overall Study|Lack of Study Medication Compliance|0|||
38075131|NCT01318083|69771093|FG001|Overall Study|Lack of Study Medication Compliance|1|||
38075132|NCT01318083|69771094|FG002|Overall Study|Lack of Study Medication Compliance|0|||
38075133|NCT01376323|69771107|FG000|Overall Study|Adverse Event|1|||
38075134|NCT01376323|69771108|FG001|Overall Study|Adverse Event|0|||
38075135|NCT01376323|69771109|FG002|Overall Study|Adverse Event|0|||
38075136|NCT01376323|69771110|FG003|Overall Study|Adverse Event|2|||
38075137|NCT01376323|69771111|FG004|Overall Study|Adverse Event|0|||
38075138|NCT01376323|69771107|FG000|Overall Study|Lost to Follow-up|0|||
38075139|NCT01376323|69771108|FG001|Overall Study|Lost to Follow-up|0|||
38075140|NCT01376323|69771109|FG002|Overall Study|Lost to Follow-up|0|||
38075141|NCT01376323|69771110|FG003|Overall Study|Lost to Follow-up|2|||
38075142|NCT01376323|69771111|FG004|Overall Study|Lost to Follow-up|0|||
38075143|NCT01376323|69771107|FG000|Overall Study|Physician Decision|1|||
38075144|NCT01376323|69771108|FG001|Overall Study|Physician Decision|0|||
38075145|NCT01376323|69771109|FG002|Overall Study|Physician Decision|2|||
38075146|NCT01376323|69771110|FG003|Overall Study|Physician Decision|1|||
38075147|NCT01376323|69771111|FG004|Overall Study|Physician Decision|1|||
38075148|NCT01376323|69771107|FG000|Overall Study|Withdrawal by Subject|0|||
38075149|NCT01376323|69771108|FG001|Overall Study|Withdrawal by Subject|1|||
38075150|NCT01376323|69771109|FG002|Overall Study|Withdrawal by Subject|1|||
38075151|NCT01376323|69771110|FG003|Overall Study|Withdrawal by Subject|0|||
38075152|NCT01376323|69771111|FG004|Overall Study|Withdrawal by Subject|0|||
38075153|NCT03725293|69771148|FG000|Overall Study|Physician Decision|9|||
38075154|NCT03725293|69771149|FG001|Overall Study|Physician Decision|6|||
38075155|NCT03725293|69771148|FG000|Overall Study|alternative vascular access needs|1|||
38075156|NCT03725293|69771149|FG001|Overall Study|alternative vascular access needs|2|||
38075157|NCT03725293|69771148|FG000|Overall Study|venous anatomy screen failures|2|||
38075158|NCT03725293|69771149|FG001|Overall Study|venous anatomy screen failures|1|||
38075159|NCT01368536|69771158|FG000|Overall Study|Adverse Event|5|||
38075160|NCT01368536|69771159|FG001|Overall Study|Adverse Event|6|||
38075161|NCT01368536|69771160|FG002|Overall Study|Adverse Event|8|||
38075162|NCT01368536|69771158|FG000|Overall Study|Abnormal laboratory value(s)|0|||
38075163|NCT01368536|69771159|FG001|Overall Study|Abnormal laboratory value(s)|1|||
38075164|NCT01368536|69771160|FG002|Overall Study|Abnormal laboratory value(s)|2|||
38075165|NCT01368536|69771158|FG000|Overall Study|Abnormal test procedure result(s)|0|||
38075166|NCT01368536|69771159|FG001|Overall Study|Abnormal test procedure result(s)|0|||
38075167|NCT01368536|69771160|FG002|Overall Study|Abnormal test procedure result(s)|1|||
38075168|NCT01368536|69771158|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
38075169|NCT01368536|69771159|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
38075170|NCT01368536|69771160|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
38075171|NCT01368536|69771158|FG000|Overall Study|No longer required study medication|0|||
38075172|NCT01368536|69771159|FG001|Overall Study|No longer required study medication|0|||
38075173|NCT01368536|69771160|FG002|Overall Study|No longer required study medication|1|||
38075174|NCT01368536|69771158|FG000|Overall Study|Withdrawal by Subject|2|||
38075175|NCT01368536|69771159|FG001|Overall Study|Withdrawal by Subject|5|||
38075176|NCT01368536|69771160|FG002|Overall Study|Withdrawal by Subject|4|||
38075177|NCT01368536|69771158|FG000|Overall Study|Lost to Follow-up|3|||
38075178|NCT01368536|69771159|FG001|Overall Study|Lost to Follow-up|3|||
38075179|NCT01368536|69771160|FG002|Overall Study|Lost to Follow-up|5|||
38075180|NCT01368536|69771158|FG000|Overall Study|Administrative problems|34|||
38075181|NCT01368536|69771159|FG001|Overall Study|Administrative problems|39|||
38075182|NCT01368536|69771160|FG002|Overall Study|Administrative problems|35|||
38075183|NCT01368536|69771158|FG000|Overall Study|Protocol deviation|0|||
38075184|NCT01368536|69771159|FG001|Overall Study|Protocol deviation|3|||
38075185|NCT01368536|69771160|FG002|Overall Study|Protocol deviation|1|||
38075186|NCT03051165|69771169|FG000|Overall Study|Withdrawal by Subject|1|||
38075187|NCT03051165|69771169|FG000|Overall Study|Early termination of study|12|||
38075188|NCT01319929|69771175|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
38075189|NCT01319929|69771176|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
38075190|NCT01319929|69771175|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
38075191|NCT01319929|69771176|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
38075192|NCT01319929|69771175|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
38075193|NCT01319929|69771176|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
38075194|NCT01319929|69771175|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
38075195|NCT01319929|69771176|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
38075196|NCT01319929|69771175|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
38075197|NCT01319929|69771176|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
38075198|NCT03110185|69771185|FG000|Overall Study|Death|0|||
38075199|NCT03110185|69771186|FG001|Overall Study|Death|1|||
38075200|NCT03110185|69771185|FG000|Overall Study|Withdrawal by Subject|2|||
38075201|NCT03110185|69771186|FG001|Overall Study|Withdrawal by Subject|7|||
38075202|NCT03110185|69771185|FG000|Overall Study|Time Constraints|0|||
38075203|NCT03110185|69771186|FG001|Overall Study|Time Constraints|6|||
38075204|NCT03110185|69771185|FG000|Overall Study|Conflict with care|5|||
38075205|NCT03110185|69771186|FG001|Overall Study|Conflict with care|12|||
38075206|NCT03110185|69771185|FG000|Overall Study|Protocol Violation|1|||
38075207|NCT03110185|69771186|FG001|Overall Study|Protocol Violation|4|||
38075208|NCT03110185|69771185|FG000|Overall Study|MRI Incompatible|2|||
38075209|NCT03110185|69771186|FG001|Overall Study|MRI Incompatible|0|||
38075210|NCT03110185|69771185|FG000|Overall Study|Patient Refusal|0|||
38075211|NCT03110185|69771186|FG001|Overall Study|Patient Refusal|1|||
38075212|NCT02858076|69771197|FG000|Overall Study|Death|6|||
38075213|NCT02858076|69771198|FG001|Overall Study|Death|3|||
37966427|NCT00460239|69653267|FG001|Overall Study|Withdrawal by Subject|0|||
38075214|NCT02858076|69771197|FG000|Overall Study|Withdrawal by Subject|1|||
38075215|NCT02858076|69771198|FG001|Overall Study|Withdrawal by Subject|5|||
38075216|NCT02858076|69771197|FG000|Overall Study|Lost to Follow-up|2|||
38075217|NCT02858076|69771198|FG001|Overall Study|Lost to Follow-up|7|||
38075218|NCT02858076|69771197|FG000|Overall Study|Completed Out of Window|1|||
38075219|NCT02858076|69771198|FG001|Overall Study|Completed Out of Window|3|||
38075220|NCT04594759|69771206|FG000|Overall Study|Lost to Follow-up|3|||
38075221|NCT02856282|69771210|FG000|Overall Study|Withdrawal by Subject|1|||
38075222|NCT03833817|69771216|FG000|Overall Study|Withdrawal by Subject|3|||
38075223|NCT03833817|69771217|FG001|Overall Study|Withdrawal by Subject|3|||
38075224|NCT03833817|69771216|FG000|Overall Study|Lost to Follow-up|3|||
38075225|NCT03833817|69771217|FG001|Overall Study|Lost to Follow-up|3|||
38075226|NCT03119701|69771225|FG000|6-day Dosing|Death|4|||
38075227|NCT03119701|69771226|FG001|6-day Dosing|Death|1|||
38075228|NCT03119701|69771225|FG000|6-day Dosing|Adverse Event|3|||
38075229|NCT03119701|69771226|FG001|6-day Dosing|Adverse Event|0|||
38075230|NCT03119701|69771225|FG000|6-day Dosing|Physician Decision|0|||
38075231|NCT03119701|69771226|FG001|6-day Dosing|Physician Decision|1|||
38075232|NCT03119701|69771225|FG000|6-day Dosing|Withdrawal by Subject|0|||
38075233|NCT03119701|69771226|FG001|6-day Dosing|Withdrawal by Subject|1|||
38075234|NCT03119701|69771225|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
38075235|NCT03119701|69771226|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
38075236|NCT02679781|69771240|FG000|Overall Study|Lost to Follow-up|1|||
38075237|NCT02679781|69771241|FG001|Overall Study|Lost to Follow-up|2|||
38075238|NCT02679781|69771240|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
38075239|NCT02679781|69771241|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
38075240|NCT02624869|69771250|FG000|Overall Study|Lost to Follow-up|0|||
38075241|NCT02624869|69771251|FG001|Overall Study|Lost to Follow-up|0|||
38075242|NCT02624869|69771252|FG002|Overall Study|Lost to Follow-up|1|||
38075243|NCT02624869|69771250|FG000|Overall Study|Withdrawal by Subject|1|||
38075244|NCT02624869|69771251|FG001|Overall Study|Withdrawal by Subject|3|||
38075245|NCT02624869|69771252|FG002|Overall Study|Withdrawal by Subject|1|||
38075246|NCT03110029|69771272|FG000|Overall Study|Withdrawal by Subject|1|||
38075247|NCT03110029|69771273|FG001|Overall Study|Withdrawal by Subject|1|||
38075248|NCT04207749|69771281|FG000|Overall Study|Lost to Follow-up|0|||
38075249|NCT04207749|69771282|FG001|Overall Study|Lost to Follow-up|2|||
38075250|NCT04207749|69771281|FG000|Overall Study|Protocol Violation|0|||
38075251|NCT04207749|69771282|FG001|Overall Study|Protocol Violation|1|||
38075252|NCT04207749|69771281|FG000|Overall Study|Withdrawal by Subject|3|||
38075253|NCT04207749|69771282|FG001|Overall Study|Withdrawal by Subject|0|||
38075254|NCT04207749|69771281|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
38075255|NCT04207749|69771282|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
38075256|NCT03043365|69771293|FG000|Weeks 0 to Week 8|Adverse Event|1|||
38075257|NCT03043365|69771294|FG001|Weeks 0 to Week 8|Adverse Event|3|||
38075258|NCT03043365|69771293|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
38075259|NCT03043365|69771294|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
38075260|NCT03043365|69771293|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
38075261|NCT03043365|69771294|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
38075262|NCT03108157|69771304|FG000|Overall Study|Protocol Violation|15|||
38075263|NCT03108157|69771305|FG001|Overall Study|Protocol Violation|4|||
38075264|NCT04421131|69771312|FG000|Overall Study|Lost to Follow-up|1|||
38075265|NCT04421131|69771312|FG000|Overall Study|Protocol Violation|2|||
38075266|NCT04421131|69771312|FG000|Overall Study|App crashed|5|||
38075267|NCT04167345|69771321|FG000|Overall Study|Other|1|||
38075268|NCT04167345|69771322|FG001|Overall Study|Other|1|||
38075269|NCT04167345|69771323|FG002|Overall Study|Other|0|||
38075270|NCT04167345|69771324|FG003|Overall Study|Other|0|||
38075271|NCT04167345|69771325|FG004|Overall Study|Other|0|||
38075272|NCT02854800|69771344|FG000|Overall Study|Protocol Violation|16|||
38075273|NCT02854800|69771345|FG001|Overall Study|Protocol Violation|11|||
38075274|NCT02854800|69771346|FG002|Overall Study|Protocol Violation|3|||
38075275|NCT02854800|69771344|FG000|Overall Study|Withdrawal by Subject|4|||
38075276|NCT02854800|69771345|FG001|Overall Study|Withdrawal by Subject|2|||
38075277|NCT02854800|69771346|FG002|Overall Study|Withdrawal by Subject|3|||
38075278|NCT02931539|69771359|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
38075279|NCT02931539|69771360|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
38075280|NCT02931539|69771361|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
38075281|NCT02931539|69771359|FG000|Period 1: Treatment Phase|Adverse Event|5|||
38075282|NCT02931539|69771360|FG001|Period 1: Treatment Phase|Adverse Event|1|||
38075283|NCT02931539|69771361|FG002|Period 1: Treatment Phase|Adverse Event|0|||
37680406|NCT02579863|69156058|FG000|Overall Study|Adverse Event|18|||
38075284|NCT02931539|69771359|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
38075285|NCT02931539|69771360|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
38075286|NCT02931539|69771361|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
38075287|NCT02931539|69771359|FG000|Period 1: Treatment Phase|Death|8|||
38075288|NCT02931539|69771360|FG001|Period 1: Treatment Phase|Death|24|||
38075289|NCT02931539|69771361|FG002|Period 1: Treatment Phase|Death|0|||
38075290|NCT02931539|69771359|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
38075291|NCT02931539|69771360|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
38075292|NCT02931539|69771361|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
38075293|NCT02931539|69771359|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
38075294|NCT02931539|69771360|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
38075295|NCT02931539|69771361|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
38075296|NCT02931539|69771359|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
38075297|NCT02931539|69771360|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
38075298|NCT02931539|69771361|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
38075299|NCT02931539|69771359|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
38075300|NCT02931539|69771360|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
38075301|NCT02931539|69771361|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
38075302|NCT04042077|69771378|FG000|Overall Study|Adverse Event|0|||
38075303|NCT04042077|69771379|FG001|Overall Study|Adverse Event|1|||
38075304|NCT04042077|69771378|FG000|Overall Study|Death|2|||
38075305|NCT04042077|69771379|FG001|Overall Study|Death|1|||
38075306|NCT04042077|69771378|FG000|Overall Study|Physician Decision|2|||
38075307|NCT04042077|69771379|FG001|Overall Study|Physician Decision|0|||
38075308|NCT04042077|69771378|FG000|Overall Study|Withdrawal by Subject|3|||
38075309|NCT04042077|69771379|FG001|Overall Study|Withdrawal by Subject|2|||
38075310|NCT04042077|69771378|FG000|Overall Study|Lack of Efficacy|0|||
38075311|NCT04042077|69771379|FG001|Overall Study|Lack of Efficacy|1|||
38075312|NCT02853318|69771400|FG000|Overall Study|Withdrawal by Subject|1|||
38075313|NCT03113071|69771410|FG000|Overall Study|Withdrawal by Subject|1|||
38075314|NCT03113071|69771411|FG001|Overall Study|Withdrawal by Subject|0|||
38075315|NCT03050307|69771419|FG000|Overall Study|Adverse Event|4|||
38075316|NCT03050307|69771420|FG001|Overall Study|Adverse Event|2|||
38075317|NCT03050307|69771419|FG000|Overall Study|Significant Protocol Deviation|0|||
38075318|NCT03050307|69771420|FG001|Overall Study|Significant Protocol Deviation|1|||
38075319|NCT03050307|69771419|FG000|Overall Study|Lost to Follow-up|0|||
38075320|NCT03050307|69771420|FG001|Overall Study|Lost to Follow-up|1|||
38075321|NCT03050307|69771419|FG000|Overall Study|Voluntary Withdrawal|3|||
38075322|NCT03050307|69771420|FG001|Overall Study|Voluntary Withdrawal|4|||
38075323|NCT03050307|69771419|FG000|Overall Study|Reason not Specified|1|||
38075324|NCT03050307|69771420|FG001|Overall Study|Reason not Specified|1|||
38075325|NCT03118765|69771446|FG000|Overall Study|Withdrawal by Subject|0|||
38075326|NCT03118765|69771447|FG001|Overall Study|Withdrawal by Subject|0|||
38075327|NCT03118765|69771448|FG002|Overall Study|Withdrawal by Subject|1|||
38075328|NCT03118765|69771449|FG003|Overall Study|Withdrawal by Subject|0|||
38075329|NCT03118765|69771450|FG004|Overall Study|Withdrawal by Subject|0|||
38075330|NCT03118765|69771446|FG000|Overall Study|Adverse Event|1|||
38075331|NCT03118765|69771447|FG001|Overall Study|Adverse Event|1|||
38075332|NCT03118765|69771448|FG002|Overall Study|Adverse Event|1|||
38075333|NCT03118765|69771449|FG003|Overall Study|Adverse Event|1|||
38075334|NCT03118765|69771450|FG004|Overall Study|Adverse Event|1|||
38075335|NCT03118765|69771446|FG000|Overall Study|Non compliance with Study Procedures|0|||
38075336|NCT03118765|69771447|FG001|Overall Study|Non compliance with Study Procedures|0|||
38075337|NCT03118765|69771448|FG002|Overall Study|Non compliance with Study Procedures|0|||
38075338|NCT03118765|69771449|FG003|Overall Study|Non compliance with Study Procedures|1|||
38075339|NCT03118765|69771450|FG004|Overall Study|Non compliance with Study Procedures|0|||
38075340|NCT03118765|69771446|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
38075341|NCT03118765|69771447|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
38075342|NCT03118765|69771448|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
38075343|NCT03118765|69771449|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
38075344|NCT03118765|69771450|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
38075345|NCT03118765|69771446|FG000|Overall Study|COPD Exacerbation|1|||
38075346|NCT03118765|69771447|FG001|Overall Study|COPD Exacerbation|0|||
38075347|NCT03118765|69771448|FG002|Overall Study|COPD Exacerbation|0|||
38075348|NCT03118765|69771449|FG003|Overall Study|COPD Exacerbation|1|||
38075349|NCT03118765|69771450|FG004|Overall Study|COPD Exacerbation|0|||
38075350|NCT03118765|69771446|FG000|Overall Study|Lost to Follow-up|1|||
38075351|NCT03118765|69771447|FG001|Overall Study|Lost to Follow-up|0|||
38075352|NCT03118765|69771448|FG002|Overall Study|Lost to Follow-up|1|||
38075353|NCT03118765|69771449|FG003|Overall Study|Lost to Follow-up|0|||
37966428|NCT00460239|69653268|FG002|Overall Study|Withdrawal by Subject|0|||
38075354|NCT03118765|69771450|FG004|Overall Study|Lost to Follow-up|0|||
38075355|NCT03118765|69771446|FG000|Overall Study|Sponsor Decision|1|||
38075356|NCT03118765|69771447|FG001|Overall Study|Sponsor Decision|0|||
38075357|NCT03118765|69771448|FG002|Overall Study|Sponsor Decision|1|||
38075358|NCT03118765|69771449|FG003|Overall Study|Sponsor Decision|0|||
38075359|NCT03118765|69771450|FG004|Overall Study|Sponsor Decision|1|||
38075360|NCT05222880|69771465|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
38075361|NCT05222880|69771465|FG000|Overall Study|Withdrew Consent during Study|1|||
38075362|NCT05222880|69771465|FG000|Overall Study|COVID-19 Related|1|||
38075363|NCT04810962|69771482|FG000|Overall Study|Adverse Event|0|||
38075364|NCT04810962|69771483|FG001|Overall Study|Adverse Event|1|||
38075365|NCT04810962|69771482|FG000|Overall Study|Lost to Follow-up|2|||
38075366|NCT04810962|69771483|FG001|Overall Study|Lost to Follow-up|1|||
38075367|NCT04810962|69771482|FG000|Overall Study|Physician Decision|1|||
38075368|NCT04810962|69771483|FG001|Overall Study|Physician Decision|0|||
38075369|NCT04810962|69771482|FG000|Overall Study|Withdrawal by Subject|1|||
38075370|NCT04810962|69771483|FG001|Overall Study|Withdrawal by Subject|3|||
38075371|NCT04810962|69771482|FG000|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|2|||
38075372|NCT04810962|69771483|FG001|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|1|||
38075373|NCT04606134|69771516|FG000|Overall Study|Adverse Event|0|||
38075374|NCT04606134|69771517|FG001|Overall Study|Adverse Event|1|||
38075375|NCT04426825|69771523|FG000|Overall Study|Continuing on study|6|||
38075376|NCT04426825|69771523|FG000|Overall Study|Death|17|||
38075377|NCT04399538|69771532|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
38075378|NCT04399538|69771533|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
38075379|NCT04399538|69771534|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
38075380|NCT04399538|69771535|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
38075381|NCT04399538|69771536|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
38075382|NCT04399538|69771532|FG000|Double-Blind Treatment|Adverse Event|0|||
38075383|NCT04399538|69771533|FG001|Double-Blind Treatment|Adverse Event|0|||
38075384|NCT04399538|69771534|FG002|Double-Blind Treatment|Adverse Event|0|||
38075385|NCT04399538|69771535|FG003|Double-Blind Treatment|Adverse Event|0|||
38075386|NCT04399538|69771536|FG004|Double-Blind Treatment|Adverse Event|1|||
38075387|NCT04399538|69771532|FG000|Follow-Up|Adverse Event|0|||
38075388|NCT04399538|69771533|FG001|Follow-Up|Adverse Event|0|||
38075389|NCT04399538|69771534|FG002|Follow-Up|Adverse Event|0|||
38075390|NCT04399538|69771535|FG003|Follow-Up|Adverse Event|0|||
38075391|NCT04399538|69771536|FG004|Follow-Up|Adverse Event|1|||
38075392|NCT04399538|69771532|FG000|Follow-Up|Withdrawal by Subject|0|||
38075393|NCT04399538|69771533|FG001|Follow-Up|Withdrawal by Subject|0|||
38075394|NCT04399538|69771534|FG002|Follow-Up|Withdrawal by Subject|0|||
38075395|NCT04399538|69771535|FG003|Follow-Up|Withdrawal by Subject|2|||
38075396|NCT04399538|69771536|FG004|Follow-Up|Withdrawal by Subject|0|||
38075397|NCT03094832|69771595|FG000|Overall Study|Lost to Follow-up|0|||
38075398|NCT03094832|69771596|FG001|Overall Study|Lost to Follow-up|0|||
38075399|NCT03094832|69771597|FG002|Overall Study|Lost to Follow-up|0|||
38075400|NCT03094832|69771598|FG003|Overall Study|Lost to Follow-up|1|||
38075401|NCT03094832|69771599|FG004|Overall Study|Lost to Follow-up|1|||
38075402|NCT03094832|69771595|FG000|Overall Study|Death|1|||
38075403|NCT03094832|69771596|FG001|Overall Study|Death|0|||
38075404|NCT03094832|69771597|FG002|Overall Study|Death|0|||
38075405|NCT03094832|69771598|FG003|Overall Study|Death|0|||
38075406|NCT03094832|69771599|FG004|Overall Study|Death|0|||
38075407|NCT03094832|69771595|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
38075408|NCT03094832|69771596|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
38075409|NCT03094832|69771597|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
38075410|NCT03094832|69771598|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
38075411|NCT03094832|69771599|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
38075412|NCT03094832|69771595|FG000|Overall Study|Other|13|||
38075413|NCT03094832|69771596|FG001|Overall Study|Other|20|||
38075414|NCT03094832|69771597|FG002|Overall Study|Other|1|||
38075415|NCT03094832|69771598|FG003|Overall Study|Other|7|||
38075416|NCT03094832|69771599|FG004|Overall Study|Other|1|||
38075417|NCT03036579|69771613|FG000|2 Years|Lost to Follow-up|1|||
38075418|NCT03036579|69771614|FG001|2 Years|Lost to Follow-up|0|||
38075419|NCT03036579|69771613|FG000|3 Years|Lost to Follow-up|0|||
38075420|NCT03036579|69771614|FG001|3 Years|Lost to Follow-up|1|||
38075421|NCT02867761|69771622|FG000|Overall Study|Participant withdrawn by investigator|0|||
38075422|NCT02867761|69771623|FG001|Overall Study|Participant withdrawn by investigator|1|||
38075423|NCT02867761|69771622|FG000|Overall Study|Lost to Follow-up|25|||
38075424|NCT02867761|69771623|FG001|Overall Study|Lost to Follow-up|18|||
38075425|NCT02867761|69771622|FG000|Overall Study|Unable to complete protocol|3|||
38075426|NCT02867761|69771623|FG001|Overall Study|Unable to complete protocol|7|||
38075427|NCT02719990|69771638|FG000|Overall Study|Physician Decision|2|||
38075428|NCT02719990|69771638|FG000|Overall Study|Withdrawal by Subject|2|||
38075429|NCT02719990|69771638|FG000|Overall Study|Study Terminated By Sponsor|32|||
38075430|NCT02494583|69771645|FG000|Overall Study|Death|224|||
38075431|NCT02494583|69771646|FG001|Overall Study|Death|214|||
38075432|NCT02494583|69771647|FG002|Overall Study|Death|225|||
38075433|NCT02494583|69771645|FG000|Overall Study|Lost to Follow-up|1|||
38075434|NCT02494583|69771646|FG001|Overall Study|Lost to Follow-up|0|||
38075435|NCT02494583|69771647|FG002|Overall Study|Lost to Follow-up|0|||
38075436|NCT02494583|69771645|FG000|Overall Study|Protocol Violation|1|||
38075437|NCT02494583|69771646|FG001|Overall Study|Protocol Violation|2|||
38075438|NCT02494583|69771647|FG002|Overall Study|Protocol Violation|0|||
38075439|NCT02494583|69771645|FG000|Overall Study|Screen Failure|0|||
38075440|NCT02494583|69771646|FG001|Overall Study|Screen Failure|1|||
38075441|NCT02494583|69771647|FG002|Overall Study|Screen Failure|0|||
38075442|NCT02494583|69771645|FG000|Overall Study|Transferred to Extension Study|15|||
38075443|NCT02494583|69771646|FG001|Overall Study|Transferred to Extension Study|15|||
38075444|NCT02494583|69771647|FG002|Overall Study|Transferred to Extension Study|6|||
38075445|NCT02494583|69771645|FG000|Overall Study|Did Not Continue on Extension Study|8|||
38075446|NCT02494583|69771646|FG001|Overall Study|Did Not Continue on Extension Study|10|||
38075447|NCT02494583|69771647|FG002|Overall Study|Did Not Continue on Extension Study|4|||
38075448|NCT02494583|69771645|FG000|Overall Study|Withdrawal by Subject|7|||
38075449|NCT02494583|69771646|FG001|Overall Study|Withdrawal by Subject|15|||
38075450|NCT02494583|69771647|FG002|Overall Study|Withdrawal by Subject|15|||
38075451|NCT02322814|69771662|FG000|Overall Study|Death|7|||
38075452|NCT02322814|69771663|FG001|Overall Study|Death|29|||
38075453|NCT02322814|69771664|FG002|Overall Study|Death|32|||
38075454|NCT02322814|69771665|FG003|Overall Study|Death|23|||
38075455|NCT02322814|69771666|FG004|Overall Study|Death|14|||
38075456|NCT02322814|69771662|FG000|Overall Study|Lost to Follow-up|1|||
38075457|NCT02322814|69771663|FG001|Overall Study|Lost to Follow-up|3|||
38075458|NCT02322814|69771664|FG002|Overall Study|Lost to Follow-up|3|||
38075459|NCT02322814|69771665|FG003|Overall Study|Lost to Follow-up|1|||
38075460|NCT02322814|69771666|FG004|Overall Study|Lost to Follow-up|0|||
38075461|NCT02322814|69771662|FG000|Overall Study|Various Reasons|2|||
38075462|NCT02322814|69771663|FG001|Overall Study|Various Reasons|0|||
38075463|NCT02322814|69771664|FG002|Overall Study|Various Reasons|1|||
38075464|NCT02322814|69771665|FG003|Overall Study|Various Reasons|1|||
38075465|NCT02322814|69771666|FG004|Overall Study|Various Reasons|0|||
38075466|NCT02322814|69771662|FG000|Overall Study|Progressive Disease|0|||
38075467|NCT02322814|69771663|FG001|Overall Study|Progressive Disease|0|||
38075468|NCT02322814|69771664|FG002|Overall Study|Progressive Disease|0|||
38075469|NCT02322814|69771665|FG003|Overall Study|Progressive Disease|1|||
38075470|NCT02322814|69771666|FG004|Overall Study|Progressive Disease|1|||
38075471|NCT02322814|69771662|FG000|Overall Study|Protocol Violation|1|||
38075472|NCT02322814|69771663|FG001|Overall Study|Protocol Violation|0|||
38075473|NCT02322814|69771664|FG002|Overall Study|Protocol Violation|0|||
38075474|NCT02322814|69771665|FG003|Overall Study|Protocol Violation|0|||
38075475|NCT02322814|69771666|FG004|Overall Study|Protocol Violation|0|||
38075476|NCT02322814|69771662|FG000|Overall Study|Study Terminated by Sponsor|0|||
38075477|NCT02322814|69771663|FG001|Overall Study|Study Terminated by Sponsor|7|||
38075478|NCT02322814|69771664|FG002|Overall Study|Study Terminated by Sponsor|9|||
38075479|NCT02322814|69771665|FG003|Overall Study|Study Terminated by Sponsor|5|||
38075480|NCT02322814|69771666|FG004|Overall Study|Study Terminated by Sponsor|13|||
38075481|NCT02322814|69771662|FG000|Overall Study|Withdrawal by Subject|5|||
38075482|NCT02322814|69771663|FG001|Overall Study|Withdrawal by Subject|4|||
38075483|NCT02322814|69771664|FG002|Overall Study|Withdrawal by Subject|2|||
38075484|NCT02322814|69771665|FG003|Overall Study|Withdrawal by Subject|1|||
38075485|NCT02322814|69771666|FG004|Overall Study|Withdrawal by Subject|3|||
38075486|NCT01333033|69771688|FG000|Overall Study|Ineligible|0|||
38075487|NCT01333033|69771689|FG001|Overall Study|Ineligible|0|||
38075488|NCT01333033|69771690|FG002|Overall Study|Ineligible|0|||
38075489|NCT01333033|69771691|FG003|Overall Study|Ineligible|0|||
38075490|NCT01333033|69771692|FG004|Overall Study|Ineligible|6|||
38075491|NCT01333033|69771693|FG005|Overall Study|Ineligible|8|||
38075492|NCT01333033|69771688|FG000|Overall Study|Withdrawal by Subject|0|||
38075493|NCT01333033|69771689|FG001|Overall Study|Withdrawal by Subject|0|||
38075494|NCT01333033|69771690|FG002|Overall Study|Withdrawal by Subject|0|||
38075495|NCT01333033|69771691|FG003|Overall Study|Withdrawal by Subject|0|||
38075496|NCT01333033|69771692|FG004|Overall Study|Withdrawal by Subject|4|||
38075497|NCT01333033|69771693|FG005|Overall Study|Withdrawal by Subject|2|||
38075498|NCT01333033|69771688|FG000|Overall Study|PET inevaluable|0|||
38075499|NCT01333033|69771689|FG001|Overall Study|PET inevaluable|0|||
38075500|NCT01333033|69771690|FG002|Overall Study|PET inevaluable|0|||
38075501|NCT01333033|69771691|FG003|Overall Study|PET inevaluable|0|||
38075502|NCT01333033|69771692|FG004|Overall Study|PET inevaluable|2|||
38075503|NCT01333033|69771693|FG005|Overall Study|PET inevaluable|4|||
38075504|NCT01333033|69771688|FG000|Overall Study|Adverse Event|0|||
38075505|NCT01333033|69771689|FG001|Overall Study|Adverse Event|0|||
38075506|NCT01333033|69771690|FG002|Overall Study|Adverse Event|0|||
38075507|NCT01333033|69771691|FG003|Overall Study|Adverse Event|0|||
38075508|NCT01333033|69771692|FG004|Overall Study|Adverse Event|2|||
38075509|NCT01333033|69771693|FG005|Overall Study|Adverse Event|1|||
38075510|NCT01333033|69771688|FG000|Overall Study|Progression|0|||
38075511|NCT01333033|69771689|FG001|Overall Study|Progression|0|||
38075512|NCT01333033|69771690|FG002|Overall Study|Progression|0|||
38075513|NCT01333033|69771691|FG003|Overall Study|Progression|0|||
37680407|NCT02579863|69156059|FG001|Overall Study|Adverse Event|11|||
38075514|NCT01333033|69771692|FG004|Overall Study|Progression|0|||
38075515|NCT01333033|69771693|FG005|Overall Study|Progression|1|||
38075516|NCT01333033|69771688|FG000|Overall Study|MD Decision|0|||
38075517|NCT01333033|69771689|FG001|Overall Study|MD Decision|0|||
38075518|NCT01333033|69771690|FG002|Overall Study|MD Decision|0|||
38075519|NCT01333033|69771691|FG003|Overall Study|MD Decision|0|||
38075520|NCT01333033|69771692|FG004|Overall Study|MD Decision|0|||
38075521|NCT01333033|69771693|FG005|Overall Study|MD Decision|2|||
38075522|NCT01192776|69771715|FG000|Overall Study|Death|8|||
38075523|NCT01192776|69771716|FG001|Overall Study|Death|15|||
38075524|NCT01192776|69771717|FG002|Overall Study|Death|18|||
38075525|NCT01192776|69771718|FG003|Overall Study|Death|15|||
38075526|NCT01192776|69771715|FG000|Overall Study|Lost to Follow-up|3|||
38075527|NCT01192776|69771716|FG001|Overall Study|Lost to Follow-up|6|||
38075528|NCT01192776|69771717|FG002|Overall Study|Lost to Follow-up|3|||
38075529|NCT01192776|69771718|FG003|Overall Study|Lost to Follow-up|5|||
38075530|NCT01367834|69771751|FG000|Overall Study|Withdrawal by Subject|2|||
38075531|NCT01367834|69771752|FG001|Overall Study|Withdrawal by Subject|2|||
38075532|NCT01367834|69771751|FG000|Overall Study|Study was ended.|0|||
38075533|NCT01367834|69771752|FG001|Overall Study|Study was ended.|1|||
38075534|NCT03106753|69771760|FG000|Overall Study|Withdrawal by Subject|0|||
38075535|NCT03106753|69771761|FG001|Overall Study|Withdrawal by Subject|1|||
38075536|NCT03045081|69771771|FG000|Overall Study|Withdrawal by Subject|6|||
38075537|NCT03045081|69771772|FG001|Overall Study|Withdrawal by Subject|11|||
38075538|NCT03107377|69771780|FG000|Overall Study|Adverse Event|3|||
38075539|NCT03107377|69771781|FG001|Overall Study|Adverse Event|3|||
38075540|NCT03107377|69771780|FG000|Overall Study|Protocol Violation|9|||
38075541|NCT03107377|69771781|FG001|Overall Study|Protocol Violation|12|||
38075542|NCT03107377|69771780|FG000|Overall Study|Physician Decision|3|||
38075543|NCT03107377|69771781|FG001|Overall Study|Physician Decision|6|||
38075544|NCT03107377|69771780|FG000|Overall Study|Pregnancy|7|||
38075545|NCT03107377|69771781|FG001|Overall Study|Pregnancy|7|||
38075546|NCT03107377|69771780|FG000|Overall Study|Withdrawal by Subject|16|||
38075547|NCT03107377|69771781|FG001|Overall Study|Withdrawal by Subject|22|||
38075548|NCT03107377|69771780|FG000|Overall Study|Lost to Follow-up|37|||
38075549|NCT03107377|69771781|FG001|Overall Study|Lost to Follow-up|34|||
38075550|NCT03107377|69771780|FG000|Overall Study|Other reason not specified|16|||
38075551|NCT03107377|69771781|FG001|Overall Study|Other reason not specified|15|||
38075552|NCT02545283|69771789|FG000|Overall Study|Lost to Follow-up|2|||
38075553|NCT02545283|69771790|FG001|Overall Study|Lost to Follow-up|4|||
38075554|NCT02545283|69771789|FG000|Overall Study|Withdrawal by Subject|5|||
38075555|NCT02545283|69771790|FG001|Overall Study|Withdrawal by Subject|9|||
38075556|NCT02545283|69771789|FG000|Overall Study|Death|109|||
38075557|NCT02545283|69771790|FG001|Overall Study|Death|211|||
38075558|NCT02545283|69771789|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
38075559|NCT02545283|69771790|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
38075560|NCT02545283|69771789|FG000|Overall Study|Study Terminated By Sponsor|33|||
38075561|NCT02545283|69771790|FG001|Overall Study|Study Terminated By Sponsor|71|||
38075562|NCT03282565|69771801|FG000|Overall Study|COVID-19 Research Shutdown|0|||
38075563|NCT03282565|69771802|FG001|Overall Study|COVID-19 Research Shutdown|2|||
38075564|NCT03282565|69771803|FG002|Overall Study|COVID-19 Research Shutdown|2|||
38075565|NCT02875613|69771811|FG000|Overall Study|Withdrawal by Subject|1|||
38075566|NCT02815267|69771821|FG000|Double-Blind Phase|Adverse Event|0|||
38075567|NCT02815267|69771822|FG001|Double-Blind Phase|Adverse Event|3|||
38075568|NCT02815267|69771821|FG000|Double-Blind Phase|Lost to Follow-up|17|||
38075569|NCT02815267|69771822|FG001|Double-Blind Phase|Lost to Follow-up|9|||
38075570|NCT02815267|69771821|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
38075571|NCT02815267|69771822|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
38075572|NCT02815267|69771821|FG000|Double-Blind Phase|Protocol Violation|3|||
38075573|NCT02815267|69771822|FG001|Double-Blind Phase|Protocol Violation|2|||
38075574|NCT02815267|69771821|FG000|Double-Blind Phase|Site withdrawal|1|||
38075575|NCT02815267|69771822|FG001|Double-Blind Phase|Site withdrawal|6|||
38075576|NCT02815267|69771821|FG000|Double-Blind Phase|Received a disallowed medication|1|||
38075577|NCT02815267|69771822|FG001|Double-Blind Phase|Received a disallowed medication|1|||
38075578|NCT02815267|69771821|FG000|Open-Label Phase|Adverse Event|1|||
38075579|NCT02815267|69771822|FG001|Open-Label Phase|Adverse Event|1|||
38075580|NCT02815267|69771821|FG000|Open-Label Phase|Lost to Follow-up|23|||
38075581|NCT02815267|69771822|FG001|Open-Label Phase|Lost to Follow-up|9|||
38075582|NCT02815267|69771821|FG000|Open-Label Phase|Withdrawal by Subject|24|||
38075583|NCT02815267|69771822|FG001|Open-Label Phase|Withdrawal by Subject|13|||
38075584|NCT02815267|69771821|FG000|Open-Label Phase|Protocol Violation|0|||
38075585|NCT02815267|69771822|FG001|Open-Label Phase|Protocol Violation|1|||
38075586|NCT02815267|69771821|FG000|Open-Label Phase|Administrative|21|||
38075587|NCT02815267|69771822|FG001|Open-Label Phase|Administrative|12|||
38075588|NCT02815267|69771821|FG000|Open-Label Phase|Other|2|||
38075589|NCT02815267|69771822|FG001|Open-Label Phase|Other|5|||
38075590|NCT02930837|69771832|FG000|Overall Study|Adverse Event|6|||
38075591|NCT02930837|69771832|FG000|Overall Study|Lost to Follow-up|5|||
38075592|NCT02930837|69771832|FG000|Overall Study|Withdrawal by Subject|1|||
38075593|NCT01343277|69771838|FG000|Overall Study|Other|3|||
38075594|NCT01343277|69771839|FG001|Overall Study|Other|3|||
38075595|NCT01343277|69771838|FG000|Overall Study|Withdrawal by Subject|18|||
38075596|NCT01343277|69771839|FG001|Overall Study|Withdrawal by Subject|13|||
38075597|NCT01343277|69771838|FG000|Overall Study|Physician Decision|1|||
38075598|NCT01343277|69771839|FG001|Overall Study|Physician Decision|2|||
38075599|NCT01343277|69771838|FG000|Overall Study|Death|10|||
38075600|NCT01343277|69771839|FG001|Overall Study|Death|1|||
38075601|NCT01343277|69771838|FG000|Overall Study|Adverse Event|67|||
38075602|NCT01343277|69771839|FG001|Overall Study|Adverse Event|13|||
38075603|NCT01343277|69771838|FG000|Overall Study|Disease progression|270|||
38075604|NCT01343277|69771839|FG001|Overall Study|Disease progression|138|||
38075605|NCT01343277|69771838|FG000|Overall Study|Randomized not treated|6|||
38075606|NCT01343277|69771839|FG001|Overall Study|Randomized not treated|21|||
38075607|NCT01343277|69771838|FG000|Overall Study|Treatment ongoing|8|||
38075608|NCT01343277|69771839|FG001|Overall Study|Treatment ongoing|2|||
38075609|NCT01343277|69771838|FG000|Overall Study|Subsequent anticancer therapy|1|||
38075610|NCT01343277|69771839|FG001|Overall Study|Subsequent anticancer therapy|0|||
38075611|NCT03135899|69771853|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
38075612|NCT03135899|69771854|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
38075613|NCT03135899|69771855|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
38075614|NCT03135899|69771856|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
38075615|NCT03135899|69771857|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
38075616|NCT03135899|69771858|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
38075617|NCT03135899|69771859|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
38075618|NCT03135899|69771860|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
38075619|NCT03135899|69771853|FG000|Overall Study|Withdrawal by Subject|0|||
38075620|NCT03135899|69771854|FG001|Overall Study|Withdrawal by Subject|0|||
38075621|NCT03135899|69771855|FG002|Overall Study|Withdrawal by Subject|0|||
38075622|NCT03135899|69771856|FG003|Overall Study|Withdrawal by Subject|0|||
38075623|NCT03135899|69771857|FG004|Overall Study|Withdrawal by Subject|0|||
38075624|NCT03135899|69771858|FG005|Overall Study|Withdrawal by Subject|2|||
38075625|NCT03135899|69771859|FG006|Overall Study|Withdrawal by Subject|0|||
38075626|NCT03135899|69771860|FG007|Overall Study|Withdrawal by Subject|0|||
38075627|NCT02487979|69771874|FG000|Overall Study|Physician Decision|2|||
38075628|NCT02487979|69771874|FG000|Overall Study|Withdrawal by Subject|2|||
38075629|NCT02487979|69771874|FG000|Overall Study|Progressive Disease|17|||
38075630|NCT03103087|69771885|FG000|Overall Study|Did not receive any study drug|1|||
38075631|NCT03103087|69771886|FG001|Overall Study|Did not receive any study drug|0|||
38075632|NCT03103087|69771887|FG002|Overall Study|Did not receive any study drug|0|||
38075633|NCT03103087|69771885|FG000|Overall Study|Protocol Violation|1|||
38075634|NCT03103087|69771886|FG001|Overall Study|Protocol Violation|2|||
38075635|NCT03103087|69771887|FG002|Overall Study|Protocol Violation|1|||
38075636|NCT03103087|69771885|FG000|Overall Study|Lack of Efficacy|2|||
38075637|NCT03103087|69771886|FG001|Overall Study|Lack of Efficacy|1|||
38075638|NCT03103087|69771887|FG002|Overall Study|Lack of Efficacy|1|||
38075639|NCT03103087|69771885|FG000|Overall Study|Pregnancy|0|||
38075640|NCT03103087|69771886|FG001|Overall Study|Pregnancy|0|||
37862346|NCT01129557|69546095|FG000|Overall Study|Novartis terminated study early|3|||
37862347|NCT01129557|69546096|FG001|Overall Study|Novartis terminated study early|3|||
37862348|NCT01129557|69546097|FG002|Overall Study|Novartis terminated study early|2|||
37862349|NCT01129011|69546118|FG000|Overall Study|Adverse Event|20|||
38075641|NCT03103087|69771887|FG002|Overall Study|Pregnancy|1|||
38075642|NCT03103087|69771885|FG000|Overall Study|Adverse Event|2|||
38075643|NCT03103087|69771886|FG001|Overall Study|Adverse Event|15|||
38075644|NCT03103087|69771887|FG002|Overall Study|Adverse Event|6|||
38075645|NCT03103087|69771885|FG000|Overall Study|Withdrawal by Subject|13|||
38075646|NCT03103087|69771886|FG001|Overall Study|Withdrawal by Subject|6|||
38075647|NCT03103087|69771887|FG002|Overall Study|Withdrawal by Subject|6|||
38075648|NCT03103087|69771885|FG000|Overall Study|Lost to Follow-up|4|||
38075649|NCT03103087|69771886|FG001|Overall Study|Lost to Follow-up|2|||
38075650|NCT03103087|69771887|FG002|Overall Study|Lost to Follow-up|7|||
38075651|NCT03103087|69771885|FG000|Overall Study|Other reason not reported|1|||
38075652|NCT03103087|69771886|FG001|Overall Study|Other reason not reported|3|||
38075653|NCT03103087|69771887|FG002|Overall Study|Other reason not reported|5|||
38075654|NCT03131999|69771899|FG000|Overall Study|Withdrawal by Subject|0|||
38075655|NCT03131999|69771900|FG001|Overall Study|Withdrawal by Subject|1|||
38075656|NCT02263885|69771915|FG000|Overall Study|Withdrawal by Subject|7|||
38075657|NCT02263885|69771915|FG000|Overall Study|Alternative Treatment|3|||
38075658|NCT02000219|69771920|FG000|14-Week Study Period|Physician Decision|1|||
38075659|NCT02000219|69771920|FG000|14-Week Study Period|Adverse Event|1|||
38075660|NCT02000219|69771920|FG000|14-Week Study Period|Underwent transplantation|1|||
38075661|NCT02000219|69771920|FG000|Continuation Period|Withdrawal by Subject|1|||
38075662|NCT02000219|69771920|FG000|Continuation Period|Had liver transplant|2|||
38075663|NCT02000219|69771920|FG000|Continuation Period|Non-compliance with study drug|2|||
38075664|NCT03101371|69771926|FG000|Overall Study|Physician Decision|0|||
38075665|NCT03101371|69771927|FG001|Overall Study|Physician Decision|1|||
38075666|NCT03101371|69771926|FG000|Overall Study|Lost to Follow-up|1|||
38075667|NCT03101371|69771927|FG001|Overall Study|Lost to Follow-up|4|||
38075668|NCT03101371|69771926|FG000|Overall Study|Did not meet eligibility criteria|2|||
38075669|NCT03101371|69771927|FG001|Overall Study|Did not meet eligibility criteria|1|||
38075670|NCT02850276|69771933|FG000|Overall Study|screen failure|43|||
38075671|NCT02850276|69771933|FG000|Overall Study|Withdrawal by Subject|14|||
38075672|NCT02850276|69771933|FG000|Overall Study|Physician Decision|2|||
38075673|NCT02850276|69771933|FG000|Overall Study|Lost to Follow-up|2|||
38075674|NCT02783768|69771938|FG000|Overall Study|Lost to Follow-up|1|||
38075675|NCT02783768|69771939|FG001|Overall Study|Lost to Follow-up|0|||
38075676|NCT03131687|69771951|FG000|Overall Study|Adverse Event|0|||
38075677|NCT03131687|69771952|FG001|Overall Study|Adverse Event|1|||
38075678|NCT03131687|69771953|FG002|Overall Study|Adverse Event|0|||
38075679|NCT03131687|69771954|FG003|Overall Study|Adverse Event|1|||
38075680|NCT03131687|69771955|FG004|Overall Study|Adverse Event|2|||
38075681|NCT03131687|69771956|FG005|Overall Study|Adverse Event|2|||
38075682|NCT03131687|69771951|FG000|Overall Study|Death|1|||
38075683|NCT03131687|69771952|FG001|Overall Study|Death|0|||
38075684|NCT03131687|69771953|FG002|Overall Study|Death|0|||
38075685|NCT03131687|69771954|FG003|Overall Study|Death|0|||
38075686|NCT03131687|69771955|FG004|Overall Study|Death|0|||
38075687|NCT03131687|69771956|FG005|Overall Study|Death|0|||
38075688|NCT03131687|69771951|FG000|Overall Study|Withdrawal by Subject|3|||
38075689|NCT03131687|69771952|FG001|Overall Study|Withdrawal by Subject|3|||
38075690|NCT03131687|69771953|FG002|Overall Study|Withdrawal by Subject|3|||
38075691|NCT03131687|69771954|FG003|Overall Study|Withdrawal by Subject|1|||
38075692|NCT03131687|69771955|FG004|Overall Study|Withdrawal by Subject|2|||
38075693|NCT03131687|69771956|FG005|Overall Study|Withdrawal by Subject|1|||
38075694|NCT03131687|69771951|FG000|Overall Study|Lost to Follow-up|1|||
38075695|NCT03131687|69771952|FG001|Overall Study|Lost to Follow-up|4|||
38075696|NCT03131687|69771953|FG002|Overall Study|Lost to Follow-up|0|||
38075697|NCT03131687|69771954|FG003|Overall Study|Lost to Follow-up|1|||
38075698|NCT03131687|69771955|FG004|Overall Study|Lost to Follow-up|4|||
38075699|NCT03131687|69771956|FG005|Overall Study|Lost to Follow-up|2|||
38075700|NCT03131687|69771951|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
38075701|NCT03131687|69771952|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
38075702|NCT03131687|69771953|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
38075703|NCT03131687|69771954|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
38075704|NCT03131687|69771955|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
38075705|NCT03131687|69771956|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
38075706|NCT03131687|69771951|FG000|Overall Study|Principle Investigator Decision|0|||
38075707|NCT03131687|69771952|FG001|Overall Study|Principle Investigator Decision|1|||
38075708|NCT03131687|69771953|FG002|Overall Study|Principle Investigator Decision|0|||
38075709|NCT03131687|69771954|FG003|Overall Study|Principle Investigator Decision|0|||
38075710|NCT03131687|69771955|FG004|Overall Study|Principle Investigator Decision|0|||
38075711|NCT03131687|69771956|FG005|Overall Study|Principle Investigator Decision|0|||
38075712|NCT03131687|69771951|FG000|Overall Study|Inadvertent Enrollment|0|||
38075713|NCT03131687|69771952|FG001|Overall Study|Inadvertent Enrollment|0|||
38075714|NCT03131687|69771953|FG002|Overall Study|Inadvertent Enrollment|0|||
38075715|NCT03131687|69771954|FG003|Overall Study|Inadvertent Enrollment|1|||
38075716|NCT03131687|69771955|FG004|Overall Study|Inadvertent Enrollment|0|||
38075717|NCT03131687|69771956|FG005|Overall Study|Inadvertent Enrollment|0|||
38075718|NCT03101293|69771985|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
38075719|NCT03101293|69771986|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
38075720|NCT02850978|69771992|FG000|Overall Study|Uncollectable CRF|27|||
38075721|NCT02850978|69771992|FG000|Overall Study|No visit since the first visit|35|||
38075722|NCT02850978|69771992|FG000|Overall Study|Adverse Event|81|||
38075723|NCT02850978|69771992|FG000|Overall Study|Lack of Efficacy|40|||
38075724|NCT02850978|69771992|FG000|Overall Study|Improvement in condition|34|||
38075725|NCT02850978|69771992|FG000|Overall Study|Lost to Follow-up|121|||
38075726|NCT02850978|69771992|FG000|Overall Study|Reason not listed|88|||
38075727|NCT03135431|69771998|FG000|Overall Study|Study Surgeon not available|2|||
38075728|NCT03135431|69771999|FG001|Overall Study|Study Surgeon not available|0|||
38075729|NCT04534517|69772021|FG000|Overall Study|Adverse Event|1|||
38075730|NCT04534517|69772021|FG000|Overall Study|Withdrawal by Subject|1|||
38075731|NCT04534517|69772021|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
38075732|NCT04534517|69772021|FG000|Overall Study|COVID-19 Related|1|||
38075733|NCT02831257|69772025|FG000|Overall Study|Lack of Efficacy|3|||
38075734|NCT02831257|69772025|FG000|Overall Study|Adverse Event|2|||
38075735|NCT02831257|69772025|FG000|Overall Study|Physician Decision|1|||
38075736|NCT02831257|69772025|FG000|Overall Study|Withdrawal by Subject|6|||
38075737|NCT03100825|69772029|FG000|Overall Study|Participant/Guardian Decision|7|||
38075738|NCT03100825|69772029|FG000|Overall Study|Physician Decision|1|||
38075739|NCT02250534|69772036|FG000|Overall Study|Lost to Follow-up|18|||
38075740|NCT02250534|69772037|FG001|Overall Study|Lost to Follow-up|28|||
38075741|NCT02250534|69772038|FG002|Overall Study|Lost to Follow-up|33|||
38075742|NCT02250534|69772036|FG000|Overall Study|Personal reasons|7|||
38075743|NCT02250534|69772037|FG001|Overall Study|Personal reasons|8|||
38075744|NCT02250534|69772038|FG002|Overall Study|Personal reasons|14|||
38075745|NCT02250534|69772036|FG000|Overall Study|Adverse Event|6|||
38075746|NCT02250534|69772037|FG001|Overall Study|Adverse Event|3|||
38075747|NCT02250534|69772038|FG002|Overall Study|Adverse Event|8|||
38075748|NCT02250534|69772036|FG000|Overall Study|incarcerated|2|||
38075749|NCT02250534|69772037|FG001|Overall Study|incarcerated|1|||
38075750|NCT02250534|69772038|FG002|Overall Study|incarcerated|2|||
38075751|NCT02250534|69772036|FG000|Overall Study|Withdrawal by Subject|0|||
38075752|NCT02250534|69772037|FG001|Overall Study|Withdrawal by Subject|1|||
38075753|NCT02250534|69772038|FG002|Overall Study|Withdrawal by Subject|2|||
38075754|NCT02250534|69772036|FG000|Overall Study|Death|0|||
38075755|NCT02250534|69772037|FG001|Overall Study|Death|1|||
38075756|NCT02250534|69772038|FG002|Overall Study|Death|1|||
38075757|NCT02250534|69772036|FG000|Overall Study|Physician Decision|1|||
38075758|NCT02250534|69772037|FG001|Overall Study|Physician Decision|3|||
38075759|NCT02250534|69772038|FG002|Overall Study|Physician Decision|1|||
38075760|NCT02250534|69772036|FG000|Overall Study|Protocol Violation|1|||
38075761|NCT02250534|69772037|FG001|Overall Study|Protocol Violation|0|||
38075762|NCT02250534|69772038|FG002|Overall Study|Protocol Violation|1|||
38075763|NCT02250534|69772036|FG000|Overall Study|Reason unknown|1|||
38075764|NCT02250534|69772037|FG001|Overall Study|Reason unknown|0|||
37966429|NCT00460239|69653269|FG003|Overall Study|Withdrawal by Subject|0|||
37966430|NCT00460239|69653270|FG004|Overall Study|Withdrawal by Subject|0|||
37966431|NCT00460239|69653271|FG005|Overall Study|Withdrawal by Subject|1|||
37966432|NCT00460239|69653272|FG006|Overall Study|Withdrawal by Subject|0|||
37966433|NCT00460239|69653273|FG007|Overall Study|Withdrawal by Subject|0|||
37966434|NCT00460239|69653274|FG008|Overall Study|Withdrawal by Subject|0|||
37966435|NCT00640835|69653289|FG000|Overall Study|Adverse Event|5|||
37966436|NCT00640835|69653290|FG001|Overall Study|Adverse Event|3|||
37966437|NCT00640835|69653289|FG000|Overall Study|Withdrawal by Subject|12|||
37966438|NCT00640835|69653290|FG001|Overall Study|Withdrawal by Subject|14|||
37966439|NCT00640835|69653289|FG000|Overall Study|Physician Decision|10|||
37966440|NCT00640835|69653290|FG001|Overall Study|Physician Decision|14|||
37966441|NCT00640835|69653289|FG000|Overall Study|Sponsor's Decision|11|||
37966442|NCT00640835|69653290|FG001|Overall Study|Sponsor's Decision|7|||
37966443|NCT00640835|69653289|FG000|Overall Study|Protocol Violation|2|||
37966444|NCT00640835|69653290|FG001|Overall Study|Protocol Violation|2|||
37966445|NCT00640835|69653289|FG000|Overall Study|Lost to Follow-up|17|||
37966446|NCT00640835|69653290|FG001|Overall Study|Lost to Follow-up|13|||
37966447|NCT00640835|69653289|FG000|Overall Study|Other Reason|19|||
37966448|NCT00640835|69653290|FG001|Overall Study|Other Reason|4|||
37966449|NCT03839355|69653298|FG000|Overall Study|Withdrawal by Subject|1|||
37966450|NCT03839355|69653299|FG001|Overall Study|Withdrawal by Subject|0|||
37966451|NCT00382018|69653309|FG000|Overall Study|Progression|0|||
37966452|NCT00382018|69653310|FG001|Overall Study|Progression|136|||
37966453|NCT00382018|69653311|FG002|Overall Study|Progression|51|||
37966454|NCT00382018|69653312|FG003|Overall Study|Progression|43|||
38075765|NCT02250534|69772038|FG002|Overall Study|Reason unknown|0|||
38075766|NCT02848326|69772052|FG000|Treatment Period|Adverse Event|5|||
38075767|NCT02848326|69772053|FG001|Treatment Period|Adverse Event|4|||
37966455|NCT00382018|69653309|FG000|Overall Study|Death|0|||
38075768|NCT02848326|69772054|FG002|Treatment Period|Adverse Event|11|||
38075769|NCT02848326|69772055|FG003|Treatment Period|Adverse Event|6|||
38075770|NCT02848326|69772056|FG004|Treatment Period|Adverse Event|5|||
38075771|NCT02848326|69772057|FG005|Treatment Period|Adverse Event|7|||
38075772|NCT02848326|69772052|FG000|Treatment Period|Withdrawal of Consent|20|||
38075773|NCT02848326|69772053|FG001|Treatment Period|Withdrawal of Consent|6|||
37966456|NCT00382018|69653310|FG001|Overall Study|Death|9|||
37966457|NCT00382018|69653311|FG002|Overall Study|Death|7|||
37966458|NCT00382018|69653312|FG003|Overall Study|Death|11|||
37966459|NCT00382018|69653309|FG000|Overall Study|Withdrawal by Subject|0|||
37966460|NCT00382018|69653310|FG001|Overall Study|Withdrawal by Subject|4|||
38075774|NCT02848326|69772054|FG002|Treatment Period|Withdrawal of Consent|9|||
38075775|NCT02848326|69772055|FG003|Treatment Period|Withdrawal of Consent|6|||
38075776|NCT02848326|69772056|FG004|Treatment Period|Withdrawal of Consent|9|||
38075777|NCT02848326|69772057|FG005|Treatment Period|Withdrawal of Consent|6|||
38075778|NCT02848326|69772052|FG000|Treatment Period|Lost to Follow-up|5|||
38075779|NCT02848326|69772053|FG001|Treatment Period|Lost to Follow-up|1|||
38075780|NCT02848326|69772054|FG002|Treatment Period|Lost to Follow-up|11|||
38075781|NCT02848326|69772055|FG003|Treatment Period|Lost to Follow-up|7|||
38075782|NCT02848326|69772056|FG004|Treatment Period|Lost to Follow-up|2|||
38075783|NCT02848326|69772057|FG005|Treatment Period|Lost to Follow-up|3|||
38075784|NCT02848326|69772052|FG000|Treatment Period|Pregnancy|0|||
38075785|NCT02848326|69772053|FG001|Treatment Period|Pregnancy|0|||
38075786|NCT02848326|69772054|FG002|Treatment Period|Pregnancy|1|||
38075787|NCT02848326|69772055|FG003|Treatment Period|Pregnancy|1|||
38075788|NCT02848326|69772056|FG004|Treatment Period|Pregnancy|0|||
38075789|NCT02848326|69772057|FG005|Treatment Period|Pregnancy|1|||
38075790|NCT02848326|69772052|FG000|Treatment Period|Protocol Violation|4|||
38075791|NCT02848326|69772053|FG001|Treatment Period|Protocol Violation|3|||
38075792|NCT02848326|69772054|FG002|Treatment Period|Protocol Violation|4|||
38075793|NCT02848326|69772055|FG003|Treatment Period|Protocol Violation|2|||
38075794|NCT02848326|69772056|FG004|Treatment Period|Protocol Violation|3|||
38075795|NCT02848326|69772057|FG005|Treatment Period|Protocol Violation|3|||
38075796|NCT02848326|69772052|FG000|Treatment Period|Non-compliance with Study Drug|4|||
38075797|NCT02848326|69772053|FG001|Treatment Period|Non-compliance with Study Drug|0|||
38075798|NCT02848326|69772054|FG002|Treatment Period|Non-compliance with Study Drug|0|||
38075799|NCT02848326|69772055|FG003|Treatment Period|Non-compliance with Study Drug|1|||
38075800|NCT02848326|69772056|FG004|Treatment Period|Non-compliance with Study Drug|0|||
38075801|NCT02848326|69772057|FG005|Treatment Period|Non-compliance with Study Drug|0|||
38075802|NCT02848326|69772052|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
38075803|NCT02848326|69772053|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
38075804|NCT02848326|69772054|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
38075805|NCT02848326|69772055|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
38075806|NCT02848326|69772056|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
38075807|NCT02848326|69772057|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
38075808|NCT02848326|69772052|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
38075809|NCT02848326|69772053|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
38075810|NCT02848326|69772054|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
38075811|NCT02848326|69772055|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
38075812|NCT02848326|69772056|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
38075813|NCT02848326|69772057|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
38075814|NCT03128723|69772071|FG000|Overall Study|Withdrawal by Subject|2|||
38075815|NCT03128411|69772075|FG000|Treatment Phase|Adverse Event|21|||
38075816|NCT03128411|69772075|FG000|Treatment Phase|Physician Decision|1|||
38075817|NCT03128411|69772075|FG000|Treatment Phase|Other|2|||
37966461|NCT00382018|69653311|FG002|Overall Study|Withdrawal by Subject|3|||
37966462|NCT00382018|69653312|FG003|Overall Study|Withdrawal by Subject|4|||
37966463|NCT00382018|69653309|FG000|Overall Study|Other, not protocol specified|0|||
37966464|NCT00382018|69653310|FG001|Overall Study|Other, not protocol specified|16|||
37966465|NCT00382018|69653311|FG002|Overall Study|Other, not protocol specified|3|||
37966466|NCT00382018|69653312|FG003|Overall Study|Other, not protocol specified|1|||
37966467|NCT00640601|69653325|FG000|Overall Study|Adverse Event|43|||
37966468|NCT00640601|69653325|FG000|Overall Study|Withdrawal by Subject|20|||
37966469|NCT00640601|69653325|FG000|Overall Study|Protocol Violation|6|||
37966470|NCT00640601|69653325|FG000|Overall Study|Lack of Efficacy|16|||
37966471|NCT00640601|69653325|FG000|Overall Study|Lost to Follow-up|9|||
37966472|NCT00640601|69653325|FG000|Overall Study|Physician Decision|8|||
37966473|NCT00640601|69653325|FG000|Overall Study|treatment naive, combination therapy|10|||
37966474|NCT03838731|69653331|FG000|Overall Study|Pregnancy|0|||
37966475|NCT03838731|69653332|FG001|Overall Study|Pregnancy|1|||
37966476|NCT03838731|69653331|FG000|Overall Study|Withdrawal of consent|1|||
37966477|NCT03838731|69653332|FG001|Overall Study|Withdrawal of consent|0|||
37966478|NCT00452439|69653340|FG000|Overall Study|Lost to Follow-up|1|||
37966479|NCT00452439|69653341|FG001|Overall Study|Lost to Follow-up|1|||
37966480|NCT00452439|69653340|FG000|Overall Study|Refused Treatment|4|||
37966481|NCT00452439|69653341|FG001|Overall Study|Refused Treatment|3|||
37966482|NCT00452439|69653340|FG000|Overall Study|Death|3|||
37966483|NCT00452439|69653341|FG001|Overall Study|Death|1|||
37966484|NCT00452439|69653340|FG000|Overall Study|Bone Marrow Transplant|0|||
37966485|NCT00452439|69653341|FG001|Overall Study|Bone Marrow Transplant|1|||
37966486|NCT00452439|69653340|FG000|Overall Study|Too Ill to Continue|0|||
37966487|NCT00452439|69653341|FG001|Overall Study|Too Ill to Continue|1|||
37966488|NCT00452439|69653340|FG000|Overall Study|Failed to achieve complete response|2|||
37966489|NCT00452439|69653341|FG001|Overall Study|Failed to achieve complete response|0|||
37966490|NCT00452439|69653340|FG000|Overall Study|Relapse|3|||
37966491|NCT00452439|69653341|FG001|Overall Study|Relapse|0|||
37966492|NCT00452439|69653340|FG000|Overall Study|Fracture|1|||
37966493|NCT00452439|69653341|FG001|Overall Study|Fracture|0|||
37966494|NCT00381940|69653347|FG000|Overall Study|Lack of Efficacy|3|||
37966495|NCT00381940|69653347|FG000|Overall Study|Protocol Violation|1|||
37966496|NCT00381940|69653347|FG000|Overall Study|Ineligible|1|||
37966497|NCT00364156|69653353|FG000|Overall Study|Withdrawal by Subject|73|||
37966498|NCT00364156|69653354|FG001|Overall Study|Withdrawal by Subject|80|||
37966499|NCT00364156|69653353|FG000|Overall Study|Protocol Violation|6|||
37966500|NCT00364156|69653354|FG001|Overall Study|Protocol Violation|1|||
37966501|NCT00452361|69653362|FG000|Overall Study|Adverse Event|8|||
37966502|NCT00452361|69653363|FG001|Overall Study|Adverse Event|0|||
37966503|NCT00452361|69653362|FG000|Overall Study|Withdrawal by Subject|0|||
37966504|NCT00452361|69653363|FG001|Overall Study|Withdrawal by Subject|1|||
37966505|NCT00452361|69653362|FG000|Overall Study|Premature termination|13|||
38075818|NCT03128411|69772075|FG000|Long Term Follow-up Phase|Death|2|||
38075819|NCT02847858|69772081|FG000|Overall Study|Lost to Follow-up|401|||
37966506|NCT00452361|69653363|FG001|Overall Study|Premature termination|9|||
37966507|NCT00640289|69653369|FG000|Overall Study|Death|3|||
37966508|NCT00640289|69653369|FG000|Overall Study|Withdrawal by Subject|1|||
37966509|NCT00640289|69653369|FG000|Overall Study|Lost to Follow-up|1|||
37966510|NCT00640289|69653369|FG000|Overall Study|Data collected under different amendment|2|||
37966511|NCT00640289|69653369|FG000|Overall Study|Transferred to another center|1|||
37966512|NCT00640289|69653369|FG000|Overall Study|Missing status|5|||
37966513|NCT00568451|69653377|FG000|Overall Study|Disease Progression|0|||
37966514|NCT00568451|69653378|FG001|Overall Study|Disease Progression|0|||
38075820|NCT02847858|69772082|FG001|Overall Study|Lost to Follow-up|269|||
38075821|NCT03124199|69772093|FG000|Overall Study|Lost to Follow-up|4|||
38075822|NCT04465916|69772099|FG000|Overall Study|Withdrawal by Subject|0|||
38075823|NCT04465916|69772100|FG001|Overall Study|Withdrawal by Subject|1|||
38075824|NCT05090852|69772106|FG000|Overall Study|Physician Decision|5|||
38075825|NCT00075816|69772121|FG000|Overall Study|Did not undergo transplantation|14|||
38075826|NCT00075816|69772122|FG001|Overall Study|Did not undergo transplantation|11|||
38075827|NCT00109772|69772136|FG000|Double-blind Treatment|Adverse Event|14|||
38075828|NCT00109772|69772137|FG001|Double-blind Treatment|Adverse Event|5|||
38075829|NCT00109772|69772136|FG000|Double-blind Treatment|Lack of Efficacy|1|||
38075830|NCT00109772|69772137|FG001|Double-blind Treatment|Lack of Efficacy|0|||
38075831|NCT00109772|69772136|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
38075832|NCT00109772|69772137|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
38075833|NCT00109772|69772136|FG000|Double-blind Treatment|Lost to Follow-up|2|||
38075834|NCT00109772|69772137|FG001|Double-blind Treatment|Lost to Follow-up|3|||
38075835|NCT00109772|69772136|FG000|Double-blind Treatment|Protocol Violation|0|||
38075836|NCT00109772|69772137|FG001|Double-blind Treatment|Protocol Violation|1|||
38075837|NCT00109772|69772136|FG000|Double-blind Treatment|Other|0|||
38075838|NCT00109772|69772137|FG001|Double-blind Treatment|Other|4|||
38075839|NCT00109772|69772136|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
38075840|NCT00109772|69772137|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
38075841|NCT00109772|69772136|FG000|Open-label Extension|Adverse Event|10|||
38075842|NCT00109772|69772137|FG001|Open-label Extension|Adverse Event|19|||
38075843|NCT00109772|69772136|FG000|Open-label Extension|Lack of Efficacy|19|||
38075844|NCT00109772|69772137|FG001|Open-label Extension|Lack of Efficacy|11|||
38075845|NCT00109772|69772136|FG000|Open-label Extension|Withdrawal by Subject|9|||
38075846|NCT00109772|69772137|FG001|Open-label Extension|Withdrawal by Subject|6|||
38075847|NCT00109772|69772136|FG000|Open-label Extension|Lost to Follow-up|1|||
38075848|NCT00109772|69772137|FG001|Open-label Extension|Lost to Follow-up|0|||
38075849|NCT00109772|69772136|FG000|Open-label Extension|Death|0|||
38075850|NCT00109772|69772137|FG001|Open-label Extension|Death|1|||
38075851|NCT00109772|69772136|FG000|Open-label Extension|Protocol Violation|2|||
38075852|NCT00109772|69772137|FG001|Open-label Extension|Protocol Violation|2|||
38075853|NCT00109772|69772136|FG000|Open-label Extension|Other|4|||
38075854|NCT00109772|69772137|FG001|Open-label Extension|Other|10|||
38075855|NCT02783066|69772143|FG000|Overall Study|Withdrawal by Subject|13|||
38075856|NCT01371305|69772154|FG000|Overall Study|Adverse Event|0|||
38075857|NCT01371305|69772155|FG001|Overall Study|Adverse Event|0|||
38075858|NCT01371305|69772156|FG002|Overall Study|Adverse Event|0|||
38075859|NCT01371305|69772157|FG003|Overall Study|Adverse Event|2|||
38075860|NCT01371305|69772158|FG004|Overall Study|Adverse Event|1|||
38075861|NCT01371305|69772159|FG005|Overall Study|Adverse Event|0|||
38075862|NCT01371305|69772154|FG000|Overall Study|Study terminated by sponsor|0|||
38075863|NCT01371305|69772155|FG001|Overall Study|Study terminated by sponsor|0|||
38075864|NCT01371305|69772156|FG002|Overall Study|Study terminated by sponsor|0|||
38075865|NCT01371305|69772157|FG003|Overall Study|Study terminated by sponsor|0|||
38075866|NCT01371305|69772158|FG004|Overall Study|Study terminated by sponsor|3|||
38075867|NCT01371305|69772159|FG005|Overall Study|Study terminated by sponsor|1|||
38075868|NCT01371305|69772154|FG000|Overall Study|Subject request|0|||
38075869|NCT01371305|69772155|FG001|Overall Study|Subject request|0|||
38075870|NCT01371305|69772156|FG002|Overall Study|Subject request|0|||
38075871|NCT01371305|69772157|FG003|Overall Study|Subject request|0|||
38075872|NCT01371305|69772158|FG004|Overall Study|Subject request|0|||
38075873|NCT01371305|69772159|FG005|Overall Study|Subject request|1|||
38075874|NCT00109928|69772174|FG000|Overall Study|Adverse Event|2|||
38075875|NCT00109928|69772174|FG000|Overall Study|Progression|6|||
38075876|NCT00109928|69772174|FG000|Overall Study|Death|2|||
38075877|NCT00109928|69772174|FG000|Overall Study|not protocol specified|2|||
38075878|NCT00109928|69772174|FG000|Overall Study|not eligible|1|||
38075879|NCT00109850|69772179|FG000|Overall Study|Adverse Event|1|||
38075880|NCT00109850|69772179|FG000|Overall Study|Death|2|||
38075881|NCT00109850|69772179|FG000|Overall Study|Ineligible|1|||
38075882|NCT01342926|69772187|FG000|Overall Study|Adverse Event|5|||
38075883|NCT01342926|69772188|FG001|Overall Study|Adverse Event|8|||
38075884|NCT01342926|69772189|FG002|Overall Study|Adverse Event|10|||
38075885|NCT01342926|69772190|FG003|Overall Study|Adverse Event|7|||
38075886|NCT01342926|69772187|FG000|Overall Study|Lost to Follow-up|0|||
38075887|NCT01342926|69772188|FG001|Overall Study|Lost to Follow-up|1|||
38075888|NCT01342926|69772189|FG002|Overall Study|Lost to Follow-up|1|||
38075889|NCT01342926|69772190|FG003|Overall Study|Lost to Follow-up|0|||
38075890|NCT01342926|69772187|FG000|Overall Study|Investigator Discretion|2|||
38075891|NCT01342926|69772188|FG001|Overall Study|Investigator Discretion|2|||
38075892|NCT01342926|69772189|FG002|Overall Study|Investigator Discretion|0|||
38075893|NCT01342926|69772190|FG003|Overall Study|Investigator Discretion|0|||
38075894|NCT01342926|69772187|FG000|Overall Study|Withdrawal by Subject|2|||
38075895|NCT01342926|69772188|FG001|Overall Study|Withdrawal by Subject|4|||
38075896|NCT01342926|69772189|FG002|Overall Study|Withdrawal by Subject|3|||
38075897|NCT01342926|69772190|FG003|Overall Study|Withdrawal by Subject|5|||
38075898|NCT01810016|69772203|FG000|Overall Study|Progressive disease|1|||
38075899|NCT01810016|69772204|FG001|Overall Study|Progressive disease|1|||
38075900|NCT01810016|69772205|FG002|Overall Study|Progressive disease|0|||
38075901|NCT01810016|69772203|FG000|Overall Study|Death|0|||
38075902|NCT01810016|69772204|FG001|Overall Study|Death|0|||
38075903|NCT01810016|69772205|FG002|Overall Study|Death|1|||
38075904|NCT02843178|69772217|FG000|Overall Study|Lost to Follow-up|8|||
38075905|NCT02843178|69772218|FG001|Overall Study|Lost to Follow-up|8|||
38075906|NCT02843178|69772219|FG002|Overall Study|Lost to Follow-up|6|||
38075907|NCT02843178|69772220|FG003|Overall Study|Lost to Follow-up|3|||
38075908|NCT02843178|69772217|FG000|Overall Study|Withdrawal by Subject|0|||
38075909|NCT02843178|69772218|FG001|Overall Study|Withdrawal by Subject|0|||
38075910|NCT02843178|69772219|FG002|Overall Study|Withdrawal by Subject|1|||
38075911|NCT02843178|69772220|FG003|Overall Study|Withdrawal by Subject|1|||
38075912|NCT01722266|69772234|FG000|Overall Study|Withdrawal by Subject|1|||
38075913|NCT01722266|69772235|FG001|Overall Study|Withdrawal by Subject|2|||
38075914|NCT01722266|69772236|FG002|Overall Study|Withdrawal by Subject|0|||
38075915|NCT01722266|69772237|FG003|Overall Study|Withdrawal by Subject|0|||
38075916|NCT01722266|69772234|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
38075917|NCT01722266|69772235|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
38075918|NCT01722266|69772236|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
38075919|NCT01722266|69772237|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
38075920|NCT01722266|69772234|FG000|Overall Study|Dropped out due to Nausea|0|||
38075921|NCT01722266|69772235|FG001|Overall Study|Dropped out due to Nausea|0|||
38075922|NCT01722266|69772236|FG002|Overall Study|Dropped out due to Nausea|2|||
38075923|NCT01722266|69772237|FG003|Overall Study|Dropped out due to Nausea|0|||
38075924|NCT03123185|69772261|FG000|Overall Study|Withdrawal by Subject|0|||
38075925|NCT03123185|69772262|FG001|Overall Study|Withdrawal by Subject|0|||
38075926|NCT03123185|69772263|FG002|Overall Study|Withdrawal by Subject|0|||
38075927|NCT03123185|69772264|FG003|Overall Study|Withdrawal by Subject|0|||
38075928|NCT03123185|69772265|FG004|Overall Study|Withdrawal by Subject|0|||
38075929|NCT03123185|69772266|FG005|Overall Study|Withdrawal by Subject|0|||
38075930|NCT03123185|69772267|FG006|Overall Study|Withdrawal by Subject|0|||
38075931|NCT03123185|69772268|FG007|Overall Study|Withdrawal by Subject|0|||
38075932|NCT03123185|69772269|FG008|Overall Study|Withdrawal by Subject|0|||
38075933|NCT03123185|69772270|FG009|Overall Study|Withdrawal by Subject|0|||
38075934|NCT03123185|69772271|FG010|Overall Study|Withdrawal by Subject|0|||
38075935|NCT03123185|69772272|FG011|Overall Study|Withdrawal by Subject|0|||
38075936|NCT03123185|69772273|FG012|Overall Study|Withdrawal by Subject|1|||
38075937|NCT03123185|69772274|FG013|Overall Study|Withdrawal by Subject|0|||
38075938|NCT02842866|69772333|FG000|Overall Study|Serious Adverse Event|0|||
38075939|NCT02842866|69772334|FG001|Overall Study|Serious Adverse Event|1|||
38075940|NCT02842866|69772333|FG000|Overall Study|Protocol Violation|4|||
38075941|NCT02842866|69772334|FG001|Overall Study|Protocol Violation|2|||
38075942|NCT02842866|69772333|FG000|Overall Study|Lost to Follow-up|2|||
37966515|NCT00568451|69653379|FG002|Overall Study|Disease Progression|2|||
37966516|NCT00568451|69653380|FG003|Overall Study|Disease Progression|7|||
37966517|NCT00459537|69653393|FG000|Overall Study|Adverse Event|1|||
37966518|NCT00459537|69653394|FG001|Overall Study|Adverse Event|6|||
37966519|NCT00459537|69653393|FG000|Overall Study|Lack of Efficacy|10|||
37966520|NCT00459537|69653394|FG001|Overall Study|Lack of Efficacy|11|||
37966521|NCT00459537|69653393|FG000|Overall Study|Withdrawal by Subject|20|||
37966522|NCT00459537|69653394|FG001|Overall Study|Withdrawal by Subject|26|||
37966523|NCT00459537|69653393|FG000|Overall Study|Lost to Follow-up|27|||
37966524|NCT00459537|69653394|FG001|Overall Study|Lost to Follow-up|30|||
37966525|NCT00459537|69653393|FG000|Overall Study|Administrative problems|3|||
37966526|NCT00459537|69653394|FG001|Overall Study|Administrative problems|0|||
37966527|NCT00459537|69653393|FG000|Overall Study|Protocol Violation|4|||
37966528|NCT00459537|69653394|FG001|Overall Study|Protocol Violation|3|||
37966529|NCT00459537|69653393|FG000|Overall Study|Missing|1|||
37966530|NCT00459537|69653394|FG001|Overall Study|Missing|0|||
38075943|NCT02842866|69772334|FG001|Overall Study|Lost to Follow-up|0|||
38075944|NCT02842866|69772333|FG000|Overall Study|Withdrawal by Subject|1|||
37966531|NCT03850509|69653402|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
37966532|NCT03850509|69653403|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
38075945|NCT02842866|69772334|FG001|Overall Study|Withdrawal by Subject|0|||
38075946|NCT01316913|69772344|FG000|Overall Study|Adverse Event|17|||
38075947|NCT01316913|69772345|FG001|Overall Study|Adverse Event|20|||
38075948|NCT01316913|69772346|FG002|Overall Study|Adverse Event|15|||
38075949|NCT01316913|69772347|FG003|Overall Study|Adverse Event|11|||
38075950|NCT01316913|69772344|FG000|Overall Study|Lack of Efficacy|22|||
38075951|NCT01316913|69772345|FG001|Overall Study|Lack of Efficacy|12|||
38075952|NCT01316913|69772346|FG002|Overall Study|Lack of Efficacy|9|||
38075953|NCT01316913|69772347|FG003|Overall Study|Lack of Efficacy|13|||
38075954|NCT01316913|69772344|FG000|Overall Study|Protocol Violation|1|||
38075955|NCT01316913|69772345|FG001|Overall Study|Protocol Violation|4|||
38075956|NCT01316913|69772346|FG002|Overall Study|Protocol Violation|4|||
38075957|NCT01316913|69772347|FG003|Overall Study|Protocol Violation|1|||
38075958|NCT01316913|69772344|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
38075959|NCT01316913|69772345|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
38075960|NCT01316913|69772346|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
38075961|NCT01316913|69772347|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
38075962|NCT01316913|69772344|FG000|Overall Study|Lost to Follow-up|0|||
38075963|NCT01316913|69772345|FG001|Overall Study|Lost to Follow-up|1|||
38075964|NCT01316913|69772346|FG002|Overall Study|Lost to Follow-up|0|||
38075965|NCT01316913|69772347|FG003|Overall Study|Lost to Follow-up|2|||
38075966|NCT01316913|69772344|FG000|Overall Study|Withdrawal by Subject|10|||
38075967|NCT01316913|69772345|FG001|Overall Study|Withdrawal by Subject|9|||
38075968|NCT01316913|69772346|FG002|Overall Study|Withdrawal by Subject|10|||
38075969|NCT01316913|69772347|FG003|Overall Study|Withdrawal by Subject|6|||
38075970|NCT02875067|69772358|FG000|Overall Study|Withdrawal by Subject|1|||
38075971|NCT02875067|69772358|FG000|Overall Study|Withdrawal by Termination of Study|5|||
38075972|NCT02781506|69772362|FG000|Overall Study|Adverse Event|5|||
38075973|NCT03132753|69772368|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
38075974|NCT03132753|69772369|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
38075975|NCT03132753|69772368|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
38075976|NCT03132753|69772369|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
38075977|NCT01468454|69772375|FG000|Overall Study|Did not have surgery after PET|9|||
38075978|NCT03067077|69772380|FG000|Overall Study|Did not receive surgery|4|||
38075979|NCT03067077|69772381|FG001|Overall Study|Did not receive surgery|5|||
38075980|NCT03067077|69772380|FG000|Overall Study|Lost to Follow-up|3|||
38075981|NCT03067077|69772381|FG001|Overall Study|Lost to Follow-up|2|||
38075982|NCT03096847|69772390|FG000|Overall Study|Other|2|||
38075983|NCT03096847|69772391|FG001|Overall Study|Other|1|||
38075984|NCT03096847|69772392|FG002|Overall Study|Other|2|||
38075985|NCT03096847|69772390|FG000|Overall Study|Lost to Follow-up|1|||
38075986|NCT03096847|69772391|FG001|Overall Study|Lost to Follow-up|0|||
38075987|NCT03096847|69772392|FG002|Overall Study|Lost to Follow-up|1|||
38075988|NCT03096847|69772390|FG000|Overall Study|Death|6|||
38075989|NCT03096847|69772391|FG001|Overall Study|Death|0|||
38075990|NCT03096847|69772392|FG002|Overall Study|Death|2|||
38075991|NCT03096847|69772390|FG000|Overall Study|Protocol Violation|3|||
38075992|NCT03096847|69772391|FG001|Overall Study|Protocol Violation|0|||
38075993|NCT03096847|69772392|FG002|Overall Study|Protocol Violation|6|||
38075994|NCT03096847|69772390|FG000|Overall Study|Physician Decision|12|||
38075995|NCT03096847|69772391|FG001|Overall Study|Physician Decision|2|||
38075996|NCT03096847|69772392|FG002|Overall Study|Physician Decision|8|||
38075997|NCT03096847|69772390|FG000|Overall Study|Withdrawal by Subject|24|||
38075998|NCT03096847|69772391|FG001|Overall Study|Withdrawal by Subject|1|||
38075999|NCT03096847|69772392|FG002|Overall Study|Withdrawal by Subject|12|||
38076000|NCT03096847|69772390|FG000|Overall Study|Adverse Event|72|||
38076001|NCT03096847|69772391|FG001|Overall Study|Adverse Event|6|||
38076002|NCT03096847|69772392|FG002|Overall Study|Adverse Event|28|||
38076003|NCT03096847|69772390|FG000|Overall Study|Progressive disease|97|||
37966533|NCT00635999|69653412|FG000|Overall Study|Withdrawal by Subject|4|||
37966534|NCT00635999|69653413|FG001|Overall Study|Withdrawal by Subject|2|||
37966535|NCT00635999|69653414|FG002|Overall Study|Withdrawal by Subject|1|||
37966536|NCT00469209|69653425|FG000|Overall Study|Adverse Event|1|||
37966537|NCT00469209|69653426|FG001|Overall Study|Adverse Event|0|||
37966538|NCT00469209|69653427|FG002|Overall Study|Adverse Event|1|||
37966539|NCT00635219|69653440|FG000|Overall Study|Adverse Event|12|||
37966540|NCT00635219|69653441|FG001|Overall Study|Adverse Event|10|||
37966541|NCT00635219|69653442|FG002|Overall Study|Adverse Event|18|||
37966542|NCT00635219|69653443|FG003|Overall Study|Adverse Event|15|||
37966543|NCT00635219|69653444|FG004|Overall Study|Adverse Event|19|||
37966544|NCT00635219|69653440|FG000|Overall Study|Lack of Efficacy|5|||
37966545|NCT00635219|69653441|FG001|Overall Study|Lack of Efficacy|6|||
37966546|NCT00635219|69653442|FG002|Overall Study|Lack of Efficacy|3|||
37966547|NCT00635219|69653443|FG003|Overall Study|Lack of Efficacy|4|||
37966548|NCT00635219|69653444|FG004|Overall Study|Lack of Efficacy|6|||
37966549|NCT00635219|69653440|FG000|Overall Study|Non-compliance With Study Product|0|||
37966550|NCT00635219|69653441|FG001|Overall Study|Non-compliance With Study Product|0|||
38076004|NCT03096847|69772391|FG001|Overall Study|Progressive disease|10|||
38076005|NCT03096847|69772392|FG002|Overall Study|Progressive disease|78|||
38076006|NCT03096847|69772390|FG000|Overall Study|Non-compliance with study medication|1|||
37966551|NCT00635219|69653442|FG002|Overall Study|Non-compliance With Study Product|0|||
37966552|NCT00635219|69653443|FG003|Overall Study|Non-compliance With Study Product|2|||
37966553|NCT00635219|69653444|FG004|Overall Study|Non-compliance With Study Product|1|||
38076007|NCT03096847|69772391|FG001|Overall Study|Non-compliance with study medication|0|||
38076008|NCT03096847|69772392|FG002|Overall Study|Non-compliance with study medication|0|||
38076009|NCT03096847|69772390|FG000|Overall Study|New therapy for study indication|1|||
38076010|NCT03096847|69772391|FG001|Overall Study|New therapy for study indication|0|||
38076011|NCT03096847|69772392|FG002|Overall Study|New therapy for study indication|1|||
38076012|NCT01365182|69772411|FG000|Overall Study|Withdrawal by Subject|10|||
38076013|NCT01365182|69772412|FG001|Overall Study|Withdrawal by Subject|13|||
38076014|NCT01365182|69772413|FG002|Overall Study|Withdrawal by Subject|12|||
38076015|NCT03128099|69772431|FG000|Overall Study|High dose task was too long|0|||
38076016|NCT03128099|69772432|FG001|Overall Study|High dose task was too long|4|||
38076017|NCT03128099|69772433|FG002|Overall Study|High dose task was too long|0|||
38076018|NCT03128099|69772431|FG000|Overall Study|Participant got a full time job.|1|||
38076019|NCT03128099|69772432|FG001|Overall Study|Participant got a full time job.|0|||
38076020|NCT03128099|69772433|FG002|Overall Study|Participant got a full time job.|0|||
38076021|NCT03128099|69772431|FG000|Overall Study|Became homeless and lost contact|1|||
38076022|NCT03128099|69772432|FG001|Overall Study|Became homeless and lost contact|0|||
38076023|NCT03128099|69772433|FG002|Overall Study|Became homeless and lost contact|0|||
38076024|NCT03128099|69772431|FG000|Overall Study|Did not complete all the assessments|0|||
38076025|NCT03128099|69772432|FG001|Overall Study|Did not complete all the assessments|0|||
38076026|NCT03128099|69772433|FG002|Overall Study|Did not complete all the assessments|1|||
38076027|NCT02886494|69772441|FG000|Overall Study|Adverse Event|1|||
38076028|NCT02886494|69772442|FG001|Overall Study|Adverse Event|0|||
38076029|NCT02886494|69772441|FG000|Overall Study|Withdrawal by Subject|12|||
38076030|NCT02886494|69772442|FG001|Overall Study|Withdrawal by Subject|3|||
38076031|NCT02886494|69772441|FG000|Overall Study|Protocol Violation|4|||
38076032|NCT02886494|69772442|FG001|Overall Study|Protocol Violation|1|||
38076033|NCT02846532|69772454|FG000|Overall Study|Lost to Follow-up|0|||
38076034|NCT02846532|69772455|FG001|Overall Study|Lost to Follow-up|1|||
38076035|NCT02846532|69772456|FG002|Overall Study|Lost to Follow-up|1|||
38076036|NCT02846532|69772454|FG000|Overall Study|Withdrawal by Subject|1|||
38076037|NCT02846532|69772455|FG001|Overall Study|Withdrawal by Subject|2|||
38076038|NCT02846532|69772456|FG002|Overall Study|Withdrawal by Subject|0|||
38076039|NCT00842348|69772475|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
38076040|NCT00842348|69772476|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
38076041|NCT00842348|69772475|FG000|Study 729|Disease progression/death|19|||
38076042|NCT00842348|69772476|FG001|Study 729|Disease progression/death|30|||
38076043|NCT00842348|69772475|FG000|Study 729|Adverse Event|1|||
38076044|NCT00842348|69772476|FG001|Study 729|Adverse Event|1|||
38076045|NCT00842348|69772475|FG000|Study 729|Protocol Violation|1|||
38076046|NCT00842348|69772476|FG001|Study 729|Protocol Violation|1|||
38076047|NCT00842348|69772475|FG000|Study 729|Withdrawal by Subject|2|||
38076048|NCT00842348|69772476|FG001|Study 729|Withdrawal by Subject|4|||
38076049|NCT00842348|69772475|FG000|Study 729|Due to Sponsor stopping the study|1|||
38076050|NCT00842348|69772476|FG001|Study 729|Due to Sponsor stopping the study|1|||
38076051|NCT00842348|69772475|FG000|Study 729|Due to non-availability of IP|0|||
38076052|NCT00842348|69772476|FG001|Study 729|Due to non-availability of IP|1|||
38076053|NCT00842348|69772475|FG000|Study 729|Sponsor's decision|1|||
38076054|NCT00842348|69772476|FG001|Study 729|Sponsor's decision|0|||
38076055|NCT00842348|69772475|FG000|Study 729|Surgical resection|1|||
38076056|NCT00842348|69772476|FG001|Study 729|Surgical resection|0|||
38076057|NCT03095599|69772488|FG000|Overall Study|Withdrawal by Subject|1|||
38076058|NCT03095599|69772489|FG001|Overall Study|Withdrawal by Subject|0|||
38076059|NCT03095599|69772488|FG000|Overall Study|Lost to Follow-up|1|||
38076060|NCT03095599|69772489|FG001|Overall Study|Lost to Follow-up|0|||
38076061|NCT03095599|69772488|FG000|Overall Study|Withdrawal prior to vaccination|1|||
38076062|NCT03095599|69772489|FG001|Overall Study|Withdrawal prior to vaccination|0|||
38076063|NCT03095521|69772499|FG000|Overall Study|Withdrawal by Subject|0|||
38076064|NCT03095521|69772500|FG001|Overall Study|Withdrawal by Subject|1|||
38076065|NCT03095521|69772499|FG000|Overall Study|Lost to Follow-up|0|||
38076066|NCT03095521|69772500|FG001|Overall Study|Lost to Follow-up|1|||
38076067|NCT03033875|69772509|FG000|Overall Study|Withdrawal by Subject|5|||
38076068|NCT03033875|69772510|FG001|Overall Study|Withdrawal by Subject|9|||
38076069|NCT03033875|69772511|FG002|Overall Study|Withdrawal by Subject|4|||
38076070|NCT03033875|69772509|FG000|Overall Study|Other|14|||
38076071|NCT03033875|69772510|FG001|Overall Study|Other|15|||
38076072|NCT03033875|69772511|FG002|Overall Study|Other|8|||
38076073|NCT01968785|69772525|FG000|Overall Study|Withdrawal by Subject|1|||
38076074|NCT01968785|69772526|FG001|Overall Study|Withdrawal by Subject|0|||
38076075|NCT03095287|69772532|FG000|Overall Study|Treatment Failure|1|||
38076076|NCT03095287|69772532|FG000|Overall Study|Adverse Event|1|||
38076077|NCT02839746|69772550|FG000|Overall Study|Not met selection criteria|12|||
38076078|NCT00033293|69772556|FG000|Overall Study|Death|0|||
38076079|NCT00033293|69772557|FG001|Overall Study|Death|1|||
38076080|NCT00033293|69772556|FG000|Overall Study|Lack of Efficacy|5|||
38076081|NCT00033293|69772557|FG001|Overall Study|Lack of Efficacy|8|||
38076082|NCT00033293|69772556|FG000|Overall Study|Lost to Follow-up|0|||
38076083|NCT00033293|69772557|FG001|Overall Study|Lost to Follow-up|1|||
38076084|NCT00033293|69772556|FG000|Overall Study|Physician Decision|3|||
38076085|NCT00033293|69772557|FG001|Overall Study|Physician Decision|1|||
38076086|NCT00033293|69772556|FG000|Overall Study|Withdrawal by Subject|1|||
38076087|NCT00033293|69772557|FG001|Overall Study|Withdrawal by Subject|0|||
38076088|NCT00033293|69772556|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
38076089|NCT00033293|69772557|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
38076090|NCT00033293|69772556|FG000|Overall Study|Treatment refused|0|||
38076091|NCT00033293|69772557|FG001|Overall Study|Treatment refused|6|||
38076092|NCT02039674|69772579|FG000|Overall Study|Adverse Event|0|||
38076093|NCT02039674|69772580|FG001|Overall Study|Adverse Event|0|||
38076094|NCT02039674|69772581|FG002|Overall Study|Adverse Event|0|||
38076095|NCT02039674|69772582|FG003|Overall Study|Adverse Event|1|||
38076096|NCT02039674|69772583|FG004|Overall Study|Adverse Event|0|||
38076097|NCT02039674|69772584|FG005|Overall Study|Adverse Event|0|||
38076098|NCT02039674|69772585|FG006|Overall Study|Adverse Event|0|||
38076099|NCT02039674|69772586|FG007|Overall Study|Adverse Event|0|||
38076100|NCT02039674|69772587|FG008|Overall Study|Adverse Event|2|||
38076101|NCT02039674|69772588|FG009|Overall Study|Adverse Event|1|||
38076102|NCT02039674|69772589|FG010|Overall Study|Adverse Event|0|||
38076103|NCT02039674|69772590|FG011|Overall Study|Adverse Event|2|||
38076104|NCT02039674|69772591|FG012|Overall Study|Adverse Event|3|||
38076105|NCT02039674|69772592|FG013|Overall Study|Adverse Event|1|||
38076106|NCT02039674|69772579|FG000|Overall Study|Death|2|||
38076107|NCT02039674|69772580|FG001|Overall Study|Death|0|||
38076108|NCT02039674|69772581|FG002|Overall Study|Death|2|||
38076109|NCT02039674|69772582|FG003|Overall Study|Death|3|||
38076110|NCT02039674|69772583|FG004|Overall Study|Death|0|||
38076111|NCT02039674|69772584|FG005|Overall Study|Death|0|||
38076112|NCT02039674|69772585|FG006|Overall Study|Death|1|||
38076113|NCT02039674|69772586|FG007|Overall Study|Death|0|||
38076114|NCT02039674|69772587|FG008|Overall Study|Death|2|||
38076115|NCT02039674|69772588|FG009|Overall Study|Death|0|||
38076116|NCT02039674|69772589|FG010|Overall Study|Death|1|||
38076117|NCT02039674|69772590|FG011|Overall Study|Death|3|||
38076118|NCT02039674|69772591|FG012|Overall Study|Death|2|||
38076119|NCT02039674|69772592|FG013|Overall Study|Death|8|||
38076120|NCT02039674|69772579|FG000|Overall Study|Excluded Medication|1|||
38076121|NCT02039674|69772580|FG001|Overall Study|Excluded Medication|1|||
38076122|NCT02039674|69772581|FG002|Overall Study|Excluded Medication|0|||
38076123|NCT02039674|69772582|FG003|Overall Study|Excluded Medication|1|||
38076124|NCT02039674|69772583|FG004|Overall Study|Excluded Medication|0|||
38076125|NCT02039674|69772584|FG005|Overall Study|Excluded Medication|1|||
38076126|NCT02039674|69772585|FG006|Overall Study|Excluded Medication|0|||
38076127|NCT02039674|69772586|FG007|Overall Study|Excluded Medication|0|||
38076128|NCT02039674|69772587|FG008|Overall Study|Excluded Medication|2|||
38076129|NCT02039674|69772588|FG009|Overall Study|Excluded Medication|3|||
38076130|NCT02039674|69772589|FG010|Overall Study|Excluded Medication|5|||
38076131|NCT02039674|69772590|FG011|Overall Study|Excluded Medication|6|||
38076132|NCT02039674|69772591|FG012|Overall Study|Excluded Medication|8|||
38076133|NCT02039674|69772592|FG013|Overall Study|Excluded Medication|3|||
38076134|NCT02039674|69772579|FG000|Overall Study|Lost to Follow-up|0|||
38076135|NCT02039674|69772580|FG001|Overall Study|Lost to Follow-up|0|||
38076136|NCT02039674|69772581|FG002|Overall Study|Lost to Follow-up|0|||
38076137|NCT02039674|69772582|FG003|Overall Study|Lost to Follow-up|0|||
38076138|NCT02039674|69772583|FG004|Overall Study|Lost to Follow-up|1|||
38076139|NCT02039674|69772584|FG005|Overall Study|Lost to Follow-up|1|||
38076140|NCT02039674|69772585|FG006|Overall Study|Lost to Follow-up|0|||
38076141|NCT02039674|69772586|FG007|Overall Study|Lost to Follow-up|0|||
38076142|NCT02039674|69772587|FG008|Overall Study|Lost to Follow-up|0|||
37862350|NCT01129011|69546119|FG001|Overall Study|Adverse Event|30|||
37862351|NCT01129011|69546118|FG000|Overall Study|Withdrawal by Subject|24|||
37862352|NCT01129011|69546119|FG001|Overall Study|Withdrawal by Subject|8|||
38076143|NCT02039674|69772588|FG009|Overall Study|Lost to Follow-up|0|||
38076144|NCT02039674|69772589|FG010|Overall Study|Lost to Follow-up|0|||
38076145|NCT02039674|69772590|FG011|Overall Study|Lost to Follow-up|2|||
38076146|NCT02039674|69772591|FG012|Overall Study|Lost to Follow-up|2|||
38076147|NCT02039674|69772592|FG013|Overall Study|Lost to Follow-up|1|||
38076148|NCT02039674|69772579|FG000|Overall Study|Physician Decision|0|||
38076149|NCT02039674|69772580|FG001|Overall Study|Physician Decision|0|||
38076150|NCT02039674|69772581|FG002|Overall Study|Physician Decision|0|||
38076151|NCT02039674|69772582|FG003|Overall Study|Physician Decision|0|||
38076152|NCT02039674|69772583|FG004|Overall Study|Physician Decision|0|||
38076153|NCT02039674|69772584|FG005|Overall Study|Physician Decision|0|||
38076154|NCT02039674|69772585|FG006|Overall Study|Physician Decision|0|||
38076155|NCT02039674|69772586|FG007|Overall Study|Physician Decision|0|||
38076156|NCT02039674|69772587|FG008|Overall Study|Physician Decision|0|||
38076157|NCT02039674|69772588|FG009|Overall Study|Physician Decision|0|||
38076158|NCT02039674|69772589|FG010|Overall Study|Physician Decision|0|||
38076159|NCT02039674|69772590|FG011|Overall Study|Physician Decision|1|||
38076160|NCT02039674|69772591|FG012|Overall Study|Physician Decision|1|||
38076161|NCT02039674|69772592|FG013|Overall Study|Physician Decision|0|||
38076162|NCT02039674|69772579|FG000|Overall Study|Progressive Disease|8|||
38076163|NCT02039674|69772580|FG001|Overall Study|Progressive Disease|8|||
38076164|NCT02039674|69772581|FG002|Overall Study|Progressive Disease|6|||
38076165|NCT02039674|69772582|FG003|Overall Study|Progressive Disease|7|||
38076166|NCT02039674|69772583|FG004|Overall Study|Progressive Disease|9|||
38076167|NCT02039674|69772584|FG005|Overall Study|Progressive Disease|10|||
38076168|NCT02039674|69772585|FG006|Overall Study|Progressive Disease|1|||
38076169|NCT02039674|69772586|FG007|Overall Study|Progressive Disease|3|||
38076170|NCT02039674|69772587|FG008|Overall Study|Progressive Disease|6|||
38076171|NCT02039674|69772588|FG009|Overall Study|Progressive Disease|4|||
38076172|NCT02039674|69772589|FG010|Overall Study|Progressive Disease|0|||
38076173|NCT02039674|69772590|FG011|Overall Study|Progressive Disease|34|||
38076174|NCT02039674|69772591|FG012|Overall Study|Progressive Disease|34|||
38076175|NCT02039674|69772592|FG013|Overall Study|Progressive Disease|18|||
38076176|NCT02039674|69772579|FG000|Overall Study|Withdrawal by Subject|1|||
38076177|NCT02039674|69772580|FG001|Overall Study|Withdrawal by Subject|2|||
38076178|NCT02039674|69772581|FG002|Overall Study|Withdrawal by Subject|3|||
38076179|NCT02039674|69772582|FG003|Overall Study|Withdrawal by Subject|0|||
38076180|NCT02039674|69772583|FG004|Overall Study|Withdrawal by Subject|1|||
38076181|NCT02039674|69772584|FG005|Overall Study|Withdrawal by Subject|0|||
38076182|NCT02039674|69772585|FG006|Overall Study|Withdrawal by Subject|0|||
38076183|NCT02039674|69772586|FG007|Overall Study|Withdrawal by Subject|0|||
38076184|NCT02039674|69772587|FG008|Overall Study|Withdrawal by Subject|0|||
38076185|NCT02039674|69772588|FG009|Overall Study|Withdrawal by Subject|1|||
38076186|NCT02039674|69772589|FG010|Overall Study|Withdrawal by Subject|1|||
38076187|NCT02039674|69772590|FG011|Overall Study|Withdrawal by Subject|4|||
38076188|NCT02039674|69772591|FG012|Overall Study|Withdrawal by Subject|6|||
38076189|NCT02039674|69772592|FG013|Overall Study|Withdrawal by Subject|2|||
38076190|NCT02039674|69772579|FG000|Overall Study|Clinical Progression|0|||
38076191|NCT02039674|69772580|FG001|Overall Study|Clinical Progression|0|||
38076192|NCT02039674|69772581|FG002|Overall Study|Clinical Progression|0|||
38076193|NCT02039674|69772582|FG003|Overall Study|Clinical Progression|0|||
38076194|NCT02039674|69772583|FG004|Overall Study|Clinical Progression|0|||
38076195|NCT02039674|69772584|FG005|Overall Study|Clinical Progression|0|||
38076196|NCT02039674|69772585|FG006|Overall Study|Clinical Progression|1|||
38076197|NCT02039674|69772586|FG007|Overall Study|Clinical Progression|0|||
38076198|NCT02039674|69772587|FG008|Overall Study|Clinical Progression|0|||
38076199|NCT02039674|69772588|FG009|Overall Study|Clinical Progression|0|||
38076200|NCT02039674|69772589|FG010|Overall Study|Clinical Progression|0|||
38076201|NCT02039674|69772590|FG011|Overall Study|Clinical Progression|0|||
38076202|NCT02039674|69772591|FG012|Overall Study|Clinical Progression|1|||
38076203|NCT02039674|69772592|FG013|Overall Study|Clinical Progression|0|||
38076204|NCT02039674|69772579|FG000|Overall Study|Sponsor Decision|1|||
38076205|NCT02039674|69772580|FG001|Overall Study|Sponsor Decision|1|||
38076206|NCT02039674|69772581|FG002|Overall Study|Sponsor Decision|1|||
38076207|NCT02039674|69772582|FG003|Overall Study|Sponsor Decision|1|||
38076208|NCT02039674|69772583|FG004|Overall Study|Sponsor Decision|1|||
38076209|NCT02039674|69772584|FG005|Overall Study|Sponsor Decision|0|||
38076210|NCT02039674|69772585|FG006|Overall Study|Sponsor Decision|0|||
38076211|NCT02039674|69772586|FG007|Overall Study|Sponsor Decision|0|||
38076212|NCT02039674|69772587|FG008|Overall Study|Sponsor Decision|0|||
38076213|NCT02039674|69772588|FG009|Overall Study|Sponsor Decision|3|||
38076214|NCT02039674|69772589|FG010|Overall Study|Sponsor Decision|0|||
38076215|NCT02039674|69772590|FG011|Overall Study|Sponsor Decision|8|||
38076216|NCT02039674|69772591|FG012|Overall Study|Sponsor Decision|5|||
38076217|NCT02039674|69772592|FG013|Overall Study|Sponsor Decision|0|||
38076218|NCT02039674|69772579|FG000|Overall Study|Other|0|||
38076219|NCT02039674|69772580|FG001|Overall Study|Other|0|||
38076220|NCT02039674|69772581|FG002|Overall Study|Other|0|||
38076221|NCT02039674|69772582|FG003|Overall Study|Other|0|||
38076222|NCT02039674|69772583|FG004|Overall Study|Other|0|||
38076223|NCT02039674|69772584|FG005|Overall Study|Other|0|||
38076224|NCT02039674|69772585|FG006|Overall Study|Other|0|||
38076225|NCT02039674|69772586|FG007|Overall Study|Other|0|||
38076226|NCT02039674|69772587|FG008|Overall Study|Other|0|||
37862353|NCT01129011|69546118|FG000|Overall Study|Lost to Follow-up|6|||
38076227|NCT02039674|69772588|FG009|Overall Study|Other|0|||
38076228|NCT02039674|69772589|FG010|Overall Study|Other|0|||
38076229|NCT02039674|69772590|FG011|Overall Study|Other|0|||
38076230|NCT02039674|69772591|FG012|Overall Study|Other|1|||
38076231|NCT02039674|69772592|FG013|Overall Study|Other|0|||
38076232|NCT03126227|69772632|FG000|Overall Study|Adverse Event|43|||
38076233|NCT03126227|69772633|FG001|Overall Study|Adverse Event|4|||
38076234|NCT03126227|69772632|FG000|Overall Study|Death|0|||
38076235|NCT03126227|69772633|FG001|Overall Study|Death|1|||
38076236|NCT03126227|69772632|FG000|Overall Study|Lost to Follow-up|0|||
38076237|NCT03126227|69772633|FG001|Overall Study|Lost to Follow-up|1|||
38076238|NCT03126227|69772632|FG000|Overall Study|Physician Decision|2|||
38076239|NCT03126227|69772633|FG001|Overall Study|Physician Decision|0|||
37862354|NCT01129011|69546119|FG001|Overall Study|Lost to Follow-up|7|||
38076240|NCT03126227|69772632|FG000|Overall Study|Protocol Violation|1|||
38076241|NCT03126227|69772633|FG001|Overall Study|Protocol Violation|0|||
38076242|NCT03126227|69772632|FG000|Overall Study|Withdrawal by Subject|19|||
38076243|NCT03126227|69772633|FG001|Overall Study|Withdrawal by Subject|3|||
38076244|NCT03126227|69772632|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
38076245|NCT03126227|69772633|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
38076246|NCT03126227|69772632|FG000|Overall Study|Lack of dosing compliance|2|||
38076247|NCT03126227|69772633|FG001|Overall Study|Lack of dosing compliance|0|||
38076248|NCT03126227|69772632|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
38076249|NCT03126227|69772633|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
38076250|NCT03126227|69772632|FG000|Overall Study|Scheduling conflict|1|||
38076251|NCT03126227|69772633|FG001|Overall Study|Scheduling conflict|0|||
38076252|NCT03099187|69772641|FG000|Double-blind Treatment|Adverse Event|19|||
38076253|NCT03099187|69772642|FG001|Double-blind Treatment|Adverse Event|1|||
38076254|NCT03099187|69772643|FG002|Double-blind Treatment|Adverse Event|0|||
38076255|NCT03099187|69772644|FG003|Double-blind Treatment|Adverse Event|0|||
38076256|NCT03099187|69772641|FG000|Double-blind Treatment|Death|1|||
38076257|NCT03099187|69772642|FG001|Double-blind Treatment|Death|3|||
38076258|NCT03099187|69772643|FG002|Double-blind Treatment|Death|0|||
38076259|NCT03099187|69772644|FG003|Double-blind Treatment|Death|0|||
38076260|NCT03099187|69772641|FG000|Double-blind Treatment|Lack of Efficacy|1|||
38076261|NCT03099187|69772642|FG001|Double-blind Treatment|Lack of Efficacy|0|||
38076262|NCT03099187|69772643|FG002|Double-blind Treatment|Lack of Efficacy|0|||
38076263|NCT03099187|69772644|FG003|Double-blind Treatment|Lack of Efficacy|0|||
38076264|NCT03099187|69772641|FG000|Double-blind Treatment|Physician Decision|2|||
38076265|NCT03099187|69772642|FG001|Double-blind Treatment|Physician Decision|1|||
38076266|NCT03099187|69772643|FG002|Double-blind Treatment|Physician Decision|0|||
38076267|NCT03099187|69772644|FG003|Double-blind Treatment|Physician Decision|0|||
38076268|NCT03099187|69772641|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
38076269|NCT03099187|69772642|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
38076270|NCT03099187|69772643|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
38076271|NCT03099187|69772644|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
38076272|NCT03099187|69772641|FG000|Double-blind Treatment|Lung transplantation|0|||
38076273|NCT03099187|69772642|FG001|Double-blind Treatment|Lung transplantation|1|||
38076274|NCT03099187|69772643|FG002|Double-blind Treatment|Lung transplantation|0|||
38076275|NCT03099187|69772644|FG003|Double-blind Treatment|Lung transplantation|0|||
38076276|NCT03099187|69772641|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
38076277|NCT03099187|69772642|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
38076278|NCT03099187|69772643|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
38076279|NCT03099187|69772644|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
38076280|NCT03099187|69772641|FG000|Double-blind Treatment|Disease progression|0|||
38076281|NCT03099187|69772642|FG001|Double-blind Treatment|Disease progression|1|||
38076282|NCT03099187|69772643|FG002|Double-blind Treatment|Disease progression|0|||
38076283|NCT03099187|69772644|FG003|Double-blind Treatment|Disease progression|0|||
38076284|NCT03099187|69772641|FG000|Double-blind Treatment|Randomization error|0|||
38076285|NCT03099187|69772642|FG001|Double-blind Treatment|Randomization error|2|||
38076286|NCT03099187|69772643|FG002|Double-blind Treatment|Randomization error|0|||
38076287|NCT03099187|69772644|FG003|Double-blind Treatment|Randomization error|0|||
38076288|NCT03099187|69772641|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
38076289|NCT03099187|69772642|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
38076290|NCT03099187|69772643|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
38076291|NCT03099187|69772644|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
38076292|NCT03099187|69772641|FG000|12-month Safety Follow-up|Adverse Event|0|||
38076293|NCT03099187|69772642|FG001|12-month Safety Follow-up|Adverse Event|0|||
38076294|NCT03099187|69772643|FG002|12-month Safety Follow-up|Adverse Event|5|||
38076295|NCT03099187|69772644|FG003|12-month Safety Follow-up|Adverse Event|12|||
38076296|NCT03099187|69772641|FG000|12-month Safety Follow-up|Death|0|||
38076297|NCT03099187|69772642|FG001|12-month Safety Follow-up|Death|0|||
38076298|NCT03099187|69772643|FG002|12-month Safety Follow-up|Death|7|||
38076299|NCT03099187|69772644|FG003|12-month Safety Follow-up|Death|9|||
38076300|NCT03099187|69772641|FG000|12-month Safety Follow-up|Lung transplantation|0|||
38076301|NCT03099187|69772642|FG001|12-month Safety Follow-up|Lung transplantation|0|||
38076302|NCT03099187|69772643|FG002|12-month Safety Follow-up|Lung transplantation|2|||
38076303|NCT03099187|69772644|FG003|12-month Safety Follow-up|Lung transplantation|1|||
38076304|NCT03099187|69772641|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
38076305|NCT03099187|69772642|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
38076306|NCT03099187|69772643|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
38076307|NCT03099187|69772644|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
38076308|NCT03099187|69772641|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
37862355|NCT01129011|69546118|FG000|Overall Study|Duodenal Ulcer|2|||
37680408|NCT02579863|69156058|FG000|Overall Study|Death|31|||
38076309|NCT03099187|69772642|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
38076310|NCT03099187|69772643|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
38076311|NCT03099187|69772644|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
38076312|NCT03099187|69772641|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
38076313|NCT03099187|69772642|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
38076314|NCT03099187|69772643|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
38076315|NCT03099187|69772644|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
38076316|NCT03099187|69772641|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
38076317|NCT03099187|69772642|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
38076318|NCT03099187|69772643|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
38076319|NCT03099187|69772644|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
38076320|NCT04535453|69772666|FG000|Overall Study|Death|0|||
38076321|NCT04535453|69772667|FG001|Overall Study|Death|1|||
38076322|NCT04535453|69772668|FG002|Overall Study|Death|0|||
38076323|NCT04535453|69772669|FG003|Overall Study|Death|0|||
38076324|NCT04535453|69772670|FG004|Overall Study|Death|0|||
38076325|NCT04535453|69772671|FG005|Overall Study|Death|0|||
38076326|NCT04535453|69772672|FG006|Overall Study|Death|0|||
38076327|NCT04535453|69772673|FG007|Overall Study|Death|0|||
38076328|NCT04535453|69772674|FG008|Overall Study|Death|0|||
38076329|NCT04535453|69772675|FG009|Overall Study|Death|0|||
38076330|NCT04535453|69772676|FG010|Overall Study|Death|0|||
38076331|NCT04535453|69772677|FG011|Overall Study|Death|0|||
38076332|NCT04535453|69772666|FG000|Overall Study|Lost to Follow-up|1|||
38076333|NCT04535453|69772667|FG001|Overall Study|Lost to Follow-up|1|||
38076334|NCT04535453|69772668|FG002|Overall Study|Lost to Follow-up|1|||
38076335|NCT04535453|69772669|FG003|Overall Study|Lost to Follow-up|0|||
38076336|NCT04535453|69772670|FG004|Overall Study|Lost to Follow-up|3|||
38076337|NCT04535453|69772671|FG005|Overall Study|Lost to Follow-up|1|||
38076338|NCT04535453|69772672|FG006|Overall Study|Lost to Follow-up|0|||
38076339|NCT04535453|69772673|FG007|Overall Study|Lost to Follow-up|0|||
38076340|NCT04535453|69772674|FG008|Overall Study|Lost to Follow-up|1|||
38076341|NCT04535453|69772675|FG009|Overall Study|Lost to Follow-up|1|||
38076342|NCT04535453|69772676|FG010|Overall Study|Lost to Follow-up|0|||
38076343|NCT04535453|69772677|FG011|Overall Study|Lost to Follow-up|0|||
38076344|NCT04535453|69772666|FG000|Overall Study|Physician Decision|0|||
38076345|NCT04535453|69772667|FG001|Overall Study|Physician Decision|0|||
38076346|NCT04535453|69772668|FG002|Overall Study|Physician Decision|0|||
38076347|NCT04535453|69772669|FG003|Overall Study|Physician Decision|1|||
38076348|NCT04535453|69772670|FG004|Overall Study|Physician Decision|0|||
38076349|NCT04535453|69772671|FG005|Overall Study|Physician Decision|0|||
38076350|NCT04535453|69772672|FG006|Overall Study|Physician Decision|0|||
38076351|NCT04535453|69772673|FG007|Overall Study|Physician Decision|0|||
38076352|NCT04535453|69772674|FG008|Overall Study|Physician Decision|0|||
38076353|NCT04535453|69772675|FG009|Overall Study|Physician Decision|0|||
38076354|NCT04535453|69772676|FG010|Overall Study|Physician Decision|0|||
38076355|NCT04535453|69772677|FG011|Overall Study|Physician Decision|0|||
38076356|NCT04535453|69772666|FG000|Overall Study|Withdrawal by Subject|3|||
38076357|NCT04535453|69772667|FG001|Overall Study|Withdrawal by Subject|6|||
38076358|NCT04535453|69772668|FG002|Overall Study|Withdrawal by Subject|3|||
38076359|NCT04535453|69772669|FG003|Overall Study|Withdrawal by Subject|3|||
38076360|NCT04535453|69772670|FG004|Overall Study|Withdrawal by Subject|2|||
38076361|NCT04535453|69772671|FG005|Overall Study|Withdrawal by Subject|1|||
38076362|NCT04535453|69772672|FG006|Overall Study|Withdrawal by Subject|1|||
38076363|NCT04535453|69772673|FG007|Overall Study|Withdrawal by Subject|1|||
38076364|NCT04535453|69772674|FG008|Overall Study|Withdrawal by Subject|1|||
38076365|NCT04535453|69772675|FG009|Overall Study|Withdrawal by Subject|1|||
38076366|NCT04535453|69772676|FG010|Overall Study|Withdrawal by Subject|0|||
38076367|NCT04535453|69772677|FG011|Overall Study|Withdrawal by Subject|1|||
38076368|NCT04535453|69772666|FG000|Overall Study|Other|0|||
38076369|NCT04535453|69772667|FG001|Overall Study|Other|0|||
38076370|NCT04535453|69772668|FG002|Overall Study|Other|1|||
38076371|NCT04535453|69772669|FG003|Overall Study|Other|0|||
38076372|NCT04535453|69772670|FG004|Overall Study|Other|1|||
38076373|NCT04535453|69772671|FG005|Overall Study|Other|0|||
38076374|NCT04535453|69772672|FG006|Overall Study|Other|1|||
38076375|NCT04535453|69772673|FG007|Overall Study|Other|1|||
38076376|NCT04535453|69772674|FG008|Overall Study|Other|1|||
38076377|NCT04535453|69772675|FG009|Overall Study|Other|0|||
38076378|NCT04535453|69772676|FG010|Overall Study|Other|0|||
38076379|NCT04535453|69772677|FG011|Overall Study|Other|0|||
38076380|NCT04463069|69772720|FG000|Overall Study|Withdrawal by Subject|2|||
38076381|NCT04463069|69772721|FG001|Overall Study|Withdrawal by Subject|10|||
38076382|NCT04463069|69772720|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
38076383|NCT04463069|69772721|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
38076384|NCT03521687|69772727|FG000|Overall Study|Adverse Event|4|||
38076385|NCT03521687|69772727|FG000|Overall Study|Physician Decision|1|||
38076386|NCT03125915|69772735|FG000|1 Month Follow up|Lost to Follow-up|3|||
38076387|NCT03125915|69772736|FG001|1 Month Follow up|Lost to Follow-up|3|||
38076388|NCT03125915|69772737|FG002|1 Month Follow up|Lost to Follow-up|2|||
38076389|NCT03125915|69772738|FG003|1 Month Follow up|Lost to Follow-up|3|||
38076390|NCT03125915|69772735|FG000|3 Month Follow-up|Lost to Follow-up|6|||
38076391|NCT03125915|69772736|FG001|3 Month Follow-up|Lost to Follow-up|4|||
38076392|NCT03125915|69772737|FG002|3 Month Follow-up|Lost to Follow-up|4|||
38076393|NCT03125915|69772738|FG003|3 Month Follow-up|Lost to Follow-up|2|||
38076394|NCT03125915|69772735|FG000|6 Month Follow-up|Lost to Follow-up|7|||
38076395|NCT03125915|69772736|FG001|6 Month Follow-up|Lost to Follow-up|3|||
38076396|NCT03125915|69772737|FG002|6 Month Follow-up|Lost to Follow-up|6|||
38076397|NCT03125915|69772738|FG003|6 Month Follow-up|Lost to Follow-up|3|||
38076398|NCT03122171|69772748|FG000|Overall Study|Withdrawal by Subject|1|||
38076399|NCT01427725|69772752|FG000|Overall Study|Lost to Follow-up|17|||
38076400|NCT01427725|69772752|FG000|Overall Study|Protocol Violation|1|||
38076401|NCT01427725|69772752|FG000|Overall Study|Drug not administered|1|||
38076402|NCT01427725|69772752|FG000|Overall Study|Failure to visit|7|||
38076403|NCT01427725|69772752|FG000|Overall Study|Adverse Event|46|||
38076404|NCT01427725|69772752|FG000|Overall Study|Failure to visit after administration|40|||
38076405|NCT01427725|69772752|FG000|Overall Study|Patient's rejection|27|||
38076406|NCT01427725|69772752|FG000|Overall Study|Transfer to a different hospital|17|||
38076407|NCT01427725|69772752|FG000|Overall Study|Lack of Efficacy|8|||
38076408|NCT01427725|69772752|FG000|Overall Study|Death|7|||
38076409|NCT01427725|69772752|FG000|Overall Study|Symptom improvement|6|||
38076410|NCT01427725|69772752|FG000|Overall Study|AE and Patient's rejection|5|||
38076411|NCT01427725|69772752|FG000|Overall Study|Physician Decision|5|||
38076412|NCT01427725|69772752|FG000|Overall Study|Exacerbation of underlying disease|5|||
38076413|NCT01427725|69772752|FG000|Overall Study|Oral feeding difficulty|5|||
38076414|NCT01427725|69772752|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
38076415|NCT01427725|69772752|FG000|Overall Study|Forgetting prescription|1|||
38076416|NCT01427725|69772752|FG000|Overall Study|Other|2|||
38076417|NCT02839200|69772763|FG000|Overall Study|Withdrawal by Subject|2|||
38076418|NCT02839200|69772764|FG001|Overall Study|Withdrawal by Subject|0|||
38076419|NCT02839200|69772765|FG002|Overall Study|Withdrawal by Subject|1|||
38076420|NCT02839200|69772766|FG003|Overall Study|Withdrawal by Subject|0|||
38076421|NCT02839200|69772767|FG004|Overall Study|Withdrawal by Subject|0|||
38076422|NCT02839200|69772768|FG005|Overall Study|Withdrawal by Subject|1|||
38076423|NCT02839200|69772763|FG000|Overall Study|Lost to Follow-up|2|||
38076424|NCT02839200|69772764|FG001|Overall Study|Lost to Follow-up|0|||
38076425|NCT02839200|69772765|FG002|Overall Study|Lost to Follow-up|0|||
38076426|NCT02839200|69772766|FG003|Overall Study|Lost to Follow-up|0|||
38076427|NCT02839200|69772767|FG004|Overall Study|Lost to Follow-up|1|||
38076428|NCT02839200|69772768|FG005|Overall Study|Lost to Follow-up|0|||
38076429|NCT02839200|69772763|FG000|Overall Study|Adverse Event|0|||
38076430|NCT02839200|69772764|FG001|Overall Study|Adverse Event|0|||
38076431|NCT02839200|69772765|FG002|Overall Study|Adverse Event|0|||
38076432|NCT02839200|69772766|FG003|Overall Study|Adverse Event|0|||
38076433|NCT02839200|69772767|FG004|Overall Study|Adverse Event|1|||
38076434|NCT02839200|69772768|FG005|Overall Study|Adverse Event|0|||
38076435|NCT02839200|69772763|FG000|Overall Study|Randomized in error|0|||
38076436|NCT02839200|69772764|FG001|Overall Study|Randomized in error|1|||
38076437|NCT02839200|69772765|FG002|Overall Study|Randomized in error|0|||
38076438|NCT02839200|69772766|FG003|Overall Study|Randomized in error|0|||
38076439|NCT02839200|69772767|FG004|Overall Study|Randomized in error|0|||
38076440|NCT02839200|69772768|FG005|Overall Study|Randomized in error|0|||
38076441|NCT03118739|69772784|FG000|Overall Study|Physician Decision|0|||
38076442|NCT03118739|69772785|FG001|Overall Study|Physician Decision|1|||
38076443|NCT03118739|69772784|FG000|Overall Study|Withdrawal by Subject|5|||
38076444|NCT03118739|69772785|FG001|Overall Study|Withdrawal by Subject|3|||
38076445|NCT03118739|69772784|FG000|Overall Study|Lost to Follow-up|2|||
38076446|NCT03118739|69772785|FG001|Overall Study|Lost to Follow-up|0|||
38076447|NCT03094195|69772794|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
38076448|NCT03094195|69772795|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
38076449|NCT03094195|69772796|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
38076450|NCT03094195|69772797|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
38076451|NCT03094195|69772798|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
38076452|NCT03094195|69772799|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
38076453|NCT03094195|69772800|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
38076454|NCT03094195|69772801|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
38076455|NCT03094195|69772794|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
38076456|NCT03094195|69772795|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
38076457|NCT03094195|69772796|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
38076458|NCT03094195|69772797|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
38076459|NCT03094195|69772798|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
38076460|NCT03094195|69772799|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
38076461|NCT03094195|69772800|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
38076462|NCT03094195|69772801|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
38076463|NCT03094195|69772794|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
38076464|NCT03094195|69772795|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
38076465|NCT03094195|69772796|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
38076466|NCT03094195|69772797|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
38076467|NCT03094195|69772798|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
38076468|NCT03094195|69772799|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
38076469|NCT03094195|69772800|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
38076470|NCT03094195|69772801|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
38076471|NCT03094195|69772794|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
38076472|NCT03094195|69772795|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
38076473|NCT03094195|69772796|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
38076474|NCT03094195|69772797|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
38076475|NCT03094195|69772798|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
38076476|NCT03094195|69772799|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
38076477|NCT03094195|69772800|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
38076478|NCT03094195|69772801|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
38076479|NCT02835690|69772822|FG000|Overall Study|Death|12|||
38076480|NCT02835690|69772823|FG001|Overall Study|Death|11|||
38076481|NCT02835690|69772824|FG002|Overall Study|Death|13|||
38076482|NCT02835690|69772822|FG000|Overall Study|Transferred to Extension Study|2|||
38076483|NCT02835690|69772823|FG001|Overall Study|Transferred to Extension Study|2|||
38076484|NCT02835690|69772824|FG002|Overall Study|Transferred to Extension Study|1|||
38076485|NCT02835690|69772822|FG000|Overall Study|Did Not Continue on Extension Study|0|||
38076486|NCT02835690|69772823|FG001|Overall Study|Did Not Continue on Extension Study|0|||
38076487|NCT02835690|69772824|FG002|Overall Study|Did Not Continue on Extension Study|1|||
38076488|NCT02835690|69772822|FG000|Overall Study|Not Treated|0|||
38076489|NCT02835690|69772823|FG001|Overall Study|Not Treated|2|||
38076490|NCT02835690|69772824|FG002|Overall Study|Not Treated|0|||
38076491|NCT02837952|69772835|FG000|Overall Study|Adverse Event|0|||
38076492|NCT02837952|69772836|FG001|Overall Study|Adverse Event|1|||
38076493|NCT02837952|69772835|FG000|Overall Study|Withdrawal by Subject|4|||
38076494|NCT02837952|69772836|FG001|Overall Study|Withdrawal by Subject|5|||
38076495|NCT02837952|69772835|FG000|Overall Study|Medication Error|1|||
38076496|NCT02837952|69772836|FG001|Overall Study|Medication Error|0|||
38076497|NCT02832167|69772842|FG000|Treatment Period 1|Disease progression|90|||
38076498|NCT02832167|69772842|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
38076499|NCT02832167|69772842|FG000|Treatment Period 1|Death|2|||
38076500|NCT02832167|69772842|FG000|Treatment Period 1|Study Drug Toxicity|6|||
38076501|NCT02832167|69772842|FG000|Treatment Period 1|Participant request to discontinue|9|||
38076502|NCT02832167|69772842|FG000|Treatment Period 1|No longer meet study criteria|1|||
38076503|NCT02832167|69772842|FG000|Treatment Period 1|Participant withdrew consent|3|||
38076504|NCT02832167|69772842|FG000|Treatment Period 1|Other reasons|6|||
38076505|NCT02832167|69772842|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
38076506|NCT02832167|69772842|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
38076507|NCT02832167|69772842|FG000|Transition From Period 1 to Period 2|Death|2|||
38076508|NCT02832167|69772842|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
38076509|NCT02832167|69772842|FG000|Treatment Period 2|Disease progression|69|||
38076510|NCT02832167|69772842|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
38076511|NCT02832167|69772842|FG000|Treatment Period 2|Maximum clinical benefit|1|||
38076512|NCT02832167|69772842|FG000|Treatment Period 2|Study Drug Toxicity|5|||
38076513|NCT02832167|69772842|FG000|Treatment Period 2|Participant request to discontinue|2|||
38076514|NCT02832167|69772842|FG000|Treatment Period 2|Participant withdrew consent|3|||
38076515|NCT02832167|69772842|FG000|Treatment Period 2|Other reasons|3|||
38076516|NCT02674529|69772848|FG000|Overall Study|Lost to Follow-up|1|||
38076517|NCT02674529|69772849|FG001|Overall Study|Lost to Follow-up|2|||
38076518|NCT02674529|69772848|FG000|Overall Study|Withdrawal by Subject|2|||
38076519|NCT02674529|69772849|FG001|Overall Study|Withdrawal by Subject|1|||
38076520|NCT02674529|69772848|FG000|Overall Study|Physician Decision|0|||
38076521|NCT02674529|69772849|FG001|Overall Study|Physician Decision|1|||
38076522|NCT02674529|69772848|FG000|Overall Study|Protocol Violation|0|||
38076523|NCT02674529|69772849|FG001|Overall Study|Protocol Violation|1|||
38076524|NCT02626949|69772860|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
38076525|NCT02626949|69772861|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
38076526|NCT02626949|69772860|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
38076527|NCT02626949|69772861|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
38076528|NCT02626949|69772860|FG000|Enrolled|Lost to Follow-up|7|||
38076529|NCT02626949|69772861|FG001|Enrolled|Lost to Follow-up|6|||
38076530|NCT02626949|69772860|FG000|Enrolled|Withdrawal by Subject|3|||
38076531|NCT02626949|69772861|FG001|Enrolled|Withdrawal by Subject|2|||
38076532|NCT03116399|69772869|FG000|Overall Study|Death|8|||
38076533|NCT03116399|69772870|FG001|Overall Study|Death|3|||
38076534|NCT03116399|69772869|FG000|Overall Study|Lost to Follow-up|7|||
38076535|NCT03116399|69772870|FG001|Overall Study|Lost to Follow-up|11|||
38076536|NCT03116399|69772869|FG000|Overall Study|Investigator Decision|1|||
38076537|NCT03116399|69772870|FG001|Overall Study|Investigator Decision|1|||
38076538|NCT03116399|69772869|FG000|Overall Study|Withdrawal by Subject|24|||
38076539|NCT03116399|69772870|FG001|Overall Study|Withdrawal by Subject|9|||
38076540|NCT03097861|69772879|FG000|Overall Study|Adverse Event|3|||
38076541|NCT03097861|69772880|FG001|Overall Study|Adverse Event|8|||
38076542|NCT03097861|69772881|FG002|Overall Study|Adverse Event|4|||
38076543|NCT03097861|69772879|FG000|Overall Study|Investigator Decision|0|||
38076544|NCT03097861|69772880|FG001|Overall Study|Investigator Decision|1|||
38076545|NCT03097861|69772881|FG002|Overall Study|Investigator Decision|0|||
38076546|NCT03097861|69772879|FG000|Overall Study|Lost to Follow-up|0|||
38076547|NCT03097861|69772880|FG001|Overall Study|Lost to Follow-up|7|||
38076548|NCT03097861|69772881|FG002|Overall Study|Lost to Follow-up|1|||
38076549|NCT03097861|69772879|FG000|Overall Study|Withdrawal by Subject|1|||
38076550|NCT03097861|69772880|FG001|Overall Study|Withdrawal by Subject|5|||
38076551|NCT03097861|69772881|FG002|Overall Study|Withdrawal by Subject|3|||
38076552|NCT03097861|69772879|FG000|Overall Study|Reason not provided|3|||
38076553|NCT03097861|69772880|FG001|Overall Study|Reason not provided|1|||
38076554|NCT03097861|69772881|FG002|Overall Study|Reason not provided|1|||
38076555|NCT01816139|69772897|FG000|Overall Study|Adverse Event|6|||
38076556|NCT01816139|69772898|FG001|Overall Study|Adverse Event|8|||
38076557|NCT01816139|69772897|FG000|Overall Study|Lack of Efficacy|1|||
38076558|NCT01816139|69772898|FG001|Overall Study|Lack of Efficacy|2|||
38076559|NCT01816139|69772897|FG000|Overall Study|Lost to Follow-up|5|||
38076560|NCT01816139|69772898|FG001|Overall Study|Lost to Follow-up|3|||
38076561|NCT01816139|69772897|FG000|Overall Study|Withdrew Consent|6|||
38076562|NCT01816139|69772898|FG001|Overall Study|Withdrew Consent|4|||
38076563|NCT01816139|69772897|FG000|Overall Study|Protocol Violation|6|||
38076564|NCT01816139|69772898|FG001|Overall Study|Protocol Violation|3|||
38076565|NCT01816139|69772897|FG000|Overall Study|Reason not Specified|4|||
38076566|NCT01816139|69772898|FG001|Overall Study|Reason not Specified|2|||
38076567|NCT02833350|69772941|FG000|Overall Study|Adverse Event|0|||
38076568|NCT02833350|69772942|FG001|Overall Study|Adverse Event|3|||
38076569|NCT02833350|69772943|FG002|Overall Study|Adverse Event|4|||
38076570|NCT02833350|69772944|FG003|Overall Study|Adverse Event|4|||
38076571|NCT02833350|69772945|FG004|Overall Study|Adverse Event|1|||
38076572|NCT02833350|69772946|FG005|Overall Study|Adverse Event|0|||
38076573|NCT02833350|69772947|FG006|Overall Study|Adverse Event|1|||
38076574|NCT02833350|69772941|FG000|Overall Study|Death|0|||
38076575|NCT02833350|69772942|FG001|Overall Study|Death|0|||
38076576|NCT02833350|69772943|FG002|Overall Study|Death|1|||
38076577|NCT02833350|69772944|FG003|Overall Study|Death|0|||
38076578|NCT02833350|69772945|FG004|Overall Study|Death|0|||
38076579|NCT02833350|69772946|FG005|Overall Study|Death|0|||
38076580|NCT02833350|69772947|FG006|Overall Study|Death|0|||
38076581|NCT02833350|69772941|FG000|Overall Study|Lack of Efficacy|0|||
38076582|NCT02833350|69772942|FG001|Overall Study|Lack of Efficacy|2|||
38076583|NCT02833350|69772943|FG002|Overall Study|Lack of Efficacy|1|||
38076584|NCT02833350|69772944|FG003|Overall Study|Lack of Efficacy|4|||
38076585|NCT02833350|69772945|FG004|Overall Study|Lack of Efficacy|0|||
38076586|NCT02833350|69772946|FG005|Overall Study|Lack of Efficacy|1|||
38076587|NCT02833350|69772947|FG006|Overall Study|Lack of Efficacy|1|||
38076588|NCT02833350|69772941|FG000|Overall Study|Lost to Follow-up|0|||
38076589|NCT02833350|69772942|FG001|Overall Study|Lost to Follow-up|1|||
38076590|NCT02833350|69772943|FG002|Overall Study|Lost to Follow-up|0|||
38076591|NCT02833350|69772944|FG003|Overall Study|Lost to Follow-up|0|||
38076592|NCT02833350|69772945|FG004|Overall Study|Lost to Follow-up|0|||
38076593|NCT02833350|69772946|FG005|Overall Study|Lost to Follow-up|0|||
38076594|NCT02833350|69772947|FG006|Overall Study|Lost to Follow-up|1|||
38076595|NCT02833350|69772941|FG000|Overall Study|Withdrawal by Subject|3|||
38076596|NCT02833350|69772942|FG001|Overall Study|Withdrawal by Subject|3|||
38076597|NCT02833350|69772943|FG002|Overall Study|Withdrawal by Subject|2|||
38076598|NCT02833350|69772944|FG003|Overall Study|Withdrawal by Subject|0|||
38076599|NCT02833350|69772945|FG004|Overall Study|Withdrawal by Subject|2|||
38076600|NCT02833350|69772946|FG005|Overall Study|Withdrawal by Subject|0|||
38076601|NCT02833350|69772947|FG006|Overall Study|Withdrawal by Subject|2|||
38076602|NCT01343043|69772970|FG000|Overall Study|Disease progression before treatment|1|||
38076603|NCT01343043|69772971|FG001|Overall Study|Disease progression before treatment|0|||
38076604|NCT01343043|69772972|FG002|Overall Study|Disease progression before treatment|0|||
38076605|NCT01343043|69772973|FG003|Overall Study|Disease progression before treatment|0|||
38076606|NCT01343043|69772970|FG000|Overall Study|Withdrawal by Subject|1|||
38076607|NCT01343043|69772971|FG001|Overall Study|Withdrawal by Subject|0|||
38076608|NCT01343043|69772972|FG002|Overall Study|Withdrawal by Subject|0|||
38076609|NCT01343043|69772973|FG003|Overall Study|Withdrawal by Subject|0|||
38076610|NCT01343043|69772970|FG000|Overall Study|Death|1|||
38076611|NCT01343043|69772971|FG001|Overall Study|Death|1|||
38076612|NCT01343043|69772972|FG002|Overall Study|Death|0|||
38076613|NCT01343043|69772973|FG003|Overall Study|Death|1|||
38076614|NCT03548987|69772988|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
38076615|NCT03548987|69772989|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
38076616|NCT03548987|69772988|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
38076617|NCT03548987|69772989|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
38076618|NCT03548987|69772988|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
38076619|NCT03548987|69772989|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
38076620|NCT03548987|69772988|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
38076621|NCT03548987|69772989|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
38076622|NCT03548987|69772988|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
38076623|NCT03548987|69772989|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
38076624|NCT03548987|69772988|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
38076625|NCT03548987|69772989|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
38076626|NCT03548987|69772988|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
38076627|NCT03548987|69772989|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
38076628|NCT03548987|69772988|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
38076629|NCT03548987|69772989|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
38076630|NCT03548987|69772988|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
38076631|NCT03548987|69772989|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
38076632|NCT03548987|69772988|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
38076633|NCT03548987|69772989|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
38076634|NCT03548987|69772988|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
38076635|NCT03548987|69772989|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
38076636|NCT03548987|69772988|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
38076637|NCT03548987|69772989|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
38076638|NCT03548987|69772988|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
38076639|NCT03548987|69772989|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
38076640|NCT03548987|69772988|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
38076641|NCT03548987|69772989|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
38076642|NCT01358760|69772999|FG000|Overall Study|Adverse Event|3|||
38076643|NCT01358760|69773000|FG001|Overall Study|Adverse Event|4|||
38076644|NCT01358760|69773001|FG002|Overall Study|Adverse Event|3|||
38076645|NCT01358760|69772999|FG000|Overall Study|Lost to Follow-up|1|||
38076646|NCT01358760|69773000|FG001|Overall Study|Lost to Follow-up|1|||
38076647|NCT01358760|69773001|FG002|Overall Study|Lost to Follow-up|3|||
38076648|NCT01358760|69772999|FG000|Overall Study|Withdrawal by Subject|5|||
38076649|NCT01358760|69773000|FG001|Overall Study|Withdrawal by Subject|3|||
38076650|NCT01358760|69773001|FG002|Overall Study|Withdrawal by Subject|2|||
38076651|NCT01358760|69772999|FG000|Overall Study|Physician Decision|1|||
38076652|NCT01358760|69773000|FG001|Overall Study|Physician Decision|0|||
38076653|NCT01358760|69773001|FG002|Overall Study|Physician Decision|1|||
38076654|NCT01358760|69772999|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
38076655|NCT01358760|69773000|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
38076656|NCT01358760|69773001|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
38076657|NCT01341990|69773011|FG000|Overall Study|Adverse Event|0|||
38076658|NCT01341990|69773012|FG001|Overall Study|Adverse Event|1|||
38076659|NCT01341990|69773011|FG000|Overall Study|Torn Study Lens|1|||
38076660|NCT01341990|69773012|FG001|Overall Study|Torn Study Lens|0|||
38076661|NCT01341990|69773011|FG000|Overall Study|Withdrawal by Subject|2|||
38076662|NCT01341990|69773012|FG001|Overall Study|Withdrawal by Subject|0|||
38076663|NCT03048747|69773018|FG000|Overall Study|Adverse Event|2|||
38076664|NCT03048747|69773018|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
38076665|NCT03048747|69773018|FG000|Overall Study|Physician Decision|1|||
38076666|NCT01991067|69773080|FG000|Overall Study|Lost to Follow-up|6|||
38076667|NCT01991067|69773081|FG001|Overall Study|Lost to Follow-up|5|||
38076668|NCT01709331|69773087|FG000|Overall Study|Adverse Event|1|||
38076669|NCT03255083|69773095|FG000|Overall Study|Clinical progression|1|||
38076670|NCT03255083|69773096|FG001|Overall Study|Clinical progression|0|||
38076671|NCT03255083|69773097|FG002|Overall Study|Clinical progression|0|||
38076672|NCT03255083|69773098|FG003|Overall Study|Clinical progression|0|||
38076673|NCT03255083|69773095|FG000|Overall Study|Adverse Event|0|||
38076674|NCT03255083|69773096|FG001|Overall Study|Adverse Event|1|||
38076675|NCT03255083|69773097|FG002|Overall Study|Adverse Event|0|||
38076676|NCT03255083|69773098|FG003|Overall Study|Adverse Event|0|||
38076677|NCT03255083|69773095|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
38076678|NCT03255083|69773096|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
38076679|NCT03255083|69773097|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
38076680|NCT03255083|69773098|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
38076681|NCT03255083|69773095|FG000|Overall Study|Withdrawal by Subject|1|||
38076682|NCT03255083|69773096|FG001|Overall Study|Withdrawal by Subject|1|||
38076683|NCT03255083|69773097|FG002|Overall Study|Withdrawal by Subject|1|||
38076684|NCT03255083|69773098|FG003|Overall Study|Withdrawal by Subject|0|||
38076685|NCT04552587|69773114|FG000|Overall Study|Lost to Follow-up|4|||
38076686|NCT01316055|69773130|FG000|Overall Study|Lost to Follow-up|1|||
38076687|NCT01316055|69773131|FG001|Overall Study|Lost to Follow-up|0|||
38076688|NCT01316055|69773132|FG002|Overall Study|Lost to Follow-up|0|||
38076689|NCT01340976|69773149|FG000|Overall Study|Physician Decision|2|||
38076690|NCT01340976|69773150|FG001|Overall Study|Physician Decision|0|||
38076691|NCT01340976|69773151|FG002|Overall Study|Physician Decision|1|||
38076692|NCT01340976|69773152|FG003|Overall Study|Physician Decision|1|||
38076693|NCT01340976|69773153|FG004|Overall Study|Physician Decision|1|||
38076694|NCT01340976|69773154|FG005|Overall Study|Physician Decision|0|||
38076695|NCT01340976|69773149|FG000|Overall Study|Death|0|||
38076696|NCT01340976|69773150|FG001|Overall Study|Death|1|||
38076697|NCT01340976|69773151|FG002|Overall Study|Death|0|||
38076698|NCT01340976|69773152|FG003|Overall Study|Death|0|||
38076699|NCT01340976|69773153|FG004|Overall Study|Death|0|||
38076700|NCT01340976|69773154|FG005|Overall Study|Death|0|||
38076701|NCT01340976|69773149|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
38076702|NCT01340976|69773150|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
38076703|NCT01340976|69773151|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
38076704|NCT01340976|69773152|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
38076705|NCT01340976|69773153|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
38076706|NCT01340976|69773154|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
38076707|NCT01340976|69773149|FG000|Overall Study|Withdrawal by Subject|0|||
38076708|NCT01340976|69773150|FG001|Overall Study|Withdrawal by Subject|0|||
38076709|NCT01340976|69773151|FG002|Overall Study|Withdrawal by Subject|0|||
38076710|NCT01340976|69773152|FG003|Overall Study|Withdrawal by Subject|1|||
38076711|NCT01340976|69773153|FG004|Overall Study|Withdrawal by Subject|1|||
38076712|NCT01340976|69773154|FG005|Overall Study|Withdrawal by Subject|0|||
38076713|NCT01340976|69773149|FG000|Overall Study|Other anemia treatment|1|||
38076714|NCT01340976|69773150|FG001|Overall Study|Other anemia treatment|0|||
38076715|NCT01340976|69773151|FG002|Overall Study|Other anemia treatment|2|||
38076716|NCT01340976|69773152|FG003|Overall Study|Other anemia treatment|1|||
38076717|NCT01340976|69773153|FG004|Overall Study|Other anemia treatment|0|||
38076718|NCT01340976|69773154|FG005|Overall Study|Other anemia treatment|1|||
38076719|NCT01340976|69773149|FG000|Overall Study|Adverse Event|0|||
38076720|NCT01340976|69773150|FG001|Overall Study|Adverse Event|1|||
38076721|NCT01340976|69773151|FG002|Overall Study|Adverse Event|0|||
38076722|NCT01340976|69773152|FG003|Overall Study|Adverse Event|0|||
38076723|NCT01340976|69773153|FG004|Overall Study|Adverse Event|0|||
38076724|NCT01340976|69773154|FG005|Overall Study|Adverse Event|0|||
38076725|NCT01680016|69773176|FG000|Overall Study|Adverse Event|0|||
38076726|NCT01680016|69773177|FG001|Overall Study|Adverse Event|0|||
38076727|NCT01680016|69773178|FG002|Overall Study|Adverse Event|1|||
38076728|NCT01680016|69773179|FG003|Overall Study|Adverse Event|4|||
38076729|NCT01680016|69773176|FG000|Overall Study|The Subject went out of The Trial|1|||
38076730|NCT01680016|69773177|FG001|Overall Study|The Subject went out of The Trial|0|||
38076731|NCT01680016|69773178|FG002|Overall Study|The Subject went out of The Trial|3|||
38076732|NCT01680016|69773179|FG003|Overall Study|The Subject went out of The Trial|0|||
38076733|NCT01680016|69773176|FG000|Overall Study|Protocol Violation|0|||
38076734|NCT01680016|69773177|FG001|Overall Study|Protocol Violation|1|||
38076735|NCT01680016|69773178|FG002|Overall Study|Protocol Violation|0|||
38076736|NCT01680016|69773179|FG003|Overall Study|Protocol Violation|0|||
38076737|NCT01680016|69773176|FG000|Overall Study|Withdrawal by Subject|5|||
38076738|NCT01680016|69773177|FG001|Overall Study|Withdrawal by Subject|7|||
38076739|NCT01680016|69773178|FG002|Overall Study|Withdrawal by Subject|1|||
38076740|NCT01680016|69773179|FG003|Overall Study|Withdrawal by Subject|1|||
38076741|NCT01340898|69773204|FG000|Primary Phase|Serious Adverse Events|0|||
38076742|NCT01340898|69773205|FG001|Primary Phase|Serious Adverse Events|0|||
38076743|NCT01340898|69773206|FG002|Primary Phase|Serious Adverse Events|1|||
38076744|NCT01340898|69773204|FG000|Primary Phase|Withdrawal by Subject|8|||
38076745|NCT01340898|69773205|FG001|Primary Phase|Withdrawal by Subject|7|||
38076746|NCT01340898|69773206|FG002|Primary Phase|Withdrawal by Subject|5|||
38076747|NCT01340898|69773204|FG000|Primary Phase|Migrated/moved from study area|4|||
38076748|NCT01340898|69773205|FG001|Primary Phase|Migrated/moved from study area|1|||
38076749|NCT01340898|69773206|FG002|Primary Phase|Migrated/moved from study area|0|||
38076750|NCT01340898|69773204|FG000|Primary Phase|Lost to Follow-up|4|||
38076751|NCT01340898|69773205|FG001|Primary Phase|Lost to Follow-up|1|||
38076752|NCT01340898|69773206|FG002|Primary Phase|Lost to Follow-up|0|||
38076753|NCT01340898|69773204|FG000|Booster Phase|Withdrawal by Subject|3|||
38076754|NCT01340898|69773205|FG001|Booster Phase|Withdrawal by Subject|0|||
38076755|NCT01340898|69773206|FG002|Booster Phase|Withdrawal by Subject|4|||
38076756|NCT01340898|69773204|FG000|Booster Phase|Migrated/moved from study area|3|||
38076757|NCT01340898|69773205|FG001|Booster Phase|Migrated/moved from study area|0|||
38076758|NCT01340898|69773206|FG002|Booster Phase|Migrated/moved from study area|0|||
38076759|NCT01340898|69773204|FG000|Booster Phase|Lost to Follow-up|4|||
38076760|NCT01340898|69773205|FG001|Booster Phase|Lost to Follow-up|2|||
38076761|NCT01340898|69773206|FG002|Booster Phase|Lost to Follow-up|3|||
38076762|NCT03097315|69773227|FG000|Overall Study|Withdrawal by Subject|1|||
38076763|NCT03039699|69773233|FG000|Overall Study|Incorrect inclusion|5|||
38076764|NCT03039699|69773234|FG001|Overall Study|Incorrect inclusion|4|||
38076765|NCT03039699|69773233|FG000|Overall Study|Lack of data to assess study endpoint|5|||
38076766|NCT03039699|69773234|FG001|Overall Study|Lack of data to assess study endpoint|3|||
37966554|NCT00635219|69653440|FG000|Overall Study|Protocol Violation|0|||
37966555|NCT00635219|69653441|FG001|Overall Study|Protocol Violation|2|||
37966556|NCT00635219|69653442|FG002|Overall Study|Protocol Violation|3|||
37966557|NCT00635219|69653443|FG003|Overall Study|Protocol Violation|2|||
37966558|NCT00635219|69653444|FG004|Overall Study|Protocol Violation|4|||
37966559|NCT00635219|69653440|FG000|Overall Study|Withdrawal of Consent|8|||
37966560|NCT00635219|69653441|FG001|Overall Study|Withdrawal of Consent|6|||
37966561|NCT00635219|69653442|FG002|Overall Study|Withdrawal of Consent|8|||
37966562|NCT00635219|69653443|FG003|Overall Study|Withdrawal of Consent|11|||
37966563|NCT00635219|69653444|FG004|Overall Study|Withdrawal of Consent|8|||
37966564|NCT00635219|69653440|FG000|Overall Study|Lost to Follow-up|0|||
37966565|NCT00635219|69653441|FG001|Overall Study|Lost to Follow-up|0|||
37966566|NCT00635219|69653442|FG002|Overall Study|Lost to Follow-up|2|||
37966567|NCT00635219|69653443|FG003|Overall Study|Lost to Follow-up|0|||
37966568|NCT00635219|69653444|FG004|Overall Study|Lost to Follow-up|3|||
37966569|NCT00635219|69653440|FG000|Overall Study|Administrative or Other Reasons|0|||
37966570|NCT00635219|69653441|FG001|Overall Study|Administrative or Other Reasons|1|||
37966571|NCT00635219|69653442|FG002|Overall Study|Administrative or Other Reasons|1|||
37966572|NCT00635219|69653443|FG003|Overall Study|Administrative or Other Reasons|0|||
37966573|NCT00635219|69653444|FG004|Overall Study|Administrative or Other Reasons|1|||
37966574|NCT00363766|69653458|FG000|Overall Study|Progressive Disease|15|||
37966575|NCT00363766|69653459|FG001|Overall Study|Progressive Disease|9|||
37966576|NCT00363766|69653458|FG000|Overall Study|Adverse Event|10|||
37966577|NCT00363766|69653459|FG001|Overall Study|Adverse Event|2|||
37966578|NCT00363766|69653458|FG000|Overall Study|Disease Related Death|1|||
37966579|NCT00363766|69653459|FG001|Overall Study|Disease Related Death|3|||
37966580|NCT00363766|69653458|FG000|Overall Study|Not Disease Related Death|3|||
37966581|NCT00363766|69653459|FG001|Overall Study|Not Disease Related Death|4|||
37966582|NCT00363766|69653458|FG000|Overall Study|Withdrawal by Subject|2|||
37966583|NCT00363766|69653459|FG001|Overall Study|Withdrawal by Subject|0|||
37966584|NCT00363766|69653458|FG000|Overall Study|Physician Decision|1|||
37966585|NCT00363766|69653459|FG001|Overall Study|Physician Decision|2|||
38076767|NCT03039699|69773233|FG000|Overall Study|Bacterial infection|12|||
38076768|NCT03039699|69773234|FG001|Overall Study|Bacterial infection|28|||
38076769|NCT02833974|69773242|FG000|Overall Study|Lost to Follow-up|1|||
37966586|NCT00468819|69653469|FG000|Overall Study|Withdrawal by Subject|4|||
37966587|NCT00468819|69653470|FG001|Overall Study|Withdrawal by Subject|0|||
38076770|NCT02833974|69773243|FG001|Overall Study|Lost to Follow-up|0|||
37862356|NCT01129011|69546119|FG001|Overall Study|Duodenal Ulcer|8|||
38076771|NCT02833974|69773242|FG000|Overall Study|Adverse Event|0|||
38076772|NCT02833974|69773243|FG001|Overall Study|Adverse Event|3|||
38076773|NCT03093415|69773252|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
38076774|NCT03093415|69773253|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
38076775|NCT03093415|69773254|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
38076776|NCT03093415|69773252|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
38076777|NCT03093415|69773253|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
38076778|NCT03093415|69773254|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
38076779|NCT03093415|69773252|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
38076780|NCT03093415|69773253|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
38076781|NCT03093415|69773254|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
38076782|NCT03093415|69773252|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
38076783|NCT03093415|69773253|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
38076784|NCT03093415|69773254|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
38076785|NCT03093415|69773252|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
38076786|NCT03093415|69773253|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
38076787|NCT03093415|69773254|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
38076788|NCT03093415|69773252|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
38076789|NCT03093415|69773253|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
38076790|NCT03093415|69773254|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
38076791|NCT03093415|69773252|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
38076792|NCT03093415|69773253|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
38076793|NCT03093415|69773254|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
38076794|NCT03093415|69773252|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
38076795|NCT03093415|69773253|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
38076796|NCT03093415|69773254|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
38076797|NCT03093415|69773252|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
38076798|NCT03093415|69773253|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
38076799|NCT03093415|69773254|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
38076800|NCT03093415|69773252|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
38076801|NCT03093415|69773253|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
38076802|NCT03093415|69773254|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
38076803|NCT03093415|69773252|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
38076804|NCT03093415|69773253|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
38076805|NCT03093415|69773254|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
38076806|NCT01358526|69773264|FG000|Open-label Titration Period|Adverse Event|95|||
38076807|NCT01358526|69773265|FG001|Open-label Titration Period|Adverse Event|0|||
38076808|NCT01358526|69773266|FG002|Open-label Titration Period|Adverse Event|0|||
38076809|NCT01358526|69773264|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
38076810|NCT01358526|69773265|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
38076811|NCT01358526|69773266|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
38076812|NCT01358526|69773264|FG000|Open-label Titration Period|Lost to Follow-up|25|||
38076813|NCT01358526|69773265|FG001|Open-label Titration Period|Lost to Follow-up|0|||
38076814|NCT01358526|69773266|FG002|Open-label Titration Period|Lost to Follow-up|0|||
38076815|NCT01358526|69773264|FG000|Open-label Titration Period|Lack of Efficacy|107|||
38076816|NCT01358526|69773265|FG001|Open-label Titration Period|Lack of Efficacy|0|||
38076817|NCT01358526|69773266|FG002|Open-label Titration Period|Lack of Efficacy|0|||
38076818|NCT01358526|69773264|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
38076819|NCT01358526|69773265|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
38076820|NCT01358526|69773266|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
38076821|NCT01358526|69773264|FG000|Open-label Titration Period|Administrative|8|||
38076822|NCT01358526|69773265|FG001|Open-label Titration Period|Administrative|0|||
38076823|NCT01358526|69773266|FG002|Open-label Titration Period|Administrative|0|||
38076824|NCT01358526|69773264|FG000|Open-label Titration Period|Did not qualify|178|||
38076825|NCT01358526|69773265|FG001|Open-label Titration Period|Did not qualify|0|||
38076826|NCT01358526|69773266|FG002|Open-label Titration Period|Did not qualify|0|||
38076827|NCT01358526|69773264|FG000|Double-blind Phase|Adverse Event|0|||
38076828|NCT01358526|69773265|FG001|Double-blind Phase|Adverse Event|24|||
38076829|NCT01358526|69773266|FG002|Double-blind Phase|Adverse Event|23|||
38076830|NCT01358526|69773264|FG000|Double-blind Phase|Withdrawal by Subject|0|||
38076831|NCT01358526|69773265|FG001|Double-blind Phase|Withdrawal by Subject|10|||
38076832|NCT01358526|69773266|FG002|Double-blind Phase|Withdrawal by Subject|8|||
38076833|NCT01358526|69773264|FG000|Double-blind Phase|Lost to Follow-up|0|||
38076834|NCT01358526|69773265|FG001|Double-blind Phase|Lost to Follow-up|4|||
38076835|NCT01358526|69773266|FG002|Double-blind Phase|Lost to Follow-up|1|||
38076836|NCT01358526|69773264|FG000|Double-blind Phase|Lack of Efficacy|0|||
38076837|NCT01358526|69773265|FG001|Double-blind Phase|Lack of Efficacy|31|||
38076838|NCT01358526|69773266|FG002|Double-blind Phase|Lack of Efficacy|73|||
38076839|NCT01358526|69773264|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
38076840|NCT01358526|69773265|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
38076841|NCT01358526|69773266|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
38076842|NCT01358526|69773264|FG000|Double-blind Phase|Administrative|0|||
38076843|NCT01358526|69773265|FG001|Double-blind Phase|Administrative|6|||
38076844|NCT01358526|69773266|FG002|Double-blind Phase|Administrative|10|||
38076845|NCT02830776|69773273|FG000|Overall Study|Lost to Follow-up|1|||
38076846|NCT03039621|69773280|FG000|Overall Study|Violation of inclusion criteria|3|||
37966588|NCT00468819|69653471|FG002|Overall Study|Withdrawal by Subject|1|||
38076847|NCT03039621|69773281|FG001|Overall Study|Violation of inclusion criteria|2|||
38076848|NCT03039621|69773280|FG000|Overall Study|Non-compliance with protocol requirement|4|||
38076849|NCT03039621|69773281|FG001|Overall Study|Non-compliance with protocol requirement|5|||
38076850|NCT03039621|69773280|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
38076851|NCT03039621|69773281|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
38076852|NCT03039621|69773280|FG000|Overall Study|Violation of non-inclusion criteria|1|||
38076853|NCT03039621|69773281|FG001|Overall Study|Violation of non-inclusion criteria|2|||
38076854|NCT03041181|69773289|FG000|Overall Study|Disease Progression|1|||
38076855|NCT03041181|69773290|FG001|Overall Study|Disease Progression|2|||
38076856|NCT02828436|69773296|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
38076857|NCT02828436|69773297|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
38076858|NCT02828436|69773296|FG000|Period 1|Lost to Follow-up|0|||
38076859|NCT02828436|69773297|FG001|Period 1|Lost to Follow-up|1|||
38076860|NCT02828436|69773296|FG000|Period 2|Withdrawal by Subject|4|||
38076861|NCT02828436|69773297|FG001|Period 2|Withdrawal by Subject|0|||
38076862|NCT02828436|69773296|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
38076863|NCT02828436|69773297|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
38076864|NCT02828436|69773296|FG000|Period 2|Lost to Follow-up|1|||
38076865|NCT02828436|69773297|FG001|Period 2|Lost to Follow-up|0|||
38076866|NCT02828124|69773311|FG000|Overall Study|Disease Progression|1|||
38076867|NCT02828124|69773312|FG001|Overall Study|Disease Progression|2|||
38076868|NCT02828124|69773313|FG002|Overall Study|Disease Progression|1|||
38076869|NCT02828124|69773314|FG003|Overall Study|Disease Progression|4|||
38076870|NCT02828124|69773311|FG000|Overall Study|AE Unrelated to Study Drug|0|||
38076871|NCT02828124|69773312|FG001|Overall Study|AE Unrelated to Study Drug|0|||
38076872|NCT02828124|69773313|FG002|Overall Study|AE Unrelated to Study Drug|0|||
38076873|NCT02828124|69773314|FG003|Overall Study|AE Unrelated to Study Drug|1|||
38076874|NCT02828124|69773311|FG000|Overall Study|Subject Withdrew Consent|0|||
38076875|NCT02828124|69773312|FG001|Overall Study|Subject Withdrew Consent|0|||
38076876|NCT02828124|69773313|FG002|Overall Study|Subject Withdrew Consent|0|||
38076877|NCT02828124|69773314|FG003|Overall Study|Subject Withdrew Consent|1|||
38076878|NCT02829996|69773329|FG000|Overall Study|Withdrawal by Subject|1|||
38076879|NCT02829996|69773330|FG001|Overall Study|Withdrawal by Subject|0|||
38076880|NCT02829996|69773331|FG002|Overall Study|Withdrawal by Subject|0|||
38076881|NCT02829996|69773332|FG003|Overall Study|Withdrawal by Subject|0|||
38076882|NCT02829996|69773333|FG004|Overall Study|Withdrawal by Subject|0|||
38076883|NCT02827500|69773347|FG000|Overall Study|Death|7|||
38076884|NCT02827500|69773348|FG001|Overall Study|Death|3|||
38076885|NCT02827500|69773347|FG000|Overall Study|Lost to Follow-up|1|||
38076886|NCT02827500|69773348|FG001|Overall Study|Lost to Follow-up|1|||
38076887|NCT02827500|69773347|FG000|Overall Study|Withdrawal by Subject|3|||
38076888|NCT02827500|69773348|FG001|Overall Study|Withdrawal by Subject|1|||
38076889|NCT02827500|69773347|FG000|Overall Study|Missing primary endpoint data|3|||
38076890|NCT02827500|69773348|FG001|Overall Study|Missing primary endpoint data|1|||
38076891|NCT02827500|69773347|FG000|Overall Study|Other|5|||
38076892|NCT02827500|69773348|FG001|Overall Study|Other|1|||
38076893|NCT02826798|69773359|FG000|Overall Study|Withdrawal by Subject|0|||
38076894|NCT02826798|69773360|FG001|Overall Study|Withdrawal by Subject|1|||
38076895|NCT02826798|69773361|FG002|Overall Study|Withdrawal by Subject|0|||
38076896|NCT02826798|69773362|FG003|Overall Study|Withdrawal by Subject|1|||
38076897|NCT02826798|69773363|FG004|Overall Study|Withdrawal by Subject|0|||
38076898|NCT02829138|69773377|FG000|Overall Study|Withdrawal by Subject|1|||
38076899|NCT02829138|69773378|FG001|Overall Study|Withdrawal by Subject|0|||
38076900|NCT02825550|69773384|FG000|Overall Study|Physician Decision|1|||
38076901|NCT02744040|69773393|FG000|Overall Study|Withdrawal by Subject|3|||
38076902|NCT02744040|69773394|FG001|Overall Study|Withdrawal by Subject|2|||
38076903|NCT02744040|69773395|FG002|Overall Study|Withdrawal by Subject|2|||
38076904|NCT02744040|69773393|FG000|Overall Study|Physician Decision|0|||
38076905|NCT02744040|69773394|FG001|Overall Study|Physician Decision|8|||
38076906|NCT02744040|69773395|FG002|Overall Study|Physician Decision|13|||
38076907|NCT02744040|69773393|FG000|Overall Study|Lost to Follow-up|3|||
38076908|NCT02744040|69773394|FG001|Overall Study|Lost to Follow-up|1|||
38076909|NCT02744040|69773395|FG002|Overall Study|Lost to Follow-up|7|||
38076910|NCT02743962|69773405|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
38076911|NCT02743962|69773406|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
38076912|NCT03094416|69773415|FG000|Run-in|Screening failure|8|||
38076913|NCT03094416|69773415|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
37862357|NCT01129011|69546118|FG000|Overall Study|misc|7|||
38076914|NCT03094416|69773415|FG000|Run-in|Withdrawal by Subject|3|||
38076915|NCT03094416|69773415|FG000|Treatment Period|Withdrawal by Subject|2|||
38076916|NCT03041025|69773423|FG000|Overall Study|Adverse Event|0|||
38076917|NCT03041025|69773424|FG001|Overall Study|Adverse Event|0|||
38076918|NCT03041025|69773425|FG002|Overall Study|Adverse Event|1|||
38076919|NCT03041025|69773423|FG000|Overall Study|Lost to Follow-up|1|||
38076920|NCT03041025|69773424|FG001|Overall Study|Lost to Follow-up|0|||
38076921|NCT03041025|69773425|FG002|Overall Study|Lost to Follow-up|0|||
38076922|NCT03041025|69773423|FG000|Overall Study|Withdrawal by Subject|0|||
38076923|NCT03041025|69773424|FG001|Overall Study|Withdrawal by Subject|0|||
38076924|NCT03041025|69773425|FG002|Overall Study|Withdrawal by Subject|1|||
38076925|NCT01338870|69773442|FG000|Overall Study|Lost to Follow-up|0|||
38076926|NCT01338870|69773443|FG001|Overall Study|Lost to Follow-up|0|||
38076927|NCT01338870|69773444|FG002|Overall Study|Lost to Follow-up|1|||
38076928|NCT01338870|69773445|FG003|Overall Study|Lost to Follow-up|0|||
38076929|NCT01338870|69773446|FG004|Overall Study|Lost to Follow-up|1|||
38076930|NCT01338870|69773447|FG005|Overall Study|Lost to Follow-up|0|||
38076931|NCT01338870|69773442|FG000|Overall Study|Withdrawal by Subject|2|||
38076932|NCT01338870|69773443|FG001|Overall Study|Withdrawal by Subject|3|||
38076933|NCT01338870|69773444|FG002|Overall Study|Withdrawal by Subject|4|||
38076934|NCT01338870|69773445|FG003|Overall Study|Withdrawal by Subject|0|||
38076935|NCT01338870|69773446|FG004|Overall Study|Withdrawal by Subject|0|||
38076936|NCT01338870|69773447|FG005|Overall Study|Withdrawal by Subject|2|||
38076937|NCT01338870|69773442|FG000|Overall Study|Other|3|||
38076938|NCT01338870|69773443|FG001|Overall Study|Other|3|||
38076939|NCT01338870|69773444|FG002|Overall Study|Other|3|||
38076940|NCT01338870|69773445|FG003|Overall Study|Other|2|||
38076941|NCT01338870|69773446|FG004|Overall Study|Other|0|||
38076942|NCT01338870|69773447|FG005|Overall Study|Other|2|||
38076943|NCT01338870|69773442|FG000|Overall Study|Protocol Violation|0|||
38076944|NCT01338870|69773443|FG001|Overall Study|Protocol Violation|2|||
38076945|NCT01338870|69773444|FG002|Overall Study|Protocol Violation|2|||
38076946|NCT01338870|69773445|FG003|Overall Study|Protocol Violation|2|||
38076947|NCT01338870|69773446|FG004|Overall Study|Protocol Violation|1|||
38076948|NCT01338870|69773447|FG005|Overall Study|Protocol Violation|1|||
38076949|NCT01338870|69773442|FG000|Overall Study|Adverse Event|4|||
38076950|NCT01338870|69773443|FG001|Overall Study|Adverse Event|4|||
38076951|NCT01338870|69773444|FG002|Overall Study|Adverse Event|1|||
38076952|NCT01338870|69773445|FG003|Overall Study|Adverse Event|5|||
38076953|NCT01338870|69773446|FG004|Overall Study|Adverse Event|4|||
38076954|NCT01338870|69773447|FG005|Overall Study|Adverse Event|1|||
38076955|NCT02824224|69773463|FG000|Overall Study|Discontinued, IUS expulsion|0|||
38076956|NCT02824224|69773464|FG001|Overall Study|Discontinued, IUS expulsion|1|||
38076957|NCT02824224|69773463|FG000|Overall Study|Did not show up for allocation visit|2|||
38076958|NCT02824224|69773464|FG001|Overall Study|Did not show up for allocation visit|0|||
38076959|NCT01338792|69773470|FG000|Overall Study|Adverse Event|2|||
38076960|NCT01338792|69773470|FG000|Overall Study|Death|1|||
38076961|NCT01338792|69773470|FG000|Overall Study|Withdrawal by Subject|1|||
38076962|NCT01314105|69773476|FG000|Overall Study|Progressive Disease|6|||
38076963|NCT01314105|69773477|FG001|Overall Study|Progressive Disease|10|||
38076964|NCT01314105|69773476|FG000|Overall Study|Refused to continue taking medication|0|||
38076965|NCT01314105|69773477|FG001|Overall Study|Refused to continue taking medication|1|||
38076966|NCT01314105|69773476|FG000|Overall Study|Other Adverse Event|1|||
38076967|NCT01314105|69773477|FG001|Overall Study|Other Adverse Event|1|||
38076968|NCT03040713|69773485|FG000|Overall Study|Positive amyloid scan|3|||
38076969|NCT01966471|69773491|FG000|Overall Study|Death|44|||
38076970|NCT01966471|69773492|FG001|Overall Study|Death|56|||
38076971|NCT01966471|69773491|FG000|Overall Study|Lost to Follow-up|46|||
38076972|NCT01966471|69773492|FG001|Overall Study|Lost to Follow-up|39|||
38076973|NCT01966471|69773491|FG000|Overall Study|Various reasons|4|||
38076974|NCT01966471|69773492|FG001|Overall Study|Various reasons|4|||
38076975|NCT01966471|69773491|FG000|Overall Study|Physician Decision|7|||
38076976|NCT01966471|69773492|FG001|Overall Study|Physician Decision|5|||
38076977|NCT01966471|69773491|FG000|Overall Study|Study Terminated By Sponsor|758|||
38076978|NCT01966471|69773492|FG001|Overall Study|Study Terminated By Sponsor|773|||
38076979|NCT01966471|69773491|FG000|Overall Study|Withdrawal by Subject|59|||
38076980|NCT01966471|69773492|FG001|Overall Study|Withdrawal by Subject|51|||
38076981|NCT03227471|69773521|FG000|Overall Study|Withdrawal by Subject|0|||
38076982|NCT03227471|69773522|FG001|Overall Study|Withdrawal by Subject|0|||
38076983|NCT03227471|69773523|FG002|Overall Study|Withdrawal by Subject|0|||
38076984|NCT03227471|69773524|FG003|Overall Study|Withdrawal by Subject|0|||
38076985|NCT03227471|69773525|FG004|Overall Study|Withdrawal by Subject|1|||
38076986|NCT03227471|69773526|FG005|Overall Study|Withdrawal by Subject|0|||
38076987|NCT03227471|69773527|FG006|Overall Study|Withdrawal by Subject|0|||
38076988|NCT03227471|69773528|FG007|Overall Study|Withdrawal by Subject|0|||
38076989|NCT03227471|69773529|FG008|Overall Study|Withdrawal by Subject|0|||
38076990|NCT03227471|69773530|FG009|Overall Study|Withdrawal by Subject|0|||
38076991|NCT03227471|69773531|FG010|Overall Study|Withdrawal by Subject|0|||
38076992|NCT03227471|69773532|FG011|Overall Study|Withdrawal by Subject|0|||
38076993|NCT03227471|69773533|FG012|Overall Study|Withdrawal by Subject|1|||
38076994|NCT03227471|69773534|FG013|Overall Study|Withdrawal by Subject|0|||
38076995|NCT03227471|69773535|FG014|Overall Study|Withdrawal by Subject|0|||
38076996|NCT03227471|69773521|FG000|Overall Study|Randomized, Never Dosed|0|||
38076997|NCT03227471|69773522|FG001|Overall Study|Randomized, Never Dosed|0|||
38076998|NCT03227471|69773523|FG002|Overall Study|Randomized, Never Dosed|0|||
38076999|NCT03227471|69773524|FG003|Overall Study|Randomized, Never Dosed|0|||
38077000|NCT03227471|69773525|FG004|Overall Study|Randomized, Never Dosed|0|||
38077001|NCT03227471|69773526|FG005|Overall Study|Randomized, Never Dosed|0|||
38077002|NCT03227471|69773527|FG006|Overall Study|Randomized, Never Dosed|0|||
38077003|NCT03227471|69773528|FG007|Overall Study|Randomized, Never Dosed|0|||
38077004|NCT03227471|69773529|FG008|Overall Study|Randomized, Never Dosed|0|||
38077005|NCT03227471|69773530|FG009|Overall Study|Randomized, Never Dosed|0|||
38077006|NCT03227471|69773531|FG010|Overall Study|Randomized, Never Dosed|0|||
38077007|NCT03227471|69773532|FG011|Overall Study|Randomized, Never Dosed|0|||
38077008|NCT03227471|69773533|FG012|Overall Study|Randomized, Never Dosed|0|||
38077009|NCT03227471|69773534|FG013|Overall Study|Randomized, Never Dosed|0|||
38077010|NCT03227471|69773535|FG014|Overall Study|Randomized, Never Dosed|1|||
38077011|NCT01354314|69773600|FG000|Overall Study|Lost to Follow-up|1|||
38077012|NCT01354314|69773601|FG001|Overall Study|Lost to Follow-up|0|||
38077013|NCT01354314|69773602|FG002|Overall Study|Lost to Follow-up|1|||
38077014|NCT01354314|69773603|FG003|Overall Study|Lost to Follow-up|1|||
38077015|NCT01354314|69773600|FG000|Overall Study|Withdrawal by Subject|0|||
38077016|NCT01354314|69773601|FG001|Overall Study|Withdrawal by Subject|0|||
38077017|NCT01354314|69773602|FG002|Overall Study|Withdrawal by Subject|1|||
38077018|NCT01354314|69773603|FG003|Overall Study|Withdrawal by Subject|0|||
38077019|NCT01354314|69773600|FG000|Overall Study|Adverse Event|0|||
38077020|NCT01354314|69773601|FG001|Overall Study|Adverse Event|0|||
38077021|NCT01354314|69773602|FG002|Overall Study|Adverse Event|0|||
38077022|NCT01354314|69773603|FG003|Overall Study|Adverse Event|1|||
38077023|NCT01354314|69773600|FG000|Overall Study|Protocol Violation|1|||
38077024|NCT01354314|69773601|FG001|Overall Study|Protocol Violation|1|||
38077025|NCT01354314|69773602|FG002|Overall Study|Protocol Violation|0|||
38077026|NCT01354314|69773603|FG003|Overall Study|Protocol Violation|0|||
38077027|NCT01354314|69773600|FG000|Overall Study|Less than 90% Adherence|4|||
38077028|NCT01354314|69773601|FG001|Overall Study|Less than 90% Adherence|2|||
38077029|NCT01354314|69773602|FG002|Overall Study|Less than 90% Adherence|6|||
38077030|NCT01354314|69773603|FG003|Overall Study|Less than 90% Adherence|4|||
38077031|NCT03194321|69773615|FG000|Overall Study|Withdrawal by Subject|1|||
38077032|NCT03194321|69773615|FG000|Overall Study|Lost to Follow-up|1|||
38077033|NCT03194321|69773615|FG000|Overall Study|Travel for Follow-up|1|||
38077034|NCT01354938|69773619|FG000|Overall Study|Lost to Follow-up|1|||
38077035|NCT03092791|69773642|FG000|Overall Study|Lost to Follow-up|0|||
37966589|NCT00468819|69653469|FG000|Overall Study|Lost to Follow-up|0|||
38077036|NCT03092791|69773643|FG001|Overall Study|Lost to Follow-up|0|||
38077037|NCT03092791|69773644|FG002|Overall Study|Lost to Follow-up|0|||
38077038|NCT03092791|69773645|FG003|Overall Study|Lost to Follow-up|0|||
38077039|NCT03092791|69773646|FG004|Overall Study|Lost to Follow-up|0|||
38077040|NCT03092791|69773647|FG005|Overall Study|Lost to Follow-up|0|||
38077041|NCT03092791|69773648|FG006|Overall Study|Lost to Follow-up|1|||
38077042|NCT03092791|69773649|FG007|Overall Study|Lost to Follow-up|0|||
38077043|NCT03092791|69773642|FG000|Overall Study|Withdrawal of Consent|0|||
38077044|NCT03092791|69773643|FG001|Overall Study|Withdrawal of Consent|0|||
38077045|NCT03092791|69773644|FG002|Overall Study|Withdrawal of Consent|0|||
38077046|NCT03092791|69773645|FG003|Overall Study|Withdrawal of Consent|0|||
38077047|NCT03092791|69773646|FG004|Overall Study|Withdrawal of Consent|4|||
38077048|NCT03092791|69773647|FG005|Overall Study|Withdrawal of Consent|12|||
38077049|NCT03092791|69773648|FG006|Overall Study|Withdrawal of Consent|6|||
38077050|NCT03092791|69773649|FG007|Overall Study|Withdrawal of Consent|4|||
38077051|NCT03092791|69773642|FG000|Overall Study|Study Termination|0|||
38077052|NCT03092791|69773643|FG001|Overall Study|Study Termination|0|||
38077053|NCT03092791|69773644|FG002|Overall Study|Study Termination|0|||
38077054|NCT03092791|69773645|FG003|Overall Study|Study Termination|0|||
38077055|NCT03092791|69773646|FG004|Overall Study|Study Termination|55|||
38077056|NCT03092791|69773647|FG005|Overall Study|Study Termination|46|||
38077057|NCT03092791|69773648|FG006|Overall Study|Study Termination|53|||
38077058|NCT03092791|69773649|FG007|Overall Study|Study Termination|55|||
38077059|NCT03092791|69773642|FG000|Overall Study|Death|0|||
38077060|NCT03092791|69773643|FG001|Overall Study|Death|0|||
38077061|NCT03092791|69773644|FG002|Overall Study|Death|0|||
38077062|NCT03092791|69773645|FG003|Overall Study|Death|0|||
37862358|NCT01129011|69546119|FG001|Overall Study|misc|4|||
38077063|NCT03092791|69773646|FG004|Overall Study|Death|0|||
38077064|NCT03092791|69773647|FG005|Overall Study|Death|1|||
38077065|NCT03092791|69773648|FG006|Overall Study|Death|0|||
38077066|NCT03092791|69773649|FG007|Overall Study|Death|1|||
38077067|NCT03092791|69773642|FG000|Overall Study|Reason Not Specified|0|||
38077068|NCT03092791|69773643|FG001|Overall Study|Reason Not Specified|0|||
38077069|NCT03092791|69773644|FG002|Overall Study|Reason Not Specified|0|||
37966590|NCT00468819|69653470|FG001|Overall Study|Lost to Follow-up|0|||
38077070|NCT03092791|69773645|FG003|Overall Study|Reason Not Specified|0|||
38077071|NCT03092791|69773646|FG004|Overall Study|Reason Not Specified|1|||
38077072|NCT03092791|69773647|FG005|Overall Study|Reason Not Specified|1|||
38077073|NCT03092791|69773648|FG006|Overall Study|Reason Not Specified|0|||
38077074|NCT03092791|69773649|FG007|Overall Study|Reason Not Specified|0|||
38077075|NCT04283461|69773677|FG000|Overall Study|Enrolled in separate trial|0|||
38077076|NCT04283461|69773678|FG001|Overall Study|Enrolled in separate trial|0|||
38077077|NCT04283461|69773679|FG002|Overall Study|Enrolled in separate trial|8|||
38077078|NCT04283461|69773680|FG003|Overall Study|Enrolled in separate trial|13|||
38077079|NCT04283461|69773681|FG004|Overall Study|Enrolled in separate trial|12|||
38077080|NCT04283461|69773682|FG005|Overall Study|Enrolled in separate trial|0|||
38077081|NCT04283461|69773683|FG006|Overall Study|Enrolled in separate trial|0|||
38077082|NCT04283461|69773684|FG007|Overall Study|Enrolled in separate trial|8|||
38077083|NCT04283461|69773685|FG008|Overall Study|Enrolled in separate trial|0|||
38077084|NCT04283461|69773686|FG009|Overall Study|Enrolled in separate trial|0|||
38077085|NCT04283461|69773687|FG010|Overall Study|Enrolled in separate trial|0|||
38077086|NCT04283461|69773688|FG011|Overall Study|Enrolled in separate trial|7|||
38077087|NCT04283461|69773689|FG012|Overall Study|Enrolled in separate trial|0|||
38077088|NCT02505425|69773720|FG000|Overall Study|Lost to Follow-up|41|||
38077089|NCT02505425|69773721|FG001|Overall Study|Lost to Follow-up|61|||
38077090|NCT02505425|69773722|FG002|Overall Study|Lost to Follow-up|31|||
38077091|NCT02505425|69773723|FG003|Overall Study|Lost to Follow-up|19|||
38077092|NCT02505425|69773720|FG000|Overall Study|Withdrawal by Subject|39|||
38077093|NCT02505425|69773721|FG001|Overall Study|Withdrawal by Subject|9|||
38077094|NCT02505425|69773722|FG002|Overall Study|Withdrawal by Subject|19|||
38077095|NCT02505425|69773723|FG003|Overall Study|Withdrawal by Subject|7|||
38077096|NCT02505425|69773720|FG000|Overall Study|Death|8|||
38077097|NCT02505425|69773721|FG001|Overall Study|Death|12|||
38077098|NCT02505425|69773722|FG002|Overall Study|Death|0|||
38077099|NCT02505425|69773723|FG003|Overall Study|Death|0|||
38077100|NCT03089047|69773735|FG000|Overall Study|Lost to Follow-up|1|||
38077101|NCT03089047|69773736|FG001|Overall Study|Lost to Follow-up|0|||
38077102|NCT01371006|69773744|FG000|Overall Study|Adverse Event|1|||
38077103|NCT01371006|69773745|FG001|Overall Study|Adverse Event|0|||
38077104|NCT01371552|69773780|FG000|Part 1, First 3 Days|Inconvenience|0|||
38077105|NCT01371552|69773781|FG001|Part 1, First 3 Days|Inconvenience|0|||
38077106|NCT01371552|69773782|FG002|Part 1, First 3 Days|Inconvenience|1|||
38077107|NCT01371552|69773783|FG003|Part 1, First 3 Days|Inconvenience|0|||
38077108|NCT01371552|69773784|FG004|Part 1, First 3 Days|Inconvenience|0|||
38077109|NCT01371552|69773785|FG005|Part 1, First 3 Days|Inconvenience|0|||
38077110|NCT02819310|69773794|FG000|Overall Study|Withdrawal by Subject|37|||
38077111|NCT02819310|69773794|FG000|Overall Study|Lost to Follow-up|16|||
38077112|NCT02819310|69773794|FG000|Overall Study|Adverse Event|13|||
38077113|NCT02819310|69773794|FG000|Overall Study|Lack of Efficacy|5|||
38077114|NCT02819310|69773794|FG000|Overall Study|Physician Decision|8|||
38077115|NCT02819310|69773794|FG000|Overall Study|Protocol Violation|30|||
38077116|NCT03087643|69773800|FG000|Overall Study|Withdrawal by Subject|2|||
38077117|NCT03087643|69773801|FG001|Overall Study|Withdrawal by Subject|4|||
38077118|NCT03087643|69773800|FG000|Overall Study|Death|2|||
38077119|NCT03087643|69773801|FG001|Overall Study|Death|2|||
38077120|NCT02821962|69773809|FG000|Overall Study|Lost to Follow-up|2|||
38077121|NCT02821962|69773810|FG001|Overall Study|Lost to Follow-up|0|||
38077122|NCT03092479|69773818|FG000|Overall Study|Lost to Follow-up|3|||
38077123|NCT03092479|69773819|FG001|Overall Study|Lost to Follow-up|2|||
38077124|NCT03092479|69773818|FG000|Overall Study|Withdrawal by Subject|4|||
38077125|NCT03092479|69773819|FG001|Overall Study|Withdrawal by Subject|0|||
38077126|NCT03086551|69773827|FG000|First Intervention|Failure to meet inclusion criterion|1|||
38077127|NCT03086551|69773828|FG001|First Intervention|Failure to meet inclusion criterion|0|||
38077128|NCT03086551|69773827|FG000|First Intervention|Lost to Follow-up|0|||
38077129|NCT03086551|69773828|FG001|First Intervention|Lost to Follow-up|1|||
38077130|NCT03086551|69773827|FG000|Washout|Lost to Follow-up|1|||
38077131|NCT03086551|69773828|FG001|Washout|Lost to Follow-up|2|||
38077132|NCT03086551|69773827|FG000|Washout|Withdrawal by Subject|2|||
38077133|NCT03086551|69773828|FG001|Washout|Withdrawal by Subject|1|||
38077134|NCT03265249|69773836|FG000|Overall Study|Withdrawal by Subject|0|||
38077135|NCT03265249|69773837|FG001|Overall Study|Withdrawal by Subject|1|||
38077136|NCT02951767|69773843|FG000|Overall Study|Ongoing at data cutoff 04 July 2016|54|||
38077137|NCT02951767|69773843|FG000|Overall Study|Withdrawal by Subject|5|||
38077138|NCT02951767|69773843|FG000|Overall Study|Death|59|||
38077139|NCT02951767|69773843|FG000|Overall Study|Lost to Follow-up|1|||
38077140|NCT03093181|69773850|FG000|Overall Study|Withdrawal by Subject|2|||
38077141|NCT03093181|69773851|FG001|Overall Study|Withdrawal by Subject|1|||
38077142|NCT03093181|69773852|FG002|Overall Study|Withdrawal by Subject|2|||
38077143|NCT03093181|69773850|FG000|Overall Study|Other (Not specified)|1|||
38077144|NCT03093181|69773851|FG001|Overall Study|Other (Not specified)|0|||
38077145|NCT03093181|69773852|FG002|Overall Study|Other (Not specified)|0|||
38077146|NCT03093181|69773850|FG000|Overall Study|Adverse Event|0|||
38077147|NCT03093181|69773851|FG001|Overall Study|Adverse Event|1|||
38077148|NCT03093181|69773852|FG002|Overall Study|Adverse Event|0|||
38077149|NCT03093181|69773850|FG000|Overall Study|Other (Protocol violation)|0|||
38077150|NCT03093181|69773851|FG001|Overall Study|Other (Protocol violation)|0|||
38077151|NCT03093181|69773852|FG002|Overall Study|Other (Protocol violation)|1|||
38077152|NCT03091777|69773863|FG000|Overall Study|Pregnancy|2|||
38077153|NCT03091777|69773864|FG001|Overall Study|Pregnancy|1|||
38077154|NCT03091777|69773865|FG002|Overall Study|Pregnancy|0|||
38077155|NCT03091777|69773863|FG000|Overall Study|Adverse Event|2|||
38077156|NCT03091777|69773864|FG001|Overall Study|Adverse Event|1|||
38077157|NCT03091777|69773865|FG002|Overall Study|Adverse Event|4|||
38077158|NCT03091777|69773863|FG000|Overall Study|Withdrawal by Subject|4|||
38077159|NCT03091777|69773864|FG001|Overall Study|Withdrawal by Subject|2|||
38077160|NCT03091777|69773865|FG002|Overall Study|Withdrawal by Subject|6|||
38077161|NCT03091777|69773863|FG000|Overall Study|Protocol Violation|2|||
38077162|NCT03091777|69773864|FG001|Overall Study|Protocol Violation|1|||
38077163|NCT03091777|69773865|FG002|Overall Study|Protocol Violation|1|||
38077164|NCT03091777|69773863|FG000|Overall Study|Lost to Follow-up|12|||
38077165|NCT03091777|69773864|FG001|Overall Study|Lost to Follow-up|14|||
38077166|NCT03091777|69773865|FG002|Overall Study|Lost to Follow-up|7|||
38077167|NCT03091777|69773863|FG000|Overall Study|Lack of Efficacy|0|||
38077168|NCT03091777|69773864|FG001|Overall Study|Lack of Efficacy|0|||
38077169|NCT03091777|69773865|FG002|Overall Study|Lack of Efficacy|5|||
38077170|NCT03091777|69773863|FG000|Overall Study|Noncompliance with study drug|2|||
38077171|NCT03091777|69773864|FG001|Overall Study|Noncompliance with study drug|3|||
38077172|NCT03091777|69773865|FG002|Overall Study|Noncompliance with study drug|1|||
38077173|NCT03091777|69773863|FG000|Overall Study|Physician Decision|1|||
38077174|NCT03091777|69773864|FG001|Overall Study|Physician Decision|0|||
38077175|NCT03091777|69773865|FG002|Overall Study|Physician Decision|1|||
38077176|NCT03091777|69773863|FG000|Overall Study|Abnormal Laboratory Value|7|||
38077177|NCT03091777|69773864|FG001|Overall Study|Abnormal Laboratory Value|11|||
38077178|NCT03091777|69773865|FG002|Overall Study|Abnormal Laboratory Value|12|||
38077179|NCT02818998|69773876|FG000|Overall Study|Adverse Event|3|||
38077180|NCT02818998|69773877|FG001|Overall Study|Adverse Event|2|||
38077181|NCT02818998|69773878|FG002|Overall Study|Adverse Event|1|||
38077182|NCT02818998|69773876|FG000|Overall Study|Lost to Follow-up|4|||
38077183|NCT02818998|69773877|FG001|Overall Study|Lost to Follow-up|1|||
38077184|NCT02818998|69773878|FG002|Overall Study|Lost to Follow-up|2|||
38077185|NCT02818998|69773876|FG000|Overall Study|Withdrawal by sponsor|0|||
38077186|NCT02818998|69773877|FG001|Overall Study|Withdrawal by sponsor|1|||
38077187|NCT02818998|69773878|FG002|Overall Study|Withdrawal by sponsor|1|||
38077188|NCT02818998|69773876|FG000|Overall Study|Death|3|||
38077189|NCT02818998|69773877|FG001|Overall Study|Death|6|||
38077190|NCT02818998|69773878|FG002|Overall Study|Death|8|||
38077191|NCT02818998|69773876|FG000|Overall Study|Withdrawal by Subject|7|||
38077192|NCT02818998|69773877|FG001|Overall Study|Withdrawal by Subject|6|||
38077193|NCT02818998|69773878|FG002|Overall Study|Withdrawal by Subject|6|||
38077194|NCT02818998|69773876|FG000|Overall Study|Physician Decision|1|||
38077195|NCT02818998|69773877|FG001|Overall Study|Physician Decision|0|||
38077196|NCT02818998|69773878|FG002|Overall Study|Physician Decision|0|||
38077197|NCT02821416|69773888|FG000|Overall Study|Adverse Event|0|||
38077198|NCT02821416|69773889|FG001|Overall Study|Adverse Event|1|||
38077199|NCT02821416|69773888|FG000|Overall Study|Withdrawal by Subject|2|||
38077200|NCT02821416|69773889|FG001|Overall Study|Withdrawal by Subject|0|||
38077201|NCT02821416|69773888|FG000|Overall Study|Lost to Follow-up|1|||
38077202|NCT02821416|69773889|FG001|Overall Study|Lost to Follow-up|0|||
38077203|NCT03108521|69773898|FG000|Overall Study|Lost to Follow-up|3|||
38077204|NCT03108521|69773899|FG001|Overall Study|Lost to Follow-up|0|||
38077205|NCT03108521|69773898|FG000|Overall Study|Lack of Efficacy|2|||
38077206|NCT03108521|69773899|FG001|Overall Study|Lack of Efficacy|0|||
38077207|NCT03108521|69773898|FG000|Overall Study|Physician Decision|4|||
38077208|NCT03108521|69773899|FG001|Overall Study|Physician Decision|0|||
38077209|NCT03108521|69773898|FG000|Overall Study|Adverse Event|3|||
38077210|NCT03108521|69773899|FG001|Overall Study|Adverse Event|0|||
38077211|NCT02817828|69773922|FG000|Overall Study|Lost to Follow-up|41|||
38077212|NCT02817828|69773922|FG000|Overall Study|Adverse event not related to bleeding|104|||
38077213|NCT02817828|69773922|FG000|Overall Study|Adverse event related to bleeding|53|||
38077214|NCT02817828|69773922|FG000|Overall Study|Protocol Violation|11|||
38077215|NCT02817828|69773922|FG000|Overall Study|Pregnancy|7|||
38077216|NCT02817828|69773922|FG000|Overall Study|Pregnancy wish|15|||
38077217|NCT02817828|69773922|FG000|Overall Study|Withdrawal by Subject|78|||
38077218|NCT02817828|69773922|FG000|Overall Study|Other|26|||
38077219|NCT02817906|69773933|FG000|Overall Study|Adverse Event|3|||
38077220|NCT02817906|69773934|FG001|Overall Study|Adverse Event|0|||
38077221|NCT02817906|69773933|FG000|Overall Study|Lack of Efficacy|1|||
38077222|NCT02817906|69773934|FG001|Overall Study|Lack of Efficacy|0|||
38077223|NCT02817906|69773933|FG000|Overall Study|Protocol Violation|1|||
38077224|NCT02817906|69773934|FG001|Overall Study|Protocol Violation|1|||
38077225|NCT02817906|69773933|FG000|Overall Study|Study Terminated by Sponsor|2|||
38077226|NCT02817906|69773934|FG001|Overall Study|Study Terminated by Sponsor|2|||
38077227|NCT02817906|69773933|FG000|Overall Study|Withdrawal by Subject|7|||
38077228|NCT02817906|69773934|FG001|Overall Study|Withdrawal by Subject|0|||
38077229|NCT02817906|69773933|FG000|Overall Study|Other|2|||
38077230|NCT02817906|69773934|FG001|Overall Study|Other|2|||
38077231|NCT02817594|69773945|FG000|Overall Study|Withdrawal by Subject|1|||
38077232|NCT02817594|69773945|FG000|Overall Study|Other|1|||
38077233|NCT02817594|69773945|FG000|Overall Study|Did Not Receive Treatment|1|||
38077234|NCT02813694|69773955|FG000|Overall Study|Physician Decision|0|||
38077235|NCT02813694|69773956|FG001|Overall Study|Physician Decision|1|||
38077236|NCT02813694|69773955|FG000|Overall Study|Withdrawal by Subject|10|||
38077237|NCT02813694|69773956|FG001|Overall Study|Withdrawal by Subject|9|||
38077238|NCT02813694|69773955|FG000|Overall Study|Lost to Follow-up|1|||
38077239|NCT02813694|69773956|FG001|Overall Study|Lost to Follow-up|1|||
38077240|NCT02813694|69773955|FG000|Overall Study|Death|3|||
38077241|NCT02813694|69773956|FG001|Overall Study|Death|3|||
38077242|NCT02813694|69773955|FG000|Overall Study|Randomized- did not receive study drug|2|||
38077243|NCT02813694|69773956|FG001|Overall Study|Randomized- did not receive study drug|0|||
38077244|NCT02813694|69773955|FG000|Overall Study|Patient hospitalized|1|||
38077245|NCT02813694|69773956|FG001|Overall Study|Patient hospitalized|0|||
38077246|NCT03103919|69773964|FG000|Overall Study|Adverse Event|2|||
38077247|NCT03103919|69773965|FG001|Overall Study|Adverse Event|2|||
38077248|NCT02810964|69773975|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
38077249|NCT02810964|69773976|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
38077250|NCT02810964|69773975|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
38077251|NCT02810964|69773976|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
38077252|NCT02810964|69773975|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
38077253|NCT02810964|69773976|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
38077254|NCT02810964|69773975|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
38077255|NCT02810964|69773976|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
38077256|NCT03103763|69773985|FG000|Overall Study|Death|15|||
38077257|NCT03103763|69773986|FG001|Overall Study|Death|5|||
38077258|NCT03103763|69773987|FG002|Overall Study|Death|5|||
38077259|NCT03103763|69773985|FG000|Overall Study|Withdrawal by Subject|0|||
38077260|NCT03103763|69773986|FG001|Overall Study|Withdrawal by Subject|3|||
38077261|NCT03103763|69773987|FG002|Overall Study|Withdrawal by Subject|2|||
38077262|NCT03101267|69774011|FG000|Primary Study Period|Withdrawal by Subject|1|||
38077263|NCT03101267|69774012|FG001|Primary Study Period|Withdrawal by Subject|2|||
38077264|NCT03101267|69774013|FG002|Primary Study Period|Withdrawal by Subject|3|||
38077265|NCT03101267|69774011|FG000|Primary Study Period|Miscellaneous|2|||
38077266|NCT03101267|69774012|FG001|Primary Study Period|Miscellaneous|0|||
38077267|NCT03101267|69774013|FG002|Primary Study Period|Miscellaneous|0|||
38077268|NCT02810418|69774028|FG000|Arm A Dose Escalation|Adverse Event|2|||
38077269|NCT02810418|69774029|FG001|Arm A Dose Escalation|Adverse Event|1|||
38077270|NCT02810418|69774030|FG002|Arm A Dose Escalation|Adverse Event|0|||
38077271|NCT02810418|69774031|FG003|Arm A Dose Escalation|Adverse Event|0|||
38077272|NCT02810418|69774032|FG004|Arm A Dose Escalation|Adverse Event|0|||
38077273|NCT02810418|69774033|FG005|Arm A Dose Escalation|Adverse Event|0|||
38077274|NCT02810418|69774034|FG006|Arm A Dose Escalation|Adverse Event|0|||
38077275|NCT02810418|69774028|FG000|Dose Expansion|Adverse Event|0|||
38077276|NCT02810418|69774029|FG001|Dose Expansion|Adverse Event|1|||
38077277|NCT02810418|69774030|FG002|Dose Expansion|Adverse Event|1|||
38077278|NCT02810418|69774031|FG003|Dose Expansion|Adverse Event|0|||
38077279|NCT02810418|69774032|FG004|Dose Expansion|Adverse Event|0|||
38077280|NCT02810418|69774033|FG005|Dose Expansion|Adverse Event|0|||
38077281|NCT02810418|69774034|FG006|Dose Expansion|Adverse Event|0|||
38077282|NCT02810418|69774028|FG000|Dose Expansion|Physician Decision|0|||
38077283|NCT02810418|69774029|FG001|Dose Expansion|Physician Decision|0|||
38077284|NCT02810418|69774030|FG002|Dose Expansion|Physician Decision|2|||
38077285|NCT02810418|69774031|FG003|Dose Expansion|Physician Decision|0|||
38077286|NCT02810418|69774032|FG004|Dose Expansion|Physician Decision|0|||
38077287|NCT02810418|69774033|FG005|Dose Expansion|Physician Decision|0|||
38077288|NCT02810418|69774034|FG006|Dose Expansion|Physician Decision|0|||
38077289|NCT02810418|69774028|FG000|Arm B Dose Escalation|Adverse Event|0|||
38077290|NCT02810418|69774029|FG001|Arm B Dose Escalation|Adverse Event|0|||
38077291|NCT02810418|69774030|FG002|Arm B Dose Escalation|Adverse Event|0|||
38077292|NCT02810418|69774031|FG003|Arm B Dose Escalation|Adverse Event|0|||
38077293|NCT02810418|69774032|FG004|Arm B Dose Escalation|Adverse Event|1|||
38077294|NCT02810418|69774033|FG005|Arm B Dose Escalation|Adverse Event|2|||
38077295|NCT02810418|69774034|FG006|Arm B Dose Escalation|Adverse Event|0|||
38077296|NCT02810340|69774100|FG000|Overall Study|Withdrawal by Subject|1|||
38077297|NCT02810340|69774101|FG001|Overall Study|Withdrawal by Subject|0|||
38077298|NCT02810340|69774102|FG002|Overall Study|Withdrawal by Subject|0|||
38077299|NCT02810340|69774100|FG000|Overall Study|Incarceration|0|||
38077300|NCT02810340|69774101|FG001|Overall Study|Incarceration|1|||
38077301|NCT02810340|69774102|FG002|Overall Study|Incarceration|0|||
38077302|NCT02810340|69774100|FG000|Overall Study|Lost to Follow-up|0|||
38077303|NCT02810340|69774101|FG001|Overall Study|Lost to Follow-up|0|||
38077304|NCT02810340|69774102|FG002|Overall Study|Lost to Follow-up|1|||
38077305|NCT02817516|69774114|FG000|Overall Study|Other|0|||
38077306|NCT02817516|69774115|FG001|Overall Study|Other|0|||
38077307|NCT02817516|69774116|FG002|Overall Study|Other|1|||
38077308|NCT02817516|69774117|FG003|Overall Study|Other|0|||
38077309|NCT02928029|69774132|FG000|Overall Study|Withdrawal by Subject|0|||
38077310|NCT02928029|69774133|FG001|Overall Study|Withdrawal by Subject|1|||
38077311|NCT02928029|69774132|FG000|Overall Study|Radiological progression|1|||
38077312|NCT02928029|69774133|FG001|Overall Study|Radiological progression|0|||
38077313|NCT02928029|69774132|FG000|Overall Study|Clinical progression|1|||
38077314|NCT02928029|69774133|FG001|Overall Study|Clinical progression|2|||
38077315|NCT02928029|69774132|FG000|Overall Study|AE not related to clinical progression|1|||
38077316|NCT02928029|69774133|FG001|Overall Study|AE not related to clinical progression|1|||
38077317|NCT02806986|69774139|FG000|Treatment Stage 1|Adverse Event|1|||
38077318|NCT02806986|69774139|FG000|Treatment Stage 2|Adverse Event|3|||
38077319|NCT02806986|69774139|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
38077320|NCT03095651|69774155|FG000|Overall Study|Lost to Follow-up|1|||
38077321|NCT03095651|69774156|FG001|Overall Study|Lost to Follow-up|1|||
38077322|NCT03095651|69774157|FG002|Overall Study|Lost to Follow-up|0|||
38077323|NCT03095651|69774158|FG003|Overall Study|Lost to Follow-up|1|||
38077324|NCT03095651|69774159|FG004|Overall Study|Lost to Follow-up|0|||
38077325|NCT03095651|69774160|FG005|Overall Study|Lost to Follow-up|0|||
38077326|NCT03095651|69774161|FG006|Overall Study|Lost to Follow-up|0|||
38077327|NCT03095651|69774162|FG007|Overall Study|Lost to Follow-up|0|||
38077328|NCT03095651|69774155|FG000|Overall Study|Withdrawal by Subject|0|||
38077329|NCT03095651|69774156|FG001|Overall Study|Withdrawal by Subject|0|||
38077330|NCT03095651|69774157|FG002|Overall Study|Withdrawal by Subject|0|||
38077331|NCT03095651|69774158|FG003|Overall Study|Withdrawal by Subject|0|||
38077332|NCT03095651|69774159|FG004|Overall Study|Withdrawal by Subject|0|||
38077333|NCT03095651|69774160|FG005|Overall Study|Withdrawal by Subject|1|||
38077334|NCT03095651|69774161|FG006|Overall Study|Withdrawal by Subject|0|||
38077335|NCT03095651|69774162|FG007|Overall Study|Withdrawal by Subject|0|||
38077336|NCT02808312|69774185|FG000|Overall Study|Enrolled but Never Treated|0|||
38077337|NCT02808312|69774186|FG001|Overall Study|Enrolled but Never Treated|0|||
38077338|NCT02808312|69774187|FG002|Overall Study|Enrolled but Never Treated|1|||
38077339|NCT02808312|69774188|FG003|Overall Study|Enrolled but Never Treated|0|||
38077340|NCT02808312|69774189|FG004|Overall Study|Enrolled but Never Treated|0|||
38077341|NCT03099161|69774209|FG000|Overall Study|Adverse Event|0|||
38077342|NCT03099161|69774210|FG001|Overall Study|Adverse Event|0|||
38077343|NCT03099161|69774211|FG002|Overall Study|Adverse Event|2|||
38077344|NCT03099161|69774209|FG000|Overall Study|Physician Decision|2|||
38077345|NCT03099161|69774210|FG001|Overall Study|Physician Decision|0|||
38077346|NCT03099161|69774211|FG002|Overall Study|Physician Decision|0|||
38077347|NCT03099161|69774209|FG000|Overall Study|Progressive Disease|1|||
38077348|NCT03099161|69774210|FG001|Overall Study|Progressive Disease|4|||
38077349|NCT03099161|69774211|FG002|Overall Study|Progressive Disease|1|||
38077350|NCT03095027|69774219|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
38077351|NCT03095027|69774220|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
38077352|NCT04227197|69774228|FG000|Randomization|Protocol Violation|1|||
38077353|NCT04227197|69774229|FG001|Randomization|Protocol Violation|0|||
38077354|NCT04227197|69774228|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
38077355|NCT04227197|69774229|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
38077356|NCT04227197|69774228|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
38077357|NCT04227197|69774229|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
38077358|NCT04227197|69774228|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
38077359|NCT04227197|69774229|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
38077360|NCT04227197|69774228|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
38077361|NCT04227197|69774229|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
38077362|NCT04227197|69774228|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
38077363|NCT04227197|69774229|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
37966591|NCT00468819|69653471|FG002|Overall Study|Lost to Follow-up|1|||
38077364|NCT04227197|69774228|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
38077365|NCT04227197|69774229|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
38077366|NCT03080935|69774240|FG000|Overall Study|Death|34|||
38077367|NCT03080935|69774241|FG001|Overall Study|Death|50|||
38077368|NCT03080935|69774240|FG000|Overall Study|Lost to Follow-up|5|||
38077369|NCT03080935|69774241|FG001|Overall Study|Lost to Follow-up|4|||
38077370|NCT03080935|69774240|FG000|Overall Study|Withdrawal by Subject|11|||
38077371|NCT03080935|69774241|FG001|Overall Study|Withdrawal by Subject|15|||
38077372|NCT02921789|69774253|FG000|Overall Study|Adverse Event|0|||
38077373|NCT02921789|69774254|FG001|Overall Study|Adverse Event|1|||
38077374|NCT02921789|69774253|FG000|Overall Study|Lost to Follow-up|1|||
38077375|NCT02921789|69774254|FG001|Overall Study|Lost to Follow-up|0|||
37862359|NCT00919867|69546131|FG000|First Intervention|Withdrawal by Subject|0|||
38077376|NCT02921789|69774253|FG000|Overall Study|Protocol Deviation|2|||
38077377|NCT02921789|69774254|FG001|Overall Study|Protocol Deviation|0|||
38077378|NCT02921789|69774253|FG000|Overall Study|Withdrawal by Subject|2|||
38077379|NCT02921789|69774254|FG001|Overall Study|Withdrawal by Subject|1|||
38077380|NCT02921789|69774253|FG000|Overall Study|Miscellaneous|3|||
38077381|NCT02921789|69774254|FG001|Overall Study|Miscellaneous|2|||
38077382|NCT03097289|69774269|FG000|Overall Study|Adverse Event|1|||
38077383|NCT03097289|69774269|FG000|Overall Study|Equipment failure|2|||
38077384|NCT03097289|69774269|FG000|Overall Study|Collected platelet product unusable|3|||
38077385|NCT02419742|69774276|FG000|Overall Study|Adverse Event|2|||
38077386|NCT02419742|69774277|FG001|Overall Study|Adverse Event|0|||
38077387|NCT02419742|69774276|FG000|Overall Study|Disease Progression|0|||
38077388|NCT02419742|69774277|FG001|Overall Study|Disease Progression|1|||
38077389|NCT02419742|69774276|FG000|Overall Study|Withdrew Consent|2|||
38077390|NCT02419742|69774277|FG001|Overall Study|Withdrew Consent|1|||
38077391|NCT02419742|69774276|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
38077392|NCT02419742|69774277|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
38077393|NCT02409290|69774287|FG000|Overall Study|Protocol Violation|3|||
38077394|NCT02409290|69774288|FG001|Overall Study|Protocol Violation|6|||
38077395|NCT02409290|69774289|FG002|Overall Study|Protocol Violation|9|||
38077396|NCT02409290|69774290|FG003|Overall Study|Protocol Violation|4|||
38077397|NCT02409290|69774287|FG000|Overall Study|No positive culture/no baseline sample|3|||
38077398|NCT02409290|69774288|FG001|Overall Study|No positive culture/no baseline sample|9|||
38077399|NCT02409290|69774289|FG002|Overall Study|No positive culture/no baseline sample|6|||
38077400|NCT02409290|69774290|FG003|Overall Study|No positive culture/no baseline sample|5|||
38077401|NCT02409290|69774287|FG000|Overall Study|Completed but not analysed as recruitment stopped to this arm|26|||
38077402|NCT02409290|69774288|FG001|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
38077403|NCT02409290|69774289|FG002|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
38077404|NCT02409290|69774290|FG003|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
38077405|NCT02898077|69774302|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
38077406|NCT02898077|69774303|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
38077407|NCT02898077|69774302|FG000|Overall Study|Lost to Follow-up|4|||
38077408|NCT02898077|69774303|FG001|Overall Study|Lost to Follow-up|3|||
38077409|NCT02898077|69774302|FG000|Overall Study|Physician Decision|0|||
38077410|NCT02898077|69774303|FG001|Overall Study|Physician Decision|2|||
38077411|NCT02898077|69774302|FG000|Overall Study|Sponsor Decision|32|||
38077412|NCT02898077|69774303|FG001|Overall Study|Sponsor Decision|13|||
38077413|NCT02898077|69774302|FG000|Overall Study|Withdrawal by Subject|6|||
38077414|NCT02898077|69774303|FG001|Overall Study|Withdrawal by Subject|3|||
38077415|NCT02898077|69774302|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
38077416|NCT02898077|69774303|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
38077417|NCT02898077|69774302|FG000|Overall Study|Ended extension period|3|||
38077418|NCT02898077|69774303|FG001|Overall Study|Ended extension period|0|||
38077419|NCT03097133|69774311|FG000|Overall Study|Lost to Follow-up|3|||
38077420|NCT03097133|69774312|FG001|Overall Study|Lost to Follow-up|2|||
38077421|NCT03097133|69774311|FG000|Overall Study|Withdrawal by Subject|2|||
38077422|NCT03097133|69774312|FG001|Overall Study|Withdrawal by Subject|5|||
38077423|NCT03097133|69774311|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
38077424|NCT03097133|69774312|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
38077425|NCT03097133|69774311|FG000|Overall Study|Other|3|||
38077426|NCT03097133|69774312|FG001|Overall Study|Other|2|||
38077427|NCT03097133|69774311|FG000|Overall Study|Adverse Event|1|||
38077428|NCT03097133|69774312|FG001|Overall Study|Adverse Event|0|||
38077429|NCT03889639|69774326|FG000|Overall Study|Withdrawal by Subject|0|||
38077430|NCT03889639|69774327|FG001|Overall Study|Withdrawal by Subject|0|||
38077431|NCT03889639|69774328|FG002|Overall Study|Withdrawal by Subject|0|||
38077432|NCT03889639|69774329|FG003|Overall Study|Withdrawal by Subject|0|||
38077433|NCT03889639|69774330|FG004|Overall Study|Withdrawal by Subject|0|||
38077434|NCT03889639|69774331|FG005|Overall Study|Withdrawal by Subject|0|||
38077435|NCT03889639|69774332|FG006|Overall Study|Withdrawal by Subject|0|||
38077436|NCT03889639|69774333|FG007|Overall Study|Withdrawal by Subject|1|||
38077437|NCT03265145|69774356|FG000|Overall Study|Protocol Violation|2|||
38077438|NCT03265145|69774357|FG001|Overall Study|Protocol Violation|0|||
38077439|NCT03265145|69774356|FG000|Overall Study|Adverse Event|1|||
38077440|NCT03265145|69774357|FG001|Overall Study|Adverse Event|0|||
38077441|NCT03265145|69774356|FG000|Overall Study|Withdrawal by Subject|23|||
38077442|NCT03265145|69774357|FG001|Overall Study|Withdrawal by Subject|19|||
38077443|NCT03265145|69774356|FG000|Overall Study|Death|12|||
38077444|NCT03265145|69774357|FG001|Overall Study|Death|12|||
38077445|NCT03265145|69774356|FG000|Overall Study|Lost to Follow-up|13|||
38077446|NCT03265145|69774357|FG001|Overall Study|Lost to Follow-up|9|||
38077447|NCT03265145|69774356|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
38077448|NCT03265145|69774357|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
37966592|NCT00468819|69653469|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
38077449|NCT03265145|69774356|FG000|Overall Study|Switched back to previous medication|1|||
38077450|NCT03265145|69774357|FG001|Overall Study|Switched back to previous medication|0|||
38077451|NCT03265145|69774356|FG000|Overall Study|Did not want to take medication|1|||
38077452|NCT03265145|69774357|FG001|Overall Study|Did not want to take medication|0|||
38077453|NCT03265145|69774356|FG000|Overall Study|Subject could not afford medication|0|||
38077454|NCT03265145|69774357|FG001|Overall Study|Subject could not afford medication|1|||
38077455|NCT03265145|69774356|FG000|Overall Study|Site closed|2|||
38077456|NCT03265145|69774357|FG001|Overall Study|Site closed|3|||
38077457|NCT03265145|69774356|FG000|Overall Study|Incorrectly randomized|16|||
38077458|NCT03265145|69774357|FG001|Overall Study|Incorrectly randomized|6|||
38077459|NCT03265145|69774356|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
38077460|NCT03265145|69774357|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
38077461|NCT03265145|69774356|FG000|Overall Study|Physician Decision|0|||
38077462|NCT03265145|69774357|FG001|Overall Study|Physician Decision|3|||
38077463|NCT03265145|69774356|FG000|Overall Study|Subject transferred to another facility|0|||
38077464|NCT03265145|69774357|FG001|Overall Study|Subject transferred to another facility|1|||
38077465|NCT05674344|69774368|FG000|Overall Study|Screen Fail|21|||
38077466|NCT05674344|69774368|FG000|Overall Study|Incomplete study procedures|3|||
38077467|NCT04424641|69774434|FG000|Overall Study|Death|1|||
38077468|NCT04424641|69774435|FG001|Overall Study|Death|2|||
38077469|NCT04424641|69774436|FG002|Overall Study|Death|3|||
38077470|NCT04424641|69774437|FG003|Overall Study|Death|0|||
38077471|NCT04424641|69774438|FG004|Overall Study|Death|3|||
38077472|NCT04424641|69774439|FG005|Overall Study|Death|0|||
38077473|NCT04424641|69774440|FG006|Overall Study|Death|1|||
38077474|NCT04424641|69774441|FG007|Overall Study|Death|2|||
38077475|NCT04424641|69774434|FG000|Overall Study|Sponsor decision|0|||
38077476|NCT04424641|69774435|FG001|Overall Study|Sponsor decision|2|||
38077477|NCT04424641|69774436|FG002|Overall Study|Sponsor decision|3|||
38077478|NCT04424641|69774437|FG003|Overall Study|Sponsor decision|7|||
38077479|NCT04424641|69774438|FG004|Overall Study|Sponsor decision|2|||
38077480|NCT04424641|69774439|FG005|Overall Study|Sponsor decision|2|||
38077481|NCT04424641|69774440|FG006|Overall Study|Sponsor decision|3|||
38077482|NCT04424641|69774441|FG007|Overall Study|Sponsor decision|4|||
38077483|NCT04424641|69774434|FG000|Overall Study|Withdrawal by Subject|0|||
38077484|NCT04424641|69774435|FG001|Overall Study|Withdrawal by Subject|0|||
38077485|NCT04424641|69774436|FG002|Overall Study|Withdrawal by Subject|0|||
38077486|NCT04424641|69774437|FG003|Overall Study|Withdrawal by Subject|0|||
38077487|NCT04424641|69774438|FG004|Overall Study|Withdrawal by Subject|1|||
38077488|NCT04424641|69774439|FG005|Overall Study|Withdrawal by Subject|0|||
38077489|NCT04424641|69774440|FG006|Overall Study|Withdrawal by Subject|0|||
38077490|NCT04424641|69774441|FG007|Overall Study|Withdrawal by Subject|0|||
38077491|NCT04424641|69774434|FG000|Overall Study|Other|0|||
38077492|NCT04424641|69774435|FG001|Overall Study|Other|0|||
38077493|NCT04424641|69774436|FG002|Overall Study|Other|1|||
38077494|NCT04424641|69774437|FG003|Overall Study|Other|0|||
38077495|NCT04424641|69774438|FG004|Overall Study|Other|0|||
38077496|NCT04424641|69774439|FG005|Overall Study|Other|0|||
38077497|NCT04424641|69774440|FG006|Overall Study|Other|0|||
38077498|NCT04424641|69774441|FG007|Overall Study|Other|0|||
38077499|NCT04276090|69774470|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
38077500|NCT04276090|69774471|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
38077501|NCT04105842|69774481|FG000|Overall Study|Withdrawal by Subject|2|||
38077502|NCT04088734|69774488|FG000|Overall Study|Other, Not Specified|5|||
38077503|NCT03868787|69774511|FG000|Overall Study|Withdrawal by Subject|2|||
38077504|NCT03868787|69774512|FG001|Overall Study|Withdrawal by Subject|1|||
38077505|NCT03457701|69774543|FG000|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
38077506|NCT03457701|69774544|FG001|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
38077507|NCT03457701|69774543|FG000|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|0|||
38077508|NCT03457701|69774544|FG001|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
38077509|NCT02694978|69774646|FG000|Overall Study|Adverse Event|10|||
38077510|NCT02694978|69774647|FG001|Overall Study|Adverse Event|9|||
38077511|NCT02694978|69774646|FG000|Overall Study|Withdrawal by Subject|22|||
38077512|NCT02694978|69774647|FG001|Overall Study|Withdrawal by Subject|19|||
38077513|NCT02694978|69774646|FG000|Overall Study|Lost to Follow-up|14|||
38077514|NCT02694978|69774647|FG001|Overall Study|Lost to Follow-up|17|||
38077515|NCT02694978|69774646|FG000|Overall Study|Death|4|||
38077516|NCT02694978|69774647|FG001|Overall Study|Death|1|||
38077517|NCT02694978|69774646|FG000|Overall Study|Other-Decision of Participant|6|||
38077518|NCT02694978|69774647|FG001|Overall Study|Other-Decision of Participant|1|||
38077519|NCT02694978|69774646|FG000|Overall Study|Other-Investigator's decision|1|||
38077520|NCT02694978|69774647|FG001|Overall Study|Other-Investigator's decision|0|||
38077521|NCT02694978|69774646|FG000|Overall Study|Other-Unable to be reached|0|||
38077522|NCT02694978|69774647|FG001|Overall Study|Other-Unable to be reached|1|||
38077523|NCT02694978|69774646|FG000|Overall Study|Other-Protocol noncompliant|2|||
38077524|NCT02694978|69774647|FG001|Overall Study|Other-Protocol noncompliant|1|||
38077525|NCT02694978|69774646|FG000|Overall Study|Other-Personal reasons|3|||
38077526|NCT02694978|69774647|FG001|Overall Study|Other-Personal reasons|3|||
38077527|NCT02694978|69774646|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
38077528|NCT02694978|69774647|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
38077529|NCT02563002|69774655|FG000|Overall Study|Death|62|||
38077530|NCT02563002|69774656|FG001|Overall Study|Death|75|||
38077531|NCT02563002|69774655|FG000|Overall Study|Lost to Follow-up|1|||
38077532|NCT02563002|69774656|FG001|Overall Study|Lost to Follow-up|0|||
38077533|NCT02563002|69774655|FG000|Overall Study|Withdrawal by Subject|0|||
38077534|NCT02563002|69774656|FG001|Overall Study|Withdrawal by Subject|9|||
38077535|NCT02563002|69774655|FG000|Overall Study|Ongoing|90|||
38077536|NCT02563002|69774656|FG001|Overall Study|Ongoing|70|||
38077537|NCT02454933|69774667|FG000|Overall Study|Progressive disease|7|||
38077538|NCT02454933|69774668|FG001|Overall Study|Progressive disease|5|||
38077539|NCT02454933|69774667|FG000|Overall Study|Adverse Event|1|||
38077540|NCT02454933|69774668|FG001|Overall Study|Adverse Event|1|||
38077541|NCT02454933|69774667|FG000|Overall Study|Withdrawal by Subject|0|||
38077542|NCT02454933|69774668|FG001|Overall Study|Withdrawal by Subject|2|||
38077543|NCT02430480|69774673|FG000|Overall Study|Death|1|||
38077544|NCT02430480|69774673|FG000|Overall Study|Anesthesia concerns|1|||
38077545|NCT02430480|69774673|FG000|Overall Study|Progressed on treatment|1|||
38077546|NCT01864018|69774687|FG000|Overall Study|Ineligible|3|||
38077547|NCT01864018|69774688|FG001|Overall Study|Ineligible|1|||
38077548|NCT01796197|69774699|FG000|Overall Study|Lost to Follow-up|1|||
38077549|NCT01796197|69774699|FG000|Overall Study|Lack of Efficacy|1|||
38077550|NCT01205048|69774705|FG000|Overall Study|Withdrawal by Subject|14|||
38077551|NCT01205048|69774705|FG000|Overall Study|Clinical Investigation Plan Violation|1|||
38077552|NCT01205048|69774705|FG000|Overall Study|Lost to Follow-up|4|||
38077553|NCT01205048|69774705|FG000|Overall Study|Other|2|||
38077554|NCT01052779|69774713|FG000|Overall Study|Adverse Event|1|||
38077555|NCT01052779|69774714|FG001|Overall Study|Adverse Event|4|||
38077556|NCT01052779|69774713|FG000|Overall Study|Withdrawal by Subject|1|||
38077557|NCT01052779|69774714|FG001|Overall Study|Withdrawal by Subject|2|||
38077558|NCT01052779|69774713|FG000|Overall Study|Other-Protocol Violation|1|||
38077559|NCT01052779|69774714|FG001|Overall Study|Other-Protocol Violation|1|||
38077560|NCT01052779|69774713|FG000|Overall Study|Other-Surgery|0|||
38077561|NCT01052779|69774714|FG001|Overall Study|Other-Surgery|2|||
38077562|NCT01052779|69774713|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
38077563|NCT01052779|69774714|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
38077564|NCT00591370|69774724|FG000|Overall Study|Not Treated|2|||
38077565|NCT03064763|69774728|FG000|Overall Study|Lost to Follow-up|1|||
38077566|NCT03064763|69774728|FG000|Overall Study|Death|8|||
38077567|NCT02782676|69774732|FG000|Overall Study|Lost to Follow-up|0|||
38077568|NCT02782676|69774733|FG001|Overall Study|Lost to Follow-up|1|||
38077569|NCT02471339|69774741|FG000|Overall Study|Did not provide follow-up data|2|||
38077570|NCT02471339|69774742|FG001|Overall Study|Did not provide follow-up data|0|||
38077571|NCT00107978|69774750|FG000|Overall Study|Adverse Event|1|||
38077572|NCT00107978|69774751|FG001|Overall Study|Adverse Event|5|||
38077573|NCT00107978|69774750|FG000|Overall Study|Death|3|||
38077574|NCT00107978|69774751|FG001|Overall Study|Death|3|||
38077575|NCT00107978|69774750|FG000|Overall Study|Lost to Follow-up|20|||
38077576|NCT00107978|69774751|FG001|Overall Study|Lost to Follow-up|28|||
38077577|NCT00107978|69774750|FG000|Overall Study|Withdrawal by Subject|4|||
38077578|NCT00107978|69774751|FG001|Overall Study|Withdrawal by Subject|9|||
38077579|NCT00107978|69774750|FG000|Overall Study|Protocol Violation|0|||
38077580|NCT00107978|69774751|FG001|Overall Study|Protocol Violation|1|||
38077581|NCT00107978|69774750|FG000|Overall Study|Other|5|||
38077582|NCT00107978|69774751|FG001|Overall Study|Other|4|||
38077583|NCT02781818|69774760|FG000|Overall Study|Lost to Follow-up|4|||
38077584|NCT02781818|69774761|FG001|Overall Study|Lost to Follow-up|2|||
38077585|NCT02781818|69774762|FG002|Overall Study|Lost to Follow-up|1|||
38077586|NCT02927873|69774776|FG000|Overall Study|Lost to Follow-up|0|||
38077587|NCT02927873|69774777|FG001|Overall Study|Lost to Follow-up|1|||
38077588|NCT02927873|69774778|FG002|Overall Study|Lost to Follow-up|0|||
38077589|NCT02927873|69774779|FG003|Overall Study|Lost to Follow-up|0|||
38077590|NCT02927873|69774780|FG004|Overall Study|Lost to Follow-up|0|||
37966593|NCT00468819|69653470|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
38077591|NCT02927873|69774781|FG005|Overall Study|Lost to Follow-up|0|||
38077592|NCT02927873|69774776|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
38077593|NCT02927873|69774777|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
38077594|NCT02927873|69774778|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
38077595|NCT02927873|69774779|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
38077596|NCT02927873|69774780|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
38077597|NCT02927873|69774781|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
38077598|NCT02927873|69774776|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
38077599|NCT02927873|69774777|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
38077600|NCT02927873|69774778|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
38077601|NCT02927873|69774779|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
38077602|NCT02927873|69774780|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
38077603|NCT02927873|69774781|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
38077604|NCT02927873|69774776|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
38077605|NCT02927873|69774777|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
38077606|NCT02927873|69774778|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
38077607|NCT02927873|69774779|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
38077608|NCT02927873|69774780|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
38077609|NCT02927873|69774781|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
38077610|NCT02927873|69774776|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
38077611|NCT02927873|69774777|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
38077612|NCT02927873|69774778|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
38077613|NCT02927873|69774779|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
38077614|NCT02927873|69774780|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
38077615|NCT02927873|69774781|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
38077616|NCT02927873|69774776|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
38077617|NCT02927873|69774777|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
38077618|NCT02927873|69774778|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
38077619|NCT02927873|69774779|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
38077620|NCT02927873|69774780|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
38077621|NCT02927873|69774781|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
38077622|NCT01220999|69774800|FG000|Overall Study|Progressive disease|0|||
38077623|NCT01220999|69774801|FG001|Overall Study|Progressive disease|0|||
38077624|NCT01220999|69774802|FG002|Overall Study|Progressive disease|1|||
38077625|NCT01220999|69774803|FG003|Overall Study|Progressive disease|0|||
38077626|NCT01220999|69774804|FG004|Overall Study|Progressive disease|0|||
38077627|NCT00142415|69774822|FG000|Overall Study|Physician Decision|0|||
38077628|NCT00142415|69774823|FG001|Overall Study|Physician Decision|0|||
38077629|NCT00142415|69774824|FG002|Overall Study|Physician Decision|0|||
38077630|NCT00142415|69774825|FG003|Overall Study|Physician Decision|0|||
38077631|NCT00142415|69774826|FG004|Overall Study|Physician Decision|1|||
38077632|NCT00142415|69774827|FG005|Overall Study|Physician Decision|2|||
38077633|NCT02781584|69774869|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
38077634|NCT02781584|69774870|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
38077635|NCT02781584|69774871|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
38077636|NCT02781584|69774872|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
38077637|NCT02781584|69774873|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
38077638|NCT02781584|69774874|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
38077639|NCT02781584|69774875|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
38077640|NCT02781584|69774876|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
38077641|NCT02781584|69774877|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
38077642|NCT02781584|69774878|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
38077643|NCT02781584|69774879|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
38077644|NCT02781584|69774880|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
38077645|NCT02781584|69774881|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
38077646|NCT02781584|69774869|FG000|Pre-treatment Phase|Adverse Event|0|||
38077647|NCT02781584|69774870|FG001|Pre-treatment Phase|Adverse Event|0|||
38077648|NCT02781584|69774871|FG002|Pre-treatment Phase|Adverse Event|0|||
38077649|NCT02781584|69774872|FG003|Pre-treatment Phase|Adverse Event|0|||
38077650|NCT02781584|69774873|FG004|Pre-treatment Phase|Adverse Event|0|||
38077651|NCT02781584|69774874|FG005|Pre-treatment Phase|Adverse Event|0|||
38077652|NCT02781584|69774875|FG006|Pre-treatment Phase|Adverse Event|0|||
38077653|NCT02781584|69774876|FG007|Pre-treatment Phase|Adverse Event|0|||
38077654|NCT02781584|69774877|FG008|Pre-treatment Phase|Adverse Event|0|||
38077655|NCT02781584|69774878|FG009|Pre-treatment Phase|Adverse Event|0|||
38077656|NCT02781584|69774879|FG010|Pre-treatment Phase|Adverse Event|0|||
38077657|NCT02781584|69774880|FG011|Pre-treatment Phase|Adverse Event|1|||
38077658|NCT02781584|69774881|FG012|Pre-treatment Phase|Adverse Event|0|||
38077659|NCT02781584|69774869|FG000|Treatment Phase|Withdrew Consent|0|||
38077660|NCT02781584|69774870|FG001|Treatment Phase|Withdrew Consent|0|||
38077661|NCT02781584|69774871|FG002|Treatment Phase|Withdrew Consent|0|||
38077662|NCT02781584|69774872|FG003|Treatment Phase|Withdrew Consent|0|||
38077663|NCT02781584|69774873|FG004|Treatment Phase|Withdrew Consent|0|||
38077664|NCT02781584|69774874|FG005|Treatment Phase|Withdrew Consent|1|||
38077665|NCT02781584|69774875|FG006|Treatment Phase|Withdrew Consent|0|||
38077666|NCT02781584|69774876|FG007|Treatment Phase|Withdrew Consent|0|||
38077667|NCT02781584|69774877|FG008|Treatment Phase|Withdrew Consent|0|||
38077668|NCT02781584|69774878|FG009|Treatment Phase|Withdrew Consent|0|||
38077669|NCT02781584|69774879|FG010|Treatment Phase|Withdrew Consent|1|||
38077670|NCT02781584|69774880|FG011|Treatment Phase|Withdrew Consent|2|||
38077671|NCT02781584|69774881|FG012|Treatment Phase|Withdrew Consent|0|||
38077672|NCT02781584|69774869|FG000|Treatment Phase|Adverse Event|0|||
38077673|NCT02781584|69774870|FG001|Treatment Phase|Adverse Event|0|||
38077674|NCT02781584|69774871|FG002|Treatment Phase|Adverse Event|0|||
38077675|NCT02781584|69774872|FG003|Treatment Phase|Adverse Event|0|||
38077676|NCT02781584|69774873|FG004|Treatment Phase|Adverse Event|0|||
38077677|NCT02781584|69774874|FG005|Treatment Phase|Adverse Event|0|||
38077678|NCT02781584|69774875|FG006|Treatment Phase|Adverse Event|0|||
38077679|NCT02781584|69774876|FG007|Treatment Phase|Adverse Event|1|||
38077680|NCT02781584|69774877|FG008|Treatment Phase|Adverse Event|0|||
38077681|NCT02781584|69774878|FG009|Treatment Phase|Adverse Event|0|||
38077682|NCT02781584|69774879|FG010|Treatment Phase|Adverse Event|0|||
38077683|NCT02781584|69774880|FG011|Treatment Phase|Adverse Event|0|||
38077684|NCT02781584|69774881|FG012|Treatment Phase|Adverse Event|0|||
38077685|NCT02776670|69774911|FG000|Overall Study|Adverse Event|0|||
38077686|NCT02776670|69774912|FG001|Overall Study|Adverse Event|2|||
38077687|NCT02776670|69774911|FG000|Overall Study|Protocol Violation|0|||
38077688|NCT02776670|69774912|FG001|Overall Study|Protocol Violation|2|||
38077689|NCT02776670|69774911|FG000|Overall Study|Withdrawal by Subject|0|||
38077690|NCT02776670|69774912|FG001|Overall Study|Withdrawal by Subject|1|||
38077691|NCT02776670|69774911|FG000|Overall Study|Other - Reason not given|0|||
38077692|NCT02776670|69774912|FG001|Overall Study|Other - Reason not given|1|||
38077693|NCT01307423|69774921|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
38077694|NCT01307423|69774922|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
38077695|NCT01307423|69774923|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
38077696|NCT01307423|69774924|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
38077697|NCT01307423|69774925|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
38077698|NCT01307423|69774926|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
38077699|NCT01307423|69774927|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
38077700|NCT01307423|69774928|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
38077701|NCT01307423|69774929|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
38077702|NCT01307423|69774921|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
38077703|NCT01307423|69774922|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
38077704|NCT01307423|69774923|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
38077705|NCT01307423|69774924|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
38077706|NCT01307423|69774925|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
38077707|NCT01307423|69774926|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
38077708|NCT01307423|69774927|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
38077709|NCT01307423|69774928|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
38077710|NCT01307423|69774929|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
38077711|NCT01307423|69774921|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
38077712|NCT01307423|69774922|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
38077713|NCT01307423|69774923|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
38077714|NCT01307423|69774924|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
38077715|NCT01307423|69774925|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
38077716|NCT01307423|69774926|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
38077717|NCT01307423|69774927|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
38077718|NCT01307423|69774928|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
38077719|NCT01307423|69774929|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
38077720|NCT01307423|69774921|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
38077721|NCT01307423|69774922|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
38077722|NCT01307423|69774923|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
38077723|NCT01307423|69774924|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
38077724|NCT01307423|69774925|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
38077725|NCT01307423|69774926|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
38077726|NCT01307423|69774927|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
38077727|NCT01307423|69774928|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
38077728|NCT01307423|69774929|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
38077729|NCT01307423|69774921|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
38077730|NCT01307423|69774922|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
38077731|NCT01307423|69774923|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
38077732|NCT01307423|69774924|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
38077733|NCT01307423|69774925|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
38077734|NCT01307423|69774926|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
38077735|NCT01307423|69774927|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
38077736|NCT01307423|69774928|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
38077737|NCT01307423|69774929|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
38077738|NCT01307423|69774921|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
38077739|NCT01307423|69774922|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
38077740|NCT01307423|69774923|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
38077741|NCT01307423|69774924|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
38077742|NCT01307423|69774925|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
38077743|NCT01307423|69774926|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
38077744|NCT01307423|69774927|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
38077745|NCT01307423|69774928|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
38077746|NCT01307423|69774929|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
38077747|NCT01307423|69774921|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
38077748|NCT01307423|69774922|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
38077749|NCT01307423|69774923|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
38077750|NCT01307423|69774924|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
38077751|NCT01307423|69774925|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
38077752|NCT01307423|69774926|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
38077753|NCT01307423|69774927|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
38077754|NCT01307423|69774928|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
38077755|NCT01307423|69774929|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
38077756|NCT01307423|69774921|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
38077757|NCT01307423|69774922|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
38077758|NCT01307423|69774923|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
38077759|NCT01307423|69774924|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
38077760|NCT01307423|69774925|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
38077761|NCT01307423|69774926|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
38077762|NCT01307423|69774927|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
38077763|NCT01307423|69774928|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
38077764|NCT01307423|69774929|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
38077765|NCT01307423|69774921|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
38077766|NCT01307423|69774922|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
38077767|NCT01307423|69774923|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
38077768|NCT01307423|69774924|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
38077769|NCT01307423|69774925|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
38077770|NCT01307423|69774926|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
38077771|NCT01307423|69774927|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
38077772|NCT01307423|69774928|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
38077773|NCT01307423|69774929|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
38077774|NCT01307423|69774921|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
38077775|NCT01307423|69774922|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
38077776|NCT01307423|69774923|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
38077777|NCT01307423|69774924|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
38077778|NCT01307423|69774925|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
38077779|NCT01307423|69774926|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
38077780|NCT01307423|69774927|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
38077781|NCT01307423|69774928|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
38077782|NCT01307423|69774929|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
38077783|NCT01307423|69774921|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
38077784|NCT01307423|69774922|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
38077785|NCT01307423|69774923|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
38077786|NCT01307423|69774924|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
38077787|NCT01307423|69774925|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
38077788|NCT01307423|69774926|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
38077789|NCT01307423|69774927|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
38077790|NCT01307423|69774928|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
38077791|NCT01307423|69774929|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
38077792|NCT01307423|69774921|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
38077793|NCT01307423|69774922|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
38077794|NCT01307423|69774923|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
38077795|NCT01307423|69774924|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
38077796|NCT01307423|69774925|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
38077797|NCT01307423|69774926|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
38077798|NCT01307423|69774927|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
38077799|NCT01307423|69774928|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
38077800|NCT01307423|69774929|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
38077801|NCT01307423|69774921|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
38077802|NCT01307423|69774922|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
37966594|NCT00468819|69653471|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
38077803|NCT01307423|69774923|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
38077804|NCT01307423|69774924|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
38077805|NCT01307423|69774925|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
38077806|NCT01307423|69774926|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
38077807|NCT01307423|69774927|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
38077808|NCT01307423|69774928|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
38077809|NCT01307423|69774929|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
38077810|NCT01307423|69774921|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
38077811|NCT01307423|69774922|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
38077812|NCT01307423|69774923|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
38077813|NCT01307423|69774924|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
38077814|NCT01307423|69774925|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
38077815|NCT01307423|69774926|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
38077816|NCT01307423|69774927|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
38077817|NCT01307423|69774928|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
38077818|NCT01307423|69774929|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
38077819|NCT01307423|69774921|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
38077820|NCT01307423|69774922|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
38077821|NCT01307423|69774923|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
38077822|NCT01307423|69774924|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
38077823|NCT01307423|69774925|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
38077824|NCT01307423|69774926|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
38077825|NCT01307423|69774927|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
38077826|NCT01307423|69774928|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
38077827|NCT01307423|69774929|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
38077828|NCT01307423|69774921|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
38077829|NCT01307423|69774922|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
38077830|NCT01307423|69774923|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
38077831|NCT01307423|69774924|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
38077832|NCT01307423|69774925|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
38077833|NCT01307423|69774926|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
38077834|NCT01307423|69774927|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
38077835|NCT01307423|69774928|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
38077836|NCT01307423|69774929|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
38077837|NCT01307423|69774921|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
38077838|NCT01307423|69774922|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
38077839|NCT01307423|69774923|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
38077840|NCT01307423|69774924|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
38077841|NCT01307423|69774925|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
38077842|NCT01307423|69774926|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
38077843|NCT01307423|69774927|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
38077844|NCT01307423|69774928|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
38077845|NCT01307423|69774929|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
37966595|NCT00451191|69653483|FG000|Overall Study|withdrawal or received alternate tx|15|||
37966596|NCT00451191|69653484|FG001|Overall Study|withdrawal or received alternate tx|11|||
37966597|NCT00451035|69653490|FG000|Overall Study|Disease progression|11|||
37966598|NCT00451035|69653490|FG000|Overall Study|Death|3|||
37966599|NCT00451035|69653490|FG000|Overall Study|New anti-neoplastic therapy|3|||
37966600|NCT00468585|69653499|FG000|Overall Study|Patient not treated|1|||
37966601|NCT00468585|69653500|FG001|Overall Study|Patient not treated|0|||
37966602|NCT00468585|69653501|FG002|Overall Study|Patient not treated|1|||
37966603|NCT00468585|69653502|FG003|Overall Study|Patient not treated|0|||
37966604|NCT00468585|69653499|FG000|Overall Study|Patient found to be ineligible|0|||
38077846|NCT01307423|69774921|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
38077847|NCT01307423|69774922|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
38077848|NCT01307423|69774923|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
37966605|NCT00468585|69653500|FG001|Overall Study|Patient found to be ineligible|0|||
38077849|NCT01307423|69774924|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
38077850|NCT01307423|69774925|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
38077851|NCT01307423|69774926|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
38077852|NCT01307423|69774927|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
38077853|NCT01307423|69774928|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
38077854|NCT01307423|69774929|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
38077855|NCT01307423|69774921|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
38077856|NCT01307423|69774922|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
38077857|NCT01307423|69774923|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
38077858|NCT01307423|69774924|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
38077859|NCT01307423|69774925|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
38077860|NCT01307423|69774926|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
38077861|NCT01307423|69774927|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
38077862|NCT01307423|69774928|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
38077863|NCT01307423|69774929|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
38077864|NCT01307423|69774921|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
38077865|NCT01307423|69774922|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
38077866|NCT01307423|69774923|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
38077867|NCT01307423|69774924|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
38077868|NCT01307423|69774925|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
38077869|NCT01307423|69774926|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
38077870|NCT01307423|69774927|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
38077871|NCT01307423|69774928|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
38077872|NCT01307423|69774929|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
38077873|NCT01307423|69774921|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
38077874|NCT01307423|69774922|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
38077875|NCT01307423|69774923|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
38077876|NCT01307423|69774924|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
38077877|NCT01307423|69774925|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
38077878|NCT01307423|69774926|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
38077879|NCT01307423|69774927|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
38077880|NCT01307423|69774928|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
38077881|NCT01307423|69774929|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
38077882|NCT01307423|69774921|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
38077883|NCT01307423|69774922|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
38077884|NCT01307423|69774923|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
38077885|NCT01307423|69774924|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
38077886|NCT01307423|69774925|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
38077887|NCT01307423|69774926|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
38077888|NCT01307423|69774927|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
38077889|NCT01307423|69774928|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
38077890|NCT01307423|69774929|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
38077891|NCT01307423|69774921|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
38077892|NCT01307423|69774922|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
38077893|NCT01307423|69774923|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
38077894|NCT01307423|69774924|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
38077895|NCT01307423|69774925|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
38077896|NCT01307423|69774926|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
38077897|NCT01307423|69774927|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
38077898|NCT01307423|69774928|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
38077899|NCT01307423|69774929|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
38077900|NCT01307423|69774921|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
38077901|NCT01307423|69774922|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
38077902|NCT01307423|69774923|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
38077903|NCT01307423|69774924|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
38077904|NCT01307423|69774925|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
38077905|NCT01307423|69774926|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
38077906|NCT01307423|69774927|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
38077907|NCT01307423|69774928|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
38077908|NCT01307423|69774929|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
38077909|NCT01307423|69774921|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
38077910|NCT01307423|69774922|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
38077911|NCT01307423|69774923|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
38077912|NCT01307423|69774924|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
38077913|NCT01307423|69774925|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
38077914|NCT01307423|69774926|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
38077915|NCT01307423|69774927|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
38077916|NCT01307423|69774928|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
38077917|NCT01307423|69774929|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
38077918|NCT01307423|69774921|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
38077919|NCT01307423|69774922|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
38077920|NCT01307423|69774923|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
38077921|NCT01307423|69774924|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
38077922|NCT01307423|69774925|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
38077923|NCT01307423|69774926|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
38077924|NCT01307423|69774927|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
38077925|NCT01307423|69774928|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
38077926|NCT01307423|69774929|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
38077927|NCT01307423|69774921|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
38077928|NCT01307423|69774922|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
38077929|NCT01307423|69774923|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
38077930|NCT01307423|69774924|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
38077931|NCT01307423|69774925|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
38077932|NCT01307423|69774926|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
38077933|NCT01307423|69774927|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
38077934|NCT01307423|69774928|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
38077935|NCT01307423|69774929|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
38077936|NCT01307423|69774921|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
38077937|NCT01307423|69774922|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
38077938|NCT01307423|69774923|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
38077939|NCT01307423|69774924|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
38077940|NCT01307423|69774925|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
38077941|NCT01307423|69774926|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
38077942|NCT01307423|69774927|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
38077943|NCT01307423|69774928|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
38077944|NCT01307423|69774929|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
38077945|NCT01307423|69774921|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
38077946|NCT01307423|69774922|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
38077947|NCT01307423|69774923|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
38077948|NCT01307423|69774924|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
38077949|NCT01307423|69774925|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
38077950|NCT01307423|69774926|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
38077951|NCT01307423|69774927|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
38077952|NCT01307423|69774928|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
38077953|NCT01307423|69774929|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
38077954|NCT01307423|69774921|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
38077955|NCT01307423|69774922|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
38077956|NCT01307423|69774923|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
38077957|NCT01307423|69774924|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
38077958|NCT01307423|69774925|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
38077959|NCT01307423|69774926|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
38077960|NCT01307423|69774927|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
38077961|NCT01307423|69774928|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
38077962|NCT01307423|69774929|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
38077963|NCT01307423|69774921|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
38077964|NCT01307423|69774922|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
38077965|NCT01307423|69774923|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
38077966|NCT01307423|69774924|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
38077967|NCT01307423|69774925|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
38077968|NCT01307423|69774926|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
38077969|NCT01307423|69774927|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
38077970|NCT01307423|69774928|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
38077971|NCT01307423|69774929|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
38077972|NCT01307423|69774921|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
38077973|NCT01307423|69774922|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
38077974|NCT01307423|69774923|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
38077975|NCT01307423|69774924|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
38077976|NCT01307423|69774925|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
38077977|NCT01307423|69774926|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
38077978|NCT01307423|69774927|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
38077979|NCT01307423|69774928|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
38077980|NCT01307423|69774929|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
38077981|NCT01307423|69774921|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
38077982|NCT01307423|69774922|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
38077983|NCT01307423|69774923|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
38077984|NCT01307423|69774924|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
38077985|NCT01307423|69774925|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
38077986|NCT01307423|69774926|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
38077987|NCT01307423|69774927|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
38077988|NCT01307423|69774928|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
38077989|NCT01307423|69774929|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
38077990|NCT01307423|69774921|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
38077991|NCT01307423|69774922|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
38077992|NCT01307423|69774923|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
38077993|NCT01307423|69774924|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
38077994|NCT01307423|69774925|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
38077995|NCT01307423|69774926|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
38077996|NCT01307423|69774927|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
38077997|NCT01307423|69774928|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
38077998|NCT01307423|69774929|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
38077999|NCT01307423|69774921|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
38078000|NCT01307423|69774922|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
38078001|NCT01307423|69774923|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
38078002|NCT01307423|69774924|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
38078003|NCT01307423|69774925|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
38078004|NCT01307423|69774926|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
38078005|NCT01307423|69774927|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
38078006|NCT01307423|69774928|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
38078007|NCT01307423|69774929|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
38078008|NCT01307423|69774921|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
38078009|NCT01307423|69774922|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
38078010|NCT01307423|69774923|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
38078011|NCT01307423|69774924|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
38078012|NCT01307423|69774925|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
38078013|NCT01307423|69774926|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
38078014|NCT01307423|69774927|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
38078015|NCT01307423|69774928|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
38078016|NCT01307423|69774929|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
38078017|NCT02778074|69774963|FG000|Overall Study|Lost to Follow-up|7|||
38078018|NCT02778074|69774964|FG001|Overall Study|Lost to Follow-up|10|||
38078019|NCT02775344|69774981|FG000|Overall Study|No ovarian cyst identified|3|||
38078020|NCT02775344|69774982|FG001|Overall Study|No ovarian cyst identified|2|||
38078021|NCT02777918|69774990|FG000|Overall Study|Medical reasons|1|||
38078022|NCT02777918|69774991|FG001|Overall Study|Medical reasons|2|||
38078023|NCT02777918|69774990|FG000|Overall Study|Too busy / stressed|1|||
38078024|NCT02777918|69774991|FG001|Overall Study|Too busy / stressed|1|||
38078025|NCT02777918|69774990|FG000|Overall Study|Withdrawal by Subject|1|||
38078026|NCT02777918|69774991|FG001|Overall Study|Withdrawal by Subject|1|||
38078027|NCT02927795|69774997|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
38078028|NCT02927795|69774997|FG000|Overall Study|Not Treated|4|||
38078029|NCT02767856|69775003|FG000|Overall Study|Lost to Follow-up|9|||
38078030|NCT02767856|69775004|FG001|Overall Study|Lost to Follow-up|1|||
38078031|NCT02767856|69775003|FG000|Overall Study|Withdrawal by Subject|2|||
38078032|NCT02767856|69775004|FG001|Overall Study|Withdrawal by Subject|1|||
38078033|NCT03087851|69775013|FG000|Overall Study|Withdraw on medical grounds|0|||
38078034|NCT03087851|69775014|FG001|Overall Study|Withdraw on medical grounds|1|||
38078035|NCT03087851|69775015|FG002|Overall Study|Withdraw on medical grounds|2|||
38078036|NCT03092375|69775027|FG000|Overall Study|Lack of Efficacy|0|||
38078037|NCT03092375|69775028|FG001|Overall Study|Lack of Efficacy|1|||
38078038|NCT03092375|69775029|FG002|Overall Study|Lack of Efficacy|1|||
38078039|NCT03092375|69775030|FG003|Overall Study|Lack of Efficacy|0|||
38078040|NCT01995513|69775047|FG000|Period 1: First Open Label Treatment|Other|34|||
38078041|NCT01995513|69775048|FG001|Period 1: First Open Label Treatment|Other|0|||
38078042|NCT01995513|69775049|FG002|Period 1: First Open Label Treatment|Other|0|||
38078043|NCT01995513|69775050|FG003|Period 1: First Open Label Treatment|Other|0|||
38078044|NCT01995513|69775047|FG000|Period 1: First Open Label Treatment|Death|14|||
38078045|NCT01995513|69775048|FG001|Period 1: First Open Label Treatment|Death|0|||
38078046|NCT01995513|69775049|FG002|Period 1: First Open Label Treatment|Death|0|||
38078047|NCT01995513|69775050|FG003|Period 1: First Open Label Treatment|Death|0|||
38078048|NCT01995513|69775047|FG000|Period 1: First Open Label Treatment|Adverse Event|40|||
38078049|NCT01995513|69775048|FG001|Period 1: First Open Label Treatment|Adverse Event|0|||
38078050|NCT01995513|69775049|FG002|Period 1: First Open Label Treatment|Adverse Event|0|||
38078051|NCT01995513|69775050|FG003|Period 1: First Open Label Treatment|Adverse Event|0|||
38078052|NCT01995513|69775047|FG000|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|43|||
38078053|NCT01995513|69775048|FG001|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
38078054|NCT01995513|69775049|FG002|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
38078055|NCT01995513|69775050|FG003|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
38078056|NCT01995513|69775047|FG000|Period 1: First Open Label Treatment|Disease Progression|92|||
38078057|NCT01995513|69775048|FG001|Period 1: First Open Label Treatment|Disease Progression|0|||
38078058|NCT01995513|69775049|FG002|Period 1: First Open Label Treatment|Disease Progression|0|||
38078059|NCT01995513|69775050|FG003|Period 1: First Open Label Treatment|Disease Progression|0|||
38078060|NCT01995513|69775047|FG000|Period 1: First Open Label Treatment|Protocol Non-Compliance|2|||
38078061|NCT01995513|69775048|FG001|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
38078062|NCT01995513|69775049|FG002|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
38078063|NCT01995513|69775050|FG003|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
38078064|NCT01995513|69775047|FG000|Period 1: First Open Label Treatment|Withdrawal by Subject|20|||
38078065|NCT01995513|69775048|FG001|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
38078066|NCT01995513|69775049|FG002|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
38078067|NCT01995513|69775050|FG003|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
38078068|NCT01995513|69775047|FG000|Period 1: Second Open Label Treatment|Other|0|||
38078069|NCT01995513|69775048|FG001|Period 1: Second Open Label Treatment|Other|2|||
38078070|NCT01995513|69775049|FG002|Period 1: Second Open Label Treatment|Other|0|||
38078071|NCT01995513|69775050|FG003|Period 1: Second Open Label Treatment|Other|0|||
38078072|NCT01995513|69775047|FG000|Period 1: Second Open Label Treatment|Disease Progression|0|||
38078073|NCT01995513|69775048|FG001|Period 1: Second Open Label Treatment|Disease Progression|11|||
38078074|NCT01995513|69775049|FG002|Period 1: Second Open Label Treatment|Disease Progression|0|||
38078075|NCT01995513|69775050|FG003|Period 1: Second Open Label Treatment|Disease Progression|0|||
38078076|NCT01995513|69775047|FG000|Period 2: Double Blind Treatment|Death|0|||
38078077|NCT01995513|69775048|FG001|Period 2: Double Blind Treatment|Death|0|||
38078078|NCT01995513|69775049|FG002|Period 2: Double Blind Treatment|Death|0|||
38078079|NCT01995513|69775050|FG003|Period 2: Double Blind Treatment|Death|1|||
38078080|NCT01995513|69775047|FG000|Period 2: Double Blind Treatment|Other|0|||
38078081|NCT01995513|69775048|FG001|Period 2: Double Blind Treatment|Other|0|||
38078082|NCT01995513|69775049|FG002|Period 2: Double Blind Treatment|Other|3|||
38078083|NCT01995513|69775050|FG003|Period 2: Double Blind Treatment|Other|3|||
38078084|NCT01995513|69775047|FG000|Period 2: Double Blind Treatment|Disease Progression|0|||
38078085|NCT01995513|69775048|FG001|Period 2: Double Blind Treatment|Disease Progression|0|||
38078086|NCT01995513|69775049|FG002|Period 2: Double Blind Treatment|Disease Progression|104|||
38078087|NCT01995513|69775050|FG003|Period 2: Double Blind Treatment|Disease Progression|107|||
38078088|NCT01995513|69775047|FG000|Period 2: Double Blind Treatment|Adverse Event|0|||
38078089|NCT01995513|69775048|FG001|Period 2: Double Blind Treatment|Adverse Event|0|||
38078090|NCT01995513|69775049|FG002|Period 2: Double Blind Treatment|Adverse Event|14|||
38078091|NCT01995513|69775050|FG003|Period 2: Double Blind Treatment|Adverse Event|5|||
38078092|NCT01995513|69775047|FG000|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
38078093|NCT01995513|69775048|FG001|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
38078094|NCT01995513|69775049|FG002|Period 2: Double Blind Treatment|Withdrawal by Subject|5|||
38078095|NCT01995513|69775050|FG003|Period 2: Double Blind Treatment|Withdrawal by Subject|8|||
38078096|NCT01995513|69775047|FG000|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
38078097|NCT01995513|69775048|FG001|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
38078098|NCT01995513|69775049|FG002|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
38078099|NCT01995513|69775050|FG003|Period 2: Double Blind Treatment|Protocol Non-Compliance|1|||
38078100|NCT02927171|69775066|FG000|Overall Study|Lost to Follow-up|0|||
38078101|NCT02927171|69775067|FG001|Overall Study|Lost to Follow-up|1|||
38078102|NCT03087617|69775077|FG000|Overall Study|Lost to Follow-up|32|||
38078103|NCT03087617|69775078|FG001|Overall Study|Lost to Follow-up|30|||
38078104|NCT03087617|69775079|FG002|Overall Study|Lost to Follow-up|30|||
38078105|NCT03087617|69775080|FG003|Overall Study|Lost to Follow-up|39|||
38078106|NCT00103610|69775092|FG000|Overall Study|Entered Rescue Procedure|10|||
38078107|NCT00103610|69775093|FG001|Overall Study|Entered Rescue Procedure|52|||
38078108|NCT00103610|69775092|FG000|Overall Study|Death|16|||
38078109|NCT00103610|69775093|FG001|Overall Study|Death|12|||
38078110|NCT00103610|69775092|FG000|Overall Study|Elective Withdrawal|4|||
38078111|NCT00103610|69775093|FG001|Overall Study|Elective Withdrawal|0|||
38078112|NCT00103610|69775092|FG000|Overall Study|Lost to Follow-up|3|||
38078113|NCT00103610|69775093|FG001|Overall Study|Lost to Follow-up|1|||
38078114|NCT00103610|69775092|FG000|Overall Study|Adverse Event|2|||
38078115|NCT00103610|69775093|FG001|Overall Study|Adverse Event|2|||
38078116|NCT00103610|69775092|FG000|Overall Study|Other|2|||
38078117|NCT00103610|69775093|FG001|Overall Study|Other|7|||
38078118|NCT00103610|69775092|FG000|Overall Study|Failed mobilization|1|||
38078119|NCT00103610|69775093|FG001|Overall Study|Failed mobilization|5|||
38078120|NCT00103610|69775092|FG000|Overall Study|Noncompliance|0|||
38078121|NCT00103610|69775093|FG001|Overall Study|Noncompliance|1|||
38078122|NCT03091439|69775102|FG000|Overall Study|Study Terminated by the Sponsor|1|||
38078123|NCT03091439|69775103|FG001|Overall Study|Study Terminated by the Sponsor|0|||
38078124|NCT03086447|69775111|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
37862360|NCT00919867|69546132|FG001|First Intervention|Withdrawal by Subject|0|||
38078125|NCT03086447|69775112|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
38078126|NCT03086447|69775111|FG000|Overall Study|Lost Lens|2|||
38078127|NCT03086447|69775112|FG001|Overall Study|Lost Lens|5|||
38078128|NCT03086447|69775111|FG000|Overall Study|Product quality complaint|0|||
38078129|NCT03086447|69775112|FG001|Overall Study|Product quality complaint|1|||
38078130|NCT03086447|69775111|FG000|Overall Study|Lens Damage|1|||
38078131|NCT03086447|69775112|FG001|Overall Study|Lens Damage|6|||
38078132|NCT03086447|69775111|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
38078133|NCT03086447|69775112|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
38078134|NCT03086447|69775111|FG000|Overall Study|Test Article No Longer Available|1|||
38078135|NCT03086447|69775112|FG001|Overall Study|Test Article No Longer Available|0|||
38078136|NCT03086447|69775111|FG000|Overall Study|Protocol Violation|2|||
38078137|NCT03086447|69775112|FG001|Overall Study|Protocol Violation|4|||
38078138|NCT03086447|69775111|FG000|Overall Study|Lost to Follow-up|0|||
38078139|NCT03086447|69775112|FG001|Overall Study|Lost to Follow-up|1|||
38078140|NCT03086447|69775111|FG000|Overall Study|Adverse Event|3|||
38078141|NCT03086447|69775112|FG001|Overall Study|Adverse Event|0|||
38078142|NCT03086447|69775111|FG000|Overall Study|Lens Discomfort|2|||
38078143|NCT03086447|69775112|FG001|Overall Study|Lens Discomfort|1|||
38078144|NCT03083639|69775143|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
38078145|NCT03083639|69775144|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
38078146|NCT03083639|69775143|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
38078147|NCT03083639|69775144|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
38078148|NCT02927431|69775153|FG000|Overall Study|Withdrawal by Subject|0|||
38078149|NCT02927431|69775154|FG001|Overall Study|Withdrawal by Subject|0|||
38078150|NCT02927431|69775155|FG002|Overall Study|Withdrawal by Subject|1|||
38078151|NCT03083483|69775168|FG000|Overall Study|Adverse Event|1|||
38078152|NCT03083483|69775169|FG001|Overall Study|Adverse Event|1|||
38078153|NCT03083483|69775170|FG002|Overall Study|Adverse Event|1|||
38078154|NCT03083483|69775168|FG000|Overall Study|Lost to Follow-up|2|||
38078155|NCT03083483|69775169|FG001|Overall Study|Lost to Follow-up|1|||
38078156|NCT03083483|69775170|FG002|Overall Study|Lost to Follow-up|1|||
38078157|NCT03083483|69775168|FG000|Overall Study|technological issues|1|||
38078158|NCT03083483|69775169|FG001|Overall Study|technological issues|0|||
38078159|NCT03083483|69775170|FG002|Overall Study|technological issues|1|||
38078160|NCT03085927|69775182|FG000|Overall Study|Withdrawal by Subject|1|||
38078161|NCT03085927|69775183|FG001|Overall Study|Withdrawal by Subject|4|||
38078162|NCT03085927|69775182|FG000|Overall Study|Lost to Follow-up|3|||
38078163|NCT03085927|69775183|FG001|Overall Study|Lost to Follow-up|1|||
38078164|NCT03085927|69775182|FG000|Overall Study|Death|1|||
38078165|NCT03085927|69775183|FG001|Overall Study|Death|0|||
38078166|NCT03085927|69775182|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
38078167|NCT03085927|69775183|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
38078168|NCT03085927|69775182|FG000|Overall Study|Dyad Became Ineligible|0|||
38078169|NCT03085927|69775183|FG001|Overall Study|Dyad Became Ineligible|1|||
38078170|NCT04392583|69775191|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
38078171|NCT04497987|69775197|FG000|Overall Study|Adverse Event|1|||
38078172|NCT04497987|69775198|FG001|Overall Study|Adverse Event|0|||
38078173|NCT04497987|69775197|FG000|Overall Study|Death|21|||
38078174|NCT04497987|69775198|FG001|Overall Study|Death|13|||
38078175|NCT04497987|69775197|FG000|Overall Study|Lost to Follow-up|19|||
38078176|NCT04497987|69775198|FG001|Overall Study|Lost to Follow-up|17|||
38078177|NCT04497987|69775197|FG000|Overall Study|Other - as reported by the investigator|22|||
38078178|NCT04497987|69775198|FG001|Overall Study|Other - as reported by the investigator|16|||
38078179|NCT04497987|69775197|FG000|Overall Study|Physician Decision|1|||
38078180|NCT04497987|69775198|FG001|Overall Study|Physician Decision|0|||
38078181|NCT04497987|69775197|FG000|Overall Study|Withdrawal by Subject|35|||
38078182|NCT04497987|69775198|FG001|Overall Study|Withdrawal by Subject|21|||
38078183|NCT00974571|69775208|FG000|Overall Study|Adverse Event|31|||
38078184|NCT00974571|69775209|FG001|Overall Study|Adverse Event|4|||
38078185|NCT00974571|69775210|FG002|Overall Study|Adverse Event|27|||
38078186|NCT00974571|69775208|FG000|Overall Study|Lack of Efficacy|3|||
38078187|NCT00974571|69775209|FG001|Overall Study|Lack of Efficacy|2|||
38078188|NCT00974571|69775210|FG002|Overall Study|Lack of Efficacy|9|||
38078189|NCT00974571|69775208|FG000|Overall Study|Lost to Follow-up|2|||
38078190|NCT00974571|69775209|FG001|Overall Study|Lost to Follow-up|1|||
38078191|NCT00974571|69775210|FG002|Overall Study|Lost to Follow-up|2|||
38078192|NCT00974571|69775208|FG000|Overall Study|Protocol Violation|13|||
37966606|NCT00468585|69653501|FG002|Overall Study|Patient found to be ineligible|1|||
38078193|NCT00974571|69775209|FG001|Overall Study|Protocol Violation|4|||
38078194|NCT00974571|69775210|FG002|Overall Study|Protocol Violation|18|||
38078195|NCT00974571|69775208|FG000|Overall Study|Withdrawal by Subject|14|||
38078196|NCT00974571|69775209|FG001|Overall Study|Withdrawal by Subject|5|||
38078197|NCT00974571|69775210|FG002|Overall Study|Withdrawal by Subject|16|||
38078198|NCT00974571|69775208|FG000|Overall Study|Patient Moved|1|||
38078199|NCT00974571|69775209|FG001|Overall Study|Patient Moved|0|||
38078200|NCT00974571|69775210|FG002|Overall Study|Patient Moved|1|||
38078201|NCT00974571|69775208|FG000|Overall Study|Other|4|||
38078202|NCT00974571|69775209|FG001|Overall Study|Other|0|||
38078203|NCT00974571|69775210|FG002|Overall Study|Other|10|||
38078204|NCT02766608|69775223|FG000|Overall Study|Adverse Event|27|||
38078205|NCT02766608|69775224|FG001|Overall Study|Adverse Event|22|||
38078206|NCT02766608|69775225|FG002|Overall Study|Adverse Event|17|||
38078207|NCT02766608|69775226|FG003|Overall Study|Adverse Event|13|||
38078208|NCT02766608|69775227|FG004|Overall Study|Adverse Event|12|||
38078209|NCT02766608|69775223|FG000|Overall Study|Withdrawal by Subject|21|||
38078210|NCT02766608|69775224|FG001|Overall Study|Withdrawal by Subject|20|||
38078211|NCT02766608|69775225|FG002|Overall Study|Withdrawal by Subject|24|||
38078212|NCT02766608|69775226|FG003|Overall Study|Withdrawal by Subject|13|||
38078213|NCT02766608|69775227|FG004|Overall Study|Withdrawal by Subject|10|||
38078214|NCT02766608|69775223|FG000|Overall Study|Lack of Efficacy|16|||
38078215|NCT02766608|69775224|FG001|Overall Study|Lack of Efficacy|15|||
38078216|NCT02766608|69775225|FG002|Overall Study|Lack of Efficacy|32|||
38078217|NCT02766608|69775226|FG003|Overall Study|Lack of Efficacy|8|||
38078218|NCT02766608|69775227|FG004|Overall Study|Lack of Efficacy|2|||
38078219|NCT02766608|69775223|FG000|Overall Study|Lost to Follow-up|6|||
38078220|NCT02766608|69775224|FG001|Overall Study|Lost to Follow-up|3|||
38078221|NCT02766608|69775225|FG002|Overall Study|Lost to Follow-up|5|||
38078222|NCT02766608|69775226|FG003|Overall Study|Lost to Follow-up|2|||
38078223|NCT02766608|69775227|FG004|Overall Study|Lost to Follow-up|2|||
38078224|NCT02766608|69775223|FG000|Overall Study|Physician Decision|3|||
38078225|NCT02766608|69775224|FG001|Overall Study|Physician Decision|2|||
38078226|NCT02766608|69775225|FG002|Overall Study|Physician Decision|3|||
38078227|NCT02766608|69775226|FG003|Overall Study|Physician Decision|1|||
38078228|NCT02766608|69775227|FG004|Overall Study|Physician Decision|2|||
38078229|NCT02766608|69775223|FG000|Overall Study|Protocol disc criteria|3|||
38078230|NCT02766608|69775224|FG001|Overall Study|Protocol disc criteria|3|||
38078231|NCT02766608|69775225|FG002|Overall Study|Protocol disc criteria|4|||
38078232|NCT02766608|69775226|FG003|Overall Study|Protocol disc criteria|0|||
38078233|NCT02766608|69775227|FG004|Overall Study|Protocol disc criteria|0|||
38078234|NCT02766608|69775223|FG000|Overall Study|Protocol Violation|0|||
38078235|NCT02766608|69775224|FG001|Overall Study|Protocol Violation|4|||
38078236|NCT02766608|69775225|FG002|Overall Study|Protocol Violation|4|||
38078237|NCT02766608|69775226|FG003|Overall Study|Protocol Violation|0|||
38078238|NCT02766608|69775227|FG004|Overall Study|Protocol Violation|1|||
38078239|NCT02766608|69775223|FG000|Overall Study|Administrative Reasons|3|||
38078240|NCT02766608|69775224|FG001|Overall Study|Administrative Reasons|1|||
38078241|NCT02766608|69775225|FG002|Overall Study|Administrative Reasons|1|||
38078242|NCT02766608|69775226|FG003|Overall Study|Administrative Reasons|0|||
38078243|NCT02766608|69775227|FG004|Overall Study|Administrative Reasons|0|||
38078244|NCT00960141|69775245|FG000|Overall Study|Adverse Event|4|||
38078245|NCT00960141|69775246|FG001|Overall Study|Adverse Event|8|||
38078246|NCT00960141|69775247|FG002|Overall Study|Adverse Event|2|||
38078247|NCT00960141|69775245|FG000|Overall Study|Lack of Efficacy|3|||
38078248|NCT00960141|69775246|FG001|Overall Study|Lack of Efficacy|4|||
38078249|NCT00960141|69775247|FG002|Overall Study|Lack of Efficacy|2|||
38078250|NCT00960141|69775245|FG000|Overall Study|Lost to Follow-up|1|||
38078251|NCT00960141|69775246|FG001|Overall Study|Lost to Follow-up|0|||
38078252|NCT00960141|69775247|FG002|Overall Study|Lost to Follow-up|0|||
38078253|NCT00960141|69775245|FG000|Overall Study|Protocol Violation|1|||
38078254|NCT00960141|69775246|FG001|Overall Study|Protocol Violation|3|||
38078255|NCT00960141|69775247|FG002|Overall Study|Protocol Violation|2|||
38078256|NCT00960141|69775245|FG000|Overall Study|Withdrawal by Subject|1|||
38078257|NCT00960141|69775246|FG001|Overall Study|Withdrawal by Subject|2|||
38078258|NCT00960141|69775247|FG002|Overall Study|Withdrawal by Subject|1|||
38078259|NCT02771522|69775255|FG000|Overall Study|Lost to Follow-up|3|||
37862361|NCT00919867|69546133|FG002|First Intervention|Withdrawal by Subject|1|||
38078260|NCT02771522|69775255|FG000|Overall Study|Withdrawal by Subject|2|||
38078261|NCT02771522|69775255|FG000|Overall Study|No white spot lesions|3|||
38078262|NCT00759655|69775264|FG000|Overall Study|Termination of the study by sponsor|1|||
38078263|NCT02771366|69775270|FG000|Period 1|Withdrawal by Subject|0|||
38078264|NCT02771366|69775271|FG001|Period 1|Withdrawal by Subject|2|||
38078265|NCT02771366|69775270|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
38078266|NCT02771366|69775271|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
38078267|NCT03396471|69775278|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
38078268|NCT03396471|69775278|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
38078269|NCT03396471|69775278|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
38078270|NCT03396471|69775278|FG000|Study Treatment - Up to 22 Months|Death|2|||
38078271|NCT03396471|69775278|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
38078272|NCT03396471|69775278|FG000|Follow up - Up to 2 Years|Death|9|||
38078273|NCT03396471|69775278|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
38078274|NCT03396471|69775278|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
38078275|NCT03396471|69775278|FG000|Follow up - Up to 2 Years|study terminated|1|||
38078276|NCT03396471|69775278|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
38078277|NCT03396471|69775278|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
38078278|NCT00103142|69775284|FG000|Overall Study|Adverse Event|1|||
38078279|NCT00103142|69775285|FG001|Overall Study|Adverse Event|0|||
38078280|NCT00103142|69775284|FG000|Overall Study|Progression of disease|2|||
38078281|NCT00103142|69775285|FG001|Overall Study|Progression of disease|1|||
37862362|NCT00919867|69546134|FG003|First Intervention|Withdrawal by Subject|0|||
37862363|NCT00919867|69546135|FG004|First Intervention|Withdrawal by Subject|0|||
37862364|NCT00919867|69546136|FG005|First Intervention|Withdrawal by Subject|0|||
37862365|NCT00919867|69546131|FG000|First Intervention|Physician Decision|0|||
37862366|NCT00919867|69546132|FG001|First Intervention|Physician Decision|0|||
37862367|NCT00919867|69546133|FG002|First Intervention|Physician Decision|0|||
37862368|NCT00919867|69546134|FG003|First Intervention|Physician Decision|0|||
37862369|NCT00919867|69546135|FG004|First Intervention|Physician Decision|0|||
37862370|NCT00919867|69546136|FG005|First Intervention|Physician Decision|1|||
37862371|NCT01215942|69546146|FG000|Treatment Period|Adverse Event|15|||
37862372|NCT01215942|69546147|FG001|Treatment Period|Adverse Event|26|||
37862373|NCT01215942|69546146|FG000|Treatment Period|Death|2|||
37862374|NCT01215942|69546147|FG001|Treatment Period|Death|4|||
37862375|NCT01215942|69546146|FG000|Treatment Period|Lack of Efficacy|23|||
37862376|NCT01215942|69546147|FG001|Treatment Period|Lack of Efficacy|62|||
38078282|NCT00943683|69775295|FG000|Overall Study|Adverse Event|3|||
38078283|NCT00943683|69775296|FG001|Overall Study|Adverse Event|3|||
38078284|NCT00943683|69775295|FG000|Overall Study|Lost to Follow-up|1|||
38078285|NCT00943683|69775296|FG001|Overall Study|Lost to Follow-up|1|||
38078286|NCT00943683|69775295|FG000|Overall Study|Protocol Violation|1|||
38078287|NCT00943683|69775296|FG001|Overall Study|Protocol Violation|2|||
38078288|NCT00943683|69775295|FG000|Overall Study|Withdrawal by Subject|1|||
38078289|NCT00943683|69775296|FG001|Overall Study|Withdrawal by Subject|0|||
38078290|NCT00943683|69775295|FG000|Overall Study|Patient Moved|1|||
38078291|NCT00943683|69775296|FG001|Overall Study|Patient Moved|0|||
38078292|NCT00911547|69775306|FG000|Overall Study|Adverse Event|8|||
38078293|NCT00911547|69775307|FG001|Overall Study|Adverse Event|27|||
38078294|NCT00911547|69775308|FG002|Overall Study|Adverse Event|11|||
38078295|NCT00911547|69775309|FG003|Overall Study|Adverse Event|6|||
38078296|NCT00911547|69775306|FG000|Overall Study|Lost to Follow-up|0|||
38078297|NCT00911547|69775307|FG001|Overall Study|Lost to Follow-up|0|||
38078298|NCT00911547|69775308|FG002|Overall Study|Lost to Follow-up|2|||
38078299|NCT00911547|69775309|FG003|Overall Study|Lost to Follow-up|1|||
38078300|NCT00911547|69775306|FG000|Overall Study|Protocol Violation|0|||
38078301|NCT00911547|69775307|FG001|Overall Study|Protocol Violation|5|||
38078302|NCT00911547|69775308|FG002|Overall Study|Protocol Violation|5|||
38078303|NCT00911547|69775309|FG003|Overall Study|Protocol Violation|1|||
38078304|NCT00911547|69775306|FG000|Overall Study|Withdrawal by Subject|3|||
38078305|NCT00911547|69775307|FG001|Overall Study|Withdrawal by Subject|10|||
38078306|NCT00911547|69775308|FG002|Overall Study|Withdrawal by Subject|4|||
38078307|NCT00911547|69775309|FG003|Overall Study|Withdrawal by Subject|8|||
38078308|NCT00899379|69775324|FG000|Overall Study|Adverse Event|2|||
38078309|NCT00899379|69775325|FG001|Overall Study|Adverse Event|2|||
38078310|NCT00899379|69775326|FG002|Overall Study|Adverse Event|1|||
38078311|NCT00899379|69775327|FG003|Overall Study|Adverse Event|1|||
38078312|NCT00899379|69775328|FG004|Overall Study|Adverse Event|2|||
38078313|NCT00899379|69775324|FG000|Overall Study|Lack of Efficacy|0|||
38078314|NCT00899379|69775325|FG001|Overall Study|Lack of Efficacy|4|||
38078315|NCT00899379|69775326|FG002|Overall Study|Lack of Efficacy|3|||
38078316|NCT00899379|69775327|FG003|Overall Study|Lack of Efficacy|0|||
38078317|NCT00899379|69775328|FG004|Overall Study|Lack of Efficacy|1|||
38078318|NCT00899379|69775324|FG000|Overall Study|Lost to Follow-up|9|||
38078319|NCT00899379|69775325|FG001|Overall Study|Lost to Follow-up|3|||
38078320|NCT00899379|69775326|FG002|Overall Study|Lost to Follow-up|0|||
38078321|NCT00899379|69775327|FG003|Overall Study|Lost to Follow-up|6|||
38078322|NCT00899379|69775328|FG004|Overall Study|Lost to Follow-up|2|||
38078323|NCT00899379|69775324|FG000|Overall Study|Protocol Violation|0|||
38078324|NCT00899379|69775325|FG001|Overall Study|Protocol Violation|0|||
37862377|NCT01215942|69546146|FG000|Treatment Period|Lost to Follow-up|3|||
37862378|NCT01215942|69546147|FG001|Treatment Period|Lost to Follow-up|4|||
38078325|NCT00899379|69775326|FG002|Overall Study|Protocol Violation|1|||
38078326|NCT00899379|69775327|FG003|Overall Study|Protocol Violation|1|||
38078327|NCT00899379|69775328|FG004|Overall Study|Protocol Violation|0|||
38078328|NCT00899379|69775324|FG000|Overall Study|Withdrawal by Subject|2|||
38078329|NCT00899379|69775325|FG001|Overall Study|Withdrawal by Subject|4|||
38078330|NCT00899379|69775326|FG002|Overall Study|Withdrawal by Subject|2|||
38078331|NCT00899379|69775327|FG003|Overall Study|Withdrawal by Subject|3|||
38078332|NCT00899379|69775328|FG004|Overall Study|Withdrawal by Subject|6|||
38078333|NCT00899379|69775324|FG000|Overall Study|Pregnancy|0|||
38078334|NCT00899379|69775325|FG001|Overall Study|Pregnancy|0|||
38078335|NCT00899379|69775326|FG002|Overall Study|Pregnancy|1|||
38078336|NCT00899379|69775327|FG003|Overall Study|Pregnancy|0|||
38078337|NCT00899379|69775328|FG004|Overall Study|Pregnancy|1|||
38078338|NCT00899379|69775324|FG000|Overall Study|Patient Uncooperative|0|||
38078339|NCT00899379|69775325|FG001|Overall Study|Patient Uncooperative|1|||
38078340|NCT00899379|69775326|FG002|Overall Study|Patient Uncooperative|0|||
37862379|NCT01215942|69546146|FG000|Treatment Period|Withdrawal by Subject|17|||
37862380|NCT01215942|69546147|FG001|Treatment Period|Withdrawal by Subject|40|||
37862381|NCT01215942|69546146|FG000|Treatment Period|Physician Decision|5|||
37862382|NCT01215942|69546147|FG001|Treatment Period|Physician Decision|5|||
37862383|NCT01215942|69546146|FG000|Treatment Period|Protocol Violation|0|||
37862384|NCT01215942|69546147|FG001|Treatment Period|Protocol Violation|1|||
37862385|NCT01215942|69546146|FG000|Treatment Period|Sponsor Decision|349|||
37862386|NCT01215942|69546147|FG001|Treatment Period|Sponsor Decision|530|||
37862387|NCT01215942|69546146|FG000|Post-Treatment Follow-Up Period|Death|0|||
37862388|NCT01215942|69546147|FG001|Post-Treatment Follow-Up Period|Death|1|||
37862389|NCT01215942|69546146|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
37862390|NCT01215942|69546147|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
37862391|NCT01215942|69546146|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
37862392|NCT01215942|69546147|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
37862393|NCT01215942|69546146|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
37862394|NCT01215942|69546147|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
37862395|NCT01215942|69546146|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
37862396|NCT01215942|69546147|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
37862397|NCT01128621|69546166|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
37862398|NCT01128621|69546167|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
37862399|NCT00918463|69546189|FG000|Overall Study|Death|1|||
37862400|NCT00918463|69546189|FG000|Overall Study|Lack of Efficacy|1|||
37862401|NCT01128543|69546193|FG000|Overall Study|Withdrawal by Subject|3|||
37862402|NCT01128543|69546193|FG000|Overall Study|Protocol Violation|1|||
37862403|NCT01128387|69546199|FG000|Overall Study|Physician Decision|0|||
37862404|NCT01128387|69546200|FG001|Overall Study|Physician Decision|1|||
37862405|NCT01214850|69546209|FG000|Overall Study|Withdrawal by Subject|38|||
37862406|NCT01214850|69546210|FG001|Overall Study|Withdrawal by Subject|31|||
37862407|NCT01214850|69546211|FG002|Overall Study|Withdrawal by Subject|28|||
37862408|NCT01214850|69546209|FG000|Overall Study|Lost to Follow-up|124|||
37862409|NCT01214850|69546210|FG001|Overall Study|Lost to Follow-up|98|||
37862410|NCT01214850|69546211|FG002|Overall Study|Lost to Follow-up|123|||
37862411|NCT01214850|69546209|FG000|Overall Study|Protocol Violation|5|||
37862412|NCT01214850|69546210|FG001|Overall Study|Protocol Violation|5|||
37862413|NCT01214850|69546211|FG002|Overall Study|Protocol Violation|6|||
37862414|NCT01214850|69546209|FG000|Overall Study|Adverse event or death|11|||
37862415|NCT01214850|69546210|FG001|Overall Study|Adverse event or death|8|||
37862416|NCT01214850|69546211|FG002|Overall Study|Adverse event or death|3|||
37862417|NCT01214850|69546209|FG000|Overall Study|Inappropriate enrollment|2|||
37862418|NCT01214850|69546210|FG001|Overall Study|Inappropriate enrollment|1|||
37862419|NCT01214850|69546211|FG002|Overall Study|Inappropriate enrollment|0|||
37862420|NCT01214850|69546209|FG000|Overall Study|Administrative reason|1|||
37862421|NCT01214850|69546210|FG001|Overall Study|Administrative reason|0|||
37862422|NCT01214850|69546211|FG002|Overall Study|Administrative reason|0|||
37862423|NCT01214850|69546209|FG000|Overall Study|Unable to classify|2|||
37862424|NCT01214850|69546210|FG001|Overall Study|Unable to classify|1|||
37862425|NCT01214850|69546211|FG002|Overall Study|Unable to classify|1|||
37862426|NCT01128153|69546224|FG000|Overall Study|Adverse Event|1|||
37862427|NCT01128153|69546225|FG001|Overall Study|Adverse Event|3|||
37862428|NCT01128153|69546224|FG000|Overall Study|Condition under investigation worsened|8|||
37862429|NCT01128153|69546225|FG001|Overall Study|Condition under investigation worsened|7|||
37862430|NCT01128153|69546224|FG000|Overall Study|Withdrawal by Subject|2|||
37862431|NCT01128153|69546225|FG001|Overall Study|Withdrawal by Subject|3|||
37862432|NCT01128153|69546224|FG000|Overall Study|Incorrect enrolment to study|2|||
37862433|NCT01128153|69546225|FG001|Overall Study|Incorrect enrolment to study|1|||
37862434|NCT01128153|69546224|FG000|Overall Study|Protocol Violation|2|||
37862435|NCT01128153|69546225|FG001|Overall Study|Protocol Violation|0|||
37862436|NCT01128153|69546224|FG000|Overall Study|Developed discontinuation criteria|1|||
37862437|NCT01128153|69546225|FG001|Overall Study|Developed discontinuation criteria|1|||
37862438|NCT00925015|69546234|FG000|Overall Study|Adverse Event|1|||
37862439|NCT00925015|69546235|FG001|Overall Study|Adverse Event|2|||
37862440|NCT00925015|69546236|FG002|Overall Study|Adverse Event|1|||
38078341|NCT00899379|69775327|FG003|Overall Study|Patient Uncooperative|1|||
37862441|NCT00925015|69546234|FG000|Overall Study|Physician Decision|0|||
37862442|NCT00925015|69546235|FG001|Overall Study|Physician Decision|1|||
37862443|NCT00925015|69546236|FG002|Overall Study|Physician Decision|0|||
37862444|NCT00925015|69546234|FG000|Overall Study|Progressive Disease|7|||
37862445|NCT00925015|69546235|FG001|Overall Study|Progressive Disease|3|||
38078342|NCT00899379|69775328|FG004|Overall Study|Patient Uncooperative|2|||
37862446|NCT00925015|69546236|FG002|Overall Study|Progressive Disease|4|||
37862447|NCT00925015|69546234|FG000|Overall Study|Withdrawal by Subject|0|||
37862448|NCT00925015|69546235|FG001|Overall Study|Withdrawal by Subject|0|||
37862449|NCT00925015|69546236|FG002|Overall Study|Withdrawal by Subject|1|||
37862450|NCT01127763|69546248|FG000|Overall Study|Adverse Event|2|||
37862451|NCT01127763|69546248|FG000|Overall Study|Withdrawal by Subject|1|||
37862452|NCT01127763|69546248|FG000|Overall Study|Physician Decision|2|||
37862453|NCT01127607|69546258|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
37862454|NCT01127607|69546259|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
38078343|NCT00899379|69775324|FG000|Overall Study|Abnormal Baseline ECG|0|||
38078344|NCT00899379|69775325|FG001|Overall Study|Abnormal Baseline ECG|0|||
38078345|NCT00899379|69775326|FG002|Overall Study|Abnormal Baseline ECG|0|||
38078346|NCT00899379|69775327|FG003|Overall Study|Abnormal Baseline ECG|1|||
38078347|NCT00899379|69775328|FG004|Overall Study|Abnormal Baseline ECG|0|||
38078348|NCT00899379|69775324|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
38078349|NCT00899379|69775325|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
38078350|NCT00899379|69775326|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
38078351|NCT00899379|69775327|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
38078352|NCT00899379|69775328|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
38078353|NCT00899379|69775324|FG000|Overall Study|Not Completed/Entered Extn|5|||
38078354|NCT00899379|69775325|FG001|Overall Study|Not Completed/Entered Extn|1|||
38078355|NCT00899379|69775326|FG002|Overall Study|Not Completed/Entered Extn|6|||
38078356|NCT00899379|69775327|FG003|Overall Study|Not Completed/Entered Extn|4|||
38078357|NCT00899379|69775328|FG004|Overall Study|Not Completed/Entered Extn|3|||
38078358|NCT00899379|69775324|FG000|Overall Study|Study Terminated|3|||
38078359|NCT00899379|69775325|FG001|Overall Study|Study Terminated|0|||
38078360|NCT00899379|69775326|FG002|Overall Study|Study Terminated|3|||
38078361|NCT00899379|69775327|FG003|Overall Study|Study Terminated|3|||
38078362|NCT00899379|69775328|FG004|Overall Study|Study Terminated|1|||
38078363|NCT00899379|69775324|FG000|Overall Study|Lost to Follow-up|3|||
38078364|NCT00899379|69775325|FG001|Overall Study|Lost to Follow-up|1|||
38078365|NCT00899379|69775326|FG002|Overall Study|Lost to Follow-up|0|||
38078366|NCT00899379|69775327|FG003|Overall Study|Lost to Follow-up|2|||
38078367|NCT00899379|69775328|FG004|Overall Study|Lost to Follow-up|5|||
38078368|NCT00899379|69775324|FG000|Overall Study|Withdrawal by Subject|4|||
38078369|NCT00899379|69775325|FG001|Overall Study|Withdrawal by Subject|7|||
38078370|NCT00899379|69775326|FG002|Overall Study|Withdrawal by Subject|4|||
38078371|NCT00899379|69775327|FG003|Overall Study|Withdrawal by Subject|7|||
38078372|NCT00899379|69775328|FG004|Overall Study|Withdrawal by Subject|2|||
38078373|NCT00899379|69775324|FG000|Overall Study|Pregnancy|1|||
38078374|NCT00899379|69775325|FG001|Overall Study|Pregnancy|0|||
38078375|NCT00899379|69775326|FG002|Overall Study|Pregnancy|0|||
38078376|NCT00899379|69775327|FG003|Overall Study|Pregnancy|0|||
38078377|NCT00899379|69775328|FG004|Overall Study|Pregnancy|0|||
38078378|NCT00899379|69775324|FG000|Overall Study|Patient Uncooperative|0|||
38078379|NCT00899379|69775325|FG001|Overall Study|Patient Uncooperative|0|||
38078380|NCT00899379|69775326|FG002|Overall Study|Patient Uncooperative|0|||
38078381|NCT00899379|69775327|FG003|Overall Study|Patient Uncooperative|1|||
38078382|NCT00899379|69775328|FG004|Overall Study|Patient Uncooperative|0|||
38078383|NCT00899379|69775324|FG000|Overall Study|Abnormal Prestudy Labs|0|||
38078384|NCT00899379|69775325|FG001|Overall Study|Abnormal Prestudy Labs|0|||
38078385|NCT00899379|69775326|FG002|Overall Study|Abnormal Prestudy Labs|0|||
38078386|NCT00899379|69775327|FG003|Overall Study|Abnormal Prestudy Labs|0|||
38078387|NCT00899379|69775328|FG004|Overall Study|Abnormal Prestudy Labs|2|||
38078388|NCT00899379|69775324|FG000|Overall Study|Abnormal Baseline ECG|0|||
38078389|NCT00899379|69775325|FG001|Overall Study|Abnormal Baseline ECG|0|||
38078390|NCT00899379|69775326|FG002|Overall Study|Abnormal Baseline ECG|1|||
38078391|NCT00899379|69775327|FG003|Overall Study|Abnormal Baseline ECG|1|||
38078392|NCT00899379|69775328|FG004|Overall Study|Abnormal Baseline ECG|0|||
38078393|NCT00899379|69775324|FG000|Overall Study|No Attack Pretreatment|3|||
38078394|NCT00899379|69775325|FG001|Overall Study|No Attack Pretreatment|5|||
38078395|NCT00899379|69775326|FG002|Overall Study|No Attack Pretreatment|5|||
38078396|NCT00899379|69775327|FG003|Overall Study|No Attack Pretreatment|6|||
38078397|NCT00899379|69775328|FG004|Overall Study|No Attack Pretreatment|4|||
38078398|NCT00899379|69775324|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
37862455|NCT01127607|69546258|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
38078399|NCT00899379|69775325|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
38078400|NCT00899379|69775326|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
38078401|NCT00899379|69775327|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
38078402|NCT00899379|69775328|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
38078403|NCT00899379|69775324|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
38078404|NCT00899379|69775325|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
37862456|NCT01127607|69546259|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
37862457|NCT00924781|69546286|FG000|Overall Study|Study terminated by sponsor|12|||
38078405|NCT00899379|69775326|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
38078406|NCT00899379|69775327|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
38078407|NCT00899379|69775328|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
38078408|NCT04326439|69775336|FG000|Overall Study|Withdrawal by Subject|1|||
38078409|NCT04326439|69775337|FG001|Overall Study|Withdrawal by Subject|0|||
38078410|NCT04326439|69775336|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
38078411|NCT04326439|69775337|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
38078412|NCT04326439|69775336|FG000|Overall Study|Relapse after Induction 2|0|||
38078413|NCT04326439|69775337|FG001|Overall Study|Relapse after Induction 2|1|||
38078414|NCT04326439|69775336|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
38078415|NCT04326439|69775337|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
38078416|NCT00145795|69775351|FG000|Overall Study|Adverse Event|1|||
38078417|NCT00145795|69775352|FG001|Overall Study|Adverse Event|0|||
38078418|NCT02771210|69775360|FG000|Period 1|Adverse Event|5|||
38078419|NCT02771210|69775361|FG001|Period 1|Adverse Event|3|||
38078420|NCT02771210|69775360|FG000|Period 1|Lack of Efficacy|3|||
38078421|NCT02771210|69775361|FG001|Period 1|Lack of Efficacy|6|||
38078422|NCT02771210|69775360|FG000|Period 1|Lost to Follow-up|2|||
38078423|NCT02771210|69775361|FG001|Period 1|Lost to Follow-up|0|||
38078424|NCT02771210|69775360|FG000|Period 1|Physician Decision|0|||
38078425|NCT02771210|69775361|FG001|Period 1|Physician Decision|1|||
38078426|NCT02771210|69775360|FG000|Period 1|Withdrawal by Subject|0|||
38078427|NCT02771210|69775361|FG001|Period 1|Withdrawal by Subject|3|||
38078428|NCT02771210|69775360|FG000|Period 1|Withdrawal of informed consent|1|||
38078429|NCT02771210|69775361|FG001|Period 1|Withdrawal of informed consent|5|||
38078430|NCT02771210|69775360|FG000|Period 2|Adverse Event|1|||
38078431|NCT02771210|69775361|FG001|Period 2|Adverse Event|0|||
38078432|NCT02771210|69775360|FG000|Period 2|Lack of Efficacy|0|||
38078433|NCT02771210|69775361|FG001|Period 2|Lack of Efficacy|1|||
38078434|NCT02771210|69775360|FG000|Period 2|Withdrawal by Subject|1|||
38078435|NCT02771210|69775361|FG001|Period 2|Withdrawal by Subject|0|||
38078436|NCT02771210|69775360|FG000|Period 2|Withdrawal of informed consent|0|||
38078437|NCT02771210|69775361|FG001|Period 2|Withdrawal of informed consent|2|||
38078438|NCT00898677|69775371|FG000|Overall Study|Adverse Event|0|||
38078439|NCT00898677|69775372|FG001|Overall Study|Adverse Event|0|||
38078440|NCT00898677|69775373|FG002|Overall Study|Adverse Event|1|||
38078441|NCT00898677|69775374|FG003|Overall Study|Adverse Event|0|||
38078442|NCT00898677|69775371|FG000|Overall Study|Lost to Follow-up|0|||
38078443|NCT00898677|69775372|FG001|Overall Study|Lost to Follow-up|0|||
38078444|NCT00898677|69775373|FG002|Overall Study|Lost to Follow-up|2|||
38078445|NCT00898677|69775374|FG003|Overall Study|Lost to Follow-up|0|||
38078446|NCT00898677|69775371|FG000|Overall Study|Protocol Violation|1|||
38078447|NCT00898677|69775372|FG001|Overall Study|Protocol Violation|1|||
38078448|NCT00898677|69775373|FG002|Overall Study|Protocol Violation|2|||
38078449|NCT00898677|69775374|FG003|Overall Study|Protocol Violation|0|||
38078450|NCT00898677|69775371|FG000|Overall Study|Withdrawal by Subject|0|||
38078451|NCT00898677|69775372|FG001|Overall Study|Withdrawal by Subject|0|||
38078452|NCT00898677|69775373|FG002|Overall Study|Withdrawal by Subject|0|||
38078453|NCT00898677|69775374|FG003|Overall Study|Withdrawal by Subject|1|||
38078454|NCT00898677|69775371|FG000|Overall Study|Not Treated: Adverse Event|0|||
38078455|NCT00898677|69775372|FG001|Overall Study|Not Treated: Adverse Event|2|||
38078456|NCT00898677|69775373|FG002|Overall Study|Not Treated: Adverse Event|1|||
38078457|NCT00898677|69775374|FG003|Overall Study|Not Treated: Adverse Event|0|||
37966607|NCT00468585|69653502|FG003|Overall Study|Patient found to be ineligible|0|||
37966608|NCT00468585|69653499|FG000|Overall Study|Adverse Event|0|||
37966609|NCT00468585|69653500|FG001|Overall Study|Adverse Event|0|||
37966610|NCT00468585|69653501|FG002|Overall Study|Adverse Event|1|||
37966611|NCT00468585|69653502|FG003|Overall Study|Adverse Event|0|||
37966612|NCT00468585|69653499|FG000|Overall Study|Withdrawal by Subject|0|||
37966613|NCT00468585|69653500|FG001|Overall Study|Withdrawal by Subject|0|||
37966614|NCT00468585|69653501|FG002|Overall Study|Withdrawal by Subject|2|||
37966615|NCT00468585|69653502|FG003|Overall Study|Withdrawal by Subject|1|||
37966616|NCT00450801|69653512|FG000|Overall Study|Death|1|||
37966617|NCT00458211|69653521|FG000|Overall Study|Lack of Efficacy|12|||
37966618|NCT00458211|69653521|FG000|Overall Study|Withdrawal by Subject|2|||
37966619|NCT00458211|69653521|FG000|Overall Study|Protocol Violation|2|||
38078458|NCT00898677|69775371|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
38078459|NCT00898677|69775372|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
38078460|NCT00898677|69775373|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
38078461|NCT00898677|69775374|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
38078462|NCT00898677|69775371|FG000|Overall Study|Not Treated: Pregnancy|0|||
38078463|NCT00898677|69775372|FG001|Overall Study|Not Treated: Pregnancy|0|||
38078464|NCT00898677|69775373|FG002|Overall Study|Not Treated: Pregnancy|1|||
38078465|NCT00898677|69775374|FG003|Overall Study|Not Treated: Pregnancy|0|||
38078466|NCT00898677|69775371|FG000|Overall Study|Not Treated: Protocol Violation|2|||
38078467|NCT00898677|69775372|FG001|Overall Study|Not Treated: Protocol Violation|0|||
38078468|NCT00898677|69775373|FG002|Overall Study|Not Treated: Protocol Violation|2|||
37966620|NCT00450723|69653529|FG000|Overall Study|Physician Decision|5|||
37966621|NCT00467961|69653534|FG000|Overall Study|Technical Failures|5|||
37966622|NCT00467961|69653534|FG000|Overall Study|Disease Progression|2|||
38078469|NCT00898677|69775374|FG003|Overall Study|Not Treated: Protocol Violation|0|||
38078470|NCT00898677|69775371|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
38078471|NCT00898677|69775372|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
38078472|NCT00898677|69775373|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
38078473|NCT00898677|69775374|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
38078474|NCT00898677|69775371|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
38078475|NCT00898677|69775372|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
38078476|NCT00898677|69775373|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
38078477|NCT00898677|69775374|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
38078478|NCT00898677|69775371|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
38078479|NCT00898677|69775372|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
38078480|NCT00898677|69775373|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
38078481|NCT00898677|69775374|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
38078482|NCT00898677|69775371|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
38078483|NCT00898677|69775372|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
38078484|NCT00898677|69775373|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
38078485|NCT00898677|69775374|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
38078486|NCT00898677|69775371|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
38078487|NCT00898677|69775372|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
38078488|NCT00898677|69775373|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
38078489|NCT00898677|69775374|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
38078490|NCT00898677|69775371|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
38078491|NCT00898677|69775372|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
38078492|NCT00898677|69775373|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
38078493|NCT00898677|69775374|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
38078494|NCT00898677|69775371|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
38078495|NCT00898677|69775372|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
38078496|NCT00898677|69775373|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
38078497|NCT00898677|69775374|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
38078498|NCT02770820|69775384|FG000|Overall Study|Death|1|||
38078499|NCT02770820|69775384|FG000|Overall Study|Physician Decision|2|||
38078500|NCT03082729|69775388|FG000|Overall Study|Lost to Follow-up|7|||
38078501|NCT03082729|69775388|FG000|Overall Study|Physician Decision|2|||
38078502|NCT03082729|69775388|FG000|Overall Study|Withdrawal by Subject|1|||
38078503|NCT03082729|69775388|FG000|Overall Study|Lack of Efficacy|9|||
38078504|NCT03082729|69775388|FG000|Overall Study|Adverse Event|4|||
38078505|NCT03082729|69775388|FG000|Overall Study|Protocol Violation|6|||
38078506|NCT03082729|69775388|FG000|Overall Study|Fear of study procedure|1|||
38078507|NCT03082729|69775388|FG000|Overall Study|Scheduling conflict|1|||
38078508|NCT02764190|69775400|FG000|Overall Study|Lost to Follow-up|17|||
38078509|NCT02764190|69775401|FG001|Overall Study|Lost to Follow-up|13|||
38078510|NCT03077659|69775410|FG000|Overall Study|Withdrawal by Subject|0|||
38078511|NCT03077659|69775411|FG001|Overall Study|Withdrawal by Subject|0|||
38078512|NCT03077659|69775412|FG002|Overall Study|Withdrawal by Subject|1|||
38078513|NCT02807883|69775423|FG000|Overall Study|Withdrawal by Subject|2|||
38078514|NCT03082261|69775427|FG000|Overall Study|Death|4|||
38078515|NCT03082261|69775427|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
38078516|NCT03082261|69775427|FG000|Overall Study|Insurance denial|1|||
38078517|NCT03082261|69775427|FG000|Overall Study|Peripheral lead added|1|||
38078518|NCT03082261|69775427|FG000|Overall Study|Withdrawal by Subject|40|||
38078519|NCT03082261|69775427|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
38078520|NCT03082261|69775427|FG000|Overall Study|Subject implanted with device other than study device|1|||
38078521|NCT03082261|69775427|FG000|Overall Study|Lost to Follow-up|14|||
38078522|NCT03082261|69775427|FG000|Overall Study|Subject moved to a different state|1|||
38078523|NCT03082261|69775427|FG000|Overall Study|Subject non-compliance|2|||
38078524|NCT03082261|69775427|FG000|Overall Study|Subject participation terminated by investigator|9|||
38078525|NCT03082261|69775427|FG000|Overall Study|Subject participation terminated by sponsor|4|||
38078526|NCT03082261|69775427|FG000|Overall Study|System explant|19|||
38078527|NCT03082261|69775427|FG000|Overall Study|Unable to place lead(s)|2|||
38078528|NCT03082261|69775427|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
38078529|NCT00102440|69775434|FG000|Overall Study|Lost to Follow-up|25|||
38078530|NCT00102440|69775435|FG001|Overall Study|Lost to Follow-up|18|||
37966623|NCT00457821|69653546|FG000|Part 2|Withdrawal by Subject|0|||
38078531|NCT00102440|69775436|FG002|Overall Study|Lost to Follow-up|21|||
38078532|NCT00102440|69775434|FG000|Overall Study|Adverse Event|16|||
38078533|NCT00102440|69775435|FG001|Overall Study|Adverse Event|23|||
38078534|NCT00102440|69775436|FG002|Overall Study|Adverse Event|8|||
38078535|NCT00102440|69775434|FG000|Overall Study|Gout Flare|10|||
38078536|NCT00102440|69775435|FG001|Overall Study|Gout Flare|28|||
38078537|NCT00102440|69775436|FG002|Overall Study|Gout Flare|9|||
38078538|NCT00102440|69775434|FG000|Overall Study|Personal Reason(s)|19|||
38078539|NCT00102440|69775435|FG001|Overall Study|Personal Reason(s)|13|||
38078540|NCT00102440|69775436|FG002|Overall Study|Personal Reason(s)|13|||
38078541|NCT00102440|69775434|FG000|Overall Study|Other|11|||
38078542|NCT00102440|69775435|FG001|Overall Study|Other|14|||
38078543|NCT00102440|69775436|FG002|Overall Study|Other|14|||
38078544|NCT00102440|69775434|FG000|Overall Study|Protocol Violation|7|||
38078545|NCT00102440|69775435|FG001|Overall Study|Protocol Violation|2|||
38078546|NCT00102440|69775436|FG002|Overall Study|Protocol Violation|1|||
38078547|NCT02762084|69775460|FG000|Overall Study|Withdrawal by Subject|1|||
38078548|NCT02762084|69775461|FG001|Overall Study|Withdrawal by Subject|0|||
38078549|NCT02762084|69775462|FG002|Overall Study|Withdrawal by Subject|0|||
38078550|NCT02762084|69775460|FG000|Overall Study|Adverse Event|0|||
38078551|NCT02762084|69775461|FG001|Overall Study|Adverse Event|0|||
38078552|NCT02762084|69775462|FG002|Overall Study|Adverse Event|1|||
38078553|NCT02763644|69775474|FG000|Overall Study|Patient/guardian decision|1|||
38078554|NCT02763644|69775475|FG001|Overall Study|Patient/guardian decision|0|||
38078555|NCT02763644|69775474|FG000|Overall Study|Death|1|||
38078556|NCT02763644|69775475|FG001|Overall Study|Death|1|||
38078557|NCT02763644|69775474|FG000|Overall Study|Adverse Event|1|||
38078558|NCT02763644|69775475|FG001|Overall Study|Adverse Event|1|||
38078559|NCT02807844|69775493|FG000|Overall Study|Physician Decision|0|||
38078560|NCT02807844|69775494|FG001|Overall Study|Physician Decision|0|||
38078561|NCT02807844|69775495|FG002|Overall Study|Physician Decision|0|||
38078562|NCT02807844|69775496|FG003|Overall Study|Physician Decision|0|||
38078563|NCT02807844|69775497|FG004|Overall Study|Physician Decision|0|||
38078564|NCT02807844|69775498|FG005|Overall Study|Physician Decision|0|||
38078565|NCT02807844|69775499|FG006|Overall Study|Physician Decision|3|||
38078566|NCT02807844|69775500|FG007|Overall Study|Physician Decision|0|||
38078567|NCT02807844|69775501|FG008|Overall Study|Physician Decision|1|||
38078568|NCT02807844|69775502|FG009|Overall Study|Physician Decision|2|||
38078569|NCT02807844|69775493|FG000|Overall Study|Death|0|||
38078570|NCT02807844|69775494|FG001|Overall Study|Death|0|||
38078571|NCT02807844|69775495|FG002|Overall Study|Death|2|||
38078572|NCT02807844|69775496|FG003|Overall Study|Death|4|||
38078573|NCT02807844|69775497|FG004|Overall Study|Death|1|||
38078574|NCT02807844|69775498|FG005|Overall Study|Death|2|||
38078575|NCT02807844|69775499|FG006|Overall Study|Death|1|||
38078576|NCT02807844|69775500|FG007|Overall Study|Death|2|||
38078577|NCT02807844|69775501|FG008|Overall Study|Death|0|||
38078578|NCT02807844|69775502|FG009|Overall Study|Death|1|||
38078579|NCT02807844|69775493|FG000|Overall Study|Withdrawal by Subject|0|||
38078580|NCT02807844|69775494|FG001|Overall Study|Withdrawal by Subject|0|||
38078581|NCT02807844|69775495|FG002|Overall Study|Withdrawal by Subject|2|||
38078582|NCT02807844|69775496|FG003|Overall Study|Withdrawal by Subject|1|||
38078583|NCT02807844|69775497|FG004|Overall Study|Withdrawal by Subject|1|||
38078584|NCT02807844|69775498|FG005|Overall Study|Withdrawal by Subject|0|||
38078585|NCT02807844|69775499|FG006|Overall Study|Withdrawal by Subject|1|||
37966624|NCT00457821|69653547|FG001|Part 2|Withdrawal by Subject|0|||
37966625|NCT00457821|69653548|FG002|Part 2|Withdrawal by Subject|0|||
37966626|NCT00457821|69653549|FG003|Part 2|Withdrawal by Subject|0|||
37966627|NCT00457821|69653550|FG004|Part 2|Withdrawal by Subject|0|||
37966628|NCT00457821|69653551|FG005|Part 2|Withdrawal by Subject|0|||
37966629|NCT00457821|69653552|FG006|Part 2|Withdrawal by Subject|0|||
37966630|NCT00457821|69653553|FG007|Part 2|Withdrawal by Subject|1|||
37966631|NCT00633893|69653573|FG000|Overall Study|Death|1|||
37966632|NCT00633893|69653574|FG001|Overall Study|Death|3|||
38078586|NCT02807844|69775500|FG007|Overall Study|Withdrawal by Subject|0|||
38078587|NCT02807844|69775501|FG008|Overall Study|Withdrawal by Subject|0|||
38078588|NCT02807844|69775502|FG009|Overall Study|Withdrawal by Subject|0|||
38078589|NCT02807844|69775493|FG000|Overall Study|Progressive disease|5|||
38078590|NCT02807844|69775494|FG001|Overall Study|Progressive disease|12|||
38078591|NCT02807844|69775495|FG002|Overall Study|Progressive disease|8|||
38078592|NCT02807844|69775496|FG003|Overall Study|Progressive disease|8|||
38078593|NCT02807844|69775497|FG004|Overall Study|Progressive disease|3|||
38078594|NCT02807844|69775498|FG005|Overall Study|Progressive disease|8|||
38078595|NCT02807844|69775499|FG006|Overall Study|Progressive disease|14|||
38078596|NCT02807844|69775500|FG007|Overall Study|Progressive disease|17|||
38078597|NCT02807844|69775501|FG008|Overall Study|Progressive disease|19|||
38078598|NCT02807844|69775502|FG009|Overall Study|Progressive disease|15|||
38078599|NCT02807844|69775493|FG000|Overall Study|Adverse Event|1|||
38078600|NCT02807844|69775494|FG001|Overall Study|Adverse Event|0|||
38078601|NCT02807844|69775495|FG002|Overall Study|Adverse Event|0|||
38078602|NCT02807844|69775496|FG003|Overall Study|Adverse Event|0|||
38078603|NCT02807844|69775497|FG004|Overall Study|Adverse Event|1|||
37966633|NCT00633893|69653575|FG002|Overall Study|Death|9|||
38078604|NCT02807844|69775498|FG005|Overall Study|Adverse Event|1|||
38078605|NCT02807844|69775499|FG006|Overall Study|Adverse Event|1|||
38078606|NCT02807844|69775500|FG007|Overall Study|Adverse Event|1|||
37966634|NCT00633893|69653573|FG000|Overall Study|Adverse Event|65|||
37966635|NCT00633893|69653574|FG001|Overall Study|Adverse Event|58|||
38078607|NCT02807844|69775501|FG008|Overall Study|Adverse Event|1|||
38078608|NCT02807844|69775502|FG009|Overall Study|Adverse Event|2|||
38078609|NCT02763254|69775528|FG000|Overall Study|Adverse Event|1|||
38078610|NCT02805972|69775534|FG000|Washout Period|Lost to Follow-up|3|||
38078611|NCT02805972|69775535|FG001|Washout Period|Lost to Follow-up|0|||
38078612|NCT03032523|69775553|FG000|Overall Study|Withdrawal by Subject|2|||
38078613|NCT03032523|69775554|FG001|Overall Study|Withdrawal by Subject|2|||
38078614|NCT03032523|69775553|FG000|Overall Study|Physician Decision|1|||
38078615|NCT03032523|69775554|FG001|Overall Study|Physician Decision|0|||
38078616|NCT03031899|69775561|FG000|Overall Study|Protocol Violation|1|||
38078617|NCT03031899|69775561|FG000|Overall Study|lesion disappeared after stopping habit|1|||
38078618|NCT03086369|69775574|FG000|Overall Study|Lost to Follow-up|1|||
38078619|NCT03086369|69775575|FG001|Overall Study|Lost to Follow-up|0|||
38078620|NCT03086369|69775576|FG002|Overall Study|Lost to Follow-up|0|||
38078621|NCT03086369|69775577|FG003|Overall Study|Lost to Follow-up|2|||
38078622|NCT03086369|69775578|FG004|Overall Study|Lost to Follow-up|1|||
38078623|NCT03086369|69775574|FG000|Overall Study|Physician Decision|0|||
38078624|NCT03086369|69775575|FG001|Overall Study|Physician Decision|0|||
38078625|NCT03086369|69775576|FG002|Overall Study|Physician Decision|0|||
38078626|NCT03086369|69775577|FG003|Overall Study|Physician Decision|1|||
38078627|NCT03086369|69775578|FG004|Overall Study|Physician Decision|2|||
38078628|NCT03086369|69775574|FG000|Overall Study|Withdrawal by Subject|0|||
38078629|NCT03086369|69775575|FG001|Overall Study|Withdrawal by Subject|0|||
38078630|NCT03086369|69775576|FG002|Overall Study|Withdrawal by Subject|0|||
38078631|NCT03086369|69775577|FG003|Overall Study|Withdrawal by Subject|5|||
38078632|NCT03086369|69775578|FG004|Overall Study|Withdrawal by Subject|3|||
38078633|NCT03086369|69775574|FG000|Overall Study|Progressive Disease|0|||
38078634|NCT03086369|69775575|FG001|Overall Study|Progressive Disease|0|||
38078635|NCT03086369|69775576|FG002|Overall Study|Progressive Disease|0|||
38078636|NCT03086369|69775577|FG003|Overall Study|Progressive Disease|1|||
38078637|NCT03086369|69775578|FG004|Overall Study|Progressive Disease|1|||
38078638|NCT00101582|69775594|FG000|Overall Study|Ineligibility determined|0|||
38078639|NCT00101582|69775595|FG001|Overall Study|Ineligibility determined|1|||
38078640|NCT00101582|69775594|FG000|Overall Study|Adverse Event|1|||
38078641|NCT00101582|69775595|FG001|Overall Study|Adverse Event|4|||
38078642|NCT00101582|69775594|FG000|Overall Study|Withdrawal by Subject|6|||
38078643|NCT00101582|69775595|FG001|Overall Study|Withdrawal by Subject|4|||
38078644|NCT00101582|69775594|FG000|Overall Study|Physician Decision|1|||
38078645|NCT00101582|69775595|FG001|Overall Study|Physician Decision|0|||
38078646|NCT00101582|69775594|FG000|Overall Study|Death|3|||
38078647|NCT00101582|69775595|FG001|Overall Study|Death|5|||
38078648|NCT00101582|69775594|FG000|Overall Study|Other|0|||
38078649|NCT00101582|69775595|FG001|Overall Study|Other|1|||
38078650|NCT03086135|69775626|FG000|Overall Study|Adverse Event|1|||
38078651|NCT03086135|69775626|FG000|Overall Study|Lost to Follow-up|2|||
38078652|NCT02762708|69775643|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
38078653|NCT02762708|69775644|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
38078654|NCT02762708|69775645|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
38078655|NCT02762708|69775646|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
38078656|NCT02760602|69775658|FG000|Overall Study|Withdrawal by Subject|1|||
38078657|NCT02760602|69775659|FG001|Overall Study|Withdrawal by Subject|0|||
38078658|NCT02760602|69775658|FG000|Overall Study|Terminated by sponsor|12|||
38078659|NCT02760602|69775659|FG001|Overall Study|Terminated by sponsor|13|||
38078660|NCT00210249|69775665|FG000|Overall Study|Lost to Follow-up|5|||
38078661|NCT00210249|69775665|FG000|Overall Study|Protocol Violation|11|||
38078662|NCT03086057|69775673|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
38078663|NCT03086057|69775674|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
38078664|NCT03086057|69775675|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
38078665|NCT03086057|69775676|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
38078666|NCT03086057|69775673|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
38078667|NCT03086057|69775674|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
38078668|NCT03086057|69775675|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
38078669|NCT03086057|69775676|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
38078670|NCT03086057|69775673|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
38078671|NCT03086057|69775674|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
38078672|NCT03086057|69775675|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
38078673|NCT03086057|69775676|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
38078674|NCT03086057|69775673|FG000|Stage 1: PrEP Uptake|Death|1|||
38078675|NCT03086057|69775674|FG001|Stage 1: PrEP Uptake|Death|0|||
38078676|NCT03086057|69775675|FG002|Stage 1: PrEP Uptake|Death|0|||
38078677|NCT03086057|69775676|FG003|Stage 1: PrEP Uptake|Death|0|||
38078678|NCT03086057|69775673|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
38078679|NCT03086057|69775674|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
38078680|NCT03086057|69775675|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
38078681|NCT03086057|69775676|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
38078682|NCT03086057|69775673|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
38078683|NCT03086057|69775674|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
38078684|NCT03086057|69775675|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
38078685|NCT03086057|69775676|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
38078686|NCT03086057|69775673|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
38078687|NCT03086057|69775674|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
38078688|NCT03086057|69775675|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
38078689|NCT03086057|69775676|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
38078690|NCT02759120|69775688|FG000|Overall Study|Death|34|||
38078691|NCT02759120|69775689|FG001|Overall Study|Death|36|||
38078692|NCT02759120|69775688|FG000|Overall Study|Lost to Follow-up|4|||
38078693|NCT02759120|69775689|FG001|Overall Study|Lost to Follow-up|7|||
38078694|NCT02759120|69775688|FG000|Overall Study|Physician Decision|3|||
38078695|NCT02759120|69775689|FG001|Overall Study|Physician Decision|0|||
38078696|NCT02759120|69775688|FG000|Overall Study|Withdrawal by Subject|28|||
38078697|NCT02759120|69775689|FG001|Overall Study|Withdrawal by Subject|15|||
38078698|NCT02759120|69775688|FG000|Overall Study|Moved out of area|3|||
38078699|NCT02759120|69775689|FG001|Overall Study|Moved out of area|4|||
38078700|NCT02759120|69775688|FG000|Overall Study|Lung transplant|3|||
38078701|NCT02759120|69775689|FG001|Overall Study|Lung transplant|5|||
38078702|NCT02759120|69775688|FG000|Overall Study|Other reason not completed|10|||
38078703|NCT02759120|69775689|FG001|Overall Study|Other reason not completed|12|||
38078704|NCT00101192|69775695|FG000|Overall Study|Ineligible|6|||
38078705|NCT00101192|69775695|FG000|Overall Study|Inevaluable|1|||
38078706|NCT03031431|69775699|FG000|Overall Study|Infant removed by maternal request|1|||
38078707|NCT03029247|69775705|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
38078708|NCT03029247|69775706|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
38078709|NCT03029247|69775705|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
38078710|NCT03029247|69775706|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
38078711|NCT03029247|69775705|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
38078712|NCT03029247|69775706|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
38078713|NCT03029247|69775705|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
38078714|NCT03029247|69775706|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
38078715|NCT04313283|69775712|FG000|Overall Study|did not complete intervention|4|||
38078716|NCT02754440|69775720|FG000|Overall Study|Protocol Violation|3|||
38078717|NCT02754440|69775721|FG001|Overall Study|Protocol Violation|2|||
38078718|NCT02754440|69775722|FG002|Overall Study|Protocol Violation|2|||
38078719|NCT02754440|69775723|FG003|Overall Study|Protocol Violation|6|||
38078720|NCT02754440|69775720|FG000|Overall Study|Adverse Event|3|||
38078721|NCT02754440|69775721|FG001|Overall Study|Adverse Event|1|||
38078722|NCT02754440|69775722|FG002|Overall Study|Adverse Event|0|||
38078723|NCT02754440|69775723|FG003|Overall Study|Adverse Event|9|||
38078724|NCT02754440|69775720|FG000|Overall Study|Withdrawal by Subject|0|||
38078725|NCT02754440|69775721|FG001|Overall Study|Withdrawal by Subject|0|||
38078726|NCT02754440|69775722|FG002|Overall Study|Withdrawal by Subject|0|||
38078727|NCT02754440|69775723|FG003|Overall Study|Withdrawal by Subject|1|||
38078728|NCT02754440|69775720|FG000|Overall Study|Equipment failure|0|||
38078729|NCT02754440|69775721|FG001|Overall Study|Equipment failure|5|||
38078730|NCT02754440|69775722|FG002|Overall Study|Equipment failure|5|||
38078731|NCT02754440|69775723|FG003|Overall Study|Equipment failure|7|||
38078732|NCT02754440|69775720|FG000|Overall Study|Subject issues not resulting in AE|0|||
38078733|NCT02754440|69775721|FG001|Overall Study|Subject issues not resulting in AE|0|||
38078734|NCT02754440|69775722|FG002|Overall Study|Subject issues not resulting in AE|0|||
38078735|NCT02754440|69775723|FG003|Overall Study|Subject issues not resulting in AE|12|||
38078736|NCT02753816|69775735|FG000|Overall Study|Protocol Violation|0|||
38078737|NCT02753816|69775736|FG001|Overall Study|Protocol Violation|1|||
38078738|NCT02753816|69775737|FG002|Overall Study|Protocol Violation|0|||
38078739|NCT02752802|69775745|FG000|Overall Study|Contrast Volume Not Collected|1|||
38078740|NCT02752802|69775746|FG001|Overall Study|Contrast Volume Not Collected|0|||
38078741|NCT02756078|69775763|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
38078742|NCT02756078|69775764|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
38078743|NCT02756078|69775763|FG000|Period 1|Lost to Follow-up|0|||
38078744|NCT02756078|69775764|FG001|Period 1|Lost to Follow-up|2|||
38078745|NCT02756078|69775763|FG000|Period 1|Protocol Violation|0|||
38078746|NCT02756078|69775764|FG001|Period 1|Protocol Violation|1|||
38078747|NCT02756078|69775763|FG000|Period 1|Adverse Event|1|||
38078748|NCT02756078|69775764|FG001|Period 1|Adverse Event|10|||
38078749|NCT02756078|69775763|FG000|Period 1|Withdrawal by Subject|6|||
38078750|NCT02756078|69775764|FG001|Period 1|Withdrawal by Subject|6|||
38078751|NCT02756078|69775763|FG000|Period 1|Lens Discomfort|2|||
38078752|NCT02756078|69775764|FG001|Period 1|Lens Discomfort|2|||
38078753|NCT02756078|69775763|FG000|Period 2|Adverse Event|3|||
38078754|NCT02756078|69775764|FG001|Period 2|Adverse Event|5|||
38078755|NCT02756078|69775763|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
38078756|NCT02756078|69775764|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
38078757|NCT02756078|69775763|FG000|Period 2|Withdrawal by Subject|3|||
38078758|NCT02756078|69775764|FG001|Period 2|Withdrawal by Subject|1|||
38078759|NCT02752958|69775770|FG000|Overall Study|Adverse Event|3|||
38078760|NCT02752958|69775770|FG000|Overall Study|Lost to Follow-up|1|||
38078761|NCT02752958|69775770|FG000|Overall Study|Protocol Violation|1|||
38078762|NCT02752958|69775770|FG000|Overall Study|Withdrawal by Subject|2|||
38078763|NCT02752958|69775770|FG000|Overall Study|Other (Reason not specified)|2|||
38078764|NCT02805660|69775783|FG000|Overall Study|Death|5|||
38078765|NCT02805660|69775784|FG001|Overall Study|Death|2|||
38078766|NCT02805660|69775785|FG002|Overall Study|Death|9|||
38078767|NCT02805660|69775786|FG003|Overall Study|Death|5|||
38078768|NCT02805660|69775787|FG004|Overall Study|Death|0|||
38078769|NCT02805660|69775788|FG005|Overall Study|Death|14|||
38078770|NCT02805660|69775789|FG006|Overall Study|Death|12|||
38078771|NCT02805660|69775783|FG000|Overall Study|Lost to Follow-up|0|||
38078772|NCT02805660|69775784|FG001|Overall Study|Lost to Follow-up|1|||
38078773|NCT02805660|69775785|FG002|Overall Study|Lost to Follow-up|1|||
38078774|NCT02805660|69775786|FG003|Overall Study|Lost to Follow-up|2|||
38078775|NCT02805660|69775787|FG004|Overall Study|Lost to Follow-up|0|||
38078776|NCT02805660|69775788|FG005|Overall Study|Lost to Follow-up|0|||
37966636|NCT00633893|69653575|FG002|Overall Study|Adverse Event|126|||
37966637|NCT00633893|69653573|FG000|Overall Study|Withdrawal by Subject|7|||
37966638|NCT00633893|69653574|FG001|Overall Study|Withdrawal by Subject|12|||
37966639|NCT00633893|69653575|FG002|Overall Study|Withdrawal by Subject|6|||
37966640|NCT00633893|69653573|FG000|Overall Study|Lost to Follow-up|2|||
37966641|NCT00633893|69653574|FG001|Overall Study|Lost to Follow-up|4|||
37966642|NCT00633893|69653575|FG002|Overall Study|Lost to Follow-up|8|||
37966643|NCT00633893|69653573|FG000|Overall Study|Poor/non-compliance|5|||
37966644|NCT00633893|69653574|FG001|Overall Study|Poor/non-compliance|12|||
37966645|NCT00633893|69653575|FG002|Overall Study|Poor/non-compliance|3|||
37966646|NCT00633893|69653573|FG000|Overall Study|Pregnancy|2|||
37966647|NCT00633893|69653574|FG001|Overall Study|Pregnancy|1|||
37966648|NCT00633893|69653575|FG002|Overall Study|Pregnancy|1|||
38078777|NCT02805660|69775789|FG006|Overall Study|Lost to Follow-up|0|||
38078778|NCT02805660|69775783|FG000|Overall Study|Withdrawal by Subject|0|||
38078779|NCT02805660|69775784|FG001|Overall Study|Withdrawal by Subject|0|||
38078780|NCT02805660|69775785|FG002|Overall Study|Withdrawal by Subject|0|||
38078781|NCT02805660|69775786|FG003|Overall Study|Withdrawal by Subject|3|||
38078782|NCT02805660|69775787|FG004|Overall Study|Withdrawal by Subject|1|||
38078783|NCT02805660|69775788|FG005|Overall Study|Withdrawal by Subject|0|||
37966649|NCT00633893|69653573|FG000|Overall Study|Not meet/no longer meets criteria|4|||
37966650|NCT00633893|69653574|FG001|Overall Study|Not meet/no longer meets criteria|6|||
38078784|NCT02805660|69775789|FG006|Overall Study|Withdrawal by Subject|2|||
38078785|NCT02805660|69775783|FG000|Overall Study|Study terminated by Sponsor|0|||
38078786|NCT02805660|69775784|FG001|Overall Study|Study terminated by Sponsor|0|||
38078787|NCT02805660|69775785|FG002|Overall Study|Study terminated by Sponsor|1|||
38078788|NCT02805660|69775786|FG003|Overall Study|Study terminated by Sponsor|4|||
38078789|NCT02805660|69775787|FG004|Overall Study|Study terminated by Sponsor|2|||
38078790|NCT02805660|69775788|FG005|Overall Study|Study terminated by Sponsor|3|||
38078791|NCT02805660|69775789|FG006|Overall Study|Study terminated by Sponsor|1|||
38078792|NCT02805660|69775783|FG000|Overall Study|Miscellaneous|0|||
38078793|NCT02805660|69775784|FG001|Overall Study|Miscellaneous|1|||
38078794|NCT02805660|69775785|FG002|Overall Study|Miscellaneous|0|||
38078795|NCT02805660|69775786|FG003|Overall Study|Miscellaneous|4|||
38078796|NCT02805660|69775787|FG004|Overall Study|Miscellaneous|0|||
38078797|NCT02805660|69775788|FG005|Overall Study|Miscellaneous|6|||
38078798|NCT02805660|69775789|FG006|Overall Study|Miscellaneous|4|||
38078799|NCT02807376|69775820|FG000|Overall Study|Intra-operative exclusion criteria|3|||
38078800|NCT02807376|69775821|FG001|Overall Study|Intra-operative exclusion criteria|0|||
38078801|NCT02807376|69775820|FG000|Overall Study|Lost to Follow-up|0|||
38078802|NCT02807376|69775821|FG001|Overall Study|Lost to Follow-up|1|||
38078803|NCT02804178|69775827|FG000|Overall Study|Adverse Event|1|||
38078804|NCT02917941|69775831|FG000|Treatment Period|Adverse Event|11|||
38078805|NCT02917941|69775831|FG000|Treatment Period|Progressive Disease|11|||
38078806|NCT02917941|69775831|FG000|Treatment Period|Reason not Specified|2|||
38078807|NCT02917941|69775831|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
38078808|NCT02917941|69775831|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
38078809|NCT01333956|69775839|FG000|Overall Study|Lost to Follow-up|1|||
38078810|NCT01333956|69775840|FG001|Overall Study|Lost to Follow-up|2|||
38078811|NCT01333956|69775841|FG002|Overall Study|Lost to Follow-up|0|||
38078812|NCT01333956|69775842|FG003|Overall Study|Lost to Follow-up|1|||
38078813|NCT01333956|69775839|FG000|Overall Study|Unable to complete study procedure|1|||
38078814|NCT01333956|69775840|FG001|Overall Study|Unable to complete study procedure|0|||
38078815|NCT01333956|69775841|FG002|Overall Study|Unable to complete study procedure|0|||
38078816|NCT01333956|69775842|FG003|Overall Study|Unable to complete study procedure|1|||
38078817|NCT01333956|69775839|FG000|Overall Study|Withdrawal by Subject|0|||
38078818|NCT01333956|69775840|FG001|Overall Study|Withdrawal by Subject|2|||
38078819|NCT01333956|69775841|FG002|Overall Study|Withdrawal by Subject|1|||
38078820|NCT01333956|69775842|FG003|Overall Study|Withdrawal by Subject|0|||
38078821|NCT01333722|69775855|FG000|Overall Study|Lack of Efficacy|0|||
38078822|NCT01333722|69775856|FG001|Overall Study|Lack of Efficacy|2|||
38078823|NCT01333722|69775855|FG000|Overall Study|Withdrawal by Subject|0|||
38078824|NCT01333722|69775856|FG001|Overall Study|Withdrawal by Subject|1|||
38078825|NCT01370694|69775864|FG000|Overall Study|Switched to rituximab|4|||
38078826|NCT01370694|69775864|FG000|Overall Study|Progressive disease|2|||
38078827|NCT03315143|69775870|FG000|Overall Study|Death|240|||
38078828|NCT03315143|69775871|FG001|Overall Study|Death|246|||
38078829|NCT03315143|69775870|FG000|Overall Study|Withdrawal by Subject|57|||
38078830|NCT03315143|69775871|FG001|Overall Study|Withdrawal by Subject|68|||
38078831|NCT03315143|69775870|FG000|Overall Study|Site Terminated by Sponsor|256|||
38078832|NCT03315143|69775871|FG001|Overall Study|Site Terminated by Sponsor|282|||
38078833|NCT03315143|69775870|FG000|Overall Study|Study Terminated by Sponsor|4723|||
38078834|NCT03315143|69775871|FG001|Overall Study|Study Terminated by Sponsor|4664|||
38078835|NCT03315143|69775870|FG000|Overall Study|Reason not Specified|16|||
38078836|NCT03315143|69775871|FG001|Overall Study|Reason not Specified|32|||
38078837|NCT02797080|69775877|FG000|Overall Study|Lost to Follow-up|1|||
38078838|NCT02797080|69775877|FG000|Overall Study|Withdrawal by Subject|1|||
38078839|NCT02915835|69775883|FG000|Overall Study|Physician Decision|1|||
38078840|NCT02915835|69775884|FG001|Overall Study|Physician Decision|0|||
38078841|NCT02915835|69775883|FG000|Overall Study|Withdrawal by Subject|0|||
38078842|NCT02915835|69775884|FG001|Overall Study|Withdrawal by Subject|1|||
38078843|NCT01370616|69775892|FG000|Overall Study|Adverse Event|11|||
38078844|NCT01370616|69775893|FG001|Overall Study|Adverse Event|16|||
38078845|NCT01370616|69775892|FG000|Overall Study|Death|1|||
38078846|NCT01370616|69775893|FG001|Overall Study|Death|0|||
38078847|NCT01370616|69775892|FG000|Overall Study|Lack of Efficacy|6|||
38078848|NCT01370616|69775893|FG001|Overall Study|Lack of Efficacy|2|||
38078849|NCT01370616|69775892|FG000|Overall Study|Lost to Follow-up|0|||
38078850|NCT01370616|69775893|FG001|Overall Study|Lost to Follow-up|3|||
38078851|NCT01370616|69775892|FG000|Overall Study|Physician Decision|6|||
38078852|NCT01370616|69775893|FG001|Overall Study|Physician Decision|6|||
38078853|NCT01370616|69775892|FG000|Overall Study|Progressive Disease|0|||
38078854|NCT01370616|69775893|FG001|Overall Study|Progressive Disease|1|||
38078855|NCT01370616|69775892|FG000|Overall Study|Recovery|1|||
38078856|NCT01370616|69775893|FG001|Overall Study|Recovery|0|||
38078857|NCT01370616|69775892|FG000|Overall Study|Technical Problems|3|||
38078858|NCT01370616|69775893|FG001|Overall Study|Technical Problems|5|||
38078859|NCT01370616|69775892|FG000|Overall Study|Withdrawal by Subject|34|||
38078860|NCT01370616|69775893|FG001|Overall Study|Withdrawal by Subject|34|||
38078861|NCT02916927|69775906|FG000|Overall Study|Discharged prior to study drug receipt|0|||
38078862|NCT02916927|69775907|FG001|Overall Study|Discharged prior to study drug receipt|2|||
38078863|NCT02916927|69775906|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
38078864|NCT02916927|69775907|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
38078865|NCT02916927|69775906|FG000|Overall Study|Withdrawal before first time point|1|||
38078866|NCT02916927|69775907|FG001|Overall Study|Withdrawal before first time point|0|||
38078867|NCT02916693|69775913|FG000|Overall Study|Lost to Follow-up|7|||
38078868|NCT02574455|69775923|FG000|Overall Study|Death|197|||
38078869|NCT02574455|69775924|FG001|Overall Study|Death|210|||
38078870|NCT02574455|69775923|FG000|Overall Study|Withdrawal of Consent|11|||
38078871|NCT02574455|69775924|FG001|Overall Study|Withdrawal of Consent|28|||
38078872|NCT02574455|69775923|FG000|Overall Study|Lost to Follow-up|4|||
38078873|NCT02574455|69775924|FG001|Overall Study|Lost to Follow-up|4|||
38078874|NCT02574455|69775923|FG000|Overall Study|Sponsor's Decision|55|||
38078875|NCT02574455|69775924|FG001|Overall Study|Sponsor's Decision|20|||
38078876|NCT02795832|69775936|FG000|Overall Study|Adverse Event|0|||
38078877|NCT02795832|69775937|FG001|Overall Study|Adverse Event|0|||
38078878|NCT02795832|69775938|FG002|Overall Study|Adverse Event|0|||
38078879|NCT02795832|69775939|FG003|Overall Study|Adverse Event|0|||
38078880|NCT02795832|69775940|FG004|Overall Study|Adverse Event|0|||
38078881|NCT02795832|69775941|FG005|Overall Study|Adverse Event|3|||
38078882|NCT02794974|69775965|FG000|Overall Study|Physician Decision|0|||
38078883|NCT02794974|69775966|FG001|Overall Study|Physician Decision|1|||
38078884|NCT02419417|69775983|FG000|Overall Study|Disease progression|5|||
38078885|NCT02419417|69775984|FG001|Overall Study|Disease progression|4|||
38078886|NCT02419417|69775985|FG002|Overall Study|Disease progression|13|||
38078887|NCT02419417|69775986|FG003|Overall Study|Disease progression|10|||
38078888|NCT02419417|69775987|FG004|Overall Study|Disease progression|10|||
38078889|NCT02419417|69775988|FG005|Overall Study|Disease progression|3|||
38078890|NCT02419417|69775989|FG006|Overall Study|Disease progression|4|||
38078891|NCT02419417|69775990|FG007|Overall Study|Disease progression|5|||
38078892|NCT02419417|69775991|FG008|Overall Study|Disease progression|13|||
38078893|NCT02419417|69775992|FG009|Overall Study|Disease progression|9|||
38078894|NCT02419417|69775993|FG010|Overall Study|Disease progression|0|||
38078895|NCT02419417|69775983|FG000|Overall Study|Study drug toxicity|0|||
38078896|NCT02419417|69775984|FG001|Overall Study|Study drug toxicity|0|||
38078897|NCT02419417|69775985|FG002|Overall Study|Study drug toxicity|0|||
38078898|NCT02419417|69775986|FG003|Overall Study|Study drug toxicity|0|||
38078899|NCT02419417|69775987|FG004|Overall Study|Study drug toxicity|1|||
38078900|NCT02419417|69775988|FG005|Overall Study|Study drug toxicity|0|||
38078901|NCT02419417|69775989|FG006|Overall Study|Study drug toxicity|0|||
38078902|NCT02419417|69775990|FG007|Overall Study|Study drug toxicity|0|||
38078903|NCT02419417|69775991|FG008|Overall Study|Study drug toxicity|0|||
38078904|NCT02419417|69775992|FG009|Overall Study|Study drug toxicity|0|||
38078905|NCT02419417|69775993|FG010|Overall Study|Study drug toxicity|0|||
38078906|NCT02419417|69775983|FG000|Overall Study|Adverse event unrelated to study drug|0|||
38078907|NCT02419417|69775984|FG001|Overall Study|Adverse event unrelated to study drug|0|||
38078908|NCT02419417|69775985|FG002|Overall Study|Adverse event unrelated to study drug|0|||
38078909|NCT02419417|69775986|FG003|Overall Study|Adverse event unrelated to study drug|0|||
38078910|NCT02419417|69775987|FG004|Overall Study|Adverse event unrelated to study drug|2|||
38078911|NCT02419417|69775988|FG005|Overall Study|Adverse event unrelated to study drug|1|||
38078912|NCT02419417|69775989|FG006|Overall Study|Adverse event unrelated to study drug|0|||
38078913|NCT02419417|69775990|FG007|Overall Study|Adverse event unrelated to study drug|1|||
38078914|NCT02419417|69775991|FG008|Overall Study|Adverse event unrelated to study drug|0|||
38078915|NCT02419417|69775992|FG009|Overall Study|Adverse event unrelated to study drug|0|||
38078916|NCT02419417|69775993|FG010|Overall Study|Adverse event unrelated to study drug|0|||
38078917|NCT02419417|69775983|FG000|Overall Study|Participant request to discontinue|0|||
38078918|NCT02419417|69775984|FG001|Overall Study|Participant request to discontinue|0|||
38078919|NCT02419417|69775985|FG002|Overall Study|Participant request to discontinue|0|||
38078920|NCT02419417|69775986|FG003|Overall Study|Participant request to discontinue|0|||
38078921|NCT02419417|69775987|FG004|Overall Study|Participant request to discontinue|0|||
38078922|NCT02419417|69775988|FG005|Overall Study|Participant request to discontinue|0|||
38078923|NCT02419417|69775989|FG006|Overall Study|Participant request to discontinue|0|||
38078924|NCT02419417|69775990|FG007|Overall Study|Participant request to discontinue|0|||
38078925|NCT02419417|69775991|FG008|Overall Study|Participant request to discontinue|0|||
38078926|NCT02419417|69775992|FG009|Overall Study|Participant request to discontinue|1|||
38078927|NCT02419417|69775993|FG010|Overall Study|Participant request to discontinue|0|||
38078928|NCT02419417|69775983|FG000|Overall Study|Withdrawal by Subject|0|||
38078929|NCT02419417|69775984|FG001|Overall Study|Withdrawal by Subject|0|||
38078930|NCT02419417|69775985|FG002|Overall Study|Withdrawal by Subject|0|||
38078931|NCT02419417|69775986|FG003|Overall Study|Withdrawal by Subject|0|||
38078932|NCT02419417|69775987|FG004|Overall Study|Withdrawal by Subject|0|||
38078933|NCT02419417|69775988|FG005|Overall Study|Withdrawal by Subject|0|||
38078934|NCT02419417|69775989|FG006|Overall Study|Withdrawal by Subject|0|||
38078935|NCT02419417|69775990|FG007|Overall Study|Withdrawal by Subject|0|||
38078936|NCT02419417|69775991|FG008|Overall Study|Withdrawal by Subject|0|||
38078937|NCT02419417|69775992|FG009|Overall Study|Withdrawal by Subject|0|||
38078938|NCT02419417|69775993|FG010|Overall Study|Withdrawal by Subject|1|||
38078939|NCT00777491|69776034|FG000|Overall Study|Protocol Violation|0|||
38078940|NCT00777491|69776035|FG001|Overall Study|Protocol Violation|2|||
38078941|NCT00777491|69776034|FG000|Overall Study|Did not receive any protocol treatment|2|||
38078942|NCT00777491|69776035|FG001|Overall Study|Did not receive any protocol treatment|0|||
38078943|NCT02066532|69776045|FG000|Phase II|Withdrawal by Subject|1|||
38078944|NCT02066532|69776046|FG001|Phase II|Withdrawal by Subject|0|||
38078945|NCT02066532|69776047|FG002|Phase II|Withdrawal by Subject|0|||
38078946|NCT02066532|69776048|FG003|Phase II|Withdrawal by Subject|0|||
38078947|NCT03077711|69776055|FG000|Overall Study|Lost to Follow-up|2|||
38078948|NCT03077711|69776056|FG001|Overall Study|Lost to Follow-up|2|||
38078949|NCT03077711|69776055|FG000|Overall Study|noncompliant taking medication|2|||
38078950|NCT03077711|69776056|FG001|Overall Study|noncompliant taking medication|0|||
38078951|NCT04311463|69776083|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
38078952|NCT04311463|69776084|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
38078953|NCT04311463|69776083|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
38078954|NCT04311463|69776084|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
38078955|NCT04311463|69776083|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
38078956|NCT04311463|69776084|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
38078957|NCT01370538|69776097|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
38078958|NCT01370538|69776098|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
38078959|NCT01370538|69776097|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
38078960|NCT01370538|69776098|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
38078961|NCT01370538|69776097|FG000|Overall Study|Adverse Event|1|||
38078962|NCT01370538|69776098|FG001|Overall Study|Adverse Event|0|||
38078963|NCT01370538|69776097|FG000|Overall Study|Protocol Violation|8|||
38078964|NCT01370538|69776098|FG001|Overall Study|Protocol Violation|5|||
38078965|NCT01370538|69776097|FG000|Overall Study|Development of study specific withdrawal|1|||
38078966|NCT01370538|69776098|FG001|Overall Study|Development of study specific withdrawal|1|||
38078967|NCT01370538|69776097|FG000|Overall Study|Lost to follow up|6|||
38078968|NCT01370538|69776098|FG001|Overall Study|Lost to follow up|10|||
38078969|NCT03402841|69776117|FG000|Overall Study|Withdrawal by Subject|3|||
38078970|NCT03402841|69776117|FG000|Overall Study|Lost to Follow-up|2|||
38078971|NCT03402841|69776117|FG000|Overall Study|Death|146|||
38078972|NCT02881957|69776132|FG000|Overall Study|Comfort care|0|||
38078973|NCT02881957|69776133|FG001|Overall Study|Comfort care|1|||
38078974|NCT02881957|69776132|FG000|Overall Study|Concurrent trial enrollment|0|||
38078975|NCT02881957|69776133|FG001|Overall Study|Concurrent trial enrollment|1|||
38078976|NCT02881957|69776132|FG000|Overall Study|Discharged within 48 hours|0|||
38078977|NCT02881957|69776133|FG001|Overall Study|Discharged within 48 hours|1|||
38078978|NCT02881957|69776132|FG000|Overall Study|Withdrawal by Subject|2|||
38078979|NCT02881957|69776133|FG001|Overall Study|Withdrawal by Subject|1|||
38078980|NCT02881957|69776132|FG000|Overall Study|Protocol Violation|1|||
38078981|NCT02881957|69776133|FG001|Overall Study|Protocol Violation|0|||
38078982|NCT03022461|69776139|FG000|Overall Study|Death|3|||
38078983|NCT02750930|69776144|FG000|Overall Study|Study closed/terminated|8|||
38078984|NCT03078907|69776150|FG000|Overall Study|Adverse Event|2|||
38078985|NCT03078907|69776151|FG001|Overall Study|Adverse Event|0|||
38078986|NCT03078907|69776150|FG000|Overall Study|Other|1|||
38078987|NCT03078907|69776151|FG001|Overall Study|Other|0|||
38078988|NCT03078907|69776150|FG000|Overall Study|Protocol Violation|0|||
38078989|NCT03078907|69776151|FG001|Overall Study|Protocol Violation|1|||
38078990|NCT03249714|69776159|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
38078991|NCT03249714|69776160|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
38078992|NCT03249714|69776159|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
38078993|NCT03249714|69776160|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
38078994|NCT03249714|69776159|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
38078995|NCT03249714|69776160|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
38078996|NCT03249714|69776159|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
38078997|NCT03249714|69776160|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
38078998|NCT02925117|69776186|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
38078999|NCT02925117|69776187|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
38079000|NCT02925117|69776188|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
38079001|NCT02925117|69776189|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
38079002|NCT02925117|69776190|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
38079003|NCT02925117|69776191|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
38079004|NCT02925117|69776192|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
38079005|NCT02925117|69776193|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
38079006|NCT02925117|69776194|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
38079007|NCT02925117|69776195|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
38079008|NCT02925117|69776196|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
38079009|NCT02925117|69776197|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
38079010|NCT02925117|69776186|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
38079011|NCT02925117|69776187|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
38079012|NCT02925117|69776188|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
38079013|NCT02925117|69776189|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
38079014|NCT02925117|69776190|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
38079015|NCT02925117|69776191|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
38079016|NCT02925117|69776192|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
38079017|NCT02925117|69776193|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
38079018|NCT02925117|69776194|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
38079019|NCT02925117|69776195|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
38079020|NCT02925117|69776196|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
38079021|NCT02925117|69776197|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
38079022|NCT02925117|69776186|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
38079023|NCT02925117|69776187|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
38079024|NCT02925117|69776188|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
38079025|NCT02925117|69776189|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
38079026|NCT02925117|69776190|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
38079027|NCT02925117|69776191|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
38079028|NCT02925117|69776192|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
38079029|NCT02925117|69776193|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
38079030|NCT02925117|69776194|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
38079031|NCT02925117|69776195|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
38079032|NCT02925117|69776196|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
38079033|NCT02925117|69776197|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
38079034|NCT02925117|69776186|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
38079035|NCT02925117|69776187|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
38079036|NCT02925117|69776188|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
38079037|NCT02925117|69776189|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
38079038|NCT02925117|69776190|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
38079039|NCT02925117|69776191|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
38079040|NCT02925117|69776192|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
38079041|NCT02925117|69776193|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
38079042|NCT02925117|69776194|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
37966651|NCT00633893|69653575|FG002|Overall Study|Not meet/no longer meets criteria|4|||
37966652|NCT00633893|69653573|FG000|Overall Study|Other|28|||
37966653|NCT00633893|69653574|FG001|Overall Study|Other|33|||
37966654|NCT00633893|69653575|FG002|Overall Study|Other|31|||
37966655|NCT00457743|69653586|FG000|Overall Study|Adverse Event|0|||
37966656|NCT00457743|69653587|FG001|Overall Study|Adverse Event|4|||
37966657|NCT00457743|69653588|FG002|Overall Study|Adverse Event|0|||
37966658|NCT00457743|69653586|FG000|Overall Study|Lack of Efficacy|3|||
37966659|NCT00457743|69653587|FG001|Overall Study|Lack of Efficacy|23|||
37966660|NCT00457743|69653588|FG002|Overall Study|Lack of Efficacy|3|||
37966661|NCT00450411|69653597|FG000|Overall Study|Protocol Violation|6|||
37966662|NCT00450411|69653597|FG000|Overall Study|No protocol treatment|2|||
37966663|NCT00644969|69653603|FG000|Treatment Phase|Randomized, not treated|1|||
37966664|NCT00644969|69653604|FG001|Treatment Phase|Randomized, not treated|0|||
37966665|NCT00644969|69653603|FG000|Treatment Phase|Adverse Event|3|||
37966666|NCT00644969|69653604|FG001|Treatment Phase|Adverse Event|0|||
37966667|NCT00644969|69653603|FG000|Treatment Phase|Withdrawal by Subject|4|||
37966668|NCT00644969|69653604|FG001|Treatment Phase|Withdrawal by Subject|0|||
37966669|NCT00644969|69653603|FG000|Treatment Phase|Lost to Follow-up|2|||
37966670|NCT00644969|69653604|FG001|Treatment Phase|Lost to Follow-up|2|||
37966671|NCT00644969|69653603|FG000|Treatment Phase|Other|4|||
37966672|NCT00644969|69653604|FG001|Treatment Phase|Other|1|||
37966673|NCT00644969|69653603|FG000|Post Treatment Phase|Death|1|||
37966674|NCT00644969|69653604|FG001|Post Treatment Phase|Death|0|||
37966675|NCT00644969|69653603|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
37966676|NCT00644969|69653604|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
37966677|NCT00644969|69653603|FG000|Post Treatment Phase|Lost to Follow-up|4|||
37966678|NCT00644969|69653604|FG001|Post Treatment Phase|Lost to Follow-up|1|||
37966679|NCT00644969|69653603|FG000|Post Treatment Phase|Other|1|||
37966680|NCT00644969|69653604|FG001|Post Treatment Phase|Other|0|||
38079043|NCT02925117|69776195|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
38079044|NCT02925117|69776196|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
38079045|NCT02925117|69776197|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
38079046|NCT02925117|69776186|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
38079047|NCT02925117|69776187|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
37966681|NCT00644423|69653612|FG000|Overall Study|Lost to Follow-up|1|||
38079048|NCT02925117|69776188|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
38079049|NCT02925117|69776189|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
37966682|NCT00644423|69653613|FG001|Overall Study|Lost to Follow-up|1|||
37966683|NCT00628355|69653621|FG000|Overall Study|Withdrawal by Subject|1|||
37966684|NCT00628355|69653622|FG001|Overall Study|Withdrawal by Subject|1|||
37966685|NCT00627497|69653633|FG000|Overall Study|Lost to Follow-up|1|||
37966686|NCT00627497|69653634|FG001|Overall Study|Lost to Follow-up|1|||
37966687|NCT00627497|69653635|FG002|Overall Study|Lost to Follow-up|0|||
38079050|NCT02925117|69776190|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
38079051|NCT02925117|69776191|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
38079052|NCT02925117|69776192|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
38079053|NCT02925117|69776193|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
38079054|NCT02925117|69776194|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
38079055|NCT02925117|69776195|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
38079056|NCT02925117|69776196|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
38079057|NCT02925117|69776197|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
38079058|NCT02925117|69776186|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
38079059|NCT02925117|69776187|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
38079060|NCT02925117|69776188|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
38079061|NCT02925117|69776189|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
38079062|NCT02925117|69776190|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
38079063|NCT02925117|69776191|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
38079064|NCT02925117|69776192|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
38079065|NCT02925117|69776193|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
38079066|NCT02925117|69776194|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
38079067|NCT02925117|69776195|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
38079068|NCT02925117|69776196|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
38079069|NCT02925117|69776197|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
38079070|NCT02925117|69776186|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
38079071|NCT02925117|69776187|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
38079072|NCT02925117|69776188|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
38079073|NCT02925117|69776189|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
38079074|NCT02925117|69776190|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
38079075|NCT02925117|69776191|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
38079076|NCT02925117|69776192|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
38079077|NCT02925117|69776193|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
38079078|NCT02925117|69776194|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
38079079|NCT02925117|69776195|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
38079080|NCT02925117|69776196|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
38079081|NCT02925117|69776197|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
38079082|NCT02925117|69776186|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
38079083|NCT02925117|69776187|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
38079084|NCT02925117|69776188|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
38079085|NCT02925117|69776189|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
38079086|NCT02925117|69776190|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
38079087|NCT02925117|69776191|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
38079088|NCT02925117|69776192|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
38079089|NCT02925117|69776193|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
38079090|NCT02925117|69776194|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
38079091|NCT02925117|69776195|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
38079092|NCT02925117|69776196|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
38079093|NCT02925117|69776197|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
38079094|NCT03075163|69776221|FG000|Overall Study|not eligible for treatment limb|138|||
38079095|NCT03075163|69776222|FG001|Overall Study|not eligible for treatment limb|138|||
38079096|NCT03078751|69776230|FG000|Overall Study|Adverse Event|4|||
38079097|NCT03078751|69776231|FG001|Overall Study|Adverse Event|0|||
38079098|NCT03078751|69776230|FG000|Overall Study|Physician Decision|1|||
38079099|NCT03078751|69776231|FG001|Overall Study|Physician Decision|0|||
38079100|NCT03078751|69776230|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
38079101|NCT03078751|69776231|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
38079102|NCT03078751|69776230|FG000|Overall Study|Subject/guardian decision|8|||
37966688|NCT00627497|69653636|FG003|Overall Study|Lost to Follow-up|0|||
37966689|NCT00648167|69653646|FG000|Overall Study|Adverse Event|6|||
38079103|NCT03078751|69776231|FG001|Overall Study|Subject/guardian decision|1|||
38079104|NCT03078751|69776230|FG000|Overall Study|Untreated|0|||
38079105|NCT03078751|69776231|FG001|Overall Study|Untreated|4|||
38079106|NCT02924883|69776239|FG000|Overall Study|Death|39|||
38079107|NCT02924883|69776240|FG001|Overall Study|Death|20|||
38079108|NCT02924883|69776239|FG000|Overall Study|Lost to Follow-up|1|||
38079109|NCT02924883|69776240|FG001|Overall Study|Lost to Follow-up|0|||
37680409|NCT02579863|69156059|FG001|Overall Study|Death|29|||
37680410|NCT02579863|69156058|FG000|Overall Study|Lost to Follow-up|2|||
37680411|NCT02579863|69156059|FG001|Overall Study|Lost to Follow-up|1|||
37680412|NCT02579863|69156058|FG000|Overall Study|Physician Decision|1|||
37680413|NCT02579863|69156059|FG001|Overall Study|Physician Decision|2|||
37680414|NCT02579863|69156058|FG000|Overall Study|Screen Failure|0|||
37680415|NCT02579863|69156059|FG001|Overall Study|Screen Failure|2|||
37680416|NCT02579863|69156058|FG000|Overall Study|Study Terminated at Selected Sites|82|||
37680417|NCT02579863|69156059|FG001|Overall Study|Study Terminated at Selected Sites|88|||
37680418|NCT02579863|69156058|FG000|Overall Study|Withdrawal by Subject|20|||
37680419|NCT02579863|69156059|FG001|Overall Study|Withdrawal by Subject|20|||
37680420|NCT02582515|69156067|FG000|Overall Study|Withdrawal by Subject|0|||
37680421|NCT02582515|69156068|FG001|Overall Study|Withdrawal by Subject|1|||
37680422|NCT02579629|69156077|FG000|Overall Study|Withdrawal by Subject|0|||
37680423|NCT02579629|69156078|FG001|Overall Study|Withdrawal by Subject|1|||
37680424|NCT02579629|69156079|FG002|Overall Study|Withdrawal by Subject|0|||
37680425|NCT02579629|69156077|FG000|Overall Study|Screen Failure|2|||
37680426|NCT02579629|69156078|FG001|Overall Study|Screen Failure|0|||
37680427|NCT02579629|69156079|FG002|Overall Study|Screen Failure|2|||
37680428|NCT02343939|69156096|FG000|Overall Study|Death|0|||
37680429|NCT02343939|69156097|FG001|Overall Study|Death|15|||
37680430|NCT02343939|69156098|FG002|Overall Study|Death|4|||
37680431|NCT02343939|69156099|FG003|Overall Study|Death|2|||
37680432|NCT02343939|69156100|FG004|Overall Study|Death|5|||
37680433|NCT02343939|69156101|FG005|Overall Study|Death|11|||
37680434|NCT02343939|69156102|FG006|Overall Study|Death|8|||
37680435|NCT02343939|69156103|FG007|Overall Study|Death|22|||
37680436|NCT02343939|69156104|FG008|Overall Study|Death|1|||
37680437|NCT02343939|69156096|FG000|Overall Study|Study terminated by sponsor|0|||
37680438|NCT02343939|69156097|FG001|Overall Study|Study terminated by sponsor|27|||
37680439|NCT02343939|69156098|FG002|Overall Study|Study terminated by sponsor|0|||
37680440|NCT02343939|69156099|FG003|Overall Study|Study terminated by sponsor|1|||
37680441|NCT02343939|69156100|FG004|Overall Study|Study terminated by sponsor|1|||
37680442|NCT02343939|69156101|FG005|Overall Study|Study terminated by sponsor|5|||
37680443|NCT02343939|69156102|FG006|Overall Study|Study terminated by sponsor|3|||
37680444|NCT02343939|69156103|FG007|Overall Study|Study terminated by sponsor|4|||
37680445|NCT02343939|69156104|FG008|Overall Study|Study terminated by sponsor|0|||
37680446|NCT02343939|69156096|FG000|Overall Study|Withdrew consent|3|||
37680447|NCT02343939|69156097|FG001|Overall Study|Withdrew consent|6|||
37680448|NCT02343939|69156098|FG002|Overall Study|Withdrew consent|1|||
37680449|NCT02343939|69156099|FG003|Overall Study|Withdrew consent|2|||
37680450|NCT02343939|69156100|FG004|Overall Study|Withdrew consent|2|||
37680451|NCT02343939|69156101|FG005|Overall Study|Withdrew consent|0|||
37680452|NCT02343939|69156102|FG006|Overall Study|Withdrew consent|0|||
37680453|NCT02343939|69156103|FG007|Overall Study|Withdrew consent|8|||
37680454|NCT02343939|69156104|FG008|Overall Study|Withdrew consent|6|||
37680455|NCT02343939|69156096|FG000|Overall Study|Treatment failure|0|||
37680456|NCT02343939|69156097|FG001|Overall Study|Treatment failure|0|||
37680457|NCT02343939|69156098|FG002|Overall Study|Treatment failure|0|||
37680458|NCT02343939|69156099|FG003|Overall Study|Treatment failure|0|||
37680459|NCT02343939|69156100|FG004|Overall Study|Treatment failure|0|||
37680460|NCT02343939|69156101|FG005|Overall Study|Treatment failure|0|||
37680461|NCT02343939|69156102|FG006|Overall Study|Treatment failure|2|||
37680462|NCT02343939|69156103|FG007|Overall Study|Treatment failure|1|||
37680463|NCT02343939|69156104|FG008|Overall Study|Treatment failure|0|||
37680464|NCT02343939|69156096|FG000|Overall Study|Investigator's discretion|0|||
37680465|NCT02343939|69156097|FG001|Overall Study|Investigator's discretion|0|||
37680466|NCT02343939|69156098|FG002|Overall Study|Investigator's discretion|0|||
37680467|NCT02343939|69156099|FG003|Overall Study|Investigator's discretion|1|||
37680468|NCT02343939|69156100|FG004|Overall Study|Investigator's discretion|0|||
37680469|NCT02343939|69156101|FG005|Overall Study|Investigator's discretion|0|||
38079110|NCT02924883|69776239|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
38079111|NCT02924883|69776240|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
38079112|NCT02924883|69776239|FG000|Overall Study|Protocol Violation|1|||
38079113|NCT02924883|69776240|FG001|Overall Study|Protocol Violation|0|||
38079114|NCT02924883|69776239|FG000|Overall Study|Withdrawal by Subject|22|||
38079115|NCT02924883|69776240|FG001|Overall Study|Withdrawal by Subject|16|||
37966690|NCT00648167|69653646|FG000|Overall Study|unable to swallow tablets|1|||
37966691|NCT00647699|69653680|FG000|Overall Study|Lost to Follow-up|5|||
38079116|NCT02924883|69776239|FG000|Overall Study|Progressive Disease|1|||
38079117|NCT02924883|69776240|FG001|Overall Study|Progressive Disease|0|||
38079118|NCT02924883|69776239|FG000|Overall Study|Study Terminated by Sponsor|69|||
38079119|NCT02924883|69776240|FG001|Overall Study|Study Terminated by Sponsor|32|||
38079120|NCT01369680|69776263|FG000|Overall Study|Lost to Follow-up|0|||
38079121|NCT01369680|69776264|FG001|Overall Study|Lost to Follow-up|0|||
38079122|NCT01369680|69776265|FG002|Overall Study|Lost to Follow-up|1|||
38079123|NCT01369680|69776266|FG003|Overall Study|Lost to Follow-up|2|||
38079124|NCT03074149|69776298|FG000|Overall Study|Reason unknown|22|||
38079125|NCT03074149|69776299|FG001|Overall Study|Reason unknown|35|||
38079126|NCT03074149|69776298|FG000|Overall Study|Death|10|||
38079127|NCT03074149|69776299|FG001|Overall Study|Death|45|||
38079128|NCT02751320|69776307|FG000|Overall Study|Adverse Event|2|||
38079129|NCT02751320|69776307|FG000|Overall Study|Withdrawal by Subject|1|||
38079130|NCT02206035|69776335|FG000|Overall Study|Physician Decision|10|||
38079131|NCT02206035|69776336|FG001|Overall Study|Physician Decision|0|||
38079132|NCT02206035|69776337|FG002|Overall Study|Physician Decision|175|||
38079133|NCT02746471|69776344|FG000|Overall Study|Death|43|||
38079134|NCT02746471|69776344|FG000|Overall Study|Exited before 36 months|1119|||
38079135|NCT02591953|69776351|FG000|Overall Study|Lost to Follow-up|6|||
37680470|NCT02343939|69156102|FG006|Overall Study|Investigator's discretion|1|||
38079136|NCT02591953|69776352|FG001|Overall Study|Lost to Follow-up|6|||
38079137|NCT03073213|69776360|FG000|Multiple Dose Period|Protocol Violation|0|||
38079138|NCT03073213|69776361|FG001|Multiple Dose Period|Protocol Violation|0|||
38079139|NCT03073213|69776362|FG002|Multiple Dose Period|Protocol Violation|1|||
38079140|NCT03070483|69776371|FG000|Overall Study|Lost to Follow-up|2|||
38079141|NCT02231762|69776376|FG000|Combination Phase|Adverse Event|10|||
38079142|NCT02231762|69776377|FG001|Combination Phase|Adverse Event|0|||
38079143|NCT02231762|69776378|FG002|Combination Phase|Adverse Event|0|||
38079144|NCT02231762|69776379|FG003|Combination Phase|Adverse Event|0|||
38079145|NCT02231762|69776376|FG000|Combination Phase|Withdrawal by Subject|2|||
38079146|NCT02231762|69776377|FG001|Combination Phase|Withdrawal by Subject|0|||
38079147|NCT02231762|69776378|FG002|Combination Phase|Withdrawal by Subject|0|||
38079148|NCT02231762|69776379|FG003|Combination Phase|Withdrawal by Subject|0|||
38079149|NCT02231762|69776376|FG000|Combination Phase|Disease Progression|6|||
38079150|NCT02231762|69776377|FG001|Combination Phase|Disease Progression|0|||
38079151|NCT02231762|69776378|FG002|Combination Phase|Disease Progression|0|||
38079152|NCT02231762|69776379|FG003|Combination Phase|Disease Progression|0|||
38079153|NCT02231762|69776376|FG000|Combination Phase|Did not meet inclusion criteria|1|||
38079154|NCT02231762|69776377|FG001|Combination Phase|Did not meet inclusion criteria|0|||
38079155|NCT02231762|69776378|FG002|Combination Phase|Did not meet inclusion criteria|0|||
38079156|NCT02231762|69776379|FG003|Combination Phase|Did not meet inclusion criteria|0|||
38079157|NCT02231762|69776376|FG000|Combination Phase|Protocol Violation|1|||
38079158|NCT02231762|69776377|FG001|Combination Phase|Protocol Violation|0|||
38079159|NCT02231762|69776378|FG002|Combination Phase|Protocol Violation|0|||
38079160|NCT02231762|69776379|FG003|Combination Phase|Protocol Violation|0|||
38079161|NCT02231762|69776376|FG000|Maintenance Phase|Disease progression|0|||
38079162|NCT02231762|69776377|FG001|Maintenance Phase|Disease progression|3|||
38079163|NCT02231762|69776378|FG002|Maintenance Phase|Disease progression|4|||
38079164|NCT02231762|69776379|FG003|Maintenance Phase|Disease progression|3|||
38079165|NCT02231762|69776376|FG000|Maintenance Phase|Adverse Event|0|||
38079166|NCT02231762|69776377|FG001|Maintenance Phase|Adverse Event|0|||
38079167|NCT02231762|69776378|FG002|Maintenance Phase|Adverse Event|1|||
38079168|NCT02231762|69776379|FG003|Maintenance Phase|Adverse Event|2|||
38079169|NCT03023397|69776396|FG000|Run-In|Failed screening allergen challenge|1|||
38079170|NCT03023397|69776397|FG001|Run-In|Failed screening allergen challenge|0|||
38079171|NCT03023397|69776398|FG002|Run-In|Failed screening allergen challenge|0|||
38079172|NCT03023397|69776396|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
38079173|NCT03023397|69776397|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
38079174|NCT03023397|69776398|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
38079175|NCT04325906|69776409|FG000|Overall Study|Withdrawal by Subject|2|||
38079176|NCT04325906|69776410|FG001|Overall Study|Withdrawal by Subject|0|||
38079177|NCT03068455|69776418|FG000|Pre-treatment Period|Disease progression|0|||
38079178|NCT03068455|69776419|FG001|Pre-treatment Period|Disease progression|1|||
38079179|NCT03068455|69776418|FG000|Pre-treatment Period|Participant withdrew consent|1|||
38079180|NCT03068455|69776419|FG001|Pre-treatment Period|Participant withdrew consent|1|||
38079181|NCT03068455|69776418|FG000|Pre-treatment Period|Poor/non-compliance|0|||
38079182|NCT03068455|69776419|FG001|Pre-treatment Period|Poor/non-compliance|1|||
38079183|NCT03068455|69776418|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
38079184|NCT03068455|69776419|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
38079185|NCT03068455|69776418|FG000|Pre-treatment Period|Not reported|2|||
38079186|NCT03068455|69776419|FG001|Pre-treatment Period|Not reported|1|||
38079187|NCT03068455|69776418|FG000|Treatment Period|Disease progression|166|||
38079188|NCT03068455|69776419|FG001|Treatment Period|Disease progression|208|||
38079189|NCT03068455|69776418|FG000|Treatment Period|Study drug toxicity|317|||
38079190|NCT03068455|69776419|FG001|Treatment Period|Study drug toxicity|104|||
38079191|NCT03068455|69776418|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
37862458|NCT00924781|69546287|FG001|Overall Study|Study terminated by sponsor|10|||
37862459|NCT01127451|69546305|FG000|Overall Study|Other|2|||
38079192|NCT03068455|69776419|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
38079193|NCT03068455|69776418|FG000|Treatment Period|Participant request to stop therapy|33|||
38079194|NCT03068455|69776419|FG001|Treatment Period|Participant request to stop therapy|20|||
38079195|NCT03068455|69776418|FG000|Treatment Period|Participant withdrew consent|5|||
38079196|NCT03068455|69776419|FG001|Treatment Period|Participant withdrew consent|10|||
38079197|NCT03068455|69776418|FG000|Treatment Period|Poor/non-compliance|3|||
38079198|NCT03068455|69776419|FG001|Treatment Period|Poor/non-compliance|0|||
38079199|NCT03068455|69776418|FG000|Treatment Period|Participant no longer meets study criteria|1|||
38079200|NCT03068455|69776419|FG001|Treatment Period|Participant no longer meets study criteria|3|||
38079201|NCT03068455|69776418|FG000|Treatment Period|Other reasons|12|||
38079202|NCT03068455|69776419|FG001|Treatment Period|Other reasons|4|||
38079203|NCT03067987|69776427|FG000|Overall Study|Lost to Follow-up|7|||
38079204|NCT03067987|69776428|FG001|Overall Study|Lost to Follow-up|10|||
38079205|NCT03067987|69776427|FG000|Overall Study|Protocol Violation|1|||
38079206|NCT03067987|69776428|FG001|Overall Study|Protocol Violation|2|||
38079207|NCT03067987|69776427|FG000|Overall Study|Withdrawal by Subject|2|||
38079208|NCT03067987|69776428|FG001|Overall Study|Withdrawal by Subject|1|||
38079209|NCT04035200|69776437|FG000|Overall Study|Lost to Follow-up|0|||
38079210|NCT04035200|69776438|FG001|Overall Study|Lost to Follow-up|1|||
38079211|NCT04035200|69776439|FG002|Overall Study|Lost to Follow-up|0|||
38079212|NCT04035200|69776437|FG000|Overall Study|Withdrawal by Subject|1|||
38079213|NCT04035200|69776438|FG001|Overall Study|Withdrawal by Subject|4|||
38079214|NCT04035200|69776439|FG002|Overall Study|Withdrawal by Subject|4|||
38079215|NCT04035200|69776437|FG000|Overall Study|COVID-19|1|||
38079216|NCT04035200|69776438|FG001|Overall Study|COVID-19|0|||
38079217|NCT04035200|69776439|FG002|Overall Study|COVID-19|0|||
38079218|NCT04035200|69776437|FG000|Overall Study|Early Termination|0|||
38079219|NCT04035200|69776438|FG001|Overall Study|Early Termination|1|||
38079220|NCT04035200|69776439|FG002|Overall Study|Early Termination|0|||
38079221|NCT04035200|69776437|FG000|Overall Study|Non-compliance|0|||
38079222|NCT04035200|69776438|FG001|Overall Study|Non-compliance|1|||
38079223|NCT04035200|69776439|FG002|Overall Study|Non-compliance|0|||
38079224|NCT03197870|69776450|FG000|Overall Study|Adverse Event|9|||
38079225|NCT03197870|69776451|FG001|Overall Study|Adverse Event|4|||
38079226|NCT03197870|69776452|FG002|Overall Study|Adverse Event|6|||
38079227|NCT03197870|69776450|FG000|Overall Study|Withdrawal by Subject|2|||
38079228|NCT03197870|69776451|FG001|Overall Study|Withdrawal by Subject|3|||
38079229|NCT03197870|69776452|FG002|Overall Study|Withdrawal by Subject|0|||
38079230|NCT03197870|69776450|FG000|Overall Study|Lost to Follow-up|2|||
38079231|NCT03197870|69776451|FG001|Overall Study|Lost to Follow-up|2|||
38079232|NCT03197870|69776452|FG002|Overall Study|Lost to Follow-up|0|||
38079233|NCT03197870|69776450|FG000|Overall Study|data not available|1|||
38079234|NCT03197870|69776451|FG001|Overall Study|data not available|1|||
38079235|NCT03197870|69776452|FG002|Overall Study|data not available|0|||
38079236|NCT04889222|69776463|FG000|Overall Study|Did not meet eligibility criteria|8|||
38079237|NCT04889222|69776463|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
38079238|NCT04889222|69776463|FG000|Overall Study|Did not proceed due to time constraints|5|||
38079239|NCT03067441|69776495|FG000|Overall Study|Withdrawal by Subject|16|||
38079240|NCT03067441|69776496|FG001|Overall Study|Withdrawal by Subject|34|||
38079241|NCT03067441|69776495|FG000|Overall Study|Lost to Follow-up|7|||
38079242|NCT03067441|69776496|FG001|Overall Study|Lost to Follow-up|5|||
38079243|NCT03067441|69776495|FG000|Overall Study|Adverse Event|7|||
38079244|NCT03067441|69776496|FG001|Overall Study|Adverse Event|14|||
38079245|NCT03067441|69776495|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
38079246|NCT03067441|69776496|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
38079247|NCT03067441|69776495|FG000|Overall Study|Physician Decision|1|||
38079248|NCT03067441|69776496|FG001|Overall Study|Physician Decision|3|||
38079249|NCT03067441|69776495|FG000|Overall Study|Other|1|||
38079250|NCT03067441|69776496|FG001|Overall Study|Other|1|||
38079251|NCT02600923|69776505|FG000|Overall Study|Death|10|||
38079252|NCT02600923|69776505|FG000|Overall Study|Adverse Event|3|||
38079253|NCT02600923|69776505|FG000|Overall Study|Global deterioration of health status|2|||
38079254|NCT02600923|69776505|FG000|Overall Study|Insufficient clinical response|6|||
37862460|NCT01127451|69546306|FG001|Overall Study|Other|1|||
37862461|NCT01127451|69546305|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
38079255|NCT02600923|69776505|FG000|Overall Study|Lost to Follow-up|1|||
38079256|NCT02600923|69776505|FG000|Overall Study|Withdrawal by Subject|5|||
38079257|NCT02600923|69776505|FG000|Overall Study|Objective progression or relapse|50|||
38079258|NCT02600923|69776505|FG000|Overall Study|Study terminated by Sponsor|53|||
38079259|NCT02600923|69776505|FG000|Overall Study|Not treated|1|||
38079260|NCT03070171|69776511|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
38079261|NCT03070171|69776512|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
38079262|NCT03070171|69776511|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
38079263|NCT03070171|69776512|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
38079264|NCT03644017|69776518|FG000|Overall Study|Access Abandonment|5|||
38079265|NCT03644017|69776518|FG000|Overall Study|Kidney Transplant|2|||
38079266|NCT00158054|69776524|FG000|Overall Study|Refused to continue|3|||
38079267|NCT00158054|69776525|FG001|Overall Study|Refused to continue|0|||
38079268|NCT00158054|69776524|FG000|Overall Study|Unavailable for follow up|7|||
38079269|NCT00158054|69776525|FG001|Overall Study|Unavailable for follow up|3|||
38079270|NCT01337960|69776534|FG000|Overall Study|Lost to Follow-up|1|||
38079271|NCT01337960|69776535|FG001|Overall Study|Lost to Follow-up|0|||
38079272|NCT01337960|69776536|FG002|Overall Study|Lost to Follow-up|0|||
38079273|NCT01337960|69776534|FG000|Overall Study|Withdrawal by Subject|1|||
38079274|NCT01337960|69776535|FG001|Overall Study|Withdrawal by Subject|0|||
38079275|NCT01337960|69776536|FG002|Overall Study|Withdrawal by Subject|0|||
38079276|NCT02750306|69776555|FG000|Overall Study|Withdrawal by Subject|5|||
38079277|NCT02750306|69776556|FG001|Overall Study|Withdrawal by Subject|2|||
38079278|NCT02750306|69776555|FG000|Overall Study|Protocol Violation|1|||
38079279|NCT02750306|69776556|FG001|Overall Study|Protocol Violation|0|||
38079280|NCT01816165|69776564|FG000|Overall Study|Adverse Event|1|||
38079281|NCT01816165|69776565|FG001|Overall Study|Adverse Event|0|||
38079282|NCT01816165|69776566|FG002|Overall Study|Adverse Event|0|||
38079283|NCT01816165|69776567|FG003|Overall Study|Adverse Event|0|||
38079284|NCT01677988|69776596|FG000|Overall Study|Lack of Efficacy|2|||
38079285|NCT02926573|69776603|FG000|Overall Study|Nausea|1|||
38079286|NCT02926573|69776604|FG001|Overall Study|Nausea|0|||
38079287|NCT02926573|69776603|FG000|Overall Study|Remain intubated|2|||
38079288|NCT02926573|69776604|FG001|Overall Study|Remain intubated|2|||
38079289|NCT02926573|69776603|FG000|Overall Study|Change in surgery plan|3|||
38079290|NCT02926573|69776604|FG001|Overall Study|Change in surgery plan|1|||
38079291|NCT02926573|69776603|FG000|Overall Study|Change to outpatient status|5|||
38079292|NCT02926573|69776604|FG001|Overall Study|Change to outpatient status|1|||
38079293|NCT02926573|69776603|FG000|Overall Study|Withdrawal by Subject|0|||
38079294|NCT02926573|69776604|FG001|Overall Study|Withdrawal by Subject|2|||
38079295|NCT02926573|69776603|FG000|Overall Study|Return to operating room|0|||
38079296|NCT02926573|69776604|FG001|Overall Study|Return to operating room|2|||
38079297|NCT02926573|69776603|FG000|Overall Study|Delirium|0|||
38079298|NCT02926573|69776604|FG001|Overall Study|Delirium|1|||
38079299|NCT00158860|69776612|FG000|Overall Study|Adverse Event|3|||
38079300|NCT00158860|69776613|FG001|Overall Study|Adverse Event|6|||
38079301|NCT00158860|69776612|FG000|Overall Study|Lost to Follow-up|11|||
38079302|NCT00158860|69776613|FG001|Overall Study|Lost to Follow-up|17|||
38079303|NCT00158860|69776612|FG000|Overall Study|Protocol Violation|8|||
38079304|NCT00158860|69776613|FG001|Overall Study|Protocol Violation|23|||
38079305|NCT00158860|69776612|FG000|Overall Study|Withdrawal by Subject|7|||
38079306|NCT00158860|69776613|FG001|Overall Study|Withdrawal by Subject|17|||
38079307|NCT00158860|69776612|FG000|Overall Study|MOVING OUT OF STATE|1|||
38079308|NCT00158860|69776613|FG001|Overall Study|MOVING OUT OF STATE|0|||
38079309|NCT00158860|69776612|FG000|Overall Study|Pregnancy|3|||
38079310|NCT00158860|69776613|FG001|Overall Study|Pregnancy|3|||
38079311|NCT00158860|69776612|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
38079312|NCT00158860|69776613|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
38079313|NCT00158860|69776612|FG000|Overall Study|SPONSOR REQUEST|0|||
38079314|NCT00158860|69776613|FG001|Overall Study|SPONSOR REQUEST|1|||
38079315|NCT00158860|69776612|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
38079316|NCT00158860|69776613|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
38079317|NCT00158860|69776612|FG000|Overall Study|Closed per sponsor|0|||
38079318|NCT00158860|69776613|FG001|Overall Study|Closed per sponsor|1|||
38079319|NCT03067129|69776624|FG000|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
38079320|NCT03067129|69776625|FG001|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
38079321|NCT03067129|69776626|FG002|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
38079322|NCT03067129|69776627|FG003|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|1|||
38079323|NCT03067129|69776624|FG000|Overall Study|Withdrawal by Subject|0|||
38079324|NCT03067129|69776625|FG001|Overall Study|Withdrawal by Subject|0|||
38079325|NCT03067129|69776626|FG002|Overall Study|Withdrawal by Subject|1|||
38079326|NCT03067129|69776627|FG003|Overall Study|Withdrawal by Subject|2|||
38079327|NCT03067129|69776624|FG000|Overall Study|Lost to Follow-up|5|||
38079328|NCT03067129|69776625|FG001|Overall Study|Lost to Follow-up|5|||
38079329|NCT03067129|69776626|FG002|Overall Study|Lost to Follow-up|4|||
38079330|NCT03067129|69776627|FG003|Overall Study|Lost to Follow-up|3|||
38079331|NCT01679236|69776649|FG000|Overall Study|Lost to Follow-up|15|||
38079332|NCT01679236|69776650|FG001|Overall Study|Lost to Follow-up|15|||
38079333|NCT01679002|69776659|FG000|Overall Study|Adverse Event|1|||
38079334|NCT01679002|69776660|FG001|Overall Study|Adverse Event|1|||
38079335|NCT01679002|69776661|FG002|Overall Study|Adverse Event|0|||
38079336|NCT04409509|69776671|FG000|Overall Study|Failure to meet randomization requirement|1|||
38079337|NCT04409509|69776672|FG001|Overall Study|Failure to meet randomization requirement|0|||
38079338|NCT04409509|69776671|FG000|Overall Study|Adverse Event|0|||
38079339|NCT04409509|69776672|FG001|Overall Study|Adverse Event|1|||
38079340|NCT04409509|69776671|FG000|Overall Study|Death|11|||
38079341|NCT04409509|69776672|FG001|Overall Study|Death|10|||
38079342|NCT04409509|69776671|FG000|Overall Study|Non-compliance with study drug|0|||
38079343|NCT04409509|69776672|FG001|Overall Study|Non-compliance with study drug|1|||
38079344|NCT04409509|69776671|FG000|Overall Study|Lost to Follow-up|0|||
38079345|NCT04409509|69776672|FG001|Overall Study|Lost to Follow-up|3|||
38079346|NCT04409509|69776671|FG000|Overall Study|Withdrawal by Subject|0|||
38079347|NCT04409509|69776672|FG001|Overall Study|Withdrawal by Subject|3|||
38079348|NCT04409509|69776671|FG000|Overall Study|Randomized by mistake|0|||
38079349|NCT04409509|69776672|FG001|Overall Study|Randomized by mistake|1|||
38079350|NCT04409509|69776671|FG000|Overall Study|Other|1|||
38079351|NCT04409509|69776672|FG001|Overall Study|Other|1|||
38079352|NCT01678924|69776683|FG000|Overall Study|Adverse Event|1|||
38079353|NCT01678924|69776684|FG001|Overall Study|Adverse Event|1|||
38079354|NCT01678924|69776685|FG002|Overall Study|Adverse Event|0|||
38079355|NCT01678924|69776686|FG003|Overall Study|Adverse Event|1|||
38079356|NCT01678924|69776683|FG000|Overall Study|Lack of Efficacy|7|||
38079357|NCT01678924|69776684|FG001|Overall Study|Lack of Efficacy|2|||
38079358|NCT01678924|69776685|FG002|Overall Study|Lack of Efficacy|0|||
38079359|NCT01678924|69776686|FG003|Overall Study|Lack of Efficacy|5|||
38079360|NCT01678924|69776683|FG000|Overall Study|Lost to Follow-up|0|||
38079361|NCT01678924|69776684|FG001|Overall Study|Lost to Follow-up|4|||
38079362|NCT01678924|69776685|FG002|Overall Study|Lost to Follow-up|0|||
38079363|NCT01678924|69776686|FG003|Overall Study|Lost to Follow-up|2|||
38079364|NCT01678924|69776683|FG000|Overall Study|Personal Reasons|2|||
38079365|NCT01678924|69776684|FG001|Overall Study|Personal Reasons|2|||
38079366|NCT01678924|69776685|FG002|Overall Study|Personal Reasons|2|||
38079367|NCT01678924|69776686|FG003|Overall Study|Personal Reasons|7|||
38079368|NCT01678924|69776683|FG000|Overall Study|Withdrawal by Subject|0|||
38079369|NCT01678924|69776684|FG001|Overall Study|Withdrawal by Subject|3|||
38079370|NCT01678924|69776685|FG002|Overall Study|Withdrawal by Subject|0|||
38079371|NCT01678924|69776686|FG003|Overall Study|Withdrawal by Subject|2|||
38079372|NCT01678924|69776683|FG000|Overall Study|Unable to attend scheduled visits|0|||
38079373|NCT01678924|69776684|FG001|Overall Study|Unable to attend scheduled visits|0|||
38079374|NCT01678924|69776685|FG002|Overall Study|Unable to attend scheduled visits|0|||
38079375|NCT01678924|69776686|FG003|Overall Study|Unable to attend scheduled visits|1|||
38079376|NCT02925793|69776700|FG000|Overall Study|Adverse Event|3|||
38079377|NCT02925793|69776701|FG001|Overall Study|Adverse Event|3|||
38079378|NCT02925793|69776702|FG002|Overall Study|Adverse Event|6|||
38079379|NCT02925793|69776700|FG000|Overall Study|Withdrawal by Subject|16|||
38079380|NCT02925793|69776701|FG001|Overall Study|Withdrawal by Subject|15|||
38079381|NCT02925793|69776702|FG002|Overall Study|Withdrawal by Subject|13|||
38079382|NCT02925793|69776700|FG000|Overall Study|Investigator Discretion|0|||
38079383|NCT02925793|69776701|FG001|Overall Study|Investigator Discretion|1|||
38079384|NCT02925793|69776702|FG002|Overall Study|Investigator Discretion|1|||
38079385|NCT02925793|69776700|FG000|Overall Study|Lost to Follow-up|2|||
38079386|NCT02925793|69776701|FG001|Overall Study|Lost to Follow-up|3|||
38079387|NCT02925793|69776702|FG002|Overall Study|Lost to Follow-up|1|||
38079388|NCT02925793|69776700|FG000|Overall Study|Lack of Efficacy|2|||
38079389|NCT02925793|69776701|FG001|Overall Study|Lack of Efficacy|6|||
38079390|NCT02925793|69776702|FG002|Overall Study|Lack of Efficacy|4|||
38079391|NCT02925793|69776700|FG000|Overall Study|Other:|2|||
38079392|NCT02925793|69776701|FG001|Overall Study|Other:|1|||
38079393|NCT02925793|69776702|FG002|Overall Study|Other:|3|||
38079394|NCT03071263|69776712|FG000|Overall Study|Adverse Event|1|||
38079395|NCT03071263|69776713|FG001|Overall Study|Adverse Event|3|||
38079396|NCT03071263|69776712|FG000|Overall Study|Withdrawal by Subject|1|||
38079397|NCT03071263|69776713|FG001|Overall Study|Withdrawal by Subject|3|||
38079398|NCT03071263|69776712|FG000|Overall Study|Physician Decision|1|||
38079399|NCT03071263|69776713|FG001|Overall Study|Physician Decision|0|||
38079400|NCT03071263|69776712|FG000|Overall Study|Participant moved to another city|0|||
38079401|NCT03071263|69776713|FG001|Overall Study|Participant moved to another city|1|||
38079402|NCT00157196|69776725|FG000|Overall Study|Ongoing at data cut-off|9|||
38079403|NCT03066193|69776729|FG000|Overall Study|Withdrawal by Subject|1|||
37966692|NCT00647699|69653681|FG001|Overall Study|Lost to Follow-up|4|||
38079404|NCT03922321|69776733|FG000|Overall Study|Participant Moved|1|||
38079405|NCT03922321|69776733|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
38079406|NCT01677910|69776740|FG000|Double-Blind Treatment Period|Adverse Event|6|||
38079407|NCT01677910|69776741|FG001|Double-Blind Treatment Period|Adverse Event|2|||
38079408|NCT01677910|69776742|FG002|Double-Blind Treatment Period|Adverse Event|3|||
38079409|NCT01677910|69776743|FG003|Double-Blind Treatment Period|Adverse Event|0|||
38079410|NCT01677910|69776740|FG000|Double-Blind Treatment Period|Physician Decision|0|||
38079411|NCT01677910|69776741|FG001|Double-Blind Treatment Period|Physician Decision|0|||
38079412|NCT01677910|69776742|FG002|Double-Blind Treatment Period|Physician Decision|1|||
38079413|NCT01677910|69776743|FG003|Double-Blind Treatment Period|Physician Decision|0|||
38079414|NCT01677910|69776740|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
38079415|NCT01677910|69776741|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
38079416|NCT01677910|69776742|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
38079417|NCT01677910|69776743|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
38079418|NCT01677910|69776740|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
38079419|NCT01677910|69776741|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
38079420|NCT01677910|69776742|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
38079421|NCT01677910|69776743|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
38079422|NCT01677910|69776740|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
38079423|NCT01677910|69776741|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
38079424|NCT01677910|69776742|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
38079425|NCT01677910|69776743|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
38079426|NCT01677910|69776740|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
38079427|NCT01677910|69776741|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
38079428|NCT01677910|69776742|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
38079429|NCT01677910|69776743|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
38079430|NCT01677910|69776740|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
38079431|NCT01677910|69776741|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
38079432|NCT01677910|69776742|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
38079433|NCT01677910|69776743|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
38079434|NCT01677910|69776740|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
38079435|NCT01677910|69776741|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
38079436|NCT01677910|69776742|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
38079437|NCT01677910|69776743|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
38079438|NCT01677910|69776740|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
38079439|NCT01677910|69776741|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
38079440|NCT01677910|69776742|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
38079441|NCT01677910|69776743|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
38079442|NCT01677910|69776740|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
38079443|NCT01677910|69776741|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
38079444|NCT01677910|69776742|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
38079445|NCT01677910|69776743|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
38079446|NCT03911713|69776758|FG000|Overall Study|Lost to Follow-up|0|||
38079447|NCT03911713|69776759|FG001|Overall Study|Lost to Follow-up|2|||
38079448|NCT03911713|69776760|FG002|Overall Study|Lost to Follow-up|0|||
38079449|NCT03911713|69776761|FG003|Overall Study|Lost to Follow-up|0|||
38079450|NCT03911713|69776762|FG004|Overall Study|Lost to Follow-up|0|||
38079451|NCT03911713|69776758|FG000|Overall Study|Other|0|||
38079452|NCT03911713|69776759|FG001|Overall Study|Other|0|||
38079453|NCT03911713|69776760|FG002|Overall Study|Other|0|||
38079454|NCT03911713|69776761|FG003|Overall Study|Other|1|||
38079455|NCT03911713|69776762|FG004|Overall Study|Other|0|||
38079456|NCT03911713|69776758|FG000|Overall Study|Randomized, Never Dosed|1|||
38079457|NCT03911713|69776759|FG001|Overall Study|Randomized, Never Dosed|0|||
38079458|NCT03911713|69776760|FG002|Overall Study|Randomized, Never Dosed|0|||
38079459|NCT03911713|69776761|FG003|Overall Study|Randomized, Never Dosed|1|||
38079460|NCT03911713|69776762|FG004|Overall Study|Randomized, Never Dosed|0|||
38079461|NCT03065023|69776780|FG000|Overall Study|Progressive Disease|0|||
38079462|NCT03065023|69776781|FG001|Overall Study|Progressive Disease|1|||
38079463|NCT03065023|69776782|FG002|Overall Study|Progressive Disease|0|||
38079464|NCT03065023|69776783|FG003|Overall Study|Progressive Disease|0|||
38079465|NCT03065023|69776784|FG004|Overall Study|Progressive Disease|0|||
38079466|NCT03065023|69776780|FG000|Overall Study|Death|2|||
38079467|NCT03065023|69776781|FG001|Overall Study|Death|0|||
38079468|NCT03065023|69776782|FG002|Overall Study|Death|1|||
38079469|NCT03065023|69776783|FG003|Overall Study|Death|1|||
38079470|NCT03065023|69776784|FG004|Overall Study|Death|0|||
38079471|NCT03065023|69776780|FG000|Overall Study|Lost to Follow-up|0|||
38079472|NCT03065023|69776781|FG001|Overall Study|Lost to Follow-up|1|||
38079473|NCT03065023|69776782|FG002|Overall Study|Lost to Follow-up|0|||
38079474|NCT03065023|69776783|FG003|Overall Study|Lost to Follow-up|0|||
38079475|NCT03065023|69776784|FG004|Overall Study|Lost to Follow-up|0|||
38079476|NCT03065023|69776780|FG000|Overall Study|Participant Decision|0|||
38079477|NCT03065023|69776781|FG001|Overall Study|Participant Decision|0|||
38079478|NCT03065023|69776782|FG002|Overall Study|Participant Decision|0|||
38079479|NCT03065023|69776783|FG003|Overall Study|Participant Decision|1|||
38079480|NCT03065023|69776784|FG004|Overall Study|Participant Decision|0|||
38079481|NCT03065023|69776780|FG000|Overall Study|Withdrawal by Subject|0|||
38079482|NCT03065023|69776781|FG001|Overall Study|Withdrawal by Subject|0|||
38079483|NCT03065023|69776782|FG002|Overall Study|Withdrawal by Subject|0|||
38079484|NCT03065023|69776783|FG003|Overall Study|Withdrawal by Subject|1|||
38079485|NCT03065023|69776784|FG004|Overall Study|Withdrawal by Subject|0|||
38079486|NCT03614923|69776797|FG000|Overall Study|Withdrawal by Subject|2|||
38079487|NCT03614923|69776798|FG001|Overall Study|Withdrawal by Subject|1|||
38079488|NCT03614923|69776799|FG002|Overall Study|Withdrawal by Subject|1|||
38079489|NCT03614923|69776797|FG000|Overall Study|Adverse Event|0|||
38079490|NCT03614923|69776798|FG001|Overall Study|Adverse Event|2|||
38079491|NCT03614923|69776799|FG002|Overall Study|Adverse Event|1|||
38079492|NCT03614923|69776797|FG000|Overall Study|Lost to Follow-up|1|||
38079493|NCT03614923|69776798|FG001|Overall Study|Lost to Follow-up|0|||
38079494|NCT03614923|69776799|FG002|Overall Study|Lost to Follow-up|1|||
38079495|NCT03614923|69776797|FG000|Overall Study|Lack of Efficacy|2|||
38079496|NCT03614923|69776798|FG001|Overall Study|Lack of Efficacy|0|||
38079497|NCT03614923|69776799|FG002|Overall Study|Lack of Efficacy|1|||
38079498|NCT03614923|69776797|FG000|Overall Study|Non-compliance|0|||
38079499|NCT03614923|69776798|FG001|Overall Study|Non-compliance|1|||
38079500|NCT03614923|69776799|FG002|Overall Study|Non-compliance|0|||
38079501|NCT03614923|69776797|FG000|Overall Study|Other|0|||
38079502|NCT03614923|69776798|FG001|Overall Study|Other|1|||
38079503|NCT03614923|69776799|FG002|Overall Study|Other|1|||
38079504|NCT05098509|69776821|FG000|Overall Study|Withdrawal by Subject|0|||
38079505|NCT05098509|69776822|FG001|Overall Study|Withdrawal by Subject|0|||
38079506|NCT05098509|69776823|FG002|Overall Study|Withdrawal by Subject|1|||
38079507|NCT05098509|69776824|FG003|Overall Study|Withdrawal by Subject|0|||
38079508|NCT05098509|69776821|FG000|Overall Study|Early study termination|1|||
38079509|NCT05098509|69776822|FG001|Overall Study|Early study termination|1|||
38079510|NCT05098509|69776823|FG002|Overall Study|Early study termination|1|||
38079511|NCT05098509|69776824|FG003|Overall Study|Early study termination|0|||
38079512|NCT04962698|69776834|FG000|Motor Imagery|Technical difficulty|1|||
38079513|NCT04962698|69776835|FG001|Motor Imagery|Technical difficulty|0|||
38079514|NCT04962698|69776834|FG000|Motor Imagery|Exclusion criteria met after enrollment|0|||
38079515|NCT04962698|69776835|FG001|Motor Imagery|Exclusion criteria met after enrollment|2|||
38079516|NCT04962698|69776834|FG000|Kinesthetic MI|Technical difficulty|1|||
38079517|NCT04962698|69776835|FG001|Kinesthetic MI|Technical difficulty|0|||
38079518|NCT04962698|69776834|FG000|Robotic-hand Interaction With MI|Technical difficulty|1|||
38079519|NCT04962698|69776835|FG001|Robotic-hand Interaction With MI|Technical difficulty|0|||
38079520|NCT04962698|69776834|FG000|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|0|||
38079521|NCT04962698|69776835|FG001|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|2|||
38079522|NCT04962698|69776834|FG000|Robotic-hand Interaction Without MI|Technical difficulty|1|||
38079523|NCT04962698|69776835|FG001|Robotic-hand Interaction Without MI|Technical difficulty|0|||
38079524|NCT04962698|69776834|FG000|Virtual-hand Interaction|Technical difficulty|1|||
38079525|NCT04962698|69776835|FG001|Virtual-hand Interaction|Technical difficulty|0|||
38079526|NCT04962698|69776834|FG000|Robotic Action Observation|Technical difficulty|1|||
38079527|NCT04962698|69776835|FG001|Robotic Action Observation|Technical difficulty|0|||
38079528|NCT04962698|69776834|FG000|Rest|Technical difficulty|1|||
38079529|NCT04962698|69776835|FG001|Rest|Technical difficulty|0|||
38079530|NCT04962698|69776834|FG000|Rest|Exclusion criteria met after enrollment|0|||
38079531|NCT04962698|69776835|FG001|Rest|Exclusion criteria met after enrollment|2|||
38079532|NCT04609514|69776844|FG000|Overall Study|Lost to Follow-up|5|||
38079533|NCT04609514|69776845|FG001|Overall Study|Lost to Follow-up|4|||
38079534|NCT04609514|69776844|FG000|Overall Study|Withdrawal by PI|0|||
38079535|NCT04609514|69776845|FG001|Overall Study|Withdrawal by PI|2|||
38079536|NCT04467840|69776854|FG000|Overall Study|Death|35|||
38079537|NCT04467840|69776855|FG001|Overall Study|Death|39|||
38079538|NCT04467840|69776854|FG000|Overall Study|Withdrawal by Subject|8|||
38079539|NCT04467840|69776855|FG001|Overall Study|Withdrawal by Subject|4|||
38079540|NCT04467840|69776854|FG000|Overall Study|Adverse Event|2|||
38079541|NCT04467840|69776855|FG001|Overall Study|Adverse Event|0|||
38079542|NCT04467840|69776854|FG000|Overall Study|Lost to Follow-up|1|||
38079543|NCT04467840|69776855|FG001|Overall Study|Lost to Follow-up|3|||
38079544|NCT04467840|69776854|FG000|Overall Study|Physician Decision|1|||
38079545|NCT04467840|69776855|FG001|Overall Study|Physician Decision|0|||
38079546|NCT04467840|69776854|FG000|Overall Study|Other|1|||
38079547|NCT04467840|69776855|FG001|Overall Study|Other|5|||
38079548|NCT04467840|69776854|FG000|Overall Study|Missing study completion status|3|||
38079549|NCT04467840|69776855|FG001|Overall Study|Missing study completion status|1|||
38079550|NCT04295499|69776865|FG000|Overall Study|moving out of state|1|||
38079551|NCT04295499|69776866|FG001|Overall Study|moving out of state|0|||
38079552|NCT04295499|69776865|FG000|Overall Study|traveling overseas for business prior to the study completion|1|||
38079553|NCT04295499|69776866|FG001|Overall Study|traveling overseas for business prior to the study completion|0|||
38079554|NCT04158648|69776872|FG000|Overall Study|Ongoing in the Study|69|||
38079555|NCT04158648|69776872|FG000|Overall Study|Withdrawal by Subject|4|||
38079556|NCT04021290|69776881|FG000|Randomized Phase (Day1 to Week 52)|Adverse Event|4|||
38079557|NCT04021290|69776882|FG001|Randomized Phase (Day1 to Week 52)|Adverse Event|3|||
38079558|NCT04021290|69776883|FG002|Randomized Phase (Day1 to Week 52)|Adverse Event|0|||
38079559|NCT04021290|69776881|FG000|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
38079560|NCT04021290|69776882|FG001|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|3|||
38079561|NCT04021290|69776883|FG002|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
38079562|NCT04021290|69776881|FG000|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|2|||
38079563|NCT04021290|69776882|FG001|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|1|||
38079564|NCT04021290|69776883|FG002|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|0|||
38079565|NCT04021290|69776881|FG000|Randomized Phase (Day1 to Week 52)|Death|1|||
38079566|NCT04021290|69776882|FG001|Randomized Phase (Day1 to Week 52)|Death|0|||
38079567|NCT04021290|69776883|FG002|Randomized Phase (Day1 to Week 52)|Death|0|||
38079568|NCT04021290|69776881|FG000|Randomized Phase (Day1 to Week 52)|Physician Decision|1|||
38079569|NCT04021290|69776882|FG001|Randomized Phase (Day1 to Week 52)|Physician Decision|2|||
38079570|NCT04021290|69776883|FG002|Randomized Phase (Day1 to Week 52)|Physician Decision|0|||
38079571|NCT04021290|69776881|FG000|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|1|||
38079572|NCT04021290|69776882|FG001|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|5|||
38079573|NCT04021290|69776883|FG002|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|0|||
38079574|NCT04021290|69776881|FG000|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|96|||
38079575|NCT04021290|69776882|FG001|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
38079576|NCT04021290|69776883|FG002|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
38079577|NCT04021290|69776881|FG000|Randomized Phase (Day1 to Week 52)|Protocol Deviation|5|||
38079578|NCT04021290|69776882|FG001|Randomized Phase (Day1 to Week 52)|Protocol Deviation|4|||
38079579|NCT04021290|69776883|FG002|Randomized Phase (Day1 to Week 52)|Protocol Deviation|0|||
38079580|NCT04021290|69776881|FG000|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
38079581|NCT04021290|69776882|FG001|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
38079582|NCT04021290|69776883|FG002|Continuation Phase (Week 52 to Week 132)|Physician Decision|1|||
38079583|NCT04021290|69776881|FG000|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
38079584|NCT04021290|69776882|FG001|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
38079585|NCT04021290|69776883|FG002|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|1|||
38079586|NCT04021290|69776881|FG000|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
38079587|NCT04021290|69776882|FG001|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
38079588|NCT04021290|69776883|FG002|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|1|||
38079589|NCT04021290|69776881|FG000|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
38079590|NCT04021290|69776882|FG001|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
38079591|NCT04021290|69776883|FG002|Continuation Phase (Week 52 to Week 132)|Adverse Event|2|||
38079592|NCT03630705|69776895|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
38079593|NCT03630705|69776896|FG001|Overall Study|Withdrawal by Parent/Guardian|6|||
38079594|NCT03630705|69776897|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
38079595|NCT03630705|69776898|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
38079596|NCT03630705|69776895|FG000|Overall Study|Lost to Follow-up|1|||
38079597|NCT03630705|69776896|FG001|Overall Study|Lost to Follow-up|2|||
38079598|NCT03630705|69776897|FG002|Overall Study|Lost to Follow-up|0|||
38079599|NCT03630705|69776898|FG003|Overall Study|Lost to Follow-up|0|||
38079600|NCT03539458|69776915|FG000|Overall Study|Death|1|||
38079601|NCT03534180|69776919|FG000|Overall Study|Withdrawal by Subject|1|||
38079602|NCT03494166|69776929|FG000|Overall Study|Death|0|||
38079603|NCT03494166|69776930|FG001|Overall Study|Death|0|||
38079604|NCT03494166|69776931|FG002|Overall Study|Death|0|||
38079605|NCT03494166|69776932|FG003|Overall Study|Death|1|||
38079606|NCT03494166|69776933|FG004|Overall Study|Death|3|||
38079607|NCT03494166|69776934|FG005|Overall Study|Death|0|||
38079608|NCT03494166|69776929|FG000|Overall Study|Lost to Follow-up|2|||
38079609|NCT03494166|69776930|FG001|Overall Study|Lost to Follow-up|2|||
38079610|NCT03494166|69776931|FG002|Overall Study|Lost to Follow-up|2|||
38079611|NCT03494166|69776932|FG003|Overall Study|Lost to Follow-up|2|||
38079612|NCT03494166|69776933|FG004|Overall Study|Lost to Follow-up|14|||
38079613|NCT03494166|69776934|FG005|Overall Study|Lost to Follow-up|0|||
38079614|NCT03494166|69776929|FG000|Overall Study|Withdrawal by Subject|10|||
38079615|NCT03494166|69776930|FG001|Overall Study|Withdrawal by Subject|7|||
38079616|NCT03494166|69776931|FG002|Overall Study|Withdrawal by Subject|0|||
38079617|NCT03494166|69776932|FG003|Overall Study|Withdrawal by Subject|5|||
38079618|NCT03494166|69776933|FG004|Overall Study|Withdrawal by Subject|3|||
38079619|NCT03494166|69776934|FG005|Overall Study|Withdrawal by Subject|17|||
38079620|NCT03494166|69776929|FG000|Overall Study|Screen failure|1|||
38079621|NCT03494166|69776930|FG001|Overall Study|Screen failure|0|||
38079622|NCT03494166|69776931|FG002|Overall Study|Screen failure|0|||
38079623|NCT03494166|69776932|FG003|Overall Study|Screen failure|0|||
38079624|NCT03494166|69776933|FG004|Overall Study|Screen failure|1|||
38079625|NCT03494166|69776934|FG005|Overall Study|Screen failure|0|||
38079626|NCT03367156|69776956|FG000|Overall Study|Lack of interest|3|||
38079627|NCT03367156|69776957|FG001|Overall Study|Lack of interest|1|||
38079628|NCT03367156|69776956|FG000|Overall Study|Death|2|||
38079629|NCT03367156|69776957|FG001|Overall Study|Death|0|||
38079630|NCT03367156|69776956|FG000|Overall Study|Lost to Follow-up|2|||
38079631|NCT03367156|69776957|FG001|Overall Study|Lost to Follow-up|1|||
38079632|NCT03367156|69776956|FG000|Overall Study|Became ineligible|1|||
38079633|NCT03367156|69776957|FG001|Overall Study|Became ineligible|2|||
38079634|NCT03367156|69776956|FG000|Overall Study|Hospitalization|1|||
38079635|NCT03367156|69776957|FG001|Overall Study|Hospitalization|0|||
38079636|NCT03367156|69776956|FG000|Overall Study|Concerned about Treatment|11|||
38079637|NCT03367156|69776957|FG001|Overall Study|Concerned about Treatment|3|||
38079638|NCT03367156|69776956|FG000|Overall Study|Started new treatment|4|||
38079639|NCT03367156|69776957|FG001|Overall Study|Started new treatment|1|||
38079640|NCT03302299|69776965|FG000|Overall Study|Protocol Violation|1|||
38079641|NCT03262935|69776972|FG000|Overall Study|Withdrawal by Subject|6|||
38079642|NCT03262935|69776973|FG001|Overall Study|Withdrawal by Subject|7|||
38079643|NCT03262935|69776972|FG000|Overall Study|End Of Follow Up By Sponsor|90|||
38079644|NCT03262935|69776973|FG001|Overall Study|End Of Follow Up By Sponsor|41|||
38079645|NCT03262935|69776972|FG000|Overall Study|Death|181|||
38079646|NCT03262935|69776973|FG001|Overall Study|Death|94|||
38079647|NCT03262935|69776972|FG000|Overall Study|Lost to Follow-up|9|||
38079648|NCT03262935|69776973|FG001|Overall Study|Lost to Follow-up|4|||
38079649|NCT03262935|69776972|FG000|Overall Study|Other reason|5|||
38079650|NCT03262935|69776973|FG001|Overall Study|Other reason|0|||
38079651|NCT03213691|69776979|FG000|Overall Study|Adverse Event|2|||
38079652|NCT03213691|69776979|FG000|Overall Study|Death|3|||
38079653|NCT03213691|69776979|FG000|Overall Study|Physician Decision|1|||
38079654|NCT03213691|69776979|FG000|Overall Study|Progressive Disease|14|||
38079655|NCT03213691|69776979|FG000|Overall Study|Ineligible|1|||
38079656|NCT02603562|69777026|FG000|Overall Study|Lost to Follow-up|1|||
38079657|NCT02586727|69777032|FG000|Overall Study|Lost to Follow-up|1|||
38079658|NCT02586727|69777033|FG001|Overall Study|Lost to Follow-up|0|||
38079659|NCT02339909|69777060|FG000|Overall Study|Became ineligible after randomisation|89|||
38079660|NCT02339909|69777061|FG001|Overall Study|Became ineligible after randomisation|63|||
38079661|NCT02339909|69777062|FG002|Overall Study|Became ineligible after randomisation|71|||
38079662|NCT02076113|69777072|FG000|Overall Study|Lost to Follow-up|4|||
38079663|NCT02076113|69777073|FG001|Overall Study|Lost to Follow-up|1|||
38079664|NCT02076113|69777072|FG000|Overall Study|Withdrawal by Subject|2|||
38079665|NCT02076113|69777073|FG001|Overall Study|Withdrawal by Subject|3|||
38079666|NCT02076113|69777072|FG000|Overall Study|Death|1|||
38079667|NCT02076113|69777073|FG001|Overall Study|Death|3|||
38079668|NCT01701674|69777082|FG000|Overall Study|Unable to safely complete treatment|1|||
38079669|NCT01586910|69777088|FG000|Overall Study|Death|4|||
38079670|NCT01586910|69777089|FG001|Overall Study|Death|4|||
38079671|NCT01586910|69777088|FG000|Overall Study|Withdrawal by Subject|6|||
38079672|NCT01586910|69777089|FG001|Overall Study|Withdrawal by Subject|43|||
38079673|NCT01586910|69777088|FG000|Overall Study|Physician withdrew Subject|5|||
38079674|NCT01586910|69777089|FG001|Overall Study|Physician withdrew Subject|24|||
38079675|NCT01496976|69777097|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
38079676|NCT02915016|69777120|FG000|Overall Study|Lost to Follow-up|4|||
38079677|NCT02915016|69777121|FG001|Overall Study|Lost to Follow-up|2|||
38079678|NCT02915016|69777122|FG002|Overall Study|Lost to Follow-up|5|||
38079679|NCT02915016|69777123|FG003|Overall Study|Lost to Follow-up|3|||
38079680|NCT02915016|69777124|FG004|Overall Study|Lost to Follow-up|5|||
38079681|NCT02915016|69777125|FG005|Overall Study|Lost to Follow-up|2|||
38079682|NCT02915016|69777126|FG006|Overall Study|Lost to Follow-up|8|||
38079683|NCT02915016|69777127|FG007|Overall Study|Lost to Follow-up|2|||
38079684|NCT02915016|69777120|FG000|Overall Study|Physician Decision|0|||
38079685|NCT02915016|69777121|FG001|Overall Study|Physician Decision|0|||
38079686|NCT02915016|69777122|FG002|Overall Study|Physician Decision|1|||
38079687|NCT02915016|69777123|FG003|Overall Study|Physician Decision|0|||
38079688|NCT02915016|69777124|FG004|Overall Study|Physician Decision|0|||
38079689|NCT02915016|69777125|FG005|Overall Study|Physician Decision|1|||
38079690|NCT02915016|69777126|FG006|Overall Study|Physician Decision|2|||
38079691|NCT02915016|69777127|FG007|Overall Study|Physician Decision|0|||
38079692|NCT02915016|69777120|FG000|Overall Study|Withdrawal by Subject|2|||
38079693|NCT02915016|69777121|FG001|Overall Study|Withdrawal by Subject|0|||
38079694|NCT02915016|69777122|FG002|Overall Study|Withdrawal by Subject|1|||
38079695|NCT02915016|69777123|FG003|Overall Study|Withdrawal by Subject|0|||
38079696|NCT02915016|69777124|FG004|Overall Study|Withdrawal by Subject|1|||
38079697|NCT02915016|69777125|FG005|Overall Study|Withdrawal by Subject|3|||
37862462|NCT01127451|69546306|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
38079698|NCT02915016|69777126|FG006|Overall Study|Withdrawal by Subject|1|||
38079699|NCT02915016|69777127|FG007|Overall Study|Withdrawal by Subject|1|||
38079700|NCT02915016|69777120|FG000|Overall Study|Elected not to continue|0|||
38079701|NCT02915016|69777121|FG001|Overall Study|Elected not to continue|0|||
38079702|NCT02915016|69777122|FG002|Overall Study|Elected not to continue|0|||
38079703|NCT02915016|69777123|FG003|Overall Study|Elected not to continue|1|||
38079704|NCT02915016|69777124|FG004|Overall Study|Elected not to continue|0|||
38079705|NCT02915016|69777125|FG005|Overall Study|Elected not to continue|0|||
38079706|NCT02915016|69777126|FG006|Overall Study|Elected not to continue|1|||
38079707|NCT02915016|69777127|FG007|Overall Study|Elected not to continue|0|||
38079708|NCT02915016|69777120|FG000|Overall Study|HIV infection|1|||
38079709|NCT02915016|69777121|FG001|Overall Study|HIV infection|1|||
38079710|NCT02915016|69777122|FG002|Overall Study|HIV infection|1|||
38079711|NCT02915016|69777123|FG003|Overall Study|HIV infection|0|||
38079712|NCT02915016|69777124|FG004|Overall Study|HIV infection|1|||
38079713|NCT02915016|69777125|FG005|Overall Study|HIV infection|0|||
38079714|NCT02915016|69777126|FG006|Overall Study|HIV infection|0|||
38079715|NCT02915016|69777127|FG007|Overall Study|HIV infection|0|||
38079716|NCT02915016|69777120|FG000|Overall Study|Participant unable to adhere|0|||
38079717|NCT02915016|69777121|FG001|Overall Study|Participant unable to adhere|0|||
38079718|NCT02915016|69777122|FG002|Overall Study|Participant unable to adhere|0|||
38079719|NCT02915016|69777123|FG003|Overall Study|Participant unable to adhere|0|||
38079720|NCT02915016|69777124|FG004|Overall Study|Participant unable to adhere|0|||
38079721|NCT02915016|69777125|FG005|Overall Study|Participant unable to adhere|0|||
38079722|NCT02915016|69777126|FG006|Overall Study|Participant unable to adhere|0|||
38079723|NCT02915016|69777127|FG007|Overall Study|Participant unable to adhere|1|||
38079724|NCT03323749|69777147|FG000|Double-blind Period|Lost to Follow-up|4|||
38079725|NCT03323749|69777148|FG001|Double-blind Period|Lost to Follow-up|5|||
38079726|NCT03323749|69777147|FG000|Double-blind Period|Adverse Event|3|||
38079727|NCT03323749|69777148|FG001|Double-blind Period|Adverse Event|1|||
38079728|NCT03323749|69777147|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
38079729|NCT03323749|69777148|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
38079730|NCT03323749|69777147|FG000|Open-Label Period|Adverse Event|3|||
38079731|NCT03323749|69777148|FG001|Open-Label Period|Adverse Event|10|||
38079732|NCT03323749|69777147|FG000|Open-Label Period|Withdrawal by Subject|7|||
38079733|NCT03323749|69777148|FG001|Open-Label Period|Withdrawal by Subject|5|||
38079734|NCT02208024|69777167|FG000|Overall Study|Withdrawal by Subject|1|||
38079735|NCT02660086|69777173|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
38079736|NCT02660086|69777174|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
38079737|NCT02660086|69777173|FG000|Overall Study- 12-month|Left full-time employment|12|||
38079738|NCT02660086|69777174|FG001|Overall Study- 12-month|Left full-time employment|20|||
38079739|NCT02660086|69777173|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
38079740|NCT02660086|69777174|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
38079741|NCT02660086|69777173|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
38079742|NCT02660086|69777174|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
38079743|NCT02660086|69777173|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
38079744|NCT02660086|69777174|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
38079745|NCT02660086|69777173|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
38079746|NCT02660086|69777174|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
38079747|NCT01678144|69777180|FG000|Stage 1: MAR Classic|Adverse Event|1|||
38079748|NCT00153920|69777184|FG000|Overall Study|Adverse Event|9|||
38079749|NCT00153920|69777184|FG000|Overall Study|Progressive Disease|9|||
38079750|NCT00153920|69777184|FG000|Overall Study|Physician Decision|3|||
38079751|NCT00153920|69777184|FG000|Overall Study|Lack of Response|3|||
38079752|NCT00153920|69777184|FG000|Overall Study|Death|2|||
38079753|NCT00153920|69777184|FG000|Overall Study|Withdrawal by Subject|1|||
38079754|NCT00153920|69777184|FG000|Overall Study|Non-Protocol Therapy|1|||
38079755|NCT00153920|69777184|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
38079756|NCT00153920|69777184|FG000|Overall Study|Progressive Disease before Trt|1|||
38079757|NCT02660242|69777188|FG000|Glucose Tabs|Lost to Follow-up|1|||
38079758|NCT02660242|69777188|FG000|Glucagon Injection|Lost to Follow-up|1|||
38079759|NCT03072043|69777204|FG000|Overall Study|Death|0|||
38079760|NCT03072043|69777205|FG001|Overall Study|Death|0|||
38079761|NCT03072043|69777206|FG002|Overall Study|Death|3|||
38079762|NCT03072043|69777204|FG000|Overall Study|Adverse Event|0|||
38079763|NCT03072043|69777205|FG001|Overall Study|Adverse Event|0|||
38079764|NCT03072043|69777206|FG002|Overall Study|Adverse Event|2|||
38079765|NCT03072043|69777204|FG000|Overall Study|Withdrawal by Subject|0|||
38079766|NCT03072043|69777205|FG001|Overall Study|Withdrawal by Subject|0|||
38079767|NCT03072043|69777206|FG002|Overall Study|Withdrawal by Subject|4|||
38079768|NCT03069313|69777218|FG000|Overall Study|Adverse Event|5|||
38079769|NCT03068767|69777224|FG000|Overall Study|Lost to Follow-up|7|||
38079770|NCT03068767|69777225|FG001|Overall Study|Lost to Follow-up|3|||
38079771|NCT03068767|69777224|FG000|Overall Study|Protocol Violation|3|||
38079772|NCT03068767|69777225|FG001|Overall Study|Protocol Violation|0|||
38079773|NCT03020745|69777239|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
38079774|NCT03020745|69777240|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
38079775|NCT03020745|69777241|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
38079776|NCT03020745|69777242|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
38079777|NCT03020745|69777243|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
38079778|NCT03020745|69777244|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
38079779|NCT03020745|69777245|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
38079780|NCT03020745|69777246|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
38079781|NCT03020745|69777247|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
38079782|NCT03020745|69777248|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
38079783|NCT03020745|69777239|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
38079784|NCT03020745|69777240|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
38079785|NCT03020745|69777241|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
38079786|NCT03020745|69777242|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
38079787|NCT03020745|69777243|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
38079788|NCT03020745|69777244|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
38079789|NCT03020745|69777245|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
38079790|NCT03020745|69777246|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
38079791|NCT03020745|69777247|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
38079792|NCT03020745|69777248|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
38079793|NCT03020745|69777239|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
38079794|NCT03020745|69777240|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
38079795|NCT03020745|69777241|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
38079796|NCT03020745|69777242|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
38079797|NCT03020745|69777243|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
38079798|NCT03020745|69777244|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
38079799|NCT03020745|69777245|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
38079800|NCT03020745|69777246|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
38079801|NCT03020745|69777247|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
38079802|NCT03020745|69777248|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
38079803|NCT03020745|69777239|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
38079804|NCT03020745|69777240|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
38079805|NCT03020745|69777241|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
38079806|NCT03020745|69777242|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
38079807|NCT03020745|69777243|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
38079808|NCT03020745|69777244|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
38079809|NCT03020745|69777245|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
38079810|NCT03020745|69777246|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
38079811|NCT03020745|69777247|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
38079812|NCT03020745|69777248|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
38079813|NCT03019965|69777283|FG000|Overall Study|Withdrawal by Subject|1|||
38079814|NCT03019965|69777284|FG001|Overall Study|Withdrawal by Subject|0|||
38079815|NCT03019965|69777283|FG000|Overall Study|Protocol Violation|1|||
38079816|NCT03019965|69777284|FG001|Overall Study|Protocol Violation|3|||
38079817|NCT03019965|69777283|FG000|Overall Study|viral or fungal infection|3|||
38079818|NCT03019965|69777284|FG001|Overall Study|viral or fungal infection|4|||
38079819|NCT03019965|69777283|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
38079820|NCT03019965|69777284|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
38079821|NCT03019965|69777283|FG000|Overall Study|Physician Decision|1|||
38079822|NCT03019965|69777284|FG001|Overall Study|Physician Decision|1|||
38079823|NCT01675882|69777303|FG000|Overall Study|Adverse Event|0|||
38079824|NCT01675882|69777304|FG001|Overall Study|Adverse Event|2|||
38079825|NCT01675882|69777305|FG002|Overall Study|Adverse Event|1|||
38079826|NCT01675882|69777306|FG003|Overall Study|Adverse Event|0|||
38079827|NCT01675882|69777303|FG000|Overall Study|Participant unwilling to continue|2|||
38079828|NCT01675882|69777304|FG001|Overall Study|Participant unwilling to continue|4|||
38079829|NCT01675882|69777305|FG002|Overall Study|Participant unwilling to continue|2|||
38079830|NCT01675882|69777306|FG003|Overall Study|Participant unwilling to continue|1|||
38079831|NCT01675882|69777303|FG000|Overall Study|Lost to Follow-up|0|||
38079832|NCT01675882|69777304|FG001|Overall Study|Lost to Follow-up|1|||
38079833|NCT01675882|69777305|FG002|Overall Study|Lost to Follow-up|0|||
38079834|NCT01675882|69777306|FG003|Overall Study|Lost to Follow-up|0|||
38079835|NCT01675882|69777303|FG000|Overall Study|Non-compliance|0|||
38079836|NCT01675882|69777304|FG001|Overall Study|Non-compliance|0|||
38079837|NCT01675882|69777305|FG002|Overall Study|Non-compliance|0|||
38079838|NCT01675882|69777306|FG003|Overall Study|Non-compliance|1|||
38079839|NCT03018249|69777318|FG000|Overall Study|Withdrawal by Subject|2|||
38079840|NCT03018249|69777319|FG001|Overall Study|Withdrawal by Subject|2|||
38079841|NCT02923245|69777337|FG000|Overall Study|ultrasound order was cancelled|2|||
38079842|NCT02923245|69777338|FG001|Overall Study|ultrasound order was cancelled|1|||
38079843|NCT00905606|69777354|FG000|Period 1|Adverse Event|0|||
38079844|NCT00905606|69777355|FG001|Period 1|Adverse Event|1|||
38079845|NCT00905606|69777354|FG000|Washout|Withdrawal by Subject|1|||
38079846|NCT00905606|69777355|FG001|Washout|Withdrawal by Subject|0|||
38079847|NCT01676896|69777362|FG000|Overall Study|Withdrawal by Subject|12|||
38079848|NCT01676896|69777363|FG001|Overall Study|Withdrawal by Subject|7|||
38079849|NCT01676896|69777364|FG002|Overall Study|Withdrawal by Subject|19|||
38079850|NCT03017235|69777374|FG000|Overall Study|Withdrawal by Subject|4|||
38079851|NCT03017235|69777375|FG001|Overall Study|Withdrawal by Subject|3|||
38079852|NCT03017235|69777374|FG000|Overall Study|Lost to Follow-up|2|||
38079853|NCT03017235|69777375|FG001|Overall Study|Lost to Follow-up|7|||
38079854|NCT03017235|69777374|FG000|Overall Study|Adverse Event|0|||
38079855|NCT03017235|69777375|FG001|Overall Study|Adverse Event|1|||
38079856|NCT03017235|69777374|FG000|Overall Study|Protocol Violation|2|||
38079857|NCT03017235|69777375|FG001|Overall Study|Protocol Violation|1|||
38079858|NCT03017235|69777374|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
38079859|NCT03017235|69777375|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
38079860|NCT03017079|69777383|FG000|Overall Study|Physician Decision|1|||
38079861|NCT03017079|69777384|FG001|Overall Study|Physician Decision|1|||
38079862|NCT03017079|69777383|FG000|Overall Study|Death|3|||
38079863|NCT03017079|69777384|FG001|Overall Study|Death|2|||
38079864|NCT03017079|69777383|FG000|Overall Study|Lack of Efficacy|2|||
38079865|NCT03017079|69777384|FG001|Overall Study|Lack of Efficacy|2|||
38079866|NCT03017079|69777383|FG000|Overall Study|Protocol Violation|0|||
38079867|NCT03017079|69777384|FG001|Overall Study|Protocol Violation|1|||
38079868|NCT03015363|69777397|FG000|Overall Study|Physician Decision|14|||
38079869|NCT03015363|69777397|FG000|Overall Study|Withdrawal by Subject|3|||
38079870|NCT02880371|69777409|FG000|Phase 1b|Lost to Follow-up|1|||
38079871|NCT02880371|69777410|FG001|Phase 1b|Lost to Follow-up|0|||
38079872|NCT02880371|69777411|FG002|Phase 1b|Lost to Follow-up|0|||
38079873|NCT02880371|69777412|FG003|Phase 1b|Lost to Follow-up|0|||
38079874|NCT02880371|69777413|FG004|Phase 1b|Lost to Follow-up|0|||
38079875|NCT02880371|69777414|FG005|Phase 1b|Lost to Follow-up|0|||
38079876|NCT02880371|69777415|FG006|Phase 1b|Lost to Follow-up|0|||
38079877|NCT02880371|69777416|FG007|Phase 1b|Lost to Follow-up|0|||
38079878|NCT02880371|69777409|FG000|Phase 1b|Participants terminated by Sponsor|1|||
38079879|NCT02880371|69777410|FG001|Phase 1b|Participants terminated by Sponsor|0|||
38079880|NCT02880371|69777411|FG002|Phase 1b|Participants terminated by Sponsor|0|||
38079881|NCT02880371|69777412|FG003|Phase 1b|Participants terminated by Sponsor|0|||
38079882|NCT02880371|69777413|FG004|Phase 1b|Participants terminated by Sponsor|0|||
38079883|NCT02880371|69777414|FG005|Phase 1b|Participants terminated by Sponsor|0|||
38079884|NCT02880371|69777415|FG006|Phase 1b|Participants terminated by Sponsor|0|||
38079885|NCT02880371|69777416|FG007|Phase 1b|Participants terminated by Sponsor|0|||
38079886|NCT02880371|69777409|FG000|Phase 1b|Withdrawal by Subject|0|||
38079887|NCT02880371|69777410|FG001|Phase 1b|Withdrawal by Subject|0|||
38079888|NCT02880371|69777411|FG002|Phase 1b|Withdrawal by Subject|1|||
38079889|NCT02880371|69777412|FG003|Phase 1b|Withdrawal by Subject|0|||
38079890|NCT02880371|69777413|FG004|Phase 1b|Withdrawal by Subject|0|||
38079891|NCT02880371|69777414|FG005|Phase 1b|Withdrawal by Subject|0|||
38079892|NCT02880371|69777415|FG006|Phase 1b|Withdrawal by Subject|0|||
38079893|NCT02880371|69777416|FG007|Phase 1b|Withdrawal by Subject|0|||
38079894|NCT02880371|69777409|FG000|Phase 1b|Death|4|||
38079895|NCT02880371|69777410|FG001|Phase 1b|Death|6|||
38079896|NCT02880371|69777411|FG002|Phase 1b|Death|5|||
38079897|NCT02880371|69777412|FG003|Phase 1b|Death|1|||
38079898|NCT02880371|69777413|FG004|Phase 1b|Death|0|||
38079899|NCT02880371|69777414|FG005|Phase 1b|Death|0|||
38079900|NCT02880371|69777415|FG006|Phase 1b|Death|0|||
38079901|NCT02880371|69777416|FG007|Phase 1b|Death|0|||
38079902|NCT02880371|69777409|FG000|Phase 1b|Enrolled but not Treated|0|||
38079903|NCT02880371|69777410|FG001|Phase 1b|Enrolled but not Treated|1|||
38079904|NCT02880371|69777411|FG002|Phase 1b|Enrolled but not Treated|0|||
38079905|NCT02880371|69777412|FG003|Phase 1b|Enrolled but not Treated|0|||
38079906|NCT02880371|69777413|FG004|Phase 1b|Enrolled but not Treated|0|||
38079907|NCT02880371|69777414|FG005|Phase 1b|Enrolled but not Treated|0|||
38079908|NCT02880371|69777415|FG006|Phase 1b|Enrolled but not Treated|0|||
38079909|NCT02880371|69777416|FG007|Phase 1b|Enrolled but not Treated|0|||
38079910|NCT02880371|69777409|FG000|Phase 2|Enrolled but not Treated|0|||
38079911|NCT02880371|69777410|FG001|Phase 2|Enrolled but not Treated|0|||
38079912|NCT02880371|69777411|FG002|Phase 2|Enrolled but not Treated|0|||
38079913|NCT02880371|69777412|FG003|Phase 2|Enrolled but not Treated|0|||
38079914|NCT02880371|69777413|FG004|Phase 2|Enrolled but not Treated|0|||
38079915|NCT02880371|69777414|FG005|Phase 2|Enrolled but not Treated|1|||
38079916|NCT02880371|69777415|FG006|Phase 2|Enrolled but not Treated|1|||
38079917|NCT02880371|69777416|FG007|Phase 2|Enrolled but not Treated|0|||
38079918|NCT02880371|69777409|FG000|Phase 2|Other|0|||
38079919|NCT02880371|69777410|FG001|Phase 2|Other|0|||
38079920|NCT02880371|69777411|FG002|Phase 2|Other|0|||
38079921|NCT02880371|69777412|FG003|Phase 2|Other|0|||
38079922|NCT02880371|69777413|FG004|Phase 2|Other|0|||
37862463|NCT01127451|69546305|FG000|Overall Study|Death|22|||
38079923|NCT02880371|69777414|FG005|Phase 2|Other|1|||
38079924|NCT02880371|69777415|FG006|Phase 2|Other|2|||
38079925|NCT02880371|69777416|FG007|Phase 2|Other|1|||
38079926|NCT02880371|69777409|FG000|Phase 2|Participants terminated by Sponsor|0|||
38079927|NCT02880371|69777410|FG001|Phase 2|Participants terminated by Sponsor|0|||
38079928|NCT02880371|69777411|FG002|Phase 2|Participants terminated by Sponsor|0|||
38079929|NCT02880371|69777412|FG003|Phase 2|Participants terminated by Sponsor|0|||
38079930|NCT02880371|69777413|FG004|Phase 2|Participants terminated by Sponsor|1|||
38079931|NCT02880371|69777414|FG005|Phase 2|Participants terminated by Sponsor|6|||
38079932|NCT02880371|69777415|FG006|Phase 2|Participants terminated by Sponsor|1|||
38079933|NCT02880371|69777416|FG007|Phase 2|Participants terminated by Sponsor|5|||
38079934|NCT02880371|69777409|FG000|Phase 2|Death|0|||
38079935|NCT02880371|69777410|FG001|Phase 2|Death|0|||
38079936|NCT02880371|69777411|FG002|Phase 2|Death|0|||
38079937|NCT02880371|69777412|FG003|Phase 2|Death|0|||
38079938|NCT02880371|69777413|FG004|Phase 2|Death|1|||
38079939|NCT02880371|69777414|FG005|Phase 2|Death|10|||
38079940|NCT02880371|69777415|FG006|Phase 2|Death|20|||
38079941|NCT02880371|69777416|FG007|Phase 2|Death|5|||
38079942|NCT02880371|69777409|FG000|Phase 2|Lost to Follow-up|0|||
38079943|NCT02880371|69777410|FG001|Phase 2|Lost to Follow-up|0|||
38079944|NCT02880371|69777411|FG002|Phase 2|Lost to Follow-up|0|||
38079945|NCT02880371|69777412|FG003|Phase 2|Lost to Follow-up|0|||
38079946|NCT02880371|69777413|FG004|Phase 2|Lost to Follow-up|0|||
38079947|NCT02880371|69777414|FG005|Phase 2|Lost to Follow-up|0|||
38079948|NCT02880371|69777415|FG006|Phase 2|Lost to Follow-up|3|||
38079949|NCT02880371|69777416|FG007|Phase 2|Lost to Follow-up|0|||
38079950|NCT02880371|69777409|FG000|Phase 2|Withdrawal by Subject|0|||
38079951|NCT02880371|69777410|FG001|Phase 2|Withdrawal by Subject|0|||
38079952|NCT02880371|69777411|FG002|Phase 2|Withdrawal by Subject|0|||
38079953|NCT02880371|69777412|FG003|Phase 2|Withdrawal by Subject|0|||
38079954|NCT02880371|69777413|FG004|Phase 2|Withdrawal by Subject|0|||
38079955|NCT02880371|69777414|FG005|Phase 2|Withdrawal by Subject|1|||
38079956|NCT02880371|69777415|FG006|Phase 2|Withdrawal by Subject|1|||
38079957|NCT02880371|69777416|FG007|Phase 2|Withdrawal by Subject|0|||
38079958|NCT02880371|69777409|FG000|Phase 2|End of Study page not completed by error|0|||
38079959|NCT02880371|69777410|FG001|Phase 2|End of Study page not completed by error|0|||
38079960|NCT02880371|69777411|FG002|Phase 2|End of Study page not completed by error|0|||
38079961|NCT02880371|69777412|FG003|Phase 2|End of Study page not completed by error|0|||
38079962|NCT02880371|69777413|FG004|Phase 2|End of Study page not completed by error|0|||
38079963|NCT02880371|69777414|FG005|Phase 2|End of Study page not completed by error|1|||
38079964|NCT02880371|69777415|FG006|Phase 2|End of Study page not completed by error|0|||
38079965|NCT02880371|69777416|FG007|Phase 2|End of Study page not completed by error|0|||
38079966|NCT02837029|69777439|FG000|Screening|Failed to meet screening requirements.|7|||
38079967|NCT02837029|69777440|FG001|Screening|Failed to meet screening requirements.|3|||
38079968|NCT02837029|69777441|FG002|Screening|Failed to meet screening requirements.|0|||
38079969|NCT02837029|69777439|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
38079970|NCT02837029|69777440|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
38079971|NCT02837029|69777441|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
38079972|NCT02837029|69777439|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
38079973|NCT02837029|69777440|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
38079974|NCT02837029|69777441|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
38079975|NCT02837029|69777439|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
38079976|NCT02837029|69777440|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
38079977|NCT02837029|69777441|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
38079978|NCT02837029|69777439|FG000|Cycle 2 and Beyond|Adverse Event|1|||
38079979|NCT02837029|69777440|FG001|Cycle 2 and Beyond|Adverse Event|0|||
38079980|NCT02837029|69777441|FG002|Cycle 2 and Beyond|Adverse Event|0|||
38079981|NCT02837029|69777439|FG000|2 Year Follow-up|Death|6|||
38079982|NCT02837029|69777440|FG001|2 Year Follow-up|Death|7|||
38079983|NCT02837029|69777441|FG002|2 Year Follow-up|Death|0|||
38079984|NCT03010527|69777453|FG000|Overall Study|Death|0|||
38079985|NCT03010527|69777454|FG001|Overall Study|Death|0|||
38079986|NCT03010527|69777455|FG002|Overall Study|Death|1|||
38079987|NCT03010527|69777453|FG000|Overall Study|Adverse Event|0|||
38079988|NCT03010527|69777454|FG001|Overall Study|Adverse Event|4|||
38079989|NCT03010527|69777455|FG002|Overall Study|Adverse Event|2|||
38079990|NCT03010527|69777453|FG000|Overall Study|Protocol Violation|0|||
38079991|NCT03010527|69777454|FG001|Overall Study|Protocol Violation|1|||
38079992|NCT03010527|69777455|FG002|Overall Study|Protocol Violation|0|||
38079993|NCT03010527|69777453|FG000|Overall Study|Lost to Follow-up|0|||
38079994|NCT03010527|69777454|FG001|Overall Study|Lost to Follow-up|2|||
37680471|NCT02343939|69156103|FG007|Overall Study|Investigator's discretion|0|||
38079995|NCT03010527|69777455|FG002|Overall Study|Lost to Follow-up|1|||
38079996|NCT03010527|69777453|FG000|Overall Study|Withdrawal by Subject|0|||
38079997|NCT03010527|69777454|FG001|Overall Study|Withdrawal by Subject|3|||
37680472|NCT02343939|69156104|FG008|Overall Study|Investigator's discretion|0|||
38079998|NCT03010527|69777455|FG002|Overall Study|Withdrawal by Subject|4|||
38079999|NCT03010527|69777453|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
38080000|NCT03010527|69777454|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
38080001|NCT03010527|69777455|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
38080002|NCT03010527|69777453|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
38080003|NCT03010527|69777454|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
38080004|NCT03010527|69777455|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
38080005|NCT03010527|69777453|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
38080006|NCT03010527|69777454|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
38080007|NCT03010527|69777455|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
38080008|NCT00794924|69777488|FG000|Overall Study|Lost to Follow-up|6|||
38080009|NCT00794924|69777489|FG001|Overall Study|Lost to Follow-up|8|||
38080010|NCT00794924|69777488|FG000|Overall Study|Withdrawal by Subject|48|||
38080011|NCT00794924|69777489|FG001|Overall Study|Withdrawal by Subject|60|||
38080012|NCT00794924|69777488|FG000|Overall Study|Adverse Event|6|||
38080013|NCT00794924|69777489|FG001|Overall Study|Adverse Event|2|||
38080014|NCT02914275|69777495|FG000|Overall Study|Lost to Follow-up|84|||
38080015|NCT02914275|69777496|FG001|Overall Study|Lost to Follow-up|29|||
38080016|NCT02914275|69777495|FG000|Overall Study|Withdrawal by Subject|26|||
38080017|NCT02914275|69777496|FG001|Overall Study|Withdrawal by Subject|10|||
38080018|NCT02914275|69777495|FG000|Overall Study|Protocol Violation|1|||
38080019|NCT02914275|69777496|FG001|Overall Study|Protocol Violation|1|||
38080020|NCT02914275|69777495|FG000|Overall Study|Physician Decision|3|||
38080021|NCT02914275|69777496|FG001|Overall Study|Physician Decision|1|||
38080022|NCT02914275|69777495|FG000|Overall Study|Other|4|||
38080023|NCT02914275|69777496|FG001|Overall Study|Other|1|||
38080024|NCT02914275|69777495|FG000|Overall Study|Excluded due to invalid informed consent|3|||
38080025|NCT02914275|69777496|FG001|Overall Study|Excluded due to invalid informed consent|0|||
38080026|NCT00792116|69777508|FG000|Overall Study|Lost to Follow-up|0|||
38080027|NCT00792116|69777509|FG001|Overall Study|Lost to Follow-up|1|||
38080028|NCT00792116|69777508|FG000|Overall Study|Discontnued intervention|1|||
38080029|NCT00792116|69777509|FG001|Overall Study|Discontnued intervention|0|||
38080030|NCT00489827|69777524|FG000|Overall Study|Intraoperative exclusion criteria|1|||
38080031|NCT00489827|69777525|FG001|Overall Study|Intraoperative exclusion criteria|1|||
38080032|NCT00489827|69777524|FG000|Overall Study|Intraoperative exclusion criteria|1|||
38080033|NCT00489827|69777525|FG001|Overall Study|Intraoperative exclusion criteria|1|||
38080034|NCT02604433|69777533|FG000|Overall Study|Withdrawal by Subject|37|||
38080035|NCT02604433|69777534|FG001|Overall Study|Withdrawal by Subject|16|||
38080036|NCT02604433|69777533|FG000|Overall Study|Adverse Event|4|||
38080037|NCT02604433|69777534|FG001|Overall Study|Adverse Event|0|||
38080038|NCT02604433|69777533|FG000|Overall Study|Other reasons|3|||
38080039|NCT02604433|69777534|FG001|Overall Study|Other reasons|5|||
38080040|NCT02604433|69777533|FG000|Overall Study|Death|4|||
38080041|NCT02604433|69777534|FG001|Overall Study|Death|1|||
38080042|NCT02604433|69777533|FG000|Overall Study|Transition to Rollover Protocol|169|||
38080043|NCT02604433|69777534|FG001|Overall Study|Transition to Rollover Protocol|82|||
38080044|NCT02604433|69777533|FG000|Overall Study|Physician Decision|1|||
38080045|NCT02604433|69777534|FG001|Overall Study|Physician Decision|1|||
38080046|NCT02604433|69777533|FG000|Overall Study|Lack of Efficacy|0|||
38080047|NCT02604433|69777534|FG001|Overall Study|Lack of Efficacy|1|||
38080048|NCT02659150|69777540|FG000|Subject Enrollment|Physician Decision|3|||
38080049|NCT02659150|69777540|FG000|Subject Enrollment|Withdrawal by Subject|2|||
38080050|NCT02659150|69777540|FG000|Baseline Imaging|Withdrawal by Subject|1|||
38080051|NCT02659150|69777540|FG000|Baseline Imaging|Physician Decision|1|||
38080052|NCT02659150|69777540|FG000|Study Drug Dosing|Adverse Event|1|||
38080053|NCT03006393|69777547|FG000|Overall Study|Withdrawal by Subject|1|||
38080054|NCT03006393|69777548|FG001|Overall Study|Withdrawal by Subject|1|||
38080055|NCT03006393|69777547|FG000|Overall Study|Pregnancy|0|||
38080056|NCT03006393|69777548|FG001|Overall Study|Pregnancy|1|||
38080057|NCT03006393|69777547|FG000|Overall Study|Lost to Follow-up|0|||
38080058|NCT03006393|69777548|FG001|Overall Study|Lost to Follow-up|1|||
38080059|NCT00882440|69777565|FG000|Overall Study|Adverse Event|2|||
38080060|NCT00882440|69777566|FG001|Overall Study|Adverse Event|2|||
38080061|NCT00882440|69777567|FG002|Overall Study|Adverse Event|2|||
38080062|NCT00882440|69777568|FG003|Overall Study|Adverse Event|1|||
38080063|NCT00882440|69777569|FG004|Overall Study|Adverse Event|1|||
38080064|NCT00882440|69777570|FG005|Overall Study|Adverse Event|4|||
38080065|NCT00882440|69777571|FG006|Overall Study|Adverse Event|2|||
38080066|NCT00882440|69777565|FG000|Overall Study|Lack of Efficacy|3|||
38080067|NCT00882440|69777566|FG001|Overall Study|Lack of Efficacy|5|||
38080068|NCT00882440|69777567|FG002|Overall Study|Lack of Efficacy|2|||
38080069|NCT00882440|69777568|FG003|Overall Study|Lack of Efficacy|0|||
38080070|NCT00882440|69777569|FG004|Overall Study|Lack of Efficacy|0|||
38080071|NCT00882440|69777570|FG005|Overall Study|Lack of Efficacy|3|||
38080072|NCT00882440|69777571|FG006|Overall Study|Lack of Efficacy|0|||
38080073|NCT00882440|69777565|FG000|Overall Study|Lost to Follow-up|2|||
38080074|NCT00882440|69777566|FG001|Overall Study|Lost to Follow-up|0|||
38080075|NCT00882440|69777567|FG002|Overall Study|Lost to Follow-up|1|||
38080076|NCT00882440|69777568|FG003|Overall Study|Lost to Follow-up|1|||
38080077|NCT00882440|69777569|FG004|Overall Study|Lost to Follow-up|1|||
38080078|NCT00882440|69777570|FG005|Overall Study|Lost to Follow-up|0|||
38080079|NCT00882440|69777571|FG006|Overall Study|Lost to Follow-up|1|||
38080080|NCT00882440|69777565|FG000|Overall Study|Protocol Violation|0|||
38080081|NCT00882440|69777566|FG001|Overall Study|Protocol Violation|0|||
38080082|NCT00882440|69777567|FG002|Overall Study|Protocol Violation|1|||
38080083|NCT00882440|69777568|FG003|Overall Study|Protocol Violation|1|||
38080084|NCT00882440|69777569|FG004|Overall Study|Protocol Violation|1|||
38080085|NCT00882440|69777570|FG005|Overall Study|Protocol Violation|0|||
38080086|NCT00882440|69777571|FG006|Overall Study|Protocol Violation|0|||
38080087|NCT00882440|69777565|FG000|Overall Study|Withdrawal by Subject|2|||
38080088|NCT00882440|69777566|FG001|Overall Study|Withdrawal by Subject|1|||
38080089|NCT00882440|69777567|FG002|Overall Study|Withdrawal by Subject|1|||
38080090|NCT00882440|69777568|FG003|Overall Study|Withdrawal by Subject|0|||
38080091|NCT00882440|69777569|FG004|Overall Study|Withdrawal by Subject|6|||
38080092|NCT00882440|69777570|FG005|Overall Study|Withdrawal by Subject|0|||
38080093|NCT00882440|69777571|FG006|Overall Study|Withdrawal by Subject|1|||
38080094|NCT00882440|69777565|FG000|Overall Study|Patient Uncooperative|2|||
38080095|NCT00882440|69777566|FG001|Overall Study|Patient Uncooperative|0|||
38080096|NCT00882440|69777567|FG002|Overall Study|Patient Uncooperative|0|||
38080097|NCT00882440|69777568|FG003|Overall Study|Patient Uncooperative|0|||
38080098|NCT00882440|69777569|FG004|Overall Study|Patient Uncooperative|1|||
38080099|NCT00882440|69777570|FG005|Overall Study|Patient Uncooperative|0|||
38080100|NCT00882440|69777571|FG006|Overall Study|Patient Uncooperative|0|||
38080101|NCT03005067|69777582|FG000|Overall Study|Withdrawal by Subject|3|||
38080102|NCT03005067|69777583|FG001|Overall Study|Withdrawal by Subject|2|||
38080103|NCT03005067|69777582|FG000|Overall Study|Adverse Event|4|||
38080104|NCT03005067|69777583|FG001|Overall Study|Adverse Event|3|||
38080105|NCT03005067|69777582|FG000|Overall Study|Other (reason not specified)|3|||
38080106|NCT03005067|69777583|FG001|Overall Study|Other (reason not specified)|1|||
38080107|NCT03005067|69777582|FG000|Overall Study|Protocol Violation|0|||
38080108|NCT03005067|69777583|FG001|Overall Study|Protocol Violation|1|||
38080109|NCT02658448|69777589|FG000|Overall Study|Lost to Follow-up|1|||
38080110|NCT00870818|69777598|FG000|Overall Study|Lost to Follow-up|3|||
38080111|NCT00870818|69777599|FG001|Overall Study|Lost to Follow-up|2|||
38080112|NCT00870818|69777600|FG002|Overall Study|Lost to Follow-up|1|||
38080113|NCT00870818|69777601|FG003|Overall Study|Lost to Follow-up|0|||
38080114|NCT00870818|69777602|FG004|Overall Study|Lost to Follow-up|0|||
38080115|NCT00870818|69777598|FG000|Overall Study|Withdrawal by Subject|0|||
38080116|NCT00870818|69777599|FG001|Overall Study|Withdrawal by Subject|0|||
38080117|NCT00870818|69777600|FG002|Overall Study|Withdrawal by Subject|1|||
38080118|NCT00870818|69777601|FG003|Overall Study|Withdrawal by Subject|2|||
38080119|NCT00870818|69777602|FG004|Overall Study|Withdrawal by Subject|0|||
38080120|NCT00870818|69777598|FG000|Overall Study|Terminated by sponsor|29|||
38080121|NCT00870818|69777599|FG001|Overall Study|Terminated by sponsor|70|||
38080122|NCT00870818|69777600|FG002|Overall Study|Terminated by sponsor|36|||
38080123|NCT00870818|69777601|FG003|Overall Study|Terminated by sponsor|36|||
38080124|NCT00870818|69777602|FG004|Overall Study|Terminated by sponsor|38|||
38080125|NCT00870818|69777598|FG000|Overall Study|Other|0|||
38080126|NCT00870818|69777599|FG001|Overall Study|Other|1|||
38080127|NCT00870818|69777600|FG002|Overall Study|Other|0|||
38080128|NCT00870818|69777601|FG003|Overall Study|Other|0|||
38080129|NCT00870818|69777602|FG004|Overall Study|Other|0|||
38080130|NCT03075761|69777616|FG000|Overall Study|Lost to Follow-up|1|||
38080131|NCT03075761|69777617|FG001|Overall Study|Lost to Follow-up|6|||
38080132|NCT03000075|69777631|FG000|Part A|Adverse Event|4|||
38080133|NCT03000075|69777632|FG001|Part A|Adverse Event|0|||
38080134|NCT03000075|69777633|FG002|Part A|Adverse Event|0|||
38080135|NCT03000075|69777634|FG003|Part A|Adverse Event|0|||
38080136|NCT03000075|69777635|FG004|Part A|Adverse Event|0|||
38080137|NCT03000075|69777636|FG005|Part A|Adverse Event|0|||
38080138|NCT03000075|69777637|FG006|Part A|Adverse Event|0|||
38080139|NCT03000075|69777631|FG000|Part B|Not dosed due to AE|0|||
38080140|NCT03000075|69777632|FG001|Part B|Not dosed due to AE|0|||
38080141|NCT03000075|69777633|FG002|Part B|Not dosed due to AE|0|||
38080142|NCT03000075|69777634|FG003|Part B|Not dosed due to AE|0|||
38080143|NCT03000075|69777635|FG004|Part B|Not dosed due to AE|0|||
38080144|NCT03000075|69777636|FG005|Part B|Not dosed due to AE|2|||
38080145|NCT03000075|69777637|FG006|Part B|Not dosed due to AE|1|||
38080146|NCT03000075|69777631|FG000|Part B|Adverse Event|0|||
38080147|NCT03000075|69777632|FG001|Part B|Adverse Event|0|||
38080148|NCT03000075|69777633|FG002|Part B|Adverse Event|0|||
38080149|NCT03000075|69777634|FG003|Part B|Adverse Event|0|||
38080150|NCT03000075|69777635|FG004|Part B|Adverse Event|1|||
38080151|NCT03000075|69777636|FG005|Part B|Adverse Event|0|||
38080152|NCT03000075|69777637|FG006|Part B|Adverse Event|0|||
38080153|NCT03073109|69777655|FG000|Overall Study|Adverse Event|0|||
38080154|NCT03073109|69777656|FG001|Overall Study|Adverse Event|1|||
38080155|NCT03073109|69777655|FG000|Overall Study|Other|2|||
38080156|NCT03073109|69777656|FG001|Overall Study|Other|0|||
38080157|NCT03073109|69777655|FG000|Overall Study|Lost to Follow-up|8|||
38080158|NCT03073109|69777656|FG001|Overall Study|Lost to Follow-up|1|||
38080159|NCT02371889|69777678|FG000|Overall Study|Adverse medication effect|11|||
38080160|NCT02371889|69777679|FG001|Overall Study|Adverse medication effect|2|||
38080161|NCT02371889|69777678|FG000|Overall Study|Lost to Follow-up|6|||
38080162|NCT02371889|69777679|FG001|Overall Study|Lost to Follow-up|5|||
38080163|NCT02371889|69777678|FG000|Overall Study|Personal time constraints|2|||
38080164|NCT02371889|69777679|FG001|Overall Study|Personal time constraints|4|||
38080165|NCT02371889|69777678|FG000|Overall Study|Lack of Efficacy|0|||
38080166|NCT02371889|69777679|FG001|Overall Study|Lack of Efficacy|2|||
38080167|NCT02371889|69777678|FG000|Overall Study|Relapse|0|||
38080168|NCT02371889|69777679|FG001|Overall Study|Relapse|1|||
38080169|NCT03072875|69777689|FG000|Overall Study|Lost to Follow-up|1|||
38080170|NCT04250077|69777697|FG000|Overall Study|Withdrawal by Subject|0|||
38080171|NCT04250077|69777698|FG001|Overall Study|Withdrawal by Subject|1|||
38080172|NCT04250077|69777699|FG002|Overall Study|Withdrawal by Subject|0|||
38080173|NCT04250077|69777697|FG000|Overall Study|Lost to Follow-up|2|||
38080174|NCT04250077|69777698|FG001|Overall Study|Lost to Follow-up|3|||
38080175|NCT04250077|69777699|FG002|Overall Study|Lost to Follow-up|0|||
38080176|NCT00859430|69777711|FG000|First Intervention|Withdrawal by Subject|0|||
38080177|NCT00859430|69777712|FG001|First Intervention|Withdrawal by Subject|1|||
38080178|NCT02913105|69777729|FG000|Overall Study|Adverse Event|11|||
38080179|NCT02913105|69777730|FG001|Overall Study|Adverse Event|0|||
38080180|NCT02913105|69777731|FG002|Overall Study|Adverse Event|4|||
38080181|NCT02913105|69777729|FG000|Overall Study|Non-Compliance With Study Drug|0|||
38080182|NCT02913105|69777730|FG001|Overall Study|Non-Compliance With Study Drug|0|||
38080183|NCT02913105|69777731|FG002|Overall Study|Non-Compliance With Study Drug|1|||
38080184|NCT02913105|69777729|FG000|Overall Study|Reason Not Specified|3|||
38080185|NCT02913105|69777730|FG001|Overall Study|Reason Not Specified|1|||
38080186|NCT02913105|69777731|FG002|Overall Study|Reason Not Specified|1|||
38080187|NCT02913105|69777729|FG000|Overall Study|Physician Decision|1|||
38080188|NCT02913105|69777730|FG001|Overall Study|Physician Decision|1|||
38080189|NCT02913105|69777731|FG002|Overall Study|Physician Decision|0|||
38080190|NCT02913105|69777729|FG000|Overall Study|Withdrawal by Subject|0|||
38080191|NCT02913105|69777730|FG001|Overall Study|Withdrawal by Subject|3|||
38080192|NCT02913105|69777731|FG002|Overall Study|Withdrawal by Subject|1|||
38080193|NCT00840632|69777749|FG000|First Intervention|Withdrawal by Subject|0|||
38080194|NCT00840632|69777750|FG001|First Intervention|Withdrawal by Subject|1|||
38080195|NCT00840632|69777749|FG000|Washout|Withdrawal by Subject|1|||
38080196|NCT00840632|69777750|FG001|Washout|Withdrawal by Subject|1|||
38080197|NCT01602562|69777767|FG000|Overall Study|Adverse Event|3|||
38080198|NCT01602562|69777768|FG001|Overall Study|Adverse Event|1|||
38080199|NCT01602562|69777767|FG000|Overall Study|Physician Decision|1|||
38080200|NCT01602562|69777768|FG001|Overall Study|Physician Decision|1|||
38080201|NCT01602562|69777767|FG000|Overall Study|Withdrawal by Subject|1|||
38080202|NCT01602562|69777768|FG001|Overall Study|Withdrawal by Subject|1|||
38080203|NCT01945775|69777777|FG000|Overall Study|Death|214|||
38080204|NCT01945775|69777778|FG001|Overall Study|Death|98|||
38080205|NCT01945775|69777777|FG000|Overall Study|Lost to Follow-up|12|||
38080206|NCT01945775|69777778|FG001|Overall Study|Lost to Follow-up|7|||
38080207|NCT01945775|69777777|FG000|Overall Study|Withdrawal by Subject|11|||
38080208|NCT01945775|69777778|FG001|Overall Study|Withdrawal by Subject|21|||
38080209|NCT01945775|69777777|FG000|Overall Study|Other|50|||
38080210|NCT01945775|69777778|FG001|Overall Study|Other|18|||
38080211|NCT03072719|69777806|FG000|Overall Study|Adverse Event|1|||
38080212|NCT03072719|69777807|FG001|Overall Study|Adverse Event|1|||
38080213|NCT00835796|69777815|FG000|First Intervention|Withdrawal by Subject|0|||
38080214|NCT00835796|69777816|FG001|First Intervention|Withdrawal by Subject|1|||
38080215|NCT00835640|69777822|FG000|Second Intervention|Protocol Violation|1|||
38080216|NCT00835640|69777823|FG001|Second Intervention|Protocol Violation|0|||
38080217|NCT02942017|69777829|FG000|Overall Study|Adverse Event|0|||
38080218|NCT02942017|69777830|FG001|Overall Study|Adverse Event|1|||
38080219|NCT02942017|69777829|FG000|Overall Study|Withdrawal by Subject|0|||
38080220|NCT02942017|69777830|FG001|Overall Study|Withdrawal by Subject|1|||
38080221|NCT02942017|69777829|FG000|Overall Study|Lost to Follow-up|1|||
38080222|NCT02942017|69777830|FG001|Overall Study|Lost to Follow-up|1|||
38080223|NCT02942017|69777829|FG000|Overall Study|Randomized but not dosed|1|||
38080224|NCT02942017|69777830|FG001|Overall Study|Randomized but not dosed|3|||
38080225|NCT00835406|69777845|FG000|Period: First Intervention|Adverse Event|0|||
38080226|NCT00835406|69777846|FG001|Period: First Intervention|Adverse Event|1|||
38080227|NCT00835406|69777845|FG000|Period: First Intervention|Withdrawal by Subject|2|||
38080228|NCT00835406|69777846|FG001|Period: First Intervention|Withdrawal by Subject|0|||
38080229|NCT00835406|69777845|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
38080230|NCT00835406|69777846|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
38080231|NCT00835172|69777852|FG000|Washout|Protocol Violation|0|||
38080232|NCT00835172|69777853|FG001|Washout|Protocol Violation|1|||
38080233|NCT01676116|69777859|FG000|Overall Study|Withdrawal criteria|2|||
38080234|NCT01676116|69777860|FG001|Overall Study|Withdrawal criteria|14|||
38080235|NCT01676116|69777859|FG000|Overall Study|Adverse Event|1|||
38080236|NCT01676116|69777860|FG001|Overall Study|Adverse Event|2|||
38080237|NCT01676116|69777859|FG000|Overall Study|Unclassified|4|||
38080238|NCT01676116|69777860|FG001|Overall Study|Unclassified|10|||
38080239|NCT01676116|69777859|FG000|Overall Study|Protocol Violation|9|||
38080240|NCT01676116|69777860|FG001|Overall Study|Protocol Violation|3|||
38080241|NCT00740480|69777866|FG000|Overall Study|Adverse Event|1|||
38080242|NCT00740480|69777866|FG000|Overall Study|Physician Decision|1|||
38080243|NCT02743520|69777869|FG000|Overall Study|Withdrawal by Subject|1|||
38080244|NCT03001557|69777888|FG000|Core Phase|Randomized but not treated|0|||
38080245|NCT03001557|69777889|FG001|Core Phase|Randomized but not treated|0|||
38080246|NCT03001557|69777890|FG002|Core Phase|Randomized but not treated|1|||
38080247|NCT03001557|69777891|FG003|Core Phase|Randomized but not treated|0|||
38080248|NCT03001557|69777892|FG004|Core Phase|Randomized but not treated|0|||
38080249|NCT03001557|69777893|FG005|Core Phase|Randomized but not treated|0|||
38080250|NCT03001557|69777894|FG006|Core Phase|Randomized but not treated|0|||
38080251|NCT03001557|69777895|FG007|Core Phase|Randomized but not treated|0|||
38080252|NCT03001557|69777888|FG000|Extension Phase|Adverse Event|0|||
38080253|NCT03001557|69777889|FG001|Extension Phase|Adverse Event|0|||
38080254|NCT03001557|69777890|FG002|Extension Phase|Adverse Event|0|||
38080255|NCT03001557|69777891|FG003|Extension Phase|Adverse Event|0|||
38080256|NCT03001557|69777892|FG004|Extension Phase|Adverse Event|0|||
38080257|NCT03001557|69777893|FG005|Extension Phase|Adverse Event|2|||
38080258|NCT03001557|69777894|FG006|Extension Phase|Adverse Event|0|||
38080259|NCT03001557|69777895|FG007|Extension Phase|Adverse Event|0|||
37862464|NCT01127451|69546306|FG001|Overall Study|Death|17|||
37862465|NCT01127451|69546305|FG000|Overall Study|Lost to Follow-up|3|||
37862466|NCT01127451|69546306|FG001|Overall Study|Lost to Follow-up|0|||
37862467|NCT01127451|69546305|FG000|Overall Study|Administrative Reason by Sponsor|2|||
37862468|NCT01127451|69546306|FG001|Overall Study|Administrative Reason by Sponsor|2|||
38080260|NCT03001557|69777888|FG000|Extension Phase|Withdrawal by Subject|0|||
38080261|NCT03001557|69777889|FG001|Extension Phase|Withdrawal by Subject|0|||
38080262|NCT03001557|69777890|FG002|Extension Phase|Withdrawal by Subject|0|||
38080263|NCT03001557|69777891|FG003|Extension Phase|Withdrawal by Subject|0|||
38080264|NCT03001557|69777892|FG004|Extension Phase|Withdrawal by Subject|0|||
38080265|NCT03001557|69777893|FG005|Extension Phase|Withdrawal by Subject|1|||
38080266|NCT03001557|69777894|FG006|Extension Phase|Withdrawal by Subject|5|||
38080267|NCT03001557|69777895|FG007|Extension Phase|Withdrawal by Subject|2|||
38080268|NCT03001557|69777888|FG000|Extension Phase|Lost to Follow-up|0|||
38080269|NCT03001557|69777889|FG001|Extension Phase|Lost to Follow-up|0|||
38080270|NCT03001557|69777890|FG002|Extension Phase|Lost to Follow-up|0|||
38080271|NCT03001557|69777891|FG003|Extension Phase|Lost to Follow-up|0|||
38080272|NCT03001557|69777892|FG004|Extension Phase|Lost to Follow-up|0|||
38080273|NCT03001557|69777893|FG005|Extension Phase|Lost to Follow-up|0|||
38080274|NCT03001557|69777894|FG006|Extension Phase|Lost to Follow-up|2|||
38080275|NCT03001557|69777895|FG007|Extension Phase|Lost to Follow-up|1|||
38080276|NCT03001557|69777888|FG000|Extension Phase|Administrative Reason|0|||
38080277|NCT03001557|69777889|FG001|Extension Phase|Administrative Reason|0|||
38080278|NCT03001557|69777890|FG002|Extension Phase|Administrative Reason|0|||
38080279|NCT03001557|69777891|FG003|Extension Phase|Administrative Reason|0|||
38080280|NCT03001557|69777892|FG004|Extension Phase|Administrative Reason|0|||
38080281|NCT03001557|69777893|FG005|Extension Phase|Administrative Reason|1|||
38080282|NCT03001557|69777894|FG006|Extension Phase|Administrative Reason|3|||
38080283|NCT03001557|69777895|FG007|Extension Phase|Administrative Reason|3|||
38080284|NCT03001557|69777888|FG000|Extension Phase|Loss of caregiver|0|||
38080285|NCT03001557|69777889|FG001|Extension Phase|Loss of caregiver|0|||
38080286|NCT03001557|69777890|FG002|Extension Phase|Loss of caregiver|0|||
38080287|NCT03001557|69777891|FG003|Extension Phase|Loss of caregiver|0|||
38080288|NCT03001557|69777892|FG004|Extension Phase|Loss of caregiver|0|||
38080289|NCT03001557|69777893|FG005|Extension Phase|Loss of caregiver|0|||
37862469|NCT01127373|69546312|FG000|Overall Study|Not Treated|3|||
37966693|NCT00647699|69653680|FG000|Overall Study|Withdrawal by Subject|3|||
38080290|NCT03001557|69777894|FG006|Extension Phase|Loss of caregiver|1|||
38080291|NCT03001557|69777895|FG007|Extension Phase|Loss of caregiver|0|||
38080292|NCT03001557|69777888|FG000|Extension Phase|Others|0|||
38080293|NCT03001557|69777889|FG001|Extension Phase|Others|0|||
38080294|NCT03001557|69777890|FG002|Extension Phase|Others|0|||
38080295|NCT03001557|69777891|FG003|Extension Phase|Others|0|||
38080296|NCT03001557|69777892|FG004|Extension Phase|Others|0|||
38080297|NCT03001557|69777893|FG005|Extension Phase|Others|1|||
38080298|NCT03001557|69777894|FG006|Extension Phase|Others|3|||
38080299|NCT03001557|69777895|FG007|Extension Phase|Others|0|||
38080300|NCT00830336|69777932|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
38080301|NCT00830336|69777933|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
38080302|NCT00830258|69777939|FG000|First Intervention|Adverse Event|1|||
38080303|NCT00830258|69777940|FG001|First Intervention|Adverse Event|0|||
38080304|NCT00830258|69777939|FG000|Washout: 7 Days|Protocol Violation|1|||
38080305|NCT00830258|69777940|FG001|Washout: 7 Days|Protocol Violation|0|||
38080306|NCT03349775|69777946|FG000|Overall Study|Side Effects|1|||
38080307|NCT03349775|69777947|FG001|Overall Study|Side Effects|2|||
38080308|NCT03349775|69777946|FG000|Overall Study|Withdrawal by Subject|1|||
38080309|NCT03349775|69777947|FG001|Overall Study|Withdrawal by Subject|1|||
38080310|NCT03349775|69777946|FG000|Overall Study|No primary outcome measurements|0|||
38080311|NCT03349775|69777947|FG001|Overall Study|No primary outcome measurements|1|||
38080312|NCT00830024|69777955|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
38080313|NCT00830024|69777956|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
38080314|NCT00829868|69777962|FG000|Washout|Physician Decision|1|||
38080315|NCT00829868|69777963|FG001|Washout|Physician Decision|0|||
38080316|NCT00829790|69777969|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
38080317|NCT00829790|69777970|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
38080318|NCT03207815|69777976|FG000|Overall Study|Protocol Violation|3|||
38080319|NCT03207815|69777977|FG001|Overall Study|Protocol Violation|1|||
38080320|NCT03207815|69777976|FG000|Overall Study|Adverse Event|1|||
38080321|NCT03207815|69777977|FG001|Overall Study|Adverse Event|2|||
38080322|NCT03207815|69777976|FG000|Overall Study|Lost to Follow-up|1|||
38080323|NCT03207815|69777977|FG001|Overall Study|Lost to Follow-up|2|||
38080324|NCT03207815|69777976|FG000|Overall Study|Investigator's Discretion|1|||
38080325|NCT03207815|69777977|FG001|Overall Study|Investigator's Discretion|1|||
38080326|NCT03207815|69777976|FG000|Overall Study|Lack of Efficacy|0|||
38080327|NCT03207815|69777977|FG001|Overall Study|Lack of Efficacy|1|||
38080328|NCT03207815|69777976|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
38080329|NCT03207815|69777977|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
38080330|NCT03207815|69777976|FG000|Overall Study|Withdrew Consent|1|||
38080331|NCT03207815|69777977|FG001|Overall Study|Withdrew Consent|0|||
38080332|NCT02911935|69777985|FG000|Overall Study|Lost to Follow-up|5|||
38080333|NCT02911935|69777986|FG001|Overall Study|Lost to Follow-up|7|||
38080334|NCT00829712|69777994|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
38080335|NCT00829712|69777995|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
38080336|NCT03069989|69778010|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
38080337|NCT03069989|69778011|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
38080338|NCT02698163|69778038|FG000|Overall Study|Lost to Follow-up|0|||
37966694|NCT00647699|69653681|FG001|Overall Study|Withdrawal by Subject|8|||
37966695|NCT00467649|69653689|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
37966696|NCT00467649|69653690|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
37966697|NCT00467649|69653691|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
37966698|NCT00467649|69653692|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
37966699|NCT00467649|69653693|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
37966700|NCT00467649|69653694|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
37966701|NCT00467649|69653689|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
37966702|NCT00467649|69653690|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
37966703|NCT00467649|69653691|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
37966704|NCT00467649|69653692|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
37966705|NCT00467649|69653693|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
37966706|NCT00467649|69653694|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
37966707|NCT00467649|69653689|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
38080339|NCT02698163|69778039|FG001|Overall Study|Lost to Follow-up|1|||
38080340|NCT03817190|69778047|FG000|Overall Study|Early Termination|13|||
38080341|NCT03817190|69778048|FG001|Overall Study|Early Termination|20|||
38080342|NCT03817190|69778047|FG000|Overall Study|Adverse Event|10|||
37966708|NCT00467649|69653690|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
38080343|NCT03817190|69778048|FG001|Overall Study|Adverse Event|17|||
38080344|NCT03817190|69778047|FG000|Overall Study|Withdrawal by Subject|12|||
38080345|NCT03817190|69778048|FG001|Overall Study|Withdrawal by Subject|8|||
38080346|NCT03817190|69778047|FG000|Overall Study|Lost to Follow-up|11|||
38080347|NCT03817190|69778048|FG001|Overall Study|Lost to Follow-up|7|||
38080348|NCT03817190|69778047|FG000|Overall Study|Lack of Efficacy|7|||
38080349|NCT03817190|69778048|FG001|Overall Study|Lack of Efficacy|5|||
38080350|NCT03817190|69778047|FG000|Overall Study|Investigator Decision|5|||
38080351|NCT03817190|69778048|FG001|Overall Study|Investigator Decision|1|||
38080352|NCT03817190|69778047|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
38080353|NCT03817190|69778048|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
38080354|NCT03817190|69778047|FG000|Overall Study|Lack of Contact|1|||
38080355|NCT03817190|69778048|FG001|Overall Study|Lack of Contact|0|||
38080356|NCT03817190|69778047|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
38080357|NCT03817190|69778048|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
38080358|NCT03797222|69778067|FG000|Overall Study|Withdrawal by Subject|1|||
38080359|NCT02742818|69778077|FG000|Overall Study|Adverse Event|0|||
38080360|NCT02742818|69778078|FG001|Overall Study|Adverse Event|1|||
38080361|NCT02742818|69778077|FG000|Overall Study|Protocol Violation|0|||
38080362|NCT02742818|69778078|FG001|Overall Study|Protocol Violation|1|||
38080363|NCT03069365|69778086|FG000|Overall Study|Adverse Event|1|||
38080364|NCT03065933|69778090|FG000|Overall Study|study terminated|5|||
38080365|NCT04256629|69778100|FG000|Overall Study|Adverse Event|0|||
38080366|NCT04256629|69778101|FG001|Overall Study|Adverse Event|0|||
38080367|NCT04256629|69778102|FG002|Overall Study|Adverse Event|0|||
38080368|NCT04256629|69778103|FG003|Overall Study|Adverse Event|0|||
38080369|NCT04256629|69778104|FG004|Overall Study|Adverse Event|0|||
38080370|NCT04256629|69778105|FG005|Overall Study|Adverse Event|1|||
38080371|NCT04256629|69778100|FG000|Overall Study|Protocol Violation|0|||
38080372|NCT04256629|69778101|FG001|Overall Study|Protocol Violation|1|||
38080373|NCT04256629|69778102|FG002|Overall Study|Protocol Violation|0|||
38080374|NCT04256629|69778103|FG003|Overall Study|Protocol Violation|0|||
38080375|NCT04256629|69778104|FG004|Overall Study|Protocol Violation|0|||
38080376|NCT04256629|69778105|FG005|Overall Study|Protocol Violation|0|||
38080377|NCT01346293|69778115|FG000|Overall Study|Protocol Violation|30|||
38080378|NCT01346293|69778116|FG001|Overall Study|Protocol Violation|9|||
38080379|NCT01346293|69778115|FG000|Overall Study|Lost to Follow-up|21|||
38080380|NCT01346293|69778116|FG001|Overall Study|Lost to Follow-up|8|||
38080381|NCT01346293|69778115|FG000|Overall Study|Withdrawal by Subject|15|||
38080382|NCT01346293|69778116|FG001|Overall Study|Withdrawal by Subject|4|||
38080383|NCT01346293|69778115|FG000|Overall Study|Other|1|||
38080384|NCT01346293|69778116|FG001|Overall Study|Other|0|||
38080385|NCT03502187|69778127|FG000|Overall Study|Withdrawal by Subject|4|||
38080386|NCT03502187|69778128|FG001|Overall Study|Withdrawal by Subject|3|||
38080387|NCT03502187|69778129|FG002|Overall Study|Withdrawal by Subject|3|||
38080388|NCT03502187|69778127|FG000|Overall Study|Lost to Follow-up|5|||
38080389|NCT03502187|69778128|FG001|Overall Study|Lost to Follow-up|4|||
38080390|NCT03502187|69778129|FG002|Overall Study|Lost to Follow-up|5|||
38080391|NCT03058705|69778137|FG000|Overall Study|Withdrawal by Subject|2|||
38080392|NCT03058705|69778137|FG000|Overall Study|Physician Decision|2|||
38080393|NCT02998671|69778146|FG000|Period 1|Study Terminated By Sponsor|2|||
38080394|NCT02998671|69778147|FG001|Period 1|Study Terminated By Sponsor|1|||
38080395|NCT02998671|69778148|FG002|Period 1|Study Terminated By Sponsor|0|||
38080396|NCT02998671|69778149|FG003|Period 1|Study Terminated By Sponsor|0|||
38080397|NCT02998671|69778150|FG004|Period 1|Study Terminated By Sponsor|1|||
38080398|NCT02998671|69778146|FG000|Period 1|Withdrawal by Subject|1|||
38080399|NCT02998671|69778147|FG001|Period 1|Withdrawal by Subject|2|||
38080400|NCT02998671|69778148|FG002|Period 1|Withdrawal by Subject|0|||
38080401|NCT02998671|69778149|FG003|Period 1|Withdrawal by Subject|0|||
38080402|NCT02998671|69778150|FG004|Period 1|Withdrawal by Subject|2|||
37966709|NCT00467649|69653691|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
37966710|NCT00467649|69653692|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
37966711|NCT00467649|69653693|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
37966712|NCT00467649|69653694|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
37966713|NCT00467649|69653689|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
38080403|NCT02998671|69778146|FG000|Period 1|Pregnancy|1|||
38080404|NCT02998671|69778147|FG001|Period 1|Pregnancy|0|||
38080405|NCT02998671|69778148|FG002|Period 1|Pregnancy|0|||
38080406|NCT02998671|69778149|FG003|Period 1|Pregnancy|0|||
38080407|NCT02998671|69778150|FG004|Period 1|Pregnancy|0|||
38080408|NCT02998671|69778146|FG000|Period 1|Adverse Event|0|||
38080409|NCT02998671|69778147|FG001|Period 1|Adverse Event|0|||
38080410|NCT02998671|69778148|FG002|Period 1|Adverse Event|0|||
38080411|NCT02998671|69778149|FG003|Period 1|Adverse Event|0|||
38080412|NCT02998671|69778150|FG004|Period 1|Adverse Event|1|||
38080413|NCT02998671|69778146|FG000|Period 2|Adverse Event|0|||
38080414|NCT02998671|69778147|FG001|Period 2|Adverse Event|1|||
38080415|NCT02998671|69778148|FG002|Period 2|Adverse Event|0|||
38080416|NCT02998671|69778149|FG003|Period 2|Adverse Event|0|||
38080417|NCT02998671|69778150|FG004|Period 2|Adverse Event|0|||
38080418|NCT02998671|69778146|FG000|Period 2|Study Terminated By Sponsor|3|||
38080419|NCT02998671|69778147|FG001|Period 2|Study Terminated By Sponsor|5|||
38080420|NCT02998671|69778148|FG002|Period 2|Study Terminated By Sponsor|1|||
38080421|NCT02998671|69778149|FG003|Period 2|Study Terminated By Sponsor|3|||
38080422|NCT02998671|69778150|FG004|Period 2|Study Terminated By Sponsor|0|||
38080423|NCT02998671|69778146|FG000|Period 2|Withdrawal by Subject|0|||
38080424|NCT02998671|69778147|FG001|Period 2|Withdrawal by Subject|1|||
38080425|NCT02998671|69778148|FG002|Period 2|Withdrawal by Subject|0|||
38080426|NCT02998671|69778149|FG003|Period 2|Withdrawal by Subject|0|||
38080427|NCT02998671|69778150|FG004|Period 2|Withdrawal by Subject|0|||
38080428|NCT02998671|69778146|FG000|Period 2|Lost to Follow-up|0|||
38080429|NCT02998671|69778147|FG001|Period 2|Lost to Follow-up|0|||
38080430|NCT02998671|69778148|FG002|Period 2|Lost to Follow-up|0|||
38080431|NCT02998671|69778149|FG003|Period 2|Lost to Follow-up|1|||
38080432|NCT02998671|69778150|FG004|Period 2|Lost to Follow-up|0|||
38080433|NCT02660827|69778170|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
38080434|NCT02660827|69778170|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
38080435|NCT02660827|69778170|FG000|From Study to End of Continued Access|Adverse Event|3|||
38080436|NCT02660827|69778170|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
38080437|NCT02660827|69778170|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
38080438|NCT02660827|69778170|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
38080439|NCT02660827|69778170|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
38080440|NCT02660827|69778170|FG000|Period 2: Continued Access Period|Adverse Event|3|||
38080441|NCT01069419|69778191|FG000|Overall Study|Adverse Event|233|||
38080442|NCT01069419|69778191|FG000|Overall Study|Lack of Efficacy|332|||
38080443|NCT01069419|69778191|FG000|Overall Study|Lost to Follow-up|49|||
38080444|NCT01069419|69778191|FG000|Overall Study|Remission of disease|11|||
38080445|NCT01069419|69778191|FG000|Overall Study|Withdrawal by Subject|34|||
38080446|NCT01069419|69778191|FG000|Overall Study|Other Reason|43|||
38080447|NCT01069419|69778191|FG000|Overall Study|Missing termination information|13|||
38080448|NCT01069341|69778195|FG000|Overall Study|Lost to Follow-up|1|||
38080449|NCT02996097|69778199|FG000|Overall Study|Lost to Follow-up|11|||
38080450|NCT02996097|69778200|FG001|Overall Study|Lost to Follow-up|11|||
38080451|NCT02992899|69778207|FG000|Overall Study|Withdrawal by Subject|1|||
38080452|NCT02992899|69778208|FG001|Overall Study|Withdrawal by Subject|0|||
38080453|NCT02992899|69778207|FG000|Overall Study|Lost to Follow-up|1|||
38080454|NCT02992899|69778208|FG001|Overall Study|Lost to Follow-up|3|||
38080455|NCT01602484|69778216|FG000|Overall Study|Airway issues unrelated to study|0|||
38080456|NCT01602484|69778217|FG001|Overall Study|Airway issues unrelated to study|1|||
38080457|NCT02989389|69778237|FG000|Period 1|Lost to Follow-up|0|||
38080458|NCT02989389|69778238|FG001|Period 1|Lost to Follow-up|1|||
38080459|NCT02989389|69778239|FG002|Period 1|Lost to Follow-up|0|||
38080460|NCT02989389|69778240|FG003|Period 1|Lost to Follow-up|0|||
38080461|NCT02989389|69778241|FG004|Period 1|Lost to Follow-up|0|||
38080462|NCT02989389|69778242|FG005|Period 1|Lost to Follow-up|0|||
38080463|NCT02989389|69778243|FG006|Period 1|Lost to Follow-up|0|||
38080464|NCT02989389|69778244|FG007|Period 1|Lost to Follow-up|0|||
38080465|NCT02989389|69778245|FG008|Period 1|Lost to Follow-up|0|||
38080466|NCT02989389|69778246|FG009|Period 1|Lost to Follow-up|0|||
38080467|NCT02989389|69778237|FG000|Period 1|Physician Decision|0|||
38080468|NCT02989389|69778238|FG001|Period 1|Physician Decision|0|||
38080469|NCT02989389|69778239|FG002|Period 1|Physician Decision|0|||
38080470|NCT02989389|69778240|FG003|Period 1|Physician Decision|0|||
38080471|NCT02989389|69778241|FG004|Period 1|Physician Decision|0|||
38080472|NCT02989389|69778242|FG005|Period 1|Physician Decision|0|||
38080473|NCT02989389|69778243|FG006|Period 1|Physician Decision|0|||
38080474|NCT02989389|69778244|FG007|Period 1|Physician Decision|0|||
38080475|NCT02989389|69778245|FG008|Period 1|Physician Decision|1|||
38080476|NCT02989389|69778246|FG009|Period 1|Physician Decision|0|||
38080477|NCT02653300|69778286|FG000|Overall Study|Withdrawal by Subject|2|||
38080478|NCT01757665|69778292|FG000|Overall Study|Still on Study - Visit Completed|240|||
38080479|NCT01757665|69778293|FG001|Overall Study|Still on Study - Visit Completed|30|||
38080480|NCT01757665|69778292|FG000|Overall Study|Still on Study - Visit Pending|398|||
38080481|NCT01757665|69778293|FG001|Overall Study|Still on Study - Visit Pending|40|||
38080482|NCT01757665|69778292|FG000|Overall Study|Still on Study - Missed Visit|14|||
38080483|NCT01757665|69778293|FG001|Overall Study|Still on Study - Missed Visit|1|||
38080484|NCT01757665|69778292|FG000|Overall Study|Death|25|||
38080485|NCT01757665|69778293|FG001|Overall Study|Death|8|||
38080486|NCT01757665|69778292|FG000|Overall Study|Explant|1|||
38080487|NCT01757665|69778293|FG001|Overall Study|Explant|2|||
38080488|NCT01757665|69778292|FG000|Overall Study|Withdrawal by Subject|10|||
38080489|NCT01757665|69778293|FG001|Overall Study|Withdrawal by Subject|0|||
38080490|NCT01757665|69778292|FG000|Overall Study|Lost to Follow-up|1|||
38080491|NCT01757665|69778293|FG001|Overall Study|Lost to Follow-up|1|||
38080492|NCT01757665|69778292|FG000|Overall Study|Not Implanted with Device|5|||
38080493|NCT01757665|69778293|FG001|Overall Study|Not Implanted with Device|1|||
38080494|NCT00430508|69778318|FG000|Overall Study|Adverse Event|2|||
38080495|NCT00430508|69778319|FG001|Overall Study|Adverse Event|3|||
38080496|NCT00430508|69778320|FG002|Overall Study|Adverse Event|5|||
38080497|NCT00430508|69778321|FG003|Overall Study|Adverse Event|3|||
38080498|NCT00430508|69778318|FG000|Overall Study|Withdrawal by Subject|0|||
38080499|NCT00430508|69778319|FG001|Overall Study|Withdrawal by Subject|1|||
38080500|NCT00430508|69778320|FG002|Overall Study|Withdrawal by Subject|1|||
38080501|NCT00430508|69778321|FG003|Overall Study|Withdrawal by Subject|1|||
38080502|NCT00430508|69778318|FG000|Overall Study|responder at visit 4|0|||
38080503|NCT00430508|69778319|FG001|Overall Study|responder at visit 4|0|||
38080504|NCT00430508|69778320|FG002|Overall Study|responder at visit 4|2|||
38080505|NCT00430508|69778321|FG003|Overall Study|responder at visit 4|0|||
38080506|NCT00430508|69778318|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
38080507|NCT00430508|69778319|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
38080508|NCT00430508|69778320|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
38080509|NCT00430508|69778321|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
38080510|NCT00430508|69778318|FG000|Overall Study|Other|1|||
38080511|NCT00430508|69778319|FG001|Overall Study|Other|1|||
38080512|NCT00430508|69778320|FG002|Overall Study|Other|3|||
38080513|NCT00430508|69778321|FG003|Overall Study|Other|0|||
38080514|NCT02988219|69778329|FG000|Overall Study|Lack of Efficacy|1|||
38080515|NCT02988219|69778330|FG001|Overall Study|Lack of Efficacy|1|||
38080516|NCT02988219|69778329|FG000|Overall Study|Withdrawal by Subject|0|||
38080517|NCT02988219|69778330|FG001|Overall Study|Withdrawal by Subject|2|||
38080518|NCT01346059|69778338|FG000|Overall Study|Withdrawal by Subject|1|||
38080519|NCT01346059|69778339|FG001|Overall Study|Withdrawal by Subject|0|||
38080520|NCT01318915|69778345|FG000|Overall Study|Lost to Follow-up|1|||
38080521|NCT02987205|69778351|FG000|Overall Study|Adverse Event|1|||
38080522|NCT02987205|69778351|FG000|Overall Study|Withdrawal by Subject|3|||
38080523|NCT02926937|69778373|FG000|Overall Study|Adverse Event|0|||
38080524|NCT02926937|69778374|FG001|Overall Study|Adverse Event|1|||
38080525|NCT02926937|69778375|FG002|Overall Study|Adverse Event|1|||
38080526|NCT02926937|69778373|FG000|Overall Study|Poor Compliance to Protocol|1|||
38080527|NCT02926937|69778374|FG001|Overall Study|Poor Compliance to Protocol|0|||
38080528|NCT02926937|69778375|FG002|Overall Study|Poor Compliance to Protocol|0|||
38080529|NCT02926937|69778373|FG000|Overall Study|Lost to Follow-up|4|||
38080530|NCT02926937|69778374|FG001|Overall Study|Lost to Follow-up|5|||
37862470|NCT01127373|69546312|FG000|Overall Study|Lost to Follow-up|7|||
37862471|NCT01127373|69546312|FG000|Overall Study|Withdrawal by Subject|1|||
38080531|NCT02926937|69778375|FG002|Overall Study|Lost to Follow-up|0|||
38080532|NCT02926937|69778373|FG000|Overall Study|At the Participant's own Request|11|||
38080533|NCT02926937|69778374|FG001|Overall Study|At the Participant's own Request|5|||
38080534|NCT02926937|69778375|FG002|Overall Study|At the Participant's own Request|8|||
38080535|NCT02926937|69778373|FG000|Overall Study|Reason not Specified|3|||
38080536|NCT02926937|69778374|FG001|Overall Study|Reason not Specified|4|||
38080537|NCT02926937|69778375|FG002|Overall Study|Reason not Specified|2|||
38080538|NCT00151892|69778386|FG000|Overall Study|Lack of Efficacy|50|||
38080539|NCT00151892|69778387|FG001|Overall Study|Lack of Efficacy|57|||
37862472|NCT01127373|69546312|FG000|Overall Study|Disease progression|1|||
37680473|NCT02343939|69156096|FG000|Overall Study|Adverse Event|0|||
37680474|NCT02343939|69156097|FG001|Overall Study|Adverse Event|0|||
38080540|NCT00151892|69778386|FG000|Overall Study|Patient request|10|||
38080541|NCT00151892|69778387|FG001|Overall Study|Patient request|7|||
38080542|NCT00151892|69778386|FG000|Overall Study|Lost to Follow-up|5|||
38080543|NCT00151892|69778387|FG001|Overall Study|Lost to Follow-up|10|||
38080544|NCT00151892|69778386|FG000|Overall Study|Adverse Event|6|||
38080545|NCT00151892|69778387|FG001|Overall Study|Adverse Event|3|||
38080546|NCT00151892|69778386|FG000|Overall Study|Protocol Violation|3|||
38080547|NCT00151892|69778387|FG001|Overall Study|Protocol Violation|3|||
38080548|NCT00151892|69778386|FG000|Overall Study|Non-compliance|0|||
38080549|NCT00151892|69778387|FG001|Overall Study|Non-compliance|1|||
38080550|NCT00151892|69778386|FG000|Overall Study|Pregnancy|0|||
38080551|NCT00151892|69778387|FG001|Overall Study|Pregnancy|1|||
38080552|NCT00151892|69778386|FG000|Overall Study|Did not return for a visit|1|||
38080553|NCT00151892|69778387|FG001|Overall Study|Did not return for a visit|0|||
38080554|NCT00151892|69778386|FG000|Overall Study|Used prohibited corticosteroids|1|||
38080555|NCT00151892|69778387|FG001|Overall Study|Used prohibited corticosteroids|0|||
38080556|NCT00151892|69778386|FG000|Overall Study|Lack of study medication at center|0|||
38080557|NCT00151892|69778387|FG001|Overall Study|Lack of study medication at center|1|||
38080558|NCT03055195|69778411|FG000|Overall Study|Lack of Efficacy|1|||
38080559|NCT03055195|69778412|FG001|Overall Study|Lack of Efficacy|0|||
38080560|NCT03055195|69778411|FG000|Overall Study|Withdrawal by Subject|6|||
38080561|NCT03055195|69778412|FG001|Overall Study|Withdrawal by Subject|7|||
38080562|NCT03055195|69778411|FG000|Overall Study|Study Terminated by Sponsor|2|||
38080563|NCT03055195|69778412|FG001|Overall Study|Study Terminated by Sponsor|6|||
38080564|NCT03055195|69778411|FG000|Overall Study|Protocol Violation|2|||
38080565|NCT03055195|69778412|FG001|Overall Study|Protocol Violation|1|||
38080566|NCT03055195|69778411|FG000|Overall Study|Physician Decision|1|||
38080567|NCT03055195|69778412|FG001|Overall Study|Physician Decision|0|||
38080568|NCT02921919|69778420|FG000|Overall Study|Other|5|||
38080569|NCT02921919|69778421|FG001|Overall Study|Other|6|||
38080570|NCT02921919|69778420|FG000|Overall Study|Lost to Follow-up|0|||
38080571|NCT02921919|69778421|FG001|Overall Study|Lost to Follow-up|1|||
38080572|NCT02921919|69778420|FG000|Overall Study|Withdrawal by Subject|5|||
38080573|NCT02921919|69778421|FG001|Overall Study|Withdrawal by Subject|1|||
38080574|NCT02921919|69778420|FG000|Overall Study|Disease Progression|47|||
38080575|NCT02921919|69778421|FG001|Overall Study|Disease Progression|38|||
38080576|NCT02921919|69778420|FG000|Overall Study|Physician Decision|3|||
38080577|NCT02921919|69778421|FG001|Overall Study|Physician Decision|2|||
38080578|NCT02921919|69778420|FG000|Overall Study|Adverse Event|6|||
38080579|NCT02921919|69778421|FG001|Overall Study|Adverse Event|4|||
38080580|NCT02910219|69778443|FG000|Overall Study|Withdrawal by Subject|1|||
38080581|NCT02910219|69778444|FG001|Overall Study|Withdrawal by Subject|1|||
38080582|NCT01068717|69778450|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
38080583|NCT01068717|69778451|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
38080584|NCT01068717|69778452|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
38080585|NCT01068717|69778453|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
38080586|NCT02921763|69778467|FG000|Overall Study|Adverse Event|4|||
38080587|NCT02921763|69778467|FG000|Overall Study|Lost to Follow-up|4|||
38080588|NCT02921763|69778467|FG000|Overall Study|Lack of Efficacy|3|||
38080589|NCT02921763|69778467|FG000|Overall Study|Protocol Violation|2|||
38080590|NCT02921763|69778467|FG000|Overall Study|Withdrawal by Subject|2|||
38080591|NCT02921763|69778467|FG000|Overall Study|Physician Decision|1|||
38080592|NCT02921763|69778467|FG000|Overall Study|No data obtained|2|||
38080593|NCT01318135|69778489|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
38080594|NCT01318135|69778490|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
38080595|NCT01318135|69778491|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
38080596|NCT01318135|69778492|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
38080597|NCT01318135|69778493|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
38080598|NCT01318135|69778494|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
38080599|NCT01318135|69778495|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
38080600|NCT01318135|69778496|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
38080601|NCT01318135|69778489|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
38080602|NCT01318135|69778490|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
38080603|NCT01318135|69778491|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
38080604|NCT01318135|69778492|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
38080605|NCT01318135|69778493|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
38080606|NCT01318135|69778494|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
38080607|NCT01318135|69778495|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
38080608|NCT01318135|69778496|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
38080609|NCT01318135|69778489|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
37680475|NCT02343939|69156098|FG002|Overall Study|Adverse Event|0|||
38080610|NCT01318135|69778490|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
38080611|NCT01318135|69778491|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
38080612|NCT01318135|69778492|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
38080613|NCT01318135|69778493|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
38080614|NCT01318135|69778494|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
38080615|NCT01318135|69778495|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
38080616|NCT01318135|69778496|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
38080617|NCT01318135|69778489|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
38080618|NCT01318135|69778490|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
38080619|NCT01318135|69778491|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
38080620|NCT01318135|69778492|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
37966714|NCT00467649|69653690|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
38080621|NCT01318135|69778493|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
38080622|NCT01318135|69778494|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
38080623|NCT01318135|69778495|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
38080624|NCT01318135|69778496|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
38080625|NCT01318135|69778489|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
38080626|NCT01318135|69778490|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
38080627|NCT01318135|69778491|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
38080628|NCT01318135|69778492|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
38080629|NCT01318135|69778493|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
38080630|NCT01318135|69778494|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
38080631|NCT01318135|69778495|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
38080632|NCT01318135|69778496|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
37966715|NCT00467649|69653691|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
37966716|NCT00467649|69653692|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
37966717|NCT00467649|69653693|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
37966718|NCT00467649|69653694|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
37966719|NCT00467649|69653689|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
37966720|NCT00467649|69653690|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
37966721|NCT00467649|69653691|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
37966722|NCT00467649|69653692|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
37966723|NCT00467649|69653693|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
37966724|NCT00467649|69653694|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
37966725|NCT00467649|69653689|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
37966726|NCT00467649|69653690|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
37966727|NCT00467649|69653691|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
37966728|NCT00467649|69653692|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
37966729|NCT00467649|69653693|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
37966730|NCT00467649|69653694|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
37966731|NCT00467649|69653689|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
37966732|NCT00467649|69653690|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
37966733|NCT00467649|69653691|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
37966734|NCT00467649|69653692|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
37966735|NCT00467649|69653693|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
37966736|NCT00467649|69653694|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
37966737|NCT00450333|69653716|FG000|Overall Study|Study terminated|47|||
37966738|NCT00450333|69653717|FG001|Overall Study|Study terminated|54|||
37966739|NCT00450333|69653718|FG002|Overall Study|Study terminated|16|||
37966740|NCT00450333|69653719|FG003|Overall Study|Study terminated|21|||
37966741|NCT00450333|69653716|FG000|Overall Study|Adverse Event|1|||
37966742|NCT00450333|69653717|FG001|Overall Study|Adverse Event|7|||
37966743|NCT00450333|69653718|FG002|Overall Study|Adverse Event|2|||
37966744|NCT00450333|69653719|FG003|Overall Study|Adverse Event|2|||
37966745|NCT00450333|69653716|FG000|Overall Study|Protocol Violation|1|||
37966746|NCT00450333|69653717|FG001|Overall Study|Protocol Violation|0|||
37966747|NCT00450333|69653718|FG002|Overall Study|Protocol Violation|1|||
37966748|NCT00450333|69653719|FG003|Overall Study|Protocol Violation|0|||
37966749|NCT00450333|69653716|FG000|Overall Study|Withdrawal by Subject|1|||
37966750|NCT00450333|69653717|FG001|Overall Study|Withdrawal by Subject|0|||
37966751|NCT00450333|69653718|FG002|Overall Study|Withdrawal by Subject|3|||
37966752|NCT00450333|69653719|FG003|Overall Study|Withdrawal by Subject|0|||
37966753|NCT00450333|69653716|FG000|Overall Study|Kidney transplant|1|||
38080633|NCT01318135|69778489|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
38080634|NCT01318135|69778490|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
38080635|NCT01318135|69778491|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
38080636|NCT01318135|69778492|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
38080637|NCT01318135|69778493|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
38080638|NCT01318135|69778494|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
38080639|NCT01318135|69778495|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
37966754|NCT00450333|69653717|FG001|Overall Study|Kidney transplant|0|||
38080640|NCT01318135|69778496|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
38080641|NCT01318135|69778489|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
38080642|NCT01318135|69778490|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
38080643|NCT01318135|69778491|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
38080644|NCT01318135|69778492|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
38080645|NCT01318135|69778493|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
38080646|NCT01318135|69778494|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
38080647|NCT01318135|69778495|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
38080648|NCT01318135|69778496|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
38080649|NCT02922153|69778508|FG000|Overall Study|Death|8|||
38080650|NCT02922153|69778509|FG001|Overall Study|Death|1|||
38080651|NCT02922153|69778508|FG000|Overall Study|Lost to Follow-up|1|||
38080652|NCT02922153|69778509|FG001|Overall Study|Lost to Follow-up|0|||
38080653|NCT02922153|69778508|FG000|Overall Study|Physician Decision|1|||
38080654|NCT02922153|69778509|FG001|Overall Study|Physician Decision|1|||
38080655|NCT02920983|69778515|FG000|Dispense 1|Unacceptable Lens Fit|0|||
38080656|NCT02920983|69778516|FG001|Dispense 1|Unacceptable Lens Fit|0|||
38080657|NCT02920983|69778517|FG002|Dispense 1|Unacceptable Lens Fit|0|||
38080658|NCT02920983|69778518|FG003|Dispense 1|Unacceptable Lens Fit|0|||
38080659|NCT02920983|69778519|FG004|Dispense 1|Unacceptable Lens Fit|1|||
38080660|NCT02920983|69778520|FG005|Dispense 1|Unacceptable Lens Fit|0|||
38080661|NCT02920983|69778515|FG000|Dispense 2|Unscceptable lens fit|1|||
38080662|NCT02920983|69778516|FG001|Dispense 2|Unscceptable lens fit|0|||
38080663|NCT02920983|69778517|FG002|Dispense 2|Unscceptable lens fit|0|||
38080664|NCT02920983|69778518|FG003|Dispense 2|Unscceptable lens fit|0|||
38080665|NCT02920983|69778519|FG004|Dispense 2|Unscceptable lens fit|1|||
38080666|NCT02920983|69778520|FG005|Dispense 2|Unscceptable lens fit|0|||
38080667|NCT02920983|69778515|FG000|Dispense 3|Unacceptable Lens Fit|1|||
38080668|NCT02920983|69778516|FG001|Dispense 3|Unacceptable Lens Fit|1|||
38080669|NCT02920983|69778517|FG002|Dispense 3|Unacceptable Lens Fit|0|||
38080670|NCT02920983|69778518|FG003|Dispense 3|Unacceptable Lens Fit|0|||
38080671|NCT02920983|69778519|FG004|Dispense 3|Unacceptable Lens Fit|1|||
38080672|NCT02920983|69778520|FG005|Dispense 3|Unacceptable Lens Fit|0|||
38080673|NCT02654002|69778537|FG000|Overall Study|Adverse Event|0|||
38080674|NCT02654002|69778538|FG001|Overall Study|Adverse Event|0|||
38080675|NCT02654002|69778539|FG002|Overall Study|Adverse Event|0|||
38080676|NCT02654002|69778540|FG003|Overall Study|Adverse Event|0|||
38080677|NCT02654002|69778541|FG004|Overall Study|Adverse Event|0|||
38080678|NCT02654002|69778542|FG005|Overall Study|Adverse Event|0|||
38080679|NCT02654002|69778543|FG006|Overall Study|Adverse Event|1|||
38080680|NCT02654002|69778544|FG007|Overall Study|Adverse Event|0|||
38080681|NCT02654002|69778545|FG008|Overall Study|Adverse Event|0|||
38080682|NCT02654002|69778537|FG000|Overall Study|Withdrew Consent|0|||
38080683|NCT02654002|69778538|FG001|Overall Study|Withdrew Consent|0|||
38080684|NCT02654002|69778539|FG002|Overall Study|Withdrew Consent|0|||
38080685|NCT02654002|69778540|FG003|Overall Study|Withdrew Consent|0|||
38080686|NCT02654002|69778541|FG004|Overall Study|Withdrew Consent|0|||
38080687|NCT02654002|69778542|FG005|Overall Study|Withdrew Consent|1|||
38080688|NCT02654002|69778543|FG006|Overall Study|Withdrew Consent|0|||
38080689|NCT02654002|69778544|FG007|Overall Study|Withdrew Consent|1|||
38080690|NCT02654002|69778545|FG008|Overall Study|Withdrew Consent|0|||
38080691|NCT01675492|69778580|FG000|Overall Study|study completed early - product approval|42|||
38080692|NCT03924622|69778591|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
38080693|NCT03924622|69778592|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
38080694|NCT03924622|69778593|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
38080695|NCT03924622|69778594|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
38080696|NCT03924622|69778595|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
38080697|NCT03924622|69778596|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
38080698|NCT04044664|69778613|FG000|Stage 1|Adverse Event|3|||
38080699|NCT04044664|69778614|FG001|Stage 1|Adverse Event|3|||
38080700|NCT04044664|69778615|FG002|Stage 1|Adverse Event|1|||
38080701|NCT04044664|69778613|FG000|Stage 1|Lost to Follow-up|3|||
38080702|NCT04044664|69778614|FG001|Stage 1|Lost to Follow-up|2|||
38080703|NCT04044664|69778615|FG002|Stage 1|Lost to Follow-up|2|||
38080704|NCT04044664|69778613|FG000|Stage 1|Withdrawal by Subject|9|||
38080705|NCT04044664|69778614|FG001|Stage 1|Withdrawal by Subject|1|||
38080706|NCT04044664|69778615|FG002|Stage 1|Withdrawal by Subject|0|||
38080707|NCT04044664|69778613|FG000|Stage 1|noncompliance, personal reason|2|||
38080708|NCT04044664|69778614|FG001|Stage 1|noncompliance, personal reason|0|||
37966755|NCT00450333|69653718|FG002|Overall Study|Kidney transplant|1|||
37680476|NCT02343939|69156099|FG003|Overall Study|Adverse Event|0|||
38080709|NCT04044664|69778615|FG002|Stage 1|noncompliance, personal reason|0|||
38080710|NCT04044664|69778613|FG000|Stage 1|randomization error|0|||
38080711|NCT04044664|69778614|FG001|Stage 1|randomization error|1|||
38080712|NCT04044664|69778615|FG002|Stage 1|randomization error|0|||
38080713|NCT04044664|69778613|FG000|Stage 2|Adverse Event|2|||
38080714|NCT04044664|69778614|FG001|Stage 2|Adverse Event|0|||
38080715|NCT04044664|69778615|FG002|Stage 2|Adverse Event|0|||
38080716|NCT04044664|69778613|FG000|Stage 2|Lost to Follow-up|3|||
38080717|NCT04044664|69778614|FG001|Stage 2|Lost to Follow-up|2|||
38080718|NCT04044664|69778615|FG002|Stage 2|Lost to Follow-up|1|||
38080719|NCT04044664|69778613|FG000|Stage 2|Withdrawal by Subject|3|||
38080720|NCT04044664|69778614|FG001|Stage 2|Withdrawal by Subject|0|||
38080721|NCT04044664|69778615|FG002|Stage 2|Withdrawal by Subject|0|||
38080722|NCT04044664|69778613|FG000|Stage 2|protocol deviation|1|||
38080723|NCT04044664|69778614|FG001|Stage 2|protocol deviation|0|||
38080724|NCT04044664|69778615|FG002|Stage 2|protocol deviation|0|||
37966756|NCT00450333|69653719|FG003|Overall Study|Kidney transplant|3|||
38080725|NCT00150176|69778625|FG000|Overall Study|Adverse Event|16|||
38080726|NCT00150176|69778626|FG001|Overall Study|Adverse Event|53|||
38080727|NCT00150176|69778625|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
38080728|NCT00150176|69778626|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
37680477|NCT02343939|69156100|FG004|Overall Study|Adverse Event|0|||
37680478|NCT02343939|69156101|FG005|Overall Study|Adverse Event|1|||
37680479|NCT02343939|69156102|FG006|Overall Study|Adverse Event|0|||
38080729|NCT00150176|69778625|FG000|Overall Study|Withdrawal by Subject|19|||
38080730|NCT00150176|69778626|FG001|Overall Study|Withdrawal by Subject|12|||
38080731|NCT00150176|69778625|FG000|Overall Study|Lost to Follow-up|3|||
38080732|NCT00150176|69778626|FG001|Overall Study|Lost to Follow-up|3|||
38080733|NCT00150176|69778625|FG000|Overall Study|OTHER|11|||
38080734|NCT00150176|69778626|FG001|Overall Study|OTHER|13|||
38080735|NCT02985879|69778636|FG000|Overall Study|Adverse Event|7|||
38080736|NCT02985879|69778637|FG001|Overall Study|Adverse Event|9|||
38080737|NCT02985879|69778638|FG002|Overall Study|Adverse Event|7|||
38080738|NCT02985879|69778636|FG000|Overall Study|Withdrew consent|6|||
38080739|NCT02985879|69778637|FG001|Overall Study|Withdrew consent|8|||
38080740|NCT02985879|69778638|FG002|Overall Study|Withdrew consent|10|||
38080741|NCT02985879|69778636|FG000|Overall Study|Lost to Follow-up|1|||
38080742|NCT02985879|69778637|FG001|Overall Study|Lost to Follow-up|0|||
38080743|NCT02985879|69778638|FG002|Overall Study|Lost to Follow-up|2|||
38080744|NCT02985879|69778636|FG000|Overall Study|Other, not specified|62|||
38080745|NCT02985879|69778637|FG001|Overall Study|Other, not specified|58|||
38080746|NCT02985879|69778638|FG002|Overall Study|Other, not specified|58|||
38080747|NCT01067469|69778654|FG000|Overall Study|Withdrawal by Subject|0|||
37862473|NCT01127139|69546316|FG000|Overall Study|Adverse Event|40|||
38080748|NCT01067469|69778655|FG001|Overall Study|Withdrawal by Subject|1|||
38080749|NCT01067469|69778654|FG000|Overall Study|Disease Progression|0|||
38080750|NCT01067469|69778655|FG001|Overall Study|Disease Progression|1|||
38080751|NCT02985021|69778661|FG000|Overall Study|Inability to comply with study procedures|1|||
38080752|NCT01066923|69778669|FG000|Overall Study|Withdrawal by Subject|3|||
38080753|NCT01066923|69778670|FG001|Overall Study|Withdrawal by Subject|3|||
38080754|NCT01066923|69778671|FG002|Overall Study|Withdrawal by Subject|8|||
38080755|NCT01066923|69778672|FG003|Overall Study|Withdrawal by Subject|8|||
38080756|NCT02919267|69778697|FG000|Overall Study|Protocol Violation|0|||
38080757|NCT02919267|69778698|FG001|Overall Study|Protocol Violation|3|||
38080758|NCT02919267|69778699|FG002|Overall Study|Protocol Violation|3|||
38080759|NCT02919267|69778700|FG003|Overall Study|Protocol Violation|4|||
38080760|NCT01368900|69778710|FG000|Overall Study|Lost to Follow-up|7|||
38080761|NCT02910063|69778716|FG000|Phase 2|Withdrawal by Subject|3|||
38080762|NCT02910063|69778717|FG001|Phase 2|Withdrawal by Subject|0|||
38080763|NCT02910063|69778718|FG002|Phase 2|Withdrawal by Subject|0|||
38080764|NCT02910063|69778716|FG000|Phase 2|Lost to Follow-up|1|||
38080765|NCT02910063|69778717|FG001|Phase 2|Lost to Follow-up|0|||
38080766|NCT02910063|69778718|FG002|Phase 2|Lost to Follow-up|0|||
38080767|NCT02910063|69778716|FG000|Phase 2|Death|24|||
38080768|NCT02910063|69778717|FG001|Phase 2|Death|0|||
38080769|NCT02910063|69778718|FG002|Phase 2|Death|0|||
38080770|NCT02909907|69778729|FG000|Overall Study|Withdrawal by Subject|0|||
38080771|NCT02909907|69778730|FG001|Overall Study|Withdrawal by Subject|1|||
38080772|NCT02651194|69778736|FG000|Overall Study|Lost to Follow-up|3|||
38080773|NCT02651194|69778736|FG000|Overall Study|Other|2|||
38080774|NCT02907177|69778742|FG000|Overall Study|Death|0|||
38080775|NCT02907177|69778743|FG001|Overall Study|Death|1|||
38080776|NCT02907177|69778742|FG000|Overall Study|Physician Decision|3|||
38080777|NCT02907177|69778743|FG001|Overall Study|Physician Decision|3|||
38080778|NCT02907177|69778742|FG000|Overall Study|Withdrawal by Subject|15|||
38080779|NCT02907177|69778743|FG001|Overall Study|Withdrawal by Subject|7|||
38080780|NCT02907177|69778742|FG000|Overall Study|Sponsor's Decision|50|||
38080781|NCT02907177|69778743|FG001|Overall Study|Sponsor's Decision|57|||
38080782|NCT02652442|69778749|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
38080783|NCT02906709|69778763|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
38080784|NCT02906709|69778764|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
38080785|NCT02906709|69778763|FG000|Phase A (Week 0 to Week 16)|Death|0|||
38080786|NCT02906709|69778764|FG001|Phase A (Week 0 to Week 16)|Death|1|||
38080787|NCT02906709|69778763|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
38080788|NCT02906709|69778764|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
38080789|NCT02906709|69778763|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
38080790|NCT02906709|69778764|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
38080791|NCT00318656|69778778|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
38080792|NCT00318656|69778779|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
38080793|NCT00318656|69778778|FG000|Overall Study|Did not receive any treatment|0|||
38080794|NCT00318656|69778779|FG001|Overall Study|Did not receive any treatment|1|||
38080795|NCT02908347|69778785|FG000|Overall Study|Adverse Event|0|||
38080796|NCT02908347|69778786|FG001|Overall Study|Adverse Event|1|||
38080797|NCT02908347|69778785|FG000|Overall Study|Lost to Follow-up|1|||
38080798|NCT02908347|69778786|FG001|Overall Study|Lost to Follow-up|0|||
38080799|NCT02983305|69778808|FG000|Overall Study|incomplete data|2|||
38080800|NCT02983305|69778809|FG001|Overall Study|incomplete data|0|||
38080801|NCT03663166|69778815|FG000|Overall Study|Withdrawal by Subject|1|||
38080802|NCT02983227|69778822|FG000|Overall Study|Adverse Event|21|||
38080803|NCT02983227|69778823|FG001|Overall Study|Adverse Event|3|||
38080804|NCT02983227|69778822|FG000|Overall Study|Death|3|||
38080805|NCT02983227|69778823|FG001|Overall Study|Death|0|||
38080806|NCT02983227|69778822|FG000|Overall Study|Lack of Efficacy|8|||
38080807|NCT02983227|69778823|FG001|Overall Study|Lack of Efficacy|1|||
38080808|NCT02983227|69778822|FG000|Overall Study|Lost to Follow-up|3|||
38080809|NCT02983227|69778823|FG001|Overall Study|Lost to Follow-up|0|||
38080810|NCT02983227|69778822|FG000|Overall Study|Multiple Reasons|2|||
38080811|NCT02983227|69778823|FG001|Overall Study|Multiple Reasons|1|||
38080812|NCT02983227|69778822|FG000|Overall Study|Physician Decision|3|||
38080813|NCT02983227|69778823|FG001|Overall Study|Physician Decision|1|||
38080814|NCT02983227|69778822|FG000|Overall Study|Withdrawal by Subject|19|||
38080815|NCT02983227|69778823|FG001|Overall Study|Withdrawal by Subject|8|||
38080816|NCT00301262|69778831|FG000|Double Blind Phase (DB)|Adverse Event|1|||
38080817|NCT00301262|69778832|FG001|Double Blind Phase (DB)|Adverse Event|0|||
38080818|NCT00301262|69778831|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
38080819|NCT00301262|69778832|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
38080820|NCT00301262|69778831|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
38080821|NCT00301262|69778832|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
38080822|NCT00301262|69778831|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
38080823|NCT00301262|69778832|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
38080824|NCT00301262|69778831|FG000|Double Blind Phase (DB)|Other|1|||
38080825|NCT00301262|69778832|FG001|Double Blind Phase (DB)|Other|4|||
38080826|NCT00301262|69778831|FG000|Open Label Phase (OL)|Adverse Event|1|||
38080827|NCT00301262|69778832|FG001|Open Label Phase (OL)|Adverse Event|0|||
38080828|NCT00301262|69778831|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
38080829|NCT00301262|69778832|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
38080830|NCT00301262|69778831|FG000|Open Label Phase (OL)|Other|2|||
38080831|NCT00301262|69778832|FG001|Open Label Phase (OL)|Other|0|||
37680480|NCT02343939|69156103|FG007|Overall Study|Adverse Event|0|||
37680481|NCT02343939|69156104|FG008|Overall Study|Adverse Event|0|||
37680482|NCT02343939|69156096|FG000|Overall Study|Never Treated With ENTO|0|||
37680483|NCT02343939|69156097|FG001|Overall Study|Never Treated With ENTO|0|||
37680484|NCT02343939|69156098|FG002|Overall Study|Never Treated With ENTO|0|||
37680485|NCT02343939|69156099|FG003|Overall Study|Never Treated With ENTO|0|||
37680486|NCT02343939|69156100|FG004|Overall Study|Never Treated With ENTO|0|||
37680487|NCT02343939|69156101|FG005|Overall Study|Never Treated With ENTO|0|||
37680488|NCT02343939|69156102|FG006|Overall Study|Never Treated With ENTO|1|||
37680489|NCT02343939|69156103|FG007|Overall Study|Never Treated With ENTO|2|||
37680490|NCT02343939|69156104|FG008|Overall Study|Never Treated With ENTO|0|||
37680491|NCT02397447|69156140|FG000|Overall Study|Lost to Follow-up|2|||
37680492|NCT02397447|69156141|FG001|Overall Study|Lost to Follow-up|2|||
37680493|NCT02397057|69156149|FG000|Overall Study|Withdrawal by Subject|6|||
37680494|NCT02397057|69156150|FG001|Overall Study|Withdrawal by Subject|7|||
37680495|NCT02397057|69156149|FG000|Overall Study|Lost to Follow-up|4|||
37680496|NCT02397057|69156150|FG001|Overall Study|Lost to Follow-up|3|||
37680497|NCT02397057|69156149|FG000|Overall Study|Death|1|||
37680498|NCT02397057|69156150|FG001|Overall Study|Death|0|||
37680499|NCT02397057|69156149|FG000|Overall Study|Adverse Event|0|||
37680500|NCT02397057|69156150|FG001|Overall Study|Adverse Event|1|||
37680501|NCT02397057|69156149|FG000|Overall Study|Physician Decision|0|||
37680502|NCT02397057|69156150|FG001|Overall Study|Physician Decision|1|||
37680503|NCT02397057|69156149|FG000|Overall Study|Subject did not receive study drug|0|||
37680504|NCT02397057|69156150|FG001|Overall Study|Subject did not receive study drug|1|||
37680505|NCT02343549|69156156|FG000|Overall Study|Death|11|||
37680506|NCT02343549|69156156|FG000|Overall Study|Withdrawal by Subject|2|||
37680507|NCT02343159|69156163|FG000|Overall Study|Early Study Termination|16|||
37680508|NCT02343159|69156164|FG001|Overall Study|Early Study Termination|19|||
37680509|NCT02343159|69156165|FG002|Overall Study|Early Study Termination|23|||
37680510|NCT02343159|69156163|FG000|Overall Study|Physician Decision|2|||
37680511|NCT02343159|69156164|FG001|Overall Study|Physician Decision|0|||
37680512|NCT02343159|69156165|FG002|Overall Study|Physician Decision|1|||
37680513|NCT02343159|69156163|FG000|Overall Study|Withdrawal by Subject|3|||
37680514|NCT02343159|69156164|FG001|Overall Study|Withdrawal by Subject|0|||
37680515|NCT02343159|69156165|FG002|Overall Study|Withdrawal by Subject|2|||
37680516|NCT02343159|69156163|FG000|Overall Study|Lost to Follow-up|0|||
37680517|NCT02343159|69156164|FG001|Overall Study|Lost to Follow-up|2|||
37680518|NCT02343159|69156165|FG002|Overall Study|Lost to Follow-up|2|||
37680519|NCT02343159|69156163|FG000|Overall Study|Adverse Event|4|||
37680520|NCT02343159|69156164|FG001|Overall Study|Adverse Event|4|||
37680521|NCT02343159|69156165|FG002|Overall Study|Adverse Event|2|||
37680522|NCT02343159|69156163|FG000|Overall Study|Sponsor Decision|0|||
37862474|NCT01127139|69546316|FG000|Overall Study|Incompliance|12|||
37862475|NCT01127139|69546316|FG000|Overall Study|Lack of Efficacy|4|||
37862476|NCT01127139|69546316|FG000|Overall Study|Reason not specified|1|||
37862477|NCT01214616|69546327|FG000|Overall Study|Progressive disease|2|||
37862478|NCT01214616|69546328|FG001|Overall Study|Progressive disease|2|||
37862479|NCT01214616|69546329|FG002|Overall Study|Progressive disease|2|||
37862480|NCT01214616|69546330|FG003|Overall Study|Progressive disease|4|||
37862481|NCT01214616|69546327|FG000|Overall Study|Dose limiting toxicity|0|||
37862482|NCT01214616|69546328|FG001|Overall Study|Dose limiting toxicity|2|||
37862483|NCT01214616|69546329|FG002|Overall Study|Dose limiting toxicity|0|||
37862484|NCT01214616|69546330|FG003|Overall Study|Dose limiting toxicity|0|||
37862485|NCT01214616|69546327|FG000|Overall Study|Other adverse events|0|||
37862486|NCT01214616|69546328|FG001|Overall Study|Other adverse events|1|||
37862487|NCT01214616|69546329|FG002|Overall Study|Other adverse events|1|||
37862488|NCT01214616|69546330|FG003|Overall Study|Other adverse events|1|||
37862489|NCT01214616|69546327|FG000|Overall Study|Withdrawal by Subject|1|||
37862490|NCT01214616|69546328|FG001|Overall Study|Withdrawal by Subject|0|||
37862491|NCT01214616|69546329|FG002|Overall Study|Withdrawal by Subject|0|||
37862492|NCT01214616|69546330|FG003|Overall Study|Withdrawal by Subject|1|||
37862493|NCT01213836|69546350|FG000|Period 1, First Intervention|Adverse Event|2|||
37862494|NCT01213836|69546351|FG001|Period 1, First Intervention|Adverse Event|1|||
37862495|NCT01213836|69546350|FG000|Period 1, First Intervention|Protocol Violation|0|||
37862496|NCT01213836|69546351|FG001|Period 1, First Intervention|Protocol Violation|1|||
37966757|NCT00450333|69653716|FG000|Overall Study|Death|3|||
37862497|NCT01213836|69546350|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
37862498|NCT01213836|69546351|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
37862499|NCT01127061|69546362|FG000|Overall Study|Lost to Follow-up|7|||
37862500|NCT01127061|69546363|FG001|Overall Study|Lost to Follow-up|10|||
37862501|NCT01127061|69546362|FG000|Overall Study|Physician Decision|3|||
37862502|NCT01127061|69546363|FG001|Overall Study|Physician Decision|3|||
37862503|NCT00924703|69546369|FG000|Overall Study|Withdrawal by Subject|11|||
37862504|NCT00924703|69546369|FG000|Overall Study|Physician Decision|5|||
37862505|NCT00924703|69546369|FG000|Overall Study|Lost to Follow-up|3|||
37966758|NCT00450333|69653717|FG001|Overall Study|Death|2|||
38080832|NCT02905149|69778859|FG000|Overall Study|Lost to Follow-up|2|||
38080833|NCT02905149|69778860|FG001|Overall Study|Lost to Follow-up|0|||
38080834|NCT02790606|69778866|FG000|Overall Study|Death|27|||
38080835|NCT02790606|69778866|FG000|Overall Study|Lost to Follow-up|4|||
38080836|NCT02790606|69778866|FG000|Overall Study|Physician Decision|3|||
38080837|NCT02790606|69778866|FG000|Overall Study|Withdrawal by Subject|1|||
38080838|NCT03077620|69778874|FG000|Overall Study|Unable to place lumbar catheter|1|||
38080839|NCT03077620|69778875|FG001|Overall Study|Unable to place lumbar catheter|0|||
38080840|NCT03077620|69778876|FG002|Overall Study|Unable to place lumbar catheter|1|||
38080841|NCT03077620|69778877|FG003|Overall Study|Unable to place lumbar catheter|0|||
38080842|NCT03077620|69778874|FG000|Overall Study|Withdrawal by Subject|0|||
38080843|NCT03077620|69778875|FG001|Overall Study|Withdrawal by Subject|1|||
37862506|NCT00924703|69546369|FG000|Overall Study|Adverse Event|2|||
37966759|NCT00450333|69653718|FG002|Overall Study|Death|2|||
38080844|NCT03077620|69778876|FG002|Overall Study|Withdrawal by Subject|0|||
38080845|NCT03077620|69778877|FG003|Overall Study|Withdrawal by Subject|0|||
38080846|NCT03077620|69778874|FG000|Overall Study|Physician Decision|0|||
38080847|NCT03077620|69778875|FG001|Overall Study|Physician Decision|0|||
38080848|NCT03077620|69778876|FG002|Overall Study|Physician Decision|1|||
38080849|NCT03077620|69778877|FG003|Overall Study|Physician Decision|0|||
38080850|NCT02982213|69778898|FG000|Overall Study|Did not complete follow up questionnaire|5|||
38080851|NCT02982213|69778899|FG001|Overall Study|Did not complete follow up questionnaire|1|||
38080852|NCT02649634|69778907|FG000|Overall Study|Withdrawal by Subject|3|||
38080853|NCT02649634|69778908|FG001|Overall Study|Withdrawal by Subject|5|||
38080854|NCT02649634|69778907|FG000|Overall Study|Lost to Follow-up|0|||
38080855|NCT02649634|69778908|FG001|Overall Study|Lost to Follow-up|1|||
38080856|NCT01066143|69778914|FG000|Overall Study|ineligible for the study|8|||
38080857|NCT02980107|69778920|FG000|Overall Study|Withdrawal by Subject|51|||
38080858|NCT02980107|69778921|FG001|Overall Study|Withdrawal by Subject|62|||
38080859|NCT02652130|69778927|FG000|Overall Study|Death|1|||
38080860|NCT02979639|69778931|FG000|Overall Study|Withdrawal based on medical judgement|1|||
38080861|NCT02979639|69778931|FG000|Overall Study|Lost to Follow-up|8|||
38080862|NCT02979639|69778931|FG000|Overall Study|Withdrawal by Subject|3|||
38080863|NCT02979639|69778931|FG000|Overall Study|Adverse Event|2|||
38080864|NCT01674634|69778935|FG000|Overall Study|Withdrawal by Subject|3|||
38080865|NCT01674634|69778935|FG000|Overall Study|Lost to Follow-up|3|||
38080866|NCT02979249|69778943|FG000|Overall Study|Lost to Follow-up|2|||
38080867|NCT02979249|69778943|FG000|Overall Study|Withdrawal by Subject|4|||
38080868|NCT02112552|69778947|FG000|Overall Study|Withdrawal by Subject|1|||
37966760|NCT00450333|69653719|FG003|Overall Study|Death|2|||
38080869|NCT02112552|69778947|FG000|Overall Study|Adverse Event|1|||
38080870|NCT02976519|69778958|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
38080871|NCT02976519|69778959|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
37966761|NCT00643565|69653731|FG000|Overall Study|Death|12|||
38080872|NCT02976519|69778960|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
38080873|NCT02976519|69778961|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
38080874|NCT02976519|69778962|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
38080875|NCT02976519|69778963|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
38080876|NCT02976519|69778964|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
37680523|NCT02343159|69156164|FG001|Overall Study|Sponsor Decision|1|||
37966762|NCT00643565|69653732|FG001|Overall Study|Death|11|||
37966763|NCT00643565|69653731|FG000|Overall Study|Withdrawal by Subject|4|||
37680524|NCT02343159|69156165|FG002|Overall Study|Sponsor Decision|0|||
37680525|NCT02343159|69156163|FG000|Overall Study|Enrollment Error|1|||
37680526|NCT02343159|69156164|FG001|Overall Study|Enrollment Error|0|||
37966764|NCT00643565|69653732|FG001|Overall Study|Withdrawal by Subject|1|||
37966765|NCT00643565|69653731|FG000|Overall Study|Lost to Follow-up|0|||
37966766|NCT00643565|69653732|FG001|Overall Study|Lost to Follow-up|6|||
37966767|NCT00643565|69653731|FG000|Overall Study|Other|7|||
37966768|NCT00643565|69653732|FG001|Overall Study|Other|8|||
37966769|NCT00643565|69653731|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
37966770|NCT00643565|69653732|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
37966771|NCT00643565|69653731|FG000|Overall Study|Recurrence of Disease|2|||
37966772|NCT00643565|69653732|FG001|Overall Study|Recurrence of Disease|1|||
37680527|NCT02343159|69156165|FG002|Overall Study|Enrollment Error|0|||
37680528|NCT02395653|69156174|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
37680529|NCT02395653|69156174|FG000|Overall Study|Consent Withdrawn at Screening|1|||
37680530|NCT02395653|69156174|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
37680531|NCT02395653|69156174|FG000|Overall Study|Investigator Decision at Screening|1|||
37680532|NCT02395653|69156174|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
37680533|NCT02395653|69156174|FG000|Overall Study|Withdrawal by Subject|1|||
37680534|NCT02395653|69156174|FG000|Overall Study|Lost to Follow-up|1|||
37680535|NCT01664923|69156180|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
37680536|NCT01664923|69156181|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
37680537|NCT01664923|69156180|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
37680538|NCT01664923|69156181|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
37966773|NCT00643565|69653731|FG000|Overall Study|Progression of Disease|18|||
37966774|NCT00643565|69653732|FG001|Overall Study|Progression of Disease|14|||
37680539|NCT01664923|69156180|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
37680540|NCT01664923|69156181|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
37680541|NCT01664923|69156180|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
37680542|NCT01664923|69156181|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
37680543|NCT01664923|69156180|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
37680544|NCT01664923|69156181|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
37680545|NCT01664923|69156180|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
37680546|NCT01664923|69156181|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
37680547|NCT01664923|69156180|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
37680548|NCT01664923|69156181|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
37680549|NCT01664923|69156180|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
37680550|NCT01664923|69156181|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
37680551|NCT01664923|69156180|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
37680552|NCT01664923|69156181|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
37680553|NCT01664923|69156180|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
37680554|NCT01664923|69156181|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
37966775|NCT00643565|69653731|FG000|Overall Study|Protocol Violation|3|||
37966776|NCT00643565|69653732|FG001|Overall Study|Protocol Violation|0|||
37966777|NCT00643565|69653731|FG000|Overall Study|Did Not Cooperate|0|||
37966778|NCT00643565|69653732|FG001|Overall Study|Did Not Cooperate|1|||
37680555|NCT01664923|69156180|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
37680556|NCT01664923|69156181|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
37966779|NCT00643565|69653731|FG000|Overall Study|Administrative|22|||
38080877|NCT02976519|69778958|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
38080878|NCT02976519|69778959|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
38080879|NCT02976519|69778960|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
38080880|NCT02976519|69778961|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
38080881|NCT02976519|69778962|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
38080882|NCT02976519|69778963|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
38080883|NCT02976519|69778964|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
38080884|NCT02976519|69778958|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
38080885|NCT02976519|69778959|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
38080886|NCT02976519|69778960|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
38080887|NCT02976519|69778961|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
38080888|NCT02976519|69778962|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
38080889|NCT02976519|69778963|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
38080890|NCT02976519|69778964|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
38080891|NCT02976519|69778958|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
38080892|NCT02976519|69778959|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
38080893|NCT02976519|69778960|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
38080894|NCT02976519|69778961|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
38080895|NCT02976519|69778962|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
38080896|NCT02976519|69778963|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
38080897|NCT02976519|69778964|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
38080898|NCT02976519|69778958|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
38080899|NCT02976519|69778959|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
38080900|NCT02976519|69778960|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
38080901|NCT02976519|69778961|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
38080902|NCT02976519|69778962|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
38080903|NCT02976519|69778963|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
38080904|NCT02976519|69778964|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
38080905|NCT02975973|69779069|FG000|Overall Study|Adverse Event|1|||
38080906|NCT02975973|69779070|FG001|Overall Study|Adverse Event|1|||
38080907|NCT02975973|69779071|FG002|Overall Study|Adverse Event|1|||
38080908|NCT02975973|69779072|FG003|Overall Study|Adverse Event|0|||
38080909|NCT01362322|69779084|FG000|Overall Study|Withdrawal by Subject|3|||
38080910|NCT01362322|69779085|FG001|Overall Study|Withdrawal by Subject|1|||
38080911|NCT01362322|69779084|FG000|Overall Study|Lost to Follow-up|2|||
38080912|NCT01362322|69779085|FG001|Overall Study|Lost to Follow-up|6|||
38080913|NCT02918877|69779093|FG000|Overall Study|Withdrawal by Subject|2|||
38080914|NCT02918877|69779094|FG001|Overall Study|Withdrawal by Subject|2|||
38080915|NCT02918877|69779093|FG000|Overall Study|Surgery cancelled|1|||
38080916|NCT02918877|69779094|FG001|Overall Study|Surgery cancelled|0|||
38080917|NCT02918877|69779093|FG000|Overall Study|Physician Decision|1|||
37862507|NCT00924703|69546369|FG000|Overall Study|Withdrawal by Sponsor|1|||
38080918|NCT02918877|69779094|FG001|Overall Study|Physician Decision|0|||
38080919|NCT02918877|69779093|FG000|Overall Study|Received intraoperative steroids|1|||
38080920|NCT02918877|69779094|FG001|Overall Study|Received intraoperative steroids|0|||
38080921|NCT02918877|69779093|FG000|Overall Study|Unable to obtain lab samples|1|||
38080922|NCT02918877|69779094|FG001|Overall Study|Unable to obtain lab samples|0|||
38080923|NCT02918877|69779093|FG000|Overall Study|Unsafe to perform BAL|0|||
38080924|NCT02918877|69779094|FG001|Overall Study|Unsafe to perform BAL|1|||
38080925|NCT01674712|69779105|FG000|Overall Study|Adverse Event|5|||
38080926|NCT01674712|69779106|FG001|Overall Study|Adverse Event|6|||
38080927|NCT01674712|69779107|FG002|Overall Study|Adverse Event|3|||
38080928|NCT01674712|69779108|FG003|Overall Study|Adverse Event|4|||
38080929|NCT01674712|69779109|FG004|Overall Study|Adverse Event|6|||
38080930|NCT01674712|69779105|FG000|Overall Study|Lost to Follow-up|1|||
38080931|NCT01674712|69779106|FG001|Overall Study|Lost to Follow-up|0|||
38080932|NCT01674712|69779107|FG002|Overall Study|Lost to Follow-up|0|||
38080933|NCT01674712|69779108|FG003|Overall Study|Lost to Follow-up|0|||
38080934|NCT01674712|69779109|FG004|Overall Study|Lost to Follow-up|0|||
38080935|NCT01674712|69779105|FG000|Overall Study|Protocol Violation|2|||
38080936|NCT01674712|69779106|FG001|Overall Study|Protocol Violation|0|||
38080937|NCT01674712|69779107|FG002|Overall Study|Protocol Violation|0|||
38080938|NCT01674712|69779108|FG003|Overall Study|Protocol Violation|0|||
38080939|NCT01674712|69779109|FG004|Overall Study|Protocol Violation|0|||
38080940|NCT01674712|69779105|FG000|Overall Study|Withdrawal by Subject|2|||
38080941|NCT01674712|69779106|FG001|Overall Study|Withdrawal by Subject|2|||
38080942|NCT01674712|69779107|FG002|Overall Study|Withdrawal by Subject|5|||
38080943|NCT01674712|69779108|FG003|Overall Study|Withdrawal by Subject|4|||
38080944|NCT01674712|69779109|FG004|Overall Study|Withdrawal by Subject|3|||
38080945|NCT01674712|69779105|FG000|Overall Study|Administrative|0|||
38080946|NCT01674712|69779106|FG001|Overall Study|Administrative|1|||
38080947|NCT01674712|69779107|FG002|Overall Study|Administrative|0|||
38080948|NCT01674712|69779108|FG003|Overall Study|Administrative|0|||
38080949|NCT01674712|69779109|FG004|Overall Study|Administrative|1|||
38080950|NCT01674712|69779105|FG000|Overall Study|Lack of Efficacy|0|||
38080951|NCT01674712|69779106|FG001|Overall Study|Lack of Efficacy|0|||
38080952|NCT01674712|69779107|FG002|Overall Study|Lack of Efficacy|1|||
38080953|NCT01674712|69779108|FG003|Overall Study|Lack of Efficacy|0|||
38080954|NCT01674712|69779109|FG004|Overall Study|Lack of Efficacy|1|||
38080955|NCT01368432|69779123|FG000|Overall Study|Lost to Follow-up|0|||
38080956|NCT01368432|69779124|FG001|Overall Study|Lost to Follow-up|1|||
38080957|NCT01063881|69779147|FG000|Overall Study|Adverse Event|12|||
38080958|NCT01063881|69779148|FG001|Overall Study|Adverse Event|2|||
38080959|NCT01063881|69779149|FG002|Overall Study|Adverse Event|0|||
38080960|NCT01063881|69779147|FG000|Overall Study|Lost to Follow-up|13|||
38080961|NCT01063881|69779148|FG001|Overall Study|Lost to Follow-up|7|||
38080962|NCT01063881|69779149|FG002|Overall Study|Lost to Follow-up|1|||
38080963|NCT01063881|69779147|FG000|Overall Study|Withdrawal by Subject|25|||
38080964|NCT01063881|69779148|FG001|Overall Study|Withdrawal by Subject|1|||
38080965|NCT01063881|69779149|FG002|Overall Study|Withdrawal by Subject|0|||
38080966|NCT01063881|69779147|FG000|Overall Study|Reason for not completed not specified|5|||
38080967|NCT01063881|69779148|FG001|Overall Study|Reason for not completed not specified|1|||
38080968|NCT01063881|69779149|FG002|Overall Study|Reason for not completed not specified|0|||
38080969|NCT01062555|69779166|FG000|Phase 1|Death|10|||
38080970|NCT01062555|69779167|FG001|Phase 1|Death|17|||
38080971|NCT01062555|69779168|FG002|Phase 1|Death|0|||
38080972|NCT01062555|69779169|FG003|Phase 1|Death|0|||
38080973|NCT01062555|69779166|FG000|Phase 1|Graft Failure|12|||
38080974|NCT01062555|69779167|FG001|Phase 1|Graft Failure|8|||
38080975|NCT01062555|69779168|FG002|Phase 1|Graft Failure|0|||
38080976|NCT01062555|69779169|FG003|Phase 1|Graft Failure|0|||
38080977|NCT01062555|69779166|FG000|Phase 1|Withdrawal by Subject|1|||
38080978|NCT01062555|69779167|FG001|Phase 1|Withdrawal by Subject|1|||
38080979|NCT01062555|69779168|FG002|Phase 1|Withdrawal by Subject|0|||
38080980|NCT01062555|69779169|FG003|Phase 1|Withdrawal by Subject|0|||
38080981|NCT01062555|69779166|FG000|Phase 2|Death|0|||
38080982|NCT01062555|69779167|FG001|Phase 2|Death|0|||
38080983|NCT01062555|69779168|FG002|Phase 2|Death|8|||
38080984|NCT01062555|69779169|FG003|Phase 2|Death|3|||
38080985|NCT01062555|69779166|FG000|Phase 2|Graft failure|0|||
38080986|NCT01062555|69779167|FG001|Phase 2|Graft failure|0|||
38080987|NCT01062555|69779168|FG002|Phase 2|Graft failure|7|||
38080988|NCT01062555|69779169|FG003|Phase 2|Graft failure|4|||
38080989|NCT01062555|69779166|FG000|Phase 2|Withdrawal by Subject|0|||
38080990|NCT01062555|69779167|FG001|Phase 2|Withdrawal by Subject|0|||
38080991|NCT01062555|69779168|FG002|Phase 2|Withdrawal by Subject|0|||
38080992|NCT01062555|69779169|FG003|Phase 2|Withdrawal by Subject|7|||
38080993|NCT01062555|69779166|FG000|Phase 2|Protocol Violation|0|||
38080994|NCT01062555|69779167|FG001|Phase 2|Protocol Violation|0|||
38080995|NCT01062555|69779168|FG002|Phase 2|Protocol Violation|0|||
38080996|NCT01062555|69779169|FG003|Phase 2|Protocol Violation|3|||
38080997|NCT01062555|69779166|FG000|Phase 2|Physician Decision|0|||
38080998|NCT01062555|69779167|FG001|Phase 2|Physician Decision|0|||
38080999|NCT01062555|69779168|FG002|Phase 2|Physician Decision|0|||
38081000|NCT01062555|69779169|FG003|Phase 2|Physician Decision|17|||
38081001|NCT01064817|69779181|FG000|Study Completion|Physician Decision|1|||
38081002|NCT01064817|69779182|FG001|Study Completion|Physician Decision|0|||
38081003|NCT01064817|69779181|FG000|Study Completion|Withdrawal by Subject|1|||
38081004|NCT01064817|69779182|FG001|Study Completion|Withdrawal by Subject|0|||
38081005|NCT01368276|69779190|FG000|Overall Study|Death|1|||
38081006|NCT01368276|69779191|FG001|Overall Study|Death|10|||
38081007|NCT01064739|69779197|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
38081008|NCT01061775|69779207|FG000|Overall Study|Physician Decision|2|||
38081009|NCT01061775|69779207|FG000|Overall Study|Lost to Follow-up|1|||
38081010|NCT02651116|69779214|FG000|Overall Study|Adverse Event|0|||
38081011|NCT02651116|69779215|FG001|Overall Study|Adverse Event|1|||
38081012|NCT02651116|69779214|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
38081013|NCT02651116|69779215|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
38081014|NCT01061385|69779223|FG000|Overall Study|Lost to Follow-up|1|||
38081015|NCT01061385|69779224|FG001|Overall Study|Lost to Follow-up|0|||
38081016|NCT01061385|69779223|FG000|Overall Study|subject decision not related to AE|0|||
38081017|NCT01061385|69779224|FG001|Overall Study|subject decision not related to AE|1|||
38081018|NCT02973477|69779233|FG000|First Intervention|Lost to Follow-up|0|||
37966780|NCT00643565|69653732|FG001|Overall Study|Administrative|16|||
37966781|NCT00643565|69653731|FG000|Overall Study|Adverse Event|5|||
37966782|NCT00643565|69653732|FG001|Overall Study|Adverse Event|8|||
37966783|NCT00643487|69653739|FG000|Overall Study|Technical difficulty|3|||
37966784|NCT00450255|69653743|FG000|Overall Study|Prior RFA ablation of liver|1|||
37966785|NCT00450177|69653750|FG000|Overall Study|Adverse Event|7|||
37966786|NCT00450177|69653751|FG001|Overall Study|Adverse Event|4|||
37966787|NCT00450177|69653750|FG000|Overall Study|Withdrawal by Subject|1|||
37966788|NCT00450177|69653751|FG001|Overall Study|Withdrawal by Subject|6|||
37966789|NCT00450177|69653750|FG000|Overall Study|Withdrawal by Primary Team|1|||
37966790|NCT00450177|69653751|FG001|Overall Study|Withdrawal by Primary Team|1|||
37966791|NCT03848949|69653759|FG000|Overall Study|Lost to Follow-up|5|||
37966792|NCT03848949|69653760|FG001|Overall Study|Lost to Follow-up|7|||
37966793|NCT00467259|69653768|FG000|Overall Study|Adverse Event|24|||
37966794|NCT00467259|69653769|FG001|Overall Study|Adverse Event|90|||
37966795|NCT00467259|69653768|FG000|Overall Study|Protocol Violation|1|||
37966796|NCT00467259|69653769|FG001|Overall Study|Protocol Violation|7|||
37966797|NCT00467259|69653768|FG000|Overall Study|Withdrawal by Subject|34|||
37966798|NCT00467259|69653769|FG001|Overall Study|Withdrawal by Subject|108|||
37966799|NCT00467259|69653768|FG000|Overall Study|Physician Decision|0|||
37966800|NCT00467259|69653769|FG001|Overall Study|Physician Decision|2|||
37966801|NCT00467259|69653768|FG000|Overall Study|Lost to Follow-up|14|||
37966802|NCT00467259|69653769|FG001|Overall Study|Lost to Follow-up|34|||
37966803|NCT00467259|69653768|FG000|Overall Study|Site Closed|2|||
37966804|NCT00467259|69653769|FG001|Overall Study|Site Closed|1|||
37966805|NCT00449865|69653777|FG000|Overall Study|Withdrawal by Subject|110|||
37966806|NCT00449865|69653778|FG001|Overall Study|Withdrawal by Subject|110|||
37966807|NCT00449865|69653777|FG000|Overall Study|Lost to Follow-up|36|||
37966808|NCT00449865|69653778|FG001|Overall Study|Lost to Follow-up|37|||
37966809|NCT00449865|69653777|FG000|Overall Study|Physician Decision|13|||
37966810|NCT00449865|69653778|FG001|Overall Study|Physician Decision|12|||
37966811|NCT00449865|69653777|FG000|Overall Study|Death|31|||
37966812|NCT00449865|69653778|FG001|Overall Study|Death|40|||
37966813|NCT00449865|69653777|FG000|Overall Study|Protocol Violation|8|||
37966814|NCT00449865|69653778|FG001|Overall Study|Protocol Violation|7|||
37966815|NCT00449865|69653777|FG000|Overall Study|Study was stopped|324|||
37966816|NCT00449865|69653778|FG001|Overall Study|Study was stopped|328|||
37966817|NCT00449787|69653786|FG000|Overall Study|Lost to Follow-up|10|||
37966818|NCT00449787|69653787|FG001|Overall Study|Lost to Follow-up|8|||
37966819|NCT00449787|69653786|FG000|Overall Study|Did not require medication|95|||
37680557|NCT01664923|69156180|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
37680558|NCT01664923|69156181|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
37680559|NCT01664923|69156180|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
37680560|NCT01664923|69156181|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
37680561|NCT01664923|69156180|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
37680562|NCT01664923|69156181|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
37699577|NCT02011893|69176451|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
37699578|NCT02011893|69176449|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
38081019|NCT02973477|69779234|FG001|First Intervention|Lost to Follow-up|2|||
38081020|NCT02973477|69779233|FG000|Washout|Withdrawal by Subject|1|||
38081021|NCT02973477|69779234|FG001|Washout|Withdrawal by Subject|0|||
38081022|NCT02973477|69779233|FG000|Second Intervention|Lost to Follow-up|1|||
38081023|NCT02973477|69779234|FG001|Second Intervention|Lost to Follow-up|0|||
38081024|NCT02788656|69779248|FG000|Overall Study|Withdrawal by Subject|1|||
38081025|NCT02788656|69779249|FG001|Overall Study|Withdrawal by Subject|0|||
38081026|NCT00283868|69779257|FG000|Overall Study|Lost to Follow-up|7|||
38081027|NCT00283868|69779258|FG001|Overall Study|Lost to Follow-up|8|||
38081028|NCT02973087|69779264|FG000|Overall Study|Withdrawal by Subject|2|||
38081029|NCT02973087|69779265|FG001|Overall Study|Withdrawal by Subject|1|||
38081030|NCT02973087|69779264|FG000|Overall Study|Adverse Event|1|||
38081031|NCT02973087|69779265|FG001|Overall Study|Adverse Event|0|||
38081032|NCT02973087|69779264|FG000|Overall Study|other|1|||
38081033|NCT02973087|69779265|FG001|Overall Study|other|1|||
38081034|NCT00271544|69779285|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
38081035|NCT00271544|69779285|FG000|Overall Study|Model 4196 lead not attempted|9|||
38081036|NCT00271544|69779285|FG000|Overall Study|Implant not attempted|4|||
38081037|NCT05342532|69779303|FG000|Overall Study|Adverse Event|5|||
38081038|NCT05342532|69779304|FG001|Overall Study|Adverse Event|20|||
38081039|NCT05342532|69779303|FG000|Overall Study|Lost to Follow-up|10|||
38081040|NCT05342532|69779304|FG001|Overall Study|Lost to Follow-up|15|||
38081041|NCT02984943|69779310|FG000|Overall Study|Withdrawal by Subject|3|||
38081042|NCT02984943|69779310|FG000|Overall Study|Physician Decision|1|||
38081043|NCT02787408|69779314|FG000|Overall Study|Death|16|||
38081044|NCT02787408|69779314|FG000|Overall Study|Withdrawal by Subject|1|||
38081045|NCT02787408|69779314|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
38081046|NCT02971605|69779318|FG000|Overall Study|Withdrawal by Subject|1|||
38081047|NCT03054337|69779330|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
38081048|NCT03054337|69779331|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
38081049|NCT03054337|69779332|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
38081050|NCT03054337|69779333|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
38081051|NCT03054337|69779334|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
38081052|NCT03054337|69779335|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
38081053|NCT01060059|69779368|FG000|Overall Study|Adverse Event|1|||
38081054|NCT01060059|69779369|FG001|Overall Study|Adverse Event|1|||
38081055|NCT01060059|69779368|FG000|Overall Study|Death|2|||
38081056|NCT01060059|69779369|FG001|Overall Study|Death|3|||
38081057|NCT01060059|69779368|FG000|Overall Study|Lost to Follow-up|18|||
38081058|NCT01060059|69779369|FG001|Overall Study|Lost to Follow-up|34|||
38081059|NCT01060059|69779368|FG000|Overall Study|entry criteria not met|4|||
38081060|NCT01060059|69779369|FG001|Overall Study|entry criteria not met|3|||
38081061|NCT01060059|69779368|FG000|Overall Study|Withdrawal by Subject|35|||
38081062|NCT01060059|69779369|FG001|Overall Study|Withdrawal by Subject|23|||
38081063|NCT01060059|69779368|FG000|Overall Study|lack of glycemic control|2|||
38081064|NCT01060059|69779369|FG001|Overall Study|lack of glycemic control|1|||
38081065|NCT01060059|69779368|FG000|Overall Study|lack of compliance|5|||
38081066|NCT01060059|69779369|FG001|Overall Study|lack of compliance|2|||
38081067|NCT02648932|69779383|FG000|Overall Study|No transplant|3|||
38081068|NCT02648932|69779384|FG001|Overall Study|No transplant|1|||
38081069|NCT02122458|69779397|FG000|Overall Study|Withdrawal by Subject|0|||
38081070|NCT02122458|69779398|FG001|Overall Study|Withdrawal by Subject|0|||
38081071|NCT02122458|69779399|FG002|Overall Study|Withdrawal by Subject|0|||
38081072|NCT02122458|69779400|FG003|Overall Study|Withdrawal by Subject|4|||
38081073|NCT02122458|69779401|FG004|Overall Study|Withdrawal by Subject|4|||
38081074|NCT02122458|69779402|FG005|Overall Study|Withdrawal by Subject|4|||
38081075|NCT02122458|69779403|FG006|Overall Study|Withdrawal by Subject|0|||
38081076|NCT02122458|69779397|FG000|Overall Study|Lost to Follow-up|1|||
38081077|NCT02122458|69779398|FG001|Overall Study|Lost to Follow-up|3|||
38081078|NCT02122458|69779399|FG002|Overall Study|Lost to Follow-up|0|||
38081079|NCT02122458|69779400|FG003|Overall Study|Lost to Follow-up|7|||
38081080|NCT02122458|69779401|FG004|Overall Study|Lost to Follow-up|5|||
38081081|NCT02122458|69779402|FG005|Overall Study|Lost to Follow-up|15|||
38081082|NCT02122458|69779403|FG006|Overall Study|Lost to Follow-up|1|||
38081083|NCT02122458|69779397|FG000|Overall Study|Did not qualify at initial testing or after chart review|1|||
38081084|NCT02122458|69779398|FG001|Overall Study|Did not qualify at initial testing or after chart review|0|||
37680563|NCT01664533|69156191|FG000|Overall Study|Death|42|||
37680564|NCT01664533|69156191|FG000|Overall Study|Lost to Follow-up|3|||
37680565|NCT01664533|69156191|FG000|Overall Study|Study termination|9|||
37680566|NCT01664533|69156191|FG000|Overall Study|Protocol Violation|3|||
37680567|NCT02584855|69156196|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
37680568|NCT02584855|69156197|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
37680569|NCT02584855|69156198|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
37680570|NCT02584855|69156199|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
37680571|NCT02584855|69156200|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
37680572|NCT02584855|69156201|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
37680573|NCT02584855|69156196|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
37680574|NCT02584855|69156197|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
37680575|NCT02584855|69156198|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
37680576|NCT02584855|69156199|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
37680577|NCT02584855|69156200|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
37680578|NCT02584855|69156201|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
37680579|NCT02584855|69156196|FG000|Open-Label Treatment Period|Adverse Event|14|||
37680580|NCT02584855|69156197|FG001|Open-Label Treatment Period|Adverse Event|0|||
37680581|NCT02584855|69156198|FG002|Open-Label Treatment Period|Adverse Event|0|||
37680582|NCT02584855|69156199|FG003|Open-Label Treatment Period|Adverse Event|0|||
37680583|NCT02584855|69156200|FG004|Open-Label Treatment Period|Adverse Event|0|||
37680584|NCT02584855|69156201|FG005|Open-Label Treatment Period|Adverse Event|0|||
38081085|NCT02122458|69779399|FG002|Overall Study|Did not qualify at initial testing or after chart review|0|||
38081086|NCT02122458|69779400|FG003|Overall Study|Did not qualify at initial testing or after chart review|0|||
38081087|NCT02122458|69779401|FG004|Overall Study|Did not qualify at initial testing or after chart review|0|||
38081088|NCT02122458|69779402|FG005|Overall Study|Did not qualify at initial testing or after chart review|0|||
38081089|NCT02122458|69779403|FG006|Overall Study|Did not qualify at initial testing or after chart review|0|||
38081090|NCT02122458|69779397|FG000|Overall Study|Adverse Event|1|||
37680585|NCT02584855|69156196|FG000|Open-Label Treatment Period|Death|2|||
37680586|NCT02584855|69156197|FG001|Open-Label Treatment Period|Death|0|||
38081091|NCT02122458|69779398|FG001|Overall Study|Adverse Event|0|||
38081092|NCT02122458|69779399|FG002|Overall Study|Adverse Event|0|||
38081093|NCT02122458|69779400|FG003|Overall Study|Adverse Event|0|||
38081094|NCT02122458|69779401|FG004|Overall Study|Adverse Event|0|||
38081095|NCT02122458|69779402|FG005|Overall Study|Adverse Event|0|||
38081096|NCT02122458|69779403|FG006|Overall Study|Adverse Event|0|||
38081097|NCT02122458|69779397|FG000|Overall Study|Experimental Error|0|||
38081098|NCT02122458|69779398|FG001|Overall Study|Experimental Error|0|||
38081099|NCT02122458|69779399|FG002|Overall Study|Experimental Error|0|||
38081100|NCT02122458|69779400|FG003|Overall Study|Experimental Error|0|||
38081101|NCT02122458|69779401|FG004|Overall Study|Experimental Error|3|||
38081102|NCT02122458|69779402|FG005|Overall Study|Experimental Error|0|||
38081103|NCT02122458|69779403|FG006|Overall Study|Experimental Error|0|||
38081104|NCT02122458|69779397|FG000|Overall Study|Deployed or Moved|0|||
38081105|NCT02122458|69779398|FG001|Overall Study|Deployed or Moved|0|||
38081106|NCT02122458|69779399|FG002|Overall Study|Deployed or Moved|0|||
38081107|NCT02122458|69779400|FG003|Overall Study|Deployed or Moved|0|||
38081108|NCT02122458|69779401|FG004|Overall Study|Deployed or Moved|1|||
38081109|NCT02122458|69779402|FG005|Overall Study|Deployed or Moved|0|||
38081110|NCT02122458|69779403|FG006|Overall Study|Deployed or Moved|0|||
38081111|NCT02122458|69779397|FG000|Overall Study|Scheduling Delays - Unable to Complete|0|||
38081112|NCT02122458|69779398|FG001|Overall Study|Scheduling Delays - Unable to Complete|1|||
38081113|NCT02122458|69779399|FG002|Overall Study|Scheduling Delays - Unable to Complete|0|||
38081114|NCT02122458|69779400|FG003|Overall Study|Scheduling Delays - Unable to Complete|4|||
37680587|NCT02584855|69156198|FG002|Open-Label Treatment Period|Death|0|||
38081115|NCT02122458|69779401|FG004|Overall Study|Scheduling Delays - Unable to Complete|1|||
38081116|NCT02122458|69779402|FG005|Overall Study|Scheduling Delays - Unable to Complete|1|||
38081117|NCT02122458|69779403|FG006|Overall Study|Scheduling Delays - Unable to Complete|0|||
37680588|NCT02584855|69156199|FG003|Open-Label Treatment Period|Death|0|||
37680589|NCT02584855|69156200|FG004|Open-Label Treatment Period|Death|0|||
37680590|NCT02584855|69156201|FG005|Open-Label Treatment Period|Death|0|||
37680591|NCT02584855|69156196|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
38081118|NCT02122458|69779397|FG000|Overall Study|Noncompliance|0|||
38081119|NCT02122458|69779398|FG001|Overall Study|Noncompliance|1|||
38081120|NCT02122458|69779399|FG002|Overall Study|Noncompliance|0|||
38081121|NCT02122458|69779400|FG003|Overall Study|Noncompliance|0|||
38081122|NCT02122458|69779401|FG004|Overall Study|Noncompliance|0|||
38081123|NCT02122458|69779402|FG005|Overall Study|Noncompliance|0|||
38081124|NCT02122458|69779403|FG006|Overall Study|Noncompliance|0|||
38081125|NCT02903511|69779419|FG000|Overall Study|Withdrawal by Subject|1|||
38081126|NCT02903511|69779420|FG001|Overall Study|Withdrawal by Subject|0|||
38081127|NCT02903511|69779419|FG000|Overall Study|Lost to Follow-up|3|||
38081128|NCT02903511|69779420|FG001|Overall Study|Lost to Follow-up|2|||
38081129|NCT01368042|69779437|FG000|Overall Study|Death|14|||
38081130|NCT01368042|69779437|FG000|Overall Study|Protocol Violation|11|||
38081131|NCT01368042|69779437|FG000|Overall Study|Lost to Follow-up|4|||
38081132|NCT01368042|69779437|FG000|Overall Study|Transplanted|1|||
38081133|NCT00126776|69779443|FG000|Overall Study|follow up complete on all patients|0|||
38081134|NCT00126776|69779444|FG001|Overall Study|follow up complete on all patients|0|||
38081135|NCT01674010|69779448|FG000|Open Treatment Phase 1|Adverse Event|10|||
38081136|NCT01674010|69779449|FG001|Open Treatment Phase 1|Adverse Event|0|||
38081137|NCT01674010|69779450|FG002|Open Treatment Phase 1|Adverse Event|0|||
38081138|NCT01674010|69779448|FG000|Open Treatment Phase 1|Death|1|||
38081139|NCT01674010|69779449|FG001|Open Treatment Phase 1|Death|0|||
37680592|NCT02584855|69156197|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
37680593|NCT02584855|69156198|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
37680594|NCT02584855|69156199|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
37680595|NCT02584855|69156200|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
37680596|NCT02584855|69156201|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
37966820|NCT00449787|69653787|FG001|Overall Study|Did not require medication|92|||
37966821|NCT00449163|69653795|FG000|Overall Study|Physician Decision|3|||
37966822|NCT00448539|69653801|FG000|Overall Study|Medication non-compliance|4|||
37966823|NCT00448539|69653802|FG001|Overall Study|Medication non-compliance|1|||
37966824|NCT00448539|69653801|FG000|Overall Study|Protocol Violation|1|||
37966825|NCT00448539|69653802|FG001|Overall Study|Protocol Violation|0|||
37966826|NCT00448539|69653801|FG000|Overall Study|Request of the investigator or sponsor|67|||
37966827|NCT00448539|69653802|FG001|Overall Study|Request of the investigator or sponsor|54|||
37966828|NCT00448539|69653801|FG000|Overall Study|Withdrawal by Subject|20|||
37966829|NCT00448539|69653802|FG001|Overall Study|Withdrawal by Subject|24|||
37966830|NCT00448539|69653801|FG000|Overall Study|Diary non-compliance|1|||
37966831|NCT00448539|69653802|FG001|Overall Study|Diary non-compliance|0|||
37966832|NCT00448539|69653801|FG000|Overall Study|Adverse Event|9|||
37966833|NCT00448539|69653802|FG001|Overall Study|Adverse Event|26|||
37966834|NCT00448539|69653801|FG000|Overall Study|Lack of Efficacy|27|||
37966835|NCT00448539|69653802|FG001|Overall Study|Lack of Efficacy|40|||
37966836|NCT00448539|69653801|FG000|Overall Study|Miscellaneous|2|||
37966837|NCT00448539|69653802|FG001|Overall Study|Miscellaneous|1|||
37966838|NCT00448539|69653801|FG000|Overall Study|Change of meds|2|||
37966839|NCT00448539|69653802|FG001|Overall Study|Change of meds|3|||
37966840|NCT00448539|69653801|FG000|Overall Study|Lost to Follow-up|1|||
37966841|NCT00448539|69653802|FG001|Overall Study|Lost to Follow-up|3|||
37966842|NCT00457665|69653810|FG000|12 Months|Drug allergy|1|||
37966843|NCT00457665|69653811|FG001|12 Months|Drug allergy|1|||
37966844|NCT00457665|69653810|FG000|12 Months|High HIV viral load|5|||
37966845|NCT00457665|69653811|FG001|12 Months|High HIV viral load|1|||
37966846|NCT00457665|69653810|FG000|12 Months|Lipodystrophy|2|||
37966847|NCT00457665|69653811|FG001|12 Months|Lipodystrophy|0|||
37966848|NCT00457665|69653810|FG000|12 Months|Withdrawal by Subject|0|||
37966849|NCT00457665|69653811|FG001|12 Months|Withdrawal by Subject|2|||
37966850|NCT00457665|69653810|FG000|12 Months|Abnormal Liver function tests|0|||
37966851|NCT00457665|69653811|FG001|12 Months|Abnormal Liver function tests|5|||
37966852|NCT00457665|69653810|FG000|24 Months|Withdrawal by Subject|3|||
37966853|NCT00457665|69653811|FG001|24 Months|Withdrawal by Subject|2|||
37966854|NCT00457665|69653810|FG000|24 Months|Lipodystrophy|1|||
37966855|NCT00457665|69653811|FG001|24 Months|Lipodystrophy|1|||
38081140|NCT01674010|69779450|FG002|Open Treatment Phase 1|Death|0|||
37966856|NCT00457665|69653810|FG000|24 Months|Abnormal liver function tests|1|||
37966857|NCT00457665|69653811|FG001|24 Months|Abnormal liver function tests|5|||
37966858|NCT00447603|69653817|FG000|Screening|Withdrawal by Subject|1|||
37966859|NCT00447603|69653818|FG001|Screening|Withdrawal by Subject|0|||
38081141|NCT01674010|69779448|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
38081142|NCT01674010|69779449|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
38081143|NCT01674010|69779450|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
38081144|NCT01674010|69779448|FG000|Open Treatment Phase 1|Physician Decision|9|||
37966860|NCT00447603|69653819|FG002|Screening|Withdrawal by Subject|0|||
37966861|NCT00447603|69653817|FG000|Screening|Protocol Violation|1|||
37966862|NCT00447603|69653818|FG001|Screening|Protocol Violation|0|||
37966863|NCT00447603|69653819|FG002|Screening|Protocol Violation|0|||
37966864|NCT00447603|69653817|FG000|Screening|Screen Failure|4|||
37966865|NCT00447603|69653818|FG001|Screening|Screen Failure|0|||
37966866|NCT00447603|69653819|FG002|Screening|Screen Failure|0|||
38081145|NCT01674010|69779449|FG001|Open Treatment Phase 1|Physician Decision|0|||
38081146|NCT01674010|69779450|FG002|Open Treatment Phase 1|Physician Decision|0|||
37680597|NCT02584855|69156196|FG000|Open-Label Treatment Period|Protocol Violation|1|||
37680598|NCT02584855|69156197|FG001|Open-Label Treatment Period|Protocol Violation|0|||
37680599|NCT02584855|69156198|FG002|Open-Label Treatment Period|Protocol Violation|0|||
37680600|NCT02584855|69156199|FG003|Open-Label Treatment Period|Protocol Violation|0|||
37680601|NCT02584855|69156200|FG004|Open-Label Treatment Period|Protocol Violation|0|||
37680602|NCT02584855|69156201|FG005|Open-Label Treatment Period|Protocol Violation|0|||
37680603|NCT02584855|69156196|FG000|Open-Label Treatment Period|No PI Available|2|||
37680604|NCT02584855|69156197|FG001|Open-Label Treatment Period|No PI Available|0|||
37680605|NCT02584855|69156198|FG002|Open-Label Treatment Period|No PI Available|0|||
37680606|NCT02584855|69156199|FG003|Open-Label Treatment Period|No PI Available|0|||
37680607|NCT02584855|69156200|FG004|Open-Label Treatment Period|No PI Available|0|||
37680608|NCT02584855|69156201|FG005|Open-Label Treatment Period|No PI Available|0|||
37680609|NCT02584855|69156196|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
37680610|NCT02584855|69156197|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
37680611|NCT02584855|69156198|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
37680612|NCT02584855|69156199|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
37680613|NCT02584855|69156200|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
37680614|NCT02584855|69156201|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
37680615|NCT02584855|69156196|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
37680616|NCT02584855|69156197|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
37680617|NCT02584855|69156198|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
37680618|NCT02584855|69156199|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
37680619|NCT02584855|69156200|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
37680620|NCT02584855|69156201|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
37680621|NCT02584855|69156196|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
37680622|NCT02584855|69156197|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
37680623|NCT02584855|69156198|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
37680624|NCT02584855|69156199|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
37680625|NCT02584855|69156200|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
37680626|NCT02584855|69156201|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
37680627|NCT02584855|69156196|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
37680628|NCT02584855|69156197|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
37680629|NCT02584855|69156198|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
37680630|NCT02584855|69156199|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
37680631|NCT02584855|69156200|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
37680632|NCT02584855|69156201|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
37680633|NCT02584855|69156196|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
37680634|NCT02584855|69156197|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
37680635|NCT02584855|69156198|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
37680636|NCT02584855|69156199|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
37680637|NCT02584855|69156200|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
37680638|NCT02584855|69156201|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
37680639|NCT02584855|69156196|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
37680640|NCT02584855|69156197|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
37680641|NCT02584855|69156198|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
37680642|NCT02584855|69156199|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
37680643|NCT02584855|69156200|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
37680644|NCT02584855|69156201|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
37680645|NCT02584855|69156196|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
37680646|NCT02584855|69156197|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
37680647|NCT02584855|69156198|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
37680648|NCT02584855|69156199|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
37680649|NCT02584855|69156200|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
37680650|NCT02584855|69156201|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
37680651|NCT02581345|69156216|FG000|Part 1: up to Week 16|Adverse Event|3|||
37680652|NCT02581345|69156217|FG001|Part 1: up to Week 16|Adverse Event|8|||
37680653|NCT02581345|69156218|FG002|Part 1: up to Week 16|Adverse Event|0|||
37680654|NCT02581345|69156219|FG003|Part 1: up to Week 16|Adverse Event|0|||
37680655|NCT02581345|69156216|FG000|Part 1: up to Week 16|Physician Decision|2|||
37680656|NCT02581345|69156217|FG001|Part 1: up to Week 16|Physician Decision|4|||
37680657|NCT02581345|69156218|FG002|Part 1: up to Week 16|Physician Decision|0|||
37680658|NCT02581345|69156219|FG003|Part 1: up to Week 16|Physician Decision|0|||
37680659|NCT02581345|69156216|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
37680660|NCT02581345|69156217|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
37680661|NCT02581345|69156218|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
37680662|NCT02581345|69156219|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
37680663|NCT02581345|69156216|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
37680664|NCT02581345|69156217|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
37680665|NCT02581345|69156218|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
37680666|NCT02581345|69156219|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
37680667|NCT02581345|69156216|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
37680668|NCT02581345|69156217|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
37862508|NCT01213524|69546375|FG000|Baseline|Withdrawal by Subject|5|||
37862509|NCT01213524|69546375|FG000|Baseline|high breath alcohol levels|1|||
37862510|NCT01213524|69546375|FG000|Baseline|Physician Decision|1|||
37862511|NCT01213524|69546375|FG000|Session 2|Withdrawal by Subject|5|||
37862512|NCT01213524|69546375|FG000|Session 3|Withdrawal by Subject|4|||
37862513|NCT01213524|69546375|FG000|Session 4|Physician Decision|1|||
37862514|NCT01213524|69546375|FG000|Session 4|Withdrawal by Subject|2|||
37862515|NCT01212744|69546386|FG000|Overall Study|Withdrawal by Subject|1|||
37862516|NCT01212588|69546394|FG000|Overall Study|Physician Decision|0|||
37862517|NCT01212588|69546395|FG001|Overall Study|Physician Decision|1|||
37966867|NCT00447603|69653817|FG000|Screening|Study Terminated by Sponsor|15|||
37680669|NCT02581345|69156218|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
37680670|NCT02581345|69156219|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
37862518|NCT01212588|69546394|FG000|Overall Study|Protocol Violation|1|||
37862519|NCT01212588|69546395|FG001|Overall Study|Protocol Violation|1|||
37862520|NCT00918385|69546403|FG000|Monotherapy|Adverse Event|1|||
37862521|NCT00918385|69546404|FG001|Monotherapy|Adverse Event|6|||
38081147|NCT01674010|69779448|FG000|Open Treatment Phase 1|Protocol Violation|7|||
38081148|NCT01674010|69779449|FG001|Open Treatment Phase 1|Protocol Violation|0|||
38081149|NCT01674010|69779450|FG002|Open Treatment Phase 1|Protocol Violation|0|||
38081150|NCT01674010|69779448|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
38081151|NCT01674010|69779449|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
38081152|NCT01674010|69779450|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
38081153|NCT01674010|69779448|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
38081154|NCT01674010|69779449|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
38081155|NCT01674010|69779450|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
38081156|NCT01674010|69779448|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
38081157|NCT01674010|69779449|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
38081158|NCT01674010|69779450|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
38081159|NCT01674010|69779448|FG000|Randomization Phase 2|Adverse Event|0|||
38081160|NCT01674010|69779449|FG001|Randomization Phase 2|Adverse Event|1|||
38081161|NCT01674010|69779450|FG002|Randomization Phase 2|Adverse Event|1|||
38081162|NCT01674010|69779448|FG000|Randomization Phase 2|Lost to Follow-up|0|||
38081163|NCT01674010|69779449|FG001|Randomization Phase 2|Lost to Follow-up|1|||
38081164|NCT01674010|69779450|FG002|Randomization Phase 2|Lost to Follow-up|2|||
37680671|NCT02581345|69156216|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
37680672|NCT02581345|69156217|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
37680673|NCT02581345|69156218|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
37680674|NCT02581345|69156219|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
37680675|NCT02581345|69156216|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
37680676|NCT02581345|69156217|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
37680677|NCT02581345|69156218|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
37680678|NCT02581345|69156219|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
37680679|NCT02581345|69156216|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
37680680|NCT02581345|69156217|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
37680681|NCT02581345|69156218|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
37680682|NCT02581345|69156219|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
37680683|NCT02581345|69156216|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
37680684|NCT02581345|69156217|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
37680685|NCT02581345|69156218|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
37680686|NCT02581345|69156219|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
37680687|NCT02581345|69156216|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
37680688|NCT02581345|69156217|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
37680689|NCT02581345|69156218|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
37680690|NCT02581345|69156219|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
37680691|NCT02581345|69156216|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
37680692|NCT02581345|69156217|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
37680693|NCT02581345|69156218|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
37680694|NCT02581345|69156219|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
37680695|NCT02581345|69156216|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
37680696|NCT02581345|69156217|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
37680697|NCT02581345|69156218|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
37680698|NCT02581345|69156219|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
37680699|NCT02581189|69156237|FG000|Overall Study|Failure to return|36|||
37680700|NCT02581189|69156237|FG000|Overall Study|Withdrew consent|5|||
37680701|NCT02581189|69156237|FG000|Overall Study|Death|3|||
37680702|NCT02581189|69156237|FG000|Overall Study|Insufficient virological response|2|||
37680703|NCT02581189|69156237|FG000|Overall Study|Other, not specified|7|||
37680704|NCT02576977|69156246|FG000|Overall Study|Adverse Event|13|||
37680705|NCT02576977|69156247|FG001|Overall Study|Adverse Event|2|||
37680706|NCT02576977|69156246|FG000|Overall Study|Death|73|||
37680707|NCT02576977|69156247|FG001|Overall Study|Death|60|||
37680708|NCT02576977|69156246|FG000|Overall Study|Screen failure|1|||
37680709|NCT02576977|69156247|FG001|Overall Study|Screen failure|0|||
37680710|NCT02576977|69156246|FG000|Overall Study|Study Terminated at Selected Sites|27|||
37680711|NCT02576977|69156247|FG001|Overall Study|Study Terminated at Selected Sites|50|||
37680712|NCT02576977|69156246|FG000|Overall Study|Withdrawal by Subject|11|||
37680713|NCT02576977|69156247|FG001|Overall Study|Withdrawal by Subject|11|||
37680714|NCT02576977|69156246|FG000|Overall Study|Final Disposition Unknown|0|||
37680715|NCT02576977|69156247|FG001|Overall Study|Final Disposition Unknown|1|||
37680716|NCT02576977|69156246|FG000|Overall Study|Lost to Follow-up|1|||
37680717|NCT02576977|69156247|FG001|Overall Study|Lost to Follow-up|0|||
37680718|NCT02576977|69156246|FG000|Overall Study|Progressive Disease|0|||
37680719|NCT02576977|69156247|FG001|Overall Study|Progressive Disease|1|||
37680720|NCT05150964|69156253|FG000|Overall Study|Lost to Follow-up|2|||
37680721|NCT04952402|69156261|FG000|Overall Study|Lost to Follow-up|1|||
37680722|NCT04952402|69156262|FG001|Overall Study|Lost to Follow-up|3|||
37680723|NCT04952402|69156261|FG000|Overall Study|Lack Of Venous Access|0|||
37680724|NCT04952402|69156262|FG001|Overall Study|Lack Of Venous Access|1|||
37680725|NCT04378010|69156301|FG000|Overall Study|Adverse Event|8|||
37680726|NCT04378010|69156302|FG001|Overall Study|Adverse Event|14|||
37680727|NCT04378010|69156303|FG002|Overall Study|Adverse Event|4|||
37680728|NCT04378010|69156301|FG000|Overall Study|Withdrawal by Subject|0|||
37680729|NCT04378010|69156302|FG001|Overall Study|Withdrawal by Subject|2|||
37680730|NCT04378010|69156303|FG002|Overall Study|Withdrawal by Subject|1|||
37680731|NCT04378010|69156301|FG000|Overall Study|Protocol Violation|2|||
37680732|NCT04378010|69156302|FG001|Overall Study|Protocol Violation|1|||
37680733|NCT04378010|69156303|FG002|Overall Study|Protocol Violation|4|||
37680734|NCT04378010|69156301|FG000|Overall Study|Study terminated by Sponsor|22|||
37680735|NCT04378010|69156302|FG001|Overall Study|Study terminated by Sponsor|16|||
37680736|NCT04378010|69156303|FG002|Overall Study|Study terminated by Sponsor|22|||
37680737|NCT04378010|69156301|FG000|Overall Study|Subject inability to complete study visit|0|||
37680738|NCT04378010|69156302|FG001|Overall Study|Subject inability to complete study visit|0|||
37680739|NCT04378010|69156303|FG002|Overall Study|Subject inability to complete study visit|1|||
37680740|NCT04378010|69156301|FG000|Overall Study|Subject never dosed|0|||
37680741|NCT04378010|69156302|FG001|Overall Study|Subject never dosed|1|||
37680742|NCT04378010|69156303|FG002|Overall Study|Subject never dosed|0|||
37680743|NCT04349072|69156314|FG000|Randomization Period|Found ineligible post enrollment|0|||
37680744|NCT04349072|69156315|FG001|Randomization Period|Found ineligible post enrollment|1|||
37680745|NCT04349072|69156314|FG000|Treatment Period|Permanent Stopping Criteria Met|0|||
37680746|NCT04349072|69156315|FG001|Treatment Period|Permanent Stopping Criteria Met|2|||
37680747|NCT04349072|69156314|FG000|Treatment Period|Proceeding With Septal Reduction Therapy (SRT)|3|||
37680748|NCT04349072|69156315|FG001|Treatment Period|Proceeding With Septal Reduction Therapy (SRT)|5|||
37680749|NCT04349072|69156314|FG000|Treatment Period|Physician Decision|0|||
37680750|NCT04349072|69156315|FG001|Treatment Period|Physician Decision|1|||
37680751|NCT04349072|69156314|FG000|Treatment Period|Protocol Violation|0|||
37680752|NCT04349072|69156315|FG001|Treatment Period|Protocol Violation|1|||
37680753|NCT04349072|69156314|FG000|Treatment Period|Withdrawal by Subject|1|||
37680754|NCT04349072|69156315|FG001|Treatment Period|Withdrawal by Subject|1|||
37680755|NCT04240886|69156321|FG000|Treatment Phase|Death|4|||
37680756|NCT04240886|69156321|FG000|Treatment Phase|Discontinuation by Subject|1|||
37680757|NCT04240886|69156321|FG000|Treatment Phase|Adverse Event|5|||
37680758|NCT04240886|69156321|FG000|Follow-up Phase|Withdrawal by Subject|1|||
37680759|NCT04240886|69156321|FG000|Follow-up Phase|Discontinuation by Subject|1|||
37680760|NCT04240886|69156321|FG000|Follow-up Phase|Death|2|||
37680761|NCT04074161|69156337|FG000|Overall Study|Withdrawal by Subject|2|||
37680762|NCT04074161|69156338|FG001|Overall Study|Withdrawal by Subject|4|||
37680763|NCT04074161|69156339|FG002|Overall Study|Withdrawal by Subject|1|||
37680764|NCT04074161|69156337|FG000|Overall Study|Lost to Follow-up|4|||
37680765|NCT04074161|69156338|FG001|Overall Study|Lost to Follow-up|5|||
37680766|NCT04074161|69156339|FG002|Overall Study|Lost to Follow-up|3|||
37680767|NCT03966157|69156349|FG000|Overall Study|Physician Decision|1|||
37680768|NCT03966157|69156350|FG001|Overall Study|Physician Decision|0|||
37680769|NCT03733210|69156358|FG000|Overall Study|Lymph nodes not collected or not evaluable|4|||
37680770|NCT03733210|69156359|FG001|Overall Study|Lymph nodes not collected or not evaluable|2|||
37680771|NCT03627468|69156367|FG000|Overall Study|Adverse Event|5|||
37680772|NCT03627468|69156368|FG001|Overall Study|Adverse Event|33|||
37680773|NCT03627468|69156367|FG000|Overall Study|Withdrawal by Subject|13|||
37680774|NCT03627468|69156368|FG001|Overall Study|Withdrawal by Subject|23|||
37680775|NCT03627468|69156367|FG000|Overall Study|Physician Decision|1|||
37680776|NCT03627468|69156368|FG001|Overall Study|Physician Decision|0|||
37680777|NCT03627468|69156367|FG000|Overall Study|Protocol Violation|0|||
37680778|NCT03627468|69156368|FG001|Overall Study|Protocol Violation|2|||
37680779|NCT03627468|69156367|FG000|Overall Study|Lost to Follow-up|10|||
37680780|NCT03627468|69156368|FG001|Overall Study|Lost to Follow-up|16|||
37680781|NCT03627468|69156367|FG000|Overall Study|Death|1|||
37680782|NCT03627468|69156368|FG001|Overall Study|Death|0|||
37680783|NCT03627468|69156367|FG000|Overall Study|Pregnancy|1|||
37680784|NCT03627468|69156368|FG001|Overall Study|Pregnancy|1|||
37680785|NCT03627468|69156367|FG000|Overall Study|Lack of Efficacy|0|||
37680786|NCT03627468|69156368|FG001|Overall Study|Lack of Efficacy|2|||
37680787|NCT03627468|69156367|FG000|Overall Study|Poor Compliance or Noncompliance|0|||
37680788|NCT03627468|69156368|FG001|Overall Study|Poor Compliance or Noncompliance|2|||
37680789|NCT03595176|69156376|FG000|Overall Study|Death|0|||
37680790|NCT03595176|69156377|FG001|Overall Study|Death|2|||
37680791|NCT03595176|69156376|FG000|Overall Study|Lost to Follow-up|0|||
37680792|NCT03595176|69156377|FG001|Overall Study|Lost to Follow-up|1|||
37680793|NCT03052816|69156386|FG000|Overall Study|Withdrawal by Subject|1|||
37680794|NCT03052816|69156387|FG001|Overall Study|Withdrawal by Subject|0|||
37680795|NCT03052816|69156386|FG000|Overall Study|Desired opioids|2|||
37680796|NCT03052816|69156387|FG001|Overall Study|Desired opioids|0|||
37680797|NCT02684058|69156407|FG000|Treatment Period|Treatment ongoing at the time of the cut-off, 23-Aug-2021|61|||
37680798|NCT02684058|69156408|FG001|Treatment Period|Treatment ongoing at the time of the cut-off, 23-Aug-2021|8|||
37680799|NCT02684058|69156409|FG002|Treatment Period|Treatment ongoing at the time of the cut-off, 23-Aug-2021|21|||
37862522|NCT00918385|69546403|FG000|Monotherapy|Complicating illness|1|||
37680800|NCT02684058|69156407|FG000|Treatment Period|Progressive disease|5|||
37680801|NCT02684058|69156408|FG001|Treatment Period|Progressive disease|9|||
37680802|NCT02684058|69156409|FG002|Treatment Period|Progressive disease|16|||
37680803|NCT02684058|69156407|FG000|Treatment Period|Adverse Event|3|||
37680804|NCT02684058|69156408|FG001|Treatment Period|Adverse Event|6|||
37680805|NCT02684058|69156409|FG002|Treatment Period|Adverse Event|1|||
37680806|NCT02684058|69156407|FG000|Treatment Period|Physician Decision|2|||
37680807|NCT02684058|69156408|FG001|Treatment Period|Physician Decision|1|||
37680808|NCT02684058|69156409|FG002|Treatment Period|Physician Decision|1|||
37680809|NCT02684058|69156407|FG000|Treatment Period|New therapy for study indication|1|||
37680810|NCT02684058|69156408|FG001|Treatment Period|New therapy for study indication|0|||
37680811|NCT02684058|69156409|FG002|Treatment Period|New therapy for study indication|0|||
37680812|NCT02684058|69156407|FG000|Treatment Period|Protocol deviation|0|||
37680813|NCT02684058|69156408|FG001|Treatment Period|Protocol deviation|1|||
37680814|NCT02684058|69156409|FG002|Treatment Period|Protocol deviation|0|||
37680815|NCT02684058|69156407|FG000|Treatment Period|Patient/guardian decision|1|||
37680816|NCT02684058|69156408|FG001|Treatment Period|Patient/guardian decision|3|||
37680817|NCT02684058|69156409|FG002|Treatment Period|Patient/guardian decision|0|||
38081165|NCT01674010|69779448|FG000|Randomization Phase 2|Mood episode recurrence|0|||
38081166|NCT01674010|69779449|FG001|Randomization Phase 2|Mood episode recurrence|8|||
38081167|NCT01674010|69779450|FG002|Randomization Phase 2|Mood episode recurrence|2|||
38081168|NCT01674010|69779448|FG000|Randomization Phase 2|Physician Decision|0|||
38081169|NCT01674010|69779449|FG001|Randomization Phase 2|Physician Decision|0|||
38081170|NCT01674010|69779450|FG002|Randomization Phase 2|Physician Decision|2|||
38081171|NCT01674010|69779448|FG000|Randomization Phase 2|Pregnancy|0|||
37680818|NCT02684058|69156407|FG000|Treatment Period|Death|0|||
37680819|NCT02684058|69156408|FG001|Treatment Period|Death|0|||
37680820|NCT02684058|69156409|FG002|Treatment Period|Death|2|||
37680821|NCT02684058|69156407|FG000|Post-treatment Efficacy Follow-up|Ongoing at the time of the cut-off, 23-Aug-2021|5|||
37680822|NCT02684058|69156408|FG001|Post-treatment Efficacy Follow-up|Ongoing at the time of the cut-off, 23-Aug-2021|13|||
37680823|NCT02684058|69156409|FG002|Post-treatment Efficacy Follow-up|Ongoing at the time of the cut-off, 23-Aug-2021|2|||
37680824|NCT02684058|69156407|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
37680825|NCT02684058|69156408|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
37680826|NCT02684058|69156409|FG002|Post-treatment Efficacy Follow-up|Physician Decision|0|||
37680827|NCT02684058|69156407|FG000|Post-treatment Efficacy Follow-up|Progressive disease|0|||
37680828|NCT02684058|69156408|FG001|Post-treatment Efficacy Follow-up|Progressive disease|1|||
37680829|NCT02684058|69156409|FG002|Post-treatment Efficacy Follow-up|Progressive disease|0|||
37680830|NCT02684058|69156407|FG000|Post-treatment Efficacy Follow-up|Patient/guardian decision|1|||
37680831|NCT02684058|69156408|FG001|Post-treatment Efficacy Follow-up|Patient/guardian decision|0|||
37680832|NCT02684058|69156409|FG002|Post-treatment Efficacy Follow-up|Patient/guardian decision|0|||
37680833|NCT02684058|69156407|FG000|Post-treatment Efficacy Follow-up|Death|0|||
37680834|NCT02684058|69156408|FG001|Post-treatment Efficacy Follow-up|Death|0|||
37680835|NCT02684058|69156409|FG002|Post-treatment Efficacy Follow-up|Death|3|||
37680836|NCT02684058|69156407|FG000|Survival Follow-up|Ongoing at the time of the cut-off, 23-Aug-2021|4|||
37680837|NCT02684058|69156408|FG001|Survival Follow-up|Ongoing at the time of the cut-off, 23-Aug-2021|0|||
38081172|NCT01674010|69779449|FG001|Randomization Phase 2|Pregnancy|1|||
38081173|NCT01674010|69779450|FG002|Randomization Phase 2|Pregnancy|1|||
38081174|NCT01674010|69779448|FG000|Randomization Phase 2|Protocol Violation|0|||
38081175|NCT01674010|69779449|FG001|Randomization Phase 2|Protocol Violation|1|||
37680838|NCT02684058|69156409|FG002|Survival Follow-up|Ongoing at the time of the cut-off, 23-Aug-2021|2|||
37680839|NCT02684058|69156407|FG000|Survival Follow-up|Other|2|||
37680840|NCT02684058|69156408|FG001|Survival Follow-up|Other|1|||
37680841|NCT02684058|69156409|FG002|Survival Follow-up|Other|0|||
37680842|NCT02684058|69156407|FG000|Survival Follow-up|Death|0|||
37680843|NCT02684058|69156408|FG001|Survival Follow-up|Death|0|||
37680844|NCT02684058|69156409|FG002|Survival Follow-up|Death|6|||
37680845|NCT02684058|69156407|FG000|Crossover Treatment Period|Treatment ongoing at the time of the cut-off, 23-Aug-2021|0|||
37680846|NCT02684058|69156408|FG001|Crossover Treatment Period|Treatment ongoing at the time of the cut-off, 23-Aug-2021|8|||
37680847|NCT02684058|69156409|FG002|Crossover Treatment Period|Treatment ongoing at the time of the cut-off, 23-Aug-2021|0|||
37680848|NCT02684058|69156407|FG000|Crossover Treatment Period|Progressive disease|0|||
37680849|NCT02684058|69156408|FG001|Crossover Treatment Period|Progressive disease|1|||
37680850|NCT02684058|69156409|FG002|Crossover Treatment Period|Progressive disease|0|||
37680851|NCT02684058|69156407|FG000|Crossover Survival Follow-up|Death|0|||
37680852|NCT02684058|69156408|FG001|Crossover Survival Follow-up|Death|1|||
37680853|NCT02684058|69156409|FG002|Crossover Survival Follow-up|Death|0|||
37680854|NCT02682238|69156425|FG000|Overall Study|Lost to Follow-up|0|||
37862523|NCT00918385|69546404|FG001|Monotherapy|Complicating illness|0|||
37966868|NCT00447603|69653818|FG001|Screening|Study Terminated by Sponsor|0|||
38081176|NCT01674010|69779450|FG002|Randomization Phase 2|Protocol Violation|1|||
37680855|NCT02682238|69156426|FG001|Overall Study|Lost to Follow-up|2|||
37680856|NCT02682238|69156425|FG000|Overall Study|Withdrawal by Subject|1|||
37680857|NCT02682238|69156426|FG001|Overall Study|Withdrawal by Subject|0|||
37680858|NCT02682238|69156425|FG000|Overall Study|Adverse Event|1|||
37680859|NCT02682238|69156426|FG001|Overall Study|Adverse Event|0|||
37680860|NCT02682238|69156425|FG000|Overall Study|Non-compliance with Study Drug|1|||
37680861|NCT02682238|69156426|FG001|Overall Study|Non-compliance with Study Drug|0|||
37680862|NCT02682238|69156425|FG000|Overall Study|Non-compliance with Protocol|0|||
37680863|NCT02682238|69156426|FG001|Overall Study|Non-compliance with Protocol|2|||
37680864|NCT02657356|69156450|FG000|Overall Study|Death|1|||
37680865|NCT02657356|69156451|FG001|Overall Study|Death|0|||
37680866|NCT02657356|69156450|FG000|Overall Study|Withdrawal by Subject|5|||
37680867|NCT02657356|69156451|FG001|Overall Study|Withdrawal by Subject|6|||
37680868|NCT02657356|69156450|FG000|Overall Study|Terminated by Sponsor|8|||
37680869|NCT02657356|69156451|FG001|Overall Study|Terminated by Sponsor|5|||
37680870|NCT02657356|69156450|FG000|Overall Study|Rolled over to EAP study|6|||
37680871|NCT02657356|69156451|FG001|Overall Study|Rolled over to EAP study|4|||
37966869|NCT00447603|69653819|FG002|Screening|Study Terminated by Sponsor|0|||
37966870|NCT00447603|69653817|FG000|Filter Period|Adverse Event|0|||
37966871|NCT00447603|69653818|FG001|Filter Period|Adverse Event|0|||
37966872|NCT00447603|69653819|FG002|Filter Period|Adverse Event|1|||
38081177|NCT01674010|69779448|FG000|Randomization Phase 2|Sponsor Decision|0|||
38081178|NCT01674010|69779449|FG001|Randomization Phase 2|Sponsor Decision|42|||
38081179|NCT01674010|69779450|FG002|Randomization Phase 2|Sponsor Decision|45|||
38081180|NCT01674010|69779448|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
38081181|NCT01674010|69779449|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
38081182|NCT01674010|69779450|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
38081183|NCT01345669|69779460|FG000|Overall Study|Primary tumour recurrence|53|||
38081184|NCT01345669|69779461|FG001|Overall Study|Primary tumour recurrence|32|||
38081185|NCT01345669|69779460|FG000|Overall Study|Second primary tumour|4|||
38081186|NCT01345669|69779461|FG001|Overall Study|Second primary tumour|3|||
38081187|NCT01345669|69779460|FG000|Overall Study|Adverse Event|63|||
38081188|NCT01345669|69779461|FG001|Overall Study|Adverse Event|9|||
38081189|NCT01345669|69779460|FG000|Overall Study|Protocol Violation|3|||
38081190|NCT01345669|69779461|FG001|Overall Study|Protocol Violation|1|||
38081191|NCT01345669|69779460|FG000|Overall Study|Lost to Follow-up|1|||
38081192|NCT01345669|69779461|FG001|Overall Study|Lost to Follow-up|1|||
38081193|NCT01345669|69779460|FG000|Overall Study|Withdrawal by Subject|52|||
38081194|NCT01345669|69779461|FG001|Overall Study|Withdrawal by Subject|13|||
38081195|NCT01345669|69779460|FG000|Overall Study|Other Reasons|111|||
38081196|NCT01345669|69779461|FG001|Overall Study|Other Reasons|60|||
37680872|NCT01719562|69156477|FG000|Overall Study|Lost to Follow-up|1|||
37680873|NCT01719562|69156478|FG001|Overall Study|Lost to Follow-up|0|||
37680874|NCT01719562|69156477|FG000|Overall Study|Death|1|||
37680875|NCT01719562|69156478|FG001|Overall Study|Death|0|||
37680876|NCT01719562|69156477|FG000|Overall Study|New cancer diagnosis|1|||
37680877|NCT01719562|69156478|FG001|Overall Study|New cancer diagnosis|0|||
37680878|NCT01700439|69156484|FG000|Overall Study|Lost to Follow-up|47|||
38081197|NCT05334212|69779467|FG000|Overall Study|Study terminated prematurely|7|||
38081198|NCT01673854|69779471|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
38081199|NCT01673854|69779471|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
38081200|NCT01673854|69779471|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
37680879|NCT01700439|69156484|FG000|Overall Study|Withdrawal by Subject|183|||
38081201|NCT01673854|69779471|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
38081202|NCT01673854|69779471|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
38081203|NCT01673854|69779471|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
38081204|NCT01673854|69779471|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
38081205|NCT01673854|69779471|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
38081206|NCT01673854|69779471|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
38081207|NCT01673854|69779471|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
38081208|NCT01673854|69779471|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
38081209|NCT01673854|69779471|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
38081210|NCT01343407|69779475|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
38081211|NCT01343407|69779476|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
38081212|NCT01343407|69779477|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
38081213|NCT01343407|69779478|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
37680880|NCT01700439|69156484|FG000|Overall Study|Death|186|||
37680881|NCT01433289|69156506|FG000|Overall Study|Pregnancy|0|||
37680882|NCT01433289|69156507|FG001|Overall Study|Pregnancy|1|||
37680883|NCT01433289|69156508|FG002|Overall Study|Pregnancy|0|||
37680884|NCT01433289|69156509|FG003|Overall Study|Pregnancy|0|||
37680885|NCT02576587|69156553|FG000|Baseline|Equipment failure|0|||
37680886|NCT02576587|69156554|FG001|Baseline|Equipment failure|1|||
37680887|NCT02576587|69156553|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
37680888|NCT02576587|69156554|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
37680889|NCT02576587|69156553|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
37680890|NCT02576587|69156554|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
37680891|NCT02576587|69156553|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
37680892|NCT02576587|69156554|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
37680893|NCT03016975|69156578|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
37680894|NCT03016975|69156579|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
37680895|NCT03016975|69156580|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
37680896|NCT03016975|69156578|FG000|At 6 Months Follow-up|Death|2|||
37680897|NCT03016975|69156579|FG001|At 6 Months Follow-up|Death|0|||
37680898|NCT03016975|69156580|FG002|At 6 Months Follow-up|Death|0|||
37862524|NCT00918385|69546403|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
37862525|NCT00918385|69546404|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
37966873|NCT00447603|69653817|FG000|Filter Period|Screen Failure|0|||
37966874|NCT00447603|69653818|FG001|Filter Period|Screen Failure|3|||
37966875|NCT00447603|69653819|FG002|Filter Period|Screen Failure|4|||
37966876|NCT00447603|69653817|FG000|Filter Period|Study terminated by Sponsor|0|||
37966877|NCT00447603|69653818|FG001|Filter Period|Study terminated by Sponsor|1|||
37966878|NCT00447603|69653819|FG002|Filter Period|Study terminated by Sponsor|10|||
37966879|NCT00447057|69653831|FG000|Overall Study|Adverse Event|4|||
37966880|NCT00447057|69653832|FG001|Overall Study|Adverse Event|10|||
37966881|NCT00447057|69653833|FG002|Overall Study|Adverse Event|0|||
37966882|NCT00447057|69653834|FG003|Overall Study|Adverse Event|3|||
37966883|NCT00447057|69653831|FG000|Overall Study|Death due to study disease|6|||
37680899|NCT03016975|69156578|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
37966884|NCT00447057|69653832|FG001|Overall Study|Death due to study disease|4|||
37680900|NCT03016975|69156579|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
37680901|NCT03016975|69156580|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
37680902|NCT03016975|69156578|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
37680903|NCT03016975|69156579|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
37680904|NCT03016975|69156580|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
37680905|NCT03016975|69156578|FG000|At 6 Months Follow-up|Aborted implant|1|||
37680906|NCT03016975|69156579|FG001|At 6 Months Follow-up|Aborted implant|0|||
37680907|NCT03016975|69156580|FG002|At 6 Months Follow-up|Aborted implant|0|||
37680908|NCT03016975|69156578|FG000|At 2 Year Follow-up|Death|1|||
37680909|NCT03016975|69156579|FG001|At 2 Year Follow-up|Death|0|||
37680910|NCT03016975|69156580|FG002|At 2 Year Follow-up|Death|0|||
37680911|NCT03016975|69156578|FG000|At 3 Year Follow-up|Death|1|||
37680912|NCT03016975|69156579|FG001|At 3 Year Follow-up|Death|0|||
37680913|NCT03016975|69156580|FG002|At 3 Year Follow-up|Death|0|||
37680914|NCT03016975|69156578|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
37680915|NCT03016975|69156579|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
37680916|NCT03016975|69156580|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
37680917|NCT05340751|69156634|FG000|Overall Study|Physician Decision|3|||
37680918|NCT02575807|69156643|FG000|Overall Study|Death|8|||
37680919|NCT02575807|69156644|FG001|Overall Study|Death|3|||
37680920|NCT02575807|69156645|FG002|Overall Study|Death|7|||
37680921|NCT02575807|69156646|FG003|Overall Study|Death|0|||
37680922|NCT02575807|69156647|FG004|Overall Study|Death|1|||
37680923|NCT02575807|69156643|FG000|Overall Study|Study terminated by Sponsor|0|||
37680924|NCT02575807|69156644|FG001|Overall Study|Study terminated by Sponsor|1|||
37680925|NCT02575807|69156645|FG002|Overall Study|Study terminated by Sponsor|7|||
37680926|NCT02575807|69156646|FG003|Overall Study|Study terminated by Sponsor|0|||
37680927|NCT02575807|69156647|FG004|Overall Study|Study terminated by Sponsor|1|||
37680928|NCT02575807|69156643|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
37680929|NCT02575807|69156644|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
37680930|NCT02575807|69156645|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
38081214|NCT01343407|69779479|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
38081215|NCT01343407|69779480|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
38081216|NCT01343407|69779475|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
38081217|NCT01343407|69779476|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
38081218|NCT01343407|69779477|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
38081219|NCT01343407|69779478|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
38081220|NCT01343407|69779479|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
38081221|NCT01343407|69779480|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
38081222|NCT01367886|69779488|FG000|Overall Study|Lost to Follow-up|4|||
38081223|NCT01367886|69779488|FG000|Overall Study|Lack of Efficacy|2|||
38081224|NCT01367886|69779488|FG000|Overall Study|Death|1|||
38081225|NCT01673698|69779495|FG000|Overall Study|Lost to Follow-up|51|||
38081226|NCT01673698|69779496|FG001|Overall Study|Lost to Follow-up|13|||
38081227|NCT02786004|69779505|FG000|Overall Study|Withdrawal by Subject|0|||
38081228|NCT02786004|69779506|FG001|Overall Study|Withdrawal by Subject|1|||
38081229|NCT03051607|69779514|FG000|Overall Study|Adverse Event|66|||
38081230|NCT01062399|69779523|FG000|Overall Study|Protocol Violation|0|||
38081231|NCT01062399|69779524|FG001|Overall Study|Protocol Violation|1|||
38081232|NCT01062399|69779525|FG002|Overall Study|Protocol Violation|0|||
38081233|NCT01062399|69779526|FG003|Overall Study|Protocol Violation|6|||
38081234|NCT01062399|69779527|FG004|Overall Study|Protocol Violation|4|||
38081235|NCT01317277|69779541|FG000|Overall Study|Lost to Follow-up|3|||
38081236|NCT01317277|69779542|FG001|Overall Study|Lost to Follow-up|1|||
38081237|NCT01317277|69779541|FG000|Overall Study|Lost MEMS|1|||
38081238|NCT01317277|69779542|FG001|Overall Study|Lost MEMS|1|||
38081239|NCT01317277|69779541|FG000|Overall Study|Unable to comply with intervention|1|||
38081240|NCT01317277|69779542|FG001|Overall Study|Unable to comply with intervention|0|||
38081241|NCT01317277|69779541|FG000|Overall Study|Withdrawal by Subject|1|||
38081242|NCT01317277|69779542|FG001|Overall Study|Withdrawal by Subject|0|||
38081243|NCT01317277|69779541|FG000|Overall Study|Adverse Event|1|||
38081244|NCT01317277|69779542|FG001|Overall Study|Adverse Event|0|||
38081245|NCT04820686|69779551|FG000|Overall Study|Withdrawal by Subject|5|||
38081246|NCT04820686|69779552|FG001|Overall Study|Withdrawal by Subject|2|||
38081247|NCT04820686|69779553|FG002|Overall Study|Withdrawal by Subject|3|||
38081248|NCT04820686|69779551|FG000|Overall Study|Study Termination|25|||
38081249|NCT04820686|69779552|FG001|Overall Study|Study Termination|13|||
38081250|NCT04820686|69779553|FG002|Overall Study|Study Termination|14|||
38081251|NCT04820686|69779551|FG000|Overall Study|Adverse Event|0|||
38081252|NCT04820686|69779552|FG001|Overall Study|Adverse Event|1|||
38081253|NCT04820686|69779553|FG002|Overall Study|Adverse Event|0|||
37680931|NCT02575807|69156646|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
37680932|NCT02575807|69156647|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
37680933|NCT02575807|69156643|FG000|Overall Study|Terminated due to physician decision|0|||
37680934|NCT02575807|69156644|FG001|Overall Study|Terminated due to physician decision|0|||
37680935|NCT02575807|69156645|FG002|Overall Study|Terminated due to physician decision|1|||
37680936|NCT02575807|69156646|FG003|Overall Study|Terminated due to physician decision|0|||
37680937|NCT02575807|69156647|FG004|Overall Study|Terminated due to physician decision|0|||
37680938|NCT02575807|69156643|FG000|Overall Study|Subject ineligible - medical implant|0|||
37680939|NCT02575807|69156644|FG001|Overall Study|Subject ineligible - medical implant|0|||
37680940|NCT02575807|69156645|FG002|Overall Study|Subject ineligible - medical implant|0|||
37680941|NCT02575807|69156646|FG003|Overall Study|Subject ineligible - medical implant|1|||
37680942|NCT02575807|69156647|FG004|Overall Study|Subject ineligible - medical implant|0|||
37680943|NCT02575807|69156643|FG000|Overall Study|Withdrawal by Subject|0|||
37680944|NCT02575807|69156644|FG001|Overall Study|Withdrawal by Subject|0|||
37680945|NCT02575807|69156645|FG002|Overall Study|Withdrawal by Subject|1|||
37680946|NCT02575807|69156646|FG003|Overall Study|Withdrawal by Subject|1|||
37680947|NCT02575807|69156647|FG004|Overall Study|Withdrawal by Subject|2|||
37680948|NCT02575339|69156673|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
37680949|NCT02575339|69156674|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
37680950|NCT02575339|69156675|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
37680951|NCT02575339|69156673|FG000|Study Treatment|Disease Progression|5|||
37680952|NCT02575339|69156674|FG001|Study Treatment|Disease Progression|2|||
37680953|NCT02575339|69156675|FG002|Study Treatment|Disease Progression|0|||
37680954|NCT02575339|69156673|FG000|Study Treatment|Adverse Event|1|||
37680955|NCT02575339|69156674|FG001|Study Treatment|Adverse Event|2|||
37680956|NCT02575339|69156675|FG002|Study Treatment|Adverse Event|0|||
37680957|NCT02575339|69156673|FG000|Follow up|Death|6|||
37680958|NCT02575339|69156674|FG001|Follow up|Death|2|||
37680959|NCT02575339|69156675|FG002|Follow up|Death|0|||
37680960|NCT02575339|69156673|FG000|Follow up|Study Terminated|0|||
37680961|NCT02575339|69156674|FG001|Follow up|Study Terminated|2|||
37680962|NCT02575339|69156675|FG002|Follow up|Study Terminated|0|||
37680963|NCT02575339|69156673|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
37680964|NCT02575339|69156674|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
37680965|NCT02575339|69156675|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
37680966|NCT01712659|69156688|FG000|Dose Escalation|Physician Decision|0|||
37680967|NCT01712659|69156689|FG001|Dose Escalation|Physician Decision|1|||
37680968|NCT01712659|69156690|FG002|Dose Escalation|Physician Decision|0|||
37680969|NCT01712659|69156691|FG003|Dose Escalation|Physician Decision|0|||
37680970|NCT01712659|69156692|FG004|Dose Escalation|Physician Decision|0|||
37680971|NCT01712659|69156688|FG000|Dose Escalation|Unable to take study drug|0|||
37680972|NCT01712659|69156689|FG001|Dose Escalation|Unable to take study drug|1|||
37680973|NCT01712659|69156690|FG002|Dose Escalation|Unable to take study drug|0|||
37680974|NCT01712659|69156691|FG003|Dose Escalation|Unable to take study drug|0|||
37680975|NCT01712659|69156692|FG004|Dose Escalation|Unable to take study drug|0|||
37680976|NCT01712659|69156688|FG000|Dose Expansion|Early disease progression|1|||
37680977|NCT01712659|69156689|FG001|Dose Expansion|Early disease progression|0|||
37680978|NCT01712659|69156690|FG002|Dose Expansion|Early disease progression|0|||
37680979|NCT01712659|69156691|FG003|Dose Expansion|Early disease progression|0|||
37680980|NCT01712659|69156692|FG004|Dose Expansion|Early disease progression|0|||
37680981|NCT01712659|69156688|FG000|Dose Expansion|Physician Decision|1|||
37680982|NCT01712659|69156689|FG001|Dose Expansion|Physician Decision|0|||
37680983|NCT01712659|69156690|FG002|Dose Expansion|Physician Decision|0|||
37680984|NCT01712659|69156691|FG003|Dose Expansion|Physician Decision|0|||
37680985|NCT01712659|69156692|FG004|Dose Expansion|Physician Decision|0|||
37680986|NCT01610713|69156718|FG000|Overall Study|Adverse Event|3|||
37680987|NCT01610713|69156719|FG001|Overall Study|Adverse Event|0|||
37680988|NCT01610713|69156718|FG000|Overall Study|Lack of Efficacy|1|||
37680989|NCT01610713|69156719|FG001|Overall Study|Lack of Efficacy|0|||
37680990|NCT01610713|69156718|FG000|Overall Study|low mood and poor motivation|1|||
37680991|NCT01610713|69156719|FG001|Overall Study|low mood and poor motivation|0|||
37680992|NCT01610713|69156718|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
37680993|NCT01610713|69156719|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
37680994|NCT01610713|69156718|FG000|Overall Study|Lost to Follow-up|0|||
37680995|NCT01610713|69156719|FG001|Overall Study|Lost to Follow-up|1|||
37680996|NCT01606189|69156725|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
37680997|NCT01606189|69156726|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
37680998|NCT01606189|69156727|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
38081254|NCT02740478|69779568|FG000|Overall Study|Withdrawal by Subject|1|||
38081255|NCT02969655|69779574|FG000|Overall Study|Withdrawal by Subject|3|||
38081256|NCT02969655|69779575|FG001|Overall Study|Withdrawal by Subject|2|||
38081257|NCT02969655|69779574|FG000|Overall Study|Physician Decision|4|||
38081258|NCT02969655|69779575|FG001|Overall Study|Physician Decision|3|||
38081259|NCT02969655|69779574|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
38081260|NCT02969655|69779575|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
38081261|NCT02969655|69779574|FG000|Overall Study|Adverse Event|10|||
38081262|NCT02969655|69779575|FG001|Overall Study|Adverse Event|8|||
38081263|NCT01317199|69779586|FG000|Dose-escalation Phase 1|Physician Decision|5|||
38081264|NCT01317199|69779587|FG001|Dose-escalation Phase 1|Physician Decision|0|||
38081265|NCT01317199|69779588|FG002|Dose-escalation Phase 1|Physician Decision|0|||
38081266|NCT01317199|69779589|FG003|Dose-escalation Phase 1|Physician Decision|0|||
38081267|NCT01317199|69779586|FG000|Dose-escalation Phase 1|Disease progression|1|||
38081268|NCT01317199|69779587|FG001|Dose-escalation Phase 1|Disease progression|0|||
37680999|NCT01606189|69156728|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
37681000|NCT01606189|69156729|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
37681001|NCT01606189|69156730|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
37681002|NCT01606189|69156725|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
37681003|NCT01606189|69156726|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
37681004|NCT01606189|69156727|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
37681005|NCT01606189|69156728|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
37681006|NCT01606189|69156729|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
37681007|NCT01606189|69156730|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
37681008|NCT01663987|69156740|FG000|Overall Study|Adverse Event|7|||
37681009|NCT01663987|69156741|FG001|Overall Study|Adverse Event|2|||
37681010|NCT01663987|69156740|FG000|Overall Study|Lost to Follow-up|1|||
37681011|NCT01663987|69156741|FG001|Overall Study|Lost to Follow-up|1|||
37681012|NCT01663987|69156740|FG000|Overall Study|Withdrawal by Subject|2|||
37681013|NCT01663987|69156741|FG001|Overall Study|Withdrawal by Subject|3|||
37681014|NCT01663987|69156740|FG000|Overall Study|Other reason not defined above|3|||
37681015|NCT01663987|69156741|FG001|Overall Study|Other reason not defined above|0|||
37681016|NCT02380677|69156759|FG000|Overall Study|Adverse Event|0|||
37681017|NCT02380677|69156760|FG001|Overall Study|Adverse Event|0|||
37681018|NCT02380677|69156761|FG002|Overall Study|Adverse Event|0|||
37681019|NCT02380677|69156762|FG003|Overall Study|Adverse Event|1|||
37681020|NCT02380677|69156763|FG004|Overall Study|Adverse Event|1|||
37681021|NCT02380677|69156764|FG005|Overall Study|Adverse Event|4|||
37681022|NCT02380677|69156765|FG006|Overall Study|Adverse Event|2|||
37681023|NCT02380677|69156766|FG007|Overall Study|Adverse Event|2|||
37681024|NCT02380677|69156767|FG008|Overall Study|Adverse Event|2|||
37681025|NCT02380677|69156768|FG009|Overall Study|Adverse Event|1|||
38081269|NCT01317199|69779588|FG002|Dose-escalation Phase 1|Disease progression|0|||
38081270|NCT01317199|69779589|FG003|Dose-escalation Phase 1|Disease progression|0|||
38081271|NCT01317199|69779586|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
38081272|NCT01317199|69779587|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
38081273|NCT01317199|69779588|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
38081274|NCT01317199|69779589|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
38081275|NCT01317199|69779586|FG000|Randomized Phase 2|Disease progression|0|||
38081276|NCT01317199|69779587|FG001|Randomized Phase 2|Disease progression|3|||
38081277|NCT01317199|69779588|FG002|Randomized Phase 2|Disease progression|7|||
38081278|NCT01317199|69779589|FG003|Randomized Phase 2|Disease progression|5|||
38081279|NCT01317199|69779586|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
38081280|NCT01317199|69779587|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
38081281|NCT01317199|69779588|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
38081282|NCT01317199|69779589|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
38081283|NCT01317199|69779586|FG000|Randomized Phase 2|Adverse Event|0|||
38081284|NCT01317199|69779587|FG001|Randomized Phase 2|Adverse Event|0|||
38081285|NCT01317199|69779588|FG002|Randomized Phase 2|Adverse Event|0|||
38081286|NCT01317199|69779589|FG003|Randomized Phase 2|Adverse Event|1|||
38081287|NCT01317199|69779586|FG000|Randomized Phase 2|Comorbidities|0|||
38081288|NCT01317199|69779587|FG001|Randomized Phase 2|Comorbidities|2|||
38081289|NCT01317199|69779588|FG002|Randomized Phase 2|Comorbidities|2|||
38081290|NCT01317199|69779589|FG003|Randomized Phase 2|Comorbidities|2|||
38081291|NCT01317199|69779586|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
38081292|NCT01317199|69779587|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
38081293|NCT01317199|69779588|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
37681026|NCT02380677|69156769|FG010|Overall Study|Adverse Event|2|||
37681027|NCT02380677|69156770|FG011|Overall Study|Adverse Event|1|||
37681028|NCT02380677|69156759|FG000|Overall Study|Physician Decision|1|||
37681029|NCT02380677|69156760|FG001|Overall Study|Physician Decision|0|||
37681030|NCT02380677|69156761|FG002|Overall Study|Physician Decision|1|||
37681031|NCT02380677|69156762|FG003|Overall Study|Physician Decision|1|||
37681032|NCT02380677|69156763|FG004|Overall Study|Physician Decision|0|||
37681033|NCT02380677|69156764|FG005|Overall Study|Physician Decision|0|||
37681034|NCT02380677|69156765|FG006|Overall Study|Physician Decision|0|||
37681035|NCT02380677|69156766|FG007|Overall Study|Physician Decision|0|||
37681036|NCT02380677|69156767|FG008|Overall Study|Physician Decision|0|||
37681037|NCT02380677|69156768|FG009|Overall Study|Physician Decision|0|||
37681038|NCT02380677|69156769|FG010|Overall Study|Physician Decision|0|||
37681039|NCT02380677|69156770|FG011|Overall Study|Physician Decision|0|||
37681040|NCT02380677|69156759|FG000|Overall Study|Lack of Efficacy|0|||
37681041|NCT02380677|69156760|FG001|Overall Study|Lack of Efficacy|1|||
37681042|NCT02380677|69156761|FG002|Overall Study|Lack of Efficacy|2|||
37681043|NCT02380677|69156762|FG003|Overall Study|Lack of Efficacy|0|||
37681044|NCT02380677|69156763|FG004|Overall Study|Lack of Efficacy|4|||
37681045|NCT02380677|69156764|FG005|Overall Study|Lack of Efficacy|1|||
37681046|NCT02380677|69156765|FG006|Overall Study|Lack of Efficacy|1|||
37681047|NCT02380677|69156766|FG007|Overall Study|Lack of Efficacy|2|||
37681048|NCT02380677|69156767|FG008|Overall Study|Lack of Efficacy|2|||
37681049|NCT02380677|69156768|FG009|Overall Study|Lack of Efficacy|0|||
37681050|NCT02380677|69156769|FG010|Overall Study|Lack of Efficacy|2|||
37681051|NCT02380677|69156770|FG011|Overall Study|Lack of Efficacy|1|||
37681052|NCT02380677|69156759|FG000|Overall Study|Withdrawal by Subject|0|||
37681053|NCT02380677|69156760|FG001|Overall Study|Withdrawal by Subject|0|||
37681054|NCT02380677|69156761|FG002|Overall Study|Withdrawal by Subject|0|||
37681055|NCT02380677|69156762|FG003|Overall Study|Withdrawal by Subject|0|||
37681056|NCT02380677|69156763|FG004|Overall Study|Withdrawal by Subject|0|||
37681057|NCT02380677|69156764|FG005|Overall Study|Withdrawal by Subject|0|||
37681058|NCT02380677|69156765|FG006|Overall Study|Withdrawal by Subject|0|||
37681059|NCT02380677|69156766|FG007|Overall Study|Withdrawal by Subject|0|||
37681060|NCT02380677|69156767|FG008|Overall Study|Withdrawal by Subject|0|||
37681061|NCT02380677|69156768|FG009|Overall Study|Withdrawal by Subject|1|||
37681062|NCT02380677|69156769|FG010|Overall Study|Withdrawal by Subject|0|||
37681063|NCT02380677|69156770|FG011|Overall Study|Withdrawal by Subject|3|||
37681064|NCT02380677|69156759|FG000|Overall Study|Other|0|||
37681065|NCT02380677|69156760|FG001|Overall Study|Other|0|||
37681066|NCT02380677|69156761|FG002|Overall Study|Other|0|||
37681067|NCT02380677|69156762|FG003|Overall Study|Other|1|||
37681068|NCT02380677|69156763|FG004|Overall Study|Other|1|||
37681069|NCT02380677|69156764|FG005|Overall Study|Other|1|||
37681070|NCT02380677|69156765|FG006|Overall Study|Other|0|||
37681071|NCT02380677|69156766|FG007|Overall Study|Other|0|||
37681072|NCT02380677|69156767|FG008|Overall Study|Other|0|||
37681073|NCT02380677|69156768|FG009|Overall Study|Other|0|||
37681074|NCT02380677|69156769|FG010|Overall Study|Other|0|||
37681075|NCT02380677|69156770|FG011|Overall Study|Other|0|||
37681076|NCT02380287|69156806|FG000|Overall Study|Adverse Event|0|||
37681077|NCT02380287|69156807|FG001|Overall Study|Adverse Event|0|||
37681078|NCT02380287|69156808|FG002|Overall Study|Adverse Event|1|||
37681079|NCT02380287|69156809|FG003|Overall Study|Adverse Event|0|||
38081294|NCT01317199|69779589|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
38081295|NCT01317199|69779586|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
37681080|NCT02380287|69156810|FG004|Overall Study|Adverse Event|0|||
38081296|NCT01317199|69779587|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
38081297|NCT01317199|69779588|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
38081298|NCT01317199|69779589|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
38081299|NCT01317199|69779586|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
38081300|NCT01317199|69779587|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
38081301|NCT01317199|69779588|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
37681081|NCT02380287|69156811|FG005|Overall Study|Adverse Event|0|||
37681082|NCT02380287|69156812|FG006|Overall Study|Adverse Event|0|||
37681083|NCT02380287|69156813|FG007|Overall Study|Adverse Event|0|||
37681084|NCT02343003|69156840|FG000|Overall Study|Withdrawal by Subject|9|||
37681085|NCT02343003|69156841|FG001|Overall Study|Withdrawal by Subject|4|||
37681086|NCT02343003|69156840|FG000|Overall Study|Lost to Follow-up|5|||
37681087|NCT02343003|69156841|FG001|Overall Study|Lost to Follow-up|1|||
37681088|NCT02343003|69156840|FG000|Overall Study|Protocol Violation|1|||
37681089|NCT02343003|69156841|FG001|Overall Study|Protocol Violation|0|||
37681090|NCT02343003|69156840|FG000|Overall Study|Death|0|||
37681091|NCT02343003|69156841|FG001|Overall Study|Death|1|||
37681092|NCT02343003|69156840|FG000|Overall Study|exclusion criteria met|1|||
37681093|NCT02343003|69156841|FG001|Overall Study|exclusion criteria met|1|||
37681094|NCT02343003|69156840|FG000|Overall Study|terminated by sponsor|2|||
37681095|NCT02343003|69156841|FG001|Overall Study|terminated by sponsor|0|||
37681096|NCT02394561|69156849|FG000|CORE Phase|Adverse Event|7|||
37681097|NCT02394561|69156850|FG001|CORE Phase|Adverse Event|9|||
37681098|NCT02394561|69156849|FG000|CORE Phase|Death|0|||
37681099|NCT02394561|69156850|FG001|CORE Phase|Death|1|||
37681100|NCT02394561|69156849|FG000|CORE Phase|Pregnancy|1|||
37681101|NCT02394561|69156850|FG001|CORE Phase|Pregnancy|0|||
37681102|NCT02394561|69156849|FG000|CORE Phase|Lost to Follow-up|1|||
37681103|NCT02394561|69156850|FG001|CORE Phase|Lost to Follow-up|0|||
37681104|NCT02394561|69156849|FG000|CORE Phase|Physician Decision|1|||
37681105|NCT02394561|69156850|FG001|CORE Phase|Physician Decision|1|||
37681106|NCT02394561|69156849|FG000|CORE Phase|Withdrawal by Subject|2|||
37681107|NCT02394561|69156850|FG001|CORE Phase|Withdrawal by Subject|2|||
37681108|NCT02394561|69156849|FG000|CORE Phase|Lack of Efficacy|1|||
37681109|NCT02394561|69156850|FG001|CORE Phase|Lack of Efficacy|6|||
37681110|NCT02394561|69156849|FG000|Extension Phase|Adverse Event|6|||
37681111|NCT02394561|69156850|FG001|Extension Phase|Adverse Event|1|||
37681112|NCT02394561|69156849|FG000|Extension Phase|Death|0|||
37681113|NCT02394561|69156850|FG001|Extension Phase|Death|1|||
37681114|NCT02394561|69156849|FG000|Extension Phase|Protocol Violation|1|||
37681115|NCT02394561|69156850|FG001|Extension Phase|Protocol Violation|0|||
37681116|NCT02394561|69156849|FG000|Extension Phase|Lost to Follow-up|1|||
37681117|NCT02394561|69156850|FG001|Extension Phase|Lost to Follow-up|0|||
37681118|NCT02394561|69156849|FG000|Extension Phase|Physician Decision|0|||
37681119|NCT02394561|69156850|FG001|Extension Phase|Physician Decision|2|||
37681120|NCT02394561|69156849|FG000|Extension Phase|Withdrawal by Subject|0|||
37681121|NCT02394561|69156850|FG001|Extension Phase|Withdrawal by Subject|5|||
37681122|NCT02394561|69156849|FG000|Extension Phase|Lack of Efficacy|3|||
37681123|NCT02394561|69156850|FG001|Extension Phase|Lack of Efficacy|3|||
37681124|NCT02342223|69156859|FG000|Overall Study|Lost to Follow-up|1|||
37681125|NCT02393547|69156863|FG000|Overall Study|Adverse Event|2|||
37681126|NCT02393547|69156863|FG000|Overall Study|Withdrawal by Subject|3|||
37681127|NCT02393547|69156863|FG000|Overall Study|Lost to Follow-up|1|||
37681128|NCT02574637|69156872|FG000|Double-blind Period|Adverse Event|1|||
37681129|NCT02574637|69156873|FG001|Double-blind Period|Adverse Event|0|||
37681130|NCT02574637|69156874|FG002|Double-blind Period|Adverse Event|0|||
37681131|NCT02574637|69156875|FG003|Double-blind Period|Adverse Event|0|||
37681132|NCT02574637|69156876|FG004|Double-blind Period|Adverse Event|0|||
37681133|NCT02574637|69156877|FG005|Double-blind Period|Adverse Event|0|||
37681134|NCT02574637|69156878|FG006|Double-blind Period|Adverse Event|0|||
37681135|NCT02574637|69156879|FG007|Double-blind Period|Adverse Event|0|||
37681136|NCT02574637|69156880|FG008|Double-blind Period|Adverse Event|0|||
37681137|NCT02574637|69156881|FG009|Double-blind Period|Adverse Event|0|||
37681138|NCT02574637|69156872|FG000|Double-blind Period|Lack of Efficacy|0|||
37681139|NCT02574637|69156873|FG001|Double-blind Period|Lack of Efficacy|0|||
37681140|NCT02574637|69156874|FG002|Double-blind Period|Lack of Efficacy|2|||
37681141|NCT02574637|69156875|FG003|Double-blind Period|Lack of Efficacy|0|||
37681142|NCT02574637|69156876|FG004|Double-blind Period|Lack of Efficacy|0|||
37681143|NCT02574637|69156877|FG005|Double-blind Period|Lack of Efficacy|0|||
37681144|NCT02574637|69156878|FG006|Double-blind Period|Lack of Efficacy|0|||
37771420|NCT01360632|69290630|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
37771421|NCT01360632|69290631|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
37771422|NCT01360632|69290632|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
37771423|NCT01360632|69290633|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
37771424|NCT01360632|69290634|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
37771425|NCT01360632|69290630|FG000|Phase B (6 Weeks)|Physician Decision|0|||
37771426|NCT01360632|69290631|FG001|Phase B (6 Weeks)|Physician Decision|0|||
38081302|NCT01317199|69779589|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
37681145|NCT02574637|69156879|FG007|Double-blind Period|Lack of Efficacy|0|||
37681146|NCT02574637|69156880|FG008|Double-blind Period|Lack of Efficacy|0|||
37681147|NCT02574637|69156881|FG009|Double-blind Period|Lack of Efficacy|0|||
37681148|NCT02574637|69156872|FG000|Double-blind Period|Protocol Deviation|1|||
37681149|NCT02574637|69156873|FG001|Double-blind Period|Protocol Deviation|0|||
37681150|NCT02574637|69156874|FG002|Double-blind Period|Protocol Deviation|0|||
37681151|NCT02574637|69156875|FG003|Double-blind Period|Protocol Deviation|0|||
37681152|NCT02574637|69156876|FG004|Double-blind Period|Protocol Deviation|0|||
37681153|NCT02574637|69156877|FG005|Double-blind Period|Protocol Deviation|0|||
37681154|NCT02574637|69156878|FG006|Double-blind Period|Protocol Deviation|0|||
37681155|NCT02574637|69156879|FG007|Double-blind Period|Protocol Deviation|0|||
37681156|NCT02574637|69156880|FG008|Double-blind Period|Protocol Deviation|0|||
37681157|NCT02574637|69156881|FG009|Double-blind Period|Protocol Deviation|0|||
37681158|NCT02574637|69156872|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
37771427|NCT01360632|69290632|FG002|Phase B (6 Weeks)|Physician Decision|0|||
37681159|NCT02574637|69156873|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
37681160|NCT02574637|69156874|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
37681161|NCT02574637|69156875|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
37681162|NCT02574637|69156876|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
37681163|NCT02574637|69156877|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
37681164|NCT02574637|69156878|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
37681165|NCT02574637|69156879|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
37681166|NCT02574637|69156880|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
37681167|NCT02574637|69156881|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
37681168|NCT02574637|69156872|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
37681169|NCT02574637|69156873|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
37681170|NCT02574637|69156874|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
37681171|NCT02574637|69156875|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
37681172|NCT02574637|69156876|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
37681173|NCT02574637|69156877|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
37681174|NCT02574637|69156878|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
37681175|NCT02574637|69156879|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
37681176|NCT02574637|69156880|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
37681177|NCT02574637|69156881|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
37681178|NCT02574637|69156872|FG000|Double-blind Period|Reason Not Specified|0|||
37681179|NCT02574637|69156873|FG001|Double-blind Period|Reason Not Specified|0|||
37681180|NCT02574637|69156874|FG002|Double-blind Period|Reason Not Specified|0|||
37681181|NCT02574637|69156875|FG003|Double-blind Period|Reason Not Specified|1|||
37681182|NCT02574637|69156876|FG004|Double-blind Period|Reason Not Specified|0|||
37681183|NCT02574637|69156877|FG005|Double-blind Period|Reason Not Specified|0|||
37681184|NCT02574637|69156878|FG006|Double-blind Period|Reason Not Specified|0|||
37681185|NCT02574637|69156879|FG007|Double-blind Period|Reason Not Specified|0|||
37681186|NCT02574637|69156880|FG008|Double-blind Period|Reason Not Specified|0|||
37681187|NCT02574637|69156881|FG009|Double-blind Period|Reason Not Specified|0|||
37681188|NCT02574637|69156872|FG000|Open-label (OL) Period|Adverse Event|0|||
37681189|NCT02574637|69156873|FG001|Open-label (OL) Period|Adverse Event|0|||
37681190|NCT02574637|69156874|FG002|Open-label (OL) Period|Adverse Event|0|||
37681191|NCT02574637|69156875|FG003|Open-label (OL) Period|Adverse Event|0|||
37681192|NCT02574637|69156876|FG004|Open-label (OL) Period|Adverse Event|0|||
37681193|NCT02574637|69156877|FG005|Open-label (OL) Period|Adverse Event|0|||
37681194|NCT02574637|69156878|FG006|Open-label (OL) Period|Adverse Event|0|||
37966885|NCT00447057|69653833|FG002|Overall Study|Death due to study disease|1|||
37966886|NCT00447057|69653834|FG003|Overall Study|Death due to study disease|1|||
37966887|NCT00447057|69653831|FG000|Overall Study|Lost to Follow-up|0|||
38081303|NCT01317199|69779586|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
38081304|NCT01317199|69779587|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
38081305|NCT01317199|69779588|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
38081306|NCT01317199|69779589|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
38081307|NCT02648698|69779608|FG000|Overall Study|Protocol Violation|1|||
38081308|NCT02648698|69779609|FG001|Overall Study|Protocol Violation|5|||
38081309|NCT02970669|69779617|FG000|Double-blind Period|Adverse Event|4|||
38081310|NCT02970669|69779618|FG001|Double-blind Period|Adverse Event|0|||
37681195|NCT02574637|69156879|FG007|Open-label (OL) Period|Adverse Event|0|||
37681196|NCT02574637|69156880|FG008|Open-label (OL) Period|Adverse Event|1|||
37681197|NCT02574637|69156881|FG009|Open-label (OL) Period|Adverse Event|0|||
38081311|NCT02970669|69779617|FG000|Double-blind Period|Death|1|||
38081312|NCT02970669|69779618|FG001|Double-blind Period|Death|0|||
38081313|NCT02970669|69779617|FG000|Double-blind Period|Study terminated by sponsor|1|||
38081314|NCT02970669|69779618|FG001|Double-blind Period|Study terminated by sponsor|2|||
38081315|NCT02970669|69779617|FG000|Double-blind Period|Physician Decision|0|||
37681198|NCT02574637|69156872|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
37681199|NCT02574637|69156873|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
38081316|NCT02970669|69779618|FG001|Double-blind Period|Physician Decision|2|||
38081317|NCT02970669|69779617|FG000|Double-blind Period|Withdrawal by Subject|2|||
38081318|NCT02970669|69779618|FG001|Double-blind Period|Withdrawal by Subject|2|||
37681200|NCT02574637|69156874|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
37681201|NCT02574637|69156875|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
37966888|NCT00447057|69653832|FG001|Overall Study|Lost to Follow-up|1|||
38081319|NCT02970669|69779617|FG000|Open-label Period|Withdrawal by Subject|2|||
38081320|NCT02970669|69779618|FG001|Open-label Period|Withdrawal by Subject|2|||
38081321|NCT02970669|69779617|FG000|Open-label Period|Adverse Event|1|||
38081322|NCT02970669|69779618|FG001|Open-label Period|Adverse Event|0|||
38081323|NCT02970669|69779617|FG000|Open-label Period|Physician Decision|1|||
38081324|NCT02970669|69779618|FG001|Open-label Period|Physician Decision|0|||
38081325|NCT02902965|69779626|FG000|Overall Study|Withdrawal by Subject|10|||
38081326|NCT02902809|69779631|FG000|Overall Study|Discontinuation of asthma program|28|||
38081327|NCT01362244|69779637|FG000|Overall Study|Adverse Event|3|||
38081328|NCT01362244|69779638|FG001|Overall Study|Adverse Event|5|||
38081329|NCT01362244|69779637|FG000|Overall Study|Lack of Efficacy|5|||
38081330|NCT01362244|69779638|FG001|Overall Study|Lack of Efficacy|11|||
38081331|NCT01362244|69779637|FG000|Overall Study|Lost to Follow-up|0|||
38081332|NCT01362244|69779638|FG001|Overall Study|Lost to Follow-up|2|||
38081333|NCT01362244|69779637|FG000|Overall Study|Protocol Violation|5|||
37966889|NCT00447057|69653833|FG002|Overall Study|Lost to Follow-up|0|||
38081334|NCT01362244|69779638|FG001|Overall Study|Protocol Violation|1|||
38081335|NCT01362244|69779637|FG000|Overall Study|Withdrawal by Subject|2|||
38081336|NCT01362244|69779638|FG001|Overall Study|Withdrawal by Subject|1|||
38081337|NCT01362244|69779637|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
38081338|NCT01362244|69779638|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
38081339|NCT01362244|69779637|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
38081340|NCT01362244|69779638|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
38081341|NCT02969187|69779646|FG000|Overall Study|Physician Decision|12|||
38081342|NCT02969187|69779647|FG001|Overall Study|Physician Decision|13|||
38081343|NCT03050359|69779657|FG000|Overall Study|Randomized But Not Treated|2|||
38081344|NCT03050359|69779658|FG001|Overall Study|Randomized But Not Treated|0|||
38081345|NCT03050359|69779657|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
38081346|NCT03050359|69779658|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
38081347|NCT03050359|69779657|FG000|Overall Study|Significant Protocol Deviation|2|||
38081348|NCT03050359|69779658|FG001|Overall Study|Significant Protocol Deviation|3|||
38081349|NCT03050359|69779657|FG000|Overall Study|Lost to Follow-up|2|||
38081350|NCT03050359|69779658|FG001|Overall Study|Lost to Follow-up|1|||
38081351|NCT03050359|69779657|FG000|Overall Study|Voluntary Withdrawal|4|||
38081352|NCT03050359|69779658|FG001|Overall Study|Voluntary Withdrawal|6|||
38081353|NCT03050359|69779657|FG000|Overall Study|Pregnancy|1|||
38081354|NCT03050359|69779658|FG001|Overall Study|Pregnancy|0|||
38081355|NCT03050359|69779657|FG000|Overall Study|Reason Not Specified|1|||
37681202|NCT02574637|69156876|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
37681203|NCT02574637|69156877|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
37681204|NCT02574637|69156878|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
38081356|NCT03050359|69779658|FG001|Overall Study|Reason Not Specified|0|||
37681205|NCT02574637|69156879|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
37681206|NCT02574637|69156880|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
38081357|NCT02785770|69779666|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
38081358|NCT02785770|69779667|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
38081359|NCT02785770|69779668|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
38081360|NCT02785770|69779669|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
38081361|NCT02785770|69779666|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
38081362|NCT02785770|69779667|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
38081363|NCT02785770|69779668|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
38081364|NCT02785770|69779669|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
37681207|NCT02574637|69156881|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
37681208|NCT02574637|69156872|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
37681209|NCT02574637|69156873|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
37681210|NCT02574637|69156874|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
37681211|NCT02574637|69156875|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
37681212|NCT02574637|69156876|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
37681213|NCT02574637|69156877|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
37681214|NCT02574637|69156878|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
37681215|NCT02574637|69156879|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
37681216|NCT02574637|69156880|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
37681217|NCT02574637|69156881|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
37681218|NCT02392611|69156911|FG000|Overall Study|Adverse Event|0|||
37681219|NCT02392611|69156912|FG001|Overall Study|Adverse Event|0|||
37966890|NCT00447057|69653834|FG003|Overall Study|Lost to Follow-up|0|||
37966891|NCT00447057|69653831|FG000|Overall Study|Entry criteria not met|1|||
37966892|NCT00447057|69653832|FG001|Overall Study|Entry criteria not met|1|||
37966893|NCT00447057|69653833|FG002|Overall Study|Entry criteria not met|0|||
37966894|NCT00447057|69653834|FG003|Overall Study|Entry criteria not met|0|||
37966895|NCT00447057|69653831|FG000|Overall Study|Protocol Violation|0|||
37966896|NCT00447057|69653832|FG001|Overall Study|Protocol Violation|1|||
37966897|NCT00447057|69653833|FG002|Overall Study|Protocol Violation|0|||
37966898|NCT00447057|69653834|FG003|Overall Study|Protocol Violation|0|||
37966899|NCT00447057|69653831|FG000|Overall Study|Withdrawal by Subject|4|||
38081365|NCT02785770|69779666|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
38081366|NCT02785770|69779667|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
38081367|NCT02785770|69779668|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
38081368|NCT02785770|69779669|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
38081369|NCT02965833|69779682|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
38081370|NCT02965833|69779683|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
38081371|NCT02965833|69779682|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
38081372|NCT02965833|69779683|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
38081373|NCT02965833|69779682|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
38081374|NCT02965833|69779683|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
38081375|NCT02965833|69779682|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
38081376|NCT02965833|69779683|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
38081377|NCT02965833|69779682|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
38081378|NCT02965833|69779683|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
38081379|NCT02968173|69779689|FG000|Overall Study|Withdrawal by Subject|1|||
38081380|NCT02785458|69779696|FG000|1 Month|Withdrawal by Subject|2|||
38081381|NCT02785458|69779697|FG001|1 Month|Withdrawal by Subject|1|||
38081382|NCT02785458|69779696|FG000|1 Month|Lost to Follow-up|38|||
37966900|NCT00447057|69653832|FG001|Overall Study|Withdrawal by Subject|5|||
37966901|NCT00447057|69653833|FG002|Overall Study|Withdrawal by Subject|1|||
37966902|NCT00447057|69653834|FG003|Overall Study|Withdrawal by Subject|1|||
38081383|NCT02785458|69779697|FG001|1 Month|Lost to Follow-up|31|||
38081384|NCT02785458|69779696|FG000|1 Month|Deemed Ineligible|1|||
38081385|NCT02785458|69779697|FG001|1 Month|Deemed Ineligible|0|||
37681220|NCT02392611|69156913|FG002|Overall Study|Adverse Event|0|||
37681221|NCT02392611|69156914|FG003|Overall Study|Adverse Event|1|||
37681222|NCT02392611|69156915|FG004|Overall Study|Adverse Event|0|||
37681223|NCT02392611|69156916|FG005|Overall Study|Adverse Event|0|||
37681224|NCT02392611|69156917|FG006|Overall Study|Adverse Event|0|||
37681225|NCT02392611|69156918|FG007|Overall Study|Adverse Event|0|||
37681226|NCT02392611|69156919|FG008|Overall Study|Adverse Event|0|||
37681227|NCT02392611|69156911|FG000|Overall Study|Progressive disease|0|||
37681228|NCT02392611|69156912|FG001|Overall Study|Progressive disease|0|||
37681229|NCT02392611|69156913|FG002|Overall Study|Progressive disease|0|||
37681230|NCT02392611|69156914|FG003|Overall Study|Progressive disease|2|||
37681231|NCT02392611|69156915|FG004|Overall Study|Progressive disease|1|||
37681232|NCT02392611|69156916|FG005|Overall Study|Progressive disease|0|||
37681233|NCT02392611|69156917|FG006|Overall Study|Progressive disease|0|||
37681234|NCT02392611|69156918|FG007|Overall Study|Progressive disease|0|||
37681235|NCT02392611|69156919|FG008|Overall Study|Progressive disease|0|||
37681236|NCT02392611|69156911|FG000|Overall Study|Death|1|||
37681237|NCT02392611|69156912|FG001|Overall Study|Death|0|||
37681238|NCT02392611|69156913|FG002|Overall Study|Death|0|||
37681239|NCT02392611|69156914|FG003|Overall Study|Death|0|||
37681240|NCT02392611|69156915|FG004|Overall Study|Death|0|||
37681241|NCT02392611|69156916|FG005|Overall Study|Death|1|||
37681242|NCT02392611|69156917|FG006|Overall Study|Death|0|||
37681243|NCT02392611|69156918|FG007|Overall Study|Death|0|||
37681244|NCT02392611|69156919|FG008|Overall Study|Death|0|||
37681245|NCT02392611|69156911|FG000|Overall Study|Withdrawal by Subject|0|||
37681246|NCT02392611|69156912|FG001|Overall Study|Withdrawal by Subject|0|||
37681247|NCT02392611|69156913|FG002|Overall Study|Withdrawal by Subject|0|||
37681248|NCT02392611|69156914|FG003|Overall Study|Withdrawal by Subject|1|||
37681249|NCT02392611|69156915|FG004|Overall Study|Withdrawal by Subject|0|||
37681250|NCT02392611|69156916|FG005|Overall Study|Withdrawal by Subject|0|||
37966903|NCT00447057|69653831|FG000|Overall Study|Physician Decision|9|||
37966904|NCT00447057|69653832|FG001|Overall Study|Physician Decision|6|||
37966905|NCT00447057|69653833|FG002|Overall Study|Physician Decision|3|||
37966906|NCT00447057|69653834|FG003|Overall Study|Physician Decision|1|||
37966907|NCT00447057|69653831|FG000|Overall Study|Sponsor decision|1|||
37966908|NCT00447057|69653832|FG001|Overall Study|Sponsor decision|1|||
37966909|NCT00447057|69653833|FG002|Overall Study|Sponsor decision|0|||
37966910|NCT00447057|69653834|FG003|Overall Study|Sponsor decision|0|||
37966911|NCT00447057|69653831|FG000|Overall Study|Progressive disease|58|||
37966912|NCT00447057|69653832|FG001|Overall Study|Progressive disease|43|||
38081386|NCT02785458|69779696|FG000|1 Month|Completed Evaluation by Baseline|42|||
37681251|NCT02392611|69156917|FG006|Overall Study|Withdrawal by Subject|0|||
37966913|NCT00447057|69653833|FG002|Overall Study|Progressive disease|13|||
37966914|NCT00447057|69653834|FG003|Overall Study|Progressive disease|18|||
38081387|NCT02785458|69779697|FG001|1 Month|Completed Evaluation by Baseline|39|||
38081388|NCT02785458|69779696|FG000|1 Month|Partial Interview|0|||
38081389|NCT02785458|69779697|FG001|1 Month|Partial Interview|4|||
38081390|NCT02785458|69779696|FG000|3 Months|Withdrawal by Subject|3|||
38081391|NCT02785458|69779697|FG001|3 Months|Withdrawal by Subject|1|||
38081392|NCT02785458|69779696|FG000|3 Months|Lost to Follow-up|25|||
38081393|NCT02785458|69779697|FG001|3 Months|Lost to Follow-up|21|||
38081394|NCT02785458|69779696|FG000|3 Months|Completed Evaluation at 1 Month|100|||
38081395|NCT02785458|69779697|FG001|3 Months|Completed Evaluation at 1 Month|89|||
38081396|NCT02784834|69779703|FG000|Overall Study|Lack of Efficacy|1|||
38081397|NCT02966223|69779707|FG000|Overall Study|Physician Decision|3|||
38081398|NCT02966223|69779707|FG000|Overall Study|Withdrawal by Subject|11|||
38081399|NCT02966223|69779707|FG000|Overall Study|Lost to Follow-up|1|||
37966915|NCT00447057|69653831|FG000|Overall Study|Death due to adverse event|0|||
37966916|NCT00447057|69653832|FG001|Overall Study|Death due to adverse event|0|||
38081400|NCT03049735|69779714|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
37681252|NCT02392611|69156918|FG007|Overall Study|Withdrawal by Subject|0|||
37681253|NCT02392611|69156919|FG008|Overall Study|Withdrawal by Subject|0|||
37681254|NCT02392611|69156911|FG000|Overall Study|Lost to Follow-up|0|||
37681255|NCT02392611|69156912|FG001|Overall Study|Lost to Follow-up|0|||
37681256|NCT02392611|69156913|FG002|Overall Study|Lost to Follow-up|0|||
37681257|NCT02392611|69156914|FG003|Overall Study|Lost to Follow-up|0|||
37681258|NCT02392611|69156915|FG004|Overall Study|Lost to Follow-up|0|||
37681259|NCT02392611|69156916|FG005|Overall Study|Lost to Follow-up|0|||
38081401|NCT03049735|69779715|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
38081402|NCT03049735|69779716|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
38081403|NCT03049735|69779714|FG000|Overall Study|Other|5|||
38081404|NCT03049735|69779715|FG001|Overall Study|Other|3|||
38081405|NCT03049735|69779716|FG002|Overall Study|Other|1|||
38081406|NCT03049735|69779714|FG000|Overall Study|Lack of Efficacy|4|||
38081407|NCT03049735|69779715|FG001|Overall Study|Lack of Efficacy|0|||
38081408|NCT03049735|69779716|FG002|Overall Study|Lack of Efficacy|3|||
38081409|NCT03049735|69779714|FG000|Overall Study|Protocol deviation|1|||
38081410|NCT03049735|69779715|FG001|Overall Study|Protocol deviation|0|||
38081411|NCT03049735|69779716|FG002|Overall Study|Protocol deviation|0|||
38081412|NCT03049735|69779714|FG000|Overall Study|Pregnancy|0|||
38081413|NCT03049735|69779715|FG001|Overall Study|Pregnancy|0|||
38081414|NCT03049735|69779716|FG002|Overall Study|Pregnancy|1|||
38081415|NCT03049735|69779714|FG000|Overall Study|Adverse Event|7|||
38081416|NCT03049735|69779715|FG001|Overall Study|Adverse Event|18|||
38081417|NCT03049735|69779716|FG002|Overall Study|Adverse Event|5|||
38081418|NCT03049735|69779714|FG000|Overall Study|Withdrawal by Subject|10|||
38081419|NCT03049735|69779715|FG001|Overall Study|Withdrawal by Subject|3|||
38081420|NCT03049735|69779716|FG002|Overall Study|Withdrawal by Subject|7|||
38081421|NCT03049735|69779714|FG000|Overall Study|Lost to Follow-up|1|||
38081422|NCT03049735|69779715|FG001|Overall Study|Lost to Follow-up|5|||
38081423|NCT03049735|69779716|FG002|Overall Study|Lost to Follow-up|5|||
38081424|NCT01295944|69779724|FG000|Overall Study|Switched to alternative treatment|1|||
38081425|NCT01295944|69779724|FG000|Overall Study|Ineligible|9|||
38081426|NCT01295944|69779724|FG000|Overall Study|Withdrawal by Subject|4|||
38081427|NCT01295944|69779724|FG000|Overall Study|Participant chose to be treated in Peru|1|||
38081428|NCT01295944|69779724|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
38081429|NCT01295944|69779724|FG000|Overall Study|Participant was diagnosed with stage 1 infiltrated ductal carcinoma of the right breast(10/03/2013).|1|||
38081430|NCT01295944|69779724|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
38081431|NCT02965599|69779730|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
38081432|NCT02965599|69779731|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
38081433|NCT02898597|69779740|FG000|Overall Study|Protocol Violation|4|||
38081434|NCT02898597|69779741|FG001|Overall Study|Protocol Violation|2|||
38081435|NCT02898597|69779740|FG000|Overall Study|Lost to Follow-up|0|||
38081436|NCT02898597|69779741|FG001|Overall Study|Lost to Follow-up|9|||
38081437|NCT02898597|69779740|FG000|Overall Study|Death|0|||
38081438|NCT02898597|69779741|FG001|Overall Study|Death|1|||
38081439|NCT02899377|69779749|FG000|Overall Study|Adverse Event|1|||
38081440|NCT02899377|69779750|FG001|Overall Study|Adverse Event|0|||
38081441|NCT01316887|69779761|FG000|Overall Study|Adverse Event|13|||
38081442|NCT01316887|69779762|FG001|Overall Study|Adverse Event|21|||
38081443|NCT01316887|69779763|FG002|Overall Study|Adverse Event|17|||
38081444|NCT01316887|69779761|FG000|Overall Study|Lack of Efficacy|9|||
38081445|NCT01316887|69779762|FG001|Overall Study|Lack of Efficacy|3|||
38081446|NCT01316887|69779763|FG002|Overall Study|Lack of Efficacy|1|||
38081447|NCT01316887|69779761|FG000|Overall Study|Protocol Violation|2|||
38081448|NCT01316887|69779762|FG001|Overall Study|Protocol Violation|6|||
38081449|NCT01316887|69779763|FG002|Overall Study|Protocol Violation|6|||
37681260|NCT02392611|69156917|FG006|Overall Study|Lost to Follow-up|1|||
37681261|NCT02392611|69156918|FG007|Overall Study|Lost to Follow-up|0|||
37681262|NCT02392611|69156919|FG008|Overall Study|Lost to Follow-up|0|||
37681263|NCT02392611|69156911|FG000|Overall Study|Enrolled, not treated|0|||
37681264|NCT02392611|69156912|FG001|Overall Study|Enrolled, not treated|0|||
37681265|NCT02392611|69156913|FG002|Overall Study|Enrolled, not treated|0|||
38081450|NCT01316887|69779761|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
38081451|NCT01316887|69779762|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
38081452|NCT01316887|69779763|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
38081453|NCT01316887|69779761|FG000|Overall Study|Study Closed/Terminated|2|||
38081454|NCT01316887|69779762|FG001|Overall Study|Study Closed/Terminated|4|||
37681266|NCT02392611|69156914|FG003|Overall Study|Enrolled, not treated|2|||
37681267|NCT02392611|69156915|FG004|Overall Study|Enrolled, not treated|0|||
37681268|NCT02392611|69156916|FG005|Overall Study|Enrolled, not treated|0|||
37681269|NCT02392611|69156917|FG006|Overall Study|Enrolled, not treated|0|||
37681270|NCT02392611|69156918|FG007|Overall Study|Enrolled, not treated|0|||
37681271|NCT02392611|69156919|FG008|Overall Study|Enrolled, not treated|0|||
37681272|NCT02378961|69156943|FG000|Overall Study|Lack of Efficacy|4|||
37681273|NCT02378961|69156944|FG001|Overall Study|Lack of Efficacy|2|||
37681274|NCT02378961|69156945|FG002|Overall Study|Lack of Efficacy|0|||
37681275|NCT02378961|69156946|FG003|Overall Study|Lack of Efficacy|1|||
37681276|NCT02378961|69156943|FG000|Overall Study|Death|0|||
37681277|NCT02378961|69156944|FG001|Overall Study|Death|0|||
37681278|NCT02378961|69156945|FG002|Overall Study|Death|1|||
37681279|NCT02378961|69156946|FG003|Overall Study|Death|0|||
37681280|NCT02378883|69156956|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
37681281|NCT02378883|69156956|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
37681282|NCT02378883|69156956|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
37681283|NCT02378883|69156956|FG000|30 Day Follow-Up|Physician Decision|2|||
37681284|NCT02378883|69156956|FG000|30 Day Follow-Up|Missed Visit|2|||
37681285|NCT02378883|69156956|FG000|30 Day Follow-Up|Death|1|||
37681286|NCT02378883|69156956|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
37681287|NCT02378883|69156956|FG000|12 Months Follow-Up|Death|2|||
37681288|NCT02340975|69156967|FG000|Overall Study|Death|6|||
37681289|NCT02340975|69156968|FG001|Overall Study|Death|23|||
37681290|NCT02340975|69156969|FG002|Overall Study|Death|21|||
37681291|NCT02340975|69156970|FG003|Overall Study|Death|7|||
37681292|NCT02340975|69156971|FG004|Overall Study|Death|21|||
37681293|NCT02340975|69156972|FG005|Overall Study|Death|13|||
37681294|NCT02340975|69156967|FG000|Overall Study|Lost to Follow-up|0|||
37681295|NCT02340975|69156968|FG001|Overall Study|Lost to Follow-up|0|||
37681296|NCT02340975|69156969|FG002|Overall Study|Lost to Follow-up|0|||
37681297|NCT02340975|69156970|FG003|Overall Study|Lost to Follow-up|0|||
37681298|NCT02340975|69156971|FG004|Overall Study|Lost to Follow-up|2|||
37681299|NCT02340975|69156972|FG005|Overall Study|Lost to Follow-up|0|||
37681300|NCT02340975|69156967|FG000|Overall Study|Withdrawal by Subject|0|||
37681301|NCT02340975|69156968|FG001|Overall Study|Withdrawal by Subject|0|||
37681302|NCT02340975|69156969|FG002|Overall Study|Withdrawal by Subject|3|||
37681303|NCT02340975|69156970|FG003|Overall Study|Withdrawal by Subject|3|||
37681304|NCT02340975|69156971|FG004|Overall Study|Withdrawal by Subject|2|||
38081455|NCT01316887|69779763|FG002|Overall Study|Study Closed/Terminated|3|||
38081456|NCT01316887|69779761|FG000|Overall Study|Lost to Follow-up|1|||
38081457|NCT01316887|69779762|FG001|Overall Study|Lost to Follow-up|7|||
38081458|NCT01316887|69779763|FG002|Overall Study|Lost to Follow-up|5|||
38081459|NCT01316887|69779761|FG000|Overall Study|Withdrawal by Subject|8|||
38081460|NCT01316887|69779762|FG001|Overall Study|Withdrawal by Subject|16|||
38081461|NCT01316887|69779763|FG002|Overall Study|Withdrawal by Subject|15|||
38081462|NCT02897349|69779774|FG000|Overall Study|Lost to Follow-up|2|||
38081463|NCT02897349|69779775|FG001|Overall Study|Lost to Follow-up|2|||
38081464|NCT02897349|69779774|FG000|Overall Study|Adverse Event|3|||
38081465|NCT02897349|69779775|FG001|Overall Study|Adverse Event|3|||
38081466|NCT02897349|69779774|FG000|Overall Study|Other than listed above|0|||
38081467|NCT02897349|69779775|FG001|Overall Study|Other than listed above|1|||
38081468|NCT03047551|69779792|FG000|Overall Study|Did not receive TAS|1|||
38081469|NCT03047551|69779793|FG001|Overall Study|Did not receive TAS|0|||
38081470|NCT03047551|69779792|FG000|Overall Study|Physician Decision|1|||
38081471|NCT03047551|69779793|FG001|Overall Study|Physician Decision|0|||
37681305|NCT02340975|69156972|FG005|Overall Study|Withdrawal by Subject|0|||
38081472|NCT03047551|69779792|FG000|Overall Study|Withdrawal by Subject|0|||
37681306|NCT02340975|69156967|FG000|Overall Study|Other|0|||
37681307|NCT02340975|69156968|FG001|Overall Study|Other|4|||
37681308|NCT02340975|69156969|FG002|Overall Study|Other|0|||
37681309|NCT02340975|69156970|FG003|Overall Study|Other|2|||
37681310|NCT02340975|69156971|FG004|Overall Study|Other|0|||
37681311|NCT02340975|69156972|FG005|Overall Study|Other|6|||
37681312|NCT02392377|69156989|FG000|Overall Study|Withdrawal by Subject|0|||
37681313|NCT02392377|69156990|FG001|Overall Study|Withdrawal by Subject|1|||
37681314|NCT02340819|69156998|FG000|Overall Study|Adverse Event|1|||
37681315|NCT02340819|69156998|FG000|Overall Study|Withdrawal by Subject|2|||
37681316|NCT02340819|69156998|FG000|Overall Study|Discontinued with other reason|1|||
37681317|NCT02340663|69157004|FG000|Overall Study|Lost to Follow-up|1|||
37681318|NCT02340663|69157005|FG001|Overall Study|Lost to Follow-up|0|||
37681319|NCT02340663|69157004|FG000|Overall Study|Protocol Violation|1|||
37681320|NCT02340663|69157005|FG001|Overall Study|Protocol Violation|0|||
37681321|NCT02340663|69157004|FG000|Overall Study|Withdrawal by Subject|3|||
37681322|NCT02340663|69157005|FG001|Overall Study|Withdrawal by Subject|1|||
37681323|NCT02573467|69157015|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
37681324|NCT02573467|69157016|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
37681325|NCT02573467|69157017|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
37681326|NCT02573467|69157018|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
37681327|NCT02573467|69157015|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
37681328|NCT02573467|69157016|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
37681329|NCT02573467|69157017|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
37681330|NCT02573467|69157018|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
37681331|NCT02573467|69157015|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
37681332|NCT02573467|69157016|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
37966917|NCT00447057|69653833|FG002|Overall Study|Death due to adverse event|1|||
37966918|NCT00447057|69653834|FG003|Overall Study|Death due to adverse event|2|||
37681333|NCT02573467|69157017|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
37681334|NCT02573467|69157018|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
37966919|NCT00447057|69653831|FG000|Overall Study|Death, study drug related|0|||
37681335|NCT02573467|69157015|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
37681336|NCT02573467|69157016|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
37681337|NCT02573467|69157017|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
37681338|NCT02573467|69157018|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
37681339|NCT02573467|69157015|FG000|Post-treatment Follow up Epoch|Death|1|||
37681340|NCT02573467|69157016|FG001|Post-treatment Follow up Epoch|Death|1|||
37681341|NCT02573467|69157017|FG002|Post-treatment Follow up Epoch|Death|0|||
37681342|NCT02573467|69157018|FG003|Post-treatment Follow up Epoch|Death|1|||
37681343|NCT02573467|69157015|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
37681344|NCT02573467|69157016|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
37681345|NCT02573467|69157017|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
37681346|NCT02573467|69157018|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
37681347|NCT02573467|69157015|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
37681348|NCT02573467|69157016|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
37681349|NCT02573467|69157017|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
37681350|NCT02573467|69157018|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
37681351|NCT02337387|69157033|FG000|Overall Study|Adverse Event|0|||
37681352|NCT02337387|69157034|FG001|Overall Study|Adverse Event|1|||
37681353|NCT02337387|69157035|FG002|Overall Study|Adverse Event|0|||
37681354|NCT02337387|69157036|FG003|Overall Study|Adverse Event|0|||
37681355|NCT02337387|69157033|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
37681356|NCT02337387|69157034|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
37681357|NCT02337387|69157035|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
37681358|NCT02337387|69157036|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
37681359|NCT02574247|69157049|FG000|Overall Study|Withdrawal by Subject|1|||
37681360|NCT02574247|69157050|FG001|Overall Study|Withdrawal by Subject|0|||
37681361|NCT02574247|69157051|FG002|Overall Study|Withdrawal by Subject|0|||
37681362|NCT02574247|69157049|FG000|Overall Study|Did not meet inclusion criteria|4|||
37681363|NCT02574247|69157050|FG001|Overall Study|Did not meet inclusion criteria|3|||
37681364|NCT02574247|69157051|FG002|Overall Study|Did not meet inclusion criteria|5|||
37681365|NCT02391363|69157063|FG000|Overall Study|Lost to Follow-up|5|||
37681366|NCT02391363|69157064|FG001|Overall Study|Lost to Follow-up|5|||
37681367|NCT02391363|69157063|FG000|Overall Study|Withdrawal by Subject|6|||
37681368|NCT02391363|69157064|FG001|Overall Study|Withdrawal by Subject|3|||
37681369|NCT02569957|69157072|FG000|Overall Study|Withdrawal by Subject|0|||
37681370|NCT02569957|69157073|FG001|Overall Study|Withdrawal by Subject|1|||
37681371|NCT01649427|69157081|FG000|Overall Study|Adverse Event|1|||
37681372|NCT01649427|69157082|FG001|Overall Study|Adverse Event|1|||
37681373|NCT01649427|69157081|FG000|Overall Study|Withdrawal by Subject|8|||
37681374|NCT01649427|69157082|FG001|Overall Study|Withdrawal by Subject|7|||
37681375|NCT01649427|69157081|FG000|Overall Study|Lost to Follow-up|0|||
37681376|NCT01649427|69157082|FG001|Overall Study|Lost to Follow-up|1|||
37681377|NCT01649427|69157081|FG000|Overall Study|Graft loss|0|||
37681378|NCT01649427|69157082|FG001|Overall Study|Graft loss|1|||
37681379|NCT01649427|69157081|FG000|Overall Study|Surgical problems during nephrectomy|2|||
37681380|NCT01649427|69157082|FG001|Overall Study|Surgical problems during nephrectomy|2|||
37681381|NCT02375373|69157088|FG000|Overall Study|Withdrawal by Subject|11|||
37681382|NCT02336607|69157096|FG000|Overall Study|Physician Decision|1|||
37681383|NCT02336607|69157097|FG001|Overall Study|Physician Decision|4|||
37681384|NCT02336607|69157098|FG002|Overall Study|Physician Decision|3|||
37681385|NCT02336607|69157099|FG003|Overall Study|Physician Decision|15|||
37681386|NCT02336607|69157096|FG000|Overall Study|Lack of Efficacy|1|||
37681387|NCT02336607|69157097|FG001|Overall Study|Lack of Efficacy|0|||
37966920|NCT00447057|69653832|FG001|Overall Study|Death, study drug related|1|||
38081473|NCT03047551|69779793|FG001|Overall Study|Withdrawal by Subject|1|||
38081474|NCT03047551|69779792|FG000|Overall Study|Probe malfunction|0|||
38081475|NCT03047551|69779793|FG001|Overall Study|Probe malfunction|1|||
38081476|NCT03047551|69779792|FG000|Overall Study|Ineligible|0|||
38081477|NCT03047551|69779793|FG001|Overall Study|Ineligible|1|||
38081478|NCT02964741|69779802|FG000|Overall Study|Protocol Violation|1|||
38081479|NCT02964741|69779803|FG001|Overall Study|Protocol Violation|0|||
38081480|NCT02964741|69779804|FG002|Overall Study|Protocol Violation|0|||
38081481|NCT02964741|69779802|FG000|Overall Study|Withdrawal by Subject|0|||
38081482|NCT02964741|69779803|FG001|Overall Study|Withdrawal by Subject|1|||
38081483|NCT02964741|69779804|FG002|Overall Study|Withdrawal by Subject|0|||
38081484|NCT02964741|69779802|FG000|Overall Study|claustrophobia|1|||
38081485|NCT02964741|69779803|FG001|Overall Study|claustrophobia|0|||
38081486|NCT02964741|69779804|FG002|Overall Study|claustrophobia|0|||
37681388|NCT02336607|69157098|FG002|Overall Study|Lack of Efficacy|0|||
37681389|NCT02336607|69157099|FG003|Overall Study|Lack of Efficacy|2|||
37681390|NCT02336607|69157096|FG000|Overall Study|Lost to Follow-up|2|||
37681391|NCT02336607|69157097|FG001|Overall Study|Lost to Follow-up|1|||
37681392|NCT02336607|69157098|FG002|Overall Study|Lost to Follow-up|0|||
37681393|NCT02336607|69157099|FG003|Overall Study|Lost to Follow-up|21|||
38081487|NCT01316419|69779810|FG000|Overall Study|Not treated|103|||
38081488|NCT01316419|69779810|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
37681394|NCT02336607|69157096|FG000|Overall Study|Protocol Violation|0|||
37681395|NCT02336607|69157097|FG001|Overall Study|Protocol Violation|1|||
37681396|NCT02336607|69157098|FG002|Overall Study|Protocol Violation|1|||
37681397|NCT02336607|69157099|FG003|Overall Study|Protocol Violation|3|||
37681398|NCT02336607|69157096|FG000|Overall Study|Adverse Event|0|||
37681399|NCT02336607|69157097|FG001|Overall Study|Adverse Event|2|||
37681400|NCT02336607|69157098|FG002|Overall Study|Adverse Event|2|||
37681401|NCT02336607|69157099|FG003|Overall Study|Adverse Event|26|||
37681402|NCT02336607|69157096|FG000|Overall Study|Withdrawal by Subject|0|||
37681403|NCT02336607|69157097|FG001|Overall Study|Withdrawal by Subject|2|||
37681404|NCT02336607|69157098|FG002|Overall Study|Withdrawal by Subject|0|||
37681405|NCT02336607|69157099|FG003|Overall Study|Withdrawal by Subject|20|||
37681406|NCT02374671|69157112|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
37681407|NCT02374671|69157113|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
37681408|NCT02374671|69157114|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
37681409|NCT02374671|69157112|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
37681410|NCT02374671|69157113|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
37681411|NCT02374671|69157114|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
37681412|NCT02374671|69157112|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
37681413|NCT02374671|69157113|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
37681414|NCT02374671|69157114|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
37681415|NCT02374671|69157112|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
37681416|NCT02374671|69157113|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
37681417|NCT02374671|69157114|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
37681418|NCT02374671|69157112|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
37681419|NCT02374671|69157113|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
37681420|NCT02374671|69157114|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
37681421|NCT02569801|69157122|FG000|Overall Study|Withdrawal by Subject|9|||
37681422|NCT02569801|69157123|FG001|Overall Study|Withdrawal by Subject|9|||
37681423|NCT02569801|69157122|FG000|Overall Study|Sponsor Decision|13|||
37681424|NCT02569801|69157123|FG001|Overall Study|Sponsor Decision|14|||
37681425|NCT02569801|69157122|FG000|Overall Study|Progressive Disease|2|||
37681426|NCT02569801|69157123|FG001|Overall Study|Progressive Disease|7|||
37681427|NCT02569801|69157122|FG000|Overall Study|Lost to Follow-up|0|||
37681428|NCT02569801|69157123|FG001|Overall Study|Lost to Follow-up|1|||
37681429|NCT02569801|69157122|FG000|Overall Study|Death|12|||
37681430|NCT02569801|69157123|FG001|Overall Study|Death|4|||
37681431|NCT02573311|69157131|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
37681432|NCT02573311|69157132|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
37681433|NCT02573311|69157131|FG000|Disposition for Part 2|Physician Decision|25|||
37681434|NCT02573311|69157132|FG001|Disposition for Part 2|Physician Decision|7|||
37681435|NCT02573311|69157131|FG000|Disposition for Part 2|Adverse Event|36|||
37681436|NCT02573311|69157132|FG001|Disposition for Part 2|Adverse Event|5|||
37862526|NCT00918385|69546403|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
37862527|NCT00918385|69546404|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
37862528|NCT00918385|69546403|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
37862529|NCT00918385|69546404|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
37862530|NCT00918385|69546403|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
37862531|NCT00918385|69546404|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
37862532|NCT01211262|69546414|FG000|Overall Study|Progressive Disease|18|||
37681437|NCT02573311|69157131|FG000|Disposition for Part 2|Lost to Follow-up|76|||
37681438|NCT02573311|69157132|FG001|Disposition for Part 2|Lost to Follow-up|7|||
37681439|NCT02573311|69157131|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
37681440|NCT02573311|69157132|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
37681441|NCT02573311|69157131|FG000|Disposition for Part 2|Investigator decision|0|||
37681442|NCT02573311|69157132|FG001|Disposition for Part 2|Investigator decision|1|||
37681443|NCT02573311|69157131|FG000|Disposition for Part 2|Other than specified above|13|||
37681444|NCT02573311|69157132|FG001|Disposition for Part 2|Other than specified above|3|||
37681445|NCT02571049|69157138|FG000|Screening|Did not meet entry criteria|2|||
37681446|NCT02571049|69157139|FG001|Screening|Did not meet entry criteria|2|||
37681447|NCT02571049|69157138|FG000|Randomization|No migraine attack|0|||
37681448|NCT02571049|69157139|FG001|Randomization|No migraine attack|1|||
37681449|NCT02571049|69157138|FG000|Randomization|Adverse Event|0|||
37681450|NCT02571049|69157139|FG001|Randomization|Adverse Event|1|||
37681451|NCT02573155|69157147|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
37681452|NCT02573155|69157148|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
37681453|NCT02573155|69157147|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
37681454|NCT02573155|69157148|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
37681455|NCT02573155|69157147|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
37681456|NCT02573155|69157148|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
37681457|NCT02573155|69157147|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
37681458|NCT02573155|69157148|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
37681459|NCT02573155|69157147|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
37681460|NCT02573155|69157148|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
37681461|NCT02573155|69157147|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
37681462|NCT02573155|69157148|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
37681463|NCT02573155|69157147|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
37681464|NCT02573155|69157148|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
37681465|NCT02573155|69157147|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
37681466|NCT02573155|69157148|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
37681467|NCT02568475|69157176|FG000|Overall Study|Lost to Follow-up|40|||
37681468|NCT02568475|69157177|FG001|Overall Study|Lost to Follow-up|39|||
37681469|NCT02568475|69157176|FG000|Overall Study|Withdrawal by Subject|2|||
37681470|NCT02568475|69157177|FG001|Overall Study|Withdrawal by Subject|0|||
37681471|NCT02568475|69157176|FG000|Overall Study|Discharged home|4|||
37681472|NCT02568475|69157177|FG001|Overall Study|Discharged home|4|||
37681473|NCT02568475|69157176|FG000|Overall Study|Short-term: Discharge location unknown|4|||
37681474|NCT02568475|69157177|FG001|Overall Study|Short-term: Discharge location unknown|0|||
37681475|NCT02568475|69157176|FG000|Overall Study|Transferred to another facility|1|||
37681476|NCT02568475|69157177|FG001|Overall Study|Transferred to another facility|0|||
37681477|NCT02568397|69157183|FG000|Period 2|Withdrawal by Subject|0|||
37681478|NCT02568397|69157184|FG001|Period 2|Withdrawal by Subject|1|||
37681479|NCT02568397|69157183|FG000|Period 2|Physician Decision|0|||
37681480|NCT02568397|69157184|FG001|Period 2|Physician Decision|1|||
37681481|NCT02566525|69157201|FG000|Overall Study|Protocol Violation|3|||
37681482|NCT02566525|69157202|FG001|Overall Study|Protocol Violation|5|||
37681483|NCT02567227|69157212|FG000|9 Weeks|Adverse Event|5|||
37681484|NCT02567227|69157213|FG001|9 Weeks|Adverse Event|5|||
37681485|NCT02567227|69157212|FG000|9 Weeks|Withdrawal by Subject|18|||
37681486|NCT02567227|69157213|FG001|9 Weeks|Withdrawal by Subject|8|||
37681487|NCT02567227|69157212|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
37681488|NCT02567227|69157213|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
37681489|NCT02567227|69157212|FG000|6 Month|Death|2|||
37681490|NCT02567227|69157213|FG001|6 Month|Death|0|||
37681491|NCT02567227|69157212|FG000|6 Month|Lost to Follow-up|43|||
37681492|NCT02567227|69157213|FG001|6 Month|Lost to Follow-up|40|||
37681493|NCT02567227|69157212|FG000|12 Months|Lost to Follow-up|31|||
37681494|NCT02567227|69157213|FG001|12 Months|Lost to Follow-up|32|||
37681495|NCT02567227|69157212|FG000|12 Months|Death|0|||
37681496|NCT02567227|69157213|FG001|12 Months|Death|2|||
37681497|NCT02336451|69157224|FG000|Overall Study|Adverse Event|1|||
37681498|NCT02336451|69157225|FG001|Overall Study|Adverse Event|2|||
37681499|NCT02336451|69157226|FG002|Overall Study|Adverse Event|0|||
37681500|NCT02336451|69157227|FG003|Overall Study|Adverse Event|6|||
37681501|NCT02336451|69157228|FG004|Overall Study|Adverse Event|4|||
37681502|NCT02336451|69157224|FG000|Overall Study|Death|6|||
37681503|NCT02336451|69157225|FG001|Overall Study|Death|2|||
37681504|NCT02336451|69157226|FG002|Overall Study|Death|3|||
37681505|NCT02336451|69157227|FG003|Overall Study|Death|6|||
38081489|NCT01316419|69779810|FG000|Overall Study|Lost to Follow-up|19|||
37681506|NCT02336451|69157228|FG004|Overall Study|Death|6|||
37681507|NCT02336451|69157224|FG000|Overall Study|Physician Decision|9|||
37681508|NCT02336451|69157225|FG001|Overall Study|Physician Decision|6|||
37681509|NCT02336451|69157226|FG002|Overall Study|Physician Decision|7|||
38081490|NCT02964039|69779817|FG000|Overall Study|Medical reason unrelated to study participation|1|||
38081491|NCT02964039|69779818|FG001|Overall Study|Medical reason unrelated to study participation|0|||
38081492|NCT02964039|69779819|FG002|Overall Study|Medical reason unrelated to study participation|3|||
38081493|NCT02964039|69779817|FG000|Overall Study|Research shutdown due to pandemic|2|||
38081494|NCT02964039|69779818|FG001|Overall Study|Research shutdown due to pandemic|0|||
38081495|NCT02964039|69779819|FG002|Overall Study|Research shutdown due to pandemic|1|||
38081496|NCT02964039|69779817|FG000|Overall Study|Withdrawal by Subject|0|||
38081497|NCT02964039|69779818|FG001|Overall Study|Withdrawal by Subject|1|||
38081498|NCT02964039|69779819|FG002|Overall Study|Withdrawal by Subject|0|||
38081499|NCT02964039|69779817|FG000|Overall Study|Lost to Follow-up|1|||
38081500|NCT02964039|69779818|FG001|Overall Study|Lost to Follow-up|0|||
38081501|NCT02964039|69779819|FG002|Overall Study|Lost to Follow-up|1|||
37966921|NCT00447057|69653833|FG002|Overall Study|Death, study drug related|0|||
37966922|NCT00447057|69653834|FG003|Overall Study|Death, study drug related|0|||
37966923|NCT00446511|69653846|FG000|Overall Study|Adverse Event|7|||
37966924|NCT00446511|69653847|FG001|Overall Study|Adverse Event|2|||
37966925|NCT00446511|69653848|FG002|Overall Study|Adverse Event|3|||
37966926|NCT00446511|69653849|FG003|Overall Study|Adverse Event|1|||
37966927|NCT00446511|69653846|FG000|Overall Study|Protocol Violation|0|||
37966928|NCT00446511|69653847|FG001|Overall Study|Protocol Violation|0|||
37966929|NCT00446511|69653848|FG002|Overall Study|Protocol Violation|0|||
37966930|NCT00446511|69653849|FG003|Overall Study|Protocol Violation|1|||
37966931|NCT00446511|69653846|FG000|Overall Study|Withdrawal by Subject|0|||
37966932|NCT00446511|69653847|FG001|Overall Study|Withdrawal by Subject|0|||
37966933|NCT00446511|69653848|FG002|Overall Study|Withdrawal by Subject|0|||
37966934|NCT00446511|69653849|FG003|Overall Study|Withdrawal by Subject|3|||
37966935|NCT00446511|69653846|FG000|Overall Study|Administrative Problems|3|||
37966936|NCT00446511|69653847|FG001|Overall Study|Administrative Problems|0|||
37966937|NCT00446511|69653848|FG002|Overall Study|Administrative Problems|4|||
37966938|NCT00446511|69653849|FG003|Overall Study|Administrative Problems|1|||
37966939|NCT00446199|69653865|FG000|Overall Study|Adverse Event|7|||
37966940|NCT00446199|69653866|FG001|Overall Study|Adverse Event|4|||
37966941|NCT00446199|69653867|FG002|Overall Study|Adverse Event|6|||
37966942|NCT00446199|69653868|FG003|Overall Study|Adverse Event|4|||
37681510|NCT02336451|69157227|FG003|Overall Study|Physician Decision|16|||
37681511|NCT02336451|69157228|FG004|Overall Study|Physician Decision|3|||
37681512|NCT02336451|69157224|FG000|Overall Study|Progressive disease|23|||
37681513|NCT02336451|69157225|FG001|Overall Study|Progressive disease|26|||
37862533|NCT01211262|69546415|FG001|Overall Study|Progressive Disease|9|||
37862534|NCT01211262|69546414|FG000|Overall Study|Adverse Event|4|||
37862535|NCT01211262|69546415|FG001|Overall Study|Adverse Event|0|||
37862536|NCT01211262|69546414|FG000|Overall Study|Withdrawal of Consent|1|||
37681514|NCT02336451|69157226|FG002|Overall Study|Progressive disease|2|||
37681515|NCT02336451|69157227|FG003|Overall Study|Progressive disease|14|||
37681516|NCT02336451|69157228|FG004|Overall Study|Progressive disease|4|||
37966943|NCT00446199|69653865|FG000|Overall Study|Lost to Follow-up|4|||
37966944|NCT00446199|69653866|FG001|Overall Study|Lost to Follow-up|5|||
37966945|NCT00446199|69653867|FG002|Overall Study|Lost to Follow-up|2|||
37966946|NCT00446199|69653868|FG003|Overall Study|Lost to Follow-up|6|||
37966947|NCT00446199|69653865|FG000|Overall Study|Protocol Violation|1|||
37862537|NCT01211262|69546415|FG001|Overall Study|Withdrawal of Consent|0|||
37966948|NCT00446199|69653866|FG001|Overall Study|Protocol Violation|2|||
37966949|NCT00446199|69653867|FG002|Overall Study|Protocol Violation|1|||
37966950|NCT00446199|69653868|FG003|Overall Study|Protocol Violation|3|||
37966951|NCT00446199|69653865|FG000|Overall Study|Withdrawal by Subject|2|||
37966952|NCT00446199|69653866|FG001|Overall Study|Withdrawal by Subject|5|||
37681517|NCT02336451|69157224|FG000|Overall Study|Protocol Violation|1|||
37681518|NCT02336451|69157225|FG001|Overall Study|Protocol Violation|0|||
37681519|NCT02336451|69157226|FG002|Overall Study|Protocol Violation|0|||
37681520|NCT02336451|69157227|FG003|Overall Study|Protocol Violation|0|||
37681521|NCT02336451|69157228|FG004|Overall Study|Protocol Violation|0|||
37681522|NCT02336451|69157224|FG000|Overall Study|Patient/guardian decision|2|||
37681523|NCT02336451|69157225|FG001|Overall Study|Patient/guardian decision|4|||
37862538|NCT01211262|69546414|FG000|Overall Study|Other|0|||
37862539|NCT01211262|69546415|FG001|Overall Study|Other|1|||
37862540|NCT01211184|69546427|FG000|Overall Study|Withdrawal by Subject|0|||
37862541|NCT01211184|69546428|FG001|Overall Study|Withdrawal by Subject|2|||
37862542|NCT01211184|69546429|FG002|Overall Study|Withdrawal by Subject|1|||
37862543|NCT00924469|69546442|FG000|Overall Study|Adverse Event|2|||
37862544|NCT00924469|69546443|FG001|Overall Study|Adverse Event|0|||
37862545|NCT00924469|69546442|FG000|Overall Study|Withdrawal by Subject|0|||
37862546|NCT00924469|69546443|FG001|Overall Study|Withdrawal by Subject|1|||
37862547|NCT00924469|69546442|FG000|Overall Study|Lost to Follow-up|0|||
37862548|NCT00924469|69546443|FG001|Overall Study|Lost to Follow-up|1|||
37862549|NCT00924313|69546449|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
37862550|NCT01209780|69546457|FG000|Overall Study|Adverse Event|0|||
37862551|NCT01209780|69546458|FG001|Overall Study|Adverse Event|1|||
37862552|NCT01209780|69546459|FG002|Overall Study|Adverse Event|0|||
37862553|NCT01209780|69546460|FG003|Overall Study|Adverse Event|0|||
37966953|NCT00446199|69653867|FG002|Overall Study|Withdrawal by Subject|9|||
37681524|NCT02336451|69157226|FG002|Overall Study|Patient/guardian decision|0|||
37862554|NCT01209780|69546461|FG004|Overall Study|Adverse Event|0|||
37681525|NCT02336451|69157227|FG003|Overall Study|Patient/guardian decision|2|||
37681526|NCT02336451|69157228|FG004|Overall Study|Patient/guardian decision|1|||
37681527|NCT02374593|69157244|FG000|Overall Study|non-compliant|2|||
37681528|NCT02374593|69157245|FG001|Overall Study|non-compliant|0|||
37681529|NCT01648101|69157258|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
37681530|NCT01648101|69157259|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
37681531|NCT01648101|69157260|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
37681532|NCT01648101|69157258|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
37681533|NCT01648101|69157259|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
37966954|NCT00446199|69653868|FG003|Overall Study|Withdrawal by Subject|10|||
37681534|NCT01648101|69157260|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
37681535|NCT01648101|69157258|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
37681536|NCT01648101|69157259|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
37862555|NCT01209780|69546457|FG000|Overall Study|Withdrawal by Subject|9|||
37862556|NCT01209780|69546458|FG001|Overall Study|Withdrawal by Subject|2|||
37862557|NCT01209780|69546459|FG002|Overall Study|Withdrawal by Subject|1|||
37862558|NCT01209780|69546460|FG003|Overall Study|Withdrawal by Subject|1|||
38081502|NCT02897115|69779829|FG000|Overall Study|Early termination of study by sponsor|11|||
38081503|NCT02897115|69779830|FG001|Overall Study|Early termination of study by sponsor|8|||
38081504|NCT02896569|69779838|FG000|Overall Study|Lost to Follow-up|2|||
38081505|NCT02896569|69779839|FG001|Overall Study|Lost to Follow-up|1|||
38081506|NCT02896569|69779838|FG000|Overall Study|Physician Decision|1|||
38081507|NCT02896569|69779839|FG001|Overall Study|Physician Decision|3|||
37862559|NCT01209780|69546461|FG004|Overall Study|Withdrawal by Subject|0|||
37862560|NCT01209780|69546457|FG000|Overall Study|Lost to Follow-up|17|||
38081508|NCT02896569|69779838|FG000|Overall Study|Adverse Event|0|||
38081509|NCT02896569|69779839|FG001|Overall Study|Adverse Event|1|||
38081510|NCT02896569|69779838|FG000|Overall Study|Withdrawal by Subject|1|||
38081511|NCT02896569|69779839|FG001|Overall Study|Withdrawal by Subject|0|||
38081512|NCT04030195|69779848|FG000|Overall Study|Withdrawal by Subject|2|||
38081513|NCT04030195|69779849|FG001|Overall Study|Withdrawal by Subject|0|||
38081514|NCT04030195|69779850|FG002|Overall Study|Withdrawal by Subject|0|||
38081515|NCT01673620|69779861|FG000|Overall Study|Adverse Event|1|||
38081516|NCT01673620|69779862|FG001|Overall Study|Adverse Event|0|||
38081517|NCT03044197|69779876|FG000|Overall Study|Withdrawal by Subject|3|||
38081518|NCT03044197|69779877|FG001|Overall Study|Withdrawal by Subject|1|||
38081519|NCT03043651|69779905|FG000|Overall Study|Death|1|||
38081520|NCT03043651|69779905|FG000|Overall Study|Progressive Disease|2|||
37862561|NCT01209780|69546458|FG001|Overall Study|Lost to Follow-up|12|||
37862562|NCT01209780|69546459|FG002|Overall Study|Lost to Follow-up|3|||
37862563|NCT01209780|69546460|FG003|Overall Study|Lost to Follow-up|9|||
37862564|NCT01209780|69546461|FG004|Overall Study|Lost to Follow-up|4|||
37681537|NCT01648101|69157260|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
37681538|NCT01648101|69157258|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
37681539|NCT01648101|69157259|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
37681540|NCT01648101|69157260|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
37681541|NCT01648101|69157258|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
37681542|NCT01648101|69157259|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
37862565|NCT01209780|69546457|FG000|Overall Study|Protocol Violation|0|||
37862566|NCT01209780|69546458|FG001|Overall Study|Protocol Violation|1|||
37862567|NCT01209780|69546459|FG002|Overall Study|Protocol Violation|0|||
37862568|NCT01209780|69546460|FG003|Overall Study|Protocol Violation|0|||
37862569|NCT01209780|69546461|FG004|Overall Study|Protocol Violation|0|||
37862570|NCT01209780|69546457|FG000|Overall Study|Inappropriate enrollment|0|||
37862571|NCT01209780|69546458|FG001|Overall Study|Inappropriate enrollment|2|||
37862572|NCT01209780|69546459|FG002|Overall Study|Inappropriate enrollment|0|||
37862573|NCT01209780|69546460|FG003|Overall Study|Inappropriate enrollment|0|||
38081521|NCT03043651|69779905|FG000|Overall Study|Adverse Event|2|||
37681543|NCT01648101|69157260|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
37681544|NCT01648101|69157258|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
37681545|NCT01648101|69157259|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
37681546|NCT01648101|69157260|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
37681547|NCT01648101|69157258|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
37681548|NCT01648101|69157259|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
37681549|NCT01648101|69157260|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
37681550|NCT01648101|69157258|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
37681551|NCT01648101|69157259|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
37681552|NCT01648101|69157260|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
37681553|NCT01648101|69157258|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
37862574|NCT01209780|69546461|FG004|Overall Study|Inappropriate enrollment|1|||
37862575|NCT00916357|69546474|FG000|Period 1|Withdrawal by Subject|1|||
37862576|NCT00916357|69546475|FG001|Period 1|Withdrawal by Subject|0|||
37862577|NCT00916357|69546476|FG002|Period 1|Withdrawal by Subject|0|||
37862578|NCT00916357|69546477|FG003|Period 1|Withdrawal by Subject|0|||
38081522|NCT03043651|69779905|FG000|Overall Study|Withdrawal by Subject|4|||
37681554|NCT01648101|69157259|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
37681555|NCT01648101|69157260|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
37681556|NCT01648101|69157258|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
37862579|NCT00916357|69546478|FG004|Period 1|Withdrawal by Subject|0|||
37862580|NCT00916357|69546479|FG005|Period 1|Withdrawal by Subject|0|||
37862581|NCT00916357|69546474|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
37862582|NCT00916357|69546475|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
37862583|NCT00916357|69546476|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
37862584|NCT00916357|69546477|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
37862585|NCT00916357|69546478|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
37862586|NCT00916357|69546479|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
37862587|NCT01209624|69546488|FG000|Overall Study|Death|2|||
37862588|NCT01209624|69546488|FG000|Overall Study|Adverse Event|13|||
37862589|NCT01209624|69546488|FG000|Overall Study|Lack of Efficacy|17|||
37862590|NCT01209624|69546488|FG000|Overall Study|Lost to Follow-up|290|||
37862591|NCT01209624|69546488|FG000|Overall Study|Other|4|||
37862592|NCT00916279|69546492|FG000|Overall Study|Death|2|||
37862593|NCT00916279|69546492|FG000|Overall Study|Lost to Follow-up|2|||
37862594|NCT01209078|69546501|FG000|Overall Study|Adverse Event|5|||
37862595|NCT01209078|69546502|FG001|Overall Study|Adverse Event|0|||
37862596|NCT01209078|69546501|FG000|Overall Study|Lost to Follow-up|4|||
37862597|NCT01209078|69546502|FG001|Overall Study|Lost to Follow-up|0|||
37862598|NCT01209078|69546501|FG000|Overall Study|Physician Decision|5|||
37862599|NCT01209078|69546502|FG001|Overall Study|Physician Decision|2|||
37862600|NCT01209078|69546501|FG000|Overall Study|Withdrawal by Subject|2|||
37862601|NCT01209078|69546502|FG001|Overall Study|Withdrawal by Subject|1|||
37862602|NCT01207596|69546510|FG000|Overall Study|Physician Decision|4|||
37966955|NCT00446199|69653865|FG000|Overall Study|Site termination|2|||
37966956|NCT00446199|69653866|FG001|Overall Study|Site termination|0|||
38081523|NCT03043651|69779905|FG000|Overall Study|Study Terminated by Sponsor|39|||
38081524|NCT03536143|69779909|FG000|Overall Study|Early termination, Sponsor decision|1|||
38081525|NCT01344759|69779919|FG000|Overall Study|Patients failed to reach sedation level|0|||
38081526|NCT01344759|69779920|FG001|Overall Study|Patients failed to reach sedation level|2|||
38081527|NCT05027451|69779943|FG000|Overall Study|Lost to Follow-up|1|||
38081528|NCT05027451|69779944|FG001|Overall Study|Lost to Follow-up|1|||
38081529|NCT04757649|69779976|FG000|Overall Study|Withdrawal by Subject|1|||
38081530|NCT04757649|69779976|FG000|Overall Study|Adverse Event|1|||
38081531|NCT04621786|69779980|FG000|Overall Study|Lost to Follow-up|9|||
38081532|NCT04621786|69779980|FG000|Overall Study|Protocol Violation|3|||
38081533|NCT04549454|69779986|FG000|T1 to T2|Lost to Follow-up|22|||
38081534|NCT04549454|69779987|FG001|T1 to T2|Lost to Follow-up|26|||
38081535|NCT04549454|69779986|FG000|T1 to T3|Lost to Follow-up|31|||
38081536|NCT04549454|69779987|FG001|T1 to T3|Lost to Follow-up|36|||
38081537|NCT03519256|69780034|FG000|Overall Study|Disease recurrence|4|||
38081538|NCT03519256|69780035|FG001|Overall Study|Disease recurrence|4|||
38081539|NCT03519256|69780036|FG002|Overall Study|Disease recurrence|5|||
38081540|NCT03519256|69780037|FG003|Overall Study|Disease recurrence|2|||
38081541|NCT03519256|69780034|FG000|Overall Study|Study drug toxicity|0|||
38081542|NCT03519256|69780035|FG001|Overall Study|Study drug toxicity|2|||
38081543|NCT03519256|69780036|FG002|Overall Study|Study drug toxicity|5|||
38081544|NCT03519256|69780037|FG003|Overall Study|Study drug toxicity|2|||
38081545|NCT03519256|69780034|FG000|Overall Study|Adverse event unrelated to study drug|0|||
38081546|NCT03519256|69780035|FG001|Overall Study|Adverse event unrelated to study drug|1|||
38081547|NCT03519256|69780036|FG002|Overall Study|Adverse event unrelated to study drug|1|||
38081548|NCT03519256|69780037|FG003|Overall Study|Adverse event unrelated to study drug|0|||
38081549|NCT03519256|69780034|FG000|Overall Study|Participant request to discontinue study treatment|0|||
38081550|NCT03519256|69780035|FG001|Overall Study|Participant request to discontinue study treatment|0|||
37862603|NCT01207596|69546510|FG000|Overall Study|Lack of Efficacy|1|||
37862604|NCT01207596|69546510|FG000|Overall Study|Adverse Event|3|||
37862605|NCT01207596|69546510|FG000|Overall Study|Withdrawal by Subject|1|||
37862606|NCT00915343|69546514|FG000|Part B - Open Label Period|Treatment switch|0|||
37862607|NCT00915343|69546515|FG001|Part B - Open Label Period|Treatment switch|0|||
37862608|NCT00915343|69546516|FG002|Part B - Open Label Period|Treatment switch|1|||
37862609|NCT00915343|69546514|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
37966957|NCT00446199|69653867|FG002|Overall Study|Site termination|0|||
37966958|NCT00446199|69653868|FG003|Overall Study|Site termination|1|||
38081551|NCT03519256|69780036|FG002|Overall Study|Participant request to discontinue study treatment|0|||
38081552|NCT03519256|69780037|FG003|Overall Study|Participant request to discontinue study treatment|2|||
38081553|NCT03519256|69780034|FG000|Overall Study|Other reasons|0|||
38081554|NCT03519256|69780035|FG001|Overall Study|Other reasons|0|||
37862610|NCT00915343|69546515|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
37862611|NCT00915343|69546516|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
37862612|NCT00911989|69546528|FG000|Overall Study|Adverse Event|1|||
37862613|NCT00910273|69546534|FG000|Overall Study|Lack of Efficacy|6|||
37862614|NCT00910273|69546535|FG001|Overall Study|Lack of Efficacy|9|||
37966959|NCT00446199|69653865|FG000|Overall Study|Randomization in Error|2|||
37862615|NCT00910273|69546534|FG000|Overall Study|Adverse Event|1|||
37862616|NCT00910273|69546535|FG001|Overall Study|Adverse Event|1|||
37862617|NCT00910273|69546534|FG000|Overall Study|Withdrawal by Subject|1|||
37681557|NCT01648101|69157259|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
37681558|NCT01648101|69157260|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
37681559|NCT01648101|69157258|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
37681560|NCT01648101|69157259|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
37681561|NCT01648101|69157260|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
37681562|NCT02336373|69157272|FG000|Overall Study|Protocol closed early|4|||
37681563|NCT02336373|69157272|FG000|Overall Study|Physician Decision|14|||
37681564|NCT02372799|69157281|FG000|Treatment Period|Adverse Event|3|||
37681565|NCT02372799|69157282|FG001|Treatment Period|Adverse Event|10|||
37681566|NCT02372799|69157283|FG002|Treatment Period|Adverse Event|6|||
37681567|NCT02372799|69157281|FG000|Treatment Period|Insufficient therapeutic response|2|||
37681568|NCT02372799|69157282|FG001|Treatment Period|Insufficient therapeutic response|2|||
37681569|NCT02372799|69157283|FG002|Treatment Period|Insufficient therapeutic response|0|||
37681570|NCT02372799|69157281|FG000|Treatment Period|Withdrawal by Subject|10|||
37681571|NCT02372799|69157282|FG001|Treatment Period|Withdrawal by Subject|10|||
37681572|NCT02372799|69157283|FG002|Treatment Period|Withdrawal by Subject|2|||
37681573|NCT02372799|69157281|FG000|Treatment Period|Lost to Follow-up|11|||
37681574|NCT02372799|69157282|FG001|Treatment Period|Lost to Follow-up|5|||
37681575|NCT02372799|69157283|FG002|Treatment Period|Lost to Follow-up|3|||
37681576|NCT02372799|69157281|FG000|Treatment Period|Protocol Violation|3|||
37862618|NCT00910273|69546535|FG001|Overall Study|Withdrawal by Subject|0|||
37862619|NCT00910273|69546534|FG000|Overall Study|Discontinuation of study by sponsor|8|||
37862620|NCT00910273|69546535|FG001|Overall Study|Discontinuation of study by sponsor|2|||
37862621|NCT00910273|69546534|FG000|Overall Study|Protocol Violation|1|||
37862622|NCT00910273|69546535|FG001|Overall Study|Protocol Violation|0|||
37862623|NCT00910273|69546534|FG000|Overall Study|Lost to Follow-up|1|||
37862624|NCT00910273|69546535|FG001|Overall Study|Lost to Follow-up|1|||
37862625|NCT00910039|69546541|FG000|Overall Study|Physician Decision|1|||
37862626|NCT00909181|69546549|FG000|Overall Study|Lost to Follow-up|39|||
37862627|NCT00909181|69546550|FG001|Overall Study|Lost to Follow-up|18|||
37862628|NCT00909181|69546551|FG002|Overall Study|Lost to Follow-up|33|||
37862629|NCT01286987|69546574|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
37681577|NCT02372799|69157282|FG001|Treatment Period|Protocol Violation|0|||
37681578|NCT02372799|69157283|FG002|Treatment Period|Protocol Violation|0|||
37681579|NCT02372799|69157281|FG000|Treatment Period|Non-compliance with study drug|4|||
37681580|NCT02372799|69157282|FG001|Treatment Period|Non-compliance with study drug|4|||
37681581|NCT02372799|69157283|FG002|Treatment Period|Non-compliance with study drug|4|||
37681582|NCT02372799|69157281|FG000|Treatment Period|Miscellaneous Reasons|1|||
37681583|NCT02372799|69157282|FG001|Treatment Period|Miscellaneous Reasons|1|||
37862630|NCT01286987|69546575|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
37862631|NCT01286987|69546576|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
37862632|NCT01286987|69546577|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
37862633|NCT01286987|69546578|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
37862634|NCT01286987|69546579|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
37862635|NCT01286987|69546580|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
38081555|NCT03519256|69780036|FG002|Overall Study|Other reasons|2|||
37681584|NCT02372799|69157283|FG002|Treatment Period|Miscellaneous Reasons|0|||
37862636|NCT01286987|69546581|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
37862637|NCT01286987|69546582|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
37862638|NCT01286987|69546583|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
37862639|NCT01286987|69546584|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
37862640|NCT01286987|69546585|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
37862641|NCT01286987|69546586|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
37862642|NCT01286987|69546587|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
37862643|NCT01286987|69546588|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
37862644|NCT01286987|69546574|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
37862645|NCT01286987|69546575|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
37862646|NCT01286987|69546576|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
37862647|NCT01286987|69546577|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
37862648|NCT01286987|69546578|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
37862649|NCT01286987|69546579|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
37862650|NCT01286987|69546580|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
37862651|NCT01286987|69546581|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
37862652|NCT01286987|69546582|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
37862653|NCT01286987|69546583|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
37862654|NCT01286987|69546584|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
37862655|NCT01286987|69546585|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
37862656|NCT01286987|69546586|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
37862657|NCT01286987|69546587|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
37862658|NCT01286987|69546588|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
37862659|NCT01286987|69546574|FG000|Part 1: Dose Escalation|Physician Decision|0|||
37862660|NCT01286987|69546575|FG001|Part 1: Dose Escalation|Physician Decision|0|||
37862661|NCT01286987|69546576|FG002|Part 1: Dose Escalation|Physician Decision|0|||
37862662|NCT01286987|69546577|FG003|Part 1: Dose Escalation|Physician Decision|0|||
37862663|NCT01286987|69546578|FG004|Part 1: Dose Escalation|Physician Decision|1|||
37862664|NCT01286987|69546579|FG005|Part 1: Dose Escalation|Physician Decision|0|||
37862665|NCT01286987|69546580|FG006|Part 1: Dose Escalation|Physician Decision|0|||
38081556|NCT03519256|69780037|FG003|Overall Study|Other reasons|0|||
37681585|NCT02372799|69157281|FG000|Down-taper Period|Lost to Follow-up|1|||
37681586|NCT02372799|69157282|FG001|Down-taper Period|Lost to Follow-up|2|||
37681587|NCT02372799|69157283|FG002|Down-taper Period|Lost to Follow-up|2|||
37681588|NCT02566993|69157293|FG000|Overall Study|Randomized but not treated|5|||
37681589|NCT02566993|69157294|FG001|Overall Study|Randomized but not treated|16|||
37681590|NCT02566993|69157293|FG000|Overall Study|Progressive disease|213|||
37681591|NCT02566993|69157294|FG001|Overall Study|Progressive disease|152|||
38081557|NCT03519256|69780034|FG000|Overall Study|Disease progression|6|||
38081558|NCT03519256|69780035|FG001|Overall Study|Disease progression|3|||
38081559|NCT03519256|69780036|FG002|Overall Study|Disease progression|2|||
38081560|NCT03519256|69780037|FG003|Overall Study|Disease progression|1|||
38081561|NCT03519256|69780034|FG000|Overall Study|Lost to Follow-up|0|||
38081562|NCT03519256|69780035|FG001|Overall Study|Lost to Follow-up|1|||
38081563|NCT03519256|69780036|FG002|Overall Study|Lost to Follow-up|0|||
38081564|NCT03519256|69780037|FG003|Overall Study|Lost to Follow-up|0|||
38081565|NCT02799602|69780073|FG000|Overall Study|Protocol Violation|1|||
38081566|NCT02799602|69780074|FG001|Overall Study|Protocol Violation|0|||
38081567|NCT02799602|69780073|FG000|Overall Study|Physician Decision|3|||
38081568|NCT02799602|69780074|FG001|Overall Study|Physician Decision|7|||
38081569|NCT02799602|69780073|FG000|Overall Study|COVID-19 pandemic related other reason|0|||
38081570|NCT02799602|69780074|FG001|Overall Study|COVID-19 pandemic related other reason|1|||
37681592|NCT02566993|69157293|FG000|Overall Study|Withdrawal by Subject|12|||
37681593|NCT02566993|69157294|FG001|Overall Study|Withdrawal by Subject|28|||
37681594|NCT02566993|69157293|FG000|Overall Study|Death|17|||
37681595|NCT02566993|69157294|FG001|Overall Study|Death|23|||
37681596|NCT02566993|69157293|FG000|Overall Study|Physician Decision|10|||
38081571|NCT02799602|69780073|FG000|Overall Study|Lost to Follow-up|4|||
38081572|NCT02799602|69780074|FG001|Overall Study|Lost to Follow-up|1|||
37681597|NCT02566993|69157294|FG001|Overall Study|Physician Decision|17|||
37862666|NCT01286987|69546581|FG007|Part 1: Dose Escalation|Physician Decision|0|||
38081573|NCT02799602|69780073|FG000|Overall Study|ADDITIONAL PRIMARY MALIGNANCY|11|||
38081574|NCT02799602|69780074|FG001|Overall Study|ADDITIONAL PRIMARY MALIGNANCY|6|||
38081575|NCT02799602|69780073|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|14|||
38081576|NCT02799602|69780074|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|12|||
38081577|NCT02799602|69780073|FG000|Overall Study|ADVERSE EVENT ASSOCIATED WITH CLINICAL DISEASE PROGRESSION|24|||
38081578|NCT02799602|69780074|FG001|Overall Study|ADVERSE EVENT ASSOCIATED WITH CLINICAL DISEASE PROGRESSION|26|||
38081579|NCT02799602|69780073|FG000|Overall Study|Withdrawal by Subject|25|||
38081580|NCT02799602|69780074|FG001|Overall Study|Withdrawal by Subject|37|||
38081581|NCT02799602|69780073|FG000|Overall Study|ADVERSE EVENT NOT ASSOCIATED WITH CLINICAL DISEASE PROGRESSION|48|||
38081582|NCT02799602|69780074|FG001|Overall Study|ADVERSE EVENT NOT ASSOCIATED WITH CLINICAL DISEASE PROGRESSION|27|||
38081583|NCT02799602|69780073|FG000|Overall Study|PROGRESSIVE DISEASE - RADIOLOGICAL PROGRESSION|84|||
38081584|NCT02799602|69780074|FG001|Overall Study|PROGRESSIVE DISEASE - RADIOLOGICAL PROGRESSION|132|||
38081585|NCT02799602|69780073|FG000|Overall Study|PROGRESSIVE DISEASE - CLINICAL PROGRESSION|127|||
38081586|NCT02799602|69780074|FG001|Overall Study|PROGRESSIVE DISEASE - CLINICAL PROGRESSION|272|||
38081587|NCT02799602|69780073|FG000|Overall Study|Death|8|||
38081588|NCT02799602|69780074|FG001|Overall Study|Death|5|||
38081589|NCT02799602|69780073|FG000|Overall Study|Other|3|||
38081590|NCT02799602|69780074|FG001|Overall Study|Other|3|||
38081591|NCT02799602|69780073|FG000|Overall Study|GCP violation|1|||
38081592|NCT02799602|69780074|FG001|Overall Study|GCP violation|0|||
38081593|NCT02243709|69780091|FG000|Phase 1|Lost to Follow-up|0|||
38081594|NCT02243709|69780092|FG001|Phase 1|Lost to Follow-up|1|||
38081595|NCT02243709|69780091|FG000|Phase 1|Withdrawal by Subject|1|||
38081596|NCT02243709|69780092|FG001|Phase 1|Withdrawal by Subject|0|||
38081597|NCT02243709|69780091|FG000|Phase 1|Protocol Violation|0|||
38081598|NCT02243709|69780092|FG001|Phase 1|Protocol Violation|1|||
38081599|NCT02243709|69780091|FG000|Phase 1|Adverse Event|0|||
38081600|NCT02243709|69780092|FG001|Phase 1|Adverse Event|1|||
38081601|NCT01891396|69780104|FG000|Overall Study|Withdrawal by Subject|4|||
38081602|NCT01891396|69780105|FG001|Overall Study|Withdrawal by Subject|4|||
38081603|NCT01891396|69780106|FG002|Overall Study|Withdrawal by Subject|3|||
38081604|NCT01891396|69780104|FG000|Overall Study|Lost to Follow-up|0|||
38081605|NCT01891396|69780105|FG001|Overall Study|Lost to Follow-up|1|||
38081606|NCT01891396|69780106|FG002|Overall Study|Lost to Follow-up|0|||
38081607|NCT01746225|69780121|FG000|Overall Study|Death|1|||
38081608|NCT01746225|69780122|FG001|Overall Study|Death|0|||
38081609|NCT01746225|69780123|FG002|Overall Study|Death|1|||
38081610|NCT01746225|69780121|FG000|Overall Study|Withdrawal by Subject|5|||
38081611|NCT01746225|69780122|FG001|Overall Study|Withdrawal by Subject|15|||
38081612|NCT01746225|69780123|FG002|Overall Study|Withdrawal by Subject|19|||
38081613|NCT01746225|69780121|FG000|Overall Study|Physician Decision|14|||
38081614|NCT01746225|69780122|FG001|Overall Study|Physician Decision|11|||
38081615|NCT01746225|69780123|FG002|Overall Study|Physician Decision|3|||
37862667|NCT01286987|69546582|FG008|Part 1: Dose Escalation|Physician Decision|0|||
37862668|NCT01286987|69546583|FG009|Part 1: Dose Escalation|Physician Decision|0|||
37862669|NCT01286987|69546584|FG010|Part 1: Dose Escalation|Physician Decision|0|||
37862670|NCT01286987|69546585|FG011|Part 1: Dose Escalation|Physician Decision|0|||
37862671|NCT01286987|69546586|FG012|Part 1: Dose Escalation|Physician Decision|0|||
37862672|NCT01286987|69546587|FG013|Part 1: Dose Escalation|Physician Decision|0|||
37862673|NCT01286987|69546588|FG014|Part 1: Dose Escalation|Physician Decision|0|||
37862674|NCT01286987|69546574|FG000|Part 2: Dose Expansion|Death|0|||
37862675|NCT01286987|69546575|FG001|Part 2: Dose Expansion|Death|0|||
37862676|NCT01286987|69546576|FG002|Part 2: Dose Expansion|Death|0|||
37862677|NCT01286987|69546577|FG003|Part 2: Dose Expansion|Death|0|||
37862678|NCT01286987|69546578|FG004|Part 2: Dose Expansion|Death|0|||
37862679|NCT01286987|69546579|FG005|Part 2: Dose Expansion|Death|0|||
37862680|NCT01286987|69546580|FG006|Part 2: Dose Expansion|Death|0|||
37862681|NCT01286987|69546581|FG007|Part 2: Dose Expansion|Death|0|||
37862682|NCT01286987|69546582|FG008|Part 2: Dose Expansion|Death|0|||
37862683|NCT01286987|69546583|FG009|Part 2: Dose Expansion|Death|0|||
37862684|NCT01286987|69546584|FG010|Part 2: Dose Expansion|Death|0|||
37862685|NCT01286987|69546585|FG011|Part 2: Dose Expansion|Death|0|||
37862686|NCT01286987|69546586|FG012|Part 2: Dose Expansion|Death|1|||
37862687|NCT01286987|69546587|FG013|Part 2: Dose Expansion|Death|1|||
37862688|NCT01286987|69546588|FG014|Part 2: Dose Expansion|Death|0|||
38081616|NCT01746225|69780121|FG000|Overall Study|Adverse Event|15|||
37862689|NCT01286987|69546574|FG000|Part 2: Dose Expansion|Physician Decision|0|||
37862690|NCT01286987|69546575|FG001|Part 2: Dose Expansion|Physician Decision|0|||
38081617|NCT01746225|69780122|FG001|Overall Study|Adverse Event|12|||
38081618|NCT01746225|69780123|FG002|Overall Study|Adverse Event|17|||
38081619|NCT01746225|69780121|FG000|Overall Study|Continuing Treatment|5|||
38081620|NCT01746225|69780122|FG001|Overall Study|Continuing Treatment|8|||
38081621|NCT01746225|69780123|FG002|Overall Study|Continuing Treatment|3|||
38081622|NCT01471522|69780144|FG000|Overall Study|Withdrawal by Subject|28|||
38081623|NCT01471522|69780145|FG001|Overall Study|Withdrawal by Subject|22|||
38081624|NCT01471522|69780144|FG000|Overall Study|Lost to Follow-up|36|||
37862691|NCT01286987|69546576|FG002|Part 2: Dose Expansion|Physician Decision|0|||
37862692|NCT01286987|69546577|FG003|Part 2: Dose Expansion|Physician Decision|0|||
37862693|NCT01286987|69546578|FG004|Part 2: Dose Expansion|Physician Decision|0|||
37862694|NCT01286987|69546579|FG005|Part 2: Dose Expansion|Physician Decision|0|||
37862695|NCT01286987|69546580|FG006|Part 2: Dose Expansion|Physician Decision|0|||
37862696|NCT01286987|69546581|FG007|Part 2: Dose Expansion|Physician Decision|0|||
37862697|NCT01286987|69546582|FG008|Part 2: Dose Expansion|Physician Decision|0|||
37862698|NCT01286987|69546583|FG009|Part 2: Dose Expansion|Physician Decision|0|||
37862699|NCT01286987|69546584|FG010|Part 2: Dose Expansion|Physician Decision|1|||
37862700|NCT01286987|69546585|FG011|Part 2: Dose Expansion|Physician Decision|1|||
37862701|NCT01286987|69546586|FG012|Part 2: Dose Expansion|Physician Decision|0|||
37862702|NCT01286987|69546587|FG013|Part 2: Dose Expansion|Physician Decision|1|||
37862703|NCT01286987|69546588|FG014|Part 2: Dose Expansion|Physician Decision|0|||
37862704|NCT01286987|69546574|FG000|Part 2: Dose Expansion|Other|0|||
37862705|NCT01286987|69546575|FG001|Part 2: Dose Expansion|Other|0|||
37862706|NCT01286987|69546576|FG002|Part 2: Dose Expansion|Other|0|||
37862707|NCT01286987|69546577|FG003|Part 2: Dose Expansion|Other|0|||
37862708|NCT01286987|69546578|FG004|Part 2: Dose Expansion|Other|0|||
37862709|NCT01286987|69546579|FG005|Part 2: Dose Expansion|Other|0|||
37862710|NCT01286987|69546580|FG006|Part 2: Dose Expansion|Other|0|||
37862711|NCT01286987|69546581|FG007|Part 2: Dose Expansion|Other|0|||
37862712|NCT01286987|69546582|FG008|Part 2: Dose Expansion|Other|0|||
37862713|NCT01286987|69546583|FG009|Part 2: Dose Expansion|Other|0|||
37862714|NCT01286987|69546584|FG010|Part 2: Dose Expansion|Other|0|||
37862715|NCT01286987|69546585|FG011|Part 2: Dose Expansion|Other|0|||
37862716|NCT01286987|69546586|FG012|Part 2: Dose Expansion|Other|0|||
37862717|NCT01286987|69546587|FG013|Part 2: Dose Expansion|Other|1|||
37862718|NCT01286987|69546588|FG014|Part 2: Dose Expansion|Other|0|||
37862719|NCT01286987|69546574|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
37862720|NCT01286987|69546575|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
37862721|NCT01286987|69546576|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
37862722|NCT01286987|69546577|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
37862723|NCT01286987|69546578|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
37862724|NCT01286987|69546579|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
37862725|NCT01286987|69546580|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
37862726|NCT01286987|69546581|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
37862727|NCT01286987|69546582|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
37862728|NCT01286987|69546583|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
37862729|NCT01286987|69546584|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
37862730|NCT01286987|69546585|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
37862731|NCT01286987|69546586|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
37862732|NCT01286987|69546587|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
37862733|NCT01286987|69546588|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
37862734|NCT01286987|69546574|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
37862735|NCT01286987|69546575|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
37862736|NCT01286987|69546576|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
37862737|NCT01286987|69546577|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
37862738|NCT01286987|69546578|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
37862739|NCT01286987|69546579|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
37862740|NCT01286987|69546580|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
37862741|NCT01286987|69546581|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
37862742|NCT01286987|69546582|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
37862743|NCT01286987|69546583|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
37862744|NCT01286987|69546584|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
37862745|NCT01286987|69546585|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
37862746|NCT01286987|69546586|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
37862747|NCT01286987|69546587|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
37862748|NCT01286987|69546588|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
37862749|NCT01286987|69546574|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
37862750|NCT01286987|69546575|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
37862751|NCT01286987|69546576|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
37862752|NCT01286987|69546577|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
37862753|NCT01286987|69546578|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
37862754|NCT01286987|69546579|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
37862755|NCT01286987|69546580|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
37862756|NCT01286987|69546581|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
37862757|NCT01286987|69546582|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
37862758|NCT01286987|69546583|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
37862759|NCT01286987|69546584|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
37862760|NCT01286987|69546585|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
37862761|NCT01286987|69546586|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
37862762|NCT01286987|69546587|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
37862763|NCT01286987|69546588|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
37862764|NCT01286753|69546631|FG000|Overall Study|Adverse Event|7|||
37862765|NCT01286753|69546632|FG001|Overall Study|Adverse Event|6|||
37862766|NCT01286753|69546631|FG000|Overall Study|Progression|11|||
37862767|NCT01286753|69546632|FG001|Overall Study|Progression|13|||
37862768|NCT01286753|69546631|FG000|Overall Study|Refused Treatment|1|||
37862769|NCT01286753|69546632|FG001|Overall Study|Refused Treatment|0|||
37862770|NCT01286753|69546631|FG000|Overall Study|Withdrawal of Consent|0|||
37862771|NCT01286753|69546632|FG001|Overall Study|Withdrawal of Consent|2|||
37862772|NCT01286753|69546631|FG000|Overall Study|Discontinued to Join Extension Study|6|||
37966960|NCT00446199|69653866|FG001|Overall Study|Randomization in Error|0|||
37966961|NCT00446199|69653867|FG002|Overall Study|Randomization in Error|1|||
37966962|NCT00446199|69653868|FG003|Overall Study|Randomization in Error|1|||
37966963|NCT00446199|69653865|FG000|Overall Study|Lack of Efficacy|1|||
37966964|NCT00446199|69653866|FG001|Overall Study|Lack of Efficacy|0|||
37966965|NCT00446199|69653867|FG002|Overall Study|Lack of Efficacy|0|||
37862773|NCT01286753|69546632|FG001|Overall Study|Discontinued to Join Extension Study|4|||
37862774|NCT01286753|69546631|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
37862775|NCT01286753|69546632|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
37862776|NCT01286129|69546641|FG000|Overall Study|Withdrawal by Subject|4|||
37862777|NCT01286129|69546642|FG001|Overall Study|Withdrawal by Subject|1|||
37862778|NCT01286129|69546641|FG000|Overall Study|Could not comply with study requirements|4|||
37862779|NCT01286129|69546642|FG001|Overall Study|Could not comply with study requirements|4|||
37862780|NCT01285349|69546653|FG000|Overall Study|Lost to Follow-up|27|||
37862781|NCT01285349|69546654|FG001|Overall Study|Lost to Follow-up|20|||
37966966|NCT00446199|69653868|FG003|Overall Study|Lack of Efficacy|1|||
37966967|NCT00446199|69653865|FG000|Overall Study|Non-compliant with study drug|1|||
37966968|NCT00446199|69653866|FG001|Overall Study|Non-compliant with study drug|0|||
38081625|NCT01471522|69780145|FG001|Overall Study|Lost to Follow-up|26|||
38081626|NCT01191008|69780152|FG000|Overall Study|Protocol Violation|7|||
38081627|NCT01191008|69780152|FG000|Overall Study|Lost to Follow-up|8|||
38081628|NCT00821587|69780158|FG000|Overall Study|Physician Decision|0|||
38081629|NCT00821587|69780159|FG001|Overall Study|Physician Decision|1|||
38081630|NCT00645801|69780167|FG000|Overall Study|unclear if patient took all the medication.|1|||
38081631|NCT00645801|69780168|FG001|Overall Study|unclear if patient took all the medication.|0|||
38081632|NCT00645801|69780167|FG000|Overall Study|Lost to Follow-up|19|||
38081633|NCT00645801|69780168|FG001|Overall Study|Lost to Follow-up|15|||
38081634|NCT00424099|69780182|FG000|Overall Study|Adverse Event|0|||
38081635|NCT00424099|69780183|FG001|Overall Study|Adverse Event|1|||
38081636|NCT00424099|69780184|FG002|Overall Study|Adverse Event|1|||
38081637|NCT00424099|69780185|FG003|Overall Study|Adverse Event|0|||
38081638|NCT00424099|69780182|FG000|Overall Study|Death|0|||
38081639|NCT00424099|69780183|FG001|Overall Study|Death|1|||
38081640|NCT00424099|69780184|FG002|Overall Study|Death|0|||
38081641|NCT00424099|69780185|FG003|Overall Study|Death|0|||
38081642|NCT00424099|69780182|FG000|Overall Study|Illness|2|||
37862782|NCT01285349|69546655|FG002|Overall Study|Lost to Follow-up|27|||
37862783|NCT01284959|69546667|FG000|Overall Study|Withdrawal by Subject|1|||
37862784|NCT01284959|69546668|FG001|Overall Study|Withdrawal by Subject|0|||
37862785|NCT01284959|69546669|FG002|Overall Study|Withdrawal by Subject|0|||
37862786|NCT01284959|69546667|FG000|Overall Study|Adverse Event|0|||
37862787|NCT01284959|69546668|FG001|Overall Study|Adverse Event|0|||
37966969|NCT00446199|69653867|FG002|Overall Study|Non-compliant with study drug|5|||
37966970|NCT00446199|69653868|FG003|Overall Study|Non-compliant with study drug|0|||
37966971|NCT00446199|69653865|FG000|Overall Study|Non-compliant with visit schedule|1|||
38081643|NCT00424099|69780183|FG001|Overall Study|Illness|0|||
38081644|NCT00424099|69780184|FG002|Overall Study|Illness|1|||
38081645|NCT00424099|69780185|FG003|Overall Study|Illness|4|||
38081646|NCT00424099|69780182|FG000|Overall Study|Lost to Follow-up|0|||
38081647|NCT00424099|69780183|FG001|Overall Study|Lost to Follow-up|0|||
38081648|NCT00424099|69780184|FG002|Overall Study|Lost to Follow-up|3|||
38081649|NCT00424099|69780185|FG003|Overall Study|Lost to Follow-up|0|||
38081650|NCT00424099|69780182|FG000|Overall Study|Hospitalized|1|||
38081651|NCT00424099|69780183|FG001|Overall Study|Hospitalized|2|||
38081652|NCT00424099|69780184|FG002|Overall Study|Hospitalized|1|||
38081653|NCT00424099|69780185|FG003|Overall Study|Hospitalized|3|||
38081654|NCT00424099|69780182|FG000|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
38081655|NCT00424099|69780183|FG001|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
38081656|NCT00424099|69780184|FG002|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
38081657|NCT00424099|69780185|FG003|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
38081658|NCT00424099|69780182|FG000|Overall Study|Withdrawal by Subject|1|||
38081659|NCT00424099|69780183|FG001|Overall Study|Withdrawal by Subject|9|||
38081660|NCT00424099|69780184|FG002|Overall Study|Withdrawal by Subject|4|||
38081661|NCT00424099|69780185|FG003|Overall Study|Withdrawal by Subject|6|||
38081662|NCT00424099|69780182|FG000|Overall Study|Physician Decision|0|||
38081663|NCT00424099|69780183|FG001|Overall Study|Physician Decision|0|||
38081664|NCT00424099|69780184|FG002|Overall Study|Physician Decision|1|||
38081665|NCT00424099|69780185|FG003|Overall Study|Physician Decision|0|||
38081666|NCT00424099|69780182|FG000|Overall Study|Missing|0|||
38081667|NCT00424099|69780183|FG001|Overall Study|Missing|0|||
38081668|NCT00424099|69780184|FG002|Overall Study|Missing|1|||
38081669|NCT00424099|69780185|FG003|Overall Study|Missing|0|||
38081670|NCT02988661|69780212|FG000|Overall Study|Death|2|||
38081671|NCT02988661|69780213|FG001|Overall Study|Death|18|||
38081672|NCT02988661|69780212|FG000|Overall Study|Lost to Follow-up|0|||
38081673|NCT02988661|69780213|FG001|Overall Study|Lost to Follow-up|33|||
38081674|NCT02988661|69780212|FG000|Overall Study|Withdrawal by Subject|0|||
38081675|NCT02988661|69780213|FG001|Overall Study|Withdrawal by Subject|6|||
38081676|NCT02988661|69780212|FG000|Overall Study|Unable to complete the 18-month survey|1|||
38081677|NCT02988661|69780213|FG001|Overall Study|Unable to complete the 18-month survey|27|||
38081678|NCT03738397|69780221|FG000|Overall Study|Adverse Event|3|||
38081679|NCT03738397|69780222|FG001|Overall Study|Adverse Event|7|||
38081680|NCT03738397|69780221|FG000|Overall Study|Withdrawal by Subject|8|||
38081681|NCT03738397|69780222|FG001|Overall Study|Withdrawal by Subject|11|||
38081682|NCT03738397|69780221|FG000|Overall Study|Lost to Follow-up|8|||
38081683|NCT03738397|69780222|FG001|Overall Study|Lost to Follow-up|5|||
38081684|NCT03738397|69780221|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
37862788|NCT01284959|69546669|FG002|Overall Study|Adverse Event|1|||
37862789|NCT01284491|69546677|FG000|Overall Study|Study termination|13|||
37862790|NCT01283009|69546685|FG000|Overall Study|Death|83|||
37862791|NCT01283009|69546686|FG001|Overall Study|Death|78|||
37862792|NCT01283009|69546685|FG000|Overall Study|Study ended early|23|||
37862793|NCT01283009|69546686|FG001|Overall Study|Study ended early|26|||
37862794|NCT01283009|69546685|FG000|Overall Study|Withdrawal by Subject|10|||
37862795|NCT01283009|69546686|FG001|Overall Study|Withdrawal by Subject|8|||
37862796|NCT01283009|69546685|FG000|Overall Study|Physician Decision|1|||
37862797|NCT01283009|69546686|FG001|Overall Study|Physician Decision|1|||
37862798|NCT01283009|69546685|FG000|Overall Study|Lost to Follow-up|1|||
37862799|NCT01283009|69546686|FG001|Overall Study|Lost to Follow-up|0|||
37862800|NCT01283009|69546685|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
37862801|NCT01283009|69546686|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
37862802|NCT01282463|69546695|FG000|Overall Study|Lost to Follow-up|1|||
37862803|NCT01282463|69546696|FG001|Overall Study|Lost to Follow-up|0|||
37862804|NCT01282463|69546697|FG002|Overall Study|Lost to Follow-up|0|||
37862805|NCT01282463|69546695|FG000|Overall Study|Withdrawal by Subject|6|||
37862806|NCT01282463|69546696|FG001|Overall Study|Withdrawal by Subject|2|||
37862807|NCT01282463|69546697|FG002|Overall Study|Withdrawal by Subject|3|||
37862808|NCT01282463|69546695|FG000|Overall Study|"Never Treated Death"|0|||
37862809|NCT01282463|69546696|FG001|Overall Study|"Never Treated Death"|1|||
37862810|NCT01282463|69546697|FG002|Overall Study|"Never Treated Death"|0|||
38081685|NCT03738397|69780222|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
38081686|NCT03738397|69780221|FG000|Overall Study|Other|4|||
38081687|NCT03738397|69780222|FG001|Overall Study|Other|6|||
38081688|NCT02960217|69780230|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
38081689|NCT02960217|69780231|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
38081690|NCT02960217|69780230|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
38081691|NCT02960217|69780231|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
38081692|NCT02960217|69780230|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
37862811|NCT01282463|69546695|FG000|Overall Study|"Never Treated PD"|0|||
37862812|NCT01282463|69546696|FG001|Overall Study|"Never Treated PD"|1|||
37862813|NCT01282463|69546697|FG002|Overall Study|"Never Treated PD"|0|||
37862814|NCT01282463|69546695|FG000|Overall Study|Protocol Violation|0|||
37862815|NCT01282463|69546696|FG001|Overall Study|Protocol Violation|0|||
37966972|NCT00446199|69653866|FG001|Overall Study|Non-compliant with visit schedule|1|||
37966973|NCT00446199|69653867|FG002|Overall Study|Non-compliant with visit schedule|1|||
37966974|NCT00446199|69653868|FG003|Overall Study|Non-compliant with visit schedule|2|||
38081693|NCT02960217|69780231|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
38081694|NCT02960217|69780230|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
38081695|NCT02960217|69780231|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
38081696|NCT02960217|69780230|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
38081697|NCT02960217|69780231|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
38081698|NCT02960217|69780230|FG000|Open-Label Extension Phase|Adverse Event|1|||
38081699|NCT02960217|69780231|FG001|Open-Label Extension Phase|Adverse Event|0|||
38081700|NCT02960217|69780230|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
38081701|NCT02960217|69780231|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
38081702|NCT02960217|69780230|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
38081703|NCT02960217|69780231|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
38081704|NCT02960217|69780230|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
38081705|NCT02960217|69780231|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
38081706|NCT02959983|69780243|FG000|Overall Study|Protocol Violation|0|||
38081707|NCT02959983|69780244|FG001|Overall Study|Protocol Violation|1|||
38081708|NCT02959983|69780243|FG000|Overall Study|Lack of Efficacy|0|||
37862816|NCT01282463|69546697|FG002|Overall Study|Protocol Violation|1|||
37862817|NCT01282463|69546695|FG000|Overall Study|Physician Decision|1|||
37862818|NCT01282463|69546696|FG001|Overall Study|Physician Decision|0|||
37862819|NCT01282463|69546697|FG002|Overall Study|Physician Decision|0|||
37862820|NCT01282229|69546713|FG000|Overall Study|Protocol Violation|2|||
37862821|NCT01281917|69546731|FG000|Overall Study|Withdrawal by Subject|1|||
37862822|NCT01281839|69546737|FG000|Overall Study|Lost to Follow-up|6|||
37862823|NCT01281839|69546738|FG001|Overall Study|Lost to Follow-up|3|||
37862824|NCT01281839|69546737|FG000|Overall Study|Withdrawal by Subject|4|||
37862825|NCT01281839|69546738|FG001|Overall Study|Withdrawal by Subject|10|||
37862826|NCT01281839|69546737|FG000|Overall Study|Reason not specified|0|||
37862827|NCT01281839|69546738|FG001|Overall Study|Reason not specified|1|||
38081709|NCT02959983|69780244|FG001|Overall Study|Lack of Efficacy|1|||
38081710|NCT02959983|69780243|FG000|Overall Study|Lost to Follow-up|12|||
38081711|NCT02959983|69780244|FG001|Overall Study|Lost to Follow-up|9|||
37681598|NCT02566993|69157293|FG000|Overall Study|Study drug-related adverse event|20|||
37771428|NCT01360632|69290633|FG003|Phase B (6 Weeks)|Physician Decision|1|||
37771429|NCT01360632|69290634|FG004|Phase B (6 Weeks)|Physician Decision|0|||
37771430|NCT01360632|69290630|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
37771431|NCT01360632|69290631|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
37771432|NCT01360632|69290632|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
37771433|NCT01360632|69290633|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
37771434|NCT01360632|69290634|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
37771435|NCT01360632|69290630|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
38081712|NCT02959983|69780243|FG000|Overall Study|Other|1|||
38081713|NCT02959983|69780244|FG001|Overall Study|Other|1|||
38081714|NCT02959983|69780243|FG000|Overall Study|Physician Decision|1|||
38081715|NCT02959983|69780244|FG001|Overall Study|Physician Decision|0|||
38081716|NCT02959983|69780243|FG000|Overall Study|Adverse Event|5|||
38081717|NCT02959983|69780244|FG001|Overall Study|Adverse Event|1|||
38081718|NCT02959983|69780243|FG000|Overall Study|Withdrawal by Subject|7|||
38081719|NCT02959983|69780244|FG001|Overall Study|Withdrawal by Subject|12|||
38081720|NCT01344447|69780250|FG000|Overall Study|Adverse Event|1|||
38081721|NCT01344447|69780250|FG000|Overall Study|Protocol Violation|1|||
38081722|NCT01344447|69780250|FG000|Overall Study|Withdrawal by Subject|1|||
38081723|NCT01344447|69780250|FG000|Overall Study|The contrast was not seen|1|||
38081724|NCT01344447|69780250|FG000|Overall Study|Physician Decision|1|||
37862828|NCT01281137|69546746|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
37862829|NCT01281137|69546747|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
37862830|NCT01281137|69546746|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
37862831|NCT01281137|69546747|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
38081725|NCT01344447|69780250|FG000|Overall Study|MRA unsuccessful|1|||
38081726|NCT01344447|69780250|FG000|Overall Study|Bolus tracking failed|1|||
38081727|NCT01344447|69780250|FG000|Overall Study|Error of power injector|1|||
38081728|NCT03513068|69780260|FG000|Overall Study|Death|1|||
38081729|NCT03513068|69780261|FG001|Overall Study|Death|0|||
37771436|NCT01360632|69290631|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
37862832|NCT01281137|69546746|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
37862833|NCT01281137|69546747|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
37862834|NCT01281137|69546746|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
37862835|NCT01281137|69546747|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
37862836|NCT01281137|69546746|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
37862837|NCT01281137|69546747|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
37862838|NCT01280981|69546771|FG000|Overall Study|Withdrawal by Subject|11|||
37862839|NCT01280981|69546771|FG000|Overall Study|Protocol Violation|2|||
37862840|NCT01280981|69546771|FG000|Overall Study|Lack of Efficacy|13|||
37862841|NCT01280981|69546771|FG000|Overall Study|Lost to Follow-up|3|||
37862842|NCT01280981|69546771|FG000|Overall Study|Adverse Event|6|||
37862843|NCT01280981|69546771|FG000|Overall Study|Irregular or discontinued menses|3|||
37862844|NCT01280981|69546771|FG000|Overall Study|Failed to return|45|||
37862845|NCT01280981|69546771|FG000|Overall Study|Non-compliance with protocol|3|||
37862846|NCT01280981|69546771|FG000|Overall Study|Withdrawal of consent|3|||
37862847|NCT01280981|69546771|FG000|Overall Study|Elective surgery|2|||
37862848|NCT01280981|69546771|FG000|Overall Study|Study site closure|1|||
37862849|NCT01280903|69546777|FG000|Overall Study|Lost to Follow-up|23|||
37862850|NCT01280903|69546778|FG001|Overall Study|Lost to Follow-up|16|||
37862851|NCT01280591|69546788|FG000|Overall Study|Withdrawal by Subject|0|||
37862852|NCT01280591|69546789|FG001|Overall Study|Withdrawal by Subject|0|||
37862853|NCT01280591|69546790|FG002|Overall Study|Withdrawal by Subject|0|||
37862854|NCT01280591|69546791|FG003|Overall Study|Withdrawal by Subject|2|||
38081730|NCT03513068|69780260|FG000|Overall Study|Withdrawal by Subject|4|||
38081731|NCT03513068|69780261|FG001|Overall Study|Withdrawal by Subject|6|||
38081732|NCT01348425|69780269|FG000|Overall Study|Imaging was not taken.|1|||
38081733|NCT01348425|69780270|FG001|Overall Study|Imaging was not taken.|1|||
38081734|NCT03041701|69780278|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
38081735|NCT03041701|69780279|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
38081736|NCT03041701|69780280|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
38081737|NCT03041701|69780278|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
38081738|NCT03041701|69780279|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
38081739|NCT03041701|69780280|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
38081740|NCT02956629|69780297|FG000|Overall Study|Adverse Event|0|||
38081741|NCT02956629|69780298|FG001|Overall Study|Adverse Event|0|||
38081742|NCT02956629|69780299|FG002|Overall Study|Adverse Event|1|||
38081743|NCT02956629|69780300|FG003|Overall Study|Adverse Event|0|||
38081744|NCT02956629|69780301|FG004|Overall Study|Adverse Event|0|||
38081745|NCT02956629|69780302|FG005|Overall Study|Adverse Event|0|||
38081746|NCT02956629|69780297|FG000|Overall Study|Lost to Follow-up|2|||
38081747|NCT02956629|69780298|FG001|Overall Study|Lost to Follow-up|5|||
38081748|NCT02956629|69780299|FG002|Overall Study|Lost to Follow-up|3|||
38081749|NCT02956629|69780300|FG003|Overall Study|Lost to Follow-up|1|||
38081750|NCT02956629|69780301|FG004|Overall Study|Lost to Follow-up|0|||
38081751|NCT02956629|69780302|FG005|Overall Study|Lost to Follow-up|1|||
38081752|NCT02956629|69780297|FG000|Overall Study|Withdrawal by Subject|3|||
37862855|NCT01280591|69546788|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
37862856|NCT01280591|69546789|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
37862857|NCT01280591|69546790|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
37862858|NCT01280591|69546791|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
37681599|NCT02566993|69157294|FG001|Overall Study|Study drug-related adverse event|41|||
37681600|NCT02566993|69157293|FG000|Overall Study|Non study drug-related adverse event|9|||
37681601|NCT02566993|69157294|FG001|Overall Study|Non study drug-related adverse event|9|||
37681602|NCT02566993|69157293|FG000|Overall Study|Symptomatic deterioration|9|||
37681603|NCT02566993|69157294|FG001|Overall Study|Symptomatic deterioration|16|||
37681604|NCT02566993|69157293|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
37681605|NCT02566993|69157294|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
37681606|NCT02566993|69157293|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
37681607|NCT02566993|69157294|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
37681608|NCT02566993|69157293|FG000|Overall Study|Screening failure|2|||
37681609|NCT02566993|69157294|FG001|Overall Study|Screening failure|0|||
37681610|NCT02566993|69157293|FG000|Overall Study|Lost to Follow-up|0|||
37681611|NCT02566993|69157294|FG001|Overall Study|Lost to Follow-up|1|||
37681612|NCT02566993|69157293|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
38081753|NCT02956629|69780298|FG001|Overall Study|Withdrawal by Subject|1|||
37862859|NCT01280357|69546801|FG000|Overall Study|Excluded no internal monitoring|14|||
37681613|NCT02566993|69157294|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
38081754|NCT02956629|69780299|FG002|Overall Study|Withdrawal by Subject|0|||
37681614|NCT02311881|69157305|FG000|Overall Study|Did not meet the study criteria|2|||
37681615|NCT02311881|69157306|FG001|Overall Study|Did not meet the study criteria|2|||
37681616|NCT02311881|69157307|FG002|Overall Study|Did not meet the study criteria|0|||
37681617|NCT02311881|69157305|FG000|Overall Study|Adverse Event|7|||
37681618|NCT02311881|69157306|FG001|Overall Study|Adverse Event|15|||
37681619|NCT02311881|69157307|FG002|Overall Study|Adverse Event|8|||
37681620|NCT02311881|69157305|FG000|Overall Study|Lost to Follow-up|3|||
37681621|NCT02311881|69157306|FG001|Overall Study|Lost to Follow-up|3|||
37681622|NCT02311881|69157307|FG002|Overall Study|Lost to Follow-up|2|||
37681623|NCT02311881|69157305|FG000|Overall Study|Protocol Violation|1|||
37681624|NCT02311881|69157306|FG001|Overall Study|Protocol Violation|2|||
37681625|NCT02311881|69157307|FG002|Overall Study|Protocol Violation|3|||
37681626|NCT02311881|69157305|FG000|Overall Study|Withdrawal of consent|14|||
37681627|NCT02311881|69157306|FG001|Overall Study|Withdrawal of consent|16|||
37681628|NCT02311881|69157307|FG002|Overall Study|Withdrawal of consent|17|||
37862860|NCT01280357|69546801|FG000|Overall Study|IInsufficient data/No data supplied|12|||
37862861|NCT01274351|69546808|FG000|Overall Study|Lost to Follow-up|1|||
37862862|NCT01274351|69546808|FG000|Overall Study|patient not compliant with the protocol|1|||
37862863|NCT01274351|69546808|FG000|Overall Study|Pregnancy|1|||
37862864|NCT01274351|69546808|FG000|Overall Study|Death|2|||
37862865|NCT01274351|69546808|FG000|Overall Study|Withdrawal by Subject|3|||
37862866|NCT01274351|69546808|FG000|Overall Study|Adverse Event|8|||
37862867|NCT01274351|69546808|FG000|Overall Study|progression of disease|3|||
37862868|NCT01274351|69546808|FG000|Overall Study|hospitalization|1|||
37681629|NCT02311881|69157305|FG000|Overall Study|Other|0|||
37681630|NCT02311881|69157306|FG001|Overall Study|Other|0|||
37681631|NCT02311881|69157307|FG002|Overall Study|Other|1|||
37681632|NCT02311881|69157305|FG000|Overall Study|Lack of Efficacy|1|||
37681633|NCT02311881|69157306|FG001|Overall Study|Lack of Efficacy|2|||
37681634|NCT02311881|69157307|FG002|Overall Study|Lack of Efficacy|0|||
37681635|NCT02311881|69157305|FG000|Overall Study|Subject has border line pregnancy test|1|||
37681636|NCT02311881|69157306|FG001|Overall Study|Subject has border line pregnancy test|0|||
37862869|NCT01271933|69546812|FG000|Single-Blind Phase|Lack of Efficacy|37|||
37862870|NCT01271933|69546813|FG001|Single-Blind Phase|Lack of Efficacy|0|||
37862871|NCT01271933|69546814|FG002|Single-Blind Phase|Lack of Efficacy|0|||
37862872|NCT01271933|69546812|FG000|Single-Blind Phase|Lost to Follow-up|10|||
37862873|NCT01271933|69546813|FG001|Single-Blind Phase|Lost to Follow-up|0|||
37862874|NCT01271933|69546814|FG002|Single-Blind Phase|Lost to Follow-up|0|||
37862875|NCT01271933|69546812|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
37862876|NCT01271933|69546813|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
37862877|NCT01271933|69546814|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
37862878|NCT01271933|69546812|FG000|Single-Blind Phase|Protocol Violation|3|||
37862879|NCT01271933|69546813|FG001|Single-Blind Phase|Protocol Violation|0|||
37862880|NCT01271933|69546814|FG002|Single-Blind Phase|Protocol Violation|0|||
37862881|NCT01271933|69546812|FG000|Single-Blind Phase|Adverse Event|52|||
37862882|NCT01271933|69546813|FG001|Single-Blind Phase|Adverse Event|0|||
37862883|NCT01271933|69546814|FG002|Single-Blind Phase|Adverse Event|0|||
37681637|NCT02311881|69157307|FG002|Overall Study|Subject has border line pregnancy test|0|||
37681638|NCT02311881|69157305|FG000|Overall Study|Withdrawal by Subject|3|||
37681639|NCT02311881|69157306|FG001|Overall Study|Withdrawal by Subject|1|||
37681640|NCT02311881|69157307|FG002|Overall Study|Withdrawal by Subject|4|||
37681641|NCT02311881|69157305|FG000|Overall Study|Sponsor Decision|1|||
37681642|NCT02311881|69157306|FG001|Overall Study|Sponsor Decision|1|||
37681643|NCT02311881|69157307|FG002|Overall Study|Sponsor Decision|1|||
37681644|NCT02311881|69157305|FG000|Overall Study|Protocol Deviation|1|||
37681645|NCT02311881|69157306|FG001|Overall Study|Protocol Deviation|0|||
37681646|NCT02311881|69157307|FG002|Overall Study|Protocol Deviation|0|||
37681647|NCT02311881|69157305|FG000|Overall Study|Non-Compliance|1|||
37681648|NCT02311881|69157306|FG001|Overall Study|Non-Compliance|0|||
37681649|NCT02311881|69157307|FG002|Overall Study|Non-Compliance|2|||
37681650|NCT02311881|69157305|FG000|Overall Study|Physician Decision|0|||
37681651|NCT02311881|69157306|FG001|Overall Study|Physician Decision|0|||
37681652|NCT02311881|69157307|FG002|Overall Study|Physician Decision|1|||
37681653|NCT02311881|69157305|FG000|Overall Study|Medical Monitor Discretion|0|||
37862884|NCT01271933|69546812|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
37681654|NCT02311881|69157306|FG001|Overall Study|Medical Monitor Discretion|0|||
37681655|NCT02311881|69157307|FG002|Overall Study|Medical Monitor Discretion|1|||
37681656|NCT02311881|69157305|FG000|Overall Study|Participant taking another medication|0|||
37681657|NCT02311881|69157306|FG001|Overall Study|Participant taking another medication|0|||
37862885|NCT01271933|69546813|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
37681658|NCT02311881|69157307|FG002|Overall Study|Participant taking another medication|1|||
37681659|NCT02311881|69157305|FG000|Overall Study|Serious Adverse Event|0|||
37681660|NCT02311881|69157306|FG001|Overall Study|Serious Adverse Event|1|||
37681661|NCT02311881|69157307|FG002|Overall Study|Serious Adverse Event|0|||
37681662|NCT02565511|69157322|FG000|Overall Study|Study terminated by Sponsor|35|||
37681663|NCT02565511|69157323|FG001|Overall Study|Study terminated by Sponsor|22|||
37966975|NCT00446199|69653865|FG000|Overall Study|Hormone fear|0|||
37681664|NCT02565511|69157324|FG002|Overall Study|Study terminated by Sponsor|235|||
37681665|NCT02565511|69157325|FG003|Overall Study|Study terminated by Sponsor|156|||
37681666|NCT02565511|69157322|FG000|Overall Study|Withdrawal by Subject|3|||
37681667|NCT02565511|69157323|FG001|Overall Study|Withdrawal by Subject|0|||
37681668|NCT02565511|69157324|FG002|Overall Study|Withdrawal by Subject|12|||
37681669|NCT02565511|69157325|FG003|Overall Study|Withdrawal by Subject|5|||
37681670|NCT02565511|69157322|FG000|Overall Study|Adverse Event|0|||
37681671|NCT02565511|69157323|FG001|Overall Study|Adverse Event|0|||
37681672|NCT02565511|69157324|FG002|Overall Study|Adverse Event|1|||
37862886|NCT01271933|69546814|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
37862887|NCT01271933|69546812|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
37862888|NCT01271933|69546813|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
37862889|NCT01271933|69546814|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
37862890|NCT01271933|69546812|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
37681673|NCT02565511|69157325|FG003|Overall Study|Adverse Event|1|||
37681674|NCT02565511|69157322|FG000|Overall Study|Lost to Follow-up|4|||
37681675|NCT02565511|69157323|FG001|Overall Study|Lost to Follow-up|1|||
37681676|NCT02565511|69157324|FG002|Overall Study|Lost to Follow-up|0|||
37681677|NCT02565511|69157325|FG003|Overall Study|Lost to Follow-up|1|||
37681678|NCT02565511|69157322|FG000|Overall Study|Physician Decision|0|||
37681679|NCT02565511|69157323|FG001|Overall Study|Physician Decision|0|||
37681680|NCT02565511|69157324|FG002|Overall Study|Physician Decision|0|||
37681681|NCT02565511|69157325|FG003|Overall Study|Physician Decision|1|||
37681682|NCT02565511|69157322|FG000|Overall Study|Protocol deviation|0|||
37681683|NCT02565511|69157323|FG001|Overall Study|Protocol deviation|0|||
37681684|NCT02565511|69157324|FG002|Overall Study|Protocol deviation|3|||
37681685|NCT02565511|69157325|FG003|Overall Study|Protocol deviation|0|||
37681686|NCT02561455|69157339|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
37681687|NCT02561455|69157340|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
37681688|NCT02561455|69157341|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
37681689|NCT02561455|69157342|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
37681690|NCT02561455|69157339|FG000|Overall Study|Withdrawal by Subject|1|||
37681691|NCT02561455|69157340|FG001|Overall Study|Withdrawal by Subject|0|||
37681692|NCT02561455|69157341|FG002|Overall Study|Withdrawal by Subject|1|||
37681693|NCT02561455|69157342|FG003|Overall Study|Withdrawal by Subject|0|||
37681694|NCT02561455|69157339|FG000|Overall Study|Disease Progression|0|||
37681695|NCT02561455|69157340|FG001|Overall Study|Disease Progression|1|||
37681696|NCT02561455|69157341|FG002|Overall Study|Disease Progression|0|||
37681697|NCT02561455|69157342|FG003|Overall Study|Disease Progression|0|||
37681698|NCT02561299|69157354|FG000|Overall Study|Death|2|||
37681699|NCT02561299|69157355|FG001|Overall Study|Death|4|||
37681700|NCT02561299|69157354|FG000|Overall Study|Lost to Follow-up|1|||
37681701|NCT02561299|69157355|FG001|Overall Study|Lost to Follow-up|0|||
37681702|NCT02561299|69157354|FG000|Overall Study|Withdrawal by Subject|2|||
37681703|NCT02561299|69157355|FG001|Overall Study|Withdrawal by Subject|2|||
37681704|NCT02566759|69157378|FG000|All Parts|Withdrawal by Subject|0|||
37681705|NCT02566759|69157379|FG001|All Parts|Withdrawal by Subject|1|||
37681706|NCT02566759|69157380|FG002|All Parts|Withdrawal by Subject|0|||
37681707|NCT02566759|69157381|FG003|All Parts|Withdrawal by Subject|0|||
37681708|NCT02566759|69157382|FG004|All Parts|Withdrawal by Subject|0|||
37681709|NCT02566759|69157383|FG005|All Parts|Withdrawal by Subject|0|||
37681710|NCT02566759|69157384|FG006|All Parts|Withdrawal by Subject|0|||
37681711|NCT02566759|69157385|FG007|All Parts|Withdrawal by Subject|0|||
37681712|NCT02566759|69157386|FG008|All Parts|Withdrawal by Subject|0|||
37681713|NCT02566759|69157387|FG009|All Parts|Withdrawal by Subject|0|||
37681714|NCT02566759|69157388|FG010|All Parts|Withdrawal by Subject|0|||
37681715|NCT02566759|69157389|FG011|All Parts|Withdrawal by Subject|0|||
37681716|NCT02566759|69157390|FG012|All Parts|Withdrawal by Subject|0|||
37681717|NCT02566759|69157391|FG013|All Parts|Withdrawal by Subject|0|||
37681718|NCT02566759|69157392|FG014|All Parts|Withdrawal by Subject|0|||
37681719|NCT02566759|69157393|FG015|All Parts|Withdrawal by Subject|0|||
37862891|NCT01271933|69546813|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
37681720|NCT02566759|69157394|FG016|All Parts|Withdrawal by Subject|0|||
37681721|NCT02566759|69157378|FG000|All Parts|Adverse Event|0|||
37681722|NCT02566759|69157379|FG001|All Parts|Adverse Event|0|||
37862892|NCT01271933|69546814|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
37681723|NCT02566759|69157380|FG002|All Parts|Adverse Event|0|||
37681724|NCT02566759|69157381|FG003|All Parts|Adverse Event|0|||
37681725|NCT02566759|69157382|FG004|All Parts|Adverse Event|0|||
37681726|NCT02566759|69157383|FG005|All Parts|Adverse Event|0|||
37681727|NCT02566759|69157384|FG006|All Parts|Adverse Event|0|||
37681728|NCT02566759|69157385|FG007|All Parts|Adverse Event|0|||
37681729|NCT02566759|69157386|FG008|All Parts|Adverse Event|0|||
37681730|NCT02566759|69157387|FG009|All Parts|Adverse Event|0|||
37681731|NCT02566759|69157388|FG010|All Parts|Adverse Event|0|||
37681732|NCT02566759|69157389|FG011|All Parts|Adverse Event|0|||
37681733|NCT02566759|69157390|FG012|All Parts|Adverse Event|1|||
37681734|NCT02566759|69157391|FG013|All Parts|Adverse Event|3|||
37681735|NCT02566759|69157392|FG014|All Parts|Adverse Event|0|||
37681736|NCT02566759|69157393|FG015|All Parts|Adverse Event|0|||
37681737|NCT02566759|69157394|FG016|All Parts|Adverse Event|0|||
37681738|NCT02566759|69157378|FG000|All Parts|Other|0|||
37681739|NCT02566759|69157379|FG001|All Parts|Other|0|||
37681740|NCT02566759|69157380|FG002|All Parts|Other|0|||
37681741|NCT02566759|69157381|FG003|All Parts|Other|0|||
37681742|NCT02566759|69157382|FG004|All Parts|Other|0|||
37681743|NCT02566759|69157383|FG005|All Parts|Other|0|||
37681744|NCT02566759|69157384|FG006|All Parts|Other|0|||
37681745|NCT02566759|69157385|FG007|All Parts|Other|0|||
37681746|NCT02566759|69157386|FG008|All Parts|Other|0|||
37681747|NCT02566759|69157387|FG009|All Parts|Other|0|||
37681748|NCT02566759|69157388|FG010|All Parts|Other|0|||
37681749|NCT02566759|69157389|FG011|All Parts|Other|0|||
37681750|NCT02566759|69157390|FG012|All Parts|Other|0|||
37681751|NCT02566759|69157391|FG013|All Parts|Other|2|||
37681752|NCT02566759|69157392|FG014|All Parts|Other|0|||
37681753|NCT02566759|69157393|FG015|All Parts|Other|0|||
37681754|NCT02566759|69157394|FG016|All Parts|Other|0|||
37681755|NCT02566759|69157378|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
37681756|NCT02566759|69157379|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
37681757|NCT02566759|69157380|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
37681758|NCT02566759|69157381|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
37681759|NCT02566759|69157382|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
37681760|NCT02566759|69157383|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
37681761|NCT02566759|69157384|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
37681762|NCT02566759|69157385|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
37681763|NCT02566759|69157386|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
37681764|NCT02566759|69157387|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
37681765|NCT02566759|69157388|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
37681766|NCT02566759|69157389|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
37681767|NCT02566759|69157390|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
37681768|NCT02566759|69157391|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
37681769|NCT02566759|69157392|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
37681770|NCT02566759|69157393|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
37681771|NCT02566759|69157394|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
37681772|NCT02335983|69157459|FG000|Overall Study|Sponsor Decision|0|||
37681773|NCT02335983|69157460|FG001|Overall Study|Sponsor Decision|0|||
37681774|NCT02335983|69157461|FG002|Overall Study|Sponsor Decision|1|||
37681775|NCT02335983|69157462|FG003|Overall Study|Sponsor Decision|1|||
37681776|NCT02335983|69157463|FG004|Overall Study|Sponsor Decision|0|||
37681777|NCT02335983|69157464|FG005|Overall Study|Sponsor Decision|1|||
37681778|NCT02335983|69157459|FG000|Overall Study|Withdrawal by Subject|3|||
37681779|NCT02335983|69157460|FG001|Overall Study|Withdrawal by Subject|2|||
37681780|NCT02335983|69157461|FG002|Overall Study|Withdrawal by Subject|2|||
37681781|NCT02335983|69157462|FG003|Overall Study|Withdrawal by Subject|1|||
37681782|NCT02335983|69157463|FG004|Overall Study|Withdrawal by Subject|3|||
37681783|NCT02335983|69157464|FG005|Overall Study|Withdrawal by Subject|9|||
37681784|NCT02335983|69157459|FG000|Overall Study|Death|0|||
37681785|NCT02335983|69157460|FG001|Overall Study|Death|0|||
37681786|NCT02335983|69157461|FG002|Overall Study|Death|2|||
37681787|NCT02335983|69157462|FG003|Overall Study|Death|0|||
37681788|NCT02335983|69157463|FG004|Overall Study|Death|0|||
37681789|NCT02335983|69157464|FG005|Overall Study|Death|0|||
37681790|NCT02335983|69157459|FG000|Overall Study|Lost to Follow-up|0|||
37681791|NCT02335983|69157460|FG001|Overall Study|Lost to Follow-up|0|||
37681792|NCT02335983|69157461|FG002|Overall Study|Lost to Follow-up|0|||
37681793|NCT02335983|69157462|FG003|Overall Study|Lost to Follow-up|0|||
37681794|NCT02335983|69157463|FG004|Overall Study|Lost to Follow-up|0|||
37681795|NCT02335983|69157464|FG005|Overall Study|Lost to Follow-up|1|||
37681796|NCT02335983|69157459|FG000|Overall Study|Protocol Specified Criteria|5|||
37681797|NCT02335983|69157460|FG001|Overall Study|Protocol Specified Criteria|7|||
37681798|NCT02335983|69157461|FG002|Overall Study|Protocol Specified Criteria|27|||
37681799|NCT02335983|69157462|FG003|Overall Study|Protocol Specified Criteria|7|||
37681800|NCT02335983|69157463|FG004|Overall Study|Protocol Specified Criteria|5|||
37681801|NCT02335983|69157464|FG005|Overall Study|Protocol Specified Criteria|21|||
37681802|NCT04640311|69157500|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
37862893|NCT01271933|69546812|FG000|Double-Blind Phase|Randomized but not treated|0|||
37862894|NCT01271933|69546813|FG001|Double-Blind Phase|Randomized but not treated|0|||
37966976|NCT00446199|69653866|FG001|Overall Study|Hormone fear|0|||
37681803|NCT04640311|69157501|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
37681804|NCT04640311|69157502|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
37681805|NCT04640311|69157503|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
37681806|NCT04640311|69157504|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
37681807|NCT04640311|69157505|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
37681808|NCT04640311|69157506|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
37681809|NCT04640311|69157507|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
37681810|NCT04640311|69157508|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
37681811|NCT04640311|69157509|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
37681812|NCT04640311|69157510|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
37681813|NCT04640311|69157511|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
37681814|NCT04640311|69157512|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
37681815|NCT04640311|69157500|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
37681816|NCT04640311|69157501|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
37681817|NCT04640311|69157502|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
37681818|NCT04640311|69157503|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
37681819|NCT04640311|69157504|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
37681820|NCT04640311|69157505|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
37681821|NCT04640311|69157506|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
37681822|NCT04640311|69157507|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
37681823|NCT04640311|69157508|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
37681824|NCT04640311|69157509|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
38081755|NCT02956629|69780300|FG003|Overall Study|Withdrawal by Subject|0|||
38081756|NCT02956629|69780301|FG004|Overall Study|Withdrawal by Subject|0|||
38081757|NCT02956629|69780302|FG005|Overall Study|Withdrawal by Subject|0|||
38081758|NCT01348347|69780319|FG000|Overall Study|Withdrawal by Subject|1|||
38081759|NCT01348347|69780320|FG001|Overall Study|Withdrawal by Subject|1|||
38081760|NCT01348347|69780321|FG002|Overall Study|Withdrawal by Subject|1|||
38081761|NCT01348347|69780319|FG000|Overall Study|Progressive disease|2|||
38081762|NCT01348347|69780320|FG001|Overall Study|Progressive disease|5|||
38081763|NCT01348347|69780321|FG002|Overall Study|Progressive disease|5|||
38081764|NCT02959671|69780330|FG000|Overall Study|Adverse Event|2|||
38081765|NCT02959671|69780330|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
38081766|NCT01597258|69780334|FG000|Overall Study|No Drug Administration|1|||
38081767|NCT02958267|69780340|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
38081768|NCT02958267|69780341|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
38081769|NCT02958267|69780340|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
38081770|NCT02958267|69780341|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
38081771|NCT02958267|69780340|FG000|Follow-up Visits|Additional treatment pursued|2|||
38081772|NCT02958267|69780341|FG001|Follow-up Visits|Additional treatment pursued|1|||
38081773|NCT01952574|69780351|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
38081774|NCT01952574|69780352|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
38081775|NCT01952574|69780353|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
38081776|NCT01952574|69780354|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
38081777|NCT01952574|69780355|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
38081778|NCT01952574|69780356|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
38081779|NCT01952574|69780357|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
38081780|NCT01952574|69780351|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
38081781|NCT01952574|69780352|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
38081782|NCT01952574|69780353|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
38081783|NCT01952574|69780354|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
37681825|NCT04640311|69157510|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
37681826|NCT04640311|69157511|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
37681827|NCT04640311|69157512|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
37681828|NCT04640311|69157500|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
37681829|NCT04640311|69157501|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
37681830|NCT04640311|69157502|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
37681831|NCT04640311|69157503|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
37681832|NCT04640311|69157504|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
37681833|NCT04640311|69157505|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
37681834|NCT04640311|69157506|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
37681835|NCT04640311|69157507|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
37681836|NCT04640311|69157508|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
37681837|NCT04640311|69157509|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
37681838|NCT04640311|69157510|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
37966977|NCT00446199|69653867|FG002|Overall Study|Hormone fear|0|||
38081784|NCT01952574|69780355|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
38081785|NCT01952574|69780356|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
38081786|NCT01952574|69780357|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
37681839|NCT04640311|69157511|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
37681840|NCT04640311|69157512|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
37681841|NCT04640311|69157500|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
37681842|NCT04640311|69157501|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
37681843|NCT04640311|69157502|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
37681844|NCT04640311|69157503|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
37681845|NCT04640311|69157504|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
37681846|NCT04640311|69157505|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
37681847|NCT04640311|69157506|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
37681848|NCT04640311|69157507|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
37681849|NCT04640311|69157508|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
37681850|NCT04640311|69157509|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
37681851|NCT04640311|69157510|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
37681852|NCT04640311|69157511|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
37681853|NCT04640311|69157512|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
37681854|NCT04640311|69157500|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
37681855|NCT04640311|69157501|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
37681856|NCT04640311|69157502|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
37681857|NCT04640311|69157503|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
37681858|NCT04640311|69157504|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
37681859|NCT04640311|69157505|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
37681860|NCT04640311|69157506|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
37681861|NCT04640311|69157507|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
37681862|NCT04640311|69157508|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
37681863|NCT04640311|69157509|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
37681864|NCT04640311|69157510|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
37681865|NCT04640311|69157511|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
37681866|NCT04640311|69157512|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
37681867|NCT04640311|69157500|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
37681868|NCT04640311|69157501|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
37681869|NCT04640311|69157502|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
37681870|NCT04640311|69157503|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
37681871|NCT04640311|69157504|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
37681872|NCT04640311|69157505|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
37681873|NCT04640311|69157506|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
37681874|NCT04640311|69157507|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
37681875|NCT04640311|69157508|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
37681876|NCT04640311|69157509|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
37681877|NCT04640311|69157510|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
37681878|NCT04640311|69157511|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
37681879|NCT04640311|69157512|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
37681880|NCT04640311|69157500|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
37681881|NCT04640311|69157501|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
37681882|NCT04640311|69157502|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
37681883|NCT04640311|69157503|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
37681884|NCT04640311|69157504|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
37681885|NCT04640311|69157505|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
37681886|NCT04640311|69157506|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
37681887|NCT04640311|69157507|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
37681888|NCT04640311|69157508|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
37681889|NCT04640311|69157509|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
37681890|NCT04640311|69157510|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
37681891|NCT04640311|69157511|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
37681892|NCT04640311|69157512|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
37681893|NCT04640311|69157500|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
37681894|NCT04640311|69157501|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
37681895|NCT04640311|69157502|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
37681896|NCT04640311|69157503|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
37681897|NCT04640311|69157504|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
37681898|NCT04640311|69157505|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
37681899|NCT04640311|69157506|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
37681900|NCT04640311|69157507|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
37681901|NCT04640311|69157508|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
37681902|NCT04640311|69157509|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
37681903|NCT04640311|69157510|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
37681904|NCT04640311|69157511|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
37681905|NCT04640311|69157512|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
37681906|NCT04640311|69157500|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
37681907|NCT04640311|69157501|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
37681908|NCT04640311|69157502|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
37681909|NCT04640311|69157503|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
37681910|NCT04640311|69157504|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
37681911|NCT04640311|69157505|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
37681912|NCT04640311|69157506|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
37681913|NCT04640311|69157507|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
37681914|NCT04640311|69157508|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
37681915|NCT04640311|69157509|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
37681916|NCT04640311|69157510|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
37681917|NCT04640311|69157511|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
37681918|NCT04640311|69157512|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
37681919|NCT02334423|69157543|FG000|Overall Study|Protocol Violation|10|||
37681920|NCT02334423|69157544|FG001|Overall Study|Protocol Violation|3|||
37681921|NCT02310789|69157550|FG000|Overall Study|Adverse Event|1|||
37681922|NCT02372253|69157556|FG000|Overall Study|Non Compliance|2|||
37681923|NCT02372253|69157557|FG001|Overall Study|Non Compliance|0|||
37681924|NCT02559895|69157569|FG000|Overall Study|Adverse Event|3|||
37681925|NCT02559895|69157570|FG001|Overall Study|Adverse Event|3|||
37681926|NCT02559895|69157571|FG002|Overall Study|Adverse Event|2|||
37862895|NCT01271933|69546814|FG002|Double-Blind Phase|Randomized but not treated|1|||
37862896|NCT01271933|69546812|FG000|Double-Blind Phase|Lack of Efficacy|0|||
38081787|NCT01952574|69780351|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
38081788|NCT01952574|69780352|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
38081789|NCT01952574|69780353|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
37681927|NCT02559895|69157572|FG003|Overall Study|Adverse Event|1|||
37681928|NCT02559895|69157569|FG000|Overall Study|Lack of Efficacy|2|||
37862897|NCT01271933|69546813|FG001|Double-Blind Phase|Lack of Efficacy|6|||
38081790|NCT01952574|69780354|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
38081791|NCT01952574|69780355|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
38081792|NCT01952574|69780356|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
38081793|NCT01952574|69780357|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
38081794|NCT01952574|69780351|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
38081795|NCT01952574|69780352|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
38081796|NCT01952574|69780353|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
38081797|NCT01952574|69780354|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
38081798|NCT01952574|69780355|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
38081799|NCT01952574|69780356|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
37681929|NCT02559895|69157570|FG001|Overall Study|Lack of Efficacy|3|||
37681930|NCT02559895|69157571|FG002|Overall Study|Lack of Efficacy|2|||
37681931|NCT02559895|69157572|FG003|Overall Study|Lack of Efficacy|8|||
37681932|NCT02559895|69157569|FG000|Overall Study|Lost to Follow-up|22|||
37681933|NCT02559895|69157570|FG001|Overall Study|Lost to Follow-up|16|||
37681934|NCT02559895|69157571|FG002|Overall Study|Lost to Follow-up|12|||
37681935|NCT02559895|69157572|FG003|Overall Study|Lost to Follow-up|17|||
37681936|NCT02559895|69157569|FG000|Overall Study|Physician Decision|1|||
37681937|NCT02559895|69157570|FG001|Overall Study|Physician Decision|1|||
37681938|NCT02559895|69157571|FG002|Overall Study|Physician Decision|3|||
37681939|NCT02559895|69157572|FG003|Overall Study|Physician Decision|0|||
37681940|NCT02559895|69157569|FG000|Overall Study|Withdrawal by Subject|16|||
37681941|NCT02559895|69157570|FG001|Overall Study|Withdrawal by Subject|9|||
37681942|NCT02559895|69157571|FG002|Overall Study|Withdrawal by Subject|20|||
38081800|NCT01952574|69780357|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
37681943|NCT02559895|69157572|FG003|Overall Study|Withdrawal by Subject|9|||
37681944|NCT02559895|69157569|FG000|Overall Study|Study Burden|10|||
37681945|NCT02559895|69157570|FG001|Overall Study|Study Burden|16|||
37681946|NCT02559895|69157571|FG002|Overall Study|Study Burden|12|||
37681947|NCT02559895|69157572|FG003|Overall Study|Study Burden|22|||
37681948|NCT02559895|69157569|FG000|Overall Study|Other|1|||
37681949|NCT02559895|69157570|FG001|Overall Study|Other|5|||
37681950|NCT02559895|69157571|FG002|Overall Study|Other|3|||
37681951|NCT02559895|69157572|FG003|Overall Study|Other|3|||
37681952|NCT02371629|69157584|FG000|Overall Study|Patient decision|14|||
37681953|NCT02371629|69157585|FG001|Overall Study|Patient decision|10|||
37681954|NCT02371629|69157584|FG000|Overall Study|Adverse Event|8|||
37681955|NCT02371629|69157585|FG001|Overall Study|Adverse Event|8|||
37681956|NCT02371629|69157584|FG000|Overall Study|Physician Decision|2|||
37681957|NCT02371629|69157585|FG001|Overall Study|Physician Decision|3|||
37681958|NCT02371629|69157584|FG000|Overall Study|Death|1|||
37681959|NCT02371629|69157585|FG001|Overall Study|Death|1|||
37681960|NCT02371629|69157584|FG000|Overall Study|Noncompliance with study treatment|1|||
37681961|NCT02371629|69157585|FG001|Overall Study|Noncompliance with study treatment|0|||
37681962|NCT02371629|69157584|FG000|Overall Study|Lack of Efficacy|0|||
37681963|NCT02371629|69157585|FG001|Overall Study|Lack of Efficacy|2|||
38081801|NCT01952574|69780351|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
38081802|NCT01952574|69780352|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
38081803|NCT01952574|69780353|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
38081804|NCT01952574|69780354|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
38081805|NCT01952574|69780355|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
37681964|NCT02371629|69157584|FG000|Overall Study|Protocol deviation|0|||
37681965|NCT02371629|69157585|FG001|Overall Study|Protocol deviation|1|||
38081806|NCT01952574|69780356|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
38081807|NCT01952574|69780357|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
38081808|NCT01952574|69780351|FG000|Open-label Treatment Phase|Missing|0|||
38081809|NCT01952574|69780352|FG001|Open-label Treatment Phase|Missing|0|||
37681966|NCT02559817|69157596|FG000|Treatment Period|Adverse Event|1|||
37681967|NCT02559817|69157597|FG001|Treatment Period|Adverse Event|0|||
37681968|NCT02559817|69157598|FG002|Treatment Period|Adverse Event|1|||
37681969|NCT02559817|69157599|FG003|Treatment Period|Adverse Event|0|||
37681970|NCT02559817|69157600|FG004|Treatment Period|Adverse Event|0|||
37681971|NCT02559817|69157596|FG000|Treatment Period|Lack of Efficacy|0|||
37681972|NCT02559817|69157597|FG001|Treatment Period|Lack of Efficacy|1|||
37681973|NCT02559817|69157598|FG002|Treatment Period|Lack of Efficacy|0|||
38081810|NCT01952574|69780353|FG002|Open-label Treatment Phase|Missing|0|||
38081811|NCT01952574|69780354|FG003|Open-label Treatment Phase|Missing|0|||
38081812|NCT01952574|69780355|FG004|Open-label Treatment Phase|Missing|4|||
38081813|NCT01952574|69780356|FG005|Open-label Treatment Phase|Missing|0|||
37681974|NCT02559817|69157599|FG003|Treatment Period|Lack of Efficacy|0|||
37681975|NCT02559817|69157600|FG004|Treatment Period|Lack of Efficacy|0|||
37681976|NCT02559817|69157596|FG000|Treatment Period|Lost to Follow-up|0|||
37681977|NCT02559817|69157597|FG001|Treatment Period|Lost to Follow-up|1|||
38081814|NCT01952574|69780357|FG006|Open-label Treatment Phase|Missing|0|||
38081815|NCT01952574|69780351|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
37681978|NCT02559817|69157598|FG002|Treatment Period|Lost to Follow-up|0|||
37681979|NCT02559817|69157599|FG003|Treatment Period|Lost to Follow-up|1|||
37681980|NCT02559817|69157600|FG004|Treatment Period|Lost to Follow-up|0|||
37681981|NCT02559817|69157596|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
37681982|NCT02559817|69157597|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
37681983|NCT02559817|69157598|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
37681984|NCT02559817|69157599|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
37681985|NCT02559817|69157600|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
37681986|NCT02559817|69157596|FG000|Treatment Period|Protocol Violation|0|||
37681987|NCT02559817|69157597|FG001|Treatment Period|Protocol Violation|0|||
37681988|NCT02559817|69157598|FG002|Treatment Period|Protocol Violation|0|||
37681989|NCT02559817|69157599|FG003|Treatment Period|Protocol Violation|1|||
38081816|NCT01952574|69780352|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
38081817|NCT01952574|69780353|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
38081818|NCT01952574|69780354|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
38081819|NCT01952574|69780355|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
38081820|NCT01952574|69780356|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
38081821|NCT01952574|69780357|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
38081822|NCT01952574|69780351|FG000|Open-label Treatment Phase|Death|0|||
38081823|NCT01952574|69780352|FG001|Open-label Treatment Phase|Death|0|||
37681990|NCT02559817|69157600|FG004|Treatment Period|Protocol Violation|0|||
37681991|NCT02564887|69157614|FG000|Overall Study|Lost to Follow-up|6|||
37681992|NCT02564887|69157615|FG001|Overall Study|Lost to Follow-up|0|||
37681993|NCT02333487|69157626|FG000|Overall Study|Adverse Event|0|||
37681994|NCT02333487|69157627|FG001|Overall Study|Adverse Event|2|||
37681995|NCT02333487|69157628|FG002|Overall Study|Adverse Event|0|||
37681996|NCT02333331|69157641|FG000|Overall Study|Adverse Event|1|||
37681997|NCT02333331|69157642|FG001|Overall Study|Adverse Event|0|||
37681998|NCT02333331|69157643|FG002|Overall Study|Adverse Event|4|||
37681999|NCT02333331|69157644|FG003|Overall Study|Adverse Event|1|||
37682000|NCT02333331|69157641|FG000|Overall Study|Death|0|||
37682001|NCT02333331|69157642|FG001|Overall Study|Death|0|||
37682002|NCT02333331|69157643|FG002|Overall Study|Death|2|||
37682003|NCT02333331|69157644|FG003|Overall Study|Death|0|||
37682004|NCT02333331|69157641|FG000|Overall Study|Lost to Follow-up|0|||
37682005|NCT02333331|69157642|FG001|Overall Study|Lost to Follow-up|0|||
37682006|NCT02333331|69157643|FG002|Overall Study|Lost to Follow-up|1|||
37682007|NCT02333331|69157644|FG003|Overall Study|Lost to Follow-up|0|||
37682008|NCT02333331|69157641|FG000|Overall Study|Physician Decision|0|||
37682009|NCT02333331|69157642|FG001|Overall Study|Physician Decision|1|||
37682010|NCT02333331|69157643|FG002|Overall Study|Physician Decision|0|||
37682011|NCT02333331|69157644|FG003|Overall Study|Physician Decision|0|||
37682012|NCT02333331|69157641|FG000|Overall Study|Protocol Deviation|0|||
37682013|NCT02333331|69157642|FG001|Overall Study|Protocol Deviation|3|||
37682014|NCT02333331|69157643|FG002|Overall Study|Protocol Deviation|2|||
37682015|NCT02333331|69157644|FG003|Overall Study|Protocol Deviation|1|||
37682016|NCT02333331|69157641|FG000|Overall Study|Patient/Guardian Decision|1|||
37682017|NCT02333331|69157642|FG001|Overall Study|Patient/Guardian Decision|2|||
38081824|NCT01952574|69780353|FG002|Open-label Treatment Phase|Death|0|||
38081825|NCT01952574|69780354|FG003|Open-label Treatment Phase|Death|0|||
38081826|NCT01952574|69780355|FG004|Open-label Treatment Phase|Death|1|||
38081827|NCT01952574|69780356|FG005|Open-label Treatment Phase|Death|0|||
38081828|NCT01952574|69780357|FG006|Open-label Treatment Phase|Death|0|||
38081829|NCT01952574|69780351|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
38081830|NCT01952574|69780352|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
38081831|NCT01952574|69780353|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
38081832|NCT01952574|69780354|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
38081833|NCT01952574|69780355|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
38081834|NCT01952574|69780356|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
37966978|NCT00446199|69653868|FG003|Overall Study|Hormone fear|1|||
38081835|NCT01952574|69780357|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
38081836|NCT01952574|69780351|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
38081837|NCT01952574|69780352|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
37682018|NCT02333331|69157643|FG002|Overall Study|Patient/Guardian Decision|9|||
37682019|NCT02333331|69157644|FG003|Overall Study|Patient/Guardian Decision|1|||
37682020|NCT02563561|69157657|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
37682021|NCT02563561|69157658|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
37682022|NCT02563561|69157659|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
37682023|NCT02563561|69157657|FG000|Overall Study|Withdrew of Consent|1|||
37682024|NCT02563561|69157658|FG001|Overall Study|Withdrew of Consent|1|||
37682025|NCT02563561|69157659|FG002|Overall Study|Withdrew of Consent|2|||
37862898|NCT01271933|69546814|FG002|Double-Blind Phase|Lack of Efficacy|9|||
37862899|NCT01271933|69546812|FG000|Double-Blind Phase|Lost to Follow-up|0|||
37862900|NCT01271933|69546813|FG001|Double-Blind Phase|Lost to Follow-up|1|||
37862901|NCT01271933|69546814|FG002|Double-Blind Phase|Lost to Follow-up|1|||
37862902|NCT01271933|69546812|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
37862903|NCT01271933|69546813|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
37862904|NCT01271933|69546814|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
37862905|NCT01271933|69546812|FG000|Double-Blind Phase|Adverse Event|0|||
37862906|NCT01271933|69546813|FG001|Double-Blind Phase|Adverse Event|3|||
38081838|NCT01952574|69780353|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
38081839|NCT01952574|69780354|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
38081840|NCT01952574|69780355|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
38081841|NCT01952574|69780356|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
37682026|NCT02563561|69157657|FG000|Overall Study|Lost to Follow-up|1|||
37862907|NCT01271933|69546814|FG002|Double-Blind Phase|Adverse Event|0|||
37862908|NCT01271933|69546812|FG000|Double-Blind Phase|Participant request-personal reason|0|||
37682027|NCT02563561|69157658|FG001|Overall Study|Lost to Follow-up|1|||
37966979|NCT00446199|69653865|FG000|Overall Study|Lost interest in study participation|0|||
37966980|NCT00446199|69653866|FG001|Overall Study|Lost interest in study participation|1|||
37966981|NCT00446199|69653867|FG002|Overall Study|Lost interest in study participation|0|||
37966982|NCT00446199|69653868|FG003|Overall Study|Lost interest in study participation|0|||
37966983|NCT00446199|69653865|FG000|Overall Study|In-/Exclusion criterion violated|2|||
37966984|NCT00446199|69653866|FG001|Overall Study|In-/Exclusion criterion violated|1|||
37966985|NCT00446199|69653867|FG002|Overall Study|In-/Exclusion criterion violated|2|||
37966986|NCT00446199|69653868|FG003|Overall Study|In-/Exclusion criterion violated|1|||
37966987|NCT00446199|69653865|FG000|Overall Study|Move|0|||
37966988|NCT00446199|69653866|FG001|Overall Study|Move|1|||
37966989|NCT00446199|69653867|FG002|Overall Study|Move|0|||
37966990|NCT00446199|69653868|FG003|Overall Study|Move|0|||
37966991|NCT00456495|69653878|FG000|Overall Study|Physician Decision|2|||
37966992|NCT00445341|69653883|FG000|Overall Study|refused further treatment|1|||
37966993|NCT00445341|69653883|FG000|Overall Study|taken off treatment too early|1|||
37966994|NCT03846453|69653889|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
37966995|NCT03846453|69653890|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
37966996|NCT03846453|69653891|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
37966997|NCT03846453|69653889|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
37966998|NCT03846453|69653890|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
37966999|NCT03846453|69653891|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
37967000|NCT03846453|69653889|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
37967001|NCT03846453|69653890|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
37967002|NCT03846453|69653891|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
37967003|NCT03846453|69653889|FG000|Placebo Run-in (14 Days)|Other|2|||
37967004|NCT03846453|69653890|FG001|Placebo Run-in (14 Days)|Other|0|||
37967005|NCT03846453|69653891|FG002|Placebo Run-in (14 Days)|Other|0|||
37967006|NCT03846453|69653889|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
37967007|NCT03846453|69653890|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
37967008|NCT03846453|69653891|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
37967009|NCT03846453|69653889|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
37967010|NCT03846453|69653890|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
37967011|NCT03846453|69653891|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
37967012|NCT03846453|69653889|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
37682028|NCT02563561|69157659|FG002|Overall Study|Lost to Follow-up|0|||
37682029|NCT02563561|69157657|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
37682030|NCT02563561|69157658|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
37682031|NCT02563561|69157659|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
37862909|NCT01271933|69546813|FG001|Double-Blind Phase|Participant request-personal reason|1|||
37967013|NCT03846453|69653890|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
37967014|NCT03846453|69653891|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
37967015|NCT03846453|69653889|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
37682032|NCT02563561|69157657|FG000|Overall Study|Investigator Decision|3|||
37682033|NCT02563561|69157658|FG001|Overall Study|Investigator Decision|4|||
37682034|NCT02563561|69157659|FG002|Overall Study|Investigator Decision|2|||
37682035|NCT02563561|69157657|FG000|Overall Study|Sponsor Decision|5|||
37682036|NCT02563561|69157658|FG001|Overall Study|Sponsor Decision|2|||
37682037|NCT02563561|69157659|FG002|Overall Study|Sponsor Decision|4|||
37682038|NCT02563561|69157657|FG000|Overall Study|Other|1|||
37682039|NCT02563561|69157658|FG001|Overall Study|Other|5|||
37682040|NCT02563561|69157659|FG002|Overall Study|Other|2|||
37682041|NCT02559505|69157675|FG000|Overall Study|Lost to Follow-up|23|||
37682042|NCT02559505|69157676|FG001|Overall Study|Lost to Follow-up|20|||
37682043|NCT02559505|69157675|FG000|Overall Study|Withdrawal by Subject|4|||
37682044|NCT02559505|69157676|FG001|Overall Study|Withdrawal by Subject|2|||
37682045|NCT04191967|69157698|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
37682046|NCT04191967|69157698|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
37682047|NCT02556307|69157704|FG000|Overall Study|Premature treatment interruption|11|||
37682048|NCT02556307|69157704|FG000|Overall Study|Lost to Follow-up|36|||
37682049|NCT02556307|69157704|FG000|Overall Study|Change to triple therapy|4|||
37682050|NCT02556307|69157704|FG000|Overall Study|Enrolled but not treated|2|||
37682051|NCT04364737|69157710|FG000|Overall Study|Withdrawal by Subject|4|||
37682052|NCT04364737|69157711|FG001|Overall Study|Withdrawal by Subject|9|||
37967016|NCT03846453|69653890|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
37682053|NCT04364737|69157710|FG000|Overall Study|Lost to Follow-up|1|||
37682054|NCT04364737|69157711|FG001|Overall Study|Lost to Follow-up|1|||
37682055|NCT02559115|69157717|FG000|Overall Study|Withdrawal by Subject|3|||
37682056|NCT01662895|69157735|FG000|Overall Study|Lost to Follow-up|0|||
37682057|NCT01662895|69157736|FG001|Overall Study|Lost to Follow-up|1|||
37862910|NCT01271933|69546814|FG002|Double-Blind Phase|Participant request-personal reason|0|||
37967017|NCT03846453|69653891|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
38081842|NCT01952574|69780357|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
38081843|NCT02959437|69780386|FG000|Overall Study|Death|33|||
38081844|NCT02959437|69780387|FG001|Overall Study|Death|3|||
38081845|NCT02959437|69780388|FG002|Overall Study|Death|0|||
38081846|NCT02959437|69780389|FG003|Overall Study|Death|0|||
38081847|NCT02959437|69780386|FG000|Overall Study|Lost to Follow-up|3|||
38081848|NCT02959437|69780387|FG001|Overall Study|Lost to Follow-up|1|||
38081849|NCT02959437|69780388|FG002|Overall Study|Lost to Follow-up|0|||
38081850|NCT02959437|69780389|FG003|Overall Study|Lost to Follow-up|0|||
38081851|NCT02959437|69780386|FG000|Overall Study|Withdrawal by Subject|11|||
38081852|NCT02959437|69780387|FG001|Overall Study|Withdrawal by Subject|3|||
38081853|NCT02959437|69780388|FG002|Overall Study|Withdrawal by Subject|0|||
38081854|NCT02959437|69780389|FG003|Overall Study|Withdrawal by Subject|0|||
38081855|NCT02959437|69780386|FG000|Overall Study|Progressive Disease|9|||
38081856|NCT02959437|69780387|FG001|Overall Study|Progressive Disease|1|||
38081857|NCT02959437|69780388|FG002|Overall Study|Progressive Disease|0|||
38081858|NCT02959437|69780389|FG003|Overall Study|Progressive Disease|0|||
38081859|NCT02959437|69780386|FG000|Overall Study|Study Terminated by Sponsor|4|||
38081860|NCT02959437|69780387|FG001|Overall Study|Study Terminated by Sponsor|0|||
38081861|NCT02959437|69780388|FG002|Overall Study|Study Terminated by Sponsor|0|||
38081862|NCT02959437|69780389|FG003|Overall Study|Study Terminated by Sponsor|0|||
38081863|NCT02959437|69780386|FG000|Overall Study|Other Unspecified|2|||
38081864|NCT02959437|69780387|FG001|Overall Study|Other Unspecified|0|||
38081865|NCT02959437|69780388|FG002|Overall Study|Other Unspecified|0|||
38081866|NCT02959437|69780389|FG003|Overall Study|Other Unspecified|0|||
38081867|NCT02957331|69780402|FG000|Overall Study|Protocol Violation|1|||
38081868|NCT02957331|69780403|FG001|Overall Study|Protocol Violation|0|||
38081869|NCT05212883|69780409|FG000|Overall Study|Invalid test result|125|||
38081870|NCT04995055|69780417|FG000|Period 1|COVID-19 Related|1|||
38081871|NCT04995055|69780418|FG001|Period 1|COVID-19 Related|0|||
38081872|NCT04995055|69780417|FG000|Period 1|Withdrawal by Subject|0|||
38081873|NCT04995055|69780418|FG001|Period 1|Withdrawal by Subject|1|||
38081874|NCT04995055|69780417|FG000|Period 1|Subject discontinued due to timing|4|||
38081875|NCT04995055|69780418|FG001|Period 1|Subject discontinued due to timing|4|||
38081876|NCT04785144|69780434|FG000|Overall Study|Withdrawal by Subject|4|||
38081877|NCT04785144|69780435|FG001|Overall Study|Withdrawal by Subject|1|||
38081878|NCT04785144|69780436|FG002|Overall Study|Withdrawal by Subject|0|||
38081879|NCT04785144|69780437|FG003|Overall Study|Withdrawal by Subject|0|||
38081880|NCT04785144|69780438|FG004|Overall Study|Withdrawal by Subject|0|||
38081881|NCT04785144|69780439|FG005|Overall Study|Withdrawal by Subject|2|||
38081882|NCT04785144|69780440|FG006|Overall Study|Withdrawal by Subject|2|||
38081883|NCT04785144|69780441|FG007|Overall Study|Withdrawal by Subject|0|||
38081884|NCT04785144|69780442|FG008|Overall Study|Withdrawal by Subject|1|||
38081885|NCT04785144|69780443|FG009|Overall Study|Withdrawal by Subject|0|||
38081886|NCT04785144|69780434|FG000|Overall Study|Lost to Follow-up|1|||
38081887|NCT04785144|69780435|FG001|Overall Study|Lost to Follow-up|0|||
38081888|NCT04785144|69780436|FG002|Overall Study|Lost to Follow-up|0|||
38081889|NCT04785144|69780437|FG003|Overall Study|Lost to Follow-up|0|||
38081890|NCT04785144|69780438|FG004|Overall Study|Lost to Follow-up|1|||
38081891|NCT04785144|69780439|FG005|Overall Study|Lost to Follow-up|2|||
38081892|NCT04785144|69780440|FG006|Overall Study|Lost to Follow-up|1|||
38081893|NCT04785144|69780441|FG007|Overall Study|Lost to Follow-up|2|||
38081894|NCT04785144|69780442|FG008|Overall Study|Lost to Follow-up|4|||
38081895|NCT04785144|69780443|FG009|Overall Study|Lost to Follow-up|1|||
38081896|NCT04785144|69780434|FG000|Overall Study|Protocol Violation|0|||
38081897|NCT04785144|69780435|FG001|Overall Study|Protocol Violation|0|||
38081898|NCT04785144|69780436|FG002|Overall Study|Protocol Violation|0|||
38081899|NCT04785144|69780437|FG003|Overall Study|Protocol Violation|0|||
38081900|NCT04785144|69780438|FG004|Overall Study|Protocol Violation|0|||
38081901|NCT04785144|69780439|FG005|Overall Study|Protocol Violation|0|||
38081902|NCT04785144|69780440|FG006|Overall Study|Protocol Violation|1|||
38081903|NCT04785144|69780441|FG007|Overall Study|Protocol Violation|0|||
38081904|NCT04785144|69780442|FG008|Overall Study|Protocol Violation|0|||
38081905|NCT04785144|69780443|FG009|Overall Study|Protocol Violation|0|||
38081906|NCT04785144|69780434|FG000|Overall Study|Physician Decision|0|||
38081907|NCT04785144|69780435|FG001|Overall Study|Physician Decision|0|||
38081908|NCT04785144|69780436|FG002|Overall Study|Physician Decision|0|||
38081909|NCT04785144|69780437|FG003|Overall Study|Physician Decision|0|||
38081910|NCT04785144|69780438|FG004|Overall Study|Physician Decision|0|||
38081911|NCT04785144|69780439|FG005|Overall Study|Physician Decision|0|||
38081912|NCT04785144|69780440|FG006|Overall Study|Physician Decision|0|||
38081913|NCT04785144|69780441|FG007|Overall Study|Physician Decision|0|||
38081914|NCT04785144|69780442|FG008|Overall Study|Physician Decision|0|||
38081915|NCT04785144|69780443|FG009|Overall Study|Physician Decision|1|||
38081916|NCT04785144|69780434|FG000|Overall Study|Unable to continue due to work schedule|0|||
38081917|NCT04785144|69780435|FG001|Overall Study|Unable to continue due to work schedule|0|||
38081918|NCT04785144|69780436|FG002|Overall Study|Unable to continue due to work schedule|0|||
38081919|NCT04785144|69780437|FG003|Overall Study|Unable to continue due to work schedule|0|||
38081920|NCT04785144|69780438|FG004|Overall Study|Unable to continue due to work schedule|0|||
37682058|NCT02557399|69157744|FG000|Overall Study|Adverse Event|6|||
37682059|NCT02557399|69157745|FG001|Overall Study|Adverse Event|5|||
37682060|NCT02557399|69157744|FG000|Overall Study|Protocol Violation|0|||
37682061|NCT02557399|69157745|FG001|Overall Study|Protocol Violation|1|||
37682062|NCT02557399|69157744|FG000|Overall Study|Protocol-defined stopping criteria|0|||
37682063|NCT02557399|69157745|FG001|Overall Study|Protocol-defined stopping criteria|1|||
37682064|NCT02557399|69157744|FG000|Overall Study|Withdrawal by Subject|1|||
37682065|NCT02557399|69157745|FG001|Overall Study|Withdrawal by Subject|1|||
37682066|NCT02555371|69157754|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
37682067|NCT02555371|69157755|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
37682068|NCT02555371|69157756|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
37682069|NCT02555371|69157757|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
37682070|NCT02555371|69157758|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
37682071|NCT02555371|69157754|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
37682072|NCT02555371|69157755|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
37682073|NCT02555371|69157756|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
37682074|NCT02555371|69157757|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
37682075|NCT02555371|69157758|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
37682076|NCT02555371|69157754|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
37682077|NCT02555371|69157755|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
37682078|NCT02555371|69157756|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
37682079|NCT02555371|69157757|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
37682080|NCT02555371|69157758|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
37682081|NCT02555371|69157754|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
37682082|NCT02555371|69157755|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
37682083|NCT02555371|69157756|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
37862911|NCT01269125|69546827|FG000|Overall Study|Adverse Event|3|||
37967018|NCT03846453|69653889|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
37967019|NCT03846453|69653890|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
37967020|NCT03846453|69653891|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
37967021|NCT00444951|69653902|FG000|Overall Study|Lost to Follow-up|1|||
37967022|NCT00444951|69653903|FG001|Overall Study|Lost to Follow-up|1|||
37967023|NCT00444951|69653904|FG002|Overall Study|Lost to Follow-up|0|||
37967024|NCT00444951|69653902|FG000|Overall Study|Withdrawal by Subject|4|||
38081921|NCT04785144|69780439|FG005|Overall Study|Unable to continue due to work schedule|0|||
37682084|NCT02555371|69157757|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
37682085|NCT02555371|69157758|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
37862912|NCT01269125|69546828|FG001|Overall Study|Adverse Event|5|||
37862913|NCT01269125|69546829|FG002|Overall Study|Adverse Event|0|||
37862914|NCT01269125|69546827|FG000|Overall Study|Lost to Follow-up|4|||
37862915|NCT01269125|69546828|FG001|Overall Study|Lost to Follow-up|0|||
37862916|NCT01269125|69546829|FG002|Overall Study|Lost to Follow-up|0|||
37862917|NCT01268891|69546839|FG000|Overall Study|Adverse Event|3|||
37862918|NCT01268891|69546840|FG001|Overall Study|Adverse Event|7|||
37862919|NCT01268891|69546839|FG000|Overall Study|Lack of Efficacy|1|||
37862920|NCT01268891|69546840|FG001|Overall Study|Lack of Efficacy|0|||
37862921|NCT01268891|69546839|FG000|Overall Study|Withdrawal of Consent|3|||
37862922|NCT01268891|69546840|FG001|Overall Study|Withdrawal of Consent|1|||
37862923|NCT01268891|69546839|FG000|Overall Study|Administrative or other reason(s)|1|||
37862924|NCT01268891|69546840|FG001|Overall Study|Administrative or other reason(s)|0|||
37862925|NCT01268501|69546846|FG000|Overall Study|Lost to Follow-up|1|||
37862926|NCT01268501|69546846|FG000|Overall Study|Withdrawal by Subject|3|||
37862927|NCT01268501|69546846|FG000|Overall Study|Unacceptable Subjective Vision|3|||
37862928|NCT01268501|69546846|FG000|Overall Study|Handling Difficulties|2|||
37862929|NCT01268267|69546850|FG000|Overall Study|Protocol Violation|1|||
37862930|NCT01267253|69546855|FG000|Overall Study|Ineligible - required test not done|1|||
37862931|NCT01267253|69546855|FG000|Overall Study|Inevaluable-never received study treatme|2|||
37862932|NCT01266317|69546859|FG000|Overall Study|Withdrawal by Subject|2|||
37862933|NCT01266161|69546865|FG000|Overall Study|Ineligible|1|||
37862934|NCT01266161|69546866|FG001|Overall Study|Ineligible|0|||
37862935|NCT01266161|69546865|FG000|Overall Study|Lack of Efficacy|0|||
37862936|NCT01266161|69546866|FG001|Overall Study|Lack of Efficacy|1|||
37862937|NCT01266161|69546865|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
37862938|NCT01266161|69546866|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
37967025|NCT00444951|69653903|FG001|Overall Study|Withdrawal by Subject|5|||
37967026|NCT00444951|69653904|FG002|Overall Study|Withdrawal by Subject|3|||
37967027|NCT00444795|69653912|FG000|Overall Study|Not Treated|1|||
37967028|NCT00444795|69653912|FG000|Overall Study|Treated Prior to the Contract Date|2|||
37862939|NCT01265849|69546875|FG000|Overall Study|Randomized//Treatment not initiated|1|||
37862940|NCT01265849|69546876|FG001|Overall Study|Randomized//Treatment not initiated|4|||
37862941|NCT01265849|69546877|FG002|Overall Study|Randomized//Treatment not initiated|0|||
37862942|NCT01265849|69546875|FG000|Overall Study|Physician Decision|1|||
37682086|NCT02555371|69157754|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
37682087|NCT02555371|69157755|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
37682088|NCT02555371|69157756|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
37682089|NCT02555371|69157757|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
37682090|NCT02555371|69157758|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
37682091|NCT02555371|69157754|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
37682092|NCT02555371|69157755|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
37682093|NCT02555371|69157756|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
37682094|NCT02555371|69157757|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
37682095|NCT02555371|69157758|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
37682096|NCT02555371|69157754|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
37682097|NCT02555371|69157755|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
37682098|NCT02555371|69157756|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
37682099|NCT02555371|69157757|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
37682100|NCT02555371|69157758|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
37682101|NCT02555371|69157754|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
37682102|NCT02555371|69157755|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
37682103|NCT02555371|69157756|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
37682104|NCT02555371|69157757|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
37682105|NCT02555371|69157758|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
37682106|NCT02555371|69157754|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
37682107|NCT02555371|69157755|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
37682108|NCT02555371|69157756|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
37682109|NCT02555371|69157757|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
37682110|NCT02555371|69157758|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
37682111|NCT02555371|69157754|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
37682112|NCT02555371|69157755|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
37682113|NCT02555371|69157756|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
37682114|NCT02555371|69157757|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
37682115|NCT02555371|69157758|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
37682116|NCT02555371|69157754|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
37682117|NCT02555371|69157755|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
37682118|NCT02555371|69157756|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
37682119|NCT02555371|69157757|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
37682120|NCT02555371|69157758|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
37682121|NCT02555371|69157754|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
37682122|NCT02555371|69157755|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
37682123|NCT02555371|69157756|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
37682124|NCT02555371|69157757|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
37682125|NCT02555371|69157758|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
37682126|NCT02555371|69157754|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
37682127|NCT02555371|69157755|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
37682128|NCT02555371|69157756|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
37682129|NCT02555371|69157757|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
37682130|NCT02555371|69157758|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
37682131|NCT02555371|69157754|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
37682132|NCT02555371|69157755|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
37682133|NCT02555371|69157756|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
37682134|NCT02555371|69157757|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
37682135|NCT02555371|69157758|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
37682136|NCT02555215|69157767|FG000|Overall Study|Other|1|||
37682137|NCT02555215|69157767|FG000|Overall Study|Investigator Decision|2|||
37682138|NCT02555683|69157774|FG000|Overall Study|Physician Decision|1|||
37682139|NCT02555683|69157775|FG001|Overall Study|Physician Decision|0|||
37682140|NCT02555683|69157776|FG002|Overall Study|Physician Decision|2|||
37682141|NCT02555683|69157774|FG000|Overall Study|Lost to Follow-up|2|||
37682142|NCT02555683|69157775|FG001|Overall Study|Lost to Follow-up|1|||
37682143|NCT02555683|69157776|FG002|Overall Study|Lost to Follow-up|2|||
37682144|NCT02555683|69157774|FG000|Overall Study|Technical Problems|1|||
37682145|NCT02555683|69157775|FG001|Overall Study|Technical Problems|1|||
37682146|NCT02555683|69157776|FG002|Overall Study|Technical Problems|0|||
38081922|NCT04785144|69780440|FG006|Overall Study|Unable to continue due to work schedule|0|||
37682147|NCT02555683|69157774|FG000|Overall Study|Protocol deviation|0|||
37682148|NCT02555683|69157775|FG001|Overall Study|Protocol deviation|1|||
38081923|NCT04785144|69780441|FG007|Overall Study|Unable to continue due to work schedule|0|||
38081924|NCT04785144|69780442|FG008|Overall Study|Unable to continue due to work schedule|0|||
38081925|NCT04785144|69780443|FG009|Overall Study|Unable to continue due to work schedule|1|||
38081926|NCT04743635|69780486|FG000|Overall Study|Lost to Follow-up|2|||
37682149|NCT02555683|69157776|FG002|Overall Study|Protocol deviation|0|||
37682150|NCT02555683|69157774|FG000|Overall Study|Lack of Efficacy|2|||
37682151|NCT02555683|69157775|FG001|Overall Study|Lack of Efficacy|0|||
37682152|NCT02555683|69157776|FG002|Overall Study|Lack of Efficacy|0|||
37682153|NCT02555683|69157774|FG000|Overall Study|Death|0|||
37682154|NCT02555683|69157775|FG001|Overall Study|Death|1|||
37682155|NCT02555683|69157776|FG002|Overall Study|Death|2|||
37682156|NCT02555683|69157774|FG000|Overall Study|Adverse Event|1|||
37682157|NCT02555683|69157775|FG001|Overall Study|Adverse Event|0|||
37682158|NCT02555683|69157776|FG002|Overall Study|Adverse Event|1|||
37682159|NCT02555683|69157774|FG000|Overall Study|Subject/guardian decision|12|||
37682160|NCT02555683|69157775|FG001|Overall Study|Subject/guardian decision|12|||
37682161|NCT02555683|69157776|FG002|Overall Study|Subject/guardian decision|22|||
37682162|NCT02555683|69157774|FG000|Overall Study|Death post Treatment/safety period|0|||
37682163|NCT02555683|69157775|FG001|Overall Study|Death post Treatment/safety period|1|||
37682164|NCT02555683|69157776|FG002|Overall Study|Death post Treatment/safety period|0|||
37682165|NCT02554981|69157784|FG000|Overall Study|Adverse Event|1|||
37682166|NCT02554981|69157784|FG000|Overall Study|Administrative Reasons|1|||
37682167|NCT02554981|69157784|FG000|Overall Study|Other Miscellaneous Reasons|3|||
37682168|NCT02556775|69157792|FG000|Overall Study|Withdrawal by Subject|1|||
37682169|NCT02556775|69157793|FG001|Overall Study|Withdrawal by Subject|0|||
37682170|NCT02556775|69157794|FG002|Overall Study|Withdrawal by Subject|1|||
37682171|NCT02556775|69157795|FG003|Overall Study|Withdrawal by Subject|0|||
37682172|NCT02556775|69157792|FG000|Overall Study|Lost to Follow-up|1|||
38081927|NCT04743635|69780487|FG001|Overall Study|Lost to Follow-up|0|||
38081928|NCT04712110|69780494|FG000|Overall Study|Lost to Follow-up|0|||
38081929|NCT04712110|69780495|FG001|Overall Study|Lost to Follow-up|1|||
38081930|NCT04712110|69780494|FG000|Overall Study|Withdrawal by Subject|0|||
38081931|NCT04712110|69780495|FG001|Overall Study|Withdrawal by Subject|4|||
38081932|NCT04712110|69780494|FG000|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|46|||
38081933|NCT04712110|69780495|FG001|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|14|||
38081934|NCT03877510|69780505|FG000|Overall Study|Death|6|||
38081935|NCT03877510|69780505|FG000|Overall Study|Lost to Follow-up|2|||
38081936|NCT03877510|69780505|FG000|Overall Study|Non-compliance with study drug|2|||
38081937|NCT03877510|69780505|FG000|Overall Study|Lack of Efficacy|14|||
38081938|NCT03877510|69780505|FG000|Overall Study|Adverse Event|20|||
38081939|NCT03877510|69780505|FG000|Overall Study|Withdrawal by Subject|22|||
38081940|NCT03877510|69780505|FG000|Overall Study|Miscellaneous|1|||
38081941|NCT03846427|69780509|FG000|Overall Study|Death|13|||
38081942|NCT03846427|69780509|FG000|Overall Study|Withdrawal by Subject|3|||
38081943|NCT03846427|69780509|FG000|Overall Study|Physician Decision|1|||
38081944|NCT03706079|69780538|FG000|Predecessor Study|Death|0|||
38081945|NCT03706079|69780539|FG001|Predecessor Study|Death|2|||
38081946|NCT03706079|69780540|FG002|Predecessor Study|Death|0|||
38081947|NCT03706079|69780541|FG003|Predecessor Study|Death|1|||
38081948|NCT03706079|69780542|FG004|Predecessor Study|Death|0|||
38081949|NCT03706079|69780543|FG005|Predecessor Study|Death|0|||
38081950|NCT03706079|69780538|FG000|Predecessor Study|Lost to Follow-up|5|||
38081951|NCT03706079|69780539|FG001|Predecessor Study|Lost to Follow-up|2|||
38081952|NCT03706079|69780540|FG002|Predecessor Study|Lost to Follow-up|0|||
38081953|NCT03706079|69780541|FG003|Predecessor Study|Lost to Follow-up|0|||
38081954|NCT03706079|69780542|FG004|Predecessor Study|Lost to Follow-up|1|||
38081955|NCT03706079|69780543|FG005|Predecessor Study|Lost to Follow-up|0|||
37682173|NCT02556775|69157793|FG001|Overall Study|Lost to Follow-up|0|||
37682174|NCT02556775|69157794|FG002|Overall Study|Lost to Follow-up|0|||
37682175|NCT02556775|69157795|FG003|Overall Study|Lost to Follow-up|0|||
37682176|NCT01662505|69157810|FG000|Overall Study|Progressive disease|6|||
37682177|NCT01662505|69157811|FG001|Overall Study|Progressive disease|1|||
37682178|NCT01662505|69157812|FG002|Overall Study|Progressive disease|5|||
37682179|NCT01662505|69157810|FG000|Overall Study|Refused cont. medication|0|||
37682180|NCT01662505|69157811|FG001|Overall Study|Refused cont. medication|0|||
38081956|NCT03706079|69780538|FG000|Predecessor Study|Withdrawal by Subject|8|||
38081957|NCT03706079|69780539|FG001|Predecessor Study|Withdrawal by Subject|15|||
38081958|NCT03706079|69780540|FG002|Predecessor Study|Withdrawal by Subject|0|||
38081959|NCT03706079|69780541|FG003|Predecessor Study|Withdrawal by Subject|5|||
38081960|NCT03706079|69780542|FG004|Predecessor Study|Withdrawal by Subject|2|||
38081961|NCT03706079|69780543|FG005|Predecessor Study|Withdrawal by Subject|0|||
37682181|NCT01662505|69157812|FG002|Overall Study|Refused cont. medication|1|||
37682182|NCT01662505|69157810|FG000|Overall Study|Not specified above|1|||
37682183|NCT01662505|69157811|FG001|Overall Study|Not specified above|3|||
37682184|NCT01662505|69157812|FG002|Overall Study|Not specified above|2|||
37682185|NCT03796195|69157821|FG000|Overall Study|Study closed early|1|||
37682186|NCT02554513|69157825|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
37682187|NCT02554513|69157826|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
37682188|NCT02554903|69157840|FG000|Overall Study|Death|1|||
37682189|NCT02554903|69157841|FG001|Overall Study|Death|1|||
37682190|NCT02554903|69157840|FG000|Overall Study|Physician Decision|2|||
37682191|NCT02554903|69157841|FG001|Overall Study|Physician Decision|2|||
37682192|NCT02554903|69157840|FG000|Overall Study|Heart Transplant|1|||
37682193|NCT02554903|69157841|FG001|Overall Study|Heart Transplant|2|||
37682194|NCT02332707|69157866|FG000|Overall Study|Adverse Event|0|||
37682195|NCT02332707|69157867|FG001|Overall Study|Adverse Event|0|||
37682196|NCT02332707|69157868|FG002|Overall Study|Adverse Event|0|||
37682197|NCT02332707|69157869|FG003|Overall Study|Adverse Event|0|||
37682198|NCT02332707|69157870|FG004|Overall Study|Adverse Event|0|||
37682199|NCT02332707|69157871|FG005|Overall Study|Adverse Event|0|||
37682200|NCT02332707|69157872|FG006|Overall Study|Adverse Event|0|||
37682201|NCT02332707|69157873|FG007|Overall Study|Adverse Event|0|||
37682202|NCT02332707|69157874|FG008|Overall Study|Adverse Event|0|||
37682203|NCT02332707|69157875|FG009|Overall Study|Adverse Event|0|||
37682204|NCT02332707|69157876|FG010|Overall Study|Adverse Event|0|||
37682205|NCT02332707|69157877|FG011|Overall Study|Adverse Event|0|||
37682206|NCT02332707|69157878|FG012|Overall Study|Adverse Event|1|||
37682207|NCT02332707|69157879|FG013|Overall Study|Adverse Event|0|||
37682208|NCT02332707|69157880|FG014|Overall Study|Adverse Event|0|||
37682209|NCT02332707|69157881|FG015|Overall Study|Adverse Event|0|||
37682210|NCT02332707|69157882|FG016|Overall Study|Adverse Event|0|||
37682211|NCT02332707|69157883|FG017|Overall Study|Adverse Event|0|||
37682212|NCT02332707|69157866|FG000|Overall Study|Lost to Follow-up|0|||
37682213|NCT02332707|69157867|FG001|Overall Study|Lost to Follow-up|0|||
37682214|NCT02332707|69157868|FG002|Overall Study|Lost to Follow-up|0|||
37862943|NCT01265849|69546876|FG001|Overall Study|Physician Decision|2|||
37862944|NCT01265849|69546877|FG002|Overall Study|Physician Decision|0|||
37862945|NCT01265849|69546875|FG000|Overall Study|Lost to Follow-up|18|||
37862946|NCT01265849|69546876|FG001|Overall Study|Lost to Follow-up|15|||
37967029|NCT03846219|69653919|FG000|Overall Study|Withdrawal by Subject|3|||
37967030|NCT03846219|69653920|FG001|Overall Study|Withdrawal by Subject|2|||
37967031|NCT03846219|69653921|FG002|Overall Study|Withdrawal by Subject|2|||
37967032|NCT03846219|69653919|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
37967033|NCT03846219|69653920|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
37967034|NCT03846219|69653921|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
37967035|NCT03846219|69653919|FG000|Overall Study|Physician Decision|0|||
37967036|NCT03846219|69653920|FG001|Overall Study|Physician Decision|0|||
38081962|NCT03706079|69780538|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
38081963|NCT03706079|69780539|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
38081964|NCT03706079|69780540|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
38081965|NCT03706079|69780541|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
38081966|NCT03706079|69780542|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
38081967|NCT03706079|69780543|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
38081968|NCT03706079|69780538|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
38081969|NCT03706079|69780539|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
38081970|NCT03706079|69780540|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
38081971|NCT03706079|69780541|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
38081972|NCT03706079|69780542|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
38081973|NCT03706079|69780543|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
38081974|NCT03706079|69780538|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
38081975|NCT03706079|69780539|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
38081976|NCT03706079|69780540|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
38081977|NCT03706079|69780541|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
38081978|NCT03706079|69780542|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
38081979|NCT03706079|69780543|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
38081980|NCT03706079|69780538|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
38081981|NCT03706079|69780539|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
38081982|NCT03706079|69780540|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
38081983|NCT03706079|69780541|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
38081984|NCT03706079|69780542|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
37862947|NCT01265849|69546877|FG002|Overall Study|Lost to Follow-up|5|||
37862948|NCT01265849|69546875|FG000|Overall Study|Not otherwise specified|1|||
37862949|NCT01265849|69546876|FG001|Overall Study|Not otherwise specified|6|||
37862950|NCT01265849|69546877|FG002|Overall Study|Not otherwise specified|1|||
37862951|NCT01265849|69546875|FG000|Overall Study|Withdrawal by Subject|25|||
37862952|NCT01265849|69546876|FG001|Overall Study|Withdrawal by Subject|34|||
37862953|NCT01265849|69546877|FG002|Overall Study|Withdrawal by Subject|13|||
37862954|NCT01265615|69546893|FG000|Overall Study|Protocol Violation|2|||
37862955|NCT01265615|69546894|FG001|Overall Study|Protocol Violation|2|||
37862956|NCT01265615|69546895|FG002|Overall Study|Protocol Violation|4|||
37967037|NCT03846219|69653921|FG002|Overall Study|Physician Decision|2|||
37967038|NCT00455325|69653937|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
37967039|NCT00455325|69653938|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
37682215|NCT02332707|69157869|FG003|Overall Study|Lost to Follow-up|0|||
37682216|NCT02332707|69157870|FG004|Overall Study|Lost to Follow-up|0|||
37682217|NCT02332707|69157871|FG005|Overall Study|Lost to Follow-up|1|||
37682218|NCT02332707|69157872|FG006|Overall Study|Lost to Follow-up|0|||
37682219|NCT02332707|69157873|FG007|Overall Study|Lost to Follow-up|0|||
37682220|NCT02332707|69157874|FG008|Overall Study|Lost to Follow-up|0|||
38081985|NCT03706079|69780543|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
38081986|NCT03706079|69780538|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
38081987|NCT03706079|69780539|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
38081988|NCT03706079|69780540|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
38081989|NCT03706079|69780541|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
38081990|NCT03706079|69780542|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
38081991|NCT03706079|69780543|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
38081992|NCT03706079|69780538|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
38081993|NCT03706079|69780539|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
38081994|NCT03706079|69780540|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
38081995|NCT03706079|69780541|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
38081996|NCT03706079|69780542|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
38081997|NCT03706079|69780543|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
38081998|NCT03706079|69780538|FG000|Long Term Extension (DESTINATION)|Death|8|||
38081999|NCT03706079|69780539|FG001|Long Term Extension (DESTINATION)|Death|2|||
38082000|NCT03706079|69780540|FG002|Long Term Extension (DESTINATION)|Death|2|||
38082001|NCT03706079|69780541|FG003|Long Term Extension (DESTINATION)|Death|1|||
37682221|NCT02332707|69157875|FG009|Overall Study|Lost to Follow-up|0|||
37862957|NCT01265615|69546896|FG003|Overall Study|Protocol Violation|3|||
37862958|NCT01264835|69546906|FG000|Overall Study|Lost to Follow-up|1|||
37862959|NCT01264679|69546910|FG000|Overall Study|Participation in Another Clinical Trial|1|||
37862960|NCT01264679|69546910|FG000|Overall Study|Physician Decision|1|||
37682222|NCT02332707|69157876|FG010|Overall Study|Lost to Follow-up|2|||
37682223|NCT02332707|69157877|FG011|Overall Study|Lost to Follow-up|0|||
37682224|NCT02332707|69157878|FG012|Overall Study|Lost to Follow-up|3|||
37682225|NCT02332707|69157879|FG013|Overall Study|Lost to Follow-up|0|||
37682226|NCT02332707|69157880|FG014|Overall Study|Lost to Follow-up|0|||
37967040|NCT00455325|69653939|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
37862961|NCT01264679|69546910|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
37862962|NCT01264679|69546910|FG000|Overall Study|Withdrawal by Subject|1|||
37682227|NCT02332707|69157881|FG015|Overall Study|Lost to Follow-up|0|||
37682228|NCT02332707|69157882|FG016|Overall Study|Lost to Follow-up|0|||
37682229|NCT02332707|69157883|FG017|Overall Study|Lost to Follow-up|0|||
37682230|NCT02332707|69157866|FG000|Overall Study|Physician Decision|0|||
37682231|NCT02332707|69157867|FG001|Overall Study|Physician Decision|0|||
37682232|NCT02332707|69157868|FG002|Overall Study|Physician Decision|0|||
37682233|NCT02332707|69157869|FG003|Overall Study|Physician Decision|1|||
37682234|NCT02332707|69157870|FG004|Overall Study|Physician Decision|0|||
37682235|NCT02332707|69157871|FG005|Overall Study|Physician Decision|0|||
37682236|NCT02332707|69157872|FG006|Overall Study|Physician Decision|0|||
37682237|NCT02332707|69157873|FG007|Overall Study|Physician Decision|0|||
37682238|NCT02332707|69157874|FG008|Overall Study|Physician Decision|0|||
37682239|NCT02332707|69157875|FG009|Overall Study|Physician Decision|0|||
37682240|NCT02332707|69157876|FG010|Overall Study|Physician Decision|0|||
37682241|NCT02332707|69157877|FG011|Overall Study|Physician Decision|0|||
37682242|NCT02332707|69157878|FG012|Overall Study|Physician Decision|1|||
37862963|NCT01263665|69546915|FG000|Overall Study|Withdrew Consent|1|||
37967041|NCT00455325|69653940|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
38082002|NCT03706079|69780542|FG004|Long Term Extension (DESTINATION)|Death|0|||
37682243|NCT02332707|69157879|FG013|Overall Study|Physician Decision|0|||
37682244|NCT02332707|69157880|FG014|Overall Study|Physician Decision|0|||
37682245|NCT02332707|69157881|FG015|Overall Study|Physician Decision|0|||
37682246|NCT02332707|69157882|FG016|Overall Study|Physician Decision|0|||
37682247|NCT02332707|69157883|FG017|Overall Study|Physician Decision|0|||
38082003|NCT03706079|69780543|FG005|Long Term Extension (DESTINATION)|Death|0|||
38082004|NCT03657160|69780557|FG000|Overall Study|Adverse Event|5|||
37682248|NCT02332707|69157866|FG000|Overall Study|Withdrawal by Subject|0|||
37682249|NCT02332707|69157867|FG001|Overall Study|Withdrawal by Subject|0|||
37682250|NCT02332707|69157868|FG002|Overall Study|Withdrawal by Subject|1|||
37682251|NCT02332707|69157869|FG003|Overall Study|Withdrawal by Subject|0|||
37682252|NCT02332707|69157870|FG004|Overall Study|Withdrawal by Subject|0|||
37682253|NCT02332707|69157871|FG005|Overall Study|Withdrawal by Subject|0|||
37682254|NCT02332707|69157872|FG006|Overall Study|Withdrawal by Subject|0|||
37682255|NCT02332707|69157873|FG007|Overall Study|Withdrawal by Subject|0|||
37682256|NCT02332707|69157874|FG008|Overall Study|Withdrawal by Subject|0|||
37682257|NCT02332707|69157875|FG009|Overall Study|Withdrawal by Subject|3|||
37682258|NCT02332707|69157876|FG010|Overall Study|Withdrawal by Subject|0|||
37682259|NCT02332707|69157877|FG011|Overall Study|Withdrawal by Subject|0|||
37682260|NCT02332707|69157878|FG012|Overall Study|Withdrawal by Subject|0|||
37682261|NCT02332707|69157879|FG013|Overall Study|Withdrawal by Subject|0|||
37682262|NCT02332707|69157880|FG014|Overall Study|Withdrawal by Subject|0|||
37682263|NCT02332707|69157881|FG015|Overall Study|Withdrawal by Subject|0|||
37682264|NCT02332707|69157882|FG016|Overall Study|Withdrawal by Subject|0|||
37682265|NCT02332707|69157883|FG017|Overall Study|Withdrawal by Subject|0|||
37682266|NCT02370615|69157923|FG000|Overall Study|Adverse Event|1|||
37682267|NCT02370615|69157924|FG001|Overall Study|Adverse Event|0|||
37682268|NCT02307513|69157939|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
37682269|NCT02307513|69157940|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
37682270|NCT02307513|69157939|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
37682271|NCT02307513|69157940|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
37682272|NCT02307513|69157939|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
37682273|NCT02307513|69157940|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
37682274|NCT02307513|69157939|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
37682275|NCT02307513|69157940|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
37682276|NCT02307513|69157939|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
37682277|NCT02307513|69157940|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
37682278|NCT02307513|69157939|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
37682279|NCT02307513|69157940|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
37682280|NCT02307513|69157939|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
37682281|NCT02307513|69157940|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
37682282|NCT02307513|69157939|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
37682283|NCT02307513|69157940|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
37682284|NCT02307513|69157939|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
37682285|NCT02307513|69157940|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
37682286|NCT02307513|69157939|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
37682287|NCT02307513|69157940|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
37682288|NCT02307513|69157939|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
37682289|NCT02307513|69157940|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
37682290|NCT02307513|69157939|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
37682291|NCT02307513|69157940|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
37682292|NCT02307513|69157939|FG000|Long-term Extension|Physician Decision|1|||
37682293|NCT02307513|69157940|FG001|Long-term Extension|Physician Decision|0|||
37682294|NCT02332239|69157952|FG000|Overall Study|Lost to Follow-up|4|||
37682295|NCT02332239|69157953|FG001|Overall Study|Lost to Follow-up|6|||
37682296|NCT02370537|69157964|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
37682297|NCT02370537|69157965|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
37682298|NCT02370537|69157966|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
37682299|NCT02370537|69157964|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
37682300|NCT02370537|69157965|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
37682301|NCT02370537|69157966|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
37682302|NCT02370537|69157964|FG000|Part B|Not randomised to receive treatment|1|||
37682303|NCT02370537|69157965|FG001|Part B|Not randomised to receive treatment|2|||
37682304|NCT02370537|69157966|FG002|Part B|Not randomised to receive treatment|259|||
37682305|NCT02370537|69157964|FG000|Part B|Withdrawal by Subject|0|||
37682306|NCT02370537|69157965|FG001|Part B|Withdrawal by Subject|1|||
37682307|NCT02370537|69157966|FG002|Part B|Withdrawal by Subject|0|||
37682308|NCT02330055|69157985|FG000|Overall Study|technical issues|2|||
37682309|NCT02330055|69157986|FG001|Overall Study|technical issues|0|||
37682310|NCT02330055|69157985|FG000|Overall Study|participant forgot to wear device|5|||
37682311|NCT02330055|69157986|FG001|Overall Study|participant forgot to wear device|5|||
37682312|NCT02330055|69157985|FG000|Overall Study|data for less than 60 minutes|3|||
37682313|NCT02330055|69157986|FG001|Overall Study|data for less than 60 minutes|3|||
37682314|NCT02330055|69157985|FG000|Overall Study|participant did not sleep|0|||
37682315|NCT02330055|69157986|FG001|Overall Study|participant did not sleep|1|||
37682316|NCT02306265|69157992|FG000|Overall Study|Withdrawal by Subject|1|||
37682317|NCT02329743|69158000|FG000|Overall Study|Adverse Event|1|||
37967042|NCT00455325|69653937|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
37967043|NCT00455325|69653938|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
37682318|NCT02329743|69158001|FG001|Overall Study|Adverse Event|1|||
37682319|NCT02329743|69158002|FG002|Overall Study|Adverse Event|3|||
37682320|NCT02329743|69158000|FG000|Overall Study|Lost to Follow-up|1|||
37682321|NCT02329743|69158001|FG001|Overall Study|Lost to Follow-up|0|||
37682322|NCT02329743|69158002|FG002|Overall Study|Lost to Follow-up|1|||
37682323|NCT02329743|69158000|FG000|Overall Study|Withdrawal by Subject|4|||
37682324|NCT02329743|69158001|FG001|Overall Study|Withdrawal by Subject|4|||
37682325|NCT02329743|69158002|FG002|Overall Study|Withdrawal by Subject|1|||
37682326|NCT02329743|69158000|FG000|Overall Study|Other|0|||
37682327|NCT02329743|69158001|FG001|Overall Study|Other|2|||
37682328|NCT02329743|69158002|FG002|Overall Study|Other|3|||
37682329|NCT02329431|69158012|FG000|Overall Study|Lost to Follow-up|20|||
37682330|NCT02329431|69158013|FG001|Overall Study|Lost to Follow-up|13|||
37682331|NCT02328105|69158019|FG000|Overall Study|Death|6|||
37682332|NCT02328105|69158019|FG000|Overall Study|Withdrawal by Subject|1|||
37682333|NCT02328105|69158019|FG000|Overall Study|Still On Study in Follow-Up|4|||
37682334|NCT02305797|69158025|FG000|Overall Study|Adverse Event|11|||
37682335|NCT02305797|69158026|FG001|Overall Study|Adverse Event|2|||
37682336|NCT02305797|69158025|FG000|Overall Study|Withdrawal by Subject|9|||
37682337|NCT02305797|69158026|FG001|Overall Study|Withdrawal by Subject|10|||
37682338|NCT02305797|69158025|FG000|Overall Study|Lack of Efficacy|6|||
37682339|NCT02305797|69158026|FG001|Overall Study|Lack of Efficacy|0|||
37682340|NCT02305797|69158025|FG000|Overall Study|Lost to Follow-up|5|||
37682341|NCT02305797|69158026|FG001|Overall Study|Lost to Follow-up|11|||
37682342|NCT02305797|69158025|FG000|Overall Study|Pregnancy|0|||
37682343|NCT02305797|69158026|FG001|Overall Study|Pregnancy|2|||
37682344|NCT02305797|69158025|FG000|Overall Study|Noncompliance|14|||
37682345|NCT02305797|69158026|FG001|Overall Study|Noncompliance|12|||
37682346|NCT02305797|69158025|FG000|Overall Study|Reason not collected|0|||
37682347|NCT02305797|69158026|FG001|Overall Study|Reason not collected|1|||
37682348|NCT01646073|69158034|FG000|Period A (12 Weeks)|Adverse Event|0|||
37682349|NCT01646073|69158035|FG001|Period A (12 Weeks)|Adverse Event|2|||
37682350|NCT01646073|69158034|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
37682351|NCT01646073|69158035|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
37682352|NCT01646073|69158034|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
37682353|NCT01646073|69158035|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
37682354|NCT01646073|69158034|FG000|Period A (12 Weeks)|Protocol Violation|0|||
37682355|NCT01646073|69158035|FG001|Period A (12 Weeks)|Protocol Violation|1|||
37682356|NCT01646073|69158034|FG000|Period A (12 Weeks)|Other|0|||
37682357|NCT01646073|69158035|FG001|Period A (12 Weeks)|Other|1|||
37682358|NCT01646073|69158034|FG000|Period B (12 Weeks)|Adverse Event|0|||
37682359|NCT01646073|69158035|FG001|Period B (12 Weeks)|Adverse Event|7|||
37682360|NCT01646073|69158034|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
37682361|NCT01646073|69158035|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
37682362|NCT01646073|69158034|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
37682363|NCT01646073|69158035|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
37682364|NCT02328027|69158046|FG000|Overall Study|Withdrawal by Subject|0|||
37682365|NCT02328027|69158047|FG001|Overall Study|Withdrawal by Subject|1|||
37682366|NCT02551159|69158057|FG000|Overall Study|Death|352|||
37682367|NCT02551159|69158058|FG001|Overall Study|Death|174|||
37682368|NCT02551159|69158059|FG002|Overall Study|Death|161|||
37967044|NCT00455325|69653939|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
37967045|NCT00455325|69653940|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
37967046|NCT00455325|69653937|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
37967047|NCT00455325|69653938|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
37682369|NCT02551159|69158057|FG000|Overall Study|Withdrawal by Subject|8|||
37682370|NCT02551159|69158058|FG001|Overall Study|Withdrawal by Subject|5|||
37682371|NCT02551159|69158059|FG002|Overall Study|Withdrawal by Subject|16|||
37682372|NCT02551159|69158057|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
37682373|NCT02551159|69158058|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
37682374|NCT02551159|69158059|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
37682375|NCT02305563|69158072|FG000|Treatment Period|Disease progression|0|||
37682376|NCT02305563|69158073|FG001|Treatment Period|Disease progression|0|||
37682377|NCT02305563|69158074|FG002|Treatment Period|Disease progression|15|||
37682378|NCT02305563|69158075|FG003|Treatment Period|Disease progression|6|||
37682379|NCT02305563|69158076|FG004|Treatment Period|Disease progression|6|||
37682380|NCT02305563|69158072|FG000|Treatment Period|Study drug toxicity|0|||
37682381|NCT02305563|69158073|FG001|Treatment Period|Study drug toxicity|0|||
37682382|NCT02305563|69158074|FG002|Treatment Period|Study drug toxicity|0|||
37682383|NCT02305563|69158075|FG003|Treatment Period|Study drug toxicity|1|||
37682384|NCT02305563|69158076|FG004|Treatment Period|Study drug toxicity|2|||
37682385|NCT02305563|69158072|FG000|Treatment Period|Death|0|||
37682386|NCT02305563|69158073|FG001|Treatment Period|Death|0|||
37967048|NCT00455325|69653939|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
37682387|NCT02305563|69158074|FG002|Treatment Period|Death|1|||
37682388|NCT02305563|69158075|FG003|Treatment Period|Death|2|||
37682389|NCT02305563|69158076|FG004|Treatment Period|Death|1|||
37682390|NCT02305563|69158072|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
37682391|NCT02305563|69158073|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
37682392|NCT02305563|69158074|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
37682393|NCT02305563|69158075|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
37682394|NCT02305563|69158076|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
37682395|NCT02305563|69158072|FG000|Treatment Period|Participant request to stop therapy|0|||
37682396|NCT02305563|69158073|FG001|Treatment Period|Participant request to stop therapy|2|||
37682397|NCT02305563|69158074|FG002|Treatment Period|Participant request to stop therapy|0|||
37682398|NCT02305563|69158075|FG003|Treatment Period|Participant request to stop therapy|1|||
37682399|NCT02305563|69158076|FG004|Treatment Period|Participant request to stop therapy|0|||
37682400|NCT02305563|69158072|FG000|Treatment Period|Participant withdrew consent|0|||
37682401|NCT02305563|69158073|FG001|Treatment Period|Participant withdrew consent|0|||
37682402|NCT02305563|69158074|FG002|Treatment Period|Participant withdrew consent|1|||
37682403|NCT02305563|69158075|FG003|Treatment Period|Participant withdrew consent|1|||
37682404|NCT02305563|69158076|FG004|Treatment Period|Participant withdrew consent|1|||
37682405|NCT02305563|69158072|FG000|Treatment Period|Maximum clinical benefit|0|||
37682406|NCT02305563|69158073|FG001|Treatment Period|Maximum clinical benefit|0|||
37682407|NCT02305563|69158074|FG002|Treatment Period|Maximum clinical benefit|0|||
37682408|NCT02305563|69158075|FG003|Treatment Period|Maximum clinical benefit|0|||
37682409|NCT02305563|69158076|FG004|Treatment Period|Maximum clinical benefit|1|||
37682410|NCT02305563|69158072|FG000|Treatment Period|Poor/non-compliance|0|||
37682411|NCT02305563|69158073|FG001|Treatment Period|Poor/non-compliance|0|||
37682412|NCT02305563|69158074|FG002|Treatment Period|Poor/non-compliance|0|||
37682413|NCT02305563|69158075|FG003|Treatment Period|Poor/non-compliance|0|||
37682414|NCT02305563|69158076|FG004|Treatment Period|Poor/non-compliance|1|||
37682415|NCT02305563|69158072|FG000|Treatment Period|Administrative reason by Sponsor|0|||
37682416|NCT02305563|69158073|FG001|Treatment Period|Administrative reason by Sponsor|0|||
37682417|NCT02305563|69158074|FG002|Treatment Period|Administrative reason by Sponsor|0|||
38082005|NCT03657160|69780558|FG001|Overall Study|Adverse Event|6|||
38082006|NCT03657160|69780557|FG000|Overall Study|Protocol Deviation|3|||
38082007|NCT03657160|69780558|FG001|Overall Study|Protocol Deviation|0|||
38082008|NCT03657160|69780557|FG000|Overall Study|Withdrawal by Subject|18|||
38082009|NCT03657160|69780558|FG001|Overall Study|Withdrawal by Subject|16|||
38082010|NCT03657160|69780557|FG000|Overall Study|Site Termination|1|||
38082011|NCT03657160|69780558|FG001|Overall Study|Site Termination|0|||
38082012|NCT03657160|69780557|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
38082013|NCT03657160|69780558|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
38082014|NCT03657160|69780557|FG000|Overall Study|Death|33|||
38082015|NCT03657160|69780558|FG001|Overall Study|Death|26|||
38082016|NCT03657160|69780557|FG000|Overall Study|Death (COVID-19-Related)|1|||
38082017|NCT03657160|69780558|FG001|Overall Study|Death (COVID-19-Related)|0|||
38082018|NCT03657160|69780557|FG000|Overall Study|Reason Not Specified|5|||
38082019|NCT03657160|69780558|FG001|Overall Study|Reason Not Specified|5|||
38082020|NCT03657160|69780557|FG000|Overall Study|Other (COVID-19-Related)|0|||
38082021|NCT03657160|69780558|FG001|Overall Study|Other (COVID-19-Related)|1|||
38082022|NCT03635320|69780568|FG000|Overall Study|not implanted the device|1|||
38082023|NCT03635320|69780569|FG001|Overall Study|not implanted the device|2|||
38082024|NCT03635320|69780568|FG000|Overall Study|Withdrawal by Subject|11|||
38082025|NCT03635320|69780569|FG001|Overall Study|Withdrawal by Subject|6|||
38082026|NCT03508726|69780586|FG000|Overall Study|Withdrawal by Subject|0|||
38082027|NCT03508726|69780587|FG001|Overall Study|Withdrawal by Subject|1|||
38082028|NCT03499964|69780596|FG000|Overall Study|Lack of Efficacy|6|||
38082029|NCT03499964|69780597|FG001|Overall Study|Lack of Efficacy|26|||
38082030|NCT03499964|69780596|FG000|Overall Study|Adverse Event|1|||
38082031|NCT03499964|69780597|FG001|Overall Study|Adverse Event|0|||
38082032|NCT03499964|69780596|FG000|Overall Study|Death|1|||
38082033|NCT03499964|69780597|FG001|Overall Study|Death|0|||
38082034|NCT03499964|69780596|FG000|Overall Study|Withdrawal by Subject|2|||
38082035|NCT03499964|69780597|FG001|Overall Study|Withdrawal by Subject|1|||
38082036|NCT03499964|69780596|FG000|Overall Study|Lost to Follow-up|1|||
38082037|NCT03499964|69780597|FG001|Overall Study|Lost to Follow-up|0|||
38082038|NCT03279692|69780603|FG000|Overall Study|Withdrawal by Subject|1|||
38082039|NCT03001882|69780620|FG000|Overall Study|Death|1|||
38082040|NCT03001882|69780621|FG001|Overall Study|Death|0|||
38082041|NCT03001882|69780622|FG002|Overall Study|Death|0|||
37682418|NCT02305563|69158075|FG003|Treatment Period|Administrative reason by Sponsor|0|||
37682419|NCT02305563|69158076|FG004|Treatment Period|Administrative reason by Sponsor|1|||
37682420|NCT02305563|69158072|FG000|Treatment Period|other reason|2|||
38082042|NCT03001882|69780623|FG003|Overall Study|Death|3|||
38082043|NCT03001882|69780620|FG000|Overall Study|Participant withdrew consent|0|||
38082044|NCT03001882|69780621|FG001|Overall Study|Participant withdrew consent|1|||
38082045|NCT03001882|69780622|FG002|Overall Study|Participant withdrew consent|0|||
38082046|NCT03001882|69780623|FG003|Overall Study|Participant withdrew consent|5|||
38082047|NCT03001882|69780620|FG000|Overall Study|Other reasons|1|||
38082048|NCT03001882|69780621|FG001|Overall Study|Other reasons|2|||
38082049|NCT03001882|69780622|FG002|Overall Study|Other reasons|0|||
37682421|NCT02305563|69158073|FG001|Treatment Period|other reason|0|||
37682422|NCT02305563|69158074|FG002|Treatment Period|other reason|2|||
37682423|NCT02305563|69158075|FG003|Treatment Period|other reason|2|||
37682424|NCT02305563|69158076|FG004|Treatment Period|other reason|1|||
37682425|NCT02305563|69158072|FG000|Treatment Period|Randomized but not treated|0|||
37682426|NCT02305563|69158073|FG001|Treatment Period|Randomized but not treated|0|||
37682427|NCT02305563|69158074|FG002|Treatment Period|Randomized but not treated|0|||
37682428|NCT02305563|69158075|FG003|Treatment Period|Randomized but not treated|0|||
37682429|NCT02305563|69158076|FG004|Treatment Period|Randomized but not treated|2|||
37682430|NCT02305563|69158072|FG000|Treatment Period|added ULO, then disease progression|0|||
37682431|NCT02305563|69158073|FG001|Treatment Period|added ULO, then disease progression|0|||
37682432|NCT02305563|69158074|FG002|Treatment Period|added ULO, then disease progression|0|||
37682433|NCT02305563|69158075|FG003|Treatment Period|added ULO, then disease progression|0|||
37682434|NCT02305563|69158076|FG004|Treatment Period|added ULO, then disease progression|4|||
37682435|NCT02305563|69158072|FG000|Treatment Period|added ULO; then other reason|0|||
37682436|NCT02305563|69158073|FG001|Treatment Period|added ULO; then other reason|0|||
37682437|NCT02305563|69158074|FG002|Treatment Period|added ULO; then other reason|0|||
37682438|NCT02305563|69158075|FG003|Treatment Period|added ULO; then other reason|0|||
37682439|NCT02305563|69158076|FG004|Treatment Period|added ULO; then other reason|1|||
37682440|NCT02305563|69158072|FG000|Treatment Period|added ULO, then request to stop|0|||
37682441|NCT02305563|69158073|FG001|Treatment Period|added ULO, then request to stop|0|||
37682442|NCT02305563|69158074|FG002|Treatment Period|added ULO, then request to stop|0|||
37682443|NCT02305563|69158075|FG003|Treatment Period|added ULO, then request to stop|0|||
37682444|NCT02305563|69158076|FG004|Treatment Period|added ULO, then request to stop|1|||
37682445|NCT02305563|69158072|FG000|Follow-up Period|Death|0|||
37682446|NCT02305563|69158073|FG001|Follow-up Period|Death|0|||
37682447|NCT02305563|69158074|FG002|Follow-up Period|Death|5|||
37682448|NCT02305563|69158075|FG003|Follow-up Period|Death|4|||
37682449|NCT02305563|69158076|FG004|Follow-up Period|Death|7|||
37682450|NCT02305563|69158072|FG000|Follow-up Period|Participant withdrew consent|0|||
37682451|NCT02305563|69158073|FG001|Follow-up Period|Participant withdrew consent|0|||
37682452|NCT02305563|69158074|FG002|Follow-up Period|Participant withdrew consent|2|||
37682453|NCT02305563|69158075|FG003|Follow-up Period|Participant withdrew consent|1|||
37682454|NCT02305563|69158076|FG004|Follow-up Period|Participant withdrew consent|0|||
37682455|NCT02305563|69158072|FG000|Follow-up Period|other reason|0|||
37682456|NCT02305563|69158073|FG001|Follow-up Period|other reason|0|||
37682457|NCT02305563|69158074|FG002|Follow-up Period|other reason|0|||
37682458|NCT02305563|69158075|FG003|Follow-up Period|other reason|0|||
37682459|NCT02305563|69158076|FG004|Follow-up Period|other reason|1|||
37682460|NCT02305563|69158072|FG000|Follow-up Period|Followup no longer required per protocol|3|||
37682461|NCT02305563|69158073|FG001|Follow-up Period|Followup no longer required per protocol|3|||
37682462|NCT02305563|69158074|FG002|Follow-up Period|Followup no longer required per protocol|4|||
37682463|NCT02305563|69158075|FG003|Follow-up Period|Followup no longer required per protocol|1|||
37682464|NCT02305563|69158076|FG004|Follow-up Period|Followup no longer required per protocol|4|||
37682465|NCT02327325|69158095|FG000|Overall Study|Withdrawal by Subject|1|||
37682466|NCT02327325|69158096|FG001|Overall Study|Withdrawal by Subject|4|||
37682467|NCT02327325|69158097|FG002|Overall Study|Withdrawal by Subject|4|||
37682468|NCT02327325|69158095|FG000|Overall Study|Excluded by Study Team|0|||
37682469|NCT02327325|69158096|FG001|Overall Study|Excluded by Study Team|0|||
37682470|NCT02327325|69158097|FG002|Overall Study|Excluded by Study Team|1|||
37682471|NCT02304705|69158107|FG000|Overall Study|Withdrawal by Subject|2|||
37682472|NCT02304705|69158108|FG001|Overall Study|Withdrawal by Subject|0|||
37682473|NCT02304705|69158107|FG000|Overall Study|Physician Decision|2|||
37682474|NCT02304705|69158108|FG001|Overall Study|Physician Decision|4|||
37682475|NCT02304705|69158107|FG000|Overall Study|Death|0|||
37682476|NCT02304705|69158108|FG001|Overall Study|Death|1|||
37682477|NCT02304705|69158107|FG000|Overall Study|Lost to Follow-up|0|||
37682478|NCT02304705|69158108|FG001|Overall Study|Lost to Follow-up|2|||
37682479|NCT02553499|69158128|FG000|Overall Study|Adverse Event|0|||
37682480|NCT02553499|69158129|FG001|Overall Study|Adverse Event|0|||
37682481|NCT02553499|69158130|FG002|Overall Study|Adverse Event|0|||
37682482|NCT02553499|69158131|FG003|Overall Study|Adverse Event|0|||
37682483|NCT02553499|69158132|FG004|Overall Study|Adverse Event|0|||
37682484|NCT02553499|69158133|FG005|Overall Study|Adverse Event|0|||
37682485|NCT02553499|69158134|FG006|Overall Study|Adverse Event|1|||
37682486|NCT02553499|69158135|FG007|Overall Study|Adverse Event|1|||
37682487|NCT02553499|69158136|FG008|Overall Study|Adverse Event|0|||
37682488|NCT02553499|69158137|FG009|Overall Study|Adverse Event|0|||
37682489|NCT02553499|69158138|FG010|Overall Study|Adverse Event|0|||
37682490|NCT02553499|69158139|FG011|Overall Study|Adverse Event|0|||
37682491|NCT02553499|69158140|FG012|Overall Study|Adverse Event|0|||
37682492|NCT02553499|69158141|FG013|Overall Study|Adverse Event|1|||
37682493|NCT02553499|69158128|FG000|Overall Study|Death|0|||
37682494|NCT02553499|69158129|FG001|Overall Study|Death|1|||
37682495|NCT02553499|69158130|FG002|Overall Study|Death|1|||
37682496|NCT02553499|69158131|FG003|Overall Study|Death|0|||
37682497|NCT02553499|69158132|FG004|Overall Study|Death|1|||
37682498|NCT02553499|69158133|FG005|Overall Study|Death|2|||
37682499|NCT02553499|69158134|FG006|Overall Study|Death|0|||
37682500|NCT02553499|69158135|FG007|Overall Study|Death|0|||
37682501|NCT02553499|69158136|FG008|Overall Study|Death|0|||
37682502|NCT02553499|69158137|FG009|Overall Study|Death|0|||
37682503|NCT02553499|69158138|FG010|Overall Study|Death|1|||
38082050|NCT03001882|69780623|FG003|Overall Study|Other reasons|5|||
38082051|NCT03001882|69780620|FG000|Overall Study|Administrative reason by sponsor|0|||
38082052|NCT03001882|69780621|FG001|Overall Study|Administrative reason by sponsor|0|||
38082053|NCT03001882|69780622|FG002|Overall Study|Administrative reason by sponsor|0|||
38082054|NCT03001882|69780623|FG003|Overall Study|Administrative reason by sponsor|1|||
38082055|NCT03001882|69780620|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
38082056|NCT03001882|69780621|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
38082057|NCT03001882|69780622|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
37682504|NCT02553499|69158139|FG011|Overall Study|Death|0|||
37682505|NCT02553499|69158140|FG012|Overall Study|Death|0|||
37682506|NCT02553499|69158141|FG013|Overall Study|Death|0|||
37682507|NCT02553499|69158128|FG000|Overall Study|Lost to Follow-up|0|||
37682508|NCT02553499|69158129|FG001|Overall Study|Lost to Follow-up|0|||
37682509|NCT02553499|69158130|FG002|Overall Study|Lost to Follow-up|0|||
37682510|NCT02553499|69158131|FG003|Overall Study|Lost to Follow-up|0|||
37682511|NCT02553499|69158132|FG004|Overall Study|Lost to Follow-up|0|||
37682512|NCT02553499|69158133|FG005|Overall Study|Lost to Follow-up|0|||
37682513|NCT02553499|69158134|FG006|Overall Study|Lost to Follow-up|1|||
37682514|NCT02553499|69158135|FG007|Overall Study|Lost to Follow-up|0|||
37682515|NCT02553499|69158136|FG008|Overall Study|Lost to Follow-up|0|||
37682516|NCT02553499|69158137|FG009|Overall Study|Lost to Follow-up|0|||
37682517|NCT02553499|69158138|FG010|Overall Study|Lost to Follow-up|0|||
37682518|NCT02553499|69158139|FG011|Overall Study|Lost to Follow-up|0|||
37682519|NCT02553499|69158140|FG012|Overall Study|Lost to Follow-up|0|||
37682520|NCT02553499|69158141|FG013|Overall Study|Lost to Follow-up|0|||
37682521|NCT02553499|69158128|FG000|Overall Study|Physician Decision|0|||
37682522|NCT02553499|69158129|FG001|Overall Study|Physician Decision|1|||
37682523|NCT02553499|69158130|FG002|Overall Study|Physician Decision|1|||
37682524|NCT02553499|69158131|FG003|Overall Study|Physician Decision|0|||
37682525|NCT02553499|69158132|FG004|Overall Study|Physician Decision|1|||
37682526|NCT02553499|69158133|FG005|Overall Study|Physician Decision|0|||
37682527|NCT02553499|69158134|FG006|Overall Study|Physician Decision|0|||
37682528|NCT02553499|69158135|FG007|Overall Study|Physician Decision|1|||
37682529|NCT02553499|69158136|FG008|Overall Study|Physician Decision|1|||
37682530|NCT02553499|69158137|FG009|Overall Study|Physician Decision|2|||
37682531|NCT02553499|69158138|FG010|Overall Study|Physician Decision|1|||
37682532|NCT02553499|69158139|FG011|Overall Study|Physician Decision|3|||
37682533|NCT02553499|69158140|FG012|Overall Study|Physician Decision|1|||
37682534|NCT02553499|69158141|FG013|Overall Study|Physician Decision|0|||
37682535|NCT02553499|69158128|FG000|Overall Study|Progressive Disease|0|||
37682536|NCT02553499|69158129|FG001|Overall Study|Progressive Disease|0|||
37682537|NCT02553499|69158130|FG002|Overall Study|Progressive Disease|0|||
37682538|NCT02553499|69158131|FG003|Overall Study|Progressive Disease|2|||
37682539|NCT02553499|69158132|FG004|Overall Study|Progressive Disease|1|||
37682540|NCT02553499|69158133|FG005|Overall Study|Progressive Disease|1|||
37682541|NCT02553499|69158134|FG006|Overall Study|Progressive Disease|1|||
37862964|NCT01263665|69546915|FG000|Overall Study|Lost to Follow-up|3|||
38082058|NCT03001882|69780623|FG003|Overall Study|Participant requested to discontinue study treatment|2|||
37682542|NCT02553499|69158135|FG007|Overall Study|Progressive Disease|0|||
37682543|NCT02553499|69158136|FG008|Overall Study|Progressive Disease|0|||
37682544|NCT02553499|69158137|FG009|Overall Study|Progressive Disease|1|||
37682545|NCT02553499|69158138|FG010|Overall Study|Progressive Disease|0|||
37682546|NCT02553499|69158139|FG011|Overall Study|Progressive Disease|0|||
37682547|NCT02553499|69158140|FG012|Overall Study|Progressive Disease|2|||
37682548|NCT02553499|69158141|FG013|Overall Study|Progressive Disease|1|||
37682549|NCT02553499|69158128|FG000|Overall Study|Study Terminated by Sponsor|0|||
37682550|NCT02553499|69158129|FG001|Overall Study|Study Terminated by Sponsor|0|||
37682551|NCT02553499|69158130|FG002|Overall Study|Study Terminated by Sponsor|0|||
37682552|NCT02553499|69158131|FG003|Overall Study|Study Terminated by Sponsor|0|||
37682553|NCT02553499|69158132|FG004|Overall Study|Study Terminated by Sponsor|0|||
37682554|NCT02553499|69158133|FG005|Overall Study|Study Terminated by Sponsor|0|||
38082059|NCT03001882|69780620|FG000|Overall Study|Not reported|0|||
38082060|NCT03001882|69780621|FG001|Overall Study|Not reported|0|||
38082061|NCT03001882|69780622|FG002|Overall Study|Not reported|0|||
38082062|NCT03001882|69780623|FG003|Overall Study|Not reported|6|||
38082063|NCT03001882|69780620|FG000|Overall Study|Maximum clinical benefit|1|||
38082064|NCT03001882|69780621|FG001|Overall Study|Maximum clinical benefit|2|||
38082065|NCT03001882|69780622|FG002|Overall Study|Maximum clinical benefit|0|||
38082066|NCT03001882|69780623|FG003|Overall Study|Maximum clinical benefit|10|||
38082067|NCT03001882|69780620|FG000|Overall Study|AE unrelated to study drug|3|||
38082068|NCT03001882|69780621|FG001|Overall Study|AE unrelated to study drug|3|||
37682555|NCT02553499|69158134|FG006|Overall Study|Study Terminated by Sponsor|0|||
37682556|NCT02553499|69158135|FG007|Overall Study|Study Terminated by Sponsor|0|||
37682557|NCT02553499|69158136|FG008|Overall Study|Study Terminated by Sponsor|1|||
37682558|NCT02553499|69158137|FG009|Overall Study|Study Terminated by Sponsor|0|||
37682559|NCT02553499|69158138|FG010|Overall Study|Study Terminated by Sponsor|0|||
37682560|NCT02553499|69158139|FG011|Overall Study|Study Terminated by Sponsor|0|||
37682561|NCT02553499|69158140|FG012|Overall Study|Study Terminated by Sponsor|0|||
37682562|NCT02553499|69158141|FG013|Overall Study|Study Terminated by Sponsor|0|||
37682563|NCT02553499|69158128|FG000|Overall Study|Withdrawal by Subject|2|||
37682564|NCT02553499|69158129|FG001|Overall Study|Withdrawal by Subject|0|||
37682565|NCT02553499|69158130|FG002|Overall Study|Withdrawal by Subject|0|||
37682566|NCT02553499|69158131|FG003|Overall Study|Withdrawal by Subject|0|||
37682567|NCT02553499|69158132|FG004|Overall Study|Withdrawal by Subject|0|||
37682568|NCT02553499|69158133|FG005|Overall Study|Withdrawal by Subject|0|||
37682569|NCT02553499|69158134|FG006|Overall Study|Withdrawal by Subject|0|||
37682570|NCT02553499|69158135|FG007|Overall Study|Withdrawal by Subject|1|||
37682571|NCT02553499|69158136|FG008|Overall Study|Withdrawal by Subject|1|||
37682572|NCT02553499|69158137|FG009|Overall Study|Withdrawal by Subject|0|||
37682573|NCT02553499|69158138|FG010|Overall Study|Withdrawal by Subject|1|||
37682574|NCT02553499|69158139|FG011|Overall Study|Withdrawal by Subject|0|||
37682575|NCT02553499|69158140|FG012|Overall Study|Withdrawal by Subject|0|||
37682576|NCT02553499|69158141|FG013|Overall Study|Withdrawal by Subject|0|||
37682577|NCT02553421|69158174|FG000|Overall Study|Lost to Follow-up|21|||
37682578|NCT02553421|69158175|FG001|Overall Study|Lost to Follow-up|1|||
37682579|NCT02553421|69158174|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
37682580|NCT02553421|69158175|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
37682581|NCT02553421|69158174|FG000|Overall Study|Improper Device Placement|3|||
37682582|NCT02553421|69158175|FG001|Overall Study|Improper Device Placement|0|||
38082069|NCT03001882|69780622|FG002|Overall Study|AE unrelated to study drug|0|||
37682583|NCT02549287|69158184|FG000|Overall Study|Lost to Follow-up|65|||
37682584|NCT02549287|69158185|FG001|Overall Study|Lost to Follow-up|26|||
38082070|NCT03001882|69780623|FG003|Overall Study|AE unrelated to study drug|11|||
38082071|NCT03001882|69780620|FG000|Overall Study|Study Drug Toxicity|8|||
38082072|NCT03001882|69780621|FG001|Overall Study|Study Drug Toxicity|5|||
38082073|NCT03001882|69780622|FG002|Overall Study|Study Drug Toxicity|0|||
38082074|NCT03001882|69780623|FG003|Overall Study|Study Drug Toxicity|37|||
38082075|NCT03001882|69780620|FG000|Overall Study|Disease progression|15|||
38082076|NCT03001882|69780621|FG001|Overall Study|Disease progression|14|||
38082077|NCT03001882|69780622|FG002|Overall Study|Disease progression|2|||
38082078|NCT03001882|69780623|FG003|Overall Study|Disease progression|90|||
38082079|NCT02985151|69780640|FG000|Original Randomization|Withdrawal by Subject|0|||
38082080|NCT02985151|69780641|FG001|Original Randomization|Withdrawal by Subject|1|||
38082081|NCT02603432|69780713|FG000|Overall Study|Ongoing|184|||
38082082|NCT02603432|69780714|FG001|Overall Study|Ongoing|144|||
38082083|NCT02603432|69780713|FG000|Overall Study|Adverse Event|1|||
38082084|NCT02603432|69780714|FG001|Overall Study|Adverse Event|0|||
38082085|NCT02603432|69780713|FG000|Overall Study|Death|144|||
38082086|NCT02603432|69780714|FG001|Overall Study|Death|177|||
38082087|NCT02603432|69780713|FG000|Overall Study|Lost to Follow-up|4|||
38082088|NCT02603432|69780714|FG001|Overall Study|Lost to Follow-up|6|||
38082089|NCT02603432|69780713|FG000|Overall Study|Progressive Disease|5|||
38082090|NCT02603432|69780714|FG001|Overall Study|Progressive Disease|5|||
38082091|NCT02603432|69780713|FG000|Overall Study|Withdrawal by Subject|9|||
38082092|NCT02603432|69780714|FG001|Overall Study|Withdrawal by Subject|17|||
38082093|NCT02603432|69780713|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
38082094|NCT02603432|69780714|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
38082095|NCT02603432|69780713|FG000|Overall Study|Other|0|||
38082096|NCT02603432|69780714|FG001|Overall Study|Other|1|||
38082097|NCT02582866|69780720|FG000|Overall Study|Death|1|||
38082098|NCT02582866|69780720|FG000|Overall Study|Lack of Efficacy|2|||
38082099|NCT02582866|69780720|FG000|Overall Study|Lost to Follow-up|2|||
38082100|NCT02582866|69780720|FG000|Overall Study|Withdrawal by Subject|7|||
38082101|NCT02582866|69780720|FG000|Overall Study|Investigator decision|5|||
38082102|NCT02582866|69780720|FG000|Overall Study|Participant wants to get pregnant|1|||
38082103|NCT02582866|69780720|FG000|Overall Study|Pregnancy|2|||
38082104|NCT02582866|69780720|FG000|Overall Study|Sponsor decision|1|||
38082105|NCT02582866|69780720|FG000|Overall Study|Withdrawal due to personal reasons|1|||
38082106|NCT02395666|69780726|FG000|Overall Study|Physician Decision|3|||
38082107|NCT02395666|69780727|FG001|Overall Study|Physician Decision|0|||
38082108|NCT02395666|69780726|FG000|Overall Study|Lost to Follow-up|1|||
38082109|NCT02395666|69780727|FG001|Overall Study|Lost to Follow-up|0|||
37682585|NCT02549287|69158184|FG000|Overall Study|Withdrawal by Subject|15|||
37682586|NCT02549287|69158185|FG001|Overall Study|Withdrawal by Subject|6|||
37682587|NCT02553265|69158191|FG000|Enrollment|Death|0|||
37682588|NCT02553265|69158192|FG001|Enrollment|Death|0|||
37682589|NCT02553265|69158193|FG002|Enrollment|Death|1|||
37682590|NCT02553265|69158191|FG000|First Intervention (28 Days)|Adverse Event|1|||
37682591|NCT02553265|69158192|FG001|First Intervention (28 Days)|Adverse Event|0|||
37682592|NCT02553265|69158193|FG002|First Intervention (28 Days)|Adverse Event|0|||
37682593|NCT02553265|69158191|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
37682594|NCT02553265|69158192|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
37682595|NCT02553265|69158193|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
37682596|NCT02553265|69158191|FG000|Second Intervention (28 Days)|Adverse Event|1|||
37682597|NCT02553265|69158192|FG001|Second Intervention (28 Days)|Adverse Event|0|||
37682598|NCT02553265|69158193|FG002|Second Intervention (28 Days)|Adverse Event|0|||
37682599|NCT02553265|69158191|FG000|Third Intervention (28 Days)|Adverse Event|1|||
37682600|NCT02553265|69158192|FG001|Third Intervention (28 Days)|Adverse Event|0|||
37682601|NCT02553265|69158193|FG002|Third Intervention (28 Days)|Adverse Event|0|||
37682602|NCT02553265|69158191|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
37682603|NCT02553265|69158192|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
37682604|NCT02553265|69158193|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
37682605|NCT02561195|69158210|FG000|Vaccination 1 to 3|Adverse Event|4|||
37682606|NCT02561195|69158211|FG001|Vaccination 1 to 3|Adverse Event|5|||
37682607|NCT02561195|69158212|FG002|Vaccination 1 to 3|Adverse Event|0|||
37682608|NCT02561195|69158213|FG003|Vaccination 1 to 3|Adverse Event|3|||
37682609|NCT02561195|69158214|FG004|Vaccination 1 to 3|Adverse Event|4|||
37682610|NCT02561195|69158215|FG005|Vaccination 1 to 3|Adverse Event|0|||
38082110|NCT02395666|69780726|FG000|Overall Study|Withdrawal by Subject|2|||
37682611|NCT02561195|69158216|FG006|Vaccination 1 to 3|Adverse Event|0|||
37682612|NCT02561195|69158217|FG007|Vaccination 1 to 3|Adverse Event|0|||
37862965|NCT01263665|69546915|FG000|Overall Study|Death|2|||
38082111|NCT02395666|69780727|FG001|Overall Study|Withdrawal by Subject|1|||
38082112|NCT01734928|69780743|FG000|Randomization|Physician Decision|0|||
38082113|NCT01734928|69780744|FG001|Randomization|Physician Decision|1|||
38082114|NCT01734928|69780743|FG000|Randomization|clinical progression|0|||
38082115|NCT01734928|69780744|FG001|Randomization|clinical progression|1|||
38082116|NCT01734928|69780743|FG000|Randomization|progressive disease|0|||
38082117|NCT01734928|69780744|FG001|Randomization|progressive disease|2|||
38082118|NCT01734928|69780743|FG000|Randomization|Withdrew informed consent|0|||
38082119|NCT01734928|69780744|FG001|Randomization|Withdrew informed consent|4|||
38082120|NCT01734928|69780743|FG000|Randomization|Death|1|||
37682613|NCT02561195|69158218|FG008|Vaccination 1 to 3|Adverse Event|0|||
37682614|NCT02561195|69158219|FG009|Vaccination 1 to 3|Adverse Event|0|||
37967049|NCT00455325|69653940|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
37967050|NCT00455325|69653937|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
37967051|NCT00455325|69653938|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
37967052|NCT00455325|69653939|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
37967053|NCT00455325|69653940|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
37967054|NCT00455325|69653937|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
37967055|NCT00455325|69653938|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
37967056|NCT00455325|69653939|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
37967057|NCT00455325|69653940|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
37967058|NCT00455325|69653937|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
37967059|NCT00455325|69653938|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
37967060|NCT00455325|69653939|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
37967061|NCT00455325|69653940|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
38082121|NCT01734928|69780744|FG001|Randomization|Death|0|||
37682615|NCT02561195|69158220|FG010|Vaccination 1 to 3|Adverse Event|0|||
37682616|NCT02561195|69158221|FG011|Vaccination 1 to 3|Adverse Event|0|||
37682617|NCT02561195|69158222|FG012|Vaccination 1 to 3|Adverse Event|0|||
37682618|NCT02561195|69158223|FG013|Vaccination 1 to 3|Adverse Event|0|||
37682619|NCT02561195|69158210|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
37682620|NCT02561195|69158211|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
37682621|NCT02561195|69158212|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
37682622|NCT02561195|69158213|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
37682623|NCT02561195|69158214|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
37682624|NCT02561195|69158215|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
37682625|NCT02561195|69158216|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
37682626|NCT02561195|69158217|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
37682627|NCT02561195|69158218|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
37682628|NCT02561195|69158219|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
37682629|NCT02561195|69158220|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
37682630|NCT02561195|69158221|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
37682631|NCT02561195|69158222|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
37682632|NCT02561195|69158223|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
37682633|NCT02561195|69158210|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
37682634|NCT02561195|69158211|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
37682635|NCT02561195|69158212|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
37682636|NCT02561195|69158213|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
37682637|NCT02561195|69158214|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
37682638|NCT02561195|69158215|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
37682639|NCT02561195|69158216|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
37682640|NCT02561195|69158217|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
37682641|NCT02561195|69158218|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
37682642|NCT02561195|69158219|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
37682643|NCT02561195|69158220|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
37682644|NCT02561195|69158221|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
37682645|NCT02561195|69158222|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
37682646|NCT02561195|69158223|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
37682647|NCT02561195|69158210|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
37682648|NCT02561195|69158211|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
37682649|NCT02561195|69158212|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
37682650|NCT02561195|69158213|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
37682651|NCT02561195|69158214|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
37682652|NCT02561195|69158215|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
37682653|NCT02561195|69158216|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
37682654|NCT02561195|69158217|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
37682655|NCT02561195|69158218|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
37682656|NCT02561195|69158219|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
37682657|NCT02561195|69158220|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
37682658|NCT02561195|69158221|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
37682659|NCT02561195|69158222|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
37682660|NCT02561195|69158223|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
37682661|NCT02561195|69158210|FG000|Vaccination 1 to 3|Other|7|||
37682662|NCT02561195|69158211|FG001|Vaccination 1 to 3|Other|3|||
37682663|NCT02561195|69158212|FG002|Vaccination 1 to 3|Other|1|||
38082122|NCT01734928|69780743|FG000|Randomization|Randomization error|1|||
38082123|NCT01734928|69780744|FG001|Randomization|Randomization error|0|||
37682664|NCT02561195|69158213|FG003|Vaccination 1 to 3|Other|7|||
37682665|NCT02561195|69158214|FG004|Vaccination 1 to 3|Other|5|||
37682666|NCT02561195|69158215|FG005|Vaccination 1 to 3|Other|1|||
37682667|NCT02561195|69158216|FG006|Vaccination 1 to 3|Other|0|||
37682668|NCT02561195|69158217|FG007|Vaccination 1 to 3|Other|0|||
37682669|NCT02561195|69158218|FG008|Vaccination 1 to 3|Other|0|||
37682670|NCT02561195|69158219|FG009|Vaccination 1 to 3|Other|0|||
37682671|NCT02561195|69158220|FG010|Vaccination 1 to 3|Other|0|||
37682672|NCT02561195|69158221|FG011|Vaccination 1 to 3|Other|0|||
37682673|NCT02561195|69158222|FG012|Vaccination 1 to 3|Other|0|||
37682674|NCT02561195|69158223|FG013|Vaccination 1 to 3|Other|0|||
37682675|NCT02561195|69158210|FG000|Vaccination 1 to 3|Protocol Violation|1|||
37682676|NCT02561195|69158211|FG001|Vaccination 1 to 3|Protocol Violation|0|||
37682677|NCT02561195|69158212|FG002|Vaccination 1 to 3|Protocol Violation|1|||
37967062|NCT00455325|69653937|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
37967063|NCT00455325|69653938|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
37967064|NCT00455325|69653939|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
37967065|NCT00455325|69653940|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
37967066|NCT00443781|69653951|FG000|Overall Study|Lost to Follow-up|10|||
37967067|NCT00443781|69653951|FG000|Overall Study|Physician Decision|2|||
37967068|NCT00443781|69653951|FG000|Overall Study|Protocol Violation|1|||
37967069|NCT00443781|69653951|FG000|Overall Study|Withdrawal by Subject|6|||
37967070|NCT00443781|69653951|FG000|Overall Study|Unable to comply with study follow up|2|||
37967071|NCT00443781|69653951|FG000|Overall Study|Investigator terminated participation|1|||
37967072|NCT00443781|69653951|FG000|Overall Study|Insurance not covered|2|||
37967073|NCT00443781|69653951|FG000|Overall Study|PD/FAD not done|1|||
37967074|NCT00443703|69653957|FG000|Overall Study|Never Treated|3|||
37967075|NCT00443703|69653958|FG001|Overall Study|Never Treated|1|||
37967076|NCT00443703|69653957|FG000|Overall Study|Adverse Event|7|||
37967077|NCT00443703|69653958|FG001|Overall Study|Adverse Event|3|||
37967078|NCT00443703|69653957|FG000|Overall Study|Lack of Efficacy|3|||
37967079|NCT00443703|69653958|FG001|Overall Study|Lack of Efficacy|1|||
37967080|NCT00443703|69653957|FG000|Overall Study|Lost to Follow-up|0|||
37967081|NCT00443703|69653958|FG001|Overall Study|Lost to Follow-up|4|||
38082124|NCT01734928|69780743|FG000|Randomization|Lost to Follow-up|1|||
38082125|NCT01734928|69780744|FG001|Randomization|Lost to Follow-up|0|||
38082126|NCT01734928|69780743|FG000|Treatment Period|Lost to Follow-up|0|||
38082127|NCT01734928|69780744|FG001|Treatment Period|Lost to Follow-up|2|||
38082128|NCT01734928|69780743|FG000|Treatment Period|Progressive Disease|167|||
38082129|NCT01734928|69780744|FG001|Treatment Period|Progressive Disease|165|||
38082130|NCT01734928|69780743|FG000|Treatment Period|Adverse Event|39|||
38082131|NCT01734928|69780744|FG001|Treatment Period|Adverse Event|52|||
38082132|NCT01734928|69780743|FG000|Treatment Period|Withdrawal of Consent|25|||
38082133|NCT01734928|69780744|FG001|Treatment Period|Withdrawal of Consent|22|||
38082134|NCT01734928|69780743|FG000|Treatment Period|Death|20|||
38082135|NCT01734928|69780744|FG001|Treatment Period|Death|9|||
38082136|NCT01734928|69780743|FG000|Treatment Period|Other Reasons|27|||
38082137|NCT01734928|69780744|FG001|Treatment Period|Other Reasons|19|||
38082138|NCT01734928|69780743|FG000|Treatment Period|Pregnancy|0|||
38082139|NCT01734928|69780744|FG001|Treatment Period|Pregnancy|1|||
38082140|NCT00667459|69780752|FG000|Overall Study|Death|0|||
38082141|NCT00667459|69780753|FG001|Overall Study|Death|2|||
38082142|NCT00667459|69780752|FG000|Overall Study|Lost to Follow-up|8|||
38082143|NCT00667459|69780753|FG001|Overall Study|Lost to Follow-up|43|||
38082144|NCT00453544|69780767|FG000|Overall Study|Withdrawal by Subject|1|||
37682678|NCT02561195|69158213|FG003|Vaccination 1 to 3|Protocol Violation|2|||
37967082|NCT00443703|69653957|FG000|Overall Study|Physician Decision|4|||
37967083|NCT00443703|69653958|FG001|Overall Study|Physician Decision|2|||
38082145|NCT00453544|69780768|FG001|Overall Study|Withdrawal by Subject|0|||
38082146|NCT00453544|69780769|FG002|Overall Study|Withdrawal by Subject|0|||
38082147|NCT00453544|69780770|FG003|Overall Study|Withdrawal by Subject|0|||
38082148|NCT00453544|69780767|FG000|Overall Study|Primary outcome measure not completed|1|||
38082149|NCT00453544|69780768|FG001|Overall Study|Primary outcome measure not completed|1|||
38082150|NCT00453544|69780769|FG002|Overall Study|Primary outcome measure not completed|0|||
37682679|NCT02561195|69158214|FG004|Vaccination 1 to 3|Protocol Violation|5|||
37682680|NCT02561195|69158215|FG005|Vaccination 1 to 3|Protocol Violation|2|||
37682681|NCT02561195|69158216|FG006|Vaccination 1 to 3|Protocol Violation|0|||
37682682|NCT02561195|69158217|FG007|Vaccination 1 to 3|Protocol Violation|0|||
37682683|NCT02561195|69158218|FG008|Vaccination 1 to 3|Protocol Violation|0|||
37682684|NCT02561195|69158219|FG009|Vaccination 1 to 3|Protocol Violation|0|||
37682685|NCT02561195|69158220|FG010|Vaccination 1 to 3|Protocol Violation|0|||
37682686|NCT02561195|69158221|FG011|Vaccination 1 to 3|Protocol Violation|0|||
37682687|NCT02561195|69158222|FG012|Vaccination 1 to 3|Protocol Violation|0|||
37682688|NCT02561195|69158223|FG013|Vaccination 1 to 3|Protocol Violation|0|||
37682689|NCT02561195|69158210|FG000|Vaccination 1 to 3|Death|2|||
37682690|NCT02561195|69158211|FG001|Vaccination 1 to 3|Death|1|||
37682691|NCT02561195|69158212|FG002|Vaccination 1 to 3|Death|0|||
37682692|NCT02561195|69158213|FG003|Vaccination 1 to 3|Death|2|||
37682693|NCT02561195|69158214|FG004|Vaccination 1 to 3|Death|0|||
37682694|NCT02561195|69158215|FG005|Vaccination 1 to 3|Death|0|||
37682695|NCT02561195|69158216|FG006|Vaccination 1 to 3|Death|0|||
37682696|NCT02561195|69158217|FG007|Vaccination 1 to 3|Death|0|||
37682697|NCT02561195|69158218|FG008|Vaccination 1 to 3|Death|0|||
37682698|NCT02561195|69158219|FG009|Vaccination 1 to 3|Death|0|||
37682699|NCT02561195|69158220|FG010|Vaccination 1 to 3|Death|0|||
37682700|NCT02561195|69158221|FG011|Vaccination 1 to 3|Death|0|||
37682701|NCT02561195|69158222|FG012|Vaccination 1 to 3|Death|0|||
37682702|NCT02561195|69158223|FG013|Vaccination 1 to 3|Death|0|||
37682703|NCT02561195|69158210|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
37682704|NCT02561195|69158211|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
37682705|NCT02561195|69158212|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
37682706|NCT02561195|69158213|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
37682707|NCT02561195|69158214|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
37682708|NCT02561195|69158215|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
37682709|NCT02561195|69158216|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
37682710|NCT02561195|69158217|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
37682711|NCT02561195|69158218|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
37682712|NCT02561195|69158219|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
37682713|NCT02561195|69158220|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
37682714|NCT02561195|69158221|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
37862966|NCT01263665|69546915|FG000|Overall Study|Amputation above the ankle|1|||
37967084|NCT00443703|69653957|FG000|Overall Study|Protocol Violation|1|||
38082151|NCT00453544|69780770|FG003|Overall Study|Primary outcome measure not completed|1|||
38082152|NCT02646124|69780794|FG000|Overall Study|Lost to Follow-up|0|||
38082153|NCT02646124|69780795|FG001|Overall Study|Lost to Follow-up|2|||
38082154|NCT01597492|69780803|FG000|Overall Study|Withdrawal by Subject|1|||
37682715|NCT02561195|69158222|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
37682716|NCT02561195|69158223|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
37682717|NCT02561195|69158210|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
37682718|NCT02561195|69158211|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
37682719|NCT02561195|69158212|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
37682720|NCT02561195|69158213|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
37682721|NCT02561195|69158214|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
37682722|NCT02561195|69158215|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
37682723|NCT02561195|69158216|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
37682724|NCT02561195|69158217|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
37967085|NCT00443703|69653958|FG001|Overall Study|Protocol Violation|1|||
37682725|NCT02561195|69158218|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
37682726|NCT02561195|69158219|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
37682727|NCT02561195|69158220|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
37682728|NCT02561195|69158221|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
37682729|NCT02561195|69158222|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
37682730|NCT02561195|69158223|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
37682731|NCT02561195|69158210|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
37682732|NCT02561195|69158211|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
37682733|NCT02561195|69158212|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
37682734|NCT02561195|69158213|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
37682735|NCT02561195|69158214|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
37682736|NCT02561195|69158215|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
37682737|NCT02561195|69158216|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
37682738|NCT02561195|69158217|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
37682739|NCT02561195|69158218|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
37682740|NCT02561195|69158219|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
37682741|NCT02561195|69158220|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
37682742|NCT02561195|69158221|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
37682743|NCT02561195|69158222|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
37682744|NCT02561195|69158223|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
38082155|NCT01597492|69780804|FG001|Overall Study|Withdrawal by Subject|2|||
38082156|NCT01597492|69780803|FG000|Overall Study|Adverse Event|3|||
38082157|NCT01597492|69780804|FG001|Overall Study|Adverse Event|0|||
38082158|NCT01597492|69780803|FG000|Overall Study|Lost to Follow-up|0|||
38082159|NCT01597492|69780804|FG001|Overall Study|Lost to Follow-up|2|||
38082160|NCT01597492|69780803|FG000|Overall Study|Other Reason|2|||
38082161|NCT01597492|69780804|FG001|Overall Study|Other Reason|0|||
38082162|NCT03423602|69780810|FG000|Overall Study|Death|1|||
38082163|NCT03423602|69780810|FG000|Overall Study|Lost to Follow-up|6|||
38082164|NCT03423602|69780810|FG000|Overall Study|Protocol Violation|1|||
38082165|NCT03423602|69780810|FG000|Overall Study|Withdrawal by Subject|4|||
38082166|NCT00109590|69780817|FG000|Overall Study|Lost to Follow-up|1|||
38082167|NCT00109590|69780818|FG001|Overall Study|Lost to Follow-up|0|||
38082168|NCT00109590|69780819|FG002|Overall Study|Lost to Follow-up|1|||
38082169|NCT00109590|69780817|FG000|Overall Study|Never Started Treatment|1|||
38082170|NCT00109590|69780818|FG001|Overall Study|Never Started Treatment|2|||
38082171|NCT00109590|69780819|FG002|Overall Study|Never Started Treatment|3|||
38082172|NCT02781558|69780843|FG000|Overall Study|Lost to Follow-up|2|||
38082173|NCT02781558|69780844|FG001|Overall Study|Lost to Follow-up|2|||
38082174|NCT02781558|69780843|FG000|Overall Study|Adverse Event|1|||
38082175|NCT02781558|69780844|FG001|Overall Study|Adverse Event|0|||
38082176|NCT03041311|69780853|FG000|Overall Study|Death|39|||
37682745|NCT02561195|69158210|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
37682746|NCT02561195|69158211|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
37682747|NCT02561195|69158212|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
37682748|NCT02561195|69158213|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
37682749|NCT02561195|69158214|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
37682750|NCT02561195|69158215|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
38082177|NCT03041311|69780854|FG001|Overall Study|Death|42|||
38082178|NCT03041311|69780853|FG000|Overall Study|Lost to Follow-up|0|||
38082179|NCT03041311|69780854|FG001|Overall Study|Lost to Follow-up|1|||
38082180|NCT03041311|69780853|FG000|Overall Study|Withdrawal by Subject|8|||
38082181|NCT03041311|69780854|FG001|Overall Study|Withdrawal by Subject|5|||
38082182|NCT03041311|69780853|FG000|Overall Study|Sponsor Terminated Study|2|||
38082183|NCT03041311|69780854|FG001|Overall Study|Sponsor Terminated Study|4|||
38082184|NCT03041311|69780853|FG000|Overall Study|Disease Progression|3|||
37682751|NCT02561195|69158216|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
37682752|NCT02561195|69158217|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
37682753|NCT02561195|69158218|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
37682754|NCT02561195|69158219|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
37682755|NCT02561195|69158220|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
37682756|NCT02561195|69158221|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
37682757|NCT02561195|69158222|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
37682758|NCT02561195|69158223|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
37682759|NCT02561195|69158210|FG000|Extension Stage (Vaccination 4)|Death|0|||
37682760|NCT02561195|69158211|FG001|Extension Stage (Vaccination 4)|Death|0|||
37682761|NCT02561195|69158212|FG002|Extension Stage (Vaccination 4)|Death|0|||
37682762|NCT02561195|69158213|FG003|Extension Stage (Vaccination 4)|Death|0|||
37682763|NCT02561195|69158214|FG004|Extension Stage (Vaccination 4)|Death|0|||
37682764|NCT02561195|69158215|FG005|Extension Stage (Vaccination 4)|Death|0|||
37682765|NCT02561195|69158216|FG006|Extension Stage (Vaccination 4)|Death|0|||
37682766|NCT02561195|69158217|FG007|Extension Stage (Vaccination 4)|Death|0|||
37682767|NCT02561195|69158218|FG008|Extension Stage (Vaccination 4)|Death|0|||
37682768|NCT02561195|69158219|FG009|Extension Stage (Vaccination 4)|Death|1|||
37682769|NCT02561195|69158220|FG010|Extension Stage (Vaccination 4)|Death|0|||
37682770|NCT02561195|69158221|FG011|Extension Stage (Vaccination 4)|Death|0|||
37682771|NCT02561195|69158222|FG012|Extension Stage (Vaccination 4)|Death|0|||
37682772|NCT02561195|69158223|FG013|Extension Stage (Vaccination 4)|Death|0|||
37682773|NCT02561195|69158210|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
37862967|NCT01263665|69546915|FG000|Overall Study|Surgical Bypass|2|||
37682774|NCT02561195|69158211|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
37682775|NCT02561195|69158212|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
37682776|NCT02561195|69158213|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
37682777|NCT02561195|69158214|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
37682778|NCT02561195|69158215|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
37682779|NCT02561195|69158216|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
37682780|NCT02561195|69158217|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
37682781|NCT02561195|69158218|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
37682782|NCT02561195|69158219|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
37682783|NCT02561195|69158220|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
37682784|NCT02561195|69158221|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
37682785|NCT02561195|69158222|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
37682786|NCT02561195|69158223|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
37682787|NCT02561195|69158210|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
37682788|NCT02561195|69158211|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
37682789|NCT02561195|69158212|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
37682790|NCT02561195|69158213|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
37682791|NCT02561195|69158214|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
37682792|NCT02561195|69158215|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
37682793|NCT02561195|69158216|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
37682794|NCT02561195|69158217|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
37682795|NCT02561195|69158218|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
37682796|NCT02561195|69158219|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
37682797|NCT02561195|69158220|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
37682798|NCT02561195|69158221|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
37682799|NCT02561195|69158222|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
37682800|NCT02561195|69158223|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
37682801|NCT02561195|69158210|FG000|Extension Stage (Vaccination 4)|Other|0|||
37682802|NCT02561195|69158211|FG001|Extension Stage (Vaccination 4)|Other|0|||
37682803|NCT02561195|69158212|FG002|Extension Stage (Vaccination 4)|Other|0|||
37682804|NCT02561195|69158213|FG003|Extension Stage (Vaccination 4)|Other|0|||
37682805|NCT02561195|69158214|FG004|Extension Stage (Vaccination 4)|Other|0|||
37682806|NCT02561195|69158215|FG005|Extension Stage (Vaccination 4)|Other|0|||
37682807|NCT02561195|69158216|FG006|Extension Stage (Vaccination 4)|Other|0|||
37682808|NCT02561195|69158217|FG007|Extension Stage (Vaccination 4)|Other|0|||
37682809|NCT02561195|69158218|FG008|Extension Stage (Vaccination 4)|Other|0|||
37682810|NCT02561195|69158219|FG009|Extension Stage (Vaccination 4)|Other|0|||
37682811|NCT02561195|69158220|FG010|Extension Stage (Vaccination 4)|Other|2|||
37682812|NCT02561195|69158221|FG011|Extension Stage (Vaccination 4)|Other|2|||
37682813|NCT02561195|69158222|FG012|Extension Stage (Vaccination 4)|Other|1|||
37682814|NCT02561195|69158223|FG013|Extension Stage (Vaccination 4)|Other|0|||
37682815|NCT02561195|69158210|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
37682816|NCT02561195|69158211|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
37682817|NCT02561195|69158212|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
37682818|NCT02561195|69158213|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
37682819|NCT02561195|69158214|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
37682820|NCT02561195|69158215|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
37682821|NCT02561195|69158216|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
37682822|NCT02561195|69158217|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
37682823|NCT02561195|69158218|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
37682824|NCT02561195|69158219|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
37682825|NCT02561195|69158220|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
37682826|NCT02561195|69158221|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
37682827|NCT02561195|69158222|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
37682828|NCT02561195|69158223|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
37682829|NCT01663103|69158257|FG000|Overall Study|Withdrawal by Subject|1|||
37682830|NCT01663103|69158258|FG001|Overall Study|Withdrawal by Subject|2|||
37682831|NCT01663103|69158257|FG000|Overall Study|Adverse Event|1|||
37682832|NCT01663103|69158258|FG001|Overall Study|Adverse Event|0|||
37682833|NCT01663103|69158257|FG000|Overall Study|dog bite|1|||
37682834|NCT01663103|69158258|FG001|Overall Study|dog bite|0|||
37682835|NCT02560025|69158277|FG000|Overall Study|Ineligible after consent/ registration|3|||
37682836|NCT02566889|69158292|FG000|Overall Study|Withdrawal by Subject|3|||
37682837|NCT02566889|69158293|FG001|Overall Study|Withdrawal by Subject|1|||
37682838|NCT02566889|69158292|FG000|Overall Study|Adverse Event|4|||
37682839|NCT02566889|69158293|FG001|Overall Study|Adverse Event|2|||
37682840|NCT02566889|69158292|FG000|Overall Study|Other|6|||
38082185|NCT03041311|69780854|FG001|Overall Study|Disease Progression|1|||
38082186|NCT03041311|69780853|FG000|Overall Study|Randomized in error, did not receive drug|2|||
37682841|NCT02566889|69158293|FG001|Overall Study|Other|2|||
37682842|NCT02566577|69158300|FG000|Overall Study|Withdrawal by Subject|1|||
37682843|NCT02566577|69158301|FG001|Overall Study|Withdrawal by Subject|1|||
37682844|NCT02566577|69158300|FG000|Overall Study|Equipment failure|1|||
38082187|NCT03041311|69780854|FG001|Overall Study|Randomized in error, did not receive drug|0|||
38082188|NCT02644096|69780870|FG000|Overall Study|Withdrawal by Subject|28|||
38082189|NCT02644096|69780871|FG001|Overall Study|Withdrawal by Subject|25|||
38082190|NCT02643628|69780879|FG000|Overall Study|Lost to Follow-up|1|||
38082191|NCT02643628|69780880|FG001|Overall Study|Lost to Follow-up|4|||
38082192|NCT02643628|69780879|FG000|Overall Study|Withdrawal by Subject|0|||
38082193|NCT02643628|69780880|FG001|Overall Study|Withdrawal by Subject|1|||
38082194|NCT02643628|69780879|FG000|Overall Study|Relocated out of state|0|||
38082195|NCT02643628|69780880|FG001|Overall Study|Relocated out of state|1|||
38082196|NCT02643472|69780890|FG000|Overall Study|Death|2|||
38082197|NCT02643472|69780891|FG001|Overall Study|Death|5|||
37682845|NCT02566577|69158301|FG001|Overall Study|Equipment failure|1|||
37682846|NCT02566577|69158300|FG000|Overall Study|Physical limitation|1|||
37682847|NCT02566577|69158301|FG001|Overall Study|Physical limitation|0|||
37682848|NCT02559713|69158313|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
37682849|NCT01358981|69158324|FG000|Period 1|Withdrawal by Subject|0|||
37682850|NCT01358981|69158325|FG001|Period 1|Withdrawal by Subject|0|||
37682851|NCT01358981|69158326|FG002|Period 1|Withdrawal by Subject|0|||
37682852|NCT01358981|69158327|FG003|Period 1|Withdrawal by Subject|1|||
38082198|NCT02643472|69780890|FG000|Overall Study|Withdrawal by Subject|3|||
37682853|NCT01358981|69158328|FG004|Period 1|Withdrawal by Subject|0|||
37967086|NCT00443703|69653957|FG000|Overall Study|Withdrawal by Subject|9|||
37967087|NCT00443703|69653958|FG001|Overall Study|Withdrawal by Subject|6|||
37682854|NCT01358981|69158329|FG005|Period 1|Withdrawal by Subject|0|||
37682855|NCT01358981|69158330|FG006|Period 1|Withdrawal by Subject|0|||
37682856|NCT02548585|69158362|FG000|Overall Study|Withdrawal by Subject|0|||
37682857|NCT02548585|69158363|FG001|Overall Study|Withdrawal by Subject|0|||
37682858|NCT02548585|69158364|FG002|Overall Study|Withdrawal by Subject|0|||
37682859|NCT02548585|69158365|FG003|Overall Study|Withdrawal by Subject|0|||
37682860|NCT02548585|69158366|FG004|Overall Study|Withdrawal by Subject|0|||
37682861|NCT02548585|69158367|FG005|Overall Study|Withdrawal by Subject|1|||
37682862|NCT02548585|69158368|FG006|Overall Study|Withdrawal by Subject|0|||
37682863|NCT02548585|69158362|FG000|Overall Study|Lost to Follow-up|1|||
37682864|NCT02548585|69158363|FG001|Overall Study|Lost to Follow-up|0|||
37682865|NCT02548585|69158364|FG002|Overall Study|Lost to Follow-up|0|||
37682866|NCT02548585|69158365|FG003|Overall Study|Lost to Follow-up|0|||
37682867|NCT02548585|69158366|FG004|Overall Study|Lost to Follow-up|0|||
37682868|NCT02548585|69158367|FG005|Overall Study|Lost to Follow-up|0|||
37682869|NCT02548585|69158368|FG006|Overall Study|Lost to Follow-up|0|||
37682870|NCT02548585|69158362|FG000|Overall Study|Other|1|||
37682871|NCT02548585|69158363|FG001|Overall Study|Other|0|||
37682872|NCT02548585|69158364|FG002|Overall Study|Other|0|||
37682873|NCT02548585|69158365|FG003|Overall Study|Other|2|||
37682874|NCT02548585|69158366|FG004|Overall Study|Other|3|||
37682875|NCT02548585|69158367|FG005|Overall Study|Other|0|||
37682876|NCT02548585|69158368|FG006|Overall Study|Other|1|||
37682877|NCT02548585|69158362|FG000|Overall Study|Randomized but not treated|0|||
37682878|NCT02548585|69158363|FG001|Overall Study|Randomized but not treated|0|||
37682879|NCT02548585|69158364|FG002|Overall Study|Randomized but not treated|0|||
37682880|NCT02548585|69158365|FG003|Overall Study|Randomized but not treated|0|||
37682881|NCT02548585|69158366|FG004|Overall Study|Randomized but not treated|0|||
37682882|NCT02548585|69158367|FG005|Overall Study|Randomized but not treated|1|||
37682883|NCT02548585|69158368|FG006|Overall Study|Randomized but not treated|0|||
37682884|NCT02547649|69158412|FG000|Overall Study|Lost to Follow-up|3|||
37682885|NCT02547649|69158413|FG001|Overall Study|Lost to Follow-up|1|||
37682886|NCT02547649|69158414|FG002|Overall Study|Lost to Follow-up|1|||
37682887|NCT02547649|69158412|FG000|Overall Study|Not vaccinated|0|||
37682888|NCT02547649|69158413|FG001|Overall Study|Not vaccinated|0|||
37682889|NCT02547649|69158414|FG002|Overall Study|Not vaccinated|1|||
37682890|NCT02547649|69158412|FG000|Overall Study|Withdrawal by Subject|0|||
37682891|NCT02547649|69158413|FG001|Overall Study|Withdrawal by Subject|4|||
37682892|NCT02547649|69158414|FG002|Overall Study|Withdrawal by Subject|2|||
37682893|NCT02535715|69158434|FG000|Overall Study|Withdrawal by Subject|0|||
37682894|NCT02535715|69158435|FG001|Overall Study|Withdrawal by Subject|0|||
37682895|NCT02535715|69158436|FG002|Overall Study|Withdrawal by Subject|1|||
37682896|NCT02336815|69158449|FG000|Overall Study|Disease Progression|45|||
37682897|NCT02336815|69158450|FG001|Overall Study|Disease Progression|70|||
37682898|NCT02336815|69158449|FG000|Overall Study|Adverse Event|18|||
37682899|NCT02336815|69158450|FG001|Overall Study|Adverse Event|39|||
37682900|NCT02336815|69158449|FG000|Overall Study|Physician Decision|11|||
37682901|NCT02336815|69158450|FG001|Overall Study|Physician Decision|4|||
37682902|NCT02336815|69158449|FG000|Overall Study|Withdrawal by Subject|3|||
37682903|NCT02336815|69158450|FG001|Overall Study|Withdrawal by Subject|2|||
37682904|NCT02336815|69158449|FG000|Overall Study|Lost to Follow-up|1|||
37682905|NCT02336815|69158450|FG001|Overall Study|Lost to Follow-up|3|||
37682906|NCT02336815|69158449|FG000|Overall Study|Other|1|||
37682907|NCT02336815|69158450|FG001|Overall Study|Other|5|||
37682908|NCT02543203|69158460|FG000|Overall Study|Unpalatable Fragrance|2|||
37862968|NCT01263509|69546921|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
37862969|NCT01263509|69546922|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
37967088|NCT00443703|69653957|FG000|Overall Study|Progressive Disease|1|||
37682909|NCT02543203|69158461|FG001|Overall Study|Unpalatable Fragrance|2|||
37682910|NCT02543203|69158460|FG000|Overall Study|Lost to Follow-up|1|||
37967089|NCT00443703|69653958|FG001|Overall Study|Progressive Disease|0|||
37967090|NCT00381706|69653970|FG000|Overall Study|Never treated|7|||
37682911|NCT02543203|69158461|FG001|Overall Study|Lost to Follow-up|0|||
37682912|NCT02543203|69158460|FG000|Overall Study|Increased Irritability|1|||
37682913|NCT02543203|69158461|FG001|Overall Study|Increased Irritability|0|||
37682914|NCT02543203|69158460|FG000|Overall Study|Family|1|||
37682915|NCT02543203|69158461|FG001|Overall Study|Family|2|||
37682916|NCT02543203|69158460|FG000|Overall Study|Negative Behavior|1|||
37682917|NCT02543203|69158461|FG001|Overall Study|Negative Behavior|0|||
37682918|NCT02543203|69158460|FG000|Overall Study|Withdrawal by Subject|0|||
37682919|NCT02543203|69158461|FG001|Overall Study|Withdrawal by Subject|1|||
37682920|NCT02546323|69158477|FG000|Overall Study|Withdrawal by Subject|36|||
37682921|NCT02546323|69158478|FG001|Overall Study|Withdrawal by Subject|33|||
37682922|NCT02546323|69158477|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
37682923|NCT02546323|69158478|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
37682924|NCT02546323|69158477|FG000|Overall Study|Adverse Event|17|||
37682925|NCT02546323|69158478|FG001|Overall Study|Adverse Event|11|||
37682926|NCT02546323|69158477|FG000|Overall Study|Patient Specific Reasons|1|||
37682927|NCT02546323|69158478|FG001|Overall Study|Patient Specific Reasons|2|||
37682928|NCT02546323|69158477|FG000|Overall Study|Lost to Follow-up|2|||
37682929|NCT02546323|69158478|FG001|Overall Study|Lost to Follow-up|3|||
37682930|NCT02546323|69158477|FG000|Overall Study|Non-compliance with Study Drug|2|||
37682931|NCT02546323|69158478|FG001|Overall Study|Non-compliance with Study Drug|2|||
37682932|NCT02546323|69158477|FG000|Overall Study|Met Withdrawal Criteria|2|||
37682933|NCT02546323|69158478|FG001|Overall Study|Met Withdrawal Criteria|14|||
37682934|NCT02545933|69158487|FG000|Overall Study|Adverse Event|3|||
37682935|NCT02545933|69158488|FG001|Overall Study|Adverse Event|0|||
37967091|NCT00381706|69653971|FG001|Overall Study|Never treated|2|||
37967092|NCT00381706|69653972|FG002|Overall Study|Never treated|1|||
37967093|NCT00535236|69653996|FG000|Overall Study|Adverse Event|1|||
37967094|NCT00535236|69653997|FG001|Overall Study|Adverse Event|0|||
37682936|NCT02545933|69158489|FG002|Overall Study|Adverse Event|0|||
37682937|NCT02545933|69158487|FG000|Overall Study|Withdrawal by Subject|2|||
37682938|NCT02545933|69158488|FG001|Overall Study|Withdrawal by Subject|3|||
37682939|NCT02545933|69158489|FG002|Overall Study|Withdrawal by Subject|3|||
37682940|NCT02545933|69158487|FG000|Overall Study|Protocol Violation|1|||
37682941|NCT02545933|69158488|FG001|Overall Study|Protocol Violation|0|||
37682942|NCT02545933|69158489|FG002|Overall Study|Protocol Violation|1|||
37682943|NCT01661179|69158497|FG000|Overall Study|Death|1|||
37682944|NCT01661179|69158497|FG000|Overall Study|Withdrawal by Subject|1|||
37682945|NCT01661179|69158497|FG000|Overall Study|Other Eligibility criteria|4|||
37682946|NCT02545543|69158503|FG000|Overall Study|Lost to Follow-up|67|||
37682947|NCT02545543|69158504|FG001|Overall Study|Lost to Follow-up|25|||
37682948|NCT02545543|69158503|FG000|Overall Study|Physician Decision|3|||
37682949|NCT02545543|69158504|FG001|Overall Study|Physician Decision|0|||
37682950|NCT02545543|69158503|FG000|Overall Study|Withdrawal by Subject|9|||
37682951|NCT02545543|69158504|FG001|Overall Study|Withdrawal by Subject|8|||
37682952|NCT02545543|69158503|FG000|Overall Study|Noncomplaince|1|||
37682953|NCT02545543|69158504|FG001|Overall Study|Noncomplaince|0|||
37682954|NCT02545543|69158503|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
37682955|NCT02545543|69158504|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
37682956|NCT02545075|69158514|FG000|Randomization|Lost to Follow-up|0|||
37682957|NCT02545075|69158515|FG001|Randomization|Lost to Follow-up|1|||
37682958|NCT02545075|69158514|FG000|Randomization|Withdrawal by Subject|0|||
37682959|NCT02545075|69158515|FG001|Randomization|Withdrawal by Subject|6|||
37682960|NCT02545075|69158514|FG000|Treatment|Disease progression|71|||
37682961|NCT02545075|69158515|FG001|Treatment|Disease progression|32|||
37682962|NCT02545075|69158514|FG000|Treatment|Participant dicontinued study treatment|7|||
37682963|NCT02545075|69158515|FG001|Treatment|Participant dicontinued study treatment|9|||
37682964|NCT02545075|69158514|FG000|Treatment|Withdrawal by Subject|1|||
37682965|NCT02545075|69158515|FG001|Treatment|Withdrawal by Subject|0|||
37682966|NCT02545075|69158514|FG000|Treatment|Adverse event not related to study drug|1|||
37682967|NCT02545075|69158515|FG001|Treatment|Adverse event not related to study drug|0|||
37682968|NCT02545075|69158514|FG000|Treatment|Death|1|||
37682969|NCT02545075|69158515|FG001|Treatment|Death|0|||
37682970|NCT02545075|69158514|FG000|Treatment|Participant drug toxicity|1|||
37682971|NCT02545075|69158515|FG001|Treatment|Participant drug toxicity|0|||
37682972|NCT02545075|69158514|FG000|Treatment|Completed treatment|40|||
37682973|NCT02545075|69158515|FG001|Treatment|Completed treatment|12|||
37682974|NCT03004183|69158530|FG000|Overall Study|Adverse Event|7|||
37682975|NCT03004183|69158530|FG000|Overall Study|Lost to Follow-up|1|||
37682976|NCT03004183|69158530|FG000|Overall Study|Physician Decision|40|||
37682977|NCT03004183|69158530|FG000|Overall Study|Withdrawal by Subject|1|||
37682978|NCT03004183|69158530|FG000|Overall Study|COVID-19|1|||
37682979|NCT02544763|69158537|FG000|Overall Study|Adverse Event|8|||
37682980|NCT02544763|69158538|FG001|Overall Study|Adverse Event|8|||
37682981|NCT02544763|69158539|FG002|Overall Study|Adverse Event|0|||
37682982|NCT02544763|69158537|FG000|Overall Study|Withdrawn by parent/guardian|1|||
38082199|NCT02643472|69780891|FG001|Overall Study|Withdrawal by Subject|2|||
37682983|NCT02544763|69158538|FG001|Overall Study|Withdrawn by parent/guardian|1|||
37682984|NCT02544763|69158539|FG002|Overall Study|Withdrawn by parent/guardian|1|||
37682985|NCT02544763|69158537|FG000|Overall Study|Met withdrawal criteria|0|||
37682986|NCT02544763|69158538|FG001|Overall Study|Met withdrawal criteria|2|||
37682987|NCT02544763|69158539|FG002|Overall Study|Met withdrawal criteria|0|||
37682988|NCT02544763|69158537|FG000|Overall Study|Physician Decision|0|||
38082200|NCT02643472|69780890|FG000|Overall Study|Protocol Violation|0|||
37682989|NCT02544763|69158538|FG001|Overall Study|Physician Decision|1|||
37682990|NCT02544763|69158539|FG002|Overall Study|Physician Decision|0|||
37682991|NCT02544763|69158537|FG000|Overall Study|Difficulties taking IMP|1|||
37682992|NCT02544763|69158538|FG001|Overall Study|Difficulties taking IMP|0|||
37682993|NCT02544763|69158539|FG002|Overall Study|Difficulties taking IMP|0|||
37682994|NCT02556203|69158549|FG000|Overall Study|Withdrawal by Subject|21|||
37682995|NCT02556203|69158550|FG001|Overall Study|Withdrawal by Subject|21|||
37967095|NCT00535236|69653998|FG002|Overall Study|Adverse Event|9|||
38082201|NCT02643472|69780891|FG001|Overall Study|Protocol Violation|1|||
38082202|NCT02643472|69780890|FG000|Overall Study|Lost to Follow-up|22|||
38082203|NCT02643472|69780891|FG001|Overall Study|Lost to Follow-up|26|||
38082204|NCT02738840|69780899|FG000|Overall Study|MRI Scan not Performed|5|||
38082205|NCT02738840|69780899|FG000|Overall Study|Lost to Follow-up|1|||
38082206|NCT02738840|69780899|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
38082207|NCT02738840|69780899|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
38082208|NCT02643394|69780905|FG000|Overall Study|Protocol Violation|4|||
38082209|NCT02643394|69780906|FG001|Overall Study|Protocol Violation|5|||
38082210|NCT03538158|69780914|FG000|Overall Study|Lost to Follow-up|13|||
38082211|NCT03538158|69780915|FG001|Overall Study|Lost to Follow-up|7|||
38082212|NCT03538158|69780914|FG000|Overall Study|Withdrawal by Subject|2|||
38082213|NCT03538158|69780915|FG001|Overall Study|Withdrawal by Subject|1|||
38082214|NCT02643082|69780921|FG000|Period 1|Adverse Event|1|||
38082215|NCT02643082|69780922|FG001|Period 1|Adverse Event|0|||
38082216|NCT00353496|69780931|FG000|Overall Study|Adverse Event|1|||
38082217|NCT00353496|69780932|FG001|Overall Study|Adverse Event|0|||
38082218|NCT00353496|69780931|FG000|Overall Study|Protocol Violation|2|||
38082219|NCT00353496|69780932|FG001|Overall Study|Protocol Violation|2|||
38082220|NCT00353496|69780931|FG000|Overall Study|Withdrawal by Subject|3|||
38082221|NCT00353496|69780932|FG001|Overall Study|Withdrawal by Subject|4|||
38082222|NCT00353496|69780931|FG000|Overall Study|Physician Decision|6|||
38082223|NCT00353496|69780932|FG001|Overall Study|Physician Decision|9|||
38082224|NCT00353496|69780931|FG000|Overall Study|Not otherwise specified|4|||
38082225|NCT00353496|69780932|FG001|Overall Study|Not otherwise specified|2|||
38082226|NCT01361464|69780948|FG000|Overall Study|Death|1|||
38082227|NCT01361464|69780948|FG000|Overall Study|Withdrawal by Subject|2|||
38082228|NCT03486912|69780956|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
38082229|NCT03486912|69780957|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
38082230|NCT03486912|69780958|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
38082231|NCT03486912|69780959|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
38082232|NCT03486912|69780956|FG000|Treatment Period|Withdrawal by Subject|3|||
38082233|NCT03486912|69780957|FG001|Treatment Period|Withdrawal by Subject|3|||
38082234|NCT03486912|69780958|FG002|Treatment Period|Withdrawal by Subject|3|||
38082235|NCT03486912|69780959|FG003|Treatment Period|Withdrawal by Subject|2|||
38082236|NCT03486912|69780956|FG000|Treatment Period|Other Reasons|0|||
38082237|NCT03486912|69780957|FG001|Treatment Period|Other Reasons|2|||
38082238|NCT03486912|69780958|FG002|Treatment Period|Other Reasons|1|||
38082239|NCT03486912|69780959|FG003|Treatment Period|Other Reasons|1|||
38082240|NCT03486912|69780956|FG000|Treatment Period|Adverse Event|0|||
38082241|NCT03486912|69780957|FG001|Treatment Period|Adverse Event|1|||
38082242|NCT03486912|69780958|FG002|Treatment Period|Adverse Event|1|||
38082243|NCT03486912|69780959|FG003|Treatment Period|Adverse Event|0|||
38082244|NCT03486912|69780956|FG000|Treatment Period|Lost to Follow-up|1|||
38082245|NCT03486912|69780957|FG001|Treatment Period|Lost to Follow-up|0|||
38082246|NCT03486912|69780958|FG002|Treatment Period|Lost to Follow-up|0|||
38082247|NCT03486912|69780959|FG003|Treatment Period|Lost to Follow-up|2|||
38082248|NCT02642614|69780973|FG000|Overall Study|Adverse Event|1|||
38082249|NCT02642614|69780974|FG001|Overall Study|Adverse Event|1|||
38082250|NCT02642614|69780975|FG002|Overall Study|Adverse Event|2|||
38082251|NCT02642614|69780976|FG003|Overall Study|Adverse Event|2|||
38082252|NCT02642614|69780973|FG000|Overall Study|Lost to Follow-up|1|||
38082253|NCT02642614|69780974|FG001|Overall Study|Lost to Follow-up|0|||
38082254|NCT02642614|69780975|FG002|Overall Study|Lost to Follow-up|0|||
38082255|NCT02642614|69780976|FG003|Overall Study|Lost to Follow-up|0|||
38082256|NCT02642614|69780973|FG000|Overall Study|Withdrawal by Subject|1|||
38082257|NCT02642614|69780974|FG001|Overall Study|Withdrawal by Subject|1|||
38082258|NCT02642614|69780975|FG002|Overall Study|Withdrawal by Subject|0|||
38082259|NCT02642614|69780976|FG003|Overall Study|Withdrawal by Subject|0|||
38082260|NCT02781324|69780991|FG000|Overall Study|Withdrawal by Subject|1|||
38082261|NCT02781324|69780992|FG001|Overall Study|Withdrawal by Subject|0|||
38082262|NCT02781324|69780991|FG000|Overall Study|Physician Decision|1|||
38082263|NCT02781324|69780992|FG001|Overall Study|Physician Decision|2|||
38082264|NCT03292146|69781002|FG000|Baseline to 12 Months|Relocation|1|||
38082265|NCT03292146|69781003|FG001|Baseline to 12 Months|Relocation|0|||
38082266|NCT03292146|69781002|FG000|Baseline to 12 Months|Seeking higher level of care for eating disorder|1|||
38082267|NCT03292146|69781003|FG001|Baseline to 12 Months|Seeking higher level of care for eating disorder|0|||
38082268|NCT03292146|69781002|FG000|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|0|||
38082269|NCT03292146|69781003|FG001|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|1|||
38082270|NCT03292146|69781002|FG000|12 Months to 24 Months|Planning pregnancy|2|||
38082271|NCT03292146|69781003|FG001|12 Months to 24 Months|Planning pregnancy|2|||
38082272|NCT03292146|69781002|FG000|12 Months to 24 Months|Personal reasons|1|||
38082273|NCT03292146|69781003|FG001|12 Months to 24 Months|Personal reasons|0|||
38082274|NCT03292146|69781002|FG000|12 Months to 24 Months|Lost to Follow-up|0|||
38082275|NCT03292146|69781003|FG001|12 Months to 24 Months|Lost to Follow-up|1|||
38082276|NCT01360996|69781012|FG000|Overall Study|Withdrawal by Subject|4|||
38082277|NCT01360996|69781013|FG001|Overall Study|Withdrawal by Subject|3|||
38082278|NCT01360996|69781014|FG002|Overall Study|Withdrawal by Subject|2|||
38082279|NCT01360996|69781012|FG000|Overall Study|Noncompliant|2|||
38082280|NCT01360996|69781013|FG001|Overall Study|Noncompliant|0|||
38082281|NCT01360996|69781014|FG002|Overall Study|Noncompliant|0|||
38082282|NCT02639338|69781023|FG000|Overall Study|Lost to Follow-up|2|||
38082283|NCT02639338|69781024|FG001|Overall Study|Lost to Follow-up|2|||
38082284|NCT02639338|69781023|FG000|Overall Study|Withdrew Consent|1|||
38082285|NCT02639338|69781024|FG001|Overall Study|Withdrew Consent|2|||
38082286|NCT02639338|69781023|FG000|Overall Study|Death|1|||
38082287|NCT02639338|69781024|FG001|Overall Study|Death|0|||
38082288|NCT02639338|69781023|FG000|Overall Study|Randomized but Not Treated|0|||
38082289|NCT02639338|69781024|FG001|Overall Study|Randomized but Not Treated|1|||
38082290|NCT01754857|69781030|FG000|Overall Study|Adverse Event|7|||
38082291|NCT01754857|69781030|FG000|Overall Study|Disease progression|3|||
38082292|NCT01754857|69781030|FG000|Overall Study|Physician Decision|2|||
38082293|NCT01754857|69781030|FG000|Overall Study|Withdrawal by Subject|3|||
38082294|NCT01754857|69781030|FG000|Overall Study|other complicating disease|1|||
38082295|NCT01754857|69781030|FG000|Overall Study|ineligible to continue onto maintenance|1|||
38082296|NCT01754857|69781030|FG000|Overall Study|Patient does not wish to be treated, but will continue to be followed for survival|1|||
38082297|NCT01754857|69781030|FG000|Overall Study|Patient decided not to begin maintenance therapy|1|||
38082298|NCT02900352|69781036|FG000|Overall Study|Lost to Follow-up|28|||
38082299|NCT02900352|69781037|FG001|Overall Study|Lost to Follow-up|17|||
38082300|NCT03040687|69781046|FG000|Overall Study|Withdrawal by Subject|1|||
38082301|NCT03040687|69781047|FG001|Overall Study|Withdrawal by Subject|0|||
38082302|NCT03040687|69781048|FG002|Overall Study|Withdrawal by Subject|0|||
38082303|NCT03042559|69781058|FG000|Overall Study|drop out|1|||
38082304|NCT03042559|69781059|FG001|Overall Study|drop out|1|||
38082305|NCT02780856|69781065|FG000|Overall Study|Lost to Follow-up|1|||
38082306|NCT02321540|69781078|FG000|Overall Study|Death|0|||
38082307|NCT02321540|69781079|FG001|Overall Study|Death|1|||
38082308|NCT02321540|69781078|FG000|Overall Study|Progression|3|||
38082309|NCT02321540|69781079|FG001|Overall Study|Progression|9|||
38082310|NCT00108732|69781109|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
38082311|NCT00108732|69781109|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
38082312|NCT00108732|69781109|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
38082313|NCT00108732|69781109|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
38082314|NCT00108732|69781109|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
38082315|NCT00108732|69781109|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
38082316|NCT00108732|69781109|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
38082317|NCT00107952|69781115|FG000|Overall Study|Death|75|||
38082318|NCT00107952|69781116|FG001|Overall Study|Death|61|||
38082319|NCT00107952|69781115|FG000|Overall Study|Lost to Follow-up|0|||
38082320|NCT00107952|69781116|FG001|Overall Study|Lost to Follow-up|3|||
38082321|NCT00107952|69781115|FG000|Overall Study|Withdrawal by Subject|9|||
38082322|NCT00107952|69781116|FG001|Overall Study|Withdrawal by Subject|6|||
38082323|NCT00107952|69781115|FG000|Overall Study|Other|2|||
38082324|NCT00107952|69781116|FG001|Overall Study|Other|5|||
38082325|NCT00107952|69781115|FG000|Overall Study|Never received study treatment|9|||
38082326|NCT00107952|69781116|FG001|Overall Study|Never received study treatment|6|||
38082327|NCT01366638|69781134|FG000|Overall Study|Withdrawal by Subject|0|||
38082328|NCT01366638|69781135|FG001|Overall Study|Withdrawal by Subject|0|||
38082329|NCT01366638|69781136|FG002|Overall Study|Withdrawal by Subject|6|||
38082330|NCT01366638|69781134|FG000|Overall Study|Other|1|||
38082331|NCT01366638|69781135|FG001|Overall Study|Other|0|||
38082332|NCT01366638|69781136|FG002|Overall Study|Other|0|||
38082333|NCT02780700|69781144|FG000|Overall Study|Progressive disease|1|||
38082334|NCT04230122|69781182|FG000|Overall Study|Lost to Follow-up|1|||
38082335|NCT04230122|69781183|FG001|Overall Study|Lost to Follow-up|0|||
38082336|NCT02780388|69781194|FG000|Overall Study|Lost to Follow-up|0|||
38082337|NCT02780388|69781195|FG001|Overall Study|Lost to Follow-up|1|||
38082338|NCT02780388|69781196|FG002|Overall Study|Lost to Follow-up|0|||
37862970|NCT01263509|69546923|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
37862971|NCT01263509|69546924|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
37862972|NCT01263509|69546921|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
37862973|NCT01263509|69546922|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
37862974|NCT01263509|69546923|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
38082339|NCT02780388|69781197|FG003|Overall Study|Lost to Follow-up|0|||
38082340|NCT02780388|69781198|FG004|Overall Study|Lost to Follow-up|0|||
38082341|NCT02780388|69781194|FG000|Overall Study|Withdrawal by Subject|1|||
38082342|NCT02780388|69781195|FG001|Overall Study|Withdrawal by Subject|1|||
38082343|NCT02780388|69781196|FG002|Overall Study|Withdrawal by Subject|0|||
38082344|NCT02780388|69781197|FG003|Overall Study|Withdrawal by Subject|0|||
38082345|NCT02780388|69781198|FG004|Overall Study|Withdrawal by Subject|0|||
38082346|NCT03491462|69781216|FG000|Overall Study|Lost to Follow-up|2|||
38082347|NCT03491462|69781217|FG001|Overall Study|Lost to Follow-up|0|||
38082348|NCT03491462|69781216|FG000|Overall Study|Adverse Event|11|||
38082349|NCT03491462|69781217|FG001|Overall Study|Adverse Event|1|||
38082350|NCT03491462|69781216|FG000|Overall Study|Physician Decision|3|||
38082351|NCT03491462|69781217|FG001|Overall Study|Physician Decision|0|||
38082352|NCT03491462|69781216|FG000|Overall Study|Withdrawal by Subject|22|||
38082353|NCT03491462|69781217|FG001|Overall Study|Withdrawal by Subject|15|||
38082354|NCT02224573|69781225|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
38082355|NCT02224573|69781226|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
38082356|NCT02224573|69781225|FG000|Treatment Phase|Started on Other IMP|1|||
38082357|NCT02224573|69781226|FG001|Treatment Phase|Started on Other IMP|0|||
38082358|NCT02224573|69781225|FG000|Treatment Phase|Participant Discontinued IMP|0|||
38082359|NCT02224573|69781226|FG001|Treatment Phase|Participant Discontinued IMP|1|||
38082360|NCT02224573|69781225|FG000|Treatment Phase|Lack of Efficacy|15|||
38082361|NCT02224573|69781226|FG001|Treatment Phase|Lack of Efficacy|8|||
38082362|NCT02224573|69781225|FG000|Treatment Phase|Began Commercial Product|1|||
38082363|NCT02224573|69781226|FG001|Treatment Phase|Began Commercial Product|0|||
38082364|NCT02224573|69781225|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
38082365|NCT02224573|69781226|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
38082366|NCT02224573|69781225|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
38082367|NCT02224573|69781226|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
38082368|NCT02224573|69781225|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
38082369|NCT02224573|69781226|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
38082370|NCT02224573|69781225|FG000|Treatment Phase|Continued Compassionate Use|1|||
38082371|NCT02224573|69781226|FG001|Treatment Phase|Continued Compassionate Use|0|||
38082372|NCT02224573|69781225|FG000|Treatment Phase|Lack of Efficiency|2|||
38082373|NCT02224573|69781226|FG001|Treatment Phase|Lack of Efficiency|1|||
38082374|NCT02224573|69781225|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
38082375|NCT02224573|69781226|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
38082376|NCT02224573|69781225|FG000|Treatment Phase|Participant Moved|2|||
38082377|NCT02224573|69781226|FG001|Treatment Phase|Participant Moved|0|||
37682996|NCT02556203|69158549|FG000|Overall Study|Lost to Follow-up|5|||
37682997|NCT02556203|69158550|FG001|Overall Study|Lost to Follow-up|5|||
37682998|NCT02556203|69158549|FG000|Overall Study|Adverse Event|1|||
37682999|NCT02556203|69158550|FG001|Overall Study|Adverse Event|0|||
37683000|NCT02558231|69158567|FG000|Overall Study|Death|4|||
37683001|NCT02558231|69158568|FG001|Overall Study|Death|12|||
37683002|NCT02558231|69158567|FG000|Overall Study|Lost to Follow-up|7|||
37683003|NCT02558231|69158568|FG001|Overall Study|Lost to Follow-up|4|||
37683004|NCT02558231|69158567|FG000|Overall Study|Withdrawal by Subject|7|||
37683005|NCT02558231|69158568|FG001|Overall Study|Withdrawal by Subject|4|||
37683006|NCT02558231|69158567|FG000|Overall Study|Physician Decision|7|||
37683007|NCT02558231|69158568|FG001|Overall Study|Physician Decision|5|||
37683008|NCT02558231|69158567|FG000|Overall Study|Sponsor Decision|0|||
37683009|NCT02558231|69158568|FG001|Overall Study|Sponsor Decision|1|||
37683010|NCT02554877|69158578|FG000|Overall Study|Adverse Event|2|||
37683011|NCT02554877|69158579|FG001|Overall Study|Adverse Event|0|||
37683012|NCT02554877|69158580|FG002|Overall Study|Adverse Event|0|||
37683013|NCT02554877|69158581|FG003|Overall Study|Adverse Event|1|||
37683014|NCT02554877|69158578|FG000|Overall Study|Lost to Follow-up|1|||
37683015|NCT02554877|69158579|FG001|Overall Study|Lost to Follow-up|1|||
37683016|NCT02554877|69158580|FG002|Overall Study|Lost to Follow-up|1|||
37683017|NCT02554877|69158581|FG003|Overall Study|Lost to Follow-up|2|||
37683018|NCT02554877|69158578|FG000|Overall Study|Did not meet entrance criteria|0|||
37683019|NCT02554877|69158579|FG001|Overall Study|Did not meet entrance criteria|0|||
37683020|NCT02554877|69158580|FG002|Overall Study|Did not meet entrance criteria|1|||
37683021|NCT02554877|69158581|FG003|Overall Study|Did not meet entrance criteria|0|||
37683022|NCT02554877|69158578|FG000|Overall Study|No longer met eligibility criteria|1|||
37683023|NCT02554877|69158579|FG001|Overall Study|No longer met eligibility criteria|0|||
38082378|NCT02224573|69781225|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
38082379|NCT02224573|69781226|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
38082380|NCT02224573|69781225|FG000|Treatment Phase|Refused Medication|1|||
38082381|NCT02224573|69781226|FG001|Treatment Phase|Refused Medication|1|||
38082382|NCT02224573|69781225|FG000|Treatment Phase|Adverse Event|26|||
37862975|NCT01263509|69546924|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
38082383|NCT02224573|69781226|FG001|Treatment Phase|Adverse Event|38|||
37683024|NCT02554877|69158580|FG002|Overall Study|No longer met eligibility criteria|1|||
37683025|NCT02554877|69158581|FG003|Overall Study|No longer met eligibility criteria|1|||
37683026|NCT02554877|69158578|FG000|Overall Study|Protocol Violation|3|||
37683027|NCT02554877|69158579|FG001|Overall Study|Protocol Violation|1|||
37683028|NCT02554877|69158580|FG002|Overall Study|Protocol Violation|1|||
37683029|NCT02554877|69158581|FG003|Overall Study|Protocol Violation|0|||
37683030|NCT02554877|69158578|FG000|Overall Study|Other|1|||
37683031|NCT02554877|69158579|FG001|Overall Study|Other|3|||
38082384|NCT02224573|69781225|FG000|Treatment Phase|Placed in Group Home|0|||
38082385|NCT02224573|69781226|FG001|Treatment Phase|Placed in Group Home|1|||
38082386|NCT02224573|69781225|FG000|Treatment Phase|Pursued Other Trials|1|||
38082387|NCT02224573|69781226|FG001|Treatment Phase|Pursued Other Trials|0|||
38082388|NCT02224573|69781225|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
38082389|NCT02224573|69781226|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
38082390|NCT02224573|69781225|FG000|Treatment Phase|Lost to Follow-up|2|||
38082391|NCT02224573|69781226|FG001|Treatment Phase|Lost to Follow-up|1|||
38082392|NCT02224573|69781225|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
38082393|NCT02224573|69781226|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
38082394|NCT02224573|69781225|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
38082395|NCT02224573|69781226|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
38082396|NCT02224573|69781225|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
38082397|NCT02224573|69781226|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
38082398|NCT02224573|69781225|FG000|Taper Phase|Adverse Event|1|||
38082399|NCT02224573|69781226|FG001|Taper Phase|Adverse Event|1|||
38082400|NCT01360840|69781236|FG000|Overall Study|Ongoing at data cut-off|10|||
38082401|NCT01360840|69781237|FG001|Overall Study|Ongoing at data cut-off|10|||
38082402|NCT01360840|69781238|FG002|Overall Study|Ongoing at data cut-off|9|||
38082403|NCT03350984|69781250|FG000|Overall Study|Death|1|||
38082404|NCT03350984|69781251|FG001|Overall Study|Death|0|||
38082405|NCT03350984|69781250|FG000|Overall Study|Lost to Follow-up|5|||
38082406|NCT03350984|69781251|FG001|Overall Study|Lost to Follow-up|6|||
38082407|NCT03350984|69781250|FG000|Overall Study|Protocol Violation|1|||
38082408|NCT03350984|69781251|FG001|Overall Study|Protocol Violation|2|||
38082409|NCT03350984|69781250|FG000|Overall Study|Physician Decision|1|||
38082410|NCT03350984|69781251|FG001|Overall Study|Physician Decision|0|||
38082411|NCT05176717|69781269|FG000|Overall Study|Sponsor Decision|1|||
38082412|NCT05176717|69781270|FG001|Overall Study|Sponsor Decision|2|||
38082413|NCT05176717|69781271|FG002|Overall Study|Sponsor Decision|2|||
38082414|NCT02770248|69781281|FG000|Overall Study|Adverse Event|0|||
38082415|NCT02770248|69781282|FG001|Overall Study|Adverse Event|1|||
38082416|NCT02770248|69781281|FG000|Overall Study|Randomized in error, prior to treatment|0|||
38082417|NCT02770248|69781282|FG001|Overall Study|Randomized in error, prior to treatment|1|||
38082418|NCT01344369|69781290|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
38082419|NCT01344369|69781291|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
38082420|NCT01344369|69781290|FG000|Washout of 28 Days|Physician Decision|0|||
37683032|NCT02554877|69158580|FG002|Overall Study|Other|0|||
37683033|NCT02554877|69158581|FG003|Overall Study|Other|3|||
37683034|NCT02554877|69158578|FG000|Overall Study|Insufficient clinical response|4|||
37683035|NCT02554877|69158579|FG001|Overall Study|Insufficient clinical response|0|||
37683036|NCT02554877|69158580|FG002|Overall Study|Insufficient clinical response|0|||
37683037|NCT02554877|69158581|FG003|Overall Study|Insufficient clinical response|0|||
37683038|NCT02554877|69158578|FG000|Overall Study|No longer willing to participate|0|||
37683039|NCT02554877|69158579|FG001|Overall Study|No longer willing to participate|2|||
37683040|NCT02554877|69158580|FG002|Overall Study|No longer willing to participate|2|||
37683041|NCT02554877|69158581|FG003|Overall Study|No longer willing to participate|0|||
37683042|NCT02554721|69158596|FG000|Overall Study|Adverse Event|1|||
37683043|NCT02554721|69158597|FG001|Overall Study|Adverse Event|0|||
38082421|NCT01344369|69781291|FG001|Washout of 28 Days|Physician Decision|1|||
38082422|NCT01344369|69781290|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
38082423|NCT01344369|69781291|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
38082424|NCT03179462|69781300|FG000|Overall Study|screening failure|1|||
38082425|NCT03179462|69781301|FG001|Overall Study|screening failure|2|||
38082426|NCT03179462|69781302|FG002|Overall Study|screening failure|0|||
37683044|NCT02554721|69158598|FG002|Overall Study|Adverse Event|0|||
37683045|NCT02554721|69158599|FG003|Overall Study|Adverse Event|0|||
37683046|NCT02554721|69158600|FG004|Overall Study|Adverse Event|1|||
37683047|NCT02554721|69158596|FG000|Overall Study|Noncompliance|0|||
37683048|NCT02554721|69158597|FG001|Overall Study|Noncompliance|0|||
37683049|NCT02554721|69158598|FG002|Overall Study|Noncompliance|0|||
37683050|NCT02554721|69158599|FG003|Overall Study|Noncompliance|0|||
37683051|NCT02554721|69158600|FG004|Overall Study|Noncompliance|1|||
37683052|NCT02552225|69158611|FG000|Overall Study|Withdrawal by Subject|1|||
37683053|NCT02552225|69158612|FG001|Overall Study|Withdrawal by Subject|0|||
38082427|NCT01314703|69781310|FG000|Overall Study|screen failure and closed enrollment|8|||
38082428|NCT01360762|69781315|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
38082429|NCT01360762|69781315|FG000|Main Study Period (12-month Treatment)|Death|5|||
38082430|NCT01360762|69781315|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
38082431|NCT01360762|69781315|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
38082432|NCT01360762|69781315|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
38082433|NCT01360762|69781315|FG000|Whole Study Period|Lost to Follow-up|10|||
38082434|NCT01360762|69781315|FG000|Whole Study Period|Death|7|||
38082435|NCT01360762|69781315|FG000|Whole Study Period|Patient relapsed|18|||
38082436|NCT01360762|69781315|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
38082437|NCT04382924|69781322|FG000|Overall Study|Death|2|||
38082438|NCT04382924|69781323|FG001|Overall Study|Death|5|||
38082439|NCT04382924|69781324|FG002|Overall Study|Death|4|||
38082440|NCT04382924|69781322|FG000|Overall Study|Protocol Violation|0|||
38082441|NCT04382924|69781323|FG001|Overall Study|Protocol Violation|1|||
38082442|NCT04382924|69781324|FG002|Overall Study|Protocol Violation|1|||
38082443|NCT04382924|69781322|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
38082444|NCT04382924|69781323|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
38082445|NCT04382924|69781324|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
38082446|NCT04382924|69781322|FG000|Overall Study|Withdrawal by Subject|6|||
38082447|NCT04382924|69781323|FG001|Overall Study|Withdrawal by Subject|3|||
38082448|NCT04382924|69781324|FG002|Overall Study|Withdrawal by Subject|6|||
38082449|NCT03044431|69781338|FG000|Overall Study|Lost to Follow-up|59|||
38082450|NCT02770170|69781346|FG000|Overall Study|Withdrawal by Subject|0|||
38082451|NCT02770170|69781347|FG001|Overall Study|Withdrawal by Subject|0|||
38082452|NCT02770170|69781348|FG002|Overall Study|Withdrawal by Subject|0|||
38082453|NCT02770170|69781349|FG003|Overall Study|Withdrawal by Subject|2|||
38082454|NCT02770170|69781346|FG000|Overall Study|due to pregnancy|1|||
38082455|NCT02770170|69781347|FG001|Overall Study|due to pregnancy|0|||
38082456|NCT02770170|69781348|FG002|Overall Study|due to pregnancy|0|||
38082457|NCT02770170|69781349|FG003|Overall Study|due to pregnancy|0|||
38082458|NCT02770170|69781346|FG000|Overall Study|Lack of Efficacy|2|||
38082459|NCT02770170|69781347|FG001|Overall Study|Lack of Efficacy|0|||
38082460|NCT02770170|69781348|FG002|Overall Study|Lack of Efficacy|0|||
38082461|NCT02770170|69781349|FG003|Overall Study|Lack of Efficacy|1|||
38082462|NCT02770170|69781346|FG000|Overall Study|Adverse Event|4|||
38082463|NCT02770170|69781347|FG001|Overall Study|Adverse Event|3|||
38082464|NCT02770170|69781348|FG002|Overall Study|Adverse Event|5|||
38082465|NCT02770170|69781349|FG003|Overall Study|Adverse Event|3|||
38082466|NCT02770170|69781346|FG000|Overall Study|due to disease worsening|0|||
38082467|NCT02770170|69781347|FG001|Overall Study|due to disease worsening|0|||
37683054|NCT02552147|69158618|FG000|First Intervention (7 Days)|Protocol Violation|1|||
37683055|NCT02552147|69158619|FG001|First Intervention (7 Days)|Protocol Violation|0|||
37683056|NCT02552147|69158618|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
37683057|NCT02552147|69158619|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
37683058|NCT01662635|69158625|FG000|Overall Study|scarce samples for evaluation|30|||
37683059|NCT02534935|69158634|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
37683060|NCT02534935|69158635|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
37683061|NCT02534935|69158636|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
37683062|NCT02534935|69158634|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
37683063|NCT02534935|69158635|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
37683064|NCT02534935|69158636|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
37683065|NCT02534935|69158634|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
37967096|NCT00535236|69653999|FG003|Overall Study|Adverse Event|3|||
38082468|NCT02770170|69781348|FG002|Overall Study|due to disease worsening|0|||
38082469|NCT02770170|69781349|FG003|Overall Study|due to disease worsening|1|||
38082470|NCT02769858|69781359|FG000|Overall Study|Withdrawal by Subject|2|||
38082471|NCT02769624|69781363|FG000|Overall Study|Lost to Follow-up|0|||
37683066|NCT02534935|69158635|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
38082472|NCT02769624|69781364|FG001|Overall Study|Lost to Follow-up|1|||
38082473|NCT03446768|69781372|FG000|Overall Study|Withdrawal by Subject|0|||
38082474|NCT03446768|69781373|FG001|Overall Study|Withdrawal by Subject|1|||
38082475|NCT02676284|69781379|FG000|Overall Study|Withdrawal by Subject|1|||
38082476|NCT02769312|69781385|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
38082477|NCT02769312|69781386|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
38082478|NCT02769312|69781385|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
38082479|NCT02769312|69781386|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
38082480|NCT02769312|69781385|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
38082481|NCT02769312|69781386|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
38082482|NCT02769312|69781385|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
38082483|NCT02769312|69781386|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
38082484|NCT02769312|69781385|FG000|Follow-up|Lost to Follow-up|1|||
38082485|NCT02769312|69781386|FG001|Follow-up|Lost to Follow-up|1|||
38082486|NCT01673386|69781393|FG000|Overall Study|Study terminated by sponsor|16|||
38082487|NCT01673386|69781394|FG001|Overall Study|Study terminated by sponsor|22|||
38082488|NCT01673386|69781393|FG000|Overall Study|Adverse Event|5|||
38082489|NCT01673386|69781394|FG001|Overall Study|Adverse Event|2|||
38082490|NCT01673386|69781393|FG000|Overall Study|Progressive disease|4|||
38082491|NCT01673386|69781394|FG001|Overall Study|Progressive disease|1|||
38082492|NCT01673386|69781393|FG000|Overall Study|Withdrawal by Subject|0|||
38082493|NCT01673386|69781394|FG001|Overall Study|Withdrawal by Subject|2|||
38082494|NCT00103740|69781402|FG000|Period 1 - Core|Adverse Event|1|||
38082495|NCT00103740|69781403|FG001|Period 1 - Core|Adverse Event|0|||
38082496|NCT00103740|69781402|FG000|Period 1 - Core|Protocol Violation|3|||
38082497|NCT00103740|69781403|FG001|Period 1 - Core|Protocol Violation|2|||
38082498|NCT00103740|69781402|FG000|Period 1 - Core|Patient withdrew consent|3|||
38082499|NCT00103740|69781403|FG001|Period 1 - Core|Patient withdrew consent|2|||
38082500|NCT00103740|69781402|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
38082501|NCT00103740|69781403|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
38082502|NCT00103740|69781402|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
38082503|NCT00103740|69781403|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
38082504|NCT00103740|69781402|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
38082505|NCT00103740|69781403|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
38082506|NCT00103740|69781402|FG000|Period 2 - Extended Observation Period|Death|6|||
38082507|NCT00103740|69781403|FG001|Period 2 - Extended Observation Period|Death|2|||
38082508|NCT00103740|69781402|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
38082509|NCT00103740|69781403|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
38082510|NCT01281644|69781409|FG000|Overall Study|Lost to Follow-up|3|||
38082511|NCT01281644|69781409|FG000|Overall Study|Withdrawal by Subject|2|||
38082512|NCT02869893|69781415|FG000|Overall Study|participant aversion to IV|5|||
38082513|NCT02869893|69781415|FG000|Overall Study|participant fear of MRI scanner|2|||
38082514|NCT02872311|69781439|FG000|Overall Study|Death|2|||
38082515|NCT02872311|69781440|FG001|Overall Study|Death|0|||
38082516|NCT02872311|69781441|FG002|Overall Study|Death|0|||
38082517|NCT02872311|69781442|FG003|Overall Study|Death|0|||
38082518|NCT02872311|69781443|FG004|Overall Study|Death|0|||
38082519|NCT02872311|69781439|FG000|Overall Study|Lost to Follow-up|2|||
38082520|NCT02872311|69781440|FG001|Overall Study|Lost to Follow-up|0|||
38082521|NCT02872311|69781441|FG002|Overall Study|Lost to Follow-up|0|||
37683067|NCT02534935|69158636|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
37683068|NCT02534935|69158634|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
37683069|NCT02534935|69158635|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
37683070|NCT02534935|69158636|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
37683071|NCT02534935|69158634|FG000|Stage 1: 24 Months|Adverse Event|0|||
37683072|NCT02534935|69158635|FG001|Stage 1: 24 Months|Adverse Event|2|||
37683073|NCT02534935|69158636|FG002|Stage 1: 24 Months|Adverse Event|0|||
37683074|NCT02534935|69158634|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
37683075|NCT02534935|69158635|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
37683076|NCT02534935|69158636|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
37683077|NCT02534935|69158634|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
37683078|NCT02534935|69158635|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
37683079|NCT02534935|69158636|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
37683080|NCT02544451|69158665|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
37683081|NCT02544451|69158666|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
37683082|NCT02544451|69158667|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
37683083|NCT02544451|69158668|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
37683084|NCT02544451|69158665|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
37683085|NCT02544451|69158666|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
37683086|NCT02544451|69158667|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
38082522|NCT02872311|69781442|FG003|Overall Study|Lost to Follow-up|0|||
38082523|NCT02872311|69781443|FG004|Overall Study|Lost to Follow-up|0|||
37683087|NCT02544451|69158668|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
37683088|NCT02544451|69158665|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
37683089|NCT02544451|69158666|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
38082524|NCT02872311|69781439|FG000|Overall Study|Protocol Violation|0|||
38082525|NCT02872311|69781440|FG001|Overall Study|Protocol Violation|2|||
38082526|NCT02872311|69781441|FG002|Overall Study|Protocol Violation|1|||
38082527|NCT02872311|69781442|FG003|Overall Study|Protocol Violation|0|||
38082528|NCT02872311|69781443|FG004|Overall Study|Protocol Violation|0|||
38082529|NCT02871375|69781471|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
38082530|NCT02871375|69781472|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
38082531|NCT02867709|69781483|FG000|Treatment Period|Adverse Event|1|||
38082532|NCT02867709|69781484|FG001|Treatment Period|Adverse Event|1|||
38082533|NCT02867709|69781485|FG002|Treatment Period|Adverse Event|2|||
38082534|NCT02867709|69781483|FG000|Treatment Period|Withdrawal of Consent|7|||
38082535|NCT02867709|69781484|FG001|Treatment Period|Withdrawal of Consent|9|||
38082536|NCT02867709|69781485|FG002|Treatment Period|Withdrawal of Consent|8|||
38082537|NCT02867709|69781483|FG000|Treatment Period|Lost to Follow-up|17|||
38082538|NCT02867709|69781484|FG001|Treatment Period|Lost to Follow-up|20|||
38082539|NCT02867709|69781485|FG002|Treatment Period|Lost to Follow-up|20|||
38082540|NCT02867709|69781483|FG000|Treatment Period|Lack of Qualifying Event|42|||
38082541|NCT02867709|69781484|FG001|Treatment Period|Lack of Qualifying Event|55|||
38082542|NCT02867709|69781485|FG002|Treatment Period|Lack of Qualifying Event|42|||
38082543|NCT02867709|69781483|FG000|Treatment Period|Protocol Violation|3|||
38082544|NCT02867709|69781484|FG001|Treatment Period|Protocol Violation|2|||
38082545|NCT02867709|69781485|FG002|Treatment Period|Protocol Violation|3|||
38082546|NCT02867709|69781483|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
38082547|NCT02867709|69781484|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
38082548|NCT02867709|69781485|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
38082549|NCT02867709|69781483|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
38082550|NCT02867709|69781484|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
38082551|NCT02867709|69781485|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
38082552|NCT02867709|69781483|FG000|Safety Follow-up Period|Pregnancy|0|||
38082553|NCT02867709|69781484|FG001|Safety Follow-up Period|Pregnancy|1|||
38082554|NCT02867709|69781485|FG002|Safety Follow-up Period|Pregnancy|0|||
38082555|NCT02867709|69781483|FG000|Safety Follow-up Period|Protocol Violation|0|||
38082556|NCT02867709|69781484|FG001|Safety Follow-up Period|Protocol Violation|1|||
38082557|NCT02867709|69781485|FG002|Safety Follow-up Period|Protocol Violation|1|||
38082558|NCT03044353|69781496|FG000|Overall Study|Adverse Event|0|||
38082559|NCT03044353|69781497|FG001|Overall Study|Adverse Event|1|||
38082560|NCT03044353|69781498|FG002|Overall Study|Adverse Event|0|||
38082561|NCT01361308|69781507|FG000|Overall Study|Withdrawal by Subject|9|||
38082562|NCT01361308|69781508|FG001|Overall Study|Withdrawal by Subject|13|||
38082563|NCT01361308|69781507|FG000|Overall Study|Physician Decision|3|||
38082564|NCT01361308|69781508|FG001|Overall Study|Physician Decision|3|||
38082565|NCT01361308|69781507|FG000|Overall Study|Lack of Efficacy|2|||
38082566|NCT01361308|69781508|FG001|Overall Study|Lack of Efficacy|0|||
38082567|NCT01361308|69781507|FG000|Overall Study|Protocol Violation|1|||
38082568|NCT01361308|69781508|FG001|Overall Study|Protocol Violation|0|||
38082569|NCT01361308|69781507|FG000|Overall Study|Lost to Follow-up|5|||
38082570|NCT01361308|69781508|FG001|Overall Study|Lost to Follow-up|4|||
38082571|NCT01361308|69781507|FG000|Overall Study|Adverse Event|8|||
38082572|NCT01361308|69781508|FG001|Overall Study|Adverse Event|4|||
38082573|NCT01361308|69781507|FG000|Overall Study|Eligibility Criteria Not Met|2|||
38082574|NCT01361308|69781508|FG001|Overall Study|Eligibility Criteria Not Met|3|||
38082575|NCT01361308|69781507|FG000|Overall Study|Failed C-SSRS|5|||
38082576|NCT01361308|69781508|FG001|Overall Study|Failed C-SSRS|2|||
38082577|NCT01361308|69781507|FG000|Overall Study|Other|0|||
38082578|NCT01361308|69781508|FG001|Overall Study|Other|1|||
38082579|NCT02872935|69781520|FG000|Overall Study|Other|0|||
38082580|NCT02872935|69781521|FG001|Overall Study|Other|1|||
38082581|NCT00103662|69781529|FG000|Overall Study|Entered Rescue Procedure|0|||
38082582|NCT00103662|69781530|FG001|Overall Study|Entered Rescue Procedure|7|||
38082583|NCT00103662|69781529|FG000|Overall Study|Death|7|||
38082584|NCT00103662|69781530|FG001|Overall Study|Death|7|||
38082585|NCT00103662|69781529|FG000|Overall Study|Elective Withdrawal|5|||
38082586|NCT00103662|69781530|FG001|Overall Study|Elective Withdrawal|5|||
38082587|NCT00103662|69781529|FG000|Overall Study|Lost to Follow-up|0|||
37683090|NCT02544451|69158667|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
37683091|NCT02544451|69158668|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
37683092|NCT02544451|69158665|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
37683093|NCT02544451|69158666|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
37683094|NCT02544451|69158667|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
37683095|NCT02544451|69158668|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
37683096|NCT02544451|69158665|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
38082588|NCT00103662|69781530|FG001|Overall Study|Lost to Follow-up|1|||
38082589|NCT00103662|69781529|FG000|Overall Study|Other|6|||
38082590|NCT00103662|69781530|FG001|Overall Study|Other|9|||
38082591|NCT00103662|69781529|FG000|Overall Study|Failed mobilization|0|||
37683097|NCT02544451|69158666|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
38082592|NCT00103662|69781530|FG001|Overall Study|Failed mobilization|4|||
38082593|NCT00103662|69781529|FG000|Overall Study|Intercurrent illness|1|||
38082594|NCT00103662|69781530|FG001|Overall Study|Intercurrent illness|0|||
38082595|NCT02865915|69781538|FG000|Overall Study|Pregnancy|1|||
38082596|NCT02865915|69781539|FG001|Overall Study|Pregnancy|0|||
38082597|NCT02865915|69781538|FG000|Overall Study|Withdrawal by Subject|1|||
38082598|NCT02865915|69781539|FG001|Overall Study|Withdrawal by Subject|1|||
38082599|NCT02865915|69781538|FG000|Overall Study|Adverse Event|0|||
38082600|NCT02865915|69781539|FG001|Overall Study|Adverse Event|4|||
38082601|NCT02865915|69781538|FG000|Overall Study|Lost to Follow-up|0|||
38082602|NCT02865915|69781539|FG001|Overall Study|Lost to Follow-up|1|||
38082603|NCT02865915|69781538|FG000|Overall Study|Protocol Violation|0|||
38082604|NCT02865915|69781539|FG001|Overall Study|Protocol Violation|1|||
38082605|NCT02865915|69781538|FG000|Overall Study|Study terminated by sponsor|23|||
38082606|NCT02865915|69781539|FG001|Overall Study|Study terminated by sponsor|18|||
38082607|NCT02865915|69781538|FG000|Overall Study|Dosing group discontinued|0|||
38082608|NCT02865915|69781539|FG001|Overall Study|Dosing group discontinued|5|||
38082609|NCT00104676|69781547|FG000|Overall Study|Death|3|||
38082610|NCT00104676|69781548|FG001|Overall Study|Death|2|||
38082611|NCT00104676|69781547|FG000|Overall Study|Withdrawal by Subject|0|||
38082612|NCT00104676|69781548|FG001|Overall Study|Withdrawal by Subject|2|||
38082613|NCT00104676|69781547|FG000|Overall Study|treatment interruption|4|||
38082614|NCT00104676|69781548|FG001|Overall Study|treatment interruption|10|||
38082615|NCT00354835|69781556|FG000|Overall Study|Death|1|||
38082616|NCT00354835|69781557|FG001|Overall Study|Death|1|||
38082617|NCT00354835|69781556|FG000|Overall Study|Physician Decision|8|||
38082618|NCT00354835|69781557|FG001|Overall Study|Physician Decision|13|||
38082619|NCT00354835|69781556|FG000|Overall Study|Withdrawal by Subject|2|||
38082620|NCT00354835|69781557|FG001|Overall Study|Withdrawal by Subject|1|||
38082621|NCT00354835|69781556|FG000|Overall Study|Ineligible|17|||
38082622|NCT00354835|69781557|FG001|Overall Study|Ineligible|16|||
38082623|NCT00354835|69781556|FG000|Overall Study|Disease progression or relapse|15|||
38082624|NCT00354835|69781557|FG001|Overall Study|Disease progression or relapse|22|||
38082625|NCT00354835|69781556|FG000|Overall Study|Adverse Event|6|||
38082626|NCT00354835|69781557|FG001|Overall Study|Adverse Event|0|||
38082627|NCT00354835|69781556|FG000|Overall Study|Refusal of further therapy|3|||
38082628|NCT00354835|69781557|FG001|Overall Study|Refusal of further therapy|8|||
38082629|NCT02768298|69781580|FG000|Overall Study|Adverse Event|1|||
38082630|NCT02768298|69781581|FG001|Overall Study|Adverse Event|4|||
38082631|NCT02768298|69781580|FG000|Overall Study|Death|2|||
38082632|NCT02768298|69781581|FG001|Overall Study|Death|1|||
38082633|NCT02768298|69781580|FG000|Overall Study|Non-compliance with study treatment|0|||
38082634|NCT02768298|69781581|FG001|Overall Study|Non-compliance with study treatment|1|||
38082635|NCT02768298|69781580|FG000|Overall Study|Subject/guardian decision|1|||
38082636|NCT02768298|69781581|FG001|Overall Study|Subject/guardian decision|0|||
38082637|NCT02768298|69781580|FG000|Overall Study|Withdrawal of informed consent|0|||
38082638|NCT02768298|69781581|FG001|Overall Study|Withdrawal of informed consent|1|||
38082639|NCT02775864|69781591|FG000|Overall Study|Data ended end of 2010|1764|||
38082640|NCT02775864|69781592|FG001|Overall Study|Data ended end of 2010|2880|||
38082641|NCT02775864|69781593|FG002|Overall Study|Data ended end of 2010|1140|||
38082642|NCT02775864|69781594|FG003|Overall Study|Data ended end of 2010|1194|||
38082643|NCT02775864|69781591|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
38082644|NCT02775864|69781592|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
38082645|NCT02775864|69781593|FG002|Overall Study|Medicaid eligibility discontinued|720|||
38082646|NCT02775864|69781594|FG003|Overall Study|Medicaid eligibility discontinued|890|||
38082647|NCT02964273|69781607|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
38082648|NCT02964273|69781608|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
38082649|NCT02964273|69781609|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
38082650|NCT02964273|69781610|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
38082651|NCT02964273|69781607|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
38082652|NCT02964273|69781608|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
38082653|NCT02964273|69781609|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
37683098|NCT02544451|69158667|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
38082654|NCT02964273|69781610|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
38082655|NCT02964273|69781607|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
38082656|NCT02964273|69781608|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
37967097|NCT00535236|69654000|FG004|Overall Study|Adverse Event|3|||
38082657|NCT02964273|69781609|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
38082658|NCT02964273|69781610|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
38082659|NCT02964273|69781607|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
38082660|NCT02964273|69781608|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
38082661|NCT02964273|69781609|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
38082662|NCT02964273|69781610|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
38082663|NCT02964273|69781607|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
38082664|NCT02964273|69781608|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
38082665|NCT02964273|69781609|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
38082666|NCT02964273|69781610|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
38082667|NCT02964273|69781607|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
38082668|NCT02964273|69781608|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
38082669|NCT02964273|69781609|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
38082670|NCT02964273|69781610|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
38082671|NCT02773446|69781629|FG000|First Admission|Withdrawal by Subject|0|||
38082672|NCT02773446|69781630|FG001|First Admission|Withdrawal by Subject|0|||
38082673|NCT02773446|69781631|FG002|First Admission|Withdrawal by Subject|0|||
38082674|NCT02773446|69781632|FG003|First Admission|Withdrawal by Subject|1|||
38082675|NCT02773446|69781633|FG004|First Admission|Withdrawal by Subject|0|||
38082676|NCT02773446|69781634|FG005|First Admission|Withdrawal by Subject|0|||
38082677|NCT02773446|69781629|FG000|First Admission|Lost to Follow-up|1|||
38082678|NCT02773446|69781630|FG001|First Admission|Lost to Follow-up|0|||
38082679|NCT02773446|69781631|FG002|First Admission|Lost to Follow-up|0|||
38082680|NCT02773446|69781632|FG003|First Admission|Lost to Follow-up|0|||
38082681|NCT02773446|69781633|FG004|First Admission|Lost to Follow-up|0|||
38082682|NCT02773446|69781634|FG005|First Admission|Lost to Follow-up|0|||
38082683|NCT02773368|69781653|FG000|Overall Study|Lost to Follow-up|4|||
38082684|NCT02773368|69781654|FG001|Overall Study|Lost to Follow-up|1|||
38082685|NCT02773368|69781653|FG000|Overall Study|Withdrawal by Subject|5|||
38082686|NCT02773368|69781654|FG001|Overall Study|Withdrawal by Subject|1|||
38082687|NCT02773368|69781653|FG000|Overall Study|Unclassified|1|||
38082688|NCT02773368|69781654|FG001|Overall Study|Unclassified|1|||
38082689|NCT02773368|69781653|FG000|Overall Study|Missing|0|||
38082690|NCT02773368|69781654|FG001|Overall Study|Missing|1|||
38082691|NCT01336647|69781663|FG000|Overall Study|Lost to Follow-up|4|||
38082692|NCT01336647|69781664|FG001|Overall Study|Lost to Follow-up|1|||
38082693|NCT01336647|69781665|FG002|Overall Study|Lost to Follow-up|3|||
38082694|NCT01336569|69781675|FG000|Overall Study|Lost to Follow-up|4|||
38082695|NCT02772978|69781679|FG000|Overall Study|Withdrawal by Subject|1|||
38082696|NCT02772978|69781680|FG001|Overall Study|Withdrawal by Subject|1|||
38082697|NCT00104052|69781685|FG000|Overall Study|Adverse Event|1|||
38082698|NCT00104052|69781685|FG000|Overall Study|Lack of Efficacy|26|||
38082699|NCT00104052|69781685|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
38082700|NCT02777970|69781692|FG000|Overall Study|Lost to Follow-up|0|||
38082701|NCT02777970|69781693|FG001|Overall Study|Lost to Follow-up|1|||
38082702|NCT02777970|69781694|FG002|Overall Study|Lost to Follow-up|0|||
38082703|NCT02777970|69781692|FG000|Overall Study|Protocol Violation|1|||
38082704|NCT02777970|69781693|FG001|Overall Study|Protocol Violation|0|||
38082705|NCT02777970|69781694|FG002|Overall Study|Protocol Violation|0|||
38082706|NCT03037489|69781706|FG000|Overall Study|Adverse Event|4|||
38082707|NCT03037489|69781707|FG001|Overall Study|Adverse Event|0|||
38082708|NCT03037489|69781706|FG000|Overall Study|Withdrawal by Subject|3|||
38082709|NCT03037489|69781707|FG001|Overall Study|Withdrawal by Subject|0|||
38082710|NCT01336023|69781716|FG000|Week 0 to Week 26|Adverse Event|8|||
38082711|NCT01336023|69781717|FG001|Week 0 to Week 26|Adverse Event|10|||
38082712|NCT01336023|69781718|FG002|Week 0 to Week 26|Adverse Event|24|||
38082713|NCT01336023|69781716|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
38082714|NCT01336023|69781717|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
38082715|NCT01336023|69781718|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
38082716|NCT01336023|69781716|FG000|Week 0 to Week 26|Protocol Violation|1|||
38082717|NCT01336023|69781717|FG001|Week 0 to Week 26|Protocol Violation|2|||
38082718|NCT01336023|69781718|FG002|Week 0 to Week 26|Protocol Violation|0|||
38082719|NCT01336023|69781716|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
38082720|NCT01336023|69781717|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
38082721|NCT01336023|69781718|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
38082722|NCT01336023|69781716|FG000|Week 0 to Week 26|Unclassified|5|||
38082723|NCT01336023|69781717|FG001|Week 0 to Week 26|Unclassified|16|||
38082724|NCT01336023|69781718|FG002|Week 0 to Week 26|Unclassified|9|||
38082725|NCT01336023|69781716|FG000|Week 27 to 52|Adverse Event|1|||
38082726|NCT01336023|69781717|FG001|Week 27 to 52|Adverse Event|5|||
38082727|NCT01336023|69781718|FG002|Week 27 to 52|Adverse Event|2|||
38082728|NCT01336023|69781716|FG000|Week 27 to 52|Protocol Violation|0|||
38082729|NCT01336023|69781717|FG001|Week 27 to 52|Protocol Violation|2|||
38082730|NCT01336023|69781718|FG002|Week 27 to 52|Protocol Violation|1|||
38082731|NCT01336023|69781716|FG000|Week 27 to 52|Withdrawal Criteria|14|||
38082732|NCT01336023|69781717|FG001|Week 27 to 52|Withdrawal Criteria|19|||
38082733|NCT01336023|69781718|FG002|Week 27 to 52|Withdrawal Criteria|16|||
38082734|NCT01336023|69781716|FG000|Week 27 to 52|Unclassified|13|||
38082735|NCT01336023|69781717|FG001|Week 27 to 52|Unclassified|18|||
38082736|NCT01336023|69781718|FG002|Week 27 to 52|Unclassified|9|||
38082737|NCT03039283|69781726|FG000|Overall Study|Protocol Violation|2|||
38082738|NCT02863575|69781748|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
38082739|NCT02863575|69781749|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
38082740|NCT02863575|69781750|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
38082741|NCT02863575|69781748|FG000|Overall Study|Withdrawal by Subject|0|||
38082742|NCT02863575|69781749|FG001|Overall Study|Withdrawal by Subject|1|||
38082743|NCT02863575|69781750|FG002|Overall Study|Withdrawal by Subject|1|||
38082744|NCT02863575|69781748|FG000|Overall Study|Adverse Event|0|||
38082745|NCT02863575|69781749|FG001|Overall Study|Adverse Event|1|||
38082746|NCT02863575|69781750|FG002|Overall Study|Adverse Event|0|||
38082747|NCT01227187|69781762|FG000|Overall Study|Physician Decision|0|||
38082748|NCT01227187|69781763|FG001|Overall Study|Physician Decision|0|||
38082749|NCT01227187|69781764|FG002|Overall Study|Physician Decision|0|||
38082750|NCT01227187|69781765|FG003|Overall Study|Physician Decision|1|||
38082751|NCT02638012|69781786|FG000|Overall Study|Lost to Follow-up|1|||
38082752|NCT00103506|69781792|FG000|Overall Study|Study closed by sponsor|34|||
38082753|NCT00103506|69781793|FG001|Overall Study|Study closed by sponsor|37|||
38082754|NCT00103506|69781792|FG000|Overall Study|Death|257|||
38082755|NCT00103506|69781793|FG001|Overall Study|Death|253|||
38082756|NCT00103506|69781792|FG000|Overall Study|Lost to Follow-up|13|||
38082757|NCT00103506|69781793|FG001|Overall Study|Lost to Follow-up|13|||
37683099|NCT02544451|69158668|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
37683100|NCT02544451|69158665|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
37683101|NCT02544451|69158666|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
37683102|NCT02544451|69158667|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
37683103|NCT02544451|69158668|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
37683104|NCT02544373|69158688|FG000|Overall Study|Lost to Follow-up|5|||
37683105|NCT02544373|69158689|FG001|Overall Study|Lost to Follow-up|3|||
37683106|NCT02544373|69158688|FG000|Overall Study|Withdrawal by Subject|8|||
37683107|NCT02544373|69158689|FG001|Overall Study|Withdrawal by Subject|2|||
37683108|NCT02551991|69158701|FG000|Overall Study|Death|5|||
37683109|NCT02551991|69158702|FG001|Overall Study|Death|7|||
37683110|NCT02551991|69158703|FG002|Overall Study|Death|8|||
37683111|NCT02551991|69158704|FG003|Overall Study|Death|7|||
37683112|NCT02551991|69158705|FG004|Overall Study|Death|17|||
37683113|NCT02551991|69158701|FG000|Overall Study|Withdrawal by Subject|1|||
37683114|NCT02551991|69158702|FG001|Overall Study|Withdrawal by Subject|0|||
37683115|NCT02551991|69158703|FG002|Overall Study|Withdrawal by Subject|0|||
37683116|NCT02551991|69158704|FG003|Overall Study|Withdrawal by Subject|0|||
37683117|NCT02551991|69158705|FG004|Overall Study|Withdrawal by Subject|2|||
37683118|NCT02551991|69158701|FG000|Overall Study|Lost to Follow-up|0|||
37683119|NCT02551991|69158702|FG001|Overall Study|Lost to Follow-up|0|||
37683120|NCT02551991|69158703|FG002|Overall Study|Lost to Follow-up|1|||
37683121|NCT02551991|69158704|FG003|Overall Study|Lost to Follow-up|0|||
38082758|NCT00103506|69781792|FG000|Overall Study|Withdrawal by Subject|18|||
38082759|NCT00103506|69781793|FG001|Overall Study|Withdrawal by Subject|21|||
38082760|NCT02765490|69781801|FG000|Overall Study|Lost to Follow-up|1|||
38082761|NCT02765490|69781802|FG001|Overall Study|Lost to Follow-up|1|||
38082762|NCT02765490|69781801|FG000|Overall Study|Other|0|||
38082763|NCT02765490|69781802|FG001|Overall Study|Other|1|||
38082764|NCT02765490|69781801|FG000|Overall Study|Death|0|||
38082765|NCT02765490|69781802|FG001|Overall Study|Death|1|||
38082766|NCT02762370|69781810|FG000|Overall Study|Protocol Violation|1|||
38082767|NCT02762370|69781811|FG001|Overall Study|Protocol Violation|0|||
38082768|NCT02639182|69781821|FG000|Overall Study|Disease Progression|50|||
38082769|NCT02639182|69781822|FG001|Overall Study|Disease Progression|49|||
38082770|NCT02639182|69781821|FG000|Overall Study|Adverse Event|7|||
38082771|NCT02639182|69781822|FG001|Overall Study|Adverse Event|5|||
38082772|NCT02639182|69781821|FG000|Overall Study|Physician Decision|3|||
38082773|NCT02639182|69781822|FG001|Overall Study|Physician Decision|3|||
38082774|NCT02639182|69781821|FG000|Overall Study|Withdrew Consent|5|||
38082775|NCT02639182|69781822|FG001|Overall Study|Withdrew Consent|4|||
38082776|NCT02639182|69781821|FG000|Overall Study|Lost to Follow-up|0|||
38082777|NCT02639182|69781822|FG001|Overall Study|Lost to Follow-up|1|||
38082778|NCT02639182|69781821|FG000|Overall Study|Study Closure|1|||
38082779|NCT02639182|69781822|FG001|Overall Study|Study Closure|2|||
38082780|NCT02639182|69781821|FG000|Overall Study|Sponsor Ended Study|0|||
38082781|NCT02639182|69781822|FG001|Overall Study|Sponsor Ended Study|1|||
38082782|NCT02639182|69781821|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
38082783|NCT02639182|69781822|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
38082784|NCT02863419|69781831|FG000|Overall Study|Lost to Follow-up|0|||
38082785|NCT02863419|69781832|FG001|Overall Study|Lost to Follow-up|1|||
37967098|NCT00535236|69654001|FG005|Overall Study|Adverse Event|0|||
37683122|NCT02551991|69158705|FG004|Overall Study|Lost to Follow-up|0|||
37683123|NCT02551991|69158701|FG000|Overall Study|Sponsor Decision|1|||
37683124|NCT02551991|69158702|FG001|Overall Study|Sponsor Decision|0|||
37683125|NCT02551991|69158703|FG002|Overall Study|Sponsor Decision|1|||
37683126|NCT02551991|69158704|FG003|Overall Study|Sponsor Decision|0|||
37683127|NCT02551991|69158705|FG004|Overall Study|Sponsor Decision|5|||
37683128|NCT02551991|69158701|FG000|Overall Study|Other|0|||
37683129|NCT02551991|69158702|FG001|Overall Study|Other|0|||
37683130|NCT02551991|69158703|FG002|Overall Study|Other|0|||
37683131|NCT02551991|69158704|FG003|Overall Study|Other|0|||
37683132|NCT02551991|69158705|FG004|Overall Study|Other|1|||
37683133|NCT01661933|69158718|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
37683134|NCT01661933|69158718|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
37683135|NCT02544217|69158730|FG000|Overall Study|Withdrawal by Subject|1|||
37683136|NCT02544217|69158731|FG001|Overall Study|Withdrawal by Subject|1|||
37967099|NCT00535236|69654002|FG006|Overall Study|Adverse Event|5|||
37967100|NCT00535236|69654003|FG007|Overall Study|Adverse Event|1|||
37967101|NCT00535236|69654004|FG008|Overall Study|Adverse Event|2|||
37967102|NCT00535236|69654005|FG009|Overall Study|Adverse Event|1|||
38082786|NCT02863419|69781833|FG002|Overall Study|Lost to Follow-up|4|||
38082787|NCT02863419|69781831|FG000|Overall Study|Withdrawal by Subject|5|||
37683137|NCT02544217|69158732|FG002|Overall Study|Withdrawal by Subject|0|||
37683138|NCT02544217|69158733|FG003|Overall Study|Withdrawal by Subject|0|||
37683139|NCT02544217|69158734|FG004|Overall Study|Withdrawal by Subject|0|||
37683140|NCT02544217|69158735|FG005|Overall Study|Withdrawal by Subject|0|||
37683141|NCT02533999|69158804|FG000|Overall Study|Lost to Follow-up|3|||
37683142|NCT02533999|69158805|FG001|Overall Study|Lost to Follow-up|5|||
37683143|NCT02533999|69158804|FG000|Overall Study|Protocol Violation|3|||
37683144|NCT02533999|69158805|FG001|Overall Study|Protocol Violation|0|||
38082788|NCT02863419|69781832|FG001|Overall Study|Withdrawal by Subject|5|||
37683145|NCT02533999|69158804|FG000|Overall Study|Adverse Event|0|||
37683146|NCT02533999|69158805|FG001|Overall Study|Adverse Event|1|||
37967103|NCT00535236|69653996|FG000|Overall Study|Lost to Follow-up|1|||
38082789|NCT02863419|69781833|FG002|Overall Study|Withdrawal by Subject|3|||
38082790|NCT02863419|69781831|FG000|Overall Study|Died|3|||
38082791|NCT02863419|69781832|FG001|Overall Study|Died|4|||
38082792|NCT02863419|69781833|FG002|Overall Study|Died|1|||
38082793|NCT02765100|69781843|FG000|Overall Study|subject found ineligible after baseline|1|||
38082794|NCT02765100|69781844|FG001|Overall Study|subject found ineligible after baseline|1|||
38082795|NCT02765100|69781843|FG000|Overall Study|Lost to Follow-up|0|||
38082796|NCT02765100|69781844|FG001|Overall Study|Lost to Follow-up|1|||
38082797|NCT02761980|69781854|FG000|Overall Study|Adverse Event|4|||
38082798|NCT02761980|69781855|FG001|Overall Study|Adverse Event|6|||
38082799|NCT02761980|69781856|FG002|Overall Study|Adverse Event|5|||
38082800|NCT02761980|69781857|FG003|Overall Study|Adverse Event|6|||
38082801|NCT02761980|69781854|FG000|Overall Study|Withdrawal by Subject|0|||
38082802|NCT02761980|69781855|FG001|Overall Study|Withdrawal by Subject|1|||
38082803|NCT02761980|69781856|FG002|Overall Study|Withdrawal by Subject|0|||
38082804|NCT02761980|69781857|FG003|Overall Study|Withdrawal by Subject|0|||
38082805|NCT02761980|69781854|FG000|Overall Study|Other|0|||
38082806|NCT02761980|69781855|FG001|Overall Study|Other|0|||
38082807|NCT02761980|69781856|FG002|Overall Study|Other|1|||
38082808|NCT02761980|69781857|FG003|Overall Study|Other|0|||
38082809|NCT02862171|69781876|FG000|Overall Study|Death|1|||
38082810|NCT02862171|69781876|FG000|Overall Study|Lost to Follow-up|13|||
38082811|NCT02862171|69781876|FG000|Overall Study|Withdrawal by Subject|57|||
38082812|NCT02862171|69781876|FG000|Overall Study|Non-compliance|4|||
38082813|NCT02862171|69781876|FG000|Overall Study|HIV-1 seroconversion|18|||
38082814|NCT02638948|69781884|FG000|Overall Study|Withdrawal by Subject|4|||
38082815|NCT02638948|69781885|FG001|Overall Study|Withdrawal by Subject|5|||
38082816|NCT02638948|69781886|FG002|Overall Study|Withdrawal by Subject|3|||
38082817|NCT02638948|69781887|FG003|Overall Study|Withdrawal by Subject|1|||
38082818|NCT02638948|69781884|FG000|Overall Study|Administrative Reason by Sponsor|0|||
38082819|NCT02638948|69781885|FG001|Overall Study|Administrative Reason by Sponsor|1|||
38082820|NCT02638948|69781886|FG002|Overall Study|Administrative Reason by Sponsor|0|||
38082821|NCT02638948|69781887|FG003|Overall Study|Administrative Reason by Sponsor|4|||
38082822|NCT02638948|69781884|FG000|Overall Study|Adverse Event|0|||
38082823|NCT02638948|69781885|FG001|Overall Study|Adverse Event|0|||
38082824|NCT02638948|69781886|FG002|Overall Study|Adverse Event|1|||
38082825|NCT02638948|69781887|FG003|Overall Study|Adverse Event|1|||
38082826|NCT02638948|69781884|FG000|Overall Study|Lack of Efficacy|1|||
38082827|NCT02638948|69781885|FG001|Overall Study|Lack of Efficacy|1|||
38082828|NCT02638948|69781886|FG002|Overall Study|Lack of Efficacy|0|||
38082829|NCT02638948|69781887|FG003|Overall Study|Lack of Efficacy|0|||
38082830|NCT02638948|69781884|FG000|Overall Study|Lost to Follow-up|0|||
38082831|NCT02638948|69781885|FG001|Overall Study|Lost to Follow-up|0|||
38082832|NCT02638948|69781886|FG002|Overall Study|Lost to Follow-up|1|||
38082833|NCT02638948|69781887|FG003|Overall Study|Lost to Follow-up|1|||
38082834|NCT02638948|69781884|FG000|Overall Study|Poor/Non-Compliance|0|||
38082835|NCT02638948|69781885|FG001|Overall Study|Poor/Non-Compliance|2|||
38082836|NCT02638948|69781886|FG002|Overall Study|Poor/Non-Compliance|1|||
38082837|NCT02638948|69781887|FG003|Overall Study|Poor/Non-Compliance|0|||
38082838|NCT02638948|69781884|FG000|Overall Study|Participant no longer met study criteria|0|||
38082839|NCT02638948|69781885|FG001|Overall Study|Participant no longer met study criteria|1|||
38082840|NCT02638948|69781886|FG002|Overall Study|Participant no longer met study criteria|0|||
38082841|NCT02638948|69781887|FG003|Overall Study|Participant no longer met study criteria|0|||
38082842|NCT02638948|69781884|FG000|Overall Study|Other than specified above|4|||
38082843|NCT02638948|69781885|FG001|Overall Study|Other than specified above|1|||
38082844|NCT02638948|69781886|FG002|Overall Study|Other than specified above|1|||
38082845|NCT02638948|69781887|FG003|Overall Study|Other than specified above|1|||
38082846|NCT00102960|69781903|FG000|Overall Study|Death|23|||
38082847|NCT00102960|69781904|FG001|Overall Study|Death|11|||
38082848|NCT00102960|69781905|FG002|Overall Study|Death|11|||
38082849|NCT00102960|69781903|FG000|Overall Study|Lost to Follow-up|6|||
38082850|NCT00102960|69781904|FG001|Overall Study|Lost to Follow-up|12|||
38082851|NCT00102960|69781905|FG002|Overall Study|Lost to Follow-up|16|||
38082852|NCT00102960|69781903|FG000|Overall Study|Withdrawal by Subject|1|||
38082853|NCT00102960|69781904|FG001|Overall Study|Withdrawal by Subject|0|||
38082854|NCT00102960|69781905|FG002|Overall Study|Withdrawal by Subject|1|||
37862976|NCT01263509|69546921|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
38082855|NCT02858895|69781917|FG000|Overall Study|Disease progression|31|||
38082856|NCT02858895|69781917|FG000|Overall Study|Death|2|||
38082857|NCT02858895|69781917|FG000|Overall Study|Adverse Event|1|||
38082858|NCT02858895|69781917|FG000|Overall Study|Withdrawal by Subject|3|||
38082859|NCT02858895|69781917|FG000|Overall Study|hospice,|1|||
38082860|NCT02858895|69781917|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
38082861|NCT02637856|69781928|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
38082862|NCT02637856|69781929|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
38082863|NCT02637856|69781928|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
38082864|NCT02637856|69781929|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
38082865|NCT02637856|69781928|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
38082866|NCT02637856|69781929|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
38082867|NCT02637856|69781928|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
38082868|NCT02637856|69781929|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
38082869|NCT02637856|69781928|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
38082870|NCT02637856|69781929|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
38082871|NCT02637856|69781928|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
38082872|NCT02637856|69781929|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
38082873|NCT02637856|69781928|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
38082874|NCT02637856|69781929|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
38082875|NCT02637856|69781928|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
38082876|NCT02637856|69781929|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
38082877|NCT02637856|69781928|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
38082878|NCT02637856|69781929|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
38082879|NCT02637856|69781928|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
38082880|NCT02637856|69781929|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
38082881|NCT02637856|69781928|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
38082882|NCT02637856|69781929|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
38082883|NCT02637856|69781928|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
38082884|NCT02637856|69781929|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
38082885|NCT02637856|69781928|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
38082886|NCT02637856|69781929|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
38082887|NCT02858037|69781935|FG000|Overall Study|Death|1|||
38082888|NCT02858037|69781935|FG000|Overall Study|Withdrawal by Subject|18|||
38082889|NCT02858037|69781935|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
38082890|NCT02858037|69781935|FG000|Overall Study|Lost to Follow-up|3|||
38082891|NCT02858037|69781935|FG000|Overall Study|Other|4|||
38082892|NCT02856555|69781942|FG000|Overall Study|Adverse Event|1|||
38082893|NCT02856555|69781943|FG001|Overall Study|Adverse Event|0|||
38082894|NCT02856555|69781944|FG002|Overall Study|Adverse Event|0|||
38082895|NCT02856555|69781942|FG000|Overall Study|Lost to Follow-up|1|||
38082896|NCT02856555|69781943|FG001|Overall Study|Lost to Follow-up|3|||
38082897|NCT02856555|69781944|FG002|Overall Study|Lost to Follow-up|0|||
38082898|NCT02856555|69781942|FG000|Overall Study|Withdrawal by Subject|3|||
38082899|NCT02856555|69781943|FG001|Overall Study|Withdrawal by Subject|0|||
38082900|NCT02856555|69781944|FG002|Overall Study|Withdrawal by Subject|0|||
38082901|NCT02856555|69781942|FG000|Overall Study|Randomized but Never Treated|0|||
38082902|NCT02856555|69781943|FG001|Overall Study|Randomized but Never Treated|1|||
38082903|NCT02856555|69781944|FG002|Overall Study|Randomized but Never Treated|0|||
38082904|NCT02637232|69781982|FG000|Overall Study|Lost to Follow-up|42|||
38082905|NCT02637232|69781982|FG000|Overall Study|Adverse Event|11|||
38082906|NCT02637232|69781982|FG000|Overall Study|patient 's decision|2|||
38082907|NCT02855541|69781986|FG000|Overall Study|Change in health status|2|||
38082908|NCT02855541|69781986|FG000|Overall Study|Withdrawal by Subject|2|||
38082909|NCT02635984|69781992|FG000|Overall Study|Lost to Follow-up|2|||
38082910|NCT02635984|69781993|FG001|Overall Study|Lost to Follow-up|4|||
38082911|NCT02635984|69781992|FG000|Overall Study|Study Arm Closed|1|||
38082912|NCT02635984|69781993|FG001|Overall Study|Study Arm Closed|0|||
38082913|NCT01147653|69782001|FG000|Year 2|Withdrawal by Subject|2|||
38082914|NCT01147653|69782002|FG001|Year 2|Withdrawal by Subject|3|||
38082915|NCT02747043|69782023|FG000|Overall Study|Other|1|||
38082916|NCT02747043|69782024|FG001|Overall Study|Other|1|||
38082917|NCT02747043|69782023|FG000|Overall Study|Adverse Event|3|||
38082918|NCT02747043|69782024|FG001|Overall Study|Adverse Event|1|||
38082919|NCT02747043|69782023|FG000|Overall Study|Withdrawal by Subject|1|||
38082920|NCT02747043|69782024|FG001|Overall Study|Withdrawal by Subject|1|||
38082921|NCT02747043|69782023|FG000|Overall Study|Physician Decision|1|||
38082922|NCT02747043|69782024|FG001|Overall Study|Physician Decision|1|||
38082923|NCT02747043|69782023|FG000|Overall Study|Protocol Violation|0|||
38082924|NCT02747043|69782024|FG001|Overall Study|Protocol Violation|1|||
38082925|NCT02747043|69782023|FG000|Overall Study|Disease progression|4|||
38082926|NCT02747043|69782024|FG001|Overall Study|Disease progression|0|||
38082927|NCT02637076|69782032|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
38082928|NCT02637076|69782033|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
38082929|NCT02637076|69782032|FG000|Overall Study|Withdrawal by Subject|0|||
38082930|NCT02637076|69782033|FG001|Overall Study|Withdrawal by Subject|4|||
38082931|NCT02854605|69782042|FG000|Overall Study|Adverse Event|1|||
38082932|NCT02854605|69782043|FG001|Overall Study|Adverse Event|5|||
38082933|NCT02854605|69782044|FG002|Overall Study|Adverse Event|2|||
38082934|NCT02854605|69782042|FG000|Overall Study|Lost to Follow-up|0|||
38082935|NCT02854605|69782043|FG001|Overall Study|Lost to Follow-up|2|||
38082936|NCT02854605|69782044|FG002|Overall Study|Lost to Follow-up|0|||
38082937|NCT02854605|69782042|FG000|Overall Study|Withdrew Consent|1|||
38082938|NCT02854605|69782043|FG001|Overall Study|Withdrew Consent|0|||
38082939|NCT02854605|69782044|FG002|Overall Study|Withdrew Consent|1|||
38082940|NCT02854605|69782042|FG000|Overall Study|Investigator's Discretion|1|||
38082941|NCT02854605|69782043|FG001|Overall Study|Investigator's Discretion|0|||
38082942|NCT02854605|69782044|FG002|Overall Study|Investigator's Discretion|0|||
38082943|NCT02854605|69782042|FG000|Overall Study|Protocol Violation|0|||
38082944|NCT02854605|69782043|FG001|Overall Study|Protocol Violation|0|||
38082945|NCT02854605|69782044|FG002|Overall Study|Protocol Violation|1|||
38082946|NCT02853435|69782067|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
38082947|NCT02853435|69782068|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
38082948|NCT02853435|69782069|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
38082949|NCT02853435|69782070|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
38082950|NCT02853435|69782071|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
38082951|NCT02853435|69782072|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
38082952|NCT02635204|69782104|FG000|Overall Study|Adverse Event|1|||
38082953|NCT02635204|69782105|FG001|Overall Study|Adverse Event|0|||
38082954|NCT02635204|69782104|FG000|Overall Study|Lost to Follow-up|1|||
38082955|NCT02635204|69782105|FG001|Overall Study|Lost to Follow-up|1|||
38082956|NCT00102804|69782113|FG000|Overall Study|Progressive Disease (PD)|307|||
38082957|NCT00102804|69782114|FG001|Overall Study|Progressive Disease (PD)|196|||
38082958|NCT00102804|69782113|FG000|Overall Study|Withdrawal by Subject|46|||
38082959|NCT00102804|69782114|FG001|Overall Study|Withdrawal by Subject|7|||
38082960|NCT00102804|69782113|FG000|Overall Study|Adverse Event|37|||
38082961|NCT00102804|69782114|FG001|Overall Study|Adverse Event|3|||
38082962|NCT00102804|69782113|FG000|Overall Study|Physician Decision|24|||
38082963|NCT00102804|69782114|FG001|Overall Study|Physician Decision|6|||
38082964|NCT00102804|69782113|FG000|Overall Study|Death|5|||
38082965|NCT00102804|69782114|FG001|Overall Study|Death|6|||
38082966|NCT00102804|69782113|FG000|Overall Study|Enrollment Criteria Not Met|6|||
38082967|NCT00102804|69782114|FG001|Overall Study|Enrollment Criteria Not Met|0|||
38082968|NCT00102804|69782113|FG000|Overall Study|Lost to Follow-up|4|||
38082969|NCT00102804|69782114|FG001|Overall Study|Lost to Follow-up|1|||
38082970|NCT00102804|69782113|FG000|Overall Study|Protocol Violation|2|||
38082971|NCT00102804|69782114|FG001|Overall Study|Protocol Violation|1|||
38082972|NCT00102804|69782113|FG000|Overall Study|Satisfactory Response|2|||
38082973|NCT00102804|69782114|FG001|Overall Study|Satisfactory Response|0|||
38082974|NCT00102804|69782113|FG000|Overall Study|Sponsor Decision|1|||
38082975|NCT00102804|69782114|FG001|Overall Study|Sponsor Decision|0|||
38082976|NCT00102804|69782113|FG000|Overall Study|Alive, Receiving Treatment|7|||
38082977|NCT00102804|69782114|FG001|Overall Study|Alive, Receiving Treatment|2|||
38082978|NCT01814072|69782152|FG000|Overall Study|Lost to Follow-up|2|||
38082979|NCT01814072|69782153|FG001|Overall Study|Lost to Follow-up|2|||
38082980|NCT01814072|69782154|FG002|Overall Study|Lost to Follow-up|2|||
38082981|NCT01814072|69782155|FG003|Overall Study|Lost to Follow-up|0|||
38082982|NCT01814072|69782156|FG004|Overall Study|Lost to Follow-up|2|||
38082983|NCT01814072|69782157|FG005|Overall Study|Lost to Follow-up|3|||
38082984|NCT01814072|69782158|FG006|Overall Study|Lost to Follow-up|3|||
38082985|NCT01814072|69782159|FG007|Overall Study|Lost to Follow-up|1|||
38082986|NCT01814072|69782160|FG008|Overall Study|Lost to Follow-up|2|||
38082987|NCT01814072|69782161|FG009|Overall Study|Lost to Follow-up|3|||
38082988|NCT01814072|69782162|FG010|Overall Study|Lost to Follow-up|1|||
38082989|NCT01814072|69782163|FG011|Overall Study|Lost to Follow-up|2|||
38082990|NCT01814072|69782164|FG012|Overall Study|Lost to Follow-up|2|||
38082991|NCT01814072|69782165|FG013|Overall Study|Lost to Follow-up|1|||
38082992|NCT01814072|69782166|FG014|Overall Study|Lost to Follow-up|2|||
38082993|NCT01814072|69782167|FG015|Overall Study|Lost to Follow-up|1|||
38082994|NCT01814072|69782168|FG016|Overall Study|Lost to Follow-up|3|||
38082995|NCT01814072|69782169|FG017|Overall Study|Lost to Follow-up|1|||
38082996|NCT01814072|69782170|FG018|Overall Study|Lost to Follow-up|3|||
38082997|NCT01814072|69782171|FG019|Overall Study|Lost to Follow-up|3|||
38082998|NCT01814072|69782172|FG020|Overall Study|Lost to Follow-up|2|||
38082999|NCT01814072|69782173|FG021|Overall Study|Lost to Follow-up|1|||
38083000|NCT01814072|69782174|FG022|Overall Study|Lost to Follow-up|3|||
38083001|NCT01814072|69782175|FG023|Overall Study|Lost to Follow-up|1|||
38083002|NCT01814072|69782176|FG024|Overall Study|Lost to Follow-up|4|||
38083003|NCT01814072|69782177|FG025|Overall Study|Lost to Follow-up|1|||
38083004|NCT01814072|69782178|FG026|Overall Study|Lost to Follow-up|1|||
38083005|NCT01814072|69782179|FG027|Overall Study|Lost to Follow-up|2|||
38083006|NCT01814072|69782180|FG028|Overall Study|Lost to Follow-up|3|||
38083007|NCT01814072|69782181|FG029|Overall Study|Lost to Follow-up|3|||
38083008|NCT01814072|69782182|FG030|Overall Study|Lost to Follow-up|2|||
38083009|NCT01814072|69782183|FG031|Overall Study|Lost to Follow-up|0|||
38083010|NCT01814072|69782152|FG000|Overall Study|Withdrawal by Subject|2|||
38083011|NCT01814072|69782153|FG001|Overall Study|Withdrawal by Subject|0|||
38083012|NCT01814072|69782154|FG002|Overall Study|Withdrawal by Subject|1|||
38083013|NCT01814072|69782155|FG003|Overall Study|Withdrawal by Subject|0|||
38083014|NCT01814072|69782156|FG004|Overall Study|Withdrawal by Subject|2|||
38083015|NCT01814072|69782157|FG005|Overall Study|Withdrawal by Subject|3|||
38083016|NCT01814072|69782158|FG006|Overall Study|Withdrawal by Subject|1|||
38083017|NCT01814072|69782159|FG007|Overall Study|Withdrawal by Subject|0|||
38083018|NCT01814072|69782160|FG008|Overall Study|Withdrawal by Subject|1|||
38083019|NCT01814072|69782161|FG009|Overall Study|Withdrawal by Subject|2|||
37683147|NCT02533999|69158804|FG000|Overall Study|Randomized but intervention not received|0|||
37683148|NCT02533999|69158805|FG001|Overall Study|Randomized but intervention not received|1|||
38083020|NCT01814072|69782162|FG010|Overall Study|Withdrawal by Subject|0|||
38083021|NCT01814072|69782163|FG011|Overall Study|Withdrawal by Subject|0|||
38083022|NCT01814072|69782164|FG012|Overall Study|Withdrawal by Subject|1|||
38083023|NCT01814072|69782165|FG013|Overall Study|Withdrawal by Subject|1|||
38083024|NCT01814072|69782166|FG014|Overall Study|Withdrawal by Subject|1|||
38083025|NCT01814072|69782167|FG015|Overall Study|Withdrawal by Subject|1|||
38083026|NCT01814072|69782168|FG016|Overall Study|Withdrawal by Subject|0|||
38083027|NCT01814072|69782169|FG017|Overall Study|Withdrawal by Subject|0|||
38083028|NCT01814072|69782170|FG018|Overall Study|Withdrawal by Subject|0|||
38083029|NCT01814072|69782171|FG019|Overall Study|Withdrawal by Subject|2|||
38083030|NCT01814072|69782172|FG020|Overall Study|Withdrawal by Subject|0|||
38083031|NCT01814072|69782173|FG021|Overall Study|Withdrawal by Subject|0|||
38083032|NCT01814072|69782174|FG022|Overall Study|Withdrawal by Subject|1|||
38083033|NCT01814072|69782175|FG023|Overall Study|Withdrawal by Subject|0|||
38083034|NCT01814072|69782176|FG024|Overall Study|Withdrawal by Subject|2|||
38083035|NCT01814072|69782177|FG025|Overall Study|Withdrawal by Subject|1|||
38083036|NCT01814072|69782178|FG026|Overall Study|Withdrawal by Subject|1|||
38083037|NCT01814072|69782179|FG027|Overall Study|Withdrawal by Subject|2|||
38083038|NCT01814072|69782180|FG028|Overall Study|Withdrawal by Subject|1|||
38083039|NCT01814072|69782181|FG029|Overall Study|Withdrawal by Subject|0|||
38083040|NCT01814072|69782182|FG030|Overall Study|Withdrawal by Subject|0|||
38083041|NCT01814072|69782183|FG031|Overall Study|Withdrawal by Subject|0|||
38083042|NCT03038113|69782238|FG000|Overall Study|Withdrawal by Subject|0|||
38083043|NCT03038113|69782239|FG001|Overall Study|Withdrawal by Subject|0|||
38083044|NCT03038113|69782240|FG002|Overall Study|Withdrawal by Subject|1|||
38083045|NCT03038113|69782241|FG003|Overall Study|Withdrawal by Subject|0|||
38083046|NCT03038113|69782242|FG004|Overall Study|Withdrawal by Subject|0|||
38083047|NCT03038113|69782243|FG005|Overall Study|Withdrawal by Subject|0|||
38083048|NCT03038113|69782244|FG006|Overall Study|Withdrawal by Subject|0|||
38083049|NCT03038113|69782245|FG007|Overall Study|Withdrawal by Subject|0|||
38083050|NCT03038113|69782246|FG008|Overall Study|Withdrawal by Subject|0|||
38083051|NCT03038113|69782247|FG009|Overall Study|Withdrawal by Subject|0|||
38083052|NCT03038113|69782248|FG010|Overall Study|Withdrawal by Subject|0|||
38083053|NCT03038113|69782249|FG011|Overall Study|Withdrawal by Subject|0|||
38083054|NCT03038113|69782250|FG012|Overall Study|Withdrawal by Subject|0|||
38083055|NCT03038113|69782251|FG013|Overall Study|Withdrawal by Subject|1|||
38083056|NCT03038113|69782238|FG000|Overall Study|Lost to Follow-up|0|||
38083057|NCT03038113|69782239|FG001|Overall Study|Lost to Follow-up|0|||
38083058|NCT03038113|69782240|FG002|Overall Study|Lost to Follow-up|0|||
38083059|NCT03038113|69782241|FG003|Overall Study|Lost to Follow-up|0|||
38083060|NCT03038113|69782242|FG004|Overall Study|Lost to Follow-up|0|||
38083061|NCT03038113|69782243|FG005|Overall Study|Lost to Follow-up|0|||
38083062|NCT03038113|69782244|FG006|Overall Study|Lost to Follow-up|1|||
38083063|NCT03038113|69782245|FG007|Overall Study|Lost to Follow-up|0|||
38083064|NCT03038113|69782246|FG008|Overall Study|Lost to Follow-up|0|||
38083065|NCT03038113|69782247|FG009|Overall Study|Lost to Follow-up|0|||
38083066|NCT03038113|69782248|FG010|Overall Study|Lost to Follow-up|0|||
38083067|NCT03038113|69782249|FG011|Overall Study|Lost to Follow-up|0|||
38083068|NCT03038113|69782250|FG012|Overall Study|Lost to Follow-up|0|||
38083069|NCT03038113|69782251|FG013|Overall Study|Lost to Follow-up|0|||
38083070|NCT00968149|69782300|FG000|Overall Study|Adverse Event|5|||
38083071|NCT00968149|69782301|FG001|Overall Study|Adverse Event|1|||
38083072|NCT00968149|69782300|FG000|Overall Study|Lack of Efficacy|0|||
38083073|NCT00968149|69782301|FG001|Overall Study|Lack of Efficacy|4|||
38083074|NCT00968149|69782300|FG000|Overall Study|Lost to Follow-up|0|||
38083075|NCT00968149|69782301|FG001|Overall Study|Lost to Follow-up|1|||
38083076|NCT00968149|69782300|FG000|Overall Study|Protocol Violation|4|||
38083077|NCT00968149|69782301|FG001|Overall Study|Protocol Violation|0|||
38083078|NCT00968149|69782300|FG000|Overall Study|Withdrawal by Subject|2|||
38083079|NCT00968149|69782301|FG001|Overall Study|Withdrawal by Subject|0|||
38083080|NCT00963469|69782310|FG000|Overall Study|Adverse Event|15|||
38083081|NCT00963469|69782311|FG001|Overall Study|Adverse Event|11|||
38083082|NCT00963469|69782312|FG002|Overall Study|Adverse Event|1|||
38083083|NCT00963469|69782310|FG000|Overall Study|Lack of Efficacy|10|||
38083084|NCT00963469|69782311|FG001|Overall Study|Lack of Efficacy|7|||
38083085|NCT00963469|69782312|FG002|Overall Study|Lack of Efficacy|2|||
38083086|NCT00963469|69782310|FG000|Overall Study|Lost to Follow-up|1|||
38083087|NCT00963469|69782311|FG001|Overall Study|Lost to Follow-up|1|||
38083088|NCT00963469|69782312|FG002|Overall Study|Lost to Follow-up|0|||
38083089|NCT00963469|69782310|FG000|Overall Study|Protocol Violation|5|||
38083090|NCT00963469|69782311|FG001|Overall Study|Protocol Violation|5|||
38083091|NCT00963469|69782312|FG002|Overall Study|Protocol Violation|3|||
37862977|NCT01263509|69546922|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
38083092|NCT00963469|69782310|FG000|Overall Study|Withdrawal by Subject|4|||
38083093|NCT00963469|69782311|FG001|Overall Study|Withdrawal by Subject|1|||
38083094|NCT00963469|69782312|FG002|Overall Study|Withdrawal by Subject|1|||
38083095|NCT00963469|69782310|FG000|Overall Study|Pre-randomization Adverse Event|1|||
38083096|NCT00963469|69782311|FG001|Overall Study|Pre-randomization Adverse Event|2|||
38083097|NCT00963469|69782312|FG002|Overall Study|Pre-randomization Adverse Event|0|||
38083098|NCT00963469|69782310|FG000|Overall Study|Moved|1|||
38083099|NCT00963469|69782311|FG001|Overall Study|Moved|0|||
38083100|NCT00963469|69782312|FG002|Overall Study|Moved|0|||
38083101|NCT00963469|69782310|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
38083102|NCT00963469|69782311|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
38083103|NCT00963469|69782312|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
38083104|NCT00897949|69782323|FG000|Overall Study|Adverse Event|1|||
38083105|NCT00897949|69782324|FG001|Overall Study|Adverse Event|1|||
38083106|NCT00897949|69782325|FG002|Overall Study|Adverse Event|0|||
38083107|NCT00897949|69782323|FG000|Overall Study|Lost to Follow-up|0|||
38083108|NCT00897949|69782324|FG001|Overall Study|Lost to Follow-up|2|||
38083109|NCT00897949|69782325|FG002|Overall Study|Lost to Follow-up|1|||
38083110|NCT00897949|69782323|FG000|Overall Study|Protocol Violation|6|||
38083111|NCT00897949|69782324|FG001|Overall Study|Protocol Violation|3|||
38083112|NCT00897949|69782325|FG002|Overall Study|Protocol Violation|1|||
38083113|NCT00897949|69782323|FG000|Overall Study|Withdrawal by Subject|1|||
38083114|NCT00897949|69782324|FG001|Overall Study|Withdrawal by Subject|2|||
38083115|NCT00897949|69782325|FG002|Overall Study|Withdrawal by Subject|0|||
38083116|NCT00897949|69782323|FG000|Overall Study|Patient Uncoorperative|0|||
38083117|NCT00897949|69782324|FG001|Overall Study|Patient Uncoorperative|2|||
38083118|NCT00897949|69782325|FG002|Overall Study|Patient Uncoorperative|1|||
38083119|NCT00897949|69782323|FG000|Overall Study|Lost to Follow-up|30|||
38083120|NCT00897949|69782324|FG001|Overall Study|Lost to Follow-up|23|||
38083121|NCT00897949|69782325|FG002|Overall Study|Lost to Follow-up|17|||
38083122|NCT00897949|69782323|FG000|Overall Study|Withdrawal by Subject|24|||
38083123|NCT00897949|69782324|FG001|Overall Study|Withdrawal by Subject|31|||
38083124|NCT00897949|69782325|FG002|Overall Study|Withdrawal by Subject|17|||
38083125|NCT00897949|69782323|FG000|Overall Study|Abnormal Prestudy Labs|2|||
38083126|NCT00897949|69782324|FG001|Overall Study|Abnormal Prestudy Labs|3|||
38083127|NCT00897949|69782325|FG002|Overall Study|Abnormal Prestudy Labs|4|||
38083128|NCT00897949|69782323|FG000|Overall Study|Abnormal Baseline ECG|2|||
38083129|NCT00897949|69782324|FG001|Overall Study|Abnormal Baseline ECG|2|||
38083130|NCT00897949|69782325|FG002|Overall Study|Abnormal Baseline ECG|4|||
38083131|NCT00897949|69782323|FG000|Overall Study|Need for Concom. Med.|0|||
38083132|NCT00897949|69782324|FG001|Overall Study|Need for Concom. Med.|1|||
38083133|NCT00897949|69782325|FG002|Overall Study|Need for Concom. Med.|1|||
38083134|NCT00897949|69782323|FG000|Overall Study|Lack of Migraine Attack|29|||
38083135|NCT00897949|69782324|FG001|Overall Study|Lack of Migraine Attack|30|||
38083136|NCT00897949|69782325|FG002|Overall Study|Lack of Migraine Attack|19|||
38083137|NCT00897949|69782323|FG000|Overall Study|Did not take study drug|9|||
38083138|NCT00897949|69782324|FG001|Overall Study|Did not take study drug|3|||
38083139|NCT00897949|69782325|FG002|Overall Study|Did not take study drug|4|||
38083140|NCT02760810|69782339|FG000|Overall Study|Protocol Violation|1|||
38083141|NCT02760654|69782345|FG000|Overall Study|Lost to Follow-up|3|||
38083142|NCT02760654|69782346|FG001|Overall Study|Lost to Follow-up|3|||
38083143|NCT02760654|69782345|FG000|Overall Study|Withdrawal by Subject|4|||
38083144|NCT02760654|69782346|FG001|Overall Study|Withdrawal by Subject|3|||
38083145|NCT00725491|69782354|FG000|Overall Study|Adverse Event|3|||
38083146|NCT00725491|69782355|FG001|Overall Study|Adverse Event|2|||
38083147|NCT00725491|69782354|FG000|Overall Study|Pregnancy|0|||
38083148|NCT00725491|69782355|FG001|Overall Study|Pregnancy|3|||
38083149|NCT00725491|69782354|FG000|Overall Study|Risk for hyperstimulation|2|||
38083150|NCT00725491|69782355|FG001|Overall Study|Risk for hyperstimulation|9|||
38083151|NCT00725491|69782354|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
38083152|NCT00725491|69782355|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
38083153|NCT00725491|69782354|FG000|Overall Study|Fertilization failure|0|||
38083154|NCT00725491|69782355|FG001|Overall Study|Fertilization failure|1|||
38083155|NCT00725491|69782354|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
38083156|NCT00725491|69782355|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
38083157|NCT02634580|69782365|FG000|Double-blind Treatment Period|Subject Request|1|||
38083158|NCT02634580|69782366|FG001|Double-blind Treatment Period|Subject Request|0|||
38083159|NCT02634580|69782367|FG002|Double-blind Treatment Period|Subject Request|1|||
38083160|NCT02634580|69782368|FG003|Double-blind Treatment Period|Subject Request|1|||
38083161|NCT02634580|69782365|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
38083162|NCT02634580|69782366|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
38083163|NCT02634580|69782367|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
38083164|NCT02634580|69782368|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
37683149|NCT02533531|69158811|FG000|Overall Study|Device did not turn on|1|||
38083165|NCT02225366|69782379|FG000|Overall Study|Lack of Efficacy|1|||
38083166|NCT02225366|69782380|FG001|Overall Study|Lack of Efficacy|0|||
38083167|NCT00697255|69782388|FG000|Stage 1a|Insufficient ovarian response|1|||
38083168|NCT00697255|69782389|FG001|Stage 1a|Insufficient ovarian response|0|||
38083169|NCT00697255|69782388|FG000|Stage 1a|Multifollicular growth|1|||
37683150|NCT02533453|69158815|FG000|Overall Study|Adverse Event|6|||
37683151|NCT02533453|69158815|FG000|Overall Study|Protocol Violation|1|||
37683152|NCT02533453|69158815|FG000|Overall Study|Withdrawal by Subject|2|||
37683153|NCT02533375|69158819|FG000|Overall Study|Lack of Efficacy|3|||
37683154|NCT02533375|69158819|FG000|Overall Study|Adverse Event|2|||
37683155|NCT02551055|69158830|FG000|Overall Study|Death|2|||
37683156|NCT02551055|69158831|FG001|Overall Study|Death|4|||
37683157|NCT02551055|69158832|FG002|Overall Study|Death|2|||
37683158|NCT02551055|69158833|FG003|Overall Study|Death|2|||
37683159|NCT02551055|69158834|FG004|Overall Study|Death|2|||
37683160|NCT02551055|69158835|FG005|Overall Study|Death|1|||
37683161|NCT02551055|69158836|FG006|Overall Study|Death|2|||
37683162|NCT02551055|69158837|FG007|Overall Study|Death|0|||
37683163|NCT02551055|69158830|FG000|Overall Study|Study Terminated by Sponsor|1|||
37683164|NCT02551055|69158831|FG001|Overall Study|Study Terminated by Sponsor|1|||
37683165|NCT02551055|69158832|FG002|Overall Study|Study Terminated by Sponsor|0|||
37683166|NCT02551055|69158833|FG003|Overall Study|Study Terminated by Sponsor|2|||
37683167|NCT02551055|69158834|FG004|Overall Study|Study Terminated by Sponsor|2|||
37683168|NCT02551055|69158835|FG005|Overall Study|Study Terminated by Sponsor|0|||
37683169|NCT02551055|69158836|FG006|Overall Study|Study Terminated by Sponsor|0|||
37683170|NCT02551055|69158837|FG007|Overall Study|Study Terminated by Sponsor|0|||
37683171|NCT02551055|69158830|FG000|Overall Study|Withdrawal by Subject|1|||
37683172|NCT02551055|69158831|FG001|Overall Study|Withdrawal by Subject|1|||
37683173|NCT02551055|69158832|FG002|Overall Study|Withdrawal by Subject|0|||
37683174|NCT02551055|69158833|FG003|Overall Study|Withdrawal by Subject|1|||
37683175|NCT02551055|69158834|FG004|Overall Study|Withdrawal by Subject|2|||
37683176|NCT02551055|69158835|FG005|Overall Study|Withdrawal by Subject|0|||
37683177|NCT02551055|69158836|FG006|Overall Study|Withdrawal by Subject|0|||
37683178|NCT02551055|69158837|FG007|Overall Study|Withdrawal by Subject|0|||
37683179|NCT02551055|69158830|FG000|Overall Study|Reason not specified|0|||
37683180|NCT02551055|69158831|FG001|Overall Study|Reason not specified|0|||
37683181|NCT02551055|69158832|FG002|Overall Study|Reason not specified|0|||
37683182|NCT02551055|69158833|FG003|Overall Study|Reason not specified|0|||
37683183|NCT02551055|69158834|FG004|Overall Study|Reason not specified|1|||
37683184|NCT02551055|69158835|FG005|Overall Study|Reason not specified|0|||
37683185|NCT02551055|69158836|FG006|Overall Study|Reason not specified|1|||
37683186|NCT02551055|69158837|FG007|Overall Study|Reason not specified|0|||
37683187|NCT02542943|69158858|FG000|Overall Study|Lost to Follow-up|1|||
37683188|NCT02542943|69158859|FG001|Overall Study|Lost to Follow-up|0|||
37683189|NCT02542943|69158860|FG002|Overall Study|Lost to Follow-up|0|||
37683190|NCT02542943|69158858|FG000|Overall Study|Withdrawal by Subject|0|||
37683191|NCT02542943|69158859|FG001|Overall Study|Withdrawal by Subject|1|||
37683192|NCT02542943|69158860|FG002|Overall Study|Withdrawal by Subject|0|||
37683193|NCT02542865|69158871|FG000|Overall Study|Identified as screen failure|1|||
38083170|NCT00697255|69782389|FG001|Stage 1a|Multifollicular growth|0|||
38083171|NCT00697255|69782388|FG000|Stage 1a|Not growing of dominant follicle|1|||
38083172|NCT00697255|69782389|FG001|Stage 1a|Not growing of dominant follicle|0|||
38083173|NCT00697255|69782388|FG000|Stage 1b|Not growing of dominant follicle|0|||
38083174|NCT00697255|69782389|FG001|Stage 1b|Not growing of dominant follicle|1|||
38083175|NCT00697255|69782388|FG000|Stage 1b|Insufficient ovarian response|0|||
38083176|NCT00697255|69782389|FG001|Stage 1b|Insufficient ovarian response|1|||
38083177|NCT02764320|69782397|FG000|Overall Study|Withdrawal by Subject|35|||
38083178|NCT02764320|69782398|FG001|Overall Study|Withdrawal by Subject|38|||
38083179|NCT02764320|69782397|FG000|Overall Study|Protocol Violation|11|||
37683194|NCT02542865|69158872|FG001|Overall Study|Identified as screen failure|0|||
37683195|NCT02542865|69158871|FG000|Overall Study|Withdrawal by Subject|16|||
37683196|NCT02542865|69158872|FG001|Overall Study|Withdrawal by Subject|0|||
37683197|NCT03644927|69158878|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
37683198|NCT03644927|69158879|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
38083180|NCT02764320|69782398|FG001|Overall Study|Protocol Violation|6|||
37683199|NCT02542631|69158886|FG000|Overall Study|Adverse Event|1|||
37683200|NCT02542631|69158887|FG001|Overall Study|Adverse Event|1|||
37683201|NCT02542631|69158886|FG000|Overall Study|Sponsor Termination|1|||
37683202|NCT02542631|69158887|FG001|Overall Study|Sponsor Termination|0|||
37683203|NCT02542631|69158886|FG000|Overall Study|Withdrawal by Subject|11|||
37683204|NCT02542631|69158887|FG001|Overall Study|Withdrawal by Subject|16|||
37683205|NCT02542631|69158886|FG000|Overall Study|Protocol Violation|1|||
37683206|NCT02542631|69158887|FG001|Overall Study|Protocol Violation|1|||
37683207|NCT02542631|69158886|FG000|Overall Study|Physician Decision|6|||
37683208|NCT02542631|69158887|FG001|Overall Study|Physician Decision|4|||
37683209|NCT02542631|69158886|FG000|Overall Study|Lost to Follow-up|6|||
37683210|NCT02542631|69158887|FG001|Overall Study|Lost to Follow-up|5|||
37683211|NCT02542631|69158886|FG000|Overall Study|Death|1|||
37683212|NCT02542631|69158887|FG001|Overall Study|Death|2|||
37683213|NCT02542631|69158886|FG000|Overall Study|Other|2|||
37683214|NCT02542631|69158887|FG001|Overall Study|Other|1|||
37683215|NCT02542631|69158886|FG000|Overall Study|Used Prohibited Medication|2|||
37683216|NCT02542631|69158887|FG001|Overall Study|Used Prohibited Medication|1|||
37683217|NCT02542397|69158893|FG000|Overall Study|Death|2|||
37683218|NCT02542397|69158893|FG000|Overall Study|Physician Decision|6|||
37683219|NCT02542397|69158893|FG000|Overall Study|Withdrawal by Subject|6|||
37683220|NCT02542397|69158893|FG000|Overall Study|Lost to Follow-up|2|||
37683221|NCT02549339|69158900|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
37683222|NCT02549339|69158901|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
37683223|NCT02549339|69158900|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
37683224|NCT02549339|69158901|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
37683225|NCT02549339|69158900|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
37683226|NCT02549339|69158901|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
37683227|NCT02549339|69158900|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
37683228|NCT02549339|69158901|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
37683229|NCT02549339|69158900|FG000|12-month Follow-up|Lack of Efficacy|0|||
37862978|NCT01263509|69546923|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
37862979|NCT01263509|69546924|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
37862980|NCT01263509|69546921|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
37862981|NCT01263509|69546922|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
37862982|NCT01263509|69546923|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
37862983|NCT01263509|69546924|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
37862984|NCT01263509|69546921|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
37862985|NCT01263509|69546922|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
37862986|NCT01263509|69546923|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
37862987|NCT01263509|69546924|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
37862988|NCT01263197|69546932|FG000|First Intervention (Period 1)|Adverse Event|0|||
37862989|NCT01263197|69546933|FG001|First Intervention (Period 1)|Adverse Event|0|||
37862990|NCT01263197|69546934|FG002|First Intervention (Period 1)|Adverse Event|0|||
37862991|NCT01263197|69546935|FG003|First Intervention (Period 1)|Adverse Event|0|||
38083181|NCT02764320|69782397|FG000|Overall Study|Adverse Event|2|||
38083182|NCT02764320|69782398|FG001|Overall Study|Adverse Event|0|||
37683230|NCT02549339|69158901|FG001|12-month Follow-up|Lack of Efficacy|2|||
37683231|NCT02549339|69158900|FG000|12-month Follow-up|Withdrawal by Subject|8|||
37683232|NCT02549339|69158901|FG001|12-month Follow-up|Withdrawal by Subject|3|||
37683233|NCT02549339|69158900|FG000|12-month Follow-up|Lost to Follow-up|1|||
37683234|NCT02549339|69158901|FG001|12-month Follow-up|Lost to Follow-up|3|||
37683235|NCT02549339|69158900|FG000|12-month Follow-up|Other|0|||
37683236|NCT02549339|69158901|FG001|12-month Follow-up|Other|3|||
37683237|NCT02549027|69158909|FG000|Washout After Period 4|Withdrawal by Subject|0|||
37683238|NCT02549027|69158910|FG001|Washout After Period 4|Withdrawal by Subject|1|||
37683239|NCT02549027|69158911|FG002|Washout After Period 4|Withdrawal by Subject|1|||
37683240|NCT02549027|69158912|FG003|Washout After Period 4|Withdrawal by Subject|1|||
37683241|NCT02549027|69158913|FG004|Washout After Period 4|Withdrawal by Subject|0|||
37683242|NCT02549027|69158914|FG005|Washout After Period 4|Withdrawal by Subject|0|||
37683243|NCT02549027|69158909|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
37683244|NCT02549027|69158910|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
37683245|NCT02549027|69158911|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
37683246|NCT02549027|69158912|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
37683247|NCT02549027|69158913|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
37683248|NCT02549027|69158914|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
37683249|NCT02529553|69158942|FG000|Overall Study|Progressive Disease|1|||
37683250|NCT02529553|69158943|FG001|Overall Study|Progressive Disease|0|||
37683251|NCT02529553|69158944|FG002|Overall Study|Progressive Disease|1|||
37683252|NCT02529553|69158945|FG003|Overall Study|Progressive Disease|3|||
37683253|NCT02529553|69158946|FG004|Overall Study|Progressive Disease|2|||
37683254|NCT02529553|69158947|FG005|Overall Study|Progressive Disease|3|||
37683255|NCT02529553|69158948|FG006|Overall Study|Progressive Disease|3|||
37683256|NCT02529553|69158949|FG007|Overall Study|Progressive Disease|5|||
37683257|NCT02529553|69158950|FG008|Overall Study|Progressive Disease|3|||
37683258|NCT02529553|69158942|FG000|Overall Study|Physician Decision|0|||
37683259|NCT02529553|69158943|FG001|Overall Study|Physician Decision|1|||
38083183|NCT02764320|69782397|FG000|Overall Study|Health Issues unable to continue|2|||
38083184|NCT02764320|69782398|FG001|Overall Study|Health Issues unable to continue|0|||
38083185|NCT02764320|69782397|FG000|Overall Study|Did not meet inclusion criteria|1|||
38083186|NCT02764320|69782398|FG001|Overall Study|Did not meet inclusion criteria|0|||
38083187|NCT02764320|69782397|FG000|Overall Study|Subject moved|0|||
38083188|NCT02764320|69782398|FG001|Overall Study|Subject moved|2|||
38083189|NCT02764320|69782397|FG000|Overall Study|Overused medication unavailable|0|||
38083190|NCT02764320|69782398|FG001|Overall Study|Overused medication unavailable|1|||
38083191|NCT02764320|69782397|FG000|Overall Study|Seeking care outside site|0|||
37683260|NCT02529553|69158944|FG002|Overall Study|Physician Decision|0|||
37683261|NCT02529553|69158945|FG003|Overall Study|Physician Decision|0|||
37683262|NCT02529553|69158946|FG004|Overall Study|Physician Decision|1|||
37683263|NCT02529553|69158947|FG005|Overall Study|Physician Decision|0|||
37683264|NCT02529553|69158948|FG006|Overall Study|Physician Decision|0|||
37683265|NCT02529553|69158949|FG007|Overall Study|Physician Decision|0|||
37683266|NCT02529553|69158950|FG008|Overall Study|Physician Decision|0|||
37683267|NCT02529553|69158942|FG000|Overall Study|Withdrawal by Subject|0|||
37683268|NCT02529553|69158943|FG001|Overall Study|Withdrawal by Subject|0|||
37683269|NCT02529553|69158944|FG002|Overall Study|Withdrawal by Subject|0|||
37683270|NCT02529553|69158945|FG003|Overall Study|Withdrawal by Subject|0|||
37683271|NCT02529553|69158946|FG004|Overall Study|Withdrawal by Subject|0|||
37683272|NCT02529553|69158947|FG005|Overall Study|Withdrawal by Subject|1|||
37683273|NCT02529553|69158948|FG006|Overall Study|Withdrawal by Subject|0|||
37683274|NCT02529553|69158949|FG007|Overall Study|Withdrawal by Subject|1|||
37683275|NCT02529553|69158950|FG008|Overall Study|Withdrawal by Subject|0|||
37683276|NCT02547935|69158974|FG000|Overall Study|Other|0|||
37683277|NCT02547935|69158975|FG001|Overall Study|Other|1|||
37683278|NCT02547935|69158976|FG002|Overall Study|Other|0|||
37683279|NCT02547935|69158974|FG000|Overall Study|Withdrawal by Subject|2|||
37683280|NCT02547935|69158975|FG001|Overall Study|Withdrawal by Subject|3|||
37683281|NCT02547935|69158976|FG002|Overall Study|Withdrawal by Subject|4|||
37683282|NCT02547935|69158974|FG000|Overall Study|Screen Failure|2|||
37683283|NCT02547935|69158975|FG001|Overall Study|Screen Failure|0|||
37683284|NCT02547935|69158976|FG002|Overall Study|Screen Failure|0|||
37683285|NCT02547935|69158974|FG000|Overall Study|Physician Decision|0|||
37683286|NCT02547935|69158975|FG001|Overall Study|Physician Decision|1|||
37683287|NCT02547935|69158976|FG002|Overall Study|Physician Decision|0|||
37683288|NCT02547935|69158974|FG000|Overall Study|Lost to Follow-up|0|||
37683289|NCT02547935|69158975|FG001|Overall Study|Lost to Follow-up|2|||
37683290|NCT02547935|69158976|FG002|Overall Study|Lost to Follow-up|1|||
37683291|NCT02547935|69158974|FG000|Overall Study|Death|1|||
37683292|NCT02547935|69158975|FG001|Overall Study|Death|1|||
37683293|NCT02547935|69158976|FG002|Overall Study|Death|0|||
37683294|NCT02554019|69158989|FG000|Overall Study|Withdrawal by Subject|1|||
37683295|NCT02554019|69158990|FG001|Overall Study|Withdrawal by Subject|0|||
37683296|NCT02554019|69158991|FG002|Overall Study|Withdrawal by Subject|2|||
37683297|NCT02554019|69158989|FG000|Overall Study|Adverse Event|1|||
37683298|NCT02554019|69158990|FG001|Overall Study|Adverse Event|0|||
37683299|NCT02554019|69158991|FG002|Overall Study|Adverse Event|0|||
37683300|NCT02327169|69159014|FG000|Overall Study|Progressive Disease|1|||
37683301|NCT02327169|69159015|FG001|Overall Study|Progressive Disease|3|||
37683302|NCT02327169|69159016|FG002|Overall Study|Progressive Disease|4|||
37683303|NCT02327169|69159017|FG003|Overall Study|Progressive Disease|3|||
37683304|NCT02327169|69159018|FG004|Overall Study|Progressive Disease|4|||
37683305|NCT02327169|69159019|FG005|Overall Study|Progressive Disease|3|||
37683306|NCT02327169|69159020|FG006|Overall Study|Progressive Disease|3|||
37683307|NCT02327169|69159021|FG007|Overall Study|Progressive Disease|3|||
37683308|NCT02327169|69159022|FG008|Overall Study|Progressive Disease|4|||
37683309|NCT02327169|69159023|FG009|Overall Study|Progressive Disease|4|||
37683310|NCT02327169|69159024|FG010|Overall Study|Progressive Disease|4|||
37683311|NCT02327169|69159025|FG011|Overall Study|Progressive Disease|3|||
37683312|NCT02327169|69159026|FG012|Overall Study|Progressive Disease|1|||
37683313|NCT02327169|69159027|FG013|Overall Study|Progressive Disease|3|||
37683314|NCT02327169|69159028|FG014|Overall Study|Progressive Disease|3|||
37683315|NCT02327169|69159014|FG000|Overall Study|Adverse Event|2|||
37683316|NCT02327169|69159015|FG001|Overall Study|Adverse Event|0|||
37683317|NCT02327169|69159016|FG002|Overall Study|Adverse Event|1|||
37683318|NCT02327169|69159017|FG003|Overall Study|Adverse Event|0|||
37683319|NCT02327169|69159018|FG004|Overall Study|Adverse Event|1|||
37683320|NCT02327169|69159019|FG005|Overall Study|Adverse Event|0|||
37683321|NCT02327169|69159020|FG006|Overall Study|Adverse Event|0|||
37683322|NCT02327169|69159021|FG007|Overall Study|Adverse Event|0|||
37683323|NCT02327169|69159022|FG008|Overall Study|Adverse Event|0|||
37683324|NCT02327169|69159023|FG009|Overall Study|Adverse Event|2|||
37683325|NCT02327169|69159024|FG010|Overall Study|Adverse Event|0|||
37683326|NCT02327169|69159025|FG011|Overall Study|Adverse Event|3|||
37683327|NCT02327169|69159026|FG012|Overall Study|Adverse Event|0|||
37683328|NCT02327169|69159027|FG013|Overall Study|Adverse Event|2|||
37683329|NCT02327169|69159028|FG014|Overall Study|Adverse Event|1|||
37683330|NCT02327169|69159014|FG000|Overall Study|Symptomatic Deterioration|0|||
37967104|NCT00535236|69653997|FG001|Overall Study|Lost to Follow-up|2|||
37683331|NCT02327169|69159015|FG001|Overall Study|Symptomatic Deterioration|0|||
37683332|NCT02327169|69159016|FG002|Overall Study|Symptomatic Deterioration|1|||
37683333|NCT02327169|69159017|FG003|Overall Study|Symptomatic Deterioration|0|||
37683334|NCT02327169|69159018|FG004|Overall Study|Symptomatic Deterioration|1|||
37683335|NCT02327169|69159019|FG005|Overall Study|Symptomatic Deterioration|1|||
37683336|NCT02327169|69159020|FG006|Overall Study|Symptomatic Deterioration|0|||
37683337|NCT02327169|69159021|FG007|Overall Study|Symptomatic Deterioration|0|||
37683338|NCT02327169|69159022|FG008|Overall Study|Symptomatic Deterioration|2|||
37683339|NCT02327169|69159023|FG009|Overall Study|Symptomatic Deterioration|1|||
37683340|NCT02327169|69159024|FG010|Overall Study|Symptomatic Deterioration|0|||
37683341|NCT02327169|69159025|FG011|Overall Study|Symptomatic Deterioration|0|||
37683342|NCT02327169|69159026|FG012|Overall Study|Symptomatic Deterioration|0|||
37683343|NCT02327169|69159027|FG013|Overall Study|Symptomatic Deterioration|2|||
37683344|NCT02327169|69159028|FG014|Overall Study|Symptomatic Deterioration|1|||
37683345|NCT02327169|69159014|FG000|Overall Study|Reason Not Specified|0|||
37683346|NCT02327169|69159015|FG001|Overall Study|Reason Not Specified|0|||
37683347|NCT02327169|69159016|FG002|Overall Study|Reason Not Specified|1|||
37683348|NCT02327169|69159017|FG003|Overall Study|Reason Not Specified|0|||
37683349|NCT02327169|69159018|FG004|Overall Study|Reason Not Specified|0|||
37683350|NCT02327169|69159019|FG005|Overall Study|Reason Not Specified|0|||
37683351|NCT02327169|69159020|FG006|Overall Study|Reason Not Specified|0|||
37683352|NCT02327169|69159021|FG007|Overall Study|Reason Not Specified|0|||
37683353|NCT02327169|69159022|FG008|Overall Study|Reason Not Specified|0|||
37683354|NCT02327169|69159023|FG009|Overall Study|Reason Not Specified|1|||
37683355|NCT02327169|69159024|FG010|Overall Study|Reason Not Specified|2|||
37683356|NCT02327169|69159025|FG011|Overall Study|Reason Not Specified|1|||
37683357|NCT02327169|69159026|FG012|Overall Study|Reason Not Specified|0|||
37683358|NCT02327169|69159027|FG013|Overall Study|Reason Not Specified|0|||
37683359|NCT02327169|69159028|FG014|Overall Study|Reason Not Specified|2|||
37683360|NCT02327169|69159014|FG000|Overall Study|Withdrawal by Subject|1|||
38083192|NCT02764320|69782398|FG001|Overall Study|Seeking care outside site|1|||
38083193|NCT02764320|69782397|FG000|Overall Study|Technology barriers|0|||
38083194|NCT02764320|69782398|FG001|Overall Study|Technology barriers|1|||
38083195|NCT02851407|69782406|FG000|Overall Study|Withdrawal by parent/guardian|2|||
38083196|NCT02851407|69782407|FG001|Overall Study|Withdrawal by parent/guardian|7|||
38083197|NCT02851407|69782406|FG000|Overall Study|Protocol deviation|0|||
38083198|NCT02851407|69782407|FG001|Overall Study|Protocol deviation|1|||
37683361|NCT02327169|69159015|FG001|Overall Study|Withdrawal by Subject|0|||
37683362|NCT02327169|69159016|FG002|Overall Study|Withdrawal by Subject|0|||
37683363|NCT02327169|69159017|FG003|Overall Study|Withdrawal by Subject|0|||
37683364|NCT02327169|69159018|FG004|Overall Study|Withdrawal by Subject|1|||
37967105|NCT00535236|69653998|FG002|Overall Study|Lost to Follow-up|0|||
38083199|NCT02851407|69782406|FG000|Overall Study|Transferred to another hospital to continue|1|||
38083200|NCT02851407|69782407|FG001|Overall Study|Transferred to another hospital to continue|0|||
38083201|NCT02851407|69782406|FG000|Overall Study|Other Death|30|||
38083202|NCT02851407|69782407|FG001|Overall Study|Other Death|20|||
37683365|NCT02327169|69159019|FG005|Overall Study|Withdrawal by Subject|0|||
37683366|NCT02327169|69159020|FG006|Overall Study|Withdrawal by Subject|0|||
37683367|NCT02327169|69159021|FG007|Overall Study|Withdrawal by Subject|1|||
37683368|NCT02327169|69159022|FG008|Overall Study|Withdrawal by Subject|0|||
37683369|NCT02327169|69159023|FG009|Overall Study|Withdrawal by Subject|0|||
37683370|NCT02327169|69159024|FG010|Overall Study|Withdrawal by Subject|0|||
37683371|NCT02327169|69159025|FG011|Overall Study|Withdrawal by Subject|0|||
37683372|NCT02327169|69159026|FG012|Overall Study|Withdrawal by Subject|0|||
37683373|NCT02327169|69159027|FG013|Overall Study|Withdrawal by Subject|0|||
37683374|NCT02327169|69159028|FG014|Overall Study|Withdrawal by Subject|3|||
37683375|NCT02327169|69159014|FG000|Overall Study|Lost to Follow-up|0|||
37683376|NCT02327169|69159015|FG001|Overall Study|Lost to Follow-up|0|||
37862992|NCT01263197|69546936|FG004|First Intervention (Period 1)|Adverse Event|0|||
38083203|NCT02851407|69782406|FG000|Overall Study|Adverse event, serious fatal|6|||
38083204|NCT02851407|69782407|FG001|Overall Study|Adverse event, serious fatal|8|||
38083205|NCT02851407|69782406|FG000|Overall Study|Consent withdrawn by participant|5|||
38083206|NCT02851407|69782407|FG001|Overall Study|Consent withdrawn by participant|3|||
38083207|NCT02851407|69782406|FG000|Overall Study|Screen failure|2|||
38083208|NCT02851407|69782407|FG001|Overall Study|Screen failure|1|||
38083209|NCT02851407|69782406|FG000|Overall Study|Disease relapse|9|||
38083210|NCT02851407|69782407|FG001|Overall Study|Disease relapse|6|||
38083211|NCT02851407|69782406|FG000|Overall Study|Physician Decision|7|||
38083212|NCT02851407|69782407|FG001|Overall Study|Physician Decision|6|||
38083213|NCT02851407|69782406|FG000|Overall Study|Transferred to hospital closer to home|0|||
38083214|NCT02851407|69782407|FG001|Overall Study|Transferred to hospital closer to home|1|||
38083215|NCT02851407|69782406|FG000|Overall Study|Enrolled in an investigational study|0|||
38083216|NCT02851407|69782407|FG001|Overall Study|Enrolled in an investigational study|1|||
38083217|NCT02851407|69782406|FG000|Overall Study|Early recovery|1|||
38083218|NCT02851407|69782407|FG001|Overall Study|Early recovery|0|||
38083219|NCT02851407|69782406|FG000|Overall Study|Adverse event, non-fatal|7|||
38083220|NCT02851407|69782407|FG001|Overall Study|Adverse event, non-fatal|5|||
38083221|NCT02851407|69782406|FG000|Overall Study|Lost to Follow-up|0|||
38083222|NCT02851407|69782407|FG001|Overall Study|Lost to Follow-up|2|||
38083223|NCT02636608|69782413|FG000|Overall Study|Failure to Return|4|||
38083224|NCT02636608|69782413|FG000|Overall Study|Insufficient Virological Response|1|||
38083225|NCT02636608|69782413|FG000|Overall Study|Death|3|||
38083226|NCT02636608|69782413|FG000|Overall Study|Other|2|||
38083227|NCT02636608|69782413|FG000|Overall Study|Did Not Receive Treatment|1|||
38083228|NCT02759562|69782422|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
38083229|NCT02759562|69782423|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
38083230|NCT02759562|69782422|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
38083231|NCT02759562|69782423|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
38083232|NCT02746575|69782430|FG000|Overall Study|Surgery cancelled or time chaned|13|||
38083233|NCT02746575|69782430|FG000|Overall Study|Received epidural|10|||
38083234|NCT02746575|69782430|FG000|Overall Study|Withdrawal by Subject|3|||
38083235|NCT02746575|69782430|FG000|Overall Study|Bradycardia/hypotension|9|||
38083236|NCT02746575|69782430|FG000|Overall Study|Study paused|8|||
38083237|NCT02746575|69782430|FG000|Overall Study|put on beta-blocker|3|||
38083238|NCT02746575|69782430|FG000|Overall Study|type of surgery|1|||
38083239|NCT02746575|69782430|FG000|Overall Study|typ of surgery|1|||
38083240|NCT02746575|69782430|FG000|Overall Study|PI unavailable|1|||
38083241|NCT02746575|69782430|FG000|Overall Study|Unknown history of CVA|1|||
38083242|NCT03625466|69782436|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
38083243|NCT03625466|69782437|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
38083244|NCT03625466|69782438|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
38083245|NCT03625466|69782436|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
38083246|NCT03625466|69782437|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
38083247|NCT03625466|69782438|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
38083248|NCT03625466|69782436|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
38083249|NCT03625466|69782437|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
37683377|NCT02327169|69159016|FG002|Overall Study|Lost to Follow-up|0|||
37683378|NCT02327169|69159017|FG003|Overall Study|Lost to Follow-up|0|||
37862993|NCT01263197|69546937|FG005|First Intervention (Period 1)|Adverse Event|1|||
37862994|NCT01263197|69546932|FG000|Washout Period 1|Protocol Violation|0|||
38083250|NCT03625466|69782438|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
38083251|NCT02853123|69782445|FG000|Treatment Period 1|Adverse Event|0|||
37683379|NCT02327169|69159018|FG004|Overall Study|Lost to Follow-up|1|||
38083252|NCT02853123|69782446|FG001|Treatment Period 1|Adverse Event|3|||
38083253|NCT02853123|69782445|FG000|Washout Period|Worsening of COPD|0|||
38083254|NCT02853123|69782446|FG001|Washout Period|Worsening of COPD|3|||
38083255|NCT02853123|69782445|FG000|Washout Period|Adverse Event|1|||
38083256|NCT02853123|69782446|FG001|Washout Period|Adverse Event|0|||
38083257|NCT02634346|69782456|FG000|Overall Study|Withdrawal by Subject|8|||
38083258|NCT02634346|69782457|FG001|Overall Study|Withdrawal by Subject|9|||
38083259|NCT02634346|69782458|FG002|Overall Study|Withdrawal by Subject|8|||
38083260|NCT02634346|69782456|FG000|Overall Study|Adverse Event|2|||
37862995|NCT01263197|69546933|FG001|Washout Period 1|Protocol Violation|0|||
37862996|NCT01263197|69546934|FG002|Washout Period 1|Protocol Violation|0|||
38083261|NCT02634346|69782457|FG001|Overall Study|Adverse Event|2|||
37683380|NCT02327169|69159019|FG005|Overall Study|Lost to Follow-up|0|||
37683381|NCT02327169|69159020|FG006|Overall Study|Lost to Follow-up|0|||
37683382|NCT02327169|69159021|FG007|Overall Study|Lost to Follow-up|0|||
37683383|NCT02327169|69159022|FG008|Overall Study|Lost to Follow-up|0|||
37683384|NCT02327169|69159023|FG009|Overall Study|Lost to Follow-up|0|||
37683385|NCT02327169|69159024|FG010|Overall Study|Lost to Follow-up|0|||
38083262|NCT02634346|69782458|FG002|Overall Study|Adverse Event|7|||
38083263|NCT02634346|69782456|FG000|Overall Study|Lack of Efficacy|1|||
38083264|NCT02634346|69782457|FG001|Overall Study|Lack of Efficacy|2|||
38083265|NCT02634346|69782458|FG002|Overall Study|Lack of Efficacy|8|||
38083266|NCT02634346|69782456|FG000|Overall Study|Lost to Follow-up|1|||
38083267|NCT02634346|69782457|FG001|Overall Study|Lost to Follow-up|0|||
38083268|NCT02634346|69782458|FG002|Overall Study|Lost to Follow-up|0|||
38083269|NCT02634346|69782456|FG000|Overall Study|Protocol Violation|0|||
38083270|NCT02634346|69782457|FG001|Overall Study|Protocol Violation|1|||
38083271|NCT02634346|69782458|FG002|Overall Study|Protocol Violation|0|||
38083272|NCT00849147|69782466|FG000|Overall Study|Withdrawal by Subject|1|||
38083273|NCT00849147|69782466|FG000|Overall Study|Protocol Violation|2|||
38083274|NCT00849147|69782466|FG000|Overall Study|Disease Relapse/Progression|2|||
38083275|NCT00101166|69782470|FG000|Overall Study|progressive disease|10|||
38083276|NCT02759016|69782476|FG000|Overall Study|Not treated with BI 836826|1|||
38083277|NCT02759016|69782477|FG001|Overall Study|Not treated with BI 836826|0|||
38083278|NCT02759016|69782476|FG000|Overall Study|Progressive disease|1|||
37862997|NCT01263197|69546935|FG003|Washout Period 1|Protocol Violation|0|||
37862998|NCT01263197|69546936|FG004|Washout Period 1|Protocol Violation|1|||
37862999|NCT01263197|69546937|FG005|Washout Period 1|Protocol Violation|0|||
38083279|NCT02759016|69782477|FG001|Overall Study|Progressive disease|0|||
38083280|NCT02759016|69782476|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
38083281|NCT02759016|69782477|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
37683386|NCT02327169|69159025|FG011|Overall Study|Lost to Follow-up|0|||
37683387|NCT02327169|69159026|FG012|Overall Study|Lost to Follow-up|0|||
37683388|NCT02327169|69159027|FG013|Overall Study|Lost to Follow-up|0|||
37683389|NCT02327169|69159028|FG014|Overall Study|Lost to Follow-up|0|||
37683390|NCT02327013|69159073|FG000|Overall Study|Adverse Event|4|||
37683391|NCT02327013|69159074|FG001|Overall Study|Adverse Event|4|||
37683392|NCT02327013|69159075|FG002|Overall Study|Adverse Event|3|||
37683393|NCT02327013|69159076|FG003|Overall Study|Adverse Event|0|||
37683394|NCT02327013|69159077|FG004|Overall Study|Adverse Event|1|||
37683395|NCT02327013|69159073|FG000|Overall Study|Lack of Efficacy|2|||
37683396|NCT02327013|69159074|FG001|Overall Study|Lack of Efficacy|0|||
37683397|NCT02327013|69159075|FG002|Overall Study|Lack of Efficacy|5|||
37683398|NCT02327013|69159076|FG003|Overall Study|Lack of Efficacy|0|||
37683399|NCT02327013|69159077|FG004|Overall Study|Lack of Efficacy|1|||
37683400|NCT02327013|69159073|FG000|Overall Study|Non-compliance with IMP|1|||
37683401|NCT02327013|69159074|FG001|Overall Study|Non-compliance with IMP|2|||
37683402|NCT02327013|69159075|FG002|Overall Study|Non-compliance with IMP|7|||
37683403|NCT02327013|69159076|FG003|Overall Study|Non-compliance with IMP|0|||
37683404|NCT02327013|69159077|FG004|Overall Study|Non-compliance with IMP|0|||
37683405|NCT02327013|69159073|FG000|Overall Study|Withdrawal of Consent|1|||
37683406|NCT02327013|69159074|FG001|Overall Study|Withdrawal of Consent|0|||
37683407|NCT02327013|69159075|FG002|Overall Study|Withdrawal of Consent|3|||
37683408|NCT02327013|69159076|FG003|Overall Study|Withdrawal of Consent|0|||
37683409|NCT02327013|69159077|FG004|Overall Study|Withdrawal of Consent|0|||
37683410|NCT02327013|69159073|FG000|Overall Study|Lost to Follow-up|2|||
37683411|NCT02327013|69159074|FG001|Overall Study|Lost to Follow-up|4|||
37683412|NCT02327013|69159075|FG002|Overall Study|Lost to Follow-up|5|||
37683413|NCT02327013|69159076|FG003|Overall Study|Lost to Follow-up|0|||
37683414|NCT02327013|69159077|FG004|Overall Study|Lost to Follow-up|0|||
37683415|NCT02327013|69159073|FG000|Overall Study|Administrative or other reason(s)|1|||
37683416|NCT02327013|69159074|FG001|Overall Study|Administrative or other reason(s)|5|||
37683417|NCT02327013|69159075|FG002|Overall Study|Administrative or other reason(s)|11|||
37683418|NCT02327013|69159076|FG003|Overall Study|Administrative or other reason(s)|1|||
37683419|NCT02327013|69159077|FG004|Overall Study|Administrative or other reason(s)|1|||
37863000|NCT01263197|69546932|FG000|Washout Period 2|Physician Decision|0|||
38083282|NCT02759016|69782476|FG000|Overall Study|Other not defined above|2|||
38083283|NCT02759016|69782477|FG001|Overall Study|Other not defined above|1|||
38083284|NCT02852967|69782489|FG000|Overall Study|Adverse Event|3|||
38083285|NCT02852967|69782490|FG001|Overall Study|Adverse Event|1|||
38083286|NCT02852967|69782491|FG002|Overall Study|Adverse Event|0|||
38083287|NCT02852967|69782492|FG003|Overall Study|Adverse Event|1|||
38083288|NCT02852967|69782493|FG004|Overall Study|Adverse Event|0|||
38083289|NCT02852967|69782489|FG000|Overall Study|Death|1|||
38083290|NCT02852967|69782490|FG001|Overall Study|Death|0|||
38083291|NCT02852967|69782491|FG002|Overall Study|Death|0|||
38083292|NCT02852967|69782492|FG003|Overall Study|Death|0|||
38083293|NCT02852967|69782493|FG004|Overall Study|Death|0|||
38083294|NCT02852967|69782489|FG000|Overall Study|Lost to Follow-up|1|||
38083295|NCT02852967|69782490|FG001|Overall Study|Lost to Follow-up|2|||
38083296|NCT02852967|69782491|FG002|Overall Study|Lost to Follow-up|3|||
38083297|NCT02852967|69782492|FG003|Overall Study|Lost to Follow-up|4|||
38083298|NCT02852967|69782493|FG004|Overall Study|Lost to Follow-up|4|||
38083299|NCT02852967|69782489|FG000|Overall Study|Withdrawal by Subject|6|||
38083300|NCT02852967|69782490|FG001|Overall Study|Withdrawal by Subject|12|||
38083301|NCT02852967|69782491|FG002|Overall Study|Withdrawal by Subject|7|||
37683420|NCT02327013|69159073|FG000|Overall Study|Protocol Violation|0|||
37683421|NCT02327013|69159074|FG001|Overall Study|Protocol Violation|0|||
37683422|NCT02327013|69159075|FG002|Overall Study|Protocol Violation|3|||
37683423|NCT02327013|69159076|FG003|Overall Study|Protocol Violation|0|||
37683424|NCT02327013|69159077|FG004|Overall Study|Protocol Violation|1|||
37683425|NCT02327013|69159073|FG000|Overall Study|Withdrawal before treatment|2|||
37683426|NCT02327013|69159074|FG001|Overall Study|Withdrawal before treatment|1|||
37683427|NCT02327013|69159075|FG002|Overall Study|Withdrawal before treatment|5|||
37683428|NCT02327013|69159076|FG003|Overall Study|Withdrawal before treatment|0|||
37683429|NCT02327013|69159077|FG004|Overall Study|Withdrawal before treatment|0|||
37683430|NCT02301975|69159100|FG000|Overall Study|Adverse Event|8|||
37683431|NCT02301975|69159101|FG001|Overall Study|Adverse Event|3|||
37683432|NCT02301975|69159102|FG002|Overall Study|Adverse Event|2|||
37683433|NCT02301975|69159100|FG000|Overall Study|Lack of Efficacy|1|||
37683434|NCT02301975|69159101|FG001|Overall Study|Lack of Efficacy|1|||
37683435|NCT02301975|69159102|FG002|Overall Study|Lack of Efficacy|1|||
37683436|NCT02301975|69159100|FG000|Overall Study|Protocol Violation|3|||
37683437|NCT02301975|69159101|FG001|Overall Study|Protocol Violation|5|||
37683438|NCT02301975|69159102|FG002|Overall Study|Protocol Violation|3|||
37683439|NCT02301975|69159100|FG000|Overall Study|Lost to Follow-up|0|||
37683440|NCT02301975|69159101|FG001|Overall Study|Lost to Follow-up|2|||
37683441|NCT02301975|69159102|FG002|Overall Study|Lost to Follow-up|2|||
37683442|NCT02301975|69159100|FG000|Overall Study|Physician Decision|4|||
37683443|NCT02301975|69159101|FG001|Overall Study|Physician Decision|2|||
37683444|NCT02301975|69159102|FG002|Overall Study|Physician Decision|3|||
37683445|NCT02301975|69159100|FG000|Overall Study|Withdrawal by Subject|15|||
37683446|NCT02301975|69159101|FG001|Overall Study|Withdrawal by Subject|12|||
37683447|NCT02301975|69159102|FG002|Overall Study|Withdrawal by Subject|11|||
37683448|NCT02301897|69159113|FG000|Treatment Course 1|Non-Compliance|0|||
37683449|NCT02301897|69159114|FG001|Treatment Course 1|Non-Compliance|0|||
37683450|NCT02301897|69159115|FG002|Treatment Course 1|Non-Compliance|1|||
37683451|NCT02301897|69159113|FG000|Treatment Course 1|Adverse Event|1|||
37683452|NCT02301897|69159114|FG001|Treatment Course 1|Adverse Event|1|||
37683453|NCT02301897|69159115|FG002|Treatment Course 1|Adverse Event|0|||
37683454|NCT02301897|69159113|FG000|Treatment Course 1|Lost to Follow-up|1|||
37683455|NCT02301897|69159114|FG001|Treatment Course 1|Lost to Follow-up|2|||
38083302|NCT02852967|69782492|FG003|Overall Study|Withdrawal by Subject|10|||
37683456|NCT02301897|69159115|FG002|Treatment Course 1|Lost to Follow-up|1|||
37683457|NCT02301897|69159113|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
37683458|NCT02301897|69159114|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
37683459|NCT02301897|69159115|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
38083303|NCT02852967|69782493|FG004|Overall Study|Withdrawal by Subject|10|||
38083304|NCT02852967|69782489|FG000|Overall Study|SAE|0|||
37683460|NCT02301897|69159113|FG000|Treatment Course 1|Withdrawal by Subject|0|||
37683461|NCT02301897|69159114|FG001|Treatment Course 1|Withdrawal by Subject|0|||
37683462|NCT02301897|69159115|FG002|Treatment Course 1|Withdrawal by Subject|2|||
37683463|NCT02301897|69159113|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
38083305|NCT02852967|69782490|FG001|Overall Study|SAE|0|||
38083306|NCT02852967|69782491|FG002|Overall Study|SAE|0|||
37683464|NCT02301897|69159114|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
38083307|NCT02852967|69782492|FG003|Overall Study|SAE|3|||
37683465|NCT02301897|69159115|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
37683466|NCT02301897|69159113|FG000|Treatment Course 2|Lost to Follow-up|0|||
37683467|NCT02301897|69159114|FG001|Treatment Course 2|Lost to Follow-up|2|||
38083308|NCT02852967|69782493|FG004|Overall Study|SAE|0|||
38083309|NCT02852967|69782489|FG000|Overall Study|Elevated Liver Enzymes|2|||
38083310|NCT02852967|69782490|FG001|Overall Study|Elevated Liver Enzymes|0|||
38083311|NCT02852967|69782491|FG002|Overall Study|Elevated Liver Enzymes|0|||
38083312|NCT02852967|69782492|FG003|Overall Study|Elevated Liver Enzymes|2|||
38083313|NCT02852967|69782493|FG004|Overall Study|Elevated Liver Enzymes|2|||
38083314|NCT02852967|69782489|FG000|Overall Study|Physician Decision|0|||
37683468|NCT02301897|69159115|FG002|Treatment Course 2|Lost to Follow-up|0|||
37683469|NCT02301897|69159113|FG000|Treatment Course 2|Pregnancy|0|||
37683470|NCT02301897|69159114|FG001|Treatment Course 2|Pregnancy|1|||
38083315|NCT02852967|69782490|FG001|Overall Study|Physician Decision|0|||
38083316|NCT02852967|69782491|FG002|Overall Study|Physician Decision|0|||
37683471|NCT02301897|69159115|FG002|Treatment Course 2|Pregnancy|1|||
38083317|NCT02852967|69782492|FG003|Overall Study|Physician Decision|1|||
37683472|NCT02301897|69159113|FG000|Treatment Course 2|Withdrawal by Subject|0|||
37683473|NCT02301897|69159114|FG001|Treatment Course 2|Withdrawal by Subject|2|||
37967106|NCT00535236|69653999|FG003|Overall Study|Lost to Follow-up|0|||
37967107|NCT00535236|69654000|FG004|Overall Study|Lost to Follow-up|2|||
38083318|NCT02852967|69782493|FG004|Overall Study|Physician Decision|0|||
38083319|NCT02852967|69782489|FG000|Overall Study|Lack of Efficacy|0|||
38083320|NCT02852967|69782490|FG001|Overall Study|Lack of Efficacy|1|||
38083321|NCT02852967|69782491|FG002|Overall Study|Lack of Efficacy|0|||
38083322|NCT02852967|69782492|FG003|Overall Study|Lack of Efficacy|0|||
38083323|NCT02852967|69782493|FG004|Overall Study|Lack of Efficacy|0|||
38083324|NCT02852967|69782489|FG000|Overall Study|Non-compliance|0|||
38083325|NCT02852967|69782490|FG001|Overall Study|Non-compliance|0|||
38083326|NCT02852967|69782491|FG002|Overall Study|Non-compliance|1|||
38083327|NCT02852967|69782492|FG003|Overall Study|Non-compliance|1|||
38083328|NCT02852967|69782493|FG004|Overall Study|Non-compliance|0|||
38083329|NCT02852967|69782489|FG000|Overall Study|Dispensing Drug Violation|0|||
38083330|NCT02852967|69782490|FG001|Overall Study|Dispensing Drug Violation|0|||
38083331|NCT02852967|69782491|FG002|Overall Study|Dispensing Drug Violation|1|||
38083332|NCT02852967|69782492|FG003|Overall Study|Dispensing Drug Violation|0|||
38083333|NCT02852967|69782493|FG004|Overall Study|Dispensing Drug Violation|0|||
38083334|NCT02852967|69782489|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
38083335|NCT02852967|69782490|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
38083336|NCT02852967|69782491|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
38083337|NCT02852967|69782492|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
38083338|NCT02852967|69782493|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
38083339|NCT02762994|69782521|FG000|Overall Study|Withdrawal by Subject|0|||
38083340|NCT02762994|69782522|FG001|Overall Study|Withdrawal by Subject|1|||
38083341|NCT02762994|69782523|FG002|Overall Study|Withdrawal by Subject|2|||
38083342|NCT02762994|69782524|FG003|Overall Study|Withdrawal by Subject|0|||
38083343|NCT02762994|69782521|FG000|Overall Study|Protocol Violation|1|||
38083344|NCT02762994|69782522|FG001|Overall Study|Protocol Violation|0|||
38083345|NCT02762994|69782523|FG002|Overall Study|Protocol Violation|0|||
38083346|NCT02762994|69782524|FG003|Overall Study|Protocol Violation|2|||
38083347|NCT02852265|69782540|FG000|3-month Follow-up|Lost to Follow-up|1|||
38083348|NCT02852265|69782541|FG001|3-month Follow-up|Lost to Follow-up|1|||
38083349|NCT02633800|69782553|FG000|Overall Study|Death|3|||
38083350|NCT02633800|69782554|FG001|Overall Study|Death|3|||
38083351|NCT02633800|69782553|FG000|Overall Study|Reason not provided|1|||
38083352|NCT02633800|69782554|FG001|Overall Study|Reason not provided|0|||
38083353|NCT02633800|69782553|FG000|Overall Study|Radiologic(al) progression|23|||
38083354|NCT02633800|69782554|FG001|Overall Study|Radiologic(al) progression|23|||
38083355|NCT02633800|69782553|FG000|Overall Study|Clinical progression|3|||
38083356|NCT02633800|69782554|FG001|Overall Study|Clinical progression|6|||
38083357|NCT02633800|69782553|FG000|Overall Study|Study terminated by sponsor|6|||
38083358|NCT02633800|69782554|FG001|Overall Study|Study terminated by sponsor|5|||
38083359|NCT02633800|69782553|FG000|Overall Study|Adverse event, non-fatal|7|||
38083360|NCT02633800|69782554|FG001|Overall Study|Adverse event, non-fatal|2|||
37967108|NCT00535236|69654001|FG005|Overall Study|Lost to Follow-up|0|||
38083361|NCT02633800|69782553|FG000|Overall Study|Withdrawal by Subject|0|||
38083362|NCT02633800|69782554|FG001|Overall Study|Withdrawal by Subject|3|||
38083363|NCT02633800|69782553|FG000|Overall Study|Patient Request|1|||
37683474|NCT02301897|69159115|FG002|Treatment Course 2|Withdrawal by Subject|0|||
37683475|NCT02301897|69159113|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
37683476|NCT02301897|69159114|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
37683477|NCT02301897|69159115|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
37683478|NCT02301429|69159123|FG000|Overall Study|not acceptable vascular anatomy|3|||
37683479|NCT02300259|69159130|FG000|Period 1|Adverse Event|0|||
37683480|NCT02300259|69159131|FG001|Period 1|Adverse Event|0|||
37683481|NCT02300259|69159132|FG002|Period 1|Adverse Event|1|||
38083364|NCT02633800|69782554|FG001|Overall Study|Patient Request|1|||
38083365|NCT03829657|69782563|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
38083366|NCT03829657|69782564|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
38083367|NCT03829657|69782565|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
38083368|NCT03829657|69782566|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
38083369|NCT03829657|69782567|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
38083370|NCT03829657|69782563|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
38083371|NCT03829657|69782564|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
38083372|NCT03829657|69782565|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
38083373|NCT03829657|69782566|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
38083374|NCT03829657|69782567|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
38083375|NCT03829657|69782563|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
38083376|NCT03829657|69782564|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
38083377|NCT03829657|69782565|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
38083378|NCT03829657|69782566|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
38083379|NCT03829657|69782567|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
38083380|NCT03829657|69782563|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
38083381|NCT03829657|69782564|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
38083382|NCT03829657|69782565|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
38083383|NCT03829657|69782566|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
38083384|NCT03829657|69782567|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
38083385|NCT03829657|69782563|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
38083386|NCT03829657|69782564|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
38083387|NCT03829657|69782565|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
38083388|NCT03829657|69782566|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
38083389|NCT03829657|69782567|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
38083390|NCT03829657|69782563|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
38083391|NCT03829657|69782564|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
38083392|NCT03829657|69782565|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
38083393|NCT03829657|69782566|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
38083394|NCT03829657|69782567|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
38083395|NCT03829657|69782563|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
38083396|NCT03829657|69782564|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
38083397|NCT03829657|69782565|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
38083398|NCT03829657|69782566|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
38083399|NCT03829657|69782567|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
38083400|NCT03829657|69782563|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
37683482|NCT02300259|69159130|FG000|Period 1|Withdrawal by Subject|0|||
37683483|NCT02300259|69159131|FG001|Period 1|Withdrawal by Subject|0|||
38083401|NCT03829657|69782564|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
38083402|NCT03829657|69782565|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
38083403|NCT03829657|69782566|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
38083404|NCT03829657|69782567|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
38083405|NCT03829657|69782563|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
38083406|NCT03829657|69782564|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
38083407|NCT03829657|69782565|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
38083408|NCT03829657|69782566|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
38083409|NCT03829657|69782567|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
38083410|NCT03829657|69782563|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
38083411|NCT03829657|69782564|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
37683484|NCT02300259|69159132|FG002|Period 1|Withdrawal by Subject|1|||
37683485|NCT02300259|69159130|FG000|Period 2|Adverse Event|1|||
37683486|NCT02300259|69159131|FG001|Period 2|Adverse Event|0|||
37683487|NCT02300259|69159132|FG002|Period 2|Adverse Event|0|||
37683488|NCT02300259|69159130|FG000|Period 2|Withdrawal by Subject|0|||
37683489|NCT02300259|69159131|FG001|Period 2|Withdrawal by Subject|0|||
37683490|NCT02300259|69159132|FG002|Period 2|Withdrawal by Subject|1|||
37683491|NCT02367885|69159154|FG000|Overall Study|Lost to Follow-up|1|||
37683492|NCT02367885|69159155|FG001|Overall Study|Lost to Follow-up|0|||
37683493|NCT02367885|69159156|FG002|Overall Study|Lost to Follow-up|0|||
37683494|NCT02367885|69159154|FG000|Overall Study|Withdrawal by Subject|1|||
37683495|NCT02367885|69159155|FG001|Overall Study|Withdrawal by Subject|0|||
37683496|NCT02367885|69159156|FG002|Overall Study|Withdrawal by Subject|0|||
37683497|NCT02367729|69159169|FG000|Overall Study|Organic disorder diagnosed|2|||
37683498|NCT02367729|69159170|FG001|Overall Study|Organic disorder diagnosed|1|||
37683499|NCT02367729|69159169|FG000|Overall Study|Adverse Event|1|||
37683500|NCT02367729|69159170|FG001|Overall Study|Adverse Event|2|||
37683501|NCT02367729|69159169|FG000|Overall Study|Withdrawal by Subject|0|||
37683502|NCT02367729|69159170|FG001|Overall Study|Withdrawal by Subject|5|||
37683503|NCT02366637|69159177|FG000|First Intervention Period|Adverse Event|0|||
37683504|NCT02366637|69159178|FG001|First Intervention Period|Adverse Event|1|||
37683505|NCT02366637|69159177|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
37683506|NCT02366637|69159178|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
37683507|NCT02366637|69159177|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
37683508|NCT02366637|69159178|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
37683509|NCT02300103|69159184|FG000|Overall Study|Lack of Efficacy|3|||
37683510|NCT02300103|69159184|FG000|Overall Study|Protocol Violation|1|||
37683511|NCT02300103|69159184|FG000|Overall Study|Withdrew Consent|2|||
37683512|NCT02326467|69159188|FG000|Overall Study|Withdrawal by Subject|1|||
37683513|NCT02299635|69159193|FG000|Overall Study|Adverse Event|2|||
37683514|NCT02299635|69159193|FG000|Overall Study|Death|1|||
37683515|NCT02299635|69159193|FG000|Overall Study|Global deterioration of health status|1|||
37683516|NCT02299635|69159193|FG000|Overall Study|Objective progression or relapse|10|||
37683517|NCT02299635|69159193|FG000|Overall Study|Withdrawal by Subject|2|||
37683518|NCT02299635|69159193|FG000|Overall Study|Other|3|||
37683519|NCT02366091|69159201|FG000|Overall Study|Withdrawal by Subject|3|||
37683520|NCT02366091|69159202|FG001|Overall Study|Withdrawal by Subject|7|||
37683521|NCT02366091|69159203|FG002|Overall Study|Withdrawal by Subject|3|||
37683522|NCT02366091|69159204|FG003|Overall Study|Withdrawal by Subject|1|||
37683523|NCT02326155|69159216|FG000|Overall Study|Adverse Event|21|||
37683524|NCT02326155|69159217|FG001|Overall Study|Adverse Event|5|||
37683525|NCT02326155|69159216|FG000|Overall Study|Death|3|||
37683526|NCT02326155|69159217|FG001|Overall Study|Death|0|||
37683527|NCT02326155|69159216|FG000|Overall Study|Lack of Efficacy|49|||
37683528|NCT02326155|69159217|FG001|Overall Study|Lack of Efficacy|5|||
37683529|NCT02326155|69159216|FG000|Overall Study|Lost to Follow-up|14|||
37683530|NCT02326155|69159217|FG001|Overall Study|Lost to Follow-up|3|||
37683531|NCT02326155|69159216|FG000|Overall Study|Protocol Violation|2|||
37683532|NCT02326155|69159217|FG001|Overall Study|Protocol Violation|0|||
37683533|NCT02326155|69159216|FG000|Overall Study|Withdrawal by Subject|34|||
37683534|NCT02326155|69159217|FG001|Overall Study|Withdrawal by Subject|11|||
37683535|NCT02326155|69159216|FG000|Overall Study|Disease progression|37|||
37683536|NCT02326155|69159217|FG001|Overall Study|Disease progression|4|||
37683537|NCT02326155|69159216|FG000|Overall Study|Study close|188|||
37683538|NCT02326155|69159217|FG001|Overall Study|Study close|21|||
37683539|NCT02326155|69159216|FG000|Overall Study|except for study close|46|||
37683540|NCT02326155|69159217|FG001|Overall Study|except for study close|13|||
37683541|NCT02299167|69159223|FG000|Overall Study|patients were excluded from the study|11|||
37683542|NCT01647711|69159232|FG000|Overall Study|Progressive disease|6|||
37683543|NCT01647711|69159233|FG001|Overall Study|Progressive disease|2|||
37683544|NCT01647711|69159234|FG002|Overall Study|Progressive disease|6|||
37683545|NCT01647711|69159235|FG003|Overall Study|Progressive disease|8|||
37683546|NCT01647711|69159236|FG004|Overall Study|Progressive disease|2|||
37863001|NCT01263197|69546933|FG001|Washout Period 2|Physician Decision|0|||
37683547|NCT01647711|69159232|FG000|Overall Study|Other adverse event|0|||
37683548|NCT01647711|69159233|FG001|Overall Study|Other adverse event|0|||
37683549|NCT01647711|69159234|FG002|Overall Study|Other adverse event|2|||
37683550|NCT01647711|69159235|FG003|Overall Study|Other adverse event|0|||
37683551|NCT01647711|69159236|FG004|Overall Study|Other adverse event|2|||
37683552|NCT01647711|69159232|FG000|Overall Study|Protocol Violation|0|||
37683553|NCT01647711|69159233|FG001|Overall Study|Protocol Violation|0|||
37683554|NCT01647711|69159234|FG002|Overall Study|Protocol Violation|0|||
37683555|NCT01647711|69159235|FG003|Overall Study|Protocol Violation|0|||
37683556|NCT01647711|69159236|FG004|Overall Study|Protocol Violation|1|||
37683557|NCT01647711|69159232|FG000|Overall Study|Refused to continue taking medication|0|||
37683558|NCT01647711|69159233|FG001|Overall Study|Refused to continue taking medication|0|||
37683559|NCT01647711|69159234|FG002|Overall Study|Refused to continue taking medication|0|||
37683560|NCT01647711|69159235|FG003|Overall Study|Refused to continue taking medication|2|||
37683561|NCT01647711|69159236|FG004|Overall Study|Refused to continue taking medication|1|||
37683562|NCT01647711|69159232|FG000|Overall Study|Other reason not defined|0|||
37683563|NCT01647711|69159233|FG001|Overall Study|Other reason not defined|1|||
37683564|NCT01647711|69159234|FG002|Overall Study|Other reason not defined|1|||
37683565|NCT01647711|69159235|FG003|Overall Study|Other reason not defined|1|||
37683566|NCT01647711|69159236|FG004|Overall Study|Other reason not defined|0|||
37683567|NCT02547233|69159252|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
37683568|NCT02547233|69159253|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
37683569|NCT02547233|69159252|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
37683570|NCT02547233|69159253|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
37683571|NCT02547233|69159252|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
37683572|NCT02547233|69159253|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
37683573|NCT02547233|69159252|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
37683574|NCT02547233|69159253|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
37683575|NCT02547233|69159252|FG000|12-month Follow-up|Withdrawal by Subject|10|||
37683576|NCT02547233|69159253|FG001|12-month Follow-up|Withdrawal by Subject|10|||
37683577|NCT02547233|69159252|FG000|12-month Follow-up|Lost to Follow-up|3|||
37683578|NCT02547233|69159253|FG001|12-month Follow-up|Lost to Follow-up|3|||
37683579|NCT02547233|69159252|FG000|12-month Follow-up|Lack of Efficacy|1|||
37683580|NCT02547233|69159253|FG001|12-month Follow-up|Lack of Efficacy|2|||
37683581|NCT02547233|69159252|FG000|12-month Follow-up|Protocol Violation|0|||
37683582|NCT02547233|69159253|FG001|12-month Follow-up|Protocol Violation|1|||
37683583|NCT02547233|69159252|FG000|12-month Follow-up|Other|0|||
37683584|NCT02547233|69159253|FG001|12-month Follow-up|Other|1|||
37683585|NCT02546765|69159265|FG000|Overall Study|Withdrawal by Subject|0|||
37683586|NCT02546765|69159266|FG001|Overall Study|Withdrawal by Subject|1|||
37683587|NCT02546765|69159267|FG002|Overall Study|Withdrawal by Subject|0|||
37683588|NCT02546765|69159268|FG003|Overall Study|Withdrawal by Subject|0|||
37683589|NCT02553629|69159291|FG000|Overall Study|Logistic reasons|3|||
37683590|NCT02553629|69159292|FG001|Overall Study|Logistic reasons|6|||
37683591|NCT02546609|69159301|FG000|Overall Study|Withdrawal by Subject|0|||
37683592|NCT02546609|69159302|FG001|Overall Study|Withdrawal by Subject|1|||
38083412|NCT03829657|69782565|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
37683593|NCT02546609|69159303|FG002|Overall Study|Withdrawal by Subject|2|||
37683594|NCT02546609|69159301|FG000|Overall Study|Adverse Event|0|||
37683595|NCT02546609|69159302|FG001|Overall Study|Adverse Event|6|||
37683596|NCT02546609|69159303|FG002|Overall Study|Adverse Event|1|||
38083413|NCT03829657|69782566|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
38083414|NCT03829657|69782567|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
38083415|NCT03035227|69782578|FG000|Overall Study|study stopped due to PI leaving institut|1|||
38083416|NCT03035227|69782579|FG001|Overall Study|study stopped due to PI leaving institut|1|||
38083417|NCT00100932|69782589|FG000|Overall Study|Adverse Event|11|||
38083418|NCT00100932|69782590|FG001|Overall Study|Adverse Event|2|||
38083419|NCT00100932|69782589|FG000|Overall Study|Withdrawal by Subject|6|||
38083420|NCT00100932|69782590|FG001|Overall Study|Withdrawal by Subject|0|||
38083421|NCT00100932|69782589|FG000|Overall Study|Progressive Disease|44|||
38083422|NCT00100932|69782590|FG001|Overall Study|Progressive Disease|18|||
38083423|NCT00100932|69782589|FG000|Overall Study|Physician Decision|7|||
38083424|NCT00100932|69782590|FG001|Overall Study|Physician Decision|5|||
38083425|NCT00100932|69782589|FG000|Overall Study|Other|5|||
38083426|NCT00100932|69782590|FG001|Overall Study|Other|2|||
38083427|NCT03180307|69782598|FG000|Overall Study|Lost to Follow-up|2|||
38083428|NCT03180307|69782599|FG001|Overall Study|Lost to Follow-up|0|||
38083429|NCT03180307|69782598|FG000|Overall Study|Death|1|||
37683597|NCT02546609|69159301|FG000|Overall Study|Protocol Violation|0|||
37683598|NCT02546609|69159302|FG001|Overall Study|Protocol Violation|1|||
37683599|NCT02546609|69159303|FG002|Overall Study|Protocol Violation|1|||
37683600|NCT02546609|69159301|FG000|Overall Study|Lost to Follow-up|2|||
37683601|NCT02546609|69159302|FG001|Overall Study|Lost to Follow-up|3|||
37683602|NCT02546609|69159303|FG002|Overall Study|Lost to Follow-up|1|||
38083430|NCT03180307|69782599|FG001|Overall Study|Death|0|||
37683603|NCT02546609|69159301|FG000|Overall Study|travel or work schedule restriction|0|||
37683604|NCT02546609|69159302|FG001|Overall Study|travel or work schedule restriction|0|||
37683605|NCT02546609|69159303|FG002|Overall Study|travel or work schedule restriction|2|||
38083431|NCT03180307|69782598|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
38083432|NCT03180307|69782599|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
38083433|NCT02848833|69782603|FG000|Overall Study|subject who are duplicated|1|||
38083434|NCT02848833|69782603|FG000|Overall Study|have not taken the study drug|11|||
38083435|NCT02848833|69782603|FG000|Overall Study|follow-up failure|6|||
38083436|NCT02848833|69782603|FG000|Overall Study|Protocol Violation|119|||
38083437|NCT03361189|69782609|FG000|Overall Study|Received heart transplant|1|||
38083438|NCT03361189|69782610|FG001|Overall Study|Received heart transplant|0|||
38083439|NCT03361189|69782609|FG000|Overall Study|Pacemake replacement|0|||
38083440|NCT03361189|69782610|FG001|Overall Study|Pacemake replacement|1|||
38083441|NCT00092131|69782618|FG000|Treatment Period I|Adverse Event|1|||
38083442|NCT00092131|69782619|FG001|Treatment Period I|Adverse Event|0|||
38083443|NCT00092131|69782618|FG000|Treatment Period II|Adverse Event|0|||
38083444|NCT00092131|69782619|FG001|Treatment Period II|Adverse Event|1|||
38083445|NCT02668783|69782627|FG000|Overall Study|Pregnancy|0|||
37683606|NCT02553317|69159313|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
37683607|NCT02553317|69159314|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
37683608|NCT02553317|69159313|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
37683609|NCT02553317|69159314|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
37683610|NCT02553317|69159313|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
37683611|NCT02553317|69159314|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
37683612|NCT02553317|69159313|FG000|Overall Treatment Period + Follow-up|Death|1|||
37683613|NCT02553317|69159314|FG001|Overall Treatment Period + Follow-up|Death|3|||
37683614|NCT02553317|69159313|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
37683615|NCT02553317|69159314|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
37683616|NCT02553317|69159313|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
37683617|NCT02553317|69159314|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
37683618|NCT02553317|69159313|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
37683619|NCT02553317|69159314|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
37683620|NCT02553317|69159313|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
37683621|NCT02553317|69159314|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
37683622|NCT02553317|69159313|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
37683623|NCT02553317|69159314|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
37683624|NCT02553317|69159313|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
37683625|NCT02553317|69159314|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
37683626|NCT02325219|69159324|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
37683627|NCT02325219|69159325|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
37683628|NCT02325219|69159326|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
37683629|NCT02325219|69159327|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
37683630|NCT02325219|69159328|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
37683631|NCT02325219|69159324|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
37683632|NCT02325219|69159325|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
37683633|NCT02325219|69159326|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
37683634|NCT02325219|69159327|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
37683635|NCT02325219|69159328|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
37683636|NCT02325219|69159324|FG000|Controlled Period (Week 0 - 16)|Other|0|||
37683637|NCT02325219|69159325|FG001|Controlled Period (Week 0 - 16)|Other|0|||
37683638|NCT02325219|69159326|FG002|Controlled Period (Week 0 - 16)|Other|1|||
37683639|NCT02325219|69159327|FG003|Controlled Period (Week 0 - 16)|Other|0|||
37683640|NCT02325219|69159328|FG004|Controlled Period (Week 0 - 16)|Other|0|||
37683641|NCT02325219|69159324|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
37683642|NCT02325219|69159325|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
37683643|NCT02325219|69159326|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
37683644|NCT02325219|69159327|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
37683645|NCT02325219|69159328|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
37683646|NCT02325219|69159324|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
37683647|NCT02325219|69159325|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
37683648|NCT02325219|69159326|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
37683649|NCT02325219|69159327|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
37683650|NCT02325219|69159328|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
37683651|NCT02325219|69159324|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
37683652|NCT02325219|69159325|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
37683653|NCT02325219|69159326|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
37683654|NCT02325219|69159327|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
37683655|NCT02325219|69159328|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
37683656|NCT02297841|69159344|FG000|Overall Study|Withdrawal by Subject|1|||
37683657|NCT02297841|69159344|FG000|Overall Study|Protocol Violation|7|||
37683658|NCT02324361|69159350|FG000|Overall Study|Lost to Follow-up|5|||
37683659|NCT02324361|69159351|FG001|Overall Study|Lost to Follow-up|2|||
37683660|NCT02365233|69159360|FG000|Overall Study|IRB withheld the data|1|||
37683661|NCT02365233|69159361|FG001|Overall Study|IRB withheld the data|2|||
37683662|NCT02365233|69159362|FG002|Overall Study|IRB withheld the data|2|||
37683663|NCT02324205|69159370|FG000|Overall Study|Withdrawal by Subject|37|||
37683664|NCT02324049|69159374|FG000|Part C|Study terminated|11|||
37683665|NCT02364999|69159380|FG000|Overall Study|Death|136|||
37683666|NCT02364999|69159381|FG001|Overall Study|Death|138|||
37683667|NCT02364999|69159380|FG000|Overall Study|Lost to Follow-up|10|||
37683668|NCT02364999|69159381|FG001|Overall Study|Lost to Follow-up|15|||
37683669|NCT02364999|69159380|FG000|Overall Study|Protocol Violation|3|||
37683670|NCT02364999|69159381|FG001|Overall Study|Protocol Violation|2|||
37683671|NCT02364999|69159380|FG000|Overall Study|Withdrawal by Subject|14|||
37683672|NCT02364999|69159381|FG001|Overall Study|Withdrawal by Subject|14|||
37683673|NCT02364999|69159380|FG000|Overall Study|Other|0|||
37683674|NCT02364999|69159381|FG001|Overall Study|Other|1|||
37683675|NCT02364999|69159380|FG000|Overall Study|Randomized but did not receive treatment|2|||
37683676|NCT02364999|69159381|FG001|Overall Study|Randomized but did not receive treatment|3|||
37683677|NCT02322879|69159390|FG000|First Intervention|Physician Decision|1|||
37683678|NCT02322879|69159391|FG001|First Intervention|Physician Decision|0|||
37683679|NCT02322411|69159399|FG000|Overall Study|Lost to Follow-up|4|||
37683680|NCT02322411|69159400|FG001|Overall Study|Lost to Follow-up|7|||
37683681|NCT02322411|69159399|FG000|Overall Study|Withdrawal by Subject|1|||
37683682|NCT02322411|69159400|FG001|Overall Study|Withdrawal by Subject|0|||
37683683|NCT02322021|69159410|FG000|Core Phase|Adverse Event|1|||
37683684|NCT02322021|69159411|FG001|Core Phase|Adverse Event|3|||
37683685|NCT02322021|69159412|FG002|Core Phase|Adverse Event|4|||
37683686|NCT02322021|69159413|FG003|Core Phase|Adverse Event|2|||
37683687|NCT02322021|69159414|FG004|Core Phase|Adverse Event|0|||
37683688|NCT02322021|69159410|FG000|Core Phase|Participant Choice|4|||
37683689|NCT02322021|69159411|FG001|Core Phase|Participant Choice|5|||
37683690|NCT02322021|69159412|FG002|Core Phase|Participant Choice|4|||
37683691|NCT02322021|69159413|FG003|Core Phase|Participant Choice|2|||
37683692|NCT02322021|69159414|FG004|Core Phase|Participant Choice|0|||
37683693|NCT02322021|69159410|FG000|Core Phase|Lost to Follow-up|0|||
37683694|NCT02322021|69159411|FG001|Core Phase|Lost to Follow-up|0|||
37683695|NCT02322021|69159412|FG002|Core Phase|Lost to Follow-up|0|||
37683696|NCT02322021|69159413|FG003|Core Phase|Lost to Follow-up|1|||
37683697|NCT02322021|69159414|FG004|Core Phase|Lost to Follow-up|0|||
37683698|NCT02322021|69159410|FG000|Core Phase|Other|0|||
37683699|NCT02322021|69159411|FG001|Core Phase|Other|0|||
37683700|NCT02322021|69159412|FG002|Core Phase|Other|1|||
37683701|NCT02322021|69159413|FG003|Core Phase|Other|0|||
37683702|NCT02322021|69159414|FG004|Core Phase|Other|0|||
37683703|NCT02322021|69159410|FG000|Extension Phase|Adverse Event|0|||
37683704|NCT02322021|69159411|FG001|Extension Phase|Adverse Event|0|||
37683705|NCT02322021|69159412|FG002|Extension Phase|Adverse Event|0|||
37683706|NCT02322021|69159413|FG003|Extension Phase|Adverse Event|0|||
37683707|NCT02322021|69159414|FG004|Extension Phase|Adverse Event|3|||
37683708|NCT02322021|69159410|FG000|Extension Phase|Participant Choice|0|||
37683709|NCT02322021|69159411|FG001|Extension Phase|Participant Choice|0|||
37683710|NCT02322021|69159412|FG002|Extension Phase|Participant Choice|0|||
37683711|NCT02322021|69159413|FG003|Extension Phase|Participant Choice|0|||
37683712|NCT02322021|69159414|FG004|Extension Phase|Participant Choice|6|||
37683713|NCT02322021|69159410|FG000|Extension Phase|Other|0|||
37683714|NCT02322021|69159411|FG001|Extension Phase|Other|0|||
37683715|NCT02322021|69159412|FG002|Extension Phase|Other|0|||
37683716|NCT02322021|69159413|FG003|Extension Phase|Other|0|||
37683717|NCT02322021|69159414|FG004|Extension Phase|Other|3|||
37683718|NCT02322021|69159410|FG000|Extension Phase|Lost to Follow-up|0|||
37683719|NCT02322021|69159411|FG001|Extension Phase|Lost to Follow-up|0|||
37683720|NCT02322021|69159412|FG002|Extension Phase|Lost to Follow-up|0|||
37683721|NCT02322021|69159413|FG003|Extension Phase|Lost to Follow-up|0|||
37683722|NCT02322021|69159414|FG004|Extension Phase|Lost to Follow-up|1|||
37683723|NCT02322021|69159410|FG000|Extension Phase|Study terminated by sponsor|0|||
37683724|NCT02322021|69159411|FG001|Extension Phase|Study terminated by sponsor|0|||
37683725|NCT02322021|69159412|FG002|Extension Phase|Study terminated by sponsor|0|||
37683726|NCT02322021|69159413|FG003|Extension Phase|Study terminated by sponsor|0|||
37683727|NCT02322021|69159414|FG004|Extension Phase|Study terminated by sponsor|28|||
37683728|NCT02363439|69159429|FG000|Overall Study|Lack of Efficacy|4|||
37683729|NCT02363283|69159433|FG000|Overall Study|Withdrawal by Subject|1|||
37683730|NCT02363283|69159433|FG000|Overall Study|Not eligible due to transaminitis|1|||
37683731|NCT02321319|69159437|FG000|Overall Study|Product discontinued|5|||
37683732|NCT02294175|69159443|FG000|Overall Study|Withdrawal by Subject|1|||
37683733|NCT02294175|69159444|FG001|Overall Study|Withdrawal by Subject|2|||
37683734|NCT02294175|69159443|FG000|Overall Study|pt taking excluded medication|3|||
37683735|NCT02294175|69159444|FG001|Overall Study|pt taking excluded medication|1|||
37683736|NCT02294175|69159443|FG000|Overall Study|Protocol Violation|1|||
37683737|NCT02294175|69159444|FG001|Overall Study|Protocol Violation|0|||
37683738|NCT02294175|69159443|FG000|Overall Study|Lost to Follow-up|0|||
37683739|NCT02294175|69159444|FG001|Overall Study|Lost to Follow-up|1|||
37683740|NCT02294175|69159443|FG000|Overall Study|wound healed|0|||
37683741|NCT02294175|69159444|FG001|Overall Study|wound healed|2|||
37683742|NCT02088541|69159455|FG000|Overall Study|Adverse Event|3|||
37683743|NCT02088541|69159456|FG001|Overall Study|Adverse Event|0|||
37683744|NCT02088541|69159457|FG002|Overall Study|Adverse Event|3|||
37683745|NCT02088541|69159458|FG003|Overall Study|Adverse Event|3|||
37683746|NCT02088541|69159459|FG004|Overall Study|Adverse Event|0|||
37683747|NCT02088541|69159455|FG000|Overall Study|Death|51|||
37683748|NCT02088541|69159456|FG001|Overall Study|Death|21|||
37683749|NCT02088541|69159457|FG002|Overall Study|Death|85|||
37683750|NCT02088541|69159458|FG003|Overall Study|Death|28|||
37683751|NCT02088541|69159459|FG004|Overall Study|Death|38|||
37683752|NCT02088541|69159455|FG000|Overall Study|Lost to Follow-up|2|||
37683753|NCT02088541|69159456|FG001|Overall Study|Lost to Follow-up|0|||
37683754|NCT02088541|69159457|FG002|Overall Study|Lost to Follow-up|1|||
37683755|NCT02088541|69159458|FG003|Overall Study|Lost to Follow-up|0|||
37683756|NCT02088541|69159459|FG004|Overall Study|Lost to Follow-up|0|||
37683757|NCT02088541|69159455|FG000|Overall Study|Physician Decision|2|||
37683758|NCT02088541|69159456|FG001|Overall Study|Physician Decision|1|||
37683759|NCT02088541|69159457|FG002|Overall Study|Physician Decision|2|||
37683760|NCT02088541|69159458|FG003|Overall Study|Physician Decision|0|||
37683761|NCT02088541|69159459|FG004|Overall Study|Physician Decision|2|||
37683762|NCT02088541|69159455|FG000|Overall Study|Disease progression|7|||
37683763|NCT02088541|69159456|FG001|Overall Study|Disease progression|1|||
37683764|NCT02088541|69159457|FG002|Overall Study|Disease progression|2|||
37683765|NCT02088541|69159458|FG003|Overall Study|Disease progression|3|||
37683766|NCT02088541|69159459|FG004|Overall Study|Disease progression|1|||
37683767|NCT02088541|69159455|FG000|Overall Study|Study terminated by sponsor|1|||
37683768|NCT02088541|69159456|FG001|Overall Study|Study terminated by sponsor|1|||
37683769|NCT02088541|69159457|FG002|Overall Study|Study terminated by sponsor|12|||
37683770|NCT02088541|69159458|FG003|Overall Study|Study terminated by sponsor|2|||
37683771|NCT02088541|69159459|FG004|Overall Study|Study terminated by sponsor|6|||
37683772|NCT02088541|69159455|FG000|Overall Study|Withdrawal by Subject|3|||
37683773|NCT02088541|69159456|FG001|Overall Study|Withdrawal by Subject|2|||
37683774|NCT02088541|69159457|FG002|Overall Study|Withdrawal by Subject|9|||
37683775|NCT02088541|69159458|FG003|Overall Study|Withdrawal by Subject|7|||
37683776|NCT02088541|69159459|FG004|Overall Study|Withdrawal by Subject|10|||
37683777|NCT02088541|69159455|FG000|Overall Study|Other|2|||
37683778|NCT02088541|69159456|FG001|Overall Study|Other|1|||
37683779|NCT02088541|69159457|FG002|Overall Study|Other|3|||
37683780|NCT02088541|69159458|FG003|Overall Study|Other|1|||
37683781|NCT02088541|69159459|FG004|Overall Study|Other|1|||
37683782|NCT02294019|69159469|FG000|Overall Study|Adverse Event|2|||
37683783|NCT02294019|69159469|FG000|Overall Study|Protocol Violation|68|||
37683784|NCT02294019|69159469|FG000|Overall Study|Lost to Follow-up|31|||
37683785|NCT02294019|69159469|FG000|Overall Study|Other|1|||
37683786|NCT02294019|69159469|FG000|Overall Study|Withdrawal by Subject|1|||
37683787|NCT02320149|69159475|FG000|Overall Study|Adverse Event|3|||
37683788|NCT02320149|69159476|FG001|Overall Study|Adverse Event|7|||
37683789|NCT02320149|69159475|FG000|Overall Study|Withdrawal of Consent|28|||
37683790|NCT02320149|69159476|FG001|Overall Study|Withdrawal of Consent|32|||
37967109|NCT00535236|69654002|FG006|Overall Study|Lost to Follow-up|0|||
38083446|NCT02668783|69782628|FG001|Overall Study|Pregnancy|1|||
38083447|NCT02668783|69782627|FG000|Overall Study|Protocol Violation|2|||
38083448|NCT02668783|69782628|FG001|Overall Study|Protocol Violation|1|||
38083449|NCT02668783|69782627|FG000|Overall Study|Study terminated by sponsor|9|||
38083450|NCT02668783|69782628|FG001|Overall Study|Study terminated by sponsor|10|||
38083451|NCT02668783|69782627|FG000|Overall Study|Subject moved|1|||
38083452|NCT02668783|69782628|FG001|Overall Study|Subject moved|0|||
38083453|NCT02668783|69782627|FG000|Overall Study|Withdrawal by Subject|1|||
38083454|NCT02668783|69782628|FG001|Overall Study|Withdrawal by Subject|0|||
38083455|NCT00101010|69782634|FG000|Overall Study|Physician Decision|1|||
38083456|NCT02848599|69782640|FG000|Overall Study|Protocol Violation|7|||
38083457|NCT02848599|69782641|FG001|Overall Study|Protocol Violation|9|||
38083458|NCT00778999|69782672|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
38083459|NCT00778999|69782673|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
38083460|NCT00778999|69782672|FG000|Overall Study|Did not receive recFSH|14|||
38083461|NCT00778999|69782673|FG001|Overall Study|Did not receive recFSH|20|||
38083462|NCT02631850|69782683|FG000|Treatment Period|Lost to Follow-up|0|||
38083463|NCT02631850|69782684|FG001|Treatment Period|Lost to Follow-up|1|||
38083464|NCT02631850|69782685|FG002|Treatment Period|Lost to Follow-up|0|||
38083465|NCT02631850|69782686|FG003|Treatment Period|Lost to Follow-up|0|||
38083466|NCT02631850|69782683|FG000|Treatment Period|Protocol Violation|1|||
38083467|NCT02631850|69782684|FG001|Treatment Period|Protocol Violation|0|||
38083468|NCT02631850|69782685|FG002|Treatment Period|Protocol Violation|0|||
38083469|NCT02631850|69782686|FG003|Treatment Period|Protocol Violation|0|||
38083470|NCT02631850|69782683|FG000|Treatment Period|Withdrawal by Subject|0|||
38083471|NCT02631850|69782684|FG001|Treatment Period|Withdrawal by Subject|5|||
38083472|NCT02631850|69782685|FG002|Treatment Period|Withdrawal by Subject|2|||
38083473|NCT02631850|69782686|FG003|Treatment Period|Withdrawal by Subject|2|||
38083474|NCT02631850|69782683|FG000|Treatment Period|Adverse Event|1|||
38083475|NCT02631850|69782684|FG001|Treatment Period|Adverse Event|0|||
38083476|NCT02631850|69782685|FG002|Treatment Period|Adverse Event|2|||
38083477|NCT02631850|69782686|FG003|Treatment Period|Adverse Event|3|||
38083478|NCT02631850|69782683|FG000|Treatment Period|Family medical issue|1|||
38083479|NCT02631850|69782684|FG001|Treatment Period|Family medical issue|0|||
37683791|NCT02320149|69159475|FG000|Overall Study|Lost to Follow-up|21|||
38083480|NCT02631850|69782685|FG002|Treatment Period|Family medical issue|0|||
38083481|NCT02631850|69782686|FG003|Treatment Period|Family medical issue|0|||
38083482|NCT02631850|69782683|FG000|6 Month Follow up|Lost to Follow-up|5|||
37683792|NCT02320149|69159476|FG001|Overall Study|Lost to Follow-up|34|||
37683793|NCT02320149|69159475|FG000|Overall Study|Protocol Violation|2|||
37967110|NCT00535236|69654003|FG007|Overall Study|Lost to Follow-up|0|||
38083483|NCT02631850|69782684|FG001|6 Month Follow up|Lost to Follow-up|8|||
38083484|NCT02631850|69782685|FG002|6 Month Follow up|Lost to Follow-up|3|||
38083485|NCT02631850|69782686|FG003|6 Month Follow up|Lost to Follow-up|5|||
38083486|NCT02631850|69782683|FG000|6 Month Follow up|Withdrawal by Subject|1|||
38083487|NCT02631850|69782684|FG001|6 Month Follow up|Withdrawal by Subject|0|||
38083488|NCT02631850|69782685|FG002|6 Month Follow up|Withdrawal by Subject|0|||
38083489|NCT02631850|69782686|FG003|6 Month Follow up|Withdrawal by Subject|2|||
38083490|NCT02631850|69782683|FG000|6 Month Follow up|Adverse Event|1|||
38083491|NCT02631850|69782684|FG001|6 Month Follow up|Adverse Event|4|||
38083492|NCT02631850|69782685|FG002|6 Month Follow up|Adverse Event|1|||
37683794|NCT02320149|69159476|FG001|Overall Study|Protocol Violation|1|||
37683795|NCT02320149|69159475|FG000|Overall Study|Noncompliance with Study Treatment|7|||
37683796|NCT02320149|69159476|FG001|Overall Study|Noncompliance with Study Treatment|2|||
37683797|NCT02320149|69159475|FG000|Overall Study|Lack of Efficacy|0|||
37683798|NCT02320149|69159476|FG001|Overall Study|Lack of Efficacy|1|||
37683799|NCT02320149|69159475|FG000|Overall Study|Other Miscellaneous Reasons|2|||
37683800|NCT02320149|69159476|FG001|Overall Study|Other Miscellaneous Reasons|3|||
37683801|NCT02540083|69159482|FG000|Overall Study|Withdrawal by Subject|16|||
37683802|NCT02293863|69159489|FG000|Overall Study|Death|4|||
37683803|NCT02293863|69159490|FG001|Overall Study|Death|6|||
37683804|NCT02293863|69159491|FG002|Overall Study|Death|4|||
37683805|NCT02293863|69159489|FG000|Overall Study|Lost to Follow-up|2|||
37683806|NCT02293863|69159490|FG001|Overall Study|Lost to Follow-up|2|||
37683807|NCT02293863|69159491|FG002|Overall Study|Lost to Follow-up|2|||
37683808|NCT02293863|69159489|FG000|Overall Study|Withdrawal by Subject|3|||
37683809|NCT02293863|69159490|FG001|Overall Study|Withdrawal by Subject|3|||
37683810|NCT02293863|69159491|FG002|Overall Study|Withdrawal by Subject|1|||
37683811|NCT02293863|69159489|FG000|Overall Study|Reason Not Specified|0|||
37683812|NCT02293863|69159490|FG001|Overall Study|Reason Not Specified|2|||
37683813|NCT02293863|69159491|FG002|Overall Study|Reason Not Specified|2|||
37683814|NCT02293395|69159503|FG000|Overall Study|Lost to Follow-up|1|||
37683815|NCT02293395|69159504|FG001|Overall Study|Lost to Follow-up|0|||
37683816|NCT02293395|69159503|FG000|Overall Study|Withdrawal by Subject|8|||
37683817|NCT02293395|69159504|FG001|Overall Study|Withdrawal by Subject|7|||
37683818|NCT02025985|69159515|FG000|Overall Study|Consent withdrawn|0|||
37683819|NCT02025985|69159516|FG001|Overall Study|Consent withdrawn|0|||
37683820|NCT02025985|69159517|FG002|Overall Study|Consent withdrawn|1|||
37683821|NCT02025985|69159518|FG003|Overall Study|Consent withdrawn|0|||
37683822|NCT02025985|69159519|FG004|Overall Study|Consent withdrawn|0|||
37683823|NCT02025985|69159515|FG000|Overall Study|Termination of study by Sponsor|4|||
37683824|NCT02025985|69159516|FG001|Overall Study|Termination of study by Sponsor|3|||
37683825|NCT02025985|69159517|FG002|Overall Study|Termination of study by Sponsor|1|||
37683826|NCT02025985|69159518|FG003|Overall Study|Termination of study by Sponsor|1|||
37683827|NCT02025985|69159519|FG004|Overall Study|Termination of study by Sponsor|3|||
37683828|NCT02025985|69159515|FG000|Overall Study|Death|21|||
37683829|NCT02025985|69159516|FG001|Overall Study|Death|20|||
37683830|NCT02025985|69159517|FG002|Overall Study|Death|23|||
37683831|NCT02025985|69159518|FG003|Overall Study|Death|20|||
37683832|NCT02025985|69159519|FG004|Overall Study|Death|17|||
37683833|NCT02528305|69159533|FG000|Overall Study|Withdrawal by Subject|1|||
37683834|NCT02528305|69159533|FG000|Overall Study|Adverse Event|1|||
37683835|NCT02528305|69159533|FG000|Overall Study|Physician Decision|1|||
37683836|NCT02532517|69159539|FG000|Overall Study|Did not complete 24-Month visit|4|||
37683837|NCT02532517|69159539|FG000|Overall Study|Failed Angiographic eligibility|1|||
37683838|NCT02532517|69159539|FG000|Overall Study|Lost to Follow-up|4|||
37683839|NCT02532517|69159539|FG000|Overall Study|Withdrawal by Subject|4|||
37683840|NCT02532517|69159539|FG000|Overall Study|Death|4|||
37683841|NCT02545049|69159545|FG000|Overall Study|Withdrawal by Subject|1|||
37683842|NCT02545049|69159546|FG001|Overall Study|Withdrawal by Subject|7|||
37683843|NCT02545049|69159545|FG000|Overall Study|Lost to Follow-up|4|||
37683844|NCT02545049|69159546|FG001|Overall Study|Lost to Follow-up|6|||
37683845|NCT02545049|69159545|FG000|Overall Study|GCP violations|37|||
37683846|NCT02545049|69159546|FG001|Overall Study|GCP violations|48|||
37683847|NCT02532283|69159554|FG000|Overall Study|Adverse Event|0|||
37683848|NCT02532283|69159555|FG001|Overall Study|Adverse Event|1|||
38083493|NCT02631850|69782686|FG003|6 Month Follow up|Adverse Event|3|||
37683849|NCT02532283|69159554|FG000|Overall Study|Death|1|||
37683850|NCT02532283|69159555|FG001|Overall Study|Death|0|||
37683851|NCT02532283|69159554|FG000|Overall Study|Lost to Follow-up|0|||
37683852|NCT02532283|69159555|FG001|Overall Study|Lost to Follow-up|1|||
37683853|NCT02532283|69159554|FG000|Overall Study|Withdrawal by Subject|8|||
37683854|NCT02532283|69159555|FG001|Overall Study|Withdrawal by Subject|3|||
37683855|NCT01295125|69159576|FG000|Overall Study|Study stopped prematurely|9|||
37683856|NCT02540291|69159584|FG000|Overall Study|Death|7|||
37683857|NCT02540291|69159585|FG001|Overall Study|Death|7|||
37683858|NCT02540291|69159586|FG002|Overall Study|Death|5|||
37683859|NCT02540291|69159587|FG003|Overall Study|Death|7|||
37683860|NCT02540291|69159584|FG000|Overall Study|Lost to Follow-up|0|||
37683861|NCT02540291|69159585|FG001|Overall Study|Lost to Follow-up|0|||
37683862|NCT02540291|69159586|FG002|Overall Study|Lost to Follow-up|1|||
37683863|NCT02540291|69159587|FG003|Overall Study|Lost to Follow-up|0|||
37683864|NCT02540291|69159584|FG000|Overall Study|Withdrawal Of Consent|0|||
37683865|NCT02540291|69159585|FG001|Overall Study|Withdrawal Of Consent|1|||
37683866|NCT02540291|69159586|FG002|Overall Study|Withdrawal Of Consent|0|||
37683867|NCT02540291|69159587|FG003|Overall Study|Withdrawal Of Consent|0|||
37683868|NCT02540291|69159584|FG000|Overall Study|Study Terminated By Sponsor|1|||
37683869|NCT02540291|69159585|FG001|Overall Study|Study Terminated By Sponsor|0|||
37683870|NCT02540291|69159586|FG002|Overall Study|Study Terminated By Sponsor|0|||
37683871|NCT02540291|69159587|FG003|Overall Study|Study Terminated By Sponsor|0|||
37683872|NCT02540291|69159584|FG000|Overall Study|Other|0|||
37683873|NCT02540291|69159585|FG001|Overall Study|Other|0|||
37683874|NCT02540291|69159586|FG002|Overall Study|Other|1|||
37683875|NCT02540291|69159587|FG003|Overall Study|Other|0|||
37683876|NCT02540213|69159599|FG000|Overall Study|Death/adverse event|18|||
37683877|NCT02540213|69159599|FG000|Overall Study|Administrative reasons|3|||
37683878|NCT02540213|69159599|FG000|Overall Study|Kidney transplant|3|||
37683879|NCT02540213|69159599|FG000|Overall Study|Lack of Efficacy|6|||
37683880|NCT02540213|69159599|FG000|Overall Study|Consent withdrawn|7|||
37683881|NCT02540213|69159599|FG000|Overall Study|Enrolled but not treated|2|||
37683882|NCT02552303|69159607|FG000|Allocation|Withdrawal by Subject|2|||
37683883|NCT02552303|69159608|FG001|Allocation|Withdrawal by Subject|1|||
37683884|NCT02552303|69159609|FG002|Allocation|Withdrawal by Subject|1|||
37683885|NCT02552303|69159610|FG003|Allocation|Withdrawal by Subject|1|||
37683886|NCT02552303|69159607|FG000|Allocation|ineligible|1|||
37683887|NCT02552303|69159608|FG001|Allocation|ineligible|1|||
37683888|NCT02552303|69159609|FG002|Allocation|ineligible|0|||
37683889|NCT02552303|69159610|FG003|Allocation|ineligible|0|||
37683890|NCT02552303|69159607|FG000|Follow-Up|Lost to Follow-up|0|||
37683891|NCT02552303|69159608|FG001|Follow-Up|Lost to Follow-up|0|||
37683892|NCT02552303|69159609|FG002|Follow-Up|Lost to Follow-up|1|||
37683893|NCT02552303|69159610|FG003|Follow-Up|Lost to Follow-up|0|||
37683894|NCT02552303|69159607|FG000|Follow-Up|ineligible|0|||
37683895|NCT02552303|69159608|FG001|Follow-Up|ineligible|2|||
37683896|NCT02552303|69159609|FG002|Follow-Up|ineligible|0|||
37683897|NCT02552303|69159610|FG003|Follow-Up|ineligible|0|||
37967111|NCT00535236|69654004|FG008|Overall Study|Lost to Follow-up|6|||
37967112|NCT00535236|69654005|FG009|Overall Study|Lost to Follow-up|1|||
37967113|NCT00535236|69653996|FG000|Overall Study|Physician Decision|0|||
37967114|NCT00535236|69653997|FG001|Overall Study|Physician Decision|0|||
37967115|NCT00535236|69653998|FG002|Overall Study|Physician Decision|0|||
37967116|NCT00535236|69653999|FG003|Overall Study|Physician Decision|0|||
37967117|NCT00535236|69654000|FG004|Overall Study|Physician Decision|1|||
37683898|NCT01660711|69159620|FG000|Overall Study|Adverse Event|7|||
37683899|NCT01660711|69159620|FG000|Overall Study|Withdrawal by Subject|1|||
37683900|NCT02544113|69159626|FG000|Overall Study|Death|3|||
37683901|NCT02544113|69159627|FG001|Overall Study|Death|4|||
37683902|NCT02538965|69159633|FG000|Treatment Period|Other = Death due to disease progression|1|||
37683903|NCT02538965|69159633|FG000|Treatment Period|Adverse Event|2|||
37967118|NCT00535236|69654001|FG005|Overall Study|Physician Decision|0|||
37967119|NCT00535236|69654002|FG006|Overall Study|Physician Decision|1|||
37967120|NCT00535236|69654003|FG007|Overall Study|Physician Decision|0|||
37683904|NCT02538965|69159633|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
37683905|NCT02538965|69159633|FG000|Treatment Period|Treatment Failure|9|||
37683906|NCT02538965|69159633|FG000|Treatment Period|Disease Progression|1|||
37683907|NCT02538965|69159633|FG000|Treatment Period|Physician Decision|2|||
37683908|NCT02538965|69159633|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
37967121|NCT00535236|69654004|FG008|Overall Study|Physician Decision|0|||
37967122|NCT00535236|69654005|FG009|Overall Study|Physician Decision|0|||
38083494|NCT02631850|69782683|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
38083495|NCT02631850|69782684|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
38083496|NCT02631850|69782685|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
38083497|NCT02631850|69782686|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
38083498|NCT00103038|69782697|FG000|Overall Study|Withdrawal by Subject|8|||
38083499|NCT00103038|69782697|FG000|Overall Study|Screen failure|3|||
38083500|NCT00103038|69782697|FG000|Overall Study|Death|1|||
38083501|NCT00103038|69782697|FG000|Overall Study|Physician Decision|1|||
38083502|NCT00620035|69782704|FG000|Overall Study|Adverse Event|106|||
38083503|NCT00620035|69782704|FG000|Overall Study|Withdrawal of Informed Consent|1|||
38083504|NCT00620035|69782704|FG000|Overall Study|Other Reason|38|||
38083505|NCT03034057|69782708|FG000|Overall Study|Withdrawal by Subject|10|||
38083506|NCT03034057|69782708|FG000|Overall Study|Protocol Violation|1|||
38083507|NCT03034057|69782708|FG000|Overall Study|Not defined|2|||
38083508|NCT03034057|69782708|FG000|Overall Study|Lost to Follow-up|19|||
38083509|NCT03034057|69782708|FG000|Overall Study|Adverse Event|22|||
38083510|NCT03034057|69782708|FG000|Overall Study|Medication error without associated AE|1|||
38083511|NCT02757768|69782714|FG000|Overall Study|Randomized Never Received Study Drug|3|||
38083512|NCT02757768|69782715|FG001|Overall Study|Randomized Never Received Study Drug|4|||
38083513|NCT02757768|69782714|FG000|Overall Study|Adverse Event|5|||
38083514|NCT02757768|69782715|FG001|Overall Study|Adverse Event|3|||
38083515|NCT02757768|69782714|FG000|Overall Study|Lack of Efficacy|2|||
38083516|NCT02757768|69782715|FG001|Overall Study|Lack of Efficacy|1|||
38083517|NCT02757768|69782714|FG000|Overall Study|Lost to Follow-up|1|||
38083518|NCT02757768|69782715|FG001|Overall Study|Lost to Follow-up|0|||
38083519|NCT02757768|69782714|FG000|Overall Study|Protocol Deviation|2|||
38083520|NCT02757768|69782715|FG001|Overall Study|Protocol Deviation|9|||
38083521|NCT02757768|69782714|FG000|Overall Study|Withdrawal by Subject|16|||
38083522|NCT02757768|69782715|FG001|Overall Study|Withdrawal by Subject|9|||
38083523|NCT02757768|69782714|FG000|Overall Study|Miscellaneous|4|||
38083524|NCT02757768|69782715|FG001|Overall Study|Miscellaneous|2|||
38083525|NCT05225389|69782723|FG000|Overall Study|Three participants were discontinued by the Investigator on day 7 due to positive COVID-19 tests.|3|||
38083526|NCT02753946|69782729|FG000|Overall Study|Adverse Event|7|||
38083527|NCT02753946|69782730|FG001|Overall Study|Adverse Event|6|||
38083528|NCT02753946|69782729|FG000|Overall Study|Withdrawal by Subject|6|||
38083529|NCT02753946|69782730|FG001|Overall Study|Withdrawal by Subject|1|||
38083530|NCT02753946|69782729|FG000|Overall Study|Lack of Efficacy|1|||
38083531|NCT02753946|69782730|FG001|Overall Study|Lack of Efficacy|0|||
38083532|NCT02753946|69782729|FG000|Overall Study|Physician Decision|0|||
38083533|NCT02753946|69782730|FG001|Overall Study|Physician Decision|2|||
38083534|NCT02756832|69782736|FG000|Overall Study|Lost for Observation after Baseline|6|||
38083535|NCT02756832|69782736|FG000|Overall Study|Lost for Observation|13|||
38083536|NCT02756832|69782736|FG000|Overall Study|Patient's Unwillingness|12|||
38083537|NCT02756832|69782736|FG000|Overall Study|Insufficient Efficacy|2|||
38083538|NCT02756832|69782736|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
38083539|NCT02756832|69782736|FG000|Overall Study|Reason not Specified|9|||
38083540|NCT02756832|69782736|FG000|Overall Study|Protocol Deviation|10|||
38083541|NCT00106080|69782742|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
38083542|NCT00106080|69782743|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
38083543|NCT02633020|69782751|FG000|Overall Study|Adverse Event|1|||
38083544|NCT02633020|69782752|FG001|Overall Study|Adverse Event|0|||
38083545|NCT00106626|69782762|FG000|Overall Study|Adverse Event|5|||
38083546|NCT00106626|69782763|FG001|Overall Study|Adverse Event|4|||
38083547|NCT00106626|69782764|FG002|Overall Study|Adverse Event|3|||
37967123|NCT00535236|69653996|FG000|Overall Study|Protocol Violation|2|||
37967124|NCT00535236|69653997|FG001|Overall Study|Protocol Violation|0|||
37967125|NCT00535236|69653998|FG002|Overall Study|Protocol Violation|1|||
37967126|NCT00535236|69653999|FG003|Overall Study|Protocol Violation|0|||
37967127|NCT00535236|69654000|FG004|Overall Study|Protocol Violation|0|||
37967128|NCT00535236|69654001|FG005|Overall Study|Protocol Violation|0|||
37967129|NCT00535236|69654002|FG006|Overall Study|Protocol Violation|0|||
37967130|NCT00535236|69654003|FG007|Overall Study|Protocol Violation|0|||
37967131|NCT00535236|69654004|FG008|Overall Study|Protocol Violation|1|||
38083548|NCT00106626|69782765|FG003|Overall Study|Adverse Event|3|||
38083549|NCT00106626|69782762|FG000|Overall Study|Progressive Disease|4|||
38083550|NCT00106626|69782763|FG001|Overall Study|Progressive Disease|1|||
38083551|NCT00106626|69782764|FG002|Overall Study|Progressive Disease|9|||
38083552|NCT00106626|69782765|FG003|Overall Study|Progressive Disease|10|||
38083553|NCT00106626|69782762|FG000|Overall Study|Received radiation on new therapy|1|||
38083554|NCT00106626|69782763|FG001|Overall Study|Received radiation on new therapy|0|||
37683909|NCT02538965|69159633|FG000|Follow-Up Period|Withdrawal by Parent|4|||
37683910|NCT02543801|69159641|FG000|Overall Study|Protocol Violation|1|||
37683911|NCT02543801|69159642|FG001|Overall Study|Protocol Violation|2|||
37683912|NCT02543801|69159643|FG002|Overall Study|Protocol Violation|0|||
37683913|NCT02543801|69159644|FG003|Overall Study|Protocol Violation|0|||
37683914|NCT02470091|69159656|FG000|Overall Study|Withdrawal by Subject|1|||
37683915|NCT02470091|69159657|FG001|Overall Study|Withdrawal by Subject|0|||
37683916|NCT02470091|69159656|FG000|Overall Study|Ineligible|0|||
37683917|NCT02470091|69159657|FG001|Overall Study|Ineligible|2|||
37683918|NCT02362503|69159668|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
37683919|NCT02362503|69159669|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
37683920|NCT02362503|69159670|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
37683921|NCT02362503|69159668|FG000|Double-blind Period-Up to 8 Days|Death|1|||
37683922|NCT02362503|69159669|FG001|Double-blind Period-Up to 8 Days|Death|0|||
37683923|NCT02362503|69159670|FG002|Double-blind Period-Up to 8 Days|Death|0|||
37683924|NCT02362503|69159668|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
37683925|NCT02362503|69159669|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
37683926|NCT02362503|69159670|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
37683927|NCT02362503|69159668|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
37683928|NCT02362503|69159669|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
37683929|NCT02362503|69159670|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
37683930|NCT02362503|69159668|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
37683931|NCT02362503|69159669|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
37683932|NCT02362503|69159670|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
37683933|NCT02362503|69159668|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
37683934|NCT02362503|69159669|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
37683935|NCT02362503|69159670|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
37683936|NCT02362503|69159668|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
37683937|NCT02362503|69159669|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
37683938|NCT02362503|69159670|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
37683939|NCT02362503|69159668|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
37683940|NCT02362503|69159669|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
37683941|NCT02362503|69159670|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
37683942|NCT02362503|69159668|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
37683943|NCT02362503|69159669|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
37683944|NCT02362503|69159670|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
37683945|NCT02362503|69159668|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
37683946|NCT02362503|69159669|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
37683947|NCT02362503|69159670|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
37683948|NCT02362503|69159668|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
37683949|NCT02362503|69159669|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
37683950|NCT02362503|69159670|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
37683951|NCT02362503|69159668|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
37683952|NCT02362503|69159669|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
37683953|NCT02362503|69159670|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
37683954|NCT02362503|69159668|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
37683955|NCT02362503|69159669|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
37683956|NCT02362503|69159670|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
37683957|NCT02362503|69159668|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
37683958|NCT02362503|69159669|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
37683959|NCT02362503|69159670|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
37683960|NCT02535065|69159681|FG000|Overall Study|Death|13|||
37683961|NCT02535065|69159681|FG000|Overall Study|Lost to Follow-up|1|||
37683962|NCT02535065|69159681|FG000|Overall Study|Withdrawal by Subject|6|||
37683963|NCT02530619|69159685|FG000|Registered for Study|Withdrawal by Subject|2|||
37683964|NCT02530619|69159685|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
37683965|NCT02530619|69159685|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
37683966|NCT02530619|69159685|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
37683967|NCT02530619|69159685|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
37683968|NCT02530619|69159685|FG000|Follow-up Period (6 Months)|Death|4|||
37683969|NCT02530619|69159685|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
37683970|NCT02530619|69159685|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
37683971|NCT02530385|69159691|FG000|Overall Study|Withdrawal by Subject|0|||
37683972|NCT02530385|69159692|FG001|Overall Study|Withdrawal by Subject|1|||
37683973|NCT02362425|69159702|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
37683974|NCT02362425|69159703|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
37683975|NCT02362425|69159704|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
37683976|NCT02362425|69159705|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
37683977|NCT02362425|69159702|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
37683978|NCT02362425|69159703|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
37683979|NCT02362425|69159704|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
37683980|NCT02362425|69159705|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
37683981|NCT02362425|69159702|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
37683982|NCT02362425|69159703|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
37683983|NCT02362425|69159704|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
37683984|NCT02362425|69159705|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
37683985|NCT02362425|69159702|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
37683986|NCT02362425|69159703|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
37683987|NCT02362425|69159704|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
37683988|NCT02362425|69159705|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
37683989|NCT02362425|69159702|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
37683990|NCT02362425|69159703|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
37683991|NCT02362425|69159704|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
37683992|NCT02362425|69159705|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
37683993|NCT02362425|69159702|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
37683994|NCT02362425|69159703|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
37683995|NCT02362425|69159704|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
37683996|NCT02362425|69159705|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
37683997|NCT02362425|69159702|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
37683998|NCT02362425|69159703|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
37683999|NCT02362425|69159704|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
37684000|NCT02362425|69159705|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
37684001|NCT02362425|69159702|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
37684002|NCT02362425|69159703|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
37684003|NCT02362425|69159704|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
37684004|NCT02362425|69159705|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
37684005|NCT02362269|69159718|FG000|Overall Study|Moved|1|||
37684006|NCT02362269|69159719|FG001|Overall Study|Moved|0|||
37684007|NCT02362269|69159718|FG000|Overall Study|Lost to Follow-up|0|||
37684008|NCT02362269|69159719|FG001|Overall Study|Lost to Follow-up|6|||
37684009|NCT02529995|69159727|FG000|Part A|Ongoing Study at Data Cut-off|14|||
37684010|NCT02529995|69159728|FG001|Part A|Ongoing Study at Data Cut-off|16|||
37684011|NCT02529995|69159727|FG000|Part A|Discontinued Study|1|||
37684012|NCT02529995|69159728|FG001|Part A|Discontinued Study|0|||
37684013|NCT02529995|69159727|FG000|Part B|Ongoing Study at Data Cut-off|0|||
37684014|NCT02529995|69159728|FG001|Part B|Ongoing Study at Data Cut-off|7|||
37684015|NCT02529995|69159727|FG000|Part B|Discontinued Study|6|||
37684016|NCT02529995|69159728|FG001|Part B|Discontinued Study|5|||
37684017|NCT02529137|69159734|FG000|Overall Study|Discontinuation for different reasons|8|||
37684018|NCT02319759|69159741|FG000|Week 0 - 16|Lack of Efficacy|1|||
37684019|NCT02319759|69159742|FG001|Week 0 - 16|Lack of Efficacy|0|||
37684020|NCT02319759|69159743|FG002|Week 0 - 16|Lack of Efficacy|0|||
37684021|NCT02319759|69159744|FG003|Week 0 - 16|Lack of Efficacy|0|||
37684022|NCT02319759|69159745|FG004|Week 0 - 16|Lack of Efficacy|0|||
37684023|NCT02319759|69159741|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
37684024|NCT02319759|69159742|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
37684025|NCT02319759|69159743|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
37684026|NCT02319759|69159744|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
37684027|NCT02319759|69159745|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
37684028|NCT02319759|69159741|FG000|Week 16 - 24|Lack of Efficacy|1|||
37684029|NCT02319759|69159742|FG001|Week 16 - 24|Lack of Efficacy|0|||
37684030|NCT02319759|69159743|FG002|Week 16 - 24|Lack of Efficacy|1|||
37684031|NCT02319759|69159744|FG003|Week 16 - 24|Lack of Efficacy|0|||
37684032|NCT02319759|69159745|FG004|Week 16 - 24|Lack of Efficacy|0|||
37684033|NCT02319759|69159741|FG000|Week 16 - 24|Lost to Follow-up|1|||
37684034|NCT02319759|69159742|FG001|Week 16 - 24|Lost to Follow-up|0|||
37684035|NCT02319759|69159743|FG002|Week 16 - 24|Lost to Follow-up|0|||
37684036|NCT02319759|69159744|FG003|Week 16 - 24|Lost to Follow-up|0|||
37684037|NCT02319759|69159745|FG004|Week 16 - 24|Lost to Follow-up|0|||
37684038|NCT02319759|69159741|FG000|Week 16 - 24|Withdrawal by Subject|0|||
37684039|NCT02319759|69159742|FG001|Week 16 - 24|Withdrawal by Subject|0|||
37684040|NCT02319759|69159743|FG002|Week 16 - 24|Withdrawal by Subject|2|||
37684041|NCT02319759|69159744|FG003|Week 16 - 24|Withdrawal by Subject|0|||
37684042|NCT02319759|69159745|FG004|Week 16 - 24|Withdrawal by Subject|0|||
37684043|NCT02319759|69159741|FG000|Week 24 - 56|Adverse Event|0|||
37684044|NCT02319759|69159742|FG001|Week 24 - 56|Adverse Event|0|||
37684045|NCT02319759|69159743|FG002|Week 24 - 56|Adverse Event|2|||
37684046|NCT02319759|69159744|FG003|Week 24 - 56|Adverse Event|0|||
37684047|NCT02319759|69159745|FG004|Week 24 - 56|Adverse Event|0|||
37684048|NCT02319759|69159741|FG000|Week 24 - 56|Lack of Efficacy|0|||
37684049|NCT02319759|69159742|FG001|Week 24 - 56|Lack of Efficacy|0|||
37684050|NCT02319759|69159743|FG002|Week 24 - 56|Lack of Efficacy|0|||
37967132|NCT00535236|69654005|FG009|Overall Study|Protocol Violation|0|||
38083555|NCT00106626|69782764|FG002|Overall Study|Received radiation on new therapy|0|||
38083556|NCT00106626|69782765|FG003|Overall Study|Received radiation on new therapy|0|||
38083557|NCT00106626|69782762|FG000|Overall Study|> 14 day delay in therapy start|0|||
38083558|NCT00106626|69782763|FG001|Overall Study|> 14 day delay in therapy start|1|||
38083559|NCT00106626|69782764|FG002|Overall Study|> 14 day delay in therapy start|0|||
38083560|NCT00106626|69782765|FG003|Overall Study|> 14 day delay in therapy start|0|||
38083561|NCT02632786|69782782|FG000|Overall Study|Adverse Event|2|||
38083562|NCT02632786|69782783|FG001|Overall Study|Adverse Event|1|||
38083563|NCT02632786|69782782|FG000|Overall Study|Death|3|||
38083564|NCT02632786|69782783|FG001|Overall Study|Death|2|||
38083565|NCT02632786|69782782|FG000|Overall Study|Physician Decision|5|||
38083566|NCT02632786|69782783|FG001|Overall Study|Physician Decision|4|||
38083567|NCT02632786|69782782|FG000|Overall Study|Withdrawal by Subject|1|||
38083568|NCT02632786|69782783|FG001|Overall Study|Withdrawal by Subject|0|||
38083569|NCT02755818|69782794|FG000|Overall Study|Withdrawal by Subject|0|||
38083570|NCT02755818|69782795|FG001|Overall Study|Withdrawal by Subject|0|||
38083571|NCT02755818|69782796|FG002|Overall Study|Withdrawal by Subject|0|||
38083572|NCT02755818|69782797|FG003|Overall Study|Withdrawal by Subject|2|||
38083573|NCT02755818|69782794|FG000|Overall Study|withdrawal by PI|0|||
38083574|NCT02755818|69782795|FG001|Overall Study|withdrawal by PI|0|||
38083575|NCT02755818|69782796|FG002|Overall Study|withdrawal by PI|1|||
38083576|NCT02755818|69782797|FG003|Overall Study|withdrawal by PI|1|||
38083577|NCT03033745|69782812|FG000|Overall Study|Protocol Violation|0|||
38083578|NCT03033745|69782813|FG001|Overall Study|Protocol Violation|0|||
38083579|NCT03033745|69782814|FG002|Overall Study|Protocol Violation|1|||
38083580|NCT03033745|69782812|FG000|Overall Study|Adverse Event|1|||
38083581|NCT03033745|69782813|FG001|Overall Study|Adverse Event|0|||
38083582|NCT03033745|69782814|FG002|Overall Study|Adverse Event|1|||
37684051|NCT02319759|69159744|FG003|Week 24 - 56|Lack of Efficacy|2|||
37684052|NCT02319759|69159745|FG004|Week 24 - 56|Lack of Efficacy|1|||
37684053|NCT02319759|69159741|FG000|Week 24 - 56|Withdrawal by Subject|0|||
37684054|NCT02319759|69159742|FG001|Week 24 - 56|Withdrawal by Subject|1|||
37684055|NCT02319759|69159743|FG002|Week 24 - 56|Withdrawal by Subject|0|||
37684056|NCT02319759|69159744|FG003|Week 24 - 56|Withdrawal by Subject|0|||
37684057|NCT02319759|69159745|FG004|Week 24 - 56|Withdrawal by Subject|0|||
38083583|NCT03033745|69782812|FG000|Overall Study|Withdrawal by Subject|0|||
38083584|NCT03033745|69782813|FG001|Overall Study|Withdrawal by Subject|1|||
38083585|NCT03033745|69782814|FG002|Overall Study|Withdrawal by Subject|0|||
37684058|NCT02319759|69159741|FG000|Week 24 - 56|Lost to Follow-up|0|||
37684059|NCT02319759|69159742|FG001|Week 24 - 56|Lost to Follow-up|0|||
37684060|NCT02319759|69159743|FG002|Week 24 - 56|Lost to Follow-up|0|||
38083586|NCT01672294|69782833|FG000|Overall Study|Withdrawal by Subject|4|||
37684061|NCT02319759|69159744|FG003|Week 24 - 56|Lost to Follow-up|0|||
37684062|NCT02319759|69159745|FG004|Week 24 - 56|Lost to Follow-up|1|||
37684063|NCT02293005|69159758|FG000|Overall Study|Adverse Event|2|||
37684064|NCT02293005|69159758|FG000|Overall Study|Death|4|||
37684065|NCT02293005|69159758|FG000|Overall Study|Lost to Follow-up|1|||
38083587|NCT01672294|69782834|FG001|Overall Study|Withdrawal by Subject|4|||
38083588|NCT01672294|69782835|FG002|Overall Study|Withdrawal by Subject|4|||
37684066|NCT02293005|69159758|FG000|Overall Study|Withdrawal by Subject|2|||
37684067|NCT02293005|69159758|FG000|Overall Study|Progression|17|||
37684068|NCT02319525|69159764|FG000|Overall Study|Withdrawal by Subject|2|||
37684069|NCT02319525|69159765|FG001|Overall Study|Withdrawal by Subject|1|||
37684070|NCT02292927|69159773|FG000|Overall Study|Protocol Violation|13|||
37684071|NCT02292927|69159774|FG001|Overall Study|Protocol Violation|7|||
37684072|NCT02292849|69159786|FG000|Overall Study|Lost to Follow-up|0|||
37684073|NCT02292849|69159787|FG001|Overall Study|Lost to Follow-up|2|||
37684074|NCT02292849|69159788|FG002|Overall Study|Lost to Follow-up|2|||
37684075|NCT02292849|69159786|FG000|Overall Study|Physician Decision|4|||
37684076|NCT02292849|69159787|FG001|Overall Study|Physician Decision|0|||
37684077|NCT02292849|69159788|FG002|Overall Study|Physician Decision|0|||
37684078|NCT02318667|69159796|FG000|Overall Study|Adverse Event|1|||
37684079|NCT02318667|69159796|FG000|Overall Study|Lack of Efficacy|6|||
37684080|NCT02318667|69159796|FG000|Overall Study|Protocol Violation|2|||
37684081|NCT02292771|69159806|FG000|Overall Study|Withdrawal by Subject|2|||
37684082|NCT02292771|69159807|FG001|Overall Study|Withdrawal by Subject|1|||
37684083|NCT02292771|69159806|FG000|Overall Study|Lost to Follow-up|2|||
37684084|NCT02292771|69159807|FG001|Overall Study|Lost to Follow-up|1|||
37684085|NCT02291913|69159817|FG000|Overall Study|Progressive Disease|32|||
37684086|NCT02291913|69159817|FG000|Overall Study|Adverse Event|11|||
37684087|NCT02291913|69159817|FG000|Overall Study|Death|2|||
37684088|NCT02291913|69159817|FG000|Overall Study|Physician Decision|1|||
37684089|NCT02291913|69159817|FG000|Overall Study|Withdrawal by Subject|1|||
37684090|NCT02291913|69159817|FG000|Overall Study|Protocol Violation|1|||
37684091|NCT02291679|69159824|FG000|Overall Study|Adverse Event|2|||
37684092|NCT02291679|69159825|FG001|Overall Study|Adverse Event|12|||
37684093|NCT02291679|69159826|FG002|Overall Study|Adverse Event|19|||
37684094|NCT02291679|69159824|FG000|Overall Study|Protocol Violation|5|||
37684095|NCT02291679|69159825|FG001|Overall Study|Protocol Violation|1|||
37684096|NCT02291679|69159826|FG002|Overall Study|Protocol Violation|7|||
37684097|NCT02291679|69159824|FG000|Overall Study|Withdrew Consent|18|||
37684098|NCT02291679|69159825|FG001|Overall Study|Withdrew Consent|10|||
37684099|NCT02291679|69159826|FG002|Overall Study|Withdrew Consent|15|||
37684100|NCT02291679|69159824|FG000|Overall Study|Lost to Follow-up|12|||
37684101|NCT02291679|69159825|FG001|Overall Study|Lost to Follow-up|10|||
37684102|NCT02291679|69159826|FG002|Overall Study|Lost to Follow-up|9|||
37684103|NCT02291679|69159824|FG000|Overall Study|Insufficient Therapeutic Response|5|||
37684104|NCT02291679|69159825|FG001|Overall Study|Insufficient Therapeutic Response|5|||
37684105|NCT02291679|69159826|FG002|Overall Study|Insufficient Therapeutic Response|7|||
37684106|NCT02291679|69159824|FG000|Overall Study|Other|2|||
37684107|NCT02291679|69159825|FG001|Overall Study|Other|4|||
37684108|NCT02291679|69159826|FG002|Overall Study|Other|2|||
37684109|NCT02291601|69159833|FG000|Abdomen|Did not qualify|333|||
37684110|NCT02291601|69159834|FG001|Abdomen|Did not qualify|54|||
38083589|NCT01672294|69782836|FG003|Overall Study|Withdrawal by Subject|4|||
38083590|NCT01672294|69782833|FG000|Overall Study|Excluded by study|1|||
38083591|NCT01672294|69782834|FG001|Overall Study|Excluded by study|1|||
38083592|NCT01672294|69782835|FG002|Overall Study|Excluded by study|0|||
37684111|NCT02291601|69159835|FG002|Abdomen|Did not qualify|339|||
37684112|NCT02291601|69159833|FG000|Groin|Did not qualify|183|||
37684113|NCT02291601|69159834|FG001|Groin|Did not qualify|30|||
38083593|NCT01672294|69782836|FG003|Overall Study|Excluded by study|0|||
38083594|NCT01672294|69782833|FG000|Overall Study|Lost to Follow-up|1|||
38083595|NCT01672294|69782834|FG001|Overall Study|Lost to Follow-up|16|||
38083596|NCT01672294|69782835|FG002|Overall Study|Lost to Follow-up|7|||
37684114|NCT02291601|69159835|FG002|Groin|Did not qualify|177|||
37684115|NCT02360475|69159850|FG000|Overall Study|Lost to Follow-up|4|||
37684116|NCT02360475|69159851|FG001|Overall Study|Lost to Follow-up|12|||
37684117|NCT02360475|69159852|FG002|Overall Study|Lost to Follow-up|6|||
37684118|NCT02360475|69159853|FG003|Overall Study|Lost to Follow-up|4|||
37684119|NCT02360475|69159850|FG000|Overall Study|Withdrawal by Subject|0|||
37684120|NCT02360475|69159851|FG001|Overall Study|Withdrawal by Subject|1|||
37684121|NCT02360475|69159852|FG002|Overall Study|Withdrawal by Subject|2|||
37863002|NCT01263197|69546934|FG002|Washout Period 2|Physician Decision|0|||
38083597|NCT01672294|69782836|FG003|Overall Study|Lost to Follow-up|9|||
38083598|NCT02755116|69782848|FG000|Overall Study|surgery converted to open, pt admitted|3|||
37684122|NCT02360475|69159853|FG003|Overall Study|Withdrawal by Subject|0|||
37684123|NCT02360475|69159850|FG000|Overall Study|Migrated/moved from study area|0|||
37684124|NCT02360475|69159851|FG001|Overall Study|Migrated/moved from study area|0|||
37684125|NCT02360475|69159852|FG002|Overall Study|Migrated/moved from study area|0|||
37684126|NCT02360475|69159853|FG003|Overall Study|Migrated/moved from study area|1|||
37684127|NCT02360397|69159863|FG000|Overall Study|Incomplete screening|3|||
37684128|NCT02360397|69159863|FG000|Overall Study|Adverse Event|1|||
38083599|NCT02755116|69782849|FG001|Overall Study|surgery converted to open, pt admitted|1|||
38083600|NCT02754492|69782859|FG000|Overall Study|Protocol Violation|2|||
38083601|NCT02754492|69782860|FG001|Overall Study|Protocol Violation|2|||
38083602|NCT02754492|69782861|FG002|Overall Study|Protocol Violation|0|||
38083603|NCT02754492|69782862|FG003|Overall Study|Protocol Violation|1|||
38083604|NCT02754492|69782859|FG000|Overall Study|Withdrawal by Subject|2|||
38083605|NCT02754492|69782860|FG001|Overall Study|Withdrawal by Subject|0|||
38083606|NCT02754492|69782861|FG002|Overall Study|Withdrawal by Subject|0|||
38083607|NCT02754492|69782862|FG003|Overall Study|Withdrawal by Subject|0|||
38083608|NCT02754492|69782859|FG000|Overall Study|Equipment malfuntion|0|||
38083609|NCT02754492|69782860|FG001|Overall Study|Equipment malfuntion|0|||
38083610|NCT02754492|69782861|FG002|Overall Study|Equipment malfuntion|2|||
38083611|NCT02754492|69782862|FG003|Overall Study|Equipment malfuntion|5|||
38083612|NCT02754492|69782859|FG000|Overall Study|Adverse Event|0|||
38083613|NCT02754492|69782860|FG001|Overall Study|Adverse Event|0|||
38083614|NCT02754492|69782861|FG002|Overall Study|Adverse Event|0|||
38083615|NCT02754492|69782862|FG003|Overall Study|Adverse Event|13|||
38083616|NCT02754492|69782859|FG000|Overall Study|Venous access issues not resulting in AE|0|||
38083617|NCT02754492|69782860|FG001|Overall Study|Venous access issues not resulting in AE|0|||
38083618|NCT02754492|69782861|FG002|Overall Study|Venous access issues not resulting in AE|0|||
38083619|NCT02754492|69782862|FG003|Overall Study|Venous access issues not resulting in AE|4|||
38083620|NCT04068688|69782881|FG000|Overall Study|Lost to Follow-up|1|||
38083621|NCT04068688|69782882|FG001|Overall Study|Lost to Follow-up|1|||
38083622|NCT04068688|69782883|FG002|Overall Study|Lost to Follow-up|0|||
38083623|NCT04068688|69782884|FG003|Overall Study|Lost to Follow-up|0|||
38083624|NCT04068688|69782885|FG004|Overall Study|Lost to Follow-up|5|||
38083625|NCT04068688|69782886|FG005|Overall Study|Lost to Follow-up|5|||
38083626|NCT04068688|69782887|FG006|Overall Study|Lost to Follow-up|0|||
38083627|NCT04068688|69782888|FG007|Overall Study|Lost to Follow-up|0|||
38083628|NCT04068688|69782889|FG008|Overall Study|Lost to Follow-up|1|||
38083629|NCT04068688|69782890|FG009|Overall Study|Lost to Follow-up|0|||
38083630|NCT04068688|69782881|FG000|Overall Study|Withdrawal by Subject|1|||
38083631|NCT04068688|69782882|FG001|Overall Study|Withdrawal by Subject|1|||
38083632|NCT04068688|69782883|FG002|Overall Study|Withdrawal by Subject|0|||
38083633|NCT04068688|69782884|FG003|Overall Study|Withdrawal by Subject|0|||
38083634|NCT04068688|69782885|FG004|Overall Study|Withdrawal by Subject|0|||
38083635|NCT04068688|69782886|FG005|Overall Study|Withdrawal by Subject|0|||
38083636|NCT04068688|69782887|FG006|Overall Study|Withdrawal by Subject|0|||
38083637|NCT04068688|69782888|FG007|Overall Study|Withdrawal by Subject|0|||
38083638|NCT04068688|69782889|FG008|Overall Study|Withdrawal by Subject|0|||
38083639|NCT04068688|69782890|FG009|Overall Study|Withdrawal by Subject|0|||
38083640|NCT04068688|69782881|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
38083641|NCT04068688|69782882|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
38083642|NCT04068688|69782883|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
38083643|NCT04068688|69782884|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
38083644|NCT04068688|69782885|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
38083645|NCT04068688|69782886|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
38083646|NCT04068688|69782887|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
38083647|NCT04068688|69782888|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
38083648|NCT04068688|69782889|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
38083649|NCT04068688|69782890|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
38083650|NCT01671748|69782918|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
38083651|NCT01671748|69782919|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
38083652|NCT01671748|69782918|FG000|4 Week run-in Phase|Adverse Event|1|||
38083653|NCT01671748|69782919|FG001|4 Week run-in Phase|Adverse Event|0|||
38083654|NCT01671748|69782918|FG000|4 Week run-in Phase|Not eligible|9|||
38083655|NCT01671748|69782919|FG001|4 Week run-in Phase|Not eligible|0|||
38083656|NCT02657889|69782929|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
38083657|NCT02657889|69782930|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
38083658|NCT02657889|69782931|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
38083659|NCT02657889|69782932|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
38083660|NCT02657889|69782929|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
38083661|NCT02657889|69782930|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
38083662|NCT02657889|69782931|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
38083663|NCT02657889|69782932|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
38083664|NCT02657889|69782929|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
38083665|NCT02657889|69782930|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
38083666|NCT02657889|69782931|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
38083667|NCT02657889|69782932|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
38083668|NCT02657889|69782929|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
37684129|NCT02317809|69159868|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
37684130|NCT02317809|69159869|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
37684131|NCT02317809|69159868|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
37684132|NCT02317809|69159869|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
37684133|NCT02359851|69159878|FG000|Overall Study|Death|1|||
37684134|NCT02359851|69159878|FG000|Overall Study|Disease progression|1|||
37684135|NCT01607905|69159889|FG000|Overall Study|Withdrawal by participant|7|||
37684136|NCT01607905|69159890|FG001|Overall Study|Withdrawal by participant|2|||
37684137|NCT01607905|69159891|FG002|Overall Study|Withdrawal by participant|4|||
37684138|NCT01607905|69159892|FG003|Overall Study|Withdrawal by participant|6|||
37684139|NCT01607905|69159893|FG004|Overall Study|Withdrawal by participant|0|||
38083669|NCT02657889|69782930|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
38083670|NCT02657889|69782931|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
38083671|NCT02657889|69782932|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
38083672|NCT02657889|69782929|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
38083673|NCT02657889|69782930|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
38083674|NCT02657889|69782931|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
38083675|NCT02657889|69782932|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
38083676|NCT02657889|69782929|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
38083677|NCT02657889|69782930|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
38083678|NCT02657889|69782931|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
38083679|NCT02657889|69782932|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
38083680|NCT02657889|69782929|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
38083681|NCT02657889|69782930|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
38083682|NCT02657889|69782931|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
38083683|NCT02657889|69782932|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
38083684|NCT02657889|69782929|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
38083685|NCT02657889|69782930|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
38083686|NCT02657889|69782931|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
38083687|NCT02657889|69782932|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
38083688|NCT02657889|69782929|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
38083689|NCT02657889|69782930|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
38083690|NCT02657889|69782931|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
38083691|NCT02657889|69782932|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
38083692|NCT02657889|69782929|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
38083693|NCT02657889|69782930|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
38083694|NCT02657889|69782931|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
38083695|NCT02657889|69782932|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
38083696|NCT02657889|69782929|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
38083697|NCT02657889|69782930|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
37684140|NCT01607905|69159894|FG005|Overall Study|Withdrawal by participant|4|||
38083698|NCT02657889|69782931|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
38083699|NCT02657889|69782932|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
38083700|NCT02657889|69782929|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
38083701|NCT02657889|69782930|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
38083702|NCT02657889|69782931|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
38083703|NCT02657889|69782932|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
38083704|NCT03034915|69782947|FG000|Overall Study|Adverse Event|29|||
38083705|NCT03034915|69782948|FG001|Overall Study|Adverse Event|32|||
38083706|NCT03034915|69782949|FG002|Overall Study|Adverse Event|22|||
38083707|NCT03034915|69782947|FG000|Overall Study|Lost to Follow-up|5|||
38083708|NCT03034915|69782948|FG001|Overall Study|Lost to Follow-up|13|||
38083709|NCT03034915|69782949|FG002|Overall Study|Lost to Follow-up|3|||
38083710|NCT03034915|69782947|FG000|Overall Study|Withdrawal by Subject|29|||
38083711|NCT03034915|69782948|FG001|Overall Study|Withdrawal by Subject|46|||
38083712|NCT03034915|69782949|FG002|Overall Study|Withdrawal by Subject|41|||
38083713|NCT03034915|69782947|FG000|Overall Study|Protocol Deviation|2|||
38083714|NCT03034915|69782948|FG001|Overall Study|Protocol Deviation|14|||
38083715|NCT03034915|69782949|FG002|Overall Study|Protocol Deviation|7|||
38083716|NCT03034915|69782947|FG000|Overall Study|Lack of Efficacy|8|||
38083717|NCT03034915|69782948|FG001|Overall Study|Lack of Efficacy|16|||
38083718|NCT03034915|69782949|FG002|Overall Study|Lack of Efficacy|18|||
38083719|NCT03034915|69782947|FG000|Overall Study|Site closed|2|||
38083720|NCT03034915|69782948|FG001|Overall Study|Site closed|2|||
38083721|NCT03034915|69782949|FG002|Overall Study|Site closed|4|||
38083722|NCT03034915|69782947|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
38083723|NCT03034915|69782948|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
38083724|NCT03034915|69782949|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
38083725|NCT03034915|69782947|FG000|Overall Study|Physician Decision|1|||
38083726|NCT03034915|69782948|FG001|Overall Study|Physician Decision|5|||
38083727|NCT03034915|69782949|FG002|Overall Study|Physician Decision|2|||
38083728|NCT02631538|69782961|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
38083729|NCT02631538|69782962|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
38083730|NCT02631538|69782963|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
38083731|NCT02631538|69782964|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
37684141|NCT01607905|69159895|FG006|Overall Study|Withdrawal by participant|12|||
37684142|NCT01607905|69159889|FG000|Overall Study|Incidence or severity of AEs|5|||
37684143|NCT01607905|69159890|FG001|Overall Study|Incidence or severity of AEs|1|||
37684144|NCT01607905|69159891|FG002|Overall Study|Incidence or severity of AEs|1|||
37684145|NCT01607905|69159892|FG003|Overall Study|Incidence or severity of AEs|3|||
37684146|NCT01607905|69159893|FG004|Overall Study|Incidence or severity of AEs|0|||
37684147|NCT01607905|69159894|FG005|Overall Study|Incidence or severity of AEs|2|||
37684148|NCT01607905|69159895|FG006|Overall Study|Incidence or severity of AEs|8|||
37684149|NCT01607905|69159889|FG000|Overall Study|Disease progression|44|||
37684150|NCT01607905|69159890|FG001|Overall Study|Disease progression|16|||
37684151|NCT01607905|69159891|FG002|Overall Study|Disease progression|15|||
37684152|NCT01607905|69159892|FG003|Overall Study|Disease progression|11|||
37684153|NCT01607905|69159893|FG004|Overall Study|Disease progression|6|||
37684154|NCT01607905|69159894|FG005|Overall Study|Disease progression|7|||
37684155|NCT01607905|69159895|FG006|Overall Study|Disease progression|21|||
37684156|NCT01607905|69159889|FG000|Overall Study|Non-compliance with study procedures|0|||
37684157|NCT01607905|69159890|FG001|Overall Study|Non-compliance with study procedures|0|||
37684158|NCT01607905|69159891|FG002|Overall Study|Non-compliance with study procedures|0|||
37684159|NCT01607905|69159892|FG003|Overall Study|Non-compliance with study procedures|0|||
37684160|NCT01607905|69159893|FG004|Overall Study|Non-compliance with study procedures|0|||
37684161|NCT01607905|69159894|FG005|Overall Study|Non-compliance with study procedures|0|||
37684162|NCT01607905|69159895|FG006|Overall Study|Non-compliance with study procedures|1|||
37684163|NCT01607905|69159889|FG000|Overall Study|Death|1|||
37684164|NCT01607905|69159890|FG001|Overall Study|Death|1|||
37684165|NCT01607905|69159891|FG002|Overall Study|Death|1|||
37684166|NCT01607905|69159892|FG003|Overall Study|Death|1|||
37684167|NCT01607905|69159893|FG004|Overall Study|Death|0|||
37684168|NCT01607905|69159894|FG005|Overall Study|Death|0|||
37684169|NCT01607905|69159895|FG006|Overall Study|Death|3|||
37684170|NCT01607905|69159889|FG000|Overall Study|Other treatments become available|1|||
37684171|NCT01607905|69159890|FG001|Overall Study|Other treatments become available|0|||
37684172|NCT01607905|69159891|FG002|Overall Study|Other treatments become available|0|||
37684173|NCT01607905|69159892|FG003|Overall Study|Other treatments become available|0|||
37684174|NCT01607905|69159893|FG004|Overall Study|Other treatments become available|0|||
37684175|NCT01607905|69159894|FG005|Overall Study|Other treatments become available|0|||
38083732|NCT02631538|69782961|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
38083733|NCT02631538|69782962|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
38083734|NCT02631538|69782963|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
38083735|NCT02631538|69782964|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
38083736|NCT02631538|69782961|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
38083737|NCT02631538|69782962|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
38083738|NCT02631538|69782963|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
38083739|NCT02631538|69782964|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
38083740|NCT02631538|69782961|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
38083741|NCT02631538|69782962|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
38083742|NCT02631538|69782963|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
38083743|NCT02631538|69782964|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
38083744|NCT02631538|69782961|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
38083745|NCT02631538|69782962|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
38083746|NCT02631538|69782963|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
38083747|NCT02631538|69782964|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
37684176|NCT01607905|69159895|FG006|Overall Study|Other treatments become available|1|||
37684177|NCT01607905|69159889|FG000|Overall Study|Investigator discretion|0|||
37684178|NCT01607905|69159890|FG001|Overall Study|Investigator discretion|0|||
37684179|NCT01607905|69159891|FG002|Overall Study|Investigator discretion|0|||
37967133|NCT00535236|69653996|FG000|Overall Study|Withdrawal by Subject|3|||
38083748|NCT02631538|69782961|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
38083749|NCT02631538|69782962|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
38083750|NCT02631538|69782963|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
38083751|NCT02631538|69782964|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
38083752|NCT04587271|69782989|FG000|Overall Study|Lost to Follow-up|2|||
38083753|NCT04587271|69782990|FG001|Overall Study|Lost to Follow-up|2|||
38083754|NCT04587271|69782991|FG002|Overall Study|Lost to Follow-up|0|||
37684180|NCT01607905|69159892|FG003|Overall Study|Investigator discretion|0|||
37684181|NCT01607905|69159893|FG004|Overall Study|Investigator discretion|0|||
38083755|NCT04587271|69782992|FG003|Overall Study|Lost to Follow-up|2|||
38083756|NCT04587271|69782993|FG004|Overall Study|Lost to Follow-up|2|||
38083757|NCT04587271|69782994|FG005|Overall Study|Lost to Follow-up|0|||
38083758|NCT04587271|69782989|FG000|Overall Study|Caregiver brought child to visits|0|||
38083759|NCT04587271|69782990|FG001|Overall Study|Caregiver brought child to visits|0|||
38083760|NCT04587271|69782991|FG002|Overall Study|Caregiver brought child to visits|0|||
38083761|NCT04587271|69782992|FG003|Overall Study|Caregiver brought child to visits|1|||
38083762|NCT04587271|69782993|FG004|Overall Study|Caregiver brought child to visits|0|||
38083763|NCT04587271|69782994|FG005|Overall Study|Caregiver brought child to visits|0|||
38083764|NCT02631148|69783009|FG000|Overall Study|8 were ineligible|8|||
38083765|NCT02631148|69783010|FG001|Overall Study|8 were ineligible|0|||
38083766|NCT02631148|69783009|FG000|Overall Study|Withdrawal by Subject|1|||
38083767|NCT02631148|69783010|FG001|Overall Study|Withdrawal by Subject|0|||
38083768|NCT02631148|69783009|FG000|Overall Study|PAH not available to study participant|1|||
38083769|NCT02631148|69783010|FG001|Overall Study|PAH not available to study participant|0|||
38083770|NCT02753400|69783018|FG000|Overall Study|Adverse Event|3|||
38083771|NCT02753400|69783019|FG001|Overall Study|Adverse Event|0|||
37684182|NCT01607905|69159894|FG005|Overall Study|Investigator discretion|1|||
38083772|NCT02753400|69783018|FG000|Overall Study|Withdrawal by Subject|2|||
38083773|NCT02753400|69783019|FG001|Overall Study|Withdrawal by Subject|1|||
38083774|NCT03943147|69783036|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
38083775|NCT03943147|69783037|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
37684183|NCT01607905|69159895|FG006|Overall Study|Investigator discretion|0|||
37684184|NCT01607905|69159889|FG000|Overall Study|Other|1|||
37684185|NCT01607905|69159890|FG001|Overall Study|Other|0|||
37684186|NCT01607905|69159891|FG002|Overall Study|Other|0|||
37684187|NCT01607905|69159892|FG003|Overall Study|Other|0|||
37684188|NCT01607905|69159893|FG004|Overall Study|Other|0|||
37684189|NCT01607905|69159894|FG005|Overall Study|Other|0|||
37684190|NCT01607905|69159895|FG006|Overall Study|Other|1|||
37684191|NCT01607905|69159889|FG000|Overall Study|Randomized but not treated|1|||
37684192|NCT01607905|69159890|FG001|Overall Study|Randomized but not treated|0|||
37684193|NCT01607905|69159891|FG002|Overall Study|Randomized but not treated|0|||
37684194|NCT01607905|69159892|FG003|Overall Study|Randomized but not treated|0|||
37684195|NCT01607905|69159893|FG004|Overall Study|Randomized but not treated|1|||
37684196|NCT01607905|69159894|FG005|Overall Study|Randomized but not treated|1|||
37684197|NCT01607905|69159895|FG006|Overall Study|Randomized but not treated|0|||
37684198|NCT02536963|69159953|FG000|Overall Study|Withdrawal by Subject|18|||
37684199|NCT02531035|69159959|FG000|Overall Study|Death|0|||
37684200|NCT02531035|69159960|FG001|Overall Study|Death|1|||
37684201|NCT02531035|69159959|FG000|Overall Study|Protocol Violation|1|||
37684202|NCT02531035|69159960|FG001|Overall Study|Protocol Violation|1|||
37684203|NCT02531035|69159959|FG000|Overall Study|Noncompliance with study drug|8|||
37684204|NCT02531035|69159960|FG001|Overall Study|Noncompliance with study drug|3|||
37684205|NCT02531035|69159959|FG000|Overall Study|Physician Decision|1|||
37684206|NCT02531035|69159960|FG001|Overall Study|Physician Decision|0|||
37684207|NCT02531035|69159959|FG000|Overall Study|Adverse Event|16|||
37684208|NCT02531035|69159960|FG001|Overall Study|Adverse Event|45|||
37684209|NCT02531035|69159959|FG000|Overall Study|Other|3|||
37684210|NCT02531035|69159960|FG001|Overall Study|Other|2|||
37684211|NCT02531035|69159959|FG000|Overall Study|Withdrawal by Subject|42|||
37684212|NCT02531035|69159960|FG001|Overall Study|Withdrawal by Subject|32|||
38083776|NCT03943147|69783036|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
38083777|NCT03943147|69783037|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
38083778|NCT03943147|69783036|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
38083779|NCT03943147|69783037|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
38083780|NCT03943147|69783036|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
38083781|NCT03943147|69783037|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
38083782|NCT03943147|69783036|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
38083783|NCT03943147|69783037|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
38083784|NCT03943147|69783036|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
38083785|NCT03943147|69783037|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
38083786|NCT03730987|69783055|FG000|Overall Study|Lost to Follow-up|2|||
38083787|NCT03730987|69783056|FG001|Overall Study|Lost to Follow-up|0|||
38083788|NCT03730987|69783057|FG002|Overall Study|Lost to Follow-up|2|||
38083789|NCT03730987|69783058|FG003|Overall Study|Lost to Follow-up|0|||
38083790|NCT03556891|69783069|FG000|Overall Study|Adverse Event|4|||
38083791|NCT03556891|69783069|FG000|Overall Study|MRI Need|3|||
38083792|NCT03556891|69783069|FG000|Overall Study|Device Failure|1|||
38083793|NCT03556891|69783069|FG000|Overall Study|Death|1|||
38083794|NCT03556891|69783069|FG000|Overall Study|Lost to Follow-up|1|||
38083795|NCT03556891|69783069|FG000|Overall Study|Missing at random|1|||
38083796|NCT03556891|69783069|FG000|Overall Study|Missing due to COVID|1|||
38083797|NCT03556891|69783069|FG000|Overall Study|Protocol Violation|1|||
38083798|NCT02844543|69783073|FG000|Overall Study|Withdrawal by Subject|4|||
38083799|NCT02844543|69783073|FG000|Overall Study|Did not meet eligibility criteria|1|||
38083800|NCT03034135|69783077|FG000|Overall Study|Withdrawal by Subject|2|||
38083801|NCT01671280|69783081|FG000|Overall Study|Withdrawal by Subject|2|||
38083802|NCT01405963|69783087|FG000|Overall Study|Moved Away|2|||
38083803|NCT01405963|69783088|FG001|Overall Study|Moved Away|0|||
37684213|NCT02531035|69159959|FG000|Overall Study|Lost to Follow-up|8|||
37684214|NCT02531035|69159960|FG001|Overall Study|Lost to Follow-up|10|||
37684215|NCT02531035|69159959|FG000|Overall Study|Randomized, not treated|2|||
37684216|NCT02531035|69159960|FG001|Overall Study|Randomized, not treated|1|||
37684217|NCT01659853|69159976|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
37684218|NCT01659853|69159977|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
37684219|NCT01659853|69159976|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
38083804|NCT01405963|69783087|FG000|Overall Study|Adverse Event|0|||
37967134|NCT00535236|69653997|FG001|Overall Study|Withdrawal by Subject|0|||
38083805|NCT01405963|69783088|FG001|Overall Study|Adverse Event|1|||
38083806|NCT01405963|69783087|FG000|Overall Study|Lost to Follow-up|0|||
38083807|NCT01405963|69783088|FG001|Overall Study|Lost to Follow-up|1|||
38083808|NCT02628418|69783108|FG000|Overall Study|Lost to Follow-up|1|||
37684220|NCT01659853|69159977|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
37684221|NCT01660243|69159989|FG000|Overall Study|Adverse Event|1|||
38083809|NCT02628418|69783109|FG001|Overall Study|Lost to Follow-up|2|||
37684222|NCT01660243|69159990|FG001|Overall Study|Adverse Event|0|||
37684223|NCT01660243|69159991|FG002|Overall Study|Adverse Event|1|||
37684224|NCT01660243|69159992|FG003|Overall Study|Adverse Event|0|||
37684225|NCT01660243|69159989|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
37684226|NCT01660243|69159990|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
37684227|NCT01660243|69159991|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
37684228|NCT01660243|69159992|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
37684229|NCT01660243|69159989|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
37684230|NCT01660243|69159990|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
37684231|NCT01660243|69159991|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
37684232|NCT01660243|69159992|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
37684233|NCT01660243|69159989|FG000|Overall Study|Randomization error|0|||
37684234|NCT01660243|69159990|FG001|Overall Study|Randomization error|0|||
37684235|NCT01660243|69159991|FG002|Overall Study|Randomization error|0|||
37684236|NCT01660243|69159992|FG003|Overall Study|Randomization error|1|||
37684237|NCT02531113|69160002|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
37684238|NCT02531113|69160002|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
37684239|NCT02531113|69160002|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
37684240|NCT02531113|69160002|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
37684241|NCT02531113|69160002|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
37684242|NCT02531113|69160002|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
37684243|NCT02531113|69160002|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
37684244|NCT02531113|69160002|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
37684245|NCT02522767|69160012|FG000|Double-blind|Withdrawal by Subject|8|||
37684246|NCT02522767|69160013|FG001|Double-blind|Withdrawal by Subject|11|||
37684247|NCT02522767|69160012|FG000|Double-blind|Lost to Follow-up|1|||
37684248|NCT02522767|69160013|FG001|Double-blind|Lost to Follow-up|0|||
37684249|NCT02522767|69160012|FG000|Double-blind|Adverse Event|1|||
37684250|NCT02522767|69160013|FG001|Double-blind|Adverse Event|10|||
37684251|NCT02522767|69160012|FG000|Double-blind|Protocol Violation|0|||
37684252|NCT02522767|69160013|FG001|Double-blind|Protocol Violation|1|||
37684253|NCT02522767|69160012|FG000|Double-blind|Lack of Efficacy|0|||
37684254|NCT02522767|69160013|FG001|Double-blind|Lack of Efficacy|2|||
37684255|NCT02522767|69160012|FG000|Double-blind|Protocol Deviation|1|||
37684256|NCT02522767|69160013|FG001|Double-blind|Protocol Deviation|0|||
37684257|NCT02522767|69160012|FG000|Open-label|Withdrawal by Subject|2|||
37684258|NCT02522767|69160013|FG001|Open-label|Withdrawal by Subject|3|||
37684259|NCT02522767|69160012|FG000|Open-label|Lost to Follow-up|0|||
37684260|NCT02522767|69160013|FG001|Open-label|Lost to Follow-up|1|||
37684261|NCT02522767|69160012|FG000|Open-label|Adverse Event|2|||
37684262|NCT02522767|69160013|FG001|Open-label|Adverse Event|1|||
37684263|NCT02522767|69160012|FG000|Open-label|Lack of Efficacy|1|||
37684264|NCT02522767|69160013|FG001|Open-label|Lack of Efficacy|1|||
37684265|NCT02522767|69160012|FG000|Open-label|Protocol Violation|0|||
37684266|NCT02522767|69160013|FG001|Open-label|Protocol Violation|1|||
37684267|NCT02522377|69160023|FG000|Overall Study|Withdrawal by Subject|1|||
37684268|NCT02522377|69160024|FG001|Overall Study|Withdrawal by Subject|0|||
37684269|NCT02522377|69160023|FG000|Overall Study|Remission Achieved|3|||
37967135|NCT00535236|69653998|FG002|Overall Study|Withdrawal by Subject|2|||
37967136|NCT00535236|69653999|FG003|Overall Study|Withdrawal by Subject|1|||
37967137|NCT00535236|69654000|FG004|Overall Study|Withdrawal by Subject|6|||
37967138|NCT00535236|69654001|FG005|Overall Study|Withdrawal by Subject|1|||
37684270|NCT02522377|69160024|FG001|Overall Study|Remission Achieved|0|||
37684271|NCT01657903|69160030|FG000|Overall Study|Lost to Follow-up|1|||
37684272|NCT01657903|69160030|FG000|Overall Study|Withdrawal by Subject|1|||
37684273|NCT01656733|69160043|FG000|Overall Study|No permission to collect birth outcomes|0|||
37684274|NCT01656733|69160044|FG001|Overall Study|No permission to collect birth outcomes|1|||
37684275|NCT01656733|69160043|FG000|Overall Study|Delivery at another hospital|0|||
37684276|NCT01656733|69160044|FG001|Overall Study|Delivery at another hospital|2|||
37684277|NCT01656733|69160043|FG000|Overall Study|Spontaneous abortion|0|||
37684278|NCT01656733|69160044|FG001|Overall Study|Spontaneous abortion|1|||
37967139|NCT00535236|69654002|FG006|Overall Study|Withdrawal by Subject|5|||
38083810|NCT02752776|69783137|FG000|Overall Study|Adverse Event|15|||
38083811|NCT02752776|69783138|FG001|Overall Study|Adverse Event|23|||
38083812|NCT02752776|69783139|FG002|Overall Study|Adverse Event|11|||
38083813|NCT02752776|69783137|FG000|Overall Study|Lack of Efficacy|2|||
38083814|NCT02752776|69783138|FG001|Overall Study|Lack of Efficacy|6|||
38083815|NCT02752776|69783139|FG002|Overall Study|Lack of Efficacy|14|||
38083816|NCT02752776|69783137|FG000|Overall Study|Lost to Follow-up|11|||
38083817|NCT02752776|69783138|FG001|Overall Study|Lost to Follow-up|12|||
38083818|NCT02752776|69783139|FG002|Overall Study|Lost to Follow-up|4|||
38083819|NCT02752776|69783137|FG000|Overall Study|Non-compliance with study treatment|0|||
38083820|NCT02752776|69783138|FG001|Overall Study|Non-compliance with study treatment|0|||
38083821|NCT02752776|69783139|FG002|Overall Study|Non-compliance with study treatment|1|||
38083822|NCT02752776|69783137|FG000|Overall Study|Physician Decision|2|||
38083823|NCT02752776|69783138|FG001|Overall Study|Physician Decision|6|||
37684279|NCT01656967|69160052|FG000|Overall Study|faulty monitor|1|||
37684280|NCT01656967|69160053|FG001|Overall Study|faulty monitor|0|||
37684281|NCT01656967|69160052|FG000|Overall Study|unsuccessful ETT insertion|3|||
37684282|NCT01656967|69160053|FG001|Overall Study|unsuccessful ETT insertion|2|||
37684283|NCT01656889|69160065|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
37684284|NCT01656889|69160066|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
37684285|NCT01656889|69160065|FG000|Treatment Period, 12 Weeks|Death|0|||
37684286|NCT01656889|69160066|FG001|Treatment Period, 12 Weeks|Death|1|||
37684287|NCT01656889|69160065|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
37684288|NCT01656889|69160066|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
37684289|NCT01656889|69160065|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
37684290|NCT01656889|69160066|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
37684291|NCT01656889|69160065|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
37684292|NCT01656889|69160066|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
37684293|NCT01656889|69160065|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
37684294|NCT01656889|69160066|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
37684295|NCT01656889|69160065|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
37684296|NCT01656889|69160066|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
37684297|NCT01656889|69160065|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
37684298|NCT01656889|69160066|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
37684299|NCT01656889|69160065|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
37684300|NCT01656889|69160066|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
37684301|NCT01656889|69160065|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
37684302|NCT01656889|69160066|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
37684303|NCT02522299|69160074|FG000|Overall Study|Adverse Event|2|||
37684304|NCT02522299|69160075|FG001|Overall Study|Adverse Event|0|||
37684305|NCT02522299|69160074|FG000|Overall Study|Physician Decision|0|||
37684306|NCT02522299|69160075|FG001|Overall Study|Physician Decision|1|||
37684307|NCT02522299|69160074|FG000|Overall Study|Withdrawal by Subject|2|||
37684308|NCT02522299|69160075|FG001|Overall Study|Withdrawal by Subject|0|||
37684309|NCT01365091|69160099|FG000|Period 1|Adverse Event|1|||
37684310|NCT01365091|69160100|FG001|Period 1|Adverse Event|0|||
37684311|NCT01365091|69160101|FG002|Period 1|Adverse Event|2|||
37684312|NCT01365091|69160102|FG003|Period 1|Adverse Event|3|||
37684313|NCT01365091|69160099|FG000|Period 1|Positive test result for drugs of abuse|1|||
37684314|NCT01365091|69160100|FG001|Period 1|Positive test result for drugs of abuse|0|||
37684315|NCT01365091|69160101|FG002|Period 1|Positive test result for drugs of abuse|0|||
37684316|NCT01365091|69160102|FG003|Period 1|Positive test result for drugs of abuse|0|||
37684317|NCT01365091|69160099|FG000|Period 1|No longer met study criteria|0|||
37684318|NCT01365091|69160100|FG001|Period 1|No longer met study criteria|1|||
37684319|NCT01365091|69160101|FG002|Period 1|No longer met study criteria|0|||
37684320|NCT01365091|69160102|FG003|Period 1|No longer met study criteria|0|||
37684321|NCT01365091|69160099|FG000|Period 1|Withdrawal by Subject|0|||
37684322|NCT01365091|69160100|FG001|Period 1|Withdrawal by Subject|1|||
37684323|NCT01365091|69160101|FG002|Period 1|Withdrawal by Subject|0|||
37684324|NCT01365091|69160102|FG003|Period 1|Withdrawal by Subject|0|||
37684325|NCT01365091|69160099|FG000|Period 1|Personal reasons|0|||
37684326|NCT01365091|69160100|FG001|Period 1|Personal reasons|0|||
37684327|NCT01365091|69160101|FG002|Period 1|Personal reasons|1|||
37684328|NCT01365091|69160102|FG003|Period 1|Personal reasons|0|||
37684329|NCT01365091|69160099|FG000|Period 2|Withdrawal by Subject|1|||
37684330|NCT01365091|69160100|FG001|Period 2|Withdrawal by Subject|0|||
37684331|NCT01365091|69160101|FG002|Period 2|Withdrawal by Subject|0|||
37684332|NCT01365091|69160102|FG003|Period 2|Withdrawal by Subject|0|||
37684333|NCT01365091|69160099|FG000|Period 2|Adverse Event|0|||
37684334|NCT01365091|69160100|FG001|Period 2|Adverse Event|0|||
37684335|NCT01365091|69160101|FG002|Period 2|Adverse Event|1|||
37684336|NCT01365091|69160102|FG003|Period 2|Adverse Event|0|||
37684337|NCT01364467|69160128|FG000|Overall Study|Lost to Follow-up|1|||
37684338|NCT01364467|69160129|FG001|Overall Study|Lost to Follow-up|2|||
37684339|NCT02520661|69160137|FG000|Overall Study|Lost to Follow-up|7|||
37684340|NCT02520661|69160138|FG001|Overall Study|Lost to Follow-up|3|||
37684341|NCT02520661|69160137|FG000|Overall Study|Admitted from ED|49|||
37684342|NCT02520661|69160138|FG001|Overall Study|Admitted from ED|48|||
37684343|NCT02520661|69160137|FG000|Overall Study|ED greater than 24 hours|29|||
37684344|NCT02520661|69160138|FG001|Overall Study|ED greater than 24 hours|38|||
37684345|NCT02520661|69160137|FG000|Overall Study|other ineligibility|14|||
37684346|NCT02520661|69160138|FG001|Overall Study|other ineligibility|22|||
37684347|NCT02520661|69160137|FG000|Overall Study|Withdrawal by Subject|7|||
37684348|NCT02520661|69160138|FG001|Overall Study|Withdrawal by Subject|16|||
37684349|NCT01364389|69160151|FG000|Overall Study|Withdrawal by Subject|0|||
37684350|NCT01364389|69160152|FG001|Overall Study|Withdrawal by Subject|1|||
37684351|NCT01364389|69160153|FG002|Overall Study|Withdrawal by Subject|0|||
37684352|NCT01364389|69160151|FG000|Overall Study|Protocol deviation|0|||
37684353|NCT01364389|69160152|FG001|Overall Study|Protocol deviation|0|||
37684354|NCT01364389|69160153|FG002|Overall Study|Protocol deviation|1|||
37684355|NCT01364389|69160151|FG000|Overall Study|Administrative problems|1|||
37684356|NCT01364389|69160152|FG001|Overall Study|Administrative problems|0|||
37684357|NCT01364389|69160153|FG002|Overall Study|Administrative problems|0|||
38083824|NCT02752776|69783139|FG002|Overall Study|Physician Decision|2|||
38083825|NCT02752776|69783137|FG000|Overall Study|Pregnancy|1|||
38083826|NCT02752776|69783138|FG001|Overall Study|Pregnancy|6|||
38083827|NCT02752776|69783139|FG002|Overall Study|Pregnancy|3|||
38083828|NCT02752776|69783137|FG000|Overall Study|Protocol Violation|10|||
38083829|NCT02752776|69783138|FG001|Overall Study|Protocol Violation|13|||
38083830|NCT02752776|69783139|FG002|Overall Study|Protocol Violation|6|||
38083831|NCT02752776|69783137|FG000|Overall Study|Subject/guardian decision|8|||
38083832|NCT02752776|69783138|FG001|Overall Study|Subject/guardian decision|6|||
38083833|NCT02752776|69783139|FG002|Overall Study|Subject/guardian decision|4|||
38083834|NCT02752776|69783137|FG000|Overall Study|Death|0|||
38083835|NCT02752776|69783138|FG001|Overall Study|Death|0|||
38083836|NCT02752776|69783139|FG002|Overall Study|Death|1|||
38083837|NCT02752776|69783137|FG000|Overall Study|Withdrawal by Subject|3|||
38083838|NCT02752776|69783138|FG001|Overall Study|Withdrawal by Subject|4|||
38083839|NCT02752776|69783139|FG002|Overall Study|Withdrawal by Subject|2|||
38083840|NCT01342965|69783151|FG000|Overall Study|Death|58|||
38083841|NCT01342965|69783152|FG001|Overall Study|Death|57|||
38083842|NCT01342965|69783151|FG000|Overall Study|Lost to Follow-up|5|||
38083843|NCT01342965|69783152|FG001|Overall Study|Lost to Follow-up|3|||
38083844|NCT01342965|69783151|FG000|Overall Study|Other Reasons- Unspecified|44|||
38083845|NCT01342965|69783152|FG001|Overall Study|Other Reasons- Unspecified|38|||
38083846|NCT01342965|69783151|FG000|Overall Study|Withdrawal by Subject|2|||
38083847|NCT01342965|69783152|FG001|Overall Study|Withdrawal by Subject|9|||
38083848|NCT02629822|69783158|FG000|Base Study|Lost to Follow-up|2|||
38083849|NCT02629822|69783158|FG000|Base Study|Non-Compliance With Study Drug|1|||
38083850|NCT02629822|69783158|FG000|Extension Study|Adverse Event|1|||
38083851|NCT02629822|69783158|FG000|Extension Study|Lost to Follow-up|1|||
38083852|NCT03462706|69783167|FG000|Overall Study|Polyp was pedunculated|1|||
38083853|NCT03462706|69783168|FG001|Overall Study|Polyp was pedunculated|0|||
38083854|NCT03462706|69783169|FG002|Overall Study|Polyp was pedunculated|1|||
38083855|NCT03462706|69783170|FG003|Overall Study|Polyp was pedunculated|0|||
38083856|NCT03462706|69783167|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
38083857|NCT03462706|69783168|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
38083858|NCT03462706|69783169|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
38083859|NCT03462706|69783170|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
38083860|NCT02840253|69783180|FG000|Overall Study|Unsuccessful block|4|||
38083861|NCT02752074|69783186|FG000|Overall Study|Lost to Follow-up|1|||
38083862|NCT02752074|69783187|FG001|Overall Study|Lost to Follow-up|4|||
38083863|NCT02752074|69783186|FG000|Overall Study|Death|146|||
38083864|NCT02752074|69783187|FG001|Overall Study|Death|129|||
38083865|NCT02752074|69783186|FG000|Overall Study|Withdrawal by Subject|9|||
38083866|NCT02752074|69783187|FG001|Overall Study|Withdrawal by Subject|10|||
38083867|NCT02835495|69783195|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
38083868|NCT02835495|69783196|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
38083869|NCT02835495|69783195|FG000|Overall Study|Declined in-person follow-up visit|4|||
38083870|NCT02835495|69783196|FG001|Overall Study|Declined in-person follow-up visit|2|||
38083871|NCT02835339|69783206|FG000|Overall Study|Did not receive allocated intervention|13|||
38083872|NCT02835339|69783207|FG001|Overall Study|Did not receive allocated intervention|16|||
38083873|NCT02832063|69783215|FG000|Overall Study|Adverse Event|2|||
38083874|NCT02832063|69783216|FG001|Overall Study|Adverse Event|1|||
38083875|NCT02832063|69783215|FG000|Overall Study|Physician Decision|5|||
38083876|NCT02832063|69783216|FG001|Overall Study|Physician Decision|7|||
38083877|NCT02832063|69783215|FG000|Overall Study|Lost to Follow-up|15|||
38083878|NCT02832063|69783216|FG001|Overall Study|Lost to Follow-up|8|||
38083879|NCT02832063|69783215|FG000|Overall Study|Withdrawal by Subject|10|||
38083880|NCT02832063|69783216|FG001|Overall Study|Withdrawal by Subject|21|||
38083881|NCT02832063|69783215|FG000|Overall Study|Other|2|||
37684358|NCT01364389|69160151|FG000|Overall Study|Adverse Event|1|||
37684359|NCT01364389|69160152|FG001|Overall Study|Adverse Event|0|||
37684360|NCT01364389|69160153|FG002|Overall Study|Adverse Event|0|||
37684361|NCT01364233|69160161|FG000|Overall Study|Lost to Follow-up|1|||
37684362|NCT02291289|69160169|FG000|Induction Treatment|Not Dosed|2|||
37684363|NCT02291289|69160170|FG001|Induction Treatment|Not Dosed|0|||
37684364|NCT02291289|69160171|FG002|Induction Treatment|Not Dosed|0|||
38083882|NCT02832063|69783216|FG001|Overall Study|Other|1|||
38083883|NCT03125902|69783235|FG000|Overall Study|Death|52|||
38083884|NCT03125902|69783236|FG001|Overall Study|Death|123|||
37684365|NCT02291289|69160172|FG003|Induction Treatment|Not Dosed|9|||
38083885|NCT03125902|69783235|FG000|Overall Study|Lost to Follow-up|1|||
38083886|NCT03125902|69783236|FG001|Overall Study|Lost to Follow-up|0|||
38083887|NCT03125902|69783235|FG000|Overall Study|Mastectomy|0|||
38083888|NCT03125902|69783236|FG001|Overall Study|Mastectomy|1|||
38083889|NCT03125902|69783235|FG000|Overall Study|Physician Decision|1|||
38083890|NCT03125902|69783236|FG001|Overall Study|Physician Decision|0|||
38083891|NCT03125902|69783235|FG000|Overall Study|Withdrawal by Subject|13|||
38083892|NCT03125902|69783236|FG001|Overall Study|Withdrawal by Subject|25|||
37684366|NCT02291289|69160173|FG004|Induction Treatment|Not Dosed|0|||
37684367|NCT02291289|69160174|FG005|Induction Treatment|Not Dosed|0|||
37684368|NCT02291289|69160175|FG006|Induction Treatment|Not Dosed|0|||
37684369|NCT02291289|69160176|FG007|Induction Treatment|Not Dosed|0|||
37684370|NCT02291289|69160177|FG008|Induction Treatment|Not Dosed|0|||
37684371|NCT02291289|69160178|FG009|Induction Treatment|Not Dosed|1|||
37684372|NCT02291289|69160179|FG010|Induction Treatment|Not Dosed|0|||
37684373|NCT02291289|69160180|FG011|Induction Treatment|Not Dosed|0|||
37684374|NCT02291289|69160169|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
37684375|NCT02291289|69160170|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
37684376|NCT02291289|69160171|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
37684377|NCT02291289|69160172|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
37684378|NCT02291289|69160173|FG004|Maintenance Treatment Phase|Withdrawal by Subject|13|||
37684379|NCT02291289|69160174|FG005|Maintenance Treatment Phase|Withdrawal by Subject|11|||
37684380|NCT02291289|69160175|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
37684381|NCT02291289|69160176|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
37684382|NCT02291289|69160177|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
37684383|NCT02291289|69160178|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
37684384|NCT02291289|69160179|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
37684385|NCT02291289|69160180|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
37684386|NCT02291289|69160169|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
37684387|NCT02291289|69160170|FG001|Maintenance Treatment Phase|Protocol Violation|1|||
37684388|NCT02291289|69160171|FG002|Maintenance Treatment Phase|Protocol Violation|0|||
37684389|NCT02291289|69160172|FG003|Maintenance Treatment Phase|Protocol Violation|0|||
37684390|NCT02291289|69160173|FG004|Maintenance Treatment Phase|Protocol Violation|2|||
37684391|NCT02291289|69160174|FG005|Maintenance Treatment Phase|Protocol Violation|1|||
37684392|NCT02291289|69160175|FG006|Maintenance Treatment Phase|Protocol Violation|0|||
37684393|NCT02291289|69160176|FG007|Maintenance Treatment Phase|Protocol Violation|0|||
37684394|NCT02291289|69160177|FG008|Maintenance Treatment Phase|Protocol Violation|0|||
37684395|NCT02291289|69160178|FG009|Maintenance Treatment Phase|Protocol Violation|0|||
37684396|NCT02291289|69160179|FG010|Maintenance Treatment Phase|Protocol Violation|0|||
37684397|NCT02291289|69160180|FG011|Maintenance Treatment Phase|Protocol Violation|0|||
37684398|NCT02291289|69160169|FG000|Maintenance Treatment Phase|Death|0|||
37684399|NCT02291289|69160170|FG001|Maintenance Treatment Phase|Death|23|||
37684400|NCT02291289|69160171|FG002|Maintenance Treatment Phase|Death|13|||
37684401|NCT02291289|69160172|FG003|Maintenance Treatment Phase|Death|0|||
37684402|NCT02291289|69160173|FG004|Maintenance Treatment Phase|Death|185|||
37684403|NCT02291289|69160174|FG005|Maintenance Treatment Phase|Death|100|||
37684404|NCT02291289|69160175|FG006|Maintenance Treatment Phase|Death|0|||
37684405|NCT02291289|69160176|FG007|Maintenance Treatment Phase|Death|1|||
37684406|NCT02291289|69160177|FG008|Maintenance Treatment Phase|Death|1|||
37684407|NCT02291289|69160178|FG009|Maintenance Treatment Phase|Death|0|||
37684408|NCT02291289|69160179|FG010|Maintenance Treatment Phase|Death|26|||
37684409|NCT02291289|69160180|FG011|Maintenance Treatment Phase|Death|11|||
37684410|NCT02291289|69160169|FG000|Maintenance Treatment Phase|Adverse Event|0|||
37684411|NCT02291289|69160170|FG001|Maintenance Treatment Phase|Adverse Event|0|||
37684412|NCT02291289|69160171|FG002|Maintenance Treatment Phase|Adverse Event|0|||
37684413|NCT02291289|69160172|FG003|Maintenance Treatment Phase|Adverse Event|0|||
37684414|NCT02291289|69160173|FG004|Maintenance Treatment Phase|Adverse Event|1|||
37684415|NCT02291289|69160174|FG005|Maintenance Treatment Phase|Adverse Event|0|||
37684416|NCT02291289|69160175|FG006|Maintenance Treatment Phase|Adverse Event|0|||
37684417|NCT02291289|69160176|FG007|Maintenance Treatment Phase|Adverse Event|0|||
37684418|NCT02291289|69160177|FG008|Maintenance Treatment Phase|Adverse Event|0|||
37684419|NCT02291289|69160178|FG009|Maintenance Treatment Phase|Adverse Event|0|||
37684420|NCT02291289|69160179|FG010|Maintenance Treatment Phase|Adverse Event|0|||
37684421|NCT02291289|69160180|FG011|Maintenance Treatment Phase|Adverse Event|0|||
37684422|NCT02291289|69160169|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
37684423|NCT02291289|69160170|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
37684424|NCT02291289|69160171|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
37863003|NCT01263197|69546935|FG003|Washout Period 2|Physician Decision|0|||
37684425|NCT02291289|69160172|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
37684426|NCT02291289|69160173|FG004|Maintenance Treatment Phase|Lost to Follow-up|12|||
37684427|NCT02291289|69160174|FG005|Maintenance Treatment Phase|Lost to Follow-up|3|||
37684428|NCT02291289|69160175|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
37684429|NCT02291289|69160176|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
37684430|NCT02291289|69160177|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
37684431|NCT02291289|69160178|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
37684432|NCT02291289|69160179|FG010|Maintenance Treatment Phase|Lost to Follow-up|2|||
37684433|NCT02291289|69160180|FG011|Maintenance Treatment Phase|Lost to Follow-up|1|||
37684434|NCT02291289|69160169|FG000|Maintenance Treatment Phase|Other|0|||
37684435|NCT02291289|69160170|FG001|Maintenance Treatment Phase|Other|0|||
37684436|NCT02291289|69160171|FG002|Maintenance Treatment Phase|Other|1|||
37684437|NCT02291289|69160172|FG003|Maintenance Treatment Phase|Other|0|||
37684438|NCT02291289|69160173|FG004|Maintenance Treatment Phase|Other|29|||
37684439|NCT02291289|69160174|FG005|Maintenance Treatment Phase|Other|8|||
37684440|NCT02291289|69160175|FG006|Maintenance Treatment Phase|Other|0|||
37684441|NCT02291289|69160176|FG007|Maintenance Treatment Phase|Other|0|||
37684442|NCT02291289|69160177|FG008|Maintenance Treatment Phase|Other|1|||
37684443|NCT02291289|69160178|FG009|Maintenance Treatment Phase|Other|0|||
37684444|NCT02291289|69160179|FG010|Maintenance Treatment Phase|Other|0|||
37684445|NCT02291289|69160180|FG011|Maintenance Treatment Phase|Other|0|||
37684446|NCT02291289|69160169|FG000|Maintenance Treatment Phase|Physician Decision|0|||
37684447|NCT02291289|69160170|FG001|Maintenance Treatment Phase|Physician Decision|0|||
37684448|NCT02291289|69160171|FG002|Maintenance Treatment Phase|Physician Decision|0|||
37684449|NCT02291289|69160172|FG003|Maintenance Treatment Phase|Physician Decision|0|||
37684450|NCT02291289|69160173|FG004|Maintenance Treatment Phase|Physician Decision|2|||
37684451|NCT02291289|69160174|FG005|Maintenance Treatment Phase|Physician Decision|0|||
37684452|NCT02291289|69160175|FG006|Maintenance Treatment Phase|Physician Decision|0|||
37684453|NCT02291289|69160176|FG007|Maintenance Treatment Phase|Physician Decision|0|||
37684454|NCT02291289|69160177|FG008|Maintenance Treatment Phase|Physician Decision|0|||
37684455|NCT02291289|69160178|FG009|Maintenance Treatment Phase|Physician Decision|0|||
37684456|NCT02291289|69160179|FG010|Maintenance Treatment Phase|Physician Decision|0|||
37684457|NCT02291289|69160180|FG011|Maintenance Treatment Phase|Physician Decision|1|||
37684458|NCT02291289|69160169|FG000|Maintenance Treatment Phase|Multiple Reasons|0|||
37684459|NCT02291289|69160170|FG001|Maintenance Treatment Phase|Multiple Reasons|0|||
37684460|NCT02291289|69160171|FG002|Maintenance Treatment Phase|Multiple Reasons|0|||
37684461|NCT02291289|69160172|FG003|Maintenance Treatment Phase|Multiple Reasons|0|||
37684462|NCT02291289|69160173|FG004|Maintenance Treatment Phase|Multiple Reasons|4|||
37684463|NCT02291289|69160174|FG005|Maintenance Treatment Phase|Multiple Reasons|1|||
37684464|NCT02291289|69160175|FG006|Maintenance Treatment Phase|Multiple Reasons|0|||
37684465|NCT02291289|69160176|FG007|Maintenance Treatment Phase|Multiple Reasons|0|||
37684466|NCT02291289|69160177|FG008|Maintenance Treatment Phase|Multiple Reasons|0|||
37684467|NCT02291289|69160178|FG009|Maintenance Treatment Phase|Multiple Reasons|0|||
37684468|NCT02291289|69160179|FG010|Maintenance Treatment Phase|Multiple Reasons|0|||
37684469|NCT02291289|69160180|FG011|Maintenance Treatment Phase|Multiple Reasons|0|||
37684470|NCT02291289|69160169|FG000|Maintenance Treatment Phase|No Treatment Received|0|||
37684471|NCT02291289|69160170|FG001|Maintenance Treatment Phase|No Treatment Received|0|||
37684472|NCT02291289|69160171|FG002|Maintenance Treatment Phase|No Treatment Received|2|||
37684473|NCT02291289|69160172|FG003|Maintenance Treatment Phase|No Treatment Received|0|||
37684474|NCT02291289|69160173|FG004|Maintenance Treatment Phase|No Treatment Received|4|||
37684475|NCT02291289|69160174|FG005|Maintenance Treatment Phase|No Treatment Received|5|||
37684476|NCT02291289|69160175|FG006|Maintenance Treatment Phase|No Treatment Received|0|||
37684477|NCT02291289|69160176|FG007|Maintenance Treatment Phase|No Treatment Received|0|||
37684478|NCT02291289|69160177|FG008|Maintenance Treatment Phase|No Treatment Received|0|||
37684479|NCT02291289|69160178|FG009|Maintenance Treatment Phase|No Treatment Received|0|||
37684480|NCT02291289|69160179|FG010|Maintenance Treatment Phase|No Treatment Received|1|||
37684481|NCT02291289|69160180|FG011|Maintenance Treatment Phase|No Treatment Received|0|||
37684482|NCT02317575|69160205|FG000|Period 1|Difficulty with venous cannulation|0|||
37684483|NCT02317575|69160206|FG001|Period 1|Difficulty with venous cannulation|1|||
37684484|NCT02317575|69160207|FG002|Period 1|Difficulty with venous cannulation|0|||
37684485|NCT02317575|69160208|FG003|Period 1|Difficulty with venous cannulation|0|||
37684486|NCT02317575|69160209|FG004|Period 1|Difficulty with venous cannulation|0|||
37684487|NCT02317575|69160205|FG000|Period 1|Withdrawal by Subject|1|||
37684488|NCT02317575|69160206|FG001|Period 1|Withdrawal by Subject|0|||
37684489|NCT02317575|69160207|FG002|Period 1|Withdrawal by Subject|0|||
37684490|NCT02317575|69160208|FG003|Period 1|Withdrawal by Subject|0|||
37684491|NCT02317575|69160209|FG004|Period 1|Withdrawal by Subject|0|||
37684492|NCT02316717|69160230|FG000|Overall Study|Adverse Event|2|||
37684493|NCT02316717|69160231|FG001|Overall Study|Adverse Event|2|||
37967140|NCT00535236|69654003|FG007|Overall Study|Withdrawal by Subject|0|||
38083893|NCT03125902|69783235|FG000|Overall Study|Study is ongoing|153|||
37967141|NCT00535236|69654004|FG008|Overall Study|Withdrawal by Subject|4|||
37684494|NCT02316717|69160232|FG002|Overall Study|Adverse Event|0|||
37684495|NCT02316717|69160230|FG000|Overall Study|Lost to Follow-up|1|||
37684496|NCT02316717|69160231|FG001|Overall Study|Lost to Follow-up|2|||
37684497|NCT02316717|69160232|FG002|Overall Study|Lost to Follow-up|1|||
38083894|NCT03125902|69783236|FG001|Overall Study|Study is ongoing|282|||
37684498|NCT02316717|69160230|FG000|Overall Study|Non compliance|3|||
37684499|NCT02316717|69160231|FG001|Overall Study|Non compliance|1|||
37684500|NCT02316717|69160232|FG002|Overall Study|Non compliance|0|||
37684501|NCT02316717|69160230|FG000|Overall Study|Protocol Violation|2|||
37684502|NCT02316717|69160231|FG001|Overall Study|Protocol Violation|0|||
37684503|NCT02316717|69160232|FG002|Overall Study|Protocol Violation|0|||
37684504|NCT02316717|69160230|FG000|Overall Study|Withdrawal by Subject|2|||
37684505|NCT02316717|69160231|FG001|Overall Study|Withdrawal by Subject|1|||
37684506|NCT02316717|69160232|FG002|Overall Study|Withdrawal by Subject|1|||
37684507|NCT02316717|69160230|FG000|Overall Study|Death|0|||
37684508|NCT02316717|69160231|FG001|Overall Study|Death|0|||
37684509|NCT02316717|69160232|FG002|Overall Study|Death|1|||
37684510|NCT02316717|69160230|FG000|Overall Study|Physician Decision|0|||
37684511|NCT02316717|69160231|FG001|Overall Study|Physician Decision|1|||
37684512|NCT02316717|69160232|FG002|Overall Study|Physician Decision|0|||
37684513|NCT02316717|69160230|FG000|Overall Study|TBC|1|||
37684514|NCT02316717|69160231|FG001|Overall Study|TBC|0|||
37684515|NCT02316717|69160232|FG002|Overall Study|TBC|0|||
37684516|NCT02290821|69160245|FG000|Overall Study|Withdrawal by Subject|1|||
37684517|NCT02290821|69160246|FG001|Overall Study|Withdrawal by Subject|1|||
37684518|NCT02290821|69160245|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
37684519|NCT02290821|69160246|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
37684520|NCT02290821|69160245|FG000|Overall Study|Lost to Follow-up|3|||
37684521|NCT02290821|69160246|FG001|Overall Study|Lost to Follow-up|2|||
37684522|NCT02289963|69160254|FG000|Overall Study|Adverse Event|1|||
37684523|NCT02289963|69160255|FG001|Overall Study|Adverse Event|2|||
37684524|NCT02289963|69160254|FG000|Overall Study|Poor compliance to protocol|1|||
37684525|NCT02289963|69160255|FG001|Overall Study|Poor compliance to protocol|0|||
37684526|NCT02289963|69160254|FG000|Overall Study|Withdrawal by Subject|1|||
37684527|NCT02289963|69160255|FG001|Overall Study|Withdrawal by Subject|0|||
37684528|NCT02289963|69160254|FG000|Overall Study|Last injection missed|2|||
37684529|NCT02289963|69160255|FG001|Overall Study|Last injection missed|2|||
37684530|NCT02289963|69160254|FG000|Overall Study|End treatment visit outside visit window|0|||
37684531|NCT02289963|69160255|FG001|Overall Study|End treatment visit outside visit window|4|||
37684532|NCT02289963|69160254|FG000|Overall Study|Other than specified above|0|||
37684533|NCT02289963|69160255|FG001|Overall Study|Other than specified above|2|||
37684534|NCT02358369|69160264|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
37684535|NCT02358369|69160265|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
37684536|NCT02358369|69160266|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
37684537|NCT02358369|69160267|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
37684538|NCT02358369|69160268|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
37684539|NCT02358369|69160264|FG000|Treatment Period A/B|Adverse Event|0|||
37684540|NCT02358369|69160265|FG001|Treatment Period A/B|Adverse Event|0|||
37684541|NCT02358369|69160266|FG002|Treatment Period A/B|Adverse Event|1|||
37684542|NCT02358369|69160267|FG003|Treatment Period A/B|Adverse Event|2|||
37684543|NCT02358369|69160268|FG004|Treatment Period A/B|Adverse Event|0|||
37684544|NCT02358369|69160264|FG000|Treatment Period A/B|Death|0|||
37684545|NCT02358369|69160265|FG001|Treatment Period A/B|Death|0|||
37684546|NCT02358369|69160266|FG002|Treatment Period A/B|Death|1|||
37684547|NCT02358369|69160267|FG003|Treatment Period A/B|Death|0|||
37684548|NCT02358369|69160268|FG004|Treatment Period A/B|Death|0|||
37684549|NCT02358369|69160264|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
37684550|NCT02358369|69160265|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
37684551|NCT02358369|69160266|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
37684552|NCT02358369|69160267|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
37684553|NCT02358369|69160268|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
37684554|NCT02358369|69160264|FG000|Treatment Period C|Adverse Event|0|||
37684555|NCT02358369|69160265|FG001|Treatment Period C|Adverse Event|0|||
37684556|NCT02358369|69160266|FG002|Treatment Period C|Adverse Event|0|||
37684557|NCT02358369|69160267|FG003|Treatment Period C|Adverse Event|0|||
37684558|NCT02358369|69160268|FG004|Treatment Period C|Adverse Event|7|||
37684559|NCT02316171|69160280|FG000|Overall Study|difficulties with urinary catheter|1|||
37684560|NCT02316171|69160281|FG001|Overall Study|difficulties with urinary catheter|0|||
37684561|NCT02316171|69160282|FG002|Overall Study|difficulties with urinary catheter|0|||
37684562|NCT02316171|69160283|FG003|Overall Study|difficulties with urinary catheter|0|||
37684563|NCT02289729|69160289|FG000|Overall Study|Lack of Efficacy|3|||
37684564|NCT02289729|69160289|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
37684565|NCT02289729|69160289|FG000|Overall Study|Withdrawal by Subject|1|||
37684566|NCT02289729|69160289|FG000|Overall Study|Death|1|||
37684567|NCT02315625|69160295|FG000|First Intervention|Disease Progression|1|||
37684568|NCT02315625|69160296|FG001|First Intervention|Disease Progression|0|||
37684569|NCT02315625|69160295|FG000|Second Intervention|Physician Decision|2|||
37684570|NCT02315625|69160296|FG001|Second Intervention|Physician Decision|1|||
37684571|NCT02315625|69160295|FG000|Second Intervention|Study closure|1|||
37684572|NCT02315625|69160296|FG001|Second Intervention|Study closure|0|||
37684573|NCT02315625|69160295|FG000|Second Intervention|Disease Progression|1|||
37684574|NCT02315625|69160296|FG001|Second Intervention|Disease Progression|0|||
37684575|NCT02357979|69160306|FG000|Overall Study|Lost to Follow-up|5|||
37684576|NCT02357979|69160307|FG001|Overall Study|Lost to Follow-up|5|||
37684577|NCT02357901|69160316|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
37684578|NCT02357901|69160317|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
37684579|NCT02357901|69160318|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
37684580|NCT02357901|69160319|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
38083895|NCT04412707|69783245|FG000|Cycle 1|Death|0|||
38083896|NCT04412707|69783246|FG001|Cycle 1|Death|3|||
38083897|NCT04412707|69783245|FG000|Cycle 1|Disease progression|1|||
38083898|NCT04412707|69783246|FG001|Cycle 1|Disease progression|2|||
38083899|NCT04412707|69783245|FG000|Cycle 2|Death|0|||
38083900|NCT04412707|69783246|FG001|Cycle 2|Death|1|||
38083901|NCT04412707|69783245|FG000|Cycle 2|Disease progression|3|||
38083902|NCT04412707|69783246|FG001|Cycle 2|Disease progression|0|||
38083903|NCT04412707|69783245|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
38083904|NCT04412707|69783246|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
38083905|NCT04412707|69783245|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
38083906|NCT04412707|69783246|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
38083907|NCT04412707|69783245|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
38083908|NCT04412707|69783246|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
38083909|NCT04412707|69783245|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
38083910|NCT04412707|69783246|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
38083911|NCT01358721|69783265|FG000|Overall Study|Withdrawal by Subject|0|||
38083912|NCT01358721|69783266|FG001|Overall Study|Withdrawal by Subject|0|||
38083913|NCT01358721|69783267|FG002|Overall Study|Withdrawal by Subject|0|||
38083914|NCT01358721|69783268|FG003|Overall Study|Withdrawal by Subject|1|||
38083915|NCT01358721|69783265|FG000|Overall Study|Death|0|||
38083916|NCT01358721|69783266|FG001|Overall Study|Death|2|||
38083917|NCT01358721|69783267|FG002|Overall Study|Death|0|||
38083918|NCT01358721|69783268|FG003|Overall Study|Death|0|||
38083919|NCT01358721|69783265|FG000|Overall Study|Study Drug Toxicity|1|||
38083920|NCT01358721|69783266|FG001|Overall Study|Study Drug Toxicity|3|||
38083921|NCT01358721|69783267|FG002|Overall Study|Study Drug Toxicity|4|||
38083922|NCT01358721|69783268|FG003|Overall Study|Study Drug Toxicity|5|||
38083923|NCT01358721|69783265|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
38083924|NCT01358721|69783266|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
38083925|NCT01358721|69783267|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
38083926|NCT01358721|69783268|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
38083927|NCT01358721|69783265|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
38083928|NCT01358721|69783266|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
38083929|NCT01358721|69783267|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
38083930|NCT01358721|69783268|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
38083931|NCT01358721|69783265|FG000|Overall Study|Adverse Event related to study drug|1|||
38083932|NCT01358721|69783266|FG001|Overall Study|Adverse Event related to study drug|0|||
37684581|NCT02357901|69160316|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
37684582|NCT02357901|69160317|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
37684583|NCT02357901|69160318|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
37684584|NCT02357901|69160319|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
37684585|NCT02357901|69160316|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
37684586|NCT02357901|69160317|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
38083933|NCT01358721|69783267|FG002|Overall Study|Adverse Event related to study drug|0|||
38083934|NCT01358721|69783268|FG003|Overall Study|Adverse Event related to study drug|1|||
38083935|NCT01358721|69783265|FG000|Overall Study|Disease Progression|19|||
38083936|NCT01358721|69783266|FG001|Overall Study|Disease Progression|15|||
38083937|NCT01358721|69783267|FG002|Overall Study|Disease Progression|17|||
38083938|NCT01358721|69783268|FG003|Overall Study|Disease Progression|15|||
38083939|NCT01358721|69783265|FG000|Overall Study|Out of State/Unmet Criteria|0|||
38083940|NCT01358721|69783266|FG001|Overall Study|Out of State/Unmet Criteria|0|||
38083941|NCT01358721|69783267|FG002|Overall Study|Out of State/Unmet Criteria|1|||
38083942|NCT01358721|69783268|FG003|Overall Study|Out of State/Unmet Criteria|0|||
37684587|NCT02357901|69160318|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
37684588|NCT02357901|69160319|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
37684589|NCT02357901|69160316|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
37684590|NCT02357901|69160317|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
37684591|NCT02357901|69160318|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
37684592|NCT02357901|69160319|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
37684593|NCT02357901|69160316|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
37684594|NCT02357901|69160317|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
37684595|NCT02357901|69160318|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
37684596|NCT02357901|69160319|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
37684597|NCT02357901|69160316|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
37684598|NCT02357901|69160317|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
37684599|NCT02357901|69160318|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
37684600|NCT02357901|69160319|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
37684601|NCT02357901|69160316|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
37684602|NCT02357901|69160317|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
37684603|NCT02357901|69160318|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
37684604|NCT02357901|69160319|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
37684605|NCT02357901|69160316|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
38083943|NCT01341639|69783280|FG000|Infant Series|Protocol Violation|1|||
38083944|NCT01341639|69783281|FG001|Infant Series|Protocol Violation|0|||
38083945|NCT01341639|69783280|FG000|Infant Series|Not Vaccinated|0|||
38083946|NCT01341639|69783281|FG001|Infant Series|Not Vaccinated|1|||
38083947|NCT01341639|69783280|FG000|Infant Series|Adverse Event|0|||
38083948|NCT01341639|69783281|FG001|Infant Series|Adverse Event|5|||
38083949|NCT01341639|69783280|FG000|Infant Series|Withdrawal by Subject|11|||
38083950|NCT01341639|69783281|FG001|Infant Series|Withdrawal by Subject|8|||
38083951|NCT01341639|69783280|FG000|Infant Series|Lost to Follow-up|0|||
38083952|NCT01341639|69783281|FG001|Infant Series|Lost to Follow-up|2|||
38083953|NCT01341639|69783280|FG000|Infant Series|Site 0048 Participants|17|||
38083954|NCT01341639|69783281|FG001|Infant Series|Site 0048 Participants|16|||
38083955|NCT01341639|69783280|FG000|Interim Period|Withdrawal by Subject|6|||
38083956|NCT01341639|69783281|FG001|Interim Period|Withdrawal by Subject|7|||
38083957|NCT01341639|69783280|FG000|Interim Period|Lost to Follow-up|2|||
38083958|NCT01341639|69783281|FG001|Interim Period|Lost to Follow-up|0|||
38083959|NCT01341639|69783280|FG000|Interim Period|Physician Decision|0|||
38083960|NCT01341639|69783281|FG001|Interim Period|Physician Decision|1|||
38083961|NCT01341639|69783280|FG000|Interim Period|Protocol Violation|0|||
38083962|NCT01341639|69783281|FG001|Interim Period|Protocol Violation|1|||
38083963|NCT01341639|69783280|FG000|Post-Treatment|Withdrawal by Subject|0|||
38083964|NCT01341639|69783281|FG001|Post-Treatment|Withdrawal by Subject|1|||
38083965|NCT01341639|69783280|FG000|Post-Treatment|Adverse Event|0|||
38083966|NCT01341639|69783281|FG001|Post-Treatment|Adverse Event|2|||
38083967|NCT02628028|69783295|FG000|Dosing Period|Withdrawal by Subject|0|||
38083968|NCT02628028|69783296|FG001|Dosing Period|Withdrawal by Subject|0|||
38083969|NCT02628028|69783297|FG002|Dosing Period|Withdrawal by Subject|1|||
38083970|NCT02628028|69783298|FG003|Dosing Period|Withdrawal by Subject|0|||
38083971|NCT02628028|69783299|FG004|Dosing Period|Withdrawal by Subject|2|||
38083972|NCT02628028|69783300|FG005|Dosing Period|Withdrawal by Subject|4|||
38083973|NCT02628028|69783301|FG006|Dosing Period|Withdrawal by Subject|1|||
38083974|NCT02628028|69783302|FG007|Dosing Period|Withdrawal by Subject|1|||
38083975|NCT02628028|69783295|FG000|Dosing Period|Adverse Event|0|||
38083976|NCT02628028|69783296|FG001|Dosing Period|Adverse Event|0|||
38083977|NCT02628028|69783297|FG002|Dosing Period|Adverse Event|0|||
38083978|NCT02628028|69783298|FG003|Dosing Period|Adverse Event|0|||
38083979|NCT02628028|69783299|FG004|Dosing Period|Adverse Event|2|||
38083980|NCT02628028|69783300|FG005|Dosing Period|Adverse Event|1|||
38083981|NCT02628028|69783301|FG006|Dosing Period|Adverse Event|3|||
38083982|NCT02628028|69783302|FG007|Dosing Period|Adverse Event|2|||
38083983|NCT02628028|69783295|FG000|Dosing Period|Death|0|||
38083984|NCT02628028|69783296|FG001|Dosing Period|Death|0|||
38083985|NCT02628028|69783297|FG002|Dosing Period|Death|0|||
38083986|NCT02628028|69783298|FG003|Dosing Period|Death|0|||
38083987|NCT02628028|69783299|FG004|Dosing Period|Death|0|||
37684606|NCT02357901|69160317|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
37684607|NCT02357901|69160318|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
38083988|NCT02628028|69783300|FG005|Dosing Period|Death|0|||
38083989|NCT02628028|69783301|FG006|Dosing Period|Death|0|||
38083990|NCT02628028|69783302|FG007|Dosing Period|Death|1|||
38083991|NCT02628028|69783295|FG000|Dosing Period|Lack of Efficacy|0|||
38083992|NCT02628028|69783296|FG001|Dosing Period|Lack of Efficacy|0|||
38083993|NCT02628028|69783297|FG002|Dosing Period|Lack of Efficacy|0|||
38083994|NCT02628028|69783298|FG003|Dosing Period|Lack of Efficacy|0|||
37684608|NCT02357901|69160319|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
37684609|NCT02357901|69160316|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
37684610|NCT02357901|69160317|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
37684611|NCT02357901|69160318|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
37684612|NCT02357901|69160319|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
37684613|NCT02357901|69160316|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
37684614|NCT02357901|69160317|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
37684615|NCT02357901|69160318|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
37684616|NCT02357901|69160319|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
37684617|NCT02357901|69160316|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
37684618|NCT02357901|69160317|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
37684619|NCT02357901|69160318|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
37684620|NCT02357901|69160319|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
37684621|NCT01601847|69160329|FG000|Overall Study|Death|1|||
37684622|NCT01601847|69160330|FG001|Overall Study|Death|0|||
37684623|NCT01601847|69160329|FG000|Overall Study|Withdrawal by Subject|11|||
37684624|NCT01601847|69160330|FG001|Overall Study|Withdrawal by Subject|7|||
37684625|NCT01601847|69160329|FG000|Overall Study|Lost to Follow-up|1|||
37684626|NCT01601847|69160330|FG001|Overall Study|Lost to Follow-up|3|||
37684627|NCT02515669|69160340|FG000|228 Week Open-Label Phase|Other|0|||
37684628|NCT02515669|69160341|FG001|228 Week Open-Label Phase|Other|0|||
37684629|NCT02515669|69160342|FG002|228 Week Open-Label Phase|Other|1|||
37684630|NCT02515669|69160343|FG003|228 Week Open-Label Phase|Other|4|||
37684631|NCT02515669|69160340|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
37684632|NCT02515669|69160341|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
37684633|NCT02515669|69160342|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
37684634|NCT02515669|69160343|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
37684635|NCT02515669|69160340|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
37684636|NCT02515669|69160341|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
37684637|NCT02515669|69160342|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
37684638|NCT02515669|69160343|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
37684639|NCT02515669|69160340|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
37684640|NCT02515669|69160341|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
37684641|NCT02515669|69160342|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
37684642|NCT02515669|69160343|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
37684643|NCT02515669|69160340|FG000|228 Week Open-Label Phase|Missing|0|||
37684644|NCT02515669|69160341|FG001|228 Week Open-Label Phase|Missing|2|||
37684645|NCT02515669|69160342|FG002|228 Week Open-Label Phase|Missing|2|||
37684646|NCT02515669|69160343|FG003|228 Week Open-Label Phase|Missing|2|||
37684647|NCT02515279|69160373|FG000|Overall Study|Adverse Event|7|||
37684648|NCT02515279|69160373|FG000|Overall Study|Lack of Efficacy|31|||
37684649|NCT02515279|69160373|FG000|Overall Study|Lost to Follow-up|9|||
37684650|NCT02515279|69160373|FG000|Overall Study|Withdrawal by Subject|18|||
37684651|NCT02515279|69160373|FG000|Overall Study|End-of-treatment visit not attended|17|||
37684652|NCT02515279|69160373|FG000|Overall Study|Other|22|||
37684653|NCT02515045|69160379|FG000|Overall Study|Adverse Event|0|||
37684654|NCT02515045|69160380|FG001|Overall Study|Adverse Event|3|||
37684655|NCT02515045|69160381|FG002|Overall Study|Adverse Event|3|||
37684656|NCT02515045|69160379|FG000|Overall Study|Lost to Follow-up|0|||
37684657|NCT02515045|69160380|FG001|Overall Study|Lost to Follow-up|1|||
37684658|NCT02515045|69160381|FG002|Overall Study|Lost to Follow-up|1|||
37684659|NCT02514577|69160391|FG000|Overall Study|Lost to Follow-up|6|||
37684660|NCT02514577|69160392|FG001|Overall Study|Lost to Follow-up|6|||
37684661|NCT02514577|69160391|FG000|Overall Study|Protocol Violation|1|||
37684662|NCT02514577|69160392|FG001|Overall Study|Protocol Violation|0|||
37684663|NCT02514577|69160391|FG000|Overall Study|Withdrawal by Subject|6|||
37684664|NCT02514577|69160392|FG001|Overall Study|Withdrawal by Subject|6|||
37684665|NCT02514577|69160391|FG000|Overall Study|Adverse Event|1|||
37684666|NCT02514577|69160392|FG001|Overall Study|Adverse Event|1|||
37684667|NCT02513485|69160400|FG000|Overall Study|Adverse Event|1|||
37684668|NCT02513485|69160401|FG001|Overall Study|Adverse Event|0|||
37684669|NCT02289417|69160410|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
37684670|NCT02289417|69160411|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
37684671|NCT02289417|69160412|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
37684672|NCT02289417|69160413|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
37684673|NCT02289417|69160414|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
37684674|NCT02289417|69160415|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
37684675|NCT02289417|69160416|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
37684676|NCT02289417|69160417|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
37684677|NCT02289417|69160418|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
37684678|NCT02289417|69160410|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
37684679|NCT02289417|69160411|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
37684680|NCT02289417|69160412|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
37684681|NCT02289417|69160413|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
37684682|NCT02289417|69160414|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
37684683|NCT02289417|69160415|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
37684684|NCT02289417|69160416|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
37684685|NCT02289417|69160417|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
37684686|NCT02289417|69160418|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
37684687|NCT02289417|69160410|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
37684688|NCT02289417|69160411|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
37684689|NCT02289417|69160412|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
37684690|NCT02289417|69160413|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
37684691|NCT02289417|69160414|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
37684692|NCT02289417|69160415|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
37684693|NCT02289417|69160416|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
37684694|NCT02289417|69160417|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
37684695|NCT02289417|69160418|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
37684696|NCT02289417|69160410|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
37684697|NCT02289417|69160411|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
37684698|NCT02289417|69160412|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
38083995|NCT02628028|69783299|FG004|Dosing Period|Lack of Efficacy|3|||
38083996|NCT02628028|69783300|FG005|Dosing Period|Lack of Efficacy|0|||
38083997|NCT02628028|69783301|FG006|Dosing Period|Lack of Efficacy|1|||
38083998|NCT02628028|69783302|FG007|Dosing Period|Lack of Efficacy|0|||
38083999|NCT02628028|69783295|FG000|Dosing Period|Study Terminated by Sponsor|0|||
38084000|NCT02628028|69783296|FG001|Dosing Period|Study Terminated by Sponsor|0|||
38084001|NCT02628028|69783297|FG002|Dosing Period|Study Terminated by Sponsor|0|||
38084002|NCT02628028|69783298|FG003|Dosing Period|Study Terminated by Sponsor|0|||
38084003|NCT02628028|69783299|FG004|Dosing Period|Study Terminated by Sponsor|7|||
38084004|NCT02628028|69783300|FG005|Dosing Period|Study Terminated by Sponsor|6|||
38084005|NCT02628028|69783301|FG006|Dosing Period|Study Terminated by Sponsor|7|||
38084006|NCT02628028|69783302|FG007|Dosing Period|Study Terminated by Sponsor|7|||
37684699|NCT02289417|69160413|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
37684700|NCT02289417|69160414|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
37684701|NCT02289417|69160415|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
37684702|NCT02289417|69160416|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
37684703|NCT02289417|69160417|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
37684704|NCT02289417|69160418|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
37684705|NCT02289417|69160410|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
37684706|NCT02289417|69160411|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
37684707|NCT02289417|69160412|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
37684708|NCT02289417|69160413|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
37684709|NCT02289417|69160414|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
37684710|NCT02289417|69160415|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
37684711|NCT02289417|69160416|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
37684712|NCT02289417|69160417|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
37684713|NCT02289417|69160418|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
37684714|NCT02289417|69160410|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
37684715|NCT02289417|69160411|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
37684716|NCT02289417|69160412|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
37684717|NCT02289417|69160413|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
37684718|NCT02289417|69160414|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
37684719|NCT02289417|69160415|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
37684720|NCT02289417|69160416|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
37684721|NCT02289417|69160417|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
37684722|NCT02289417|69160418|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
37684723|NCT02289417|69160410|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
37684724|NCT02289417|69160411|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
37684725|NCT02289417|69160412|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
37684726|NCT02289417|69160413|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
37684727|NCT02289417|69160414|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
37684728|NCT02289417|69160415|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
37684729|NCT02289417|69160416|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
37684730|NCT02289417|69160417|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
37863004|NCT01263197|69546936|FG004|Washout Period 2|Physician Decision|0|||
37863005|NCT01263197|69546937|FG005|Washout Period 2|Physician Decision|1|||
38084007|NCT02628028|69783295|FG000|Dosing Period|Physician Decision|0|||
38084008|NCT02628028|69783296|FG001|Dosing Period|Physician Decision|0|||
38084009|NCT02628028|69783297|FG002|Dosing Period|Physician Decision|0|||
37684731|NCT02289417|69160418|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
37684732|NCT02289417|69160410|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
37684733|NCT02289417|69160411|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
37684734|NCT02289417|69160412|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
37684735|NCT02289417|69160413|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
37684736|NCT02289417|69160414|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
37684737|NCT02289417|69160415|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
37684738|NCT02289417|69160416|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
37684739|NCT02289417|69160417|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
37684740|NCT02289417|69160418|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
37684741|NCT02289417|69160410|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
37684742|NCT02289417|69160411|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
37684743|NCT02289417|69160412|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
37684744|NCT02289417|69160413|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
37684745|NCT02289417|69160414|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
37684746|NCT02289417|69160415|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
37684747|NCT02289417|69160416|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
37684748|NCT02289417|69160417|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
37684749|NCT02289417|69160418|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
37684750|NCT02289417|69160410|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
37684751|NCT02289417|69160411|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
37684752|NCT02289417|69160412|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
37684753|NCT02289417|69160413|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
37684754|NCT02289417|69160414|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
37684755|NCT02289417|69160415|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
37684756|NCT02289417|69160416|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
37684757|NCT02289417|69160417|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
37684758|NCT02289417|69160418|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
37684759|NCT02289417|69160410|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
37684760|NCT02289417|69160411|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
37684761|NCT02289417|69160412|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
37684762|NCT02289417|69160413|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
37684763|NCT02289417|69160414|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
37684764|NCT02289417|69160415|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
37684765|NCT02289417|69160416|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
37684766|NCT02289417|69160417|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
37684767|NCT02289417|69160418|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
37684768|NCT02289417|69160410|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
37684769|NCT02289417|69160411|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
37684770|NCT02289417|69160412|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
37684771|NCT02289417|69160413|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
37684772|NCT02289417|69160414|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
37684773|NCT02289417|69160415|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
37684774|NCT02289417|69160416|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
37684775|NCT02289417|69160417|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
37684776|NCT02289417|69160418|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
37684777|NCT02289417|69160410|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
37684778|NCT02289417|69160411|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
37684779|NCT02289417|69160412|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
37684780|NCT02289417|69160413|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
37684781|NCT02289417|69160414|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
37684782|NCT02289417|69160415|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
37684783|NCT02289417|69160416|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
37684784|NCT02289417|69160417|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
37684785|NCT02289417|69160418|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
37684786|NCT02289417|69160410|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
37684787|NCT02289417|69160411|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
37684788|NCT02289417|69160412|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
38084010|NCT02628028|69783298|FG003|Dosing Period|Physician Decision|0|||
38084011|NCT02628028|69783299|FG004|Dosing Period|Physician Decision|0|||
38084012|NCT02628028|69783300|FG005|Dosing Period|Physician Decision|1|||
38084013|NCT02628028|69783301|FG006|Dosing Period|Physician Decision|0|||
38084014|NCT02628028|69783302|FG007|Dosing Period|Physician Decision|0|||
38084015|NCT02628028|69783295|FG000|Dosing Period|Site Terminated by Sponsor|0|||
38084016|NCT02628028|69783296|FG001|Dosing Period|Site Terminated by Sponsor|0|||
38084017|NCT02628028|69783297|FG002|Dosing Period|Site Terminated by Sponsor|0|||
38084018|NCT02628028|69783298|FG003|Dosing Period|Site Terminated by Sponsor|0|||
38084019|NCT02628028|69783299|FG004|Dosing Period|Site Terminated by Sponsor|0|||
38084020|NCT02628028|69783300|FG005|Dosing Period|Site Terminated by Sponsor|1|||
38084021|NCT02628028|69783301|FG006|Dosing Period|Site Terminated by Sponsor|1|||
38084022|NCT02628028|69783302|FG007|Dosing Period|Site Terminated by Sponsor|0|||
38084023|NCT02628028|69783295|FG000|Dosing Period|Lost to Follow-up|0|||
38084024|NCT02628028|69783296|FG001|Dosing Period|Lost to Follow-up|0|||
38084025|NCT02628028|69783297|FG002|Dosing Period|Lost to Follow-up|0|||
38084026|NCT02628028|69783298|FG003|Dosing Period|Lost to Follow-up|0|||
38084027|NCT02628028|69783299|FG004|Dosing Period|Lost to Follow-up|0|||
38084028|NCT02628028|69783300|FG005|Dosing Period|Lost to Follow-up|0|||
38084029|NCT02628028|69783301|FG006|Dosing Period|Lost to Follow-up|1|||
38084030|NCT02628028|69783302|FG007|Dosing Period|Lost to Follow-up|0|||
38084031|NCT02628028|69783295|FG000|Dosing Period|Other|0|||
38084032|NCT02628028|69783296|FG001|Dosing Period|Other|0|||
38084033|NCT02628028|69783297|FG002|Dosing Period|Other|0|||
38084034|NCT02628028|69783298|FG003|Dosing Period|Other|0|||
38084035|NCT02628028|69783299|FG004|Dosing Period|Other|2|||
38084036|NCT02628028|69783300|FG005|Dosing Period|Other|1|||
38084037|NCT02628028|69783301|FG006|Dosing Period|Other|2|||
38084038|NCT02628028|69783302|FG007|Dosing Period|Other|4|||
38084039|NCT02628028|69783295|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
38084040|NCT02628028|69783296|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
38084041|NCT02628028|69783297|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
38084042|NCT02628028|69783298|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
38084043|NCT02628028|69783299|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
38084044|NCT02628028|69783300|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
38084045|NCT02628028|69783301|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
38084046|NCT02628028|69783302|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
38084047|NCT02628028|69783295|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
38084048|NCT02628028|69783296|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
38084049|NCT02628028|69783297|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
38084050|NCT02628028|69783298|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
38084051|NCT02628028|69783299|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
38084052|NCT02628028|69783300|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
38084053|NCT02628028|69783301|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
38084054|NCT02628028|69783302|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
38084055|NCT02628028|69783295|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
38084056|NCT02628028|69783296|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
38084057|NCT02628028|69783297|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
38084058|NCT02628028|69783298|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
38084059|NCT02628028|69783299|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
38084060|NCT02628028|69783300|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
38084061|NCT02628028|69783301|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
38084062|NCT02628028|69783302|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
38084063|NCT02628028|69783295|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
38084064|NCT02628028|69783296|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
38084065|NCT02628028|69783297|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
38084066|NCT02628028|69783298|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
38084067|NCT02628028|69783299|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
38084068|NCT02628028|69783300|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
38084069|NCT02628028|69783301|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
38084070|NCT02628028|69783302|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
38084071|NCT02628028|69783295|FG000|Long-term Extension (LTE) Period|Other|0|||
38084072|NCT02628028|69783296|FG001|Long-term Extension (LTE) Period|Other|0|||
38084073|NCT02628028|69783297|FG002|Long-term Extension (LTE) Period|Other|0|||
38084074|NCT02628028|69783298|FG003|Long-term Extension (LTE) Period|Other|0|||
38084075|NCT02628028|69783299|FG004|Long-term Extension (LTE) Period|Other|0|||
38084076|NCT02628028|69783300|FG005|Long-term Extension (LTE) Period|Other|3|||
37684789|NCT02289417|69160413|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
38084077|NCT02628028|69783301|FG006|Long-term Extension (LTE) Period|Other|4|||
38084078|NCT02628028|69783302|FG007|Long-term Extension (LTE) Period|Other|3|||
38084079|NCT03977701|69783334|FG000|Overall Study|COVID-19 pandemic|0|||
38084080|NCT03977701|69783335|FG001|Overall Study|COVID-19 pandemic|0|||
38084081|NCT03977701|69783336|FG002|Overall Study|COVID-19 pandemic|0|||
38084082|NCT03977701|69783337|FG003|Overall Study|COVID-19 pandemic|0|||
38084083|NCT03977701|69783338|FG004|Overall Study|COVID-19 pandemic|0|||
38084084|NCT03977701|69783339|FG005|Overall Study|COVID-19 pandemic|1|||
37684790|NCT02289417|69160414|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
37684791|NCT02289417|69160415|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
37684792|NCT02289417|69160416|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
37684793|NCT02289417|69160417|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
37684794|NCT02289417|69160418|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
37684795|NCT02512861|69160436|FG000|Overall Study|Protocol Violation|3|||
37684796|NCT02512861|69160437|FG001|Overall Study|Protocol Violation|7|||
37684797|NCT02512861|69160436|FG000|Overall Study|Physician Decision|3|||
38084085|NCT03977701|69783340|FG006|Overall Study|COVID-19 pandemic|0|||
38084086|NCT03977701|69783341|FG007|Overall Study|COVID-19 pandemic|1|||
38084087|NCT03977701|69783342|FG008|Overall Study|COVID-19 pandemic|0|||
38084088|NCT03977701|69783343|FG009|Overall Study|COVID-19 pandemic|0|||
38084089|NCT02814526|69783382|FG000|Overall Study|Adverse Event|4|||
38084090|NCT02814526|69783383|FG001|Overall Study|Adverse Event|3|||
38084091|NCT02814526|69783382|FG000|Overall Study|Death|1|||
38084092|NCT02814526|69783383|FG001|Overall Study|Death|1|||
38084093|NCT02814526|69783382|FG000|Overall Study|Lost to Follow-up|3|||
38084094|NCT02814526|69783383|FG001|Overall Study|Lost to Follow-up|4|||
38084095|NCT02814526|69783382|FG000|Overall Study|non site physician decision|1|||
38084096|NCT02814526|69783383|FG001|Overall Study|non site physician decision|0|||
38084097|NCT02814526|69783382|FG000|Overall Study|participant noncompliance|1|||
38084098|NCT02814526|69783383|FG001|Overall Study|participant noncompliance|1|||
38084099|NCT02814526|69783382|FG000|Overall Study|Withdrawal by Subject|20|||
38084100|NCT02814526|69783383|FG001|Overall Study|Withdrawal by Subject|14|||
38084101|NCT02814526|69783382|FG000|Overall Study|safety risk|2|||
38084102|NCT02814526|69783383|FG001|Overall Study|safety risk|1|||
38084103|NCT02814526|69783382|FG000|Overall Study|early termination-study terminated|1|||
38084104|NCT02814526|69783383|FG001|Overall Study|early termination-study terminated|2|||
38084105|NCT02814526|69783382|FG000|Overall Study|Other|0|||
38084106|NCT02814526|69783383|FG001|Overall Study|Other|4|||
38084107|NCT02329834|69783391|FG000|Overall Study|Physician Decision|1|||
38084108|NCT02329834|69783392|FG001|Overall Study|Physician Decision|0|||
38084109|NCT01340937|69783403|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
38084110|NCT01340937|69783404|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
38084111|NCT01340937|69783405|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
38084112|NCT01340937|69783406|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
38084113|NCT01340937|69783403|FG000|Period 1: Infant Series|Adverse Event|0|||
38084114|NCT01340937|69783404|FG001|Period 1: Infant Series|Adverse Event|1|||
38084115|NCT01340937|69783405|FG002|Period 1: Infant Series|Adverse Event|4|||
38084116|NCT01340937|69783406|FG003|Period 1: Infant Series|Adverse Event|0|||
38084117|NCT01340937|69783403|FG000|Period 1: Infant Series|Death|2|||
38084118|NCT01340937|69783404|FG001|Period 1: Infant Series|Death|0|||
38084119|NCT01340937|69783405|FG002|Period 1: Infant Series|Death|2|||
38084120|NCT01340937|69783406|FG003|Period 1: Infant Series|Death|0|||
38084121|NCT01340937|69783403|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
37684798|NCT02512861|69160437|FG001|Overall Study|Physician Decision|1|||
37684799|NCT02512861|69160436|FG000|Overall Study|Withdrawal by Subject|0|||
37684800|NCT02512861|69160437|FG001|Overall Study|Withdrawal by Subject|1|||
37684801|NCT02288559|69160447|FG000|Overall Study|Adverse Event|1|||
37684802|NCT02288559|69160448|FG001|Overall Study|Adverse Event|1|||
37684803|NCT02288559|69160449|FG002|Overall Study|Adverse Event|5|||
37684804|NCT02288559|69160450|FG003|Overall Study|Adverse Event|0|||
37684805|NCT02288559|69160447|FG000|Overall Study|Death|0|||
37684806|NCT02288559|69160448|FG001|Overall Study|Death|0|||
37684807|NCT02288559|69160449|FG002|Overall Study|Death|1|||
37684808|NCT02288559|69160450|FG003|Overall Study|Death|0|||
37684809|NCT02288559|69160447|FG000|Overall Study|Lost to Follow-up|0|||
37684810|NCT02288559|69160448|FG001|Overall Study|Lost to Follow-up|0|||
37684811|NCT02288559|69160449|FG002|Overall Study|Lost to Follow-up|0|||
37684812|NCT02288559|69160450|FG003|Overall Study|Lost to Follow-up|1|||
37684813|NCT02288559|69160447|FG000|Overall Study|Withdrawal by Subject|0|||
37684814|NCT02288559|69160448|FG001|Overall Study|Withdrawal by Subject|0|||
37684815|NCT02288559|69160449|FG002|Overall Study|Withdrawal by Subject|2|||
37684816|NCT02288559|69160450|FG003|Overall Study|Withdrawal by Subject|1|||
37684817|NCT02288559|69160447|FG000|Overall Study|Reason Not Specified|0|||
37684818|NCT02288559|69160448|FG001|Overall Study|Reason Not Specified|0|||
37684819|NCT02288559|69160449|FG002|Overall Study|Reason Not Specified|3|||
38084122|NCT01340937|69783404|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
38084123|NCT01340937|69783405|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
38084124|NCT01340937|69783406|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
38084125|NCT01340937|69783403|FG000|Period 1: Infant Series|Physician Decision|2|||
38084126|NCT01340937|69783404|FG001|Period 1: Infant Series|Physician Decision|3|||
37684820|NCT02288559|69160450|FG003|Overall Study|Reason Not Specified|0|||
37684821|NCT02288325|69160462|FG000|Run-in Period|Adverse Event|48|||
37684822|NCT02288325|69160463|FG001|Run-in Period|Adverse Event|0|||
37684823|NCT02288325|69160464|FG002|Run-in Period|Adverse Event|0|||
37684824|NCT02288325|69160462|FG000|Run-in Period|Lack of Efficacy|16|||
37684825|NCT02288325|69160463|FG001|Run-in Period|Lack of Efficacy|0|||
37684826|NCT02288325|69160464|FG002|Run-in Period|Lack of Efficacy|0|||
38084127|NCT01340937|69783405|FG002|Period 1: Infant Series|Physician Decision|1|||
38084128|NCT01340937|69783406|FG003|Period 1: Infant Series|Physician Decision|0|||
38084129|NCT01340937|69783403|FG000|Period 1: Infant Series|Protocol Violation|1|||
38084130|NCT01340937|69783404|FG001|Period 1: Infant Series|Protocol Violation|4|||
38084131|NCT01340937|69783405|FG002|Period 1: Infant Series|Protocol Violation|4|||
38084132|NCT01340937|69783406|FG003|Period 1: Infant Series|Protocol Violation|3|||
38084133|NCT01340937|69783403|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
38084134|NCT01340937|69783404|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
38084135|NCT01340937|69783405|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
38084136|NCT01340937|69783406|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
38084137|NCT01340937|69783403|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
38084138|NCT01340937|69783404|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
38084139|NCT01340937|69783405|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
38084140|NCT01340937|69783406|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
38084141|NCT01340937|69783403|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
38084142|NCT01340937|69783404|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
38084143|NCT01340937|69783405|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
38084144|NCT01340937|69783406|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
38084145|NCT01340937|69783403|FG000|Period 2: Interim Period|Adverse Event|1|||
38084146|NCT01340937|69783404|FG001|Period 2: Interim Period|Adverse Event|0|||
38084147|NCT01340937|69783405|FG002|Period 2: Interim Period|Adverse Event|1|||
38084148|NCT01340937|69783406|FG003|Period 2: Interim Period|Adverse Event|0|||
38084149|NCT01340937|69783403|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
38084150|NCT01340937|69783404|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
38084151|NCT01340937|69783405|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
38084152|NCT01340937|69783406|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
38084153|NCT01340937|69783403|FG000|Period 2: Interim Period|Physician Decision|0|||
38084154|NCT01340937|69783404|FG001|Period 2: Interim Period|Physician Decision|1|||
38084155|NCT01340937|69783405|FG002|Period 2: Interim Period|Physician Decision|1|||
38084156|NCT01340937|69783406|FG003|Period 2: Interim Period|Physician Decision|0|||
38084157|NCT01340937|69783403|FG000|Period 2: Interim Period|Protocol Violation|5|||
38084158|NCT01340937|69783404|FG001|Period 2: Interim Period|Protocol Violation|3|||
38084159|NCT01340937|69783405|FG002|Period 2: Interim Period|Protocol Violation|6|||
38084160|NCT01340937|69783406|FG003|Period 2: Interim Period|Protocol Violation|3|||
38084161|NCT01340937|69783403|FG000|Period 2: Interim Period|Technical problems|4|||
38084162|NCT01340937|69783404|FG001|Period 2: Interim Period|Technical problems|4|||
38084163|NCT01340937|69783405|FG002|Period 2: Interim Period|Technical problems|6|||
38084164|NCT01340937|69783406|FG003|Period 2: Interim Period|Technical problems|3|||
38084165|NCT01340937|69783403|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
38084166|NCT01340937|69783404|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
38084167|NCT01340937|69783405|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
38084168|NCT01340937|69783406|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
38084169|NCT01340937|69783403|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
38084170|NCT01340937|69783404|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
38084171|NCT01340937|69783405|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
38084172|NCT01340937|69783406|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
38084173|NCT01340937|69783403|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
38084174|NCT01340937|69783404|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
38084175|NCT01340937|69783405|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
38084176|NCT01340937|69783406|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
38084177|NCT01340937|69783403|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
38084178|NCT01340937|69783404|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
38084179|NCT01340937|69783405|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
38084180|NCT01340937|69783406|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
38084181|NCT03028129|69783424|FG000|Overall Study|Adverse Event|13|||
38084182|NCT03028129|69783425|FG001|Overall Study|Adverse Event|2|||
38084183|NCT03028129|69783424|FG000|Overall Study|Lost to Follow-up|50|||
38084184|NCT03028129|69783425|FG001|Overall Study|Lost to Follow-up|38|||
37684827|NCT02288325|69160462|FG000|Run-in Period|Withdrawal of Consent|28|||
37684828|NCT02288325|69160463|FG001|Run-in Period|Withdrawal of Consent|0|||
38084185|NCT03028129|69783424|FG000|Overall Study|Physician Decision|0|||
38084186|NCT03028129|69783425|FG001|Overall Study|Physician Decision|1|||
38084187|NCT03028129|69783424|FG000|Overall Study|Protocol Violation|1|||
38084188|NCT03028129|69783425|FG001|Overall Study|Protocol Violation|1|||
38084189|NCT03028129|69783424|FG000|Overall Study|Withdrawal by Subject|62|||
37684829|NCT02288325|69160464|FG002|Run-in Period|Withdrawal of Consent|0|||
37684830|NCT02288325|69160462|FG000|Run-in Period|Lost to Follow-up|25|||
38084190|NCT03028129|69783425|FG001|Overall Study|Withdrawal by Subject|45|||
37684831|NCT02288325|69160463|FG001|Run-in Period|Lost to Follow-up|0|||
37684832|NCT02288325|69160464|FG002|Run-in Period|Lost to Follow-up|0|||
37684833|NCT02288325|69160462|FG000|Run-in Period|Protocol Violation|17|||
37684834|NCT02288325|69160463|FG001|Run-in Period|Protocol Violation|0|||
37684835|NCT02288325|69160464|FG002|Run-in Period|Protocol Violation|0|||
37684836|NCT02288325|69160462|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
38084191|NCT01309672|69783431|FG000|Overall Study|Lack of Efficacy|20|||
38084192|NCT01309672|69783431|FG000|Overall Study|Other|9|||
38084193|NCT01309672|69783431|FG000|Overall Study|Adverse Event|5|||
38084194|NCT01309672|69783431|FG000|Overall Study|Withdrawal by Subject|3|||
38084195|NCT03026257|69783442|FG000|Overall Study|Adverse Event|3|||
38084196|NCT03026257|69783443|FG001|Overall Study|Adverse Event|0|||
38084197|NCT03026257|69783444|FG002|Overall Study|Adverse Event|0|||
38084198|NCT03026257|69783445|FG003|Overall Study|Adverse Event|0|||
38084199|NCT03026257|69783446|FG004|Overall Study|Adverse Event|0|||
38084200|NCT03026257|69783447|FG005|Overall Study|Adverse Event|0|||
38084201|NCT03026257|69783442|FG000|Overall Study|Lost to Follow-up|1|||
38084202|NCT03026257|69783443|FG001|Overall Study|Lost to Follow-up|0|||
38084203|NCT03026257|69783444|FG002|Overall Study|Lost to Follow-up|0|||
38084204|NCT03026257|69783445|FG003|Overall Study|Lost to Follow-up|0|||
38084205|NCT03026257|69783446|FG004|Overall Study|Lost to Follow-up|0|||
38084206|NCT03026257|69783447|FG005|Overall Study|Lost to Follow-up|0|||
38084207|NCT03026257|69783442|FG000|Overall Study|Protocol Violation|1|||
38084208|NCT03026257|69783443|FG001|Overall Study|Protocol Violation|0|||
38084209|NCT03026257|69783444|FG002|Overall Study|Protocol Violation|0|||
38084210|NCT03026257|69783445|FG003|Overall Study|Protocol Violation|1|||
38084211|NCT03026257|69783446|FG004|Overall Study|Protocol Violation|1|||
38084212|NCT03026257|69783447|FG005|Overall Study|Protocol Violation|0|||
38084213|NCT03026257|69783442|FG000|Overall Study|Withdrawal by Subject|1|||
38084214|NCT03026257|69783443|FG001|Overall Study|Withdrawal by Subject|1|||
38084215|NCT03026257|69783444|FG002|Overall Study|Withdrawal by Subject|0|||
38084216|NCT03026257|69783445|FG003|Overall Study|Withdrawal by Subject|0|||
38084217|NCT03026257|69783446|FG004|Overall Study|Withdrawal by Subject|0|||
38084218|NCT03026257|69783447|FG005|Overall Study|Withdrawal by Subject|0|||
38084219|NCT01670188|69783463|FG000|Overall Study|Death|0|||
38084220|NCT01670188|69783464|FG001|Overall Study|Death|1|||
38084221|NCT01933048|69783472|FG000|Overall Study|Lost to Follow-up|15|||
38084222|NCT01933048|69783473|FG001|Overall Study|Lost to Follow-up|18|||
38084223|NCT01933048|69783472|FG000|Overall Study|personal reasons|1|||
38084224|NCT01933048|69783473|FG001|Overall Study|personal reasons|1|||
38084225|NCT01933048|69783472|FG000|Overall Study|Protocol Violation|7|||
38084226|NCT01933048|69783473|FG001|Overall Study|Protocol Violation|8|||
38084227|NCT01933048|69783472|FG000|Overall Study|Physician Decision|1|||
38084228|NCT01933048|69783473|FG001|Overall Study|Physician Decision|0|||
38084229|NCT01933048|69783472|FG000|Overall Study|unknown reasons|1|||
38084230|NCT01933048|69783473|FG001|Overall Study|unknown reasons|1|||
38084231|NCT02751450|69783484|FG000|Overall Study|Adverse Event|1|||
38084232|NCT02751450|69783485|FG001|Overall Study|Adverse Event|0|||
38084233|NCT01515748|69783495|FG000|Overall Study|Withdrawal by Subject|32|||
38084234|NCT01515748|69783496|FG001|Overall Study|Withdrawal by Subject|41|||
38084235|NCT01515748|69783495|FG000|Overall Study|Lost to Follow-up|2|||
38084236|NCT01515748|69783496|FG001|Overall Study|Lost to Follow-up|4|||
38084237|NCT01515748|69783495|FG000|Overall Study|Ongoing|86|||
38084238|NCT01515748|69783496|FG001|Overall Study|Ongoing|90|||
38084239|NCT01358175|69783506|FG000|Overall Study|Death|1|||
38084240|NCT01358175|69783507|FG001|Overall Study|Death|0|||
38084241|NCT01358175|69783508|FG002|Overall Study|Death|1|||
38084242|NCT01358175|69783506|FG000|Overall Study|Withdrawal by Subject|9|||
38084243|NCT01358175|69783507|FG001|Overall Study|Withdrawal by Subject|5|||
38084244|NCT01358175|69783508|FG002|Overall Study|Withdrawal by Subject|10|||
38084245|NCT01358175|69783506|FG000|Overall Study|Technical issues|0|||
38084246|NCT01358175|69783507|FG001|Overall Study|Technical issues|1|||
38084247|NCT01358175|69783508|FG002|Overall Study|Technical issues|0|||
38084248|NCT01358175|69783506|FG000|Overall Study|Pregnancy|0|||
37863006|NCT01263197|69546932|FG000|Washout Period 2|Protocol Violation|0|||
37863007|NCT01263197|69546933|FG001|Washout Period 2|Protocol Violation|0|||
38084249|NCT01358175|69783507|FG001|Overall Study|Pregnancy|1|||
38084250|NCT01358175|69783508|FG002|Overall Study|Pregnancy|0|||
38084251|NCT01358175|69783506|FG000|Overall Study|Physician Decision|1|||
38084252|NCT01358175|69783507|FG001|Overall Study|Physician Decision|0|||
37863008|NCT01263197|69546934|FG002|Washout Period 2|Protocol Violation|0|||
37684837|NCT02288325|69160463|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
38084253|NCT01358175|69783508|FG002|Overall Study|Physician Decision|0|||
38084254|NCT01358175|69783506|FG000|Overall Study|Non Compliance with Study Treatment|0|||
38084255|NCT01358175|69783507|FG001|Overall Study|Non Compliance with Study Treatment|1|||
38084256|NCT01358175|69783508|FG002|Overall Study|Non Compliance with Study Treatment|1|||
38084257|NCT01358175|69783506|FG000|Overall Study|Lost to Follow-up|1|||
38084258|NCT01358175|69783507|FG001|Overall Study|Lost to Follow-up|1|||
38084259|NCT01358175|69783508|FG002|Overall Study|Lost to Follow-up|3|||
38084260|NCT01358175|69783506|FG000|Overall Study|Lack of Efficacy|3|||
37684838|NCT02288325|69160464|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
37684839|NCT02288325|69160462|FG000|Run-in Period|Reason not Specified|8|||
37684840|NCT02288325|69160463|FG001|Run-in Period|Reason not Specified|0|||
37684841|NCT02288325|69160464|FG002|Run-in Period|Reason not Specified|0|||
37684842|NCT02288325|69160462|FG000|Stabilization Period|Adverse Event|13|||
37684843|NCT02288325|69160463|FG001|Stabilization Period|Adverse Event|0|||
37684844|NCT02288325|69160464|FG002|Stabilization Period|Adverse Event|0|||
37684845|NCT02288325|69160462|FG000|Stabilization Period|Lack of Efficacy|22|||
37684846|NCT02288325|69160463|FG001|Stabilization Period|Lack of Efficacy|0|||
37684847|NCT02288325|69160464|FG002|Stabilization Period|Lack of Efficacy|0|||
37684848|NCT02288325|69160462|FG000|Stabilization Period|Withdrawal of Consent|23|||
37684849|NCT02288325|69160463|FG001|Stabilization Period|Withdrawal of Consent|0|||
37684850|NCT02288325|69160464|FG002|Stabilization Period|Withdrawal of Consent|0|||
37684851|NCT02288325|69160462|FG000|Stabilization Period|Lost to Follow-up|12|||
37684852|NCT02288325|69160463|FG001|Stabilization Period|Lost to Follow-up|0|||
37684853|NCT02288325|69160464|FG002|Stabilization Period|Lost to Follow-up|0|||
37684854|NCT02288325|69160462|FG000|Stabilization Period|Protocol Violation|8|||
37684855|NCT02288325|69160463|FG001|Stabilization Period|Protocol Violation|0|||
37684856|NCT02288325|69160464|FG002|Stabilization Period|Protocol Violation|0|||
37684857|NCT02288325|69160462|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
37684858|NCT02288325|69160463|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
38084261|NCT01358175|69783507|FG001|Overall Study|Lack of Efficacy|8|||
38084262|NCT01358175|69783508|FG002|Overall Study|Lack of Efficacy|6|||
38084263|NCT01358175|69783506|FG000|Overall Study|Adverse Event|6|||
38084264|NCT01358175|69783507|FG001|Overall Study|Adverse Event|11|||
38084265|NCT01358175|69783508|FG002|Overall Study|Adverse Event|11|||
38084266|NCT04116229|69783522|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
38084267|NCT04116229|69783523|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
38084268|NCT04116229|69783522|FG000|Overall Study|Scheduling not possible.|0|||
38084269|NCT04116229|69783523|FG001|Overall Study|Scheduling not possible.|1|||
38084270|NCT02210832|69783532|FG000|Overall Study|Pregnancy termination .|3|||
38084271|NCT02210832|69783533|FG001|Overall Study|Pregnancy termination .|4|||
38084272|NCT02210832|69783534|FG002|Overall Study|Pregnancy termination .|1|||
38084273|NCT02210832|69783532|FG000|Overall Study|Lost to Follow-up|26|||
38084274|NCT02210832|69783533|FG001|Overall Study|Lost to Follow-up|32|||
38084275|NCT02210832|69783534|FG002|Overall Study|Lost to Follow-up|17|||
38084276|NCT02833077|69783547|FG000|Overall Study|Adverse Event|1|||
38084277|NCT02833077|69783548|FG001|Overall Study|Adverse Event|2|||
38084278|NCT02833077|69783547|FG000|Overall Study|Lost to Follow-up|10|||
38084279|NCT02833077|69783548|FG001|Overall Study|Lost to Follow-up|1|||
38084280|NCT02833077|69783547|FG000|Overall Study|Personal Reasons|6|||
38084281|NCT02833077|69783548|FG001|Overall Study|Personal Reasons|4|||
38084282|NCT02833077|69783547|FG000|Overall Study|Protocol Deviation|0|||
38084283|NCT02833077|69783548|FG001|Overall Study|Protocol Deviation|1|||
38084284|NCT01355679|69783555|FG000|Overall Study|benign tumor types found at biopsy|2|||
38084285|NCT02832375|69783562|FG000|Overall Study|Lost to Follow-up|1|||
38084286|NCT02832375|69783563|FG001|Overall Study|Lost to Follow-up|0|||
38084287|NCT02832375|69783562|FG000|Overall Study|Withdrawal of Consent|1|||
38084288|NCT02832375|69783563|FG001|Overall Study|Withdrawal of Consent|0|||
38084289|NCT02925403|69783572|FG000|Overall Study|Lost to Follow-up|0|||
38084290|NCT02925403|69783573|FG001|Overall Study|Lost to Follow-up|1|||
38084291|NCT02626780|69783579|FG000|Overall Study|Withdrawal by Subject|3|||
38084292|NCT02831673|69783594|FG000|Double-blind (Day 1 to Week 96)|Adverse Event|10|||
38084293|NCT02831673|69783595|FG001|Double-blind (Day 1 to Week 96)|Adverse Event|7|||
38084294|NCT02831673|69783596|FG002|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
38084295|NCT02831673|69783597|FG003|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
38084296|NCT02831673|69783598|FG004|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
38084297|NCT02831673|69783594|FG000|Double-blind (Day 1 to Week 96)|Lack of Efficacy|4|||
38084298|NCT02831673|69783595|FG001|Double-blind (Day 1 to Week 96)|Lack of Efficacy|2|||
38084299|NCT02831673|69783596|FG002|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
38084300|NCT02831673|69783597|FG003|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
38084301|NCT02831673|69783598|FG004|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
38084302|NCT02831673|69783594|FG000|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
38084303|NCT02831673|69783595|FG001|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
38084304|NCT02831673|69783596|FG002|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
37684859|NCT02288325|69160464|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
38084305|NCT02831673|69783597|FG003|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
38084306|NCT02831673|69783598|FG004|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
38084307|NCT02831673|69783594|FG000|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|2|||
37684860|NCT02288325|69160462|FG000|Stabilization Period|Reason not Specified|15|||
38084308|NCT02831673|69783595|FG001|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|6|||
38084309|NCT02831673|69783596|FG002|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
37684861|NCT02288325|69160463|FG001|Stabilization Period|Reason not Specified|0|||
37684862|NCT02288325|69160464|FG002|Stabilization Period|Reason not Specified|0|||
37684863|NCT02288325|69160462|FG000|Double-blind Treatment Period|Adverse Event|0|||
37684864|NCT02288325|69160463|FG001|Double-blind Treatment Period|Adverse Event|2|||
37684865|NCT02288325|69160464|FG002|Double-blind Treatment Period|Adverse Event|5|||
37684866|NCT02288325|69160462|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
37684867|NCT02288325|69160463|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
37684868|NCT02288325|69160464|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
37684869|NCT02288325|69160462|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
37684870|NCT02288325|69160463|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
37684871|NCT02288325|69160464|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
37684872|NCT02288325|69160462|FG000|Double-blind Treatment Period|Protocol Violation|0|||
37684873|NCT02288325|69160463|FG001|Double-blind Treatment Period|Protocol Violation|1|||
37684874|NCT02288325|69160464|FG002|Double-blind Treatment Period|Protocol Violation|2|||
37684875|NCT02288325|69160462|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
37684876|NCT02288325|69160463|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
37684877|NCT02288325|69160464|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
37684878|NCT02288325|69160462|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
37684879|NCT02288325|69160463|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
37684880|NCT02288325|69160464|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
37684881|NCT02509117|69160481|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
37684882|NCT02509117|69160482|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
37684883|NCT02509117|69160483|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
37684884|NCT02509117|69160484|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
37684885|NCT02509117|69160485|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
37684886|NCT02509117|69160486|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
37684887|NCT02509117|69160487|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
37684888|NCT02509117|69160488|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
37684889|NCT02509117|69160489|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
37684890|NCT02509117|69160490|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
37684891|NCT02509117|69160481|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
37684892|NCT02509117|69160482|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
37684893|NCT02509117|69160483|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
37684894|NCT02509117|69160484|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
37684895|NCT02509117|69160485|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
37684896|NCT02509117|69160486|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
37684897|NCT02509117|69160487|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
37684898|NCT02509117|69160488|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
37684899|NCT02509117|69160489|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
37684900|NCT02509117|69160490|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
37684901|NCT02509117|69160481|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
37684902|NCT02509117|69160482|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
37684903|NCT02509117|69160483|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
37684904|NCT02509117|69160484|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
37684905|NCT02509117|69160485|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
37684906|NCT02509117|69160486|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
37684907|NCT02509117|69160487|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
37684908|NCT02509117|69160488|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
37684909|NCT02509117|69160489|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
37684910|NCT02509117|69160490|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
37684911|NCT01654549|69160530|FG000|Overall Study|H.pylori eradication not successful|0|||
37684912|NCT01654549|69160531|FG001|Overall Study|H.pylori eradication not successful|1|||
37684913|NCT02508649|69160545|FG000|Overall Study|Withdrawal by Subject|4|||
37684914|NCT02508649|69160546|FG001|Overall Study|Withdrawal by Subject|6|||
37684915|NCT02508649|69160547|FG002|Overall Study|Withdrawal by Subject|5|||
37684916|NCT02508649|69160548|FG003|Overall Study|Withdrawal by Subject|6|||
37684917|NCT02508649|69160545|FG000|Overall Study|Investigator withdrew the subject|1|||
37684918|NCT02508649|69160546|FG001|Overall Study|Investigator withdrew the subject|2|||
37684919|NCT02508649|69160547|FG002|Overall Study|Investigator withdrew the subject|1|||
37684920|NCT02508649|69160548|FG003|Overall Study|Investigator withdrew the subject|0|||
37684921|NCT02508649|69160545|FG000|Overall Study|Post randomization screening failure|12|||
37684922|NCT02508649|69160546|FG001|Overall Study|Post randomization screening failure|4|||
37684923|NCT02508649|69160547|FG002|Overall Study|Post randomization screening failure|9|||
37863009|NCT01263197|69546935|FG003|Washout Period 2|Protocol Violation|1|||
37863010|NCT01263197|69546936|FG004|Washout Period 2|Protocol Violation|0|||
37684924|NCT02508649|69160548|FG003|Overall Study|Post randomization screening failure|3|||
37684925|NCT02508649|69160545|FG000|Overall Study|Lost to Follow-up|1|||
37684926|NCT02508649|69160546|FG001|Overall Study|Lost to Follow-up|1|||
37684927|NCT02508649|69160547|FG002|Overall Study|Lost to Follow-up|0|||
37684928|NCT02508649|69160548|FG003|Overall Study|Lost to Follow-up|1|||
37684929|NCT02505217|69160563|FG000|Overall Study|Withdrawal by Subject|1|||
37684930|NCT02505217|69160564|FG001|Overall Study|Withdrawal by Subject|2|||
37684931|NCT02504827|69160570|FG000|Overall Study|Could not produce sputum|1|||
37684932|NCT02504671|69160580|FG000|Overall Study|Withdrawal by Subject|1|||
37684933|NCT02504671|69160581|FG001|Overall Study|Withdrawal by Subject|5|||
37684934|NCT02504671|69160582|FG002|Overall Study|Withdrawal by Subject|4|||
37684935|NCT02504671|69160583|FG003|Overall Study|Withdrawal by Subject|4|||
37684936|NCT02504671|69160584|FG004|Overall Study|Withdrawal by Subject|5|||
37684937|NCT02504671|69160585|FG005|Overall Study|Withdrawal by Subject|3|||
37684938|NCT02504671|69160580|FG000|Overall Study|Lack of Efficacy|1|||
37684939|NCT02504671|69160581|FG001|Overall Study|Lack of Efficacy|3|||
37684940|NCT02504671|69160582|FG002|Overall Study|Lack of Efficacy|1|||
37684941|NCT02504671|69160583|FG003|Overall Study|Lack of Efficacy|0|||
37684942|NCT02504671|69160584|FG004|Overall Study|Lack of Efficacy|4|||
37684943|NCT02504671|69160585|FG005|Overall Study|Lack of Efficacy|4|||
38084310|NCT02831673|69783597|FG003|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
38084311|NCT02831673|69783598|FG004|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
38084312|NCT02831673|69783594|FG000|Double-blind (Day 1 to Week 96)|Lost to Follow-up|13|||
38084313|NCT02831673|69783595|FG001|Double-blind (Day 1 to Week 96)|Lost to Follow-up|7|||
38084314|NCT02831673|69783596|FG002|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
38084315|NCT02831673|69783597|FG003|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
38084316|NCT02831673|69783598|FG004|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
38084317|NCT02831673|69783594|FG000|Double-blind (Day 1 to Week 96)|Physician Decision|9|||
38084318|NCT02831673|69783595|FG001|Double-blind (Day 1 to Week 96)|Physician Decision|4|||
38084319|NCT02831673|69783596|FG002|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
38084320|NCT02831673|69783597|FG003|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
38084321|NCT02831673|69783598|FG004|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
38084322|NCT02831673|69783594|FG000|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|11|||
38084323|NCT02831673|69783595|FG001|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|6|||
38084324|NCT02831673|69783596|FG002|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
38084325|NCT02831673|69783597|FG003|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
38084326|NCT02831673|69783598|FG004|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
38084327|NCT02831673|69783594|FG000|Double-blind (Day 1 to Week 96)|Randomized but not treated|3|||
38084328|NCT02831673|69783595|FG001|Double-blind (Day 1 to Week 96)|Randomized but not treated|2|||
38084329|NCT02831673|69783596|FG002|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
38084330|NCT02831673|69783597|FG003|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
38084331|NCT02831673|69783598|FG004|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
38084332|NCT02831673|69783594|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
38084333|NCT02831673|69783595|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
38084334|NCT02831673|69783596|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|3|||
38084335|NCT02831673|69783597|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
38084336|NCT02831673|69783598|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
38084337|NCT02831673|69783594|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
38084338|NCT02831673|69783595|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
38084339|NCT02831673|69783596|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|1|||
38084340|NCT02831673|69783597|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
38084341|NCT02831673|69783598|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
38084342|NCT02831673|69783594|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
38084343|NCT02831673|69783595|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
38084344|NCT02831673|69783596|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
38084345|NCT02831673|69783597|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|1|||
38084346|NCT02831673|69783598|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
38084347|NCT02831673|69783594|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
38084348|NCT02831673|69783595|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
38084349|NCT02831673|69783596|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|2|||
37684944|NCT02504671|69160580|FG000|Overall Study|Adverse Event|1|||
37684945|NCT02504671|69160581|FG001|Overall Study|Adverse Event|1|||
37684946|NCT02504671|69160582|FG002|Overall Study|Adverse Event|0|||
37684947|NCT02504671|69160583|FG003|Overall Study|Adverse Event|1|||
37684948|NCT02504671|69160584|FG004|Overall Study|Adverse Event|0|||
37684949|NCT02504671|69160585|FG005|Overall Study|Adverse Event|2|||
37684950|NCT02504671|69160580|FG000|Overall Study|Protocol Violation|2|||
37684951|NCT02504671|69160581|FG001|Overall Study|Protocol Violation|1|||
37684952|NCT02504671|69160582|FG002|Overall Study|Protocol Violation|0|||
37684953|NCT02504671|69160583|FG003|Overall Study|Protocol Violation|0|||
37684954|NCT02504671|69160584|FG004|Overall Study|Protocol Violation|0|||
37684955|NCT02504671|69160585|FG005|Overall Study|Protocol Violation|1|||
37684956|NCT02504671|69160580|FG000|Overall Study|Lost to Follow-up|0|||
37684957|NCT02504671|69160581|FG001|Overall Study|Lost to Follow-up|0|||
37684958|NCT02504671|69160582|FG002|Overall Study|Lost to Follow-up|2|||
37684959|NCT02504671|69160583|FG003|Overall Study|Lost to Follow-up|0|||
37967142|NCT00535236|69654005|FG009|Overall Study|Withdrawal by Subject|2|||
37967143|NCT00370552|69654033|FG000|Overall Study|Adverse Event|2|||
37967144|NCT00370552|69654034|FG001|Overall Study|Adverse Event|2|||
37967145|NCT00370552|69654035|FG002|Overall Study|Adverse Event|2|||
37967146|NCT00370552|69654033|FG000|Overall Study|Disease progression|23|||
37967147|NCT00370552|69654034|FG001|Overall Study|Disease progression|23|||
37967148|NCT00370552|69654035|FG002|Overall Study|Disease progression|15|||
37967149|NCT00370552|69654033|FG000|Overall Study|Maximum clinical benefit|3|||
37967150|NCT00370552|69654034|FG001|Overall Study|Maximum clinical benefit|5|||
37967151|NCT00370552|69654035|FG002|Overall Study|Maximum clinical benefit|5|||
37967152|NCT00370552|69654033|FG000|Overall Study|Poor or noncompliance|0|||
37967153|NCT00370552|69654034|FG001|Overall Study|Poor or noncompliance|0|||
37967154|NCT00370552|69654035|FG002|Overall Study|Poor or noncompliance|1|||
37967155|NCT00370552|69654033|FG000|Overall Study|Study drug toxicity|11|||
37967156|NCT00370552|69654034|FG001|Overall Study|Study drug toxicity|8|||
37967157|NCT00370552|69654035|FG002|Overall Study|Study drug toxicity|6|||
38084350|NCT02831673|69783597|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|1|||
38084351|NCT02831673|69783598|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
38084352|NCT02831673|69783594|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
38084353|NCT02831673|69783595|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
38084354|NCT02831673|69783596|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
38084355|NCT02831673|69783597|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|6|||
38084356|NCT02831673|69783598|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
38084357|NCT02831673|69783594|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
38084358|NCT02831673|69783595|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
38084359|NCT02831673|69783596|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
38084360|NCT02831673|69783597|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|4|||
38084361|NCT02831673|69783598|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
38084362|NCT02831673|69783594|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
38084363|NCT02831673|69783595|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
38084364|NCT02831673|69783596|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|6|||
38084365|NCT02831673|69783597|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|5|||
38084366|NCT02831673|69783598|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
37684960|NCT02504671|69160584|FG004|Overall Study|Lost to Follow-up|0|||
37684961|NCT02504671|69160585|FG005|Overall Study|Lost to Follow-up|1|||
37684962|NCT02504671|69160580|FG000|Overall Study|Protocol defined stopping criteria|7|||
37684963|NCT02504671|69160581|FG001|Overall Study|Protocol defined stopping criteria|4|||
37967158|NCT00370552|69654033|FG000|Overall Study|Withdrawal by Subject|2|||
37967159|NCT00370552|69654034|FG001|Overall Study|Withdrawal by Subject|0|||
37967160|NCT00370552|69654035|FG002|Overall Study|Withdrawal by Subject|1|||
37967161|NCT00370552|69654033|FG000|Overall Study|Still on treatment|1|||
37967162|NCT00370552|69654034|FG001|Overall Study|Still on treatment|3|||
37684964|NCT02504671|69160582|FG002|Overall Study|Protocol defined stopping criteria|3|||
37684965|NCT02504671|69160583|FG003|Overall Study|Protocol defined stopping criteria|5|||
37684966|NCT02504671|69160584|FG004|Overall Study|Protocol defined stopping criteria|3|||
37684967|NCT02504671|69160585|FG005|Overall Study|Protocol defined stopping criteria|3|||
37684968|NCT02314143|69160602|FG000|Overall Study|Adverse Event|0|||
37684969|NCT02314143|69160603|FG001|Overall Study|Adverse Event|6|||
37684970|NCT02314143|69160604|FG002|Overall Study|Adverse Event|4|||
37684971|NCT02314143|69160602|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
37684972|NCT02314143|69160603|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
37684973|NCT02314143|69160604|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
37684974|NCT02314143|69160602|FG000|Overall Study|Physician Decision|2|||
37684975|NCT02314143|69160603|FG001|Overall Study|Physician Decision|1|||
37684976|NCT02314143|69160604|FG002|Overall Study|Physician Decision|0|||
37684977|NCT02314143|69160602|FG000|Overall Study|Withdrawal by Subject|1|||
37684978|NCT02314143|69160603|FG001|Overall Study|Withdrawal by Subject|0|||
37684979|NCT02314143|69160604|FG002|Overall Study|Withdrawal by Subject|1|||
37684980|NCT02288091|69160613|FG000|Overall Study|Lost to Follow-up|1|||
37684981|NCT02288091|69160613|FG000|Overall Study|Screen fail|7|||
37684982|NCT02503501|69160619|FG000|Overall Study|Physician Decision|1|||
37684983|NCT02503501|69160620|FG001|Overall Study|Physician Decision|0|||
37684984|NCT02503501|69160619|FG000|Overall Study|Protocol Violation|0|||
37684985|NCT02503501|69160620|FG001|Overall Study|Protocol Violation|1|||
37684986|NCT02503501|69160619|FG000|Overall Study|Withdrawal by Subject|0|||
37684987|NCT02503501|69160620|FG001|Overall Study|Withdrawal by Subject|2|||
37684988|NCT02502097|69160630|FG000|Period 1|Adverse Event|0|||
37684989|NCT02502097|69160631|FG001|Period 1|Adverse Event|0|||
37684990|NCT02502097|69160632|FG002|Period 1|Adverse Event|1|||
37684991|NCT02502097|69160633|FG003|Period 1|Adverse Event|0|||
37684992|NCT02502097|69160630|FG000|Wash Out Period|Adverse Event|0|||
37684993|NCT02502097|69160631|FG001|Wash Out Period|Adverse Event|1|||
37684994|NCT02502097|69160632|FG002|Wash Out Period|Adverse Event|1|||
37684995|NCT02502097|69160633|FG003|Wash Out Period|Adverse Event|1|||
37684996|NCT02502097|69160630|FG000|Period 2|Adverse Event|0|||
37684997|NCT02502097|69160631|FG001|Period 2|Adverse Event|0|||
37684998|NCT02502097|69160632|FG002|Period 2|Adverse Event|1|||
37684999|NCT02502097|69160633|FG003|Period 2|Adverse Event|0|||
37685000|NCT02501629|69160642|FG000|Overall Study|Death|0|||
37685001|NCT02501629|69160643|FG001|Overall Study|Death|1|||
37685002|NCT02501629|69160642|FG000|Overall Study|Withdrawn from study by sponsor|1|||
37685003|NCT02501629|69160643|FG001|Overall Study|Withdrawn from study by sponsor|0|||
37685004|NCT02501629|69160642|FG000|Overall Study|Early termination by sponsor|1|||
37685005|NCT02501629|69160643|FG001|Overall Study|Early termination by sponsor|0|||
37685006|NCT02501629|69160642|FG000|Overall Study|Withdrawal by Subject|3|||
37685007|NCT02501629|69160643|FG001|Overall Study|Withdrawal by Subject|5|||
37685008|NCT02501629|69160642|FG000|Overall Study|Subject did not return to site|0|||
37685009|NCT02501629|69160643|FG001|Overall Study|Subject did not return to site|1|||
37685010|NCT02501473|69160656|FG000|Overall Study|Study Terminated|2|||
37685011|NCT02501473|69160657|FG001|Overall Study|Study Terminated|3|||
37685012|NCT02501473|69160658|FG002|Overall Study|Study Terminated|7|||
37685013|NCT02501473|69160659|FG003|Overall Study|Study Terminated|9|||
37685014|NCT02501473|69160660|FG004|Overall Study|Study Terminated|2|||
37685015|NCT02501473|69160661|FG005|Overall Study|Study Terminated|10|||
37685016|NCT02501473|69160662|FG006|Overall Study|Study Terminated|1|||
37685017|NCT02501473|69160663|FG007|Overall Study|Study Terminated|0|||
37685018|NCT02501473|69160656|FG000|Overall Study|Withdrawal by Subject|0|||
37685019|NCT02501473|69160657|FG001|Overall Study|Withdrawal by Subject|0|||
37685020|NCT02501473|69160658|FG002|Overall Study|Withdrawal by Subject|3|||
37685021|NCT02501473|69160659|FG003|Overall Study|Withdrawal by Subject|3|||
37685022|NCT02501473|69160660|FG004|Overall Study|Withdrawal by Subject|2|||
37685023|NCT02501473|69160661|FG005|Overall Study|Withdrawal by Subject|2|||
37685024|NCT02501473|69160662|FG006|Overall Study|Withdrawal by Subject|0|||
37685025|NCT02501473|69160663|FG007|Overall Study|Withdrawal by Subject|0|||
37685026|NCT02501473|69160656|FG000|Overall Study|Death|0|||
37685027|NCT02501473|69160657|FG001|Overall Study|Death|0|||
37685028|NCT02501473|69160658|FG002|Overall Study|Death|1|||
37685029|NCT02501473|69160659|FG003|Overall Study|Death|1|||
37685030|NCT02501473|69160660|FG004|Overall Study|Death|0|||
37685031|NCT02501473|69160661|FG005|Overall Study|Death|1|||
37685032|NCT02501473|69160662|FG006|Overall Study|Death|0|||
37685033|NCT02501473|69160663|FG007|Overall Study|Death|0|||
37685034|NCT02501473|69160656|FG000|Overall Study|Lost to Follow-up|1|||
37685035|NCT02501473|69160657|FG001|Overall Study|Lost to Follow-up|0|||
37685036|NCT02501473|69160658|FG002|Overall Study|Lost to Follow-up|1|||
37685037|NCT02501473|69160659|FG003|Overall Study|Lost to Follow-up|0|||
37685038|NCT02501473|69160660|FG004|Overall Study|Lost to Follow-up|0|||
37685039|NCT02501473|69160661|FG005|Overall Study|Lost to Follow-up|1|||
37685040|NCT02501473|69160662|FG006|Overall Study|Lost to Follow-up|0|||
37685041|NCT02501473|69160663|FG007|Overall Study|Lost to Follow-up|0|||
37685042|NCT02501473|69160656|FG000|Overall Study|Reason not specified|0|||
37967163|NCT00370552|69654035|FG002|Overall Study|Still on treatment|2|||
37967164|NCT00370552|69654033|FG000|Overall Study|Never treated|1|||
38084367|NCT02831673|69783594|FG000|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
38084368|NCT02831673|69783595|FG001|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
38084369|NCT02831673|69783596|FG002|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
38084370|NCT02831673|69783597|FG003|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
38084371|NCT02831673|69783598|FG004|Continuation Phase(Week 148 to Week 280)|Adverse Event|1|||
38084372|NCT02831673|69783594|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
38084373|NCT02831673|69783595|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
38084374|NCT02831673|69783596|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
38084375|NCT02831673|69783597|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
38084376|NCT02831673|69783598|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
38084377|NCT02831673|69783594|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
38084378|NCT02831673|69783595|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
38084379|NCT02831673|69783596|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
38084380|NCT02831673|69783597|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
38084381|NCT02831673|69783598|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|10|||
38084382|NCT02831673|69783594|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
38084383|NCT02831673|69783595|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
38084384|NCT02831673|69783596|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
38084385|NCT02831673|69783597|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
38084386|NCT02831673|69783598|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|2|||
38084387|NCT02831673|69783594|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
38084388|NCT02831673|69783595|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
38084389|NCT02831673|69783596|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
38084390|NCT02831673|69783597|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
38084391|NCT02831673|69783598|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|7|||
38084392|NCT02830893|69783616|FG000|Overall Study|Relocation to out of the country|1|||
38084393|NCT02830893|69783617|FG001|Overall Study|Relocation to out of the country|0|||
38084394|NCT02830893|69783616|FG000|Overall Study|Lost to Follow-up|0|||
38084395|NCT02830893|69783617|FG001|Overall Study|Lost to Follow-up|2|||
38084396|NCT02830893|69783616|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
38084397|NCT02830893|69783617|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
38084398|NCT02625922|69783625|FG000|Overall Study|Non-availability of IMP|1|||
38084399|NCT02625922|69783626|FG001|Overall Study|Non-availability of IMP|1|||
38084400|NCT02625922|69783625|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
38084401|NCT02625922|69783626|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
38084402|NCT03350035|69783638|FG000|Overall Study|Lack of Efficacy|2|||
38084403|NCT03350035|69783639|FG001|Overall Study|Lack of Efficacy|0|||
38084404|NCT03350035|69783640|FG002|Overall Study|Lack of Efficacy|0|||
38084405|NCT03350035|69783638|FG000|Overall Study|Subject discharged to hospice|0|||
38084406|NCT03350035|69783639|FG001|Overall Study|Subject discharged to hospice|0|||
38084407|NCT03350035|69783640|FG002|Overall Study|Subject discharged to hospice|1|||
38084408|NCT01358331|69783674|FG000|Overall Study|Lost to Follow-up|0|||
38084409|NCT01358331|69783675|FG001|Overall Study|Lost to Follow-up|0|||
38084410|NCT01358331|69783676|FG002|Overall Study|Lost to Follow-up|0|||
38084411|NCT01358331|69783677|FG003|Overall Study|Lost to Follow-up|1|||
38084412|NCT01358331|69783678|FG004|Overall Study|Lost to Follow-up|0|||
38084413|NCT01358331|69783679|FG005|Overall Study|Lost to Follow-up|0|||
38084414|NCT01358331|69783674|FG000|Overall Study|Withdrawal by Subject|0|||
38084415|NCT01358331|69783675|FG001|Overall Study|Withdrawal by Subject|0|||
37685043|NCT02501473|69160657|FG001|Overall Study|Reason not specified|0|||
37685044|NCT02501473|69160658|FG002|Overall Study|Reason not specified|1|||
37685045|NCT02501473|69160659|FG003|Overall Study|Reason not specified|1|||
37685046|NCT02501473|69160660|FG004|Overall Study|Reason not specified|0|||
37685047|NCT02501473|69160661|FG005|Overall Study|Reason not specified|0|||
37685048|NCT02501473|69160662|FG006|Overall Study|Reason not specified|0|||
37685049|NCT02501473|69160663|FG007|Overall Study|Reason not specified|0|||
37685050|NCT02501161|69160681|FG000|Overall Study|Adverse Event|2|||
37685051|NCT02501161|69160682|FG001|Overall Study|Adverse Event|6|||
37685052|NCT02501161|69160681|FG000|Overall Study|Lost to Follow-up|7|||
37685053|NCT02501161|69160682|FG001|Overall Study|Lost to Follow-up|4|||
37685054|NCT02501161|69160681|FG000|Overall Study|Withdrawal by Subject|10|||
37685055|NCT02501161|69160682|FG001|Overall Study|Withdrawal by Subject|15|||
37685056|NCT02501161|69160681|FG000|Overall Study|Other|3|||
37685057|NCT02501161|69160682|FG001|Overall Study|Other|0|||
37685058|NCT02500537|69160690|FG000|Overall Study|Death|2|||
37685059|NCT02500537|69160691|FG001|Overall Study|Death|0|||
37685060|NCT02500537|69160690|FG000|Overall Study|Lost to Follow-up|0|||
37685061|NCT02500537|69160691|FG001|Overall Study|Lost to Follow-up|1|||
37685062|NCT02500537|69160690|FG000|Overall Study|Withdrawal by Subject|1|||
37685063|NCT02500537|69160691|FG001|Overall Study|Withdrawal by Subject|0|||
37685064|NCT02498821|69160700|FG000|Overall Study|Screen failure|3|||
37685065|NCT02498821|69160701|FG001|Overall Study|Screen failure|5|||
37685066|NCT02313909|69160709|FG000|Overall Study|Consent withdrawn by participant|33|||
37685067|NCT02313909|69160710|FG001|Overall Study|Consent withdrawn by participant|33|||
37685068|NCT02313909|69160709|FG000|Overall Study|Lost to Follow-up|24|||
37685069|NCT02313909|69160710|FG001|Overall Study|Lost to Follow-up|17|||
37685070|NCT02287467|69160718|FG000|Overall Study|Protocol Violation|12|||
37685071|NCT02287467|69160719|FG001|Overall Study|Protocol Violation|9|||
37685072|NCT02287233|69160731|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
37685073|NCT02287233|69160732|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
37685074|NCT02287233|69160733|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
37685075|NCT02287233|69160731|FG000|Overall Study|Adverse Event Related to Progression|0|||
37685076|NCT02287233|69160732|FG001|Overall Study|Adverse Event Related to Progression|2|||
37685077|NCT02287233|69160733|FG002|Overall Study|Adverse Event Related to Progression|8|||
37685078|NCT02287233|69160731|FG000|Overall Study|Physician Decision|1|||
37685079|NCT02287233|69160732|FG001|Overall Study|Physician Decision|2|||
37685080|NCT02287233|69160733|FG002|Overall Study|Physician Decision|4|||
37685081|NCT02287233|69160731|FG000|Overall Study|Progressive Disease with Death|0|||
37685082|NCT02287233|69160732|FG001|Overall Study|Progressive Disease with Death|0|||
37685083|NCT02287233|69160733|FG002|Overall Study|Progressive Disease with Death|10|||
37685084|NCT02287233|69160731|FG000|Overall Study|Progressive Disease Without Death|2|||
37685085|NCT02287233|69160732|FG001|Overall Study|Progressive Disease Without Death|3|||
37685086|NCT02287233|69160733|FG002|Overall Study|Progressive Disease Without Death|20|||
37685087|NCT02287233|69160731|FG000|Overall Study|Withdrawal by Subject|1|||
37685088|NCT02287233|69160732|FG001|Overall Study|Withdrawal by Subject|1|||
37685089|NCT02287233|69160733|FG002|Overall Study|Withdrawal by Subject|7|||
37685090|NCT02287233|69160731|FG000|Overall Study|Other|3|||
37685091|NCT02287233|69160732|FG001|Overall Study|Other|0|||
37685092|NCT02287233|69160733|FG002|Overall Study|Other|15|||
37685093|NCT02287233|69160731|FG000|Overall Study|Did Not Receive Treatment|0|||
37685094|NCT02287233|69160732|FG001|Overall Study|Did Not Receive Treatment|0|||
37685095|NCT02287233|69160733|FG002|Overall Study|Did Not Receive Treatment|2|||
37685096|NCT01646385|69160746|FG000|Overall Study|Death|202|||
37685097|NCT01646385|69160747|FG001|Overall Study|Death|222|||
37685098|NCT01646385|69160746|FG000|Overall Study|Switched to alternate biologic|636|||
37685099|NCT01646385|69160747|FG001|Overall Study|Switched to alternate biologic|649|||
37685100|NCT02286843|69160753|FG000|Overall Study|Not Treated|4|||
37685101|NCT02286843|69160753|FG000|Overall Study|Protocol Violation|1|||
37685102|NCT02286843|69160753|FG000|Overall Study|Withdrawal by Subject|1|||
37863011|NCT01263197|69546937|FG005|Washout Period 2|Protocol Violation|0|||
38084416|NCT01358331|69783676|FG002|Overall Study|Withdrawal by Subject|0|||
37685103|NCT02282163|69160757|FG000|Overall Study|Protocol Violation|1|||
37685104|NCT02281773|69160775|FG000|Overall Study|Adverse Event|6|||
37685105|NCT02281773|69160776|FG001|Overall Study|Adverse Event|1|||
37685106|NCT02281773|69160777|FG002|Overall Study|Adverse Event|4|||
37685107|NCT02281773|69160778|FG003|Overall Study|Adverse Event|8|||
37685108|NCT02281773|69160779|FG004|Overall Study|Adverse Event|9|||
37685109|NCT02281773|69160775|FG000|Overall Study|Protocol Violation|1|||
37685110|NCT02281773|69160776|FG001|Overall Study|Protocol Violation|0|||
37685111|NCT02281773|69160777|FG002|Overall Study|Protocol Violation|0|||
37685112|NCT02281773|69160778|FG003|Overall Study|Protocol Violation|2|||
37685113|NCT02281773|69160779|FG004|Overall Study|Protocol Violation|2|||
37685114|NCT02281773|69160775|FG000|Overall Study|Lost to Follow-up|2|||
37685115|NCT02281773|69160776|FG001|Overall Study|Lost to Follow-up|2|||
37685116|NCT02281773|69160777|FG002|Overall Study|Lost to Follow-up|6|||
37685117|NCT02281773|69160778|FG003|Overall Study|Lost to Follow-up|2|||
37685118|NCT02281773|69160779|FG004|Overall Study|Lost to Follow-up|10|||
37685119|NCT02281773|69160775|FG000|Overall Study|Withdrawal by Subject|2|||
37685120|NCT02281773|69160776|FG001|Overall Study|Withdrawal by Subject|8|||
37685121|NCT02281773|69160777|FG002|Overall Study|Withdrawal by Subject|6|||
37685122|NCT02281773|69160778|FG003|Overall Study|Withdrawal by Subject|6|||
37685123|NCT02281773|69160779|FG004|Overall Study|Withdrawal by Subject|8|||
37685124|NCT02281773|69160775|FG000|Overall Study|Other Reason|0|||
37685125|NCT02281773|69160776|FG001|Overall Study|Other Reason|4|||
37685126|NCT02281773|69160777|FG002|Overall Study|Other Reason|2|||
37685127|NCT02281773|69160778|FG003|Overall Study|Other Reason|3|||
37685128|NCT02281773|69160779|FG004|Overall Study|Other Reason|1|||
37685129|NCT02285361|69160791|FG000|Overall Study|Protocol Violation|43|||
37685130|NCT02285361|69160791|FG000|Overall Study|Lost to Follow-up|5|||
37685131|NCT02285361|69160791|FG000|Overall Study|Not taken GIOTRIF|2|||
37685132|NCT02285361|69160791|FG000|Overall Study|Consented prior to the contract date|1|||
37685133|NCT02354235|69160797|FG000|Overall Study|Adverse Event|2|||
37685134|NCT02354235|69160798|FG001|Overall Study|Adverse Event|2|||
37685135|NCT02354235|69160797|FG000|Overall Study|Physician Decision|0|||
37685136|NCT02354235|69160798|FG001|Overall Study|Physician Decision|1|||
37685137|NCT02354235|69160797|FG000|Overall Study|Withdrawal by Subject|1|||
37685138|NCT02354235|69160798|FG001|Overall Study|Withdrawal by Subject|3|||
37685139|NCT02354235|69160797|FG000|Overall Study|Conflict with the stopping criteria|0|||
37685140|NCT02354235|69160798|FG001|Overall Study|Conflict with the stopping criteria|1|||
37685141|NCT02280291|69160808|FG000|Overall Study|Lost to Follow-up|2|||
37685142|NCT02280291|69160809|FG001|Overall Study|Lost to Follow-up|1|||
37685143|NCT02280291|69160810|FG002|Overall Study|Lost to Follow-up|3|||
37685144|NCT02280291|69160811|FG003|Overall Study|Lost to Follow-up|8|||
37685145|NCT02280291|69160808|FG000|Overall Study|Protocol Violation|1|||
37685146|NCT02280291|69160809|FG001|Overall Study|Protocol Violation|0|||
37685147|NCT02280291|69160810|FG002|Overall Study|Protocol Violation|0|||
37685148|NCT02280291|69160811|FG003|Overall Study|Protocol Violation|0|||
37685149|NCT02280291|69160808|FG000|Overall Study|Other|1|||
37685150|NCT02280291|69160809|FG001|Overall Study|Other|1|||
37685151|NCT02280291|69160810|FG002|Overall Study|Other|0|||
37685152|NCT02280291|69160811|FG003|Overall Study|Other|0|||
37685153|NCT02284893|69160825|FG000|26 Week (Short Term)|Adverse Event|1|||
37685154|NCT02284893|69160826|FG001|26 Week (Short Term)|Adverse Event|9|||
37685155|NCT02284893|69160825|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
37685156|NCT02284893|69160826|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
37685157|NCT02284893|69160825|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
37685158|NCT02284893|69160826|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
37685159|NCT02284893|69160825|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
37685160|NCT02284893|69160826|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
37685161|NCT02284893|69160825|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
37685162|NCT02284893|69160826|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
37685163|NCT02284893|69160825|FG000|26 Week (Short Term)|Other|1|||
37685164|NCT02284893|69160826|FG001|26 Week (Short Term)|Other|1|||
37685165|NCT02284893|69160825|FG000|52 Week (Long Term)|Adverse Event|3|||
37685166|NCT02284893|69160826|FG001|52 Week (Long Term)|Adverse Event|1|||
37685167|NCT02284893|69160825|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
37685168|NCT02284893|69160826|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
37685169|NCT02284893|69160825|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
37967165|NCT00370552|69654034|FG001|Overall Study|Never treated|0|||
37685170|NCT02284893|69160826|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
37685171|NCT02284893|69160825|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
37685172|NCT02284893|69160826|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
37685173|NCT02284893|69160825|FG000|52 Week (Long Term)|Non-Compliance|2|||
37685174|NCT02284893|69160826|FG001|52 Week (Long Term)|Non-Compliance|3|||
37685175|NCT02284347|69160832|FG000|Overall Study|Lost to Follow-up|2|||
37685176|NCT02284347|69160832|FG000|Overall Study|Withdrawn prior to treatment|1|||
37685177|NCT02279043|69160839|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
37685178|NCT02279043|69160840|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
37685179|NCT02279043|69160841|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
37685180|NCT02279043|69160839|FG000|Overall Study|Lost to Follow-up|46|||
37685181|NCT02279043|69160840|FG001|Overall Study|Lost to Follow-up|88|||
37685182|NCT02279043|69160841|FG002|Overall Study|Lost to Follow-up|0|||
37685183|NCT02283411|69160847|FG000|Overall Study|Withdrawal by Subject|3|||
37685184|NCT02283411|69160847|FG000|Overall Study|Screen Failed|28|||
37685185|NCT02351817|69160851|FG000|Period 1|Adverse Event|1|||
37685186|NCT02351817|69160852|FG001|Period 1|Adverse Event|2|||
37685187|NCT02351817|69160851|FG000|Period 1|Lack of Efficacy|0|||
37685188|NCT02351817|69160852|FG001|Period 1|Lack of Efficacy|1|||
37685189|NCT02351817|69160851|FG000|Period 2|Adverse Event|0|||
37685190|NCT02351817|69160852|FG001|Period 2|Adverse Event|2|||
37967166|NCT00370552|69654035|FG002|Overall Study|Never treated|0|||
37685191|NCT02351817|69160851|FG000|Period 2|Protocol Violation|1|||
37685192|NCT02351817|69160852|FG001|Period 2|Protocol Violation|0|||
37685193|NCT02351349|69160861|FG000|Overall Study|Withdrawal by Subject|2|||
37685194|NCT02351349|69160862|FG001|Overall Study|Withdrawal by Subject|3|||
37685195|NCT02484547|69160876|FG000|Placebo-Controlled Period|Adverse Event|10|||
37685196|NCT02484547|69160877|FG001|Placebo-Controlled Period|Adverse Event|13|||
37685197|NCT02484547|69160878|FG002|Placebo-Controlled Period|Adverse Event|20|||
37685198|NCT02484547|69160879|FG003|Placebo-Controlled Period|Adverse Event|0|||
37685199|NCT02484547|69160880|FG004|Placebo-Controlled Period|Adverse Event|0|||
37685200|NCT02484547|69160881|FG005|Placebo-Controlled Period|Adverse Event|0|||
37685201|NCT02484547|69160882|FG006|Placebo-Controlled Period|Adverse Event|0|||
37685202|NCT02484547|69160876|FG000|Placebo-Controlled Period|Change of Treatment|0|||
37685203|NCT02484547|69160877|FG001|Placebo-Controlled Period|Change of Treatment|0|||
37685204|NCT02484547|69160878|FG002|Placebo-Controlled Period|Change of Treatment|1|||
37685205|NCT02484547|69160879|FG003|Placebo-Controlled Period|Change of Treatment|0|||
37685206|NCT02484547|69160880|FG004|Placebo-Controlled Period|Change of Treatment|0|||
37685207|NCT02484547|69160881|FG005|Placebo-Controlled Period|Change of Treatment|0|||
37685208|NCT02484547|69160882|FG006|Placebo-Controlled Period|Change of Treatment|0|||
37685209|NCT02484547|69160876|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
37685210|NCT02484547|69160877|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
37685211|NCT02484547|69160878|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
37685212|NCT02484547|69160879|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
37685213|NCT02484547|69160880|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
37967167|NCT00370552|69654033|FG000|Overall Study|Physician Decision|1|||
37685214|NCT02484547|69160881|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
37685215|NCT02484547|69160882|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
37685216|NCT02484547|69160876|FG000|Placebo-Controlled Period|Death|5|||
37685217|NCT02484547|69160877|FG001|Placebo-Controlled Period|Death|0|||
37685218|NCT02484547|69160878|FG002|Placebo-Controlled Period|Death|6|||
37685219|NCT02484547|69160879|FG003|Placebo-Controlled Period|Death|0|||
37685220|NCT02484547|69160880|FG004|Placebo-Controlled Period|Death|0|||
37685221|NCT02484547|69160881|FG005|Placebo-Controlled Period|Death|0|||
37685222|NCT02484547|69160882|FG006|Placebo-Controlled Period|Death|0|||
37685223|NCT02484547|69160876|FG000|Placebo-Controlled Period|Disease Progression|2|||
37685224|NCT02484547|69160877|FG001|Placebo-Controlled Period|Disease Progression|0|||
37685225|NCT02484547|69160878|FG002|Placebo-Controlled Period|Disease Progression|1|||
37685226|NCT02484547|69160879|FG003|Placebo-Controlled Period|Disease Progression|0|||
37685227|NCT02484547|69160880|FG004|Placebo-Controlled Period|Disease Progression|0|||
37685228|NCT02484547|69160881|FG005|Placebo-Controlled Period|Disease Progression|0|||
37685229|NCT02484547|69160882|FG006|Placebo-Controlled Period|Disease Progression|0|||
37685230|NCT02484547|69160876|FG000|Placebo-Controlled Period|Investigator Decision|2|||
37685231|NCT02484547|69160877|FG001|Placebo-Controlled Period|Investigator Decision|2|||
37685232|NCT02484547|69160878|FG002|Placebo-Controlled Period|Investigator Decision|5|||
37685233|NCT02484547|69160879|FG003|Placebo-Controlled Period|Investigator Decision|0|||
37685234|NCT02484547|69160880|FG004|Placebo-Controlled Period|Investigator Decision|0|||
37685235|NCT02484547|69160881|FG005|Placebo-Controlled Period|Investigator Decision|0|||
37685236|NCT02484547|69160882|FG006|Placebo-Controlled Period|Investigator Decision|0|||
37685237|NCT02484547|69160876|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
37685238|NCT02484547|69160877|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
37685239|NCT02484547|69160878|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
37685240|NCT02484547|69160879|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
37685241|NCT02484547|69160880|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
37685242|NCT02484547|69160881|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
37685243|NCT02484547|69160882|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
37685244|NCT02484547|69160876|FG000|Placebo-Controlled Period|Relocation|1|||
37685245|NCT02484547|69160877|FG001|Placebo-Controlled Period|Relocation|1|||
37685246|NCT02484547|69160878|FG002|Placebo-Controlled Period|Relocation|1|||
37685247|NCT02484547|69160879|FG003|Placebo-Controlled Period|Relocation|0|||
37685248|NCT02484547|69160880|FG004|Placebo-Controlled Period|Relocation|0|||
37685249|NCT02484547|69160881|FG005|Placebo-Controlled Period|Relocation|0|||
37685250|NCT02484547|69160882|FG006|Placebo-Controlled Period|Relocation|0|||
37685251|NCT02484547|69160876|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
37685252|NCT02484547|69160877|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
37685253|NCT02484547|69160878|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
37685254|NCT02484547|69160879|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
37685255|NCT02484547|69160880|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
37685256|NCT02484547|69160881|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
37685257|NCT02484547|69160882|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
37685258|NCT02484547|69160876|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
37685259|NCT02484547|69160877|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
37685260|NCT02484547|69160878|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
37685261|NCT02484547|69160879|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
37685262|NCT02484547|69160880|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
37685263|NCT02484547|69160881|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
37685264|NCT02484547|69160882|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
37685265|NCT02484547|69160876|FG000|Placebo-Controlled Period|Reason not Specified|216|||
37685266|NCT02484547|69160877|FG001|Placebo-Controlled Period|Reason not Specified|194|||
37685267|NCT02484547|69160878|FG002|Placebo-Controlled Period|Reason not Specified|183|||
37685268|NCT02484547|69160879|FG003|Placebo-Controlled Period|Reason not Specified|0|||
37685269|NCT02484547|69160880|FG004|Placebo-Controlled Period|Reason not Specified|0|||
37685270|NCT02484547|69160881|FG005|Placebo-Controlled Period|Reason not Specified|0|||
37685271|NCT02484547|69160882|FG006|Placebo-Controlled Period|Reason not Specified|0|||
37685272|NCT02484547|69160876|FG000|Long-Term Extension Period|Adverse Event|0|||
37685273|NCT02484547|69160877|FG001|Long-Term Extension Period|Adverse Event|0|||
37685274|NCT02484547|69160878|FG002|Long-Term Extension Period|Adverse Event|0|||
37685275|NCT02484547|69160879|FG003|Long-Term Extension Period|Adverse Event|0|||
37685276|NCT02484547|69160880|FG004|Long-Term Extension Period|Adverse Event|1|||
37685277|NCT02484547|69160881|FG005|Long-Term Extension Period|Adverse Event|3|||
37685278|NCT02484547|69160882|FG006|Long-Term Extension Period|Adverse Event|2|||
37685279|NCT02484547|69160876|FG000|Long-Term Extension Period|Death|0|||
37685280|NCT02484547|69160877|FG001|Long-Term Extension Period|Death|0|||
37685281|NCT02484547|69160878|FG002|Long-Term Extension Period|Death|0|||
37685282|NCT02484547|69160879|FG003|Long-Term Extension Period|Death|0|||
37685283|NCT02484547|69160880|FG004|Long-Term Extension Period|Death|0|||
37685284|NCT02484547|69160881|FG005|Long-Term Extension Period|Death|3|||
37685285|NCT02484547|69160882|FG006|Long-Term Extension Period|Death|0|||
37685286|NCT02484547|69160876|FG000|Long-Term Extension Period|Disease Progression|0|||
37685287|NCT02484547|69160877|FG001|Long-Term Extension Period|Disease Progression|0|||
37685288|NCT02484547|69160878|FG002|Long-Term Extension Period|Disease Progression|0|||
37685289|NCT02484547|69160879|FG003|Long-Term Extension Period|Disease Progression|0|||
37685290|NCT02484547|69160880|FG004|Long-Term Extension Period|Disease Progression|2|||
37685291|NCT02484547|69160881|FG005|Long-Term Extension Period|Disease Progression|4|||
37685292|NCT02484547|69160882|FG006|Long-Term Extension Period|Disease Progression|0|||
37685293|NCT02484547|69160876|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
37685294|NCT02484547|69160877|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
37685295|NCT02484547|69160878|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
37685296|NCT02484547|69160879|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
37685297|NCT02484547|69160880|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
37685298|NCT02484547|69160881|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
37685299|NCT02484547|69160882|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
37685300|NCT02484547|69160876|FG000|Long-Term Extension Period|Loss of Capacity|0|||
37685301|NCT02484547|69160877|FG001|Long-Term Extension Period|Loss of Capacity|0|||
37685302|NCT02484547|69160878|FG002|Long-Term Extension Period|Loss of Capacity|0|||
37685303|NCT02484547|69160879|FG003|Long-Term Extension Period|Loss of Capacity|0|||
37685304|NCT02484547|69160880|FG004|Long-Term Extension Period|Loss of Capacity|1|||
37685305|NCT02484547|69160881|FG005|Long-Term Extension Period|Loss of Capacity|0|||
37685306|NCT02484547|69160882|FG006|Long-Term Extension Period|Loss of Capacity|0|||
37685307|NCT02484547|69160876|FG000|Long-Term Extension Period|Change of Treatment|0|||
37685308|NCT02484547|69160877|FG001|Long-Term Extension Period|Change of Treatment|0|||
37685309|NCT02484547|69160878|FG002|Long-Term Extension Period|Change of Treatment|0|||
37685310|NCT02484547|69160879|FG003|Long-Term Extension Period|Change of Treatment|0|||
37685311|NCT02484547|69160880|FG004|Long-Term Extension Period|Change of Treatment|0|||
37685312|NCT02484547|69160881|FG005|Long-Term Extension Period|Change of Treatment|0|||
37685313|NCT02484547|69160882|FG006|Long-Term Extension Period|Change of Treatment|1|||
37685314|NCT02484547|69160876|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
37685315|NCT02484547|69160877|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
37685316|NCT02484547|69160878|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
37685317|NCT02484547|69160879|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
37685318|NCT02484547|69160880|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
37685319|NCT02484547|69160881|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
37685320|NCT02484547|69160882|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
37685321|NCT02484547|69160876|FG000|Long-Term Extension Period|Investigator Decision|0|||
37685322|NCT02484547|69160877|FG001|Long-Term Extension Period|Investigator Decision|0|||
37685323|NCT02484547|69160878|FG002|Long-Term Extension Period|Investigator Decision|0|||
37685324|NCT02484547|69160879|FG003|Long-Term Extension Period|Investigator Decision|2|||
37685325|NCT02484547|69160880|FG004|Long-Term Extension Period|Investigator Decision|1|||
37685326|NCT02484547|69160881|FG005|Long-Term Extension Period|Investigator Decision|0|||
37685327|NCT02484547|69160882|FG006|Long-Term Extension Period|Investigator Decision|1|||
37685328|NCT02484547|69160876|FG000|Long-Term Extension Period|Relocation|0|||
37685329|NCT02484547|69160877|FG001|Long-Term Extension Period|Relocation|0|||
37685330|NCT02484547|69160878|FG002|Long-Term Extension Period|Relocation|0|||
37685331|NCT02484547|69160879|FG003|Long-Term Extension Period|Relocation|1|||
37685332|NCT02484547|69160880|FG004|Long-Term Extension Period|Relocation|1|||
37685333|NCT02484547|69160881|FG005|Long-Term Extension Period|Relocation|0|||
37685334|NCT02484547|69160882|FG006|Long-Term Extension Period|Relocation|0|||
37685335|NCT02484547|69160876|FG000|Long-Term Extension Period|Study Visit Burden|0|||
37685336|NCT02484547|69160877|FG001|Long-Term Extension Period|Study Visit Burden|0|||
37685337|NCT02484547|69160878|FG002|Long-Term Extension Period|Study Visit Burden|0|||
37685338|NCT02484547|69160879|FG003|Long-Term Extension Period|Study Visit Burden|2|||
37685339|NCT02484547|69160880|FG004|Long-Term Extension Period|Study Visit Burden|0|||
37685340|NCT02484547|69160881|FG005|Long-Term Extension Period|Study Visit Burden|0|||
37685341|NCT02484547|69160882|FG006|Long-Term Extension Period|Study Visit Burden|3|||
37685342|NCT02484547|69160876|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
37685343|NCT02484547|69160877|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
37685344|NCT02484547|69160878|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
37685345|NCT02484547|69160879|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
37685346|NCT02484547|69160880|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
37685347|NCT02484547|69160881|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
37685348|NCT02484547|69160882|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
37685349|NCT02484547|69160876|FG000|Long-Term Extension Period|Reason not Specified|0|||
37685350|NCT02484547|69160877|FG001|Long-Term Extension Period|Reason not Specified|0|||
37685351|NCT02484547|69160878|FG002|Long-Term Extension Period|Reason not Specified|0|||
37685352|NCT02484547|69160879|FG003|Long-Term Extension Period|Reason not Specified|119|||
37685353|NCT02484547|69160880|FG004|Long-Term Extension Period|Reason not Specified|117|||
37685354|NCT02484547|69160881|FG005|Long-Term Extension Period|Reason not Specified|223|||
37685355|NCT02484547|69160882|FG006|Long-Term Extension Period|Reason not Specified|231|||
37685356|NCT02517541|69160894|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
37685357|NCT02517541|69160894|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
37685358|NCT02517541|69160894|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
37685359|NCT02517541|69160894|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
37685360|NCT02517541|69160894|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
37685361|NCT02517541|69160894|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
37685362|NCT02496091|69160900|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
37685363|NCT02483611|69160908|FG000|Overall Study|Protocol Violation|0|||
37685364|NCT02483611|69160909|FG001|Overall Study|Protocol Violation|0|||
37685365|NCT02483611|69160910|FG002|Overall Study|Protocol Violation|1|||
37685366|NCT02483533|69160920|FG000|Overall Study|Lack of Efficacy|50|||
37685367|NCT02483533|69160921|FG001|Overall Study|Lack of Efficacy|50|||
37685368|NCT02482129|69160929|FG000|Overall Study|Adverse Event-prior to treatment|0|||
37685369|NCT02482129|69160930|FG001|Overall Study|Adverse Event-prior to treatment|1|||
37685370|NCT02482129|69160929|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
37685371|NCT02482129|69160930|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
37685372|NCT02482129|69160929|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
37685373|NCT02482129|69160930|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
37685374|NCT02482129|69160929|FG000|Overall Study|Criteria not met-prior to treatment|1|||
37685375|NCT02482129|69160930|FG001|Overall Study|Criteria not met-prior to treatment|0|||
37685376|NCT02482129|69160929|FG000|Overall Study|Adverse Event|1|||
37685377|NCT02482129|69160930|FG001|Overall Study|Adverse Event|0|||
38084417|NCT01358331|69783677|FG003|Overall Study|Withdrawal by Subject|1|||
38084418|NCT01358331|69783678|FG004|Overall Study|Withdrawal by Subject|1|||
38084419|NCT01358331|69783679|FG005|Overall Study|Withdrawal by Subject|1|||
38084420|NCT01358331|69783674|FG000|Overall Study|Adverse Events|1|||
38084421|NCT01358331|69783675|FG001|Overall Study|Adverse Events|1|||
38084422|NCT01358331|69783676|FG002|Overall Study|Adverse Events|1|||
37685378|NCT02482129|69160929|FG000|Overall Study|Withdrawal by Subject|2|||
37685379|NCT02482129|69160930|FG001|Overall Study|Withdrawal by Subject|0|||
37685380|NCT02482129|69160929|FG000|Overall Study|Criteria not met|1|||
37685381|NCT02482129|69160930|FG001|Overall Study|Criteria not met|0|||
37685382|NCT02495857|69160941|FG000|Overall Study|Adverse Event|5|||
37685383|NCT02495857|69160942|FG001|Overall Study|Adverse Event|0|||
37685384|NCT02495857|69160943|FG002|Overall Study|Adverse Event|1|||
37685385|NCT02495857|69160941|FG000|Overall Study|Withdrawal by Subject|9|||
37685386|NCT02495857|69160942|FG001|Overall Study|Withdrawal by Subject|6|||
37685387|NCT02495857|69160943|FG002|Overall Study|Withdrawal by Subject|10|||
37685388|NCT02495857|69160941|FG000|Overall Study|Physician Decision|0|||
37685389|NCT02495857|69160942|FG001|Overall Study|Physician Decision|1|||
37685390|NCT02495857|69160943|FG002|Overall Study|Physician Decision|0|||
37685391|NCT02495857|69160941|FG000|Overall Study|Protocol Violation|1|||
38084423|NCT01358331|69783677|FG003|Overall Study|Adverse Events|0|||
38084424|NCT01358331|69783678|FG004|Overall Study|Adverse Events|1|||
38084425|NCT01358331|69783679|FG005|Overall Study|Adverse Events|5|||
38084426|NCT01358331|69783674|FG000|Overall Study|Symptomatic Deterioration|0|||
37685392|NCT02495857|69160942|FG001|Overall Study|Protocol Violation|1|||
37685393|NCT02495857|69160943|FG002|Overall Study|Protocol Violation|2|||
37685394|NCT02495857|69160941|FG000|Overall Study|Lost to Follow-up|4|||
37685395|NCT02495857|69160942|FG001|Overall Study|Lost to Follow-up|5|||
37685396|NCT02495857|69160943|FG002|Overall Study|Lost to Follow-up|3|||
37685397|NCT02495857|69160941|FG000|Overall Study|Other|3|||
37685398|NCT02495857|69160942|FG001|Overall Study|Other|3|||
37685399|NCT02495857|69160943|FG002|Overall Study|Other|2|||
38084427|NCT01358331|69783675|FG001|Overall Study|Symptomatic Deterioration|0|||
37685400|NCT02495389|69160951|FG000|Overall Study|Withdrawal by Subject|40|||
37685401|NCT02495233|69160957|FG000|Overall Study|Miscellaneous|0|||
37685402|NCT02495233|69160958|FG001|Overall Study|Miscellaneous|1|||
37685403|NCT02495077|69160966|FG000|Overall Study|Adverse Event|0|||
37685404|NCT02495077|69160967|FG001|Overall Study|Adverse Event|1|||
37685405|NCT02495077|69160968|FG002|Overall Study|Adverse Event|1|||
37685406|NCT02495077|69160969|FG003|Overall Study|Adverse Event|0|||
37685407|NCT02495077|69160966|FG000|Overall Study|Death|3|||
37685408|NCT02495077|69160967|FG001|Overall Study|Death|5|||
38084428|NCT01358331|69783676|FG002|Overall Study|Symptomatic Deterioration|0|||
38084429|NCT01358331|69783677|FG003|Overall Study|Symptomatic Deterioration|0|||
38084430|NCT01358331|69783678|FG004|Overall Study|Symptomatic Deterioration|1|||
38084431|NCT01358331|69783679|FG005|Overall Study|Symptomatic Deterioration|0|||
38084432|NCT01358331|69783674|FG000|Overall Study|Participants did not wish to continue|0|||
38084433|NCT01358331|69783675|FG001|Overall Study|Participants did not wish to continue|0|||
38084434|NCT01358331|69783676|FG002|Overall Study|Participants did not wish to continue|0|||
38084435|NCT01358331|69783677|FG003|Overall Study|Participants did not wish to continue|0|||
38084436|NCT01358331|69783678|FG004|Overall Study|Participants did not wish to continue|1|||
38084437|NCT01358331|69783679|FG005|Overall Study|Participants did not wish to continue|0|||
38084438|NCT01358331|69783674|FG000|Overall Study|Progress of disease under investigation|1|||
38084439|NCT01358331|69783675|FG001|Overall Study|Progress of disease under investigation|2|||
38084440|NCT01358331|69783676|FG002|Overall Study|Progress of disease under investigation|3|||
38084441|NCT01358331|69783677|FG003|Overall Study|Progress of disease under investigation|1|||
38084442|NCT01358331|69783678|FG004|Overall Study|Progress of disease under investigation|3|||
38084443|NCT01358331|69783679|FG005|Overall Study|Progress of disease under investigation|0|||
38084444|NCT02828241|69783695|FG000|Overall Study|Adverse Event|7|||
38084445|NCT02828241|69783696|FG001|Overall Study|Adverse Event|2|||
38084446|NCT02828241|69783695|FG000|Overall Study|Protocol Violation|1|||
38084447|NCT02828241|69783696|FG001|Overall Study|Protocol Violation|0|||
38084448|NCT01355523|69783705|FG000|Overall Study|Withdrawal by Subject|1|||
38084449|NCT01355523|69783706|FG001|Overall Study|Withdrawal by Subject|4|||
38084450|NCT01355523|69783705|FG000|Overall Study|Lost to Follow-up|0|||
38084451|NCT01355523|69783706|FG001|Overall Study|Lost to Follow-up|2|||
38084452|NCT01355523|69783705|FG000|Overall Study|Protocol Violation|0|||
38084453|NCT01355523|69783706|FG001|Overall Study|Protocol Violation|2|||
38084454|NCT01355523|69783705|FG000|Overall Study|Adverse Event|0|||
38084455|NCT01355523|69783706|FG001|Overall Study|Adverse Event|2|||
38084456|NCT02625220|69783712|FG000|Overall Study|Adverse Event|2|||
38084457|NCT02625220|69783712|FG000|Overall Study|Lost to Follow-up|2|||
38084458|NCT02625220|69783712|FG000|Overall Study|Protocol Violation|1|||
38084459|NCT02625220|69783712|FG000|Overall Study|Study discontinued at site|2|||
38084460|NCT02826603|69783718|FG000|Overall Study|Adverse Event|17|||
38084461|NCT02826603|69783719|FG001|Overall Study|Adverse Event|9|||
38084462|NCT02826603|69783718|FG000|Overall Study|Lack of Efficacy|4|||
38084463|NCT02826603|69783719|FG001|Overall Study|Lack of Efficacy|9|||
38084464|NCT02826603|69783718|FG000|Overall Study|Lost to Follow-up|13|||
38084465|NCT02826603|69783719|FG001|Overall Study|Lost to Follow-up|12|||
38084466|NCT02826603|69783718|FG000|Overall Study|Noncompliance with treatment|0|||
38084467|NCT02826603|69783719|FG001|Overall Study|Noncompliance with treatment|2|||
38084468|NCT02826603|69783718|FG000|Overall Study|Physician Decision|1|||
38084469|NCT02826603|69783719|FG001|Overall Study|Physician Decision|7|||
38084470|NCT02826603|69783718|FG000|Overall Study|Pregnancy|1|||
38084471|NCT02826603|69783719|FG001|Overall Study|Pregnancy|2|||
38084472|NCT02826603|69783718|FG000|Overall Study|Protocol Violation|3|||
38084473|NCT02826603|69783719|FG001|Overall Study|Protocol Violation|3|||
38084474|NCT02826603|69783718|FG000|Overall Study|Withdrawal by Subject|20|||
38084475|NCT02826603|69783719|FG001|Overall Study|Withdrawal by Subject|19|||
38084476|NCT02826603|69783718|FG000|Overall Study|Death|2|||
38084477|NCT02826603|69783719|FG001|Overall Study|Death|0|||
38084478|NCT02826603|69783718|FG000|Overall Study|New therapy for study indication|0|||
38084479|NCT02826603|69783719|FG001|Overall Study|New therapy for study indication|1|||
38084480|NCT05270460|69783735|FG000|Overall Study|Adverse Event|0|||
38084481|NCT05270460|69783736|FG001|Overall Study|Adverse Event|1|||
37685409|NCT02495077|69160968|FG002|Overall Study|Death|0|||
37685410|NCT02495077|69160969|FG003|Overall Study|Death|0|||
37685411|NCT02495077|69160966|FG000|Overall Study|Lost to Follow-up|6|||
37685412|NCT02495077|69160967|FG001|Overall Study|Lost to Follow-up|4|||
37685413|NCT02495077|69160968|FG002|Overall Study|Lost to Follow-up|0|||
37685414|NCT02495077|69160969|FG003|Overall Study|Lost to Follow-up|0|||
37685415|NCT02495077|69160966|FG000|Overall Study|Physician Decision|2|||
37685416|NCT02495077|69160967|FG001|Overall Study|Physician Decision|1|||
37685417|NCT02495077|69160968|FG002|Overall Study|Physician Decision|4|||
37685418|NCT02495077|69160969|FG003|Overall Study|Physician Decision|0|||
37685419|NCT02495077|69160966|FG000|Overall Study|Protocol Violation|0|||
37685420|NCT02495077|69160967|FG001|Overall Study|Protocol Violation|1|||
37685421|NCT02495077|69160968|FG002|Overall Study|Protocol Violation|0|||
37685422|NCT02495077|69160969|FG003|Overall Study|Protocol Violation|0|||
37685423|NCT02495077|69160966|FG000|Overall Study|Screen Failure|0|||
37685424|NCT02495077|69160967|FG001|Overall Study|Screen Failure|0|||
37685425|NCT02495077|69160968|FG002|Overall Study|Screen Failure|0|||
37685426|NCT02495077|69160969|FG003|Overall Study|Screen Failure|48|||
37685427|NCT02495077|69160966|FG000|Overall Study|Withdrawal by Subject|7|||
37685428|NCT02495077|69160967|FG001|Overall Study|Withdrawal by Subject|7|||
37685429|NCT02495077|69160968|FG002|Overall Study|Withdrawal by Subject|7|||
37685430|NCT02495077|69160969|FG003|Overall Study|Withdrawal by Subject|0|||
37685431|NCT02495077|69160966|FG000|Overall Study|Covid-19 research restrictions|1|||
37685432|NCT02495077|69160967|FG001|Overall Study|Covid-19 research restrictions|0|||
37685433|NCT02495077|69160968|FG002|Overall Study|Covid-19 research restrictions|0|||
37685434|NCT02495077|69160969|FG003|Overall Study|Covid-19 research restrictions|0|||
37685435|NCT02495077|69160966|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
37685436|NCT02495077|69160967|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
37685437|NCT02495077|69160968|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
37685438|NCT02495077|69160969|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
37685439|NCT02495077|69160966|FG000|Overall Study|Incarcerated|0|||
37685440|NCT02495077|69160967|FG001|Overall Study|Incarcerated|1|||
37685441|NCT02495077|69160968|FG002|Overall Study|Incarcerated|0|||
37685442|NCT02495077|69160969|FG003|Overall Study|Incarcerated|0|||
37685443|NCT02495077|69160966|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
37685444|NCT02495077|69160967|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
37685445|NCT02495077|69160968|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
37685446|NCT02495077|69160969|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
37685447|NCT02495077|69160966|FG000|Overall Study|Timing of transplant and randomization|0|||
37685448|NCT02495077|69160967|FG001|Overall Study|Timing of transplant and randomization|0|||
37685449|NCT02495077|69160968|FG002|Overall Study|Timing of transplant and randomization|5|||
37685450|NCT02495077|69160969|FG003|Overall Study|Timing of transplant and randomization|0|||
37685451|NCT02278341|69160977|FG000|Overall Study|Randomized but never received study drug|1|||
37685452|NCT02278341|69160978|FG001|Overall Study|Randomized but never received study drug|1|||
37685453|NCT02278341|69160977|FG000|Overall Study|Adverse Event|3|||
37685454|NCT02278341|69160978|FG001|Overall Study|Adverse Event|0|||
37685455|NCT02278341|69160977|FG000|Overall Study|Death|68|||
37685456|NCT02278341|69160978|FG001|Overall Study|Death|56|||
37685457|NCT02278341|69160977|FG000|Overall Study|Withdrawal by Subject|30|||
37685458|NCT02278341|69160978|FG001|Overall Study|Withdrawal by Subject|19|||
37685459|NCT02278341|69160977|FG000|Overall Study|Lost to Follow-up|0|||
37685460|NCT02278341|69160978|FG001|Overall Study|Lost to Follow-up|1|||
37685461|NCT02278341|69160977|FG000|Overall Study|Physician Decision|1|||
37685462|NCT02278341|69160978|FG001|Overall Study|Physician Decision|1|||
37685463|NCT02278341|69160977|FG000|Overall Study|Miscellaneous|15|||
37685464|NCT02278341|69160978|FG001|Overall Study|Miscellaneous|14|||
37685465|NCT02282631|69160987|FG000|Overall Study|Lost to Follow-up|2|||
37685466|NCT02282631|69160988|FG001|Overall Study|Lost to Follow-up|0|||
37685467|NCT02278263|69161003|FG000|Overall Study|Protocol Violation|7|||
37685468|NCT02278263|69161004|FG001|Overall Study|Protocol Violation|0|||
37685469|NCT02278263|69161005|FG002|Overall Study|Protocol Violation|9|||
37685470|NCT02349789|69161016|FG000|Overall Study|Withdrawal by Subject|2|||
37685471|NCT02349711|69161022|FG000|Overall Study|Withdrawal by Subject|2|||
37685472|NCT02349711|69161023|FG001|Overall Study|Withdrawal by Subject|1|||
37685473|NCT02349711|69161022|FG000|Overall Study|Lost to Follow-up|1|||
37685474|NCT02349711|69161023|FG001|Overall Study|Lost to Follow-up|1|||
37685475|NCT02494921|69161034|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
37685476|NCT02494921|69161035|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
37685477|NCT02494921|69161036|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
37685478|NCT02494921|69161037|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
37685479|NCT02494921|69161038|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
37685480|NCT02494921|69161034|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
37685481|NCT02494921|69161035|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
37685482|NCT02494921|69161036|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
37685483|NCT02494921|69161037|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
37685484|NCT02494921|69161038|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
37685485|NCT02494921|69161034|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
37685486|NCT02494921|69161035|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
37685487|NCT02494921|69161036|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
37967168|NCT00370552|69654034|FG001|Overall Study|Physician Decision|1|||
37967169|NCT00370552|69654035|FG002|Overall Study|Physician Decision|0|||
37967170|NCT00370552|69654033|FG000|Overall Study|Investigator decision|2|||
37967171|NCT00370552|69654034|FG001|Overall Study|Investigator decision|1|||
37967172|NCT00370552|69654035|FG002|Overall Study|Investigator decision|0|||
37967173|NCT00370552|69654033|FG000|Overall Study|High risk of allergic reaction|0|||
37967174|NCT00370552|69654034|FG001|Overall Study|High risk of allergic reaction|1|||
37967175|NCT00370552|69654035|FG002|Overall Study|High risk of allergic reaction|0|||
37967176|NCT00370552|69654033|FG000|Overall Study|Planned radiation for palliation|0|||
37967177|NCT00370552|69654034|FG001|Overall Study|Planned radiation for palliation|1|||
37967178|NCT00370552|69654035|FG002|Overall Study|Planned radiation for palliation|0|||
37967179|NCT00537030|69654043|FG000|Overall Study|Physician Decision|2|||
37967180|NCT00537030|69654043|FG000|Overall Study|Withdrawal by Subject|2|||
37967181|NCT00537030|69654043|FG000|Overall Study|≥ Grade 2 allergy|7|||
37967182|NCT00537030|69654043|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
37967183|NCT00537030|69654043|FG000|Overall Study|Ineligible|2|||
37967184|NCT00537030|69654043|FG000|Overall Study|Inevaluable|2|||
37967185|NCT00381238|69654047|FG000|Overall Study|Adverse Event|3|||
37967186|NCT00381238|69654047|FG000|Overall Study|Protocol Violation|1|||
37967187|NCT00381238|69654047|FG000|Overall Study|Withdrawal by Subject|4|||
37967188|NCT00381238|69654047|FG000|Overall Study|Lack of Efficacy|2|||
37967189|NCT00381238|69654047|FG000|Overall Study|Withdrew by physician|1|||
37967190|NCT00381238|69654047|FG000|Overall Study|Disease progression|1|||
37967191|NCT03896022|69654054|FG000|Overall Study|Withdrawal by Subject|1|||
38084482|NCT05270460|69783737|FG002|Overall Study|Adverse Event|0|||
38084483|NCT05270460|69783735|FG000|Overall Study|Early Termination|0|||
38084484|NCT05270460|69783736|FG001|Overall Study|Early Termination|1|||
38084485|NCT05270460|69783737|FG002|Overall Study|Early Termination|0|||
38084486|NCT04622592|69783753|FG000|Overall Study|Death|0|||
38084487|NCT04622592|69783754|FG001|Overall Study|Death|0|||
38084488|NCT04622592|69783755|FG002|Overall Study|Death|1|||
37685488|NCT02494921|69161037|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
37685489|NCT02494921|69161038|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
37685490|NCT01653847|69161058|FG000|Overall Study|Withdrawal by Subject|1|||
37685491|NCT01653847|69161059|FG001|Overall Study|Withdrawal by Subject|0|||
37685492|NCT02493751|69161067|FG000|Overall Study|Withdrawal by Subject|2|||
37685493|NCT02493751|69161068|FG001|Overall Study|Withdrawal by Subject|8|||
37685494|NCT02493751|69161067|FG000|Overall Study|Death|6|||
37685495|NCT02493751|69161068|FG001|Overall Study|Death|13|||
37685496|NCT02493751|69161067|FG000|Overall Study|Lost to Follow-up|2|||
37685497|NCT02493751|69161068|FG001|Overall Study|Lost to Follow-up|3|||
37685498|NCT02493751|69161067|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
37685499|NCT02493751|69161068|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
37685500|NCT02493517|69161077|FG000|Overall Study|Protocol Violation|1|||
37685501|NCT02493517|69161078|FG001|Overall Study|Protocol Violation|2|||
37685502|NCT02493517|69161077|FG000|Overall Study|Withdrawal by Subject|1|||
37685503|NCT02493517|69161078|FG001|Overall Study|Withdrawal by Subject|2|||
37685504|NCT02493517|69161077|FG000|Overall Study|Adverse Event|0|||
37685505|NCT02493517|69161078|FG001|Overall Study|Adverse Event|2|||
37685506|NCT02493517|69161077|FG000|Overall Study|Missed study visit|0|||
37967192|NCT03896022|69654055|FG001|Overall Study|Withdrawal by Subject|0|||
37967193|NCT03896022|69654056|FG002|Overall Study|Withdrawal by Subject|0|||
38084489|NCT04622592|69783756|FG003|Overall Study|Death|0|||
38084490|NCT04622592|69783757|FG004|Overall Study|Death|0|||
37685507|NCT02493517|69161078|FG001|Overall Study|Missed study visit|1|||
37685508|NCT02493361|69161086|FG000|Overall Study|Withdrawal by Subject|3|||
37685509|NCT02493127|69161092|FG000|Overall Study|Lost to Follow-up|1|||
37685510|NCT02493127|69161093|FG001|Overall Study|Lost to Follow-up|1|||
37967194|NCT03896022|69654054|FG000|Overall Study|Did not have procedure|3|||
37967195|NCT03896022|69654055|FG001|Overall Study|Did not have procedure|0|||
37967196|NCT03896022|69654056|FG002|Overall Study|Did not have procedure|0|||
37967197|NCT03831880|69654068|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
37967198|NCT03831880|69654069|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
37967199|NCT03831880|69654068|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
37967200|NCT03831880|69654069|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
38084491|NCT04622592|69783758|FG005|Overall Study|Death|0|||
38084492|NCT04622592|69783759|FG006|Overall Study|Death|0|||
38084493|NCT04622592|69783760|FG007|Overall Study|Death|1|||
38084494|NCT04622592|69783753|FG000|Overall Study|Lost to Follow-up|0|||
38084495|NCT04622592|69783754|FG001|Overall Study|Lost to Follow-up|0|||
38084496|NCT04622592|69783755|FG002|Overall Study|Lost to Follow-up|0|||
38084497|NCT04622592|69783756|FG003|Overall Study|Lost to Follow-up|3|||
38084498|NCT04622592|69783757|FG004|Overall Study|Lost to Follow-up|1|||
38084499|NCT04622592|69783758|FG005|Overall Study|Lost to Follow-up|0|||
38084500|NCT04622592|69783759|FG006|Overall Study|Lost to Follow-up|2|||
38084501|NCT04622592|69783760|FG007|Overall Study|Lost to Follow-up|2|||
38084502|NCT04622592|69783753|FG000|Overall Study|Physician Decision|0|||
38084503|NCT04622592|69783754|FG001|Overall Study|Physician Decision|0|||
38084504|NCT04622592|69783755|FG002|Overall Study|Physician Decision|0|||
38084505|NCT04622592|69783756|FG003|Overall Study|Physician Decision|0|||
38084506|NCT04622592|69783757|FG004|Overall Study|Physician Decision|1|||
38084507|NCT04622592|69783758|FG005|Overall Study|Physician Decision|0|||
38084508|NCT04622592|69783759|FG006|Overall Study|Physician Decision|0|||
38084509|NCT04622592|69783760|FG007|Overall Study|Physician Decision|0|||
38084510|NCT04622592|69783753|FG000|Overall Study|Withdrawal by Subject|1|||
38084511|NCT04622592|69783754|FG001|Overall Study|Withdrawal by Subject|0|||
38084512|NCT04622592|69783755|FG002|Overall Study|Withdrawal by Subject|2|||
38084513|NCT04622592|69783756|FG003|Overall Study|Withdrawal by Subject|0|||
38084514|NCT04622592|69783757|FG004|Overall Study|Withdrawal by Subject|0|||
38084515|NCT04622592|69783758|FG005|Overall Study|Withdrawal by Subject|0|||
38084516|NCT04622592|69783759|FG006|Overall Study|Withdrawal by Subject|1|||
38084517|NCT04622592|69783760|FG007|Overall Study|Withdrawal by Subject|4|||
38084518|NCT04622592|69783753|FG000|Overall Study|Other than specified above|0|||
38084519|NCT04622592|69783754|FG001|Overall Study|Other than specified above|0|||
38084520|NCT04622592|69783755|FG002|Overall Study|Other than specified above|1|||
38084521|NCT04622592|69783756|FG003|Overall Study|Other than specified above|0|||
38084522|NCT04622592|69783757|FG004|Overall Study|Other than specified above|0|||
38084523|NCT04622592|69783758|FG005|Overall Study|Other than specified above|0|||
38084524|NCT04622592|69783759|FG006|Overall Study|Other than specified above|0|||
38084525|NCT04622592|69783760|FG007|Overall Study|Other than specified above|0|||
38084526|NCT04523220|69783781|FG000|Main Treatment Period|Physician Decision|1|||
38084527|NCT04523220|69783782|FG001|Main Treatment Period|Physician Decision|1|||
38084528|NCT04523220|69783783|FG002|Main Treatment Period|Physician Decision|0|||
38084529|NCT04523220|69783781|FG000|Main Treatment Period|Other|5|||
38084530|NCT04523220|69783782|FG001|Main Treatment Period|Other|2|||
37685511|NCT02478463|69161101|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
37685512|NCT02478463|69161101|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
37685513|NCT02478463|69161101|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
37685514|NCT02491411|69161107|FG000|Overall Study|Physician Decision|4|||
37685515|NCT02517463|69161113|FG000|Overall Study|Lost to Follow-up|5|||
37685516|NCT02517463|69161114|FG001|Overall Study|Lost to Follow-up|2|||
38084531|NCT04523220|69783783|FG002|Main Treatment Period|Other|4|||
38084532|NCT04523220|69783781|FG000|Main Treatment Period|Subject Decision|5|||
38084533|NCT04523220|69783782|FG001|Main Treatment Period|Subject Decision|7|||
38084534|NCT04523220|69783783|FG002|Main Treatment Period|Subject Decision|3|||
38084535|NCT04523220|69783781|FG000|Main Treatment Period|Death|5|||
38084536|NCT04523220|69783782|FG001|Main Treatment Period|Death|11|||
38084537|NCT04523220|69783783|FG002|Main Treatment Period|Death|4|||
38084538|NCT04523220|69783781|FG000|Main Treatment Period|Adverse Event|11|||
38084539|NCT04523220|69783782|FG001|Main Treatment Period|Adverse Event|9|||
38084540|NCT04523220|69783783|FG002|Main Treatment Period|Adverse Event|9|||
38084541|NCT04523220|69783781|FG000|Main Treatment Period|Withdrawal by Subject|3|||
38084542|NCT04523220|69783782|FG001|Main Treatment Period|Withdrawal by Subject|3|||
37685517|NCT02516605|69161125|FG000|Overall Study|Protocol Violation|0|||
38084543|NCT04523220|69783783|FG002|Main Treatment Period|Withdrawal by Subject|4|||
38084544|NCT04523220|69783781|FG000|Main Treatment Period|Study drug never adminstered|10|||
38084545|NCT04523220|69783782|FG001|Main Treatment Period|Study drug never adminstered|3|||
38084546|NCT04523220|69783783|FG002|Main Treatment Period|Study drug never adminstered|5|||
38084547|NCT04523220|69783781|FG000|Extension Treatment Period|Physician Decision|1|||
38084548|NCT04523220|69783782|FG001|Extension Treatment Period|Physician Decision|0|||
38084549|NCT04523220|69783783|FG002|Extension Treatment Period|Physician Decision|3|||
38084550|NCT04523220|69783781|FG000|Extension Treatment Period|Other|2|||
38084551|NCT04523220|69783782|FG001|Extension Treatment Period|Other|6|||
38084552|NCT04523220|69783783|FG002|Extension Treatment Period|Other|6|||
38084553|NCT04523220|69783781|FG000|Extension Treatment Period|Subject Decision|5|||
37685518|NCT02516605|69161126|FG001|Overall Study|Protocol Violation|0|||
37685519|NCT02516605|69161127|FG002|Overall Study|Protocol Violation|0|||
37685520|NCT02516605|69161128|FG003|Overall Study|Protocol Violation|0|||
38084554|NCT04523220|69783782|FG001|Extension Treatment Period|Subject Decision|2|||
38084555|NCT04523220|69783783|FG002|Extension Treatment Period|Subject Decision|4|||
38084556|NCT04523220|69783781|FG000|Extension Treatment Period|Death|6|||
38084557|NCT04523220|69783782|FG001|Extension Treatment Period|Death|4|||
38084558|NCT04523220|69783783|FG002|Extension Treatment Period|Death|7|||
38084559|NCT04523220|69783781|FG000|Extension Treatment Period|Adverse Event|6|||
38084560|NCT04523220|69783782|FG001|Extension Treatment Period|Adverse Event|7|||
38084561|NCT04523220|69783783|FG002|Extension Treatment Period|Adverse Event|9|||
38084562|NCT04523220|69783781|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
38084563|NCT04523220|69783782|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
38084564|NCT04523220|69783783|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
38084565|NCT04523220|69783781|FG000|Extension Treatment Period|Study drug never administered|0|||
38084566|NCT04523220|69783782|FG001|Extension Treatment Period|Study drug never administered|1|||
38084567|NCT04523220|69783783|FG002|Extension Treatment Period|Study drug never administered|0|||
38084568|NCT04222088|69783814|FG000|Overall Study|Lost to Follow-up|5|||
38084569|NCT04222088|69783815|FG001|Overall Study|Lost to Follow-up|1|||
38084570|NCT04222088|69783814|FG000|Overall Study|Withdrawal by Subject|4|||
38084571|NCT04222088|69783815|FG001|Overall Study|Withdrawal by Subject|0|||
38084572|NCT03981614|69783824|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
38084573|NCT03981614|69783825|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
38084574|NCT03981614|69783826|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
38084575|NCT03978520|69783842|FG000|Overall Study|Adverse Event|2|||
38084576|NCT03978520|69783843|FG001|Overall Study|Adverse Event|5|||
38084577|NCT03978520|69783844|FG002|Overall Study|Adverse Event|3|||
38084578|NCT03978520|69783845|FG003|Overall Study|Adverse Event|5|||
38084579|NCT03978520|69783846|FG004|Overall Study|Adverse Event|6|||
38084580|NCT03978520|69783842|FG000|Overall Study|Withdrawal by Subject|10|||
38084581|NCT03978520|69783843|FG001|Overall Study|Withdrawal by Subject|4|||
38084582|NCT03978520|69783844|FG002|Overall Study|Withdrawal by Subject|5|||
38084583|NCT03978520|69783845|FG003|Overall Study|Withdrawal by Subject|6|||
38084584|NCT03978520|69783846|FG004|Overall Study|Withdrawal by Subject|5|||
38084585|NCT03978520|69783842|FG000|Overall Study|Lost to Follow-up|2|||
38084586|NCT03978520|69783843|FG001|Overall Study|Lost to Follow-up|2|||
38084587|NCT03978520|69783844|FG002|Overall Study|Lost to Follow-up|2|||
38084588|NCT03978520|69783845|FG003|Overall Study|Lost to Follow-up|0|||
38084589|NCT03978520|69783846|FG004|Overall Study|Lost to Follow-up|1|||
38084590|NCT03978520|69783842|FG000|Overall Study|COVID-19 infection|0|||
38084591|NCT03978520|69783843|FG001|Overall Study|COVID-19 infection|1|||
38084592|NCT03978520|69783844|FG002|Overall Study|COVID-19 infection|0|||
38084593|NCT03978520|69783845|FG003|Overall Study|COVID-19 infection|0|||
38084594|NCT03978520|69783846|FG004|Overall Study|COVID-19 infection|0|||
38084595|NCT03978520|69783842|FG000|Overall Study|Other, not specified|9|||
38084596|NCT03978520|69783843|FG001|Overall Study|Other, not specified|4|||
38084597|NCT03978520|69783844|FG002|Overall Study|Other, not specified|1|||
38084598|NCT03978520|69783845|FG003|Overall Study|Other, not specified|1|||
38084599|NCT03978520|69783846|FG004|Overall Study|Other, not specified|2|||
38084600|NCT03978520|69783842|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
38084601|NCT03978520|69783843|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
38084602|NCT03978520|69783844|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
38084603|NCT03978520|69783845|FG003|Overall Study|Sponsor decision based on interim analysis data review|33|||
38084604|NCT03978520|69783846|FG004|Overall Study|Sponsor decision based on interim analysis data review|24|||
38084605|NCT03929393|69783858|FG000|Overall Study|Death|1|||
38084606|NCT03929393|69783859|FG001|Overall Study|Death|0|||
38084607|NCT03929393|69783858|FG000|Overall Study|Time Commitment|2|||
38084608|NCT03929393|69783859|FG001|Overall Study|Time Commitment|5|||
38084609|NCT03929393|69783858|FG000|Overall Study|Motor Vehicle Accident|0|||
38084610|NCT03929393|69783859|FG001|Overall Study|Motor Vehicle Accident|1|||
38084611|NCT03929393|69783858|FG000|Overall Study|Difficulty Using Videoconferencing Technology|0|||
38084612|NCT03929393|69783859|FG001|Overall Study|Difficulty Using Videoconferencing Technology|1|||
38084613|NCT03929393|69783858|FG000|Overall Study|Other|1|||
38084614|NCT03929393|69783859|FG001|Overall Study|Other|3|||
38084615|NCT03874715|69783867|FG000|Overall Study|Adverse Event|2|||
38084616|NCT03874715|69783868|FG001|Overall Study|Adverse Event|0|||
38084617|NCT03874715|69783867|FG000|Overall Study|Poor compliance to protocol|5|||
38084618|NCT03874715|69783868|FG001|Overall Study|Poor compliance to protocol|1|||
37685521|NCT02516605|69161129|FG004|Overall Study|Protocol Violation|1|||
38084619|NCT03874715|69783867|FG000|Overall Study|Withdrawal by Subject|1|||
38084620|NCT03874715|69783868|FG001|Overall Study|Withdrawal by Subject|0|||
38084621|NCT03874715|69783867|FG000|Overall Study|Other-unspecified|1|||
38084622|NCT03874715|69783868|FG001|Overall Study|Other-unspecified|0|||
38084623|NCT03502200|69783880|FG000|Overall Study|Adverse Event|1|||
38084624|NCT03502200|69783881|FG001|Overall Study|Adverse Event|0|||
38084625|NCT03502200|69783880|FG000|Overall Study|Lost to Follow-up|36|||
38084626|NCT03502200|69783881|FG001|Overall Study|Lost to Follow-up|38|||
38084627|NCT03502200|69783880|FG000|Overall Study|Study Team Decision|1|||
38084628|NCT03502200|69783881|FG001|Overall Study|Study Team Decision|1|||
37685522|NCT02516605|69161125|FG000|Overall Study|Withdrawal by Subject|0|||
38084629|NCT03502200|69783880|FG000|Overall Study|Withdrawal by Subject|5|||
37685523|NCT02516605|69161126|FG001|Overall Study|Withdrawal by Subject|0|||
38084630|NCT03502200|69783881|FG001|Overall Study|Withdrawal by Subject|7|||
38084631|NCT03502200|69783880|FG000|Overall Study|Death|0|||
38084632|NCT03502200|69783881|FG001|Overall Study|Death|2|||
38084633|NCT03361306|69783887|FG000|Overall Study|Death|5|||
38084634|NCT03361306|69783887|FG000|Overall Study|Still On Study (on study treatment)|3|||
38084635|NCT03361306|69783887|FG000|Overall Study|Still On Study (in follow up)|7|||
38084636|NCT03336242|69783893|FG000|Overall Study|Adverse Event|0|||
38084637|NCT03336242|69783894|FG001|Overall Study|Adverse Event|1|||
38084638|NCT03334435|69783905|FG000|Overall Study|Ongoing as of Week 52|70|||
38084639|NCT03334435|69783906|FG001|Overall Study|Ongoing as of Week 52|32|||
38084640|NCT03334435|69783907|FG002|Overall Study|Ongoing as of Week 52|379|||
38084641|NCT03334435|69783908|FG003|Overall Study|Ongoing as of Week 52|519|||
38084642|NCT03334435|69783909|FG004|Overall Study|Ongoing as of Week 52|146|||
38084643|NCT03334435|69783905|FG000|Overall Study|Lack of Efficacy|3|||
38084644|NCT03334435|69783906|FG001|Overall Study|Lack of Efficacy|5|||
38084645|NCT03334435|69783907|FG002|Overall Study|Lack of Efficacy|76|||
38084646|NCT03334435|69783908|FG003|Overall Study|Lack of Efficacy|140|||
38084647|NCT03334435|69783909|FG004|Overall Study|Lack of Efficacy|61|||
38084648|NCT03334435|69783905|FG000|Overall Study|Adverse Event|2|||
38084649|NCT03334435|69783906|FG001|Overall Study|Adverse Event|1|||
38084650|NCT03334435|69783907|FG002|Overall Study|Adverse Event|9|||
38084651|NCT03334435|69783908|FG003|Overall Study|Adverse Event|23|||
38084652|NCT03334435|69783909|FG004|Overall Study|Adverse Event|13|||
38084653|NCT03334435|69783905|FG000|Overall Study|Withdrawal by Subject|11|||
38084654|NCT03334435|69783906|FG001|Overall Study|Withdrawal by Subject|4|||
38084655|NCT03334435|69783907|FG002|Overall Study|Withdrawal by Subject|38|||
38084656|NCT03334435|69783908|FG003|Overall Study|Withdrawal by Subject|42|||
38084657|NCT03334435|69783909|FG004|Overall Study|Withdrawal by Subject|20|||
38084658|NCT03334435|69783905|FG000|Overall Study|Lost to Follow-up|3|||
38084659|NCT03334435|69783906|FG001|Overall Study|Lost to Follow-up|0|||
38084660|NCT03334435|69783907|FG002|Overall Study|Lost to Follow-up|2|||
38084661|NCT03334435|69783908|FG003|Overall Study|Lost to Follow-up|1|||
38084662|NCT03334435|69783909|FG004|Overall Study|Lost to Follow-up|1|||
38084663|NCT03334435|69783905|FG000|Overall Study|Death|0|||
38084664|NCT03334435|69783906|FG001|Overall Study|Death|0|||
38084665|NCT03334435|69783907|FG002|Overall Study|Death|0|||
38084666|NCT03334435|69783908|FG003|Overall Study|Death|1|||
38084667|NCT03334435|69783909|FG004|Overall Study|Death|0|||
38084668|NCT03334435|69783905|FG000|Overall Study|Other|0|||
38084669|NCT03334435|69783906|FG001|Overall Study|Other|1|||
38084670|NCT03334435|69783907|FG002|Overall Study|Other|3|||
38084671|NCT03334435|69783908|FG003|Overall Study|Other|2|||
38084672|NCT03334435|69783909|FG004|Overall Study|Other|1|||
38084673|NCT02919449|69783982|FG000|Overall Study|Withdrawal by Subject|1|||
38084674|NCT02919449|69783982|FG000|Overall Study|Investigator decision|1|||
38084675|NCT02769832|69783986|FG000|Overall Study|Death|30|||
38084676|NCT02530970|69783991|FG000|Overall Study|Adverse Event|8|||
38084677|NCT02530970|69783991|FG000|Overall Study|Lost to Follow-up|88|||
38084678|NCT02530970|69783991|FG000|Overall Study|Physician Decision|5|||
38084679|NCT02530970|69783991|FG000|Overall Study|Withdrawal by Subject|14|||
38084680|NCT02530970|69783991|FG000|Overall Study|Death|6|||
38084681|NCT02530970|69783991|FG000|Overall Study|Hospitalization|1|||
38084682|NCT02530970|69783991|FG000|Overall Study|Insurance|2|||
38084683|NCT02530970|69783991|FG000|Overall Study|Explant|2|||
38084684|NCT02530970|69783991|FG000|Overall Study|Change in Provider|5|||
38084685|NCT02530970|69783991|FG000|Overall Study|Relocation|3|||
38084686|NCT02418156|69783995|FG000|Overall Study|Lost to Follow-up|12|||
38084687|NCT02418156|69783995|FG000|Overall Study|Death|2|||
38084688|NCT02418156|69783995|FG000|Overall Study|Physician Decision|1|||
38084689|NCT02418156|69783995|FG000|Overall Study|Withdrawal by Subject|1|||
37685524|NCT02516605|69161127|FG002|Overall Study|Withdrawal by Subject|0|||
37685525|NCT02516605|69161128|FG003|Overall Study|Withdrawal by Subject|1|||
37685526|NCT02516605|69161129|FG004|Overall Study|Withdrawal by Subject|0|||
37967201|NCT00380692|69654092|FG000|Study Period II - Double Blind|Adverse Event|1|||
37685527|NCT02490475|69161149|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
38084690|NCT02418156|69783995|FG000|Overall Study|Subject refused to return|1|||
38084691|NCT01850524|69784035|FG000|Overall Study|Lost to Follow-up|5|||
37685528|NCT02490475|69161150|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
38084692|NCT01850524|69784036|FG001|Overall Study|Lost to Follow-up|10|||
38084693|NCT01850524|69784035|FG000|Overall Study|Withdrawal by Subject|24|||
37685529|NCT02490475|69161151|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
38084694|NCT01850524|69784036|FG001|Overall Study|Withdrawal by Subject|22|||
38084695|NCT01850524|69784035|FG000|Overall Study|Reason not Specified|142|||
38084696|NCT01850524|69784036|FG001|Overall Study|Reason not Specified|141|||
37685530|NCT02490475|69161152|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
37685531|NCT02490475|69161149|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
38084697|NCT01609842|69784053|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
38084698|NCT01609842|69784054|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
37685532|NCT02490475|69161150|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
37685533|NCT02490475|69161151|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
37685534|NCT02490475|69161152|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
37685535|NCT02490475|69161149|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
37685536|NCT02490475|69161150|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
37685537|NCT02490475|69161151|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
37685538|NCT02490475|69161152|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
37685539|NCT02490475|69161149|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
37685540|NCT02490475|69161150|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
37685541|NCT02490475|69161151|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
37685542|NCT02490475|69161152|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
37685543|NCT02490475|69161149|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
37685544|NCT02490475|69161150|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
37685545|NCT02490475|69161151|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
37685546|NCT02490475|69161152|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
37685547|NCT02490475|69161149|FG000|Period 2: Extension Phase|Refused Treatment|0|||
37685548|NCT02490475|69161150|FG001|Period 2: Extension Phase|Refused Treatment|0|||
37685549|NCT02490475|69161151|FG002|Period 2: Extension Phase|Refused Treatment|0|||
37685550|NCT02490475|69161152|FG003|Period 2: Extension Phase|Refused Treatment|1|||
37685551|NCT02490475|69161149|FG000|Period 2: Extension Phase|Adverse Event|0|||
37685552|NCT02490475|69161150|FG001|Period 2: Extension Phase|Adverse Event|0|||
37685553|NCT02490475|69161151|FG002|Period 2: Extension Phase|Adverse Event|1|||
37685554|NCT02490475|69161152|FG003|Period 2: Extension Phase|Adverse Event|0|||
37685555|NCT02477839|69161175|FG000|Overall Study|Adverse Event|0|||
37685556|NCT02477839|69161176|FG001|Overall Study|Adverse Event|1|||
37685557|NCT02477839|69161175|FG000|Overall Study|Protocol Violation|0|||
37685558|NCT02477839|69161176|FG001|Overall Study|Protocol Violation|2|||
37685559|NCT02477839|69161175|FG000|Overall Study|Withdrawal by Subject|3|||
37685560|NCT02477839|69161176|FG001|Overall Study|Withdrawal by Subject|3|||
37685561|NCT02477839|69161175|FG000|Overall Study|Participant had PGS during V6|0|||
37685562|NCT02477839|69161176|FG001|Overall Study|Participant had PGS during V6|1|||
37685563|NCT02477839|69161175|FG000|Overall Study|Parents decided to stop medication|0|||
37685564|NCT02477839|69161176|FG001|Overall Study|Parents decided to stop medication|1|||
37685565|NCT02477839|69161175|FG000|Overall Study|Lack of tolerability|0|||
37685566|NCT02477839|69161176|FG001|Overall Study|Lack of tolerability|1|||
37685567|NCT02477839|69161175|FG000|Overall Study|Exclusion criterion|0|||
37685568|NCT02477839|69161176|FG001|Overall Study|Exclusion criterion|1|||
37685569|NCT02489773|69161186|FG000|Overall Study|Lost to Follow-up|4|||
37685570|NCT02489773|69161187|FG001|Overall Study|Lost to Follow-up|1|||
37685571|NCT02489773|69161186|FG000|Overall Study|Physician Decision|1|||
37685572|NCT02489773|69161187|FG001|Overall Study|Physician Decision|0|||
37685573|NCT02489773|69161186|FG000|Overall Study|Withdrawal by Subject|1|||
37685574|NCT02489773|69161187|FG001|Overall Study|Withdrawal by Subject|0|||
37685575|NCT02489773|69161186|FG000|Overall Study|Leave the country or the state|1|||
37685576|NCT02489773|69161187|FG001|Overall Study|Leave the country or the state|1|||
37685577|NCT02488915|69161193|FG000|Overall Study|Death|21|||
37685578|NCT02488915|69161193|FG000|Overall Study|Lost to Follow-up|4|||
37685579|NCT02488915|69161193|FG000|Overall Study|Withdrawal by Subject|1|||
37685580|NCT02488681|69161197|FG000|Overall Study|Implant unsuccessful|7|||
37685581|NCT02477605|69161203|FG000|Overall Study|Discontinued prior to treatment|1|||
37685582|NCT02477605|69161204|FG001|Overall Study|Discontinued prior to treatment|0|||
37685583|NCT02477605|69161203|FG000|Overall Study|Lost to Follow-up|0|||
37685584|NCT02477605|69161204|FG001|Overall Study|Lost to Follow-up|2|||
37685585|NCT02477605|69161203|FG000|Overall Study|Withdrawal by Subject|0|||
37685586|NCT02477605|69161204|FG001|Overall Study|Withdrawal by Subject|1|||
37685587|NCT02477605|69161203|FG000|Overall Study|Administered gas during surgery|0|||
37685588|NCT02477605|69161204|FG001|Overall Study|Administered gas during surgery|1|||
37685589|NCT02477527|69161214|FG000|Overall Study|Lost to Follow-up|2|||
37685590|NCT02477527|69161214|FG000|Overall Study|Withdrawal by Subject|1|||
37685591|NCT02477527|69161214|FG000|Overall Study|Screen Failure|3|||
37685592|NCT02477215|69161222|FG000|Dose Escalation Phase|Physician Decision|1|||
37685593|NCT02477215|69161223|FG001|Dose Escalation Phase|Physician Decision|2|||
37685594|NCT02477215|69161224|FG002|Dose Escalation Phase|Physician Decision|0|||
37685595|NCT02477215|69161222|FG000|Fixed Dose Phase|Physician Decision|0|||
37685596|NCT02477215|69161223|FG001|Fixed Dose Phase|Physician Decision|7|||
37685597|NCT02477215|69161224|FG002|Fixed Dose Phase|Physician Decision|0|||
37685598|NCT02487199|69161237|FG000|Overall Study|Withdrew Consent|0|||
37685599|NCT02487199|69161238|FG001|Overall Study|Withdrew Consent|1|||
37685600|NCT02475733|69161246|FG000|Overall Study|Withdrawal by Subject|1|||
37685601|NCT02475733|69161247|FG001|Overall Study|Withdrawal by Subject|0|||
37685602|NCT02475733|69161246|FG000|Overall Study|Physician Decision|1|||
37685603|NCT02475733|69161247|FG001|Overall Study|Physician Decision|0|||
37685604|NCT02486653|69161255|FG000|Overall Study|Withdrawal by Subject|1|||
38084699|NCT01569594|69784064|FG000|Overall Study|Physician Decision|4|||
38084700|NCT01569594|69784064|FG000|Overall Study|Death|13|||
38084701|NCT01569594|69784064|FG000|Overall Study|Lost to Follow-up|22|||
38084702|NCT01569594|69784064|FG000|Overall Study|Adverse Event|2|||
38084703|NCT01569594|69784064|FG000|Overall Study|Withdrawal by Subject|13|||
38084704|NCT01569594|69784064|FG000|Overall Study|Other|4|||
38084705|NCT01569594|69784064|FG000|Overall Study|No ECM used|9|||
38084706|NCT01207492|69784068|FG000|Overall Study|Still on study|1|||
38084707|NCT01207492|69784068|FG000|Overall Study|Withdrawal by Subject|9|||
38084708|NCT01207492|69784068|FG000|Overall Study|Physician Decision|1|||
38084709|NCT01207492|69784068|FG000|Overall Study|Progressive disease|3|||
38084710|NCT01207492|69784068|FG000|Overall Study|Toxicity|1|||
37967202|NCT00380692|69654093|FG001|Study Period II - Double Blind|Adverse Event|0|||
37967203|NCT00380692|69654092|FG000|Study Period II - Double Blind|Protocol Violation|2|||
37967204|NCT00380692|69654093|FG001|Study Period II - Double Blind|Protocol Violation|2|||
37967205|NCT00380692|69654092|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
37967206|NCT00380692|69654093|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
37967207|NCT00380692|69654092|FG000|Study Period II - Double Blind|Physician Decision|0|||
37967208|NCT00380692|69654093|FG001|Study Period II - Double Blind|Physician Decision|1|||
37967209|NCT00380692|69654092|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
37967210|NCT00380692|69654093|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
37967211|NCT00380692|69654092|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
37967212|NCT00380692|69654093|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
37967213|NCT00380692|69654092|FG000|Study Period III - Open Label|Adverse Event|5|||
37967214|NCT00380692|69654093|FG001|Study Period III - Open Label|Adverse Event|3|||
37967215|NCT00380692|69654092|FG000|Study Period III - Open Label|Protocol Violation|0|||
37967216|NCT00380692|69654093|FG001|Study Period III - Open Label|Protocol Violation|0|||
37967217|NCT00380692|69654092|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
37967218|NCT00380692|69654093|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
37967219|NCT00380692|69654092|FG000|Study Period III - Open Label|Physician Decision|0|||
37967220|NCT00380692|69654093|FG001|Study Period III - Open Label|Physician Decision|3|||
37967221|NCT00380692|69654092|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
37967222|NCT00380692|69654093|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
37967223|NCT00380692|69654092|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
37967224|NCT00380692|69654093|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
37967225|NCT00536874|69654099|FG000|Overall Study|Adverse Event|1|||
37967226|NCT00536874|69654099|FG000|Overall Study|Death|2|||
37967227|NCT00536874|69654099|FG000|Overall Study|Withdrawal by Subject|1|||
38084711|NCT00593840|69784072|FG000|Overall Study|Withdrawal by Subject|1|||
38084712|NCT01329900|69784105|FG000|Overall Study|Elevated creatinine/renal function|1|||
38084713|NCT02825043|69784109|FG000|Overall Study|Lost to Follow-up|4|||
38084714|NCT02750592|69784124|FG000|Overall Study|Adverse Event|3|||
38084715|NCT02750592|69784124|FG000|Overall Study|Lack of Efficacy|2|||
38084716|NCT02624986|69784136|FG000|Overall Study|Death|0|||
38084717|NCT02624986|69784137|FG001|Overall Study|Death|1|||
38084718|NCT02624986|69784138|FG002|Overall Study|Death|2|||
38084719|NCT02624986|69784139|FG003|Overall Study|Death|2|||
37967228|NCT00380068|69654103|FG000|Overall Study|Adverse Event|40|||
37967229|NCT00380068|69654103|FG000|Overall Study|Withdrawal by Subject|10|||
38084720|NCT02624986|69784140|FG004|Overall Study|Death|2|||
37685605|NCT02486653|69161256|FG001|Overall Study|Withdrawal by Subject|3|||
38084721|NCT02624986|69784141|FG005|Overall Study|Death|0|||
38084722|NCT02624986|69784142|FG006|Overall Study|Death|0|||
38084723|NCT02624986|69784143|FG007|Overall Study|Death|1|||
38084724|NCT02624986|69784136|FG000|Overall Study|Study Terminated by Sponsor|1|||
38084725|NCT02624986|69784137|FG001|Overall Study|Study Terminated by Sponsor|1|||
38084726|NCT02624986|69784138|FG002|Overall Study|Study Terminated by Sponsor|0|||
38084727|NCT02624986|69784139|FG003|Overall Study|Study Terminated by Sponsor|1|||
38084728|NCT02624986|69784140|FG004|Overall Study|Study Terminated by Sponsor|2|||
38084729|NCT02624986|69784141|FG005|Overall Study|Study Terminated by Sponsor|2|||
38084730|NCT02624986|69784142|FG006|Overall Study|Study Terminated by Sponsor|4|||
38084731|NCT02624986|69784143|FG007|Overall Study|Study Terminated by Sponsor|3|||
38084732|NCT02624986|69784136|FG000|Overall Study|Progressive Disease|0|||
38084733|NCT02624986|69784137|FG001|Overall Study|Progressive Disease|1|||
38084734|NCT02624986|69784138|FG002|Overall Study|Progressive Disease|0|||
38084735|NCT02624986|69784139|FG003|Overall Study|Progressive Disease|0|||
38084736|NCT02624986|69784140|FG004|Overall Study|Progressive Disease|0|||
38084737|NCT02624986|69784141|FG005|Overall Study|Progressive Disease|0|||
38084738|NCT02624986|69784142|FG006|Overall Study|Progressive Disease|0|||
38084739|NCT02624986|69784143|FG007|Overall Study|Progressive Disease|0|||
38084740|NCT02624986|69784136|FG000|Overall Study|Protocol Violation|1|||
38084741|NCT02624986|69784137|FG001|Overall Study|Protocol Violation|0|||
37685606|NCT02486653|69161255|FG000|Overall Study|Protocol Violation|1|||
37685607|NCT02486653|69161256|FG001|Overall Study|Protocol Violation|0|||
37685608|NCT02486653|69161255|FG000|Overall Study|surgery cancelled|4|||
38084742|NCT02624986|69784138|FG002|Overall Study|Protocol Violation|0|||
38084743|NCT02624986|69784139|FG003|Overall Study|Protocol Violation|0|||
38084744|NCT02624986|69784140|FG004|Overall Study|Protocol Violation|0|||
38084745|NCT02624986|69784141|FG005|Overall Study|Protocol Violation|0|||
38084746|NCT02624986|69784142|FG006|Overall Study|Protocol Violation|0|||
38084747|NCT02624986|69784143|FG007|Overall Study|Protocol Violation|0|||
38084748|NCT02624986|69784136|FG000|Overall Study|Withdrawal by Subject|0|||
38084749|NCT02624986|69784137|FG001|Overall Study|Withdrawal by Subject|0|||
38084750|NCT02624986|69784138|FG002|Overall Study|Withdrawal by Subject|0|||
38084751|NCT02624986|69784139|FG003|Overall Study|Withdrawal by Subject|0|||
38084752|NCT02624986|69784140|FG004|Overall Study|Withdrawal by Subject|0|||
38084753|NCT02624986|69784141|FG005|Overall Study|Withdrawal by Subject|0|||
38084754|NCT02624986|69784142|FG006|Overall Study|Withdrawal by Subject|0|||
38084755|NCT02624986|69784143|FG007|Overall Study|Withdrawal by Subject|1|||
37685609|NCT02486653|69161256|FG001|Overall Study|surgery cancelled|1|||
37685610|NCT02475655|69161264|FG000|Overall Study|Lost to Follow-up|0|||
37685611|NCT02475655|69161265|FG001|Overall Study|Lost to Follow-up|1|||
37685612|NCT02475265|69161271|FG000|Overall Study|Physician Decision|1|||
37685613|NCT02475265|69161271|FG000|Overall Study|Withdrawal by Subject|2|||
37685614|NCT02485717|69161278|FG000|Overall Study|Lost to Follow-up|6|||
37685615|NCT02485717|69161279|FG001|Overall Study|Lost to Follow-up|0|||
37685616|NCT02485717|69161280|FG002|Overall Study|Lost to Follow-up|0|||
37685617|NCT02485717|69161278|FG000|Overall Study|Withdrawal by Subject|0|||
37685618|NCT02485717|69161279|FG001|Overall Study|Withdrawal by Subject|0|||
37685619|NCT02485717|69161280|FG002|Overall Study|Withdrawal by Subject|1|||
37685620|NCT02485717|69161278|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
37685621|NCT02485717|69161279|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
37685622|NCT02485717|69161280|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
37685623|NCT02485717|69161278|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
37685624|NCT02485717|69161279|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
37685625|NCT02485717|69161280|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
37685626|NCT02451007|69161288|FG000|Overall Study|Withdrawal by Subject|4|||
37685627|NCT02451007|69161288|FG000|Overall Study|Adverse Event|1|||
37685628|NCT02451007|69161288|FG000|Overall Study|Disease Progression|2|||
37685629|NCT02485483|69161294|FG000|Overall Study|Depression at baseline|15|||
37685630|NCT02485483|69161295|FG001|Overall Study|Depression at baseline|0|||
37685631|NCT02485483|69161294|FG000|Overall Study|Discontinued after baseline|39|||
37685632|NCT02485483|69161295|FG001|Overall Study|Discontinued after baseline|0|||
37685633|NCT02473471|69161301|FG000|Overall Study|poor oral hygiene|2|||
37685634|NCT02473471|69161301|FG000|Overall Study|Lost to Follow-up|1|||
37967230|NCT00380068|69654103|FG000|Overall Study|Not compliant|6|||
37967231|NCT00380068|69654103|FG000|Overall Study|Lost to Follow-up|1|||
37967232|NCT00380068|69654103|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
37967233|NCT00380068|69654103|FG000|Overall Study|Lung transplant|3|||
37967234|NCT00380068|69654103|FG000|Overall Study|Physician Decision|2|||
37967235|NCT00380068|69654103|FG000|Overall Study|Partipant moved away|1|||
37967236|NCT00380068|69654103|FG000|Overall Study|Lack of Efficacy|5|||
37967237|NCT00536484|69654109|FG000|Overall Study|Adverse Event|21|||
37967238|NCT00536484|69654110|FG001|Overall Study|Adverse Event|34|||
37685635|NCT02450539|69161313|FG000|Overall Study|Withdrawal by Subject|12|||
37685636|NCT02450539|69161314|FG001|Overall Study|Withdrawal by Subject|6|||
37685637|NCT02450539|69161313|FG000|Overall Study|Lost to Follow-up|4|||
37685638|NCT02450539|69161314|FG001|Overall Study|Lost to Follow-up|1|||
37967239|NCT00536484|69654109|FG000|Overall Study|Withdrawal by Subject|11|||
38084756|NCT02587598|69784176|FG000|Overall Study|Death|4|||
38084757|NCT02587598|69784177|FG001|Overall Study|Death|8|||
38084758|NCT02587598|69784178|FG002|Overall Study|Death|4|||
38084759|NCT02587598|69784179|FG003|Overall Study|Death|16|||
38084760|NCT02587598|69784180|FG004|Overall Study|Death|9|||
38084761|NCT02587598|69784181|FG005|Overall Study|Death|4|||
38084762|NCT02587598|69784182|FG006|Overall Study|Death|6|||
38084763|NCT02587598|69784183|FG007|Overall Study|Death|7|||
38084764|NCT02587598|69784184|FG008|Overall Study|Death|9|||
37685639|NCT02449915|69161325|FG000|Overall Study|Exclusion criteria - drug use|1|||
37685640|NCT02449915|69161326|FG001|Overall Study|Exclusion criteria - drug use|0|||
37685641|NCT02449915|69161325|FG000|Overall Study|Withdrawal by Subject|0|||
37685642|NCT02449915|69161326|FG001|Overall Study|Withdrawal by Subject|2|||
37685643|NCT02449915|69161325|FG000|Overall Study|Intraoperative surgical findings|1|||
37685644|NCT02449915|69161326|FG001|Overall Study|Intraoperative surgical findings|1|||
37685645|NCT02449915|69161325|FG000|Overall Study|Abnormal preop lab|0|||
37685646|NCT02449915|69161326|FG001|Overall Study|Abnormal preop lab|1|||
37685647|NCT02420119|69161332|FG000|Overall Study|insufficient laboratory data|5|||
37685648|NCT02473393|69161340|FG000|Overall Study|Adverse Event|0|||
37685649|NCT02473393|69161341|FG001|Overall Study|Adverse Event|0|||
37685650|NCT02473393|69161342|FG002|Overall Study|Adverse Event|1|||
37685651|NCT02473393|69161343|FG003|Overall Study|Adverse Event|0|||
37685652|NCT02473393|69161340|FG000|Overall Study|Withdrawal by Subject|0|||
37685653|NCT02473393|69161341|FG001|Overall Study|Withdrawal by Subject|0|||
37685654|NCT02473393|69161342|FG002|Overall Study|Withdrawal by Subject|1|||
37685655|NCT02473393|69161343|FG003|Overall Study|Withdrawal by Subject|1|||
37685656|NCT02419573|69161355|FG000|Overall Study|Lost to Follow-up|3|||
37685657|NCT02419573|69161356|FG001|Overall Study|Lost to Follow-up|0|||
37685658|NCT02419573|69161355|FG000|Overall Study|Withdrawal by Subject|1|||
37685659|NCT02419573|69161356|FG001|Overall Study|Withdrawal by Subject|0|||
37685660|NCT02472847|69161364|FG000|Overall Study|Withdrawal by Subject|1|||
37685661|NCT02472847|69161365|FG001|Overall Study|Withdrawal by Subject|5|||
37685662|NCT02472145|69161374|FG000|Overall Study|Death|10|||
37685663|NCT02472145|69161375|FG001|Overall Study|Death|101|||
37685664|NCT02472145|69161376|FG002|Overall Study|Death|99|||
37685665|NCT02472145|69161374|FG000|Overall Study|Lost to Follow-up|0|||
37685666|NCT02472145|69161375|FG001|Overall Study|Lost to Follow-up|1|||
37685667|NCT02472145|69161376|FG002|Overall Study|Lost to Follow-up|0|||
37685668|NCT02472145|69161374|FG000|Overall Study|Withdrawal by Subject|0|||
37685669|NCT02472145|69161375|FG001|Overall Study|Withdrawal by Subject|9|||
37685670|NCT02472145|69161376|FG002|Overall Study|Withdrawal by Subject|13|||
37685671|NCT02472145|69161374|FG000|Overall Study|Sponsor decision|0|||
37685672|NCT02472145|69161375|FG001|Overall Study|Sponsor decision|3|||
37685673|NCT02472145|69161376|FG002|Overall Study|Sponsor decision|2|||
37685674|NCT02472145|69161374|FG000|Overall Study|Other|0|||
37685675|NCT02472145|69161375|FG001|Overall Study|Other|45|||
37685676|NCT02472145|69161376|FG002|Overall Study|Other|43|||
37685677|NCT02448043|69161385|FG000|Overall Study|Withdrawal by Subject|2|||
37685678|NCT02448043|69161386|FG001|Overall Study|Withdrawal by Subject|2|||
37685679|NCT02448043|69161385|FG000|Overall Study|Protocol Violation|1|||
37685680|NCT02448043|69161386|FG001|Overall Study|Protocol Violation|2|||
37685681|NCT02447887|69161395|FG000|Overall Study|Study was terminated|3|||
37685682|NCT02471755|69161401|FG000|Overall Study|Withdrawal by Subject|1|||
37685683|NCT02471755|69161402|FG001|Overall Study|Withdrawal by Subject|0|||
37685684|NCT02471755|69161401|FG000|Overall Study|Lost to Follow-up|0|||
37685685|NCT02471755|69161402|FG001|Overall Study|Lost to Follow-up|1|||
37685686|NCT02470429|69161410|FG000|Overall Study|Adverse Event|1|||
37685687|NCT02470429|69161411|FG001|Overall Study|Adverse Event|0|||
37685688|NCT02470429|69161410|FG000|Overall Study|Withdrawal by Subject|1|||
37685689|NCT02470429|69161411|FG001|Overall Study|Withdrawal by Subject|0|||
37685690|NCT02447497|69161422|FG000|Overall Study|Did not meet treatment day baseline.|6|||
37685691|NCT02447497|69161423|FG001|Overall Study|Did not meet treatment day baseline.|5|||
37685692|NCT02447497|69161424|FG002|Overall Study|Did not meet treatment day baseline.|2|||
37685693|NCT02447497|69161425|FG003|Overall Study|Did not meet treatment day baseline.|2|||
37685694|NCT02447497|69161422|FG000|Overall Study|Dressing was compromised|0|||
37685695|NCT02447497|69161423|FG001|Overall Study|Dressing was compromised|1|||
37685696|NCT02447497|69161424|FG002|Overall Study|Dressing was compromised|0|||
37685697|NCT02447497|69161425|FG003|Overall Study|Dressing was compromised|0|||
37685698|NCT02417935|69161445|FG000|Treatment Period|Adverse Event|12|||
37863012|NCT01263197|69546932|FG000|Third Intervention (Period 3)|Adverse Event|0|||
37685699|NCT02417935|69161446|FG001|Treatment Period|Adverse Event|10|||
37685700|NCT02417935|69161445|FG000|Treatment Period|Lost to Follow-up|1|||
37685701|NCT02417935|69161446|FG001|Treatment Period|Lost to Follow-up|0|||
37685702|NCT02417935|69161445|FG000|Treatment Period|Entry Criteria not met|0|||
37685703|NCT02417935|69161446|FG001|Treatment Period|Entry Criteria not met|1|||
37685704|NCT02417935|69161445|FG000|Treatment Period|Protocol Violation|2|||
37685705|NCT02417935|69161446|FG001|Treatment Period|Protocol Violation|1|||
37685706|NCT02417935|69161445|FG000|Treatment Period|Withdrawal by Subject|3|||
37685707|NCT02417935|69161446|FG001|Treatment Period|Withdrawal by Subject|3|||
37685708|NCT02417935|69161445|FG000|Treatment Period|Physician Decision|3|||
37685709|NCT02417935|69161446|FG001|Treatment Period|Physician Decision|1|||
37685710|NCT02417233|69161455|FG000|Overall Study|Death|4|||
37685711|NCT02417233|69161456|FG001|Overall Study|Death|10|||
37685712|NCT02417233|69161457|FG002|Overall Study|Death|14|||
37685713|NCT02417233|69161455|FG000|Overall Study|Lost to Follow-up|27|||
37685714|NCT02417233|69161456|FG001|Overall Study|Lost to Follow-up|39|||
37685715|NCT02417233|69161457|FG002|Overall Study|Lost to Follow-up|34|||
37685716|NCT02417233|69161455|FG000|Overall Study|Protocol Violation|2|||
37685717|NCT02417233|69161456|FG001|Overall Study|Protocol Violation|0|||
37685718|NCT02417233|69161457|FG002|Overall Study|Protocol Violation|2|||
37685719|NCT02417233|69161455|FG000|Overall Study|Withdrawal by Subject|2|||
37685720|NCT02417233|69161456|FG001|Overall Study|Withdrawal by Subject|1|||
37685721|NCT02417233|69161457|FG002|Overall Study|Withdrawal by Subject|8|||
37685722|NCT02417233|69161455|FG000|Overall Study|Relocation out of study area|1|||
37685723|NCT02417233|69161456|FG001|Overall Study|Relocation out of study area|0|||
37685724|NCT02417233|69161457|FG002|Overall Study|Relocation out of study area|1|||
37685725|NCT02417233|69161455|FG000|Overall Study|Mentally unstable|0|||
37685726|NCT02417233|69161456|FG001|Overall Study|Mentally unstable|1|||
37685727|NCT02417233|69161457|FG002|Overall Study|Mentally unstable|0|||
37685728|NCT02447029|69161468|FG000|Overall Study|Withdrawal by Subject|3|||
37685729|NCT02447029|69161469|FG001|Overall Study|Withdrawal by Subject|2|||
37685730|NCT02416453|69161486|FG000|Overall Study|Adverse Event|0|||
37685731|NCT02416453|69161487|FG001|Overall Study|Adverse Event|0|||
37685732|NCT02416453|69161488|FG002|Overall Study|Adverse Event|0|||
37685733|NCT02416453|69161489|FG003|Overall Study|Adverse Event|2|||
37685734|NCT02416453|69161490|FG004|Overall Study|Adverse Event|0|||
37685735|NCT02416453|69161491|FG005|Overall Study|Adverse Event|1|||
37685736|NCT02416453|69161492|FG006|Overall Study|Adverse Event|0|||
37685737|NCT02416453|69161493|FG007|Overall Study|Adverse Event|0|||
37685738|NCT02416453|69161494|FG008|Overall Study|Adverse Event|0|||
37685739|NCT02416453|69161495|FG009|Overall Study|Adverse Event|0|||
37685740|NCT02416453|69161496|FG010|Overall Study|Adverse Event|0|||
37685741|NCT02416453|69161486|FG000|Overall Study|Lost to Follow-up|1|||
37685742|NCT02416453|69161487|FG001|Overall Study|Lost to Follow-up|3|||
37685743|NCT02416453|69161488|FG002|Overall Study|Lost to Follow-up|0|||
37685744|NCT02416453|69161489|FG003|Overall Study|Lost to Follow-up|8|||
37685745|NCT02416453|69161490|FG004|Overall Study|Lost to Follow-up|0|||
37685746|NCT02416453|69161491|FG005|Overall Study|Lost to Follow-up|5|||
37685747|NCT02416453|69161492|FG006|Overall Study|Lost to Follow-up|1|||
37685748|NCT02416453|69161493|FG007|Overall Study|Lost to Follow-up|3|||
37685749|NCT02416453|69161494|FG008|Overall Study|Lost to Follow-up|1|||
37685750|NCT02416453|69161495|FG009|Overall Study|Lost to Follow-up|0|||
37685751|NCT02416453|69161496|FG010|Overall Study|Lost to Follow-up|0|||
37685752|NCT02416453|69161486|FG000|Overall Study|Physician Decision|0|||
37685753|NCT02416453|69161487|FG001|Overall Study|Physician Decision|0|||
37685754|NCT02416453|69161488|FG002|Overall Study|Physician Decision|0|||
37685755|NCT02416453|69161489|FG003|Overall Study|Physician Decision|0|||
37685756|NCT02416453|69161490|FG004|Overall Study|Physician Decision|0|||
37685757|NCT02416453|69161491|FG005|Overall Study|Physician Decision|1|||
37685758|NCT02416453|69161492|FG006|Overall Study|Physician Decision|1|||
37685759|NCT02416453|69161493|FG007|Overall Study|Physician Decision|1|||
37685760|NCT02416453|69161494|FG008|Overall Study|Physician Decision|0|||
37685761|NCT02416453|69161495|FG009|Overall Study|Physician Decision|0|||
37967240|NCT00536484|69654110|FG001|Overall Study|Withdrawal by Subject|11|||
37967241|NCT00536484|69654109|FG000|Overall Study|Lost to Follow-up|8|||
37685762|NCT02416453|69161496|FG010|Overall Study|Physician Decision|0|||
37967242|NCT00536484|69654110|FG001|Overall Study|Lost to Follow-up|6|||
37967243|NCT00536484|69654109|FG000|Overall Study|Lack of Efficacy|16|||
37967244|NCT00536484|69654110|FG001|Overall Study|Lack of Efficacy|5|||
37685763|NCT02416453|69161486|FG000|Overall Study|Withdrawal by Subject|2|||
37685764|NCT02416453|69161487|FG001|Overall Study|Withdrawal by Subject|0|||
37685765|NCT02416453|69161488|FG002|Overall Study|Withdrawal by Subject|0|||
37685766|NCT02416453|69161489|FG003|Overall Study|Withdrawal by Subject|5|||
37685767|NCT02416453|69161490|FG004|Overall Study|Withdrawal by Subject|1|||
37685768|NCT02416453|69161491|FG005|Overall Study|Withdrawal by Subject|8|||
37685769|NCT02416453|69161492|FG006|Overall Study|Withdrawal by Subject|0|||
37685770|NCT02416453|69161493|FG007|Overall Study|Withdrawal by Subject|8|||
37685771|NCT02416453|69161494|FG008|Overall Study|Withdrawal by Subject|4|||
37685772|NCT02416453|69161495|FG009|Overall Study|Withdrawal by Subject|0|||
37685773|NCT02416453|69161496|FG010|Overall Study|Withdrawal by Subject|0|||
37685774|NCT02416453|69161486|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
37685775|NCT02416453|69161487|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
37685776|NCT02416453|69161488|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
37685777|NCT02416453|69161489|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
37685778|NCT02416453|69161490|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
37685779|NCT02416453|69161491|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
37685780|NCT02416453|69161492|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
37685781|NCT02416453|69161493|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
37685782|NCT02416453|69161494|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
37685783|NCT02416453|69161495|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
37685784|NCT02416453|69161496|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
37685785|NCT02416453|69161486|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
37685786|NCT02416453|69161487|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
37685787|NCT02416453|69161488|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
37685788|NCT02416453|69161489|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
37685789|NCT02416453|69161490|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
37685790|NCT02416453|69161491|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
37685791|NCT02416453|69161492|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
37685792|NCT02416453|69161493|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
37685793|NCT02416453|69161494|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
37685794|NCT02416453|69161495|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
37685795|NCT02416453|69161496|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
37685796|NCT02469961|69161528|FG000|Overall Study|Physician Decision|4|||
37685797|NCT02469961|69161529|FG001|Overall Study|Physician Decision|1|||
37685798|NCT02415595|69161544|FG000|Overall Study|Administrative reason by sponsor|39|||
37685799|NCT02415595|69161545|FG001|Overall Study|Administrative reason by sponsor|40|||
37685800|NCT02415595|69161546|FG002|Overall Study|Administrative reason by sponsor|41|||
37685801|NCT02415595|69161547|FG003|Overall Study|Administrative reason by sponsor|39|||
37685802|NCT02415595|69161544|FG000|Overall Study|Adverse Event|1|||
37685803|NCT02415595|69161545|FG001|Overall Study|Adverse Event|3|||
37685804|NCT02415595|69161546|FG002|Overall Study|Adverse Event|5|||
37685805|NCT02415595|69161547|FG003|Overall Study|Adverse Event|10|||
37685806|NCT02415595|69161544|FG000|Overall Study|Lack of Efficacy|4|||
37685807|NCT02415595|69161545|FG001|Overall Study|Lack of Efficacy|4|||
37685808|NCT02415595|69161546|FG002|Overall Study|Lack of Efficacy|0|||
37685809|NCT02415595|69161547|FG003|Overall Study|Lack of Efficacy|0|||
37685810|NCT02415595|69161544|FG000|Overall Study|Lost to Follow-up|1|||
37685811|NCT02415595|69161545|FG001|Overall Study|Lost to Follow-up|3|||
37967245|NCT00536484|69654109|FG000|Overall Study|Other|4|||
38084765|NCT02587598|69784185|FG009|Overall Study|Death|1|||
38084766|NCT02587598|69784186|FG010|Overall Study|Death|3|||
38084767|NCT02587598|69784176|FG000|Overall Study|Study Terminated by the Sponsor|0|||
38084768|NCT02587598|69784177|FG001|Overall Study|Study Terminated by the Sponsor|1|||
38084769|NCT02587598|69784178|FG002|Overall Study|Study Terminated by the Sponsor|0|||
38084770|NCT02587598|69784179|FG003|Overall Study|Study Terminated by the Sponsor|3|||
38084771|NCT02587598|69784180|FG004|Overall Study|Study Terminated by the Sponsor|0|||
38084772|NCT02587598|69784181|FG005|Overall Study|Study Terminated by the Sponsor|1|||
38084773|NCT02587598|69784182|FG006|Overall Study|Study Terminated by the Sponsor|0|||
38084774|NCT02587598|69784183|FG007|Overall Study|Study Terminated by the Sponsor|0|||
38084775|NCT02587598|69784184|FG008|Overall Study|Study Terminated by the Sponsor|0|||
38084776|NCT02587598|69784185|FG009|Overall Study|Study Terminated by the Sponsor|1|||
38084777|NCT02587598|69784186|FG010|Overall Study|Study Terminated by the Sponsor|6|||
38084778|NCT02587598|69784176|FG000|Overall Study|Reason for study withdrawal not specified|0|||
38084779|NCT02587598|69784177|FG001|Overall Study|Reason for study withdrawal not specified|1|||
38084780|NCT02587598|69784178|FG002|Overall Study|Reason for study withdrawal not specified|0|||
38084781|NCT02587598|69784179|FG003|Overall Study|Reason for study withdrawal not specified|0|||
38084782|NCT02587598|69784180|FG004|Overall Study|Reason for study withdrawal not specified|0|||
38084783|NCT02587598|69784181|FG005|Overall Study|Reason for study withdrawal not specified|0|||
38084784|NCT02587598|69784182|FG006|Overall Study|Reason for study withdrawal not specified|0|||
37685812|NCT02415595|69161546|FG002|Overall Study|Lost to Follow-up|1|||
37685813|NCT02415595|69161547|FG003|Overall Study|Lost to Follow-up|1|||
38084785|NCT02587598|69784183|FG007|Overall Study|Reason for study withdrawal not specified|0|||
37685814|NCT02415595|69161544|FG000|Overall Study|Poor/Non-compliance|1|||
37685815|NCT02415595|69161545|FG001|Overall Study|Poor/Non-compliance|0|||
37685816|NCT02415595|69161546|FG002|Overall Study|Poor/Non-compliance|1|||
37685817|NCT02415595|69161547|FG003|Overall Study|Poor/Non-compliance|0|||
37685818|NCT02415595|69161544|FG000|Overall Study|Reached stopping criteria|0|||
37685819|NCT02415595|69161545|FG001|Overall Study|Reached stopping criteria|1|||
37685820|NCT02415595|69161546|FG002|Overall Study|Reached stopping criteria|1|||
37685821|NCT02415595|69161547|FG003|Overall Study|Reached stopping criteria|0|||
37685822|NCT02415595|69161544|FG000|Overall Study|Withdrawal by Subject|4|||
37685823|NCT02415595|69161545|FG001|Overall Study|Withdrawal by Subject|0|||
37685824|NCT02415595|69161546|FG002|Overall Study|Withdrawal by Subject|1|||
37685825|NCT02415595|69161547|FG003|Overall Study|Withdrawal by Subject|3|||
37685826|NCT02415595|69161544|FG000|Overall Study|Other|0|||
37685827|NCT02415595|69161545|FG001|Overall Study|Other|1|||
37685828|NCT02415595|69161546|FG002|Overall Study|Other|1|||
37685829|NCT02415595|69161547|FG003|Overall Study|Other|0|||
37685830|NCT02446717|69161563|FG000|Overall Study|Adverse Event|0|||
37685831|NCT02446717|69161564|FG001|Overall Study|Adverse Event|0|||
37685832|NCT02446717|69161565|FG002|Overall Study|Adverse Event|1|||
37685833|NCT02446717|69161566|FG003|Overall Study|Adverse Event|0|||
37685834|NCT02446717|69161567|FG004|Overall Study|Adverse Event|0|||
37685835|NCT02446717|69161563|FG000|Overall Study|Lost to Follow-up|0|||
37685836|NCT02446717|69161564|FG001|Overall Study|Lost to Follow-up|1|||
37685837|NCT02446717|69161565|FG002|Overall Study|Lost to Follow-up|1|||
37685838|NCT02446717|69161566|FG003|Overall Study|Lost to Follow-up|0|||
37685839|NCT02446717|69161567|FG004|Overall Study|Lost to Follow-up|1|||
37685840|NCT02446717|69161563|FG000|Overall Study|Withdrew consent|0|||
37685841|NCT02446717|69161564|FG001|Overall Study|Withdrew consent|0|||
37685842|NCT02446717|69161565|FG002|Overall Study|Withdrew consent|0|||
37685843|NCT02446717|69161566|FG003|Overall Study|Withdrew consent|1|||
37685844|NCT02446717|69161567|FG004|Overall Study|Withdrew consent|0|||
37685845|NCT02469415|69161579|FG000|Overall Study|Withdrawal by Subject|1|||
37685846|NCT02469415|69161579|FG000|Overall Study|Investigational agent placed on hold|2|||
37685847|NCT02446171|69161587|FG000|Overall Study|Withdrawal by Subject|0|||
37685848|NCT02446171|69161588|FG001|Overall Study|Withdrawal by Subject|0|||
37685849|NCT02446171|69161589|FG002|Overall Study|Withdrawal by Subject|2|||
37685850|NCT02446171|69161590|FG003|Overall Study|Withdrawal by Subject|0|||
37685851|NCT02446015|69161604|FG000|Overall Study|Adverse Event|0|||
37685852|NCT02446015|69161605|FG001|Overall Study|Adverse Event|1|||
37685853|NCT02446015|69161604|FG000|Overall Study|Withdrawal by Subject|1|||
37685854|NCT02446015|69161605|FG001|Overall Study|Withdrawal by Subject|0|||
37685855|NCT02415127|69161614|FG000|Overall Study|Adverse Event|1|||
37685856|NCT02415127|69161615|FG001|Overall Study|Adverse Event|0|||
37685857|NCT02468557|69161621|FG000|Overall Study|Adverse Event|1|||
37685858|NCT02468557|69161621|FG000|Overall Study|Death|1|||
37685859|NCT02468557|69161621|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
37685860|NCT02468557|69161621|FG000|Overall Study|All Enrolled but Never Dosed|4|||
37685861|NCT02413489|69161632|FG000|Overall Study|Death|11|||
37685862|NCT02413489|69161633|FG001|Overall Study|Death|3|||
37685863|NCT02413489|69161634|FG002|Overall Study|Death|4|||
37685864|NCT02413489|69161632|FG000|Overall Study|Withdrawal by Subject|2|||
37685865|NCT02413489|69161633|FG001|Overall Study|Withdrawal by Subject|0|||
37685866|NCT02413489|69161634|FG002|Overall Study|Withdrawal by Subject|0|||
38084786|NCT02587598|69784184|FG008|Overall Study|Reason for study withdrawal not specified|0|||
38084787|NCT02587598|69784185|FG009|Overall Study|Reason for study withdrawal not specified|0|||
37685867|NCT02413489|69161632|FG000|Overall Study|Study Terminated By Sponsor|2|||
37685868|NCT02413489|69161633|FG001|Overall Study|Study Terminated By Sponsor|13|||
37685869|NCT02413489|69161634|FG002|Overall Study|Study Terminated By Sponsor|1|||
37685870|NCT02413333|69161646|FG000|Period 1|Adverse Event|1|||
37685871|NCT02413333|69161647|FG001|Period 1|Adverse Event|0|||
37685872|NCT02413333|69161646|FG000|Period 1|Reason Not Specified|0|||
37685873|NCT02413333|69161647|FG001|Period 1|Reason Not Specified|1|||
37685874|NCT02413333|69161646|FG000|Period 2|Protocol Deviation|1|||
37685875|NCT02413333|69161647|FG001|Period 2|Protocol Deviation|0|||
37685876|NCT02413255|69161670|FG000|Overall Study|Voluntary Withdrawal|0|||
37685877|NCT02413255|69161671|FG001|Overall Study|Voluntary Withdrawal|0|||
37685878|NCT02413255|69161672|FG002|Overall Study|Voluntary Withdrawal|0|||
37967246|NCT00536484|69654110|FG001|Overall Study|Other|0|||
37685879|NCT02413255|69161673|FG003|Overall Study|Voluntary Withdrawal|0|||
37685880|NCT02413255|69161674|FG004|Overall Study|Voluntary Withdrawal|0|||
37685881|NCT02413255|69161675|FG005|Overall Study|Voluntary Withdrawal|0|||
37685882|NCT02413255|69161676|FG006|Overall Study|Voluntary Withdrawal|0|||
37685883|NCT02413255|69161677|FG007|Overall Study|Voluntary Withdrawal|0|||
37685884|NCT02413255|69161678|FG008|Overall Study|Voluntary Withdrawal|0|||
37685885|NCT02413255|69161679|FG009|Overall Study|Voluntary Withdrawal|0|||
37685886|NCT02413255|69161680|FG010|Overall Study|Voluntary Withdrawal|0|||
37685887|NCT02413255|69161681|FG011|Overall Study|Voluntary Withdrawal|0|||
37685888|NCT02413255|69161682|FG012|Overall Study|Voluntary Withdrawal|0|||
37685889|NCT02413255|69161683|FG013|Overall Study|Voluntary Withdrawal|0|||
37685890|NCT02413255|69161684|FG014|Overall Study|Voluntary Withdrawal|1|||
37685891|NCT02413255|69161685|FG015|Overall Study|Voluntary Withdrawal|0|||
37685892|NCT02413255|69161686|FG016|Overall Study|Voluntary Withdrawal|0|||
37685893|NCT02444533|69161739|FG000|Overall Study|Not able to complete forms|0|||
37685894|NCT02444533|69161740|FG001|Overall Study|Not able to complete forms|2|||
37685895|NCT02444533|69161739|FG000|Overall Study|Only gave post-procedure complications|2|||
37685896|NCT02444533|69161740|FG001|Overall Study|Only gave post-procedure complications|2|||
37685897|NCT01651039|69161746|FG000|Overall Study|Non-evaluables|5|||
37685898|NCT01651039|69161746|FG000|Overall Study|Physician Decision|2|||
37685899|NCT01651039|69161746|FG000|Overall Study|Withdrawal by Subject|1|||
37685900|NCT01651039|69161746|FG000|Overall Study|Progressive Disease|22|||
37685901|NCT02349633|69161764|FG000|Overall Study|Death|0|||
37685902|NCT02349633|69161765|FG001|Overall Study|Death|1|||
37685903|NCT02349633|69161766|FG002|Overall Study|Death|0|||
37685904|NCT02349633|69161767|FG003|Overall Study|Death|0|||
37685905|NCT02349633|69161768|FG004|Overall Study|Death|0|||
37685906|NCT02349633|69161769|FG005|Overall Study|Death|1|||
37685907|NCT02349633|69161770|FG006|Overall Study|Death|1|||
37685908|NCT02349633|69161771|FG007|Overall Study|Death|1|||
37685909|NCT02349633|69161772|FG008|Overall Study|Death|0|||
37685910|NCT02349633|69161773|FG009|Overall Study|Death|1|||
37685911|NCT02349633|69161774|FG010|Overall Study|Death|0|||
37685912|NCT02349633|69161775|FG011|Overall Study|Death|0|||
37685913|NCT02349633|69161776|FG012|Overall Study|Death|0|||
37685914|NCT02349633|69161777|FG013|Overall Study|Death|0|||
37685915|NCT02349633|69161764|FG000|Overall Study|Withdrawal by Subject|0|||
37685916|NCT02349633|69161765|FG001|Overall Study|Withdrawal by Subject|0|||
37685917|NCT02349633|69161766|FG002|Overall Study|Withdrawal by Subject|0|||
37685918|NCT02349633|69161767|FG003|Overall Study|Withdrawal by Subject|1|||
37685919|NCT02349633|69161768|FG004|Overall Study|Withdrawal by Subject|0|||
37685920|NCT02349633|69161769|FG005|Overall Study|Withdrawal by Subject|0|||
37685921|NCT02349633|69161770|FG006|Overall Study|Withdrawal by Subject|0|||
37685922|NCT02349633|69161771|FG007|Overall Study|Withdrawal by Subject|2|||
37685923|NCT02349633|69161772|FG008|Overall Study|Withdrawal by Subject|2|||
37685924|NCT02349633|69161773|FG009|Overall Study|Withdrawal by Subject|1|||
37685925|NCT02349633|69161774|FG010|Overall Study|Withdrawal by Subject|0|||
37685926|NCT02349633|69161775|FG011|Overall Study|Withdrawal by Subject|0|||
37685927|NCT02349633|69161776|FG012|Overall Study|Withdrawal by Subject|0|||
37685928|NCT02349633|69161777|FG013|Overall Study|Withdrawal by Subject|0|||
37685929|NCT02349633|69161764|FG000|Overall Study|Withdrawal of informed consent|0|||
37685930|NCT02349633|69161765|FG001|Overall Study|Withdrawal of informed consent|0|||
37685931|NCT02349633|69161766|FG002|Overall Study|Withdrawal of informed consent|0|||
37685932|NCT02349633|69161767|FG003|Overall Study|Withdrawal of informed consent|1|||
37685933|NCT02349633|69161768|FG004|Overall Study|Withdrawal of informed consent|1|||
37685934|NCT02349633|69161769|FG005|Overall Study|Withdrawal of informed consent|0|||
38084788|NCT02587598|69784186|FG010|Overall Study|Reason for study withdrawal not specified|0|||
38084789|NCT02587598|69784176|FG000|Overall Study|Withdrawal by Subject|0|||
38084790|NCT02587598|69784177|FG001|Overall Study|Withdrawal by Subject|1|||
38084791|NCT02587598|69784178|FG002|Overall Study|Withdrawal by Subject|0|||
38084792|NCT02587598|69784179|FG003|Overall Study|Withdrawal by Subject|2|||
38084793|NCT02587598|69784180|FG004|Overall Study|Withdrawal by Subject|3|||
38084794|NCT02587598|69784181|FG005|Overall Study|Withdrawal by Subject|1|||
38084795|NCT02587598|69784182|FG006|Overall Study|Withdrawal by Subject|0|||
38084796|NCT02587598|69784183|FG007|Overall Study|Withdrawal by Subject|0|||
38084797|NCT02587598|69784184|FG008|Overall Study|Withdrawal by Subject|0|||
38084798|NCT02587598|69784185|FG009|Overall Study|Withdrawal by Subject|1|||
37685935|NCT02349633|69161770|FG006|Overall Study|Withdrawal of informed consent|0|||
37685936|NCT02349633|69161771|FG007|Overall Study|Withdrawal of informed consent|3|||
37685937|NCT02349633|69161772|FG008|Overall Study|Withdrawal of informed consent|0|||
37685938|NCT02349633|69161773|FG009|Overall Study|Withdrawal of informed consent|0|||
37685939|NCT02349633|69161774|FG010|Overall Study|Withdrawal of informed consent|0|||
38084799|NCT02587598|69784186|FG010|Overall Study|Withdrawal by Subject|2|||
38084800|NCT02587598|69784176|FG000|Overall Study|Physician Decision|0|||
38084801|NCT02587598|69784177|FG001|Overall Study|Physician Decision|0|||
38084802|NCT02587598|69784178|FG002|Overall Study|Physician Decision|0|||
38084803|NCT02587598|69784179|FG003|Overall Study|Physician Decision|0|||
37685940|NCT02349633|69161775|FG011|Overall Study|Withdrawal of informed consent|0|||
37685941|NCT02349633|69161776|FG012|Overall Study|Withdrawal of informed consent|0|||
37685942|NCT02349633|69161777|FG013|Overall Study|Withdrawal of informed consent|0|||
37685943|NCT02349633|69161764|FG000|Overall Study|Transition to compassionate use|0|||
37685944|NCT02349633|69161765|FG001|Overall Study|Transition to compassionate use|0|||
37685945|NCT02349633|69161766|FG002|Overall Study|Transition to compassionate use|0|||
37685946|NCT02349633|69161767|FG003|Overall Study|Transition to compassionate use|0|||
37685947|NCT02349633|69161768|FG004|Overall Study|Transition to compassionate use|1|||
37685948|NCT02349633|69161769|FG005|Overall Study|Transition to compassionate use|0|||
37685949|NCT02349633|69161770|FG006|Overall Study|Transition to compassionate use|0|||
37685950|NCT02349633|69161771|FG007|Overall Study|Transition to compassionate use|3|||
37685951|NCT02349633|69161772|FG008|Overall Study|Transition to compassionate use|0|||
37685952|NCT02349633|69161773|FG009|Overall Study|Transition to compassionate use|1|||
37685953|NCT02349633|69161774|FG010|Overall Study|Transition to compassionate use|0|||
37685954|NCT02349633|69161775|FG011|Overall Study|Transition to compassionate use|0|||
37685955|NCT02349633|69161776|FG012|Overall Study|Transition to compassionate use|0|||
37685956|NCT02349633|69161777|FG013|Overall Study|Transition to compassionate use|0|||
37685957|NCT02349633|69161764|FG000|Overall Study|Early termination of survival follow-up|0|||
37685958|NCT02349633|69161765|FG001|Overall Study|Early termination of survival follow-up|0|||
37685959|NCT02349633|69161766|FG002|Overall Study|Early termination of survival follow-up|0|||
37685960|NCT02349633|69161767|FG003|Overall Study|Early termination of survival follow-up|0|||
37685961|NCT02349633|69161768|FG004|Overall Study|Early termination of survival follow-up|0|||
37685962|NCT02349633|69161769|FG005|Overall Study|Early termination of survival follow-up|0|||
37685963|NCT02349633|69161770|FG006|Overall Study|Early termination of survival follow-up|0|||
37685964|NCT02349633|69161771|FG007|Overall Study|Early termination of survival follow-up|4|||
37685965|NCT02349633|69161772|FG008|Overall Study|Early termination of survival follow-up|0|||
37685966|NCT02349633|69161773|FG009|Overall Study|Early termination of survival follow-up|0|||
37685967|NCT02349633|69161774|FG010|Overall Study|Early termination of survival follow-up|0|||
37685968|NCT02349633|69161775|FG011|Overall Study|Early termination of survival follow-up|0|||
37685969|NCT02349633|69161776|FG012|Overall Study|Early termination of survival follow-up|0|||
37685970|NCT02349633|69161777|FG013|Overall Study|Early termination of survival follow-up|0|||
37685971|NCT02349633|69161764|FG000|Overall Study|Termination by sponsor|0|||
37685972|NCT02349633|69161765|FG001|Overall Study|Termination by sponsor|0|||
37685973|NCT02349633|69161766|FG002|Overall Study|Termination by sponsor|0|||
37685974|NCT02349633|69161767|FG003|Overall Study|Termination by sponsor|0|||
37685975|NCT02349633|69161768|FG004|Overall Study|Termination by sponsor|0|||
37685976|NCT02349633|69161769|FG005|Overall Study|Termination by sponsor|0|||
37685977|NCT02349633|69161770|FG006|Overall Study|Termination by sponsor|0|||
37685978|NCT02349633|69161771|FG007|Overall Study|Termination by sponsor|1|||
37685979|NCT02349633|69161772|FG008|Overall Study|Termination by sponsor|0|||
37685980|NCT02349633|69161773|FG009|Overall Study|Termination by sponsor|2|||
37685981|NCT02349633|69161774|FG010|Overall Study|Termination by sponsor|0|||
37685982|NCT02349633|69161775|FG011|Overall Study|Termination by sponsor|0|||
37685983|NCT02349633|69161776|FG012|Overall Study|Termination by sponsor|0|||
37685984|NCT02349633|69161777|FG013|Overall Study|Termination by sponsor|0|||
37685985|NCT02349633|69161764|FG000|Overall Study|Other|0|||
37685986|NCT02349633|69161765|FG001|Overall Study|Other|0|||
37685987|NCT02349633|69161766|FG002|Overall Study|Other|0|||
37685988|NCT02349633|69161767|FG003|Overall Study|Other|0|||
37685989|NCT02349633|69161768|FG004|Overall Study|Other|0|||
37685990|NCT02349633|69161769|FG005|Overall Study|Other|0|||
37685991|NCT02349633|69161770|FG006|Overall Study|Other|0|||
37685992|NCT02349633|69161771|FG007|Overall Study|Other|2|||
37685993|NCT02349633|69161772|FG008|Overall Study|Other|0|||
37685994|NCT02349633|69161773|FG009|Overall Study|Other|0|||
37685995|NCT02349633|69161774|FG010|Overall Study|Other|0|||
37685996|NCT02349633|69161775|FG011|Overall Study|Other|0|||
37685997|NCT02349633|69161776|FG012|Overall Study|Other|0|||
37685998|NCT02349633|69161777|FG013|Overall Study|Other|0|||
37685999|NCT02275611|69161842|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
37686000|NCT02275611|69161843|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
37686001|NCT02275611|69161844|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
37686002|NCT02275611|69161845|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
37686003|NCT02275065|69161862|FG000|Overall Study|Randomized but not treated|1|||
38084804|NCT02587598|69784180|FG004|Overall Study|Physician Decision|0|||
37686004|NCT02275065|69161863|FG001|Overall Study|Randomized but not treated|0|||
37686005|NCT02275065|69161864|FG002|Overall Study|Randomized but not treated|1|||
38084805|NCT02587598|69784181|FG005|Overall Study|Physician Decision|0|||
37967247|NCT00370396|69654119|FG000|Overall Study|Withdrawal by Subject|0|||
37967248|NCT00370396|69654120|FG001|Overall Study|Withdrawal by Subject|0|||
37967249|NCT00370396|69654121|FG002|Overall Study|Withdrawal by Subject|1|||
37967250|NCT00370396|69654119|FG000|Overall Study|Lost to Follow-up|11|||
37686006|NCT02275065|69161865|FG003|Overall Study|Randomized but not treated|1|||
37686007|NCT02275065|69161866|FG004|Overall Study|Randomized but not treated|0|||
37686008|NCT02273973|69161880|FG000|Overall Study|Adverse Event|4|||
37686009|NCT02273973|69161881|FG001|Overall Study|Adverse Event|0|||
37686010|NCT02273973|69161880|FG000|Overall Study|Withdrawal by Subject|2|||
37686011|NCT02273973|69161881|FG001|Overall Study|Withdrawal by Subject|3|||
37686012|NCT02273973|69161880|FG000|Overall Study|Death|1|||
37686013|NCT02273973|69161881|FG001|Overall Study|Death|0|||
37686014|NCT02273973|69161880|FG000|Overall Study|Non-compliance|1|||
37686015|NCT02273973|69161881|FG001|Overall Study|Non-compliance|0|||
37686016|NCT02273973|69161880|FG000|Overall Study|Protocol Violation|1|||
37686017|NCT02273973|69161881|FG001|Overall Study|Protocol Violation|0|||
37686018|NCT02273973|69161880|FG000|Overall Study|Progression of disease|0|||
37686019|NCT02273973|69161881|FG001|Overall Study|Progression of disease|2|||
37686020|NCT02273973|69161880|FG000|Overall Study|Lost to Follow-up|0|||
37686021|NCT02273973|69161881|FG001|Overall Study|Lost to Follow-up|1|||
37686022|NCT02273973|69161880|FG000|Overall Study|Physician Decision|0|||
37686023|NCT02273973|69161881|FG001|Overall Study|Physician Decision|1|||
37686024|NCT02273973|69161880|FG000|Overall Study|Reason not specified|0|||
37686025|NCT02273973|69161881|FG001|Overall Study|Reason not specified|1|||
37686026|NCT02273739|69161891|FG000|Overall Study|Progression of Disease|3|||
37686027|NCT02273739|69161892|FG001|Overall Study|Progression of Disease|4|||
37686028|NCT02273739|69161893|FG002|Overall Study|Progression of Disease|5|||
37686029|NCT02273739|69161894|FG003|Overall Study|Progression of Disease|2|||
38084806|NCT02587598|69784182|FG006|Overall Study|Physician Decision|0|||
37686030|NCT02273739|69161891|FG000|Overall Study|Death|0|||
37686031|NCT02273739|69161892|FG001|Overall Study|Death|0|||
37686032|NCT02273739|69161893|FG002|Overall Study|Death|0|||
37967251|NCT00370396|69654120|FG001|Overall Study|Lost to Follow-up|1|||
37967252|NCT00370396|69654121|FG002|Overall Study|Lost to Follow-up|0|||
37967253|NCT00455013|69654132|FG000|Short Term Period|Adverse Event|2|||
37967254|NCT00455013|69654133|FG001|Short Term Period|Adverse Event|5|||
37686033|NCT02273739|69161894|FG003|Overall Study|Death|2|||
37686034|NCT02273739|69161891|FG000|Overall Study|Adverse Event|0|||
37686035|NCT02273739|69161892|FG001|Overall Study|Adverse Event|0|||
37686036|NCT02273739|69161893|FG002|Overall Study|Adverse Event|0|||
37686037|NCT02273739|69161894|FG003|Overall Study|Adverse Event|1|||
37686038|NCT02273739|69161891|FG000|Overall Study|Withdrawal by Subject|0|||
37686039|NCT02273739|69161892|FG001|Overall Study|Withdrawal by Subject|0|||
37686040|NCT02273739|69161893|FG002|Overall Study|Withdrawal by Subject|2|||
37686041|NCT02273739|69161894|FG003|Overall Study|Withdrawal by Subject|1|||
38084807|NCT02587598|69784183|FG007|Overall Study|Physician Decision|0|||
38084808|NCT02587598|69784184|FG008|Overall Study|Physician Decision|0|||
38084809|NCT02587598|69784185|FG009|Overall Study|Physician Decision|0|||
38084810|NCT02587598|69784186|FG010|Overall Study|Physician Decision|3|||
38084811|NCT02485574|69784222|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
38084812|NCT02624284|69784234|FG000|Overall Study|Withdrawal by Subject|3|||
38084813|NCT02624284|69784235|FG001|Overall Study|Withdrawal by Subject|6|||
38084814|NCT02624284|69784236|FG002|Overall Study|Withdrawal by Subject|3|||
38084815|NCT02624284|69784234|FG000|Overall Study|Protocol Violation|9|||
38084816|NCT02624284|69784235|FG001|Overall Study|Protocol Violation|10|||
38084817|NCT02624284|69784236|FG002|Overall Study|Protocol Violation|7|||
38084818|NCT02624284|69784234|FG000|Overall Study|Revealed exclusionary condition|2|||
37686042|NCT02273739|69161891|FG000|Overall Study|Physician Decision|0|||
37686043|NCT02273739|69161892|FG001|Overall Study|Physician Decision|0|||
37967255|NCT00455013|69654134|FG002|Short Term Period|Adverse Event|0|||
37967256|NCT00455013|69654132|FG000|Short Term Period|Withdrawal by Subject|0|||
37967257|NCT00455013|69654133|FG001|Short Term Period|Withdrawal by Subject|0|||
37967258|NCT00455013|69654134|FG002|Short Term Period|Withdrawal by Subject|1|||
37967259|NCT00455013|69654132|FG000|Short Term Period|Lack of Efficacy|4|||
37967260|NCT00455013|69654133|FG001|Short Term Period|Lack of Efficacy|0|||
37686044|NCT02273739|69161893|FG002|Overall Study|Physician Decision|0|||
37686045|NCT02273739|69161894|FG003|Overall Study|Physician Decision|1|||
37686046|NCT02273037|69161911|FG000|Overall Study|Lost to Follow-up|1|||
37686047|NCT02273037|69161912|FG001|Overall Study|Lost to Follow-up|0|||
37686048|NCT02273037|69161911|FG000|Overall Study|Delivered before monitoring initiated|1|||
37686049|NCT02273037|69161912|FG001|Overall Study|Delivered before monitoring initiated|3|||
37686050|NCT02273037|69161911|FG000|Overall Study|Breech delivery|2|||
37686051|NCT02273037|69161912|FG001|Overall Study|Breech delivery|3|||
37863013|NCT01263197|69546933|FG001|Third Intervention (Period 3)|Adverse Event|1|||
37967261|NCT00455013|69654134|FG002|Short Term Period|Lack of Efficacy|0|||
37967262|NCT00455013|69654132|FG000|Short Term Period|Other|0|||
37967263|NCT00455013|69654133|FG001|Short Term Period|Other|0|||
37967264|NCT00455013|69654134|FG002|Short Term Period|Other|1|||
37967265|NCT00455013|69654132|FG000|Long Term Extension (LTE)|Adverse Event|0|||
37967266|NCT00455013|69654133|FG001|Long Term Extension (LTE)|Adverse Event|1|||
38084819|NCT02624284|69784235|FG001|Overall Study|Revealed exclusionary condition|2|||
37863014|NCT01263197|69546934|FG002|Third Intervention (Period 3)|Adverse Event|0|||
37967267|NCT00455013|69654134|FG002|Long Term Extension (LTE)|Adverse Event|1|||
37967268|NCT00455013|69654132|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
37967269|NCT00455013|69654133|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
37686052|NCT02273037|69161911|FG000|Overall Study|Multiple delivery|2|||
37686053|NCT02273037|69161912|FG001|Overall Study|Multiple delivery|2|||
37686054|NCT02273037|69161911|FG000|Overall Study|Other complication|2|||
37686055|NCT02273037|69161912|FG001|Overall Study|Other complication|0|||
37686056|NCT02465515|69161922|FG000|Overall Study|Investigator site closed|4|||
37686057|NCT02465515|69161923|FG001|Overall Study|Investigator site closed|5|||
37686058|NCT02465515|69161922|FG000|Overall Study|Withdrawal by Subject|74|||
37686059|NCT02465515|69161923|FG001|Overall Study|Withdrawal by Subject|43|||
37686060|NCT02465515|69161922|FG000|Overall Study|Physician Decision|8|||
37686061|NCT02465515|69161923|FG001|Overall Study|Physician Decision|12|||
37686062|NCT02465515|69161922|FG000|Overall Study|Lost to Follow-up|68|||
37686063|NCT02465515|69161923|FG001|Overall Study|Lost to Follow-up|51|||
37686064|NCT02412631|69161931|FG000|Overall Study|Adverse Event|1|||
37686065|NCT02412631|69161932|FG001|Overall Study|Adverse Event|2|||
37686066|NCT02412631|69161931|FG000|Overall Study|Lost to Follow-up|5|||
37686067|NCT02412631|69161932|FG001|Overall Study|Lost to Follow-up|9|||
37686068|NCT02412631|69161931|FG000|Overall Study|Withdrawal by Subject|9|||
37686069|NCT02412631|69161932|FG001|Overall Study|Withdrawal by Subject|3|||
37686070|NCT02412631|69161931|FG000|Overall Study|Early stop by FDA|5|||
37686071|NCT02412631|69161932|FG001|Overall Study|Early stop by FDA|2|||
37686072|NCT02412631|69161931|FG000|Overall Study|Unspecified reason|6|||
37686073|NCT02412631|69161932|FG001|Overall Study|Unspecified reason|8|||
37686074|NCT02272803|69161940|FG000|Overall Study|Disease progression|16|||
37686075|NCT02272803|69161941|FG001|Overall Study|Disease progression|8|||
37686076|NCT02272803|69161940|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
37686077|NCT02272803|69161941|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
37686078|NCT02272803|69161940|FG000|Overall Study|Study drug toxicity|4|||
37686079|NCT02272803|69161941|FG001|Overall Study|Study drug toxicity|9|||
37686080|NCT02272803|69161940|FG000|Overall Study|Participant request to discontinue study treatment|3|||
37686081|NCT02272803|69161941|FG001|Overall Study|Participant request to discontinue study treatment|7|||
37686082|NCT02272803|69161940|FG000|Overall Study|Maximum clinical benefit|4|||
37686083|NCT02272803|69161941|FG001|Overall Study|Maximum clinical benefit|2|||
37686084|NCT02272803|69161940|FG000|Overall Study|Poor/non-compliance|2|||
37686085|NCT02272803|69161941|FG001|Overall Study|Poor/non-compliance|2|||
37686086|NCT02272803|69161940|FG000|Overall Study|Withdrawal by Subject|2|||
37686087|NCT02272803|69161941|FG001|Overall Study|Withdrawal by Subject|1|||
37686088|NCT02272803|69161940|FG000|Overall Study|Death|0|||
37686089|NCT02272803|69161941|FG001|Overall Study|Death|1|||
37686090|NCT02272803|69161940|FG000|Overall Study|Other reasons|1|||
37686091|NCT02272803|69161941|FG001|Overall Study|Other reasons|3|||
37686092|NCT02272803|69161940|FG000|Overall Study|Administrative reason by sponsor|5|||
37686093|NCT02272803|69161941|FG001|Overall Study|Administrative reason by sponsor|4|||
37686094|NCT02272725|69161949|FG000|Overall Study|equipment malfunction|2|||
37686095|NCT02272725|69161950|FG001|Overall Study|equipment malfunction|0|||
37686096|NCT01650805|69161958|FG000|Overall Study|Withdrawal by Subject|1|||
37686097|NCT01650805|69161959|FG001|Overall Study|Withdrawal by Subject|0|||
37686098|NCT02442349|69161965|FG000|Overall Study|Death|14|||
37686099|NCT02442349|69161965|FG000|Overall Study|Withdrawal by Subject|8|||
37686100|NCT02442349|69161965|FG000|Overall Study|On-going Study at Data Cut-off|149|||
37686101|NCT02411539|69161971|FG000|Overall Study|Lost to Follow-up|2|||
37967270|NCT00455013|69654134|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
37686102|NCT02411539|69161972|FG001|Overall Study|Lost to Follow-up|0|||
37686103|NCT02411539|69161971|FG000|Overall Study|Confounding medical condition|0|||
37686104|NCT02411539|69161972|FG001|Overall Study|Confounding medical condition|1|||
37686105|NCT02465437|69161985|FG000|Overall Study|Physician Decision|0|||
37686106|NCT02465437|69161986|FG001|Overall Study|Physician Decision|0|||
37686107|NCT02465437|69161987|FG002|Overall Study|Physician Decision|1|||
37967271|NCT00455013|69654132|FG000|Long Term Extension (LTE)|Death|1|||
37967272|NCT00455013|69654133|FG001|Long Term Extension (LTE)|Death|1|||
37967273|NCT00455013|69654134|FG002|Long Term Extension (LTE)|Death|0|||
37967274|NCT00455013|69654132|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
37967275|NCT00455013|69654133|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
37967276|NCT00455013|69654134|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
37967277|NCT00455013|69654132|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
37967278|NCT00455013|69654133|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
37967279|NCT00455013|69654134|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
37967280|NCT00455013|69654132|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
37967281|NCT00455013|69654133|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
37686108|NCT02465437|69161988|FG003|Overall Study|Physician Decision|0|||
37686109|NCT02465437|69161985|FG000|Overall Study|Withdrawal by Subject|1|||
37686110|NCT02465437|69161986|FG001|Overall Study|Withdrawal by Subject|0|||
37686111|NCT02465437|69161987|FG002|Overall Study|Withdrawal by Subject|0|||
37686112|NCT02465437|69161988|FG003|Overall Study|Withdrawal by Subject|1|||
37686113|NCT02465437|69161985|FG000|Overall Study|Adverse Event|0|||
37686114|NCT02465437|69161986|FG001|Overall Study|Adverse Event|1|||
37686115|NCT02465437|69161987|FG002|Overall Study|Adverse Event|0|||
37686116|NCT02465437|69161988|FG003|Overall Study|Adverse Event|0|||
37967282|NCT00455013|69654134|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
37967283|NCT00455013|69654132|FG000|Long Term Extension (LTE)|non-specified|0|||
37967284|NCT00455013|69654133|FG001|Long Term Extension (LTE)|non-specified|0|||
37967285|NCT00455013|69654134|FG002|Long Term Extension (LTE)|non-specified|1|||
37967286|NCT00363298|69654144|FG000|First Study Week|Lack of Efficacy|6|||
37686117|NCT02442271|69161996|FG000|Overall Study|Adverse Event|1|||
37686118|NCT02442271|69161996|FG000|Overall Study|Withdrew Consent|1|||
37686119|NCT02442271|69161996|FG000|Overall Study|Lost to Follow-up|1|||
37686120|NCT02442271|69161996|FG000|Overall Study|Other|1|||
37686121|NCT02465203|69162017|FG000|Overall Study|Protocol Violation|1|||
37686122|NCT02465203|69162018|FG001|Overall Study|Protocol Violation|1|||
37686123|NCT02465203|69162019|FG002|Overall Study|Protocol Violation|1|||
37686124|NCT02465203|69162017|FG000|Overall Study|Study terminated by sponsor|50|||
37686125|NCT02465203|69162018|FG001|Overall Study|Study terminated by sponsor|34|||
37686126|NCT02465203|69162019|FG002|Overall Study|Study terminated by sponsor|11|||
37686127|NCT02465203|69162017|FG000|Overall Study|New therapy for study indication|4|||
37686128|NCT02465203|69162018|FG001|Overall Study|New therapy for study indication|0|||
37686129|NCT02465203|69162019|FG002|Overall Study|New therapy for study indication|0|||
37686130|NCT02465203|69162017|FG000|Overall Study|Patient/guardian decision|1|||
37686131|NCT02465203|69162018|FG001|Overall Study|Patient/guardian decision|1|||
37686132|NCT02465203|69162019|FG002|Overall Study|Patient/guardian decision|1|||
37686133|NCT02463409|69162026|FG000|Overall Study|Withdrawal by Subject|1|||
37686134|NCT02463409|69162026|FG000|Overall Study|Screen failure|1|||
37686135|NCT02528357|69162049|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
37686136|NCT02528357|69162050|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
37686137|NCT02528357|69162051|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
37686138|NCT02528357|69162052|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
37686139|NCT02528357|69162053|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
37686140|NCT02528357|69162054|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
37686141|NCT02528357|69162055|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
37686142|NCT02528357|69162056|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
37967287|NCT00363298|69654145|FG001|First Study Week|Lack of Efficacy|5|||
37967288|NCT00363298|69654144|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
37967289|NCT00363298|69654145|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
37967290|NCT00363142|69654154|FG000|Overall Study|Adverse Event|2|||
37686143|NCT02528357|69162057|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
37686144|NCT02528357|69162058|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
37686145|NCT02528357|69162059|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
37686146|NCT02528357|69162060|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
37686147|NCT02528357|69162061|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
37686148|NCT02528357|69162062|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
37686149|NCT02528357|69162063|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
37686150|NCT02528357|69162064|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
37686151|NCT02528357|69162065|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
37686152|NCT02528357|69162066|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
37686153|NCT02528357|69162067|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
37686154|NCT02528357|69162049|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
37686155|NCT02528357|69162050|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
37686156|NCT02528357|69162051|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
37686157|NCT02528357|69162052|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
37686158|NCT02528357|69162053|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
37686159|NCT02528357|69162054|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
37686160|NCT02528357|69162055|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
37967291|NCT00363142|69654155|FG001|Overall Study|Adverse Event|0|||
37967292|NCT00363142|69654154|FG000|Overall Study|Lack of Efficacy|0|||
37686161|NCT02528357|69162056|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
37686162|NCT02528357|69162057|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
37686163|NCT02528357|69162058|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
37686164|NCT02528357|69162059|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
37686165|NCT02528357|69162060|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
37686166|NCT02528357|69162061|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
37686167|NCT02528357|69162062|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
37686168|NCT02528357|69162063|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
37686169|NCT02528357|69162064|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
37686170|NCT02528357|69162065|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
37686171|NCT02528357|69162066|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
37686172|NCT02528357|69162067|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
37686173|NCT02528357|69162049|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
37686174|NCT02528357|69162050|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
37686175|NCT02528357|69162051|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
37686176|NCT02528357|69162052|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
37686177|NCT02528357|69162053|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
37686178|NCT02528357|69162054|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
37686179|NCT02528357|69162055|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
37686180|NCT02528357|69162056|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
37686181|NCT02528357|69162057|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
37686182|NCT02528357|69162058|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
37686183|NCT02528357|69162059|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
37686184|NCT02528357|69162060|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
37686185|NCT02528357|69162061|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
37686186|NCT02528357|69162062|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
37686187|NCT02528357|69162063|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
37686188|NCT02528357|69162064|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
37686189|NCT02528357|69162065|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
37686190|NCT02528357|69162066|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
37686191|NCT02528357|69162067|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
37686192|NCT02528357|69162049|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
37686193|NCT02528357|69162050|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
37686194|NCT02528357|69162051|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
37686195|NCT02528357|69162052|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
37686196|NCT02528357|69162053|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
37686197|NCT02528357|69162054|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
37967293|NCT00363142|69654155|FG001|Overall Study|Lack of Efficacy|1|||
37967294|NCT00363142|69654154|FG000|Overall Study|Lost to Follow-up|1|||
37967295|NCT00363142|69654155|FG001|Overall Study|Lost to Follow-up|0|||
37967296|NCT00363142|69654154|FG000|Overall Study|Non-compliance|1|||
37967297|NCT00363142|69654155|FG001|Overall Study|Non-compliance|1|||
37967298|NCT00363142|69654154|FG000|Overall Study|Withdrawal by Subject|3|||
37967299|NCT00363142|69654155|FG001|Overall Study|Withdrawal by Subject|1|||
37967300|NCT00454857|69654164|FG000|Overall Study|Withdrawal by Subject|15|||
37967301|NCT00454857|69654164|FG000|Overall Study|Lost to Follow-up|16|||
37967302|NCT00454857|69654164|FG000|Overall Study|Noncompliance|6|||
37967303|NCT00454857|69654164|FG000|Overall Study|Death|5|||
37967304|NCT00454857|69654164|FG000|Overall Study|Other|11|||
37967305|NCT00454857|69654164|FG000|Overall Study|Reason unknown|1|||
37967306|NCT00379912|69654170|FG000|Overall Study|Lack of Efficacy|1|||
37967307|NCT00379912|69654171|FG001|Overall Study|Lack of Efficacy|0|||
37967308|NCT00379834|69654183|FG000|Overall Study|Time constraints|2|||
37967309|NCT00379210|69654189|FG000|Overall Study|Withdrawal by Subject|10|||
37967310|NCT00379210|69654190|FG001|Overall Study|Withdrawal by Subject|7|||
37967311|NCT00378898|69654198|FG000|Overall Study|Withdrawal by Subject|10|||
37967312|NCT00378898|69654199|FG001|Overall Study|Withdrawal by Subject|5|||
38084820|NCT02624284|69784236|FG002|Overall Study|Revealed exclusionary condition|0|||
38084821|NCT02624284|69784234|FG000|Overall Study|Adverse Event|0|||
38084822|NCT02624284|69784235|FG001|Overall Study|Adverse Event|0|||
38084823|NCT02624284|69784236|FG002|Overall Study|Adverse Event|1|||
38084824|NCT02738450|69784248|FG000|Overall Study|Withdrawal by Subject|0|||
38084825|NCT02738450|69784249|FG001|Overall Study|Withdrawal by Subject|2|||
38084826|NCT02738450|69784250|FG002|Overall Study|Withdrawal by Subject|0|||
38084827|NCT02624050|69784261|FG000|Overall Study|Physician Decision|4|||
38084828|NCT02624050|69784262|FG001|Overall Study|Physician Decision|0|||
38084829|NCT02624050|69784261|FG000|Overall Study|Protocol Violation|2|||
38084830|NCT02624050|69784262|FG001|Overall Study|Protocol Violation|0|||
38084831|NCT01338987|69784278|FG000|Overall Study|enrolled on new protocol|0|||
38084832|NCT01338987|69784279|FG001|Overall Study|enrolled on new protocol|0|||
38084833|NCT01338987|69784280|FG002|Overall Study|enrolled on new protocol|1|||
38084834|NCT01338987|69784281|FG003|Overall Study|enrolled on new protocol|0|||
38084835|NCT01338987|69784282|FG004|Overall Study|enrolled on new protocol|0|||
38084836|NCT01338987|69784278|FG000|Overall Study|Disease progression on study|2|||
38084837|NCT01338987|69784279|FG001|Overall Study|Disease progression on study|1|||
38084838|NCT01338987|69784280|FG002|Overall Study|Disease progression on study|1|||
38084839|NCT01338987|69784281|FG003|Overall Study|Disease progression on study|0|||
38084840|NCT01338987|69784282|FG004|Overall Study|Disease progression on study|0|||
38084841|NCT03706430|69784296|FG000|Overall Study|No A-Line placed|5|||
38084842|NCT03706430|69784296|FG000|Overall Study|Subject had gel nail polish|1|||
38084843|NCT03706430|69784296|FG000|Overall Study|Nail length causing difficulties with sensor|1|||
38084844|NCT03706430|69784296|FG000|Overall Study|Cancelled Case|6|||
38084845|NCT03706430|69784296|FG000|Overall Study|Physician Decision|2|||
38084846|NCT02738138|69784318|FG000|Overall Study|Adverse Event|0|||
38084847|NCT02738138|69784319|FG001|Overall Study|Adverse Event|1|||
38084848|NCT02738138|69784318|FG000|Overall Study|Lost to Follow-up|2|||
38084849|NCT02738138|69784319|FG001|Overall Study|Lost to Follow-up|0|||
38084850|NCT02738138|69784318|FG000|Overall Study|Other - not further specified|1|||
38084851|NCT02738138|69784319|FG001|Overall Study|Other - not further specified|0|||
38084852|NCT01355289|69784328|FG000|Core Study|Adverse Event, Non-Fatal|1|||
38084853|NCT01355289|69784329|FG001|Core Study|Adverse Event, Non-Fatal|0|||
38084854|NCT01355289|69784330|FG002|Core Study|Adverse Event, Non-Fatal|0|||
38084855|NCT01355289|69784331|FG003|Core Study|Adverse Event, Non-Fatal|0|||
38084856|NCT01355289|69784332|FG004|Core Study|Adverse Event, Non-Fatal|0|||
38084857|NCT01355289|69784328|FG000|Core Study|Inadequate Therapeutic Effect|0|||
38084858|NCT01355289|69784329|FG001|Core Study|Inadequate Therapeutic Effect|0|||
38084859|NCT01355289|69784330|FG002|Core Study|Inadequate Therapeutic Effect|0|||
38084860|NCT01355289|69784331|FG003|Core Study|Inadequate Therapeutic Effect|1|||
38084861|NCT01355289|69784332|FG004|Core Study|Inadequate Therapeutic Effect|0|||
38084862|NCT01355289|69784328|FG000|Core Study|Other|0|||
38084863|NCT01355289|69784329|FG001|Core Study|Other|0|||
38084864|NCT01355289|69784330|FG002|Core Study|Other|0|||
38084865|NCT01355289|69784331|FG003|Core Study|Other|1|||
38084866|NCT01355289|69784332|FG004|Core Study|Other|0|||
38084867|NCT01355289|69784328|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
38084868|NCT01355289|69784329|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
38084869|NCT01355289|69784330|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
38084870|NCT01355289|69784331|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
37686198|NCT02528357|69162055|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
37686199|NCT02528357|69162056|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
37686200|NCT02528357|69162057|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
37686201|NCT02528357|69162058|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
37686202|NCT02528357|69162059|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
37699579|NCT02011893|69176450|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
38084871|NCT01355289|69784332|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
38084872|NCT01355289|69784328|FG000|Open Label Extension|Lost to Follow-up|0|||
38084873|NCT01355289|69784329|FG001|Open Label Extension|Lost to Follow-up|0|||
38084874|NCT01355289|69784330|FG002|Open Label Extension|Lost to Follow-up|0|||
38084875|NCT01355289|69784331|FG003|Open Label Extension|Lost to Follow-up|0|||
38084876|NCT01355289|69784332|FG004|Open Label Extension|Lost to Follow-up|1|||
38084877|NCT01355289|69784328|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
38084878|NCT01355289|69784329|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
38084879|NCT01355289|69784330|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
38084880|NCT01355289|69784331|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
38084881|NCT01355289|69784332|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
38084882|NCT01355289|69784328|FG000|Open Label Extension|Other|0|||
37686203|NCT02528357|69162060|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
37686204|NCT02528357|69162061|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
37686205|NCT02528357|69162062|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
37686206|NCT02528357|69162063|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
37686207|NCT02528357|69162064|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
37686208|NCT02528357|69162065|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
37686209|NCT02528357|69162066|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
37686210|NCT02528357|69162067|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
37686211|NCT02528357|69162049|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
37863015|NCT01263197|69546935|FG003|Third Intervention (Period 3)|Adverse Event|0|||
38084883|NCT01355289|69784329|FG001|Open Label Extension|Other|0|||
38084884|NCT01355289|69784330|FG002|Open Label Extension|Other|0|||
38084885|NCT01355289|69784331|FG003|Open Label Extension|Other|0|||
38084886|NCT01355289|69784332|FG004|Open Label Extension|Other|3|||
38084887|NCT02737592|69784345|FG000|Overall Study|Withdrawal by Subject|1|||
38084888|NCT02737358|69784372|FG000|Overall Study|Withdrawal by Subject|7|||
38084889|NCT02737358|69784373|FG001|Overall Study|Withdrawal by Subject|12|||
38084890|NCT02737358|69784372|FG000|Overall Study|Lost to Follow-up|2|||
38084891|NCT02737358|69784373|FG001|Overall Study|Lost to Follow-up|3|||
38084892|NCT01354431|69784382|FG000|Pre-Treatment Period|Not reported|1|||
38084893|NCT01354431|69784383|FG001|Pre-Treatment Period|Not reported|0|||
38084894|NCT01354431|69784384|FG002|Pre-Treatment Period|Not reported|0|||
38084895|NCT01354431|69784382|FG000|Treatment Period|Disease Progression|50|||
38084896|NCT01354431|69784383|FG001|Treatment Period|Disease Progression|40|||
38084897|NCT01354431|69784384|FG002|Treatment Period|Disease Progression|44|||
38084898|NCT01354431|69784382|FG000|Treatment Period|Study Drug Toxicity|5|||
38084899|NCT01354431|69784383|FG001|Treatment Period|Study Drug Toxicity|8|||
38084900|NCT01354431|69784384|FG002|Treatment Period|Study Drug Toxicity|4|||
38084901|NCT01354431|69784382|FG000|Treatment Period|Death|0|||
38084902|NCT01354431|69784383|FG001|Treatment Period|Death|1|||
38084903|NCT01354431|69784384|FG002|Treatment Period|Death|0|||
38084904|NCT01354431|69784382|FG000|Treatment Period|AE unrelated to study drug|1|||
38084905|NCT01354431|69784383|FG001|Treatment Period|AE unrelated to study drug|2|||
38084906|NCT01354431|69784384|FG002|Treatment Period|AE unrelated to study drug|5|||
38084907|NCT01354431|69784382|FG000|Treatment Period|Participant request to discontinue|2|||
38084908|NCT01354431|69784383|FG001|Treatment Period|Participant request to discontinue|2|||
38084909|NCT01354431|69784384|FG002|Treatment Period|Participant request to discontinue|1|||
38084910|NCT01354431|69784382|FG000|Treatment Period|Participant withdrew consent|0|||
38084911|NCT01354431|69784383|FG001|Treatment Period|Participant withdrew consent|1|||
38084912|NCT01354431|69784384|FG002|Treatment Period|Participant withdrew consent|0|||
38084913|NCT01354431|69784382|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
38084914|NCT01354431|69784383|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
38084915|NCT01354431|69784384|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
38084916|NCT02736578|69784394|FG000|Overall Study|Adverse Event|1|||
38084917|NCT02736578|69784395|FG001|Overall Study|Adverse Event|0|||
38084918|NCT02622724|69784407|FG000|Overall Study|Death|51|||
38084919|NCT02622724|69784408|FG001|Overall Study|Death|53|||
38084920|NCT02622724|69784407|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
38084921|NCT02622724|69784408|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
38084922|NCT02622724|69784407|FG000|Overall Study|Early termination of study|38|||
38084923|NCT02622724|69784408|FG001|Overall Study|Early termination of study|43|||
38084924|NCT01354353|69784426|FG000|Overall Study|Adverse Event|1|||
37686212|NCT02528357|69162050|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
37686213|NCT02528357|69162051|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
37686214|NCT02528357|69162052|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
37686215|NCT02528357|69162053|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
37686216|NCT02528357|69162054|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
37686217|NCT02528357|69162055|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
37686218|NCT02528357|69162056|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
37686219|NCT02528357|69162057|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
37686220|NCT02528357|69162058|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
37686221|NCT02528357|69162059|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
37686222|NCT02528357|69162060|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
37686223|NCT02528357|69162061|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
37686224|NCT02528357|69162062|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
37686225|NCT02528357|69162063|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
37686226|NCT02528357|69162064|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
37686227|NCT02528357|69162065|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
37686228|NCT02528357|69162066|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
37686229|NCT02528357|69162067|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
37686230|NCT02528357|69162049|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
37686231|NCT02528357|69162050|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
37686232|NCT02528357|69162051|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
37686233|NCT02528357|69162052|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
37686234|NCT02528357|69162053|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
37686235|NCT02528357|69162054|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
37686236|NCT02528357|69162055|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
37686237|NCT02528357|69162056|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
37686238|NCT02528357|69162057|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
37686239|NCT02528357|69162058|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
37686240|NCT02528357|69162059|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
37686241|NCT02528357|69162060|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
37686242|NCT02528357|69162061|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
37686243|NCT02528357|69162062|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
37686244|NCT02528357|69162063|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
37686245|NCT02528357|69162064|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
37686246|NCT02528357|69162065|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
37686247|NCT02528357|69162066|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
37686248|NCT02528357|69162067|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
37686249|NCT02528357|69162049|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
37686250|NCT02528357|69162050|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
37686251|NCT02528357|69162051|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
37686252|NCT02528357|69162052|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
37686253|NCT02528357|69162053|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
37686254|NCT02528357|69162054|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
37686255|NCT02528357|69162055|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
37686256|NCT02528357|69162056|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
37686257|NCT02528357|69162057|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
37686258|NCT02528357|69162058|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
37686259|NCT02528357|69162059|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
37686260|NCT02528357|69162060|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
37686261|NCT02528357|69162061|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
37686262|NCT02528357|69162062|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
37686263|NCT02528357|69162063|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
37686264|NCT02528357|69162064|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
37686265|NCT02528357|69162065|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
37686266|NCT02528357|69162066|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
37686267|NCT02528357|69162067|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
37686268|NCT02528357|69162049|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
37686269|NCT02528357|69162050|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
37686270|NCT02528357|69162051|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
37699580|NCT02011893|69176451|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
38084925|NCT01354353|69784427|FG001|Overall Study|Adverse Event|0|||
37686271|NCT02528357|69162052|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
37686272|NCT02528357|69162053|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
37686273|NCT02528357|69162054|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
37686274|NCT02528357|69162055|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
37686275|NCT02528357|69162056|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
37686276|NCT02528357|69162057|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
37686277|NCT02528357|69162058|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
37686278|NCT02528357|69162059|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
37686279|NCT02528357|69162060|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
37686280|NCT02528357|69162061|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
38084926|NCT01354353|69784428|FG002|Overall Study|Adverse Event|0|||
38084927|NCT01354353|69784429|FG003|Overall Study|Adverse Event|4|||
38084928|NCT01354353|69784430|FG004|Overall Study|Adverse Event|0|||
38084929|NCT01354353|69784431|FG005|Overall Study|Adverse Event|5|||
38084930|NCT01354353|69784426|FG000|Overall Study|Entry Criteria Not Met|0|||
38084931|NCT01354353|69784427|FG001|Overall Study|Entry Criteria Not Met|0|||
38084932|NCT01354353|69784428|FG002|Overall Study|Entry Criteria Not Met|0|||
38084933|NCT01354353|69784429|FG003|Overall Study|Entry Criteria Not Met|1|||
38084934|NCT01354353|69784430|FG004|Overall Study|Entry Criteria Not Met|1|||
38084935|NCT01354353|69784431|FG005|Overall Study|Entry Criteria Not Met|0|||
38084936|NCT01354353|69784426|FG000|Overall Study|Physician Decision|0|||
38084937|NCT01354353|69784427|FG001|Overall Study|Physician Decision|1|||
38084938|NCT01354353|69784428|FG002|Overall Study|Physician Decision|1|||
38084939|NCT01354353|69784429|FG003|Overall Study|Physician Decision|0|||
38084940|NCT01354353|69784430|FG004|Overall Study|Physician Decision|0|||
38084941|NCT01354353|69784431|FG005|Overall Study|Physician Decision|0|||
37686281|NCT02528357|69162062|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
37686282|NCT02528357|69162063|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
37686283|NCT02528357|69162064|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
37686284|NCT02528357|69162065|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
37686285|NCT02528357|69162066|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
37686286|NCT02528357|69162067|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
37686287|NCT02528357|69162049|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
37686288|NCT02528357|69162050|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
37686289|NCT02528357|69162051|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
37686290|NCT02528357|69162052|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
37686291|NCT02528357|69162053|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
37686292|NCT02528357|69162054|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
37686293|NCT02528357|69162055|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
37686294|NCT02528357|69162056|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
37686295|NCT02528357|69162057|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
37686296|NCT02528357|69162058|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
37686297|NCT02528357|69162059|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
37686298|NCT02528357|69162060|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
37686299|NCT02528357|69162061|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
37686300|NCT02528357|69162062|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
37686301|NCT02528357|69162063|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
37686302|NCT02528357|69162064|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
37686303|NCT02528357|69162065|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
37686304|NCT02528357|69162066|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
37686305|NCT02528357|69162067|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
37686306|NCT02528357|69162049|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
37686307|NCT02528357|69162050|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
37686308|NCT02528357|69162051|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
38084942|NCT01354353|69784426|FG000|Overall Study|Withdrawal by Subject|2|||
38084943|NCT01354353|69784427|FG001|Overall Study|Withdrawal by Subject|0|||
38084944|NCT01354353|69784428|FG002|Overall Study|Withdrawal by Subject|1|||
38084945|NCT01354353|69784429|FG003|Overall Study|Withdrawal by Subject|0|||
38084946|NCT01354353|69784430|FG004|Overall Study|Withdrawal by Subject|0|||
38084947|NCT01354353|69784431|FG005|Overall Study|Withdrawal by Subject|1|||
38084948|NCT02622568|69784454|FG000|Overall Study|Lost to Follow-up|5|||
38084949|NCT02622568|69784455|FG001|Overall Study|Lost to Follow-up|5|||
37686309|NCT02528357|69162052|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
37686310|NCT02528357|69162053|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
37686311|NCT02528357|69162054|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
37686312|NCT02528357|69162055|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
37686313|NCT02528357|69162056|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
37686314|NCT02528357|69162057|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
37686315|NCT02528357|69162058|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
37686316|NCT02528357|69162059|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
37686317|NCT02528357|69162060|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
37686318|NCT02528357|69162061|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
37686319|NCT02528357|69162062|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
37686320|NCT02528357|69162063|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
37686321|NCT02528357|69162064|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
37686322|NCT02528357|69162065|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
37686323|NCT02528357|69162066|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
37686324|NCT02528357|69162067|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
37686325|NCT02463331|69162109|FG000|Overall Study|Adverse Event|4|||
37686326|NCT02463331|69162110|FG001|Overall Study|Adverse Event|2|||
37686327|NCT02463331|69162109|FG000|Overall Study|Lost to Follow-up|1|||
37686328|NCT02463331|69162110|FG001|Overall Study|Lost to Follow-up|1|||
37686329|NCT02463331|69162109|FG000|Overall Study|Pregnancy|2|||
37686330|NCT02463331|69162110|FG001|Overall Study|Pregnancy|3|||
37686331|NCT02463331|69162109|FG000|Overall Study|Lack of Efficacy|6|||
37686332|NCT02463331|69162110|FG001|Overall Study|Lack of Efficacy|0|||
37686333|NCT02463331|69162109|FG000|Overall Study|Physician Decision|3|||
37686334|NCT02463331|69162110|FG001|Overall Study|Physician Decision|0|||
37686335|NCT02410837|69162116|FG000|Overall Study|Death|387|||
37686336|NCT02410837|69162116|FG000|Overall Study|Lost to Follow-up|50|||
37686337|NCT02410837|69162116|FG000|Overall Study|Withdrawal by Subject|44|||
37686338|NCT02410837|69162116|FG000|Overall Study|Physician Decision|6|||
37686339|NCT02410837|69162116|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
37686340|NCT02314247|69162122|FG000|Overall Study|Adverse Event|2|||
37686341|NCT02314247|69162123|FG001|Overall Study|Adverse Event|1|||
37686342|NCT02314247|69162124|FG002|Overall Study|Adverse Event|0|||
37686343|NCT02314247|69162122|FG000|Overall Study|Withdrawal by Subject|1|||
37686344|NCT02314247|69162123|FG001|Overall Study|Withdrawal by Subject|3|||
37686345|NCT02314247|69162124|FG002|Overall Study|Withdrawal by Subject|1|||
37686346|NCT02314247|69162122|FG000|Overall Study|Progression of Disease|6|||
37686347|NCT02314247|69162123|FG001|Overall Study|Progression of Disease|2|||
37686348|NCT02314247|69162124|FG002|Overall Study|Progression of Disease|0|||
37686349|NCT02463097|69162134|FG000|Overall Study|Withdrawal by Subject|1|||
37686350|NCT02441179|69162140|FG000|Overall Study|Withdrawal by Subject|1|||
37686351|NCT02441179|69162141|FG001|Overall Study|Withdrawal by Subject|1|||
37686352|NCT02462473|69162148|FG000|Overall Study|Death|1|||
38084950|NCT01354899|69784461|FG000|Overall Study|discharge from the hospital|2|||
38084951|NCT01354899|69784461|FG000|Overall Study|Protocol Violation|1|||
38084952|NCT01353963|69784465|FG000|Overall Study|Adverse Event|2|||
38084953|NCT02820597|69784474|FG000|Overall Study|Lost to Follow-up|12|||
38084954|NCT02822235|69784480|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
38084955|NCT02822235|69784481|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
38084956|NCT02822235|69784480|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
38084957|NCT02822235|69784481|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
38084958|NCT02822235|69784480|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
38084959|NCT02822235|69784481|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
38084960|NCT02822235|69784480|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
37686353|NCT02462473|69162148|FG000|Overall Study|Other|3|||
37686354|NCT02440789|69162161|FG000|Overall Study|Withdrawal by Subject|3|||
37686355|NCT02440789|69162161|FG000|Overall Study|Not willing to adhere to reqs|1|||
37686356|NCT02462083|69162165|FG000|Overall Study|Sponsor request|39|||
37686357|NCT02462083|69162165|FG000|Overall Study|Withdrawal by Subject|87|||
37686358|NCT02462083|69162165|FG000|Overall Study|Lost to Follow-up|41|||
37686359|NCT02462083|69162165|FG000|Overall Study|Lack of Efficacy|151|||
37686360|NCT02462083|69162165|FG000|Overall Study|Pregnancy|1|||
37686361|NCT02462083|69162165|FG000|Overall Study|Protocol Violation|6|||
37686362|NCT02462083|69162165|FG000|Overall Study|Adverse Event|33|||
38084961|NCT02822235|69784481|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
38084962|NCT02822235|69784480|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
37686363|NCT02462083|69162165|FG000|Overall Study|Worsening condition|16|||
37686364|NCT02462083|69162165|FG000|Overall Study|Other than specified|45|||
37686365|NCT02538341|69162171|FG000|Overall Study|Lost to Follow-up|51|||
37686366|NCT02538341|69162172|FG001|Overall Study|Lost to Follow-up|46|||
37686367|NCT02538341|69162171|FG000|Overall Study|Withdrawal by Subject|3|||
37686368|NCT02538341|69162172|FG001|Overall Study|Withdrawal by Subject|1|||
37686369|NCT02538341|69162171|FG000|Overall Study|Death|2|||
37686370|NCT02538341|69162172|FG001|Overall Study|Death|0|||
37686371|NCT02538107|69162178|FG000|Overall Study|Did not receive any Mircera dose|11|||
37686372|NCT02538107|69162178|FG000|Overall Study|Missing|5|||
37686373|NCT02538107|69162178|FG000|Overall Study|Necessity of dialysis|20|||
37686374|NCT02538107|69162178|FG000|Overall Study|Administration of other ESA|11|||
37686375|NCT02538107|69162178|FG000|Overall Study|No further treatment necessary|18|||
37686376|NCT02538107|69162178|FG000|Overall Study|Withdrawal by Subject|17|||
37686377|NCT02538107|69162178|FG000|Overall Study|Death|4|||
37686378|NCT02538107|69162178|FG000|Overall Study|Administrative reason|5|||
37686379|NCT02538107|69162178|FG000|Overall Study|Adverse Event|4|||
37686380|NCT02538107|69162178|FG000|Overall Study|Surgery|1|||
37686381|NCT02538107|69162178|FG000|Overall Study|Other|7|||
37686382|NCT02538107|69162178|FG000|Overall Study|Not recorded|7|||
37686383|NCT02538029|69162195|FG000|Overall Study|unable to complete cognitive assessments|1|||
37686384|NCT02538029|69162196|FG001|Overall Study|unable to complete cognitive assessments|0|||
37686385|NCT02538029|69162197|FG002|Overall Study|unable to complete cognitive assessments|1|||
37686386|NCT02272413|69162209|FG000|Randomized Through Treatment Start|Not treated|3|||
37686387|NCT02272413|69162210|FG001|Randomized Through Treatment Start|Not treated|5|||
37686388|NCT02272413|69162209|FG000|Pre-switch Period|Adverse Event|38|||
37686389|NCT02272413|69162210|FG001|Pre-switch Period|Adverse Event|37|||
37686390|NCT02272413|69162209|FG000|Pre-switch Period|Death|26|||
37686391|NCT02272413|69162210|FG001|Pre-switch Period|Death|26|||
37686392|NCT02272413|69162209|FG000|Pre-switch Period|Withdrawal by Subject|27|||
37686393|NCT02272413|69162210|FG001|Pre-switch Period|Withdrawal by Subject|15|||
37686394|NCT02272413|69162209|FG000|Pre-switch Period|Physician Decision|6|||
37686395|NCT02272413|69162210|FG001|Pre-switch Period|Physician Decision|18|||
37686396|NCT02272413|69162209|FG000|Pre-switch Period|Progressive disease|185|||
37686397|NCT02272413|69162210|FG001|Pre-switch Period|Progressive disease|173|||
37686398|NCT02272413|69162209|FG000|Pre-switch Period|Lost to Follow-up|0|||
37686399|NCT02272413|69162210|FG001|Pre-switch Period|Lost to Follow-up|2|||
37686400|NCT02272413|69162209|FG000|Pre-switch Period|Protocol Violation|1|||
37686401|NCT02272413|69162210|FG001|Pre-switch Period|Protocol Violation|0|||
37686402|NCT02272413|69162209|FG000|Pre-switch Period|Other than listed|10|||
38084963|NCT02822235|69784481|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
38084964|NCT02822235|69784480|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
38084965|NCT02822235|69784481|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
38084966|NCT02817555|69784496|FG000|Overall Study|Death|1|||
38084967|NCT02817555|69784497|FG001|Overall Study|Death|3|||
38084968|NCT02817555|69784496|FG000|Overall Study|moved away|1|||
38084969|NCT02817555|69784497|FG001|Overall Study|moved away|0|||
38084970|NCT02817555|69784496|FG000|Overall Study|transplant|1|||
38084971|NCT02817555|69784497|FG001|Overall Study|transplant|1|||
38084972|NCT02817555|69784496|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
38084973|NCT02817555|69784497|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
38084974|NCT02817087|69784505|FG000|Overall Study|Withdrawal by Subject|2|||
37686403|NCT02272413|69162210|FG001|Pre-switch Period|Other than listed|11|||
37686404|NCT02272413|69162209|FG000|Post-switch Period|Adverse Event|4|||
37686405|NCT02272413|69162210|FG001|Post-switch Period|Adverse Event|4|||
37967313|NCT00378898|69654198|FG000|Overall Study|Protocol Violation|1|||
37967314|NCT00378898|69654199|FG001|Overall Study|Protocol Violation|1|||
37967315|NCT00378508|69654209|FG000|Overall Study|Withdrawal by Subject|1|||
37967316|NCT00378508|69654210|FG001|Overall Study|Withdrawal by Subject|3|||
37967317|NCT00378508|69654209|FG000|Overall Study|Lost to Follow-up|1|||
37967318|NCT00378508|69654210|FG001|Overall Study|Lost to Follow-up|0|||
37967319|NCT00454779|69654219|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
37967320|NCT00454779|69654220|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
38084975|NCT02817087|69784506|FG001|Overall Study|Withdrawal by Subject|0|||
38084976|NCT02813577|69784512|FG000|Overall Study|Study terminated|4|||
38084977|NCT02815293|69784519|FG000|Overall Study|Study termination by sponsor|10|||
37686406|NCT02272413|69162209|FG000|Post-switch Period|Death|3|||
37686407|NCT02272413|69162210|FG001|Post-switch Period|Death|2|||
37686408|NCT02272413|69162209|FG000|Post-switch Period|Withdrawal by Subject|1|||
37686409|NCT02272413|69162210|FG001|Post-switch Period|Withdrawal by Subject|2|||
37686410|NCT02272413|69162209|FG000|Post-switch Period|Physician Decision|1|||
37686411|NCT02272413|69162210|FG001|Post-switch Period|Physician Decision|1|||
37686412|NCT02272413|69162209|FG000|Post-switch Period|Progressive disease|21|||
38084978|NCT02815293|69784520|FG001|Overall Study|Study termination by sponsor|7|||
37686413|NCT02272413|69162210|FG001|Post-switch Period|Progressive disease|21|||
37686414|NCT02272413|69162209|FG000|Post-switch Period|Study terminated by sponsor|8|||
37686415|NCT02272413|69162210|FG001|Post-switch Period|Study terminated by sponsor|11|||
37967321|NCT00454779|69654219|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
37967322|NCT00454779|69654220|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
37967323|NCT00454779|69654219|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
37967324|NCT00454779|69654220|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
37967325|NCT00454779|69654219|FG000|First-line Treatment Phase|Protocol Violation|0|||
37967326|NCT00454779|69654220|FG001|First-line Treatment Phase|Protocol Violation|1|||
37967327|NCT00454779|69654219|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
37967328|NCT00454779|69654220|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
37967329|NCT00454779|69654219|FG000|First-line Treatment Phase|Ongoing|1|||
37686416|NCT02272413|69162209|FG000|Post-switch Period|Other than listed|4|||
37686417|NCT02272413|69162210|FG001|Post-switch Period|Other than listed|5|||
37686418|NCT02396381|69162222|FG000|Overall Study|Adverse Event|3|||
37686419|NCT02396381|69162223|FG001|Overall Study|Adverse Event|2|||
37686420|NCT02396381|69162222|FG000|Overall Study|Withdrawal by Subject|33|||
37686421|NCT02396381|69162223|FG001|Overall Study|Withdrawal by Subject|24|||
37686422|NCT02396381|69162222|FG000|Overall Study|Lost to Follow-up|49|||
37686423|NCT02396381|69162223|FG001|Overall Study|Lost to Follow-up|31|||
37686424|NCT02396381|69162222|FG000|Overall Study|Protocol Violation|1|||
37686425|NCT02396381|69162223|FG001|Overall Study|Protocol Violation|0|||
37686426|NCT02396381|69162222|FG000|Overall Study|Site terminated by sponsor|7|||
37686427|NCT02396381|69162223|FG001|Overall Study|Site terminated by sponsor|8|||
37686428|NCT02396381|69162222|FG000|Overall Study|Physician Decision|5|||
37686429|NCT02396381|69162223|FG001|Overall Study|Physician Decision|5|||
37686430|NCT02396381|69162222|FG000|Overall Study|Pregnancy|2|||
37686431|NCT02396381|69162223|FG001|Overall Study|Pregnancy|0|||
37686432|NCT02396381|69162222|FG000|Overall Study|Non-compliance with study procedures|1|||
37686433|NCT02396381|69162223|FG001|Overall Study|Non-compliance with study procedures|0|||
37686434|NCT02396381|69162222|FG000|Overall Study|Moved out of town/state|1|||
37686435|NCT02396381|69162223|FG001|Overall Study|Moved out of town/state|3|||
37686436|NCT02396381|69162222|FG000|Overall Study|Could not complete visit|1|||
37686437|NCT02396381|69162223|FG001|Overall Study|Could not complete visit|0|||
37686438|NCT02396381|69162222|FG000|Overall Study|Possible conflict of interest|1|||
37686439|NCT02396381|69162223|FG001|Overall Study|Possible conflict of interest|0|||
37686440|NCT02396381|69162222|FG000|Overall Study|Randomization/Screening Error|3|||
37686441|NCT02396381|69162223|FG001|Overall Study|Randomization/Screening Error|1|||
37686442|NCT02532647|69162235|FG000|Overall Study|Did not receive trial medication|1|||
37686443|NCT02532647|69162236|FG001|Overall Study|Did not receive trial medication|0|||
37686444|NCT02532647|69162237|FG002|Overall Study|Did not receive trial medication|1|||
37686445|NCT02537015|69162245|FG000|Overall Study|Adverse Event|3|||
37686446|NCT02537015|69162245|FG000|Overall Study|Withdrawal by Subject|2|||
37686447|NCT02537015|69162245|FG000|Overall Study|Other Miscellaneous Reasons|1|||
37686448|NCT02271945|69162251|FG000|Overall Study|Death|3|||
37686449|NCT02271945|69162252|FG001|Overall Study|Death|3|||
37686450|NCT02271945|69162251|FG000|Overall Study|Withdrawal by Subject|1|||
37686451|NCT02271945|69162252|FG001|Overall Study|Withdrawal by Subject|1|||
37686452|NCT02271945|69162251|FG000|Overall Study|Other|1|||
37686453|NCT02271945|69162252|FG001|Overall Study|Other|1|||
37686454|NCT01660763|69162260|FG000|Overall Study|Lack of Efficacy|45|||
37686455|NCT01660763|69162261|FG001|Overall Study|Lack of Efficacy|50|||
37686456|NCT01660763|69162260|FG000|Overall Study|Adverse Event|22|||
37686457|NCT01660763|69162261|FG001|Overall Study|Adverse Event|7|||
37686458|NCT01660763|69162260|FG000|Overall Study|Protocol Violation|1|||
37686459|NCT01660763|69162261|FG001|Overall Study|Protocol Violation|0|||
37686460|NCT01660763|69162260|FG000|Overall Study|Withdrawal by Subject|4|||
37686461|NCT01660763|69162261|FG001|Overall Study|Withdrawal by Subject|0|||
37686462|NCT01660763|69162260|FG000|Overall Study|Patient ready for early discharge|28|||
37686463|NCT01660763|69162261|FG001|Overall Study|Patient ready for early discharge|4|||
37686464|NCT01937117|69162267|FG000|Overall Study|Disease Progression|7|||
37686465|NCT01937117|69162267|FG000|Overall Study|Physician Decision|4|||
37686466|NCT01937117|69162267|FG000|Overall Study|Adverse Event|2|||
37686467|NCT02268045|69162273|FG000|Overall Study|Death|4|||
37686468|NCT02268045|69162274|FG001|Overall Study|Death|4|||
37686469|NCT02268045|69162273|FG000|Overall Study|Disease Progression|2|||
37686470|NCT02268045|69162274|FG001|Overall Study|Disease Progression|1|||
37967330|NCT00454779|69654220|FG001|First-line Treatment Phase|Ongoing|0|||
37967331|NCT00454779|69654219|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
37967332|NCT00454779|69654220|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
37967333|NCT00454779|69654219|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
37686471|NCT02268045|69162273|FG000|Overall Study|Adverse Event|7|||
37686472|NCT02268045|69162274|FG001|Overall Study|Adverse Event|7|||
37686473|NCT02268045|69162273|FG000|Overall Study|Withdrawal by Subject|2|||
37686474|NCT02268045|69162274|FG001|Overall Study|Withdrawal by Subject|6|||
37686475|NCT02268045|69162273|FG000|Overall Study|Physician Decision|0|||
37686476|NCT02268045|69162274|FG001|Overall Study|Physician Decision|1|||
37686477|NCT02268045|69162273|FG000|Overall Study|Protocol Violation|1|||
37967334|NCT00454779|69654220|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
37686478|NCT02268045|69162274|FG001|Overall Study|Protocol Violation|1|||
37686479|NCT02536781|69162284|FG000|Overall Study|Lost to Follow-up|2|||
37686480|NCT02536781|69162285|FG001|Overall Study|Lost to Follow-up|0|||
37686481|NCT02267187|69162291|FG000|Overall Study|Physician Decision|2|||
37686482|NCT02267187|69162291|FG000|Overall Study|Screen fail|3|||
37686483|NCT02532179|69162295|FG000|Overall Study|Lost to Follow-up|1|||
37686484|NCT02532179|69162295|FG000|Overall Study|Pregnancy|1|||
37686485|NCT02532179|69162295|FG000|Overall Study|Subject received depot steroid injection|1|||
37686486|NCT02409667|69162299|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
37686487|NCT02409667|69162300|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
37686488|NCT02409667|69162301|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
37686489|NCT02409667|69162302|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
37686490|NCT02409667|69162303|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
37686491|NCT02409667|69162299|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
37686492|NCT02409667|69162300|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
37686493|NCT02409667|69162301|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
37686494|NCT02409667|69162302|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
37686495|NCT02409667|69162303|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
37686496|NCT02409667|69162299|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
37686497|NCT02409667|69162300|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
37686498|NCT02409667|69162301|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
37686499|NCT02409667|69162302|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
37686500|NCT02409667|69162303|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
37686501|NCT02409667|69162299|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
37686502|NCT02409667|69162300|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
37686503|NCT02409667|69162301|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
37686504|NCT02409667|69162302|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
37686505|NCT02409667|69162303|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
37686506|NCT02409667|69162299|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
37686507|NCT02409667|69162300|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
37686508|NCT02409667|69162301|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
37686509|NCT02409667|69162302|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
37686510|NCT02409667|69162303|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
37686511|NCT02409667|69162299|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
37686512|NCT02409667|69162300|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
37686513|NCT02409667|69162301|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
37686514|NCT02409667|69162302|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
37686515|NCT02409667|69162303|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
37686516|NCT02409667|69162299|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
37686517|NCT02409667|69162300|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
37686518|NCT02409667|69162301|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
37686519|NCT02409667|69162302|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
37686520|NCT02409667|69162303|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
37686521|NCT02409667|69162299|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
37686522|NCT02409667|69162300|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
37686523|NCT02409667|69162301|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
37686524|NCT02409667|69162302|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
38084979|NCT02815293|69784521|FG002|Overall Study|Study termination by sponsor|0|||
38084980|NCT02815293|69784519|FG000|Overall Study|Participants not randomized|0|||
38084981|NCT02815293|69784520|FG001|Overall Study|Participants not randomized|0|||
38084982|NCT02815293|69784521|FG002|Overall Study|Participants not randomized|18|||
37686525|NCT02409667|69162303|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
37686526|NCT02409667|69162299|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
37686527|NCT02409667|69162300|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
37686528|NCT02409667|69162301|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
37686529|NCT02409667|69162302|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
37686530|NCT02409667|69162303|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
37686531|NCT02409667|69162299|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
37686532|NCT02409667|69162300|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
37686533|NCT02409667|69162301|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
37686534|NCT02409667|69162302|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
38084983|NCT02815293|69784519|FG000|Overall Study|Adverse Event|0|||
38084984|NCT02815293|69784520|FG001|Overall Study|Adverse Event|1|||
38084985|NCT02815293|69784521|FG002|Overall Study|Adverse Event|0|||
38084986|NCT02813421|69784529|FG000|Overall Study|Withdrawal by Subject|1|||
38084987|NCT02813421|69784530|FG001|Overall Study|Withdrawal by Subject|2|||
37686535|NCT02409667|69162303|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
37686536|NCT02409667|69162299|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
37686537|NCT02409667|69162300|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
37686538|NCT02409667|69162301|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
37686539|NCT02409667|69162302|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
37686540|NCT02409667|69162303|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
37686541|NCT02409667|69162299|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
37686542|NCT02409667|69162300|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
37686543|NCT02409667|69162301|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
37686544|NCT02409667|69162302|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
37686545|NCT02409667|69162303|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
37686546|NCT02409667|69162299|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
37686547|NCT02409667|69162300|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
37686548|NCT02409667|69162301|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
37686549|NCT02409667|69162302|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
37686550|NCT02409667|69162303|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
37686551|NCT02409667|69162299|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
37686552|NCT02409667|69162300|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
37686553|NCT02409667|69162301|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
37686554|NCT02409667|69162302|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
37686555|NCT02409667|69162303|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
37686556|NCT02409667|69162299|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
37686557|NCT02409667|69162300|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
37686558|NCT02409667|69162301|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
37686559|NCT02409667|69162302|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
37686560|NCT02409667|69162303|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
37686561|NCT02409667|69162299|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
37686562|NCT02409667|69162300|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
37686563|NCT02409667|69162301|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
37686564|NCT02409667|69162302|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
37686565|NCT02409667|69162303|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
37686566|NCT01641939|69162317|FG000|Overall Study|Death|90|||
37686567|NCT01641939|69162318|FG001|Overall Study|Death|187|||
38084988|NCT02813421|69784529|FG000|Overall Study|Lost to Follow-up|1|||
38084989|NCT02813421|69784530|FG001|Overall Study|Lost to Follow-up|1|||
38084990|NCT03672188|69784551|FG000|Overall Study|Withdrawal by Subject|0|||
38084991|NCT03672188|69784552|FG001|Overall Study|Withdrawal by Subject|0|||
38084992|NCT03672188|69784553|FG002|Overall Study|Withdrawal by Subject|0|||
38084993|NCT03672188|69784554|FG003|Overall Study|Withdrawal by Subject|3|||
38084994|NCT03672188|69784555|FG004|Overall Study|Withdrawal by Subject|0|||
38084995|NCT03672188|69784556|FG005|Overall Study|Withdrawal by Subject|0|||
38084996|NCT03672188|69784557|FG006|Overall Study|Withdrawal by Subject|0|||
38084997|NCT03672188|69784558|FG007|Overall Study|Withdrawal by Subject|0|||
38084998|NCT03672188|69784559|FG008|Overall Study|Withdrawal by Subject|0|||
38084999|NCT03672188|69784560|FG009|Overall Study|Withdrawal by Subject|0|||
38085000|NCT03672188|69784561|FG010|Overall Study|Withdrawal by Subject|0|||
38085001|NCT03672188|69784562|FG011|Overall Study|Withdrawal by Subject|0|||
38085002|NCT03672188|69784563|FG012|Overall Study|Withdrawal by Subject|0|||
38085003|NCT03672188|69784564|FG013|Overall Study|Withdrawal by Subject|0|||
38085004|NCT03672188|69784565|FG014|Overall Study|Withdrawal by Subject|0|||
38085005|NCT03672188|69784551|FG000|Overall Study|Death|0|||
38085006|NCT03672188|69784552|FG001|Overall Study|Death|0|||
38085007|NCT03672188|69784553|FG002|Overall Study|Death|0|||
38085008|NCT03672188|69784554|FG003|Overall Study|Death|0|||
38085009|NCT03672188|69784555|FG004|Overall Study|Death|0|||
38085010|NCT03672188|69784556|FG005|Overall Study|Death|0|||
38085011|NCT03672188|69784557|FG006|Overall Study|Death|0|||
38085012|NCT03672188|69784558|FG007|Overall Study|Death|0|||
38085013|NCT03672188|69784559|FG008|Overall Study|Death|0|||
38085014|NCT03672188|69784560|FG009|Overall Study|Death|0|||
38085015|NCT03672188|69784561|FG010|Overall Study|Death|0|||
38085016|NCT03672188|69784562|FG011|Overall Study|Death|0|||
38085017|NCT03672188|69784563|FG012|Overall Study|Death|1|||
37686568|NCT01641939|69162319|FG002|Overall Study|Death|61|||
37686569|NCT01641939|69162317|FG000|Overall Study|Lost to Follow-up|3|||
37686570|NCT01641939|69162318|FG001|Overall Study|Lost to Follow-up|2|||
37686571|NCT01641939|69162319|FG002|Overall Study|Lost to Follow-up|1|||
37686572|NCT01641939|69162317|FG000|Overall Study|Withdrawal by Subject|14|||
37686573|NCT01641939|69162318|FG001|Overall Study|Withdrawal by Subject|11|||
37686574|NCT01641939|69162319|FG002|Overall Study|Withdrawal by Subject|5|||
37967335|NCT00454779|69654219|FG000|Second-line Treatment Phase|Ongoing|0|||
37967336|NCT00454779|69654220|FG001|Second-line Treatment Phase|Ongoing|1|||
38085018|NCT03672188|69784564|FG013|Overall Study|Death|0|||
38085019|NCT03672188|69784565|FG014|Overall Study|Death|0|||
38085020|NCT03672188|69784551|FG000|Overall Study|Lost to Follow-up|0|||
38085021|NCT03672188|69784552|FG001|Overall Study|Lost to Follow-up|0|||
38085022|NCT03672188|69784553|FG002|Overall Study|Lost to Follow-up|1|||
38085023|NCT03672188|69784554|FG003|Overall Study|Lost to Follow-up|0|||
38085024|NCT03672188|69784555|FG004|Overall Study|Lost to Follow-up|0|||
38085025|NCT03672188|69784556|FG005|Overall Study|Lost to Follow-up|0|||
38085026|NCT03672188|69784557|FG006|Overall Study|Lost to Follow-up|0|||
38085027|NCT03672188|69784558|FG007|Overall Study|Lost to Follow-up|0|||
38085028|NCT03672188|69784559|FG008|Overall Study|Lost to Follow-up|0|||
38085029|NCT03672188|69784560|FG009|Overall Study|Lost to Follow-up|0|||
38085030|NCT03672188|69784561|FG010|Overall Study|Lost to Follow-up|0|||
38085031|NCT03672188|69784562|FG011|Overall Study|Lost to Follow-up|0|||
38085032|NCT03672188|69784563|FG012|Overall Study|Lost to Follow-up|0|||
38085033|NCT03672188|69784564|FG013|Overall Study|Lost to Follow-up|0|||
38085034|NCT03672188|69784565|FG014|Overall Study|Lost to Follow-up|0|||
38085035|NCT02620384|69784633|FG000|Overall Study|Adverse Event|2|||
38085036|NCT02620384|69784634|FG001|Overall Study|Adverse Event|1|||
38085037|NCT02620384|69784633|FG000|Overall Study|Discharged prior to 2nd dose|2|||
38085038|NCT02620384|69784634|FG001|Overall Study|Discharged prior to 2nd dose|5|||
38085039|NCT02620384|69784633|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
38085040|NCT02620384|69784634|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
38085041|NCT03915860|69784640|FG000|Overall Study|Adverse Event|3|||
38085042|NCT03915860|69784640|FG000|Overall Study|Withdrawal by Subject|6|||
38085043|NCT03915860|69784640|FG000|Overall Study|Lost to Follow-up|2|||
38085044|NCT03915860|69784640|FG000|Overall Study|Other than specified|3|||
38085045|NCT05047211|69784655|FG000|Overall Study|Lost to Follow-up|8|||
38085046|NCT05047211|69784656|FG001|Overall Study|Lost to Follow-up|5|||
38085047|NCT04958642|69784665|FG000|Overall Study|Transferred to OLEX program|3|||
38085048|NCT04958642|69784666|FG001|Overall Study|Transferred to OLEX program|0|||
38085049|NCT04958642|69784667|FG002|Overall Study|Transferred to OLEX program|5|||
38085050|NCT04958642|69784665|FG000|Overall Study|Death|0|||
38085051|NCT04958642|69784666|FG001|Overall Study|Death|0|||
38085052|NCT04958642|69784667|FG002|Overall Study|Death|1|||
38085053|NCT04958642|69784665|FG000|Overall Study|Withdrawal by Subject|4|||
38085054|NCT04958642|69784666|FG001|Overall Study|Withdrawal by Subject|9|||
38085055|NCT04958642|69784667|FG002|Overall Study|Withdrawal by Subject|13|||
38085056|NCT04958642|69784665|FG000|Overall Study|Investigator's Decision|0|||
38085057|NCT04958642|69784666|FG001|Overall Study|Investigator's Decision|0|||
38085058|NCT04958642|69784667|FG002|Overall Study|Investigator's Decision|1|||
38085059|NCT04958642|69784665|FG000|Overall Study|Adverse Event|1|||
38085060|NCT04958642|69784666|FG001|Overall Study|Adverse Event|0|||
38085061|NCT04958642|69784667|FG002|Overall Study|Adverse Event|1|||
38085062|NCT04958642|69784665|FG000|Overall Study|Termination by Sponsor/Regulatory Authorities|8|||
37686575|NCT01641939|69162317|FG000|Overall Study|Study Terminated by Sponsor|10|||
37686576|NCT01641939|69162318|FG001|Overall Study|Study Terminated by Sponsor|28|||
37686577|NCT01641939|69162319|FG002|Overall Study|Study Terminated by Sponsor|3|||
37686578|NCT01641861|69162331|FG000|Overall Study|Lost to Follow-up|21|||
37686579|NCT01641861|69162332|FG001|Overall Study|Lost to Follow-up|16|||
37686580|NCT01641861|69162331|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
37686581|NCT01641861|69162332|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
37686582|NCT01641861|69162331|FG000|Overall Study|Died due to drowning|0|||
37686583|NCT01641861|69162332|FG001|Overall Study|Died due to drowning|1|||
37686584|NCT02409355|69162340|FG000|Overall Study|Withdrawal by Subject|1|||
37686585|NCT02409355|69162341|FG001|Overall Study|Withdrawal by Subject|0|||
37686586|NCT02409355|69162340|FG000|Overall Study|Death|1|||
37686587|NCT02409355|69162341|FG001|Overall Study|Death|1|||
37686588|NCT02409355|69162340|FG000|Overall Study|Study terminated by Sponsor|2|||
37686589|NCT02409355|69162341|FG001|Overall Study|Study terminated by Sponsor|3|||
38085063|NCT04958642|69784666|FG001|Overall Study|Termination by Sponsor/Regulatory Authorities|4|||
38085064|NCT04958642|69784667|FG002|Overall Study|Termination by Sponsor/Regulatory Authorities|13|||
37686590|NCT02408887|69162349|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
37686591|NCT02408887|69162350|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
38085065|NCT04958642|69784665|FG000|Overall Study|Lost to Follow-up|1|||
38085066|NCT04958642|69784666|FG001|Overall Study|Lost to Follow-up|0|||
38085067|NCT04958642|69784667|FG002|Overall Study|Lost to Follow-up|0|||
37686592|NCT02408887|69162349|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
37686593|NCT02408887|69162350|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
37967337|NCT00439569|69654230|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
38085068|NCT04958642|69784665|FG000|Overall Study|Transferred to EAP following study termination|0|||
38085069|NCT04958642|69784666|FG001|Overall Study|Transferred to EAP following study termination|0|||
38085070|NCT04958642|69784667|FG002|Overall Study|Transferred to EAP following study termination|1|||
38085071|NCT04958642|69784665|FG000|Overall Study|Transferred to Expanded Access Program|1|||
38085072|NCT04958642|69784666|FG001|Overall Study|Transferred to Expanded Access Program|0|||
37686594|NCT02266875|69162358|FG000|Overall Study|Withdrawal by Subject|9|||
37686595|NCT02266875|69162359|FG001|Overall Study|Withdrawal by Subject|0|||
37686596|NCT02266875|69162358|FG000|Overall Study|Lost to Follow-up|2|||
37686597|NCT02266875|69162359|FG001|Overall Study|Lost to Follow-up|0|||
37686598|NCT02438371|69162367|FG000|Overall Study|Lost to Follow-up|3|||
37686599|NCT02438371|69162368|FG001|Overall Study|Lost to Follow-up|2|||
37686600|NCT02438371|69162367|FG000|Overall Study|Withdrawal by Subject|1|||
37686601|NCT02438371|69162368|FG001|Overall Study|Withdrawal by Subject|1|||
37686602|NCT02438137|69162376|FG000|Overall Study|Lost to Follow-up|3|||
37686603|NCT02438137|69162377|FG001|Overall Study|Lost to Follow-up|2|||
37686604|NCT02438137|69162376|FG000|Overall Study|Adverse Event|1|||
37686605|NCT02438137|69162377|FG001|Overall Study|Adverse Event|0|||
37686606|NCT02438137|69162376|FG000|Overall Study|Withdrawal by Subject|4|||
38085073|NCT04958642|69784667|FG002|Overall Study|Transferred to Expanded Access Program|0|||
38085074|NCT04439357|69784675|FG000|Overall Study|Disease Progression|4|||
38085075|NCT04321343|69784683|FG000|Overall Study|Adverse Event|0|||
38085076|NCT04321343|69784684|FG001|Overall Study|Adverse Event|0|||
38085077|NCT04321343|69784685|FG002|Overall Study|Adverse Event|1|||
38085078|NCT04321343|69784686|FG003|Overall Study|Adverse Event|0|||
38085079|NCT04321343|69784683|FG000|Overall Study|Death|0|||
38085080|NCT04321343|69784684|FG001|Overall Study|Death|0|||
38085081|NCT04321343|69784685|FG002|Overall Study|Death|0|||
38085082|NCT04321343|69784686|FG003|Overall Study|Death|1|||
38085083|NCT04321343|69784683|FG000|Overall Study|Pregnancy|1|||
38085084|NCT04321343|69784684|FG001|Overall Study|Pregnancy|0|||
38085085|NCT04321343|69784685|FG002|Overall Study|Pregnancy|0|||
38085086|NCT04321343|69784686|FG003|Overall Study|Pregnancy|0|||
38085087|NCT04321343|69784683|FG000|Overall Study|Protocol Violation|1|||
38085088|NCT04321343|69784684|FG001|Overall Study|Protocol Violation|1|||
38085089|NCT04321343|69784685|FG002|Overall Study|Protocol Violation|1|||
38085090|NCT04321343|69784686|FG003|Overall Study|Protocol Violation|1|||
38085091|NCT04321343|69784683|FG000|Overall Study|Withdrawal by Subject|0|||
38085092|NCT04321343|69784684|FG001|Overall Study|Withdrawal by Subject|6|||
38085093|NCT04321343|69784685|FG002|Overall Study|Withdrawal by Subject|0|||
38085094|NCT04321343|69784686|FG003|Overall Study|Withdrawal by Subject|2|||
38085095|NCT04321343|69784683|FG000|Overall Study|Lost to Follow-up|2|||
38085096|NCT04321343|69784684|FG001|Overall Study|Lost to Follow-up|2|||
38085097|NCT04321343|69784685|FG002|Overall Study|Lost to Follow-up|1|||
38085098|NCT04321343|69784686|FG003|Overall Study|Lost to Follow-up|3|||
38085099|NCT04238754|69784700|FG000|Washout - 1 Week|Lost to Follow-up|1|||
38085100|NCT04238754|69784701|FG001|Washout - 1 Week|Lost to Follow-up|0|||
38085101|NCT04150068|69784723|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
38085102|NCT04150068|69784724|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
38085103|NCT04150068|69784725|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
38085104|NCT04150068|69784723|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
37686607|NCT02438137|69162377|FG001|Overall Study|Withdrawal by Subject|3|||
37686608|NCT02438137|69162376|FG000|Overall Study|Physician Decision|0|||
37686609|NCT02438137|69162377|FG001|Overall Study|Physician Decision|1|||
37686610|NCT02437903|69162385|FG000|Overall Study|Adverse Event|1|||
37686611|NCT02437903|69162385|FG000|Overall Study|Withdrawal by Subject|1|||
37686612|NCT02437903|69162385|FG000|Overall Study|Lost to Follow-up|3|||
37686613|NCT02437513|69162390|FG000|Overall Study|Withdrawal by Subject|2|||
37686614|NCT02460991|69162396|FG000|Overall Study|Withdrawal by Subject|0|||
37686615|NCT02460991|69162397|FG001|Overall Study|Withdrawal by Subject|2|||
37686616|NCT02407249|69162408|FG000|Overall Study|Did not complete 12-month follow-up|13|||
37686617|NCT02407249|69162408|FG000|Overall Study|Not treated|13|||
37686618|NCT02460679|69162412|FG000|Overall Study|Investigator Decision|1|||
37686619|NCT02460679|69162412|FG000|Overall Study|Withdrawal by Subject|4|||
37686620|NCT02459899|69162420|FG000|Overall Study|Adverse Event|1|||
37686621|NCT02459899|69162421|FG001|Overall Study|Adverse Event|1|||
37686622|NCT02459899|69162422|FG002|Overall Study|Adverse Event|0|||
37686623|NCT02459899|69162423|FG003|Overall Study|Adverse Event|0|||
37686624|NCT02459899|69162420|FG000|Overall Study|Lost to Follow-up|1|||
37686625|NCT02459899|69162421|FG001|Overall Study|Lost to Follow-up|2|||
37686626|NCT02459899|69162422|FG002|Overall Study|Lost to Follow-up|0|||
38085105|NCT04150068|69784724|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
38085106|NCT04150068|69784725|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
38085107|NCT03920293|69784734|FG000|Overall Study|Withdrawal by Subject|2|||
38085108|NCT03920293|69784735|FG001|Overall Study|Withdrawal by Subject|1|||
37686627|NCT02459899|69162423|FG003|Overall Study|Lost to Follow-up|1|||
38085109|NCT03920293|69784734|FG000|Overall Study|Physician Decision|1|||
38085110|NCT03920293|69784735|FG001|Overall Study|Physician Decision|2|||
38085111|NCT03920293|69784734|FG000|Overall Study|Adverse Event|0|||
38085112|NCT03920293|69784735|FG001|Overall Study|Adverse Event|2|||
38085113|NCT03920293|69784734|FG000|Overall Study|Sponsor Decision|0|||
38085114|NCT03920293|69784735|FG001|Overall Study|Sponsor Decision|1|||
38085115|NCT03920293|69784734|FG000|Overall Study|Death|2|||
38085116|NCT03920293|69784735|FG001|Overall Study|Death|0|||
38085117|NCT03920293|69784734|FG000|Overall Study|Protocol Violation|1|||
37686628|NCT02459899|69162420|FG000|Overall Study|Non-compliance with the treatment|0|||
37686629|NCT02459899|69162421|FG001|Overall Study|Non-compliance with the treatment|0|||
37686630|NCT02459899|69162422|FG002|Overall Study|Non-compliance with the treatment|0|||
37686631|NCT02459899|69162423|FG003|Overall Study|Non-compliance with the treatment|1|||
37686632|NCT02459899|69162420|FG000|Overall Study|Withdrawal by Subject|1|||
37686633|NCT02459899|69162421|FG001|Overall Study|Withdrawal by Subject|3|||
37686634|NCT02459899|69162422|FG002|Overall Study|Withdrawal by Subject|0|||
37686635|NCT02459899|69162423|FG003|Overall Study|Withdrawal by Subject|0|||
37686636|NCT02436889|69162435|FG000|Overall Study|No improvement in symptoms|1|||
37686637|NCT02436889|69162436|FG001|Overall Study|No improvement in symptoms|0|||
37686638|NCT02436889|69162435|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
38085118|NCT03920293|69784735|FG001|Overall Study|Protocol Violation|0|||
38085119|NCT03920293|69784734|FG000|Overall Study|Noncompliance|1|||
38085120|NCT03920293|69784735|FG001|Overall Study|Noncompliance|0|||
38085121|NCT03478956|69784752|FG000|Overall Study|Adverse Event|1|||
38085122|NCT03478956|69784753|FG001|Overall Study|Adverse Event|0|||
38085123|NCT03478956|69784752|FG000|Overall Study|Withdrawal by Subject|0|||
38085124|NCT03478956|69784753|FG001|Overall Study|Withdrawal by Subject|1|||
38085125|NCT03478956|69784752|FG000|Overall Study|Ongoing in the Study|11|||
38085126|NCT03478956|69784753|FG001|Overall Study|Ongoing in the Study|11|||
38085127|NCT03317496|69784767|FG000|Phase 1b Lead-in: Treatment|Adverse Event|3|||
38085128|NCT03317496|69784768|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
38085129|NCT03317496|69784769|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
38085130|NCT03317496|69784770|FG003|Phase 1b Lead-in: Treatment|Adverse Event|1|||
38085131|NCT03317496|69784771|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
38085132|NCT03317496|69784767|FG000|Phase 1b Lead-in: Treatment|Physician Decision|0|||
38085133|NCT03317496|69784768|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
38085134|NCT03317496|69784769|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
38085135|NCT03317496|69784770|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
38085136|NCT03317496|69784771|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
38085137|NCT03317496|69784767|FG000|Phase 1b Lead-in: Treatment|Death|0|||
38085138|NCT03317496|69784768|FG001|Phase 1b Lead-in: Treatment|Death|0|||
38085139|NCT03317496|69784769|FG002|Phase 1b Lead-in: Treatment|Death|1|||
38085140|NCT03317496|69784770|FG003|Phase 1b Lead-in: Treatment|Death|0|||
38085141|NCT03317496|69784771|FG004|Phase 1b Lead-in: Treatment|Death|0|||
38085142|NCT03317496|69784767|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
38085143|NCT03317496|69784768|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
38085144|NCT03317496|69784769|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
38085145|NCT03317496|69784770|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
38085146|NCT03317496|69784771|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
38085147|NCT03317496|69784767|FG000|Phase 1b Lead-in: Treatment|Other|2|||
38085148|NCT03317496|69784768|FG001|Phase 1b Lead-in: Treatment|Other|1|||
38085149|NCT03317496|69784769|FG002|Phase 1b Lead-in: Treatment|Other|0|||
38085150|NCT03317496|69784770|FG003|Phase 1b Lead-in: Treatment|Other|0|||
38085151|NCT03317496|69784771|FG004|Phase 1b Lead-in: Treatment|Other|0|||
38085152|NCT03317496|69784767|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
38085153|NCT03317496|69784768|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
38085154|NCT03317496|69784769|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
38085155|NCT03317496|69784770|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
37686639|NCT02436889|69162436|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
37686640|NCT02436811|69162445|FG000|Overall Study|Lost to Follow-up|2|||
37686641|NCT02436811|69162446|FG001|Overall Study|Lost to Follow-up|9|||
37686642|NCT02436811|69162447|FG002|Overall Study|Lost to Follow-up|7|||
37686643|NCT02436577|69162461|FG000|Overall Study|Protocol Deviation|0|||
37686644|NCT02436577|69162462|FG001|Overall Study|Protocol Deviation|1|||
37686645|NCT02436577|69162463|FG002|Overall Study|Protocol Deviation|0|||
37686646|NCT02436577|69162464|FG003|Overall Study|Protocol Deviation|0|||
37686647|NCT02436577|69162465|FG004|Overall Study|Protocol Deviation|0|||
37686648|NCT02436577|69162466|FG005|Overall Study|Protocol Deviation|0|||
37686649|NCT02265705|69162476|FG000|Treatment Period Week 0-24|Adverse Event|3|||
37686650|NCT02265705|69162477|FG001|Treatment Period Week 0-24|Adverse Event|2|||
37686651|NCT02265705|69162478|FG002|Treatment Period Week 0-24|Adverse Event|0|||
37686652|NCT02265705|69162479|FG003|Treatment Period Week 0-24|Adverse Event|0|||
37686653|NCT02265705|69162480|FG004|Treatment Period Week 0-24|Adverse Event|0|||
37686654|NCT02265705|69162481|FG005|Treatment Period Week 0-24|Adverse Event|0|||
37686655|NCT02265705|69162482|FG006|Treatment Period Week 0-24|Adverse Event|0|||
38085156|NCT03317496|69784771|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
38085157|NCT03317496|69784767|FG000|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
38085158|NCT03317496|69784768|FG001|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
38085159|NCT03317496|69784769|FG002|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
38085160|NCT03317496|69784770|FG003|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
38085161|NCT03317496|69784771|FG004|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
38085162|NCT03317496|69784767|FG000|Phase 1b Lead-in: Follow-up|Death|3|||
37686656|NCT02265705|69162476|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
38085163|NCT03317496|69784768|FG001|Phase 1b Lead-in: Follow-up|Death|8|||
38085164|NCT03317496|69784769|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
38085165|NCT03317496|69784770|FG003|Phase 1b Lead-in: Follow-up|Death|4|||
38085166|NCT03317496|69784771|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
38085167|NCT03317496|69784767|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
38085168|NCT03317496|69784768|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
38085169|NCT03317496|69784769|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
38085170|NCT03317496|69784770|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
38085171|NCT03317496|69784771|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
38085172|NCT03317496|69784767|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
38085173|NCT03317496|69784768|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
38085174|NCT03317496|69784769|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
38085175|NCT03317496|69784770|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
38085176|NCT03317496|69784771|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
38085177|NCT03317496|69784767|FG000|Phase 1b Lead-in: Follow-up|Other|0|||
38085178|NCT03317496|69784768|FG001|Phase 1b Lead-in: Follow-up|Other|1|||
38085179|NCT03317496|69784769|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
38085180|NCT03317496|69784770|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
38085181|NCT03317496|69784771|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
38085182|NCT03317496|69784767|FG000|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|2|||
38085183|NCT03317496|69784768|FG001|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|3|||
38085184|NCT03317496|69784769|FG002|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
38085185|NCT03317496|69784770|FG003|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|1|||
38085186|NCT03317496|69784771|FG004|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
38085187|NCT03317496|69784767|FG000|Phase 2: Treatment|Adverse Event|0|||
38085188|NCT03317496|69784768|FG001|Phase 2: Treatment|Adverse Event|0|||
38085189|NCT03317496|69784769|FG002|Phase 2: Treatment|Adverse Event|0|||
38085190|NCT03317496|69784770|FG003|Phase 2: Treatment|Adverse Event|0|||
38085191|NCT03317496|69784771|FG004|Phase 2: Treatment|Adverse Event|6|||
38085192|NCT03317496|69784767|FG000|Phase 2: Treatment|Progressive disease|0|||
38085193|NCT03317496|69784768|FG001|Phase 2: Treatment|Progressive disease|0|||
38085194|NCT03317496|69784769|FG002|Phase 2: Treatment|Progressive disease|0|||
38085195|NCT03317496|69784770|FG003|Phase 2: Treatment|Progressive disease|0|||
38085196|NCT03317496|69784771|FG004|Phase 2: Treatment|Progressive disease|22|||
38085197|NCT03317496|69784767|FG000|Phase 2: Treatment|Other|0|||
38085198|NCT03317496|69784768|FG001|Phase 2: Treatment|Other|0|||
38085199|NCT03317496|69784769|FG002|Phase 2: Treatment|Other|0|||
38085200|NCT03317496|69784770|FG003|Phase 2: Treatment|Other|0|||
38085201|NCT03317496|69784771|FG004|Phase 2: Treatment|Other|4|||
38085202|NCT03317496|69784767|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
38085203|NCT03317496|69784768|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
38085204|NCT03317496|69784769|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
38085205|NCT03317496|69784770|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
38085206|NCT03317496|69784771|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
38085207|NCT03317496|69784767|FG000|Phase 2: Treatment|Physician Decision|0|||
38085208|NCT03317496|69784768|FG001|Phase 2: Treatment|Physician Decision|0|||
38085209|NCT03317496|69784769|FG002|Phase 2: Treatment|Physician Decision|0|||
38085210|NCT03317496|69784770|FG003|Phase 2: Treatment|Physician Decision|0|||
38085211|NCT03317496|69784771|FG004|Phase 2: Treatment|Physician Decision|1|||
38085212|NCT03317496|69784767|FG000|Phase 2: Treatment|Death|0|||
37686657|NCT02265705|69162477|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
37686658|NCT02265705|69162478|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
37686659|NCT02265705|69162479|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
37686660|NCT02265705|69162480|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
37686661|NCT02265705|69162481|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
37686662|NCT02265705|69162482|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
37686663|NCT02265705|69162476|FG000|Treatment Period Week 0-24|Physician Decision|1|||
37686664|NCT02265705|69162477|FG001|Treatment Period Week 0-24|Physician Decision|0|||
37686665|NCT02265705|69162478|FG002|Treatment Period Week 0-24|Physician Decision|0|||
37967338|NCT00439569|69654230|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
38085213|NCT03317496|69784768|FG001|Phase 2: Treatment|Death|0|||
38085214|NCT03317496|69784769|FG002|Phase 2: Treatment|Death|0|||
38085215|NCT03317496|69784770|FG003|Phase 2: Treatment|Death|0|||
38085216|NCT03317496|69784771|FG004|Phase 2: Treatment|Death|1|||
38085217|NCT03317496|69784767|FG000|Phase 2: Follow-up|Death|0|||
38085218|NCT03317496|69784768|FG001|Phase 2: Follow-up|Death|0|||
38085219|NCT03317496|69784769|FG002|Phase 2: Follow-up|Death|0|||
38085220|NCT03317496|69784770|FG003|Phase 2: Follow-up|Death|0|||
38085221|NCT03317496|69784771|FG004|Phase 2: Follow-up|Death|24|||
38085222|NCT03317496|69784767|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
37686666|NCT02265705|69162479|FG003|Treatment Period Week 0-24|Physician Decision|0|||
38085223|NCT03317496|69784768|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
38085224|NCT03317496|69784769|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
38085225|NCT03317496|69784770|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
38085226|NCT03317496|69784771|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
38085227|NCT03317496|69784767|FG000|Phase 2: Follow-up|Other|0|||
38085228|NCT03317496|69784768|FG001|Phase 2: Follow-up|Other|0|||
38085229|NCT03317496|69784769|FG002|Phase 2: Follow-up|Other|0|||
38085230|NCT03317496|69784770|FG003|Phase 2: Follow-up|Other|0|||
38085231|NCT03317496|69784771|FG004|Phase 2: Follow-up|Other|1|||
38085232|NCT03317496|69784767|FG000|Phase 2: Follow-up|Study terminated by sponsor|0|||
38085233|NCT03317496|69784768|FG001|Phase 2: Follow-up|Study terminated by sponsor|0|||
38085234|NCT03317496|69784769|FG002|Phase 2: Follow-up|Study terminated by sponsor|0|||
38085235|NCT03317496|69784770|FG003|Phase 2: Follow-up|Study terminated by sponsor|0|||
38085236|NCT03317496|69784771|FG004|Phase 2: Follow-up|Study terminated by sponsor|7|||
38085237|NCT02836249|69784793|FG000|Overall Study|Randomized but Never Treated|0|||
38085238|NCT02836249|69784794|FG001|Overall Study|Randomized but Never Treated|1|||
38085239|NCT02836249|69784793|FG000|Overall Study|Pregnancy|2|||
38085240|NCT02836249|69784794|FG001|Overall Study|Pregnancy|0|||
38085241|NCT02836249|69784793|FG000|Overall Study|Withdrew Consent|0|||
38085242|NCT02836249|69784794|FG001|Overall Study|Withdrew Consent|1|||
38085243|NCT02836249|69784793|FG000|Overall Study|Lost to Follow-up|0|||
38085244|NCT02836249|69784794|FG001|Overall Study|Lost to Follow-up|1|||
38085245|NCT02836249|69784793|FG000|Overall Study|Still on Study|121|||
38085246|NCT02836249|69784794|FG001|Overall Study|Still on Study|55|||
38085247|NCT01849562|69784807|FG000|Overall Study|Lost to Follow-up|1|||
38085248|NCT01849562|69784808|FG001|Overall Study|Lost to Follow-up|0|||
38085249|NCT01849562|69784809|FG002|Overall Study|Lost to Follow-up|0|||
38085250|NCT01849562|69784807|FG000|Overall Study|Non-compliance with Study Drug|1|||
38085251|NCT01849562|69784808|FG001|Overall Study|Non-compliance with Study Drug|0|||
38085252|NCT01849562|69784809|FG002|Overall Study|Non-compliance with Study Drug|0|||
38085253|NCT01700179|69784818|FG000|Overall Study|Physician Decision|2|||
38085254|NCT00665223|69784834|FG000|Randomized Phase (26 Weeks)|Adverse Event|13|||
38085255|NCT00665223|69784835|FG001|Randomized Phase (26 Weeks)|Adverse Event|9|||
38085256|NCT00665223|69784836|FG002|Randomized Phase (26 Weeks)|Adverse Event|15|||
38085257|NCT00665223|69784834|FG000|Randomized Phase (26 Weeks)|Death|0|||
38085258|NCT00665223|69784835|FG001|Randomized Phase (26 Weeks)|Death|0|||
38085259|NCT00665223|69784836|FG002|Randomized Phase (26 Weeks)|Death|1|||
38085260|NCT00665223|69784834|FG000|Randomized Phase (26 Weeks)|Withdrawal by Subject|5|||
38085261|NCT00665223|69784835|FG001|Randomized Phase (26 Weeks)|Withdrawal by Subject|2|||
38085262|NCT00665223|69784836|FG002|Randomized Phase (26 Weeks)|Withdrawal by Subject|3|||
38085263|NCT00665223|69784834|FG000|Randomized Phase (26 Weeks)|Protocol Violation|0|||
38085264|NCT00665223|69784835|FG001|Randomized Phase (26 Weeks)|Protocol Violation|1|||
38085265|NCT00665223|69784836|FG002|Randomized Phase (26 Weeks)|Protocol Violation|1|||
37686667|NCT02265705|69162480|FG004|Treatment Period Week 0-24|Physician Decision|0|||
37686668|NCT02265705|69162481|FG005|Treatment Period Week 0-24|Physician Decision|0|||
37686669|NCT02265705|69162482|FG006|Treatment Period Week 0-24|Physician Decision|0|||
37686670|NCT02265705|69162476|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
37686671|NCT02265705|69162477|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
37686672|NCT02265705|69162478|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
37686673|NCT02265705|69162479|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
37686674|NCT02265705|69162480|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
37686675|NCT02265705|69162481|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
37686676|NCT02265705|69162482|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
37686677|NCT02265705|69162476|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
37686678|NCT02265705|69162477|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
37686679|NCT02265705|69162478|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
37686680|NCT02265705|69162479|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
37686681|NCT02265705|69162480|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
37686682|NCT02265705|69162481|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
37686683|NCT02265705|69162482|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
37686684|NCT02265705|69162476|FG000|Rescue Period|Withdrawal by Subject|0|||
37686685|NCT02265705|69162477|FG001|Rescue Period|Withdrawal by Subject|0|||
38085266|NCT00665223|69784834|FG000|Randomized Phase (26 Weeks)|Other than specified|0|||
38085267|NCT00665223|69784835|FG001|Randomized Phase (26 Weeks)|Other than specified|0|||
38085268|NCT00665223|69784836|FG002|Randomized Phase (26 Weeks)|Other than specified|1|||
38085269|NCT00665223|69784834|FG000|Open-Label Period (26 Weeks)|Adverse Event|8|||
38085270|NCT00665223|69784835|FG001|Open-Label Period (26 Weeks)|Adverse Event|11|||
38085271|NCT00665223|69784836|FG002|Open-Label Period (26 Weeks)|Adverse Event|7|||
38085272|NCT00665223|69784834|FG000|Open-Label Period (26 Weeks)|Death|0|||
38085273|NCT00665223|69784835|FG001|Open-Label Period (26 Weeks)|Death|1|||
38085274|NCT00665223|69784836|FG002|Open-Label Period (26 Weeks)|Death|0|||
38085275|NCT00665223|69784834|FG000|Open-Label Period (26 Weeks)|Lost to Follow-up|3|||
38085276|NCT00665223|69784835|FG001|Open-Label Period (26 Weeks)|Lost to Follow-up|1|||
38085277|NCT00665223|69784836|FG002|Open-Label Period (26 Weeks)|Lost to Follow-up|2|||
37686686|NCT02265705|69162478|FG002|Rescue Period|Withdrawal by Subject|1|||
38085278|NCT00665223|69784834|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|5|||
38085279|NCT00665223|69784835|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|3|||
38085280|NCT00665223|69784836|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|4|||
38085281|NCT00665223|69784834|FG000|Open-Label Period (26 Weeks)|Protocol Violation|0|||
38085282|NCT00665223|69784835|FG001|Open-Label Period (26 Weeks)|Protocol Violation|1|||
37967339|NCT00439569|69654230|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
37967340|NCT00443079|69654236|FG000|Overall Study|Lost to Follow-up|0|||
37967341|NCT00443079|69654237|FG001|Overall Study|Lost to Follow-up|1|||
37967342|NCT00427635|69654273|FG000|Treatment Phase|Withdrawal by Subject|1|||
37967343|NCT00427635|69654274|FG001|Treatment Phase|Withdrawal by Subject|0|||
37967344|NCT00427635|69654273|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
38085283|NCT00665223|69784836|FG002|Open-Label Period (26 Weeks)|Protocol Violation|0|||
38085284|NCT00665223|69784834|FG000|Open-Label Period (26 Weeks)|Other than specified|0|||
38085285|NCT00665223|69784835|FG001|Open-Label Period (26 Weeks)|Other than specified|0|||
38085286|NCT00665223|69784836|FG002|Open-Label Period (26 Weeks)|Other than specified|2|||
38085287|NCT03786380|69784857|FG000|Overall Study|Adverse Event|1|||
38085288|NCT03786380|69784858|FG001|Overall Study|Adverse Event|0|||
38085289|NCT03786380|69784859|FG002|Overall Study|Adverse Event|0|||
38085290|NCT03786380|69784860|FG003|Overall Study|Adverse Event|3|||
38085291|NCT03786380|69784861|FG004|Overall Study|Adverse Event|1|||
38085292|NCT03786380|69784857|FG000|Overall Study|Lack of Efficacy|0|||
38085293|NCT03786380|69784858|FG001|Overall Study|Lack of Efficacy|0|||
38085294|NCT03786380|69784859|FG002|Overall Study|Lack of Efficacy|0|||
38085295|NCT03786380|69784860|FG003|Overall Study|Lack of Efficacy|0|||
38085296|NCT03786380|69784861|FG004|Overall Study|Lack of Efficacy|1|||
38085297|NCT03786380|69784857|FG000|Overall Study|Withdrawal by Subject|1|||
38085298|NCT03786380|69784858|FG001|Overall Study|Withdrawal by Subject|2|||
38085299|NCT03786380|69784859|FG002|Overall Study|Withdrawal by Subject|2|||
38085300|NCT03786380|69784860|FG003|Overall Study|Withdrawal by Subject|1|||
38085301|NCT03786380|69784861|FG004|Overall Study|Withdrawal by Subject|2|||
38085302|NCT03786380|69784857|FG000|Overall Study|Lost to Follow-up|3|||
38085303|NCT03786380|69784858|FG001|Overall Study|Lost to Follow-up|0|||
38085304|NCT03786380|69784859|FG002|Overall Study|Lost to Follow-up|1|||
38085305|NCT03786380|69784860|FG003|Overall Study|Lost to Follow-up|2|||
38085306|NCT03786380|69784861|FG004|Overall Study|Lost to Follow-up|0|||
38085307|NCT03786380|69784857|FG000|Overall Study|Physician Decision|0|||
38085308|NCT03786380|69784858|FG001|Overall Study|Physician Decision|0|||
38085309|NCT03786380|69784859|FG002|Overall Study|Physician Decision|1|||
38085310|NCT03786380|69784860|FG003|Overall Study|Physician Decision|0|||
38085311|NCT03786380|69784861|FG004|Overall Study|Physician Decision|0|||
38085312|NCT03786380|69784857|FG000|Overall Study|Study Terminated by the Sponsor|30|||
37967345|NCT00427635|69654274|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
37967346|NCT00427011|69654280|FG000|Overall Study|Adverse Event|10|||
38085313|NCT03786380|69784858|FG001|Overall Study|Study Terminated by the Sponsor|20|||
38085314|NCT03786380|69784859|FG002|Overall Study|Study Terminated by the Sponsor|50|||
38085315|NCT03786380|69784860|FG003|Overall Study|Study Terminated by the Sponsor|57|||
37686687|NCT02265705|69162479|FG003|Rescue Period|Withdrawal by Subject|0|||
37686688|NCT02265705|69162480|FG004|Rescue Period|Withdrawal by Subject|0|||
37686689|NCT02265705|69162481|FG005|Rescue Period|Withdrawal by Subject|0|||
37686690|NCT02265705|69162482|FG006|Rescue Period|Withdrawal by Subject|0|||
37686691|NCT02265705|69162476|FG000|Rescue Period|Death|0|||
37686692|NCT02265705|69162477|FG001|Rescue Period|Death|0|||
37686693|NCT02265705|69162478|FG002|Rescue Period|Death|1|||
37686694|NCT02265705|69162479|FG003|Rescue Period|Death|0|||
37967347|NCT00427011|69654280|FG000|Overall Study|Withdrawal by Subject|1|||
37967348|NCT00427011|69654280|FG000|Overall Study|Lack of Efficacy|2|||
37967349|NCT00427011|69654280|FG000|Overall Study|Other|12|||
37967350|NCT03891264|69654285|FG000|Overall Study|Adverse Event|1|||
37967351|NCT03891264|69654285|FG000|Overall Study|Withdrawal by Subject|2|||
37967352|NCT03891264|69654285|FG000|Overall Study|Physician Decision|2|||
37967353|NCT00439179|69654293|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
37967354|NCT00439179|69654294|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
38085316|NCT03786380|69784861|FG004|Overall Study|Study Terminated by the Sponsor|23|||
38085317|NCT03786380|69784857|FG000|Overall Study|Reason Not Specified|0|||
38085318|NCT03786380|69784858|FG001|Overall Study|Reason Not Specified|0|||
38085319|NCT03786380|69784859|FG002|Overall Study|Reason Not Specified|0|||
38085320|NCT03786380|69784860|FG003|Overall Study|Reason Not Specified|0|||
38085321|NCT03786380|69784861|FG004|Overall Study|Reason Not Specified|1|||
38085322|NCT02626000|69784873|FG000|Overall Study|Decision by Sponsor|1|||
38085323|NCT02626000|69784873|FG000|Overall Study|Death|29|||
38085324|NCT02736890|69784889|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
38085325|NCT02736890|69784890|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
38085326|NCT02736890|69784889|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
38085327|NCT02736890|69784890|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
38085328|NCT02779556|69784898|FG000|Baseline|Partial baseline interview completed|1|||
38085329|NCT02779556|69784899|FG001|Baseline|Partial baseline interview completed|0|||
38085330|NCT02779556|69784898|FG000|3 Months|Lost to Follow-up|40|||
38085331|NCT02779556|69784899|FG001|3 Months|Lost to Follow-up|29|||
38085332|NCT02779556|69784898|FG000|3 Months|Missed 3 month clinic visit|27|||
38085333|NCT02779556|69784899|FG001|3 Months|Missed 3 month clinic visit|19|||
38085334|NCT02779556|69784898|FG000|6 Month|Lost to Follow-up|33|||
38085335|NCT02779556|69784899|FG001|6 Month|Lost to Follow-up|39|||
38085336|NCT02779556|69784898|FG000|6 Month HbA1c|No value collected during window|69|||
38085337|NCT02779556|69784899|FG001|6 Month HbA1c|No value collected during window|50|||
38085338|NCT02779556|69784898|FG000|12 Month HbA1c|No value collected during window|138|||
38085339|NCT02779556|69784899|FG001|12 Month HbA1c|No value collected during window|102|||
38085340|NCT01669798|69784905|FG000|Overall Study|Physician Decision|5|||
38085341|NCT02334722|69784911|FG000|Overall Study|Lost to Follow-up|4|||
38085342|NCT02334722|69784912|FG001|Overall Study|Lost to Follow-up|0|||
38085343|NCT02334722|69784911|FG000|Overall Study|6 week questionnaire not completed|2|||
38085344|NCT02334722|69784912|FG001|Overall Study|6 week questionnaire not completed|0|||
38085345|NCT02334722|69784911|FG000|Overall Study|Unable to obtain medication|1|||
37967355|NCT00439179|69654295|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
37967356|NCT00439179|69654296|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
37967357|NCT00438633|69654311|FG000|Overall Study|Withdrawal by Subject|1|||
37967358|NCT00438633|69654312|FG001|Overall Study|Withdrawal by Subject|0|||
37967359|NCT00438633|69654311|FG000|Overall Study|Lost to Follow-up|15|||
37967360|NCT00438633|69654312|FG001|Overall Study|Lost to Follow-up|17|||
37967361|NCT00438399|69654321|FG000|Overall Study|Lost to Follow-up|2|||
37967362|NCT00438399|69654322|FG001|Overall Study|Lost to Follow-up|2|||
37967363|NCT00438399|69654323|FG002|Overall Study|Lost to Follow-up|1|||
37967364|NCT00438399|69654324|FG003|Overall Study|Lost to Follow-up|1|||
37967365|NCT00438399|69654325|FG004|Overall Study|Lost to Follow-up|1|||
37863016|NCT01263197|69546936|FG004|Third Intervention (Period 3)|Adverse Event|0|||
37967366|NCT00438399|69654326|FG005|Overall Study|Lost to Follow-up|1|||
37967367|NCT00438399|69654321|FG000|Overall Study|Adverse Event|0|||
37967368|NCT00438399|69654322|FG001|Overall Study|Adverse Event|0|||
37967369|NCT00438399|69654323|FG002|Overall Study|Adverse Event|1|||
38085346|NCT02334722|69784912|FG001|Overall Study|Unable to obtain medication|1|||
38085347|NCT02334722|69784911|FG000|Overall Study|Withdrawal by Subject|0|||
37967370|NCT00438399|69654324|FG003|Overall Study|Adverse Event|1|||
37967371|NCT00438399|69654325|FG004|Overall Study|Adverse Event|0|||
37967372|NCT00438399|69654326|FG005|Overall Study|Adverse Event|1|||
37967373|NCT00438399|69654321|FG000|Overall Study|Withdrawal by Subject|5|||
37967374|NCT00438399|69654322|FG001|Overall Study|Withdrawal by Subject|6|||
37967375|NCT00438399|69654323|FG002|Overall Study|Withdrawal by Subject|3|||
37967376|NCT00438399|69654324|FG003|Overall Study|Withdrawal by Subject|2|||
37967377|NCT00438399|69654325|FG004|Overall Study|Withdrawal by Subject|2|||
37686695|NCT02265705|69162480|FG004|Rescue Period|Death|0|||
37686696|NCT02265705|69162481|FG005|Rescue Period|Death|0|||
37967378|NCT00438399|69654326|FG005|Overall Study|Withdrawal by Subject|2|||
38085348|NCT02334722|69784912|FG001|Overall Study|Withdrawal by Subject|3|||
38085349|NCT02334722|69784911|FG000|Overall Study|Adverse Event|0|||
37863017|NCT01263197|69546937|FG005|Third Intervention (Period 3)|Adverse Event|0|||
37863018|NCT01263119|69546951|FG000|Period 1|Protocol Violation|2|||
37863019|NCT01263119|69546951|FG000|Period 2|Adverse Event|2|||
37863020|NCT01262651|69546961|FG000|Overall Study|Adverse Event|40|||
37863021|NCT01262651|69546962|FG001|Overall Study|Adverse Event|35|||
37863022|NCT01262651|69546961|FG000|Overall Study|Withdrawal by Subject|15|||
37863023|NCT01262651|69546962|FG001|Overall Study|Withdrawal by Subject|11|||
37863024|NCT01262651|69546961|FG000|Overall Study|Withdrawal by Investigator|2|||
37863025|NCT01262651|69546962|FG001|Overall Study|Withdrawal by Investigator|2|||
37863026|NCT01262651|69546961|FG000|Overall Study|Met Withdrawal Criteria|1|||
37863027|NCT01262651|69546962|FG001|Overall Study|Met Withdrawal Criteria|0|||
37863028|NCT01262573|69546970|FG000|Overall Study|Withdrawal by Subject|0|||
37863029|NCT01262573|69546971|FG001|Overall Study|Withdrawal by Subject|1|||
37863030|NCT01262027|69546977|FG000|Overall Study|Adverse Event|1|||
37863031|NCT01262027|69546977|FG000|Overall Study|Withdrawal by Subject|3|||
37863032|NCT01262027|69546977|FG000|Overall Study|Protocol Violation|1|||
37863033|NCT01261793|69546984|FG000|Overall Study|Lack of Efficacy|44|||
37863034|NCT01261793|69546985|FG001|Overall Study|Lack of Efficacy|37|||
37863035|NCT01261793|69546986|FG002|Overall Study|Lack of Efficacy|32|||
37863036|NCT01261793|69546984|FG000|Overall Study|Protocol Violation|3|||
37863037|NCT01261793|69546985|FG001|Overall Study|Protocol Violation|5|||
37863038|NCT01261793|69546986|FG002|Overall Study|Protocol Violation|6|||
37863039|NCT01261793|69546984|FG000|Overall Study|Lost to Follow-up|10|||
37863040|NCT01261793|69546985|FG001|Overall Study|Lost to Follow-up|3|||
37863041|NCT01261793|69546986|FG002|Overall Study|Lost to Follow-up|7|||
37863042|NCT01261793|69546984|FG000|Overall Study|Withdrawal by Subject|12|||
37863043|NCT01261793|69546985|FG001|Overall Study|Withdrawal by Subject|14|||
37863044|NCT01261793|69546986|FG002|Overall Study|Withdrawal by Subject|14|||
37863045|NCT01261793|69546984|FG000|Overall Study|Death|3|||
37863046|NCT01261793|69546985|FG001|Overall Study|Death|1|||
37863047|NCT01261793|69546986|FG002|Overall Study|Death|0|||
37863048|NCT01261793|69546984|FG000|Overall Study|Adverse Event|9|||
37863049|NCT01261793|69546985|FG001|Overall Study|Adverse Event|24|||
37863050|NCT01261793|69546986|FG002|Overall Study|Adverse Event|19|||
37863051|NCT01261793|69546984|FG000|Overall Study|Patient non-availability|1|||
37863052|NCT01261793|69546985|FG001|Overall Study|Patient non-availability|1|||
37863053|NCT01261793|69546986|FG002|Overall Study|Patient non-availability|1|||
37863054|NCT01261793|69546984|FG000|Overall Study|Suspected pregnancy|1|||
37863055|NCT01261793|69546985|FG001|Overall Study|Suspected pregnancy|1|||
37863056|NCT01261793|69546986|FG002|Overall Study|Suspected pregnancy|0|||
37863057|NCT01261793|69546984|FG000|Overall Study|Patient non-compliance|1|||
37863058|NCT01261793|69546985|FG001|Overall Study|Patient non-compliance|0|||
37863059|NCT01261793|69546986|FG002|Overall Study|Patient non-compliance|1|||
37863060|NCT01261793|69546984|FG000|Overall Study|Patient pregnant|1|||
37863061|NCT01261793|69546985|FG001|Overall Study|Patient pregnant|0|||
37863062|NCT01261793|69546986|FG002|Overall Study|Patient pregnant|0|||
37863063|NCT01261793|69546984|FG000|Overall Study|Outside the study area|0|||
37863064|NCT01261793|69546985|FG001|Overall Study|Outside the study area|2|||
37863065|NCT01261793|69546986|FG002|Overall Study|Outside the study area|1|||
37863066|NCT01261793|69546984|FG000|Overall Study|Lack of efficacy & patient not available|0|||
37863067|NCT01261793|69546985|FG001|Overall Study|Lack of efficacy & patient not available|1|||
37863068|NCT01261793|69546986|FG002|Overall Study|Lack of efficacy & patient not available|0|||
37863069|NCT01261793|69546984|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
37863070|NCT01261793|69546985|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
37863071|NCT01261793|69546986|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
37863072|NCT01261793|69546984|FG000|Overall Study|Randomization error|0|||
37863073|NCT01261793|69546985|FG001|Overall Study|Randomization error|1|||
37863074|NCT01261793|69546986|FG002|Overall Study|Randomization error|0|||
37863075|NCT01261793|69546984|FG000|Overall Study|Patient unable to start IV line|0|||
37863076|NCT01261793|69546985|FG001|Overall Study|Patient unable to start IV line|0|||
37863077|NCT01261793|69546986|FG002|Overall Study|Patient unable to start IV line|1|||
37863078|NCT01261325|69546997|FG000|Overall Study|Lack of Efficacy|1|||
37863079|NCT01261325|69546998|FG001|Overall Study|Lack of Efficacy|1|||
37863080|NCT01261325|69546999|FG002|Overall Study|Lack of Efficacy|0|||
37863081|NCT01261325|69546997|FG000|Overall Study|Withdrawal by Subject|2|||
37863082|NCT01261325|69546998|FG001|Overall Study|Withdrawal by Subject|2|||
37863083|NCT01261325|69546999|FG002|Overall Study|Withdrawal by Subject|4|||
37863084|NCT01261325|69546997|FG000|Overall Study|SAE, non-fatal|1|||
37863085|NCT01261325|69546998|FG001|Overall Study|SAE, non-fatal|5|||
37863086|NCT01261325|69546999|FG002|Overall Study|SAE, non-fatal|1|||
37863087|NCT01261325|69546997|FG000|Overall Study|AE, non-serious non-fatal|9|||
37863088|NCT01261325|69546998|FG001|Overall Study|AE, non-serious non-fatal|15|||
37863089|NCT01261325|69546999|FG002|Overall Study|AE, non-serious non-fatal|13|||
37863090|NCT01261325|69546997|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
37863091|NCT01261325|69546998|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
37863092|NCT01261325|69546999|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
37863093|NCT01261325|69546997|FG000|Overall Study|Non Compliance|2|||
37863094|NCT01261325|69546998|FG001|Overall Study|Non Compliance|0|||
37863095|NCT01261325|69546999|FG002|Overall Study|Non Compliance|0|||
37863096|NCT01261325|69546997|FG000|Overall Study|Patient Randomized by Mistake|0|||
37863097|NCT01261325|69546998|FG001|Overall Study|Patient Randomized by Mistake|1|||
37863098|NCT01261325|69546999|FG002|Overall Study|Patient Randomized by Mistake|0|||
37863099|NCT01261325|69546997|FG000|Overall Study|Erroneously Randomized|1|||
37863100|NCT01261325|69546998|FG001|Overall Study|Erroneously Randomized|0|||
37863101|NCT01261325|69546999|FG002|Overall Study|Erroneously Randomized|0|||
37863102|NCT01261325|69546997|FG000|Overall Study|Screen Failure|1|||
37863103|NCT01261325|69546998|FG001|Overall Study|Screen Failure|0|||
37863104|NCT01261325|69546999|FG002|Overall Study|Screen Failure|0|||
37863105|NCT01261325|69546997|FG000|Overall Study|Randomized in Error|0|||
37863106|NCT01261325|69546998|FG001|Overall Study|Randomized in Error|0|||
37863107|NCT01261325|69546999|FG002|Overall Study|Randomized in Error|1|||
37863108|NCT01261325|69546997|FG000|Overall Study|Protocol Violation|0|||
37863109|NCT01261325|69546998|FG001|Overall Study|Protocol Violation|3|||
37863110|NCT01261325|69546999|FG002|Overall Study|Protocol Violation|1|||
37863111|NCT01261325|69546997|FG000|Overall Study|Lost to Follow-up|0|||
37863112|NCT01261325|69546998|FG001|Overall Study|Lost to Follow-up|1|||
37863113|NCT01261325|69546999|FG002|Overall Study|Lost to Follow-up|3|||
37863114|NCT01261325|69546997|FG000|Overall Study|AE, serious fatal|0|||
37863115|NCT01261325|69546998|FG001|Overall Study|AE, serious fatal|0|||
38085350|NCT02334722|69784912|FG001|Overall Study|Adverse Event|2|||
38085351|NCT02334722|69784911|FG000|Overall Study|Physician Decision|0|||
38085352|NCT02334722|69784912|FG001|Overall Study|Physician Decision|1|||
38085353|NCT00812708|69784927|FG000|Overall Study|Device could not be implanted|2|||
38085354|NCT00812708|69784927|FG000|Overall Study|Lack of medical insurance|1|||
38085355|NCT00812708|69784927|FG000|Overall Study|Switched to another study|1|||
38085356|NCT00812708|69784927|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
38085357|NCT00812708|69784927|FG000|Overall Study|Signed consent but later withdrew|3|||
38085358|NCT03761810|69784943|FG000|Overall Study|Adverse Event|12|||
38085359|NCT03761810|69784944|FG001|Overall Study|Adverse Event|0|||
38085360|NCT03761810|69784943|FG000|Overall Study|Lost to Follow-up|15|||
38085361|NCT03761810|69784944|FG001|Overall Study|Lost to Follow-up|7|||
38085362|NCT03761810|69784943|FG000|Overall Study|Pregnancy|1|||
38085363|NCT03761810|69784944|FG001|Overall Study|Pregnancy|0|||
38085364|NCT03761810|69784943|FG000|Overall Study|Withdrawal by Subject|14|||
38085365|NCT03761810|69784944|FG001|Overall Study|Withdrawal by Subject|5|||
38085366|NCT03761810|69784943|FG000|Overall Study|Physician Decision|1|||
38085367|NCT03761810|69784944|FG001|Overall Study|Physician Decision|0|||
38085368|NCT03761810|69784943|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
38085369|NCT03761810|69784944|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
38085370|NCT03761810|69784943|FG000|Overall Study|Other Than Specified|1|||
37863116|NCT01261325|69546999|FG002|Overall Study|AE, serious fatal|2|||
37863117|NCT01260701|69547010|FG000|Overall Study|Adverse Event|9|||
37863118|NCT01260701|69547010|FG000|Overall Study|Withdrawal by Subject|2|||
37863119|NCT01260701|69547010|FG000|Overall Study|Progression|53|||
37863120|NCT01260701|69547010|FG000|Overall Study|Death|2|||
37863121|NCT01260701|69547010|FG000|Overall Study|Not protocol specified|3|||
37863122|NCT01260701|69547010|FG000|Overall Study|Under review|1|||
37863123|NCT01260701|69547010|FG000|Overall Study|Ineligible|4|||
38085371|NCT03761810|69784944|FG001|Overall Study|Other Than Specified|0|||
38085372|NCT02811159|69784955|FG000|Treatment Course 1|Lost to Follow-up|1|||
38085373|NCT01889186|69784961|FG000|Overall Study|Adverse event- not related to progression|18|||
38085374|NCT01889186|69784962|FG001|Overall Study|Adverse event- not related to progression|5|||
38085375|NCT01889186|69784961|FG000|Overall Study|Adverse event- related to progression|7|||
38085376|NCT01889186|69784962|FG001|Overall Study|Adverse event- related to progression|2|||
38085377|NCT01889186|69784961|FG000|Overall Study|COVID-19 logistical restrictions|1|||
38085378|NCT01889186|69784962|FG001|Overall Study|COVID-19 logistical restrictions|0|||
38085379|NCT01889186|69784961|FG000|Overall Study|Investigator request|1|||
38085380|NCT01889186|69784962|FG001|Overall Study|Investigator request|1|||
38085381|NCT01889186|69784961|FG000|Overall Study|Progressive disease- Richter's|12|||
38085382|NCT01889186|69784962|FG001|Overall Study|Progressive disease- Richter's|7|||
38085383|NCT01889186|69784961|FG000|Overall Study|Progressive disease per protocol|46|||
38085384|NCT01889186|69784962|FG001|Overall Study|Progressive disease per protocol|17|||
38085385|NCT01889186|69784961|FG000|Overall Study|Stem cell transplant|2|||
38085386|NCT01889186|69784962|FG001|Overall Study|Stem cell transplant|1|||
38085387|NCT01889186|69784961|FG000|Overall Study|Withdrew consent|2|||
38085388|NCT01889186|69784962|FG001|Overall Study|Withdrew consent|3|||
38085389|NCT01889186|69784961|FG000|Overall Study|Other, not specified|18|||
37863124|NCT01260701|69547010|FG000|Overall Study|Did not begin protocol therapy|1|||
37863125|NCT01260467|69547014|FG000|Overall Study|Withdrawal by Subject|2|||
37863126|NCT01260311|69547020|FG000|Overall Study|Adverse Event|11|||
37863127|NCT01260311|69547020|FG000|Overall Study|Lack of Efficacy|4|||
37863128|NCT01260311|69547020|FG000|Overall Study|Lost to Follow-up|25|||
37863129|NCT01260311|69547020|FG000|Overall Study|Withdrawal by Subject|6|||
37863130|NCT01260311|69547020|FG000|Overall Study|Financial Constraints|77|||
38085390|NCT01889186|69784962|FG001|Overall Study|Other, not specified|15|||
38085391|NCT01510184|69784972|FG000|Overall Study|Sponsor discretion|28|||
38085392|NCT01510184|69784973|FG001|Overall Study|Sponsor discretion|28|||
38085393|NCT01510184|69784972|FG000|Overall Study|Death|1|||
38085394|NCT01510184|69784973|FG001|Overall Study|Death|2|||
38085395|NCT01510184|69784972|FG000|Overall Study|Withdrawal by Subject|1|||
38085396|NCT01510184|69784973|FG001|Overall Study|Withdrawal by Subject|4|||
38085397|NCT01510184|69784972|FG000|Overall Study|Other|0|||
38085398|NCT01510184|69784973|FG001|Overall Study|Other|1|||
38085399|NCT02809833|69784998|FG000|Overall Study|Death|3|||
38085400|NCT02809833|69784998|FG000|Overall Study|Intolerance|54|||
38085401|NCT02809833|69784998|FG000|Overall Study|Lack of Efficacy|89|||
38085402|NCT02809833|69784998|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
38085403|NCT02809833|69784998|FG000|Overall Study|Noncompliance|1|||
38085404|NCT02809833|69784998|FG000|Overall Study|Withdrawal by Subject|34|||
38085405|NCT02809833|69784998|FG000|Overall Study|Lost to Follow-up|35|||
38085406|NCT02809833|69784998|FG000|Overall Study|Adverse Event (AE)|24|||
38085407|NCT02809833|69784998|FG000|Overall Study|Other|5|||
38085408|NCT02809833|69784998|FG000|Overall Study|Missing Information|52|||
38085409|NCT02797262|69785004|FG000|Overall Study|Withdrawal by Subject|5|||
38085410|NCT02797262|69785005|FG001|Overall Study|Withdrawal by Subject|1|||
38085411|NCT02797262|69785004|FG000|Overall Study|Lost to Follow-up|10|||
38085412|NCT02797262|69785005|FG001|Overall Study|Lost to Follow-up|7|||
38085413|NCT02797262|69785004|FG000|Overall Study|Death|1|||
38085414|NCT02797262|69785005|FG001|Overall Study|Death|2|||
38085415|NCT02797262|69785004|FG000|Overall Study|Adverse Event|1|||
38085416|NCT02797262|69785005|FG001|Overall Study|Adverse Event|0|||
38085417|NCT02797262|69785004|FG000|Overall Study|COVID-19|2|||
38085418|NCT02797262|69785005|FG001|Overall Study|COVID-19|1|||
38085419|NCT02797262|69785004|FG000|Overall Study|Out-of-country|1|||
38085420|NCT02797262|69785005|FG001|Overall Study|Out-of-country|0|||
38085421|NCT02809053|69785013|FG000|Overall Study|Death|0|||
38085422|NCT02809053|69785014|FG001|Overall Study|Death|1|||
38085423|NCT02809053|69785013|FG000|Overall Study|Lost to Follow-up|3|||
38085424|NCT02809053|69785014|FG001|Overall Study|Lost to Follow-up|1|||
38085425|NCT02809053|69785013|FG000|Overall Study|Withdrawal by Subject|2|||
38085426|NCT02809053|69785014|FG001|Overall Study|Withdrawal by Subject|3|||
38085427|NCT02809053|69785013|FG000|Overall Study|Disease Progression|2|||
38085428|NCT02809053|69785014|FG001|Overall Study|Disease Progression|1|||
37863131|NCT01260311|69547020|FG000|Overall Study|Gone to Province|2|||
37863132|NCT01260311|69547020|FG000|Overall Study|Medication Stopped|1|||
37863133|NCT01260311|69547020|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
37863134|NCT01259375|69547024|FG000|Overall Study|Adverse Event|1|||
37863135|NCT01259297|69547047|FG000|Double Blind Randomized Period|Death|1|||
37863136|NCT01259297|69547048|FG001|Double Blind Randomized Period|Death|1|||
37863137|NCT01259297|69547049|FG002|Double Blind Randomized Period|Death|1|||
37863138|NCT01259297|69547050|FG003|Double Blind Randomized Period|Death|2|||
37863139|NCT01259297|69547051|FG004|Double Blind Randomized Period|Death|1|||
37863140|NCT01259297|69547052|FG005|Double Blind Randomized Period|Death|5|||
37863141|NCT01259297|69547053|FG006|Double Blind Randomized Period|Death|2|||
37863142|NCT01259297|69547054|FG007|Double Blind Randomized Period|Death|1|||
37863143|NCT01259297|69547047|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
37863144|NCT01259297|69547048|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
37863145|NCT01259297|69547049|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
37863146|NCT01259297|69547050|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
37863147|NCT01259297|69547051|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
37863148|NCT01259297|69547052|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
37863149|NCT01259297|69547053|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
37863150|NCT01259297|69547054|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
37863151|NCT01259297|69547047|FG000|Double Blind Randomized Period|Other reasons|0|||
38085429|NCT02808975|69785022|FG000|Overall Study|Adverse Event|3|||
38085430|NCT02808975|69785023|FG001|Overall Study|Adverse Event|4|||
38085431|NCT02808975|69785022|FG000|Overall Study|Withdrew consent|9|||
38085432|NCT02808975|69785023|FG001|Overall Study|Withdrew consent|8|||
38085433|NCT02808975|69785022|FG000|Overall Study|Lost to Follow-up|4|||
38085434|NCT02808975|69785023|FG001|Overall Study|Lost to Follow-up|6|||
38085435|NCT02808975|69785022|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
38085436|NCT02808975|69785023|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
38085437|NCT02808975|69785022|FG000|Overall Study|Other, not specified|5|||
37863152|NCT01259297|69547048|FG001|Double Blind Randomized Period|Other reasons|1|||
37863153|NCT01259297|69547049|FG002|Double Blind Randomized Period|Other reasons|0|||
37863154|NCT01259297|69547050|FG003|Double Blind Randomized Period|Other reasons|0|||
38085438|NCT02808975|69785023|FG001|Overall Study|Other, not specified|1|||
38085439|NCT02976038|69785029|FG000|Overall Study|Physician Decision|22|||
38085440|NCT02976038|69785029|FG000|Overall Study|Withdrawal by Subject|3|||
38085441|NCT02976038|69785029|FG000|Overall Study|Lost to Follow-up|2|||
37863155|NCT01259297|69547051|FG004|Double Blind Randomized Period|Other reasons|1|||
37863156|NCT01259297|69547052|FG005|Double Blind Randomized Period|Other reasons|2|||
37863157|NCT01259297|69547053|FG006|Double Blind Randomized Period|Other reasons|3|||
37863158|NCT01259297|69547054|FG007|Double Blind Randomized Period|Other reasons|1|||
37863159|NCT01126437|69547074|FG000|Overall Study|Not treated|11|||
37863160|NCT01126437|69547075|FG001|Overall Study|Not treated|18|||
37863161|NCT01126437|69547076|FG002|Overall Study|Not treated|19|||
37863162|NCT01126437|69547074|FG000|Overall Study|Sites with data irregularities/fraud|6|||
37863163|NCT01126437|69547075|FG001|Overall Study|Sites with data irregularities/fraud|6|||
37863164|NCT01126437|69547076|FG002|Overall Study|Sites with data irregularities/fraud|7|||
37863165|NCT01126437|69547074|FG000|Overall Study|Adverse Event|602|||
37863166|NCT01126437|69547075|FG001|Overall Study|Adverse Event|606|||
37863167|NCT01126437|69547076|FG002|Overall Study|Adverse Event|635|||
37863168|NCT01126437|69547074|FG000|Overall Study|Lack of Efficacy|65|||
37863169|NCT01126437|69547075|FG001|Overall Study|Lack of Efficacy|60|||
37863170|NCT01126437|69547076|FG002|Overall Study|Lack of Efficacy|59|||
37863171|NCT01126437|69547074|FG000|Overall Study|Protocol Violation|64|||
37863172|NCT01126437|69547075|FG001|Overall Study|Protocol Violation|66|||
37863173|NCT01126437|69547076|FG002|Overall Study|Protocol Violation|41|||
37863174|NCT01126437|69547074|FG000|Overall Study|Lost to Follow-up|52|||
37863175|NCT01126437|69547075|FG001|Overall Study|Lost to Follow-up|63|||
37863176|NCT01126437|69547076|FG002|Overall Study|Lost to Follow-up|55|||
37863177|NCT01126437|69547074|FG000|Overall Study|Withdrawal by Subject|331|||
37863178|NCT01126437|69547075|FG001|Overall Study|Withdrawal by Subject|335|||
37863179|NCT01126437|69547076|FG002|Overall Study|Withdrawal by Subject|319|||
37863180|NCT01126437|69547074|FG000|Overall Study|Other reason not specified|210|||
37863181|NCT01126437|69547075|FG001|Overall Study|Other reason not specified|176|||
37863182|NCT01126437|69547076|FG002|Overall Study|Other reason not specified|178|||
37863183|NCT01258595|69547086|FG000|Overall Study|Lost to Follow-up|1|||
37863184|NCT01258595|69547087|FG001|Overall Study|Lost to Follow-up|0|||
37863185|NCT01258595|69547086|FG000|Overall Study|Withdrawal by Subject|0|||
37863186|NCT01258595|69547087|FG001|Overall Study|Withdrawal by Subject|1|||
37863187|NCT01257737|69547095|FG000|Overall Study|Lost to Follow-up|1|||
37863188|NCT01257737|69547096|FG001|Overall Study|Lost to Follow-up|2|||
37863189|NCT01257737|69547095|FG000|Overall Study|Liver transplant|1|||
37863190|NCT01257737|69547096|FG001|Overall Study|Liver transplant|0|||
37863191|NCT01257737|69547095|FG000|Overall Study|Relocation out of the country|0|||
37863192|NCT01257737|69547096|FG001|Overall Study|Relocation out of the country|1|||
37863193|NCT01257737|69547095|FG000|Overall Study|Withdrew from study|0|||
37863194|NCT01257737|69547096|FG001|Overall Study|Withdrew from study|1|||
37863195|NCT01126359|69547103|FG000|First Intervention (20-minutes)|Physician Decision|0|||
37863196|NCT01126359|69547104|FG001|First Intervention (20-minutes)|Physician Decision|1|||
37863197|NCT01125813|69547114|FG000|Overall Study|Death|1|||
37863198|NCT01125813|69547114|FG000|Overall Study|Withdrawal by Subject|1|||
37863199|NCT01125813|69547114|FG000|Overall Study|Screen Failures|4|||
37863200|NCT00996892|69547118|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
37863201|NCT00996892|69547119|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
37863202|NCT00996892|69547120|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
37863203|NCT00996892|69547121|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
37863204|NCT00996892|69547122|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
37863205|NCT00996892|69547123|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
37863206|NCT00996892|69547124|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
38085442|NCT02976038|69785029|FG000|Overall Study|Adverse Event|1|||
38085443|NCT02808819|69785054|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
37967379|NCT00438399|69654321|FG000|Overall Study|Protocol Violation|0|||
37967380|NCT00438399|69654322|FG001|Overall Study|Protocol Violation|0|||
37967381|NCT00438399|69654323|FG002|Overall Study|Protocol Violation|1|||
37967382|NCT00438399|69654324|FG003|Overall Study|Protocol Violation|0|||
37967383|NCT00438399|69654325|FG004|Overall Study|Protocol Violation|0|||
37967384|NCT00438399|69654326|FG005|Overall Study|Protocol Violation|1|||
37967385|NCT00438399|69654321|FG000|Overall Study|Subje stopped study|0|||
37967386|NCT00438399|69654322|FG001|Overall Study|Subje stopped study|0|||
37967387|NCT00438399|69654323|FG002|Overall Study|Subje stopped study|1|||
37967388|NCT00438399|69654324|FG003|Overall Study|Subje stopped study|0|||
37967389|NCT00438399|69654325|FG004|Overall Study|Subje stopped study|0|||
37967390|NCT00438399|69654326|FG005|Overall Study|Subje stopped study|0|||
38085444|NCT02808819|69785055|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
37967391|NCT00438399|69654321|FG000|Overall Study|Pregnancy|0|||
38085445|NCT02808819|69785054|FG000|Overall Study|Withdrawal by Subject|10|||
37863207|NCT00996892|69547125|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
37863208|NCT00996892|69547126|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
37863209|NCT00996892|69547127|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
37863210|NCT00996892|69547128|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
37863211|NCT00996892|69547129|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
37863212|NCT00996892|69547130|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
37863213|NCT00996892|69547131|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
37967392|NCT00438399|69654322|FG001|Overall Study|Pregnancy|0|||
37863214|NCT00996892|69547132|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
37863215|NCT00996892|69547133|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
37863216|NCT00996892|69547134|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
37863217|NCT00996892|69547135|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
37863218|NCT00996892|69547136|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
37863219|NCT00996892|69547137|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
37863220|NCT00996892|69547118|FG000|Dose-Escalation Stage 1|Death|1|||
37863221|NCT00996892|69547119|FG001|Dose-Escalation Stage 1|Death|0|||
37863222|NCT00996892|69547120|FG002|Dose-Escalation Stage 1|Death|0|||
37863223|NCT00996892|69547121|FG003|Dose-Escalation Stage 1|Death|0|||
37863224|NCT00996892|69547122|FG004|Dose-Escalation Stage 1|Death|0|||
37863225|NCT00996892|69547123|FG005|Dose-Escalation Stage 1|Death|1|||
37863226|NCT00996892|69547124|FG006|Dose-Escalation Stage 1|Death|0|||
37863227|NCT00996892|69547125|FG007|Dose-Escalation Stage 1|Death|0|||
37863228|NCT00996892|69547126|FG008|Dose-Escalation Stage 1|Death|0|||
38085446|NCT02808819|69785055|FG001|Overall Study|Withdrawal by Subject|13|||
38085447|NCT02808819|69785054|FG000|Overall Study|Site terminated by sponsor|2|||
38085448|NCT02808819|69785055|FG001|Overall Study|Site terminated by sponsor|0|||
38085449|NCT02808819|69785054|FG000|Overall Study|Pregnancy|1|||
38085450|NCT02808819|69785055|FG001|Overall Study|Pregnancy|0|||
38085451|NCT02808819|69785054|FG000|Overall Study|Lost to Follow-up|1|||
38085452|NCT02808819|69785055|FG001|Overall Study|Lost to Follow-up|6|||
38085453|NCT02808819|69785054|FG000|Overall Study|Protocol Violation|0|||
38085454|NCT02808819|69785055|FG001|Overall Study|Protocol Violation|1|||
38085455|NCT02808819|69785054|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
38085456|NCT02808819|69785055|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
38085457|NCT02808819|69785054|FG000|Overall Study|Death|1|||
38085458|NCT02808819|69785055|FG001|Overall Study|Death|0|||
38085459|NCT02808819|69785054|FG000|Overall Study|Adverse Event|3|||
38085460|NCT02808819|69785055|FG001|Overall Study|Adverse Event|4|||
38085461|NCT02808429|69785065|FG000|Overall Study|Lost to Follow-up|1|||
38085462|NCT02808429|69785066|FG001|Overall Study|Lost to Follow-up|0|||
38085463|NCT02808429|69785067|FG002|Overall Study|Lost to Follow-up|0|||
38085464|NCT02808429|69785065|FG000|Overall Study|Protocol Violation|0|||
38085465|NCT02808429|69785066|FG001|Overall Study|Protocol Violation|1|||
38085466|NCT02808429|69785067|FG002|Overall Study|Protocol Violation|0|||
38085467|NCT02808429|69785065|FG000|Overall Study|Premature study termination by sponsor|2|||
38085468|NCT02808429|69785066|FG001|Overall Study|Premature study termination by sponsor|0|||
38085469|NCT02808429|69785067|FG002|Overall Study|Premature study termination by sponsor|1|||
38085470|NCT02808429|69785065|FG000|Overall Study|Relocation|0|||
38085471|NCT02808429|69785066|FG001|Overall Study|Relocation|0|||
38085472|NCT02808429|69785067|FG002|Overall Study|Relocation|1|||
37863229|NCT00996892|69547127|FG009|Dose-Escalation Stage 1|Death|0|||
37863230|NCT00996892|69547128|FG010|Dose-Escalation Stage 1|Death|0|||
37863231|NCT00996892|69547129|FG011|Dose-Escalation Stage 1|Death|0|||
37863232|NCT00996892|69547130|FG012|Dose-Escalation Stage 1|Death|0|||
37863233|NCT00996892|69547131|FG013|Dose-Escalation Stage 1|Death|0|||
37863234|NCT00996892|69547132|FG014|Dose-Escalation Stage 1|Death|0|||
37863235|NCT00996892|69547133|FG015|Dose-Escalation Stage 1|Death|0|||
37863236|NCT00996892|69547134|FG016|Dose-Escalation Stage 1|Death|0|||
37863237|NCT00996892|69547135|FG017|Dose-Escalation Stage 1|Death|0|||
37863238|NCT00996892|69547136|FG018|Dose-Escalation Stage 1|Death|0|||
37863239|NCT00996892|69547137|FG019|Dose-Escalation Stage 1|Death|0|||
37863240|NCT00996892|69547118|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
37863241|NCT00996892|69547119|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
37863242|NCT00996892|69547120|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
37863243|NCT00996892|69547121|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
37863244|NCT00996892|69547122|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
37863245|NCT00996892|69547123|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
37863246|NCT00996892|69547124|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
37863247|NCT00996892|69547125|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
37967393|NCT00438399|69654323|FG002|Overall Study|Pregnancy|0|||
38085473|NCT01594762|69785077|FG000|Overall Study|Withdrawal by Subject|1|||
38085474|NCT01594762|69785078|FG001|Overall Study|Withdrawal by Subject|0|||
38085475|NCT01594762|69785077|FG000|Overall Study|Lost to Follow-up|10|||
38085476|NCT01594762|69785078|FG001|Overall Study|Lost to Follow-up|10|||
38085477|NCT02615470|69785086|FG000|Overall Study|Lost to Follow-up|21|||
38085478|NCT02615470|69785087|FG001|Overall Study|Lost to Follow-up|32|||
37863248|NCT00996892|69547126|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
37863249|NCT00996892|69547127|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
37863250|NCT00996892|69547128|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
37863251|NCT00996892|69547129|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
37863252|NCT00996892|69547130|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
37863253|NCT00996892|69547131|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
38085479|NCT02806947|69785095|FG000|Overall Study|Withdrawal by Subject|5|||
38085480|NCT02806947|69785096|FG001|Overall Study|Withdrawal by Subject|1|||
38085481|NCT02806713|69785104|FG000|Overall Study|Urethral injury during procedure|1|||
37863254|NCT00996892|69547132|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
37863255|NCT00996892|69547133|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
37863256|NCT00996892|69547134|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
37863257|NCT00996892|69547135|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
37863258|NCT00996892|69547136|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
37863259|NCT00996892|69547137|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
37863260|NCT00996892|69547118|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
37863261|NCT00996892|69547119|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
37863262|NCT00996892|69547120|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
37863263|NCT00996892|69547121|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
37863264|NCT00996892|69547122|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
37863265|NCT00996892|69547123|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
37863266|NCT00996892|69547124|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
37863267|NCT00996892|69547125|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
37863268|NCT00996892|69547126|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
37863269|NCT00996892|69547127|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
37863270|NCT00996892|69547128|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
37863271|NCT00996892|69547129|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
37863272|NCT00996892|69547130|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
37863273|NCT00996892|69547131|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
37863274|NCT00996892|69547132|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
37863275|NCT00996892|69547133|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
37863276|NCT00996892|69547134|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
37863277|NCT00996892|69547135|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
37863278|NCT00996892|69547136|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
37863279|NCT00996892|69547137|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
37863280|NCT00996892|69547118|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
37863281|NCT00996892|69547119|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
37863282|NCT00996892|69547120|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
37863283|NCT00996892|69547121|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
37863284|NCT00996892|69547122|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
37863285|NCT00996892|69547123|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
37863286|NCT00996892|69547124|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
37863287|NCT00996892|69547125|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
37863288|NCT00996892|69547126|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
37863289|NCT00996892|69547127|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
37863290|NCT00996892|69547128|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
37863291|NCT00996892|69547129|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
37863292|NCT00996892|69547130|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
37863293|NCT00996892|69547131|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
37863294|NCT00996892|69547132|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
37863295|NCT00996892|69547133|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
37863296|NCT00996892|69547134|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
37863297|NCT00996892|69547135|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
37863298|NCT00996892|69547136|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
37863299|NCT00996892|69547137|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
37863300|NCT00996892|69547118|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
37863301|NCT00996892|69547119|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
37863302|NCT00996892|69547120|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
37863303|NCT00996892|69547121|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
37863304|NCT00996892|69547122|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
37863305|NCT00996892|69547123|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
37863306|NCT00996892|69547124|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
37863307|NCT00996892|69547125|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
37863308|NCT00996892|69547126|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
37863309|NCT00996892|69547127|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
37863310|NCT00996892|69547128|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
37863311|NCT00996892|69547129|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
37863312|NCT00996892|69547130|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
37863313|NCT00996892|69547131|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
37863314|NCT00996892|69547132|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
37863315|NCT00996892|69547133|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
37863316|NCT00996892|69547134|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
37863317|NCT00996892|69547135|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
37863318|NCT00996892|69547136|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
38085482|NCT02806713|69785105|FG001|Overall Study|Urethral injury during procedure|0|||
37863319|NCT00996892|69547137|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
37863320|NCT00996892|69547118|FG000|Dose-Escalation Stage 1A|Death|0|||
37863321|NCT00996892|69547119|FG001|Dose-Escalation Stage 1A|Death|0|||
37863322|NCT00996892|69547120|FG002|Dose-Escalation Stage 1A|Death|0|||
38085483|NCT02806713|69785104|FG000|Overall Study|cancelled surgery|1|||
38085484|NCT02806713|69785105|FG001|Overall Study|cancelled surgery|2|||
38085485|NCT02807493|69785113|FG000|Overall Study|Adverse Event|5|||
38085486|NCT02807493|69785114|FG001|Overall Study|Adverse Event|2|||
38085487|NCT02807493|69785113|FG000|Overall Study|Lost to Follow-up|6|||
38085488|NCT02807493|69785114|FG001|Overall Study|Lost to Follow-up|0|||
38085489|NCT02807493|69785113|FG000|Overall Study|Physician Decision|4|||
38085490|NCT02807493|69785114|FG001|Overall Study|Physician Decision|1|||
38085491|NCT02807493|69785113|FG000|Overall Study|Protocol Violation|7|||
38085492|NCT02807493|69785114|FG001|Overall Study|Protocol Violation|0|||
38085493|NCT02807493|69785113|FG000|Overall Study|Withdrawal by Subject|17|||
38085494|NCT02807493|69785114|FG001|Overall Study|Withdrawal by Subject|10|||
38085495|NCT02807493|69785113|FG000|Overall Study|Other withdrawal|17|||
38085496|NCT02807493|69785114|FG001|Overall Study|Other withdrawal|0|||
38085497|NCT02807493|69785113|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
38085498|NCT02807493|69785114|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
38085499|NCT02807259|69785122|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
38085500|NCT02807259|69785123|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
38085501|NCT02807259|69785122|FG000|Midline (3 Months)|migration, refusal, not available|30|||
38085502|NCT02807259|69785123|FG001|Midline (3 Months)|migration, refusal, not available|34|||
38085503|NCT02807259|69785122|FG000|Endline (3 Months)|migration, refusal, not available|35|||
38085504|NCT02807259|69785123|FG001|Endline (3 Months)|migration, refusal, not available|87|||
38085505|NCT02802345|69785133|FG000|Overall Study|Not Treated|0|||
38085506|NCT02802345|69785134|FG001|Overall Study|Not Treated|1|||
38085507|NCT02802345|69785133|FG000|Overall Study|Adverse Event|28|||
38085508|NCT02802345|69785134|FG001|Overall Study|Adverse Event|20|||
38085509|NCT02802345|69785133|FG000|Overall Study|Withdrawal by Subject|3|||
38085510|NCT02802345|69785134|FG001|Overall Study|Withdrawal by Subject|3|||
38085511|NCT02802345|69785133|FG000|Overall Study|Protocol Violation|0|||
38085512|NCT02802345|69785134|FG001|Overall Study|Protocol Violation|1|||
38085513|NCT02802345|69785133|FG000|Overall Study|Other than listed|1|||
38085514|NCT02802345|69785134|FG001|Overall Study|Other than listed|5|||
38085515|NCT02801877|69785144|FG000|Overall Study|Lost to Follow-up|1|||
38085516|NCT02801877|69785145|FG001|Overall Study|Lost to Follow-up|1|||
38085517|NCT02801877|69785146|FG002|Overall Study|Lost to Follow-up|2|||
38085518|NCT02801877|69785147|FG003|Overall Study|Lost to Follow-up|0|||
38085519|NCT02801877|69785144|FG000|Overall Study|Never Started Treatment|2|||
38085520|NCT02801877|69785145|FG001|Overall Study|Never Started Treatment|0|||
38085521|NCT02801877|69785146|FG002|Overall Study|Never Started Treatment|4|||
38085522|NCT02801877|69785147|FG003|Overall Study|Never Started Treatment|0|||
38085523|NCT02805309|69785160|FG000|Overall Study|Lost to Follow-up|2|||
38085524|NCT02805309|69785161|FG001|Overall Study|Lost to Follow-up|2|||
38085525|NCT02805309|69785162|FG002|Overall Study|Lost to Follow-up|2|||
38085526|NCT02805309|69785160|FG000|Overall Study|Post-Randomization Exclusion|0|||
38085527|NCT02805309|69785161|FG001|Overall Study|Post-Randomization Exclusion|2|||
38085528|NCT02805309|69785162|FG002|Overall Study|Post-Randomization Exclusion|1|||
38085529|NCT02804763|69785174|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
38085530|NCT02804763|69785175|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
38085531|NCT02804763|69785176|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
38085532|NCT02804763|69785177|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
38085533|NCT02804763|69785174|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
38085534|NCT02804763|69785175|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
38085535|NCT02804763|69785176|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
38085536|NCT02804763|69785177|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
38085537|NCT02804763|69785174|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
38085538|NCT02804763|69785175|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
38085539|NCT02804763|69785176|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
38085540|NCT02804763|69785177|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
38085541|NCT02804763|69785174|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
38085542|NCT02804763|69785175|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
38085543|NCT02804763|69785176|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
38085544|NCT02804763|69785177|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
38085545|NCT02804763|69785174|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
38085546|NCT02804763|69785175|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
38085547|NCT02804763|69785176|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
38085548|NCT02804763|69785177|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
38085549|NCT02804763|69785174|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
38085550|NCT02804763|69785175|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
38085551|NCT02804763|69785176|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
38085552|NCT02804763|69785177|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
38085553|NCT02748057|69785193|FG000|Overall Study|Adverse Event|1|||
38085554|NCT02748057|69785194|FG001|Overall Study|Adverse Event|0|||
38085555|NCT02748057|69785193|FG000|Overall Study|Physician Decision|0|||
38085556|NCT02748057|69785194|FG001|Overall Study|Physician Decision|1|||
38085557|NCT02748057|69785193|FG000|Overall Study|Protocol Violation|2|||
38085558|NCT02748057|69785194|FG001|Overall Study|Protocol Violation|1|||
38085559|NCT02748057|69785193|FG000|Overall Study|Participant Moved|1|||
38085560|NCT02748057|69785194|FG001|Overall Study|Participant Moved|0|||
38085561|NCT02748057|69785193|FG000|Overall Study|Withdrawal by Subject|1|||
38085562|NCT02748057|69785194|FG001|Overall Study|Withdrawal by Subject|0|||
38085563|NCT02748213|69785202|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
38085564|NCT02748213|69785203|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
38085565|NCT02748213|69785202|FG000|Overall Study|Abnormal Laboratory Test|1|||
38085566|NCT02748213|69785203|FG001|Overall Study|Abnormal Laboratory Test|0|||
38085567|NCT02748213|69785202|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
38085568|NCT02748213|69785203|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
38085569|NCT02748213|69785202|FG000|Overall Study|Death|5|||
38085570|NCT02748213|69785203|FG001|Overall Study|Death|3|||
38085571|NCT02748213|69785202|FG000|Overall Study|Insufficient Therapeutic Response|56|||
38085572|NCT02748213|69785203|FG001|Overall Study|Insufficient Therapeutic Response|57|||
38085573|NCT02748213|69785202|FG000|Overall Study|Violation of Selection Criteria|2|||
38085574|NCT02748213|69785203|FG001|Overall Study|Violation of Selection Criteria|0|||
38085575|NCT02748213|69785202|FG000|Overall Study|Protocol Violation|6|||
38085576|NCT02748213|69785203|FG001|Overall Study|Protocol Violation|4|||
37967394|NCT00438399|69654324|FG003|Overall Study|Pregnancy|0|||
37967395|NCT00438399|69654325|FG004|Overall Study|Pregnancy|0|||
37967396|NCT00438399|69654326|FG005|Overall Study|Pregnancy|1|||
37967397|NCT00438399|69654321|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
37967398|NCT00438399|69654322|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
38085577|NCT02748213|69785202|FG000|Overall Study|Refused Treatment*|6|||
38085578|NCT02748213|69785203|FG001|Overall Study|Refused Treatment*|6|||
37967399|NCT00438399|69654323|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
37967400|NCT00438399|69654324|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
37686697|NCT02265705|69162482|FG006|Rescue Period|Death|0|||
37686698|NCT02265705|69162476|FG000|Rescue Period|Lack of Efficacy|0|||
37686699|NCT02265705|69162477|FG001|Rescue Period|Lack of Efficacy|0|||
37686700|NCT02265705|69162478|FG002|Rescue Period|Lack of Efficacy|1|||
37686701|NCT02265705|69162479|FG003|Rescue Period|Lack of Efficacy|0|||
37686702|NCT02265705|69162480|FG004|Rescue Period|Lack of Efficacy|0|||
37686703|NCT02265705|69162481|FG005|Rescue Period|Lack of Efficacy|0|||
37863323|NCT00996892|69547121|FG003|Dose-Escalation Stage 1A|Death|0|||
37863324|NCT00996892|69547122|FG004|Dose-Escalation Stage 1A|Death|0|||
37863325|NCT00996892|69547123|FG005|Dose-Escalation Stage 1A|Death|0|||
37863326|NCT00996892|69547124|FG006|Dose-Escalation Stage 1A|Death|0|||
37863327|NCT00996892|69547125|FG007|Dose-Escalation Stage 1A|Death|0|||
37863328|NCT00996892|69547126|FG008|Dose-Escalation Stage 1A|Death|0|||
37863329|NCT00996892|69547127|FG009|Dose-Escalation Stage 1A|Death|2|||
37863330|NCT00996892|69547128|FG010|Dose-Escalation Stage 1A|Death|0|||
37863331|NCT00996892|69547129|FG011|Dose-Escalation Stage 1A|Death|1|||
37863332|NCT00996892|69547130|FG012|Dose-Escalation Stage 1A|Death|1|||
37863333|NCT00996892|69547131|FG013|Dose-Escalation Stage 1A|Death|0|||
37686704|NCT02265705|69162482|FG006|Rescue Period|Lack of Efficacy|0|||
37686705|NCT02265705|69162476|FG000|Open Label Period|Adverse Event|0|||
37863334|NCT00996892|69547132|FG014|Dose-Escalation Stage 1A|Death|0|||
37863335|NCT00996892|69547133|FG015|Dose-Escalation Stage 1A|Death|0|||
37967401|NCT00438399|69654325|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
38085579|NCT02748213|69785202|FG000|Overall Study|Failure to Return|1|||
38085580|NCT02748213|69785203|FG001|Overall Study|Failure to Return|0|||
38085581|NCT02748213|69785202|FG000|Overall Study|Other|30|||
38085582|NCT02748213|69785203|FG001|Overall Study|Other|29|||
38085583|NCT02613910|69785209|FG000|Overall Study|Termination of study|1|||
38085584|NCT02802735|69785216|FG000|Overall Study|Withdrawal by Subject|0|||
38085585|NCT02802735|69785217|FG001|Overall Study|Withdrawal by Subject|1|||
38085586|NCT02802735|69785218|FG002|Overall Study|Withdrawal by Subject|0|||
37686706|NCT02265705|69162477|FG001|Open Label Period|Adverse Event|0|||
37686707|NCT02265705|69162478|FG002|Open Label Period|Adverse Event|0|||
38085587|NCT02802735|69785219|FG003|Overall Study|Withdrawal by Subject|0|||
37686708|NCT02265705|69162479|FG003|Open Label Period|Adverse Event|2|||
37686709|NCT02265705|69162480|FG004|Open Label Period|Adverse Event|2|||
37863336|NCT00996892|69547134|FG016|Dose-Escalation Stage 1A|Death|0|||
37863337|NCT00996892|69547135|FG017|Dose-Escalation Stage 1A|Death|0|||
38085588|NCT02802735|69785220|FG004|Overall Study|Withdrawal by Subject|0|||
38085589|NCT02799381|69785250|FG000|Overall Study|Withdrew consent|3|||
38085590|NCT02799381|69785251|FG001|Overall Study|Withdrew consent|2|||
38085591|NCT02799381|69785250|FG000|Overall Study|Adverse Event|0|||
38085592|NCT02799381|69785251|FG001|Overall Study|Adverse Event|1|||
37686710|NCT02265705|69162481|FG005|Open Label Period|Adverse Event|0|||
37686711|NCT02265705|69162482|FG006|Open Label Period|Adverse Event|0|||
38085593|NCT02799381|69785250|FG000|Overall Study|Participant did not take any study drug|1|||
38085594|NCT02799381|69785251|FG001|Overall Study|Participant did not take any study drug|0|||
38085595|NCT01333059|69785259|FG000|Overall Study|Physician Decision|3|||
38085596|NCT01333059|69785260|FG001|Overall Study|Physician Decision|3|||
38085597|NCT01333059|69785259|FG000|Overall Study|Protocol Violation|3|||
38085598|NCT01333059|69785260|FG001|Overall Study|Protocol Violation|0|||
38085599|NCT01370733|69785270|FG000|Overall Study|Withdrawal by Subject|8|||
38085600|NCT01370733|69785271|FG001|Overall Study|Withdrawal by Subject|8|||
38085601|NCT01370733|69785270|FG000|Overall Study|Lost to Follow-up|3|||
38085602|NCT01370733|69785271|FG001|Overall Study|Lost to Follow-up|0|||
38085603|NCT01370733|69785270|FG000|Overall Study|Adverse Event|2|||
38085604|NCT01370733|69785271|FG001|Overall Study|Adverse Event|4|||
38085605|NCT01370733|69785270|FG000|Overall Study|Lack of Efficacy|3|||
38085606|NCT01370733|69785271|FG001|Overall Study|Lack of Efficacy|5|||
38085607|NCT01370733|69785270|FG000|Overall Study|Physician Decision|0|||
38085608|NCT01370733|69785271|FG001|Overall Study|Physician Decision|2|||
38085609|NCT01370733|69785270|FG000|Overall Study|Protocol Violation|1|||
38085610|NCT01370733|69785271|FG001|Overall Study|Protocol Violation|3|||
38085611|NCT02613364|69785280|FG000|Overall Study|Other|19|||
38085612|NCT02613364|69785281|FG001|Overall Study|Other|29|||
38085613|NCT02613364|69785282|FG002|Overall Study|Other|17|||
38085614|NCT02613364|69785280|FG000|Overall Study|Too time consuming|21|||
38085615|NCT02613364|69785281|FG001|Overall Study|Too time consuming|26|||
38085616|NCT02613364|69785282|FG002|Overall Study|Too time consuming|26|||
38085617|NCT02613364|69785280|FG000|Overall Study|Withdrawal by Subject|13|||
38085618|NCT02613364|69785281|FG001|Overall Study|Withdrawal by Subject|18|||
38085619|NCT02613364|69785282|FG002|Overall Study|Withdrawal by Subject|17|||
38085620|NCT02613364|69785280|FG000|Overall Study|Medical|12|||
38085621|NCT02613364|69785281|FG001|Overall Study|Medical|13|||
38085622|NCT02613364|69785282|FG002|Overall Study|Medical|9|||
38085623|NCT02613364|69785280|FG000|Overall Study|Disliked Study Procedure|1|||
38085624|NCT02613364|69785281|FG001|Overall Study|Disliked Study Procedure|1|||
38085625|NCT02613364|69785282|FG002|Overall Study|Disliked Study Procedure|4|||
37967402|NCT00438399|69654326|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
38085626|NCT02613364|69785280|FG000|Overall Study|Disliked Intervention|0|||
38085627|NCT02613364|69785281|FG001|Overall Study|Disliked Intervention|3|||
38085628|NCT02613364|69785282|FG002|Overall Study|Disliked Intervention|3|||
38085629|NCT01370655|69785302|FG000|Period 1|Adverse Event|2|||
38085630|NCT01370655|69785303|FG001|Period 1|Adverse Event|0|||
38085631|NCT01370655|69785304|FG002|Period 1|Adverse Event|0|||
38085632|NCT01370655|69785305|FG003|Period 1|Adverse Event|0|||
38085633|NCT01370655|69785306|FG004|Period 1|Adverse Event|0|||
38085634|NCT01370655|69785307|FG005|Period 1|Adverse Event|0|||
38085635|NCT01370655|69785308|FG006|Period 1|Adverse Event|1|||
38085636|NCT01370655|69785309|FG007|Period 1|Adverse Event|0|||
38085637|NCT01370655|69785310|FG008|Period 1|Adverse Event|0|||
38085638|NCT01370655|69785311|FG009|Period 1|Adverse Event|0|||
38085639|NCT01370655|69785312|FG010|Period 1|Adverse Event|0|||
38085640|NCT01370655|69785313|FG011|Period 1|Adverse Event|0|||
38085641|NCT01370655|69785302|FG000|Period 2|Adverse Event|0|||
38085642|NCT01370655|69785303|FG001|Period 2|Adverse Event|0|||
37686712|NCT02265705|69162476|FG000|Open Label Period|Physician Decision|0|||
38085643|NCT01370655|69785304|FG002|Period 2|Adverse Event|1|||
38085644|NCT01370655|69785305|FG003|Period 2|Adverse Event|0|||
38085645|NCT01370655|69785306|FG004|Period 2|Adverse Event|1|||
38085646|NCT01370655|69785307|FG005|Period 2|Adverse Event|0|||
38085647|NCT01370655|69785308|FG006|Period 2|Adverse Event|0|||
38085648|NCT01370655|69785309|FG007|Period 2|Adverse Event|1|||
38085649|NCT01370655|69785310|FG008|Period 2|Adverse Event|0|||
38085650|NCT01370655|69785311|FG009|Period 2|Adverse Event|0|||
38085651|NCT01370655|69785312|FG010|Period 2|Adverse Event|0|||
38085652|NCT01370655|69785313|FG011|Period 2|Adverse Event|0|||
38085653|NCT01370655|69785302|FG000|Period 2|met protocol specified stopping criteria|0|||
38085654|NCT01370655|69785303|FG001|Period 2|met protocol specified stopping criteria|0|||
38085655|NCT01370655|69785304|FG002|Period 2|met protocol specified stopping criteria|1|||
38085656|NCT01370655|69785305|FG003|Period 2|met protocol specified stopping criteria|0|||
38085657|NCT01370655|69785306|FG004|Period 2|met protocol specified stopping criteria|0|||
38085658|NCT01370655|69785307|FG005|Period 2|met protocol specified stopping criteria|0|||
38085659|NCT01370655|69785308|FG006|Period 2|met protocol specified stopping criteria|1|||
38085660|NCT01370655|69785309|FG007|Period 2|met protocol specified stopping criteria|0|||
38085661|NCT01370655|69785310|FG008|Period 2|met protocol specified stopping criteria|1|||
38085662|NCT01370655|69785311|FG009|Period 2|met protocol specified stopping criteria|0|||
38085663|NCT01370655|69785312|FG010|Period 2|met protocol specified stopping criteria|1|||
38085664|NCT01370655|69785313|FG011|Period 2|met protocol specified stopping criteria|0|||
38085665|NCT01370655|69785302|FG000|Period 2|Withdrawal by Subject|0|||
38085666|NCT01370655|69785303|FG001|Period 2|Withdrawal by Subject|0|||
38085667|NCT01370655|69785304|FG002|Period 2|Withdrawal by Subject|0|||
38085668|NCT01370655|69785305|FG003|Period 2|Withdrawal by Subject|0|||
38085669|NCT01370655|69785306|FG004|Period 2|Withdrawal by Subject|0|||
38085670|NCT01370655|69785307|FG005|Period 2|Withdrawal by Subject|0|||
38085671|NCT01370655|69785308|FG006|Period 2|Withdrawal by Subject|0|||
38085672|NCT01370655|69785309|FG007|Period 2|Withdrawal by Subject|0|||
38085673|NCT01370655|69785310|FG008|Period 2|Withdrawal by Subject|1|||
38085674|NCT01370655|69785311|FG009|Period 2|Withdrawal by Subject|0|||
38085675|NCT01370655|69785312|FG010|Period 2|Withdrawal by Subject|0|||
38085676|NCT01370655|69785313|FG011|Period 2|Withdrawal by Subject|0|||
38085677|NCT02612194|69785326|FG000|Overall Study|Death|5|||
38085678|NCT02612194|69785327|FG001|Overall Study|Death|0|||
38085679|NCT02612194|69785328|FG002|Overall Study|Death|2|||
38085680|NCT02612194|69785326|FG000|Overall Study|Early Study Termination|1|||
38085681|NCT02612194|69785327|FG001|Overall Study|Early Study Termination|0|||
38085682|NCT02612194|69785328|FG002|Overall Study|Early Study Termination|0|||
38085683|NCT02798211|69785338|FG000|Period 1|Adverse Event|1|||
38085684|NCT02798211|69785339|FG001|Period 1|Adverse Event|1|||
38085685|NCT02798211|69785340|FG002|Period 1|Adverse Event|0|||
37686713|NCT02265705|69162477|FG001|Open Label Period|Physician Decision|0|||
37686714|NCT02265705|69162478|FG002|Open Label Period|Physician Decision|0|||
37686715|NCT02265705|69162479|FG003|Open Label Period|Physician Decision|0|||
37686716|NCT02265705|69162480|FG004|Open Label Period|Physician Decision|1|||
37686717|NCT02265705|69162481|FG005|Open Label Period|Physician Decision|0|||
37686718|NCT02265705|69162482|FG006|Open Label Period|Physician Decision|0|||
37686719|NCT02265705|69162476|FG000|Open Label Period|Withdrawal by Subject|0|||
37686720|NCT02265705|69162477|FG001|Open Label Period|Withdrawal by Subject|0|||
38085686|NCT02798211|69785341|FG003|Period 1|Adverse Event|0|||
37686721|NCT02265705|69162478|FG002|Open Label Period|Withdrawal by Subject|0|||
37686722|NCT02265705|69162479|FG003|Open Label Period|Withdrawal by Subject|0|||
37686723|NCT02265705|69162480|FG004|Open Label Period|Withdrawal by Subject|2|||
37686724|NCT02265705|69162481|FG005|Open Label Period|Withdrawal by Subject|0|||
37686725|NCT02265705|69162482|FG006|Open Label Period|Withdrawal by Subject|0|||
37686726|NCT02265705|69162476|FG000|Follow-up Period|Sponsor Decision|0|||
37686727|NCT02265705|69162477|FG001|Follow-up Period|Sponsor Decision|0|||
37686728|NCT02265705|69162478|FG002|Follow-up Period|Sponsor Decision|0|||
37686729|NCT02265705|69162479|FG003|Follow-up Period|Sponsor Decision|0|||
37686730|NCT02265705|69162480|FG004|Follow-up Period|Sponsor Decision|0|||
37686731|NCT02265705|69162481|FG005|Follow-up Period|Sponsor Decision|1|||
37686732|NCT02265705|69162482|FG006|Follow-up Period|Sponsor Decision|6|||
37686733|NCT02265705|69162476|FG000|Follow-up Period|Adverse Event|0|||
37686734|NCT02265705|69162477|FG001|Follow-up Period|Adverse Event|0|||
37686735|NCT02265705|69162478|FG002|Follow-up Period|Adverse Event|0|||
38085687|NCT02798211|69785342|FG004|Period 1|Adverse Event|0|||
38085688|NCT02798211|69785343|FG005|Period 1|Adverse Event|0|||
38085689|NCT02798211|69785338|FG000|Period 1|Lost to Follow-up|2|||
37863338|NCT00996892|69547136|FG018|Dose-Escalation Stage 1A|Death|0|||
38085690|NCT02798211|69785339|FG001|Period 1|Lost to Follow-up|1|||
38085691|NCT02798211|69785340|FG002|Period 1|Lost to Follow-up|0|||
38085692|NCT02798211|69785341|FG003|Period 1|Lost to Follow-up|0|||
38085693|NCT02798211|69785342|FG004|Period 1|Lost to Follow-up|0|||
37686736|NCT02265705|69162479|FG003|Follow-up Period|Adverse Event|0|||
37686737|NCT02265705|69162480|FG004|Follow-up Period|Adverse Event|0|||
37686738|NCT02265705|69162481|FG005|Follow-up Period|Adverse Event|0|||
37686739|NCT02265705|69162482|FG006|Follow-up Period|Adverse Event|3|||
37686740|NCT02265705|69162476|FG000|Follow-up Period|Physician Decision|0|||
37686741|NCT02265705|69162477|FG001|Follow-up Period|Physician Decision|0|||
37686742|NCT02265705|69162478|FG002|Follow-up Period|Physician Decision|0|||
37686743|NCT02265705|69162479|FG003|Follow-up Period|Physician Decision|0|||
38085694|NCT02798211|69785343|FG005|Period 1|Lost to Follow-up|0|||
38085695|NCT02798211|69785338|FG000|Period 1|Protocol Violation|0|||
38085696|NCT02798211|69785339|FG001|Period 1|Protocol Violation|0|||
38085697|NCT02798211|69785340|FG002|Period 1|Protocol Violation|2|||
38085698|NCT02798211|69785341|FG003|Period 1|Protocol Violation|0|||
38085699|NCT02798211|69785342|FG004|Period 1|Protocol Violation|0|||
38085700|NCT02798211|69785343|FG005|Period 1|Protocol Violation|0|||
38085701|NCT02798211|69785338|FG000|Period 1|Withdrawal by Subject|1|||
38085702|NCT02798211|69785339|FG001|Period 1|Withdrawal by Subject|1|||
38085703|NCT02798211|69785340|FG002|Period 1|Withdrawal by Subject|0|||
38085704|NCT02798211|69785341|FG003|Period 1|Withdrawal by Subject|0|||
38085705|NCT02798211|69785342|FG004|Period 1|Withdrawal by Subject|0|||
38085706|NCT02798211|69785343|FG005|Period 1|Withdrawal by Subject|0|||
38085707|NCT02798211|69785338|FG000|Period 1|Death|0|||
38085708|NCT02798211|69785339|FG001|Period 1|Death|0|||
38085709|NCT02798211|69785340|FG002|Period 1|Death|1|||
38085710|NCT02798211|69785341|FG003|Period 1|Death|0|||
38085711|NCT02798211|69785342|FG004|Period 1|Death|0|||
38085712|NCT02798211|69785343|FG005|Period 1|Death|0|||
38085713|NCT02798211|69785338|FG000|Period 1|Withdrawal of Informed Consent|2|||
38085714|NCT02798211|69785339|FG001|Period 1|Withdrawal of Informed Consent|7|||
38085715|NCT02798211|69785340|FG002|Period 1|Withdrawal of Informed Consent|3|||
38085716|NCT02798211|69785341|FG003|Period 1|Withdrawal of Informed Consent|0|||
38085717|NCT02798211|69785342|FG004|Period 1|Withdrawal of Informed Consent|0|||
38085718|NCT02798211|69785343|FG005|Period 1|Withdrawal of Informed Consent|0|||
37686744|NCT02265705|69162480|FG004|Follow-up Period|Physician Decision|0|||
37686745|NCT02265705|69162481|FG005|Follow-up Period|Physician Decision|0|||
37686746|NCT02265705|69162482|FG006|Follow-up Period|Physician Decision|1|||
37686747|NCT02265705|69162476|FG000|Follow-up Period|Withdrawal by Subject|0|||
37686748|NCT02265705|69162477|FG001|Follow-up Period|Withdrawal by Subject|0|||
37686749|NCT02265705|69162478|FG002|Follow-up Period|Withdrawal by Subject|0|||
37686750|NCT02265705|69162479|FG003|Follow-up Period|Withdrawal by Subject|0|||
37686751|NCT02265705|69162480|FG004|Follow-up Period|Withdrawal by Subject|0|||
37686752|NCT02265705|69162481|FG005|Follow-up Period|Withdrawal by Subject|0|||
37686753|NCT02265705|69162482|FG006|Follow-up Period|Withdrawal by Subject|1|||
37686754|NCT02459665|69162497|FG000|Overall Study|Withdrawal by Subject|0|||
37686755|NCT02459665|69162498|FG001|Overall Study|Withdrawal by Subject|1|||
37686756|NCT02459665|69162499|FG002|Overall Study|Withdrawal by Subject|1|||
37686757|NCT02459665|69162500|FG003|Overall Study|Withdrawal by Subject|2|||
37686758|NCT02265237|69162521|FG000|As Treated (Overall Study)|Adverse Event|1|||
37686759|NCT02265237|69162522|FG001|As Treated (Overall Study)|Adverse Event|1|||
37686760|NCT02265237|69162523|FG002|As Treated (Overall Study)|Adverse Event|0|||
37686761|NCT02265237|69162524|FG003|As Treated (Overall Study)|Adverse Event|0|||
37686762|NCT02265237|69162521|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
37686763|NCT02265237|69162522|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
37686764|NCT02265237|69162523|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
37686765|NCT02265237|69162524|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
37686766|NCT02265237|69162521|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
37686767|NCT02265237|69162522|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
37686768|NCT02265237|69162523|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
37686769|NCT02265237|69162524|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
37686770|NCT02265237|69162521|FG000|As Treated (Overall Study)|Other|2|||
37686771|NCT02265237|69162522|FG001|As Treated (Overall Study)|Other|0|||
37686772|NCT02265237|69162523|FG002|As Treated (Overall Study)|Other|3|||
37686773|NCT02265237|69162524|FG003|As Treated (Overall Study)|Other|1|||
37686774|NCT02263365|69162537|FG000|Overall Study|Physician Decision|22|||
37686775|NCT02263365|69162538|FG001|Overall Study|Physician Decision|18|||
37686776|NCT02261493|69162548|FG000|Overall Study|Noncompliance|0|||
38085719|NCT02798211|69785338|FG000|Period 2|Withdrawal by Subject|2|||
38085720|NCT02798211|69785339|FG001|Period 2|Withdrawal by Subject|0|||
38085721|NCT02798211|69785340|FG002|Period 2|Withdrawal by Subject|0|||
38085722|NCT02798211|69785341|FG003|Period 2|Withdrawal by Subject|0|||
37686777|NCT02261493|69162549|FG001|Overall Study|Noncompliance|0|||
37686778|NCT02261493|69162550|FG002|Overall Study|Noncompliance|2|||
38085723|NCT02798211|69785342|FG004|Period 2|Withdrawal by Subject|2|||
38085724|NCT02798211|69785343|FG005|Period 2|Withdrawal by Subject|2|||
37686779|NCT02261493|69162548|FG000|Overall Study|Physician Decision|0|||
37686780|NCT02261493|69162549|FG001|Overall Study|Physician Decision|1|||
38085725|NCT02798211|69785338|FG000|Period 2|Adverse Event|5|||
38085726|NCT02798211|69785339|FG001|Period 2|Adverse Event|0|||
38085727|NCT02798211|69785340|FG002|Period 2|Adverse Event|0|||
37686781|NCT02261493|69162550|FG002|Overall Study|Physician Decision|0|||
37686782|NCT02261493|69162548|FG000|Overall Study|Undisclosed alcohol abuse|0|||
37686783|NCT02261493|69162549|FG001|Overall Study|Undisclosed alcohol abuse|1|||
37686784|NCT02261493|69162550|FG002|Overall Study|Undisclosed alcohol abuse|0|||
37686785|NCT02261493|69162548|FG000|Overall Study|Protocol Violation|1|||
37686786|NCT02261493|69162549|FG001|Overall Study|Protocol Violation|0|||
37686787|NCT02261493|69162550|FG002|Overall Study|Protocol Violation|0|||
37863339|NCT00996892|69547137|FG019|Dose-Escalation Stage 1A|Death|0|||
37863340|NCT00996892|69547118|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
37863341|NCT00996892|69547119|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
37863342|NCT00996892|69547120|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
37863343|NCT00996892|69547121|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
37863344|NCT00996892|69547122|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
37863345|NCT00996892|69547123|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
37863346|NCT00996892|69547124|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
38085728|NCT02798211|69785341|FG003|Period 2|Adverse Event|0|||
38085729|NCT02798211|69785342|FG004|Period 2|Adverse Event|1|||
38085730|NCT02798211|69785343|FG005|Period 2|Adverse Event|0|||
38085731|NCT02798211|69785338|FG000|Period 2|Lack of Efficacy|1|||
38085732|NCT02798211|69785339|FG001|Period 2|Lack of Efficacy|0|||
38085733|NCT02798211|69785340|FG002|Period 2|Lack of Efficacy|0|||
38085734|NCT02798211|69785341|FG003|Period 2|Lack of Efficacy|1|||
38085735|NCT02798211|69785342|FG004|Period 2|Lack of Efficacy|0|||
38085736|NCT02798211|69785343|FG005|Period 2|Lack of Efficacy|1|||
38085737|NCT02798211|69785338|FG000|Period 2|Lost to Follow-up|3|||
37686788|NCT02261493|69162548|FG000|Overall Study|Personal Reasons|14|||
37686789|NCT02261493|69162549|FG001|Overall Study|Personal Reasons|14|||
37686790|NCT02261493|69162550|FG002|Overall Study|Personal Reasons|16|||
37686791|NCT02261493|69162548|FG000|Overall Study|Lost to Follow-up|14|||
37686792|NCT02261493|69162549|FG001|Overall Study|Lost to Follow-up|27|||
37686793|NCT02261493|69162550|FG002|Overall Study|Lost to Follow-up|8|||
37686794|NCT02261493|69162548|FG000|Overall Study|Pregnancy|1|||
37686795|NCT02261493|69162549|FG001|Overall Study|Pregnancy|2|||
37686796|NCT02261493|69162550|FG002|Overall Study|Pregnancy|0|||
37686797|NCT02261493|69162548|FG000|Overall Study|Lack of Efficacy|0|||
37686798|NCT02261493|69162549|FG001|Overall Study|Lack of Efficacy|1|||
37686799|NCT02261493|69162550|FG002|Overall Study|Lack of Efficacy|0|||
37686800|NCT02261493|69162548|FG000|Overall Study|Adverse Event|0|||
37686801|NCT02261493|69162549|FG001|Overall Study|Adverse Event|1|||
37686802|NCT02261493|69162550|FG002|Overall Study|Adverse Event|0|||
37686803|NCT02260791|69162560|FG000|Overall Study|Lost to Follow-up|4|||
37686804|NCT02260791|69162561|FG001|Overall Study|Lost to Follow-up|4|||
37686805|NCT02260791|69162560|FG000|Overall Study|Lack of Efficacy|2|||
37686806|NCT02260791|69162561|FG001|Overall Study|Lack of Efficacy|1|||
37686807|NCT02260791|69162560|FG000|Overall Study|Adverse Event|13|||
37686808|NCT02260791|69162561|FG001|Overall Study|Adverse Event|9|||
37686809|NCT02260791|69162560|FG000|Overall Study|Death|1|||
37686810|NCT02260791|69162561|FG001|Overall Study|Death|0|||
37686811|NCT02260791|69162560|FG000|Overall Study|Withdrawal by Subject|11|||
37686812|NCT02260791|69162561|FG001|Overall Study|Withdrawal by Subject|16|||
37686813|NCT02260791|69162560|FG000|Overall Study|Screen failure|0|||
37686814|NCT02260791|69162561|FG001|Overall Study|Screen failure|1|||
37686815|NCT02260791|69162560|FG000|Overall Study|Protocol deviation|2|||
37686816|NCT02260791|69162561|FG001|Overall Study|Protocol deviation|3|||
37686817|NCT02260635|69162569|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
37686818|NCT02260635|69162570|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
37686819|NCT02260635|69162569|FG000|Open-Label Extension|Study Termination|25|||
37686820|NCT02260635|69162570|FG001|Open-Label Extension|Study Termination|25|||
37686821|NCT02260635|69162569|FG000|Open-Label Extension|Withdrawal by Subject|1|||
37686822|NCT02260635|69162570|FG001|Open-Label Extension|Withdrawal by Subject|0|||
37686823|NCT02259231|69162585|FG000|Overall Study|Adverse Event|1|||
37686824|NCT02259231|69162586|FG001|Overall Study|Adverse Event|1|||
37686825|NCT02259231|69162587|FG002|Overall Study|Adverse Event|2|||
37686826|NCT02259231|69162588|FG003|Overall Study|Adverse Event|0|||
37686827|NCT02259231|69162589|FG004|Overall Study|Adverse Event|0|||
37686828|NCT02259231|69162590|FG005|Overall Study|Adverse Event|0|||
37686829|NCT02259231|69162591|FG006|Overall Study|Adverse Event|0|||
37863347|NCT00996892|69547125|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
37863348|NCT00996892|69547126|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
37863349|NCT00996892|69547127|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
38085738|NCT02798211|69785339|FG001|Period 2|Lost to Follow-up|0|||
37686830|NCT02259231|69162585|FG000|Overall Study|Progressive Disease|4|||
37686831|NCT02259231|69162586|FG001|Overall Study|Progressive Disease|5|||
38085739|NCT02798211|69785340|FG002|Period 2|Lost to Follow-up|0|||
38085740|NCT02798211|69785341|FG003|Period 2|Lost to Follow-up|0|||
37686832|NCT02259231|69162587|FG002|Overall Study|Progressive Disease|4|||
37686833|NCT02259231|69162588|FG003|Overall Study|Progressive Disease|5|||
37686834|NCT02259231|69162589|FG004|Overall Study|Progressive Disease|4|||
37686835|NCT02259231|69162590|FG005|Overall Study|Progressive Disease|5|||
37686836|NCT02259231|69162591|FG006|Overall Study|Progressive Disease|4|||
37686837|NCT02259231|69162585|FG000|Overall Study|Sponsor termination of study|1|||
37686838|NCT02259231|69162586|FG001|Overall Study|Sponsor termination of study|0|||
37686839|NCT02259231|69162587|FG002|Overall Study|Sponsor termination of study|0|||
38085741|NCT02798211|69785342|FG004|Period 2|Lost to Follow-up|2|||
38085742|NCT02798211|69785343|FG005|Period 2|Lost to Follow-up|0|||
38085743|NCT02798211|69785338|FG000|Period 2|Physician Decision|1|||
38085744|NCT02798211|69785339|FG001|Period 2|Physician Decision|0|||
38085745|NCT02798211|69785340|FG002|Period 2|Physician Decision|0|||
38085746|NCT02798211|69785341|FG003|Period 2|Physician Decision|1|||
38085747|NCT02798211|69785342|FG004|Period 2|Physician Decision|1|||
38085748|NCT02798211|69785343|FG005|Period 2|Physician Decision|0|||
38085749|NCT02798211|69785338|FG000|Period 2|Pregnancy|0|||
38085750|NCT02798211|69785339|FG001|Period 2|Pregnancy|0|||
38085751|NCT02798211|69785340|FG002|Period 2|Pregnancy|0|||
38085752|NCT02798211|69785341|FG003|Period 2|Pregnancy|2|||
38085753|NCT02798211|69785342|FG004|Period 2|Pregnancy|0|||
38085754|NCT02798211|69785343|FG005|Period 2|Pregnancy|0|||
38085755|NCT02798211|69785338|FG000|Period 2|Technical problems|1|||
38085756|NCT02798211|69785339|FG001|Period 2|Technical problems|0|||
38085757|NCT02798211|69785340|FG002|Period 2|Technical problems|0|||
38085758|NCT02798211|69785341|FG003|Period 2|Technical problems|1|||
38085759|NCT02798211|69785342|FG004|Period 2|Technical problems|0|||
38085760|NCT02798211|69785343|FG005|Period 2|Technical problems|0|||
38085761|NCT02798211|69785338|FG000|Period 2|Withdrawal of Informed Consent|1|||
38085762|NCT02798211|69785339|FG001|Period 2|Withdrawal of Informed Consent|0|||
38085763|NCT02798211|69785340|FG002|Period 2|Withdrawal of Informed Consent|0|||
38085764|NCT02798211|69785341|FG003|Period 2|Withdrawal of Informed Consent|2|||
38085765|NCT02798211|69785342|FG004|Period 2|Withdrawal of Informed Consent|2|||
38085766|NCT02798211|69785343|FG005|Period 2|Withdrawal of Informed Consent|3|||
38085767|NCT02799069|69785358|FG000|Overall Study|Adverse Event|0|||
38085768|NCT02799069|69785359|FG001|Overall Study|Adverse Event|2|||
37686840|NCT02259231|69162588|FG003|Overall Study|Sponsor termination of study|1|||
37686841|NCT02259231|69162589|FG004|Overall Study|Sponsor termination of study|2|||
37686842|NCT02259231|69162590|FG005|Overall Study|Sponsor termination of study|1|||
37686843|NCT02259231|69162591|FG006|Overall Study|Sponsor termination of study|1|||
37686844|NCT02258529|69162607|FG000|Overall Study|Study Terminated by Sponsor|9|||
37686845|NCT02258529|69162607|FG000|Overall Study|Adverse Event|1|||
37686846|NCT02256969|69162614|FG000|Overall Study|Screenfailed or withdrew|2|||
37686847|NCT02256969|69162615|FG001|Overall Study|Screenfailed or withdrew|1|||
37686848|NCT02256969|69162616|FG002|Overall Study|Screenfailed or withdrew|1|||
37686849|NCT02256891|69162626|FG000|Overall Study|Death|0|||
37686850|NCT02256891|69162627|FG001|Overall Study|Death|2|||
37686851|NCT02256891|69162626|FG000|Overall Study|Lost to Follow-up|0|||
37686852|NCT02256891|69162627|FG001|Overall Study|Lost to Follow-up|3|||
37686853|NCT02256891|69162626|FG000|Overall Study|Physician Decision|7|||
37686854|NCT02256891|69162627|FG001|Overall Study|Physician Decision|3|||
37686855|NCT02256891|69162626|FG000|Overall Study|Screen Fail|5|||
37686856|NCT02256891|69162627|FG001|Overall Study|Screen Fail|4|||
37686857|NCT02256891|69162626|FG000|Overall Study|Equipment Malfunction|0|||
37686858|NCT02256891|69162627|FG001|Overall Study|Equipment Malfunction|1|||
37686859|NCT02256267|69162635|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
37686860|NCT02256267|69162635|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
37686861|NCT01641471|69162644|FG000|Overall Study|Withdrawal by Subject|19|||
37686862|NCT01641471|69162645|FG001|Overall Study|Withdrawal by Subject|19|||
37686863|NCT01641471|69162644|FG000|Overall Study|Lost to Follow-up|2|||
37686864|NCT01641471|69162645|FG001|Overall Study|Lost to Follow-up|4|||
37686865|NCT01641471|69162644|FG000|Overall Study|Protocol Violation|2|||
37686866|NCT01641471|69162645|FG001|Overall Study|Protocol Violation|4|||
38085769|NCT02799069|69785360|FG002|Overall Study|Adverse Event|2|||
38085770|NCT02799069|69785358|FG000|Overall Study|Lack of Efficacy|2|||
38085771|NCT02799069|69785359|FG001|Overall Study|Lack of Efficacy|0|||
38085772|NCT02799069|69785360|FG002|Overall Study|Lack of Efficacy|0|||
37686867|NCT02255565|69162654|FG000|Overall Study|Withdrawal by Subject|0|||
37686868|NCT02255565|69162655|FG001|Overall Study|Withdrawal by Subject|1|||
37686869|NCT02255565|69162656|FG002|Overall Study|Withdrawal by Subject|0|||
37686870|NCT01640301|69162699|FG000|Overall Study|Death|0|||
37686871|NCT01640301|69162700|FG001|Overall Study|Death|8|||
37686872|NCT01642407|69162708|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
37686873|NCT01642407|69162708|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
38085773|NCT02799069|69785358|FG000|Overall Study|Lost to Follow-up|1|||
38085774|NCT02799069|69785359|FG001|Overall Study|Lost to Follow-up|1|||
38085775|NCT02799069|69785360|FG002|Overall Study|Lost to Follow-up|0|||
38085776|NCT02799069|69785358|FG000|Overall Study|Withdrawal by Subject|4|||
38085777|NCT02799069|69785359|FG001|Overall Study|Withdrawal by Subject|4|||
38085778|NCT02799069|69785360|FG002|Overall Study|Withdrawal by Subject|3|||
38085779|NCT02799069|69785358|FG000|Overall Study|Protocol Violation|1|||
38085780|NCT02799069|69785359|FG001|Overall Study|Protocol Violation|0|||
37686874|NCT01642407|69162708|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
37686875|NCT02255097|69162712|FG000|Overall Study|Death|151|||
37686876|NCT02255097|69162712|FG000|Overall Study|Lost to Follow-up|5|||
37686877|NCT02255097|69162712|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
37686878|NCT02255097|69162712|FG000|Overall Study|Withdrawal by Subject|7|||
37686879|NCT02255097|69162712|FG000|Overall Study|Allocated but not treated|1|||
37686880|NCT02254551|69162717|FG000|Dose Escalation|Physician Decision|1|||
37686881|NCT02254551|69162717|FG000|Dose Escalation|Dose-limiting toxicity|2|||
37686882|NCT01641237|69162724|FG000|Period II|Withdrawal by Subject|1|||
37686883|NCT01641237|69162725|FG001|Period II|Withdrawal by Subject|0|||
37686884|NCT01641237|69162726|FG002|Period II|Withdrawal by Subject|0|||
37686885|NCT01641237|69162727|FG003|Period II|Withdrawal by Subject|0|||
37686886|NCT01641237|69162724|FG000|Period III|Lost to Follow-up|1|||
37686887|NCT01641237|69162725|FG001|Period III|Lost to Follow-up|0|||
37686888|NCT01641237|69162726|FG002|Period III|Lost to Follow-up|0|||
37686889|NCT01641237|69162727|FG003|Period III|Lost to Follow-up|0|||
37686890|NCT01639833|69162739|FG000|Overall Study|Death|4|||
37686891|NCT01639833|69162740|FG001|Overall Study|Death|2|||
37686892|NCT01639833|69162739|FG000|Overall Study|Withdrawal by Subject|2|||
37686893|NCT01639833|69162740|FG001|Overall Study|Withdrawal by Subject|2|||
37686894|NCT01639131|69162746|FG000|Overall Study|Disease Progression|6|||
37686895|NCT01641159|69162752|FG000|Overall Study|Lost to Follow-up|2|||
37686896|NCT01641159|69162753|FG001|Overall Study|Lost to Follow-up|1|||
37686897|NCT01641159|69162752|FG000|Overall Study|Withdrawal by Subject|0|||
37686898|NCT01641159|69162753|FG001|Overall Study|Withdrawal by Subject|1|||
37686899|NCT01641081|69162759|FG000|Period 1|Sponsor request (potential unblinding)|0|||
37686900|NCT01641081|69162760|FG001|Period 1|Sponsor request (potential unblinding)|0|||
37686901|NCT01641081|69162761|FG002|Period 1|Sponsor request (potential unblinding)|0|||
37686902|NCT01641081|69162762|FG003|Period 1|Sponsor request (potential unblinding)|0|||
37686903|NCT01641081|69162763|FG004|Period 1|Sponsor request (potential unblinding)|0|||
37686904|NCT01641081|69162764|FG005|Period 1|Sponsor request (potential unblinding)|0|||
37686905|NCT01641081|69162765|FG006|Period 1|Sponsor request (potential unblinding)|1|||
37686906|NCT01641081|69162766|FG007|Period 1|Sponsor request (potential unblinding)|0|||
37686907|NCT01641081|69162767|FG008|Period 1|Sponsor request (potential unblinding)|0|||
37686908|NCT01641081|69162768|FG009|Period 1|Sponsor request (potential unblinding)|0|||
37686909|NCT01641081|69162759|FG000|Period 1|Protocol Violation|0|||
37686910|NCT01641081|69162760|FG001|Period 1|Protocol Violation|0|||
37686911|NCT01641081|69162761|FG002|Period 1|Protocol Violation|0|||
37686912|NCT01641081|69162762|FG003|Period 1|Protocol Violation|0|||
37686913|NCT01641081|69162763|FG004|Period 1|Protocol Violation|1|||
37686914|NCT01641081|69162764|FG005|Period 1|Protocol Violation|0|||
37686915|NCT01641081|69162765|FG006|Period 1|Protocol Violation|0|||
37686916|NCT01641081|69162766|FG007|Period 1|Protocol Violation|1|||
37686917|NCT01641081|69162767|FG008|Period 1|Protocol Violation|0|||
37686918|NCT01641081|69162768|FG009|Period 1|Protocol Violation|0|||
37686919|NCT01641081|69162759|FG000|Period 1|Adverse Event|1|||
37686920|NCT01641081|69162760|FG001|Period 1|Adverse Event|0|||
37686921|NCT01641081|69162761|FG002|Period 1|Adverse Event|0|||
37686922|NCT01641081|69162762|FG003|Period 1|Adverse Event|0|||
37686923|NCT01641081|69162763|FG004|Period 1|Adverse Event|0|||
38085781|NCT02799069|69785360|FG002|Overall Study|Protocol Violation|2|||
38085782|NCT01669174|69785370|FG000|Overall Study|Subject withdrew consent|2|||
38085783|NCT01669174|69785371|FG001|Overall Study|Subject withdrew consent|2|||
38085784|NCT01669174|69785370|FG000|Overall Study|Lost to Follow-up|1|||
38085785|NCT01669174|69785371|FG001|Overall Study|Lost to Follow-up|0|||
38085786|NCT01669174|69785370|FG000|Overall Study|Adverse Event|2|||
38085787|NCT01669174|69785371|FG001|Overall Study|Adverse Event|2|||
38085788|NCT01669174|69785370|FG000|Overall Study|Administrative problems|1|||
38085789|NCT01669174|69785371|FG001|Overall Study|Administrative problems|2|||
38085790|NCT02798835|69785380|FG000|Overall Study|Protocol Violation|0|||
37686924|NCT01641081|69162764|FG005|Period 1|Adverse Event|0|||
37686925|NCT01641081|69162765|FG006|Period 1|Adverse Event|0|||
37686926|NCT01641081|69162766|FG007|Period 1|Adverse Event|2|||
37686927|NCT01641081|69162767|FG008|Period 1|Adverse Event|0|||
38085791|NCT02798835|69785381|FG001|Overall Study|Protocol Violation|0|||
37686928|NCT01641081|69162768|FG009|Period 1|Adverse Event|0|||
37686929|NCT01641081|69162759|FG000|Period 2|Adverse Event|0|||
37686930|NCT01641081|69162760|FG001|Period 2|Adverse Event|0|||
37686931|NCT01641081|69162761|FG002|Period 2|Adverse Event|0|||
37686932|NCT01641081|69162762|FG003|Period 2|Adverse Event|0|||
37686933|NCT01641081|69162763|FG004|Period 2|Adverse Event|0|||
37686934|NCT01641081|69162764|FG005|Period 2|Adverse Event|1|||
37686935|NCT01641081|69162765|FG006|Period 2|Adverse Event|0|||
37686936|NCT01641081|69162766|FG007|Period 2|Adverse Event|0|||
37686937|NCT01641081|69162767|FG008|Period 2|Adverse Event|0|||
37686938|NCT01641081|69162768|FG009|Period 2|Adverse Event|0|||
37686939|NCT01641081|69162759|FG000|Period 2|Withdrawal by Subject|0|||
37686940|NCT01641081|69162760|FG001|Period 2|Withdrawal by Subject|0|||
38085792|NCT02798835|69785382|FG002|Overall Study|Protocol Violation|3|||
38085793|NCT02611882|69785393|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
38085794|NCT02611882|69785394|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
38085795|NCT02611882|69785395|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
38085796|NCT02796963|69785406|FG000|Overall Study|Lost to Follow-up|89|||
38085797|NCT02796963|69785407|FG001|Overall Study|Lost to Follow-up|76|||
38085798|NCT02796963|69785408|FG002|Overall Study|Lost to Follow-up|69|||
38085799|NCT02796963|69785409|FG003|Overall Study|Lost to Follow-up|72|||
38085800|NCT02796651|69785419|FG000|Overall Study|Adverse Event|6|||
38085801|NCT02796651|69785419|FG000|Overall Study|Lost to Follow-up|1|||
38085802|NCT02796651|69785419|FG000|Overall Study|Withdrawal by Subject|4|||
38085803|NCT02796651|69785419|FG000|Overall Study|Protocol Violation|4|||
38085804|NCT02796651|69785419|FG000|Overall Study|Lack of Efficacy|1|||
38085805|NCT02796651|69785419|FG000|Overall Study|Other|10|||
38085806|NCT02613208|69785434|FG000|Overall Study|Withdrawal by Subject|1|||
38085807|NCT02613208|69785434|FG000|Overall Study|Change of address|2|||
38085808|NCT02613208|69785434|FG000|Overall Study|Physician Decision|2|||
38085809|NCT02613208|69785434|FG000|Overall Study|Lost to Follow-up|5|||
38085810|NCT02613208|69785434|FG000|Overall Study|Death|37|||
38085811|NCT01668784|69785440|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
38085812|NCT01668784|69785441|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
38085813|NCT01668784|69785440|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
38085814|NCT01668784|69785441|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
38085815|NCT01668784|69785440|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
38085816|NCT01668784|69785441|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
38085817|NCT01668784|69785440|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
38085818|NCT01668784|69785441|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
38085819|NCT01668784|69785440|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
38085820|NCT01668784|69785441|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
38085821|NCT01668784|69785440|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
38085822|NCT01668784|69785441|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
38085823|NCT01668784|69785440|FG000|Treatment Period|Disease Progression|316|||
38085824|NCT01668784|69785441|FG001|Treatment Period|Disease Progression|293|||
38085825|NCT01668784|69785440|FG000|Treatment Period|Study Drug Toxicity|46|||
38085826|NCT01668784|69785441|FG001|Treatment Period|Study Drug Toxicity|53|||
38085827|NCT01668784|69785440|FG000|Treatment Period|Death|1|||
38085828|NCT01668784|69785441|FG001|Treatment Period|Death|1|||
38085829|NCT01668784|69785440|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
38085830|NCT01668784|69785441|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
38085831|NCT01668784|69785440|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
38085832|NCT01668784|69785441|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
38085833|NCT01668784|69785440|FG000|Treatment Period|Withdrawal by Subject|5|||
38085834|NCT01668784|69785441|FG001|Treatment Period|Withdrawal by Subject|3|||
38085835|NCT01668784|69785440|FG000|Treatment Period|Maximal Clinical Benefit|3|||
38085836|NCT01668784|69785441|FG001|Treatment Period|Maximal Clinical Benefit|3|||
38085837|NCT01668784|69785440|FG000|Treatment Period|Other|2|||
38085838|NCT01668784|69785441|FG001|Treatment Period|Other|8|||
38085839|NCT01668784|69785440|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
38085840|NCT01668784|69785441|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
38085841|NCT02750514|69785452|FG000|Track 1|Disease progression|20|||
38085842|NCT02750514|69785453|FG001|Track 1|Disease progression|1|||
38085843|NCT02750514|69785454|FG002|Track 1|Disease progression|0|||
38085844|NCT02750514|69785455|FG003|Track 1|Disease progression|1|||
38085845|NCT02750514|69785456|FG004|Track 1|Disease progression|0|||
38085846|NCT02750514|69785452|FG000|Track 1|Adverse event unrelated to study drug|1|||
38085847|NCT02750514|69785453|FG001|Track 1|Adverse event unrelated to study drug|0|||
38085848|NCT02750514|69785454|FG002|Track 1|Adverse event unrelated to study drug|0|||
38085849|NCT02750514|69785455|FG003|Track 1|Adverse event unrelated to study drug|0|||
38085850|NCT02750514|69785456|FG004|Track 1|Adverse event unrelated to study drug|0|||
38085851|NCT02750514|69785452|FG000|Track 1|Study drug toxicity|4|||
38085852|NCT02750514|69785453|FG001|Track 1|Study drug toxicity|1|||
38085853|NCT02750514|69785454|FG002|Track 1|Study drug toxicity|0|||
38085854|NCT02750514|69785455|FG003|Track 1|Study drug toxicity|1|||
37967403|NCT00426231|69654337|FG000|Overall Study|Withdrawal by Subject|9|||
38085855|NCT02750514|69785456|FG004|Track 1|Study drug toxicity|0|||
38085856|NCT02750514|69785452|FG000|Track 1|Participant request to discontinue|1|||
38085857|NCT02750514|69785453|FG001|Track 1|Participant request to discontinue|0|||
38085858|NCT02750514|69785454|FG002|Track 1|Participant request to discontinue|0|||
38085859|NCT02750514|69785455|FG003|Track 1|Participant request to discontinue|0|||
38085860|NCT02750514|69785456|FG004|Track 1|Participant request to discontinue|0|||
38085861|NCT02750514|69785452|FG000|Track 1|Other reasons|1|||
38085862|NCT02750514|69785453|FG001|Track 1|Other reasons|0|||
38085863|NCT02750514|69785454|FG002|Track 1|Other reasons|0|||
38085864|NCT02750514|69785455|FG003|Track 1|Other reasons|0|||
38085865|NCT02750514|69785456|FG004|Track 1|Other reasons|0|||
38085866|NCT02750514|69785452|FG000|Track 2|Disease progression|4|||
38085867|NCT02750514|69785453|FG001|Track 2|Disease progression|5|||
38085868|NCT02750514|69785454|FG002|Track 2|Disease progression|2|||
38085869|NCT02750514|69785455|FG003|Track 2|Disease progression|5|||
38085870|NCT02750514|69785456|FG004|Track 2|Disease progression|0|||
38085871|NCT02750514|69785452|FG000|Track 2|Adverse event unrelated to study drug|1|||
38085872|NCT02750514|69785453|FG001|Track 2|Adverse event unrelated to study drug|0|||
38085873|NCT02750514|69785454|FG002|Track 2|Adverse event unrelated to study drug|0|||
38085874|NCT02750514|69785455|FG003|Track 2|Adverse event unrelated to study drug|0|||
38085875|NCT02750514|69785456|FG004|Track 2|Adverse event unrelated to study drug|0|||
38085876|NCT02750514|69785452|FG000|Track 2|Study drug toxicity|1|||
38085877|NCT02750514|69785453|FG001|Track 2|Study drug toxicity|2|||
38085878|NCT02750514|69785454|FG002|Track 2|Study drug toxicity|0|||
38085879|NCT02750514|69785455|FG003|Track 2|Study drug toxicity|2|||
38085880|NCT02750514|69785456|FG004|Track 2|Study drug toxicity|0|||
38085881|NCT02750514|69785452|FG000|Track 2|Participant withdrew consent|0|||
38085882|NCT02750514|69785453|FG001|Track 2|Participant withdrew consent|1|||
38085883|NCT02750514|69785454|FG002|Track 2|Participant withdrew consent|0|||
38085884|NCT02750514|69785455|FG003|Track 2|Participant withdrew consent|0|||
38085885|NCT02750514|69785456|FG004|Track 2|Participant withdrew consent|0|||
38085886|NCT02750514|69785452|FG000|Track 3|Disease progression|0|||
38085887|NCT02750514|69785453|FG001|Track 3|Disease progression|24|||
38085888|NCT02750514|69785454|FG002|Track 3|Disease progression|13|||
38085889|NCT02750514|69785455|FG003|Track 3|Disease progression|14|||
38085890|NCT02750514|69785456|FG004|Track 3|Disease progression|0|||
38085891|NCT02750514|69785452|FG000|Track 3|Adverse event unrelated to study drug|0|||
38085892|NCT02750514|69785453|FG001|Track 3|Adverse event unrelated to study drug|1|||
38085893|NCT02750514|69785454|FG002|Track 3|Adverse event unrelated to study drug|1|||
38085894|NCT02750514|69785455|FG003|Track 3|Adverse event unrelated to study drug|1|||
38085895|NCT02750514|69785456|FG004|Track 3|Adverse event unrelated to study drug|0|||
38085896|NCT02750514|69785452|FG000|Track 3|Study drug toxicity|0|||
38085897|NCT02750514|69785453|FG001|Track 3|Study drug toxicity|3|||
38085898|NCT02750514|69785454|FG002|Track 3|Study drug toxicity|0|||
38085899|NCT02750514|69785455|FG003|Track 3|Study drug toxicity|1|||
38085900|NCT02750514|69785456|FG004|Track 3|Study drug toxicity|0|||
38085901|NCT02750514|69785452|FG000|Track 3|Participant request to discontinue|0|||
38085902|NCT02750514|69785453|FG001|Track 3|Participant request to discontinue|2|||
38085903|NCT02750514|69785454|FG002|Track 3|Participant request to discontinue|0|||
37686941|NCT01641081|69162761|FG002|Period 2|Withdrawal by Subject|0|||
37686942|NCT01641081|69162762|FG003|Period 2|Withdrawal by Subject|1|||
37686943|NCT01641081|69162763|FG004|Period 2|Withdrawal by Subject|0|||
37686944|NCT01641081|69162764|FG005|Period 2|Withdrawal by Subject|0|||
37686945|NCT01641081|69162765|FG006|Period 2|Withdrawal by Subject|2|||
37686946|NCT01641081|69162766|FG007|Period 2|Withdrawal by Subject|0|||
37686947|NCT01641081|69162767|FG008|Period 2|Withdrawal by Subject|0|||
37686948|NCT01641081|69162768|FG009|Period 2|Withdrawal by Subject|0|||
37686949|NCT01641081|69162759|FG000|Period 2|Protocol Violation|1|||
37686950|NCT01641081|69162760|FG001|Period 2|Protocol Violation|0|||
37686951|NCT01641081|69162761|FG002|Period 2|Protocol Violation|0|||
37686952|NCT01641081|69162762|FG003|Period 2|Protocol Violation|0|||
37686953|NCT01641081|69162763|FG004|Period 2|Protocol Violation|0|||
37686954|NCT01641081|69162764|FG005|Period 2|Protocol Violation|0|||
37686955|NCT01641081|69162765|FG006|Period 2|Protocol Violation|0|||
37686956|NCT01641081|69162766|FG007|Period 2|Protocol Violation|0|||
37686957|NCT01641081|69162767|FG008|Period 2|Protocol Violation|0|||
37686958|NCT01641081|69162768|FG009|Period 2|Protocol Violation|0|||
37686959|NCT01641081|69162759|FG000|Period 3|Adverse Event|0|||
37686960|NCT01641081|69162760|FG001|Period 3|Adverse Event|0|||
37686961|NCT01641081|69162761|FG002|Period 3|Adverse Event|1|||
37686962|NCT01641081|69162762|FG003|Period 3|Adverse Event|0|||
38085904|NCT02750514|69785455|FG003|Track 3|Participant request to discontinue|0|||
38085905|NCT02750514|69785456|FG004|Track 3|Participant request to discontinue|0|||
38085906|NCT02750514|69785452|FG000|Track 3|Participant withdrew consent|0|||
37686963|NCT01641081|69162763|FG004|Period 3|Adverse Event|0|||
37686964|NCT01641081|69162764|FG005|Period 3|Adverse Event|0|||
37686965|NCT01641081|69162765|FG006|Period 3|Adverse Event|0|||
38085907|NCT02750514|69785453|FG001|Track 3|Participant withdrew consent|3|||
38085908|NCT02750514|69785454|FG002|Track 3|Participant withdrew consent|1|||
38085909|NCT02750514|69785455|FG003|Track 3|Participant withdrew consent|0|||
38085910|NCT02750514|69785456|FG004|Track 3|Participant withdrew consent|0|||
38085911|NCT02750514|69785452|FG000|Track 3|Other reasons|0|||
37686966|NCT01641081|69162766|FG007|Period 3|Adverse Event|0|||
37686967|NCT01641081|69162767|FG008|Period 3|Adverse Event|0|||
37686968|NCT01641081|69162768|FG009|Period 3|Adverse Event|0|||
37686969|NCT01641081|69162759|FG000|Period 3|Withdrawal by Subject|0|||
38085912|NCT02750514|69785453|FG001|Track 3|Other reasons|3|||
37686970|NCT01641081|69162760|FG001|Period 3|Withdrawal by Subject|0|||
37686971|NCT01641081|69162761|FG002|Period 3|Withdrawal by Subject|0|||
37686972|NCT01641081|69162762|FG003|Period 3|Withdrawal by Subject|0|||
38085913|NCT02750514|69785454|FG002|Track 3|Other reasons|0|||
38085914|NCT02750514|69785455|FG003|Track 3|Other reasons|0|||
38085915|NCT02750514|69785456|FG004|Track 3|Other reasons|0|||
38085916|NCT02750514|69785452|FG000|Track 4|Study drug toxicity|0|||
38085917|NCT02750514|69785453|FG001|Track 4|Study drug toxicity|6|||
38085918|NCT02750514|69785454|FG002|Track 4|Study drug toxicity|0|||
38085919|NCT02750514|69785455|FG003|Track 4|Study drug toxicity|5|||
38085920|NCT02750514|69785456|FG004|Track 4|Study drug toxicity|0|||
38085921|NCT02750514|69785452|FG000|Track 4|Participant request to discontinue|0|||
38085922|NCT02750514|69785453|FG001|Track 4|Participant request to discontinue|1|||
38085923|NCT02750514|69785454|FG002|Track 4|Participant request to discontinue|0|||
38085924|NCT02750514|69785455|FG003|Track 4|Participant request to discontinue|1|||
38085925|NCT02750514|69785456|FG004|Track 4|Participant request to discontinue|0|||
38085926|NCT02750514|69785452|FG000|Track 4|Participant withdrew consent|0|||
38085927|NCT02750514|69785453|FG001|Track 4|Participant withdrew consent|1|||
38085928|NCT02750514|69785454|FG002|Track 4|Participant withdrew consent|0|||
38085929|NCT02750514|69785455|FG003|Track 4|Participant withdrew consent|0|||
38085930|NCT02750514|69785456|FG004|Track 4|Participant withdrew consent|0|||
38085931|NCT02750514|69785452|FG000|Track 4|Other reasons|0|||
38085932|NCT02750514|69785453|FG001|Track 4|Other reasons|5|||
38085933|NCT02750514|69785454|FG002|Track 4|Other reasons|0|||
38085934|NCT02750514|69785455|FG003|Track 4|Other reasons|3|||
38085935|NCT02750514|69785456|FG004|Track 4|Other reasons|0|||
38085936|NCT02750514|69785452|FG000|Track 4|Disease progression|0|||
38085937|NCT02750514|69785453|FG001|Track 4|Disease progression|33|||
38085938|NCT02750514|69785454|FG002|Track 4|Disease progression|0|||
38085939|NCT02750514|69785455|FG003|Track 4|Disease progression|32|||
38085940|NCT02750514|69785456|FG004|Track 4|Disease progression|0|||
38085941|NCT02750514|69785452|FG000|Track 4|Adverse event unrelated to study drug|0|||
37686973|NCT01641081|69162763|FG004|Period 3|Withdrawal by Subject|0|||
37686974|NCT01641081|69162764|FG005|Period 3|Withdrawal by Subject|0|||
37686975|NCT01641081|69162765|FG006|Period 3|Withdrawal by Subject|0|||
37686976|NCT01641081|69162766|FG007|Period 3|Withdrawal by Subject|0|||
37686977|NCT01641081|69162767|FG008|Period 3|Withdrawal by Subject|1|||
37686978|NCT01641081|69162768|FG009|Period 3|Withdrawal by Subject|0|||
37686979|NCT01641081|69162759|FG000|Period 4|Adverse Event|0|||
37686980|NCT01641081|69162760|FG001|Period 4|Adverse Event|1|||
37686981|NCT01641081|69162761|FG002|Period 4|Adverse Event|0|||
37686982|NCT01641081|69162762|FG003|Period 4|Adverse Event|1|||
37686983|NCT01641081|69162763|FG004|Period 4|Adverse Event|0|||
37686984|NCT01641081|69162764|FG005|Period 4|Adverse Event|0|||
37686985|NCT01641081|69162765|FG006|Period 4|Adverse Event|0|||
37686986|NCT01641081|69162766|FG007|Period 4|Adverse Event|0|||
37686987|NCT01641081|69162767|FG008|Period 4|Adverse Event|0|||
37686988|NCT01641081|69162768|FG009|Period 4|Adverse Event|0|||
37686989|NCT01641081|69162759|FG000|Period 5|Adverse Event|0|||
37686990|NCT01641081|69162760|FG001|Period 5|Adverse Event|0|||
37686991|NCT01641081|69162761|FG002|Period 5|Adverse Event|2|||
37686992|NCT01641081|69162762|FG003|Period 5|Adverse Event|0|||
37686993|NCT01641081|69162763|FG004|Period 5|Adverse Event|0|||
37686994|NCT01641081|69162764|FG005|Period 5|Adverse Event|0|||
37686995|NCT01641081|69162765|FG006|Period 5|Adverse Event|0|||
37686996|NCT01641081|69162766|FG007|Period 5|Adverse Event|0|||
37686997|NCT01641081|69162767|FG008|Period 5|Adverse Event|0|||
37686998|NCT01641081|69162768|FG009|Period 5|Adverse Event|0|||
37686999|NCT01640925|69162782|FG000|Overall Study|Withdrawal by Subject|1|||
37687000|NCT01640925|69162783|FG001|Overall Study|Withdrawal by Subject|0|||
37687001|NCT01640925|69162782|FG000|Overall Study|Previously enrolled in this trial|13|||
37687002|NCT01640925|69162783|FG001|Overall Study|Previously enrolled in this trial|11|||
37687003|NCT01638429|69162789|FG000|Overall Study|Withdrawal by Subject|1|||
37687004|NCT01639755|69162797|FG000|Overall Study|Study Ongoing|15|||
37687005|NCT01639755|69162797|FG000|Overall Study|Patient had device explantation|4|||
37687006|NCT01601535|69162807|FG000|Phase 1|Adverse Event|1|||
37687007|NCT01601535|69162808|FG001|Phase 1|Adverse Event|0|||
37687008|NCT01601535|69162809|FG002|Phase 1|Adverse Event|2|||
38085942|NCT02750514|69785453|FG001|Track 4|Adverse event unrelated to study drug|5|||
38085943|NCT02750514|69785454|FG002|Track 4|Adverse event unrelated to study drug|0|||
38085944|NCT02750514|69785455|FG003|Track 4|Adverse event unrelated to study drug|0|||
38085945|NCT02750514|69785456|FG004|Track 4|Adverse event unrelated to study drug|0|||
38085946|NCT02750514|69785452|FG000|Track 4|Death|0|||
38085947|NCT02750514|69785453|FG001|Track 4|Death|0|||
38085948|NCT02750514|69785454|FG002|Track 4|Death|0|||
37687009|NCT01601535|69162810|FG003|Phase 1|Adverse Event|1|||
37687010|NCT01601535|69162811|FG004|Phase 1|Adverse Event|0|||
37687011|NCT01601535|69162812|FG005|Phase 1|Adverse Event|0|||
37687012|NCT01601535|69162807|FG000|Phase 1|Withdrawal by Subject|2|||
37687013|NCT01601535|69162808|FG001|Phase 1|Withdrawal by Subject|1|||
37687014|NCT01601535|69162809|FG002|Phase 1|Withdrawal by Subject|1|||
37687015|NCT01601535|69162810|FG003|Phase 1|Withdrawal by Subject|2|||
37687016|NCT01601535|69162811|FG004|Phase 1|Withdrawal by Subject|0|||
37687017|NCT01601535|69162812|FG005|Phase 1|Withdrawal by Subject|0|||
37687018|NCT01601535|69162807|FG000|Phase 1|Progressive Disease|2|||
37687019|NCT01601535|69162808|FG001|Phase 1|Progressive Disease|3|||
37687020|NCT01601535|69162809|FG002|Phase 1|Progressive Disease|2|||
37687021|NCT01601535|69162810|FG003|Phase 1|Progressive Disease|1|||
37687022|NCT01601535|69162811|FG004|Phase 1|Progressive Disease|0|||
37687023|NCT01601535|69162812|FG005|Phase 1|Progressive Disease|0|||
37687024|NCT01601535|69162807|FG000|Phase 1|Started Another Treatment|1|||
37687025|NCT01601535|69162808|FG001|Phase 1|Started Another Treatment|2|||
38085949|NCT02750514|69785455|FG003|Track 4|Death|1|||
38085950|NCT02750514|69785456|FG004|Track 4|Death|0|||
38085951|NCT02750514|69785452|FG000|Track 5|Disease progression|0|||
38085952|NCT02750514|69785453|FG001|Track 5|Disease progression|0|||
38085953|NCT02750514|69785454|FG002|Track 5|Disease progression|0|||
38085954|NCT02750514|69785455|FG003|Track 5|Disease progression|0|||
38085955|NCT02750514|69785456|FG004|Track 5|Disease progression|34|||
38085956|NCT02750514|69785452|FG000|Track 5|Adverse event unrelated to study drug|0|||
38085957|NCT02750514|69785453|FG001|Track 5|Adverse event unrelated to study drug|0|||
38085958|NCT02750514|69785454|FG002|Track 5|Adverse event unrelated to study drug|0|||
38085959|NCT02750514|69785455|FG003|Track 5|Adverse event unrelated to study drug|0|||
38085960|NCT02750514|69785456|FG004|Track 5|Adverse event unrelated to study drug|2|||
38085961|NCT02750514|69785452|FG000|Track 5|Study drug toxicity|0|||
38085962|NCT02750514|69785453|FG001|Track 5|Study drug toxicity|0|||
38085963|NCT02750514|69785454|FG002|Track 5|Study drug toxicity|0|||
38085964|NCT02750514|69785455|FG003|Track 5|Study drug toxicity|0|||
38085965|NCT02750514|69785456|FG004|Track 5|Study drug toxicity|2|||
38085966|NCT02750514|69785452|FG000|Track 5|Participant request to discontinue|0|||
38085967|NCT02750514|69785453|FG001|Track 5|Participant request to discontinue|0|||
38085968|NCT02750514|69785454|FG002|Track 5|Participant request to discontinue|0|||
38085969|NCT02750514|69785455|FG003|Track 5|Participant request to discontinue|0|||
38085970|NCT02750514|69785456|FG004|Track 5|Participant request to discontinue|3|||
38085971|NCT02750514|69785452|FG000|Track 5|Other reasons|0|||
38085972|NCT02750514|69785453|FG001|Track 5|Other reasons|0|||
38085973|NCT02750514|69785454|FG002|Track 5|Other reasons|0|||
38085974|NCT02750514|69785455|FG003|Track 5|Other reasons|0|||
38085975|NCT02750514|69785456|FG004|Track 5|Other reasons|2|||
38085976|NCT02612428|69785478|FG000|VTL-308|Death|14|||
38085977|NCT02612428|69785479|FG001|VTL-308|Death|16|||
38085978|NCT02612428|69785478|FG000|VTL-308|Withdrawal by Subject|0|||
38085979|NCT02612428|69785479|FG001|VTL-308|Withdrawal by Subject|1|||
38085980|NCT02612428|69785478|FG000|VTL-308E|Death|9|||
38085981|NCT02612428|69785479|FG001|VTL-308E|Death|7|||
38085982|NCT02612428|69785478|FG000|VTL-308E|Lost to Follow-up|2|||
38085983|NCT02612428|69785479|FG001|VTL-308E|Lost to Follow-up|0|||
38085984|NCT03679884|69785490|FG000|Overall Study|Other|12|||
38085985|NCT03679884|69785491|FG001|Overall Study|Other|12|||
38085986|NCT03679884|69785492|FG002|Overall Study|Other|12|||
38085987|NCT03679884|69785493|FG003|Overall Study|Other|7|||
38085988|NCT03679884|69785494|FG004|Overall Study|Other|8|||
38085989|NCT03679884|69785490|FG000|Overall Study|Lack of Efficacy|15|||
38085990|NCT03679884|69785491|FG001|Overall Study|Lack of Efficacy|29|||
37687026|NCT01601535|69162809|FG002|Phase 1|Started Another Treatment|0|||
38085991|NCT03679884|69785492|FG002|Overall Study|Lack of Efficacy|13|||
38085992|NCT03679884|69785493|FG003|Overall Study|Lack of Efficacy|29|||
38085993|NCT03679884|69785494|FG004|Overall Study|Lack of Efficacy|10|||
38085994|NCT03679884|69785490|FG000|Overall Study|Death|1|||
38085995|NCT03679884|69785491|FG001|Overall Study|Death|0|||
38085996|NCT03679884|69785492|FG002|Overall Study|Death|0|||
38085997|NCT03679884|69785493|FG003|Overall Study|Death|0|||
38085998|NCT03679884|69785494|FG004|Overall Study|Death|0|||
38085999|NCT03679884|69785490|FG000|Overall Study|Adverse Event|2|||
38086000|NCT03679884|69785491|FG001|Overall Study|Adverse Event|10|||
38086001|NCT03679884|69785492|FG002|Overall Study|Adverse Event|9|||
38086002|NCT03679884|69785493|FG003|Overall Study|Adverse Event|6|||
38086003|NCT03679884|69785494|FG004|Overall Study|Adverse Event|6|||
38086004|NCT03679884|69785490|FG000|Overall Study|Withdrawal by Subject|12|||
38086005|NCT03679884|69785491|FG001|Overall Study|Withdrawal by Subject|23|||
38086006|NCT03679884|69785492|FG002|Overall Study|Withdrawal by Subject|8|||
38086007|NCT03679884|69785493|FG003|Overall Study|Withdrawal by Subject|8|||
38086008|NCT03679884|69785494|FG004|Overall Study|Withdrawal by Subject|9|||
38086009|NCT03679884|69785490|FG000|Overall Study|Lost to Follow-up|1|||
38086010|NCT03679884|69785491|FG001|Overall Study|Lost to Follow-up|4|||
38086011|NCT03679884|69785492|FG002|Overall Study|Lost to Follow-up|2|||
38086012|NCT03679884|69785493|FG003|Overall Study|Lost to Follow-up|0|||
37863350|NCT00996892|69547128|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
37863351|NCT00996892|69547129|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
37863352|NCT00996892|69547130|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
37863353|NCT00996892|69547131|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
37863354|NCT00996892|69547132|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
37863355|NCT00996892|69547133|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
37863356|NCT00996892|69547134|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
37863357|NCT00996892|69547135|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
37863358|NCT00996892|69547136|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
37863359|NCT00996892|69547137|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
37863360|NCT00996892|69547118|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
37863361|NCT00996892|69547119|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
38086013|NCT03679884|69785494|FG004|Overall Study|Lost to Follow-up|3|||
38086014|NCT01329978|69785509|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
38086015|NCT01329978|69785510|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
38086016|NCT01329978|69785511|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
38086017|NCT01329978|69785512|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
37687027|NCT01601535|69162810|FG003|Phase 1|Started Another Treatment|0|||
37687028|NCT01601535|69162811|FG004|Phase 1|Started Another Treatment|0|||
38086018|NCT01329978|69785513|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
38086019|NCT01329978|69785509|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
38086020|NCT01329978|69785510|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
38086021|NCT01329978|69785511|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
37687029|NCT01601535|69162812|FG005|Phase 1|Started Another Treatment|0|||
37687030|NCT01601535|69162807|FG000|Phase 2|Adverse Event|0|||
37687031|NCT01601535|69162808|FG001|Phase 2|Adverse Event|0|||
37687032|NCT01601535|69162809|FG002|Phase 2|Adverse Event|0|||
37687033|NCT01601535|69162810|FG003|Phase 2|Adverse Event|0|||
37687034|NCT01601535|69162811|FG004|Phase 2|Adverse Event|5|||
37687035|NCT01601535|69162812|FG005|Phase 2|Adverse Event|1|||
37687036|NCT01601535|69162807|FG000|Phase 2|Withdrawal by Subject|0|||
37687037|NCT01601535|69162808|FG001|Phase 2|Withdrawal by Subject|0|||
37687038|NCT01601535|69162809|FG002|Phase 2|Withdrawal by Subject|0|||
37687039|NCT01601535|69162810|FG003|Phase 2|Withdrawal by Subject|0|||
37687040|NCT01601535|69162811|FG004|Phase 2|Withdrawal by Subject|8|||
37687041|NCT01601535|69162812|FG005|Phase 2|Withdrawal by Subject|2|||
37687042|NCT01601535|69162807|FG000|Phase 2|Progressive Disease|0|||
37687043|NCT01601535|69162808|FG001|Phase 2|Progressive Disease|0|||
37687044|NCT01601535|69162809|FG002|Phase 2|Progressive Disease|0|||
37687045|NCT01601535|69162810|FG003|Phase 2|Progressive Disease|0|||
37687046|NCT01601535|69162811|FG004|Phase 2|Progressive Disease|5|||
37687047|NCT01601535|69162812|FG005|Phase 2|Progressive Disease|7|||
37687048|NCT01601535|69162807|FG000|Phase 2|Started Another Treatment|0|||
37687049|NCT01601535|69162808|FG001|Phase 2|Started Another Treatment|0|||
37687050|NCT01601535|69162809|FG002|Phase 2|Started Another Treatment|0|||
37687051|NCT01601535|69162810|FG003|Phase 2|Started Another Treatment|0|||
37687052|NCT01601535|69162811|FG004|Phase 2|Started Another Treatment|1|||
37687053|NCT01601535|69162812|FG005|Phase 2|Started Another Treatment|2|||
38086022|NCT01329978|69785512|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
38086023|NCT01329978|69785513|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
38086024|NCT01329978|69785509|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
38086025|NCT01329978|69785510|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
38086026|NCT01329978|69785511|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
38086027|NCT01329978|69785512|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
38086028|NCT01329978|69785513|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
38086029|NCT01329978|69785509|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
38086030|NCT01329978|69785510|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
37687054|NCT01638819|69162837|FG000|Overall Study|Lost to Follow-up|1|||
37687055|NCT01638819|69162838|FG001|Overall Study|Lost to Follow-up|0|||
37687056|NCT01363713|69162843|FG000|Overall Study|Adverse Event|1|||
37687057|NCT01363713|69162843|FG000|Overall Study|Protocol Violation|3|||
37687058|NCT01363713|69162843|FG000|Overall Study|Withdrawal by Subject|2|||
37687059|NCT01637961|69162847|FG000|Overall Study|Ineligible: wrong primary|1|||
37687060|NCT01637961|69162847|FG000|Overall Study|Ineligible: inadequate pathology|1|||
37687061|NCT04183335|69162859|FG000|Overall Study|Adverse Event|1|||
37687062|NCT04183335|69162860|FG001|Overall Study|Adverse Event|0|||
37687063|NCT04183335|69162859|FG000|Overall Study|Withdrawal by Subject|12|||
37687064|NCT04183335|69162860|FG001|Overall Study|Withdrawal by Subject|3|||
37687065|NCT04199793|69162868|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
37687066|NCT04199793|69162869|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
37687067|NCT04199793|69162868|FG000|Overall Study|Withdrawal by Subject|1|||
37687068|NCT04199793|69162869|FG001|Overall Study|Withdrawal by Subject|1|||
37687069|NCT01636947|69162877|FG000|Overall Study|Not Treated|2|||
37687070|NCT01636947|69162878|FG001|Overall Study|Not Treated|2|||
37687071|NCT01636947|69162877|FG000|Overall Study|Lost to Follow-up|4|||
37687072|NCT01636947|69162878|FG001|Overall Study|Lost to Follow-up|0|||
37687073|NCT01636947|69162877|FG000|Overall Study|Protocol Violation|1|||
37687074|NCT01636947|69162878|FG001|Overall Study|Protocol Violation|1|||
37687075|NCT01636947|69162877|FG000|Overall Study|Withdrawal by Subject|3|||
37687076|NCT01636947|69162878|FG001|Overall Study|Withdrawal by Subject|3|||
37687077|NCT01636947|69162877|FG000|Overall Study|Adverse Event|1|||
37687078|NCT01636947|69162878|FG001|Overall Study|Adverse Event|1|||
37687079|NCT01636947|69162877|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
37687080|NCT01636947|69162878|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
37687081|NCT01635933|69162886|FG000|Overall Study|Adverse Event|1|||
37687082|NCT01635933|69162887|FG001|Overall Study|Adverse Event|0|||
37687083|NCT01635933|69162886|FG000|Overall Study|Lost to Follow-up|0|||
37687084|NCT01635933|69162887|FG001|Overall Study|Lost to Follow-up|5|||
37687085|NCT01635933|69162886|FG000|Overall Study|Subject decision|1|||
37687086|NCT01635933|69162887|FG001|Overall Study|Subject decision|1|||
37687087|NCT01635933|69162886|FG000|Overall Study|Noncompliance|0|||
37687088|NCT01635933|69162887|FG001|Overall Study|Noncompliance|1|||
37687089|NCT01635933|69162886|FG000|Overall Study|No longer had transportation|0|||
37687090|NCT01635933|69162887|FG001|Overall Study|No longer had transportation|1|||
37687091|NCT01635855|69162893|FG000|Overall Study|Withdrawal by Subject|4|||
37687092|NCT03052725|69162899|FG000|Overall Study|Adverse Event|2|||
37687093|NCT03052725|69162900|FG001|Overall Study|Adverse Event|0|||
37687094|NCT03052725|69162899|FG000|Overall Study|Withdrawal by Subject|3|||
37687095|NCT03052725|69162900|FG001|Overall Study|Withdrawal by Subject|4|||
37687096|NCT03052725|69162899|FG000|Overall Study|Pregnancy|0|||
37687097|NCT03052725|69162900|FG001|Overall Study|Pregnancy|1|||
37687098|NCT03052725|69162899|FG000|Overall Study|Site closure|0|||
37687099|NCT03052725|69162900|FG001|Overall Study|Site closure|1|||
37687100|NCT03052725|69162899|FG000|Overall Study|Study terminated by sponsor|143|||
38086031|NCT01329978|69785511|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
38086032|NCT01329978|69785512|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
38086033|NCT01329978|69785513|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
38086034|NCT01329978|69785509|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
38086035|NCT01329978|69785510|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
38086036|NCT01329978|69785511|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
38086037|NCT01329978|69785512|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
37687101|NCT03052725|69162900|FG001|Overall Study|Study terminated by sponsor|144|||
37687102|NCT01635153|69162924|FG000|Overall Study|Lost to Follow-up|40|||
37687103|NCT01635153|69162925|FG001|Overall Study|Lost to Follow-up|43|||
37687104|NCT01636713|69162934|FG000|Overall Study|Adverse Event|16|||
37687105|NCT01636713|69162935|FG001|Overall Study|Adverse Event|16|||
37687106|NCT01636713|69162936|FG002|Overall Study|Adverse Event|7|||
37687107|NCT01636713|69162934|FG000|Overall Study|Lack of Efficacy|6|||
37687108|NCT01636713|69162935|FG001|Overall Study|Lack of Efficacy|6|||
37687109|NCT01636713|69162936|FG002|Overall Study|Lack of Efficacy|2|||
37687110|NCT01636713|69162934|FG000|Overall Study|Protocol Violation|3|||
37687111|NCT01636713|69162935|FG001|Overall Study|Protocol Violation|0|||
37687112|NCT01636713|69162936|FG002|Overall Study|Protocol Violation|1|||
37687113|NCT01636713|69162934|FG000|Overall Study|Lost to Follow-up|0|||
37687114|NCT01636713|69162935|FG001|Overall Study|Lost to Follow-up|0|||
37687115|NCT01636713|69162936|FG002|Overall Study|Lost to Follow-up|1|||
37687116|NCT01636713|69162934|FG000|Overall Study|Withdrawal by Subject|5|||
37687117|NCT01636713|69162935|FG001|Overall Study|Withdrawal by Subject|4|||
37687118|NCT01636713|69162936|FG002|Overall Study|Withdrawal by Subject|8|||
37687119|NCT01636713|69162934|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
37687120|NCT01636713|69162935|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
37687121|NCT01636713|69162936|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
37687122|NCT01600053|69162944|FG000|Overall Study|Adverse Event|2|||
37687123|NCT01600053|69162944|FG000|Overall Study|trial will not meet the interim endpoint|9|||
37687124|NCT01068249|69162948|FG000|Overall Study|Death|1|||
37687125|NCT01068249|69162948|FG000|Overall Study|Withdrawal by Subject|3|||
37687126|NCT02246673|69162967|FG000|Overall Study|Sponsor Decision|1|||
37687127|NCT02246673|69162968|FG001|Overall Study|Sponsor Decision|0|||
37687128|NCT02246673|69162969|FG002|Overall Study|Sponsor Decision|0|||
37687129|NCT02246673|69162970|FG003|Overall Study|Sponsor Decision|0|||
37687130|NCT02246673|69162971|FG004|Overall Study|Sponsor Decision|0|||
37687131|NCT02246673|69162967|FG000|Overall Study|Withdrawal by Subject|0|||
37687132|NCT02246673|69162968|FG001|Overall Study|Withdrawal by Subject|0|||
37687133|NCT02246673|69162969|FG002|Overall Study|Withdrawal by Subject|0|||
37687134|NCT02246673|69162970|FG003|Overall Study|Withdrawal by Subject|0|||
37687135|NCT02246673|69162971|FG004|Overall Study|Withdrawal by Subject|1|||
37687136|NCT02246673|69162967|FG000|Overall Study|Lost to Follow-up|0|||
37687137|NCT02246673|69162968|FG001|Overall Study|Lost to Follow-up|0|||
37687138|NCT02246673|69162969|FG002|Overall Study|Lost to Follow-up|0|||
37687139|NCT02246673|69162970|FG003|Overall Study|Lost to Follow-up|1|||
37687140|NCT02246673|69162971|FG004|Overall Study|Lost to Follow-up|0|||
37687141|NCT02246673|69162967|FG000|Overall Study|Protocol Violation|0|||
37687142|NCT02246673|69162968|FG001|Overall Study|Protocol Violation|0|||
37687143|NCT02246673|69162969|FG002|Overall Study|Protocol Violation|0|||
37687144|NCT02246673|69162970|FG003|Overall Study|Protocol Violation|1|||
37687145|NCT02246673|69162971|FG004|Overall Study|Protocol Violation|0|||
37687146|NCT02246439|69163033|FG000|Overall Study|Adverse Event|3|||
37687147|NCT02246439|69163034|FG001|Overall Study|Adverse Event|0|||
37687148|NCT02246439|69163033|FG000|Overall Study|Lost to Follow-up|7|||
37687149|NCT02246439|69163034|FG001|Overall Study|Lost to Follow-up|5|||
37687150|NCT02246439|69163033|FG000|Overall Study|Protocol Violation|0|||
37687151|NCT02246439|69163034|FG001|Overall Study|Protocol Violation|2|||
37687152|NCT02246439|69163033|FG000|Overall Study|Physician Decision|0|||
37687153|NCT02246439|69163034|FG001|Overall Study|Physician Decision|1|||
37687154|NCT02246439|69163033|FG000|Overall Study|Unkonwn|1|||
37687155|NCT02246439|69163034|FG001|Overall Study|Unkonwn|3|||
37687156|NCT02246439|69163033|FG000|Overall Study|Withdrawal by Subject|1|||
37687157|NCT02246439|69163034|FG001|Overall Study|Withdrawal by Subject|0|||
37687158|NCT02245737|69163043|FG000|Overall Study|Adverse Event|23|||
37687159|NCT02245737|69163044|FG001|Overall Study|Adverse Event|26|||
37687160|NCT02245737|69163045|FG002|Overall Study|Adverse Event|33|||
37687161|NCT02245737|69163043|FG000|Overall Study|Condition Worsened|9|||
37687162|NCT02245737|69163044|FG001|Overall Study|Condition Worsened|10|||
37687163|NCT02245737|69163045|FG002|Overall Study|Condition Worsened|9|||
37687164|NCT02245737|69163043|FG000|Overall Study|Death|2|||
37687165|NCT02245737|69163044|FG001|Overall Study|Death|4|||
37687166|NCT02245737|69163045|FG002|Overall Study|Death|4|||
37687167|NCT02245737|69163043|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
37687168|NCT02245737|69163044|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
37687169|NCT02245737|69163045|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
37687170|NCT02245737|69163043|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
37687171|NCT02245737|69163044|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
37687172|NCT02245737|69163045|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
37687173|NCT02245737|69163043|FG000|Overall Study|Lost to Follow-up|2|||
37687174|NCT02245737|69163044|FG001|Overall Study|Lost to Follow-up|5|||
37687175|NCT02245737|69163045|FG002|Overall Study|Lost to Follow-up|4|||
37687176|NCT02245737|69163043|FG000|Overall Study|Other-determined by Investigator|9|||
37687177|NCT02245737|69163044|FG001|Overall Study|Other-determined by Investigator|10|||
37687178|NCT02245737|69163045|FG002|Overall Study|Other-determined by Investigator|10|||
37687179|NCT02245737|69163043|FG000|Overall Study|Physician Decision|6|||
37687180|NCT02245737|69163044|FG001|Overall Study|Physician Decision|3|||
38086038|NCT01329978|69785513|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
38086039|NCT01329978|69785509|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
38086040|NCT01329978|69785510|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
38086041|NCT01329978|69785511|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
38086042|NCT01329978|69785512|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
38086043|NCT01329978|69785513|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
38086044|NCT01329978|69785509|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
37687181|NCT02245737|69163045|FG002|Overall Study|Physician Decision|6|||
37687182|NCT02245737|69163043|FG000|Overall Study|Protocol Violation|3|||
37687183|NCT02245737|69163044|FG001|Overall Study|Protocol Violation|2|||
37687184|NCT02245737|69163045|FG002|Overall Study|Protocol Violation|3|||
37687185|NCT02245737|69163043|FG000|Overall Study|Withdrawal by Subject|40|||
37687186|NCT02245737|69163044|FG001|Overall Study|Withdrawal by Subject|41|||
37687187|NCT02245737|69163045|FG002|Overall Study|Withdrawal by Subject|44|||
37687188|NCT02245737|69163043|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
37687189|NCT02245737|69163044|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
38086045|NCT01329978|69785510|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
37687190|NCT02245737|69163045|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
37687191|NCT02245737|69163043|FG000|Overall Study|Sponsor Decision|445|||
37687192|NCT02245737|69163044|FG001|Overall Study|Sponsor Decision|430|||
37687193|NCT02245737|69163045|FG002|Overall Study|Sponsor Decision|432|||
37687194|NCT02244957|69163057|FG000|Overall Study|Lack of Efficacy|1|||
37687195|NCT02244957|69163058|FG001|Overall Study|Lack of Efficacy|0|||
37687196|NCT02243865|69163068|FG000|Overall Study|Protocol Violation|1|||
38086046|NCT01329978|69785511|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
38086047|NCT01329978|69785512|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
38086048|NCT01329978|69785513|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
38086049|NCT01338012|69785525|FG000|Overall Study|Death|4|||
38086050|NCT01338012|69785525|FG000|Overall Study|Study terminated|4|||
38086051|NCT04905498|69785531|FG000|Overall Study|Lost to Follow-up|0|||
38086052|NCT04905498|69785532|FG001|Overall Study|Lost to Follow-up|2|||
38086053|NCT04905498|69785531|FG000|Overall Study|COVID lockdown|1|||
38086054|NCT04905498|69785532|FG001|Overall Study|COVID lockdown|0|||
38086055|NCT02607280|69785540|FG000|Overall Study|Adverse Event|4|||
38086056|NCT02607280|69785541|FG001|Overall Study|Adverse Event|0|||
38086057|NCT02607280|69785540|FG000|Overall Study|Decrease in CrCl <15|0|||
37687197|NCT02243865|69163069|FG001|Overall Study|Protocol Violation|3|||
37687198|NCT02243865|69163068|FG000|Overall Study|Lost to Follow-up|1|||
37687199|NCT02243865|69163069|FG001|Overall Study|Lost to Follow-up|1|||
37687200|NCT02243865|69163068|FG000|Overall Study|Withdrawal by Subject|1|||
37687201|NCT02243865|69163069|FG001|Overall Study|Withdrawal by Subject|0|||
37687202|NCT02243865|69163068|FG000|Overall Study|Adverse Event|1|||
37687203|NCT02243865|69163069|FG001|Overall Study|Adverse Event|1|||
37687204|NCT02243631|69163079|FG000|Overall Study|no synovial fluid on second aspirate|0|||
37687205|NCT02243631|69163080|FG001|Overall Study|no synovial fluid on second aspirate|1|||
37687206|NCT02242305|69163088|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
37687207|NCT02242305|69163089|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
37687208|NCT02242305|69163088|FG000|Overall Study|Adverse Event|1|||
37687209|NCT02242305|69163089|FG001|Overall Study|Adverse Event|0|||
38086058|NCT02607280|69785541|FG001|Overall Study|Decrease in CrCl <15|1|||
38086059|NCT02202434|69785551|FG000|Overall Study|Death|70|||
38086060|NCT02202434|69785552|FG001|Overall Study|Death|39|||
38086061|NCT02202434|69785553|FG002|Overall Study|Death|13|||
38086062|NCT02202434|69785554|FG003|Overall Study|Death|27|||
38086063|NCT02202434|69785551|FG000|Overall Study|Lost to Follow-up|1|||
38086064|NCT02202434|69785552|FG001|Overall Study|Lost to Follow-up|1|||
38086065|NCT02202434|69785553|FG002|Overall Study|Lost to Follow-up|1|||
38086066|NCT02202434|69785554|FG003|Overall Study|Lost to Follow-up|0|||
38086067|NCT02202434|69785551|FG000|Overall Study|Physician Decision|2|||
38086068|NCT02202434|69785552|FG001|Overall Study|Physician Decision|3|||
38086069|NCT02202434|69785553|FG002|Overall Study|Physician Decision|0|||
38086070|NCT02202434|69785554|FG003|Overall Study|Physician Decision|0|||
38086071|NCT02202434|69785551|FG000|Overall Study|Withdrawal by Subject|13|||
38086072|NCT02202434|69785552|FG001|Overall Study|Withdrawal by Subject|14|||
38086073|NCT02202434|69785553|FG002|Overall Study|Withdrawal by Subject|1|||
38086074|NCT02202434|69785554|FG003|Overall Study|Withdrawal by Subject|4|||
38086075|NCT02202434|69785551|FG000|Overall Study|Completed Study|1|||
38086076|NCT02202434|69785552|FG001|Overall Study|Completed Study|0|||
38086077|NCT02202434|69785553|FG002|Overall Study|Completed Study|0|||
38086078|NCT02202434|69785554|FG003|Overall Study|Completed Study|0|||
38086079|NCT02202434|69785551|FG000|Overall Study|Visit Missed|21|||
38086080|NCT02202434|69785552|FG001|Overall Study|Visit Missed|12|||
38086081|NCT02202434|69785553|FG002|Overall Study|Visit Missed|0|||
38086082|NCT02202434|69785554|FG003|Overall Study|Visit Missed|5|||
38086083|NCT02202434|69785551|FG000|Overall Study|Other|1|||
38086084|NCT02202434|69785552|FG001|Overall Study|Other|0|||
38086085|NCT02202434|69785553|FG002|Overall Study|Other|0|||
38086086|NCT02202434|69785554|FG003|Overall Study|Other|1|||
38086087|NCT02784288|69785564|FG000|Overall Study|Patients neck dissection had spillage and therefore needed to come off protocol|1|||
38086088|NCT01230242|69785569|FG000|Overall Study|Physician Decision|2|||
38086089|NCT01230242|69785569|FG000|Overall Study|Withdrawal by Subject|1|||
38086090|NCT02608450|69785575|FG000|Overall Study|Lost to Follow-up|39|||
38086091|NCT02608450|69785576|FG001|Overall Study|Lost to Follow-up|32|||
37687210|NCT02242305|69163088|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
37687211|NCT02242305|69163089|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
37687212|NCT02242305|69163088|FG000|Overall Study|Subject withdraws inform consent|0|||
37687213|NCT02242305|69163089|FG001|Overall Study|Subject withdraws inform consent|4|||
38086092|NCT02608450|69785575|FG000|Overall Study|Withdrawal by Subject|21|||
38086093|NCT02608450|69785576|FG001|Overall Study|Withdrawal by Subject|15|||
38086094|NCT02608450|69785575|FG000|Overall Study|Adverse Event|3|||
37687214|NCT02242305|69163088|FG000|Overall Study|Lost to Follow-up|2|||
37687215|NCT02242305|69163089|FG001|Overall Study|Lost to Follow-up|0|||
37687216|NCT02240121|69163097|FG000|Overall Study|Protocol Violation|1|||
37687217|NCT02240121|69163098|FG001|Overall Study|Protocol Violation|2|||
38086095|NCT02608450|69785576|FG001|Overall Study|Adverse Event|6|||
37687218|NCT02240121|69163097|FG000|Overall Study|Physician Decision|0|||
37687219|NCT02240121|69163098|FG001|Overall Study|Physician Decision|1|||
37863362|NCT00996892|69547120|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
38086096|NCT02608450|69785575|FG000|Overall Study|Withdrawal by parent|2|||
38086097|NCT02608450|69785576|FG001|Overall Study|Withdrawal by parent|3|||
38086098|NCT02608450|69785575|FG000|Overall Study|Lack of Efficacy|0|||
38086099|NCT02608450|69785576|FG001|Overall Study|Lack of Efficacy|3|||
38086100|NCT02608450|69785575|FG000|Overall Study|Noncompliance with study drug|0|||
38086101|NCT02608450|69785576|FG001|Overall Study|Noncompliance with study drug|2|||
38086102|NCT02608450|69785575|FG000|Overall Study|Physician Decision|0|||
38086103|NCT02608450|69785576|FG001|Overall Study|Physician Decision|1|||
38086104|NCT02608450|69785575|FG000|Overall Study|Pregnancy|0|||
38086105|NCT02608450|69785576|FG001|Overall Study|Pregnancy|1|||
38086106|NCT02608450|69785575|FG000|Overall Study|Progressive disease|1|||
38086107|NCT02608450|69785576|FG001|Overall Study|Progressive disease|0|||
38086108|NCT02608450|69785575|FG000|Overall Study|Multiple reasons|0|||
38086109|NCT02608450|69785576|FG001|Overall Study|Multiple reasons|2|||
38086110|NCT04918784|69785584|FG000|Overall Study|Amputation - no longer eligible|1|||
38086111|NCT04918784|69785585|FG001|Overall Study|Amputation - no longer eligible|2|||
38086112|NCT04918784|69785584|FG000|Overall Study|Death|1|||
38086113|NCT04918784|69785585|FG001|Overall Study|Death|0|||
38086114|NCT04918784|69785584|FG000|Overall Study|patient non-compliance|3|||
38086115|NCT04918784|69785585|FG001|Overall Study|patient non-compliance|1|||
38086116|NCT04918784|69785584|FG000|Overall Study|Adverse Event|1|||
38086117|NCT04918784|69785585|FG001|Overall Study|Adverse Event|0|||
38086118|NCT04786444|69785618|FG000|Overall Study|Withdrawal by Subject|4|||
38086119|NCT04786444|69785619|FG001|Overall Study|Withdrawal by Subject|7|||
38086120|NCT04786444|69785620|FG002|Overall Study|Withdrawal by Subject|2|||
38086121|NCT04786444|69785618|FG000|Overall Study|Lost to Follow-up|11|||
38086122|NCT04786444|69785619|FG001|Overall Study|Lost to Follow-up|9|||
37687220|NCT02240121|69163097|FG000|Overall Study|Change in protocol interpretation|1|||
37687221|NCT02240121|69163098|FG001|Overall Study|Change in protocol interpretation|0|||
37687222|NCT02240121|69163097|FG000|Overall Study|Lack of Efficacy|2|||
37687223|NCT02240121|69163098|FG001|Overall Study|Lack of Efficacy|3|||
37687224|NCT02240121|69163097|FG000|Overall Study|Site closed|1|||
37687225|NCT02240121|69163098|FG001|Overall Study|Site closed|1|||
37687226|NCT02240121|69163097|FG000|Overall Study|Pregnancy|1|||
37687227|NCT02240121|69163098|FG001|Overall Study|Pregnancy|0|||
37687228|NCT02240121|69163097|FG000|Overall Study|Adverse Event|2|||
37687229|NCT02240121|69163098|FG001|Overall Study|Adverse Event|4|||
37687230|NCT02240121|69163097|FG000|Overall Study|Withdrawal by Subject|6|||
37687231|NCT02240121|69163098|FG001|Overall Study|Withdrawal by Subject|2|||
37687232|NCT02240121|69163097|FG000|Overall Study|Lost to Follow-up|3|||
37687233|NCT02240121|69163098|FG001|Overall Study|Lost to Follow-up|4|||
37687234|NCT02240121|69163097|FG000|Overall Study|Other than specified|1|||
37687235|NCT02240121|69163098|FG001|Overall Study|Other than specified|3|||
37687236|NCT02239263|69163104|FG000|Overall Study|Protocol Violation|6|||
37687237|NCT02238483|69163112|FG000|Overall Study|Withdrawal by Subject|2|||
37687238|NCT02238483|69163113|FG001|Overall Study|Withdrawal by Subject|7|||
37687239|NCT02238483|69163112|FG000|Overall Study|Lost to Follow-up|1|||
37687240|NCT02238483|69163113|FG001|Overall Study|Lost to Follow-up|1|||
37687241|NCT02238483|69163112|FG000|Overall Study|Protocol Violation|1|||
37687242|NCT02238483|69163113|FG001|Overall Study|Protocol Violation|2|||
37687243|NCT02238483|69163112|FG000|Overall Study|Death|1|||
37687244|NCT02238483|69163113|FG001|Overall Study|Death|0|||
37687245|NCT02238483|69163112|FG000|Overall Study|Adverse Event|7|||
37687246|NCT02238483|69163113|FG001|Overall Study|Adverse Event|3|||
37687247|NCT02238483|69163112|FG000|Overall Study|Withdrawn due to physician decision|1|||
37687248|NCT02238483|69163113|FG001|Overall Study|Withdrawn due to physician decision|0|||
37687249|NCT02238483|69163112|FG000|Overall Study|Completion status not recorded|1|||
37687250|NCT02238483|69163113|FG001|Overall Study|Completion status not recorded|1|||
37687251|NCT02238483|69163112|FG000|Overall Study|Illness in family member|1|||
37687252|NCT02238483|69163113|FG001|Overall Study|Illness in family member|0|||
37687253|NCT01632891|69163121|FG000|Overall Study|Lost to Follow-up|0|||
37687254|NCT01632891|69163122|FG001|Overall Study|Lost to Follow-up|1|||
37687255|NCT01632891|69163121|FG000|Overall Study|Withdrawal by Subject|1|||
37687256|NCT01632891|69163122|FG001|Overall Study|Withdrawal by Subject|0|||
37687257|NCT02208999|69163134|FG000|Overall Study|Lost to Follow-up|1|||
37687258|NCT02208843|69163153|FG000|Overall Study|Clinical symptoms of progression|2|||
37687259|NCT02208843|69163153|FG000|Overall Study|Progression disease according to RECIST|24|||
37687260|NCT02208843|69163153|FG000|Overall Study|Adverse Event|12|||
37687261|NCT02208843|69163153|FG000|Overall Study|Protocol Violation|1|||
38086123|NCT04786444|69785620|FG002|Overall Study|Lost to Follow-up|10|||
37687262|NCT02208843|69163153|FG000|Overall Study|Withdrawal by Subject|1|||
37687263|NCT02208843|69163153|FG000|Overall Study|Switched to commercial afatinib|20|||
37687264|NCT02208063|69163159|FG000|Overall Study|Death|3|||
37687265|NCT02208063|69163160|FG001|Overall Study|Death|5|||
37687266|NCT02208063|69163159|FG000|Overall Study|Not Specified in report|3|||
37687267|NCT02208063|69163160|FG001|Overall Study|Not Specified in report|4|||
37687268|NCT02208063|69163159|FG000|Overall Study|Withdrawal by Subject|5|||
38086124|NCT04786444|69785618|FG000|Overall Study|Subject would like to become pregnant|0|||
38086125|NCT04786444|69785619|FG001|Overall Study|Subject would like to become pregnant|1|||
38086126|NCT04786444|69785620|FG002|Overall Study|Subject would like to become pregnant|0|||
38086127|NCT04692155|69785637|FG000|Overall Study|Death|1|||
38086128|NCT04499963|69785643|FG000|Overall Study|Adverse Event|3|||
37687269|NCT02208063|69163160|FG001|Overall Study|Withdrawal by Subject|2|||
37687270|NCT02208063|69163159|FG000|Overall Study|Lost to Follow-up|1|||
37687271|NCT02208063|69163160|FG001|Overall Study|Lost to Follow-up|0|||
37687272|NCT02207907|69163168|FG000|Overall Study|Lost to Follow-up|3|||
37687273|NCT02207907|69163169|FG001|Overall Study|Lost to Follow-up|1|||
37687274|NCT02207907|69163168|FG000|Overall Study|Withdrawal by Subject|5|||
37687275|NCT02207907|69163169|FG001|Overall Study|Withdrawal by Subject|6|||
37687276|NCT02207907|69163168|FG000|Overall Study|Did not meet study criteria|3|||
37687277|NCT02207907|69163169|FG001|Overall Study|Did not meet study criteria|0|||
37687278|NCT02207907|69163168|FG000|Overall Study|Pregnancy|0|||
37687279|NCT02207907|69163169|FG001|Overall Study|Pregnancy|1|||
37687280|NCT02207829|69163178|FG000|Overall Study|Adverse Event|10|||
37687281|NCT02207829|69163179|FG001|Overall Study|Adverse Event|9|||
37687282|NCT02207829|69163178|FG000|Overall Study|Lack of Efficacy|7|||
37687283|NCT02207829|69163179|FG001|Overall Study|Lack of Efficacy|5|||
37687284|NCT02207829|69163178|FG000|Overall Study|Lost to Follow-up|2|||
37687285|NCT02207829|69163179|FG001|Overall Study|Lost to Follow-up|2|||
37687286|NCT02207829|69163178|FG000|Overall Study|Protocol deviation|5|||
37687287|NCT02207829|69163179|FG001|Overall Study|Protocol deviation|4|||
37687288|NCT02207829|69163178|FG000|Overall Study|Withdrew consent|18|||
37687289|NCT02207829|69163179|FG001|Overall Study|Withdrew consent|14|||
37687290|NCT02237157|69163185|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
37687291|NCT02237157|69163186|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
37687292|NCT02237157|69163187|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
37687293|NCT02237157|69163188|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
37687294|NCT02237157|69163185|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
37687295|NCT02237157|69163186|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
37687296|NCT02237157|69163187|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
37687297|NCT02237157|69163188|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
37687298|NCT02237001|69163195|FG000|Overall Study|Lost to Follow-up|2|||
37687299|NCT02237001|69163195|FG000|Overall Study|Withdrawal by Subject|1|||
37687300|NCT02237001|69163195|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
37687301|NCT02237001|69163195|FG000|Overall Study|Re-operation|4|||
37687302|NCT02237001|69163195|FG000|Overall Study|Incarceration|1|||
37687303|NCT02236611|69163201|FG000|Overall Study|Adverse Event|10|||
37687304|NCT02236611|69163202|FG001|Overall Study|Adverse Event|16|||
37687305|NCT02236611|69163201|FG000|Overall Study|Lack of Efficacy|4|||
37687306|NCT02236611|69163202|FG001|Overall Study|Lack of Efficacy|7|||
38086129|NCT04499963|69785644|FG001|Overall Study|Adverse Event|0|||
38086130|NCT04499963|69785643|FG000|Overall Study|Death|3|||
38086131|NCT04499963|69785644|FG001|Overall Study|Death|0|||
38086132|NCT04499963|69785643|FG000|Overall Study|Lack of Efficacy|7|||
38086133|NCT04499963|69785644|FG001|Overall Study|Lack of Efficacy|0|||
38086134|NCT04499963|69785643|FG000|Overall Study|Lost to Follow-up|2|||
38086135|NCT04499963|69785644|FG001|Overall Study|Lost to Follow-up|0|||
38086136|NCT04330482|69785661|FG000|Overall Study|Lost to Follow-up|2|||
38086137|NCT04330482|69785662|FG001|Overall Study|Lost to Follow-up|1|||
38086138|NCT04330482|69785661|FG000|Overall Study|Withdrawal by Subject|0|||
38086139|NCT04330482|69785662|FG001|Overall Study|Withdrawal by Subject|3|||
38086140|NCT04325503|69785668|FG000|Overall Study|Withdrawal by Subject|1|||
38086141|NCT04325503|69785668|FG000|Overall Study|PI decided to remove them from trial as they lacked motor symptoms being studied.|2|||
38086142|NCT04109222|69785679|FG000|Overall Study|Adverse Event|1|||
38086143|NCT04109222|69785680|FG001|Overall Study|Adverse Event|0|||
38086144|NCT04109222|69785681|FG002|Overall Study|Adverse Event|0|||
38086145|NCT03573297|69785720|FG000|Open Label Treatment Period|Adverse Event|67|||
38086146|NCT03573297|69785721|FG001|Open Label Treatment Period|Adverse Event|0|||
38086147|NCT03573297|69785722|FG002|Open Label Treatment Period|Adverse Event|0|||
38086148|NCT03573297|69785723|FG003|Open Label Treatment Period|Adverse Event|0|||
38086149|NCT03573297|69785720|FG000|Open Label Treatment Period|Lack of Efficacy|35|||
38086150|NCT03573297|69785721|FG001|Open Label Treatment Period|Lack of Efficacy|0|||
38086151|NCT03573297|69785722|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
38086152|NCT03573297|69785723|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
38086153|NCT03573297|69785720|FG000|Open Label Treatment Period|Withdrawal by Subject|104|||
37687307|NCT02236611|69163201|FG000|Overall Study|Lost to Follow-up|0|||
37687308|NCT02236611|69163202|FG001|Overall Study|Lost to Follow-up|2|||
38086154|NCT03573297|69785721|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
38086155|NCT03573297|69785722|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
37687309|NCT02236611|69163201|FG000|Overall Study|Protocol deviation|3|||
37687310|NCT02236611|69163202|FG001|Overall Study|Protocol deviation|5|||
37687311|NCT02236611|69163201|FG000|Overall Study|Withdrew consent|9|||
37687312|NCT02236611|69163202|FG001|Overall Study|Withdrew consent|4|||
37687313|NCT02234583|69163210|FG000|Overall Study|Adverse Event|172|||
37687314|NCT02234583|69163211|FG001|Overall Study|Adverse Event|156|||
37687315|NCT02234583|69163210|FG000|Overall Study|Withdrawal by Subject|109|||
37687316|NCT02234583|69163211|FG001|Overall Study|Withdrawal by Subject|157|||
38086156|NCT03573297|69785723|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
38086157|NCT03573297|69785720|FG000|Open Label Treatment Period|Lost to Follow-up|55|||
38086158|NCT03573297|69785721|FG001|Open Label Treatment Period|Lost to Follow-up|0|||
38086159|NCT03573297|69785722|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
38086160|NCT03573297|69785723|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
38086161|NCT03573297|69785720|FG000|Open Label Treatment Period|Pregnancy|1|||
38086162|NCT03573297|69785721|FG001|Open Label Treatment Period|Pregnancy|0|||
38086163|NCT03573297|69785722|FG002|Open Label Treatment Period|Pregnancy|0|||
38086164|NCT03573297|69785723|FG003|Open Label Treatment Period|Pregnancy|0|||
38086165|NCT03573297|69785720|FG000|Open Label Treatment Period|Protocol Violation|17|||
38086166|NCT03573297|69785721|FG001|Open Label Treatment Period|Protocol Violation|0|||
38086167|NCT03573297|69785722|FG002|Open Label Treatment Period|Protocol Violation|0|||
37687317|NCT02234583|69163210|FG000|Overall Study|Lost to Follow-up|0|||
37687318|NCT02234583|69163211|FG001|Overall Study|Lost to Follow-up|1|||
37687319|NCT02234583|69163210|FG000|Overall Study|Lack of Efficacy|58|||
37687320|NCT02234583|69163211|FG001|Overall Study|Lack of Efficacy|103|||
37687321|NCT02234583|69163210|FG000|Overall Study|Protocol Violation|35|||
37687322|NCT02234583|69163211|FG001|Overall Study|Protocol Violation|42|||
37687323|NCT02234583|69163210|FG000|Overall Study|Other|39|||
37687324|NCT02234583|69163211|FG001|Overall Study|Other|97|||
37687325|NCT03686397|69163225|FG000|Overall Study|Lack of Efficacy|3|||
37687326|NCT03686397|69163226|FG001|Overall Study|Lack of Efficacy|5|||
37687327|NCT03686397|69163225|FG000|Overall Study|Adverse Event|0|||
37687328|NCT03686397|69163226|FG001|Overall Study|Adverse Event|1|||
37687329|NCT03686397|69163225|FG000|Overall Study|Protocol Violation|0|||
37687330|NCT03686397|69163226|FG001|Overall Study|Protocol Violation|1|||
37687331|NCT03686397|69163225|FG000|Overall Study|Withdrawal by Subject|0|||
37863363|NCT00996892|69547121|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
37687332|NCT03686397|69163226|FG001|Overall Study|Withdrawal by Subject|1|||
37687333|NCT03686397|69163225|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
37687334|NCT03686397|69163226|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
37687335|NCT02233803|69163232|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
37687336|NCT02233803|69163233|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
37687337|NCT02233803|69163232|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
37687338|NCT02233803|69163233|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
37687339|NCT02233803|69163232|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
37687340|NCT02233803|69163233|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
37687341|NCT02233803|69163232|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
37687342|NCT02233803|69163233|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
37687343|NCT02233803|69163232|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
37687344|NCT02233803|69163233|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
37687345|NCT02233803|69163232|FG000|Washout Period (4-Wks)|Physician Decision|1|||
37687346|NCT02233803|69163233|FG001|Washout Period (4-Wks)|Physician Decision|0|||
37687347|NCT02233803|69163232|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
37687348|NCT02233803|69163233|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
37687349|NCT02233803|69163232|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
37687350|NCT02233803|69163233|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
37687351|NCT02233803|69163232|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
37687352|NCT02233803|69163233|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
37687353|NCT02233647|69163241|FG000|Overall Study|Adverse Event|1|||
37687354|NCT02233413|69163247|FG000|Overall Study|Lost to Follow-up|7|||
37687355|NCT02233413|69163248|FG001|Overall Study|Lost to Follow-up|9|||
37687356|NCT02233413|69163247|FG000|Overall Study|Withdrawal by Subject|4|||
37687357|NCT02233413|69163248|FG001|Overall Study|Withdrawal by Subject|5|||
37687358|NCT01632579|69163254|FG000|Washout Period|Adverse Event|1|||
37687359|NCT01632579|69163255|FG001|Washout Period|Adverse Event|0|||
37687360|NCT01632579|69163256|FG002|Washout Period|Adverse Event|0|||
37687361|NCT01632579|69163257|FG003|Washout Period|Adverse Event|0|||
37687362|NCT01632579|69163258|FG004|Washout Period|Adverse Event|0|||
37687363|NCT01632579|69163259|FG005|Washout Period|Adverse Event|0|||
37687364|NCT01632579|69163260|FG006|Washout Period|Adverse Event|0|||
37687365|NCT01632579|69163261|FG007|Washout Period|Adverse Event|0|||
37687366|NCT01632579|69163262|FG008|Washout Period|Adverse Event|0|||
37687367|NCT01632579|69163254|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
37687368|NCT01632579|69163255|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
37687369|NCT01632579|69163256|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
37687370|NCT01632579|69163257|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
37687371|NCT01632579|69163258|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
37863364|NCT00996892|69547122|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
37967404|NCT00426231|69654338|FG001|Overall Study|Withdrawal by Subject|12|||
37967405|NCT00425607|69654344|FG000|Overall Study|Death|1|||
37967406|NCT00425607|69654344|FG000|Overall Study|Withdrawal by Subject|1|||
37967407|NCT00437073|69654350|FG000|Overall Study|Sponsor Terminated Study|1|||
37967408|NCT00437073|69654351|FG001|Overall Study|Sponsor Terminated Study|0|||
37967409|NCT00437073|69654350|FG000|Overall Study|Physician Decision|0|||
37967410|NCT00437073|69654351|FG001|Overall Study|Physician Decision|1|||
37967411|NCT00425373|69654366|FG000|Overall Study|Adverse Event|2|||
37967412|NCT00425373|69654367|FG001|Overall Study|Adverse Event|2|||
37967413|NCT00425373|69654368|FG002|Overall Study|Adverse Event|0|||
37967414|NCT00425373|69654369|FG003|Overall Study|Adverse Event|1|||
37967415|NCT00425373|69654370|FG004|Overall Study|Adverse Event|4|||
37967416|NCT00425373|69654371|FG005|Overall Study|Adverse Event|6|||
37967417|NCT00425373|69654372|FG006|Overall Study|Adverse Event|2|||
37967418|NCT00425373|69654373|FG007|Overall Study|Adverse Event|3|||
37967419|NCT00425373|69654374|FG008|Overall Study|Adverse Event|8|||
37967420|NCT00425373|69654366|FG000|Overall Study|Lost to Follow-up|0|||
37967421|NCT00425373|69654367|FG001|Overall Study|Lost to Follow-up|1|||
37967422|NCT00425373|69654368|FG002|Overall Study|Lost to Follow-up|0|||
37967423|NCT00425373|69654369|FG003|Overall Study|Lost to Follow-up|0|||
37967424|NCT00425373|69654370|FG004|Overall Study|Lost to Follow-up|1|||
37967425|NCT00425373|69654371|FG005|Overall Study|Lost to Follow-up|0|||
37967426|NCT00425373|69654372|FG006|Overall Study|Lost to Follow-up|0|||
37967427|NCT00425373|69654373|FG007|Overall Study|Lost to Follow-up|0|||
38086168|NCT03573297|69785723|FG003|Open Label Treatment Period|Protocol Violation|0|||
38086169|NCT03573297|69785720|FG000|Open Label Treatment Period|Non-Compliance With Study Drug|25|||
38086170|NCT03573297|69785721|FG001|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
38086171|NCT03573297|69785722|FG002|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
38086172|NCT03573297|69785723|FG003|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
38086173|NCT03573297|69785720|FG000|Open Label Treatment Period|Study Terminated by Sponsor|2|||
38086174|NCT03573297|69785721|FG001|Open Label Treatment Period|Study Terminated by Sponsor|0|||
38086175|NCT03573297|69785722|FG002|Open Label Treatment Period|Study Terminated by Sponsor|0|||
38086176|NCT03573297|69785723|FG003|Open Label Treatment Period|Study Terminated by Sponsor|0|||
38086177|NCT03573297|69785720|FG000|Open Label Treatment Period|Failure to Meet Randomization Criteria|143|||
38086178|NCT03573297|69785721|FG001|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
38086179|NCT03573297|69785722|FG002|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
38086180|NCT03573297|69785723|FG003|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
38086181|NCT03573297|69785720|FG000|Open Label Treatment Period|Other, Not Specified|7|||
38086182|NCT03573297|69785721|FG001|Open Label Treatment Period|Other, Not Specified|0|||
38086183|NCT03573297|69785722|FG002|Open Label Treatment Period|Other, Not Specified|0|||
38086184|NCT03573297|69785723|FG003|Open Label Treatment Period|Other, Not Specified|0|||
38086185|NCT03573297|69785720|FG000|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|0|||
38086186|NCT03573297|69785721|FG001|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|29|||
38086187|NCT03573297|69785722|FG002|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|25|||
38086188|NCT03573297|69785723|FG003|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|26|||
38086189|NCT03573297|69785720|FG000|Double-Blind Treatment Period|Adverse Event|0|||
38086190|NCT03573297|69785721|FG001|Double-Blind Treatment Period|Adverse Event|1|||
38086191|NCT03573297|69785722|FG002|Double-Blind Treatment Period|Adverse Event|5|||
38086192|NCT03573297|69785723|FG003|Double-Blind Treatment Period|Adverse Event|1|||
38086193|NCT03573297|69785720|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
38086194|NCT03573297|69785721|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
38086195|NCT03573297|69785722|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
38086196|NCT03573297|69785723|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
38086197|NCT03573297|69785720|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
38086198|NCT03573297|69785721|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
38086199|NCT03573297|69785722|FG002|Double-Blind Treatment Period|Withdrawal by Subject|11|||
38086200|NCT03573297|69785723|FG003|Double-Blind Treatment Period|Withdrawal by Subject|14|||
38086201|NCT03573297|69785720|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
38086202|NCT03573297|69785721|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
38086203|NCT03573297|69785722|FG002|Double-Blind Treatment Period|Lost to Follow-up|4|||
38086204|NCT03573297|69785723|FG003|Double-Blind Treatment Period|Lost to Follow-up|9|||
38086205|NCT03573297|69785720|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
38086206|NCT03573297|69785721|FG001|Double-Blind Treatment Period|Protocol Violation|3|||
38086207|NCT03573297|69785722|FG002|Double-Blind Treatment Period|Protocol Violation|8|||
38086208|NCT03573297|69785723|FG003|Double-Blind Treatment Period|Protocol Violation|4|||
38086209|NCT03573297|69785720|FG000|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
38086210|NCT03573297|69785721|FG001|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
38086211|NCT03573297|69785722|FG002|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
38086212|NCT03573297|69785723|FG003|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
38086213|NCT03573297|69785720|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
38086214|NCT03573297|69785721|FG001|Double-Blind Treatment Period|Other, Not Specified|5|||
38086215|NCT03573297|69785722|FG002|Double-Blind Treatment Period|Other, Not Specified|8|||
37687372|NCT01632579|69163259|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
37967428|NCT00425373|69654374|FG008|Overall Study|Lost to Follow-up|0|||
37967429|NCT00425373|69654366|FG000|Overall Study|Protocol Violation|1|||
37967430|NCT00425373|69654367|FG001|Overall Study|Protocol Violation|0|||
38086216|NCT03573297|69785723|FG003|Double-Blind Treatment Period|Other, Not Specified|6|||
38086217|NCT03536884|69785734|FG000|Initial Treatment Period Week 0-16|Adverse Event|8|||
38086218|NCT03536884|69785735|FG001|Initial Treatment Period Week 0-16|Adverse Event|6|||
38086219|NCT03536884|69785736|FG002|Initial Treatment Period Week 0-16|Adverse Event|0|||
38086220|NCT03536884|69785737|FG003|Initial Treatment Period Week 0-16|Adverse Event|0|||
38086221|NCT03536884|69785738|FG004|Initial Treatment Period Week 0-16|Adverse Event|0|||
38086222|NCT03536884|69785734|FG000|Initial Treatment Period Week 0-16|Lost to Follow-up|0|||
38086223|NCT03536884|69785735|FG001|Initial Treatment Period Week 0-16|Lost to Follow-up|3|||
38086224|NCT03536884|69785736|FG002|Initial Treatment Period Week 0-16|Lost to Follow-up|0|||
38086225|NCT03536884|69785737|FG003|Initial Treatment Period Week 0-16|Lost to Follow-up|0|||
38086226|NCT03536884|69785738|FG004|Initial Treatment Period Week 0-16|Lost to Follow-up|0|||
38086227|NCT03536884|69785734|FG000|Initial Treatment Period Week 0-16|Withdrawal by Subject|3|||
38086228|NCT03536884|69785735|FG001|Initial Treatment Period Week 0-16|Withdrawal by Subject|4|||
38086229|NCT03536884|69785736|FG002|Initial Treatment Period Week 0-16|Withdrawal by Subject|0|||
38086230|NCT03536884|69785737|FG003|Initial Treatment Period Week 0-16|Withdrawal by Subject|0|||
38086231|NCT03536884|69785738|FG004|Initial Treatment Period Week 0-16|Withdrawal by Subject|0|||
38086232|NCT03536884|69785734|FG000|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|0|||
38086233|NCT03536884|69785735|FG001|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|1|||
38086234|NCT03536884|69785736|FG002|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|0|||
38086235|NCT03536884|69785737|FG003|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|0|||
38086236|NCT03536884|69785738|FG004|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|0|||
38086237|NCT03536884|69785734|FG000|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|0|||
38086238|NCT03536884|69785735|FG001|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|1|||
38086239|NCT03536884|69785736|FG002|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|0|||
38086240|NCT03536884|69785737|FG003|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|0|||
38086241|NCT03536884|69785738|FG004|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|0|||
38086242|NCT03536884|69785734|FG000|Initial Treatment Period Week 0-16|Unable to attend visits|0|||
38086243|NCT03536884|69785735|FG001|Initial Treatment Period Week 0-16|Unable to attend visits|1|||
37687373|NCT01632579|69163260|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
37687374|NCT01632579|69163261|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
37687375|NCT01632579|69163262|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
37687376|NCT01632345|69163291|FG000|Treatment: Part I|Adverse Event|1|||
37687377|NCT01632345|69163292|FG001|Treatment: Part I|Adverse Event|4|||
37687378|NCT01632345|69163293|FG002|Treatment: Part I|Adverse Event|2|||
37687379|NCT01632345|69163294|FG003|Treatment: Part I|Adverse Event|1|||
37687380|NCT01632345|69163295|FG004|Treatment: Part I|Adverse Event|3|||
37687381|NCT01632345|69163296|FG005|Treatment: Part I|Adverse Event|0|||
37687382|NCT01632345|69163297|FG006|Treatment: Part I|Adverse Event|0|||
37687383|NCT01632345|69163291|FG000|Treatment: Part I|Lack of Efficacy|0|||
37687384|NCT01632345|69163292|FG001|Treatment: Part I|Lack of Efficacy|1|||
38086244|NCT03536884|69785736|FG002|Initial Treatment Period Week 0-16|Unable to attend visits|0|||
38086245|NCT03536884|69785737|FG003|Initial Treatment Period Week 0-16|Unable to attend visits|0|||
38086246|NCT03536884|69785738|FG004|Initial Treatment Period Week 0-16|Unable to attend visits|0|||
38086247|NCT03536884|69785734|FG000|Maintenance Treatment Period Week 16-48|Death|0|||
37687385|NCT01632345|69163293|FG002|Treatment: Part I|Lack of Efficacy|0|||
37687386|NCT01632345|69163294|FG003|Treatment: Part I|Lack of Efficacy|1|||
37687387|NCT01632345|69163295|FG004|Treatment: Part I|Lack of Efficacy|1|||
37687388|NCT01632345|69163296|FG005|Treatment: Part I|Lack of Efficacy|0|||
37687389|NCT01632345|69163297|FG006|Treatment: Part I|Lack of Efficacy|0|||
37687390|NCT01632345|69163291|FG000|Treatment: Part I|Lost to Follow-up|3|||
37687391|NCT01632345|69163292|FG001|Treatment: Part I|Lost to Follow-up|2|||
37687392|NCT01632345|69163293|FG002|Treatment: Part I|Lost to Follow-up|1|||
38086248|NCT03536884|69785735|FG001|Maintenance Treatment Period Week 16-48|Death|0|||
38086249|NCT03536884|69785736|FG002|Maintenance Treatment Period Week 16-48|Death|1|||
38086250|NCT03536884|69785737|FG003|Maintenance Treatment Period Week 16-48|Death|0|||
38086251|NCT03536884|69785738|FG004|Maintenance Treatment Period Week 16-48|Death|1|||
38086252|NCT03536884|69785734|FG000|Maintenance Treatment Period Week 16-48|Adverse Event|0|||
38086253|NCT03536884|69785735|FG001|Maintenance Treatment Period Week 16-48|Adverse Event|0|||
37967431|NCT00425373|69654368|FG002|Overall Study|Protocol Violation|1|||
37967432|NCT00425373|69654369|FG003|Overall Study|Protocol Violation|0|||
37687393|NCT01632345|69163294|FG003|Treatment: Part I|Lost to Follow-up|3|||
37967433|NCT00425373|69654370|FG004|Overall Study|Protocol Violation|0|||
37687394|NCT01632345|69163295|FG004|Treatment: Part I|Lost to Follow-up|4|||
37687395|NCT01632345|69163296|FG005|Treatment: Part I|Lost to Follow-up|0|||
38086254|NCT03536884|69785736|FG002|Maintenance Treatment Period Week 16-48|Adverse Event|1|||
38086255|NCT03536884|69785737|FG003|Maintenance Treatment Period Week 16-48|Adverse Event|3|||
38086256|NCT03536884|69785738|FG004|Maintenance Treatment Period Week 16-48|Adverse Event|3|||
38086257|NCT03536884|69785734|FG000|Maintenance Treatment Period Week 16-48|Lack of Efficacy|0|||
38086258|NCT03536884|69785735|FG001|Maintenance Treatment Period Week 16-48|Lack of Efficacy|0|||
38086259|NCT03536884|69785736|FG002|Maintenance Treatment Period Week 16-48|Lack of Efficacy|0|||
38086260|NCT03536884|69785737|FG003|Maintenance Treatment Period Week 16-48|Lack of Efficacy|1|||
38086261|NCT03536884|69785738|FG004|Maintenance Treatment Period Week 16-48|Lack of Efficacy|4|||
38086262|NCT03536884|69785734|FG000|Maintenance Treatment Period Week 16-48|Lost to Follow-up|0|||
38086263|NCT03536884|69785735|FG001|Maintenance Treatment Period Week 16-48|Lost to Follow-up|0|||
38086264|NCT03536884|69785736|FG002|Maintenance Treatment Period Week 16-48|Lost to Follow-up|1|||
38086265|NCT03536884|69785737|FG003|Maintenance Treatment Period Week 16-48|Lost to Follow-up|2|||
38086266|NCT03536884|69785738|FG004|Maintenance Treatment Period Week 16-48|Lost to Follow-up|8|||
38086267|NCT03536884|69785734|FG000|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|0|||
38086268|NCT03536884|69785735|FG001|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|0|||
38086269|NCT03536884|69785736|FG002|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|7|||
38086270|NCT03536884|69785737|FG003|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|3|||
38086271|NCT03536884|69785738|FG004|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|12|||
38086272|NCT03536884|69785734|FG000|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|0|||
38086273|NCT03536884|69785735|FG001|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|0|||
38086274|NCT03536884|69785736|FG002|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|0|||
38086275|NCT03536884|69785737|FG003|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|0|||
37863365|NCT00996892|69547123|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
37863366|NCT00996892|69547124|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
37863367|NCT00996892|69547125|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
38086276|NCT03536884|69785738|FG004|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|1|||
38086277|NCT03225287|69785774|FG000|Overall Study|Adverse Event|0|||
37687396|NCT01632345|69163297|FG006|Treatment: Part I|Lost to Follow-up|0|||
37687397|NCT01632345|69163291|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
37687398|NCT01632345|69163292|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
37687399|NCT01632345|69163293|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
37687400|NCT01632345|69163294|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
37687401|NCT01632345|69163295|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
37687402|NCT01632345|69163296|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
37687403|NCT01632345|69163297|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
37687404|NCT01632345|69163291|FG000|Treatment: Part I|Physician Decision|2|||
37687405|NCT01632345|69163292|FG001|Treatment: Part I|Physician Decision|1|||
38086278|NCT03225287|69785775|FG001|Overall Study|Adverse Event|0|||
38086279|NCT03225287|69785776|FG002|Overall Study|Adverse Event|1|||
38086280|NCT03225287|69785774|FG000|Overall Study|Protocol non-compliance|0|||
38086281|NCT03225287|69785775|FG001|Overall Study|Protocol non-compliance|0|||
38086282|NCT03225287|69785776|FG002|Overall Study|Protocol non-compliance|1|||
38086283|NCT03225287|69785774|FG000|Overall Study|Subject withdraws consent|3|||
38086284|NCT03225287|69785775|FG001|Overall Study|Subject withdraws consent|0|||
38086285|NCT03225287|69785776|FG002|Overall Study|Subject withdraws consent|0|||
38086286|NCT03225287|69785774|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
38086287|NCT03225287|69785775|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
38086288|NCT03225287|69785776|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
38086289|NCT03225287|69785774|FG000|Overall Study|Trial drug not effective|0|||
38086290|NCT03225287|69785775|FG001|Overall Study|Trial drug not effective|1|||
37687406|NCT01632345|69163293|FG002|Treatment: Part I|Physician Decision|0|||
37687407|NCT01632345|69163294|FG003|Treatment: Part I|Physician Decision|0|||
37967434|NCT00425373|69654371|FG005|Overall Study|Protocol Violation|0|||
37967435|NCT00425373|69654372|FG006|Overall Study|Protocol Violation|0|||
37967436|NCT00425373|69654373|FG007|Overall Study|Protocol Violation|5|||
37967437|NCT00425373|69654374|FG008|Overall Study|Protocol Violation|3|||
37967438|NCT00425373|69654366|FG000|Overall Study|Withdrawal by Subject|2|||
37967439|NCT00425373|69654367|FG001|Overall Study|Withdrawal by Subject|0|||
37967440|NCT00425373|69654368|FG002|Overall Study|Withdrawal by Subject|2|||
37967441|NCT00425373|69654369|FG003|Overall Study|Withdrawal by Subject|1|||
37967442|NCT00425373|69654370|FG004|Overall Study|Withdrawal by Subject|4|||
37967443|NCT00425373|69654371|FG005|Overall Study|Withdrawal by Subject|0|||
37967444|NCT00425373|69654372|FG006|Overall Study|Withdrawal by Subject|2|||
37967445|NCT00425373|69654373|FG007|Overall Study|Withdrawal by Subject|2|||
37967446|NCT00425373|69654374|FG008|Overall Study|Withdrawal by Subject|2|||
37687408|NCT01632345|69163295|FG004|Treatment: Part I|Physician Decision|1|||
37687409|NCT01632345|69163296|FG005|Treatment: Part I|Physician Decision|0|||
37967447|NCT00425373|69654366|FG000|Overall Study|Lack of Efficacy|0|||
37967448|NCT00425373|69654367|FG001|Overall Study|Lack of Efficacy|0|||
37967449|NCT00425373|69654368|FG002|Overall Study|Lack of Efficacy|0|||
38086291|NCT03225287|69785776|FG002|Overall Study|Trial drug not effective|0|||
38086292|NCT03225287|69785774|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
38086293|NCT03225287|69785775|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
38086294|NCT03225287|69785776|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
38086295|NCT03225287|69785774|FG000|Overall Study|Stem cell transplantation|0|||
38086296|NCT03225287|69785775|FG001|Overall Study|Stem cell transplantation|1|||
38086297|NCT03225287|69785776|FG002|Overall Study|Stem cell transplantation|0|||
38086298|NCT03140670|69785784|FG000|Overall Study|Withdrawal by Subject|2|||
38086299|NCT03140670|69785784|FG000|Overall Study|Lost to Follow-up|1|||
38086300|NCT03140670|69785784|FG000|Overall Study|Physician Decision|1|||
38086301|NCT02970318|69785790|FG000|Overall for Arm A & Main for Arm B|Lost to Follow-up|2|||
37687410|NCT01632345|69163297|FG006|Treatment: Part I|Physician Decision|0|||
37687411|NCT01632345|69163291|FG000|Treatment: Part I|Pregnancy|0|||
37687412|NCT01632345|69163292|FG001|Treatment: Part I|Pregnancy|1|||
37687413|NCT01632345|69163293|FG002|Treatment: Part I|Pregnancy|0|||
37687414|NCT01632345|69163294|FG003|Treatment: Part I|Pregnancy|0|||
37687415|NCT01632345|69163295|FG004|Treatment: Part I|Pregnancy|0|||
37687416|NCT01632345|69163296|FG005|Treatment: Part I|Pregnancy|0|||
37687417|NCT01632345|69163297|FG006|Treatment: Part I|Pregnancy|0|||
37687418|NCT01632345|69163291|FG000|Treatment: Part I|Protocol Deviation|0|||
37687419|NCT01632345|69163292|FG001|Treatment: Part I|Protocol Deviation|0|||
37687420|NCT01632345|69163293|FG002|Treatment: Part I|Protocol Deviation|1|||
37687421|NCT01632345|69163294|FG003|Treatment: Part I|Protocol Deviation|1|||
37687422|NCT01632345|69163295|FG004|Treatment: Part I|Protocol Deviation|0|||
37687423|NCT01632345|69163296|FG005|Treatment: Part I|Protocol Deviation|0|||
37687424|NCT01632345|69163297|FG006|Treatment: Part I|Protocol Deviation|0|||
37687425|NCT01632345|69163291|FG000|Treatment: Part I|Withdrawal by Subject|3|||
38086302|NCT02970318|69785791|FG001|Overall for Arm A & Main for Arm B|Lost to Follow-up|1|||
38086303|NCT02970318|69785792|FG002|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
38086304|NCT02970318|69785793|FG003|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
38086305|NCT02970318|69785790|FG000|Overall for Arm A & Main for Arm B|Withdrawal by Subject|13|||
38086306|NCT02970318|69785791|FG001|Overall for Arm A & Main for Arm B|Withdrawal by Subject|14|||
38086307|NCT02970318|69785792|FG002|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
38086308|NCT02970318|69785793|FG003|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
38086309|NCT02970318|69785790|FG000|Overall for Arm A & Main for Arm B|Death|41|||
38086310|NCT02970318|69785791|FG001|Overall for Arm A & Main for Arm B|Death|33|||
38086311|NCT02970318|69785792|FG002|Overall for Arm A & Main for Arm B|Death|0|||
38086312|NCT02970318|69785793|FG003|Overall for Arm A & Main for Arm B|Death|0|||
38086313|NCT02970318|69785790|FG000|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
38086314|NCT02970318|69785791|FG001|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|80|||
38086315|NCT02970318|69785792|FG002|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
38086316|NCT02970318|69785793|FG003|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
38086317|NCT02970318|69785790|FG000|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
38086318|NCT02970318|69785791|FG001|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
37687426|NCT01632345|69163292|FG001|Treatment: Part I|Withdrawal by Subject|4|||
37687427|NCT01632345|69163293|FG002|Treatment: Part I|Withdrawal by Subject|4|||
37687428|NCT01632345|69163294|FG003|Treatment: Part I|Withdrawal by Subject|1|||
37687429|NCT01632345|69163295|FG004|Treatment: Part I|Withdrawal by Subject|4|||
37687430|NCT01632345|69163296|FG005|Treatment: Part I|Withdrawal by Subject|0|||
37687431|NCT01632345|69163297|FG006|Treatment: Part I|Withdrawal by Subject|0|||
37687432|NCT01632345|69163291|FG000|Treatment: Part II|Adverse Event|0|||
37687433|NCT01632345|69163292|FG001|Treatment: Part II|Adverse Event|0|||
37687434|NCT01632345|69163293|FG002|Treatment: Part II|Adverse Event|0|||
37687435|NCT01632345|69163294|FG003|Treatment: Part II|Adverse Event|0|||
37687436|NCT01632345|69163295|FG004|Treatment: Part II|Adverse Event|0|||
37687437|NCT01632345|69163296|FG005|Treatment: Part II|Adverse Event|3|||
37687438|NCT01632345|69163297|FG006|Treatment: Part II|Adverse Event|8|||
37687439|NCT01632345|69163291|FG000|Treatment: Part II|Lost to Follow-up|0|||
37687440|NCT01632345|69163292|FG001|Treatment: Part II|Lost to Follow-up|0|||
37967450|NCT00425373|69654369|FG003|Overall Study|Lack of Efficacy|0|||
37967451|NCT00425373|69654370|FG004|Overall Study|Lack of Efficacy|1|||
37967452|NCT00425373|69654371|FG005|Overall Study|Lack of Efficacy|3|||
38086319|NCT02970318|69785792|FG002|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|2|||
38086320|NCT02970318|69785793|FG003|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
38086321|NCT02970318|69785790|FG000|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
37687441|NCT01632345|69163293|FG002|Treatment: Part II|Lost to Follow-up|0|||
37687442|NCT01632345|69163294|FG003|Treatment: Part II|Lost to Follow-up|0|||
37687443|NCT01632345|69163295|FG004|Treatment: Part II|Lost to Follow-up|0|||
37687444|NCT01632345|69163296|FG005|Treatment: Part II|Lost to Follow-up|3|||
37687445|NCT01632345|69163297|FG006|Treatment: Part II|Lost to Follow-up|1|||
38086322|NCT02970318|69785791|FG001|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
38086323|NCT02970318|69785792|FG002|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
38086324|NCT02970318|69785793|FG003|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
38086325|NCT02970318|69785790|FG000|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
38086326|NCT02970318|69785791|FG001|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
38086327|NCT02970318|69785792|FG002|ArmB: Inv.Choice Crossed Over to Acala|Death|18|||
37687446|NCT01632345|69163291|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
37687447|NCT01632345|69163292|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
37863368|NCT00996892|69547126|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
37863369|NCT00996892|69547127|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
37863370|NCT00996892|69547128|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
37863371|NCT00996892|69547129|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
37863372|NCT00996892|69547130|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
37863373|NCT00996892|69547131|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
37863374|NCT00996892|69547132|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
37863375|NCT00996892|69547133|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
37863376|NCT00996892|69547134|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
37863377|NCT00996892|69547135|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
37863378|NCT00996892|69547136|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
37863379|NCT00996892|69547137|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
37863380|NCT00996892|69547118|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
38086328|NCT02970318|69785793|FG003|ArmB: Inv.Choice Crossed Over to Acala|Death|2|||
38086329|NCT02779855|69785804|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
38086330|NCT02779855|69785805|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
37863381|NCT00996892|69547119|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
37863382|NCT00996892|69547120|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
37863383|NCT00996892|69547121|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
37863384|NCT00996892|69547122|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
37863385|NCT00996892|69547123|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
37863386|NCT00996892|69547124|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
37863387|NCT00996892|69547125|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
37863388|NCT00996892|69547126|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
37863389|NCT00996892|69547127|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
37863390|NCT00996892|69547128|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
37863391|NCT00996892|69547129|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
37863392|NCT00996892|69547130|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
37863393|NCT00996892|69547131|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
37863394|NCT00996892|69547132|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
37863395|NCT00996892|69547133|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
37863396|NCT00996892|69547134|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
37863397|NCT00996892|69547135|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
37863398|NCT00996892|69547136|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
37863399|NCT00996892|69547137|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
37863400|NCT00996892|69547118|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
37863401|NCT00996892|69547119|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
37863402|NCT00996892|69547120|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
37863403|NCT00996892|69547121|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
37863404|NCT00996892|69547122|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
37863405|NCT00996892|69547123|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
38086331|NCT02779855|69785806|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
38086332|NCT02682927|69785821|FG000|Overall Study|Adverse Event|0|||
38086333|NCT02682927|69785822|FG001|Overall Study|Adverse Event|0|||
38086334|NCT02682927|69785823|FG002|Overall Study|Adverse Event|5|||
38086335|NCT02682927|69785824|FG003|Overall Study|Adverse Event|1|||
38086336|NCT02682927|69785825|FG004|Overall Study|Adverse Event|0|||
38086337|NCT02682927|69785826|FG005|Overall Study|Adverse Event|2|||
38086338|NCT02682927|69785821|FG000|Overall Study|Death|0|||
38086339|NCT02682927|69785822|FG001|Overall Study|Death|0|||
37863406|NCT00996892|69547124|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
37863407|NCT00996892|69547125|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
38086340|NCT02682927|69785823|FG002|Overall Study|Death|0|||
38086341|NCT02682927|69785824|FG003|Overall Study|Death|1|||
38086342|NCT02682927|69785825|FG004|Overall Study|Death|0|||
38086343|NCT02682927|69785826|FG005|Overall Study|Death|0|||
38086344|NCT02682927|69785821|FG000|Overall Study|Lack of Efficacy|1|||
38086345|NCT02682927|69785822|FG001|Overall Study|Lack of Efficacy|0|||
38086346|NCT02682927|69785823|FG002|Overall Study|Lack of Efficacy|0|||
38086347|NCT02682927|69785824|FG003|Overall Study|Lack of Efficacy|1|||
38086348|NCT02682927|69785825|FG004|Overall Study|Lack of Efficacy|0|||
38086349|NCT02682927|69785826|FG005|Overall Study|Lack of Efficacy|0|||
38086350|NCT02682927|69785821|FG000|Overall Study|Other|0|||
38086351|NCT02682927|69785822|FG001|Overall Study|Other|0|||
38086352|NCT02682927|69785823|FG002|Overall Study|Other|0|||
38086353|NCT02682927|69785824|FG003|Overall Study|Other|2|||
38086354|NCT02682927|69785825|FG004|Overall Study|Other|0|||
38086355|NCT02682927|69785826|FG005|Overall Study|Other|0|||
38086356|NCT02682927|69785821|FG000|Overall Study|Withdrawal by Subject|2|||
38086357|NCT02682927|69785822|FG001|Overall Study|Withdrawal by Subject|0|||
38086358|NCT02682927|69785823|FG002|Overall Study|Withdrawal by Subject|1|||
38086359|NCT02682927|69785824|FG003|Overall Study|Withdrawal by Subject|0|||
38086360|NCT02682927|69785825|FG004|Overall Study|Withdrawal by Subject|1|||
38086361|NCT02682927|69785826|FG005|Overall Study|Withdrawal by Subject|1|||
38086362|NCT02566850|69785881|FG000|Overall Study|Protocol Violation|1|||
38086363|NCT02453282|69785901|FG000|Overall Study|Death|275|||
38086364|NCT02453282|69785902|FG001|Overall Study|Death|277|||
37863408|NCT00996892|69547126|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
37967453|NCT00425373|69654372|FG006|Overall Study|Lack of Efficacy|3|||
37967454|NCT00425373|69654373|FG007|Overall Study|Lack of Efficacy|0|||
37687448|NCT01632345|69163293|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
37687449|NCT01632345|69163294|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
37687450|NCT01632345|69163295|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
37687451|NCT01632345|69163296|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
37687452|NCT01632345|69163297|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
37687453|NCT01632345|69163291|FG000|Treatment: Part II|Withdrawal by Subject|0|||
37687454|NCT01632345|69163292|FG001|Treatment: Part II|Withdrawal by Subject|0|||
37687455|NCT01632345|69163293|FG002|Treatment: Part II|Withdrawal by Subject|0|||
37687456|NCT01632345|69163294|FG003|Treatment: Part II|Withdrawal by Subject|0|||
37687457|NCT01632345|69163295|FG004|Treatment: Part II|Withdrawal by Subject|0|||
37687458|NCT01632345|69163296|FG005|Treatment: Part II|Withdrawal by Subject|2|||
37687459|NCT01632345|69163297|FG006|Treatment: Part II|Withdrawal by Subject|2|||
37687460|NCT02232243|69163315|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
37687461|NCT02232243|69163316|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
37687462|NCT02232243|69163317|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
37687463|NCT02205333|69163335|FG000|Overall Study|Death|5|||
37687464|NCT02205333|69163336|FG001|Overall Study|Death|6|||
37687465|NCT02205333|69163337|FG002|Overall Study|Death|2|||
37687466|NCT02205333|69163338|FG003|Overall Study|Death|6|||
37967455|NCT00425373|69654374|FG008|Overall Study|Lack of Efficacy|5|||
37967456|NCT03894540|69654400|FG000|Overall Study|Adverse Event|0|||
37967457|NCT03894540|69654401|FG001|Overall Study|Adverse Event|0|||
37967458|NCT03894540|69654402|FG002|Overall Study|Adverse Event|0|||
37967459|NCT03894540|69654403|FG003|Overall Study|Adverse Event|0|||
37967460|NCT03894540|69654404|FG004|Overall Study|Adverse Event|1|||
37967461|NCT03894540|69654405|FG005|Overall Study|Adverse Event|0|||
37967462|NCT03894540|69654400|FG000|Overall Study|Withdrawal by Subject|0|||
37967463|NCT03894540|69654401|FG001|Overall Study|Withdrawal by Subject|0|||
37967464|NCT03894540|69654402|FG002|Overall Study|Withdrawal by Subject|0|||
37967465|NCT03894540|69654403|FG003|Overall Study|Withdrawal by Subject|0|||
38086365|NCT02453282|69785903|FG002|Overall Study|Death|296|||
37687467|NCT02205333|69163339|FG004|Overall Study|Death|5|||
37687468|NCT02205333|69163340|FG005|Overall Study|Death|3|||
37687469|NCT02205333|69163341|FG006|Overall Study|Death|3|||
37967466|NCT03894540|69654404|FG004|Overall Study|Withdrawal by Subject|1|||
38086366|NCT02453282|69785901|FG000|Overall Study|Lost to Follow-up|1|||
38086367|NCT02453282|69785902|FG001|Overall Study|Lost to Follow-up|0|||
38086368|NCT02453282|69785903|FG002|Overall Study|Lost to Follow-up|2|||
38086369|NCT02453282|69785901|FG000|Overall Study|Withdrawal by Subject|12|||
37687470|NCT02205333|69163342|FG007|Overall Study|Death|2|||
37687471|NCT02205333|69163343|FG008|Overall Study|Death|0|||
37687472|NCT02205333|69163335|FG000|Overall Study|Withdrawal by Subject|1|||
37967467|NCT03894540|69654405|FG005|Overall Study|Withdrawal by Subject|0|||
37687473|NCT02205333|69163336|FG001|Overall Study|Withdrawal by Subject|0|||
38086370|NCT02453282|69785902|FG001|Overall Study|Withdrawal by Subject|10|||
38086371|NCT02453282|69785903|FG002|Overall Study|Withdrawal by Subject|11|||
37687474|NCT02205333|69163337|FG002|Overall Study|Withdrawal by Subject|0|||
37687475|NCT02205333|69163338|FG003|Overall Study|Withdrawal by Subject|1|||
37687476|NCT02205333|69163339|FG004|Overall Study|Withdrawal by Subject|0|||
37687477|NCT02205333|69163340|FG005|Overall Study|Withdrawal by Subject|0|||
37687478|NCT02205333|69163341|FG006|Overall Study|Withdrawal by Subject|2|||
37687479|NCT02205333|69163342|FG007|Overall Study|Withdrawal by Subject|0|||
37687480|NCT02205333|69163343|FG008|Overall Study|Withdrawal by Subject|0|||
37687481|NCT02230683|69163363|FG000|Overall Study|Adverse Event|1|||
37687482|NCT02230527|69163375|FG000|Overall Study|Withdrawal by Subject|1|||
37687483|NCT02230527|69163376|FG001|Overall Study|Withdrawal by Subject|1|||
37687484|NCT02230527|69163375|FG000|Overall Study|Death|1|||
37687485|NCT02230527|69163376|FG001|Overall Study|Death|0|||
37687486|NCT02230527|69163375|FG000|Overall Study|Lost to Follow-up|2|||
37687487|NCT02230527|69163376|FG001|Overall Study|Lost to Follow-up|1|||
37687488|NCT02230527|69163375|FG000|Overall Study|Other|1|||
37687489|NCT02230527|69163376|FG001|Overall Study|Other|0|||
37687490|NCT02204319|69163382|FG000|Overall Study|Pregnancy|1|||
37687491|NCT02204319|69163382|FG000|Overall Study|Withdrawal by Subject|2|||
37687492|NCT02204007|69163389|FG000|Overall Study|Surgery Canceled|1|||
37687493|NCT02204007|69163390|FG001|Overall Study|Surgery Canceled|1|||
37687494|NCT02203851|69163396|FG000|Overall Study|Lost to Follow-up|4|||
37687495|NCT02203851|69163396|FG000|Overall Study|Withdrawal by Subject|6|||
37687496|NCT02203851|69163396|FG000|Overall Study|Other|1|||
37687497|NCT02228967|69163409|FG000|Overall Study|Lost to Follow-up|146|||
37687498|NCT02228967|69163410|FG001|Overall Study|Lost to Follow-up|142|||
37687499|NCT02228967|69163409|FG000|Overall Study|Withdrawal by Subject|13|||
37687500|NCT02228967|69163410|FG001|Overall Study|Withdrawal by Subject|18|||
37687501|NCT02227875|69163418|FG000|Overall Study|Protocol Violation|10|||
37687502|NCT02227875|69163419|FG001|Overall Study|Protocol Violation|7|||
37687503|NCT02227875|69163418|FG000|Overall Study|Other|1|||
37687504|NCT02227875|69163419|FG001|Overall Study|Other|3|||
37687505|NCT02227875|69163418|FG000|Overall Study|Physician Decision|1|||
37687506|NCT02227875|69163419|FG001|Overall Study|Physician Decision|0|||
37687507|NCT02227875|69163418|FG000|Overall Study|Adverse Event|3|||
37687508|NCT02227875|69163419|FG001|Overall Study|Adverse Event|0|||
37687509|NCT02227875|69163418|FG000|Overall Study|Withdrawal by Subject|12|||
37687510|NCT02227875|69163419|FG001|Overall Study|Withdrawal by Subject|13|||
37687511|NCT02227875|69163418|FG000|Overall Study|Lost to Follow-up|10|||
37687512|NCT02227875|69163419|FG001|Overall Study|Lost to Follow-up|10|||
37687513|NCT02203149|69163430|FG000|Part 1|Adverse Event|0|||
37687514|NCT02203149|69163431|FG001|Part 1|Adverse Event|1|||
37687515|NCT02203149|69163432|FG002|Part 1|Adverse Event|0|||
37687516|NCT02203149|69163433|FG003|Part 1|Adverse Event|0|||
37687517|NCT02203149|69163434|FG004|Part 1|Adverse Event|0|||
37687518|NCT02203149|69163430|FG000|Part 2|Death|0|||
37687519|NCT02203149|69163431|FG001|Part 2|Death|0|||
37687520|NCT02203149|69163432|FG002|Part 2|Death|1|||
37687521|NCT02203149|69163433|FG003|Part 2|Death|1|||
37687522|NCT02203149|69163434|FG004|Part 2|Death|0|||
37687523|NCT02203149|69163430|FG000|Part 2|Withdrawal by Subject|0|||
38086372|NCT02453282|69785901|FG000|Overall Study|Participants ongoing at data cut-off|85|||
38086373|NCT02453282|69785902|FG001|Overall Study|Participants ongoing at data cut-off|84|||
38086374|NCT02453282|69785903|FG002|Overall Study|Participants ongoing at data cut-off|62|||
37687524|NCT02203149|69163431|FG001|Part 2|Withdrawal by Subject|0|||
37687525|NCT02203149|69163432|FG002|Part 2|Withdrawal by Subject|0|||
37687526|NCT02203149|69163433|FG003|Part 2|Withdrawal by Subject|1|||
37687527|NCT02203149|69163434|FG004|Part 2|Withdrawal by Subject|0|||
37687528|NCT02203149|69163430|FG000|Part 2|Adverse Event|0|||
37687529|NCT02203149|69163431|FG001|Part 2|Adverse Event|0|||
37687530|NCT02203149|69163432|FG002|Part 2|Adverse Event|0|||
37687531|NCT02203149|69163433|FG003|Part 2|Adverse Event|1|||
37687532|NCT02203149|69163434|FG004|Part 2|Adverse Event|1|||
37687533|NCT02203071|69163458|FG000|Overall Study|Lost to Follow-up|3|||
37687534|NCT02203071|69163459|FG001|Overall Study|Lost to Follow-up|1|||
37687535|NCT02202837|69163467|FG000|Overall Study|Enbrel treatment discontinued|36|||
37687536|NCT02202837|69163468|FG001|Overall Study|Enbrel treatment discontinued|4|||
37687537|NCT02202837|69163467|FG000|Overall Study|Other|10|||
37687538|NCT02202837|69163468|FG001|Overall Study|Other|0|||
37687539|NCT02202837|69163467|FG000|Overall Study|Lost to Follow-up|7|||
37687540|NCT02202837|69163468|FG001|Overall Study|Lost to Follow-up|1|||
38086375|NCT02453282|69785901|FG000|Overall Study|Other|1|||
37687541|NCT02202759|69163477|FG000|Overall Study|Study Terminated by Sponsor|3|||
38086376|NCT02453282|69785902|FG001|Overall Study|Other|1|||
37687542|NCT02202759|69163478|FG001|Overall Study|Study Terminated by Sponsor|3|||
37687543|NCT02202759|69163479|FG002|Overall Study|Study Terminated by Sponsor|3|||
37687544|NCT02202759|69163477|FG000|Overall Study|Withdrawal by Subject|2|||
37687545|NCT02202759|69163478|FG001|Overall Study|Withdrawal by Subject|1|||
37687546|NCT02202759|69163479|FG002|Overall Study|Withdrawal by Subject|1|||
37687547|NCT02202759|69163477|FG000|Overall Study|Reason not Specified|4|||
37687548|NCT02202759|69163478|FG001|Overall Study|Reason not Specified|11|||
37687549|NCT02202759|69163479|FG002|Overall Study|Reason not Specified|10|||
37687550|NCT02226549|69163488|FG000|Overall Study|Randomized but Never Treated|1|||
37687551|NCT02226549|69163489|FG001|Overall Study|Randomized but Never Treated|0|||
37687552|NCT02226549|69163488|FG000|Overall Study|Lost to Follow-up|0|||
37687553|NCT02226549|69163489|FG001|Overall Study|Lost to Follow-up|1|||
37687554|NCT02226003|69163498|FG000|Overall Study|Lost to Follow-up|2|||
37687555|NCT02226003|69163499|FG001|Overall Study|Lost to Follow-up|1|||
37687556|NCT02226003|69163500|FG002|Overall Study|Lost to Follow-up|3|||
37687557|NCT02226003|69163498|FG000|Overall Study|Withdrawal by Subject|0|||
37687558|NCT02226003|69163499|FG001|Overall Study|Withdrawal by Subject|0|||
37687559|NCT02226003|69163500|FG002|Overall Study|Withdrawal by Subject|3|||
37687560|NCT02225223|69163510|FG000|Overall Study|Death|10|||
37687561|NCT02225223|69163511|FG001|Overall Study|Death|1|||
37687562|NCT02225223|69163510|FG000|Overall Study|Lost to Follow-up|5|||
37687563|NCT02225223|69163511|FG001|Overall Study|Lost to Follow-up|0|||
37687564|NCT02225223|69163510|FG000|Overall Study|Other|1|||
37687565|NCT02225223|69163511|FG001|Overall Study|Other|2|||
37687566|NCT02225223|69163510|FG000|Overall Study|Physician Decision|1|||
37687567|NCT02225223|69163511|FG001|Overall Study|Physician Decision|0|||
37687568|NCT02225223|69163510|FG000|Overall Study|Withdrawal by Subject|2|||
37687569|NCT02225223|69163511|FG001|Overall Study|Withdrawal by Subject|2|||
37687570|NCT01634139|69163520|FG000|Overall Study|Non compliant with protocol|1|||
37687571|NCT01634139|69163521|FG001|Overall Study|Non compliant with protocol|0|||
37687572|NCT01634139|69163522|FG002|Overall Study|Non compliant with protocol|0|||
37687573|NCT01634139|69163520|FG000|Overall Study|Consent withdrawn not due to AE|4|||
37687574|NCT01634139|69163521|FG001|Overall Study|Consent withdrawn not due to AE|3|||
37687575|NCT01634139|69163522|FG002|Overall Study|Consent withdrawn not due to AE|2|||
37687576|NCT01634139|69163520|FG000|Overall Study|Other|4|||
37687577|NCT01634139|69163521|FG001|Overall Study|Other|0|||
37687578|NCT01634139|69163522|FG002|Overall Study|Other|3|||
37687579|NCT01634139|69163520|FG000|Overall Study|Lost to Follow-up|0|||
37687580|NCT01634139|69163521|FG001|Overall Study|Lost to Follow-up|2|||
37687581|NCT01634139|69163522|FG002|Overall Study|Lost to Follow-up|0|||
37687582|NCT01634139|69163520|FG000|Overall Study|Not treated|1|||
37687583|NCT01634139|69163521|FG001|Overall Study|Not treated|1|||
37687584|NCT01634139|69163522|FG002|Overall Study|Not treated|0|||
37687585|NCT02224755|69163532|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
37687586|NCT02224755|69163533|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
37687587|NCT02224755|69163532|FG000|Two Year Follow up Post-implant|Death|103|||
37687588|NCT02224755|69163533|FG001|Two Year Follow up Post-implant|Death|98|||
37687589|NCT02224755|69163532|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
37687590|NCT02224755|69163533|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
37687591|NCT02224755|69163532|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
37687592|NCT02224755|69163533|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
37687593|NCT02224755|69163532|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
37687594|NCT02224755|69163533|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
37687595|NCT02404441|69163553|FG000|Phase 1 Part|Adverse Event|1|||
37687596|NCT02404441|69163554|FG001|Phase 1 Part|Adverse Event|0|||
37687597|NCT02404441|69163555|FG002|Phase 1 Part|Adverse Event|0|||
37687598|NCT02404441|69163556|FG003|Phase 1 Part|Adverse Event|0|||
37687599|NCT02404441|69163557|FG004|Phase 1 Part|Adverse Event|0|||
37687600|NCT02404441|69163558|FG005|Phase 1 Part|Adverse Event|0|||
37687601|NCT02404441|69163559|FG006|Phase 1 Part|Adverse Event|0|||
37687602|NCT02404441|69163560|FG007|Phase 1 Part|Adverse Event|0|||
37687603|NCT02404441|69163561|FG008|Phase 1 Part|Adverse Event|0|||
37687604|NCT02404441|69163562|FG009|Phase 1 Part|Adverse Event|0|||
37687605|NCT02404441|69163553|FG000|Phase 1 Part|Physician Decision|0|||
37687606|NCT02404441|69163554|FG001|Phase 1 Part|Physician Decision|1|||
37687607|NCT02404441|69163555|FG002|Phase 1 Part|Physician Decision|0|||
37687608|NCT02404441|69163556|FG003|Phase 1 Part|Physician Decision|0|||
37687609|NCT02404441|69163557|FG004|Phase 1 Part|Physician Decision|0|||
37687610|NCT02404441|69163558|FG005|Phase 1 Part|Physician Decision|0|||
37687611|NCT02404441|69163559|FG006|Phase 1 Part|Physician Decision|0|||
37687612|NCT02404441|69163560|FG007|Phase 1 Part|Physician Decision|0|||
37687613|NCT02404441|69163561|FG008|Phase 1 Part|Physician Decision|0|||
37687614|NCT02404441|69163562|FG009|Phase 1 Part|Physician Decision|0|||
37687615|NCT02404441|69163553|FG000|Phase 1 Part|Progressive Disease|14|||
37687616|NCT02404441|69163554|FG001|Phase 1 Part|Progressive Disease|11|||
37687617|NCT02404441|69163555|FG002|Phase 1 Part|Progressive Disease|7|||
37687618|NCT02404441|69163556|FG003|Phase 1 Part|Progressive Disease|6|||
37687619|NCT02404441|69163557|FG004|Phase 1 Part|Progressive Disease|9|||
37687620|NCT02404441|69163558|FG005|Phase 1 Part|Progressive Disease|0|||
37687621|NCT02404441|69163559|FG006|Phase 1 Part|Progressive Disease|0|||
37687622|NCT02404441|69163560|FG007|Phase 1 Part|Progressive Disease|0|||
37687623|NCT02404441|69163561|FG008|Phase 1 Part|Progressive Disease|0|||
37687624|NCT02404441|69163562|FG009|Phase 1 Part|Progressive Disease|0|||
37687625|NCT02404441|69163553|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
37687626|NCT02404441|69163554|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
37687627|NCT02404441|69163555|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
37687628|NCT02404441|69163556|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
37687629|NCT02404441|69163557|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
37687630|NCT02404441|69163558|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
37687631|NCT02404441|69163559|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
37687632|NCT02404441|69163560|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
37687633|NCT02404441|69163561|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
37687634|NCT02404441|69163562|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
37687635|NCT02404441|69163553|FG000|Phase 1 Part|Death|1|||
37687636|NCT02404441|69163554|FG001|Phase 1 Part|Death|1|||
37687637|NCT02404441|69163555|FG002|Phase 1 Part|Death|1|||
37687638|NCT02404441|69163556|FG003|Phase 1 Part|Death|0|||
37687639|NCT02404441|69163557|FG004|Phase 1 Part|Death|1|||
37687640|NCT02404441|69163558|FG005|Phase 1 Part|Death|0|||
37687641|NCT02404441|69163559|FG006|Phase 1 Part|Death|0|||
37687642|NCT02404441|69163560|FG007|Phase 1 Part|Death|0|||
37687643|NCT02404441|69163561|FG008|Phase 1 Part|Death|0|||
37687644|NCT02404441|69163562|FG009|Phase 1 Part|Death|0|||
37687645|NCT02404441|69163553|FG000|Phase 2 Part|Adverse Event|0|||
37687646|NCT02404441|69163554|FG001|Phase 2 Part|Adverse Event|0|||
37687647|NCT02404441|69163555|FG002|Phase 2 Part|Adverse Event|0|||
37687648|NCT02404441|69163556|FG003|Phase 2 Part|Adverse Event|0|||
37687649|NCT02404441|69163557|FG004|Phase 2 Part|Adverse Event|0|||
37687650|NCT02404441|69163558|FG005|Phase 2 Part|Adverse Event|2|||
37687651|NCT02404441|69163559|FG006|Phase 2 Part|Adverse Event|3|||
37687652|NCT02404441|69163560|FG007|Phase 2 Part|Adverse Event|3|||
37863409|NCT00996892|69547127|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
38086377|NCT02453282|69785903|FG002|Overall Study|Other|1|||
38086378|NCT02408120|69785915|FG000|Overall Study|Withdrawal by Subject|0|||
38086379|NCT02408120|69785916|FG001|Overall Study|Withdrawal by Subject|1|||
38086380|NCT02408120|69785915|FG000|Overall Study|Treatment Refusal|1|||
38086381|NCT02408120|69785916|FG001|Overall Study|Treatment Refusal|0|||
38086382|NCT02408120|69785915|FG000|Overall Study|Received Steroids|1|||
38086383|NCT02408120|69785916|FG001|Overall Study|Received Steroids|1|||
38086384|NCT02408120|69785915|FG000|Overall Study|Discharged same day|1|||
38086385|NCT02408120|69785916|FG001|Overall Study|Discharged same day|1|||
38086386|NCT02408120|69785915|FG000|Overall Study|Did not receive insulin|1|||
38086387|NCT02408120|69785916|FG001|Overall Study|Did not receive insulin|2|||
38086388|NCT02391545|69785924|FG000|Overall Study|Death|0|||
38086389|NCT02391545|69785925|FG001|Overall Study|Death|2|||
38086390|NCT02391545|69785924|FG000|Overall Study|Lost to Follow-up|0|||
38086391|NCT02391545|69785925|FG001|Overall Study|Lost to Follow-up|1|||
38086392|NCT02391545|69785924|FG000|Overall Study|Termination of study by sponsor|20|||
38086393|NCT02391545|69785925|FG001|Overall Study|Termination of study by sponsor|20|||
38086394|NCT02391545|69785924|FG000|Overall Study|Withdrawal by Subject|0|||
38086395|NCT02391545|69785925|FG001|Overall Study|Withdrawal by Subject|1|||
38086396|NCT02391545|69785924|FG000|Overall Study|Other Reasons|6|||
38086397|NCT02391545|69785925|FG001|Overall Study|Other Reasons|4|||
38086398|NCT01920932|69785932|FG000|Overall Study|Death|1|||
38086399|NCT01920932|69785932|FG000|Overall Study|Withdrawal of consent|1|||
38086400|NCT01774253|69785953|FG000|Overall Study|Lack of Efficacy|4|||
38086401|NCT01774253|69785953|FG000|Overall Study|Physician Decision|2|||
38086402|NCT01774253|69785953|FG000|Overall Study|Withdrawal by Subject|2|||
38086403|NCT01774253|69785953|FG000|Overall Study|Death|1|||
38086404|NCT01505608|69786013|FG000|Phase I|Lack of Efficacy|0|||
38086405|NCT01505608|69786014|FG001|Phase I|Lack of Efficacy|4|||
38086406|NCT01505608|69786013|FG000|Phase I|Adverse Event|0|||
38086407|NCT01505608|69786014|FG001|Phase I|Adverse Event|1|||
38086408|NCT01505608|69786013|FG000|Phase I|Withdrawal by Subject|0|||
38086409|NCT01505608|69786014|FG001|Phase I|Withdrawal by Subject|1|||
38086410|NCT01505608|69786013|FG000|Phase II|Lack of Efficacy|2|||
38086411|NCT01505608|69786014|FG001|Phase II|Lack of Efficacy|1|||
38086412|NCT01505608|69786013|FG000|Phase II|Protocol Violation|0|||
38086413|NCT01505608|69786014|FG001|Phase II|Protocol Violation|1|||
38086414|NCT01483820|69786048|FG000|Overall Study|Lack of Efficacy|6|||
38086415|NCT01483820|69786048|FG000|Overall Study|Adverse Event|1|||
37687653|NCT02404441|69163561|FG008|Phase 2 Part|Adverse Event|6|||
37687654|NCT02404441|69163562|FG009|Phase 2 Part|Adverse Event|1|||
37687655|NCT02404441|69163553|FG000|Phase 2 Part|Physician Decision|0|||
37687656|NCT02404441|69163554|FG001|Phase 2 Part|Physician Decision|0|||
37687657|NCT02404441|69163555|FG002|Phase 2 Part|Physician Decision|0|||
37863410|NCT00996892|69547128|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
37863411|NCT00996892|69547129|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
38086416|NCT01483820|69786048|FG000|Overall Study|Death|1|||
38086417|NCT01364597|69786056|FG000|Overall Study|Adverse Event|4|||
38086418|NCT01364597|69786057|FG001|Overall Study|Adverse Event|5|||
38086419|NCT01364597|69786058|FG002|Overall Study|Adverse Event|16|||
38086420|NCT01364597|69786059|FG003|Overall Study|Adverse Event|7|||
38086421|NCT01364597|69786056|FG000|Overall Study|Lack of Efficacy|4|||
38086422|NCT01364597|69786057|FG001|Overall Study|Lack of Efficacy|4|||
37687658|NCT02404441|69163556|FG003|Phase 2 Part|Physician Decision|0|||
38086423|NCT01364597|69786058|FG002|Overall Study|Lack of Efficacy|23|||
38086424|NCT01364597|69786059|FG003|Overall Study|Lack of Efficacy|8|||
38086425|NCT01364597|69786056|FG000|Overall Study|Protocol Violation|0|||
38086426|NCT01364597|69786057|FG001|Overall Study|Protocol Violation|0|||
38086427|NCT01364597|69786058|FG002|Overall Study|Protocol Violation|2|||
38086428|NCT01364597|69786059|FG003|Overall Study|Protocol Violation|0|||
38086429|NCT01364597|69786056|FG000|Overall Study|Lost to Follow-up|0|||
38086430|NCT01364597|69786057|FG001|Overall Study|Lost to Follow-up|0|||
38086431|NCT01364597|69786058|FG002|Overall Study|Lost to Follow-up|5|||
38086432|NCT01364597|69786059|FG003|Overall Study|Lost to Follow-up|3|||
38086433|NCT01364597|69786056|FG000|Overall Study|Withdrawal by Subject|4|||
38086434|NCT01364597|69786057|FG001|Overall Study|Withdrawal by Subject|1|||
38086435|NCT01364597|69786058|FG002|Overall Study|Withdrawal by Subject|18|||
38086436|NCT01364597|69786059|FG003|Overall Study|Withdrawal by Subject|6|||
38086437|NCT01364597|69786056|FG000|Overall Study|Non compliance|1|||
38086438|NCT01364597|69786057|FG001|Overall Study|Non compliance|0|||
38086439|NCT01364597|69786058|FG002|Overall Study|Non compliance|1|||
38086440|NCT01364597|69786059|FG003|Overall Study|Non compliance|0|||
38086441|NCT01364597|69786056|FG000|Overall Study|Lack of compliance|1|||
38086442|NCT01364597|69786057|FG001|Overall Study|Lack of compliance|0|||
38086443|NCT01364597|69786058|FG002|Overall Study|Lack of compliance|0|||
38086444|NCT01364597|69786059|FG003|Overall Study|Lack of compliance|0|||
38086445|NCT01364597|69786056|FG000|Overall Study|End of treatment epilepsy|1|||
38086446|NCT01364597|69786057|FG001|Overall Study|End of treatment epilepsy|0|||
38086447|NCT01364597|69786058|FG002|Overall Study|End of treatment epilepsy|0|||
38086448|NCT01364597|69786059|FG003|Overall Study|End of treatment epilepsy|0|||
37687659|NCT02404441|69163557|FG004|Phase 2 Part|Physician Decision|0|||
38086449|NCT01364597|69786056|FG000|Overall Study|No Seizures|1|||
38086450|NCT01364597|69786057|FG001|Overall Study|No Seizures|0|||
38086451|NCT01364597|69786058|FG002|Overall Study|No Seizures|0|||
38086452|NCT01364597|69786059|FG003|Overall Study|No Seizures|0|||
38086453|NCT01364597|69786056|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
38086454|NCT01364597|69786057|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
38086455|NCT01364597|69786058|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
38086456|NCT01364597|69786059|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
38086457|NCT01364597|69786056|FG000|Overall Study|Cure|1|||
38086458|NCT01364597|69786057|FG001|Overall Study|Cure|0|||
38086459|NCT01364597|69786058|FG002|Overall Study|Cure|0|||
38086460|NCT01364597|69786059|FG003|Overall Study|Cure|0|||
38086461|NCT01364597|69786056|FG000|Overall Study|Patient was moving|0|||
38086462|NCT01364597|69786057|FG001|Overall Study|Patient was moving|1|||
38086463|NCT01364597|69786058|FG002|Overall Study|Patient was moving|0|||
38086464|NCT01364597|69786059|FG003|Overall Study|Patient was moving|0|||
38086465|NCT01364597|69786056|FG000|Overall Study|Seizures resolved|0|||
38086466|NCT01364597|69786057|FG001|Overall Study|Seizures resolved|0|||
38086467|NCT01364597|69786058|FG002|Overall Study|Seizures resolved|1|||
38086468|NCT01364597|69786059|FG003|Overall Study|Seizures resolved|0|||
38086469|NCT01364597|69786056|FG000|Overall Study|Patient became seizure-free after surgery|0|||
38086470|NCT01364597|69786057|FG001|Overall Study|Patient became seizure-free after surgery|0|||
38086471|NCT01364597|69786058|FG002|Overall Study|Patient became seizure-free after surgery|1|||
38086472|NCT01364597|69786059|FG003|Overall Study|Patient became seizure-free after surgery|0|||
38086473|NCT01364597|69786056|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
38086474|NCT01364597|69786057|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
38086475|NCT01364597|69786058|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
38086476|NCT01364597|69786059|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
38086477|NCT01364597|69786056|FG000|Overall Study|Patient cured from Epilepsy|0|||
38086478|NCT01364597|69786057|FG001|Overall Study|Patient cured from Epilepsy|0|||
38086479|NCT01364597|69786058|FG002|Overall Study|Patient cured from Epilepsy|1|||
38086480|NCT01364597|69786059|FG003|Overall Study|Patient cured from Epilepsy|0|||
38086481|NCT01364597|69786056|FG000|Overall Study|Investigator decision|0|||
38086482|NCT01364597|69786057|FG001|Overall Study|Investigator decision|0|||
37687660|NCT02404441|69163558|FG005|Phase 2 Part|Physician Decision|7|||
37687661|NCT02404441|69163559|FG006|Phase 2 Part|Physician Decision|9|||
37687662|NCT02404441|69163560|FG007|Phase 2 Part|Physician Decision|2|||
37687663|NCT02404441|69163561|FG008|Phase 2 Part|Physician Decision|1|||
37687664|NCT02404441|69163562|FG009|Phase 2 Part|Physician Decision|3|||
37687665|NCT02404441|69163553|FG000|Phase 2 Part|Progressive disease|0|||
37687666|NCT02404441|69163554|FG001|Phase 2 Part|Progressive disease|0|||
38086483|NCT01364597|69786058|FG002|Overall Study|Investigator decision|1|||
38086484|NCT01364597|69786059|FG003|Overall Study|Investigator decision|0|||
38086485|NCT01364597|69786056|FG000|Overall Study|Sponsor recommended discontinuation|0|||
38086486|NCT01364597|69786057|FG001|Overall Study|Sponsor recommended discontinuation|0|||
38086487|NCT01364597|69786058|FG002|Overall Study|Sponsor recommended discontinuation|0|||
38086488|NCT01364597|69786059|FG003|Overall Study|Sponsor recommended discontinuation|1|||
38086489|NCT01364597|69786056|FG000|Overall Study|Parents went abroad with the patient|0|||
38086490|NCT01364597|69786057|FG001|Overall Study|Parents went abroad with the patient|0|||
38086491|NCT01364597|69786058|FG002|Overall Study|Parents went abroad with the patient|1|||
37687667|NCT02404441|69163555|FG002|Phase 2 Part|Progressive disease|0|||
37687668|NCT02404441|69163556|FG003|Phase 2 Part|Progressive disease|0|||
37687669|NCT02404441|69163557|FG004|Phase 2 Part|Progressive disease|0|||
37687670|NCT02404441|69163558|FG005|Phase 2 Part|Progressive disease|43|||
37687671|NCT02404441|69163559|FG006|Phase 2 Part|Progressive disease|32|||
37687672|NCT02404441|69163560|FG007|Phase 2 Part|Progressive disease|31|||
37687673|NCT02404441|69163561|FG008|Phase 2 Part|Progressive disease|39|||
37687674|NCT02404441|69163562|FG009|Phase 2 Part|Progressive disease|27|||
37687675|NCT02404441|69163553|FG000|Phase 2 Part|Subject/guardian decision|0|||
37687676|NCT02404441|69163554|FG001|Phase 2 Part|Subject/guardian decision|0|||
37687677|NCT02404441|69163555|FG002|Phase 2 Part|Subject/guardian decision|0|||
37687678|NCT02404441|69163556|FG003|Phase 2 Part|Subject/guardian decision|0|||
37687679|NCT02404441|69163557|FG004|Phase 2 Part|Subject/guardian decision|0|||
37687680|NCT02404441|69163558|FG005|Phase 2 Part|Subject/guardian decision|3|||
37687681|NCT02404441|69163559|FG006|Phase 2 Part|Subject/guardian decision|9|||
38086492|NCT01364597|69786059|FG003|Overall Study|Parents went abroad with the patient|0|||
38086493|NCT01364597|69786056|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
38086494|NCT01364597|69786057|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
38086495|NCT01364597|69786058|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
38086496|NCT01364597|69786059|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
38086497|NCT01364597|69786056|FG000|Overall Study|BRV administration dropout|0|||
38086498|NCT01364597|69786057|FG001|Overall Study|BRV administration dropout|0|||
38086499|NCT01364597|69786058|FG002|Overall Study|BRV administration dropout|1|||
38086500|NCT01364597|69786059|FG003|Overall Study|BRV administration dropout|0|||
38086501|NCT01364597|69786056|FG000|Overall Study|Dropout|0|||
38086502|NCT01364597|69786057|FG001|Overall Study|Dropout|0|||
38086503|NCT01364597|69786058|FG002|Overall Study|Dropout|3|||
38086504|NCT01364597|69786059|FG003|Overall Study|Dropout|1|||
38086505|NCT01364597|69786056|FG000|Overall Study|Unreliable subject|0|||
38086506|NCT01364597|69786057|FG001|Overall Study|Unreliable subject|0|||
38086507|NCT01364597|69786058|FG002|Overall Study|Unreliable subject|0|||
38086508|NCT01364597|69786059|FG003|Overall Study|Unreliable subject|1|||
38086509|NCT01364597|69786056|FG000|Overall Study|Other|0|||
38086510|NCT01364597|69786057|FG001|Overall Study|Other|0|||
38086511|NCT01364597|69786058|FG002|Overall Study|Other|0|||
38086512|NCT01364597|69786059|FG003|Overall Study|Other|1|||
38086513|NCT01106898|69786083|FG000|Overall Study|Adverse Event|6|||
38086514|NCT01059071|69786087|FG000|Overall Study|Lack of Efficacy|1|||
38086515|NCT01059071|69786088|FG001|Overall Study|Lack of Efficacy|4|||
38086516|NCT01059071|69786089|FG002|Overall Study|Lack of Efficacy|2|||
38086517|NCT01059071|69786090|FG003|Overall Study|Lack of Efficacy|3|||
38086518|NCT01059071|69786087|FG000|Overall Study|Withdrawal by Subject|1|||
38086519|NCT01059071|69786088|FG001|Overall Study|Withdrawal by Subject|0|||
38086520|NCT01059071|69786089|FG002|Overall Study|Withdrawal by Subject|0|||
38086521|NCT01059071|69786090|FG003|Overall Study|Withdrawal by Subject|2|||
38086522|NCT01059071|69786087|FG000|Overall Study|Physician Decision|0|||
38086523|NCT01059071|69786088|FG001|Overall Study|Physician Decision|0|||
38086524|NCT01059071|69786089|FG002|Overall Study|Physician Decision|0|||
38086525|NCT01059071|69786090|FG003|Overall Study|Physician Decision|1|||
38086526|NCT00923702|69786103|FG000|Overall Study|Ongoing enrollment|0|||
38086527|NCT00923702|69786104|FG001|Overall Study|Ongoing enrollment|0|||
38086528|NCT00923702|69786105|FG002|Overall Study|Ongoing enrollment|0|||
38086529|NCT00923702|69786106|FG003|Overall Study|Ongoing enrollment|0|||
38086530|NCT00923702|69786107|FG004|Overall Study|Ongoing enrollment|354|||
38086531|NCT00867568|69786119|FG000|Overall Study|Lack of Efficacy|10|||
38086532|NCT00867568|69786119|FG000|Overall Study|Adverse Event|4|||
38086533|NCT00867568|69786119|FG000|Overall Study|Withdrawal by Subject|1|||
38086534|NCT00737698|69786126|FG000|Overall Study|Withdrawal by Subject|6|||
38086535|NCT00737698|69786127|FG001|Overall Study|Withdrawal by Subject|5|||
38086536|NCT00737698|69786128|FG002|Overall Study|Withdrawal by Subject|3|||
38086537|NCT00737698|69786126|FG000|Overall Study|Death|0|||
38086538|NCT00737698|69786127|FG001|Overall Study|Death|0|||
38086539|NCT00737698|69786128|FG002|Overall Study|Death|1|||
38086540|NCT01668004|69786163|FG000|Overall Study|Adverse Event|7|||
38086541|NCT01668004|69786163|FG000|Overall Study|Withdrawal by Subject|2|||
38086542|NCT01668004|69786163|FG000|Overall Study|Lost to Follow-up|5|||
38086543|NCT01668004|69786163|FG000|Overall Study|Lack of Efficacy|9|||
37687682|NCT02404441|69163560|FG007|Phase 2 Part|Subject/guardian decision|0|||
37687683|NCT02404441|69163561|FG008|Phase 2 Part|Subject/guardian decision|3|||
37687684|NCT02404441|69163562|FG009|Phase 2 Part|Subject/guardian decision|2|||
38086544|NCT01668004|69786163|FG000|Overall Study|Non-compliance with treatment|2|||
38086545|NCT01667926|69786171|FG000|Overall Study|Withdrawal by Subject|1|||
38086546|NCT01667926|69786172|FG001|Overall Study|Withdrawal by Subject|2|||
38086547|NCT01667926|69786173|FG002|Overall Study|Withdrawal by Subject|2|||
38086548|NCT01667926|69786171|FG000|Overall Study|Physician Decision|0|||
37687685|NCT02404441|69163553|FG000|Phase 2 Part|Death|0|||
37687686|NCT02404441|69163554|FG001|Phase 2 Part|Death|0|||
38086549|NCT01667926|69786172|FG001|Overall Study|Physician Decision|0|||
37687687|NCT02404441|69163555|FG002|Phase 2 Part|Death|0|||
38086550|NCT01667926|69786173|FG002|Overall Study|Physician Decision|1|||
38086551|NCT01667926|69786171|FG000|Overall Study|Time committment|0|||
38086552|NCT01667926|69786172|FG001|Overall Study|Time committment|0|||
38086553|NCT01667926|69786173|FG002|Overall Study|Time committment|2|||
38086554|NCT01667926|69786171|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
38086555|NCT01667926|69786172|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
38086556|NCT01667926|69786173|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
38086557|NCT01667926|69786171|FG000|Overall Study|Lost to Follow-up|1|||
38086558|NCT01667926|69786172|FG001|Overall Study|Lost to Follow-up|2|||
38086559|NCT01667926|69786173|FG002|Overall Study|Lost to Follow-up|1|||
38086560|NCT01667926|69786171|FG000|Overall Study|Side effects|3|||
38086561|NCT01667926|69786172|FG001|Overall Study|Side effects|0|||
38086562|NCT01667926|69786173|FG002|Overall Study|Side effects|0|||
38086563|NCT02604160|69786181|FG000|Overall Study|Protocol Violation|0|||
38086564|NCT02604160|69786182|FG001|Overall Study|Protocol Violation|1|||
38086565|NCT02604160|69786181|FG000|Overall Study|Physician Decision|0|||
38086566|NCT02604160|69786182|FG001|Overall Study|Physician Decision|1|||
38086567|NCT01359904|69786192|FG000|Overall Study|Withdrawal by Subject|1|||
38086568|NCT01359904|69786193|FG001|Overall Study|Withdrawal by Subject|0|||
38086569|NCT05044234|69786270|FG000|Overall Study|Lost to Follow-up|2|||
38086570|NCT05044234|69786271|FG001|Overall Study|Lost to Follow-up|1|||
38086571|NCT05044234|69786272|FG002|Overall Study|Lost to Follow-up|1|||
38086572|NCT05044234|69786273|FG003|Overall Study|Lost to Follow-up|2|||
38086573|NCT05044234|69786270|FG000|Overall Study|Withdrawal by Subject|6|||
38086574|NCT05044234|69786271|FG001|Overall Study|Withdrawal by Subject|4|||
38086575|NCT05044234|69786272|FG002|Overall Study|Withdrawal by Subject|5|||
38086576|NCT05044234|69786273|FG003|Overall Study|Withdrawal by Subject|8|||
38086577|NCT05044234|69786270|FG000|Overall Study|Study terminated by Sponsor|21|||
38086578|NCT05044234|69786271|FG001|Overall Study|Study terminated by Sponsor|21|||
38086579|NCT05044234|69786272|FG002|Overall Study|Study terminated by Sponsor|20|||
38086580|NCT05044234|69786273|FG003|Overall Study|Study terminated by Sponsor|14|||
38086581|NCT05044234|69786270|FG000|Overall Study|Other, not specified|0|||
38086582|NCT05044234|69786271|FG001|Overall Study|Other, not specified|0|||
38086583|NCT05044234|69786272|FG002|Overall Study|Other, not specified|1|||
38086584|NCT05044234|69786273|FG003|Overall Study|Other, not specified|2|||
38086585|NCT05044234|69786270|FG000|Overall Study|Delayed data entry|0|||
38086586|NCT05044234|69786271|FG001|Overall Study|Delayed data entry|0|||
38086587|NCT05044234|69786272|FG002|Overall Study|Delayed data entry|0|||
38086588|NCT05044234|69786273|FG003|Overall Study|Delayed data entry|1|||
38086589|NCT04725812|69786291|FG000|Overall Study|Withdrawal by Subject|1|||
38086590|NCT04147247|69786322|FG000|Overall Study|Progressive disease|3|||
38086591|NCT04147247|69786323|FG001|Overall Study|Progressive disease|3|||
38086592|NCT04147247|69786324|FG002|Overall Study|Progressive disease|4|||
38086593|NCT04147247|69786325|FG003|Overall Study|Progressive disease|4|||
38086594|NCT04147247|69786326|FG004|Overall Study|Progressive disease|3|||
38086595|NCT04147247|69786322|FG000|Overall Study|Physician Decision|0|||
38086596|NCT04147247|69786323|FG001|Overall Study|Physician Decision|1|||
38086597|NCT04147247|69786324|FG002|Overall Study|Physician Decision|0|||
38086598|NCT04147247|69786325|FG003|Overall Study|Physician Decision|0|||
38086599|NCT04147247|69786326|FG004|Overall Study|Physician Decision|0|||
38086600|NCT04147247|69786322|FG000|Overall Study|Clinical Disease Progression|0|||
38086601|NCT04147247|69786323|FG001|Overall Study|Clinical Disease Progression|0|||
38086602|NCT04147247|69786324|FG002|Overall Study|Clinical Disease Progression|0|||
38086603|NCT04147247|69786325|FG003|Overall Study|Clinical Disease Progression|0|||
38086604|NCT04147247|69786326|FG004|Overall Study|Clinical Disease Progression|1|||
38086605|NCT04147247|69786322|FG000|Overall Study|Adverse Event|0|||
38086606|NCT04147247|69786323|FG001|Overall Study|Adverse Event|0|||
38086607|NCT04147247|69786324|FG002|Overall Study|Adverse Event|1|||
38086608|NCT04147247|69786325|FG003|Overall Study|Adverse Event|0|||
38086609|NCT04147247|69786326|FG004|Overall Study|Adverse Event|1|||
38086610|NCT04080167|69786341|FG000|Overall Study|Lost to Follow-up-Patients|7|||
38086611|NCT04080167|69786342|FG001|Overall Study|Lost to Follow-up-Patients|14|||
38086612|NCT04080167|69786343|FG002|Overall Study|Lost to Follow-up-Patients|0|||
38086613|NCT04080167|69786341|FG000|Overall Study|Lost to Follow-up-Providers|2|||
38086614|NCT04080167|69786342|FG001|Overall Study|Lost to Follow-up-Providers|2|||
38086615|NCT04080167|69786343|FG002|Overall Study|Lost to Follow-up-Providers|0|||
38086616|NCT04080167|69786341|FG000|Overall Study|Withdrawal by Subject|1|||
38086617|NCT04080167|69786342|FG001|Overall Study|Withdrawal by Subject|2|||
38086618|NCT04080167|69786343|FG002|Overall Study|Withdrawal by Subject|0|||
38086619|NCT04080167|69786341|FG000|Overall Study|Withdrawal by Provider|0|||
37687688|NCT02404441|69163556|FG003|Phase 2 Part|Death|0|||
38086620|NCT04080167|69786342|FG001|Overall Study|Withdrawal by Provider|0|||
38086621|NCT04080167|69786343|FG002|Overall Study|Withdrawal by Provider|4|||
38086622|NCT04080167|69786341|FG000|Overall Study|Death-Patient|2|||
38086623|NCT04080167|69786342|FG001|Overall Study|Death-Patient|1|||
38086624|NCT04080167|69786343|FG002|Overall Study|Death-Patient|0|||
38086625|NCT04080167|69786341|FG000|Overall Study|Hydroxyurea New Starts|0|||
38086626|NCT04080167|69786342|FG001|Overall Study|Hydroxyurea New Starts|0|||
38086627|NCT04080167|69786343|FG002|Overall Study|Hydroxyurea New Starts|1|||
38086628|NCT04080167|69786341|FG000|Overall Study|Did not complete the baseline survey/activities|0|||
38086629|NCT04080167|69786342|FG001|Overall Study|Did not complete the baseline survey/activities|4|||
38086630|NCT04080167|69786343|FG002|Overall Study|Did not complete the baseline survey/activities|0|||
38086631|NCT04070378|69786350|FG000|Overall Study|Withdrawal by Subject|2|||
38086632|NCT04070378|69786350|FG000|Overall Study|Screen Failure|6|||
38086633|NCT04070378|69786350|FG000|Overall Study|Physician Decision|1|||
38086634|NCT04070378|69786350|FG000|Overall Study|Adverse Event|1|||
38086635|NCT04007367|69786354|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
38086636|NCT04007367|69786355|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
38086637|NCT04007367|69786356|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
38086638|NCT04007367|69786354|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
38086639|NCT04007367|69786355|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
38086640|NCT04007367|69786356|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
38086641|NCT04007367|69786354|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
38086642|NCT04007367|69786355|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
38086643|NCT04007367|69786356|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
38086644|NCT04007367|69786354|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
38086645|NCT04007367|69786355|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
37687689|NCT02404441|69163557|FG004|Phase 2 Part|Death|0|||
37687690|NCT02404441|69163558|FG005|Phase 2 Part|Death|4|||
37687691|NCT02404441|69163559|FG006|Phase 2 Part|Death|8|||
37687692|NCT02404441|69163560|FG007|Phase 2 Part|Death|4|||
37687693|NCT02404441|69163561|FG008|Phase 2 Part|Death|10|||
37687694|NCT02404441|69163562|FG009|Phase 2 Part|Death|9|||
37687695|NCT02101281|69163608|FG000|Overall Study|Adverse Event|0|||
37687696|NCT02101281|69163609|FG001|Overall Study|Adverse Event|1|||
37687697|NCT02224599|69163621|FG000|Overall Study|Physician Decision|1|||
37687698|NCT02224599|69163621|FG000|Overall Study|Progression of Disease|1|||
37687699|NCT02201901|69163628|FG000|Overall Study|Randomized but never treated|0|||
37687700|NCT02201901|69163629|FG001|Overall Study|Randomized but never treated|1|||
37687701|NCT02201901|69163630|FG002|Overall Study|Randomized but never treated|0|||
37687702|NCT02201901|69163628|FG000|Overall Study|Lack of Efficacy|7|||
38086646|NCT04007367|69786356|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
38086647|NCT04007367|69786354|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
38086648|NCT04007367|69786355|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
38086649|NCT04007367|69786356|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
38086650|NCT03900650|69786383|FG000|Overall Study|Withdrawal by Subject|1|||
38086651|NCT03900650|69786384|FG001|Overall Study|Withdrawal by Subject|1|||
38086652|NCT03900650|69786385|FG002|Overall Study|Withdrawal by Subject|0|||
38086653|NCT03900650|69786386|FG003|Overall Study|Withdrawal by Subject|0|||
38086654|NCT03900650|69786383|FG000|Overall Study|Withdrawn by staff|1|||
38086655|NCT03900650|69786384|FG001|Overall Study|Withdrawn by staff|0|||
38086656|NCT03900650|69786385|FG002|Overall Study|Withdrawn by staff|0|||
38086657|NCT03900650|69786386|FG003|Overall Study|Withdrawn by staff|0|||
38086658|NCT03890120|69786398|FG000|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|119|||
38086659|NCT03890120|69786399|FG001|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|57|||
38086660|NCT03890120|69786400|FG002|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
38086661|NCT03890120|69786401|FG003|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
38086662|NCT03890120|69786398|FG000|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|17|||
38086663|NCT03890120|69786399|FG001|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|7|||
38086664|NCT03890120|69786400|FG002|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
38086665|NCT03890120|69786401|FG003|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
38086666|NCT03890120|69786398|FG000|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|12|||
38086667|NCT03890120|69786399|FG001|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|4|||
38086668|NCT03890120|69786400|FG002|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
38086669|NCT03890120|69786401|FG003|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
38086670|NCT03890120|69786398|FG000|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|4|||
38086671|NCT03890120|69786399|FG001|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|1|||
38086672|NCT03890120|69786400|FG002|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
38086673|NCT03890120|69786401|FG003|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
37687703|NCT02201901|69163629|FG001|Overall Study|Lack of Efficacy|1|||
37687704|NCT02201901|69163630|FG002|Overall Study|Lack of Efficacy|6|||
38086674|NCT03890120|69786398|FG000|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|1|||
38086675|NCT03890120|69786399|FG001|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|2|||
38086676|NCT03890120|69786400|FG002|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
37687705|NCT02201901|69163628|FG000|Overall Study|Death|3|||
37687706|NCT02201901|69163629|FG001|Overall Study|Death|3|||
37687707|NCT02201901|69163630|FG002|Overall Study|Death|3|||
37687708|NCT02201901|69163628|FG000|Overall Study|Lost to Follow-up|2|||
37687709|NCT02201901|69163629|FG001|Overall Study|Lost to Follow-up|3|||
37687710|NCT02201901|69163630|FG002|Overall Study|Lost to Follow-up|2|||
37687711|NCT02201901|69163628|FG000|Overall Study|Withdrew Consent|2|||
37687712|NCT02201901|69163629|FG001|Overall Study|Withdrew Consent|0|||
37687713|NCT02201901|69163630|FG002|Overall Study|Withdrew Consent|2|||
37687714|NCT02201901|69163628|FG000|Overall Study|Adverse Event|1|||
37687715|NCT02201901|69163629|FG001|Overall Study|Adverse Event|1|||
37687716|NCT02201901|69163630|FG002|Overall Study|Adverse Event|0|||
37687717|NCT02201277|69163641|FG000|Overall Study|Death|3|||
37687718|NCT02201277|69163642|FG001|Overall Study|Death|4|||
37687719|NCT02201277|69163641|FG000|Overall Study|Lost to Follow-up|2|||
37687720|NCT02201277|69163642|FG001|Overall Study|Lost to Follow-up|1|||
37687721|NCT02201277|69163641|FG000|Overall Study|Failed retrieval|1|||
37687722|NCT02201277|69163642|FG001|Overall Study|Failed retrieval|0|||
37687723|NCT02201277|69163641|FG000|Overall Study|Physician Decision|1|||
37687724|NCT02201277|69163642|FG001|Overall Study|Physician Decision|0|||
37687725|NCT02224053|69163652|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
37687726|NCT02224053|69163652|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
37687727|NCT02224053|69163652|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
37687728|NCT02224053|69163652|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
37687729|NCT02224053|69163652|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
37687730|NCT02457793|69163664|FG000|Overall Study|Reason not specified|0|||
37687731|NCT02457793|69163665|FG001|Overall Study|Reason not specified|0|||
37687732|NCT02457793|69163666|FG002|Overall Study|Reason not specified|0|||
37687733|NCT02457793|69163667|FG003|Overall Study|Reason not specified|1|||
37687734|NCT02457793|69163668|FG004|Overall Study|Reason not specified|1|||
37687735|NCT02457793|69163669|FG005|Overall Study|Reason not specified|1|||
37687736|NCT02457793|69163664|FG000|Overall Study|Withdrawal by Subject|0|||
37687737|NCT02457793|69163665|FG001|Overall Study|Withdrawal by Subject|4|||
37687738|NCT02457793|69163666|FG002|Overall Study|Withdrawal by Subject|2|||
37687739|NCT02457793|69163667|FG003|Overall Study|Withdrawal by Subject|2|||
37687740|NCT02457793|69163668|FG004|Overall Study|Withdrawal by Subject|2|||
37687741|NCT02457793|69163669|FG005|Overall Study|Withdrawal by Subject|2|||
37687742|NCT02457793|69163664|FG000|Overall Study|Adverse Event|0|||
38086677|NCT03890120|69786401|FG003|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
38086678|NCT03890120|69786398|FG000|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|1|||
38086679|NCT03890120|69786399|FG001|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|2|||
38086680|NCT03890120|69786400|FG002|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
38086681|NCT03890120|69786401|FG003|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
38086682|NCT03890120|69786398|FG000|Blinded Treatment Phase (100.3 Weeks)|Death|1|||
38086683|NCT03890120|69786399|FG001|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
38086684|NCT03890120|69786400|FG002|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
38086685|NCT03890120|69786401|FG003|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
38086686|NCT03890120|69786398|FG000|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
38086687|NCT03890120|69786399|FG001|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|1|||
38086688|NCT03890120|69786400|FG002|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
38086689|NCT03890120|69786401|FG003|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
38086690|NCT03890120|69786398|FG000|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
38086691|NCT03890120|69786399|FG001|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|1|||
38086692|NCT03890120|69786400|FG002|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
38086693|NCT03890120|69786401|FG003|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
38086694|NCT03890120|69786398|FG000|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
38086695|NCT03890120|69786399|FG001|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
37687743|NCT02457793|69163665|FG001|Overall Study|Adverse Event|0|||
37687744|NCT02457793|69163666|FG002|Overall Study|Adverse Event|0|||
37687745|NCT02457793|69163667|FG003|Overall Study|Adverse Event|1|||
37687746|NCT02457793|69163668|FG004|Overall Study|Adverse Event|0|||
37687747|NCT02457793|69163669|FG005|Overall Study|Adverse Event|0|||
37687748|NCT02457793|69163664|FG000|Overall Study|Physician Decision|1|||
37687749|NCT02457793|69163665|FG001|Overall Study|Physician Decision|0|||
37687750|NCT02457793|69163666|FG002|Overall Study|Physician Decision|1|||
37687751|NCT02457793|69163667|FG003|Overall Study|Physician Decision|1|||
37687752|NCT02457793|69163668|FG004|Overall Study|Physician Decision|1|||
37687753|NCT02457793|69163669|FG005|Overall Study|Physician Decision|3|||
37687754|NCT01650259|69163686|FG000|Overall Study|Improvement|105|||
37687755|NCT01650259|69163687|FG001|Overall Study|Improvement|0|||
37687756|NCT01650259|69163686|FG000|Overall Study|Adverse Event|127|||
37687757|NCT01650259|69163687|FG001|Overall Study|Adverse Event|0|||
37687758|NCT01650259|69163686|FG000|Overall Study|Lack of Efficacy|143|||
37687759|NCT01650259|69163687|FG001|Overall Study|Lack of Efficacy|0|||
38086696|NCT03890120|69786400|FG002|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|76|||
37687760|NCT01650259|69163686|FG000|Overall Study|Lost to Follow-up|435|||
37687761|NCT01650259|69163687|FG001|Overall Study|Lost to Follow-up|0|||
37687762|NCT01650259|69163686|FG000|Overall Study|Patients had no visit after entry|70|||
38086697|NCT03890120|69786401|FG003|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|42|||
38086698|NCT03890120|69786398|FG000|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
38086699|NCT03890120|69786399|FG001|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
38086700|NCT03890120|69786400|FG002|Open-Label Extension Phase (45 Weeks)|Adverse Event|3|||
38086701|NCT03890120|69786401|FG003|Open-Label Extension Phase (45 Weeks)|Adverse Event|1|||
38086702|NCT03890120|69786398|FG000|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
38086703|NCT03890120|69786399|FG001|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
38086704|NCT03890120|69786400|FG002|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
38086705|NCT03890120|69786401|FG003|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|2|||
38086706|NCT03890120|69786398|FG000|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
38086707|NCT03890120|69786399|FG001|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
38086708|NCT03890120|69786400|FG002|Open-Label Extension Phase (45 Weeks)|Withdrew consent|1|||
38086709|NCT03890120|69786401|FG003|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
38086710|NCT03875235|69786413|FG000|Overall Study|Ongoing study treatment|63|||
38086711|NCT03875235|69786414|FG001|Overall Study|Ongoing study treatment|20|||
38086712|NCT03875235|69786413|FG000|Overall Study|Off treatment|77|||
37687763|NCT01650259|69163687|FG001|Overall Study|Patients had no visit after entry|0|||
37687764|NCT01650259|69163686|FG000|Overall Study|CRF not collected|98|||
37687765|NCT01650259|69163687|FG001|Overall Study|CRF not collected|82|||
37687766|NCT01650259|69163686|FG000|Overall Study|Not treated|1|||
37687767|NCT01650259|69163687|FG001|Overall Study|Not treated|7|||
37687768|NCT01650259|69163686|FG000|Overall Study|Other than listed|64|||
37687769|NCT01650259|69163687|FG001|Overall Study|Other than listed|146|||
37687770|NCT02434939|69163693|FG000|Overall Study|Lack of Efficacy|34|||
37687771|NCT02434939|69163694|FG001|Overall Study|Lack of Efficacy|48|||
37687772|NCT02434939|69163693|FG000|Overall Study|Withdrawal by Subject|3|||
37687773|NCT02434939|69163694|FG001|Overall Study|Withdrawal by Subject|0|||
37687774|NCT02434939|69163693|FG000|Overall Study|Adverse Event|0|||
37687775|NCT02434939|69163694|FG001|Overall Study|Adverse Event|1|||
37687776|NCT02434471|69163701|FG000|Overall Study|Physician Decision|9|||
37687777|NCT02457637|69163706|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
38086713|NCT03875235|69786414|FG001|Overall Study|Off treatment|91|||
38086714|NCT03875235|69786413|FG000|Overall Study|Withdrawal by Subject|3|||
38086715|NCT03875235|69786414|FG001|Overall Study|Withdrawal by Subject|10|||
38086716|NCT03875235|69786413|FG000|Overall Study|Death|198|||
38086717|NCT03875235|69786414|FG001|Overall Study|Death|223|||
38086718|NCT03783689|69786428|FG000|Overall Study|Adverse Event|2|||
38086719|NCT03783689|69786429|FG001|Overall Study|Adverse Event|0|||
38086720|NCT03783689|69786428|FG000|Overall Study|Lost to Follow-up|2|||
38086721|NCT03783689|69786429|FG001|Overall Study|Lost to Follow-up|1|||
38086722|NCT03783689|69786428|FG000|Overall Study|Physician Decision|2|||
38086723|NCT03783689|69786429|FG001|Overall Study|Physician Decision|1|||
38086724|NCT03783689|69786428|FG000|Overall Study|Withdrawal by Subject|3|||
38086725|NCT03783689|69786429|FG001|Overall Study|Withdrawal by Subject|3|||
38086726|NCT03771664|69786438|FG000|Overall Study|Adverse Event|1|||
38086727|NCT03771664|69786439|FG001|Overall Study|Adverse Event|0|||
38086728|NCT03771664|69786438|FG000|Overall Study|Lost to Follow-up|1|||
38086729|NCT03771664|69786439|FG001|Overall Study|Lost to Follow-up|0|||
38086730|NCT03771664|69786438|FG000|Overall Study|Withdrawal by Participant|1|||
38086731|NCT03771664|69786439|FG001|Overall Study|Withdrawal by Participant|4|||
38086732|NCT03771664|69786438|FG000|Overall Study|Randomized but not Treated|0|||
38086733|NCT03771664|69786439|FG001|Overall Study|Randomized but not Treated|1|||
38086734|NCT03743415|69786455|FG000|Overall Study|Death|5|||
38086735|NCT03743415|69786456|FG001|Overall Study|Death|3|||
38086736|NCT03743415|69786457|FG002|Overall Study|Death|1|||
37687778|NCT02457325|69163713|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
37687779|NCT02457325|69163714|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
37687780|NCT02434081|69163720|FG000|Overall Study|Death (never started treatment)|2|||
37863412|NCT00996892|69547130|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
38086737|NCT03743415|69786458|FG003|Overall Study|Death|4|||
38086738|NCT03743415|69786459|FG004|Overall Study|Death|0|||
38086739|NCT03743415|69786460|FG005|Overall Study|Death|0|||
38086740|NCT03743415|69786461|FG006|Overall Study|Death|0|||
38086741|NCT03743415|69786462|FG007|Overall Study|Death|0|||
38086742|NCT03743415|69786463|FG008|Overall Study|Death|1|||
38086743|NCT03743415|69786464|FG009|Overall Study|Death|0|||
38086744|NCT03743415|69786455|FG000|Overall Study|Withdrawal by Subject|1|||
38086745|NCT03743415|69786456|FG001|Overall Study|Withdrawal by Subject|0|||
38086746|NCT03743415|69786457|FG002|Overall Study|Withdrawal by Subject|4|||
38086747|NCT03743415|69786458|FG003|Overall Study|Withdrawal by Subject|5|||
38086748|NCT03743415|69786459|FG004|Overall Study|Withdrawal by Subject|5|||
38086749|NCT03743415|69786460|FG005|Overall Study|Withdrawal by Subject|2|||
38086750|NCT03743415|69786461|FG006|Overall Study|Withdrawal by Subject|2|||
38086751|NCT03743415|69786462|FG007|Overall Study|Withdrawal by Subject|5|||
38086752|NCT03743415|69786463|FG008|Overall Study|Withdrawal by Subject|9|||
37687781|NCT02434081|69163720|FG000|Overall Study|Death|2|||
37687782|NCT02434081|69163720|FG000|Overall Study|Progression|20|||
38086753|NCT03743415|69786464|FG009|Overall Study|Withdrawal by Subject|10|||
38086754|NCT03743415|69786455|FG000|Overall Study|Lost to Follow-up|2|||
38086755|NCT03743415|69786456|FG001|Overall Study|Lost to Follow-up|0|||
38086756|NCT03743415|69786457|FG002|Overall Study|Lost to Follow-up|2|||
38086757|NCT03743415|69786458|FG003|Overall Study|Lost to Follow-up|1|||
38086758|NCT03743415|69786459|FG004|Overall Study|Lost to Follow-up|1|||
38086759|NCT03743415|69786460|FG005|Overall Study|Lost to Follow-up|0|||
38086760|NCT03743415|69786461|FG006|Overall Study|Lost to Follow-up|1|||
38086761|NCT03743415|69786462|FG007|Overall Study|Lost to Follow-up|4|||
38086762|NCT03743415|69786463|FG008|Overall Study|Lost to Follow-up|13|||
38086763|NCT03743415|69786464|FG009|Overall Study|Lost to Follow-up|13|||
38086764|NCT03672175|69786483|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
37687783|NCT02434081|69163720|FG000|Overall Study|Adverse Event|20|||
37687784|NCT02434081|69163720|FG000|Overall Study|Physician Decision|2|||
37687785|NCT02434081|69163720|FG000|Overall Study|Withdrawal by Subject|1|||
37687786|NCT02434081|69163720|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
37687787|NCT02222493|69163726|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
37687788|NCT02222493|69163727|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
37687789|NCT02222493|69163726|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
37687790|NCT02222493|69163727|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
37687791|NCT02222493|69163726|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
37687792|NCT02222493|69163727|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
37687793|NCT02222493|69163726|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
37687794|NCT02222493|69163727|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
37687795|NCT02222493|69163726|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
37687796|NCT02222493|69163727|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
37687797|NCT02222493|69163726|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
37687798|NCT02222493|69163727|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
37687799|NCT02222493|69163726|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
37687800|NCT02222493|69163727|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
37687801|NCT02222493|69163726|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
37687802|NCT02222493|69163727|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
37687803|NCT02222493|69163726|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
37687804|NCT02222493|69163727|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
37687805|NCT02222493|69163726|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
37687806|NCT02222493|69163727|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
37687807|NCT02222493|69163726|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
37687808|NCT02222493|69163727|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
37687809|NCT02222493|69163726|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
37687810|NCT02222493|69163727|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
37687811|NCT02222493|69163726|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
37687812|NCT02222493|69163727|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
37687813|NCT02222493|69163726|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
37687814|NCT02222493|69163727|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
37687815|NCT02222493|69163726|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
37687816|NCT02222493|69163727|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
37687817|NCT02222493|69163726|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
37687818|NCT02222493|69163727|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
37687819|NCT02222493|69163726|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
37687820|NCT02222493|69163727|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
37687821|NCT02222493|69163726|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
37687822|NCT02222493|69163727|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
37687823|NCT02222493|69163726|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
37687824|NCT02222493|69163727|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
37687825|NCT02222493|69163726|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
37687826|NCT02222493|69163727|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
37687827|NCT02222493|69163726|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
37687828|NCT02222493|69163727|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
37687829|NCT02222493|69163726|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
38086765|NCT03672175|69786484|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
38086766|NCT03672175|69786485|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
38086767|NCT03672175|69786483|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
38086768|NCT03672175|69786484|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
38086769|NCT03672175|69786485|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
38086770|NCT03672175|69786483|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
38086771|NCT03672175|69786484|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
37687830|NCT02222493|69163727|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
37687831|NCT02433379|69163746|FG000|Overall Study|Screen Failures|55|||
37687832|NCT02433379|69163746|FG000|Overall Study|Death|57|||
37687833|NCT02433379|69163746|FG000|Overall Study|Total Withdrawals|209|||
37687834|NCT02199795|69163754|FG000|Overall Study|no longer met inclusion criteria|1|||
37687835|NCT02199795|69163755|FG001|Overall Study|no longer met inclusion criteria|0|||
37687836|NCT02199795|69163754|FG000|Overall Study|withdrew due to shoulder pain|1|||
37687837|NCT02199795|69163755|FG001|Overall Study|withdrew due to shoulder pain|0|||
37687838|NCT02403817|69163763|FG000|Overall Study|Withdrawal by Subject|5|||
37687839|NCT02403817|69163764|FG001|Overall Study|Withdrawal by Subject|0|||
37687840|NCT02403271|69163770|FG000|Period 1|Other varied reasons|1|||
37687841|NCT02403271|69163771|FG001|Period 1|Other varied reasons|0|||
37687842|NCT02403271|69163770|FG000|Period 2|Withdrawal by Subject|0|||
37687843|NCT02403271|69163771|FG001|Period 2|Withdrawal by Subject|14|||
37687844|NCT02403271|69163770|FG000|Period 2|Death|0|||
37687845|NCT02403271|69163771|FG001|Period 2|Death|84|||
37687846|NCT02403271|69163770|FG000|Period 2|Lost to Follow-up|0|||
37687847|NCT02403271|69163771|FG001|Period 2|Lost to Follow-up|2|||
37687848|NCT02403271|69163770|FG000|Period 2|Study Terminated by Sponsor|0|||
37687849|NCT02403271|69163771|FG001|Period 2|Study Terminated by Sponsor|14|||
37687850|NCT02403271|69163770|FG000|Period 2|Other varied reasons|0|||
37687851|NCT02403271|69163771|FG001|Period 2|Other varied reasons|10|||
37687852|NCT02219685|69163779|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
37687853|NCT02219685|69163780|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
37687854|NCT02219685|69163779|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
37687855|NCT02219685|69163780|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
37687856|NCT02457247|69163792|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
37687857|NCT02457247|69163793|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
37687858|NCT02457247|69163794|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
37687859|NCT02457247|69163795|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
37687860|NCT02457247|69163792|FG000|Period 1|Significant Protocol Deviation|1|||
38086772|NCT03672175|69786485|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
38086773|NCT03672175|69786483|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
38086774|NCT03672175|69786484|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
38086775|NCT03672175|69786485|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
38086776|NCT03672175|69786483|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
38086777|NCT03672175|69786484|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
37687861|NCT02457247|69163793|FG001|Period 1|Significant Protocol Deviation|1|||
37687862|NCT02457247|69163794|FG002|Period 1|Significant Protocol Deviation|0|||
37687863|NCT02457247|69163795|FG003|Period 1|Significant Protocol Deviation|0|||
37687864|NCT02457247|69163792|FG000|Period 1|Voluntary Withdrawal|1|||
37687865|NCT02457247|69163793|FG001|Period 1|Voluntary Withdrawal|0|||
37687866|NCT02457247|69163794|FG002|Period 1|Voluntary Withdrawal|0|||
37687867|NCT02457247|69163795|FG003|Period 1|Voluntary Withdrawal|0|||
37687868|NCT02457247|69163792|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
37687869|NCT02457247|69163793|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
37687870|NCT02457247|69163794|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
37687871|NCT02457247|69163795|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
37687872|NCT02457247|69163792|FG000|Period 2|Significant Protocol Deviation|1|||
37687873|NCT02457247|69163793|FG001|Period 2|Significant Protocol Deviation|0|||
37687874|NCT02457247|69163794|FG002|Period 2|Significant Protocol Deviation|0|||
37687875|NCT02457247|69163795|FG003|Period 2|Significant Protocol Deviation|0|||
37687876|NCT02457247|69163792|FG000|Period 2|Lost to Follow-up|0|||
37687877|NCT02457247|69163793|FG001|Period 2|Lost to Follow-up|1|||
37687878|NCT02457247|69163794|FG002|Period 2|Lost to Follow-up|0|||
37687879|NCT02457247|69163795|FG003|Period 2|Lost to Follow-up|0|||
37687880|NCT02457247|69163792|FG000|Period 2|Voluntary Withdrawal|1|||
37687881|NCT02457247|69163793|FG001|Period 2|Voluntary Withdrawal|1|||
37687882|NCT02457247|69163794|FG002|Period 2|Voluntary Withdrawal|0|||
37687883|NCT02457247|69163795|FG003|Period 2|Voluntary Withdrawal|0|||
37687884|NCT02401867|69163811|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
37687885|NCT02401867|69163811|FG000|Analysis|Cervical assay could not be conducted|9|||
37687886|NCT02198235|69163819|FG000|Overall Study|Lost to Follow-up|3|||
37687887|NCT02198235|69163820|FG001|Overall Study|Lost to Follow-up|2|||
37687888|NCT02198235|69163821|FG002|Overall Study|Lost to Follow-up|2|||
37687889|NCT02253147|69163829|FG000|Overall Study|Protocol Violation|30|||
37687890|NCT02253147|69163829|FG000|Overall Study|Did not consent to study extension|9|||
37687891|NCT02253147|69163829|FG000|Overall Study|Conditional re-treatment at W52|5|||
37687892|NCT02253147|69163829|FG000|Overall Study|Lost to Follow-up|2|||
37687893|NCT02253147|69163829|FG000|Overall Study|Withdrawal by Subject|1|||
37687894|NCT02217501|69163837|FG000|Overall Study|Death|3|||
37687895|NCT02217501|69163838|FG001|Overall Study|Death|4|||
37687896|NCT01649869|69163846|FG000|Overall Study|Family member illness|1|||
37687897|NCT01649869|69163847|FG001|Overall Study|Family member illness|0|||
37687898|NCT01649869|69163846|FG000|Overall Study|Required treatment outside protocol|1|||
37687899|NCT01649869|69163847|FG001|Overall Study|Required treatment outside protocol|0|||
37687900|NCT01649869|69163846|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
37687901|NCT01649869|69163847|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
37687902|NCT02197377|69163857|FG000|Overall Study|Insertion Failure|0|||
37687903|NCT02197377|69163858|FG001|Overall Study|Insertion Failure|3|||
37687904|NCT02400307|69163866|FG000|Overall Study|Enrolled and Never Dosed|1|||
37687905|NCT02400307|69163867|FG001|Overall Study|Enrolled and Never Dosed|0|||
37687906|NCT02196675|69163876|FG000|Overall Study|Withdrawal by Subject|1|||
37687907|NCT02196675|69163877|FG001|Overall Study|Withdrawal by Subject|0|||
37687908|NCT02196675|69163878|FG002|Overall Study|Withdrawal by Subject|0|||
37687909|NCT02196675|69163876|FG000|Overall Study|Intra-operative surgical exclusion|1|||
37687910|NCT02196675|69163877|FG001|Overall Study|Intra-operative surgical exclusion|1|||
37687911|NCT02196675|69163878|FG002|Overall Study|Intra-operative surgical exclusion|0|||
37687912|NCT02196675|69163876|FG000|Overall Study|Protocol Violation|0|||
37687913|NCT02196675|69163877|FG001|Overall Study|Protocol Violation|1|||
37687914|NCT02196675|69163878|FG002|Overall Study|Protocol Violation|0|||
37687915|NCT02196675|69163876|FG000|Overall Study|Death|0|||
37687916|NCT02196675|69163877|FG001|Overall Study|Death|0|||
37687917|NCT02196675|69163878|FG002|Overall Study|Death|1|||
37687918|NCT02399449|69163888|FG000|Overall Study|Withdrawal by Subject|3|||
37687919|NCT02399449|69163889|FG001|Overall Study|Withdrawal by Subject|9|||
37687920|NCT02399449|69163888|FG000|Overall Study|Physician Decision|0|||
37687921|NCT02399449|69163889|FG001|Overall Study|Physician Decision|1|||
37687922|NCT02217345|69163897|FG000|Overall Study|Lost to Follow-up|2|||
37687923|NCT02217345|69163898|FG001|Overall Study|Lost to Follow-up|1|||
37687924|NCT02217345|69163897|FG000|Overall Study|Withdrawal by Subject|3|||
37687925|NCT02217345|69163898|FG001|Overall Study|Withdrawal by Subject|2|||
37687926|NCT02217345|69163897|FG000|Overall Study|Adverse Event|2|||
37687927|NCT02217345|69163898|FG001|Overall Study|Adverse Event|1|||
37687928|NCT02217345|69163897|FG000|Overall Study|Physician Decision|0|||
37687929|NCT02217345|69163898|FG001|Overall Study|Physician Decision|1|||
37687930|NCT01652287|69163906|FG000|Overall Study|Withdrawal by Subject|2|||
37687931|NCT01652287|69163907|FG001|Overall Study|Withdrawal by Subject|0|||
37687932|NCT02251743|69163915|FG000|Overall Study|Withdrawal by Subject|1|||
37687933|NCT02251743|69163916|FG001|Overall Study|Withdrawal by Subject|1|||
37687934|NCT02428855|69163922|FG000|Overall Study|Withdrawal by Subject|2|||
37687935|NCT02428699|69163926|FG000|Washout Period 1|Screen Failure|1|||
37687936|NCT02428699|69163927|FG001|Washout Period 1|Screen Failure|2|||
37687937|NCT02428231|69163940|FG000|Overall Study|Other|10|||
37687938|NCT02428231|69163941|FG001|Overall Study|Other|16|||
37687939|NCT02428231|69163940|FG000|Overall Study|Required Symptomatic Therapy|0|||
37687940|NCT02428231|69163941|FG001|Overall Study|Required Symptomatic Therapy|1|||
37687941|NCT02428231|69163940|FG000|Overall Study|Adverse Event|3|||
37687942|NCT02428231|69163941|FG001|Overall Study|Adverse Event|0|||
37687943|NCT02397889|69163949|FG000|Overall Study|Physician Decision|1|||
37687944|NCT02397889|69163950|FG001|Overall Study|Physician Decision|0|||
37687945|NCT02397655|69163956|FG000|Overall Study|data not completed|1301|||
37687946|NCT02396953|69163963|FG000|Overall Study|Withdrawal by Subject|0|||
37687947|NCT02396953|69163964|FG001|Overall Study|Withdrawal by Subject|0|||
37687948|NCT02396953|69163965|FG002|Overall Study|Withdrawal by Subject|1|||
37687949|NCT02396953|69163963|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
37687950|NCT02396953|69163964|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
37687951|NCT02396953|69163965|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
37687952|NCT02396953|69163963|FG000|Overall Study|Personal Reasons|1|||
37687953|NCT02396953|69163964|FG001|Overall Study|Personal Reasons|1|||
37687954|NCT02396953|69163965|FG002|Overall Study|Personal Reasons|0|||
37687955|NCT02387983|69163980|FG000|Overall Study|Adverse Event|4|||
37687956|NCT02387983|69163980|FG000|Overall Study|Protocol Violation|1|||
37687957|NCT02387983|69163980|FG000|Overall Study|Withdrawal by Subject|2|||
37687958|NCT02395627|69163987|FG000|Overall Study|Withdrawal by Subject|0|||
37687959|NCT02395627|69163988|FG001|Overall Study|Withdrawal by Subject|2|||
37687960|NCT02395627|69163989|FG002|Overall Study|Withdrawal by Subject|0|||
37687961|NCT02395627|69163987|FG000|Overall Study|Did not receive pembrolizumab|3|||
37687962|NCT02395627|69163988|FG001|Overall Study|Did not receive pembrolizumab|1|||
37687963|NCT02395627|69163989|FG002|Overall Study|Did not receive pembrolizumab|0|||
37687964|NCT02395471|69164001|FG000|Overall Study|Lost to Follow-up|2|||
37687965|NCT02395471|69164002|FG001|Overall Study|Lost to Follow-up|0|||
37687966|NCT02395471|69164001|FG000|Overall Study|Withdrawal by Subject|2|||
37687967|NCT02395471|69164002|FG001|Overall Study|Withdrawal by Subject|1|||
37687968|NCT02395471|69164001|FG000|Overall Study|Physician Decision|1|||
37687969|NCT02395471|69164002|FG001|Overall Study|Physician Decision|0|||
37687970|NCT02395471|69164001|FG000|Overall Study|Protocol Violation|0|||
37687971|NCT02395471|69164002|FG001|Overall Study|Protocol Violation|1|||
37687972|NCT02395471|69164001|FG000|Overall Study|Failure to swollow sponge twice|1|||
37687973|NCT02395471|69164002|FG001|Overall Study|Failure to swollow sponge twice|0|||
37687974|NCT02395471|69164001|FG000|Overall Study|Patient did not return for procedure|0|||
37687975|NCT02395471|69164002|FG001|Overall Study|Patient did not return for procedure|1|||
37687976|NCT02395471|69164001|FG000|Overall Study|Subject not eligible|1|||
37687977|NCT02395471|69164002|FG001|Overall Study|Subject not eligible|0|||
37687978|NCT02395081|69164020|FG000|Overall Study|Withdrawal by Subject|1|||
37687979|NCT02395081|69164021|FG001|Overall Study|Withdrawal by Subject|1|||
37687980|NCT02395081|69164022|FG002|Overall Study|Withdrawal by Subject|0|||
37687981|NCT02395081|69164020|FG000|Overall Study|Moved where blood couldn't be collected|4|||
37687982|NCT02395081|69164021|FG001|Overall Study|Moved where blood couldn't be collected|1|||
37687983|NCT02395081|69164022|FG002|Overall Study|Moved where blood couldn't be collected|3|||
37687984|NCT02395081|69164020|FG000|Overall Study|Fetal Loss|2|||
37687985|NCT02395081|69164021|FG001|Overall Study|Fetal Loss|3|||
37687986|NCT02395081|69164022|FG002|Overall Study|Fetal Loss|1|||
37687987|NCT02394925|69164033|FG000|Overall Study|Adverse Event|1|||
37687988|NCT02394925|69164033|FG000|Overall Study|Lens Discomfort|3|||
37687989|NCT02394925|69164033|FG000|Overall Study|Lens handling difficulities|5|||
37687990|NCT02394925|69164033|FG000|Overall Study|Lost to Follow-up|9|||
37687991|NCT02394925|69164033|FG000|Overall Study|Protocol Violation|5|||
37687992|NCT02394925|69164033|FG000|Overall Study|No longer meet eligibility criteria|1|||
37687993|NCT02394925|69164033|FG000|Overall Study|Unsatisfactory Visual Response|5|||
37687994|NCT02427607|69164037|FG000|Overall Study|Withdrawal by Subject|1|||
37687995|NCT02425111|69164041|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
37687996|NCT02425111|69164041|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
37687997|NCT02425111|69164041|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
37687998|NCT02425111|69164041|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
37687999|NCT02425111|69164041|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
37688000|NCT02425111|69164041|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
37688001|NCT02424565|69164046|FG000|Period 1 (D0)|Protocol Violation|0|||
37688002|NCT02424565|69164047|FG001|Period 1 (D0)|Protocol Violation|1|||
37688003|NCT02424253|69164055|FG000|Overall Study|Other, unspecified|1|||
37688004|NCT02424253|69164056|FG001|Overall Study|Other, unspecified|0|||
37688005|NCT02424253|69164055|FG000|Overall Study|Compliance problems|1|||
37688006|NCT02424253|69164056|FG001|Overall Study|Compliance problems|0|||
37688007|NCT02424253|69164055|FG000|Overall Study|Physician Decision|2|||
37688008|NCT02424253|69164056|FG001|Overall Study|Physician Decision|0|||
37688009|NCT02424253|69164055|FG000|Overall Study|Lack of Efficacy|0|||
37688010|NCT02424253|69164056|FG001|Overall Study|Lack of Efficacy|7|||
37688011|NCT02424253|69164055|FG000|Overall Study|Adverse Event|2|||
37688012|NCT02424253|69164056|FG001|Overall Study|Adverse Event|0|||
37688013|NCT02424253|69164055|FG000|Overall Study|Consent withdrawn by subject|4|||
37688014|NCT02424253|69164056|FG001|Overall Study|Consent withdrawn by subject|1|||
37688015|NCT02424253|69164055|FG000|Overall Study|Lost to Follow-up|1|||
37688016|NCT02424253|69164056|FG001|Overall Study|Lost to Follow-up|1|||
37688017|NCT02393755|69164064|FG000|Overall Study|Withdrawal by Subject|0|||
37688018|NCT02393755|69164065|FG001|Overall Study|Withdrawal by Subject|3|||
37688019|NCT02393755|69164064|FG000|Overall Study|Adverse Event|0|||
37688020|NCT02393755|69164065|FG001|Overall Study|Adverse Event|2|||
37688021|NCT02393755|69164064|FG000|Overall Study|Physician Decision|0|||
37688022|NCT02393755|69164065|FG001|Overall Study|Physician Decision|2|||
37688023|NCT02393209|69164072|FG000|Overall Study|Study Terminated by Sponsor|1|||
37688024|NCT02393209|69164073|FG001|Overall Study|Study Terminated by Sponsor|1|||
38086778|NCT03672175|69786485|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
38086779|NCT03672175|69786483|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
38086780|NCT03672175|69786484|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
38086781|NCT03672175|69786485|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
38086782|NCT03672175|69786483|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
38086783|NCT03672175|69786484|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
38086784|NCT03672175|69786485|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
38086785|NCT03672175|69786483|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
38086786|NCT03672175|69786484|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
38086787|NCT03672175|69786485|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
38086788|NCT03672175|69786483|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
38086789|NCT03672175|69786484|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
38086790|NCT03672175|69786485|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
38086791|NCT03672175|69786483|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
38086792|NCT03672175|69786484|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
37688025|NCT02393209|69164074|FG002|Overall Study|Study Terminated by Sponsor|0|||
37688026|NCT02393209|69164075|FG003|Overall Study|Study Terminated by Sponsor|0|||
37688027|NCT02393209|69164072|FG000|Overall Study|Withdrawal by Patient|1|||
38086793|NCT03672175|69786485|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
37688028|NCT02393209|69164073|FG001|Overall Study|Withdrawal by Patient|0|||
37688029|NCT02393209|69164074|FG002|Overall Study|Withdrawal by Patient|0|||
37688030|NCT02393209|69164075|FG003|Overall Study|Withdrawal by Patient|0|||
37688031|NCT02393209|69164072|FG000|Overall Study|Death|2|||
37688032|NCT02393209|69164073|FG001|Overall Study|Death|2|||
38086794|NCT03672175|69786483|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
38086795|NCT03672175|69786484|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
38086796|NCT03672175|69786485|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
38086797|NCT03672175|69786483|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
38086798|NCT03672175|69786484|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
38086799|NCT03672175|69786485|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
38086800|NCT03524118|69786526|FG000|Overall Study|Lost to Follow-up|0|||
38086801|NCT03524118|69786527|FG001|Overall Study|Lost to Follow-up|0|||
38086802|NCT03524118|69786528|FG002|Overall Study|Lost to Follow-up|0|||
38086803|NCT03524118|69786529|FG003|Overall Study|Lost to Follow-up|0|||
38086804|NCT03524118|69786530|FG004|Overall Study|Lost to Follow-up|1|||
38086805|NCT03524118|69786531|FG005|Overall Study|Lost to Follow-up|0|||
38086806|NCT03524118|69786526|FG000|Overall Study|Other|0|||
38086807|NCT03524118|69786527|FG001|Overall Study|Other|1|||
38086808|NCT03524118|69786528|FG002|Overall Study|Other|0|||
38086809|NCT03524118|69786529|FG003|Overall Study|Other|0|||
37688033|NCT02393209|69164074|FG002|Overall Study|Death|0|||
37688034|NCT02393209|69164075|FG003|Overall Study|Death|0|||
38086810|NCT03524118|69786530|FG004|Overall Study|Other|1|||
38086811|NCT03524118|69786531|FG005|Overall Study|Other|1|||
38086812|NCT03524118|69786526|FG000|Overall Study|Physician Decision|0|||
38086813|NCT03524118|69786527|FG001|Overall Study|Physician Decision|0|||
38086814|NCT03524118|69786528|FG002|Overall Study|Physician Decision|0|||
38086815|NCT03524118|69786529|FG003|Overall Study|Physician Decision|0|||
38086816|NCT03524118|69786530|FG004|Overall Study|Physician Decision|1|||
38086817|NCT03524118|69786531|FG005|Overall Study|Physician Decision|0|||
38086818|NCT03524118|69786526|FG000|Overall Study|Protocol Violation|0|||
38086819|NCT03524118|69786527|FG001|Overall Study|Protocol Violation|0|||
38086820|NCT03524118|69786528|FG002|Overall Study|Protocol Violation|1|||
38086821|NCT03524118|69786529|FG003|Overall Study|Protocol Violation|0|||
38086822|NCT03524118|69786530|FG004|Overall Study|Protocol Violation|1|||
38086823|NCT03524118|69786531|FG005|Overall Study|Protocol Violation|0|||
38086824|NCT03524118|69786526|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
38086825|NCT03524118|69786527|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
38086826|NCT03524118|69786528|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
38086827|NCT03524118|69786529|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
38086828|NCT03524118|69786530|FG004|Overall Study|Withdrawal by Parent/Guardian|3|||
38086829|NCT03524118|69786531|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
38086830|NCT03472586|69786545|FG000|Overall Study|Physician Decision|6|||
38086831|NCT03472586|69786545|FG000|Overall Study|Death|6|||
38086832|NCT03472586|69786545|FG000|Overall Study|Adverse Event|1|||
38086833|NCT03437265|69786549|FG000|Overall Study|Protocol Violation|6|||
38086834|NCT03414424|69786555|FG000|Overall Study|Screened out after consent|0|||
38086835|NCT03414424|69786556|FG001|Overall Study|Screened out after consent|2|||
38086836|NCT03414424|69786555|FG000|Overall Study|Lost to Follow-up|0|||
38086837|NCT03414424|69786556|FG001|Overall Study|Lost to Follow-up|1|||
38086838|NCT03349476|69786562|FG000|Overall Study|Physician Decision|3|||
38086839|NCT03312634|69786568|FG000|Overall Study|Adverse Event|11|||
38086840|NCT03312634|69786569|FG001|Overall Study|Adverse Event|0|||
38086841|NCT03312634|69786568|FG000|Overall Study|Sponsor request|2|||
38086842|NCT03312634|69786569|FG001|Overall Study|Sponsor request|0|||
38086843|NCT03312634|69786568|FG000|Overall Study|Withdrawal by Subject|31|||
38086844|NCT03312634|69786569|FG001|Overall Study|Withdrawal by Subject|9|||
38086845|NCT03312634|69786568|FG000|Overall Study|Enrolled in an interventional study|0|||
38086846|NCT03312634|69786569|FG001|Overall Study|Enrolled in an interventional study|52|||
38086847|NCT03312634|69786568|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
38086848|NCT03312634|69786569|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
38086849|NCT03312634|69786568|FG000|Overall Study|Death|0|||
38086850|NCT03312634|69786569|FG001|Overall Study|Death|1|||
38086851|NCT03312634|69786568|FG000|Overall Study|Non-compliance|0|||
38086852|NCT03312634|69786569|FG001|Overall Study|Non-compliance|2|||
37688035|NCT02393209|69164072|FG000|Overall Study|Death due to Disease Progression|2|||
38086853|NCT03312634|69786568|FG000|Overall Study|Lost to Follow-up|0|||
38086854|NCT03312634|69786569|FG001|Overall Study|Lost to Follow-up|1|||
38086855|NCT03312634|69786568|FG000|Overall Study|Enrolled into non-interventional study|0|||
37688036|NCT02393209|69164073|FG001|Overall Study|Death due to Disease Progression|2|||
37688037|NCT02393209|69164074|FG002|Overall Study|Death due to Disease Progression|0|||
37688038|NCT02393209|69164075|FG003|Overall Study|Death due to Disease Progression|0|||
37863413|NCT00996892|69547131|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
38086856|NCT03312634|69786569|FG001|Overall Study|Enrolled into non-interventional study|5|||
38086857|NCT03312634|69786568|FG000|Overall Study|Worsening clinical condition|0|||
38086858|NCT03312634|69786569|FG001|Overall Study|Worsening clinical condition|1|||
38086859|NCT03312634|69786568|FG000|Overall Study|Participant did not want to travel|0|||
38086860|NCT03312634|69786569|FG001|Overall Study|Participant did not want to travel|1|||
38086861|NCT03312634|69786568|FG000|Overall Study|Physician Decision|1|||
38086862|NCT03312634|69786569|FG001|Overall Study|Physician Decision|0|||
38086863|NCT03312634|69786568|FG000|Overall Study|Other|13|||
38086864|NCT03312634|69786569|FG001|Overall Study|Other|0|||
38086865|NCT03000569|69786578|FG000|Overall Study|Withdrawal by Subject|1|||
38086866|NCT03000569|69786579|FG001|Overall Study|Withdrawal by Subject|0|||
38086867|NCT02205359|69786617|FG000|Overall Study|Death|293|||
37688039|NCT02393209|69164072|FG000|Overall Study|Death from Legionella Infection|0|||
37688040|NCT02393209|69164073|FG001|Overall Study|Death from Legionella Infection|1|||
37688041|NCT02393209|69164074|FG002|Overall Study|Death from Legionella Infection|0|||
37688042|NCT02393209|69164075|FG003|Overall Study|Death from Legionella Infection|0|||
37688043|NCT02393209|69164072|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
37688044|NCT02393209|69164073|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
37688045|NCT02393209|69164074|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
37688046|NCT02393209|69164075|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
37688047|NCT02393209|69164072|FG000|Overall Study|Lost to Follow-up|0|||
37688048|NCT02393209|69164073|FG001|Overall Study|Lost to Follow-up|1|||
37688049|NCT02393209|69164074|FG002|Overall Study|Lost to Follow-up|0|||
38086868|NCT02205359|69786618|FG001|Overall Study|Death|327|||
38086869|NCT02205359|69786617|FG000|Overall Study|Lost to Follow-up|182|||
38086870|NCT02205359|69786618|FG001|Overall Study|Lost to Follow-up|162|||
38086871|NCT02205359|69786617|FG000|Overall Study|Physician Decision|51|||
38086872|NCT02205359|69786618|FG001|Overall Study|Physician Decision|53|||
38086873|NCT02205359|69786617|FG000|Overall Study|Withdrawal by Subject|167|||
38086874|NCT02205359|69786618|FG001|Overall Study|Withdrawal by Subject|169|||
38086875|NCT02101775|69786628|FG000|Overall Study|Adverse Event|4|||
38086876|NCT02101775|69786629|FG001|Overall Study|Adverse Event|0|||
38086877|NCT02101775|69786630|FG002|Overall Study|Adverse Event|0|||
38086878|NCT02101775|69786628|FG000|Overall Study|Admission to Hospital|0|||
38086879|NCT02101775|69786629|FG001|Overall Study|Admission to Hospital|1|||
38086880|NCT02101775|69786630|FG002|Overall Study|Admission to Hospital|0|||
38086881|NCT01979536|69786646|FG000|Overall Study|Physician Decision|2|||
38086882|NCT01979536|69786647|FG001|Overall Study|Physician Decision|3|||
38086883|NCT01979536|69786646|FG000|Overall Study|Withdrawal by Subject|0|||
38086884|NCT01979536|69786647|FG001|Overall Study|Withdrawal by Subject|1|||
38086885|NCT01979536|69786646|FG000|Overall Study|Refusal|0|||
37688050|NCT02393209|69164075|FG003|Overall Study|Lost to Follow-up|0|||
37688051|NCT02424097|69164086|FG000|Overall Study|Lost to Follow-up|1|||
37688052|NCT02424097|69164087|FG001|Overall Study|Lost to Follow-up|2|||
37688053|NCT02392507|69164093|FG000|Induction Regimen|Death|3|||
37688054|NCT02392507|69164093|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
37688055|NCT02392507|69164093|FG000|Induction Regimen|Physician Decision|1|||
37688056|NCT02392507|69164093|FG000|Induction Regimen|Withdrawal by Subject|2|||
37688057|NCT02392507|69164093|FG000|Maintenance Regimen|Death|1|||
37688058|NCT02392507|69164093|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
37688059|NCT02386345|69164102|FG000|Overall Study|Not treated|14|||
37688060|NCT02386345|69164102|FG000|Overall Study|Lost to Follow-up|1|||
37688061|NCT02386345|69164102|FG000|Overall Study|Adverse Event|5|||
37688062|NCT02386345|69164102|FG000|Overall Study|Repeat Procedure|10|||
37688063|NCT02386345|69164102|FG000|Overall Study|Did not complete 12-month follow-up|72|||
37688064|NCT01651117|69164110|FG000|Overall Study|Death|2|||
37688065|NCT01651117|69164111|FG001|Overall Study|Death|3|||
37688066|NCT01651117|69164112|FG002|Overall Study|Death|2|||
37688067|NCT01651117|69164113|FG003|Overall Study|Death|2|||
37688068|NCT02386189|69164128|FG000|Overall Study|Lost to Follow-up|2|||
37688069|NCT02386189|69164129|FG001|Overall Study|Lost to Follow-up|3|||
37688070|NCT02386189|69164128|FG000|Overall Study|Withdrawal by Subject|1|||
37688071|NCT02386189|69164129|FG001|Overall Study|Withdrawal by Subject|0|||
37688072|NCT02386189|69164128|FG000|Overall Study|Death|1|||
37688073|NCT02386189|69164129|FG001|Overall Study|Death|0|||
37688074|NCT02385799|69164137|FG000|Overall Study|Lost to Follow-up|1|||
37688075|NCT02385799|69164138|FG001|Overall Study|Lost to Follow-up|2|||
37688076|NCT02385799|69164137|FG000|Overall Study|Adverse Event|4|||
37688077|NCT02385799|69164138|FG001|Overall Study|Adverse Event|2|||
37688078|NCT02385799|69164137|FG000|Overall Study|Withdrawal by Subject|0|||
38086886|NCT01979536|69786647|FG001|Overall Study|Refusal|1|||
37688079|NCT02385799|69164138|FG001|Overall Study|Withdrawal by Subject|4|||
37688080|NCT02422303|69164146|FG000|Overall Study|Lost to Follow-up|1|||
37967468|NCT03894540|69654400|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
38086887|NCT01979536|69786646|FG000|Overall Study|Relapse|0|||
37688081|NCT02422303|69164147|FG001|Overall Study|Lost to Follow-up|1|||
37688082|NCT02392195|69164153|FG000|Overall Study|Lost to Follow-up|4|||
37688083|NCT02392195|69164153|FG000|Overall Study|Withdrawal by Subject|4|||
37688084|NCT02391961|69164159|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
37688085|NCT02391961|69164160|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
37688086|NCT02391961|69164159|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
38086888|NCT01979536|69786647|FG001|Overall Study|Relapse|1|||
38086889|NCT01979536|69786646|FG000|Overall Study|Study terminated by Sponsor|0|||
38086890|NCT01979536|69786647|FG001|Overall Study|Study terminated by Sponsor|1|||
38086891|NCT01979536|69786646|FG000|Overall Study|Did not start treatment|0|||
38086892|NCT01979536|69786647|FG001|Overall Study|Did not start treatment|1|||
38086893|NCT01798992|69786670|FG000|Overall Study|Administrative withdrawal|0|||
37688087|NCT02391961|69164160|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
37688088|NCT02391961|69164159|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
37688089|NCT02391961|69164160|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
37688090|NCT02384941|69164169|FG000|Overall Study|Adverse Event|11|||
37688091|NCT02384941|69164170|FG001|Overall Study|Adverse Event|13|||
37688092|NCT02384941|69164171|FG002|Overall Study|Adverse Event|17|||
37688093|NCT02384941|69164169|FG000|Overall Study|Lost to Follow-up|3|||
37688094|NCT02384941|69164170|FG001|Overall Study|Lost to Follow-up|2|||
37688095|NCT02384941|69164171|FG002|Overall Study|Lost to Follow-up|1|||
37688096|NCT02384941|69164169|FG000|Overall Study|Non-Compliance With Study Drug|2|||
37688097|NCT02384941|69164170|FG001|Overall Study|Non-Compliance With Study Drug|0|||
37688098|NCT02384941|69164171|FG002|Overall Study|Non-Compliance With Study Drug|1|||
37688099|NCT02384941|69164169|FG000|Overall Study|Physician Decision|1|||
37688100|NCT02384941|69164170|FG001|Overall Study|Physician Decision|1|||
37688101|NCT02384941|69164171|FG002|Overall Study|Physician Decision|0|||
37688102|NCT02384941|69164169|FG000|Overall Study|Protocol Violation|3|||
38086894|NCT01798992|69786671|FG001|Overall Study|Administrative withdrawal|1|||
38086895|NCT01798992|69786672|FG002|Overall Study|Administrative withdrawal|0|||
38086896|NCT01798992|69786673|FG003|Overall Study|Administrative withdrawal|1|||
38086897|NCT01798992|69786670|FG000|Overall Study|Lost to Follow-up|0|||
38086898|NCT01798992|69786671|FG001|Overall Study|Lost to Follow-up|1|||
38086899|NCT01798992|69786672|FG002|Overall Study|Lost to Follow-up|1|||
38086900|NCT01798992|69786673|FG003|Overall Study|Lost to Follow-up|0|||
38086901|NCT01798992|69786670|FG000|Overall Study|Insufficient biopsy tissue|0|||
38086902|NCT01798992|69786671|FG001|Overall Study|Insufficient biopsy tissue|0|||
38086903|NCT01798992|69786672|FG002|Overall Study|Insufficient biopsy tissue|1|||
38086904|NCT01798992|69786673|FG003|Overall Study|Insufficient biopsy tissue|0|||
38086905|NCT01570868|69786684|FG000|Overall Study|Adverse Event|8|||
38086906|NCT01570868|69786685|FG001|Overall Study|Adverse Event|1|||
38086907|NCT01570868|69786684|FG000|Overall Study|FDA Recommendation|23|||
37688103|NCT02384941|69164170|FG001|Overall Study|Protocol Violation|0|||
37688104|NCT02384941|69164171|FG002|Overall Study|Protocol Violation|0|||
37688105|NCT02384941|69164169|FG000|Overall Study|Withdrawal by Subject|26|||
37688106|NCT02384941|69164170|FG001|Overall Study|Withdrawal by Subject|19|||
37688107|NCT02384941|69164171|FG002|Overall Study|Withdrawal by Subject|20|||
37688108|NCT02384941|69164169|FG000|Overall Study|Pregnancy|0|||
37688109|NCT02384941|69164170|FG001|Overall Study|Pregnancy|0|||
37688110|NCT02384941|69164171|FG002|Overall Study|Pregnancy|1|||
37688111|NCT02384941|69164169|FG000|Overall Study|Other than specified above|4|||
37688112|NCT02384941|69164170|FG001|Overall Study|Other than specified above|0|||
37688113|NCT02384941|69164171|FG002|Overall Study|Other than specified above|1|||
37688114|NCT02384395|69164180|FG000|Overall Study|Physician Decision|4|||
37688115|NCT02384395|69164180|FG000|Overall Study|Withdrawal by Subject|3|||
37688116|NCT02384395|69164180|FG000|Overall Study|Lost to Follow-up|3|||
37688117|NCT02420353|69164186|FG000|Overall Study|Withdrawal by Subject|0|||
37688118|NCT02420353|69164187|FG001|Overall Study|Withdrawal by Subject|1|||
37688119|NCT02391337|69164195|FG000|6 Months Follow-up|Death|5|||
37688120|NCT02391337|69164196|FG001|6 Months Follow-up|Death|4|||
37688121|NCT02391337|69164195|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
37688122|NCT02391337|69164196|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
37688123|NCT02391337|69164195|FG000|12 Months Follow-up|Death|2|||
37688124|NCT02391337|69164196|FG001|12 Months Follow-up|Death|0|||
37688125|NCT02391337|69164195|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
37688126|NCT02391337|69164196|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
37688127|NCT02391337|69164195|FG000|12 Months Follow-up|Lost to Follow-up|0|||
37688128|NCT02391337|69164196|FG001|12 Months Follow-up|Lost to Follow-up|2|||
37688129|NCT02382991|69164204|FG000|Overall Study|Adverse Event|1|||
37688130|NCT02382991|69164205|FG001|Overall Study|Adverse Event|2|||
37688131|NCT02382991|69164204|FG000|Overall Study|Lost to Follow-up|1|||
37688132|NCT02382991|69164205|FG001|Overall Study|Lost to Follow-up|0|||
37688133|NCT02382991|69164204|FG000|Overall Study|Withdrawal by Subject|0|||
38086908|NCT01570868|69786685|FG001|Overall Study|FDA Recommendation|3|||
37688134|NCT02382991|69164205|FG001|Overall Study|Withdrawal by Subject|1|||
37688135|NCT02390557|69164213|FG000|Wave 2|Survey non-respondent|72|||
37688136|NCT02390557|69164214|FG001|Wave 2|Survey non-respondent|41|||
37688137|NCT02390557|69164215|FG002|Wave 2|Survey non-respondent|23|||
37688138|NCT01649791|69164223|FG000|Overall Study|Disease Progression|2|||
37688139|NCT01649791|69164223|FG000|Overall Study|Adverse Event|1|||
37688140|NCT01649557|69164230|FG000|Overall Study|Lost to Follow-up|5|||
37688141|NCT01649557|69164231|FG001|Overall Study|Lost to Follow-up|0|||
37688142|NCT01649557|69164232|FG002|Overall Study|Lost to Follow-up|3|||
37688143|NCT01649557|69164230|FG000|Overall Study|Adverse Event|7|||
37688144|NCT01649557|69164231|FG001|Overall Study|Adverse Event|5|||
37688145|NCT01649557|69164232|FG002|Overall Study|Adverse Event|1|||
37688146|NCT01649557|69164230|FG000|Overall Study|Met withdrawal criteria|4|||
37688147|NCT01649557|69164231|FG001|Overall Study|Met withdrawal criteria|0|||
38086909|NCT01570868|69786684|FG000|Overall Study|Physician Decision|10|||
38086910|NCT01570868|69786685|FG001|Overall Study|Physician Decision|4|||
38086911|NCT01570868|69786684|FG000|Overall Study|Lost to Follow-up|1|||
37688148|NCT01649557|69164232|FG002|Overall Study|Met withdrawal criteria|0|||
37688149|NCT01649557|69164230|FG000|Overall Study|Physician Decision|8|||
38086912|NCT01570868|69786685|FG001|Overall Study|Lost to Follow-up|0|||
38086913|NCT01570868|69786684|FG000|Overall Study|Withdrawal by Subject|1|||
38086914|NCT01570868|69786685|FG001|Overall Study|Withdrawal by Subject|0|||
38086915|NCT01251965|69786698|FG000|Overall Study|Participant/physician decision|1|||
38086916|NCT01251965|69786699|FG001|Overall Study|Participant/physician decision|2|||
38086917|NCT01251965|69786700|FG002|Overall Study|Participant/physician decision|0|||
38086918|NCT01251965|69786698|FG000|Overall Study|Death|0|||
38086919|NCT01251965|69786699|FG001|Overall Study|Death|0|||
38086920|NCT01251965|69786700|FG002|Overall Study|Death|11|||
38086921|NCT01190644|69786709|FG000|Overall Study|Death|2|||
38086922|NCT01190644|69786709|FG000|Overall Study|Disease progression|1|||
38086923|NCT01065454|69786718|FG000|Treatment|Adverse Event|7|||
38086924|NCT01065454|69786719|FG001|Treatment|Adverse Event|4|||
38086925|NCT01065454|69786720|FG002|Treatment|Adverse Event|3|||
38086926|NCT01065454|69786721|FG003|Treatment|Adverse Event|6|||
38086927|NCT01065454|69786718|FG000|Treatment|Death|1|||
38086928|NCT01065454|69786719|FG001|Treatment|Death|0|||
38086929|NCT01065454|69786720|FG002|Treatment|Death|0|||
38086930|NCT01065454|69786721|FG003|Treatment|Death|0|||
38086931|NCT01065454|69786718|FG000|Treatment|Non-compliance|1|||
38086932|NCT01065454|69786719|FG001|Treatment|Non-compliance|0|||
38086933|NCT01065454|69786720|FG002|Treatment|Non-compliance|0|||
38086934|NCT01065454|69786721|FG003|Treatment|Non-compliance|1|||
38086935|NCT01065454|69786718|FG000|Treatment|Protocol Decision|0|||
38086936|NCT01065454|69786719|FG001|Treatment|Protocol Decision|0|||
38086937|NCT01065454|69786720|FG002|Treatment|Protocol Decision|3|||
38086938|NCT01065454|69786721|FG003|Treatment|Protocol Decision|2|||
38086939|NCT01065454|69786718|FG000|Treatment|Protocol Violation|1|||
38086940|NCT01065454|69786719|FG001|Treatment|Protocol Violation|0|||
38086941|NCT01065454|69786720|FG002|Treatment|Protocol Violation|1|||
38086942|NCT01065454|69786721|FG003|Treatment|Protocol Violation|0|||
38086943|NCT01065454|69786718|FG000|Treatment|Withdrawal by Subject|3|||
38086944|NCT01065454|69786719|FG001|Treatment|Withdrawal by Subject|1|||
38086945|NCT01065454|69786720|FG002|Treatment|Withdrawal by Subject|2|||
38086946|NCT01065454|69786721|FG003|Treatment|Withdrawal by Subject|3|||
38086947|NCT01065454|69786718|FG000|Follow up|Adverse Event|1|||
38086948|NCT01065454|69786719|FG001|Follow up|Adverse Event|0|||
38086949|NCT01065454|69786720|FG002|Follow up|Adverse Event|0|||
38086950|NCT01065454|69786721|FG003|Follow up|Adverse Event|1|||
38086951|NCT01065454|69786718|FG000|Follow up|Death|0|||
38086952|NCT01065454|69786719|FG001|Follow up|Death|1|||
38086953|NCT01065454|69786720|FG002|Follow up|Death|1|||
38086954|NCT01065454|69786721|FG003|Follow up|Death|0|||
38086955|NCT01065454|69786718|FG000|Follow up|Lost to Follow-up|0|||
38086956|NCT01065454|69786719|FG001|Follow up|Lost to Follow-up|0|||
38086957|NCT01065454|69786720|FG002|Follow up|Lost to Follow-up|0|||
38086958|NCT01065454|69786721|FG003|Follow up|Lost to Follow-up|1|||
38086959|NCT01065454|69786718|FG000|Follow up|Progressive disease|0|||
38086960|NCT01065454|69786719|FG001|Follow up|Progressive disease|0|||
38086961|NCT01065454|69786720|FG002|Follow up|Progressive disease|0|||
38086962|NCT01065454|69786721|FG003|Follow up|Progressive disease|1|||
38086963|NCT01065454|69786718|FG000|Follow up|Withdrawal by Subject|1|||
38086964|NCT01065454|69786719|FG001|Follow up|Withdrawal by Subject|1|||
38086965|NCT01065454|69786720|FG002|Follow up|Withdrawal by Subject|1|||
38086966|NCT01065454|69786721|FG003|Follow up|Withdrawal by Subject|0|||
38086967|NCT01065454|69786718|FG000|Follow up|study ongoing|37|||
38086968|NCT01065454|69786719|FG001|Follow up|study ongoing|22|||
38086969|NCT01065454|69786720|FG002|Follow up|study ongoing|15|||
38086970|NCT01065454|69786721|FG003|Follow up|study ongoing|41|||
38086971|NCT00849290|69786731|FG000|Overall Study|Adverse Event|3|||
38086972|NCT00849290|69786731|FG000|Overall Study|Death|14|||
38086973|NCT00849290|69786731|FG000|Overall Study|Withdrawal by Subject|11|||
38086974|NCT00849290|69786731|FG000|Overall Study|Lost to Follow-up|2|||
38086975|NCT00849290|69786731|FG000|Overall Study|Protocol Violation|5|||
38086976|NCT00849290|69786731|FG000|Overall Study|Disease Progression|20|||
38086977|NCT00542451|69786739|FG000|Overall Study|Adverse Event|31|||
37688150|NCT01649557|69164231|FG001|Overall Study|Physician Decision|2|||
38086978|NCT00542451|69786739|FG000|Overall Study|Withdrawal by Subject|30|||
38086979|NCT00542451|69786739|FG000|Overall Study|Physician Decision|4|||
38086980|NCT00542451|69786739|FG000|Overall Study|Recurrent disease|1|||
38086981|NCT00542451|69786739|FG000|Overall Study|unknown reason|1|||
38086982|NCT00542451|69786739|FG000|Overall Study|Death|2|||
38086983|NCT00542451|69786739|FG000|Overall Study|Lost to Follow-up|10|||
38086984|NCT00506493|69786746|FG000|Overall Study|Death|6|||
38086985|NCT00506493|69786746|FG000|Overall Study|Withdrawal by Subject|5|||
37688151|NCT01649557|69164232|FG002|Overall Study|Physician Decision|1|||
37967469|NCT03894540|69654401|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
37967470|NCT03894540|69654402|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
37967471|NCT03894540|69654403|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
37688152|NCT01649557|69164230|FG000|Overall Study|Withdrawal by Subject|15|||
37688153|NCT01649557|69164231|FG001|Overall Study|Withdrawal by Subject|5|||
37688154|NCT01649557|69164232|FG002|Overall Study|Withdrawal by Subject|4|||
37688155|NCT01649557|69164230|FG000|Overall Study|Protocol deviation|0|||
37688156|NCT01649557|69164231|FG001|Overall Study|Protocol deviation|2|||
37688157|NCT01649557|69164232|FG002|Overall Study|Protocol deviation|0|||
37688158|NCT01649557|69164230|FG000|Overall Study|Lack of Efficacy|5|||
37688159|NCT01649557|69164231|FG001|Overall Study|Lack of Efficacy|0|||
37688160|NCT01649557|69164232|FG002|Overall Study|Lack of Efficacy|0|||
37688161|NCT02390245|69164240|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
37688162|NCT02390245|69164241|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
37688163|NCT02390245|69164242|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
37688164|NCT02390245|69164240|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
37688165|NCT02390245|69164241|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
37688166|NCT02390245|69164242|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
37688167|NCT02390167|69164251|FG000|Overall Study|Lost to Follow-up|1|||
37688168|NCT02347657|69164261|FG000|Overall Study|Physician Decision|0|||
37688169|NCT02347657|69164262|FG001|Overall Study|Physician Decision|1|||
37688170|NCT02347657|69164261|FG000|Overall Study|Adverse Event|8|||
37688171|NCT02347657|69164262|FG001|Overall Study|Adverse Event|4|||
37688172|NCT02347657|69164261|FG000|Overall Study|Withdrawal by Subject|6|||
37688173|NCT02347657|69164262|FG001|Overall Study|Withdrawal by Subject|7|||
37688174|NCT02347657|69164261|FG000|Overall Study|Randomized but not treated|1|||
37688175|NCT02347657|69164262|FG001|Overall Study|Randomized but not treated|0|||
37688176|NCT02347657|69164261|FG000|Overall Study|Other|3|||
37688177|NCT02347657|69164262|FG001|Overall Study|Other|3|||
37688178|NCT02347189|69164269|FG000|Overall Study|No implant attempted of study device|9|||
37688179|NCT02347189|69164269|FG000|Overall Study|No primary outcome data available|2|||
37688180|NCT02382133|69164284|FG000|Overall Study|Death|22|||
37688181|NCT02382133|69164284|FG000|Overall Study|transfer out of ICU|4|||
37688182|NCT02382133|69164284|FG000|Overall Study|Physician Decision|2|||
37688183|NCT02382133|69164284|FG000|Overall Study|arterial catheter loss|4|||
37688184|NCT02382133|69164284|FG000|Overall Study|pressure injury both sites|1|||
37688185|NCT02346877|69164290|FG000|Overall Study|Adverse Event|1|||
37688186|NCT02346877|69164291|FG001|Overall Study|Adverse Event|0|||
37688187|NCT02346877|69164290|FG000|Overall Study|Administrative Decision|1|||
37688188|NCT02346877|69164291|FG001|Overall Study|Administrative Decision|0|||
37688189|NCT02346877|69164290|FG000|Overall Study|Sponsor Decision|12|||
37688190|NCT02346877|69164291|FG001|Overall Study|Sponsor Decision|0|||
37688191|NCT02346877|69164290|FG000|Overall Study|Missing|5|||
37688192|NCT02346877|69164291|FG001|Overall Study|Missing|0|||
37688193|NCT02346721|69164297|FG000|Overall Study|Withdrew Consent|3|||
37688194|NCT02346721|69164297|FG000|Overall Study|Lack of Efficacy|1|||
37688195|NCT02389621|69164305|FG000|Treatment Period|Withdrawal by Subject|1|||
37688196|NCT02389621|69164306|FG001|Treatment Period|Withdrawal by Subject|1|||
37688197|NCT02389621|69164305|FG000|Posttreatment Period|Adverse Event|3|||
37688198|NCT02389621|69164306|FG001|Posttreatment Period|Adverse Event|1|||
37688199|NCT02389621|69164305|FG000|Posttreatment Period|Withdrawal by Subject|3|||
37688200|NCT02389621|69164306|FG001|Posttreatment Period|Withdrawal by Subject|2|||
37688201|NCT02389621|69164305|FG000|Posttreatment Period|Lost to Follow-up|1|||
37688202|NCT02389621|69164306|FG001|Posttreatment Period|Lost to Follow-up|1|||
37688203|NCT02389621|69164305|FG000|Posttreatment Period|Other - Miscellaneous|2|||
37688204|NCT02389621|69164306|FG001|Posttreatment Period|Other - Miscellaneous|0|||
37688205|NCT02388997|69164318|FG000|Overall Study|Adverse Event|1|||
37688206|NCT02388997|69164319|FG001|Overall Study|Adverse Event|2|||
37688207|NCT02388997|69164318|FG000|Overall Study|Withdrawal by Subject|2|||
37688208|NCT02388997|69164319|FG001|Overall Study|Withdrawal by Subject|1|||
37688209|NCT02388997|69164318|FG000|Overall Study|Lung function exclusion criteria|0|||
37688210|NCT02388997|69164319|FG001|Overall Study|Lung function exclusion criteria|2|||
37688211|NCT02388997|69164318|FG000|Overall Study|Tested positive for virus during run-in|0|||
37688212|NCT02388997|69164319|FG001|Overall Study|Tested positive for virus during run-in|1|||
37688213|NCT02388763|69164325|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
37688214|NCT02388763|69164326|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
37688215|NCT02388763|69164325|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
37688216|NCT02388763|69164326|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
37688217|NCT02388295|69164338|FG000|Dose Escalation Week 1|Adverse Event|1|||
37688218|NCT02388295|69164339|FG001|Dose Escalation Week 1|Adverse Event|2|||
37688219|NCT02388295|69164340|FG002|Dose Escalation Week 1|Adverse Event|1|||
37688220|NCT02388295|69164338|FG000|Dose Escalation Week 1|Determined not eligible|1|||
37688221|NCT02388295|69164339|FG001|Dose Escalation Week 1|Determined not eligible|1|||
37688222|NCT02388295|69164340|FG002|Dose Escalation Week 1|Determined not eligible|1|||
37688223|NCT02388295|69164338|FG000|Dose Escalation Week 2|Protocol Violation|0|||
37688224|NCT02388295|69164339|FG001|Dose Escalation Week 2|Protocol Violation|1|||
37688225|NCT02388295|69164340|FG002|Dose Escalation Week 2|Protocol Violation|0|||
37688226|NCT02388295|69164338|FG000|Dose Escalation Week 2|Determined not eligible|1|||
37688227|NCT02388295|69164339|FG001|Dose Escalation Week 2|Determined not eligible|1|||
37688228|NCT02388295|69164340|FG002|Dose Escalation Week 2|Determined not eligible|1|||
37688229|NCT02388295|69164338|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
37688230|NCT02388295|69164339|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
37688231|NCT02388295|69164340|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
37688232|NCT02345161|69164350|FG000|Overall Study|Withdrawal by Subject|25|||
37688233|NCT02345161|69164351|FG001|Overall Study|Withdrawal by Subject|33|||
37688234|NCT02345161|69164350|FG000|Overall Study|Adverse Event|16|||
37688235|NCT02345161|69164351|FG001|Overall Study|Adverse Event|19|||
37688236|NCT02345161|69164350|FG000|Overall Study|Physician Decision|4|||
37688237|NCT02345161|69164351|FG001|Overall Study|Physician Decision|4|||
37688238|NCT02345161|69164350|FG000|Overall Study|Lost to Follow-up|0|||
37688239|NCT02345161|69164351|FG001|Overall Study|Lost to Follow-up|1|||
37688240|NCT02251275|69164367|FG000|Overall Study|Adverse Event|23|||
37688241|NCT02251275|69164368|FG001|Overall Study|Adverse Event|60|||
37688242|NCT02251275|69164369|FG002|Overall Study|Adverse Event|28|||
37688243|NCT02251275|69164370|FG003|Overall Study|Adverse Event|0|||
37688244|NCT02251275|69164371|FG004|Overall Study|Adverse Event|0|||
37688245|NCT02251275|69164367|FG000|Overall Study|Lost to Follow-up|5|||
37688246|NCT02251275|69164368|FG001|Overall Study|Lost to Follow-up|6|||
37688247|NCT02251275|69164369|FG002|Overall Study|Lost to Follow-up|4|||
37688248|NCT02251275|69164370|FG003|Overall Study|Lost to Follow-up|0|||
37688249|NCT02251275|69164371|FG004|Overall Study|Lost to Follow-up|0|||
37688250|NCT02251275|69164367|FG000|Overall Study|Physician Decision|19|||
37688251|NCT02251275|69164368|FG001|Overall Study|Physician Decision|30|||
37688252|NCT02251275|69164369|FG002|Overall Study|Physician Decision|26|||
37688253|NCT02251275|69164370|FG003|Overall Study|Physician Decision|0|||
37688254|NCT02251275|69164371|FG004|Overall Study|Physician Decision|1|||
37688255|NCT02251275|69164367|FG000|Overall Study|Protocol Deviation|0|||
37688256|NCT02251275|69164368|FG001|Overall Study|Protocol Deviation|0|||
37688257|NCT02251275|69164369|FG002|Overall Study|Protocol Deviation|1|||
37688258|NCT02251275|69164370|FG003|Overall Study|Protocol Deviation|0|||
37688259|NCT02251275|69164371|FG004|Overall Study|Protocol Deviation|0|||
37688260|NCT02251275|69164367|FG000|Overall Study|Withdrawal by Subject|25|||
37688261|NCT02251275|69164368|FG001|Overall Study|Withdrawal by Subject|51|||
37688262|NCT02251275|69164369|FG002|Overall Study|Withdrawal by Subject|35|||
37688263|NCT02251275|69164370|FG003|Overall Study|Withdrawal by Subject|1|||
37688264|NCT02251275|69164371|FG004|Overall Study|Withdrawal by Subject|0|||
37688265|NCT02379637|69164385|FG000|Overall Study|Protocol Violation|0|||
37688266|NCT02379637|69164386|FG001|Overall Study|Protocol Violation|1|||
37688267|NCT02379637|69164385|FG000|Overall Study|Adverse Event|1|||
37688268|NCT02379637|69164386|FG001|Overall Study|Adverse Event|0|||
37688269|NCT02379637|69164385|FG000|Overall Study|Withdrawal by Subject|1|||
37688270|NCT02379637|69164386|FG001|Overall Study|Withdrawal by Subject|0|||
37688271|NCT02195583|69164392|FG000|Overall Study|Lost to Follow-up|1|||
37688272|NCT02195583|69164392|FG000|Overall Study|Withdrawal by Subject|4|||
37688273|NCT02195583|69164392|FG000|Overall Study|Adverse Event|2|||
37688274|NCT02195583|69164392|FG000|Overall Study|Other Reason|2|||
37688275|NCT02379091|69164411|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
37688276|NCT02379091|69164412|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
37688277|NCT02379091|69164413|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
37688278|NCT02379091|69164414|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
37688279|NCT02379091|69164411|FG000|Overall Study|Principal Investigator Discretion|0|||
37688280|NCT02379091|69164412|FG001|Overall Study|Principal Investigator Discretion|1|||
37688281|NCT02379091|69164413|FG002|Overall Study|Principal Investigator Discretion|0|||
37688282|NCT02379091|69164414|FG003|Overall Study|Principal Investigator Discretion|0|||
37688283|NCT02379091|69164411|FG000|Overall Study|Lost to Follow-up|0|||
37688284|NCT02379091|69164412|FG001|Overall Study|Lost to Follow-up|0|||
37688285|NCT02379091|69164413|FG002|Overall Study|Lost to Follow-up|0|||
37688286|NCT02379091|69164414|FG003|Overall Study|Lost to Follow-up|1|||
37688287|NCT02379091|69164411|FG000|Overall Study|Voluntary Withdrawal|2|||
37688288|NCT02379091|69164412|FG001|Overall Study|Voluntary Withdrawal|5|||
37688289|NCT02379091|69164413|FG002|Overall Study|Voluntary Withdrawal|2|||
37688290|NCT02379091|69164414|FG003|Overall Study|Voluntary Withdrawal|4|||
37688291|NCT02379091|69164411|FG000|Overall Study|Study Termination|7|||
37688292|NCT02379091|69164412|FG001|Overall Study|Study Termination|2|||
37688293|NCT02379091|69164413|FG002|Overall Study|Study Termination|5|||
37688294|NCT02379091|69164414|FG003|Overall Study|Study Termination|8|||
37688295|NCT02379091|69164411|FG000|Overall Study|Lack of Efficacy|3|||
37688296|NCT02379091|69164412|FG001|Overall Study|Lack of Efficacy|0|||
37688297|NCT02379091|69164413|FG002|Overall Study|Lack of Efficacy|0|||
37688298|NCT02379091|69164414|FG003|Overall Study|Lack of Efficacy|0|||
37688299|NCT02378935|69164433|FG000|Overall Study|Lack of Efficacy|10|||
37688300|NCT02378935|69164434|FG001|Overall Study|Lack of Efficacy|0|||
37688301|NCT02378935|69164435|FG002|Overall Study|Lack of Efficacy|2|||
37688302|NCT02378935|69164436|FG003|Overall Study|Lack of Efficacy|6|||
37688303|NCT02378935|69164437|FG004|Overall Study|Lack of Efficacy|0|||
37688304|NCT02378935|69164438|FG005|Overall Study|Lack of Efficacy|0|||
37688305|NCT02378935|69164439|FG006|Overall Study|Lack of Efficacy|0|||
37688306|NCT02378935|69164433|FG000|Overall Study|Death|0|||
37688307|NCT02378935|69164434|FG001|Overall Study|Death|0|||
37688308|NCT02378935|69164435|FG002|Overall Study|Death|1|||
37688309|NCT02378935|69164436|FG003|Overall Study|Death|0|||
37688310|NCT02378935|69164437|FG004|Overall Study|Death|0|||
37688311|NCT02378935|69164438|FG005|Overall Study|Death|0|||
37688312|NCT02378935|69164439|FG006|Overall Study|Death|0|||
37688313|NCT02250651|69164458|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
37688314|NCT02250651|69164459|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
37688315|NCT02250651|69164460|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
37688316|NCT02250651|69164458|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
37688317|NCT02250651|69164459|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
37688318|NCT02250651|69164460|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
37688319|NCT02250651|69164458|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
37688320|NCT02250651|69164459|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
37688321|NCT02250651|69164460|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
37688322|NCT02250651|69164458|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
37688323|NCT02250651|69164459|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
37688324|NCT02250651|69164460|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
37688325|NCT02250651|69164458|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
37688326|NCT02250651|69164459|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
37688327|NCT02250651|69164460|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
37688328|NCT02250651|69164458|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
37688329|NCT02250651|69164459|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
37688330|NCT02250651|69164460|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
37688331|NCT02250651|69164458|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
37688332|NCT02250651|69164459|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
37688333|NCT02250651|69164460|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
37688334|NCT02250651|69164458|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
37688335|NCT02250651|69164459|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
37688336|NCT02250651|69164460|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
37688337|NCT02250651|69164458|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
37688338|NCT02250651|69164459|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
37688339|NCT02250651|69164460|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
37688340|NCT02250651|69164458|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
37688341|NCT02250651|69164459|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
37688342|NCT02250651|69164460|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
37688343|NCT02250651|69164458|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
37688344|NCT02250651|69164459|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
37688345|NCT02250651|69164460|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
37688346|NCT02250651|69164458|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
37688347|NCT02250651|69164459|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
37688348|NCT02250651|69164460|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
37688349|NCT02250651|69164458|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
37688350|NCT02250651|69164459|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
37688351|NCT02250651|69164460|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
37688352|NCT02250651|69164458|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
37688353|NCT02250651|69164459|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
37688354|NCT02250651|69164460|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
37688355|NCT02250651|69164458|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
37688356|NCT02250651|69164459|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
37688357|NCT02250651|69164460|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
37688358|NCT02377921|69164470|FG000|Overall Study|Subject non-compliance|1|||
37688359|NCT02377921|69164471|FG001|Overall Study|Subject non-compliance|1|||
37688360|NCT02311153|69164479|FG000|Overall Study|Lost to Follow-up|5|||
37688361|NCT02311153|69164480|FG001|Overall Study|Lost to Follow-up|7|||
37688362|NCT02195427|69164488|FG000|Overall Study|Did not consent to study extension|13|||
37688363|NCT02195427|69164489|FG001|Overall Study|Did not consent to study extension|9|||
37688364|NCT02195427|69164488|FG000|Overall Study|Withdrawal by Subject|4|||
37688365|NCT02195427|69164489|FG001|Overall Study|Withdrawal by Subject|2|||
37688366|NCT02195427|69164488|FG000|Overall Study|Lost to Follow-up|0|||
37688367|NCT02195427|69164489|FG001|Overall Study|Lost to Follow-up|1|||
37688368|NCT02195427|69164488|FG000|Overall Study|Protocol Violation|7|||
37688369|NCT02195427|69164489|FG001|Overall Study|Protocol Violation|14|||
37688370|NCT02195427|69164488|FG000|Overall Study|Conditional re-treatment at W52|2|||
37688371|NCT02195427|69164489|FG001|Overall Study|Conditional re-treatment at W52|1|||
37688372|NCT02214225|69164502|FG000|Overall Study|Lost to Follow-up|46|||
37688373|NCT02214225|69164503|FG001|Overall Study|Lost to Follow-up|18|||
37688374|NCT02214225|69164504|FG002|Overall Study|Lost to Follow-up|18|||
37688375|NCT02214225|69164502|FG000|Overall Study|Withdrawal by Subject|2|||
37688376|NCT02214225|69164503|FG001|Overall Study|Withdrawal by Subject|0|||
37688377|NCT02214225|69164504|FG002|Overall Study|Withdrawal by Subject|2|||
37688378|NCT02214225|69164502|FG000|Overall Study|Death|5|||
37688379|NCT02214225|69164503|FG001|Overall Study|Death|0|||
37688380|NCT02214225|69164504|FG002|Overall Study|Death|1|||
37688381|NCT02214225|69164502|FG000|Overall Study|randomized in error, not vaccinated|2|||
37688382|NCT02214225|69164503|FG001|Overall Study|randomized in error, not vaccinated|1|||
37688383|NCT02214225|69164504|FG002|Overall Study|randomized in error, not vaccinated|1|||
37688384|NCT02250183|69164535|FG000|Overall Study|Withdrawal by Subject|2|||
37688385|NCT02250183|69164535|FG000|Overall Study|Adverse Event|5|||
37688386|NCT02250183|69164535|FG000|Overall Study|Lost to Follow-up|1|||
37688387|NCT02249949|69164542|FG000|Overall Study|Cancelled prior to treatment|2|||
37688388|NCT02249091|69164548|FG000|Overall Study|Lack of Efficacy|8|||
37688389|NCT02249091|69164549|FG001|Overall Study|Lack of Efficacy|3|||
37863414|NCT00996892|69547132|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
37688390|NCT02249091|69164548|FG000|Overall Study|Physician Decision|4|||
37688391|NCT02249091|69164549|FG001|Overall Study|Physician Decision|1|||
37688392|NCT02249091|69164548|FG000|Overall Study|Withdrawal by Subject|2|||
37688393|NCT02249091|69164549|FG001|Overall Study|Withdrawal by Subject|2|||
37688394|NCT02249091|69164548|FG000|Overall Study|Death|3|||
37688395|NCT02249091|69164549|FG001|Overall Study|Death|4|||
37688396|NCT02249091|69164548|FG000|Overall Study|Adverse Event|1|||
37688397|NCT02249091|69164549|FG001|Overall Study|Adverse Event|0|||
37688398|NCT02249091|69164548|FG000|Overall Study|Stable disease with following SCT|0|||
37863415|NCT00996892|69547133|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
37688399|NCT02249091|69164549|FG001|Overall Study|Stable disease with following SCT|1|||
37688400|NCT02249091|69164548|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
37688401|NCT02249091|69164549|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
37688402|NCT02249091|69164548|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
37688403|NCT02249091|69164549|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
37688404|NCT02249091|69164548|FG000|Overall Study|Refractory AML|1|||
37688405|NCT02249091|69164549|FG001|Overall Study|Refractory AML|1|||
37688406|NCT02248857|69164558|FG000|3 Month|Withdrawal by Subject|9|||
37688407|NCT02248857|69164559|FG001|3 Month|Withdrawal by Subject|3|||
37688408|NCT02248857|69164560|FG002|3 Month|Withdrawal by Subject|4|||
37688409|NCT02248857|69164558|FG000|3 Month|Unable to reach for 3 month|35|||
37688410|NCT02248857|69164559|FG001|3 Month|Unable to reach for 3 month|29|||
37688411|NCT02248857|69164560|FG002|3 Month|Unable to reach for 3 month|26|||
37688412|NCT02248857|69164558|FG000|3 Month|Partially completed, unable to finish|2|||
37688413|NCT02248857|69164559|FG001|3 Month|Partially completed, unable to finish|2|||
37688414|NCT02248857|69164560|FG002|3 Month|Partially completed, unable to finish|1|||
37688415|NCT02248857|69164558|FG000|6 Month|Lost to Follow-up|27|||
37688416|NCT02248857|69164559|FG001|6 Month|Lost to Follow-up|26|||
37688417|NCT02248857|69164560|FG002|6 Month|Lost to Follow-up|15|||
37688418|NCT02248857|69164558|FG000|6 Month|Partially completed, unable to finish|0|||
37688419|NCT02248857|69164559|FG001|6 Month|Partially completed, unable to finish|1|||
37688420|NCT02248857|69164560|FG002|6 Month|Partially completed, unable to finish|0|||
37688421|NCT02248857|69164558|FG000|6 Month|Withdrawal by Subject|0|||
37688422|NCT02248857|69164559|FG001|6 Month|Withdrawal by Subject|2|||
37688423|NCT02248857|69164560|FG002|6 Month|Withdrawal by Subject|2|||
37688424|NCT02248857|69164558|FG000|6 Month|Death|1|||
37688425|NCT02248857|69164559|FG001|6 Month|Death|0|||
37688426|NCT02248857|69164560|FG002|6 Month|Death|0|||
37688427|NCT02213055|69164570|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
37688428|NCT02213055|69164571|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
37688429|NCT02213055|69164570|FG000|Overall Study|Protocol was not Followed during Study|1|||
37688430|NCT02213055|69164571|FG001|Overall Study|Protocol was not Followed during Study|0|||
37688431|NCT02213055|69164570|FG000|Overall Study|Documentation Issue at Enrollment|1|||
37688432|NCT02213055|69164571|FG001|Overall Study|Documentation Issue at Enrollment|0|||
37688433|NCT02213055|69164570|FG000|Overall Study|Documentation Issue during Study|10|||
37688434|NCT02213055|69164571|FG001|Overall Study|Documentation Issue during Study|0|||
37688435|NCT02213055|69164570|FG000|Overall Study|Did not have Live Lice|8|||
37688436|NCT02213055|69164571|FG001|Overall Study|Did not have Live Lice|0|||
37688437|NCT02213055|69164570|FG000|Overall Study|Had another Treatment during the Study|3|||
37688438|NCT02213055|69164571|FG001|Overall Study|Had another Treatment during the Study|0|||
37688439|NCT02213055|69164570|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
37688440|NCT02213055|69164571|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
37688441|NCT02213055|69164570|FG000|Overall Study|Did not Return to School|5|||
37688442|NCT02213055|69164571|FG001|Overall Study|Did not Return to School|0|||
37688443|NCT02310763|69164580|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
37688444|NCT02310763|69164581|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
37688445|NCT02310763|69164582|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
37688446|NCT02310763|69164580|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
37688447|NCT02310763|69164581|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
37688448|NCT02310763|69164582|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
37688449|NCT02310763|69164580|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
37688450|NCT02310763|69164581|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
37688451|NCT02310763|69164582|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
37688452|NCT02310763|69164580|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
37688453|NCT02310763|69164581|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
37688454|NCT02310763|69164582|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
37688455|NCT02310763|69164580|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
37688456|NCT02310763|69164581|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
37688457|NCT02310763|69164582|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
37688458|NCT02342743|69164608|FG000|Baseline Period|Withdrawal by Subject|3|||
37688459|NCT02342743|69164608|FG000|Baseline Period|Lost to Follow-up|2|||
37688460|NCT02342743|69164608|FG000|Baseline Period|Change in prophylactic medication|3|||
37688461|NCT02342743|69164608|FG000|Baseline Period|Screening failure regarding baseline|7|||
37688462|NCT02342743|69164608|FG000|Treatment Period|Withdrawal by Subject|2|||
37688463|NCT02342743|69164608|FG000|Treatment Period|Lost to Follow-up|8|||
37688464|NCT02342743|69164608|FG000|Treatment Period|Change in prophylactic medication|1|||
37688465|NCT02377063|69164612|FG000|Overall Study|Non-compliance|5|||
37688466|NCT02309515|69164618|FG000|Overall Study|Withdrawal by Subject|0|||
37688467|NCT02309515|69164619|FG001|Overall Study|Withdrawal by Subject|1|||
37688468|NCT02309359|69164630|FG000|Overall Study|Adverse Event|4|||
37688469|NCT02309359|69164631|FG001|Overall Study|Adverse Event|5|||
37688470|NCT02309359|69164632|FG002|Overall Study|Adverse Event|5|||
37688471|NCT02309359|69164633|FG003|Overall Study|Adverse Event|4|||
37688472|NCT02309359|69164634|FG004|Overall Study|Adverse Event|4|||
37688473|NCT02309359|69164630|FG000|Overall Study|Death|1|||
37688474|NCT02309359|69164631|FG001|Overall Study|Death|0|||
37688475|NCT02309359|69164632|FG002|Overall Study|Death|0|||
37688476|NCT02309359|69164633|FG003|Overall Study|Death|0|||
37688477|NCT02309359|69164634|FG004|Overall Study|Death|0|||
37688478|NCT02309359|69164630|FG000|Overall Study|Withdrawal by Subject|2|||
37688479|NCT02309359|69164631|FG001|Overall Study|Withdrawal by Subject|2|||
37688480|NCT02309359|69164632|FG002|Overall Study|Withdrawal by Subject|4|||
37688481|NCT02309359|69164633|FG003|Overall Study|Withdrawal by Subject|4|||
37688482|NCT02309359|69164634|FG004|Overall Study|Withdrawal by Subject|0|||
37688483|NCT02309359|69164630|FG000|Overall Study|Lack of Efficacy|3|||
37688484|NCT02309359|69164631|FG001|Overall Study|Lack of Efficacy|1|||
37688485|NCT02309359|69164632|FG002|Overall Study|Lack of Efficacy|0|||
37688486|NCT02309359|69164633|FG003|Overall Study|Lack of Efficacy|0|||
37688487|NCT02309359|69164634|FG004|Overall Study|Lack of Efficacy|3|||
37688488|NCT02309359|69164630|FG000|Overall Study|Lost to Follow-up|0|||
37688489|NCT02309359|69164631|FG001|Overall Study|Lost to Follow-up|0|||
37688490|NCT02309359|69164632|FG002|Overall Study|Lost to Follow-up|0|||
37688491|NCT02309359|69164633|FG003|Overall Study|Lost to Follow-up|1|||
37688492|NCT02309359|69164634|FG004|Overall Study|Lost to Follow-up|0|||
37688493|NCT02309359|69164630|FG000|Overall Study|Other|2|||
37688494|NCT02309359|69164631|FG001|Overall Study|Other|0|||
37688495|NCT02309359|69164632|FG002|Overall Study|Other|2|||
37688496|NCT02309359|69164633|FG003|Overall Study|Other|3|||
37688497|NCT02309359|69164634|FG004|Overall Study|Other|2|||
37688498|NCT02247531|69164650|FG000|Overall Study|Adverse Event|3|||
37688499|NCT02247531|69164651|FG001|Overall Study|Adverse Event|4|||
37688500|NCT02247531|69164652|FG002|Overall Study|Adverse Event|9|||
37688501|NCT02247531|69164650|FG000|Overall Study|Death|8|||
37688502|NCT02247531|69164651|FG001|Overall Study|Death|9|||
37688503|NCT02247531|69164652|FG002|Overall Study|Death|5|||
37688504|NCT02247531|69164650|FG000|Overall Study|Lost to Follow-up|1|||
37688505|NCT02247531|69164651|FG001|Overall Study|Lost to Follow-up|8|||
37688506|NCT02247531|69164652|FG002|Overall Study|Lost to Follow-up|3|||
37688507|NCT02247531|69164650|FG000|Overall Study|Non-compliance|2|||
37688508|NCT02247531|69164651|FG001|Overall Study|Non-compliance|2|||
37688509|NCT02247531|69164652|FG002|Overall Study|Non-compliance|0|||
37688510|NCT02247531|69164650|FG000|Overall Study|Withdrawal by Subject|26|||
37688511|NCT02247531|69164651|FG001|Overall Study|Withdrawal by Subject|31|||
37688512|NCT02247531|69164652|FG002|Overall Study|Withdrawal by Subject|25|||
37688513|NCT02247531|69164650|FG000|Overall Study|Study Terminated by Sponsor|64|||
37688514|NCT02247531|69164651|FG001|Overall Study|Study Terminated by Sponsor|66|||
37688515|NCT02247531|69164652|FG002|Overall Study|Study Terminated by Sponsor|62|||
37688516|NCT02247531|69164650|FG000|Overall Study|Physician Decision|0|||
37688517|NCT02247531|69164651|FG001|Overall Study|Physician Decision|2|||
37688518|NCT02247531|69164652|FG002|Overall Study|Physician Decision|2|||
37688519|NCT02247531|69164650|FG000|Overall Study|Unspecified Reason|2|||
37688520|NCT02247531|69164651|FG001|Overall Study|Unspecified Reason|3|||
37688521|NCT02247531|69164652|FG002|Overall Study|Unspecified Reason|4|||
37688522|NCT02375971|69164663|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
37688523|NCT02375971|69164664|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
37688524|NCT02375971|69164665|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
37688525|NCT02375971|69164663|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
37688526|NCT02375971|69164664|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
37688527|NCT02375971|69164665|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
37688528|NCT02375971|69164663|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
37688529|NCT02375971|69164664|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
37688530|NCT02375971|69164665|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
37688531|NCT02375971|69164663|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
37688532|NCT02375971|69164664|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
37688533|NCT02375971|69164665|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
37688534|NCT02375971|69164663|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
37688535|NCT02375971|69164664|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
37688536|NCT02375971|69164665|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
37688537|NCT02375971|69164663|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
37688538|NCT02375971|69164664|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
37688539|NCT02375971|69164665|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
37688540|NCT02375971|69164663|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
37688541|NCT02375971|69164664|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
37688542|NCT02375971|69164665|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
37688543|NCT02375971|69164663|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
37688544|NCT02375971|69164664|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
37688545|NCT02375971|69164665|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
37688546|NCT02308735|69164677|FG000|Overall Study|Physician Decision|2|||
37688547|NCT02308735|69164678|FG001|Overall Study|Physician Decision|0|||
37688548|NCT02308735|69164679|FG002|Overall Study|Physician Decision|0|||
37688549|NCT02308735|69164680|FG003|Overall Study|Physician Decision|2|||
37688550|NCT02212197|69164693|FG000|Overall Study|Need for radiotherapy|1|||
37688551|NCT02212197|69164694|FG001|Overall Study|Need for radiotherapy|0|||
37688552|NCT02212197|69164695|FG002|Overall Study|Need for radiotherapy|0|||
37688553|NCT02193165|69164706|FG000|4 Week Product Use|Lost to Follow-up|1|||
37688554|NCT02193165|69164707|FG001|4 Week Product Use|Lost to Follow-up|1|||
37688555|NCT02193165|69164708|FG002|4 Week Product Use|Lost to Follow-up|1|||
37688556|NCT02193165|69164706|FG000|6 Week Product Use|Lost to Follow-up|0|||
37688557|NCT02193165|69164707|FG001|6 Week Product Use|Lost to Follow-up|1|||
37688558|NCT02193165|69164708|FG002|6 Week Product Use|Lost to Follow-up|0|||
37688559|NCT01617460|69164716|FG000|Overall Study|Adverse Event|10|||
37688560|NCT01617460|69164716|FG000|Overall Study|Physician Decision|16|||
37688561|NCT01617460|69164716|FG000|Overall Study|Protocol Violation|5|||
37688562|NCT01617460|69164716|FG000|Overall Study|Withdrawal by Subject|9|||
37688563|NCT01890148|69164720|FG000|Overall Study|Adverse Event|1|||
37688564|NCT01889602|69164727|FG000|First Intervention|Adverse Event|1|||
37688565|NCT01889602|69164728|FG001|First Intervention|Adverse Event|1|||
37688566|NCT01889602|69164729|FG002|First Intervention|Adverse Event|1|||
37688567|NCT01889602|69164727|FG000|First Intervention|Protocol Violation|0|||
37688568|NCT01889602|69164728|FG001|First Intervention|Protocol Violation|1|||
37688569|NCT01889602|69164729|FG002|First Intervention|Protocol Violation|1|||
37688570|NCT01889602|69164727|FG000|First Intervention|Study ending|0|||
37688571|NCT01889602|69164728|FG001|First Intervention|Study ending|1|||
37688572|NCT01889602|69164729|FG002|First Intervention|Study ending|0|||
37688573|NCT01889602|69164727|FG000|Second Intervention|Adverse Event|0|||
37688574|NCT01889602|69164728|FG001|Second Intervention|Adverse Event|0|||
37688575|NCT01889602|69164729|FG002|Second Intervention|Adverse Event|1|||
37688576|NCT01889602|69164727|FG000|Second Intervention|Study ending|1|||
37688577|NCT01889602|69164728|FG001|Second Intervention|Study ending|0|||
37688578|NCT01889602|69164729|FG002|Second Intervention|Study ending|0|||
37688579|NCT01889602|69164727|FG000|Second Intervention|Withdrawal by Subject|0|||
37688580|NCT01889602|69164728|FG001|Second Intervention|Withdrawal by Subject|0|||
37688581|NCT01889602|69164729|FG002|Second Intervention|Withdrawal by Subject|1|||
37688582|NCT01889602|69164727|FG000|Third Intervention|Protocol Violation|1|||
37688583|NCT01889602|69164728|FG001|Third Intervention|Protocol Violation|0|||
37688584|NCT01889602|69164729|FG002|Third Intervention|Protocol Violation|0|||
37688585|NCT01889602|69164727|FG000|Third Intervention|Withdrawal by Subject|2|||
37688586|NCT01889602|69164728|FG001|Third Intervention|Withdrawal by Subject|2|||
37688587|NCT01889602|69164729|FG002|Third Intervention|Withdrawal by Subject|0|||
37688588|NCT01935700|69164747|FG000|Overall Study|Withdrawal by Subject|1|||
37688589|NCT01935700|69164748|FG001|Overall Study|Withdrawal by Subject|0|||
37688590|NCT01935700|69164747|FG000|Overall Study|Physician Decision|4|||
37688591|NCT01935700|69164748|FG001|Overall Study|Physician Decision|0|||
37688592|NCT01618162|69164758|FG000|Overall Study|Protocol Violation|13|||
37688593|NCT01618162|69164759|FG001|Overall Study|Protocol Violation|10|||
37863416|NCT00996892|69547134|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
37688594|NCT01618162|69164758|FG000|Overall Study|Adverse Event|9|||
37688595|NCT01618162|69164759|FG001|Overall Study|Adverse Event|2|||
37688596|NCT01618162|69164758|FG000|Overall Study|Withdrawal Criteria|2|||
37688597|NCT01618162|69164759|FG001|Overall Study|Withdrawal Criteria|10|||
37688598|NCT01618162|69164758|FG000|Overall Study|Unclassified|14|||
37688599|NCT01618162|69164759|FG001|Overall Study|Unclassified|13|||
37688600|NCT02193087|69164769|FG000|Overall Study|Adverse Event|2|||
37688601|NCT02193087|69164770|FG001|Overall Study|Adverse Event|0|||
37688602|NCT02193087|69164771|FG002|Overall Study|Adverse Event|0|||
37688603|NCT02193087|69164772|FG003|Overall Study|Adverse Event|11|||
37688604|NCT02193087|69164769|FG000|Overall Study|Lost to Follow-up|14|||
37688605|NCT02193087|69164770|FG001|Overall Study|Lost to Follow-up|6|||
37688606|NCT02193087|69164771|FG002|Overall Study|Lost to Follow-up|4|||
37688607|NCT02193087|69164772|FG003|Overall Study|Lost to Follow-up|37|||
37688608|NCT02193087|69164769|FG000|Overall Study|Protocol Violation|2|||
37688609|NCT02193087|69164770|FG001|Overall Study|Protocol Violation|0|||
37688610|NCT02193087|69164771|FG002|Overall Study|Protocol Violation|1|||
37688611|NCT02193087|69164772|FG003|Overall Study|Protocol Violation|2|||
37688612|NCT02193087|69164769|FG000|Overall Study|Withdrawal by Subject|10|||
37688613|NCT02193087|69164770|FG001|Overall Study|Withdrawal by Subject|3|||
37863417|NCT00996892|69547135|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
37688614|NCT02193087|69164771|FG002|Overall Study|Withdrawal by Subject|1|||
37688615|NCT02193087|69164772|FG003|Overall Study|Withdrawal by Subject|19|||
37688616|NCT02193087|69164769|FG000|Overall Study|Other Reason Not Specified|7|||
37688617|NCT02193087|69164770|FG001|Overall Study|Other Reason Not Specified|2|||
37688618|NCT02193087|69164771|FG002|Overall Study|Other Reason Not Specified|1|||
37688619|NCT02193087|69164772|FG003|Overall Study|Other Reason Not Specified|9|||
37688620|NCT02193087|69164769|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
37688621|NCT02193087|69164770|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
37688622|NCT02193087|69164771|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
37688623|NCT02193087|69164772|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
37688624|NCT01617070|69164789|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
37688625|NCT02341417|69164802|FG000|Overall Study|Withdrawal by Subject|0|||
37688626|NCT02341417|69164803|FG001|Overall Study|Withdrawal by Subject|2|||
37688627|NCT02341417|69164804|FG002|Overall Study|Withdrawal by Subject|0|||
37688628|NCT02341417|69164802|FG000|Overall Study|Decision by sponsor|2|||
37688629|NCT02341417|69164803|FG001|Overall Study|Decision by sponsor|0|||
37688630|NCT02341417|69164804|FG002|Overall Study|Decision by sponsor|0|||
37688631|NCT02341417|69164802|FG000|Overall Study|Death|0|||
37688632|NCT02341417|69164803|FG001|Overall Study|Death|0|||
37688633|NCT02341417|69164804|FG002|Overall Study|Death|1|||
37688634|NCT01888900|69164815|FG000|Overall Study|failed treatment|0|||
37688635|NCT01888900|69164816|FG001|Overall Study|failed treatment|2|||
37688636|NCT02340949|69164826|FG000|Overall Study|Adverse Event|4|||
37688637|NCT02340949|69164827|FG001|Overall Study|Adverse Event|2|||
37688638|NCT02340949|69164826|FG000|Overall Study|Withdrawal by Subject|2|||
37688639|NCT02340949|69164827|FG001|Overall Study|Withdrawal by Subject|0|||
37688640|NCT02340949|69164826|FG000|Overall Study|Progression disease|6|||
37688641|NCT02340949|69164827|FG001|Overall Study|Progression disease|2|||
37688642|NCT02340949|69164826|FG000|Overall Study|Death|3|||
37688643|NCT02340949|69164827|FG001|Overall Study|Death|0|||
37688644|NCT02340949|69164826|FG000|Overall Study|Physician Decision|1|||
37688645|NCT02340949|69164827|FG001|Overall Study|Physician Decision|0|||
37688646|NCT01646203|69164836|FG000|Overall Study|Adverse Event|2|||
37688647|NCT01646203|69164837|FG001|Overall Study|Adverse Event|0|||
37688648|NCT01646203|69164838|FG002|Overall Study|Adverse Event|1|||
37688649|NCT01646203|69164836|FG000|Overall Study|Withdrawal by Subject|0|||
37688650|NCT01646203|69164837|FG001|Overall Study|Withdrawal by Subject|1|||
37688651|NCT01646203|69164838|FG002|Overall Study|Withdrawal by Subject|0|||
37688652|NCT01646203|69164836|FG000|Overall Study|Physician's Decision|0|||
37688653|NCT01646203|69164837|FG001|Overall Study|Physician's Decision|1|||
37688654|NCT01646203|69164838|FG002|Overall Study|Physician's Decision|0|||
37688655|NCT02375347|69164851|FG000|Overall Study|Protocol Violation|1|||
37688656|NCT02374957|69164857|FG000|Overall Study|Patient did not complete forms correctly|1|||
37688657|NCT02374957|69164858|FG001|Overall Study|Patient did not complete forms correctly|0|||
37688658|NCT02374255|69164868|FG000|Overall Study|Withdrawal by Subject|2|||
37688659|NCT02374255|69164869|FG001|Overall Study|Withdrawal by Subject|0|||
37688660|NCT02374255|69164870|FG002|Overall Study|Withdrawal by Subject|0|||
37688661|NCT02374255|69164871|FG003|Overall Study|Withdrawal by Subject|0|||
37688662|NCT02308033|69164889|FG000|Overall Study|Normal Gram stain at Baseline|13|||
37688663|NCT02308033|69164890|FG001|Overall Study|Normal Gram stain at Baseline|10|||
37688664|NCT02308033|69164889|FG000|Overall Study|Positive for STD at Baseline|7|||
37688665|NCT02308033|69164890|FG001|Overall Study|Positive for STD at Baseline|4|||
37688666|NCT02308033|69164889|FG000|Overall Study|Lost to Follow-up|6|||
37688667|NCT02308033|69164890|FG001|Overall Study|Lost to Follow-up|5|||
37688668|NCT02339155|69164898|FG000|Overall Study|Adverse Event|0|||
37688669|NCT02339155|69164899|FG001|Overall Study|Adverse Event|6|||
37688670|NCT02339155|69164898|FG000|Overall Study|Death|1|||
37688671|NCT02339155|69164899|FG001|Overall Study|Death|1|||
37688672|NCT02339155|69164898|FG000|Overall Study|Lost to Follow-up|8|||
37688673|NCT02339155|69164899|FG001|Overall Study|Lost to Follow-up|9|||
37688674|NCT02339155|69164898|FG000|Overall Study|Physician Decision|2|||
37688675|NCT02339155|69164899|FG001|Overall Study|Physician Decision|1|||
37688676|NCT02339155|69164898|FG000|Overall Study|Withdrawal by Subject|4|||
37688677|NCT02339155|69164899|FG001|Overall Study|Withdrawal by Subject|4|||
37688678|NCT02211261|69164918|FG000|Overall Study|Withdrawal by Subject|0|||
37688679|NCT02211261|69164919|FG001|Overall Study|Withdrawal by Subject|0|||
37688680|NCT02211261|69164920|FG002|Overall Study|Withdrawal by Subject|1|||
37688681|NCT02211261|69164921|FG003|Overall Study|Withdrawal by Subject|0|||
37688682|NCT02211261|69164922|FG004|Overall Study|Withdrawal by Subject|2|||
37688683|NCT02211261|69164923|FG005|Overall Study|Withdrawal by Subject|0|||
37688684|NCT02211261|69164924|FG006|Overall Study|Withdrawal by Subject|0|||
37688685|NCT02211261|69164925|FG007|Overall Study|Withdrawal by Subject|0|||
37688686|NCT02211261|69164926|FG008|Overall Study|Withdrawal by Subject|0|||
37688687|NCT02211261|69164927|FG009|Overall Study|Withdrawal by Subject|0|||
37688688|NCT02211261|69164928|FG010|Overall Study|Withdrawal by Subject|0|||
37688689|NCT02211261|69164918|FG000|Overall Study|Other|0|||
37688690|NCT02211261|69164919|FG001|Overall Study|Other|0|||
37688691|NCT02211261|69164920|FG002|Overall Study|Other|0|||
37688692|NCT02211261|69164921|FG003|Overall Study|Other|0|||
37688693|NCT02211261|69164922|FG004|Overall Study|Other|0|||
37688694|NCT02211261|69164923|FG005|Overall Study|Other|1|||
37688695|NCT02211261|69164924|FG006|Overall Study|Other|0|||
37688696|NCT02211261|69164925|FG007|Overall Study|Other|0|||
37688697|NCT02211261|69164926|FG008|Overall Study|Other|0|||
37967472|NCT03894540|69654404|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
37967473|NCT03894540|69654405|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
37967474|NCT03894540|69654400|FG000|Overall Study|Progressive Disease Clinical|1|||
37967475|NCT03894540|69654401|FG001|Overall Study|Progressive Disease Clinical|1|||
37967476|NCT03894540|69654402|FG002|Overall Study|Progressive Disease Clinical|0|||
37967477|NCT03894540|69654403|FG003|Overall Study|Progressive Disease Clinical|1|||
37967478|NCT03894540|69654404|FG004|Overall Study|Progressive Disease Clinical|5|||
37967479|NCT03894540|69654405|FG005|Overall Study|Progressive Disease Clinical|1|||
37967480|NCT03894540|69654400|FG000|Overall Study|Study termination by sponsor|0|||
37967481|NCT03894540|69654401|FG001|Overall Study|Study termination by sponsor|0|||
37967482|NCT03894540|69654402|FG002|Overall Study|Study termination by sponsor|0|||
37967483|NCT03894540|69654403|FG003|Overall Study|Study termination by sponsor|0|||
37967484|NCT03894540|69654404|FG004|Overall Study|Study termination by sponsor|2|||
37967485|NCT03894540|69654405|FG005|Overall Study|Study termination by sponsor|0|||
37967486|NCT00535626|69654423|FG000|Overall Study|Death|15|||
37967487|NCT00535626|69654423|FG000|Overall Study|Lost to Follow-up|29|||
37967488|NCT00535626|69654423|FG000|Overall Study|Withdrawal by Subject|20|||
37967489|NCT00535626|69654423|FG000|Overall Study|Removal/revision of study component|8|||
37967490|NCT00535626|69654423|FG000|Overall Study|Subject terminated|31|||
37967491|NCT00535626|69654423|FG000|Overall Study|Unable to return|2|||
37967492|NCT03889704|69654446|FG000|Overall Study|Study terminated due to pandemic|1|||
37967493|NCT03887442|69654452|FG000|Overall Study|Adverse Event|1|||
37967494|NCT03887442|69654453|FG001|Overall Study|Adverse Event|0|||
37967495|NCT00425061|69654468|FG000|Overall Study|Adverse Event|1|||
37967496|NCT00425061|69654469|FG001|Overall Study|Adverse Event|0|||
37967497|NCT00425061|69654470|FG002|Overall Study|Adverse Event|0|||
37967498|NCT00425061|69654471|FG003|Overall Study|Adverse Event|2|||
37967499|NCT00425061|69654472|FG004|Overall Study|Adverse Event|2|||
37967500|NCT00425061|69654473|FG005|Overall Study|Adverse Event|0|||
37967501|NCT00425061|69654474|FG006|Overall Study|Adverse Event|0|||
37967502|NCT00425061|69654468|FG000|Overall Study|Lost to Follow-up|0|||
37967503|NCT00425061|69654469|FG001|Overall Study|Lost to Follow-up|1|||
37967504|NCT00425061|69654470|FG002|Overall Study|Lost to Follow-up|0|||
37967505|NCT00425061|69654471|FG003|Overall Study|Lost to Follow-up|0|||
37688698|NCT02211261|69164927|FG009|Overall Study|Other|2|||
37688699|NCT02211261|69164928|FG010|Overall Study|Other|0|||
37688700|NCT02211261|69164918|FG000|Overall Study|Lost to Follow-up|0|||
37967506|NCT00425061|69654472|FG004|Overall Study|Lost to Follow-up|0|||
37967507|NCT00425061|69654473|FG005|Overall Study|Lost to Follow-up|0|||
37967508|NCT00425061|69654474|FG006|Overall Study|Lost to Follow-up|0|||
37688701|NCT02211261|69164919|FG001|Overall Study|Lost to Follow-up|0|||
37688702|NCT02211261|69164920|FG002|Overall Study|Lost to Follow-up|0|||
37688703|NCT02211261|69164921|FG003|Overall Study|Lost to Follow-up|0|||
37967509|NCT00425061|69654468|FG000|Overall Study|Protocol Violation|1|||
37967510|NCT00425061|69654469|FG001|Overall Study|Protocol Violation|0|||
37967511|NCT00425061|69654470|FG002|Overall Study|Protocol Violation|0|||
37863418|NCT00996892|69547136|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
37967512|NCT00425061|69654471|FG003|Overall Study|Protocol Violation|0|||
37863419|NCT00996892|69547137|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
37863420|NCT00996892|69547118|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
37688704|NCT02211261|69164922|FG004|Overall Study|Lost to Follow-up|0|||
37688705|NCT02211261|69164923|FG005|Overall Study|Lost to Follow-up|0|||
37688706|NCT02211261|69164924|FG006|Overall Study|Lost to Follow-up|0|||
37688707|NCT02211261|69164925|FG007|Overall Study|Lost to Follow-up|1|||
37688708|NCT02211261|69164926|FG008|Overall Study|Lost to Follow-up|0|||
37688709|NCT02211261|69164927|FG009|Overall Study|Lost to Follow-up|0|||
37688710|NCT02211261|69164928|FG010|Overall Study|Lost to Follow-up|0|||
37688711|NCT02170077|69164964|FG000|Overall Study|Withdrawal by Subject|3|||
37688712|NCT02170077|69164965|FG001|Overall Study|Withdrawal by Subject|4|||
37688713|NCT02170077|69164966|FG002|Overall Study|Withdrawal by Subject|2|||
37688714|NCT02170077|69164964|FG000|Overall Study|Adverse Event|4|||
37688715|NCT02170077|69164965|FG001|Overall Study|Adverse Event|4|||
37688716|NCT02170077|69164966|FG002|Overall Study|Adverse Event|4|||
37688717|NCT02170077|69164964|FG000|Overall Study|Lost to Follow-up|0|||
37688718|NCT02170077|69164965|FG001|Overall Study|Lost to Follow-up|1|||
37688719|NCT02170077|69164966|FG002|Overall Study|Lost to Follow-up|0|||
37688720|NCT02170077|69164964|FG000|Overall Study|Exclusion criteria|2|||
37688721|NCT02170077|69164965|FG001|Overall Study|Exclusion criteria|2|||
37688722|NCT02170077|69164966|FG002|Overall Study|Exclusion criteria|5|||
37688723|NCT02170077|69164964|FG000|Overall Study|Exacerbation of seizures|0|||
37688724|NCT02170077|69164965|FG001|Overall Study|Exacerbation of seizures|2|||
37688725|NCT02170077|69164966|FG002|Overall Study|Exacerbation of seizures|1|||
37688726|NCT02210091|69164976|FG000|Overall Study|Physician Decision|0|||
37688727|NCT02210091|69164977|FG001|Overall Study|Physician Decision|1|||
37688728|NCT02210091|69164976|FG000|Overall Study|Withdrawal by Sponsor|0|||
37688729|NCT02210091|69164977|FG001|Overall Study|Withdrawal by Sponsor|1|||
37688730|NCT02338999|69165001|FG000|First Intervention|Withdrawal by Subject|3|||
37688731|NCT02338999|69165002|FG001|First Intervention|Withdrawal by Subject|1|||
37688732|NCT02338999|69165001|FG000|Washout Period|Withdrawal by Subject|0|||
37688733|NCT02338999|69165002|FG001|Washout Period|Withdrawal by Subject|2|||
37688734|NCT02338999|69165001|FG000|Second Intervention|Withdrawal by Subject|0|||
37688735|NCT02338999|69165002|FG001|Second Intervention|Withdrawal by Subject|2|||
37688736|NCT02169219|69165008|FG000|Overall Study|Lack of Efficacy|6|||
37688737|NCT02191605|69165022|FG000|Overall Study|Lost to Follow-up|9|||
37688738|NCT02191605|69165023|FG001|Overall Study|Lost to Follow-up|4|||
37688739|NCT02191605|69165024|FG002|Overall Study|Lost to Follow-up|7|||
37688740|NCT02191605|69165025|FG003|Overall Study|Lost to Follow-up|3|||
37688741|NCT02191605|69165026|FG004|Overall Study|Lost to Follow-up|4|||
37688742|NCT02191137|69165038|FG000|Treatment|Death|4|||
37688743|NCT02191137|69165038|FG000|Treatment|Withdrawal by Subject|3|||
37688744|NCT02191137|69165038|FG000|Treatment|Adverse Event|2|||
37688745|NCT02191137|69165038|FG000|Treatment|Other|1|||
37688746|NCT02191137|69165038|FG000|Follow-up|Lost to Follow-up|2|||
37688747|NCT02191137|69165038|FG000|Follow-up|Ongoing/unknown|2|||
37688748|NCT02191137|69165038|FG000|Follow-up|Adverse Event|1|||
37688749|NCT02168439|69165044|FG000|Overall Study|Protocol Violation|0|||
37688750|NCT02168439|69165045|FG001|Overall Study|Protocol Violation|2|||
37688751|NCT02190591|69165053|FG000|Overall Study|Withdrawal by Subject|1|||
37688752|NCT02190591|69165054|FG001|Overall Study|Withdrawal by Subject|8|||
37688753|NCT02190591|69165053|FG000|Overall Study|Protocol Violation|1|||
37688754|NCT02190591|69165054|FG001|Overall Study|Protocol Violation|0|||
37688755|NCT02190591|69165053|FG000|Overall Study|did not use peanut ball as instructed|0|||
37688756|NCT02190591|69165054|FG001|Overall Study|did not use peanut ball as instructed|2|||
37688757|NCT02190591|69165053|FG000|Overall Study|face presentation so she was ineligible|0|||
37688758|NCT02190591|69165054|FG001|Overall Study|face presentation so she was ineligible|1|||
37688759|NCT02190435|69165062|FG000|Overall Study|First 12 patients were lead-ins|12|||
37688760|NCT02190435|69165063|FG001|Overall Study|First 12 patients were lead-ins|0|||
37688761|NCT02190435|69165062|FG000|Overall Study|3 consented screen fails|3|||
37688762|NCT02190435|69165063|FG001|Overall Study|3 consented screen fails|0|||
37688763|NCT02338843|69165071|FG000|Overall Study|Adverse Event|2|||
37688764|NCT02338843|69165072|FG001|Overall Study|Adverse Event|1|||
37688765|NCT02338843|69165071|FG000|Overall Study|Death|40|||
37688766|NCT02338843|69165072|FG001|Overall Study|Death|53|||
37688767|NCT02338843|69165071|FG000|Overall Study|Physician Decision|1|||
37688768|NCT02338843|69165072|FG001|Overall Study|Physician Decision|0|||
37688769|NCT02338843|69165071|FG000|Overall Study|Withdrawal by Subject|0|||
37688770|NCT02338843|69165072|FG001|Overall Study|Withdrawal by Subject|2|||
37688771|NCT02338843|69165071|FG000|Overall Study|Subject Recovered|0|||
37688772|NCT02338843|69165072|FG001|Overall Study|Subject Recovered|2|||
37688773|NCT02338843|69165071|FG000|Overall Study|Discontinued prior to randomizat|1|||
37688774|NCT02338843|69165072|FG001|Overall Study|Discontinued prior to randomizat|0|||
37688775|NCT02190279|69165081|FG000|Overall Study|Withdrawal consent|1|||
37688776|NCT02190279|69165082|FG001|Overall Study|Withdrawal consent|0|||
37688777|NCT02190279|69165083|FG002|Overall Study|Withdrawal consent|1|||
37688778|NCT02190279|69165081|FG000|Overall Study|Lost to Follow-up|2|||
37688779|NCT02190279|69165082|FG001|Overall Study|Lost to Follow-up|0|||
37688780|NCT02190279|69165083|FG002|Overall Study|Lost to Follow-up|0|||
37688781|NCT02190279|69165081|FG000|Overall Study|Refused further treatment|0|||
37688782|NCT02190279|69165082|FG001|Overall Study|Refused further treatment|0|||
37688783|NCT02190279|69165083|FG002|Overall Study|Refused further treatment|1|||
37688784|NCT02190279|69165081|FG000|Overall Study|Screening failure|0|||
37688785|NCT02190279|69165082|FG001|Overall Study|Screening failure|0|||
37688786|NCT02190279|69165083|FG002|Overall Study|Screening failure|1|||
37688787|NCT02135445|69165095|FG000|Overall Study|Lost to Follow-up|1|||
37688788|NCT02135445|69165096|FG001|Overall Study|Lost to Follow-up|0|||
37688789|NCT02135445|69165095|FG000|Overall Study|Withdrawal by Subject|1|||
37688790|NCT02135445|69165096|FG001|Overall Study|Withdrawal by Subject|0|||
37688791|NCT02374099|69165104|FG000|Overall Study|Adverse Event|1|||
37688792|NCT02374099|69165105|FG001|Overall Study|Adverse Event|0|||
37688793|NCT02374099|69165104|FG000|Overall Study|Progressive Disease|35|||
37688794|NCT02374099|69165105|FG001|Overall Study|Progressive Disease|40|||
37688795|NCT02374099|69165104|FG000|Overall Study|Withdrawal by Subject|5|||
37688796|NCT02374099|69165105|FG001|Overall Study|Withdrawal by Subject|1|||
37688797|NCT02374099|69165104|FG000|Overall Study|Miscellaneous|2|||
37688798|NCT02374099|69165105|FG001|Overall Study|Miscellaneous|3|||
37688799|NCT02374099|69165104|FG000|Overall Study|Randomized, but not treated|2|||
37688800|NCT02374099|69165105|FG001|Overall Study|Randomized, but not treated|1|||
37688801|NCT02374099|69165104|FG000|Overall Study|Study Terminated by Sponsor|3|||
37688802|NCT02374099|69165105|FG001|Overall Study|Study Terminated by Sponsor|4|||
37688803|NCT02134977|69165111|FG000|Overall Study|Protocol Deviation|102|||
37688804|NCT02374021|69165117|FG000|Overall Study|Adverse Event|1|||
37688805|NCT02374021|69165118|FG001|Overall Study|Adverse Event|0|||
37688806|NCT02374021|69165117|FG000|Overall Study|Lost to Follow-up|3|||
37688807|NCT02374021|69165118|FG001|Overall Study|Lost to Follow-up|2|||
37688808|NCT02374021|69165117|FG000|Overall Study|Physician Decision|0|||
37688809|NCT02374021|69165118|FG001|Overall Study|Physician Decision|3|||
37688810|NCT02374021|69165117|FG000|Overall Study|Withdrawal by Subject|6|||
37688811|NCT02374021|69165118|FG001|Overall Study|Withdrawal by Subject|5|||
37688812|NCT02374021|69165117|FG000|Overall Study|Poor Adherence|0|||
37863421|NCT00996892|69547119|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
37688813|NCT02374021|69165118|FG001|Overall Study|Poor Adherence|1|||
37688814|NCT02374021|69165117|FG000|Overall Study|Scan protocol not followed|0|||
37688815|NCT02374021|69165118|FG001|Overall Study|Scan protocol not followed|1|||
37688816|NCT02374021|69165117|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
37688817|NCT02374021|69165118|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
37688818|NCT02372383|69165126|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
37688819|NCT02372383|69165127|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
37688820|NCT02372383|69165128|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
37688821|NCT01648699|69165138|FG000|Overall Study|Death|1|||
37688822|NCT01648699|69165138|FG000|Overall Study|Lost to Follow-up|2|||
37688823|NCT01648699|69165138|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
37688824|NCT02134353|69165153|FG000|Overall Study|Adverse Event|10|||
37688825|NCT02134353|69165154|FG001|Overall Study|Adverse Event|6|||
37688826|NCT02134353|69165153|FG000|Overall Study|Lost to Follow-up|1|||
37688827|NCT02134353|69165154|FG001|Overall Study|Lost to Follow-up|1|||
37688828|NCT02134353|69165153|FG000|Overall Study|Lack of Efficacy|2|||
37688829|NCT02134353|69165154|FG001|Overall Study|Lack of Efficacy|1|||
37688830|NCT02134353|69165153|FG000|Overall Study|Withdrawal by Subject|12|||
37688831|NCT02134353|69165154|FG001|Overall Study|Withdrawal by Subject|13|||
37688832|NCT02134353|69165153|FG000|Overall Study|Death|0|||
37688833|NCT02134353|69165154|FG001|Overall Study|Death|1|||
37688834|NCT02134353|69165153|FG000|Overall Study|Pregnancy|0|||
37688835|NCT02134353|69165154|FG001|Overall Study|Pregnancy|1|||
37688836|NCT02134353|69165153|FG000|Overall Study|Relocation|1|||
37688837|NCT02134353|69165154|FG001|Overall Study|Relocation|0|||
37688838|NCT02134353|69165153|FG000|Overall Study|Other - Patient's Choice|0|||
37688839|NCT02134353|69165154|FG001|Overall Study|Other - Patient's Choice|1|||
37688840|NCT01646125|69165162|FG000|Overall Study|Untreated|2|||
37688841|NCT01646125|69165163|FG001|Overall Study|Untreated|5|||
37688842|NCT01646125|69165162|FG000|Overall Study|Adverse Event|2|||
37688843|NCT01646125|69165163|FG001|Overall Study|Adverse Event|1|||
37688844|NCT01646125|69165162|FG000|Overall Study|Death|1|||
37688845|NCT01646125|69165163|FG001|Overall Study|Death|1|||
37688846|NCT01646125|69165162|FG000|Overall Study|Physician Decision|1|||
37688847|NCT01646125|69165163|FG001|Overall Study|Physician Decision|3|||
37688848|NCT01646125|69165162|FG000|Overall Study|Progressive disease|22|||
37688849|NCT01646125|69165163|FG001|Overall Study|Progressive disease|16|||
37688850|NCT01646125|69165162|FG000|Overall Study|Study terminated by sponsor|2|||
37688851|NCT01646125|69165163|FG001|Overall Study|Study terminated by sponsor|1|||
37688852|NCT01646125|69165162|FG000|Overall Study|Subject/Guardian decision|1|||
37688853|NCT01646125|69165163|FG001|Overall Study|Subject/Guardian decision|1|||
37688854|NCT01362790|69165176|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
37688855|NCT01362790|69165177|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
37688856|NCT01362790|69165178|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
37688857|NCT01362790|69165179|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
37688858|NCT01362790|69165180|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
37688859|NCT01362790|69165181|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
37688860|NCT01362790|69165182|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
37688861|NCT01362790|69165176|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
37688862|NCT01362790|69165177|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
37688863|NCT01362790|69165178|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
37688864|NCT01362790|69165179|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
37688865|NCT01362790|69165180|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
37688866|NCT01362790|69165181|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
37863422|NCT00996892|69547120|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
37863423|NCT00996892|69547121|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
37688867|NCT01362790|69165182|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
37688868|NCT01362790|69165176|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
37688869|NCT01362790|69165177|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
37688870|NCT01362790|69165178|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
37863424|NCT00996892|69547122|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
37688871|NCT01362790|69165179|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
37688872|NCT01362790|69165180|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
37688873|NCT01362790|69165181|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
37688874|NCT01362790|69165182|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
37688875|NCT01362790|69165176|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
37688876|NCT01362790|69165177|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
37688877|NCT01362790|69165178|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
37688878|NCT01362790|69165179|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
37688879|NCT01362790|69165180|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
37688880|NCT01362790|69165181|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
37688881|NCT01362790|69165182|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
37688882|NCT01362790|69165176|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
37688883|NCT01362790|69165177|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
37688884|NCT01362790|69165178|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
37688885|NCT01362790|69165179|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
37688886|NCT01362790|69165180|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
37688887|NCT01362790|69165181|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
37688888|NCT01362790|69165182|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
37688889|NCT01362790|69165176|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
37688890|NCT01362790|69165177|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
37688891|NCT01362790|69165178|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
37688892|NCT01362790|69165179|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
37688893|NCT01362790|69165180|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
37688894|NCT01362790|69165181|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
37688895|NCT01362790|69165182|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
37688896|NCT01362790|69165176|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
37688897|NCT01362790|69165177|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
37688898|NCT01362790|69165178|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
37688899|NCT01362790|69165179|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
37688900|NCT01362790|69165180|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
37688901|NCT01362790|69165181|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
37688902|NCT01362790|69165182|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
37688903|NCT01362790|69165176|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
37688904|NCT01362790|69165177|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
37688905|NCT01362790|69165178|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
37688906|NCT01362790|69165179|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
37688907|NCT01362790|69165180|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
37688908|NCT01362790|69165181|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
37688909|NCT01362790|69165182|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
37688910|NCT01362790|69165176|FG000|Pilot Phase & Phase 2|Death on study|0|||
37688911|NCT01362790|69165177|FG001|Pilot Phase & Phase 2|Death on study|0|||
37688912|NCT01362790|69165178|FG002|Pilot Phase & Phase 2|Death on study|0|||
37688913|NCT01362790|69165179|FG003|Pilot Phase & Phase 2|Death on study|1|||
37688914|NCT01362790|69165180|FG004|Pilot Phase & Phase 2|Death on study|0|||
37688915|NCT01362790|69165181|FG005|Pilot Phase & Phase 2|Death on study|0|||
37688916|NCT01362790|69165182|FG006|Pilot Phase & Phase 2|Death on study|0|||
37688917|NCT01362790|69165176|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
37688918|NCT01362790|69165177|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
37688919|NCT01362790|69165178|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
37688920|NCT01362790|69165179|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
37688921|NCT01362790|69165180|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
37688922|NCT01362790|69165181|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
37688923|NCT01362790|69165182|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
37688924|NCT01362790|69165176|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
37688925|NCT01362790|69165177|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
37688926|NCT01362790|69165178|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
37688927|NCT01362790|69165179|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
37688928|NCT01362790|69165180|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
37688929|NCT01362790|69165181|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
37688930|NCT01362790|69165182|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
37688931|NCT01362790|69165176|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
37688932|NCT01362790|69165177|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
37688933|NCT01362790|69165178|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
37688934|NCT01362790|69165179|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
37688935|NCT01362790|69165180|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
37688936|NCT01362790|69165181|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
37688937|NCT01362790|69165182|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
37688938|NCT02167893|69165202|FG000|Overall Study|Investigator transferred|85|||
37688939|NCT02167893|69165202|FG000|Overall Study|Investigator health reasons|10|||
37967513|NCT00425061|69654472|FG004|Overall Study|Protocol Violation|0|||
37688940|NCT02167893|69165202|FG000|Overall Study|Case report forms not collected|68|||
37688941|NCT02167035|69165208|FG000|Overall Study|Adverse Event|2|||
37688942|NCT02167035|69165209|FG001|Overall Study|Adverse Event|2|||
37688943|NCT02167035|69165208|FG000|Overall Study|Lost to Follow-up|3|||
37688944|NCT02167035|69165209|FG001|Overall Study|Lost to Follow-up|3|||
37688945|NCT02167035|69165208|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
37688946|NCT02167035|69165209|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
37688947|NCT01615198|69165219|FG000|Overall Study|Withdrawal by Subject|5|||
37688948|NCT01615198|69165220|FG001|Overall Study|Withdrawal by Subject|5|||
37688949|NCT01615198|69165219|FG000|Overall Study|Protocol deviation|1|||
37688950|NCT01615198|69165220|FG001|Overall Study|Protocol deviation|1|||
37688951|NCT01615198|69165219|FG000|Overall Study|Physician Decision|5|||
37688952|NCT01615198|69165220|FG001|Overall Study|Physician Decision|1|||
37688953|NCT01615198|69165219|FG000|Overall Study|Lost to Follow-up|1|||
37688954|NCT01615198|69165220|FG001|Overall Study|Lost to Follow-up|1|||
37688955|NCT01615198|69165219|FG000|Overall Study|Lack of Efficacy|1|||
37688956|NCT01615198|69165220|FG001|Overall Study|Lack of Efficacy|6|||
37688957|NCT01615198|69165219|FG000|Overall Study|Adverse Event|11|||
37688958|NCT01615198|69165220|FG001|Overall Study|Adverse Event|5|||
37688959|NCT02337907|69165232|FG000|Overall Study|Other than listed|1|||
37688960|NCT02337907|69165233|FG001|Overall Study|Other than listed|0|||
37688961|NCT02337907|69165234|FG002|Overall Study|Other than listed|0|||
37688962|NCT02337907|69165235|FG003|Overall Study|Other than listed|1|||
37688963|NCT02337907|69165236|FG004|Overall Study|Other than listed|1|||
37688964|NCT02337907|69165237|FG005|Overall Study|Other than listed|0|||
37688965|NCT02337907|69165232|FG000|Overall Study|Withdrawal by Subject|2|||
37688966|NCT02337907|69165233|FG001|Overall Study|Withdrawal by Subject|3|||
37688967|NCT02337907|69165234|FG002|Overall Study|Withdrawal by Subject|0|||
37688968|NCT02337907|69165235|FG003|Overall Study|Withdrawal by Subject|2|||
37688969|NCT02337907|69165236|FG004|Overall Study|Withdrawal by Subject|5|||
37688970|NCT02337907|69165237|FG005|Overall Study|Withdrawal by Subject|0|||
37688971|NCT02337907|69165232|FG000|Overall Study|Lost to Follow-up|0|||
37688972|NCT02337907|69165233|FG001|Overall Study|Lost to Follow-up|0|||
37688973|NCT02337907|69165234|FG002|Overall Study|Lost to Follow-up|0|||
37967514|NCT00425061|69654473|FG005|Overall Study|Protocol Violation|0|||
37863425|NCT00996892|69547123|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
37967515|NCT00425061|69654474|FG006|Overall Study|Protocol Violation|0|||
37688974|NCT02337907|69165235|FG003|Overall Study|Lost to Follow-up|0|||
37688975|NCT02337907|69165236|FG004|Overall Study|Lost to Follow-up|0|||
37688976|NCT02337907|69165237|FG005|Overall Study|Lost to Follow-up|1|||
37688977|NCT02337907|69165232|FG000|Overall Study|Adverse Event|1|||
37688978|NCT02337907|69165233|FG001|Overall Study|Adverse Event|1|||
37688979|NCT02337907|69165234|FG002|Overall Study|Adverse Event|1|||
37688980|NCT02337907|69165235|FG003|Overall Study|Adverse Event|1|||
37688981|NCT02337907|69165236|FG004|Overall Study|Adverse Event|4|||
37688982|NCT02337907|69165237|FG005|Overall Study|Adverse Event|0|||
37688983|NCT01913470|69165254|FG000|Overall Study|Lost to Follow-up|0|||
37688984|NCT01913470|69165255|FG001|Overall Study|Lost to Follow-up|1|||
37688985|NCT01913470|69165254|FG000|Overall Study|Physician Decision|0|||
37688986|NCT01913470|69165255|FG001|Overall Study|Physician Decision|1|||
37688987|NCT01913470|69165254|FG000|Overall Study|Withdrawal by Subject|0|||
37688988|NCT01913470|69165255|FG001|Overall Study|Withdrawal by Subject|1|||
37688989|NCT02372071|69165262|FG000|Overall Study|Protocol Violation|18|||
37688990|NCT02337751|69165269|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
37688991|NCT02337751|69165270|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
37688992|NCT02337751|69165269|FG000|Overall Study|Voluntary Withdrawal|6|||
37688993|NCT02337751|69165270|FG001|Overall Study|Voluntary Withdrawal|8|||
37688994|NCT02337751|69165269|FG000|Overall Study|Lack of Efficacy|2|||
37688995|NCT02337751|69165270|FG001|Overall Study|Lack of Efficacy|5|||
37688996|NCT02337751|69165269|FG000|Overall Study|Investigator's Judgement|1|||
37863426|NCT00996892|69547124|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
37863427|NCT00996892|69547125|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
37863428|NCT00996892|69547126|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
37863429|NCT00996892|69547127|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
37863430|NCT00996892|69547128|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
37863431|NCT00996892|69547129|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
37863432|NCT00996892|69547130|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
37863433|NCT00996892|69547131|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
37688997|NCT02337751|69165270|FG001|Overall Study|Investigator's Judgement|0|||
37863434|NCT00996892|69547132|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
37863435|NCT00996892|69547133|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
37863436|NCT00996892|69547134|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
37688998|NCT02166333|69165281|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
37967516|NCT00425061|69654468|FG000|Overall Study|Withdrawal by Subject|0|||
37967517|NCT00425061|69654469|FG001|Overall Study|Withdrawal by Subject|1|||
37967518|NCT00425061|69654470|FG002|Overall Study|Withdrawal by Subject|0|||
37967519|NCT00425061|69654471|FG003|Overall Study|Withdrawal by Subject|0|||
37967520|NCT00425061|69654472|FG004|Overall Study|Withdrawal by Subject|1|||
37967521|NCT00425061|69654473|FG005|Overall Study|Withdrawal by Subject|0|||
37967522|NCT00425061|69654474|FG006|Overall Study|Withdrawal by Subject|3|||
37967523|NCT00425061|69654468|FG000|Overall Study|Sponsor's request|0|||
37967524|NCT00425061|69654469|FG001|Overall Study|Sponsor's request|0|||
37967525|NCT00425061|69654470|FG002|Overall Study|Sponsor's request|0|||
37967526|NCT00425061|69654471|FG003|Overall Study|Sponsor's request|0|||
37967527|NCT00425061|69654472|FG004|Overall Study|Sponsor's request|19|||
37967528|NCT00425061|69654473|FG005|Overall Study|Sponsor's request|4|||
37967529|NCT00425061|69654474|FG006|Overall Study|Sponsor's request|15|||
37967530|NCT00425061|69654468|FG000|Overall Study|Physician Decision|0|||
37967531|NCT00425061|69654469|FG001|Overall Study|Physician Decision|0|||
37967532|NCT00425061|69654470|FG002|Overall Study|Physician Decision|0|||
37967533|NCT00425061|69654471|FG003|Overall Study|Physician Decision|0|||
37688999|NCT02166333|69165282|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
37967534|NCT00425061|69654472|FG004|Overall Study|Physician Decision|1|||
37967535|NCT00425061|69654473|FG005|Overall Study|Physician Decision|0|||
37967536|NCT00425061|69654474|FG006|Overall Study|Physician Decision|0|||
37689000|NCT02166333|69165283|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
37689001|NCT02166333|69165284|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
37863437|NCT00996892|69547135|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
37689002|NCT02166333|69165285|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
37689003|NCT02166333|69165286|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
37689004|NCT02166333|69165281|FG000|Stage 1|Death|4|||
37689005|NCT02166333|69165282|FG001|Stage 1|Death|0|||
37689006|NCT02166333|69165283|FG002|Stage 1|Death|2|||
37689007|NCT02166333|69165284|FG003|Stage 1|Death|0|||
37689008|NCT02166333|69165285|FG004|Stage 1|Death|3|||
37689009|NCT02166333|69165286|FG005|Stage 1|Death|2|||
37689010|NCT02166333|69165281|FG000|Stage 1|Lost to Follow-up|12|||
37689011|NCT02166333|69165282|FG001|Stage 1|Lost to Follow-up|0|||
37689012|NCT02166333|69165283|FG002|Stage 1|Lost to Follow-up|6|||
37689013|NCT02166333|69165284|FG003|Stage 1|Lost to Follow-up|0|||
37689014|NCT02166333|69165285|FG004|Stage 1|Lost to Follow-up|3|||
37863438|NCT00996892|69547136|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
37689015|NCT02166333|69165286|FG005|Stage 1|Lost to Follow-up|3|||
37689016|NCT02166333|69165281|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
37689017|NCT02166333|69165282|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
37689018|NCT02166333|69165283|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
37689019|NCT02166333|69165284|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
37689020|NCT02166333|69165285|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
37689021|NCT02166333|69165286|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
37689022|NCT02166333|69165281|FG000|Stage 2|Death|4|||
37689023|NCT02166333|69165282|FG001|Stage 2|Death|2|||
37689024|NCT02166333|69165283|FG002|Stage 2|Death|1|||
37863439|NCT00996892|69547137|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
37689025|NCT02166333|69165284|FG003|Stage 2|Death|0|||
37689026|NCT02166333|69165285|FG004|Stage 2|Death|0|||
37689027|NCT02166333|69165286|FG005|Stage 2|Death|1|||
37689028|NCT02166333|69165281|FG000|Stage 2|Lost to Follow-up|23|||
37689029|NCT02166333|69165282|FG001|Stage 2|Lost to Follow-up|4|||
37689030|NCT02166333|69165283|FG002|Stage 2|Lost to Follow-up|11|||
37689031|NCT02166333|69165284|FG003|Stage 2|Lost to Follow-up|9|||
37689032|NCT02166333|69165285|FG004|Stage 2|Lost to Follow-up|3|||
37689033|NCT02166333|69165286|FG005|Stage 2|Lost to Follow-up|6|||
37689034|NCT02132949|69165300|FG000|Overall Study|Death|7|||
37689035|NCT02132949|69165301|FG001|Overall Study|Death|13|||
37689036|NCT02132949|69165300|FG000|Overall Study|Lost to Follow-up|14|||
37689037|NCT02132949|69165301|FG001|Overall Study|Lost to Follow-up|4|||
37689038|NCT02132949|69165300|FG000|Overall Study|Withdrawal by Subject|6|||
37689039|NCT02132949|69165301|FG001|Overall Study|Withdrawal by Subject|5|||
37689040|NCT02132949|69165300|FG000|Overall Study|Noncompliance|5|||
37689041|NCT02132949|69165301|FG001|Overall Study|Noncompliance|1|||
37689042|NCT02132949|69165300|FG000|Overall Study|Physician Decision|3|||
37689043|NCT02132949|69165301|FG001|Overall Study|Physician Decision|1|||
37689044|NCT02132949|69165300|FG000|Overall Study|Disease Progression|3|||
37689045|NCT02132949|69165301|FG001|Overall Study|Disease Progression|0|||
37689046|NCT02132949|69165300|FG000|Overall Study|Adverse Event|2|||
37689047|NCT02132949|69165301|FG001|Overall Study|Adverse Event|1|||
37689048|NCT02132949|69165300|FG000|Overall Study|Withdrew Prior to Treatment|1|||
37689049|NCT02132949|69165301|FG001|Overall Study|Withdrew Prior to Treatment|2|||
37689050|NCT02132949|69165300|FG000|Overall Study|Reason Unspecified|0|||
37689051|NCT02132949|69165301|FG001|Overall Study|Reason Unspecified|1|||
37689052|NCT02165397|69165310|FG000|Overall Study|Death|7|||
37689053|NCT02165397|69165311|FG001|Overall Study|Death|10|||
37967537|NCT00425061|69654468|FG000|Overall Study|Other|0|||
37967538|NCT00425061|69654469|FG001|Overall Study|Other|0|||
37967539|NCT00425061|69654470|FG002|Overall Study|Other|0|||
37967540|NCT00425061|69654471|FG003|Overall Study|Other|0|||
37967541|NCT00425061|69654472|FG004|Overall Study|Other|3|||
37967542|NCT00425061|69654473|FG005|Overall Study|Other|0|||
37967543|NCT00425061|69654474|FG006|Overall Study|Other|1|||
37967544|NCT00424827|69654492|FG000|Overall Study|Adverse Event|1|||
37967545|NCT03885726|69654497|FG000|Overall Study|Staffing issues/lost interest|1|||
37967546|NCT03885726|69654497|FG000|Overall Study|Early discharge from hospital|3|||
37967547|NCT00377962|69654507|FG000|Core Study: 0-12 Months|Adverse Event|18|||
37967548|NCT00377962|69654508|FG001|Core Study: 0-12 Months|Adverse Event|2|||
37967549|NCT00377962|69654507|FG000|Core Study: 0-12 Months|Death|3|||
37967550|NCT00377962|69654508|FG001|Core Study: 0-12 Months|Death|0|||
37967551|NCT00377962|69654507|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
37967552|NCT00377962|69654508|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
37967553|NCT00377962|69654507|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
37967554|NCT00377962|69654508|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
37967555|NCT00377962|69654507|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
37967556|NCT00377962|69654508|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
37967557|NCT00377962|69654507|FG000|Extension Study: 12-24 Months|Death|1|||
37967558|NCT00377962|69654508|FG001|Extension Study: 12-24 Months|Death|1|||
37967559|NCT00377962|69654507|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
37689054|NCT02165397|69165312|FG002|Overall Study|Death|8|||
37967560|NCT00377962|69654508|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
37689055|NCT02165397|69165310|FG000|Overall Study|Lost to Follow-up|1|||
37689056|NCT02165397|69165311|FG001|Overall Study|Lost to Follow-up|3|||
37689057|NCT02165397|69165312|FG002|Overall Study|Lost to Follow-up|0|||
37689058|NCT02165397|69165310|FG000|Overall Study|Withdrawal by Subject|6|||
37689059|NCT02165397|69165311|FG001|Overall Study|Withdrawal by Subject|6|||
37689060|NCT02165397|69165312|FG002|Overall Study|Withdrawal by Subject|1|||
37689061|NCT02165397|69165310|FG000|Overall Study|Other, Not Specified|0|||
37689062|NCT02165397|69165311|FG001|Overall Study|Other, Not Specified|0|||
37689063|NCT02165397|69165312|FG002|Overall Study|Other, Not Specified|1|||
37689064|NCT02132637|69165324|FG000|Study Period 1|Withdrawal by Subject|0|||
37689065|NCT02132637|69165325|FG001|Study Period 1|Withdrawal by Subject|4|||
37689066|NCT02132637|69165324|FG000|Study Period 1|Physician Decision|1|||
37689067|NCT02132637|69165325|FG001|Study Period 1|Physician Decision|0|||
37689068|NCT02132637|69165324|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
37689069|NCT02132637|69165325|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
37689070|NCT02132637|69165324|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
37689071|NCT02132637|69165325|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
37689072|NCT02164929|69165335|FG000|Overall Study|Converted to open procedure|1|||
37689073|NCT02164929|69165336|FG001|Overall Study|Converted to open procedure|0|||
37689074|NCT02164929|69165337|FG002|Overall Study|Converted to open procedure|0|||
37689075|NCT02164929|69165338|FG003|Overall Study|Converted to open procedure|2|||
37689076|NCT02164929|69165335|FG000|Overall Study|Failed regional block|0|||
37689077|NCT02164929|69165336|FG001|Overall Study|Failed regional block|0|||
37689078|NCT02164929|69165337|FG002|Overall Study|Failed regional block|1|||
37689079|NCT02164929|69165338|FG003|Overall Study|Failed regional block|0|||
37689080|NCT01888432|69165350|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
37689081|NCT01888432|69165351|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
37689082|NCT01888432|69165350|FG000|12-month Analysis (FAS)|Physician Decision|1|||
37689083|NCT01888432|69165351|FG001|12-month Analysis (FAS)|Physician Decision|1|||
37689084|NCT01888432|69165350|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
37689085|NCT01888432|69165351|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
37689086|NCT01888432|69165350|FG000|12-month Analysis (FAS)|Death|4|||
37689087|NCT01888432|69165351|FG001|12-month Analysis (FAS)|Death|3|||
37689088|NCT01888432|69165350|FG000|24-month Analysis (FAS)|Graft loss|0|||
37689089|NCT01888432|69165351|FG001|24-month Analysis (FAS)|Graft loss|1|||
37689090|NCT01888432|69165350|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
37689091|NCT01888432|69165351|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
37967561|NCT00377962|69654507|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
37967562|NCT00377962|69654508|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
37967563|NCT00377962|69654507|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
37967564|NCT00377962|69654508|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
37967565|NCT00424749|69654520|FG000|Overall Study|Withdrawal by Subject|1|||
37967566|NCT00424593|69654526|FG000|Acute Double-Blind Period|Adverse Event|16|||
37967567|NCT00424593|69654527|FG001|Acute Double-Blind Period|Adverse Event|7|||
37967568|NCT00424593|69654526|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
37967569|NCT00424593|69654527|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
37967570|NCT00424593|69654526|FG000|Acute Double-Blind Period|Protocol Violation|2|||
37967571|NCT00424593|69654527|FG001|Acute Double-Blind Period|Protocol Violation|2|||
37967572|NCT00424593|69654526|FG000|Acute Double-Blind Period|Physician Decision|1|||
37967573|NCT00424593|69654527|FG001|Acute Double-Blind Period|Physician Decision|2|||
37967574|NCT00424593|69654526|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
37967575|NCT00424593|69654527|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
37967576|NCT00424593|69654526|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
37967577|NCT00424593|69654527|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
37967578|NCT00424593|69654526|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
37967579|NCT00424593|69654527|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
37967580|NCT00424593|69654526|FG000|Dose-Blind Extension Period|Adverse Event|18|||
37967581|NCT00424593|69654527|FG001|Dose-Blind Extension Period|Adverse Event|0|||
37967582|NCT00424593|69654526|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
37967583|NCT00424593|69654527|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
37967584|NCT00424593|69654526|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
37967585|NCT00424593|69654527|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
37967586|NCT00424593|69654526|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
37967587|NCT00424593|69654527|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
37967588|NCT00424593|69654526|FG000|Dose-Blind Extension Period|Physician Decision|3|||
37967589|NCT00424593|69654527|FG001|Dose-Blind Extension Period|Physician Decision|0|||
37967590|NCT00369382|69654535|FG000|Overall Study|Death|0|||
37967591|NCT00369382|69654536|FG001|Overall Study|Death|2|||
37967592|NCT00369382|69654535|FG000|Overall Study|Physician Decision|2|||
37967593|NCT00369382|69654536|FG001|Overall Study|Physician Decision|1|||
37967594|NCT00369382|69654535|FG000|Overall Study|Withdrawal by Subject|5|||
37967595|NCT00369382|69654536|FG001|Overall Study|Withdrawal by Subject|0|||
37967596|NCT00369382|69654535|FG000|Overall Study|Randomized, not treated|2|||
37967597|NCT00369382|69654536|FG001|Overall Study|Randomized, not treated|0|||
37967598|NCT00369382|69654535|FG000|Overall Study|Other|1|||
37967599|NCT00369382|69654536|FG001|Overall Study|Other|0|||
37967600|NCT00424515|69654545|FG000|Overall Study|Progressive Disease|10|||
37967601|NCT00424515|69654546|FG001|Overall Study|Progressive Disease|11|||
37967602|NCT00424515|69654545|FG000|Overall Study|Adverse Event|0|||
37967603|NCT00424515|69654546|FG001|Overall Study|Adverse Event|1|||
37967604|NCT00424515|69654545|FG000|Overall Study|Intercurrent Illness|0|||
37967605|NCT00424515|69654546|FG001|Overall Study|Intercurrent Illness|1|||
37967606|NCT00424515|69654545|FG000|Overall Study|Withdrawal by Subject|1|||
37967607|NCT00424515|69654546|FG001|Overall Study|Withdrawal by Subject|0|||
37967608|NCT00377260|69654554|FG000|Overall Study|Lost to Follow-up|0|||
37967609|NCT00377260|69654555|FG001|Overall Study|Lost to Follow-up|1|||
37967610|NCT00377260|69654554|FG000|Overall Study|Withdrawal by Subject|2|||
37967611|NCT00377260|69654555|FG001|Overall Study|Withdrawal by Subject|4|||
37967612|NCT00441441|69654563|FG000|Overall Study|Adverse Event|2|||
37967613|NCT00441441|69654564|FG001|Overall Study|Adverse Event|1|||
37967614|NCT00441441|69654563|FG000|Overall Study|Protocol Violation|4|||
37967615|NCT00441441|69654564|FG001|Overall Study|Protocol Violation|6|||
37967616|NCT00441441|69654563|FG000|Overall Study|Exacerbation of asthma|1|||
37967617|NCT00441441|69654564|FG001|Overall Study|Exacerbation of asthma|2|||
37967618|NCT00441441|69654563|FG000|Overall Study|Withdrawal by Subject|1|||
37967619|NCT00441441|69654564|FG001|Overall Study|Withdrawal by Subject|2|||
37967620|NCT00441441|69654563|FG000|Overall Study|Other|3|||
37967621|NCT00441441|69654564|FG001|Overall Study|Other|3|||
37967622|NCT00436917|69654584|FG000|Overall Study|Withdrawal by Subject|13|||
37967623|NCT00436917|69654584|FG000|Overall Study|Adverse Event|2|||
37967624|NCT00436917|69654584|FG000|Overall Study|Physician Decision|1|||
37967625|NCT00436917|69654584|FG000|Overall Study|Death|1|||
37967626|NCT00436917|69654584|FG000|Overall Study|Lost to Follow-up|1|||
37863440|NCT00996892|69547118|FG000|Expansion Stage 2|Adverse Event|0|||
37967627|NCT00436917|69654584|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
37967628|NCT00436917|69654584|FG000|Overall Study|Increased creatinine|1|||
37967629|NCT00436917|69654584|FG000|Overall Study|Personal conflicts of patient|1|||
37863441|NCT00996892|69547119|FG001|Expansion Stage 2|Adverse Event|0|||
37863442|NCT00996892|69547120|FG002|Expansion Stage 2|Adverse Event|0|||
37863443|NCT00996892|69547121|FG003|Expansion Stage 2|Adverse Event|0|||
37863444|NCT00996892|69547122|FG004|Expansion Stage 2|Adverse Event|0|||
37967630|NCT00436605|69654588|FG000|Overall Study|Protocol Violation|3|||
37967631|NCT00368992|69654592|FG000|Overall Study|Ineligible|5|||
37967632|NCT00368992|69654592|FG000|Overall Study|Refused treatment|3|||
37967633|NCT00368992|69654592|FG000|Overall Study|Lack of Efficacy|63|||
37967634|NCT00368992|69654592|FG000|Overall Study|Adverse Event|26|||
37863445|NCT00996892|69547123|FG005|Expansion Stage 2|Adverse Event|0|||
37863446|NCT00996892|69547124|FG006|Expansion Stage 2|Adverse Event|0|||
37689092|NCT01888432|69165350|FG000|24-month Analysis (FAS)|Physician Decision|2|||
37689093|NCT01888432|69165351|FG001|24-month Analysis (FAS)|Physician Decision|4|||
37689094|NCT01888432|69165350|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
37689095|NCT01888432|69165351|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
37689096|NCT01888432|69165350|FG000|24-month Analysis (FAS)|Death|8|||
37689097|NCT01888432|69165351|FG001|24-month Analysis (FAS)|Death|4|||
37689098|NCT01888432|69165350|FG000|36-month Analysis (Extension)|Death|1|||
37689099|NCT01888432|69165351|FG001|36-month Analysis (Extension)|Death|0|||
37863447|NCT00996892|69547125|FG007|Expansion Stage 2|Adverse Event|0|||
37863448|NCT00996892|69547126|FG008|Expansion Stage 2|Adverse Event|0|||
37689100|NCT02188719|69165363|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
37689101|NCT02188719|69165364|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
37689102|NCT02188719|69165365|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
37689103|NCT02188719|69165366|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
37689104|NCT01934140|69165376|FG000|Persistence Phase (Year 6-10)|Other|24|||
37689105|NCT01934140|69165377|FG001|Persistence Phase (Year 6-10)|Other|6|||
37689106|NCT01934140|69165376|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
37689107|NCT01934140|69165377|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
37689108|NCT01934140|69165376|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
37689109|NCT01934140|69165377|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
37689110|NCT01934140|69165376|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
37689111|NCT01934140|69165377|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
37689112|NCT01934140|69165376|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
37689113|NCT01934140|69165377|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
37689114|NCT01934140|69165376|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
37689115|NCT01934140|69165377|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
37689116|NCT01934140|69165376|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
37689117|NCT01934140|69165377|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
37689118|NCT01934140|69165376|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
37689119|NCT01934140|69165377|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
37689120|NCT01933672|69165385|FG000|Metformin Run-in Period|Adverse Event|1|||
37689121|NCT01933672|69165386|FG001|Metformin Run-in Period|Adverse Event|0|||
37689122|NCT01933672|69165387|FG002|Metformin Run-in Period|Adverse Event|0|||
37689123|NCT01933672|69165388|FG003|Metformin Run-in Period|Adverse Event|0|||
37689124|NCT01933672|69165389|FG004|Metformin Run-in Period|Adverse Event|0|||
37689125|NCT01933672|69165390|FG005|Metformin Run-in Period|Adverse Event|0|||
37689126|NCT01933672|69165391|FG006|Metformin Run-in Period|Adverse Event|0|||
37689127|NCT01933672|69165385|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
37689128|NCT01933672|69165386|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
37689129|NCT01933672|69165387|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
37689130|NCT01933672|69165388|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
37689131|NCT01933672|69165389|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
37689132|NCT01933672|69165390|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
37689133|NCT01933672|69165391|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
37689134|NCT01933672|69165385|FG000|Metformin Run-in Period|Other|5|||
37689135|NCT01933672|69165386|FG001|Metformin Run-in Period|Other|0|||
37689136|NCT01933672|69165387|FG002|Metformin Run-in Period|Other|0|||
37689137|NCT01933672|69165388|FG003|Metformin Run-in Period|Other|0|||
37689138|NCT01933672|69165389|FG004|Metformin Run-in Period|Other|0|||
37689139|NCT01933672|69165390|FG005|Metformin Run-in Period|Other|0|||
37689140|NCT01933672|69165391|FG006|Metformin Run-in Period|Other|0|||
37689141|NCT01933672|69165385|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
37689142|NCT01933672|69165386|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
37689143|NCT01933672|69165387|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
37689144|NCT01933672|69165388|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
37689145|NCT01933672|69165389|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
37689146|NCT01933672|69165390|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
37689147|NCT01933672|69165391|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
37689148|NCT01933672|69165385|FG000|First Intervention Period (12-16 Days)|Other|0|||
37689149|NCT01933672|69165386|FG001|First Intervention Period (12-16 Days)|Other|0|||
37689150|NCT01933672|69165387|FG002|First Intervention Period (12-16 Days)|Other|1|||
37967635|NCT00368992|69654592|FG000|Overall Study|Death|4|||
37967636|NCT00368992|69654592|FG000|Overall Study|Other|9|||
37689151|NCT01933672|69165388|FG003|First Intervention Period (12-16 Days)|Other|0|||
37689152|NCT01933672|69165389|FG004|First Intervention Period (12-16 Days)|Other|0|||
37689153|NCT01933672|69165390|FG005|First Intervention Period (12-16 Days)|Other|1|||
37689154|NCT01933672|69165391|FG006|First Intervention Period (12-16 Days)|Other|0|||
37689155|NCT01933672|69165385|FG000|Second Intervention Period (12-16 Days)|Other|0|||
37689156|NCT01933672|69165386|FG001|Second Intervention Period (12-16 Days)|Other|1|||
37689157|NCT01933672|69165387|FG002|Second Intervention Period (12-16 Days)|Other|1|||
37689158|NCT01933672|69165388|FG003|Second Intervention Period (12-16 Days)|Other|0|||
37689159|NCT01933672|69165389|FG004|Second Intervention Period (12-16 Days)|Other|0|||
37689160|NCT01933672|69165390|FG005|Second Intervention Period (12-16 Days)|Other|0|||
37689161|NCT01933672|69165391|FG006|Second Intervention Period (12-16 Days)|Other|0|||
37689162|NCT01933672|69165385|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
37689163|NCT01933672|69165386|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
37689164|NCT01933672|69165387|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
37689165|NCT01933672|69165388|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
37689166|NCT01933672|69165389|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
37689167|NCT01933672|69165390|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
37689168|NCT01933672|69165391|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
37689169|NCT01933672|69165385|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
37689170|NCT01933672|69165386|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
37689171|NCT01933672|69165387|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
37689172|NCT01933672|69165388|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
37689173|NCT01933672|69165389|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
37689174|NCT01933672|69165390|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
37689175|NCT01933672|69165391|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
37689176|NCT02164539|69165410|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
37689177|NCT02164539|69165411|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
37689178|NCT02164539|69165412|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
37689179|NCT02164539|69165413|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
37689180|NCT02164539|69165414|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
37689181|NCT02164539|69165415|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
37689182|NCT02164539|69165416|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
37689183|NCT02164539|69165410|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
37689184|NCT02164539|69165411|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
37689185|NCT02164539|69165412|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
37689186|NCT02164539|69165413|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
37689187|NCT02164539|69165414|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
37689188|NCT02164539|69165415|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
37689189|NCT02164539|69165416|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
37689190|NCT02164539|69165410|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
37689191|NCT02164539|69165411|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
37689192|NCT02164539|69165412|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
37689193|NCT02164539|69165413|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
37689194|NCT02164539|69165414|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
37689195|NCT02164539|69165415|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
37689196|NCT02164539|69165416|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
37689197|NCT02164539|69165410|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
37689198|NCT02164539|69165411|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
37689199|NCT02164539|69165412|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
37967637|NCT00376246|69654597|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
37967638|NCT00376246|69654598|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
37967639|NCT00376246|69654597|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
37967640|NCT00376246|69654598|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
37967641|NCT00376246|69654597|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
37967642|NCT00376246|69654598|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
37967643|NCT00368836|69654608|FG000|Phase II|Screen Failure|1|||
37689200|NCT02164539|69165413|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
37689201|NCT02164539|69165414|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
37689202|NCT02164539|69165415|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
37689203|NCT02164539|69165416|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
37689204|NCT02164539|69165410|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
37689205|NCT02164539|69165411|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
37689206|NCT02164539|69165412|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
37689207|NCT02164539|69165413|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
37689208|NCT02164539|69165414|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
37689209|NCT02164539|69165415|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
37689210|NCT02164539|69165416|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
37689211|NCT02164539|69165410|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
37689212|NCT02164539|69165411|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
37689213|NCT02164539|69165412|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
37689214|NCT02164539|69165413|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
37689215|NCT02164539|69165414|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
37689216|NCT02164539|69165415|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
37689217|NCT02164539|69165416|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
37689218|NCT02188485|69165433|FG000|Overall Study|Withdrawal by Subject|2|||
37689219|NCT02188485|69165434|FG001|Overall Study|Withdrawal by Subject|1|||
37689220|NCT02188485|69165433|FG000|Overall Study|PI withdrew, lack of capacity|0|||
37689221|NCT02188485|69165434|FG001|Overall Study|PI withdrew, lack of capacity|2|||
37689222|NCT02132247|69165442|FG000|Overall Study|Protocol Violation|1|||
37689223|NCT02132247|69165443|FG001|Overall Study|Protocol Violation|0|||
37689224|NCT01629381|69165451|FG000|Overall Study|Withdrawal by Subject|2|||
37689225|NCT01629381|69165452|FG001|Overall Study|Withdrawal by Subject|5|||
37689226|NCT02131311|69165462|FG000|Overall Study|Adverse Event|2|||
37689227|NCT02131311|69165462|FG000|Overall Study|Protocol Violation|1|||
37689228|NCT02131311|69165462|FG000|Overall Study|Lost to Follow-up|1|||
37689229|NCT01628913|69165469|FG000|Overall Study|Adverse Event|12|||
37689230|NCT01628913|69165470|FG001|Overall Study|Adverse Event|5|||
37689231|NCT01628913|69165469|FG000|Overall Study|Disease Progression|11|||
37689232|NCT01628913|69165470|FG001|Overall Study|Disease Progression|14|||
37689233|NCT01628913|69165469|FG000|Overall Study|Protocol Violation|1|||
37689234|NCT01628913|69165470|FG001|Overall Study|Protocol Violation|0|||
37689235|NCT01628913|69165469|FG000|Overall Study|Death|1|||
37689236|NCT01628913|69165470|FG001|Overall Study|Death|0|||
37689237|NCT01628913|69165469|FG000|Overall Study|study terminated by Sponsor|4|||
37689238|NCT01628913|69165470|FG001|Overall Study|study terminated by Sponsor|9|||
37689239|NCT01628913|69165469|FG000|Overall Study|Withdrawal by Subject|1|||
37689240|NCT01628913|69165470|FG001|Overall Study|Withdrawal by Subject|0|||
37689241|NCT01628913|69165469|FG000|Overall Study|Physician Decision|1|||
37689242|NCT01628913|69165470|FG001|Overall Study|Physician Decision|3|||
37689243|NCT02164383|69165478|FG000|Overall Study|Lost to Follow-up|1|||
37689244|NCT02164383|69165479|FG001|Overall Study|Lost to Follow-up|0|||
37689245|NCT02131233|69165487|FG000|Overall Study|Not Treated|2|||
37689246|NCT02131233|69165488|FG001|Overall Study|Not Treated|3|||
37689247|NCT02131233|69165487|FG000|Overall Study|Adverse Event|7|||
37689248|NCT02131233|69165488|FG001|Overall Study|Adverse Event|6|||
37689249|NCT02131233|69165487|FG000|Overall Study|Death|0|||
37689250|NCT02131233|69165488|FG001|Overall Study|Death|1|||
37689251|NCT02131233|69165487|FG000|Overall Study|Lack of Efficacy|6|||
37689252|NCT02131233|69165488|FG001|Overall Study|Lack of Efficacy|3|||
37689253|NCT02131233|69165487|FG000|Overall Study|Lost to Follow-up|14|||
37689254|NCT02131233|69165488|FG001|Overall Study|Lost to Follow-up|13|||
37689255|NCT02131233|69165487|FG000|Overall Study|Non-Compliance With Study Drug|8|||
37689256|NCT02131233|69165488|FG001|Overall Study|Non-Compliance With Study Drug|5|||
37689257|NCT02131233|69165487|FG000|Overall Study|Physician Decision|7|||
37689258|NCT02131233|69165488|FG001|Overall Study|Physician Decision|0|||
37689259|NCT02131233|69165487|FG000|Overall Study|Pregnancy|4|||
37689260|NCT02131233|69165488|FG001|Overall Study|Pregnancy|0|||
37689261|NCT02131233|69165487|FG000|Overall Study|Withdrawal by Subject|18|||
37689262|NCT02131233|69165488|FG001|Overall Study|Withdrawal by Subject|11|||
37689263|NCT02131155|69165496|FG000|Overall Study|Adverse Event|1|||
37689264|NCT02131155|69165497|FG001|Overall Study|Adverse Event|0|||
37689265|NCT02131155|69165496|FG000|Overall Study|Treatment completed|1|||
37689266|NCT02131155|69165497|FG001|Overall Study|Treatment completed|0|||
37689267|NCT02131155|69165496|FG000|Overall Study|Primary tumour recurrence|2|||
37689268|NCT02131155|69165497|FG001|Overall Study|Primary tumour recurrence|1|||
37689269|NCT02131155|69165496|FG000|Overall Study|Refused to continue study medication|1|||
37689270|NCT02131155|69165497|FG001|Overall Study|Refused to continue study medication|0|||
37689271|NCT02131155|69165496|FG000|Overall Study|Study early termination|20|||
37689272|NCT02131155|69165497|FG001|Overall Study|Study early termination|10|||
37689273|NCT01933594|69165509|FG000|Overall Study|Lost to Follow-up|1|||
37689274|NCT01933594|69165510|FG001|Overall Study|Lost to Follow-up|0|||
37689275|NCT01933594|69165511|FG002|Overall Study|Lost to Follow-up|0|||
37689276|NCT01933594|69165512|FG003|Overall Study|Lost to Follow-up|0|||
37967644|NCT00368836|69654608|FG000|Phase II|Withdrawal by Subject|1|||
37689277|NCT01933594|69165513|FG004|Overall Study|Lost to Follow-up|1|||
37863449|NCT00996892|69547127|FG009|Expansion Stage 2|Adverse Event|0|||
37689278|NCT01933594|69165514|FG005|Overall Study|Lost to Follow-up|0|||
37689279|NCT01933594|69165509|FG000|Overall Study|Ineligible for subsequent study step|0|||
37689280|NCT01933594|69165510|FG001|Overall Study|Ineligible for subsequent study step|0|||
37689281|NCT01933594|69165511|FG002|Overall Study|Ineligible for subsequent study step|0|||
37863450|NCT00996892|69547128|FG010|Expansion Stage 2|Adverse Event|0|||
37689282|NCT01933594|69165512|FG003|Overall Study|Ineligible for subsequent study step|0|||
37689283|NCT01933594|69165513|FG004|Overall Study|Ineligible for subsequent study step|1|||
37689284|NCT01933594|69165514|FG005|Overall Study|Ineligible for subsequent study step|0|||
37689285|NCT01932970|69165532|FG000|Overall Study|Withdrawal by Subject|5|||
37689286|NCT01932970|69165532|FG000|Overall Study|Death|1|||
37689287|NCT01932970|69165532|FG000|Overall Study|Lost to Follow-up|2|||
37689288|NCT01932970|69165532|FG000|Overall Study|Protocol Specified Criteria|10|||
37689289|NCT01912768|69165538|FG000|Overall Study|Adverse Event|2|||
37689290|NCT01912768|69165539|FG001|Overall Study|Adverse Event|0|||
37689291|NCT01912768|69165538|FG000|Overall Study|Lost to Follow-up|2|||
37689292|NCT01912768|69165539|FG001|Overall Study|Lost to Follow-up|1|||
37689293|NCT01912768|69165538|FG000|Overall Study|Withdrawal by Subject|5|||
37689294|NCT01912768|69165539|FG001|Overall Study|Withdrawal by Subject|3|||
37689295|NCT01912768|69165538|FG000|Overall Study|Randomized in error|1|||
37689296|NCT01912768|69165539|FG001|Overall Study|Randomized in error|0|||
37689297|NCT02305849|69165549|FG000|Overall Study|Adverse Event|10|||
37689298|NCT02305849|69165550|FG001|Overall Study|Adverse Event|12|||
37689299|NCT02305849|69165551|FG002|Overall Study|Adverse Event|7|||
37689300|NCT02305849|69165552|FG003|Overall Study|Adverse Event|3|||
37689301|NCT02305849|69165549|FG000|Overall Study|Lack of Efficacy|10|||
37689302|NCT02305849|69165550|FG001|Overall Study|Lack of Efficacy|6|||
37689303|NCT02305849|69165551|FG002|Overall Study|Lack of Efficacy|3|||
37689304|NCT02305849|69165552|FG003|Overall Study|Lack of Efficacy|9|||
37689305|NCT02305849|69165549|FG000|Overall Study|Withdrawal by Subject|2|||
37689306|NCT02305849|69165550|FG001|Overall Study|Withdrawal by Subject|2|||
37689307|NCT02305849|69165551|FG002|Overall Study|Withdrawal by Subject|1|||
37689308|NCT02305849|69165552|FG003|Overall Study|Withdrawal by Subject|4|||
37689309|NCT02305849|69165549|FG000|Overall Study|Lost to Follow-up|0|||
37863451|NCT00996892|69547129|FG011|Expansion Stage 2|Adverse Event|0|||
37689310|NCT02305849|69165550|FG001|Overall Study|Lost to Follow-up|2|||
37689311|NCT02305849|69165551|FG002|Overall Study|Lost to Follow-up|0|||
37689312|NCT02305849|69165552|FG003|Overall Study|Lost to Follow-up|0|||
37689313|NCT02305849|69165549|FG000|Overall Study|Protocol Violation|3|||
37689314|NCT02305849|69165550|FG001|Overall Study|Protocol Violation|2|||
37689315|NCT02305849|69165551|FG002|Overall Study|Protocol Violation|1|||
37689316|NCT02305849|69165552|FG003|Overall Study|Protocol Violation|1|||
37689317|NCT02305849|69165549|FG000|Overall Study|Lab data met discontinuation criteria|0|||
37863452|NCT00996892|69547130|FG012|Expansion Stage 2|Adverse Event|0|||
37863453|NCT00996892|69547131|FG013|Expansion Stage 2|Adverse Event|0|||
37689318|NCT02305849|69165550|FG001|Overall Study|Lab data met discontinuation criteria|1|||
37689319|NCT02305849|69165551|FG002|Overall Study|Lab data met discontinuation criteria|2|||
37689320|NCT02305849|69165552|FG003|Overall Study|Lab data met discontinuation criteria|1|||
37689321|NCT02305849|69165549|FG000|Overall Study|Miscellaneous|1|||
37689322|NCT02305849|69165550|FG001|Overall Study|Miscellaneous|2|||
37689323|NCT02305849|69165551|FG002|Overall Study|Miscellaneous|4|||
37689324|NCT02305849|69165552|FG003|Overall Study|Miscellaneous|1|||
37689325|NCT02305849|69165549|FG000|Overall Study|Not fulfill eligibility criteria|1|||
37689326|NCT02305849|69165550|FG001|Overall Study|Not fulfill eligibility criteria|1|||
37689327|NCT02305849|69165551|FG002|Overall Study|Not fulfill eligibility criteria|0|||
37689328|NCT02305849|69165552|FG003|Overall Study|Not fulfill eligibility criteria|0|||
37689329|NCT02371759|69165591|FG000|Overall Study|Protocol Violation|3|||
37689330|NCT02371759|69165592|FG001|Overall Study|Protocol Violation|1|||
37689331|NCT02371759|69165593|FG002|Overall Study|Protocol Violation|1|||
37689332|NCT02371759|69165594|FG003|Overall Study|Protocol Violation|0|||
37689333|NCT02371759|69165595|FG004|Overall Study|Protocol Violation|3|||
37689334|NCT02371759|69165596|FG005|Overall Study|Protocol Violation|1|||
37689335|NCT02371759|69165597|FG006|Overall Study|Protocol Violation|0|||
37689336|NCT02371759|69165598|FG007|Overall Study|Protocol Violation|3|||
37689337|NCT02371759|69165591|FG000|Overall Study|Withdrawal by Subject|0|||
37689338|NCT02371759|69165592|FG001|Overall Study|Withdrawal by Subject|0|||
37689339|NCT02371759|69165593|FG002|Overall Study|Withdrawal by Subject|0|||
37689340|NCT02371759|69165594|FG003|Overall Study|Withdrawal by Subject|0|||
37689341|NCT02371759|69165595|FG004|Overall Study|Withdrawal by Subject|0|||
37689342|NCT02371759|69165596|FG005|Overall Study|Withdrawal by Subject|0|||
37689343|NCT02371759|69165597|FG006|Overall Study|Withdrawal by Subject|0|||
37689344|NCT02371759|69165598|FG007|Overall Study|Withdrawal by Subject|1|||
37689345|NCT02531633|69165621|FG000|Part A (52 Weeks)|Sponsor request|24|||
37689346|NCT02531633|69165622|FG001|Part A (52 Weeks)|Sponsor request|24|||
37689347|NCT02531633|69165623|FG002|Part A (52 Weeks)|Sponsor request|18|||
37689348|NCT02531633|69165624|FG003|Part A (52 Weeks)|Sponsor request|18|||
37689349|NCT02531633|69165625|FG004|Part A (52 Weeks)|Sponsor request|19|||
37689350|NCT02531633|69165626|FG005|Part A (52 Weeks)|Sponsor request|0|||
37689351|NCT02531633|69165627|FG006|Part A (52 Weeks)|Sponsor request|0|||
37689352|NCT02531633|69165628|FG007|Part A (52 Weeks)|Sponsor request|0|||
37689353|NCT02531633|69165629|FG008|Part A (52 Weeks)|Sponsor request|0|||
37689354|NCT02531633|69165630|FG009|Part A (52 Weeks)|Sponsor request|0|||
37689355|NCT02531633|69165621|FG000|Part A (52 Weeks)|Protocol Violation|1|||
37689356|NCT02531633|69165622|FG001|Part A (52 Weeks)|Protocol Violation|0|||
37689357|NCT02531633|69165623|FG002|Part A (52 Weeks)|Protocol Violation|0|||
37689358|NCT02531633|69165624|FG003|Part A (52 Weeks)|Protocol Violation|0|||
37689359|NCT02531633|69165625|FG004|Part A (52 Weeks)|Protocol Violation|0|||
37689360|NCT02531633|69165626|FG005|Part A (52 Weeks)|Protocol Violation|0|||
37689361|NCT02531633|69165627|FG006|Part A (52 Weeks)|Protocol Violation|0|||
37689362|NCT02531633|69165628|FG007|Part A (52 Weeks)|Protocol Violation|0|||
37689363|NCT02531633|69165629|FG008|Part A (52 Weeks)|Protocol Violation|0|||
37689364|NCT02531633|69165630|FG009|Part A (52 Weeks)|Protocol Violation|0|||
37689365|NCT02531633|69165621|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
37689366|NCT02531633|69165622|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
37689367|NCT02531633|69165623|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
37689368|NCT02531633|69165624|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
37689369|NCT02531633|69165625|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
37689370|NCT02531633|69165626|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
37689371|NCT02531633|69165627|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
37689372|NCT02531633|69165628|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
37689373|NCT02531633|69165629|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
37689374|NCT02531633|69165630|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
37689375|NCT02531633|69165621|FG000|Part A (52 Weeks)|Physician Decision|1|||
37689376|NCT02531633|69165622|FG001|Part A (52 Weeks)|Physician Decision|4|||
37689377|NCT02531633|69165623|FG002|Part A (52 Weeks)|Physician Decision|3|||
37689378|NCT02531633|69165624|FG003|Part A (52 Weeks)|Physician Decision|1|||
37689379|NCT02531633|69165625|FG004|Part A (52 Weeks)|Physician Decision|0|||
37689380|NCT02531633|69165626|FG005|Part A (52 Weeks)|Physician Decision|0|||
37689381|NCT02531633|69165627|FG006|Part A (52 Weeks)|Physician Decision|0|||
37863454|NCT00996892|69547132|FG014|Expansion Stage 2|Adverse Event|0|||
37689382|NCT02531633|69165628|FG007|Part A (52 Weeks)|Physician Decision|0|||
37689383|NCT02531633|69165629|FG008|Part A (52 Weeks)|Physician Decision|0|||
37689384|NCT02531633|69165630|FG009|Part A (52 Weeks)|Physician Decision|0|||
37967645|NCT00368836|69654608|FG000|Phase II|unable to collect blood and/or breath|17|||
37689385|NCT02531633|69165621|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
37689386|NCT02531633|69165622|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
37967646|NCT00368836|69654608|FG000|Phase II|Protocol Violation|2|||
37689387|NCT02531633|69165623|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
37689388|NCT02531633|69165624|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
37689389|NCT02531633|69165625|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
37689390|NCT02531633|69165626|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
37967647|NCT00376168|69654617|FG000|Overall Study|Adverse Event|1|||
37967648|NCT00376168|69654618|FG001|Overall Study|Adverse Event|1|||
37967649|NCT00376168|69654617|FG000|Overall Study|Pregnancy|1|||
37967650|NCT00376168|69654618|FG001|Overall Study|Pregnancy|0|||
37967651|NCT00375934|69654626|FG000|Overall Study|Adverse Event|1|||
37967652|NCT00375934|69654627|FG001|Overall Study|Adverse Event|1|||
37967653|NCT00375934|69654626|FG000|Overall Study|Withdrawal by Subject|2|||
37967654|NCT00375934|69654627|FG001|Overall Study|Withdrawal by Subject|2|||
37967655|NCT00375934|69654626|FG000|Overall Study|Lack of Efficacy|0|||
37967656|NCT00375934|69654627|FG001|Overall Study|Lack of Efficacy|2|||
37967657|NCT00375934|69654626|FG000|Overall Study|Physician Decision|0|||
37967658|NCT00375934|69654627|FG001|Overall Study|Physician Decision|1|||
37967659|NCT00642941|69654645|FG000|Overall Study|Physician Decision|3|||
37967660|NCT00642941|69654646|FG001|Overall Study|Physician Decision|1|||
37967661|NCT00642941|69654647|FG002|Overall Study|Physician Decision|0|||
37967662|NCT00642941|69654648|FG003|Overall Study|Physician Decision|0|||
37967663|NCT00642941|69654649|FG004|Overall Study|Physician Decision|0|||
37967664|NCT00642941|69654650|FG005|Overall Study|Physician Decision|0|||
37967665|NCT00642941|69654651|FG006|Overall Study|Physician Decision|1|||
37967666|NCT00642941|69654652|FG007|Overall Study|Physician Decision|0|||
37967667|NCT00642941|69654653|FG008|Overall Study|Physician Decision|0|||
37967668|NCT00642941|69654654|FG009|Overall Study|Physician Decision|1|||
37967669|NCT00642941|69654655|FG010|Overall Study|Physician Decision|0|||
37967670|NCT00642941|69654656|FG011|Overall Study|Physician Decision|1|||
37967671|NCT00642941|69654645|FG000|Overall Study|Death|4|||
37967672|NCT00642941|69654646|FG001|Overall Study|Death|0|||
37967673|NCT00642941|69654647|FG002|Overall Study|Death|1|||
37967674|NCT00642941|69654648|FG003|Overall Study|Death|1|||
37967675|NCT00642941|69654649|FG004|Overall Study|Death|2|||
37967676|NCT00642941|69654650|FG005|Overall Study|Death|1|||
37967677|NCT00642941|69654651|FG006|Overall Study|Death|0|||
37689391|NCT02531633|69165627|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
37863455|NCT00996892|69547133|FG015|Expansion Stage 2|Adverse Event|0|||
37967678|NCT00642941|69654652|FG007|Overall Study|Death|0|||
37967679|NCT00642941|69654653|FG008|Overall Study|Death|0|||
37967680|NCT00642941|69654654|FG009|Overall Study|Death|0|||
37967681|NCT00642941|69654655|FG010|Overall Study|Death|0|||
37967682|NCT00642941|69654656|FG011|Overall Study|Death|1|||
37967683|NCT00642941|69654645|FG000|Overall Study|Study closed by Sponsor|0|||
37967684|NCT00642941|69654646|FG001|Overall Study|Study closed by Sponsor|1|||
37967685|NCT00642941|69654647|FG002|Overall Study|Study closed by Sponsor|0|||
37967686|NCT00642941|69654648|FG003|Overall Study|Study closed by Sponsor|0|||
37689392|NCT02531633|69165628|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
37689393|NCT02531633|69165629|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
37689394|NCT02531633|69165630|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
37689395|NCT02531633|69165621|FG000|Part A (52 Weeks)|Other|2|||
37689396|NCT02531633|69165622|FG001|Part A (52 Weeks)|Other|0|||
37689397|NCT02531633|69165623|FG002|Part A (52 Weeks)|Other|0|||
37689398|NCT02531633|69165624|FG003|Part A (52 Weeks)|Other|0|||
37689399|NCT02531633|69165625|FG004|Part A (52 Weeks)|Other|0|||
37689400|NCT02531633|69165626|FG005|Part A (52 Weeks)|Other|0|||
37689401|NCT02531633|69165627|FG006|Part A (52 Weeks)|Other|0|||
37689402|NCT02531633|69165628|FG007|Part A (52 Weeks)|Other|0|||
37689403|NCT02531633|69165629|FG008|Part A (52 Weeks)|Other|0|||
37689404|NCT02531633|69165630|FG009|Part A (52 Weeks)|Other|0|||
37689405|NCT02531633|69165621|FG000|Part B (104 Weeks)|Sponsor request|0|||
37689406|NCT02531633|69165622|FG001|Part B (104 Weeks)|Sponsor request|0|||
37689407|NCT02531633|69165623|FG002|Part B (104 Weeks)|Sponsor request|0|||
37689408|NCT02531633|69165624|FG003|Part B (104 Weeks)|Sponsor request|0|||
37689409|NCT02531633|69165625|FG004|Part B (104 Weeks)|Sponsor request|0|||
37689410|NCT02531633|69165626|FG005|Part B (104 Weeks)|Sponsor request|8|||
37689411|NCT02531633|69165627|FG006|Part B (104 Weeks)|Sponsor request|5|||
37689412|NCT02531633|69165628|FG007|Part B (104 Weeks)|Sponsor request|3|||
37689413|NCT02531633|69165629|FG008|Part B (104 Weeks)|Sponsor request|5|||
37689414|NCT02531633|69165630|FG009|Part B (104 Weeks)|Sponsor request|4|||
37689415|NCT02531633|69165621|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
37689416|NCT02531633|69165622|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
37689417|NCT02531633|69165623|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
37689418|NCT02531633|69165624|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
37689419|NCT02531633|69165625|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
37863456|NCT00996892|69547134|FG016|Expansion Stage 2|Adverse Event|0|||
37689420|NCT02531633|69165626|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
37689421|NCT02531633|69165627|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
37689422|NCT02531633|69165628|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
37689423|NCT02531633|69165629|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
37863457|NCT00996892|69547135|FG017|Expansion Stage 2|Adverse Event|0|||
37863458|NCT00996892|69547136|FG018|Expansion Stage 2|Adverse Event|3|||
37967687|NCT00642941|69654649|FG004|Overall Study|Study closed by Sponsor|0|||
37967688|NCT00642941|69654650|FG005|Overall Study|Study closed by Sponsor|0|||
37967689|NCT00642941|69654651|FG006|Overall Study|Study closed by Sponsor|0|||
37967690|NCT00642941|69654652|FG007|Overall Study|Study closed by Sponsor|0|||
37967691|NCT00642941|69654653|FG008|Overall Study|Study closed by Sponsor|0|||
37967692|NCT00642941|69654654|FG009|Overall Study|Study closed by Sponsor|0|||
37967693|NCT00642941|69654655|FG010|Overall Study|Study closed by Sponsor|0|||
37967694|NCT00642941|69654656|FG011|Overall Study|Study closed by Sponsor|0|||
37967695|NCT00642941|69654645|FG000|Overall Study|Withdrawal by Subject|1|||
37967696|NCT00642941|69654646|FG001|Overall Study|Withdrawal by Subject|0|||
37689424|NCT02531633|69165630|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
37689425|NCT02536313|69165672|FG000|Overall Study|Lack of Efficacy|0|||
37689426|NCT02536313|69165673|FG001|Overall Study|Lack of Efficacy|1|||
37689427|NCT02187861|69165685|FG000|Overall Study|Adverse Event|2|||
37689428|NCT02187861|69165686|FG001|Overall Study|Adverse Event|1|||
37689429|NCT02187861|69165687|FG002|Overall Study|Adverse Event|2|||
37689430|NCT02187861|69165688|FG003|Overall Study|Adverse Event|1|||
37689431|NCT02187861|69165685|FG000|Overall Study|Death|0|||
37689432|NCT02187861|69165686|FG001|Overall Study|Death|3|||
37689433|NCT02187861|69165687|FG002|Overall Study|Death|1|||
37689434|NCT02187861|69165688|FG003|Overall Study|Death|2|||
37689435|NCT02187861|69165685|FG000|Overall Study|Physician Decision|0|||
37863459|NCT00996892|69547137|FG019|Expansion Stage 2|Adverse Event|0|||
37863460|NCT00996892|69547118|FG000|Expansion Stage 2|Death|0|||
37863461|NCT00996892|69547119|FG001|Expansion Stage 2|Death|0|||
37863462|NCT00996892|69547120|FG002|Expansion Stage 2|Death|0|||
37863463|NCT00996892|69547121|FG003|Expansion Stage 2|Death|0|||
37863464|NCT00996892|69547122|FG004|Expansion Stage 2|Death|0|||
37863465|NCT00996892|69547123|FG005|Expansion Stage 2|Death|0|||
37863466|NCT00996892|69547124|FG006|Expansion Stage 2|Death|0|||
37863467|NCT00996892|69547125|FG007|Expansion Stage 2|Death|0|||
37689436|NCT02187861|69165686|FG001|Overall Study|Physician Decision|1|||
37689437|NCT02187861|69165687|FG002|Overall Study|Physician Decision|0|||
37689438|NCT02187861|69165688|FG003|Overall Study|Physician Decision|3|||
37689439|NCT02187861|69165685|FG000|Overall Study|Progressive Disease|4|||
37689440|NCT02187861|69165686|FG001|Overall Study|Progressive Disease|42|||
37689441|NCT02187861|69165687|FG002|Overall Study|Progressive Disease|19|||
37863468|NCT00996892|69547126|FG008|Expansion Stage 2|Death|0|||
37863469|NCT00996892|69547127|FG009|Expansion Stage 2|Death|0|||
37689442|NCT02187861|69165688|FG003|Overall Study|Progressive Disease|22|||
37689443|NCT02187861|69165685|FG000|Overall Study|Withdrawal by Subject|0|||
37689444|NCT02187861|69165686|FG001|Overall Study|Withdrawal by Subject|0|||
37689445|NCT02187861|69165687|FG002|Overall Study|Withdrawal by Subject|3|||
37689446|NCT02187861|69165688|FG003|Overall Study|Withdrawal by Subject|3|||
37689447|NCT02187861|69165685|FG000|Overall Study|Other|0|||
37689448|NCT02187861|69165686|FG001|Overall Study|Other|1|||
37689449|NCT02187861|69165687|FG002|Overall Study|Other|7|||
37689450|NCT02187861|69165688|FG003|Overall Study|Other|1|||
37689451|NCT02163993|69165703|FG000|Treatment Period|Adverse Event|0|||
37689452|NCT02163993|69165704|FG001|Treatment Period|Adverse Event|1|||
37689453|NCT02163993|69165705|FG002|Treatment Period|Adverse Event|0|||
37689454|NCT02163993|69165706|FG003|Treatment Period|Adverse Event|0|||
37689455|NCT02163993|69165707|FG004|Treatment Period|Adverse Event|1|||
37689456|NCT02163993|69165703|FG000|Treatment Period|Lost to Follow-up|2|||
37689457|NCT02163993|69165704|FG001|Treatment Period|Lost to Follow-up|3|||
37689458|NCT02163993|69165705|FG002|Treatment Period|Lost to Follow-up|1|||
37689459|NCT02163993|69165706|FG003|Treatment Period|Lost to Follow-up|3|||
37689460|NCT02163993|69165707|FG004|Treatment Period|Lost to Follow-up|1|||
37689461|NCT02163993|69165703|FG000|Treatment Period|Physician Decision|1|||
37689462|NCT02163993|69165704|FG001|Treatment Period|Physician Decision|0|||
37689463|NCT02163993|69165705|FG002|Treatment Period|Physician Decision|0|||
37689464|NCT02163993|69165706|FG003|Treatment Period|Physician Decision|0|||
37689465|NCT02163993|69165707|FG004|Treatment Period|Physician Decision|0|||
37689466|NCT02163993|69165703|FG000|Treatment Period|Protocol Violation|2|||
37689467|NCT02163993|69165704|FG001|Treatment Period|Protocol Violation|1|||
37689468|NCT02163993|69165705|FG002|Treatment Period|Protocol Violation|0|||
37689469|NCT02163993|69165706|FG003|Treatment Period|Protocol Violation|1|||
37689470|NCT02163993|69165707|FG004|Treatment Period|Protocol Violation|2|||
37689471|NCT02163993|69165703|FG000|Treatment Period|Withdrawal by Subject|6|||
37689472|NCT02163993|69165704|FG001|Treatment Period|Withdrawal by Subject|4|||
37689473|NCT02163993|69165705|FG002|Treatment Period|Withdrawal by Subject|1|||
37689474|NCT02163993|69165706|FG003|Treatment Period|Withdrawal by Subject|4|||
37689475|NCT02163993|69165707|FG004|Treatment Period|Withdrawal by Subject|1|||
37689476|NCT02163993|69165703|FG000|Treatment Period|Not treated|1|||
37863470|NCT00996892|69547128|FG010|Expansion Stage 2|Death|0|||
37689477|NCT02163993|69165704|FG001|Treatment Period|Not treated|0|||
37689478|NCT02163993|69165705|FG002|Treatment Period|Not treated|0|||
37689479|NCT02163993|69165706|FG003|Treatment Period|Not treated|1|||
37689480|NCT02163993|69165707|FG004|Treatment Period|Not treated|2|||
37689481|NCT02163993|69165703|FG000|Post-treatment Period|Adverse Event|0|||
37689482|NCT02163993|69165704|FG001|Post-treatment Period|Adverse Event|0|||
37689483|NCT02163993|69165705|FG002|Post-treatment Period|Adverse Event|1|||
37689484|NCT02163993|69165706|FG003|Post-treatment Period|Adverse Event|0|||
37689485|NCT02163993|69165707|FG004|Post-treatment Period|Adverse Event|0|||
37689486|NCT02163993|69165703|FG000|Post-treatment Period|Lost to Follow-up|2|||
37689487|NCT02163993|69165704|FG001|Post-treatment Period|Lost to Follow-up|2|||
37689488|NCT02163993|69165705|FG002|Post-treatment Period|Lost to Follow-up|3|||
37689489|NCT02163993|69165706|FG003|Post-treatment Period|Lost to Follow-up|1|||
37689490|NCT02163993|69165707|FG004|Post-treatment Period|Lost to Follow-up|0|||
37689491|NCT02163993|69165703|FG000|Post-treatment Period|Protocol Violation|0|||
37689492|NCT02163993|69165704|FG001|Post-treatment Period|Protocol Violation|0|||
37689493|NCT02163993|69165705|FG002|Post-treatment Period|Protocol Violation|0|||
37689494|NCT02163993|69165706|FG003|Post-treatment Period|Protocol Violation|0|||
37689495|NCT02163993|69165707|FG004|Post-treatment Period|Protocol Violation|1|||
37689496|NCT02163993|69165703|FG000|Post-treatment Period|Withdrawal by Subject|2|||
37689497|NCT02163993|69165704|FG001|Post-treatment Period|Withdrawal by Subject|4|||
37689498|NCT02163993|69165705|FG002|Post-treatment Period|Withdrawal by Subject|0|||
37689499|NCT02163993|69165706|FG003|Post-treatment Period|Withdrawal by Subject|1|||
37689500|NCT02163993|69165707|FG004|Post-treatment Period|Withdrawal by Subject|2|||
37689501|NCT02527421|69165730|FG000|Overall Study|Withdrawal by Subject|1|||
37689502|NCT02527421|69165731|FG001|Overall Study|Withdrawal by Subject|0|||
37689503|NCT02163915|69165742|FG000|Overall Study|Withdrawal by Subject|2|||
37689504|NCT02163915|69165743|FG001|Overall Study|Withdrawal by Subject|0|||
37689505|NCT02163915|69165744|FG002|Overall Study|Withdrawal by Subject|2|||
37689506|NCT02163915|69165745|FG003|Overall Study|Withdrawal by Subject|2|||
37689507|NCT02163915|69165746|FG004|Overall Study|Withdrawal by Subject|2|||
37689508|NCT02163915|69165742|FG000|Overall Study|Study termination|1|||
37689509|NCT02163915|69165743|FG001|Overall Study|Study termination|0|||
37689510|NCT02163915|69165744|FG002|Overall Study|Study termination|0|||
37689511|NCT02163915|69165745|FG003|Overall Study|Study termination|0|||
37689512|NCT02163915|69165746|FG004|Overall Study|Study termination|2|||
37689513|NCT02163915|69165742|FG000|Overall Study|Physician Decision|0|||
37689514|NCT02163915|69165743|FG001|Overall Study|Physician Decision|0|||
37689515|NCT02163915|69165744|FG002|Overall Study|Physician Decision|0|||
37689516|NCT02163915|69165745|FG003|Overall Study|Physician Decision|1|||
37689517|NCT02163915|69165746|FG004|Overall Study|Physician Decision|0|||
37689518|NCT02163759|69165765|FG000|Overall Study|Withdrawal by Subject|1|||
37689519|NCT02163759|69165766|FG001|Overall Study|Withdrawal by Subject|5|||
37689520|NCT02163759|69165767|FG002|Overall Study|Withdrawal by Subject|1|||
37689521|NCT02163759|69165765|FG000|Overall Study|Adverse Event|0|||
37689522|NCT02163759|69165766|FG001|Overall Study|Adverse Event|0|||
37689523|NCT02163759|69165767|FG002|Overall Study|Adverse Event|1|||
37689524|NCT02163759|69165765|FG000|Overall Study|Death|0|||
37689525|NCT02163759|69165766|FG001|Overall Study|Death|0|||
37689526|NCT02163759|69165767|FG002|Overall Study|Death|1|||
37689527|NCT02371369|69165780|FG000|Part 1|Physician Decision|0|||
37689528|NCT02371369|69165781|FG001|Part 1|Physician Decision|3|||
37689529|NCT02371369|69165780|FG000|Part 1|Adverse Event|8|||
37689530|NCT02371369|69165781|FG001|Part 1|Adverse Event|0|||
37689531|NCT02371369|69165780|FG000|Part 1|Withdrawal by Subject|1|||
37689532|NCT02371369|69165781|FG001|Part 1|Withdrawal by Subject|6|||
37689533|NCT02371369|69165780|FG000|Part 1|Disease progression|0|||
37689534|NCT02371369|69165781|FG001|Part 1|Disease progression|1|||
37863471|NCT00996892|69547129|FG011|Expansion Stage 2|Death|0|||
37689535|NCT02371369|69165780|FG000|Part 1|Protocol Violation|0|||
37689536|NCT02371369|69165781|FG001|Part 1|Protocol Violation|1|||
37689537|NCT02371369|69165780|FG000|Part 2|Adverse Event|6|||
37689538|NCT02371369|69165781|FG001|Part 2|Adverse Event|5|||
37689539|NCT02371369|69165780|FG000|Part 2|Withdrawal by Subject|16|||
37689540|NCT02371369|69165781|FG001|Part 2|Withdrawal by Subject|6|||
37689541|NCT02371369|69165780|FG000|Part 2|Investigator decision|1|||
37689542|NCT02371369|69165781|FG001|Part 2|Investigator decision|2|||
37689543|NCT02371369|69165780|FG000|Part 2|Death|0|||
37689544|NCT02371369|69165781|FG001|Part 2|Death|1|||
37689545|NCT02371369|69165780|FG000|Part 2|Disease progression|1|||
37689546|NCT02371369|69165781|FG001|Part 2|Disease progression|0|||
37689547|NCT02371369|69165780|FG000|Part 2|Subject Noncompliance|1|||
37689548|NCT02371369|69165781|FG001|Part 2|Subject Noncompliance|0|||
37689549|NCT02371369|69165780|FG000|Part 2|Lost to Follow-up|1|||
37689550|NCT02371369|69165781|FG001|Part 2|Lost to Follow-up|1|||
37689551|NCT02371369|69165780|FG000|Part 2|Subject transitioned to commercial supply|6|||
37689552|NCT02371369|69165781|FG001|Part 2|Subject transitioned to commercial supply|4|||
37689553|NCT02371369|69165780|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
37689554|NCT02371369|69165781|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
37689555|NCT02371369|69165780|FG000|Part 2|Surgical resection of tumor|1|||
37689556|NCT02371369|69165781|FG001|Part 2|Surgical resection of tumor|1|||
37689557|NCT02371369|69165780|FG000|Part 2|Other|0|||
37689558|NCT02371369|69165781|FG001|Part 2|Other|1|||
37689559|NCT02187783|69165803|FG000|Overall Study|Adverse Event|8|||
37863472|NCT00996892|69547130|FG012|Expansion Stage 2|Death|0|||
37863473|NCT00996892|69547131|FG013|Expansion Stage 2|Death|0|||
37863474|NCT00996892|69547132|FG014|Expansion Stage 2|Death|0|||
37689560|NCT02187783|69165803|FG000|Overall Study|Death|3|||
37689561|NCT02187783|69165803|FG000|Overall Study|Progressive disease|80|||
37967697|NCT00642941|69654647|FG002|Overall Study|Withdrawal by Subject|0|||
37689562|NCT02187783|69165803|FG000|Overall Study|Protocol Violation|3|||
37689563|NCT02187783|69165803|FG000|Overall Study|Physician Decision|2|||
37689564|NCT02187783|69165803|FG000|Overall Study|Withdrawal by Subject|9|||
37689565|NCT02187783|69165803|FG000|Overall Study|Study terminated by sponsor|1|||
37967698|NCT00642941|69654648|FG003|Overall Study|Withdrawal by Subject|2|||
37967699|NCT00642941|69654649|FG004|Overall Study|Withdrawal by Subject|0|||
37967700|NCT00642941|69654650|FG005|Overall Study|Withdrawal by Subject|0|||
37967701|NCT00642941|69654651|FG006|Overall Study|Withdrawal by Subject|2|||
37967702|NCT00642941|69654652|FG007|Overall Study|Withdrawal by Subject|0|||
37967703|NCT00642941|69654653|FG008|Overall Study|Withdrawal by Subject|1|||
37967704|NCT00642941|69654654|FG009|Overall Study|Withdrawal by Subject|0|||
37967705|NCT00642941|69654655|FG010|Overall Study|Withdrawal by Subject|0|||
37967706|NCT00642941|69654656|FG011|Overall Study|Withdrawal by Subject|1|||
37967707|NCT00642941|69654645|FG000|Overall Study|Protocol Violation|0|||
37967708|NCT00642941|69654646|FG001|Overall Study|Protocol Violation|0|||
37967709|NCT00642941|69654647|FG002|Overall Study|Protocol Violation|0|||
37863475|NCT00996892|69547133|FG015|Expansion Stage 2|Death|0|||
37689566|NCT02337361|69165809|FG000|3-month Follow-up|Lost to Follow-up|19|||
37689567|NCT02337361|69165810|FG001|3-month Follow-up|Lost to Follow-up|14|||
37689568|NCT02337361|69165809|FG000|6-month Follow-up|Lost to Follow-up|2|||
37689569|NCT02337361|69165810|FG001|6-month Follow-up|Lost to Follow-up|4|||
37689570|NCT02336737|69165817|FG000|Overall Study|Withdrawal by Subject|5|||
37689571|NCT02336737|69165817|FG000|Overall Study|Physician Decision|8|||
37967710|NCT00642941|69654648|FG003|Overall Study|Protocol Violation|0|||
37967711|NCT00642941|69654649|FG004|Overall Study|Protocol Violation|0|||
37689572|NCT02130765|69165826|FG000|Overall Study|Did not receive treatment|4|||
37689573|NCT02130765|69165827|FG001|Overall Study|Did not receive treatment|0|||
37689574|NCT02130765|69165828|FG002|Overall Study|Did not receive treatment|0|||
37689575|NCT02130765|69165829|FG003|Overall Study|Did not receive treatment|0|||
37689576|NCT02305381|69165844|FG000|Overall Study|Unclassified|5|||
37689577|NCT02305381|69165845|FG001|Overall Study|Unclassified|5|||
37689578|NCT02305381|69165846|FG002|Overall Study|Unclassified|7|||
37689579|NCT02336425|69165858|FG000|Overall Study|Study terminated.|2|||
37689580|NCT02336425|69165859|FG001|Overall Study|Study terminated.|2|||
37689581|NCT02336425|69165860|FG002|Overall Study|Study terminated.|3|||
37689582|NCT02336425|69165861|FG003|Overall Study|Study terminated.|3|||
37689583|NCT02163447|69165874|FG000|Overall Study|Withdrawal by Subject|2|||
37689584|NCT02163447|69165875|FG001|Overall Study|Withdrawal by Subject|0|||
37689585|NCT02163447|69165876|FG002|Overall Study|Withdrawal by Subject|1|||
37689586|NCT02163447|69165874|FG000|Overall Study|Lost to Follow-up|1|||
37689587|NCT02163447|69165875|FG001|Overall Study|Lost to Follow-up|3|||
37967712|NCT00642941|69654650|FG005|Overall Study|Protocol Violation|0|||
37967713|NCT00642941|69654651|FG006|Overall Study|Protocol Violation|1|||
37967714|NCT00642941|69654652|FG007|Overall Study|Protocol Violation|0|||
37967715|NCT00642941|69654653|FG008|Overall Study|Protocol Violation|0|||
37967716|NCT00642941|69654654|FG009|Overall Study|Protocol Violation|0|||
37967717|NCT00642941|69654655|FG010|Overall Study|Protocol Violation|0|||
37967718|NCT00642941|69654656|FG011|Overall Study|Protocol Violation|0|||
37967719|NCT00642941|69654645|FG000|Overall Study|Adverse Event|1|||
37967720|NCT00642941|69654646|FG001|Overall Study|Adverse Event|1|||
37967721|NCT00642941|69654647|FG002|Overall Study|Adverse Event|0|||
37967722|NCT00642941|69654648|FG003|Overall Study|Adverse Event|0|||
37967723|NCT00642941|69654649|FG004|Overall Study|Adverse Event|0|||
37967724|NCT00642941|69654650|FG005|Overall Study|Adverse Event|0|||
37967725|NCT00642941|69654651|FG006|Overall Study|Adverse Event|1|||
37967726|NCT00642941|69654652|FG007|Overall Study|Adverse Event|1|||
37967727|NCT00642941|69654653|FG008|Overall Study|Adverse Event|0|||
37967728|NCT00642941|69654654|FG009|Overall Study|Adverse Event|1|||
37967729|NCT00642941|69654655|FG010|Overall Study|Adverse Event|0|||
37967730|NCT00642941|69654656|FG011|Overall Study|Adverse Event|0|||
37967731|NCT00642941|69654645|FG000|Overall Study|Other|1|||
37967732|NCT00642941|69654646|FG001|Overall Study|Other|1|||
37689588|NCT02163447|69165876|FG002|Overall Study|Lost to Follow-up|0|||
37689589|NCT02163447|69165874|FG000|Overall Study|Moved out of study area|2|||
37689590|NCT02163447|69165875|FG001|Overall Study|Moved out of study area|3|||
37689591|NCT02163447|69165876|FG002|Overall Study|Moved out of study area|2|||
37689592|NCT02163447|69165874|FG000|Overall Study|Became HIV infected at time of delivery|1|||
37689593|NCT02163447|69165875|FG001|Overall Study|Became HIV infected at time of delivery|0|||
37689594|NCT02163447|69165876|FG002|Overall Study|Became HIV infected at time of delivery|0|||
37689595|NCT02370667|69165897|FG000|Overall Study|Lost to Follow-up|0|||
37689596|NCT02370667|69165898|FG001|Overall Study|Lost to Follow-up|1|||
37689597|NCT02370667|69165899|FG002|Overall Study|Lost to Follow-up|0|||
37689598|NCT02130297|69165907|FG000|Overall Study|Lost to Follow-up|4|||
37689599|NCT01931956|69165915|FG000|Overall Study|Death|42|||
37689600|NCT01931956|69165916|FG001|Overall Study|Death|7|||
37689601|NCT01931956|69165917|FG002|Overall Study|Death|379|||
37689602|NCT01931956|69165918|FG003|Overall Study|Death|96|||
37689603|NCT01931956|69165915|FG000|Overall Study|Withdrawal by Subject|5|||
37689604|NCT01931956|69165916|FG001|Overall Study|Withdrawal by Subject|0|||
37689605|NCT01931956|69165917|FG002|Overall Study|Withdrawal by Subject|70|||
37689606|NCT01931956|69165918|FG003|Overall Study|Withdrawal by Subject|30|||
37689607|NCT01931956|69165915|FG000|Overall Study|Lost to Follow-up|2|||
37689608|NCT01931956|69165916|FG001|Overall Study|Lost to Follow-up|0|||
37689609|NCT01931956|69165917|FG002|Overall Study|Lost to Follow-up|11|||
37689610|NCT01931956|69165918|FG003|Overall Study|Lost to Follow-up|7|||
37689611|NCT01931956|69165915|FG000|Overall Study|Expected|2|||
37689612|NCT01931956|69165916|FG001|Overall Study|Expected|0|||
37689613|NCT01931956|69165917|FG002|Overall Study|Expected|6|||
37689614|NCT01931956|69165918|FG003|Overall Study|Expected|0|||
37689615|NCT01931956|69165915|FG000|Overall Study|Not due|0|||
37689616|NCT01931956|69165916|FG001|Overall Study|Not due|0|||
37689617|NCT01931956|69165917|FG002|Overall Study|Not due|21|||
37689618|NCT01931956|69165918|FG003|Overall Study|Not due|0|||
37689619|NCT01887418|69165944|FG000|Overall Study|Travelling difficulties|0|||
37689620|NCT01887418|69165945|FG001|Overall Study|Travelling difficulties|0|||
37689621|NCT01887418|69165946|FG002|Overall Study|Travelling difficulties|1|||
37689622|NCT01886716|69165958|FG000|Week 1|Lost to Follow-up|0|||
37689623|NCT01886716|69165959|FG001|Week 1|Lost to Follow-up|0|||
37689624|NCT01886716|69165960|FG002|Week 1|Lost to Follow-up|2|||
37689625|NCT01886716|69165961|FG003|Week 1|Lost to Follow-up|2|||
37689626|NCT01886716|69165958|FG000|Week 2|Lost to Follow-up|3|||
37689627|NCT01886716|69165959|FG001|Week 2|Lost to Follow-up|2|||
37689628|NCT01886716|69165960|FG002|Week 2|Lost to Follow-up|1|||
37689629|NCT01886716|69165961|FG003|Week 2|Lost to Follow-up|3|||
37689630|NCT01886716|69165958|FG000|Week 3|Lost to Follow-up|1|||
37689631|NCT01886716|69165959|FG001|Week 3|Lost to Follow-up|1|||
37689632|NCT01886716|69165960|FG002|Week 3|Lost to Follow-up|0|||
37689633|NCT01886716|69165961|FG003|Week 3|Lost to Follow-up|1|||
37689634|NCT01912612|69165973|FG000|Overall Study|Adverse Event|4|||
37689635|NCT01912612|69165974|FG001|Overall Study|Adverse Event|0|||
37689636|NCT01912612|69165975|FG002|Overall Study|Adverse Event|0|||
37689637|NCT01912612|69165973|FG000|Overall Study|Withdrew consent|1|||
37689638|NCT01912612|69165974|FG001|Overall Study|Withdrew consent|0|||
37689639|NCT01912612|69165975|FG002|Overall Study|Withdrew consent|0|||
37689640|NCT01912612|69165973|FG000|Overall Study|Study design change|0|||
37689641|NCT01912612|69165974|FG001|Overall Study|Study design change|0|||
37689642|NCT01912612|69165975|FG002|Overall Study|Study design change|3|||
37689643|NCT02370511|69165984|FG000|Overall Study|Death|10|||
37689644|NCT02370511|69165985|FG001|Overall Study|Death|7|||
37689645|NCT02370511|69165986|FG002|Overall Study|Death|1|||
37689646|NCT02370511|69165984|FG000|Overall Study|Withdrawal by Subject|2|||
37689647|NCT02370511|69165985|FG001|Overall Study|Withdrawal by Subject|0|||
37689648|NCT02370511|69165986|FG002|Overall Study|Withdrawal by Subject|0|||
37771437|NCT01360632|69290632|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
37771438|NCT01360632|69290633|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
37771439|NCT01360632|69290634|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
37771440|NCT01360632|69290630|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
37771441|NCT01360632|69290631|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
37771442|NCT01360632|69290632|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
37771443|NCT01360632|69290633|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
37771444|NCT01360632|69290634|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
37771445|NCT01360632|69290630|FG000|Phase A+|Lost to Follow-up|0|||
37771446|NCT01360632|69290631|FG001|Phase A+|Lost to Follow-up|0|||
37771447|NCT01360632|69290632|FG002|Phase A+|Lost to Follow-up|0|||
37771448|NCT01360632|69290633|FG003|Phase A+|Lost to Follow-up|0|||
37689649|NCT02370511|69165984|FG000|Overall Study|Lost to Follow-up|0|||
37689650|NCT02370511|69165985|FG001|Overall Study|Lost to Follow-up|4|||
37689651|NCT02370511|69165986|FG002|Overall Study|Lost to Follow-up|0|||
37689652|NCT02303041|69165996|FG000|Overall Study|Adverse Event|1|||
37689653|NCT02303041|69165997|FG001|Overall Study|Adverse Event|2|||
37689654|NCT02302807|69166005|FG000|Overall Study|Withdrawal by Subject|28|||
37689655|NCT02302807|69166006|FG001|Overall Study|Withdrawal by Subject|11|||
37689656|NCT02302807|69166005|FG000|Overall Study|Lost to Follow-up|4|||
37689657|NCT02302807|69166006|FG001|Overall Study|Lost to Follow-up|6|||
37689658|NCT02302807|69166005|FG000|Overall Study|Death|397|||
37689659|NCT02302807|69166006|FG001|Overall Study|Death|385|||
37689660|NCT02302807|69166005|FG000|Overall Study|Study Terminated By Sponsor|35|||
37689661|NCT02302807|69166006|FG001|Overall Study|Study Terminated By Sponsor|64|||
37689662|NCT02302807|69166005|FG000|Overall Study|Physician Decision|0|||
37689663|NCT02302807|69166006|FG001|Overall Study|Physician Decision|1|||
37689664|NCT02335489|69166025|FG000|Overall Study|Sponsor terminated study|4|||
37689665|NCT02335489|69166025|FG000|Overall Study|Lost to Follow-up|1|||
37689666|NCT02335489|69166025|FG000|Overall Study|Withdrawal by Subject|2|||
37689667|NCT02335489|69166025|FG000|Overall Study|Physician Decision|2|||
37771449|NCT01360632|69290634|FG004|Phase A+|Lost to Follow-up|2|||
37771450|NCT01360632|69290630|FG000|Phase A+|Adverse Event|0|||
37771451|NCT01360632|69290631|FG001|Phase A+|Adverse Event|0|||
37771452|NCT01360632|69290632|FG002|Phase A+|Adverse Event|0|||
37771453|NCT01360632|69290633|FG003|Phase A+|Adverse Event|0|||
37967733|NCT00642941|69654647|FG002|Overall Study|Other|1|||
37967734|NCT00642941|69654648|FG003|Overall Study|Other|1|||
37689668|NCT02335489|69166025|FG000|Overall Study|Lack of Efficacy|1|||
37689669|NCT02527343|69166031|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
37689670|NCT02527343|69166032|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
37689671|NCT02527343|69166033|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
37689672|NCT02527343|69166034|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
37689673|NCT02527343|69166035|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
37689674|NCT02527343|69166036|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
37771454|NCT01360632|69290634|FG004|Phase A+|Adverse Event|2|||
37771455|NCT01360632|69290630|FG000|Phase A+|Met Withdrawal Criteria|0|||
37771456|NCT01360632|69290631|FG001|Phase A+|Met Withdrawal Criteria|0|||
37771457|NCT01360632|69290632|FG002|Phase A+|Met Withdrawal Criteria|0|||
37771458|NCT01360632|69290633|FG003|Phase A+|Met Withdrawal Criteria|0|||
37771459|NCT01360632|69290634|FG004|Phase A+|Met Withdrawal Criteria|7|||
37771460|NCT01360632|69290630|FG000|Phase A+|Physician Decision|0|||
37771461|NCT01360632|69290631|FG001|Phase A+|Physician Decision|0|||
37771462|NCT01360632|69290632|FG002|Phase A+|Physician Decision|0|||
37771463|NCT01360632|69290633|FG003|Phase A+|Physician Decision|0|||
37771464|NCT01360632|69290634|FG004|Phase A+|Physician Decision|3|||
37771465|NCT01360632|69290630|FG000|Phase A+|Withdrawal by Subject|0|||
37771466|NCT01360632|69290631|FG001|Phase A+|Withdrawal by Subject|0|||
37771467|NCT01360632|69290632|FG002|Phase A+|Withdrawal by Subject|0|||
37771468|NCT01360632|69290633|FG003|Phase A+|Withdrawal by Subject|0|||
37771469|NCT01360632|69290634|FG004|Phase A+|Withdrawal by Subject|8|||
37771470|NCT01360632|69290630|FG000|Phase A+|Protocol Deviation|0|||
37771471|NCT01360632|69290631|FG001|Phase A+|Protocol Deviation|0|||
37771472|NCT01360632|69290632|FG002|Phase A+|Protocol Deviation|0|||
37771473|NCT01360632|69290633|FG003|Phase A+|Protocol Deviation|0|||
37771474|NCT01360632|69290634|FG004|Phase A+|Protocol Deviation|3|||
37771475|NCT04157400|69290680|FG000|Overall Study|Withdrawal by Subject|1|||
37771476|NCT04157400|69290680|FG000|Overall Study|Lost to Follow-up|3|||
37771477|NCT02626182|69290754|FG000|Overall Study|Adverse Event|2|||
37771478|NCT02626182|69290755|FG001|Overall Study|Adverse Event|0|||
37771479|NCT01669902|69290862|FG000|Overall Study|Adverse Event|11|||
37771480|NCT01669902|69290862|FG000|Overall Study|Lack of Efficacy|10|||
37771481|NCT01669902|69290862|FG000|Overall Study|Other|8|||
37771482|NCT01670292|69290895|FG000|Overall Study|Lost to Follow-up|14|||
37771483|NCT01360554|69291132|FG000|Overall Study|Death|359|||
37771484|NCT01360554|69291133|FG001|Overall Study|Death|371|||
37771485|NCT01360554|69291132|FG000|Overall Study|Lost to Follow-up|4|||
37771486|NCT01360554|69291133|FG001|Overall Study|Lost to Follow-up|4|||
37771487|NCT01360554|69291132|FG000|Overall Study|Withdrawal by Subject|23|||
37771488|NCT01360554|69291133|FG001|Overall Study|Withdrawal by Subject|24|||
37771489|NCT01360554|69291132|FG000|Overall Study|Study terminated by sponsor|49|||
37771490|NCT01360554|69291133|FG001|Overall Study|Study terminated by sponsor|37|||
37771491|NCT01360554|69291132|FG000|Overall Study|Other, not specified|1|||
37771492|NCT01360554|69291133|FG001|Overall Study|Other, not specified|0|||
37689675|NCT02527343|69166031|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
37689676|NCT02527343|69166032|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
37689677|NCT02527343|69166033|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
37689678|NCT02527343|69166034|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
37689679|NCT02527343|69166035|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
37689680|NCT02527343|69166036|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
37689681|NCT02527343|69166031|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
37689682|NCT02527343|69166032|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
37689683|NCT02527343|69166033|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
37689684|NCT02527343|69166034|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
37689685|NCT02527343|69166035|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
37689686|NCT02527343|69166036|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
37771493|NCT01360554|69291132|FG000|Overall Study|Randomized but not treated.|3|||
37771494|NCT01360554|69291133|FG001|Overall Study|Randomized but not treated.|3|||
37771495|NCT01360398|69291155|FG000|Overall Study|Withdrawal by Subject|14|||
37771496|NCT01360398|69291155|FG000|Overall Study|Other|7|||
37771497|NCT01360398|69291155|FG000|Overall Study|Migrated/moved from study area|1|||
37771498|NCT02626026|69291165|FG000|Overall Study|Randomized but Never Treated|0|||
37771499|NCT02626026|69291166|FG001|Overall Study|Randomized but Never Treated|0|||
37771500|NCT02626026|69291167|FG002|Overall Study|Randomized but Never Treated|0|||
37771501|NCT02626026|69291168|FG003|Overall Study|Randomized but Never Treated|0|||
37771502|NCT02626026|69291169|FG004|Overall Study|Randomized but Never Treated|1|||
37771503|NCT02626026|69291170|FG005|Overall Study|Randomized but Never Treated|0|||
37771504|NCT01765296|69291430|FG000|Overall Study|Protocol Violation|0|||
37771505|NCT01765296|69291431|FG001|Overall Study|Protocol Violation|5|||
37771506|NCT01765296|69291432|FG002|Overall Study|Protocol Violation|4|||
37771507|NCT01765296|69291430|FG000|Overall Study|Withdrawal by Subject|4|||
37771508|NCT01765296|69291431|FG001|Overall Study|Withdrawal by Subject|2|||
37771509|NCT01765296|69291432|FG002|Overall Study|Withdrawal by Subject|2|||
37771510|NCT01765296|69291430|FG000|Overall Study|Adverse Event|1|||
37771511|NCT01765296|69291431|FG001|Overall Study|Adverse Event|13|||
37771512|NCT01765296|69291432|FG002|Overall Study|Adverse Event|5|||
37771513|NCT01765296|69291430|FG000|Overall Study|Lack of Efficacy|0|||
37771514|NCT01765296|69291431|FG001|Overall Study|Lack of Efficacy|0|||
37771515|NCT01765296|69291432|FG002|Overall Study|Lack of Efficacy|2|||
37771516|NCT02089685|69291506|FG000|Overall Study|Adverse Event|1|||
37771517|NCT02089685|69291507|FG001|Overall Study|Adverse Event|0|||
37771518|NCT02089685|69291508|FG002|Overall Study|Adverse Event|0|||
37771519|NCT02089685|69291509|FG003|Overall Study|Adverse Event|0|||
37771520|NCT02089685|69291510|FG004|Overall Study|Adverse Event|1|||
37771521|NCT02089685|69291511|FG005|Overall Study|Adverse Event|0|||
37771522|NCT02089685|69291506|FG000|Overall Study|Clinical Progression|4|||
37771523|NCT02089685|69291507|FG001|Overall Study|Clinical Progression|0|||
37771524|NCT02089685|69291508|FG002|Overall Study|Clinical Progression|0|||
37771525|NCT02089685|69291509|FG003|Overall Study|Clinical Progression|5|||
37771526|NCT02089685|69291510|FG004|Overall Study|Clinical Progression|1|||
37771527|NCT02089685|69291511|FG005|Overall Study|Clinical Progression|2|||
37771528|NCT02089685|69291506|FG000|Overall Study|Excluded Medication|1|||
37771529|NCT02089685|69291507|FG001|Overall Study|Excluded Medication|0|||
37771530|NCT02089685|69291508|FG002|Overall Study|Excluded Medication|0|||
37771531|NCT02089685|69291509|FG003|Overall Study|Excluded Medication|11|||
37771532|NCT02089685|69291510|FG004|Overall Study|Excluded Medication|2|||
37771533|NCT02089685|69291511|FG005|Overall Study|Excluded Medication|1|||
37771534|NCT02089685|69291506|FG000|Overall Study|Progressive disease|13|||
37771535|NCT02089685|69291507|FG001|Overall Study|Progressive disease|10|||
37771536|NCT02089685|69291508|FG002|Overall Study|Progressive disease|3|||
37771537|NCT02089685|69291509|FG003|Overall Study|Progressive disease|51|||
37771538|NCT02089685|69291510|FG004|Overall Study|Progressive disease|17|||
37771539|NCT02089685|69291511|FG005|Overall Study|Progressive disease|12|||
37771540|NCT02089685|69291506|FG000|Overall Study|Follow up ended by sponsor|2|||
37771541|NCT02089685|69291507|FG001|Overall Study|Follow up ended by sponsor|2|||
37771542|NCT02089685|69291508|FG002|Overall Study|Follow up ended by sponsor|0|||
37771543|NCT02089685|69291509|FG003|Overall Study|Follow up ended by sponsor|70|||
37771544|NCT02089685|69291510|FG004|Overall Study|Follow up ended by sponsor|26|||
37771545|NCT02089685|69291511|FG005|Overall Study|Follow up ended by sponsor|26|||
37771546|NCT02089685|69291506|FG000|Overall Study|Withdrawal by Subject|0|||
37771547|NCT02089685|69291507|FG001|Overall Study|Withdrawal by Subject|2|||
37771548|NCT02089685|69291508|FG002|Overall Study|Withdrawal by Subject|0|||
37689687|NCT02527343|69166031|FG000|RT Period: Weeks 1 to 52|Other|4|||
37689688|NCT02527343|69166032|FG001|RT Period: Weeks 1 to 52|Other|3|||
37689689|NCT02527343|69166033|FG002|RT Period: Weeks 1 to 52|Other|0|||
37689690|NCT02527343|69166034|FG003|RT Period: Weeks 1 to 52|Other|0|||
37689691|NCT02527343|69166035|FG004|RT Period: Weeks 1 to 52|Other|0|||
37689692|NCT02527343|69166036|FG005|RT Period: Weeks 1 to 52|Other|0|||
37689693|NCT02527343|69166031|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
37689694|NCT02527343|69166032|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
37689695|NCT02527343|69166033|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
37689696|NCT02527343|69166034|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
37689697|NCT02527343|69166035|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
37689698|NCT02527343|69166036|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
37771549|NCT02089685|69291509|FG003|Overall Study|Withdrawal by Subject|8|||
37771550|NCT02089685|69291510|FG004|Overall Study|Withdrawal by Subject|1|||
37771551|NCT02089685|69291511|FG005|Overall Study|Withdrawal by Subject|1|||
37771552|NCT02089685|69291506|FG000|Overall Study|Status not recorded|1|||
37771553|NCT02089685|69291507|FG001|Overall Study|Status not recorded|0|||
37771554|NCT02089685|69291508|FG002|Overall Study|Status not recorded|0|||
37771555|NCT02089685|69291509|FG003|Overall Study|Status not recorded|0|||
37771556|NCT02089685|69291510|FG004|Overall Study|Status not recorded|1|||
37771557|NCT02089685|69291511|FG005|Overall Study|Status not recorded|0|||
37771558|NCT02089685|69291506|FG000|Overall Study|Death|0|||
37771559|NCT02089685|69291507|FG001|Overall Study|Death|0|||
37771560|NCT02089685|69291508|FG002|Overall Study|Death|0|||
37771561|NCT02089685|69291509|FG003|Overall Study|Death|7|||
37771562|NCT02089685|69291510|FG004|Overall Study|Death|2|||
37771563|NCT02089685|69291511|FG005|Overall Study|Death|5|||
37771564|NCT02089685|69291506|FG000|Overall Study|Lost to Follow-up|0|||
37771565|NCT02089685|69291507|FG001|Overall Study|Lost to Follow-up|0|||
37771566|NCT02089685|69291508|FG002|Overall Study|Lost to Follow-up|0|||
37771567|NCT02089685|69291509|FG003|Overall Study|Lost to Follow-up|1|||
37771568|NCT02089685|69291510|FG004|Overall Study|Lost to Follow-up|0|||
37771569|NCT02089685|69291511|FG005|Overall Study|Lost to Follow-up|0|||
37771570|NCT02089685|69291506|FG000|Overall Study|Physician Decision|0|||
37771571|NCT02089685|69291507|FG001|Overall Study|Physician Decision|0|||
37771572|NCT02089685|69291508|FG002|Overall Study|Physician Decision|0|||
37771573|NCT02089685|69291509|FG003|Overall Study|Physician Decision|0|||
37771574|NCT02089685|69291510|FG004|Overall Study|Physician Decision|0|||
37771575|NCT02089685|69291511|FG005|Overall Study|Physician Decision|4|||
37771576|NCT02089685|69291506|FG000|Overall Study|Screen failure|1|||
37771577|NCT02089685|69291507|FG001|Overall Study|Screen failure|0|||
37771578|NCT02089685|69291508|FG002|Overall Study|Screen failure|0|||
37771579|NCT02089685|69291509|FG003|Overall Study|Screen failure|0|||
37771580|NCT02089685|69291510|FG004|Overall Study|Screen failure|0|||
37771581|NCT02089685|69291511|FG005|Overall Study|Screen failure|0|||
37771582|NCT05282004|69291569|FG000|Overall Study|Adverse Event|2|||
37771583|NCT05004649|69291573|FG000|Overall Study|Eligibility Criteria - Threshold|4|||
37771584|NCT05004649|69291573|FG000|Overall Study|Lost to Follow-up|1|||
37771585|NCT05004649|69291573|FG000|Overall Study|Withdrawal by Subject|2|||
37771586|NCT05004649|69291573|FG000|Overall Study|COVID-19|1|||
37771587|NCT04666298|69291583|FG000|Overall Study|Subject decision|1|||
37771588|NCT04666298|69291584|FG001|Overall Study|Subject decision|0|||
37771589|NCT04666298|69291585|FG002|Overall Study|Subject decision|0|||
37689699|NCT02527343|69166031|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
37689700|NCT02527343|69166032|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
37689701|NCT02527343|69166033|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
37689702|NCT02527343|69166034|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
37689703|NCT02527343|69166035|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
37689704|NCT02527343|69166036|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
37689705|NCT02527343|69166031|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
37689706|NCT02527343|69166032|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
37689707|NCT02527343|69166033|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
37689708|NCT02527343|69166034|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
37689709|NCT02527343|69166035|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
37689710|NCT02527343|69166036|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
37689711|NCT02527343|69166031|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
37689712|NCT02527343|69166032|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
37689713|NCT02527343|69166033|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
37689714|NCT02527343|69166034|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
37689715|NCT02527343|69166035|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
37689716|NCT02527343|69166036|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
37771590|NCT04666298|69291586|FG003|Overall Study|Subject decision|2|||
37689717|NCT02527343|69166031|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
37771591|NCT04666298|69291583|FG000|Overall Study|Death|1|||
37771592|NCT04666298|69291584|FG001|Overall Study|Death|0|||
37771593|NCT04666298|69291585|FG002|Overall Study|Death|0|||
37771594|NCT04666298|69291586|FG003|Overall Study|Death|0|||
37771595|NCT04666298|69291583|FG000|Overall Study|Lost to Follow-up|0|||
37771596|NCT04666298|69291584|FG001|Overall Study|Lost to Follow-up|0|||
37771597|NCT04666298|69291585|FG002|Overall Study|Lost to Follow-up|0|||
37771598|NCT04666298|69291586|FG003|Overall Study|Lost to Follow-up|1|||
37771599|NCT04666298|69291583|FG000|Overall Study|Physician Decision|0|||
37771600|NCT04666298|69291584|FG001|Overall Study|Physician Decision|0|||
37771601|NCT04666298|69291585|FG002|Overall Study|Physician Decision|0|||
37771602|NCT04666298|69291586|FG003|Overall Study|Physician Decision|1|||
37771603|NCT04666298|69291583|FG000|Overall Study|Protocol deviation|0|||
37771604|NCT04666298|69291584|FG001|Overall Study|Protocol deviation|0|||
37771605|NCT04666298|69291585|FG002|Overall Study|Protocol deviation|1|||
37771606|NCT04666298|69291586|FG003|Overall Study|Protocol deviation|0|||
37771607|NCT04188301|69291625|FG000|Month 3|Lost to Follow-up|0|||
37771608|NCT04188301|69291626|FG001|Month 3|Lost to Follow-up|0|||
37771609|NCT04188301|69291627|FG002|Month 3|Lost to Follow-up|1|||
37771610|NCT04188301|69291625|FG000|Month 12|Lost to Follow-up|0|||
37771611|NCT04188301|69291626|FG001|Month 12|Lost to Follow-up|0|||
37771612|NCT04188301|69291627|FG002|Month 12|Lost to Follow-up|2|||
37771613|NCT04188301|69291625|FG000|Month 12|Death|1|||
37771614|NCT04188301|69291626|FG001|Month 12|Death|1|||
37771615|NCT04188301|69291627|FG002|Month 12|Death|0|||
37689718|NCT02527343|69166032|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
37689719|NCT02527343|69166033|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
37689720|NCT02527343|69166034|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
37689721|NCT02527343|69166035|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
37689722|NCT02527343|69166036|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
37689723|NCT02527343|69166031|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
37689724|NCT02527343|69166032|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
37689725|NCT02527343|69166033|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
37689726|NCT02527343|69166034|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
37689727|NCT02527343|69166035|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
37689728|NCT02527343|69166036|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
37689729|NCT02527343|69166031|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
37689730|NCT02527343|69166032|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
37689731|NCT02527343|69166033|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
37689732|NCT02527343|69166034|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
37689733|NCT02527343|69166035|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
37771616|NCT04188301|69291625|FG000|Month 18|Lost to Follow-up|6|||
37771617|NCT04188301|69291626|FG001|Month 18|Lost to Follow-up|0|||
37771618|NCT04188301|69291627|FG002|Month 18|Lost to Follow-up|0|||
37771619|NCT04006925|69291637|FG000|Overall Study|Side effects|2|||
37771620|NCT04006925|69291638|FG001|Overall Study|Side effects|0|||
37771621|NCT03597061|69291650|FG000|Overall Study|Lost to Follow-up|1|||
37771622|NCT03597061|69291651|FG001|Overall Study|Lost to Follow-up|0|||
37771623|NCT03597061|69291650|FG000|Overall Study|Protocol Violation|0|||
37771624|NCT03597061|69291651|FG001|Overall Study|Protocol Violation|1|||
37771625|NCT03148795|69291679|FG000|Overall Study|Death|6|||
37771626|NCT03148795|69291679|FG000|Overall Study|Adverse Event|5|||
37771627|NCT03148795|69291679|FG000|Overall Study|Other|15|||
37771628|NCT03148795|69291679|FG000|Overall Study|No Longer Clinically Benefitting|2|||
37771629|NCT03148795|69291679|FG000|Overall Study|Global Deterioration Of Health Status|6|||
37771630|NCT03148795|69291679|FG000|Overall Study|Withdrawal by Subject|2|||
37771631|NCT03148795|69291679|FG000|Overall Study|Progressive Disease|62|||
37771632|NCT03148795|69291679|FG000|Overall Study|Ongoing|30|||
37771633|NCT03146845|69291685|FG000|Overall Study|Reference ulcer healed|1|||
37771634|NCT03146845|69291686|FG001|Overall Study|Reference ulcer healed|0|||
37771635|NCT03146845|69291685|FG000|Overall Study|Physician Decision|1|||
37771636|NCT03146845|69291686|FG001|Overall Study|Physician Decision|0|||
37771637|NCT03146845|69291685|FG000|Overall Study|Adverse Event|1|||
37689734|NCT02527343|69166036|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
37689735|NCT02527343|69166031|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
37689736|NCT02527343|69166032|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
37689737|NCT02527343|69166033|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
37689738|NCT02527343|69166034|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
37689739|NCT02527343|69166035|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
37689740|NCT02527343|69166036|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
37689741|NCT02527343|69166031|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
37689742|NCT02527343|69166032|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
37689743|NCT02527343|69166033|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
37689744|NCT02527343|69166034|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
37689745|NCT02527343|69166035|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
37689746|NCT02527343|69166036|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
37689747|NCT01931566|69166054|FG000|Overall Study|Randomized But Not Treated|6|||
37771638|NCT03146845|69291686|FG001|Overall Study|Adverse Event|0|||
37771639|NCT03146845|69291685|FG000|Overall Study|Withdrawal by Subject|2|||
37771640|NCT03146845|69291686|FG001|Overall Study|Withdrawal by Subject|0|||
37771641|NCT03146845|69291685|FG000|Overall Study|Noncompliance|0|||
37771642|NCT03146845|69291686|FG001|Overall Study|Noncompliance|1|||
37689748|NCT01931566|69166055|FG001|Overall Study|Randomized But Not Treated|9|||
37689749|NCT01931566|69166056|FG002|Overall Study|Randomized But Not Treated|14|||
37771643|NCT03146845|69291685|FG000|Overall Study|Protocol Violation|0|||
37771644|NCT03146845|69291686|FG001|Overall Study|Protocol Violation|2|||
37771645|NCT03146845|69291685|FG000|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|0|||
37771646|NCT03146845|69291686|FG001|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|1|||
37771647|NCT02975700|69291692|FG000|Overall Study|Adverse Event|1|||
37771648|NCT02975700|69291692|FG000|Overall Study|Progressive disease|3|||
37771649|NCT02975700|69291692|FG000|Overall Study|Failed screening criteria|2|||
37771650|NCT02895360|69291702|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
37771651|NCT02895360|69291703|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
37771652|NCT02895360|69291704|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
37771653|NCT02895360|69291705|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
37771654|NCT02895360|69291706|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
37771655|NCT02895360|69291707|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
37771656|NCT02895360|69291702|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
37771657|NCT02895360|69291703|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
37771658|NCT02895360|69291704|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
37771659|NCT02895360|69291705|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
37771660|NCT02895360|69291706|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
37771661|NCT02895360|69291707|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
37771662|NCT02895360|69291702|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
37771663|NCT02895360|69291703|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
37771664|NCT02895360|69291704|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
37771665|NCT02895360|69291705|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
37771666|NCT02895360|69291706|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
37771667|NCT02895360|69291707|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
37771668|NCT02895360|69291702|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
37967735|NCT00642941|69654649|FG004|Overall Study|Other|0|||
37967736|NCT00642941|69654650|FG005|Overall Study|Other|1|||
37967737|NCT00642941|69654651|FG006|Overall Study|Other|0|||
37967738|NCT00642941|69654652|FG007|Overall Study|Other|1|||
37967739|NCT00642941|69654653|FG008|Overall Study|Other|0|||
37967740|NCT00642941|69654654|FG009|Overall Study|Other|0|||
37689750|NCT01931566|69166054|FG000|Overall Study|Adverse Event|37|||
37689751|NCT01931566|69166055|FG001|Overall Study|Adverse Event|167|||
37689752|NCT01931566|69166056|FG002|Overall Study|Adverse Event|132|||
37689753|NCT01931566|69166054|FG000|Overall Study|Major Protocol Deviation|5|||
37689754|NCT01931566|69166055|FG001|Overall Study|Major Protocol Deviation|14|||
37689755|NCT01931566|69166056|FG002|Overall Study|Major Protocol Deviation|21|||
37689756|NCT01931566|69166054|FG000|Overall Study|Lost to Follow-up|3|||
37689757|NCT01931566|69166055|FG001|Overall Study|Lost to Follow-up|26|||
37689758|NCT01931566|69166056|FG002|Overall Study|Lost to Follow-up|23|||
37689759|NCT01931566|69166054|FG000|Overall Study|Voluntary Withdrawal|78|||
37689760|NCT01931566|69166055|FG001|Overall Study|Voluntary Withdrawal|245|||
37689761|NCT01931566|69166056|FG002|Overall Study|Voluntary Withdrawal|225|||
37967741|NCT00642941|69654655|FG010|Overall Study|Other|0|||
37967742|NCT00642941|69654656|FG011|Overall Study|Other|1|||
37689762|NCT01931566|69166054|FG000|Overall Study|Study Termination|289|||
37689763|NCT01931566|69166055|FG001|Overall Study|Study Termination|968|||
37689764|NCT01931566|69166056|FG002|Overall Study|Study Termination|1037|||
37689765|NCT01931566|69166054|FG000|Overall Study|Reason Not Specified|11|||
37689766|NCT01931566|69166055|FG001|Overall Study|Reason Not Specified|47|||
37689767|NCT01931566|69166056|FG002|Overall Study|Reason Not Specified|53|||
37689768|NCT01931566|69166054|FG000|Overall Study|Missing|0|||
37689769|NCT01931566|69166055|FG001|Overall Study|Missing|0|||
37689770|NCT01931566|69166056|FG002|Overall Study|Missing|1|||
37689771|NCT01912456|69166067|FG000|Period 1|Physician Decision|0|||
37771669|NCT02895360|69291703|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
37771670|NCT02895360|69291704|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
37967743|NCT00642941|69654645|FG000|Overall Study|Disease progression|60|||
37967744|NCT00642941|69654646|FG001|Overall Study|Disease progression|50|||
37967745|NCT00642941|69654647|FG002|Overall Study|Disease progression|5|||
37967746|NCT00642941|69654648|FG003|Overall Study|Disease progression|36|||
37967747|NCT00642941|69654649|FG004|Overall Study|Disease progression|23|||
37967748|NCT00642941|69654650|FG005|Overall Study|Disease progression|39|||
37771671|NCT02895360|69291705|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
37771672|NCT02895360|69291706|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
37771673|NCT02895360|69291707|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
37967749|NCT00642941|69654651|FG006|Overall Study|Disease progression|18|||
37967750|NCT00642941|69654652|FG007|Overall Study|Disease progression|12|||
37967751|NCT00642941|69654653|FG008|Overall Study|Disease progression|10|||
37689772|NCT01912456|69166068|FG001|Period 1|Physician Decision|0|||
37689773|NCT01912456|69166069|FG002|Period 1|Physician Decision|1|||
37689774|NCT01912456|69166070|FG003|Period 1|Physician Decision|0|||
37689775|NCT01912456|69166067|FG000|Period 1|non-compliance|1|||
37689776|NCT01912456|69166068|FG001|Period 1|non-compliance|0|||
37689777|NCT01912456|69166069|FG002|Period 1|non-compliance|0|||
37689778|NCT01912456|69166070|FG003|Period 1|non-compliance|1|||
37689779|NCT01912456|69166067|FG000|Period 1|Adverse Event|1|||
37689780|NCT01912456|69166068|FG001|Period 1|Adverse Event|0|||
37689781|NCT01912456|69166069|FG002|Period 1|Adverse Event|0|||
37689782|NCT01912456|69166070|FG003|Period 1|Adverse Event|1|||
37689783|NCT01912456|69166067|FG000|Period 1|Withdrawal by Subject|0|||
37689784|NCT01912456|69166068|FG001|Period 1|Withdrawal by Subject|1|||
37689785|NCT01912456|69166069|FG002|Period 1|Withdrawal by Subject|1|||
37689786|NCT01912456|69166070|FG003|Period 1|Withdrawal by Subject|1|||
37689787|NCT01912456|69166067|FG000|Period 2|Lack of Efficacy|0|||
37689788|NCT01912456|69166068|FG001|Period 2|Lack of Efficacy|2|||
37689789|NCT01912456|69166069|FG002|Period 2|Lack of Efficacy|0|||
37689790|NCT01912456|69166070|FG003|Period 2|Lack of Efficacy|0|||
37689791|NCT01912456|69166067|FG000|Period 2|Adverse Event|0|||
37689792|NCT01912456|69166068|FG001|Period 2|Adverse Event|0|||
37689793|NCT01912456|69166069|FG002|Period 2|Adverse Event|0|||
37689794|NCT01912456|69166070|FG003|Period 2|Adverse Event|1|||
37689795|NCT01885936|69166082|FG000|Overall Study|Withdrawal by Subject|1|||
37689796|NCT01885936|69166083|FG001|Overall Study|Withdrawal by Subject|0|||
37689797|NCT01912222|69166092|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
37689798|NCT01912222|69166093|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
37689799|NCT01912222|69166094|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
37689800|NCT01912222|69166092|FG000|Part B: Treatment Period|Progressive disease|10|||
37689801|NCT01912222|69166093|FG001|Part B: Treatment Period|Progressive disease|12|||
37689802|NCT01912222|69166094|FG002|Part B: Treatment Period|Progressive disease|15|||
37689803|NCT01912222|69166092|FG000|Part B: Treatment Period|Adverse Event|1|||
37689804|NCT01912222|69166093|FG001|Part B: Treatment Period|Adverse Event|2|||
37689805|NCT01912222|69166094|FG002|Part B: Treatment Period|Adverse Event|3|||
37689806|NCT01912222|69166092|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
37689807|NCT01912222|69166093|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
37689808|NCT01912222|69166094|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
37689809|NCT02525861|69166105|FG000|Overall Study|Adverse Event|1|||
37689810|NCT02525861|69166106|FG001|Overall Study|Adverse Event|0|||
37689811|NCT02525861|69166105|FG000|Overall Study|Withdrawal by Subject|0|||
37689812|NCT02525861|69166106|FG001|Overall Study|Withdrawal by Subject|1|||
37689813|NCT02525861|69166105|FG000|Overall Study|Physician Decision|0|||
37689814|NCT02525861|69166106|FG001|Overall Study|Physician Decision|1|||
37689815|NCT02524847|69166114|FG000|Overall Study|Adverse Event|4|||
37689816|NCT02524847|69166114|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
37689817|NCT02524847|69166114|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
37689818|NCT02524847|69166114|FG000|Overall Study|Death|1|||
37689819|NCT02524847|69166114|FG000|Overall Study|Reason not Specified|1|||
37689820|NCT02525627|69166121|FG000|Overall Study|Revision|1|||
37689821|NCT02525627|69166122|FG001|Overall Study|Revision|1|||
37689822|NCT02525627|69166121|FG000|Overall Study|Withdrawal by Subject|1|||
37689823|NCT02525627|69166122|FG001|Overall Study|Withdrawal by Subject|2|||
37689824|NCT02525627|69166121|FG000|Overall Study|Death|1|||
37689825|NCT02525627|69166122|FG001|Overall Study|Death|0|||
37689826|NCT02525627|69166121|FG000|Overall Study|Site terminated|11|||
37689827|NCT02525627|69166122|FG001|Overall Study|Site terminated|10|||
37689828|NCT02129205|69166138|FG000|Overall Study|Withdrawal by Subject|0|||
37689829|NCT02129205|69166139|FG001|Overall Study|Withdrawal by Subject|0|||
37689830|NCT02129205|69166140|FG002|Overall Study|Withdrawal by Subject|0|||
37689831|NCT02129205|69166141|FG003|Overall Study|Withdrawal by Subject|0|||
37689832|NCT02129205|69166142|FG004|Overall Study|Withdrawal by Subject|1|||
37689833|NCT02129205|69166143|FG005|Overall Study|Withdrawal by Subject|1|||
37689834|NCT02129205|69166144|FG006|Overall Study|Withdrawal by Subject|1|||
37689835|NCT02129205|69166145|FG007|Overall Study|Withdrawal by Subject|0|||
37689836|NCT02129205|69166146|FG008|Overall Study|Withdrawal by Subject|1|||
37689837|NCT02129205|69166147|FG009|Overall Study|Withdrawal by Subject|0|||
37689838|NCT02129205|69166138|FG000|Overall Study|Other|1|||
37689839|NCT02129205|69166139|FG001|Overall Study|Other|0|||
37689840|NCT02129205|69166140|FG002|Overall Study|Other|0|||
37689841|NCT02129205|69166141|FG003|Overall Study|Other|0|||
37689842|NCT02129205|69166142|FG004|Overall Study|Other|2|||
37689843|NCT02129205|69166143|FG005|Overall Study|Other|3|||
37689844|NCT02129205|69166144|FG006|Overall Study|Other|3|||
37689845|NCT02129205|69166145|FG007|Overall Study|Other|2|||
37689846|NCT02129205|69166146|FG008|Overall Study|Other|1|||
37689847|NCT02129205|69166147|FG009|Overall Study|Other|0|||
37771674|NCT02895360|69291702|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
37771675|NCT02895360|69291703|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
37771676|NCT02895360|69291704|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
37771677|NCT02895360|69291705|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
37771678|NCT02895360|69291706|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
37771679|NCT02895360|69291707|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
37771680|NCT02895360|69291702|FG000|Phase 2a|Adverse Event|0|||
37771681|NCT02895360|69291703|FG001|Phase 2a|Adverse Event|0|||
37771682|NCT02895360|69291704|FG002|Phase 2a|Adverse Event|0|||
37689848|NCT02128269|69166171|FG000|Treatment Period|Adverse Event|1|||
37689849|NCT02128269|69166171|FG000|Treatment Period|Physician Decision|1|||
37689850|NCT01626885|69166175|FG000|Overall Study|Adverse Event|8|||
37689851|NCT01626885|69166175|FG000|Overall Study|Withdrawal by Subject|4|||
37689852|NCT02524379|69166179|FG000|Overall Study|Death|1|||
37689853|NCT02524145|69166186|FG000|Overall Study|Withdrawal by Subject|2|||
37689854|NCT02524145|69166187|FG001|Overall Study|Withdrawal by Subject|2|||
37771683|NCT02895360|69291705|FG003|Phase 2a|Adverse Event|0|||
37771684|NCT02895360|69291706|FG004|Phase 2a|Adverse Event|0|||
37771685|NCT02895360|69291707|FG005|Phase 2a|Adverse Event|1|||
37771686|NCT02895360|69291702|FG000|Phase 2a|Progressive disease|0|||
37771687|NCT02895360|69291703|FG001|Phase 2a|Progressive disease|0|||
37771688|NCT02895360|69291704|FG002|Phase 2a|Progressive disease|0|||
37771689|NCT02895360|69291705|FG003|Phase 2a|Progressive disease|0|||
37771690|NCT02895360|69291706|FG004|Phase 2a|Progressive disease|11|||
37771691|NCT02895360|69291707|FG005|Phase 2a|Progressive disease|11|||
37771692|NCT02863809|69291741|FG000|Overall Study|Adverse Event|8|||
37771693|NCT02863809|69291742|FG001|Overall Study|Adverse Event|8|||
37771694|NCT02863809|69291741|FG000|Overall Study|Withdrawal by Subject|0|||
37771695|NCT02863809|69291742|FG001|Overall Study|Withdrawal by Subject|1|||
37771696|NCT02863809|69291741|FG000|Overall Study|Lost to Follow-up|1|||
37771697|NCT02863809|69291742|FG001|Overall Study|Lost to Follow-up|1|||
37771698|NCT02863809|69291741|FG000|Overall Study|Death|1|||
37771699|NCT02863809|69291742|FG001|Overall Study|Death|0|||
37771700|NCT02753530|69291766|FG000|Overall Study|Adverse Event|7|||
37771701|NCT02753530|69291767|FG001|Overall Study|Adverse Event|1|||
37863476|NCT00996892|69547134|FG016|Expansion Stage 2|Death|0|||
37967752|NCT00642941|69654654|FG009|Overall Study|Disease progression|7|||
37967753|NCT00642941|69654655|FG010|Overall Study|Disease progression|12|||
37967754|NCT00642941|69654656|FG011|Overall Study|Disease progression|7|||
37967755|NCT00531960|69654705|FG000|Overall Study|Adverse Event|5|||
37967756|NCT00531960|69654706|FG001|Overall Study|Adverse Event|4|||
37967757|NCT00531960|69654705|FG000|Overall Study|Death|3|||
37967758|NCT00531960|69654706|FG001|Overall Study|Death|2|||
37689855|NCT02524145|69166188|FG002|Overall Study|Withdrawal by Subject|3|||
37771702|NCT02753530|69291766|FG000|Overall Study|Death|0|||
37967759|NCT00531960|69654705|FG000|Overall Study|Lack of Efficacy|42|||
37967760|NCT00531960|69654706|FG001|Overall Study|Lack of Efficacy|41|||
37967761|NCT00531960|69654705|FG000|Overall Study|Violation of Selection Criteria|2|||
37967762|NCT00531960|69654706|FG001|Overall Study|Violation of Selection Criteria|0|||
37771703|NCT02753530|69291767|FG001|Overall Study|Death|1|||
37771704|NCT02753530|69291766|FG000|Overall Study|Physician Decision|0|||
37771705|NCT02753530|69291767|FG001|Overall Study|Physician Decision|1|||
37771706|NCT02753530|69291766|FG000|Overall Study|Protocol Violation|1|||
37771707|NCT02753530|69291767|FG001|Overall Study|Protocol Violation|0|||
37967763|NCT00531960|69654705|FG000|Overall Study|Refused Treatment|5|||
37771708|NCT02753530|69291766|FG000|Overall Study|Withdrawal by Subject|4|||
37863477|NCT00996892|69547135|FG017|Expansion Stage 2|Death|0|||
37689856|NCT01658813|69166196|FG000|Overall Study|Disease progression|3|||
37689857|NCT02187471|69166208|FG000|Overall Study|Protocol Violation|4|||
37689858|NCT02187471|69166209|FG001|Overall Study|Protocol Violation|5|||
37689859|NCT02187471|69166210|FG002|Overall Study|Protocol Violation|4|||
37967764|NCT00531960|69654706|FG001|Overall Study|Refused Treatment|6|||
37689860|NCT02187471|69166211|FG003|Overall Study|Protocol Violation|4|||
37771709|NCT02753530|69291767|FG001|Overall Study|Withdrawal by Subject|3|||
37771710|NCT02289079|69291779|FG000|Overall Study|Physician Decision|2|||
37771711|NCT02289079|69291780|FG001|Overall Study|Physician Decision|0|||
37771712|NCT02289079|69291779|FG000|Overall Study|Lost to Follow-up|0|||
37771713|NCT02289079|69291780|FG001|Overall Study|Lost to Follow-up|1|||
37771714|NCT00602667|69291847|FG000|Overall Study|Still on Therapy|0|||
37771715|NCT00602667|69291848|FG001|Overall Study|Still on Therapy|2|||
37771716|NCT00602667|69291849|FG002|Overall Study|Still on Therapy|2|||
37771717|NCT00602667|69291847|FG000|Overall Study|Death|0|||
37771718|NCT00602667|69291848|FG001|Overall Study|Death|1|||
37771719|NCT00602667|69291849|FG002|Overall Study|Death|1|||
37771720|NCT00602667|69291847|FG000|Overall Study|Family request|3|||
37771721|NCT00602667|69291848|FG001|Overall Study|Family request|25|||
37771722|NCT00602667|69291849|FG002|Overall Study|Family request|6|||
37771723|NCT00602667|69291847|FG000|Overall Study|Excessive toxicity|1|||
37771724|NCT00602667|69291848|FG001|Overall Study|Excessive toxicity|1|||
37771725|NCT00602667|69291849|FG002|Overall Study|Excessive toxicity|0|||
37771726|NCT00602667|69291847|FG000|Overall Study|Second malignancy|0|||
37771727|NCT00602667|69291848|FG001|Overall Study|Second malignancy|1|||
37967765|NCT00531960|69654705|FG000|Overall Study|Other|4|||
37967766|NCT00531960|69654706|FG001|Overall Study|Other|10|||
37863478|NCT00996892|69547136|FG018|Expansion Stage 2|Death|2|||
37863479|NCT00996892|69547137|FG019|Expansion Stage 2|Death|0|||
37863480|NCT00996892|69547118|FG000|Expansion Stage 2|Physician Decision|0|||
37863481|NCT00996892|69547119|FG001|Expansion Stage 2|Physician Decision|0|||
37863482|NCT00996892|69547120|FG002|Expansion Stage 2|Physician Decision|0|||
37863483|NCT00996892|69547121|FG003|Expansion Stage 2|Physician Decision|0|||
37863484|NCT00996892|69547122|FG004|Expansion Stage 2|Physician Decision|0|||
37863485|NCT00996892|69547123|FG005|Expansion Stage 2|Physician Decision|0|||
37863486|NCT00996892|69547124|FG006|Expansion Stage 2|Physician Decision|0|||
37863487|NCT00996892|69547125|FG007|Expansion Stage 2|Physician Decision|0|||
37771728|NCT00602667|69291849|FG002|Overall Study|Second malignancy|0|||
37771729|NCT00602667|69291847|FG000|Overall Study|Physician Decision|2|||
37771730|NCT00602667|69291848|FG001|Overall Study|Physician Decision|3|||
37967767|NCT00361504|69654714|FG000|Overall Study|Withdrawal by Subject|94|||
37771731|NCT00602667|69291849|FG002|Overall Study|Physician Decision|8|||
37863488|NCT00996892|69547126|FG008|Expansion Stage 2|Physician Decision|0|||
37771732|NCT00602667|69291847|FG000|Overall Study|Progressive disease|13|||
37771733|NCT00602667|69291848|FG001|Overall Study|Progressive disease|48|||
37771734|NCT00602667|69291849|FG002|Overall Study|Progressive disease|45|||
37771735|NCT00602667|69291847|FG000|Overall Study|Progressive disease prior to therapy|0|||
37771736|NCT00602667|69291848|FG001|Overall Study|Progressive disease prior to therapy|0|||
37771737|NCT00602667|69291849|FG002|Overall Study|Progressive disease prior to therapy|1|||
37771738|NCT02088905|69291892|FG000|Overall Study|Withdrawal by Subject|5|||
37771739|NCT02088905|69291893|FG001|Overall Study|Withdrawal by Subject|1|||
37771740|NCT02088047|69291901|FG000|Overall Study|Withdrawal by Subject|1|||
37771741|NCT02088047|69291902|FG001|Overall Study|Withdrawal by Subject|0|||
37771742|NCT02086565|69291928|FG000|Overall Study|Lost to Follow-up|9|||
37771743|NCT02086565|69291929|FG001|Overall Study|Lost to Follow-up|7|||
37771744|NCT02086565|69291928|FG000|Overall Study|Withdrawal by Subject|2|||
37771745|NCT02086565|69291929|FG001|Overall Study|Withdrawal by Subject|1|||
37771746|NCT02086565|69291928|FG000|Overall Study|Death|3|||
37771747|NCT02086565|69291929|FG001|Overall Study|Death|2|||
37771748|NCT02086565|69291928|FG000|Overall Study|withdrawn by research team|2|||
37771749|NCT02086565|69291929|FG001|Overall Study|withdrawn by research team|2|||
37771750|NCT02085941|69291937|FG000|Overall Study|Lack of Efficacy|1|||
37771751|NCT02085941|69291938|FG001|Overall Study|Lack of Efficacy|0|||
37967768|NCT00361504|69654715|FG001|Overall Study|Withdrawal by Subject|31|||
37771752|NCT02085941|69291937|FG000|Overall Study|Death|6|||
37771753|NCT02085941|69291938|FG001|Overall Study|Death|1|||
37771754|NCT02085941|69291937|FG000|Overall Study|Lost to Follow-up|1|||
37771755|NCT02085941|69291938|FG001|Overall Study|Lost to Follow-up|0|||
37771756|NCT02085941|69291937|FG000|Overall Study|Physician Decision|0|||
37689861|NCT02187471|69166208|FG000|Overall Study|Missing|0|||
37967769|NCT00361504|69654714|FG000|Overall Study|Lost to Follow-up|40|||
37689862|NCT02187471|69166209|FG001|Overall Study|Missing|0|||
37863489|NCT00996892|69547127|FG009|Expansion Stage 2|Physician Decision|0|||
37863490|NCT00996892|69547128|FG010|Expansion Stage 2|Physician Decision|0|||
37863491|NCT00996892|69547129|FG011|Expansion Stage 2|Physician Decision|0|||
37863492|NCT00996892|69547130|FG012|Expansion Stage 2|Physician Decision|0|||
37863493|NCT00996892|69547131|FG013|Expansion Stage 2|Physician Decision|0|||
37863494|NCT00996892|69547132|FG014|Expansion Stage 2|Physician Decision|0|||
37689863|NCT02187471|69166210|FG002|Overall Study|Missing|0|||
37863495|NCT00996892|69547133|FG015|Expansion Stage 2|Physician Decision|0|||
37863496|NCT00996892|69547134|FG016|Expansion Stage 2|Physician Decision|0|||
37863497|NCT00996892|69547135|FG017|Expansion Stage 2|Physician Decision|0|||
37863498|NCT00996892|69547136|FG018|Expansion Stage 2|Physician Decision|1|||
37863499|NCT00996892|69547137|FG019|Expansion Stage 2|Physician Decision|0|||
37863500|NCT00996892|69547118|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
37863501|NCT00996892|69547119|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
37863502|NCT00996892|69547120|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
37863503|NCT00996892|69547121|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
37863504|NCT00996892|69547122|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
37863505|NCT00996892|69547123|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
37863506|NCT00996892|69547124|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
37863507|NCT00996892|69547125|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
37863508|NCT00996892|69547126|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
37863509|NCT00996892|69547127|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
37863510|NCT00996892|69547128|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
37863511|NCT00996892|69547129|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
37863512|NCT00996892|69547130|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
37863513|NCT00996892|69547131|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
37863514|NCT00996892|69547132|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
37863515|NCT00996892|69547133|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
37863516|NCT00996892|69547134|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
37863517|NCT00996892|69547135|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
37863518|NCT00996892|69547136|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
37967770|NCT00361504|69654715|FG001|Overall Study|Lost to Follow-up|7|||
37863519|NCT00996892|69547137|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
37863520|NCT00996892|69547118|FG000|Expansion Stage 2|Disease Progression|0|||
37771757|NCT02085941|69291938|FG001|Overall Study|Physician Decision|2|||
37771758|NCT02085785|69291946|FG000|Overall Study|Withdrawal by Subject|2|||
37771759|NCT02085785|69291947|FG001|Overall Study|Withdrawal by Subject|1|||
37863521|NCT00996892|69547119|FG001|Expansion Stage 2|Disease Progression|0|||
37689864|NCT02187471|69166211|FG003|Overall Study|Missing|1|||
37689865|NCT02187471|69166208|FG000|Overall Study|Lack of Efficacy|18|||
37689866|NCT02187471|69166209|FG001|Overall Study|Lack of Efficacy|9|||
37689867|NCT02187471|69166210|FG002|Overall Study|Lack of Efficacy|13|||
37689868|NCT02187471|69166211|FG003|Overall Study|Lack of Efficacy|11|||
37689869|NCT02187471|69166208|FG000|Overall Study|Adverse Event|24|||
37689870|NCT02187471|69166209|FG001|Overall Study|Adverse Event|34|||
37689871|NCT02187471|69166210|FG002|Overall Study|Adverse Event|44|||
37689872|NCT02187471|69166211|FG003|Overall Study|Adverse Event|36|||
37689873|NCT02187471|69166208|FG000|Overall Study|Withdrawal by Subject|23|||
37689874|NCT02187471|69166209|FG001|Overall Study|Withdrawal by Subject|29|||
37771760|NCT02085785|69291946|FG000|Overall Study|Lost to Follow-up|0|||
37771761|NCT02085785|69291947|FG001|Overall Study|Lost to Follow-up|1|||
37771762|NCT02085161|69291975|FG000|Overall Study|Not Treated|1|||
37771763|NCT02085161|69291976|FG001|Overall Study|Not Treated|0|||
37771764|NCT02085161|69291977|FG002|Overall Study|Not Treated|0|||
37771765|NCT02085161|69291978|FG003|Overall Study|Not Treated|0|||
37689875|NCT02187471|69166210|FG002|Overall Study|Withdrawal by Subject|22|||
37689876|NCT02187471|69166211|FG003|Overall Study|Withdrawal by Subject|24|||
37689877|NCT02187471|69166208|FG000|Overall Study|Other|7|||
37771766|NCT02085161|69291975|FG000|Overall Study|Adverse Event|8|||
37771767|NCT02085161|69291976|FG001|Overall Study|Adverse Event|5|||
37771768|NCT02085161|69291977|FG002|Overall Study|Adverse Event|4|||
37771769|NCT02085161|69291978|FG003|Overall Study|Adverse Event|5|||
37771770|NCT02085161|69291975|FG000|Overall Study|Protocol Violation|0|||
37771771|NCT02085161|69291976|FG001|Overall Study|Protocol Violation|1|||
37771772|NCT02085161|69291977|FG002|Overall Study|Protocol Violation|0|||
37771773|NCT02085161|69291978|FG003|Overall Study|Protocol Violation|1|||
37771774|NCT02085161|69291975|FG000|Overall Study|Withdrawal by Subject|2|||
37771775|NCT02085161|69291976|FG001|Overall Study|Withdrawal by Subject|4|||
37771776|NCT02085161|69291977|FG002|Overall Study|Withdrawal by Subject|0|||
37771777|NCT02085161|69291978|FG003|Overall Study|Withdrawal by Subject|3|||
37771778|NCT02085161|69291975|FG000|Overall Study|Other Reason|1|||
37771779|NCT02085161|69291976|FG001|Overall Study|Other Reason|0|||
37771780|NCT02085161|69291977|FG002|Overall Study|Other Reason|1|||
37771781|NCT02085161|69291978|FG003|Overall Study|Other Reason|1|||
37771782|NCT02082977|69292861|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
37771783|NCT02082977|69292862|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
37771784|NCT02082977|69292863|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
37771785|NCT02082977|69292864|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
37771786|NCT02082977|69292865|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
37771787|NCT02082977|69292866|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
37771788|NCT02082977|69292867|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
37689878|NCT02187471|69166209|FG001|Overall Study|Other|5|||
37689879|NCT02187471|69166210|FG002|Overall Study|Other|3|||
37689880|NCT02187471|69166211|FG003|Overall Study|Other|4|||
37771789|NCT02082977|69292868|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
37771790|NCT02082977|69292869|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
37689881|NCT02525471|69166222|FG000|Overall Study|Screen Failure|6|||
37689882|NCT02525471|69166222|FG000|Overall Study|Withdrawal by Subject|4|||
37689883|NCT02525471|69166222|FG000|Overall Study|Death|1|||
37689884|NCT01658735|69166230|FG000|Overall Study|Lack of Efficacy|1|||
37689885|NCT01658735|69166231|FG001|Overall Study|Lack of Efficacy|0|||
37689886|NCT01658735|69166232|FG002|Overall Study|Lack of Efficacy|1|||
37771791|NCT02082977|69292870|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
37771792|NCT02082977|69292861|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
37771793|NCT02082977|69292862|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
37771794|NCT02082977|69292863|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
37689887|NCT01658735|69166230|FG000|Overall Study|Lost to Follow-up|1|||
37689888|NCT01658735|69166231|FG001|Overall Study|Lost to Follow-up|1|||
37771795|NCT02082977|69292864|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
37771796|NCT02082977|69292865|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
37771797|NCT02082977|69292866|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
37771798|NCT02082977|69292867|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
37771799|NCT02082977|69292868|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
37771800|NCT02082977|69292869|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
37771801|NCT02082977|69292870|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
37771802|NCT02082977|69292861|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
37771803|NCT02082977|69292862|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
37771804|NCT02082977|69292863|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
37771805|NCT02082977|69292864|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
37771806|NCT02082977|69292865|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
37771807|NCT02082977|69292866|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
37771808|NCT02082977|69292867|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
37771809|NCT02082977|69292868|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
37771810|NCT02082977|69292869|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
37771811|NCT02082977|69292870|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
37771812|NCT02082977|69292861|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
37771813|NCT02082977|69292862|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
37771814|NCT02082977|69292863|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
37771815|NCT02082977|69292864|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
37771816|NCT02082977|69292865|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
37771817|NCT02082977|69292866|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
37771818|NCT02082977|69292867|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
37771819|NCT02082977|69292868|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
37771820|NCT02082977|69292869|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
37771821|NCT02082977|69292870|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
37771822|NCT02082977|69292861|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
37771823|NCT02082977|69292862|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
37689889|NCT01658735|69166232|FG002|Overall Study|Lost to Follow-up|0|||
37771824|NCT02082977|69292863|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
37771825|NCT02082977|69292864|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
37863522|NCT00996892|69547120|FG002|Expansion Stage 2|Disease Progression|0|||
37967771|NCT00361504|69654714|FG000|Overall Study|Adverse Event|203|||
37689890|NCT01658735|69166230|FG000|Overall Study|Protocol Violation|0|||
37689891|NCT01658735|69166231|FG001|Overall Study|Protocol Violation|1|||
37689892|NCT01658735|69166232|FG002|Overall Study|Protocol Violation|0|||
37689893|NCT01658735|69166230|FG000|Overall Study|Withdrawal by Subject|3|||
37689894|NCT01658735|69166231|FG001|Overall Study|Withdrawal by Subject|5|||
37689895|NCT01658735|69166232|FG002|Overall Study|Withdrawal by Subject|3|||
37689896|NCT02523599|69166242|FG000|Overall Study|Adverse Event|1|||
37689897|NCT02523599|69166243|FG001|Overall Study|Adverse Event|0|||
37689898|NCT02523599|69166242|FG000|Overall Study|Physician Decision|1|||
37689899|NCT02523599|69166243|FG001|Overall Study|Physician Decision|0|||
37771826|NCT02082977|69292865|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
37771827|NCT02082977|69292866|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
37967772|NCT00361504|69654715|FG001|Overall Study|Adverse Event|82|||
37967773|NCT00361504|69654714|FG000|Overall Study|Lack of Efficacy|72|||
37967774|NCT00361504|69654715|FG001|Overall Study|Lack of Efficacy|7|||
37967775|NCT00361504|69654714|FG000|Overall Study|Resolution of Pain|2|||
37967776|NCT00361504|69654715|FG001|Overall Study|Resolution of Pain|0|||
37967777|NCT00361504|69654714|FG000|Overall Study|Study medication non compliant|42|||
37967778|NCT00361504|69654715|FG001|Overall Study|Study medication non compliant|15|||
37967779|NCT00361504|69654714|FG000|Overall Study|All other|28|||
37967780|NCT00361504|69654715|FG001|Overall Study|All other|3|||
37967781|NCT00361270|69654725|FG000|Overall Study|Death|0|||
37689900|NCT02523599|69166242|FG000|Overall Study|Lost to Follow-up|4|||
37689901|NCT02523599|69166243|FG001|Overall Study|Lost to Follow-up|1|||
37689902|NCT02523599|69166242|FG000|Overall Study|Did not return for Day 30 visit|2|||
37689903|NCT02523599|69166243|FG001|Overall Study|Did not return for Day 30 visit|0|||
37689904|NCT02187159|69166253|FG000|Overall Study|Protocol Violation|4|||
37967782|NCT00361270|69654726|FG001|Overall Study|Death|0|||
37967783|NCT00361270|69654727|FG002|Overall Study|Death|0|||
37967784|NCT00361270|69654728|FG003|Overall Study|Death|2|||
37967785|NCT00361270|69654725|FG000|Overall Study|Lost to Follow-up|4|||
37689905|NCT02187159|69166254|FG001|Overall Study|Protocol Violation|6|||
37689906|NCT02187159|69166255|FG002|Overall Study|Protocol Violation|3|||
37689907|NCT02187159|69166256|FG003|Overall Study|Protocol Violation|4|||
37689908|NCT02187159|69166253|FG000|Overall Study|Lack of Efficacy|10|||
37689909|NCT02187159|69166254|FG001|Overall Study|Lack of Efficacy|5|||
37689910|NCT02187159|69166255|FG002|Overall Study|Lack of Efficacy|4|||
37689911|NCT02187159|69166256|FG003|Overall Study|Lack of Efficacy|7|||
37689912|NCT02187159|69166253|FG000|Overall Study|Adverse Event|28|||
37689913|NCT02187159|69166254|FG001|Overall Study|Adverse Event|33|||
37689914|NCT02187159|69166255|FG002|Overall Study|Adverse Event|42|||
37689915|NCT02187159|69166256|FG003|Overall Study|Adverse Event|50|||
37689916|NCT02187159|69166253|FG000|Overall Study|Withdrawal by Subject|24|||
37967786|NCT00361270|69654726|FG001|Overall Study|Lost to Follow-up|1|||
37967787|NCT00361270|69654727|FG002|Overall Study|Lost to Follow-up|0|||
37967788|NCT00361270|69654728|FG003|Overall Study|Lost to Follow-up|0|||
37967789|NCT00361270|69654725|FG000|Overall Study|Physician Decision|0|||
37967790|NCT00361270|69654726|FG001|Overall Study|Physician Decision|0|||
37967791|NCT00361270|69654727|FG002|Overall Study|Physician Decision|1|||
37967792|NCT00361270|69654728|FG003|Overall Study|Physician Decision|0|||
37967793|NCT00361270|69654725|FG000|Overall Study|Protocol Violation|9|||
37967794|NCT00361270|69654726|FG001|Overall Study|Protocol Violation|4|||
37967795|NCT00361270|69654727|FG002|Overall Study|Protocol Violation|5|||
37967796|NCT00361270|69654728|FG003|Overall Study|Protocol Violation|4|||
37967797|NCT00361270|69654725|FG000|Overall Study|Withdrawal by Subject|6|||
37967798|NCT00361270|69654726|FG001|Overall Study|Withdrawal by Subject|6|||
37967799|NCT00361270|69654727|FG002|Overall Study|Withdrawal by Subject|3|||
37967800|NCT00361270|69654728|FG003|Overall Study|Withdrawal by Subject|7|||
37967801|NCT00361270|69654725|FG000|Overall Study|Afraid of Hypnosis|1|||
37967802|NCT00361270|69654726|FG001|Overall Study|Afraid of Hypnosis|2|||
37967803|NCT00361270|69654727|FG002|Overall Study|Afraid of Hypnosis|0|||
37967804|NCT00361270|69654728|FG003|Overall Study|Afraid of Hypnosis|0|||
37967805|NCT00361270|69654725|FG000|Overall Study|Problems with Transportation|4|||
37967806|NCT00361270|69654726|FG001|Overall Study|Problems with Transportation|0|||
37967807|NCT00361270|69654727|FG002|Overall Study|Problems with Transportation|0|||
37967808|NCT00361270|69654728|FG003|Overall Study|Problems with Transportation|0|||
37689917|NCT02187159|69166254|FG001|Overall Study|Withdrawal by Subject|28|||
37689918|NCT02187159|69166255|FG002|Overall Study|Withdrawal by Subject|25|||
37689919|NCT02187159|69166256|FG003|Overall Study|Withdrawal by Subject|26|||
37771828|NCT02082977|69292867|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
37771829|NCT02082977|69292868|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
37771830|NCT02082977|69292869|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
37771831|NCT02082977|69292870|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
37771832|NCT01624259|69292904|FG000|Overall Study|Adverse Event|18|||
37771833|NCT01624259|69292905|FG001|Overall Study|Adverse Event|18|||
37771834|NCT01624259|69292904|FG000|Overall Study|Protocol Violation|1|||
37771835|NCT01624259|69292905|FG001|Overall Study|Protocol Violation|2|||
37771836|NCT01624259|69292904|FG000|Overall Study|Withdrawal by Subject|5|||
37771837|NCT01624259|69292905|FG001|Overall Study|Withdrawal by Subject|7|||
37771838|NCT01624259|69292904|FG000|Overall Study|Physician Decision|1|||
37771839|NCT01624259|69292905|FG001|Overall Study|Physician Decision|1|||
37771840|NCT01624259|69292904|FG000|Overall Study|Lost to Follow-up|2|||
37771841|NCT01624259|69292905|FG001|Overall Study|Lost to Follow-up|3|||
37771842|NCT01624259|69292904|FG000|Overall Study|Abnormal laboratory measure|3|||
37771843|NCT01624259|69292905|FG001|Overall Study|Abnormal laboratory measure|0|||
37689920|NCT02187159|69166253|FG000|Overall Study|Other|3|||
37689921|NCT02187159|69166254|FG001|Overall Study|Other|7|||
37689922|NCT02187159|69166255|FG002|Overall Study|Other|3|||
37689923|NCT02187159|69166256|FG003|Overall Study|Other|9|||
37689924|NCT02335411|69166269|FG000|Overall Study|Death|223|||
37771844|NCT02081417|69292915|FG000|Overall Study|Lost to Follow-up|26|||
37771845|NCT02081417|69292916|FG001|Overall Study|Lost to Follow-up|23|||
37967809|NCT00361270|69654725|FG000|Overall Study|Adverse Event|0|||
37967810|NCT00361270|69654726|FG001|Overall Study|Adverse Event|1|||
37771846|NCT02081417|69292915|FG000|Overall Study|Moved Away|1|||
37771847|NCT02081417|69292916|FG001|Overall Study|Moved Away|2|||
37967811|NCT00361270|69654727|FG002|Overall Study|Adverse Event|1|||
37967812|NCT00361270|69654728|FG003|Overall Study|Adverse Event|0|||
37967813|NCT00367744|69654747|FG000|Overall Study|Lost to Follow-up|4|||
37967814|NCT00367744|69654748|FG001|Overall Study|Lost to Follow-up|5|||
37967815|NCT03883386|69654757|FG000|First Assignment|Lost to Follow-up|1|||
37967816|NCT03883386|69654758|FG001|First Assignment|Lost to Follow-up|0|||
37967817|NCT03883386|69654757|FG000|First Assignment|Withdrawal by Subject|1|||
37967818|NCT03883386|69654758|FG001|First Assignment|Withdrawal by Subject|1|||
37967819|NCT00530946|69654768|FG000|Overall Study|Adverse Event|1|||
37771848|NCT02081417|69292915|FG000|Overall Study|Incarcerated|2|||
37863523|NCT00996892|69547121|FG003|Expansion Stage 2|Disease Progression|0|||
37689925|NCT02335411|69166270|FG001|Overall Study|Death|22|||
37689926|NCT02335411|69166271|FG002|Overall Study|Death|26|||
37689927|NCT02335411|69166269|FG000|Overall Study|Physician Decision|3|||
37967820|NCT00530946|69654769|FG001|Overall Study|Adverse Event|2|||
37689928|NCT02335411|69166270|FG001|Overall Study|Physician Decision|0|||
37967821|NCT00530946|69654770|FG002|Overall Study|Adverse Event|1|||
37967822|NCT00530946|69654771|FG003|Overall Study|Adverse Event|1|||
37967823|NCT00530946|69654768|FG000|Overall Study|Protocol Violation|0|||
37967824|NCT00530946|69654769|FG001|Overall Study|Protocol Violation|0|||
37967825|NCT00530946|69654770|FG002|Overall Study|Protocol Violation|0|||
37967826|NCT00530946|69654771|FG003|Overall Study|Protocol Violation|1|||
37967827|NCT00530946|69654768|FG000|Overall Study|Noncompliance|1|||
37967828|NCT00530946|69654769|FG001|Overall Study|Noncompliance|0|||
37967829|NCT00530946|69654770|FG002|Overall Study|Noncompliance|0|||
37967830|NCT00530946|69654771|FG003|Overall Study|Noncompliance|0|||
37967831|NCT00424047|69654783|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
37967832|NCT00424047|69654784|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
37689929|NCT02335411|69166271|FG002|Overall Study|Physician Decision|0|||
37689930|NCT02335411|69166269|FG000|Overall Study|Protocol Violation|1|||
37771849|NCT02081417|69292916|FG001|Overall Study|Incarcerated|2|||
37771850|NCT02081417|69292915|FG000|Overall Study|Death|4|||
37771851|NCT02081417|69292916|FG001|Overall Study|Death|3|||
37771852|NCT02081417|69292915|FG000|Overall Study|Withdrawal by Subject|4|||
37771853|NCT02081417|69292916|FG001|Overall Study|Withdrawal by Subject|0|||
37771854|NCT02081417|69292915|FG000|Overall Study|Admitted to Residential Treatment|2|||
37771855|NCT02081417|69292916|FG001|Overall Study|Admitted to Residential Treatment|0|||
37771856|NCT02081417|69292915|FG000|Overall Study|Did not start treatment|17|||
37771857|NCT02081417|69292916|FG001|Overall Study|Did not start treatment|21|||
37771858|NCT02081183|69292924|FG000|Overall Study|Lost to Follow-up|0|||
37771859|NCT02081183|69292925|FG001|Overall Study|Lost to Follow-up|1|||
37771860|NCT02081183|69292924|FG000|Overall Study|Protocol Violation|1|||
37771861|NCT02081183|69292925|FG001|Overall Study|Protocol Violation|0|||
37771862|NCT02081183|69292924|FG000|Overall Study|Other|3|||
37771863|NCT02081183|69292925|FG001|Overall Study|Other|3|||
37771864|NCT02080871|69292931|FG000|Overall Study|Death|1|||
37771865|NCT02080871|69292931|FG000|Overall Study|Lost to Follow-up|1|||
37771866|NCT02080481|69292937|FG000|Overall Study|Never received a block.|1|||
37771867|NCT02080481|69292938|FG001|Overall Study|Never received a block.|0|||
37771868|NCT02080403|69292946|FG000|Overall Study|Adverse Event|5|||
37689931|NCT02335411|69166270|FG001|Overall Study|Protocol Violation|0|||
37689932|NCT02335411|69166271|FG002|Overall Study|Protocol Violation|0|||
37689933|NCT02335411|69166269|FG000|Overall Study|Withdrawal by Subject|11|||
37689934|NCT02335411|69166270|FG001|Overall Study|Withdrawal by Subject|0|||
37689935|NCT02335411|69166271|FG002|Overall Study|Withdrawal by Subject|3|||
37689936|NCT02335411|69166269|FG000|Overall Study|Sponsor Decision|12|||
37689937|NCT02335411|69166270|FG001|Overall Study|Sponsor Decision|3|||
37689938|NCT02335411|69166271|FG002|Overall Study|Sponsor Decision|2|||
37689939|NCT02335411|69166269|FG000|Overall Study|Adverse Event|9|||
37689940|NCT02335411|69166270|FG001|Overall Study|Adverse Event|0|||
37689941|NCT02335411|69166271|FG002|Overall Study|Adverse Event|0|||
37689942|NCT02186301|69166285|FG000|Overall Study|Progressive Disease|7|||
37689943|NCT02186301|69166286|FG001|Overall Study|Progressive Disease|22|||
37771869|NCT02080403|69292947|FG001|Overall Study|Adverse Event|1|||
37771870|NCT02080403|69292946|FG000|Overall Study|Death|0|||
37771871|NCT02080403|69292947|FG001|Overall Study|Death|2|||
37771872|NCT02080403|69292946|FG000|Overall Study|Lost to Follow-up|2|||
37771873|NCT02080403|69292947|FG001|Overall Study|Lost to Follow-up|0|||
37771874|NCT02080403|69292946|FG000|Overall Study|Pregnancy|0|||
37863524|NCT00996892|69547122|FG004|Expansion Stage 2|Disease Progression|0|||
37689944|NCT02186301|69166287|FG002|Overall Study|Progressive Disease|27|||
37689945|NCT02186301|69166285|FG000|Overall Study|Adverse Event|5|||
37771875|NCT02080403|69292947|FG001|Overall Study|Pregnancy|1|||
37771876|NCT02080403|69292946|FG000|Overall Study|Protocol Violation|3|||
37771877|NCT02080403|69292947|FG001|Overall Study|Protocol Violation|7|||
37771878|NCT02080403|69292946|FG000|Overall Study|Withdrawal by Subject|5|||
37689946|NCT02186301|69166286|FG001|Overall Study|Adverse Event|5|||
37689947|NCT02186301|69166287|FG002|Overall Study|Adverse Event|5|||
37689948|NCT02186301|69166285|FG000|Overall Study|Death|1|||
37689949|NCT02186301|69166286|FG001|Overall Study|Death|0|||
37689950|NCT02186301|69166287|FG002|Overall Study|Death|0|||
37967833|NCT00424047|69654783|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
37967834|NCT00424047|69654784|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
37967835|NCT00424047|69654783|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
37967836|NCT00424047|69654784|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
37967837|NCT00424047|69654783|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
37967838|NCT00424047|69654784|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
37967839|NCT00424047|69654783|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
37967840|NCT00424047|69654784|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
37967841|NCT00424047|69654783|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
37967842|NCT00424047|69654784|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
37967843|NCT00424047|69654783|FG000|On Study at Time of Unblinding|Adverse Event|22|||
37967844|NCT00424047|69654784|FG001|On Study at Time of Unblinding|Adverse Event|12|||
37967845|NCT00424047|69654783|FG000|On Study at Time of Unblinding|Progression of disease|92|||
37967846|NCT00424047|69654784|FG001|On Study at Time of Unblinding|Progression of disease|128|||
37967847|NCT00424047|69654783|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
37967848|NCT00424047|69654784|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
37967849|NCT00424047|69654783|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
37967850|NCT00424047|69654784|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
37967851|NCT00424047|69654783|FG000|On Study at Time of Unblinding|Death|11|||
37967852|NCT00424047|69654784|FG001|On Study at Time of Unblinding|Death|11|||
37967853|NCT00424047|69654783|FG000|On Study at Time of Unblinding|Other|5|||
37967854|NCT00424047|69654784|FG001|On Study at Time of Unblinding|Other|4|||
37967855|NCT00424047|69654783|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
37967856|NCT00424047|69654784|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
37967857|NCT00424047|69654783|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
37967858|NCT00424047|69654784|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
37967859|NCT00424047|69654783|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
37967860|NCT00424047|69654784|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
37967861|NCT00424047|69654783|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
37967862|NCT00424047|69654784|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
37967863|NCT00424047|69654783|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
37967864|NCT00424047|69654784|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
37967865|NCT00530790|69654795|FG000|Overall Study|Adverse Event|2|||
37967866|NCT00530790|69654795|FG000|Overall Study|Withdrawal by Subject|2|||
37967867|NCT00530790|69654795|FG000|Overall Study|Physician Decision|1|||
37967868|NCT00530088|69654799|FG000|Overall Study|Disease Progression|4|||
37967869|NCT00530088|69654799|FG000|Overall Study|Physician Decision|4|||
37967870|NCT00530088|69654799|FG000|Overall Study|Other Not Specified|2|||
37967871|NCT00360568|69654805|FG000|Overall Study|Adverse Event|1|||
37967872|NCT00360568|69654806|FG001|Overall Study|Adverse Event|2|||
37689951|NCT02186301|69166285|FG000|Overall Study|Withdrawal by Subject|5|||
37689952|NCT02186301|69166286|FG001|Overall Study|Withdrawal by Subject|1|||
37689953|NCT02186301|69166287|FG002|Overall Study|Withdrawal by Subject|3|||
37689954|NCT02186301|69166285|FG000|Overall Study|Physician Decision|1|||
37967873|NCT00360568|69654805|FG000|Overall Study|Lack of Efficacy|1|||
37967874|NCT00360568|69654806|FG001|Overall Study|Lack of Efficacy|0|||
37967875|NCT00360568|69654805|FG000|Overall Study|Withdrawal by Subject|0|||
37967876|NCT00360568|69654806|FG001|Overall Study|Withdrawal by Subject|3|||
37967877|NCT00436215|69654814|FG000|Overall Study|Refused further treatment|3|||
37967878|NCT00436215|69654814|FG000|Overall Study|Small bowel obstruction|1|||
37967879|NCT00441363|69654820|FG000|Overall Study|Adverse Event|4|||
37967880|NCT00441363|69654821|FG001|Overall Study|Adverse Event|2|||
37967881|NCT00441363|69654820|FG000|Overall Study|Withdrawal by Subject|3|||
37967882|NCT00441363|69654821|FG001|Overall Study|Withdrawal by Subject|4|||
37967883|NCT00441363|69654820|FG000|Overall Study|Physician Decision|6|||
37967884|NCT00441363|69654821|FG001|Overall Study|Physician Decision|7|||
37967885|NCT00441363|69654820|FG000|Overall Study|Lost to Follow-up|2|||
37967886|NCT00441363|69654821|FG001|Overall Study|Lost to Follow-up|2|||
37967887|NCT00441363|69654820|FG000|Overall Study|Other|2|||
37967888|NCT00441363|69654821|FG001|Overall Study|Other|0|||
37689955|NCT02186301|69166286|FG001|Overall Study|Physician Decision|0|||
37689956|NCT02186301|69166287|FG002|Overall Study|Physician Decision|1|||
37689957|NCT02186301|69166285|FG000|Overall Study|Study Terminated by Sponsor|1|||
37967889|NCT00530712|69654827|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
37967890|NCT00530712|69654827|FG000|30 Day Follow-up Visit|Missed Visit|5|||
37967891|NCT00530712|69654827|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
37967892|NCT00530712|69654827|FG000|6 Month Follow-up Visit|Missed Visit|3|||
37967893|NCT00530712|69654827|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
37967894|NCT00530712|69654827|FG000|6 Month Follow-up Visit|Death|2|||
37967895|NCT00530712|69654827|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
37967896|NCT00530712|69654827|FG000|12 Month Follow-up Visit|Missed Visit|3|||
37967897|NCT00530712|69654827|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
37967898|NCT00530712|69654827|FG000|12 Month Follow-up Visit|Death|9|||
37967899|NCT00626795|69654835|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
37689958|NCT02186301|69166286|FG001|Overall Study|Study Terminated by Sponsor|0|||
37967900|NCT00626795|69654836|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
37967901|NCT00626795|69654837|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
37689959|NCT02186301|69166287|FG002|Overall Study|Study Terminated by Sponsor|11|||
37689960|NCT02186301|69166285|FG000|Overall Study|Protocol Deviation|0|||
37689961|NCT02186301|69166286|FG001|Overall Study|Protocol Deviation|2|||
37689962|NCT02186301|69166287|FG002|Overall Study|Protocol Deviation|0|||
37689963|NCT02186301|69166285|FG000|Overall Study|Missing|0|||
37863525|NCT00996892|69547123|FG005|Expansion Stage 2|Disease Progression|0|||
37863526|NCT00996892|69547124|FG006|Expansion Stage 2|Disease Progression|0|||
37967902|NCT00626795|69654835|FG000|Blinded Treatment|Lack of Efficacy|2|||
37967903|NCT00626795|69654836|FG001|Blinded Treatment|Lack of Efficacy|0|||
37967904|NCT00626795|69654837|FG002|Blinded Treatment|Lack of Efficacy|0|||
37967905|NCT00626795|69654835|FG000|Blinded Treatment|Unacceptable adverse event|0|||
37967906|NCT00626795|69654836|FG001|Blinded Treatment|Unacceptable adverse event|0|||
37967907|NCT00626795|69654837|FG002|Blinded Treatment|Unacceptable adverse event|1|||
37967908|NCT00626795|69654835|FG000|Blinded Treatment|Protocol Violation|0|||
37689964|NCT02186301|69166286|FG001|Overall Study|Missing|0|||
37967909|NCT00626795|69654836|FG001|Blinded Treatment|Protocol Violation|1|||
37967910|NCT00626795|69654837|FG002|Blinded Treatment|Protocol Violation|1|||
37967911|NCT00626795|69654835|FG000|Blinded Treatment|Withdrawal by Subject|1|||
37967912|NCT00626795|69654836|FG001|Blinded Treatment|Withdrawal by Subject|1|||
37967913|NCT00626795|69654837|FG002|Blinded Treatment|Withdrawal by Subject|0|||
37967914|NCT00626795|69654835|FG000|Blinded Treatment|Other reasons|2|||
37967915|NCT00626795|69654836|FG001|Blinded Treatment|Other reasons|0|||
37967916|NCT00626795|69654837|FG002|Blinded Treatment|Other reasons|2|||
37967917|NCT00626795|69654835|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
37967918|NCT00626795|69654836|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
37967919|NCT00626795|69654837|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
37967920|NCT00626639|69654851|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
37967921|NCT00626639|69654852|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
37967922|NCT00626561|69654860|FG000|Overall Study|Withdrawal by Subject|2|||
37967923|NCT00626561|69654860|FG000|Overall Study|Disease Progression|2|||
37967924|NCT03880266|69654872|FG000|Overall Study|Withdrawal by Subject|0|||
37967925|NCT03880266|69654873|FG001|Overall Study|Withdrawal by Subject|1|||
37967926|NCT03880266|69654874|FG002|Overall Study|Withdrawal by Subject|1|||
37967927|NCT03880266|69654875|FG003|Overall Study|Withdrawal by Subject|0|||
37967928|NCT03880266|69654876|FG004|Overall Study|Withdrawal by Subject|0|||
37967929|NCT03880266|69654877|FG005|Overall Study|Withdrawal by Subject|0|||
37967930|NCT03880266|69654878|FG006|Overall Study|Withdrawal by Subject|0|||
37967931|NCT03880266|69654879|FG007|Overall Study|Withdrawal by Subject|0|||
37967932|NCT00423891|69654900|FG000|Enrolled|Withdrawal by Subject|0|||
37967933|NCT00423891|69654901|FG001|Enrolled|Withdrawal by Subject|0|||
37967934|NCT00423891|69654902|FG002|Enrolled|Withdrawal by Subject|1|||
37967935|NCT00423891|69654900|FG000|Enrolled|Lost to Follow-up|0|||
37967936|NCT00423891|69654901|FG001|Enrolled|Lost to Follow-up|0|||
37967937|NCT00423891|69654902|FG002|Enrolled|Lost to Follow-up|1|||
37967938|NCT00423891|69654900|FG000|Enrolled|No longer met criteria|11|||
37967939|NCT00423891|69654901|FG001|Enrolled|No longer met criteria|2|||
37967940|NCT00423891|69654902|FG002|Enrolled|No longer met criteria|1|||
37967941|NCT00423891|69654900|FG000|Treatment|Withdrawal by Subject|1|||
37967942|NCT00423891|69654901|FG001|Treatment|Withdrawal by Subject|0|||
37967943|NCT00423891|69654902|FG002|Treatment|Withdrawal by Subject|0|||
37967944|NCT00423891|69654900|FG000|Treatment|Lost to Follow-up|1|||
37967945|NCT00423891|69654901|FG001|Treatment|Lost to Follow-up|0|||
37689965|NCT02186301|69166287|FG002|Overall Study|Missing|2|||
37689966|NCT02186301|69166285|FG000|Overall Study|Other|0|||
37689967|NCT02186301|69166286|FG001|Overall Study|Other|0|||
37689968|NCT02186301|69166287|FG002|Overall Study|Other|1|||
37689969|NCT02186223|69166297|FG000|Overall Study|Not eligible for device placement|6|||
37771879|NCT02080403|69292947|FG001|Overall Study|Withdrawal by Subject|1|||
37771880|NCT02080091|69292953|FG000|Overall Study|Study Terminated|22|||
37689970|NCT02186223|69166297|FG000|Overall Study|Unable to obtain femoral access|3|||
37689971|NCT02186223|69166297|FG000|Overall Study|Death|3|||
37689972|NCT02186223|69166297|FG000|Overall Study|Device in place less than 48 hours|9|||
37771881|NCT02080091|69292953|FG000|Overall Study|Death|1|||
37967946|NCT00423891|69654902|FG002|Treatment|Lost to Follow-up|0|||
37967947|NCT00423891|69654900|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
37967948|NCT00423891|69654901|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
37967949|NCT00423891|69654902|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
37689973|NCT02163057|69166304|FG000|Overall Study|Participant Refusal to Continue|2|||
37967950|NCT00423891|69654900|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
37967951|NCT00423891|69654901|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
37967952|NCT00423891|69654902|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
37967953|NCT00423813|69654915|FG000|Overall Study|Adverse Event|11|||
37967954|NCT00423813|69654916|FG001|Overall Study|Adverse Event|30|||
37967955|NCT00423813|69654917|FG002|Overall Study|Adverse Event|40|||
37967956|NCT00423813|69654915|FG000|Overall Study|Withdrawal by Subject|6|||
37967957|NCT00423813|69654916|FG001|Overall Study|Withdrawal by Subject|8|||
37967958|NCT00423813|69654917|FG002|Overall Study|Withdrawal by Subject|5|||
37967959|NCT00423813|69654915|FG000|Overall Study|Lost to Follow-up|5|||
37967960|NCT00423813|69654916|FG001|Overall Study|Lost to Follow-up|4|||
37967961|NCT00423813|69654917|FG002|Overall Study|Lost to Follow-up|4|||
37967962|NCT00423813|69654915|FG000|Overall Study|Lack of Efficacy|23|||
37967963|NCT00423813|69654916|FG001|Overall Study|Lack of Efficacy|18|||
37967964|NCT00423813|69654917|FG002|Overall Study|Lack of Efficacy|19|||
37967965|NCT00423813|69654915|FG000|Overall Study|Physician Decision|2|||
37967966|NCT00423813|69654916|FG001|Overall Study|Physician Decision|0|||
37967967|NCT00423813|69654917|FG002|Overall Study|Physician Decision|0|||
37967968|NCT00423813|69654915|FG000|Overall Study|Sponsor Decision|0|||
37967969|NCT00423813|69654916|FG001|Overall Study|Sponsor Decision|1|||
37967970|NCT00423813|69654917|FG002|Overall Study|Sponsor Decision|0|||
37967971|NCT00423813|69654915|FG000|Overall Study|Protocol Violation|9|||
37967972|NCT00423813|69654916|FG001|Overall Study|Protocol Violation|4|||
37967973|NCT00423813|69654917|FG002|Overall Study|Protocol Violation|4|||
37967974|NCT00423813|69654915|FG000|Overall Study|Pregnancy|0|||
37967975|NCT00423813|69654916|FG001|Overall Study|Pregnancy|0|||
37967976|NCT00423813|69654917|FG002|Overall Study|Pregnancy|1|||
37967977|NCT00423813|69654915|FG000|Overall Study|Subject started night shift work|1|||
37967978|NCT00423813|69654916|FG001|Overall Study|Subject started night shift work|0|||
37967979|NCT00423813|69654917|FG002|Overall Study|Subject started night shift work|0|||
37967980|NCT00423813|69654915|FG000|Overall Study|Will start exclusionary medications|0|||
37967981|NCT00423813|69654916|FG001|Overall Study|Will start exclusionary medications|1|||
37967982|NCT00423813|69654917|FG002|Overall Study|Will start exclusionary medications|0|||
37967983|NCT00423813|69654915|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
37967984|NCT00423813|69654916|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
37967985|NCT00423813|69654917|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
37967986|NCT03687372|69654927|FG000|Overall Study|Lost to Follow-up|12|||
37967987|NCT03687372|69654928|FG001|Overall Study|Lost to Follow-up|21|||
37967988|NCT03687372|69654927|FG000|Overall Study|Withdrawal by Subject|4|||
37967989|NCT03687372|69654928|FG001|Overall Study|Withdrawal by Subject|17|||
37967990|NCT03687372|69654927|FG000|Overall Study|Investigator Decision|1|||
37967991|NCT03687372|69654928|FG001|Overall Study|Investigator Decision|1|||
37967992|NCT00626405|69654938|FG000|Overall Study|Deemed Ineligible|1|||
37967993|NCT00626405|69654939|FG001|Overall Study|Deemed Ineligible|0|||
37967994|NCT00626405|69654938|FG000|Overall Study|Withdrawal by Subject|0|||
37967995|NCT00626405|69654939|FG001|Overall Study|Withdrawal by Subject|1|||
37967996|NCT00358150|69654945|FG000|Overall Study|Adverse Event|3|||
37967997|NCT00358150|69654945|FG000|Overall Study|Withdrawal by Subject|1|||
37967998|NCT00358150|69654945|FG000|Overall Study|Undefined|3|||
37967999|NCT05061966|69654972|FG000|Overall Study|Lost to Follow-up|13|||
37968000|NCT05061966|69654973|FG001|Overall Study|Lost to Follow-up|13|||
37968001|NCT05027815|69654981|FG000|Overall Study|Death|2|||
37968002|NCT05027815|69654982|FG001|Overall Study|Death|1|||
37968003|NCT04827134|69654992|FG000|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
37968004|NCT04827134|69654993|FG001|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
37968005|NCT04827134|69654994|FG002|Treatment Period 1 (1 Day)|Withdrawal by Subject|1|||
37968006|NCT04827134|69654995|FG003|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
37968007|NCT04818593|69655009|FG000|Overall Study|Low Oocyte Yield|8|||
37968008|NCT04818593|69655010|FG001|Overall Study|Low Oocyte Yield|8|||
37968009|NCT04818593|69655009|FG000|Overall Study|Not ICSI Insemination|7|||
37968010|NCT04818593|69655010|FG001|Overall Study|Not ICSI Insemination|7|||
37968011|NCT04818593|69655009|FG000|Overall Study|Poor Sperm Quality|2|||
37968012|NCT04818593|69655010|FG001|Overall Study|Poor Sperm Quality|2|||
37968013|NCT04818593|69655009|FG000|Overall Study|Withdrawal by Subject|2|||
37968014|NCT04818593|69655010|FG001|Overall Study|Withdrawal by Subject|2|||
37968015|NCT04818593|69655009|FG000|Overall Study|Conversion to IUI due to low response|1|||
37968016|NCT04818593|69655010|FG001|Overall Study|Conversion to IUI due to low response|1|||
37968017|NCT04680975|69655016|FG000|Overall Study|Adverse Event|3|||
37968018|NCT04680975|69655016|FG000|Overall Study|Death|1|||
37968019|NCT04680975|69655016|FG000|Overall Study|Progressive Disease|1|||
37968020|NCT04680975|69655016|FG000|Overall Study|Withdrawal by Subject|1|||
37968021|NCT04673786|69655022|FG000|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
37968022|NCT04673786|69655023|FG001|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
37968023|NCT04673786|69655024|FG002|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|0|||
37968024|NCT04673786|69655022|FG000|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
37968025|NCT04673786|69655023|FG001|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|1|||
37968026|NCT04673786|69655024|FG002|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
37968027|NCT04673786|69655022|FG000|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|9|||
37968028|NCT04673786|69655023|FG001|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|3|||
37968029|NCT04673786|69655024|FG002|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|1|||
37968030|NCT04673786|69655022|FG000|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|2|||
37968031|NCT04673786|69655023|FG001|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
37968032|NCT04673786|69655024|FG002|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
37968033|NCT04673786|69655022|FG000|Treatment Period II (Weeks 16 to 52)|Death|1|||
37968034|NCT04673786|69655023|FG001|Treatment Period II (Weeks 16 to 52)|Death|0|||
37968035|NCT04673786|69655024|FG002|Treatment Period II (Weeks 16 to 52)|Death|0|||
37968036|NCT04673786|69655022|FG000|Treatment Period II (Weeks 16 to 52)|Adverse Event|2|||
37968037|NCT04673786|69655023|FG001|Treatment Period II (Weeks 16 to 52)|Adverse Event|0|||
37968038|NCT04673786|69655024|FG002|Treatment Period II (Weeks 16 to 52)|Adverse Event|1|||
37968039|NCT04583969|69655048|FG000|Overall Study|Death|31|||
37968040|NCT04583969|69655049|FG001|Overall Study|Death|38|||
37968041|NCT04583969|69655048|FG000|Overall Study|Lost to Follow-up|16|||
37968042|NCT04583969|69655049|FG001|Overall Study|Lost to Follow-up|13|||
37968043|NCT04583969|69655048|FG000|Overall Study|Protocol Violation|1|||
37968044|NCT04583969|69655049|FG001|Overall Study|Protocol Violation|0|||
37968045|NCT04583969|69655048|FG000|Overall Study|Withdrawal by Subject|3|||
37689974|NCT02163057|69166305|FG001|Overall Study|Participant Refusal to Continue|2|||
37689975|NCT02163057|69166304|FG000|Overall Study|Participant Significant Noncompliance|0|||
37689976|NCT02163057|69166305|FG001|Overall Study|Participant Significant Noncompliance|1|||
37689977|NCT02163057|69166304|FG000|Overall Study|Progression of Disease|1|||
37689978|NCT02163057|69166305|FG001|Overall Study|Progression of Disease|2|||
37689979|NCT02185521|69166313|FG000|Overall Study|Withdrawal by Subject|1|||
37968046|NCT04583969|69655049|FG001|Overall Study|Withdrawal by Subject|3|||
37689980|NCT02185521|69166313|FG000|Overall Study|Protocol Violation|1|||
37968047|NCT04583969|69655048|FG000|Overall Study|RANDOMIZED BUT NOT DOSED|2|||
37968048|NCT04583969|69655049|FG001|Overall Study|RANDOMIZED BUT NOT DOSED|4|||
37968049|NCT04583969|69655048|FG000|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|1|||
37968050|NCT04583969|69655049|FG001|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|0|||
37968051|NCT04583969|69655048|FG000|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|1|||
37968052|NCT04583969|69655049|FG001|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|0|||
37968053|NCT04583969|69655048|FG000|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
37968054|NCT04583969|69655049|FG001|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
37968055|NCT04583969|69655048|FG000|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|1|||
37968056|NCT04583969|69655049|FG001|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|0|||
37968057|NCT04561115|69655055|FG000|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|1|||
37968058|NCT04561115|69655056|FG001|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|0|||
37968059|NCT04561115|69655055|FG000|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
37968060|NCT04561115|69655056|FG001|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
37968061|NCT04561115|69655055|FG000|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
37968062|NCT04561115|69655056|FG001|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
37968063|NCT04546425|69655064|FG000|Overall Study|Protocol Violation|2|||
37968064|NCT04546425|69655065|FG001|Overall Study|Protocol Violation|1|||
37968065|NCT04546425|69655064|FG000|Overall Study|Adverse Event|3|||
37968066|NCT04546425|69655065|FG001|Overall Study|Adverse Event|0|||
37968067|NCT04546425|69655064|FG000|Overall Study|No Longer met eligibility criteria|3|||
37968068|NCT04546425|69655065|FG001|Overall Study|No Longer met eligibility criteria|3|||
37968069|NCT04546425|69655064|FG000|Overall Study|Withdrawal by parent/guardian|7|||
37968070|NCT04546425|69655065|FG001|Overall Study|Withdrawal by parent/guardian|5|||
37968071|NCT04546425|69655064|FG000|Overall Study|Lost to Follow-up|5|||
37968072|NCT04546425|69655065|FG001|Overall Study|Lost to Follow-up|4|||
37968073|NCT04546425|69655064|FG000|Overall Study|Other|0|||
37968074|NCT04546425|69655065|FG001|Overall Study|Other|1|||
37968075|NCT04366258|69655071|FG000|Baseline Assessments|Screen Failure|21|||
37968076|NCT04366258|69655071|FG000|Baseline Assessments|Early Termination|3|||
37968077|NCT04101331|69655119|FG000|Overall Study|Adverse Event|7|||
37968078|NCT04101331|69655119|FG000|Overall Study|Disease progression|79|||
37968079|NCT04101331|69655119|FG000|Overall Study|Withdrawal by Subject|1|||
37968080|NCT04101331|69655119|FG000|Overall Study|Investigator decision|6|||
37968081|NCT04101331|69655119|FG000|Overall Study|Death|6|||
37968082|NCT04101331|69655119|FG000|Overall Study|Allogenic transplant|1|||
37968083|NCT04082884|69655123|FG000|Overall Study|Withdrawal by Subject|1|||
37968084|NCT03891667|69655129|FG000|Overall Study|Physician Decision|1|||
37968085|NCT03891667|69655130|FG001|Overall Study|Physician Decision|0|||
37968086|NCT03891667|69655129|FG000|Overall Study|COVID related pause|1|||
37968087|NCT03891667|69655130|FG001|Overall Study|COVID related pause|1|||
37968088|NCT03891667|69655129|FG000|Overall Study|Withdrawal by Subject|0|||
37968089|NCT03891667|69655130|FG001|Overall Study|Withdrawal by Subject|1|||
37968090|NCT03891667|69655129|FG000|Overall Study|Adverse Event|0|||
37968091|NCT03891667|69655130|FG001|Overall Study|Adverse Event|1|||
37968092|NCT03715153|69655154|FG000|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
37968093|NCT03715153|69655155|FG001|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
37968094|NCT03715153|69655154|FG000|Double-blind Period (From W0 to W26)|Non medical reason|8|||
37968095|NCT03715153|69655155|FG001|Double-blind Period (From W0 to W26)|Non medical reason|2|||
37968096|NCT03715153|69655154|FG000|Double-blind Period (From W0 to W26)|Adverse Event|8|||
37689981|NCT01599585|69166320|FG000|Overall Study|Withdrawal by Subject|16|||
37689982|NCT01599585|69166321|FG001|Overall Study|Withdrawal by Subject|9|||
37689983|NCT01599585|69166320|FG000|Overall Study|Lost to Follow-up|3|||
37689984|NCT01599585|69166321|FG001|Overall Study|Lost to Follow-up|5|||
37689985|NCT01599585|69166320|FG000|Overall Study|randomized did not start treatment|3|||
37968097|NCT03715153|69655155|FG001|Double-blind Period (From W0 to W26)|Adverse Event|6|||
37968098|NCT03715153|69655154|FG000|Open-label Period (From W26 to W52)|Adverse Event|8|||
37968099|NCT03715153|69655155|FG001|Open-label Period (From W26 to W52)|Adverse Event|3|||
37771882|NCT02080091|69292953|FG000|Overall Study|Withdrawal by Subject|1|||
37771883|NCT02080091|69292953|FG000|Overall Study|Other|1|||
37771884|NCT02079077|69292959|FG000|Overall Study|Lost to Follow-up|5|||
37771885|NCT02079077|69292960|FG001|Overall Study|Lost to Follow-up|7|||
37771886|NCT02079077|69292959|FG000|Overall Study|Became STIs Positive|1|||
37771887|NCT02079077|69292960|FG001|Overall Study|Became STIs Positive|2|||
37771888|NCT02078219|69292988|FG000|Overall Study|Other|2|||
37771889|NCT02078219|69292989|FG001|Overall Study|Other|2|||
37771890|NCT02078219|69292990|FG002|Overall Study|Other|3|||
37771891|NCT02078219|69292991|FG003|Overall Study|Other|0|||
37771892|NCT02078219|69292992|FG004|Overall Study|Other|1|||
37771893|NCT02078219|69292988|FG000|Overall Study|Withdrawal by Subject|0|||
37771894|NCT02078219|69292989|FG001|Overall Study|Withdrawal by Subject|1|||
37771895|NCT02078219|69292990|FG002|Overall Study|Withdrawal by Subject|0|||
37689986|NCT01599585|69166321|FG001|Overall Study|randomized did not start treatment|3|||
37689987|NCT02185053|69166327|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
37689988|NCT02185053|69166328|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
37689989|NCT02185053|69166329|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
37689990|NCT02185053|69166327|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
37689991|NCT02185053|69166328|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
37689992|NCT02185053|69166329|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
37689993|NCT02185053|69166327|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
37689994|NCT02185053|69166328|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
37689995|NCT02185053|69166329|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
37689996|NCT02185053|69166327|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
37689997|NCT02185053|69166328|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
37689998|NCT02185053|69166329|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
37689999|NCT02185053|69166327|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
37690000|NCT02185053|69166328|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
37690001|NCT02185053|69166329|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
37690002|NCT02185053|69166327|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
37690003|NCT02185053|69166328|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
37690004|NCT02185053|69166329|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
37690005|NCT02185053|69166327|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
37690006|NCT02185053|69166328|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
37690007|NCT02185053|69166329|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
37690008|NCT02185053|69166327|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
37690009|NCT02185053|69166328|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
37690010|NCT02185053|69166329|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
37690011|NCT02161731|69166338|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
37771896|NCT02078219|69292991|FG003|Overall Study|Withdrawal by Subject|1|||
37771897|NCT02078219|69292992|FG004|Overall Study|Withdrawal by Subject|1|||
37771898|NCT02078219|69292988|FG000|Overall Study|Protocol Violation|0|||
37771899|NCT02078219|69292989|FG001|Overall Study|Protocol Violation|0|||
37771900|NCT02078219|69292990|FG002|Overall Study|Protocol Violation|0|||
37771901|NCT02078219|69292991|FG003|Overall Study|Protocol Violation|1|||
37771902|NCT02078219|69292992|FG004|Overall Study|Protocol Violation|0|||
37690012|NCT02161731|69166339|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
37690013|NCT02161731|69166338|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
37690014|NCT02161731|69166339|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
37690015|NCT02124759|69166349|FG000|Overall Study|Withdrawal by Subject|3|||
37690016|NCT02124759|69166350|FG001|Overall Study|Withdrawal by Subject|1|||
37690017|NCT02124759|69166351|FG002|Overall Study|Withdrawal by Subject|1|||
37690018|NCT02124759|69166349|FG000|Overall Study|Screen Fail|2|||
37690019|NCT02124759|69166350|FG001|Overall Study|Screen Fail|2|||
37690020|NCT02124759|69166351|FG002|Overall Study|Screen Fail|3|||
37690021|NCT02302339|69166368|FG000|Overall Study|Lost to Follow-up|1|||
37690022|NCT02302339|69166369|FG001|Overall Study|Lost to Follow-up|0|||
37690023|NCT02302339|69166370|FG002|Overall Study|Lost to Follow-up|0|||
37690024|NCT02302339|69166371|FG003|Overall Study|Lost to Follow-up|0|||
37690025|NCT02302339|69166368|FG000|Overall Study|Withdrawal by Subject|0|||
37690026|NCT02302339|69166369|FG001|Overall Study|Withdrawal by Subject|2|||
37690027|NCT02302339|69166370|FG002|Overall Study|Withdrawal by Subject|1|||
37690028|NCT02302339|69166371|FG003|Overall Study|Withdrawal by Subject|0|||
37690029|NCT02161575|69166382|FG000|Overall Study|Protocol Violation|8|||
37690030|NCT02161575|69166382|FG000|Overall Study|Lack of Efficacy|1|||
37690031|NCT02161575|69166382|FG000|Overall Study|Adverse Event|2|||
37690032|NCT02370121|69166388|FG000|Overall Study|Lost to Follow-up|1|||
37690033|NCT02370121|69166389|FG001|Overall Study|Lost to Follow-up|1|||
37690034|NCT02161185|69166395|FG000|Treatment Phase|Administrative/Other|7|||
37690035|NCT02159469|69166399|FG000|Overall Study|Missing Completion status|1|||
37690036|NCT02159469|69166399|FG000|Overall Study|Adverse Event|5|||
37690037|NCT02159469|69166399|FG000|Overall Study|Non-compliance|2|||
37863527|NCT00996892|69547125|FG007|Expansion Stage 2|Disease Progression|0|||
37690038|NCT02159469|69166399|FG000|Overall Study|Withdrawal by Subject|9|||
37690039|NCT02159469|69166399|FG000|Overall Study|Lost to Follow-up|1|||
37690040|NCT02159469|69166399|FG000|Overall Study|Sponsor's request|2|||
37690041|NCT02159469|69166399|FG000|Overall Study|Met Stopping Criteria|3|||
37771903|NCT02078219|69292988|FG000|Overall Study|Death|0|||
37771904|NCT02078219|69292989|FG001|Overall Study|Death|0|||
37771905|NCT02078219|69292990|FG002|Overall Study|Death|0|||
37771906|NCT02078219|69292991|FG003|Overall Study|Death|1|||
37771907|NCT02078219|69292992|FG004|Overall Study|Death|0|||
37771908|NCT02078219|69292988|FG000|Overall Study|Adverse Event|1|||
37771909|NCT02078219|69292989|FG001|Overall Study|Adverse Event|1|||
37771910|NCT02078219|69292990|FG002|Overall Study|Adverse Event|3|||
37771911|NCT02078219|69292991|FG003|Overall Study|Adverse Event|1|||
37771912|NCT02078219|69292992|FG004|Overall Study|Adverse Event|0|||
37771913|NCT02075255|69293007|FG000|Overall Study|Study specific withdrawal criteria|0|||
37771914|NCT02075255|69293008|FG001|Overall Study|Study specific withdrawal criteria|1|||
37771915|NCT02075255|69293009|FG002|Overall Study|Study specific withdrawal criteria|1|||
37771916|NCT02075255|69293007|FG000|Overall Study|Withdrawal by Subject|4|||
37771917|NCT02075255|69293008|FG001|Overall Study|Withdrawal by Subject|1|||
37771918|NCT02075255|69293009|FG002|Overall Study|Withdrawal by Subject|0|||
37771919|NCT02075255|69293007|FG000|Overall Study|Lost to Follow-up|0|||
37771920|NCT02075255|69293008|FG001|Overall Study|Lost to Follow-up|0|||
37771921|NCT02075255|69293009|FG002|Overall Study|Lost to Follow-up|1|||
37771922|NCT02075255|69293007|FG000|Overall Study|Adverse Event|0|||
37771923|NCT02075255|69293008|FG001|Overall Study|Adverse Event|0|||
37771924|NCT02075255|69293009|FG002|Overall Study|Adverse Event|1|||
37771925|NCT02075255|69293007|FG000|Overall Study|Death|0|||
37771926|NCT02075255|69293008|FG001|Overall Study|Death|2|||
37771927|NCT02075255|69293009|FG002|Overall Study|Death|0|||
37771928|NCT02400671|69293180|FG000|Overall Study|Death|5|||
37771929|NCT02400671|69293181|FG001|Overall Study|Death|3|||
37771930|NCT02400671|69293182|FG002|Overall Study|Death|4|||
37771931|NCT02400671|69293180|FG000|Overall Study|Lost to Follow-up|20|||
37771932|NCT02400671|69293181|FG001|Overall Study|Lost to Follow-up|27|||
37771933|NCT02400671|69293182|FG002|Overall Study|Lost to Follow-up|24|||
37771934|NCT02400671|69293180|FG000|Overall Study|Withdrawal by Subject|2|||
37771935|NCT02400671|69293181|FG001|Overall Study|Withdrawal by Subject|2|||
37771936|NCT02400671|69293182|FG002|Overall Study|Withdrawal by Subject|0|||
37771937|NCT00089999|69293192|FG000|Overall Study|Adverse Event|4|||
37771938|NCT00089999|69293193|FG001|Overall Study|Adverse Event|7|||
37771939|NCT00089999|69293192|FG000|Overall Study|Withdrawal by Subject|0|||
37771940|NCT00089999|69293193|FG001|Overall Study|Withdrawal by Subject|4|||
37771941|NCT00089999|69293192|FG000|Overall Study|Lost to Follow-up|2|||
37690042|NCT02159469|69166399|FG000|Overall Study|Other|1|||
37690043|NCT02159469|69166399|FG000|Overall Study|Multiple|29|||
37771942|NCT00089999|69293193|FG001|Overall Study|Lost to Follow-up|1|||
37771943|NCT00089999|69293192|FG000|Overall Study|Radiological Progression of Cancer|52|||
37771944|NCT00089999|69293193|FG001|Overall Study|Radiological Progression of Cancer|44|||
37771945|NCT00089999|69293192|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
37771946|NCT00089999|69293193|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
37771947|NCT00089999|69293192|FG000|Overall Study|Death|3|||
37771948|NCT00089999|69293193|FG001|Overall Study|Death|3|||
37771949|NCT00089999|69293192|FG000|Overall Study|Poor General Condition|1|||
37690044|NCT02123511|69166406|FG000|Overall Study|Cancelled treatment|1|||
37690045|NCT02123511|69166407|FG001|Overall Study|Cancelled treatment|0|||
37690046|NCT02123511|69166406|FG000|Overall Study|Incomplete data|1|||
37690047|NCT02123511|69166407|FG001|Overall Study|Incomplete data|3|||
37690048|NCT02123511|69166406|FG000|Overall Study|Ineligible|0|||
37690049|NCT02123511|69166407|FG001|Overall Study|Ineligible|1|||
37771950|NCT00089999|69293193|FG001|Overall Study|Poor General Condition|0|||
37771951|NCT00089999|69293192|FG000|Overall Study|Clinical Progression|1|||
37771952|NCT00089999|69293193|FG001|Overall Study|Clinical Progression|2|||
37690050|NCT02122887|69166415|FG000|Overall Study|Withdrawal by Subject|20|||
37690051|NCT02122887|69166416|FG001|Overall Study|Withdrawal by Subject|2|||
37771953|NCT00089999|69293192|FG000|Overall Study|Physician Decision|2|||
37771954|NCT00089999|69293193|FG001|Overall Study|Physician Decision|2|||
37771955|NCT00089999|69293192|FG000|Overall Study|Patient Underwent Surgery|2|||
37771956|NCT00089999|69293193|FG001|Overall Study|Patient Underwent Surgery|0|||
37771957|NCT00089999|69293192|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
37968100|NCT03715153|69655154|FG000|Open-label Period (From W26 to W52)|Non medical reason|31|||
37968101|NCT03715153|69655155|FG001|Open-label Period (From W26 to W52)|Non medical reason|38|||
37968102|NCT03715153|69655154|FG000|Open-label Period (From W26 to W52)|Protocol Violation|1|||
37968103|NCT03715153|69655155|FG001|Open-label Period (From W26 to W52)|Protocol Violation|1|||
37968104|NCT03569293|69655184|FG000|Overall Study|Adverse Event|4|||
37968105|NCT03569293|69655185|FG001|Overall Study|Adverse Event|1|||
37968106|NCT03569293|69655186|FG002|Overall Study|Adverse Event|5|||
37968107|NCT03569293|69655187|FG003|Overall Study|Adverse Event|1|||
37968108|NCT03569293|69655188|FG004|Overall Study|Adverse Event|0|||
37690052|NCT02182947|69166422|FG000|Overall Study|Withdrawal by Subject|7|||
37690053|NCT02182947|69166422|FG000|Overall Study|Lost to Follow-up|3|||
37690054|NCT02182947|69166422|FG000|Overall Study|Failed screening activities|8|||
37690055|NCT02370043|69166426|FG000|Overall Study|Withdrawal by Subject|0|||
37690056|NCT02370043|69166427|FG001|Overall Study|Withdrawal by Subject|0|||
37690057|NCT02370043|69166428|FG002|Overall Study|Withdrawal by Subject|0|||
37690058|NCT02370043|69166429|FG003|Overall Study|Withdrawal by Subject|0|||
37690059|NCT02370043|69166430|FG004|Overall Study|Withdrawal by Subject|1|||
37690060|NCT02370043|69166431|FG005|Overall Study|Withdrawal by Subject|1|||
37690061|NCT02301403|69166461|FG000|Overall Study|Withdrawal by Subject|28|||
37690062|NCT02301403|69166462|FG001|Overall Study|Withdrawal by Subject|41|||
37690063|NCT02301169|69166470|FG000|Overall Study|Adverse Event|1|||
37690064|NCT02301169|69166471|FG001|Overall Study|Adverse Event|0|||
37968109|NCT03569293|69655189|FG005|Overall Study|Adverse Event|0|||
37968110|NCT03569293|69655184|FG000|Overall Study|Withdrawal by Subject|16|||
37690065|NCT02333383|69166477|FG000|Overall Study|Adalimumab discontinuation|21|||
37690066|NCT02333383|69166477|FG000|Overall Study|Lost to Follow-up|15|||
37690067|NCT02333383|69166477|FG000|Overall Study|Withdrawal by Subject|3|||
37771958|NCT00089999|69293193|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
37771959|NCT00089843|69293204|FG000|Overall Study|Withdrawal by Subject|1|||
37771960|NCT00089843|69293205|FG001|Overall Study|Withdrawal by Subject|4|||
37771961|NCT00089843|69293206|FG002|Overall Study|Withdrawal by Subject|5|||
37771962|NCT00089843|69293207|FG003|Overall Study|Withdrawal by Subject|6|||
37771963|NCT00089843|69293204|FG000|Overall Study|Physician Decision|1|||
37771964|NCT00089843|69293205|FG001|Overall Study|Physician Decision|0|||
37771965|NCT00089843|69293206|FG002|Overall Study|Physician Decision|0|||
37771966|NCT00089843|69293207|FG003|Overall Study|Physician Decision|1|||
37771967|NCT00089297|69293217|FG000|Overall Study|Adverse Event|9|||
37771968|NCT00089297|69293217|FG000|Overall Study|Death|1|||
37771969|NCT00089297|69293217|FG000|Overall Study|Withdrawal by Subject|12|||
37771970|NCT00089297|69293217|FG000|Overall Study|Disease progression|2|||
37771971|NCT00089297|69293217|FG000|Overall Study|Ineligible|11|||
37771972|NCT00089297|69293217|FG000|Overall Study|Secondary malignancy|1|||
37771973|NCT00089297|69293217|FG000|Overall Study|IRB approval not ready|1|||
37771974|NCT00089297|69293217|FG000|Overall Study|Non-compliance|1|||
37771975|NCT00088907|69293259|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
37771976|NCT00088907|69293260|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
37771977|NCT00088907|69293259|FG000|Randomized Study (Step 1)|Adverse Event|14|||
37771978|NCT00088907|69293260|FG001|Randomized Study (Step 1)|Adverse Event|19|||
37771979|NCT00088907|69293259|FG000|Randomized Study (Step 1)|Death|11|||
37771980|NCT00088907|69293260|FG001|Randomized Study (Step 1)|Death|12|||
37771981|NCT00088907|69293259|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
37771982|NCT00088907|69293260|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
37771983|NCT00088907|69293259|FG000|Randomized Study (Step 1)|complicating disease|3|||
37690068|NCT02333383|69166477|FG000|Overall Study|Transfer to another hospital|2|||
37690069|NCT02332915|69166483|FG000|Overall Study|Moved out of region|3|||
37690070|NCT02332915|69166484|FG001|Overall Study|Moved out of region|0|||
37690071|NCT02332915|69166483|FG000|Overall Study|Unrelated illness|1|||
37690072|NCT02332915|69166484|FG001|Overall Study|Unrelated illness|1|||
37690073|NCT02332915|69166483|FG000|Overall Study|Travel distance prohibitive|0|||
37690074|NCT02332915|69166484|FG001|Overall Study|Travel distance prohibitive|1|||
37690075|NCT02332915|69166483|FG000|Overall Study|did not meet inclusion criteria|2|||
37690076|NCT02332915|69166484|FG001|Overall Study|did not meet inclusion criteria|4|||
37690077|NCT02369341|69166497|FG000|Overall Study|Migrated/moved from study area|1|||
37690078|NCT02369341|69166498|FG001|Overall Study|Migrated/moved from study area|0|||
37690079|NCT02121795|69166510|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
37690080|NCT02121795|69166511|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
37771984|NCT00088907|69293260|FG001|Randomized Study (Step 1)|complicating disease|1|||
37771985|NCT00088907|69293259|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
37771986|NCT00088907|69293260|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
37771987|NCT00088907|69293259|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
37771988|NCT00088907|69293260|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
37771989|NCT00088907|69293259|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
37771990|NCT00088907|69293260|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
37771991|NCT00088907|69293259|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
37771992|NCT00088907|69293260|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
37771993|NCT00088907|69293259|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
37771994|NCT00088907|69293260|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
37771995|NCT00088907|69293259|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
37771996|NCT00088907|69293260|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
37771997|NCT00088829|69293267|FG000|Overall Study|PI left institution and study was close|22|||
37771998|NCT00088595|69293271|FG000|Overall Study|Adverse Event|11|||
37771999|NCT00088595|69293271|FG000|Overall Study|Withdrawal by Subject|8|||
37772000|NCT00088595|69293271|FG000|Overall Study|Ongoing (After Core)|7|||
37772001|NCT00088595|69293271|FG000|Overall Study|New Cancer Therapy|2|||
37772002|NCT00088205|69293285|FG000|Overall Study|Adverse Event|4|||
37772003|NCT00088205|69293285|FG000|Overall Study|Progressive Disease|51|||
37772004|NCT00088205|69293285|FG000|Overall Study|Physician Decision|1|||
37772005|NCT00088205|69293285|FG000|Overall Study|Death Due to Study Disease|4|||
37772006|NCT00085709|69293379|FG000|Overall Study|Adverse Event|8|||
37772007|NCT00085709|69293380|FG001|Overall Study|Adverse Event|0|||
37772008|NCT00085709|69293379|FG000|Overall Study|Death|8|||
37772009|NCT00085709|69293380|FG001|Overall Study|Death|2|||
37772010|NCT00085709|69293379|FG000|Overall Study|Refusal unrelated to adverse events|1|||
37772011|NCT00085709|69293380|FG001|Overall Study|Refusal unrelated to adverse events|2|||
37772012|NCT00085709|69293379|FG000|Overall Study|Progression|3|||
37772013|NCT00085709|69293380|FG001|Overall Study|Progression|4|||
37772014|NCT00085709|69293379|FG000|Overall Study|Not protocol specified|12|||
37772015|NCT00085709|69293380|FG001|Overall Study|Not protocol specified|22|||
37772016|NCT00085709|69293379|FG000|Overall Study|Not eligible|19|||
37772017|NCT00085709|69293380|FG001|Overall Study|Not eligible|19|||
37772018|NCT00085709|69293379|FG000|Overall Study|Withdrawal by Subject|2|||
37772019|NCT00085709|69293380|FG001|Overall Study|Withdrawal by Subject|1|||
37772020|NCT00085631|69293415|FG000|Overall Study|Missing Data|4|||
37772021|NCT00085631|69293416|FG001|Overall Study|Missing Data|11|||
37772022|NCT00085631|69293417|FG002|Overall Study|Missing Data|7|||
37772023|NCT00084929|69293433|FG000|Overall Study|ineligible - medical contraindication|1|||
37772024|NCT00084929|69293433|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
37772025|NCT00084929|69293433|FG000|Overall Study|Ineligible - Medical history|6|||
37772026|NCT00084929|69293433|FG000|Overall Study|Withdrawal by Subject|10|||
37772027|NCT00084929|69293433|FG000|Overall Study|Missing/incomplete CTC exam|9|||
37772028|NCT00084929|69293433|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
37863528|NCT00996892|69547126|FG008|Expansion Stage 2|Disease Progression|0|||
37772029|NCT00084617|69293491|FG000|Overall Study|Withdrawal by Subject|7|||
37772030|NCT00084617|69293491|FG000|Overall Study|Lack of Efficacy|1|||
37772031|NCT00084617|69293491|FG000|Overall Study|Protocol Violation|1|||
37968111|NCT03569293|69655185|FG001|Overall Study|Withdrawal by Subject|2|||
37968112|NCT03569293|69655186|FG002|Overall Study|Withdrawal by Subject|4|||
37968113|NCT03569293|69655187|FG003|Overall Study|Withdrawal by Subject|1|||
37968114|NCT03569293|69655188|FG004|Overall Study|Withdrawal by Subject|0|||
37968115|NCT03569293|69655189|FG005|Overall Study|Withdrawal by Subject|0|||
37968116|NCT03569293|69655184|FG000|Overall Study|Lost to Follow-up|1|||
37968117|NCT03569293|69655185|FG001|Overall Study|Lost to Follow-up|3|||
37968118|NCT03569293|69655186|FG002|Overall Study|Lost to Follow-up|1|||
37968119|NCT03569293|69655187|FG003|Overall Study|Lost to Follow-up|1|||
37968120|NCT03569293|69655188|FG004|Overall Study|Lost to Follow-up|0|||
37968121|NCT03569293|69655189|FG005|Overall Study|Lost to Follow-up|0|||
37968122|NCT03569293|69655184|FG000|Overall Study|Other|8|||
37968123|NCT03569293|69655185|FG001|Overall Study|Other|2|||
37968124|NCT03569293|69655186|FG002|Overall Study|Other|1|||
37968125|NCT03569293|69655187|FG003|Overall Study|Other|1|||
37968126|NCT03569293|69655188|FG004|Overall Study|Other|0|||
37968127|NCT03569293|69655189|FG005|Overall Study|Other|0|||
37968128|NCT03569293|69655184|FG000|Overall Study|Ongoing at Time of Analysis|8|||
37968129|NCT03569293|69655185|FG001|Overall Study|Ongoing at Time of Analysis|1|||
37968130|NCT03569293|69655186|FG002|Overall Study|Ongoing at Time of Analysis|3|||
37968131|NCT03569293|69655187|FG003|Overall Study|Ongoing at Time of Analysis|0|||
37968132|NCT03569293|69655188|FG004|Overall Study|Ongoing at Time of Analysis|0|||
37968133|NCT03569293|69655189|FG005|Overall Study|Ongoing at Time of Analysis|0|||
37968134|NCT03464136|69655205|FG000|Overall Study|Lost to Follow-up|5|||
37968135|NCT03464136|69655206|FG001|Overall Study|Lost to Follow-up|8|||
37968136|NCT03464136|69655205|FG000|Overall Study|Withdrawal by Subject|16|||
37968137|NCT03464136|69655206|FG001|Overall Study|Withdrawal by Subject|13|||
37968138|NCT03464136|69655205|FG000|Overall Study|Death|1|||
37968139|NCT03464136|69655206|FG001|Overall Study|Death|0|||
37968140|NCT03464136|69655205|FG000|Overall Study|Other|8|||
37968141|NCT03464136|69655206|FG001|Overall Study|Other|4|||
37968142|NCT03020823|69655230|FG000|Overall Study|Physician Decision|4|||
37968143|NCT03020823|69655230|FG000|Overall Study|Lack of Efficacy|4|||
37968144|NCT03020823|69655230|FG000|Overall Study|Adverse Event|2|||
37968145|NCT02969369|69655238|FG000|Study|Adverse Event|1|||
37968146|NCT02969369|69655239|FG001|Study|Adverse Event|6|||
37968147|NCT02969369|69655238|FG000|Study|Lack of Efficacy|0|||
37968148|NCT02969369|69655239|FG001|Study|Lack of Efficacy|1|||
37968149|NCT02969369|69655238|FG000|Study|Lost to Follow-up|0|||
37968150|NCT02969369|69655239|FG001|Study|Lost to Follow-up|1|||
37968151|NCT02969369|69655238|FG000|Study|Withdrawal by Subject|3|||
37968152|NCT02969369|69655239|FG001|Study|Withdrawal by Subject|5|||
37968153|NCT02969369|69655238|FG000|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
37968154|NCT02969369|69655239|FG001|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
37968155|NCT02969369|69655238|FG000|Double-blind Period|Adverse Event|1|||
37968156|NCT02969369|69655239|FG001|Double-blind Period|Adverse Event|5|||
37968157|NCT02969369|69655238|FG000|Double-blind Period|Lost to Follow-up|0|||
37968158|NCT02969369|69655239|FG001|Double-blind Period|Lost to Follow-up|1|||
37968159|NCT02969369|69655238|FG000|Double-blind Period|Withdrawal by Subject|2|||
37968160|NCT02969369|69655239|FG001|Double-blind Period|Withdrawal by Subject|3|||
37968161|NCT02969369|69655238|FG000|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
37968162|NCT02969369|69655239|FG001|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
37968163|NCT02969369|69655238|FG000|Open-label SEP-363856 Period|Adverse Event|0|||
37968164|NCT02969369|69655239|FG001|Open-label SEP-363856 Period|Adverse Event|1|||
37968165|NCT02969369|69655238|FG000|Open-label SEP-363856 Period|Lack of Efficacy|0|||
37968166|NCT02969369|69655239|FG001|Open-label SEP-363856 Period|Lack of Efficacy|1|||
37968167|NCT02969369|69655238|FG000|Open-label SEP-363856 Period|Withdrawal by Subject|1|||
37968168|NCT02969369|69655239|FG001|Open-label SEP-363856 Period|Withdrawal by Subject|2|||
37968169|NCT02583269|69655268|FG000|Overall Study|Patient hospitalized prior to start|1|||
37772032|NCT00083915|69293585|FG000|Overall Study|Death|6|||
37968170|NCT02583269|69655269|FG001|Overall Study|Patient hospitalized prior to start|0|||
37968171|NCT02583269|69655270|FG002|Overall Study|Patient hospitalized prior to start|0|||
37968172|NCT02583269|69655271|FG003|Overall Study|Patient hospitalized prior to start|0|||
37968173|NCT02583269|69655272|FG004|Overall Study|Patient hospitalized prior to start|0|||
37968174|NCT02546921|69655292|FG000|Overall Study|Adverse Event|0|||
37968175|NCT02546921|69655293|FG001|Overall Study|Adverse Event|5|||
37772033|NCT00083915|69293586|FG001|Overall Study|Death|3|||
37968176|NCT02546921|69655294|FG002|Overall Study|Adverse Event|2|||
37968177|NCT02546921|69655295|FG003|Overall Study|Adverse Event|0|||
37968178|NCT02546921|69655296|FG004|Overall Study|Adverse Event|0|||
37968179|NCT02546921|69655297|FG005|Overall Study|Adverse Event|0|||
37772034|NCT00083915|69293585|FG000|Overall Study|Physician Decision|11|||
37772035|NCT00083915|69293586|FG001|Overall Study|Physician Decision|6|||
37772036|NCT00083915|69293585|FG000|Overall Study|Withdrawal by Subject|8|||
37772037|NCT00083915|69293586|FG001|Overall Study|Withdrawal by Subject|3|||
37772038|NCT00083915|69293585|FG000|Overall Study|disease progression|18|||
37772039|NCT00083915|69293586|FG001|Overall Study|disease progression|23|||
37772040|NCT00083915|69293585|FG000|Overall Study|Failure to collect|3|||
37772041|NCT00083915|69293586|FG001|Overall Study|Failure to collect|0|||
37772042|NCT00083915|69293585|FG000|Overall Study|No response|3|||
37772043|NCT00083915|69293586|FG001|Overall Study|No response|1|||
37772044|NCT00083915|69293585|FG000|Overall Study|Insurance issues|1|||
37772045|NCT00083915|69293586|FG001|Overall Study|Insurance issues|1|||
37772046|NCT04362761|69294220|FG000|Part A (48 Weeks)|Adverse Event|2|||
37772047|NCT04362761|69294220|FG000|Part A (48 Weeks)|Withdrawal of consent (not due to AE)|4|||
37772048|NCT04362761|69294220|FG000|Part A (48 Weeks)|Commercial drug is available for participant|2|||
37772049|NCT04362761|69294220|FG000|Part A (48 Weeks)|Other|5|||
37772050|NCT04362761|69294220|FG000|Part B (86 Weeks)|Commercial drug is available for participant|46|||
37772051|NCT04362761|69294220|FG000|Part B (86 Weeks)|Other|4|||
37772052|NCT00632749|69294416|FG000|Overall Study|Progressive disease|3|||
37772053|NCT00632749|69294417|FG001|Overall Study|Progressive disease|2|||
37772054|NCT00632749|69294418|FG002|Overall Study|Progressive disease|2|||
37772055|NCT00632749|69294419|FG003|Overall Study|Progressive disease|2|||
37772056|NCT00632749|69294420|FG004|Overall Study|Progressive disease|4|||
37772057|NCT00632749|69294421|FG005|Overall Study|Progressive disease|4|||
37772058|NCT00632749|69294422|FG006|Overall Study|Progressive disease|3|||
37772059|NCT00632749|69294423|FG007|Overall Study|Progressive disease|2|||
37772060|NCT00632749|69294424|FG008|Overall Study|Progressive disease|3|||
37772061|NCT00632749|69294425|FG009|Overall Study|Progressive disease|2|||
37772062|NCT00632749|69294426|FG010|Overall Study|Progressive disease|4|||
37772063|NCT00632749|69294427|FG011|Overall Study|Progressive disease|3|||
37772064|NCT00632749|69294428|FG012|Overall Study|Progressive disease|2|||
37772065|NCT00632749|69294429|FG013|Overall Study|Progressive disease|4|||
37772066|NCT00632749|69294416|FG000|Overall Study|Other Adverse event|1|||
37772067|NCT00632749|69294417|FG001|Overall Study|Other Adverse event|1|||
37772068|NCT00632749|69294418|FG002|Overall Study|Other Adverse event|1|||
37772069|NCT00632749|69294419|FG003|Overall Study|Other Adverse event|1|||
37772070|NCT00632749|69294420|FG004|Overall Study|Other Adverse event|2|||
37772071|NCT00632749|69294421|FG005|Overall Study|Other Adverse event|4|||
37772072|NCT00632749|69294422|FG006|Overall Study|Other Adverse event|1|||
37772073|NCT00632749|69294423|FG007|Overall Study|Other Adverse event|2|||
37772074|NCT00632749|69294424|FG008|Overall Study|Other Adverse event|2|||
37772075|NCT00632749|69294425|FG009|Overall Study|Other Adverse event|0|||
37772076|NCT00632749|69294426|FG010|Overall Study|Other Adverse event|1|||
37772077|NCT00632749|69294427|FG011|Overall Study|Other Adverse event|0|||
37772078|NCT00632749|69294428|FG012|Overall Study|Other Adverse event|1|||
37772079|NCT00632749|69294429|FG013|Overall Study|Other Adverse event|0|||
37772080|NCT00632749|69294416|FG000|Overall Study|Refuse to continue medication|0|||
37772081|NCT00632749|69294417|FG001|Overall Study|Refuse to continue medication|0|||
37772082|NCT00632749|69294418|FG002|Overall Study|Refuse to continue medication|0|||
37772083|NCT00632749|69294419|FG003|Overall Study|Refuse to continue medication|1|||
37772084|NCT00632749|69294420|FG004|Overall Study|Refuse to continue medication|0|||
37772085|NCT00632749|69294421|FG005|Overall Study|Refuse to continue medication|0|||
37772086|NCT00632749|69294422|FG006|Overall Study|Refuse to continue medication|0|||
37772087|NCT00632749|69294423|FG007|Overall Study|Refuse to continue medication|0|||
37772088|NCT00632749|69294424|FG008|Overall Study|Refuse to continue medication|0|||
37772089|NCT00632749|69294425|FG009|Overall Study|Refuse to continue medication|1|||
37772090|NCT00632749|69294426|FG010|Overall Study|Refuse to continue medication|0|||
37772091|NCT00632749|69294427|FG011|Overall Study|Refuse to continue medication|0|||
37772092|NCT00632749|69294428|FG012|Overall Study|Refuse to continue medication|0|||
37772093|NCT00632749|69294429|FG013|Overall Study|Refuse to continue medication|0|||
37772094|NCT00632749|69294416|FG000|Overall Study|Reason other than those specified above|0|||
37772095|NCT00632749|69294417|FG001|Overall Study|Reason other than those specified above|2|||
37772096|NCT00632749|69294418|FG002|Overall Study|Reason other than those specified above|0|||
37772097|NCT00632749|69294419|FG003|Overall Study|Reason other than those specified above|0|||
37772098|NCT00632749|69294420|FG004|Overall Study|Reason other than those specified above|1|||
37772099|NCT00632749|69294421|FG005|Overall Study|Reason other than those specified above|0|||
37772100|NCT00632749|69294422|FG006|Overall Study|Reason other than those specified above|1|||
37772101|NCT00632749|69294423|FG007|Overall Study|Reason other than those specified above|0|||
37772102|NCT00632749|69294424|FG008|Overall Study|Reason other than those specified above|0|||
37772103|NCT00632749|69294425|FG009|Overall Study|Reason other than those specified above|0|||
37772104|NCT00632749|69294426|FG010|Overall Study|Reason other than those specified above|2|||
37772105|NCT00632749|69294427|FG011|Overall Study|Reason other than those specified above|1|||
37772106|NCT00632749|69294428|FG012|Overall Study|Reason other than those specified above|0|||
37772107|NCT00632749|69294429|FG013|Overall Study|Reason other than those specified above|2|||
37772108|NCT00632359|69294490|FG000|Overall Study|Withdrawal by Subject|2|||
37772109|NCT00632203|69294497|FG000|Overall Study|Did not start study treatment|1|||
37772110|NCT00632203|69294498|FG001|Overall Study|Did not start study treatment|0|||
37772111|NCT03830333|69294519|FG000|Overall Study|Death|0|||
37772112|NCT03830333|69294520|FG001|Overall Study|Death|1|||
37772113|NCT03830333|69294519|FG000|Overall Study|Withdrawal by Subject|5|||
37772114|NCT03830333|69294520|FG001|Overall Study|Withdrawal by Subject|1|||
37772115|NCT03830333|69294519|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
37772116|NCT03830333|69294520|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
37690081|NCT02121795|69166510|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
37690082|NCT02121795|69166511|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
37690083|NCT02121795|69166510|FG000|Double-Blind Phase|Lost to Follow-up|7|||
37690084|NCT02121795|69166511|FG001|Double-Blind Phase|Lost to Follow-up|4|||
37690085|NCT02121795|69166510|FG000|Double-Blind Phase|Physician Decision|2|||
37690086|NCT02121795|69166511|FG001|Double-Blind Phase|Physician Decision|5|||
37690087|NCT02121795|69166510|FG000|Double-Blind Phase|Adverse Event|5|||
37690088|NCT02121795|69166511|FG001|Double-Blind Phase|Adverse Event|0|||
37690089|NCT02121795|69166510|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
37690090|NCT02121795|69166511|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
37690091|NCT02121795|69166510|FG000|Double-Blind Phase|Protocol Violation|0|||
37690092|NCT02121795|69166511|FG001|Double-Blind Phase|Protocol Violation|3|||
37772117|NCT00631969|69294606|FG000|Overall Study|Adverse Event|3|||
37772118|NCT00631969|69294607|FG001|Overall Study|Adverse Event|1|||
37772119|NCT00631969|69294606|FG000|Overall Study|Lack of Efficacy|2|||
37772120|NCT00631969|69294607|FG001|Overall Study|Lack of Efficacy|8|||
37772121|NCT00631969|69294606|FG000|Overall Study|Lost to Follow-up|2|||
37772122|NCT00631969|69294607|FG001|Overall Study|Lost to Follow-up|1|||
37772123|NCT00631969|69294606|FG000|Overall Study|Protocol Violation|1|||
37772124|NCT00631969|69294607|FG001|Overall Study|Protocol Violation|1|||
37772125|NCT00631969|69294606|FG000|Overall Study|Consent Withdrawn|5|||
37772126|NCT00631969|69294607|FG001|Overall Study|Consent Withdrawn|7|||
37772127|NCT00631969|69294606|FG000|Overall Study|Noncompliant With Study Medication|0|||
37772128|NCT00631969|69294607|FG001|Overall Study|Noncompliant With Study Medication|1|||
37772129|NCT00631969|69294606|FG000|Overall Study|No Drug Exposure|2|||
37772130|NCT00631969|69294607|FG001|Overall Study|No Drug Exposure|2|||
37772131|NCT00631657|69294643|FG000|6-Month Treatment Period|Adverse Event|47|||
37772132|NCT00631657|69294644|FG001|6-Month Treatment Period|Adverse Event|0|||
37772133|NCT00631657|69294645|FG002|6-Month Treatment Period|Adverse Event|7|||
37772134|NCT00631657|69294643|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
37772135|NCT00631657|69294644|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
37772136|NCT00631657|69294645|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
37772137|NCT00631657|69294643|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
37772138|NCT00631657|69294644|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
37772139|NCT00631657|69294645|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
37772140|NCT00631657|69294643|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
37772141|NCT00631657|69294644|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
37772142|NCT00631657|69294645|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
37772143|NCT00631657|69294643|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
37772144|NCT00631657|69294644|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
37772145|NCT00631657|69294645|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
37772146|NCT00631657|69294643|FG000|6-Month Treatment Period|Other|16|||
37772147|NCT00631657|69294644|FG001|6-Month Treatment Period|Other|0|||
37772148|NCT00631657|69294645|FG002|6-Month Treatment Period|Other|4|||
37772149|NCT00631657|69294643|FG000|6-Month Treatment Period|Not Treated|2|||
37772150|NCT00631657|69294644|FG001|6-Month Treatment Period|Not Treated|0|||
37772151|NCT00631657|69294645|FG002|6-Month Treatment Period|Not Treated|1|||
37772152|NCT00631657|69294643|FG000|7-Day Discontinuation Period|Not Treated|1|||
37772153|NCT00631657|69294644|FG001|7-Day Discontinuation Period|Not Treated|1|||
37772154|NCT00631657|69294645|FG002|7-Day Discontinuation Period|Not Treated|1|||
37772155|NCT00631657|69294643|FG000|7-Day Discontinuation Period|Other|1|||
37772156|NCT00631657|69294644|FG001|7-Day Discontinuation Period|Other|0|||
37772157|NCT00631657|69294645|FG002|7-Day Discontinuation Period|Other|0|||
37772158|NCT00631189|69294683|FG000|Initial Phase|Protocol Violation|347|||
37772159|NCT00631189|69294684|FG001|Initial Phase|Protocol Violation|0|||
37772160|NCT00631189|69294685|FG002|Initial Phase|Protocol Violation|0|||
37772161|NCT00631189|69294686|FG003|Initial Phase|Protocol Violation|0|||
37772162|NCT00631189|69294683|FG000|Initial Phase|Withdrawal by Subject|4|||
37772163|NCT00631189|69294684|FG001|Initial Phase|Withdrawal by Subject|0|||
37772164|NCT00631189|69294685|FG002|Initial Phase|Withdrawal by Subject|0|||
37772165|NCT00631189|69294686|FG003|Initial Phase|Withdrawal by Subject|0|||
37772166|NCT00631189|69294683|FG000|Treatment Phase|Withdrawal by Subject|0|||
37772167|NCT00631189|69294684|FG001|Treatment Phase|Withdrawal by Subject|2|||
37772168|NCT00631189|69294685|FG002|Treatment Phase|Withdrawal by Subject|1|||
37772169|NCT00631189|69294686|FG003|Treatment Phase|Withdrawal by Subject|1|||
37772170|NCT00631189|69294683|FG000|Treatment Phase|Protocol Violation|0|||
37772171|NCT00631189|69294684|FG001|Treatment Phase|Protocol Violation|1|||
37772172|NCT00631189|69294685|FG002|Treatment Phase|Protocol Violation|6|||
37772173|NCT00631189|69294686|FG003|Treatment Phase|Protocol Violation|2|||
37772174|NCT00631189|69294683|FG000|Treatment Phase|Adverse Event|0|||
37772175|NCT00631189|69294684|FG001|Treatment Phase|Adverse Event|3|||
37772176|NCT00631189|69294685|FG002|Treatment Phase|Adverse Event|2|||
37772177|NCT00631189|69294686|FG003|Treatment Phase|Adverse Event|4|||
37772178|NCT00631189|69294683|FG000|Treatment Phase|Lost to Follow-up|0|||
37772179|NCT00631189|69294684|FG001|Treatment Phase|Lost to Follow-up|1|||
37772180|NCT00631189|69294685|FG002|Treatment Phase|Lost to Follow-up|0|||
37772181|NCT00631189|69294686|FG003|Treatment Phase|Lost to Follow-up|0|||
37772182|NCT00631189|69294683|FG000|Treatment Phase|Pregnancy|0|||
37772183|NCT00631189|69294684|FG001|Treatment Phase|Pregnancy|0|||
37772184|NCT00631189|69294685|FG002|Treatment Phase|Pregnancy|1|||
37772185|NCT00631189|69294686|FG003|Treatment Phase|Pregnancy|0|||
37772186|NCT00631189|69294683|FG000|Treatment Phase|patient did not take pravastatin|0|||
37772187|NCT00631189|69294684|FG001|Treatment Phase|patient did not take pravastatin|0|||
37772188|NCT00631189|69294685|FG002|Treatment Phase|patient did not take pravastatin|1|||
37690093|NCT02121795|69166510|FG000|Double-Blind Phase|Death|1|||
37690094|NCT02121795|69166511|FG001|Double-Blind Phase|Death|1|||
37690095|NCT02121795|69166510|FG000|Open-Label Phase|Physician Decision|8|||
37690096|NCT02121795|69166511|FG001|Open-Label Phase|Physician Decision|8|||
37690097|NCT02121795|69166510|FG000|Open-Label Phase|Withdrawal by Subject|3|||
37690098|NCT02121795|69166511|FG001|Open-Label Phase|Withdrawal by Subject|2|||
37690099|NCT02121795|69166510|FG000|Open-Label Phase|Lost to Follow-up|1|||
37772189|NCT00631189|69294686|FG003|Treatment Phase|patient did not take pravastatin|0|||
37772190|NCT00630877|69294699|FG000|Overall Study|Adverse Event|11|||
37772191|NCT00630877|69294700|FG001|Overall Study|Adverse Event|8|||
37772192|NCT00630877|69294701|FG002|Overall Study|Adverse Event|7|||
37772193|NCT00630877|69294699|FG000|Overall Study|Withdrawal by Subject|3|||
37772194|NCT00630877|69294700|FG001|Overall Study|Withdrawal by Subject|4|||
37772195|NCT00630877|69294701|FG002|Overall Study|Withdrawal by Subject|0|||
37772196|NCT00630877|69294699|FG000|Overall Study|Lost to Follow-up|2|||
37772197|NCT00630877|69294700|FG001|Overall Study|Lost to Follow-up|0|||
37772198|NCT00630877|69294701|FG002|Overall Study|Lost to Follow-up|0|||
37772199|NCT00630877|69294699|FG000|Overall Study|Noncompliance|2|||
37772200|NCT00630877|69294700|FG001|Overall Study|Noncompliance|3|||
37772201|NCT00630877|69294701|FG002|Overall Study|Noncompliance|1|||
37772202|NCT00630877|69294699|FG000|Overall Study|Protocol violation|1|||
37772203|NCT00630877|69294700|FG001|Overall Study|Protocol violation|0|||
37772204|NCT00630877|69294701|FG002|Overall Study|Protocol violation|1|||
37772205|NCT00630877|69294699|FG000|Overall Study|Personal reasons|0|||
37772206|NCT00630877|69294700|FG001|Overall Study|Personal reasons|0|||
37772207|NCT00630877|69294701|FG002|Overall Study|Personal reasons|1|||
37833510|NCT01263496|69517271|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
37833511|NCT01263496|69517272|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
37833512|NCT01263496|69517273|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
37833513|NCT01263496|69517274|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
37833514|NCT01263496|69517275|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
37833515|NCT01263496|69517276|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
37690100|NCT02121795|69166511|FG001|Open-Label Phase|Lost to Follow-up|0|||
37690101|NCT02158533|69166522|FG000|Stage 1|Adverse Event|6|||
37690102|NCT02158533|69166523|FG001|Stage 1|Adverse Event|4|||
37690103|NCT02158533|69166524|FG002|Stage 1|Adverse Event|7|||
37690104|NCT02158533|69166525|FG003|Stage 1|Adverse Event|0|||
37690105|NCT02158533|69166526|FG004|Stage 1|Adverse Event|0|||
37690106|NCT02158533|69166527|FG005|Stage 1|Adverse Event|0|||
37690107|NCT02158533|69166522|FG000|Stage 1|Withdrawal by Subject|3|||
37833516|NCT01263496|69517268|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
37690108|NCT02158533|69166523|FG001|Stage 1|Withdrawal by Subject|2|||
37690109|NCT02158533|69166524|FG002|Stage 1|Withdrawal by Subject|1|||
37968180|NCT02546921|69655298|FG006|Overall Study|Adverse Event|0|||
37690110|NCT02158533|69166525|FG003|Stage 1|Withdrawal by Subject|0|||
37690111|NCT02158533|69166526|FG004|Stage 1|Withdrawal by Subject|0|||
37690112|NCT02158533|69166527|FG005|Stage 1|Withdrawal by Subject|0|||
37833517|NCT01263496|69517269|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
37690113|NCT02158533|69166522|FG000|Stage 1|Lack of Efficacy|1|||
37690114|NCT02158533|69166523|FG001|Stage 1|Lack of Efficacy|0|||
37690115|NCT02158533|69166524|FG002|Stage 1|Lack of Efficacy|0|||
37690116|NCT02158533|69166525|FG003|Stage 1|Lack of Efficacy|0|||
37690117|NCT02158533|69166526|FG004|Stage 1|Lack of Efficacy|0|||
37690118|NCT02158533|69166527|FG005|Stage 1|Lack of Efficacy|0|||
37690119|NCT02158533|69166522|FG000|Stage 1|Lost to Follow-up|3|||
37690120|NCT02158533|69166523|FG001|Stage 1|Lost to Follow-up|1|||
37690121|NCT02158533|69166524|FG002|Stage 1|Lost to Follow-up|0|||
37690122|NCT02158533|69166525|FG003|Stage 1|Lost to Follow-up|0|||
37863529|NCT00996892|69547127|FG009|Expansion Stage 2|Disease Progression|0|||
37690123|NCT02158533|69166526|FG004|Stage 1|Lost to Follow-up|0|||
37690124|NCT02158533|69166527|FG005|Stage 1|Lost to Follow-up|0|||
37690125|NCT02158533|69166522|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
37772208|NCT02915783|69294713|FG000|Overall Study|Death|21|||
37772209|NCT02915783|69294713|FG000|Overall Study|Lost to Follow-up|1|||
37772210|NCT02915783|69294713|FG000|Overall Study|Withdrawal by Subject|2|||
37772211|NCT00630331|69294728|FG000|Overall Study|Death|2|||
37772212|NCT00630331|69294729|FG001|Overall Study|Death|1|||
37772213|NCT00630331|69294730|FG002|Overall Study|Death|1|||
37772214|NCT00630331|69294728|FG000|Overall Study|Adverse Event|1|||
37772215|NCT00630331|69294729|FG001|Overall Study|Adverse Event|0|||
37772216|NCT00630331|69294730|FG002|Overall Study|Adverse Event|0|||
37772217|NCT00630331|69294728|FG000|Overall Study|Withdrawal by Subject|12|||
37772218|NCT00630331|69294729|FG001|Overall Study|Withdrawal by Subject|7|||
37772219|NCT00630331|69294730|FG002|Overall Study|Withdrawal by Subject|5|||
37772220|NCT00630331|69294728|FG000|Overall Study|Lost to Follow-up|175|||
37772221|NCT00630331|69294729|FG001|Overall Study|Lost to Follow-up|143|||
37772222|NCT00630331|69294730|FG002|Overall Study|Lost to Follow-up|170|||
37772223|NCT00630331|69294728|FG000|Overall Study|Inappropriate enrollment|3|||
37772224|NCT00630331|69294729|FG001|Overall Study|Inappropriate enrollment|6|||
37772225|NCT00630331|69294730|FG002|Overall Study|Inappropriate enrollment|3|||
37772226|NCT00630331|69294728|FG000|Overall Study|Unable to classify|9|||
37772227|NCT00630331|69294729|FG001|Overall Study|Unable to classify|4|||
37772228|NCT00630331|69294730|FG002|Overall Study|Unable to classify|3|||
37772229|NCT00630331|69294728|FG000|Overall Study|Protocol Violation|4|||
37772230|NCT00630331|69294729|FG001|Overall Study|Protocol Violation|5|||
37772231|NCT00630331|69294730|FG002|Overall Study|Protocol Violation|6|||
37772232|NCT00639509|69294773|FG000|Overall Study|Death|1|||
37772233|NCT00638963|69294779|FG000|Overall Study|Withdrawal by Subject|1|||
37772234|NCT00638963|69294780|FG001|Overall Study|Withdrawal by Subject|0|||
37772235|NCT00638183|69294786|FG000|Overall Study|Adverse Event|23|||
37772236|NCT00638183|69294786|FG000|Overall Study|Lack of Efficacy|14|||
37772237|NCT00638183|69294786|FG000|Overall Study|Physician Decision|9|||
37772238|NCT00638183|69294786|FG000|Overall Study|Lost to Follow-up|46|||
37772239|NCT00638183|69294786|FG000|Overall Study|Other reason not defined above|27|||
37772240|NCT00638027|69294792|FG000|Overall Study|Adverse Event|0|||
37772241|NCT00638027|69294793|FG001|Overall Study|Adverse Event|2|||
37772242|NCT00636155|69294799|FG000|Overall Study|Adverse Event|8|||
37772243|NCT00636155|69294799|FG000|Overall Study|Lack of Efficacy|1|||
37772244|NCT00636155|69294799|FG000|Overall Study|Withdrawal by Subject|3|||
37772245|NCT00636155|69294799|FG000|Overall Study|Stem cell transplant|1|||
37772246|NCT00636155|69294799|FG000|Overall Study|Physician Decision|5|||
37772247|NCT00634907|69294805|FG000|Overall Study|Withdrawal by Subject|3|||
37772248|NCT00634907|69294806|FG001|Overall Study|Withdrawal by Subject|0|||
37772249|NCT00634907|69294805|FG000|Overall Study|Physician Decision|3|||
37772250|NCT00634907|69294806|FG001|Overall Study|Physician Decision|9|||
37772251|NCT00634907|69294805|FG000|Overall Study|Withdrawal by Subject|11|||
37772252|NCT00634907|69294806|FG001|Overall Study|Withdrawal by Subject|8|||
37690126|NCT02158533|69166523|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
37690127|NCT02158533|69166524|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
37690128|NCT02158533|69166525|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
37690129|NCT02158533|69166526|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
37690130|NCT02158533|69166527|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
37690131|NCT02158533|69166522|FG000|Stage 1|Non-compliance with study visits|1|||
37690132|NCT02158533|69166523|FG001|Stage 1|Non-compliance with study visits|0|||
37690133|NCT02158533|69166524|FG002|Stage 1|Non-compliance with study visits|0|||
37690134|NCT02158533|69166525|FG003|Stage 1|Non-compliance with study visits|0|||
37690135|NCT02158533|69166526|FG004|Stage 1|Non-compliance with study visits|0|||
37690136|NCT02158533|69166527|FG005|Stage 1|Non-compliance with study visits|0|||
37772253|NCT00634751|69294820|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
37772254|NCT00634751|69294821|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
37772255|NCT00634751|69294822|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
37772256|NCT00634751|69294823|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
37772257|NCT00634751|69294820|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
37772258|NCT00634751|69294821|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
37772259|NCT00634751|69294822|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
37772260|NCT00634751|69294823|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
37772261|NCT00634751|69294820|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
37772262|NCT00634751|69294821|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
37772263|NCT00634751|69294822|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
37772264|NCT00634751|69294823|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
37772265|NCT00634049|69294858|FG000|Overall Study|Never received study drug|1|||
37772266|NCT00634049|69294858|FG000|Overall Study|Died prior to receiving study drug|1|||
37772267|NCT00634049|69294858|FG000|Overall Study|Screening failure|1|||
37772268|NCT00632099|69294897|FG000|Overall Study|Lost to Follow-up|3|||
37772269|NCT00632099|69294898|FG001|Overall Study|Lost to Follow-up|3|||
37772270|NCT00632021|69294906|FG000|Overall Study|Withdrawal/death|4|||
37772271|NCT00632021|69294907|FG001|Overall Study|Withdrawal/death|7|||
37772272|NCT00631475|69294914|FG000|Overall Study|Death|18|||
37772273|NCT00631475|69294914|FG000|Overall Study|Adverse Event|14|||
37772274|NCT00631475|69294914|FG000|Overall Study|Withdrew consent|5|||
37772275|NCT00631475|69294914|FG000|Overall Study|Preparation for lung transplant|8|||
37772276|NCT00631163|69294935|FG000|Number of Participants in Year 1|Adverse Event|12|||
37772277|NCT00631163|69294935|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
37690137|NCT02158533|69166522|FG000|Stage 2|Adverse Event|0|||
37690138|NCT02158533|69166523|FG001|Stage 2|Adverse Event|0|||
37690139|NCT02158533|69166524|FG002|Stage 2|Adverse Event|0|||
37690140|NCT02158533|69166525|FG003|Stage 2|Adverse Event|0|||
37690141|NCT02158533|69166526|FG004|Stage 2|Adverse Event|0|||
37690142|NCT02158533|69166527|FG005|Stage 2|Adverse Event|1|||
37690143|NCT02158533|69166522|FG000|Stage 2|Lack of Efficacy|0|||
37690144|NCT02158533|69166523|FG001|Stage 2|Lack of Efficacy|0|||
37690145|NCT02158533|69166524|FG002|Stage 2|Lack of Efficacy|0|||
37690146|NCT02158533|69166525|FG003|Stage 2|Lack of Efficacy|0|||
37690147|NCT02158533|69166526|FG004|Stage 2|Lack of Efficacy|1|||
37690148|NCT02158533|69166527|FG005|Stage 2|Lack of Efficacy|0|||
37690149|NCT02158533|69166522|FG000|Stage 2|Lost to Follow-up|0|||
37690150|NCT02158533|69166523|FG001|Stage 2|Lost to Follow-up|0|||
37690151|NCT02158533|69166524|FG002|Stage 2|Lost to Follow-up|0|||
37690152|NCT02158533|69166525|FG003|Stage 2|Lost to Follow-up|1|||
37690153|NCT02158533|69166526|FG004|Stage 2|Lost to Follow-up|1|||
37690154|NCT02158533|69166527|FG005|Stage 2|Lost to Follow-up|2|||
37690155|NCT02158533|69166522|FG000|Stage 2|Withdrawal by Subject|0|||
37772278|NCT00631163|69294935|FG000|Number of Participants in Year 1|Death|6|||
37772279|NCT00631163|69294935|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
37833518|NCT01263496|69517270|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
37690156|NCT02158533|69166523|FG001|Stage 2|Withdrawal by Subject|0|||
37690157|NCT02158533|69166524|FG002|Stage 2|Withdrawal by Subject|0|||
37690158|NCT02158533|69166525|FG003|Stage 2|Withdrawal by Subject|0|||
37690159|NCT02158533|69166526|FG004|Stage 2|Withdrawal by Subject|1|||
37772280|NCT00631163|69294935|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
37772281|NCT00631163|69294935|FG000|Number of Participants in Year 1|Administrative problems|6|||
37690160|NCT02158533|69166527|FG005|Stage 2|Withdrawal by Subject|2|||
37772282|NCT00631163|69294935|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
37772283|NCT00631163|69294935|FG000|Number of Participants in Year 2|Adverse Event|1|||
37772284|NCT00631163|69294935|FG000|Number of Participants in Year 2|Protocol Violation|1|||
37772285|NCT00631163|69294935|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
37772286|NCT00631007|69294952|FG000|Overall Study|Adverse Event|0|||
37772287|NCT00631007|69294953|FG001|Overall Study|Adverse Event|2|||
37772288|NCT00631007|69294954|FG002|Overall Study|Adverse Event|0|||
37772289|NCT00631007|69294955|FG003|Overall Study|Adverse Event|2|||
37772290|NCT00631007|69294956|FG004|Overall Study|Adverse Event|3|||
37772291|NCT00631007|69294957|FG005|Overall Study|Adverse Event|2|||
37772292|NCT00631007|69294952|FG000|Overall Study|Lost to Follow-up|2|||
37772293|NCT00631007|69294953|FG001|Overall Study|Lost to Follow-up|1|||
37863530|NCT00996892|69547128|FG010|Expansion Stage 2|Disease Progression|0|||
37772294|NCT00631007|69294954|FG002|Overall Study|Lost to Follow-up|2|||
37772295|NCT00631007|69294955|FG003|Overall Study|Lost to Follow-up|4|||
37690161|NCT02158533|69166522|FG000|Stage 2|Physician Decision|0|||
37690162|NCT02158533|69166523|FG001|Stage 2|Physician Decision|0|||
37772296|NCT00631007|69294956|FG004|Overall Study|Lost to Follow-up|5|||
37772297|NCT00631007|69294957|FG005|Overall Study|Lost to Follow-up|3|||
37772298|NCT00631007|69294952|FG000|Overall Study|Physician Decision|1|||
37690163|NCT02158533|69166524|FG002|Stage 2|Physician Decision|0|||
37690164|NCT02158533|69166525|FG003|Stage 2|Physician Decision|0|||
37690165|NCT02158533|69166526|FG004|Stage 2|Physician Decision|1|||
37690166|NCT02158533|69166527|FG005|Stage 2|Physician Decision|0|||
37690167|NCT02158533|69166522|FG000|Stage 2|Pregnancy|0|||
37690168|NCT02158533|69166523|FG001|Stage 2|Pregnancy|0|||
37690169|NCT02158533|69166524|FG002|Stage 2|Pregnancy|0|||
37690170|NCT02158533|69166525|FG003|Stage 2|Pregnancy|1|||
37690171|NCT02158533|69166526|FG004|Stage 2|Pregnancy|0|||
37690172|NCT02158533|69166527|FG005|Stage 2|Pregnancy|0|||
37690173|NCT02158533|69166522|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
37690174|NCT02158533|69166523|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
37690175|NCT02158533|69166524|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
37690176|NCT02158533|69166525|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
37690177|NCT02158533|69166526|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
37690178|NCT02158533|69166527|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
37690179|NCT02158533|69166522|FG000|Stage 2|Non-adherence with study visits|0|||
37690180|NCT02158533|69166523|FG001|Stage 2|Non-adherence with study visits|0|||
37690181|NCT02158533|69166524|FG002|Stage 2|Non-adherence with study visits|0|||
37690182|NCT02158533|69166525|FG003|Stage 2|Non-adherence with study visits|0|||
37690183|NCT02158533|69166526|FG004|Stage 2|Non-adherence with study visits|0|||
37690184|NCT02158533|69166527|FG005|Stage 2|Non-adherence with study visits|1|||
37690185|NCT02120781|69166543|FG000|Overall Study|Physician Decision|2|||
37690186|NCT02120781|69166544|FG001|Overall Study|Physician Decision|0|||
37690187|NCT02120781|69166543|FG000|Overall Study|Completion not documented|2|||
37690188|NCT02120781|69166544|FG001|Overall Study|Completion not documented|1|||
37690189|NCT02120625|69166550|FG000|Overall Study|Physician Decision|2|||
37690190|NCT02120469|69166557|FG000|Overall Study|HER-2/neu-amplified|1|||
37690191|NCT02120469|69166558|FG001|Overall Study|HER-2/neu-amplified|0|||
37690192|NCT02120469|69166559|FG002|Overall Study|HER-2/neu-amplified|1|||
37690193|NCT02157519|69166572|FG000|Overall Study|Death|3|||
37690194|NCT02157519|69166573|FG001|Overall Study|Death|1|||
37772299|NCT00631007|69294953|FG001|Overall Study|Physician Decision|0|||
37690195|NCT02157519|69166572|FG000|Overall Study|Withdrawal by Subject|7|||
37690196|NCT02157519|69166573|FG001|Overall Study|Withdrawal by Subject|0|||
37690197|NCT02157519|69166572|FG000|Overall Study|Lost to Follow-up|1|||
37772300|NCT00631007|69294954|FG002|Overall Study|Physician Decision|1|||
37772301|NCT00631007|69294955|FG003|Overall Study|Physician Decision|0|||
37772302|NCT00631007|69294956|FG004|Overall Study|Physician Decision|0|||
37772303|NCT00631007|69294957|FG005|Overall Study|Physician Decision|2|||
37772304|NCT00631007|69294952|FG000|Overall Study|Persistent Hyperglycemia|2|||
37772305|NCT00631007|69294953|FG001|Overall Study|Persistent Hyperglycemia|2|||
37772306|NCT00631007|69294954|FG002|Overall Study|Persistent Hyperglycemia|5|||
37772307|NCT00631007|69294955|FG003|Overall Study|Persistent Hyperglycemia|1|||
37772308|NCT00631007|69294956|FG004|Overall Study|Persistent Hyperglycemia|2|||
37772309|NCT00631007|69294957|FG005|Overall Study|Persistent Hyperglycemia|5|||
37772310|NCT00631007|69294952|FG000|Overall Study|Withdrawal by Subject|4|||
37772311|NCT00631007|69294953|FG001|Overall Study|Withdrawal by Subject|5|||
37772312|NCT00631007|69294954|FG002|Overall Study|Withdrawal by Subject|2|||
37772313|NCT00631007|69294955|FG003|Overall Study|Withdrawal by Subject|2|||
37772314|NCT00631007|69294956|FG004|Overall Study|Withdrawal by Subject|1|||
37772315|NCT00631007|69294957|FG005|Overall Study|Withdrawal by Subject|3|||
37772316|NCT00631007|69294952|FG000|Overall Study|Other|2|||
37772317|NCT00631007|69294953|FG001|Overall Study|Other|1|||
37772318|NCT00631007|69294954|FG002|Overall Study|Other|0|||
37772319|NCT00631007|69294955|FG003|Overall Study|Other|0|||
37772320|NCT00631007|69294956|FG004|Overall Study|Other|1|||
37690198|NCT02157519|69166573|FG001|Overall Study|Lost to Follow-up|0|||
37690199|NCT02180061|69166581|FG000|Overall Study|Adverse Event|4|||
37690200|NCT02180061|69166582|FG001|Overall Study|Adverse Event|2|||
37690201|NCT02180061|69166581|FG000|Overall Study|Clinical Progression|5|||
37690202|NCT02180061|69166582|FG001|Overall Study|Clinical Progression|1|||
37690203|NCT02180061|69166581|FG000|Overall Study|Progressive Disease|15|||
37690204|NCT02180061|69166582|FG001|Overall Study|Progressive Disease|5|||
37690205|NCT02180061|69166581|FG000|Overall Study|Physician Decision|1|||
37690206|NCT02180061|69166582|FG001|Overall Study|Physician Decision|0|||
37690207|NCT02179515|69166591|FG000|Overall Study|switched to alternative treatment|0|||
37690208|NCT02179515|69166592|FG001|Overall Study|switched to alternative treatment|1|||
37690209|NCT02179515|69166593|FG002|Overall Study|switched to alternative treatment|1|||
37690210|NCT02179515|69166591|FG000|Overall Study|Death|0|||
37690211|NCT02179515|69166592|FG001|Overall Study|Death|1|||
37690212|NCT02179515|69166593|FG002|Overall Study|Death|1|||
37690213|NCT02179515|69166591|FG000|Overall Study|refused further treatment|0|||
37690214|NCT02179515|69166592|FG001|Overall Study|refused further treatment|3|||
37690215|NCT02179515|69166593|FG002|Overall Study|refused further treatment|4|||
37690216|NCT02179515|69166591|FG000|Overall Study|Disease progression on study|2|||
37690217|NCT02179515|69166592|FG001|Overall Study|Disease progression on study|11|||
37690218|NCT02179515|69166593|FG002|Overall Study|Disease progression on study|8|||
37690219|NCT02120157|69166605|FG000|Overall Study|Death|8|||
37690220|NCT02119299|69166611|FG000|Overall Study|Withdrawal by Subject|7|||
37690221|NCT02119299|69166611|FG000|Overall Study|Lack of Efficacy|1|||
37690222|NCT02119299|69166611|FG000|Overall Study|Pregnancy|1|||
37690223|NCT02156271|69166617|FG000|Overall Study|Physician Decision|4|||
37690224|NCT02156271|69166618|FG001|Overall Study|Physician Decision|3|||
37690225|NCT01365455|69166627|FG000|Induction Period|Adverse Event|5|||
37690226|NCT01365455|69166628|FG001|Induction Period|Adverse Event|3|||
37690227|NCT01365455|69166629|FG002|Induction Period|Adverse Event|4|||
37690228|NCT01365455|69166630|FG003|Induction Period|Adverse Event|0|||
37772321|NCT00631007|69294957|FG005|Overall Study|Other|0|||
37772322|NCT00630539|69294984|FG000|Overall Study|Adverse Event|1|||
37772323|NCT00630539|69294985|FG001|Overall Study|Adverse Event|3|||
37690229|NCT01365455|69166631|FG004|Induction Period|Adverse Event|0|||
37690230|NCT01365455|69166627|FG000|Induction Period|Lack of Efficacy|1|||
37690231|NCT01365455|69166628|FG001|Induction Period|Lack of Efficacy|1|||
37690232|NCT01365455|69166629|FG002|Induction Period|Lack of Efficacy|0|||
37690233|NCT01365455|69166630|FG003|Induction Period|Lack of Efficacy|0|||
37690234|NCT01365455|69166631|FG004|Induction Period|Lack of Efficacy|0|||
37690235|NCT01365455|69166627|FG000|Induction Period|Pregnancy|0|||
37690236|NCT01365455|69166628|FG001|Induction Period|Pregnancy|1|||
37772324|NCT00630539|69294986|FG002|Overall Study|Adverse Event|1|||
37772325|NCT00630539|69294987|FG003|Overall Study|Adverse Event|2|||
37772326|NCT00630539|69294984|FG000|Overall Study|Withdrawal by Subject|0|||
37772327|NCT00630539|69294985|FG001|Overall Study|Withdrawal by Subject|1|||
37772328|NCT00630539|69294986|FG002|Overall Study|Withdrawal by Subject|0|||
37772329|NCT00630539|69294987|FG003|Overall Study|Withdrawal by Subject|1|||
37690237|NCT01365455|69166629|FG002|Induction Period|Pregnancy|0|||
37690238|NCT01365455|69166630|FG003|Induction Period|Pregnancy|0|||
37690239|NCT01365455|69166631|FG004|Induction Period|Pregnancy|0|||
37690240|NCT01365455|69166627|FG000|Induction Period|Protocol deviation|0|||
37690241|NCT01365455|69166628|FG001|Induction Period|Protocol deviation|1|||
37690242|NCT01365455|69166629|FG002|Induction Period|Protocol deviation|1|||
37690243|NCT01365455|69166630|FG003|Induction Period|Protocol deviation|0|||
37690244|NCT01365455|69166631|FG004|Induction Period|Protocol deviation|0|||
37772330|NCT00630305|69295065|FG000|Overall Study|Withdrawal by Subject|1|||
37772331|NCT00630305|69295065|FG000|Overall Study|Inability to insert contact lens|1|||
37772332|NCT01926197|69295291|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
37772333|NCT01926197|69295292|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
37772334|NCT01926197|69295291|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
37772335|NCT01926197|69295292|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
37772336|NCT00989963|69295317|FG000|Overall Study|Adverse Event|1|||
37772337|NCT00989963|69295318|FG001|Overall Study|Adverse Event|1|||
37772338|NCT00989963|69295319|FG002|Overall Study|Adverse Event|1|||
37772339|NCT00989573|69295357|FG000|Overall Study|Adverse Event|8|||
37772340|NCT00989573|69295358|FG001|Overall Study|Adverse Event|12|||
37772341|NCT00989573|69295359|FG002|Overall Study|Adverse Event|4|||
37772342|NCT00989573|69295357|FG000|Overall Study|Physician Decision|0|||
37772343|NCT00989573|69295358|FG001|Overall Study|Physician Decision|2|||
37772344|NCT00989573|69295359|FG002|Overall Study|Physician Decision|0|||
37772345|NCT00989573|69295357|FG000|Overall Study|Protocol Violation|1|||
37772346|NCT00989573|69295358|FG001|Overall Study|Protocol Violation|1|||
37772347|NCT00989573|69295359|FG002|Overall Study|Protocol Violation|1|||
37772348|NCT00989573|69295357|FG000|Overall Study|Withdrawal by Subject|4|||
37772349|NCT00989573|69295358|FG001|Overall Study|Withdrawal by Subject|7|||
37772350|NCT00989573|69295359|FG002|Overall Study|Withdrawal by Subject|3|||
37772351|NCT04126213|69295433|FG000|Overall Study|Lost to Follow-up|9|||
37772352|NCT04126213|69295434|FG001|Overall Study|Lost to Follow-up|1|||
37772353|NCT04126213|69295435|FG002|Overall Study|Lost to Follow-up|5|||
37772354|NCT04126213|69295436|FG003|Overall Study|Lost to Follow-up|10|||
37772355|NCT04126213|69295437|FG004|Overall Study|Lost to Follow-up|4|||
37772356|NCT04126213|69295438|FG005|Overall Study|Lost to Follow-up|7|||
37772357|NCT04126213|69295433|FG000|Overall Study|Withdrawal by Subject|3|||
37772358|NCT04126213|69295434|FG001|Overall Study|Withdrawal by Subject|2|||
37772359|NCT04126213|69295435|FG002|Overall Study|Withdrawal by Subject|1|||
37772360|NCT04126213|69295436|FG003|Overall Study|Withdrawal by Subject|1|||
37772361|NCT04126213|69295437|FG004|Overall Study|Withdrawal by Subject|1|||
37772362|NCT04126213|69295438|FG005|Overall Study|Withdrawal by Subject|1|||
37772363|NCT04126213|69295433|FG000|Overall Study|Other|0|||
37772364|NCT04126213|69295434|FG001|Overall Study|Other|0|||
37772365|NCT04126213|69295435|FG002|Overall Study|Other|2|||
37863531|NCT00996892|69547129|FG011|Expansion Stage 2|Disease Progression|0|||
37863532|NCT00996892|69547130|FG012|Expansion Stage 2|Disease Progression|0|||
37863533|NCT00996892|69547131|FG013|Expansion Stage 2|Disease Progression|0|||
37863534|NCT00996892|69547132|FG014|Expansion Stage 2|Disease Progression|0|||
37863535|NCT00996892|69547133|FG015|Expansion Stage 2|Disease Progression|0|||
37863536|NCT00996892|69547134|FG016|Expansion Stage 2|Disease Progression|0|||
37863537|NCT00996892|69547135|FG017|Expansion Stage 2|Disease Progression|0|||
37863538|NCT00996892|69547136|FG018|Expansion Stage 2|Disease Progression|28|||
37863539|NCT00996892|69547137|FG019|Expansion Stage 2|Disease Progression|0|||
37863540|NCT00996892|69547118|FG000|Expansion Stage 2A|Adverse Event|0|||
37863541|NCT00996892|69547119|FG001|Expansion Stage 2A|Adverse Event|0|||
37690245|NCT01365455|69166627|FG000|Induction Period|Subject/guardian decision|9|||
37690246|NCT01365455|69166628|FG001|Induction Period|Subject/guardian decision|1|||
37690247|NCT01365455|69166629|FG002|Induction Period|Subject/guardian decision|8|||
37863542|NCT00996892|69547120|FG002|Expansion Stage 2A|Adverse Event|0|||
37863543|NCT00996892|69547121|FG003|Expansion Stage 2A|Adverse Event|0|||
37690248|NCT01365455|69166630|FG003|Induction Period|Subject/guardian decision|0|||
37690249|NCT01365455|69166631|FG004|Induction Period|Subject/guardian decision|0|||
37690250|NCT01365455|69166627|FG000|Induction Period|Lost to Follow-up|0|||
37690251|NCT01365455|69166628|FG001|Induction Period|Lost to Follow-up|0|||
37863544|NCT00996892|69547122|FG004|Expansion Stage 2A|Adverse Event|0|||
37863545|NCT00996892|69547123|FG005|Expansion Stage 2A|Adverse Event|0|||
37863546|NCT00996892|69547124|FG006|Expansion Stage 2A|Adverse Event|0|||
37863547|NCT00996892|69547125|FG007|Expansion Stage 2A|Adverse Event|0|||
37690252|NCT01365455|69166629|FG002|Induction Period|Lost to Follow-up|3|||
37690253|NCT01365455|69166630|FG003|Induction Period|Lost to Follow-up|0|||
37690254|NCT01365455|69166631|FG004|Induction Period|Lost to Follow-up|0|||
37772366|NCT04126213|69295436|FG003|Overall Study|Other|2|||
37863548|NCT00996892|69547126|FG008|Expansion Stage 2A|Adverse Event|0|||
37863549|NCT00996892|69547127|FG009|Expansion Stage 2A|Adverse Event|0|||
37772367|NCT04126213|69295437|FG004|Overall Study|Other|0|||
37772368|NCT04126213|69295438|FG005|Overall Study|Other|1|||
37863550|NCT00996892|69547128|FG010|Expansion Stage 2A|Adverse Event|0|||
37863551|NCT00996892|69547129|FG011|Expansion Stage 2A|Adverse Event|0|||
37863552|NCT00996892|69547130|FG012|Expansion Stage 2A|Adverse Event|0|||
37863553|NCT00996892|69547131|FG013|Expansion Stage 2A|Adverse Event|0|||
37863554|NCT00996892|69547132|FG014|Expansion Stage 2A|Adverse Event|0|||
37863555|NCT00996892|69547133|FG015|Expansion Stage 2A|Adverse Event|0|||
37863556|NCT00996892|69547134|FG016|Expansion Stage 2A|Adverse Event|0|||
37863557|NCT00996892|69547135|FG017|Expansion Stage 2A|Adverse Event|0|||
37863558|NCT00996892|69547136|FG018|Expansion Stage 2A|Adverse Event|0|||
37863559|NCT00996892|69547137|FG019|Expansion Stage 2A|Adverse Event|8|||
37863560|NCT00996892|69547118|FG000|Expansion Stage 2A|Physician Decision|0|||
37863561|NCT00996892|69547119|FG001|Expansion Stage 2A|Physician Decision|0|||
37863562|NCT00996892|69547120|FG002|Expansion Stage 2A|Physician Decision|0|||
37772369|NCT04126213|69295433|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
37772370|NCT04126213|69295434|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
37772371|NCT04126213|69295435|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
37772372|NCT04126213|69295436|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
37772373|NCT04126213|69295437|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
37772374|NCT04126213|69295438|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
37772375|NCT04128319|69295455|FG000|Overall Study|Death|3|||
37772376|NCT05038293|69295501|FG000|Overall Study|device was not operating properly for one subject.|1|||
37772377|NCT05038293|69295502|FG001|Overall Study|device was not operating properly for one subject.|0|||
37772378|NCT05038293|69295501|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
37772379|NCT05038293|69295502|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
37772380|NCT04753164|69295519|FG000|Overall Study|Adverse Event|0|||
37772381|NCT04753164|69295520|FG001|Overall Study|Adverse Event|2|||
37772382|NCT04753164|69295519|FG000|Overall Study|Withdrawal by Subject|9|||
37772383|NCT04753164|69295520|FG001|Overall Study|Withdrawal by Subject|7|||
37772384|NCT04753164|69295519|FG000|Overall Study|Lost to Follow-up|6|||
37772385|NCT04753164|69295520|FG001|Overall Study|Lost to Follow-up|6|||
37772386|NCT04753164|69295519|FG000|Overall Study|Other|12|||
37772387|NCT04753164|69295520|FG001|Overall Study|Other|5|||
37772388|NCT04729101|69295528|FG000|Overall Study|Adverse Event|1|||
37772389|NCT04729101|69295529|FG001|Overall Study|Adverse Event|0|||
37772390|NCT04729101|69295528|FG000|Overall Study|Physician Decision|1|||
37772391|NCT04729101|69295529|FG001|Overall Study|Physician Decision|0|||
37772392|NCT04729101|69295528|FG000|Overall Study|Withdrawal by Subject|1|||
37772393|NCT04729101|69295529|FG001|Overall Study|Withdrawal by Subject|0|||
37772394|NCT04569968|69295555|FG000|Overall Study|Lost to Follow-up|2|||
37863563|NCT00996892|69547121|FG003|Expansion Stage 2A|Physician Decision|0|||
37968181|NCT02546921|69655292|FG000|Overall Study|Evidence of Disease Progression|1|||
37968182|NCT02546921|69655293|FG001|Overall Study|Evidence of Disease Progression|0|||
37772395|NCT04569968|69295556|FG001|Overall Study|Lost to Follow-up|5|||
37772396|NCT04569968|69295555|FG000|Overall Study|Story of head and/or neck surgery|2|||
37772397|NCT04569968|69295556|FG001|Overall Study|Story of head and/or neck surgery|2|||
37772398|NCT04569968|69295555|FG000|Overall Study|Time of stroke onset|8|||
37772399|NCT04569968|69295556|FG001|Overall Study|Time of stroke onset|7|||
37772400|NCT04569968|69295555|FG000|Overall Study|Type of strokr|12|||
37772401|NCT04569968|69295556|FG001|Overall Study|Type of strokr|8|||
37772402|NCT04569968|69295555|FG000|Overall Study|Cooperation|8|||
37772403|NCT04569968|69295556|FG001|Overall Study|Cooperation|8|||
37772404|NCT04569968|69295555|FG000|Overall Study|Age interval|17|||
37772405|NCT04569968|69295556|FG001|Overall Study|Age interval|6|||
37772406|NCT04569968|69295555|FG000|Overall Study|Denial of participation to the study|0|||
37772407|NCT04569968|69295556|FG001|Overall Study|Denial of participation to the study|3|||
37772408|NCT04569968|69295555|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
37772409|NCT04569968|69295556|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
37772410|NCT04569968|69295555|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
37772411|NCT04569968|69295556|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
37772412|NCT04569968|69295555|FG000|Overall Study|Quarantine|1|||
37772413|NCT04569968|69295556|FG001|Overall Study|Quarantine|0|||
37772414|NCT04569968|69295555|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
37772415|NCT04569968|69295556|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
37772416|NCT04569968|69295555|FG000|Overall Study|Repetitive stroke|8|||
37772417|NCT04569968|69295556|FG001|Overall Study|Repetitive stroke|0|||
37772418|NCT04569968|69295555|FG000|Overall Study|Insufficient mastication|1|||
37772419|NCT04569968|69295556|FG001|Overall Study|Insufficient mastication|0|||
37772420|NCT04569968|69295555|FG000|Overall Study|Infection|1|||
37772421|NCT04569968|69295556|FG001|Overall Study|Infection|0|||
37772422|NCT03385304|69295564|FG000|Overall Study|Death|19|||
37772423|NCT03385304|69295565|FG001|Overall Study|Death|7|||
37968183|NCT02546921|69655294|FG002|Overall Study|Evidence of Disease Progression|0|||
37690255|NCT01365455|69166627|FG000|Maintenance Period|Adverse Event|12|||
37690256|NCT01365455|69166628|FG001|Maintenance Period|Adverse Event|5|||
37690257|NCT01365455|69166629|FG002|Maintenance Period|Adverse Event|1|||
37690258|NCT01365455|69166630|FG003|Maintenance Period|Adverse Event|2|||
37690259|NCT01365455|69166631|FG004|Maintenance Period|Adverse Event|4|||
37690260|NCT01365455|69166627|FG000|Maintenance Period|Lack of Efficacy|10|||
37690261|NCT01365455|69166628|FG001|Maintenance Period|Lack of Efficacy|2|||
37690262|NCT01365455|69166629|FG002|Maintenance Period|Lack of Efficacy|0|||
37690263|NCT01365455|69166630|FG003|Maintenance Period|Lack of Efficacy|2|||
37690264|NCT01365455|69166631|FG004|Maintenance Period|Lack of Efficacy|2|||
37690265|NCT01365455|69166627|FG000|Maintenance Period|Lost to Follow-up|2|||
37690266|NCT01365455|69166628|FG001|Maintenance Period|Lost to Follow-up|4|||
37690267|NCT01365455|69166629|FG002|Maintenance Period|Lost to Follow-up|0|||
37690268|NCT01365455|69166630|FG003|Maintenance Period|Lost to Follow-up|0|||
37690269|NCT01365455|69166631|FG004|Maintenance Period|Lost to Follow-up|3|||
37772424|NCT03385304|69295564|FG000|Overall Study|Lost to Follow-up|17|||
37772425|NCT03385304|69295565|FG001|Overall Study|Lost to Follow-up|14|||
37772426|NCT03385304|69295564|FG000|Overall Study|Withdrawal by Subject|3|||
37772427|NCT03385304|69295565|FG001|Overall Study|Withdrawal by Subject|2|||
37772428|NCT03385304|69295564|FG000|Overall Study|Incarceration|2|||
37772429|NCT03385304|69295565|FG001|Overall Study|Incarceration|3|||
37690270|NCT01365455|69166627|FG000|Maintenance Period|Non-compliance with study treatment|0|||
37690271|NCT01365455|69166628|FG001|Maintenance Period|Non-compliance with study treatment|0|||
37690272|NCT01365455|69166629|FG002|Maintenance Period|Non-compliance with study treatment|0|||
37772430|NCT03325608|69295575|FG000|Overall Study|Lost to Follow-up|47|||
37772431|NCT03325608|69295576|FG001|Overall Study|Lost to Follow-up|47|||
37772432|NCT03325608|69295577|FG002|Overall Study|Lost to Follow-up|41|||
37772433|NCT03325608|69295578|FG003|Overall Study|Lost to Follow-up|41|||
37772434|NCT03325608|69295575|FG000|Overall Study|Death|44|||
37772435|NCT03325608|69295576|FG001|Overall Study|Death|0|||
37772436|NCT03325608|69295577|FG002|Overall Study|Death|41|||
37772437|NCT03325608|69295578|FG003|Overall Study|Death|0|||
37772438|NCT03325608|69295575|FG000|Overall Study|Death of Care Recipient|0|||
37772439|NCT03325608|69295576|FG001|Overall Study|Death of Care Recipient|44|||
37772440|NCT03325608|69295577|FG002|Overall Study|Death of Care Recipient|0|||
37772441|NCT03325608|69295578|FG003|Overall Study|Death of Care Recipient|41|||
37772442|NCT03325608|69295575|FG000|Overall Study|Withdrawal by Subject|44|||
37772443|NCT03325608|69295576|FG001|Overall Study|Withdrawal by Subject|44|||
37772444|NCT03325608|69295577|FG002|Overall Study|Withdrawal by Subject|30|||
37772445|NCT03325608|69295578|FG003|Overall Study|Withdrawal by Subject|30|||
37772446|NCT03183141|69295588|FG000|Overall Study|Withdrawal by Subject|2|||
37772447|NCT03183141|69295589|FG001|Overall Study|Withdrawal by Subject|4|||
37772448|NCT03183141|69295588|FG000|Overall Study|Death|0|||
37772449|NCT03183141|69295589|FG001|Overall Study|Death|8|||
37772450|NCT02957539|69295598|FG000|Baseline to Week 16|Lost to Follow-up|8|||
37772451|NCT02957539|69295599|FG001|Baseline to Week 16|Lost to Follow-up|10|||
37772452|NCT02957539|69295600|FG002|Baseline to Week 16|Lost to Follow-up|16|||
37772453|NCT02957539|69295598|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
37772454|NCT02957539|69295599|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
37690273|NCT01365455|69166630|FG003|Maintenance Period|Non-compliance with study treatment|1|||
37690274|NCT01365455|69166631|FG004|Maintenance Period|Non-compliance with study treatment|0|||
37690275|NCT01365455|69166627|FG000|Maintenance Period|Physician Decision|0|||
37690276|NCT01365455|69166628|FG001|Maintenance Period|Physician Decision|1|||
37690277|NCT01365455|69166629|FG002|Maintenance Period|Physician Decision|0|||
37690278|NCT01365455|69166630|FG003|Maintenance Period|Physician Decision|0|||
37690279|NCT01365455|69166631|FG004|Maintenance Period|Physician Decision|1|||
37690280|NCT01365455|69166627|FG000|Maintenance Period|Pregnancy|0|||
37690281|NCT01365455|69166628|FG001|Maintenance Period|Pregnancy|4|||
37690282|NCT01365455|69166629|FG002|Maintenance Period|Pregnancy|0|||
37772455|NCT02957539|69295600|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
37772456|NCT02957539|69295598|FG000|Week 16 to 32|Withdrawal by Subject|3|||
37772457|NCT02957539|69295599|FG001|Week 16 to 32|Withdrawal by Subject|3|||
37772458|NCT02957539|69295600|FG002|Week 16 to 32|Withdrawal by Subject|1|||
37772459|NCT02957539|69295598|FG000|Week 16 to 32|Lost to Follow-up|8|||
37772460|NCT02957539|69295599|FG001|Week 16 to 32|Lost to Follow-up|7|||
37772461|NCT02957539|69295600|FG002|Week 16 to 32|Lost to Follow-up|5|||
37772462|NCT02957539|69295598|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
37772463|NCT02957539|69295599|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
37772464|NCT02957539|69295600|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
37772465|NCT02957539|69295598|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
37772466|NCT02957539|69295599|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
37772467|NCT02957539|69295600|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
37772468|NCT02690077|69295613|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
37772469|NCT02690077|69295614|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
37772470|NCT02690077|69295613|FG000|Overall Study|Withdrawal by Subject|0|||
37772471|NCT02690077|69295614|FG001|Overall Study|Withdrawal by Subject|5|||
37772472|NCT02690077|69295613|FG000|Overall Study|Excluded by IRB|0|||
37772473|NCT02690077|69295614|FG001|Overall Study|Excluded by IRB|2|||
37772474|NCT02275780|69295622|FG000|Base Study: 96 Weeks|Adverse Event|6|||
37772475|NCT02275780|69295623|FG001|Base Study: 96 Weeks|Adverse Event|14|||
37772476|NCT02275780|69295622|FG000|Base Study: 96 Weeks|Death|3|||
37772477|NCT02275780|69295623|FG001|Base Study: 96 Weeks|Death|1|||
37772478|NCT02275780|69295622|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
37772479|NCT02275780|69295623|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
37772480|NCT02275780|69295622|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
37772481|NCT02275780|69295623|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
37772482|NCT02275780|69295622|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
37772483|NCT02275780|69295623|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
37772484|NCT02275780|69295622|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
37772485|NCT02275780|69295623|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
37772486|NCT02275780|69295622|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
37772487|NCT02275780|69295623|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
37772488|NCT02275780|69295622|FG000|Base Study: 96 Weeks|Physician Decision|2|||
37772489|NCT02275780|69295623|FG001|Base Study: 96 Weeks|Physician Decision|4|||
37772490|NCT02275780|69295622|FG000|Base Study: 96 Weeks|Pregnancy|2|||
37772491|NCT02275780|69295623|FG001|Base Study: 96 Weeks|Pregnancy|1|||
37772492|NCT02275780|69295622|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
37772493|NCT02275780|69295623|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
37772494|NCT02275780|69295622|FG000|Extension Study: up to 192 Weeks|Ongoing|260|||
37772495|NCT02275780|69295623|FG001|Extension Study: up to 192 Weeks|Ongoing|233|||
37772496|NCT00545077|69295631|FG000|Overall Study|Treatment not received|5|||
37772497|NCT00545077|69295632|FG001|Overall Study|Treatment not received|1|||
37772498|NCT00545077|69295631|FG000|Overall Study|Disease Progression|131|||
37772499|NCT00545077|69295632|FG001|Overall Study|Disease Progression|98|||
37772500|NCT00545077|69295631|FG000|Overall Study|Withdrawal by Subject|3|||
37772501|NCT00545077|69295632|FG001|Overall Study|Withdrawal by Subject|14|||
37772502|NCT00545077|69295631|FG000|Overall Study|Physician Decision|6|||
37772503|NCT00545077|69295632|FG001|Overall Study|Physician Decision|3|||
37772504|NCT00545077|69295631|FG000|Overall Study|Lost to Follow-up|2|||
37772505|NCT00545077|69295632|FG001|Overall Study|Lost to Follow-up|0|||
37772506|NCT00545077|69295631|FG000|Overall Study|Protocol Violation|1|||
37772507|NCT00545077|69295632|FG001|Overall Study|Protocol Violation|0|||
37772508|NCT00545077|69295631|FG000|Overall Study|Adverse Event|0|||
37772509|NCT00545077|69295632|FG001|Overall Study|Adverse Event|31|||
37772510|NCT00545077|69295631|FG000|Overall Study|Death|0|||
37772511|NCT00545077|69295632|FG001|Overall Study|Death|8|||
37772512|NCT00130533|69295640|FG000|Overall Study|Withdrawal by Subject|33|||
37772513|NCT00130533|69295641|FG001|Overall Study|Withdrawal by Subject|6|||
37772514|NCT00130533|69295640|FG000|Overall Study|Adverse Event|34|||
37772515|NCT00130533|69295641|FG001|Overall Study|Adverse Event|1|||
37772516|NCT00130533|69295640|FG000|Overall Study|Disease relapse|9|||
37863564|NCT00996892|69547122|FG004|Expansion Stage 2A|Physician Decision|0|||
37772517|NCT00130533|69295641|FG001|Overall Study|Disease relapse|13|||
37772518|NCT00130533|69295640|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
37772519|NCT00130533|69295641|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
37772520|NCT00130533|69295640|FG000|Overall Study|Death|4|||
37772521|NCT00130533|69295641|FG001|Overall Study|Death|2|||
37772522|NCT00130533|69295640|FG000|Overall Study|Protocol Violation|5|||
37772523|NCT00130533|69295641|FG001|Overall Study|Protocol Violation|1|||
37772524|NCT00130533|69295640|FG000|Overall Study|Lost to Follow-up|1|||
37772525|NCT00130533|69295641|FG001|Overall Study|Lost to Follow-up|1|||
37772526|NCT00130533|69295640|FG000|Overall Study|Sponsor´s decision|2|||
37772527|NCT00130533|69295641|FG001|Overall Study|Sponsor´s decision|0|||
37690283|NCT01365455|69166630|FG003|Maintenance Period|Pregnancy|0|||
37690284|NCT01365455|69166631|FG004|Maintenance Period|Pregnancy|2|||
37690285|NCT01365455|69166627|FG000|Maintenance Period|Protocol deviation|1|||
37690286|NCT01365455|69166628|FG001|Maintenance Period|Protocol deviation|1|||
37690287|NCT01365455|69166629|FG002|Maintenance Period|Protocol deviation|0|||
37690288|NCT01365455|69166630|FG003|Maintenance Period|Protocol deviation|0|||
37690289|NCT01365455|69166631|FG004|Maintenance Period|Protocol deviation|0|||
37690290|NCT01365455|69166627|FG000|Maintenance Period|Subject/guardian decision|4|||
37772528|NCT00130533|69295640|FG000|Overall Study|Second Primary Malignancy|0|||
37690291|NCT01365455|69166628|FG001|Maintenance Period|Subject/guardian decision|6|||
37690292|NCT01365455|69166629|FG002|Maintenance Period|Subject/guardian decision|2|||
37690293|NCT01365455|69166630|FG003|Maintenance Period|Subject/guardian decision|4|||
37863565|NCT00996892|69547123|FG005|Expansion Stage 2A|Physician Decision|0|||
37690294|NCT01365455|69166631|FG004|Maintenance Period|Subject/guardian decision|1|||
37690295|NCT02155881|69166651|FG000|Overall Study|Withdrawal by Subject|0|||
37772529|NCT00130533|69295641|FG001|Overall Study|Second Primary Malignancy|1|||
37772530|NCT00130533|69295640|FG000|Overall Study|Other|12|||
37772531|NCT00130533|69295641|FG001|Overall Study|Other|5|||
37772532|NCT00129935|69295649|FG000|Overall Study|Adverse Event|18|||
37772533|NCT00129935|69295650|FG001|Overall Study|Adverse Event|56|||
37772534|NCT00129935|69295649|FG000|Overall Study|Death|1|||
37772535|NCT00129935|69295650|FG001|Overall Study|Death|1|||
37772536|NCT00129935|69295649|FG000|Overall Study|Withdrawal by Subject|7|||
37772537|NCT00129935|69295650|FG001|Overall Study|Withdrawal by Subject|20|||
37772538|NCT00129935|69295649|FG000|Overall Study|Protocol Violation|0|||
37772539|NCT00129935|69295650|FG001|Overall Study|Protocol Violation|4|||
37772540|NCT00129935|69295649|FG000|Overall Study|Physician Decision|3|||
37772541|NCT00129935|69295650|FG001|Overall Study|Physician Decision|4|||
37772542|NCT00129935|69295649|FG000|Overall Study|Recurrence|1|||
37772543|NCT00129935|69295650|FG001|Overall Study|Recurrence|3|||
37772544|NCT00129935|69295649|FG000|Overall Study|Second primary|0|||
37772545|NCT00129935|69295650|FG001|Overall Study|Second primary|1|||
37772546|NCT00129935|69295649|FG000|Overall Study|Other|3|||
37772547|NCT00129935|69295650|FG001|Overall Study|Other|2|||
37772548|NCT00129935|69295649|FG000|Overall Study|Crossed to the other arm|2|||
37772549|NCT00129935|69295650|FG001|Overall Study|Crossed to the other arm|1|||
37772550|NCT00129935|69295649|FG000|Overall Study|Incorrect study treatment|1|||
37772551|NCT00129935|69295650|FG001|Overall Study|Incorrect study treatment|0|||
37772552|NCT01647828|69295665|FG000|Overall Study|Death|3|||
37772553|NCT01647828|69295666|FG001|Overall Study|Death|4|||
37772554|NCT01647828|69295667|FG002|Overall Study|Death|4|||
37772555|NCT01647828|69295668|FG003|Overall Study|Death|5|||
37772556|NCT01647828|69295669|FG004|Overall Study|Death|6|||
37772557|NCT01647828|69295670|FG005|Overall Study|Death|3|||
37772558|NCT01647828|69295671|FG006|Overall Study|Death|10|||
37772559|NCT01647828|69295672|FG007|Overall Study|Death|60|||
37772560|NCT01647828|69295673|FG008|Overall Study|Death|71|||
37772561|NCT01647828|69295665|FG000|Overall Study|Withdrawal by Subject|2|||
37772562|NCT01647828|69295666|FG001|Overall Study|Withdrawal by Subject|0|||
37772563|NCT01647828|69295667|FG002|Overall Study|Withdrawal by Subject|0|||
37772564|NCT01647828|69295668|FG003|Overall Study|Withdrawal by Subject|1|||
37772565|NCT01647828|69295669|FG004|Overall Study|Withdrawal by Subject|0|||
37772566|NCT01647828|69295670|FG005|Overall Study|Withdrawal by Subject|0|||
37772567|NCT01647828|69295671|FG006|Overall Study|Withdrawal by Subject|1|||
37772568|NCT01647828|69295672|FG007|Overall Study|Withdrawal by Subject|0|||
37772569|NCT01647828|69295673|FG008|Overall Study|Withdrawal by Subject|2|||
37772570|NCT01647828|69295665|FG000|Overall Study|Study terminated by Sponsor|0|||
37772571|NCT01647828|69295666|FG001|Overall Study|Study terminated by Sponsor|0|||
37772572|NCT01647828|69295667|FG002|Overall Study|Study terminated by Sponsor|0|||
37772573|NCT01647828|69295668|FG003|Overall Study|Study terminated by Sponsor|0|||
37772574|NCT01647828|69295669|FG004|Overall Study|Study terminated by Sponsor|0|||
37772575|NCT01647828|69295670|FG005|Overall Study|Study terminated by Sponsor|0|||
37772576|NCT01647828|69295671|FG006|Overall Study|Study terminated by Sponsor|1|||
37772577|NCT01647828|69295672|FG007|Overall Study|Study terminated by Sponsor|26|||
37772578|NCT01647828|69295673|FG008|Overall Study|Study terminated by Sponsor|16|||
37772579|NCT01647828|69295665|FG000|Overall Study|Lost to Follow-up|0|||
37772580|NCT01647828|69295666|FG001|Overall Study|Lost to Follow-up|0|||
37772581|NCT01647828|69295667|FG002|Overall Study|Lost to Follow-up|0|||
37772582|NCT01647828|69295668|FG003|Overall Study|Lost to Follow-up|0|||
37772583|NCT01647828|69295669|FG004|Overall Study|Lost to Follow-up|0|||
37772584|NCT01647828|69295670|FG005|Overall Study|Lost to Follow-up|0|||
37772585|NCT01647828|69295671|FG006|Overall Study|Lost to Follow-up|0|||
37772586|NCT01647828|69295672|FG007|Overall Study|Lost to Follow-up|2|||
37772587|NCT01647828|69295673|FG008|Overall Study|Lost to Follow-up|0|||
37690296|NCT02155881|69166652|FG001|Overall Study|Withdrawal by Subject|2|||
37690297|NCT02155881|69166651|FG000|Overall Study|Inappropriately randomized|2|||
37690298|NCT02155881|69166652|FG001|Overall Study|Inappropriately randomized|2|||
37690299|NCT01658579|69166662|FG000|Treatment Period A|Other|0|||
37690300|NCT01658579|69166663|FG001|Treatment Period A|Other|0|||
37690301|NCT01658579|69166664|FG002|Treatment Period A|Other|1|||
37690302|NCT01658579|69166665|FG003|Treatment Period A|Other|1|||
37690303|NCT01658579|69166662|FG000|Treatment Period A|Adverse Event|1|||
37690304|NCT01658579|69166663|FG001|Treatment Period A|Adverse Event|0|||
37690305|NCT01658579|69166664|FG002|Treatment Period A|Adverse Event|0|||
37690306|NCT01658579|69166665|FG003|Treatment Period A|Adverse Event|0|||
37690307|NCT01658579|69166662|FG000|Treatment Period B|Other|0|||
37690308|NCT01658579|69166663|FG001|Treatment Period B|Other|0|||
37690309|NCT01658579|69166664|FG002|Treatment Period B|Other|0|||
37690310|NCT01658579|69166665|FG003|Treatment Period B|Other|1|||
37772588|NCT00989261|69295695|FG000|Overall Study|Still in follow up|12|||
37772589|NCT00989261|69295696|FG001|Overall Study|Still in follow up|21|||
37772590|NCT00989261|69295695|FG000|Overall Study|Withdrawal by Subject|0|||
37772591|NCT00989261|69295696|FG001|Overall Study|Withdrawal by Subject|1|||
37690311|NCT02154087|69166671|FG000|Overall Study|Study Termination|1|||
37690312|NCT02118597|69166675|FG000|Overall Study|Sponsor terminated the study|14|||
37690313|NCT02118597|69166675|FG000|Overall Study|Serious Adverse Event|1|||
37772592|NCT00989261|69295695|FG000|Overall Study|Lost to Follow-up|3|||
37772593|NCT00989261|69295696|FG001|Overall Study|Lost to Follow-up|0|||
37772594|NCT00988559|69295715|FG000|Overall Study|Withdrawal by Subject|1|||
37772595|NCT00988559|69295716|FG001|Overall Study|Withdrawal by Subject|1|||
37772596|NCT00988559|69295717|FG002|Overall Study|Withdrawal by Subject|0|||
37690314|NCT02118597|69166675|FG000|Overall Study|Investigator's decision|1|||
37690315|NCT01659125|69166679|FG000|Overall Study|Withdrawal by Subject|2|||
37690316|NCT01659125|69166679|FG000|Overall Study|Lost to Follow-up|7|||
37772597|NCT00988559|69295718|FG003|Overall Study|Withdrawal by Subject|1|||
37772598|NCT00988559|69295715|FG000|Overall Study|Pregnancy|0|||
37772599|NCT00988559|69295716|FG001|Overall Study|Pregnancy|1|||
37772600|NCT00988559|69295717|FG002|Overall Study|Pregnancy|1|||
37772601|NCT00988559|69295718|FG003|Overall Study|Pregnancy|0|||
37772602|NCT00988559|69295715|FG000|Overall Study|Lost to Follow-up|0|||
37772603|NCT00988559|69295716|FG001|Overall Study|Lost to Follow-up|0|||
37772604|NCT00988559|69295717|FG002|Overall Study|Lost to Follow-up|1|||
37772605|NCT00988559|69295718|FG003|Overall Study|Lost to Follow-up|0|||
37863566|NCT00996892|69547124|FG006|Expansion Stage 2A|Physician Decision|0|||
37863567|NCT00996892|69547125|FG007|Expansion Stage 2A|Physician Decision|0|||
37863568|NCT00996892|69547126|FG008|Expansion Stage 2A|Physician Decision|0|||
37772606|NCT00988169|69295728|FG000|Overall Study|Withdrawal by Subject|1|||
37772607|NCT00988091|69295755|FG000|Double-blind Period|Withdrawal by Subject|15|||
37772608|NCT00988091|69295756|FG001|Double-blind Period|Withdrawal by Subject|13|||
37772609|NCT00988091|69295755|FG000|Double-blind Period|Lost to Follow-up|12|||
37772610|NCT00988091|69295756|FG001|Double-blind Period|Lost to Follow-up|14|||
37772611|NCT00988091|69295755|FG000|Double-blind Period|Other|8|||
37772612|NCT00988091|69295756|FG001|Double-blind Period|Other|8|||
37772613|NCT00988091|69295755|FG000|Double-blind Period|Adverse Event|6|||
37772614|NCT00988091|69295756|FG001|Double-blind Period|Adverse Event|9|||
37772615|NCT00988091|69295755|FG000|Double-blind Period|Use of exclusionary medication|2|||
37772616|NCT00988091|69295756|FG001|Double-blind Period|Use of exclusionary medication|3|||
37772617|NCT00988091|69295755|FG000|Open-label Period|Adverse Event|4|||
37772618|NCT00988091|69295756|FG001|Open-label Period|Adverse Event|7|||
37772619|NCT00988091|69295755|FG000|Open-label Period|Use of exclusionary medication|1|||
37772620|NCT00988091|69295756|FG001|Open-label Period|Use of exclusionary medication|1|||
37772621|NCT00988091|69295755|FG000|Open-label Period|Protocol Violation|1|||
37772622|NCT00988091|69295756|FG001|Open-label Period|Protocol Violation|1|||
37772623|NCT00988091|69295755|FG000|Open-label Period|Withdrawal by Subject|10|||
37772624|NCT00988091|69295756|FG001|Open-label Period|Withdrawal by Subject|16|||
37772625|NCT00988091|69295755|FG000|Open-label Period|Lost to Follow-up|3|||
37772626|NCT00988091|69295756|FG001|Open-label Period|Lost to Follow-up|5|||
37772627|NCT00988091|69295755|FG000|Open-label Period|Other|2|||
37772628|NCT00988091|69295756|FG001|Open-label Period|Other|3|||
37772629|NCT02623218|69296046|FG000|Overall Study|Lost to Follow-up|0|||
37772630|NCT02623218|69296047|FG001|Overall Study|Lost to Follow-up|1|||
37772631|NCT02623218|69296048|FG002|Overall Study|Lost to Follow-up|0|||
37772632|NCT02623218|69296049|FG003|Overall Study|Lost to Follow-up|0|||
37772633|NCT02623218|69296050|FG004|Overall Study|Lost to Follow-up|0|||
37772634|NCT02622828|69296075|FG000|Overall Study|participant withdrew|3|||
37772635|NCT02621034|69296211|FG000|Overall Study|Lost to Follow-up|3|||
37772636|NCT02621034|69296212|FG001|Overall Study|Lost to Follow-up|2|||
37772637|NCT02621034|69296213|FG002|Overall Study|Lost to Follow-up|5|||
37863569|NCT00996892|69547127|FG009|Expansion Stage 2A|Physician Decision|0|||
37863570|NCT00996892|69547128|FG010|Expansion Stage 2A|Physician Decision|0|||
37690317|NCT01659125|69166679|FG000|Overall Study|Technical Problem|1|||
37690318|NCT01659125|69166679|FG000|Overall Study|Time Constraints|2|||
37690319|NCT01659125|69166679|FG000|Overall Study|Failed to Start Treatment|2|||
37690320|NCT01657253|69166685|FG000|Overall Study|Lost to Follow-up|6|||
37690321|NCT01657253|69166686|FG001|Overall Study|Lost to Follow-up|5|||
37690322|NCT01657253|69166685|FG000|Overall Study|Withdrawal by Subject|11|||
37690323|NCT01657253|69166686|FG001|Overall Study|Withdrawal by Subject|12|||
37690324|NCT01657253|69166685|FG000|Overall Study|Adverse Event|0|||
37690325|NCT01657253|69166686|FG001|Overall Study|Adverse Event|1|||
37690326|NCT02117427|69166695|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
37690327|NCT02117427|69166696|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
37690328|NCT02117427|69166697|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
37690329|NCT02117427|69166695|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
37690330|NCT02117427|69166696|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
37690331|NCT02117427|69166697|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
37690332|NCT02117427|69166695|FG000|Overall Study|Physician Decision|0|||
37772638|NCT02620020|69296286|FG000|Overall Study|Adverse Event|8|||
37772639|NCT02620020|69296287|FG001|Overall Study|Adverse Event|4|||
37772640|NCT02620020|69296288|FG002|Overall Study|Adverse Event|3|||
37772641|NCT02620020|69296289|FG003|Overall Study|Adverse Event|5|||
37772642|NCT02620020|69296286|FG000|Overall Study|Lost to Follow-up|4|||
37772643|NCT02620020|69296287|FG001|Overall Study|Lost to Follow-up|8|||
37772644|NCT02620020|69296288|FG002|Overall Study|Lost to Follow-up|1|||
37772645|NCT02620020|69296289|FG003|Overall Study|Lost to Follow-up|4|||
37772646|NCT02620020|69296286|FG000|Overall Study|Physician Decision|7|||
37772647|NCT02620020|69296287|FG001|Overall Study|Physician Decision|4|||
37772648|NCT02620020|69296288|FG002|Overall Study|Physician Decision|3|||
37772649|NCT02620020|69296289|FG003|Overall Study|Physician Decision|4|||
37772650|NCT02620020|69296286|FG000|Overall Study|Protocol Violation|5|||
37772651|NCT02620020|69296287|FG001|Overall Study|Protocol Violation|2|||
37772652|NCT02620020|69296288|FG002|Overall Study|Protocol Violation|1|||
37772653|NCT02620020|69296289|FG003|Overall Study|Protocol Violation|1|||
37772654|NCT02620020|69296286|FG000|Overall Study|Withdrawal by Subject|20|||
37772655|NCT02620020|69296287|FG001|Overall Study|Withdrawal by Subject|16|||
37772656|NCT02620020|69296288|FG002|Overall Study|Withdrawal by Subject|17|||
37772657|NCT02620020|69296289|FG003|Overall Study|Withdrawal by Subject|12|||
37772658|NCT02620020|69296286|FG000|Overall Study|Death|0|||
37772659|NCT02620020|69296287|FG001|Overall Study|Death|1|||
37772660|NCT02620020|69296288|FG002|Overall Study|Death|0|||
37772661|NCT02620020|69296289|FG003|Overall Study|Death|0|||
37772662|NCT02549989|69296299|FG000|Overall Study|Adverse Event|4|||
37772663|NCT02549989|69296299|FG000|Overall Study|Death|1|||
37772664|NCT02549989|69296299|FG000|Overall Study|Lack of Efficacy|19|||
37772665|NCT02549989|69296299|FG000|Overall Study|Withdrawal by Subject|3|||
37772666|NCT00987935|69296458|FG000|Overall Study|Progressive disease|3|||
37772667|NCT00987935|69296459|FG001|Overall Study|Progressive disease|2|||
37772668|NCT00987935|69296460|FG002|Overall Study|Progressive disease|3|||
37772669|NCT00987935|69296461|FG003|Overall Study|Progressive disease|2|||
37772670|NCT00987935|69296462|FG004|Overall Study|Progressive disease|5|||
37772671|NCT00987935|69296463|FG005|Overall Study|Progressive disease|3|||
37772672|NCT00987935|69296464|FG006|Overall Study|Progressive disease|9|||
37772673|NCT00987935|69296465|FG007|Overall Study|Progressive disease|48|||
37772674|NCT00987935|69296466|FG008|Overall Study|Progressive disease|23|||
37772675|NCT00987935|69296458|FG000|Overall Study|Adverse Event|0|||
37772676|NCT00987935|69296459|FG001|Overall Study|Adverse Event|1|||
37772677|NCT00987935|69296460|FG002|Overall Study|Adverse Event|0|||
37772678|NCT00987935|69296461|FG003|Overall Study|Adverse Event|1|||
37772679|NCT00987935|69296462|FG004|Overall Study|Adverse Event|1|||
37772680|NCT00987935|69296463|FG005|Overall Study|Adverse Event|0|||
37772681|NCT00987935|69296464|FG006|Overall Study|Adverse Event|2|||
37968184|NCT02546921|69655295|FG003|Overall Study|Evidence of Disease Progression|0|||
37968185|NCT02546921|69655296|FG004|Overall Study|Evidence of Disease Progression|1|||
37690333|NCT02117427|69166696|FG001|Overall Study|Physician Decision|2|||
37690334|NCT02117427|69166697|FG002|Overall Study|Physician Decision|0|||
37690335|NCT02117427|69166695|FG000|Overall Study|No longer meets inclusion criteria|0|||
37690336|NCT02117427|69166696|FG001|Overall Study|No longer meets inclusion criteria|1|||
37690337|NCT02117427|69166697|FG002|Overall Study|No longer meets inclusion criteria|0|||
37690338|NCT02117427|69166695|FG000|Overall Study|Death|0|||
37690339|NCT02117427|69166696|FG001|Overall Study|Death|1|||
37690340|NCT02117427|69166697|FG002|Overall Study|Death|0|||
37690341|NCT02117349|69166705|FG000|Overall Study|Withdrawal by Subject|1|||
37690342|NCT02117349|69166706|FG001|Overall Study|Withdrawal by Subject|0|||
37690343|NCT02117349|69166705|FG000|Overall Study|Lost to Follow-up|1|||
37690344|NCT02117349|69166706|FG001|Overall Study|Lost to Follow-up|1|||
37690345|NCT02117349|69166705|FG000|Overall Study|Death|1|||
37772682|NCT00987935|69296465|FG007|Overall Study|Adverse Event|10|||
37772683|NCT00987935|69296466|FG008|Overall Study|Adverse Event|6|||
37772684|NCT00987935|69296458|FG000|Overall Study|Refused to continue taking trial med.|1|||
37772685|NCT00987935|69296459|FG001|Overall Study|Refused to continue taking trial med.|0|||
37772686|NCT00987935|69296460|FG002|Overall Study|Refused to continue taking trial med.|0|||
37772687|NCT00987935|69296461|FG003|Overall Study|Refused to continue taking trial med.|0|||
37772688|NCT00987935|69296462|FG004|Overall Study|Refused to continue taking trial med.|1|||
37772689|NCT00987935|69296463|FG005|Overall Study|Refused to continue taking trial med.|0|||
37772690|NCT00987935|69296464|FG006|Overall Study|Refused to continue taking trial med.|4|||
37772691|NCT00987935|69296465|FG007|Overall Study|Refused to continue taking trial med.|4|||
37772692|NCT00987935|69296466|FG008|Overall Study|Refused to continue taking trial med.|2|||
37772693|NCT00987935|69296458|FG000|Overall Study|Reason other than those specified above|0|||
37772694|NCT00987935|69296459|FG001|Overall Study|Reason other than those specified above|0|||
37772695|NCT00987935|69296460|FG002|Overall Study|Reason other than those specified above|0|||
37772696|NCT00987935|69296461|FG003|Overall Study|Reason other than those specified above|0|||
37772697|NCT00987935|69296462|FG004|Overall Study|Reason other than those specified above|0|||
37772698|NCT00987935|69296463|FG005|Overall Study|Reason other than those specified above|0|||
37690346|NCT02117349|69166706|FG001|Overall Study|Death|0|||
37690347|NCT01626495|69166712|FG000|Overall Study|Adverse Event|3|||
37690348|NCT01626495|69166712|FG000|Overall Study|Disease progression|27|||
37690349|NCT01626495|69166712|FG000|Overall Study|Withdrawal by Subject|1|||
37690350|NCT01626495|69166712|FG000|Overall Study|Administrative problem|1|||
37690351|NCT01626495|69166712|FG000|Overall Study|Death|2|||
37690352|NCT01626495|69166712|FG000|Overall Study|Physician Decision|1|||
37690353|NCT01626495|69166712|FG000|Overall Study|New cancer therapy|16|||
37690354|NCT01626495|69166712|FG000|Overall Study|Manufacturing failure|1|||
37690355|NCT02177175|69166718|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
37690356|NCT02177175|69166719|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
37690357|NCT02153073|69166725|FG000|Overall Study|Case Report Forms Uncollected|230|||
37690358|NCT02153073|69166725|FG000|Overall Study|Protocol Deviation|68|||
37690359|NCT01657877|69166729|FG000|Overall Study|Withdrawal by Subject|4|||
37690360|NCT01657877|69166729|FG000|Overall Study|Protocol Violation|6|||
37690361|NCT01657877|69166729|FG000|Overall Study|Adverse Event|2|||
37690362|NCT01657877|69166729|FG000|Overall Study|Other Reason|2|||
37772699|NCT00987935|69296464|FG006|Overall Study|Reason other than those specified above|0|||
37772700|NCT00987935|69296465|FG007|Overall Study|Reason other than those specified above|0|||
37772701|NCT00987935|69296466|FG008|Overall Study|Reason other than those specified above|1|||
37772702|NCT01597050|69296494|FG000|Overall Study|Withdrawal by Subject|1|||
37772703|NCT01597050|69296495|FG001|Overall Study|Withdrawal by Subject|0|||
37772704|NCT00987623|69296512|FG000|Overall Study|Lost to Follow-up|2|||
37772705|NCT00987623|69296513|FG001|Overall Study|Lost to Follow-up|1|||
37772706|NCT00987623|69296512|FG000|Overall Study|Time/job conflict|2|||
37772707|NCT00987623|69296513|FG001|Overall Study|Time/job conflict|0|||
37772708|NCT00987623|69296512|FG000|Overall Study|Discomfort|1|||
37772709|NCT00987623|69296513|FG001|Overall Study|Discomfort|0|||
37772710|NCT00987623|69296512|FG000|Overall Study|Biomicroscopy|0|||
37772711|NCT00987623|69296513|FG001|Overall Study|Biomicroscopy|1|||
37772712|NCT00987623|69296512|FG000|Overall Study|Influenza|0|||
37772713|NCT00987623|69296513|FG001|Overall Study|Influenza|1|||
37772714|NCT00987467|69296519|FG000|Overall Study|Lost to Follow-up|2|||
37772715|NCT04990440|69296527|FG000|Overall Study|Sponsor's Decision|0|||
37772716|NCT04990440|69296528|FG001|Overall Study|Sponsor's Decision|0|||
37772717|NCT04990440|69296529|FG002|Overall Study|Sponsor's Decision|1|||
37772718|NCT04829747|69296537|FG000|Overall Study|Protocol Violation|1|||
37772719|NCT04258423|69296575|FG000|Overall Study|Study Closure|2|||
37772720|NCT04258423|69296576|FG001|Overall Study|Study Closure|2|||
37863571|NCT00996892|69547129|FG011|Expansion Stage 2A|Physician Decision|0|||
37968186|NCT02546921|69655297|FG005|Overall Study|Evidence of Disease Progression|0|||
37968187|NCT02546921|69655298|FG006|Overall Study|Evidence of Disease Progression|0|||
37968188|NCT02546921|69655292|FG000|Overall Study|Patient Choice|0|||
37863572|NCT00996892|69547130|FG012|Expansion Stage 2A|Physician Decision|0|||
37863573|NCT00996892|69547131|FG013|Expansion Stage 2A|Physician Decision|0|||
37863574|NCT00996892|69547132|FG014|Expansion Stage 2A|Physician Decision|0|||
37863575|NCT00996892|69547133|FG015|Expansion Stage 2A|Physician Decision|0|||
37863576|NCT00996892|69547134|FG016|Expansion Stage 2A|Physician Decision|0|||
37968189|NCT02546921|69655293|FG001|Overall Study|Patient Choice|1|||
37968190|NCT02546921|69655294|FG002|Overall Study|Patient Choice|0|||
37968191|NCT02546921|69655295|FG003|Overall Study|Patient Choice|0|||
37968192|NCT02546921|69655296|FG004|Overall Study|Patient Choice|0|||
37968193|NCT02546921|69655297|FG005|Overall Study|Patient Choice|1|||
37968194|NCT02546921|69655298|FG006|Overall Study|Patient Choice|0|||
37772721|NCT04178967|69296584|FG000|Induction Period|Adverse Event|4|||
37863577|NCT00996892|69547135|FG017|Expansion Stage 2A|Physician Decision|0|||
37863578|NCT00996892|69547136|FG018|Expansion Stage 2A|Physician Decision|0|||
37863579|NCT00996892|69547137|FG019|Expansion Stage 2A|Physician Decision|2|||
37863580|NCT00996892|69547118|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
37863581|NCT00996892|69547119|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
37863582|NCT00996892|69547120|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
37863583|NCT00996892|69547121|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
37863584|NCT00996892|69547122|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
37863585|NCT00996892|69547123|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
37863586|NCT00996892|69547124|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
37863587|NCT00996892|69547125|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
37863588|NCT00996892|69547126|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
37863589|NCT00996892|69547127|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
37863590|NCT00996892|69547128|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
37863591|NCT00996892|69547129|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
37968195|NCT02513329|69655332|FG000|Overall Study|Lost to Follow-up|5|||
37968196|NCT02513329|69655333|FG001|Overall Study|Lost to Follow-up|2|||
37772722|NCT04178967|69296585|FG001|Induction Period|Adverse Event|6|||
37772723|NCT04178967|69296586|FG002|Induction Period|Adverse Event|0|||
37772724|NCT04178967|69296587|FG003|Induction Period|Adverse Event|0|||
37772725|NCT04178967|69296588|FG004|Induction Period|Adverse Event|0|||
37772726|NCT04178967|69296589|FG005|Induction Period|Adverse Event|0|||
37863592|NCT00996892|69547130|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
37863593|NCT00996892|69547131|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
37863594|NCT00996892|69547132|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
37863595|NCT00996892|69547133|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
37863596|NCT00996892|69547134|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
37863597|NCT00996892|69547135|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
37863598|NCT00996892|69547136|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
37863599|NCT00996892|69547137|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
37863600|NCT00996892|69547118|FG000|Expansion Stage 2A|Disease Progression|0|||
37863601|NCT00996892|69547119|FG001|Expansion Stage 2A|Disease Progression|0|||
37772727|NCT04178967|69296590|FG006|Induction Period|Adverse Event|0|||
37772728|NCT04178967|69296591|FG007|Induction Period|Adverse Event|0|||
37772729|NCT04178967|69296592|FG008|Induction Period|Adverse Event|0|||
37772730|NCT04178967|69296593|FG009|Induction Period|Adverse Event|0|||
37772731|NCT04178967|69296594|FG010|Induction Period|Adverse Event|0|||
37772732|NCT04178967|69296584|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
37772733|NCT04178967|69296585|FG001|Induction Period|Due to Epidemic/Pandemic|4|||
37772734|NCT04178967|69296586|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
37690363|NCT02175771|69166754|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
37690364|NCT02175771|69166755|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
37690365|NCT02175771|69166756|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
37690366|NCT02175771|69166757|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
37690367|NCT02175771|69166758|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
37690368|NCT02175771|69166759|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
37690369|NCT02175771|69166760|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
37690370|NCT02175771|69166761|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
37690371|NCT02175771|69166762|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
37690372|NCT02175771|69166754|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
37690373|NCT02175771|69166755|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
37690374|NCT02175771|69166756|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
37690375|NCT02175771|69166757|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
37690376|NCT02175771|69166758|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
37690377|NCT02175771|69166759|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
37772735|NCT04178967|69296587|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
37772736|NCT04178967|69296588|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
37772737|NCT04178967|69296589|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
37772738|NCT04178967|69296590|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
37690378|NCT02175771|69166760|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
37690379|NCT02175771|69166761|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
37690380|NCT02175771|69166762|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
37690381|NCT02175771|69166754|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
37690382|NCT02175771|69166755|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
37690383|NCT02175771|69166756|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
37690384|NCT02175771|69166757|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
37690385|NCT02175771|69166758|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
37690386|NCT02175771|69166759|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
37690387|NCT02175771|69166760|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
37772739|NCT04178967|69296591|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
37772740|NCT04178967|69296592|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
37772741|NCT04178967|69296593|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
37772742|NCT04178967|69296594|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
37772743|NCT04178967|69296584|FG000|Induction Period|Lack of Efficacy|4|||
37772744|NCT04178967|69296585|FG001|Induction Period|Lack of Efficacy|1|||
37772745|NCT04178967|69296586|FG002|Induction Period|Lack of Efficacy|0|||
37772746|NCT04178967|69296587|FG003|Induction Period|Lack of Efficacy|0|||
37772747|NCT04178967|69296588|FG004|Induction Period|Lack of Efficacy|0|||
37772748|NCT04178967|69296589|FG005|Induction Period|Lack of Efficacy|0|||
37772749|NCT04178967|69296590|FG006|Induction Period|Lack of Efficacy|0|||
37772750|NCT04178967|69296591|FG007|Induction Period|Lack of Efficacy|0|||
37772751|NCT04178967|69296592|FG008|Induction Period|Lack of Efficacy|0|||
37772752|NCT04178967|69296593|FG009|Induction Period|Lack of Efficacy|0|||
37772753|NCT04178967|69296594|FG010|Induction Period|Lack of Efficacy|0|||
37772754|NCT04178967|69296584|FG000|Induction Period|Protocol Violation|0|||
37772755|NCT04178967|69296585|FG001|Induction Period|Protocol Violation|6|||
37690388|NCT02175771|69166761|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
37690389|NCT02175771|69166762|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
37690390|NCT02175771|69166754|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
37690391|NCT02175771|69166755|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
37690392|NCT02175771|69166756|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
37690393|NCT02175771|69166757|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
37690394|NCT02175771|69166758|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
37690395|NCT02175771|69166759|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
37690396|NCT02175771|69166760|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
37690397|NCT02175771|69166761|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
37690398|NCT02175771|69166762|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
37690399|NCT02175771|69166754|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
37690400|NCT02175771|69166755|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
37690401|NCT02175771|69166756|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
37690402|NCT02175771|69166757|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
37690403|NCT02175771|69166758|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
37690404|NCT02175771|69166759|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
37690405|NCT02175771|69166760|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
37690406|NCT02175771|69166761|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
37690407|NCT02175771|69166762|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
37690408|NCT02175771|69166754|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
37690409|NCT02175771|69166755|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
37690410|NCT02175771|69166756|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
37690411|NCT02175771|69166757|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
37690412|NCT02175771|69166758|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
37690413|NCT02175771|69166759|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
37690414|NCT02175771|69166760|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
37690415|NCT02175771|69166761|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
37690416|NCT02175771|69166762|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
37690417|NCT02175771|69166754|FG000|Run-In Period (Pre-assignment)|Other|8|||
37690418|NCT02175771|69166755|FG001|Run-In Period (Pre-assignment)|Other|0|||
37772756|NCT04178967|69296586|FG002|Induction Period|Protocol Violation|0|||
37772757|NCT04178967|69296587|FG003|Induction Period|Protocol Violation|0|||
37772758|NCT04178967|69296588|FG004|Induction Period|Protocol Violation|0|||
37772759|NCT04178967|69296589|FG005|Induction Period|Protocol Violation|0|||
37772760|NCT04178967|69296590|FG006|Induction Period|Protocol Violation|0|||
37772761|NCT04178967|69296591|FG007|Induction Period|Protocol Violation|0|||
37772762|NCT04178967|69296592|FG008|Induction Period|Protocol Violation|0|||
37772763|NCT04178967|69296593|FG009|Induction Period|Protocol Violation|0|||
37772764|NCT04178967|69296594|FG010|Induction Period|Protocol Violation|0|||
37772765|NCT04178967|69296584|FG000|Induction Period|Withdrawal by Subject|6|||
37772766|NCT04178967|69296585|FG001|Induction Period|Withdrawal by Subject|4|||
37772767|NCT04178967|69296586|FG002|Induction Period|Withdrawal by Subject|0|||
37772768|NCT04178967|69296587|FG003|Induction Period|Withdrawal by Subject|0|||
37772769|NCT04178967|69296588|FG004|Induction Period|Withdrawal by Subject|0|||
37772770|NCT04178967|69296589|FG005|Induction Period|Withdrawal by Subject|0|||
37772771|NCT04178967|69296590|FG006|Induction Period|Withdrawal by Subject|0|||
37772772|NCT04178967|69296591|FG007|Induction Period|Withdrawal by Subject|0|||
37772773|NCT04178967|69296592|FG008|Induction Period|Withdrawal by Subject|0|||
37772774|NCT04178967|69296593|FG009|Induction Period|Withdrawal by Subject|0|||
37772775|NCT04178967|69296594|FG010|Induction Period|Withdrawal by Subject|0|||
37772776|NCT04178967|69296584|FG000|Induction Period|Lost to Follow-up|2|||
37772777|NCT04178967|69296585|FG001|Induction Period|Lost to Follow-up|0|||
37772778|NCT04178967|69296586|FG002|Induction Period|Lost to Follow-up|0|||
37772779|NCT04178967|69296587|FG003|Induction Period|Lost to Follow-up|0|||
37772780|NCT04178967|69296588|FG004|Induction Period|Lost to Follow-up|0|||
37772781|NCT04178967|69296589|FG005|Induction Period|Lost to Follow-up|0|||
37772782|NCT04178967|69296590|FG006|Induction Period|Lost to Follow-up|0|||
37772783|NCT04178967|69296591|FG007|Induction Period|Lost to Follow-up|0|||
37772784|NCT04178967|69296592|FG008|Induction Period|Lost to Follow-up|0|||
37772785|NCT04178967|69296593|FG009|Induction Period|Lost to Follow-up|0|||
37772786|NCT04178967|69296594|FG010|Induction Period|Lost to Follow-up|0|||
37772787|NCT04178967|69296584|FG000|Induction Period|Participant Missed Study Visits|0|||
37772788|NCT04178967|69296585|FG001|Induction Period|Participant Missed Study Visits|1|||
37772789|NCT04178967|69296586|FG002|Induction Period|Participant Missed Study Visits|0|||
37772790|NCT04178967|69296587|FG003|Induction Period|Participant Missed Study Visits|0|||
37772791|NCT04178967|69296588|FG004|Induction Period|Participant Missed Study Visits|0|||
37772792|NCT04178967|69296589|FG005|Induction Period|Participant Missed Study Visits|0|||
37772793|NCT04178967|69296590|FG006|Induction Period|Participant Missed Study Visits|0|||
37772794|NCT04178967|69296591|FG007|Induction Period|Participant Missed Study Visits|0|||
37772795|NCT04178967|69296592|FG008|Induction Period|Participant Missed Study Visits|0|||
37772796|NCT04178967|69296593|FG009|Induction Period|Participant Missed Study Visits|0|||
37772797|NCT04178967|69296594|FG010|Induction Period|Participant Missed Study Visits|0|||
37772798|NCT04178967|69296584|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
37772799|NCT04178967|69296585|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
37772800|NCT04178967|69296586|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
37772801|NCT04178967|69296587|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
37772802|NCT04178967|69296588|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
37772803|NCT04178967|69296589|FG005|Maintenance Blinded Treatment Period|Adverse Event|1|||
37772804|NCT04178967|69296590|FG006|Maintenance Blinded Treatment Period|Adverse Event|2|||
37772805|NCT04178967|69296591|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
37772806|NCT04178967|69296592|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
37772807|NCT04178967|69296593|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
37772808|NCT04178967|69296594|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
37772809|NCT04178967|69296584|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
37772810|NCT04178967|69296585|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
37772811|NCT04178967|69296586|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
37772812|NCT04178967|69296587|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
37772813|NCT04178967|69296588|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
37772814|NCT04178967|69296589|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
37772815|NCT04178967|69296590|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
37772816|NCT04178967|69296591|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
37772817|NCT04178967|69296592|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
37772818|NCT04178967|69296593|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
37772819|NCT04178967|69296594|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
37968197|NCT02425826|69655343|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
37968198|NCT02425826|69655344|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
37968199|NCT02425826|69655345|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
37772820|NCT04178967|69296584|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
37772821|NCT04178967|69296585|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
37772822|NCT04178967|69296586|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
37772823|NCT04178967|69296587|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
37772824|NCT04178967|69296588|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
37772825|NCT04178967|69296589|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
37772826|NCT04178967|69296590|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
37772827|NCT04178967|69296591|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
37772828|NCT04178967|69296592|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
37772829|NCT04178967|69296593|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
37772830|NCT04178967|69296594|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
37772831|NCT04178967|69296584|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
37772832|NCT04178967|69296585|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
37772833|NCT04178967|69296586|FG002|Maintenance Blinded Treatment Period|Physician Decision|0|||
37772834|NCT04178967|69296587|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
37772835|NCT04178967|69296588|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
37772836|NCT04178967|69296589|FG005|Maintenance Blinded Treatment Period|Physician Decision|0|||
37772837|NCT04178967|69296590|FG006|Maintenance Blinded Treatment Period|Physician Decision|1|||
37772838|NCT04178967|69296591|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
37772839|NCT04178967|69296592|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
37772840|NCT04178967|69296593|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
37772841|NCT04178967|69296594|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
37772842|NCT04178967|69296584|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
37772843|NCT04178967|69296585|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
37772844|NCT04178967|69296586|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
37772845|NCT04178967|69296587|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
37772846|NCT04178967|69296588|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
37772847|NCT04178967|69296589|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
37772848|NCT04178967|69296590|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
37772849|NCT04178967|69296591|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|4|||
37772850|NCT04178967|69296592|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
37772851|NCT04178967|69296593|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
37772852|NCT04178967|69296594|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
37772853|NCT04178967|69296584|FG000|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
37772854|NCT04178967|69296585|FG001|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
37772855|NCT04178967|69296586|FG002|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
37772856|NCT04178967|69296587|FG003|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
37772857|NCT04178967|69296588|FG004|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
37772858|NCT04178967|69296589|FG005|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
37772859|NCT04178967|69296590|FG006|Maintenance Blinded Treatment Period|Sponsor Decision|4|||
37772860|NCT04178967|69296591|FG007|Maintenance Blinded Treatment Period|Sponsor Decision|6|||
37772861|NCT04178967|69296592|FG008|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
37772862|NCT04178967|69296593|FG009|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
37772863|NCT04178967|69296594|FG010|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
37772864|NCT04178967|69296584|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
37772865|NCT04178967|69296585|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
37772866|NCT04178967|69296586|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
37772867|NCT04178967|69296587|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
37772868|NCT04178967|69296588|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
37772869|NCT04178967|69296589|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|3|||
37772870|NCT04178967|69296590|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
37772871|NCT04178967|69296591|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
37772872|NCT04178967|69296592|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
37772873|NCT04178967|69296593|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
37772874|NCT04178967|69296594|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
37772875|NCT04178967|69296584|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
37772876|NCT04178967|69296585|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
37772877|NCT04178967|69296586|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
37772878|NCT04178967|69296587|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
37772879|NCT04178967|69296588|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
37863602|NCT00996892|69547120|FG002|Expansion Stage 2A|Disease Progression|0|||
37863603|NCT00996892|69547121|FG003|Expansion Stage 2A|Disease Progression|0|||
37968200|NCT02425826|69655343|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
37968201|NCT02425826|69655344|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
37968202|NCT02425826|69655345|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
37968203|NCT02425826|69655343|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
37968204|NCT02425826|69655344|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
37968205|NCT02425826|69655345|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
37968206|NCT02425826|69655343|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
37968207|NCT02425826|69655344|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
37968208|NCT02425826|69655345|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
37968209|NCT02425826|69655343|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
37968210|NCT02425826|69655344|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
37968211|NCT02425826|69655345|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
37968212|NCT02425826|69655343|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
37968213|NCT02425826|69655344|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
37968214|NCT02425826|69655345|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
37690419|NCT02175771|69166756|FG002|Run-In Period (Pre-assignment)|Other|0|||
37690420|NCT02175771|69166757|FG003|Run-In Period (Pre-assignment)|Other|0|||
37690421|NCT02175771|69166758|FG004|Run-In Period (Pre-assignment)|Other|0|||
37690422|NCT02175771|69166759|FG005|Run-In Period (Pre-assignment)|Other|0|||
37690423|NCT02175771|69166760|FG006|Run-In Period (Pre-assignment)|Other|0|||
37690424|NCT02175771|69166761|FG007|Run-In Period (Pre-assignment)|Other|0|||
37690425|NCT02175771|69166762|FG008|Run-In Period (Pre-assignment)|Other|0|||
37690426|NCT02175771|69166754|FG000|Treatment Period|Adverse Event|0|||
37690427|NCT02175771|69166755|FG001|Treatment Period|Adverse Event|2|||
37690428|NCT02175771|69166756|FG002|Treatment Period|Adverse Event|1|||
37863604|NCT00996892|69547122|FG004|Expansion Stage 2A|Disease Progression|0|||
37772880|NCT04178967|69296589|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
37772881|NCT04178967|69296590|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
37772882|NCT04178967|69296591|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
37772883|NCT04178967|69296592|FG008|Maintenance Open Label Escape Arm|Adverse Event|3|||
37772884|NCT04178967|69296593|FG009|Maintenance Open Label Escape Arm|Adverse Event|3|||
37772885|NCT04178967|69296594|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
37772886|NCT04178967|69296584|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
37772887|NCT04178967|69296585|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
37772888|NCT04178967|69296586|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
37772889|NCT04178967|69296587|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
37772890|NCT04178967|69296588|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
37772891|NCT04178967|69296589|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
37772892|NCT04178967|69296590|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
37772893|NCT04178967|69296591|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
37772894|NCT04178967|69296592|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|16|||
37772895|NCT04178967|69296593|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|27|||
37772896|NCT04178967|69296594|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|2|||
37772897|NCT04178967|69296584|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
37772898|NCT04178967|69296585|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
37772899|NCT04178967|69296586|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
37772900|NCT04178967|69296587|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
37772901|NCT04178967|69296588|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
37772902|NCT04178967|69296589|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
37772903|NCT04178967|69296590|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
37772904|NCT04178967|69296591|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
37772905|NCT04178967|69296592|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
37772906|NCT04178967|69296593|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
37772907|NCT04178967|69296594|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
37772908|NCT04178967|69296584|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
37772909|NCT04178967|69296585|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
37772910|NCT04178967|69296586|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
37772911|NCT04178967|69296587|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
37772912|NCT04178967|69296588|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
37772913|NCT04178967|69296589|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
37772914|NCT04178967|69296590|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
37772915|NCT04178967|69296591|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
37772916|NCT04178967|69296592|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|4|||
37772917|NCT04178967|69296593|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|9|||
37772918|NCT04178967|69296594|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
37772919|NCT04178967|69296584|FG000|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
37772920|NCT04178967|69296585|FG001|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
37772921|NCT04178967|69296586|FG002|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
37772922|NCT04178967|69296587|FG003|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
37772923|NCT04178967|69296588|FG004|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
37772924|NCT04178967|69296589|FG005|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
37772925|NCT04178967|69296590|FG006|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
37772926|NCT04178967|69296591|FG007|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
37772927|NCT04178967|69296592|FG008|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
37772928|NCT04178967|69296593|FG009|Maintenance Open Label Escape Arm|Sponsor Decision|1|||
37772929|NCT04178967|69296594|FG010|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
37772930|NCT04178967|69296584|FG000|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
37772931|NCT04178967|69296585|FG001|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
37772932|NCT04178967|69296586|FG002|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
37772933|NCT04178967|69296587|FG003|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
37772934|NCT04178967|69296588|FG004|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
37772935|NCT04178967|69296589|FG005|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
37772936|NCT04178967|69296590|FG006|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
37772937|NCT04178967|69296591|FG007|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
37772938|NCT04178967|69296592|FG008|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
37772939|NCT04178967|69296593|FG009|Maintenance Open Label Escape Arm|Participant Missed Study Visits|1|||
37772940|NCT04178967|69296594|FG010|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
37772941|NCT04163900|69296616|FG000|Overall Study|Radiological disease progression|112|||
37772942|NCT04163900|69296617|FG001|Overall Study|Radiological disease progression|127|||
37772943|NCT04163900|69296616|FG000|Overall Study|Study closure|98|||
37772944|NCT04163900|69296617|FG001|Overall Study|Study closure|133|||
37772945|NCT04163900|69296616|FG000|Overall Study|Adverse Event|78|||
37772946|NCT04163900|69296617|FG001|Overall Study|Adverse Event|32|||
37772947|NCT04163900|69296616|FG000|Overall Study|Withdrawal by Subject|37|||
37772948|NCT04163900|69296617|FG001|Overall Study|Withdrawal by Subject|34|||
37772949|NCT04163900|69296616|FG000|Overall Study|Death|29|||
37772950|NCT04163900|69296617|FG001|Overall Study|Death|16|||
37690429|NCT02175771|69166757|FG003|Treatment Period|Adverse Event|1|||
37690430|NCT02175771|69166758|FG004|Treatment Period|Adverse Event|1|||
37690431|NCT02175771|69166759|FG005|Treatment Period|Adverse Event|3|||
37690432|NCT02175771|69166760|FG006|Treatment Period|Adverse Event|2|||
37690433|NCT02175771|69166761|FG007|Treatment Period|Adverse Event|0|||
37690434|NCT02175771|69166762|FG008|Treatment Period|Adverse Event|1|||
37690435|NCT02175771|69166754|FG000|Treatment Period|Withdrawal by Subject|0|||
37690436|NCT02175771|69166755|FG001|Treatment Period|Withdrawal by Subject|9|||
37690437|NCT02175771|69166756|FG002|Treatment Period|Withdrawal by Subject|3|||
37690438|NCT02175771|69166757|FG003|Treatment Period|Withdrawal by Subject|6|||
37772951|NCT04163900|69296616|FG000|Overall Study|Physician Decision|17|||
37772952|NCT04163900|69296617|FG001|Overall Study|Physician Decision|25|||
37772953|NCT04163900|69296616|FG000|Overall Study|Clinical disease progression|14|||
37772954|NCT04163900|69296617|FG001|Overall Study|Clinical disease progression|13|||
37772955|NCT04163900|69296616|FG000|Overall Study|Protocol Violation|3|||
37772956|NCT04163900|69296617|FG001|Overall Study|Protocol Violation|4|||
37772957|NCT04163900|69296616|FG000|Overall Study|Lost to Follow-up|0|||
37772958|NCT04163900|69296617|FG001|Overall Study|Lost to Follow-up|1|||
37772959|NCT04161495|69296625|FG000|Overall Study|Withdrawal by Subject|3|||
37772960|NCT04161495|69296626|FG001|Overall Study|Withdrawal by Subject|0|||
37772961|NCT04161495|69296625|FG000|Overall Study|Protocol Violation|1|||
37772962|NCT04161495|69296626|FG001|Overall Study|Protocol Violation|0|||
37772963|NCT04161495|69296625|FG000|Overall Study|Prohibited concomitant medication|3|||
37772964|NCT04161495|69296626|FG001|Overall Study|Prohibited concomitant medication|0|||
37772965|NCT04161495|69296625|FG000|Overall Study|Adverse Event|1|||
37772966|NCT04161495|69296626|FG001|Overall Study|Adverse Event|0|||
37772967|NCT04161495|69296625|FG000|Overall Study|Other - Unspecified|1|||
37772968|NCT04161495|69296626|FG001|Overall Study|Other - Unspecified|0|||
37772969|NCT04161495|69296625|FG000|Overall Study|Death|0|||
37772970|NCT04161495|69296626|FG001|Overall Study|Death|1|||
37772971|NCT04108000|69296655|FG000|Overall Study|Death of patient|1|||
37772972|NCT04108000|69296656|FG001|Overall Study|Death of patient|0|||
37772973|NCT04108000|69296657|FG002|Overall Study|Death of patient|1|||
37772974|NCT04108000|69296658|FG003|Overall Study|Death of patient|0|||
37772975|NCT04108000|69296655|FG000|Overall Study|Withdrawal by Subject|2|||
37772976|NCT04108000|69296656|FG001|Overall Study|Withdrawal by Subject|2|||
37772977|NCT04108000|69296657|FG002|Overall Study|Withdrawal by Subject|0|||
37772978|NCT04108000|69296658|FG003|Overall Study|Withdrawal by Subject|0|||
37772979|NCT04108000|69296655|FG000|Overall Study|Death of surrogate partner|0|||
37772980|NCT04108000|69296656|FG001|Overall Study|Death of surrogate partner|1|||
37772981|NCT04108000|69296657|FG002|Overall Study|Death of surrogate partner|0|||
37772982|NCT04108000|69296658|FG003|Overall Study|Death of surrogate partner|1|||
37772983|NCT03945266|69296674|FG000|Overall Study|Withdrawal by Subject|1|||
37772984|NCT03945266|69296675|FG001|Overall Study|Withdrawal by Subject|0|||
37772985|NCT03945266|69296674|FG000|Overall Study|Miscarriage|0|||
37772986|NCT03945266|69296675|FG001|Overall Study|Miscarriage|2|||
37772987|NCT03945266|69296674|FG000|Overall Study|Lost to Follow-up|1|||
37772988|NCT03945266|69296675|FG001|Overall Study|Lost to Follow-up|0|||
37772989|NCT03916484|69296689|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
37772990|NCT03916484|69296690|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|1|||
37772991|NCT03916484|69296691|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
37772992|NCT03916484|69296692|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
37772993|NCT03916484|69296689|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
37772994|NCT03916484|69296690|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|11|||
37772995|NCT03916484|69296691|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|4|||
37772996|NCT03916484|69296692|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
37772997|NCT03769311|69296707|FG000|Overall Study|Withdrawal by Subject|1|||
37772998|NCT03738566|69296715|FG000|Initial Study Phase|Withdrawal by Subject|1|||
37772999|NCT03738566|69296716|FG001|Initial Study Phase|Withdrawal by Subject|1|||
37773000|NCT03738566|69296717|FG002|Initial Study Phase|Withdrawal by Subject|2|||
37773001|NCT03738566|69296718|FG003|Initial Study Phase|Withdrawal by Subject|0|||
37773002|NCT03738566|69296715|FG000|Initial Study Phase|Death|0|||
37773003|NCT03738566|69296716|FG001|Initial Study Phase|Death|1|||
37773004|NCT03738566|69296717|FG002|Initial Study Phase|Death|0|||
37773005|NCT03738566|69296718|FG003|Initial Study Phase|Death|0|||
37773006|NCT03738566|69296715|FG000|Initial Study Phase|Treatment failure|5|||
37773007|NCT03738566|69296716|FG001|Initial Study Phase|Treatment failure|0|||
37773008|NCT03738566|69296717|FG002|Initial Study Phase|Treatment failure|0|||
37773009|NCT03738566|69296718|FG003|Initial Study Phase|Treatment failure|0|||
37773010|NCT03738566|69296715|FG000|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
37773011|NCT03738566|69296716|FG001|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
37773012|NCT03738566|69296717|FG002|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
37773013|NCT03738566|69296718|FG003|Cross-over for Treatment Failure|Withdrawal by Subject|1|||
37773014|NCT03533751|69296753|FG000|Overall Study|Withdrawal by Subject|12|||
37773015|NCT03533751|69296754|FG001|Overall Study|Withdrawal by Subject|6|||
37690439|NCT02175771|69166758|FG004|Treatment Period|Withdrawal by Subject|2|||
37690440|NCT02175771|69166759|FG005|Treatment Period|Withdrawal by Subject|4|||
37690441|NCT02175771|69166760|FG006|Treatment Period|Withdrawal by Subject|2|||
37690442|NCT02175771|69166761|FG007|Treatment Period|Withdrawal by Subject|9|||
37690443|NCT02175771|69166762|FG008|Treatment Period|Withdrawal by Subject|2|||
37690444|NCT02175771|69166754|FG000|Treatment Period|Noncompliance|0|||
37690445|NCT02175771|69166755|FG001|Treatment Period|Noncompliance|1|||
37690446|NCT02175771|69166756|FG002|Treatment Period|Noncompliance|2|||
37690447|NCT02175771|69166757|FG003|Treatment Period|Noncompliance|0|||
37690448|NCT02175771|69166758|FG004|Treatment Period|Noncompliance|0|||
37690449|NCT02175771|69166759|FG005|Treatment Period|Noncompliance|0|||
37690450|NCT02175771|69166760|FG006|Treatment Period|Noncompliance|0|||
37690451|NCT02175771|69166761|FG007|Treatment Period|Noncompliance|0|||
37690452|NCT02175771|69166762|FG008|Treatment Period|Noncompliance|1|||
37690453|NCT02175771|69166754|FG000|Treatment Period|Protocol Violation|0|||
37690454|NCT02175771|69166755|FG001|Treatment Period|Protocol Violation|0|||
37690455|NCT02175771|69166756|FG002|Treatment Period|Protocol Violation|0|||
37690456|NCT02175771|69166757|FG003|Treatment Period|Protocol Violation|0|||
37690457|NCT02175771|69166758|FG004|Treatment Period|Protocol Violation|0|||
37690458|NCT02175771|69166759|FG005|Treatment Period|Protocol Violation|0|||
37690459|NCT02175771|69166760|FG006|Treatment Period|Protocol Violation|0|||
37690460|NCT02175771|69166761|FG007|Treatment Period|Protocol Violation|1|||
37690461|NCT02175771|69166762|FG008|Treatment Period|Protocol Violation|0|||
37690462|NCT02175771|69166754|FG000|Treatment Period|Disease progression|0|||
37690463|NCT02175771|69166755|FG001|Treatment Period|Disease progression|0|||
37690464|NCT02175771|69166756|FG002|Treatment Period|Disease progression|0|||
37690465|NCT02175771|69166757|FG003|Treatment Period|Disease progression|0|||
37690466|NCT02175771|69166758|FG004|Treatment Period|Disease progression|0|||
37773016|NCT03533751|69296755|FG002|Overall Study|Withdrawal by Subject|11|||
37773017|NCT03533751|69296756|FG003|Overall Study|Withdrawal by Subject|9|||
37773018|NCT03533751|69296757|FG004|Overall Study|Withdrawal by Subject|10|||
37773019|NCT03533751|69296753|FG000|Overall Study|Adverse Event|4|||
37773020|NCT03533751|69296754|FG001|Overall Study|Adverse Event|7|||
37773021|NCT03533751|69296755|FG002|Overall Study|Adverse Event|2|||
37773022|NCT03533751|69296756|FG003|Overall Study|Adverse Event|4|||
37773023|NCT03533751|69296757|FG004|Overall Study|Adverse Event|5|||
37773024|NCT03533751|69296753|FG000|Overall Study|Physician Decision|0|||
37773025|NCT03533751|69296754|FG001|Overall Study|Physician Decision|2|||
37773026|NCT03533751|69296755|FG002|Overall Study|Physician Decision|1|||
37773027|NCT03533751|69296756|FG003|Overall Study|Physician Decision|2|||
37773028|NCT03533751|69296757|FG004|Overall Study|Physician Decision|1|||
37773029|NCT03533751|69296753|FG000|Overall Study|Sponsor Decision|0|||
37773030|NCT03533751|69296754|FG001|Overall Study|Sponsor Decision|0|||
37773031|NCT03533751|69296755|FG002|Overall Study|Sponsor Decision|1|||
37773032|NCT03533751|69296756|FG003|Overall Study|Sponsor Decision|1|||
37773033|NCT03533751|69296757|FG004|Overall Study|Sponsor Decision|0|||
37773034|NCT03533751|69296753|FG000|Overall Study|Lost to Follow-up|3|||
37773035|NCT03533751|69296754|FG001|Overall Study|Lost to Follow-up|7|||
37773036|NCT03533751|69296755|FG002|Overall Study|Lost to Follow-up|6|||
37773037|NCT03533751|69296756|FG003|Overall Study|Lost to Follow-up|4|||
37773038|NCT03533751|69296757|FG004|Overall Study|Lost to Follow-up|3|||
37773039|NCT03533751|69296753|FG000|Overall Study|Use of any excluded/prohibited medications|0|||
37773040|NCT03533751|69296754|FG001|Overall Study|Use of any excluded/prohibited medications|1|||
37773041|NCT03533751|69296755|FG002|Overall Study|Use of any excluded/prohibited medications|0|||
37773042|NCT03533751|69296756|FG003|Overall Study|Use of any excluded/prohibited medications|0|||
37773043|NCT03533751|69296757|FG004|Overall Study|Use of any excluded/prohibited medications|1|||
37773044|NCT03533751|69296753|FG000|Overall Study|Other|0|||
37773045|NCT03533751|69296754|FG001|Overall Study|Other|2|||
37773046|NCT03533751|69296755|FG002|Overall Study|Other|1|||
37773047|NCT03533751|69296756|FG003|Overall Study|Other|0|||
37773048|NCT03533751|69296757|FG004|Overall Study|Other|3|||
37773049|NCT04856917|69296776|FG000|Overall Study|Withdrawal by Subject|4|||
37773050|NCT04856917|69296777|FG001|Overall Study|Withdrawal by Subject|3|||
37773051|NCT04856917|69296778|FG002|Overall Study|Withdrawal by Subject|1|||
37773052|NCT04856917|69296776|FG000|Overall Study|Lost to Follow-up|3|||
37773053|NCT04856917|69296777|FG001|Overall Study|Lost to Follow-up|1|||
37773054|NCT04856917|69296778|FG002|Overall Study|Lost to Follow-up|1|||
37773055|NCT04856917|69296776|FG000|Overall Study|Used of Prohibited Medication or Treatment|0|||
37968215|NCT02425826|69655343|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
37968216|NCT02425826|69655344|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
37773056|NCT04856917|69296777|FG001|Overall Study|Used of Prohibited Medication or Treatment|1|||
37773057|NCT04856917|69296778|FG002|Overall Study|Used of Prohibited Medication or Treatment|2|||
37773058|NCT04856917|69296776|FG000|Overall Study|Other|1|||
37773059|NCT04856917|69296777|FG001|Overall Study|Other|1|||
37773060|NCT04856917|69296778|FG002|Overall Study|Other|0|||
37773061|NCT04615247|69296816|FG000|Overall Study|Adverse Event|0|||
37968217|NCT02425826|69655345|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
37773062|NCT04615247|69296817|FG001|Overall Study|Adverse Event|2|||
37773063|NCT04615247|69296816|FG000|Overall Study|Withdrawal by Subject|1|||
37773064|NCT04615247|69296817|FG001|Overall Study|Withdrawal by Subject|1|||
37773065|NCT04552132|69296838|FG000|Overall Study|Lost to Follow-up|4|||
37968218|NCT02425826|69655343|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
37968219|NCT02425826|69655344|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
37968220|NCT02425826|69655345|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
37773066|NCT04552132|69296839|FG001|Overall Study|Lost to Follow-up|3|||
37773067|NCT04552132|69296838|FG000|Overall Study|Protocol Violation|1|||
37773068|NCT04552132|69296839|FG001|Overall Study|Protocol Violation|0|||
37773069|NCT04421456|69296848|FG000|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
37773070|NCT04421456|69296849|FG001|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
37773071|NCT04421456|69296850|FG002|Randomized Placebo Run-in Period|Placebo Run-in Failures|18|||
37773072|NCT04421456|69296848|FG000|Randomized Treatment Period|Adverse Event|0|||
37773073|NCT04421456|69296849|FG001|Randomized Treatment Period|Adverse Event|1|||
37773074|NCT04421456|69296850|FG002|Randomized Treatment Period|Adverse Event|0|||
37773075|NCT04421456|69296848|FG000|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
37773076|NCT04421456|69296849|FG001|Randomized Treatment Period|Withdrawal of parent/legal representative consent|0|||
37773077|NCT04421456|69296850|FG002|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
37773078|NCT04421456|69296848|FG000|Randomized Treatment Period|Lost to Follow-up|2|||
37773079|NCT04421456|69296849|FG001|Randomized Treatment Period|Lost to Follow-up|2|||
37773080|NCT04421456|69296850|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
37773081|NCT04421456|69296848|FG000|Randomized Treatment Period|Participant non-compliance|1|||
37773082|NCT04421456|69296849|FG001|Randomized Treatment Period|Participant non-compliance|1|||
37773083|NCT04421456|69296850|FG002|Randomized Treatment Period|Participant non-compliance|2|||
37773084|NCT04421456|69296848|FG000|Randomized Treatment Period|Other|0|||
37773085|NCT04421456|69296849|FG001|Randomized Treatment Period|Other|1|||
37773086|NCT04421456|69296850|FG002|Randomized Treatment Period|Other|3|||
37773087|NCT04341363|69296859|FG000|Overall Study|Adverse Event|1|||
37773088|NCT04341363|69296859|FG000|Overall Study|Withdrawal by Subject|1|||
37968221|NCT02425826|69655343|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
37773089|NCT04268303|69296870|FG000|Overall Study|Lost to Follow-up|1|||
37773090|NCT04268303|69296871|FG001|Overall Study|Lost to Follow-up|1|||
37773091|NCT04268303|69296872|FG002|Overall Study|Lost to Follow-up|2|||
37773092|NCT04268303|69296870|FG000|Overall Study|Withdrawal by Subject|0|||
37773093|NCT04268303|69296871|FG001|Overall Study|Withdrawal by Subject|1|||
37773094|NCT04268303|69296872|FG002|Overall Study|Withdrawal by Subject|1|||
37773095|NCT04268303|69296870|FG000|Overall Study|Adverse Event|2|||
37773096|NCT04268303|69296871|FG001|Overall Study|Adverse Event|0|||
37773097|NCT04268303|69296872|FG002|Overall Study|Adverse Event|0|||
37773098|NCT04092452|69296916|FG000|Overall Study|Adverse Event|1|||
37773099|NCT04092452|69296917|FG001|Overall Study|Adverse Event|3|||
37773100|NCT04092452|69296918|FG002|Overall Study|Adverse Event|3|||
37773101|NCT04092452|69296919|FG003|Overall Study|Adverse Event|7|||
37773102|NCT04092452|69296916|FG000|Overall Study|Lack of Efficacy|1|||
37773103|NCT04092452|69296917|FG001|Overall Study|Lack of Efficacy|1|||
37773104|NCT04092452|69296918|FG002|Overall Study|Lack of Efficacy|1|||
37773105|NCT04092452|69296919|FG003|Overall Study|Lack of Efficacy|0|||
37968222|NCT02425826|69655344|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
37773106|NCT04092452|69296916|FG000|Overall Study|Lost to Follow-up|4|||
37773107|NCT04092452|69296917|FG001|Overall Study|Lost to Follow-up|3|||
37773108|NCT04092452|69296918|FG002|Overall Study|Lost to Follow-up|5|||
37773109|NCT04092452|69296919|FG003|Overall Study|Lost to Follow-up|1|||
37773110|NCT04092452|69296916|FG000|Overall Study|Non-Compliance With Study Drug|0|||
37773111|NCT04092452|69296917|FG001|Overall Study|Non-Compliance With Study Drug|0|||
37773112|NCT04092452|69296918|FG002|Overall Study|Non-Compliance With Study Drug|1|||
37773113|NCT04092452|69296919|FG003|Overall Study|Non-Compliance With Study Drug|1|||
37773114|NCT04092452|69296916|FG000|Overall Study|Physician Decision|1|||
37773115|NCT04092452|69296917|FG001|Overall Study|Physician Decision|0|||
37773116|NCT04092452|69296918|FG002|Overall Study|Physician Decision|1|||
37773117|NCT04092452|69296919|FG003|Overall Study|Physician Decision|0|||
37773118|NCT04092452|69296916|FG000|Overall Study|Pregnancy|2|||
37773119|NCT04092452|69296917|FG001|Overall Study|Pregnancy|0|||
37773120|NCT04092452|69296918|FG002|Overall Study|Pregnancy|0|||
37773121|NCT04092452|69296919|FG003|Overall Study|Pregnancy|0|||
37773122|NCT04092452|69296916|FG000|Overall Study|Protocol Deviation|1|||
37773123|NCT04092452|69296917|FG001|Overall Study|Protocol Deviation|0|||
37773124|NCT04092452|69296918|FG002|Overall Study|Protocol Deviation|0|||
37773125|NCT04092452|69296919|FG003|Overall Study|Protocol Deviation|0|||
37773126|NCT04092452|69296916|FG000|Overall Study|Withdrawal by Subject|3|||
37773127|NCT04092452|69296917|FG001|Overall Study|Withdrawal by Subject|10|||
37773128|NCT04092452|69296918|FG002|Overall Study|Withdrawal by Subject|3|||
37773129|NCT04092452|69296919|FG003|Overall Study|Withdrawal by Subject|5|||
37773130|NCT04092452|69296916|FG000|Overall Study|Other|0|||
37773131|NCT04092452|69296917|FG001|Overall Study|Other|0|||
37773132|NCT04092452|69296918|FG002|Overall Study|Other|1|||
37773133|NCT04092452|69296919|FG003|Overall Study|Other|2|||
37773134|NCT04029116|69296934|FG000|Overall Study|Adverse Event|0|||
37773135|NCT04029116|69296935|FG001|Overall Study|Adverse Event|2|||
37773136|NCT04029116|69296934|FG000|Overall Study|Lost to Follow-up|3|||
37773137|NCT04029116|69296935|FG001|Overall Study|Lost to Follow-up|5|||
37773138|NCT04029116|69296934|FG000|Overall Study|Physician Decision|2|||
37773139|NCT04029116|69296935|FG001|Overall Study|Physician Decision|0|||
37773140|NCT04029116|69296934|FG000|Overall Study|Pregnancy|1|||
37773141|NCT04029116|69296935|FG001|Overall Study|Pregnancy|2|||
37773142|NCT04029116|69296934|FG000|Overall Study|Withdrawal by Subject|4|||
37773143|NCT04029116|69296935|FG001|Overall Study|Withdrawal by Subject|6|||
37773144|NCT04029116|69296934|FG000|Overall Study|Other|2|||
37773145|NCT04029116|69296935|FG001|Overall Study|Other|1|||
37773146|NCT03734029|69296966|FG000|Overall Study|Progressive disease as per RECIST v1.1|220|||
37773147|NCT03734029|69296967|FG001|Overall Study|Progressive disease as per RECIST v1.1|130|||
37773148|NCT03734029|69296966|FG000|Overall Study|Adverse Event|60|||
37773149|NCT03734029|69296967|FG001|Overall Study|Adverse Event|14|||
37773150|NCT03734029|69296966|FG000|Overall Study|Withdrawal by Subject|12|||
37773151|NCT03734029|69296967|FG001|Overall Study|Withdrawal by Subject|11|||
37773152|NCT03734029|69296966|FG000|Overall Study|Clinical progression by investigator|10|||
37773153|NCT03734029|69296967|FG001|Overall Study|Clinical progression by investigator|8|||
37773154|NCT03734029|69296966|FG000|Overall Study|Death|5|||
37773155|NCT03734029|69296967|FG001|Overall Study|Death|2|||
37773156|NCT03734029|69296966|FG000|Overall Study|Physician Decision|4|||
37773157|NCT03734029|69296967|FG001|Overall Study|Physician Decision|3|||
37773158|NCT03734029|69296966|FG000|Overall Study|Other|2|||
37773159|NCT03734029|69296967|FG001|Overall Study|Other|0|||
37773160|NCT03734029|69296966|FG000|Overall Study|Lost to Follow-up|0|||
37773161|NCT03734029|69296967|FG001|Overall Study|Lost to Follow-up|1|||
37773162|NCT03734029|69296966|FG000|Overall Study|Randomized, but not treated|2|||
37773163|NCT03734029|69296967|FG001|Overall Study|Randomized, but not treated|12|||
37773164|NCT03732820|69296975|FG000|Overall Study|Death|143|||
37773165|NCT03732820|69296976|FG001|Overall Study|Death|169|||
37773166|NCT03732820|69296975|FG000|Overall Study|Screen failure|0|||
37773167|NCT03732820|69296976|FG001|Overall Study|Screen failure|1|||
37773168|NCT03732820|69296975|FG000|Overall Study|Ongoing study at data cut off|239|||
37773169|NCT03732820|69296976|FG001|Overall Study|Ongoing study at data cut off|216|||
37773170|NCT03732820|69296975|FG000|Overall Study|Failure to meet randomisation criteria|1|||
37773171|NCT03732820|69296976|FG001|Overall Study|Failure to meet randomisation criteria|1|||
37773172|NCT03732820|69296975|FG000|Overall Study|Lost to Follow-up|1|||
37773173|NCT03732820|69296976|FG001|Overall Study|Lost to Follow-up|0|||
37773174|NCT03732820|69296975|FG000|Overall Study|Patient decision|13|||
37773175|NCT03732820|69296976|FG001|Overall Study|Patient decision|8|||
37773176|NCT03732820|69296975|FG000|Overall Study|Other|2|||
37773177|NCT03732820|69296976|FG001|Overall Study|Other|2|||
37773178|NCT03724032|69296985|FG000|Overall Study|Physician Decision|1|||
37773179|NCT03724032|69296986|FG001|Overall Study|Physician Decision|0|||
37773180|NCT03724032|69296987|FG002|Overall Study|Physician Decision|0|||
37773181|NCT03724032|69296985|FG000|Overall Study|Protocol Violation|2|||
37773182|NCT03724032|69296986|FG001|Overall Study|Protocol Violation|2|||
37773183|NCT03724032|69296987|FG002|Overall Study|Protocol Violation|1|||
37773184|NCT03657797|69297008|FG000|Overall Study|Lost to Follow-up|0|||
37773185|NCT03657797|69297009|FG001|Overall Study|Lost to Follow-up|1|||
37773186|NCT03657797|69297010|FG002|Overall Study|Lost to Follow-up|1|||
37773187|NCT03657797|69297011|FG003|Overall Study|Lost to Follow-up|0|||
37773188|NCT03657797|69297008|FG000|Overall Study|Physician Decision|0|||
37773189|NCT03657797|69297009|FG001|Overall Study|Physician Decision|1|||
37773190|NCT03657797|69297010|FG002|Overall Study|Physician Decision|0|||
37773191|NCT03657797|69297011|FG003|Overall Study|Physician Decision|0|||
37773192|NCT03657797|69297008|FG000|Overall Study|Withdrawal by Subject|0|||
37773193|NCT03657797|69297009|FG001|Overall Study|Withdrawal by Subject|1|||
37773194|NCT03657797|69297010|FG002|Overall Study|Withdrawal by Subject|2|||
37773195|NCT03657797|69297011|FG003|Overall Study|Withdrawal by Subject|0|||
37773196|NCT03657797|69297008|FG000|Overall Study|Adverse Event|0|||
37773197|NCT03657797|69297009|FG001|Overall Study|Adverse Event|0|||
37773198|NCT03657797|69297010|FG002|Overall Study|Adverse Event|2|||
37773199|NCT03657797|69297011|FG003|Overall Study|Adverse Event|0|||
37773200|NCT03551938|69297027|FG000|3-Month Follow Up|Lost to Follow-up|39|||
37773201|NCT03551938|69297028|FG001|3-Month Follow Up|Lost to Follow-up|38|||
37773202|NCT03551938|69297027|FG000|6-Month Follow Up|Lost to Follow-up|46|||
37773203|NCT03551938|69297028|FG001|6-Month Follow Up|Lost to Follow-up|42|||
37773204|NCT03551938|69297027|FG000|9-Month Follow Up|Lost to Follow-up|44|||
37773205|NCT03551938|69297028|FG001|9-Month Follow Up|Lost to Follow-up|43|||
37773206|NCT03525600|69297037|FG000|Overall Study|Adverse Event|9|||
37773207|NCT03525600|69297038|FG001|Overall Study|Adverse Event|6|||
37773208|NCT03525600|69297039|FG002|Overall Study|Adverse Event|5|||
37773209|NCT03525600|69297040|FG003|Overall Study|Adverse Event|3|||
37773210|NCT03525600|69297037|FG000|Overall Study|Lost to Follow-up|2|||
37773211|NCT03525600|69297038|FG001|Overall Study|Lost to Follow-up|4|||
37773212|NCT03525600|69297039|FG002|Overall Study|Lost to Follow-up|4|||
37773213|NCT03525600|69297040|FG003|Overall Study|Lost to Follow-up|0|||
37773214|NCT03525600|69297037|FG000|Overall Study|Physician Decision|1|||
37773215|NCT03525600|69297038|FG001|Overall Study|Physician Decision|0|||
37773216|NCT03525600|69297039|FG002|Overall Study|Physician Decision|2|||
37773217|NCT03525600|69297040|FG003|Overall Study|Physician Decision|0|||
37773218|NCT03525600|69297037|FG000|Overall Study|Consent withdrawal|36|||
37773219|NCT03525600|69297038|FG001|Overall Study|Consent withdrawal|20|||
37773220|NCT03525600|69297039|FG002|Overall Study|Consent withdrawal|6|||
37773221|NCT03525600|69297040|FG003|Overall Study|Consent withdrawal|13|||
37773222|NCT03525600|69297037|FG000|Overall Study|Death|7|||
37773223|NCT03525600|69297038|FG001|Overall Study|Death|6|||
37773224|NCT03525600|69297039|FG002|Overall Study|Death|4|||
37773225|NCT03525600|69297040|FG003|Overall Study|Death|3|||
37773226|NCT03525600|69297037|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
37773227|NCT03525600|69297038|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|10|||
37863605|NCT00996892|69547123|FG005|Expansion Stage 2A|Disease Progression|0|||
37863606|NCT00996892|69547124|FG006|Expansion Stage 2A|Disease Progression|0|||
37863607|NCT00996892|69547125|FG007|Expansion Stage 2A|Disease Progression|0|||
37863608|NCT00996892|69547126|FG008|Expansion Stage 2A|Disease Progression|0|||
37863609|NCT00996892|69547127|FG009|Expansion Stage 2A|Disease Progression|0|||
37863610|NCT00996892|69547128|FG010|Expansion Stage 2A|Disease Progression|0|||
37863611|NCT00996892|69547129|FG011|Expansion Stage 2A|Disease Progression|0|||
37863612|NCT00996892|69547130|FG012|Expansion Stage 2A|Disease Progression|0|||
37863613|NCT00996892|69547131|FG013|Expansion Stage 2A|Disease Progression|0|||
37863614|NCT00996892|69547132|FG014|Expansion Stage 2A|Disease Progression|0|||
37863615|NCT00996892|69547133|FG015|Expansion Stage 2A|Disease Progression|0|||
37863616|NCT00996892|69547134|FG016|Expansion Stage 2A|Disease Progression|0|||
37863617|NCT00996892|69547135|FG017|Expansion Stage 2A|Disease Progression|0|||
37863618|NCT00996892|69547136|FG018|Expansion Stage 2A|Disease Progression|0|||
37863619|NCT00996892|69547137|FG019|Expansion Stage 2A|Disease Progression|31|||
37863620|NCT01257581|69547201|FG000|Overall Study|Early Termination|3|||
37863621|NCT01257581|69547202|FG001|Overall Study|Early Termination|1|||
37863622|NCT01257581|69547203|FG002|Overall Study|Early Termination|2|||
37863623|NCT01257581|69547201|FG000|Overall Study|Death|2|||
37863624|NCT01257581|69547202|FG001|Overall Study|Death|2|||
37863625|NCT01257581|69547203|FG002|Overall Study|Death|4|||
37773228|NCT03525600|69297039|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
37773229|NCT03525600|69297040|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
37773230|NCT03525600|69297037|FG000|Overall Study|Other|0|||
37773231|NCT03525600|69297038|FG001|Overall Study|Other|1|||
37773232|NCT03525600|69297039|FG002|Overall Study|Other|0|||
37773233|NCT03525600|69297040|FG003|Overall Study|Other|0|||
37773234|NCT03472040|69297057|FG000|Overall Study|Physician Decision|0|||
37773235|NCT03472040|69297058|FG001|Overall Study|Physician Decision|3|||
37773236|NCT03472040|69297057|FG000|Overall Study|Withdrawal by Subject|10|||
37773237|NCT03472040|69297058|FG001|Overall Study|Withdrawal by Subject|23|||
37773238|NCT03472040|69297057|FG000|Overall Study|Perceived Lack of Efficacy|29|||
37773239|NCT03472040|69297058|FG001|Overall Study|Perceived Lack of Efficacy|30|||
37773240|NCT03472040|69297057|FG000|Overall Study|Lab Abnormality or Adverse Event (AE)|7|||
37773241|NCT03472040|69297058|FG001|Overall Study|Lab Abnormality or Adverse Event (AE)|25|||
37773242|NCT03472040|69297057|FG000|Overall Study|Intercurrent Illness/Medical Condition|2|||
37773243|NCT03472040|69297058|FG001|Overall Study|Intercurrent Illness/Medical Condition|3|||
37773244|NCT03472040|69297057|FG000|Overall Study|Other - Not Otherwise Specified (NOS)|4|||
37773245|NCT03472040|69297058|FG001|Overall Study|Other - Not Otherwise Specified (NOS)|19|||
37773246|NCT03472040|69297057|FG000|Overall Study|Subject Non-compliance|2|||
37773247|NCT03472040|69297058|FG001|Overall Study|Subject Non-compliance|5|||
37773248|NCT03472040|69297057|FG000|Overall Study|Discontinuation due to Rash|0|||
37773249|NCT03472040|69297058|FG001|Overall Study|Discontinuation due to Rash|1|||
37773250|NCT03472040|69297057|FG000|Overall Study|Subsequent Ineligibility|0|||
37773251|NCT03472040|69297058|FG001|Overall Study|Subsequent Ineligibility|2|||
37773252|NCT03472040|69297057|FG000|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|46|||
37773253|NCT03472040|69297058|FG001|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|175|||
37773254|NCT03323385|69297076|FG000|Overall Study|Withdrawal by Subject|1|||
37773255|NCT03323385|69297077|FG001|Overall Study|Withdrawal by Subject|2|||
37773256|NCT03323385|69297076|FG000|Overall Study|Noncompliance|0|||
37773257|NCT03323385|69297077|FG001|Overall Study|Noncompliance|1|||
37773258|NCT03161483|69297087|FG000|Placebo Controlled Phase|Participant Withdrew Consent|0|||
37773259|NCT03161483|69297088|FG001|Placebo Controlled Phase|Participant Withdrew Consent|1|||
37773260|NCT03161483|69297089|FG002|Placebo Controlled Phase|Participant Withdrew Consent|0|||
37773261|NCT03161483|69297090|FG003|Placebo Controlled Phase|Participant Withdrew Consent|0|||
37773262|NCT03161483|69297087|FG000|Treatment Period|Death|1|||
37773263|NCT03161483|69297088|FG001|Treatment Period|Death|0|||
37773264|NCT03161483|69297089|FG002|Treatment Period|Death|0|||
37773265|NCT03161483|69297090|FG003|Treatment Period|Death|0|||
37773266|NCT03161483|69297087|FG000|Treatment Period|Adverse Event|5|||
37773267|NCT03161483|69297088|FG001|Treatment Period|Adverse Event|2|||
37773268|NCT03161483|69297089|FG002|Treatment Period|Adverse Event|1|||
37773269|NCT03161483|69297090|FG003|Treatment Period|Adverse Event|11|||
37773270|NCT03161483|69297087|FG000|Treatment Period|Pregnancy|1|||
37773271|NCT03161483|69297088|FG001|Treatment Period|Pregnancy|0|||
37773272|NCT03161483|69297089|FG002|Treatment Period|Pregnancy|0|||
37773273|NCT03161483|69297090|FG003|Treatment Period|Pregnancy|0|||
37773274|NCT03161483|69297087|FG000|Treatment Period|Lack of Efficacy|0|||
37773275|NCT03161483|69297088|FG001|Treatment Period|Lack of Efficacy|0|||
37773276|NCT03161483|69297089|FG002|Treatment Period|Lack of Efficacy|0|||
37773277|NCT03161483|69297090|FG003|Treatment Period|Lack of Efficacy|1|||
37773278|NCT03161483|69297087|FG000|Treatment Period|Withdrawal by Subject|2|||
37773279|NCT03161483|69297088|FG001|Treatment Period|Withdrawal by Subject|5|||
37773280|NCT03161483|69297089|FG002|Treatment Period|Withdrawal by Subject|2|||
37773281|NCT03161483|69297090|FG003|Treatment Period|Withdrawal by Subject|6|||
37773282|NCT03161483|69297087|FG000|Treatment Period|Lost to Follow-up|0|||
37773283|NCT03161483|69297088|FG001|Treatment Period|Lost to Follow-up|0|||
37773284|NCT03161483|69297089|FG002|Treatment Period|Lost to Follow-up|0|||
37773285|NCT03161483|69297090|FG003|Treatment Period|Lost to Follow-up|1|||
37690467|NCT02175771|69166759|FG005|Treatment Period|Disease progression|0|||
37690468|NCT02175771|69166760|FG006|Treatment Period|Disease progression|0|||
37690469|NCT02175771|69166761|FG007|Treatment Period|Disease progression|2|||
37690470|NCT02175771|69166762|FG008|Treatment Period|Disease progression|0|||
37690471|NCT02175771|69166754|FG000|Treatment Period|Lost to Follow-up|0|||
37690472|NCT02175771|69166755|FG001|Treatment Period|Lost to Follow-up|3|||
37690473|NCT02175771|69166756|FG002|Treatment Period|Lost to Follow-up|1|||
37690474|NCT02175771|69166757|FG003|Treatment Period|Lost to Follow-up|3|||
37690475|NCT02175771|69166758|FG004|Treatment Period|Lost to Follow-up|1|||
37690476|NCT02175771|69166759|FG005|Treatment Period|Lost to Follow-up|2|||
37690477|NCT02175771|69166760|FG006|Treatment Period|Lost to Follow-up|1|||
37690478|NCT02175771|69166761|FG007|Treatment Period|Lost to Follow-up|2|||
37690479|NCT02175771|69166762|FG008|Treatment Period|Lost to Follow-up|2|||
37690480|NCT02175771|69166754|FG000|Treatment Period|Lack of Efficacy|0|||
37773286|NCT03161483|69297087|FG000|Treatment Period|Protocol Violation|0|||
37773287|NCT03161483|69297088|FG001|Treatment Period|Protocol Violation|0|||
37690481|NCT02175771|69166755|FG001|Treatment Period|Lack of Efficacy|0|||
37690482|NCT02175771|69166756|FG002|Treatment Period|Lack of Efficacy|0|||
37690483|NCT02175771|69166757|FG003|Treatment Period|Lack of Efficacy|0|||
37690484|NCT02175771|69166758|FG004|Treatment Period|Lack of Efficacy|0|||
37690485|NCT02175771|69166759|FG005|Treatment Period|Lack of Efficacy|1|||
37690486|NCT02175771|69166760|FG006|Treatment Period|Lack of Efficacy|0|||
37690487|NCT02175771|69166761|FG007|Treatment Period|Lack of Efficacy|1|||
37690488|NCT02175771|69166762|FG008|Treatment Period|Lack of Efficacy|0|||
37773288|NCT03161483|69297089|FG002|Treatment Period|Protocol Violation|0|||
37773289|NCT03161483|69297090|FG003|Treatment Period|Protocol Violation|1|||
37773290|NCT03161483|69297087|FG000|Treatment Period|Other reasons|1|||
37773291|NCT03161483|69297088|FG001|Treatment Period|Other reasons|1|||
37773292|NCT03161483|69297089|FG002|Treatment Period|Other reasons|0|||
37773293|NCT03161483|69297090|FG003|Treatment Period|Other reasons|0|||
37863626|NCT01257503|69547213|FG000|Overall Study|Lost to Follow-up|7|||
37863627|NCT01257503|69547214|FG001|Overall Study|Lost to Follow-up|10|||
37773294|NCT03132636|69297104|FG000|Overall Study|Adverse Event|1|||
37773295|NCT03132636|69297105|FG001|Overall Study|Adverse Event|2|||
37773296|NCT03132636|69297104|FG000|Overall Study|Death|4|||
37773297|NCT03132636|69297105|FG001|Overall Study|Death|7|||
37773298|NCT03132636|69297104|FG000|Overall Study|Lost to Follow-up|2|||
37773299|NCT03132636|69297105|FG001|Overall Study|Lost to Follow-up|2|||
37773300|NCT03132636|69297104|FG000|Overall Study|Protocol Violation|1|||
37773301|NCT03132636|69297105|FG001|Overall Study|Protocol Violation|1|||
37773302|NCT03132636|69297104|FG000|Overall Study|Participant Decision|1|||
37773303|NCT03132636|69297105|FG001|Overall Study|Participant Decision|9|||
37773304|NCT03132636|69297104|FG000|Overall Study|Sponsor Decision|0|||
37773305|NCT03132636|69297105|FG001|Overall Study|Sponsor Decision|1|||
37773306|NCT03132636|69297104|FG000|Overall Study|Progressive disease|32|||
37773307|NCT03132636|69297105|FG001|Overall Study|Progressive disease|36|||
37773308|NCT03132636|69297104|FG000|Overall Study|Withdrawal of consent|2|||
37773309|NCT03132636|69297105|FG001|Overall Study|Withdrawal of consent|5|||
37773310|NCT03132636|69297104|FG000|Overall Study|Study ongoing|9|||
37773311|NCT03132636|69297105|FG001|Overall Study|Study ongoing|10|||
37773312|NCT03132636|69297104|FG000|Overall Study|Other|1|||
37773313|NCT03132636|69297105|FG001|Overall Study|Other|2|||
37773314|NCT02906202|69297111|FG000|Overall Study|Discontinued after mobilization due to pregnancy|1|||
37773315|NCT02869789|69297119|FG000|Overall Study|Disease progression|184|||
37773316|NCT02869789|69297120|FG001|Overall Study|Disease progression|109|||
37773317|NCT02869789|69297121|FG002|Overall Study|Disease progression|260|||
37690489|NCT02175771|69166754|FG000|Treatment Period|Other|0|||
37690490|NCT02175771|69166755|FG001|Treatment Period|Other|1|||
37690491|NCT02175771|69166756|FG002|Treatment Period|Other|0|||
37690492|NCT02175771|69166757|FG003|Treatment Period|Other|3|||
37690493|NCT02175771|69166758|FG004|Treatment Period|Other|1|||
37690494|NCT02175771|69166759|FG005|Treatment Period|Other|0|||
37690495|NCT02175771|69166760|FG006|Treatment Period|Other|0|||
37690496|NCT02175771|69166761|FG007|Treatment Period|Other|2|||
37690497|NCT02175771|69166762|FG008|Treatment Period|Other|0|||
37690498|NCT01657799|69166783|FG000|Overall Study|Adverse Event Related to progression|6|||
37690499|NCT01657799|69166784|FG001|Overall Study|Adverse Event Related to progression|8|||
37690500|NCT01657799|69166785|FG002|Overall Study|Adverse Event Related to progression|12|||
37690501|NCT01657799|69166783|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
37690502|NCT01657799|69166784|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
37690503|NCT01657799|69166785|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
37690504|NCT01657799|69166783|FG000|Overall Study|Withdrawal by Subject|13|||
37690505|NCT01657799|69166784|FG001|Overall Study|Withdrawal by Subject|10|||
37773318|NCT02869789|69297122|FG003|Overall Study|Disease progression|19|||
37773319|NCT02869789|69297119|FG000|Overall Study|Study drug toxicity|90|||
37773320|NCT02869789|69297120|FG001|Overall Study|Study drug toxicity|32|||
37773321|NCT02869789|69297121|FG002|Overall Study|Study drug toxicity|55|||
37773322|NCT02869789|69297122|FG003|Overall Study|Study drug toxicity|14|||
37773323|NCT02869789|69297119|FG000|Overall Study|Death|7|||
37773324|NCT02869789|69297120|FG001|Overall Study|Death|3|||
37773325|NCT02869789|69297121|FG002|Overall Study|Death|5|||
37773326|NCT02869789|69297122|FG003|Overall Study|Death|1|||
37773327|NCT02869789|69297119|FG000|Overall Study|Adverse Event unrelated to study drug|30|||
37773328|NCT02869789|69297120|FG001|Overall Study|Adverse Event unrelated to study drug|18|||
37773329|NCT02869789|69297121|FG002|Overall Study|Adverse Event unrelated to study drug|21|||
37773330|NCT02869789|69297122|FG003|Overall Study|Adverse Event unrelated to study drug|6|||
37968223|NCT02425826|69655345|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
37968224|NCT02425826|69655343|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
37968225|NCT02425826|69655344|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
37968226|NCT02425826|69655345|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
37968227|NCT02406027|69655358|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
37968228|NCT02406027|69655359|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
37968229|NCT02406027|69655360|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
37968230|NCT02406027|69655361|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
37968231|NCT02406027|69655362|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
37968232|NCT02406027|69655363|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
37968233|NCT02406027|69655364|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
37968234|NCT02406027|69655358|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
37968235|NCT02406027|69655359|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
37968236|NCT02406027|69655360|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
37968237|NCT02406027|69655361|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
37968238|NCT02406027|69655362|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
37968239|NCT02406027|69655363|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
37968240|NCT02406027|69655364|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
37968241|NCT02406027|69655358|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
37968242|NCT02406027|69655359|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
37968243|NCT02406027|69655360|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
37968244|NCT02406027|69655361|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
37968245|NCT02406027|69655362|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
37968246|NCT02406027|69655363|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
37968247|NCT02406027|69655364|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
37968248|NCT02406027|69655358|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
37968249|NCT02406027|69655359|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
37968250|NCT02406027|69655360|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
37968251|NCT02406027|69655361|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
37968252|NCT02406027|69655362|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
37773331|NCT02869789|69297119|FG000|Overall Study|Participant request to discontinue study treatment|10|||
37773332|NCT02869789|69297120|FG001|Overall Study|Participant request to discontinue study treatment|5|||
37773333|NCT02869789|69297121|FG002|Overall Study|Participant request to discontinue study treatment|5|||
37773334|NCT02869789|69297122|FG003|Overall Study|Participant request to discontinue study treatment|3|||
37773335|NCT02869789|69297119|FG000|Overall Study|Withdrawal by Subject|5|||
37773336|NCT02869789|69297120|FG001|Overall Study|Withdrawal by Subject|2|||
37773337|NCT02869789|69297121|FG002|Overall Study|Withdrawal by Subject|7|||
37773338|NCT02869789|69297122|FG003|Overall Study|Withdrawal by Subject|2|||
37773339|NCT02869789|69297119|FG000|Overall Study|Lost to Follow-up|0|||
37773340|NCT02869789|69297120|FG001|Overall Study|Lost to Follow-up|0|||
37773341|NCT02869789|69297121|FG002|Overall Study|Lost to Follow-up|2|||
37773342|NCT02869789|69297122|FG003|Overall Study|Lost to Follow-up|0|||
37773343|NCT02869789|69297119|FG000|Overall Study|Maximum clinical benefit|5|||
37773344|NCT02869789|69297120|FG001|Overall Study|Maximum clinical benefit|2|||
37773345|NCT02869789|69297121|FG002|Overall Study|Maximum clinical benefit|1|||
37773346|NCT02869789|69297122|FG003|Overall Study|Maximum clinical benefit|0|||
37773347|NCT02869789|69297119|FG000|Overall Study|Poor/Non-compliance|0|||
37773348|NCT02869789|69297120|FG001|Overall Study|Poor/Non-compliance|2|||
37773349|NCT02869789|69297121|FG002|Overall Study|Poor/Non-compliance|1|||
37773350|NCT02869789|69297122|FG003|Overall Study|Poor/Non-compliance|0|||
37773351|NCT02869789|69297119|FG000|Overall Study|Participant no longer meets study criteria|0|||
37773352|NCT02869789|69297120|FG001|Overall Study|Participant no longer meets study criteria|1|||
37773353|NCT02869789|69297121|FG002|Overall Study|Participant no longer meets study criteria|1|||
37773354|NCT02869789|69297122|FG003|Overall Study|Participant no longer meets study criteria|0|||
37773355|NCT02869789|69297119|FG000|Overall Study|Administrative reason by sponsor|0|||
37773356|NCT02869789|69297120|FG001|Overall Study|Administrative reason by sponsor|0|||
37773357|NCT02869789|69297121|FG002|Overall Study|Administrative reason by sponsor|1|||
37773358|NCT02869789|69297122|FG003|Overall Study|Administrative reason by sponsor|0|||
37773359|NCT02869789|69297119|FG000|Overall Study|Other reasons|4|||
37773360|NCT02869789|69297120|FG001|Overall Study|Other reasons|8|||
37773361|NCT02869789|69297121|FG002|Overall Study|Other reasons|6|||
37773362|NCT02869789|69297122|FG003|Overall Study|Other reasons|0|||
37773363|NCT02760485|69297143|FG000|Phase 1|Death|3|||
37773364|NCT02760485|69297144|FG001|Phase 1|Death|6|||
37773365|NCT02760485|69297145|FG002|Phase 1|Death|0|||
37773366|NCT02760485|69297143|FG000|Phase 1|Withdrawal by Subject|2|||
37773367|NCT02760485|69297144|FG001|Phase 1|Withdrawal by Subject|0|||
37773368|NCT02760485|69297145|FG002|Phase 1|Withdrawal by Subject|0|||
37773369|NCT02760485|69297143|FG000|Phase 1|Progressive Disease|1|||
37773370|NCT02760485|69297144|FG001|Phase 1|Progressive Disease|0|||
37773371|NCT02760485|69297145|FG002|Phase 1|Progressive Disease|0|||
37773372|NCT02760485|69297143|FG000|Phase 1|Amendment Removed Survival Follow-up|0|||
37773373|NCT02760485|69297144|FG001|Phase 1|Amendment Removed Survival Follow-up|1|||
37773374|NCT02760485|69297145|FG002|Phase 1|Amendment Removed Survival Follow-up|0|||
37773375|NCT02760485|69297143|FG000|Phase 1|Unknown; Did Not Complete End-of-Study Visit|1|||
37773376|NCT02760485|69297144|FG001|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
37773377|NCT02760485|69297145|FG002|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
37773378|NCT02760485|69297143|FG000|Phase 2|Death|0|||
37773379|NCT02760485|69297144|FG001|Phase 2|Death|0|||
37773380|NCT02760485|69297145|FG002|Phase 2|Death|12|||
37773381|NCT02760485|69297143|FG000|Phase 2|Withdrawal by Subject|0|||
37773382|NCT02760485|69297144|FG001|Phase 2|Withdrawal by Subject|0|||
37773383|NCT02760485|69297145|FG002|Phase 2|Withdrawal by Subject|3|||
37773384|NCT02760485|69297143|FG000|Phase 2|Progressive Disease|0|||
37773385|NCT02760485|69297144|FG001|Phase 2|Progressive Disease|0|||
37773386|NCT02760485|69297145|FG002|Phase 2|Progressive Disease|1|||
37773387|NCT02760485|69297143|FG000|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
37773388|NCT02760485|69297144|FG001|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
37773389|NCT02760485|69297145|FG002|Phase 2|Unknown; Did Not Complete End-of-Study Visit|3|||
37773390|NCT02634333|69297180|FG000|Overall Study|Completed out of Window|3|||
37773391|NCT02634333|69297181|FG001|Overall Study|Completed out of Window|2|||
37773392|NCT02634333|69297180|FG000|Overall Study|Missed Visit|5|||
37773393|NCT02634333|69297181|FG001|Overall Study|Missed Visit|2|||
37773394|NCT02634333|69297180|FG000|Overall Study|Lost to Follow-up|12|||
37773395|NCT02634333|69297181|FG001|Overall Study|Lost to Follow-up|7|||
37773396|NCT02634333|69297180|FG000|Overall Study|Withdrawal by Subject|9|||
37773397|NCT02634333|69297181|FG001|Overall Study|Withdrawal by Subject|13|||
37773398|NCT02634333|69297180|FG000|Overall Study|Death|11|||
37773399|NCT02634333|69297181|FG001|Overall Study|Death|8|||
37773400|NCT02515630|69297190|FG000|Overall Study|Withdrawal by Subject|5|||
37773401|NCT02515630|69297190|FG000|Overall Study|Adverse Event|4|||
37773402|NCT02515630|69297190|FG000|Overall Study|Physician Decision|4|||
37773403|NCT02515630|69297190|FG000|Overall Study|Death|2|||
37773404|NCT02515630|69297190|FG000|Overall Study|Disease Progression|1|||
37773405|NCT02450331|69297199|FG000|Overall Study|Death|162|||
37690506|NCT01657799|69166785|FG002|Overall Study|Withdrawal by Subject|10|||
37690507|NCT01657799|69166783|FG000|Overall Study|Lost to Follow-up|1|||
37690508|NCT01657799|69166784|FG001|Overall Study|Lost to Follow-up|0|||
37690509|NCT01657799|69166785|FG002|Overall Study|Lost to Follow-up|1|||
37690510|NCT01657799|69166783|FG000|Overall Study|Disease Progression|2|||
37690511|NCT01657799|69166784|FG001|Overall Study|Disease Progression|4|||
37690512|NCT01657799|69166785|FG002|Overall Study|Disease Progression|4|||
37773406|NCT02450331|69297200|FG001|Overall Study|Death|171|||
37773407|NCT02450331|69297199|FG000|Overall Study|Lost to Follow-up|14|||
37690513|NCT01657799|69166783|FG000|Overall Study|Progressive Disease Clinical|7|||
37690514|NCT01657799|69166784|FG001|Overall Study|Progressive Disease Clinical|4|||
37773408|NCT02450331|69297200|FG001|Overall Study|Lost to Follow-up|12|||
37773409|NCT02450331|69297199|FG000|Overall Study|Withdrawal by Subject|55|||
37773410|NCT02450331|69297200|FG001|Overall Study|Withdrawal by Subject|44|||
37773411|NCT02450331|69297199|FG000|Overall Study|Non-specified other|1|||
37773412|NCT02450331|69297200|FG001|Overall Study|Non-specified other|1|||
37773413|NCT02335944|69297217|FG000|Treatment Phase|Progressive Disease|2|||
37773414|NCT02335944|69297218|FG001|Treatment Phase|Progressive Disease|5|||
37773415|NCT02335944|69297219|FG002|Treatment Phase|Progressive Disease|2|||
37773416|NCT02335944|69297220|FG003|Treatment Phase|Progressive Disease|11|||
37773417|NCT02335944|69297221|FG004|Treatment Phase|Progressive Disease|4|||
37773418|NCT02335944|69297222|FG005|Treatment Phase|Progressive Disease|25|||
37773419|NCT02335944|69297223|FG006|Treatment Phase|Progressive Disease|2|||
37773420|NCT02335944|69297224|FG007|Treatment Phase|Progressive Disease|30|||
37773421|NCT02335944|69297225|FG008|Treatment Phase|Progressive Disease|27|||
37773422|NCT02335944|69297226|FG009|Treatment Phase|Progressive Disease|0|||
37773423|NCT02335944|69297217|FG000|Treatment Phase|Adverse Event|2|||
37773424|NCT02335944|69297218|FG001|Treatment Phase|Adverse Event|0|||
37773425|NCT02335944|69297219|FG002|Treatment Phase|Adverse Event|0|||
37773426|NCT02335944|69297220|FG003|Treatment Phase|Adverse Event|2|||
37773427|NCT02335944|69297221|FG004|Treatment Phase|Adverse Event|1|||
37773428|NCT02335944|69297222|FG005|Treatment Phase|Adverse Event|15|||
37773429|NCT02335944|69297223|FG006|Treatment Phase|Adverse Event|0|||
37773430|NCT02335944|69297224|FG007|Treatment Phase|Adverse Event|5|||
37773431|NCT02335944|69297225|FG008|Treatment Phase|Adverse Event|7|||
37773432|NCT02335944|69297226|FG009|Treatment Phase|Adverse Event|0|||
37773433|NCT02335944|69297217|FG000|Treatment Phase|Physician Decision|0|||
37773434|NCT02335944|69297218|FG001|Treatment Phase|Physician Decision|0|||
37773435|NCT02335944|69297219|FG002|Treatment Phase|Physician Decision|0|||
37773436|NCT02335944|69297220|FG003|Treatment Phase|Physician Decision|1|||
37773437|NCT02335944|69297221|FG004|Treatment Phase|Physician Decision|0|||
37773438|NCT02335944|69297222|FG005|Treatment Phase|Physician Decision|6|||
37773439|NCT02335944|69297223|FG006|Treatment Phase|Physician Decision|1|||
37773440|NCT02335944|69297224|FG007|Treatment Phase|Physician Decision|2|||
37773441|NCT02335944|69297225|FG008|Treatment Phase|Physician Decision|1|||
37773442|NCT02335944|69297226|FG009|Treatment Phase|Physician Decision|0|||
37773443|NCT02335944|69297217|FG000|Treatment Phase|Study Terminated By Sponsor|0|||
37773444|NCT02335944|69297218|FG001|Treatment Phase|Study Terminated By Sponsor|0|||
37773445|NCT02335944|69297219|FG002|Treatment Phase|Study Terminated By Sponsor|0|||
37773446|NCT02335944|69297220|FG003|Treatment Phase|Study Terminated By Sponsor|1|||
37773447|NCT02335944|69297221|FG004|Treatment Phase|Study Terminated By Sponsor|0|||
37773448|NCT02335944|69297222|FG005|Treatment Phase|Study Terminated By Sponsor|3|||
37773449|NCT02335944|69297223|FG006|Treatment Phase|Study Terminated By Sponsor|0|||
37773450|NCT02335944|69297224|FG007|Treatment Phase|Study Terminated By Sponsor|1|||
37773451|NCT02335944|69297225|FG008|Treatment Phase|Study Terminated By Sponsor|1|||
37773452|NCT02335944|69297226|FG009|Treatment Phase|Study Terminated By Sponsor|0|||
37773453|NCT02335944|69297217|FG000|Treatment Phase|Subject/Guardian Decision|0|||
37773454|NCT02335944|69297218|FG001|Treatment Phase|Subject/Guardian Decision|0|||
37773455|NCT02335944|69297219|FG002|Treatment Phase|Subject/Guardian Decision|1|||
37773456|NCT02335944|69297220|FG003|Treatment Phase|Subject/Guardian Decision|0|||
37773457|NCT02335944|69297221|FG004|Treatment Phase|Subject/Guardian Decision|0|||
37773458|NCT02335944|69297222|FG005|Treatment Phase|Subject/Guardian Decision|1|||
37773459|NCT02335944|69297223|FG006|Treatment Phase|Subject/Guardian Decision|0|||
37773460|NCT02335944|69297224|FG007|Treatment Phase|Subject/Guardian Decision|4|||
37773461|NCT02335944|69297225|FG008|Treatment Phase|Subject/Guardian Decision|0|||
37968253|NCT02406027|69655363|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
37690515|NCT01657799|69166785|FG002|Overall Study|Progressive Disease Clinical|7|||
37690516|NCT01657799|69166783|FG000|Overall Study|Radiographic & Clinical Progression|16|||
37690517|NCT01657799|69166784|FG001|Overall Study|Radiographic & Clinical Progression|11|||
37690518|NCT01657799|69166785|FG002|Overall Study|Radiographic & Clinical Progression|15|||
37690519|NCT01657799|69166783|FG000|Overall Study|Other|52|||
37690520|NCT01657799|69166784|FG001|Overall Study|Other|62|||
37690521|NCT01657799|69166785|FG002|Overall Study|Other|49|||
37690522|NCT02116803|69166795|FG000|Overall Study|Adverse Event|2|||
37690523|NCT02116803|69166796|FG001|Overall Study|Adverse Event|1|||
37690524|NCT02116803|69166795|FG000|Overall Study|Physician Decision|1|||
37773462|NCT02335944|69297226|FG009|Treatment Phase|Subject/Guardian Decision|0|||
37773463|NCT02335944|69297217|FG000|Post-treatment Follow-up|Progressive Disease|0|||
37773464|NCT02335944|69297218|FG001|Post-treatment Follow-up|Progressive Disease|0|||
37773465|NCT02335944|69297219|FG002|Post-treatment Follow-up|Progressive Disease|0|||
37773466|NCT02335944|69297220|FG003|Post-treatment Follow-up|Progressive Disease|1|||
37773467|NCT02335944|69297221|FG004|Post-treatment Follow-up|Progressive Disease|0|||
37773468|NCT02335944|69297222|FG005|Post-treatment Follow-up|Progressive Disease|9|||
37773469|NCT02335944|69297223|FG006|Post-treatment Follow-up|Progressive Disease|0|||
37773470|NCT02335944|69297224|FG007|Post-treatment Follow-up|Progressive Disease|2|||
37773471|NCT02335944|69297225|FG008|Post-treatment Follow-up|Progressive Disease|3|||
37773472|NCT02335944|69297226|FG009|Post-treatment Follow-up|Progressive Disease|0|||
37773473|NCT02335944|69297217|FG000|Post-treatment Follow-up|Subject/Guardian Decision|0|||
37690525|NCT02116803|69166796|FG001|Overall Study|Physician Decision|0|||
37690526|NCT02116803|69166795|FG000|Overall Study|Progressive disease|4|||
37690527|NCT02116803|69166796|FG001|Overall Study|Progressive disease|0|||
37690528|NCT02116803|69166795|FG000|Overall Study|Study terminated by sponsor|2|||
37690529|NCT02116803|69166796|FG001|Overall Study|Study terminated by sponsor|1|||
37863628|NCT01257503|69547213|FG000|Overall Study|Over 5 years old at enrollment|0|||
37690530|NCT02116803|69166795|FG000|Overall Study|Death|1|||
37690531|NCT02116803|69166796|FG001|Overall Study|Death|0|||
37690532|NCT02115321|69166804|FG000|Overall Study|Death|1|||
37690533|NCT02115321|69166805|FG001|Overall Study|Death|0|||
37690534|NCT02367781|69166813|FG000|Overall Study|Withdrawal by Subject|20|||
37690535|NCT02367781|69166814|FG001|Overall Study|Withdrawal by Subject|13|||
37690536|NCT02367781|69166813|FG000|Overall Study|Protocol Violation|0|||
37690537|NCT02367781|69166814|FG001|Overall Study|Protocol Violation|1|||
37690538|NCT02367781|69166813|FG000|Overall Study|Physician Decision|7|||
37690539|NCT02367781|69166814|FG001|Overall Study|Physician Decision|0|||
37690540|NCT02367781|69166813|FG000|Overall Study|Randomized in Error|5|||
37690541|NCT02367781|69166814|FG001|Overall Study|Randomized in Error|4|||
37690542|NCT02367781|69166813|FG000|Overall Study|Non-Compliance|1|||
37690543|NCT02367781|69166814|FG001|Overall Study|Non-Compliance|0|||
37690544|NCT02367781|69166813|FG000|Overall Study|Lost to Follow-up|1|||
37690545|NCT02367781|69166814|FG001|Overall Study|Lost to Follow-up|2|||
37690546|NCT02367781|69166813|FG000|Overall Study|Death|330|||
37690547|NCT02367781|69166814|FG001|Overall Study|Death|176|||
37690548|NCT02367781|69166813|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
37773474|NCT02335944|69297218|FG001|Post-treatment Follow-up|Subject/Guardian Decision|0|||
37773475|NCT02335944|69297219|FG002|Post-treatment Follow-up|Subject/Guardian Decision|0|||
37773476|NCT02335944|69297220|FG003|Post-treatment Follow-up|Subject/Guardian Decision|0|||
37773477|NCT02335944|69297221|FG004|Post-treatment Follow-up|Subject/Guardian Decision|0|||
37773478|NCT02335944|69297222|FG005|Post-treatment Follow-up|Subject/Guardian Decision|2|||
37773479|NCT02335944|69297223|FG006|Post-treatment Follow-up|Subject/Guardian Decision|0|||
37773480|NCT02335944|69297224|FG007|Post-treatment Follow-up|Subject/Guardian Decision|0|||
37773481|NCT02335944|69297225|FG008|Post-treatment Follow-up|Subject/Guardian Decision|0|||
37773482|NCT02335944|69297226|FG009|Post-treatment Follow-up|Subject/Guardian Decision|0|||
37773483|NCT02335944|69297217|FG000|Post-treatment Follow-up|Terminated by Sponsor|0|||
37773484|NCT02335944|69297218|FG001|Post-treatment Follow-up|Terminated by Sponsor|0|||
37773485|NCT02335944|69297219|FG002|Post-treatment Follow-up|Terminated by Sponsor|0|||
37773486|NCT02335944|69297220|FG003|Post-treatment Follow-up|Terminated by Sponsor|0|||
37773487|NCT02335944|69297221|FG004|Post-treatment Follow-up|Terminated by Sponsor|0|||
37773488|NCT02335944|69297222|FG005|Post-treatment Follow-up|Terminated by Sponsor|0|||
37773489|NCT02335944|69297223|FG006|Post-treatment Follow-up|Terminated by Sponsor|0|||
37773490|NCT02335944|69297224|FG007|Post-treatment Follow-up|Terminated by Sponsor|2|||
37773491|NCT02335944|69297225|FG008|Post-treatment Follow-up|Terminated by Sponsor|0|||
37773492|NCT02335944|69297226|FG009|Post-treatment Follow-up|Terminated by Sponsor|0|||
37773493|NCT02335944|69297217|FG000|Post-treatment Follow-up|Adverse Event|0|||
37773494|NCT02335944|69297218|FG001|Post-treatment Follow-up|Adverse Event|0|||
37773495|NCT02335944|69297219|FG002|Post-treatment Follow-up|Adverse Event|0|||
37690549|NCT02367781|69166814|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
37690550|NCT02367781|69166813|FG000|Overall Study|Prolonged Hospitalization|1|||
37690551|NCT02367781|69166814|FG001|Overall Study|Prolonged Hospitalization|0|||
37690552|NCT02367781|69166813|FG000|Overall Study|Death Prior First Dose|1|||
37690553|NCT02367781|69166814|FG001|Overall Study|Death Prior First Dose|0|||
37690554|NCT02367781|69166813|FG000|Overall Study|Administrative-Change Facility|1|||
37690555|NCT02367781|69166814|FG001|Overall Study|Administrative-Change Facility|0|||
37690556|NCT02367781|69166813|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
37690557|NCT02367781|69166814|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
37690558|NCT02367781|69166813|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
37690559|NCT02367781|69166814|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
37690560|NCT02367781|69166813|FG000|Overall Study|Study Terminated by Sponsor|3|||
37690561|NCT02367781|69166814|FG001|Overall Study|Study Terminated by Sponsor|1|||
37690562|NCT02367781|69166813|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
37690563|NCT02367781|69166814|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
37690564|NCT02367781|69166813|FG000|Overall Study|Sponsor Decision|2|||
37690565|NCT02367781|69166814|FG001|Overall Study|Sponsor Decision|0|||
37690566|NCT02367781|69166813|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
37699581|NCT02011893|69176449|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
37773496|NCT02335944|69297220|FG003|Post-treatment Follow-up|Adverse Event|0|||
37773497|NCT02335944|69297221|FG004|Post-treatment Follow-up|Adverse Event|0|||
37773498|NCT02335944|69297222|FG005|Post-treatment Follow-up|Adverse Event|1|||
37773499|NCT02335944|69297223|FG006|Post-treatment Follow-up|Adverse Event|0|||
37773500|NCT02335944|69297224|FG007|Post-treatment Follow-up|Adverse Event|0|||
37773501|NCT02335944|69297225|FG008|Post-treatment Follow-up|Adverse Event|0|||
37773502|NCT02335944|69297226|FG009|Post-treatment Follow-up|Adverse Event|0|||
37773503|NCT02335944|69297217|FG000|Post-treatment Follow-up|Death|0|||
37773504|NCT02335944|69297218|FG001|Post-treatment Follow-up|Death|0|||
37773505|NCT02335944|69297219|FG002|Post-treatment Follow-up|Death|0|||
37773506|NCT02335944|69297220|FG003|Post-treatment Follow-up|Death|1|||
37773507|NCT02335944|69297221|FG004|Post-treatment Follow-up|Death|0|||
37773508|NCT02335944|69297222|FG005|Post-treatment Follow-up|Death|1|||
37773509|NCT02335944|69297223|FG006|Post-treatment Follow-up|Death|0|||
37773510|NCT02335944|69297224|FG007|Post-treatment Follow-up|Death|0|||
37773511|NCT02335944|69297225|FG008|Post-treatment Follow-up|Death|0|||
37773512|NCT02335944|69297226|FG009|Post-treatment Follow-up|Death|0|||
37773513|NCT02335944|69297217|FG000|Post-treatment Follow-up|Physician Decision|1|||
37863629|NCT01257503|69547214|FG001|Overall Study|Over 5 years old at enrollment|1|||
37863630|NCT01257503|69547213|FG000|Overall Study|strep culture positive at enrollment|1|||
37968254|NCT02406027|69655364|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
37690567|NCT02367781|69166814|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
37690568|NCT02152761|69166826|FG000|Epoch: Treatment Epoch|Technical problems|0|||
37690569|NCT02152761|69166827|FG001|Epoch: Treatment Epoch|Technical problems|0|||
37690570|NCT02152761|69166828|FG002|Epoch: Treatment Epoch|Technical problems|0|||
37690571|NCT02152761|69166829|FG003|Epoch: Treatment Epoch|Technical problems|1|||
37690572|NCT02152761|69166826|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
37690573|NCT02152761|69166827|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
37690574|NCT02152761|69166828|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
37690575|NCT02152761|69166829|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
37690576|NCT02152761|69166826|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
37690577|NCT02152761|69166827|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
37690578|NCT02152761|69166828|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
37690579|NCT02152761|69166829|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
37690580|NCT02152761|69166826|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
37690581|NCT02152761|69166827|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
37690582|NCT02152761|69166828|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
37690583|NCT02152761|69166829|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
37690584|NCT02152761|69166826|FG000|Epoch: Treatment Epoch|Death|0|||
37773514|NCT02335944|69297218|FG001|Post-treatment Follow-up|Physician Decision|0|||
37773515|NCT02335944|69297219|FG002|Post-treatment Follow-up|Physician Decision|0|||
37773516|NCT02335944|69297220|FG003|Post-treatment Follow-up|Physician Decision|0|||
37773517|NCT02335944|69297221|FG004|Post-treatment Follow-up|Physician Decision|0|||
37773518|NCT02335944|69297222|FG005|Post-treatment Follow-up|Physician Decision|0|||
37773519|NCT02335944|69297223|FG006|Post-treatment Follow-up|Physician Decision|0|||
37773520|NCT02335944|69297224|FG007|Post-treatment Follow-up|Physician Decision|1|||
37773521|NCT02335944|69297225|FG008|Post-treatment Follow-up|Physician Decision|0|||
37773522|NCT02335944|69297226|FG009|Post-treatment Follow-up|Physician Decision|0|||
37773523|NCT02326974|69297264|FG000|Overall Study|Withdrawal by Subject|2|||
37773524|NCT02326974|69297264|FG000|Overall Study|failed heterogenity evaluation|5|||
37773525|NCT02200445|69297312|FG000|Overall Study|Lack of Efficacy|1|||
37773526|NCT02200445|69297313|FG001|Overall Study|Lack of Efficacy|2|||
37773527|NCT02200445|69297314|FG002|Overall Study|Lack of Efficacy|2|||
37773528|NCT02200445|69297312|FG000|Overall Study|Adverse Event|0|||
37773529|NCT02200445|69297313|FG001|Overall Study|Adverse Event|2|||
37773530|NCT02200445|69297314|FG002|Overall Study|Adverse Event|0|||
37773531|NCT02120352|69297322|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
37773532|NCT02120352|69297323|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
37773533|NCT02120352|69297324|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
37773534|NCT02120352|69297325|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
37773535|NCT02120352|69297322|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
37773536|NCT02120352|69297323|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
37773537|NCT02120352|69297324|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
37773538|NCT02120352|69297325|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
37773539|NCT02120352|69297322|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
37773540|NCT02120352|69297323|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
37773541|NCT02120352|69297324|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
37773542|NCT02120352|69297325|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
37773543|NCT02120352|69297322|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
37773544|NCT02120352|69297323|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
37773545|NCT02120352|69297324|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
37773546|NCT02120352|69297325|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
37773547|NCT02120352|69297322|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
37690585|NCT02152761|69166827|FG001|Epoch: Treatment Epoch|Death|3|||
37773548|NCT02120352|69297323|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
37773549|NCT02120352|69297324|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
37863631|NCT01257503|69547214|FG001|Overall Study|strep culture positive at enrollment|0|||
37773550|NCT02120352|69297325|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
37773551|NCT02120352|69297322|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
37773552|NCT02120352|69297323|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
37773553|NCT02120352|69297324|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
37773554|NCT02120352|69297325|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
37773555|NCT02120352|69297322|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
37773556|NCT02120352|69297323|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
37773557|NCT02120352|69297324|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
37773558|NCT02120352|69297325|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
37773559|NCT02120352|69297322|FG000|Maintenance Period (32 Weeks)|Adverse Event|0|||
37773560|NCT02120352|69297323|FG001|Maintenance Period (32 Weeks)|Adverse Event|0|||
37773561|NCT02120352|69297324|FG002|Maintenance Period (32 Weeks)|Adverse Event|6|||
37773562|NCT02120352|69297325|FG003|Maintenance Period (32 Weeks)|Adverse Event|1|||
37773563|NCT02120352|69297322|FG000|Maintenance Period (32 Weeks)|Lack of Efficacy|0|||
37773564|NCT02120352|69297323|FG001|Maintenance Period (32 Weeks)|Lack of Efficacy|1|||
37773565|NCT02120352|69297324|FG002|Maintenance Period (32 Weeks)|Lack of Efficacy|0|||
37773566|NCT02120352|69297325|FG003|Maintenance Period (32 Weeks)|Lack of Efficacy|1|||
37773567|NCT02120352|69297322|FG000|Maintenance Period (32 Weeks)|Protocol Violation|0|||
37773568|NCT02120352|69297323|FG001|Maintenance Period (32 Weeks)|Protocol Violation|0|||
37773569|NCT02120352|69297324|FG002|Maintenance Period (32 Weeks)|Protocol Violation|2|||
37773570|NCT02120352|69297325|FG003|Maintenance Period (32 Weeks)|Protocol Violation|0|||
37773571|NCT02120352|69297322|FG000|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|0|||
37773572|NCT02120352|69297323|FG001|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|0|||
37773573|NCT02120352|69297324|FG002|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|1|||
37773574|NCT02120352|69297325|FG003|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|1|||
37773575|NCT02120352|69297322|FG000|Maintenance Period (32 Weeks)|Lost to Follow-up|0|||
37773576|NCT02120352|69297323|FG001|Maintenance Period (32 Weeks)|Lost to Follow-up|0|||
37773577|NCT02120352|69297324|FG002|Maintenance Period (32 Weeks)|Lost to Follow-up|0|||
37773578|NCT02120352|69297325|FG003|Maintenance Period (32 Weeks)|Lost to Follow-up|1|||
37773579|NCT02120352|69297322|FG000|Maintenance Period (32 Weeks)|Withdrawal by Subject|0|||
37773580|NCT02120352|69297323|FG001|Maintenance Period (32 Weeks)|Withdrawal by Subject|2|||
37773581|NCT02120352|69297324|FG002|Maintenance Period (32 Weeks)|Withdrawal by Subject|1|||
37773582|NCT02120352|69297325|FG003|Maintenance Period (32 Weeks)|Withdrawal by Subject|2|||
37773583|NCT02120352|69297322|FG000|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|0|||
37773584|NCT02120352|69297323|FG001|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|112|||
37773585|NCT02120352|69297324|FG002|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|105|||
37773586|NCT02120352|69297325|FG003|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|50|||
37773587|NCT02058693|69297341|FG000|Phase 1|Withdrawal by Subject|3|||
37773588|NCT02058693|69297342|FG001|Phase 1|Withdrawal by Subject|2|||
37773589|NCT02058693|69297341|FG000|Phase 1|Adverse Event|0|||
37773590|NCT02058693|69297342|FG001|Phase 1|Adverse Event|1|||
37773591|NCT02058693|69297341|FG000|Phase 1|Lack of Efficacy|1|||
37773592|NCT02058693|69297342|FG001|Phase 1|Lack of Efficacy|0|||
37773593|NCT02058693|69297341|FG000|Phase 1|Physician Decision|1|||
37773594|NCT02058693|69297342|FG001|Phase 1|Physician Decision|1|||
37773595|NCT02058693|69297341|FG000|Phase 2|Withdrawal by Subject|0|||
37773596|NCT02058693|69297342|FG001|Phase 2|Withdrawal by Subject|2|||
37773597|NCT02039856|69297352|FG000|Overall Study|Death|5|||
37773598|NCT02039856|69297353|FG001|Overall Study|Death|3|||
37773599|NCT02039856|69297352|FG000|Overall Study|Partial survey completion|61|||
37773600|NCT02039856|69297353|FG001|Overall Study|Partial survey completion|26|||
37773601|NCT02039856|69297352|FG000|Overall Study|Lost to Follow-up|388|||
37773602|NCT02039856|69297353|FG001|Overall Study|Lost to Follow-up|206|||
37773603|NCT02039856|69297352|FG000|Overall Study|Withdrawal by Subject|1573|||
37773604|NCT02039856|69297353|FG001|Overall Study|Withdrawal by Subject|618|||
37773605|NCT01796392|69297363|FG000|Overall Study|Withdrawal by Subject|2|||
37773606|NCT01796392|69297364|FG001|Overall Study|Withdrawal by Subject|0|||
37773607|NCT01796392|69297363|FG000|Overall Study|Death|5|||
37773608|NCT01796392|69297364|FG001|Overall Study|Death|1|||
37773609|NCT01796392|69297363|FG000|Overall Study|Excluded for medical reasons|1|||
37773610|NCT01796392|69297364|FG001|Overall Study|Excluded for medical reasons|2|||
37773611|NCT01796392|69297363|FG000|Overall Study|Lost to Follow-up|1|||
37773612|NCT01796392|69297364|FG001|Overall Study|Lost to Follow-up|0|||
37773613|NCT01571635|69297375|FG000|Overall Study|Adverse Event|3|||
37773614|NCT01571635|69297376|FG001|Overall Study|Adverse Event|0|||
37773615|NCT01571635|69297377|FG002|Overall Study|Adverse Event|2|||
37773616|NCT01571635|69297378|FG003|Overall Study|Adverse Event|3|||
37773617|NCT01571635|69297379|FG004|Overall Study|Adverse Event|5|||
37773618|NCT01571635|69297375|FG000|Overall Study|Other reasons|2|||
37773619|NCT01571635|69297376|FG001|Overall Study|Other reasons|1|||
37773620|NCT01571635|69297377|FG002|Overall Study|Other reasons|2|||
37773621|NCT01571635|69297378|FG003|Overall Study|Other reasons|2|||
37773622|NCT01571635|69297379|FG004|Overall Study|Other reasons|1|||
37773623|NCT01571635|69297375|FG000|Overall Study|Study terminated by sponsor|0|||
37773624|NCT01571635|69297376|FG001|Overall Study|Study terminated by sponsor|4|||
37773625|NCT01571635|69297377|FG002|Overall Study|Study terminated by sponsor|1|||
37773626|NCT01571635|69297378|FG003|Overall Study|Study terminated by sponsor|3|||
37773627|NCT01571635|69297379|FG004|Overall Study|Study terminated by sponsor|1|||
37773628|NCT01571635|69297375|FG000|Overall Study|Withdrew consent|1|||
37773629|NCT01571635|69297376|FG001|Overall Study|Withdrew consent|1|||
37773630|NCT01571635|69297377|FG002|Overall Study|Withdrew consent|2|||
37773631|NCT01571635|69297378|FG003|Overall Study|Withdrew consent|3|||
37773632|NCT01571635|69297379|FG004|Overall Study|Withdrew consent|0|||
37773633|NCT01571635|69297375|FG000|Overall Study|Lack of Efficacy|0|||
37773634|NCT01571635|69297376|FG001|Overall Study|Lack of Efficacy|2|||
37773635|NCT01571635|69297377|FG002|Overall Study|Lack of Efficacy|0|||
37773636|NCT01571635|69297378|FG003|Overall Study|Lack of Efficacy|1|||
37773637|NCT01571635|69297379|FG004|Overall Study|Lack of Efficacy|2|||
37773638|NCT01248715|69297393|FG000|Overall Study|Not influenza positive|501|||
37773639|NCT01248715|69297394|FG001|Overall Study|Not influenza positive|510|||
37773640|NCT00812214|69297446|FG000|Overall Study|Lost to Follow-up|3|||
37773641|NCT00812214|69297447|FG001|Overall Study|Lost to Follow-up|1|||
37773642|NCT00217425|69297454|FG000|Overall Study|Never started treatment|2|||
37773643|NCT00217425|69297454|FG000|Overall Study|Patient ineligible|5|||
37773644|NCT00217425|69297454|FG000|Overall Study|Lack of Efficacy|13|||
37773645|NCT00217425|69297454|FG000|Overall Study|Adverse Event|8|||
37773646|NCT00217425|69297454|FG000|Overall Study|Withdrawal by Subject|4|||
37773647|NCT00217425|69297454|FG000|Overall Study|Other complicating disease|1|||
37773648|NCT00217425|69297454|FG000|Overall Study|Other|4|||
37773649|NCT03208231|69297473|FG000|Overall Study|Death|1|||
37773650|NCT03208231|69297474|FG001|Overall Study|Death|2|||
37773651|NCT03208231|69297473|FG000|Overall Study|Moved and unable to get to clinic|1|||
37773652|NCT03208231|69297474|FG001|Overall Study|Moved and unable to get to clinic|0|||
37773653|NCT03208231|69297473|FG000|Overall Study|Unwilling to adhere to study requirements|0|||
37863632|NCT00995566|69547220|FG000|Overall Study|Adverse Event|2|||
37773654|NCT03208231|69297474|FG001|Overall Study|Unwilling to adhere to study requirements|1|||
37773655|NCT03102242|69297497|FG000|Overall Study|Adverse Event|2|||
37773656|NCT03097328|69297501|FG000|Overall Study|Still on Therapy|2|||
37773657|NCT03097328|69297501|FG000|Overall Study|Progressive Disease|29|||
37773658|NCT03097328|69297501|FG000|Overall Study|Adverse Event|4|||
37773659|NCT03097328|69297501|FG000|Overall Study|Withdrawal by Subject|1|||
37773660|NCT03097328|69297501|FG000|Overall Study|Physician Decision|1|||
37773661|NCT03097328|69297501|FG000|Overall Study|Patient Decision|1|||
37773662|NCT03097328|69297501|FG000|Overall Study|Ineligible for Study Drug|1|||
37773663|NCT03033602|69297507|FG000|Overall Study|Withdrawal by Subject|11|||
37773664|NCT03033602|69297508|FG001|Overall Study|Withdrawal by Subject|21|||
37773665|NCT03033602|69297507|FG000|Overall Study|discontinued for medical reason or decision by study team|9|||
37773666|NCT03033602|69297508|FG001|Overall Study|discontinued for medical reason or decision by study team|16|||
37773667|NCT02994784|69297519|FG000|6 Months Follow-up|Lost to Follow-up|3|||
37773668|NCT02948829|69297523|FG000|Overall Study|Lost to Follow-up|2|||
37773669|NCT02948829|69297523|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
37773670|NCT02948829|69297523|FG000|Overall Study|Pregnancy|1|||
37773671|NCT02948829|69297523|FG000|Overall Study|Other: Reason not Specified|8|||
37773672|NCT02617446|69297554|FG000|Overall Study|Withdrawal by Subject|0|||
37773673|NCT02617446|69297555|FG001|Overall Study|Withdrawal by Subject|2|||
37773674|NCT02617446|69297556|FG002|Overall Study|Withdrawal by Subject|0|||
37773675|NCT02617446|69297554|FG000|Overall Study|Adverse Event|1|||
37773676|NCT02617446|69297555|FG001|Overall Study|Adverse Event|0|||
37773677|NCT02617446|69297556|FG002|Overall Study|Adverse Event|5|||
37773678|NCT02617446|69297554|FG000|Overall Study|Lost to Follow-up|3|||
37773679|NCT02617446|69297555|FG001|Overall Study|Lost to Follow-up|0|||
37773680|NCT02617446|69297556|FG002|Overall Study|Lost to Follow-up|0|||
37773681|NCT02617446|69297554|FG000|Overall Study|Death|0|||
37773682|NCT02617446|69297555|FG001|Overall Study|Death|0|||
37773683|NCT02617446|69297556|FG002|Overall Study|Death|2|||
37773684|NCT02549170|69297570|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|17|||
37773685|NCT02549170|69297571|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|4|||
37773686|NCT02549170|69297572|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
37773687|NCT02549170|69297573|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
37773688|NCT02549170|69297574|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
37773689|NCT02549170|69297570|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|5|||
37773690|NCT02549170|69297571|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|2|||
37773691|NCT02549170|69297572|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
37773692|NCT02549170|69297573|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
37773693|NCT02549170|69297574|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
37773694|NCT02549170|69297570|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|2|||
37773695|NCT02549170|69297571|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|8|||
37773696|NCT02549170|69297572|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
37773697|NCT02549170|69297573|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
37773698|NCT02549170|69297574|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
37773699|NCT02410902|69297591|FG000|Overall Study|Adverse Event|2|||
37773700|NCT02410902|69297592|FG001|Overall Study|Adverse Event|3|||
37773701|NCT02410902|69297591|FG000|Overall Study|Lost to Follow-up|4|||
37773702|NCT02410902|69297592|FG001|Overall Study|Lost to Follow-up|1|||
37773703|NCT02410902|69297591|FG000|Overall Study|Protocol Violation|1|||
37773704|NCT02410902|69297592|FG001|Overall Study|Protocol Violation|4|||
37773705|NCT02410902|69297591|FG000|Overall Study|Withdrawal by Subject|6|||
37773706|NCT02410902|69297592|FG001|Overall Study|Withdrawal by Subject|8|||
37773707|NCT02410902|69297591|FG000|Overall Study|Non-Compliance|8|||
37773708|NCT02410902|69297592|FG001|Overall Study|Non-Compliance|2|||
37773709|NCT02101736|69297602|FG000|Overall Study|Protocol Violation|3|||
37773710|NCT02101736|69297603|FG001|Overall Study|Protocol Violation|0|||
37773711|NCT02101736|69297602|FG000|Overall Study|Withdrawal by Subject|1|||
37773712|NCT02101736|69297603|FG001|Overall Study|Withdrawal by Subject|1|||
37773713|NCT01918397|69297615|FG000|Overall Study|Never started treatment|2|||
37773714|NCT01918397|69297616|FG001|Overall Study|Never started treatment|1|||
37773715|NCT01918397|69297617|FG002|Overall Study|Never started treatment|0|||
37773716|NCT01918397|69297618|FG003|Overall Study|Never started treatment|0|||
37773717|NCT01918397|69297615|FG000|Overall Study|Adverse Event|1|||
37773718|NCT01918397|69297616|FG001|Overall Study|Adverse Event|1|||
37773719|NCT01918397|69297617|FG002|Overall Study|Adverse Event|1|||
37773720|NCT01918397|69297618|FG003|Overall Study|Adverse Event|0|||
37773721|NCT01918397|69297615|FG000|Overall Study|Lack of compliance|2|||
37773722|NCT01918397|69297616|FG001|Overall Study|Lack of compliance|2|||
37773723|NCT01918397|69297617|FG002|Overall Study|Lack of compliance|3|||
37773724|NCT01918397|69297618|FG003|Overall Study|Lack of compliance|0|||
37773725|NCT01918397|69297615|FG000|Overall Study|Pregnancy|0|||
37773726|NCT01918397|69297616|FG001|Overall Study|Pregnancy|1|||
37773727|NCT01918397|69297617|FG002|Overall Study|Pregnancy|0|||
37773728|NCT01918397|69297618|FG003|Overall Study|Pregnancy|0|||
37773729|NCT01918397|69297615|FG000|Overall Study|Rifampin susceptible|0|||
37773730|NCT01918397|69297616|FG001|Overall Study|Rifampin susceptible|0|||
37773731|NCT01918397|69297617|FG002|Overall Study|Rifampin susceptible|0|||
37773732|NCT01918397|69297618|FG003|Overall Study|Rifampin susceptible|2|||
37773733|NCT01918397|69297615|FG000|Overall Study|Treatment failure|0|||
37773734|NCT01918397|69297616|FG001|Overall Study|Treatment failure|0|||
37773735|NCT01918397|69297617|FG002|Overall Study|Treatment failure|0|||
37773736|NCT01918397|69297618|FG003|Overall Study|Treatment failure|1|||
37773737|NCT01918397|69297615|FG000|Overall Study|Withdrawal by Subject|3|||
37773738|NCT01918397|69297616|FG001|Overall Study|Withdrawal by Subject|2|||
37773739|NCT01918397|69297617|FG002|Overall Study|Withdrawal by Subject|1|||
37773740|NCT01918397|69297618|FG003|Overall Study|Withdrawal by Subject|1|||
37773741|NCT01918397|69297615|FG000|Overall Study|XDR at baseline|0|||
37773742|NCT01918397|69297616|FG001|Overall Study|XDR at baseline|0|||
37773743|NCT01918397|69297617|FG002|Overall Study|XDR at baseline|1|||
37773744|NCT01918397|69297618|FG003|Overall Study|XDR at baseline|0|||
37773745|NCT01918397|69297615|FG000|Overall Study|Lost to Follow-up|2|||
37773746|NCT01918397|69297616|FG001|Overall Study|Lost to Follow-up|1|||
37773747|NCT01918397|69297617|FG002|Overall Study|Lost to Follow-up|1|||
37773748|NCT01918397|69297618|FG003|Overall Study|Lost to Follow-up|1|||
37773749|NCT01918397|69297615|FG000|Overall Study|Increased QTc|1|||
37773750|NCT01918397|69297616|FG001|Overall Study|Increased QTc|0|||
37773751|NCT01918397|69297617|FG002|Overall Study|Increased QTc|0|||
37773752|NCT01918397|69297618|FG003|Overall Study|Increased QTc|1|||
37773753|NCT01918397|69297615|FG000|Overall Study|Death|0|||
37773754|NCT01918397|69297616|FG001|Overall Study|Death|0|||
37773755|NCT01918397|69297617|FG002|Overall Study|Death|1|||
37773756|NCT01918397|69297618|FG003|Overall Study|Death|0|||
37773757|NCT01918397|69297615|FG000|Overall Study|Involved in another investigative trial|0|||
37773758|NCT01918397|69297616|FG001|Overall Study|Involved in another investigative trial|0|||
37773759|NCT01918397|69297617|FG002|Overall Study|Involved in another investigative trial|0|||
37773760|NCT01918397|69297618|FG003|Overall Study|Involved in another investigative trial|1|||
37773761|NCT00986921|69297652|FG000|Overall Study|Physician Decision|1|||
37773762|NCT00986921|69297653|FG001|Overall Study|Physician Decision|0|||
37773763|NCT01596972|69297664|FG000|Overall Study|Physician Decision|1|||
37773764|NCT01596972|69297665|FG001|Overall Study|Physician Decision|9|||
37773765|NCT01596972|69297664|FG000|Overall Study|Lost to Follow-up|0|||
37773766|NCT01596972|69297665|FG001|Overall Study|Lost to Follow-up|4|||
37773767|NCT01596972|69297664|FG000|Overall Study|Withdrawal by Subject|0|||
37773768|NCT01596972|69297665|FG001|Overall Study|Withdrawal by Subject|1|||
37773769|NCT00985751|69297766|FG000|Overall Study|Adverse Event|0|||
37773770|NCT00985751|69297767|FG001|Overall Study|Adverse Event|0|||
37773771|NCT00985751|69297768|FG002|Overall Study|Adverse Event|0|||
37773772|NCT00985751|69297769|FG003|Overall Study|Adverse Event|0|||
37773773|NCT00985751|69297770|FG004|Overall Study|Adverse Event|1|||
37773774|NCT01596582|69297815|FG000|Overall Study|Deemed ineligible after study visit|3|||
37773775|NCT01596582|69297816|FG001|Overall Study|Deemed ineligible after study visit|6|||
37773776|NCT01596582|69297815|FG000|Overall Study|Missing all outcome data|1|||
37773777|NCT01596582|69297816|FG001|Overall Study|Missing all outcome data|1|||
37773778|NCT01596504|69297832|FG000|Overall Study|Participant's Private Reason|0|||
37773779|NCT01596504|69297833|FG001|Overall Study|Participant's Private Reason|1|||
37773780|NCT01596504|69297834|FG002|Overall Study|Participant's Private Reason|0|||
37773781|NCT01596504|69297832|FG000|Overall Study|Adverse Event|1|||
37773782|NCT01596504|69297833|FG001|Overall Study|Adverse Event|2|||
37773783|NCT01596504|69297834|FG002|Overall Study|Adverse Event|1|||
37773784|NCT01596504|69297832|FG000|Overall Study|Withdrawal by Subject|1|||
37773785|NCT01596504|69297833|FG001|Overall Study|Withdrawal by Subject|0|||
37773786|NCT01596504|69297834|FG002|Overall Study|Withdrawal by Subject|0|||
37773787|NCT02616900|69297889|FG000|Overall Study|Lack of Efficacy|7|||
37773788|NCT02616900|69297889|FG000|Overall Study|Lost to Follow-up|2|||
37773789|NCT02616900|69297889|FG000|Overall Study|Protocol Violation|5|||
37773790|NCT02616900|69297889|FG000|Overall Study|Withdrawal by Subject|3|||
37773791|NCT02616900|69297889|FG000|Overall Study|Incomplete data|6|||
37773792|NCT00985673|69298001|FG000|Overall Study|Lost to Follow-up|6|||
37773793|NCT00985673|69298002|FG001|Overall Study|Lost to Follow-up|7|||
37773794|NCT00985673|69298003|FG002|Overall Study|Lost to Follow-up|6|||
37773795|NCT00985673|69298004|FG003|Overall Study|Lost to Follow-up|10|||
37773796|NCT00985673|69298005|FG004|Overall Study|Lost to Follow-up|5|||
37773797|NCT00985673|69298006|FG005|Overall Study|Lost to Follow-up|3|||
37773798|NCT00985673|69298001|FG000|Overall Study|Withdrawal by Subject|0|||
37773799|NCT00985673|69298002|FG001|Overall Study|Withdrawal by Subject|4|||
37773800|NCT00985673|69298003|FG002|Overall Study|Withdrawal by Subject|5|||
37773801|NCT00985673|69298004|FG003|Overall Study|Withdrawal by Subject|2|||
37773802|NCT00985673|69298005|FG004|Overall Study|Withdrawal by Subject|2|||
37773803|NCT00985673|69298006|FG005|Overall Study|Withdrawal by Subject|3|||
37773804|NCT00985673|69298001|FG000|Overall Study|Other|1|||
37773805|NCT00985673|69298002|FG001|Overall Study|Other|0|||
37773806|NCT00985673|69298003|FG002|Overall Study|Other|1|||
37773807|NCT00985673|69298004|FG003|Overall Study|Other|0|||
37773808|NCT00985673|69298005|FG004|Overall Study|Other|1|||
37773809|NCT00985673|69298006|FG005|Overall Study|Other|0|||
37773810|NCT00985439|69298052|FG000|Overall Study|Adverse Event|0|||
37773811|NCT00985439|69298053|FG001|Overall Study|Adverse Event|0|||
37773812|NCT00985439|69298054|FG002|Overall Study|Adverse Event|1|||
37773813|NCT00985439|69298055|FG003|Overall Study|Adverse Event|0|||
37773814|NCT02618928|69298065|FG000|Overall Study|Failure to Return|28|||
37773815|NCT02618928|69298065|FG000|Overall Study|Insufficient Virological Response|1|||
37773816|NCT02618928|69298065|FG000|Overall Study|Withdrawal by Subject|2|||
37773817|NCT02618928|69298065|FG000|Overall Study|Death|3|||
37773818|NCT02618928|69298065|FG000|Overall Study|Other|11|||
37773819|NCT02618928|69298065|FG000|Overall Study|Missing|6|||
37773820|NCT02618928|69298065|FG000|Overall Study|Treatment Never Started|7|||
37773821|NCT00983957|69298076|FG000|Overall Study|Adverse Event|1|||
37773822|NCT00983957|69298076|FG000|Overall Study|Personal Reasons|1|||
37773823|NCT00981149|69298130|FG000|Overall Study|Lost to Follow-up|1|||
37773824|NCT00981149|69298131|FG001|Overall Study|Lost to Follow-up|2|||
37773825|NCT00981149|69298130|FG000|Overall Study|Withdrawal by Subject|1|||
37773826|NCT00981149|69298131|FG001|Overall Study|Withdrawal by Subject|1|||
37773827|NCT01595646|69298189|FG000|Overall Study|Withdrawal by Subject|1|||
37773828|NCT01595646|69298190|FG001|Overall Study|Withdrawal by Subject|0|||
37773829|NCT01595646|69298191|FG002|Overall Study|Withdrawal by Subject|0|||
37773830|NCT00981461|69298219|FG000|Overall Study|Lost to Follow-up|5|||
37773831|NCT00981461|69298220|FG001|Overall Study|Lost to Follow-up|2|||
37773832|NCT02618616|69298237|FG000|Overall Study|Lack of Efficacy|4|||
37773833|NCT02618616|69298238|FG001|Overall Study|Lack of Efficacy|0|||
37773834|NCT02618616|69298237|FG000|Overall Study|Pregnancy|0|||
37773835|NCT02618616|69298238|FG001|Overall Study|Pregnancy|1|||
37773836|NCT02618616|69298237|FG000|Overall Study|Adverse Event|8|||
37773837|NCT02618616|69298238|FG001|Overall Study|Adverse Event|0|||
37773838|NCT02618616|69298237|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
37773839|NCT02618616|69298238|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
37773840|NCT02618616|69298237|FG000|Overall Study|Consent withdrawn by subject|8|||
37773841|NCT02618616|69298238|FG001|Overall Study|Consent withdrawn by subject|5|||
37773842|NCT02618616|69298237|FG000|Overall Study|Lost to Follow-up|0|||
37773843|NCT02618616|69298238|FG001|Overall Study|Lost to Follow-up|1|||
37773844|NCT02618382|69298317|FG000|Overall Study|Physician Decision|1|||
37773845|NCT02618382|69298317|FG000|Overall Study|Withdrawal by Subject|1|||
37773846|NCT02618382|69298317|FG000|Overall Study|Protocol Violation|1|||
37773847|NCT00980057|69298361|FG000|Overall Study|Death|13|||
37773848|NCT00980057|69298362|FG001|Overall Study|Death|3|||
37773849|NCT00980057|69298361|FG000|Overall Study|Adverse Event|0|||
37773850|NCT00980057|69298362|FG001|Overall Study|Adverse Event|1|||
37773851|NCT00980057|69298361|FG000|Overall Study|Physician Decision|4|||
37773852|NCT00980057|69298362|FG001|Overall Study|Physician Decision|0|||
37773853|NCT00980057|69298361|FG000|Overall Study|Lost to Follow-up|1|||
37773854|NCT00980057|69298362|FG001|Overall Study|Lost to Follow-up|0|||
37773855|NCT00980057|69298361|FG000|Overall Study|Withdrawal by Subject|1|||
37773856|NCT00980057|69298362|FG001|Overall Study|Withdrawal by Subject|1|||
37773857|NCT04126733|69298483|FG000|Treatment Period|Progressive Disease - Radiological Progression|47|||
37773858|NCT04126733|69298483|FG000|Treatment Period|Adverse Event|8|||
37773859|NCT04126733|69298483|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
37773860|NCT04126733|69298483|FG000|Treatment Period|Physician Decision|5|||
37773861|NCT04126733|69298483|FG000|Treatment Period|Death|1|||
37773862|NCT04126733|69298483|FG000|Treatment Period|Other Reasons|2|||
37773863|NCT04126733|69298483|FG000|Active Follow-up Period|Death|13|||
37773864|NCT04126733|69298483|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
37773865|NCT04126733|69298483|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
37773866|NCT04126733|69298483|FG000|Active Follow-up Period|Other Reasons|1|||
37773867|NCT04126733|69298483|FG000|Long-term Follow-up Period|Death|22|||
37773868|NCT04126733|69298483|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
37773869|NCT04126733|69298483|FG000|Long-term Follow-up Period|Ongoing with Long Term Follow-up|6|||
37773870|NCT00988247|69298518|FG000|Overall Study|Adverse Event|17|||
37773871|NCT00988247|69298519|FG001|Overall Study|Adverse Event|3|||
37773872|NCT00988247|69298518|FG000|Overall Study|Withdrawal by Subject|44|||
37773873|NCT00988247|69298519|FG001|Overall Study|Withdrawal by Subject|13|||
37773874|NCT00988247|69298518|FG000|Overall Study|Pregnancy|1|||
37773875|NCT00988247|69298519|FG001|Overall Study|Pregnancy|2|||
37773876|NCT00988247|69298518|FG000|Overall Study|Lost to Follow-up|11|||
37773877|NCT00988247|69298519|FG001|Overall Study|Lost to Follow-up|2|||
37773878|NCT00988247|69298518|FG000|Overall Study|Protocol Violation|4|||
37773879|NCT00988247|69298519|FG001|Overall Study|Protocol Violation|5|||
37773880|NCT00988247|69298518|FG000|Overall Study|Sponsor requested withdrawal|3|||
37773881|NCT00988247|69298519|FG001|Overall Study|Sponsor requested withdrawal|1|||
37773882|NCT00988247|69298518|FG000|Overall Study|Other|3|||
37773883|NCT00988247|69298519|FG001|Overall Study|Other|0|||
37773884|NCT00984659|69298529|FG000|2-week Run-in Period|Adverse Event|8|||
37773885|NCT00984659|69298530|FG001|2-week Run-in Period|Adverse Event|0|||
37773886|NCT00984659|69298531|FG002|2-week Run-in Period|Adverse Event|0|||
37773887|NCT00984659|69298532|FG003|2-week Run-in Period|Adverse Event|0|||
37773888|NCT00984659|69298529|FG000|2-week Run-in Period|Protocol Violation|5|||
37773889|NCT00984659|69298530|FG001|2-week Run-in Period|Protocol Violation|0|||
37773890|NCT00984659|69298531|FG002|2-week Run-in Period|Protocol Violation|0|||
37773891|NCT00984659|69298532|FG003|2-week Run-in Period|Protocol Violation|0|||
37773892|NCT00984659|69298529|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
37773893|NCT00984659|69298530|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
37773894|NCT00984659|69298531|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
37773895|NCT00984659|69298532|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
37773896|NCT00984659|69298529|FG000|2-week Run-in Period|Lost to Follow-up|3|||
37773897|NCT00984659|69298530|FG001|2-week Run-in Period|Lost to Follow-up|0|||
37773898|NCT00984659|69298531|FG002|2-week Run-in Period|Lost to Follow-up|0|||
37773899|NCT00984659|69298532|FG003|2-week Run-in Period|Lost to Follow-up|0|||
37773900|NCT00984659|69298529|FG000|2-week Run-in Period|Physician Decision|10|||
37773901|NCT00984659|69298530|FG001|2-week Run-in Period|Physician Decision|0|||
37773902|NCT00984659|69298531|FG002|2-week Run-in Period|Physician Decision|0|||
37773903|NCT00984659|69298532|FG003|2-week Run-in Period|Physician Decision|0|||
37773904|NCT00984659|69298529|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
37773905|NCT00984659|69298530|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
37773906|NCT00984659|69298531|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
37773907|NCT00984659|69298532|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
37773908|NCT00984659|69298529|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
37773909|NCT00984659|69298530|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
37773910|NCT00984659|69298531|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
37773911|NCT00984659|69298532|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
37773912|NCT00984659|69298529|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
37773913|NCT00984659|69298530|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
37773914|NCT00984659|69298531|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
37773915|NCT00984659|69298532|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
37773916|NCT00984659|69298529|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
37773917|NCT00984659|69298530|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
37773918|NCT00984659|69298531|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
37773919|NCT00984659|69298532|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
37773920|NCT00984659|69298529|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
37773921|NCT00984659|69298530|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
37773922|NCT00984659|69298531|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
37773923|NCT00984659|69298532|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
37773924|NCT00984659|69298529|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
37773925|NCT00984659|69298530|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
37773926|NCT00984659|69298531|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
37773927|NCT00984659|69298532|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
37773928|NCT00984659|69298529|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
37968255|NCT02406027|69655358|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
37968256|NCT02406027|69655359|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
37968257|NCT02406027|69655360|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
37773929|NCT00984659|69298530|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
37773930|NCT00984659|69298531|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
37773931|NCT00984659|69298532|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
37773932|NCT00982319|69298541|FG000|Overall Study|Surgery date change|1|||
37773933|NCT00982319|69298542|FG001|Overall Study|Surgery date change|0|||
37773934|NCT00982319|69298541|FG000|Overall Study|Preop values out of acceptable range|1|||
37773935|NCT00982319|69298542|FG001|Overall Study|Preop values out of acceptable range|1|||
37773936|NCT00982319|69298541|FG000|Overall Study|Pregnancy|0|||
37773937|NCT00982319|69298542|FG001|Overall Study|Pregnancy|1|||
37773938|NCT02612064|69298554|FG000|Overall Study|Withdrawal by Subject|1|||
37773939|NCT02612064|69298555|FG001|Overall Study|Withdrawal by Subject|1|||
37773940|NCT02612064|69298554|FG000|Overall Study|Other|0|||
37773941|NCT02612064|69298555|FG001|Overall Study|Other|2|||
37773942|NCT02614560|69298574|FG000|Overall Study|Death|6|||
37773943|NCT02614560|69298575|FG001|Overall Study|Death|2|||
37773944|NCT01669122|69298592|FG000|Period I|Lost to Follow-up|1|||
37773945|NCT01669122|69298592|FG000|Washout Period II|Protocol Violation|2|||
37773946|NCT02611752|69298625|FG000|Overall Study|Adverse Event|0|||
37773947|NCT02611752|69298626|FG001|Overall Study|Adverse Event|1|||
37773948|NCT02611362|69298647|FG000|Overall Study|Withdrawal by Subject|7|||
37773949|NCT02611362|69298648|FG001|Overall Study|Withdrawal by Subject|2|||
37773950|NCT02611362|69298647|FG000|Overall Study|Lost to Follow-up|2|||
37773951|NCT02611362|69298648|FG001|Overall Study|Lost to Follow-up|4|||
37773952|NCT01594476|69298668|FG000|Overall Study|Protocol Violation|1|||
37773953|NCT01594476|69298669|FG001|Overall Study|Protocol Violation|3|||
37773954|NCT01668966|69298683|FG000|Overall Study|Withdrawal by Subject|1|||
37773955|NCT01668966|69298683|FG000|Overall Study|Death|1|||
37773956|NCT01668966|69298683|FG000|Overall Study|Not treated|2|||
37773957|NCT02609724|69298690|FG000|Overall Study|Death|2|||
37773958|NCT02609724|69298691|FG001|Overall Study|Death|0|||
37773959|NCT02609724|69298692|FG002|Overall Study|Death|1|||
37773960|NCT02609724|69298690|FG000|Overall Study|Withdrawal by Subject|1|||
37773961|NCT02609724|69298691|FG001|Overall Study|Withdrawal by Subject|2|||
37773962|NCT02609724|69298692|FG002|Overall Study|Withdrawal by Subject|3|||
37773963|NCT02609724|69298690|FG000|Overall Study|Illness|2|||
37773964|NCT02609724|69298691|FG001|Overall Study|Illness|1|||
37773965|NCT02609724|69298692|FG002|Overall Study|Illness|0|||
37773966|NCT02610816|69298721|FG000|Phase 1|Withdrawal by Subject|2|||
37773967|NCT02610816|69298722|FG001|Phase 1|Withdrawal by Subject|6|||
37773968|NCT02610816|69298723|FG002|Phase 1|Withdrawal by Subject|0|||
37773969|NCT02610816|69298724|FG003|Phase 1|Withdrawal by Subject|0|||
37773970|NCT02610816|69298721|FG000|Phase 1|Lost to Follow-up|2|||
37773971|NCT02610816|69298722|FG001|Phase 1|Lost to Follow-up|1|||
37773972|NCT02610816|69298723|FG002|Phase 1|Lost to Follow-up|0|||
37773973|NCT02610816|69298724|FG003|Phase 1|Lost to Follow-up|0|||
37773974|NCT02610816|69298721|FG000|Phase 1|Physician Decision|0|||
37773975|NCT02610816|69298722|FG001|Phase 1|Physician Decision|1|||
37773976|NCT02610816|69298723|FG002|Phase 1|Physician Decision|0|||
37773977|NCT02610816|69298724|FG003|Phase 1|Physician Decision|0|||
37773978|NCT02610816|69298721|FG000|Phase 2|Withdrawal by Subject|0|||
37773979|NCT02610816|69298722|FG001|Phase 2|Withdrawal by Subject|0|||
37773980|NCT02610816|69298723|FG002|Phase 2|Withdrawal by Subject|9|||
37773981|NCT02610816|69298724|FG003|Phase 2|Withdrawal by Subject|3|||
37773982|NCT02610816|69298721|FG000|Phase 2|Lost to Follow-up|0|||
37773983|NCT02610816|69298722|FG001|Phase 2|Lost to Follow-up|0|||
37773984|NCT02610816|69298723|FG002|Phase 2|Lost to Follow-up|2|||
37773985|NCT02610816|69298724|FG003|Phase 2|Lost to Follow-up|0|||
37773986|NCT02610816|69298721|FG000|Phase 2|Physician Decision|0|||
37863633|NCT00995566|69547220|FG000|Overall Study|Early study termination|52|||
37863634|NCT01257425|69547226|FG000|Overall Study|Lack of Efficacy|3|||
37863635|NCT01257425|69547227|FG001|Overall Study|Lack of Efficacy|3|||
37773987|NCT02610816|69298722|FG001|Phase 2|Physician Decision|0|||
37773988|NCT02610816|69298723|FG002|Phase 2|Physician Decision|0|||
37773989|NCT02610816|69298724|FG003|Phase 2|Physician Decision|2|||
37773990|NCT02610816|69298721|FG000|Phase 2|Pregnancy|0|||
37773991|NCT02610816|69298722|FG001|Phase 2|Pregnancy|0|||
37773992|NCT02610816|69298723|FG002|Phase 2|Pregnancy|0|||
37773993|NCT02610816|69298724|FG003|Phase 2|Pregnancy|1|||
37773994|NCT02612610|69298820|FG000|Overall Study|Withdrawal by Subject|1|||
37773995|NCT02612610|69298821|FG001|Overall Study|Withdrawal by Subject|1|||
37773996|NCT02612610|69298822|FG002|Overall Study|Withdrawal by Subject|0|||
37773997|NCT02612610|69298823|FG003|Overall Study|Withdrawal by Subject|2|||
37773998|NCT02612610|69298820|FG000|Overall Study|Adverse Event|2|||
37773999|NCT02612610|69298821|FG001|Overall Study|Adverse Event|2|||
37774000|NCT02612610|69298822|FG002|Overall Study|Adverse Event|3|||
37774001|NCT02612610|69298823|FG003|Overall Study|Adverse Event|10|||
37774002|NCT02612610|69298820|FG000|Overall Study|Lost to Follow-up|0|||
37774003|NCT02612610|69298821|FG001|Overall Study|Lost to Follow-up|1|||
37774004|NCT02612610|69298822|FG002|Overall Study|Lost to Follow-up|0|||
37774005|NCT02612610|69298823|FG003|Overall Study|Lost to Follow-up|0|||
37774006|NCT02612610|69298820|FG000|Overall Study|Protocol Violation|0|||
37774007|NCT02612610|69298821|FG001|Overall Study|Protocol Violation|1|||
37774008|NCT02612610|69298822|FG002|Overall Study|Protocol Violation|1|||
37774009|NCT02612610|69298823|FG003|Overall Study|Protocol Violation|0|||
37774010|NCT02612610|69298820|FG000|Overall Study|Lack of Efficacy|1|||
37774011|NCT02612610|69298821|FG001|Overall Study|Lack of Efficacy|2|||
37774012|NCT02612610|69298822|FG002|Overall Study|Lack of Efficacy|0|||
37774013|NCT02612610|69298823|FG003|Overall Study|Lack of Efficacy|1|||
37774014|NCT02612610|69298820|FG000|Overall Study|Physician Decision|0|||
37774015|NCT02612610|69298821|FG001|Overall Study|Physician Decision|1|||
37774016|NCT02612610|69298822|FG002|Overall Study|Physician Decision|0|||
37774017|NCT02612610|69298823|FG003|Overall Study|Physician Decision|0|||
37774018|NCT02612610|69298820|FG000|Overall Study|Noncompliance|1|||
37774019|NCT02612610|69298821|FG001|Overall Study|Noncompliance|0|||
37774020|NCT02612610|69298822|FG002|Overall Study|Noncompliance|0|||
37774021|NCT02612610|69298823|FG003|Overall Study|Noncompliance|0|||
37774022|NCT02612610|69298820|FG000|Overall Study|Cough Improvement|0|||
37774023|NCT02612610|69298821|FG001|Overall Study|Cough Improvement|0|||
37774024|NCT02612610|69298822|FG002|Overall Study|Cough Improvement|1|||
37774025|NCT02612610|69298823|FG003|Overall Study|Cough Improvement|0|||
37774026|NCT02610192|69299036|FG000|Overall Study|Received other treatment|8|||
37774027|NCT02610192|69299036|FG000|Overall Study|Physician Decision|1|||
37774028|NCT02609178|69299164|FG000|First Crown|Withdrawal by Subject|0|||
37774029|NCT02609178|69299165|FG001|First Crown|Withdrawal by Subject|0|||
37774030|NCT02609178|69299166|FG002|First Crown|Withdrawal by Subject|1|||
37774031|NCT02609178|69299167|FG003|First Crown|Withdrawal by Subject|1|||
37774032|NCT02609178|69299168|FG004|First Crown|Withdrawal by Subject|0|||
37774033|NCT02609178|69299169|FG005|First Crown|Withdrawal by Subject|0|||
37774034|NCT02607228|69299393|FG000|Overall Study|Progressive Disease|4|||
37774035|NCT02607228|69299394|FG001|Overall Study|Progressive Disease|3|||
37774036|NCT02607228|69299395|FG002|Overall Study|Progressive Disease|1|||
37774037|NCT02607228|69299396|FG003|Overall Study|Progressive Disease|5|||
37774038|NCT02607228|69299397|FG004|Overall Study|Progressive Disease|4|||
37774039|NCT02607228|69299398|FG005|Overall Study|Progressive Disease|3|||
37774040|NCT02607228|69299399|FG006|Overall Study|Progressive Disease|1|||
37774041|NCT02607228|69299393|FG000|Overall Study|Adverse Event|1|||
37774042|NCT02607228|69299394|FG001|Overall Study|Adverse Event|0|||
37774043|NCT02607228|69299395|FG002|Overall Study|Adverse Event|1|||
37774044|NCT02607228|69299396|FG003|Overall Study|Adverse Event|0|||
37774045|NCT02607228|69299397|FG004|Overall Study|Adverse Event|1|||
37774046|NCT02607228|69299398|FG005|Overall Study|Adverse Event|1|||
37774047|NCT02607228|69299399|FG006|Overall Study|Adverse Event|1|||
37774048|NCT02607228|69299393|FG000|Overall Study|Investigator's Discretion|0|||
37774049|NCT02607228|69299394|FG001|Overall Study|Investigator's Discretion|0|||
37774050|NCT02607228|69299395|FG002|Overall Study|Investigator's Discretion|1|||
37774051|NCT02607228|69299396|FG003|Overall Study|Investigator's Discretion|0|||
37774052|NCT02607228|69299397|FG004|Overall Study|Investigator's Discretion|0|||
37774053|NCT02607228|69299398|FG005|Overall Study|Investigator's Discretion|1|||
37774054|NCT02607228|69299399|FG006|Overall Study|Investigator's Discretion|0|||
37774055|NCT02607228|69299393|FG000|Overall Study|Withdrew Consent|0|||
37863636|NCT01257425|69547226|FG000|Overall Study|Adverse Event|1|||
37863637|NCT01257425|69547227|FG001|Overall Study|Adverse Event|1|||
37863638|NCT01257425|69547226|FG000|Overall Study|Protocol Violation|1|||
37863639|NCT01257425|69547227|FG001|Overall Study|Protocol Violation|1|||
37774056|NCT02607228|69299394|FG001|Overall Study|Withdrew Consent|1|||
37774057|NCT02607228|69299395|FG002|Overall Study|Withdrew Consent|0|||
37774058|NCT02607228|69299396|FG003|Overall Study|Withdrew Consent|0|||
37774059|NCT02607228|69299397|FG004|Overall Study|Withdrew Consent|0|||
37774060|NCT02607228|69299398|FG005|Overall Study|Withdrew Consent|1|||
37774061|NCT02607228|69299399|FG006|Overall Study|Withdrew Consent|0|||
37774062|NCT02607228|69299393|FG000|Overall Study|Study Terminated by Sponsor|0|||
37774063|NCT02607228|69299394|FG001|Overall Study|Study Terminated by Sponsor|0|||
37774064|NCT02607228|69299395|FG002|Overall Study|Study Terminated by Sponsor|0|||
37863640|NCT01257425|69547226|FG000|Overall Study|Withdrawal by Subject|0|||
37863641|NCT01257425|69547227|FG001|Overall Study|Withdrawal by Subject|1|||
37774065|NCT02607228|69299396|FG003|Overall Study|Study Terminated by Sponsor|1|||
37774066|NCT02607228|69299397|FG004|Overall Study|Study Terminated by Sponsor|0|||
37774067|NCT02607228|69299398|FG005|Overall Study|Study Terminated by Sponsor|0|||
37774068|NCT02607228|69299399|FG006|Overall Study|Study Terminated by Sponsor|0|||
37774069|NCT01668654|69299441|FG000|Overall Study|Study Closed/Terminated|3|||
37774070|NCT01668654|69299441|FG000|Overall Study|Withdrawal by Subject|1|||
37774071|NCT02608476|69299535|FG000|Overall Study|Withdrawal by Subject|30|||
37774072|NCT02608476|69299536|FG001|Overall Study|Withdrawal by Subject|37|||
37774073|NCT02608476|69299535|FG000|Overall Study|Lost to Follow-up|24|||
37774074|NCT02608476|69299536|FG001|Overall Study|Lost to Follow-up|24|||
37774075|NCT02608476|69299535|FG000|Overall Study|Adverse Event|2|||
37774076|NCT02608476|69299536|FG001|Overall Study|Adverse Event|8|||
37774077|NCT02608476|69299535|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
37774078|NCT02608476|69299536|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
37774079|NCT02608476|69299535|FG000|Overall Study|Noncompliance with treatment|1|||
37774080|NCT02608476|69299536|FG001|Overall Study|Noncompliance with treatment|5|||
37774081|NCT02608476|69299535|FG000|Overall Study|Lack of Efficacy|3|||
37774082|NCT02608476|69299536|FG001|Overall Study|Lack of Efficacy|1|||
37774083|NCT02608476|69299535|FG000|Overall Study|Other|0|||
37774084|NCT02608476|69299536|FG001|Overall Study|Other|1|||
37774085|NCT02608476|69299535|FG000|Overall Study|Physician Decision|1|||
37774086|NCT02608476|69299536|FG001|Overall Study|Physician Decision|0|||
37774087|NCT02608476|69299535|FG000|Overall Study|Pregnancy|0|||
37774088|NCT02608476|69299536|FG001|Overall Study|Pregnancy|1|||
37774089|NCT02608476|69299535|FG000|Overall Study|Progressive disease|1|||
37774090|NCT02608476|69299536|FG001|Overall Study|Progressive disease|0|||
37774091|NCT02607306|69299674|FG000|Overall Study|Adverse Event|8|||
37774092|NCT02607306|69299675|FG001|Overall Study|Adverse Event|6|||
37774093|NCT02607306|69299676|FG002|Overall Study|Adverse Event|6|||
37774094|NCT02607306|69299674|FG000|Overall Study|Unclassified|1|||
37774095|NCT02607306|69299675|FG001|Overall Study|Unclassified|4|||
37774096|NCT02607306|69299676|FG002|Overall Study|Unclassified|0|||
37774097|NCT02607306|69299674|FG000|Overall Study|Withdrawal by Subject|8|||
37774098|NCT02607306|69299675|FG001|Overall Study|Withdrawal by Subject|10|||
37774099|NCT02607306|69299676|FG002|Overall Study|Withdrawal by Subject|2|||
37774100|NCT02607306|69299674|FG000|Overall Study|Lack of Efficacy|0|||
37774101|NCT02607306|69299675|FG001|Overall Study|Lack of Efficacy|1|||
37774102|NCT02607306|69299676|FG002|Overall Study|Lack of Efficacy|1|||
37774103|NCT02607306|69299674|FG000|Overall Study|Protocol Violation|4|||
37774104|NCT02607306|69299675|FG001|Overall Study|Protocol Violation|2|||
37774105|NCT02607306|69299676|FG002|Overall Study|Protocol Violation|1|||
37774106|NCT02603952|69299999|FG000|Overall Study|Withdrawal by Subject|1|||
37774107|NCT02603952|69300000|FG001|Overall Study|Withdrawal by Subject|0|||
37774108|NCT02603952|69300001|FG002|Overall Study|Withdrawal by Subject|0|||
37774109|NCT02603952|69300002|FG003|Overall Study|Withdrawal by Subject|0|||
37774110|NCT02603952|69299999|FG000|Overall Study|Received oseltamivir by error|0|||
37774111|NCT02603952|69300000|FG001|Overall Study|Received oseltamivir by error|0|||
37774112|NCT02603952|69300001|FG002|Overall Study|Received oseltamivir by error|0|||
37774113|NCT02603952|69300002|FG003|Overall Study|Received oseltamivir by error|1|||
37774114|NCT02603172|69300516|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
37774115|NCT02603172|69300517|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
37774116|NCT02603172|69300518|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
37774117|NCT02603172|69300519|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
37774118|NCT02603172|69300520|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
37774119|NCT02603172|69300521|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
37774120|NCT02603172|69300522|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
37774121|NCT02603172|69300523|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
37774122|NCT02605824|69300644|FG000|Overall Study|Physician Decision|1|||
37774123|NCT02605824|69300645|FG001|Overall Study|Physician Decision|0|||
37774124|NCT02605122|69300775|FG000|Overall Study|Withdrawal by Subject|4|||
37774125|NCT02605122|69300776|FG001|Overall Study|Withdrawal by Subject|1|||
37774126|NCT02605122|69300775|FG000|Overall Study|Lost to Follow-up|1|||
37774127|NCT02605122|69300776|FG001|Overall Study|Lost to Follow-up|1|||
37774128|NCT01454102|69300827|FG000|Overall Study|Continuing in the treatment period|0|||
37774129|NCT01454102|69300828|FG001|Overall Study|Continuing in the treatment period|0|||
37774130|NCT01454102|69300829|FG002|Overall Study|Continuing in the treatment period|0|||
37774131|NCT01454102|69300830|FG003|Overall Study|Continuing in the treatment period|0|||
37774132|NCT01454102|69300831|FG004|Overall Study|Continuing in the treatment period|3|||
37774133|NCT01454102|69300832|FG005|Overall Study|Continuing in the treatment period|3|||
37863642|NCT01257425|69547226|FG000|Overall Study|Death|1|||
37774134|NCT01454102|69300833|FG006|Overall Study|Continuing in the treatment period|2|||
37774135|NCT01454102|69300834|FG007|Overall Study|Continuing in the treatment period|0|||
37774136|NCT01454102|69300835|FG008|Overall Study|Continuing in the treatment period|1|||
37774137|NCT01454102|69300836|FG009|Overall Study|Continuing in the treatment period|0|||
37774138|NCT01454102|69300837|FG010|Overall Study|Continuing in the treatment period|0|||
37774139|NCT01454102|69300838|FG011|Overall Study|Continuing in the treatment period|4|||
37774140|NCT01454102|69300839|FG012|Overall Study|Continuing in the treatment period|7|||
37774141|NCT01454102|69300840|FG013|Overall Study|Continuing in the treatment period|4|||
37774142|NCT01454102|69300841|FG014|Overall Study|Continuing in the treatment period|3|||
37774143|NCT01454102|69300842|FG015|Overall Study|Continuing in the treatment period|1|||
37774144|NCT02602080|69300936|FG000|Overall Study|Protocol Violation|6|||
37774145|NCT02602080|69300937|FG001|Overall Study|Protocol Violation|1|||
37774146|NCT02602080|69300938|FG002|Overall Study|Protocol Violation|3|||
37774147|NCT02604342|69301022|FG000|Overall Study|Death|32|||
37774148|NCT02604342|69301023|FG001|Overall Study|Death|16|||
37774149|NCT02604342|69301022|FG000|Overall Study|Progression of disease|1|||
37774150|NCT02604342|69301023|FG001|Overall Study|Progression of disease|0|||
37774151|NCT02604342|69301022|FG000|Overall Study|Withdrawal by Subject|5|||
37774152|NCT02604342|69301023|FG001|Overall Study|Withdrawal by Subject|6|||
37774153|NCT02604342|69301022|FG000|Overall Study|Other|1|||
37774154|NCT02604342|69301023|FG001|Overall Study|Other|0|||
37774155|NCT02604342|69301022|FG000|Overall Study|Study Termination by Sponsor|1|||
37774156|NCT02604342|69301023|FG001|Overall Study|Study Termination by Sponsor|0|||
37774157|NCT02604342|69301022|FG000|Overall Study|Lost to Follow-up|1|||
37774158|NCT02604342|69301023|FG001|Overall Study|Lost to Follow-up|1|||
37774159|NCT02604342|69301022|FG000|Overall Study|Physician Decision|2|||
37774160|NCT02604342|69301023|FG001|Overall Study|Physician Decision|0|||
37774161|NCT02604264|69301052|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
37774162|NCT02604264|69301053|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
37774163|NCT02601300|69301090|FG000|Induction Phase|Lack of Efficacy|2|||
37774164|NCT02601300|69301090|FG000|Induction Phase|Protocol Violation|1|||
37774165|NCT02601300|69301090|FG000|Extension Phase|Withdrawal by Subject|3|||
37774166|NCT02601300|69301090|FG000|Extension Phase|Adverse Event|4|||
37774167|NCT02601300|69301090|FG000|Extension Phase|Lack of Efficacy|10|||
37774168|NCT01471340|69301129|FG000|Overall Study|Death|5|||
37774169|NCT01471340|69301130|FG001|Overall Study|Death|4|||
37774170|NCT01471340|69301129|FG000|Overall Study|Lost to Follow-up|0|||
37774171|NCT01471340|69301130|FG001|Overall Study|Lost to Follow-up|1|||
37774172|NCT01471340|69301129|FG000|Overall Study|Investigational site closure|0|||
37774173|NCT01471340|69301130|FG001|Overall Study|Investigational site closure|1|||
37774174|NCT01471340|69301129|FG000|Overall Study|Invalid informed consent|1|||
37774175|NCT01471340|69301130|FG001|Overall Study|Invalid informed consent|0|||
37774176|NCT01492400|69301152|FG000|Overall Study|Miscellaneous Reasons|2|||
37774177|NCT01492400|69301153|FG001|Overall Study|Miscellaneous Reasons|3|||
37774178|NCT01492400|69301152|FG000|Overall Study|Personal Reasons|0|||
37774179|NCT01492400|69301153|FG001|Overall Study|Personal Reasons|5|||
37690586|NCT02152761|69166828|FG002|Epoch: Treatment Epoch|Death|1|||
37690587|NCT02152761|69166829|FG003|Epoch: Treatment Epoch|Death|0|||
37690588|NCT02152761|69166826|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
37690589|NCT02152761|69166827|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
37690590|NCT02152761|69166828|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
37690591|NCT02152761|69166829|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
37690592|NCT02152761|69166826|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
37690593|NCT02152761|69166827|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
37690594|NCT02152761|69166828|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
37690595|NCT02152761|69166829|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
37690596|NCT02152761|69166826|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
37690597|NCT02152761|69166827|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
37690598|NCT02152761|69166828|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
37690599|NCT02152761|69166829|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
37690600|NCT02152761|69166826|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
37690601|NCT02152761|69166827|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
37690602|NCT02152761|69166828|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
37690603|NCT02152761|69166829|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
37690604|NCT02152761|69166826|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
37690605|NCT02152761|69166827|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
37690606|NCT02152761|69166828|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
37690607|NCT02152761|69166829|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
37690608|NCT02152605|69166851|FG000|Overall Study|Adverse Event|6|||
37690609|NCT02152605|69166852|FG001|Overall Study|Adverse Event|8|||
37774180|NCT01492400|69301152|FG000|Overall Study|Lost to Follow-up|3|||
37690610|NCT02152605|69166851|FG000|Overall Study|Lack of Efficacy|7|||
37774181|NCT01492400|69301153|FG001|Overall Study|Lost to Follow-up|1|||
37774182|NCT01492400|69301152|FG000|Overall Study|Pregnancy|0|||
37774183|NCT01492400|69301153|FG001|Overall Study|Pregnancy|1|||
37774184|NCT01492400|69301152|FG000|Overall Study|Lack of Efficacy|1|||
37774185|NCT01492400|69301153|FG001|Overall Study|Lack of Efficacy|1|||
37774186|NCT01492400|69301152|FG000|Overall Study|Adverse Event|10|||
37774187|NCT01492400|69301153|FG001|Overall Study|Adverse Event|5|||
37774188|NCT02596854|69301278|FG000|Overall Study|Withdrawn|8|||
37774189|NCT02592876|69301415|FG000|Overall Study|Withdrawal by Subject|3|||
37774190|NCT02592876|69301416|FG001|Overall Study|Withdrawal by Subject|3|||
37774191|NCT02592876|69301415|FG000|Overall Study|Study Termination by Sponsor|32|||
37774192|NCT02592876|69301416|FG001|Overall Study|Study Termination by Sponsor|27|||
37774193|NCT02592876|69301415|FG000|Overall Study|Lost to Follow-up|0|||
37774194|NCT02592876|69301416|FG001|Overall Study|Lost to Follow-up|1|||
37774195|NCT02592876|69301415|FG000|Overall Study|Death|6|||
37774196|NCT02592876|69301416|FG001|Overall Study|Death|9|||
37774197|NCT01492088|69301433|FG000|Overall Study|Withdrawal by Patient|0|||
37774198|NCT01492088|69301434|FG001|Overall Study|Withdrawal by Patient|2|||
37774199|NCT01492088|69301435|FG002|Overall Study|Withdrawal by Patient|0|||
37774200|NCT01492088|69301433|FG000|Overall Study|Death|1|||
37774201|NCT01492088|69301434|FG001|Overall Study|Death|6|||
37774202|NCT01492088|69301435|FG002|Overall Study|Death|2|||
37774203|NCT01492088|69301433|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
37774204|NCT01492088|69301434|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
37774205|NCT01492088|69301435|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
37774206|NCT01492088|69301433|FG000|Overall Study|Alive at Last Follow-up|0|||
37774207|NCT01492088|69301434|FG001|Overall Study|Alive at Last Follow-up|6|||
37774208|NCT01492088|69301435|FG002|Overall Study|Alive at Last Follow-up|11|||
37774209|NCT02592798|69301677|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
37774210|NCT02592798|69301678|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
37774211|NCT02592798|69301677|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
37774212|NCT02592798|69301678|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
37774213|NCT02592798|69301677|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
37774214|NCT02592798|69301678|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
37774215|NCT02592798|69301677|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
37774216|NCT02592798|69301678|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
37774217|NCT02592798|69301677|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
37774218|NCT02592798|69301678|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
37774219|NCT02592798|69301677|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
37774220|NCT02592798|69301678|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
37774221|NCT02592798|69301677|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
37774222|NCT02592798|69301678|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
37774223|NCT02592798|69301677|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
37774224|NCT02592798|69301678|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
37774225|NCT02592798|69301677|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
37774226|NCT02592798|69301678|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
37774227|NCT02592798|69301677|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
37774228|NCT02592798|69301678|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
37774229|NCT02592798|69301677|FG000|Transition From DB2 to OLE|Other reasons|1|||
37774230|NCT02592798|69301678|FG001|Transition From DB2 to OLE|Other reasons|0|||
37774231|NCT02592798|69301677|FG000|Open Label Period (OLE)|Other reasons|0|||
37774232|NCT02592798|69301678|FG001|Open Label Period (OLE)|Other reasons|2|||
37774233|NCT02592798|69301677|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
37774234|NCT02592798|69301678|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
37774235|NCT02592798|69301677|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
37774236|NCT02592798|69301678|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
37774237|NCT02592798|69301677|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
37774238|NCT02592798|69301678|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
37774239|NCT02592798|69301677|FG000|Open Label Period (OLE)|Adverse Event|0|||
37774240|NCT02592798|69301678|FG001|Open Label Period (OLE)|Adverse Event|1|||
37774241|NCT00081653|69301718|FG000|Overall Study|Adverse Event|23|||
37774242|NCT00081653|69301719|FG001|Overall Study|Adverse Event|17|||
37774243|NCT00081653|69301718|FG000|Overall Study|Lost to Follow-up|2|||
37774244|NCT00081653|69301719|FG001|Overall Study|Lost to Follow-up|4|||
37968258|NCT02406027|69655361|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
37774245|NCT00081653|69301718|FG000|Overall Study|Refused Treatment|18|||
37774246|NCT00081653|69301719|FG001|Overall Study|Refused Treatment|14|||
37774247|NCT00081653|69301718|FG000|Overall Study|Low bone mineral density|1|||
37774248|NCT00081653|69301719|FG001|Overall Study|Low bone mineral density|0|||
37774249|NCT00081653|69301718|FG000|Overall Study|Bone loss|2|||
37774250|NCT00081653|69301719|FG001|Overall Study|Bone loss|0|||
37774251|NCT00081653|69301718|FG000|Overall Study|Participant leaving country|1|||
37774252|NCT00081653|69301719|FG001|Overall Study|Participant leaving country|0|||
37774253|NCT00081653|69301718|FG000|Overall Study|Loss of bone mass|0|||
37774254|NCT00081653|69301719|FG001|Overall Study|Loss of bone mass|2|||
37774255|NCT02596620|69301780|FG000|Overall Study|Lost to Follow-up|1|||
37774256|NCT02596620|69301781|FG001|Overall Study|Lost to Follow-up|1|||
37774257|NCT02596230|69301937|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
37774258|NCT02596230|69301938|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
37774259|NCT02596230|69301939|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
37774260|NCT02596230|69301940|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
37774261|NCT02596230|69301941|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
37774262|NCT02596230|69301937|FG000|Objective 2, One Year|Lost to Follow-up|0|||
37774263|NCT02596230|69301938|FG001|Objective 2, One Year|Lost to Follow-up|41|||
37774264|NCT02596230|69301939|FG002|Objective 2, One Year|Lost to Follow-up|41|||
37774265|NCT02596230|69301940|FG003|Objective 2, One Year|Lost to Follow-up|32|||
37774266|NCT02596230|69301941|FG004|Objective 2, One Year|Lost to Follow-up|46|||
37774267|NCT02596230|69301937|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
37774268|NCT02596230|69301938|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
37774269|NCT02596230|69301939|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
37774270|NCT02596230|69301940|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
37774271|NCT02596230|69301941|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
37774272|NCT02596230|69301937|FG000|Objective 2, One Year|Adverse drug reaction|0|||
37774273|NCT02596230|69301938|FG001|Objective 2, One Year|Adverse drug reaction|1|||
37774274|NCT02596230|69301939|FG002|Objective 2, One Year|Adverse drug reaction|0|||
37774275|NCT02596230|69301940|FG003|Objective 2, One Year|Adverse drug reaction|0|||
37774276|NCT02596230|69301941|FG004|Objective 2, One Year|Adverse drug reaction|0|||
37774277|NCT02596230|69301937|FG000|Objective 2, One Year|Death|0|||
37774278|NCT02596230|69301938|FG001|Objective 2, One Year|Death|12|||
37774279|NCT02596230|69301939|FG002|Objective 2, One Year|Death|41|||
37774280|NCT02596230|69301940|FG003|Objective 2, One Year|Death|21|||
37774281|NCT02596230|69301941|FG004|Objective 2, One Year|Death|30|||
37774282|NCT02596230|69301937|FG000|Objective 2, One Year|Other|0|||
37774283|NCT02596230|69301938|FG001|Objective 2, One Year|Other|3|||
37774284|NCT02596230|69301939|FG002|Objective 2, One Year|Other|2|||
37774285|NCT02596230|69301940|FG003|Objective 2, One Year|Other|0|||
37774286|NCT02596230|69301941|FG004|Objective 2, One Year|Other|0|||
37774287|NCT01667562|69301990|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
37774288|NCT01667562|69301991|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
37774289|NCT01667562|69301990|FG000|Erlotinib Phase|Lost to Follow-up|0|||
37774290|NCT01667562|69301991|FG001|Erlotinib Phase|Lost to Follow-up|1|||
37774291|NCT01667562|69301990|FG000|Erlotinib Phase|Adverse Event|0|||
37774292|NCT01667562|69301991|FG001|Erlotinib Phase|Adverse Event|1|||
37774293|NCT01667562|69301990|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
37774294|NCT01667562|69301991|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
37774295|NCT02595528|69302028|FG000|Overall Study|Withdrawal by Subject|1|||
37774296|NCT02595528|69302029|FG001|Overall Study|Withdrawal by Subject|2|||
37774297|NCT02595528|69302030|FG002|Overall Study|Withdrawal by Subject|1|||
37774298|NCT02595528|69302031|FG003|Overall Study|Withdrawal by Subject|3|||
37774299|NCT02595528|69302028|FG000|Overall Study|Lost to Follow-up|1|||
37774300|NCT02595528|69302029|FG001|Overall Study|Lost to Follow-up|1|||
37774301|NCT02595528|69302030|FG002|Overall Study|Lost to Follow-up|0|||
37774302|NCT02595528|69302031|FG003|Overall Study|Lost to Follow-up|1|||
37774303|NCT02595450|69302059|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
37774304|NCT02595450|69302059|FG000|Overall Study|Enrolled, but not treated|8|||
37774305|NCT02592018|69302063|FG000|Overall Study|Adverse Event|1|||
37774306|NCT02592018|69302063|FG000|Overall Study|Lost to Follow-up|1|||
37774307|NCT02591238|69302071|FG000|Overall Study|Pregnancy|1|||
37774308|NCT02591238|69302072|FG001|Overall Study|Pregnancy|0|||
37774309|NCT02591238|69302073|FG002|Overall Study|Pregnancy|0|||
37774310|NCT02591238|69302074|FG003|Overall Study|Pregnancy|0|||
37774311|NCT02591238|69302071|FG000|Overall Study|Withdrawal by Subject|0|||
37774312|NCT02591238|69302072|FG001|Overall Study|Withdrawal by Subject|0|||
37774313|NCT02591238|69302073|FG002|Overall Study|Withdrawal by Subject|0|||
37968259|NCT02406027|69655362|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
37774314|NCT02591238|69302074|FG003|Overall Study|Withdrawal by Subject|1|||
37774315|NCT02591238|69302071|FG000|Overall Study|influenza|0|||
37774316|NCT02591238|69302072|FG001|Overall Study|influenza|0|||
37774317|NCT02591238|69302073|FG002|Overall Study|influenza|0|||
37774318|NCT02591238|69302074|FG003|Overall Study|influenza|1|||
37774319|NCT02591238|69302071|FG000|Overall Study|personal circumstances|0|||
37774320|NCT02591238|69302072|FG001|Overall Study|personal circumstances|0|||
37774321|NCT02591238|69302073|FG002|Overall Study|personal circumstances|0|||
37774322|NCT02591238|69302074|FG003|Overall Study|personal circumstances|1|||
37774323|NCT02591238|69302071|FG000|Overall Study|personal circumstances|0|||
37774324|NCT02591238|69302072|FG001|Overall Study|personal circumstances|1|||
37774325|NCT02591238|69302073|FG002|Overall Study|personal circumstances|0|||
37774326|NCT02591238|69302074|FG003|Overall Study|personal circumstances|0|||
37774327|NCT02597946|69302156|FG000|Overall Study|Withdrawal by Subject|1|||
37774328|NCT02597946|69302156|FG000|Overall Study|Progressive disease|16|||
37774329|NCT02597946|69302156|FG000|Overall Study|Other than above|1|||
37774330|NCT02597712|69302162|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
37774331|NCT02597712|69302163|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
37774332|NCT02597712|69302162|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
37774333|NCT02597712|69302163|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
37774334|NCT02597712|69302162|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
37774335|NCT02597712|69302163|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
37774336|NCT02597478|69302171|FG000|Overall Study|Withdrawal by Subject|2|||
37774337|NCT02597478|69302172|FG001|Overall Study|Withdrawal by Subject|0|||
37774338|NCT02597478|69302171|FG000|Overall Study|Change of opioid dose|1|||
37774339|NCT02597478|69302172|FG001|Overall Study|Change of opioid dose|0|||
37774340|NCT02597478|69302171|FG000|Overall Study|Insufficient exertional dyspnea|0|||
37774341|NCT02597478|69302172|FG001|Overall Study|Insufficient exertional dyspnea|1|||
37774342|NCT01471028|69302267|FG000|VTI-208|Adverse Event|39|||
37774343|NCT01471028|69302268|FG001|VTI-208|Adverse Event|41|||
37774344|NCT01471028|69302267|FG000|VTI-208|Withdrawal by Subject|0|||
37774345|NCT01471028|69302268|FG001|VTI-208|Withdrawal by Subject|2|||
37774346|NCT01471028|69302267|FG000|VTI-208|Lost to Follow-up|1|||
37774347|NCT01471028|69302268|FG001|VTI-208|Lost to Follow-up|1|||
37774348|NCT01471028|69302267|FG000|VTI-208E|Death|7|||
37774349|NCT01471028|69302268|FG001|VTI-208E|Death|10|||
37774350|NCT01471028|69302267|FG000|VTI-208E|Withdrawal by Subject|1|||
37774351|NCT01471028|69302268|FG001|VTI-208E|Withdrawal by Subject|0|||
37774352|NCT01471028|69302267|FG000|VTI-208E|Lost to Follow-up|0|||
37774353|NCT01471028|69302268|FG001|VTI-208E|Lost to Follow-up|2|||
37774354|NCT01491854|69302282|FG000|Overall Study|mainly due to premature termination|93|||
37774355|NCT01491854|69302282|FG000|Overall Study|Death|1|||
37774356|NCT01491854|69302282|FG000|Overall Study|Withdrawal by Subject|3|||
37774357|NCT01491854|69302282|FG000|Overall Study|Lost to Follow-up|33|||
37774358|NCT01470248|69302290|FG000|Overall Study|Withdrawal by Subject|1|||
37774359|NCT01490918|69302310|FG000|Overall Study|Lost to Follow-up|2|||
37774360|NCT01490918|69302311|FG001|Overall Study|Lost to Follow-up|1|||
37774361|NCT01490918|69302312|FG002|Overall Study|Lost to Follow-up|0|||
37774362|NCT01490918|69302310|FG000|Overall Study|Withdrawal by Subject|7|||
37774363|NCT01490918|69302311|FG001|Overall Study|Withdrawal by Subject|8|||
37774364|NCT01490918|69302312|FG002|Overall Study|Withdrawal by Subject|3|||
37774365|NCT01490918|69302310|FG000|Overall Study|Adverse Event|0|||
37774366|NCT01490918|69302311|FG001|Overall Study|Adverse Event|0|||
37774367|NCT01490918|69302312|FG002|Overall Study|Adverse Event|1|||
37774368|NCT01490918|69302310|FG000|Overall Study|other cause|4|||
37774369|NCT01490918|69302311|FG001|Overall Study|other cause|5|||
37774370|NCT01490918|69302312|FG002|Overall Study|other cause|8|||
37774371|NCT01490840|69302344|FG000|Phase 1|Lost to Follow-up|1|||
37774372|NCT01490840|69302345|FG001|Phase 1|Lost to Follow-up|0|||
37774373|NCT01490840|69302344|FG000|Phase 1|Adverse Event|2|||
37774374|NCT01490840|69302345|FG001|Phase 1|Adverse Event|1|||
37774375|NCT01490840|69302344|FG000|Phase 1|Withdrawal by Subject|6|||
37774376|NCT01490840|69302345|FG001|Phase 1|Withdrawal by Subject|5|||
37774377|NCT01490840|69302344|FG000|Phase 1|Visit 6a omitted|1|||
37774378|NCT01490840|69302345|FG001|Phase 1|Visit 6a omitted|0|||
37774379|NCT01490840|69302344|FG000|Phase 2|Withdrawal by Subject|4|||
37774380|NCT01490840|69302345|FG001|Phase 2|Withdrawal by Subject|3|||
37774381|NCT01490840|69302344|FG000|Phase 2|Permanent interruption of fingolimod|0|||
37774382|NCT01490840|69302345|FG001|Phase 2|Permanent interruption of fingolimod|1|||
37774383|NCT01490840|69302344|FG000|Phase 2|Lost to Follow-up|1|||
37774384|NCT01490840|69302345|FG001|Phase 2|Lost to Follow-up|1|||
37774385|NCT01490840|69302344|FG000|Phase 2|Adverse Event|1|||
37774386|NCT01490840|69302345|FG001|Phase 2|Adverse Event|1|||
37774387|NCT01490450|69302377|FG000|Period 1|Lack of Efficacy|2|||
37968260|NCT02406027|69655363|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
37968261|NCT02406027|69655364|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
37968262|NCT02406027|69655358|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
37968263|NCT02406027|69655359|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
37774388|NCT01490450|69302378|FG001|Period 1|Lack of Efficacy|0|||
37863643|NCT01257425|69547227|FG001|Overall Study|Death|0|||
37863644|NCT00995488|69547233|FG000|Overall Study|Withdrawal by Subject|1|||
37774389|NCT01490450|69302379|FG002|Period 1|Lack of Efficacy|3|||
37774390|NCT01490450|69302380|FG003|Period 1|Lack of Efficacy|0|||
37774391|NCT01490450|69302377|FG000|Period 1|Adverse Event|0|||
37774392|NCT01490450|69302378|FG001|Period 1|Adverse Event|0|||
37968264|NCT02406027|69655360|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
37774393|NCT01490450|69302379|FG002|Period 1|Adverse Event|0|||
37774394|NCT01490450|69302380|FG003|Period 1|Adverse Event|5|||
37774395|NCT01490450|69302377|FG000|Period 1|Request to discontinue treatment|1|||
37774396|NCT01490450|69302378|FG001|Period 1|Request to discontinue treatment|0|||
37774397|NCT01490450|69302379|FG002|Period 1|Request to discontinue treatment|0|||
37774398|NCT01490450|69302380|FG003|Period 1|Request to discontinue treatment|0|||
37774399|NCT01490450|69302377|FG000|Period 1|Withdrawal by Subject|0|||
37774400|NCT01490450|69302378|FG001|Period 1|Withdrawal by Subject|0|||
37774401|NCT01490450|69302379|FG002|Period 1|Withdrawal by Subject|0|||
37774402|NCT01490450|69302380|FG003|Period 1|Withdrawal by Subject|3|||
37774403|NCT01490450|69302377|FG000|Period 1|No longer met study criteria|0|||
37774404|NCT01490450|69302378|FG001|Period 1|No longer met study criteria|1|||
37774405|NCT01490450|69302379|FG002|Period 1|No longer met study criteria|1|||
37774406|NCT01490450|69302380|FG003|Period 1|No longer met study criteria|0|||
37774407|NCT01490450|69302377|FG000|Period 2|Lack of Efficacy|0|||
37774408|NCT01490450|69302378|FG001|Period 2|Lack of Efficacy|0|||
37774409|NCT01490450|69302379|FG002|Period 2|Lack of Efficacy|0|||
37774410|NCT01490450|69302380|FG003|Period 2|Lack of Efficacy|1|||
37774411|NCT01490450|69302377|FG000|Period 2|Adverse Event|1|||
37774412|NCT01490450|69302378|FG001|Period 2|Adverse Event|1|||
37774413|NCT01490450|69302379|FG002|Period 2|Adverse Event|0|||
37774414|NCT01490450|69302380|FG003|Period 2|Adverse Event|1|||
37774415|NCT01490450|69302377|FG000|Period 2|Withdrawal by Subject|1|||
37774416|NCT01490450|69302378|FG001|Period 2|Withdrawal by Subject|0|||
37774417|NCT01490450|69302379|FG002|Period 2|Withdrawal by Subject|0|||
37774418|NCT01490450|69302380|FG003|Period 2|Withdrawal by Subject|0|||
37774419|NCT01490450|69302377|FG000|Period 2|Lost to Follow-up|0|||
37774420|NCT01490450|69302378|FG001|Period 2|Lost to Follow-up|0|||
37774421|NCT01490450|69302379|FG002|Period 2|Lost to Follow-up|0|||
37774422|NCT01490450|69302380|FG003|Period 2|Lost to Follow-up|2|||
37774423|NCT01469546|69302424|FG000|Received 5 mg Dose|Adverse Event|13|||
37774424|NCT01469546|69302424|FG000|Received 5 mg Dose|Death|2|||
37774425|NCT01469546|69302424|FG000|Received 5 mg Dose|Protocol Violation|2|||
37774426|NCT01469546|69302424|FG000|Received 5 mg Dose|Progressive Disease|3|||
37774427|NCT01469546|69302424|FG000|Received 5 mg Dose|Physician Decision|3|||
37774428|NCT00081497|69302430|FG000|Overall Study|Adverse Event|2|||
37774429|NCT00081497|69302431|FG001|Overall Study|Adverse Event|0|||
37774430|NCT00081497|69302430|FG000|Overall Study|Death|0|||
37774431|NCT00081497|69302431|FG001|Overall Study|Death|1|||
37774432|NCT00081497|69302430|FG000|Overall Study|Withdrawal by Subject|1|||
37774433|NCT00081497|69302431|FG001|Overall Study|Withdrawal by Subject|0|||
37774434|NCT00081497|69302430|FG000|Overall Study|Non-compliance|0|||
37774435|NCT00081497|69302431|FG001|Overall Study|Non-compliance|1|||
37774436|NCT00081263|69302445|FG000|Overall Study|clerical error|1|||
37774437|NCT00081263|69302446|FG001|Overall Study|clerical error|0|||
37774438|NCT00081263|69302445|FG000|Overall Study|wrong cell type|7|||
37774439|NCT00081263|69302446|FG001|Overall Study|wrong cell type|5|||
37774440|NCT00081263|69302445|FG000|Overall Study|improper pre-protocol therapy|0|||
37774441|NCT00081263|69302446|FG001|Overall Study|improper pre-protocol therapy|1|||
37774442|NCT00081263|69302445|FG000|Overall Study|Inadequate pathology|0|||
37774443|NCT00081263|69302446|FG001|Overall Study|Inadequate pathology|1|||
37774444|NCT00081263|69302445|FG000|Overall Study|Never treated|4|||
37774445|NCT00081263|69302446|FG001|Overall Study|Never treated|5|||
37774446|NCT00081263|69302445|FG000|Overall Study|Inadequate data|5|||
37774447|NCT00081263|69302446|FG001|Overall Study|Inadequate data|10|||
37774448|NCT01490294|69302456|FG000|Overall Study|Prematurely discontinuation|4|||
37774449|NCT01490294|69302457|FG001|Overall Study|Prematurely discontinuation|0|||
37774450|NCT01490294|69302458|FG002|Overall Study|Prematurely discontinuation|1|||
37774451|NCT01490294|69302459|FG003|Overall Study|Prematurely discontinuation|1|||
37774452|NCT01490294|69302456|FG000|Overall Study|Adverse Event|1|||
37774453|NCT01490294|69302457|FG001|Overall Study|Adverse Event|0|||
37774454|NCT01490294|69302458|FG002|Overall Study|Adverse Event|0|||
37774455|NCT01490294|69302459|FG003|Overall Study|Adverse Event|0|||
37863645|NCT01256879|69547237|FG000|Overall Study|Withdrawal by Subject|1|||
37968265|NCT02406027|69655361|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
37774456|NCT00080483|69302486|FG000|Overall Study|Lost to Follow-up|1|||
37774457|NCT00080483|69302487|FG001|Overall Study|Lost to Follow-up|1|||
37774458|NCT00080483|69302486|FG000|Overall Study|Physician Decision|1|||
37774459|NCT00080483|69302487|FG001|Overall Study|Physician Decision|1|||
37774460|NCT00089141|69302508|FG000|Overall Study|Termination of trial|18|||
37774461|NCT00089141|69302509|FG001|Overall Study|Termination of trial|24|||
37774462|NCT02588664|69302555|FG000|Overall Study|Death|56|||
37774463|NCT02588664|69302556|FG001|Overall Study|Death|55|||
37774464|NCT02588664|69302555|FG000|Overall Study|Lost to Follow-up|1305|||
37774465|NCT02588664|69302556|FG001|Overall Study|Lost to Follow-up|990|||
37774466|NCT00083759|69302619|FG000|Overall Study|Adverse Event|5|||
37774467|NCT00083759|69302620|FG001|Overall Study|Adverse Event|3|||
37774468|NCT00083759|69302619|FG000|Overall Study|Lost to Follow-up|1|||
37774469|NCT00083759|69302620|FG001|Overall Study|Lost to Follow-up|0|||
37774470|NCT00083759|69302619|FG000|Overall Study|Death|1|||
37774471|NCT00083759|69302620|FG001|Overall Study|Death|1|||
37774472|NCT00083759|69302619|FG000|Overall Study|Inadequate Therapeutic Response|32|||
37774473|NCT00083759|69302620|FG001|Overall Study|Inadequate Therapeutic Response|35|||
37774474|NCT00083759|69302619|FG000|Overall Study|Subject Withdrew Consent|2|||
37774475|NCT00083759|69302620|FG001|Overall Study|Subject Withdrew Consent|2|||
37774476|NCT00083759|69302619|FG000|Overall Study|Non-Compliance|1|||
37774477|NCT00083759|69302620|FG001|Overall Study|Non-Compliance|0|||
37774478|NCT00083759|69302619|FG000|Overall Study|Sponsor's Discretion|28|||
37774479|NCT00083759|69302620|FG001|Overall Study|Sponsor's Discretion|29|||
37774480|NCT00083759|69302619|FG000|Overall Study|Other|14|||
37774481|NCT00083759|69302620|FG001|Overall Study|Other|13|||
37774482|NCT00089609|69302746|FG000|Overall Study|Withdrawal by Subject|3|||
37774483|NCT00089609|69302747|FG001|Overall Study|Withdrawal by Subject|1|||
37774484|NCT02440581|69302888|FG000|Overall Study|Death|0|||
37774485|NCT02440581|69302889|FG001|Overall Study|Death|0|||
37774486|NCT02440581|69302890|FG002|Overall Study|Death|7|||
37774487|NCT02440581|69302891|FG003|Overall Study|Death|5|||
37774488|NCT02440581|69302888|FG000|Overall Study|Transplanted|1|||
37774489|NCT02440581|69302889|FG001|Overall Study|Transplanted|0|||
37774490|NCT02440581|69302890|FG002|Overall Study|Transplanted|3|||
37774491|NCT02440581|69302891|FG003|Overall Study|Transplanted|2|||
37774492|NCT02440581|69302888|FG000|Overall Study|Withdrawal by Subject|4|||
37774493|NCT02440581|69302889|FG001|Overall Study|Withdrawal by Subject|11|||
37774494|NCT02440581|69302890|FG002|Overall Study|Withdrawal by Subject|3|||
37774495|NCT02440581|69302891|FG003|Overall Study|Withdrawal by Subject|7|||
37774496|NCT01359150|69302903|FG000|Overall Study|Lack of Efficacy|1|||
37774497|NCT01359150|69302904|FG001|Overall Study|Lack of Efficacy|1|||
37774498|NCT01359150|69302903|FG000|Overall Study|Withdrawal by Subject|1|||
37774499|NCT01359150|69302904|FG001|Overall Study|Withdrawal by Subject|1|||
37774500|NCT01359150|69302903|FG000|Overall Study|Adverse Event|4|||
37774501|NCT01359150|69302904|FG001|Overall Study|Adverse Event|3|||
37774502|NCT01359150|69302903|FG000|Overall Study|Other|1|||
37774503|NCT01359150|69302904|FG001|Overall Study|Other|0|||
37774504|NCT01469000|69302965|FG000|Overall Study|Withdrawal by Subject|16|||
37774505|NCT01469000|69302966|FG001|Overall Study|Withdrawal by Subject|3|||
37774506|NCT01469000|69302965|FG000|Overall Study|Sponsor Decision|4|||
37774507|NCT01469000|69302966|FG001|Overall Study|Sponsor Decision|1|||
37774508|NCT01490060|69302979|FG000|Cycle 1|Change of Treatment|0|||
37774509|NCT01490060|69302980|FG001|Cycle 1|Change of Treatment|1|||
37774510|NCT01490060|69302981|FG002|Cycle 1|Change of Treatment|1|||
37774511|NCT01490060|69302982|FG003|Cycle 1|Change of Treatment|1|||
37774512|NCT01490060|69302979|FG000|Cycle 1|Insurance Denied|0|||
37774513|NCT01490060|69302980|FG001|Cycle 1|Insurance Denied|0|||
37774514|NCT01490060|69302981|FG002|Cycle 1|Insurance Denied|2|||
37774515|NCT01490060|69302982|FG003|Cycle 1|Insurance Denied|0|||
37774516|NCT01490060|69302979|FG000|Cycle 1|Withdrawal by Subject|0|||
37774517|NCT01490060|69302980|FG001|Cycle 1|Withdrawal by Subject|0|||
37774518|NCT01490060|69302981|FG002|Cycle 1|Withdrawal by Subject|0|||
37774519|NCT01490060|69302982|FG003|Cycle 1|Withdrawal by Subject|1|||
37774520|NCT01490060|69302979|FG000|Cycle 1|Treatment at Another Facility|0|||
37774521|NCT01490060|69302980|FG001|Cycle 1|Treatment at Another Facility|0|||
37774522|NCT01490060|69302981|FG002|Cycle 1|Treatment at Another Facility|0|||
37774523|NCT01490060|69302982|FG003|Cycle 1|Treatment at Another Facility|1|||
37774524|NCT01490060|69302979|FG000|Cycle 2|Change of Treatment|1|||
37774525|NCT01490060|69302980|FG001|Cycle 2|Change of Treatment|1|||
37690611|NCT02152605|69166852|FG001|Overall Study|Lack of Efficacy|4|||
37690612|NCT02152605|69166851|FG000|Overall Study|Protocol deviation|1|||
37690613|NCT02152605|69166852|FG001|Overall Study|Protocol deviation|4|||
37690614|NCT02152605|69166851|FG000|Overall Study|Lost to Follow-up|1|||
37690615|NCT02152605|69166852|FG001|Overall Study|Lost to Follow-up|0|||
37690616|NCT02152605|69166851|FG000|Overall Study|Withdrew consent|4|||
37690617|NCT02152605|69166852|FG001|Overall Study|Withdrew consent|2|||
37690618|NCT02152371|69166861|FG000|Overall Study|Adverse Event|6|||
37690619|NCT02152371|69166862|FG001|Overall Study|Adverse Event|2|||
37690620|NCT02152371|69166861|FG000|Overall Study|Withdrawal by Subject|3|||
37690621|NCT02152371|69166862|FG001|Overall Study|Withdrawal by Subject|7|||
37690622|NCT02152371|69166861|FG000|Overall Study|Protocol Violation|2|||
37690623|NCT02152371|69166862|FG001|Overall Study|Protocol Violation|3|||
37690624|NCT02152371|69166861|FG000|Overall Study|Lost to Follow-up|1|||
37690625|NCT02152371|69166862|FG001|Overall Study|Lost to Follow-up|0|||
37774526|NCT01490060|69302981|FG002|Cycle 2|Change of Treatment|0|||
37774527|NCT01490060|69302982|FG003|Cycle 2|Change of Treatment|0|||
37774528|NCT01490060|69302979|FG000|Cycle 2|Non-Compliance|0|||
37774529|NCT01490060|69302980|FG001|Cycle 2|Non-Compliance|0|||
37774530|NCT01490060|69302981|FG002|Cycle 2|Non-Compliance|1|||
37774531|NCT01490060|69302982|FG003|Cycle 2|Non-Compliance|0|||
37774532|NCT01490060|69302979|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
37774533|NCT01490060|69302980|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
37774534|NCT01490060|69302981|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
37690626|NCT02152371|69166861|FG000|Overall Study|Lack of Efficacy|0|||
37774535|NCT01490060|69302982|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
37774536|NCT01452152|69303034|FG000|Overall Study|Study termination by sponsor|5|||
37774537|NCT01452152|69303035|FG001|Overall Study|Study termination by sponsor|0|||
37774538|NCT01452152|69303036|FG002|Overall Study|Study termination by sponsor|4|||
37774539|NCT01451762|69303047|FG000|Overall Study|Lost to Follow-up|3|||
37774540|NCT01451762|69303048|FG001|Overall Study|Lost to Follow-up|6|||
37774541|NCT01451762|69303049|FG002|Overall Study|Lost to Follow-up|6|||
37774542|NCT01468844|69303084|FG000|Overall Study|Adverse Event|1|||
37774543|NCT01468844|69303085|FG001|Overall Study|Adverse Event|0|||
37774544|NCT01468844|69303084|FG000|Overall Study|Withdrawal by Subject|1|||
37774545|NCT01468844|69303085|FG001|Overall Study|Withdrawal by Subject|0|||
37774546|NCT01451606|69303109|FG000|Overall Study|Withdrawal by Subject|4|||
37774547|NCT01451606|69303110|FG001|Overall Study|Withdrawal by Subject|3|||
37774548|NCT00473343|69303165|FG000|Overall Study|Adverse Event|9|||
37774549|NCT00473343|69303165|FG000|Overall Study|Lost to Follow-up|8|||
37774550|NCT00473343|69303165|FG000|Overall Study|Treatment failure|27|||
37774551|NCT00473343|69303165|FG000|Overall Study|Withdrew consent|3|||
37774552|NCT00473343|69303165|FG000|Overall Study|Other un-specified reason|3|||
37774553|NCT02587962|69303622|FG000|Overall Study|Adverse Event|0|||
37774554|NCT02587962|69303623|FG001|Overall Study|Adverse Event|0|||
37774555|NCT02587962|69303624|FG002|Overall Study|Adverse Event|1|||
37774556|NCT02587962|69303625|FG003|Overall Study|Adverse Event|0|||
37774557|NCT02587962|69303626|FG004|Overall Study|Adverse Event|0|||
37774558|NCT02587962|69303622|FG000|Overall Study|Withdrawal by Subject|0|||
37774559|NCT02587962|69303623|FG001|Overall Study|Withdrawal by Subject|0|||
37774560|NCT02587962|69303624|FG002|Overall Study|Withdrawal by Subject|1|||
37774561|NCT02587962|69303625|FG003|Overall Study|Withdrawal by Subject|1|||
37774562|NCT02587962|69303626|FG004|Overall Study|Withdrawal by Subject|4|||
37774563|NCT02587962|69303622|FG000|Overall Study|Radiological progression|2|||
37774564|NCT02587962|69303623|FG001|Overall Study|Radiological progression|2|||
37774565|NCT02587962|69303624|FG002|Overall Study|Radiological progression|2|||
37774566|NCT02587962|69303625|FG003|Overall Study|Radiological progression|5|||
37774567|NCT02587962|69303626|FG004|Overall Study|Radiological progression|10|||
37774568|NCT02587962|69303622|FG000|Overall Study|Clinical progression|0|||
37774569|NCT02587962|69303623|FG001|Overall Study|Clinical progression|1|||
37774570|NCT02587962|69303624|FG002|Overall Study|Clinical progression|2|||
37774571|NCT02587962|69303625|FG003|Overall Study|Clinical progression|0|||
37774572|NCT02587962|69303626|FG004|Overall Study|Clinical progression|1|||
37774573|NCT01440374|69303771|FG000|Part 1: Open-label Phase|Adverse Event|5|||
37774574|NCT01440374|69303772|FG001|Part 1: Open-label Phase|Adverse Event|0|||
37774575|NCT01440374|69303773|FG002|Part 1: Open-label Phase|Adverse Event|0|||
37774576|NCT01440374|69303774|FG003|Part 1: Open-label Phase|Adverse Event|0|||
37774577|NCT01440374|69303771|FG000|Part 1: Open-label Phase|Physician Decision|1|||
37774578|NCT01440374|69303772|FG001|Part 1: Open-label Phase|Physician Decision|0|||
37774579|NCT01440374|69303773|FG002|Part 1: Open-label Phase|Physician Decision|0|||
37774580|NCT01440374|69303774|FG003|Part 1: Open-label Phase|Physician Decision|0|||
37774581|NCT01440374|69303771|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
37774582|NCT01440374|69303772|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
37774583|NCT01440374|69303773|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
37774584|NCT01440374|69303774|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
37774585|NCT01440374|69303771|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
37774586|NCT01440374|69303772|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
37774587|NCT01440374|69303773|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
37774588|NCT01440374|69303774|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
37774589|NCT01440374|69303771|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
37774590|NCT01440374|69303772|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
37774591|NCT01440374|69303773|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
37774592|NCT01440374|69303774|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
37774593|NCT01440374|69303771|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
37690627|NCT02152371|69166862|FG001|Overall Study|Lack of Efficacy|1|||
37690628|NCT02152371|69166861|FG000|Overall Study|Physician Decision|0|||
37690629|NCT02152371|69166862|FG001|Overall Study|Physician Decision|2|||
37690630|NCT02152371|69166861|FG000|Overall Study|Reason Not Given|0|||
37690631|NCT02152371|69166862|FG001|Overall Study|Reason Not Given|1|||
37690632|NCT02332291|69166870|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
37690633|NCT02332291|69166871|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
37690634|NCT02332291|69166870|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
37690635|NCT02332291|69166871|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
37774594|NCT01440374|69303772|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
37774595|NCT01440374|69303773|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
37774596|NCT01440374|69303774|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
37774597|NCT01440374|69303771|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
37690636|NCT02332291|69166870|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
37774598|NCT01440374|69303772|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
37774599|NCT01440374|69303773|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
37774600|NCT01440374|69303774|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
37774601|NCT01440374|69303771|FG000|Part 2; Double-blind Phase|Not treated|0|||
37774602|NCT01440374|69303772|FG001|Part 2; Double-blind Phase|Not treated|0|||
37774603|NCT01440374|69303773|FG002|Part 2; Double-blind Phase|Not treated|1|||
37774604|NCT01440374|69303774|FG003|Part 2; Double-blind Phase|Not treated|0|||
37774605|NCT01440374|69303771|FG000|Part 3: Extension|Withdrawal by Subject|0|||
37774606|NCT01440374|69303772|FG001|Part 3: Extension|Withdrawal by Subject|0|||
37774607|NCT01440374|69303773|FG002|Part 3: Extension|Withdrawal by Subject|0|||
37774608|NCT01440374|69303774|FG003|Part 3: Extension|Withdrawal by Subject|5|||
37774609|NCT01440374|69303771|FG000|Part 3: Extension|Adverse Event|0|||
37774610|NCT01440374|69303772|FG001|Part 3: Extension|Adverse Event|0|||
37774611|NCT01440374|69303773|FG002|Part 3: Extension|Adverse Event|0|||
37774612|NCT01440374|69303774|FG003|Part 3: Extension|Adverse Event|13|||
37774613|NCT01440374|69303771|FG000|Part 3: Extension|Physician Decision|0|||
37774614|NCT01440374|69303772|FG001|Part 3: Extension|Physician Decision|0|||
37774615|NCT01440374|69303773|FG002|Part 3: Extension|Physician Decision|0|||
37774616|NCT01440374|69303774|FG003|Part 3: Extension|Physician Decision|14|||
37774617|NCT01666782|69303922|FG000|Overall Study|Received 2 doses of vaccine|0|||
37774618|NCT01666782|69303923|FG001|Overall Study|Received 2 doses of vaccine|1|||
37774619|NCT01666782|69303922|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
37774620|NCT01666782|69303923|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
37774621|NCT01439360|69303939|FG000|Overall Study|Adverse Event|4|||
37774622|NCT01439360|69303940|FG001|Overall Study|Adverse Event|16|||
37774623|NCT01439360|69303939|FG000|Overall Study|Lost to Follow-up|43|||
37774624|NCT01439360|69303940|FG001|Overall Study|Lost to Follow-up|58|||
37774625|NCT01439360|69303939|FG000|Overall Study|Others|10|||
37774626|NCT01439360|69303940|FG001|Overall Study|Others|5|||
37774627|NCT01439360|69303939|FG000|Overall Study|Protocol Violation|1|||
37774628|NCT01439360|69303940|FG001|Overall Study|Protocol Violation|0|||
37774629|NCT01439360|69303939|FG000|Overall Study|Withdrawal by Subject|140|||
37774630|NCT01439360|69303940|FG001|Overall Study|Withdrawal by Subject|129|||
37774631|NCT01439204|69304117|FG000|Overall Study|Withdrawal by Subject|0|||
37774632|NCT01439204|69304118|FG001|Overall Study|Withdrawal by Subject|1|||
37774633|NCT01439204|69304117|FG000|Overall Study|Lost to Follow-up|0|||
37774634|NCT01439204|69304118|FG001|Overall Study|Lost to Follow-up|2|||
37774635|NCT01439204|69304117|FG000|Overall Study|No longer meets study criteria|1|||
37774636|NCT01439204|69304118|FG001|Overall Study|No longer meets study criteria|0|||
37774637|NCT01439204|69304117|FG000|Overall Study|poor/non-compliance|3|||
37774638|NCT01439204|69304118|FG001|Overall Study|poor/non-compliance|0|||
37774639|NCT01439126|69304164|FG000|Overall Study|Adverse Event|2|||
37774640|NCT01439126|69304165|FG001|Overall Study|Adverse Event|0|||
37774641|NCT01439126|69304164|FG000|Overall Study|Withdrawal by Subject|5|||
37774642|NCT01439126|69304165|FG001|Overall Study|Withdrawal by Subject|21|||
37774643|NCT01439126|69304164|FG000|Overall Study|Protocol Violation|6|||
37774644|NCT01439126|69304165|FG001|Overall Study|Protocol Violation|4|||
37774645|NCT01439126|69304164|FG000|Overall Study|Lost to Follow-up|6|||
37774646|NCT01439126|69304165|FG001|Overall Study|Lost to Follow-up|3|||
37774647|NCT01439126|69304164|FG000|Overall Study|Other-Use of prohibited treatment|0|||
37774648|NCT01439126|69304165|FG001|Overall Study|Other-Use of prohibited treatment|2|||
37774649|NCT01439126|69304164|FG000|Overall Study|Other-Miscellaneous|12|||
37774650|NCT01439126|69304165|FG001|Overall Study|Other-Miscellaneous|12|||
37774651|NCT01449812|69304191|FG000|Overall Study|Migrated/moved from study area|1|||
37774652|NCT01449812|69304192|FG001|Overall Study|Migrated/moved from study area|0|||
37863646|NCT01125189|69547250|FG000|Treatment Period|Lack of Efficacy|15|||
37774653|NCT01449812|69304193|FG002|Overall Study|Migrated/moved from study area|0|||
37774654|NCT01449812|69304191|FG000|Overall Study|Withdrawal by Subject|0|||
37774655|NCT01449812|69304192|FG001|Overall Study|Withdrawal by Subject|0|||
37774656|NCT01449812|69304193|FG002|Overall Study|Withdrawal by Subject|1|||
37774657|NCT01449812|69304191|FG000|Overall Study|Lost to Follow-up|1|||
37774658|NCT01449812|69304192|FG001|Overall Study|Lost to Follow-up|0|||
37774659|NCT01449812|69304193|FG002|Overall Study|Lost to Follow-up|0|||
37774660|NCT01665144|69304246|FG000|Overall Study|New therapy for study indication|2|||
37774661|NCT01665144|69304247|FG001|Overall Study|New therapy for study indication|1|||
37774662|NCT01665144|69304246|FG000|Overall Study|Technical problems|2|||
37774663|NCT01665144|69304247|FG001|Overall Study|Technical problems|0|||
37774664|NCT01665144|69304246|FG000|Overall Study|Death|3|||
37774665|NCT01665144|69304247|FG001|Overall Study|Death|1|||
37774666|NCT01665144|69304246|FG000|Overall Study|Protocol deviation|3|||
37774667|NCT01665144|69304247|FG001|Overall Study|Protocol deviation|1|||
37774668|NCT01665144|69304246|FG000|Overall Study|Non-compliance w/study treatment|5|||
37774669|NCT01665144|69304247|FG001|Overall Study|Non-compliance w/study treatment|0|||
37774670|NCT01665144|69304246|FG000|Overall Study|Progressive disease|8|||
37774671|NCT01665144|69304247|FG001|Overall Study|Progressive disease|4|||
37863647|NCT01125189|69547251|FG001|Treatment Period|Lack of Efficacy|18|||
37774672|NCT01665144|69304246|FG000|Overall Study|Lost to Follow-up|9|||
37774673|NCT01665144|69304247|FG001|Overall Study|Lost to Follow-up|8|||
37774674|NCT01665144|69304246|FG000|Overall Study|Physician Decision|13|||
37774675|NCT01665144|69304247|FG001|Overall Study|Physician Decision|1|||
37774676|NCT01665144|69304246|FG000|Overall Study|Lack of Efficacy|16|||
37774677|NCT01665144|69304247|FG001|Overall Study|Lack of Efficacy|11|||
37774678|NCT01665144|69304246|FG000|Overall Study|Adverse Event|45|||
37774679|NCT01665144|69304247|FG001|Overall Study|Adverse Event|18|||
37774680|NCT01665144|69304246|FG000|Overall Study|Withdrawal by Subject|96|||
37774681|NCT01665144|69304247|FG001|Overall Study|Withdrawal by Subject|77|||
37774682|NCT01466660|69304382|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
37774683|NCT01466660|69304383|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
37774684|NCT01466660|69304382|FG000|Overall Study|Worsening of underlying cancer disease|5|||
37774685|NCT01466660|69304383|FG001|Overall Study|Worsening of underlying cancer disease|2|||
37774686|NCT01466660|69304382|FG000|Overall Study|Other adverse event|19|||
37774687|NCT01466660|69304383|FG001|Overall Study|Other adverse event|18|||
37774688|NCT01466660|69304382|FG000|Overall Study|Protocol Violation|2|||
37774689|NCT01466660|69304383|FG001|Overall Study|Protocol Violation|1|||
37774690|NCT01466660|69304382|FG000|Overall Study|Refused continuation of trial medication|4|||
37774691|NCT01466660|69304383|FG001|Overall Study|Refused continuation of trial medication|3|||
37774692|NCT01466660|69304382|FG000|Overall Study|Other reason not defined above|10|||
37774693|NCT01466660|69304383|FG001|Overall Study|Other reason not defined above|8|||
37774694|NCT01466348|69304408|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
37774695|NCT01466348|69304409|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
37774696|NCT01466270|69304432|FG000|Overall Study|Withdrawal by Subject|4|||
37774697|NCT01466270|69304433|FG001|Overall Study|Withdrawal by Subject|1|||
37774698|NCT01466270|69304432|FG000|Overall Study|Physician Decision|1|||
37774699|NCT01466270|69304433|FG001|Overall Study|Physician Decision|0|||
37774700|NCT01466270|69304432|FG000|Overall Study|Lost to Follow-up|1|||
37774701|NCT01466270|69304433|FG001|Overall Study|Lost to Follow-up|3|||
37774702|NCT01466270|69304432|FG000|Overall Study|Progression|1|||
37774703|NCT01466270|69304433|FG001|Overall Study|Progression|0|||
37774704|NCT01466270|69304432|FG000|Overall Study|Toxicity|4|||
37774705|NCT01466270|69304433|FG001|Overall Study|Toxicity|1|||
37774706|NCT01466270|69304432|FG000|Overall Study|Multiple|1|||
37774707|NCT01466270|69304433|FG001|Overall Study|Multiple|1|||
37774708|NCT01466192|69304466|FG000|Overall Study|Physician Decision|1|||
37774709|NCT01466192|69304466|FG000|Overall Study|Withdrawal by Subject|3|||
37774710|NCT01438814|69304486|FG000|Overall Study|Adverse Event|3|||
37774711|NCT01438814|69304487|FG001|Overall Study|Adverse Event|3|||
37774712|NCT01438814|69304486|FG000|Overall Study|Protocol Violation|1|||
37774713|NCT01438814|69304487|FG001|Overall Study|Protocol Violation|2|||
37774714|NCT01438814|69304486|FG000|Overall Study|Lost to Follow-up|4|||
37774715|NCT01438814|69304487|FG001|Overall Study|Lost to Follow-up|3|||
37774716|NCT01438814|69304486|FG000|Overall Study|Withdrawal by Subject|4|||
37774717|NCT01438814|69304487|FG001|Overall Study|Withdrawal by Subject|2|||
37774718|NCT01438814|69304486|FG000|Overall Study|Other|2|||
37774719|NCT01438814|69304487|FG001|Overall Study|Other|4|||
37774720|NCT02926833|69305068|FG000|Overall Study|Full Consent Withdrawal|0|||
37774721|NCT02926833|69305069|FG001|Overall Study|Full Consent Withdrawal|0|||
37774722|NCT02926833|69305070|FG002|Overall Study|Full Consent Withdrawal|0|||
37774723|NCT02926833|69305071|FG003|Overall Study|Full Consent Withdrawal|2|||
37774724|NCT02926833|69305068|FG000|Overall Study|Death|1|||
37774725|NCT02926833|69305069|FG001|Overall Study|Death|1|||
37774726|NCT02926833|69305070|FG002|Overall Study|Death|1|||
37774727|NCT02926833|69305071|FG003|Overall Study|Death|7|||
37774728|NCT02926833|69305068|FG000|Overall Study|Still on study|2|||
37774729|NCT02926833|69305069|FG001|Overall Study|Still on study|3|||
37774730|NCT02926833|69305070|FG002|Overall Study|Still on study|5|||
37774731|NCT02926833|69305071|FG003|Overall Study|Still on study|14|||
37774732|NCT02926833|69305068|FG000|Overall Study|Adverse Event|0|||
37774733|NCT02926833|69305069|FG001|Overall Study|Adverse Event|0|||
37774734|NCT02926833|69305070|FG002|Overall Study|Adverse Event|1|||
37774735|NCT02926833|69305071|FG003|Overall Study|Adverse Event|0|||
37774736|NCT02851797|69305118|FG000|Overall Study|Withdrawal by Subject|4|||
37774737|NCT02851797|69305119|FG001|Overall Study|Withdrawal by Subject|2|||
37774738|NCT02851797|69305118|FG000|Overall Study|Adverse Event|3|||
37774739|NCT02851797|69305119|FG001|Overall Study|Adverse Event|0|||
37774740|NCT01666314|69305343|FG000|Overall Study|Adverse Event|3|||
37774741|NCT01666314|69305344|FG001|Overall Study|Adverse Event|13|||
37774742|NCT01666314|69305345|FG002|Overall Study|Adverse Event|7|||
37774743|NCT01666314|69305346|FG003|Overall Study|Adverse Event|7|||
37774744|NCT01666314|69305343|FG000|Overall Study|Progressive Disease|11|||
37774745|NCT01666314|69305344|FG001|Overall Study|Progressive Disease|9|||
37774746|NCT01666314|69305345|FG002|Overall Study|Progressive Disease|19|||
37774747|NCT01666314|69305346|FG003|Overall Study|Progressive Disease|20|||
37774748|NCT01666314|69305343|FG000|Overall Study|Symptomatic Deterioration|1|||
37774749|NCT01666314|69305344|FG001|Overall Study|Symptomatic Deterioration|0|||
37774750|NCT01666314|69305345|FG002|Overall Study|Symptomatic Deterioration|2|||
37774751|NCT01666314|69305346|FG003|Overall Study|Symptomatic Deterioration|0|||
37774752|NCT01666314|69305343|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
37774753|NCT01666314|69305344|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
37774754|NCT01666314|69305345|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
37774755|NCT01666314|69305346|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
37774756|NCT01666314|69305343|FG000|Overall Study|Withdrawal by Subject|1|||
37774757|NCT01666314|69305344|FG001|Overall Study|Withdrawal by Subject|1|||
37774758|NCT01666314|69305345|FG002|Overall Study|Withdrawal by Subject|2|||
37774759|NCT01666314|69305346|FG003|Overall Study|Withdrawal by Subject|3|||
37774760|NCT01666314|69305343|FG000|Overall Study|Reason not Specified|10|||
37774761|NCT01666314|69305344|FG001|Overall Study|Reason not Specified|7|||
37774762|NCT01666314|69305345|FG002|Overall Study|Reason not Specified|5|||
37774763|NCT01666314|69305346|FG003|Overall Study|Reason not Specified|5|||
37774764|NCT01666002|69305377|FG000|Overall Study|Lost to Follow-up|5|||
37774765|NCT01666002|69305378|FG001|Overall Study|Lost to Follow-up|0|||
37774766|NCT01665768|69305450|FG000|Overall Study|Adverse Event|3|||
37774767|NCT01665768|69305450|FG000|Overall Study|Lack of Efficacy|19|||
37774768|NCT01665768|69305450|FG000|Overall Study|Withdrawal by Subject|1|||
37774769|NCT02584452|69305658|FG000|Overall Study|Physician Decision|1|||
37774770|NCT02584452|69305659|FG001|Overall Study|Physician Decision|1|||
37774771|NCT02584452|69305658|FG000|Overall Study|Lost to Follow-up|1|||
37774772|NCT02584452|69305659|FG001|Overall Study|Lost to Follow-up|1|||
37774773|NCT02586012|69305706|FG000|Overall Study|Withdrawal by Subject|1|||
37774774|NCT02586012|69305707|FG001|Overall Study|Withdrawal by Subject|1|||
37774775|NCT02586012|69305708|FG002|Overall Study|Withdrawal by Subject|0|||
37774776|NCT02586012|69305709|FG003|Overall Study|Withdrawal by Subject|1|||
37774777|NCT02586012|69305710|FG004|Overall Study|Withdrawal by Subject|0|||
37774778|NCT02586012|69305711|FG005|Overall Study|Withdrawal by Subject|2|||
37774779|NCT02586012|69305706|FG000|Overall Study|Protocol Violation|0|||
37774780|NCT02586012|69305707|FG001|Overall Study|Protocol Violation|0|||
37774781|NCT02586012|69305708|FG002|Overall Study|Protocol Violation|0|||
37774782|NCT02586012|69305709|FG003|Overall Study|Protocol Violation|0|||
37774783|NCT02586012|69305710|FG004|Overall Study|Protocol Violation|0|||
37774784|NCT02586012|69305711|FG005|Overall Study|Protocol Violation|1|||
37774785|NCT02586012|69305706|FG000|Overall Study|study terminated|0|||
37774786|NCT02586012|69305707|FG001|Overall Study|study terminated|2|||
37774787|NCT02586012|69305708|FG002|Overall Study|study terminated|1|||
37774788|NCT02586012|69305709|FG003|Overall Study|study terminated|1|||
37774789|NCT02586012|69305710|FG004|Overall Study|study terminated|1|||
37863648|NCT01125189|69547252|FG002|Treatment Period|Lack of Efficacy|25|||
37690637|NCT02332291|69166871|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
37690638|NCT02332291|69166870|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
37690639|NCT02332291|69166871|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
37690640|NCT02332291|69166870|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
37690641|NCT02332291|69166871|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
37690642|NCT02332291|69166870|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
37690643|NCT02332291|69166871|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
37690644|NCT01656395|69166887|FG000|Overall Study|Adverse Event|1|||
37690645|NCT01656395|69166888|FG001|Overall Study|Adverse Event|14|||
37690646|NCT01656395|69166889|FG002|Overall Study|Adverse Event|5|||
37690647|NCT01656395|69166890|FG003|Overall Study|Adverse Event|4|||
37774790|NCT02586012|69305711|FG005|Overall Study|study terminated|0|||
37774791|NCT02582814|69305722|FG000|Overall Study|Study-specific withdrawal criteria|1|||
37774792|NCT02582814|69305723|FG001|Overall Study|Study-specific withdrawal criteria|0|||
37774793|NCT02582814|69305722|FG000|Overall Study|Withdrawal by Subject|4|||
37863649|NCT01125189|69547250|FG000|Treatment Period|Adverse Event|7|||
37863650|NCT01125189|69547251|FG001|Treatment Period|Adverse Event|8|||
37863651|NCT01125189|69547252|FG002|Treatment Period|Adverse Event|8|||
37863652|NCT01125189|69547250|FG000|Treatment Period|Withdrawal by Subject|3|||
37863653|NCT01125189|69547251|FG001|Treatment Period|Withdrawal by Subject|1|||
37863654|NCT01125189|69547252|FG002|Treatment Period|Withdrawal by Subject|1|||
37863655|NCT01125189|69547250|FG000|Treatment Period|Death|1|||
37863656|NCT01125189|69547251|FG001|Treatment Period|Death|0|||
37863657|NCT01125189|69547252|FG002|Treatment Period|Death|0|||
37863658|NCT01125189|69547250|FG000|Treatment Period|Lost to Follow-up|1|||
37863659|NCT01125189|69547251|FG001|Treatment Period|Lost to Follow-up|2|||
37863660|NCT01125189|69547252|FG002|Treatment Period|Lost to Follow-up|1|||
37863661|NCT01125189|69547250|FG000|Treatment Period|Poor compliance/noncompliance|0|||
37774794|NCT02582814|69305723|FG001|Overall Study|Withdrawal by Subject|3|||
37774795|NCT02582814|69305722|FG000|Overall Study|Adverse Event|4|||
37774796|NCT02582814|69305723|FG001|Overall Study|Adverse Event|4|||
37774797|NCT02585934|69305871|FG000|Overall Study|Lost to Follow-up|2|||
37774798|NCT02585934|69305872|FG001|Overall Study|Lost to Follow-up|2|||
37774799|NCT02585934|69305871|FG000|Overall Study|Protocol Violation|14|||
37774800|NCT02585934|69305872|FG001|Overall Study|Protocol Violation|11|||
37774801|NCT02585934|69305871|FG000|Overall Study|Adverse Event|21|||
37774802|NCT02585934|69305872|FG001|Overall Study|Adverse Event|22|||
37774803|NCT02585934|69305871|FG000|Overall Study|Physician Decision|3|||
37774804|NCT02585934|69305872|FG001|Overall Study|Physician Decision|2|||
37774805|NCT02585934|69305871|FG000|Overall Study|Withdrawal by Subject|7|||
37774806|NCT02585934|69305872|FG001|Overall Study|Withdrawal by Subject|21|||
37774807|NCT02585934|69305871|FG000|Overall Study|Lack of Efficacy|2|||
37774808|NCT02585934|69305872|FG001|Overall Study|Lack of Efficacy|1|||
37774809|NCT02585934|69305871|FG000|Overall Study|Death|2|||
37774810|NCT02585934|69305872|FG001|Overall Study|Death|0|||
37774811|NCT02585934|69305871|FG000|Overall Study|Caregiver Withdrew Consent|7|||
37774812|NCT02585934|69305872|FG001|Overall Study|Caregiver Withdrew Consent|7|||
37774813|NCT02585934|69305871|FG000|Overall Study|Sponsor Termination|1|||
37774814|NCT02585934|69305872|FG001|Overall Study|Sponsor Termination|2|||
37774815|NCT02585934|69305871|FG000|Overall Study|Another Reason|10|||
37774816|NCT02585934|69305872|FG001|Overall Study|Another Reason|5|||
37774817|NCT02582658|69305901|FG000|Overall Study|Failure to Return|10|||
37774818|NCT02582658|69305901|FG000|Overall Study|Insufficient Virological Response|2|||
37774819|NCT02582658|69305901|FG000|Overall Study|Withdrawn Consent|1|||
37774820|NCT02582658|69305901|FG000|Overall Study|Death|1|||
37774821|NCT02582658|69305901|FG000|Overall Study|Not further specified|11|||
37774822|NCT02585778|69306003|FG000|Overall Study|Adverse Event|17|||
37774823|NCT02585778|69306004|FG001|Overall Study|Adverse Event|4|||
37774824|NCT02585778|69306003|FG000|Overall Study|Participant did not wish to continue|9|||
37774825|NCT02585778|69306004|FG001|Overall Study|Participant did not wish to continue|4|||
37774826|NCT02585778|69306003|FG000|Overall Study|Poor compliance to study protocol|0|||
37774827|NCT02585778|69306004|FG001|Overall Study|Poor compliance to study protocol|2|||
37774828|NCT02585778|69306003|FG000|Overall Study|Death|0|||
37774829|NCT02585778|69306004|FG001|Overall Study|Death|1|||
37774830|NCT02585778|69306003|FG000|Overall Study|Randomized but not treated|1|||
37774831|NCT02585778|69306004|FG001|Overall Study|Randomized but not treated|2|||
37774832|NCT02585778|69306003|FG000|Overall Study|Other than specified above|6|||
37774833|NCT02585778|69306004|FG001|Overall Study|Other than specified above|2|||
37774834|NCT01438424|69306027|FG000|Overall Study|Continuing treatment|29|||
37774835|NCT01438424|69306027|FG000|Overall Study|Minimal virologic response|95|||
37774836|NCT01438424|69306027|FG000|Overall Study|Not identified|55|||
37774837|NCT01438424|69306027|FG000|Overall Study|Withdrawal by Subject|104|||
37774838|NCT01438424|69306027|FG000|Overall Study|Progression of chronic hepatitis B|22|||
37774839|NCT01438424|69306027|FG000|Overall Study|Death|22|||
37774840|NCT01438424|69306027|FG000|Overall Study|Adverse Event|17|||
37774841|NCT01438424|69306027|FG000|Overall Study|Lost to Follow-up|17|||
37774842|NCT01438424|69306027|FG000|Overall Study|Abnormal laboratory test result|14|||
37774843|NCT01438424|69306027|FG000|Overall Study|Need for drug prohibited by protocol|14|||
37863662|NCT01125189|69547251|FG001|Treatment Period|Poor compliance/noncompliance|1|||
37863663|NCT01125189|69547252|FG002|Treatment Period|Poor compliance/noncompliance|0|||
37774844|NCT01438424|69306027|FG000|Overall Study|Pregnancy|7|||
37774845|NCT01438424|69306027|FG000|Overall Study|No longer met inclusion criteria|1|||
37774846|NCT01438424|69306027|FG000|Overall Study|Participant noncompliance|20|||
37774847|NCT02580240|69306043|FG000|Overall Study|Physician Decision|2|||
37774848|NCT02580240|69306044|FG001|Overall Study|Physician Decision|0|||
37774849|NCT01465958|69306050|FG000|Run-in Phase|Protocol Violation|1|||
37774850|NCT01465958|69306051|FG001|Run-in Phase|Protocol Violation|0|||
37774851|NCT01465958|69306050|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
37774852|NCT01465958|69306051|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
37774853|NCT02581488|69306264|FG000|Overall Study|Adverse Event|6|||
37774854|NCT02581488|69306265|FG001|Overall Study|Adverse Event|7|||
37774855|NCT02581488|69306264|FG000|Overall Study|Lost to Follow-up|1|||
37774856|NCT02581488|69306265|FG001|Overall Study|Lost to Follow-up|0|||
37774857|NCT02581488|69306264|FG000|Overall Study|Withdrawal by Subject|1|||
37774858|NCT02581488|69306265|FG001|Overall Study|Withdrawal by Subject|0|||
37774859|NCT02581488|69306264|FG000|Overall Study|Non-Compliance|1|||
37774860|NCT02581488|69306265|FG001|Overall Study|Non-Compliance|0|||
37774861|NCT02581488|69306264|FG000|Overall Study|Protocol Violation|0|||
37774862|NCT02581488|69306265|FG001|Overall Study|Protocol Violation|4|||
37774863|NCT02581410|69306308|FG000|Vaccination Phase|Adverse Event|2|||
37774864|NCT02581410|69306309|FG001|Vaccination Phase|Adverse Event|1|||
37774865|NCT02581410|69306308|FG000|Vaccination Phase|Withdrawal by Subject|0|||
37774866|NCT02581410|69306309|FG001|Vaccination Phase|Withdrawal by Subject|1|||
37774867|NCT02581410|69306308|FG000|Vaccination Phase|Migrated/moved from study area|0|||
37774868|NCT02581410|69306309|FG001|Vaccination Phase|Migrated/moved from study area|1|||
37774869|NCT02581410|69306308|FG000|End of Study Phase|Adverse Event|4|||
37968266|NCT02406027|69655362|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
37968267|NCT02406027|69655363|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
37968268|NCT02406027|69655364|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
37968269|NCT02406027|69655358|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
37968270|NCT02406027|69655359|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
37968271|NCT02406027|69655360|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
37968272|NCT02406027|69655361|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
37968273|NCT02406027|69655362|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
37774870|NCT02581410|69306309|FG001|End of Study Phase|Adverse Event|3|||
37690648|NCT01656395|69166891|FG004|Overall Study|Adverse Event|5|||
37690649|NCT01656395|69166892|FG005|Overall Study|Adverse Event|7|||
37690650|NCT01656395|69166893|FG006|Overall Study|Adverse Event|0|||
37690651|NCT01656395|69166894|FG007|Overall Study|Adverse Event|0|||
37690652|NCT01656395|69166887|FG000|Overall Study|Lack of Efficacy|1|||
37690653|NCT01656395|69166888|FG001|Overall Study|Lack of Efficacy|8|||
37690654|NCT01656395|69166889|FG002|Overall Study|Lack of Efficacy|6|||
37690655|NCT01656395|69166890|FG003|Overall Study|Lack of Efficacy|1|||
37774871|NCT02581410|69306308|FG000|End of Study Phase|Withdrawal by Subject|1|||
37774872|NCT02581410|69306309|FG001|End of Study Phase|Withdrawal by Subject|2|||
37774873|NCT02581410|69306308|FG000|End of Study Phase|Migrated/moved from study area|0|||
37774874|NCT02581410|69306309|FG001|End of Study Phase|Migrated/moved from study area|3|||
37774875|NCT02581410|69306308|FG000|End of Study Phase|Lost to Follow-up|0|||
37968274|NCT02406027|69655363|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
37968275|NCT02406027|69655364|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
37690656|NCT01656395|69166891|FG004|Overall Study|Lack of Efficacy|1|||
37690657|NCT01656395|69166892|FG005|Overall Study|Lack of Efficacy|6|||
37774876|NCT02581410|69306309|FG001|End of Study Phase|Lost to Follow-up|2|||
37774877|NCT02581410|69306308|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
37774878|NCT02581410|69306309|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
37774879|NCT01664130|69306368|FG000|Overall Study|competing secondary disease|2|||
37774880|NCT02579928|69306399|FG000|Overall Study|Withdrawal by Subject|1|||
37774881|NCT02579928|69306400|FG001|Overall Study|Withdrawal by Subject|0|||
37774882|NCT00551460|69306494|FG000|Overall Study|Adverse Event|1|||
37774883|NCT00551460|69306494|FG000|Overall Study|Withdrawal by Subject|1|||
37774884|NCT00551460|69306494|FG000|Overall Study|Physician Decision|1|||
37774885|NCT00551460|69306494|FG000|Overall Study|Death|7|||
37774886|NCT00551460|69306494|FG000|Overall Study|Ineligible|4|||
37774887|NCT00551460|69306494|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
37774888|NCT02579772|69306555|FG000|Overall Study|Withdrawal by Subject|0|||
37774889|NCT02579772|69306556|FG001|Overall Study|Withdrawal by Subject|1|||
37774890|NCT02579772|69306555|FG000|Overall Study|Usage of additional antioxidants|1|||
37774891|NCT02579772|69306556|FG001|Overall Study|Usage of additional antioxidants|0|||
37774892|NCT02579772|69306555|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
37774893|NCT02579772|69306556|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
37774894|NCT02579616|69306629|FG000|Overall Study|Participants did not receive treatment|3|||
37774895|NCT04027608|69306689|FG000|Overall Study|Withdrawal by Subject|13|||
37774896|NCT04027608|69306690|FG001|Overall Study|Withdrawal by Subject|2|||
37774897|NCT04027608|69306689|FG000|Overall Study|Protocol Violation|2|||
37774898|NCT04027608|69306690|FG001|Overall Study|Protocol Violation|1|||
37774899|NCT04027608|69306689|FG000|Overall Study|Physician Decision|1|||
37774900|NCT04027608|69306690|FG001|Overall Study|Physician Decision|0|||
37774901|NCT04027608|69306689|FG000|Overall Study|Lost to Follow-up|20|||
37774902|NCT04027608|69306690|FG001|Overall Study|Lost to Follow-up|4|||
37774903|NCT01664052|69306781|FG000|Phase 1|No device placement|6|||
37774904|NCT01664052|69306782|FG001|Phase 1|No device placement|0|||
37774905|NCT01664052|69306781|FG000|Phase 1|No HSG 1 hr post placement|1|||
37774906|NCT01664052|69306782|FG001|Phase 1|No HSG 1 hr post placement|0|||
37774907|NCT01664052|69306781|FG000|Phase 2|No device placement|0|||
37774908|NCT01664052|69306782|FG001|Phase 2|No device placement|4|||
37774909|NCT01465802|69306829|FG000|Overall Study|Study terminated by sponsor|1|||
37774910|NCT01465802|69306830|FG001|Overall Study|Study terminated by sponsor|0|||
37863664|NCT01125189|69547250|FG000|Treatment Period|Participants requested to discontinue|1|||
37863665|NCT01125189|69547251|FG001|Treatment Period|Participants requested to discontinue|3|||
37690658|NCT01656395|69166893|FG006|Overall Study|Lack of Efficacy|0|||
37774911|NCT01465802|69306831|FG002|Overall Study|Study terminated by sponsor|0|||
37774912|NCT01465802|69306832|FG003|Overall Study|Study terminated by sponsor|1|||
37774913|NCT01465802|69306833|FG004|Overall Study|Study terminated by sponsor|7|||
37774914|NCT01465802|69306829|FG000|Overall Study|Withdrawal by Subject|7|||
37774915|NCT01465802|69306830|FG001|Overall Study|Withdrawal by Subject|7|||
37774916|NCT01465802|69306831|FG002|Overall Study|Withdrawal by Subject|0|||
37774917|NCT01465802|69306832|FG003|Overall Study|Withdrawal by Subject|8|||
37774918|NCT01465802|69306833|FG004|Overall Study|Withdrawal by Subject|1|||
37774919|NCT01465802|69306829|FG000|Overall Study|Lost to Follow-up|1|||
37774920|NCT01465802|69306830|FG001|Overall Study|Lost to Follow-up|1|||
37774921|NCT01465802|69306831|FG002|Overall Study|Lost to Follow-up|0|||
37774922|NCT01465802|69306832|FG003|Overall Study|Lost to Follow-up|0|||
37774923|NCT01465802|69306833|FG004|Overall Study|Lost to Follow-up|0|||
37774924|NCT01465802|69306829|FG000|Overall Study|Reason not specified|9|||
37774925|NCT01465802|69306830|FG001|Overall Study|Reason not specified|4|||
37774926|NCT01465802|69306831|FG002|Overall Study|Reason not specified|0|||
37774927|NCT01465802|69306832|FG003|Overall Study|Reason not specified|10|||
37774928|NCT01465802|69306833|FG004|Overall Study|Reason not specified|2|||
37774929|NCT01465802|69306829|FG000|Overall Study|Death|15|||
37774930|NCT01465802|69306830|FG001|Overall Study|Death|12|||
37774931|NCT01465802|69306831|FG002|Overall Study|Death|0|||
37774932|NCT01465802|69306832|FG003|Overall Study|Death|10|||
37774933|NCT01465802|69306833|FG004|Overall Study|Death|2|||
37774934|NCT01437878|69306878|FG000|Overall Study|Withdrawal by Subject|1|||
37774935|NCT01437878|69306879|FG001|Overall Study|Withdrawal by Subject|0|||
37774936|NCT01465178|69306905|FG000|Overall Study|Withdrawal by Subject|1|||
37774937|NCT01465178|69306906|FG001|Overall Study|Withdrawal by Subject|0|||
37774938|NCT01445678|69307012|FG000|Overall Study|Adverse Event|12|||
37774939|NCT01445678|69307013|FG001|Overall Study|Adverse Event|8|||
37774940|NCT01445678|69307012|FG000|Overall Study|Lack of Efficacy|0|||
37774941|NCT01445678|69307013|FG001|Overall Study|Lack of Efficacy|2|||
37774942|NCT01445678|69307012|FG000|Overall Study|Lost to Follow-up|8|||
37774943|NCT01445678|69307013|FG001|Overall Study|Lost to Follow-up|5|||
37774944|NCT01445678|69307012|FG000|Overall Study|Protocol Violation|1|||
37774945|NCT01445678|69307013|FG001|Overall Study|Protocol Violation|1|||
37774946|NCT01445678|69307012|FG000|Overall Study|Withdrawal by Subject|9|||
37774947|NCT01445678|69307013|FG001|Overall Study|Withdrawal by Subject|5|||
37774948|NCT03769194|69307032|FG000|Overall Study|Withdrawal by Subject|0|||
37774949|NCT03769194|69307033|FG001|Overall Study|Withdrawal by Subject|7|||
37774950|NCT03769194|69307034|FG002|Overall Study|Withdrawal by Subject|4|||
37774951|NCT03769194|69307035|FG003|Overall Study|Withdrawal by Subject|1|||
37774952|NCT03769194|69307032|FG000|Overall Study|moved from study area|0|||
37774953|NCT03769194|69307033|FG001|Overall Study|moved from study area|2|||
37774954|NCT03769194|69307034|FG002|Overall Study|moved from study area|1|||
37774955|NCT03769194|69307035|FG003|Overall Study|moved from study area|1|||
37774956|NCT03769194|69307032|FG000|Overall Study|Lost to Follow-up|3|||
37774957|NCT03769194|69307033|FG001|Overall Study|Lost to Follow-up|6|||
37774958|NCT03769194|69307034|FG002|Overall Study|Lost to Follow-up|3|||
37774959|NCT03769194|69307035|FG003|Overall Study|Lost to Follow-up|6|||
37774960|NCT03769194|69307032|FG000|Overall Study|other|1|||
37774961|NCT03769194|69307033|FG001|Overall Study|other|3|||
37774962|NCT03769194|69307034|FG002|Overall Study|other|0|||
37774963|NCT03769194|69307035|FG003|Overall Study|other|1|||
37774964|NCT01465022|69307061|FG000|Overall Study|Lost to Follow-up|15|||
37774965|NCT01465022|69307062|FG001|Overall Study|Lost to Follow-up|14|||
37774966|NCT01465022|69307063|FG002|Overall Study|Lost to Follow-up|0|||
37774967|NCT01465022|69307061|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
37774968|NCT01465022|69307062|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
37774969|NCT01465022|69307063|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
37774970|NCT01465022|69307061|FG000|Overall Study|Not Randomized|0|||
37774971|NCT01465022|69307062|FG001|Overall Study|Not Randomized|0|||
37774972|NCT01465022|69307063|FG002|Overall Study|Not Randomized|70|||
37774973|NCT01464788|69307107|FG000|Overall Study|Lost to Follow-up|0|||
37774974|NCT01464788|69307108|FG001|Overall Study|Lost to Follow-up|1|||
37774975|NCT01464788|69307109|FG002|Overall Study|Lost to Follow-up|0|||
37774976|NCT01464788|69307107|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
37774977|NCT01464788|69307108|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
37774978|NCT01464788|69307109|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
37774979|NCT01444898|69307119|FG000|Overall Study|Withdrawal by Subject|1|||
37774980|NCT01419626|69307141|FG000|Overall Study|Protocol Violation|3|||
37774981|NCT01419626|69307142|FG001|Overall Study|Protocol Violation|2|||
37774982|NCT01419626|69307143|FG002|Overall Study|Protocol Violation|2|||
37774983|NCT01419626|69307141|FG000|Overall Study|Withdrawal by Subject|1|||
37774984|NCT01419626|69307142|FG001|Overall Study|Withdrawal by Subject|0|||
37774985|NCT01419626|69307143|FG002|Overall Study|Withdrawal by Subject|0|||
37774986|NCT01419626|69307141|FG000|Overall Study|Lost to Follow-up|0|||
37774987|NCT01419626|69307142|FG001|Overall Study|Lost to Follow-up|1|||
37774988|NCT01419626|69307143|FG002|Overall Study|Lost to Follow-up|1|||
37774989|NCT01444742|69307182|FG000|Overall Study|Death|1|||
37774990|NCT01444430|69307382|FG000|Overall Study|Withdrawal by Subject|53|||
37774991|NCT01444430|69307383|FG001|Overall Study|Withdrawal by Subject|72|||
37774992|NCT01444430|69307382|FG000|Overall Study|Death|6|||
37774993|NCT01444430|69307383|FG001|Overall Study|Death|8|||
37774994|NCT01444430|69307382|FG000|Overall Study|Lost to Follow-up|2|||
37774995|NCT01444430|69307383|FG001|Overall Study|Lost to Follow-up|0|||
37774996|NCT01444430|69307382|FG000|Overall Study|CRF termination module not completed.|0|||
37774997|NCT01444430|69307383|FG001|Overall Study|CRF termination module not completed.|1|||
37774998|NCT01436162|69307459|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
37774999|NCT01436162|69307460|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
37775000|NCT01436162|69307461|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
37775001|NCT01436162|69307459|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
37775002|NCT01436162|69307460|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
37775003|NCT01436162|69307461|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
37775004|NCT01436162|69307459|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
37775005|NCT01436162|69307460|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
37775006|NCT01436162|69307461|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
37775007|NCT01436162|69307459|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
37775008|NCT01436162|69307460|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
37775009|NCT01436162|69307461|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
37775010|NCT01436162|69307459|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
37775011|NCT01436162|69307460|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
37775012|NCT01436162|69307461|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
37775013|NCT01436162|69307459|FG000|Single-blind Lead-in Phase|Other|107|||
37775014|NCT01436162|69307460|FG001|Single-blind Lead-in Phase|Other|0|||
37775015|NCT01436162|69307461|FG002|Single-blind Lead-in Phase|Other|0|||
37775016|NCT01436162|69307459|FG000|Randomized Phase|Adverse Event|1|||
37775017|NCT01436162|69307460|FG001|Randomized Phase|Adverse Event|5|||
37775018|NCT01436162|69307461|FG002|Randomized Phase|Adverse Event|6|||
37775019|NCT01436162|69307459|FG000|Randomized Phase|Protocol Violation|4|||
37775020|NCT01436162|69307460|FG001|Randomized Phase|Protocol Violation|4|||
37775021|NCT01436162|69307461|FG002|Randomized Phase|Protocol Violation|2|||
37775022|NCT01436162|69307459|FG000|Randomized Phase|Withdrawal by Subject|16|||
37775023|NCT01436162|69307460|FG001|Randomized Phase|Withdrawal by Subject|9|||
37775024|NCT01436162|69307461|FG002|Randomized Phase|Withdrawal by Subject|8|||
37775025|NCT01436162|69307459|FG000|Randomized Phase|Lost to Follow-up|17|||
37775026|NCT01436162|69307460|FG001|Randomized Phase|Lost to Follow-up|5|||
37775027|NCT01436162|69307461|FG002|Randomized Phase|Lost to Follow-up|4|||
37775028|NCT01436162|69307459|FG000|Randomized Phase|Lack of Efficacy|0|||
37775029|NCT01436162|69307460|FG001|Randomized Phase|Lack of Efficacy|1|||
37775030|NCT01436162|69307461|FG002|Randomized Phase|Lack of Efficacy|1|||
37775031|NCT01436162|69307459|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
37775032|NCT01436162|69307460|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
37775033|NCT01436162|69307461|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
37775034|NCT01436162|69307459|FG000|Randomized Phase|Other|2|||
37775035|NCT01436162|69307460|FG001|Randomized Phase|Other|5|||
37775036|NCT01436162|69307461|FG002|Randomized Phase|Other|4|||
37775037|NCT02579382|69307473|FG000|Main Study Phase|Lost to Follow-up|0|||
37775038|NCT02579382|69307474|FG001|Main Study Phase|Lost to Follow-up|0|||
37775039|NCT02579382|69307475|FG002|Main Study Phase|Lost to Follow-up|2|||
37775040|NCT02579382|69307476|FG003|Main Study Phase|Lost to Follow-up|0|||
37775041|NCT02579382|69307473|FG000|Main Study Phase|Withdrew Consent|0|||
37775042|NCT02579382|69307474|FG001|Main Study Phase|Withdrew Consent|0|||
37775043|NCT02579382|69307475|FG002|Main Study Phase|Withdrew Consent|0|||
37775044|NCT02579382|69307476|FG003|Main Study Phase|Withdrew Consent|2|||
37775045|NCT02579382|69307473|FG000|Main Study Phase|Lack of Efficacy|0|||
37775046|NCT02579382|69307474|FG001|Main Study Phase|Lack of Efficacy|0|||
37775047|NCT02579382|69307475|FG002|Main Study Phase|Lack of Efficacy|0|||
37775048|NCT02579382|69307476|FG003|Main Study Phase|Lack of Efficacy|1|||
37775049|NCT02579382|69307473|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
37775050|NCT02579382|69307474|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
37775051|NCT02579382|69307475|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
37775052|NCT02579382|69307476|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
37775053|NCT02579382|69307473|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
37775054|NCT02579382|69307474|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
37775055|NCT02579382|69307475|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
37775056|NCT02579382|69307476|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
37775057|NCT02579382|69307473|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
37775058|NCT02579382|69307474|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
37775059|NCT02579382|69307475|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
37775060|NCT02579382|69307476|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
37775061|NCT02579382|69307473|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
37775062|NCT02579382|69307474|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
37775063|NCT02579382|69307475|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
37968276|NCT02406027|69655358|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
37968277|NCT02406027|69655359|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
37968278|NCT02406027|69655360|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
37968279|NCT02406027|69655361|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
37968280|NCT02406027|69655362|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
37968281|NCT02406027|69655363|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
37968282|NCT02406027|69655364|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
37968283|NCT02406027|69655358|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
37968284|NCT02406027|69655359|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
37968285|NCT02406027|69655360|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
37968286|NCT02406027|69655361|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
37968287|NCT02406027|69655362|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
37968288|NCT02406027|69655363|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
37968289|NCT02406027|69655364|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
37775064|NCT02579382|69307476|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
37775065|NCT02579382|69307473|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
37775066|NCT02579382|69307474|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
37968290|NCT02406027|69655358|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
37968291|NCT02406027|69655359|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
37775067|NCT02579382|69307475|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
37775068|NCT02579382|69307476|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
37775069|NCT02579382|69307473|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
37775070|NCT02579382|69307474|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
37775071|NCT02579382|69307475|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
37775072|NCT02579382|69307476|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
37775073|NCT01436084|69307503|FG000|Overall Study|Disease Progression|2|||
37775074|NCT01436084|69307503|FG000|Overall Study|Withdrawal by Subject|1|||
37775075|NCT01436084|69307503|FG000|Overall Study|Early Closure of Study|1|||
37775076|NCT01419314|69307518|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
37775077|NCT01419314|69307519|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
37775078|NCT01419314|69307518|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
37775079|NCT01419314|69307519|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
37775080|NCT01419314|69307518|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
37775081|NCT01419314|69307519|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
37775082|NCT01419236|69307576|FG000|Overall Study|Adverse Event|1|||
37775083|NCT01419236|69307577|FG001|Overall Study|Adverse Event|0|||
37775084|NCT01419236|69307576|FG000|Overall Study|Lack of Efficacy|0|||
37775085|NCT01419236|69307577|FG001|Overall Study|Lack of Efficacy|1|||
37775086|NCT01419236|69307576|FG000|Overall Study|Lost to Follow-up|1|||
37775087|NCT01419236|69307577|FG001|Overall Study|Lost to Follow-up|0|||
37775088|NCT01419236|69307576|FG000|Overall Study|Physician Decision|1|||
37775089|NCT01419236|69307577|FG001|Overall Study|Physician Decision|0|||
37775090|NCT01419236|69307576|FG000|Overall Study|Withdrawal by Subject|1|||
37775091|NCT01419236|69307577|FG001|Overall Study|Withdrawal by Subject|4|||
37775092|NCT01419236|69307576|FG000|Overall Study|Entry Criteria Not Met|1|||
37775093|NCT01419236|69307577|FG001|Overall Study|Entry Criteria Not Met|0|||
37775094|NCT03323658|69307590|FG000|Overall Study|Adverse Event|0|||
37775095|NCT03323658|69307591|FG001|Overall Study|Adverse Event|1|||
37775096|NCT03323658|69307592|FG002|Overall Study|Adverse Event|0|||
37775097|NCT01443026|69307617|FG000|Overall Study|Physician Decision|1|||
37775098|NCT01443026|69307618|FG001|Overall Study|Physician Decision|0|||
37775099|NCT01443026|69307617|FG000|Overall Study|Death|0|||
37775100|NCT01443026|69307618|FG001|Overall Study|Death|1|||
37775101|NCT01443026|69307617|FG000|Overall Study|Withdrawal by Subject|0|||
37775102|NCT01443026|69307618|FG001|Overall Study|Withdrawal by Subject|3|||
37775103|NCT01443026|69307617|FG000|Overall Study|Lost to Follow-up|2|||
37775104|NCT01443026|69307618|FG001|Overall Study|Lost to Follow-up|1|||
37775105|NCT01442714|69307652|FG000|Overall Study|Death|11|||
37775106|NCT01442714|69307652|FG000|Overall Study|Withdrawal by Subject|1|||
37775107|NCT01418378|69307665|FG000|Overall Study|Death|1|||
37775108|NCT01418378|69307666|FG001|Overall Study|Death|2|||
37775109|NCT01418378|69307665|FG000|Overall Study|Physician Decision|0|||
37775110|NCT01418378|69307666|FG001|Overall Study|Physician Decision|1|||
37775111|NCT01418378|69307665|FG000|Overall Study|ligament imbalance|0|||
37775112|NCT01418378|69307666|FG001|Overall Study|ligament imbalance|1|||
37775113|NCT01418378|69307665|FG000|Overall Study|developed chronic myopathy|0|||
37775114|NCT01418378|69307666|FG001|Overall Study|developed chronic myopathy|1|||
37775115|NCT01435928|69307687|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
37775116|NCT01435928|69307688|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
37775117|NCT01435928|69307689|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
37775118|NCT01435928|69307687|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
37775119|NCT01435928|69307688|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
37775120|NCT01435928|69307689|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
37775121|NCT01435928|69307687|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
37775122|NCT01435928|69307688|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
37775123|NCT01435928|69307689|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
37863666|NCT01125189|69547252|FG002|Treatment Period|Participants requested to discontinue|4|||
37775124|NCT01435928|69307687|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
37775125|NCT01435928|69307688|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
37775126|NCT01435928|69307689|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
37775127|NCT01435928|69307687|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
37775128|NCT01435928|69307688|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
37775129|NCT01435928|69307689|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
37775130|NCT01435928|69307687|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
37775131|NCT01435928|69307688|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
37775132|NCT01435928|69307689|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
37775133|NCT01435928|69307687|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
37775134|NCT01435928|69307688|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
37775135|NCT01435928|69307689|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
37775136|NCT01435928|69307687|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
37775137|NCT01435928|69307688|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
37775138|NCT01435928|69307689|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
37775139|NCT01435928|69307687|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
37775140|NCT01435928|69307688|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
37775141|NCT01435928|69307689|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
37775142|NCT01435928|69307687|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
37775143|NCT01435928|69307688|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
37775144|NCT01435928|69307689|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
37775145|NCT01435928|69307687|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
37775146|NCT01435928|69307688|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
37775147|NCT01435928|69307689|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
37775148|NCT01435928|69307687|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
37775149|NCT01435928|69307688|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
37775150|NCT01435928|69307689|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
37775151|NCT01435928|69307687|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
37775152|NCT01435928|69307688|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
37775153|NCT01435928|69307689|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
37775154|NCT01435928|69307687|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
37775155|NCT01435928|69307688|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
37775156|NCT01435928|69307689|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
37775157|NCT01435928|69307687|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
37775158|NCT01435928|69307688|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
37775159|NCT01435928|69307689|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
37775160|NCT01435928|69307687|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
37775161|NCT01435928|69307688|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
37690659|NCT01656395|69166894|FG007|Overall Study|Lack of Efficacy|0|||
37690660|NCT01656395|69166887|FG000|Overall Study|Lost to Follow-up|1|||
37690661|NCT01656395|69166888|FG001|Overall Study|Lost to Follow-up|0|||
37690662|NCT01656395|69166889|FG002|Overall Study|Lost to Follow-up|0|||
37690663|NCT01656395|69166890|FG003|Overall Study|Lost to Follow-up|0|||
37690664|NCT01656395|69166891|FG004|Overall Study|Lost to Follow-up|0|||
37690665|NCT01656395|69166892|FG005|Overall Study|Lost to Follow-up|0|||
37690666|NCT01656395|69166893|FG006|Overall Study|Lost to Follow-up|0|||
37690667|NCT01656395|69166894|FG007|Overall Study|Lost to Follow-up|0|||
37690668|NCT01656395|69166887|FG000|Overall Study|Non-Compliance with Study Drug|1|||
37690669|NCT01656395|69166888|FG001|Overall Study|Non-Compliance with Study Drug|1|||
37690670|NCT01656395|69166889|FG002|Overall Study|Non-Compliance with Study Drug|0|||
37690671|NCT01656395|69166890|FG003|Overall Study|Non-Compliance with Study Drug|0|||
37690672|NCT01656395|69166891|FG004|Overall Study|Non-Compliance with Study Drug|1|||
37690673|NCT01656395|69166892|FG005|Overall Study|Non-Compliance with Study Drug|1|||
37690674|NCT01656395|69166893|FG006|Overall Study|Non-Compliance with Study Drug|0|||
37775162|NCT01435928|69307689|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
37775163|NCT01416272|69307701|FG000|Overall Study|Unacceptable distance visual acuity|2|||
37775164|NCT01416272|69307701|FG000|Overall Study|Lost to Follow-up|1|||
37775165|NCT01416272|69307701|FG000|Overall Study|Study related complaints|1|||
37775166|NCT01435772|69308191|FG000|Overall Study|Adverse Event|1|||
37775167|NCT01435772|69308192|FG001|Overall Study|Adverse Event|0|||
37775168|NCT01435772|69308193|FG002|Overall Study|Adverse Event|2|||
37775169|NCT01435772|69308191|FG000|Overall Study|Withdrawal by Subject|0|||
37775170|NCT01435772|69308192|FG001|Overall Study|Withdrawal by Subject|1|||
37775171|NCT01435772|69308193|FG002|Overall Study|Withdrawal by Subject|3|||
37775172|NCT01435772|69308191|FG000|Overall Study|Other - study termination|2|||
37775173|NCT01435772|69308192|FG001|Overall Study|Other - study termination|2|||
37775174|NCT01435772|69308193|FG002|Overall Study|Other - study termination|10|||
37775175|NCT01435616|69308412|FG000|Overall Study|Adverse Event|39|||
37775176|NCT01435616|69308413|FG001|Overall Study|Adverse Event|21|||
37775177|NCT01435616|69308412|FG000|Overall Study|Death|7|||
37775178|NCT01435616|69308413|FG001|Overall Study|Death|2|||
37775179|NCT01435616|69308412|FG000|Overall Study|Lost to Follow-up|22|||
37775180|NCT01435616|69308413|FG001|Overall Study|Lost to Follow-up|13|||
37775181|NCT01435616|69308412|FG000|Overall Study|Protocol Violation|16|||
37775182|NCT01435616|69308413|FG001|Overall Study|Protocol Violation|13|||
37775183|NCT01435616|69308412|FG000|Overall Study|Withdrawal by Subject|66|||
37775184|NCT01435616|69308413|FG001|Overall Study|Withdrawal by Subject|24|||
37775185|NCT01435616|69308412|FG000|Overall Study|Physician Decision|20|||
37775186|NCT01435616|69308413|FG001|Overall Study|Physician Decision|7|||
37775187|NCT01435616|69308412|FG000|Overall Study|Sponsor Decision|1|||
37690675|NCT01656395|69166894|FG007|Overall Study|Non-Compliance with Study Drug|0|||
37690676|NCT01656395|69166887|FG000|Overall Study|Other|0|||
37690677|NCT01656395|69166888|FG001|Overall Study|Other|0|||
37690678|NCT01656395|69166889|FG002|Overall Study|Other|1|||
37690679|NCT01656395|69166890|FG003|Overall Study|Other|0|||
37690680|NCT01656395|69166891|FG004|Overall Study|Other|0|||
37690681|NCT01656395|69166892|FG005|Overall Study|Other|1|||
37690682|NCT01656395|69166893|FG006|Overall Study|Other|0|||
37690683|NCT01656395|69166894|FG007|Overall Study|Other|0|||
37690684|NCT01656395|69166887|FG000|Overall Study|Physician Decision|2|||
37690685|NCT01656395|69166888|FG001|Overall Study|Physician Decision|3|||
37690686|NCT01656395|69166889|FG002|Overall Study|Physician Decision|3|||
37690687|NCT01656395|69166890|FG003|Overall Study|Physician Decision|2|||
37690688|NCT01656395|69166891|FG004|Overall Study|Physician Decision|3|||
37690689|NCT01656395|69166892|FG005|Overall Study|Physician Decision|3|||
37690690|NCT01656395|69166893|FG006|Overall Study|Physician Decision|0|||
37690691|NCT01656395|69166894|FG007|Overall Study|Physician Decision|0|||
37690692|NCT01656395|69166887|FG000|Overall Study|Pregnancy|0|||
37690693|NCT01656395|69166888|FG001|Overall Study|Pregnancy|0|||
37690694|NCT01656395|69166889|FG002|Overall Study|Pregnancy|1|||
37690695|NCT01656395|69166890|FG003|Overall Study|Pregnancy|0|||
37690696|NCT01656395|69166891|FG004|Overall Study|Pregnancy|0|||
37775188|NCT01435616|69308413|FG001|Overall Study|Sponsor Decision|0|||
37863667|NCT01125189|69547250|FG000|Treatment Period|Other reasons|1|||
37690697|NCT01656395|69166892|FG005|Overall Study|Pregnancy|0|||
37690698|NCT01656395|69166893|FG006|Overall Study|Pregnancy|0|||
37690699|NCT01656395|69166894|FG007|Overall Study|Pregnancy|0|||
37690700|NCT01656395|69166887|FG000|Overall Study|Progressive Disease|0|||
37690701|NCT01656395|69166888|FG001|Overall Study|Progressive Disease|0|||
37690702|NCT01656395|69166889|FG002|Overall Study|Progressive Disease|0|||
37690703|NCT01656395|69166890|FG003|Overall Study|Progressive Disease|0|||
37775189|NCT01435460|69308472|FG000|Overall Study|Adverse Event|2|||
37775190|NCT01435460|69308473|FG001|Overall Study|Adverse Event|1|||
37775191|NCT01435460|69308472|FG000|Overall Study|Lost to Follow-up|6|||
37775192|NCT01435460|69308473|FG001|Overall Study|Lost to Follow-up|1|||
37775193|NCT01435460|69308472|FG000|Overall Study|Withdrawal by Subject|1|||
37775194|NCT01435460|69308473|FG001|Overall Study|Withdrawal by Subject|3|||
37775195|NCT01435460|69308472|FG000|Overall Study|Protocol Violation|0|||
37775196|NCT01435460|69308473|FG001|Overall Study|Protocol Violation|1|||
37775197|NCT01435460|69308472|FG000|Overall Study|Did not meet eligibility criteria|2|||
37775198|NCT01435460|69308473|FG001|Overall Study|Did not meet eligibility criteria|0|||
37775199|NCT01435382|69308559|FG000|Overall Study|Lost to Follow-up|1|||
37775200|NCT01435382|69308560|FG001|Overall Study|Lost to Follow-up|0|||
37775201|NCT01435382|69308561|FG002|Overall Study|Lost to Follow-up|1|||
37775202|NCT01435382|69308562|FG003|Overall Study|Lost to Follow-up|0|||
37775203|NCT01435382|69308559|FG000|Overall Study|Withdrawal by Subject|0|||
37775204|NCT01435382|69308560|FG001|Overall Study|Withdrawal by Subject|2|||
37775205|NCT01435382|69308561|FG002|Overall Study|Withdrawal by Subject|0|||
37775206|NCT01435382|69308562|FG003|Overall Study|Withdrawal by Subject|1|||
37863668|NCT01125189|69547251|FG001|Treatment Period|Other reasons|1|||
37775207|NCT01414166|69308627|FG000|Overall Study|Adverse Event|10|||
37775208|NCT01414166|69308628|FG001|Overall Study|Adverse Event|2|||
37775209|NCT01414166|69308627|FG000|Overall Study|Lost to Follow-up|4|||
37775210|NCT01414166|69308628|FG001|Overall Study|Lost to Follow-up|1|||
37775211|NCT01414166|69308627|FG000|Overall Study|Non-compliance with study drug|2|||
37775212|NCT01414166|69308628|FG001|Overall Study|Non-compliance with study drug|0|||
37775213|NCT01414166|69308627|FG000|Overall Study|Physician Decision|2|||
37775214|NCT01414166|69308628|FG001|Overall Study|Physician Decision|0|||
37775215|NCT01414166|69308627|FG000|Overall Study|Protocol Violation|2|||
37775216|NCT01414166|69308628|FG001|Overall Study|Protocol Violation|0|||
37775217|NCT01414166|69308627|FG000|Overall Study|Study terminated by Sponsor|68|||
37775218|NCT01414166|69308628|FG001|Overall Study|Study terminated by Sponsor|75|||
37775219|NCT01414166|69308627|FG000|Overall Study|Withdrawal by Subject|3|||
37775220|NCT01414166|69308628|FG001|Overall Study|Withdrawal by Subject|5|||
37775221|NCT01434680|69308638|FG000|Overall Study|Withdrawal by Subject|1|||
37775222|NCT01434680|69308639|FG001|Overall Study|Withdrawal by Subject|0|||
37775223|NCT01434680|69308640|FG002|Overall Study|Withdrawal by Subject|2|||
37775224|NCT01434680|69308641|FG003|Overall Study|Withdrawal by Subject|0|||
37775225|NCT01434680|69308638|FG000|Overall Study|Lost to Follow-up|1|||
37775226|NCT01434680|69308639|FG001|Overall Study|Lost to Follow-up|1|||
37775227|NCT01434680|69308640|FG002|Overall Study|Lost to Follow-up|0|||
37775228|NCT01434680|69308641|FG003|Overall Study|Lost to Follow-up|0|||
37775229|NCT01434680|69308638|FG000|Overall Study|Protocol Violation|1|||
37775230|NCT01434680|69308639|FG001|Overall Study|Protocol Violation|1|||
37775231|NCT01434680|69308640|FG002|Overall Study|Protocol Violation|0|||
37775232|NCT01434680|69308641|FG003|Overall Study|Protocol Violation|0|||
37775233|NCT01433978|69308774|FG000|Core Study|Adverse Event, Non-Fatal|0|||
37775234|NCT01433978|69308775|FG001|Core Study|Adverse Event, Non-Fatal|1|||
37775235|NCT01433978|69308776|FG002|Core Study|Adverse Event, Non-Fatal|0|||
37775236|NCT01433978|69308774|FG000|Core Study|Lack of Efficacy|5|||
37775237|NCT01433978|69308775|FG001|Core Study|Lack of Efficacy|1|||
37775238|NCT01433978|69308776|FG002|Core Study|Lack of Efficacy|0|||
37775239|NCT01433978|69308774|FG000|Core Study|Study Terminated by Sponsor|6|||
37775240|NCT01433978|69308775|FG001|Core Study|Study Terminated by Sponsor|9|||
38043645|NCT02180867|69731804|FG000|Overall Study|Withdrawal by Subject|0|||
37775241|NCT01433978|69308776|FG002|Core Study|Study Terminated by Sponsor|0|||
37775242|NCT01433978|69308774|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
37775243|NCT01433978|69308775|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
37775244|NCT01433978|69308776|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
37775245|NCT01433978|69308774|FG000|Extension Phase|Lack of Efficacy|0|||
38043646|NCT02180867|69731805|FG001|Overall Study|Withdrawal by Subject|0|||
38043647|NCT02180867|69731806|FG002|Overall Study|Withdrawal by Subject|0|||
38043648|NCT02180867|69731807|FG003|Overall Study|Withdrawal by Subject|1|||
38043649|NCT02180867|69731808|FG004|Overall Study|Withdrawal by Subject|1|||
38043650|NCT02180867|69731809|FG005|Overall Study|Withdrawal by Subject|0|||
38043651|NCT02180867|69731810|FG006|Overall Study|Withdrawal by Subject|0|||
38043652|NCT02180867|69731804|FG000|Overall Study|Ineligible|1|||
38043653|NCT02180867|69731805|FG001|Overall Study|Ineligible|2|||
38043654|NCT02180867|69731806|FG002|Overall Study|Ineligible|0|||
38043655|NCT02180867|69731807|FG003|Overall Study|Ineligible|3|||
38043656|NCT02180867|69731808|FG004|Overall Study|Ineligible|5|||
38043657|NCT02180867|69731809|FG005|Overall Study|Ineligible|0|||
38043658|NCT02180867|69731810|FG006|Overall Study|Ineligible|0|||
38043659|NCT02180867|69731804|FG000|Overall Study|Repeat Eligibility Studies|0|||
38043660|NCT02180867|69731805|FG001|Overall Study|Repeat Eligibility Studies|0|||
38043661|NCT02180867|69731806|FG002|Overall Study|Repeat Eligibility Studies|0|||
38043662|NCT02180867|69731807|FG003|Overall Study|Repeat Eligibility Studies|0|||
38043663|NCT02180867|69731808|FG004|Overall Study|Repeat Eligibility Studies|1|||
38043664|NCT02180867|69731809|FG005|Overall Study|Repeat Eligibility Studies|0|||
38043665|NCT02180867|69731810|FG006|Overall Study|Repeat Eligibility Studies|0|||
38043666|NCT02180867|69731804|FG000|Overall Study|Refusal of further protocol therapy|1|||
38043667|NCT02180867|69731805|FG001|Overall Study|Refusal of further protocol therapy|0|||
38043668|NCT02180867|69731806|FG002|Overall Study|Refusal of further protocol therapy|2|||
37775246|NCT01433978|69308775|FG001|Extension Phase|Lack of Efficacy|0|||
37775247|NCT01433978|69308776|FG002|Extension Phase|Lack of Efficacy|1|||
37775248|NCT01433978|69308774|FG000|Extension Phase|Study Terminated by Sponsor|0|||
37775249|NCT01433978|69308775|FG001|Extension Phase|Study Terminated by Sponsor|0|||
37775250|NCT01433978|69308776|FG002|Extension Phase|Study Terminated by Sponsor|4|||
37775251|NCT01433354|69308825|FG000|Overall Study|Adverse Event|6|||
37775252|NCT01433354|69308825|FG000|Overall Study|Lost to Follow-up|1|||
37775253|NCT01433354|69308825|FG000|Overall Study|Administrative problems|90|||
37775254|NCT01433354|69308825|FG000|Overall Study|Protocol Violation|2|||
37775255|NCT01433354|69308825|FG000|Overall Study|Lack of Efficacy|17|||
37775256|NCT01433354|69308825|FG000|Overall Study|Subject Withdrew Consent|3|||
37775257|NCT04508023|69309336|FG000|Overall Study|Withdrawal by Subject|1|||
37775258|NCT04508023|69309337|FG001|Overall Study|Withdrawal by Subject|2|||
37775259|NCT04187144|69309345|FG000|Overall Study|Lost to Follow-up|12|||
37775260|NCT04187144|69309346|FG001|Overall Study|Lost to Follow-up|11|||
37775261|NCT04187144|69309345|FG000|Overall Study|Withdrawal by Subject|20|||
37775262|NCT04187144|69309346|FG001|Overall Study|Withdrawal by Subject|18|||
37775263|NCT04187144|69309345|FG000|Overall Study|Adverse Event|19|||
37775264|NCT04187144|69309346|FG001|Overall Study|Adverse Event|4|||
37775265|NCT04187144|69309345|FG000|Overall Study|Physician Decision|5|||
37775266|NCT04187144|69309346|FG001|Overall Study|Physician Decision|3|||
37775267|NCT04187144|69309345|FG000|Overall Study|Screening Failure due to creatinine clearance and body mass index|0|||
37775268|NCT04187144|69309346|FG001|Overall Study|Screening Failure due to creatinine clearance and body mass index|1|||
37775269|NCT04187144|69309345|FG000|Overall Study|Protocol Deviation|1|||
37775270|NCT04187144|69309346|FG001|Overall Study|Protocol Deviation|4|||
37775271|NCT04027946|69309352|FG000|Overall Study|Screen failures|3|||
37775272|NCT03856047|69309373|FG000|Overall Study|Withdrawal by Subject|0|||
37775273|NCT03856047|69309374|FG001|Overall Study|Withdrawal by Subject|1|||
37775274|NCT03856047|69309375|FG002|Overall Study|Withdrawal by Subject|1|||
37775275|NCT03856047|69309376|FG003|Overall Study|Withdrawal by Subject|0|||
37775276|NCT03856047|69309377|FG004|Overall Study|Withdrawal by Subject|3|||
37775277|NCT03856047|69309378|FG005|Overall Study|Withdrawal by Subject|0|||
37775278|NCT03856047|69309379|FG006|Overall Study|Withdrawal by Subject|2|||
37775279|NCT03856047|69309373|FG000|Overall Study|Lost to Follow-up|4|||
37775280|NCT03856047|69309374|FG001|Overall Study|Lost to Follow-up|2|||
37775281|NCT03856047|69309375|FG002|Overall Study|Lost to Follow-up|3|||
37775282|NCT03856047|69309376|FG003|Overall Study|Lost to Follow-up|1|||
37775283|NCT03856047|69309377|FG004|Overall Study|Lost to Follow-up|4|||
37775284|NCT03856047|69309378|FG005|Overall Study|Lost to Follow-up|4|||
37775285|NCT03856047|69309379|FG006|Overall Study|Lost to Follow-up|4|||
37775286|NCT03112603|69309430|FG000|End of Randomization Period|Lost to Follow-up|3|||
37775287|NCT03112603|69309431|FG001|End of Randomization Period|Lost to Follow-up|0|||
37775288|NCT03112603|69309432|FG002|End of Randomization Period|Lost to Follow-up|0|||
37775289|NCT03112603|69309430|FG000|End of Randomization Period|Participant/Guardian Decision|7|||
37775290|NCT03112603|69309431|FG001|End of Randomization Period|Participant/Guardian Decision|14|||
37775291|NCT03112603|69309432|FG002|End of Randomization Period|Participant/Guardian Decision|0|||
37775292|NCT03112603|69309430|FG000|End of Randomization Period|Physician Decision|43|||
37775293|NCT03112603|69309431|FG001|End of Randomization Period|Physician Decision|18|||
37775294|NCT03112603|69309432|FG002|End of Randomization Period|Physician Decision|0|||
37775295|NCT03112603|69309430|FG000|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|4|||
37775296|NCT03112603|69309431|FG001|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|5|||
37775297|NCT03112603|69309432|FG002|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|0|||
37775298|NCT03112603|69309430|FG000|End of Randomization Period|Death|10|||
37775299|NCT03112603|69309431|FG001|End of Randomization Period|Death|7|||
37775300|NCT03112603|69309432|FG002|End of Randomization Period|Death|0|||
37775301|NCT03112603|69309430|FG000|End of Randomization Period|Disease Relapse|12|||
37775302|NCT03112603|69309431|FG001|End of Randomization Period|Disease Relapse|7|||
37775303|NCT03112603|69309432|FG002|End of Randomization Period|Disease Relapse|0|||
37775304|NCT03112603|69309430|FG000|End of Randomization Period|Lack of Efficacy|25|||
37775305|NCT03112603|69309431|FG001|End of Randomization Period|Lack of Efficacy|77|||
37775306|NCT03112603|69309432|FG002|End of Randomization Period|Lack of Efficacy|0|||
37775307|NCT03112603|69309430|FG000|End of Randomization Period|Adverse Event|32|||
37775308|NCT03112603|69309431|FG001|End of Randomization Period|Adverse Event|12|||
37775309|NCT03112603|69309432|FG002|End of Randomization Period|Adverse Event|0|||
37775310|NCT03112603|69309430|FG000|End of Cross Over Period|Death|0|||
37775311|NCT03112603|69309431|FG001|End of Cross Over Period|Death|0|||
37775312|NCT03112603|69309432|FG002|End of Cross Over Period|Death|2|||
37775313|NCT03112603|69309430|FG000|End of Cross Over Period|Participant/Guardian Decision|0|||
37775314|NCT03112603|69309431|FG001|End of Cross Over Period|Participant/Guardian Decision|0|||
37775315|NCT03112603|69309432|FG002|End of Cross Over Period|Participant/Guardian Decision|7|||
37775316|NCT03112603|69309430|FG000|End of Cross Over Period|Physician Decision|0|||
37775317|NCT03112603|69309431|FG001|End of Cross Over Period|Physician Decision|0|||
37775318|NCT03112603|69309432|FG002|End of Cross Over Period|Physician Decision|29|||
37775319|NCT03112603|69309430|FG000|End of Cross Over Period|Lack of Efficacy|0|||
37775320|NCT03112603|69309431|FG001|End of Cross Over Period|Lack of Efficacy|0|||
37775321|NCT03112603|69309432|FG002|End of Cross Over Period|Lack of Efficacy|8|||
37775322|NCT03112603|69309430|FG000|End of Cross Over Period|Adverse Event|0|||
37775323|NCT03112603|69309431|FG001|End of Cross Over Period|Adverse Event|0|||
37775324|NCT03112603|69309432|FG002|End of Cross Over Period|Adverse Event|6|||
37775325|NCT03112603|69309430|FG000|End of Cross Over Period|Disease Relapse|0|||
37775326|NCT03112603|69309431|FG001|End of Cross Over Period|Disease Relapse|0|||
37775327|NCT03112603|69309432|FG002|End of Cross Over Period|Disease Relapse|2|||
37775328|NCT02725528|69309447|FG000|Overall Study|Lost to Follow-up|1|||
37775329|NCT02725528|69309448|FG001|Overall Study|Lost to Follow-up|4|||
37775330|NCT02725528|69309447|FG000|Overall Study|Withdrawal by Subject|0|||
37775331|NCT02725528|69309448|FG001|Overall Study|Withdrawal by Subject|1|||
37775332|NCT02627963|69309465|FG000|Overall Study|Randomized but not treated|2|||
37775333|NCT02627963|69309466|FG001|Overall Study|Randomized but not treated|6|||
37690704|NCT01656395|69166891|FG004|Overall Study|Progressive Disease|0|||
37690705|NCT01656395|69166892|FG005|Overall Study|Progressive Disease|1|||
37690706|NCT01656395|69166893|FG006|Overall Study|Progressive Disease|0|||
37690707|NCT01656395|69166894|FG007|Overall Study|Progressive Disease|0|||
37690708|NCT01656395|69166887|FG000|Overall Study|Protocol Violation|6|||
37690709|NCT01656395|69166888|FG001|Overall Study|Protocol Violation|6|||
37690710|NCT01656395|69166889|FG002|Overall Study|Protocol Violation|9|||
37690711|NCT01656395|69166890|FG003|Overall Study|Protocol Violation|2|||
37690712|NCT01656395|69166891|FG004|Overall Study|Protocol Violation|4|||
37690713|NCT01656395|69166892|FG005|Overall Study|Protocol Violation|10|||
37690714|NCT01656395|69166893|FG006|Overall Study|Protocol Violation|0|||
37690715|NCT01656395|69166894|FG007|Overall Study|Protocol Violation|0|||
37690716|NCT01656395|69166887|FG000|Overall Study|Screen Failure|2|||
37690717|NCT01656395|69166888|FG001|Overall Study|Screen Failure|1|||
37690718|NCT01656395|69166889|FG002|Overall Study|Screen Failure|7|||
37690719|NCT01656395|69166890|FG003|Overall Study|Screen Failure|1|||
37690720|NCT01656395|69166891|FG004|Overall Study|Screen Failure|0|||
37690721|NCT01656395|69166892|FG005|Overall Study|Screen Failure|8|||
37968292|NCT02406027|69655360|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
37968293|NCT02406027|69655361|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
37775334|NCT02585258|69309474|FG000|Overall Study|Adverse Event|28|||
37775335|NCT02585258|69309475|FG001|Overall Study|Adverse Event|29|||
37775336|NCT02585258|69309474|FG000|Overall Study|Death|3|||
37775337|NCT02585258|69309475|FG001|Overall Study|Death|2|||
37775338|NCT02585258|69309474|FG000|Overall Study|Lack of Efficacy|7|||
37775339|NCT02585258|69309475|FG001|Overall Study|Lack of Efficacy|9|||
37775340|NCT02585258|69309474|FG000|Overall Study|includes covid-related access problems|42|||
37775341|NCT02585258|69309475|FG001|Overall Study|includes covid-related access problems|46|||
37775342|NCT02585258|69309474|FG000|Overall Study|Lost to Follow-up|5|||
37775343|NCT02585258|69309475|FG001|Overall Study|Lost to Follow-up|2|||
37775344|NCT02132611|69309492|FG000|Overall Study|Death|2|||
37775345|NCT01941030|69309498|FG000|Overall Study|Death|3|||
37775346|NCT01941030|69309499|FG001|Overall Study|Death|2|||
37775347|NCT01941030|69309498|FG000|Overall Study|Lost to Follow-up|6|||
37775348|NCT01941030|69309499|FG001|Overall Study|Lost to Follow-up|5|||
37775349|NCT01941030|69309498|FG000|Overall Study|Withdrawal by Subject|4|||
37775350|NCT01941030|69309499|FG001|Overall Study|Withdrawal by Subject|6|||
37775351|NCT01092416|69309510|FG000|Enrollment|Atherectomy device not inserted|3|||
37775352|NCT01092416|69309510|FG000|30-Day Follow-up|Death|2|||
37775353|NCT01092416|69309510|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
37775354|NCT01092416|69309510|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
37775355|NCT01092416|69309510|FG000|12-Month Follow-up|Death|16|||
37775356|NCT01092416|69309510|FG000|12-Month Follow-up|Lost to Follow-up|4|||
37775357|NCT01092416|69309510|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
37775358|NCT01092416|69309510|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
37775359|NCT01092416|69309510|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
37775360|NCT00701220|69309519|FG000|Overall Study|Withdrawal by Subject|0|||
37775361|NCT00701220|69309520|FG001|Overall Study|Withdrawal by Subject|2|||
37775362|NCT00701220|69309519|FG000|Overall Study|Protocol Violation|2|||
37775363|NCT00701220|69309520|FG001|Overall Study|Protocol Violation|0|||
37775364|NCT00559845|69309594|FG000|Overall Study|Withdrew Consent|1|||
37775365|NCT00559845|69309594|FG000|Overall Study|Disease Progression|1|||
37775366|NCT00559845|69309594|FG000|Overall Study|Adverse Event|3|||
37775367|NCT00559845|69309594|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
37775368|NCT00559845|69309594|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
37775369|NCT01393964|69309697|FG000|Overall Study|Disease Progression|4|||
37775370|NCT01393964|69309698|FG001|Overall Study|Disease Progression|3|||
37775371|NCT01393964|69309699|FG002|Overall Study|Disease Progression|5|||
37775372|NCT01393964|69309697|FG000|Overall Study|Study drug toxicity|1|||
37775373|NCT01393964|69309698|FG001|Overall Study|Study drug toxicity|0|||
37775374|NCT01393964|69309699|FG002|Overall Study|Study drug toxicity|0|||
37775375|NCT01393964|69309697|FG000|Overall Study|Withdrawal by Subject|0|||
37775376|NCT01393964|69309698|FG001|Overall Study|Withdrawal by Subject|0|||
37775377|NCT01393964|69309699|FG002|Overall Study|Withdrawal by Subject|1|||
37775378|NCT01393964|69309697|FG000|Overall Study|Adverse event unrelated to study drug|0|||
37775379|NCT01393964|69309698|FG001|Overall Study|Adverse event unrelated to study drug|3|||
37775380|NCT01393964|69309699|FG002|Overall Study|Adverse event unrelated to study drug|0|||
37775381|NCT01393964|69309697|FG000|Overall Study|Subject request stop study treatment|0|||
37775382|NCT01393964|69309698|FG001|Overall Study|Subject request stop study treatment|1|||
37775383|NCT01393964|69309699|FG002|Overall Study|Subject request stop study treatment|0|||
37775384|NCT01393964|69309697|FG000|Overall Study|Subject decided to move to transplant|1|||
37775385|NCT01393964|69309698|FG001|Overall Study|Subject decided to move to transplant|0|||
37775386|NCT01393964|69309699|FG002|Overall Study|Subject decided to move to transplant|0|||
37775387|NCT01393964|69309697|FG000|Overall Study|Subject switched to commercial supply|1|||
37775388|NCT01393964|69309698|FG001|Overall Study|Subject switched to commercial supply|0|||
37863669|NCT01125189|69547252|FG002|Treatment Period|Other reasons|0|||
37775389|NCT01393964|69309699|FG002|Overall Study|Subject switched to commercial supply|2|||
37775390|NCT01393964|69309697|FG000|Overall Study|Subject plateaued in terms of effect|1|||
37775391|NCT01393964|69309698|FG001|Overall Study|Subject plateaued in terms of effect|0|||
37775392|NCT01393964|69309699|FG002|Overall Study|Subject plateaued in terms of effect|0|||
37775393|NCT01393964|69309697|FG000|Overall Study|Investigator removed subject from study|0|||
37775394|NCT01393964|69309698|FG001|Overall Study|Investigator removed subject from study|1|||
37775395|NCT01393964|69309699|FG002|Overall Study|Investigator removed subject from study|0|||
37775396|NCT01393964|69309697|FG000|Overall Study|Subject converted to roll-over study|0|||
37775397|NCT01393964|69309698|FG001|Overall Study|Subject converted to roll-over study|1|||
37775398|NCT01393964|69309699|FG002|Overall Study|Subject converted to roll-over study|0|||
37775399|NCT01393964|69309697|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
37775400|NCT01393964|69309698|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
37775401|NCT01393964|69309699|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
37775402|NCT01393730|69309787|FG000|Overall Study|Withdrawal by Subject|3|||
37775403|NCT01393730|69309787|FG000|Overall Study|Other|2|||
37775404|NCT01393730|69309787|FG000|Overall Study|Adverse Event|1|||
37775405|NCT01393106|69309806|FG000|Overall Study|Adverse Event|3|||
37775406|NCT01393106|69309806|FG000|Overall Study|Withdrawal by Subject|1|||
37775407|NCT01393106|69309806|FG000|Overall Study|Lack of Efficacy|1|||
37775408|NCT00553059|69309812|FG000|Overall Study|Deemed ineligible|1|||
37775409|NCT00553059|69309813|FG001|Overall Study|Deemed ineligible|1|||
37775410|NCT00553059|69309812|FG000|Overall Study|Drug supply not available|0|||
37775411|NCT00553059|69309813|FG001|Overall Study|Drug supply not available|1|||
37775412|NCT01413542|69309846|FG000|Overall Study|Physician Decision|1|||
37775413|NCT01413542|69309847|FG001|Overall Study|Physician Decision|0|||
37775414|NCT01413542|69309848|FG002|Overall Study|Physician Decision|3|||
37863670|NCT01125189|69547250|FG000|Treatment Period|Completed 24 week treatment period only|2|||
37863671|NCT01125189|69547251|FG001|Treatment Period|Completed 24 week treatment period only|1|||
37863672|NCT01125189|69547252|FG002|Treatment Period|Completed 24 week treatment period only|2|||
37690722|NCT01656395|69166893|FG006|Overall Study|Screen Failure|0|||
37690723|NCT01656395|69166894|FG007|Overall Study|Screen Failure|0|||
37690724|NCT01656395|69166887|FG000|Overall Study|Withdrawal by Subject|3|||
37690725|NCT01656395|69166888|FG001|Overall Study|Withdrawal by Subject|1|||
37690726|NCT01656395|69166889|FG002|Overall Study|Withdrawal by Subject|4|||
37690727|NCT01656395|69166890|FG003|Overall Study|Withdrawal by Subject|2|||
37690728|NCT01656395|69166891|FG004|Overall Study|Withdrawal by Subject|0|||
37690729|NCT01656395|69166892|FG005|Overall Study|Withdrawal by Subject|3|||
37690730|NCT01656395|69166893|FG006|Overall Study|Withdrawal by Subject|0|||
37690731|NCT01656395|69166894|FG007|Overall Study|Withdrawal by Subject|0|||
37690732|NCT02114931|69166910|FG000|Overall Study|Withdrawal by Subject|15|||
37690733|NCT02114931|69166911|FG001|Overall Study|Withdrawal by Subject|18|||
37690734|NCT02114931|69166910|FG000|Overall Study|Adverse Event|4|||
37690735|NCT02114931|69166911|FG001|Overall Study|Adverse Event|6|||
37690736|NCT02114931|69166910|FG000|Overall Study|Lost to Follow-up|3|||
37690737|NCT02114931|69166911|FG001|Overall Study|Lost to Follow-up|3|||
37690738|NCT02114931|69166910|FG000|Overall Study|Physician Decision|1|||
37690739|NCT02114931|69166911|FG001|Overall Study|Physician Decision|2|||
37690740|NCT02114931|69166910|FG000|Overall Study|Other|2|||
37690741|NCT02114931|69166911|FG001|Overall Study|Other|1|||
37690742|NCT01657019|69166917|FG000|Overall Study|Withdrawal by Subject|65|||
37690743|NCT01657019|69166917|FG000|Overall Study|Adverse Event|55|||
37690744|NCT01657019|69166917|FG000|Overall Study|Lost to Follow-up|48|||
37690745|NCT01657019|69166917|FG000|Overall Study|Protocol Violation|6|||
37690746|NCT01657019|69166917|FG000|Overall Study|Lack of Efficacy|3|||
37690747|NCT01657019|69166917|FG000|Overall Study|Other|58|||
37690748|NCT02329327|69166923|FG000|Overall Study|Death|78|||
37690749|NCT02329327|69166924|FG001|Overall Study|Death|0|||
37690750|NCT02329327|69166923|FG000|Overall Study|Withdrawal by Subject|3|||
37690751|NCT02329327|69166924|FG001|Overall Study|Withdrawal by Subject|0|||
37690752|NCT02329327|69166923|FG000|Overall Study|Lost to Follow-up|4|||
37690753|NCT02329327|69166924|FG001|Overall Study|Lost to Follow-up|0|||
37690754|NCT02328937|69166943|FG000|Period 1|Lost to Follow-up|0|||
37690755|NCT02328937|69166944|FG001|Period 1|Lost to Follow-up|0|||
37690756|NCT02328937|69166945|FG002|Period 1|Lost to Follow-up|0|||
37690757|NCT02328937|69166946|FG003|Period 1|Lost to Follow-up|1|||
37690758|NCT02328937|69166947|FG004|Period 1|Lost to Follow-up|0|||
37690759|NCT02328937|69166948|FG005|Period 1|Lost to Follow-up|0|||
37690760|NCT02328937|69166943|FG000|Period 2|Adverse Event|0|||
37690761|NCT02328937|69166944|FG001|Period 2|Adverse Event|0|||
37690762|NCT02328937|69166945|FG002|Period 2|Adverse Event|1|||
37690763|NCT02328937|69166946|FG003|Period 2|Adverse Event|0|||
37690764|NCT02328937|69166947|FG004|Period 2|Adverse Event|0|||
37690765|NCT02328937|69166948|FG005|Period 2|Adverse Event|0|||
37690766|NCT02328547|69166958|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
37775415|NCT01413542|69309849|FG003|Overall Study|Physician Decision|0|||
37775416|NCT01413542|69309846|FG000|Overall Study|Adverse Event|0|||
37775417|NCT01413542|69309847|FG001|Overall Study|Adverse Event|0|||
37775418|NCT01413542|69309848|FG002|Overall Study|Adverse Event|0|||
37775419|NCT01413542|69309849|FG003|Overall Study|Adverse Event|1|||
37775420|NCT01432730|69309881|FG000|Period 1|Adverse Event|2|||
37775421|NCT01432730|69309882|FG001|Period 1|Adverse Event|0|||
37775422|NCT01432730|69309881|FG000|Period 2|Adverse Event|0|||
37775423|NCT01432730|69309882|FG001|Period 2|Adverse Event|4|||
37775424|NCT01432574|69309897|FG000|Overall Study|Moved|2|||
37775425|NCT01432574|69309897|FG000|Overall Study|Not interested|1|||
37775426|NCT01392560|69309930|FG000|Overall Study|Adverse Event|2|||
37775427|NCT01392560|69309930|FG000|Overall Study|not entered|8|||
37775428|NCT01392560|69309930|FG000|Overall Study|discontinued during placebo run-in|2|||
37775429|NCT00552279|69309991|FG000|Overall Study|Adverse Event|0|||
37775430|NCT00552279|69309992|FG001|Overall Study|Adverse Event|1|||
37775431|NCT00552279|69309991|FG000|Overall Study|Withdrawal by Subject|12|||
37775432|NCT00552279|69309992|FG001|Overall Study|Withdrawal by Subject|1|||
37775433|NCT00552279|69309991|FG000|Overall Study|Lost to Follow-up|1|||
37775434|NCT00552279|69309992|FG001|Overall Study|Lost to Follow-up|0|||
37775435|NCT00552279|69309991|FG000|Overall Study|Other|1|||
37775436|NCT00552279|69309992|FG001|Overall Study|Other|1|||
37775437|NCT00559377|69310033|FG000|Overall Study|Withdrawal by Subject|9|||
37775438|NCT01412060|69310040|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
37775439|NCT01412060|69310041|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
37775440|NCT01412060|69310042|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
37775441|NCT01412060|69310040|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
37775442|NCT01412060|69310041|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
37775443|NCT01412060|69310042|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
37775444|NCT01412060|69310040|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
37775445|NCT01412060|69310041|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
37775446|NCT01412060|69310042|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
37775447|NCT01412060|69310040|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
37775448|NCT01412060|69310041|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
37775449|NCT01412060|69310042|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
37775450|NCT01412060|69310040|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
37775451|NCT01412060|69310041|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
37775452|NCT01412060|69310042|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
37775453|NCT01412060|69310040|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
37690767|NCT02328547|69166959|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
37690768|NCT02328547|69166958|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
37690769|NCT02328547|69166959|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
37690770|NCT02300311|69166973|FG000|Overall Study|Other than the reason specified|1|||
37690771|NCT02300311|69166974|FG001|Overall Study|Other than the reason specified|0|||
37690772|NCT02300311|69166973|FG000|Overall Study|Refused to continue taking medication|18|||
37690773|NCT02300311|69166974|FG001|Overall Study|Refused to continue taking medication|0|||
37775454|NCT01412060|69310041|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
37775455|NCT01412060|69310042|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
37775456|NCT01412060|69310040|FG000|Period Between RIP and SP|Adverse Event|4|||
37775457|NCT01412060|69310041|FG001|Period Between RIP and SP|Adverse Event|0|||
37775458|NCT01412060|69310042|FG002|Period Between RIP and SP|Adverse Event|0|||
37775459|NCT01412060|69310040|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
37863673|NCT01125189|69547250|FG000|Follow up Period|Withdrawal by Subject|3|||
37863674|NCT01125189|69547251|FG001|Follow up Period|Withdrawal by Subject|2|||
37775460|NCT01412060|69310041|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
37863675|NCT01125189|69547252|FG002|Follow up Period|Withdrawal by Subject|5|||
37775461|NCT01412060|69310042|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
37775462|NCT01412060|69310040|FG000|Period Between RIP and SP|Protocol Violation|2|||
37775463|NCT01412060|69310041|FG001|Period Between RIP and SP|Protocol Violation|0|||
37775464|NCT01412060|69310042|FG002|Period Between RIP and SP|Protocol Violation|0|||
37775465|NCT01412060|69310040|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
37775466|NCT01412060|69310041|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
37775467|NCT01412060|69310042|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
37775468|NCT01412060|69310040|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
37775469|NCT01412060|69310041|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
37775470|NCT01412060|69310042|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
37775471|NCT01412060|69310040|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
37775472|NCT01412060|69310041|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
37775473|NCT01412060|69310042|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
37775474|NCT01412060|69310040|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
37775475|NCT01412060|69310041|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
37775476|NCT01412060|69310042|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
37775477|NCT01412060|69310040|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
37775478|NCT01412060|69310041|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
37775479|NCT01412060|69310042|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
37775480|NCT01412060|69310040|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
37775481|NCT01412060|69310041|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
37775482|NCT01412060|69310042|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
37775483|NCT01412060|69310040|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
37775484|NCT01412060|69310041|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
37775485|NCT01412060|69310042|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
37775486|NCT01412060|69310040|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
37775487|NCT01412060|69310041|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
37775488|NCT01412060|69310042|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
37775489|NCT01412060|69310040|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
37775490|NCT01412060|69310041|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
37775491|NCT01412060|69310042|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
37775492|NCT01412060|69310040|FG000|Period Between SP and DBP|Protocol Violation|2|||
37775493|NCT01412060|69310041|FG001|Period Between SP and DBP|Protocol Violation|0|||
37775494|NCT01412060|69310042|FG002|Period Between SP and DBP|Protocol Violation|0|||
37775495|NCT01412060|69310040|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
37775496|NCT01412060|69310041|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
37775497|NCT01412060|69310042|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
37775498|NCT01412060|69310040|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
37775499|NCT01412060|69310041|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
37775500|NCT01412060|69310042|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
37968294|NCT02406027|69655362|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
37968295|NCT02406027|69655363|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
37968296|NCT02406027|69655364|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
37968297|NCT02278120|69655382|FG000|Overall Study|Progressive disease|122|||
37968298|NCT02278120|69655383|FG001|Overall Study|Progressive disease|174|||
37968299|NCT02278120|69655382|FG000|Overall Study|Patient/guardian decision|14|||
37968300|NCT02278120|69655383|FG001|Overall Study|Patient/guardian decision|8|||
37968301|NCT02278120|69655382|FG000|Overall Study|Adverse Event|12|||
37968302|NCT02278120|69655383|FG001|Overall Study|Adverse Event|10|||
37968303|NCT02278120|69655382|FG000|Overall Study|Physician Decision|8|||
37968304|NCT02278120|69655383|FG001|Overall Study|Physician Decision|19|||
37968305|NCT02278120|69655382|FG000|Overall Study|Death|3|||
37968306|NCT02278120|69655383|FG001|Overall Study|Death|3|||
37968307|NCT02278120|69655382|FG000|Overall Study|Lost to Follow-up|2|||
37968308|NCT02278120|69655383|FG001|Overall Study|Lost to Follow-up|0|||
37968309|NCT02278120|69655382|FG000|Overall Study|Protocol Violation|0|||
37968310|NCT02278120|69655383|FG001|Overall Study|Protocol Violation|2|||
37968311|NCT02255357|69655391|FG000|Overall Study|Physician Decision|10|||
37968312|NCT02255357|69655392|FG001|Overall Study|Physician Decision|24|||
37968313|NCT02211131|69655400|FG000|Overall Study|Death|26|||
37968314|NCT02211131|69655401|FG001|Overall Study|Death|16|||
37968315|NCT02211131|69655400|FG000|Overall Study|Lost to Follow-up|4|||
37968316|NCT02211131|69655401|FG001|Overall Study|Lost to Follow-up|3|||
37968317|NCT02211131|69655400|FG000|Overall Study|Decision by Sponsor|1|||
37968318|NCT02211131|69655401|FG001|Overall Study|Decision by Sponsor|1|||
37968319|NCT02211131|69655400|FG000|Overall Study|Withdrawal by Subject|3|||
37968320|NCT02211131|69655401|FG001|Overall Study|Withdrawal by Subject|8|||
37968321|NCT02155647|69655416|FG000|Overall Study|Still on Treatment|26|||
37968322|NCT02155647|69655417|FG001|Overall Study|Still on Treatment|26|||
37968323|NCT02155647|69655416|FG000|Overall Study|Off-Treatment, but follow up ongoing|15|||
37968324|NCT02155647|69655417|FG001|Overall Study|Off-Treatment, but follow up ongoing|26|||
37968325|NCT02134587|69655427|FG000|Overall Study|Did not completed all meetings|30|||
37968326|NCT01752920|69655444|FG000|Overall Study|Adverse Event|1|||
37968327|NCT01752920|69655445|FG001|Overall Study|Adverse Event|0|||
37968328|NCT01752920|69655446|FG002|Overall Study|Adverse Event|5|||
37968329|NCT01752920|69655447|FG003|Overall Study|Adverse Event|10|||
37968330|NCT01752920|69655444|FG000|Overall Study|Clinical Disease Progression|6|||
37968331|NCT01752920|69655445|FG001|Overall Study|Clinical Disease Progression|4|||
37968332|NCT01752920|69655446|FG002|Overall Study|Clinical Disease Progression|1|||
37968333|NCT01752920|69655447|FG003|Overall Study|Clinical Disease Progression|13|||
37968334|NCT01752920|69655444|FG000|Overall Study|Physician Decision|1|||
37968335|NCT01752920|69655445|FG001|Overall Study|Physician Decision|0|||
37968336|NCT01752920|69655446|FG002|Overall Study|Physician Decision|0|||
37968337|NCT01752920|69655447|FG003|Overall Study|Physician Decision|3|||
37968338|NCT01752920|69655444|FG000|Overall Study|Radiographic Disease Progression|20|||
37968339|NCT01752920|69655445|FG001|Overall Study|Radiographic Disease Progression|7|||
37968340|NCT01752920|69655446|FG002|Overall Study|Radiographic Disease Progression|12|||
37968341|NCT01752920|69655447|FG003|Overall Study|Radiographic Disease Progression|29|||
37775501|NCT01412060|69310040|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
37775502|NCT01412060|69310041|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
37775503|NCT01412060|69310042|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
37775504|NCT01412060|69310040|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
37775505|NCT01412060|69310041|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
37775506|NCT01412060|69310042|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
37775507|NCT01412060|69310040|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
37775508|NCT01412060|69310041|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
37775509|NCT01412060|69310042|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
37775510|NCT01412060|69310040|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
37775511|NCT01412060|69310041|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
37775512|NCT01412060|69310042|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
37775513|NCT01412060|69310040|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
37775514|NCT01412060|69310041|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
37775515|NCT01412060|69310042|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
37775516|NCT01412060|69310040|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
37775517|NCT01412060|69310041|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
37775518|NCT01412060|69310042|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
37775519|NCT01412060|69310040|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
37775520|NCT01412060|69310041|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
37775521|NCT01412060|69310042|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
37775522|NCT01412060|69310040|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
37775523|NCT01412060|69310041|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
37775524|NCT01412060|69310042|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
37775525|NCT00551421|69310073|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
37775526|NCT01891643|69310093|FG000|Overall Study|Adverse event unrelated to study drug|2|||
37775527|NCT01891643|69310094|FG001|Overall Study|Adverse event unrelated to study drug|5|||
37968342|NCT01752920|69655444|FG000|Overall Study|Study Terminated by Sponsor|0|||
37968343|NCT01752920|69655445|FG001|Overall Study|Study Terminated by Sponsor|0|||
37968344|NCT01752920|69655446|FG002|Overall Study|Study Terminated by Sponsor|0|||
37968345|NCT01752920|69655447|FG003|Overall Study|Study Terminated by Sponsor|1|||
37968346|NCT01752920|69655444|FG000|Overall Study|Withdrawal by Subject|0|||
37690774|NCT02300233|69166987|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
37690775|NCT02300233|69166988|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
37690776|NCT02300233|69166989|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
37690777|NCT02300233|69166987|FG000|Overall Study|Withdrawal by Subject|1|||
37690778|NCT02300233|69166988|FG001|Overall Study|Withdrawal by Subject|0|||
37690779|NCT02300233|69166989|FG002|Overall Study|Withdrawal by Subject|3|||
37690780|NCT02300233|69166987|FG000|Overall Study|Investigator Judgement|0|||
37775528|NCT01891643|69310093|FG000|Overall Study|Disease Progression|4|||
37775529|NCT01891643|69310094|FG001|Overall Study|Disease Progression|3|||
37690781|NCT02300233|69166988|FG001|Overall Study|Investigator Judgement|0|||
37690782|NCT02300233|69166989|FG002|Overall Study|Investigator Judgement|1|||
37690783|NCT02300233|69166987|FG000|Overall Study|Reason Not Specified|0|||
37690784|NCT02300233|69166988|FG001|Overall Study|Reason Not Specified|0|||
37775530|NCT01891643|69310093|FG000|Overall Study|Study Drug Toxicity|3|||
37775531|NCT01891643|69310094|FG001|Overall Study|Study Drug Toxicity|0|||
37775532|NCT01891643|69310093|FG000|Overall Study|Maximum Clinical Benefit|0|||
37775533|NCT01891643|69310094|FG001|Overall Study|Maximum Clinical Benefit|1|||
37775534|NCT01891643|69310093|FG000|Overall Study|Poor/Non-compliance|0|||
37775535|NCT01891643|69310094|FG001|Overall Study|Poor/Non-compliance|1|||
37775536|NCT01891643|69310093|FG000|Overall Study|Participant request to discontinue|1|||
37775537|NCT01891643|69310094|FG001|Overall Study|Participant request to discontinue|0|||
37775538|NCT01392326|69310228|FG000|Overall Study|Death|2|||
37775539|NCT01392326|69310229|FG001|Overall Study|Death|0|||
37775540|NCT01392326|69310230|FG002|Overall Study|Death|0|||
37775541|NCT01392326|69310228|FG000|Overall Study|Withdrawal by Subject|12|||
37775542|NCT01392326|69310229|FG001|Overall Study|Withdrawal by Subject|11|||
37775543|NCT01392326|69310230|FG002|Overall Study|Withdrawal by Subject|15|||
37775544|NCT01392326|69310228|FG000|Overall Study|Protocol Violation|2|||
37775545|NCT01392326|69310229|FG001|Overall Study|Protocol Violation|0|||
37775546|NCT01392326|69310230|FG002|Overall Study|Protocol Violation|0|||
37775547|NCT01392326|69310228|FG000|Overall Study|Pregnancy|0|||
37775548|NCT01392326|69310229|FG001|Overall Study|Pregnancy|0|||
37775549|NCT01392326|69310230|FG002|Overall Study|Pregnancy|1|||
37775550|NCT01392326|69310228|FG000|Overall Study|Physician Decision|7|||
37775551|NCT01392326|69310229|FG001|Overall Study|Physician Decision|5|||
37775552|NCT01392326|69310230|FG002|Overall Study|Physician Decision|2|||
37775553|NCT01392326|69310228|FG000|Overall Study|Lost to Follow-up|1|||
37775554|NCT01392326|69310229|FG001|Overall Study|Lost to Follow-up|3|||
37775555|NCT01392326|69310230|FG002|Overall Study|Lost to Follow-up|4|||
37775556|NCT01392326|69310228|FG000|Overall Study|Lack of Efficacy|14|||
37775557|NCT01392326|69310229|FG001|Overall Study|Lack of Efficacy|10|||
37775558|NCT01392326|69310230|FG002|Overall Study|Lack of Efficacy|15|||
37775559|NCT01392326|69310228|FG000|Overall Study|Adverse Event|9|||
37775560|NCT01392326|69310229|FG001|Overall Study|Adverse Event|6|||
37775561|NCT01392326|69310230|FG002|Overall Study|Adverse Event|11|||
37775562|NCT01432262|69310273|FG000|Overall Study|Withdrawal by Subject|2|||
37775563|NCT01432262|69310274|FG001|Overall Study|Withdrawal by Subject|1|||
37775564|NCT01410890|69310294|FG000|Overall Study|Withdrawal by Subject|0|||
37775565|NCT01410890|69310295|FG001|Overall Study|Withdrawal by Subject|1|||
37968347|NCT01752920|69655445|FG001|Overall Study|Withdrawal by Subject|1|||
37968348|NCT01752920|69655446|FG002|Overall Study|Withdrawal by Subject|0|||
37968349|NCT01752920|69655447|FG003|Overall Study|Withdrawal by Subject|1|||
37968350|NCT01752920|69655444|FG000|Overall Study|Lack of clinical benefit|1|||
37968351|NCT01752920|69655445|FG001|Overall Study|Lack of clinical benefit|1|||
37968352|NCT01752920|69655446|FG002|Overall Study|Lack of clinical benefit|1|||
37863676|NCT01125189|69547250|FG000|Follow up Period|Death|1|||
37863677|NCT01125189|69547251|FG001|Follow up Period|Death|0|||
37863678|NCT01125189|69547252|FG002|Follow up Period|Death|0|||
37863679|NCT01125189|69547250|FG000|Follow up Period|Lost to Follow-up|12|||
37863680|NCT01125189|69547251|FG001|Follow up Period|Lost to Follow-up|9|||
37863681|NCT01125189|69547252|FG002|Follow up Period|Lost to Follow-up|6|||
37863682|NCT01125189|69547250|FG000|Follow up Period|Other reasons|4|||
37863683|NCT01125189|69547251|FG001|Follow up Period|Other reasons|4|||
37863684|NCT01125189|69547252|FG002|Follow up Period|Other reasons|5|||
37863685|NCT01256567|69547263|FG000|Overall Study|Withdrawal by Subject|1|||
37863686|NCT00996736|69547270|FG000|Overall Study|Death|1|||
37863687|NCT00996736|69547271|FG001|Overall Study|Death|1|||
37863688|NCT00996736|69547270|FG000|Overall Study|Lost to Follow-up|15|||
37863689|NCT00996736|69547271|FG001|Overall Study|Lost to Follow-up|14|||
37863690|NCT00996736|69547270|FG000|Overall Study|Visit not within 3-month window|5|||
37863691|NCT00996736|69547271|FG001|Overall Study|Visit not within 3-month window|3|||
37863692|NCT00996658|69547279|FG000|Overall Study|Adverse Event|2|||
37968353|NCT01752920|69655447|FG003|Overall Study|Lack of clinical benefit|1|||
37775566|NCT01431950|69310305|FG000|Overall Study|Study Site Closed/Terminated|7|||
37775567|NCT01431950|69310306|FG001|Overall Study|Study Site Closed/Terminated|3|||
37775568|NCT01431950|69310305|FG000|Overall Study|Withdrawal by Subject|4|||
37775569|NCT01431950|69310306|FG001|Overall Study|Withdrawal by Subject|3|||
37775570|NCT01431950|69310305|FG000|Overall Study|Protocol Violation|2|||
37863693|NCT00996658|69547280|FG001|Overall Study|Adverse Event|5|||
37863694|NCT00996658|69547279|FG000|Overall Study|Protocol Violation|0|||
37968354|NCT00976963|69655461|FG000|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|2|||
37968355|NCT00976963|69655462|FG001|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|0|||
37968356|NCT00976963|69655461|FG000|Overall Study|administrative error|1|||
37968357|NCT00976963|69655462|FG001|Overall Study|administrative error|0|||
37968358|NCT00976963|69655461|FG000|Overall Study|allergic reaction due to previously unknown allergy|1|||
37968359|NCT00976963|69655462|FG001|Overall Study|allergic reaction due to previously unknown allergy|0|||
37968360|NCT00423735|69655479|FG000|Overall Study|Ineligible / No protocol treatment|8|||
37968361|NCT00423735|69655480|FG001|Overall Study|Ineligible / No protocol treatment|6|||
37968362|NCT00423735|69655481|FG002|Overall Study|Ineligible / No protocol treatment|0|||
37968363|NCT00626327|69655494|FG000|Overall Study|Withdrawal by Subject|21|||
37968364|NCT00626327|69655495|FG001|Overall Study|Withdrawal by Subject|29|||
37968365|NCT00626327|69655496|FG002|Overall Study|Withdrawal by Subject|30|||
37968366|NCT00626327|69655494|FG000|Overall Study|Adverse Event|1|||
37968367|NCT00626327|69655495|FG001|Overall Study|Adverse Event|0|||
37968368|NCT00626327|69655496|FG002|Overall Study|Adverse Event|0|||
37968369|NCT00626327|69655494|FG000|Overall Study|Lost to Follow-up|24|||
37968370|NCT00626327|69655495|FG001|Overall Study|Lost to Follow-up|21|||
37690785|NCT02300233|69166989|FG002|Overall Study|Reason Not Specified|5|||
37690786|NCT02175225|69167000|FG000|Overall Study|Withdrawal by Subject|1|||
37690787|NCT02175225|69167001|FG001|Overall Study|Withdrawal by Subject|2|||
37690788|NCT02175225|69167000|FG000|Overall Study|Lost to Follow-up|6|||
37690789|NCT02175225|69167001|FG001|Overall Study|Lost to Follow-up|7|||
37690790|NCT02175225|69167000|FG000|Overall Study|Study drug not administered|1|||
37690791|NCT02175225|69167001|FG001|Overall Study|Study drug not administered|2|||
37690792|NCT02299375|69167009|FG000|Overall Study|Adverse Event, serious fatal|1|||
37690793|NCT02299375|69167010|FG001|Overall Study|Adverse Event, serious fatal|3|||
37690794|NCT02299375|69167009|FG000|Overall Study|Adverse Event, non-fatal|8|||
37690795|NCT02299375|69167010|FG001|Overall Study|Adverse Event, non-fatal|9|||
37690796|NCT02299375|69167009|FG000|Overall Study|Lack of Efficacy|1|||
37690797|NCT02299375|69167010|FG001|Overall Study|Lack of Efficacy|3|||
37690798|NCT02299375|69167009|FG000|Overall Study|Protocol Violation|1|||
37690799|NCT02299375|69167010|FG001|Overall Study|Protocol Violation|3|||
37690800|NCT02299375|69167009|FG000|Overall Study|Other: Met stopping criteria|1|||
37690801|NCT02299375|69167010|FG001|Overall Study|Other: Met stopping criteria|0|||
37690802|NCT02299375|69167009|FG000|Overall Study|Other: Study closed/terminated|66|||
37690803|NCT02299375|69167010|FG001|Overall Study|Other: Study closed/terminated|55|||
37690804|NCT02299375|69167009|FG000|Overall Study|Lost to Follow-up|0|||
37690805|NCT02299375|69167010|FG001|Overall Study|Lost to Follow-up|2|||
37690806|NCT02299375|69167009|FG000|Overall Study|Physician Decision|1|||
37690807|NCT02299375|69167010|FG001|Overall Study|Physician Decision|1|||
37690808|NCT02299375|69167009|FG000|Overall Study|Withdrawal by Subject|1|||
37690809|NCT02299375|69167010|FG001|Overall Study|Withdrawal by Subject|4|||
37690810|NCT02151903|69167019|FG000|Overall Study|Withdrawal by Subject|1|||
37690811|NCT02151903|69167020|FG001|Overall Study|Withdrawal by Subject|0|||
37690812|NCT02151903|69167019|FG000|Overall Study|Progressive disease|2|||
37690813|NCT02151903|69167020|FG001|Overall Study|Progressive disease|1|||
37690814|NCT02151591|69167028|FG000|Overall Study|Lost to Follow-up|6|||
37690815|NCT02151591|69167029|FG001|Overall Study|Lost to Follow-up|3|||
37690816|NCT02174523|69167037|FG000|Overall Study|Withdrawal by Subject|1|||
37690817|NCT02174523|69167038|FG001|Overall Study|Withdrawal by Subject|0|||
37690818|NCT02297815|69167045|FG000|Overall Study|Lost to Follow-up|236|||
37690819|NCT02297815|69167046|FG001|Overall Study|Lost to Follow-up|140|||
37690820|NCT02114385|69167056|FG000|Overall Study|Withdrawal by Subject|3|||
37690821|NCT02114385|69167057|FG001|Overall Study|Withdrawal by Subject|2|||
37690822|NCT02114385|69167056|FG000|Overall Study|Lost to Follow-up|0|||
37690823|NCT02114385|69167057|FG001|Overall Study|Lost to Follow-up|6|||
37690824|NCT02114151|69167063|FG000|Overall Study|Death|1|||
37968371|NCT00626327|69655496|FG002|Overall Study|Lost to Follow-up|23|||
37968372|NCT00626327|69655494|FG000|Overall Study|Inappropriate enrollment|4|||
37968373|NCT00626327|69655495|FG001|Overall Study|Inappropriate enrollment|5|||
37968374|NCT00626327|69655496|FG002|Overall Study|Inappropriate enrollment|3|||
37968375|NCT00626327|69655494|FG000|Overall Study|Administrative Reason|2|||
37968376|NCT00626327|69655495|FG001|Overall Study|Administrative Reason|0|||
37968377|NCT00626327|69655496|FG002|Overall Study|Administrative Reason|6|||
37968378|NCT00626327|69655494|FG000|Overall Study|Protocol Violation|26|||
37968379|NCT00626327|69655495|FG001|Overall Study|Protocol Violation|4|||
37968380|NCT00626327|69655496|FG002|Overall Study|Protocol Violation|26|||
37968381|NCT00357994|69655514|FG000|Overall Study|Adverse Event|1|||
37968382|NCT00357994|69655515|FG001|Overall Study|Adverse Event|2|||
37968383|NCT00357994|69655514|FG000|Overall Study|Lack of Efficacy|0|||
37863695|NCT00996658|69547280|FG001|Overall Study|Protocol Violation|1|||
37863696|NCT00996658|69547279|FG000|Overall Study|Lost to Follow-up|2|||
37690825|NCT02114151|69167063|FG000|Overall Study|Lost to Follow-up|1|||
37690826|NCT02114151|69167063|FG000|Overall Study|Withdrawal by Subject|5|||
37690827|NCT02297503|69167069|FG000|Overall Study|Withdrawal by Subject|1|||
37690828|NCT02297503|69167070|FG001|Overall Study|Withdrawal by Subject|1|||
37690829|NCT02297503|69167069|FG000|Overall Study|Protocol Violation|1|||
37690830|NCT02297503|69167070|FG001|Overall Study|Protocol Violation|0|||
37690831|NCT02297503|69167069|FG000|Overall Study|Pregnancy|0|||
37690832|NCT02297503|69167070|FG001|Overall Study|Pregnancy|1|||
37863697|NCT00996658|69547280|FG001|Overall Study|Lost to Follow-up|5|||
37863698|NCT00996658|69547279|FG000|Overall Study|Non-compliance issues|3|||
37863699|NCT00996658|69547280|FG001|Overall Study|Non-compliance issues|3|||
37968384|NCT00357994|69655515|FG001|Overall Study|Lack of Efficacy|1|||
37690833|NCT02297503|69167069|FG000|Overall Study|Lost to Follow-up|0|||
37690834|NCT02297503|69167070|FG001|Overall Study|Lost to Follow-up|1|||
37863700|NCT00996658|69547279|FG000|Overall Study|Other|9|||
37968385|NCT00357994|69655514|FG000|Overall Study|Protocol Violation|1|||
37690835|NCT02297503|69167069|FG000|Overall Study|Medical reason|0|||
37690836|NCT02297503|69167070|FG001|Overall Study|Medical reason|1|||
37690837|NCT02113449|69167085|FG000|Overall Study|Adverse Event|4|||
37690838|NCT02366923|69167093|FG000|Overall Study|Withdrawal by Subject|1|||
37690839|NCT02366923|69167093|FG000|Overall Study|Positive Slit Lamp Findings|2|||
37690840|NCT02366923|69167093|FG000|Overall Study|High Astigmatism|3|||
37690841|NCT02326597|69167100|FG000|Overall Study|Lost to Follow-up|42|||
37690842|NCT02326597|69167101|FG001|Overall Study|Lost to Follow-up|32|||
37690843|NCT02366767|69167111|FG000|Overall Study|left for home after 1 day at camp|1|||
37690844|NCT02366767|69167112|FG001|Overall Study|left for home after 1 day at camp|0|||
37690845|NCT02150343|69167122|FG000|Overall Study|Adverse Event|2|||
37690846|NCT02150343|69167123|FG001|Overall Study|Adverse Event|0|||
37690847|NCT02150343|69167124|FG002|Overall Study|Adverse Event|1|||
37690848|NCT02150343|69167125|FG003|Overall Study|Adverse Event|1|||
37690849|NCT02150343|69167122|FG000|Overall Study|Withdrawal by Subject|13|||
37690850|NCT02150343|69167123|FG001|Overall Study|Withdrawal by Subject|10|||
37690851|NCT02150343|69167124|FG002|Overall Study|Withdrawal by Subject|9|||
37690852|NCT02150343|69167125|FG003|Overall Study|Withdrawal by Subject|4|||
37968386|NCT00357994|69655515|FG001|Overall Study|Protocol Violation|0|||
37968387|NCT00423657|69655523|FG000|Overall Study|Withdrew consent|10|||
37968388|NCT00423657|69655524|FG001|Overall Study|Withdrew consent|8|||
37690853|NCT02150343|69167122|FG000|Overall Study|Lost to Follow-up|4|||
37690854|NCT02150343|69167123|FG001|Overall Study|Lost to Follow-up|4|||
37690855|NCT02150343|69167124|FG002|Overall Study|Lost to Follow-up|2|||
37690856|NCT02150343|69167125|FG003|Overall Study|Lost to Follow-up|3|||
37968389|NCT00423657|69655523|FG000|Overall Study|Non-compliance|0|||
37968390|NCT00423657|69655524|FG001|Overall Study|Non-compliance|1|||
37968391|NCT00423657|69655523|FG000|Overall Study|Other|15|||
37968392|NCT00423657|69655524|FG001|Overall Study|Other|16|||
37968393|NCT00423657|69655523|FG000|Overall Study|Request of sponsor/investigator|1|||
37968394|NCT00423657|69655524|FG001|Overall Study|Request of sponsor/investigator|0|||
37968395|NCT00367432|69655530|FG000|First Period (16 Weeks)|Adverse Event|6|||
37968396|NCT00367432|69655531|FG001|First Period (16 Weeks)|Adverse Event|0|||
37968397|NCT00367432|69655530|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
37968398|NCT00367432|69655531|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
37968399|NCT00367432|69655530|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
37968400|NCT00367432|69655531|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
37968401|NCT00367432|69655530|FG000|First Period (16 Weeks)|Other Reason|2|||
37968402|NCT00367432|69655531|FG001|First Period (16 Weeks)|Other Reason|0|||
37968403|NCT00367432|69655530|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
37968404|NCT00367432|69655531|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
37968405|NCT00367432|69655530|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
37968406|NCT00367432|69655531|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
37968407|NCT00367432|69655530|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
37968408|NCT00367432|69655531|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
37968409|NCT00367432|69655530|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
37968410|NCT00367432|69655531|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
37968411|NCT00367432|69655530|FG000|Second Period (up to 54 Months)|Other Reason|6|||
37968412|NCT00367432|69655531|FG001|Second Period (up to 54 Months)|Other Reason|2|||
37968413|NCT00623363|69655537|FG000|Overall Study|Adverse Event|2|||
37968414|NCT00623363|69655538|FG001|Overall Study|Adverse Event|2|||
37968415|NCT00423267|69655547|FG000|Period A|Withdrawal by Subject|0|||
37968416|NCT00423267|69655548|FG001|Period A|Withdrawal by Subject|1|||
37968417|NCT00423267|69655547|FG000|Period A|Non-compliance with protocol|1|||
37968418|NCT00423267|69655548|FG001|Period A|Non-compliance with protocol|0|||
37968419|NCT00423267|69655547|FG000|Period A|Administrative|1|||
37968420|NCT00423267|69655548|FG001|Period A|Administrative|0|||
37968421|NCT00626093|69655556|FG000|Overall Study|Lost to Follow-up|5|||
37968422|NCT00626093|69655556|FG000|Overall Study|Death|1|||
37968423|NCT00626093|69655556|FG000|Overall Study|Physician Decision|4|||
37968424|NCT00626093|69655556|FG000|Overall Study|Withdrawal by Subject|6|||
37968425|NCT00626093|69655556|FG000|Overall Study|Protocol Violation|1|||
37968426|NCT00626093|69655556|FG000|Overall Study|One of the required devices not implante|6|||
37968427|NCT00357760|69655562|FG000|Overall Study|Disease progression|44|||
37968428|NCT00357760|69655563|FG001|Overall Study|Disease progression|17|||
37968429|NCT00357760|69655562|FG000|Overall Study|Adverse Event|10|||
37968430|NCT00357760|69655563|FG001|Overall Study|Adverse Event|7|||
37968431|NCT00357760|69655562|FG000|Overall Study|Death|0|||
37968432|NCT00357760|69655563|FG001|Overall Study|Death|3|||
37968433|NCT00357760|69655562|FG000|Overall Study|Alternative therapy|1|||
37968434|NCT00357760|69655563|FG001|Overall Study|Alternative therapy|0|||
37968435|NCT00357760|69655562|FG000|Overall Study|Withdrawal by Subject|0|||
37968436|NCT00357760|69655563|FG001|Overall Study|Withdrawal by Subject|2|||
37968437|NCT00357760|69655562|FG000|Overall Study|Never started treatment|2|||
37968438|NCT00357760|69655563|FG001|Overall Study|Never started treatment|1|||
37968439|NCT00357760|69655562|FG000|Overall Study|Ineligible|0|||
37968440|NCT00357760|69655563|FG001|Overall Study|Ineligible|2|||
37968441|NCT00357760|69655562|FG000|Overall Study|Physician Decision|2|||
37968442|NCT00357760|69655563|FG001|Overall Study|Physician Decision|1|||
37968443|NCT00357760|69655562|FG000|Overall Study|Protocol Violation|0|||
37968444|NCT00357760|69655563|FG001|Overall Study|Protocol Violation|1|||
37968445|NCT00357760|69655562|FG000|Overall Study|To receive hospice care|0|||
37968446|NCT00357760|69655563|FG001|Overall Study|To receive hospice care|1|||
37968447|NCT00622739|69655571|FG000|Overall Study|Physician Decision|1|||
37968448|NCT00622739|69655572|FG001|Overall Study|Physician Decision|0|||
37968449|NCT00622739|69655571|FG000|Overall Study|Adverse Event|1|||
37968450|NCT00622739|69655572|FG001|Overall Study|Adverse Event|2|||
37968451|NCT00622739|69655571|FG000|Overall Study|Lack of Efficacy|0|||
37968452|NCT00622739|69655572|FG001|Overall Study|Lack of Efficacy|2|||
37968453|NCT00622739|69655571|FG000|Overall Study|Withdrawal by Subject|0|||
37968454|NCT00622739|69655572|FG001|Overall Study|Withdrawal by Subject|1|||
37968455|NCT00622739|69655571|FG000|Overall Study|Lost to Follow-up|0|||
37968456|NCT00622739|69655572|FG001|Overall Study|Lost to Follow-up|1|||
37968457|NCT00435825|69655584|FG000|Overall Study|Abnormality of Laboratory Test|0|||
37968458|NCT00435825|69655585|FG001|Overall Study|Abnormality of Laboratory Test|1|||
37968459|NCT00435825|69655586|FG002|Overall Study|Abnormality of Laboratory Test|0|||
37968460|NCT00435825|69655587|FG003|Overall Study|Abnormality of Laboratory Test|0|||
37968461|NCT00435825|69655584|FG000|Overall Study|Insufficient Therapeutic Response|3|||
37968462|NCT00435825|69655585|FG001|Overall Study|Insufficient Therapeutic Response|1|||
37968463|NCT00435825|69655586|FG002|Overall Study|Insufficient Therapeutic Response|0|||
37968464|NCT00435825|69655587|FG003|Overall Study|Insufficient Therapeutic Response|3|||
37690857|NCT02150343|69167122|FG000|Overall Study|Other|2|||
37690858|NCT02150343|69167123|FG001|Overall Study|Other|6|||
37690859|NCT02150343|69167124|FG002|Overall Study|Other|0|||
37690860|NCT02150343|69167125|FG003|Overall Study|Other|2|||
37968465|NCT00435825|69655584|FG000|Overall Study|Other Protocol Violation|1|||
37968466|NCT00435825|69655585|FG001|Overall Study|Other Protocol Violation|0|||
37968467|NCT00435825|69655586|FG002|Overall Study|Other Protocol Violation|0|||
37968468|NCT00435825|69655587|FG003|Overall Study|Other Protocol Violation|0|||
37968469|NCT00435825|69655584|FG000|Overall Study|Refused treatment|2|||
37968470|NCT00435825|69655585|FG001|Overall Study|Refused treatment|0|||
37968471|NCT00435825|69655586|FG002|Overall Study|Refused treatment|0|||
37968472|NCT00435825|69655587|FG003|Overall Study|Refused treatment|5|||
37968473|NCT00435825|69655584|FG000|Overall Study|Failure to return|5|||
37968474|NCT00435825|69655585|FG001|Overall Study|Failure to return|0|||
37968475|NCT00435825|69655586|FG002|Overall Study|Failure to return|4|||
37690861|NCT02149875|69167138|FG000|Overall Study|Lost to Follow-up|3|||
37690862|NCT02149875|69167139|FG001|Overall Study|Lost to Follow-up|4|||
37690863|NCT02149875|69167140|FG002|Overall Study|Lost to Follow-up|5|||
37690864|NCT02149875|69167138|FG000|Overall Study|Withdrawal by Subject|3|||
37690865|NCT02149875|69167139|FG001|Overall Study|Withdrawal by Subject|2|||
37690866|NCT02149875|69167140|FG002|Overall Study|Withdrawal by Subject|2|||
37690867|NCT02149875|69167138|FG000|Overall Study|Physician Decision|1|||
37690868|NCT02149875|69167139|FG001|Overall Study|Physician Decision|2|||
37690869|NCT02149875|69167140|FG002|Overall Study|Physician Decision|2|||
37690870|NCT02112045|69167150|FG000|Overall Study|Withdrawal by Subject|1|||
37690871|NCT02112045|69167151|FG001|Overall Study|Withdrawal by Subject|0|||
37690872|NCT01629693|69167159|FG000|Overall Study|Lost to Follow-up|2|||
37690873|NCT01629693|69167160|FG001|Overall Study|Lost to Follow-up|4|||
37690874|NCT01629693|69167159|FG000|Overall Study|Withdrawal by Subject|2|||
37690875|NCT01629693|69167160|FG001|Overall Study|Withdrawal by Subject|2|||
37690876|NCT01629693|69167159|FG000|Overall Study|Adverse Event|1|||
37690877|NCT01629693|69167160|FG001|Overall Study|Adverse Event|0|||
37690878|NCT01629693|69167159|FG000|Overall Study|Investigator decision|0|||
37690879|NCT01629693|69167160|FG001|Overall Study|Investigator decision|1|||
37690880|NCT01629693|69167159|FG000|Overall Study|Poor comfort of study lenses|0|||
37690881|NCT01629693|69167160|FG001|Overall Study|Poor comfort of study lenses|2|||
37690882|NCT01629693|69167159|FG000|Overall Study|Subject decision unrelated to AE|0|||
37690883|NCT01629693|69167160|FG001|Overall Study|Subject decision unrelated to AE|1|||
37690884|NCT02147691|69167168|FG000|Overall Study|Withdrawal by Subject|2|||
37968476|NCT00435825|69655587|FG003|Overall Study|Failure to return|0|||
37968477|NCT00435825|69655584|FG000|Overall Study|Did not receive study drug|1|||
37968478|NCT00435825|69655585|FG001|Overall Study|Did not receive study drug|0|||
37968479|NCT00435825|69655586|FG002|Overall Study|Did not receive study drug|2|||
37968480|NCT00435825|69655587|FG003|Overall Study|Did not receive study drug|0|||
37968481|NCT00435825|69655584|FG000|Overall Study|Did not enter follow-up|0|||
37968482|NCT00435825|69655585|FG001|Overall Study|Did not enter follow-up|4|||
37968483|NCT00435825|69655586|FG002|Overall Study|Did not enter follow-up|1|||
37968484|NCT00435825|69655587|FG003|Overall Study|Did not enter follow-up|3|||
37968485|NCT00435825|69655584|FG000|Overall Study|Did not complete full follow-up period|6|||
37968486|NCT00435825|69655585|FG001|Overall Study|Did not complete full follow-up period|6|||
37968487|NCT00435825|69655586|FG002|Overall Study|Did not complete full follow-up period|4|||
37968488|NCT00435825|69655587|FG003|Overall Study|Did not complete full follow-up period|5|||
37968489|NCT00574145|69655599|FG000|Overall Study|Withdrawal by Subject|2|||
37968490|NCT00574145|69655600|FG001|Overall Study|Withdrawal by Subject|1|||
37968491|NCT00423189|69655609|FG000|Overall Study|Death|0|||
37968492|NCT00423189|69655610|FG001|Overall Study|Death|1|||
37968493|NCT00423189|69655611|FG002|Overall Study|Death|0|||
37968494|NCT00422799|69655624|FG000|Overall Study|Withdrawal by Subject|6|||
37968495|NCT00422799|69655624|FG000|Overall Study|Adverse Event|7|||
37968496|NCT00435045|69655630|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
37968497|NCT00435045|69655631|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
37968498|NCT00435045|69655630|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
37968499|NCT00435045|69655631|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
37968500|NCT00435045|69655630|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
37968501|NCT00435045|69655631|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
37968502|NCT00435045|69655630|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
37968503|NCT00435045|69655631|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
37968504|NCT00435045|69655630|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
37968505|NCT00435045|69655631|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
37968506|NCT00435045|69655630|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
37775571|NCT01431950|69310306|FG001|Overall Study|Protocol Violation|3|||
37775572|NCT01431950|69310305|FG000|Overall Study|Adverse Event|2|||
37775573|NCT01431950|69310306|FG001|Overall Study|Adverse Event|2|||
37775574|NCT01431950|69310305|FG000|Overall Study|Physician Decision|2|||
37775575|NCT01431950|69310306|FG001|Overall Study|Physician Decision|1|||
37775576|NCT01431950|69310305|FG000|Overall Study|Lack of Efficacy|2|||
37775577|NCT01431950|69310306|FG001|Overall Study|Lack of Efficacy|1|||
37775578|NCT01431950|69310305|FG000|Overall Study|Lost to Follow-up|0|||
37775579|NCT01431950|69310306|FG001|Overall Study|Lost to Follow-up|1|||
37775580|NCT01431950|69310305|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
37775581|NCT01431950|69310306|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
37775582|NCT00551031|69310317|FG000|Overall Study|Adverse Event|0|||
37775583|NCT00551031|69310318|FG001|Overall Study|Adverse Event|1|||
37775584|NCT00551031|69310319|FG002|Overall Study|Adverse Event|0|||
37775585|NCT00551031|69310320|FG003|Overall Study|Adverse Event|0|||
37775586|NCT00551031|69310321|FG004|Overall Study|Adverse Event|0|||
37775587|NCT00551031|69310317|FG000|Overall Study|Protocol Violation|1|||
37775588|NCT00551031|69310318|FG001|Overall Study|Protocol Violation|1|||
37775589|NCT00551031|69310319|FG002|Overall Study|Protocol Violation|0|||
37775590|NCT00551031|69310320|FG003|Overall Study|Protocol Violation|0|||
37863701|NCT00996658|69547280|FG001|Overall Study|Other|7|||
37863702|NCT01124643|69547286|FG000|Overall Study|Death|1|||
37863703|NCT01256411|69547294|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
37863704|NCT01256411|69547295|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
37863705|NCT01256411|69547296|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
37863706|NCT01256411|69547297|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
37863707|NCT01256411|69547298|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
37863708|NCT01256411|69547299|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
37863709|NCT01256411|69547294|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
37863710|NCT01256411|69547295|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
37863711|NCT01256411|69547296|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
37863712|NCT01256411|69547297|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
37863713|NCT01256411|69547298|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
37863714|NCT01256411|69547299|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
37863715|NCT01256411|69547294|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
37863716|NCT01256411|69547295|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
37863717|NCT01256411|69547296|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
37863718|NCT01256411|69547297|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
37863719|NCT01256411|69547298|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
37863720|NCT01256411|69547299|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
37863721|NCT01256411|69547294|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
37863722|NCT01256411|69547295|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
37863723|NCT01256411|69547296|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
37863724|NCT01256411|69547297|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
37863725|NCT01256411|69547298|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
37863726|NCT01256411|69547299|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
37863727|NCT01256411|69547294|FG000|Extension by Maximum Treatment|Adverse Event|4|||
37863728|NCT01256411|69547295|FG001|Extension by Maximum Treatment|Adverse Event|2|||
37863729|NCT01256411|69547296|FG002|Extension by Maximum Treatment|Adverse Event|1|||
37863730|NCT01256411|69547297|FG003|Extension by Maximum Treatment|Adverse Event|0|||
37775591|NCT00551031|69310321|FG004|Overall Study|Protocol Violation|0|||
37775592|NCT00551031|69310317|FG000|Overall Study|Lost to Follow-up|0|||
37968507|NCT00435045|69655631|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
37968508|NCT00435045|69655630|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
37968509|NCT00435045|69655631|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
37968510|NCT00435045|69655630|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
37968511|NCT00435045|69655631|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
37968512|NCT00435045|69655630|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
37968513|NCT00435045|69655631|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
37968514|NCT00435045|69655630|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
37968515|NCT00435045|69655631|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
37775593|NCT00551031|69310318|FG001|Overall Study|Lost to Follow-up|1|||
37775594|NCT00551031|69310319|FG002|Overall Study|Lost to Follow-up|0|||
37775595|NCT00551031|69310320|FG003|Overall Study|Lost to Follow-up|1|||
37775596|NCT00551031|69310321|FG004|Overall Study|Lost to Follow-up|1|||
37775597|NCT00551031|69310317|FG000|Overall Study|Withdrawal by Subject|0|||
37775598|NCT00551031|69310318|FG001|Overall Study|Withdrawal by Subject|4|||
37775599|NCT00551031|69310319|FG002|Overall Study|Withdrawal by Subject|1|||
37775600|NCT00551031|69310320|FG003|Overall Study|Withdrawal by Subject|2|||
37775601|NCT00551031|69310321|FG004|Overall Study|Withdrawal by Subject|0|||
37775602|NCT00551031|69310317|FG000|Overall Study|Serious Adverse Event|0|||
37775603|NCT00551031|69310318|FG001|Overall Study|Serious Adverse Event|2|||
37775604|NCT00551031|69310319|FG002|Overall Study|Serious Adverse Event|1|||
37775605|NCT00551031|69310320|FG003|Overall Study|Serious Adverse Event|0|||
37775606|NCT00551031|69310321|FG004|Overall Study|Serious Adverse Event|0|||
37775607|NCT00551031|69310317|FG000|Overall Study|Did not receive vaccine|1|||
37775608|NCT00551031|69310318|FG001|Overall Study|Did not receive vaccine|2|||
37775609|NCT00551031|69310319|FG002|Overall Study|Did not receive vaccine|0|||
37775610|NCT00551031|69310320|FG003|Overall Study|Did not receive vaccine|0|||
37775611|NCT00551031|69310321|FG004|Overall Study|Did not receive vaccine|0|||
37775612|NCT01431716|69310333|FG000|Overall Study|Withdrawal of consent|1|||
37775613|NCT00550953|69310339|FG000|Overall Study|Adverse Event|4|||
37775614|NCT00550953|69310340|FG001|Overall Study|Adverse Event|3|||
37775615|NCT00550953|69310339|FG000|Overall Study|Not able to visit the site|2|||
37775616|NCT00550953|69310340|FG001|Overall Study|Not able to visit the site|3|||
37775617|NCT00558831|69310375|FG000|Overall Study|Lost to Follow-up|1|||
37775618|NCT01431638|69310384|FG000|Overall Study|Adverse Event|1|||
37775619|NCT01431638|69310385|FG001|Overall Study|Adverse Event|3|||
37775620|NCT01431638|69310386|FG002|Overall Study|Adverse Event|1|||
37775621|NCT01431638|69310384|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
37775622|NCT01431638|69310385|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
37775623|NCT01431638|69310386|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
37775624|NCT01431638|69310384|FG000|Overall Study|Participants condition no longer requires study drug|0|||
37775625|NCT01431638|69310385|FG001|Overall Study|Participants condition no longer requires study drug|1|||
37775626|NCT01431638|69310386|FG002|Overall Study|Participants condition no longer requires study drug|0|||
37775627|NCT01431638|69310384|FG000|Overall Study|Participant withdrew consent|14|||
37775628|NCT01431638|69310385|FG001|Overall Study|Participant withdrew consent|5|||
37775629|NCT01431638|69310386|FG002|Overall Study|Participant withdrew consent|8|||
37775630|NCT01431638|69310384|FG000|Overall Study|Lost to Follow-up|7|||
37775631|NCT01431638|69310385|FG001|Overall Study|Lost to Follow-up|9|||
37775632|NCT01431638|69310386|FG002|Overall Study|Lost to Follow-up|7|||
37775633|NCT01431638|69310384|FG000|Overall Study|Administrative problems|1|||
37775634|NCT01431638|69310385|FG001|Overall Study|Administrative problems|4|||
37775635|NCT01431638|69310386|FG002|Overall Study|Administrative problems|6|||
37775636|NCT01431638|69310384|FG000|Overall Study|Death|1|||
37775637|NCT01431638|69310385|FG001|Overall Study|Death|0|||
37775638|NCT01431638|69310386|FG002|Overall Study|Death|0|||
37775639|NCT01431638|69310384|FG000|Overall Study|Protocol deviation|1|||
37775640|NCT01431638|69310385|FG001|Overall Study|Protocol deviation|1|||
37775641|NCT01431638|69310386|FG002|Overall Study|Protocol deviation|4|||
37775642|NCT01431638|69310384|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
37775643|NCT01431638|69310385|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
37775644|NCT01431638|69310386|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
37775645|NCT01392170|69310394|FG000|Overall Study|Withdrawal by Subject|1|||
37775646|NCT01392170|69310394|FG000|Overall Study|Ineligible|1|||
37775647|NCT00558753|69310400|FG000|Overall Study|Lost to Follow-up|5|||
37775648|NCT00558753|69310401|FG001|Overall Study|Lost to Follow-up|7|||
37775649|NCT01391546|69310409|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
37775650|NCT01391546|69310410|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
37775651|NCT01410110|69310419|FG000|Overall Study|Withdrawal by Subject|4|||
37775652|NCT01410110|69310420|FG001|Overall Study|Withdrawal by Subject|2|||
37775653|NCT01391000|69310428|FG000|Overall Study|Lost to Follow-up|2|||
37775654|NCT01391000|69310429|FG001|Overall Study|Lost to Follow-up|0|||
37775655|NCT01390844|69310504|FG000|Treatment Phase|Adverse Event|12|||
37775656|NCT01390844|69310505|FG001|Treatment Phase|Adverse Event|2|||
37775657|NCT01390844|69310506|FG002|Treatment Phase|Adverse Event|3|||
37775658|NCT01390844|69310507|FG003|Treatment Phase|Adverse Event|2|||
37775659|NCT01390844|69310504|FG000|Treatment Phase|Treatment Failure|23|||
37968516|NCT00435045|69655630|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
37968517|NCT00435045|69655631|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
37968518|NCT00441129|69655639|FG000|Overall Study|Withdrawal by Subject|6|||
37968519|NCT00441129|69655640|FG001|Overall Study|Withdrawal by Subject|14|||
37968520|NCT00622505|69655648|FG000|Overall Study|Adverse Event|9|||
37968521|NCT00622505|69655649|FG001|Overall Study|Adverse Event|7|||
37968522|NCT00622505|69655648|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
37968523|NCT00622505|69655649|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
37968524|NCT00622505|69655648|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
37968525|NCT00622505|69655649|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
37775660|NCT01390844|69310505|FG001|Treatment Phase|Treatment Failure|25|||
37775661|NCT01390844|69310506|FG002|Treatment Phase|Treatment Failure|10|||
37775662|NCT01390844|69310507|FG003|Treatment Phase|Treatment Failure|13|||
37775663|NCT01390844|69310504|FG000|Treatment Phase|Non-Medical Reasons|5|||
37775664|NCT01390844|69310505|FG001|Treatment Phase|Non-Medical Reasons|1|||
37775665|NCT01390844|69310506|FG002|Treatment Phase|Non-Medical Reasons|8|||
37775666|NCT01390844|69310507|FG003|Treatment Phase|Non-Medical Reasons|1|||
37775667|NCT01390844|69310504|FG000|Treatment Phase|Non-GCP Compliant|0|||
37775668|NCT01390844|69310505|FG001|Treatment Phase|Non-GCP Compliant|0|||
37775669|NCT01390844|69310506|FG002|Treatment Phase|Non-GCP Compliant|10|||
37775670|NCT01390844|69310507|FG003|Treatment Phase|Non-GCP Compliant|3|||
37775671|NCT01390844|69310504|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
37775672|NCT01390844|69310505|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
37775673|NCT01390844|69310506|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
37775674|NCT01390844|69310507|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
37775675|NCT01430624|69310520|FG000|Overall Study|Lost to Follow-up|23|||
37775676|NCT01430624|69310521|FG001|Overall Study|Lost to Follow-up|29|||
37775677|NCT01430624|69310522|FG002|Overall Study|Lost to Follow-up|27|||
37775678|NCT01430624|69310520|FG000|Overall Study|technical or eligibility|5|||
37775679|NCT01430624|69310521|FG001|Overall Study|technical or eligibility|5|||
37775680|NCT01430624|69310522|FG002|Overall Study|technical or eligibility|2|||
37775681|NCT01430468|69310547|FG000|Overall Study|Physician Decision|2|||
37775682|NCT01430468|69310548|FG001|Overall Study|Physician Decision|1|||
37775683|NCT01430468|69310547|FG000|Overall Study|Withdrawal by Subject|5|||
37775684|NCT01430468|69310548|FG001|Overall Study|Withdrawal by Subject|5|||
37775685|NCT01409564|69310569|FG000|Overall Study|low medication compliance|4|||
37775686|NCT01409564|69310570|FG001|Overall Study|low medication compliance|3|||
37775687|NCT01409564|69310569|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
37775688|NCT01409564|69310570|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
37775689|NCT01390298|69310580|FG000|Overall Study|Death|1|||
37775690|NCT01390298|69310580|FG000|Overall Study|long term ICU admission|1|||
37775691|NCT01390298|69310580|FG000|Overall Study|Withdrawal by Subject|14|||
37775692|NCT01390298|69310580|FG000|Overall Study|Lost to Follow-up|7|||
37775693|NCT01390298|69310580|FG000|Overall Study|Surgery cancelled|1|||
37775694|NCT01390220|69310598|FG000|Test Dose Phase|Adverse Event|17|||
37775695|NCT01390220|69310599|FG001|Test Dose Phase|Adverse Event|0|||
37775696|NCT01390220|69310600|FG002|Test Dose Phase|Adverse Event|0|||
37775697|NCT01390220|69310598|FG000|Test Dose Phase|Withdrawal by Subject|8|||
37775698|NCT01390220|69310599|FG001|Test Dose Phase|Withdrawal by Subject|0|||
37775699|NCT01390220|69310600|FG002|Test Dose Phase|Withdrawal by Subject|0|||
37775700|NCT01390220|69310598|FG000|Test Dose Phase|Lost to Follow-up|2|||
37775701|NCT01390220|69310599|FG001|Test Dose Phase|Lost to Follow-up|0|||
37775702|NCT01390220|69310600|FG002|Test Dose Phase|Lost to Follow-up|0|||
37775703|NCT01390220|69310598|FG000|Test Dose Phase|Protocol Violation|8|||
37775704|NCT01390220|69310599|FG001|Test Dose Phase|Protocol Violation|0|||
37775705|NCT01390220|69310600|FG002|Test Dose Phase|Protocol Violation|0|||
37775706|NCT01390220|69310598|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
37775707|NCT01390220|69310599|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
37775708|NCT01390220|69310600|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
37775709|NCT01390220|69310598|FG000|Test Dose Phase|Study/Site closure|6|||
37775710|NCT01390220|69310599|FG001|Test Dose Phase|Study/Site closure|0|||
37968526|NCT00622505|69655648|FG000|Overall Study|Withdrawal by Subject|12|||
37968527|NCT00622505|69655649|FG001|Overall Study|Withdrawal by Subject|5|||
37968528|NCT00622505|69655648|FG000|Overall Study|Administrative Problems|2|||
37775711|NCT01390220|69310600|FG002|Test Dose Phase|Study/Site closure|0|||
37968529|NCT00622505|69655649|FG001|Overall Study|Administrative Problems|4|||
37968530|NCT00622505|69655648|FG000|Overall Study|Death|2|||
37775712|NCT01390220|69310598|FG000|Test Dose Phase|Caregiver no longer available|5|||
37775713|NCT01390220|69310599|FG001|Test Dose Phase|Caregiver no longer available|0|||
37775714|NCT01390220|69310600|FG002|Test Dose Phase|Caregiver no longer available|0|||
37775715|NCT01390220|69310598|FG000|Test Dose Phase|Noncompliance|2|||
37775716|NCT01390220|69310599|FG001|Test Dose Phase|Noncompliance|0|||
37775717|NCT01390220|69310600|FG002|Test Dose Phase|Noncompliance|0|||
37775718|NCT01390220|69310598|FG000|Test Dose Phase|Logistical|6|||
37775719|NCT01390220|69310599|FG001|Test Dose Phase|Logistical|0|||
37775720|NCT01390220|69310600|FG002|Test Dose Phase|Logistical|0|||
37775721|NCT01390220|69310598|FG000|Comparative Phase|Withdrawal by Subject|0|||
37775722|NCT01390220|69310599|FG001|Comparative Phase|Withdrawal by Subject|1|||
37775723|NCT01390220|69310600|FG002|Comparative Phase|Withdrawal by Subject|0|||
37775724|NCT00550173|69310630|FG000|Overall Study|Death|45|||
37775725|NCT00550173|69310631|FG001|Overall Study|Death|38|||
37775726|NCT00550173|69310632|FG002|Overall Study|Death|50|||
37775727|NCT00550173|69310630|FG000|Overall Study|Physician Decision|1|||
37775728|NCT00550173|69310631|FG001|Overall Study|Physician Decision|2|||
37775729|NCT00550173|69310632|FG002|Overall Study|Physician Decision|2|||
37775730|NCT00550173|69310630|FG000|Overall Study|Withdrawal by Subject|9|||
37775731|NCT00550173|69310631|FG001|Overall Study|Withdrawal by Subject|12|||
37775732|NCT00550173|69310632|FG002|Overall Study|Withdrawal by Subject|17|||
37775733|NCT00550173|69310630|FG000|Overall Study|Sponsor Decision|13|||
37775734|NCT00550173|69310631|FG001|Overall Study|Sponsor Decision|7|||
37775735|NCT00550173|69310632|FG002|Overall Study|Sponsor Decision|1|||
37775736|NCT00550173|69310630|FG000|Overall Study|Lost to Follow-up|4|||
37775737|NCT00550173|69310631|FG001|Overall Study|Lost to Follow-up|4|||
37775738|NCT00550173|69310632|FG002|Overall Study|Lost to Follow-up|3|||
37775739|NCT01429298|69310643|FG000|Overall Study|Protocol Violation|4|||
37775740|NCT01429298|69310644|FG001|Overall Study|Protocol Violation|6|||
37775741|NCT01408706|69310656|FG000|Overall Study|Physician Decision|1|||
37775742|NCT01408706|69310657|FG001|Overall Study|Physician Decision|0|||
37775743|NCT01408628|69310665|FG000|Consented|Withdrawal by Subject|12|||
37690885|NCT02147691|69167169|FG001|Overall Study|Withdrawal by Subject|0|||
37690886|NCT02147691|69167168|FG000|Overall Study|Adverse Event|2|||
37690887|NCT02147691|69167169|FG001|Overall Study|Adverse Event|0|||
37775744|NCT01408628|69310665|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
37775745|NCT01408628|69310665|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
37775746|NCT01408628|69310665|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
37775747|NCT01389752|69310670|FG000|Study Period 1|Sponsor decision|0|||
37775748|NCT01389752|69310671|FG001|Study Period 1|Sponsor decision|2|||
37775749|NCT01389752|69310670|FG000|Study Period 2|Sponsor decision|1|||
37775750|NCT01389752|69310671|FG001|Study Period 2|Sponsor decision|0|||
37775751|NCT01428128|69310678|FG000|Overall Study|Withdrawal by Subject|4|||
37775752|NCT01428128|69310678|FG000|Overall Study|Screen failure by p53|10|||
37775753|NCT01428128|69310678|FG000|Overall Study|Received Neulasta in one cycle|2|||
37775754|NCT01428128|69310678|FG000|Overall Study|Adverse Event|1|||
37775755|NCT01407926|69310683|FG000|Overall Study|Lost to Follow-up|55|||
37775756|NCT01427972|69310710|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
37775757|NCT01427972|69310711|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
37775758|NCT01427972|69310712|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
37775759|NCT01427972|69310713|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
37775760|NCT01427972|69310714|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
37775761|NCT01427972|69310715|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
37690888|NCT02147691|69167168|FG000|Overall Study|Lost to Follow-up|0|||
37690889|NCT02147691|69167169|FG001|Overall Study|Lost to Follow-up|1|||
37690890|NCT02111811|69167177|FG000|Treatment Phase|Lost to Follow-up|22|||
37775762|NCT01427972|69310716|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
37690891|NCT02111811|69167178|FG001|Treatment Phase|Lost to Follow-up|18|||
37690892|NCT02111811|69167177|FG000|Treatment Phase|Death|2|||
37775763|NCT01427972|69310717|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
37775764|NCT01427972|69310718|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
37775765|NCT01427972|69310719|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
37775766|NCT01427972|69310720|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
37775767|NCT01427972|69310721|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
37690893|NCT02111811|69167178|FG001|Treatment Phase|Death|0|||
37775768|NCT01427972|69310710|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
37775769|NCT01427972|69310711|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
37968531|NCT00622505|69655649|FG001|Overall Study|Death|2|||
37775770|NCT01427972|69310712|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
37775771|NCT01427972|69310713|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
37775772|NCT01427972|69310714|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
37775773|NCT01427972|69310715|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
37775774|NCT01427972|69310716|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
37775775|NCT01427972|69310717|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
37775776|NCT01427972|69310718|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
37775777|NCT01427972|69310719|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
37775778|NCT01427972|69310720|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
37775779|NCT01427972|69310721|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
37775780|NCT01427972|69310710|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
37775781|NCT01427972|69310711|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
37775782|NCT01427972|69310712|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
37775783|NCT01427972|69310713|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
37775784|NCT01427972|69310714|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
37775785|NCT01427972|69310715|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
37775786|NCT01427972|69310716|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
37775787|NCT01427972|69310717|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
37775788|NCT01427972|69310718|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
37775789|NCT01427972|69310719|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
37775790|NCT01427972|69310720|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
37775791|NCT01427972|69310721|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
37775792|NCT01427738|69310758|FG000|Overall Study|Death|12|||
37775793|NCT01427738|69310759|FG001|Overall Study|Death|9|||
37775794|NCT01427738|69310758|FG000|Overall Study|Severe debilitation, unable to continue|0|||
37775795|NCT01427738|69310759|FG001|Overall Study|Severe debilitation, unable to continue|1|||
37775796|NCT01427738|69310758|FG000|Overall Study|Subject unable to get to clinic|5|||
37775797|NCT01427738|69310759|FG001|Overall Study|Subject unable to get to clinic|2|||
37775798|NCT01427738|69310758|FG000|Overall Study|Withdrawal by Subject|0|||
37775799|NCT01427738|69310759|FG001|Overall Study|Withdrawal by Subject|2|||
37968532|NCT00357370|69655658|FG000|Cohort 2|Lack of Efficacy|0|||
37690894|NCT02111811|69167177|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
37690895|NCT02111811|69167178|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
37690896|NCT02111811|69167177|FG000|Follow up Period (Aim 2)|Death|2|||
37690897|NCT02111811|69167178|FG001|Follow up Period (Aim 2)|Death|0|||
37690898|NCT01655693|69167187|FG000|Overall Study|Progression of Disease|92|||
37690899|NCT01655693|69167188|FG001|Overall Study|Progression of Disease|76|||
37690900|NCT01655693|69167189|FG002|Overall Study|Progression of Disease|58|||
37690901|NCT01655693|69167187|FG000|Overall Study|Death|8|||
37690902|NCT01655693|69167188|FG001|Overall Study|Death|9|||
37690903|NCT01655693|69167189|FG002|Overall Study|Death|12|||
37690904|NCT01655693|69167187|FG000|Overall Study|Serious Adverse Event|3|||
37690905|NCT01655693|69167188|FG001|Overall Study|Serious Adverse Event|15|||
37690906|NCT01655693|69167189|FG002|Overall Study|Serious Adverse Event|11|||
37690907|NCT01655693|69167187|FG000|Overall Study|Withdrawal by Subject|3|||
37690908|NCT01655693|69167188|FG001|Overall Study|Withdrawal by Subject|2|||
37690909|NCT01655693|69167189|FG002|Overall Study|Withdrawal by Subject|20|||
37690910|NCT01655693|69167187|FG000|Overall Study|Adverse Event|3|||
37775800|NCT01427738|69310758|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
37775801|NCT01427738|69310759|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
37775802|NCT01427738|69310758|FG000|Overall Study|Lost to Follow-up|1|||
37775803|NCT01427738|69310759|FG001|Overall Study|Lost to Follow-up|5|||
37775804|NCT01426958|69310765|FG000|Overall Study|Adverse Event|2|||
37775805|NCT02578992|69310943|FG000|Overall Study|equipment not available or malfunction|3|||
37775806|NCT02578992|69310944|FG001|Overall Study|equipment not available or malfunction|3|||
37775807|NCT00558519|69311008|FG000|Overall Study|Ph+|20|||
37863731|NCT01256411|69547298|FG004|Extension by Maximum Treatment|Adverse Event|0|||
37863732|NCT01256411|69547299|FG005|Extension by Maximum Treatment|Adverse Event|0|||
37863733|NCT01256411|69547294|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
37968533|NCT00357370|69655659|FG001|Cohort 2|Lack of Efficacy|2|||
37775808|NCT00558519|69311008|FG000|Overall Study|Ineligible|1|||
37775809|NCT00558519|69311008|FG000|Overall Study|Insufficient data|1|||
37968534|NCT00357370|69655660|FG002|Cohort 2|Lack of Efficacy|1|||
37968535|NCT00357370|69655658|FG000|Cohort 2|Adverse Event|1|||
37968536|NCT00357370|69655659|FG001|Cohort 2|Adverse Event|1|||
37968537|NCT00357370|69655660|FG002|Cohort 2|Adverse Event|1|||
37968538|NCT00357370|69655658|FG000|Cohort 2|Lost to Follow-up|0|||
37968539|NCT00357370|69655659|FG001|Cohort 2|Lost to Follow-up|1|||
37968540|NCT00357370|69655660|FG002|Cohort 2|Lost to Follow-up|0|||
37968541|NCT00357370|69655658|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
37968542|NCT00357370|69655659|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
37968543|NCT00357370|69655660|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
37968544|NCT00357370|69655658|FG000|Cohort 2|Withdrawal by Subject|0|||
37968545|NCT00357370|69655659|FG001|Cohort 2|Withdrawal by Subject|2|||
37968546|NCT00357370|69655660|FG002|Cohort 2|Withdrawal by Subject|0|||
37968547|NCT00574847|69655670|FG000|Overall Study|Adverse Event|2|||
37968548|NCT00574847|69655671|FG001|Overall Study|Adverse Event|0|||
37968549|NCT00574847|69655670|FG000|Overall Study|Death|1|||
37968550|NCT00574847|69655671|FG001|Overall Study|Death|0|||
37968551|NCT00574847|69655670|FG000|Overall Study|Withdrawal by Subject|2|||
37968552|NCT00574847|69655671|FG001|Overall Study|Withdrawal by Subject|2|||
37968553|NCT00574847|69655670|FG000|Overall Study|Physician Decision|1|||
37968554|NCT00574847|69655671|FG001|Overall Study|Physician Decision|0|||
37968555|NCT00574847|69655670|FG000|Overall Study|Did not receive medication (declined)|2|||
37968556|NCT00574847|69655671|FG001|Overall Study|Did not receive medication (declined)|5|||
37968557|NCT00348790|69655677|FG000|Completed Treatment|Withdrawal by Subject|4|||
37968558|NCT00348790|69655677|FG000|Completed Treatment|Disease progression|14|||
37968559|NCT00348790|69655677|FG000|Completed Treatment|Adverse Event|4|||
37690911|NCT01655693|69167188|FG001|Overall Study|Adverse Event|11|||
37690912|NCT01655693|69167189|FG002|Overall Study|Adverse Event|3|||
37690913|NCT01655693|69167187|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
37690914|NCT01655693|69167188|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
37690915|NCT01655693|69167189|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
37690916|NCT01655693|69167187|FG000|Overall Study|Non-Compliance|0|||
37690917|NCT01655693|69167188|FG001|Overall Study|Non-Compliance|0|||
37690918|NCT01655693|69167189|FG002|Overall Study|Non-Compliance|7|||
37690919|NCT01655693|69167187|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
37690920|NCT01655693|69167188|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
37690921|NCT01655693|69167189|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
37690922|NCT01655693|69167187|FG000|Overall Study|Protocol Violation|1|||
37690923|NCT01655693|69167188|FG001|Overall Study|Protocol Violation|0|||
37690924|NCT01655693|69167189|FG002|Overall Study|Protocol Violation|3|||
37690925|NCT01655693|69167187|FG000|Overall Study|Lost to Follow-up|1|||
37690926|NCT01655693|69167188|FG001|Overall Study|Lost to Follow-up|0|||
37690927|NCT01655693|69167189|FG002|Overall Study|Lost to Follow-up|1|||
37690928|NCT01655693|69167187|FG000|Overall Study|Screening Failure|1|||
37690929|NCT01655693|69167188|FG001|Overall Study|Screening Failure|0|||
37690930|NCT01655693|69167189|FG002|Overall Study|Screening Failure|0|||
37690931|NCT01655693|69167187|FG000|Overall Study|Other|8|||
37690932|NCT01655693|69167188|FG001|Overall Study|Other|6|||
37690933|NCT01655693|69167189|FG002|Overall Study|Other|15|||
37690934|NCT01655381|69167207|FG000|Overall Study|Investigator Decision|1|||
37690935|NCT01655381|69167207|FG000|Overall Study|Moved to Another City|1|||
37690936|NCT01655381|69167207|FG000|Overall Study|Insufficient Treatment Response|1|||
37775810|NCT00558519|69311008|FG000|Overall Study|Never received treatment|1|||
37775811|NCT00558285|69311052|FG000|Overall Study|Adverse Event|1|||
37775812|NCT00558285|69311053|FG001|Overall Study|Adverse Event|1|||
37775813|NCT00558285|69311054|FG002|Overall Study|Adverse Event|4|||
37775814|NCT00558285|69311055|FG003|Overall Study|Adverse Event|1|||
37775815|NCT00558285|69311056|FG004|Overall Study|Adverse Event|2|||
37775816|NCT00558285|69311052|FG000|Overall Study|Abnormal test procedure result(s)|1|||
37775817|NCT00558285|69311053|FG001|Overall Study|Abnormal test procedure result(s)|0|||
37775818|NCT00558285|69311054|FG002|Overall Study|Abnormal test procedure result(s)|0|||
37775819|NCT00558285|69311055|FG003|Overall Study|Abnormal test procedure result(s)|0|||
37775820|NCT00558285|69311056|FG004|Overall Study|Abnormal test procedure result(s)|0|||
37775821|NCT00558285|69311052|FG000|Overall Study|Subject withdrew consent|2|||
37775822|NCT00558285|69311053|FG001|Overall Study|Subject withdrew consent|0|||
37775823|NCT00558285|69311054|FG002|Overall Study|Subject withdrew consent|1|||
37775824|NCT00558285|69311055|FG003|Overall Study|Subject withdrew consent|1|||
37775825|NCT00558285|69311056|FG004|Overall Study|Subject withdrew consent|1|||
37775826|NCT00558285|69311052|FG000|Overall Study|Lost to Follow-up|1|||
37775827|NCT00558285|69311053|FG001|Overall Study|Lost to Follow-up|1|||
37775828|NCT00558285|69311054|FG002|Overall Study|Lost to Follow-up|0|||
37775829|NCT00558285|69311055|FG003|Overall Study|Lost to Follow-up|0|||
37775830|NCT00558285|69311056|FG004|Overall Study|Lost to Follow-up|0|||
37775831|NCT00558285|69311052|FG000|Overall Study|Administrative problems|0|||
37775832|NCT00558285|69311053|FG001|Overall Study|Administrative problems|0|||
37775833|NCT00558285|69311054|FG002|Overall Study|Administrative problems|0|||
37775834|NCT00558285|69311055|FG003|Overall Study|Administrative problems|1|||
37775835|NCT00558285|69311056|FG004|Overall Study|Administrative problems|1|||
37775836|NCT00558285|69311052|FG000|Overall Study|Protocol deviation|1|||
37775837|NCT00558285|69311053|FG001|Overall Study|Protocol deviation|1|||
37775838|NCT00558285|69311054|FG002|Overall Study|Protocol deviation|0|||
37775839|NCT00558285|69311055|FG003|Overall Study|Protocol deviation|1|||
37775840|NCT00558285|69311056|FG004|Overall Study|Protocol deviation|0|||
37968560|NCT00348790|69655677|FG000|Completed Treatment|Required surgery|2|||
37968561|NCT00348790|69655677|FG000|Completed Treatment|Unable to travel to study site|1|||
37775841|NCT01389596|69311071|FG000|Overall Study|Protocol Violation|3|||
37775842|NCT01389596|69311072|FG001|Overall Study|Protocol Violation|4|||
37775843|NCT01389596|69311073|FG002|Overall Study|Protocol Violation|3|||
37775844|NCT01389596|69311071|FG000|Overall Study|Withdrawal by Subject|1|||
37775845|NCT01389596|69311072|FG001|Overall Study|Withdrawal by Subject|2|||
37775846|NCT01389596|69311073|FG002|Overall Study|Withdrawal by Subject|2|||
37775847|NCT01389596|69311071|FG000|Overall Study|Insufficient Clinical Response|3|||
37775848|NCT01389596|69311072|FG001|Overall Study|Insufficient Clinical Response|4|||
37775849|NCT01389596|69311073|FG002|Overall Study|Insufficient Clinical Response|5|||
37775850|NCT01389596|69311071|FG000|Overall Study|Adverse Event|1|||
37775851|NCT01389596|69311072|FG001|Overall Study|Adverse Event|4|||
37775852|NCT01389596|69311073|FG002|Overall Study|Adverse Event|0|||
37775853|NCT01389596|69311071|FG000|Overall Study|Death|0|||
37775854|NCT01389596|69311072|FG001|Overall Study|Death|1|||
37775855|NCT01389596|69311073|FG002|Overall Study|Death|0|||
37775856|NCT01389596|69311071|FG000|Overall Study|Other Unspecified|2|||
37775857|NCT01389596|69311072|FG001|Overall Study|Other Unspecified|1|||
37775858|NCT01389596|69311073|FG002|Overall Study|Other Unspecified|0|||
37775859|NCT01405898|69311109|FG000|Overall Study|Withdrawal by Subject|2|||
37775860|NCT01405898|69311110|FG001|Overall Study|Withdrawal by Subject|2|||
37775861|NCT01389128|69311136|FG000|Overall Study|Fetal distress|1|||
37775862|NCT01389128|69311137|FG001|Overall Study|Fetal distress|0|||
37775863|NCT01389128|69311136|FG000|Overall Study|Cervix dilation stop|1|||
37775864|NCT01389128|69311137|FG001|Overall Study|Cervix dilation stop|2|||
37775865|NCT01389128|69311136|FG000|Overall Study|Rapid labor evolution|3|||
37775866|NCT01389128|69311137|FG001|Overall Study|Rapid labor evolution|2|||
37968562|NCT00360490|69655684|FG000|Overall Study|Adverse Event|4|||
37968563|NCT00360490|69655685|FG001|Overall Study|Adverse Event|2|||
37968564|NCT00360490|69655684|FG000|Overall Study|Lost to Follow-up|2|||
37690937|NCT01656161|69167212|FG000|Overall Study|Death|3|||
37690938|NCT01656161|69167212|FG000|Overall Study|Adverse Event|2|||
37690939|NCT01656161|69167212|FG000|Overall Study|Protocol Violation|1|||
37690940|NCT01656161|69167212|FG000|Overall Study|Withdrawal by Subject|1|||
37690941|NCT02111577|69167221|FG000|Overall Study|Protocol Violation|2|||
37690942|NCT02111577|69167222|FG001|Overall Study|Protocol Violation|0|||
37690943|NCT02111577|69167221|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
37690944|NCT02111577|69167222|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
37690945|NCT02111577|69167221|FG000|Overall Study|Failure to produce study treatment|6|||
37690946|NCT02111577|69167222|FG001|Overall Study|Failure to produce study treatment|0|||
37690947|NCT02111577|69167221|FG000|Overall Study|Death|518|||
37775867|NCT01389128|69311136|FG000|Overall Study|Intolerance to procedure|0|||
37775868|NCT01389128|69311137|FG001|Overall Study|Intolerance to procedure|2|||
37775869|NCT01388816|69311168|FG000|Overall Study|Adverse Event|0|||
37775870|NCT01388816|69311169|FG001|Overall Study|Adverse Event|2|||
37775871|NCT01388816|69311170|FG002|Overall Study|Adverse Event|0|||
37775872|NCT01388816|69311171|FG003|Overall Study|Adverse Event|0|||
37775873|NCT01388816|69311168|FG000|Overall Study|Lost to Follow-up|0|||
37775874|NCT01388816|69311169|FG001|Overall Study|Lost to Follow-up|1|||
37775875|NCT01388816|69311170|FG002|Overall Study|Lost to Follow-up|0|||
37775876|NCT01388816|69311171|FG003|Overall Study|Lost to Follow-up|0|||
37775877|NCT01388816|69311168|FG000|Overall Study|Withdrawal by Subject|2|||
37775878|NCT01388816|69311169|FG001|Overall Study|Withdrawal by Subject|1|||
37775879|NCT01388816|69311170|FG002|Overall Study|Withdrawal by Subject|1|||
37775880|NCT01388816|69311171|FG003|Overall Study|Withdrawal by Subject|0|||
37775881|NCT01388816|69311168|FG000|Overall Study|Protocol Violation|0|||
37775882|NCT01388816|69311169|FG001|Overall Study|Protocol Violation|0|||
37775883|NCT01388816|69311170|FG002|Overall Study|Protocol Violation|2|||
37775884|NCT01388816|69311171|FG003|Overall Study|Protocol Violation|0|||
37775885|NCT00555477|69311325|FG000|Overall Study|Adverse Event|0|||
37775886|NCT00555477|69311326|FG001|Overall Study|Adverse Event|9|||
37775887|NCT00555477|69311325|FG000|Overall Study|Withdrawal by Subject|1|||
37775888|NCT00555477|69311326|FG001|Overall Study|Withdrawal by Subject|2|||
37775889|NCT00555477|69311325|FG000|Overall Study|Physician Decision|1|||
37775890|NCT00555477|69311326|FG001|Overall Study|Physician Decision|2|||
37775891|NCT00554619|69311343|FG000|Overall Study|Adverse Event|1|||
37775892|NCT00554619|69311343|FG000|Overall Study|Physician Decision|1|||
37775893|NCT00554619|69311343|FG000|Overall Study|Liver Function Test Abnormality|1|||
37775894|NCT01426412|69311403|FG000|Overall Study|Withdrawal by Subject|1|||
37775895|NCT01426412|69311404|FG001|Overall Study|Withdrawal by Subject|0|||
37775896|NCT01426412|69311405|FG002|Overall Study|Withdrawal by Subject|0|||
37775897|NCT01426412|69311406|FG003|Overall Study|Withdrawal by Subject|0|||
37775898|NCT01426412|69311407|FG004|Overall Study|Withdrawal by Subject|1|||
37968565|NCT00360490|69655685|FG001|Overall Study|Lost to Follow-up|1|||
37968566|NCT00360490|69655684|FG000|Overall Study|Physician Decision|2|||
37968567|NCT00360490|69655685|FG001|Overall Study|Physician Decision|1|||
37968568|NCT00360490|69655684|FG000|Overall Study|Protocol Violation|0|||
37968569|NCT00360490|69655685|FG001|Overall Study|Protocol Violation|4|||
37968570|NCT00360490|69655684|FG000|Overall Study|Withdrawal by Subject|1|||
37968571|NCT00360490|69655685|FG001|Overall Study|Withdrawal by Subject|3|||
37968572|NCT00624377|69655691|FG000|Overall Study|Lost to Follow-up|355|||
37968573|NCT00624377|69655691|FG000|Overall Study|Withdrawal by Subject|100|||
37968574|NCT00624377|69655691|FG000|Overall Study|Adverse Event|14|||
37968575|NCT00624377|69655691|FG000|Overall Study|Other|91|||
37968576|NCT00624377|69655691|FG000|Overall Study|Non-evaluable population|84|||
37968577|NCT00624065|69655697|FG000|Overall Study|Adverse Event|5|||
37968578|NCT00624065|69655698|FG001|Overall Study|Adverse Event|6|||
37968579|NCT00624065|69655697|FG000|Overall Study|Lost to Follow-up|4|||
37968580|NCT00624065|69655698|FG001|Overall Study|Lost to Follow-up|1|||
37968581|NCT00624065|69655697|FG000|Overall Study|Consent withdrawn|6|||
37968582|NCT00624065|69655698|FG001|Overall Study|Consent withdrawn|5|||
37968583|NCT00624065|69655697|FG000|Overall Study|Lack of Efficacy|0|||
37968584|NCT00624065|69655698|FG001|Overall Study|Lack of Efficacy|3|||
37968585|NCT00624065|69655697|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
37968586|NCT00624065|69655698|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
37968587|NCT00360412|69655706|FG000|Overall Study|Adverse Event|37|||
37968588|NCT00360412|69655707|FG001|Overall Study|Adverse Event|65|||
37968589|NCT00360412|69655706|FG000|Overall Study|Protocol Violation|2|||
37968590|NCT00360412|69655707|FG001|Overall Study|Protocol Violation|5|||
37968591|NCT00360412|69655706|FG000|Overall Study|Patient withdrew consent|27|||
37968592|NCT00360412|69655707|FG001|Overall Study|Patient withdrew consent|52|||
37775899|NCT01426412|69311408|FG005|Overall Study|Withdrawal by Subject|0|||
37775900|NCT01426412|69311409|FG006|Overall Study|Withdrawal by Subject|0|||
37775901|NCT01426412|69311410|FG007|Overall Study|Withdrawal by Subject|3|||
37775902|NCT01426412|69311411|FG008|Overall Study|Withdrawal by Subject|1|||
37775903|NCT00554229|69311615|FG000|Overall Study|Lost to Follow-up|3|||
37775904|NCT00554229|69311616|FG001|Overall Study|Lost to Follow-up|6|||
37775905|NCT00554229|69311615|FG000|Overall Study|Withdrawal by Subject|29|||
37775906|NCT00554229|69311616|FG001|Overall Study|Withdrawal by Subject|37|||
37775907|NCT00554229|69311615|FG000|Overall Study|Adverse Event|71|||
37775908|NCT00554229|69311616|FG001|Overall Study|Adverse Event|39|||
37775909|NCT00554229|69311615|FG000|Overall Study|Protocol Violation|3|||
37775910|NCT00554229|69311616|FG001|Overall Study|Protocol Violation|3|||
37775911|NCT00554229|69311615|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
37775912|NCT00554229|69311616|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
37775913|NCT00554229|69311615|FG000|Overall Study|Randomised but no treatment received|1|||
37775914|NCT00554229|69311616|FG001|Overall Study|Randomised but no treatment received|0|||
37775915|NCT01405820|69311726|FG000|Randomized Treatment Period|Adverse Event|3|||
37775916|NCT01405820|69311727|FG001|Randomized Treatment Period|Adverse Event|3|||
37775917|NCT01405820|69311728|FG002|Randomized Treatment Period|Adverse Event|3|||
37775918|NCT01405820|69311729|FG003|Randomized Treatment Period|Adverse Event|0|||
37775919|NCT01405820|69311730|FG004|Randomized Treatment Period|Adverse Event|2|||
37775920|NCT01405820|69311731|FG005|Randomized Treatment Period|Adverse Event|1|||
37775921|NCT01405820|69311726|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
37775922|NCT01405820|69311727|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
37775923|NCT01405820|69311728|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
37775924|NCT01405820|69311729|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
37775925|NCT01405820|69311730|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
37775926|NCT01405820|69311731|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
37775927|NCT01405820|69311726|FG000|Randomized Treatment Period|Other|2|||
37775928|NCT01405820|69311727|FG001|Randomized Treatment Period|Other|2|||
37775929|NCT01405820|69311728|FG002|Randomized Treatment Period|Other|1|||
37775930|NCT01405820|69311729|FG003|Randomized Treatment Period|Other|1|||
37775931|NCT01405820|69311730|FG004|Randomized Treatment Period|Other|0|||
37775932|NCT01405820|69311731|FG005|Randomized Treatment Period|Other|0|||
37775933|NCT01405820|69311726|FG000|Randomized Treatment Period|Physician Decision|0|||
37775934|NCT01405820|69311727|FG001|Randomized Treatment Period|Physician Decision|2|||
37775935|NCT01405820|69311728|FG002|Randomized Treatment Period|Physician Decision|1|||
37775936|NCT01405820|69311729|FG003|Randomized Treatment Period|Physician Decision|0|||
37968593|NCT00360412|69655706|FG000|Overall Study|Lack of therapeutic efficacy|46|||
37968594|NCT00360412|69655707|FG001|Overall Study|Lack of therapeutic efficacy|61|||
37968595|NCT00360412|69655706|FG000|Overall Study|Physician Decision|2|||
37968596|NCT00360412|69655707|FG001|Overall Study|Physician Decision|4|||
37968597|NCT00360412|69655706|FG000|Overall Study|Other|5|||
37968598|NCT00360412|69655707|FG001|Overall Study|Other|6|||
37968599|NCT00360412|69655706|FG000|Overall Study|Study termination by Sponsor|214|||
37775937|NCT01405820|69311730|FG004|Randomized Treatment Period|Physician Decision|0|||
37775938|NCT01405820|69311731|FG005|Randomized Treatment Period|Physician Decision|0|||
37775939|NCT01405820|69311726|FG000|Randomized Treatment Period|Rescue|0|||
37775940|NCT01405820|69311727|FG001|Randomized Treatment Period|Rescue|1|||
37775941|NCT01405820|69311728|FG002|Randomized Treatment Period|Rescue|13|||
37775942|NCT01405820|69311729|FG003|Randomized Treatment Period|Rescue|10|||
37775943|NCT01405820|69311730|FG004|Randomized Treatment Period|Rescue|8|||
37775944|NCT01405820|69311731|FG005|Randomized Treatment Period|Rescue|8|||
37775945|NCT01405820|69311726|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
37775946|NCT01405820|69311727|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
37775947|NCT01405820|69311728|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
37775948|NCT01405820|69311729|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
37775949|NCT01405820|69311730|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
37775950|NCT01405820|69311731|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
37775951|NCT01405820|69311726|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
37775952|NCT01405820|69311727|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
37775953|NCT01405820|69311728|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
37775954|NCT01405820|69311729|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
37775955|NCT01405820|69311730|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
37775956|NCT01405820|69311731|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
37775957|NCT01405820|69311726|FG000|Randomized Treatment Period|Death|0|||
37775958|NCT01405820|69311727|FG001|Randomized Treatment Period|Death|0|||
37775959|NCT01405820|69311728|FG002|Randomized Treatment Period|Death|0|||
37775960|NCT01405820|69311729|FG003|Randomized Treatment Period|Death|1|||
37775961|NCT01405820|69311730|FG004|Randomized Treatment Period|Death|0|||
37775962|NCT01405820|69311731|FG005|Randomized Treatment Period|Death|0|||
37775963|NCT01405820|69311726|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
37775964|NCT01405820|69311727|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
37775965|NCT01405820|69311728|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
37775966|NCT01405820|69311729|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
37690948|NCT02111577|69167222|FG001|Overall Study|Death|254|||
37690949|NCT02111577|69167221|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
37690950|NCT02111577|69167222|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
37690951|NCT02111577|69167221|FG000|Overall Study|Adverse Event|1|||
37690952|NCT02111577|69167222|FG001|Overall Study|Adverse Event|1|||
37690953|NCT02111577|69167221|FG000|Overall Study|Withdrawal by Subject|51|||
37775967|NCT01405820|69311730|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
37775968|NCT01405820|69311731|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
37775969|NCT01405820|69311726|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
37775970|NCT01405820|69311727|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
37775971|NCT01405820|69311728|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
37775972|NCT01405820|69311729|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
37775973|NCT01405820|69311730|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
37775974|NCT01405820|69311731|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
37775975|NCT01405820|69311726|FG000|Open-Label Treatment Period|Other|1|||
37775976|NCT01405820|69311727|FG001|Open-Label Treatment Period|Other|1|||
37775977|NCT01405820|69311728|FG002|Open-Label Treatment Period|Other|1|||
37775978|NCT01405820|69311729|FG003|Open-Label Treatment Period|Other|1|||
37775979|NCT01405820|69311730|FG004|Open-Label Treatment Period|Other|1|||
37775980|NCT01405820|69311731|FG005|Open-Label Treatment Period|Other|1|||
37775981|NCT01405820|69311726|FG000|Open-Label Treatment Period|Physician Decision|0|||
37775982|NCT01405820|69311727|FG001|Open-Label Treatment Period|Physician Decision|0|||
37775983|NCT01405820|69311728|FG002|Open-Label Treatment Period|Physician Decision|1|||
37775984|NCT01405820|69311729|FG003|Open-Label Treatment Period|Physician Decision|2|||
37775985|NCT01405820|69311730|FG004|Open-Label Treatment Period|Physician Decision|1|||
37968600|NCT00360412|69655707|FG001|Overall Study|Study termination by Sponsor|469|||
37968601|NCT00623831|69655715|FG000|Overall Study|Withdrawal by Subject|1|||
37968602|NCT00623831|69655716|FG001|Overall Study|Withdrawal by Subject|0|||
37968603|NCT00623831|69655715|FG000|Overall Study|Progressive Disease|0|||
37690954|NCT02111577|69167222|FG001|Overall Study|Withdrawal by Subject|23|||
37690955|NCT02111577|69167221|FG000|Overall Study|Disease progression|0|||
37690956|NCT02111577|69167222|FG001|Overall Study|Disease progression|1|||
37690957|NCT02111577|69167221|FG000|Overall Study|Lost to Follow-up|19|||
37690958|NCT02111577|69167222|FG001|Overall Study|Lost to Follow-up|10|||
37690959|NCT02170779|69167232|FG000|Overall Study|Withdrawal by Subject|1|||
37690960|NCT02170779|69167233|FG001|Overall Study|Withdrawal by Subject|0|||
37775986|NCT01405820|69311731|FG005|Open-Label Treatment Period|Physician Decision|0|||
37775987|NCT01405820|69311726|FG000|Open-Label Treatment Period|Adverse Event|0|||
37775988|NCT01405820|69311727|FG001|Open-Label Treatment Period|Adverse Event|0|||
37775989|NCT01405820|69311728|FG002|Open-Label Treatment Period|Adverse Event|0|||
37968604|NCT00623831|69655716|FG001|Overall Study|Progressive Disease|1|||
37690961|NCT02170779|69167232|FG000|Overall Study|Lost to Follow-up|0|||
37690962|NCT02170779|69167233|FG001|Overall Study|Lost to Follow-up|1|||
37968605|NCT00360334|69655727|FG000|Overall Study|Adverse Event|7|||
37968606|NCT00360334|69655728|FG001|Overall Study|Adverse Event|4|||
37968607|NCT00360334|69655727|FG000|Overall Study|Protocol Violation|1|||
37968608|NCT00360334|69655728|FG001|Overall Study|Protocol Violation|1|||
37968609|NCT00360334|69655727|FG000|Overall Study|Physician Decision|2|||
37968610|NCT00360334|69655728|FG001|Overall Study|Physician Decision|3|||
37968611|NCT00360334|69655727|FG000|Overall Study|Lack of Efficacy|0|||
37968612|NCT00360334|69655728|FG001|Overall Study|Lack of Efficacy|1|||
37968613|NCT00360334|69655727|FG000|Overall Study|Entry criterion not met|1|||
37968614|NCT00360334|69655728|FG001|Overall Study|Entry criterion not met|2|||
37968615|NCT00360334|69655727|FG000|Overall Study|Subject decision|8|||
37968616|NCT00360334|69655728|FG001|Overall Study|Subject decision|2|||
37968617|NCT00422097|69655740|FG000|Dose Level 2|Still on treatment|0|||
37968618|NCT00422097|69655741|FG001|Dose Level 2|Still on treatment|1|||
37968619|NCT00422097|69655742|FG002|Dose Level 2|Still on treatment|0|||
37968620|NCT00422097|69655743|FG003|Dose Level 2|Still on treatment|0|||
37968621|NCT00422097|69655744|FG004|Dose Level 2|Still on treatment|0|||
37968622|NCT00422097|69655745|FG005|Dose Level 2|Still on treatment|0|||
37968623|NCT00422097|69655746|FG006|Dose Level 2|Still on treatment|0|||
37968624|NCT00422097|69655747|FG007|Dose Level 2|Still on treatment|0|||
37968625|NCT00348556|69655771|FG000|Overall Study|Adverse Event|1|||
37968626|NCT00434967|69655779|FG000|Overall Study|Adverse Event|2|||
37968627|NCT00434967|69655780|FG001|Overall Study|Adverse Event|4|||
37968628|NCT00434967|69655781|FG002|Overall Study|Adverse Event|3|||
37968629|NCT00434967|69655782|FG003|Overall Study|Adverse Event|3|||
37968630|NCT00434967|69655779|FG000|Overall Study|Lost to Follow-up|0|||
37968631|NCT00434967|69655780|FG001|Overall Study|Lost to Follow-up|0|||
37968632|NCT00434967|69655781|FG002|Overall Study|Lost to Follow-up|1|||
37968633|NCT00434967|69655782|FG003|Overall Study|Lost to Follow-up|0|||
37968634|NCT00434967|69655779|FG000|Overall Study|Withdrawal by Subject|2|||
37968635|NCT00434967|69655780|FG001|Overall Study|Withdrawal by Subject|2|||
37775990|NCT01405820|69311729|FG003|Open-Label Treatment Period|Adverse Event|1|||
37775991|NCT01405820|69311730|FG004|Open-Label Treatment Period|Adverse Event|0|||
37775992|NCT01405820|69311731|FG005|Open-Label Treatment Period|Adverse Event|0|||
37775993|NCT01405742|69311760|FG000|Overall Study|Lost to Follow-up|1|||
37775994|NCT01405742|69311761|FG001|Overall Study|Lost to Follow-up|0|||
37775995|NCT01425632|69311790|FG000|Overall Study|Adverse Event|0|||
37775996|NCT01425632|69311791|FG001|Overall Study|Adverse Event|1|||
37775997|NCT01425632|69311792|FG002|Overall Study|Adverse Event|1|||
37775998|NCT01425632|69311790|FG000|Overall Study|Physician Decision|1|||
37775999|NCT01425632|69311791|FG001|Overall Study|Physician Decision|0|||
37776000|NCT01425632|69311792|FG002|Overall Study|Physician Decision|0|||
37776001|NCT01425632|69311790|FG000|Overall Study|Protocol Violation|0|||
37776002|NCT01425632|69311791|FG001|Overall Study|Protocol Violation|0|||
37776003|NCT01425632|69311792|FG002|Overall Study|Protocol Violation|2|||
37776004|NCT01425632|69311790|FG000|Overall Study|Withdrawal by Subject|0|||
37776005|NCT01425632|69311791|FG001|Overall Study|Withdrawal by Subject|0|||
37776006|NCT01425632|69311792|FG002|Overall Study|Withdrawal by Subject|1|||
37776007|NCT01405508|69311829|FG000|Overall Study|AE, non-serious non-fatal|1|||
37776008|NCT01405508|69311830|FG001|Overall Study|AE, non-serious non-fatal|1|||
37776009|NCT01405508|69311831|FG002|Overall Study|AE, non-serious non-fatal|0|||
37776010|NCT01405508|69311832|FG003|Overall Study|AE, non-serious non-fatal|0|||
37776011|NCT01405196|69311968|FG000|Overall Study|Study Terminated by Sponsor|0|||
37776012|NCT01405196|69311969|FG001|Overall Study|Study Terminated by Sponsor|0|||
37776013|NCT01405196|69311970|FG002|Overall Study|Study Terminated by Sponsor|9|||
37776014|NCT01405196|69311971|FG003|Overall Study|Study Terminated by Sponsor|0|||
37776015|NCT01405196|69311968|FG000|Overall Study|Other|2|||
37968636|NCT00434967|69655781|FG002|Overall Study|Withdrawal by Subject|4|||
37776016|NCT01405196|69311969|FG001|Overall Study|Other|2|||
37776017|NCT01405196|69311970|FG002|Overall Study|Other|5|||
37776018|NCT01405196|69311971|FG003|Overall Study|Other|0|||
37968637|NCT00434967|69655782|FG003|Overall Study|Withdrawal by Subject|6|||
37968638|NCT00434967|69655779|FG000|Overall Study|Randomized in error|0|||
37968639|NCT00434967|69655780|FG001|Overall Study|Randomized in error|0|||
37968640|NCT00434967|69655781|FG002|Overall Study|Randomized in error|0|||
37968641|NCT00434967|69655782|FG003|Overall Study|Randomized in error|1|||
37776019|NCT01405196|69311968|FG000|Overall Study|Withdrawal by Subject|4|||
37776020|NCT01405196|69311969|FG001|Overall Study|Withdrawal by Subject|6|||
37776021|NCT01405196|69311970|FG002|Overall Study|Withdrawal by Subject|3|||
37776022|NCT01405196|69311971|FG003|Overall Study|Withdrawal by Subject|6|||
37968642|NCT00434967|69655779|FG000|Overall Study|Protocol Violation|0|||
37968643|NCT00434967|69655780|FG001|Overall Study|Protocol Violation|1|||
37968644|NCT00434967|69655781|FG002|Overall Study|Protocol Violation|0|||
37968645|NCT00434967|69655782|FG003|Overall Study|Protocol Violation|1|||
37968646|NCT00434967|69655779|FG000|Overall Study|Physician Decision|1|||
37968647|NCT00434967|69655780|FG001|Overall Study|Physician Decision|1|||
37968648|NCT00434967|69655781|FG002|Overall Study|Physician Decision|1|||
37968649|NCT00434967|69655782|FG003|Overall Study|Physician Decision|0|||
37968650|NCT00434967|69655779|FG000|Overall Study|Patient Disposition Challenges|2|||
37968651|NCT00434967|69655780|FG001|Overall Study|Patient Disposition Challenges|0|||
37968652|NCT00434967|69655781|FG002|Overall Study|Patient Disposition Challenges|0|||
37968653|NCT00434967|69655782|FG003|Overall Study|Patient Disposition Challenges|3|||
37968654|NCT00356590|69655792|FG000|Overall Study|Adverse Event|54|||
37968655|NCT00356590|69655792|FG000|Overall Study|Death|10|||
37968656|NCT00356590|69655792|FG000|Overall Study|Lost to Follow-up|35|||
37968657|NCT00356590|69655792|FG000|Overall Study|Physician Decision|46|||
37968658|NCT00356590|69655792|FG000|Overall Study|Withdrawal by Subject|41|||
37968659|NCT00356590|69655792|FG000|Overall Study|Completed month 12 only|2|||
37968660|NCT00356590|69655792|FG000|Overall Study|Protocol issues|6|||
37968661|NCT00356590|69655792|FG000|Overall Study|Response status|28|||
37968662|NCT00356590|69655792|FG000|Overall Study|Other|52|||
37968663|NCT00356278|69655799|FG000|Overall Study|Withdrawal by Subject|25|||
37968664|NCT00356278|69655800|FG001|Overall Study|Withdrawal by Subject|15|||
37968665|NCT00356278|69655801|FG002|Overall Study|Withdrawal by Subject|19|||
37968666|NCT00356200|69655811|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
37968667|NCT00356200|69655812|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
37968668|NCT00356200|69655811|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
37968669|NCT00356200|69655812|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
37968670|NCT00356122|69655824|FG000|TREATMENT|Lack of Efficacy|26|||
37968671|NCT00356122|69655824|FG000|TREATMENT|Adverse Event|10|||
37968672|NCT00356122|69655824|FG000|TREATMENT|Subject's request|4|||
37968673|NCT00356122|69655824|FG000|TREATMENT|Other|4|||
37968674|NCT00356122|69655824|FG000|TREATMENT|Did not receive study medication|1|||
37968675|NCT00356122|69655824|FG000|FOLLOW-UP|Death|37|||
37968676|NCT00356122|69655824|FG000|FOLLOW-UP|Lost to Follow-up|2|||
37968677|NCT00356122|69655824|FG000|FOLLOW-UP|Other|2|||
37968678|NCT00347932|69655830|FG000|Overall Study|Adverse Event|4|||
37968679|NCT00347932|69655831|FG001|Overall Study|Adverse Event|5|||
37968680|NCT00347932|69655830|FG000|Overall Study|Lack of Efficacy|3|||
37968681|NCT00347932|69655831|FG001|Overall Study|Lack of Efficacy|14|||
37968682|NCT00347932|69655830|FG000|Overall Study|Lost to Follow-up|10|||
37968683|NCT00347932|69655831|FG001|Overall Study|Lost to Follow-up|9|||
37968684|NCT00347932|69655830|FG000|Overall Study|Withdrawal by Subject|10|||
37968685|NCT00347932|69655831|FG001|Overall Study|Withdrawal by Subject|16|||
37968686|NCT00347932|69655830|FG000|Overall Study|Did not meet inclusion criteria|4|||
37968687|NCT00347932|69655831|FG001|Overall Study|Did not meet inclusion criteria|8|||
37968688|NCT00528996|69655842|FG000|Overall Study|Other reasons than listing|6|||
37968689|NCT00528996|69655843|FG001|Overall Study|Other reasons than listing|7|||
37968690|NCT00528996|69655844|FG002|Overall Study|Other reasons than listing|14|||
37968691|NCT00528996|69655845|FG003|Overall Study|Other reasons than listing|11|||
37690963|NCT02147067|69167241|FG000|Overall Study|Withdrawal by Subject|2|||
37690964|NCT02147067|69167242|FG001|Overall Study|Withdrawal by Subject|2|||
37690965|NCT02170389|69167248|FG000|Overall Study|Study terminated prior to start of treat|1|||
37690966|NCT02146599|69167252|FG000|Overall Study|Failed to meet inclusion criteria|5|||
37690967|NCT02146365|69167262|FG000|Overall Study|Lost to Follow-up|2|||
37690968|NCT02146365|69167263|FG001|Overall Study|Lost to Follow-up|1|||
37968692|NCT00528996|69655846|FG004|Overall Study|Other reasons than listing|5|||
37690969|NCT02146365|69167264|FG002|Overall Study|Lost to Follow-up|3|||
37690970|NCT02146365|69167265|FG003|Overall Study|Lost to Follow-up|3|||
37690971|NCT02146365|69167266|FG004|Overall Study|Lost to Follow-up|1|||
37690972|NCT02146365|69167267|FG005|Overall Study|Lost to Follow-up|1|||
37690973|NCT02146365|69167268|FG006|Overall Study|Lost to Follow-up|0|||
37690974|NCT02146365|69167269|FG007|Overall Study|Lost to Follow-up|1|||
37968693|NCT00528996|69655842|FG000|Overall Study|Refused continue medication|16|||
37968694|NCT00528996|69655843|FG001|Overall Study|Refused continue medication|0|||
37690975|NCT02146365|69167262|FG000|Overall Study|Withdrawal by Subject|1|||
37690976|NCT02146365|69167263|FG001|Overall Study|Withdrawal by Subject|2|||
37968695|NCT00528996|69655844|FG002|Overall Study|Refused continue medication|3|||
37968696|NCT00528996|69655845|FG003|Overall Study|Refused continue medication|3|||
37968697|NCT00528996|69655846|FG004|Overall Study|Refused continue medication|6|||
37968698|NCT00528996|69655842|FG000|Overall Study|Lost to Follow-up|2|||
37968699|NCT00528996|69655843|FG001|Overall Study|Lost to Follow-up|0|||
37968700|NCT00528996|69655844|FG002|Overall Study|Lost to Follow-up|4|||
37968701|NCT00528996|69655845|FG003|Overall Study|Lost to Follow-up|1|||
37968702|NCT00528996|69655846|FG004|Overall Study|Lost to Follow-up|3|||
37968703|NCT00528996|69655842|FG000|Overall Study|Protocol Violation|1|||
37968704|NCT00528996|69655843|FG001|Overall Study|Protocol Violation|2|||
37968705|NCT00528996|69655844|FG002|Overall Study|Protocol Violation|3|||
37776023|NCT01405196|69311968|FG000|Overall Study|Adverse Event|2|||
37776024|NCT01405196|69311969|FG001|Overall Study|Adverse Event|2|||
37776025|NCT01405196|69311970|FG002|Overall Study|Adverse Event|0|||
37776026|NCT01405196|69311971|FG003|Overall Study|Adverse Event|2|||
37776027|NCT01405196|69311968|FG000|Overall Study|Death|1|||
37776028|NCT01405196|69311969|FG001|Overall Study|Death|0|||
37776029|NCT01405196|69311970|FG002|Overall Study|Death|3|||
37776030|NCT01405196|69311971|FG003|Overall Study|Death|0|||
37776031|NCT01405196|69311968|FG000|Overall Study|Lost to Follow-up|2|||
37776032|NCT01405196|69311969|FG001|Overall Study|Lost to Follow-up|2|||
37776033|NCT01405196|69311970|FG002|Overall Study|Lost to Follow-up|3|||
37776034|NCT01405196|69311971|FG003|Overall Study|Lost to Follow-up|1|||
37776035|NCT01402700|69312021|FG000|Overall Study|Death|3|||
37776036|NCT01402700|69312021|FG000|Overall Study|Withdrawal by Subject|3|||
37776037|NCT01402700|69312021|FG000|Overall Study|Missed Visit|1|||
37776038|NCT01424930|69312143|FG000|Overall Study|Adverse Event|0|||
37776039|NCT01424930|69312144|FG001|Overall Study|Adverse Event|1|||
37776040|NCT01424930|69312143|FG000|Overall Study|Death|1|||
37776041|NCT01424930|69312144|FG001|Overall Study|Death|0|||
37776042|NCT01424930|69312143|FG000|Overall Study|Progressive Disease|3|||
37776043|NCT01424930|69312144|FG001|Overall Study|Progressive Disease|6|||
37776044|NCT01424930|69312143|FG000|Overall Study|Screen Failure|0|||
37776045|NCT01424930|69312144|FG001|Overall Study|Screen Failure|1|||
37776046|NCT01424930|69312143|FG000|Overall Study|Reason not specified|0|||
37776047|NCT01424930|69312144|FG001|Overall Study|Reason not specified|6|||
37776048|NCT01424306|69312159|FG000|Overall Study|Protocol Violation|0|||
37776049|NCT01424306|69312160|FG001|Overall Study|Protocol Violation|0|||
37776050|NCT01424306|69312161|FG002|Overall Study|Protocol Violation|0|||
37776051|NCT01424306|69312162|FG003|Overall Study|Protocol Violation|0|||
37776052|NCT01424306|69312163|FG004|Overall Study|Protocol Violation|1|||
37776053|NCT01424306|69312164|FG005|Overall Study|Protocol Violation|0|||
37776054|NCT01424228|69312208|FG000|Overall Study|Withdrawal by Subject|27|||
37776055|NCT01424228|69312209|FG001|Overall Study|Withdrawal by Subject|11|||
37776056|NCT01424228|69312208|FG000|Overall Study|Adverse Event|10|||
37776057|NCT01424228|69312209|FG001|Overall Study|Adverse Event|14|||
37776058|NCT01424228|69312208|FG000|Overall Study|Sponsor's decision|9|||
37776059|NCT01424228|69312209|FG001|Overall Study|Sponsor's decision|12|||
37776060|NCT01424228|69312208|FG000|Overall Study|Lack of Efficacy|5|||
37776061|NCT01424228|69312209|FG001|Overall Study|Lack of Efficacy|7|||
37776062|NCT01424228|69312208|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
37776063|NCT01424228|69312209|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
37776064|NCT01424228|69312208|FG000|Overall Study|Non-compliance|2|||
37776065|NCT01424228|69312209|FG001|Overall Study|Non-compliance|0|||
37776066|NCT01424228|69312208|FG000|Overall Study|Worsening of symptoms|1|||
37776067|NCT01424228|69312209|FG001|Overall Study|Worsening of symptoms|0|||
37776068|NCT01424228|69312208|FG000|Overall Study|Unplanned journey|0|||
37690977|NCT02146365|69167264|FG002|Overall Study|Withdrawal by Subject|1|||
37690978|NCT02146365|69167265|FG003|Overall Study|Withdrawal by Subject|5|||
37690979|NCT02146365|69167266|FG004|Overall Study|Withdrawal by Subject|1|||
37690980|NCT02146365|69167267|FG005|Overall Study|Withdrawal by Subject|0|||
37690981|NCT02146365|69167268|FG006|Overall Study|Withdrawal by Subject|0|||
37690982|NCT02146365|69167269|FG007|Overall Study|Withdrawal by Subject|0|||
37690983|NCT02146365|69167262|FG000|Overall Study|Unable to Comply with Protocol|0|||
37690984|NCT02146365|69167263|FG001|Overall Study|Unable to Comply with Protocol|1|||
37690985|NCT02146365|69167264|FG002|Overall Study|Unable to Comply with Protocol|1|||
37690986|NCT02146365|69167265|FG003|Overall Study|Unable to Comply with Protocol|0|||
37690987|NCT02146365|69167266|FG004|Overall Study|Unable to Comply with Protocol|0|||
37690988|NCT02146365|69167267|FG005|Overall Study|Unable to Comply with Protocol|0|||
37690989|NCT02146365|69167268|FG006|Overall Study|Unable to Comply with Protocol|0|||
37690990|NCT02146365|69167269|FG007|Overall Study|Unable to Comply with Protocol|0|||
37690991|NCT02146365|69167262|FG000|Overall Study|Other|1|||
37690992|NCT02146365|69167263|FG001|Overall Study|Other|0|||
37690993|NCT02146365|69167264|FG002|Overall Study|Other|2|||
37690994|NCT02146365|69167265|FG003|Overall Study|Other|1|||
37776069|NCT01424228|69312209|FG001|Overall Study|Unplanned journey|1|||
37776070|NCT01423916|69312218|FG000|Overall Study|Adverse Event|5|||
37776071|NCT01423916|69312219|FG001|Overall Study|Adverse Event|9|||
37776072|NCT01423916|69312220|FG002|Overall Study|Adverse Event|2|||
37690995|NCT02146365|69167266|FG004|Overall Study|Other|0|||
37690996|NCT02146365|69167267|FG005|Overall Study|Other|0|||
37776073|NCT01423916|69312218|FG000|Overall Study|Met Withdrawal Criteria|1|||
37776074|NCT01423916|69312219|FG001|Overall Study|Met Withdrawal Criteria|1|||
37690997|NCT02146365|69167268|FG006|Overall Study|Other|0|||
37776075|NCT01423916|69312220|FG002|Overall Study|Met Withdrawal Criteria|1|||
37776076|NCT01423916|69312218|FG000|Overall Study|Physician Decision|1|||
37776077|NCT01423916|69312219|FG001|Overall Study|Physician Decision|0|||
37776078|NCT01423916|69312220|FG002|Overall Study|Physician Decision|1|||
37776079|NCT01423916|69312218|FG000|Overall Study|Withdrawal by Subject|3|||
37776080|NCT01423916|69312219|FG001|Overall Study|Withdrawal by Subject|10|||
37776081|NCT01423916|69312220|FG002|Overall Study|Withdrawal by Subject|3|||
37776082|NCT01423916|69312218|FG000|Overall Study|Protocol Deviation|1|||
37776083|NCT01423916|69312219|FG001|Overall Study|Protocol Deviation|0|||
37776084|NCT01423916|69312220|FG002|Overall Study|Protocol Deviation|0|||
37776085|NCT01423604|69312339|FG000|Safety Run-In|Adverse Event|3|||
37776086|NCT01423604|69312340|FG001|Safety Run-In|Adverse Event|0|||
37776087|NCT01423604|69312339|FG000|Safety Run-In|Death|1|||
37776088|NCT01423604|69312340|FG001|Safety Run-In|Death|0|||
37776089|NCT01423604|69312339|FG000|Safety Run-In|Physician Decision|1|||
37776090|NCT01423604|69312340|FG001|Safety Run-In|Physician Decision|0|||
37776091|NCT01423604|69312339|FG000|Safety Run-In|Disease progression|3|||
37776092|NCT01423604|69312340|FG001|Safety Run-In|Disease progression|0|||
37776093|NCT01423604|69312339|FG000|Safety Run-In|Patient decision|1|||
37776094|NCT01423604|69312340|FG001|Safety Run-In|Patient decision|0|||
37776095|NCT01423604|69312339|FG000|Randomized|Adverse Event|4|||
37776096|NCT01423604|69312340|FG001|Randomized|Adverse Event|10|||
37776097|NCT01423604|69312339|FG000|Randomized|Death|1|||
37776098|NCT01423604|69312340|FG001|Randomized|Death|0|||
37776099|NCT01423604|69312339|FG000|Randomized|Physician Decision|16|||
37776100|NCT01423604|69312340|FG001|Randomized|Physician Decision|13|||
37776101|NCT01423604|69312339|FG000|Randomized|Other - unspecified|37|||
37776102|NCT01423604|69312340|FG001|Randomized|Other - unspecified|31|||
37776103|NCT01423604|69312339|FG000|Randomized|Patient decision|5|||
37776104|NCT01423604|69312340|FG001|Randomized|Patient decision|9|||
37776105|NCT01402544|69312356|FG000|Overall Study|Withdrawal by Subject|6|||
37776106|NCT01401842|69312362|FG000|Overall Study|Withdrawal by Subject|3|||
37776107|NCT01401842|69312363|FG001|Overall Study|Withdrawal by Subject|2|||
37776108|NCT01401842|69312362|FG000|Overall Study|academic reason|4|||
37776109|NCT01401842|69312363|FG001|Overall Study|academic reason|1|||
37776110|NCT01401842|69312362|FG000|Overall Study|changed companies|20|||
37776111|NCT01401842|69312363|FG001|Overall Study|changed companies|34|||
37776112|NCT01401842|69312362|FG000|Overall Study|discharged from US Army|3|||
37776113|NCT01401842|69312363|FG001|Overall Study|discharged from US Army|4|||
37776114|NCT01401842|69312362|FG000|Overall Study|invalid follow-up strength data|1|||
37776115|NCT01401842|69312363|FG001|Overall Study|invalid follow-up strength data|4|||
37776116|NCT01401842|69312362|FG000|Overall Study|on profile|9|||
37776117|NCT01401842|69312363|FG001|Overall Study|on profile|5|||
37776118|NCT01401842|69312362|FG000|Overall Study|other/unknown|28|||
37776119|NCT01401842|69312363|FG001|Overall Study|other/unknown|17|||
37776120|NCT01422824|69312369|FG000|Overall Study|Case record form not evaluated|1|||
37776121|NCT01422824|69312369|FG000|Overall Study|Lost to Follow-up|37|||
37776122|NCT01401530|69312432|FG000|Overall Study|Disease Progression|1|||
37776123|NCT01401530|69312433|FG001|Overall Study|Disease Progression|2|||
37968706|NCT00528996|69655845|FG003|Overall Study|Protocol Violation|3|||
37968707|NCT00528996|69655846|FG004|Overall Study|Protocol Violation|2|||
37690998|NCT02146365|69167269|FG007|Overall Study|Other|0|||
37690999|NCT02146131|69167289|FG000|Overall Study|Physician Decision|61|||
37691000|NCT02146131|69167290|FG001|Overall Study|Physician Decision|56|||
37691001|NCT02107131|69167298|FG000|Overall Study|Lost to Follow-up|4|||
37691002|NCT02107131|69167299|FG001|Overall Study|Lost to Follow-up|4|||
37691003|NCT02107131|69167298|FG000|Overall Study|Physician Decision|1|||
37691004|NCT02107131|69167299|FG001|Overall Study|Physician Decision|0|||
37691005|NCT02107131|69167298|FG000|Overall Study|Withdrawal by Subject|2|||
37691006|NCT02107131|69167299|FG001|Overall Study|Withdrawal by Subject|0|||
37691007|NCT02107131|69167298|FG000|Overall Study|mental instability|1|||
37691008|NCT02107131|69167299|FG001|Overall Study|mental instability|0|||
37776124|NCT01401530|69312434|FG002|Overall Study|Disease Progression|1|||
37776125|NCT01401530|69312432|FG000|Overall Study|Adverse Event|1|||
37776126|NCT01401530|69312433|FG001|Overall Study|Adverse Event|1|||
37776127|NCT01401530|69312434|FG002|Overall Study|Adverse Event|1|||
37776128|NCT01401530|69312432|FG000|Overall Study|Participant Choice|1|||
37776129|NCT01401530|69312433|FG001|Overall Study|Participant Choice|2|||
37776130|NCT01401530|69312434|FG002|Overall Study|Participant Choice|1|||
37776131|NCT01401530|69312432|FG000|Overall Study|Physician Decision|0|||
37776132|NCT01401530|69312433|FG001|Overall Study|Physician Decision|1|||
37776133|NCT01401530|69312434|FG002|Overall Study|Physician Decision|0|||
37776134|NCT01387022|69312446|FG000|Overall Study|Death|1|||
37776135|NCT01387022|69312447|FG001|Overall Study|Death|1|||
37776136|NCT01387022|69312446|FG000|Overall Study|Lost to Follow-up|0|||
37776137|NCT01387022|69312447|FG001|Overall Study|Lost to Follow-up|3|||
37776138|NCT01386944|69312473|FG000|Overall Study|Adverse Event|26|||
37691009|NCT02107131|69167298|FG000|Overall Study|Death|0|||
37776139|NCT01386944|69312473|FG000|Overall Study|Lack of Efficacy|14|||
37776140|NCT01386944|69312473|FG000|Overall Study|Lost to Follow-up|8|||
37776141|NCT01386944|69312473|FG000|Overall Study|Unspecified reason|8|||
37776142|NCT01386788|69312484|FG000|Overall Study|Lost to Follow-up|2|||
37776143|NCT01386554|69312549|FG000|Overall Study|Lost to Follow-up|0|||
37776144|NCT01386554|69312550|FG001|Overall Study|Lost to Follow-up|0|||
37776145|NCT01386554|69312551|FG002|Overall Study|Lost to Follow-up|1|||
37776146|NCT01386554|69312549|FG000|Overall Study|Adverse Event|2|||
37776147|NCT01386554|69312550|FG001|Overall Study|Adverse Event|5|||
37691010|NCT02107131|69167299|FG001|Overall Study|Death|1|||
37691011|NCT02107131|69167298|FG000|Overall Study|Protocol Violation|0|||
37691012|NCT02107131|69167299|FG001|Overall Study|Protocol Violation|4|||
37691013|NCT02106975|69167309|FG000|Overall Study|Death|25|||
37691014|NCT02106975|69167310|FG001|Overall Study|Death|39|||
37691015|NCT02145429|69167318|FG000|Overall Study|Death|4|||
37691016|NCT02145429|69167319|FG001|Overall Study|Death|5|||
37691017|NCT02145429|69167318|FG000|Overall Study|Lost to Follow-up|4|||
37691018|NCT02145429|69167319|FG001|Overall Study|Lost to Follow-up|3|||
37691019|NCT02145429|69167318|FG000|Overall Study|Withdrawal by Subject|8|||
37691020|NCT02145429|69167319|FG001|Overall Study|Withdrawal by Subject|3|||
37691021|NCT02144337|69167327|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
37691022|NCT02144337|69167328|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
37691023|NCT02144337|69167327|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
37691024|NCT02144337|69167328|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
37691025|NCT02144337|69167327|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
37691026|NCT02144337|69167328|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
37691027|NCT02144337|69167327|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
37691028|NCT02144337|69167328|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
37691029|NCT02144337|69167327|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
37691030|NCT02144337|69167328|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
37691031|NCT02520011|69167338|FG000|Overall Study|Adverse Event|0|||
37691032|NCT02520011|69167339|FG001|Overall Study|Adverse Event|1|||
37691033|NCT02520011|69167340|FG002|Overall Study|Adverse Event|2|||
37691034|NCT02520011|69167338|FG000|Overall Study|Death|0|||
37691035|NCT02520011|69167339|FG001|Overall Study|Death|8|||
37691036|NCT02520011|69167340|FG002|Overall Study|Death|1|||
37691037|NCT02520011|69167338|FG000|Overall Study|Lack of Efficacy|4|||
37691038|NCT02520011|69167339|FG001|Overall Study|Lack of Efficacy|26|||
37691039|NCT02520011|69167340|FG002|Overall Study|Lack of Efficacy|4|||
37691040|NCT02520011|69167338|FG000|Overall Study|Physician Decision|0|||
37691041|NCT02520011|69167339|FG001|Overall Study|Physician Decision|2|||
37691042|NCT02520011|69167340|FG002|Overall Study|Physician Decision|0|||
37691043|NCT02520011|69167338|FG000|Overall Study|Withdrawal by Subject|1|||
37691044|NCT02520011|69167339|FG001|Overall Study|Withdrawal by Subject|3|||
37691045|NCT02520011|69167340|FG002|Overall Study|Withdrawal by Subject|0|||
37691046|NCT02520011|69167338|FG000|Overall Study|Protocol Deviation|0|||
37776148|NCT01386554|69312551|FG002|Overall Study|Adverse Event|2|||
37776149|NCT01386554|69312549|FG000|Overall Study|Progressive disease|1|||
37776150|NCT01386554|69312550|FG001|Overall Study|Progressive disease|2|||
37776151|NCT01386554|69312551|FG002|Overall Study|Progressive disease|2|||
37776152|NCT01386554|69312549|FG000|Overall Study|Administration of live vaccines|0|||
37776153|NCT01386554|69312550|FG001|Overall Study|Administration of live vaccines|1|||
37776154|NCT01386554|69312551|FG002|Overall Study|Administration of live vaccines|0|||
37776155|NCT01386554|69312549|FG000|Overall Study|Investigator discretion|0|||
37968708|NCT00528996|69655842|FG000|Overall Study|Lack of Efficacy|7|||
37968709|NCT00528996|69655843|FG001|Overall Study|Lack of Efficacy|2|||
37691047|NCT02520011|69167339|FG001|Overall Study|Protocol Deviation|1|||
37691048|NCT02520011|69167340|FG002|Overall Study|Protocol Deviation|0|||
37776156|NCT01386554|69312550|FG001|Overall Study|Investigator discretion|0|||
37776157|NCT01386554|69312551|FG002|Overall Study|Investigator discretion|1|||
37776158|NCT01386554|69312549|FG000|Overall Study|Reason not collected|0|||
37776159|NCT01386554|69312550|FG001|Overall Study|Reason not collected|1|||
37776160|NCT01386554|69312551|FG002|Overall Study|Reason not collected|0|||
37776161|NCT01386008|69312576|FG000|Overall Study|exited w/o incident /study discontinued|17|||
37776162|NCT01386008|69312576|FG000|Overall Study|Adverse Event|3|||
37968710|NCT00528996|69655844|FG002|Overall Study|Lack of Efficacy|1|||
37691049|NCT02520011|69167338|FG000|Overall Study|Patient went to hospice|0|||
37776163|NCT01421342|69312724|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
37776164|NCT01421342|69312725|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
37776165|NCT01421342|69312726|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
37968711|NCT00528996|69655845|FG003|Overall Study|Lack of Efficacy|3|||
37691050|NCT02520011|69167339|FG001|Overall Study|Patient went to hospice|1|||
37691051|NCT02520011|69167340|FG002|Overall Study|Patient went to hospice|0|||
37691052|NCT02520011|69167338|FG000|Overall Study|Progressive disease following response|0|||
37691053|NCT02520011|69167339|FG001|Overall Study|Progressive disease following response|4|||
37776166|NCT01421342|69312724|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
37776167|NCT01421342|69312725|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
37776168|NCT01421342|69312726|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
37776169|NCT01421342|69312724|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
37776170|NCT01421342|69312725|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
37776171|NCT01421342|69312726|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
37776172|NCT01421342|69312724|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
37776173|NCT01421342|69312725|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
37776174|NCT01421342|69312726|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
37776175|NCT01421342|69312724|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
37776176|NCT01421342|69312725|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
37776177|NCT01421342|69312726|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
37776178|NCT01421342|69312724|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
37776179|NCT01421342|69312725|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
37776180|NCT01421342|69312726|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
37776181|NCT01421342|69312724|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
37691054|NCT02520011|69167340|FG002|Overall Study|Progressive disease following response|2|||
37691055|NCT02519231|69167355|FG000|Overall Study|Lost to Follow-up|2|||
37691056|NCT02519231|69167356|FG001|Overall Study|Lost to Follow-up|5|||
37691057|NCT02519231|69167355|FG000|Overall Study|Withdrawal by Subject|0|||
37691058|NCT02519231|69167356|FG001|Overall Study|Withdrawal by Subject|1|||
37776182|NCT01421342|69312725|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
37776183|NCT01421342|69312726|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
37776184|NCT01421342|69312724|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
37776185|NCT01421342|69312725|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
37776186|NCT01421342|69312726|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
37776187|NCT01421342|69312724|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
37776188|NCT01421342|69312725|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
37776189|NCT01421342|69312726|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
37776190|NCT01421342|69312724|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
37776191|NCT01421342|69312725|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
37776192|NCT01421342|69312726|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
37776193|NCT01421342|69312724|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
37776194|NCT01421342|69312725|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
37776195|NCT01421342|69312726|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
37776196|NCT01421342|69312724|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
37776197|NCT01421342|69312725|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
37776198|NCT01421342|69312726|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
37776199|NCT01421342|69312724|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
37776200|NCT01421342|69312725|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
37776201|NCT01421342|69312726|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
37776202|NCT01421342|69312724|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
37776203|NCT01421342|69312725|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
37776204|NCT01421342|69312726|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
37776205|NCT01421342|69312724|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
37776206|NCT01421342|69312725|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
37691059|NCT02106351|69167367|FG000|Treatment Cycle 1|Adverse Event|2|||
37691060|NCT02106351|69167368|FG001|Treatment Cycle 1|Adverse Event|0|||
37691061|NCT02106351|69167369|FG002|Treatment Cycle 1|Adverse Event|0|||
37691062|NCT02106351|69167367|FG000|Treatment Cycle 1|Consent withdrawn|1|||
37691063|NCT02106351|69167368|FG001|Treatment Cycle 1|Consent withdrawn|0|||
37691064|NCT02106351|69167369|FG002|Treatment Cycle 1|Consent withdrawn|2|||
37691065|NCT02106351|69167367|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
37776207|NCT01421342|69312726|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
37776208|NCT01421342|69312724|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
37776209|NCT01421342|69312725|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
37776210|NCT01421342|69312726|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
37776211|NCT01421342|69312724|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
37776212|NCT01421342|69312725|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
37776213|NCT01421342|69312726|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
37776214|NCT01421342|69312724|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
37776215|NCT01421342|69312725|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
37776216|NCT01421342|69312726|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
37776217|NCT01421342|69312724|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
37776218|NCT01421342|69312725|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
37776219|NCT01421342|69312726|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
37776220|NCT01421342|69312724|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
37776221|NCT01421342|69312725|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
37776222|NCT01421342|69312726|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
37776223|NCT01421342|69312724|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
37776224|NCT01421342|69312725|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
37776225|NCT01421342|69312726|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
37776226|NCT01421342|69312724|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
37776227|NCT01421342|69312725|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
37776228|NCT01421342|69312726|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
37776229|NCT01421342|69312724|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
37776230|NCT01421342|69312725|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
37776231|NCT01421342|69312726|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
37776232|NCT01421342|69312724|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
37776233|NCT01421342|69312725|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
37776234|NCT01421342|69312726|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
37776235|NCT01421342|69312724|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
37776236|NCT01421342|69312725|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
37776237|NCT01421342|69312726|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
37776238|NCT01421342|69312724|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
37776239|NCT01421342|69312725|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
37776240|NCT01421342|69312726|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
37776241|NCT01421342|69312724|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
37776242|NCT01421342|69312725|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
37776243|NCT01421342|69312726|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
37776244|NCT01421342|69312724|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
37776245|NCT01421342|69312725|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
37776246|NCT01421342|69312726|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
37776247|NCT01384760|69312749|FG000|Overall Study|Lost to Follow-up|0|||
37776248|NCT01384760|69312750|FG001|Overall Study|Lost to Follow-up|6|||
37968712|NCT00528996|69655846|FG004|Overall Study|Lack of Efficacy|3|||
37776249|NCT01384760|69312749|FG000|Overall Study|Protocol Violation|16|||
37776250|NCT01384760|69312750|FG001|Overall Study|Protocol Violation|0|||
37776251|NCT01384292|69312790|FG000|Part B|Severe non-compliance to protocol|1|||
37776252|NCT01384292|69312791|FG001|Part B|Severe non-compliance to protocol|0|||
37776253|NCT01384292|69312792|FG002|Part B|Severe non-compliance to protocol|0|||
37776254|NCT01401452|69312802|FG000|Overall Study|Adverse reaction|9|||
37776255|NCT01401452|69312802|FG000|Overall Study|Lost to Follow-up|12|||
37776256|NCT01401452|69312802|FG000|Overall Study|Lack of Efficacy|30|||
37776257|NCT01401452|69312802|FG000|Overall Study|Participant developed breast cancer|1|||
37776258|NCT01401452|69312802|FG000|Overall Study|Tx stopped due to financial reasons|1|||
37776259|NCT01401452|69312802|FG000|Overall Study|Tx stopped by psychiatrist|1|||
37776260|NCT01401452|69312802|FG000|Overall Study|No more visits within the 36 wk followup|4|||
37968713|NCT00528996|69655842|FG000|Overall Study|Adverse Event|32|||
37968714|NCT00528996|69655843|FG001|Overall Study|Adverse Event|13|||
37968715|NCT00528996|69655844|FG002|Overall Study|Adverse Event|18|||
37968716|NCT00528996|69655845|FG003|Overall Study|Adverse Event|29|||
37968717|NCT00528996|69655846|FG004|Overall Study|Adverse Event|18|||
37968718|NCT00359788|69655863|FG000|Overall Study|Adverse Event|11|||
37968719|NCT00359788|69655864|FG001|Overall Study|Adverse Event|10|||
37776261|NCT01401452|69312802|FG000|Overall Study|Subject did not come to follow up visits|2|||
37968720|NCT00359788|69655863|FG000|Overall Study|Lack of Efficacy|1|||
37968721|NCT00359788|69655864|FG001|Overall Study|Lack of Efficacy|2|||
37968722|NCT00359788|69655863|FG000|Overall Study|Lost to Follow-up|3|||
37968723|NCT00359788|69655864|FG001|Overall Study|Lost to Follow-up|2|||
37968724|NCT00359788|69655863|FG000|Overall Study|Withdrawal by Subject|4|||
37776262|NCT01401452|69312802|FG000|Overall Study|Subject didn't return for routine visits|1|||
37776263|NCT01401452|69312802|FG000|Overall Study|Subject moved to another city|1|||
37776264|NCT01401452|69312802|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
37776265|NCT01401452|69312802|FG000|Overall Study|Psoriatic arthritis|1|||
37776266|NCT01401452|69312802|FG000|Overall Study|Participant stopped Tx|2|||
37776267|NCT01401452|69312802|FG000|Overall Study|Discontinuation for personal reasons|1|||
37776268|NCT01401452|69312802|FG000|Overall Study|Treatment failure|1|||
37776269|NCT01401452|69312802|FG000|Overall Study|Unsatisfactory output|1|||
37776270|NCT01401452|69312802|FG000|Overall Study|Subject withdrew because of Tx success|1|||
37776271|NCT01401452|69312802|FG000|Overall Study|Subject chose to discontinue treatment|1|||
37776272|NCT01401452|69312802|FG000|Overall Study|Participant withdrew consent|1|||
37776273|NCT01401062|69312837|FG000|Overall Study|Death|9|||
37776274|NCT01401062|69312838|FG001|Overall Study|Death|7|||
37776275|NCT01401062|69312837|FG000|Overall Study|Physician Decision|1|||
37776276|NCT01401062|69312838|FG001|Overall Study|Physician Decision|0|||
37776277|NCT01401062|69312837|FG000|Overall Study|Withdrawal by Subject|1|||
37776278|NCT01401062|69312838|FG001|Overall Study|Withdrawal by Subject|1|||
37776279|NCT01400516|69312871|FG000|Primary Trial|Withdrawal by Subject|0|||
37776280|NCT01400516|69312872|FG001|Primary Trial|Withdrawal by Subject|2|||
37776281|NCT01383356|69312878|FG000|Period 1|Adverse Event|5|||
37776282|NCT01383356|69312879|FG001|Period 1|Adverse Event|3|||
37776283|NCT01383356|69312878|FG000|Period 1|Non-compliance|3|||
37776284|NCT01383356|69312879|FG001|Period 1|Non-compliance|0|||
37776285|NCT01383356|69312878|FG000|Period 1|Out of Range Mid-study-Test|0|||
37776286|NCT01383356|69312879|FG001|Period 1|Out of Range Mid-study-Test|1|||
37776287|NCT01383356|69312878|FG000|Period 1|Personal|0|||
37776288|NCT01383356|69312879|FG001|Period 1|Personal|2|||
37776289|NCT05740098|69312905|FG000|Overall Study|Lost to Follow-up|26|||
37776290|NCT05740098|69312906|FG001|Overall Study|Lost to Follow-up|17|||
37776291|NCT05740098|69312907|FG002|Overall Study|Lost to Follow-up|21|||
37776294|NCT05059080|69312924|FG000|Overall Study|Withdrawal by Subject|3|||
37776295|NCT05059080|69312924|FG000|Overall Study|Study Terminated by Sponsor|64|||
37776296|NCT05012163|69312932|FG000|Overall Study|Protocol Violation|0|||
37776297|NCT05012163|69312933|FG001|Overall Study|Protocol Violation|0|||
37776298|NCT05012163|69312934|FG002|Overall Study|Protocol Violation|1|||
37776299|NCT05012163|69312935|FG003|Overall Study|Protocol Violation|1|||
37776300|NCT05009251|69312950|FG000|Overall Study|Protocol Violation|100|||
37776301|NCT05009251|69312951|FG001|Overall Study|Protocol Violation|105|||
37776302|NCT05009251|69312952|FG002|Overall Study|Protocol Violation|119|||
37776303|NCT05009251|69312953|FG003|Overall Study|Protocol Violation|120|||
37776304|NCT05009251|69312954|FG004|Overall Study|Protocol Violation|119|||
37776305|NCT05009251|69312950|FG000|Overall Study|Death|25|||
37776306|NCT05009251|69312951|FG001|Overall Study|Death|22|||
37776307|NCT05009251|69312952|FG002|Overall Study|Death|24|||
37776308|NCT05009251|69312953|FG003|Overall Study|Death|19|||
37776309|NCT05009251|69312954|FG004|Overall Study|Death|15|||
37776310|NCT04839692|69312968|FG000|Overall Study|Withdrawal by Subject|0|||
37776311|NCT04839692|69312969|FG001|Overall Study|Withdrawal by Subject|3|||
37776312|NCT04839692|69312968|FG000|Overall Study|Physician Decision|1|||
37776313|NCT04839692|69312969|FG001|Overall Study|Physician Decision|0|||
37776314|NCT04476017|69312997|FG000|Part A (28 Days)|Withdrawal by Subject|1|||
37776315|NCT04476017|69312998|FG001|Part A (28 Days)|Withdrawal by Subject|0|||
37776316|NCT04422639|69313007|FG000|Overall Study|Death|1|||
37776317|NCT04422639|69313008|FG001|Overall Study|Death|0|||
37776318|NCT04422639|69313007|FG000|Overall Study|study closed prior to completion of FU visits|0|||
37776319|NCT04422639|69313008|FG001|Overall Study|study closed prior to completion of FU visits|2|||
37776320|NCT04384107|69313016|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
37776321|NCT04384107|69313017|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
37776322|NCT04384107|69313016|FG000|Overall Study|Lost to Follow-up|1|||
37776323|NCT04384107|69313017|FG001|Overall Study|Lost to Follow-up|0|||
37776324|NCT04275089|69313023|FG000|Overall Study|Unable to be fit with Reia pessary|1|||
37776325|NCT04096326|69313058|FG000|Overall Study|Withdrawal by Subject|0|||
37776326|NCT04096326|69313059|FG001|Overall Study|Withdrawal by Subject|0|||
37776327|NCT04096326|69313060|FG002|Overall Study|Withdrawal by Subject|0|||
37776328|NCT04096326|69313061|FG003|Overall Study|Withdrawal by Subject|0|||
37776329|NCT04096326|69313062|FG004|Overall Study|Withdrawal by Subject|0|||
37776330|NCT04096326|69313063|FG005|Overall Study|Withdrawal by Subject|0|||
37776331|NCT04096326|69313064|FG006|Overall Study|Withdrawal by Subject|1|||
37968725|NCT00359788|69655864|FG001|Overall Study|Withdrawal by Subject|1|||
37968726|NCT00359788|69655863|FG000|Overall Study|Protocol Violation|4|||
37968727|NCT00359788|69655864|FG001|Overall Study|Protocol Violation|2|||
37968728|NCT03878160|69655873|FG000|Overall Study|Lost to Follow-up|1|||
37968729|NCT03878160|69655874|FG001|Overall Study|Lost to Follow-up|1|||
37968730|NCT03878160|69655875|FG002|Overall Study|Lost to Follow-up|1|||
37968731|NCT03878160|69655873|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
37968732|NCT03878160|69655874|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
37968733|NCT03878160|69655875|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
37776332|NCT04096326|69313065|FG007|Overall Study|Withdrawal by Subject|0|||
37968734|NCT00623597|69655885|FG000|Overall Study|Failed to return|1|||
37968735|NCT00623597|69655886|FG001|Overall Study|Failed to return|0|||
37968736|NCT00347776|69655897|FG000|1.5 Month Follow-up|Death|2|||
37776333|NCT04096326|69313066|FG008|Overall Study|Withdrawal by Subject|0|||
37776334|NCT04096326|69313067|FG009|Overall Study|Withdrawal by Subject|0|||
37776335|NCT04096326|69313058|FG000|Overall Study|Lost to Follow-up|0|||
37776336|NCT04096326|69313059|FG001|Overall Study|Lost to Follow-up|1|||
37776337|NCT04096326|69313060|FG002|Overall Study|Lost to Follow-up|0|||
37776338|NCT04096326|69313061|FG003|Overall Study|Lost to Follow-up|0|||
37776339|NCT04096326|69313062|FG004|Overall Study|Lost to Follow-up|0|||
37776340|NCT04096326|69313063|FG005|Overall Study|Lost to Follow-up|0|||
37776341|NCT04096326|69313064|FG006|Overall Study|Lost to Follow-up|0|||
37776342|NCT04096326|69313065|FG007|Overall Study|Lost to Follow-up|0|||
37776343|NCT04096326|69313066|FG008|Overall Study|Lost to Follow-up|0|||
37776344|NCT04096326|69313067|FG009|Overall Study|Lost to Follow-up|0|||
37776345|NCT04096326|69313058|FG000|Overall Study|COVID-19-related reasons|0|||
37776346|NCT04096326|69313059|FG001|Overall Study|COVID-19-related reasons|0|||
37776347|NCT04096326|69313060|FG002|Overall Study|COVID-19-related reasons|0|||
37776348|NCT04096326|69313061|FG003|Overall Study|COVID-19-related reasons|0|||
37776349|NCT04096326|69313062|FG004|Overall Study|COVID-19-related reasons|1|||
37776350|NCT04096326|69313063|FG005|Overall Study|COVID-19-related reasons|5|||
37776351|NCT04096326|69313064|FG006|Overall Study|COVID-19-related reasons|0|||
37776352|NCT04096326|69313065|FG007|Overall Study|COVID-19-related reasons|0|||
37776353|NCT04096326|69313066|FG008|Overall Study|COVID-19-related reasons|0|||
37776354|NCT04096326|69313067|FG009|Overall Study|COVID-19-related reasons|0|||
37776355|NCT04072822|69313091|FG000|Treatment|Adverse Event|9|||
37776356|NCT04072822|69313092|FG001|Treatment|Adverse Event|5|||
37776357|NCT04072822|69313091|FG000|Treatment|Met Stopping Criteria|13|||
37776358|NCT04072822|69313092|FG001|Treatment|Met Stopping Criteria|24|||
37776359|NCT04072822|69313091|FG000|Treatment|Averse Event and Met Stopping Criteria|2|||
37776360|NCT04072822|69313092|FG001|Treatment|Averse Event and Met Stopping Criteria|9|||
37776361|NCT04072822|69313091|FG000|Treatment|Withdrawal by Subject|0|||
37776362|NCT04072822|69313092|FG001|Treatment|Withdrawal by Subject|2|||
37776363|NCT04072822|69313091|FG000|Treatment|Death|0|||
37776364|NCT04072822|69313092|FG001|Treatment|Death|2|||
37776365|NCT04072822|69313091|FG000|Treatment|Lost to Follow-up|11|||
37968737|NCT00347776|69655898|FG001|1.5 Month Follow-up|Death|0|||
37968738|NCT00347776|69655899|FG002|1.5 Month Follow-up|Death|0|||
37776366|NCT04072822|69313092|FG001|Treatment|Lost to Follow-up|3|||
37776367|NCT04072822|69313091|FG000|Treatment|Physician Decision|1|||
37776368|NCT04072822|69313092|FG001|Treatment|Physician Decision|0|||
37776369|NCT04072822|69313091|FG000|Treatment|Other|7|||
37776370|NCT04072822|69313092|FG001|Treatment|Other|9|||
37776371|NCT04072822|69313091|FG000|Follow-up|Withdrawal by Subject|1|||
37863734|NCT01256411|69547295|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
37968739|NCT00347776|69655897|FG000|1.5 Month Follow-up|reached the endpoint|12|||
37968740|NCT00347776|69655898|FG001|1.5 Month Follow-up|reached the endpoint|8|||
37776372|NCT04072822|69313092|FG001|Follow-up|Withdrawal by Subject|0|||
37968741|NCT00347776|69655899|FG002|1.5 Month Follow-up|reached the endpoint|12|||
37776373|NCT04072822|69313091|FG000|Follow-up|Lost to Follow-up|5|||
37776374|NCT04072822|69313092|FG001|Follow-up|Lost to Follow-up|4|||
37776375|NCT04031846|69313100|FG000|Overall Study|Lost to Follow-up|4|||
37776376|NCT04031846|69313101|FG001|Overall Study|Lost to Follow-up|4|||
37776377|NCT04031846|69313100|FG000|Overall Study|Physician Decision|0|||
37776378|NCT04031846|69313101|FG001|Overall Study|Physician Decision|1|||
37776379|NCT04031846|69313100|FG000|Overall Study|Protocol Violation|1|||
37691066|NCT02106351|69167368|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
37776380|NCT04031846|69313101|FG001|Overall Study|Protocol Violation|1|||
37776381|NCT04031846|69313100|FG000|Overall Study|Withdrawal By Parent/Guardian|17|||
37776382|NCT04031846|69313101|FG001|Overall Study|Withdrawal By Parent/Guardian|17|||
37776383|NCT03893448|69313110|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
37776384|NCT03893448|69313111|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
37776385|NCT03893448|69313110|FG000|Overall Study|Physician Decision|8|||
37776386|NCT03893448|69313111|FG001|Overall Study|Physician Decision|14|||
37776387|NCT03893448|69313110|FG000|Overall Study|Lost to Follow-up|34|||
37776388|NCT03893448|69313111|FG001|Overall Study|Lost to Follow-up|27|||
37776389|NCT03893448|69313110|FG000|Overall Study|Death|1|||
37776390|NCT03893448|69313111|FG001|Overall Study|Death|0|||
37776391|NCT03692871|69313134|FG000|Overall Study|Death|1|||
37776392|NCT03692871|69313135|FG001|Overall Study|Death|1|||
37776393|NCT03692871|69313134|FG000|Overall Study|Lost to Follow-up|24|||
37776394|NCT03692871|69313135|FG001|Overall Study|Lost to Follow-up|9|||
37776395|NCT03692871|69313134|FG000|Overall Study|Physician Decision|22|||
37776396|NCT03692871|69313135|FG001|Overall Study|Physician Decision|7|||
37776397|NCT03692871|69313134|FG000|Overall Study|Protocol Deviation|1|||
37691067|NCT02106351|69167369|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
37691068|NCT02106351|69167367|FG000|Treatment Cycle 1|Other|0|||
37691069|NCT02106351|69167368|FG001|Treatment Cycle 1|Other|3|||
37776398|NCT03692871|69313135|FG001|Overall Study|Protocol Deviation|0|||
37776399|NCT03692871|69313134|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
37776400|NCT03692871|69313135|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
37776401|NCT03565900|69313143|FG000|Overall Study|Disposition Unknown|4|||
37776402|NCT03565900|69313144|FG001|Overall Study|Disposition Unknown|1|||
37776403|NCT03565900|69313143|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
37776404|NCT03565900|69313144|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
37776405|NCT03565900|69313143|FG000|Overall Study|Withdrawal by Subject|4|||
37776406|NCT03565900|69313144|FG001|Overall Study|Withdrawal by Subject|5|||
37968742|NCT00347776|69655897|FG000|6 Month Follow-up|Death|2|||
37968743|NCT00347776|69655898|FG001|6 Month Follow-up|Death|1|||
37691070|NCT02106351|69167369|FG002|Treatment Cycle 1|Other|1|||
37691071|NCT02106351|69167367|FG000|Treatment Cycle 1|Randomised but not treated|1|||
37691072|NCT02106351|69167368|FG001|Treatment Cycle 1|Randomised but not treated|0|||
37691073|NCT02106351|69167369|FG002|Treatment Cycle 1|Randomised but not treated|1|||
37691074|NCT02106351|69167367|FG000|Treatment Cycle 2|Adverse Event|0|||
37691075|NCT02106351|69167368|FG001|Treatment Cycle 2|Adverse Event|2|||
37691076|NCT02106351|69167369|FG002|Treatment Cycle 2|Adverse Event|0|||
37691077|NCT02106351|69167367|FG000|Treatment Cycle 2|Consent withdrawn|0|||
37691078|NCT02106351|69167368|FG001|Treatment Cycle 2|Consent withdrawn|1|||
37691079|NCT02106351|69167369|FG002|Treatment Cycle 2|Consent withdrawn|1|||
37691080|NCT02106351|69167367|FG000|Treatment Cycle 2|Other|0|||
37691081|NCT02106351|69167368|FG001|Treatment Cycle 2|Other|2|||
37691082|NCT02106351|69167369|FG002|Treatment Cycle 2|Other|2|||
37691083|NCT02106351|69167367|FG000|Treatment Cycle 3|Adverse Event|0|||
37691084|NCT02106351|69167368|FG001|Treatment Cycle 3|Adverse Event|1|||
37691085|NCT02106351|69167369|FG002|Treatment Cycle 3|Adverse Event|0|||
37691086|NCT02106351|69167367|FG000|Treatment Cycle 3|Consent withdrawn|0|||
37691087|NCT02106351|69167368|FG001|Treatment Cycle 3|Consent withdrawn|0|||
37691088|NCT02106351|69167369|FG002|Treatment Cycle 3|Consent withdrawn|2|||
37691089|NCT02106351|69167367|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
37968744|NCT00347776|69655899|FG002|6 Month Follow-up|Death|3|||
37691090|NCT02106351|69167368|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
37776407|NCT03565900|69313143|FG000|Overall Study|Randomized By Mistake|0|||
37776408|NCT03565900|69313144|FG001|Overall Study|Randomized By Mistake|2|||
37776409|NCT03565900|69313143|FG000|Overall Study|Physician Decision|7|||
37968745|NCT00347776|69655897|FG000|6 Month Follow-up|reached endpont|20|||
37691091|NCT02106351|69167369|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
37691092|NCT02106351|69167367|FG000|Treatment Cycle 3|Other|0|||
37691093|NCT02106351|69167368|FG001|Treatment Cycle 3|Other|2|||
37691094|NCT02106351|69167369|FG002|Treatment Cycle 3|Other|3|||
37776410|NCT03565900|69313144|FG001|Overall Study|Physician Decision|11|||
37776411|NCT03565900|69313143|FG000|Overall Study|Death|9|||
37968746|NCT00347776|69655898|FG001|6 Month Follow-up|reached endpont|12|||
37776412|NCT03565900|69313144|FG001|Overall Study|Death|7|||
37776413|NCT03443869|69313183|FG000|Overall Study|Death|3|||
37776414|NCT03443869|69313184|FG001|Overall Study|Death|3|||
37776415|NCT03443869|69313183|FG000|Overall Study|Withdrawal by Subject|34|||
37776416|NCT03443869|69313184|FG001|Overall Study|Withdrawal by Subject|22|||
37776417|NCT03443869|69313183|FG000|Overall Study|Lost to Follow-up|1|||
37776418|NCT03443869|69313184|FG001|Overall Study|Lost to Follow-up|2|||
37776419|NCT03443869|69313183|FG000|Overall Study|Physician Decision|3|||
37776420|NCT03443869|69313184|FG001|Overall Study|Physician Decision|3|||
37776421|NCT03443869|69313183|FG000|Overall Study|Other|4|||
37776422|NCT03443869|69313184|FG001|Overall Study|Other|4|||
37776423|NCT03260140|69313192|FG000|Overall Study|Death|4|||
37776424|NCT03260140|69313193|FG001|Overall Study|Death|1|||
37776425|NCT03260140|69313192|FG000|Overall Study|Withdrawal by Subject|1|||
37776426|NCT03260140|69313193|FG001|Overall Study|Withdrawal by Subject|4|||
37776427|NCT03253796|69313204|FG000|Period 1: Run-In|Adverse Event|4|||
37776428|NCT03253796|69313205|FG001|Period 1: Run-In|Adverse Event|0|||
37776429|NCT03253796|69313206|FG002|Period 1: Run-In|Adverse Event|0|||
37776430|NCT03253796|69313207|FG003|Period 1: Run-In|Adverse Event|0|||
37776431|NCT03253796|69313208|FG004|Period 1: Run-In|Adverse Event|0|||
37776432|NCT03253796|69313204|FG000|Period 1: Run-In|Lack of Efficacy|1|||
37776433|NCT03253796|69313205|FG001|Period 1: Run-In|Lack of Efficacy|0|||
37776434|NCT03253796|69313206|FG002|Period 1: Run-In|Lack of Efficacy|0|||
37776435|NCT03253796|69313207|FG003|Period 1: Run-In|Lack of Efficacy|0|||
37776436|NCT03253796|69313208|FG004|Period 1: Run-In|Lack of Efficacy|0|||
37776437|NCT03253796|69313204|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
37776438|NCT03253796|69313205|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
37776439|NCT03253796|69313206|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
37776440|NCT03253796|69313207|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
37776441|NCT03253796|69313208|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
37776442|NCT03253796|69313204|FG000|Period 1: Run-In|Protocol Violation|5|||
37776443|NCT03253796|69313205|FG001|Period 1: Run-In|Protocol Violation|0|||
37776444|NCT03253796|69313206|FG002|Period 1: Run-In|Protocol Violation|0|||
37776445|NCT03253796|69313207|FG003|Period 1: Run-In|Protocol Violation|0|||
37776446|NCT03253796|69313208|FG004|Period 1: Run-In|Protocol Violation|0|||
37776447|NCT03253796|69313204|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
37776448|NCT03253796|69313205|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
37776449|NCT03253796|69313206|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
37776450|NCT03253796|69313207|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
37776451|NCT03253796|69313208|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
37776452|NCT03253796|69313204|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
37776453|NCT03253796|69313205|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
37776454|NCT03253796|69313206|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
37691095|NCT02106351|69167367|FG000|Treatment Cycle 4|Consent withdrawn|0|||
37691096|NCT02106351|69167368|FG001|Treatment Cycle 4|Consent withdrawn|0|||
37691097|NCT02106351|69167369|FG002|Treatment Cycle 4|Consent withdrawn|2|||
37691098|NCT02106351|69167367|FG000|Treatment Cycle 4|Other|0|||
37691099|NCT02106351|69167368|FG001|Treatment Cycle 4|Other|1|||
37691100|NCT02106351|69167369|FG002|Treatment Cycle 4|Other|0|||
37691101|NCT02143947|69167385|FG000|Overall Study|Lost to Follow-up|4|||
37691102|NCT02143947|69167386|FG001|Overall Study|Lost to Follow-up|2|||
37691103|NCT02075073|69167397|FG000|Overall Study|Withdrawal by Subject|0|||
37691104|NCT02075073|69167398|FG001|Overall Study|Withdrawal by Subject|1|||
37691105|NCT02075073|69167399|FG002|Overall Study|Withdrawal by Subject|0|||
37691106|NCT02074059|69167413|FG000|Overall Study|Death|0|||
37691107|NCT02074059|69167414|FG001|Overall Study|Death|0|||
37776455|NCT03253796|69313207|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
37691108|NCT02074059|69167415|FG002|Overall Study|Death|0|||
37691109|NCT02074059|69167416|FG003|Overall Study|Death|0|||
37776456|NCT03253796|69313208|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
37776457|NCT03253796|69313204|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
37776458|NCT03253796|69313205|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
37776459|NCT03253796|69313206|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
37776460|NCT03253796|69313207|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
37691110|NCT02074059|69167417|FG004|Overall Study|Death|1|||
37691111|NCT02074059|69167418|FG005|Overall Study|Death|1|||
37776461|NCT03253796|69313208|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
37776462|NCT03253796|69313204|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
37776463|NCT03253796|69313205|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
37776464|NCT03253796|69313206|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
37776465|NCT03253796|69313207|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
37776466|NCT03253796|69313208|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
37776467|NCT03253796|69313204|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
37776468|NCT03253796|69313205|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
37776469|NCT03253796|69313206|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
37776470|NCT03253796|69313207|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
37776471|NCT03253796|69313208|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
37776472|NCT03253796|69313204|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
37776473|NCT03253796|69313205|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
37776474|NCT03253796|69313206|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
37776475|NCT03253796|69313207|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
37776476|NCT03253796|69313208|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
37776477|NCT03253796|69313204|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
37776478|NCT03253796|69313205|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
37863735|NCT01256411|69547296|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
37863736|NCT01256411|69547297|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
37863737|NCT01256411|69547298|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
37863738|NCT01256411|69547299|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
37863739|NCT01256411|69547294|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
37863740|NCT01256411|69547295|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
37863741|NCT01256411|69547296|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
37968747|NCT00347776|69655899|FG002|6 Month Follow-up|reached endpont|15|||
37968748|NCT00347776|69655897|FG000|12 Month Follow-up|Lost to Follow-up|7|||
37968749|NCT00347776|69655898|FG001|12 Month Follow-up|Lost to Follow-up|6|||
37968750|NCT00347776|69655899|FG002|12 Month Follow-up|Lost to Follow-up|6|||
37968751|NCT00347776|69655897|FG000|12 Month Follow-up|Death|3|||
37968752|NCT00347776|69655898|FG001|12 Month Follow-up|Death|4|||
37968753|NCT00347776|69655899|FG002|12 Month Follow-up|Death|4|||
37968754|NCT00347776|69655897|FG000|12 Month Follow-up|Reached endpoint|13|||
37968755|NCT00347776|69655898|FG001|12 Month Follow-up|Reached endpoint|6|||
37968756|NCT00347776|69655899|FG002|12 Month Follow-up|Reached endpoint|9|||
37968757|NCT03829228|69655907|FG000|Overall Study|Protocol Violation|1|||
37968758|NCT00529542|69655913|FG000|Overall Study|Withdrawal by Subject|1|||
37968759|NCT00529542|69655914|FG001|Overall Study|Withdrawal by Subject|0|||
37968760|NCT00529542|69655913|FG000|Overall Study|Lost to Follow-up|0|||
37968761|NCT00529542|69655914|FG001|Overall Study|Lost to Follow-up|1|||
37968762|NCT00621959|69655922|FG000|Overall Study|Adverse Event|4|||
37968763|NCT00621959|69655923|FG001|Overall Study|Adverse Event|2|||
37968764|NCT00621959|69655922|FG000|Overall Study|Lack of Efficacy|1|||
37968765|NCT00621959|69655923|FG001|Overall Study|Lack of Efficacy|1|||
37968766|NCT00621959|69655922|FG000|Overall Study|Lost to Follow-up|0|||
37968767|NCT00621959|69655923|FG001|Overall Study|Lost to Follow-up|2|||
37968768|NCT00621959|69655922|FG000|Overall Study|Withdrawal by Subject|1|||
37968769|NCT00621959|69655923|FG001|Overall Study|Withdrawal by Subject|1|||
37968770|NCT00621959|69655922|FG000|Overall Study|Other|1|||
37968771|NCT00621959|69655923|FG001|Overall Study|Other|3|||
37968772|NCT03877224|69655931|FG000|Overall Study|Death|3|||
37968773|NCT03877224|69655932|FG001|Overall Study|Death|2|||
37968774|NCT03877224|69655931|FG000|Overall Study|Withdrawal by Subject|1|||
37968775|NCT03877224|69655932|FG001|Overall Study|Withdrawal by Subject|6|||
37968776|NCT03877224|69655931|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
37968777|NCT03877224|69655932|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
37968778|NCT00528606|69655940|FG000|Overall Study|Withdrew consent|4|||
37968779|NCT00528606|69655941|FG001|Overall Study|Withdrew consent|3|||
37968780|NCT00528606|69655940|FG000|Overall Study|Lost to Follow-up|4|||
37968781|NCT00528606|69655941|FG001|Overall Study|Lost to Follow-up|1|||
37968782|NCT00528606|69655940|FG000|Overall Study|Adverse Event|3|||
37968783|NCT00528606|69655941|FG001|Overall Study|Adverse Event|0|||
37968784|NCT00528606|69655940|FG000|Overall Study|Other|2|||
37691112|NCT02143713|69167437|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
37691113|NCT02143713|69167438|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
37691114|NCT02143713|69167439|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
37691115|NCT02143713|69167440|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
37691116|NCT02143713|69167437|FG000|Treatment Period (6 Months)|Adverse Event|7|||
37691117|NCT02143713|69167438|FG001|Treatment Period (6 Months)|Adverse Event|8|||
37691118|NCT02143713|69167439|FG002|Treatment Period (6 Months)|Adverse Event|8|||
37691119|NCT02143713|69167440|FG003|Treatment Period (6 Months)|Adverse Event|9|||
37691120|NCT02143713|69167437|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
37691121|NCT02143713|69167438|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
37691122|NCT02143713|69167439|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
37691123|NCT02143713|69167440|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
37691124|NCT02143713|69167437|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
37691125|NCT02143713|69167438|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
37691126|NCT02143713|69167439|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
37691127|NCT02143713|69167440|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
37691128|NCT02143713|69167437|FG000|Treatment Period (6 Months)|Pregnancy|0|||
37691129|NCT02143713|69167438|FG001|Treatment Period (6 Months)|Pregnancy|2|||
37691130|NCT02143713|69167439|FG002|Treatment Period (6 Months)|Pregnancy|2|||
37691131|NCT02143713|69167440|FG003|Treatment Period (6 Months)|Pregnancy|0|||
37691132|NCT02143713|69167437|FG000|Treatment Period (6 Months)|Non-compliance|1|||
37691133|NCT02143713|69167438|FG001|Treatment Period (6 Months)|Non-compliance|0|||
37691134|NCT02143713|69167439|FG002|Treatment Period (6 Months)|Non-compliance|0|||
37691135|NCT02143713|69167440|FG003|Treatment Period (6 Months)|Non-compliance|3|||
37691136|NCT02143713|69167437|FG000|Treatment Period (6 Months)|Other|3|||
37691137|NCT02143713|69167438|FG001|Treatment Period (6 Months)|Other|0|||
37691138|NCT02143713|69167439|FG002|Treatment Period (6 Months)|Other|3|||
37776479|NCT03253796|69313206|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
37776480|NCT03253796|69313207|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
37776481|NCT03253796|69313208|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
37776482|NCT03073733|69313226|FG000|Overall Study|Lost to Follow-up|1|||
37776483|NCT03073733|69313227|FG001|Overall Study|Lost to Follow-up|0|||
37776484|NCT03073733|69313228|FG002|Overall Study|Lost to Follow-up|0|||
37776485|NCT03073733|69313226|FG000|Overall Study|Physician Decision|0|||
37776486|NCT03073733|69313227|FG001|Overall Study|Physician Decision|1|||
37776487|NCT03073733|69313228|FG002|Overall Study|Physician Decision|0|||
37776488|NCT03073733|69313226|FG000|Overall Study|Withdrawal by Subject|0|||
37776489|NCT03073733|69313227|FG001|Overall Study|Withdrawal by Subject|0|||
37776490|NCT03073733|69313228|FG002|Overall Study|Withdrawal by Subject|1|||
37776491|NCT03029143|69313238|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
37776492|NCT03029143|69313239|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
37776493|NCT03029143|69313240|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
37776494|NCT03029143|69313238|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
37776495|NCT03029143|69313239|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
37776496|NCT03029143|69313240|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
37776497|NCT03029143|69313238|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
37776498|NCT03029143|69313239|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
37776499|NCT03029143|69313240|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
37776500|NCT03029143|69313238|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
37776501|NCT03029143|69313239|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
37863742|NCT01256411|69547297|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
37863743|NCT01256411|69547298|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
37863744|NCT01256411|69547299|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
37863745|NCT01256411|69547294|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
37863746|NCT01256411|69547295|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
37863747|NCT01256411|69547296|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
37863748|NCT01256411|69547297|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
37863749|NCT01256411|69547298|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
37863750|NCT01256411|69547299|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
37968785|NCT00528606|69655941|FG001|Overall Study|Other|0|||
37968786|NCT00621257|69655952|FG000|Overall Study|Lost to Follow-up|4|||
37776502|NCT03029143|69313240|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
37776503|NCT03029143|69313238|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
37863751|NCT01256411|69547294|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
37776504|NCT03029143|69313239|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
37776505|NCT03029143|69313240|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
37776506|NCT03029143|69313238|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
37776507|NCT03029143|69313239|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
37776508|NCT03029143|69313240|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
37776509|NCT03029143|69313238|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
37776510|NCT03029143|69313239|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
37776511|NCT03029143|69313240|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
37776512|NCT03029143|69313238|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
37776513|NCT03029143|69313239|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
37776514|NCT03029143|69313240|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
37776515|NCT03029143|69313238|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
37776516|NCT03029143|69313239|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
37776517|NCT03029143|69313240|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
37776518|NCT03029143|69313238|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
37776519|NCT03029143|69313239|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
37776520|NCT03029143|69313240|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
37776521|NCT03029143|69313238|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
37776522|NCT03029143|69313239|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
37776523|NCT03029143|69313240|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
37776524|NCT02971137|69313251|FG000|Overall Study|Lost to Follow-up|44|||
37776525|NCT02971137|69313252|FG001|Overall Study|Lost to Follow-up|56|||
37776526|NCT02953262|69313262|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
37776527|NCT02953262|69313263|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
37776528|NCT02953262|69313264|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
37776529|NCT02953262|69313265|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
37776530|NCT02763579|69313281|FG000|Global Period|Death|167|||
37776531|NCT02763579|69313282|FG001|Global Period|Death|151|||
37776532|NCT02763579|69313283|FG002|Global Period|Death|0|||
37776533|NCT02763579|69313284|FG003|Global Period|Death|0|||
37776534|NCT02763579|69313281|FG000|Global Period|Lost to Follow-up|2|||
37776535|NCT02763579|69313282|FG001|Global Period|Lost to Follow-up|4|||
37776536|NCT02763579|69313283|FG002|Global Period|Lost to Follow-up|0|||
37776537|NCT02763579|69313284|FG003|Global Period|Lost to Follow-up|0|||
37776538|NCT02763579|69313281|FG000|Global Period|Physician Decision|0|||
37776539|NCT02763579|69313282|FG001|Global Period|Physician Decision|2|||
37776540|NCT02763579|69313283|FG002|Global Period|Physician Decision|0|||
37776541|NCT02763579|69313284|FG003|Global Period|Physician Decision|0|||
37776542|NCT02763579|69313281|FG000|Global Period|Study Terminated By Sponsor|21|||
37776543|NCT02763579|69313282|FG001|Global Period|Study Terminated By Sponsor|26|||
37776544|NCT02763579|69313283|FG002|Global Period|Study Terminated By Sponsor|0|||
37776545|NCT02763579|69313284|FG003|Global Period|Study Terminated By Sponsor|0|||
37776546|NCT02763579|69313281|FG000|Global Period|Withdrawal by Subject|12|||
37776547|NCT02763579|69313282|FG001|Global Period|Withdrawal by Subject|18|||
37776548|NCT02763579|69313283|FG002|Global Period|Withdrawal by Subject|0|||
37776549|NCT02763579|69313284|FG003|Global Period|Withdrawal by Subject|0|||
37776550|NCT02763579|69313281|FG000|China Period|Death|0|||
37776551|NCT02763579|69313282|FG001|China Period|Death|0|||
37776552|NCT02763579|69313283|FG002|China Period|Death|46|||
37776553|NCT02763579|69313284|FG003|China Period|Death|48|||
37776554|NCT02763579|69313281|FG000|China Period|Lost to Follow-up|0|||
37776555|NCT02763579|69313282|FG001|China Period|Lost to Follow-up|0|||
37776556|NCT02763579|69313283|FG002|China Period|Lost to Follow-up|1|||
37776557|NCT02763579|69313284|FG003|China Period|Lost to Follow-up|1|||
37776558|NCT02763579|69313281|FG000|China Period|Physician Decision|0|||
37776559|NCT02763579|69313282|FG001|China Period|Physician Decision|0|||
37776560|NCT02763579|69313283|FG002|China Period|Physician Decision|0|||
37776561|NCT02763579|69313284|FG003|China Period|Physician Decision|1|||
37776562|NCT02763579|69313281|FG000|China Period|Study Terminated By Sponsor|0|||
37776563|NCT02763579|69313282|FG001|China Period|Study Terminated By Sponsor|0|||
37776564|NCT02763579|69313283|FG002|China Period|Study Terminated By Sponsor|3|||
37776565|NCT02763579|69313284|FG003|China Period|Study Terminated By Sponsor|4|||
37776566|NCT02763579|69313281|FG000|China Period|Withdrawal by Subject|0|||
37776567|NCT02763579|69313282|FG001|China Period|Withdrawal by Subject|0|||
37776568|NCT02763579|69313283|FG002|China Period|Withdrawal by Subject|3|||
37776569|NCT02763579|69313284|FG003|China Period|Withdrawal by Subject|3|||
37776570|NCT02623699|69313328|FG000|Part A (Up to 63 Days)|Consent Withdrawn|0|||
37776571|NCT02623699|69313329|FG001|Part A (Up to 63 Days)|Consent Withdrawn|1|||
37776572|NCT02623699|69313330|FG002|Part A (Up to 63 Days)|Consent Withdrawn|0|||
37776573|NCT02623699|69313331|FG003|Part A (Up to 63 Days)|Consent Withdrawn|0|||
37776574|NCT02623699|69313332|FG004|Part A (Up to 63 Days)|Consent Withdrawn|0|||
37776575|NCT02623699|69313333|FG005|Part A (Up to 63 Days)|Consent Withdrawn|0|||
37776576|NCT02623699|69313334|FG006|Part A (Up to 63 Days)|Consent Withdrawn|0|||
37776577|NCT02623699|69313335|FG007|Part A (Up to 63 Days)|Consent Withdrawn|0|||
37776578|NCT02623699|69313336|FG008|Part A (Up to 63 Days)|Consent Withdrawn|0|||
37776579|NCT02623699|69313337|FG009|Part A (Up to 63 Days)|Consent Withdrawn|0|||
37776580|NCT02623699|69313338|FG010|Part A (Up to 63 Days)|Consent Withdrawn|0|||
37776581|NCT02623699|69313339|FG011|Part A (Up to 63 Days)|Consent Withdrawn|0|||
37776582|NCT02623699|69313328|FG000|Part B (Up to 289 Days)|Lost to Follow-up|0|||
37776583|NCT02623699|69313329|FG001|Part B (Up to 289 Days)|Lost to Follow-up|0|||
37776584|NCT02623699|69313330|FG002|Part B (Up to 289 Days)|Lost to Follow-up|0|||
37776585|NCT02623699|69313331|FG003|Part B (Up to 289 Days)|Lost to Follow-up|0|||
37776586|NCT02623699|69313332|FG004|Part B (Up to 289 Days)|Lost to Follow-up|0|||
37776587|NCT02623699|69313333|FG005|Part B (Up to 289 Days)|Lost to Follow-up|0|||
37776588|NCT02623699|69313334|FG006|Part B (Up to 289 Days)|Lost to Follow-up|1|||
37968787|NCT00621257|69655953|FG001|Overall Study|Lost to Follow-up|0|||
37968788|NCT00621257|69655954|FG002|Overall Study|Lost to Follow-up|2|||
37968789|NCT00621257|69655955|FG003|Overall Study|Lost to Follow-up|4|||
37968790|NCT00621257|69655956|FG004|Overall Study|Lost to Follow-up|7|||
37968791|NCT00621257|69655952|FG000|Overall Study|Adverse Event|0|||
37968792|NCT00621257|69655953|FG001|Overall Study|Adverse Event|1|||
37968793|NCT00621257|69655954|FG002|Overall Study|Adverse Event|1|||
37968794|NCT00621257|69655955|FG003|Overall Study|Adverse Event|0|||
37968795|NCT00621257|69655956|FG004|Overall Study|Adverse Event|0|||
37968796|NCT00621257|69655952|FG000|Overall Study|Physician Decision|0|||
37968797|NCT00621257|69655953|FG001|Overall Study|Physician Decision|2|||
37776589|NCT02623699|69313335|FG007|Part B (Up to 289 Days)|Lost to Follow-up|0|||
37776590|NCT02623699|69313336|FG008|Part B (Up to 289 Days)|Lost to Follow-up|0|||
37776591|NCT02623699|69313337|FG009|Part B (Up to 289 Days)|Lost to Follow-up|0|||
37776592|NCT02623699|69313338|FG010|Part B (Up to 289 Days)|Lost to Follow-up|0|||
37776593|NCT02623699|69313339|FG011|Part B (Up to 289 Days)|Lost to Follow-up|0|||
37776594|NCT02623699|69313328|FG000|Part B (Up to 289 Days)|Consent Withdrawn|0|||
37776595|NCT02623699|69313329|FG001|Part B (Up to 289 Days)|Consent Withdrawn|0|||
37776596|NCT02623699|69313330|FG002|Part B (Up to 289 Days)|Consent Withdrawn|0|||
37776597|NCT02623699|69313331|FG003|Part B (Up to 289 Days)|Consent Withdrawn|0|||
37776598|NCT02623699|69313332|FG004|Part B (Up to 289 Days)|Consent Withdrawn|0|||
37776599|NCT02623699|69313333|FG005|Part B (Up to 289 Days)|Consent Withdrawn|1|||
37776600|NCT02623699|69313334|FG006|Part B (Up to 289 Days)|Consent Withdrawn|0|||
37776601|NCT02623699|69313335|FG007|Part B (Up to 289 Days)|Consent Withdrawn|0|||
37776602|NCT02623699|69313336|FG008|Part B (Up to 289 Days)|Consent Withdrawn|0|||
37776603|NCT02623699|69313337|FG009|Part B (Up to 289 Days)|Consent Withdrawn|0|||
37776604|NCT02623699|69313338|FG010|Part B (Up to 289 Days)|Consent Withdrawn|0|||
37776605|NCT02623699|69313339|FG011|Part B (Up to 289 Days)|Consent Withdrawn|0|||
37776606|NCT02623699|69313328|FG000|Part B (Up to 289 Days)|Death|0|||
37776607|NCT02623699|69313329|FG001|Part B (Up to 289 Days)|Death|0|||
37776608|NCT02623699|69313330|FG002|Part B (Up to 289 Days)|Death|0|||
37776609|NCT02623699|69313331|FG003|Part B (Up to 289 Days)|Death|0|||
37776610|NCT02623699|69313332|FG004|Part B (Up to 289 Days)|Death|0|||
37776611|NCT02623699|69313333|FG005|Part B (Up to 289 Days)|Death|1|||
37968798|NCT00621257|69655954|FG002|Overall Study|Physician Decision|0|||
37968799|NCT00621257|69655955|FG003|Overall Study|Physician Decision|1|||
37691139|NCT02143713|69167440|FG003|Treatment Period (6 Months)|Other|2|||
37691140|NCT02143713|69167437|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
37691141|NCT02143713|69167438|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
37691142|NCT02143713|69167439|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
37691143|NCT02143713|69167440|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
37776612|NCT02623699|69313334|FG006|Part B (Up to 289 Days)|Death|1|||
37968800|NCT00621257|69655956|FG004|Overall Study|Physician Decision|1|||
37691144|NCT02143713|69167437|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
37691145|NCT02143713|69167438|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
37691146|NCT02143713|69167439|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
37691147|NCT02143713|69167440|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
37968801|NCT00621257|69655952|FG000|Overall Study|Withdrawal by Subject|0|||
37968802|NCT00621257|69655953|FG001|Overall Study|Withdrawal by Subject|0|||
37776613|NCT02623699|69313335|FG007|Part B (Up to 289 Days)|Death|0|||
37776614|NCT02623699|69313336|FG008|Part B (Up to 289 Days)|Death|1|||
37776615|NCT02623699|69313337|FG009|Part B (Up to 289 Days)|Death|0|||
37776616|NCT02623699|69313338|FG010|Part B (Up to 289 Days)|Death|0|||
37776617|NCT02623699|69313339|FG011|Part B (Up to 289 Days)|Death|0|||
37776618|NCT02623699|69313328|FG000|Part C (Up to 236 Days)|Adverse Event|0|||
37776619|NCT02623699|69313329|FG001|Part C (Up to 236 Days)|Adverse Event|0|||
37776620|NCT02623699|69313330|FG002|Part C (Up to 236 Days)|Adverse Event|0|||
37776621|NCT02623699|69313331|FG003|Part C (Up to 236 Days)|Adverse Event|0|||
37776622|NCT02623699|69313332|FG004|Part C (Up to 236 Days)|Adverse Event|0|||
37776623|NCT02623699|69313333|FG005|Part C (Up to 236 Days)|Adverse Event|0|||
37776624|NCT02623699|69313334|FG006|Part C (Up to 236 Days)|Adverse Event|0|||
37776625|NCT02623699|69313335|FG007|Part C (Up to 236 Days)|Adverse Event|0|||
37776626|NCT02623699|69313336|FG008|Part C (Up to 236 Days)|Adverse Event|0|||
37776627|NCT02623699|69313337|FG009|Part C (Up to 236 Days)|Adverse Event|0|||
37776628|NCT02623699|69313338|FG010|Part C (Up to 236 Days)|Adverse Event|0|||
37776629|NCT02623699|69313339|FG011|Part C (Up to 236 Days)|Adverse Event|2|||
37776630|NCT02623699|69313328|FG000|Part C (Up to 236 Days)|Consent Withdrawn|0|||
37776631|NCT02623699|69313329|FG001|Part C (Up to 236 Days)|Consent Withdrawn|0|||
37776632|NCT02623699|69313330|FG002|Part C (Up to 236 Days)|Consent Withdrawn|0|||
37691148|NCT02143713|69167437|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
37691149|NCT02143713|69167438|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
37691150|NCT02143713|69167439|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
37691151|NCT02143713|69167440|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
37691152|NCT02143713|69167437|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
37691153|NCT02143713|69167438|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
37691154|NCT02143713|69167439|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
37691155|NCT02143713|69167440|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
37776633|NCT02623699|69313331|FG003|Part C (Up to 236 Days)|Consent Withdrawn|0|||
37691156|NCT02143713|69167437|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
37691157|NCT02143713|69167438|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
37691158|NCT02143713|69167439|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
37691159|NCT02143713|69167440|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
37776634|NCT02623699|69313332|FG004|Part C (Up to 236 Days)|Consent Withdrawn|0|||
37776635|NCT02623699|69313333|FG005|Part C (Up to 236 Days)|Consent Withdrawn|0|||
37776636|NCT02623699|69313334|FG006|Part C (Up to 236 Days)|Consent Withdrawn|0|||
37776637|NCT02623699|69313335|FG007|Part C (Up to 236 Days)|Consent Withdrawn|0|||
37776638|NCT02623699|69313336|FG008|Part C (Up to 236 Days)|Consent Withdrawn|0|||
37776639|NCT02623699|69313337|FG009|Part C (Up to 236 Days)|Consent Withdrawn|0|||
37776640|NCT02623699|69313338|FG010|Part C (Up to 236 Days)|Consent Withdrawn|1|||
37776641|NCT02623699|69313339|FG011|Part C (Up to 236 Days)|Consent Withdrawn|2|||
37776642|NCT02623699|69313328|FG000|Part C (Up to 236 Days)|Death|0|||
37776643|NCT02623699|69313329|FG001|Part C (Up to 236 Days)|Death|0|||
37776644|NCT02623699|69313330|FG002|Part C (Up to 236 Days)|Death|0|||
37776645|NCT02623699|69313331|FG003|Part C (Up to 236 Days)|Death|0|||
37776646|NCT02623699|69313332|FG004|Part C (Up to 236 Days)|Death|0|||
37776647|NCT02623699|69313333|FG005|Part C (Up to 236 Days)|Death|0|||
37776648|NCT02623699|69313334|FG006|Part C (Up to 236 Days)|Death|0|||
37776649|NCT02623699|69313335|FG007|Part C (Up to 236 Days)|Death|0|||
37776650|NCT02623699|69313336|FG008|Part C (Up to 236 Days)|Death|0|||
37776651|NCT02623699|69313337|FG009|Part C (Up to 236 Days)|Death|0|||
37776652|NCT02623699|69313338|FG010|Part C (Up to 236 Days)|Death|0|||
37776653|NCT02623699|69313339|FG011|Part C (Up to 236 Days)|Death|1|||
37776654|NCT02623699|69313328|FG000|Part C (Up to 236 Days)|Disease Progression|0|||
37776655|NCT02623699|69313329|FG001|Part C (Up to 236 Days)|Disease Progression|0|||
37776656|NCT02623699|69313330|FG002|Part C (Up to 236 Days)|Disease Progression|0|||
37776657|NCT02623699|69313331|FG003|Part C (Up to 236 Days)|Disease Progression|0|||
37776658|NCT02623699|69313332|FG004|Part C (Up to 236 Days)|Disease Progression|0|||
37776659|NCT02623699|69313333|FG005|Part C (Up to 236 Days)|Disease Progression|0|||
37776660|NCT02623699|69313334|FG006|Part C (Up to 236 Days)|Disease Progression|0|||
37776661|NCT02623699|69313335|FG007|Part C (Up to 236 Days)|Disease Progression|0|||
37776662|NCT02623699|69313336|FG008|Part C (Up to 236 Days)|Disease Progression|0|||
37776663|NCT02623699|69313337|FG009|Part C (Up to 236 Days)|Disease Progression|0|||
37776664|NCT02623699|69313338|FG010|Part C (Up to 236 Days)|Disease Progression|2|||
37776665|NCT02623699|69313339|FG011|Part C (Up to 236 Days)|Disease Progression|3|||
37776666|NCT02501642|69313380|FG000|Overall Study|Lost to Follow-up|7|||
37776667|NCT02501642|69313381|FG001|Overall Study|Lost to Follow-up|11|||
37776668|NCT02475954|69313389|FG000|Overall Study|Withdrawal by Subject|2|||
37776669|NCT02475954|69313390|FG001|Overall Study|Withdrawal by Subject|2|||
37776670|NCT02475954|69313389|FG000|Overall Study|Lost to Follow-up|11|||
37776671|NCT02475954|69313390|FG001|Overall Study|Lost to Follow-up|9|||
37776672|NCT02475954|69313389|FG000|Overall Study|Death|1|||
37776673|NCT02475954|69313390|FG001|Overall Study|Death|1|||
37776674|NCT02459587|69313399|FG000|3-Month Follow-up Assessment|Death|0|||
37776675|NCT02459587|69313400|FG001|3-Month Follow-up Assessment|Death|2|||
37776676|NCT02459587|69313399|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
37776677|NCT02459587|69313400|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
37776678|NCT02459587|69313399|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
37776679|NCT02459587|69313400|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
37776680|NCT02459587|69313399|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
37776681|NCT02459587|69313400|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
37776682|NCT02459587|69313399|FG000|6-month Follow-up Assessment|Death|2|||
37776683|NCT02459587|69313400|FG001|6-month Follow-up Assessment|Death|1|||
37776684|NCT02459587|69313399|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
37776685|NCT02459587|69313400|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
37776686|NCT02459587|69313399|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
37776687|NCT02459587|69313400|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
37776688|NCT02459587|69313399|FG000|12-month Follow-up Assessment|Death|2|||
37776689|NCT02459587|69313400|FG001|12-month Follow-up Assessment|Death|0|||
37776690|NCT02459587|69313399|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
37776691|NCT02459587|69313400|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
37776692|NCT02459587|69313399|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
37776693|NCT02459587|69313400|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
37776694|NCT02459587|69313399|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
37776695|NCT02459587|69313400|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
37776696|NCT02281084|69313411|FG000|Overall Study|Adverse Event|1|||
37776697|NCT02281084|69313412|FG001|Overall Study|Adverse Event|0|||
37776698|NCT02281084|69313413|FG002|Overall Study|Adverse Event|0|||
37776699|NCT02281084|69313414|FG003|Overall Study|Adverse Event|0|||
37776700|NCT02281084|69313411|FG000|Overall Study|Withdrawal by Subject|1|||
37776701|NCT02281084|69313412|FG001|Overall Study|Withdrawal by Subject|2|||
37776702|NCT02281084|69313413|FG002|Overall Study|Withdrawal by Subject|0|||
37776703|NCT02281084|69313414|FG003|Overall Study|Withdrawal by Subject|0|||
37776704|NCT02281084|69313411|FG000|Overall Study|Death|20|||
37776705|NCT02281084|69313412|FG001|Overall Study|Death|16|||
37776706|NCT02281084|69313413|FG002|Overall Study|Death|3|||
37776707|NCT02281084|69313414|FG003|Overall Study|Death|5|||
37776708|NCT02281084|69313411|FG000|Overall Study|Physician Decision|0|||
37776709|NCT02281084|69313412|FG001|Overall Study|Physician Decision|0|||
37776710|NCT02281084|69313413|FG002|Overall Study|Physician Decision|1|||
37776711|NCT02281084|69313414|FG003|Overall Study|Physician Decision|0|||
37776712|NCT01966120|69313435|FG000|Overall Study|Withdrawal by Subject|0|||
37776713|NCT01966120|69313436|FG001|Overall Study|Withdrawal by Subject|5|||
37776714|NCT01966120|69313435|FG000|Overall Study|Lost to Follow-up|1|||
37776715|NCT01966120|69313436|FG001|Overall Study|Lost to Follow-up|1|||
37776716|NCT01399736|69313479|FG000|Overall Study|Withdrawal by Subject|4|||
37776717|NCT01399736|69313480|FG001|Overall Study|Withdrawal by Subject|2|||
37776718|NCT01399736|69313479|FG000|Overall Study|Lost to Follow-up|0|||
37776719|NCT01399736|69313480|FG001|Overall Study|Lost to Follow-up|2|||
37776720|NCT04372927|69313610|FG000|Overall Study|Death|1|||
37776721|NCT01381874|69313617|FG000|Overall Study|Lost to Follow-up|1|||
37776722|NCT01381874|69313618|FG001|Overall Study|Lost to Follow-up|1|||
37776723|NCT01381874|69313619|FG002|Overall Study|Lost to Follow-up|0|||
37776724|NCT01381874|69313617|FG000|Overall Study|Withdrawal by Subject|9|||
37776725|NCT01381874|69313618|FG001|Overall Study|Withdrawal by Subject|10|||
37776726|NCT01381874|69313619|FG002|Overall Study|Withdrawal by Subject|9|||
37776727|NCT01381874|69313617|FG000|Overall Study|Other|67|||
37776728|NCT01381874|69313618|FG001|Overall Study|Other|52|||
37776729|NCT01381874|69313619|FG002|Overall Study|Other|67|||
37776730|NCT01399190|69313627|FG000|Overall Study|Not Eligible for Final Analysis|5|||
37776731|NCT01399190|69313627|FG000|Overall Study|Adverse Event|8|||
37776732|NCT01399190|69313627|FG000|Overall Study|Participant's Request|5|||
37776733|NCT01399190|69313627|FG000|Overall Study|Physician Decision|2|||
37776734|NCT01381718|69313645|FG000|Overall Study|Withdrawal by Subject|2|||
37776735|NCT01381718|69313646|FG001|Overall Study|Withdrawal by Subject|5|||
37776736|NCT01381718|69313645|FG000|Overall Study|Lost to Follow-up|3|||
37776737|NCT01381718|69313646|FG001|Overall Study|Lost to Follow-up|5|||
37776738|NCT01381718|69313645|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
37776739|NCT01381718|69313646|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
37776740|NCT01398956|69313665|FG000|Overall Study|Withdrawal by Subject|4|||
37776741|NCT01398956|69313665|FG000|Overall Study|AE, non-serious non-fatal|4|||
37776742|NCT01398956|69313665|FG000|Overall Study|Withdrawal Criteria No.3|1|||
37776743|NCT01398956|69313665|FG000|Overall Study|Subject moved a long distance|1|||
37776744|NCT01381562|69313691|FG000|Overall Study|Adverse Event|0|||
37776745|NCT01381562|69313692|FG001|Overall Study|Adverse Event|1|||
37776746|NCT01381562|69313693|FG002|Overall Study|Adverse Event|0|||
37776747|NCT01381016|69313716|FG000|Overall Study|Lost to Follow-up|1|||
37776748|NCT01381016|69313717|FG001|Overall Study|Lost to Follow-up|1|||
37776749|NCT01381016|69313716|FG000|Overall Study|Screen Failure|2|||
37776750|NCT01381016|69313717|FG001|Overall Study|Screen Failure|2|||
37776751|NCT01381016|69313716|FG000|Overall Study|Withdrawal by Subject|0|||
37776752|NCT01381016|69313717|FG001|Overall Study|Withdrawal by Subject|1|||
37776753|NCT01381016|69313716|FG000|Overall Study|Physician Decision|0|||
37776754|NCT01381016|69313717|FG001|Overall Study|Physician Decision|2|||
37776755|NCT01398410|69313744|FG000|Overall Study|Adverse Event|12|||
37776756|NCT01398410|69313745|FG001|Overall Study|Adverse Event|16|||
37776757|NCT01398410|69313744|FG000|Overall Study|Participants Choice|8|||
37776758|NCT01398410|69313745|FG001|Overall Study|Participants Choice|11|||
37776759|NCT01398410|69313744|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
37776760|NCT01398410|69313745|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
37776761|NCT01398410|69313744|FG000|Overall Study|Other|36|||
37776762|NCT01398410|69313745|FG001|Overall Study|Other|29|||
37776763|NCT01380782|69313811|FG000|Overall Study|Adverse Event|0|||
37776764|NCT01380782|69313812|FG001|Overall Study|Adverse Event|1|||
37776765|NCT01380782|69313813|FG002|Overall Study|Adverse Event|0|||
37776766|NCT01380782|69313814|FG003|Overall Study|Adverse Event|0|||
37776767|NCT01380782|69313811|FG000|Overall Study|Death|1|||
37776768|NCT01380782|69313812|FG001|Overall Study|Death|0|||
37776769|NCT01380782|69313813|FG002|Overall Study|Death|0|||
37776770|NCT01380782|69313814|FG003|Overall Study|Death|0|||
37776771|NCT01380782|69313811|FG000|Overall Study|Lack of Efficacy|10|||
37776772|NCT01380782|69313812|FG001|Overall Study|Lack of Efficacy|9|||
37776773|NCT01380782|69313813|FG002|Overall Study|Lack of Efficacy|10|||
37776774|NCT01380782|69313814|FG003|Overall Study|Lack of Efficacy|3|||
37776775|NCT01380782|69313811|FG000|Overall Study|Physician Decision|1|||
37776776|NCT01380782|69313812|FG001|Overall Study|Physician Decision|0|||
37776777|NCT01380782|69313813|FG002|Overall Study|Physician Decision|0|||
37776778|NCT01380782|69313814|FG003|Overall Study|Physician Decision|0|||
37776779|NCT01380782|69313811|FG000|Overall Study|Withdrawal by Subject|0|||
37776780|NCT01380782|69313812|FG001|Overall Study|Withdrawal by Subject|0|||
37776781|NCT01380782|69313813|FG002|Overall Study|Withdrawal by Subject|1|||
37776782|NCT01380782|69313814|FG003|Overall Study|Withdrawal by Subject|1|||
37776783|NCT01398176|69313828|FG000|Overall Study|Lost to Follow-up|1|||
37776784|NCT01398176|69313829|FG001|Overall Study|Lost to Follow-up|3|||
37776785|NCT01398176|69313828|FG000|Overall Study|Physician Decision|2|||
37776786|NCT01398176|69313829|FG001|Overall Study|Physician Decision|3|||
37776787|NCT01397786|69313882|FG000|Phase A|Lost to Follow-up|0|||
37776788|NCT01397786|69313883|FG001|Phase A|Lost to Follow-up|0|||
37776789|NCT01397786|69313884|FG002|Phase A|Lost to Follow-up|6|||
37776790|NCT01397786|69313882|FG000|Phase A|Adverse Event|0|||
37776791|NCT01397786|69313883|FG001|Phase A|Adverse Event|0|||
37776792|NCT01397786|69313884|FG002|Phase A|Adverse Event|8|||
37776793|NCT01397786|69313882|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
37776794|NCT01397786|69313883|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
37776795|NCT01397786|69313884|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
37776796|NCT01397786|69313882|FG000|Phase A|Physician Decision|0|||
37776797|NCT01397786|69313883|FG001|Phase A|Physician Decision|0|||
37776798|NCT01397786|69313884|FG002|Phase A|Physician Decision|1|||
37776799|NCT01397786|69313882|FG000|Phase A|Withdrawal by Subject|0|||
37776800|NCT01397786|69313883|FG001|Phase A|Withdrawal by Subject|0|||
37776801|NCT01397786|69313884|FG002|Phase A|Withdrawal by Subject|5|||
37776802|NCT01397786|69313882|FG000|Phase A|Lack of Efficacy|0|||
37776803|NCT01397786|69313883|FG001|Phase A|Lack of Efficacy|0|||
37776804|NCT01397786|69313884|FG002|Phase A|Lack of Efficacy|1|||
37776805|NCT01397786|69313882|FG000|Phase B|Lost to Follow-up|22|||
37776806|NCT01397786|69313883|FG001|Phase B|Lost to Follow-up|12|||
37776807|NCT01397786|69313884|FG002|Phase B|Lost to Follow-up|22|||
37776808|NCT01397786|69313882|FG000|Phase B|Adverse Event|109|||
37776809|NCT01397786|69313883|FG001|Phase B|Adverse Event|23|||
37776810|NCT01397786|69313884|FG002|Phase B|Adverse Event|27|||
37776811|NCT01397786|69313882|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
37776812|NCT01397786|69313883|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
37776813|NCT01397786|69313884|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
37776814|NCT01397786|69313882|FG000|Phase B|Physician Decision|9|||
37776815|NCT01397786|69313883|FG001|Phase B|Physician Decision|1|||
37776816|NCT01397786|69313884|FG002|Phase B|Physician Decision|3|||
37776817|NCT01397786|69313882|FG000|Phase B|Withdrawal by Subject|102|||
37776818|NCT01397786|69313883|FG001|Phase B|Withdrawal by Subject|45|||
37776819|NCT01397786|69313884|FG002|Phase B|Withdrawal by Subject|30|||
37776820|NCT01397786|69313882|FG000|Phase B|Protocol Deviation|1|||
37776821|NCT01397786|69313883|FG001|Phase B|Protocol Deviation|2|||
37776822|NCT01397786|69313884|FG002|Phase B|Protocol Deviation|4|||
37776823|NCT01397786|69313882|FG000|Phase B|Lack of Efficacy|22|||
37776824|NCT01397786|69313883|FG001|Phase B|Lack of Efficacy|7|||
37776825|NCT01397786|69313884|FG002|Phase B|Lack of Efficacy|14|||
37776826|NCT01397162|69313946|FG000|Overall Study|Adverse Event|4|||
37776827|NCT01397162|69313947|FG001|Overall Study|Adverse Event|0|||
37776828|NCT01397162|69313948|FG002|Overall Study|Adverse Event|0|||
37776829|NCT01397162|69313949|FG003|Overall Study|Adverse Event|0|||
37776830|NCT01397162|69313950|FG004|Overall Study|Adverse Event|0|||
37776831|NCT01397162|69313946|FG000|Overall Study|Not yet defined|3|||
37776832|NCT01397162|69313947|FG001|Overall Study|Not yet defined|4|||
37776833|NCT01397162|69313948|FG002|Overall Study|Not yet defined|3|||
37776834|NCT01397162|69313949|FG003|Overall Study|Not yet defined|5|||
37776835|NCT01397162|69313950|FG004|Overall Study|Not yet defined|3|||
37776836|NCT01397084|69313983|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
37776837|NCT01397084|69313983|FG000|Overall Study|Protocol Violation|2|||
37776838|NCT01397084|69313983|FG000|Overall Study|Adverse Event|2|||
37776839|NCT01397084|69313983|FG000|Overall Study|Withdrawal by Subject|1|||
37776840|NCT01397084|69313983|FG000|Overall Study|Lost to Follow-up|1|||
37776841|NCT01397084|69313983|FG000|Overall Study|Used other proton pump inhibitor|1|||
37776842|NCT01396148|69314023|FG000|Overall Study|Patient Decision|1|||
37776843|NCT01396070|69314056|FG000|Overall Study|Withdrawal by Subject|2|||
37776844|NCT01396070|69314056|FG000|Overall Study|Death|2|||
37776845|NCT01396070|69314056|FG000|Overall Study|Adverse Event|8|||
37776846|NCT01396070|69314056|FG000|Overall Study|Physician Decision|3|||
37776847|NCT01396070|69314056|FG000|Overall Study|Lack of Efficacy|4|||
37776848|NCT01395914|69314073|FG000|Overall Study|Unrelated to study drug AE|6|||
37776849|NCT01395914|69314074|FG001|Overall Study|Unrelated to study drug AE|1|||
37776850|NCT01395914|69314073|FG000|Overall Study|Death|23|||
37776851|NCT01395914|69314074|FG001|Overall Study|Death|17|||
37776852|NCT01395914|69314073|FG000|Overall Study|Other|9|||
37776853|NCT01395914|69314074|FG001|Overall Study|Other|3|||
37776854|NCT01395914|69314073|FG000|Overall Study|Withdrawal by patient|27|||
37776855|NCT01395914|69314074|FG001|Overall Study|Withdrawal by patient|14|||
37776856|NCT01395914|69314073|FG000|Overall Study|Study drug-related AE|1|||
37776857|NCT01395914|69314074|FG001|Overall Study|Study drug-related AE|0|||
37776858|NCT01395914|69314073|FG000|Overall Study|Lost to Follow-up|6|||
37776859|NCT01395914|69314074|FG001|Overall Study|Lost to Follow-up|2|||
37776860|NCT01395758|69314332|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
37776861|NCT01395758|69314333|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
37776862|NCT01395758|69314334|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
37776863|NCT01395524|69314392|FG000|Overall Study|Non-compliance with study schedule|1|||
37776864|NCT01395524|69314393|FG001|Overall Study|Non-compliance with study schedule|0|||
37776865|NCT01395524|69314394|FG002|Overall Study|Non-compliance with study schedule|1|||
37776866|NCT01395524|69314392|FG000|Overall Study|Lost to Follow-up|3|||
37776867|NCT01395524|69314393|FG001|Overall Study|Lost to Follow-up|1|||
37776868|NCT01395524|69314394|FG002|Overall Study|Lost to Follow-up|1|||
37776869|NCT01395524|69314392|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
37776870|NCT01395524|69314393|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
37776871|NCT01395524|69314394|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
37776872|NCT01395524|69314392|FG000|Overall Study|Severe noncompliance with protocol|1|||
37776873|NCT01395524|69314393|FG001|Overall Study|Severe noncompliance with protocol|0|||
37776874|NCT01395524|69314394|FG002|Overall Study|Severe noncompliance with protocol|0|||
37776875|NCT01395524|69314392|FG000|Overall Study|Adverse Event|4|||
37776876|NCT01395524|69314393|FG001|Overall Study|Adverse Event|4|||
37776877|NCT01395524|69314394|FG002|Overall Study|Adverse Event|3|||
37776878|NCT01395524|69314392|FG000|Overall Study|Death|1|||
37776879|NCT01395524|69314393|FG001|Overall Study|Death|0|||
37776880|NCT01395524|69314394|FG002|Overall Study|Death|0|||
37776881|NCT01395524|69314392|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
37776882|NCT01395524|69314393|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
37776883|NCT01395524|69314394|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
37776884|NCT01395524|69314392|FG000|Overall Study|Withdrawal by Subject|4|||
37776885|NCT01395524|69314393|FG001|Overall Study|Withdrawal by Subject|8|||
37776886|NCT01395524|69314394|FG002|Overall Study|Withdrawal by Subject|8|||
37776887|NCT01395524|69314392|FG000|Overall Study|Did not receive treatment|1|||
37776888|NCT01395524|69314393|FG001|Overall Study|Did not receive treatment|1|||
37776889|NCT01395524|69314394|FG002|Overall Study|Did not receive treatment|3|||
37776890|NCT01395524|69314392|FG000|Overall Study|Subject had spinal surgery|0|||
37776891|NCT01395524|69314393|FG001|Overall Study|Subject had spinal surgery|0|||
37776892|NCT01395524|69314394|FG002|Overall Study|Subject had spinal surgery|1|||
37776893|NCT01395368|69314402|FG000|Overall Study|Physician Decision|14|||
37691160|NCT02143713|69167437|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
37691161|NCT02143713|69167438|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
37691162|NCT02143713|69167439|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
37691163|NCT02143713|69167440|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
37691164|NCT02143713|69167437|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
37691165|NCT02143713|69167438|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
37691166|NCT02143713|69167439|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
37691167|NCT02143713|69167440|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
37691168|NCT02143713|69167437|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
37691169|NCT02143713|69167438|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
37776894|NCT01395368|69314402|FG000|Overall Study|Withdrawal by Subject|2|||
37776895|NCT01394978|69314409|FG000|Overall Study|Withdrawal by Subject|2|||
37776896|NCT01394978|69314410|FG001|Overall Study|Withdrawal by Subject|4|||
37776897|NCT01394978|69314409|FG000|Overall Study|Lost to Follow-up|13|||
37776898|NCT01394978|69314410|FG001|Overall Study|Lost to Follow-up|20|||
37776899|NCT01394978|69314409|FG000|Overall Study|Death|6|||
37776900|NCT01394978|69314410|FG001|Overall Study|Death|7|||
37776901|NCT01394276|69314417|FG000|Overall Study|Related Adverse event (AEs)|15|||
37776902|NCT01394276|69314417|FG000|Overall Study|Not related AEs|9|||
37776903|NCT01394276|69314417|FG000|Overall Study|Remission of disease|2|||
37776904|NCT01394276|69314417|FG000|Overall Study|Insufficient therapeutic effect|17|||
37776905|NCT01394276|69314417|FG000|Overall Study|Insufficient compliance|9|||
37776906|NCT01394276|69314417|FG000|Overall Study|Lost to Follow-up|5|||
37776907|NCT01394276|69314417|FG000|Overall Study|Participant moved to another site|1|||
37776908|NCT01394276|69314417|FG000|Overall Study|Pregnancy|1|||
37776909|NCT01394276|69314417|FG000|Overall Study|unavailability of drug at the Hospital|2|||
37776910|NCT01394276|69314417|FG000|Overall Study|Symptoms of concurrent diseases|1|||
37776911|NCT00211172|69314517|FG000|Overall Study|Died or lost health plan eligibility|39|||
37776912|NCT00211172|69314518|FG001|Overall Study|Died or lost health plan eligibility|32|||
37776913|NCT00210626|69314569|FG000|Overall Study|Adverse Event|1|||
37776914|NCT00210626|69314570|FG001|Overall Study|Adverse Event|2|||
37776915|NCT00210626|69314569|FG000|Overall Study|Protocol Violation|1|||
37776916|NCT00210626|69314570|FG001|Overall Study|Protocol Violation|5|||
37776917|NCT00210626|69314569|FG000|Overall Study|Lost to Follow-up|11|||
37776918|NCT00210626|69314570|FG001|Overall Study|Lost to Follow-up|11|||
37776919|NCT00210626|69314569|FG000|Overall Study|Death|1|||
37776920|NCT00210626|69314570|FG001|Overall Study|Death|0|||
37776921|NCT00210626|69314569|FG000|Overall Study|Withdrawal by Subject|29|||
37776922|NCT00210626|69314570|FG001|Overall Study|Withdrawal by Subject|20|||
37776923|NCT00210626|69314569|FG000|Overall Study|Physician Decision|0|||
37776924|NCT00210626|69314570|FG001|Overall Study|Physician Decision|2|||
37776925|NCT00210626|69314569|FG000|Overall Study|Sponser Request|1|||
37776926|NCT00210626|69314570|FG001|Overall Study|Sponser Request|0|||
37776927|NCT00210626|69314569|FG000|Overall Study|Other|4|||
37776928|NCT00210626|69314570|FG001|Overall Study|Other|5|||
37776929|NCT00217022|69314592|FG000|Overall Study|Withdrawal by Subject|1|||
37776930|NCT00217022|69314593|FG001|Overall Study|Withdrawal by Subject|1|||
37776931|NCT00219284|69314940|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
37776932|NCT00219284|69314941|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
37776933|NCT00219284|69314940|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
37776934|NCT00219284|69314941|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
37776935|NCT00219284|69314940|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
37776936|NCT00219284|69314941|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
37776937|NCT00219284|69314940|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
37776938|NCT00219284|69314941|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
37776939|NCT00219284|69314940|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
37776940|NCT00219284|69314941|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
37776941|NCT00219284|69314940|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
37776942|NCT00219284|69314941|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
37776943|NCT00219284|69314940|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
37776944|NCT00219284|69314941|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
37776945|NCT00219284|69314940|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
37776946|NCT00219284|69314941|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
37776947|NCT00219284|69314940|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
37776948|NCT00219284|69314941|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
37776949|NCT00216476|69315080|FG000|Overall Study|Withdrawal by Subject|59|||
37776950|NCT00216476|69315081|FG001|Overall Study|Withdrawal by Subject|72|||
37776951|NCT00216476|69315082|FG002|Overall Study|Withdrawal by Subject|9|||
37776952|NCT00216476|69315080|FG000|Overall Study|Lost to Follow-up|10|||
37776953|NCT00216476|69315081|FG001|Overall Study|Lost to Follow-up|9|||
37776954|NCT00216476|69315082|FG002|Overall Study|Lost to Follow-up|1|||
37776955|NCT00216476|69315080|FG000|Overall Study|Adverse Event|6|||
37776956|NCT00216476|69315081|FG001|Overall Study|Adverse Event|10|||
37776957|NCT00216476|69315082|FG002|Overall Study|Adverse Event|1|||
37776958|NCT00216476|69315080|FG000|Overall Study|Lack of Efficacy|4|||
37776959|NCT00216476|69315081|FG001|Overall Study|Lack of Efficacy|3|||
37776960|NCT00216476|69315082|FG002|Overall Study|Lack of Efficacy|0|||
37776961|NCT00216476|69315080|FG000|Overall Study|Death|2|||
37776962|NCT00216476|69315081|FG001|Overall Study|Death|0|||
37776963|NCT00216476|69315082|FG002|Overall Study|Death|0|||
37776964|NCT00216476|69315080|FG000|Overall Study|Pregnancy|0|||
37776965|NCT00216476|69315081|FG001|Overall Study|Pregnancy|1|||
37776966|NCT00216476|69315082|FG002|Overall Study|Pregnancy|1|||
37776967|NCT00216476|69315080|FG000|Overall Study|Other|0|||
37776968|NCT00216476|69315081|FG001|Overall Study|Other|0|||
37776969|NCT00216476|69315082|FG002|Overall Study|Other|1|||
37968803|NCT00621257|69655954|FG002|Overall Study|Withdrawal by Subject|0|||
37968804|NCT00621257|69655955|FG003|Overall Study|Withdrawal by Subject|1|||
37968805|NCT00621257|69655956|FG004|Overall Study|Withdrawal by Subject|1|||
37968806|NCT00528840|69655968|FG000|Overall Study|Lost to Follow-up|10|||
37968807|NCT00528840|69655968|FG000|Overall Study|Adverse Event|1|||
37968808|NCT00528840|69655968|FG000|Overall Study|Withdrawal by Subject|17|||
37968809|NCT00528840|69655968|FG000|Overall Study|Death|2|||
37968810|NCT00528840|69655968|FG000|Overall Study|Administrative Reasons|1|||
37968811|NCT00528840|69655968|FG000|Overall Study|Other|2|||
37968812|NCT00528528|69655976|FG000|Overall Study|Lost to Follow-up|0|||
37968813|NCT00528528|69655977|FG001|Overall Study|Lost to Follow-up|0|||
37968814|NCT00528528|69655978|FG002|Overall Study|Lost to Follow-up|1|||
37968815|NCT00528528|69655979|FG003|Overall Study|Lost to Follow-up|1|||
37968816|NCT00528528|69655976|FG000|Overall Study|Ineligible to continue the trial|0|||
37968817|NCT00528528|69655977|FG001|Overall Study|Ineligible to continue the trial|0|||
37968818|NCT00528528|69655978|FG002|Overall Study|Ineligible to continue the trial|0|||
37968819|NCT00528528|69655979|FG003|Overall Study|Ineligible to continue the trial|1|||
37968820|NCT00528528|69655976|FG000|Overall Study|Other|0|||
37968821|NCT00528528|69655977|FG001|Overall Study|Other|1|||
37968822|NCT00528528|69655978|FG002|Overall Study|Other|0|||
37968823|NCT00528528|69655979|FG003|Overall Study|Other|0|||
37968824|NCT00528528|69655976|FG000|Overall Study|Withdrawal by Subject|3|||
37968825|NCT00528528|69655977|FG001|Overall Study|Withdrawal by Subject|2|||
37968826|NCT00528528|69655978|FG002|Overall Study|Withdrawal by Subject|1|||
37968827|NCT00528528|69655979|FG003|Overall Study|Withdrawal by Subject|1|||
37968828|NCT00528528|69655976|FG000|Overall Study|Ongoing participant|0|||
37968829|NCT00528528|69655977|FG001|Overall Study|Ongoing participant|0|||
37968830|NCT00528528|69655978|FG002|Overall Study|Ongoing participant|1|||
37968831|NCT00528528|69655979|FG003|Overall Study|Ongoing participant|0|||
37968832|NCT00620555|69655991|FG000|Overall Study|Adverse Event|4|||
37968833|NCT00620555|69655991|FG000|Overall Study|Protocol Violation|2|||
37968834|NCT00620555|69655991|FG000|Overall Study|Lack of Efficacy|12|||
37968835|NCT00620555|69655991|FG000|Overall Study|Withdrawal by Subject|1|||
37968836|NCT00620555|69655991|FG000|Overall Study|Choice of other treatment|1|||
37968837|NCT00620555|69655991|FG000|Overall Study|Visit failure against planned|1|||
37968838|NCT00529386|69655995|FG000|Overall Study|Lost to Follow-up|1|||
37968839|NCT03875118|69656001|FG000|Overall Study|Withdrawal by Subject|4|||
37968840|NCT03875118|69656002|FG001|Overall Study|Withdrawal by Subject|4|||
37776970|NCT00216476|69315080|FG000|Overall Study|Refuses Injection|11|||
37776971|NCT00216476|69315081|FG001|Overall Study|Refuses Injection|0|||
37776972|NCT00216476|69315082|FG002|Overall Study|Refuses Injection|0|||
37776973|NCT00216476|69315080|FG000|Overall Study|No Further Need for Treatment|3|||
37776974|NCT00216476|69315081|FG001|Overall Study|No Further Need for Treatment|4|||
37776975|NCT00216476|69315082|FG002|Overall Study|No Further Need for Treatment|1|||
37776976|NCT00216476|69315080|FG000|Overall Study|Non-compliance|0|||
37776977|NCT00216476|69315081|FG001|Overall Study|Non-compliance|4|||
37776978|NCT00216476|69315082|FG002|Overall Study|Non-compliance|1|||
37776979|NCT00216476|69315080|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
37776980|NCT00216476|69315081|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
37776981|NCT00216476|69315082|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
37776982|NCT00216476|69315080|FG000|Overall Study|Administrative Reasons|1|||
37776983|NCT00216476|69315081|FG001|Overall Study|Administrative Reasons|1|||
37776984|NCT00216476|69315082|FG002|Overall Study|Administrative Reasons|0|||
37776985|NCT00216476|69315080|FG000|Overall Study|Protocol Deviation|5|||
37776986|NCT00216476|69315081|FG001|Overall Study|Protocol Deviation|1|||
37968841|NCT00529308|69656010|FG000|Overall Study|Withdrawal by Subject|1|||
37968842|NCT00529308|69656011|FG001|Overall Study|Withdrawal by Subject|1|||
37968843|NCT03875508|69656017|FG000|Overall Study|Adverse Event|1|||
37968844|NCT03875508|69656017|FG000|Overall Study|Lost to Follow-up|8|||
37776987|NCT00216476|69315082|FG002|Overall Study|Protocol Deviation|0|||
37776988|NCT00216476|69315080|FG000|Overall Study|Patient Moved|2|||
37776989|NCT00216476|69315081|FG001|Overall Study|Patient Moved|2|||
37776990|NCT00216476|69315082|FG002|Overall Study|Patient Moved|0|||
37776991|NCT00216086|69315133|FG000|Overall Study|Protocol Violation|1|||
37776992|NCT00216086|69315133|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
37776993|NCT00216086|69315133|FG000|Overall Study|Social Reasons|2|||
37776994|NCT00215150|69315164|FG000|Open Label Phase|Lost to Follow-up|7|||
37776995|NCT00215150|69315164|FG000|Open Label Phase|Withdrawal by Subject|1|||
37968845|NCT03875508|69656017|FG000|Overall Study|Lack of Efficacy|1|||
37968846|NCT03875508|69656017|FG000|Overall Study|Other, not specified|2|||
37968847|NCT00620321|69656023|FG000|Overall Study|Adverse Event|1|||
37968848|NCT00620321|69656024|FG001|Overall Study|Adverse Event|1|||
37968849|NCT00620321|69656023|FG000|Overall Study|Death|1|||
37968850|NCT00620321|69656024|FG001|Overall Study|Death|1|||
37776996|NCT00215150|69315164|FG000|Open Label Phase|Did not complete a post base visit|13|||
37776997|NCT00215150|69315164|FG000|Open Label Phase|Did not meet randomization criteria|9|||
37776998|NCT00215150|69315164|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
37776999|NCT00215150|69315164|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
37777000|NCT00215150|69315164|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
37777001|NCT00214136|69315172|FG000|Overall Study|Death|5|||
37777002|NCT00213980|69315178|FG000|Overall Study|Withdrawal by Subject|3|||
37777003|NCT00213980|69315179|FG001|Overall Study|Withdrawal by Subject|1|||
37777004|NCT00213980|69315178|FG000|Overall Study|Adverse Event|1|||
37777005|NCT00213980|69315179|FG001|Overall Study|Adverse Event|1|||
37777006|NCT00213980|69315178|FG000|Overall Study|Disease progression|0|||
37777007|NCT00213980|69315179|FG001|Overall Study|Disease progression|2|||
37777008|NCT00213980|69315178|FG000|Overall Study|Developed ovarian cancer|1|||
37777009|NCT00213980|69315179|FG001|Overall Study|Developed ovarian cancer|0|||
37777010|NCT00213980|69315178|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
37777011|NCT00213980|69315179|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
37777012|NCT05086289|69315238|FG000|Overall Study|Adverse Event|4|||
37777013|NCT05086289|69315239|FG001|Overall Study|Adverse Event|2|||
37777014|NCT05086289|69315238|FG000|Overall Study|Lost to Follow-up|2|||
37777015|NCT05086289|69315239|FG001|Overall Study|Lost to Follow-up|0|||
37777016|NCT05086289|69315238|FG000|Overall Study|Non-compliance with study drug|2|||
37777017|NCT05086289|69315239|FG001|Overall Study|Non-compliance with study drug|1|||
37777018|NCT05086289|69315238|FG000|Overall Study|Physician Decision|2|||
37777019|NCT05086289|69315239|FG001|Overall Study|Physician Decision|0|||
37777020|NCT05086289|69315238|FG000|Overall Study|Withdrawal by Subject|5|||
37777021|NCT05086289|69315239|FG001|Overall Study|Withdrawal by Subject|2|||
37777022|NCT05045144|69315252|FG000|Overall Study|Lost to Follow-up|3|||
37777023|NCT05045144|69315253|FG001|Overall Study|Lost to Follow-up|2|||
37777024|NCT05045144|69315254|FG002|Overall Study|Lost to Follow-up|3|||
37777025|NCT05045144|69315255|FG003|Overall Study|Lost to Follow-up|5|||
37777026|NCT05045144|69315256|FG004|Overall Study|Lost to Follow-up|13|||
37777027|NCT05045144|69315252|FG000|Overall Study|Withdrawal by Subject|0|||
37777028|NCT05045144|69315253|FG001|Overall Study|Withdrawal by Subject|1|||
37777029|NCT05045144|69315254|FG002|Overall Study|Withdrawal by Subject|0|||
37777030|NCT05045144|69315255|FG003|Overall Study|Withdrawal by Subject|0|||
37777031|NCT05045144|69315256|FG004|Overall Study|Withdrawal by Subject|0|||
37777032|NCT05045144|69315252|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
37777033|NCT05045144|69315253|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
37777034|NCT05045144|69315254|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
37777035|NCT05045144|69315255|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
37777036|NCT05045144|69315256|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
37777037|NCT05016765|69315272|FG000|Overall Study|Lost to Follow-up|4|||
37777038|NCT04982029|69315279|FG000|Overall Study|Lost to Follow-up|2|||
37777039|NCT04982029|69315280|FG001|Overall Study|Lost to Follow-up|3|||
37777040|NCT04897867|69315294|FG000|Overall Study|Withdrawal of Consent|1|||
37777041|NCT04897867|69315294|FG000|Overall Study|Pregnancy|1|||
37777042|NCT04897867|69315294|FG000|Overall Study|Lost to Follow-up|7|||
37777043|NCT04897867|69315294|FG000|Overall Study|Reason not Specified|2|||
37777044|NCT04161157|69315335|FG000|Overall Study|Lost to Follow-up|4|||
37777045|NCT04161157|69315335|FG000|Overall Study|Death|3|||
37777046|NCT04161157|69315335|FG000|Overall Study|Ineligible|2|||
37777047|NCT04161157|69315335|FG000|Overall Study|Withdrawal by Subject|4|||
37777048|NCT04035187|69315343|FG000|Overall Study|Withdrawal by Subject|2|||
37777049|NCT04035187|69315344|FG001|Overall Study|Withdrawal by Subject|1|||
37777050|NCT04035187|69315345|FG002|Overall Study|Withdrawal by Subject|0|||
37777051|NCT04035187|69315346|FG003|Overall Study|Withdrawal by Subject|0|||
37777052|NCT04035187|69315343|FG000|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
37968851|NCT00620321|69656023|FG000|Overall Study|Physician Decision|0|||
37968852|NCT00620321|69656024|FG001|Overall Study|Physician Decision|7|||
37777053|NCT04035187|69315344|FG001|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
37777054|NCT04035187|69315345|FG002|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
37777055|NCT04035187|69315346|FG003|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
37777056|NCT03852719|69315359|FG000|Overall Study|Still on study after Week 96|49|||
37777057|NCT03852719|69315360|FG001|Overall Study|Still on study after Week 96|47|||
37777058|NCT03852719|69315361|FG002|Overall Study|Still on study after Week 96|47|||
37777059|NCT03852719|69315359|FG000|Overall Study|Withdrawal of consent|0|||
37777060|NCT03852719|69315360|FG001|Overall Study|Withdrawal of consent|2|||
37777061|NCT03852719|69315361|FG002|Overall Study|Withdrawal of consent|2|||
37777062|NCT03852719|69315359|FG000|Overall Study|Physician Decision|0|||
37777063|NCT03852719|69315360|FG001|Overall Study|Physician Decision|0|||
37777064|NCT03852719|69315361|FG002|Overall Study|Physician Decision|1|||
37777065|NCT03852719|69315359|FG000|Overall Study|Pregnancy|1|||
37777066|NCT03852719|69315360|FG001|Overall Study|Pregnancy|0|||
37777067|NCT03852719|69315361|FG002|Overall Study|Pregnancy|0|||
37777068|NCT03852719|69315359|FG000|Overall Study|Death|1|||
37777069|NCT03852719|69315360|FG001|Overall Study|Death|0|||
37777070|NCT03852719|69315361|FG002|Overall Study|Death|0|||
37777071|NCT03785145|69315378|FG000|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|0|||
37777072|NCT03785145|69315379|FG001|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|1|||
37777073|NCT03785145|69315378|FG000|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|6|||
37777074|NCT03785145|69315379|FG001|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|9|||
37777075|NCT03785145|69315378|FG000|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
37777076|NCT03785145|69315379|FG001|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
37777077|NCT03785145|69315378|FG000|Cycle 1 - Double Blind (Days 1-180)|Death|0|||
37777078|NCT03785145|69315379|FG001|Cycle 1 - Double Blind (Days 1-180)|Death|1|||
37968853|NCT00620321|69656023|FG000|Overall Study|Progressive Disease|5|||
37968854|NCT00620321|69656024|FG001|Overall Study|Progressive Disease|5|||
37968855|NCT00620321|69656023|FG000|Overall Study|Sponsor Decision|0|||
37777079|NCT03785145|69315378|FG000|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|1|||
37777080|NCT03785145|69315379|FG001|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|0|||
37777081|NCT03785145|69315378|FG000|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|1|||
37777082|NCT03785145|69315379|FG001|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|5|||
37777083|NCT03785145|69315378|FG000|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|1|||
37777084|NCT03785145|69315379|FG001|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|6|||
37777085|NCT03785145|69315378|FG000|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|2|||
37777086|NCT03785145|69315379|FG001|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|3|||
37777087|NCT03785145|69315378|FG000|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|0|||
37777088|NCT03785145|69315379|FG001|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|1|||
37777089|NCT03785145|69315378|FG000|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|0|||
37777090|NCT03785145|69315379|FG001|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|1|||
37777091|NCT03785145|69315378|FG000|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|0|||
37777092|NCT03785145|69315379|FG001|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|1|||
37777093|NCT03673462|69315387|FG000|Overall Study|Adverse Event|11|||
37777094|NCT03673462|69315388|FG001|Overall Study|Adverse Event|1|||
37777095|NCT03673462|69315387|FG000|Overall Study|Protocol Violation|25|||
37777096|NCT03673462|69315388|FG001|Overall Study|Protocol Violation|11|||
37777097|NCT03673462|69315387|FG000|Overall Study|Withdrawal by Parent/Guardian|162|||
37777098|NCT03673462|69315388|FG001|Overall Study|Withdrawal by Parent/Guardian|56|||
37777099|NCT03673462|69315387|FG000|Overall Study|Lost to Follow-up|102|||
37777100|NCT03673462|69315388|FG001|Overall Study|Lost to Follow-up|19|||
37777101|NCT03662659|69315399|FG000|Pre-treatment|Participant no longer met study criteria|1|||
37777102|NCT03662659|69315400|FG001|Pre-treatment|Participant no longer met study criteria|1|||
37968856|NCT00620321|69656024|FG001|Overall Study|Sponsor Decision|1|||
37691170|NCT02143713|69167439|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
37691171|NCT02143713|69167440|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
37691172|NCT02143713|69167437|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
37691173|NCT02143713|69167438|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
37691174|NCT02143713|69167439|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
37777103|NCT03662659|69315399|FG000|Pre-treatment|Other reasons|1|||
37777104|NCT03662659|69315400|FG001|Pre-treatment|Other reasons|0|||
37777105|NCT03662659|69315399|FG000|Treatment|Completed Treatment|0|||
37777106|NCT03662659|69315400|FG001|Treatment|Completed Treatment|3|||
37777107|NCT03662659|69315399|FG000|Treatment|Disease Progression|69|||
37777108|NCT03662659|69315400|FG001|Treatment|Disease Progression|78|||
37777109|NCT03662659|69315399|FG000|Treatment|Study Drug Toxicity|18|||
37777110|NCT03662659|69315400|FG001|Treatment|Study Drug Toxicity|8|||
37777111|NCT03662659|69315399|FG000|Treatment|Death|12|||
37777112|NCT03662659|69315400|FG001|Treatment|Death|7|||
37968857|NCT00620321|69656023|FG000|Overall Study|Withdrawal by Subject|1|||
37968858|NCT00620321|69656024|FG001|Overall Study|Withdrawal by Subject|1|||
37968859|NCT00621023|69656030|FG000|Overall Study|Death|5|||
37968860|NCT00621023|69656030|FG000|Overall Study|Follow up discontinued|1|||
37968861|NCT00528372|69656043|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
37968862|NCT00528372|69656044|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
37777113|NCT03662659|69315399|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
37777114|NCT03662659|69315400|FG001|Treatment|Adverse Event unrelated to Study Drug|4|||
37777115|NCT03662659|69315399|FG000|Treatment|Withdrawal by Subject|1|||
37777116|NCT03662659|69315400|FG001|Treatment|Withdrawal by Subject|1|||
37777117|NCT03662659|69315399|FG000|Treatment|Poor/Non-compliance|1|||
37777118|NCT03662659|69315400|FG001|Treatment|Poor/Non-compliance|0|||
37777119|NCT03662659|69315399|FG000|Treatment|Participant no longer meets study criteria|1|||
37777120|NCT03662659|69315400|FG001|Treatment|Participant no longer meets study criteria|0|||
37777121|NCT03662659|69315399|FG000|Treatment|Other reasons|6|||
37777122|NCT03662659|69315400|FG001|Treatment|Other reasons|5|||
37777123|NCT03381274|69315428|FG000|Overall Study|Death|2|||
37777124|NCT03381274|69315429|FG001|Overall Study|Death|9|||
37777125|NCT03381274|69315430|FG002|Overall Study|Death|3|||
37777126|NCT03381274|69315431|FG003|Overall Study|Death|2|||
37777127|NCT03381274|69315432|FG004|Overall Study|Death|3|||
37777128|NCT03381274|69315428|FG000|Overall Study|Lost to Follow-up|0|||
37777129|NCT03381274|69315429|FG001|Overall Study|Lost to Follow-up|0|||
37777130|NCT03381274|69315430|FG002|Overall Study|Lost to Follow-up|0|||
37777131|NCT03381274|69315431|FG003|Overall Study|Lost to Follow-up|1|||
37777132|NCT03381274|69315432|FG004|Overall Study|Lost to Follow-up|0|||
37777133|NCT03381274|69315428|FG000|Overall Study|Withdrawal by Subject|2|||
37777134|NCT03381274|69315429|FG001|Overall Study|Withdrawal by Subject|1|||
37777135|NCT03381274|69315430|FG002|Overall Study|Withdrawal by Subject|3|||
37777136|NCT03381274|69315431|FG003|Overall Study|Withdrawal by Subject|1|||
37777137|NCT03381274|69315432|FG004|Overall Study|Withdrawal by Subject|0|||
37777138|NCT03381274|69315428|FG000|Overall Study|Other|1|||
37777139|NCT03381274|69315429|FG001|Overall Study|Other|11|||
37777140|NCT03381274|69315430|FG002|Overall Study|Other|0|||
37777141|NCT03381274|69315431|FG003|Overall Study|Other|2|||
37777142|NCT03381274|69315432|FG004|Overall Study|Other|2|||
37777143|NCT03320330|69315451|FG000|Overall Study|Lack of Efficacy|5|||
37777144|NCT03320330|69315452|FG001|Overall Study|Lack of Efficacy|5|||
37777145|NCT03320330|69315453|FG002|Overall Study|Lack of Efficacy|14|||
37777146|NCT03320330|69315451|FG000|Overall Study|Physician Decision|1|||
37777147|NCT03320330|69315452|FG001|Overall Study|Physician Decision|0|||
37777148|NCT03320330|69315453|FG002|Overall Study|Physician Decision|0|||
37777149|NCT03284788|69315486|FG000|Overall Study|Withdrawal by Subject|2|||
37777150|NCT03082612|69315492|FG000|Overall Study|Lost to Follow-up|2|||
37777151|NCT03082612|69315493|FG001|Overall Study|Lost to Follow-up|0|||
37777152|NCT02824627|69315532|FG000|Overall Study|Adverse Event|1|||
37777153|NCT02824627|69315533|FG001|Overall Study|Adverse Event|2|||
37777154|NCT02824627|69315532|FG000|Overall Study|Lost to Follow-up|2|||
37777155|NCT02824627|69315533|FG001|Overall Study|Lost to Follow-up|1|||
37777156|NCT02759861|69315539|FG000|Overall Study|Death|1|||
37777157|NCT02743611|69315544|FG000|Overall Study|Early study termination due to Sponsor discretion|4|||
37777158|NCT02743611|69315545|FG001|Overall Study|Early study termination due to Sponsor discretion|0|||
37777159|NCT02743611|69315546|FG002|Overall Study|Early study termination due to Sponsor discretion|0|||
37777160|NCT02743611|69315547|FG003|Overall Study|Early study termination due to Sponsor discretion|0|||
37777161|NCT01873833|69315574|FG000|Overall Study|Withdrawal by Subject|1|||
37968863|NCT00528372|69656045|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
37968864|NCT00528372|69656046|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
37968865|NCT00528372|69656047|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
37968866|NCT00528372|69656048|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
37968867|NCT00528372|69656049|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
37968868|NCT00528372|69656050|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
37968869|NCT00528372|69656051|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
37968870|NCT00528372|69656043|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
37777162|NCT04388527|69316023|FG000|Overall Study|Death|14|||
37777163|NCT04388527|69316023|FG000|Overall Study|Withdrawal by Subject|2|||
37777164|NCT04388527|69316023|FG000|Overall Study|Lost to Follow-up|1|||
37777165|NCT03649321|69316050|FG000|Overall Study|Withdrawal by Subject|1|||
37968871|NCT00528372|69656044|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
37777166|NCT03649321|69316051|FG001|Overall Study|Withdrawal by Subject|0|||
37777167|NCT03649321|69316050|FG000|Overall Study|Death|1|||
37777168|NCT03649321|69316051|FG001|Overall Study|Death|0|||
37777169|NCT04149002|69316284|FG000|Overall Study|Lost to Follow-up|1|||
37777170|NCT04149002|69316285|FG001|Overall Study|Lost to Follow-up|0|||
37777171|NCT04149002|69316284|FG000|Overall Study|Withdrawal by Subject|1|||
37777172|NCT04149002|69316285|FG001|Overall Study|Withdrawal by Subject|0|||
37777173|NCT00555321|69316359|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
37777174|NCT00555321|69316360|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
37777175|NCT00555321|69316361|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
37777176|NCT00555321|69316362|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
37777177|NCT00555321|69316363|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
37777178|NCT00555321|69316359|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
37777179|NCT00555321|69316360|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
37777180|NCT00555321|69316361|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
37777181|NCT00555321|69316362|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
37777182|NCT00555321|69316363|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
37777183|NCT00555321|69316359|FG000|Treatment Phase up to 12-months|Death|2|||
37777184|NCT00555321|69316360|FG001|Treatment Phase up to 12-months|Death|1|||
37777185|NCT00555321|69316361|FG002|Treatment Phase up to 12-months|Death|4|||
37777186|NCT00555321|69316362|FG003|Treatment Phase up to 12-months|Death|0|||
37777187|NCT00555321|69316363|FG004|Treatment Phase up to 12-months|Death|0|||
37777188|NCT00555321|69316359|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
37777189|NCT00555321|69316360|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
37968872|NCT00528372|69656045|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
37777190|NCT00555321|69316361|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
37777191|NCT00555321|69316362|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
37777192|NCT00555321|69316363|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
37777193|NCT00555321|69316359|FG000|Treatment Phase up to 12-months|Other Reason|1|||
37777194|NCT00555321|69316360|FG001|Treatment Phase up to 12-months|Other Reason|3|||
37777195|NCT00555321|69316361|FG002|Treatment Phase up to 12-months|Other Reason|2|||
37777196|NCT00555321|69316362|FG003|Treatment Phase up to 12-months|Other Reason|0|||
37777197|NCT00555321|69316363|FG004|Treatment Phase up to 12-months|Other Reason|0|||
37777198|NCT00555321|69316359|FG000|Treatment Phase up to 12-months|Never treated|2|||
37777199|NCT00555321|69316360|FG001|Treatment Phase up to 12-months|Never treated|3|||
37777200|NCT00555321|69316361|FG002|Treatment Phase up to 12-months|Never treated|1|||
37777201|NCT00555321|69316362|FG003|Treatment Phase up to 12-months|Never treated|0|||
37777202|NCT00555321|69316363|FG004|Treatment Phase up to 12-months|Never treated|4|||
37777203|NCT00555321|69316359|FG000|Long-term Extension Phase|Adverse Event|2|||
37777204|NCT00555321|69316360|FG001|Long-term Extension Phase|Adverse Event|5|||
37777205|NCT00555321|69316361|FG002|Long-term Extension Phase|Adverse Event|2|||
37777206|NCT00555321|69316362|FG003|Long-term Extension Phase|Adverse Event|1|||
37777207|NCT00555321|69316363|FG004|Long-term Extension Phase|Adverse Event|0|||
37777208|NCT00555321|69316359|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
37777209|NCT00555321|69316360|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
37777210|NCT00555321|69316361|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
37777211|NCT00555321|69316362|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
37777212|NCT00555321|69316363|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
37777213|NCT00555321|69316359|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
37777214|NCT00555321|69316360|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
37777215|NCT00555321|69316361|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
37777216|NCT00555321|69316362|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
37777217|NCT00555321|69316363|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
37777218|NCT00555321|69316359|FG000|Long-term Extension Phase|Death|2|||
37777219|NCT00555321|69316360|FG001|Long-term Extension Phase|Death|0|||
37777220|NCT00555321|69316361|FG002|Long-term Extension Phase|Death|0|||
37777221|NCT00555321|69316362|FG003|Long-term Extension Phase|Death|3|||
37777222|NCT00555321|69316363|FG004|Long-term Extension Phase|Death|0|||
37777223|NCT00555321|69316359|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
37777224|NCT00555321|69316360|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
37777225|NCT00555321|69316361|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
37777226|NCT00555321|69316362|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
37777227|NCT00555321|69316363|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
37777228|NCT00555321|69316359|FG000|Long-term Extension Phase|Other Reason|1|||
37777229|NCT00555321|69316360|FG001|Long-term Extension Phase|Other Reason|0|||
37777230|NCT00555321|69316361|FG002|Long-term Extension Phase|Other Reason|2|||
37777231|NCT00555321|69316362|FG003|Long-term Extension Phase|Other Reason|0|||
37777232|NCT00555321|69316363|FG004|Long-term Extension Phase|Other Reason|0|||
37777233|NCT03589976|69316875|FG000|Overall Study|Death|5|||
37777234|NCT03589976|69316876|FG001|Overall Study|Death|1|||
37777235|NCT03589976|69316875|FG000|Overall Study|Adverse Event|5|||
37777236|NCT03589976|69316876|FG001|Overall Study|Adverse Event|1|||
37777237|NCT03589976|69316875|FG000|Overall Study|Withdrawal by Subject|4|||
37777238|NCT03589976|69316876|FG001|Overall Study|Withdrawal by Subject|1|||
37777239|NCT03589976|69316875|FG000|Overall Study|Lost to Follow-up|1|||
37777240|NCT03589976|69316876|FG001|Overall Study|Lost to Follow-up|0|||
37777241|NCT03589976|69316875|FG000|Overall Study|Other|4|||
37777242|NCT03589976|69316876|FG001|Overall Study|Other|3|||
37777243|NCT03029780|69317032|FG000|Overall Study|Disease Progression|20|||
37777244|NCT03029780|69317033|FG001|Overall Study|Disease Progression|22|||
37777245|NCT03029780|69317032|FG000|Overall Study|Study Drug Toxicity|15|||
37777246|NCT03029780|69317033|FG001|Overall Study|Study Drug Toxicity|11|||
37777247|NCT03029780|69317032|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
37777248|NCT03029780|69317033|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
37777249|NCT03029780|69317032|FG000|Overall Study|Participant request to discontinue study treatment|4|||
37777250|NCT03029780|69317033|FG001|Overall Study|Participant request to discontinue study treatment|1|||
37777251|NCT03029780|69317032|FG000|Overall Study|Maximum clinical benefit|1|||
37777252|NCT03029780|69317033|FG001|Overall Study|Maximum clinical benefit|0|||
37777253|NCT03029780|69317032|FG000|Overall Study|Participant no longer meets study criteria|0|||
37777254|NCT03029780|69317033|FG001|Overall Study|Participant no longer meets study criteria|1|||
37777255|NCT03029780|69317032|FG000|Overall Study|Other reasons|6|||
37777256|NCT03029780|69317033|FG001|Overall Study|Other reasons|6|||
37777257|NCT03029780|69317032|FG000|Overall Study|Not reported|1|||
37777258|NCT03029780|69317033|FG001|Overall Study|Not reported|1|||
37777259|NCT03029780|69317032|FG000|Overall Study|Death|2|||
37777260|NCT03029780|69317033|FG001|Overall Study|Death|6|||
37777261|NCT03029234|69317093|FG000|Overall Study|Sponsor Decision|1|||
37777262|NCT03029234|69317093|FG000|Overall Study|Withdrawal by Subject|5|||
37777263|NCT03029234|69317093|FG000|Overall Study|Death|91|||
37777264|NCT03029234|69317093|FG000|Overall Study|Lost to Follow-up|2|||
37777265|NCT03991299|69317764|FG000|Overall Study|Study closed, sponsor decision|3|||
37777266|NCT03991299|69317764|FG000|Overall Study|Withdrawal by Subject|1|||
37777267|NCT03155373|69317782|FG000|Overall Study|No longer required surgery|1|||
37777268|NCT03155373|69317782|FG000|Overall Study|Protocol Violation|1|||
37777269|NCT03155373|69317782|FG000|Overall Study|Death|2|||
37777270|NCT03155373|69317782|FG000|Overall Study|Withdrawal by Subject|3|||
37863752|NCT01256411|69547295|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
37691175|NCT02143713|69167440|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
37691176|NCT02519855|69167453|FG000|Overall Study|Adverse Event|0|||
37691177|NCT02519855|69167454|FG001|Overall Study|Adverse Event|1|||
37691178|NCT02519855|69167453|FG000|Overall Study|Lost to Follow-up|3|||
37691179|NCT02519855|69167454|FG001|Overall Study|Lost to Follow-up|3|||
37691180|NCT02142387|69167462|FG000|Overall Study|<19 years old|49|||
37691181|NCT02142387|69167463|FG001|Overall Study|<19 years old|326|||
37691182|NCT02142387|69167462|FG000|Overall Study|non-cardiac etiology|504|||
37691183|NCT02142387|69167463|FG001|Overall Study|non-cardiac etiology|3431|||
37691184|NCT02142387|69167462|FG000|Overall Study|CPR not performed|74|||
37777271|NCT05310084|69318225|FG000|Overall Study|Withdrawal by Subject|2|||
37777272|NCT05310084|69318226|FG001|Overall Study|Withdrawal by Subject|3|||
37777273|NCT05310084|69318225|FG000|Overall Study|Participant availability|0|||
37777274|NCT05310084|69318226|FG001|Overall Study|Participant availability|4|||
37777275|NCT05310084|69318225|FG000|Overall Study|Lost to Follow-up|1|||
37777276|NCT05310084|69318226|FG001|Overall Study|Lost to Follow-up|1|||
37777277|NCT05310084|69318225|FG000|Overall Study|Adverse Event|1|||
37777278|NCT05310084|69318226|FG001|Overall Study|Adverse Event|1|||
37777279|NCT05310084|69318225|FG000|Overall Study|Randomized but not vaccinated|4|||
37777280|NCT05310084|69318226|FG001|Overall Study|Randomized but not vaccinated|2|||
37968873|NCT00528372|69656046|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
37968874|NCT00528372|69656047|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
37968875|NCT00528372|69656048|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
37968876|NCT00528372|69656049|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
37968877|NCT00528372|69656050|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
37968878|NCT00528372|69656051|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
37968879|NCT00528372|69656043|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
37968880|NCT00528372|69656044|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
37691185|NCT02142387|69167463|FG001|Overall Study|CPR not performed|473|||
37968881|NCT00528372|69656045|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
37968882|NCT00528372|69656046|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
37863753|NCT01256411|69547296|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
37691186|NCT02142387|69167462|FG000|Overall Study|witnessed by paramedic|139|||
37691187|NCT02142387|69167463|FG001|Overall Study|witnessed by paramedic|917|||
37691188|NCT02142387|69167462|FG000|Overall Study|incomplete data|1|||
37691189|NCT02142387|69167463|FG001|Overall Study|incomplete data|9|||
37691190|NCT02142387|69167462|FG000|Overall Study|occurred not at home|298|||
37691191|NCT02142387|69167463|FG001|Overall Study|occurred not at home|2474|||
37691192|NCT02518919|69167472|FG000|Overall Study|Protocol Violation|1|||
37968883|NCT00528372|69656047|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
37968884|NCT00528372|69656048|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
37968885|NCT00528372|69656049|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
37968886|NCT00528372|69656050|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
37968887|NCT00528372|69656051|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
37968888|NCT00528372|69656043|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
37968889|NCT00528372|69656044|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
37968890|NCT00528372|69656045|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
37968891|NCT00528372|69656046|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
37968892|NCT00528372|69656047|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
37777303|NCT04581863|69318279|FG000|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|17|||
37777304|NCT04581863|69318280|FG001|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|31|||
37777305|NCT04349891|69318307|FG000|First Intervention - 4 Weeks|Withdrawal by Subject|3|||
37777306|NCT04349891|69318308|FG001|First Intervention - 4 Weeks|Withdrawal by Subject|4|||
37777307|NCT04349891|69318307|FG000|First Intervention - 4 Weeks|Adverse Event|1|||
37777308|NCT04349891|69318308|FG001|First Intervention - 4 Weeks|Adverse Event|1|||
37777309|NCT04349891|69318307|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
37777310|NCT04349891|69318308|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
37777311|NCT04349891|69318307|FG000|Second Intervention - 4 Weeks|Withdrawal by Subject|2|||
37777312|NCT04349891|69318308|FG001|Second Intervention - 4 Weeks|Withdrawal by Subject|0|||
37968893|NCT00528372|69656048|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
37968894|NCT00528372|69656049|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
37968895|NCT00528372|69656050|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
37968896|NCT00528372|69656051|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
37968897|NCT00528372|69656043|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
37968898|NCT00528372|69656044|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
37968899|NCT00528372|69656045|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
37968900|NCT00528372|69656046|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
37968901|NCT00528372|69656047|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
37968902|NCT00528372|69656048|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
37968903|NCT00528372|69656049|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
37968904|NCT00528372|69656050|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
37968905|NCT00528372|69656051|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
37968906|NCT00528372|69656043|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
37968907|NCT00528372|69656044|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
37968908|NCT00528372|69656045|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
37968909|NCT00528372|69656046|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
37968910|NCT00528372|69656047|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
37968911|NCT00528372|69656048|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
37968912|NCT00528372|69656049|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
37968913|NCT00528372|69656050|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
37968914|NCT00528372|69656051|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
37968915|NCT00528372|69656043|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
37968916|NCT00528372|69656044|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
37968917|NCT00528372|69656045|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
37968918|NCT00528372|69656046|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
37968919|NCT00528372|69656047|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
37968920|NCT00528372|69656048|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
37968921|NCT00528372|69656049|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
37968922|NCT00528372|69656050|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
37968923|NCT00528372|69656051|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
37968924|NCT00528372|69656043|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
37691193|NCT02518919|69167473|FG001|Overall Study|Protocol Violation|1|||
37968925|NCT00528372|69656044|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
37968926|NCT00528372|69656045|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
37968927|NCT00528372|69656046|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
37968928|NCT00528372|69656047|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
37968929|NCT00528372|69656048|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
37968930|NCT00528372|69656049|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
37968931|NCT00528372|69656050|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
37968932|NCT00528372|69656051|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
37968933|NCT00528372|69656043|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
37968934|NCT00528372|69656044|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
37968935|NCT00528372|69656045|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
37968936|NCT00528372|69656046|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
37968937|NCT00528372|69656047|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
37968938|NCT00528372|69656048|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
37968939|NCT00528372|69656049|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
37968940|NCT00528372|69656050|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
37968941|NCT00528372|69656051|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
37968942|NCT00528372|69656043|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
37968943|NCT00528372|69656044|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
37968944|NCT00528372|69656045|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
37968945|NCT00528372|69656046|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
37968946|NCT00528372|69656047|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
37968947|NCT00528372|69656048|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
37968948|NCT00528372|69656049|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
37968949|NCT00528372|69656050|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
37968950|NCT00528372|69656051|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
37968951|NCT00528372|69656043|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
37968952|NCT00528372|69656044|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
37968953|NCT00528372|69656045|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
37968954|NCT00528372|69656046|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
37968955|NCT00528372|69656047|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
37968956|NCT00528372|69656048|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
37968957|NCT00528372|69656049|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
37968958|NCT00528372|69656050|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
37968959|NCT00528372|69656051|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
37968960|NCT00528372|69656043|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
37968961|NCT00528372|69656044|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
37968962|NCT00528372|69656045|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
37968963|NCT00528372|69656046|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
37968964|NCT00528372|69656047|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
37968965|NCT00528372|69656048|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
37968966|NCT00528372|69656049|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
37968967|NCT00528372|69656050|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
37968968|NCT00528372|69656051|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
37968969|NCT00528372|69656043|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
37968970|NCT00528372|69656044|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
37968971|NCT00528372|69656045|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
37968972|NCT00528372|69656046|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
37691194|NCT02518919|69167474|FG002|Overall Study|Protocol Violation|2|||
37691195|NCT02518685|69167484|FG000|Overall Study|Adverse Event|29|||
37691196|NCT02518685|69167485|FG001|Overall Study|Adverse Event|1|||
37691197|NCT02518685|69167484|FG000|Overall Study|Withdrawal by Subject|10|||
37691198|NCT02518685|69167485|FG001|Overall Study|Withdrawal by Subject|3|||
37691199|NCT02518685|69167484|FG000|Overall Study|relocation, study fatigue|7|||
37691200|NCT02518685|69167485|FG001|Overall Study|relocation, study fatigue|2|||
37691201|NCT02518685|69167484|FG000|Overall Study|Pregnancy|1|||
37691202|NCT02518685|69167485|FG001|Overall Study|Pregnancy|0|||
37691203|NCT02518685|69167484|FG000|Overall Study|Physician Decision|1|||
37691204|NCT02518685|69167485|FG001|Overall Study|Physician Decision|0|||
37691205|NCT02518685|69167484|FG000|Overall Study|Lost to Follow-up|1|||
37968973|NCT00528372|69656047|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
37968974|NCT00528372|69656048|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
37968975|NCT00528372|69656049|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
37968976|NCT00528372|69656050|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
37968977|NCT00528372|69656051|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
37968978|NCT00528372|69656043|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
37968979|NCT00528372|69656044|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
37968980|NCT00528372|69656045|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
37968981|NCT00528372|69656046|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
37777414|NCT02258451|69318485|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|90|||
37777415|NCT02258451|69318486|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|101|||
37777416|NCT02258451|69318485|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
37777417|NCT02258451|69318486|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
37777418|NCT02258451|69318485|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
37777419|NCT02258451|69318486|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
37777420|NCT02258451|69318485|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
37777421|NCT02258451|69318486|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
37777422|NCT02258451|69318485|FG000|Overall Study|Discontinuation all treatment due to death|4|||
37777423|NCT02258451|69318486|FG001|Overall Study|Discontinuation all treatment due to death|3|||
37777424|NCT02258451|69318485|FG000|Overall Study|Discontinuation all treatment due to withdrawal by participant|21|||
37777425|NCT02258451|69318486|FG001|Overall Study|Discontinuation all treatment due to withdrawal by participant|13|||
37777426|NCT02258451|69318485|FG000|Overall Study|Discontinuation all treatment due to end point reached|1|||
37777427|NCT02258451|69318486|FG001|Overall Study|Discontinuation all treatment due to end point reached|1|||
37777428|NCT02258451|69318485|FG000|Overall Study|Discontinuation all treatment due to physician decision|0|||
37777429|NCT02258451|69318486|FG001|Overall Study|Discontinuation all treatment due to physician decision|2|||
37777430|NCT02258451|69318485|FG000|Overall Study|Discontinuation all treatment due to study terminated by sponsor|0|||
37777431|NCT02258451|69318486|FG001|Overall Study|Discontinuation all treatment due to study terminated by sponsor|3|||
37777432|NCT02258451|69318485|FG000|Overall Study|Other reason|1|||
37777433|NCT02258451|69318486|FG001|Overall Study|Other reason|1|||
37777434|NCT02258451|69318485|FG000|Overall Study|Never treated|2|||
37777435|NCT02258451|69318486|FG001|Overall Study|Never treated|3|||
37777436|NCT02168270|69318494|FG000|Overall Study|Lack of Efficacy|4|||
37968982|NCT00528372|69656047|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
37968983|NCT00528372|69656048|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
37968984|NCT00528372|69656049|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
37968985|NCT00528372|69656050|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
37968986|NCT00528372|69656051|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
37968987|NCT00528372|69656043|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
37968988|NCT00528372|69656044|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
37968989|NCT00528372|69656045|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
37968990|NCT00528372|69656046|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
37968991|NCT00528372|69656047|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
37968992|NCT00528372|69656048|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
37968993|NCT00528372|69656049|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
37968994|NCT00528372|69656050|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
37968995|NCT00528372|69656051|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
37968996|NCT00527982|69656099|FG000|Overall Study|Physician Decision|1|||
37968997|NCT00527982|69656100|FG001|Overall Study|Physician Decision|0|||
37968998|NCT00527904|69656106|FG000|Overall Study|Adverse Event|45|||
37968999|NCT00527904|69656106|FG000|Overall Study|Withdrawal by Subject|21|||
37969000|NCT00527904|69656106|FG000|Overall Study|Lost to Follow-up|8|||
37969001|NCT00527904|69656106|FG000|Overall Study|misc|22|||
37969002|NCT00619619|69656118|FG000|Overall Study|Physician Decision|0|||
37969003|NCT00619619|69656119|FG001|Overall Study|Physician Decision|0|||
37969004|NCT00619619|69656120|FG002|Overall Study|Physician Decision|1|||
37969005|NCT00619619|69656121|FG003|Overall Study|Physician Decision|0|||
37969006|NCT00619619|69656122|FG004|Overall Study|Physician Decision|0|||
37969007|NCT00619619|69656123|FG005|Overall Study|Physician Decision|0|||
37969008|NCT00619619|69656124|FG006|Overall Study|Physician Decision|0|||
37969009|NCT00619619|69656125|FG007|Overall Study|Physician Decision|0|||
37969010|NCT00619619|69656118|FG000|Overall Study|Protocol Violation|0|||
37969011|NCT00619619|69656119|FG001|Overall Study|Protocol Violation|0|||
37969012|NCT00619619|69656120|FG002|Overall Study|Protocol Violation|0|||
37969013|NCT00619619|69656121|FG003|Overall Study|Protocol Violation|1|||
37969014|NCT00619619|69656122|FG004|Overall Study|Protocol Violation|0|||
37969015|NCT00619619|69656123|FG005|Overall Study|Protocol Violation|0|||
37969016|NCT00619619|69656124|FG006|Overall Study|Protocol Violation|1|||
37969017|NCT00619619|69656125|FG007|Overall Study|Protocol Violation|1|||
37969018|NCT00619619|69656118|FG000|Overall Study|Adverse Event|0|||
37969019|NCT00619619|69656119|FG001|Overall Study|Adverse Event|0|||
37969020|NCT00619619|69656120|FG002|Overall Study|Adverse Event|0|||
37969021|NCT00619619|69656121|FG003|Overall Study|Adverse Event|0|||
37969022|NCT00619619|69656122|FG004|Overall Study|Adverse Event|2|||
37969023|NCT00619619|69656123|FG005|Overall Study|Adverse Event|0|||
37969024|NCT00619619|69656124|FG006|Overall Study|Adverse Event|0|||
37969025|NCT00619619|69656125|FG007|Overall Study|Adverse Event|2|||
37969026|NCT00527826|69656148|FG000|Overall Study|Adverse Event|10|||
37969027|NCT00527826|69656149|FG001|Overall Study|Adverse Event|10|||
37969028|NCT00527826|69656148|FG000|Overall Study|Lost to Follow-up|3|||
37969029|NCT00527826|69656149|FG001|Overall Study|Lost to Follow-up|2|||
37969030|NCT00527826|69656148|FG000|Overall Study|Withdrawal by Subject|5|||
37969031|NCT00527826|69656149|FG001|Overall Study|Withdrawal by Subject|8|||
37969032|NCT00527826|69656148|FG000|Overall Study|Inclusion Criteria Not Met|3|||
37969033|NCT00527826|69656149|FG001|Overall Study|Inclusion Criteria Not Met|3|||
37969034|NCT00527826|69656148|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
37969035|NCT00527826|69656149|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
37969036|NCT00527826|69656148|FG000|Overall Study|Additional Intake of Viani forte|0|||
37969037|NCT00527826|69656149|FG001|Overall Study|Additional Intake of Viani forte|1|||
37969038|NCT00527826|69656148|FG000|Overall Study|Participant moved away|0|||
37969039|NCT00527826|69656149|FG001|Overall Study|Participant moved away|1|||
37691206|NCT02518685|69167485|FG001|Overall Study|Lost to Follow-up|4|||
37691207|NCT02520089|69167494|FG000|Overall Study|Lost to Follow-up|3|||
37691208|NCT02520089|69167495|FG001|Overall Study|Lost to Follow-up|4|||
37691209|NCT02105961|69167504|FG000|Overall Study|Adverse Event|18|||
37691210|NCT02105961|69167505|FG001|Overall Study|Adverse Event|7|||
37691211|NCT02105961|69167506|FG002|Overall Study|Adverse Event|13|||
37691212|NCT02105961|69167504|FG000|Overall Study|Lack of Efficacy|3|||
37691213|NCT02105961|69167505|FG001|Overall Study|Lack of Efficacy|0|||
37691214|NCT02105961|69167506|FG002|Overall Study|Lack of Efficacy|3|||
37691215|NCT02105961|69167504|FG000|Overall Study|Lost to Follow-up|2|||
37691216|NCT02105961|69167505|FG001|Overall Study|Lost to Follow-up|0|||
37691217|NCT02105961|69167506|FG002|Overall Study|Lost to Follow-up|1|||
37691218|NCT02105961|69167504|FG000|Overall Study|Physician Decision|3|||
37691219|NCT02105961|69167505|FG001|Overall Study|Physician Decision|3|||
37691220|NCT02105961|69167506|FG002|Overall Study|Physician Decision|2|||
37691221|NCT02105961|69167504|FG000|Overall Study|Withdrawal by Subject|15|||
37969040|NCT00527748|69656158|FG000|Overall Study|Other|3|||
37969041|NCT00619385|69656165|FG000|Overall Study|Adverse Event|0|||
37969042|NCT00619385|69656166|FG001|Overall Study|Adverse Event|0|||
37691222|NCT02105961|69167505|FG001|Overall Study|Withdrawal by Subject|7|||
37969043|NCT00619385|69656167|FG002|Overall Study|Adverse Event|3|||
37833519|NCT01263496|69517271|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
37833520|NCT01263496|69517272|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
37691223|NCT02105961|69167506|FG002|Overall Study|Withdrawal by Subject|11|||
37833521|NCT01263496|69517273|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
37833522|NCT01263496|69517274|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
37833523|NCT01263496|69517275|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
37969044|NCT00619385|69656165|FG000|Overall Study|Other|1|||
37969045|NCT00619385|69656166|FG001|Overall Study|Other|2|||
37969046|NCT00619385|69656167|FG002|Overall Study|Other|1|||
37969047|NCT00619307|69656180|FG000|Overall Study|Adverse Event|0|||
37969048|NCT00619307|69656181|FG001|Overall Study|Adverse Event|1|||
37969049|NCT00619307|69656180|FG000|Overall Study|Lost to Follow-up|0|||
37969050|NCT00619307|69656181|FG001|Overall Study|Lost to Follow-up|1|||
37969051|NCT00619307|69656180|FG000|Overall Study|Protocol Violation|3|||
37969052|NCT00619307|69656181|FG001|Overall Study|Protocol Violation|0|||
37969053|NCT00619307|69656180|FG000|Overall Study|Withdrew consent|1|||
37969054|NCT00619307|69656181|FG001|Overall Study|Withdrew consent|0|||
37969055|NCT00619307|69656180|FG000|Overall Study|Severe migraine|0|||
37969056|NCT00619307|69656181|FG001|Overall Study|Severe migraine|1|||
37969057|NCT00619307|69656180|FG000|Overall Study|MS attack plus steroids|0|||
37969058|NCT00619307|69656181|FG001|Overall Study|MS attack plus steroids|1|||
37969059|NCT00619229|69656189|FG000|Overall Study|Withdrawal by Subject|1|||
37969060|NCT00619229|69656190|FG001|Overall Study|Withdrawal by Subject|1|||
37969061|NCT00619229|69656189|FG000|Overall Study|Lost to Follow-up|1|||
37777493|NCT02775903|69318839|FG000|Overall Study|Death|7|||
37777494|NCT02775903|69318840|FG001|Overall Study|Death|11|||
37777495|NCT02775903|69318841|FG002|Overall Study|Death|12|||
37777496|NCT02775903|69318842|FG003|Overall Study|Death|11|||
37777497|NCT02775903|69318839|FG000|Overall Study|Adverse Event|0|||
37777498|NCT02775903|69318840|FG001|Overall Study|Adverse Event|1|||
37777499|NCT02775903|69318841|FG002|Overall Study|Adverse Event|12|||
37777500|NCT02775903|69318842|FG003|Overall Study|Adverse Event|3|||
37777501|NCT02775903|69318839|FG000|Overall Study|Progressive disease|15|||
37777502|NCT02775903|69318840|FG001|Overall Study|Progressive disease|14|||
37777503|NCT02775903|69318841|FG002|Overall Study|Progressive disease|30|||
37777504|NCT02775903|69318842|FG003|Overall Study|Progressive disease|20|||
37777505|NCT02775903|69318839|FG000|Overall Study|Lack of Efficacy|2|||
37777506|NCT02775903|69318840|FG001|Overall Study|Lack of Efficacy|2|||
37777507|NCT02775903|69318841|FG002|Overall Study|Lack of Efficacy|2|||
37777508|NCT02775903|69318842|FG003|Overall Study|Lack of Efficacy|6|||
37777509|NCT02775903|69318839|FG000|Overall Study|Withdrawal by Subject|7|||
37777510|NCT02775903|69318840|FG001|Overall Study|Withdrawal by Subject|5|||
37777511|NCT02775903|69318841|FG002|Overall Study|Withdrawal by Subject|5|||
37777512|NCT02775903|69318842|FG003|Overall Study|Withdrawal by Subject|8|||
37777513|NCT02775903|69318839|FG000|Overall Study|Other reasons|7|||
37777514|NCT02775903|69318840|FG001|Overall Study|Other reasons|8|||
37863754|NCT01256411|69547297|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
37863755|NCT01256411|69547298|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
37777515|NCT02775903|69318841|FG002|Overall Study|Other reasons|2|||
37777516|NCT02775903|69318842|FG003|Overall Study|Other reasons|12|||
37777517|NCT02723019|69318911|FG000|Overall Study|Death|17|||
37777518|NCT02723019|69318912|FG001|Overall Study|Death|13|||
37777519|NCT02723019|69318911|FG000|Overall Study|Withdrawal by Subject|11|||
37777520|NCT02723019|69318912|FG001|Overall Study|Withdrawal by Subject|7|||
37863756|NCT01256411|69547299|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
37863757|NCT01256411|69547294|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
37863758|NCT01256411|69547295|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
37863759|NCT01256411|69547296|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
37969062|NCT00619229|69656190|FG001|Overall Study|Lost to Follow-up|0|||
37969063|NCT00619229|69656189|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
37969064|NCT00619229|69656190|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
37969065|NCT00619229|69656189|FG000|Overall Study|Investigator planned Cataract Operation|1|||
37969066|NCT00619229|69656190|FG001|Overall Study|Investigator planned Cataract Operation|0|||
37969067|NCT00619151|69656198|FG000|Overall Study|Study terminated prior to followup|1|||
37969068|NCT00619151|69656199|FG001|Overall Study|Study terminated prior to followup|0|||
37969069|NCT00618995|69656205|FG000|Period 1|Adverse Event|0|||
37969070|NCT00618995|69656206|FG001|Period 1|Adverse Event|0|||
37777521|NCT02723019|69318911|FG000|Overall Study|Lost to Follow-up|57|||
37777522|NCT02723019|69318912|FG001|Overall Study|Lost to Follow-up|70|||
37777523|NCT00088166|69319162|FG000|Overall Study|Adverse Event|11|||
37777524|NCT00088166|69319163|FG001|Overall Study|Adverse Event|9|||
37777525|NCT00088166|69319162|FG000|Overall Study|Death|3|||
37777526|NCT00088166|69319163|FG001|Overall Study|Death|1|||
37777527|NCT00088166|69319162|FG000|Overall Study|Lost to Follow-up|0|||
37777528|NCT00088166|69319163|FG001|Overall Study|Lost to Follow-up|1|||
37777529|NCT00088166|69319162|FG000|Overall Study|Physician Decision|4|||
37777530|NCT00088166|69319163|FG001|Overall Study|Physician Decision|1|||
37777531|NCT00088166|69319162|FG000|Overall Study|Protocol Violation|1|||
37777532|NCT00088166|69319163|FG001|Overall Study|Protocol Violation|5|||
37777533|NCT00088166|69319162|FG000|Overall Study|Patient deterioration|29|||
37777534|NCT00088166|69319163|FG001|Overall Study|Patient deterioration|39|||
37777535|NCT00088166|69319162|FG000|Overall Study|Withdrawal by Subject|5|||
37777536|NCT00088166|69319163|FG001|Overall Study|Withdrawal by Subject|5|||
37777537|NCT00087698|69319207|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
37777538|NCT00087698|69319207|FG000|Overall Study|Death from Other Causes|3|||
37777539|NCT00087698|69319207|FG000|Overall Study|Adverse Event|4|||
37969071|NCT00618995|69656207|FG002|Period 1|Adverse Event|1|||
37691224|NCT02141997|69167519|FG000|Overall Study|Adverse Event|0|||
37691225|NCT02141997|69167520|FG001|Overall Study|Adverse Event|2|||
37691226|NCT02141997|69167521|FG002|Overall Study|Adverse Event|0|||
37691227|NCT02141997|69167522|FG003|Overall Study|Adverse Event|1|||
37691228|NCT02141997|69167519|FG000|Overall Study|Participant noncompliance|1|||
37691229|NCT02141997|69167520|FG001|Overall Study|Participant noncompliance|0|||
37691230|NCT02141997|69167521|FG002|Overall Study|Participant noncompliance|0|||
37691231|NCT02141997|69167522|FG003|Overall Study|Participant noncompliance|0|||
37691232|NCT02141997|69167519|FG000|Overall Study|Withdrew consent|1|||
37691233|NCT02141997|69167520|FG001|Overall Study|Withdrew consent|0|||
37691234|NCT02141997|69167521|FG002|Overall Study|Withdrew consent|3|||
37691235|NCT02141997|69167522|FG003|Overall Study|Withdrew consent|0|||
37691236|NCT02141997|69167519|FG000|Overall Study|Other|1|||
37691237|NCT02141997|69167520|FG001|Overall Study|Other|4|||
37691238|NCT02141997|69167521|FG002|Overall Study|Other|0|||
37691239|NCT02141997|69167522|FG003|Overall Study|Other|0|||
37691240|NCT01628367|69167534|FG000|Overall Study|Adverse Event|1|||
37691241|NCT01628367|69167535|FG001|Overall Study|Adverse Event|0|||
37691242|NCT01627899|69167541|FG000|Overall Study|Study terminated early by sponsor.|5|||
37691243|NCT02519777|69167548|FG000|Overall Study|Death|1|||
37777540|NCT00087698|69319207|FG000|Overall Study|Withdrawal by Subject|4|||
37777541|NCT00087698|69319207|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
37691244|NCT02519777|69167549|FG001|Overall Study|Death|0|||
37691245|NCT02519777|69167550|FG002|Overall Study|Death|0|||
37691246|NCT02519777|69167548|FG000|Overall Study|Lost to Follow-up|0|||
37777542|NCT00087698|69319207|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
37777543|NCT00087698|69319207|FG000|Overall Study|Clinical Relapse|1|||
37777544|NCT00087698|69319207|FG000|Overall Study|Death from Study Disease|2|||
37691247|NCT02519777|69167549|FG001|Overall Study|Lost to Follow-up|4|||
37777545|NCT00087698|69319207|FG000|Overall Study|Death from Study Drug Toxicity|2|||
37777546|NCT00087698|69319207|FG000|Overall Study|Protocol Violation|1|||
37777547|NCT00087152|69319225|FG000|Overall Study|Ineligible|6|||
37777548|NCT00086996|69319277|FG000|Overall Study|Adverse Event|29|||
37777549|NCT00086996|69319277|FG000|Overall Study|Death|4|||
37969072|NCT00618995|69656208|FG003|Period 1|Adverse Event|0|||
37969073|NCT00618995|69656205|FG000|Period 1|Protocol Violation|0|||
37969074|NCT00618995|69656206|FG001|Period 1|Protocol Violation|1|||
37969075|NCT00618995|69656207|FG002|Period 1|Protocol Violation|1|||
37969076|NCT00618995|69656208|FG003|Period 1|Protocol Violation|0|||
37969077|NCT00618995|69656205|FG000|Period 2|Protocol Violation|0|||
37777550|NCT00086996|69319277|FG000|Overall Study|progression/relapse|7|||
37777551|NCT00086996|69319277|FG000|Overall Study|Withdrawal by Subject|13|||
37777552|NCT00086996|69319277|FG000|Overall Study|Other|6|||
37777553|NCT00086996|69319277|FG000|Overall Study|not eligible|5|||
37777554|NCT00086684|69319579|FG000|Overall Study|Adverse Event|12|||
37777555|NCT00086684|69319580|FG001|Overall Study|Adverse Event|17|||
37777556|NCT00086684|69319581|FG002|Overall Study|Adverse Event|14|||
37777557|NCT00086684|69319579|FG000|Overall Study|Lack of Efficacy|6|||
37777558|NCT00086684|69319580|FG001|Overall Study|Lack of Efficacy|6|||
37777559|NCT00086684|69319581|FG002|Overall Study|Lack of Efficacy|5|||
37777560|NCT00086684|69319579|FG000|Overall Study|Lost to Follow-up|15|||
37777561|NCT00086684|69319580|FG001|Overall Study|Lost to Follow-up|8|||
37777562|NCT00086684|69319581|FG002|Overall Study|Lost to Follow-up|10|||
37777563|NCT00086684|69319579|FG000|Overall Study|Protocol Violation|8|||
37777564|NCT00086684|69319580|FG001|Overall Study|Protocol Violation|3|||
37777565|NCT00086684|69319581|FG002|Overall Study|Protocol Violation|0|||
37777566|NCT00086684|69319579|FG000|Overall Study|Withdrawal by Subject|0|||
37777567|NCT00086684|69319580|FG001|Overall Study|Withdrawal by Subject|4|||
37777568|NCT00086684|69319581|FG002|Overall Study|Withdrawal by Subject|10|||
37777569|NCT00086684|69319579|FG000|Overall Study|NONCOMPLIANCE|5|||
37777570|NCT00086684|69319580|FG001|Overall Study|NONCOMPLIANCE|7|||
37777571|NCT00086684|69319581|FG002|Overall Study|NONCOMPLIANCE|6|||
37777572|NCT00086684|69319579|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
37777573|NCT00086684|69319580|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
37777574|NCT00086684|69319581|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
37777575|NCT00086684|69319579|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
37777576|NCT00086684|69319580|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
37777577|NCT00086684|69319581|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
37777578|NCT00086684|69319579|FG000|Overall Study|Other|4|||
37777579|NCT00086684|69319580|FG001|Overall Study|Other|2|||
37777580|NCT00086684|69319581|FG002|Overall Study|Other|3|||
37777581|NCT00082628|69319645|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
37777582|NCT00082628|69319646|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
37777583|NCT00082628|69319647|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
37777584|NCT00082628|69319648|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
37777585|NCT00082628|69319649|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
37777586|NCT00082628|69319645|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
37969078|NCT00618995|69656206|FG001|Period 2|Protocol Violation|0|||
37969079|NCT00618995|69656207|FG002|Period 2|Protocol Violation|1|||
37969080|NCT00618995|69656208|FG003|Period 2|Protocol Violation|0|||
37969081|NCT00618995|69656205|FG000|Period 4|Adverse Event|1|||
37969082|NCT00618995|69656206|FG001|Period 4|Adverse Event|0|||
37969083|NCT00618995|69656207|FG002|Period 4|Adverse Event|0|||
37969084|NCT00618995|69656208|FG003|Period 4|Adverse Event|0|||
37777587|NCT00082628|69319646|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
37777588|NCT00082628|69319647|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
37863760|NCT01256411|69547297|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
37777589|NCT00082628|69319648|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
37777590|NCT00082628|69319649|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
37969085|NCT03685344|69656222|FG000|Overall Study|Withdrawal by Subject|1|||
37969086|NCT03685344|69656223|FG001|Overall Study|Withdrawal by Subject|1|||
37863761|NCT01256411|69547298|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
37969087|NCT03685344|69656224|FG002|Overall Study|Withdrawal by Subject|2|||
37969088|NCT03685344|69656225|FG003|Overall Study|Withdrawal by Subject|0|||
37969089|NCT03685344|69656222|FG000|Overall Study|Physician Decision|1|||
37969090|NCT03685344|69656223|FG001|Overall Study|Physician Decision|1|||
37863762|NCT01256411|69547299|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
37863763|NCT00996580|69547313|FG000|Overall Study|Adverse Event|466|||
37863764|NCT00996580|69547313|FG000|Overall Study|Lost to Follow-up|480|||
37863765|NCT00996580|69547313|FG000|Overall Study|Noncompliance with the protocol|137|||
37863766|NCT00996580|69547313|FG000|Overall Study|Physician Decision|5|||
37969091|NCT03685344|69656224|FG002|Overall Study|Physician Decision|5|||
37969092|NCT03685344|69656225|FG003|Overall Study|Physician Decision|0|||
37969093|NCT03685344|69656222|FG000|Overall Study|Death|1|||
37969094|NCT03685344|69656223|FG001|Overall Study|Death|1|||
37969095|NCT03685344|69656224|FG002|Overall Study|Death|0|||
37969096|NCT03685344|69656225|FG003|Overall Study|Death|0|||
37969097|NCT00520572|69656241|FG000|Overall Study|Adverse Event|9|||
37969098|NCT00520572|69656242|FG001|Overall Study|Adverse Event|3|||
37969099|NCT00520572|69656243|FG002|Overall Study|Adverse Event|6|||
37969100|NCT00520572|69656244|FG003|Overall Study|Adverse Event|9|||
37969101|NCT00520572|69656245|FG004|Overall Study|Adverse Event|7|||
37969102|NCT00520572|69656246|FG005|Overall Study|Adverse Event|2|||
37777591|NCT00082628|69319645|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
37777592|NCT00082628|69319646|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
37777593|NCT00082628|69319647|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
37777594|NCT00082628|69319648|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
37777595|NCT00082628|69319649|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
37777596|NCT00082628|69319645|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
37777597|NCT00082628|69319646|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
37777598|NCT00082628|69319647|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
37777599|NCT00082628|69319648|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
37777600|NCT00082628|69319649|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
37777601|NCT00082628|69319645|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
37777602|NCT00082628|69319646|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
37777603|NCT00082628|69319647|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
37777604|NCT00082628|69319648|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
37777605|NCT00082628|69319649|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
37777606|NCT00082628|69319645|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
37777607|NCT00082628|69319646|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
37777608|NCT00082628|69319647|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
37777609|NCT00082628|69319648|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
37777610|NCT00082628|69319649|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
37777611|NCT00082628|69319645|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
37777612|NCT00082628|69319646|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
37777613|NCT00082628|69319647|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
37777614|NCT00082628|69319648|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
37863767|NCT00996580|69547313|FG000|Overall Study|Pregnancy|68|||
37863768|NCT00996580|69547313|FG000|Overall Study|Protocol Violation|16|||
37863769|NCT00996580|69547313|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
37863770|NCT00996580|69547313|FG000|Overall Study|Withdrawal by Subject|217|||
37863771|NCT00996580|69547313|FG000|Overall Study|Other|29|||
37863772|NCT01124175|69547322|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
37863773|NCT01124175|69547323|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
37863774|NCT01256177|69547331|FG000|Overall Study|Withdrawal by Subject|23|||
37863775|NCT01256177|69547332|FG001|Overall Study|Withdrawal by Subject|22|||
37969103|NCT00520572|69656241|FG000|Overall Study|Withdrawal by Subject|0|||
37969104|NCT00520572|69656242|FG001|Overall Study|Withdrawal by Subject|9|||
37969105|NCT00520572|69656243|FG002|Overall Study|Withdrawal by Subject|5|||
37969106|NCT00520572|69656244|FG003|Overall Study|Withdrawal by Subject|2|||
37969107|NCT00520572|69656245|FG004|Overall Study|Withdrawal by Subject|2|||
37863776|NCT01256177|69547331|FG000|Overall Study|Lost to Follow-up|2|||
37863777|NCT01256177|69547332|FG001|Overall Study|Lost to Follow-up|2|||
37863778|NCT01256177|69547331|FG000|Overall Study|Adverse Event|8|||
37777615|NCT00082628|69319649|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
37777616|NCT02993263|69319991|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
37777617|NCT01274533|69320019|FG000|Overall Study|Withdrawal by Subject|1|||
37777618|NCT01274533|69320019|FG000|Overall Study|Non-compliance|1|||
37777619|NCT01274533|69320019|FG000|Overall Study|Disease progression|2|||
37777620|NCT01273597|69320023|FG000|Overall Study|Adverse Event|5|||
37777621|NCT01273597|69320023|FG000|Overall Study|Underwent Kidney Transplantation|2|||
37777622|NCT01273597|69320023|FG000|Overall Study|Reason Not Reported|1|||
37777623|NCT01273519|69320030|FG000|Overall Study|Adverse Event|3|||
37777624|NCT01273519|69320031|FG001|Overall Study|Adverse Event|0|||
37777625|NCT01273519|69320032|FG002|Overall Study|Adverse Event|0|||
37777626|NCT01273519|69320030|FG000|Overall Study|Lost to Follow-up|2|||
37777627|NCT01273519|69320031|FG001|Overall Study|Lost to Follow-up|1|||
37777628|NCT01273519|69320032|FG002|Overall Study|Lost to Follow-up|3|||
37777629|NCT01273519|69320030|FG000|Overall Study|Lack of Efficacy|8|||
37777630|NCT01273519|69320031|FG001|Overall Study|Lack of Efficacy|3|||
37777631|NCT01273519|69320032|FG002|Overall Study|Lack of Efficacy|4|||
37777632|NCT01273519|69320030|FG000|Overall Study|Other|6|||
37777633|NCT01273519|69320031|FG001|Overall Study|Other|1|||
37777634|NCT01273519|69320032|FG002|Overall Study|Other|1|||
37777635|NCT01272661|69320089|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
37777636|NCT01272661|69320090|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
37777637|NCT01272661|69320091|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
37777638|NCT04276051|69320257|FG000|Overall Study|Lost to Follow-up|0|||
37777639|NCT04276051|69320258|FG001|Overall Study|Lost to Follow-up|1|||
37777640|NCT04276051|69320257|FG000|Overall Study|Physician Decision|0|||
37777641|NCT04276051|69320258|FG001|Overall Study|Physician Decision|1|||
37777642|NCT04276051|69320257|FG000|Overall Study|Withdrawal by Subject|1|||
37777643|NCT04276051|69320258|FG001|Overall Study|Withdrawal by Subject|1|||
37969108|NCT00520572|69656246|FG005|Overall Study|Withdrawal by Subject|0|||
37969109|NCT00520572|69656241|FG000|Overall Study|Protocol Violation|0|||
37969110|NCT00520572|69656242|FG001|Overall Study|Protocol Violation|0|||
37969111|NCT00520572|69656243|FG002|Overall Study|Protocol Violation|1|||
37969112|NCT00520572|69656244|FG003|Overall Study|Protocol Violation|0|||
37777644|NCT00081770|69320518|FG000|Overall Study|Adverse Event|130|||
37777645|NCT00081770|69320519|FG001|Overall Study|Adverse Event|98|||
37777646|NCT00081770|69320520|FG002|Overall Study|Adverse Event|136|||
37777647|NCT00081770|69320518|FG000|Overall Study|Lack of Efficacy|262|||
37777648|NCT00081770|69320519|FG001|Overall Study|Lack of Efficacy|357|||
37969113|NCT00520572|69656245|FG004|Overall Study|Protocol Violation|0|||
37969114|NCT00520572|69656246|FG005|Overall Study|Protocol Violation|0|||
37777649|NCT00081770|69320520|FG002|Overall Study|Lack of Efficacy|211|||
37777650|NCT00081770|69320518|FG000|Overall Study|Lost to Follow-up|45|||
37777651|NCT00081770|69320519|FG001|Overall Study|Lost to Follow-up|34|||
37777652|NCT00081770|69320520|FG002|Overall Study|Lost to Follow-up|45|||
37777653|NCT00081770|69320518|FG000|Overall Study|Protocol Violation|15|||
37969115|NCT00520572|69656241|FG000|Overall Study|Lack of Efficacy|1|||
37969116|NCT00520572|69656242|FG001|Overall Study|Lack of Efficacy|1|||
37969117|NCT00520572|69656243|FG002|Overall Study|Lack of Efficacy|1|||
37969118|NCT00520572|69656244|FG003|Overall Study|Lack of Efficacy|2|||
37969119|NCT00520572|69656245|FG004|Overall Study|Lack of Efficacy|1|||
37969120|NCT00520572|69656246|FG005|Overall Study|Lack of Efficacy|0|||
37969121|NCT00520572|69656241|FG000|Overall Study|Lost to Follow-up|0|||
37969122|NCT00520572|69656242|FG001|Overall Study|Lost to Follow-up|0|||
37969123|NCT00520572|69656243|FG002|Overall Study|Lost to Follow-up|0|||
37969124|NCT00520572|69656244|FG003|Overall Study|Lost to Follow-up|0|||
37969125|NCT00520572|69656245|FG004|Overall Study|Lost to Follow-up|1|||
37969126|NCT00520572|69656246|FG005|Overall Study|Lost to Follow-up|0|||
37969127|NCT00520572|69656241|FG000|Overall Study|Incorrect enrollment|1|||
37969128|NCT00520572|69656242|FG001|Overall Study|Incorrect enrollment|0|||
37969129|NCT00520572|69656243|FG002|Overall Study|Incorrect enrollment|1|||
37969130|NCT00520572|69656244|FG003|Overall Study|Incorrect enrollment|0|||
37969131|NCT00520572|69656245|FG004|Overall Study|Incorrect enrollment|1|||
37969132|NCT00520572|69656246|FG005|Overall Study|Incorrect enrollment|0|||
37969133|NCT00520572|69656241|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
37969134|NCT00520572|69656242|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
37969135|NCT00520572|69656243|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
37691248|NCT02519777|69167550|FG002|Overall Study|Lost to Follow-up|2|||
37777654|NCT00081770|69320519|FG001|Overall Study|Protocol Violation|10|||
37691249|NCT02519777|69167548|FG000|Overall Study|Withdrawal by Subject|3|||
37691250|NCT02519777|69167549|FG001|Overall Study|Withdrawal by Subject|1|||
37777655|NCT00081770|69320520|FG002|Overall Study|Protocol Violation|10|||
37777656|NCT00081770|69320518|FG000|Overall Study|Withdrawal by Subject|45|||
37777657|NCT00081770|69320519|FG001|Overall Study|Withdrawal by Subject|40|||
37777658|NCT00081770|69320520|FG002|Overall Study|Withdrawal by Subject|42|||
37777659|NCT00081770|69320518|FG000|Overall Study|Did not meet protocol eligibility|2|||
37777660|NCT00081770|69320519|FG001|Overall Study|Did not meet protocol eligibility|0|||
37777661|NCT00081770|69320520|FG002|Overall Study|Did not meet protocol eligibility|3|||
37777662|NCT00081770|69320518|FG000|Overall Study|Administrative|1|||
37777663|NCT00081770|69320519|FG001|Overall Study|Administrative|0|||
37777664|NCT00081770|69320520|FG002|Overall Study|Administrative|1|||
37777665|NCT00081770|69320518|FG000|Overall Study|Other|2|||
37777666|NCT00081770|69320519|FG001|Overall Study|Other|7|||
37777667|NCT00081770|69320520|FG002|Overall Study|Other|8|||
37777668|NCT00081458|69320620|FG000|Overall Study|Adverse Event|1|||
37777669|NCT00081458|69320621|FG001|Overall Study|Adverse Event|5|||
37777670|NCT00081458|69320622|FG002|Overall Study|Adverse Event|2|||
37777671|NCT00081458|69320620|FG000|Overall Study|Withdrawal by Subject|0|||
37777672|NCT00081458|69320621|FG001|Overall Study|Withdrawal by Subject|3|||
37777673|NCT00081458|69320622|FG002|Overall Study|Withdrawal by Subject|1|||
37777674|NCT00081458|69320620|FG000|Overall Study|Randomized but not dosed|0|||
37777675|NCT00081458|69320621|FG001|Overall Study|Randomized but not dosed|0|||
37777676|NCT00081458|69320622|FG002|Overall Study|Randomized but not dosed|1|||
37969136|NCT00520572|69656244|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
37969137|NCT00520572|69656245|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
37691251|NCT02519777|69167550|FG002|Overall Study|Withdrawal by Subject|0|||
37691252|NCT02519777|69167548|FG000|Overall Study|Severe Debilitation|1|||
37691253|NCT02519777|69167549|FG001|Overall Study|Severe Debilitation|1|||
37691254|NCT02519777|69167550|FG002|Overall Study|Severe Debilitation|1|||
37691255|NCT02519777|69167548|FG000|Overall Study|Not able to get to clinic|1|||
37691256|NCT02519777|69167549|FG001|Overall Study|Not able to get to clinic|2|||
37691257|NCT02519777|69167550|FG002|Overall Study|Not able to get to clinic|1|||
37777677|NCT01271803|69320699|FG000|Overall Study|Progressive disease|0|||
37777678|NCT01271803|69320700|FG001|Overall Study|Progressive disease|0|||
37777679|NCT01271803|69320701|FG002|Overall Study|Progressive disease|2|||
37777680|NCT01271803|69320699|FG000|Overall Study|Death|53|||
37969138|NCT00520572|69656246|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
37969139|NCT00520572|69656241|FG000|Overall Study|Long break in taking Medication|0|||
37969140|NCT00520572|69656242|FG001|Overall Study|Long break in taking Medication|0|||
37691258|NCT02515331|69167561|FG000|Overall Study|Withdrawal by Subject|0|||
37691259|NCT02515331|69167562|FG001|Overall Study|Withdrawal by Subject|0|||
37777681|NCT01271803|69320700|FG001|Overall Study|Death|34|||
37777682|NCT01271803|69320701|FG002|Overall Study|Death|0|||
37777683|NCT01271803|69320699|FG000|Overall Study|Withdrawal by Subject|1|||
37777684|NCT01271803|69320700|FG001|Overall Study|Withdrawal by Subject|5|||
37777685|NCT01271803|69320701|FG002|Overall Study|Withdrawal by Subject|0|||
37777686|NCT01271803|69320699|FG000|Overall Study|Lost to Follow-up|1|||
37777687|NCT01271803|69320700|FG001|Overall Study|Lost to Follow-up|0|||
37777688|NCT01271803|69320701|FG002|Overall Study|Lost to Follow-up|0|||
37777689|NCT00080288|69320752|FG000|Overall Study|Adverse Event|7|||
37777690|NCT00080288|69320753|FG001|Overall Study|Adverse Event|4|||
37777691|NCT00080288|69320752|FG000|Overall Study|Lost to Follow-up|3|||
37777692|NCT00080288|69320753|FG001|Overall Study|Lost to Follow-up|5|||
37777693|NCT00080288|69320752|FG000|Overall Study|Physician Decision|6|||
37777694|NCT00080288|69320753|FG001|Overall Study|Physician Decision|2|||
37777695|NCT00080288|69320752|FG000|Overall Study|Withdrawal by Subject|3|||
37777696|NCT00080288|69320753|FG001|Overall Study|Withdrawal by Subject|16|||
37777697|NCT00080288|69320752|FG000|Overall Study|Miscellaneous|11|||
37777698|NCT00080288|69320753|FG001|Overall Study|Miscellaneous|11|||
37777699|NCT01271725|69320819|FG000|Part A|Progressive disease according to RECIST|8|||
37777700|NCT01271725|69320820|FG001|Part A|Progressive disease according to RECIST|0|||
37777701|NCT01271725|69320819|FG000|Part A|Clinical signs/symptoms of progression|2|||
37777702|NCT01271725|69320820|FG001|Part A|Clinical signs/symptoms of progression|0|||
37777703|NCT01271725|69320819|FG000|Part A|Other Adverse Event|8|||
37777704|NCT01271725|69320820|FG001|Part A|Other Adverse Event|0|||
37777705|NCT01271725|69320819|FG000|Part A|Lost to Follow-up|1|||
37777706|NCT01271725|69320820|FG001|Part A|Lost to Follow-up|0|||
37777707|NCT01271725|69320819|FG000|Part A|Withdrawal by Subject|12|||
37777708|NCT01271725|69320820|FG001|Part A|Withdrawal by Subject|0|||
37777709|NCT01271725|69320819|FG000|Part A|Other than specified|3|||
37777710|NCT01271725|69320820|FG001|Part A|Other than specified|0|||
37777711|NCT01271725|69320819|FG000|Part A|Protocol Violation|1|||
37969141|NCT00520572|69656243|FG002|Overall Study|Long break in taking Medication|0|||
37969142|NCT00520572|69656244|FG003|Overall Study|Long break in taking Medication|1|||
37969143|NCT00520572|69656245|FG004|Overall Study|Long break in taking Medication|0|||
37969144|NCT00520572|69656246|FG005|Overall Study|Long break in taking Medication|0|||
37969145|NCT00520572|69656241|FG000|Overall Study|Did not receive Treatment|1|||
37969146|NCT00520572|69656242|FG001|Overall Study|Did not receive Treatment|0|||
37969147|NCT00520572|69656243|FG002|Overall Study|Did not receive Treatment|1|||
37969148|NCT00520572|69656244|FG003|Overall Study|Did not receive Treatment|0|||
37691260|NCT02515331|69167563|FG002|Overall Study|Withdrawal by Subject|1|||
37969149|NCT00520572|69656245|FG004|Overall Study|Did not receive Treatment|0|||
37969150|NCT00520572|69656246|FG005|Overall Study|Did not receive Treatment|0|||
37969151|NCT00573833|69656260|FG000|Overall Study|Not Treated|2|||
37777712|NCT01271725|69320820|FG001|Part A|Protocol Violation|0|||
37777713|NCT01271725|69320819|FG000|Part B|Other than specified|0|||
37777714|NCT01271725|69320820|FG001|Part B|Other than specified|2|||
37777715|NCT01271725|69320819|FG000|Part B|Clinical signs/symptoms of progression|0|||
37969152|NCT00520494|69656264|FG000|Overall Study|Withdrawal by Subject|1|||
37969153|NCT00527514|69656268|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
37969154|NCT00527514|69656268|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
37691261|NCT02515331|69167561|FG000|Overall Study|Protocol deviation|0|||
37691262|NCT02515331|69167562|FG001|Overall Study|Protocol deviation|0|||
37691263|NCT02515331|69167563|FG002|Overall Study|Protocol deviation|3|||
37691264|NCT02515331|69167561|FG000|Overall Study|Adverse Event|2|||
37777716|NCT01271725|69320820|FG001|Part B|Clinical signs/symptoms of progression|2|||
37777717|NCT01271725|69320819|FG000|Part B|Other Adverse Event|0|||
37777718|NCT01271725|69320820|FG001|Part B|Other Adverse Event|1|||
37777719|NCT01271725|69320819|FG000|Part B|Protocol Violation|0|||
37777720|NCT01271725|69320820|FG001|Part B|Protocol Violation|1|||
37777721|NCT01271725|69320819|FG000|Part B|Withdrawal by Subject|0|||
37777722|NCT01271725|69320820|FG001|Part B|Withdrawal by Subject|6|||
37777723|NCT01270321|69320845|FG000|Overall Study|Death|3|||
37777724|NCT01270321|69320846|FG001|Overall Study|Death|1|||
37969155|NCT00527514|69656268|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
37969156|NCT00527514|69656268|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
37691265|NCT02515331|69167562|FG001|Overall Study|Adverse Event|0|||
37691266|NCT02515331|69167563|FG002|Overall Study|Adverse Event|0|||
37691267|NCT02515097|69167573|FG000|Overall Study|Lost to Follow-up|4|||
37691268|NCT02515097|69167574|FG001|Overall Study|Lost to Follow-up|2|||
37777725|NCT01270321|69320847|FG002|Overall Study|Death|4|||
37777726|NCT01270321|69320845|FG000|Overall Study|Adverse Event|7|||
37777727|NCT01270321|69320846|FG001|Overall Study|Adverse Event|9|||
37777728|NCT01270321|69320847|FG002|Overall Study|Adverse Event|5|||
37777729|NCT00249769|69320941|FG000|Overall Study|Withdrawal by Subject|1|||
37777730|NCT00249769|69320942|FG001|Overall Study|Withdrawal by Subject|10|||
37777731|NCT00249769|69320943|FG002|Overall Study|Withdrawal by Subject|6|||
37777732|NCT00249769|69320941|FG000|Overall Study|Migration from Study Area|1|||
37777733|NCT00249769|69320942|FG001|Overall Study|Migration from Study Area|3|||
37777734|NCT00249769|69320943|FG002|Overall Study|Migration from Study Area|14|||
37777735|NCT00249769|69320941|FG000|Overall Study|Miscellaneous|0|||
37777736|NCT00249769|69320942|FG001|Overall Study|Miscellaneous|2|||
37777737|NCT00249769|69320943|FG002|Overall Study|Miscellaneous|2|||
37777738|NCT00249769|69320941|FG000|Overall Study|Adverse Event|0|||
37777739|NCT00249769|69320942|FG001|Overall Study|Adverse Event|0|||
37777740|NCT00249769|69320943|FG002|Overall Study|Adverse Event|1|||
37777741|NCT00249769|69320941|FG000|Overall Study|Physician Decision|0|||
37777742|NCT00249769|69320942|FG001|Overall Study|Physician Decision|0|||
37777743|NCT00249769|69320943|FG002|Overall Study|Physician Decision|2|||
37777744|NCT00249769|69320941|FG000|Overall Study|Lost to Follow-up|0|||
37777745|NCT00249769|69320942|FG001|Overall Study|Lost to Follow-up|0|||
37777746|NCT00249769|69320943|FG002|Overall Study|Lost to Follow-up|3|||
37777747|NCT00249613|69320953|FG000|12 Month Follow-up|Death|1|||
37777748|NCT00249613|69320954|FG001|12 Month Follow-up|Death|1|||
37777749|NCT00249613|69320953|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
37777750|NCT00249613|69320954|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
37777751|NCT00249613|69320953|FG000|12 Month Follow-up|Lost to Follow-up|10|||
37691269|NCT02515097|69167573|FG000|Overall Study|Withdrawal by Subject|1|||
37691270|NCT02515097|69167574|FG001|Overall Study|Withdrawal by Subject|3|||
37691271|NCT02515097|69167573|FG000|Overall Study|Adverse Event|2|||
37777752|NCT00249613|69320954|FG001|12 Month Follow-up|Lost to Follow-up|8|||
37777753|NCT00248833|69320990|FG000|Overall Study|Adverse Event|2|||
37777754|NCT00248833|69320991|FG001|Overall Study|Adverse Event|0|||
37777755|NCT00248833|69320992|FG002|Overall Study|Adverse Event|0|||
37777756|NCT00248833|69320990|FG000|Overall Study|Withdrawal by Subject|0|||
37777757|NCT00248833|69320991|FG001|Overall Study|Withdrawal by Subject|1|||
37777758|NCT00248833|69320992|FG002|Overall Study|Withdrawal by Subject|1|||
37777759|NCT00248833|69320990|FG000|Overall Study|Lost to Follow-up|1|||
37777760|NCT00248833|69320991|FG001|Overall Study|Lost to Follow-up|1|||
37777761|NCT00248833|69320992|FG002|Overall Study|Lost to Follow-up|1|||
37777762|NCT00248833|69320990|FG000|Overall Study|Other|0|||
37777763|NCT00248833|69320991|FG001|Overall Study|Other|1|||
37777764|NCT00248833|69320992|FG002|Overall Study|Other|0|||
37777765|NCT00247273|69321163|FG000|Overall Study|Adverse Event|85|||
37777766|NCT00247273|69321164|FG001|Overall Study|Adverse Event|80|||
37777767|NCT00247273|69321163|FG000|Overall Study|Physician Decision|6|||
37777768|NCT00247273|69321164|FG001|Overall Study|Physician Decision|3|||
37691272|NCT02515097|69167574|FG001|Overall Study|Adverse Event|1|||
37969157|NCT00527514|69656268|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
37969158|NCT00527514|69656268|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
37969159|NCT00527514|69656268|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
37969160|NCT00618449|69656281|FG000|Overall Study|Lost to Follow-up|98|||
37691273|NCT02141295|69167583|FG000|Overall Study|Adverse Event|1|||
37691274|NCT02141295|69167584|FG001|Overall Study|Adverse Event|18|||
37691275|NCT02141295|69167585|FG002|Overall Study|Adverse Event|11|||
37691276|NCT02141295|69167583|FG000|Overall Study|Physician Decision|2|||
37691277|NCT02141295|69167584|FG001|Overall Study|Physician Decision|19|||
37691278|NCT02141295|69167585|FG002|Overall Study|Physician Decision|14|||
37691279|NCT02141295|69167583|FG000|Overall Study|Study terminated by sponsor|0|||
37777769|NCT00247273|69321163|FG000|Overall Study|Lost to Follow-up|7|||
37777770|NCT00247273|69321164|FG001|Overall Study|Lost to Follow-up|7|||
37777771|NCT00247273|69321163|FG000|Overall Study|Withdrawal by Subject|46|||
37969161|NCT00618449|69656282|FG001|Overall Study|Lost to Follow-up|110|||
37969162|NCT03684642|69656291|FG000|Overall Study|Adverse Event|6|||
37777772|NCT00247273|69321164|FG001|Overall Study|Withdrawal by Subject|47|||
37777773|NCT00247273|69321163|FG000|Overall Study|Did not take any study drug|2|||
37777774|NCT00247273|69321164|FG001|Overall Study|Did not take any study drug|0|||
37777775|NCT00246259|69321252|FG000|Overall Study|Other|3|||
37777776|NCT00246259|69321253|FG001|Overall Study|Other|3|||
37777777|NCT00246259|69321252|FG000|Overall Study|Not stable by Week 18|2|||
37969163|NCT03684642|69656292|FG001|Overall Study|Adverse Event|15|||
37969164|NCT03684642|69656293|FG002|Overall Study|Adverse Event|11|||
37969165|NCT03684642|69656291|FG000|Overall Study|Withdrawal by Subject|35|||
37691280|NCT02141295|69167584|FG001|Overall Study|Study terminated by sponsor|6|||
37691281|NCT02141295|69167585|FG002|Overall Study|Study terminated by sponsor|6|||
37969166|NCT03684642|69656292|FG001|Overall Study|Withdrawal by Subject|53|||
37691282|NCT02141295|69167583|FG000|Overall Study|Non-compliance|0|||
37691283|NCT02141295|69167584|FG001|Overall Study|Non-compliance|1|||
37691284|NCT02141295|69167585|FG002|Overall Study|Non-compliance|0|||
37969167|NCT03684642|69656293|FG002|Overall Study|Withdrawal by Subject|23|||
37969168|NCT03684642|69656291|FG000|Overall Study|Lack of Efficacy|0|||
37969169|NCT03684642|69656292|FG001|Overall Study|Lack of Efficacy|0|||
37969170|NCT03684642|69656293|FG002|Overall Study|Lack of Efficacy|1|||
37969171|NCT03684642|69656291|FG000|Overall Study|Poor compliance to protocol|0|||
37969172|NCT03684642|69656292|FG001|Overall Study|Poor compliance to protocol|4|||
37969173|NCT03684642|69656293|FG002|Overall Study|Poor compliance to protocol|1|||
37969174|NCT03684642|69656291|FG000|Overall Study|Other than specified|62|||
37969175|NCT03684642|69656292|FG001|Overall Study|Other than specified|60|||
37969176|NCT03684642|69656293|FG002|Overall Study|Other than specified|67|||
37969177|NCT03684642|69656291|FG000|Overall Study|Randomized and not treated|0|||
37969178|NCT03684642|69656292|FG001|Overall Study|Randomized and not treated|0|||
37969179|NCT03684642|69656293|FG002|Overall Study|Randomized and not treated|1|||
37969180|NCT03684642|69656291|FG000|Overall Study|Missing completion status but alive at last contact|0|||
37969181|NCT03684642|69656292|FG001|Overall Study|Missing completion status but alive at last contact|1|||
37969182|NCT03684642|69656293|FG002|Overall Study|Missing completion status but alive at last contact|2|||
37969183|NCT00519636|69656305|FG000|Treatment Period 1|Adverse Event|1|||
37969184|NCT00519636|69656306|FG001|Treatment Period 1|Adverse Event|0|||
37969185|NCT00519636|69656307|FG002|Treatment Period 1|Adverse Event|1|||
37969186|NCT00519636|69656308|FG003|Treatment Period 1|Adverse Event|0|||
37691285|NCT02141295|69167583|FG000|Overall Study|Progressive disease|3|||
37691286|NCT02141295|69167584|FG001|Overall Study|Progressive disease|32|||
37691287|NCT02141295|69167585|FG002|Overall Study|Progressive disease|50|||
37691288|NCT02141295|69167583|FG000|Overall Study|Reason not specified|0|||
37691289|NCT02141295|69167584|FG001|Overall Study|Reason not specified|9|||
37863779|NCT01256177|69547332|FG001|Overall Study|Adverse Event|9|||
37691290|NCT02141295|69167585|FG002|Overall Study|Reason not specified|10|||
37691291|NCT02141295|69167583|FG000|Overall Study|Withdrawal by Subject|0|||
37863780|NCT01256177|69547331|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
37969187|NCT00519636|69656305|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
37969188|NCT00519636|69656306|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
37777778|NCT00246259|69321253|FG001|Overall Study|Not stable by Week 18|1|||
37777779|NCT00246259|69321252|FG000|Overall Study|Participant non-compliant|4|||
37777780|NCT00246259|69321253|FG001|Overall Study|Participant non-compliant|9|||
37777781|NCT00246259|69321252|FG000|Overall Study|Lack of Efficacy|2|||
37777782|NCT00246259|69321253|FG001|Overall Study|Lack of Efficacy|2|||
37777783|NCT00246259|69321252|FG000|Overall Study|Investigator withdrew participant|2|||
37777784|NCT00246259|69321253|FG001|Overall Study|Investigator withdrew participant|0|||
37777785|NCT00246259|69321252|FG000|Overall Study|Adverse Event|5|||
37777786|NCT00246259|69321253|FG001|Overall Study|Adverse Event|0|||
37777787|NCT00246259|69321252|FG000|Overall Study|Lost to Follow-up|3|||
37777788|NCT00246259|69321253|FG001|Overall Study|Lost to Follow-up|4|||
37777789|NCT00246259|69321252|FG000|Overall Study|Withdrawal by Subject|5|||
37777790|NCT00246259|69321253|FG001|Overall Study|Withdrawal by Subject|1|||
37777791|NCT00246259|69321252|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
37777792|NCT00246259|69321253|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
37777793|NCT00246025|69321305|FG000|Overall Study|Adverse Event|7|||
37777794|NCT00246025|69321306|FG001|Overall Study|Adverse Event|9|||
37777795|NCT00246025|69321307|FG002|Overall Study|Adverse Event|9|||
37777796|NCT00246025|69321308|FG003|Overall Study|Adverse Event|10|||
37777797|NCT00246025|69321305|FG000|Overall Study|Withdrawal by Subject|3|||
37777798|NCT00246025|69321306|FG001|Overall Study|Withdrawal by Subject|0|||
37777799|NCT00246025|69321307|FG002|Overall Study|Withdrawal by Subject|1|||
37777800|NCT00246025|69321308|FG003|Overall Study|Withdrawal by Subject|2|||
37777801|NCT00246025|69321305|FG000|Overall Study|unsuitable medical history was found|0|||
37777802|NCT00246025|69321306|FG001|Overall Study|unsuitable medical history was found|0|||
37777803|NCT00246025|69321307|FG002|Overall Study|unsuitable medical history was found|0|||
37777804|NCT00246025|69321308|FG003|Overall Study|unsuitable medical history was found|1|||
37777805|NCT00245011|69321438|FG000|Overall Study|Lack of Efficacy|1|||
37777806|NCT00244855|69321457|FG000|Overall Study|Withdrawal by Subject|0|||
37777807|NCT00244855|69321458|FG001|Overall Study|Withdrawal by Subject|1|||
37777808|NCT00244621|69321488|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
37777809|NCT00244621|69321489|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
37777810|NCT00244621|69321490|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
37969189|NCT00519636|69656307|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
37969190|NCT00519636|69656308|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
37777811|NCT00244621|69321488|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
37777812|NCT00244621|69321489|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
37777813|NCT00244621|69321490|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
37777814|NCT00244621|69321488|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
37777815|NCT00244621|69321489|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
37777816|NCT00244621|69321490|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
37777817|NCT00244621|69321488|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
37777818|NCT00244621|69321489|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
37777819|NCT00244621|69321490|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
37777820|NCT00244621|69321488|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
37777821|NCT00244621|69321489|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
37777822|NCT00244621|69321490|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
37777823|NCT00244621|69321488|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
37777824|NCT00244621|69321489|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
37777825|NCT00244621|69321490|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
37777826|NCT00244621|69321488|FG000|Open-label Treatment Period|Adverse Event|0|||
37777827|NCT00244621|69321489|FG001|Open-label Treatment Period|Adverse Event|0|||
37777828|NCT00244621|69321490|FG002|Open-label Treatment Period|Adverse Event|1|||
37777829|NCT00244621|69321488|FG000|Open-label Treatment Period|Moved abroad|0|||
37777830|NCT00244621|69321489|FG001|Open-label Treatment Period|Moved abroad|0|||
37777831|NCT00244621|69321490|FG002|Open-label Treatment Period|Moved abroad|1|||
37777832|NCT00243841|69321573|FG000|Overall Study|Physician Decision|0|||
37777833|NCT00243841|69321574|FG001|Overall Study|Physician Decision|0|||
37969191|NCT00519636|69656305|FG000|Washout Period|Adverse Event|2|||
37969192|NCT00519636|69656306|FG001|Washout Period|Adverse Event|1|||
37969193|NCT00519636|69656307|FG002|Washout Period|Adverse Event|1|||
37777834|NCT00243841|69321575|FG002|Overall Study|Physician Decision|1|||
37777835|NCT00243841|69321576|FG003|Overall Study|Physician Decision|0|||
37777836|NCT00243841|69321577|FG004|Overall Study|Physician Decision|0|||
37777837|NCT00243841|69321578|FG005|Overall Study|Physician Decision|2|||
37969194|NCT00519636|69656308|FG003|Washout Period|Adverse Event|0|||
37777838|NCT02980731|69321771|FG000|Overall Study|Death|63|||
37777839|NCT02980731|69321771|FG000|Overall Study|Withdrawal by Subject|6|||
37777840|NCT02980731|69321771|FG000|Overall Study|Lost to Follow-up|5|||
37777841|NCT02980731|69321771|FG000|Overall Study|Study terminated by Sponsor|4|||
37777842|NCT02980731|69321771|FG000|Overall Study|Completed survival follow-up period|65|||
37777843|NCT02980731|69321771|FG000|Overall Study|COVID-19 infection|1|||
37777844|NCT02980731|69321771|FG000|Overall Study|Other, not specified|66|||
37777845|NCT02641587|69321811|FG000|Confinement Period|Adverse Event|1|||
37777846|NCT02641587|69321812|FG001|Confinement Period|Adverse Event|0|||
37777847|NCT02641587|69321811|FG000|Confinement Period|Withdrawal by Subject|2|||
37777848|NCT02641587|69321812|FG001|Confinement Period|Withdrawal by Subject|1|||
37777849|NCT02641587|69321811|FG000|Ambulatory Period|Withdrawal by Subject|1|||
37777850|NCT02641587|69321812|FG001|Ambulatory Period|Withdrawal by Subject|0|||
37777851|NCT04672083|69321919|FG000|Overall Study|Lost to Follow-up|1|||
37777852|NCT04672083|69321920|FG001|Overall Study|Lost to Follow-up|0|||
37777853|NCT04672083|69321921|FG002|Overall Study|Lost to Follow-up|0|||
37777854|NCT04672083|69321922|FG003|Overall Study|Lost to Follow-up|0|||
37777855|NCT04672083|69321923|FG004|Overall Study|Lost to Follow-up|0|||
37777856|NCT01781637|69322026|FG000|Overall Study|Adverse Event|1|||
37969195|NCT00519636|69656305|FG000|Washout Period|Lost to Follow-up|1|||
37969196|NCT00519636|69656306|FG001|Washout Period|Lost to Follow-up|0|||
37969197|NCT00519636|69656307|FG002|Washout Period|Lost to Follow-up|0|||
37969198|NCT00519636|69656308|FG003|Washout Period|Lost to Follow-up|0|||
37969199|NCT00519636|69656305|FG000|Washout Period|Protocol Violation|0|||
37969200|NCT00519636|69656306|FG001|Washout Period|Protocol Violation|0|||
37969201|NCT00519636|69656307|FG002|Washout Period|Protocol Violation|1|||
37969202|NCT00519636|69656308|FG003|Washout Period|Protocol Violation|2|||
37969203|NCT00519636|69656305|FG000|Washout Period|Withdrawal by Subject|1|||
37969204|NCT00519636|69656306|FG001|Washout Period|Withdrawal by Subject|0|||
37969205|NCT00519636|69656307|FG002|Washout Period|Withdrawal by Subject|1|||
37969206|NCT00519636|69656308|FG003|Washout Period|Withdrawal by Subject|0|||
37969207|NCT00519636|69656305|FG000|Washout Period|Failed to meet continuation criteria|14|||
37969208|NCT00519636|69656306|FG001|Washout Period|Failed to meet continuation criteria|11|||
37969209|NCT00519636|69656307|FG002|Washout Period|Failed to meet continuation criteria|9|||
37969210|NCT00519636|69656308|FG003|Washout Period|Failed to meet continuation criteria|3|||
37969211|NCT00519636|69656305|FG000|Washout Period|Out of pollen area > 48 hours|1|||
37969212|NCT00519636|69656306|FG001|Washout Period|Out of pollen area > 48 hours|0|||
37969213|NCT00519636|69656307|FG002|Washout Period|Out of pollen area > 48 hours|0|||
37969214|NCT00519636|69656308|FG003|Washout Period|Out of pollen area > 48 hours|0|||
37969215|NCT00519636|69656305|FG000|Washout Period|Participating in study at another site|1|||
37969216|NCT00519636|69656306|FG001|Washout Period|Participating in study at another site|0|||
37969217|NCT00519636|69656307|FG002|Washout Period|Participating in study at another site|0|||
37969218|NCT00519636|69656308|FG003|Washout Period|Participating in study at another site|0|||
37969219|NCT00519636|69656305|FG000|Washout Period|Non-compliant|0|||
37969220|NCT00519636|69656306|FG001|Washout Period|Non-compliant|1|||
37969221|NCT00519636|69656307|FG002|Washout Period|Non-compliant|0|||
37969222|NCT00519636|69656308|FG003|Washout Period|Non-compliant|0|||
37969223|NCT00519636|69656305|FG000|Washout Period|Per doctors request|0|||
37969224|NCT00519636|69656306|FG001|Washout Period|Per doctors request|1|||
37969225|NCT00519636|69656307|FG002|Washout Period|Per doctors request|0|||
37969226|NCT00519636|69656308|FG003|Washout Period|Per doctors request|0|||
37969227|NCT00519636|69656305|FG000|Washout Period|Subject randomized in error|0|||
37969228|NCT00519636|69656306|FG001|Washout Period|Subject randomized in error|0|||
37969229|NCT00519636|69656307|FG002|Washout Period|Subject randomized in error|1|||
37969230|NCT00519636|69656308|FG003|Washout Period|Subject randomized in error|0|||
37969231|NCT00519636|69656305|FG000|Washout Period|Prohibited medications|0|||
37969232|NCT00519636|69656306|FG001|Washout Period|Prohibited medications|0|||
37969233|NCT00519636|69656307|FG002|Washout Period|Prohibited medications|1|||
37969234|NCT00519636|69656308|FG003|Washout Period|Prohibited medications|0|||
37969235|NCT00519636|69656305|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
37969236|NCT00519636|69656306|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
37969237|NCT00519636|69656307|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
37777857|NCT01781637|69322027|FG001|Overall Study|Adverse Event|0|||
37777858|NCT01781637|69322026|FG000|Overall Study|Lack of Efficacy|2|||
37777859|NCT01781637|69322027|FG001|Overall Study|Lack of Efficacy|6|||
37863781|NCT01256177|69547332|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
37969238|NCT00519636|69656308|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
37969239|NCT00519636|69656305|FG000|Treatment Period 2|Subject randomized in error|0|||
37969240|NCT00519636|69656306|FG001|Treatment Period 2|Subject randomized in error|1|||
37969241|NCT00519636|69656307|FG002|Treatment Period 2|Subject randomized in error|0|||
37969242|NCT00519636|69656308|FG003|Treatment Period 2|Subject randomized in error|0|||
37777860|NCT01781637|69322026|FG000|Overall Study|Withdrawal by Subject|1|||
37777861|NCT01781637|69322027|FG001|Overall Study|Withdrawal by Subject|0|||
37969243|NCT00519636|69656305|FG000|Treatment Period 2|Per doctors request|0|||
37969244|NCT00519636|69656306|FG001|Treatment Period 2|Per doctors request|0|||
37969245|NCT00519636|69656307|FG002|Treatment Period 2|Per doctors request|1|||
37969246|NCT00519636|69656308|FG003|Treatment Period 2|Per doctors request|0|||
37969247|NCT00519636|69656305|FG000|Treatment Period 2|Subject misrandomized|0|||
37969248|NCT00519636|69656306|FG001|Treatment Period 2|Subject misrandomized|0|||
37777862|NCT01459497|69322075|FG000|Overall Study|Inability to meet trial constraints.|1|||
37777863|NCT01459497|69322076|FG001|Overall Study|Inability to meet trial constraints.|0|||
37777864|NCT01459497|69322075|FG000|Overall Study|Physician Decision|1|||
37777865|NCT01459497|69322076|FG001|Overall Study|Physician Decision|1|||
37777866|NCT01459497|69322075|FG000|Overall Study|Hospitalization.|0|||
37777867|NCT01459497|69322076|FG001|Overall Study|Hospitalization.|3|||
37777868|NCT01459497|69322075|FG000|Overall Study|Disease progression.|0|||
37777869|NCT01459497|69322076|FG001|Overall Study|Disease progression.|1|||
37777870|NCT04575584|69322425|FG000|Overall Study|Death|6|||
37777871|NCT04575584|69322426|FG001|Overall Study|Death|4|||
37777872|NCT04575584|69322427|FG002|Overall Study|Death|6|||
37777873|NCT04575584|69322428|FG003|Overall Study|Death|2|||
37777874|NCT04575584|69322429|FG004|Overall Study|Death|0|||
37777875|NCT04575584|69322430|FG005|Overall Study|Death|0|||
37777876|NCT04575584|69322425|FG000|Overall Study|Lost to Follow-up|1|||
37777877|NCT04575584|69322426|FG001|Overall Study|Lost to Follow-up|1|||
37777878|NCT04575584|69322427|FG002|Overall Study|Lost to Follow-up|1|||
37777879|NCT04575584|69322428|FG003|Overall Study|Lost to Follow-up|1|||
37777880|NCT04575584|69322429|FG004|Overall Study|Lost to Follow-up|0|||
37777881|NCT04575584|69322430|FG005|Overall Study|Lost to Follow-up|0|||
37777882|NCT04575584|69322425|FG000|Overall Study|Physician Decision|0|||
37777883|NCT04575584|69322426|FG001|Overall Study|Physician Decision|1|||
37777884|NCT04575584|69322427|FG002|Overall Study|Physician Decision|1|||
37777885|NCT04575584|69322428|FG003|Overall Study|Physician Decision|1|||
37777886|NCT04575584|69322429|FG004|Overall Study|Physician Decision|0|||
37777887|NCT04575584|69322430|FG005|Overall Study|Physician Decision|0|||
37777888|NCT04575584|69322425|FG000|Overall Study|Withdrawal by Subject|7|||
37777889|NCT04575584|69322426|FG001|Overall Study|Withdrawal by Subject|9|||
37777890|NCT04575584|69322427|FG002|Overall Study|Withdrawal by Subject|5|||
37777891|NCT04575584|69322428|FG003|Overall Study|Withdrawal by Subject|3|||
37777892|NCT04575584|69322429|FG004|Overall Study|Withdrawal by Subject|0|||
37777893|NCT04575584|69322430|FG005|Overall Study|Withdrawal by Subject|0|||
37777894|NCT04575584|69322425|FG000|Overall Study|Not recorded|0|||
37777895|NCT04575584|69322426|FG001|Overall Study|Not recorded|0|||
37777896|NCT04575584|69322427|FG002|Overall Study|Not recorded|0|||
37863782|NCT01256177|69547331|FG000|Overall Study|Condition under Investigation Worsened|1|||
37863783|NCT01256177|69547332|FG001|Overall Study|Condition under Investigation Worsened|0|||
37863784|NCT01256177|69547331|FG000|Overall Study|Lack of Efficacy|11|||
37863785|NCT01256177|69547332|FG001|Overall Study|Lack of Efficacy|2|||
37863786|NCT01256177|69547331|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
37863787|NCT01256177|69547332|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
37863788|NCT00999544|69547338|FG000|Overall Study|Withdrawal by Subject|1|||
37863789|NCT01124097|69547375|FG000|Overall Study|Withdrawal by Subject|4|||
37863790|NCT01124097|69547376|FG001|Overall Study|Withdrawal by Subject|3|||
37863791|NCT01124097|69547377|FG002|Overall Study|Withdrawal by Subject|2|||
37863792|NCT01124097|69547378|FG003|Overall Study|Withdrawal by Subject|3|||
37863793|NCT01124097|69547375|FG000|Overall Study|Lack of Efficacy|2|||
37863794|NCT01124097|69547376|FG001|Overall Study|Lack of Efficacy|3|||
37863795|NCT01124097|69547377|FG002|Overall Study|Lack of Efficacy|1|||
37777897|NCT04575584|69322428|FG003|Overall Study|Not recorded|1|||
37777898|NCT04575584|69322429|FG004|Overall Study|Not recorded|0|||
37863796|NCT01124097|69547378|FG003|Overall Study|Lack of Efficacy|3|||
37863797|NCT01124097|69547375|FG000|Overall Study|Adverse Event|24|||
37969249|NCT00519636|69656307|FG002|Treatment Period 2|Subject misrandomized|0|||
37969250|NCT00519636|69656308|FG003|Treatment Period 2|Subject misrandomized|1|||
37777899|NCT04575584|69322430|FG005|Overall Study|Not recorded|0|||
37777900|NCT03721965|69322469|FG000|Overall Study|Death|1|||
37777901|NCT03721965|69322469|FG000|Overall Study|Study Terminated by Sponsor|1|||
37777902|NCT03873116|69322525|FG000|Overall Study|Study drug discontinuation due to rash|0|||
37777903|NCT03873116|69322526|FG001|Overall Study|Study drug discontinuation due to rash|0|||
37777904|NCT03873116|69322527|FG002|Overall Study|Study drug discontinuation due to rash|1|||
37777905|NCT03686384|69322975|FG000|Overall Study|Lack of Efficacy|4|||
37777906|NCT03686384|69322976|FG001|Overall Study|Lack of Efficacy|13|||
37777907|NCT03686384|69322975|FG000|Overall Study|Lost to Follow-up|3|||
37777908|NCT03686384|69322976|FG001|Overall Study|Lost to Follow-up|0|||
37777909|NCT03686384|69322975|FG000|Overall Study|Physician Decision|0|||
37777910|NCT03686384|69322976|FG001|Overall Study|Physician Decision|1|||
37777911|NCT03686384|69322975|FG000|Overall Study|Took prohibited medication|0|||
37777912|NCT03686384|69322976|FG001|Overall Study|Took prohibited medication|1|||
37777913|NCT00240331|69323048|FG000|Overall Study|Withdrawal by Subject|125|||
37777914|NCT00240331|69323049|FG001|Overall Study|Withdrawal by Subject|132|||
37777915|NCT00240331|69323048|FG000|Overall Study|Option selected by investigator|1|||
37777916|NCT00240331|69323049|FG001|Overall Study|Option selected by investigator|2|||
37777917|NCT00240097|69323055|FG000|Part I|Adverse Event|1|||
37777918|NCT00240097|69323055|FG000|Part I|Death|1|||
37777919|NCT00240097|69323055|FG000|Part I|histology|1|||
37777920|NCT00240097|69323055|FG000|Part I|unevaluable|1|||
37777921|NCT00240097|69323055|FG000|Part II|did not continue from Part I|23|||
37777922|NCT03620162|69323146|FG000|Overall Study|Physician Decision|4|||
37777923|NCT03620162|69323147|FG001|Overall Study|Physician Decision|0|||
37777924|NCT03620162|69323148|FG002|Overall Study|Physician Decision|1|||
37969251|NCT00519636|69656305|FG000|Post Study Period|Subject randomized in error|0|||
37969252|NCT00519636|69656306|FG001|Post Study Period|Subject randomized in error|0|||
37969253|NCT00519636|69656307|FG002|Post Study Period|Subject randomized in error|0|||
37863798|NCT01124097|69547376|FG001|Overall Study|Adverse Event|15|||
37863799|NCT01124097|69547377|FG002|Overall Study|Adverse Event|15|||
37863800|NCT01124097|69547378|FG003|Overall Study|Adverse Event|7|||
37863801|NCT01124097|69547375|FG000|Overall Study|Protocol Violation|2|||
37863802|NCT01124097|69547376|FG001|Overall Study|Protocol Violation|0|||
37863803|NCT01124097|69547377|FG002|Overall Study|Protocol Violation|2|||
37863804|NCT01124097|69547378|FG003|Overall Study|Protocol Violation|1|||
37863805|NCT01124097|69547375|FG000|Overall Study|Physician Decision|2|||
37863806|NCT01124097|69547376|FG001|Overall Study|Physician Decision|1|||
37863807|NCT01124097|69547377|FG002|Overall Study|Physician Decision|0|||
37863808|NCT01124097|69547378|FG003|Overall Study|Physician Decision|0|||
37863809|NCT01123941|69547390|FG000|Overall Study|Lost to Follow-up|2|||
37863810|NCT01123941|69547391|FG001|Overall Study|Lost to Follow-up|1|||
37863811|NCT01123395|69547397|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
37969254|NCT00519636|69656308|FG003|Post Study Period|Subject randomized in error|1|||
37969255|NCT00618371|69656322|FG000|Overall Study|Withdrawal by Subject|2|||
37777925|NCT03620162|69323149|FG003|Overall Study|Physician Decision|0|||
37777926|NCT03620162|69323150|FG004|Overall Study|Physician Decision|2|||
37777927|NCT03620162|69323146|FG000|Overall Study|Lost to Follow-up|2|||
37777928|NCT03620162|69323147|FG001|Overall Study|Lost to Follow-up|6|||
37863812|NCT01123395|69547398|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
37863813|NCT01255787|69547408|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
37969256|NCT00526890|69656327|FG000|Overall Study|Adverse Event|2|||
37777929|NCT03620162|69323148|FG002|Overall Study|Lost to Follow-up|7|||
37777930|NCT03620162|69323149|FG003|Overall Study|Lost to Follow-up|3|||
37969257|NCT03864900|69656333|FG000|Overall Study|Withdrawal by Subject|1|||
37969258|NCT03864900|69656334|FG001|Overall Study|Withdrawal by Subject|1|||
37969259|NCT03864900|69656333|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
37969260|NCT03864900|69656334|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
37969261|NCT00526656|69656340|FG000|Overall Study|Death|1|||
37969262|NCT00526656|69656340|FG000|Overall Study|Refused surgery|1|||
37969263|NCT00617903|69656347|FG000|Overall Study|Withdrawal by Subject|2|||
37969264|NCT00617903|69656348|FG001|Overall Study|Withdrawal by Subject|3|||
37969265|NCT00617903|69656347|FG000|Overall Study|Lost to Follow-up|1|||
37969266|NCT00617903|69656348|FG001|Overall Study|Lost to Follow-up|1|||
37969267|NCT00617903|69656347|FG000|Overall Study|Lack of Efficacy|0|||
37969268|NCT00617903|69656348|FG001|Overall Study|Lack of Efficacy|1|||
37969269|NCT00617903|69656347|FG000|Overall Study|Adverse Event|0|||
37969270|NCT00617903|69656348|FG001|Overall Study|Adverse Event|1|||
37969271|NCT00617903|69656347|FG000|Overall Study|noncompliance|0|||
37969272|NCT00617903|69656348|FG001|Overall Study|noncompliance|1|||
37969273|NCT00526110|69656356|FG000|Overall Study|Adverse Event|2|||
37969274|NCT00526110|69656357|FG001|Overall Study|Adverse Event|9|||
37969275|NCT00526110|69656356|FG000|Overall Study|Disease Progression|0|||
37777931|NCT03620162|69323150|FG004|Overall Study|Lost to Follow-up|2|||
37777932|NCT03620162|69323146|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
37777933|NCT03620162|69323147|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
37777934|NCT03620162|69323148|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
37777935|NCT03620162|69323149|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
37777936|NCT03620162|69323150|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
37777937|NCT03084302|69323291|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
37777938|NCT03084302|69323291|FG000|Overall Study|No valid objective monitor data|6|||
37777939|NCT01279681|69323433|FG000|Overall Study|Disease Progression|9|||
37777940|NCT01279681|69323434|FG001|Overall Study|Disease Progression|6|||
37777941|NCT01279681|69323433|FG000|Overall Study|Withdrawal by Subject|3|||
37777942|NCT01279681|69323434|FG001|Overall Study|Withdrawal by Subject|4|||
37777943|NCT01279681|69323433|FG000|Overall Study|Adverse Event|2|||
37777944|NCT01279681|69323434|FG001|Overall Study|Adverse Event|3|||
37777945|NCT01279681|69323433|FG000|Overall Study|Death|0|||
37777946|NCT01279681|69323434|FG001|Overall Study|Death|1|||
37777947|NCT01279681|69323433|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
37777948|NCT01279681|69323434|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
37777949|NCT01279681|69323433|FG000|Overall Study|Physician Decision|1|||
37777950|NCT01279681|69323434|FG001|Overall Study|Physician Decision|0|||
37777951|NCT01279681|69323433|FG000|Overall Study|Other Reason|0|||
37777952|NCT01279681|69323434|FG001|Overall Study|Other Reason|2|||
37777953|NCT01279057|69323452|FG000|Overall Study|Adverse Event|1|||
37777954|NCT01279057|69323453|FG001|Overall Study|Adverse Event|0|||
37777955|NCT01279057|69323454|FG002|Overall Study|Adverse Event|1|||
37777956|NCT01279057|69323452|FG000|Overall Study|Insufficient therapeutic response|0|||
37777957|NCT01279057|69323453|FG001|Overall Study|Insufficient therapeutic response|0|||
37777958|NCT01279057|69323454|FG002|Overall Study|Insufficient therapeutic response|1|||
37777959|NCT01279057|69323452|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
37969276|NCT00526110|69656357|FG001|Overall Study|Disease Progression|19|||
37969277|NCT00526110|69656356|FG000|Overall Study|Maximal Response|0|||
37777960|NCT01279057|69323453|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
37969278|NCT00526110|69656357|FG001|Overall Study|Maximal Response|6|||
37777961|NCT01279057|69323454|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
37969279|NCT00526110|69656356|FG000|Overall Study|Withdrawal by Subject|0|||
37969280|NCT00526110|69656357|FG001|Overall Study|Withdrawal by Subject|2|||
37969281|NCT00526110|69656356|FG000|Overall Study|Poor Tolerance|0|||
37969282|NCT00526110|69656357|FG001|Overall Study|Poor Tolerance|5|||
37969283|NCT00512148|69656363|FG000|Primay Study Period|Withdrawal by Subject|1|||
37969284|NCT00511836|69656371|FG000|Double-blind Period|Lost to Follow-up|1|||
37969285|NCT00511836|69656372|FG001|Double-blind Period|Lost to Follow-up|0|||
37969286|NCT00573755|69656394|FG000|Overall Study|Still receiving treatment|1|||
37969287|NCT00573755|69656395|FG001|Overall Study|Still receiving treatment|0|||
37777962|NCT01279057|69323452|FG000|Overall Study|Withdrew consent|2|||
37777963|NCT01279057|69323453|FG001|Overall Study|Withdrew consent|0|||
37777964|NCT01279057|69323454|FG002|Overall Study|Withdrew consent|1|||
37777965|NCT01279057|69323452|FG000|Overall Study|Pregnancy|0|||
37777966|NCT01279057|69323453|FG001|Overall Study|Pregnancy|1|||
37777967|NCT01279057|69323454|FG002|Overall Study|Pregnancy|0|||
37777968|NCT01279057|69323452|FG000|Overall Study|Other|3|||
37777969|NCT01279057|69323453|FG001|Overall Study|Other|3|||
37777970|NCT01279057|69323454|FG002|Overall Study|Other|0|||
37777971|NCT02999633|69323462|FG000|Overall Study|Adverse Event|2|||
37777972|NCT02999633|69323462|FG000|Overall Study|Progressive disease|12|||
37777973|NCT01278745|69323564|FG000|Overall Study|Death|2|||
37777974|NCT01278745|69323565|FG001|Overall Study|Death|5|||
37777975|NCT01278745|69323566|FG002|Overall Study|Death|7|||
37777976|NCT01278745|69323567|FG003|Overall Study|Death|0|||
37777977|NCT01278745|69323564|FG000|Overall Study|Physician Decision|1|||
37777978|NCT01278745|69323565|FG001|Overall Study|Physician Decision|0|||
37777979|NCT01278745|69323566|FG002|Overall Study|Physician Decision|0|||
37777980|NCT01278745|69323567|FG003|Overall Study|Physician Decision|9|||
37777981|NCT01278745|69323564|FG000|Overall Study|Withdrawal by Subject|1|||
37777982|NCT01278745|69323565|FG001|Overall Study|Withdrawal by Subject|1|||
37777983|NCT01278745|69323566|FG002|Overall Study|Withdrawal by Subject|5|||
37777984|NCT01278745|69323567|FG003|Overall Study|Withdrawal by Subject|1|||
37777985|NCT01278745|69323564|FG000|Overall Study|Sponsor Decision|1|||
37777986|NCT01278745|69323565|FG001|Overall Study|Sponsor Decision|0|||
37777987|NCT01278745|69323566|FG002|Overall Study|Sponsor Decision|62|||
37777988|NCT01278745|69323567|FG003|Overall Study|Sponsor Decision|6|||
37777989|NCT01278745|69323564|FG000|Overall Study|Ineligible|0|||
37777990|NCT01278745|69323565|FG001|Overall Study|Ineligible|0|||
37777991|NCT01278745|69323566|FG002|Overall Study|Ineligible|42|||
37777992|NCT01278745|69323567|FG003|Overall Study|Ineligible|61|||
37777993|NCT01278745|69323564|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
37777994|NCT01278745|69323565|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
37777995|NCT01278745|69323566|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
37777996|NCT01278745|69323567|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
37777997|NCT03006926|69323577|FG000|Overall Study|Death|0|||
37777998|NCT03006926|69323578|FG001|Overall Study|Death|33|||
37777999|NCT03006926|69323577|FG000|Overall Study|Ongoing Survival Follow-up|0|||
37778000|NCT03006926|69323578|FG001|Overall Study|Ongoing Survival Follow-up|26|||
37778001|NCT03006926|69323577|FG000|Overall Study|Ongoing-on Treatment|0|||
37778002|NCT03006926|69323578|FG001|Overall Study|Ongoing-on Treatment|36|||
37778003|NCT03006926|69323577|FG000|Overall Study|Lost to Follow-up|0|||
37778004|NCT03006926|69323578|FG001|Overall Study|Lost to Follow-up|1|||
37778005|NCT03006926|69323577|FG000|Overall Study|Withdrawal by Subject|0|||
37969288|NCT00524316|69656401|FG000|Overall Study|Withdrawal by Subject|2|||
37969289|NCT00524316|69656401|FG000|Overall Study|Adverse Event|7|||
37778006|NCT03006926|69323578|FG001|Overall Study|Withdrawal by Subject|2|||
37778007|NCT01277887|69323640|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
37778008|NCT01277887|69323641|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
37778009|NCT01277887|69323640|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
37969290|NCT00524316|69656401|FG000|Overall Study|Disease Progression|7|||
37778010|NCT01277887|69323641|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
37778011|NCT01277887|69323640|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
37778012|NCT01277887|69323641|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
37969291|NCT03861936|69656418|FG000|Overall Study|Withdrawal by Subject|4|||
37969292|NCT03861936|69656419|FG001|Overall Study|Withdrawal by Subject|1|||
37969293|NCT03861936|69656420|FG002|Overall Study|Withdrawal by Subject|3|||
37969294|NCT03861936|69656418|FG000|Overall Study|Lost to Follow-up|5|||
37691292|NCT02141295|69167584|FG001|Overall Study|Withdrawal by Subject|9|||
37691293|NCT02141295|69167585|FG002|Overall Study|Withdrawal by Subject|4|||
37691294|NCT02514551|69167597|FG000|Overall Study|Lost to Follow-up|0|||
37778013|NCT01276327|69323655|FG000|Overall Study|Adverse Event|1|||
37778014|NCT01276327|69323656|FG001|Overall Study|Adverse Event|3|||
37778015|NCT01276327|69323655|FG000|Overall Study|Withdrawal by Subject|1|||
37778016|NCT01276327|69323656|FG001|Overall Study|Withdrawal by Subject|0|||
37778017|NCT00639002|69323778|FG000|Overall Study|Death|1|||
37778018|NCT00639002|69323778|FG000|Overall Study|Adverse Event|1|||
37778019|NCT00639002|69323778|FG000|Overall Study|Protocol Violation|1|||
37778020|NCT00639002|69323778|FG000|Overall Study|Disease progression|3|||
37778021|NCT00639002|69323778|FG000|Overall Study|Physician Decision|6|||
37778022|NCT00639002|69323778|FG000|Overall Study|Lack of Efficacy|1|||
37778023|NCT00638846|69323814|FG000|Overall Study|Adverse Event|0|||
37778024|NCT00638846|69323815|FG001|Overall Study|Adverse Event|1|||
37778025|NCT00638846|69323814|FG000|Overall Study|Lost to Follow-up|3|||
37778026|NCT00638846|69323815|FG001|Overall Study|Lost to Follow-up|2|||
37778027|NCT00638846|69323814|FG000|Overall Study|lens issue|1|||
37778028|NCT00638846|69323815|FG001|Overall Study|lens issue|3|||
37778029|NCT00638456|69323823|FG000|Overall Study|Withdrawal by Subject|6|||
37778030|NCT00638456|69323824|FG001|Overall Study|Withdrawal by Subject|2|||
37778031|NCT00638378|69323853|FG000|Overall Study|Death|2|||
37778032|NCT00638378|69323853|FG000|Overall Study|Adverse Event|1|||
37778033|NCT00638378|69323853|FG000|Overall Study|Disease progression|15|||
37778034|NCT00638378|69323853|FG000|Overall Study|Physician Decision|4|||
37778035|NCT03807349|69324030|FG000|Overall Study|Early Study Termination|9|||
37778036|NCT03802825|69324040|FG000|Overall Study|Lost to follow-up for intervention|12|||
37778037|NCT03802825|69324041|FG001|Overall Study|Lost to follow-up for intervention|3|||
37778038|NCT03802825|69324040|FG000|Overall Study|Received only 1 component of intervention|0|||
37778039|NCT03802825|69324041|FG001|Overall Study|Received only 1 component of intervention|13|||
37778040|NCT03808909|69324060|FG000|Overall Study|Lost to Follow-up|3|||
37778041|NCT03808909|69324061|FG001|Overall Study|Lost to Follow-up|0|||
37778042|NCT03802513|69324082|FG000|Overall Study|Lost to Follow-up|1|||
37778043|NCT01276223|69324273|FG000|Overall Study|Adverse Event|7|||
37778044|NCT01276223|69324274|FG001|Overall Study|Adverse Event|4|||
37778045|NCT01276223|69324275|FG002|Overall Study|Adverse Event|1|||
37778046|NCT01276223|69324273|FG000|Overall Study|Lost to Follow-up|0|||
37778047|NCT01276223|69324274|FG001|Overall Study|Lost to Follow-up|0|||
37778048|NCT01276223|69324275|FG002|Overall Study|Lost to Follow-up|1|||
37778049|NCT01276223|69324273|FG000|Overall Study|Other|0|||
37778050|NCT01276223|69324274|FG001|Overall Study|Other|0|||
37778051|NCT01276223|69324275|FG002|Overall Study|Other|1|||
37778052|NCT01276223|69324273|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
37778053|NCT01276223|69324274|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
37778054|NCT01276223|69324275|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
37778055|NCT01276223|69324273|FG000|Overall Study|Protocol Violation|1|||
37778056|NCT01276223|69324274|FG001|Overall Study|Protocol Violation|0|||
37778057|NCT01276223|69324275|FG002|Overall Study|Protocol Violation|0|||
37778058|NCT01275833|69324284|FG000|Overall Study|Study terminated|1|||
37778059|NCT01275833|69324285|FG001|Overall Study|Study terminated|1|||
37778060|NCT01275755|69324293|FG000|Double-blind Treatment Period|Adverse Event|0|||
37778061|NCT01275755|69324294|FG001|Double-blind Treatment Period|Adverse Event|2|||
37778062|NCT01275755|69324293|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
37778063|NCT01275755|69324294|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
37778064|NCT01275755|69324293|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
37778065|NCT01275755|69324294|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
37691295|NCT02514551|69167598|FG001|Overall Study|Lost to Follow-up|1|||
37691296|NCT02514551|69167597|FG000|Overall Study|Participant Never Treated|0|||
37778066|NCT01275755|69324293|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
37691297|NCT02514551|69167598|FG001|Overall Study|Participant Never Treated|2|||
37691298|NCT02141217|69167607|FG000|Overall Study|Adverse Event|1|||
37691299|NCT02141217|69167608|FG001|Overall Study|Adverse Event|2|||
37778067|NCT01275755|69324294|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
37778068|NCT01275131|69324325|FG000|Period 1|Withdrawal by Subject|1|||
37778069|NCT01275131|69324326|FG001|Period 1|Withdrawal by Subject|0|||
37778070|NCT01275131|69324327|FG002|Period 1|Withdrawal by Subject|3|||
37691300|NCT02141217|69167607|FG000|Overall Study|Protocol Violation|1|||
37778071|NCT01275131|69324328|FG003|Period 1|Withdrawal by Subject|2|||
37778072|NCT01275131|69324325|FG000|Period 1|Physician Decision|1|||
37691301|NCT02141217|69167608|FG001|Overall Study|Protocol Violation|4|||
37691302|NCT02141217|69167607|FG000|Overall Study|Withdrawal by Subject|6|||
37969295|NCT03861936|69656419|FG001|Overall Study|Lost to Follow-up|3|||
37691303|NCT02141217|69167608|FG001|Overall Study|Withdrawal by Subject|0|||
37863814|NCT01255787|69547409|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
37863815|NCT01255787|69547410|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
37863816|NCT01255787|69547411|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
37863817|NCT01255787|69547408|FG000|Overall Study|Major Protocol Deviation|1|||
37863818|NCT01255787|69547409|FG001|Overall Study|Major Protocol Deviation|1|||
37863819|NCT01255787|69547410|FG002|Overall Study|Major Protocol Deviation|0|||
37863820|NCT01255787|69547411|FG003|Overall Study|Major Protocol Deviation|4|||
37863821|NCT01255787|69547408|FG000|Overall Study|Lost to Follow-up|1|||
37863822|NCT01255787|69547409|FG001|Overall Study|Lost to Follow-up|2|||
37863823|NCT01255787|69547410|FG002|Overall Study|Lost to Follow-up|4|||
37778073|NCT01275131|69324326|FG001|Period 1|Physician Decision|0|||
37778074|NCT01275131|69324327|FG002|Period 1|Physician Decision|0|||
37778075|NCT01275131|69324328|FG003|Period 1|Physician Decision|0|||
37778076|NCT01275131|69324325|FG000|Period 2 (Crossover)|Adverse Event|0|||
37863824|NCT01255787|69547411|FG003|Overall Study|Lost to Follow-up|2|||
37863825|NCT01255787|69547408|FG000|Overall Study|Withdrawal of Consent|3|||
37863826|NCT01255787|69547409|FG001|Overall Study|Withdrawal of Consent|9|||
37863827|NCT01255787|69547410|FG002|Overall Study|Withdrawal of Consent|3|||
37863828|NCT01255787|69547411|FG003|Overall Study|Withdrawal of Consent|4|||
37778077|NCT01275131|69324326|FG001|Period 2 (Crossover)|Adverse Event|1|||
37778078|NCT01275131|69324327|FG002|Period 2 (Crossover)|Adverse Event|0|||
37778079|NCT01275131|69324328|FG003|Period 2 (Crossover)|Adverse Event|0|||
37778080|NCT01275131|69324325|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
37778081|NCT01275131|69324326|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
37778082|NCT01275131|69324327|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
37778083|NCT01275131|69324328|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
37778084|NCT01274429|69324357|FG000|Overall Study|Study closed do to lack of funding|5|||
37778085|NCT01273883|69324361|FG000|First Intervention|Adverse Event|2|||
37969296|NCT03861936|69656420|FG002|Overall Study|Lost to Follow-up|3|||
37969297|NCT03861936|69656418|FG000|Overall Study|Physician Decision|0|||
37969298|NCT03861936|69656419|FG001|Overall Study|Physician Decision|1|||
37969299|NCT03861936|69656420|FG002|Overall Study|Physician Decision|0|||
37969300|NCT03861936|69656418|FG000|Overall Study|Protocol Deviation|0|||
37969301|NCT03861936|69656419|FG001|Overall Study|Protocol Deviation|0|||
37969302|NCT03861936|69656420|FG002|Overall Study|Protocol Deviation|1|||
37863829|NCT01255787|69547408|FG000|Overall Study|Pregnancy|0|||
37863830|NCT01255787|69547409|FG001|Overall Study|Pregnancy|0|||
37863831|NCT01255787|69547410|FG002|Overall Study|Pregnancy|0|||
37863832|NCT01255787|69547411|FG003|Overall Study|Pregnancy|1|||
37863833|NCT01255787|69547408|FG000|Overall Study|Lack of Efficacy|2|||
37863834|NCT01255787|69547409|FG001|Overall Study|Lack of Efficacy|2|||
37691304|NCT02141217|69167607|FG000|Overall Study|Lost to Follow-up|1|||
37691305|NCT02141217|69167608|FG001|Overall Study|Lost to Follow-up|1|||
37691306|NCT02141217|69167607|FG000|Overall Study|Physician Decision|1|||
37691307|NCT02141217|69167608|FG001|Overall Study|Physician Decision|0|||
37691308|NCT02141217|69167607|FG000|Overall Study|Surgical Intervention|1|||
37691309|NCT02141217|69167608|FG001|Overall Study|Surgical Intervention|1|||
37691310|NCT02138253|69167619|FG000|Overall Study|Adverse Event|3|||
37691311|NCT02138253|69167620|FG001|Overall Study|Adverse Event|3|||
37691312|NCT02138253|69167619|FG000|Overall Study|Lost to Follow-up|2|||
37691313|NCT02138253|69167620|FG001|Overall Study|Lost to Follow-up|1|||
37691314|NCT02138253|69167619|FG000|Overall Study|Physician Decision|2|||
37691315|NCT02138253|69167620|FG001|Overall Study|Physician Decision|0|||
37691316|NCT02138253|69167619|FG000|Overall Study|Non compliance|1|||
37691317|NCT02138253|69167620|FG001|Overall Study|Non compliance|0|||
37691318|NCT02138253|69167619|FG000|Overall Study|Withdrawal by Subject|1|||
37691319|NCT02138253|69167620|FG001|Overall Study|Withdrawal by Subject|0|||
37691320|NCT02514473|69167628|FG000|Overall Study|Adverse Event|0|||
37691321|NCT02514473|69167629|FG001|Overall Study|Adverse Event|2|||
37691322|NCT02514473|69167628|FG000|Overall Study|Withdrawal by Subject|2|||
37691323|NCT02514473|69167629|FG001|Overall Study|Withdrawal by Subject|1|||
37691324|NCT02514473|69167628|FG000|Overall Study|Lost to Follow-up|0|||
37691325|NCT02514473|69167629|FG001|Overall Study|Lost to Follow-up|1|||
37969303|NCT03861936|69656418|FG000|Overall Study|Reason not Specified|5|||
37778086|NCT01273883|69324362|FG001|First Intervention|Adverse Event|1|||
37778087|NCT01273883|69324361|FG000|Second Intervention|Lost to Follow-up|1|||
37778088|NCT01273883|69324362|FG001|Second Intervention|Lost to Follow-up|1|||
37778089|NCT01273883|69324361|FG000|Second Intervention|Lack of Efficacy|1|||
37778090|NCT01273883|69324362|FG001|Second Intervention|Lack of Efficacy|0|||
37863835|NCT01255787|69547410|FG002|Overall Study|Lack of Efficacy|2|||
37863836|NCT01255787|69547411|FG003|Overall Study|Lack of Efficacy|2|||
37863837|NCT01255787|69547408|FG000|Overall Study|Noncompliance with Study Drug|3|||
37691326|NCT02514473|69167628|FG000|Overall Study|Other|1|||
37691327|NCT02514473|69167629|FG001|Overall Study|Other|1|||
37691328|NCT02513771|69167638|FG000|Overall Study|Lost to Follow-up|1|||
37691329|NCT02513771|69167639|FG001|Overall Study|Lost to Follow-up|1|||
37863838|NCT01255787|69547409|FG001|Overall Study|Noncompliance with Study Drug|1|||
37863839|NCT01255787|69547410|FG002|Overall Study|Noncompliance with Study Drug|0|||
37691330|NCT02513771|69167638|FG000|Overall Study|Not being able to get to clinic|1|||
37691331|NCT02513771|69167639|FG001|Overall Study|Not being able to get to clinic|0|||
37691332|NCT02104947|69167647|FG000|Overall Study|Withdrawal by Subject|10|||
37691333|NCT02104947|69167648|FG001|Overall Study|Withdrawal by Subject|3|||
37691334|NCT02104947|69167647|FG000|Overall Study|Lost to Follow-up|4|||
37691335|NCT02104947|69167648|FG001|Overall Study|Lost to Follow-up|4|||
37691336|NCT02104947|69167647|FG000|Overall Study|Protocol Violation|6|||
37691337|NCT02104947|69167648|FG001|Overall Study|Protocol Violation|8|||
37691338|NCT02104947|69167647|FG000|Overall Study|Adverse Event|57|||
37691339|NCT02104947|69167648|FG001|Overall Study|Adverse Event|38|||
37691340|NCT02104947|69167647|FG000|Overall Study|Other than stated above|2|||
37691341|NCT02104947|69167648|FG001|Overall Study|Other than stated above|3|||
37778091|NCT01273805|69324370|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
37778092|NCT01273805|69324371|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
37778093|NCT01273181|69324381|FG000|Phase I, Dose 1|Study termination|1|||
37691342|NCT02513459|69167658|FG000|Overall Study|Adverse Event|7|||
37691343|NCT02513459|69167658|FG000|Overall Study|Withdrew consent|5|||
37691344|NCT02513459|69167658|FG000|Overall Study|Loss of efficacy|2|||
37691345|NCT02513459|69167658|FG000|Overall Study|Pregnancy|2|||
37691346|NCT02513459|69167658|FG000|Overall Study|Subject decision|2|||
37691347|NCT02513459|69167658|FG000|Overall Study|Lack of response|1|||
37691348|NCT02513459|69167658|FG000|Overall Study|Reproductive plans|1|||
37691349|NCT02513459|69167658|FG000|Overall Study|Surgery planned-- not done|1|||
37691350|NCT02104557|69167667|FG000|Overall Study|Adverse Event|24|||
37691351|NCT02104557|69167667|FG000|Overall Study|Lost to Follow-up|34|||
37691352|NCT02104557|69167667|FG000|Overall Study|Violated the usage and dosage|14|||
37691353|NCT02104557|69167667|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
37691354|NCT02104557|69167667|FG000|Overall Study|Administered Sayana prior to the contract|1|||
37691355|NCT02104557|69167667|FG000|Overall Study|Other|17|||
37691356|NCT02104557|69167667|FG000|Overall Study|Change to other contraception methods|5|||
37691357|NCT02104557|69167667|FG000|Overall Study|Discontinuation due to no pain|1|||
37691358|NCT02104557|69167667|FG000|Overall Study|Withdrawal consent|2|||
37691359|NCT02104557|69167667|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
37691360|NCT02104557|69167667|FG000|Overall Study|Discontinuation of contraception|9|||
37691361|NCT02069379|69167673|FG000|Baseline Measurements|Lost to Follow-up|1|||
37691362|NCT02069379|69167674|FG001|Baseline Measurements|Lost to Follow-up|0|||
37691363|NCT02069379|69167675|FG002|Baseline Measurements|Lost to Follow-up|0|||
37691364|NCT02069379|69167676|FG003|Baseline Measurements|Lost to Follow-up|0|||
37691365|NCT02069379|69167673|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
37691366|NCT02069379|69167674|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
37691367|NCT02069379|69167675|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
37691368|NCT02069379|69167676|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
37691369|NCT02069379|69167673|FG000|First Treatment Arm|Lost to Follow-up|0|||
37691370|NCT02069379|69167674|FG001|First Treatment Arm|Lost to Follow-up|1|||
37691371|NCT02069379|69167675|FG002|First Treatment Arm|Lost to Follow-up|1|||
37691372|NCT02069379|69167676|FG003|First Treatment Arm|Lost to Follow-up|0|||
37691373|NCT02069379|69167673|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
37691374|NCT02069379|69167674|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
37691375|NCT02069379|69167675|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
37691376|NCT02069379|69167676|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
37691377|NCT02069379|69167673|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
37691378|NCT02069379|69167674|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
37691379|NCT02069379|69167675|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
37691380|NCT02069379|69167676|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
37691381|NCT02069379|69167673|FG000|Second Treatment Arm|Lost to Follow-up|0|||
37691382|NCT02069379|69167674|FG001|Second Treatment Arm|Lost to Follow-up|0|||
37691383|NCT02069379|69167675|FG002|Second Treatment Arm|Lost to Follow-up|1|||
37691384|NCT02069379|69167676|FG003|Second Treatment Arm|Lost to Follow-up|0|||
37691385|NCT02511431|69167692|FG000|Treatment|Lost to Follow-up|0|||
37778094|NCT01273181|69324382|FG001|Phase I, Dose 1|Study termination|0|||
37691386|NCT02511431|69167693|FG001|Treatment|Lost to Follow-up|0|||
37691387|NCT02511431|69167694|FG002|Treatment|Lost to Follow-up|1|||
37691388|NCT02511431|69167695|FG003|Treatment|Lost to Follow-up|0|||
37691389|NCT02511431|69167696|FG004|Treatment|Lost to Follow-up|0|||
37691390|NCT02511431|69167697|FG005|Treatment|Lost to Follow-up|1|||
37691391|NCT02137785|69167714|FG000|Overall Study|Lost to Follow-up|1|||
37691392|NCT02137785|69167715|FG001|Overall Study|Lost to Follow-up|0|||
37691393|NCT02137785|69167714|FG000|Overall Study|Withdrawal by Subject|1|||
37778095|NCT01273181|69324383|FG002|Phase I, Dose 1|Study termination|0|||
37778096|NCT01273181|69324384|FG003|Phase I, Dose 1|Study termination|0|||
37778097|NCT01273181|69324381|FG000|Phase I, Dose 2|Death during treatment|0|||
37778098|NCT01273181|69324382|FG001|Phase I, Dose 2|Death during treatment|1|||
37778099|NCT01273181|69324383|FG002|Phase I, Dose 2|Death during treatment|0|||
37778100|NCT01273181|69324384|FG003|Phase I, Dose 2|Death during treatment|0|||
37778101|NCT01273181|69324381|FG000|Phase 2, Dose 1|Study termination|0|||
37778102|NCT01273181|69324382|FG001|Phase 2, Dose 1|Study termination|0|||
37778103|NCT01273181|69324383|FG002|Phase 2, Dose 1|Study termination|1|||
37778104|NCT01273181|69324384|FG003|Phase 2, Dose 1|Study termination|0|||
37778105|NCT01273181|69324381|FG000|Phase 2, Dose 2|Death during treatment|0|||
37778106|NCT01273181|69324382|FG001|Phase 2, Dose 2|Death during treatment|0|||
37778107|NCT01273181|69324383|FG002|Phase 2, Dose 2|Death during treatment|0|||
37778108|NCT01273181|69324384|FG003|Phase 2, Dose 2|Death during treatment|1|||
37778109|NCT01272947|69324400|FG000|Overall Study|Abnormal Laboratory Value|2|||
37778110|NCT01272947|69324401|FG001|Overall Study|Abnormal Laboratory Value|2|||
37778111|NCT01279343|69324409|FG000|Overall Study|Did not receive treatment|2|||
37778112|NCT01279343|69324410|FG001|Overall Study|Did not receive treatment|6|||
37778113|NCT01278797|69324416|FG000|Period 1|Adverse Event|0|||
37778114|NCT01278797|69324417|FG001|Period 1|Adverse Event|1|||
37778115|NCT01278797|69324416|FG000|Period 1|Protocol Violation|1|||
37778116|NCT01278797|69324417|FG001|Period 1|Protocol Violation|0|||
37778117|NCT01272869|69324425|FG000|Period 2 (14 Days)|Adverse Event|1|||
37778118|NCT01272869|69324426|FG001|Period 2 (14 Days)|Adverse Event|0|||
37778119|NCT01272635|69324434|FG000|Overall Study|Lost to Follow-up|31|||
37778120|NCT01272635|69324435|FG001|Overall Study|Lost to Follow-up|20|||
37778121|NCT01272635|69324436|FG002|Overall Study|Lost to Follow-up|31|||
37778122|NCT01272635|69324437|FG003|Overall Study|Lost to Follow-up|23|||
37778123|NCT01272011|69324448|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
37778124|NCT01272011|69324449|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
37778125|NCT01272011|69324450|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
37778126|NCT01270841|69324471|FG000|Overall Study|Adverse Event|0|||
37778127|NCT01270841|69324472|FG001|Overall Study|Adverse Event|1|||
37778128|NCT01270841|69324473|FG002|Overall Study|Adverse Event|0|||
37778129|NCT01270841|69324474|FG003|Overall Study|Adverse Event|3|||
37778130|NCT01270841|69324471|FG000|Overall Study|Withdrawal by Subject|3|||
37778131|NCT01270841|69324472|FG001|Overall Study|Withdrawal by Subject|2|||
37778132|NCT01270841|69324473|FG002|Overall Study|Withdrawal by Subject|3|||
37778133|NCT01270841|69324474|FG003|Overall Study|Withdrawal by Subject|3|||
37778134|NCT01270841|69324471|FG000|Overall Study|Lost to Follow-up|3|||
37778135|NCT01270841|69324472|FG001|Overall Study|Lost to Follow-up|1|||
37778136|NCT01270841|69324473|FG002|Overall Study|Lost to Follow-up|4|||
37778137|NCT01270841|69324474|FG003|Overall Study|Lost to Follow-up|2|||
37778138|NCT01270841|69324471|FG000|Overall Study|Physician Decision|0|||
37778139|NCT01270841|69324472|FG001|Overall Study|Physician Decision|1|||
37778140|NCT01270841|69324473|FG002|Overall Study|Physician Decision|0|||
37691394|NCT02137785|69167715|FG001|Overall Study|Withdrawal by Subject|4|||
37691395|NCT02137785|69167714|FG000|Overall Study|subject moved out of state|1|||
37691396|NCT02137785|69167715|FG001|Overall Study|subject moved out of state|0|||
37691397|NCT01655069|69167725|FG000|Overall Study|Physician Decision|0|||
37691398|NCT01655069|69167726|FG001|Overall Study|Physician Decision|0|||
37778141|NCT01270841|69324474|FG003|Overall Study|Physician Decision|0|||
37691399|NCT01655069|69167727|FG002|Overall Study|Physician Decision|0|||
37691400|NCT01655069|69167728|FG003|Overall Study|Physician Decision|1|||
37691401|NCT01655069|69167725|FG000|Overall Study|Adverse Event|6|||
37778142|NCT01270841|69324471|FG000|Overall Study|Did not qualify|6|||
37691402|NCT01655069|69167726|FG001|Overall Study|Adverse Event|7|||
37778143|NCT01270841|69324472|FG001|Overall Study|Did not qualify|3|||
37778144|NCT01270841|69324473|FG002|Overall Study|Did not qualify|4|||
37778145|NCT01270841|69324474|FG003|Overall Study|Did not qualify|5|||
37778146|NCT01270841|69324471|FG000|Overall Study|Protocol Violation|1|||
37778147|NCT01270841|69324472|FG001|Overall Study|Protocol Violation|5|||
37778148|NCT01270841|69324473|FG002|Overall Study|Protocol Violation|0|||
37778149|NCT01270841|69324474|FG003|Overall Study|Protocol Violation|0|||
37778150|NCT01270841|69324471|FG000|Overall Study|Enrolled in error|0|||
37778151|NCT01270841|69324472|FG001|Overall Study|Enrolled in error|1|||
37778152|NCT01270841|69324473|FG002|Overall Study|Enrolled in error|0|||
37778153|NCT01270841|69324474|FG003|Overall Study|Enrolled in error|0|||
37778154|NCT01270139|69324487|FG000|Overall Study|Adverse Event|8|||
37778155|NCT01270139|69324488|FG001|Overall Study|Adverse Event|17|||
37778156|NCT01270139|69324489|FG002|Overall Study|Adverse Event|18|||
37778157|NCT01270139|69324487|FG000|Overall Study|Lost to Follow-up|10|||
37778158|NCT01270139|69324488|FG001|Overall Study|Lost to Follow-up|9|||
37778159|NCT01270139|69324489|FG002|Overall Study|Lost to Follow-up|2|||
37778160|NCT01278407|69324507|FG000|Confirmatory Phase|Adverse Event|5|||
37778161|NCT01278407|69324508|FG001|Confirmatory Phase|Adverse Event|10|||
37778162|NCT01278407|69324509|FG002|Confirmatory Phase|Adverse Event|1|||
37778163|NCT01278407|69324510|FG003|Confirmatory Phase|Adverse Event|0|||
37778164|NCT01278407|69324511|FG004|Confirmatory Phase|Adverse Event|0|||
37778165|NCT01278407|69324507|FG000|Confirmatory Phase|Participant's Choice|3|||
37778166|NCT01278407|69324508|FG001|Confirmatory Phase|Participant's Choice|5|||
37778167|NCT01278407|69324509|FG002|Confirmatory Phase|Participant's Choice|3|||
37778168|NCT01278407|69324510|FG003|Confirmatory Phase|Participant's Choice|0|||
37778169|NCT01278407|69324511|FG004|Confirmatory Phase|Participant's Choice|0|||
37778170|NCT01278407|69324507|FG000|Confirmatory Phase|Other|1|||
37778171|NCT01278407|69324508|FG001|Confirmatory Phase|Other|1|||
37778172|NCT01278407|69324509|FG002|Confirmatory Phase|Other|2|||
37778173|NCT01278407|69324510|FG003|Confirmatory Phase|Other|0|||
37778174|NCT01278407|69324511|FG004|Confirmatory Phase|Other|0|||
37778175|NCT01278407|69324507|FG000|Extension Phase|Adverse Event|0|||
37778176|NCT01278407|69324508|FG001|Extension Phase|Adverse Event|0|||
37778177|NCT01278407|69324509|FG002|Extension Phase|Adverse Event|0|||
37778178|NCT01278407|69324510|FG003|Extension Phase|Adverse Event|7|||
37778179|NCT01278407|69324511|FG004|Extension Phase|Adverse Event|16|||
37778180|NCT01278407|69324507|FG000|Extension Phase|Participant's Choice|0|||
37778181|NCT01278407|69324508|FG001|Extension Phase|Participant's Choice|0|||
37778182|NCT01278407|69324509|FG002|Extension Phase|Participant's Choice|0|||
37778183|NCT01278407|69324510|FG003|Extension Phase|Participant's Choice|4|||
37778184|NCT01278407|69324511|FG004|Extension Phase|Participant's Choice|11|||
37778185|NCT01278407|69324507|FG000|Extension Phase|Other|0|||
37778186|NCT01278407|69324508|FG001|Extension Phase|Other|0|||
37778187|NCT01278407|69324509|FG002|Extension Phase|Other|0|||
37778188|NCT01278407|69324510|FG003|Extension Phase|Other|1|||
37778189|NCT01278407|69324511|FG004|Extension Phase|Other|3|||
37778190|NCT01278173|69324521|FG000|Overall Study|Lack of Efficacy|13|||
37778191|NCT01278173|69324521|FG000|Overall Study|Adverse Event|8|||
37778192|NCT01278173|69324521|FG000|Overall Study|Administrative or other reason|4|||
37778193|NCT01278173|69324521|FG000|Overall Study|Protocol Violation|1|||
37778194|NCT01278173|69324521|FG000|Overall Study|Withdrawal by Subject|1|||
37778195|NCT01277861|69324554|FG000|Overall Study|Physician Decision|2|||
37778196|NCT01277861|69324555|FG001|Overall Study|Physician Decision|2|||
37778197|NCT01277549|69324582|FG000|Overall Study|Failed to meet eligibility criteria|13|||
37778198|NCT01277549|69324583|FG001|Overall Study|Failed to meet eligibility criteria|9|||
37863840|NCT01255787|69547411|FG003|Overall Study|Noncompliance with Study Drug|0|||
37778199|NCT01277549|69324582|FG000|Overall Study|Withdrawal by Subject|1|||
37778200|NCT01277549|69324583|FG001|Overall Study|Withdrawal by Subject|3|||
37778201|NCT01277549|69324582|FG000|Overall Study|Protocol Violation|10|||
37778202|NCT01277549|69324583|FG001|Overall Study|Protocol Violation|1|||
37863841|NCT01123161|69547423|FG000|Overall Study|Lost to Follow-up|1|||
37778203|NCT01277549|69324582|FG000|Overall Study|Physician Decision|2|||
37863842|NCT01123161|69547424|FG001|Overall Study|Lost to Follow-up|0|||
37778204|NCT01277549|69324583|FG001|Overall Study|Physician Decision|1|||
37778205|NCT01276847|69324595|FG000|Overall Study|Withdrawal by Subject|1|||
37778206|NCT01276847|69324596|FG001|Overall Study|Withdrawal by Subject|0|||
37778207|NCT01276847|69324597|FG002|Overall Study|Withdrawal by Subject|0|||
37778208|NCT01276457|69324629|FG000|Core Study|Adverse Event|6|||
37778209|NCT01276457|69324630|FG001|Core Study|Adverse Event|3|||
37778210|NCT01276457|69324629|FG000|Core Study|Lost to Follow-up|1|||
37778211|NCT01276457|69324630|FG001|Core Study|Lost to Follow-up|2|||
37778212|NCT01276457|69324629|FG000|Core Study|Administrative problems|1|||
37778213|NCT01276457|69324630|FG001|Core Study|Administrative problems|1|||
37778214|NCT01276457|69324629|FG000|Core Study|Death|2|||
37778215|NCT01276457|69324630|FG001|Core Study|Death|2|||
37778216|NCT01276457|69324629|FG000|Core Study|Lack of Efficacy|3|||
37778217|NCT01276457|69324630|FG001|Core Study|Lack of Efficacy|12|||
37778218|NCT01276457|69324629|FG000|Extension Study|Lost to Follow-up|3|||
37778219|NCT01276457|69324630|FG001|Extension Study|Lost to Follow-up|0|||
37778220|NCT01276457|69324629|FG000|Extension Study|Death|0|||
37778221|NCT01276457|69324630|FG001|Extension Study|Death|1|||
37778222|NCT01276457|69324629|FG000|Extension Study|Lack of Efficacy|3|||
37778223|NCT01276457|69324630|FG001|Extension Study|Lack of Efficacy|1|||
37778224|NCT01276379|69324720|FG000|Overall Study|Screening failure|40|||
37778225|NCT03809663|69325016|FG000|Overall Study|Decision by sponsor|24|||
37778226|NCT03809663|69325017|FG001|Overall Study|Decision by sponsor|18|||
37778227|NCT03809663|69325018|FG002|Overall Study|Decision by sponsor|20|||
37778228|NCT03809663|69325019|FG003|Overall Study|Decision by sponsor|20|||
37778229|NCT03809663|69325020|FG004|Overall Study|Decision by sponsor|0|||
37778230|NCT03809663|69325021|FG005|Overall Study|Decision by sponsor|0|||
37778231|NCT03809663|69325016|FG000|Overall Study|Withdrawal by Subject|26|||
37778232|NCT03809663|69325017|FG001|Overall Study|Withdrawal by Subject|22|||
37778233|NCT03809663|69325018|FG002|Overall Study|Withdrawal by Subject|27|||
37778234|NCT03809663|69325019|FG003|Overall Study|Withdrawal by Subject|26|||
37778235|NCT03809663|69325020|FG004|Overall Study|Withdrawal by Subject|0|||
37778236|NCT03809663|69325021|FG005|Overall Study|Withdrawal by Subject|0|||
37778237|NCT03809663|69325016|FG000|Overall Study|Lost to Follow-up|1|||
37778238|NCT03809663|69325017|FG001|Overall Study|Lost to Follow-up|4|||
37778239|NCT03809663|69325018|FG002|Overall Study|Lost to Follow-up|1|||
37778240|NCT03809663|69325019|FG003|Overall Study|Lost to Follow-up|1|||
37778241|NCT03809663|69325020|FG004|Overall Study|Lost to Follow-up|0|||
37778242|NCT03809663|69325021|FG005|Overall Study|Lost to Follow-up|0|||
37778243|NCT00249821|69325083|FG000|Overall Study|Technical problem|0|||
37778244|NCT00249821|69325084|FG001|Overall Study|Technical problem|1|||
37778245|NCT00248651|69325159|FG000|Overall Study|Withdrawal by Subject|28|||
37778246|NCT00248651|69325160|FG001|Overall Study|Withdrawal by Subject|40|||
37778247|NCT00248651|69325161|FG002|Overall Study|Withdrawal by Subject|32|||
37778248|NCT00248495|69325198|FG000|Overall Study|Withdrawal by Subject|1|||
37778249|NCT03802565|69325295|FG000|Overall Study|Adverse Event|0|||
37778250|NCT03802565|69325296|FG001|Overall Study|Adverse Event|1|||
37778251|NCT03802565|69325297|FG002|Overall Study|Adverse Event|2|||
37778252|NCT03802565|69325298|FG003|Overall Study|Adverse Event|1|||
37778253|NCT03802565|69325299|FG004|Overall Study|Adverse Event|1|||
37778254|NCT03802565|69325295|FG000|Overall Study|Withdrawal by Subject|2|||
37778255|NCT03802565|69325296|FG001|Overall Study|Withdrawal by Subject|2|||
37778256|NCT03802565|69325297|FG002|Overall Study|Withdrawal by Subject|2|||
37778257|NCT03802565|69325298|FG003|Overall Study|Withdrawal by Subject|0|||
37778258|NCT03802565|69325299|FG004|Overall Study|Withdrawal by Subject|1|||
37778259|NCT03802565|69325295|FG000|Overall Study|Protocol Violation|2|||
37778260|NCT03802565|69325296|FG001|Overall Study|Protocol Violation|1|||
37778261|NCT03802565|69325297|FG002|Overall Study|Protocol Violation|4|||
37778262|NCT03802565|69325298|FG003|Overall Study|Protocol Violation|5|||
37778263|NCT03802565|69325299|FG004|Overall Study|Protocol Violation|1|||
37778264|NCT03802565|69325295|FG000|Overall Study|Lost to Follow-up|0|||
37778265|NCT03802565|69325296|FG001|Overall Study|Lost to Follow-up|0|||
37778266|NCT03802565|69325297|FG002|Overall Study|Lost to Follow-up|1|||
37778267|NCT03802565|69325298|FG003|Overall Study|Lost to Follow-up|0|||
37778268|NCT03802565|69325299|FG004|Overall Study|Lost to Follow-up|0|||
37778269|NCT03802565|69325295|FG000|Overall Study|Subjects Related to Each Other|1|||
37778270|NCT03802565|69325296|FG001|Overall Study|Subjects Related to Each Other|0|||
37778271|NCT03802565|69325297|FG002|Overall Study|Subjects Related to Each Other|0|||
37778272|NCT03802565|69325298|FG003|Overall Study|Subjects Related to Each Other|2|||
37778273|NCT03802565|69325299|FG004|Overall Study|Subjects Related to Each Other|1|||
37778274|NCT03802565|69325295|FG000|Overall Study|Elevated Enzymes|0|||
37691403|NCT01655069|69167727|FG002|Overall Study|Adverse Event|2|||
37691404|NCT01655069|69167728|FG003|Overall Study|Adverse Event|3|||
37691405|NCT01655069|69167725|FG000|Overall Study|Lack of Efficacy|0|||
37691406|NCT01655069|69167726|FG001|Overall Study|Lack of Efficacy|1|||
37691407|NCT01655069|69167727|FG002|Overall Study|Lack of Efficacy|0|||
37691408|NCT01655069|69167728|FG003|Overall Study|Lack of Efficacy|0|||
37691409|NCT01655069|69167725|FG000|Overall Study|No Treatment Needed|0|||
37691410|NCT01655069|69167726|FG001|Overall Study|No Treatment Needed|1|||
37691411|NCT01655069|69167727|FG002|Overall Study|No Treatment Needed|0|||
37691412|NCT01655069|69167728|FG003|Overall Study|No Treatment Needed|0|||
37691413|NCT01655069|69167725|FG000|Overall Study|Withdrawal by Subject|2|||
37691414|NCT01655069|69167726|FG001|Overall Study|Withdrawal by Subject|3|||
37691415|NCT01655069|69167727|FG002|Overall Study|Withdrawal by Subject|0|||
37691416|NCT01655069|69167728|FG003|Overall Study|Withdrawal by Subject|0|||
37691417|NCT02068599|69167739|FG000|Overall Study|Adverse Event|4|||
37691418|NCT02068599|69167740|FG001|Overall Study|Adverse Event|1|||
37691419|NCT02068599|69167741|FG002|Overall Study|Adverse Event|1|||
37691420|NCT02068599|69167739|FG000|Overall Study|Withdrawal by Subject|2|||
37691421|NCT02068599|69167740|FG001|Overall Study|Withdrawal by Subject|7|||
37691422|NCT02068599|69167741|FG002|Overall Study|Withdrawal by Subject|5|||
37691423|NCT02068599|69167739|FG000|Overall Study|Protocol Violation|4|||
37691424|NCT02068599|69167740|FG001|Overall Study|Protocol Violation|2|||
37691425|NCT02068599|69167741|FG002|Overall Study|Protocol Violation|3|||
37691426|NCT02068599|69167739|FG000|Overall Study|Lost to Follow-up|1|||
37691427|NCT02068599|69167740|FG001|Overall Study|Lost to Follow-up|0|||
37691428|NCT02068599|69167741|FG002|Overall Study|Lost to Follow-up|0|||
37691429|NCT02068599|69167739|FG000|Overall Study|Lack of Efficacy|0|||
37691430|NCT02068599|69167740|FG001|Overall Study|Lack of Efficacy|0|||
37691431|NCT02068599|69167741|FG002|Overall Study|Lack of Efficacy|3|||
37691432|NCT02068599|69167739|FG000|Overall Study|Noncompliance|0|||
37691433|NCT02068599|69167740|FG001|Overall Study|Noncompliance|0|||
37691434|NCT02068599|69167741|FG002|Overall Study|Noncompliance|1|||
37691435|NCT01654601|69167751|FG000|1st Administration|Withdrawal by Subject|2|||
37691436|NCT01654601|69167752|FG001|1st Administration|Withdrawal by Subject|0|||
37691437|NCT01654601|69167751|FG000|1st Administration|Protocol Violation|0|||
37691438|NCT01654601|69167752|FG001|1st Administration|Protocol Violation|2|||
37691439|NCT01654601|69167751|FG000|2nd Administration|Adverse Event|1|||
37691440|NCT01654601|69167752|FG001|2nd Administration|Adverse Event|0|||
37691441|NCT01654601|69167751|FG000|2nd Administration|Protocol Violation|0|||
37778275|NCT03802565|69325296|FG001|Overall Study|Elevated Enzymes|0|||
37778276|NCT03802565|69325297|FG002|Overall Study|Elevated Enzymes|0|||
37691442|NCT01654601|69167752|FG001|2nd Administration|Protocol Violation|1|||
37691443|NCT01654523|69167758|FG000|Overall Study|Withdrawal by Subject|1|||
37691444|NCT02508935|69167762|FG000|Overall Study|Withdrawal by Subject|1|||
37691445|NCT02508935|69167762|FG000|Overall Study|Withdrawal by Caregiver|8|||
37691446|NCT02508935|69167762|FG000|Overall Study|Pain Score <4|1|||
37691447|NCT02508935|69167762|FG000|Overall Study|Emesis|3|||
37691448|NCT02508935|69167762|FG000|Overall Study|Adverse Event|3|||
37691449|NCT02508935|69167762|FG000|Overall Study|Protocol Violation|1|||
37691450|NCT02508935|69167762|FG000|Overall Study|Physician Decision|1|||
37691451|NCT02508935|69167762|FG000|Overall Study|Trial terminated by sponsor|5|||
37691452|NCT02508701|69167772|FG000|Overall Study|Lost to Follow-up|9|||
37778277|NCT03802565|69325298|FG003|Overall Study|Elevated Enzymes|0|||
37778278|NCT03802565|69325299|FG004|Overall Study|Elevated Enzymes|2|||
37778279|NCT00245765|69325343|FG000|Overall Study|Adverse Event|1|||
37691453|NCT02508701|69167773|FG001|Overall Study|Lost to Follow-up|5|||
37691454|NCT02508701|69167774|FG002|Overall Study|Lost to Follow-up|5|||
37691455|NCT02508701|69167775|FG003|Overall Study|Lost to Follow-up|3|||
37691456|NCT02507375|69167791|FG000|Overall Study|Progressive Disease|4|||
37691457|NCT02507375|69167792|FG001|Overall Study|Progressive Disease|5|||
37691458|NCT02507375|69167791|FG000|Overall Study|Death|0|||
37691459|NCT02507375|69167792|FG001|Overall Study|Death|1|||
37691460|NCT02507375|69167791|FG000|Overall Study|Refused treatment|0|||
37691461|NCT02507375|69167792|FG001|Overall Study|Refused treatment|1|||
37691462|NCT02507375|69167791|FG000|Overall Study|Adverse Event|0|||
37691463|NCT02507375|69167792|FG001|Overall Study|Adverse Event|1|||
37691464|NCT02507219|69167802|FG000|Overall Study|Physician Decision|1|||
37691465|NCT02507219|69167803|FG001|Overall Study|Physician Decision|0|||
37691466|NCT02507219|69167804|FG002|Overall Study|Physician Decision|0|||
37691467|NCT02507219|69167805|FG003|Overall Study|Physician Decision|0|||
37691468|NCT02507219|69167806|FG004|Overall Study|Physician Decision|0|||
37691469|NCT02507219|69167807|FG005|Overall Study|Physician Decision|0|||
37691470|NCT02507219|69167802|FG000|Overall Study|Withdrawal by Subject|0|||
37691471|NCT02507219|69167803|FG001|Overall Study|Withdrawal by Subject|0|||
37691472|NCT02507219|69167804|FG002|Overall Study|Withdrawal by Subject|0|||
37691473|NCT02507219|69167805|FG003|Overall Study|Withdrawal by Subject|0|||
37691474|NCT02507219|69167806|FG004|Overall Study|Withdrawal by Subject|1|||
37691475|NCT02507219|69167807|FG005|Overall Study|Withdrawal by Subject|0|||
37691476|NCT02483975|69167817|FG000|Overall Study|Adverse Event|0|||
37863843|NCT01123161|69547423|FG000|Overall Study|Withdrawal by Subject|1|||
37863844|NCT01123161|69547424|FG001|Overall Study|Withdrawal by Subject|0|||
37863845|NCT01255631|69547435|FG000|Overall Study|poor enrollment, no data analyzed|9|||
37863846|NCT01255631|69547436|FG001|Overall Study|poor enrollment, no data analyzed|6|||
37863847|NCT00999466|69547445|FG000|Main Part|Withdrawal by Subject|0|||
37863848|NCT00999466|69547446|FG001|Main Part|Withdrawal by Subject|0|||
37863849|NCT00999466|69547447|FG002|Main Part|Withdrawal by Subject|2|||
37863850|NCT00999466|69547445|FG000|Main Part|Adverse Event|0|||
37863851|NCT00999466|69547446|FG001|Main Part|Adverse Event|4|||
37863852|NCT00999466|69547447|FG002|Main Part|Adverse Event|2|||
37863853|NCT01255163|69547457|FG000|Overall Study|Withdrawal by Subject|1|||
37863854|NCT01255163|69547458|FG001|Overall Study|Withdrawal by Subject|0|||
37863855|NCT01255163|69547457|FG000|Overall Study|Lost to Follow-up|2|||
37691477|NCT02483975|69167818|FG001|Overall Study|Adverse Event|1|||
37691478|NCT02483975|69167817|FG000|Overall Study|Lost to Follow-up|0|||
37691479|NCT02483975|69167818|FG001|Overall Study|Lost to Follow-up|1|||
37691480|NCT02483975|69167817|FG000|Overall Study|Physician Decision|2|||
37691481|NCT02483975|69167818|FG001|Overall Study|Physician Decision|0|||
37691482|NCT02047227|69167829|FG000|Overall Study|Adverse Event|2|||
37691483|NCT02047227|69167830|FG001|Overall Study|Adverse Event|4|||
37778280|NCT00245765|69325344|FG001|Overall Study|Adverse Event|1|||
37778281|NCT00245765|69325345|FG002|Overall Study|Adverse Event|0|||
37778282|NCT00245765|69325343|FG000|Overall Study|Lack of Efficacy|14|||
37778283|NCT00245765|69325344|FG001|Overall Study|Lack of Efficacy|7|||
37778284|NCT00245765|69325345|FG002|Overall Study|Lack of Efficacy|0|||
37778285|NCT00245765|69325343|FG000|Overall Study|Lost to Follow-up|1|||
37778286|NCT00245765|69325344|FG001|Overall Study|Lost to Follow-up|2|||
37778287|NCT00245765|69325345|FG002|Overall Study|Lost to Follow-up|0|||
37778288|NCT00245765|69325343|FG000|Overall Study|Withdrawal by Subject|1|||
37778289|NCT00245765|69325344|FG001|Overall Study|Withdrawal by Subject|0|||
37778290|NCT00245765|69325345|FG002|Overall Study|Withdrawal by Subject|3|||
37778291|NCT00245765|69325343|FG000|Overall Study|Other reason|2|||
37778292|NCT00245765|69325344|FG001|Overall Study|Other reason|0|||
37778293|NCT00245765|69325345|FG002|Overall Study|Other reason|1|||
37778294|NCT00245765|69325343|FG000|Overall Study|Other|13|||
37778295|NCT00245765|69325344|FG001|Overall Study|Other|4|||
37778296|NCT00245765|69325345|FG002|Overall Study|Other|4|||
37778297|NCT00245063|69325417|FG000|Overall Study|Adverse Event|6|||
37778298|NCT00245063|69325418|FG001|Overall Study|Adverse Event|5|||
37778299|NCT00245063|69325417|FG000|Overall Study|Death|1|||
37778300|NCT00245063|69325418|FG001|Overall Study|Death|0|||
37778301|NCT04329091|69325483|FG000|Overall Study|Physician Decision|5|||
37863856|NCT01255163|69547458|FG001|Overall Study|Lost to Follow-up|0|||
37863857|NCT01255163|69547457|FG000|Overall Study|Adverse Event|0|||
37863858|NCT01255163|69547458|FG001|Overall Study|Adverse Event|2|||
37691484|NCT02047227|69167829|FG000|Overall Study|Lost to Follow-up|0|||
37691485|NCT02047227|69167830|FG001|Overall Study|Lost to Follow-up|3|||
37691486|NCT02047227|69167829|FG000|Overall Study|Protocol Violation|1|||
37691487|NCT02047227|69167830|FG001|Overall Study|Protocol Violation|0|||
37691488|NCT02047227|69167829|FG000|Overall Study|Spontaneous pregnancy|1|||
37691489|NCT02047227|69167830|FG001|Overall Study|Spontaneous pregnancy|0|||
37691490|NCT02047227|69167829|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
37691491|NCT02047227|69167830|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
37863859|NCT01255163|69547457|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
37863860|NCT01255163|69547458|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
37863861|NCT01123083|69547468|FG000|Overall Study|Investigator recommendation|1|||
37863862|NCT01123083|69547469|FG001|Overall Study|Investigator recommendation|1|||
37863863|NCT01123083|69547468|FG000|Overall Study|Administrative reasons|0|||
37863864|NCT01123083|69547469|FG001|Overall Study|Administrative reasons|4|||
37863865|NCT01123083|69547468|FG000|Overall Study|Lost to Follow-up|2|||
37778302|NCT00244751|69325490|FG000|Overall Study|Adverse Event|7|||
37778303|NCT00244751|69325491|FG001|Overall Study|Adverse Event|7|||
37778304|NCT00244751|69325492|FG002|Overall Study|Adverse Event|5|||
37778305|NCT00244751|69325490|FG000|Overall Study|Lost to Follow-up|0|||
37778306|NCT00244751|69325491|FG001|Overall Study|Lost to Follow-up|1|||
37778307|NCT00244751|69325492|FG002|Overall Study|Lost to Follow-up|0|||
37778308|NCT00244751|69325490|FG000|Overall Study|Protocol Violation|1|||
37778309|NCT00244751|69325491|FG001|Overall Study|Protocol Violation|0|||
37778310|NCT00244751|69325492|FG002|Overall Study|Protocol Violation|1|||
37778311|NCT00244751|69325490|FG000|Overall Study|Withdrawal by Subject|7|||
37778312|NCT00244751|69325491|FG001|Overall Study|Withdrawal by Subject|5|||
37778313|NCT00244751|69325492|FG002|Overall Study|Withdrawal by Subject|3|||
37778314|NCT00244751|69325490|FG000|Overall Study|Elevated liver enzymes|1|||
37778315|NCT00244751|69325491|FG001|Overall Study|Elevated liver enzymes|0|||
37778316|NCT00244751|69325492|FG002|Overall Study|Elevated liver enzymes|0|||
37778317|NCT00244751|69325490|FG000|Overall Study|Lack of compliance with protocol|0|||
37778318|NCT00244751|69325491|FG001|Overall Study|Lack of compliance with protocol|1|||
37778319|NCT00244751|69325492|FG002|Overall Study|Lack of compliance with protocol|0|||
37778320|NCT00244751|69325490|FG000|Overall Study|Safety reasons|0|||
37778321|NCT00244751|69325491|FG001|Overall Study|Safety reasons|1|||
37778322|NCT00244751|69325492|FG002|Overall Study|Safety reasons|0|||
37778323|NCT00244751|69325490|FG000|Overall Study|Participant randomized by mistake|0|||
37778324|NCT00244751|69325491|FG001|Overall Study|Participant randomized by mistake|0|||
37778325|NCT00244751|69325492|FG002|Overall Study|Participant randomized by mistake|1|||
37778326|NCT00243659|69325534|FG000|Overall Study|Withdrawal by Subject|1|||
37778327|NCT00243659|69325535|FG001|Overall Study|Withdrawal by Subject|1|||
37778328|NCT00243659|69325534|FG000|Overall Study|Protocol Violation|1|||
37778329|NCT00243659|69325535|FG001|Overall Study|Protocol Violation|2|||
37778330|NCT00243347|69325550|FG000|Overall Study|Lack of Efficacy|4|||
37778331|NCT00243347|69325550|FG000|Overall Study|Adverse Event|2|||
37778332|NCT00243347|69325550|FG000|Overall Study|Death|1|||
37778333|NCT00243347|69325550|FG000|Overall Study|Withdrawal by Subject|5|||
37778334|NCT00243347|69325550|FG000|Overall Study|Condition worsened|7|||
37778335|NCT00243269|69325558|FG000|Overall Study|Protocol Violation|2|||
37778336|NCT00243269|69325559|FG001|Overall Study|Protocol Violation|1|||
37778337|NCT00243269|69325560|FG002|Overall Study|Protocol Violation|0|||
37778338|NCT00243269|69325561|FG003|Overall Study|Protocol Violation|1|||
37778339|NCT00243269|69325558|FG000|Overall Study|Lost to Follow-up|1|||
37778340|NCT00243269|69325559|FG001|Overall Study|Lost to Follow-up|0|||
37863866|NCT01123083|69547469|FG001|Overall Study|Lost to Follow-up|6|||
37863867|NCT01123083|69547468|FG000|Overall Study|Adverse Event|1|||
37863868|NCT01123083|69547469|FG001|Overall Study|Adverse Event|0|||
37863869|NCT01123083|69547468|FG000|Overall Study|Withdrew for another reason not covered|0|||
37863870|NCT01123083|69547469|FG001|Overall Study|Withdrew for another reason not covered|1|||
37863871|NCT01123083|69547468|FG000|Overall Study|Participant/legal representative request|7|||
37863872|NCT01123083|69547469|FG001|Overall Study|Participant/legal representative request|3|||
37863873|NCT01254305|69547478|FG000|Overall Study|Adverse Event|6|||
37863874|NCT01254305|69547479|FG001|Overall Study|Adverse Event|3|||
37863875|NCT01254305|69547480|FG002|Overall Study|Adverse Event|2|||
37863876|NCT01254305|69547478|FG000|Overall Study|Lack of Efficacy|1|||
37863877|NCT01254305|69547479|FG001|Overall Study|Lack of Efficacy|0|||
37863878|NCT01254305|69547480|FG002|Overall Study|Lack of Efficacy|1|||
37863879|NCT01254305|69547478|FG000|Overall Study|Protocol Violation|1|||
37863880|NCT01254305|69547479|FG001|Overall Study|Protocol Violation|7|||
37863881|NCT01254305|69547480|FG002|Overall Study|Protocol Violation|3|||
37863882|NCT01254305|69547478|FG000|Overall Study|Withdrawal by Subject|4|||
37778341|NCT00243269|69325560|FG002|Overall Study|Lost to Follow-up|1|||
37778342|NCT00243269|69325561|FG003|Overall Study|Lost to Follow-up|3|||
37778343|NCT00242567|69326785|FG000|Overall Study|Adverse Event|70|||
37778344|NCT00242567|69326786|FG001|Overall Study|Adverse Event|43|||
37778345|NCT00242567|69326785|FG000|Overall Study|Disease Progression|17|||
37778346|NCT00242567|69326786|FG001|Overall Study|Disease Progression|22|||
37778347|NCT00242567|69326785|FG000|Overall Study|Symptomatic deterioration|9|||
37778348|NCT00242567|69326786|FG001|Overall Study|Symptomatic deterioration|3|||
37778349|NCT00242567|69326785|FG000|Overall Study|Lack of Efficacy|2|||
37863883|NCT01254305|69547479|FG001|Overall Study|Withdrawal by Subject|2|||
37863884|NCT01254305|69547480|FG002|Overall Study|Withdrawal by Subject|4|||
37863885|NCT01254305|69547478|FG000|Overall Study|Lost to Follow-up|10|||
37863886|NCT01254305|69547479|FG001|Overall Study|Lost to Follow-up|6|||
37969304|NCT03861936|69656419|FG001|Overall Study|Reason not Specified|5|||
37863887|NCT01254305|69547480|FG002|Overall Study|Lost to Follow-up|5|||
37863888|NCT01254305|69547478|FG000|Overall Study|Other Reasons|0|||
37863889|NCT01254305|69547479|FG001|Overall Study|Other Reasons|0|||
37863890|NCT01254305|69547480|FG002|Overall Study|Other Reasons|2|||
37863891|NCT01122927|69547491|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
37863892|NCT01122927|69547492|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
37863893|NCT01122927|69547491|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
37863894|NCT01122927|69547492|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
37863895|NCT01122927|69547491|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
37863896|NCT01122927|69547492|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
37863897|NCT01122927|69547491|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
37863898|NCT01122927|69547492|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
37863899|NCT01122927|69547491|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
37778350|NCT00242567|69326786|FG001|Overall Study|Lack of Efficacy|2|||
37778351|NCT00242567|69326785|FG000|Overall Study|Lost to Follow-up|9|||
37778352|NCT00242567|69326786|FG001|Overall Study|Lost to Follow-up|19|||
37778353|NCT00242567|69326785|FG000|Overall Study|Withdrawal by Subject|33|||
37778354|NCT00242567|69326786|FG001|Overall Study|Withdrawal by Subject|28|||
37778355|NCT00242567|69326785|FG000|Overall Study|Protocol Violation|12|||
37778356|NCT00242567|69326786|FG001|Overall Study|Protocol Violation|12|||
37778357|NCT00242567|69326785|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
37778358|NCT00242567|69326786|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
37778359|NCT00242567|69326785|FG000|Overall Study|Other|14|||
37778360|NCT00242567|69326786|FG001|Overall Study|Other|9|||
37778361|NCT00241631|69326796|FG000|Run in (2 Weeks)|Physician Decision|3|||
37778362|NCT00241631|69326797|FG001|Run in (2 Weeks)|Physician Decision|3|||
37778363|NCT00241631|69326796|FG000|Phase 1 (4 Weeks)|sore throat|1|||
37778364|NCT00241631|69326797|FG001|Phase 1 (4 Weeks)|sore throat|0|||
37778365|NCT00241631|69326796|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
37778366|NCT00241631|69326797|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
37778367|NCT00241631|69326796|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
37778368|NCT00241631|69326797|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
37778369|NCT00241631|69326796|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
37778370|NCT00241631|69326797|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
37778371|NCT00240071|69326812|FG000|Overall Study|Withdrawal by Subject|3|||
37778372|NCT03761277|69327804|FG000|Enrollment to Implant|Screen Failure|17|||
37778373|NCT03761277|69327804|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
37778374|NCT03761277|69327804|FG000|Enrollment to Implant|Physician Decision|2|||
37778375|NCT03761277|69327804|FG000|Enrollment to Implant|Site Closure|3|||
37778376|NCT03761277|69327804|FG000|Enrollment to Implant|Sponsor Request|2|||
37778377|NCT03761277|69327804|FG000|Post-Implant to 6 Months|Adverse Event|2|||
37778378|NCT03761277|69327804|FG000|Post-Implant to 6 Months|Death|1|||
37778379|NCT03761277|69327804|FG000|Post-Implant to 6 Months|Site Closure|2|||
37778380|NCT03761277|69327804|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
37778381|NCT03761277|69327804|FG000|6 Months to 12 Months|Physician Decision|2|||
37778382|NCT03761277|69327804|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
37778383|NCT04099641|69327855|FG000|Overall Study|Death|46|||
37778384|NCT04099641|69327856|FG001|Overall Study|Death|12|||
37778385|NCT04099641|69327855|FG000|Overall Study|Lost to Follow-up|1|||
37778386|NCT04099641|69327856|FG001|Overall Study|Lost to Follow-up|0|||
37778387|NCT04099641|69327855|FG000|Overall Study|Withdrawal by Subject|2|||
37778388|NCT04099641|69327856|FG001|Overall Study|Withdrawal by Subject|0|||
37778389|NCT03123393|69327982|FG000|Overall Study|Study Terminated by Sponsor|6|||
37778390|NCT03123393|69327983|FG001|Overall Study|Study Terminated by Sponsor|9|||
37778391|NCT03123393|69327982|FG000|Overall Study|Withdrawal by Subject|2|||
37778392|NCT03123393|69327983|FG001|Overall Study|Withdrawal by Subject|1|||
37778393|NCT03123393|69327982|FG000|Overall Study|Reason not Specified|13|||
37778394|NCT03123393|69327983|FG001|Overall Study|Reason not Specified|13|||
37778395|NCT02834247|69328605|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
37863900|NCT01122927|69547492|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
37863901|NCT01122927|69547491|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
37778396|NCT02834247|69328606|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
37778397|NCT02834247|69328607|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
37863902|NCT01122927|69547492|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
37778398|NCT02834247|69328608|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
37778399|NCT02834247|69328605|FG000|Dose Escalation Phase|Death|5|||
37778400|NCT02834247|69328606|FG001|Dose Escalation Phase|Death|6|||
37863903|NCT01122927|69547491|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
37863904|NCT01122927|69547492|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
37863905|NCT01122927|69547491|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
37778401|NCT02834247|69328607|FG002|Dose Escalation Phase|Death|5|||
37778402|NCT02834247|69328608|FG003|Dose Escalation Phase|Death|0|||
37778403|NCT02834247|69328605|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
37778404|NCT02834247|69328606|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
37778405|NCT02834247|69328607|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
37778406|NCT02834247|69328608|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
37778407|NCT02834247|69328605|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
37778408|NCT02834247|69328606|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
37778409|NCT02834247|69328607|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
37778410|NCT02834247|69328608|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
37778411|NCT02834247|69328605|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
37778412|NCT02834247|69328606|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
37778413|NCT02834247|69328607|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
37778414|NCT02834247|69328608|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
37778415|NCT02834247|69328605|FG000|Dose Expansion Phase|Death|0|||
37778416|NCT02834247|69328606|FG001|Dose Expansion Phase|Death|0|||
37778417|NCT02834247|69328607|FG002|Dose Expansion Phase|Death|0|||
37863906|NCT01122927|69547492|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
37863907|NCT01122927|69547491|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
37863908|NCT01122927|69547492|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
37863909|NCT01122927|69547491|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
37863910|NCT01122927|69547492|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
37863911|NCT01122927|69547491|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
37863912|NCT01122927|69547492|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
37863913|NCT01122927|69547491|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
37863914|NCT01122927|69547492|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
37778418|NCT02834247|69328608|FG003|Dose Expansion Phase|Death|8|||
37778419|NCT02834247|69328605|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
37778420|NCT02834247|69328606|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
37778421|NCT02834247|69328607|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
37778422|NCT02834247|69328608|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
37778423|NCT02834247|69328605|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
37778424|NCT02834247|69328606|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
37778425|NCT02834247|69328607|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
37778426|NCT02834247|69328608|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
37778427|NCT01839331|69329888|FG000|Overall Study|Early Termination|3|||
37778428|NCT01839331|69329889|FG001|Overall Study|Early Termination|0|||
37778429|NCT01839331|69329890|FG002|Overall Study|Early Termination|1|||
37778430|NCT01839331|69329891|FG003|Overall Study|Early Termination|2|||
37778431|NCT01839331|69329888|FG000|Overall Study|Protocol Violation|1|||
37778432|NCT01839331|69329889|FG001|Overall Study|Protocol Violation|6|||
37778433|NCT01839331|69329890|FG002|Overall Study|Protocol Violation|4|||
37778434|NCT01839331|69329891|FG003|Overall Study|Protocol Violation|3|||
37778435|NCT02859064|69330194|FG000|Overall Study|Progressive Disease|3|||
37778436|NCT02859064|69330194|FG000|Overall Study|Physician Decision|1|||
37778437|NCT02859064|69330194|FG000|Overall Study|Withdrawal by Subject|1|||
37778438|NCT02859064|69330194|FG000|Overall Study|Death|1|||
37778439|NCT01606176|69330233|FG000|Overall Study|Adverse Event|2|||
37778440|NCT01606176|69330234|FG001|Overall Study|Adverse Event|3|||
37778441|NCT01606176|69330233|FG000|Overall Study|Disease progression|1|||
37778442|NCT01606176|69330234|FG001|Overall Study|Disease progression|0|||
37778443|NCT01606176|69330233|FG000|Overall Study|Withdrawal by Subject|1|||
37778444|NCT01606176|69330234|FG001|Overall Study|Withdrawal by Subject|0|||
37778445|NCT01663896|69330300|FG000|Overall Study|Various reasons|43|||
37778446|NCT02576652|69330353|FG000|Overall Study|Withdrawal by Subject|2|||
37778447|NCT02575950|69330437|FG000|Overall Study|Withdrawal by Subject|0|||
37778448|NCT02575950|69330438|FG001|Overall Study|Withdrawal by Subject|0|||
37778449|NCT02575950|69330439|FG002|Overall Study|Withdrawal by Subject|0|||
37778450|NCT02575950|69330440|FG003|Overall Study|Withdrawal by Subject|2|||
37778451|NCT02575950|69330437|FG000|Overall Study|Lost to Follow-up|0|||
37778452|NCT02575950|69330438|FG001|Overall Study|Lost to Follow-up|1|||
37778453|NCT02575950|69330439|FG002|Overall Study|Lost to Follow-up|0|||
37778454|NCT02575950|69330440|FG003|Overall Study|Lost to Follow-up|3|||
37778455|NCT01049581|69330522|FG000|Overall Study|Lost to Follow-up|2|||
37863915|NCT01254227|69547502|FG000|Overall Study|Withdrawal by Subject|6|||
37778456|NCT01049581|69330523|FG001|Overall Study|Lost to Follow-up|1|||
37778457|NCT02571972|69330541|FG000|Overall Study|Protocol Violation|2|||
37778458|NCT02571972|69330541|FG000|Overall Study|Withdrawal by Subject|2|||
37778459|NCT02166905|69330639|FG000|Overall Study|Withdrawal by Subject|1|||
37778460|NCT02166905|69330640|FG001|Overall Study|Withdrawal by Subject|0|||
37778461|NCT02166905|69330641|FG002|Overall Study|Withdrawal by Subject|0|||
37863916|NCT01254227|69547502|FG000|Overall Study|Lost to Follow-up|6|||
37863917|NCT01254227|69547502|FG000|Overall Study|Adverse Event|5|||
37863918|NCT01254227|69547502|FG000|Overall Study|Abnormal test procedure result|5|||
37778462|NCT02166905|69330642|FG003|Overall Study|Withdrawal by Subject|0|||
37778463|NCT01501955|69330689|FG000|Overall Study|Withdrawal by Subject|1|||
37778464|NCT01501955|69330690|FG001|Overall Study|Withdrawal by Subject|0|||
37778465|NCT01501955|69330689|FG000|Overall Study|Adverse Event|1|||
37778466|NCT01501955|69330690|FG001|Overall Study|Adverse Event|3|||
37778467|NCT02574312|69330818|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
37778468|NCT02574312|69330819|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
37778469|NCT01049035|69330841|FG000|Overall Study|Serious adverse event|0|||
37778470|NCT01049035|69330842|FG001|Overall Study|Serious adverse event|1|||
37778471|NCT01049035|69330843|FG002|Overall Study|Serious adverse event|1|||
37778472|NCT01049035|69330844|FG003|Overall Study|Serious adverse event|2|||
37778473|NCT01049035|69330845|FG004|Overall Study|Serious adverse event|0|||
37778474|NCT01049035|69330846|FG005|Overall Study|Serious adverse event|0|||
37778475|NCT01049035|69330847|FG006|Overall Study|Serious adverse event|0|||
37778476|NCT01049035|69330841|FG000|Overall Study|Other adverse event (AE)|0|||
37778477|NCT01049035|69330842|FG001|Overall Study|Other adverse event (AE)|0|||
37778478|NCT01049035|69330843|FG002|Overall Study|Other adverse event (AE)|0|||
37778479|NCT01049035|69330844|FG003|Overall Study|Other adverse event (AE)|1|||
37778480|NCT01049035|69330845|FG004|Overall Study|Other adverse event (AE)|0|||
37778481|NCT01049035|69330846|FG005|Overall Study|Other adverse event (AE)|0|||
37778482|NCT01049035|69330847|FG006|Overall Study|Other adverse event (AE)|0|||
37778483|NCT01049035|69330841|FG000|Overall Study|Non-compliance with the protocol|12|||
37778484|NCT01049035|69330842|FG001|Overall Study|Non-compliance with the protocol|6|||
37778485|NCT01049035|69330843|FG002|Overall Study|Non-compliance with the protocol|14|||
37778486|NCT01049035|69330844|FG003|Overall Study|Non-compliance with the protocol|5|||
37778487|NCT01049035|69330845|FG004|Overall Study|Non-compliance with the protocol|3|||
37778488|NCT01049035|69330846|FG005|Overall Study|Non-compliance with the protocol|4|||
37778489|NCT01049035|69330847|FG006|Overall Study|Non-compliance with the protocol|10|||
37778490|NCT01049035|69330841|FG000|Overall Study|Lost to Follow-up|5|||
37778491|NCT01049035|69330842|FG001|Overall Study|Lost to Follow-up|4|||
37778492|NCT01049035|69330843|FG002|Overall Study|Lost to Follow-up|4|||
37778493|NCT01049035|69330844|FG003|Overall Study|Lost to Follow-up|1|||
37778494|NCT01049035|69330845|FG004|Overall Study|Lost to Follow-up|0|||
37778495|NCT01049035|69330846|FG005|Overall Study|Lost to Follow-up|3|||
37778496|NCT01049035|69330847|FG006|Overall Study|Lost to Follow-up|3|||
37778497|NCT01049035|69330841|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
37778498|NCT01049035|69330842|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
37778499|NCT01049035|69330843|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
37778500|NCT01049035|69330844|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
37778501|NCT01049035|69330845|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
37778502|NCT01049035|69330846|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
37863919|NCT01254227|69547502|FG000|Overall Study|Administrative problems|2|||
37778503|NCT01049035|69330847|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
37863920|NCT01254227|69547502|FG000|Overall Study|Death|1|||
37863921|NCT01254227|69547502|FG000|Overall Study|Protocol deviation|1|||
37863922|NCT00995410|69547506|FG000|Overall Study|Adverse Event|51|||
37863923|NCT00995410|69547506|FG000|Overall Study|Withdrawal by Subject|7|||
37863924|NCT00995410|69547506|FG000|Overall Study|Lost to Follow-up|2|||
37863925|NCT00995410|69547506|FG000|Overall Study|Misc|28|||
37863926|NCT00995020|69547512|FG000|Overall Study|margin analysis not performed|2|||
37863927|NCT00995020|69547513|FG001|Overall Study|margin analysis not performed|5|||
37863928|NCT00995020|69547512|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
37863929|NCT00995020|69547513|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
37863930|NCT01122381|69547523|FG000|Overall Study|study terminated early|0|||
37863931|NCT01122381|69547524|FG001|Overall Study|study terminated early|1|||
37778504|NCT01048333|69330873|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
37778505|NCT01048333|69330874|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
37778506|NCT01048333|69330875|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
37778507|NCT01048333|69330876|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
37778508|NCT01048333|69330877|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
37778509|NCT01048333|69330878|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
37778510|NCT02323113|69330893|FG000|Overall Study|Adverse Event|3|||
37778511|NCT02323113|69330894|FG001|Overall Study|Adverse Event|3|||
37778512|NCT02323113|69330895|FG002|Overall Study|Adverse Event|2|||
37863932|NCT00996034|69547530|FG000|Overall Study|Lost to Follow-up|2|||
37863933|NCT00996034|69547530|FG000|Overall Study|withdrawn by PI|1|||
37778513|NCT02323113|69330896|FG003|Overall Study|Adverse Event|5|||
37778514|NCT02323113|69330897|FG004|Overall Study|Adverse Event|8|||
37778515|NCT02323113|69330898|FG005|Overall Study|Adverse Event|3|||
37778516|NCT02323113|69330899|FG006|Overall Study|Adverse Event|6|||
37778517|NCT02323113|69330900|FG007|Overall Study|Adverse Event|0|||
37778518|NCT02323113|69330893|FG000|Overall Study|Progressive Disease|0|||
37778519|NCT02323113|69330894|FG001|Overall Study|Progressive Disease|1|||
37778520|NCT02323113|69330895|FG002|Overall Study|Progressive Disease|1|||
37778521|NCT02323113|69330896|FG003|Overall Study|Progressive Disease|0|||
37778522|NCT02323113|69330897|FG004|Overall Study|Progressive Disease|0|||
37778523|NCT02323113|69330898|FG005|Overall Study|Progressive Disease|3|||
37778524|NCT02323113|69330899|FG006|Overall Study|Progressive Disease|0|||
37778525|NCT02323113|69330900|FG007|Overall Study|Progressive Disease|0|||
37778526|NCT02323113|69330893|FG000|Overall Study|Symptomatic Deterioration|0|||
37778527|NCT02323113|69330894|FG001|Overall Study|Symptomatic Deterioration|0|||
37778528|NCT02323113|69330895|FG002|Overall Study|Symptomatic Deterioration|1|||
37778529|NCT02323113|69330896|FG003|Overall Study|Symptomatic Deterioration|0|||
37778530|NCT02323113|69330897|FG004|Overall Study|Symptomatic Deterioration|1|||
37778531|NCT02323113|69330898|FG005|Overall Study|Symptomatic Deterioration|0|||
37778532|NCT02323113|69330899|FG006|Overall Study|Symptomatic Deterioration|0|||
37778533|NCT02323113|69330900|FG007|Overall Study|Symptomatic Deterioration|0|||
37778534|NCT02323113|69330893|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
37778535|NCT02323113|69330894|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
37778536|NCT02323113|69330895|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
37863934|NCT01253447|69547534|FG000|Overall Study|Adverse Event|2|||
37863935|NCT01121991|69547539|FG000|Overall Study|Lack of Ovarian Response|2|||
37778537|NCT02323113|69330896|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
37778538|NCT02323113|69330897|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
37778539|NCT02323113|69330898|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
37863936|NCT01121991|69547539|FG000|Overall Study|No Oocytes Retrieved|3|||
37778540|NCT02323113|69330899|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
37778541|NCT02323113|69330900|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
37778542|NCT02323113|69330893|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
37778543|NCT02323113|69330894|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
37778544|NCT02323113|69330895|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
37778545|NCT02323113|69330896|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
37778546|NCT02323113|69330897|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
37778547|NCT02323113|69330898|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
37778548|NCT02323113|69330899|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
37778549|NCT02323113|69330900|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
37778550|NCT02281383|69330947|FG000|Overall Study|Progressive Disease|1|||
37778551|NCT02281383|69330947|FG000|Overall Study|Withdrawal by Subject|6|||
37778552|NCT02281383|69330947|FG000|Overall Study|Protocol Violation|2|||
37778553|NCT02281383|69330947|FG000|Overall Study|Death|1|||
37778554|NCT02281383|69330947|FG000|Overall Study|Adverse Event|2|||
37778555|NCT01047553|69330953|FG000|Overall Study|Adverse Event|10|||
37778556|NCT01047553|69330954|FG001|Overall Study|Adverse Event|5|||
37778557|NCT01047553|69330953|FG000|Overall Study|Withdrawal by Subject|4|||
37778558|NCT01047553|69330954|FG001|Overall Study|Withdrawal by Subject|2|||
37778559|NCT01047553|69330953|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
37778560|NCT01047553|69330954|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
37778561|NCT01047553|69330953|FG000|Overall Study|Lost to Follow-up|1|||
37778562|NCT01047553|69330954|FG001|Overall Study|Lost to Follow-up|0|||
37778563|NCT01047553|69330953|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
37778564|NCT01047553|69330954|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
37778565|NCT01047553|69330953|FG000|Overall Study|PI's decision|0|||
37778566|NCT01047553|69330954|FG001|Overall Study|PI's decision|1|||
37778567|NCT01046695|69330986|FG000|Overall Study|Subject had a pacemaker|0|||
37778568|NCT01046695|69330987|FG001|Overall Study|Subject had a pacemaker|1|||
37778569|NCT01046695|69330986|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
37778570|NCT01046695|69330987|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
37778571|NCT03304379|69331002|FG000|Overall Study|Protocol Violation|8|||
37778572|NCT03304379|69331003|FG001|Overall Study|Protocol Violation|10|||
37778573|NCT03304379|69331004|FG002|Overall Study|Protocol Violation|5|||
37778574|NCT03304379|69331005|FG003|Overall Study|Protocol Violation|0|||
37778575|NCT03304379|69331006|FG004|Overall Study|Protocol Violation|2|||
37778576|NCT03304379|69331002|FG000|Overall Study|Adverse Event|4|||
37778577|NCT03304379|69331003|FG001|Overall Study|Adverse Event|20|||
37778578|NCT03304379|69331004|FG002|Overall Study|Adverse Event|17|||
37778579|NCT03304379|69331005|FG003|Overall Study|Adverse Event|1|||
37778580|NCT03304379|69331006|FG004|Overall Study|Adverse Event|0|||
37691492|NCT02047227|69167829|FG000|Overall Study|No oocytes retrieved|21|||
37691493|NCT02047227|69167830|FG001|Overall Study|No oocytes retrieved|20|||
37691494|NCT02047227|69167829|FG000|Overall Study|No fertilization|61|||
37691495|NCT02047227|69167830|FG001|Overall Study|No fertilization|51|||
37691496|NCT02047227|69167829|FG000|Overall Study|Intention to freeze all embryos|1|||
37691497|NCT02047227|69167830|FG001|Overall Study|Intention to freeze all embryos|0|||
37691498|NCT02047227|69167829|FG000|Overall Study|All embryos discarded|12|||
37691499|NCT02047227|69167830|FG001|Overall Study|All embryos discarded|11|||
37691500|NCT02047227|69167829|FG000|Overall Study|Other|10|||
37691501|NCT02047227|69167830|FG001|Overall Study|Other|9|||
37691502|NCT02483585|69167838|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
37778581|NCT03304379|69331002|FG000|Overall Study|Lack of Efficacy|17|||
37778582|NCT03304379|69331003|FG001|Overall Study|Lack of Efficacy|16|||
37778583|NCT03304379|69331004|FG002|Overall Study|Lack of Efficacy|20|||
37778584|NCT03304379|69331005|FG003|Overall Study|Lack of Efficacy|0|||
37778585|NCT03304379|69331006|FG004|Overall Study|Lack of Efficacy|0|||
37778586|NCT03304379|69331002|FG000|Overall Study|Physician Decision|6|||
37778587|NCT03304379|69331003|FG001|Overall Study|Physician Decision|10|||
37778588|NCT03304379|69331004|FG002|Overall Study|Physician Decision|6|||
37778589|NCT03304379|69331005|FG003|Overall Study|Physician Decision|9|||
37778590|NCT03304379|69331006|FG004|Overall Study|Physician Decision|10|||
37778591|NCT03304379|69331002|FG000|Overall Study|Withdrawal by Subject|26|||
37778592|NCT03304379|69331003|FG001|Overall Study|Withdrawal by Subject|58|||
37778593|NCT03304379|69331004|FG002|Overall Study|Withdrawal by Subject|66|||
37778594|NCT03304379|69331005|FG003|Overall Study|Withdrawal by Subject|3|||
37778595|NCT03304379|69331006|FG004|Overall Study|Withdrawal by Subject|5|||
37778596|NCT03304379|69331002|FG000|Overall Study|Lost to Follow-up|8|||
37778597|NCT03304379|69331003|FG001|Overall Study|Lost to Follow-up|24|||
37778598|NCT03304379|69331004|FG002|Overall Study|Lost to Follow-up|35|||
37778599|NCT03304379|69331005|FG003|Overall Study|Lost to Follow-up|4|||
37778600|NCT03304379|69331006|FG004|Overall Study|Lost to Follow-up|0|||
37778601|NCT03304379|69331002|FG000|Overall Study|Death|1|||
37778602|NCT03304379|69331003|FG001|Overall Study|Death|2|||
37778603|NCT03304379|69331004|FG002|Overall Study|Death|0|||
37778604|NCT03304379|69331005|FG003|Overall Study|Death|0|||
37778605|NCT03304379|69331006|FG004|Overall Study|Death|0|||
37778606|NCT03304379|69331002|FG000|Overall Study|Other|0|||
37778607|NCT03304379|69331003|FG001|Overall Study|Other|1|||
37778608|NCT03304379|69331004|FG002|Overall Study|Other|0|||
37778609|NCT03304379|69331005|FG003|Overall Study|Other|0|||
37778610|NCT03304379|69331006|FG004|Overall Study|Other|0|||
37778611|NCT01044433|69331079|FG000|Overall Study|Lost to Follow-up|3|||
37778612|NCT01044433|69331079|FG000|Overall Study|Withdrawal by Subject|3|||
37778613|NCT01043185|69331088|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
37778614|NCT01043185|69331089|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
37778615|NCT01043185|69331090|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
37778616|NCT01043185|69331091|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
37778617|NCT01043185|69331092|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
37863937|NCT01121991|69547539|FG000|Overall Study|No Fertilization|1|||
37863938|NCT00994240|69547545|FG000|Overall Study|Lost to Follow-up|3|||
37969305|NCT03861936|69656420|FG002|Overall Study|Reason not Specified|3|||
37778618|NCT01043185|69331093|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
37778619|NCT01043185|69331094|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
37778620|NCT01043185|69331095|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
37778621|NCT01043185|69331096|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
37778622|NCT01043185|69331097|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
37778623|NCT01042093|69331122|FG000|Overall Study|Protocol Violation|2|||
37778624|NCT01042093|69331123|FG001|Overall Study|Protocol Violation|2|||
37778625|NCT01042093|69331124|FG002|Overall Study|Protocol Violation|2|||
37778626|NCT01042093|69331125|FG003|Overall Study|Protocol Violation|3|||
37778627|NCT01042093|69331122|FG000|Overall Study|Withdrawal by Subject|0|||
37778628|NCT01042093|69331123|FG001|Overall Study|Withdrawal by Subject|0|||
37778629|NCT01042093|69331124|FG002|Overall Study|Withdrawal by Subject|0|||
37778630|NCT01042093|69331125|FG003|Overall Study|Withdrawal by Subject|1|||
37778631|NCT01041859|69331155|FG000|Open-Label Titration|Adverse Event|69|||
37778632|NCT01041859|69331156|FG001|Open-Label Titration|Adverse Event|0|||
37778633|NCT01041859|69331157|FG002|Open-Label Titration|Adverse Event|0|||
37778634|NCT01041859|69331155|FG000|Open-Label Titration|Lack of Efficacy|3|||
37778635|NCT01041859|69331156|FG001|Open-Label Titration|Lack of Efficacy|0|||
37778636|NCT01041859|69331157|FG002|Open-Label Titration|Lack of Efficacy|0|||
37778637|NCT01041859|69331155|FG000|Open-Label Titration|Lost to Follow-up|1|||
37778638|NCT01041859|69331156|FG001|Open-Label Titration|Lost to Follow-up|0|||
37778639|NCT01041859|69331157|FG002|Open-Label Titration|Lost to Follow-up|0|||
37778640|NCT01041859|69331155|FG000|Open-Label Titration|Physician Decision|1|||
37778641|NCT01041859|69331156|FG001|Open-Label Titration|Physician Decision|0|||
37778642|NCT01041859|69331157|FG002|Open-Label Titration|Physician Decision|0|||
37778643|NCT01041859|69331155|FG000|Open-Label Titration|Protocol Violation|1|||
37778644|NCT01041859|69331156|FG001|Open-Label Titration|Protocol Violation|0|||
37778645|NCT01041859|69331157|FG002|Open-Label Titration|Protocol Violation|0|||
37778646|NCT01041859|69331155|FG000|Open-Label Titration|Other|7|||
37778647|NCT01041859|69331156|FG001|Open-Label Titration|Other|0|||
37778648|NCT01041859|69331157|FG002|Open-Label Titration|Other|0|||
37778649|NCT01041859|69331155|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
37778650|NCT01041859|69331156|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
37778651|NCT01041859|69331157|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
37778652|NCT01041859|69331155|FG000|Open-Label Titration|Withdrawal by Subject|11|||
37778653|NCT01041859|69331156|FG001|Open-Label Titration|Withdrawal by Subject|0|||
37778654|NCT01041859|69331157|FG002|Open-Label Titration|Withdrawal by Subject|0|||
37778655|NCT01041859|69331155|FG000|Double-Blind Maintenance|Adverse Event|0|||
37778656|NCT01041859|69331156|FG001|Double-Blind Maintenance|Adverse Event|23|||
37778657|NCT01041859|69331157|FG002|Double-Blind Maintenance|Adverse Event|13|||
37778658|NCT01041859|69331155|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
37778659|NCT01041859|69331156|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
37778660|NCT01041859|69331157|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
37778661|NCT01041859|69331155|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
37778662|NCT01041859|69331156|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
37778663|NCT01041859|69331157|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
37778664|NCT01041859|69331155|FG000|Double-Blind Maintenance|Physician Decision|0|||
37778665|NCT01041859|69331156|FG001|Double-Blind Maintenance|Physician Decision|2|||
37778666|NCT01041859|69331157|FG002|Double-Blind Maintenance|Physician Decision|1|||
37778667|NCT01041859|69331155|FG000|Double-Blind Maintenance|Protocol Violation|0|||
37778668|NCT01041859|69331156|FG001|Double-Blind Maintenance|Protocol Violation|1|||
37778669|NCT01041859|69331157|FG002|Double-Blind Maintenance|Protocol Violation|3|||
37778670|NCT01041859|69331155|FG000|Double-Blind Maintenance|Other|0|||
37778671|NCT01041859|69331156|FG001|Double-Blind Maintenance|Other|6|||
37778672|NCT01041859|69331157|FG002|Double-Blind Maintenance|Other|2|||
37778673|NCT01041859|69331155|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
37778674|NCT01041859|69331156|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
37778675|NCT01041859|69331157|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
37778676|NCT01041859|69331155|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
37778677|NCT01041859|69331156|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
37778678|NCT01041859|69331157|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
37691503|NCT02483585|69167839|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
37691504|NCT02483585|69167838|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
37691505|NCT02483585|69167839|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
37691506|NCT02483585|69167838|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
37691507|NCT02483585|69167839|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
37691508|NCT02483585|69167838|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
37691509|NCT02483585|69167839|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
37691510|NCT02483585|69167838|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
37691511|NCT02483585|69167839|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
37778679|NCT01040845|69331166|FG000|Overall Study|Withdrawal by Subject|1|||
37778680|NCT01040845|69331167|FG001|Overall Study|Withdrawal by Subject|1|||
37778681|NCT01040845|69331166|FG000|Overall Study|Physician Decision|1|||
37778682|NCT01040845|69331167|FG001|Overall Study|Physician Decision|0|||
37778683|NCT01040689|69331175|FG000|Overall Study|Adverse Event|0|||
37778684|NCT01040689|69331176|FG001|Overall Study|Adverse Event|0|||
37778685|NCT01040689|69331177|FG002|Overall Study|Adverse Event|2|||
37778686|NCT01040689|69331178|FG003|Overall Study|Adverse Event|4|||
37778687|NCT01040689|69331175|FG000|Overall Study|Lack of Efficacy|0|||
37691512|NCT02483585|69167838|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
37778688|NCT01040689|69331176|FG001|Overall Study|Lack of Efficacy|0|||
37778689|NCT01040689|69331177|FG002|Overall Study|Lack of Efficacy|1|||
37778690|NCT01040689|69331178|FG003|Overall Study|Lack of Efficacy|0|||
37778691|NCT01040689|69331175|FG000|Overall Study|Lost to Follow-up|1|||
37778692|NCT01040689|69331176|FG001|Overall Study|Lost to Follow-up|0|||
37778693|NCT01040689|69331177|FG002|Overall Study|Lost to Follow-up|0|||
37778694|NCT01040689|69331178|FG003|Overall Study|Lost to Follow-up|0|||
37778695|NCT01040689|69331175|FG000|Overall Study|Withdrawal by Subject|2|||
37778696|NCT01040689|69331176|FG001|Overall Study|Withdrawal by Subject|1|||
37778697|NCT01040689|69331177|FG002|Overall Study|Withdrawal by Subject|1|||
37778698|NCT01040689|69331178|FG003|Overall Study|Withdrawal by Subject|0|||
37778699|NCT01040689|69331175|FG000|Overall Study|Other reasons not listed above|0|||
37778700|NCT01040689|69331176|FG001|Overall Study|Other reasons not listed above|1|||
37778701|NCT01040689|69331177|FG002|Overall Study|Other reasons not listed above|0|||
37778702|NCT01040689|69331178|FG003|Overall Study|Other reasons not listed above|0|||
37778703|NCT01047319|69331227|FG000|Overall Study|Teva requested participant withdrawal|3|||
37778704|NCT01047319|69331228|FG001|Overall Study|Teva requested participant withdrawal|0|||
37778705|NCT01047319|69331229|FG002|Overall Study|Teva requested participant withdrawal|1|||
37691513|NCT02483585|69167839|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
37691514|NCT02483585|69167838|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
37691515|NCT02483585|69167839|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
37691516|NCT02046993|69167851|FG000|Overall Study|Withdrawal by Subject|2|||
37691517|NCT02046993|69167852|FG001|Overall Study|Withdrawal by Subject|10|||
37691518|NCT02046993|69167851|FG000|Overall Study|Lost to Follow-up|1|||
37691519|NCT02046993|69167852|FG001|Overall Study|Lost to Follow-up|1|||
37691520|NCT02101983|69167862|FG000|Overall Study|Physician Decision|1|||
37691521|NCT02101983|69167863|FG001|Overall Study|Physician Decision|0|||
37691522|NCT02482805|69167872|FG000|Overall Study|Lost to Follow-up|4|||
37691523|NCT02482805|69167873|FG001|Overall Study|Lost to Follow-up|4|||
37691524|NCT02482805|69167874|FG002|Overall Study|Lost to Follow-up|0|||
37691525|NCT02503865|69167885|FG000|Overall Study|Moved out of area|1|||
37691526|NCT02503865|69167886|FG001|Overall Study|Moved out of area|8|||
37691527|NCT02503865|69167887|FG002|Overall Study|Moved out of area|0|||
37691528|NCT02503865|69167885|FG000|Overall Study|Refused treatment|4|||
37691529|NCT02503865|69167886|FG001|Overall Study|Refused treatment|39|||
37691530|NCT02503865|69167887|FG002|Overall Study|Refused treatment|2|||
37691531|NCT01623531|69167898|FG000|Overall Study|Death|1|||
37691532|NCT01623531|69167899|FG001|Overall Study|Death|0|||
37691533|NCT01623531|69167898|FG000|Overall Study|Protocol Violation|2|||
37691534|NCT01623531|69167899|FG001|Overall Study|Protocol Violation|1|||
37691535|NCT01623531|69167898|FG000|Overall Study|Missing data at primary outcome time poi|1|||
37691536|NCT01623531|69167899|FG001|Overall Study|Missing data at primary outcome time poi|1|||
37691537|NCT02503787|69167908|FG000|Enrollment|Withdrawal by Subject|6|||
37691538|NCT02503787|69167908|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
37691539|NCT02503787|69167908|FG000|Enrollment|Physician Decision|2|||
37691540|NCT02503787|69167908|FG000|Enrollment|Insurance issue|2|||
37691541|NCT02503787|69167908|FG000|Enrollment|Lost to Follow-up|1|||
37691542|NCT02503787|69167908|FG000|Enrollment|Study closure|1|||
37691543|NCT02503787|69167908|FG000|Enrollment|Adverse Event|1|||
37691544|NCT02503787|69167908|FG000|Enrollment|Protocol Violation|1|||
37691545|NCT02503787|69167908|FG000|Enrollment|Inability to implant system|1|||
37691546|NCT02503787|69167908|FG000|Enrollment|Unable to be programmed|1|||
37691547|NCT02503787|69167908|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
37691548|NCT02503787|69167908|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
37778706|NCT01047319|69331227|FG000|Overall Study|Protocol Violation|3|||
37778707|NCT01047319|69331228|FG001|Overall Study|Protocol Violation|2|||
37778708|NCT01047319|69331229|FG002|Overall Study|Protocol Violation|4|||
37778709|NCT01047319|69331227|FG000|Overall Study|Lack of Efficacy|4|||
37778710|NCT01047319|69331228|FG001|Overall Study|Lack of Efficacy|3|||
37778711|NCT01047319|69331229|FG002|Overall Study|Lack of Efficacy|3|||
37691549|NCT02503787|69167908|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
37691550|NCT02503787|69167908|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
37691551|NCT02503787|69167908|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
37691552|NCT02503787|69167908|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
37778712|NCT01047319|69331227|FG000|Overall Study|Death|5|||
37778713|NCT01047319|69331228|FG001|Overall Study|Death|1|||
37778714|NCT01047319|69331229|FG002|Overall Study|Death|5|||
37778715|NCT01047319|69331227|FG000|Overall Study|Pregnancy|13|||
37778716|NCT01047319|69331228|FG001|Overall Study|Pregnancy|8|||
37778717|NCT01047319|69331229|FG002|Overall Study|Pregnancy|8|||
37778718|NCT01047319|69331227|FG000|Overall Study|Physician Decision|12|||
37778719|NCT01047319|69331228|FG001|Overall Study|Physician Decision|9|||
37778720|NCT01047319|69331229|FG002|Overall Study|Physician Decision|10|||
37778721|NCT01047319|69331227|FG000|Overall Study|Lost to Follow-up|14|||
37778722|NCT01047319|69331228|FG001|Overall Study|Lost to Follow-up|10|||
37778723|NCT01047319|69331229|FG002|Overall Study|Lost to Follow-up|10|||
37778724|NCT01047319|69331227|FG000|Overall Study|Adverse Event|16|||
37778725|NCT01047319|69331228|FG001|Overall Study|Adverse Event|27|||
37778726|NCT01047319|69331229|FG002|Overall Study|Adverse Event|21|||
37778727|NCT01047319|69331227|FG000|Overall Study|Withdrawal by Subject|77|||
37778728|NCT01047319|69331228|FG001|Overall Study|Withdrawal by Subject|75|||
37778729|NCT01047319|69331229|FG002|Overall Study|Withdrawal by Subject|87|||
37778730|NCT01047319|69331227|FG000|Overall Study|Study terminated by Sponsor|198|||
37778731|NCT01047319|69331228|FG001|Overall Study|Study terminated by Sponsor|215|||
37778732|NCT01047319|69331229|FG002|Overall Study|Study terminated by Sponsor|203|||
37778733|NCT00014911|69331546|FG000|Overall Study|Adverse Event|1|||
37778734|NCT00014911|69331546|FG000|Overall Study|Lost to Follow-up|1|||
37778735|NCT00014911|69331546|FG000|Overall Study|Withdrawal by Subject|6|||
37778736|NCT00014911|69331546|FG000|Overall Study|Unknown Reasons|2|||
37778737|NCT00014911|69331546|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
37778738|NCT01049009|69332079|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
37778739|NCT01049009|69332080|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
37778740|NCT01049009|69332079|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
37778741|NCT01049009|69332080|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
37778742|NCT01049009|69332079|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
37691553|NCT02482571|69167912|FG000|Overall Study|Adverse Event|1|||
37691554|NCT02482571|69167912|FG000|Overall Study|Scanner or Respiract failure|3|||
37691555|NCT02482571|69167912|FG000|Overall Study|Withdrawal by Subject|4|||
37691556|NCT02481947|69167919|FG000|Overall Study|Withdrawal by Subject|24|||
37691557|NCT02481947|69167920|FG001|Overall Study|Withdrawal by Subject|10|||
37691558|NCT02481947|69167919|FG000|Overall Study|Lost to Follow-up|11|||
37691559|NCT02481947|69167920|FG001|Overall Study|Lost to Follow-up|5|||
37691560|NCT02481947|69167919|FG000|Overall Study|Adverse Event|6|||
37691561|NCT02481947|69167920|FG001|Overall Study|Adverse Event|11|||
37691562|NCT02481947|69167919|FG000|Overall Study|Physician Decision|4|||
37691563|NCT02481947|69167920|FG001|Overall Study|Physician Decision|5|||
37691564|NCT02481947|69167919|FG000|Overall Study|Protocol Violation|1|||
37691565|NCT02481947|69167920|FG001|Overall Study|Protocol Violation|5|||
37691566|NCT02503085|69167926|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
37691567|NCT02503085|69167927|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
37691568|NCT02503085|69167928|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
37778743|NCT01049009|69332080|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
37778744|NCT01049009|69332079|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
37778745|NCT01049009|69332080|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
37778746|NCT01047683|69332102|FG000|Overall Study|Adverse Event|3|||
37778747|NCT01047683|69332103|FG001|Overall Study|Adverse Event|1|||
37778748|NCT01047683|69332104|FG002|Overall Study|Adverse Event|0|||
37778749|NCT01047683|69332102|FG000|Overall Study|Withdrew Consent|1|||
37778750|NCT01047683|69332103|FG001|Overall Study|Withdrew Consent|4|||
37778751|NCT01047683|69332104|FG002|Overall Study|Withdrew Consent|2|||
37778752|NCT01047683|69332102|FG000|Overall Study|Lost to Follow-up|0|||
37778753|NCT01047683|69332103|FG001|Overall Study|Lost to Follow-up|1|||
37778754|NCT01047683|69332104|FG002|Overall Study|Lost to Follow-up|0|||
37778755|NCT01047683|69332102|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
37778756|NCT01047683|69332103|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
37778757|NCT01047683|69332104|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
37778758|NCT01047293|69332192|FG000|Overall Study|DLT criteria not fulfilled|1|||
37778759|NCT01047293|69332193|FG001|Overall Study|DLT criteria not fulfilled|1|||
37778760|NCT01047293|69332194|FG002|Overall Study|DLT criteria not fulfilled|0|||
37778761|NCT01047293|69332195|FG003|Overall Study|DLT criteria not fulfilled|0|||
37778762|NCT01045967|69332204|FG000|Second Intervention|Protocol Violation|0|||
37778763|NCT01045967|69332205|FG001|Second Intervention|Protocol Violation|1|||
37778764|NCT01045421|69332791|FG000|Phase 1|Progressive Disease|0|||
37778765|NCT01045421|69332792|FG001|Phase 1|Progressive Disease|0|||
37778766|NCT01045421|69332793|FG002|Phase 1|Progressive Disease|0|||
37778767|NCT01045421|69332794|FG003|Phase 1|Progressive Disease|0|||
37778768|NCT01045421|69332795|FG004|Phase 1|Progressive Disease|1|||
37778769|NCT01045421|69332796|FG005|Phase 1|Progressive Disease|0|||
37778770|NCT01045421|69332797|FG006|Phase 1|Progressive Disease|0|||
37778771|NCT01045421|69332798|FG007|Phase 1|Progressive Disease|0|||
37778772|NCT01045421|69332799|FG008|Phase 1|Progressive Disease|0|||
37778773|NCT01045421|69332800|FG009|Phase 1|Progressive Disease|0|||
37778774|NCT01045421|69332801|FG010|Phase 1|Progressive Disease|0|||
37778775|NCT01045421|69332791|FG000|Phase 1|Withdrawal by Subject|0|||
37778776|NCT01045421|69332792|FG001|Phase 1|Withdrawal by Subject|0|||
37778777|NCT01045421|69332793|FG002|Phase 1|Withdrawal by Subject|0|||
37778778|NCT01045421|69332794|FG003|Phase 1|Withdrawal by Subject|1|||
37778779|NCT01045421|69332795|FG004|Phase 1|Withdrawal by Subject|0|||
37778780|NCT01045421|69332796|FG005|Phase 1|Withdrawal by Subject|0|||
37778781|NCT01045421|69332797|FG006|Phase 1|Withdrawal by Subject|0|||
37778782|NCT01045421|69332798|FG007|Phase 1|Withdrawal by Subject|0|||
37778783|NCT01045421|69332799|FG008|Phase 1|Withdrawal by Subject|0|||
37778784|NCT01045421|69332800|FG009|Phase 1|Withdrawal by Subject|0|||
37778785|NCT01045421|69332801|FG010|Phase 1|Withdrawal by Subject|0|||
37778786|NCT01045421|69332791|FG000|Phase 2|Progressive Disease|0|||
37778787|NCT01045421|69332792|FG001|Phase 2|Progressive Disease|0|||
37778788|NCT01045421|69332793|FG002|Phase 2|Progressive Disease|0|||
37778789|NCT01045421|69332794|FG003|Phase 2|Progressive Disease|0|||
37778790|NCT01045421|69332795|FG004|Phase 2|Progressive Disease|0|||
37778791|NCT01045421|69332796|FG005|Phase 2|Progressive Disease|0|||
37778792|NCT01045421|69332797|FG006|Phase 2|Progressive Disease|0|||
37778793|NCT01045421|69332798|FG007|Phase 2|Progressive Disease|1|||
37778794|NCT01045421|69332799|FG008|Phase 2|Progressive Disease|1|||
37778795|NCT01045421|69332800|FG009|Phase 2|Progressive Disease|1|||
37778796|NCT01045421|69332801|FG010|Phase 2|Progressive Disease|1|||
37778797|NCT01045421|69332791|FG000|Phase 2|Death|0|||
37778798|NCT01045421|69332792|FG001|Phase 2|Death|0|||
37778799|NCT01045421|69332793|FG002|Phase 2|Death|0|||
37778800|NCT01045421|69332794|FG003|Phase 2|Death|0|||
37778801|NCT01045421|69332795|FG004|Phase 2|Death|0|||
37778802|NCT01045421|69332796|FG005|Phase 2|Death|0|||
37778803|NCT01045421|69332797|FG006|Phase 2|Death|0|||
37778804|NCT01045421|69332798|FG007|Phase 2|Death|1|||
37778805|NCT01045421|69332799|FG008|Phase 2|Death|1|||
37778806|NCT01045421|69332800|FG009|Phase 2|Death|2|||
37778807|NCT01045421|69332801|FG010|Phase 2|Death|0|||
37778808|NCT01045421|69332791|FG000|Phase 2|Other|0|||
37778809|NCT01045421|69332792|FG001|Phase 2|Other|0|||
37778810|NCT01045421|69332793|FG002|Phase 2|Other|0|||
37778811|NCT01045421|69332794|FG003|Phase 2|Other|0|||
37778812|NCT01045421|69332795|FG004|Phase 2|Other|0|||
37778813|NCT01045421|69332796|FG005|Phase 2|Other|0|||
37778814|NCT01045421|69332797|FG006|Phase 2|Other|0|||
37778815|NCT01045421|69332798|FG007|Phase 2|Other|3|||
37778816|NCT01045421|69332799|FG008|Phase 2|Other|0|||
37778817|NCT01045421|69332800|FG009|Phase 2|Other|0|||
37778818|NCT01045421|69332801|FG010|Phase 2|Other|1|||
37778819|NCT01042535|69332849|FG000|Overall Study|disease progression prior to treatment|3|||
37778820|NCT01042535|69332849|FG000|Overall Study|disease progression during treatment|3|||
37778821|NCT01042535|69332849|FG000|Overall Study|complications from other disease|2|||
37778822|NCT01041287|69332855|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
37778823|NCT01041287|69332856|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
37778824|NCT01041287|69332855|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
37778825|NCT01041287|69332856|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
37778826|NCT01040351|69332877|FG000|Overall Study|poor ovarian response|1|||
37778827|NCT01040351|69332878|FG001|Overall Study|poor ovarian response|2|||
37778828|NCT02049957|69332898|FG000|Overall Study|Progressive Disease|5|||
37778829|NCT02049957|69332899|FG001|Overall Study|Progressive Disease|4|||
37778830|NCT02049957|69332900|FG002|Overall Study|Progressive Disease|2|||
37778831|NCT02049957|69332901|FG003|Overall Study|Progressive Disease|2|||
37778832|NCT02049957|69332902|FG004|Overall Study|Progressive Disease|6|||
37778833|NCT02049957|69332903|FG005|Overall Study|Progressive Disease|35|||
37778834|NCT02049957|69332904|FG006|Overall Study|Progressive Disease|7|||
37778835|NCT02049957|69332905|FG007|Overall Study|Progressive Disease|26|||
37778836|NCT02049957|69332906|FG008|Overall Study|Progressive Disease|6|||
37778837|NCT02049957|69332898|FG000|Overall Study|Adverse Event|1|||
37778838|NCT02049957|69332899|FG001|Overall Study|Adverse Event|1|||
37778839|NCT02049957|69332900|FG002|Overall Study|Adverse Event|1|||
37778840|NCT02049957|69332901|FG003|Overall Study|Adverse Event|0|||
37778841|NCT02049957|69332902|FG004|Overall Study|Adverse Event|0|||
37778842|NCT02049957|69332903|FG005|Overall Study|Adverse Event|5|||
37778843|NCT02049957|69332904|FG006|Overall Study|Adverse Event|0|||
37778844|NCT02049957|69332905|FG007|Overall Study|Adverse Event|6|||
37778845|NCT02049957|69332906|FG008|Overall Study|Adverse Event|1|||
37778846|NCT02049957|69332898|FG000|Overall Study|Study Terminated by Sponsor|0|||
37778847|NCT02049957|69332899|FG001|Overall Study|Study Terminated by Sponsor|1|||
37778848|NCT02049957|69332900|FG002|Overall Study|Study Terminated by Sponsor|0|||
37778849|NCT02049957|69332901|FG003|Overall Study|Study Terminated by Sponsor|0|||
37778850|NCT02049957|69332902|FG004|Overall Study|Study Terminated by Sponsor|0|||
37778851|NCT02049957|69332903|FG005|Overall Study|Study Terminated by Sponsor|0|||
37778852|NCT02049957|69332904|FG006|Overall Study|Study Terminated by Sponsor|1|||
37778853|NCT02049957|69332905|FG007|Overall Study|Study Terminated by Sponsor|0|||
37778854|NCT02049957|69332906|FG008|Overall Study|Study Terminated by Sponsor|0|||
37778855|NCT02049957|69332898|FG000|Overall Study|Withdrawal by Subject|0|||
37778856|NCT02049957|69332899|FG001|Overall Study|Withdrawal by Subject|0|||
37778857|NCT02049957|69332900|FG002|Overall Study|Withdrawal by Subject|0|||
37778858|NCT02049957|69332901|FG003|Overall Study|Withdrawal by Subject|1|||
37778859|NCT02049957|69332902|FG004|Overall Study|Withdrawal by Subject|0|||
37778860|NCT02049957|69332903|FG005|Overall Study|Withdrawal by Subject|2|||
37778861|NCT02049957|69332904|FG006|Overall Study|Withdrawal by Subject|0|||
37778862|NCT02049957|69332905|FG007|Overall Study|Withdrawal by Subject|3|||
37778863|NCT02049957|69332906|FG008|Overall Study|Withdrawal by Subject|1|||
37778864|NCT02049957|69332898|FG000|Overall Study|Physician Decision|0|||
37778865|NCT02049957|69332899|FG001|Overall Study|Physician Decision|0|||
37969306|NCT00434577|69656433|FG000|Months 0-3|Serious Adverse Event|0|||
37969307|NCT00434577|69656434|FG001|Months 0-3|Serious Adverse Event|0|||
37778866|NCT02049957|69332900|FG002|Overall Study|Physician Decision|0|||
37778867|NCT02049957|69332901|FG003|Overall Study|Physician Decision|0|||
37778868|NCT02049957|69332902|FG004|Overall Study|Physician Decision|0|||
37778869|NCT02049957|69332903|FG005|Overall Study|Physician Decision|1|||
37778870|NCT02049957|69332904|FG006|Overall Study|Physician Decision|0|||
37778871|NCT02049957|69332905|FG007|Overall Study|Physician Decision|0|||
37778872|NCT02049957|69332906|FG008|Overall Study|Physician Decision|0|||
37778873|NCT00014495|69333169|FG000|Overall Study|Death|0|||
37969308|NCT00434577|69656435|FG002|Months 0-3|Serious Adverse Event|1|||
37778874|NCT00014495|69333170|FG001|Overall Study|Death|0|||
37778875|NCT00014495|69333171|FG002|Overall Study|Death|1|||
37778876|NCT00014495|69333172|FG003|Overall Study|Death|0|||
37778877|NCT00014495|69333169|FG000|Overall Study|Clinical deterioration|0|||
37778878|NCT00014495|69333170|FG001|Overall Study|Clinical deterioration|0|||
37778879|NCT00014495|69333171|FG002|Overall Study|Clinical deterioration|0|||
37778880|NCT00014495|69333172|FG003|Overall Study|Clinical deterioration|1|||
37778881|NCT01351623|69335184|FG000|Overall Study|Protocol Violation|2|||
37778882|NCT01351623|69335184|FG000|Overall Study|Adverse Event|4|||
37778883|NCT01351623|69335184|FG000|Overall Study|Withdrawal by Subject|1|||
37778884|NCT01351623|69335184|FG000|Overall Study|Death|2|||
37778885|NCT03670953|69335325|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
37778886|NCT03670953|69335326|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
37778887|NCT03670953|69335327|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
37778888|NCT03670953|69335328|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
37778889|NCT03670953|69335325|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
37778890|NCT03670953|69335326|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
37778891|NCT03670953|69335327|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
37778892|NCT03670953|69335328|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
37778893|NCT03670953|69335325|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
37778894|NCT03670953|69335326|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
37778895|NCT03670953|69335327|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
37778896|NCT03670953|69335328|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
37778897|NCT03670953|69335325|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
37778898|NCT03670953|69335326|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
37778899|NCT03670953|69335327|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
37778900|NCT03670953|69335328|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
37778901|NCT03670953|69335325|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
37778902|NCT03670953|69335326|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
37778903|NCT03670953|69335327|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
37778904|NCT03670953|69335328|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
37778905|NCT03670953|69335325|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
37778906|NCT03670953|69335326|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
37778907|NCT03670953|69335327|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
37778908|NCT03670953|69335328|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
37778909|NCT03670953|69335325|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
37778910|NCT03670953|69335326|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
37778911|NCT03670953|69335327|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
37778912|NCT03670953|69335328|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
37778913|NCT03670953|69335325|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
37778914|NCT03670953|69335326|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
37691569|NCT02503085|69167929|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
37691570|NCT02481869|69167938|FG000|Overall Study|Lost to Follow-up|3|||
37691571|NCT02481869|69167939|FG001|Overall Study|Lost to Follow-up|4|||
37691572|NCT02481869|69167938|FG000|Overall Study|Withdrawal by Subject|2|||
37691573|NCT02481869|69167939|FG001|Overall Study|Withdrawal by Subject|0|||
37691574|NCT02502149|69167946|FG000|Intermediate|Discontinued prematurely|1|||
37691575|NCT02502149|69167947|FG001|Intermediate|Discontinued prematurely|0|||
37691576|NCT02502149|69167948|FG002|Intermediate|Discontinued prematurely|0|||
37691577|NCT02502149|69167949|FG003|Intermediate|Discontinued prematurely|0|||
37691578|NCT02502149|69167950|FG004|Intermediate|Discontinued prematurely|0|||
37691579|NCT02480621|69167969|FG000|Randomization|Withdrawal by Subject|1|||
37691580|NCT02480621|69167970|FG001|Randomization|Withdrawal by Subject|0|||
37691581|NCT02480621|69167969|FG000|Randomization|Surgeon did not give intervention|0|||
37691582|NCT02480621|69167970|FG001|Randomization|Surgeon did not give intervention|1|||
37691583|NCT02480621|69167969|FG000|Follow Up|Lost to Follow-up|4|||
37691584|NCT02480621|69167970|FG001|Follow Up|Lost to Follow-up|2|||
37691585|NCT02046603|69167978|FG000|Overall Study|Other|11|||
37691586|NCT02046603|69167979|FG001|Overall Study|Other|66|||
37691587|NCT02046603|69167978|FG000|Overall Study|Protocol Violation|0|||
37778915|NCT03670953|69335327|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
37778916|NCT03670953|69335328|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
37778917|NCT03670953|69335325|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
37778918|NCT03670953|69335326|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
37778919|NCT03670953|69335327|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
37778920|NCT03670953|69335328|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
37778921|NCT03670953|69335325|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
37778922|NCT03670953|69335326|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
37778923|NCT03670953|69335327|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
37778924|NCT03670953|69335328|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
37778925|NCT03670953|69335325|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
37778926|NCT03670953|69335326|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
37691588|NCT02046603|69167979|FG001|Overall Study|Protocol Violation|1|||
37691589|NCT02046603|69167978|FG000|Overall Study|Participant/legal guardian decision|1|||
37778927|NCT03670953|69335327|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
37778928|NCT03670953|69335328|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
37778929|NCT03670953|69335325|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
37778930|NCT03670953|69335326|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
37778931|NCT03670953|69335327|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
37778932|NCT03670953|69335328|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
37778933|NCT03670953|69335325|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
37778934|NCT03670953|69335326|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
37778935|NCT03670953|69335327|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
37778936|NCT03670953|69335328|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
37778937|NCT03670953|69335325|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
37778938|NCT03670953|69335326|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
37778939|NCT03670953|69335327|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
37778940|NCT03670953|69335328|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
37778941|NCT03670953|69335325|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
37778942|NCT03670953|69335326|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
37778943|NCT03670953|69335327|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
37778944|NCT03670953|69335328|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
37778945|NCT03670953|69335325|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
37778946|NCT03670953|69335326|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
37778947|NCT03670953|69335327|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
37778948|NCT03670953|69335328|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
37778949|NCT03670953|69335325|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
37778950|NCT03670953|69335326|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
37778951|NCT03670953|69335327|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
37778952|NCT03670953|69335328|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
37778953|NCT03670953|69335325|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
37778954|NCT03670953|69335326|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
37778955|NCT03670953|69335327|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
37778956|NCT03670953|69335328|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
37778957|NCT00636818|69335354|FG000|Overall Study|Adverse Event|1|||
37969309|NCT00434577|69656436|FG003|Months 0-3|Serious Adverse Event|0|||
37969310|NCT00434577|69656437|FG004|Months 0-3|Serious Adverse Event|0|||
37969311|NCT00434577|69656433|FG000|Months 0-3|Adverse Event|0|||
37969312|NCT00434577|69656434|FG001|Months 0-3|Adverse Event|1|||
37969313|NCT00434577|69656435|FG002|Months 0-3|Adverse Event|1|||
37969314|NCT00434577|69656436|FG003|Months 0-3|Adverse Event|0|||
37969315|NCT00434577|69656437|FG004|Months 0-3|Adverse Event|0|||
37969316|NCT00434577|69656433|FG000|Months 0-3|Lost to Follow-up|0|||
37969317|NCT00434577|69656434|FG001|Months 0-3|Lost to Follow-up|0|||
37969318|NCT00434577|69656435|FG002|Months 0-3|Lost to Follow-up|0|||
37969319|NCT00434577|69656436|FG003|Months 0-3|Lost to Follow-up|0|||
37969320|NCT00434577|69656437|FG004|Months 0-3|Lost to Follow-up|2|||
37969321|NCT00434577|69656433|FG000|Months 0-3|Protocol Violation|1|||
37969322|NCT00434577|69656434|FG001|Months 0-3|Protocol Violation|0|||
37969323|NCT00434577|69656435|FG002|Months 0-3|Protocol Violation|1|||
37969324|NCT00434577|69656436|FG003|Months 0-3|Protocol Violation|0|||
37969325|NCT00434577|69656437|FG004|Months 0-3|Protocol Violation|0|||
37969326|NCT00434577|69656433|FG000|Months 0-3|Withdrawal by Subject|2|||
37969327|NCT00434577|69656434|FG001|Months 0-3|Withdrawal by Subject|1|||
37691590|NCT02046603|69167979|FG001|Overall Study|Participant/legal guardian decision|3|||
37691591|NCT02046603|69167978|FG000|Overall Study|Physician Decision|2|||
37691592|NCT02046603|69167979|FG001|Overall Study|Physician Decision|1|||
37691593|NCT02046603|69167978|FG000|Overall Study|Lost to Follow-up|1|||
37691594|NCT02046603|69167979|FG001|Overall Study|Lost to Follow-up|2|||
37691595|NCT02046603|69167978|FG000|Overall Study|Death|0|||
37691596|NCT02046603|69167979|FG001|Overall Study|Death|1|||
37691597|NCT02046603|69167978|FG000|Overall Study|Adverse Event|0|||
37691598|NCT02046603|69167979|FG001|Overall Study|Adverse Event|1|||
37691599|NCT01885078|69167994|FG000|Treatment Period|Adverse Event|52|||
37778958|NCT00636818|69335354|FG000|Overall Study|Lost to Follow-up|2|||
37778959|NCT00636818|69335354|FG000|Overall Study|Entry Criteria Exclusion|3|||
37778960|NCT00636818|69335354|FG000|Overall Study|Protocol Violation|1|||
37969328|NCT00434577|69656435|FG002|Months 0-3|Withdrawal by Subject|1|||
37969329|NCT00434577|69656436|FG003|Months 0-3|Withdrawal by Subject|1|||
37969330|NCT00434577|69656437|FG004|Months 0-3|Withdrawal by Subject|1|||
37969331|NCT00434421|69656449|FG000|Overall Study|Withdrawal by Subject|1|||
37969332|NCT00434421|69656449|FG000|Overall Study|Non-compliance with study treatment|1|||
37969333|NCT00421707|69656455|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
37969334|NCT00421707|69656456|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
37969335|NCT00421707|69656455|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
37969336|NCT00421707|69656456|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
37969337|NCT00421707|69656455|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
37969338|NCT00421707|69656456|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
37969339|NCT00421707|69656455|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
37969340|NCT00421707|69656456|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
37969341|NCT00421707|69656455|FG000|Period 2: Washout|Adverse Event|1|||
37969342|NCT00421707|69656456|FG001|Period 2: Washout|Adverse Event|1|||
37969343|NCT00421707|69656455|FG000|Period 2: Washout|Withdrawal by Subject|0|||
37969344|NCT00421707|69656456|FG001|Period 2: Washout|Withdrawal by Subject|1|||
37969345|NCT00421707|69656455|FG000|Period 2: Washout|Lost to Follow-up|0|||
37969346|NCT00421707|69656456|FG001|Period 2: Washout|Lost to Follow-up|1|||
37969347|NCT00421707|69656455|FG000|Period 2: Washout|Other: Pregnancy|0|||
37969348|NCT00421707|69656456|FG001|Period 2: Washout|Other: Pregnancy|1|||
37969349|NCT00421707|69656455|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
37969350|NCT00421707|69656456|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
37969351|NCT00421707|69656455|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
37969352|NCT00421707|69656456|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
37969353|NCT00421707|69656455|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
37969354|NCT00421707|69656456|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
37969355|NCT00518622|69656482|FG000|Overall Study|Lost to Follow-up|0|||
37969356|NCT00518622|69656483|FG001|Overall Study|Lost to Follow-up|0|||
37778961|NCT00636818|69335354|FG000|Overall Study|Withdrawal by Subject|4|||
37778962|NCT03127137|69335360|FG000|Overall Study|Requested sedation after consent|1|||
37778963|NCT03127137|69335361|FG001|Overall Study|Requested sedation after consent|0|||
37778964|NCT03127137|69335360|FG000|Overall Study|Malfunction in electronic data collection|1|||
37778965|NCT03127137|69335361|FG001|Overall Study|Malfunction in electronic data collection|0|||
37778966|NCT03127137|69335360|FG000|Overall Study|Post procedure testing could not be obtained|0|||
37969357|NCT00518622|69656484|FG002|Overall Study|Lost to Follow-up|1|||
37969358|NCT00518622|69656485|FG003|Overall Study|Lost to Follow-up|0|||
37969359|NCT00518622|69656486|FG004|Overall Study|Lost to Follow-up|0|||
37969360|NCT00518622|69656487|FG005|Overall Study|Lost to Follow-up|0|||
37969361|NCT00518622|69656488|FG006|Overall Study|Lost to Follow-up|0|||
37969362|NCT00518622|69656489|FG007|Overall Study|Lost to Follow-up|0|||
37969363|NCT00518622|69656482|FG000|Overall Study|Study medication taken incorrectly|0|||
37969364|NCT00518622|69656483|FG001|Overall Study|Study medication taken incorrectly|1|||
37969365|NCT00518622|69656484|FG002|Overall Study|Study medication taken incorrectly|0|||
37691600|NCT01885078|69167995|FG001|Treatment Period|Adverse Event|136|||
37691601|NCT01885078|69167996|FG002|Treatment Period|Adverse Event|30|||
37691602|NCT01885078|69167997|FG003|Treatment Period|Adverse Event|73|||
37691603|NCT01885078|69167998|FG004|Treatment Period|Adverse Event|17|||
37691604|NCT01885078|69167999|FG005|Treatment Period|Adverse Event|72|||
37691605|NCT01885078|69168000|FG006|Treatment Period|Adverse Event|24|||
37691606|NCT01885078|69168001|FG007|Treatment Period|Adverse Event|5|||
37691607|NCT01885078|69168002|FG008|Treatment Period|Adverse Event|0|||
37691608|NCT01885078|69168003|FG009|Treatment Period|Adverse Event|0|||
37691609|NCT01885078|69167994|FG000|Treatment Period|Death|13|||
37691610|NCT01885078|69167995|FG001|Treatment Period|Death|33|||
37778967|NCT03127137|69335361|FG001|Overall Study|Post procedure testing could not be obtained|1|||
37778968|NCT00636506|69335369|FG000|Overall Study|Lost to Follow-up|8|||
37691611|NCT01885078|69167996|FG002|Treatment Period|Death|5|||
37778969|NCT00636506|69335369|FG000|Overall Study|Explanted|1|||
37778970|NCT00636506|69335369|FG000|Overall Study|Withdrawal by Subject|6|||
37778971|NCT00636506|69335369|FG000|Overall Study|Procedure aborted|1|||
37969366|NCT00518622|69656485|FG003|Overall Study|Study medication taken incorrectly|0|||
37969367|NCT00518622|69656486|FG004|Overall Study|Study medication taken incorrectly|0|||
37969368|NCT00518622|69656487|FG005|Overall Study|Study medication taken incorrectly|0|||
37969369|NCT00518622|69656488|FG006|Overall Study|Study medication taken incorrectly|0|||
37969370|NCT00518622|69656489|FG007|Overall Study|Study medication taken incorrectly|0|||
37969371|NCT03783078|69656507|FG000|Overall Study|Participants Ongoing|29|||
37691612|NCT01885078|69167997|FG003|Treatment Period|Death|9|||
37778972|NCT00636194|69335393|FG000|Overall Study|Study related symptoms and complaints|1|||
37778973|NCT00636194|69335394|FG001|Overall Study|Study related symptoms and complaints|0|||
37778974|NCT00636194|69335393|FG000|Overall Study|Protocol Violation|2|||
37778975|NCT00636194|69335394|FG001|Overall Study|Protocol Violation|0|||
37778976|NCT00635804|69335460|FG000|Overall Study|Adverse Event|0|||
37778977|NCT00635804|69335461|FG001|Overall Study|Adverse Event|0|||
37778978|NCT00635804|69335462|FG002|Overall Study|Adverse Event|0|||
37778979|NCT00635804|69335463|FG003|Overall Study|Adverse Event|0|||
37778980|NCT00635804|69335464|FG004|Overall Study|Adverse Event|0|||
37778981|NCT00635804|69335465|FG005|Overall Study|Adverse Event|1|||
37778982|NCT00635804|69335466|FG006|Overall Study|Adverse Event|0|||
37778983|NCT00635804|69335467|FG007|Overall Study|Adverse Event|0|||
37778984|NCT00635804|69335460|FG000|Overall Study|Withdrawal by Subject|1|||
37778985|NCT00635804|69335461|FG001|Overall Study|Withdrawal by Subject|0|||
37778986|NCT00635804|69335462|FG002|Overall Study|Withdrawal by Subject|0|||
37778987|NCT00635804|69335463|FG003|Overall Study|Withdrawal by Subject|0|||
37778988|NCT00635804|69335464|FG004|Overall Study|Withdrawal by Subject|0|||
37778989|NCT00635804|69335465|FG005|Overall Study|Withdrawal by Subject|0|||
37778990|NCT00635804|69335466|FG006|Overall Study|Withdrawal by Subject|0|||
37778991|NCT00635804|69335467|FG007|Overall Study|Withdrawal by Subject|0|||
37778992|NCT00635648|69335497|FG000|Overall Study|Adverse Event|12|||
37778993|NCT00635648|69335497|FG000|Overall Study|Withdrawal by Subject|9|||
37778994|NCT00635648|69335497|FG000|Overall Study|Physician Decision|4|||
37778995|NCT00635648|69335497|FG000|Overall Study|Rapid progression of baseline disease|4|||
37778996|NCT00635648|69335497|FG000|Overall Study|Use of other antifungal agent needed|1|||
37778997|NCT00635648|69335497|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
37778998|NCT00635648|69335497|FG000|Overall Study|Noncompliance with protocol|1|||
37778999|NCT00635648|69335497|FG000|Overall Study|Other reason|2|||
37779000|NCT00635102|69335522|FG000|Overall Study|Withdrawal by Subject|7|||
37779001|NCT00635102|69335523|FG001|Overall Study|Withdrawal by Subject|8|||
37779002|NCT00635024|69335538|FG000|Overall Study|Adverse Event|1|||
37779003|NCT00634244|69335596|FG000|Overall Study|Never started treatment|0|||
37779004|NCT00634244|69335597|FG001|Overall Study|Never started treatment|1|||
37779005|NCT00634244|69335598|FG002|Overall Study|Never started treatment|0|||
37779006|NCT00634244|69335596|FG000|Overall Study|Death|1|||
37779007|NCT00634244|69335597|FG001|Overall Study|Death|6|||
37779008|NCT00634244|69335598|FG002|Overall Study|Death|0|||
37779009|NCT00634244|69335596|FG000|Overall Study|Adverse Event|0|||
37779010|NCT00634244|69335597|FG001|Overall Study|Adverse Event|2|||
37779011|NCT00634244|69335598|FG002|Overall Study|Adverse Event|0|||
37779012|NCT00634244|69335596|FG000|Overall Study|Withdrawal by Subject|0|||
37779013|NCT00634244|69335597|FG001|Overall Study|Withdrawal by Subject|1|||
37779014|NCT00634244|69335598|FG002|Overall Study|Withdrawal by Subject|0|||
37779015|NCT00634244|69335596|FG000|Overall Study|Physician Decision|0|||
37779016|NCT00634244|69335597|FG001|Overall Study|Physician Decision|1|||
37779017|NCT00634244|69335598|FG002|Overall Study|Physician Decision|0|||
37779018|NCT00634244|69335596|FG000|Overall Study|Disease progression/relapse|0|||
37779019|NCT00634244|69335597|FG001|Overall Study|Disease progression/relapse|1|||
37779020|NCT00634244|69335598|FG002|Overall Study|Disease progression/relapse|0|||
37779021|NCT00634244|69335596|FG000|Overall Study|Other complicating disease|0|||
37779022|NCT00634244|69335597|FG001|Overall Study|Other complicating disease|1|||
37779023|NCT00634244|69335598|FG002|Overall Study|Other complicating disease|0|||
37779024|NCT00634088|69335782|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
37779025|NCT00634088|69335783|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
37779026|NCT00634088|69335784|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
37779027|NCT00634088|69335785|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
37779028|NCT00634088|69335782|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
37779029|NCT00634088|69335783|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
37779030|NCT00634088|69335784|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
37779031|NCT00634088|69335785|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
37779032|NCT00634088|69335782|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
37779033|NCT00634088|69335783|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
37779034|NCT00634088|69335784|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
37779035|NCT00634088|69335785|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
37779036|NCT00634088|69335782|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
37779037|NCT00634088|69335783|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
37779038|NCT00634088|69335784|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
37779039|NCT00634088|69335785|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
37779040|NCT00634088|69335782|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
37779041|NCT00634088|69335783|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
37779042|NCT00634088|69335784|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
37969372|NCT03783078|69656507|FG000|Overall Study|Death|26|||
37969373|NCT00517296|69656513|FG000|Overall Study|Withdrawal by Subject|1|||
37969374|NCT00517296|69656514|FG001|Overall Study|Withdrawal by Subject|0|||
37969375|NCT00516906|69656522|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
37969376|NCT00516906|69656523|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
37969377|NCT00523848|69656529|FG000|Overall Study|Adverse Event|11|||
37779043|NCT00634088|69335785|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
37779044|NCT00634088|69335782|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
37779045|NCT00634088|69335783|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
37779046|NCT00634088|69335784|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
37779047|NCT00634088|69335785|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
37779048|NCT00634010|69335885|FG000|Overall Study|Adverse Event|2|||
37779049|NCT00634010|69335886|FG001|Overall Study|Adverse Event|5|||
37779050|NCT00634010|69335885|FG000|Overall Study|Withdrawal by Subject|5|||
37779051|NCT00634010|69335886|FG001|Overall Study|Withdrawal by Subject|6|||
37779052|NCT00634010|69335885|FG000|Overall Study|Physician Decision|1|||
37779053|NCT00634010|69335886|FG001|Overall Study|Physician Decision|1|||
37779054|NCT00634010|69335885|FG000|Overall Study|Disease Progression|1|||
37779055|NCT00634010|69335886|FG001|Overall Study|Disease Progression|1|||
37779056|NCT00634010|69335885|FG000|Overall Study|Non-Compliant|1|||
37779057|NCT00634010|69335886|FG001|Overall Study|Non-Compliant|1|||
37779058|NCT00633932|69335899|FG000|Overall Study|Adverse Event|1|||
37779059|NCT00633932|69335900|FG001|Overall Study|Adverse Event|3|||
37779060|NCT00633932|69335901|FG002|Overall Study|Adverse Event|4|||
37779061|NCT00633932|69335899|FG000|Overall Study|Withdrawal by Subject|3|||
37779062|NCT00633932|69335900|FG001|Overall Study|Withdrawal by Subject|9|||
37779063|NCT00633932|69335901|FG002|Overall Study|Withdrawal by Subject|1|||
37779064|NCT00633932|69335899|FG000|Overall Study|Lost to Follow-up|1|||
37779065|NCT00633932|69335900|FG001|Overall Study|Lost to Follow-up|0|||
37779066|NCT00633932|69335901|FG002|Overall Study|Lost to Follow-up|2|||
37779067|NCT00633932|69335899|FG000|Overall Study|Protocol Violation|5|||
37779068|NCT00633932|69335900|FG001|Overall Study|Protocol Violation|2|||
37779069|NCT00633932|69335901|FG002|Overall Study|Protocol Violation|3|||
37779070|NCT00633932|69335899|FG000|Overall Study|Physician Decision|0|||
37779071|NCT00633932|69335900|FG001|Overall Study|Physician Decision|0|||
37779072|NCT00633932|69335901|FG002|Overall Study|Physician Decision|1|||
37779073|NCT00633932|69335899|FG000|Overall Study|Doctor's judgement|1|||
37779074|NCT00633932|69335900|FG001|Overall Study|Doctor's judgement|0|||
37779075|NCT00633932|69335901|FG002|Overall Study|Doctor's judgement|0|||
37779076|NCT00633932|69335899|FG000|Overall Study|Moved Away|1|||
37779077|NCT00633932|69335900|FG001|Overall Study|Moved Away|0|||
37779078|NCT00633932|69335901|FG002|Overall Study|Moved Away|0|||
37779079|NCT00633464|69336031|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
37779080|NCT00633464|69336032|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
37779081|NCT00633464|69336031|FG000|Overall Study|Never Treated (Randomized in error)|0|||
37779082|NCT00633464|69336032|FG001|Overall Study|Never Treated (Randomized in error)|1|||
37779083|NCT00633152|69336073|FG000|Overall Study|Adverse Event|1|||
37779084|NCT00633152|69336074|FG001|Overall Study|Adverse Event|0|||
37779085|NCT00633152|69336073|FG000|Overall Study|Randomized, did not receive study drug|5|||
37779086|NCT00633152|69336074|FG001|Overall Study|Randomized, did not receive study drug|2|||
37779087|NCT00633152|69336073|FG000|Overall Study|Withdrawal by Subject|1|||
37779088|NCT00633152|69336074|FG001|Overall Study|Withdrawal by Subject|1|||
37779089|NCT00633152|69336073|FG000|Overall Study|Lost to Follow-up|4|||
37779090|NCT00633152|69336074|FG001|Overall Study|Lost to Follow-up|1|||
37779091|NCT00633152|69336073|FG000|Overall Study|Miscellaneous Other|3|||
37779092|NCT00633152|69336074|FG001|Overall Study|Miscellaneous Other|2|||
37779093|NCT00633074|69336093|FG000|Overall Study|Adverse Event|1|||
37779094|NCT00633074|69336094|FG001|Overall Study|Adverse Event|0|||
37779095|NCT00630344|69336281|FG000|Overall Study|Adverse Event|5|||
37779096|NCT00630344|69336281|FG000|Overall Study|Progressive Disease|19|||
37969378|NCT00523848|69656529|FG000|Overall Study|Withdrawal by Subject|2|||
37969379|NCT00523848|69656529|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
37969380|NCT00523848|69656529|FG000|Overall Study|Disease Progression|5|||
37779097|NCT00630344|69336281|FG000|Overall Study|Physician Decision|9|||
37779098|NCT00630344|69336281|FG000|Overall Study|Withdrawal by Subject|1|||
37779099|NCT00630344|69336281|FG000|Overall Study|Intercurrent Illness|1|||
37779100|NCT00630344|69336281|FG000|Overall Study|Other|1|||
37779101|NCT02913261|69336307|FG000|Overall Study|Technical problems|0|||
37779102|NCT02913261|69336308|FG001|Overall Study|Technical problems|1|||
37779103|NCT02913261|69336307|FG000|Overall Study|Lack of Efficacy|32|||
37863939|NCT00994240|69547546|FG001|Overall Study|Lost to Follow-up|2|||
37969381|NCT00523848|69656529|FG000|Overall Study|Other, unspecified|4|||
37969382|NCT00617669|69656535|FG000|Overall Study|Withdrawal by Subject|71|||
37969383|NCT00617669|69656536|FG001|Overall Study|Withdrawal by Subject|77|||
37779104|NCT02913261|69336308|FG001|Overall Study|Lack of Efficacy|69|||
37779105|NCT02913261|69336307|FG000|Overall Study|Adverse Event|27|||
37779106|NCT02913261|69336308|FG001|Overall Study|Adverse Event|5|||
37779107|NCT02913261|69336307|FG000|Overall Study|Death|25|||
37779108|NCT02913261|69336308|FG001|Overall Study|Death|22|||
37779109|NCT02913261|69336307|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
37779110|NCT02913261|69336308|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
37691613|NCT01885078|69167998|FG004|Treatment Period|Death|2|||
37691614|NCT01885078|69167999|FG005|Treatment Period|Death|10|||
37691615|NCT01885078|69168000|FG006|Treatment Period|Death|3|||
37691616|NCT01885078|69168001|FG007|Treatment Period|Death|2|||
37691617|NCT01885078|69168002|FG008|Treatment Period|Death|0|||
37691618|NCT01885078|69168003|FG009|Treatment Period|Death|0|||
37779111|NCT02913261|69336307|FG000|Overall Study|Disease relapse|8|||
37779112|NCT02913261|69336308|FG001|Overall Study|Disease relapse|13|||
37779113|NCT02913261|69336307|FG000|Overall Study|Physician Decision|8|||
37779114|NCT02913261|69336308|FG001|Overall Study|Physician Decision|9|||
37779115|NCT02913261|69336307|FG000|Overall Study|Subject/guardian decision|4|||
37779116|NCT02913261|69336308|FG001|Overall Study|Subject/guardian decision|6|||
37779117|NCT02913261|69336307|FG000|Overall Study|Graft loss|2|||
37779118|NCT02913261|69336308|FG001|Overall Study|Graft loss|0|||
37779119|NCT00635882|69336372|FG000|Overall Study|Protocol Violation|1|||
37779120|NCT00635882|69336373|FG001|Overall Study|Protocol Violation|0|||
37779121|NCT00635882|69336374|FG002|Overall Study|Protocol Violation|0|||
37779122|NCT00635882|69336375|FG003|Overall Study|Protocol Violation|0|||
37779123|NCT00635882|69336376|FG004|Overall Study|Protocol Violation|0|||
37779124|NCT00635882|69336377|FG005|Overall Study|Protocol Violation|0|||
37779125|NCT00986570|69336628|FG000|Overall Study|Lost to Follow-up|6|||
37779126|NCT00986570|69336628|FG000|Overall Study|Potential bias for objective assessment|1|||
37779127|NCT00986258|69336632|FG000|Observation Period|Not eligible to be dosed|11|||
37779128|NCT00986258|69336632|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
37779129|NCT00986258|69336632|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
37779130|NCT00986258|69336632|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
37779131|NCT00986258|69336632|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
37779132|NCT00986258|69336632|FG000|Titration and Optimal Dose Period|Other|1|||
37779133|NCT00986258|69336632|FG000|Maintenance Period|Adverse Event|5|||
37779134|NCT00986258|69336632|FG000|Maintenance Period|Lack of Efficacy|2|||
37779135|NCT00986258|69336632|FG000|Maintenance Period|Withdrawal by Subject|2|||
37779136|NCT00986180|69336648|FG000|Overall Study|Adverse Event|21|||
37779137|NCT00986180|69336649|FG001|Overall Study|Adverse Event|23|||
37779138|NCT00986180|69336648|FG000|Overall Study|Lack of Efficacy|4|||
37779139|NCT00986180|69336649|FG001|Overall Study|Lack of Efficacy|3|||
37779140|NCT00986180|69336648|FG000|Overall Study|Lost to Follow-up|5|||
37779141|NCT00986180|69336649|FG001|Overall Study|Lost to Follow-up|7|||
37779142|NCT00986180|69336648|FG000|Overall Study|Physician Decision|1|||
37779143|NCT00986180|69336649|FG001|Overall Study|Physician Decision|3|||
37779144|NCT00986180|69336648|FG000|Overall Study|Protocol Violation|2|||
37779145|NCT00986180|69336649|FG001|Overall Study|Protocol Violation|0|||
37779146|NCT00986180|69336648|FG000|Overall Study|Withdrawal by Subject|1|||
37779147|NCT00986180|69336649|FG001|Overall Study|Withdrawal by Subject|9|||
37779148|NCT00986180|69336648|FG000|Overall Study|Miscellanies|10|||
37779149|NCT00986180|69336649|FG001|Overall Study|Miscellanies|11|||
37779150|NCT00986102|69336831|FG000|Overall Study|Lost to Follow-up|0|||
37779151|NCT00986102|69336832|FG001|Overall Study|Lost to Follow-up|1|||
37779152|NCT00986102|69336833|FG002|Overall Study|Lost to Follow-up|0|||
37779153|NCT00986102|69336834|FG003|Overall Study|Lost to Follow-up|1|||
37779154|NCT00986102|69336831|FG000|Overall Study|Withdrawal by Subject|1|||
37779155|NCT00986102|69336832|FG001|Overall Study|Withdrawal by Subject|1|||
37779156|NCT00986102|69336833|FG002|Overall Study|Withdrawal by Subject|0|||
37779157|NCT00986102|69336834|FG003|Overall Study|Withdrawal by Subject|0|||
37779158|NCT00985946|69336857|FG000|Overall Study|Lost to Follow-up|6|||
37779159|NCT00985946|69336857|FG000|Overall Study|Withdrawal by Subject|1|||
37691619|NCT01885078|69167994|FG000|Treatment Period|Lack of Efficacy|12|||
37691620|NCT01885078|69167995|FG001|Treatment Period|Lack of Efficacy|33|||
37779160|NCT00985790|69336872|FG000|Overall Study|Withdrawal by Subject|1|||
37779161|NCT00985790|69336873|FG001|Overall Study|Withdrawal by Subject|1|||
37779162|NCT00985790|69336872|FG000|Overall Study|Lost to Follow-up|6|||
37779163|NCT00985790|69336873|FG001|Overall Study|Lost to Follow-up|7|||
37779164|NCT00985712|69336900|FG000|Overall Study|Adverse Event|0|||
37779165|NCT00985712|69336901|FG001|Overall Study|Adverse Event|1|||
37779166|NCT00985712|69336900|FG000|Overall Study|Lost to Follow-up|2|||
37779167|NCT00985712|69336901|FG001|Overall Study|Lost to Follow-up|2|||
37969384|NCT00617669|69656535|FG000|Overall Study|Lost to Follow-up|3|||
37969385|NCT00617669|69656536|FG001|Overall Study|Lost to Follow-up|2|||
37691621|NCT01885078|69167996|FG002|Treatment Period|Lack of Efficacy|10|||
37691622|NCT01885078|69167997|FG003|Treatment Period|Lack of Efficacy|23|||
37779168|NCT00985712|69336900|FG000|Overall Study|Protocol Violation|0|||
37779169|NCT00985712|69336901|FG001|Overall Study|Protocol Violation|1|||
37779170|NCT00985712|69336900|FG000|Overall Study|Withdrawal by Subject|4|||
37779171|NCT00985712|69336901|FG001|Overall Study|Withdrawal by Subject|1|||
37779172|NCT00985712|69336900|FG000|Overall Study|Sponsor decision|0|||
37779173|NCT00985712|69336901|FG001|Overall Study|Sponsor decision|2|||
37969386|NCT00617669|69656535|FG000|Overall Study|Adverse Event|87|||
37969387|NCT00617669|69656536|FG001|Overall Study|Adverse Event|76|||
37969388|NCT00617669|69656535|FG000|Overall Study|Protocol Violation|2|||
37969389|NCT00617669|69656536|FG001|Overall Study|Protocol Violation|3|||
37779174|NCT00985166|69337008|FG000|Overall Study|Lost to Follow-up|3|||
37779175|NCT00985166|69337009|FG001|Overall Study|Lost to Follow-up|2|||
37779176|NCT00985166|69337010|FG002|Overall Study|Lost to Follow-up|2|||
37779177|NCT00985166|69337008|FG000|Overall Study|Withdrawal by Subject|3|||
37779178|NCT00985166|69337009|FG001|Overall Study|Withdrawal by Subject|2|||
37779179|NCT00985166|69337010|FG002|Overall Study|Withdrawal by Subject|0|||
37779180|NCT00985166|69337008|FG000|Overall Study|Test not done|2|||
37779181|NCT00985166|69337009|FG001|Overall Study|Test not done|0|||
37779182|NCT00985166|69337010|FG002|Overall Study|Test not done|4|||
37779183|NCT00985166|69337008|FG000|Overall Study|Other|1|||
37779184|NCT00985166|69337009|FG001|Overall Study|Other|0|||
37779185|NCT00985166|69337010|FG002|Overall Study|Other|1|||
37779186|NCT01341405|69337256|FG000|Overall Study|Adverse Event|0|||
37779187|NCT01341405|69337257|FG001|Overall Study|Adverse Event|1|||
37779188|NCT01341405|69337258|FG002|Overall Study|Adverse Event|1|||
37779189|NCT01341405|69337256|FG000|Overall Study|Withdrawal by Subject|3|||
37779190|NCT01341405|69337257|FG001|Overall Study|Withdrawal by Subject|2|||
37779191|NCT01341405|69337258|FG002|Overall Study|Withdrawal by Subject|1|||
37779192|NCT00633945|69338505|FG000|Overall Study|Physician Decision|2|||
37779193|NCT02574078|69338769|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
37779194|NCT02574078|69338770|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
37779195|NCT02574078|69338771|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
37779196|NCT02574078|69338772|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
37779197|NCT02574078|69338773|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
37779198|NCT02574078|69338774|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
37779199|NCT02574078|69338775|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
37779200|NCT02574078|69338776|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
37779201|NCT02574078|69338777|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
37779202|NCT02574078|69338778|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
37779203|NCT02574078|69338779|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
37779204|NCT02574078|69338780|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
37779205|NCT02574078|69338781|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
37779206|NCT02574078|69338769|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
37779207|NCT02574078|69338770|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
37779208|NCT02574078|69338771|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
37779209|NCT02574078|69338772|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
37779210|NCT02574078|69338773|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
37779211|NCT02574078|69338774|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
37779212|NCT02574078|69338775|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
37779213|NCT02574078|69338776|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
37779214|NCT02574078|69338777|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
37779215|NCT02574078|69338778|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
37779216|NCT02574078|69338779|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
37779217|NCT02574078|69338780|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
37779218|NCT02574078|69338781|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
37779219|NCT02574078|69338769|FG000|Pre-Treatment Period|Other reasons|0|||
37779220|NCT02574078|69338770|FG001|Pre-Treatment Period|Other reasons|0|||
37779221|NCT02574078|69338771|FG002|Pre-Treatment Period|Other reasons|0|||
37779222|NCT02574078|69338772|FG003|Pre-Treatment Period|Other reasons|0|||
37779223|NCT02574078|69338773|FG004|Pre-Treatment Period|Other reasons|0|||
37779224|NCT02574078|69338774|FG005|Pre-Treatment Period|Other reasons|0|||
37779225|NCT02574078|69338775|FG006|Pre-Treatment Period|Other reasons|2|||
37779226|NCT02574078|69338776|FG007|Pre-Treatment Period|Other reasons|0|||
37779227|NCT02574078|69338777|FG008|Pre-Treatment Period|Other reasons|0|||
37779228|NCT02574078|69338778|FG009|Pre-Treatment Period|Other reasons|0|||
37969390|NCT00617669|69656535|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
37969391|NCT00617669|69656536|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
37969392|NCT00617669|69656535|FG000|Overall Study|Patients randomized but not treated|2|||
37779229|NCT02574078|69338779|FG010|Pre-Treatment Period|Other reasons|2|||
37779230|NCT02574078|69338780|FG011|Pre-Treatment Period|Other reasons|0|||
37779231|NCT02574078|69338781|FG012|Pre-Treatment Period|Other reasons|0|||
37969393|NCT00617669|69656536|FG001|Overall Study|Patients randomized but not treated|3|||
37969394|NCT03682848|69656542|FG000|Overall Study|Withdrawal by Subject|2|||
37969395|NCT03682848|69656542|FG000|Overall Study|Site closed|5|||
37779232|NCT02574078|69338769|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
37779233|NCT02574078|69338770|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
37779234|NCT02574078|69338771|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
37969396|NCT03682848|69656542|FG000|Overall Study|Protocol Deviation|1|||
37969397|NCT03682848|69656542|FG000|Overall Study|Adverse Event|1|||
37779235|NCT02574078|69338772|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
37691623|NCT01885078|69167998|FG004|Treatment Period|Lack of Efficacy|24|||
37691624|NCT01885078|69167999|FG005|Treatment Period|Lack of Efficacy|58|||
37691625|NCT01885078|69168000|FG006|Treatment Period|Lack of Efficacy|9|||
37691626|NCT01885078|69168001|FG007|Treatment Period|Lack of Efficacy|5|||
37691627|NCT01885078|69168002|FG008|Treatment Period|Lack of Efficacy|0|||
37691628|NCT01885078|69168003|FG009|Treatment Period|Lack of Efficacy|0|||
37691629|NCT01885078|69167994|FG000|Treatment Period|Lost to Follow-up|16|||
37691630|NCT01885078|69167995|FG001|Treatment Period|Lost to Follow-up|19|||
37691631|NCT01885078|69167996|FG002|Treatment Period|Lost to Follow-up|7|||
37691632|NCT01885078|69167997|FG003|Treatment Period|Lost to Follow-up|9|||
37691633|NCT01885078|69167998|FG004|Treatment Period|Lost to Follow-up|2|||
37691634|NCT01885078|69167999|FG005|Treatment Period|Lost to Follow-up|8|||
37691635|NCT01885078|69168000|FG006|Treatment Period|Lost to Follow-up|2|||
37691636|NCT01885078|69168001|FG007|Treatment Period|Lost to Follow-up|0|||
37691637|NCT01885078|69168002|FG008|Treatment Period|Lost to Follow-up|0|||
37691638|NCT01885078|69168003|FG009|Treatment Period|Lost to Follow-up|0|||
37691639|NCT01885078|69167994|FG000|Treatment Period|Physician Decision|19|||
37691640|NCT01885078|69167995|FG001|Treatment Period|Physician Decision|21|||
37691641|NCT01885078|69167996|FG002|Treatment Period|Physician Decision|5|||
37691642|NCT01885078|69167997|FG003|Treatment Period|Physician Decision|12|||
37691643|NCT01885078|69167998|FG004|Treatment Period|Physician Decision|9|||
37691644|NCT01885078|69167999|FG005|Treatment Period|Physician Decision|24|||
37691645|NCT01885078|69168000|FG006|Treatment Period|Physician Decision|4|||
37691646|NCT01885078|69168001|FG007|Treatment Period|Physician Decision|3|||
37691647|NCT01885078|69168002|FG008|Treatment Period|Physician Decision|0|||
37691648|NCT01885078|69168003|FG009|Treatment Period|Physician Decision|0|||
37691649|NCT01885078|69167994|FG000|Treatment Period|Protocol Violation|3|||
37691650|NCT01885078|69167995|FG001|Treatment Period|Protocol Violation|5|||
37691651|NCT01885078|69167996|FG002|Treatment Period|Protocol Violation|0|||
37691652|NCT01885078|69167997|FG003|Treatment Period|Protocol Violation|3|||
37691653|NCT01885078|69167998|FG004|Treatment Period|Protocol Violation|1|||
37691654|NCT01885078|69167999|FG005|Treatment Period|Protocol Violation|6|||
37691655|NCT01885078|69168000|FG006|Treatment Period|Protocol Violation|0|||
37691656|NCT01885078|69168001|FG007|Treatment Period|Protocol Violation|0|||
37691657|NCT01885078|69168002|FG008|Treatment Period|Protocol Violation|0|||
37691658|NCT01885078|69168003|FG009|Treatment Period|Protocol Violation|0|||
37691659|NCT01885078|69167994|FG000|Treatment Period|Sponsor Decision|245|||
37691660|NCT01885078|69167995|FG001|Treatment Period|Sponsor Decision|648|||
37691661|NCT01885078|69167996|FG002|Treatment Period|Sponsor Decision|49|||
37691662|NCT01885078|69167997|FG003|Treatment Period|Sponsor Decision|90|||
37691663|NCT01885078|69167998|FG004|Treatment Period|Sponsor Decision|20|||
37691664|NCT01885078|69167999|FG005|Treatment Period|Sponsor Decision|38|||
37691665|NCT01885078|69168000|FG006|Treatment Period|Sponsor Decision|162|||
37691666|NCT01885078|69168001|FG007|Treatment Period|Sponsor Decision|3|||
37691667|NCT01885078|69168002|FG008|Treatment Period|Sponsor Decision|0|||
37691668|NCT01885078|69168003|FG009|Treatment Period|Sponsor Decision|0|||
37691669|NCT01885078|69167994|FG000|Treatment Period|Withdrawal by Subject|72|||
37691670|NCT01885078|69167995|FG001|Treatment Period|Withdrawal by Subject|132|||
37691671|NCT01885078|69167996|FG002|Treatment Period|Withdrawal by Subject|25|||
37691672|NCT01885078|69167997|FG003|Treatment Period|Withdrawal by Subject|63|||
37691673|NCT01885078|69167998|FG004|Treatment Period|Withdrawal by Subject|15|||
37691674|NCT01885078|69167999|FG005|Treatment Period|Withdrawal by Subject|34|||
37691675|NCT01885078|69168000|FG006|Treatment Period|Withdrawal by Subject|17|||
37691676|NCT01885078|69168001|FG007|Treatment Period|Withdrawal by Subject|10|||
37691677|NCT01885078|69168002|FG008|Treatment Period|Withdrawal by Subject|0|||
37691678|NCT01885078|69168003|FG009|Treatment Period|Withdrawal by Subject|0|||
37691679|NCT01885078|69167994|FG000|Treatment Period|Other|0|||
37691680|NCT01885078|69167995|FG001|Treatment Period|Other|0|||
37691681|NCT01885078|69167996|FG002|Treatment Period|Other|0|||
37691682|NCT01885078|69167997|FG003|Treatment Period|Other|1|||
37779236|NCT02574078|69338773|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
37779237|NCT02574078|69338774|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
37779238|NCT02574078|69338775|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
37779239|NCT02574078|69338776|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
37691683|NCT01885078|69167998|FG004|Treatment Period|Other|0|||
37691684|NCT01885078|69167999|FG005|Treatment Period|Other|0|||
37691685|NCT01885078|69168000|FG006|Treatment Period|Other|0|||
37691686|NCT01885078|69168001|FG007|Treatment Period|Other|0|||
37691687|NCT01885078|69168002|FG008|Treatment Period|Other|0|||
37691688|NCT01885078|69168003|FG009|Treatment Period|Other|0|||
37779240|NCT02574078|69338777|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
37779241|NCT02574078|69338778|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
37691689|NCT01885078|69167994|FG000|Step-down Period|Sponsor Decision|0|||
37691690|NCT01885078|69167995|FG001|Step-down Period|Sponsor Decision|0|||
37691691|NCT01885078|69167996|FG002|Step-down Period|Sponsor Decision|0|||
37691692|NCT01885078|69167997|FG003|Step-down Period|Sponsor Decision|0|||
37779242|NCT02574078|69338779|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
37779243|NCT02574078|69338780|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
37779244|NCT02574078|69338781|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
37779245|NCT02574078|69338769|FG000|Treatment Period|Disease progression|6|||
37779246|NCT02574078|69338770|FG001|Treatment Period|Disease progression|4|||
37779247|NCT02574078|69338771|FG002|Treatment Period|Disease progression|7|||
37779248|NCT02574078|69338772|FG003|Treatment Period|Disease progression|18|||
37779249|NCT02574078|69338773|FG004|Treatment Period|Disease progression|16|||
37779250|NCT02574078|69338774|FG005|Treatment Period|Disease progression|26|||
37779251|NCT02574078|69338775|FG006|Treatment Period|Disease progression|5|||
37779252|NCT02574078|69338776|FG007|Treatment Period|Disease progression|9|||
37779253|NCT02574078|69338777|FG008|Treatment Period|Disease progression|8|||
37779254|NCT02574078|69338778|FG009|Treatment Period|Disease progression|5|||
37779255|NCT02574078|69338779|FG010|Treatment Period|Disease progression|20|||
37779256|NCT02574078|69338780|FG011|Treatment Period|Disease progression|29|||
37779257|NCT02574078|69338781|FG012|Treatment Period|Disease progression|2|||
37779258|NCT02574078|69338769|FG000|Treatment Period|Study drug toxicity|1|||
37779259|NCT02574078|69338770|FG001|Treatment Period|Study drug toxicity|1|||
37779260|NCT02574078|69338771|FG002|Treatment Period|Study drug toxicity|0|||
37779261|NCT02574078|69338772|FG003|Treatment Period|Study drug toxicity|5|||
37779262|NCT02574078|69338773|FG004|Treatment Period|Study drug toxicity|3|||
37779263|NCT02574078|69338774|FG005|Treatment Period|Study drug toxicity|1|||
37779264|NCT02574078|69338775|FG006|Treatment Period|Study drug toxicity|2|||
37779265|NCT02574078|69338776|FG007|Treatment Period|Study drug toxicity|0|||
37779266|NCT02574078|69338777|FG008|Treatment Period|Study drug toxicity|2|||
37779267|NCT02574078|69338778|FG009|Treatment Period|Study drug toxicity|1|||
37779268|NCT02574078|69338779|FG010|Treatment Period|Study drug toxicity|16|||
37779269|NCT02574078|69338780|FG011|Treatment Period|Study drug toxicity|2|||
37779270|NCT02574078|69338781|FG012|Treatment Period|Study drug toxicity|4|||
37779271|NCT02574078|69338769|FG000|Treatment Period|Death|2|||
37779272|NCT02574078|69338770|FG001|Treatment Period|Death|0|||
37779273|NCT02574078|69338771|FG002|Treatment Period|Death|0|||
37779274|NCT02574078|69338772|FG003|Treatment Period|Death|0|||
37779275|NCT02574078|69338773|FG004|Treatment Period|Death|1|||
37779276|NCT02574078|69338774|FG005|Treatment Period|Death|1|||
37779277|NCT02574078|69338775|FG006|Treatment Period|Death|1|||
37779278|NCT02574078|69338776|FG007|Treatment Period|Death|1|||
37779279|NCT02574078|69338777|FG008|Treatment Period|Death|7|||
37779280|NCT02574078|69338778|FG009|Treatment Period|Death|1|||
37969398|NCT00510510|69656549|FG000|Overall Study|Adverse Event|4|||
37969399|NCT00510510|69656550|FG001|Overall Study|Adverse Event|3|||
37969400|NCT00510510|69656551|FG002|Overall Study|Adverse Event|6|||
37969401|NCT00510510|69656549|FG000|Overall Study|Lack of Efficacy|0|||
37969402|NCT00510510|69656550|FG001|Overall Study|Lack of Efficacy|1|||
37969403|NCT00510510|69656551|FG002|Overall Study|Lack of Efficacy|1|||
37969404|NCT00510510|69656549|FG000|Overall Study|Subjects no longer requires study drug|0|||
37969405|NCT00510510|69656550|FG001|Overall Study|Subjects no longer requires study drug|0|||
37969406|NCT00510510|69656551|FG002|Overall Study|Subjects no longer requires study drug|2|||
37969407|NCT00510510|69656549|FG000|Overall Study|Withdrawal by Subject|1|||
37969408|NCT00510510|69656550|FG001|Overall Study|Withdrawal by Subject|2|||
37969409|NCT00510510|69656551|FG002|Overall Study|Withdrawal by Subject|3|||
37969410|NCT00510510|69656549|FG000|Overall Study|Lost to Follow-up|0|||
37969411|NCT00510510|69656550|FG001|Overall Study|Lost to Follow-up|0|||
37969412|NCT00510510|69656551|FG002|Overall Study|Lost to Follow-up|1|||
37969413|NCT00510510|69656549|FG000|Overall Study|Protocol Violation|0|||
37969414|NCT00510510|69656550|FG001|Overall Study|Protocol Violation|3|||
37969415|NCT00510510|69656551|FG002|Overall Study|Protocol Violation|4|||
37969416|NCT00617591|69656559|FG000|Overall Study|Withdrew consent during Induction|4|||
37969417|NCT00617591|69656559|FG000|Overall Study|Withdrew consent during Maintenance|6|||
37779281|NCT02574078|69338779|FG010|Treatment Period|Death|0|||
37779282|NCT02574078|69338780|FG011|Treatment Period|Death|2|||
37779283|NCT02574078|69338781|FG012|Treatment Period|Death|1|||
37779284|NCT02574078|69338769|FG000|Treatment Period|Adverse event unrelated to drug|0|||
37779285|NCT02574078|69338770|FG001|Treatment Period|Adverse event unrelated to drug|0|||
37779286|NCT02574078|69338771|FG002|Treatment Period|Adverse event unrelated to drug|1|||
37969418|NCT00510276|69656566|FG000|Acute Double-Blind Phase|Adverse Event|21|||
37969419|NCT00510276|69656567|FG001|Acute Double-Blind Phase|Adverse Event|6|||
37969420|NCT00510276|69656566|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
37969421|NCT00510276|69656567|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
37779287|NCT02574078|69338772|FG003|Treatment Period|Adverse event unrelated to drug|0|||
37779288|NCT02574078|69338773|FG004|Treatment Period|Adverse event unrelated to drug|2|||
37779289|NCT02574078|69338774|FG005|Treatment Period|Adverse event unrelated to drug|3|||
37779290|NCT02574078|69338775|FG006|Treatment Period|Adverse event unrelated to drug|0|||
37779291|NCT02574078|69338776|FG007|Treatment Period|Adverse event unrelated to drug|0|||
37779292|NCT02574078|69338777|FG008|Treatment Period|Adverse event unrelated to drug|1|||
37779293|NCT02574078|69338778|FG009|Treatment Period|Adverse event unrelated to drug|2|||
37779294|NCT02574078|69338779|FG010|Treatment Period|Adverse event unrelated to drug|4|||
37779295|NCT02574078|69338780|FG011|Treatment Period|Adverse event unrelated to drug|1|||
37779296|NCT02574078|69338781|FG012|Treatment Period|Adverse event unrelated to drug|0|||
37779297|NCT02574078|69338769|FG000|Treatment Period|Administrative reason by Sponsor|0|||
37779298|NCT02574078|69338770|FG001|Treatment Period|Administrative reason by Sponsor|1|||
37779299|NCT02574078|69338771|FG002|Treatment Period|Administrative reason by Sponsor|0|||
37779300|NCT02574078|69338772|FG003|Treatment Period|Administrative reason by Sponsor|0|||
37779301|NCT02574078|69338773|FG004|Treatment Period|Administrative reason by Sponsor|0|||
37779302|NCT02574078|69338774|FG005|Treatment Period|Administrative reason by Sponsor|0|||
37779303|NCT02574078|69338775|FG006|Treatment Period|Administrative reason by Sponsor|1|||
37779304|NCT02574078|69338776|FG007|Treatment Period|Administrative reason by Sponsor|0|||
37779305|NCT02574078|69338777|FG008|Treatment Period|Administrative reason by Sponsor|0|||
37779306|NCT02574078|69338778|FG009|Treatment Period|Administrative reason by Sponsor|0|||
37779307|NCT02574078|69338779|FG010|Treatment Period|Administrative reason by Sponsor|0|||
37779308|NCT02574078|69338780|FG011|Treatment Period|Administrative reason by Sponsor|0|||
37779309|NCT02574078|69338781|FG012|Treatment Period|Administrative reason by Sponsor|3|||
37779310|NCT02574078|69338769|FG000|Treatment Period|Other reasons|1|||
37779311|NCT02574078|69338770|FG001|Treatment Period|Other reasons|0|||
37779312|NCT02574078|69338771|FG002|Treatment Period|Other reasons|1|||
37779313|NCT02574078|69338772|FG003|Treatment Period|Other reasons|3|||
37779314|NCT02574078|69338773|FG004|Treatment Period|Other reasons|3|||
37779315|NCT02574078|69338774|FG005|Treatment Period|Other reasons|1|||
37779316|NCT02574078|69338775|FG006|Treatment Period|Other reasons|2|||
37779317|NCT02574078|69338776|FG007|Treatment Period|Other reasons|1|||
37779318|NCT02574078|69338777|FG008|Treatment Period|Other reasons|3|||
37779319|NCT02574078|69338778|FG009|Treatment Period|Other reasons|1|||
37779320|NCT02574078|69338779|FG010|Treatment Period|Other reasons|1|||
37779321|NCT02574078|69338780|FG011|Treatment Period|Other reasons|3|||
37779322|NCT02574078|69338781|FG012|Treatment Period|Other reasons|1|||
37779323|NCT02574078|69338769|FG000|Treatment Period|Participant request to stop drug|0|||
37779324|NCT02574078|69338770|FG001|Treatment Period|Participant request to stop drug|0|||
37779325|NCT02574078|69338771|FG002|Treatment Period|Participant request to stop drug|0|||
37779326|NCT02574078|69338772|FG003|Treatment Period|Participant request to stop drug|2|||
37779327|NCT02574078|69338773|FG004|Treatment Period|Participant request to stop drug|4|||
37691693|NCT01885078|69167998|FG004|Step-down Period|Sponsor Decision|0|||
37691694|NCT01885078|69167999|FG005|Step-down Period|Sponsor Decision|0|||
37691695|NCT01885078|69168000|FG006|Step-down Period|Sponsor Decision|0|||
37691696|NCT01885078|69168001|FG007|Step-down Period|Sponsor Decision|0|||
37691697|NCT01885078|69168002|FG008|Step-down Period|Sponsor Decision|1|||
37691698|NCT01885078|69168003|FG009|Step-down Period|Sponsor Decision|1|||
37691699|NCT01885078|69167994|FG000|Step-down Period|Adverse Event|0|||
37691700|NCT01885078|69167995|FG001|Step-down Period|Adverse Event|0|||
37779328|NCT02574078|69338774|FG005|Treatment Period|Participant request to stop drug|0|||
37779329|NCT02574078|69338775|FG006|Treatment Period|Participant request to stop drug|1|||
37779330|NCT02574078|69338776|FG007|Treatment Period|Participant request to stop drug|0|||
37691701|NCT01885078|69167996|FG002|Step-down Period|Adverse Event|0|||
37691702|NCT01885078|69167997|FG003|Step-down Period|Adverse Event|0|||
37779331|NCT02574078|69338777|FG008|Treatment Period|Participant request to stop drug|3|||
37779332|NCT02574078|69338778|FG009|Treatment Period|Participant request to stop drug|2|||
37779333|NCT02574078|69338779|FG010|Treatment Period|Participant request to stop drug|2|||
37779334|NCT02574078|69338780|FG011|Treatment Period|Participant request to stop drug|4|||
37779335|NCT02574078|69338781|FG012|Treatment Period|Participant request to stop drug|1|||
37779336|NCT02574078|69338769|FG000|Treatment Period|Participant withdrew consent|0|||
37779337|NCT02574078|69338770|FG001|Treatment Period|Participant withdrew consent|0|||
37779338|NCT02574078|69338771|FG002|Treatment Period|Participant withdrew consent|0|||
37779339|NCT02574078|69338772|FG003|Treatment Period|Participant withdrew consent|0|||
37779340|NCT02574078|69338773|FG004|Treatment Period|Participant withdrew consent|1|||
37779341|NCT02574078|69338774|FG005|Treatment Period|Participant withdrew consent|1|||
37779342|NCT02574078|69338775|FG006|Treatment Period|Participant withdrew consent|0|||
37779343|NCT02574078|69338776|FG007|Treatment Period|Participant withdrew consent|1|||
37779344|NCT02574078|69338777|FG008|Treatment Period|Participant withdrew consent|0|||
37779345|NCT02574078|69338778|FG009|Treatment Period|Participant withdrew consent|2|||
37779346|NCT02574078|69338779|FG010|Treatment Period|Participant withdrew consent|1|||
37779347|NCT02574078|69338780|FG011|Treatment Period|Participant withdrew consent|4|||
37779348|NCT02574078|69338781|FG012|Treatment Period|Participant withdrew consent|1|||
37779349|NCT02574078|69338769|FG000|Treatment Period|Participant no longer meets criteria|0|||
37779350|NCT02574078|69338770|FG001|Treatment Period|Participant no longer meets criteria|0|||
37779351|NCT02574078|69338771|FG002|Treatment Period|Participant no longer meets criteria|0|||
37779352|NCT02574078|69338772|FG003|Treatment Period|Participant no longer meets criteria|0|||
37779353|NCT02574078|69338773|FG004|Treatment Period|Participant no longer meets criteria|1|||
37779354|NCT02574078|69338774|FG005|Treatment Period|Participant no longer meets criteria|0|||
37779355|NCT02574078|69338775|FG006|Treatment Period|Participant no longer meets criteria|0|||
37779356|NCT02574078|69338776|FG007|Treatment Period|Participant no longer meets criteria|0|||
37779357|NCT02574078|69338777|FG008|Treatment Period|Participant no longer meets criteria|0|||
37779358|NCT02574078|69338778|FG009|Treatment Period|Participant no longer meets criteria|1|||
37779359|NCT02574078|69338779|FG010|Treatment Period|Participant no longer meets criteria|1|||
37779360|NCT02574078|69338780|FG011|Treatment Period|Participant no longer meets criteria|1|||
37779361|NCT02574078|69338781|FG012|Treatment Period|Participant no longer meets criteria|0|||
37779362|NCT02574078|69338769|FG000|Treatment Period|Lost to Follow-up|0|||
37779363|NCT02574078|69338770|FG001|Treatment Period|Lost to Follow-up|0|||
37779364|NCT02574078|69338771|FG002|Treatment Period|Lost to Follow-up|0|||
37779365|NCT02574078|69338772|FG003|Treatment Period|Lost to Follow-up|0|||
37779366|NCT02574078|69338773|FG004|Treatment Period|Lost to Follow-up|0|||
37779367|NCT02574078|69338774|FG005|Treatment Period|Lost to Follow-up|0|||
37779368|NCT02574078|69338775|FG006|Treatment Period|Lost to Follow-up|0|||
37779369|NCT02574078|69338776|FG007|Treatment Period|Lost to Follow-up|0|||
37779370|NCT02574078|69338777|FG008|Treatment Period|Lost to Follow-up|0|||
37779371|NCT02574078|69338778|FG009|Treatment Period|Lost to Follow-up|1|||
37779372|NCT02574078|69338779|FG010|Treatment Period|Lost to Follow-up|0|||
37779373|NCT02574078|69338780|FG011|Treatment Period|Lost to Follow-up|1|||
37779374|NCT02574078|69338781|FG012|Treatment Period|Lost to Follow-up|0|||
37779375|NCT02574078|69338769|FG000|Treatment Period|Maximum clinical benefit|0|||
37779376|NCT02574078|69338770|FG001|Treatment Period|Maximum clinical benefit|0|||
37863940|NCT00994240|69547545|FG000|Overall Study|Withdrawal by Subject|1|||
37863941|NCT00994240|69547546|FG001|Overall Study|Withdrawal by Subject|0|||
37779377|NCT02574078|69338771|FG002|Treatment Period|Maximum clinical benefit|0|||
37779378|NCT02574078|69338772|FG003|Treatment Period|Maximum clinical benefit|0|||
37863942|NCT00994240|69547545|FG000|Overall Study|study termination|2|||
37863943|NCT00994240|69547546|FG001|Overall Study|study termination|3|||
37779379|NCT02574078|69338773|FG004|Treatment Period|Maximum clinical benefit|0|||
37779380|NCT02574078|69338774|FG005|Treatment Period|Maximum clinical benefit|0|||
37779381|NCT02574078|69338775|FG006|Treatment Period|Maximum clinical benefit|0|||
37779382|NCT02574078|69338776|FG007|Treatment Period|Maximum clinical benefit|0|||
37779383|NCT02574078|69338777|FG008|Treatment Period|Maximum clinical benefit|0|||
37779384|NCT02574078|69338778|FG009|Treatment Period|Maximum clinical benefit|1|||
37779385|NCT02574078|69338779|FG010|Treatment Period|Maximum clinical benefit|0|||
37779386|NCT02574078|69338780|FG011|Treatment Period|Maximum clinical benefit|0|||
37779387|NCT02574078|69338781|FG012|Treatment Period|Maximum clinical benefit|0|||
37779388|NCT02565810|69338899|FG000|Overall Study|Withdrawal by Subject|1|||
37779389|NCT02561832|69339064|FG000|Overall Study|Withdrawal by Subject|1|||
37779390|NCT02561832|69339065|FG001|Overall Study|Withdrawal by Subject|1|||
37779391|NCT02561832|69339064|FG000|Overall Study|Adverse Event|3|||
37779392|NCT02561832|69339065|FG001|Overall Study|Adverse Event|0|||
37779393|NCT02561832|69339064|FG000|Overall Study|Disease progression|3|||
37779394|NCT02561832|69339065|FG001|Overall Study|Disease progression|3|||
37779395|NCT00985088|69340709|FG000|Overall Study|Serious Adverse Event|1|||
37779396|NCT00985088|69340710|FG001|Overall Study|Serious Adverse Event|1|||
37779397|NCT00985088|69340711|FG002|Overall Study|Serious Adverse Event|0|||
37779398|NCT00985088|69340712|FG003|Overall Study|Serious Adverse Event|0|||
37779399|NCT00985088|69340713|FG004|Overall Study|Serious Adverse Event|0|||
37779400|NCT00985088|69340714|FG005|Overall Study|Serious Adverse Event|0|||
37779401|NCT00985088|69340715|FG006|Overall Study|Serious Adverse Event|0|||
37779402|NCT00985088|69340716|FG007|Overall Study|Serious Adverse Event|1|||
37779403|NCT00985088|69340709|FG000|Overall Study|Adverse Event|0|||
37779404|NCT00985088|69340710|FG001|Overall Study|Adverse Event|0|||
37779405|NCT00985088|69340711|FG002|Overall Study|Adverse Event|1|||
37779406|NCT00985088|69340712|FG003|Overall Study|Adverse Event|0|||
37779407|NCT00985088|69340713|FG004|Overall Study|Adverse Event|0|||
37779408|NCT00985088|69340714|FG005|Overall Study|Adverse Event|0|||
37779409|NCT00985088|69340715|FG006|Overall Study|Adverse Event|0|||
37779410|NCT00985088|69340716|FG007|Overall Study|Adverse Event|0|||
37779411|NCT00985088|69340709|FG000|Overall Study|Withdrawal by Subject|4|||
37779412|NCT00985088|69340710|FG001|Overall Study|Withdrawal by Subject|0|||
37779413|NCT00985088|69340711|FG002|Overall Study|Withdrawal by Subject|0|||
37969422|NCT00510276|69656566|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
37969423|NCT00510276|69656567|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
37969424|NCT00510276|69656566|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
37969425|NCT00510276|69656567|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
37969426|NCT00510276|69656566|FG000|Acute Double-Blind Phase|Physician Decision|0|||
37691703|NCT01885078|69167998|FG004|Step-down Period|Adverse Event|0|||
37691704|NCT01885078|69167999|FG005|Step-down Period|Adverse Event|0|||
37691705|NCT01885078|69168000|FG006|Step-down Period|Adverse Event|0|||
37691706|NCT01885078|69168001|FG007|Step-down Period|Adverse Event|0|||
37691707|NCT01885078|69168002|FG008|Step-down Period|Adverse Event|29|||
37691708|NCT01885078|69168003|FG009|Step-down Period|Adverse Event|38|||
37691709|NCT01885078|69167994|FG000|Step-down Period|Withdrawal by Subject|0|||
37691710|NCT01885078|69167995|FG001|Step-down Period|Withdrawal by Subject|0|||
37691711|NCT01885078|69167996|FG002|Step-down Period|Withdrawal by Subject|0|||
37691712|NCT01885078|69167997|FG003|Step-down Period|Withdrawal by Subject|0|||
37691713|NCT01885078|69167998|FG004|Step-down Period|Withdrawal by Subject|0|||
37691714|NCT01885078|69167999|FG005|Step-down Period|Withdrawal by Subject|0|||
37691715|NCT01885078|69168000|FG006|Step-down Period|Withdrawal by Subject|0|||
37691716|NCT01885078|69168001|FG007|Step-down Period|Withdrawal by Subject|0|||
37691717|NCT01885078|69168002|FG008|Step-down Period|Withdrawal by Subject|25|||
37691718|NCT01885078|69168003|FG009|Step-down Period|Withdrawal by Subject|15|||
37691719|NCT01885078|69167994|FG000|Step-down Period|Physician Decision|0|||
37691720|NCT01885078|69167995|FG001|Step-down Period|Physician Decision|0|||
37691721|NCT01885078|69167996|FG002|Step-down Period|Physician Decision|0|||
37691722|NCT01885078|69167997|FG003|Step-down Period|Physician Decision|0|||
37691723|NCT01885078|69167998|FG004|Step-down Period|Physician Decision|0|||
37691724|NCT01885078|69167999|FG005|Step-down Period|Physician Decision|0|||
37691725|NCT01885078|69168000|FG006|Step-down Period|Physician Decision|0|||
37691726|NCT01885078|69168001|FG007|Step-down Period|Physician Decision|0|||
37691727|NCT01885078|69168002|FG008|Step-down Period|Physician Decision|7|||
37691728|NCT01885078|69168003|FG009|Step-down Period|Physician Decision|2|||
37691729|NCT01885078|69167994|FG000|Step-down Period|Death|0|||
37691730|NCT01885078|69167995|FG001|Step-down Period|Death|0|||
37691731|NCT01885078|69167996|FG002|Step-down Period|Death|0|||
37691732|NCT01885078|69167997|FG003|Step-down Period|Death|0|||
37691733|NCT01885078|69167998|FG004|Step-down Period|Death|0|||
37691734|NCT01885078|69167999|FG005|Step-down Period|Death|0|||
37691735|NCT01885078|69168000|FG006|Step-down Period|Death|0|||
37691736|NCT01885078|69168001|FG007|Step-down Period|Death|0|||
37691737|NCT01885078|69168002|FG008|Step-down Period|Death|4|||
37779414|NCT00985088|69340712|FG003|Overall Study|Withdrawal by Subject|1|||
37779415|NCT00985088|69340713|FG004|Overall Study|Withdrawal by Subject|3|||
37779416|NCT00985088|69340714|FG005|Overall Study|Withdrawal by Subject|2|||
37779417|NCT00985088|69340715|FG006|Overall Study|Withdrawal by Subject|1|||
37779418|NCT00985088|69340716|FG007|Overall Study|Withdrawal by Subject|2|||
37779419|NCT00985088|69340709|FG000|Overall Study|Migrated/moved from study area|0|||
37779420|NCT00985088|69340710|FG001|Overall Study|Migrated/moved from study area|0|||
37779421|NCT00985088|69340711|FG002|Overall Study|Migrated/moved from study area|1|||
37779422|NCT00985088|69340712|FG003|Overall Study|Migrated/moved from study area|0|||
37779423|NCT00985088|69340713|FG004|Overall Study|Migrated/moved from study area|0|||
37779424|NCT00985088|69340714|FG005|Overall Study|Migrated/moved from study area|0|||
37779425|NCT00985088|69340715|FG006|Overall Study|Migrated/moved from study area|0|||
37779426|NCT00985088|69340716|FG007|Overall Study|Migrated/moved from study area|1|||
37779427|NCT00985088|69340709|FG000|Overall Study|Lost to Follow-up|6|||
37779428|NCT00985088|69340710|FG001|Overall Study|Lost to Follow-up|1|||
37779429|NCT00985088|69340711|FG002|Overall Study|Lost to Follow-up|2|||
37779430|NCT00985088|69340712|FG003|Overall Study|Lost to Follow-up|6|||
37779431|NCT00985088|69340713|FG004|Overall Study|Lost to Follow-up|6|||
37779432|NCT00985088|69340714|FG005|Overall Study|Lost to Follow-up|5|||
37779433|NCT00985088|69340715|FG006|Overall Study|Lost to Follow-up|3|||
37779434|NCT00985088|69340716|FG007|Overall Study|Lost to Follow-up|2|||
37779435|NCT00984542|69340762|FG000|Overall Study|disease progression|19|||
37779436|NCT00984542|69340762|FG000|Overall Study|toxicity|7|||
37779437|NCT00984542|69340762|FG000|Overall Study|Death|7|||
37779438|NCT00984542|69340762|FG000|Overall Study|complicating disease|3|||
37779439|NCT00984542|69340762|FG000|Overall Study|Withdrawal by Subject|3|||
37779440|NCT00984542|69340762|FG000|Overall Study|clinical deterioration|2|||
37779441|NCT00983918|69340771|FG000|Overall Study|conversion to open cholecystectomy|0|||
37779442|NCT00983918|69340772|FG001|Overall Study|conversion to open cholecystectomy|2|||
37779443|NCT00983918|69340773|FG002|Overall Study|conversion to open cholecystectomy|2|||
37779444|NCT00983918|69340774|FG003|Overall Study|conversion to open cholecystectomy|2|||
37779445|NCT00983528|69340784|FG000|Overall Study|Death|4|||
37779446|NCT00983528|69340784|FG000|Overall Study|Lost to Follow-up|1|||
37779447|NCT00983528|69340784|FG000|Overall Study|Study Terminated|1|||
37779448|NCT00983372|69340788|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
37779449|NCT00983372|69340788|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
37779450|NCT00983372|69340788|FG000|Diltiazem ER Alone|Adverse Event|1|||
37779451|NCT00983294|69340820|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
37779452|NCT00983294|69340820|FG000|Colchicine With Azithromycin|Adverse Event|1|||
37779453|NCT00982280|69340836|FG000|Observation Period|Not eligible to be dosed|19|||
37779454|NCT00982280|69340836|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
37779455|NCT00982280|69340836|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
37779456|NCT00982280|69340836|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
37779457|NCT00982280|69340836|FG000|Maintenance Period|Adverse Event|1|||
37779458|NCT00981578|69340854|FG000|Overall Study|Death|1|||
37779459|NCT00981578|69340854|FG000|Overall Study|Withdrawal by Subject|2|||
37779460|NCT00980798|69340877|FG000|Overall Study|Adverse Event|7|||
37779461|NCT00980798|69340878|FG001|Overall Study|Adverse Event|36|||
37779462|NCT00980798|69340877|FG000|Overall Study|Lack of Efficacy|16|||
37779463|NCT00980798|69340878|FG001|Overall Study|Lack of Efficacy|5|||
37779464|NCT00980798|69340877|FG000|Overall Study|Lost to Follow-up|0|||
37779465|NCT00980798|69340878|FG001|Overall Study|Lost to Follow-up|1|||
37779466|NCT00980798|69340877|FG000|Overall Study|Physician Decision|2|||
37779467|NCT00980798|69340878|FG001|Overall Study|Physician Decision|1|||
37779468|NCT00980798|69340877|FG000|Overall Study|Withdrawal by Subject|8|||
37779469|NCT00980798|69340878|FG001|Overall Study|Withdrawal by Subject|11|||
37779470|NCT00980798|69340877|FG000|Overall Study|Other|0|||
37779471|NCT00980798|69340878|FG001|Overall Study|Other|1|||
37779472|NCT00980330|69341023|FG000|Overall Study|Adverse Event|0|||
37779473|NCT00980330|69341024|FG001|Overall Study|Adverse Event|0|||
37779474|NCT00980330|69341025|FG002|Overall Study|Adverse Event|0|||
37779475|NCT00980330|69341026|FG003|Overall Study|Adverse Event|1|||
37779476|NCT00980330|69341027|FG004|Overall Study|Adverse Event|0|||
37779477|NCT00980330|69341028|FG005|Overall Study|Adverse Event|0|||
37779478|NCT00980330|69341029|FG006|Overall Study|Adverse Event|0|||
37779479|NCT00980330|69341023|FG000|Overall Study|Lost to Follow-up|1|||
37779480|NCT00980330|69341024|FG001|Overall Study|Lost to Follow-up|1|||
37779481|NCT00980330|69341025|FG002|Overall Study|Lost to Follow-up|4|||
37779482|NCT00980330|69341026|FG003|Overall Study|Lost to Follow-up|2|||
37779483|NCT00980330|69341027|FG004|Overall Study|Lost to Follow-up|1|||
37779484|NCT00980330|69341028|FG005|Overall Study|Lost to Follow-up|1|||
37779485|NCT00980330|69341029|FG006|Overall Study|Lost to Follow-up|2|||
37779486|NCT00980330|69341023|FG000|Overall Study|Withdrawal by Subject|2|||
37779487|NCT00980330|69341024|FG001|Overall Study|Withdrawal by Subject|4|||
37779488|NCT00980330|69341025|FG002|Overall Study|Withdrawal by Subject|4|||
37779489|NCT00980330|69341026|FG003|Overall Study|Withdrawal by Subject|1|||
37779490|NCT00980330|69341027|FG004|Overall Study|Withdrawal by Subject|3|||
37779491|NCT00980330|69341028|FG005|Overall Study|Withdrawal by Subject|2|||
37779492|NCT00980330|69341029|FG006|Overall Study|Withdrawal by Subject|5|||
37779493|NCT00980330|69341023|FG000|Overall Study|(not specified)|2|||
37779494|NCT00980330|69341024|FG001|Overall Study|(not specified)|0|||
37779495|NCT00980330|69341025|FG002|Overall Study|(not specified)|0|||
37779496|NCT00980330|69341026|FG003|Overall Study|(not specified)|1|||
37779497|NCT00980330|69341027|FG004|Overall Study|(not specified)|1|||
37779498|NCT00980330|69341028|FG005|Overall Study|(not specified)|1|||
37779499|NCT00980330|69341029|FG006|Overall Study|(not specified)|0|||
37779500|NCT00980174|69341073|FG000|Overall Study|Withdrawal by Subject|1|||
37779501|NCT00980174|69341074|FG001|Overall Study|Withdrawal by Subject|4|||
37779502|NCT00980174|69341073|FG000|Overall Study|Adverse Event|0|||
37779503|NCT00980174|69341074|FG001|Overall Study|Adverse Event|3|||
37779504|NCT00980174|69341073|FG000|Overall Study|Ineligibility determined|2|||
37779505|NCT00980174|69341074|FG001|Overall Study|Ineligibility determined|1|||
37779506|NCT00980174|69341073|FG000|Overall Study|Death|1|||
37779507|NCT00980174|69341074|FG001|Overall Study|Death|1|||
37779508|NCT00980174|69341073|FG000|Overall Study|Other|0|||
37779509|NCT00980174|69341074|FG001|Overall Study|Other|1|||
37779510|NCT00980018|69341102|FG000|Overall Study|Adverse Event|8|||
37779511|NCT00980018|69341102|FG000|Overall Study|Patient withdrew consent|3|||
37779512|NCT00980018|69341102|FG000|Overall Study|Lost to Follow-up|1|||
37779513|NCT00988052|69341120|FG000|Overall Study|Missing|1|||
37779514|NCT00988052|69341121|FG001|Overall Study|Missing|0|||
37779515|NCT00988052|69341120|FG000|Overall Study|Teva requested subject withdrawal|3|||
37779516|NCT00988052|69341121|FG001|Overall Study|Teva requested subject withdrawal|1|||
37779517|NCT00988052|69341120|FG000|Overall Study|Death|1|||
37779518|NCT00988052|69341121|FG001|Overall Study|Death|3|||
37779519|NCT00988052|69341120|FG000|Overall Study|Protocol Violation|6|||
37779520|NCT00988052|69341121|FG001|Overall Study|Protocol Violation|5|||
37779521|NCT00988052|69341120|FG000|Overall Study|Pregnancy|6|||
37779522|NCT00988052|69341121|FG001|Overall Study|Pregnancy|6|||
37779523|NCT00988052|69341120|FG000|Overall Study|Lack of Efficacy|8|||
37779524|NCT00988052|69341121|FG001|Overall Study|Lack of Efficacy|7|||
37779525|NCT00988052|69341120|FG000|Overall Study|Lost to Follow-up|6|||
37779526|NCT00988052|69341121|FG001|Overall Study|Lost to Follow-up|11|||
37779527|NCT00988052|69341120|FG000|Overall Study|Physician Decision|27|||
37779528|NCT00988052|69341121|FG001|Overall Study|Physician Decision|28|||
37779529|NCT00988052|69341120|FG000|Overall Study|Adverse Event|35|||
37779530|NCT00988052|69341121|FG001|Overall Study|Adverse Event|28|||
37779531|NCT00988052|69341120|FG000|Overall Study|Withdrawal by Subject|90|||
37779532|NCT00988052|69341121|FG001|Overall Study|Withdrawal by Subject|91|||
37779533|NCT00988052|69341120|FG000|Overall Study|Study terminated by sponsor|240|||
37779534|NCT00988052|69341121|FG001|Overall Study|Study terminated by sponsor|236|||
37779535|NCT02569710|69341222|FG000|Overall Study|Adverse Event|1|||
37779536|NCT02569710|69341223|FG001|Overall Study|Adverse Event|0|||
37779537|NCT02569710|69341224|FG002|Overall Study|Adverse Event|0|||
37779538|NCT02569710|69341225|FG003|Overall Study|Adverse Event|0|||
37779539|NCT02569710|69341226|FG004|Overall Study|Adverse Event|0|||
37779540|NCT02569710|69341227|FG005|Overall Study|Adverse Event|0|||
37779541|NCT02569710|69341228|FG006|Overall Study|Adverse Event|0|||
37779542|NCT02569710|69341229|FG007|Overall Study|Adverse Event|0|||
37779543|NCT02569710|69341230|FG008|Overall Study|Adverse Event|0|||
37779544|NCT02569710|69341231|FG009|Overall Study|Adverse Event|0|||
37779545|NCT02569710|69341222|FG000|Overall Study|Lost to Follow-up|0|||
37779546|NCT02569710|69341223|FG001|Overall Study|Lost to Follow-up|0|||
37779547|NCT02569710|69341224|FG002|Overall Study|Lost to Follow-up|0|||
37779548|NCT02569710|69341225|FG003|Overall Study|Lost to Follow-up|0|||
37779549|NCT02569710|69341226|FG004|Overall Study|Lost to Follow-up|0|||
37779550|NCT02569710|69341227|FG005|Overall Study|Lost to Follow-up|0|||
37779551|NCT02569710|69341228|FG006|Overall Study|Lost to Follow-up|1|||
37779552|NCT02569710|69341229|FG007|Overall Study|Lost to Follow-up|0|||
37779553|NCT02569710|69341230|FG008|Overall Study|Lost to Follow-up|1|||
37779554|NCT02569710|69341231|FG009|Overall Study|Lost to Follow-up|0|||
37691738|NCT01885078|69168003|FG009|Step-down Period|Death|3|||
37691739|NCT01885078|69167994|FG000|Step-down Period|Lost to Follow-up|0|||
37691740|NCT01885078|69167995|FG001|Step-down Period|Lost to Follow-up|0|||
37691741|NCT01885078|69167996|FG002|Step-down Period|Lost to Follow-up|0|||
37691742|NCT01885078|69167997|FG003|Step-down Period|Lost to Follow-up|0|||
37691743|NCT01885078|69167998|FG004|Step-down Period|Lost to Follow-up|0|||
37691744|NCT01885078|69167999|FG005|Step-down Period|Lost to Follow-up|0|||
37691745|NCT01885078|69168000|FG006|Step-down Period|Lost to Follow-up|0|||
37691746|NCT01885078|69168001|FG007|Step-down Period|Lost to Follow-up|0|||
37691747|NCT01885078|69168002|FG008|Step-down Period|Lost to Follow-up|1|||
37691748|NCT01885078|69168003|FG009|Step-down Period|Lost to Follow-up|1|||
37691749|NCT01885078|69167994|FG000|Step-down Period|Lack of Efficacy|0|||
37691750|NCT01885078|69167995|FG001|Step-down Period|Lack of Efficacy|0|||
37691751|NCT01885078|69167996|FG002|Step-down Period|Lack of Efficacy|0|||
37969427|NCT00510276|69656567|FG001|Acute Double-Blind Phase|Physician Decision|3|||
37969428|NCT00510276|69656566|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
37691752|NCT01885078|69167997|FG003|Step-down Period|Lack of Efficacy|0|||
37691753|NCT01885078|69167998|FG004|Step-down Period|Lack of Efficacy|0|||
37779555|NCT02569710|69341222|FG000|Overall Study|Virologic failure|0|||
37779556|NCT02569710|69341223|FG001|Overall Study|Virologic failure|0|||
37779557|NCT02569710|69341224|FG002|Overall Study|Virologic failure|0|||
37779558|NCT02569710|69341225|FG003|Overall Study|Virologic failure|0|||
37779559|NCT02569710|69341226|FG004|Overall Study|Virologic failure|1|||
37779560|NCT02569710|69341227|FG005|Overall Study|Virologic failure|0|||
37779561|NCT02569710|69341228|FG006|Overall Study|Virologic failure|1|||
37779562|NCT02569710|69341229|FG007|Overall Study|Virologic failure|0|||
37779563|NCT02569710|69341230|FG008|Overall Study|Virologic failure|0|||
37779564|NCT02569710|69341231|FG009|Overall Study|Virologic failure|0|||
37779565|NCT02569710|69341222|FG000|Overall Study|Withdrawal by Subject|0|||
37779566|NCT02569710|69341223|FG001|Overall Study|Withdrawal by Subject|0|||
37779567|NCT02569710|69341224|FG002|Overall Study|Withdrawal by Subject|0|||
37779568|NCT02569710|69341225|FG003|Overall Study|Withdrawal by Subject|0|||
37779569|NCT02569710|69341226|FG004|Overall Study|Withdrawal by Subject|0|||
37779570|NCT02569710|69341227|FG005|Overall Study|Withdrawal by Subject|1|||
37779571|NCT02569710|69341228|FG006|Overall Study|Withdrawal by Subject|0|||
37779572|NCT02569710|69341229|FG007|Overall Study|Withdrawal by Subject|0|||
37779573|NCT02569710|69341230|FG008|Overall Study|Withdrawal by Subject|0|||
37779574|NCT02569710|69341231|FG009|Overall Study|Withdrawal by Subject|0|||
37779575|NCT02569476|69341333|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
37779576|NCT02569476|69341333|FG000|Overall Study|Death|33|||
37779577|NCT02569476|69341333|FG000|Overall Study|Withdrawal by Subject|9|||
37779578|NCT02569476|69341333|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
37779579|NCT02569476|69341333|FG000|Overall Study|Palliative care|1|||
37779580|NCT02569476|69341333|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
37779581|NCT02569476|69341333|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
37779582|NCT02565576|69341405|FG000|Overall Study|abnormal lab value|2|||
37779583|NCT02565576|69341406|FG001|Overall Study|abnormal lab value|0|||
37779584|NCT02565576|69341405|FG000|Overall Study|subject / guardian decision|1|||
37779585|NCT02565576|69341406|FG001|Overall Study|subject / guardian decision|3|||
37779586|NCT02565576|69341405|FG000|Overall Study|Lost to Follow-up|1|||
37779587|NCT02565576|69341406|FG001|Overall Study|Lost to Follow-up|0|||
37779588|NCT02565576|69341405|FG000|Overall Study|Death|0|||
37779589|NCT02565576|69341406|FG001|Overall Study|Death|2|||
37779590|NCT02565576|69341405|FG000|Overall Study|Adverse Event|1|||
37779591|NCT02565576|69341406|FG001|Overall Study|Adverse Event|0|||
37779592|NCT02569398|69341437|FG000|Overall Study|Adverse Event|0|||
37779593|NCT02569398|69341438|FG001|Overall Study|Adverse Event|1|||
37779594|NCT02569398|69341439|FG002|Overall Study|Adverse Event|6|||
37779595|NCT02569398|69341437|FG000|Overall Study|Withdrawal by Subject|43|||
37779596|NCT02569398|69341438|FG001|Overall Study|Withdrawal by Subject|43|||
37779597|NCT02569398|69341439|FG002|Overall Study|Withdrawal by Subject|30|||
37779598|NCT02569398|69341437|FG000|Overall Study|Study terminated by sponsor|130|||
37779599|NCT02569398|69341438|FG001|Overall Study|Study terminated by sponsor|131|||
37779600|NCT02569398|69341439|FG002|Overall Study|Study terminated by sponsor|134|||
37779601|NCT02569398|69341437|FG000|Overall Study|Other|12|||
37779602|NCT02569398|69341438|FG001|Overall Study|Other|14|||
37779603|NCT02569398|69341439|FG002|Overall Study|Other|13|||
37779604|NCT02569242|69341483|FG000|Overall Study|Death|1|||
37779605|NCT02569242|69341484|FG001|Overall Study|Death|0|||
37779606|NCT02569242|69341483|FG000|Overall Study|Withdrawal by Subject|0|||
37779607|NCT02569242|69341484|FG001|Overall Study|Withdrawal by Subject|1|||
37779608|NCT01663740|69341552|FG000|Overall Study|Lost to Follow-up|1|||
37779609|NCT01663740|69341553|FG001|Overall Study|Lost to Follow-up|4|||
37779610|NCT01663740|69341552|FG000|Overall Study|Other|9|||
37779611|NCT01663740|69341553|FG001|Overall Study|Other|2|||
37779612|NCT01663740|69341552|FG000|Overall Study|Inclusion/Exclusion not met|1|||
37779613|NCT01663740|69341553|FG001|Overall Study|Inclusion/Exclusion not met|0|||
37779614|NCT01663740|69341552|FG000|Overall Study|Death|0|||
37779615|NCT01663740|69341553|FG001|Overall Study|Death|1|||
37779616|NCT01663740|69341552|FG000|Overall Study|Withdrawal by Subject|2|||
37779617|NCT01663740|69341553|FG001|Overall Study|Withdrawal by Subject|1|||
37779618|NCT01663740|69341552|FG000|Overall Study|No end of study status|3|||
37691754|NCT01885078|69167999|FG005|Step-down Period|Lack of Efficacy|0|||
37779619|NCT01663740|69341553|FG001|Overall Study|No end of study status|0|||
37779620|NCT01663506|69341669|FG000|Overall Study|Lack of Efficacy|3|||
37691755|NCT01885078|69168000|FG006|Step-down Period|Lack of Efficacy|0|||
37691756|NCT01885078|69168001|FG007|Step-down Period|Lack of Efficacy|0|||
37691757|NCT01885078|69168002|FG008|Step-down Period|Lack of Efficacy|1|||
37691758|NCT01885078|69168003|FG009|Step-down Period|Lack of Efficacy|0|||
37691759|NCT01885078|69167994|FG000|Step-down Period|Protocol Violation|0|||
37691760|NCT01885078|69167995|FG001|Step-down Period|Protocol Violation|0|||
37691761|NCT01885078|69167996|FG002|Step-down Period|Protocol Violation|0|||
37779621|NCT01663506|69341669|FG000|Overall Study|Consent Withdrawal by Subject|1|||
37779622|NCT01663506|69341669|FG000|Overall Study|Lost to Follow-up|1|||
37779623|NCT01663506|69341669|FG000|Overall Study|Adverse Event|1|||
37691762|NCT01885078|69167997|FG003|Step-down Period|Protocol Violation|0|||
37779624|NCT01663506|69341669|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
37779625|NCT02568384|69341673|FG000|Overall Study|Mobile devices incompatible with App|2|||
37779626|NCT02965976|69341780|FG000|Overall Study|Withdrawal by Subject|2|||
37779627|NCT02965976|69341781|FG001|Overall Study|Withdrawal by Subject|0|||
37779628|NCT04125680|69341799|FG000|Overall Study|Lost to Follow-up|15|||
37779629|NCT02565186|69341823|FG000|Overall Study|Adverse Event|113|||
37779630|NCT02565186|69341824|FG001|Overall Study|Adverse Event|148|||
37779631|NCT02565186|69341823|FG000|Overall Study|Lost to Follow-up|102|||
37779632|NCT02565186|69341824|FG001|Overall Study|Lost to Follow-up|93|||
37779633|NCT02565186|69341823|FG000|Overall Study|Non-Compliance|57|||
37779634|NCT02565186|69341824|FG001|Overall Study|Non-Compliance|55|||
37779635|NCT02565186|69341823|FG000|Overall Study|Withdrawal by Subject|229|||
37779636|NCT02565186|69341824|FG001|Overall Study|Withdrawal by Subject|214|||
37779637|NCT02565186|69341823|FG000|Overall Study|Physician Decision|18|||
37779638|NCT02565186|69341824|FG001|Overall Study|Physician Decision|16|||
37779639|NCT02565186|69341823|FG000|Overall Study|Sponsor Request|5|||
37779640|NCT02565186|69341824|FG001|Overall Study|Sponsor Request|9|||
37779641|NCT02565186|69341823|FG000|Overall Study|Missing|1|||
37779642|NCT02565186|69341824|FG001|Overall Study|Missing|0|||
37779643|NCT02565186|69341823|FG000|Overall Study|Did Not Receive Study Drug|55|||
37779644|NCT02565186|69341824|FG001|Overall Study|Did Not Receive Study Drug|86|||
37779645|NCT02568072|69341830|FG000|Overall Study|Unavailable for appointment|23|||
37779646|NCT02568072|69341830|FG000|Overall Study|Unable to contact|3|||
37779647|NCT02568072|69341830|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
37779648|NCT02568072|69341830|FG000|Overall Study|Withdrawal by Subject|1|||
37779649|NCT02568072|69341830|FG000|Overall Study|Sustained injury, marathon not run|24|||
37779650|NCT02565108|69341837|FG000|Overall Study|Adverse Event|1|||
37779651|NCT02565108|69341838|FG001|Overall Study|Adverse Event|0|||
37779652|NCT02565108|69341837|FG000|Overall Study|Withdrew Consent|1|||
37779653|NCT02565108|69341838|FG001|Overall Study|Withdrew Consent|0|||
37779654|NCT02564952|69341844|FG000|Overall Study|Adverse Event|6|||
37779655|NCT02564952|69341844|FG000|Overall Study|Lost to Follow-up|1|||
37779656|NCT02564952|69341844|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
37779657|NCT02564952|69341844|FG000|Overall Study|Withdrawal by Subject|1|||
37779658|NCT02564952|69341844|FG000|Overall Study|Low Efficacy|1|||
37779659|NCT02564952|69341844|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
37779660|NCT02566902|69341850|FG000|Overall Study|Protocol Violation|2|||
37779661|NCT02566902|69341851|FG001|Overall Study|Protocol Violation|1|||
37779662|NCT02564796|69341859|FG000|Overall Study|Physician Decision|2|||
37779663|NCT02564796|69341860|FG001|Overall Study|Physician Decision|2|||
37779664|NCT02564718|69341868|FG000|Overall Study|Withdrew from treatment|0|||
37779665|NCT02564718|69341869|FG001|Overall Study|Withdrew from treatment|1|||
37779666|NCT01453946|69341875|FG000|Overall Study|Did not receive drug for the taper phase|1|||
37779667|NCT01453946|69341875|FG000|Overall Study|Protocol Violation|2|||
37779668|NCT01453946|69341875|FG000|Overall Study|Lack of Efficacy|3|||
37779669|NCT01453946|69341875|FG000|Overall Study|Adverse Event|3|||
37779670|NCT02563548|69341997|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
37863944|NCT01253369|69547552|FG000|Overall Study|Adverse Event|4|||
37863945|NCT01253369|69547552|FG000|Overall Study|Withdrawal by Subject|2|||
37779671|NCT02563548|69341998|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
37779672|NCT02563548|69341999|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
37779673|NCT02563548|69342000|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
37779674|NCT02563548|69342001|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
37779675|NCT02563548|69342002|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
37779676|NCT02563548|69341997|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
37779677|NCT02563548|69341998|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
37779678|NCT02563548|69341999|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
37779679|NCT02563548|69342000|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
37779680|NCT02563548|69342001|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
37779681|NCT02563548|69342002|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
37779682|NCT02563548|69341997|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
37779683|NCT02563548|69341998|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
37779684|NCT02563548|69341999|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
37779685|NCT02563548|69342000|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
37779686|NCT02563548|69342001|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
37779687|NCT02563548|69342002|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
37779688|NCT02563548|69341997|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
37779689|NCT02563548|69341998|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
37779690|NCT02563548|69341999|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
37779691|NCT02563548|69342000|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
37779692|NCT02563548|69342001|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
37779693|NCT02563548|69342002|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
37779694|NCT02563548|69341997|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
37779695|NCT02563548|69341998|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
37779696|NCT02563548|69341999|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
37779697|NCT02563548|69342000|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
37779698|NCT02563548|69342001|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
37779699|NCT02563548|69342002|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
37969429|NCT00510276|69656567|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
37969430|NCT00510276|69656566|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
37969431|NCT00510276|69656567|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
37969432|NCT00510276|69656566|FG000|Acute Double-Blind Phase|Subject Decision|26|||
37969433|NCT00510276|69656567|FG001|Acute Double-Blind Phase|Subject Decision|28|||
37969434|NCT00510276|69656566|FG000|Extension Open-Label Phase|Adverse Event|9|||
37691763|NCT01885078|69167998|FG004|Step-down Period|Protocol Violation|0|||
37691764|NCT01885078|69167999|FG005|Step-down Period|Protocol Violation|0|||
37691765|NCT01885078|69168000|FG006|Step-down Period|Protocol Violation|0|||
37691766|NCT01885078|69168001|FG007|Step-down Period|Protocol Violation|0|||
37691767|NCT01885078|69168002|FG008|Step-down Period|Protocol Violation|1|||
37691768|NCT01885078|69168003|FG009|Step-down Period|Protocol Violation|1|||
37691769|NCT02046369|69168026|FG000|Overall Study|Adverse Event|3|||
37691770|NCT02046369|69168027|FG001|Overall Study|Adverse Event|3|||
37691771|NCT02046369|69168026|FG000|Overall Study|Lack of Efficacy|3|||
37691772|NCT02046369|69168027|FG001|Overall Study|Lack of Efficacy|3|||
37691773|NCT02046369|69168026|FG000|Overall Study|Lost to Follow-up|3|||
37691774|NCT02046369|69168027|FG001|Overall Study|Lost to Follow-up|3|||
37691775|NCT02046369|69168026|FG000|Overall Study|Protocol Violation|1|||
37691776|NCT02046369|69168027|FG001|Overall Study|Protocol Violation|2|||
37691777|NCT02046369|69168026|FG000|Overall Study|Withdrawal by Subject|3|||
37691778|NCT02046369|69168027|FG001|Overall Study|Withdrawal by Subject|6|||
37691779|NCT02046369|69168026|FG000|Overall Study|never received study drug|0|||
37691780|NCT02046369|69168027|FG001|Overall Study|never received study drug|1|||
37691781|NCT02046369|69168026|FG000|Overall Study|non compliance|1|||
37691782|NCT02046369|69168027|FG001|Overall Study|non compliance|0|||
37691783|NCT02101359|69168035|FG000|Overall Study|Not included|23|||
37691784|NCT02101359|69168036|FG001|Overall Study|Not included|13|||
37691785|NCT02101359|69168035|FG000|Overall Study|Withdrawal by Subject|5|||
37691786|NCT02101359|69168036|FG001|Overall Study|Withdrawal by Subject|4|||
37691787|NCT02101359|69168035|FG000|Overall Study|Lost to Follow-up|1|||
37691788|NCT02101359|69168036|FG001|Overall Study|Lost to Follow-up|0|||
37691789|NCT02101359|69168035|FG000|Overall Study|Protocol Violation|0|||
37691790|NCT02101359|69168036|FG001|Overall Study|Protocol Violation|2|||
37691791|NCT02100969|69168042|FG000|Overall Study|Did not pass screening phase|1|||
37691792|NCT01885000|69168049|FG000|Overall Study|Adverse Event|1|||
37691793|NCT01885000|69168050|FG001|Overall Study|Adverse Event|0|||
37691794|NCT01885000|69168049|FG000|Overall Study|Withdrawal by Subject|1|||
37691795|NCT01885000|69168050|FG001|Overall Study|Withdrawal by Subject|1|||
37969435|NCT00510276|69656567|FG001|Extension Open-Label Phase|Adverse Event|18|||
37691796|NCT01885000|69168049|FG000|Overall Study|Protocol Violation|0|||
37691797|NCT01885000|69168050|FG001|Overall Study|Protocol Violation|1|||
37691798|NCT01884688|69168056|FG000|Overall Study|Screen Failure|2|||
37691799|NCT01883362|69168062|FG000|Treatment|Adverse Event|1|||
37691800|NCT01883362|69168063|FG001|Treatment|Adverse Event|8|||
37691801|NCT01883362|69168062|FG000|Treatment|Withdrawal by Subject|6|||
37779700|NCT02563548|69341997|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
37779701|NCT02563548|69341998|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
37779702|NCT02563548|69341999|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
37779703|NCT02563548|69342000|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
37779704|NCT02563548|69342001|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
37779705|NCT02563548|69342002|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
37779706|NCT02563548|69341997|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
37779707|NCT02563548|69341998|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
37779708|NCT02563548|69341999|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
37779709|NCT02563548|69342000|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
37779710|NCT02563548|69342001|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
37779711|NCT02563548|69342002|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
37779712|NCT02563548|69341997|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
37779713|NCT02563548|69341998|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
37779714|NCT02563548|69341999|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
37779715|NCT02563548|69342000|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
37779716|NCT02563548|69342001|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
37779717|NCT02563548|69342002|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
37779718|NCT02563548|69341997|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
37779719|NCT02563548|69341998|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
37779720|NCT02563548|69341999|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
37779721|NCT02563548|69342000|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
37779722|NCT02563548|69342001|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
37779723|NCT02563548|69342002|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
37691802|NCT01883362|69168063|FG001|Treatment|Withdrawal by Subject|2|||
37691803|NCT01883362|69168062|FG000|Treatment|Administrative problems|4|||
37691804|NCT01883362|69168063|FG001|Treatment|Administrative problems|1|||
37691805|NCT01883362|69168062|FG000|Treatment|Relapse|4|||
37691806|NCT01883362|69168063|FG001|Treatment|Relapse|2|||
37691807|NCT01883362|69168062|FG000|Treatment|Randomized, not treated|1|||
37691808|NCT01883362|69168063|FG001|Treatment|Randomized, not treated|1|||
37691809|NCT01883362|69168062|FG000|Post Treatment Follow-up|Protocol Violation|0|||
37691810|NCT01883362|69168063|FG001|Post Treatment Follow-up|Protocol Violation|1|||
37691811|NCT01883362|69168062|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
37691812|NCT01883362|69168063|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
37691813|NCT01883362|69168062|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
37691814|NCT01883362|69168063|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
37691815|NCT01883362|69168062|FG000|Post Treatment Follow-up|Administrative problems|2|||
37691816|NCT01883362|69168063|FG001|Post Treatment Follow-up|Administrative problems|0|||
37691817|NCT01883362|69168062|FG000|Post Treatment Follow-up|Death|8|||
37691818|NCT01883362|69168063|FG001|Post Treatment Follow-up|Death|4|||
37691819|NCT01883362|69168062|FG000|Post Treatment Follow-up|Relapse|1|||
37691820|NCT01883362|69168063|FG001|Post Treatment Follow-up|Relapse|2|||
37691821|NCT02100813|69168081|FG000|Overall Study|Adverse Event|0|||
37691822|NCT02100813|69168082|FG001|Overall Study|Adverse Event|0|||
37691823|NCT02100813|69168083|FG002|Overall Study|Adverse Event|0|||
37691824|NCT02100813|69168084|FG003|Overall Study|Adverse Event|0|||
37691825|NCT02100813|69168085|FG004|Overall Study|Adverse Event|0|||
37691826|NCT02100813|69168086|FG005|Overall Study|Adverse Event|0|||
37691827|NCT02100813|69168087|FG006|Overall Study|Adverse Event|0|||
37691828|NCT02100813|69168088|FG007|Overall Study|Adverse Event|1|||
37691829|NCT01930162|69168110|FG000|Overall Study|Abnormal test procedure result(s)|4|||
37691830|NCT01930162|69168110|FG000|Overall Study|Death|1|||
37691831|NCT02045979|69168118|FG000|Overall Study|Informed Consent Withdrawn|2|||
37691832|NCT02045979|69168119|FG001|Overall Study|Informed Consent Withdrawn|0|||
37691833|NCT02045979|69168120|FG002|Overall Study|Informed Consent Withdrawn|1|||
37691834|NCT02045979|69168118|FG000|Overall Study|not specified above|0|||
37691835|NCT02045979|69168119|FG001|Overall Study|not specified above|1|||
37691836|NCT02045979|69168120|FG002|Overall Study|not specified above|0|||
37691837|NCT01929226|69168130|FG000|Overall Study|Lost to Follow-up|4|||
37779724|NCT02563548|69341997|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
37779725|NCT02563548|69341998|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
37779726|NCT02563548|69341999|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
37779727|NCT02563548|69342000|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
37779728|NCT02563548|69342001|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
37779729|NCT02563548|69342002|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
37779730|NCT02563548|69341997|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
37779731|NCT02563548|69341998|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
37779732|NCT02563548|69341999|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
37779733|NCT02563548|69342000|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
37779734|NCT02563548|69342001|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
37779735|NCT02563548|69342002|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
37779736|NCT02563548|69341997|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
37779737|NCT02563548|69341998|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
37779738|NCT02563548|69341999|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
37779739|NCT02563548|69342000|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
37779740|NCT02563548|69342001|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
37779741|NCT02563548|69342002|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
37779742|NCT02559570|69342083|FG000|Overall Study|Adverse Event|0|||
37779743|NCT02559570|69342084|FG001|Overall Study|Adverse Event|2|||
37779744|NCT02559570|69342085|FG002|Overall Study|Adverse Event|0|||
37779745|NCT02559570|69342086|FG003|Overall Study|Adverse Event|1|||
37779746|NCT02559570|69342087|FG004|Overall Study|Adverse Event|0|||
37779747|NCT02559570|69342083|FG000|Overall Study|Withdrawal of Consent|0|||
37779748|NCT02559570|69342084|FG001|Overall Study|Withdrawal of Consent|0|||
37779749|NCT02559570|69342085|FG002|Overall Study|Withdrawal of Consent|1|||
37779750|NCT02559570|69342086|FG003|Overall Study|Withdrawal of Consent|2|||
37779751|NCT02559570|69342087|FG004|Overall Study|Withdrawal of Consent|1|||
37779752|NCT02559570|69342083|FG000|Overall Study|Lost to Follow-up|1|||
37779753|NCT02559570|69342084|FG001|Overall Study|Lost to Follow-up|0|||
37779754|NCT02559570|69342085|FG002|Overall Study|Lost to Follow-up|0|||
37779755|NCT02559570|69342086|FG003|Overall Study|Lost to Follow-up|0|||
37779756|NCT02559570|69342087|FG004|Overall Study|Lost to Follow-up|0|||
37779757|NCT02559570|69342083|FG000|Overall Study|Protocol Violation|1|||
37779758|NCT02559570|69342084|FG001|Overall Study|Protocol Violation|0|||
37779759|NCT02559570|69342085|FG002|Overall Study|Protocol Violation|0|||
37779760|NCT02559570|69342086|FG003|Overall Study|Protocol Violation|0|||
37779761|NCT02559570|69342087|FG004|Overall Study|Protocol Violation|1|||
37779762|NCT02559570|69342083|FG000|Overall Study|Other Miscellaneous Reasons|0|||
37779763|NCT02559570|69342084|FG001|Overall Study|Other Miscellaneous Reasons|0|||
37779764|NCT02559570|69342085|FG002|Overall Study|Other Miscellaneous Reasons|1|||
37779765|NCT02559570|69342086|FG003|Overall Study|Other Miscellaneous Reasons|0|||
37779766|NCT02559570|69342087|FG004|Overall Study|Other Miscellaneous Reasons|0|||
37779767|NCT02559414|69342442|FG000|Overall Study|Lost to Follow-up|0|||
37779768|NCT02559414|69342443|FG001|Overall Study|Lost to Follow-up|1|||
37779769|NCT02559414|69342444|FG002|Overall Study|Lost to Follow-up|0|||
37779770|NCT02559414|69342442|FG000|Overall Study|Withdrawal by Subject|1|||
37779771|NCT02559414|69342443|FG001|Overall Study|Withdrawal by Subject|0|||
37779772|NCT02559414|69342444|FG002|Overall Study|Withdrawal by Subject|1|||
37779773|NCT02559414|69342442|FG000|Overall Study|Other|0|||
37779774|NCT02559414|69342443|FG001|Overall Study|Other|1|||
37779775|NCT02559414|69342444|FG002|Overall Study|Other|1|||
37779776|NCT02558790|69342519|FG000|Overall Study|Lost to Follow-up|2|||
37779777|NCT02558790|69342519|FG000|Overall Study|Physician Decision|1|||
37779778|NCT02558790|69342519|FG000|Overall Study|Withdrawal by Subject|1|||
37779779|NCT02558790|69342519|FG000|Overall Study|Screen Fail|3|||
37779780|NCT02556138|69342545|FG000|Overall Study|Withdrawal by Subject|1|||
37779781|NCT02558400|69342628|FG000|Overall Study|Adverse Event|47|||
37779782|NCT02558400|69342629|FG001|Overall Study|Adverse Event|53|||
37779783|NCT02558400|69342630|FG002|Overall Study|Adverse Event|4|||
37779784|NCT02558400|69342628|FG000|Overall Study|Withdrawal by Subject|13|||
37779785|NCT02558400|69342629|FG001|Overall Study|Withdrawal by Subject|9|||
37779786|NCT02558400|69342630|FG002|Overall Study|Withdrawal by Subject|8|||
37779787|NCT02558400|69342628|FG000|Overall Study|Non-Compliant|0|||
37779788|NCT02558400|69342629|FG001|Overall Study|Non-Compliant|1|||
37779789|NCT02558400|69342630|FG002|Overall Study|Non-Compliant|3|||
37779790|NCT02558400|69342628|FG000|Overall Study|Lost to Follow-up|5|||
37779791|NCT02558400|69342629|FG001|Overall Study|Lost to Follow-up|5|||
37779792|NCT02558400|69342630|FG002|Overall Study|Lost to Follow-up|4|||
37779793|NCT02558400|69342628|FG000|Overall Study|Lack of Efficacy|0|||
37779794|NCT02558400|69342629|FG001|Overall Study|Lack of Efficacy|13|||
37779795|NCT02558400|69342630|FG002|Overall Study|Lack of Efficacy|1|||
37779796|NCT02558400|69342628|FG000|Overall Study|Disallowed Concurrent Medication|6|||
37969436|NCT00510276|69656566|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
37969437|NCT00510276|69656567|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
37969438|NCT00510276|69656566|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
37969439|NCT00510276|69656567|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
37969440|NCT00510276|69656566|FG000|Extension Open-Label Phase|Physician Decision|2|||
37969441|NCT00510276|69656567|FG001|Extension Open-Label Phase|Physician Decision|3|||
37969442|NCT00510276|69656566|FG000|Extension Open-Label Phase|Protocol Violation|0|||
37969443|NCT00510276|69656567|FG001|Extension Open-Label Phase|Protocol Violation|1|||
37969444|NCT00510276|69656566|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
37969445|NCT00510276|69656567|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
37969446|NCT00510276|69656566|FG000|Extension Open-Label Phase|Subject Decision|7|||
37969447|NCT00510276|69656567|FG001|Extension Open-Label Phase|Subject Decision|9|||
37969448|NCT00616655|69656583|FG000|Overall Study|Adverse Event|10|||
37969449|NCT00616655|69656584|FG001|Overall Study|Adverse Event|7|||
37969450|NCT00616655|69656585|FG002|Overall Study|Adverse Event|12|||
37969451|NCT00616655|69656583|FG000|Overall Study|Lack of Efficacy|5|||
37969452|NCT00616655|69656584|FG001|Overall Study|Lack of Efficacy|5|||
37969453|NCT00616655|69656585|FG002|Overall Study|Lack of Efficacy|5|||
37969454|NCT00616655|69656583|FG000|Overall Study|Lost to Follow-up|3|||
37969455|NCT00616655|69656584|FG001|Overall Study|Lost to Follow-up|12|||
37969456|NCT00616655|69656585|FG002|Overall Study|Lost to Follow-up|10|||
37969457|NCT00616655|69656583|FG000|Overall Study|Protocol Violation|2|||
37969458|NCT00616655|69656584|FG001|Overall Study|Protocol Violation|4|||
37969459|NCT00616655|69656585|FG002|Overall Study|Protocol Violation|3|||
37969460|NCT00616655|69656583|FG000|Overall Study|Withdrawal by Subject|9|||
37969461|NCT00616655|69656584|FG001|Overall Study|Withdrawal by Subject|7|||
37969462|NCT00616655|69656585|FG002|Overall Study|Withdrawal by Subject|11|||
37969463|NCT00616655|69656583|FG000|Overall Study|Does not meet in/ex criteria|0|||
37969464|NCT00616655|69656584|FG001|Overall Study|Does not meet in/ex criteria|0|||
37969465|NCT00616655|69656585|FG002|Overall Study|Does not meet in/ex criteria|2|||
37969466|NCT00616655|69656583|FG000|Overall Study|Other|6|||
37969467|NCT00616655|69656584|FG001|Overall Study|Other|6|||
37779797|NCT02558400|69342629|FG001|Overall Study|Disallowed Concurrent Medication|7|||
37779798|NCT02558400|69342630|FG002|Overall Study|Disallowed Concurrent Medication|5|||
37779799|NCT02558400|69342628|FG000|Overall Study|Physician Decision|2|||
37779800|NCT02558400|69342629|FG001|Overall Study|Physician Decision|2|||
37779801|NCT02558400|69342630|FG002|Overall Study|Physician Decision|0|||
37779802|NCT02558400|69342628|FG000|Overall Study|Protocol Violation|6|||
37779803|NCT02558400|69342629|FG001|Overall Study|Protocol Violation|3|||
37779804|NCT02558400|69342630|FG002|Overall Study|Protocol Violation|8|||
37779805|NCT02558400|69342628|FG000|Overall Study|Death|0|||
37779806|NCT02558400|69342629|FG001|Overall Study|Death|1|||
37779807|NCT02558400|69342630|FG002|Overall Study|Death|0|||
37779808|NCT02558400|69342628|FG000|Overall Study|Ineligible for the study|0|||
37779809|NCT02558400|69342629|FG001|Overall Study|Ineligible for the study|2|||
37779810|NCT02558400|69342630|FG002|Overall Study|Ineligible for the study|0|||
37779811|NCT01662648|69342762|FG000|Overall Study|Death|1|||
37779812|NCT01662648|69342763|FG001|Overall Study|Death|3|||
37779813|NCT01662648|69342762|FG000|Overall Study|Adverse Event|40|||
37779814|NCT01662648|69342763|FG001|Overall Study|Adverse Event|37|||
37779815|NCT01662648|69342762|FG000|Overall Study|Lack of Efficacy|17|||
37779816|NCT01662648|69342763|FG001|Overall Study|Lack of Efficacy|16|||
37779817|NCT01662648|69342762|FG000|Overall Study|Participant ineligible to continue trial|1|||
37779818|NCT01662648|69342763|FG001|Overall Study|Participant ineligible to continue trial|1|||
37779819|NCT01662648|69342762|FG000|Overall Study|Lost to Follow-up|24|||
37779820|NCT01662648|69342763|FG001|Overall Study|Lost to Follow-up|36|||
37969468|NCT00616655|69656585|FG002|Overall Study|Other|5|||
37969469|NCT00510198|69656595|FG000|Overall Study|Withdrawal by Subject|5|||
37969470|NCT00510198|69656596|FG001|Overall Study|Withdrawal by Subject|4|||
37969471|NCT00516048|69656606|FG000|Overall Study|Death|0|||
37969472|NCT00516048|69656607|FG001|Overall Study|Death|0|||
37969473|NCT00516048|69656608|FG002|Overall Study|Death|1|||
37779821|NCT01662648|69342762|FG000|Overall Study|Withdrawal by Subject|36|||
37779822|NCT01662648|69342763|FG001|Overall Study|Withdrawal by Subject|53|||
37779823|NCT01662648|69342762|FG000|Overall Study|Participant non-compliant|16|||
37779824|NCT01662648|69342763|FG001|Overall Study|Participant non-compliant|20|||
37779825|NCT01662648|69342762|FG000|Overall Study|Other|8|||
37779826|NCT01662648|69342763|FG001|Overall Study|Other|11|||
37779827|NCT01662648|69342762|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
37779828|NCT01662648|69342763|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
37779829|NCT01662648|69342762|FG000|Overall Study|LOE and other reason unspecified|1|||
37969474|NCT00516048|69656606|FG000|Overall Study|Subject Decision|0|||
37969475|NCT00516048|69656607|FG001|Overall Study|Subject Decision|2|||
37969476|NCT00516048|69656608|FG002|Overall Study|Subject Decision|0|||
37969477|NCT00617357|69656616|FG000|Overall Study|Lost to Follow-up|7|||
37969478|NCT00617357|69656616|FG000|Overall Study|Death|5|||
37779830|NCT01662648|69342763|FG001|Overall Study|LOE and other reason unspecified|0|||
37779831|NCT01662648|69342762|FG000|Overall Study|LOE and Participant non-compliant|0|||
37779832|NCT01662648|69342763|FG001|Overall Study|LOE and Participant non-compliant|1|||
37779833|NCT02556918|69342828|FG000|Overall Study|Protocol Violation|5|||
37779834|NCT02556918|69342829|FG001|Overall Study|Protocol Violation|6|||
37779835|NCT02556918|69342828|FG000|Overall Study|Withdrawal by Subject|4|||
37779836|NCT02556918|69342829|FG001|Overall Study|Withdrawal by Subject|4|||
37779837|NCT01662492|69342945|FG000|Overall Study|Other miscellaneous reasons.|1|||
37779838|NCT01662492|69342946|FG001|Overall Study|Other miscellaneous reasons.|0|||
37779839|NCT01662492|69342947|FG002|Overall Study|Other miscellaneous reasons.|1|||
37779840|NCT01662492|69342945|FG000|Overall Study|Withdrawal by Subject|0|||
37779841|NCT01662492|69342946|FG001|Overall Study|Withdrawal by Subject|0|||
37779842|NCT01662492|69342947|FG002|Overall Study|Withdrawal by Subject|1|||
37779843|NCT01662492|69342945|FG000|Overall Study|Protocol Violation|1|||
37779844|NCT01662492|69342946|FG001|Overall Study|Protocol Violation|0|||
37779845|NCT01662492|69342947|FG002|Overall Study|Protocol Violation|0|||
37779846|NCT01662492|69342945|FG000|Overall Study|Lost to Follow-up|0|||
37779847|NCT01662492|69342946|FG001|Overall Study|Lost to Follow-up|0|||
37779848|NCT01662492|69342947|FG002|Overall Study|Lost to Follow-up|2|||
37779849|NCT01662492|69342945|FG000|Overall Study|Lack of Efficacy|1|||
37779850|NCT01662492|69342946|FG001|Overall Study|Lack of Efficacy|1|||
37779851|NCT01662492|69342947|FG002|Overall Study|Lack of Efficacy|2|||
37779852|NCT02552238|69343117|FG000|Overall Study|Withdrawal by Subject|2|||
37779853|NCT02552238|69343117|FG000|Overall Study|Adverse Event|2|||
37779854|NCT01662102|69343335|FG000|Overall Study|Sponsor's decision|1|||
37779855|NCT01662102|69343336|FG001|Overall Study|Sponsor's decision|0|||
37779856|NCT02554656|69343376|FG000|Overall Study|Protocol Violation|3|||
37779857|NCT04053868|69343424|FG000|Overall Study|Withdrawal by Subject|1|||
37779858|NCT04053868|69343425|FG001|Overall Study|Withdrawal by Subject|0|||
37779859|NCT03414684|69343540|FG000|First-course Treatment|Complete response|0|||
37779860|NCT03414684|69343541|FG001|First-course Treatment|Complete response|1|||
37779861|NCT03414684|69343540|FG000|First-course Treatment|Intercurrent illness|1|||
37779862|NCT03414684|69343541|FG001|First-course Treatment|Intercurrent illness|0|||
37779863|NCT03414684|69343540|FG000|First-course Treatment|Progressive Disease|31|||
37779864|NCT03414684|69343541|FG001|First-course Treatment|Progressive Disease|32|||
37969479|NCT00617357|69656616|FG000|Overall Study|insurance concerns|2|||
37969480|NCT00617357|69656616|FG000|Overall Study|Withdrawal by Subject|1|||
37969481|NCT00617357|69656616|FG000|Overall Study|Physician Decision|1|||
37969482|NCT00420927|69656628|FG000|Period 1|Adverse Event|19|||
37969483|NCT00420927|69656629|FG001|Period 1|Adverse Event|15|||
37969484|NCT00420927|69656630|FG002|Period 1|Adverse Event|0|||
37969485|NCT00420927|69656631|FG003|Period 1|Adverse Event|0|||
37969486|NCT00420927|69656632|FG004|Period 1|Adverse Event|0|||
37779865|NCT03414684|69343540|FG000|First-course Treatment|Adverse Event|1|||
37779866|NCT03414684|69343541|FG001|First-course Treatment|Adverse Event|2|||
37779867|NCT03414684|69343540|FG000|First-course Treatment|Physician Decision|0|||
37969487|NCT00420927|69656633|FG005|Period 1|Adverse Event|0|||
37969488|NCT00420927|69656634|FG006|Period 1|Adverse Event|0|||
37691838|NCT01929226|69168131|FG001|Overall Study|Lost to Follow-up|0|||
37691839|NCT01929226|69168130|FG000|Overall Study|Withdrawal by Subject|1|||
37691840|NCT01929226|69168131|FG001|Overall Study|Withdrawal by Subject|1|||
37691841|NCT02045433|69168138|FG000|Overall Study|Withdrawal by Subject|1|||
37691842|NCT01911442|69168145|FG000|Overall Study|Adverse Event|2|||
37691843|NCT01911442|69168146|FG001|Overall Study|Adverse Event|2|||
37691844|NCT01911442|69168147|FG002|Overall Study|Adverse Event|4|||
37779868|NCT03414684|69343541|FG001|First-course Treatment|Physician Decision|1|||
37779869|NCT03414684|69343540|FG000|First-course Treatment|Withdrawal by Subject|0|||
37779870|NCT03414684|69343541|FG001|First-course Treatment|Withdrawal by Subject|1|||
37779871|NCT03414684|69343540|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
37779872|NCT03414684|69343541|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
37969489|NCT00420927|69656628|FG000|Period 1|Withdrawal by Subject|7|||
37969490|NCT00420927|69656629|FG001|Period 1|Withdrawal by Subject|12|||
37969491|NCT00420927|69656630|FG002|Period 1|Withdrawal by Subject|0|||
37969492|NCT00420927|69656631|FG003|Period 1|Withdrawal by Subject|0|||
37779873|NCT03414684|69343540|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
37779874|NCT03414684|69343541|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
37969493|NCT00420927|69656632|FG004|Period 1|Withdrawal by Subject|0|||
37969494|NCT00420927|69656633|FG005|Period 1|Withdrawal by Subject|0|||
37969495|NCT00420927|69656634|FG006|Period 1|Withdrawal by Subject|0|||
37969496|NCT00420927|69656628|FG000|Period 1|Lost to Follow-up|8|||
37969497|NCT00420927|69656629|FG001|Period 1|Lost to Follow-up|6|||
37691845|NCT01911442|69168145|FG000|Overall Study|Lack of Efficacy|1|||
37779875|NCT03414684|69343540|FG000|First-course Treatment|Still on treatment|3|||
37779876|NCT03414684|69343541|FG001|First-course Treatment|Still on treatment|0|||
37779877|NCT03414684|69343540|FG000|First-course Treatment|Never started protocol therapy|2|||
37779878|NCT03414684|69343541|FG001|First-course Treatment|Never started protocol therapy|1|||
37779879|NCT03414684|69343540|FG000|Crossover Treatment|Progressive disease|0|||
37779880|NCT03414684|69343541|FG001|Crossover Treatment|Progressive disease|12|||
37779881|NCT03414684|69343540|FG000|Crossover Treatment|Adverse Event|0|||
37779882|NCT03414684|69343541|FG001|Crossover Treatment|Adverse Event|3|||
37779883|NCT03414684|69343540|FG000|Crossover Treatment|Physician Decision|0|||
37779884|NCT03414684|69343541|FG001|Crossover Treatment|Physician Decision|1|||
37969498|NCT00420927|69656630|FG002|Period 1|Lost to Follow-up|0|||
37969499|NCT00420927|69656631|FG003|Period 1|Lost to Follow-up|0|||
37969500|NCT00420927|69656632|FG004|Period 1|Lost to Follow-up|0|||
37969501|NCT00420927|69656633|FG005|Period 1|Lost to Follow-up|0|||
37969502|NCT00420927|69656634|FG006|Period 1|Lost to Follow-up|0|||
37969503|NCT00420927|69656628|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
37969504|NCT00420927|69656629|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
37969505|NCT00420927|69656630|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
37969506|NCT00420927|69656631|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
37969507|NCT00420927|69656632|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
37969508|NCT00420927|69656633|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
37969509|NCT00420927|69656634|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
37969510|NCT00420927|69656628|FG000|Period 1|Death|2|||
37969511|NCT00420927|69656629|FG001|Period 1|Death|0|||
37969512|NCT00420927|69656630|FG002|Period 1|Death|0|||
37969513|NCT00420927|69656631|FG003|Period 1|Death|0|||
37969514|NCT00420927|69656632|FG004|Period 1|Death|0|||
37969515|NCT00420927|69656633|FG005|Period 1|Death|0|||
37969516|NCT00420927|69656634|FG006|Period 1|Death|0|||
37969517|NCT00420927|69656628|FG000|Period 1|Subject moved/relocated|0|||
37969518|NCT00420927|69656629|FG001|Period 1|Subject moved/relocated|2|||
37969519|NCT00420927|69656630|FG002|Period 1|Subject moved/relocated|0|||
37691846|NCT01911442|69168146|FG001|Overall Study|Lack of Efficacy|1|||
37691847|NCT01911442|69168147|FG002|Overall Study|Lack of Efficacy|1|||
37691848|NCT01911442|69168145|FG000|Overall Study|Lost to Follow-up|2|||
37691849|NCT01911442|69168146|FG001|Overall Study|Lost to Follow-up|0|||
37691850|NCT01911442|69168147|FG002|Overall Study|Lost to Follow-up|1|||
37691851|NCT01911442|69168145|FG000|Overall Study|Withdrawal by Subject|1|||
37691852|NCT01911442|69168146|FG001|Overall Study|Withdrawal by Subject|0|||
37691853|NCT01911442|69168147|FG002|Overall Study|Withdrawal by Subject|6|||
37691854|NCT01911442|69168145|FG000|Overall Study|Mother's Work Schedule|0|||
37691855|NCT01911442|69168146|FG001|Overall Study|Mother's Work Schedule|1|||
37691856|NCT01911442|69168147|FG002|Overall Study|Mother's Work Schedule|0|||
37691857|NCT01928758|69168161|FG000|Overall Study|Lost to Follow-up|14|||
37691858|NCT01928758|69168162|FG001|Overall Study|Lost to Follow-up|9|||
37691859|NCT01928758|69168161|FG000|Overall Study|Withdrawal by Subject|5|||
37691860|NCT01928758|69168162|FG001|Overall Study|Withdrawal by Subject|2|||
37691861|NCT01928758|69168161|FG000|Overall Study|Adverse Event|3|||
37691862|NCT01928758|69168162|FG001|Overall Study|Adverse Event|5|||
37691863|NCT01928758|69168161|FG000|Overall Study|Protocol Violation|3|||
37691864|NCT01928758|69168162|FG001|Overall Study|Protocol Violation|4|||
37691865|NCT01910116|69168171|FG000|Overall Study|Adverse Event|0|||
37691866|NCT01910116|69168172|FG001|Overall Study|Adverse Event|3|||
37691867|NCT01910116|69168171|FG000|Overall Study|Lack of Efficacy|3|||
37691868|NCT01910116|69168172|FG001|Overall Study|Lack of Efficacy|4|||
37691869|NCT01910116|69168171|FG000|Overall Study|Lost to Follow-up|1|||
37691870|NCT01910116|69168172|FG001|Overall Study|Lost to Follow-up|0|||
37691871|NCT01910116|69168171|FG000|Overall Study|Protocol Violation|1|||
37691872|NCT01910116|69168172|FG001|Overall Study|Protocol Violation|2|||
37691873|NCT01910116|69168171|FG000|Overall Study|Withdrawal by Subject|8|||
37691874|NCT01910116|69168172|FG001|Overall Study|Withdrawal by Subject|3|||
37969520|NCT00420927|69656631|FG003|Period 1|Subject moved/relocated|0|||
37969521|NCT00420927|69656632|FG004|Period 1|Subject moved/relocated|0|||
37969522|NCT00420927|69656633|FG005|Period 1|Subject moved/relocated|0|||
37969523|NCT00420927|69656634|FG006|Period 1|Subject moved/relocated|0|||
37969524|NCT00420927|69656628|FG000|Period 1|Noncompliant with study drug|1|||
37969525|NCT00420927|69656629|FG001|Period 1|Noncompliant with study drug|1|||
37969526|NCT00420927|69656630|FG002|Period 1|Noncompliant with study drug|0|||
37691875|NCT01910116|69168171|FG000|Overall Study|uncertain allocation|1|||
37691876|NCT01910116|69168172|FG001|Overall Study|uncertain allocation|3|||
37691877|NCT01910116|69168171|FG000|Overall Study|incomplete data|0|||
37691878|NCT01910116|69168172|FG001|Overall Study|incomplete data|1|||
37691879|NCT01614886|69168180|FG000|Overall Study|Adverse Event|15|||
37691880|NCT01614886|69168181|FG001|Overall Study|Adverse Event|20|||
37691881|NCT01614886|69168180|FG000|Overall Study|Withdrawal by Subject|4|||
37779885|NCT03414684|69343540|FG000|Crossover Treatment|Still on treatment|0|||
37969527|NCT00420927|69656631|FG003|Period 1|Noncompliant with study drug|0|||
37969528|NCT00420927|69656632|FG004|Period 1|Noncompliant with study drug|0|||
37969529|NCT00420927|69656633|FG005|Period 1|Noncompliant with study drug|0|||
37969530|NCT00420927|69656634|FG006|Period 1|Noncompliant with study drug|0|||
37969531|NCT00420927|69656628|FG000|Period 1|Randomization error|1|||
37969532|NCT00420927|69656629|FG001|Period 1|Randomization error|0|||
37969533|NCT00420927|69656630|FG002|Period 1|Randomization error|0|||
37969534|NCT00420927|69656631|FG003|Period 1|Randomization error|0|||
37969535|NCT00420927|69656632|FG004|Period 1|Randomization error|0|||
37969536|NCT00420927|69656633|FG005|Period 1|Randomization error|0|||
37969537|NCT00420927|69656634|FG006|Period 1|Randomization error|0|||
37969538|NCT00420927|69656628|FG000|Period 1|Suspected tuberculosis/positive test|1|||
37969539|NCT00420927|69656629|FG001|Period 1|Suspected tuberculosis/positive test|1|||
37969540|NCT00420927|69656630|FG002|Period 1|Suspected tuberculosis/positive test|0|||
37969541|NCT00420927|69656631|FG003|Period 1|Suspected tuberculosis/positive test|0|||
37969542|NCT00420927|69656632|FG004|Period 1|Suspected tuberculosis/positive test|0|||
37779886|NCT03414684|69343541|FG001|Crossover Treatment|Still on treatment|2|||
37779887|NCT02551692|69343620|FG000|Overall Study|Lost to Follow-up|0|||
37779888|NCT02551692|69343621|FG001|Overall Study|Lost to Follow-up|1|||
37779889|NCT02551692|69343622|FG002|Overall Study|Lost to Follow-up|4|||
37779890|NCT02551692|69343620|FG000|Overall Study|Withdrawal by Subject|1|||
37779891|NCT02551692|69343621|FG001|Overall Study|Withdrawal by Subject|0|||
37779892|NCT02551692|69343622|FG002|Overall Study|Withdrawal by Subject|1|||
37779893|NCT02553330|69343709|FG000|Overall Study|Study Terminated by Sponsor|2|||
37779894|NCT02553330|69343710|FG001|Overall Study|Study Terminated by Sponsor|13|||
37779895|NCT02553330|69343711|FG002|Overall Study|Study Terminated by Sponsor|12|||
37779896|NCT02553330|69343709|FG000|Overall Study|Withdrawal by Subject|3|||
37779897|NCT02553330|69343710|FG001|Overall Study|Withdrawal by Subject|19|||
37779898|NCT02553330|69343711|FG002|Overall Study|Withdrawal by Subject|21|||
37779899|NCT02553330|69343709|FG000|Overall Study|Other|0|||
37779900|NCT02553330|69343710|FG001|Overall Study|Other|1|||
37779901|NCT02553330|69343711|FG002|Overall Study|Other|0|||
37779902|NCT02553330|69343709|FG000|Overall Study|Non compliance to study treatment|0|||
37779903|NCT02553330|69343710|FG001|Overall Study|Non compliance to study treatment|1|||
37779904|NCT02553330|69343711|FG002|Overall Study|Non compliance to study treatment|0|||
37779905|NCT02553330|69343709|FG000|Overall Study|Adverse Event|0|||
37779906|NCT02553330|69343710|FG001|Overall Study|Adverse Event|1|||
37779907|NCT02553330|69343711|FG002|Overall Study|Adverse Event|0|||
37779908|NCT02553330|69343709|FG000|Overall Study|Lost to Follow-up|0|||
37779909|NCT02553330|69343710|FG001|Overall Study|Lost to Follow-up|4|||
37779910|NCT02553330|69343711|FG002|Overall Study|Lost to Follow-up|4|||
37779911|NCT02550288|69343753|FG000|Overall Study|Adverse Event|0|||
37779912|NCT02550288|69343754|FG001|Overall Study|Adverse Event|1|||
37779913|NCT02550288|69343755|FG002|Overall Study|Adverse Event|0|||
37779914|NCT02550288|69343756|FG003|Overall Study|Adverse Event|0|||
37779915|NCT02550288|69343757|FG004|Overall Study|Adverse Event|0|||
37779916|NCT02550288|69343753|FG000|Overall Study|Physician Decision|0|||
37779917|NCT02550288|69343754|FG001|Overall Study|Physician Decision|0|||
37779918|NCT02550288|69343755|FG002|Overall Study|Physician Decision|0|||
37779919|NCT02550288|69343756|FG003|Overall Study|Physician Decision|1|||
37779920|NCT02550288|69343757|FG004|Overall Study|Physician Decision|0|||
37779921|NCT02550288|69343753|FG000|Overall Study|Protocol Violation|2|||
37779922|NCT02550288|69343754|FG001|Overall Study|Protocol Violation|2|||
37779923|NCT02550288|69343755|FG002|Overall Study|Protocol Violation|1|||
37779924|NCT02550288|69343756|FG003|Overall Study|Protocol Violation|0|||
37779925|NCT02550288|69343757|FG004|Overall Study|Protocol Violation|3|||
37863946|NCT01253369|69547552|FG000|Overall Study|Death|1|||
37863947|NCT01253369|69547552|FG000|Overall Study|Progressive disease|23|||
37863948|NCT01253369|69547552|FG000|Overall Study|Not Evaluable|3|||
37863949|NCT01121913|69547556|FG000|First Intervention Period|Adverse Event|0|||
37863950|NCT01121913|69547557|FG001|First Intervention Period|Adverse Event|0|||
37863951|NCT01121913|69547558|FG002|First Intervention Period|Adverse Event|1|||
37863952|NCT01121913|69547559|FG003|First Intervention Period|Adverse Event|0|||
37863953|NCT01121913|69547556|FG000|First Washout Period|Withdrawal by Subject|1|||
37863954|NCT01121913|69547557|FG001|First Washout Period|Withdrawal by Subject|0|||
37863955|NCT01121913|69547558|FG002|First Washout Period|Withdrawal by Subject|0|||
37863956|NCT01121913|69547559|FG003|First Washout Period|Withdrawal by Subject|0|||
37779926|NCT02550288|69343753|FG000|Overall Study|Participant moved|0|||
37969543|NCT00420927|69656633|FG005|Period 1|Suspected tuberculosis/positive test|0|||
37969544|NCT00420927|69656634|FG006|Period 1|Suspected tuberculosis/positive test|0|||
37969545|NCT00420927|69656628|FG000|Period 1|Study site closure|0|||
37969546|NCT00420927|69656629|FG001|Period 1|Study site closure|1|||
37779927|NCT02550288|69343754|FG001|Overall Study|Participant moved|0|||
37779928|NCT02550288|69343755|FG002|Overall Study|Participant moved|0|||
37779929|NCT02550288|69343756|FG003|Overall Study|Participant moved|1|||
37779930|NCT02550288|69343757|FG004|Overall Study|Participant moved|0|||
37779931|NCT02550288|69343753|FG000|Overall Study|Withdrawal by Subject|0|||
37779932|NCT02550288|69343754|FG001|Overall Study|Withdrawal by Subject|0|||
37969547|NCT00420927|69656630|FG002|Period 1|Study site closure|0|||
37969548|NCT00420927|69656631|FG003|Period 1|Study site closure|0|||
37969549|NCT00420927|69656632|FG004|Period 1|Study site closure|0|||
37969550|NCT00420927|69656633|FG005|Period 1|Study site closure|0|||
37969551|NCT00420927|69656634|FG006|Period 1|Study site closure|0|||
37969552|NCT00420927|69656628|FG000|Period 1|Subject received new diagnosis|0|||
37969553|NCT00420927|69656629|FG001|Period 1|Subject received new diagnosis|2|||
37969554|NCT00420927|69656630|FG002|Period 1|Subject received new diagnosis|0|||
37969555|NCT00420927|69656631|FG003|Period 1|Subject received new diagnosis|0|||
37969556|NCT00420927|69656632|FG004|Period 1|Subject received new diagnosis|0|||
37969557|NCT00420927|69656633|FG005|Period 1|Subject received new diagnosis|0|||
37969558|NCT00420927|69656634|FG006|Period 1|Subject received new diagnosis|0|||
37969559|NCT00420927|69656628|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
37969560|NCT00420927|69656629|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
37969561|NCT00420927|69656630|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
37969562|NCT00420927|69656631|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
37969563|NCT00420927|69656632|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
37969564|NCT00420927|69656633|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
37969565|NCT00420927|69656634|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
37969566|NCT00420927|69656628|FG000|Period 1|Failed to meet entry criteria|8|||
37969567|NCT00420927|69656629|FG001|Period 1|Failed to meet entry criteria|7|||
37969568|NCT00420927|69656630|FG002|Period 1|Failed to meet entry criteria|0|||
37969569|NCT00420927|69656631|FG003|Period 1|Failed to meet entry criteria|0|||
37969570|NCT00420927|69656632|FG004|Period 1|Failed to meet entry criteria|0|||
37969571|NCT00420927|69656633|FG005|Period 1|Failed to meet entry criteria|0|||
37969572|NCT00420927|69656634|FG006|Period 1|Failed to meet entry criteria|0|||
37969573|NCT00420927|69656628|FG000|Period 1|Took prohibited medication|1|||
37969574|NCT00420927|69656629|FG001|Period 1|Took prohibited medication|3|||
37969575|NCT00420927|69656630|FG002|Period 1|Took prohibited medication|0|||
37969576|NCT00420927|69656631|FG003|Period 1|Took prohibited medication|0|||
37969577|NCT00420927|69656632|FG004|Period 1|Took prohibited medication|0|||
37969578|NCT00420927|69656633|FG005|Period 1|Took prohibited medication|0|||
37969579|NCT00420927|69656634|FG006|Period 1|Took prohibited medication|0|||
37969580|NCT00420927|69656628|FG000|Period 2|Adverse Event|0|||
37969581|NCT00420927|69656629|FG001|Period 2|Adverse Event|0|||
37969582|NCT00420927|69656630|FG002|Period 2|Adverse Event|7|||
37969583|NCT00420927|69656631|FG003|Period 2|Adverse Event|3|||
37969584|NCT00420927|69656632|FG004|Period 2|Adverse Event|17|||
37969585|NCT00420927|69656633|FG005|Period 2|Adverse Event|6|||
37969586|NCT00420927|69656634|FG006|Period 2|Adverse Event|20|||
37969587|NCT00420927|69656628|FG000|Period 2|Withdrawal by Subject|0|||
37969588|NCT00420927|69656629|FG001|Period 2|Withdrawal by Subject|0|||
37969589|NCT00420927|69656630|FG002|Period 2|Withdrawal by Subject|1|||
37969590|NCT00420927|69656631|FG003|Period 2|Withdrawal by Subject|3|||
37969591|NCT00420927|69656632|FG004|Period 2|Withdrawal by Subject|11|||
37969592|NCT00420927|69656633|FG005|Period 2|Withdrawal by Subject|2|||
37969593|NCT00420927|69656634|FG006|Period 2|Withdrawal by Subject|12|||
37969594|NCT00420927|69656628|FG000|Period 2|Lost to Follow-up|0|||
37969595|NCT00420927|69656629|FG001|Period 2|Lost to Follow-up|0|||
37969596|NCT00420927|69656630|FG002|Period 2|Lost to Follow-up|2|||
37969597|NCT00420927|69656631|FG003|Period 2|Lost to Follow-up|2|||
37969598|NCT00420927|69656632|FG004|Period 2|Lost to Follow-up|6|||
37969599|NCT00420927|69656633|FG005|Period 2|Lost to Follow-up|3|||
37969600|NCT00420927|69656634|FG006|Period 2|Lost to Follow-up|9|||
37969601|NCT00420927|69656628|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
37969602|NCT00420927|69656629|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
37969603|NCT00420927|69656630|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
37969604|NCT00420927|69656631|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
37969605|NCT00420927|69656632|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
37691882|NCT01614886|69168181|FG001|Overall Study|Withdrawal by Subject|4|||
37691883|NCT01614886|69168180|FG000|Overall Study|Death|1|||
37969606|NCT00420927|69656633|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
37969607|NCT00420927|69656634|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
37969608|NCT00420927|69656628|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
37969609|NCT00420927|69656629|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
37969610|NCT00420927|69656630|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
37969611|NCT00420927|69656631|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
37969612|NCT00420927|69656632|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
37969613|NCT00420927|69656633|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
37969614|NCT00420927|69656634|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
37969615|NCT00420927|69656628|FG000|Period 2|Subject unable to find transportation|0|||
37969616|NCT00420927|69656629|FG001|Period 2|Subject unable to find transportation|0|||
37969617|NCT00420927|69656630|FG002|Period 2|Subject unable to find transportation|0|||
37969618|NCT00420927|69656631|FG003|Period 2|Subject unable to find transportation|0|||
37969619|NCT00420927|69656632|FG004|Period 2|Subject unable to find transportation|0|||
37969620|NCT00420927|69656633|FG005|Period 2|Subject unable to find transportation|0|||
37969621|NCT00420927|69656634|FG006|Period 2|Subject unable to find transportation|1|||
37969622|NCT00420927|69656628|FG000|Period 2|Physician Decision|0|||
37969623|NCT00420927|69656629|FG001|Period 2|Physician Decision|0|||
37969624|NCT00420927|69656630|FG002|Period 2|Physician Decision|0|||
37969625|NCT00420927|69656631|FG003|Period 2|Physician Decision|0|||
37969626|NCT00420927|69656632|FG004|Period 2|Physician Decision|1|||
37969627|NCT00420927|69656633|FG005|Period 2|Physician Decision|1|||
37969628|NCT00420927|69656634|FG006|Period 2|Physician Decision|0|||
37969629|NCT00420927|69656628|FG000|Period 2|Sponsor decision|0|||
37969630|NCT00420927|69656629|FG001|Period 2|Sponsor decision|0|||
37969631|NCT00420927|69656630|FG002|Period 2|Sponsor decision|1|||
37969632|NCT00420927|69656631|FG003|Period 2|Sponsor decision|0|||
37969633|NCT00420927|69656632|FG004|Period 2|Sponsor decision|0|||
37969634|NCT00420927|69656633|FG005|Period 2|Sponsor decision|0|||
37969635|NCT00420927|69656634|FG006|Period 2|Sponsor decision|1|||
37969636|NCT00420927|69656628|FG000|Period 2|Randomization error|0|||
37969637|NCT00420927|69656629|FG001|Period 2|Randomization error|0|||
37969638|NCT00420927|69656630|FG002|Period 2|Randomization error|0|||
37969639|NCT00420927|69656631|FG003|Period 2|Randomization error|0|||
37969640|NCT00420927|69656632|FG004|Period 2|Randomization error|1|||
37969641|NCT00420927|69656633|FG005|Period 2|Randomization error|1|||
37969642|NCT00420927|69656634|FG006|Period 2|Randomization error|0|||
37969643|NCT00420927|69656628|FG000|Period 2|Noncompliant with study drug|0|||
37969644|NCT00420927|69656629|FG001|Period 2|Noncompliant with study drug|0|||
37969645|NCT00420927|69656630|FG002|Period 2|Noncompliant with study drug|0|||
37969646|NCT00420927|69656631|FG003|Period 2|Noncompliant with study drug|1|||
37969647|NCT00420927|69656632|FG004|Period 2|Noncompliant with study drug|0|||
37969648|NCT00420927|69656633|FG005|Period 2|Noncompliant with study drug|0|||
37969649|NCT00420927|69656634|FG006|Period 2|Noncompliant with study drug|2|||
37969650|NCT00420927|69656628|FG000|Period 2|Methotrexate intolerance|0|||
37969651|NCT00420927|69656629|FG001|Period 2|Methotrexate intolerance|0|||
37969652|NCT00420927|69656630|FG002|Period 2|Methotrexate intolerance|0|||
37969653|NCT00420927|69656631|FG003|Period 2|Methotrexate intolerance|0|||
37969654|NCT00420927|69656632|FG004|Period 2|Methotrexate intolerance|0|||
37969655|NCT00420927|69656633|FG005|Period 2|Methotrexate intolerance|0|||
37969656|NCT00420927|69656634|FG006|Period 2|Methotrexate intolerance|1|||
37969657|NCT00420927|69656628|FG000|Period 2|Took prohibited medication|0|||
37969658|NCT00420927|69656629|FG001|Period 2|Took prohibited medication|0|||
37969659|NCT00420927|69656630|FG002|Period 2|Took prohibited medication|0|||
37969660|NCT00420927|69656631|FG003|Period 2|Took prohibited medication|0|||
37969661|NCT00420927|69656632|FG004|Period 2|Took prohibited medication|1|||
37969662|NCT00420927|69656633|FG005|Period 2|Took prohibited medication|0|||
37969663|NCT00420927|69656634|FG006|Period 2|Took prohibited medication|0|||
37969664|NCT00573443|69656651|FG000|Double-Blind Phase|Lost to Follow-up|1|||
37969665|NCT00573443|69656652|FG001|Double-Blind Phase|Lost to Follow-up|3|||
37969666|NCT00573443|69656653|FG002|Double-Blind Phase|Lost to Follow-up|2|||
37969667|NCT00573443|69656651|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
37969668|NCT00573443|69656652|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
37969669|NCT00573443|69656653|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
37969670|NCT00573443|69656651|FG000|Double-Blind Phase|Adverse Event|1|||
37969671|NCT00573443|69656652|FG001|Double-Blind Phase|Adverse Event|5|||
37969672|NCT00573443|69656653|FG002|Double-Blind Phase|Adverse Event|0|||
37969673|NCT00573443|69656651|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
37969674|NCT00573443|69656652|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
37969675|NCT00573443|69656653|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
37969676|NCT00573443|69656651|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
37969677|NCT00573443|69656652|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
37969678|NCT00573443|69656653|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
37969679|NCT00573443|69656651|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
37969680|NCT00573443|69656652|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
37969681|NCT00573443|69656653|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
37969682|NCT00573443|69656651|FG000|Double-Blind Phase|Protocol Violation|0|||
37969683|NCT00573443|69656652|FG001|Double-Blind Phase|Protocol Violation|2|||
37969684|NCT00573443|69656653|FG002|Double-Blind Phase|Protocol Violation|1|||
37969685|NCT00573443|69656651|FG000|Double-Blind Phase|Other|0|||
37969686|NCT00573443|69656652|FG001|Double-Blind Phase|Other|2|||
37969687|NCT00573443|69656653|FG002|Double-Blind Phase|Other|3|||
37969688|NCT00573443|69656651|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
37969689|NCT00573443|69656652|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
37969690|NCT00573443|69656653|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
37969691|NCT00573443|69656651|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
37969692|NCT00573443|69656652|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
37969693|NCT00573443|69656653|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
37969694|NCT00573443|69656651|FG000|Open-Label Extension Phase|Adverse Event|3|||
37969695|NCT00573443|69656652|FG001|Open-Label Extension Phase|Adverse Event|0|||
37969696|NCT00573443|69656653|FG002|Open-Label Extension Phase|Adverse Event|0|||
37969697|NCT00573443|69656651|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
37969698|NCT00573443|69656652|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
37969699|NCT00573443|69656653|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
37969700|NCT00573443|69656651|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
37969701|NCT00573443|69656652|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
37969702|NCT00573443|69656653|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
37969703|NCT00573443|69656651|FG000|Open-Label Extension Phase|Protocol Violation|2|||
37969704|NCT00573443|69656652|FG001|Open-Label Extension Phase|Protocol Violation|0|||
37969705|NCT00573443|69656653|FG002|Open-Label Extension Phase|Protocol Violation|0|||
37969706|NCT00573443|69656651|FG000|Open-Label Extension Phase|Other|2|||
37969707|NCT00573443|69656652|FG001|Open-Label Extension Phase|Other|0|||
37969708|NCT00573443|69656653|FG002|Open-Label Extension Phase|Other|0|||
37969709|NCT00420849|69656662|FG000|Overall Study|Lack of Efficacy|154|||
37969710|NCT00420849|69656662|FG000|Overall Study|Adverse Event|107|||
37779933|NCT02550288|69343755|FG002|Overall Study|Withdrawal by Subject|0|||
37779934|NCT02550288|69343756|FG003|Overall Study|Withdrawal by Subject|1|||
37779935|NCT02550288|69343757|FG004|Overall Study|Withdrawal by Subject|0|||
37779936|NCT01662336|69343818|FG000|Overall Study|Adverse Event|1|||
37779937|NCT01662336|69343818|FG000|Overall Study|No longer on LPV/r|30|||
37779938|NCT01662336|69343818|FG000|Overall Study|Other|29|||
37779939|NCT01662336|69343818|FG000|Overall Study|Withdrawal by Subject|6|||
37779940|NCT02549352|69343837|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
37779941|NCT02549352|69343838|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
37779942|NCT02549352|69343837|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
37779943|NCT02549352|69343838|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
37779944|NCT02549352|69343837|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
37779945|NCT02549352|69343838|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
37779946|NCT02549352|69343837|FG000|12-month Follow-up|Withdrawal by Subject|4|||
37779947|NCT02549352|69343838|FG001|12-month Follow-up|Withdrawal by Subject|5|||
37779948|NCT02549352|69343837|FG000|12-month Follow-up|Lost to Follow-up|3|||
37779949|NCT02549352|69343838|FG001|12-month Follow-up|Lost to Follow-up|2|||
37779950|NCT02549352|69343837|FG000|12-month Follow-up|Death|0|||
37779951|NCT02549352|69343838|FG001|12-month Follow-up|Death|1|||
37779952|NCT02549352|69343837|FG000|12-month Follow-up|Protocol Violation|0|||
37779953|NCT02549352|69343838|FG001|12-month Follow-up|Protocol Violation|1|||
37779954|NCT02549352|69343837|FG000|12-month Follow-up|Other|1|||
37779955|NCT02549352|69343838|FG001|12-month Follow-up|Other|3|||
37779956|NCT02554890|69344015|FG000|Double-blind|Adverse Event|45|||
37779957|NCT02554890|69344016|FG001|Double-blind|Adverse Event|51|||
37779958|NCT02554890|69344015|FG000|Double-blind|Death|6|||
37779959|NCT02554890|69344016|FG001|Double-blind|Death|4|||
37779960|NCT02554890|69344015|FG000|Double-blind|Protocol Violation|1|||
37779961|NCT02554890|69344016|FG001|Double-blind|Protocol Violation|1|||
37779962|NCT02554890|69344015|FG000|Double-blind|Physician Decision|4|||
37779963|NCT02554890|69344016|FG001|Double-blind|Physician Decision|3|||
37779964|NCT02554890|69344015|FG000|Double-blind|Subject/Guardian decision|21|||
37779965|NCT02554890|69344016|FG001|Double-blind|Subject/Guardian decision|16|||
37779966|NCT02554890|69344015|FG000|Double-blind|Lost to Follow-up|7|||
37779967|NCT02554890|69344016|FG001|Double-blind|Lost to Follow-up|5|||
37779968|NCT02554890|69344015|FG000|Double-blind|Technical problems|1|||
37779969|NCT02554890|69344016|FG001|Double-blind|Technical problems|0|||
37779970|NCT02554890|69344015|FG000|Double-blind|Withdrawal by Subject|5|||
37779971|NCT02554890|69344016|FG001|Double-blind|Withdrawal by Subject|6|||
37779972|NCT02554890|69344015|FG000|Double-blind|Noncompliance with study treatment|6|||
37779973|NCT02554890|69344016|FG001|Double-blind|Noncompliance with study treatment|5|||
37779974|NCT02554890|69344015|FG000|Open-label|Adverse Event|0|||
37779975|NCT02554890|69344016|FG001|Open-label|Adverse Event|30|||
37779976|NCT02554890|69344015|FG000|Open-label|Death|0|||
37779977|NCT02554890|69344016|FG001|Open-label|Death|1|||
37779978|NCT02554890|69344015|FG000|Open-label|Physician Decision|0|||
37779979|NCT02554890|69344016|FG001|Open-label|Physician Decision|1|||
37779980|NCT02554890|69344015|FG000|Open-label|Subject/Guardian decision|0|||
37779981|NCT02554890|69344016|FG001|Open-label|Subject/Guardian decision|11|||
37969711|NCT00420849|69656662|FG000|Overall Study|Withdrawal by Subject|28|||
37691884|NCT01614886|69168181|FG001|Overall Study|Death|0|||
37691885|NCT01614886|69168180|FG000|Overall Study|Protocol deviation|0|||
37691886|NCT01614886|69168181|FG001|Overall Study|Protocol deviation|2|||
37691887|NCT01880554|69168187|FG000|Overall Study|Protocol Violation|14|||
37691888|NCT01880554|69168187|FG000|Overall Study|Simon's design requirements|2|||
37691889|NCT02100657|69168195|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
37691890|NCT02100657|69168196|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
37691891|NCT02100657|69168197|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
37691892|NCT02100657|69168195|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
37691893|NCT02100657|69168196|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
37691894|NCT02100657|69168197|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
37691895|NCT02100657|69168195|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
37691896|NCT02100657|69168196|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
37691897|NCT02100657|69168197|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
37779982|NCT02554890|69344015|FG000|Open-label|Lost to Follow-up|0|||
37779983|NCT02554890|69344016|FG001|Open-label|Lost to Follow-up|7|||
37779984|NCT02554890|69344015|FG000|Open-label|Technical problems|0|||
37779985|NCT02554890|69344016|FG001|Open-label|Technical problems|1|||
37779986|NCT02554890|69344015|FG000|Open-label|Withdrawal by Subject|0|||
37779987|NCT02554890|69344016|FG001|Open-label|Withdrawal by Subject|1|||
37779988|NCT02552316|69344033|FG000|Overall Study|Withdrawal by Subject|1|||
37779989|NCT02552316|69344033|FG000|Overall Study|Withdrawal due to non-compliance|1|||
37779990|NCT02543346|69344081|FG000|Second Priming Visit|Withdrawal by Subject|0|||
37779991|NCT02543346|69344082|FG001|Second Priming Visit|Withdrawal by Subject|2|||
37779992|NCT02543346|69344083|FG002|Second Priming Visit|Withdrawal by Subject|2|||
37779993|NCT02543346|69344084|FG003|Second Priming Visit|Withdrawal by Subject|2|||
37779994|NCT02543346|69344081|FG000|Second Priming Visit|Adverse Event|1|||
37779995|NCT02543346|69344082|FG001|Second Priming Visit|Adverse Event|0|||
37779996|NCT02543346|69344083|FG002|Second Priming Visit|Adverse Event|0|||
37779997|NCT02543346|69344084|FG003|Second Priming Visit|Adverse Event|0|||
37779998|NCT02549196|69344098|FG000|Overall Study|Protocol Violation|0|||
37779999|NCT02549196|69344099|FG001|Overall Study|Protocol Violation|0|||
37780000|NCT02549196|69344100|FG002|Overall Study|Protocol Violation|0|||
37780001|NCT02549196|69344101|FG003|Overall Study|Protocol Violation|1|||
37780002|NCT02549196|69344098|FG000|Overall Study|Withdrawal by Subject|1|||
37780003|NCT02549196|69344099|FG001|Overall Study|Withdrawal by Subject|0|||
37780004|NCT02549196|69344100|FG002|Overall Study|Withdrawal by Subject|1|||
37780005|NCT02549196|69344101|FG003|Overall Study|Withdrawal by Subject|0|||
37780006|NCT02904954|69344113|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
37780007|NCT02904954|69344114|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
37780008|NCT02904954|69344113|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
37780009|NCT02904954|69344114|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
37691898|NCT02100657|69168195|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
37691899|NCT02100657|69168196|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
37780010|NCT02904954|69344113|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
37780011|NCT02904954|69344114|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
37780012|NCT02904954|69344113|FG000|Adjuvant Durvalumab|Recurrence|2|||
37780013|NCT02904954|69344114|FG001|Adjuvant Durvalumab|Recurrence|0|||
37780014|NCT02904954|69344113|FG000|Adjuvant Durvalumab|Adverse Event|2|||
37780015|NCT02904954|69344114|FG001|Adjuvant Durvalumab|Adverse Event|6|||
37780016|NCT02904954|69344113|FG000|Adjuvant Durvalumab|Participant wishes|12|||
37780017|NCT02904954|69344114|FG001|Adjuvant Durvalumab|Participant wishes|7|||
37780018|NCT02904954|69344113|FG000|Adjuvant Durvalumab|Physician Decision|2|||
37780019|NCT02904954|69344114|FG001|Adjuvant Durvalumab|Physician Decision|1|||
37780020|NCT02904954|69344113|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
37780021|NCT02904954|69344114|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
37780022|NCT02904954|69344113|FG000|Adjuvant Durvalumab|Death|0|||
37780023|NCT02904954|69344114|FG001|Adjuvant Durvalumab|Death|1|||
37780024|NCT02904954|69344113|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
37780025|NCT02904954|69344114|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
37780026|NCT02548962|69344230|FG000|Overall Study|Withdrawal by Subject|1|||
37780027|NCT02548962|69344231|FG001|Overall Study|Withdrawal by Subject|0|||
37780028|NCT02548650|69344258|FG000|Triple Therapy|Adverse Event|1|||
37780029|NCT02548650|69344259|FG001|Triple Therapy|Adverse Event|0|||
37780030|NCT02548650|69344258|FG000|Triple Therapy|Withdrawal by Subject|0|||
37780031|NCT02548650|69344259|FG001|Triple Therapy|Withdrawal by Subject|4|||
37780032|NCT02548650|69344258|FG000|Double Therapy|Adverse Event|1|||
37780033|NCT02548650|69344259|FG001|Double Therapy|Adverse Event|1|||
37780034|NCT02548650|69344258|FG000|Double Therapy|Withdrawal by Subject|0|||
37780035|NCT02548650|69344259|FG001|Double Therapy|Withdrawal by Subject|1|||
37780036|NCT02535000|69344354|FG000|Overall Study|Cancellation of surgery.|1|||
37780037|NCT02535000|69344355|FG001|Overall Study|Cancellation of surgery.|2|||
37780038|NCT03110562|69344484|FG000|Overall Study|Withdrawal by Subject|37|||
37780039|NCT03110562|69344485|FG001|Overall Study|Withdrawal by Subject|35|||
37780040|NCT03110562|69344484|FG000|Overall Study|Death|47|||
37780041|NCT03110562|69344485|FG001|Overall Study|Death|61|||
37780042|NCT03110562|69344484|FG000|Overall Study|Lost to Follow-up|7|||
37780043|NCT03110562|69344485|FG001|Overall Study|Lost to Follow-up|6|||
37691900|NCT02100657|69168197|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
37691901|NCT02100657|69168195|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
37691902|NCT02100657|69168196|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
37691903|NCT02100657|69168197|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
37691904|NCT02100657|69168195|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
37691905|NCT02100657|69168196|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
37691906|NCT02100657|69168197|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
37780044|NCT03110562|69344484|FG000|Overall Study|Other|2|||
37780045|NCT03110562|69344485|FG001|Overall Study|Other|1|||
37780046|NCT03110562|69344484|FG000|Overall Study|Randomized but never treated|0|||
37780047|NCT03110562|69344485|FG001|Overall Study|Randomized but never treated|3|||
37780048|NCT03110562|69344484|FG000|Overall Study|Ongoing|102|||
37780049|NCT03110562|69344485|FG001|Overall Study|Ongoing|101|||
37780050|NCT02546856|69344528|FG000|4 Months Evaluation|Death|2|||
37780051|NCT02546856|69344529|FG001|4 Months Evaluation|Death|3|||
37780052|NCT02546856|69344528|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
37780053|NCT02546856|69344529|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
37780054|NCT02546856|69344528|FG000|4 Months Evaluation|Lost to Follow-up|3|||
37780055|NCT02546856|69344529|FG001|4 Months Evaluation|Lost to Follow-up|3|||
37780056|NCT02546856|69344528|FG000|4 Months Evaluation|Physician Decision|3|||
37780057|NCT02546856|69344529|FG001|4 Months Evaluation|Physician Decision|0|||
37780058|NCT02546856|69344528|FG000|4 Months Evaluation|Working or living abroad|5|||
37780059|NCT02546856|69344529|FG001|4 Months Evaluation|Working or living abroad|1|||
37780060|NCT02546856|69344528|FG000|4 Months Evaluation|reasons not due to titration|4|||
37780061|NCT02546856|69344529|FG001|4 Months Evaluation|reasons not due to titration|1|||
37780062|NCT02546856|69344528|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
37780063|NCT02546856|69344529|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
37780064|NCT02546856|69344528|FG000|6 Months Evaluation|Death|1|||
37780065|NCT02546856|69344529|FG001|6 Months Evaluation|Death|1|||
37780066|NCT02546856|69344528|FG000|6 Months Evaluation|Lost to Follow-up|1|||
37780067|NCT02546856|69344529|FG001|6 Months Evaluation|Lost to Follow-up|1|||
37780068|NCT02546856|69344528|FG000|6 Months Evaluation|Working or living abroad|6|||
37780069|NCT02546856|69344529|FG001|6 Months Evaluation|Working or living abroad|4|||
37780070|NCT02546856|69344528|FG000|6 Months Evaluation|reasons not due to titration|0|||
37780071|NCT02546856|69344529|FG001|6 Months Evaluation|reasons not due to titration|1|||
37780072|NCT02696616|69344654|FG000|Overall Study|Adverse Event|0|||
37780073|NCT02696616|69344655|FG001|Overall Study|Adverse Event|1|||
37780074|NCT02696616|69344656|FG002|Overall Study|Adverse Event|0|||
37780075|NCT02696616|69344657|FG003|Overall Study|Adverse Event|0|||
37780076|NCT02696616|69344658|FG004|Overall Study|Adverse Event|0|||
37780077|NCT02696616|69344659|FG005|Overall Study|Adverse Event|0|||
37780078|NCT02696616|69344660|FG006|Overall Study|Adverse Event|0|||
37780079|NCT01661790|69344703|FG000|Overall Study|Lost to Follow-up|0|||
37780080|NCT01661790|69344704|FG001|Overall Study|Lost to Follow-up|2|||
37780081|NCT02546544|69344724|FG000|Overall Study|Disease Progression|14|||
37780082|NCT02546544|69344724|FG000|Overall Study|Adverse Event|1|||
37780083|NCT02546544|69344724|FG000|Overall Study|Withdrawal by Subject|1|||
37780084|NCT05593211|69345015|FG000|Overall Study|Withdrawal by Subject|1|||
37780085|NCT02533674|69345354|FG000|Dose Level I|Progressive disease|1|||
37780086|NCT02533674|69345355|FG001|Dose Level I|Progressive disease|0|||
37780087|NCT02533674|69345356|FG002|Dose Level I|Progressive disease|0|||
37780088|NCT02533674|69345357|FG003|Dose Level I|Progressive disease|0|||
37780089|NCT02533674|69345358|FG004|Dose Level I|Progressive disease|0|||
37780090|NCT02533674|69345359|FG005|Dose Level I|Progressive disease|0|||
37780091|NCT02533674|69345360|FG006|Dose Level I|Progressive disease|0|||
37780092|NCT02533674|69345361|FG007|Dose Level I|Progressive disease|0|||
37780093|NCT02533674|69345354|FG000|Dose Level I|Withdrawal by Subject|1|||
37780094|NCT02533674|69345355|FG001|Dose Level I|Withdrawal by Subject|0|||
37780095|NCT02533674|69345356|FG002|Dose Level I|Withdrawal by Subject|0|||
37780096|NCT02533674|69345357|FG003|Dose Level I|Withdrawal by Subject|0|||
37780097|NCT02533674|69345358|FG004|Dose Level I|Withdrawal by Subject|0|||
37969712|NCT00420849|69656662|FG000|Overall Study|Death|18|||
37969713|NCT00420849|69656662|FG000|Overall Study|Other|14|||
37969714|NCT00420849|69656662|FG000|Overall Study|Transplant|8|||
37969715|NCT00420849|69656662|FG000|Overall Study|Protocol Violation|1|||
37969716|NCT00420849|69656662|FG000|Overall Study|Lost to Follow-up|1|||
37969717|NCT00617279|69656671|FG000|Overall Study|Study terminated by Sponsor|10|||
37969718|NCT00617279|69656672|FG001|Overall Study|Study terminated by Sponsor|15|||
37969719|NCT00617279|69656671|FG000|Overall Study|Graft abandonment|2|||
37969720|NCT00617279|69656672|FG001|Overall Study|Graft abandonment|0|||
37969721|NCT00617279|69656671|FG000|Overall Study|Lost to Follow-up|1|||
37969722|NCT00617279|69656672|FG001|Overall Study|Lost to Follow-up|0|||
37969723|NCT00617279|69656671|FG000|Overall Study|Death|1|||
37969724|NCT00617279|69656672|FG001|Overall Study|Death|2|||
37969725|NCT00420381|69656678|FG000|Overall Study|Protocol Violation|1|||
37969726|NCT00617201|69656684|FG000|Overall Study|Lost to Follow-up|9|||
37691907|NCT02100657|69168195|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
37691908|NCT02100657|69168196|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
37691909|NCT02100657|69168197|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
37691910|NCT02100657|69168195|FG000|Cohort 3: Dose Level 3|Death|0|||
37691911|NCT02100657|69168196|FG001|Cohort 3: Dose Level 3|Death|0|||
37691912|NCT02100657|69168197|FG002|Cohort 3: Dose Level 3|Death|1|||
37691913|NCT02100657|69168195|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
37691914|NCT02100657|69168196|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
37691915|NCT02100657|69168197|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
37691916|NCT02100657|69168195|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
37691917|NCT02100657|69168196|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
37780098|NCT02533674|69345359|FG005|Dose Level I|Withdrawal by Subject|0|||
37780099|NCT02533674|69345360|FG006|Dose Level I|Withdrawal by Subject|0|||
37780100|NCT02533674|69345361|FG007|Dose Level I|Withdrawal by Subject|0|||
37780101|NCT02533674|69345354|FG000|Dose Level I|Physician Decision|1|||
37780102|NCT02533674|69345355|FG001|Dose Level I|Physician Decision|0|||
37780103|NCT02533674|69345356|FG002|Dose Level I|Physician Decision|0|||
37780104|NCT02533674|69345357|FG003|Dose Level I|Physician Decision|0|||
37969727|NCT00617201|69656685|FG001|Overall Study|Lost to Follow-up|13|||
37780105|NCT02533674|69345358|FG004|Dose Level I|Physician Decision|0|||
37780106|NCT02533674|69345359|FG005|Dose Level I|Physician Decision|0|||
37780107|NCT02533674|69345360|FG006|Dose Level I|Physician Decision|0|||
37780108|NCT02533674|69345361|FG007|Dose Level I|Physician Decision|0|||
37780109|NCT02533674|69345354|FG000|Dose Level I|Death|1|||
37780110|NCT02533674|69345355|FG001|Dose Level I|Death|0|||
37780111|NCT02533674|69345356|FG002|Dose Level I|Death|0|||
37780112|NCT02533674|69345357|FG003|Dose Level I|Death|0|||
37780113|NCT02533674|69345358|FG004|Dose Level I|Death|0|||
37780114|NCT02533674|69345359|FG005|Dose Level I|Death|0|||
37780115|NCT02533674|69345360|FG006|Dose Level I|Death|0|||
37691918|NCT02100657|69168197|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
37691919|NCT02100657|69168195|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
37691920|NCT02100657|69168196|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
37691921|NCT02100657|69168197|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
37691922|NCT02100657|69168195|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
37691923|NCT02100657|69168196|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
37691924|NCT02100657|69168197|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
37691925|NCT02100657|69168195|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
37691926|NCT02100657|69168196|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
37691927|NCT02100657|69168197|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
37691928|NCT02067663|69168208|FG000|Overall Study|Lost to Follow-up|13|||
37691929|NCT02067663|69168209|FG001|Overall Study|Lost to Follow-up|14|||
37780116|NCT02533674|69345361|FG007|Dose Level I|Death|0|||
37691930|NCT01909804|69168227|FG000|Overall Study|Randomized but Never Treated|0|||
37691931|NCT01909804|69168228|FG001|Overall Study|Randomized but Never Treated|0|||
37691932|NCT01909804|69168229|FG002|Overall Study|Randomized but Never Treated|0|||
37780117|NCT02533674|69345354|FG000|Dose Level I|Never Treated|1|||
37780118|NCT02533674|69345355|FG001|Dose Level I|Never Treated|0|||
37780119|NCT02533674|69345356|FG002|Dose Level I|Never Treated|0|||
37780120|NCT02533674|69345357|FG003|Dose Level I|Never Treated|0|||
37780121|NCT02533674|69345358|FG004|Dose Level I|Never Treated|0|||
37780122|NCT02533674|69345359|FG005|Dose Level I|Never Treated|0|||
37780123|NCT02533674|69345360|FG006|Dose Level I|Never Treated|0|||
37780124|NCT02533674|69345361|FG007|Dose Level I|Never Treated|0|||
37780125|NCT02533674|69345354|FG000|Dose Level II|Progressive disease|0|||
37780126|NCT02533674|69345355|FG001|Dose Level II|Progressive disease|3|||
37780127|NCT02533674|69345356|FG002|Dose Level II|Progressive disease|0|||
37780128|NCT02533674|69345357|FG003|Dose Level II|Progressive disease|0|||
37780129|NCT02533674|69345358|FG004|Dose Level II|Progressive disease|0|||
37780130|NCT02533674|69345359|FG005|Dose Level II|Progressive disease|0|||
37780131|NCT02533674|69345360|FG006|Dose Level II|Progressive disease|0|||
37780132|NCT02533674|69345361|FG007|Dose Level II|Progressive disease|0|||
37780133|NCT02533674|69345354|FG000|Dose Level II|Withdrawal by Subject|0|||
37780134|NCT02533674|69345355|FG001|Dose Level II|Withdrawal by Subject|1|||
37780135|NCT02533674|69345356|FG002|Dose Level II|Withdrawal by Subject|0|||
37780136|NCT02533674|69345357|FG003|Dose Level II|Withdrawal by Subject|0|||
37780137|NCT02533674|69345358|FG004|Dose Level II|Withdrawal by Subject|0|||
37780138|NCT02533674|69345359|FG005|Dose Level II|Withdrawal by Subject|0|||
37780139|NCT02533674|69345360|FG006|Dose Level II|Withdrawal by Subject|0|||
37780140|NCT02533674|69345361|FG007|Dose Level II|Withdrawal by Subject|0|||
37780141|NCT02533674|69345354|FG000|Dose Level II|Treatment-related AE|0|||
37780142|NCT02533674|69345355|FG001|Dose Level II|Treatment-related AE|1|||
37780143|NCT02533674|69345356|FG002|Dose Level II|Treatment-related AE|0|||
37780144|NCT02533674|69345357|FG003|Dose Level II|Treatment-related AE|0|||
37780145|NCT02533674|69345358|FG004|Dose Level II|Treatment-related AE|0|||
37780146|NCT02533674|69345359|FG005|Dose Level II|Treatment-related AE|0|||
37780147|NCT02533674|69345360|FG006|Dose Level II|Treatment-related AE|0|||
37780148|NCT02533674|69345361|FG007|Dose Level II|Treatment-related AE|0|||
37780149|NCT02533674|69345354|FG000|Dose Level II|Physician Decision|0|||
37691933|NCT01909804|69168230|FG003|Overall Study|Randomized but Never Treated|0|||
37691934|NCT01909804|69168231|FG004|Overall Study|Randomized but Never Treated|0|||
37691935|NCT01909804|69168232|FG005|Overall Study|Randomized but Never Treated|0|||
37691936|NCT01909804|69168233|FG006|Overall Study|Randomized but Never Treated|1|||
37691937|NCT01909804|69168234|FG007|Overall Study|Randomized but Never Treated|0|||
37691938|NCT01909804|69168235|FG008|Overall Study|Randomized but Never Treated|0|||
37691939|NCT01909804|69168236|FG009|Overall Study|Randomized but Never Treated|0|||
37691940|NCT01909804|69168237|FG010|Overall Study|Randomized but Never Treated|0|||
37691941|NCT01909804|69168238|FG011|Overall Study|Randomized but Never Treated|1|||
37691942|NCT01909804|69168227|FG000|Overall Study|Death|0|||
37780150|NCT02533674|69345355|FG001|Dose Level II|Physician Decision|1|||
37780151|NCT02533674|69345356|FG002|Dose Level II|Physician Decision|0|||
37780152|NCT02533674|69345357|FG003|Dose Level II|Physician Decision|0|||
37780153|NCT02533674|69345358|FG004|Dose Level II|Physician Decision|0|||
37780154|NCT02533674|69345359|FG005|Dose Level II|Physician Decision|0|||
37780155|NCT02533674|69345360|FG006|Dose Level II|Physician Decision|0|||
37780156|NCT02533674|69345361|FG007|Dose Level II|Physician Decision|0|||
37969728|NCT00420303|69656695|FG000|Overall Study|Serious Adverse Event|1|||
37969729|NCT00420303|69656696|FG001|Overall Study|Serious Adverse Event|0|||
37969730|NCT00420303|69656695|FG000|Overall Study|Lack of Efficacy|0|||
37969731|NCT00420303|69656696|FG001|Overall Study|Lack of Efficacy|3|||
37969732|NCT00420303|69656695|FG000|Overall Study|Physician Decision|0|||
37969733|NCT00420303|69656696|FG001|Overall Study|Physician Decision|1|||
37969734|NCT00617123|69656704|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
37969735|NCT00617123|69656705|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
37969736|NCT00617123|69656704|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
37969737|NCT00617123|69656705|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
37969738|NCT00617123|69656704|FG000|Referral Screening Period|Adverse Event|0|||
37969739|NCT00617123|69656705|FG001|Referral Screening Period|Adverse Event|1|||
37969740|NCT00617123|69656704|FG000|Study Treatment Period|Withdrawal by Subject|8|||
37969741|NCT00617123|69656705|FG001|Study Treatment Period|Withdrawal by Subject|12|||
37969742|NCT00617123|69656704|FG000|Study Treatment Period|Adverse Event|7|||
37969743|NCT00617123|69656705|FG001|Study Treatment Period|Adverse Event|3|||
37969744|NCT00617123|69656704|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
37969745|NCT00617123|69656705|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
37969746|NCT00617123|69656704|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
37969747|NCT00617123|69656705|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
37969748|NCT00419757|69656713|FG000|Overall Study|Adverse Event|1|||
37969749|NCT00419757|69656714|FG001|Overall Study|Adverse Event|4|||
37969750|NCT00419757|69656713|FG000|Overall Study|Lost to Follow-up|1|||
37969751|NCT00419757|69656714|FG001|Overall Study|Lost to Follow-up|4|||
37969752|NCT00419757|69656713|FG000|Overall Study|Withdrawal by Subject|7|||
37969753|NCT00419757|69656714|FG001|Overall Study|Withdrawal by Subject|1|||
37969754|NCT00419757|69656713|FG000|Overall Study|Protocol Violation|2|||
37969755|NCT00419757|69656714|FG001|Overall Study|Protocol Violation|3|||
37969756|NCT00419757|69656713|FG000|Overall Study|Study specific discontinuation criteria|4|||
37969757|NCT00419757|69656714|FG001|Overall Study|Study specific discontinuation criteria|8|||
37969758|NCT00419757|69656713|FG000|Overall Study|Multiple reasons|3|||
37969759|NCT00419757|69656714|FG001|Overall Study|Multiple reasons|1|||
37863957|NCT01121913|69547556|FG000|Second Intervention Period|Adverse Event|0|||
37691943|NCT01909804|69168228|FG001|Overall Study|Death|0|||
37691944|NCT01909804|69168229|FG002|Overall Study|Death|0|||
37691945|NCT01909804|69168230|FG003|Overall Study|Death|0|||
37691946|NCT01909804|69168231|FG004|Overall Study|Death|0|||
37691947|NCT01909804|69168232|FG005|Overall Study|Death|0|||
37691948|NCT01909804|69168233|FG006|Overall Study|Death|0|||
37691949|NCT01909804|69168234|FG007|Overall Study|Death|0|||
37863958|NCT01121913|69547557|FG001|Second Intervention Period|Adverse Event|0|||
37969760|NCT00434109|69656722|FG000|Overall Study|Physician Decision|9|||
37969761|NCT00434109|69656722|FG000|Overall Study|Adverse Event|5|||
37969762|NCT00434109|69656722|FG000|Overall Study|Protocol Violation|1|||
37969763|NCT00434109|69656722|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
37969764|NCT00433329|69656726|FG000|Overall Study|Adverse Event|9|||
37969765|NCT00433329|69656726|FG000|Overall Study|Death|4|||
37691950|NCT01909804|69168235|FG008|Overall Study|Death|0|||
37969766|NCT00433329|69656726|FG000|Overall Study|Withdrew consent|3|||
37969767|NCT00433329|69656726|FG000|Overall Study|Discontinued sildenafil|2|||
37969768|NCT00433329|69656726|FG000|Overall Study|Moved out of state|1|||
37969769|NCT00433329|69656726|FG000|Overall Study|Lost to Follow-up|1|||
37969770|NCT00433329|69656726|FG000|Overall Study|Physician Decision|1|||
37969771|NCT00616421|69656733|FG000|Overall Study|Withdrawal by Subject|9|||
37969772|NCT00616421|69656734|FG001|Overall Study|Withdrawal by Subject|11|||
37969773|NCT00616421|69656735|FG002|Overall Study|Withdrawal by Subject|8|||
37780157|NCT02533674|69345354|FG000|Dose Level II|Non-treatment-related AE|0|||
37969774|NCT00616421|69656733|FG000|Overall Study|Lost to Follow-up|12|||
37969775|NCT00616421|69656734|FG001|Overall Study|Lost to Follow-up|26|||
37969776|NCT00616421|69656735|FG002|Overall Study|Lost to Follow-up|30|||
37969777|NCT00616421|69656733|FG000|Overall Study|Inappropriate enrollment|3|||
37969778|NCT00616421|69656734|FG001|Overall Study|Inappropriate enrollment|0|||
37969779|NCT00616421|69656735|FG002|Overall Study|Inappropriate enrollment|1|||
37969780|NCT00616421|69656733|FG000|Overall Study|Administrative reason|1|||
37969781|NCT00616421|69656734|FG001|Overall Study|Administrative reason|0|||
37969782|NCT00616421|69656735|FG002|Overall Study|Administrative reason|0|||
37969783|NCT00616421|69656733|FG000|Overall Study|Protocol Violation|0|||
37969784|NCT00616421|69656734|FG001|Overall Study|Protocol Violation|1|||
37969785|NCT00616421|69656735|FG002|Overall Study|Protocol Violation|2|||
37969786|NCT00616421|69656733|FG000|Overall Study|Unable to classify|1|||
37969787|NCT00616421|69656734|FG001|Overall Study|Unable to classify|0|||
37969788|NCT00616421|69656735|FG002|Overall Study|Unable to classify|0|||
37969789|NCT00433017|69656759|FG000|Overall Study|Adverse Event|5|||
37969790|NCT00433017|69656760|FG001|Overall Study|Adverse Event|3|||
37969791|NCT00433017|69656759|FG000|Overall Study|Withdrawal by Subject|4|||
37969792|NCT00433017|69656760|FG001|Overall Study|Withdrawal by Subject|5|||
37969793|NCT00433017|69656759|FG000|Overall Study|Lost to Follow-up|3|||
37969794|NCT00433017|69656760|FG001|Overall Study|Lost to Follow-up|4|||
37969795|NCT00433017|69656759|FG000|Overall Study|Administrative problems|80|||
37969796|NCT00433017|69656760|FG001|Overall Study|Administrative problems|86|||
37969797|NCT00433017|69656759|FG000|Overall Study|Protocol Violation|1|||
37969798|NCT00433017|69656760|FG001|Overall Study|Protocol Violation|0|||
37969799|NCT00433017|69656759|FG000|Overall Study|Death|2|||
37969800|NCT00433017|69656760|FG001|Overall Study|Death|2|||
37969801|NCT00433017|69656759|FG000|Overall Study|Subject no longer requires study drug|1|||
37969802|NCT00433017|69656760|FG001|Overall Study|Subject no longer requires study drug|1|||
37969803|NCT00615719|69656792|FG000|Overall Study|Physician Decision|5|||
37969804|NCT00418665|69656799|FG000|Treatment Period|Ineligibility determined|1|||
37969805|NCT00418665|69656800|FG001|Treatment Period|Ineligibility determined|1|||
37969806|NCT00418665|69656801|FG002|Treatment Period|Ineligibility determined|0|||
37969807|NCT00418665|69656799|FG000|Treatment Period|Adverse Event|2|||
37969808|NCT00418665|69656800|FG001|Treatment Period|Adverse Event|2|||
37969809|NCT00418665|69656801|FG002|Treatment Period|Adverse Event|0|||
37969810|NCT00418665|69656799|FG000|Treatment Period|Withdrawal by Subject|0|||
37969811|NCT00418665|69656800|FG001|Treatment Period|Withdrawal by Subject|3|||
37969812|NCT00418665|69656801|FG002|Treatment Period|Withdrawal by Subject|1|||
37969813|NCT00418665|69656799|FG000|Treatment Period|Requirement for alternative therapy|1|||
37969814|NCT00418665|69656800|FG001|Treatment Period|Requirement for alternative therapy|0|||
37969815|NCT00418665|69656801|FG002|Treatment Period|Requirement for alternative therapy|0|||
37969816|NCT00418665|69656799|FG000|Treatment Period|Physician Decision|1|||
37969817|NCT00418665|69656800|FG001|Treatment Period|Physician Decision|0|||
37969818|NCT00418665|69656801|FG002|Treatment Period|Physician Decision|3|||
37969819|NCT00418665|69656799|FG000|Treatment Extension|Adverse Event|1|||
37969820|NCT00418665|69656800|FG001|Treatment Extension|Adverse Event|0|||
37969821|NCT00418665|69656801|FG002|Treatment Extension|Adverse Event|0|||
37691951|NCT01909804|69168236|FG009|Overall Study|Death|0|||
37691952|NCT01909804|69168237|FG010|Overall Study|Death|1|||
37691953|NCT01909804|69168238|FG011|Overall Study|Death|0|||
37691954|NCT01909804|69168227|FG000|Overall Study|Lack of Efficacy|4|||
37969822|NCT00418665|69656799|FG000|Treatment Extension|Withdrawal by Subject|1|||
37969823|NCT00418665|69656800|FG001|Treatment Extension|Withdrawal by Subject|0|||
37969824|NCT00418665|69656801|FG002|Treatment Extension|Withdrawal by Subject|0|||
37969825|NCT00418665|69656799|FG000|Treatment Extension|Requirement for alternative therapy|2|||
37969826|NCT00418665|69656800|FG001|Treatment Extension|Requirement for alternative therapy|2|||
37969827|NCT00418665|69656801|FG002|Treatment Extension|Requirement for alternative therapy|0|||
37969828|NCT00418665|69656799|FG000|Treatment Extension|Physician Decision|2|||
37969829|NCT00418665|69656800|FG001|Treatment Extension|Physician Decision|2|||
37969830|NCT00418665|69656801|FG002|Treatment Extension|Physician Decision|1|||
37969831|NCT00418665|69656799|FG000|Treatment Extension|Death|0|||
37969832|NCT00418665|69656800|FG001|Treatment Extension|Death|0|||
37969833|NCT00418665|69656801|FG002|Treatment Extension|Death|1|||
37969834|NCT00432237|69656813|FG000|Overall Study|Adverse Event|0|||
37969835|NCT00432237|69656814|FG001|Overall Study|Adverse Event|0|||
37969836|NCT00432237|69656815|FG002|Overall Study|Adverse Event|0|||
37780158|NCT02533674|69345355|FG001|Dose Level II|Non-treatment-related AE|1|||
37863959|NCT01121913|69547558|FG002|Second Intervention Period|Adverse Event|1|||
37863960|NCT01121913|69547559|FG003|Second Intervention Period|Adverse Event|0|||
37969837|NCT00432237|69656816|FG003|Overall Study|Adverse Event|1|||
37969838|NCT00432237|69656813|FG000|Overall Study|Lack of Efficacy|0|||
37969839|NCT00432237|69656814|FG001|Overall Study|Lack of Efficacy|0|||
37969840|NCT00432237|69656815|FG002|Overall Study|Lack of Efficacy|0|||
37969841|NCT00432237|69656816|FG003|Overall Study|Lack of Efficacy|1|||
37969842|NCT00432237|69656813|FG000|Overall Study|Lost to Follow-up|10|||
37969843|NCT00432237|69656814|FG001|Overall Study|Lost to Follow-up|10|||
37969844|NCT00432237|69656815|FG002|Overall Study|Lost to Follow-up|18|||
37969845|NCT00432237|69656816|FG003|Overall Study|Lost to Follow-up|18|||
37969846|NCT00432237|69656813|FG000|Overall Study|Physician Decision|1|||
37969847|NCT00432237|69656814|FG001|Overall Study|Physician Decision|3|||
37969848|NCT00432237|69656815|FG002|Overall Study|Physician Decision|2|||
37969849|NCT00432237|69656816|FG003|Overall Study|Physician Decision|1|||
37969850|NCT00432237|69656813|FG000|Overall Study|Pregnancy|0|||
37969851|NCT00432237|69656814|FG001|Overall Study|Pregnancy|1|||
37969852|NCT00432237|69656815|FG002|Overall Study|Pregnancy|0|||
37969853|NCT00432237|69656816|FG003|Overall Study|Pregnancy|0|||
37969854|NCT00432237|69656813|FG000|Overall Study|Protocol Violation|13|||
37969855|NCT00432237|69656814|FG001|Overall Study|Protocol Violation|10|||
37969856|NCT00432237|69656815|FG002|Overall Study|Protocol Violation|11|||
37969857|NCT00432237|69656816|FG003|Overall Study|Protocol Violation|8|||
37969858|NCT00432237|69656813|FG000|Overall Study|Withdrawal by Subject|5|||
37969859|NCT00432237|69656814|FG001|Overall Study|Withdrawal by Subject|6|||
37969860|NCT00432237|69656815|FG002|Overall Study|Withdrawal by Subject|9|||
37969861|NCT00432237|69656816|FG003|Overall Study|Withdrawal by Subject|11|||
37969862|NCT00432237|69656813|FG000|Overall Study|Lack of Qualifying Event|38|||
37969863|NCT00432237|69656814|FG001|Overall Study|Lack of Qualifying Event|71|||
37969864|NCT00432237|69656815|FG002|Overall Study|Lack of Qualifying Event|69|||
37969865|NCT00432237|69656816|FG003|Overall Study|Lack of Qualifying Event|84|||
37969866|NCT00531284|69656843|FG000|Overall Study|Progressive Disease|1|||
37969867|NCT00531284|69656844|FG001|Overall Study|Progressive Disease|3|||
37969868|NCT00531284|69656845|FG002|Overall Study|Progressive Disease|5|||
37969869|NCT00531284|69656846|FG003|Overall Study|Progressive Disease|42|||
37969870|NCT00531284|69656847|FG004|Overall Study|Progressive Disease|4|||
37969871|NCT00531284|69656848|FG005|Overall Study|Progressive Disease|4|||
37969872|NCT00531284|69656849|FG006|Overall Study|Progressive Disease|3|||
37969873|NCT00531284|69656850|FG007|Overall Study|Progressive Disease|8|||
37969874|NCT00531284|69656851|FG008|Overall Study|Progressive Disease|6|||
37969875|NCT00531284|69656852|FG009|Overall Study|Progressive Disease|3|||
37969876|NCT00531284|69656853|FG010|Overall Study|Progressive Disease|3|||
37691955|NCT01909804|69168228|FG001|Overall Study|Lack of Efficacy|1|||
37780159|NCT02533674|69345356|FG002|Dose Level II|Non-treatment-related AE|0|||
37780160|NCT02533674|69345357|FG003|Dose Level II|Non-treatment-related AE|0|||
37969877|NCT00531284|69656854|FG011|Overall Study|Progressive Disease|14|||
37969878|NCT00531284|69656855|FG012|Overall Study|Progressive Disease|2|||
37969879|NCT00531284|69656856|FG013|Overall Study|Progressive Disease|1|||
37969880|NCT00531284|69656857|FG014|Overall Study|Progressive Disease|2|||
37969881|NCT00531284|69656858|FG015|Overall Study|Progressive Disease|11|||
37969882|NCT00531284|69656859|FG016|Overall Study|Progressive Disease|5|||
37969883|NCT00531284|69656843|FG000|Overall Study|Adverse Event|0|||
37969884|NCT00531284|69656844|FG001|Overall Study|Adverse Event|1|||
37969885|NCT00531284|69656845|FG002|Overall Study|Adverse Event|1|||
37969886|NCT00531284|69656846|FG003|Overall Study|Adverse Event|7|||
37969887|NCT00531284|69656847|FG004|Overall Study|Adverse Event|0|||
37969888|NCT00531284|69656848|FG005|Overall Study|Adverse Event|2|||
37969889|NCT00531284|69656849|FG006|Overall Study|Adverse Event|3|||
37780161|NCT02533674|69345358|FG004|Dose Level II|Non-treatment-related AE|0|||
37780162|NCT02533674|69345359|FG005|Dose Level II|Non-treatment-related AE|0|||
37780163|NCT02533674|69345360|FG006|Dose Level II|Non-treatment-related AE|0|||
37780164|NCT02533674|69345361|FG007|Dose Level II|Non-treatment-related AE|0|||
37780165|NCT02533674|69345354|FG000|Dose Level III|Progressive disease|0|||
37780166|NCT02533674|69345355|FG001|Dose Level III|Progressive disease|0|||
37780167|NCT02533674|69345356|FG002|Dose Level III|Progressive disease|2|||
37780168|NCT02533674|69345357|FG003|Dose Level III|Progressive disease|0|||
37780169|NCT02533674|69345358|FG004|Dose Level III|Progressive disease|0|||
37780170|NCT02533674|69345359|FG005|Dose Level III|Progressive disease|0|||
37969890|NCT00531284|69656850|FG007|Overall Study|Adverse Event|2|||
37969891|NCT00531284|69656851|FG008|Overall Study|Adverse Event|3|||
37969892|NCT00531284|69656852|FG009|Overall Study|Adverse Event|0|||
37691956|NCT01909804|69168229|FG002|Overall Study|Lack of Efficacy|0|||
37691957|NCT01909804|69168230|FG003|Overall Study|Lack of Efficacy|0|||
37691958|NCT01909804|69168231|FG004|Overall Study|Lack of Efficacy|7|||
37691959|NCT01909804|69168232|FG005|Overall Study|Lack of Efficacy|3|||
37691960|NCT01909804|69168233|FG006|Overall Study|Lack of Efficacy|1|||
37691961|NCT01909804|69168234|FG007|Overall Study|Lack of Efficacy|1|||
37691962|NCT01909804|69168235|FG008|Overall Study|Lack of Efficacy|0|||
37691963|NCT01909804|69168236|FG009|Overall Study|Lack of Efficacy|1|||
37691964|NCT01909804|69168237|FG010|Overall Study|Lack of Efficacy|0|||
37691965|NCT01909804|69168238|FG011|Overall Study|Lack of Efficacy|1|||
37691966|NCT01909804|69168227|FG000|Overall Study|Withdrew Consent|0|||
37691967|NCT01909804|69168228|FG001|Overall Study|Withdrew Consent|0|||
37780171|NCT02533674|69345360|FG006|Dose Level III|Progressive disease|0|||
37969893|NCT00531284|69656853|FG010|Overall Study|Adverse Event|0|||
37969894|NCT00531284|69656854|FG011|Overall Study|Adverse Event|5|||
37969895|NCT00531284|69656855|FG012|Overall Study|Adverse Event|0|||
37969896|NCT00531284|69656856|FG013|Overall Study|Adverse Event|1|||
37969897|NCT00531284|69656857|FG014|Overall Study|Adverse Event|1|||
37780172|NCT02533674|69345361|FG007|Dose Level III|Progressive disease|0|||
37969898|NCT00531284|69656858|FG015|Overall Study|Adverse Event|0|||
37969899|NCT00531284|69656859|FG016|Overall Study|Adverse Event|2|||
37969900|NCT00531284|69656843|FG000|Overall Study|Withdrawal by Subject|1|||
37969901|NCT00531284|69656844|FG001|Overall Study|Withdrawal by Subject|0|||
37969902|NCT00531284|69656845|FG002|Overall Study|Withdrawal by Subject|0|||
37969903|NCT00531284|69656846|FG003|Overall Study|Withdrawal by Subject|4|||
37969904|NCT00531284|69656847|FG004|Overall Study|Withdrawal by Subject|0|||
37969905|NCT00531284|69656848|FG005|Overall Study|Withdrawal by Subject|0|||
37969906|NCT00531284|69656849|FG006|Overall Study|Withdrawal by Subject|0|||
37969907|NCT00531284|69656850|FG007|Overall Study|Withdrawal by Subject|0|||
37969908|NCT00531284|69656851|FG008|Overall Study|Withdrawal by Subject|0|||
37969909|NCT00531284|69656852|FG009|Overall Study|Withdrawal by Subject|0|||
37969910|NCT00531284|69656853|FG010|Overall Study|Withdrawal by Subject|0|||
37969911|NCT00531284|69656854|FG011|Overall Study|Withdrawal by Subject|3|||
37969912|NCT00531284|69656855|FG012|Overall Study|Withdrawal by Subject|0|||
37969913|NCT00531284|69656856|FG013|Overall Study|Withdrawal by Subject|1|||
37969914|NCT00531284|69656857|FG014|Overall Study|Withdrawal by Subject|0|||
37969915|NCT00531284|69656858|FG015|Overall Study|Withdrawal by Subject|1|||
37969916|NCT00531284|69656859|FG016|Overall Study|Withdrawal by Subject|1|||
37969917|NCT00531284|69656843|FG000|Overall Study|Other|1|||
37969918|NCT00531284|69656844|FG001|Overall Study|Other|0|||
37969919|NCT00531284|69656845|FG002|Overall Study|Other|0|||
37969920|NCT00531284|69656846|FG003|Overall Study|Other|10|||
37969921|NCT00531284|69656847|FG004|Overall Study|Other|2|||
37969922|NCT00531284|69656848|FG005|Overall Study|Other|1|||
37969923|NCT00531284|69656849|FG006|Overall Study|Other|0|||
37969924|NCT00531284|69656850|FG007|Overall Study|Other|0|||
37969925|NCT00531284|69656851|FG008|Overall Study|Other|2|||
37969926|NCT00531284|69656852|FG009|Overall Study|Other|1|||
37969927|NCT00531284|69656853|FG010|Overall Study|Other|0|||
37969928|NCT00531284|69656854|FG011|Overall Study|Other|2|||
37969929|NCT00531284|69656855|FG012|Overall Study|Other|0|||
37969930|NCT00531284|69656856|FG013|Overall Study|Other|0|||
37969931|NCT00531284|69656857|FG014|Overall Study|Other|1|||
37969932|NCT00531284|69656858|FG015|Overall Study|Other|0|||
37969933|NCT00531284|69656859|FG016|Overall Study|Other|0|||
37969934|NCT00531206|69656915|FG000|Overall Study|Adverse Event related|5|||
37969935|NCT00531206|69656915|FG000|Overall Study|Lack of Efficacy|2|||
37969936|NCT00531206|69656915|FG000|Overall Study|Lost to Follow-up|5|||
37969937|NCT00531206|69656915|FG000|Overall Study|including non-related adverse events|8|||
37969938|NCT00530816|69656922|FG000|Overall Study|Progressive Disease|16|||
37969939|NCT00530816|69656923|FG001|Overall Study|Progressive Disease|24|||
37969940|NCT00530816|69656924|FG002|Overall Study|Progressive Disease|24|||
37969941|NCT00530816|69656922|FG000|Overall Study|Adverse Event|6|||
37969942|NCT00530816|69656923|FG001|Overall Study|Adverse Event|13|||
37969943|NCT00530816|69656924|FG002|Overall Study|Adverse Event|7|||
37969944|NCT00530816|69656922|FG000|Overall Study|Other|3|||
37969945|NCT00530816|69656923|FG001|Overall Study|Other|3|||
37780173|NCT02533674|69345354|FG000|Dose Level III|Withdrawal by Subject|0|||
37780174|NCT02533674|69345355|FG001|Dose Level III|Withdrawal by Subject|0|||
37969946|NCT00530816|69656924|FG002|Overall Study|Other|4|||
37969947|NCT00530816|69656922|FG000|Overall Study|Withdrawal by Subject|1|||
37969948|NCT00530816|69656923|FG001|Overall Study|Withdrawal by Subject|2|||
37969949|NCT00530816|69656924|FG002|Overall Study|Withdrawal by Subject|6|||
37969950|NCT00615017|69656938|FG000|Overall Study|Adverse Event|0|||
37969951|NCT00615017|69656939|FG001|Overall Study|Adverse Event|1|||
37969952|NCT00615017|69656940|FG002|Overall Study|Adverse Event|2|||
37969953|NCT00615017|69656941|FG003|Overall Study|Adverse Event|0|||
37969954|NCT00615017|69656942|FG004|Overall Study|Adverse Event|0|||
37969955|NCT00615017|69656943|FG005|Overall Study|Adverse Event|1|||
37969956|NCT00615017|69656938|FG000|Overall Study|Death|0|||
37969957|NCT00615017|69656939|FG001|Overall Study|Death|0|||
37780175|NCT02533674|69345356|FG002|Dose Level III|Withdrawal by Subject|1|||
37969958|NCT00615017|69656940|FG002|Overall Study|Death|2|||
37969959|NCT00615017|69656941|FG003|Overall Study|Death|0|||
37969960|NCT00615017|69656942|FG004|Overall Study|Death|1|||
37969961|NCT00615017|69656943|FG005|Overall Study|Death|1|||
37969962|NCT00615017|69656938|FG000|Overall Study|Sepsis resolved|0|||
37969963|NCT00615017|69656939|FG001|Overall Study|Sepsis resolved|0|||
37969964|NCT00615017|69656940|FG002|Overall Study|Sepsis resolved|1|||
37969965|NCT00615017|69656941|FG003|Overall Study|Sepsis resolved|0|||
37969966|NCT00615017|69656942|FG004|Overall Study|Sepsis resolved|0|||
37969967|NCT00615017|69656943|FG005|Overall Study|Sepsis resolved|0|||
37969968|NCT00615017|69656938|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
37969969|NCT00615017|69656939|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
37969970|NCT00615017|69656940|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
37969971|NCT00615017|69656941|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
37780176|NCT02533674|69345357|FG003|Dose Level III|Withdrawal by Subject|0|||
37780177|NCT02533674|69345358|FG004|Dose Level III|Withdrawal by Subject|0|||
37780178|NCT02533674|69345359|FG005|Dose Level III|Withdrawal by Subject|0|||
37780179|NCT02533674|69345360|FG006|Dose Level III|Withdrawal by Subject|0|||
37780180|NCT02533674|69345361|FG007|Dose Level III|Withdrawal by Subject|0|||
37780181|NCT02533674|69345354|FG000|Dose Level III|Treatment-related AE|0|||
37780182|NCT02533674|69345355|FG001|Dose Level III|Treatment-related AE|0|||
37969972|NCT00615017|69656942|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
37969973|NCT00615017|69656943|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
37969974|NCT00615017|69656938|FG000|Overall Study|Physician discontinued drug|0|||
37969975|NCT00615017|69656939|FG001|Overall Study|Physician discontinued drug|0|||
37969976|NCT00615017|69656940|FG002|Overall Study|Physician discontinued drug|0|||
37969977|NCT00615017|69656941|FG003|Overall Study|Physician discontinued drug|0|||
37969978|NCT00615017|69656942|FG004|Overall Study|Physician discontinued drug|0|||
37969979|NCT00615017|69656943|FG005|Overall Study|Physician discontinued drug|1|||
37969980|NCT00614939|69656959|FG000|Overall Study|Withdrawal by Subject|10|||
37969981|NCT00614939|69656960|FG001|Overall Study|Withdrawal by Subject|17|||
37969982|NCT00614939|69656959|FG000|Overall Study|Study specific discontinuation criteris|13|||
37969983|NCT00614939|69656960|FG001|Overall Study|Study specific discontinuation criteris|16|||
37969984|NCT00614939|69656959|FG000|Overall Study|Adverse Event|2|||
37969985|NCT00614939|69656960|FG001|Overall Study|Adverse Event|5|||
37969986|NCT00614939|69656959|FG000|Overall Study|Incorrect enrollment|1|||
37969987|NCT00614939|69656960|FG001|Overall Study|Incorrect enrollment|2|||
37969988|NCT00614939|69656959|FG000|Overall Study|Death|4|||
37969989|NCT00614939|69656960|FG001|Overall Study|Death|3|||
37969990|NCT00614939|69656959|FG000|Overall Study|Poor/non-compliance|4|||
37969991|NCT00614939|69656960|FG001|Overall Study|Poor/non-compliance|0|||
37969992|NCT00614939|69656959|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
37969993|NCT00614939|69656960|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
37969994|NCT00530504|69656966|FG000|Overall Study|Death|54|||
37969995|NCT00530504|69656966|FG000|Overall Study|Lost to Follow-up|26|||
37969996|NCT00530504|69656966|FG000|Overall Study|Withdrawal by Subject|39|||
37969997|NCT00530504|69656966|FG000|Overall Study|Exited study due to other reasons|33|||
37969998|NCT04720664|69656996|FG000|Overall Study|Adverse Event|2|||
37969999|NCT04720664|69656996|FG000|Overall Study|Lack of Efficacy|9|||
37970000|NCT04371198|69657009|FG000|Overall Study|inadequate sample|4|||
37970001|NCT04288154|69657015|FG000|Overall Study|Withdrawal by Subject|9|||
37970002|NCT04288154|69657016|FG001|Overall Study|Withdrawal by Subject|9|||
37970003|NCT04258579|69657022|FG000|Overall Study|Withdrawal by Subject|7|||
37970004|NCT04258579|69657022|FG000|Overall Study|Lost to Follow-up|3|||
37780183|NCT02533674|69345356|FG002|Dose Level III|Treatment-related AE|1|||
37970005|NCT04258579|69657022|FG000|Overall Study|Protocol Violation|2|||
37970006|NCT04258579|69657022|FG000|Overall Study|Adverse Event|1|||
37970007|NCT03945214|69657030|FG000|Overall Study|Lost to Follow-up|3|||
37970008|NCT03945214|69657031|FG001|Overall Study|Lost to Follow-up|4|||
37970009|NCT03945214|69657032|FG002|Overall Study|Lost to Follow-up|7|||
37970010|NCT03945214|69657033|FG003|Overall Study|Lost to Follow-up|4|||
37970011|NCT03829683|69657045|FG000|Overall Study|Lost to Follow-up|1|||
37970012|NCT03829683|69657046|FG001|Overall Study|Lost to Follow-up|0|||
37970013|NCT03829683|69657045|FG000|Overall Study|Physician Decision|3|||
37970014|NCT03829683|69657046|FG001|Overall Study|Physician Decision|1|||
37970015|NCT03829683|69657045|FG000|Overall Study|Withdrawal by Subject|0|||
37970016|NCT03829683|69657046|FG001|Overall Study|Withdrawal by Subject|1|||
37970017|NCT03829683|69657045|FG000|Overall Study|Discharge from hospital|1|||
37970018|NCT03829683|69657046|FG001|Overall Study|Discharge from hospital|0|||
37970019|NCT03810456|69657055|FG000|Treatment|Urgent Family Matters|3|||
37970020|NCT03810456|69657056|FG001|Treatment|Urgent Family Matters|0|||
37970021|NCT03810456|69657057|FG002|Treatment|Urgent Family Matters|0|||
37970022|NCT03810456|69657055|FG000|Treatment|Scheduling Conflicts|0|||
37970023|NCT03810456|69657056|FG001|Treatment|Scheduling Conflicts|11|||
37970024|NCT03810456|69657057|FG002|Treatment|Scheduling Conflicts|0|||
37970025|NCT03810456|69657055|FG000|Treatment|No Longer Interested|0|||
37970026|NCT03810456|69657056|FG001|Treatment|No Longer Interested|12|||
37970027|NCT03810456|69657057|FG002|Treatment|No Longer Interested|0|||
37970028|NCT03810456|69657055|FG000|Treatment|Transportation Issues|0|||
37970029|NCT03810456|69657056|FG001|Treatment|Transportation Issues|1|||
37970030|NCT03810456|69657057|FG002|Treatment|Transportation Issues|0|||
37970031|NCT03810456|69657055|FG000|1 Month Follow-Up|Lost to Follow-up|7|||
37970032|NCT03810456|69657056|FG001|1 Month Follow-Up|Lost to Follow-up|4|||
37970033|NCT03810456|69657057|FG002|1 Month Follow-Up|Lost to Follow-up|15|||
37970034|NCT03810456|69657055|FG000|1 Month Follow-Up|Relocated to Different State|1|||
37970035|NCT03810456|69657056|FG001|1 Month Follow-Up|Relocated to Different State|0|||
37970036|NCT03810456|69657057|FG002|1 Month Follow-Up|Relocated to Different State|1|||
37970037|NCT03810456|69657055|FG000|1 Month Follow-Up|Withdrawal by Subject|1|||
37970038|NCT03810456|69657056|FG001|1 Month Follow-Up|Withdrawal by Subject|0|||
37970039|NCT03810456|69657057|FG002|1 Month Follow-Up|Withdrawal by Subject|0|||
37970040|NCT03810456|69657055|FG000|3 Month Follow-Up|Lost to Follow-up|11|||
37691968|NCT01909804|69168229|FG002|Overall Study|Withdrew Consent|0|||
37691969|NCT01909804|69168230|FG003|Overall Study|Withdrew Consent|0|||
37691970|NCT01909804|69168231|FG004|Overall Study|Withdrew Consent|1|||
37970041|NCT03810456|69657056|FG001|3 Month Follow-Up|Lost to Follow-up|11|||
37970042|NCT03810456|69657057|FG002|3 Month Follow-Up|Lost to Follow-up|14|||
37970043|NCT03810456|69657055|FG000|3 Month Follow-Up|Withdrawal by Subject|1|||
37970044|NCT03810456|69657056|FG001|3 Month Follow-Up|Withdrawal by Subject|0|||
37970045|NCT03810456|69657057|FG002|3 Month Follow-Up|Withdrawal by Subject|0|||
37970046|NCT03810456|69657055|FG000|6 Month Follow-Up|Lost to Follow-up|12|||
37970047|NCT03810456|69657056|FG001|6 Month Follow-Up|Lost to Follow-up|9|||
37970048|NCT03810456|69657057|FG002|6 Month Follow-Up|Lost to Follow-up|18|||
37970049|NCT03810456|69657055|FG000|6 Month Follow-Up|Withdrawal by Subject|1|||
37970050|NCT03810456|69657056|FG001|6 Month Follow-Up|Withdrawal by Subject|0|||
37970051|NCT03810456|69657057|FG002|6 Month Follow-Up|Withdrawal by Subject|0|||
37970052|NCT03450057|69657069|FG000|Overall Study|Death|17|||
37970053|NCT03450057|69657069|FG000|Overall Study|ICF withdrawal|4|||
37970054|NCT03450057|69657069|FG000|Overall Study|Lost to Follow-up|2|||
37970055|NCT03353415|69657082|FG000|Masked CGM Wear|Lost to Follow-up|2|||
37970056|NCT03353415|69657082|FG000|Unmasked CGM Wear|Excluded due to missing data.|1|||
37970057|NCT02658890|69657124|FG000|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
37691971|NCT01909804|69168232|FG005|Overall Study|Withdrew Consent|1|||
37691972|NCT01909804|69168233|FG006|Overall Study|Withdrew Consent|0|||
37970058|NCT02658890|69657125|FG001|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
37970059|NCT02658890|69657126|FG002|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
37970060|NCT02658890|69657127|FG003|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
37970061|NCT02658890|69657128|FG004|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
37970062|NCT02658890|69657129|FG005|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
37970063|NCT02658890|69657130|FG006|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
37691973|NCT01909804|69168234|FG007|Overall Study|Withdrew Consent|0|||
37780184|NCT02533674|69345357|FG003|Dose Level III|Treatment-related AE|0|||
37970064|NCT02658890|69657131|FG007|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
37970065|NCT02658890|69657132|FG008|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|1|||
37970066|NCT02658890|69657133|FG009|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
37970067|NCT02658890|69657134|FG010|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
37970068|NCT02658890|69657135|FG011|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
37970069|NCT02658890|69657136|FG012|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
37970070|NCT02658890|69657137|FG013|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
37691974|NCT01909804|69168235|FG008|Overall Study|Withdrew Consent|0|||
37970071|NCT02658890|69657138|FG014|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
37970072|NCT02658890|69657139|FG015|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
37691975|NCT01909804|69168236|FG009|Overall Study|Withdrew Consent|0|||
37970073|NCT02658890|69657140|FG016|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
37970074|NCT02658890|69657141|FG017|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
37970075|NCT02658890|69657142|FG018|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
37970076|NCT02658890|69657143|FG019|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
37970077|NCT02658890|69657144|FG020|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
37970078|NCT02658890|69657145|FG021|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
37970079|NCT02658890|69657146|FG022|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
37970080|NCT02658890|69657147|FG023|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
37970081|NCT02658890|69657148|FG024|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
37970082|NCT02658890|69657149|FG025|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
37970083|NCT02658890|69657150|FG026|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
37970084|NCT02658890|69657124|FG000|Treatment Phase|Adverse Event|0|||
37970085|NCT02658890|69657125|FG001|Treatment Phase|Adverse Event|1|||
37970086|NCT02658890|69657126|FG002|Treatment Phase|Adverse Event|2|||
37970087|NCT02658890|69657127|FG003|Treatment Phase|Adverse Event|2|||
37970088|NCT02658890|69657128|FG004|Treatment Phase|Adverse Event|1|||
37970089|NCT02658890|69657129|FG005|Treatment Phase|Adverse Event|0|||
37970090|NCT02658890|69657130|FG006|Treatment Phase|Adverse Event|0|||
37970091|NCT02658890|69657131|FG007|Treatment Phase|Adverse Event|2|||
37970092|NCT02658890|69657132|FG008|Treatment Phase|Adverse Event|1|||
37970093|NCT02658890|69657133|FG009|Treatment Phase|Adverse Event|2|||
37970094|NCT02658890|69657134|FG010|Treatment Phase|Adverse Event|3|||
37970095|NCT02658890|69657135|FG011|Treatment Phase|Adverse Event|0|||
37970096|NCT02658890|69657136|FG012|Treatment Phase|Adverse Event|1|||
37970097|NCT02658890|69657137|FG013|Treatment Phase|Adverse Event|4|||
37970098|NCT02658890|69657138|FG014|Treatment Phase|Adverse Event|0|||
37970099|NCT02658890|69657139|FG015|Treatment Phase|Adverse Event|0|||
37970100|NCT02658890|69657140|FG016|Treatment Phase|Adverse Event|0|||
37970101|NCT02658890|69657141|FG017|Treatment Phase|Adverse Event|0|||
37970102|NCT02658890|69657142|FG018|Treatment Phase|Adverse Event|5|||
37970103|NCT02658890|69657143|FG019|Treatment Phase|Adverse Event|1|||
37970104|NCT02658890|69657144|FG020|Treatment Phase|Adverse Event|3|||
37970105|NCT02658890|69657145|FG021|Treatment Phase|Adverse Event|0|||
37970106|NCT02658890|69657146|FG022|Treatment Phase|Adverse Event|5|||
37970107|NCT02658890|69657147|FG023|Treatment Phase|Adverse Event|0|||
37970108|NCT02658890|69657148|FG024|Treatment Phase|Adverse Event|0|||
37970109|NCT02658890|69657149|FG025|Treatment Phase|Adverse Event|2|||
37970110|NCT02658890|69657150|FG026|Treatment Phase|Adverse Event|1|||
37970111|NCT02658890|69657124|FG000|Treatment Phase|Death|0|||
37970112|NCT02658890|69657125|FG001|Treatment Phase|Death|0|||
37970113|NCT02658890|69657126|FG002|Treatment Phase|Death|0|||
37970114|NCT02658890|69657127|FG003|Treatment Phase|Death|0|||
37970115|NCT02658890|69657128|FG004|Treatment Phase|Death|0|||
37970116|NCT02658890|69657129|FG005|Treatment Phase|Death|0|||
37970117|NCT02658890|69657130|FG006|Treatment Phase|Death|0|||
37970118|NCT02658890|69657131|FG007|Treatment Phase|Death|0|||
37970119|NCT02658890|69657132|FG008|Treatment Phase|Death|0|||
37970120|NCT02658890|69657133|FG009|Treatment Phase|Death|0|||
37970121|NCT02658890|69657134|FG010|Treatment Phase|Death|0|||
37970122|NCT02658890|69657135|FG011|Treatment Phase|Death|0|||
37970123|NCT02658890|69657136|FG012|Treatment Phase|Death|0|||
37970124|NCT02658890|69657137|FG013|Treatment Phase|Death|0|||
37970125|NCT02658890|69657138|FG014|Treatment Phase|Death|0|||
37970126|NCT02658890|69657139|FG015|Treatment Phase|Death|0|||
37970127|NCT02658890|69657140|FG016|Treatment Phase|Death|0|||
37970128|NCT02658890|69657141|FG017|Treatment Phase|Death|0|||
37970129|NCT02658890|69657142|FG018|Treatment Phase|Death|1|||
37970130|NCT02658890|69657143|FG019|Treatment Phase|Death|0|||
37970131|NCT02658890|69657144|FG020|Treatment Phase|Death|0|||
37970132|NCT02658890|69657145|FG021|Treatment Phase|Death|0|||
37970133|NCT02658890|69657146|FG022|Treatment Phase|Death|0|||
37970134|NCT02658890|69657147|FG023|Treatment Phase|Death|0|||
37780185|NCT02533674|69345358|FG004|Dose Level III|Treatment-related AE|0|||
37780186|NCT02533674|69345359|FG005|Dose Level III|Treatment-related AE|0|||
37780187|NCT02533674|69345360|FG006|Dose Level III|Treatment-related AE|0|||
37780188|NCT02533674|69345361|FG007|Dose Level III|Treatment-related AE|0|||
37780189|NCT02533674|69345354|FG000|Dose Level IV|Progressive disease|0|||
37780190|NCT02533674|69345355|FG001|Dose Level IV|Progressive disease|0|||
37970135|NCT02658890|69657148|FG024|Treatment Phase|Death|0|||
37970136|NCT02658890|69657149|FG025|Treatment Phase|Death|0|||
37970137|NCT02658890|69657150|FG026|Treatment Phase|Death|0|||
37970138|NCT02658890|69657124|FG000|Treatment Phase|Lost to Follow-up|0|||
37970139|NCT02658890|69657125|FG001|Treatment Phase|Lost to Follow-up|0|||
37970140|NCT02658890|69657126|FG002|Treatment Phase|Lost to Follow-up|0|||
37970141|NCT02658890|69657127|FG003|Treatment Phase|Lost to Follow-up|0|||
37691976|NCT01909804|69168237|FG010|Overall Study|Withdrew Consent|0|||
37691977|NCT01909804|69168238|FG011|Overall Study|Withdrew Consent|0|||
37691978|NCT01909804|69168227|FG000|Overall Study|Protocol Violation|0|||
37691979|NCT01909804|69168228|FG001|Overall Study|Protocol Violation|0|||
37691980|NCT01909804|69168229|FG002|Overall Study|Protocol Violation|0|||
37691981|NCT01909804|69168230|FG003|Overall Study|Protocol Violation|0|||
37691982|NCT01909804|69168231|FG004|Overall Study|Protocol Violation|0|||
37691983|NCT01909804|69168232|FG005|Overall Study|Protocol Violation|0|||
37691984|NCT01909804|69168233|FG006|Overall Study|Protocol Violation|0|||
37691985|NCT01909804|69168234|FG007|Overall Study|Protocol Violation|0|||
37691986|NCT01909804|69168235|FG008|Overall Study|Protocol Violation|0|||
37691987|NCT01909804|69168236|FG009|Overall Study|Protocol Violation|0|||
37691988|NCT01909804|69168237|FG010|Overall Study|Protocol Violation|0|||
37691989|NCT01909804|69168238|FG011|Overall Study|Protocol Violation|1|||
37691990|NCT01880086|69168262|FG000|Overall Study|Lost to Follow-up|1|||
37691991|NCT01880086|69168263|FG001|Overall Study|Lost to Follow-up|1|||
37970142|NCT02658890|69657128|FG004|Treatment Phase|Lost to Follow-up|0|||
37970143|NCT02658890|69657129|FG005|Treatment Phase|Lost to Follow-up|0|||
37970144|NCT02658890|69657130|FG006|Treatment Phase|Lost to Follow-up|1|||
37970145|NCT02658890|69657131|FG007|Treatment Phase|Lost to Follow-up|0|||
37970146|NCT02658890|69657132|FG008|Treatment Phase|Lost to Follow-up|0|||
37970147|NCT02658890|69657133|FG009|Treatment Phase|Lost to Follow-up|0|||
37970148|NCT02658890|69657134|FG010|Treatment Phase|Lost to Follow-up|0|||
37970149|NCT02658890|69657135|FG011|Treatment Phase|Lost to Follow-up|0|||
37970150|NCT02658890|69657136|FG012|Treatment Phase|Lost to Follow-up|0|||
37970151|NCT02658890|69657137|FG013|Treatment Phase|Lost to Follow-up|0|||
37970152|NCT02658890|69657138|FG014|Treatment Phase|Lost to Follow-up|0|||
37970153|NCT02658890|69657139|FG015|Treatment Phase|Lost to Follow-up|0|||
37970154|NCT02658890|69657140|FG016|Treatment Phase|Lost to Follow-up|0|||
37970155|NCT02658890|69657141|FG017|Treatment Phase|Lost to Follow-up|0|||
37970156|NCT02658890|69657142|FG018|Treatment Phase|Lost to Follow-up|0|||
37970157|NCT02658890|69657143|FG019|Treatment Phase|Lost to Follow-up|0|||
37691992|NCT01879852|69168271|FG000|Overall Study|Withdrawal by Subject|2|||
37691993|NCT01879852|69168272|FG001|Overall Study|Withdrawal by Subject|0|||
37691994|NCT01879618|69168278|FG000|Overall Study|Does not meet entrance criteria|1|||
37691995|NCT01879618|69168278|FG000|Overall Study|Withdrawal by Subject|1|||
37691996|NCT01879618|69168278|FG000|Overall Study|Surgery;changed schedule; not available|8|||
37691997|NCT01879618|69168278|FG000|Overall Study|Protocol Violation|6|||
37691998|NCT01879618|69168278|FG000|Overall Study|Adverse Event|5|||
37691999|NCT01926886|69168282|FG000|Overall Study|Administrative/other|1|||
37692000|NCT01926886|69168283|FG001|Overall Study|Administrative/other|0|||
37692001|NCT01926886|69168282|FG000|Overall Study|Adverse event/intercurrent illness|4|||
37692002|NCT01926886|69168283|FG001|Overall Study|Adverse event/intercurrent illness|0|||
37970158|NCT02658890|69657144|FG020|Treatment Phase|Lost to Follow-up|0|||
37970159|NCT02658890|69657145|FG021|Treatment Phase|Lost to Follow-up|0|||
37970160|NCT02658890|69657146|FG022|Treatment Phase|Lost to Follow-up|0|||
37970161|NCT02658890|69657147|FG023|Treatment Phase|Lost to Follow-up|0|||
37692003|NCT01926886|69168282|FG000|Overall Study|Disease progression/recurrence|4|||
37970162|NCT02658890|69657148|FG024|Treatment Phase|Lost to Follow-up|0|||
37970163|NCT02658890|69657149|FG025|Treatment Phase|Lost to Follow-up|0|||
37970164|NCT02658890|69657150|FG026|Treatment Phase|Lost to Follow-up|0|||
37970165|NCT02658890|69657124|FG000|Treatment Phase|Maximum Clinical Benefit|0|||
37692004|NCT01926886|69168283|FG001|Overall Study|Disease progression/recurrence|0|||
37692005|NCT01926886|69168282|FG000|Overall Study|Withdrawal by Subject|15|||
37970166|NCT02658890|69657125|FG001|Treatment Phase|Maximum Clinical Benefit|0|||
37970167|NCT02658890|69657126|FG002|Treatment Phase|Maximum Clinical Benefit|0|||
37970168|NCT02658890|69657127|FG003|Treatment Phase|Maximum Clinical Benefit|0|||
37970169|NCT02658890|69657128|FG004|Treatment Phase|Maximum Clinical Benefit|0|||
37692006|NCT01926886|69168283|FG001|Overall Study|Withdrawal by Subject|0|||
37692007|NCT01926886|69168282|FG000|Overall Study|Failure to return|3|||
37692008|NCT01926886|69168283|FG001|Overall Study|Failure to return|0|||
37692009|NCT01926886|69168282|FG000|Overall Study|Recurrence of disease|1|||
37692010|NCT01926886|69168283|FG001|Overall Study|Recurrence of disease|0|||
37692011|NCT01926886|69168282|FG000|Overall Study|Progression of disease|2|||
37692012|NCT01926886|69168283|FG001|Overall Study|Progression of disease|0|||
37692013|NCT01926886|69168282|FG000|Overall Study|Death|1|||
37692014|NCT01926886|69168283|FG001|Overall Study|Death|0|||
37692015|NCT01926886|69168282|FG000|Overall Study|Did not cooperate|1|||
37692016|NCT01926886|69168283|FG001|Overall Study|Did not cooperate|0|||
37692017|NCT01909336|69168292|FG000|Overall Study|Lost to Follow-up|4|||
37692018|NCT01909336|69168293|FG001|Overall Study|Lost to Follow-up|2|||
37970170|NCT02658890|69657129|FG005|Treatment Phase|Maximum Clinical Benefit|0|||
37970171|NCT02658890|69657130|FG006|Treatment Phase|Maximum Clinical Benefit|0|||
37780191|NCT02533674|69345356|FG002|Dose Level IV|Progressive disease|0|||
37780192|NCT02533674|69345357|FG003|Dose Level IV|Progressive disease|3|||
37780193|NCT02533674|69345358|FG004|Dose Level IV|Progressive disease|0|||
37970172|NCT02658890|69657131|FG007|Treatment Phase|Maximum Clinical Benefit|0|||
37970173|NCT02658890|69657132|FG008|Treatment Phase|Maximum Clinical Benefit|0|||
37970174|NCT02658890|69657133|FG009|Treatment Phase|Maximum Clinical Benefit|0|||
37692019|NCT01909336|69168294|FG002|Overall Study|Lost to Follow-up|2|||
37692020|NCT01909336|69168292|FG000|Overall Study|Physician Decision|0|||
37692021|NCT01909336|69168293|FG001|Overall Study|Physician Decision|1|||
37692022|NCT01909336|69168294|FG002|Overall Study|Physician Decision|1|||
37692023|NCT01926028|69168305|FG000|Overall Study|Lost to Follow-up|7|||
37692024|NCT01926028|69168306|FG001|Overall Study|Lost to Follow-up|6|||
37692025|NCT01926028|69168307|FG002|Overall Study|Lost to Follow-up|0|||
37692026|NCT01926028|69168305|FG000|Overall Study|Physician Decision|1|||
37692027|NCT01926028|69168306|FG001|Overall Study|Physician Decision|5|||
37692028|NCT01926028|69168307|FG002|Overall Study|Physician Decision|0|||
37692029|NCT01926028|69168305|FG000|Overall Study|Withdrawal by Subject|9|||
37692030|NCT01926028|69168306|FG001|Overall Study|Withdrawal by Subject|9|||
37692031|NCT01926028|69168307|FG002|Overall Study|Withdrawal by Subject|2|||
37692032|NCT01926028|69168305|FG000|Overall Study|Non compliance or other reasons|4|||
37692033|NCT01926028|69168306|FG001|Overall Study|Non compliance or other reasons|2|||
37692034|NCT01926028|69168307|FG002|Overall Study|Non compliance or other reasons|0|||
37692035|NCT01925950|69168318|FG000|Part 2|Withdrawal by Subject|1|||
37692036|NCT01925950|69168319|FG001|Part 2|Withdrawal by Subject|0|||
37692037|NCT01878292|69168328|FG000|Randomized|Protocol Violation|1|||
37692038|NCT01878292|69168329|FG001|Randomized|Protocol Violation|0|||
37692039|NCT01878292|69168330|FG002|Randomized|Protocol Violation|0|||
37692040|NCT01878292|69168328|FG000|Randomized|Lost to Follow-up|1|||
37692041|NCT01878292|69168329|FG001|Randomized|Lost to Follow-up|0|||
37692042|NCT01878292|69168330|FG002|Randomized|Lost to Follow-up|0|||
37692043|NCT01878292|69168328|FG000|Randomized|Adverse Event|1|||
37692044|NCT01878292|69168329|FG001|Randomized|Adverse Event|0|||
37692045|NCT01878292|69168330|FG002|Randomized|Adverse Event|0|||
37692046|NCT01878292|69168328|FG000|Double-blind Treatment Period|Other Reasons|2|||
37692047|NCT01878292|69168329|FG001|Double-blind Treatment Period|Other Reasons|0|||
37692048|NCT01878292|69168330|FG002|Double-blind Treatment Period|Other Reasons|0|||
37692049|NCT01878292|69168328|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
37692050|NCT01878292|69168329|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
37692051|NCT01878292|69168330|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
37692052|NCT01878292|69168328|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
37692053|NCT01878292|69168329|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
37692054|NCT01878292|69168330|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
37692055|NCT01878292|69168328|FG000|Double-blind Treatment Period|Protocol Violation|3|||
37692056|NCT01878292|69168329|FG001|Double-blind Treatment Period|Protocol Violation|4|||
37692057|NCT01878292|69168330|FG002|Double-blind Treatment Period|Protocol Violation|2|||
37692058|NCT01878292|69168328|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
37692059|NCT01878292|69168329|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
37692060|NCT01878292|69168330|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
37692061|NCT01878292|69168328|FG000|Double-blind Treatment Period|Adverse Event|4|||
37692062|NCT01878292|69168329|FG001|Double-blind Treatment Period|Adverse Event|9|||
37692063|NCT01878292|69168330|FG002|Double-blind Treatment Period|Adverse Event|8|||
37692064|NCT01878292|69168328|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
37692065|NCT01878292|69168329|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
37692066|NCT01878292|69168330|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
37692067|NCT01908634|69168338|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
37692068|NCT01908634|69168338|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
37692069|NCT01878214|69168348|FG000|Overall Study|Withdrawal by Subject|18|||
37692070|NCT01878214|69168349|FG001|Overall Study|Withdrawal by Subject|7|||
37780194|NCT02533674|69345359|FG005|Dose Level IV|Progressive disease|0|||
37780195|NCT02533674|69345360|FG006|Dose Level IV|Progressive disease|0|||
37780196|NCT02533674|69345361|FG007|Dose Level IV|Progressive disease|0|||
37780197|NCT02533674|69345354|FG000|Dose Level IV|Withdrawal by Subject|0|||
37970175|NCT02658890|69657134|FG010|Treatment Phase|Maximum Clinical Benefit|0|||
37970176|NCT02658890|69657135|FG011|Treatment Phase|Maximum Clinical Benefit|0|||
37970177|NCT02658890|69657136|FG012|Treatment Phase|Maximum Clinical Benefit|0|||
37970178|NCT02658890|69657137|FG013|Treatment Phase|Maximum Clinical Benefit|1|||
37970179|NCT02658890|69657138|FG014|Treatment Phase|Maximum Clinical Benefit|0|||
37970180|NCT02658890|69657139|FG015|Treatment Phase|Maximum Clinical Benefit|0|||
37970181|NCT02658890|69657140|FG016|Treatment Phase|Maximum Clinical Benefit|0|||
37970182|NCT02658890|69657141|FG017|Treatment Phase|Maximum Clinical Benefit|0|||
37970183|NCT02658890|69657142|FG018|Treatment Phase|Maximum Clinical Benefit|1|||
37970184|NCT02658890|69657143|FG019|Treatment Phase|Maximum Clinical Benefit|0|||
37970185|NCT02658890|69657144|FG020|Treatment Phase|Maximum Clinical Benefit|0|||
37970186|NCT02658890|69657145|FG021|Treatment Phase|Maximum Clinical Benefit|0|||
37970187|NCT02658890|69657146|FG022|Treatment Phase|Maximum Clinical Benefit|2|||
37970188|NCT02658890|69657147|FG023|Treatment Phase|Maximum Clinical Benefit|0|||
37970189|NCT02658890|69657148|FG024|Treatment Phase|Maximum Clinical Benefit|0|||
37970190|NCT02658890|69657149|FG025|Treatment Phase|Maximum Clinical Benefit|0|||
37970191|NCT02658890|69657150|FG026|Treatment Phase|Maximum Clinical Benefit|0|||
37970192|NCT02658890|69657124|FG000|Treatment Phase|Non-compliance With Study Drug|0|||
37970193|NCT02658890|69657125|FG001|Treatment Phase|Non-compliance With Study Drug|0|||
37970194|NCT02658890|69657126|FG002|Treatment Phase|Non-compliance With Study Drug|1|||
37970195|NCT02658890|69657127|FG003|Treatment Phase|Non-compliance With Study Drug|0|||
37970196|NCT02658890|69657128|FG004|Treatment Phase|Non-compliance With Study Drug|0|||
37970197|NCT02658890|69657129|FG005|Treatment Phase|Non-compliance With Study Drug|0|||
37970198|NCT02658890|69657130|FG006|Treatment Phase|Non-compliance With Study Drug|0|||
37970199|NCT02658890|69657131|FG007|Treatment Phase|Non-compliance With Study Drug|0|||
37970200|NCT02658890|69657132|FG008|Treatment Phase|Non-compliance With Study Drug|0|||
37970201|NCT02658890|69657133|FG009|Treatment Phase|Non-compliance With Study Drug|0|||
37970202|NCT02658890|69657134|FG010|Treatment Phase|Non-compliance With Study Drug|0|||
37970203|NCT02658890|69657135|FG011|Treatment Phase|Non-compliance With Study Drug|0|||
37970204|NCT02658890|69657136|FG012|Treatment Phase|Non-compliance With Study Drug|0|||
37970205|NCT02658890|69657137|FG013|Treatment Phase|Non-compliance With Study Drug|0|||
37970206|NCT02658890|69657138|FG014|Treatment Phase|Non-compliance With Study Drug|0|||
37970207|NCT02658890|69657139|FG015|Treatment Phase|Non-compliance With Study Drug|0|||
37970208|NCT02658890|69657140|FG016|Treatment Phase|Non-compliance With Study Drug|0|||
37970209|NCT02658890|69657141|FG017|Treatment Phase|Non-compliance With Study Drug|0|||
37970210|NCT02658890|69657142|FG018|Treatment Phase|Non-compliance With Study Drug|1|||
37970211|NCT02658890|69657143|FG019|Treatment Phase|Non-compliance With Study Drug|0|||
37970212|NCT02658890|69657144|FG020|Treatment Phase|Non-compliance With Study Drug|0|||
37970213|NCT02658890|69657145|FG021|Treatment Phase|Non-compliance With Study Drug|0|||
37970214|NCT02658890|69657146|FG022|Treatment Phase|Non-compliance With Study Drug|0|||
37970215|NCT02658890|69657147|FG023|Treatment Phase|Non-compliance With Study Drug|0|||
37970216|NCT02658890|69657148|FG024|Treatment Phase|Non-compliance With Study Drug|0|||
37970217|NCT02658890|69657149|FG025|Treatment Phase|Non-compliance With Study Drug|0|||
37970218|NCT02658890|69657150|FG026|Treatment Phase|Non-compliance With Study Drug|0|||
37970219|NCT02658890|69657124|FG000|Treatment Phase|Other Reasons|0|||
37970220|NCT02658890|69657125|FG001|Treatment Phase|Other Reasons|0|||
37970221|NCT02658890|69657126|FG002|Treatment Phase|Other Reasons|0|||
37970222|NCT02658890|69657127|FG003|Treatment Phase|Other Reasons|0|||
37970223|NCT02658890|69657128|FG004|Treatment Phase|Other Reasons|0|||
37970224|NCT02658890|69657129|FG005|Treatment Phase|Other Reasons|0|||
37970225|NCT02658890|69657130|FG006|Treatment Phase|Other Reasons|1|||
37970226|NCT02658890|69657131|FG007|Treatment Phase|Other Reasons|0|||
37970227|NCT02658890|69657132|FG008|Treatment Phase|Other Reasons|1|||
37692071|NCT01878214|69168348|FG000|Overall Study|Death|0|||
37970228|NCT02658890|69657133|FG009|Treatment Phase|Other Reasons|0|||
37692072|NCT01878214|69168349|FG001|Overall Study|Death|1|||
37692073|NCT01878214|69168348|FG000|Overall Study|Lost to Follow-up|35|||
37692074|NCT01878214|69168349|FG001|Overall Study|Lost to Follow-up|36|||
37692075|NCT01907854|69168357|FG000|Overall Study|Protocol Violation|1|||
37692076|NCT01907854|69168358|FG001|Overall Study|Protocol Violation|1|||
37692077|NCT01907854|69168357|FG000|Overall Study|Withdrawal by Subject|9|||
37692078|NCT01907854|69168358|FG001|Overall Study|Withdrawal by Subject|7|||
37692079|NCT01907854|69168357|FG000|Overall Study|Lost to Follow-up|2|||
37692080|NCT01907854|69168358|FG001|Overall Study|Lost to Follow-up|2|||
37692081|NCT01907854|69168357|FG000|Overall Study|Unclassified|4|||
37692082|NCT01907854|69168358|FG001|Overall Study|Unclassified|3|||
37692083|NCT02480153|69168366|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
37692084|NCT02480153|69168367|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
37692085|NCT02480153|69168368|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
37970229|NCT02658890|69657134|FG010|Treatment Phase|Other Reasons|0|||
37970230|NCT02658890|69657135|FG011|Treatment Phase|Other Reasons|0|||
37970231|NCT02658890|69657136|FG012|Treatment Phase|Other Reasons|0|||
37970232|NCT02658890|69657137|FG013|Treatment Phase|Other Reasons|2|||
37970233|NCT02658890|69657138|FG014|Treatment Phase|Other Reasons|0|||
37970234|NCT02658890|69657139|FG015|Treatment Phase|Other Reasons|0|||
37970235|NCT02658890|69657140|FG016|Treatment Phase|Other Reasons|0|||
37970236|NCT02658890|69657141|FG017|Treatment Phase|Other Reasons|0|||
37970237|NCT02658890|69657142|FG018|Treatment Phase|Other Reasons|1|||
37970238|NCT02658890|69657143|FG019|Treatment Phase|Other Reasons|0|||
37970239|NCT02658890|69657144|FG020|Treatment Phase|Other Reasons|0|||
37970240|NCT02658890|69657145|FG021|Treatment Phase|Other Reasons|0|||
37970241|NCT02658890|69657146|FG022|Treatment Phase|Other Reasons|0|||
37970242|NCT02658890|69657147|FG023|Treatment Phase|Other Reasons|0|||
37970243|NCT02658890|69657148|FG024|Treatment Phase|Other Reasons|1|||
37970244|NCT02658890|69657149|FG025|Treatment Phase|Other Reasons|0|||
37970245|NCT02658890|69657150|FG026|Treatment Phase|Other Reasons|1|||
37970246|NCT02658890|69657124|FG000|Treatment Phase|Progressive Disease|6|||
37970247|NCT02658890|69657125|FG001|Treatment Phase|Progressive Disease|7|||
37970248|NCT02658890|69657126|FG002|Treatment Phase|Progressive Disease|6|||
37970249|NCT02658890|69657127|FG003|Treatment Phase|Progressive Disease|12|||
37970250|NCT02658890|69657128|FG004|Treatment Phase|Progressive Disease|6|||
37970251|NCT02658890|69657129|FG005|Treatment Phase|Progressive Disease|18|||
37970252|NCT02658890|69657130|FG006|Treatment Phase|Progressive Disease|12|||
37970253|NCT02658890|69657131|FG007|Treatment Phase|Progressive Disease|19|||
37970254|NCT02658890|69657132|FG008|Treatment Phase|Progressive Disease|26|||
37970255|NCT02658890|69657133|FG009|Treatment Phase|Progressive Disease|8|||
37970256|NCT02658890|69657134|FG010|Treatment Phase|Progressive Disease|7|||
37970257|NCT02658890|69657135|FG011|Treatment Phase|Progressive Disease|9|||
37970258|NCT02658890|69657136|FG012|Treatment Phase|Progressive Disease|8|||
37970259|NCT02658890|69657137|FG013|Treatment Phase|Progressive Disease|29|||
37970260|NCT02658890|69657138|FG014|Treatment Phase|Progressive Disease|6|||
37970261|NCT02658890|69657139|FG015|Treatment Phase|Progressive Disease|2|||
37970262|NCT02658890|69657140|FG016|Treatment Phase|Progressive Disease|32|||
37970263|NCT02658890|69657141|FG017|Treatment Phase|Progressive Disease|14|||
37970264|NCT02658890|69657142|FG018|Treatment Phase|Progressive Disease|40|||
37970265|NCT02658890|69657143|FG019|Treatment Phase|Progressive Disease|32|||
37970266|NCT02658890|69657144|FG020|Treatment Phase|Progressive Disease|19|||
37970267|NCT02658890|69657145|FG021|Treatment Phase|Progressive Disease|30|||
37970268|NCT02658890|69657146|FG022|Treatment Phase|Progressive Disease|15|||
37970269|NCT02658890|69657147|FG023|Treatment Phase|Progressive Disease|0|||
37970270|NCT02658890|69657148|FG024|Treatment Phase|Progressive Disease|0|||
37970271|NCT02658890|69657149|FG025|Treatment Phase|Progressive Disease|14|||
37970272|NCT02658890|69657150|FG026|Treatment Phase|Progressive Disease|11|||
37970273|NCT02658890|69657124|FG000|Treatment Phase|Study Drug Toxicity|0|||
37970274|NCT02658890|69657125|FG001|Treatment Phase|Study Drug Toxicity|0|||
37970275|NCT02658890|69657126|FG002|Treatment Phase|Study Drug Toxicity|2|||
37970276|NCT02658890|69657127|FG003|Treatment Phase|Study Drug Toxicity|0|||
37970277|NCT02658890|69657128|FG004|Treatment Phase|Study Drug Toxicity|0|||
37970278|NCT02658890|69657129|FG005|Treatment Phase|Study Drug Toxicity|0|||
37970279|NCT02658890|69657130|FG006|Treatment Phase|Study Drug Toxicity|0|||
37970280|NCT02658890|69657131|FG007|Treatment Phase|Study Drug Toxicity|0|||
37970281|NCT02658890|69657132|FG008|Treatment Phase|Study Drug Toxicity|3|||
37970282|NCT02658890|69657133|FG009|Treatment Phase|Study Drug Toxicity|0|||
37970283|NCT02658890|69657134|FG010|Treatment Phase|Study Drug Toxicity|1|||
37692086|NCT02480153|69168366|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
37692087|NCT02480153|69168367|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
37780198|NCT02533674|69345355|FG001|Dose Level IV|Withdrawal by Subject|0|||
37970284|NCT02658890|69657135|FG011|Treatment Phase|Study Drug Toxicity|1|||
37970285|NCT02658890|69657136|FG012|Treatment Phase|Study Drug Toxicity|2|||
37970286|NCT02658890|69657137|FG013|Treatment Phase|Study Drug Toxicity|9|||
37970287|NCT02658890|69657138|FG014|Treatment Phase|Study Drug Toxicity|0|||
37970288|NCT02658890|69657139|FG015|Treatment Phase|Study Drug Toxicity|1|||
37970289|NCT02658890|69657140|FG016|Treatment Phase|Study Drug Toxicity|1|||
37970290|NCT02658890|69657141|FG017|Treatment Phase|Study Drug Toxicity|0|||
37970291|NCT02658890|69657142|FG018|Treatment Phase|Study Drug Toxicity|8|||
37970292|NCT02658890|69657143|FG019|Treatment Phase|Study Drug Toxicity|3|||
37970293|NCT02658890|69657144|FG020|Treatment Phase|Study Drug Toxicity|2|||
37970294|NCT02658890|69657145|FG021|Treatment Phase|Study Drug Toxicity|0|||
37970295|NCT02658890|69657146|FG022|Treatment Phase|Study Drug Toxicity|8|||
37970296|NCT02658890|69657147|FG023|Treatment Phase|Study Drug Toxicity|0|||
37970297|NCT02658890|69657148|FG024|Treatment Phase|Study Drug Toxicity|0|||
37970298|NCT02658890|69657149|FG025|Treatment Phase|Study Drug Toxicity|2|||
37780199|NCT02533674|69345356|FG002|Dose Level IV|Withdrawal by Subject|0|||
37780200|NCT02533674|69345357|FG003|Dose Level IV|Withdrawal by Subject|1|||
37780201|NCT02533674|69345358|FG004|Dose Level IV|Withdrawal by Subject|0|||
37780202|NCT02533674|69345359|FG005|Dose Level IV|Withdrawal by Subject|0|||
37780203|NCT02533674|69345360|FG006|Dose Level IV|Withdrawal by Subject|0|||
37780204|NCT02533674|69345361|FG007|Dose Level IV|Withdrawal by Subject|0|||
37780205|NCT02533674|69345354|FG000|Dose Level IV|Physician Decision|0|||
37780206|NCT02533674|69345355|FG001|Dose Level IV|Physician Decision|0|||
37780207|NCT02533674|69345356|FG002|Dose Level IV|Physician Decision|0|||
37780208|NCT02533674|69345357|FG003|Dose Level IV|Physician Decision|1|||
37780209|NCT02533674|69345358|FG004|Dose Level IV|Physician Decision|0|||
37780210|NCT02533674|69345359|FG005|Dose Level IV|Physician Decision|0|||
37780211|NCT02533674|69345360|FG006|Dose Level IV|Physician Decision|0|||
37780212|NCT02533674|69345361|FG007|Dose Level IV|Physician Decision|0|||
37780213|NCT02533674|69345354|FG000|Dose Level V|Progressive disease|0|||
37780214|NCT02533674|69345355|FG001|Dose Level V|Progressive disease|0|||
37780215|NCT02533674|69345356|FG002|Dose Level V|Progressive disease|0|||
37780216|NCT02533674|69345357|FG003|Dose Level V|Progressive disease|0|||
37780217|NCT02533674|69345358|FG004|Dose Level V|Progressive disease|3|||
37780218|NCT02533674|69345359|FG005|Dose Level V|Progressive disease|0|||
37692088|NCT02480153|69168368|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
37692089|NCT02480153|69168366|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
37692090|NCT02480153|69168367|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
37692091|NCT02480153|69168368|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
37692092|NCT02480153|69168366|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
37692093|NCT02480153|69168367|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
37692094|NCT02480153|69168368|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
37780219|NCT02533674|69345360|FG006|Dose Level V|Progressive disease|0|||
37780220|NCT02533674|69345361|FG007|Dose Level V|Progressive disease|0|||
37780221|NCT02533674|69345354|FG000|Dose Level V|Withdrawal by Subject|0|||
37780222|NCT02533674|69345355|FG001|Dose Level V|Withdrawal by Subject|0|||
37780223|NCT02533674|69345356|FG002|Dose Level V|Withdrawal by Subject|0|||
37780224|NCT02533674|69345357|FG003|Dose Level V|Withdrawal by Subject|0|||
37780225|NCT02533674|69345358|FG004|Dose Level V|Withdrawal by Subject|1|||
37780226|NCT02533674|69345359|FG005|Dose Level V|Withdrawal by Subject|0|||
37780227|NCT02533674|69345360|FG006|Dose Level V|Withdrawal by Subject|0|||
37692095|NCT02480153|69168366|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
37692096|NCT02480153|69168367|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
37692097|NCT02480153|69168368|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
37692098|NCT02480153|69168366|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
37692099|NCT02480153|69168367|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
37692100|NCT02480153|69168368|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
37692101|NCT02480153|69168366|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
37692102|NCT02480153|69168367|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
37692103|NCT02480153|69168368|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
37699582|NCT02011893|69176450|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
37780228|NCT02533674|69345361|FG007|Dose Level V|Withdrawal by Subject|0|||
37780229|NCT02533674|69345354|FG000|Dose Level V|Physician Decision|0|||
37780230|NCT02533674|69345355|FG001|Dose Level V|Physician Decision|0|||
37863961|NCT01121913|69547556|FG000|Second Washout Period|Withdrawal by Subject|0|||
37970299|NCT02658890|69657150|FG026|Treatment Phase|Study Drug Toxicity|0|||
37970300|NCT02658890|69657124|FG000|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
37970301|NCT02658890|69657125|FG001|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
37970302|NCT02658890|69657126|FG002|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
37970303|NCT02658890|69657127|FG003|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
37970304|NCT02658890|69657128|FG004|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
37970305|NCT02658890|69657129|FG005|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
37970306|NCT02658890|69657130|FG006|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
37970307|NCT02658890|69657131|FG007|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
37970308|NCT02658890|69657132|FG008|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
37970309|NCT02658890|69657133|FG009|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
37970310|NCT02658890|69657134|FG010|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
37970311|NCT02658890|69657135|FG011|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
37970312|NCT02658890|69657136|FG012|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
37970313|NCT02658890|69657137|FG013|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
37970314|NCT02658890|69657138|FG014|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
37970315|NCT02658890|69657139|FG015|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
37970316|NCT02658890|69657140|FG016|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
37970317|NCT02658890|69657141|FG017|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
37970318|NCT02658890|69657142|FG018|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
37970319|NCT02658890|69657143|FG019|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
37970320|NCT02658890|69657144|FG020|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
37970321|NCT02658890|69657145|FG021|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
37970322|NCT02658890|69657146|FG022|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
37970323|NCT02658890|69657147|FG023|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
37970324|NCT02658890|69657148|FG024|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
37970325|NCT02658890|69657149|FG025|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
37970326|NCT02658890|69657150|FG026|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
37970327|NCT02658890|69657124|FG000|Treatment Phase|Withdrawal by Subject|0|||
37970328|NCT02658890|69657125|FG001|Treatment Phase|Withdrawal by Subject|1|||
37970329|NCT02658890|69657126|FG002|Treatment Phase|Withdrawal by Subject|0|||
37970330|NCT02658890|69657127|FG003|Treatment Phase|Withdrawal by Subject|0|||
37970331|NCT02658890|69657128|FG004|Treatment Phase|Withdrawal by Subject|0|||
37970332|NCT02658890|69657129|FG005|Treatment Phase|Withdrawal by Subject|0|||
37970333|NCT02658890|69657130|FG006|Treatment Phase|Withdrawal by Subject|1|||
37970334|NCT02658890|69657131|FG007|Treatment Phase|Withdrawal by Subject|0|||
37970335|NCT02658890|69657132|FG008|Treatment Phase|Withdrawal by Subject|0|||
37970336|NCT02658890|69657133|FG009|Treatment Phase|Withdrawal by Subject|1|||
37780231|NCT02533674|69345356|FG002|Dose Level V|Physician Decision|0|||
37780232|NCT02533674|69345357|FG003|Dose Level V|Physician Decision|0|||
37780233|NCT02533674|69345358|FG004|Dose Level V|Physician Decision|1|||
37780234|NCT02533674|69345359|FG005|Dose Level V|Physician Decision|0|||
37863962|NCT01121913|69547557|FG001|Second Washout Period|Withdrawal by Subject|0|||
37863963|NCT01121913|69547558|FG002|Second Washout Period|Withdrawal by Subject|1|||
37970337|NCT02658890|69657134|FG010|Treatment Phase|Withdrawal by Subject|0|||
37970338|NCT02658890|69657135|FG011|Treatment Phase|Withdrawal by Subject|0|||
37780235|NCT02533674|69345360|FG006|Dose Level V|Physician Decision|0|||
37780236|NCT02533674|69345361|FG007|Dose Level V|Physician Decision|0|||
37863964|NCT01121913|69547559|FG003|Second Washout Period|Withdrawal by Subject|0|||
37863965|NCT01121913|69547556|FG000|Third Washout Period|Adverse Event|1|||
37970339|NCT02658890|69657136|FG012|Treatment Phase|Withdrawal by Subject|1|||
37970340|NCT02658890|69657137|FG013|Treatment Phase|Withdrawal by Subject|3|||
37970341|NCT02658890|69657138|FG014|Treatment Phase|Withdrawal by Subject|0|||
37970342|NCT02658890|69657139|FG015|Treatment Phase|Withdrawal by Subject|0|||
37970343|NCT02658890|69657140|FG016|Treatment Phase|Withdrawal by Subject|1|||
37970344|NCT02658890|69657141|FG017|Treatment Phase|Withdrawal by Subject|0|||
37970345|NCT02658890|69657142|FG018|Treatment Phase|Withdrawal by Subject|4|||
37970346|NCT02658890|69657143|FG019|Treatment Phase|Withdrawal by Subject|3|||
37970347|NCT02658890|69657144|FG020|Treatment Phase|Withdrawal by Subject|0|||
37970348|NCT02658890|69657145|FG021|Treatment Phase|Withdrawal by Subject|4|||
37970349|NCT02658890|69657146|FG022|Treatment Phase|Withdrawal by Subject|1|||
37970350|NCT02658890|69657147|FG023|Treatment Phase|Withdrawal by Subject|1|||
37970351|NCT02658890|69657148|FG024|Treatment Phase|Withdrawal by Subject|0|||
37692104|NCT02480153|69168366|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
37692105|NCT02480153|69168367|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
37692106|NCT02480153|69168368|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
37692107|NCT02480153|69168366|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
37692108|NCT02480153|69168367|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
37692109|NCT02480153|69168368|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
37692110|NCT02480153|69168366|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
37692111|NCT02480153|69168367|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
37692112|NCT02480153|69168368|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
37692113|NCT02480153|69168366|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
37692114|NCT02480153|69168367|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
37692115|NCT02480153|69168368|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
37692116|NCT02480153|69168366|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
37692117|NCT02480153|69168367|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
37692118|NCT02480153|69168368|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
37780237|NCT02533674|69345354|FG000|Dose Level VI|Progressive disease|0|||
37780238|NCT02533674|69345355|FG001|Dose Level VI|Progressive disease|0|||
37780239|NCT02533674|69345356|FG002|Dose Level VI|Progressive disease|0|||
37780240|NCT02533674|69345357|FG003|Dose Level VI|Progressive disease|0|||
37970352|NCT02658890|69657149|FG025|Treatment Phase|Withdrawal by Subject|0|||
37970353|NCT02658890|69657150|FG026|Treatment Phase|Withdrawal by Subject|0|||
37970354|NCT02597062|69657242|FG000|Overall Study|Ineligible|1|||
37970355|NCT05159362|69657283|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
37970356|NCT05159362|69657284|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
37970357|NCT05159362|69657285|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
37970358|NCT04975191|69657300|FG000|Overall Study|Protocol Violation|1|||
37970359|NCT04975191|69657301|FG001|Overall Study|Protocol Violation|2|||
37970360|NCT04975191|69657302|FG002|Overall Study|Protocol Violation|2|||
37970361|NCT04975191|69657303|FG003|Overall Study|Protocol Violation|2|||
37970362|NCT04975191|69657300|FG000|Overall Study|Lost to Follow-up|13|||
37970363|NCT04975191|69657301|FG001|Overall Study|Lost to Follow-up|3|||
37970364|NCT04975191|69657302|FG002|Overall Study|Lost to Follow-up|8|||
37970365|NCT04975191|69657303|FG003|Overall Study|Lost to Follow-up|8|||
37970366|NCT04492020|69657329|FG000|Overall Study|Adverse Event|1|||
37970367|NCT04492020|69657330|FG001|Overall Study|Adverse Event|3|||
37970368|NCT04492020|69657329|FG000|Overall Study|Withdrawal by Subject|4|||
37970369|NCT04492020|69657330|FG001|Overall Study|Withdrawal by Subject|3|||
37970370|NCT04492020|69657329|FG000|Overall Study|Lost to Follow-up|4|||
37970371|NCT04492020|69657330|FG001|Overall Study|Lost to Follow-up|3|||
37970372|NCT04492020|69657329|FG000|Overall Study|Protocol Violation|5|||
37970373|NCT04492020|69657330|FG001|Overall Study|Protocol Violation|2|||
37970374|NCT04492020|69657329|FG000|Overall Study|Lack of Qualifying Event|25|||
37970375|NCT04492020|69657330|FG001|Overall Study|Lack of Qualifying Event|27|||
37970376|NCT04492020|69657329|FG000|Overall Study|Non-compliance with Study Drug|2|||
37970377|NCT04492020|69657330|FG001|Overall Study|Non-compliance with Study Drug|1|||
37970378|NCT04382911|69657336|FG000|Overall Study|unable to be imaged prior to surgery|2|||
37970379|NCT04072575|69657344|FG000|Overall Study|Physician Decision|1|||
37970380|NCT04072575|69657344|FG000|Overall Study|Adverse Event|7|||
37970381|NCT04072575|69657344|FG000|Overall Study|Withdrawal by Subject|14|||
37970382|NCT04072575|69657344|FG000|Overall Study|Other|2|||
37970383|NCT03911869|69657350|FG000|Safety Lead-in Phase|Death|7|||
37970384|NCT03911869|69657351|FG001|Safety Lead-in Phase|Death|0|||
37970385|NCT03911869|69657352|FG002|Safety Lead-in Phase|Death|0|||
37780241|NCT02533674|69345358|FG004|Dose Level VI|Progressive disease|0|||
37780242|NCT02533674|69345359|FG005|Dose Level VI|Progressive disease|7|||
37780243|NCT02533674|69345360|FG006|Dose Level VI|Progressive disease|0|||
37970386|NCT03911869|69657350|FG000|Safety Lead-in Phase|Study termination by sponsor|2|||
37970387|NCT03911869|69657351|FG001|Safety Lead-in Phase|Study termination by sponsor|0|||
37970388|NCT03911869|69657352|FG002|Safety Lead-in Phase|Study termination by sponsor|0|||
37970389|NCT03911869|69657350|FG000|Safety Lead-in Phase|Other|1|||
37970390|NCT03911869|69657351|FG001|Safety Lead-in Phase|Other|0|||
37970391|NCT03911869|69657352|FG002|Safety Lead-in Phase|Other|0|||
37970392|NCT03911869|69657350|FG000|Phase 2|Death|0|||
37970393|NCT03911869|69657351|FG001|Phase 2|Death|3|||
37970394|NCT03911869|69657352|FG002|Phase 2|Death|0|||
37692119|NCT02480153|69168366|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
37692120|NCT02480153|69168367|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
37780244|NCT02533674|69345361|FG007|Dose Level VI|Progressive disease|0|||
37970395|NCT03897088|69657361|FG000|Overall Study|Withdrawal by Subject|12|||
37970396|NCT03897088|69657362|FG001|Overall Study|Withdrawal by Subject|12|||
37970397|NCT03897088|69657361|FG000|Overall Study|Lost to Follow-up|7|||
37970398|NCT03897088|69657362|FG001|Overall Study|Lost to Follow-up|15|||
37970399|NCT03897088|69657361|FG000|Overall Study|Sponsor Decision|1|||
37970400|NCT03897088|69657362|FG001|Overall Study|Sponsor Decision|2|||
37970401|NCT03897088|69657361|FG000|Overall Study|COVID-19|2|||
37970402|NCT03897088|69657362|FG001|Overall Study|COVID-19|0|||
37970403|NCT03897088|69657361|FG000|Overall Study|Other|3|||
37970404|NCT03897088|69657362|FG001|Overall Study|Other|0|||
37970405|NCT03897088|69657361|FG000|Overall Study|Non-compliance with Study Drug|1|||
37970406|NCT03897088|69657362|FG001|Overall Study|Non-compliance with Study Drug|1|||
37970407|NCT03897088|69657361|FG000|Overall Study|Pregnancy|0|||
37970408|NCT03897088|69657362|FG001|Overall Study|Pregnancy|1|||
37970409|NCT03700684|69657390|FG000|Overall Study|COVID-19|0|||
37970410|NCT03700684|69657391|FG001|Overall Study|COVID-19|0|||
37970411|NCT03700684|69657392|FG002|Overall Study|COVID-19|2|||
37970412|NCT03659136|69657402|FG000|Overall Study|Not treated|2|||
37970413|NCT03659136|69657403|FG001|Overall Study|Not treated|0|||
37970414|NCT03659136|69657402|FG000|Overall Study|Covid-19 related|1|||
37970415|NCT03659136|69657403|FG001|Overall Study|Covid-19 related|1|||
37970416|NCT03659136|69657402|FG000|Overall Study|Withdrawal by Subject|1|||
37970417|NCT03659136|69657403|FG001|Overall Study|Withdrawal by Subject|6|||
37970418|NCT03659136|69657402|FG000|Overall Study|Adverse Event|4|||
37970419|NCT03659136|69657403|FG001|Overall Study|Adverse Event|6|||
37970420|NCT03659136|69657402|FG000|Overall Study|Progressive disease|37|||
37970421|NCT03659136|69657403|FG001|Overall Study|Progressive disease|31|||
37970422|NCT03659136|69657402|FG000|Overall Study|Study closure|2|||
37970423|NCT03659136|69657403|FG001|Overall Study|Study closure|2|||
37970424|NCT03659136|69657402|FG000|Overall Study|Sponsor decision/recommendation|3|||
37970425|NCT03659136|69657403|FG001|Overall Study|Sponsor decision/recommendation|2|||
37970426|NCT03659136|69657402|FG000|Overall Study|Switched to other drug/therapy|2|||
37970427|NCT03659136|69657403|FG001|Overall Study|Switched to other drug/therapy|2|||
37970428|NCT03659136|69657402|FG000|Overall Study|Lack of clinical benefit|0|||
37970429|NCT03659136|69657403|FG001|Overall Study|Lack of clinical benefit|1|||
37970430|NCT03390036|69657438|FG000|Overall Study|Lost to Follow-up|1|||
37970431|NCT03390036|69657439|FG001|Overall Study|Lost to Follow-up|0|||
37970432|NCT03390036|69657440|FG002|Overall Study|Lost to Follow-up|0|||
37970433|NCT03390036|69657438|FG000|Overall Study|Lack of Efficacy|1|||
37970434|NCT03390036|69657439|FG001|Overall Study|Lack of Efficacy|0|||
37970435|NCT03390036|69657440|FG002|Overall Study|Lack of Efficacy|0|||
37970436|NCT03341936|69657465|FG000|Overall Study|Ineligible|1|||
37970437|NCT03341936|69657465|FG000|Overall Study|Disease Progression|2|||
37970438|NCT03341936|69657465|FG000|Overall Study|Withdrew Consent|4|||
37970439|NCT03341936|69657465|FG000|Overall Study|Non-Compliance|1|||
37970440|NCT03341936|69657465|FG000|Overall Study|Physician Decision|1|||
37970441|NCT03341936|69657465|FG000|Overall Study|Withdrawal by Subject|1|||
37970442|NCT03341936|69657465|FG000|Overall Study|Other|1|||
37780245|NCT02533674|69345354|FG000|Dose Level VI|Withdrawal by Subject|0|||
37780246|NCT02533674|69345355|FG001|Dose Level VI|Withdrawal by Subject|0|||
37780247|NCT02533674|69345356|FG002|Dose Level VI|Withdrawal by Subject|0|||
37780248|NCT02533674|69345357|FG003|Dose Level VI|Withdrawal by Subject|0|||
37780249|NCT02533674|69345358|FG004|Dose Level VI|Withdrawal by Subject|0|||
37780250|NCT02533674|69345359|FG005|Dose Level VI|Withdrawal by Subject|1|||
37780251|NCT02533674|69345360|FG006|Dose Level VI|Withdrawal by Subject|0|||
37780252|NCT02533674|69345361|FG007|Dose Level VI|Withdrawal by Subject|0|||
37780253|NCT02533674|69345354|FG000|Dose Level VI|Treatment-related AE|0|||
37780254|NCT02533674|69345355|FG001|Dose Level VI|Treatment-related AE|0|||
37780255|NCT02533674|69345356|FG002|Dose Level VI|Treatment-related AE|0|||
37780256|NCT02533674|69345357|FG003|Dose Level VI|Treatment-related AE|0|||
37780257|NCT02533674|69345358|FG004|Dose Level VI|Treatment-related AE|0|||
37780258|NCT02533674|69345359|FG005|Dose Level VI|Treatment-related AE|1|||
37780259|NCT02533674|69345360|FG006|Dose Level VI|Treatment-related AE|0|||
37780260|NCT02533674|69345361|FG007|Dose Level VI|Treatment-related AE|0|||
37780261|NCT02533674|69345354|FG000|Dose Level VII|Progressive disease|0|||
37970443|NCT03284203|69657469|FG000|Overall Study|Lost to Follow-up|3|||
37970444|NCT03233724|69657488|FG000|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
37692121|NCT02480153|69168368|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
37692122|NCT02480153|69168366|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
37692123|NCT02480153|69168367|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
37692124|NCT02480153|69168368|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
37692125|NCT02480153|69168366|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
37692126|NCT02480153|69168367|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
37692127|NCT02480153|69168368|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
37692128|NCT02480153|69168366|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
37692129|NCT02480153|69168367|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
37692130|NCT02480153|69168368|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
37970445|NCT03233724|69657489|FG001|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
37970446|NCT03233724|69657490|FG002|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
37970447|NCT03233724|69657491|FG003|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
37970448|NCT03233724|69657492|FG004|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|1|||
37970449|NCT03233724|69657488|FG000|Phase I Dose Escalation|Best interest of participant|1|||
37970450|NCT03233724|69657489|FG001|Phase I Dose Escalation|Best interest of participant|1|||
37970451|NCT03233724|69657490|FG002|Phase I Dose Escalation|Best interest of participant|1|||
37970452|NCT03233724|69657491|FG003|Phase I Dose Escalation|Best interest of participant|0|||
37970453|NCT03233724|69657492|FG004|Phase I Dose Escalation|Best interest of participant|0|||
37970454|NCT03233724|69657488|FG000|Phase I Dose Escalation|Physician Decision|0|||
37970455|NCT03233724|69657489|FG001|Phase I Dose Escalation|Physician Decision|0|||
37970456|NCT03233724|69657490|FG002|Phase I Dose Escalation|Physician Decision|1|||
37970457|NCT03233724|69657491|FG003|Phase I Dose Escalation|Physician Decision|0|||
37970458|NCT03233724|69657492|FG004|Phase I Dose Escalation|Physician Decision|0|||
37970459|NCT03233724|69657488|FG000|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
37970460|NCT03233724|69657489|FG001|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
37970461|NCT03233724|69657490|FG002|Phase I Dose Escalation|Delay >3 weeks on treatment|1|||
37970462|NCT03233724|69657491|FG003|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
37692131|NCT02480153|69168366|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
37970463|NCT03233724|69657492|FG004|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
37970464|NCT03026283|69657506|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
37780262|NCT02533674|69345355|FG001|Dose Level VII|Progressive disease|0|||
37970465|NCT03026283|69657507|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
37970466|NCT03026283|69657508|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
37970467|NCT03026283|69657509|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
37780263|NCT02533674|69345356|FG002|Dose Level VII|Progressive disease|0|||
37780264|NCT02533674|69345357|FG003|Dose Level VII|Progressive disease|0|||
37780265|NCT02533674|69345358|FG004|Dose Level VII|Progressive disease|0|||
37780266|NCT02533674|69345359|FG005|Dose Level VII|Progressive disease|0|||
37780267|NCT02533674|69345360|FG006|Dose Level VII|Progressive disease|10|||
37780268|NCT02533674|69345361|FG007|Dose Level VII|Progressive disease|0|||
37780269|NCT02533674|69345354|FG000|Dose Level VII|Withdrawal by Subject|0|||
37780270|NCT02533674|69345355|FG001|Dose Level VII|Withdrawal by Subject|0|||
37780271|NCT02533674|69345356|FG002|Dose Level VII|Withdrawal by Subject|0|||
37780272|NCT02533674|69345357|FG003|Dose Level VII|Withdrawal by Subject|0|||
37780273|NCT02533674|69345358|FG004|Dose Level VII|Withdrawal by Subject|0|||
37780274|NCT02533674|69345359|FG005|Dose Level VII|Withdrawal by Subject|0|||
37780275|NCT02533674|69345360|FG006|Dose Level VII|Withdrawal by Subject|3|||
37780276|NCT02533674|69345361|FG007|Dose Level VII|Withdrawal by Subject|0|||
37780277|NCT02533674|69345354|FG000|Dose Level VII|Treatment-related AE|0|||
37780278|NCT02533674|69345355|FG001|Dose Level VII|Treatment-related AE|0|||
37780279|NCT02533674|69345356|FG002|Dose Level VII|Treatment-related AE|0|||
37780280|NCT02533674|69345357|FG003|Dose Level VII|Treatment-related AE|0|||
37780281|NCT02533674|69345358|FG004|Dose Level VII|Treatment-related AE|0|||
37780282|NCT02533674|69345359|FG005|Dose Level VII|Treatment-related AE|0|||
37780283|NCT02533674|69345360|FG006|Dose Level VII|Treatment-related AE|1|||
37780284|NCT02533674|69345361|FG007|Dose Level VII|Treatment-related AE|0|||
37780285|NCT02533674|69345354|FG000|Dose Level VII|Death|0|||
37780286|NCT02533674|69345355|FG001|Dose Level VII|Death|0|||
37780287|NCT02533674|69345356|FG002|Dose Level VII|Death|0|||
37780288|NCT02533674|69345357|FG003|Dose Level VII|Death|0|||
37780289|NCT02533674|69345358|FG004|Dose Level VII|Death|0|||
37780290|NCT02533674|69345359|FG005|Dose Level VII|Death|0|||
37780291|NCT02533674|69345360|FG006|Dose Level VII|Death|2|||
37780292|NCT02533674|69345361|FG007|Dose Level VII|Death|0|||
37780293|NCT02533674|69345354|FG000|Dose Level VIII|Progressive disease|0|||
37780294|NCT02533674|69345355|FG001|Dose Level VIII|Progressive disease|0|||
37692132|NCT02480153|69168367|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
37692133|NCT02480153|69168368|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
37692134|NCT02480153|69168366|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
37692135|NCT02480153|69168367|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
37692136|NCT02480153|69168368|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
37692137|NCT02500979|69168393|FG000|Period 1|Hyperglycemia|1|||
37692138|NCT02500979|69168394|FG001|Period 1|Hyperglycemia|0|||
37692139|NCT02500979|69168393|FG000|Period 1|Severe non-compliance to protocol|0|||
37780295|NCT02533674|69345356|FG002|Dose Level VIII|Progressive disease|0|||
37780296|NCT02533674|69345357|FG003|Dose Level VIII|Progressive disease|0|||
37780297|NCT02533674|69345358|FG004|Dose Level VIII|Progressive disease|0|||
37780298|NCT02533674|69345359|FG005|Dose Level VIII|Progressive disease|0|||
37780299|NCT02533674|69345360|FG006|Dose Level VIII|Progressive disease|0|||
37780300|NCT02533674|69345361|FG007|Dose Level VIII|Progressive disease|3|||
37780301|NCT02533674|69345354|FG000|Dose Level VIII|Withdrawal by Subject|0|||
37780302|NCT02533674|69345355|FG001|Dose Level VIII|Withdrawal by Subject|0|||
37780303|NCT02533674|69345356|FG002|Dose Level VIII|Withdrawal by Subject|0|||
37780304|NCT02533674|69345357|FG003|Dose Level VIII|Withdrawal by Subject|0|||
37780305|NCT02533674|69345358|FG004|Dose Level VIII|Withdrawal by Subject|0|||
37780306|NCT02533674|69345359|FG005|Dose Level VIII|Withdrawal by Subject|0|||
37780307|NCT02533674|69345360|FG006|Dose Level VIII|Withdrawal by Subject|0|||
37780308|NCT02533674|69345361|FG007|Dose Level VIII|Withdrawal by Subject|1|||
37692140|NCT02500979|69168394|FG001|Period 1|Severe non-compliance to protocol|1|||
37780309|NCT02533674|69345354|FG000|Dose Level VIII|Treatment-related AE|0|||
37780310|NCT02533674|69345355|FG001|Dose Level VIII|Treatment-related AE|0|||
37780311|NCT02533674|69345356|FG002|Dose Level VIII|Treatment-related AE|0|||
37970468|NCT03026283|69657510|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
37692141|NCT02500979|69168393|FG000|Period 1|Adverse Event|1|||
37692142|NCT02500979|69168394|FG001|Period 1|Adverse Event|0|||
37970469|NCT03026283|69657511|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
37970470|NCT03026283|69657512|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
37970471|NCT03026283|69657513|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
37970472|NCT03026283|69657506|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
37970473|NCT03026283|69657507|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
37970474|NCT03026283|69657508|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
37970475|NCT03026283|69657509|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
37970476|NCT03026283|69657510|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
37970477|NCT03026283|69657511|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
37970478|NCT03026283|69657512|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
37970479|NCT03026283|69657513|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
37970480|NCT03026283|69657506|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
37970481|NCT03026283|69657507|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
37970482|NCT03026283|69657508|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
37970483|NCT03026283|69657509|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
37970484|NCT03026283|69657510|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
37970485|NCT03026283|69657511|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
37970486|NCT03026283|69657512|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
37970487|NCT03026283|69657513|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
37970488|NCT03026283|69657506|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
37970489|NCT03026283|69657507|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
37970490|NCT03026283|69657508|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
37970491|NCT03026283|69657509|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
37970492|NCT03026283|69657510|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
37970493|NCT03026283|69657511|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
37970494|NCT03026283|69657512|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
37970495|NCT03026283|69657513|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
37970496|NCT03026283|69657506|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
37970497|NCT03026283|69657507|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
37970498|NCT03026283|69657508|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
37970499|NCT03026283|69657509|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
37970500|NCT03026283|69657510|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
37970501|NCT03026283|69657511|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
37970502|NCT03026283|69657512|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
37970503|NCT03026283|69657513|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
37970504|NCT03026283|69657506|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
37970505|NCT03026283|69657507|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
37970506|NCT03026283|69657508|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
37970507|NCT03026283|69657509|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
37970508|NCT03026283|69657510|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
37970509|NCT03026283|69657511|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
37970510|NCT03026283|69657512|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
37970511|NCT03026283|69657513|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
37970512|NCT03026283|69657506|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
37970513|NCT03026283|69657507|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
37970514|NCT03026283|69657508|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
37970515|NCT03026283|69657509|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
37970516|NCT03026283|69657510|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
37970517|NCT03026283|69657511|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
37970518|NCT03026283|69657512|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
37970519|NCT03026283|69657513|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
37970520|NCT03026283|69657506|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
37970521|NCT03026283|69657507|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
37970522|NCT03026283|69657508|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
37970523|NCT03026283|69657509|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
37970524|NCT03026283|69657510|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
37970525|NCT03026283|69657511|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
37692143|NCT02500979|69168393|FG000|Period 1|Subject decision|2|||
37970526|NCT03026283|69657512|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
37970527|NCT03026283|69657513|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
37970528|NCT03026283|69657506|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
37970529|NCT03026283|69657507|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
37970530|NCT03026283|69657508|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
37970531|NCT03026283|69657509|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
37970532|NCT03026283|69657510|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
37970533|NCT03026283|69657511|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
37970534|NCT03026283|69657512|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
37970535|NCT03026283|69657513|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
37780312|NCT02533674|69345357|FG003|Dose Level VIII|Treatment-related AE|0|||
37780313|NCT02533674|69345358|FG004|Dose Level VIII|Treatment-related AE|0|||
37780314|NCT02533674|69345359|FG005|Dose Level VIII|Treatment-related AE|0|||
37780315|NCT02533674|69345360|FG006|Dose Level VIII|Treatment-related AE|0|||
37780316|NCT02533674|69345361|FG007|Dose Level VIII|Treatment-related AE|1|||
37780317|NCT02533674|69345354|FG000|Dose Level VIII|Never treated|0|||
37780318|NCT02533674|69345355|FG001|Dose Level VIII|Never treated|0|||
37780319|NCT02533674|69345356|FG002|Dose Level VIII|Never treated|0|||
37780320|NCT02533674|69345357|FG003|Dose Level VIII|Never treated|0|||
37780321|NCT02533674|69345358|FG004|Dose Level VIII|Never treated|0|||
37780322|NCT02533674|69345359|FG005|Dose Level VIII|Never treated|0|||
37780323|NCT02533674|69345360|FG006|Dose Level VIII|Never treated|0|||
37780324|NCT02533674|69345361|FG007|Dose Level VIII|Never treated|1|||
37780325|NCT02540850|69345382|FG000|Overall Study|Lost to Follow-up|69|||
37780326|NCT02540850|69345383|FG001|Overall Study|Lost to Follow-up|66|||
37780327|NCT02540850|69345384|FG002|Overall Study|Lost to Follow-up|34|||
37780328|NCT01662024|69345392|FG000|Overall Study|Pregnancy|2|||
37780329|NCT01662024|69345392|FG000|Overall Study|Withdrawal by Subject|3|||
37780330|NCT02544750|69345461|FG000|Overall Study|Physician Decision|3|||
37780331|NCT02544750|69345462|FG001|Overall Study|Physician Decision|1|||
37780332|NCT02544750|69345461|FG000|Overall Study|Other reasons|69|||
37780333|NCT02544750|69345462|FG001|Overall Study|Other reasons|39|||
37780334|NCT02544750|69345461|FG000|Overall Study|Met withdrawal criteria|2|||
37780335|NCT02544750|69345462|FG001|Overall Study|Met withdrawal criteria|2|||
37780336|NCT02544750|69345461|FG000|Overall Study|Transition To Commercial Product|1|||
37780337|NCT02544750|69345462|FG001|Overall Study|Transition To Commercial Product|0|||
37780338|NCT02544750|69345461|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
37780339|NCT02544750|69345462|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
37780340|NCT02544750|69345461|FG000|Overall Study|Adverse Event|8|||
37780341|NCT02544750|69345462|FG001|Overall Study|Adverse Event|10|||
37780342|NCT02544750|69345461|FG000|Overall Study|Withdrawal by Subject|10|||
37780343|NCT02544750|69345462|FG001|Overall Study|Withdrawal by Subject|4|||
37780344|NCT02544750|69345461|FG000|Overall Study|Lost to Follow-up|1|||
37780345|NCT02544750|69345462|FG001|Overall Study|Lost to Follow-up|0|||
37780346|NCT02540538|69345508|FG000|Overall Study|Pregnancy|0|||
37780347|NCT02540538|69345509|FG001|Overall Study|Pregnancy|1|||
37780348|NCT02540538|69345510|FG002|Overall Study|Pregnancy|0|||
37780349|NCT04697056|69345543|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
37780350|NCT04697056|69345544|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
37970536|NCT02166463|69657580|FG000|Overall Study|Lost to Follow-up|0|||
37970537|NCT02166463|69657581|FG001|Overall Study|Lost to Follow-up|1|||
37970538|NCT02166463|69657580|FG000|Overall Study|Physician Decision|10|||
37970539|NCT02166463|69657581|FG001|Overall Study|Physician Decision|10|||
37970540|NCT02166463|69657580|FG000|Overall Study|Ineligible|11|||
37970541|NCT02166463|69657581|FG001|Overall Study|Ineligible|2|||
37970542|NCT02166463|69657580|FG000|Overall Study|Progressive Disease|9|||
37970543|NCT02166463|69657581|FG001|Overall Study|Progressive Disease|6|||
37970544|NCT02166463|69657580|FG000|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
37970545|NCT02166463|69657581|FG001|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
37970546|NCT02166463|69657580|FG000|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|1|||
37970547|NCT02166463|69657581|FG001|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|0|||
37970548|NCT02166463|69657580|FG000|Overall Study|Refusal of further protocol therapy|5|||
37970549|NCT02166463|69657581|FG001|Overall Study|Refusal of further protocol therapy|6|||
37970550|NCT01994954|69657589|FG000|Overall Study|Death|1|||
37970551|NCT01994954|69657590|FG001|Overall Study|Death|0|||
37970552|NCT01994954|69657589|FG000|Overall Study|Withdrawal by Subject|9|||
37970553|NCT01994954|69657590|FG001|Overall Study|Withdrawal by Subject|14|||
37970554|NCT01994954|69657589|FG000|Overall Study|Physician Decision|2|||
37970555|NCT01994954|69657590|FG001|Overall Study|Physician Decision|2|||
37970556|NCT01994954|69657589|FG000|Overall Study|Lost to Follow-up|8|||
37970557|NCT01994954|69657590|FG001|Overall Study|Lost to Follow-up|10|||
37970558|NCT01994954|69657589|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
37970559|NCT01994954|69657590|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
37970560|NCT00380367|69657667|FG000|Overall Study|Lost to Follow-up|1|||
37970561|NCT00380367|69657667|FG000|Overall Study|Withdrawal by Subject|1|||
37970562|NCT00531050|69657677|FG000|Part 1: Period 1|Adverse Event|0|||
37970563|NCT00531050|69657678|FG001|Part 1: Period 1|Adverse Event|1|||
37970564|NCT00531050|69657679|FG002|Part 1: Period 1|Adverse Event|0|||
37970565|NCT00531050|69657680|FG003|Part 1: Period 1|Adverse Event|0|||
37970566|NCT00531050|69657681|FG004|Part 1: Period 1|Adverse Event|0|||
37970567|NCT00531050|69657682|FG005|Part 1: Period 1|Adverse Event|0|||
37970568|NCT00531050|69657677|FG000|Part 1: Period 1|Protocol Deviation|0|||
37970569|NCT00531050|69657678|FG001|Part 1: Period 1|Protocol Deviation|0|||
37970570|NCT00531050|69657679|FG002|Part 1: Period 1|Protocol Deviation|0|||
37970571|NCT00531050|69657680|FG003|Part 1: Period 1|Protocol Deviation|1|||
37970572|NCT00531050|69657681|FG004|Part 1: Period 1|Protocol Deviation|0|||
37970573|NCT00531050|69657682|FG005|Part 1: Period 1|Protocol Deviation|0|||
37970574|NCT00531050|69657677|FG000|Part 1: Period 3|Adverse Event|1|||
37970575|NCT00531050|69657678|FG001|Part 1: Period 3|Adverse Event|0|||
37970576|NCT00531050|69657679|FG002|Part 1: Period 3|Adverse Event|0|||
37970577|NCT00531050|69657680|FG003|Part 1: Period 3|Adverse Event|0|||
37970578|NCT00531050|69657681|FG004|Part 1: Period 3|Adverse Event|0|||
37970579|NCT00531050|69657682|FG005|Part 1: Period 3|Adverse Event|0|||
37970580|NCT00531050|69657677|FG000|Part 2: Period 1|Adverse Event|0|||
37970581|NCT00531050|69657678|FG001|Part 2: Period 1|Adverse Event|0|||
37970582|NCT00531050|69657679|FG002|Part 2: Period 1|Adverse Event|0|||
37970583|NCT00531050|69657680|FG003|Part 2: Period 1|Adverse Event|0|||
37970584|NCT00531050|69657681|FG004|Part 2: Period 1|Adverse Event|0|||
37970585|NCT00531050|69657682|FG005|Part 2: Period 1|Adverse Event|1|||
37970586|NCT00531050|69657677|FG000|Part 2: Period 3|Abnormal test procedure|1|||
37970587|NCT00531050|69657678|FG001|Part 2: Period 3|Abnormal test procedure|0|||
37970588|NCT00531050|69657679|FG002|Part 2: Period 3|Abnormal test procedure|0|||
37970589|NCT00531050|69657680|FG003|Part 2: Period 3|Abnormal test procedure|0|||
37970590|NCT00531050|69657681|FG004|Part 2: Period 3|Abnormal test procedure|0|||
37970591|NCT00531050|69657682|FG005|Part 2: Period 3|Abnormal test procedure|1|||
37970592|NCT00530348|69657701|FG000|Overall Study|Adverse Event|5|||
37970593|NCT00530348|69657702|FG001|Overall Study|Adverse Event|1|||
37970594|NCT00530348|69657701|FG000|Overall Study|Death|0|||
37970595|NCT00530348|69657702|FG001|Overall Study|Death|1|||
37970596|NCT00530348|69657701|FG000|Overall Study|Lack of Efficacy|2|||
37970597|NCT00530348|69657702|FG001|Overall Study|Lack of Efficacy|0|||
37970598|NCT00530348|69657701|FG000|Overall Study|Lost to Follow-up|0|||
37970599|NCT00530348|69657702|FG001|Overall Study|Lost to Follow-up|2|||
37970600|NCT00530348|69657701|FG000|Overall Study|Physician Decision|1|||
37970601|NCT00530348|69657702|FG001|Overall Study|Physician Decision|2|||
37970602|NCT00530348|69657701|FG000|Overall Study|Pregnancy|1|||
37970603|NCT00530348|69657702|FG001|Overall Study|Pregnancy|0|||
37970604|NCT00530348|69657701|FG000|Overall Study|Withdrawal by Subject|12|||
37970605|NCT00530348|69657702|FG001|Overall Study|Withdrawal by Subject|12|||
37970606|NCT00530348|69657701|FG000|Overall Study|Randomised in error|1|||
37970607|NCT00530348|69657702|FG001|Overall Study|Randomised in error|0|||
37970608|NCT00530348|69657701|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
37970609|NCT00530348|69657702|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
37970610|NCT03886220|69657710|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
37970611|NCT03886220|69657711|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
37970612|NCT03886220|69657710|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
37970613|NCT03886220|69657711|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
37970614|NCT03886220|69657710|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
37970615|NCT03886220|69657711|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
37970616|NCT00530270|69657719|FG000|Overall Study|Protocol Violation|1|||
37970617|NCT00530270|69657720|FG001|Overall Study|Protocol Violation|0|||
37970618|NCT03885596|69657730|FG000|Overall Study|Withdrawal by Subject|2|||
37970619|NCT03885596|69657731|FG001|Overall Study|Withdrawal by Subject|1|||
37970620|NCT03885596|69657732|FG002|Overall Study|Withdrawal by Subject|0|||
37970621|NCT03885596|69657733|FG003|Overall Study|Withdrawal by Subject|0|||
37970622|NCT00529100|69657749|FG000|Overall Study|Adverse Event|0|||
37970623|NCT00529100|69657750|FG001|Overall Study|Adverse Event|5|||
37970624|NCT00529100|69657749|FG000|Overall Study|Protocol Violation|0|||
37970625|NCT00529100|69657750|FG001|Overall Study|Protocol Violation|1|||
37970626|NCT00529100|69657749|FG000|Overall Study|Progressive Disease|0|||
37970627|NCT00529100|69657750|FG001|Overall Study|Progressive Disease|1|||
37970628|NCT00529100|69657749|FG000|Overall Study|Withdrawal by Subject|0|||
37970629|NCT00529100|69657750|FG001|Overall Study|Withdrawal by Subject|1|||
37970630|NCT00529100|69657749|FG000|Overall Study|Participant Ineligibility|0|||
37970631|NCT00529100|69657750|FG001|Overall Study|Participant Ineligibility|1|||
37970632|NCT03878108|69657762|FG000|Overall Study|Adverse Event|1|||
37970633|NCT03878108|69657763|FG001|Overall Study|Adverse Event|0|||
37970634|NCT00529958|69657772|FG000|2-Year Follow-up|Lost to Follow-up|1|||
37970635|NCT00529958|69657773|FG001|2-Year Follow-up|Lost to Follow-up|2|||
37863966|NCT01121913|69547557|FG001|Third Washout Period|Adverse Event|0|||
37863967|NCT01121913|69547558|FG002|Third Washout Period|Adverse Event|0|||
37970636|NCT00529958|69657774|FG002|2-Year Follow-up|Lost to Follow-up|2|||
37970637|NCT00529958|69657772|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
37970638|NCT00529958|69657773|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
37970639|NCT00529958|69657774|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
37970640|NCT00529958|69657772|FG000|5-Year Follow-up|Lost to Follow-up|2|||
37970641|NCT00529958|69657773|FG001|5-Year Follow-up|Lost to Follow-up|3|||
37970642|NCT00529958|69657774|FG002|5-Year Follow-up|Lost to Follow-up|1|||
37970643|NCT00529958|69657772|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
37970644|NCT00529958|69657773|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
37970645|NCT00529958|69657774|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
37970646|NCT00529802|69657782|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
37970647|NCT00529802|69657782|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
37970648|NCT00529802|69657782|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
37970649|NCT00529802|69657782|FG000|Evaluable for Primary Endpoint|Death|1|||
37970650|NCT00529802|69657782|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
37970651|NCT00529802|69657782|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
37970652|NCT00529802|69657782|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
37970653|NCT00528866|69657788|FG000|Overall Study|Protocol Violation|6|||
37970654|NCT00614393|69657798|FG000|Overall Study|Adverse Event|20|||
37970655|NCT00614393|69657799|FG001|Overall Study|Adverse Event|2|||
37970656|NCT00614393|69657800|FG002|Overall Study|Adverse Event|3|||
37970657|NCT00614393|69657801|FG003|Overall Study|Adverse Event|13|||
37970658|NCT00614393|69657802|FG004|Overall Study|Adverse Event|21|||
37970659|NCT00614393|69657798|FG000|Overall Study|Lost to Follow-up|0|||
37970660|NCT00614393|69657799|FG001|Overall Study|Lost to Follow-up|0|||
37970661|NCT00614393|69657800|FG002|Overall Study|Lost to Follow-up|0|||
37970662|NCT00614393|69657801|FG003|Overall Study|Lost to Follow-up|1|||
37970663|NCT00614393|69657802|FG004|Overall Study|Lost to Follow-up|2|||
37970664|NCT00614393|69657798|FG000|Overall Study|Physician Decision|17|||
37970665|NCT00614393|69657799|FG001|Overall Study|Physician Decision|0|||
37970666|NCT00614393|69657800|FG002|Overall Study|Physician Decision|1|||
37970667|NCT00614393|69657801|FG003|Overall Study|Physician Decision|8|||
37970668|NCT00614393|69657802|FG004|Overall Study|Physician Decision|9|||
37970669|NCT00614393|69657798|FG000|Overall Study|Progressive Disease|118|||
37970670|NCT00614393|69657799|FG001|Overall Study|Progressive Disease|5|||
37970671|NCT00614393|69657800|FG002|Overall Study|Progressive Disease|5|||
37970672|NCT00614393|69657801|FG003|Overall Study|Progressive Disease|138|||
37970673|NCT00614393|69657802|FG004|Overall Study|Progressive Disease|130|||
37970674|NCT00614393|69657798|FG000|Overall Study|Protocol Violation|1|||
37970675|NCT00614393|69657799|FG001|Overall Study|Protocol Violation|0|||
37970676|NCT00614393|69657800|FG002|Overall Study|Protocol Violation|0|||
37970677|NCT00614393|69657801|FG003|Overall Study|Protocol Violation|0|||
37970678|NCT00614393|69657802|FG004|Overall Study|Protocol Violation|0|||
37970679|NCT00614393|69657798|FG000|Overall Study|Terminated by Sponsor|0|||
37970680|NCT00614393|69657799|FG001|Overall Study|Terminated by Sponsor|0|||
37970681|NCT00614393|69657800|FG002|Overall Study|Terminated by Sponsor|0|||
37970682|NCT00614393|69657801|FG003|Overall Study|Terminated by Sponsor|0|||
37970683|NCT00614393|69657802|FG004|Overall Study|Terminated by Sponsor|1|||
37970684|NCT00614393|69657798|FG000|Overall Study|Withdrawal by Subject|20|||
37970685|NCT00614393|69657799|FG001|Overall Study|Withdrawal by Subject|1|||
37970686|NCT00614393|69657800|FG002|Overall Study|Withdrawal by Subject|1|||
37970687|NCT00614393|69657801|FG003|Overall Study|Withdrawal by Subject|16|||
37970688|NCT00614393|69657802|FG004|Overall Study|Withdrawal by Subject|13|||
37970689|NCT00614393|69657798|FG000|Overall Study|Other|4|||
37970690|NCT00614393|69657799|FG001|Overall Study|Other|0|||
37970691|NCT00614393|69657800|FG002|Overall Study|Other|0|||
37970692|NCT00614393|69657801|FG003|Overall Study|Other|4|||
37970693|NCT00614393|69657802|FG004|Overall Study|Other|2|||
37970694|NCT00614393|69657798|FG000|Overall Study|Not Treated|0|||
37970695|NCT00614393|69657799|FG001|Overall Study|Not Treated|0|||
37970696|NCT00614393|69657800|FG002|Overall Study|Not Treated|0|||
37970697|NCT00614393|69657801|FG003|Overall Study|Not Treated|0|||
37970698|NCT00614393|69657802|FG004|Overall Study|Not Treated|2|||
37970699|NCT00612677|69657814|FG000|Overall Study|study closed before treatment started|1|||
37692144|NCT02500979|69168394|FG001|Period 1|Subject decision|0|||
37780367|NCT02532972|69345699|FG000|Overall Study|Withdrawal by Subject|1|||
37780368|NCT03187834|69345752|FG000|Overall Study|Lost to Follow-up|0|||
37780369|NCT03187834|69345753|FG001|Overall Study|Lost to Follow-up|1|||
37780370|NCT03187834|69345754|FG002|Overall Study|Lost to Follow-up|2|||
37780371|NCT03187834|69345755|FG003|Overall Study|Lost to Follow-up|2|||
37780372|NCT03187834|69345752|FG000|Overall Study|Had invalid anthropometric measurements|5|||
37780373|NCT03187834|69345753|FG001|Overall Study|Had invalid anthropometric measurements|3|||
37780374|NCT03187834|69345754|FG002|Overall Study|Had invalid anthropometric measurements|4|||
37780375|NCT03187834|69345755|FG003|Overall Study|Had invalid anthropometric measurements|2|||
37780376|NCT03713944|69345908|FG000|Study Treatment|Patient non-compliance|1|||
37780377|NCT03713944|69345908|FG000|Study Treatment|Alternative Cancer Therapy|3|||
37780378|NCT03713944|69345908|FG000|Study Treatment|Disease Progression|18|||
37780379|NCT03713944|69345908|FG000|Study Treatment|AE/Side Effects/Complications|2|||
37780380|NCT03713944|69345908|FG000|Study Treatment|Death|2|||
37780381|NCT03713944|69345908|FG000|Study Treatment|Withdrawal by Subject|1|||
37780382|NCT03713944|69345908|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
37780383|NCT03713944|69345908|FG000|Study Treatment|Symptomatic Deterioration|2|||
37780384|NCT03713944|69345908|FG000|Follow up|Withdrawal by Subject|2|||
37780385|NCT03713944|69345908|FG000|Follow up|Death|11|||
37780386|NCT03713944|69345908|FG000|Follow up|Study Terminated|3|||
37780387|NCT01572662|69345986|FG000|Overall Study|Withdrawal by Subject|1|||
37780388|NCT01572662|69345987|FG001|Overall Study|Withdrawal by Subject|0|||
37780389|NCT01572662|69345986|FG000|Overall Study|Physician Decision|0|||
37970700|NCT00613925|69657820|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
37970701|NCT00613925|69657821|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
37970702|NCT00613301|69657827|FG000|Overall Study|Adverse Event|49|||
37970703|NCT00613301|69657827|FG000|Overall Study|Lost to Follow-up|88|||
37692145|NCT02500979|69168393|FG000|Period 2|Change in risk|1|||
37692146|NCT02500979|69168394|FG001|Period 2|Change in risk|0|||
37692147|NCT02500901|69168400|FG000|Overall Study|Disease ProgressionDD|2|||
37692148|NCT02479139|69168410|FG000|Overall Study|Lost to Follow-up|2|||
37692149|NCT02479139|69168411|FG001|Overall Study|Lost to Follow-up|4|||
37692150|NCT02479139|69168412|FG002|Overall Study|Lost to Follow-up|4|||
37692151|NCT02479139|69168413|FG003|Overall Study|Lost to Follow-up|2|||
37692152|NCT02479139|69168414|FG004|Overall Study|Lost to Follow-up|3|||
37692153|NCT02479139|69168415|FG005|Overall Study|Lost to Follow-up|5|||
37692154|NCT02479139|69168410|FG000|Overall Study|Withdrew Consent|5|||
37692155|NCT02479139|69168411|FG001|Overall Study|Withdrew Consent|6|||
37692156|NCT02479139|69168412|FG002|Overall Study|Withdrew Consent|1|||
37692157|NCT02479139|69168413|FG003|Overall Study|Withdrew Consent|4|||
37692158|NCT02479139|69168414|FG004|Overall Study|Withdrew Consent|1|||
37692159|NCT02479139|69168415|FG005|Overall Study|Withdrew Consent|1|||
37692160|NCT02479139|69168410|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
37692161|NCT02479139|69168411|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
37692162|NCT02479139|69168412|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
37692163|NCT02479139|69168413|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
37692164|NCT02479139|69168414|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
37692165|NCT02479139|69168415|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
37692166|NCT02479139|69168410|FG000|Overall Study|Other Miscellaneous Reasons|1|||
37692167|NCT02479139|69168411|FG001|Overall Study|Other Miscellaneous Reasons|0|||
37692168|NCT02479139|69168412|FG002|Overall Study|Other Miscellaneous Reasons|1|||
37692169|NCT02479139|69168413|FG003|Overall Study|Other Miscellaneous Reasons|1|||
37692170|NCT02479139|69168414|FG004|Overall Study|Other Miscellaneous Reasons|1|||
37692171|NCT02479139|69168415|FG005|Overall Study|Other Miscellaneous Reasons|0|||
37692172|NCT02478359|69168431|FG000|Overall Study|Disenrolled from health plan|106|||
37780390|NCT01572662|69345987|FG001|Overall Study|Physician Decision|1|||
37780391|NCT02325154|69346017|FG000|Overall Study|Physician Decision|1|||
37780392|NCT00493870|69346144|FG000|Overall Study|Lost to Follow-up|12|||
37780393|NCT00493870|69346145|FG001|Overall Study|Lost to Follow-up|15|||
37863968|NCT01121913|69547559|FG003|Third Washout Period|Adverse Event|0|||
37970704|NCT00613301|69657827|FG000|Overall Study|Withdrawal by Subject|5|||
37692173|NCT02478359|69168432|FG001|Overall Study|Disenrolled from health plan|65|||
37692174|NCT01877668|69168445|FG000|Overall Study|Death|0|||
37692175|NCT01877668|69168446|FG001|Overall Study|Death|0|||
37692176|NCT01877668|69168447|FG002|Overall Study|Death|0|||
37970705|NCT00613301|69657827|FG000|Overall Study|Death|6|||
37692177|NCT01877668|69168448|FG003|Overall Study|Death|1|||
37970706|NCT00613301|69657827|FG000|Overall Study|Lack of Efficacy|13|||
37970707|NCT00613301|69657827|FG000|Overall Study|Physician Decision|2|||
37970708|NCT00613301|69657827|FG000|Overall Study|No data was collected|53|||
37970709|NCT00613301|69657827|FG000|Overall Study|Irregularly enrolled patients|12|||
37970710|NCT00609947|69657832|FG000|Overall Study|Death|1|||
37970711|NCT00609869|69657837|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
37970712|NCT00609869|69657837|FG000|Overall Study|Severe hematologic toxicity|1|||
37970713|NCT00609869|69657837|FG000|Overall Study|Withdrawal by Subject|1|||
37970714|NCT00609869|69657837|FG000|Overall Study|Seizures|1|||
37970715|NCT00609869|69657837|FG000|Overall Study|Severe tumor flare reaction|1|||
37970716|NCT00609869|69657837|FG000|Overall Study|Hepatitis B infection|1|||
37970717|NCT00609869|69657837|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
37970718|NCT00609869|69657837|FG000|Overall Study|Mantle cell: not evaluable|4|||
37970719|NCT00529568|69657843|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
37970720|NCT00529568|69657844|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
37970721|NCT00529568|69657845|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
37970722|NCT00529568|69657843|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
37970723|NCT00529568|69657844|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
37970724|NCT00529568|69657845|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
37970725|NCT00529568|69657843|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
37970726|NCT00529568|69657844|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
37970727|NCT00529568|69657845|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
37970728|NCT00529568|69657843|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
37970729|NCT00529568|69657844|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
37970730|NCT00529568|69657845|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
37970731|NCT00529568|69657843|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
37970732|NCT00529568|69657844|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
37970733|NCT00529568|69657845|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
37970734|NCT00529568|69657843|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
37970735|NCT00529568|69657844|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
37970736|NCT00529568|69657845|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
37970737|NCT00529568|69657843|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
37970738|NCT00529568|69657844|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
37970739|NCT00529568|69657845|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
37970740|NCT00529568|69657843|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
37970741|NCT00529568|69657844|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
37970742|NCT00529568|69657845|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
37970743|NCT00529568|69657843|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
37970744|NCT00529568|69657844|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
37970745|NCT00529568|69657845|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
37970746|NCT00529568|69657843|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
37970747|NCT00529568|69657844|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
37970748|NCT00529568|69657845|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
37970749|NCT00529568|69657843|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
37970750|NCT00529568|69657844|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
37970751|NCT00529568|69657845|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
37970752|NCT00611975|69657856|FG000|Overall Study|Withdrawal by Subject|3|||
37970753|NCT00611975|69657857|FG001|Overall Study|Withdrawal by Subject|7|||
37970754|NCT00611975|69657856|FG000|Overall Study|Pregnancy|2|||
37970755|NCT00611975|69657857|FG001|Overall Study|Pregnancy|1|||
37970756|NCT00573131|69657865|FG000|Overall Study|Withdrawal by Subject|10|||
37692178|NCT01877668|69168449|FG004|Overall Study|Death|0|||
37692179|NCT01877668|69168445|FG000|Overall Study|No longer met study criteria|1|||
37970757|NCT00573131|69657866|FG001|Overall Study|Withdrawal by Subject|8|||
37970758|NCT00521144|69657877|FG000|Overall Study|Not Treated|0|||
37970759|NCT00521144|69657878|FG001|Overall Study|Not Treated|0|||
37970760|NCT00521144|69657879|FG002|Overall Study|Not Treated|0|||
37970761|NCT00521144|69657880|FG003|Overall Study|Not Treated|1|||
37970762|NCT00521144|69657881|FG004|Overall Study|Not Treated|0|||
37970763|NCT00521144|69657877|FG000|Overall Study|Adverse Event|0|||
37970764|NCT00521144|69657878|FG001|Overall Study|Adverse Event|1|||
37970765|NCT00521144|69657879|FG002|Overall Study|Adverse Event|0|||
37970766|NCT00521144|69657880|FG003|Overall Study|Adverse Event|0|||
37970767|NCT00521144|69657881|FG004|Overall Study|Adverse Event|1|||
37970768|NCT00521144|69657877|FG000|Overall Study|Progressive Disease|4|||
37970769|NCT00521144|69657878|FG001|Overall Study|Progressive Disease|2|||
37970770|NCT00521144|69657879|FG002|Overall Study|Progressive Disease|2|||
37970771|NCT00521144|69657880|FG003|Overall Study|Progressive Disease|0|||
37970772|NCT00521144|69657881|FG004|Overall Study|Progressive Disease|6|||
37970773|NCT00520676|69657895|FG000|Overall Study|Death|84|||
37692180|NCT01877668|69168446|FG001|Overall Study|No longer met study criteria|0|||
37970774|NCT00520676|69657896|FG001|Overall Study|Death|81|||
37970775|NCT00520676|69657895|FG000|Overall Study|Lost to Follow-up|6|||
37970776|NCT00520676|69657896|FG001|Overall Study|Lost to Follow-up|10|||
37970777|NCT00520676|69657895|FG000|Overall Study|Physician Decision|4|||
37970778|NCT00520676|69657896|FG001|Overall Study|Physician Decision|1|||
37970779|NCT00520676|69657895|FG000|Overall Study|Withdrawal by Subject|7|||
37970780|NCT00520676|69657896|FG001|Overall Study|Withdrawal by Subject|11|||
37970781|NCT00610649|69657913|FG000|Overall Study|Adverse Event|1|||
37970782|NCT00610649|69657914|FG001|Overall Study|Adverse Event|0|||
37970783|NCT00610649|69657915|FG002|Overall Study|Adverse Event|0|||
37970784|NCT00610649|69657916|FG003|Overall Study|Adverse Event|0|||
37970785|NCT00610649|69657917|FG004|Overall Study|Adverse Event|0|||
37970786|NCT00610649|69657918|FG005|Overall Study|Adverse Event|0|||
37970787|NCT00610649|69657919|FG006|Overall Study|Adverse Event|0|||
37970788|NCT00610649|69657920|FG007|Overall Study|Adverse Event|0|||
37970789|NCT00610649|69657921|FG008|Overall Study|Adverse Event|0|||
37970790|NCT00610649|69657922|FG009|Overall Study|Adverse Event|0|||
37970791|NCT00610649|69657923|FG010|Overall Study|Adverse Event|1|||
37970792|NCT00610649|69657913|FG000|Overall Study|Family Emergency|0|||
37970793|NCT00610649|69657914|FG001|Overall Study|Family Emergency|1|||
37970794|NCT00610649|69657915|FG002|Overall Study|Family Emergency|0|||
37970795|NCT00610649|69657916|FG003|Overall Study|Family Emergency|0|||
37970796|NCT00610649|69657917|FG004|Overall Study|Family Emergency|0|||
37970797|NCT00610649|69657918|FG005|Overall Study|Family Emergency|0|||
37970798|NCT00610649|69657919|FG006|Overall Study|Family Emergency|0|||
37970799|NCT00610649|69657920|FG007|Overall Study|Family Emergency|0|||
37970800|NCT00610649|69657921|FG008|Overall Study|Family Emergency|0|||
37970801|NCT00610649|69657922|FG009|Overall Study|Family Emergency|0|||
37970802|NCT00610649|69657923|FG010|Overall Study|Family Emergency|0|||
37970803|NCT00610649|69657913|FG000|Overall Study|Withdrawal by Subject|0|||
37970804|NCT00610649|69657914|FG001|Overall Study|Withdrawal by Subject|0|||
37970805|NCT00610649|69657915|FG002|Overall Study|Withdrawal by Subject|0|||
37970806|NCT00610649|69657916|FG003|Overall Study|Withdrawal by Subject|0|||
37970807|NCT00610649|69657917|FG004|Overall Study|Withdrawal by Subject|0|||
37970808|NCT00610649|69657918|FG005|Overall Study|Withdrawal by Subject|0|||
37970809|NCT00610649|69657919|FG006|Overall Study|Withdrawal by Subject|0|||
37970810|NCT00610649|69657920|FG007|Overall Study|Withdrawal by Subject|0|||
37970811|NCT00610649|69657921|FG008|Overall Study|Withdrawal by Subject|0|||
37970812|NCT00610649|69657922|FG009|Overall Study|Withdrawal by Subject|1|||
37970813|NCT00610649|69657923|FG010|Overall Study|Withdrawal by Subject|0|||
37970814|NCT00608543|69657947|FG000|Overall Study|Adverse Event|4|||
37970815|NCT00520130|69657954|FG000|Overall Study|Disease progression on study|4|||
37970816|NCT00520130|69657955|FG001|Overall Study|Disease progression on study|0|||
37970817|NCT00520130|69657954|FG000|Overall Study|Physician Decision|1|||
37970818|NCT00520130|69657955|FG001|Overall Study|Physician Decision|1|||
37970819|NCT00519896|69657965|FG000|Overall Study|Protocol Violation|1|||
37970820|NCT00519896|69657965|FG000|Overall Study|Adverse Event|1|||
37970821|NCT00527618|69657978|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
37970822|NCT00527618|69657979|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
37970823|NCT00527618|69657978|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
37970824|NCT00527618|69657979|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
37970825|NCT00527618|69657978|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
37692181|NCT01877668|69168447|FG002|Overall Study|No longer met study criteria|1|||
37970826|NCT00527618|69657979|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
37970827|NCT00527618|69657978|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
37970828|NCT00527618|69657979|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
37970829|NCT00527618|69657978|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
37970830|NCT00527618|69657979|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
37970831|NCT00527618|69657978|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
37970832|NCT00527618|69657979|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
37970833|NCT00527072|69657986|FG000|Overall Study|Adverse Event|13|||
37970834|NCT00527072|69657986|FG000|Overall Study|Lack of Efficacy|11|||
37970835|NCT00527072|69657986|FG000|Overall Study|Lost to Follow-up|3|||
37970836|NCT00527072|69657986|FG000|Overall Study|Protocol Violation|2|||
37970837|NCT00527072|69657986|FG000|Overall Study|Withdrawal by Subject|7|||
37970838|NCT00526994|69657994|FG000|Overall Study|Lost to Follow-up|98|||
37970839|NCT00526994|69657995|FG001|Overall Study|Lost to Follow-up|108|||
37970840|NCT00526994|69657996|FG002|Overall Study|Lost to Follow-up|96|||
37970841|NCT00526994|69657994|FG000|Overall Study|Death|4|||
37970842|NCT00526994|69657995|FG001|Overall Study|Death|3|||
37970843|NCT00526994|69657996|FG002|Overall Study|Death|3|||
37970844|NCT00526994|69657994|FG000|Overall Study|Withdrawal by Subject|2|||
37970845|NCT00526994|69657995|FG001|Overall Study|Withdrawal by Subject|7|||
37970846|NCT00526994|69657996|FG002|Overall Study|Withdrawal by Subject|5|||
37970847|NCT00526994|69657994|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
37970848|NCT00526994|69657995|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
37970849|NCT00526994|69657996|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
37970850|NCT00519428|69658007|FG000|Overall Study|Adverse Event|5|||
37970851|NCT00519428|69658008|FG001|Overall Study|Adverse Event|2|||
37970852|NCT00519428|69658009|FG002|Overall Study|Adverse Event|10|||
37970853|NCT00519428|69658007|FG000|Overall Study|Lost to Follow-up|7|||
37970854|NCT00519428|69658008|FG001|Overall Study|Lost to Follow-up|7|||
37970855|NCT00519428|69658009|FG002|Overall Study|Lost to Follow-up|6|||
37970856|NCT00519428|69658007|FG000|Overall Study|Withdrawal by Subject|8|||
37970857|NCT00519428|69658008|FG001|Overall Study|Withdrawal by Subject|3|||
37970858|NCT00519428|69658009|FG002|Overall Study|Withdrawal by Subject|7|||
37970859|NCT00519428|69658007|FG000|Overall Study|unstated|1|||
37970860|NCT00519428|69658008|FG001|Overall Study|unstated|3|||
37970861|NCT00519428|69658009|FG002|Overall Study|unstated|2|||
37970862|NCT00432159|69658025|FG000|Overall Study|Death|0|||
37970863|NCT00432159|69658026|FG001|Overall Study|Death|1|||
37970864|NCT00432159|69658027|FG002|Overall Study|Death|0|||
37970865|NCT00432159|69658028|FG003|Overall Study|Death|0|||
37970866|NCT00432159|69658029|FG004|Overall Study|Death|0|||
37970867|NCT00432159|69658025|FG000|Overall Study|Failure|9|||
37970868|NCT00432159|69658026|FG001|Overall Study|Failure|5|||
37970869|NCT00432159|69658027|FG002|Overall Study|Failure|3|||
37970870|NCT00432159|69658028|FG003|Overall Study|Failure|2|||
37970871|NCT00432159|69658029|FG004|Overall Study|Failure|3|||
37970872|NCT00432159|69658025|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
37970873|NCT00432159|69658026|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
37970874|NCT00432159|69658027|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
37970875|NCT00432159|69658028|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
37970876|NCT00432159|69658029|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
37970877|NCT00519194|69658041|FG000|Overall Study|Withdrawal by Subject|9|||
37970878|NCT00519194|69658041|FG000|Overall Study|Death|9|||
37970879|NCT00519194|69658041|FG000|Overall Study|Lost to Follow-up|3|||
37970880|NCT00431847|69658049|FG000|Overall Study|completion of less than two study visits|6|||
37970881|NCT00431847|69658050|FG001|Overall Study|completion of less than two study visits|3|||
37970882|NCT00431847|69658051|FG002|Overall Study|completion of less than two study visits|4|||
37970883|NCT00431847|69658052|FG003|Overall Study|completion of less than two study visits|14|||
37970884|NCT00431847|69658053|FG004|Overall Study|completion of less than two study visits|0|||
37970885|NCT00431847|69658049|FG000|Overall Study|Protocol Violation|0|||
37970886|NCT00431847|69658050|FG001|Overall Study|Protocol Violation|0|||
37970887|NCT00431847|69658051|FG002|Overall Study|Protocol Violation|0|||
37970888|NCT00431847|69658052|FG003|Overall Study|Protocol Violation|0|||
37970889|NCT00431847|69658053|FG004|Overall Study|Protocol Violation|1|||
37970890|NCT00431067|69658063|FG000|Overall Study|Other Adverse Event|9|||
37970891|NCT00431067|69658063|FG000|Overall Study|Progressive disease|30|||
37970892|NCT00431067|69658063|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
37970893|NCT00430989|69658069|FG000|Overall Study|Lost to Follow-up|2|||
37970894|NCT00430989|69658070|FG001|Overall Study|Lost to Follow-up|3|||
37970895|NCT00430989|69658069|FG000|Overall Study|Withdrawal by Subject|15|||
37970896|NCT00430989|69658070|FG001|Overall Study|Withdrawal by Subject|14|||
37970897|NCT00430989|69658069|FG000|Overall Study|Protocol Violation|30|||
37970898|NCT00430989|69658070|FG001|Overall Study|Protocol Violation|37|||
37970899|NCT00430989|69658069|FG000|Overall Study|Not eligible|13|||
37780401|NCT03951753|69346418|FG000|Overall Study|Adverse Event|1|||
37780402|NCT03951753|69346419|FG001|Overall Study|Adverse Event|0|||
37780403|NCT03951753|69346420|FG002|Overall Study|Adverse Event|3|||
37780404|NCT03951753|69346418|FG000|Overall Study|Withdrawal by Subject|3|||
37780405|NCT03951753|69346419|FG001|Overall Study|Withdrawal by Subject|1|||
37780406|NCT03951753|69346420|FG002|Overall Study|Withdrawal by Subject|0|||
37970900|NCT00430989|69658070|FG001|Overall Study|Not eligible|6|||
37780407|NCT03951753|69346418|FG000|Overall Study|Lost to Follow-up|0|||
37780408|NCT03951753|69346419|FG001|Overall Study|Lost to Follow-up|0|||
37780409|NCT03951753|69346420|FG002|Overall Study|Lost to Follow-up|1|||
37970901|NCT00430755|69658078|FG000|Overall Study|Withdrawal by Subject|53|||
37780410|NCT03941964|69346430|FG000|Overall Study|Adverse Event|1|||
37780411|NCT03941964|69346431|FG001|Overall Study|Adverse Event|8|||
37970902|NCT00518882|69658084|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
37970903|NCT00518882|69658085|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
37970904|NCT00518882|69658084|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
37970905|NCT00518882|69658085|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
37970906|NCT00518882|69658084|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
37970907|NCT00518882|69658085|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
37970908|NCT00518882|69658084|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
37970909|NCT00518882|69658085|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
37970910|NCT00518882|69658084|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
37970911|NCT00518882|69658085|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
37970912|NCT00518882|69658084|FG000|Double-Blind, Week 0-26|Subject decision|1|||
37970913|NCT00518882|69658085|FG001|Double-Blind, Week 0-26|Subject decision|1|||
37970914|NCT00518882|69658084|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
37970915|NCT00518882|69658085|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
37970916|NCT00518882|69658084|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
37970917|NCT00518882|69658085|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
37970918|NCT00518882|69658084|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
37970919|NCT00518882|69658085|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
37970920|NCT00518882|69658084|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
37970921|NCT00518882|69658085|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
37970922|NCT00518882|69658084|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
37970923|NCT00518882|69658085|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
37970924|NCT00518882|69658084|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
37970925|NCT00518882|69658085|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
37970926|NCT00518882|69658084|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
37970927|NCT00518882|69658085|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
37970928|NCT00518882|69658084|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
37970929|NCT00518882|69658085|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
37692182|NCT01877668|69168448|FG003|Overall Study|No longer met study criteria|0|||
37780412|NCT03941964|69346430|FG000|Overall Study|Progressive disease|7|||
37970930|NCT00518882|69658084|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
37970931|NCT00518882|69658085|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
37970932|NCT00518882|69658084|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
37970933|NCT00518882|69658085|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
37970934|NCT00518882|69658084|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
37970935|NCT00518882|69658085|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
37970936|NCT00518882|69658084|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
37970937|NCT00518882|69658085|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
37970938|NCT00518882|69658084|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
37970939|NCT00518882|69658085|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
37970940|NCT00518882|69658084|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
37970941|NCT00518882|69658085|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
37970942|NCT00518882|69658084|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
37970943|NCT00518882|69658085|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
37970944|NCT00518882|69658084|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
37970945|NCT00518882|69658085|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
37970946|NCT00518882|69658084|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
37970947|NCT00518882|69658085|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
37970948|NCT00518882|69658084|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
37970949|NCT00518882|69658085|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
37970950|NCT00518336|69658093|FG000|Year 7|Lost to Follow-up|2|||
37970951|NCT00518336|69658094|FG001|Year 7|Lost to Follow-up|0|||
37970952|NCT00518336|69658093|FG000|Year 7|Could not attend in time|0|||
37970953|NCT00518336|69658094|FG001|Year 7|Could not attend in time|3|||
37970954|NCT00518336|69658093|FG000|Year 8|Lost to Follow-up|1|||
37970955|NCT00518336|69658094|FG001|Year 8|Lost to Follow-up|1|||
37970956|NCT00518336|69658093|FG000|Year 8|Could not attend in time|0|||
37970957|NCT00518336|69658094|FG001|Year 8|Could not attend in time|1|||
37970958|NCT00518336|69658093|FG000|Year 9|Migrated/moved from study area|1|||
37970959|NCT00518336|69658094|FG001|Year 9|Migrated/moved from study area|1|||
37970960|NCT00518336|69658093|FG000|Year 9|Lost to Follow-up|3|||
37970961|NCT00518336|69658094|FG001|Year 9|Lost to Follow-up|0|||
37970962|NCT00518336|69658093|FG000|Year 9|Personal reasons|1|||
37970963|NCT00518336|69658094|FG001|Year 9|Personal reasons|0|||
37970964|NCT00518180|69658103|FG000|Overall Study|Withdrawal by Subject|29|||
37970965|NCT00518180|69658104|FG001|Overall Study|Withdrawal by Subject|30|||
37970966|NCT00518180|69658105|FG002|Overall Study|Withdrawal by Subject|42|||
37970967|NCT00518180|69658103|FG000|Overall Study|Lost to Follow-up|30|||
37970968|NCT00518180|69658104|FG001|Overall Study|Lost to Follow-up|28|||
37970969|NCT00518180|69658105|FG002|Overall Study|Lost to Follow-up|34|||
37970970|NCT00518180|69658103|FG000|Overall Study|Administrative reason|0|||
37970971|NCT00518180|69658104|FG001|Overall Study|Administrative reason|2|||
37970972|NCT00518180|69658105|FG002|Overall Study|Administrative reason|2|||
37970973|NCT00518180|69658103|FG000|Overall Study|Protocol Violation|5|||
37970974|NCT00518180|69658104|FG001|Overall Study|Protocol Violation|7|||
37970975|NCT00518180|69658105|FG002|Overall Study|Protocol Violation|4|||
37780413|NCT03941964|69346431|FG001|Overall Study|Progressive disease|3|||
37970976|NCT00518180|69658103|FG000|Overall Study|Unable to classify|0|||
37970977|NCT00518180|69658104|FG001|Overall Study|Unable to classify|2|||
37970978|NCT00518180|69658105|FG002|Overall Study|Unable to classify|0|||
37970979|NCT00518180|69658103|FG000|Overall Study|Adverse Event|1|||
37970980|NCT00518180|69658104|FG001|Overall Study|Adverse Event|0|||
37970981|NCT00518180|69658105|FG002|Overall Study|Adverse Event|0|||
37970982|NCT00525902|69658122|FG000|Overall Study|Lack of Efficacy|1|||
37970983|NCT00525824|69658130|FG000|Overall Study|Adverse Event|7|||
37970984|NCT00525824|69658131|FG001|Overall Study|Adverse Event|11|||
37970985|NCT00525824|69658132|FG002|Overall Study|Adverse Event|6|||
37970986|NCT00525824|69658133|FG003|Overall Study|Adverse Event|7|||
37970987|NCT00525824|69658130|FG000|Overall Study|Withdrawal by Subject|5|||
37970988|NCT00525824|69658131|FG001|Overall Study|Withdrawal by Subject|9|||
37970989|NCT00525824|69658132|FG002|Overall Study|Withdrawal by Subject|3|||
37970990|NCT00525824|69658133|FG003|Overall Study|Withdrawal by Subject|4|||
37780414|NCT03941964|69346430|FG000|Overall Study|Lack of Efficacy|0|||
37780415|NCT03941964|69346431|FG001|Overall Study|Lack of Efficacy|1|||
37780416|NCT03941964|69346430|FG000|Overall Study|Death|3|||
37780417|NCT03941964|69346431|FG001|Overall Study|Death|1|||
37780418|NCT03941964|69346430|FG000|Overall Study|Withdrew consent|1|||
37780419|NCT03941964|69346431|FG001|Overall Study|Withdrew consent|3|||
37780420|NCT03941964|69346430|FG000|Overall Study|Physician Decision|9|||
37780421|NCT03941964|69346431|FG001|Overall Study|Physician Decision|2|||
37780422|NCT03941964|69346430|FG000|Overall Study|Other, not specified|2|||
37780423|NCT03941964|69346431|FG001|Overall Study|Other, not specified|1|||
37780424|NCT03837509|69346461|FG000|Phase 1|Death|5|||
37780425|NCT03837509|69346462|FG001|Phase 1|Death|2|||
37780426|NCT03837509|69346463|FG002|Phase 1|Death|0|||
37780427|NCT03837509|69346464|FG003|Phase 1|Death|0|||
37780428|NCT03837509|69346465|FG004|Phase 1|Death|0|||
37780429|NCT03837509|69346461|FG000|Phase 2|Death|0|||
37780430|NCT03837509|69346462|FG001|Phase 2|Death|0|||
37780431|NCT03837509|69346463|FG002|Phase 2|Death|0|||
37780432|NCT03837509|69346464|FG003|Phase 2|Death|1|||
37780433|NCT03837509|69346465|FG004|Phase 2|Death|1|||
37780434|NCT03822117|69346485|FG000|Overall Study|Death|18|||
37780435|NCT03822117|69346486|FG001|Overall Study|Death|17|||
37780436|NCT03822117|69346487|FG002|Overall Study|Death|12|||
37780437|NCT03822117|69346488|FG003|Overall Study|Death|4|||
37780438|NCT03822117|69346485|FG000|Overall Study|Lost to Follow-up|1|||
37780439|NCT03822117|69346486|FG001|Overall Study|Lost to Follow-up|2|||
37780440|NCT03822117|69346487|FG002|Overall Study|Lost to Follow-up|3|||
37780441|NCT03822117|69346488|FG003|Overall Study|Lost to Follow-up|0|||
37780442|NCT03822117|69346485|FG000|Overall Study|Study Terminated by Sponsor|25|||
37780443|NCT03822117|69346486|FG001|Overall Study|Study Terminated by Sponsor|11|||
37780444|NCT03822117|69346487|FG002|Overall Study|Study Terminated by Sponsor|6|||
37780445|NCT03822117|69346488|FG003|Overall Study|Study Terminated by Sponsor|0|||
37780446|NCT03822117|69346485|FG000|Overall Study|Withdrawal by Subject|4|||
37780447|NCT03822117|69346486|FG001|Overall Study|Withdrawal by Subject|0|||
37780448|NCT03822117|69346487|FG002|Overall Study|Withdrawal by Subject|3|||
37780449|NCT03822117|69346488|FG003|Overall Study|Withdrawal by Subject|0|||
37780450|NCT03822117|69346485|FG000|Overall Study|Disease Progression|1|||
37970991|NCT00525824|69658130|FG000|Overall Study|Lost to Follow-up|4|||
37970992|NCT00525824|69658131|FG001|Overall Study|Lost to Follow-up|2|||
37780451|NCT03822117|69346486|FG001|Overall Study|Disease Progression|2|||
37780452|NCT03822117|69346487|FG002|Overall Study|Disease Progression|1|||
37780453|NCT03822117|69346488|FG003|Overall Study|Disease Progression|0|||
37780454|NCT03822117|69346485|FG000|Overall Study|Never Returned to Hospital|0|||
37780455|NCT03822117|69346486|FG001|Overall Study|Never Returned to Hospital|0|||
37780456|NCT03822117|69346487|FG002|Overall Study|Never Returned to Hospital|1|||
37970993|NCT00525824|69658132|FG002|Overall Study|Lost to Follow-up|4|||
37970994|NCT00525824|69658133|FG003|Overall Study|Lost to Follow-up|0|||
37970995|NCT00525824|69658130|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
37970996|NCT00525824|69658131|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
37970997|NCT00525824|69658132|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
37970998|NCT00525824|69658133|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
37970999|NCT00525824|69658130|FG000|Overall Study|Severe non-compliance|0|||
37971000|NCT00525824|69658131|FG001|Overall Study|Severe non-compliance|1|||
37971001|NCT00525824|69658132|FG002|Overall Study|Severe non-compliance|1|||
37971002|NCT00525824|69658133|FG003|Overall Study|Severe non-compliance|1|||
37971003|NCT00525824|69658130|FG000|Overall Study|Safety reasons|1|||
37971004|NCT00525824|69658131|FG001|Overall Study|Safety reasons|0|||
37971005|NCT00525824|69658132|FG002|Overall Study|Safety reasons|1|||
37971006|NCT00525824|69658133|FG003|Overall Study|Safety reasons|0|||
37971007|NCT00525824|69658130|FG000|Overall Study|Other|1|||
37971008|NCT00525824|69658131|FG001|Overall Study|Other|3|||
37971009|NCT00525824|69658132|FG002|Overall Study|Other|3|||
37971010|NCT00525824|69658133|FG003|Overall Study|Other|1|||
37971011|NCT00525590|69658147|FG000|Overall Study|Adverse Event|3|||
37971012|NCT00525590|69658147|FG000|Overall Study|Physician Decision|3|||
37971013|NCT00525590|69658147|FG000|Overall Study|Withdrawal by Subject|16|||
37971014|NCT00525590|69658147|FG000|Overall Study|Lost to Follow-up|1|||
37971015|NCT00525590|69658147|FG000|Overall Study|Death|9|||
37971016|NCT00525590|69658147|FG000|Overall Study|Other|13|||
37971017|NCT00430677|69658154|FG000|Short-term Period|Death|1|||
37971018|NCT00430677|69658155|FG001|Short-term Period|Death|1|||
37971019|NCT00430677|69658156|FG002|Short-term Period|Death|5|||
37971020|NCT00430677|69658154|FG000|Short-term Period|Adverse Event|15|||
37971021|NCT00430677|69658155|FG001|Short-term Period|Adverse Event|13|||
37971022|NCT00430677|69658156|FG002|Short-term Period|Adverse Event|9|||
37971023|NCT00430677|69658154|FG000|Short-term Period|Lack of Efficacy|5|||
37971024|NCT00430677|69658155|FG001|Short-term Period|Lack of Efficacy|6|||
37971025|NCT00430677|69658156|FG002|Short-term Period|Lack of Efficacy|4|||
37971026|NCT00430677|69658154|FG000|Short-term Period|Withdrawal by Subject|1|||
37971027|NCT00430677|69658155|FG001|Short-term Period|Withdrawal by Subject|1|||
37971028|NCT00430677|69658156|FG002|Short-term Period|Withdrawal by Subject|2|||
37971029|NCT00430677|69658154|FG000|Short-term Period|Participant no longer met study criteria|1|||
37971030|NCT00430677|69658155|FG001|Short-term Period|Participant no longer met study criteria|1|||
37780457|NCT03822117|69346488|FG003|Overall Study|Never Returned to Hospital|0|||
37780458|NCT03497897|69346502|FG000|Overall Study|Adverse Event|1|||
37780459|NCT03497897|69346503|FG001|Overall Study|Adverse Event|1|||
37780460|NCT03497897|69346504|FG002|Overall Study|Adverse Event|1|||
37780461|NCT03497897|69346502|FG000|Overall Study|Lost to Follow-up|2|||
37780462|NCT03497897|69346503|FG001|Overall Study|Lost to Follow-up|0|||
37780463|NCT03497897|69346504|FG002|Overall Study|Lost to Follow-up|2|||
37780464|NCT03497897|69346502|FG000|Overall Study|Physician Decision|1|||
37780465|NCT03497897|69346503|FG001|Overall Study|Physician Decision|0|||
37780466|NCT03497897|69346504|FG002|Overall Study|Physician Decision|0|||
37780467|NCT03497897|69346502|FG000|Overall Study|Subject/Guardian Decision|2|||
37780468|NCT03497897|69346503|FG001|Overall Study|Subject/Guardian Decision|1|||
37692183|NCT01877668|69168449|FG004|Overall Study|No longer met study criteria|0|||
37692184|NCT01877668|69168445|FG000|Overall Study|Insufficient clinical response|0|||
37692185|NCT01877668|69168446|FG001|Overall Study|Insufficient clinical response|1|||
37692186|NCT01877668|69168447|FG002|Overall Study|Insufficient clinical response|2|||
37692187|NCT01877668|69168448|FG003|Overall Study|Insufficient clinical response|2|||
37692188|NCT01877668|69168449|FG004|Overall Study|Insufficient clinical response|0|||
37692189|NCT01877668|69168445|FG000|Overall Study|Lost to Follow-up|0|||
37692190|NCT01877668|69168446|FG001|Overall Study|Lost to Follow-up|2|||
37692191|NCT01877668|69168447|FG002|Overall Study|Lost to Follow-up|1|||
37692192|NCT01877668|69168448|FG003|Overall Study|Lost to Follow-up|0|||
37692193|NCT01877668|69168449|FG004|Overall Study|Lost to Follow-up|0|||
37692194|NCT01877668|69168445|FG000|Overall Study|Withdrawal by Subject|2|||
37863969|NCT00994162|69547571|FG000|Overall Study|Withdrawal by Subject|1|||
37971031|NCT00430677|69658156|FG002|Short-term Period|Participant no longer met study criteria|2|||
37971032|NCT00430677|69658154|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
37692195|NCT01877668|69168446|FG001|Overall Study|Withdrawal by Subject|0|||
37692196|NCT01877668|69168447|FG002|Overall Study|Withdrawal by Subject|3|||
37692197|NCT01877668|69168448|FG003|Overall Study|Withdrawal by Subject|2|||
37692198|NCT01877668|69168449|FG004|Overall Study|Withdrawal by Subject|2|||
37780469|NCT03497897|69346504|FG002|Overall Study|Subject/Guardian Decision|3|||
37780470|NCT03428217|69346515|FG000|Overall Study|Death|89|||
37971033|NCT00430677|69658155|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
37971034|NCT00430677|69658156|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
37971035|NCT00430677|69658154|FG000|Short-term Period|Pregnancy|0|||
37971036|NCT00430677|69658155|FG001|Short-term Period|Pregnancy|2|||
37971037|NCT00430677|69658156|FG002|Short-term Period|Pregnancy|0|||
37971038|NCT00430677|69658154|FG000|Long-term Extension Period|Death|1|||
37971039|NCT00430677|69658155|FG001|Long-term Extension Period|Death|0|||
37971040|NCT00430677|69658156|FG002|Long-term Extension Period|Death|0|||
37971041|NCT00430677|69658154|FG000|Long-term Extension Period|Adverse Event|3|||
37971042|NCT00430677|69658155|FG001|Long-term Extension Period|Adverse Event|2|||
37971043|NCT00430677|69658156|FG002|Long-term Extension Period|Adverse Event|5|||
37971044|NCT00430677|69658154|FG000|Long-term Extension Period|Lack of Efficacy|5|||
37971045|NCT00430677|69658155|FG001|Long-term Extension Period|Lack of Efficacy|3|||
37692199|NCT01877668|69168445|FG000|Overall Study|Other|1|||
37971046|NCT00430677|69658156|FG002|Long-term Extension Period|Lack of Efficacy|8|||
37971047|NCT00430677|69658154|FG000|Long-term Extension Period|Lost to Follow-up|1|||
37971048|NCT00430677|69658155|FG001|Long-term Extension Period|Lost to Follow-up|1|||
37971049|NCT00430677|69658156|FG002|Long-term Extension Period|Lost to Follow-up|1|||
37971050|NCT00430677|69658154|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
37971051|NCT00430677|69658155|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
37971052|NCT00430677|69658156|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
37971053|NCT00430677|69658154|FG000|Long-term Extension Period|Pregnancy|1|||
37971054|NCT00430677|69658155|FG001|Long-term Extension Period|Pregnancy|1|||
37971055|NCT00430677|69658156|FG002|Long-term Extension Period|Pregnancy|0|||
37971056|NCT00430677|69658154|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
37971057|NCT00430677|69658155|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
37971058|NCT00430677|69658156|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
37971059|NCT00430677|69658154|FG000|Long-term Extension Period|Other|2|||
37971060|NCT00430677|69658155|FG001|Long-term Extension Period|Other|1|||
37971061|NCT00430677|69658156|FG002|Long-term Extension Period|Other|1|||
37971062|NCT00430677|69658154|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
37971063|NCT00430677|69658155|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
37971064|NCT00430677|69658156|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
37971065|NCT00525512|69658184|FG000|Double-Blind Phase|Adverse Event|48|||
37971066|NCT00525512|69658185|FG001|Double-Blind Phase|Adverse Event|28|||
37971067|NCT00525512|69658186|FG002|Double-Blind Phase|Adverse Event|0|||
37971068|NCT00525512|69658187|FG003|Double-Blind Phase|Adverse Event|0|||
37971069|NCT00525512|69658184|FG000|Double-Blind Phase|Protocol Violation|3|||
37971070|NCT00525512|69658185|FG001|Double-Blind Phase|Protocol Violation|1|||
37971071|NCT00525512|69658186|FG002|Double-Blind Phase|Protocol Violation|0|||
37971072|NCT00525512|69658187|FG003|Double-Blind Phase|Protocol Violation|0|||
37971073|NCT00525512|69658184|FG000|Double-Blind Phase|Lost to Follow-up|3|||
37971074|NCT00525512|69658185|FG001|Double-Blind Phase|Lost to Follow-up|7|||
37971075|NCT00525512|69658186|FG002|Double-Blind Phase|Lost to Follow-up|0|||
37971076|NCT00525512|69658187|FG003|Double-Blind Phase|Lost to Follow-up|0|||
37971077|NCT00525512|69658184|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
37971078|NCT00525512|69658185|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
37971079|NCT00525512|69658186|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
37971080|NCT00525512|69658187|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
37971081|NCT00525512|69658184|FG000|Double-Blind Phase|Lack of Efficacy|13|||
37971082|NCT00525512|69658185|FG001|Double-Blind Phase|Lack of Efficacy|5|||
37971083|NCT00525512|69658186|FG002|Double-Blind Phase|Lack of Efficacy|0|||
37971084|NCT00525512|69658187|FG003|Double-Blind Phase|Lack of Efficacy|0|||
37971085|NCT00525512|69658184|FG000|Double-Blind Phase|Other reason (not specified)|12|||
37971086|NCT00525512|69658185|FG001|Double-Blind Phase|Other reason (not specified)|13|||
37971087|NCT00525512|69658186|FG002|Double-Blind Phase|Other reason (not specified)|0|||
37971088|NCT00525512|69658187|FG003|Double-Blind Phase|Other reason (not specified)|0|||
37971089|NCT00525512|69658184|FG000|Open-Label Phase|Adverse Event|0|||
37971090|NCT00525512|69658185|FG001|Open-Label Phase|Adverse Event|0|||
37692200|NCT01877668|69168446|FG001|Overall Study|Other|1|||
37780471|NCT03428217|69346516|FG001|Overall Study|Death|93|||
37780472|NCT03428217|69346515|FG000|Overall Study|Withdrawal by Subject|8|||
37780473|NCT03428217|69346516|FG001|Overall Study|Withdrawal by Subject|7|||
37971091|NCT00525512|69658186|FG002|Open-Label Phase|Adverse Event|1|||
37971092|NCT00525512|69658187|FG003|Open-Label Phase|Adverse Event|0|||
37971093|NCT00525512|69658184|FG000|Open-Label Phase|Lost to Follow-up|0|||
37971094|NCT00525512|69658185|FG001|Open-Label Phase|Lost to Follow-up|0|||
37971095|NCT00525512|69658186|FG002|Open-Label Phase|Lost to Follow-up|1|||
37971096|NCT00525512|69658187|FG003|Open-Label Phase|Lost to Follow-up|0|||
37971097|NCT00525512|69658184|FG000|Open-Label Phase|Other reason (not specified)|0|||
37971098|NCT00525512|69658185|FG001|Open-Label Phase|Other reason (not specified)|0|||
37971099|NCT00525512|69658186|FG002|Open-Label Phase|Other reason (not specified)|4|||
37971100|NCT00525512|69658187|FG003|Open-Label Phase|Other reason (not specified)|5|||
37971101|NCT00517634|69658199|FG000|Second Treatment Period|Withdrawal by Subject|0|||
37971102|NCT00517634|69658200|FG001|Second Treatment Period|Withdrawal by Subject|0|||
37971103|NCT00517634|69658201|FG002|Second Treatment Period|Withdrawal by Subject|0|||
37971104|NCT00517634|69658202|FG003|Second Treatment Period|Withdrawal by Subject|0|||
37971105|NCT00517634|69658203|FG004|Second Treatment Period|Withdrawal by Subject|1|||
37971106|NCT00517634|69658204|FG005|Second Treatment Period|Withdrawal by Subject|0|||
37971107|NCT03683576|69658216|FG000|Overall Study|Withdrawal by Subject|2|||
37971108|NCT03683576|69658217|FG001|Overall Study|Withdrawal by Subject|0|||
37971109|NCT03683576|69658218|FG002|Overall Study|Withdrawal by Subject|8|||
37971110|NCT03683576|69658219|FG003|Overall Study|Withdrawal by Subject|3|||
37971111|NCT03683576|69658216|FG000|Overall Study|Adverse Event|3|||
37971112|NCT03683576|69658217|FG001|Overall Study|Adverse Event|0|||
37971113|NCT03683576|69658218|FG002|Overall Study|Adverse Event|0|||
37971114|NCT03683576|69658219|FG003|Overall Study|Adverse Event|4|||
37971115|NCT03683576|69658216|FG000|Overall Study|Lack of Efficacy|1|||
37971116|NCT03683576|69658217|FG001|Overall Study|Lack of Efficacy|0|||
37971117|NCT03683576|69658218|FG002|Overall Study|Lack of Efficacy|1|||
37971118|NCT03683576|69658219|FG003|Overall Study|Lack of Efficacy|1|||
37971119|NCT03683576|69658216|FG000|Overall Study|Lost to Follow-up|0|||
37971120|NCT03683576|69658217|FG001|Overall Study|Lost to Follow-up|1|||
37971121|NCT03683576|69658218|FG002|Overall Study|Lost to Follow-up|2|||
37971122|NCT03683576|69658219|FG003|Overall Study|Lost to Follow-up|0|||
37971123|NCT03683576|69658216|FG000|Overall Study|Other, Not Specified|0|||
37971124|NCT03683576|69658217|FG001|Overall Study|Other, Not Specified|2|||
37971125|NCT03683576|69658218|FG002|Overall Study|Other, Not Specified|0|||
37780474|NCT03428217|69346515|FG000|Overall Study|Lost to Follow-up|1|||
37780475|NCT03428217|69346516|FG001|Overall Study|Lost to Follow-up|3|||
37971126|NCT03683576|69658219|FG003|Overall Study|Other, Not Specified|0|||
37971127|NCT03683576|69658216|FG000|Overall Study|Protocol Violation|0|||
37971128|NCT03683576|69658217|FG001|Overall Study|Protocol Violation|1|||
37971129|NCT03683576|69658218|FG002|Overall Study|Protocol Violation|1|||
37971130|NCT03683576|69658219|FG003|Overall Study|Protocol Violation|0|||
37971131|NCT03863834|69658229|FG000|Overall Study|Lost to Follow-up|3|||
37971132|NCT00430521|69658241|FG000|Overall Study|Adverse Event|0|||
37971133|NCT00430521|69658242|FG001|Overall Study|Adverse Event|0|||
37971134|NCT00430521|69658243|FG002|Overall Study|Adverse Event|0|||
37971135|NCT00430521|69658244|FG003|Overall Study|Adverse Event|0|||
37971136|NCT00430521|69658245|FG004|Overall Study|Adverse Event|0|||
37971137|NCT00430521|69658246|FG005|Overall Study|Adverse Event|2|||
37971138|NCT00430521|69658247|FG006|Overall Study|Adverse Event|1|||
37971139|NCT00430521|69658248|FG007|Overall Study|Adverse Event|0|||
37971140|NCT00430521|69658241|FG000|Overall Study|Lost to Follow-up|7|||
37971141|NCT00430521|69658242|FG001|Overall Study|Lost to Follow-up|8|||
37971142|NCT00430521|69658243|FG002|Overall Study|Lost to Follow-up|3|||
37971143|NCT00430521|69658244|FG003|Overall Study|Lost to Follow-up|5|||
37971144|NCT00430521|69658245|FG004|Overall Study|Lost to Follow-up|5|||
37971145|NCT00430521|69658246|FG005|Overall Study|Lost to Follow-up|2|||
37971146|NCT00430521|69658247|FG006|Overall Study|Lost to Follow-up|8|||
37971147|NCT00430521|69658248|FG007|Overall Study|Lost to Follow-up|10|||
37971148|NCT00430521|69658241|FG000|Overall Study|Pregnancy|0|||
37971149|NCT00430521|69658242|FG001|Overall Study|Pregnancy|0|||
37971150|NCT00430521|69658243|FG002|Overall Study|Pregnancy|0|||
37971151|NCT00430521|69658244|FG003|Overall Study|Pregnancy|0|||
37971152|NCT00430521|69658245|FG004|Overall Study|Pregnancy|0|||
37971153|NCT00430521|69658246|FG005|Overall Study|Pregnancy|0|||
37971154|NCT00430521|69658247|FG006|Overall Study|Pregnancy|1|||
37971155|NCT00430521|69658248|FG007|Overall Study|Pregnancy|0|||
37971156|NCT00430521|69658241|FG000|Overall Study|Vaccine Expired|0|||
37971157|NCT00430521|69658242|FG001|Overall Study|Vaccine Expired|0|||
37971158|NCT00430521|69658243|FG002|Overall Study|Vaccine Expired|0|||
37971159|NCT00430521|69658244|FG003|Overall Study|Vaccine Expired|0|||
37971160|NCT00430521|69658245|FG004|Overall Study|Vaccine Expired|0|||
37971161|NCT00430521|69658246|FG005|Overall Study|Vaccine Expired|1|||
37971162|NCT00430521|69658247|FG006|Overall Study|Vaccine Expired|0|||
37971163|NCT00430521|69658248|FG007|Overall Study|Vaccine Expired|0|||
37971164|NCT00430521|69658241|FG000|Overall Study|Protocol Violation|1|||
37971165|NCT00430521|69658242|FG001|Overall Study|Protocol Violation|0|||
37971166|NCT00430521|69658243|FG002|Overall Study|Protocol Violation|0|||
37971167|NCT00430521|69658244|FG003|Overall Study|Protocol Violation|0|||
37971168|NCT00430521|69658245|FG004|Overall Study|Protocol Violation|0|||
37971169|NCT00430521|69658246|FG005|Overall Study|Protocol Violation|0|||
37971170|NCT00430521|69658247|FG006|Overall Study|Protocol Violation|0|||
37971171|NCT00430521|69658248|FG007|Overall Study|Protocol Violation|0|||
37971172|NCT00430521|69658241|FG000|Overall Study|Withdrawal by Subject|3|||
37971173|NCT00430521|69658242|FG001|Overall Study|Withdrawal by Subject|1|||
37971174|NCT00430521|69658243|FG002|Overall Study|Withdrawal by Subject|0|||
37971175|NCT00430521|69658244|FG003|Overall Study|Withdrawal by Subject|3|||
37971176|NCT00430521|69658245|FG004|Overall Study|Withdrawal by Subject|0|||
37971177|NCT00430521|69658246|FG005|Overall Study|Withdrawal by Subject|0|||
37971178|NCT00430521|69658247|FG006|Overall Study|Withdrawal by Subject|0|||
37971179|NCT00430521|69658248|FG007|Overall Study|Withdrawal by Subject|2|||
37971180|NCT00429663|69658281|FG000|Overall Study|Lost to Follow-up|24|||
37971181|NCT00429663|69658282|FG001|Overall Study|Lost to Follow-up|31|||
37971182|NCT00429663|69658281|FG000|Overall Study|Physician Decision|6|||
37971183|NCT00429663|69658282|FG001|Overall Study|Physician Decision|3|||
37780476|NCT03428217|69346515|FG000|Overall Study|Study terminated by sponsor|124|||
37780477|NCT03428217|69346516|FG001|Overall Study|Study terminated by sponsor|118|||
37780478|NCT03428217|69346515|FG000|Overall Study|Other, Not Specified|1|||
37780479|NCT03428217|69346516|FG001|Overall Study|Other, Not Specified|0|||
37780480|NCT03189719|69346526|FG000|Overall Study|Death|260|||
37780481|NCT03189719|69346527|FG001|Overall Study|Death|308|||
37780482|NCT03189719|69346526|FG000|Overall Study|Withdrawal by Subject|5|||
37780483|NCT03189719|69346527|FG001|Overall Study|Withdrawal by Subject|3|||
37780484|NCT03189719|69346526|FG000|Overall Study|Ongoing in Study|108|||
37780485|NCT03189719|69346527|FG001|Overall Study|Ongoing in Study|65|||
37780486|NCT02969525|69346538|FG000|Double-Blind Period|Adverse Event|0|||
37780487|NCT02969525|69346539|FG001|Double-Blind Period|Adverse Event|0|||
37780488|NCT02969525|69346540|FG002|Double-Blind Period|Adverse Event|1|||
37780489|NCT02969525|69346541|FG003|Double-Blind Period|Adverse Event|1|||
37780490|NCT02969525|69346542|FG004|Double-Blind Period|Adverse Event|0|||
37780491|NCT02969525|69346543|FG005|Double-Blind Period|Adverse Event|0|||
37780492|NCT02969525|69346544|FG006|Double-Blind Period|Adverse Event|0|||
37780493|NCT02969525|69346545|FG007|Double-Blind Period|Adverse Event|0|||
37780494|NCT02969525|69346546|FG008|Double-Blind Period|Adverse Event|0|||
37780495|NCT02969525|69346547|FG009|Double-Blind Period|Adverse Event|0|||
37780496|NCT02969525|69346548|FG010|Double-Blind Period|Adverse Event|0|||
37780497|NCT02969525|69346549|FG011|Double-Blind Period|Adverse Event|0|||
37780498|NCT02969525|69346538|FG000|Double-Blind Period|LOW EGFR|0|||
37780499|NCT02969525|69346539|FG001|Double-Blind Period|LOW EGFR|0|||
37780500|NCT02969525|69346540|FG002|Double-Blind Period|LOW EGFR|0|||
37780501|NCT02969525|69346541|FG003|Double-Blind Period|LOW EGFR|1|||
37780502|NCT02969525|69346542|FG004|Double-Blind Period|LOW EGFR|0|||
37780503|NCT02969525|69346543|FG005|Double-Blind Period|LOW EGFR|0|||
37780504|NCT02969525|69346544|FG006|Double-Blind Period|LOW EGFR|0|||
37780505|NCT02969525|69346545|FG007|Double-Blind Period|LOW EGFR|0|||
37780506|NCT02969525|69346546|FG008|Double-Blind Period|LOW EGFR|0|||
37780507|NCT02969525|69346547|FG009|Double-Blind Period|LOW EGFR|0|||
37780508|NCT02969525|69346548|FG010|Double-Blind Period|LOW EGFR|0|||
37780509|NCT02969525|69346549|FG011|Double-Blind Period|LOW EGFR|0|||
37780510|NCT02969525|69346538|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
37780511|NCT02969525|69346539|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
37780512|NCT02969525|69346540|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
37780513|NCT02969525|69346541|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
37780514|NCT02969525|69346542|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
37780515|NCT02969525|69346543|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
37780516|NCT02969525|69346544|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
37780517|NCT02969525|69346545|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
37780518|NCT02969525|69346546|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
37780519|NCT02969525|69346547|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
37780520|NCT02969525|69346548|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
37780521|NCT02969525|69346549|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
37780522|NCT02969525|69346538|FG000|Dose-Blind Period|Adverse Event|0|||
37780523|NCT02969525|69346539|FG001|Dose-Blind Period|Adverse Event|0|||
37780524|NCT02969525|69346540|FG002|Dose-Blind Period|Adverse Event|0|||
37780525|NCT02969525|69346541|FG003|Dose-Blind Period|Adverse Event|0|||
37780526|NCT02969525|69346542|FG004|Dose-Blind Period|Adverse Event|0|||
37780527|NCT02969525|69346543|FG005|Dose-Blind Period|Adverse Event|0|||
37780528|NCT02969525|69346544|FG006|Dose-Blind Period|Adverse Event|0|||
37780529|NCT02969525|69346545|FG007|Dose-Blind Period|Adverse Event|0|||
37780530|NCT02969525|69346546|FG008|Dose-Blind Period|Adverse Event|0|||
37780531|NCT02969525|69346547|FG009|Dose-Blind Period|Adverse Event|1|||
37971184|NCT00429663|69658281|FG000|Overall Study|Withdrawal by Subject|2|||
37780532|NCT02969525|69346548|FG010|Dose-Blind Period|Adverse Event|1|||
37780533|NCT02969525|69346549|FG011|Dose-Blind Period|Adverse Event|1|||
37780534|NCT02969525|69346538|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
37780535|NCT02969525|69346539|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
37780536|NCT02969525|69346540|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
37780537|NCT02969525|69346541|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
37780538|NCT02969525|69346542|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
37780539|NCT02969525|69346543|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
37780540|NCT02969525|69346544|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
37780541|NCT02969525|69346545|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
37780542|NCT02969525|69346546|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
37780543|NCT02969525|69346547|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
37780544|NCT02969525|69346548|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
37780545|NCT02969525|69346549|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
37863970|NCT00994162|69547571|FG000|Overall Study|Lost to Follow-up|2|||
37971185|NCT00429663|69658282|FG001|Overall Study|Withdrawal by Subject|5|||
37971186|NCT00429663|69658281|FG000|Overall Study|Death|4|||
37971187|NCT00429663|69658282|FG001|Overall Study|Death|0|||
37971188|NCT00429585|69658290|FG000|Overall Study|Death|1|||
37971189|NCT00429585|69658291|FG001|Overall Study|Death|0|||
37971190|NCT00429585|69658290|FG000|Overall Study|Lost to Follow-up|27|||
37971191|NCT00429585|69658291|FG001|Overall Study|Lost to Follow-up|20|||
37971192|NCT00429585|69658290|FG000|Overall Study|Physician Decision|2|||
37971193|NCT00429585|69658291|FG001|Overall Study|Physician Decision|0|||
37971194|NCT05607043|69658297|FG000|Overall Study|Lost to Follow-up|2|||
37971195|NCT04550221|69658324|FG000|Overall Study|Lost to Follow-up|0|||
37971196|NCT04550221|69658325|FG001|Overall Study|Lost to Follow-up|4|||
37971197|NCT04550221|69658324|FG000|Overall Study|Withdrawn|3|||
37971198|NCT04550221|69658325|FG001|Overall Study|Withdrawn|0|||
37971199|NCT04550221|69658324|FG000|Overall Study|Moved from the study area after receiving the intervention|2|||
37971200|NCT04550221|69658325|FG001|Overall Study|Moved from the study area after receiving the intervention|0|||
37971201|NCT04193176|69658346|FG000|Overall Study|Withdrawal by Subject|6|||
37971202|NCT04193176|69658347|FG001|Overall Study|Withdrawal by Subject|10|||
37971203|NCT05384834|69658353|FG000|Overall Study|Lost to Follow-up|43|||
37971204|NCT05384834|69658353|FG000|Overall Study|Withdrawal by Subject|5|||
37971205|NCT05101486|69658360|FG000|Overall Study|Death|1|||
37971206|NCT05101486|69658361|FG001|Overall Study|Death|0|||
37971207|NCT05101486|69658362|FG002|Overall Study|Death|1|||
37971208|NCT05101486|69658360|FG000|Overall Study|Lost to Follow-up|12|||
37971209|NCT05101486|69658361|FG001|Overall Study|Lost to Follow-up|8|||
37971210|NCT05101486|69658362|FG002|Overall Study|Lost to Follow-up|17|||
37971211|NCT05101486|69658360|FG000|Overall Study|Physician Decision|1|||
37971212|NCT05101486|69658361|FG001|Overall Study|Physician Decision|0|||
37971213|NCT05101486|69658362|FG002|Overall Study|Physician Decision|0|||
37971214|NCT05101486|69658360|FG000|Overall Study|Protocol Violation|0|||
37971215|NCT05101486|69658361|FG001|Overall Study|Protocol Violation|0|||
37971216|NCT05101486|69658362|FG002|Overall Study|Protocol Violation|1|||
37971217|NCT05101486|69658360|FG000|Overall Study|Withdrawal by Subject|5|||
37971218|NCT05101486|69658361|FG001|Overall Study|Withdrawal by Subject|2|||
37971219|NCT05101486|69658362|FG002|Overall Study|Withdrawal by Subject|4|||
37971220|NCT05101486|69658360|FG000|Overall Study|Randomized but not vaccinated|1|||
37971221|NCT05101486|69658361|FG001|Overall Study|Randomized but not vaccinated|1|||
37971222|NCT05101486|69658362|FG002|Overall Study|Randomized but not vaccinated|1|||
37971223|NCT05083585|69658372|FG000|Overall Study|Death|1|||
37971224|NCT05083585|69658373|FG001|Overall Study|Death|1|||
37971225|NCT05083585|69658372|FG000|Overall Study|Lost to Follow-up|1|||
37971226|NCT05083585|69658373|FG001|Overall Study|Lost to Follow-up|1|||
37971227|NCT05083585|69658372|FG000|Overall Study|Withdrawal by Subject|2|||
37971228|NCT05083585|69658373|FG001|Overall Study|Withdrawal by Subject|0|||
37971229|NCT05083585|69658372|FG000|Overall Study|Randomized but not vaccinated|2|||
37971230|NCT05083585|69658373|FG001|Overall Study|Randomized but not vaccinated|0|||
37971231|NCT05071313|69658381|FG000|Overall Study|Lost to Follow-up|17|||
37971232|NCT05071313|69658382|FG001|Overall Study|Lost to Follow-up|10|||
37971233|NCT05071313|69658381|FG000|Overall Study|Physician Decision|1|||
37971234|NCT05071313|69658382|FG001|Overall Study|Physician Decision|6|||
37971235|NCT05071313|69658381|FG000|Overall Study|Death|1|||
37971236|NCT05071313|69658382|FG001|Overall Study|Death|0|||
37971237|NCT05071313|69658381|FG000|Overall Study|Withdrawal by Subject|10|||
37971238|NCT05071313|69658382|FG001|Overall Study|Withdrawal by Subject|15|||
37971239|NCT05071313|69658381|FG000|Overall Study|Other|1|||
37971240|NCT05071313|69658382|FG001|Overall Study|Other|0|||
37692201|NCT01877668|69168447|FG002|Overall Study|Other|1|||
37692202|NCT01877668|69168448|FG003|Overall Study|Other|1|||
37692203|NCT01877668|69168449|FG004|Overall Study|Other|3|||
37780546|NCT02969525|69346538|FG000|Dose-Blind Period|Non-cooperating patient|0|||
37692204|NCT01877668|69168445|FG000|Overall Study|Protocol Violation|1|||
37971241|NCT05071313|69658381|FG000|Overall Study|Randomized but not vaccinated|4|||
37971242|NCT05071313|69658382|FG001|Overall Study|Randomized but not vaccinated|2|||
37971243|NCT05019729|69658410|FG000|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
37971244|NCT05019729|69658411|FG001|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
37971245|NCT05019729|69658412|FG002|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
37971246|NCT05019729|69658413|FG003|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
37971247|NCT05019729|69658414|FG004|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|3|||
37971248|NCT05019729|69658415|FG005|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
37971249|NCT04544475|69658463|FG000|Overall Study|Withdrawal by Subject|1|||
37692205|NCT01877668|69168446|FG001|Overall Study|Protocol Violation|1|||
37692206|NCT01877668|69168447|FG002|Overall Study|Protocol Violation|0|||
37692207|NCT01877668|69168448|FG003|Overall Study|Protocol Violation|0|||
37692208|NCT01877668|69168449|FG004|Overall Study|Protocol Violation|3|||
37971250|NCT04544475|69658464|FG001|Overall Study|Withdrawal by Subject|3|||
37971251|NCT04045613|69658495|FG000|Overall Study|Adverse Event|2|||
37971252|NCT04045613|69658496|FG001|Overall Study|Adverse Event|2|||
37971253|NCT04045613|69658497|FG002|Overall Study|Adverse Event|1|||
37971254|NCT04045613|69658498|FG003|Overall Study|Adverse Event|1|||
37971255|NCT04045613|69658499|FG004|Overall Study|Adverse Event|0|||
37971256|NCT04045613|69658500|FG005|Overall Study|Adverse Event|0|||
37971257|NCT04045613|69658501|FG006|Overall Study|Adverse Event|1|||
37971258|NCT04045613|69658495|FG000|Overall Study|Withdrawal by Subject|0|||
37971259|NCT04045613|69658496|FG001|Overall Study|Withdrawal by Subject|5|||
37971260|NCT04045613|69658497|FG002|Overall Study|Withdrawal by Subject|0|||
37971261|NCT04045613|69658498|FG003|Overall Study|Withdrawal by Subject|0|||
37971262|NCT04045613|69658499|FG004|Overall Study|Withdrawal by Subject|0|||
37971263|NCT04045613|69658500|FG005|Overall Study|Withdrawal by Subject|1|||
37971264|NCT04045613|69658501|FG006|Overall Study|Withdrawal by Subject|0|||
37971265|NCT04045613|69658495|FG000|Overall Study|Physician Decision|2|||
37971266|NCT04045613|69658496|FG001|Overall Study|Physician Decision|0|||
37971267|NCT04045613|69658497|FG002|Overall Study|Physician Decision|0|||
37971268|NCT04045613|69658498|FG003|Overall Study|Physician Decision|0|||
37971269|NCT04045613|69658499|FG004|Overall Study|Physician Decision|1|||
37971270|NCT04045613|69658500|FG005|Overall Study|Physician Decision|0|||
37971271|NCT04045613|69658501|FG006|Overall Study|Physician Decision|0|||
37971272|NCT04045613|69658495|FG000|Overall Study|Death|3|||
37971273|NCT04045613|69658496|FG001|Overall Study|Death|0|||
37971274|NCT04045613|69658497|FG002|Overall Study|Death|0|||
37971275|NCT04045613|69658498|FG003|Overall Study|Death|0|||
37971276|NCT04045613|69658499|FG004|Overall Study|Death|0|||
37971277|NCT04045613|69658500|FG005|Overall Study|Death|0|||
37971278|NCT04045613|69658501|FG006|Overall Study|Death|1|||
37971279|NCT04045613|69658495|FG000|Overall Study|Other reasons|0|||
37971280|NCT04045613|69658496|FG001|Overall Study|Other reasons|1|||
37971281|NCT04045613|69658497|FG002|Overall Study|Other reasons|0|||
37971282|NCT04045613|69658498|FG003|Overall Study|Other reasons|0|||
37971283|NCT04045613|69658499|FG004|Overall Study|Other reasons|0|||
37971284|NCT04045613|69658500|FG005|Overall Study|Other reasons|0|||
37971285|NCT04045613|69658501|FG006|Overall Study|Other reasons|1|||
37971286|NCT04045613|69658495|FG000|Overall Study|Progressive disease: Clinical progression|1|||
37971287|NCT04045613|69658496|FG001|Overall Study|Progressive disease: Clinical progression|0|||
37971288|NCT04045613|69658497|FG002|Overall Study|Progressive disease: Clinical progression|3|||
37971289|NCT04045613|69658498|FG003|Overall Study|Progressive disease: Clinical progression|1|||
37971290|NCT04045613|69658499|FG004|Overall Study|Progressive disease: Clinical progression|1|||
37971291|NCT04045613|69658500|FG005|Overall Study|Progressive disease: Clinical progression|3|||
37971292|NCT04045613|69658501|FG006|Overall Study|Progressive disease: Clinical progression|3|||
37971293|NCT04045613|69658495|FG000|Overall Study|Progressive disease: Radiological progression|24|||
37971294|NCT04045613|69658496|FG001|Overall Study|Progressive disease: Radiological progression|6|||
37780547|NCT02969525|69346539|FG001|Dose-Blind Period|Non-cooperating patient|0|||
37780548|NCT02969525|69346540|FG002|Dose-Blind Period|Non-cooperating patient|0|||
37780549|NCT02969525|69346541|FG003|Dose-Blind Period|Non-cooperating patient|0|||
37780550|NCT02969525|69346542|FG004|Dose-Blind Period|Non-cooperating patient|0|||
37780551|NCT02969525|69346543|FG005|Dose-Blind Period|Non-cooperating patient|0|||
37780552|NCT02969525|69346544|FG006|Dose-Blind Period|Non-cooperating patient|0|||
37780553|NCT02969525|69346545|FG007|Dose-Blind Period|Non-cooperating patient|0|||
37780554|NCT02969525|69346546|FG008|Dose-Blind Period|Non-cooperating patient|0|||
37780555|NCT02969525|69346547|FG009|Dose-Blind Period|Non-cooperating patient|0|||
37780556|NCT02969525|69346548|FG010|Dose-Blind Period|Non-cooperating patient|0|||
37971295|NCT04045613|69658497|FG002|Overall Study|Progressive disease: Radiological progression|8|||
37971296|NCT04045613|69658498|FG003|Overall Study|Progressive disease: Radiological progression|0|||
37971297|NCT04045613|69658499|FG004|Overall Study|Progressive disease: Radiological progression|6|||
37692209|NCT01877668|69168445|FG000|Overall Study|Adverse event related to study drug|2|||
37692210|NCT01877668|69168446|FG001|Overall Study|Adverse event related to study drug|2|||
37692211|NCT01877668|69168447|FG002|Overall Study|Adverse event related to study drug|2|||
37692212|NCT01877668|69168448|FG003|Overall Study|Adverse event related to study drug|2|||
37692213|NCT01877668|69168449|FG004|Overall Study|Adverse event related to study drug|1|||
37692214|NCT01877668|69168445|FG000|Overall Study|Adverse event unrelated to study drug|4|||
37692215|NCT01877668|69168446|FG001|Overall Study|Adverse event unrelated to study drug|1|||
37692216|NCT01877668|69168447|FG002|Overall Study|Adverse event unrelated to study drug|2|||
37780557|NCT02969525|69346549|FG011|Dose-Blind Period|Non-cooperating patient|1|||
37780558|NCT02969525|69346538|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
37971298|NCT04045613|69658500|FG005|Overall Study|Progressive disease: Radiological progression|6|||
37971299|NCT04045613|69658501|FG006|Overall Study|Progressive disease: Radiological progression|11|||
37971300|NCT03964207|69658531|FG000|First Treatment|Withdrawal by Subject|1|||
37971301|NCT03964207|69658532|FG001|First Treatment|Withdrawal by Subject|2|||
37971302|NCT03964207|69658531|FG000|First Treatment|Protocol Violation|1|||
37971303|NCT03964207|69658532|FG001|First Treatment|Protocol Violation|0|||
37780559|NCT02969525|69346539|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
37780560|NCT02969525|69346540|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
37780561|NCT02969525|69346541|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
37780562|NCT02969525|69346542|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
37780563|NCT02969525|69346543|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
37780564|NCT02969525|69346544|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
37780565|NCT02969525|69346545|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
37780566|NCT02969525|69346546|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
37780567|NCT02969525|69346547|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
37780568|NCT02969525|69346548|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
37780569|NCT02969525|69346549|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
37780570|NCT04232215|69346580|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
37780571|NCT04232215|69346581|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
37780572|NCT02399813|69346596|FG000|Overall Study|Progressive Disease-Radiographic|2|||
37780573|NCT02399813|69346596|FG000|Overall Study|Death|20|||
37780574|NCT02399813|69346596|FG000|Overall Study|Withdrawal by Subject|3|||
37780575|NCT02399813|69346596|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
37780576|NCT02399813|69346596|FG000|Overall Study|Lost to Follow-up|2|||
37780577|NCT02399813|69346596|FG000|Overall Study|Other than specified|5|||
37780578|NCT02291055|69346605|FG000|Overall Study|Death|2|||
37780579|NCT02291055|69346606|FG001|Overall Study|Death|2|||
37780580|NCT02291055|69346607|FG002|Overall Study|Death|5|||
37780581|NCT02291055|69346608|FG003|Overall Study|Death|8|||
37780582|NCT02291055|69346609|FG004|Overall Study|Death|12|||
37780583|NCT02291055|69346605|FG000|Overall Study|Lost to Follow-up|0|||
37780584|NCT02291055|69346606|FG001|Overall Study|Lost to Follow-up|0|||
37780585|NCT02291055|69346607|FG002|Overall Study|Lost to Follow-up|0|||
37780586|NCT02291055|69346608|FG003|Overall Study|Lost to Follow-up|1|||
37780587|NCT02291055|69346609|FG004|Overall Study|Lost to Follow-up|2|||
37780588|NCT02291055|69346605|FG000|Overall Study|Withdrawal by Subject|3|||
37780589|NCT02291055|69346606|FG001|Overall Study|Withdrawal by Subject|1|||
37780590|NCT02291055|69346607|FG002|Overall Study|Withdrawal by Subject|1|||
37780591|NCT02291055|69346608|FG003|Overall Study|Withdrawal by Subject|5|||
37780592|NCT02291055|69346609|FG004|Overall Study|Withdrawal by Subject|10|||
37780593|NCT02291055|69346605|FG000|Overall Study|Progressive Disease|0|||
37780594|NCT02291055|69346606|FG001|Overall Study|Progressive Disease|0|||
37780595|NCT02291055|69346607|FG002|Overall Study|Progressive Disease|1|||
37780596|NCT02291055|69346608|FG003|Overall Study|Progressive Disease|4|||
37780597|NCT02291055|69346609|FG004|Overall Study|Progressive Disease|2|||
37780598|NCT02291055|69346605|FG000|Overall Study|Study Terminated by Sponsor|0|||
37780599|NCT02291055|69346606|FG001|Overall Study|Study Terminated by Sponsor|0|||
37971304|NCT03964207|69658531|FG000|First Treatment|Lost to Follow-up|1|||
37971305|NCT03964207|69658532|FG001|First Treatment|Lost to Follow-up|0|||
37971306|NCT03964207|69658531|FG000|Second Treatment|Lost to Follow-up|0|||
37971307|NCT03964207|69658532|FG001|Second Treatment|Lost to Follow-up|1|||
37971308|NCT03964207|69658531|FG000|Second Treatment|Adverse Event|1|||
37971309|NCT03964207|69658532|FG001|Second Treatment|Adverse Event|2|||
37971310|NCT03947255|69658541|FG000|Overall Study|Study Closure by Sponsor|2|||
37971311|NCT03947255|69658542|FG001|Overall Study|Study Closure by Sponsor|2|||
37971312|NCT03947255|69658541|FG000|Overall Study|Withdrawal by Subject|2|||
37971313|NCT03947255|69658542|FG001|Overall Study|Withdrawal by Subject|2|||
37971314|NCT03947255|69658541|FG000|Overall Study|Lost to Follow-up|2|||
37971315|NCT03947255|69658542|FG001|Overall Study|Lost to Follow-up|0|||
37971316|NCT03947255|69658541|FG000|Overall Study|Death|0|||
37780600|NCT02291055|69346607|FG002|Overall Study|Study Terminated by Sponsor|0|||
37780601|NCT02291055|69346608|FG003|Overall Study|Study Terminated by Sponsor|5|||
37780602|NCT02291055|69346609|FG004|Overall Study|Study Terminated by Sponsor|1|||
37780603|NCT02291055|69346605|FG000|Overall Study|Other|0|||
37780604|NCT02291055|69346606|FG001|Overall Study|Other|2|||
37780605|NCT02291055|69346607|FG002|Overall Study|Other|1|||
37863971|NCT00994162|69547571|FG000|Overall Study|Product Complaint|1|||
37863972|NCT00994162|69547571|FG000|Overall Study|Poor Compliance|5|||
37863973|NCT00994162|69547571|FG000|Overall Study|Lack of Response|3|||
37780606|NCT02291055|69346608|FG003|Overall Study|Other|4|||
37780607|NCT02291055|69346609|FG004|Overall Study|Other|0|||
37780608|NCT00723697|69346625|FG000|Overall Study|Physician questionnaires not received|2|||
37971317|NCT03947255|69658542|FG001|Overall Study|Death|2|||
37780609|NCT00723697|69346625|FG000|Overall Study|Missing Informed Consent Form|10|||
37863974|NCT00994162|69547571|FG000|Overall Study|Discharged from Hospital|4|||
37971318|NCT03929757|69658550|FG000|Main Study: Up to Day 365|Withdrawal by parent/guardian|2|||
37971319|NCT03929757|69658551|FG001|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
37971320|NCT03929757|69658552|FG002|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
37971321|NCT03929757|69658550|FG000|Main Study: Up to Day 365|Other|1|||
37971322|NCT03929757|69658551|FG001|Main Study: Up to Day 365|Other|0|||
37971323|NCT03929757|69658552|FG002|Main Study: Up to Day 365|Other|0|||
37971324|NCT03929757|69658550|FG000|Extension Study: Up to Extension Day 85|Adverse Event|0|||
37971325|NCT03929757|69658551|FG001|Extension Study: Up to Extension Day 85|Adverse Event|0|||
37971326|NCT03929757|69658552|FG002|Extension Study: Up to Extension Day 85|Adverse Event|1|||
37971327|NCT03748823|69658561|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
37971328|NCT03748823|69658562|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
37971329|NCT03748823|69658561|FG000|Extension Period|Withdrawal by Subject|1|||
37971330|NCT03748823|69658562|FG001|Extension Period|Withdrawal by Subject|2|||
37971331|NCT03748823|69658561|FG000|Extension Period|Death|0|||
37971332|NCT03748823|69658562|FG001|Extension Period|Death|1|||
37692217|NCT01877668|69168448|FG003|Overall Study|Adverse event unrelated to study drug|0|||
37692218|NCT01877668|69168449|FG004|Overall Study|Adverse event unrelated to study drug|1|||
37692219|NCT01877278|69168467|FG000|Overall Study|Lost to Follow-up|3|||
37692220|NCT01877278|69168468|FG001|Overall Study|Lost to Follow-up|3|||
37692221|NCT01906372|69168474|FG000|Overall Study|Withdrawal by Subject|2|||
37692222|NCT01925170|69168479|FG000|Overall Study|Unverified cancer status|53|||
37692223|NCT01925014|69168487|FG000|Overall Study|Inappropriate enrollment|4|||
37692224|NCT01925014|69168488|FG001|Overall Study|Inappropriate enrollment|6|||
37692225|NCT01925014|69168487|FG000|Overall Study|Withdrawal by Subject|5|||
37692226|NCT01925014|69168488|FG001|Overall Study|Withdrawal by Subject|13|||
37692227|NCT01876810|69168494|FG000|Overall Study|Physician Decision|0|||
37692228|NCT01876810|69168495|FG001|Overall Study|Physician Decision|1|||
37692229|NCT01876732|69168504|FG000|Overall Study|MMA was not over 800mg/dL|75|||
37780610|NCT00723697|69346625|FG000|Overall Study|Other exclusion criteria applied|6|||
37780611|NCT00684073|69346632|FG000|Selection|Selection/non-selection criteria|3|||
37780612|NCT00684073|69346632|FG000|Selection|Death|1|||
37780613|NCT00684073|69346632|FG000|Selection|noncompliance|1|||
37780614|NCT00684073|69346632|FG000|Selection|Lost to Follow-up|1|||
37780615|NCT00684073|69346632|FG000|Selection|request of the sponsor|1|||
37780616|NCT00684073|69346632|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
37780617|NCT02539368|69348573|FG000|Overall Study|Death|4|||
37780618|NCT02539368|69348574|FG001|Overall Study|Death|2|||
37780619|NCT02539368|69348575|FG002|Overall Study|Death|1|||
37780620|NCT02539368|69348576|FG003|Overall Study|Death|0|||
37780621|NCT02539368|69348577|FG004|Overall Study|Death|0|||
37780622|NCT02539368|69348573|FG000|Overall Study|Withdrawal by Subject|44|||
37780623|NCT02539368|69348574|FG001|Overall Study|Withdrawal by Subject|35|||
37780624|NCT02539368|69348575|FG002|Overall Study|Withdrawal by Subject|9|||
37780625|NCT02539368|69348576|FG003|Overall Study|Withdrawal by Subject|1|||
37780626|NCT02539368|69348577|FG004|Overall Study|Withdrawal by Subject|3|||
37780627|NCT02539368|69348573|FG000|Overall Study|Physician Decision|49|||
37971333|NCT03748823|69658561|FG000|Extension Period|Protocol Violation|1|||
37971334|NCT03748823|69658562|FG001|Extension Period|Protocol Violation|0|||
37971335|NCT03748823|69658561|FG000|Extension Period|Ongoing in the Extension Period|41|||
37971336|NCT03748823|69658562|FG001|Extension Period|Ongoing in the Extension Period|84|||
37971337|NCT03548558|69658585|FG000|Phase 1: 16 Total Fortnightly Sessions|Death|2|||
37971338|NCT03548558|69658586|FG001|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
37971339|NCT03548558|69658587|FG002|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
37971340|NCT03548558|69658588|FG003|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
37971341|NCT03548558|69658589|FG004|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
37692230|NCT01905592|69168511|FG000|Overall Study|Disease Progression|51|||
37692231|NCT01905592|69168512|FG001|Overall Study|Disease Progression|110|||
37780628|NCT02539368|69348574|FG001|Overall Study|Physician Decision|15|||
37780629|NCT02539368|69348575|FG002|Overall Study|Physician Decision|7|||
37780630|NCT02539368|69348576|FG003|Overall Study|Physician Decision|0|||
37780631|NCT02539368|69348577|FG004|Overall Study|Physician Decision|2|||
37780632|NCT02539368|69348573|FG000|Overall Study|Lost to Follow-up|96|||
37780633|NCT02539368|69348574|FG001|Overall Study|Lost to Follow-up|21|||
37780634|NCT02539368|69348575|FG002|Overall Study|Lost to Follow-up|16|||
37692232|NCT01905592|69168511|FG000|Overall Study|Toxicity|1|||
37971342|NCT03548558|69658590|FG005|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
37971343|NCT03548558|69658591|FG006|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
37971344|NCT03548558|69658585|FG000|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
37971345|NCT03548558|69658586|FG001|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
37971346|NCT03548558|69658587|FG002|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
37971347|NCT03548558|69658588|FG003|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
37971348|NCT03548558|69658589|FG004|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|2|||
37971349|NCT03548558|69658590|FG005|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
37971350|NCT03548558|69658591|FG006|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
37971351|NCT03548558|69658585|FG000|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|7|||
37971352|NCT03548558|69658586|FG001|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|15|||
37971353|NCT03548558|69658587|FG002|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|9|||
37971354|NCT03548558|69658588|FG003|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|13|||
37971355|NCT03548558|69658589|FG004|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|24|||
37971356|NCT03548558|69658590|FG005|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
37971357|NCT03548558|69658591|FG006|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
37971358|NCT03548558|69658585|FG000|Phase 2: Booster Sessions Every 2 Months|Death|0|||
37971359|NCT03548558|69658586|FG001|Phase 2: Booster Sessions Every 2 Months|Death|0|||
37971360|NCT03548558|69658587|FG002|Phase 2: Booster Sessions Every 2 Months|Death|0|||
37971361|NCT03548558|69658588|FG003|Phase 2: Booster Sessions Every 2 Months|Death|0|||
37971362|NCT03548558|69658589|FG004|Phase 2: Booster Sessions Every 2 Months|Death|3|||
37971363|NCT03548558|69658590|FG005|Phase 2: Booster Sessions Every 2 Months|Death|1|||
37971364|NCT03548558|69658591|FG006|Phase 2: Booster Sessions Every 2 Months|Death|1|||
37971365|NCT03548558|69658585|FG000|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
37971366|NCT03548558|69658586|FG001|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
37971367|NCT03548558|69658587|FG002|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
37971368|NCT03548558|69658588|FG003|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
37971369|NCT03548558|69658589|FG004|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|4|||
37971370|NCT03548558|69658590|FG005|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
37971371|NCT03548558|69658591|FG006|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
37971372|NCT03548558|69658585|FG000|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
37971373|NCT03548558|69658586|FG001|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
37971374|NCT03548558|69658587|FG002|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
37971375|NCT03548558|69658588|FG003|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
37971376|NCT03548558|69658589|FG004|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|62|||
37971377|NCT03548558|69658590|FG005|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|67|||
37971378|NCT03548558|69658591|FG006|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|61|||
37971379|NCT03384654|69658629|FG000|Overall Study|Withdrawal by Subject|0|||
37971380|NCT03384654|69658630|FG001|Overall Study|Withdrawal by Subject|0|||
37971381|NCT03384654|69658631|FG002|Overall Study|Withdrawal by Subject|1|||
37971382|NCT03384654|69658632|FG003|Overall Study|Withdrawal by Subject|0|||
37971383|NCT03364673|69658673|FG000|Overall Study|Withdrawal by Subject|2|||
37971384|NCT03364673|69658673|FG000|Overall Study|Injury unrelated to study|3|||
37971385|NCT03330405|69658688|FG000|Overall Study|Other|1|||
37971386|NCT03330405|69658689|FG001|Overall Study|Other|3|||
37971387|NCT03330405|69658690|FG002|Overall Study|Other|1|||
37971388|NCT03330405|69658691|FG003|Overall Study|Other|0|||
37971389|NCT03330405|69658692|FG004|Overall Study|Other|2|||
37971390|NCT03330405|69658693|FG005|Overall Study|Other|0|||
37971391|NCT03330405|69658694|FG006|Overall Study|Other|1|||
37971392|NCT03330405|69658695|FG007|Overall Study|Other|0|||
37971393|NCT03330405|69658696|FG008|Overall Study|Other|0|||
37971394|NCT03330405|69658697|FG009|Overall Study|Other|0|||
37971395|NCT03330405|69658698|FG010|Overall Study|Other|0|||
37971396|NCT03330405|69658688|FG000|Overall Study|Progressive disease|8|||
37971397|NCT03330405|69658689|FG001|Overall Study|Progressive disease|27|||
37971398|NCT03330405|69658690|FG002|Overall Study|Progressive disease|4|||
37971399|NCT03330405|69658691|FG003|Overall Study|Progressive disease|18|||
37971400|NCT03330405|69658692|FG004|Overall Study|Progressive disease|16|||
37971401|NCT03330405|69658693|FG005|Overall Study|Progressive disease|14|||
37971402|NCT03330405|69658694|FG006|Overall Study|Progressive disease|7|||
37971403|NCT03330405|69658695|FG007|Overall Study|Progressive disease|29|||
37971404|NCT03330405|69658696|FG008|Overall Study|Progressive disease|9|||
37971405|NCT03330405|69658697|FG009|Overall Study|Progressive disease|11|||
37971406|NCT03330405|69658698|FG010|Overall Study|Progressive disease|5|||
37971407|NCT03330405|69658688|FG000|Overall Study|Withdrawal by Subject|1|||
37971408|NCT03330405|69658689|FG001|Overall Study|Withdrawal by Subject|4|||
37971409|NCT03330405|69658690|FG002|Overall Study|Withdrawal by Subject|0|||
37971410|NCT03330405|69658691|FG003|Overall Study|Withdrawal by Subject|1|||
37971411|NCT03330405|69658692|FG004|Overall Study|Withdrawal by Subject|1|||
37971412|NCT03330405|69658693|FG005|Overall Study|Withdrawal by Subject|1|||
37971413|NCT03330405|69658694|FG006|Overall Study|Withdrawal by Subject|0|||
37971414|NCT03330405|69658695|FG007|Overall Study|Withdrawal by Subject|2|||
37971415|NCT03330405|69658696|FG008|Overall Study|Withdrawal by Subject|2|||
37971416|NCT03330405|69658697|FG009|Overall Study|Withdrawal by Subject|1|||
37971417|NCT03330405|69658698|FG010|Overall Study|Withdrawal by Subject|1|||
37971418|NCT03330405|69658688|FG000|Overall Study|Global deterioration of health status|2|||
37971419|NCT03330405|69658689|FG001|Overall Study|Global deterioration of health status|3|||
37971420|NCT03330405|69658690|FG002|Overall Study|Global deterioration of health status|0|||
37971421|NCT03330405|69658691|FG003|Overall Study|Global deterioration of health status|2|||
37971422|NCT03330405|69658692|FG004|Overall Study|Global deterioration of health status|3|||
37971423|NCT03330405|69658693|FG005|Overall Study|Global deterioration of health status|3|||
37971424|NCT03330405|69658694|FG006|Overall Study|Global deterioration of health status|0|||
37971425|NCT03330405|69658695|FG007|Overall Study|Global deterioration of health status|2|||
37971426|NCT03330405|69658696|FG008|Overall Study|Global deterioration of health status|8|||
37971427|NCT03330405|69658697|FG009|Overall Study|Global deterioration of health status|4|||
37971428|NCT03330405|69658698|FG010|Overall Study|Global deterioration of health status|1|||
37971429|NCT03330405|69658688|FG000|Overall Study|Adverse Event|0|||
37971430|NCT03330405|69658689|FG001|Overall Study|Adverse Event|1|||
37971431|NCT03330405|69658690|FG002|Overall Study|Adverse Event|0|||
37971432|NCT03330405|69658691|FG003|Overall Study|Adverse Event|1|||
37971433|NCT03330405|69658692|FG004|Overall Study|Adverse Event|1|||
37971434|NCT03330405|69658693|FG005|Overall Study|Adverse Event|1|||
37971435|NCT03330405|69658694|FG006|Overall Study|Adverse Event|3|||
37971436|NCT03330405|69658695|FG007|Overall Study|Adverse Event|4|||
37971437|NCT03330405|69658696|FG008|Overall Study|Adverse Event|2|||
37971438|NCT03330405|69658697|FG009|Overall Study|Adverse Event|2|||
37971439|NCT03330405|69658698|FG010|Overall Study|Adverse Event|2|||
37971440|NCT03330405|69658688|FG000|Overall Study|Death|0|||
37971441|NCT03330405|69658689|FG001|Overall Study|Death|4|||
37971442|NCT03330405|69658690|FG002|Overall Study|Death|0|||
37971443|NCT03330405|69658691|FG003|Overall Study|Death|0|||
37971444|NCT03330405|69658692|FG004|Overall Study|Death|0|||
37971445|NCT03330405|69658693|FG005|Overall Study|Death|1|||
37971446|NCT03330405|69658694|FG006|Overall Study|Death|0|||
37971447|NCT03330405|69658695|FG007|Overall Study|Death|2|||
37971448|NCT03330405|69658696|FG008|Overall Study|Death|0|||
37971449|NCT03330405|69658697|FG009|Overall Study|Death|0|||
37971450|NCT03330405|69658698|FG010|Overall Study|Death|0|||
37971451|NCT03330405|69658688|FG000|Overall Study|Physician Decision|0|||
37971452|NCT03330405|69658689|FG001|Overall Study|Physician Decision|0|||
37971453|NCT03330405|69658690|FG002|Overall Study|Physician Decision|0|||
37971454|NCT03330405|69658691|FG003|Overall Study|Physician Decision|0|||
37971455|NCT03330405|69658692|FG004|Overall Study|Physician Decision|0|||
37971456|NCT03330405|69658693|FG005|Overall Study|Physician Decision|0|||
37971457|NCT03330405|69658694|FG006|Overall Study|Physician Decision|0|||
37971458|NCT03330405|69658695|FG007|Overall Study|Physician Decision|1|||
37971459|NCT03330405|69658696|FG008|Overall Study|Physician Decision|0|||
37971460|NCT03330405|69658697|FG009|Overall Study|Physician Decision|0|||
37971461|NCT03330405|69658698|FG010|Overall Study|Physician Decision|0|||
37971462|NCT03141177|69658755|FG000|Overall Study|Death|62|||
37971463|NCT03141177|69658756|FG001|Overall Study|Death|13|||
37971464|NCT03141177|69658757|FG002|Overall Study|Death|84|||
37971465|NCT03141177|69658755|FG000|Overall Study|Participant withdrew consent|9|||
37971466|NCT03141177|69658756|FG001|Overall Study|Participant withdrew consent|2|||
37971467|NCT03141177|69658757|FG002|Overall Study|Participant withdrew consent|13|||
37971468|NCT03141177|69658755|FG000|Overall Study|Not reported|1|||
37971469|NCT03141177|69658756|FG001|Overall Study|Not reported|0|||
37971470|NCT03141177|69658757|FG002|Overall Study|Not reported|1|||
37971471|NCT03141177|69658755|FG000|Overall Study|Lost to Follow-up|2|||
37971472|NCT03141177|69658756|FG001|Overall Study|Lost to Follow-up|1|||
37971473|NCT03141177|69658757|FG002|Overall Study|Lost to Follow-up|1|||
37971474|NCT03141177|69658755|FG000|Overall Study|Other reasons|4|||
37971475|NCT03141177|69658756|FG001|Overall Study|Other reasons|0|||
37971476|NCT03141177|69658757|FG002|Overall Study|Other reasons|11|||
37971477|NCT03141177|69658755|FG000|Overall Study|Participants did not start treatment period|3|||
37971478|NCT03141177|69658756|FG001|Overall Study|Participants did not start treatment period|0|||
37971479|NCT03141177|69658757|FG002|Overall Study|Participants did not start treatment period|8|||
37971480|NCT02734004|69658857|FG000|Overall Study|Death|36|||
37971481|NCT02734004|69658858|FG001|Overall Study|Death|24|||
37971482|NCT02734004|69658859|FG002|Overall Study|Death|26|||
37971483|NCT02734004|69658860|FG003|Overall Study|Death|35|||
37971484|NCT02734004|69658861|FG004|Overall Study|Death|13|||
37971485|NCT02734004|69658862|FG005|Overall Study|Death|17|||
37971486|NCT02734004|69658863|FG006|Overall Study|Death|20|||
37971487|NCT02734004|69658857|FG000|Overall Study|Lost to Follow-up|1|||
37971488|NCT02734004|69658858|FG001|Overall Study|Lost to Follow-up|1|||
37971489|NCT02734004|69658859|FG002|Overall Study|Lost to Follow-up|0|||
37971490|NCT02734004|69658860|FG003|Overall Study|Lost to Follow-up|0|||
37971491|NCT02734004|69658861|FG004|Overall Study|Lost to Follow-up|1|||
37971492|NCT02734004|69658862|FG005|Overall Study|Lost to Follow-up|0|||
37971493|NCT02734004|69658863|FG006|Overall Study|Lost to Follow-up|0|||
37971494|NCT02734004|69658857|FG000|Overall Study|Withdrawal by Subject|3|||
37971495|NCT02734004|69658858|FG001|Overall Study|Withdrawal by Subject|1|||
37971496|NCT02734004|69658859|FG002|Overall Study|Withdrawal by Subject|1|||
37971497|NCT02734004|69658860|FG003|Overall Study|Withdrawal by Subject|1|||
37971498|NCT02734004|69658861|FG004|Overall Study|Withdrawal by Subject|3|||
37971499|NCT02734004|69658862|FG005|Overall Study|Withdrawal by Subject|0|||
37971500|NCT02734004|69658863|FG006|Overall Study|Withdrawal by Subject|2|||
37971501|NCT02734004|69658857|FG000|Overall Study|Other|0|||
37971502|NCT02734004|69658858|FG001|Overall Study|Other|8|||
37971503|NCT02734004|69658859|FG002|Overall Study|Other|7|||
37971504|NCT02734004|69658860|FG003|Overall Study|Other|4|||
37971505|NCT02734004|69658861|FG004|Overall Study|Other|34|||
37971506|NCT02734004|69658862|FG005|Overall Study|Other|14|||
37971507|NCT02734004|69658863|FG006|Overall Study|Other|10|||
37971508|NCT02683239|69658893|FG000|Overall Study|Protocol Violation|35|||
37971509|NCT02683239|69658894|FG001|Overall Study|Protocol Violation|23|||
37971510|NCT02683239|69658895|FG002|Overall Study|Protocol Violation|26|||
37971511|NCT02683239|69658896|FG003|Overall Study|Protocol Violation|4|||
37971512|NCT02683239|69658897|FG004|Overall Study|Protocol Violation|35|||
37971513|NCT02683239|69658898|FG005|Overall Study|Protocol Violation|4|||
37971514|NCT02683239|69658899|FG006|Overall Study|Protocol Violation|5|||
37971515|NCT02683239|69658893|FG000|Overall Study|Adverse Event|64|||
37971516|NCT02683239|69658894|FG001|Overall Study|Adverse Event|39|||
37971517|NCT02683239|69658895|FG002|Overall Study|Adverse Event|42|||
37971518|NCT02683239|69658896|FG003|Overall Study|Adverse Event|16|||
37971519|NCT02683239|69658897|FG004|Overall Study|Adverse Event|189|||
37971520|NCT02683239|69658898|FG005|Overall Study|Adverse Event|9|||
37971521|NCT02683239|69658899|FG006|Overall Study|Adverse Event|9|||
37971522|NCT02683239|69658893|FG000|Overall Study|Physician Decision|38|||
37971523|NCT02683239|69658894|FG001|Overall Study|Physician Decision|19|||
37971524|NCT02683239|69658895|FG002|Overall Study|Physician Decision|14|||
37971525|NCT02683239|69658896|FG003|Overall Study|Physician Decision|73|||
37971526|NCT02683239|69658897|FG004|Overall Study|Physician Decision|143|||
37971527|NCT02683239|69658898|FG005|Overall Study|Physician Decision|14|||
37971528|NCT02683239|69658899|FG006|Overall Study|Physician Decision|15|||
37971529|NCT02683239|69658893|FG000|Overall Study|Withdrawal by Subject|187|||
37971530|NCT02683239|69658894|FG001|Overall Study|Withdrawal by Subject|99|||
37971531|NCT02683239|69658895|FG002|Overall Study|Withdrawal by Subject|91|||
37971532|NCT02683239|69658896|FG003|Overall Study|Withdrawal by Subject|18|||
37971533|NCT02683239|69658897|FG004|Overall Study|Withdrawal by Subject|248|||
37971534|NCT02683239|69658898|FG005|Overall Study|Withdrawal by Subject|22|||
37971535|NCT02683239|69658899|FG006|Overall Study|Withdrawal by Subject|28|||
37971536|NCT02683239|69658893|FG000|Overall Study|Lost to Follow-up|77|||
37971537|NCT02683239|69658894|FG001|Overall Study|Lost to Follow-up|24|||
37971538|NCT02683239|69658895|FG002|Overall Study|Lost to Follow-up|25|||
37971539|NCT02683239|69658896|FG003|Overall Study|Lost to Follow-up|7|||
37971540|NCT02683239|69658897|FG004|Overall Study|Lost to Follow-up|88|||
37971541|NCT02683239|69658898|FG005|Overall Study|Lost to Follow-up|8|||
37971542|NCT02683239|69658899|FG006|Overall Study|Lost to Follow-up|11|||
37971543|NCT02683239|69658893|FG000|Overall Study|Death|9|||
37971544|NCT02683239|69658894|FG001|Overall Study|Death|5|||
37971545|NCT02683239|69658895|FG002|Overall Study|Death|8|||
37971546|NCT02683239|69658896|FG003|Overall Study|Death|0|||
37971547|NCT02683239|69658897|FG004|Overall Study|Death|12|||
37971548|NCT02683239|69658898|FG005|Overall Study|Death|1|||
37971549|NCT02683239|69658899|FG006|Overall Study|Death|0|||
37971550|NCT02683239|69658893|FG000|Overall Study|Lack of Efficacy|50|||
37971551|NCT02683239|69658894|FG001|Overall Study|Lack of Efficacy|23|||
37971552|NCT02683239|69658895|FG002|Overall Study|Lack of Efficacy|12|||
37971553|NCT02683239|69658896|FG003|Overall Study|Lack of Efficacy|2|||
37971554|NCT02683239|69658897|FG004|Overall Study|Lack of Efficacy|29|||
37971555|NCT02683239|69658898|FG005|Overall Study|Lack of Efficacy|2|||
37971556|NCT02683239|69658899|FG006|Overall Study|Lack of Efficacy|3|||
37971557|NCT02683239|69658893|FG000|Overall Study|Missing data|0|||
37971558|NCT02683239|69658894|FG001|Overall Study|Missing data|1|||
37971559|NCT02683239|69658895|FG002|Overall Study|Missing data|1|||
37971560|NCT02683239|69658896|FG003|Overall Study|Missing data|0|||
37971561|NCT02683239|69658897|FG004|Overall Study|Missing data|1|||
37971562|NCT02683239|69658898|FG005|Overall Study|Missing data|0|||
37971563|NCT02683239|69658899|FG006|Overall Study|Missing data|0|||
37971564|NCT02097134|69658915|FG000|Overall Study|Physician Decision|4|||
37971565|NCT02097134|69658915|FG000|Overall Study|Non-Protocol Therapy|1|||
37971566|NCT02097134|69658915|FG000|Overall Study|Progressive Disease|3|||
37971567|NCT02097134|69658915|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
37971568|NCT01859130|69658920|FG000|Overall Study|Death|4|||
37971569|NCT01859130|69658920|FG000|Overall Study|Lost to Follow-up|16|||
37971570|NCT01859130|69658920|FG000|Overall Study|Sponsor terminated: 47 Not specified: 3|53|||
37971571|NCT01859130|69658920|FG000|Overall Study|Physician Decision|6|||
37971572|NCT01859130|69658920|FG000|Overall Study|Withdrawal by Subject|17|||
37971573|NCT01859130|69658920|FG000|Overall Study|Adverse Event|11|||
37971574|NCT01174043|69658937|FG000|Overall Study|Disease progression|5|||
37971575|NCT01174043|69658937|FG000|Overall Study|Adverse Event|3|||
37971576|NCT01174043|69658937|FG000|Overall Study|Death|1|||
37971577|NCT01174043|69658937|FG000|Overall Study|Withdrawal by Subject|2|||
37971578|NCT04050982|69658943|FG000|Overall Study|Did not meet eligibility criteria|0|||
37971579|NCT04050982|69658944|FG001|Overall Study|Did not meet eligibility criteria|1|||
37971580|NCT04050982|69658945|FG002|Overall Study|Did not meet eligibility criteria|0|||
37971581|NCT04050982|69658943|FG000|Overall Study|Withdrawal by Subject|1|||
37971582|NCT04050982|69658944|FG001|Overall Study|Withdrawal by Subject|0|||
37971583|NCT04050982|69658945|FG002|Overall Study|Withdrawal by Subject|0|||
37971584|NCT04050982|69658943|FG000|Overall Study|Unable to enroll on platform|1|||
37971585|NCT04050982|69658944|FG001|Overall Study|Unable to enroll on platform|0|||
37971586|NCT04050982|69658945|FG002|Overall Study|Unable to enroll on platform|0|||
37971587|NCT03905265|69658955|FG000|Overall Study|Withdrawal by Subject|1|||
37971588|NCT03905265|69658956|FG001|Overall Study|Withdrawal by Subject|1|||
37971589|NCT03905265|69658957|FG002|Overall Study|Withdrawal by Subject|0|||
37971590|NCT03905265|69658958|FG003|Overall Study|Withdrawal by Subject|0|||
37971591|NCT03848845|69658971|FG000|Overall Study|Lost to Follow-up|0|||
37971592|NCT03848845|69658972|FG001|Overall Study|Lost to Follow-up|1|||
37971593|NCT03848845|69658973|FG002|Overall Study|Lost to Follow-up|0|||
37971594|NCT03848845|69658971|FG000|Overall Study|Withdrawal by Subject|3|||
37971595|NCT03848845|69658972|FG001|Overall Study|Withdrawal by Subject|2|||
37971596|NCT03848845|69658973|FG002|Overall Study|Withdrawal by Subject|6|||
37971597|NCT03848845|69658971|FG000|Overall Study|In Follow-up|0|||
37971598|NCT03848845|69658972|FG001|Overall Study|In Follow-up|1|||
37971599|NCT03848845|69658973|FG002|Overall Study|In Follow-up|12|||
37971600|NCT03848845|69658971|FG000|Overall Study|On Study Treatment|0|||
37971601|NCT03848845|69658972|FG001|Overall Study|On Study Treatment|0|||
37971602|NCT03848845|69658973|FG002|Overall Study|On Study Treatment|4|||
37971603|NCT03848845|69658971|FG000|Overall Study|Physician Decision|0|||
37971604|NCT03848845|69658972|FG001|Overall Study|Physician Decision|0|||
37971605|NCT03848845|69658973|FG002|Overall Study|Physician Decision|1|||
37971606|NCT03742037|69658986|FG000|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
37971607|NCT03742037|69658987|FG001|Treatment Period 1 (1st Dose - Month 6)|Death|1|||
37971608|NCT03742037|69658988|FG002|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
37971609|NCT03742037|69658989|FG003|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
37971610|NCT03742037|69658990|FG004|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
37971611|NCT03742037|69658991|FG005|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
37971612|NCT03742037|69658992|FG006|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
37971613|NCT03742037|69658986|FG000|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
37971614|NCT03742037|69658987|FG001|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|1|||
37971615|NCT03742037|69658988|FG002|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|4|||
37971616|NCT03742037|69658989|FG003|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
37971617|NCT03742037|69658990|FG004|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
37971618|NCT03742037|69658991|FG005|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|3|||
37971619|NCT03742037|69658992|FG006|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|2|||
37971620|NCT03742037|69658986|FG000|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
37971621|NCT03742037|69658987|FG001|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|1|||
37971622|NCT03742037|69658988|FG002|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
37971623|NCT03742037|69658989|FG003|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
37971624|NCT03742037|69658990|FG004|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
37971625|NCT03742037|69658991|FG005|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
37971626|NCT03742037|69658992|FG006|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
37971627|NCT03742037|69658986|FG000|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
37971628|NCT03742037|69658987|FG001|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
37971629|NCT03742037|69658988|FG002|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
37971630|NCT03742037|69658989|FG003|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
37971631|NCT03742037|69658990|FG004|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
37971632|NCT03742037|69658991|FG005|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
37971633|NCT03742037|69658992|FG006|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
37971634|NCT03742037|69658986|FG000|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
37971635|NCT03742037|69658987|FG001|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|3|||
37971636|NCT03742037|69658988|FG002|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|7|||
37971637|NCT03742037|69658989|FG003|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
37971638|NCT03742037|69658990|FG004|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
37971639|NCT03742037|69658991|FG005|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|6|||
37971640|NCT03742037|69658992|FG006|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
37971641|NCT03742037|69658986|FG000|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
37971642|NCT03742037|69658987|FG001|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
37971643|NCT03742037|69658988|FG002|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
37971644|NCT03742037|69658989|FG003|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
37971645|NCT03742037|69658990|FG004|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
37971646|NCT03742037|69658991|FG005|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|1|||
37971647|NCT03742037|69658992|FG006|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
37971648|NCT03742037|69658986|FG000|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
37971649|NCT03742037|69658987|FG001|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
37971650|NCT03742037|69658988|FG002|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
37971651|NCT03742037|69658989|FG003|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
37971652|NCT03742037|69658990|FG004|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
37971653|NCT03742037|69658991|FG005|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
37971654|NCT03742037|69658992|FG006|Treatment Period 1 (1st Dose - Month 6)|Other reasons|1|||
37971655|NCT03742037|69658986|FG000|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
37780635|NCT02539368|69348576|FG003|Overall Study|Lost to Follow-up|4|||
37780636|NCT02539368|69348577|FG004|Overall Study|Lost to Follow-up|3|||
37780637|NCT02539368|69348573|FG000|Overall Study|Adverse Event|44|||
37780638|NCT02539368|69348574|FG001|Overall Study|Adverse Event|5|||
37971656|NCT03742037|69658987|FG001|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
37971657|NCT03742037|69658988|FG002|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
37971658|NCT03742037|69658989|FG003|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
37971659|NCT03742037|69658990|FG004|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
37971660|NCT03742037|69658991|FG005|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
37971661|NCT03742037|69658992|FG006|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|1|||
37971662|NCT03742037|69658986|FG000|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
37971663|NCT03742037|69658987|FG001|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|2|||
37971664|NCT03742037|69658988|FG002|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|3|||
37971665|NCT03742037|69658989|FG003|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
37971666|NCT03742037|69658990|FG004|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
37780639|NCT02539368|69348575|FG002|Overall Study|Adverse Event|9|||
37971667|NCT03742037|69658991|FG005|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
37971668|NCT03742037|69658992|FG006|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|4|||
37971669|NCT03742037|69658986|FG000|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
37971670|NCT03742037|69658987|FG001|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
37971671|NCT03742037|69658988|FG002|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
37971672|NCT03742037|69658989|FG003|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
37971673|NCT03742037|69658990|FG004|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
37971674|NCT03742037|69658991|FG005|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
37971675|NCT03742037|69658992|FG006|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|1|||
37971676|NCT03742037|69658986|FG000|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
37971677|NCT03742037|69658987|FG001|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|1|||
37971678|NCT03742037|69658988|FG002|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|2|||
37971679|NCT03742037|69658989|FG003|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
37971680|NCT03742037|69658990|FG004|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
37971681|NCT03742037|69658991|FG005|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
37971682|NCT03742037|69658992|FG006|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
37971683|NCT03742037|69658986|FG000|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
37971684|NCT03742037|69658987|FG001|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
37971685|NCT03742037|69658988|FG002|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
37971686|NCT03742037|69658989|FG003|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
37971687|NCT03742037|69658990|FG004|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
37971688|NCT03742037|69658991|FG005|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
37971689|NCT03742037|69658992|FG006|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
37971690|NCT03742037|69658986|FG000|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
37971691|NCT03742037|69658987|FG001|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|1|||
37971692|NCT03742037|69658988|FG002|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|3|||
37971693|NCT03742037|69658989|FG003|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
37971694|NCT03742037|69658990|FG004|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
37971695|NCT03742037|69658991|FG005|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
37971696|NCT03742037|69658992|FG006|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
37971697|NCT03742037|69658986|FG000|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
37971698|NCT03742037|69658987|FG001|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
37971699|NCT03742037|69658988|FG002|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
37971700|NCT03742037|69658989|FG003|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
37971701|NCT03742037|69658990|FG004|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
37971702|NCT03742037|69658991|FG005|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
37971703|NCT03742037|69658992|FG006|Treatment Period 2 (Month 6 - Month 12)|Other reasons|1|||
37971704|NCT03742037|69658986|FG000|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
37971705|NCT03742037|69658987|FG001|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
37971706|NCT03742037|69658988|FG002|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|1|||
37971707|NCT03742037|69658989|FG003|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
37971708|NCT03742037|69658990|FG004|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
37971709|NCT03742037|69658991|FG005|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
37971710|NCT03742037|69658992|FG006|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
37971711|NCT03714815|69659009|FG000|Overall Study|Physician Decision|2|||
37971712|NCT03714815|69659009|FG000|Overall Study|Withdrawal by Subject|2|||
37971713|NCT03714815|69659009|FG000|Overall Study|Death|11|||
37971714|NCT03640312|69659019|FG000|Overall Study|Lost to Follow-up|3|||
37971715|NCT03640312|69659020|FG001|Overall Study|Lost to Follow-up|6|||
37971716|NCT02254278|69659041|FG000|Overall Study|Protocol Violation|1|||
37971717|NCT02254278|69659042|FG001|Overall Study|Protocol Violation|1|||
37971718|NCT01998841|69659054|FG000|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
37971719|NCT01998841|69659055|FG001|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
37971720|NCT01998841|69659056|FG002|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|3|||
37971721|NCT01998841|69659057|FG003|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
37971722|NCT01998841|69659058|FG004|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
37971723|NCT01998841|69659054|FG000|Study Period B|Ongoing in the Study at the Time of Primary Completion Date|0|||
37780640|NCT02539368|69348576|FG003|Overall Study|Adverse Event|0|||
37780641|NCT02539368|69348577|FG004|Overall Study|Adverse Event|3|||
37780642|NCT02539368|69348573|FG000|Overall Study|Participant Non-compliant|13|||
37780643|NCT02539368|69348574|FG001|Overall Study|Participant Non-compliant|2|||
37971724|NCT01998841|69659055|FG001|Study Period B|Ongoing in the Study at the Time of Primary Completion Date|0|||
37971725|NCT01998841|69659056|FG002|Study Period B|Ongoing in the Study at the Time of Primary Completion Date|0|||
37971726|NCT01998841|69659057|FG003|Study Period B|Ongoing in the Study at the Time of Primary Completion Date|147|||
37780644|NCT02539368|69348575|FG002|Overall Study|Participant Non-compliant|1|||
37780645|NCT02539368|69348576|FG003|Overall Study|Participant Non-compliant|1|||
37780646|NCT02539368|69348577|FG004|Overall Study|Participant Non-compliant|0|||
37780647|NCT02539368|69348573|FG000|Overall Study|Other|145|||
37780648|NCT02539368|69348574|FG001|Overall Study|Other|18|||
37780649|NCT02539368|69348575|FG002|Overall Study|Other|24|||
37780650|NCT02539368|69348576|FG003|Overall Study|Other|1|||
37780651|NCT02539368|69348577|FG004|Overall Study|Other|3|||
37780652|NCT02539368|69348573|FG000|Overall Study|Missing|10|||
37780653|NCT02539368|69348574|FG001|Overall Study|Missing|3|||
37780654|NCT02539368|69348575|FG002|Overall Study|Missing|0|||
37780655|NCT02539368|69348576|FG003|Overall Study|Missing|0|||
37780656|NCT02539368|69348577|FG004|Overall Study|Missing|0|||
37780657|NCT02539134|69348730|FG000|Overall Study|Lost to Follow-up|1|||
37780658|NCT02539134|69348731|FG001|Overall Study|Lost to Follow-up|0|||
37780659|NCT02539134|69348732|FG002|Overall Study|Lost to Follow-up|0|||
37780660|NCT02539134|69348733|FG003|Overall Study|Lost to Follow-up|0|||
37780661|NCT02539134|69348734|FG004|Overall Study|Lost to Follow-up|0|||
37780662|NCT02539134|69348735|FG005|Overall Study|Lost to Follow-up|0|||
37780663|NCT02538900|69348839|FG000|Overall Study|Death|2|||
37780664|NCT02538900|69348840|FG001|Overall Study|Death|2|||
37780665|NCT02538900|69348841|FG002|Overall Study|Death|2|||
37780666|NCT02538900|69348839|FG000|Overall Study|Withdrawal by Subject|18|||
37780667|NCT02538900|69348840|FG001|Overall Study|Withdrawal by Subject|16|||
37780668|NCT02538900|69348841|FG002|Overall Study|Withdrawal by Subject|15|||
37780669|NCT01986348|69349321|FG000|Overall Study|Death|8|||
37780670|NCT01986348|69349322|FG001|Overall Study|Death|22|||
37780671|NCT01986348|69349323|FG002|Overall Study|Death|10|||
37780672|NCT01986348|69349324|FG003|Overall Study|Death|21|||
37780673|NCT01986348|69349321|FG000|Overall Study|Lost to Follow-up|0|||
37780674|NCT01986348|69349322|FG001|Overall Study|Lost to Follow-up|0|||
37780675|NCT01986348|69349323|FG002|Overall Study|Lost to Follow-up|0|||
37780676|NCT01986348|69349324|FG003|Overall Study|Lost to Follow-up|2|||
37780677|NCT01986348|69349321|FG000|Overall Study|Physician Decision|0|||
37780678|NCT01986348|69349322|FG001|Overall Study|Physician Decision|0|||
37780679|NCT01986348|69349323|FG002|Overall Study|Physician Decision|0|||
37780680|NCT01986348|69349324|FG003|Overall Study|Physician Decision|1|||
37780681|NCT01986348|69349321|FG000|Overall Study|Progressive Disease|0|||
37780682|NCT01986348|69349322|FG001|Overall Study|Progressive Disease|0|||
37780683|NCT01986348|69349323|FG002|Overall Study|Progressive Disease|2|||
37780684|NCT01986348|69349324|FG003|Overall Study|Progressive Disease|0|||
37780685|NCT01986348|69349321|FG000|Overall Study|Withdrawal by Participant|0|||
37780686|NCT01986348|69349322|FG001|Overall Study|Withdrawal by Participant|1|||
37780687|NCT01986348|69349323|FG002|Overall Study|Withdrawal by Participant|2|||
37780688|NCT01986348|69349324|FG003|Overall Study|Withdrawal by Participant|1|||
37780689|NCT01986348|69349321|FG000|Overall Study|Study Terminated by Sponsor|0|||
37780690|NCT01986348|69349322|FG001|Overall Study|Study Terminated by Sponsor|0|||
37692233|NCT01905592|69168512|FG001|Overall Study|Toxicity|16|||
37692234|NCT01905592|69168511|FG000|Overall Study|Physician Decision|0|||
37692235|NCT01905592|69168512|FG001|Overall Study|Physician Decision|2|||
37692236|NCT01905592|69168511|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
37692237|NCT01905592|69168512|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
37692238|NCT01905592|69168511|FG000|Overall Study|Protocol Violation|0|||
37692239|NCT01905592|69168512|FG001|Overall Study|Protocol Violation|1|||
37692240|NCT01905592|69168511|FG000|Overall Study|Sponsor's decision|1|||
37692241|NCT01905592|69168512|FG001|Overall Study|Sponsor's decision|1|||
37692242|NCT01905592|69168511|FG000|Overall Study|Not treated|7|||
37692243|NCT01905592|69168512|FG001|Overall Study|Not treated|3|||
37780691|NCT01986348|69349323|FG002|Overall Study|Study Terminated by Sponsor|0|||
37780692|NCT01986348|69349324|FG003|Overall Study|Study Terminated by Sponsor|3|||
37780693|NCT01986348|69349321|FG000|Overall Study|Other-unspecified|0|||
37780694|NCT01986348|69349322|FG001|Overall Study|Other-unspecified|1|||
37780695|NCT01986348|69349323|FG002|Overall Study|Other-unspecified|0|||
37780696|NCT01986348|69349324|FG003|Overall Study|Other-unspecified|2|||
37780697|NCT02543892|69349897|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
37780698|NCT02543892|69349898|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
37780699|NCT02543892|69349899|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
37780700|NCT02543892|69349900|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
37780701|NCT02543892|69349901|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
37780702|NCT02543892|69349902|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
37780703|NCT02543892|69349903|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
37863975|NCT00994162|69547571|FG000|Overall Study|Death|2|||
37971727|NCT01998841|69659058|FG004|Study Period B|Ongoing in the Study at the Time of Primary Completion Date|72|||
37971728|NCT01607879|69659068|FG000|Overall Study|Death|1|||
37971729|NCT01607879|69659069|FG001|Overall Study|Death|0|||
37971730|NCT00352027|69659080|FG000|Overall Study|Progressive disease|3|||
37971731|NCT00440271|69659122|FG000|Overall Study|Protocol Violation|1|||
37971732|NCT00440271|69659123|FG001|Overall Study|Protocol Violation|1|||
37971733|NCT00440271|69659122|FG000|Overall Study|Adverse Event|0|||
37971734|NCT00440271|69659123|FG001|Overall Study|Adverse Event|1|||
37971735|NCT00440271|69659122|FG000|Overall Study|Lost to Follow-up|1|||
37971736|NCT00440271|69659123|FG001|Overall Study|Lost to Follow-up|0|||
37971737|NCT00440271|69659122|FG000|Overall Study|Withdrawal by Subject|0|||
37971738|NCT00440271|69659123|FG001|Overall Study|Withdrawal by Subject|2|||
37971739|NCT00440271|69659122|FG000|Overall Study|Lack of Efficacy|0|||
37971740|NCT00440271|69659123|FG001|Overall Study|Lack of Efficacy|1|||
37971741|NCT00440271|69659122|FG000|Overall Study|Due to closure of trial|8|||
37971742|NCT00440271|69659123|FG001|Overall Study|Due to closure of trial|10|||
37971743|NCT00440271|69659122|FG000|Overall Study|Other|2|||
37971744|NCT00440271|69659123|FG001|Overall Study|Other|0|||
37971745|NCT00346216|69659132|FG000|Overall Study|Other|181|||
37971746|NCT00346216|69659133|FG001|Overall Study|Other|231|||
37971747|NCT00346216|69659134|FG002|Overall Study|Other|205|||
37971748|NCT00346216|69659132|FG000|Overall Study|No longer willing to participate|600|||
37971749|NCT00346216|69659133|FG001|Overall Study|No longer willing to participate|606|||
37971750|NCT00346216|69659134|FG002|Overall Study|No longer willing to participate|585|||
37971751|NCT00346216|69659132|FG000|Overall Study|Withdrawal by Subject|661|||
37971752|NCT00346216|69659133|FG001|Overall Study|Withdrawal by Subject|692|||
37971753|NCT00346216|69659134|FG002|Overall Study|Withdrawal by Subject|651|||
37971754|NCT00346216|69659132|FG000|Overall Study|Lost to Follow-up|611|||
37971755|NCT00346216|69659133|FG001|Overall Study|Lost to Follow-up|588|||
37971756|NCT00346216|69659134|FG002|Overall Study|Lost to Follow-up|542|||
37971757|NCT00346216|69659132|FG000|Overall Study|Physician Decision|80|||
37971758|NCT00346216|69659133|FG001|Overall Study|Physician Decision|76|||
37971759|NCT00346216|69659134|FG002|Overall Study|Physician Decision|59|||
37971760|NCT00346216|69659132|FG000|Overall Study|Does not meet entrance criteria|13|||
37971761|NCT00346216|69659133|FG001|Overall Study|Does not meet entrance criteria|10|||
37971762|NCT00346216|69659134|FG002|Overall Study|Does not meet entrance criteria|8|||
37971763|NCT00346216|69659132|FG000|Overall Study|Death|189|||
37971764|NCT00346216|69659133|FG001|Overall Study|Death|192|||
37971765|NCT00346216|69659134|FG002|Overall Study|Death|228|||
37971766|NCT00346216|69659132|FG000|Overall Study|Study terminated by sponsor|11|||
37971767|NCT00346216|69659133|FG001|Overall Study|Study terminated by sponsor|4|||
37780704|NCT02543892|69349904|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
37971768|NCT00346216|69659134|FG002|Overall Study|Study terminated by sponsor|8|||
37971769|NCT00346216|69659132|FG000|Overall Study|Missing Subject Summary Status|62|||
37971770|NCT00346216|69659133|FG001|Overall Study|Missing Subject Summary Status|61|||
37971771|NCT00346216|69659134|FG002|Overall Study|Missing Subject Summary Status|62|||
37971772|NCT00417963|69659142|FG000|Overall Study|Lost to Follow-up|3|||
37971773|NCT00417963|69659142|FG000|Overall Study|Withdrawal by Subject|18|||
37692244|NCT01905592|69168511|FG000|Overall Study|Withdrawal by Subject|10|||
37692245|NCT01905592|69168512|FG001|Overall Study|Withdrawal by Subject|2|||
37692246|NCT01876420|69168518|FG000|Overall Study|Missed 30 day visit|1|||
37971774|NCT00417963|69659142|FG000|Overall Study|Death|17|||
37692247|NCT01875874|69168522|FG000|Overall Study|Death|3|||
37971775|NCT00417963|69659142|FG000|Overall Study|Study device could not be deployed|3|||
37971776|NCT00429273|69659154|FG000|Overall Study|Lost to Follow-up|1|||
37971777|NCT00429273|69659155|FG001|Overall Study|Lost to Follow-up|2|||
37971778|NCT00429273|69659156|FG002|Overall Study|Lost to Follow-up|2|||
37971779|NCT00429273|69659154|FG000|Overall Study|Physician Decision|6|||
37971780|NCT00429273|69659155|FG001|Overall Study|Physician Decision|5|||
37971781|NCT00429273|69659156|FG002|Overall Study|Physician Decision|5|||
37971782|NCT00429273|69659154|FG000|Overall Study|Adverse Event|1|||
37971783|NCT00429273|69659155|FG001|Overall Study|Adverse Event|1|||
37971784|NCT00429273|69659156|FG002|Overall Study|Adverse Event|2|||
37971785|NCT00359632|69659166|FG000|Overall Study|Death|2|||
37971786|NCT00359632|69659167|FG001|Overall Study|Death|0|||
37971787|NCT00359632|69659166|FG000|Overall Study|Adverse Event|1|||
37971788|NCT00359632|69659167|FG001|Overall Study|Adverse Event|0|||
37971789|NCT00359632|69659166|FG000|Overall Study|Non-compliance with visit schedule|1|||
37971790|NCT00359632|69659167|FG001|Overall Study|Non-compliance with visit schedule|0|||
37971791|NCT00417885|69659173|FG000|Overall Study|Adverse Event|1|||
37971792|NCT00417885|69659173|FG000|Overall Study|Objective Progression or Relapse|3|||
37971793|NCT00417885|69659173|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
37971794|NCT04488770|69659190|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
37971795|NCT04488770|69659191|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
37971796|NCT04488770|69659192|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
37971797|NCT04488770|69659193|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
37971798|NCT04488770|69659194|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
37971799|NCT04488770|69659195|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
37971800|NCT04488770|69659196|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
37971801|NCT04488770|69659197|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
37971802|NCT04488770|69659198|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
37971803|NCT04488770|69659199|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
37971804|NCT04488770|69659200|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
37971805|NCT04488770|69659201|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
37971806|NCT04488770|69659202|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
37971807|NCT04488770|69659190|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
37971808|NCT04488770|69659191|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
37971809|NCT04488770|69659192|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
37971810|NCT04488770|69659193|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
37971811|NCT04488770|69659194|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
37971812|NCT04488770|69659195|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
37971813|NCT04488770|69659196|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
37971814|NCT04488770|69659197|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
37971815|NCT04488770|69659198|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
37971816|NCT04488770|69659199|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
37971817|NCT04488770|69659200|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
37971818|NCT04488770|69659201|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
37780705|NCT02543892|69349897|FG000|Received Vaccination 2|Physician Decision|0|||
37780706|NCT02543892|69349898|FG001|Received Vaccination 2|Physician Decision|0|||
37780707|NCT02543892|69349899|FG002|Received Vaccination 2|Physician Decision|0|||
37780708|NCT02543892|69349900|FG003|Received Vaccination 2|Physician Decision|0|||
37780709|NCT02543892|69349901|FG004|Received Vaccination 2|Physician Decision|0|||
37780710|NCT02543892|69349902|FG005|Received Vaccination 2|Physician Decision|1|||
37780711|NCT02543892|69349903|FG006|Received Vaccination 2|Physician Decision|0|||
37780712|NCT02543892|69349904|FG007|Received Vaccination 2|Physician Decision|0|||
37780713|NCT02543892|69349897|FG000|Received Vaccination 2|Adverse Event|0|||
37780714|NCT02543892|69349898|FG001|Received Vaccination 2|Adverse Event|1|||
37780715|NCT02543892|69349899|FG002|Received Vaccination 2|Adverse Event|0|||
37780716|NCT02543892|69349900|FG003|Received Vaccination 2|Adverse Event|0|||
37780717|NCT02543892|69349901|FG004|Received Vaccination 2|Adverse Event|0|||
37780718|NCT02543892|69349902|FG005|Received Vaccination 2|Adverse Event|0|||
37780719|NCT02543892|69349903|FG006|Received Vaccination 2|Adverse Event|0|||
37971819|NCT04488770|69659202|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
37971820|NCT04488770|69659190|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
37971821|NCT04488770|69659191|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
37971822|NCT04488770|69659192|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
37971823|NCT04488770|69659193|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
37971824|NCT04488770|69659194|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
37971825|NCT04488770|69659195|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
37971826|NCT04488770|69659196|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
37971827|NCT04488770|69659197|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
37971828|NCT04488770|69659198|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
37971829|NCT04488770|69659199|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
37971830|NCT04488770|69659200|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
37971831|NCT04488770|69659201|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
37971832|NCT04488770|69659202|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
37971833|NCT04488770|69659190|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
37971834|NCT04488770|69659191|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
37971835|NCT04488770|69659192|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
37971836|NCT04488770|69659193|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
37971837|NCT04488770|69659194|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
37971838|NCT04488770|69659195|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
37971839|NCT04488770|69659196|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
37971840|NCT04488770|69659197|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
37971841|NCT04488770|69659198|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
37971842|NCT04488770|69659199|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
37971843|NCT04488770|69659200|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
37971844|NCT04488770|69659201|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
37971845|NCT04488770|69659202|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
37971846|NCT00525044|69659248|FG000|Overall Study|Lost to Follow-up|0|||
37971847|NCT00525044|69659249|FG001|Overall Study|Lost to Follow-up|1|||
37971848|NCT00355342|69659257|FG000|Overall Study|Adverse Event|13|||
37971849|NCT00355342|69659258|FG001|Overall Study|Adverse Event|15|||
37971850|NCT00355342|69659257|FG000|Overall Study|Lost to Follow-up|4|||
37971851|NCT00355342|69659258|FG001|Overall Study|Lost to Follow-up|2|||
37971852|NCT00355342|69659257|FG000|Overall Study|Withdrawal by Subject|14|||
37971853|NCT00355342|69659258|FG001|Overall Study|Withdrawal by Subject|11|||
37971854|NCT00355342|69659257|FG000|Overall Study|Sponsor terminated study|2|||
37971855|NCT00355342|69659258|FG001|Overall Study|Sponsor terminated study|2|||
37971856|NCT00355342|69659257|FG000|Overall Study|Overcompliant-PI discretion|1|||
37971857|NCT00355342|69659258|FG001|Overall Study|Overcompliant-PI discretion|0|||
37971858|NCT00355342|69659257|FG000|Overall Study|Use of prohibited medication|1|||
37971859|NCT00355342|69659258|FG001|Overall Study|Use of prohibited medication|0|||
37971860|NCT00355342|69659257|FG000|Overall Study|COPD exacerbation|1|||
37971861|NCT00355342|69659258|FG001|Overall Study|COPD exacerbation|1|||
37971862|NCT00355342|69659257|FG000|Overall Study|Dispensed wrong study drug kit|1|||
37971863|NCT00355342|69659258|FG001|Overall Study|Dispensed wrong study drug kit|0|||
37971864|NCT00355342|69659257|FG000|Overall Study|Non-compliance with Dexa scans|1|||
37971865|NCT00355342|69659258|FG001|Overall Study|Non-compliance with Dexa scans|0|||
37971866|NCT00355342|69659257|FG000|Overall Study|Withdrawal by participant and physician|1|||
37971867|NCT00355342|69659258|FG001|Overall Study|Withdrawal by participant and physician|0|||
37971868|NCT00355342|69659257|FG000|Overall Study|Participant relocated|0|||
37971869|NCT00355342|69659258|FG001|Overall Study|Participant relocated|1|||
37971870|NCT00355342|69659257|FG000|Overall Study|Participant discontinued study drug|0|||
37971871|NCT00355342|69659258|FG001|Overall Study|Participant discontinued study drug|1|||
37971872|NCT00355342|69659257|FG000|Overall Study|Study management|0|||
37971873|NCT00355342|69659258|FG001|Overall Study|Study management|1|||
37971874|NCT00355342|69659257|FG000|Overall Study|Protocol Violation|0|||
37971875|NCT00355342|69659258|FG001|Overall Study|Protocol Violation|1|||
37971876|NCT00355342|69659257|FG000|Overall Study|Use of protocol excluded medication|0|||
37971877|NCT00355342|69659258|FG001|Overall Study|Use of protocol excluded medication|1|||
37971878|NCT01573754|69659266|FG000|Overall Study|Noncompliance or remission not achieved|3|||
37971879|NCT01573754|69659267|FG001|Overall Study|Noncompliance or remission not achieved|15|||
37971880|NCT00355264|69659273|FG000|Extension (Variable Duration)|Adverse Event|1|||
37971881|NCT00355264|69659273|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
37971882|NCT00355030|69659284|FG000|Study Period 1 Treatment|Adverse Event|1|||
37971883|NCT00355030|69659285|FG001|Study Period 1 Treatment|Adverse Event|1|||
37971884|NCT00355030|69659284|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
37971885|NCT00355030|69659285|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
37971886|NCT00355030|69659284|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
37971887|NCT00355030|69659285|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
37971888|NCT00355030|69659284|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
37971889|NCT00355030|69659285|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
37971890|NCT00355030|69659284|FG000|Study Period 1 Treatment|Physician Decision|0|||
37971891|NCT00355030|69659285|FG001|Study Period 1 Treatment|Physician Decision|1|||
37971892|NCT00355030|69659284|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
37971893|NCT00355030|69659285|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
37971894|NCT00355030|69659284|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
37971895|NCT00355030|69659285|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
37971896|NCT00355030|69659284|FG000|Study Period 1 Treatment|Other|2|||
37971897|NCT00355030|69659285|FG001|Study Period 1 Treatment|Other|6|||
37971898|NCT00355030|69659284|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
37971899|NCT00355030|69659285|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
37971900|NCT00355030|69659284|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
37971901|NCT00355030|69659285|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
37971902|NCT00354172|69659291|FG000|Overall Study|Did not receive transplant|1|||
37971903|NCT00345592|69659297|FG000|Overall Study|Death|14|||
37971904|NCT00345592|69659298|FG001|Overall Study|Death|16|||
37971905|NCT00345592|69659297|FG000|Overall Study|Withdrawal by Subject|11|||
37971906|NCT00345592|69659298|FG001|Overall Study|Withdrawal by Subject|8|||
37971907|NCT00353704|69659306|FG000|Overall Study|Protocol Violation|3|||
37971908|NCT00353704|69659307|FG001|Overall Study|Protocol Violation|1|||
37971909|NCT00512252|69659316|FG000|Overall Study|Lost to Follow-up|0|||
37971910|NCT00512252|69659317|FG001|Overall Study|Lost to Follow-up|0|||
37971911|NCT00512252|69659318|FG002|Overall Study|Lost to Follow-up|1|||
37971912|NCT00512252|69659316|FG000|Overall Study|Protocol Violation|0|||
37971913|NCT00512252|69659317|FG001|Overall Study|Protocol Violation|0|||
37971914|NCT00512252|69659318|FG002|Overall Study|Protocol Violation|1|||
37971915|NCT00512252|69659316|FG000|Overall Study|Death|0|||
37971916|NCT00512252|69659317|FG001|Overall Study|Death|0|||
37971917|NCT00512252|69659318|FG002|Overall Study|Death|1|||
37971918|NCT00516386|69659333|FG000|Overall Study|not interested in the study|4|||
37971919|NCT00516386|69659333|FG000|Overall Study|Lost to Follow-up|2|||
37971920|NCT00524420|69659339|FG000|Overall Study|Lack of Efficacy|1|||
37971921|NCT00524420|69659340|FG001|Overall Study|Lack of Efficacy|0|||
37971922|NCT00512096|69659348|FG000|Overall Study|Adverse Event|2|||
37971923|NCT00512096|69659348|FG000|Overall Study|Withdrawal by Subject|2|||
37971924|NCT00512096|69659348|FG000|Overall Study|Lack of Efficacy|3|||
37971925|NCT00524030|69659354|FG000|Overall Study|Lack of Efficacy|10|||
37971926|NCT00524030|69659355|FG001|Overall Study|Lack of Efficacy|24|||
37971927|NCT00524030|69659354|FG000|Overall Study|Lost to Follow-up|0|||
37971928|NCT00524030|69659355|FG001|Overall Study|Lost to Follow-up|2|||
37971929|NCT00524030|69659354|FG000|Overall Study|Withdrawal by Subject|3|||
37971930|NCT00524030|69659355|FG001|Overall Study|Withdrawal by Subject|8|||
37971931|NCT00524030|69659354|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
37971932|NCT00524030|69659355|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
37971933|NCT00524030|69659354|FG000|Overall Study|Protocol Violation|0|||
37971934|NCT00524030|69659355|FG001|Overall Study|Protocol Violation|1|||
37971935|NCT00524030|69659354|FG000|Overall Study|Pregnancy|1|||
37971936|NCT00524030|69659355|FG001|Overall Study|Pregnancy|0|||
37971937|NCT00524030|69659354|FG000|Overall Study|Adverse Event|3|||
37971938|NCT00524030|69659355|FG001|Overall Study|Adverse Event|21|||
37971939|NCT00524030|69659354|FG000|Overall Study|Death|0|||
37971940|NCT00524030|69659355|FG001|Overall Study|Death|1|||
37971941|NCT00523718|69659364|FG000|Overall Study|Withdrawal by Subject|1|||
37971942|NCT00523718|69659365|FG001|Overall Study|Withdrawal by Subject|0|||
37971943|NCT00523718|69659364|FG000|Overall Study|Protocol Violation|2|||
37971944|NCT00523718|69659365|FG001|Overall Study|Protocol Violation|0|||
37971945|NCT00523640|69659371|FG000|Overall Study|Death|1|||
37692248|NCT02500121|69168529|FG000|Overall Study|Lost to Follow-up|0|||
37971946|NCT00345358|69659379|FG000|Primary Vaccination Phase|Other|0|||
37971947|NCT00345358|69659380|FG001|Primary Vaccination Phase|Other|1|||
37971948|NCT00345358|69659381|FG002|Primary Vaccination Phase|Other|1|||
37971949|NCT00345358|69659382|FG003|Primary Vaccination Phase|Other|0|||
37971950|NCT00345358|69659379|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
37971951|NCT00345358|69659380|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
37971952|NCT00345358|69659381|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
37692249|NCT02500121|69168530|FG001|Overall Study|Lost to Follow-up|1|||
37780720|NCT02543892|69349904|FG007|Received Vaccination 2|Adverse Event|0|||
37971953|NCT00345358|69659382|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
37971954|NCT00345358|69659379|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
37971955|NCT00345358|69659380|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
37971956|NCT00345358|69659381|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
37780721|NCT02543892|69349897|FG000|Had Immunology Data|Withdrawal by Subject|0|||
37780722|NCT02543892|69349898|FG001|Had Immunology Data|Withdrawal by Subject|0|||
37780723|NCT02543892|69349899|FG002|Had Immunology Data|Withdrawal by Subject|0|||
37971957|NCT00345358|69659382|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
37971958|NCT00345358|69659379|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
37971959|NCT00345358|69659380|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
37971960|NCT00345358|69659381|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
37971961|NCT00345358|69659382|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
37971962|NCT00345358|69659379|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
37971963|NCT00345358|69659380|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
37971964|NCT00345358|69659381|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
37971965|NCT00345358|69659382|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
37971966|NCT00345358|69659379|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
37971967|NCT00345358|69659380|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
37971968|NCT00345358|69659381|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
37971969|NCT00345358|69659382|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
37971970|NCT03869684|69659395|FG000|Overall Study|Adverse Event|0|||
37971971|NCT03869684|69659396|FG001|Overall Study|Adverse Event|3|||
37971972|NCT03869684|69659397|FG002|Overall Study|Adverse Event|1|||
37971973|NCT03869684|69659395|FG000|Overall Study|Withdrawal by Subject|1|||
37971974|NCT03869684|69659396|FG001|Overall Study|Withdrawal by Subject|0|||
37780724|NCT02543892|69349900|FG003|Had Immunology Data|Withdrawal by Subject|0|||
37780725|NCT02543892|69349901|FG004|Had Immunology Data|Withdrawal by Subject|0|||
37780726|NCT02543892|69349902|FG005|Had Immunology Data|Withdrawal by Subject|0|||
37780727|NCT02543892|69349903|FG006|Had Immunology Data|Withdrawal by Subject|1|||
37780728|NCT02543892|69349904|FG007|Had Immunology Data|Withdrawal by Subject|0|||
37780729|NCT02543658|69349985|FG000|Overall Study|Lack of Efficacy|0|||
37780730|NCT02543658|69349986|FG001|Overall Study|Lack of Efficacy|4|||
37780731|NCT01607892|69350741|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
37780732|NCT01607892|69350742|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
37780733|NCT01607892|69350743|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
37780734|NCT01607892|69350744|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
37780735|NCT01607892|69350745|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
37780736|NCT01607892|69350741|FG000|Overall Study|Death|4|||
37780737|NCT01607892|69350742|FG001|Overall Study|Death|2|||
37780738|NCT01607892|69350743|FG002|Overall Study|Death|8|||
37780739|NCT01607892|69350744|FG003|Overall Study|Death|10|||
37780740|NCT01607892|69350745|FG004|Overall Study|Death|3|||
37780741|NCT01607892|69350741|FG000|Overall Study|Investigator discretion|2|||
37780742|NCT01607892|69350742|FG001|Overall Study|Investigator discretion|4|||
37780743|NCT01607892|69350743|FG002|Overall Study|Investigator discretion|4|||
37780744|NCT01607892|69350744|FG003|Overall Study|Investigator discretion|8|||
37780745|NCT01607892|69350745|FG004|Overall Study|Investigator discretion|0|||
37780746|NCT01607892|69350741|FG000|Overall Study|Other treatments became available|1|||
37780747|NCT01607892|69350742|FG001|Overall Study|Other treatments became available|1|||
37780748|NCT01607892|69350743|FG002|Overall Study|Other treatments became available|0|||
37780749|NCT01607892|69350744|FG003|Overall Study|Other treatments became available|0|||
37780750|NCT01607892|69350745|FG004|Overall Study|Other treatments became available|2|||
37780751|NCT01607892|69350741|FG000|Overall Study|Intercurrent illness|1|||
37780752|NCT01607892|69350742|FG001|Overall Study|Intercurrent illness|0|||
37780753|NCT01607892|69350743|FG002|Overall Study|Intercurrent illness|0|||
37780754|NCT01607892|69350744|FG003|Overall Study|Intercurrent illness|3|||
37780755|NCT01607892|69350745|FG004|Overall Study|Intercurrent illness|0|||
37863976|NCT00994162|69547571|FG000|Overall Study|Care Transferred to Another Physician|2|||
37971975|NCT03869684|69659397|FG002|Overall Study|Withdrawal by Subject|0|||
37971976|NCT03869684|69659395|FG000|Overall Study|Lost to Follow-up|1|||
37971977|NCT03869684|69659396|FG001|Overall Study|Lost to Follow-up|0|||
37780756|NCT01607892|69350741|FG000|Overall Study|Non-Compliance with study procedures|0|||
37780757|NCT01607892|69350742|FG001|Overall Study|Non-Compliance with study procedures|0|||
37780758|NCT01607892|69350743|FG002|Overall Study|Non-Compliance with study procedures|1|||
37780759|NCT01607892|69350744|FG003|Overall Study|Non-Compliance with study procedures|0|||
37780760|NCT01607892|69350745|FG004|Overall Study|Non-Compliance with study procedures|0|||
37971978|NCT03869684|69659397|FG002|Overall Study|Lost to Follow-up|0|||
37971979|NCT03869684|69659395|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
37971980|NCT03869684|69659396|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
37971981|NCT03869684|69659397|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
37971982|NCT00516074|69659407|FG000|Overall Study|Adverse Event|0|||
37971983|NCT00516074|69659408|FG001|Overall Study|Adverse Event|1|||
37971984|NCT00516074|69659407|FG000|Overall Study|Subject Decision|4|||
37971985|NCT00516074|69659408|FG001|Overall Study|Subject Decision|2|||
37971986|NCT00516074|69659407|FG000|Overall Study|Loss of Glucose Control|2|||
37971987|NCT00516074|69659408|FG001|Overall Study|Loss of Glucose Control|0|||
37971988|NCT00515294|69659418|FG000|Overall Study|Lost to Follow-up|3|||
37971989|NCT00515294|69659419|FG001|Overall Study|Lost to Follow-up|2|||
37971990|NCT00515294|69659420|FG002|Overall Study|Lost to Follow-up|3|||
37971991|NCT00515294|69659421|FG003|Overall Study|Lost to Follow-up|1|||
37971992|NCT00515294|69659418|FG000|Overall Study|Driver simulator problems|1|||
37971993|NCT00515294|69659419|FG001|Overall Study|Driver simulator problems|1|||
37971994|NCT00515294|69659420|FG002|Overall Study|Driver simulator problems|1|||
37971995|NCT00515294|69659421|FG003|Overall Study|Driver simulator problems|3|||
37971996|NCT00515294|69659418|FG000|Overall Study|Caffeine amount inaccurate|5|||
37971997|NCT00515294|69659419|FG001|Overall Study|Caffeine amount inaccurate|0|||
37971998|NCT00515294|69659420|FG002|Overall Study|Caffeine amount inaccurate|7|||
37971999|NCT00515294|69659421|FG003|Overall Study|Caffeine amount inaccurate|0|||
37972000|NCT00345046|69659434|FG000|Overall Study|Protocol Violation|1|||
37972001|NCT00345046|69659435|FG001|Overall Study|Protocol Violation|1|||
37972002|NCT00345046|69659436|FG002|Overall Study|Protocol Violation|2|||
37972003|NCT00515216|69659444|FG000|Overall Study|Withdrawal by Subject|1|||
37972004|NCT01004978|69659451|FG000|Overall Study|Disease progression|31|||
37972005|NCT01004978|69659452|FG001|Overall Study|Disease progression|48|||
37972006|NCT01004978|69659451|FG000|Overall Study|Adverse Event|42|||
37972007|NCT01004978|69659452|FG001|Overall Study|Adverse Event|22|||
37972008|NCT01004978|69659451|FG000|Overall Study|Death|3|||
37972009|NCT01004978|69659452|FG001|Overall Study|Death|2|||
37972010|NCT01004978|69659451|FG000|Overall Study|Withdrawal by Subject|16|||
37972011|NCT01004978|69659452|FG001|Overall Study|Withdrawal by Subject|16|||
37972012|NCT01004978|69659451|FG000|Overall Study|Alternative therapy|4|||
37972013|NCT01004978|69659452|FG001|Overall Study|Alternative therapy|8|||
37972014|NCT01004978|69659451|FG000|Overall Study|Physician Decision|6|||
37972015|NCT01004978|69659452|FG001|Overall Study|Physician Decision|3|||
37972016|NCT01004978|69659451|FG000|Overall Study|Other complicating disease|2|||
37972017|NCT01004978|69659452|FG001|Overall Study|Other complicating disease|2|||
37972018|NCT01004978|69659451|FG000|Overall Study|Protocol Violation|2|||
37972019|NCT01004978|69659452|FG001|Overall Study|Protocol Violation|3|||
37972020|NCT01004978|69659451|FG000|Overall Study|Non-compliance|3|||
37972021|NCT01004978|69659452|FG001|Overall Study|Non-compliance|2|||
37972022|NCT01004978|69659451|FG000|Overall Study|Ineligible|1|||
37780761|NCT01607892|69350741|FG000|Overall Study|Consent withdrawn by participant|9|||
37780762|NCT01607892|69350742|FG001|Overall Study|Consent withdrawn by participant|4|||
37972023|NCT01004978|69659452|FG001|Overall Study|Ineligible|0|||
37972024|NCT01004978|69659451|FG000|Overall Study|Unblinded|0|||
37972025|NCT01004978|69659452|FG001|Overall Study|Unblinded|1|||
37972026|NCT01004978|69659451|FG000|Overall Study|Performance status worsening|0|||
37972027|NCT01004978|69659452|FG001|Overall Study|Performance status worsening|1|||
37972028|NCT01004978|69659451|FG000|Overall Study|Never started treatment|8|||
37972029|NCT01004978|69659452|FG001|Overall Study|Never started treatment|9|||
37972030|NCT00522626|69659458|FG000|Overall Study|Lost to Follow-up|7|||
37780763|NCT01607892|69350743|FG002|Overall Study|Consent withdrawn by participant|24|||
37972031|NCT00440193|69659464|FG000|Treatment Period|Adverse Event|74|||
37780764|NCT01607892|69350744|FG003|Overall Study|Consent withdrawn by participant|14|||
37780765|NCT01607892|69350745|FG004|Overall Study|Consent withdrawn by participant|4|||
37780766|NCT01607892|69350741|FG000|Overall Study|Disease progression|38|||
37780767|NCT01607892|69350742|FG001|Overall Study|Disease progression|13|||
37780768|NCT01607892|69350743|FG002|Overall Study|Disease progression|37|||
37780769|NCT01607892|69350744|FG003|Overall Study|Disease progression|57|||
37780770|NCT01607892|69350745|FG004|Overall Study|Disease progression|9|||
37780771|NCT01607892|69350741|FG000|Overall Study|Incidence or severity of Adverse events|3|||
37780772|NCT01607892|69350742|FG001|Overall Study|Incidence or severity of Adverse events|3|||
37780773|NCT01607892|69350743|FG002|Overall Study|Incidence or severity of Adverse events|7|||
37780774|NCT01607892|69350744|FG003|Overall Study|Incidence or severity of Adverse events|2|||
37780775|NCT01607892|69350745|FG004|Overall Study|Incidence or severity of Adverse events|6|||
37780776|NCT02530242|69350791|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
37780777|NCT02530242|69350792|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
37780778|NCT02537574|69350816|FG000|Overall Study|Adverse Event|1|||
37780779|NCT02537574|69350817|FG001|Overall Study|Adverse Event|3|||
37780780|NCT02537574|69350818|FG002|Overall Study|Adverse Event|2|||
37780781|NCT02537574|69350816|FG000|Overall Study|Lost to Follow-up|40|||
37780782|NCT02537574|69350817|FG001|Overall Study|Lost to Follow-up|51|||
37780783|NCT02537574|69350818|FG002|Overall Study|Lost to Follow-up|55|||
37780784|NCT02537574|69350816|FG000|Overall Study|Noncompliance with study drug|0|||
37780785|NCT02537574|69350817|FG001|Overall Study|Noncompliance with study drug|1|||
37780786|NCT02537574|69350818|FG002|Overall Study|Noncompliance with study drug|1|||
37780787|NCT02537574|69350816|FG000|Overall Study|Physician Decision|2|||
37780788|NCT02537574|69350817|FG001|Overall Study|Physician Decision|0|||
37780789|NCT02537574|69350818|FG002|Overall Study|Physician Decision|0|||
37780790|NCT02537574|69350816|FG000|Overall Study|Protocol Violation|4|||
37780791|NCT02537574|69350817|FG001|Overall Study|Protocol Violation|2|||
37780792|NCT02537574|69350818|FG002|Overall Study|Protocol Violation|3|||
37780793|NCT02537574|69350816|FG000|Overall Study|Withdrawal by Subject|37|||
37780794|NCT02537574|69350817|FG001|Overall Study|Withdrawal by Subject|27|||
37780795|NCT02537574|69350818|FG002|Overall Study|Withdrawal by Subject|29|||
37780796|NCT02537574|69350816|FG000|Overall Study|Lack of Efficacy|14|||
37692250|NCT02500121|69168529|FG000|Overall Study|Withdrawal by Subject|1|||
37692251|NCT02500121|69168530|FG001|Overall Study|Withdrawal by Subject|1|||
37692252|NCT02500121|69168529|FG000|Overall Study|Death|26|||
37692253|NCT02500121|69168530|FG001|Overall Study|Death|24|||
37692254|NCT01875250|69168540|FG000|Overall Study|Adverse Event|2|||
37692255|NCT01875250|69168541|FG001|Overall Study|Adverse Event|0|||
37692256|NCT01904032|69168551|FG000|Overall Study|Adverse Event|3|||
37692257|NCT01904032|69168552|FG001|Overall Study|Adverse Event|1|||
37692258|NCT01904032|69168551|FG000|Overall Study|Lost to Follow-up|4|||
37692259|NCT01904032|69168552|FG001|Overall Study|Lost to Follow-up|2|||
37780797|NCT02537574|69350817|FG001|Overall Study|Lack of Efficacy|16|||
37780798|NCT02537574|69350818|FG002|Overall Study|Lack of Efficacy|15|||
37780799|NCT02537574|69350816|FG000|Overall Study|Duplicate Patient|1|||
37692260|NCT01903876|69168560|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
37692261|NCT01903876|69168561|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
37780800|NCT02537574|69350817|FG001|Overall Study|Duplicate Patient|0|||
37780801|NCT02537574|69350818|FG002|Overall Study|Duplicate Patient|0|||
37780802|NCT02537574|69350816|FG000|Overall Study|Patient not Stable|0|||
37972032|NCT00440193|69659465|FG001|Treatment Period|Adverse Event|67|||
37972033|NCT00440193|69659464|FG000|Treatment Period|Death|19|||
37972034|NCT00440193|69659465|FG001|Treatment Period|Death|22|||
37780803|NCT02537574|69350817|FG001|Overall Study|Patient not Stable|1|||
37780804|NCT02537574|69350818|FG002|Overall Study|Patient not Stable|0|||
37972035|NCT00440193|69659464|FG000|Treatment Period|Lack of Efficacy|0|||
37972036|NCT00440193|69659465|FG001|Treatment Period|Lack of Efficacy|1|||
37972037|NCT00440193|69659464|FG000|Treatment Period|Lost to Follow-up|12|||
37972038|NCT00440193|69659465|FG001|Treatment Period|Lost to Follow-up|18|||
37972039|NCT00440193|69659464|FG000|Treatment Period|Physician Decision|3|||
37972040|NCT00440193|69659465|FG001|Treatment Period|Physician Decision|6|||
37972041|NCT00440193|69659464|FG000|Treatment Period|Protocol Violation|16|||
37972042|NCT00440193|69659465|FG001|Treatment Period|Protocol Violation|19|||
37972043|NCT00440193|69659464|FG000|Treatment Period|Withdrawal by Subject|36|||
37972044|NCT00440193|69659465|FG001|Treatment Period|Withdrawal by Subject|77|||
37972045|NCT00440193|69659464|FG000|Treatment Period|Clinical endpoint reached|28|||
37972046|NCT00440193|69659465|FG001|Treatment Period|Clinical endpoint reached|25|||
37972047|NCT00440193|69659464|FG000|Treatment Period|Study terminated by sponsor|102|||
37972048|NCT00440193|69659465|FG001|Treatment Period|Study terminated by sponsor|94|||
37972049|NCT00440193|69659464|FG000|Treatment Period|Protocol driven decision point|2|||
37972050|NCT00440193|69659465|FG001|Treatment Period|Protocol driven decision point|2|||
37972051|NCT00440193|69659464|FG000|Treatment Period|Switch to commercial drug|0|||
37972052|NCT00440193|69659465|FG001|Treatment Period|Switch to commercial drug|2|||
37972053|NCT00440193|69659464|FG000|Treatment Period|Technical problems|1|||
37972054|NCT00440193|69659465|FG001|Treatment Period|Technical problems|1|||
37972055|NCT00440193|69659464|FG000|Treatment Period|Participant convenience|5|||
37972056|NCT00440193|69659465|FG001|Treatment Period|Participant convenience|2|||
37972057|NCT00440193|69659464|FG000|Treatment Period|Participant did not receive treatment|7|||
37972058|NCT00440193|69659465|FG001|Treatment Period|Participant did not receive treatment|13|||
37972059|NCT00440193|69659464|FG000|Treatment Period|Site closed by investigator|0|||
37972060|NCT00440193|69659465|FG001|Treatment Period|Site closed by investigator|2|||
37972061|NCT00440193|69659464|FG000|Observational Period|Adverse Event|2|||
37972062|NCT00440193|69659465|FG001|Observational Period|Adverse Event|2|||
37972063|NCT00440193|69659464|FG000|Observational Period|Death|15|||
37972064|NCT00440193|69659465|FG001|Observational Period|Death|20|||
37972065|NCT00440193|69659464|FG000|Observational Period|Lost to Follow-up|12|||
37972066|NCT00440193|69659465|FG001|Observational Period|Lost to Follow-up|8|||
37972067|NCT00440193|69659464|FG000|Observational Period|Protocol Violation|1|||
37972068|NCT00440193|69659465|FG001|Observational Period|Protocol Violation|0|||
37972069|NCT00440193|69659464|FG000|Observational Period|Withdrawal by Subject|11|||
37972070|NCT00440193|69659465|FG001|Observational Period|Withdrawal by Subject|8|||
37972071|NCT00440193|69659464|FG000|Observational Period|Physician Decision|1|||
37972072|NCT00440193|69659465|FG001|Observational Period|Physician Decision|0|||
37972073|NCT00440193|69659464|FG000|Observational Period|Clinical endpoint reached|1|||
37972074|NCT00440193|69659465|FG001|Observational Period|Clinical endpoint reached|0|||
37972075|NCT00440193|69659464|FG000|Observational Period|Participant convenience|2|||
37972076|NCT00440193|69659465|FG001|Observational Period|Participant convenience|0|||
37972077|NCT00511472|69659473|FG000|Overall Study|Clinical Adverse Event|1|||
37972078|NCT00511472|69659474|FG001|Overall Study|Clinical Adverse Event|2|||
37972079|NCT00511472|69659473|FG000|Overall Study|Laboratory Adverse Event|0|||
37972080|NCT00511472|69659474|FG001|Overall Study|Laboratory Adverse Event|2|||
37972081|NCT00511472|69659473|FG000|Overall Study|Not reported|2|||
37972082|NCT00511472|69659474|FG001|Overall Study|Not reported|2|||
37972083|NCT00514904|69659491|FG000|Overall Study|Withdrawal by Subject|3|||
37780805|NCT02537574|69350816|FG000|Overall Study|Incarceration|0|||
37780806|NCT02537574|69350817|FG001|Overall Study|Incarceration|1|||
37972084|NCT00514904|69659492|FG001|Overall Study|Withdrawal by Subject|2|||
37972085|NCT00514904|69659491|FG000|Overall Study|Lost to Follow-up|21|||
37972086|NCT00514904|69659492|FG001|Overall Study|Lost to Follow-up|3|||
37972087|NCT00440115|69659501|FG000|Overall Study|Death|7|||
37972088|NCT00440115|69659502|FG001|Overall Study|Death|9|||
37972089|NCT00440115|69659503|FG002|Overall Study|Death|5|||
37972090|NCT00440115|69659501|FG000|Overall Study|Incarceration|0|||
37972091|NCT00440115|69659502|FG001|Overall Study|Incarceration|2|||
37972092|NCT00440115|69659503|FG002|Overall Study|Incarceration|1|||
37972093|NCT00440037|69659511|FG000|Overall Study|Withdrawal by Subject|6|||
37972094|NCT00440037|69659511|FG000|Overall Study|Administrative decision|3|||
37972095|NCT00417027|69659518|FG000|Overall Study|Protocol Violation|0|||
37972096|NCT00417027|69659519|FG001|Overall Study|Protocol Violation|5|||
37972097|NCT00417027|69659520|FG002|Overall Study|Protocol Violation|5|||
37972098|NCT00416949|69659528|FG000|Overall Study|Patients refused to participate|5|||
37972099|NCT00416715|69659532|FG000|Overall Study|Not evaluable for joint aches|7|||
37972100|NCT00416715|69659532|FG000|Overall Study|Vitamin D levels not evaluable|8|||
37972101|NCT00406029|69659544|FG000|Overall Study|Adverse Event|12|||
37972102|NCT00406029|69659545|FG001|Overall Study|Adverse Event|2|||
37972103|NCT00406029|69659546|FG002|Overall Study|Adverse Event|5|||
37972104|NCT00406029|69659547|FG003|Overall Study|Adverse Event|10|||
37972105|NCT00406029|69659548|FG004|Overall Study|Adverse Event|7|||
37972106|NCT00406029|69659544|FG000|Overall Study|Withdrawal by Subject|3|||
37972107|NCT00406029|69659545|FG001|Overall Study|Withdrawal by Subject|4|||
37972108|NCT00406029|69659546|FG002|Overall Study|Withdrawal by Subject|2|||
37972109|NCT00406029|69659547|FG003|Overall Study|Withdrawal by Subject|2|||
37972110|NCT00406029|69659548|FG004|Overall Study|Withdrawal by Subject|0|||
37972111|NCT00406029|69659544|FG000|Overall Study|Protocol Violation|1|||
37972112|NCT00406029|69659545|FG001|Overall Study|Protocol Violation|2|||
37972113|NCT00406029|69659546|FG002|Overall Study|Protocol Violation|0|||
37972114|NCT00406029|69659547|FG003|Overall Study|Protocol Violation|2|||
37972115|NCT00406029|69659548|FG004|Overall Study|Protocol Violation|0|||
37972116|NCT00406029|69659544|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
37972117|NCT00406029|69659545|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
37972118|NCT00406029|69659546|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
37972119|NCT00406029|69659547|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
37972120|NCT00406029|69659548|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
37972121|NCT00406029|69659544|FG000|Overall Study|Randomized in Error|0|||
37972122|NCT00406029|69659545|FG001|Overall Study|Randomized in Error|0|||
37972123|NCT00406029|69659546|FG002|Overall Study|Randomized in Error|2|||
37972124|NCT00406029|69659547|FG003|Overall Study|Randomized in Error|3|||
37972125|NCT00406029|69659548|FG004|Overall Study|Randomized in Error|1|||
37972126|NCT00514514|69659563|FG000|Pre-phase|Death|10|||
37972127|NCT00514514|69659564|FG001|Pre-phase|Death|0|||
37972128|NCT00514514|69659565|FG002|Pre-phase|Death|0|||
37972129|NCT00514514|69659563|FG000|Pre-phase|administrative problems|2|||
37972130|NCT00514514|69659564|FG001|Pre-phase|administrative problems|0|||
37972131|NCT00514514|69659565|FG002|Pre-phase|administrative problems|0|||
37972132|NCT00514514|69659563|FG000|Pre-phase|Protocol Violation|6|||
37972133|NCT00514514|69659564|FG001|Pre-phase|Protocol Violation|0|||
37972134|NCT00514514|69659565|FG002|Pre-phase|Protocol Violation|0|||
37972135|NCT00514514|69659563|FG000|Pre-phase|condition no longer requires study drug|7|||
37972136|NCT00514514|69659564|FG001|Pre-phase|condition no longer requires study drug|0|||
37972137|NCT00514514|69659565|FG002|Pre-phase|condition no longer requires study drug|0|||
37972138|NCT00514514|69659563|FG000|Pre-phase|abnormal test procedure results|15|||
37972139|NCT00514514|69659564|FG001|Pre-phase|abnormal test procedure results|0|||
37972140|NCT00514514|69659565|FG002|Pre-phase|abnormal test procedure results|0|||
37972141|NCT00514514|69659563|FG000|Pre-phase|Lost to Follow-up|2|||
37972142|NCT00514514|69659564|FG001|Pre-phase|Lost to Follow-up|0|||
37972143|NCT00514514|69659565|FG002|Pre-phase|Lost to Follow-up|0|||
37972144|NCT00514514|69659563|FG000|Pre-phase|abnormal lab values|23|||
37972145|NCT00514514|69659564|FG001|Pre-phase|abnormal lab values|0|||
37780807|NCT02537574|69350818|FG002|Overall Study|Incarceration|0|||
37780808|NCT02537574|69350816|FG000|Overall Study|Failed Naloxone Challenge|0|||
37780809|NCT02537574|69350817|FG001|Overall Study|Failed Naloxone Challenge|1|||
37692262|NCT01903876|69168560|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
37692263|NCT01903876|69168561|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
37692264|NCT01921348|69168569|FG000|Overall Study|Withdrawal by Subject|1|||
37692265|NCT01921348|69168570|FG001|Overall Study|Withdrawal by Subject|0|||
37692266|NCT01921348|69168569|FG000|Overall Study|Lost to Follow-up|0|||
37692267|NCT01921348|69168570|FG001|Overall Study|Lost to Follow-up|2|||
37692268|NCT01921270|69168576|FG000|Overall Study|Withdrawal by Subject|1|||
37692269|NCT02325739|69168591|FG000|Phase I Part|Adverse Event|1|||
37692270|NCT02325739|69168592|FG001|Phase I Part|Adverse Event|0|||
37692271|NCT02325739|69168593|FG002|Phase I Part|Adverse Event|1|||
37692272|NCT02325739|69168594|FG003|Phase I Part|Adverse Event|2|||
37692273|NCT02325739|69168595|FG004|Phase I Part|Adverse Event|3|||
37780810|NCT02537574|69350818|FG002|Overall Study|Failed Naloxone Challenge|0|||
37972146|NCT00514514|69659565|FG002|Pre-phase|abnormal lab values|0|||
37972147|NCT00514514|69659563|FG000|Pre-phase|Lack of Efficacy|35|||
37972148|NCT00514514|69659564|FG001|Pre-phase|Lack of Efficacy|0|||
37972149|NCT00514514|69659565|FG002|Pre-phase|Lack of Efficacy|0|||
37972150|NCT00514514|69659563|FG000|Pre-phase|Adverse Event|137|||
37692274|NCT02325739|69168596|FG005|Phase I Part|Adverse Event|1|||
37972151|NCT00514514|69659564|FG001|Pre-phase|Adverse Event|0|||
37972152|NCT00514514|69659565|FG002|Pre-phase|Adverse Event|0|||
37972153|NCT00514514|69659563|FG000|Pre-phase|Withdrawal by Subject|66|||
37972154|NCT00514514|69659564|FG001|Pre-phase|Withdrawal by Subject|0|||
37972155|NCT00514514|69659565|FG002|Pre-phase|Withdrawal by Subject|0|||
37972156|NCT00514514|69659563|FG000|Randomized - 9 Month|Death|3|||
37972157|NCT00514514|69659564|FG001|Randomized - 9 Month|Death|2|||
37972158|NCT00514514|69659565|FG002|Randomized - 9 Month|Death|2|||
37972159|NCT00514514|69659563|FG000|Randomized - 9 Month|Administrative problems|1|||
37972160|NCT00514514|69659564|FG001|Randomized - 9 Month|Administrative problems|1|||
37972161|NCT00514514|69659565|FG002|Randomized - 9 Month|Administrative problems|2|||
37972162|NCT00514514|69659563|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
37972163|NCT00514514|69659564|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
37972164|NCT00514514|69659565|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
37780811|NCT02537574|69350816|FG000|Overall Study|Transportation Issues|0|||
37972165|NCT00514514|69659563|FG000|Randomized - 9 Month|Protocol Violation|1|||
37972166|NCT00514514|69659564|FG001|Randomized - 9 Month|Protocol Violation|1|||
37972167|NCT00514514|69659565|FG002|Randomized - 9 Month|Protocol Violation|0|||
37972168|NCT00514514|69659563|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
37972169|NCT00514514|69659564|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
37972170|NCT00514514|69659565|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
37972171|NCT00514514|69659563|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
37972172|NCT00514514|69659564|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
37972173|NCT00514514|69659565|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
37972174|NCT00514514|69659563|FG000|Randomized - 9 Month|Adverse Event|25|||
37972175|NCT00514514|69659564|FG001|Randomized - 9 Month|Adverse Event|44|||
37972176|NCT00514514|69659565|FG002|Randomized - 9 Month|Adverse Event|27|||
37972177|NCT00514514|69659563|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
37780812|NCT02537574|69350817|FG001|Overall Study|Transportation Issues|0|||
37780813|NCT02537574|69350818|FG002|Overall Study|Transportation Issues|1|||
37780814|NCT02537574|69350816|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
37780815|NCT02537574|69350817|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
37972178|NCT00514514|69659564|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
37972179|NCT00514514|69659565|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
37972180|NCT00514514|69659563|FG000|Extension - 4 Years|Lost to Follow-up|12|||
37972181|NCT00514514|69659564|FG001|Extension - 4 Years|Lost to Follow-up|10|||
37972182|NCT00514514|69659565|FG002|Extension - 4 Years|Lost to Follow-up|9|||
37972183|NCT00514514|69659563|FG000|Extension - 4 Years|Administrative problems|3|||
37972184|NCT00514514|69659564|FG001|Extension - 4 Years|Administrative problems|1|||
37972185|NCT00514514|69659565|FG002|Extension - 4 Years|Administrative problems|1|||
37972186|NCT00514514|69659563|FG000|Extension - 4 Years|Death|8|||
37972187|NCT00514514|69659564|FG001|Extension - 4 Years|Death|3|||
37972188|NCT00514514|69659565|FG002|Extension - 4 Years|Death|6|||
37972189|NCT00514514|69659563|FG000|Extension - 4 Years|Adverse Event|9|||
37972190|NCT00514514|69659564|FG001|Extension - 4 Years|Adverse Event|6|||
37972191|NCT00514514|69659565|FG002|Extension - 4 Years|Adverse Event|3|||
37972192|NCT00405639|69659575|FG000|Overall Study|Withdrawal by Subject|1|||
37972193|NCT00405639|69659576|FG001|Overall Study|Withdrawal by Subject|0|||
37972194|NCT00405639|69659575|FG000|Overall Study|Adverse Event|1|||
37972195|NCT00405639|69659576|FG001|Overall Study|Adverse Event|0|||
37972196|NCT00405639|69659575|FG000|Overall Study|Seizure prior to receiving BNP|1|||
37972197|NCT00405639|69659576|FG001|Overall Study|Seizure prior to receiving BNP|0|||
37972198|NCT00439725|69659584|FG000|Treatment Period|Withdrawal by Subject|22|||
37780816|NCT02537574|69350818|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
37780817|NCT02537574|69350816|FG000|Overall Study|Noncompliance with Protocol|0|||
37780818|NCT02537574|69350817|FG001|Overall Study|Noncompliance with Protocol|0|||
37780819|NCT02537574|69350818|FG002|Overall Study|Noncompliance with Protocol|1|||
37972199|NCT00439725|69659585|FG001|Treatment Period|Withdrawal by Subject|19|||
37972200|NCT00439725|69659584|FG000|Treatment Period|Study terminated by sponsor|156|||
37972201|NCT00439725|69659585|FG001|Treatment Period|Study terminated by sponsor|148|||
37972202|NCT00439725|69659584|FG000|Treatment Period|Site closed by investigator|1|||
37972203|NCT00439725|69659585|FG001|Treatment Period|Site closed by investigator|2|||
37972204|NCT00439725|69659584|FG000|Treatment Period|Adverse Event|39|||
37972205|NCT00439725|69659585|FG001|Treatment Period|Adverse Event|18|||
37972206|NCT00439725|69659584|FG000|Treatment Period|Physician Decision|1|||
37972207|NCT00439725|69659585|FG001|Treatment Period|Physician Decision|1|||
37972208|NCT00439725|69659584|FG000|Treatment Period|Protocol Violation|2|||
37972209|NCT00439725|69659585|FG001|Treatment Period|Protocol Violation|1|||
37972210|NCT00439725|69659584|FG000|Treatment Period|Clinical endpoint reached|6|||
37972211|NCT00439725|69659585|FG001|Treatment Period|Clinical endpoint reached|50|||
37972212|NCT00439725|69659584|FG000|Treatment Period|Technical problems|1|||
37972213|NCT00439725|69659585|FG001|Treatment Period|Technical problems|0|||
37972214|NCT00439725|69659584|FG000|Treatment Period|Lost to Follow-up|1|||
37972215|NCT00439725|69659585|FG001|Treatment Period|Lost to Follow-up|1|||
37972216|NCT00439725|69659584|FG000|Treatment Period|Participant convenience|1|||
37972217|NCT00439725|69659585|FG001|Treatment Period|Participant convenience|0|||
37972218|NCT00439725|69659584|FG000|Treatment Period|Protocol driven decision point|1|||
37972219|NCT00439725|69659585|FG001|Treatment Period|Protocol driven decision point|1|||
37780820|NCT02531802|69351483|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
37780821|NCT02531802|69351484|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
37780822|NCT02531802|69351485|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
37780823|NCT02531802|69351486|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
37780824|NCT02531802|69351487|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
37780825|NCT02531802|69351488|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
37780826|NCT02531802|69351489|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
37780827|NCT02531802|69351490|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
37780828|NCT02531802|69351491|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
37780829|NCT02531802|69351492|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
37780830|NCT02531802|69351493|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
37780831|NCT02531802|69351494|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
37780832|NCT02531802|69351495|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
37780833|NCT02531802|69351496|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
37780834|NCT02531802|69351497|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
37780835|NCT02531802|69351498|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
37780836|NCT02531802|69351499|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
37780837|NCT02531802|69351500|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
37972220|NCT00439725|69659584|FG000|Treatment Period|Death|1|||
37972221|NCT00439725|69659585|FG001|Treatment Period|Death|1|||
37972222|NCT00439725|69659584|FG000|Treatment Period|Participant did not receive treatment|4|||
37972223|NCT00439725|69659585|FG001|Treatment Period|Participant did not receive treatment|4|||
37692275|NCT02325739|69168597|FG006|Phase I Part|Adverse Event|0|||
37692276|NCT02325739|69168598|FG007|Phase I Part|Adverse Event|2|||
37692277|NCT02325739|69168599|FG008|Phase I Part|Adverse Event|0|||
37692278|NCT02325739|69168600|FG009|Phase I Part|Adverse Event|0|||
37692279|NCT02325739|69168601|FG010|Phase I Part|Adverse Event|0|||
37692280|NCT02325739|69168591|FG000|Phase I Part|Progressive disease|9|||
37692281|NCT02325739|69168592|FG001|Phase I Part|Progressive disease|6|||
37692282|NCT02325739|69168593|FG002|Phase I Part|Progressive disease|3|||
37692283|NCT02325739|69168594|FG003|Phase I Part|Progressive disease|23|||
37692284|NCT02325739|69168595|FG004|Phase I Part|Progressive disease|14|||
37692285|NCT02325739|69168596|FG005|Phase I Part|Progressive disease|6|||
37692286|NCT02325739|69168597|FG006|Phase I Part|Progressive disease|6|||
37692287|NCT02325739|69168598|FG007|Phase I Part|Progressive disease|3|||
37692288|NCT02325739|69168599|FG008|Phase I Part|Progressive disease|0|||
37692289|NCT02325739|69168600|FG009|Phase I Part|Progressive disease|0|||
37692290|NCT02325739|69168601|FG010|Phase I Part|Progressive disease|0|||
37692291|NCT02325739|69168591|FG000|Phase I Part|Subject/guardian decision|1|||
37692292|NCT02325739|69168592|FG001|Phase I Part|Subject/guardian decision|0|||
37692293|NCT02325739|69168593|FG002|Phase I Part|Subject/guardian decision|1|||
37692294|NCT02325739|69168594|FG003|Phase I Part|Subject/guardian decision|1|||
37692295|NCT02325739|69168595|FG004|Phase I Part|Subject/guardian decision|0|||
37692296|NCT02325739|69168596|FG005|Phase I Part|Subject/guardian decision|0|||
37692297|NCT02325739|69168597|FG006|Phase I Part|Subject/guardian decision|0|||
37692298|NCT02325739|69168598|FG007|Phase I Part|Subject/guardian decision|1|||
37692299|NCT02325739|69168599|FG008|Phase I Part|Subject/guardian decision|0|||
37692300|NCT02325739|69168600|FG009|Phase I Part|Subject/guardian decision|0|||
37692301|NCT02325739|69168601|FG010|Phase I Part|Subject/guardian decision|0|||
37972224|NCT00439725|69659584|FG000|Observational Period|Withdrawal by Subject|2|||
37972225|NCT00439725|69659585|FG001|Observational Period|Withdrawal by Subject|2|||
37972226|NCT00439725|69659584|FG000|Observational Period|Lost to Follow-up|0|||
37972227|NCT00439725|69659585|FG001|Observational Period|Lost to Follow-up|1|||
37972228|NCT00439725|69659584|FG000|Observational Period|Death|0|||
37972229|NCT00439725|69659585|FG001|Observational Period|Death|2|||
37972230|NCT00439725|69659584|FG000|Observational Period|Study termination by sponsor|1|||
37972231|NCT00439725|69659585|FG001|Observational Period|Study termination by sponsor|1|||
37972232|NCT00439725|69659584|FG000|Observational Period|Clinical endpoint reached|3|||
37972233|NCT00439725|69659585|FG001|Observational Period|Clinical endpoint reached|1|||
37972234|NCT00439725|69659584|FG000|Observational Period|Technical problems|1|||
37972235|NCT00439725|69659585|FG001|Observational Period|Technical problems|0|||
37972236|NCT00439725|69659584|FG000|Observational Period|Participant convenience|1|||
37972237|NCT00439725|69659585|FG001|Observational Period|Participant convenience|0|||
37972238|NCT00521586|69659593|FG000|Initial Vaccination (Year 0)|Subject request|8|||
37972239|NCT00521586|69659594|FG001|Initial Vaccination (Year 0)|Subject request|11|||
37972240|NCT00521586|69659593|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
37972241|NCT00521586|69659594|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
37972242|NCT00521586|69659593|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
37972243|NCT00521586|69659594|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
37972244|NCT00521586|69659593|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
37972245|NCT00521586|69659594|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
37972246|NCT00521586|69659593|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
37972247|NCT00521586|69659594|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
37972248|NCT00521586|69659593|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
37972249|NCT00521586|69659594|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
37972250|NCT00521586|69659593|FG000|Initial Vaccination (Year 0)|Death|1|||
37863977|NCT00994162|69547571|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
37972251|NCT00521586|69659594|FG001|Initial Vaccination (Year 0)|Death|0|||
37972252|NCT00521586|69659593|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
37972253|NCT00521586|69659594|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
37972254|NCT00521586|69659593|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
37972255|NCT00521586|69659594|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
37972256|NCT00521586|69659593|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
37972257|NCT00521586|69659594|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
37972258|NCT00521586|69659593|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
37972259|NCT00521586|69659594|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
37972260|NCT00521586|69659593|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
37972261|NCT00521586|69659594|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
37972262|NCT00521586|69659593|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
37972263|NCT00521586|69659594|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
37972264|NCT00521586|69659593|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
37972265|NCT00521586|69659594|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
37972266|NCT00521586|69659593|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
37972267|NCT00521586|69659594|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
37863978|NCT00994162|69547571|FG000|Overall Study|Physician Decision|2|||
37972268|NCT00521586|69659593|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
37972269|NCT00521586|69659594|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
37972270|NCT00521586|69659593|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
37972271|NCT00521586|69659594|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
37972272|NCT00521586|69659593|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
37972273|NCT00521586|69659594|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
37972274|NCT00521586|69659593|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
37972275|NCT00521586|69659594|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
37972276|NCT00515502|69659612|FG000|Treatment Period 1|Adverse Event|0|||
37972277|NCT00515502|69659613|FG001|Treatment Period 1|Adverse Event|0|||
37972278|NCT00515502|69659614|FG002|Treatment Period 1|Adverse Event|0|||
37972279|NCT00515502|69659615|FG003|Treatment Period 1|Adverse Event|0|||
37972280|NCT00515502|69659616|FG004|Treatment Period 1|Adverse Event|0|||
37972281|NCT00515502|69659617|FG005|Treatment Period 1|Adverse Event|0|||
37972282|NCT00515502|69659618|FG006|Treatment Period 1|Adverse Event|1|||
37972283|NCT00515502|69659619|FG007|Treatment Period 1|Adverse Event|0|||
37972284|NCT00515502|69659620|FG008|Treatment Period 1|Adverse Event|1|||
37972285|NCT00515502|69659621|FG009|Treatment Period 1|Adverse Event|0|||
37780838|NCT02531802|69351501|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
37780839|NCT02531802|69351502|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
37780840|NCT02531802|69351503|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
37780841|NCT02531802|69351483|FG000|Received Vaccination 2|Physician Decision|0|||
37780842|NCT02531802|69351484|FG001|Received Vaccination 2|Physician Decision|0|||
37780843|NCT02531802|69351485|FG002|Received Vaccination 2|Physician Decision|0|||
37780844|NCT02531802|69351486|FG003|Received Vaccination 2|Physician Decision|0|||
37780845|NCT02531802|69351487|FG004|Received Vaccination 2|Physician Decision|0|||
37780846|NCT02531802|69351488|FG005|Received Vaccination 2|Physician Decision|1|||
37780847|NCT02531802|69351489|FG006|Received Vaccination 2|Physician Decision|0|||
37780848|NCT02531802|69351490|FG007|Received Vaccination 2|Physician Decision|0|||
37780849|NCT02531802|69351491|FG008|Received Vaccination 2|Physician Decision|0|||
37780850|NCT02531802|69351492|FG009|Received Vaccination 2|Physician Decision|2|||
37780851|NCT02531802|69351493|FG010|Received Vaccination 2|Physician Decision|0|||
37780852|NCT02531802|69351494|FG011|Received Vaccination 2|Physician Decision|0|||
37780853|NCT02531802|69351495|FG012|Received Vaccination 2|Physician Decision|0|||
37780854|NCT02531802|69351496|FG013|Received Vaccination 2|Physician Decision|1|||
37780855|NCT02531802|69351497|FG014|Received Vaccination 2|Physician Decision|0|||
37780856|NCT02531802|69351498|FG015|Received Vaccination 2|Physician Decision|0|||
37780857|NCT02531802|69351499|FG016|Received Vaccination 2|Physician Decision|0|||
37780858|NCT02531802|69351500|FG017|Received Vaccination 2|Physician Decision|1|||
37780859|NCT02531802|69351501|FG018|Received Vaccination 2|Physician Decision|0|||
37780860|NCT02531802|69351502|FG019|Received Vaccination 2|Physician Decision|0|||
37780861|NCT02531802|69351503|FG020|Received Vaccination 2|Physician Decision|0|||
37780862|NCT02531802|69351483|FG000|Received Vaccination 2|Adverse Event|0|||
37780863|NCT02531802|69351484|FG001|Received Vaccination 2|Adverse Event|0|||
37780864|NCT02531802|69351485|FG002|Received Vaccination 2|Adverse Event|0|||
37780865|NCT02531802|69351486|FG003|Received Vaccination 2|Adverse Event|0|||
37780866|NCT02531802|69351487|FG004|Received Vaccination 2|Adverse Event|0|||
37780867|NCT02531802|69351488|FG005|Received Vaccination 2|Adverse Event|2|||
37780868|NCT02531802|69351489|FG006|Received Vaccination 2|Adverse Event|0|||
37780869|NCT02531802|69351490|FG007|Received Vaccination 2|Adverse Event|0|||
37780870|NCT02531802|69351491|FG008|Received Vaccination 2|Adverse Event|0|||
37780871|NCT02531802|69351492|FG009|Received Vaccination 2|Adverse Event|0|||
37780872|NCT02531802|69351493|FG010|Received Vaccination 2|Adverse Event|0|||
37780873|NCT02531802|69351494|FG011|Received Vaccination 2|Adverse Event|0|||
37780874|NCT02531802|69351495|FG012|Received Vaccination 2|Adverse Event|0|||
37780875|NCT02531802|69351496|FG013|Received Vaccination 2|Adverse Event|0|||
37780876|NCT02531802|69351497|FG014|Received Vaccination 2|Adverse Event|0|||
37780877|NCT02531802|69351498|FG015|Received Vaccination 2|Adverse Event|0|||
37780878|NCT02531802|69351499|FG016|Received Vaccination 2|Adverse Event|0|||
37780879|NCT02531802|69351500|FG017|Received Vaccination 2|Adverse Event|2|||
37780880|NCT02531802|69351501|FG018|Received Vaccination 2|Adverse Event|1|||
37780881|NCT02531802|69351502|FG019|Received Vaccination 2|Adverse Event|0|||
37780882|NCT02531802|69351503|FG020|Received Vaccination 2|Adverse Event|1|||
37780883|NCT02531802|69351483|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
37780884|NCT02531802|69351484|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
37972286|NCT00515502|69659622|FG010|Treatment Period 1|Adverse Event|0|||
37972287|NCT00515502|69659623|FG011|Treatment Period 1|Adverse Event|1|||
37972288|NCT00515502|69659612|FG000|Treatment Period 2|Adverse Event|0|||
37972289|NCT00515502|69659613|FG001|Treatment Period 2|Adverse Event|1|||
37972290|NCT00515502|69659614|FG002|Treatment Period 2|Adverse Event|0|||
37972291|NCT00515502|69659615|FG003|Treatment Period 2|Adverse Event|0|||
37780885|NCT02531802|69351485|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
37780886|NCT02531802|69351486|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
37780887|NCT02531802|69351487|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
37972292|NCT00515502|69659616|FG004|Treatment Period 2|Adverse Event|0|||
37972293|NCT00515502|69659617|FG005|Treatment Period 2|Adverse Event|0|||
37972294|NCT00515502|69659618|FG006|Treatment Period 2|Adverse Event|0|||
37972295|NCT00515502|69659619|FG007|Treatment Period 2|Adverse Event|0|||
37972296|NCT00515502|69659620|FG008|Treatment Period 2|Adverse Event|0|||
37972297|NCT00515502|69659621|FG009|Treatment Period 2|Adverse Event|0|||
37972298|NCT00515502|69659622|FG010|Treatment Period 2|Adverse Event|0|||
37972299|NCT00515502|69659623|FG011|Treatment Period 2|Adverse Event|0|||
37972300|NCT00439647|69659642|FG000|Overall Study|Withdrawal by Subject|25|||
37972301|NCT00439647|69659643|FG001|Overall Study|Withdrawal by Subject|22|||
37972302|NCT00439647|69659642|FG000|Overall Study|Death|15|||
37972303|NCT00439647|69659643|FG001|Overall Study|Death|18|||
37972304|NCT00439647|69659642|FG000|Overall Study|Adverse Event|11|||
37972305|NCT00439647|69659643|FG001|Overall Study|Adverse Event|11|||
37972306|NCT00439647|69659642|FG000|Overall Study|Lost to Follow-up|4|||
37972307|NCT00439647|69659643|FG001|Overall Study|Lost to Follow-up|12|||
37972308|NCT00439647|69659642|FG000|Overall Study|Protocol Violation|3|||
37972309|NCT00439647|69659643|FG001|Overall Study|Protocol Violation|4|||
37972310|NCT00439647|69659642|FG000|Overall Study|Lack of Efficacy|0|||
37972311|NCT00439647|69659643|FG001|Overall Study|Lack of Efficacy|4|||
37972312|NCT00515112|69659651|FG000|Overall Study|Death|0|||
37972313|NCT00515112|69659652|FG001|Overall Study|Death|1|||
37972314|NCT00515112|69659651|FG000|Overall Study|The study was terminated|3|||
37972315|NCT00515112|69659652|FG001|Overall Study|The study was terminated|2|||
37972316|NCT00404547|69659660|FG000|Overall Study|Adverse Event|39|||
37972317|NCT00404547|69659661|FG001|Overall Study|Adverse Event|6|||
37972318|NCT00404547|69659660|FG000|Overall Study|Withdrawal by Subject|19|||
37972319|NCT00404547|69659661|FG001|Overall Study|Withdrawal by Subject|2|||
37972320|NCT00404547|69659660|FG000|Overall Study|Protocol Violation|0|||
37972321|NCT00404547|69659661|FG001|Overall Study|Protocol Violation|1|||
37972322|NCT00404547|69659660|FG000|Overall Study|Lost to Follow-up|20|||
37972323|NCT00404547|69659661|FG001|Overall Study|Lost to Follow-up|9|||
37972324|NCT00404547|69659660|FG000|Overall Study|Lack of compliance|5|||
37972325|NCT00404547|69659661|FG001|Overall Study|Lack of compliance|1|||
37972326|NCT00404547|69659660|FG000|Overall Study|Other|4|||
37972327|NCT00404547|69659661|FG001|Overall Study|Other|0|||
37972328|NCT00404547|69659660|FG000|Overall Study|Reason not stated|3|||
37972329|NCT00404547|69659661|FG001|Overall Study|Reason not stated|6|||
37972330|NCT00515034|69659671|FG000|Overall Study|Adverse Event|2|||
37972331|NCT00515034|69659672|FG001|Overall Study|Adverse Event|0|||
37972332|NCT00515034|69659673|FG002|Overall Study|Adverse Event|1|||
37972333|NCT00515034|69659674|FG003|Overall Study|Adverse Event|0|||
37972334|NCT00515034|69659671|FG000|Overall Study|Death|4|||
37972335|NCT00515034|69659672|FG001|Overall Study|Death|2|||
37972336|NCT00515034|69659673|FG002|Overall Study|Death|1|||
37972337|NCT00515034|69659674|FG003|Overall Study|Death|3|||
37972338|NCT00515034|69659671|FG000|Overall Study|Withdrawal by Subject|1|||
37972339|NCT00515034|69659672|FG001|Overall Study|Withdrawal by Subject|0|||
37972340|NCT00515034|69659673|FG002|Overall Study|Withdrawal by Subject|3|||
37972341|NCT00515034|69659674|FG003|Overall Study|Withdrawal by Subject|0|||
37972342|NCT00515034|69659671|FG000|Overall Study|Physician Decision|0|||
37972343|NCT00515034|69659672|FG001|Overall Study|Physician Decision|0|||
37972344|NCT00515034|69659673|FG002|Overall Study|Physician Decision|1|||
37972345|NCT00515034|69659674|FG003|Overall Study|Physician Decision|1|||
37972346|NCT00515034|69659671|FG000|Overall Study|Other|1|||
37972347|NCT00515034|69659672|FG001|Overall Study|Other|0|||
37972348|NCT00515034|69659673|FG002|Overall Study|Other|2|||
37972349|NCT00515034|69659674|FG003|Overall Study|Other|1|||
37972350|NCT00404235|69659686|FG000|Overall Study|Withdrawal by Subject|1|||
37972351|NCT00404235|69659687|FG001|Overall Study|Withdrawal by Subject|2|||
37972352|NCT00404079|69659695|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
37972353|NCT00404079|69659696|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
37972354|NCT00403845|69659702|FG000|Treatment Period 1|Subject withdrew consent|1|||
37972355|NCT00403845|69659703|FG001|Treatment Period 1|Subject withdrew consent|0|||
37972356|NCT00403845|69659704|FG002|Treatment Period 1|Subject withdrew consent|0|||
37972357|NCT00403845|69659705|FG003|Treatment Period 1|Subject withdrew consent|0|||
37972358|NCT00403845|69659702|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
37972359|NCT00403845|69659703|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
37972360|NCT00403845|69659704|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
37972361|NCT00403845|69659705|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
37972362|NCT00403845|69659702|FG000|Treatment Period 2|Subject withdrew consent|1|||
37972363|NCT00403845|69659703|FG001|Treatment Period 2|Subject withdrew consent|0|||
37972364|NCT00403845|69659704|FG002|Treatment Period 2|Subject withdrew consent|0|||
37972365|NCT00403845|69659705|FG003|Treatment Period 2|Subject withdrew consent|0|||
37972366|NCT00403845|69659702|FG000|Treatment Period 3|Subject withdrew consent|0|||
37972367|NCT00403845|69659703|FG001|Treatment Period 3|Subject withdrew consent|0|||
37972368|NCT00403845|69659704|FG002|Treatment Period 3|Subject withdrew consent|0|||
37972369|NCT00403845|69659705|FG003|Treatment Period 3|Subject withdrew consent|1|||
37972370|NCT00403845|69659702|FG000|Treatment Period 3|Adverse Event|0|||
37972371|NCT00403845|69659703|FG001|Treatment Period 3|Adverse Event|0|||
37972372|NCT00403845|69659704|FG002|Treatment Period 3|Adverse Event|0|||
37972373|NCT00403845|69659705|FG003|Treatment Period 3|Adverse Event|1|||
37972374|NCT00509262|69659717|FG000|Overall Study|Adverse Event|16|||
37972375|NCT00509262|69659718|FG001|Overall Study|Adverse Event|18|||
37972376|NCT00509262|69659717|FG000|Overall Study|Other|2|||
37972377|NCT00509262|69659718|FG001|Overall Study|Other|2|||
37972378|NCT00509262|69659717|FG000|Overall Study|Lack of Efficacy|1|||
37972379|NCT00509262|69659718|FG001|Overall Study|Lack of Efficacy|0|||
37972380|NCT00509262|69659717|FG000|Overall Study|Lost to Follow-up|1|||
37972381|NCT00509262|69659718|FG001|Overall Study|Lost to Follow-up|6|||
37972382|NCT00509262|69659717|FG000|Overall Study|Physician Decision|1|||
37972383|NCT00509262|69659718|FG001|Overall Study|Physician Decision|3|||
37972384|NCT00509262|69659717|FG000|Overall Study|Protocol Violation|2|||
37972385|NCT00509262|69659718|FG001|Overall Study|Protocol Violation|2|||
37972386|NCT00509262|69659717|FG000|Overall Study|Withdrawal by Subject|24|||
37972387|NCT00509262|69659718|FG001|Overall Study|Withdrawal by Subject|11|||
37972388|NCT00607997|69659728|FG000|Overall Study|Lack of Efficacy|6|||
37972389|NCT00607997|69659729|FG001|Overall Study|Lack of Efficacy|20|||
37972390|NCT00607997|69659730|FG002|Overall Study|Lack of Efficacy|14|||
37972391|NCT00607997|69659731|FG003|Overall Study|Lack of Efficacy|10|||
37972392|NCT00607997|69659728|FG000|Overall Study|Death|8|||
37972393|NCT00607997|69659729|FG001|Overall Study|Death|5|||
37972394|NCT00607997|69659730|FG002|Overall Study|Death|2|||
37972395|NCT00607997|69659731|FG003|Overall Study|Death|5|||
37972396|NCT00607997|69659728|FG000|Overall Study|Adverse Event|3|||
37972397|NCT00607997|69659729|FG001|Overall Study|Adverse Event|1|||
37972398|NCT00607997|69659730|FG002|Overall Study|Adverse Event|2|||
37972399|NCT00607997|69659731|FG003|Overall Study|Adverse Event|0|||
37972400|NCT00607997|69659728|FG000|Overall Study|Physician Decision|4|||
37972401|NCT00607997|69659729|FG001|Overall Study|Physician Decision|1|||
37972402|NCT00607997|69659730|FG002|Overall Study|Physician Decision|0|||
37972403|NCT00607997|69659731|FG003|Overall Study|Physician Decision|0|||
37972404|NCT00607997|69659728|FG000|Overall Study|Relapse, recurrent illness|4|||
37972405|NCT00607997|69659729|FG001|Overall Study|Relapse, recurrent illness|0|||
37972406|NCT00607997|69659730|FG002|Overall Study|Relapse, recurrent illness|2|||
37972407|NCT00607997|69659731|FG003|Overall Study|Relapse, recurrent illness|0|||
37972408|NCT00607997|69659728|FG000|Overall Study|Other without explanation|2|||
37972409|NCT00607997|69659729|FG001|Overall Study|Other without explanation|0|||
37972410|NCT00607997|69659730|FG002|Overall Study|Other without explanation|4|||
37972411|NCT00607997|69659731|FG003|Overall Study|Other without explanation|1|||
37972412|NCT00509106|69659748|FG000|Overall Study|Adverse Event|3|||
37972413|NCT00509106|69659749|FG001|Overall Study|Adverse Event|2|||
37972414|NCT00509106|69659748|FG000|Overall Study|Noncompliance|0|||
37972415|NCT00509106|69659749|FG001|Overall Study|Noncompliance|1|||
37972416|NCT00509106|69659748|FG000|Overall Study|At the request of sponsor/investigator|1|||
37972417|NCT00509106|69659749|FG001|Overall Study|At the request of sponsor/investigator|2|||
37972418|NCT00509106|69659748|FG000|Overall Study|Withdrew consent|4|||
37972419|NCT00509106|69659749|FG001|Overall Study|Withdrew consent|8|||
37972420|NCT00509106|69659748|FG000|Overall Study|Lost to Follow-up|16|||
37972421|NCT00509106|69659749|FG001|Overall Study|Lost to Follow-up|10|||
37972422|NCT00509106|69659748|FG000|Overall Study|Other|1|||
37972423|NCT00509106|69659749|FG001|Overall Study|Other|0|||
37972424|NCT00509106|69659748|FG000|Overall Study|Death|6|||
37972425|NCT00509106|69659749|FG001|Overall Study|Death|6|||
37972426|NCT00607919|69659757|FG000|Acute Phase|Adverse Event|9|||
37972427|NCT00607919|69659758|FG001|Acute Phase|Adverse Event|2|||
37972428|NCT00607919|69659757|FG000|Acute Phase|Entry Criteria Not Met|1|||
37972429|NCT00607919|69659758|FG001|Acute Phase|Entry Criteria Not Met|1|||
37972430|NCT00607919|69659757|FG000|Acute Phase|Lack of Efficacy|1|||
37972431|NCT00607919|69659758|FG001|Acute Phase|Lack of Efficacy|2|||
37972432|NCT00607919|69659757|FG000|Acute Phase|Lost to Follow-up|9|||
37972433|NCT00607919|69659758|FG001|Acute Phase|Lost to Follow-up|3|||
37972434|NCT00607919|69659757|FG000|Acute Phase|Parent/Caregiver Decision|6|||
37972435|NCT00607919|69659758|FG001|Acute Phase|Parent/Caregiver Decision|4|||
37972436|NCT00607919|69659757|FG000|Acute Phase|Protocol Violation|5|||
37972437|NCT00607919|69659758|FG001|Acute Phase|Protocol Violation|1|||
37972438|NCT00607919|69659757|FG000|Acute Phase|Withdrawal by Subject|3|||
37972439|NCT00607919|69659758|FG001|Acute Phase|Withdrawal by Subject|3|||
37972440|NCT00607919|69659757|FG000|Open-Label Phase|Adverse Event|1|||
37972441|NCT00607919|69659758|FG001|Open-Label Phase|Adverse Event|5|||
37972442|NCT00607919|69659757|FG000|Open-Label Phase|Lost to Follow-up|4|||
37972443|NCT00607919|69659758|FG001|Open-Label Phase|Lost to Follow-up|1|||
37972444|NCT00607919|69659757|FG000|Open-Label Phase|Protocol Violation|2|||
37972445|NCT00607919|69659758|FG001|Open-Label Phase|Protocol Violation|2|||
37972446|NCT00607919|69659757|FG000|Open-Label Phase|Withdrawal by Subject|2|||
37972447|NCT00607919|69659758|FG001|Open-Label Phase|Withdrawal by Subject|2|||
37972448|NCT00607919|69659757|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
37972449|NCT00607919|69659758|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
37972450|NCT00344968|69659769|FG000|Overall Study|Adverse Event|5|||
37972451|NCT00344968|69659770|FG001|Overall Study|Adverse Event|4|||
37972452|NCT00344968|69659771|FG002|Overall Study|Adverse Event|15|||
37972453|NCT00344968|69659769|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
37972454|NCT00344968|69659770|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
37972455|NCT00344968|69659771|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
37972456|NCT00344968|69659769|FG000|Overall Study|Protocol Violation|2|||
37972457|NCT00344968|69659770|FG001|Overall Study|Protocol Violation|2|||
37972458|NCT00344968|69659771|FG002|Overall Study|Protocol Violation|5|||
37972459|NCT00344968|69659769|FG000|Overall Study|Withdrawal by Subject|14|||
37972460|NCT00344968|69659770|FG001|Overall Study|Withdrawal by Subject|31|||
37972461|NCT00344968|69659771|FG002|Overall Study|Withdrawal by Subject|27|||
37972462|NCT00344968|69659769|FG000|Overall Study|Lost to Follow-up|24|||
37972463|NCT00344968|69659770|FG001|Overall Study|Lost to Follow-up|37|||
37972464|NCT00344968|69659771|FG002|Overall Study|Lost to Follow-up|37|||
37972465|NCT00344968|69659769|FG000|Overall Study|Death|11|||
37972466|NCT00344968|69659770|FG001|Overall Study|Death|27|||
37972467|NCT00344968|69659771|FG002|Overall Study|Death|31|||
37972468|NCT00344968|69659769|FG000|Overall Study|Other|0|||
37972469|NCT00344968|69659770|FG001|Overall Study|Other|1|||
37972470|NCT00344968|69659771|FG002|Overall Study|Other|0|||
37972471|NCT00509028|69659782|FG000|Overall Study|Adverse Event|2|||
37972472|NCT00509028|69659783|FG001|Overall Study|Adverse Event|0|||
37972473|NCT00509028|69659782|FG000|Overall Study|Withdrawal by Subject|4|||
37972474|NCT00509028|69659783|FG001|Overall Study|Withdrawal by Subject|3|||
37972475|NCT00509028|69659782|FG000|Overall Study|Lost to Follow-up|0|||
37972476|NCT00509028|69659783|FG001|Overall Study|Lost to Follow-up|1|||
37972477|NCT00509028|69659782|FG000|Overall Study|Protocol Violation|4|||
37972478|NCT00509028|69659783|FG001|Overall Study|Protocol Violation|2|||
37972479|NCT00509028|69659782|FG000|Overall Study|Non-compliance|2|||
37972480|NCT00509028|69659783|FG001|Overall Study|Non-compliance|1|||
37972481|NCT00352846|69659791|FG000|Overall Study|Disease progression|0|||
37972482|NCT00352846|69659792|FG001|Overall Study|Disease progression|2|||
37972483|NCT00352846|69659791|FG000|Overall Study|Withdrawal by Subject|3|||
37972484|NCT00352846|69659792|FG001|Overall Study|Withdrawal by Subject|8|||
37972485|NCT00352846|69659791|FG000|Overall Study|Ineligible|3|||
37972486|NCT00352846|69659792|FG001|Overall Study|Ineligible|2|||
37972487|NCT00352846|69659791|FG000|Overall Study|Non-compliance|2|||
37972488|NCT00352846|69659792|FG001|Overall Study|Non-compliance|0|||
37972489|NCT00352846|69659791|FG000|Overall Study|Death|0|||
37972490|NCT00352846|69659792|FG001|Overall Study|Death|1|||
37972491|NCT00508872|69659798|FG000|Overall Study|Lost to Follow-up|1|||
37972492|NCT00508872|69659798|FG000|Overall Study|Physician Decision|1|||
37972493|NCT00508482|69659805|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
37972494|NCT00508482|69659806|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
37972495|NCT00508482|69659807|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
37972496|NCT00508482|69659805|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
37972497|NCT00508482|69659806|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
37972498|NCT00508482|69659807|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
37972499|NCT00508482|69659805|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
37780888|NCT02531802|69351488|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
37780889|NCT02531802|69351489|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
37780890|NCT02531802|69351490|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
37780891|NCT02531802|69351491|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
37780892|NCT02531802|69351492|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
37780893|NCT02531802|69351493|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
37780894|NCT02531802|69351494|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
37780895|NCT02531802|69351495|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
37780896|NCT02531802|69351496|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
37780897|NCT02531802|69351497|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
37780898|NCT02531802|69351498|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
37780899|NCT02531802|69351499|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
37780900|NCT02531802|69351500|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
37780901|NCT02531802|69351501|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
37780902|NCT02531802|69351502|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
37780903|NCT02531802|69351503|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
37780904|NCT01602666|69351606|FG000|Induction Chemotherapy|Death|2|||
37780905|NCT01602666|69351607|FG001|Induction Chemotherapy|Death|1|||
37780906|NCT01602666|69351606|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
37780907|NCT01602666|69351607|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
37780908|NCT01602666|69351606|FG000|Induction Chemotherapy|Physician Decision|12|||
37780909|NCT01602666|69351607|FG001|Induction Chemotherapy|Physician Decision|5|||
37780910|NCT01602666|69351606|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
37780911|NCT01602666|69351607|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
37780912|NCT01602666|69351606|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
37780913|NCT01602666|69351607|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
37780914|NCT01602666|69351606|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
37780915|NCT01602666|69351607|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
37780916|NCT01602666|69351606|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
37780917|NCT01602666|69351607|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
37780918|NCT01602666|69351606|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
37780919|NCT01602666|69351607|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
37780920|NCT01602666|69351606|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
37780921|NCT01602666|69351607|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
37780922|NCT01602666|69351606|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
37780923|NCT01602666|69351607|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
37972500|NCT00508482|69659806|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
37780924|NCT01602666|69351606|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
37780925|NCT01602666|69351607|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
37780926|NCT02531646|69351618|FG000|Overall Study|equip. image processing issue|5|||
37780927|NCT02531646|69351619|FG001|Overall Study|equip. image processing issue|1|||
37972501|NCT00508482|69659807|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
37972502|NCT00344500|69659818|FG000|Overall Study|Adverse Event|6|||
37972503|NCT00344500|69659819|FG001|Overall Study|Adverse Event|2|||
37972504|NCT00344500|69659820|FG002|Overall Study|Adverse Event|0|||
37972505|NCT00344500|69659818|FG000|Overall Study|Lost to Follow-up|5|||
37972506|NCT00344500|69659819|FG001|Overall Study|Lost to Follow-up|13|||
37972507|NCT00344500|69659820|FG002|Overall Study|Lost to Follow-up|1|||
37972508|NCT00344500|69659818|FG000|Overall Study|Withdrawal by Subject|7|||
37972509|NCT00344500|69659819|FG001|Overall Study|Withdrawal by Subject|10|||
37972510|NCT00344500|69659820|FG002|Overall Study|Withdrawal by Subject|0|||
37972511|NCT00344500|69659818|FG000|Overall Study|Protocol Violation|4|||
37972512|NCT00344500|69659819|FG001|Overall Study|Protocol Violation|7|||
37972513|NCT00344500|69659820|FG002|Overall Study|Protocol Violation|1|||
37972514|NCT00344500|69659818|FG000|Overall Study|Not Noted|1|||
37972515|NCT00344500|69659819|FG001|Overall Study|Not Noted|3|||
37972516|NCT00344500|69659820|FG002|Overall Study|Not Noted|0|||
37972517|NCT00344032|69659829|FG000|Overall Study|Adverse Event|0|||
37972518|NCT00344032|69659830|FG001|Overall Study|Adverse Event|1|||
37972519|NCT00344032|69659829|FG000|Overall Study|Withdrawal by Subject|6|||
37972520|NCT00344032|69659830|FG001|Overall Study|Withdrawal by Subject|2|||
37972521|NCT00344032|69659829|FG000|Overall Study|Lost to Follow-up|4|||
37972522|NCT00344032|69659830|FG001|Overall Study|Lost to Follow-up|6|||
37972523|NCT00344032|69659829|FG000|Overall Study|Physician Decision|4|||
37972524|NCT00344032|69659830|FG001|Overall Study|Physician Decision|1|||
37972525|NCT00607373|69659838|FG000|Treatment Period|Adverse Event|0|||
37972526|NCT00607373|69659839|FG001|Treatment Period|Adverse Event|4|||
37972527|NCT00607373|69659838|FG000|Treatment Period|Physician Decision|0|||
37972528|NCT00607373|69659839|FG001|Treatment Period|Physician Decision|1|||
37972529|NCT00607373|69659838|FG000|Treatment Period|Withdrawal by Subject|0|||
37972530|NCT00607373|69659839|FG001|Treatment Period|Withdrawal by Subject|1|||
37972531|NCT00607373|69659838|FG000|Follow-up Period|Other|0|||
37972532|NCT00607373|69659839|FG001|Follow-up Period|Other|1|||
37972533|NCT00607373|69659838|FG000|Follow-up Period|Protocol Violation|0|||
37972534|NCT00607373|69659839|FG001|Follow-up Period|Protocol Violation|1|||
37972535|NCT00607373|69659838|FG000|Follow-up Period|Withdrawal by Subject|1|||
37972536|NCT00607373|69659839|FG001|Follow-up Period|Withdrawal by Subject|3|||
37972537|NCT00508404|69659845|FG000|Overall Study|Ongoing at Data Cut-off|12|||
37972538|NCT00508404|69659845|FG000|Overall Study|Adverse Event|2|||
37972539|NCT00508404|69659845|FG000|Overall Study|Death|16|||
37972540|NCT00508404|69659845|FG000|Overall Study|Physician Decision|2|||
37972541|NCT00508404|69659845|FG000|Overall Study|Withdrawal by Subject|3|||
37972542|NCT00508404|69659845|FG000|Overall Study|Protocol-specified Criteria|2|||
37972543|NCT00508404|69659845|FG000|Overall Study|Lost to Follow-up|2|||
37972544|NCT00508404|69659845|FG000|Overall Study|Other - Not Specified|3|||
37972545|NCT00352690|69659852|FG000|Overall Study|Determined to be ineligible|2|||
37972546|NCT00352690|69659853|FG001|Overall Study|Determined to be ineligible|0|||
37972547|NCT00609245|69659859|FG000|Overall Study|Adverse Event|1|||
37972548|NCT00343642|69659868|FG000|Overall Study|Lost to Follow-up|0|||
37972549|NCT00343642|69659869|FG001|Overall Study|Lost to Follow-up|1|||
37972550|NCT00343642|69659870|FG002|Overall Study|Lost to Follow-up|0|||
37972551|NCT00343642|69659868|FG000|Overall Study|Pregnancy|1|||
37972552|NCT00343642|69659869|FG001|Overall Study|Pregnancy|0|||
37972553|NCT00343642|69659870|FG002|Overall Study|Pregnancy|2|||
37972554|NCT00343642|69659868|FG000|Overall Study|Withdrawal by Subject|2|||
37972555|NCT00343642|69659869|FG001|Overall Study|Withdrawal by Subject|3|||
37972556|NCT00343642|69659870|FG002|Overall Study|Withdrawal by Subject|4|||
37972557|NCT00343642|69659868|FG000|Overall Study|Adverse Event|0|||
37972558|NCT00343642|69659869|FG001|Overall Study|Adverse Event|0|||
37972559|NCT00343642|69659870|FG002|Overall Study|Adverse Event|1|||
37972560|NCT00343642|69659868|FG000|Overall Study|Flare up|6|||
37972561|NCT00343642|69659869|FG001|Overall Study|Flare up|4|||
37972562|NCT00343642|69659870|FG002|Overall Study|Flare up|0|||
37972563|NCT00609167|69659883|FG000|Overall Study|Withdrawal by Subject|1|||
37972564|NCT00609167|69659884|FG001|Overall Study|Withdrawal by Subject|0|||
37972565|NCT00609167|69659883|FG000|Overall Study|Lack of Efficacy|1|||
37972566|NCT00609167|69659884|FG001|Overall Study|Lack of Efficacy|0|||
37972567|NCT00609167|69659883|FG000|Overall Study|Adverse Event|5|||
37972568|NCT00609167|69659884|FG001|Overall Study|Adverse Event|1|||
37972569|NCT00609167|69659883|FG000|Overall Study|Disease Progression|1|||
37972570|NCT00609167|69659884|FG001|Overall Study|Disease Progression|0|||
37972571|NCT00609167|69659883|FG000|Overall Study|Stem Cell Transplant|0|||
37972572|NCT00609167|69659884|FG001|Overall Study|Stem Cell Transplant|6|||
37972573|NCT00606281|69659892|FG000|Overall Study|Adverse Event|11|||
37972574|NCT00606281|69659893|FG001|Overall Study|Adverse Event|12|||
37972575|NCT00606281|69659892|FG000|Overall Study|Death|1|||
37972576|NCT00606281|69659893|FG001|Overall Study|Death|0|||
37972577|NCT00606281|69659892|FG000|Overall Study|Lack of Efficacy|28|||
37972578|NCT00606281|69659893|FG001|Overall Study|Lack of Efficacy|35|||
37972579|NCT00606281|69659892|FG000|Overall Study|Physician Decision|0|||
37972580|NCT00606281|69659893|FG001|Overall Study|Physician Decision|1|||
37972581|NCT00606281|69659892|FG000|Overall Study|Protocol Violation|3|||
37972582|NCT00606281|69659893|FG001|Overall Study|Protocol Violation|3|||
37972583|NCT00606281|69659892|FG000|Overall Study|Withdrawal by Subject|11|||
37972584|NCT00606281|69659893|FG001|Overall Study|Withdrawal by Subject|13|||
37972585|NCT00606281|69659892|FG000|Overall Study|Progression to depressive phase|1|||
37972586|NCT00606281|69659893|FG001|Overall Study|Progression to depressive phase|1|||
37972587|NCT00606281|69659892|FG000|Overall Study|Change of residence or other commitments|1|||
37972588|NCT00606281|69659893|FG001|Overall Study|Change of residence or other commitments|1|||
37972589|NCT00506142|69659901|FG000|Overall Study|Adverse Event|8|||
37972590|NCT00506142|69659902|FG001|Overall Study|Adverse Event|7|||
37972591|NCT00506142|69659901|FG000|Overall Study|Lack of Efficacy|21|||
37972592|NCT00506142|69659902|FG001|Overall Study|Lack of Efficacy|7|||
37972593|NCT00506142|69659901|FG000|Overall Study|Withdrawal by Subject|4|||
37972594|NCT00506142|69659902|FG001|Overall Study|Withdrawal by Subject|5|||
37972595|NCT00506142|69659901|FG000|Overall Study|Physician Decision|1|||
37972596|NCT00506142|69659902|FG001|Overall Study|Physician Decision|0|||
37972597|NCT00506142|69659901|FG000|Overall Study|New health condition|1|||
37972598|NCT00506142|69659902|FG001|Overall Study|New health condition|0|||
37972599|NCT00514020|69659908|FG000|Overall Study|Adverse Event|6|||
37972600|NCT00514020|69659908|FG000|Overall Study|Withdrawal by Subject|3|||
37972601|NCT00514020|69659908|FG000|Overall Study|Physician Decision|1|||
37972602|NCT00514020|69659908|FG000|Overall Study|disease progression|9|||
37972603|NCT00514020|69659908|FG000|Overall Study|other complicating disease|2|||
37972604|NCT00514020|69659908|FG000|Overall Study|patient went to radiation treatment|1|||
37972605|NCT00514020|69659908|FG000|Overall Study|"patients moved to the no tx group"|6|||
37972606|NCT00513708|69659915|FG000|Overall Study|Lost to Follow-up|4|||
37972607|NCT00513708|69659916|FG001|Overall Study|Lost to Follow-up|4|||
37972608|NCT00513708|69659917|FG002|Overall Study|Lost to Follow-up|4|||
37972609|NCT00513474|69659927|FG000|Overall Study|Death|6|||
37972610|NCT00513474|69659928|FG001|Overall Study|Death|9|||
37972611|NCT00513474|69659927|FG000|Overall Study|Participant Withdrew Consent|1|||
37972612|NCT00513474|69659928|FG001|Overall Study|Participant Withdrew Consent|0|||
37972613|NCT00505752|69659938|FG000|Overall Study|Adverse Event|1|||
37972614|NCT00505752|69659939|FG001|Overall Study|Adverse Event|0|||
37972615|NCT00505752|69659940|FG002|Overall Study|Adverse Event|1|||
37972616|NCT00505752|69659941|FG003|Overall Study|Adverse Event|0|||
37972617|NCT00505752|69659938|FG000|Overall Study|Lost to Follow-up|1|||
37972618|NCT00505752|69659939|FG001|Overall Study|Lost to Follow-up|0|||
37972619|NCT00505752|69659940|FG002|Overall Study|Lost to Follow-up|0|||
37972620|NCT00505752|69659941|FG003|Overall Study|Lost to Follow-up|0|||
37972621|NCT00505752|69659938|FG000|Overall Study|Lack of ovarian response|1|||
37972622|NCT00505752|69659939|FG001|Overall Study|Lack of ovarian response|3|||
37972623|NCT00505752|69659940|FG002|Overall Study|Lack of ovarian response|0|||
37972624|NCT00505752|69659941|FG003|Overall Study|Lack of ovarian response|0|||
37972625|NCT00505752|69659938|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
37972626|NCT00505752|69659939|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
37972627|NCT00505752|69659940|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
37972628|NCT00505752|69659941|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
37972629|NCT00505752|69659938|FG000|Overall Study|No oocytes retrieved|0|||
37972630|NCT00505752|69659939|FG001|Overall Study|No oocytes retrieved|2|||
37972631|NCT00505752|69659940|FG002|Overall Study|No oocytes retrieved|0|||
37972632|NCT00505752|69659941|FG003|Overall Study|No oocytes retrieved|1|||
37972633|NCT00505752|69659938|FG000|Overall Study|No Fertilization|1|||
37972634|NCT00505752|69659939|FG001|Overall Study|No Fertilization|1|||
37972635|NCT00505752|69659940|FG002|Overall Study|No Fertilization|2|||
37972636|NCT00505752|69659941|FG003|Overall Study|No Fertilization|1|||
37972637|NCT00505752|69659938|FG000|Overall Study|All embryos/blastocysts discarded|0|||
37972638|NCT00505752|69659939|FG001|Overall Study|All embryos/blastocysts discarded|0|||
37972639|NCT00505752|69659940|FG002|Overall Study|All embryos/blastocysts discarded|1|||
37972640|NCT00505752|69659941|FG003|Overall Study|All embryos/blastocysts discarded|1|||
37972641|NCT00505752|69659938|FG000|Overall Study|Other|1|||
37972642|NCT00505752|69659939|FG001|Overall Study|Other|2|||
37972643|NCT00505752|69659940|FG002|Overall Study|Other|1|||
37972644|NCT00505752|69659941|FG003|Overall Study|Other|2|||
37972645|NCT03601637|69659953|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
37972646|NCT03601637|69659954|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
37972647|NCT03601637|69659953|FG000|Overall Study|Adverse Event|1|||
37972648|NCT03601637|69659954|FG001|Overall Study|Adverse Event|1|||
37972649|NCT03601637|69659953|FG000|Overall Study|Other|0|||
37972650|NCT03601637|69659954|FG001|Overall Study|Other|1|||
37972651|NCT00343252|69659969|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
37972652|NCT00343252|69659970|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
37972653|NCT00343252|69659969|FG000|6 Months (All Treated Participants)|Death|0|||
37972654|NCT00343252|69659970|FG001|6 Months (All Treated Participants)|Death|2|||
37972655|NCT00343252|69659969|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
37972656|NCT00343252|69659970|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
37972657|NCT00343252|69659969|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
37972658|NCT00343252|69659970|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
37972659|NCT00343252|69659969|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
37972660|NCT00343252|69659970|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
37972661|NCT00343252|69659969|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
37972662|NCT00343252|69659970|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
37972663|NCT00343252|69659969|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
37972664|NCT00343252|69659970|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
37972665|NCT00343252|69659969|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
37972666|NCT00343252|69659970|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
37972667|NCT00343252|69659969|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
37972668|NCT00343252|69659970|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
37972669|NCT00343252|69659969|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
37972670|NCT00343252|69659970|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
37972671|NCT00343252|69659969|FG000|12 Months (All Treated Participants)|Death|3|||
37972672|NCT00343252|69659970|FG001|12 Months (All Treated Participants)|Death|3|||
37972673|NCT00343252|69659969|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
37972674|NCT00343252|69659970|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
37972675|NCT00343252|69659969|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
37972676|NCT00343252|69659970|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
37972677|NCT00343252|69659969|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
37972678|NCT00343252|69659970|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
37972679|NCT00343252|69659969|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
37972680|NCT00343252|69659970|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
37780928|NCT02531646|69351620|FG002|Overall Study|equip. image processing issue|0|||
37780929|NCT02536404|69351685|FG000|Overall Study|Adverse Event|5|||
37972681|NCT00343252|69659969|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
37972682|NCT00343252|69659970|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
37972683|NCT00343252|69659969|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
37972684|NCT00343252|69659970|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
37972685|NCT00343252|69659969|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
37972686|NCT00343252|69659970|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
37972687|NCT00343252|69659969|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
37972688|NCT00343252|69659970|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
37972689|NCT00343252|69659969|FG000|18 Months (All Treated Participants)|Death|4|||
37972690|NCT00343252|69659970|FG001|18 Months (All Treated Participants)|Death|5|||
37972691|NCT00343252|69659969|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
37972692|NCT00343252|69659970|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
37780930|NCT02536404|69351686|FG001|Overall Study|Adverse Event|0|||
37780931|NCT02536404|69351685|FG000|Overall Study|Withdrawal by Subject|4|||
37780932|NCT02536404|69351686|FG001|Overall Study|Withdrawal by Subject|1|||
37780933|NCT02536404|69351685|FG000|Overall Study|Physician Decision|10|||
37780934|NCT02536404|69351686|FG001|Overall Study|Physician Decision|0|||
37780935|NCT02536404|69351685|FG000|Overall Study|Sponsor decision|1|||
37780936|NCT02536404|69351686|FG001|Overall Study|Sponsor decision|0|||
37780937|NCT01659996|69352646|FG000|Overall Study|Protocol Violation|3|||
37780938|NCT01659996|69352647|FG001|Overall Study|Protocol Violation|3|||
37780939|NCT01659996|69352648|FG002|Overall Study|Protocol Violation|3|||
37780940|NCT01659996|69352646|FG000|Overall Study|Lost to Follow-up|1|||
37780941|NCT01659996|69352647|FG001|Overall Study|Lost to Follow-up|3|||
37780942|NCT01659996|69352648|FG002|Overall Study|Lost to Follow-up|2|||
37780943|NCT01659996|69352646|FG000|Overall Study|Adverse Event|0|||
37780944|NCT01659996|69352647|FG001|Overall Study|Adverse Event|0|||
37780945|NCT01659996|69352648|FG002|Overall Study|Adverse Event|1|||
37780946|NCT01659996|69352646|FG000|Overall Study|Withdrawal by Subject|4|||
37780947|NCT01659996|69352647|FG001|Overall Study|Withdrawal by Subject|1|||
37780948|NCT01659996|69352648|FG002|Overall Study|Withdrawal by Subject|5|||
37780949|NCT02525874|69353007|FG000|Overall Study|Other|1|||
37780950|NCT02525874|69353007|FG000|Overall Study|Investigator Decision|1|||
37780951|NCT02525874|69353007|FG000|Overall Study|Consent withdrawn|22|||
37780952|NCT02525874|69353007|FG000|Overall Study|Non-compliance with study drug|3|||
37780953|NCT02525874|69353007|FG000|Overall Study|Adverse Event|17|||
37780954|NCT02525874|69353007|FG000|Overall Study|Lost to Follow-up|7|||
37780955|NCT02525874|69353007|FG000|Overall Study|Disease progression, defined by protocol|2|||
37780956|NCT02525874|69353007|FG000|Overall Study|Disease relapse|4|||
37780957|NCT02525874|69353007|FG000|Overall Study|Alternative Treatment for MS|2|||
37780958|NCT02525874|69353007|FG000|Overall Study|New lesions in Brain|1|||
37780959|NCT02528214|69353017|FG000|Overall Study|Protocol Violation|0|||
37780960|NCT02528214|69353018|FG001|Overall Study|Protocol Violation|1|||
37780961|NCT02528214|69353017|FG000|Overall Study|Adverse Event|0|||
37780962|NCT02528214|69353018|FG001|Overall Study|Adverse Event|1|||
37780963|NCT02528214|69353017|FG000|Overall Study|Other than specified above|0|||
37780964|NCT02528214|69353018|FG001|Overall Study|Other than specified above|1|||
37780965|NCT05348681|69353062|FG000|Overall Study|Study terminated by Sponsor|8|||
37780966|NCT05348681|69353063|FG001|Overall Study|Study terminated by Sponsor|3|||
37780967|NCT05348681|69353062|FG000|Overall Study|Withdrawal by Subject|1|||
37780968|NCT05348681|69353063|FG001|Overall Study|Withdrawal by Subject|1|||
37780969|NCT05348681|69353062|FG000|Overall Study|Lost to Follow-up|1|||
37780970|NCT05348681|69353063|FG001|Overall Study|Lost to Follow-up|1|||
37972693|NCT00343252|69659969|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
37692302|NCT02325739|69168591|FG000|Phase I Part|Death|0|||
37692303|NCT02325739|69168592|FG001|Phase I Part|Death|0|||
37692304|NCT02325739|69168593|FG002|Phase I Part|Death|0|||
37692305|NCT02325739|69168594|FG003|Phase I Part|Death|0|||
37692306|NCT02325739|69168595|FG004|Phase I Part|Death|2|||
37692307|NCT02325739|69168596|FG005|Phase I Part|Death|0|||
37692308|NCT02325739|69168597|FG006|Phase I Part|Death|0|||
37692309|NCT02325739|69168598|FG007|Phase I Part|Death|0|||
37692310|NCT02325739|69168599|FG008|Phase I Part|Death|0|||
37692311|NCT02325739|69168600|FG009|Phase I Part|Death|0|||
37692312|NCT02325739|69168601|FG010|Phase I Part|Death|0|||
37692313|NCT02325739|69168591|FG000|Phase II Part|Adverse Event|0|||
37692314|NCT02325739|69168592|FG001|Phase II Part|Adverse Event|0|||
37692315|NCT02325739|69168593|FG002|Phase II Part|Adverse Event|0|||
37692316|NCT02325739|69168594|FG003|Phase II Part|Adverse Event|0|||
37780971|NCT05348681|69353062|FG000|Overall Study|Adverse Event|1|||
37780972|NCT05348681|69353063|FG001|Overall Study|Adverse Event|0|||
37692317|NCT02325739|69168595|FG004|Phase II Part|Adverse Event|0|||
37692318|NCT02325739|69168596|FG005|Phase II Part|Adverse Event|0|||
37692319|NCT02325739|69168597|FG006|Phase II Part|Adverse Event|0|||
37692320|NCT02325739|69168598|FG007|Phase II Part|Adverse Event|0|||
37780973|NCT05348681|69353062|FG000|Overall Study|Other|2|||
37780974|NCT05348681|69353063|FG001|Overall Study|Other|1|||
37780975|NCT04423757|69353089|FG000|Overall Study|Adverse Event|2|||
37780976|NCT04423757|69353090|FG001|Overall Study|Adverse Event|0|||
37863979|NCT00994162|69547571|FG000|Overall Study|Surrounding Wound Erythematous|1|||
37780977|NCT04423757|69353089|FG000|Overall Study|Not treated|1|||
37780978|NCT04423757|69353090|FG001|Overall Study|Not treated|1|||
37780979|NCT04379713|69353098|FG000|Overall Study|Adverse Event|2|||
37692321|NCT02325739|69168599|FG008|Phase II Part|Adverse Event|4|||
37692322|NCT02325739|69168600|FG009|Phase II Part|Adverse Event|5|||
37780980|NCT04379713|69353099|FG001|Overall Study|Adverse Event|0|||
37692323|NCT02325739|69168601|FG010|Phase II Part|Adverse Event|1|||
37692324|NCT02325739|69168591|FG000|Phase II Part|Physician Decision|0|||
37692325|NCT02325739|69168592|FG001|Phase II Part|Physician Decision|0|||
37692326|NCT02325739|69168593|FG002|Phase II Part|Physician Decision|0|||
37692327|NCT02325739|69168594|FG003|Phase II Part|Physician Decision|0|||
37692328|NCT02325739|69168595|FG004|Phase II Part|Physician Decision|0|||
37972694|NCT00343252|69659970|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
37972695|NCT00343252|69659969|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
37972696|NCT00343252|69659970|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
37972697|NCT00343252|69659969|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
37972698|NCT00343252|69659970|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
37972699|NCT00343252|69659969|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
37972700|NCT00343252|69659970|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
37972701|NCT00343252|69659969|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
37972702|NCT00343252|69659970|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
37972703|NCT00343252|69659969|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
37972704|NCT00343252|69659970|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
37972705|NCT00342628|69659979|FG000|Overall Study|Withdrawal by Subject|19|||
37972706|NCT00342628|69659980|FG001|Overall Study|Withdrawal by Subject|19|||
37972707|NCT00342628|69659981|FG002|Overall Study|Withdrawal by Subject|18|||
37972708|NCT00342628|69659979|FG000|Overall Study|Death|1|||
37972709|NCT00342628|69659980|FG001|Overall Study|Death|1|||
37972710|NCT00342628|69659981|FG002|Overall Study|Death|0|||
37972711|NCT00342628|69659979|FG000|Overall Study|moved residence|0|||
37972712|NCT00342628|69659980|FG001|Overall Study|moved residence|1|||
37972713|NCT00342628|69659981|FG002|Overall Study|moved residence|1|||
37972714|NCT00505284|69659994|FG000|Overall Study|Adverse Event|3|||
37972715|NCT00505284|69659995|FG001|Overall Study|Adverse Event|7|||
37972716|NCT00505284|69659996|FG002|Overall Study|Adverse Event|9|||
37972717|NCT00505284|69659997|FG003|Overall Study|Adverse Event|14|||
37972718|NCT00505284|69659998|FG004|Overall Study|Adverse Event|22|||
37972719|NCT00505284|69659994|FG000|Overall Study|Protocol Violation|0|||
37972720|NCT00505284|69659995|FG001|Overall Study|Protocol Violation|1|||
37972721|NCT00505284|69659996|FG002|Overall Study|Protocol Violation|1|||
37972722|NCT00505284|69659997|FG003|Overall Study|Protocol Violation|0|||
37972723|NCT00505284|69659998|FG004|Overall Study|Protocol Violation|0|||
37972724|NCT00505284|69659994|FG000|Overall Study|Withdrawal by Subject|2|||
37972725|NCT00505284|69659995|FG001|Overall Study|Withdrawal by Subject|6|||
37972726|NCT00505284|69659996|FG002|Overall Study|Withdrawal by Subject|1|||
37972727|NCT00505284|69659997|FG003|Overall Study|Withdrawal by Subject|0|||
37972728|NCT00505284|69659998|FG004|Overall Study|Withdrawal by Subject|6|||
37972729|NCT00505284|69659994|FG000|Overall Study|Lack of Efficacy|0|||
37972730|NCT00505284|69659995|FG001|Overall Study|Lack of Efficacy|1|||
37972731|NCT00505284|69659996|FG002|Overall Study|Lack of Efficacy|1|||
37972732|NCT00505284|69659997|FG003|Overall Study|Lack of Efficacy|1|||
37972733|NCT00505284|69659998|FG004|Overall Study|Lack of Efficacy|1|||
37972734|NCT00505284|69659994|FG000|Overall Study|Physician Decision|0|||
37972735|NCT00505284|69659995|FG001|Overall Study|Physician Decision|1|||
37972736|NCT00505284|69659996|FG002|Overall Study|Physician Decision|0|||
37972737|NCT00505284|69659997|FG003|Overall Study|Physician Decision|0|||
37972738|NCT00505284|69659998|FG004|Overall Study|Physician Decision|0|||
37972739|NCT00505284|69659994|FG000|Overall Study|Other|5|||
37972740|NCT00505284|69659995|FG001|Overall Study|Other|0|||
37972741|NCT00505284|69659996|FG002|Overall Study|Other|0|||
37972742|NCT00505284|69659997|FG003|Overall Study|Other|4|||
37972743|NCT00505284|69659998|FG004|Overall Study|Other|4|||
37972744|NCT00337168|69660010|FG000|Overall Study|Death|5|||
37972745|NCT00337168|69660010|FG000|Overall Study|Not protocol specified|2|||
37972746|NCT00337168|69660010|FG000|Overall Study|Did not start therapy|1|||
37972747|NCT00606905|69660017|FG000|Overall Study|No Pregnancy|9|||
37972748|NCT00606905|69660018|FG001|Overall Study|No Pregnancy|6|||
37972749|NCT00606905|69660017|FG000|Overall Study|Non-Index Pregnancy|1|||
37972750|NCT00606905|69660018|FG001|Overall Study|Non-Index Pregnancy|4|||
37972751|NCT00606905|69660017|FG000|Overall Study|Withdrew|5|||
37972752|NCT00606905|69660018|FG001|Overall Study|Withdrew|5|||
37972753|NCT00606593|69660024|FG000|Overall Study|Adverse Event|0|||
37972754|NCT00606593|69660025|FG001|Overall Study|Adverse Event|0|||
37972755|NCT00606593|69660026|FG002|Overall Study|Adverse Event|0|||
37972756|NCT00606593|69660027|FG003|Overall Study|Adverse Event|1|||
37972757|NCT00606593|69660028|FG004|Overall Study|Adverse Event|1|||
37972758|NCT00606593|69660029|FG005|Overall Study|Adverse Event|0|||
37780981|NCT04379713|69353098|FG000|Overall Study|Physician Decision|2|||
37972759|NCT00606593|69660030|FG006|Overall Study|Adverse Event|1|||
37972760|NCT00606593|69660031|FG007|Overall Study|Adverse Event|2|||
37972761|NCT00606593|69660032|FG008|Overall Study|Adverse Event|1|||
37972762|NCT00606593|69660033|FG009|Overall Study|Adverse Event|0|||
37780982|NCT04379713|69353099|FG001|Overall Study|Physician Decision|1|||
37972763|NCT00606593|69660024|FG000|Overall Study|Withdrawal of consent|1|||
37972764|NCT00606593|69660025|FG001|Overall Study|Withdrawal of consent|0|||
37972765|NCT00606593|69660026|FG002|Overall Study|Withdrawal of consent|1|||
37972766|NCT00606593|69660027|FG003|Overall Study|Withdrawal of consent|0|||
37972767|NCT00606593|69660028|FG004|Overall Study|Withdrawal of consent|0|||
37972768|NCT00606593|69660029|FG005|Overall Study|Withdrawal of consent|0|||
37972769|NCT00606593|69660030|FG006|Overall Study|Withdrawal of consent|0|||
37972770|NCT00606593|69660031|FG007|Overall Study|Withdrawal of consent|0|||
37972771|NCT00606593|69660032|FG008|Overall Study|Withdrawal of consent|0|||
37972772|NCT00606593|69660033|FG009|Overall Study|Withdrawal of consent|0|||
37972773|NCT00606593|69660024|FG000|Overall Study|Administrative/Other|0|||
37972774|NCT00606593|69660025|FG001|Overall Study|Administrative/Other|0|||
37972775|NCT00606593|69660026|FG002|Overall Study|Administrative/Other|1|||
37972776|NCT00606593|69660027|FG003|Overall Study|Administrative/Other|0|||
37972777|NCT00606593|69660028|FG004|Overall Study|Administrative/Other|0|||
37972778|NCT00606593|69660029|FG005|Overall Study|Administrative/Other|0|||
37972779|NCT00606593|69660030|FG006|Overall Study|Administrative/Other|0|||
37972780|NCT00606593|69660031|FG007|Overall Study|Administrative/Other|0|||
37972781|NCT00606593|69660032|FG008|Overall Study|Administrative/Other|0|||
37972782|NCT00606593|69660033|FG009|Overall Study|Administrative/Other|0|||
37972783|NCT00605267|69660048|FG000|Overall Study|Adverse Event|0|||
37972784|NCT00605267|69660049|FG001|Overall Study|Adverse Event|1|||
37972785|NCT00605267|69660048|FG000|Overall Study|Lack of Efficacy|1|||
37972786|NCT00605267|69660049|FG001|Overall Study|Lack of Efficacy|5|||
37972787|NCT00605267|69660048|FG000|Overall Study|Withdrawal by Subject|2|||
37972788|NCT00605267|69660049|FG001|Overall Study|Withdrawal by Subject|3|||
37972789|NCT00605813|69660055|FG000|Overall Study|Protocol Violation|25|||
37972790|NCT00604721|69660068|FG000|Overall Study|Physician Decision|1|||
37972791|NCT00604721|69660068|FG000|Overall Study|Withdrawal by Subject|1|||
37972792|NCT00605657|69660073|FG000|Overall Study|Adverse Event|1|||
37972793|NCT00605657|69660073|FG000|Overall Study|Protocol Violation|1|||
37972794|NCT00604565|69660079|FG000|Overall Study|Study terminated|0|||
37972795|NCT00604565|69660080|FG001|Overall Study|Study terminated|3|||
37972796|NCT00605345|69660088|FG000|Overall Study|Withdrawal by Subject|1|||
37972797|NCT00605345|69660089|FG001|Overall Study|Withdrawal by Subject|0|||
37972798|NCT00605345|69660088|FG000|Overall Study|Adverse Event|0|||
37972799|NCT00605345|69660089|FG001|Overall Study|Adverse Event|1|||
37972800|NCT00605345|69660088|FG000|Overall Study|Protocol Violation|0|||
37972801|NCT00605345|69660089|FG001|Overall Study|Protocol Violation|2|||
37972802|NCT00604175|69660098|FG000|Entry Through Week 28|Death|2|||
37972803|NCT00604175|69660099|FG001|Entry Through Week 28|Death|0|||
37972804|NCT00604175|69660100|FG002|Entry Through Week 28|Death|0|||
37972805|NCT00604175|69660098|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
37972806|NCT00604175|69660099|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
37972807|NCT00604175|69660100|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
37972808|NCT00604175|69660098|FG000|Entry Through Week 28|Lost to Follow-up|4|||
37972809|NCT00604175|69660099|FG001|Entry Through Week 28|Lost to Follow-up|3|||
37972810|NCT00604175|69660100|FG002|Entry Through Week 28|Lost to Follow-up|0|||
37972811|NCT00604175|69660098|FG000|Entry Through Week 28|Ineligible|1|||
37972812|NCT00604175|69660099|FG001|Entry Through Week 28|Ineligible|0|||
37972813|NCT00604175|69660100|FG002|Entry Through Week 28|Ineligible|0|||
37972814|NCT00604175|69660098|FG000|Entry Through Week 28|Did not start intervention|2|||
37972815|NCT00604175|69660099|FG001|Entry Through Week 28|Did not start intervention|0|||
37972816|NCT00604175|69660100|FG002|Entry Through Week 28|Did not start intervention|1|||
37972817|NCT00604175|69660098|FG000|Week 29 Through Week 72|Death|0|||
37972818|NCT00604175|69660099|FG001|Week 29 Through Week 72|Death|0|||
37972819|NCT00604175|69660100|FG002|Week 29 Through Week 72|Death|1|||
37972820|NCT00604175|69660098|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
37972821|NCT00604175|69660099|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
37972822|NCT00604175|69660100|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
37972823|NCT00604175|69660098|FG000|Week 29 Through Week 72|Site closure|0|||
37972824|NCT00604175|69660099|FG001|Week 29 Through Week 72|Site closure|1|||
37972825|NCT00604175|69660100|FG002|Week 29 Through Week 72|Site closure|0|||
37972826|NCT00604175|69660098|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
37972827|NCT00604175|69660099|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
37972828|NCT00604175|69660100|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
37972829|NCT00605189|69660135|FG000|Overall Study|Adverse Event|1|||
37972830|NCT00605189|69660136|FG001|Overall Study|Adverse Event|0|||
37972831|NCT00605189|69660137|FG002|Overall Study|Adverse Event|0|||
37972832|NCT00605189|69660135|FG000|Overall Study|Other|2|||
37972833|NCT00605189|69660136|FG001|Overall Study|Other|2|||
37972834|NCT00605189|69660137|FG002|Overall Study|Other|0|||
37972835|NCT00340834|69660150|FG000|Core Phase of Study|Adverse Event|26|||
37972836|NCT00340834|69660151|FG001|Core Phase of Study|Adverse Event|9|||
37972837|NCT00340834|69660152|FG002|Core Phase of Study|Adverse Event|9|||
37972838|NCT00340834|69660153|FG003|Core Phase of Study|Adverse Event|0|||
37972839|NCT00340834|69660154|FG004|Core Phase of Study|Adverse Event|0|||
37972840|NCT00340834|69660150|FG000|Core Phase of Study|Withdrawal by Subject|11|||
37972841|NCT00340834|69660151|FG001|Core Phase of Study|Withdrawal by Subject|9|||
37972842|NCT00340834|69660152|FG002|Core Phase of Study|Withdrawal by Subject|16|||
37972843|NCT00340834|69660153|FG003|Core Phase of Study|Withdrawal by Subject|0|||
37972844|NCT00340834|69660154|FG004|Core Phase of Study|Withdrawal by Subject|0|||
37972845|NCT00340834|69660150|FG000|Core Phase of Study|Administrative Problems|6|||
37972846|NCT00340834|69660151|FG001|Core Phase of Study|Administrative Problems|2|||
37972847|NCT00340834|69660152|FG002|Core Phase of Study|Administrative Problems|7|||
37972848|NCT00340834|69660153|FG003|Core Phase of Study|Administrative Problems|0|||
37972849|NCT00340834|69660154|FG004|Core Phase of Study|Administrative Problems|0|||
37972850|NCT00340834|69660150|FG000|Core Phase of Study|Lack of Efficacy|3|||
37972851|NCT00340834|69660151|FG001|Core Phase of Study|Lack of Efficacy|3|||
37972852|NCT00340834|69660152|FG002|Core Phase of Study|Lack of Efficacy|7|||
37972853|NCT00340834|69660153|FG003|Core Phase of Study|Lack of Efficacy|0|||
37972854|NCT00340834|69660154|FG004|Core Phase of Study|Lack of Efficacy|0|||
37972855|NCT00340834|69660150|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
37972856|NCT00340834|69660151|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
37972857|NCT00340834|69660152|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
37972858|NCT00340834|69660153|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
37972859|NCT00340834|69660154|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
37972860|NCT00340834|69660150|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
37972861|NCT00340834|69660151|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
37972862|NCT00340834|69660152|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
37972863|NCT00340834|69660153|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
37972864|NCT00340834|69660154|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
37972865|NCT00340834|69660150|FG000|Core Phase of Study|Lost to Follow-up|1|||
37972866|NCT00340834|69660151|FG001|Core Phase of Study|Lost to Follow-up|1|||
37972867|NCT00340834|69660152|FG002|Core Phase of Study|Lost to Follow-up|4|||
37972868|NCT00340834|69660153|FG003|Core Phase of Study|Lost to Follow-up|0|||
37972869|NCT00340834|69660154|FG004|Core Phase of Study|Lost to Follow-up|0|||
37972870|NCT00340834|69660150|FG000|Core Phase of Study|Death|2|||
37972871|NCT00340834|69660151|FG001|Core Phase of Study|Death|0|||
37972872|NCT00340834|69660152|FG002|Core Phase of Study|Death|0|||
37972873|NCT00340834|69660153|FG003|Core Phase of Study|Death|0|||
37972874|NCT00340834|69660154|FG004|Core Phase of Study|Death|0|||
37972875|NCT00340834|69660150|FG000|Core Phase of Study|Protocol Violation|0|||
37972876|NCT00340834|69660151|FG001|Core Phase of Study|Protocol Violation|0|||
37972877|NCT00340834|69660152|FG002|Core Phase of Study|Protocol Violation|2|||
37972878|NCT00340834|69660153|FG003|Core Phase of Study|Protocol Violation|0|||
37972879|NCT00340834|69660154|FG004|Core Phase of Study|Protocol Violation|0|||
37972880|NCT00340834|69660150|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
37972881|NCT00340834|69660151|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
37972882|NCT00340834|69660152|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
37972883|NCT00340834|69660153|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
37972884|NCT00340834|69660154|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
37972885|NCT00340834|69660150|FG000|Extension Phase of Study|Subject withdrew consent|26|||
37972886|NCT00340834|69660151|FG001|Extension Phase of Study|Subject withdrew consent|31|||
37972887|NCT00340834|69660152|FG002|Extension Phase of Study|Subject withdrew consent|0|||
37972888|NCT00340834|69660153|FG003|Extension Phase of Study|Subject withdrew consent|12|||
37972889|NCT00340834|69660154|FG004|Extension Phase of Study|Subject withdrew consent|15|||
37972890|NCT00340834|69660150|FG000|Extension Phase of Study|Adverse Event|21|||
37972891|NCT00340834|69660151|FG001|Extension Phase of Study|Adverse Event|22|||
37780983|NCT04379713|69353098|FG000|Overall Study|Protocol Violation|11|||
37972892|NCT00340834|69660152|FG002|Extension Phase of Study|Adverse Event|0|||
37972893|NCT00340834|69660153|FG003|Extension Phase of Study|Adverse Event|19|||
37972894|NCT00340834|69660154|FG004|Extension Phase of Study|Adverse Event|7|||
37972895|NCT00340834|69660150|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
37972896|NCT00340834|69660151|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
37972897|NCT00340834|69660152|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
37972898|NCT00340834|69660153|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
37972899|NCT00340834|69660154|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
37972900|NCT00340834|69660150|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
37972901|NCT00340834|69660151|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
37972902|NCT00340834|69660152|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
37972903|NCT00340834|69660153|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
37972904|NCT00340834|69660154|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
37972905|NCT00340834|69660150|FG000|Extension Phase of Study|Lost to Follow-up|1|||
37972906|NCT00340834|69660151|FG001|Extension Phase of Study|Lost to Follow-up|1|||
37972907|NCT00340834|69660152|FG002|Extension Phase of Study|Lost to Follow-up|0|||
37972908|NCT00340834|69660153|FG003|Extension Phase of Study|Lost to Follow-up|2|||
37972909|NCT00340834|69660154|FG004|Extension Phase of Study|Lost to Follow-up|3|||
37972910|NCT00340834|69660150|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
37972911|NCT00340834|69660151|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
37972912|NCT00340834|69660152|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
37972913|NCT00340834|69660153|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
37972914|NCT00340834|69660154|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
37972915|NCT00340834|69660150|FG000|Extension Phase of Study|Administrative problems|3|||
37972916|NCT00340834|69660151|FG001|Extension Phase of Study|Administrative problems|0|||
37972917|NCT00340834|69660152|FG002|Extension Phase of Study|Administrative problems|0|||
37972918|NCT00340834|69660153|FG003|Extension Phase of Study|Administrative problems|1|||
37972919|NCT00340834|69660154|FG004|Extension Phase of Study|Administrative problems|1|||
37972920|NCT00340834|69660150|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
37972921|NCT00340834|69660151|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
37972922|NCT00340834|69660152|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
37972923|NCT00340834|69660153|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
37972924|NCT00340834|69660154|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
37972925|NCT00340834|69660150|FG000|Extension Phase of Study|Protocol Violation|3|||
37972926|NCT00340834|69660151|FG001|Extension Phase of Study|Protocol Violation|0|||
37972927|NCT00340834|69660152|FG002|Extension Phase of Study|Protocol Violation|0|||
37972928|NCT00340834|69660153|FG003|Extension Phase of Study|Protocol Violation|0|||
37972929|NCT00340834|69660154|FG004|Extension Phase of Study|Protocol Violation|0|||
37972930|NCT00340834|69660150|FG000|Extension Phase of Study|Death|0|||
37972931|NCT00340834|69660151|FG001|Extension Phase of Study|Death|0|||
37972932|NCT00340834|69660152|FG002|Extension Phase of Study|Death|0|||
37972933|NCT00340834|69660153|FG003|Extension Phase of Study|Death|0|||
37972934|NCT00340834|69660154|FG004|Extension Phase of Study|Death|1|||
37780984|NCT04379713|69353099|FG001|Overall Study|Protocol Violation|6|||
37780985|NCT04379713|69353098|FG000|Overall Study|No longer met eligibility criteria|14|||
37780986|NCT04379713|69353099|FG001|Overall Study|No longer met eligibility criteria|11|||
37780987|NCT04379713|69353098|FG000|Overall Study|Withdrawal by parent/guardian|36|||
37780988|NCT04379713|69353099|FG001|Overall Study|Withdrawal by parent/guardian|15|||
37780989|NCT04379713|69353098|FG000|Overall Study|Lost to Follow-up|31|||
37780990|NCT04379713|69353099|FG001|Overall Study|Lost to Follow-up|21|||
37780991|NCT04085328|69353107|FG000|Overall Study|Witihdrew Consent|16|||
37780992|NCT04085328|69353108|FG001|Overall Study|Witihdrew Consent|16|||
37780993|NCT04085328|69353107|FG000|Overall Study|Adverse Event|8|||
37780994|NCT04085328|69353108|FG001|Overall Study|Adverse Event|7|||
37780995|NCT04085328|69353107|FG000|Overall Study|Lost to Follow-up|7|||
37780996|NCT04085328|69353108|FG001|Overall Study|Lost to Follow-up|2|||
37780997|NCT04085328|69353107|FG000|Overall Study|Physician Decision|0|||
37780998|NCT04085328|69353108|FG001|Overall Study|Physician Decision|1|||
37780999|NCT04085328|69353107|FG000|Overall Study|Pregnancy|0|||
37781000|NCT04085328|69353108|FG001|Overall Study|Pregnancy|1|||
37781001|NCT04085328|69353107|FG000|Overall Study|Reasons Related to COVID-19|5|||
37781002|NCT04085328|69353108|FG001|Overall Study|Reasons Related to COVID-19|8|||
37781003|NCT04085328|69353107|FG000|Overall Study|Did not meet inclusion criteria|1|||
37781004|NCT04085328|69353108|FG001|Overall Study|Did not meet inclusion criteria|1|||
37781005|NCT04085328|69353107|FG000|Overall Study|Early termination|1|||
37781006|NCT04085328|69353108|FG001|Overall Study|Early termination|0|||
37781007|NCT03789110|69353121|FG000|Overall Study|Adverse Event|2|||
37781008|NCT03789110|69353121|FG000|Overall Study|Physician Decision|1|||
37781009|NCT03789110|69353121|FG000|Overall Study|Withdrawal by Subject|2|||
37972935|NCT00603941|69660167|FG000|Overall Study|Disease progression|6|||
37972936|NCT00603941|69660168|FG001|Overall Study|Disease progression|7|||
37972937|NCT00603941|69660169|FG002|Overall Study|Disease progression|1|||
37781010|NCT03789110|69353121|FG000|Overall Study|Lack of Efficacy|22|||
37781011|NCT03789110|69353121|FG000|Overall Study|still on treatment|3|||
37781012|NCT03074474|69353143|FG000|Overall Study|Lost to Follow-up|10|||
37781013|NCT03074474|69353143|FG000|Overall Study|Withdrawal by Subject|10|||
37972938|NCT00603941|69660167|FG000|Overall Study|Adverse Event|1|||
37972939|NCT00603941|69660168|FG001|Overall Study|Adverse Event|0|||
37972940|NCT00603941|69660169|FG002|Overall Study|Adverse Event|1|||
37972941|NCT00603941|69660167|FG000|Overall Study|Physician Decision|0|||
37972942|NCT00603941|69660168|FG001|Overall Study|Physician Decision|1|||
37972943|NCT00603941|69660169|FG002|Overall Study|Physician Decision|0|||
37972944|NCT00603941|69660167|FG000|Overall Study|Withdrawal by Subject|0|||
37972945|NCT00603941|69660168|FG001|Overall Study|Withdrawal by Subject|2|||
37972946|NCT00603941|69660169|FG002|Overall Study|Withdrawal by Subject|0|||
37972947|NCT00340678|69660182|FG000|Overall Study|Lost to Follow-up|1|||
37972948|NCT00340678|69660183|FG001|Overall Study|Lost to Follow-up|0|||
37972949|NCT00340678|69660184|FG002|Overall Study|Lost to Follow-up|0|||
37972950|NCT00340678|69660185|FG003|Overall Study|Lost to Follow-up|0|||
37972951|NCT00336544|69660195|FG000|Overall Study|Lack of Efficacy|8|||
37972952|NCT00336544|69660196|FG001|Overall Study|Lack of Efficacy|5|||
37972953|NCT00336544|69660195|FG000|Overall Study|Adverse Event|4|||
37972954|NCT00336544|69660196|FG001|Overall Study|Adverse Event|9|||
37972955|NCT00336544|69660195|FG000|Overall Study|Withdrawal by Subject|4|||
37972956|NCT00336544|69660196|FG001|Overall Study|Withdrawal by Subject|3|||
37972957|NCT00336544|69660195|FG000|Overall Study|Other|3|||
37972958|NCT00336544|69660196|FG001|Overall Study|Other|5|||
37972959|NCT00605033|69660204|FG000|Overall Study|Adverse Event|2|||
37972960|NCT00605033|69660205|FG001|Overall Study|Adverse Event|2|||
37972961|NCT00605033|69660204|FG000|Overall Study|Lost to Follow-up|1|||
37972962|NCT00605033|69660205|FG001|Overall Study|Lost to Follow-up|1|||
37972963|NCT00605033|69660204|FG000|Overall Study|Withdrawal by Subject|3|||
37972964|NCT00605033|69660205|FG001|Overall Study|Withdrawal by Subject|4|||
37972965|NCT00605033|69660204|FG000|Overall Study|Protocol Violation|1|||
37972966|NCT00605033|69660205|FG001|Overall Study|Protocol Violation|1|||
37972967|NCT00339040|69660213|FG000|Stage I|Not able to attend clinic|1|||
37972968|NCT00339040|69660214|FG001|Stage I|Not able to attend clinic|0|||
37972969|NCT00339040|69660213|FG000|Stage I|Protocol Violation|1|||
37972970|NCT00339040|69660214|FG001|Stage I|Protocol Violation|1|||
37972971|NCT00339040|69660213|FG000|Stage II|Lost to Follow-up|3|||
37972972|NCT00339040|69660214|FG001|Stage II|Lost to Follow-up|0|||
37972973|NCT00339040|69660213|FG000|Stage II|Withdrawal by Subject|1|||
37972974|NCT00339040|69660214|FG001|Stage II|Withdrawal by Subject|2|||
37972975|NCT00339040|69660213|FG000|Stage II|Protocol Violation|3|||
37972976|NCT00339040|69660214|FG001|Stage II|Protocol Violation|0|||
37972977|NCT00339040|69660213|FG000|Stage II|Not able to attend clinic|1|||
37972978|NCT00339040|69660214|FG001|Stage II|Not able to attend clinic|0|||
37972979|NCT00339040|69660213|FG000|Stage II|Site closing|2|||
37972980|NCT00339040|69660214|FG001|Stage II|Site closing|0|||
37972981|NCT00338962|69660224|FG000|Overall Study|Lost to Follow-up|3|||
37972982|NCT00338962|69660225|FG001|Overall Study|Lost to Follow-up|3|||
37972983|NCT00338962|69660226|FG002|Overall Study|Lost to Follow-up|2|||
37972984|NCT00338962|69660227|FG003|Overall Study|Lost to Follow-up|3|||
37972985|NCT00338962|69660224|FG000|Overall Study|Withdrawal by Subject|1|||
37972986|NCT00338962|69660225|FG001|Overall Study|Withdrawal by Subject|0|||
37972987|NCT00338962|69660226|FG002|Overall Study|Withdrawal by Subject|0|||
37972988|NCT00338962|69660227|FG003|Overall Study|Withdrawal by Subject|0|||
37972989|NCT00338962|69660224|FG000|Overall Study|No Transportation|2|||
37972990|NCT00338962|69660225|FG001|Overall Study|No Transportation|0|||
37972991|NCT00338962|69660226|FG002|Overall Study|No Transportation|0|||
37972992|NCT00338962|69660227|FG003|Overall Study|No Transportation|0|||
37972993|NCT00338962|69660224|FG000|Overall Study|Time Constraint|2|||
37972994|NCT00338962|69660225|FG001|Overall Study|Time Constraint|0|||
37972995|NCT00338962|69660226|FG002|Overall Study|Time Constraint|0|||
37972996|NCT00338962|69660227|FG003|Overall Study|Time Constraint|0|||
37972997|NCT00338962|69660224|FG000|Overall Study|Moved|0|||
37972998|NCT00338962|69660225|FG001|Overall Study|Moved|1|||
37972999|NCT00338962|69660226|FG002|Overall Study|Moved|0|||
37973000|NCT00338962|69660227|FG003|Overall Study|Moved|0|||
37863980|NCT00994162|69547571|FG000|Overall Study|Machine Losing Vaccum|1|||
37973001|NCT00338962|69660224|FG000|Overall Study|Adverse Event|0|||
37973002|NCT00338962|69660225|FG001|Overall Study|Adverse Event|0|||
37973003|NCT00338962|69660226|FG002|Overall Study|Adverse Event|2|||
37973004|NCT00338962|69660227|FG003|Overall Study|Adverse Event|0|||
37973005|NCT00338962|69660224|FG000|Overall Study|Poor Compliance|0|||
37973006|NCT00338962|69660225|FG001|Overall Study|Poor Compliance|0|||
37973007|NCT00338962|69660226|FG002|Overall Study|Poor Compliance|2|||
37973008|NCT00338962|69660227|FG003|Overall Study|Poor Compliance|0|||
37973009|NCT00568061|69660239|FG000|Overall Study|Inclusion / exclusion criteria|5|||
37973010|NCT00568061|69660240|FG001|Overall Study|Inclusion / exclusion criteria|1|||
37973011|NCT00568061|69660239|FG000|Overall Study|Adverse Event|0|||
37973012|NCT00568061|69660240|FG001|Overall Study|Adverse Event|1|||
37973013|NCT00338884|69660247|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
37973014|NCT00338884|69660247|FG000|Overall Study|Adverse Event|14|||
37973015|NCT00338884|69660247|FG000|Overall Study|Death|8|||
37973016|NCT00338884|69660247|FG000|Overall Study|Other|4|||
37973017|NCT00338884|69660247|FG000|Overall Study|Global Deterioration of Health Status|3|||
37973018|NCT00338884|69660247|FG000|Overall Study|Withdrawal by Subject|3|||
37973019|NCT00338884|69660247|FG000|Overall Study|Lost to Follow-up|1|||
37973020|NCT00338884|69660247|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
37973021|NCT00338806|69660253|FG000|Acute Phase|Withdrawal by Subject|0|||
37973022|NCT00338806|69660254|FG001|Acute Phase|Withdrawal by Subject|1|||
37973023|NCT00338806|69660253|FG000|Follow-up|Lost to Follow-up|1|||
37973024|NCT00338806|69660254|FG001|Follow-up|Lost to Follow-up|3|||
37973025|NCT03038100|69660264|FG000|Overall Study|Death|289|||
37973026|NCT03038100|69660265|FG001|Overall Study|Death|272|||
37973027|NCT03038100|69660264|FG000|Overall Study|Lost to Follow-up|9|||
37973028|NCT03038100|69660265|FG001|Overall Study|Lost to Follow-up|10|||
37973029|NCT03038100|69660264|FG000|Overall Study|Protocol Deviation|1|||
37973030|NCT03038100|69660265|FG001|Overall Study|Protocol Deviation|4|||
37973031|NCT03038100|69660264|FG000|Overall Study|Withdrawal by Subject|45|||
37973032|NCT03038100|69660265|FG001|Overall Study|Withdrawal by Subject|51|||
37973033|NCT03038100|69660264|FG000|Overall Study|Study Terminated By Sponsor|305|||
37973034|NCT03038100|69660265|FG001|Overall Study|Study Terminated By Sponsor|311|||
37973035|NCT03038100|69660264|FG000|Overall Study|Physician Decision|1|||
37973036|NCT03038100|69660265|FG001|Overall Study|Physician Decision|3|||
37973037|NCT00338728|69660272|FG000|Overall Study|Screen Failure|14|||
37973038|NCT00336856|69660276|FG000|Overall Study|Withdrawal by Subject|3|||
37973039|NCT00336856|69660276|FG000|Overall Study|Found ineligible at time of analysis|1|||
37973040|NCT00566501|69660282|FG000|Overall Study|Adverse Event|68|||
37973041|NCT00566501|69660283|FG001|Overall Study|Adverse Event|59|||
37973042|NCT00566501|69660282|FG000|Overall Study|Medication Non-compliance|5|||
37973043|NCT00566501|69660283|FG001|Overall Study|Medication Non-compliance|0|||
37973044|NCT00566501|69660282|FG000|Overall Study|Protocol Violation|2|||
37973045|NCT00566501|69660283|FG001|Overall Study|Protocol Violation|2|||
37973046|NCT00566501|69660282|FG000|Overall Study|Request of Investigator or Sponsor|6|||
37973047|NCT00566501|69660283|FG001|Overall Study|Request of Investigator or Sponsor|7|||
37973048|NCT00566501|69660282|FG000|Overall Study|Withdrawal by Subject|33|||
37973049|NCT00566501|69660283|FG001|Overall Study|Withdrawal by Subject|30|||
37973050|NCT00566501|69660282|FG000|Overall Study|Lack of Efficacy|8|||
37973051|NCT00566501|69660283|FG001|Overall Study|Lack of Efficacy|3|||
37973052|NCT00566501|69660282|FG000|Overall Study|Other|25|||
37973053|NCT00566501|69660283|FG001|Overall Study|Other|21|||
37973054|NCT00504894|69660292|FG000|Overall Study|fMRI technical problems|1|||
37973055|NCT00504894|69660293|FG001|Overall Study|fMRI technical problems|1|||
37973056|NCT00504894|69660294|FG002|Overall Study|fMRI technical problems|0|||
37973057|NCT00504894|69660292|FG000|Overall Study|Withdrawal by Subject|0|||
37973058|NCT00504894|69660293|FG001|Overall Study|Withdrawal by Subject|1|||
37973059|NCT00504894|69660294|FG002|Overall Study|Withdrawal by Subject|0|||
37973060|NCT00504894|69660292|FG000|Overall Study|Infusion technical problems|0|||
37973061|NCT00504894|69660293|FG001|Overall Study|Infusion technical problems|1|||
37973062|NCT00504894|69660294|FG002|Overall Study|Infusion technical problems|0|||
37973063|NCT00504894|69660292|FG000|Overall Study|poor subject data|2|||
37973064|NCT00504894|69660293|FG001|Overall Study|poor subject data|0|||
37973065|NCT00504894|69660294|FG002|Overall Study|poor subject data|0|||
37973066|NCT00513240|69660304|FG000|Overall Study|Did not have intended surgery|3|||
37973067|NCT00513240|69660305|FG001|Overall Study|Did not have intended surgery|0|||
37973068|NCT00513240|69660304|FG000|Overall Study|Death|3|||
37973069|NCT00513240|69660305|FG001|Overall Study|Death|3|||
37973070|NCT00513240|69660304|FG000|Overall Study|Withdrawal by Subject|7|||
37973071|NCT00513240|69660305|FG001|Overall Study|Withdrawal by Subject|4|||
37973072|NCT00504426|69660318|FG000|Overall Study|Adverse Event|0|||
37973073|NCT00504426|69660319|FG001|Overall Study|Adverse Event|0|||
37973074|NCT00504426|69660320|FG002|Overall Study|Adverse Event|2|||
37973075|NCT00504426|69660321|FG003|Overall Study|Adverse Event|0|||
37973076|NCT00504426|69660318|FG000|Overall Study|Protocol Violation|1|||
37973077|NCT00504426|69660319|FG001|Overall Study|Protocol Violation|1|||
37973078|NCT00504426|69660320|FG002|Overall Study|Protocol Violation|2|||
37973079|NCT00504426|69660321|FG003|Overall Study|Protocol Violation|0|||
37973080|NCT00504426|69660318|FG000|Overall Study|Withdrawal by Subject|2|||
37973081|NCT00504426|69660319|FG001|Overall Study|Withdrawal by Subject|0|||
37973082|NCT00504426|69660320|FG002|Overall Study|Withdrawal by Subject|0|||
37973083|NCT00504426|69660321|FG003|Overall Study|Withdrawal by Subject|0|||
37973084|NCT00504348|69660334|FG000|Overall Study|Adverse Event|3|||
37973085|NCT00504348|69660334|FG000|Overall Study|Lack of Efficacy|4|||
37973086|NCT00504348|69660334|FG000|Overall Study|Physician Decision|1|||
37973087|NCT00507546|69660340|FG000|Overall Study|Withdrawal by Subject|1|||
37973088|NCT00507546|69660341|FG001|Overall Study|Withdrawal by Subject|0|||
37973089|NCT00507546|69660340|FG000|Overall Study|Protocol Violation|1|||
37973090|NCT00507546|69660341|FG001|Overall Study|Protocol Violation|0|||
37973091|NCT00507546|69660340|FG000|Overall Study|Physician Decision|0|||
37973092|NCT00507546|69660341|FG001|Overall Study|Physician Decision|1|||
37973093|NCT00567593|69660349|FG000|Overall Study|Adverse Event|1|||
37973094|NCT00567593|69660349|FG000|Overall Study|Physician Decision|1|||
37973095|NCT00335764|69660358|FG000|Overall Study|wrong histology|1|||
37973096|NCT00335764|69660359|FG001|Overall Study|wrong histology|0|||
37973097|NCT00335764|69660360|FG002|Overall Study|wrong histology|0|||
37973098|NCT00335764|69660361|FG003|Overall Study|wrong histology|0|||
37973099|NCT00335764|69660362|FG004|Overall Study|wrong histology|1|||
37973100|NCT00567359|69660398|FG000|Overall Study|Withdrawal by Subject|1|||
37973101|NCT00492726|69660404|FG000|Overall Study|Adverse Event|10|||
37973102|NCT00492726|69660405|FG001|Overall Study|Adverse Event|6|||
37973103|NCT00492726|69660404|FG000|Overall Study|Death|7|||
37973104|NCT00492726|69660405|FG001|Overall Study|Death|2|||
37973105|NCT00492726|69660404|FG000|Overall Study|Lack of Efficacy|0|||
37973106|NCT00492726|69660405|FG001|Overall Study|Lack of Efficacy|2|||
37973107|NCT00492726|69660404|FG000|Overall Study|Lost to Follow-up|27|||
37973108|NCT00492726|69660405|FG001|Overall Study|Lost to Follow-up|19|||
37973109|NCT00492726|69660404|FG000|Overall Study|Physician Decision|0|||
37973110|NCT00492726|69660405|FG001|Overall Study|Physician Decision|1|||
37973111|NCT00492726|69660404|FG000|Overall Study|Withdrawal by Subject|6|||
37973112|NCT00492726|69660405|FG001|Overall Study|Withdrawal by Subject|3|||
37973113|NCT00492726|69660404|FG000|Overall Study|Non compliant with study medication|0|||
37973114|NCT00492726|69660405|FG001|Overall Study|Non compliant with study medication|3|||
37973115|NCT00309946|69660411|FG000|Overall Study|Withdrawal by Subject|1|||
37973116|NCT00492648|69660417|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
37973117|NCT00492648|69660418|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
37973118|NCT00506922|69660429|FG000|Overall Study|Physician Decision|0|||
37973119|NCT00506922|69660430|FG001|Overall Study|Physician Decision|0|||
37973120|NCT00506922|69660431|FG002|Overall Study|Physician Decision|0|||
37973121|NCT00506922|69660432|FG003|Overall Study|Physician Decision|2|||
37973122|NCT00506922|69660433|FG004|Overall Study|Physician Decision|0|||
37973123|NCT00506922|69660429|FG000|Overall Study|Withdrawal by Subject|0|||
37973124|NCT00506922|69660430|FG001|Overall Study|Withdrawal by Subject|0|||
37973125|NCT00506922|69660431|FG002|Overall Study|Withdrawal by Subject|0|||
37973126|NCT00506922|69660432|FG003|Overall Study|Withdrawal by Subject|0|||
37973127|NCT00506922|69660433|FG004|Overall Study|Withdrawal by Subject|1|||
37973128|NCT00492024|69660443|FG000|Treatment|Adverse Event|3|||
37973129|NCT00492024|69660444|FG001|Treatment|Adverse Event|1|||
37973130|NCT00492024|69660443|FG000|Treatment|Lack of Efficacy|21|||
37973131|NCT00492024|69660444|FG001|Treatment|Lack of Efficacy|20|||
37973132|NCT00492024|69660443|FG000|Treatment|Lost to Follow-up|3|||
37973133|NCT00492024|69660444|FG001|Treatment|Lost to Follow-up|1|||
37973134|NCT00492024|69660443|FG000|Treatment|Withdrawal by Subject|2|||
37973135|NCT00492024|69660444|FG001|Treatment|Withdrawal by Subject|0|||
37973136|NCT00492024|69660443|FG000|Follow up|Lack of Efficacy|0|||
37973137|NCT00492024|69660444|FG001|Follow up|Lack of Efficacy|1|||
37973138|NCT00492024|69660443|FG000|Follow up|Lost to Follow-up|1|||
37973139|NCT00492024|69660444|FG001|Follow up|Lost to Follow-up|1|||
37973140|NCT00491556|69660452|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
37973141|NCT00491556|69660453|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
37973142|NCT00491556|69660452|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
37973143|NCT00491556|69660453|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
37973144|NCT00491556|69660452|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
37973145|NCT00491556|69660453|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
37973146|NCT00491556|69660452|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
37973147|NCT00491556|69660453|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
37973148|NCT00491556|69660452|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
37973149|NCT00491556|69660453|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
37973150|NCT00491556|69660452|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
37973151|NCT00491556|69660453|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
37973152|NCT00491556|69660452|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
37973153|NCT00491556|69660453|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
37973154|NCT00491556|69660452|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
37973155|NCT00491556|69660453|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
37973156|NCT00491556|69660452|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
37973157|NCT00491556|69660453|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
37973158|NCT00491556|69660452|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
37973159|NCT00491556|69660453|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
37973160|NCT00491556|69660452|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
37973161|NCT00491556|69660453|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
37973162|NCT00491556|69660452|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
37973163|NCT00491556|69660453|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
37973164|NCT00491556|69660452|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
37973165|NCT00491556|69660453|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
37973166|NCT00491556|69660452|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
37973167|NCT00491556|69660453|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
37973168|NCT00491556|69660452|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
37973169|NCT00491556|69660453|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
37973170|NCT00491556|69660452|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
37973171|NCT00491556|69660453|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
37973172|NCT00491556|69660452|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
37973173|NCT00491556|69660453|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
37973174|NCT00491556|69660452|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
37973175|NCT00491556|69660453|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
37973176|NCT00491556|69660452|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
37973177|NCT00491556|69660453|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
37973178|NCT00491556|69660452|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
37973179|NCT00491556|69660453|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
37973180|NCT00506454|69660461|FG000|Overall Study|Withdrawal by Subject|1|||
37973181|NCT00506454|69660462|FG001|Overall Study|Withdrawal by Subject|1|||
37973182|NCT00485472|69660470|FG000|Overall Study|Adverse Event|8|||
37973183|NCT00485472|69660471|FG001|Overall Study|Adverse Event|5|||
37973184|NCT00485472|69660470|FG000|Overall Study|Lack of Efficacy|5|||
37973185|NCT00485472|69660471|FG001|Overall Study|Lack of Efficacy|4|||
37973186|NCT00485472|69660470|FG000|Overall Study|Withdrawal by Subject|1|||
37973187|NCT00485472|69660471|FG001|Overall Study|Withdrawal by Subject|0|||
37973188|NCT00485472|69660470|FG000|Overall Study|Protocol Violation|0|||
37973189|NCT00485472|69660471|FG001|Overall Study|Protocol Violation|1|||
37973190|NCT00485472|69660470|FG000|Overall Study|Other|2|||
37973191|NCT00485472|69660471|FG001|Overall Study|Other|1|||
37973192|NCT00485472|69660470|FG000|Overall Study|Lost to Follow-up|0|||
37973193|NCT00485472|69660471|FG001|Overall Study|Lost to Follow-up|1|||
37973194|NCT00491400|69660479|FG000|Overall Study|Withdrawal by Subject|5|||
37973195|NCT00491400|69660480|FG001|Overall Study|Withdrawal by Subject|4|||
37692329|NCT02325739|69168596|FG005|Phase II Part|Physician Decision|0|||
37781014|NCT03074474|69353143|FG000|Overall Study|Death|4|||
37781015|NCT03074474|69353143|FG000|Overall Study|1 exited due to recurrence and 2 exited due to mesh removal.|3|||
37692330|NCT02325739|69168597|FG006|Phase II Part|Physician Decision|0|||
37973196|NCT00491322|69660490|FG000|Overall Study|Protocol Violation|1|||
37973197|NCT00491322|69660491|FG001|Overall Study|Protocol Violation|0|||
37973198|NCT00491322|69660490|FG000|Overall Study|Pregnancy|0|||
37973199|NCT00491322|69660491|FG001|Overall Study|Pregnancy|1|||
37973200|NCT00502320|69660499|FG000|Overall Study|Lost to Follow-up|1|||
37973201|NCT00502320|69660500|FG001|Overall Study|Lost to Follow-up|1|||
37973202|NCT00502320|69660499|FG000|Overall Study|Withdrew Consent|1|||
37973203|NCT00502320|69660500|FG001|Overall Study|Withdrew Consent|0|||
37973204|NCT00502320|69660499|FG000|Overall Study|No longer met criteria|1|||
37973205|NCT00502320|69660500|FG001|Overall Study|No longer met criteria|0|||
37973206|NCT00502320|69660499|FG000|Overall Study|Screen Failure|0|||
37973207|NCT00502320|69660500|FG001|Overall Study|Screen Failure|1|||
37973208|NCT00502320|69660499|FG000|Overall Study|Adverse Event|3|||
37973209|NCT00502320|69660500|FG001|Overall Study|Adverse Event|5|||
37973210|NCT02567825|69660508|FG000|Overall Study|No follow-up post-randomization|5|||
37973211|NCT02567825|69660509|FG001|Overall Study|No follow-up post-randomization|1|||
37973212|NCT02567825|69660508|FG000|Overall Study|Follow-up less than 23 months|16|||
37973213|NCT02567825|69660509|FG001|Overall Study|Follow-up less than 23 months|20|||
37973214|NCT00490776|69660515|FG000|Overall Study|Withdrawal by Subject|1|||
37973215|NCT00490776|69660515|FG000|Overall Study|Administrative Problems|1|||
37973216|NCT00490776|69660515|FG000|Overall Study|Death|1|||
37973217|NCT00490776|69660515|FG000|Overall Study|New Cancer Therapy|1|||
37973218|NCT00490776|69660515|FG000|Overall Study|Disease Progression|5|||
37973219|NCT00566735|69660521|FG000|Overall Study|Withdrawal by Subject|0|||
37973220|NCT00566735|69660522|FG001|Overall Study|Withdrawal by Subject|1|||
37973221|NCT00566735|69660521|FG000|Overall Study|Refused neuropsychological testing|2|||
37973222|NCT00566735|69660522|FG001|Overall Study|Refused neuropsychological testing|5|||
37973223|NCT00566735|69660521|FG000|Overall Study|Switched into a manic episode|0|||
37973224|NCT00566735|69660522|FG001|Overall Study|Switched into a manic episode|1|||
37973225|NCT00566111|69660530|FG000|Overall Study|Adverse Event|0|||
37973226|NCT00566111|69660531|FG001|Overall Study|Adverse Event|2|||
37973227|NCT00514046|69660546|FG000|Overall Study|transferred to another protocol|2|||
37973228|NCT00514046|69660547|FG001|Overall Study|transferred to another protocol|1|||
37973229|NCT00514046|69660548|FG002|Overall Study|transferred to another protocol|3|||
37973230|NCT00514046|69660549|FG003|Overall Study|transferred to another protocol|0|||
37973231|NCT00514046|69660550|FG004|Overall Study|transferred to another protocol|1|||
37973232|NCT00514046|69660551|FG005|Overall Study|transferred to another protocol|0|||
37973233|NCT00514046|69660552|FG006|Overall Study|transferred to another protocol|0|||
37973234|NCT00514046|69660553|FG007|Overall Study|transferred to another protocol|0|||
37973235|NCT00514046|69660554|FG008|Overall Study|transferred to another protocol|0|||
37973236|NCT00514046|69660546|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
37973237|NCT00514046|69660547|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
37973238|NCT00514046|69660548|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
37973239|NCT00514046|69660549|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
37973240|NCT00514046|69660550|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
37973241|NCT00514046|69660551|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
37973242|NCT00514046|69660552|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
37973243|NCT00514046|69660553|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
37692331|NCT02325739|69168598|FG007|Phase II Part|Physician Decision|0|||
37781016|NCT02744391|69353152|FG000|Overall Study|Lost to Follow-up|9|||
37781017|NCT02744391|69353152|FG000|Overall Study|Physician Decision|2|||
37692332|NCT02325739|69168599|FG008|Phase II Part|Physician Decision|0|||
37692333|NCT02325739|69168600|FG009|Phase II Part|Physician Decision|1|||
37692334|NCT02325739|69168601|FG010|Phase II Part|Physician Decision|0|||
37692335|NCT02325739|69168591|FG000|Phase II Part|Progressive disease|0|||
37692336|NCT02325739|69168592|FG001|Phase II Part|Progressive disease|0|||
37692337|NCT02325739|69168593|FG002|Phase II Part|Progressive disease|0|||
37692338|NCT02325739|69168594|FG003|Phase II Part|Progressive disease|0|||
37692339|NCT02325739|69168595|FG004|Phase II Part|Progressive disease|0|||
37692340|NCT02325739|69168596|FG005|Phase II Part|Progressive disease|0|||
37692341|NCT02325739|69168597|FG006|Phase II Part|Progressive disease|0|||
37692342|NCT02325739|69168598|FG007|Phase II Part|Progressive disease|0|||
37692343|NCT02325739|69168599|FG008|Phase II Part|Progressive disease|22|||
37781018|NCT02744391|69353152|FG000|Overall Study|Withdrawal by Subject|3|||
37973244|NCT00514046|69660554|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
37973245|NCT00514046|69660546|FG000|Overall Study|Disease progression on study|0|||
37973246|NCT00514046|69660547|FG001|Overall Study|Disease progression on study|0|||
37973247|NCT00514046|69660548|FG002|Overall Study|Disease progression on study|2|||
37692344|NCT02325739|69168600|FG009|Phase II Part|Progressive disease|29|||
37781019|NCT02462837|69353158|FG000|Overall Study|pt developed hives|1|||
37781020|NCT02462837|69353159|FG001|Overall Study|pt developed hives|0|||
37973248|NCT00514046|69660549|FG003|Overall Study|Disease progression on study|0|||
37973249|NCT00514046|69660550|FG004|Overall Study|Disease progression on study|0|||
37973250|NCT00514046|69660551|FG005|Overall Study|Disease progression on study|1|||
37973251|NCT00514046|69660552|FG006|Overall Study|Disease progression on study|0|||
37973252|NCT00514046|69660553|FG007|Overall Study|Disease progression on study|0|||
37973253|NCT00514046|69660554|FG008|Overall Study|Disease progression on study|0|||
37973254|NCT00564629|69660578|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
37973255|NCT00564629|69660579|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
37973256|NCT00564395|69660585|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
37973257|NCT00564395|69660586|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
37973258|NCT00564395|69660585|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
37973259|NCT00564395|69660586|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
37973260|NCT00502242|69660594|FG000|Overall Study|Lack of Efficacy|1|||
37973261|NCT00502242|69660595|FG001|Overall Study|Lack of Efficacy|11|||
37973262|NCT00502242|69660594|FG000|Overall Study|Adverse Event|31|||
37973263|NCT00502242|69660595|FG001|Overall Study|Adverse Event|20|||
37973264|NCT00502242|69660594|FG000|Overall Study|Physician Decision|2|||
37973265|NCT00502242|69660595|FG001|Overall Study|Physician Decision|3|||
37973266|NCT00502242|69660594|FG000|Overall Study|Other - Unspecified|8|||
37973267|NCT00502242|69660595|FG001|Overall Study|Other - Unspecified|14|||
37973268|NCT00502242|69660594|FG000|Overall Study|Protocol Violation|3|||
37973269|NCT00502242|69660595|FG001|Overall Study|Protocol Violation|1|||
37973270|NCT00502242|69660594|FG000|Overall Study|Withdrawal by Subject|6|||
37973271|NCT00502242|69660595|FG001|Overall Study|Withdrawal by Subject|7|||
37973272|NCT03972137|69660605|FG000|Overall Study|Lost to Follow-up|2|||
37973273|NCT03972137|69660605|FG000|Overall Study|Withdrawal by Subject|4|||
37973274|NCT00490698|69660621|FG000|Overall Study|Withdrawal by Subject|1|||
37973275|NCT00490698|69660621|FG000|Overall Study|Disease Progression|7|||
37973276|NCT00490698|69660621|FG000|Overall Study|Physician Decision|2|||
37973277|NCT03855228|69660629|FG000|Overall Study|Adverse Event|2|||
37973278|NCT03855228|69660630|FG001|Overall Study|Adverse Event|4|||
37973279|NCT03855228|69660631|FG002|Overall Study|Adverse Event|4|||
37973280|NCT03855228|69660632|FG003|Overall Study|Adverse Event|8|||
37973281|NCT03855228|69660629|FG000|Overall Study|Treatment Failure|1|||
37973282|NCT03855228|69660630|FG001|Overall Study|Treatment Failure|2|||
37973283|NCT03855228|69660631|FG002|Overall Study|Treatment Failure|1|||
37973284|NCT03855228|69660632|FG003|Overall Study|Treatment Failure|8|||
37973285|NCT03855228|69660629|FG000|Overall Study|Lost to Follow-up|0|||
37973286|NCT03855228|69660630|FG001|Overall Study|Lost to Follow-up|0|||
37973287|NCT03855228|69660631|FG002|Overall Study|Lost to Follow-up|0|||
37973288|NCT03855228|69660632|FG003|Overall Study|Lost to Follow-up|1|||
37973289|NCT03855228|69660629|FG000|Overall Study|Protocol Violation|0|||
37973290|NCT03855228|69660630|FG001|Overall Study|Protocol Violation|1|||
37973291|NCT03855228|69660631|FG002|Overall Study|Protocol Violation|2|||
37973292|NCT03855228|69660632|FG003|Overall Study|Protocol Violation|1|||
37973293|NCT03855228|69660629|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
37973294|NCT03855228|69660630|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
37973295|NCT03855228|69660631|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
37973296|NCT03855228|69660632|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
37973297|NCT00511238|69660644|FG000|Overall Study|Adverse Event|13|||
37973298|NCT00511238|69660645|FG001|Overall Study|Adverse Event|33|||
37973299|NCT00511238|69660644|FG000|Overall Study|Withdrawal by Subject|2|||
37973300|NCT00511238|69660645|FG001|Overall Study|Withdrawal by Subject|22|||
37973301|NCT00511238|69660644|FG000|Overall Study|Progressive Disease|23|||
37973302|NCT00511238|69660645|FG001|Overall Study|Progressive Disease|157|||
37973303|NCT00511238|69660644|FG000|Overall Study|various reasons|4|||
37973304|NCT00511238|69660645|FG001|Overall Study|various reasons|14|||
37692345|NCT02325739|69168601|FG010|Phase II Part|Progressive disease|18|||
37973305|NCT00513500|69660663|FG000|Overall Study|Lost to Follow-up|35|||
37973306|NCT00513500|69660664|FG001|Overall Study|Lost to Follow-up|39|||
37973307|NCT00513500|69660663|FG000|Overall Study|Death|2|||
37973308|NCT00513500|69660664|FG001|Overall Study|Death|1|||
37973309|NCT00513500|69660663|FG000|Overall Study|Hospitalized|4|||
37973310|NCT00513500|69660664|FG001|Overall Study|Hospitalized|14|||
37973311|NCT03969719|69660673|FG000|Overall Study|Other reasons not specified|1|||
37692346|NCT02325739|69168591|FG000|Phase II Part|Subject/guardian decision|0|||
37692347|NCT02325739|69168592|FG001|Phase II Part|Subject/guardian decision|0|||
37973312|NCT03969719|69660674|FG001|Overall Study|Other reasons not specified|1|||
37973313|NCT03969719|69660675|FG002|Overall Study|Other reasons not specified|3|||
37973314|NCT03969719|69660673|FG000|Overall Study|Withdrawal by Subject|2|||
37973315|NCT03969719|69660674|FG001|Overall Study|Withdrawal by Subject|3|||
37973316|NCT03969719|69660675|FG002|Overall Study|Withdrawal by Subject|2|||
37973317|NCT03969719|69660673|FG000|Overall Study|Protocol Violation|1|||
37973318|NCT03969719|69660674|FG001|Overall Study|Protocol Violation|2|||
37973319|NCT03969719|69660675|FG002|Overall Study|Protocol Violation|0|||
37973320|NCT03969719|69660673|FG000|Overall Study|Adverse Event|0|||
37973321|NCT03969719|69660674|FG001|Overall Study|Adverse Event|2|||
37973322|NCT03969719|69660675|FG002|Overall Study|Adverse Event|0|||
37973323|NCT03969719|69660673|FG000|Overall Study|Lost to Follow-up|0|||
37973324|NCT03969719|69660674|FG001|Overall Study|Lost to Follow-up|1|||
37973325|NCT03969719|69660675|FG002|Overall Study|Lost to Follow-up|0|||
37781021|NCT02462837|69353158|FG000|Overall Study|Withdrawal by Subject|1|||
37781022|NCT02462837|69353159|FG001|Overall Study|Withdrawal by Subject|0|||
37781023|NCT02346201|69353167|FG000|Overall Study|Adverse Event|3|||
37781024|NCT02346201|69353168|FG001|Overall Study|Adverse Event|2|||
37781025|NCT02346201|69353167|FG000|Overall Study|Lost to Follow-up|1|||
37781026|NCT02346201|69353168|FG001|Overall Study|Lost to Follow-up|0|||
37781027|NCT02346201|69353167|FG000|Overall Study|Withdrawal by Subject|6|||
37781028|NCT02346201|69353168|FG001|Overall Study|Withdrawal by Subject|3|||
37781029|NCT02346201|69353167|FG000|Overall Study|Unavailable for future follow-up|0|||
37781030|NCT02346201|69353168|FG001|Overall Study|Unavailable for future follow-up|1|||
37781031|NCT02346201|69353167|FG000|Overall Study|Physician Decision|0|||
37781032|NCT02346201|69353168|FG001|Overall Study|Physician Decision|1|||
37781033|NCT02346201|69353167|FG000|Overall Study|Missed final visit|0|||
37781034|NCT02346201|69353168|FG001|Overall Study|Missed final visit|2|||
37781035|NCT01866930|69353188|FG000|Treatment Period|Other|1|||
37781036|NCT01866930|69353189|FG001|Treatment Period|Other|0|||
37781037|NCT01866930|69353188|FG000|Treatment Period|Death|0|||
37781038|NCT01866930|69353189|FG001|Treatment Period|Death|2|||
37781039|NCT01866930|69353188|FG000|Treatment Period|Poor/non compliance|0|||
37781040|NCT01866930|69353189|FG001|Treatment Period|Poor/non compliance|2|||
37781041|NCT01866930|69353188|FG000|Treatment Period|No longer meets study criteria|0|||
37781042|NCT01866930|69353189|FG001|Treatment Period|No longer meets study criteria|1|||
37781043|NCT01866930|69353188|FG000|Treatment Period|Withdrawal by Subject|2|||
37781044|NCT01866930|69353189|FG001|Treatment Period|Withdrawal by Subject|8|||
37781045|NCT01866930|69353188|FG000|Treatment Period|Lack of Efficacy|1|||
37781046|NCT01866930|69353189|FG001|Treatment Period|Lack of Efficacy|9|||
37781047|NCT01866930|69353188|FG000|Treatment Period|Adverse Event|4|||
37781048|NCT01866930|69353189|FG001|Treatment Period|Adverse Event|12|||
37781049|NCT01866930|69353188|FG000|Treatment Period|Lost to Follow-up|1|||
37781050|NCT01866930|69353189|FG001|Treatment Period|Lost to Follow-up|1|||
37781051|NCT01866930|69353188|FG000|Follow-up Period|Lost to Follow-up|1|||
37781052|NCT01866930|69353189|FG001|Follow-up Period|Lost to Follow-up|1|||
37973326|NCT00511004|69660686|FG000|Overall Study|Lost to Follow-up|0|||
37973327|NCT00511004|69660687|FG001|Overall Study|Lost to Follow-up|0|||
37973328|NCT00511004|69660688|FG002|Overall Study|Lost to Follow-up|4|||
37973329|NCT02877134|69660715|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
37973330|NCT02877134|69660716|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
37973331|NCT02877134|69660717|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
37973332|NCT02877134|69660718|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
37973333|NCT02877134|69660719|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
37973334|NCT02877134|69660720|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
37973335|NCT02877134|69660721|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
37781053|NCT01866930|69353188|FG000|Follow-up Period|Other|1|||
37781054|NCT01866930|69353189|FG001|Follow-up Period|Other|5|||
37973336|NCT02877134|69660722|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
37781055|NCT01866930|69353188|FG000|Follow-up Period|No longer required per protocol|1|||
37781056|NCT01866930|69353189|FG001|Follow-up Period|No longer required per protocol|0|||
37973337|NCT02877134|69660723|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
37973338|NCT02877134|69660724|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
37973339|NCT02877134|69660725|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
37973340|NCT02877134|69660726|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
37973341|NCT02877134|69660715|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
37781057|NCT01866930|69353188|FG000|Follow-up Period|Withdrawal by Subject|3|||
37781058|NCT01866930|69353189|FG001|Follow-up Period|Withdrawal by Subject|3|||
37973342|NCT02877134|69660716|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
37973343|NCT02877134|69660717|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
37973344|NCT02877134|69660718|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
37973345|NCT02877134|69660719|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
37973346|NCT02877134|69660720|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
37973347|NCT02877134|69660721|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
37973348|NCT02877134|69660722|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
37973349|NCT02877134|69660723|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
37973350|NCT02877134|69660724|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
37973351|NCT02877134|69660725|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
37973352|NCT02877134|69660726|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
37973353|NCT02877134|69660715|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
37973354|NCT02877134|69660716|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
37973355|NCT02877134|69660717|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
37973356|NCT02877134|69660718|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
37973357|NCT02877134|69660719|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
37973358|NCT02877134|69660720|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
37973359|NCT02877134|69660721|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
37973360|NCT02877134|69660722|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
37973361|NCT02877134|69660723|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
37973362|NCT02877134|69660724|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
37973363|NCT02877134|69660725|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
37973364|NCT02877134|69660726|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
37973365|NCT02877134|69660715|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
37973366|NCT02877134|69660716|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
37973367|NCT02877134|69660717|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
37973368|NCT02877134|69660718|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
37973369|NCT02877134|69660719|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
37973370|NCT02877134|69660720|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
37973371|NCT02877134|69660721|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
37973372|NCT02877134|69660722|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
37973373|NCT02877134|69660723|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
37973374|NCT02877134|69660724|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
37973375|NCT02877134|69660725|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
37973376|NCT02877134|69660726|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
37973377|NCT02877134|69660715|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
37973378|NCT02877134|69660716|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
37973379|NCT02877134|69660717|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
37973380|NCT02877134|69660718|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
37973381|NCT02877134|69660719|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
37973382|NCT02877134|69660720|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
37973383|NCT02877134|69660721|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
37973384|NCT02877134|69660722|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
37973385|NCT02877134|69660723|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
37973386|NCT02877134|69660724|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
37973387|NCT02877134|69660725|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
37973388|NCT02877134|69660726|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
37973389|NCT02877134|69660715|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
37973390|NCT02877134|69660716|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
37973391|NCT02877134|69660717|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
37692348|NCT02325739|69168593|FG002|Phase II Part|Subject/guardian decision|0|||
37692349|NCT02325739|69168594|FG003|Phase II Part|Subject/guardian decision|0|||
37973392|NCT02877134|69660718|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
37973393|NCT02877134|69660719|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
37973394|NCT02877134|69660720|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
37973395|NCT02877134|69660721|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
37973396|NCT02877134|69660722|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
37973397|NCT02877134|69660723|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
37973398|NCT02877134|69660724|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
37973399|NCT02877134|69660725|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
37973400|NCT02877134|69660726|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
37973401|NCT02877134|69660715|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
37973402|NCT02877134|69660716|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
37973403|NCT02877134|69660717|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
37973404|NCT02877134|69660718|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
37973405|NCT02877134|69660719|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
37973406|NCT02877134|69660720|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
37973407|NCT02877134|69660721|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
37973408|NCT02877134|69660722|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
37973409|NCT02877134|69660723|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
37973410|NCT02877134|69660724|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
37973411|NCT02877134|69660725|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
37973412|NCT02877134|69660726|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
37973413|NCT02877134|69660715|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
37973414|NCT02877134|69660716|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
37973415|NCT02877134|69660717|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
37973416|NCT02877134|69660718|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
37973417|NCT02877134|69660719|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
37973418|NCT02877134|69660720|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
37973419|NCT02877134|69660721|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
37973420|NCT02877134|69660722|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
37973421|NCT02877134|69660723|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
37973422|NCT02877134|69660724|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
37973423|NCT02877134|69660725|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
37973424|NCT02877134|69660726|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
37973425|NCT00563381|69660752|FG000|Overall Study|Adverse Event|264|||
37973426|NCT00563381|69660753|FG001|Overall Study|Adverse Event|292|||
37973427|NCT00563381|69660752|FG000|Overall Study|Protocol Violation|66|||
37973428|NCT00563381|69660753|FG001|Overall Study|Protocol Violation|74|||
37973429|NCT00563381|69660752|FG000|Overall Study|Lost to Follow-up|7|||
37973430|NCT00563381|69660753|FG001|Overall Study|Lost to Follow-up|15|||
37973431|NCT00563381|69660752|FG000|Overall Study|Withdrawal by Subject|192|||
37973432|NCT00563381|69660753|FG001|Overall Study|Withdrawal by Subject|209|||
37973433|NCT00563381|69660752|FG000|Overall Study|Lack of Efficacy|32|||
37973434|NCT00563381|69660753|FG001|Overall Study|Lack of Efficacy|24|||
37973435|NCT00563381|69660752|FG000|Overall Study|Individual different reasons|24|||
37973436|NCT00563381|69660753|FG001|Overall Study|Individual different reasons|34|||
37973437|NCT00512798|69660761|FG000|Overall Study|Death|0|||
37973438|NCT00512798|69660762|FG001|Overall Study|Death|3|||
37973439|NCT00512798|69660761|FG000|Overall Study|Adverse Event|2|||
37973440|NCT00512798|69660762|FG001|Overall Study|Adverse Event|4|||
37973441|NCT00512798|69660761|FG000|Overall Study|Progression of disease|14|||
37973442|NCT00512798|69660762|FG001|Overall Study|Progression of disease|20|||
37973443|NCT00512798|69660761|FG000|Overall Study|Withdrawal by Subject|3|||
37973444|NCT00512798|69660762|FG001|Overall Study|Withdrawal by Subject|0|||
37973445|NCT00565721|69660769|FG000|Overall Study|Screen Failure|2|||
37973446|NCT00565721|69660769|FG000|Overall Study|Lost to Follow-up|6|||
37973447|NCT00565721|69660769|FG000|Overall Study|Technical Problems|1|||
37973448|NCT00565721|69660769|FG000|Overall Study|Physician Decision|2|||
37973449|NCT00565721|69660769|FG000|Overall Study|Other reasons|6|||
37863981|NCT00994162|69547571|FG000|Overall Study|Patient Lived Too Far Away|1|||
37863982|NCT00994162|69547571|FG000|Overall Study|Above Knee Amputation|1|||
37863983|NCT00994162|69547571|FG000|Overall Study|Reason Not Reported By Site|1|||
37863984|NCT00993928|69547578|FG000|Overall Study|Withdrawal by Subject|4|||
37863985|NCT00993928|69547579|FG001|Overall Study|Withdrawal by Subject|7|||
37863986|NCT00993928|69547578|FG000|Overall Study|ineligible|1|||
37973450|NCT00561977|69660799|FG000|Overall Study|Withdrawal by Subject|0|||
37973451|NCT00561977|69660800|FG001|Overall Study|Withdrawal by Subject|2|||
37973452|NCT00561977|69660801|FG002|Overall Study|Withdrawal by Subject|1|||
37973453|NCT00561977|69660799|FG000|Overall Study|Pregnancy|0|||
37973454|NCT00561977|69660800|FG001|Overall Study|Pregnancy|1|||
37973455|NCT00561977|69660801|FG002|Overall Study|Pregnancy|1|||
37973456|NCT00561821|69660813|FG000|Overall Study|Not treated|0|||
37973457|NCT00561821|69660814|FG001|Overall Study|Not treated|0|||
37973458|NCT00561821|69660815|FG002|Overall Study|Not treated|1|||
37973459|NCT00561821|69660816|FG003|Overall Study|Not treated|0|||
37692350|NCT02325739|69168595|FG004|Phase II Part|Subject/guardian decision|0|||
37863987|NCT00993928|69547579|FG001|Overall Study|ineligible|0|||
37973460|NCT00561821|69660813|FG000|Overall Study|Withdrawal by Subject|0|||
37973461|NCT00561821|69660814|FG001|Overall Study|Withdrawal by Subject|1|||
37973462|NCT00561821|69660815|FG002|Overall Study|Withdrawal by Subject|0|||
37973463|NCT00561821|69660816|FG003|Overall Study|Withdrawal by Subject|2|||
37973464|NCT00561821|69660813|FG000|Overall Study|Reasons not related to trial|2|||
37973465|NCT00561821|69660814|FG001|Overall Study|Reasons not related to trial|1|||
37973466|NCT00561821|69660815|FG002|Overall Study|Reasons not related to trial|0|||
37973467|NCT00561821|69660816|FG003|Overall Study|Reasons not related to trial|0|||
37781059|NCT01621568|69353197|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
37781060|NCT01621568|69353198|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
37781061|NCT01621568|69353197|FG000|Week 5-6 No Treatment|Death|1|||
37781062|NCT01621568|69353198|FG001|Week 5-6 No Treatment|Death|0|||
37781063|NCT00813293|69353218|FG000|Overall Study|Intercurrent illness|1|||
37781064|NCT00813293|69353219|FG001|Overall Study|Intercurrent illness|0|||
37781065|NCT00813293|69353218|FG000|Overall Study|Adverse Event|0|||
37781066|NCT00813293|69353219|FG001|Overall Study|Adverse Event|1|||
37781067|NCT00481091|69353235|FG000|Overall Study|Withdrawal by Subject|0|||
37781068|NCT00481091|69353236|FG001|Overall Study|Withdrawal by Subject|1|||
37781069|NCT00481091|69353237|FG002|Overall Study|Withdrawal by Subject|1|||
37781070|NCT00481091|69353238|FG003|Overall Study|Withdrawal by Subject|0|||
37781071|NCT00481091|69353239|FG004|Overall Study|Withdrawal by Subject|0|||
37781072|NCT00481091|69353240|FG005|Overall Study|Withdrawal by Subject|0|||
37781073|NCT00481091|69353241|FG006|Overall Study|Withdrawal by Subject|0|||
37781074|NCT00481091|69353242|FG007|Overall Study|Withdrawal by Subject|0|||
37781075|NCT00481091|69353243|FG008|Overall Study|Withdrawal by Subject|1|||
37781076|NCT00481091|69353244|FG009|Overall Study|Withdrawal by Subject|6|||
37781077|NCT00481091|69353235|FG000|Overall Study|Other, Not Specified|0|||
37781078|NCT00481091|69353236|FG001|Overall Study|Other, Not Specified|1|||
37781079|NCT00481091|69353237|FG002|Overall Study|Other, Not Specified|1|||
37781080|NCT00481091|69353238|FG003|Overall Study|Other, Not Specified|0|||
37781081|NCT00481091|69353239|FG004|Overall Study|Other, Not Specified|0|||
37781082|NCT00481091|69353240|FG005|Overall Study|Other, Not Specified|1|||
37781083|NCT00481091|69353241|FG006|Overall Study|Other, Not Specified|0|||
37781084|NCT00481091|69353242|FG007|Overall Study|Other, Not Specified|0|||
37781085|NCT00481091|69353243|FG008|Overall Study|Other, Not Specified|0|||
37781086|NCT00481091|69353244|FG009|Overall Study|Other, Not Specified|4|||
37781087|NCT00481091|69353235|FG000|Overall Study|Adverse Event|1|||
37781088|NCT00481091|69353236|FG001|Overall Study|Adverse Event|2|||
37781089|NCT00481091|69353237|FG002|Overall Study|Adverse Event|0|||
37781090|NCT00481091|69353238|FG003|Overall Study|Adverse Event|1|||
37781091|NCT00481091|69353239|FG004|Overall Study|Adverse Event|1|||
37781092|NCT00481091|69353240|FG005|Overall Study|Adverse Event|1|||
37781093|NCT00481091|69353241|FG006|Overall Study|Adverse Event|2|||
37781094|NCT00481091|69353242|FG007|Overall Study|Adverse Event|1|||
37781095|NCT00481091|69353243|FG008|Overall Study|Adverse Event|1|||
37781096|NCT00481091|69353244|FG009|Overall Study|Adverse Event|6|||
37781097|NCT00481091|69353235|FG000|Overall Study|Progressive disease clinical|0|||
37781098|NCT00481091|69353236|FG001|Overall Study|Progressive disease clinical|0|||
37781099|NCT00481091|69353237|FG002|Overall Study|Progressive disease clinical|0|||
37781100|NCT00481091|69353238|FG003|Overall Study|Progressive disease clinical|0|||
37781101|NCT00481091|69353239|FG004|Overall Study|Progressive disease clinical|0|||
37781102|NCT00481091|69353240|FG005|Overall Study|Progressive disease clinical|0|||
37781103|NCT00481091|69353241|FG006|Overall Study|Progressive disease clinical|0|||
37781104|NCT00481091|69353242|FG007|Overall Study|Progressive disease clinical|0|||
37781105|NCT00481091|69353243|FG008|Overall Study|Progressive disease clinical|1|||
37781106|NCT00481091|69353244|FG009|Overall Study|Progressive disease clinical|7|||
37781107|NCT00481091|69353235|FG000|Overall Study|Progressive disease clinical National Cancer Institute|1|||
37781108|NCT00481091|69353236|FG001|Overall Study|Progressive disease clinical National Cancer Institute|1|||
37781109|NCT00481091|69353237|FG002|Overall Study|Progressive disease clinical National Cancer Institute|0|||
37781110|NCT00481091|69353238|FG003|Overall Study|Progressive disease clinical National Cancer Institute|0|||
37781111|NCT00481091|69353239|FG004|Overall Study|Progressive disease clinical National Cancer Institute|0|||
37781112|NCT00481091|69353240|FG005|Overall Study|Progressive disease clinical National Cancer Institute|1|||
37781113|NCT00481091|69353241|FG006|Overall Study|Progressive disease clinical National Cancer Institute|0|||
37781114|NCT00481091|69353242|FG007|Overall Study|Progressive disease clinical National Cancer Institute|0|||
37781115|NCT00481091|69353243|FG008|Overall Study|Progressive disease clinical National Cancer Institute|0|||
37781116|NCT00481091|69353244|FG009|Overall Study|Progressive disease clinical National Cancer Institute|0|||
37781117|NCT00481091|69353235|FG000|Overall Study|Progressive disease other|1|||
37781118|NCT00481091|69353236|FG001|Overall Study|Progressive disease other|1|||
37973468|NCT00561821|69660813|FG000|Overall Study|Other (reason not specified)|1|||
37973469|NCT00561821|69660814|FG001|Overall Study|Other (reason not specified)|1|||
37781119|NCT00481091|69353237|FG002|Overall Study|Progressive disease other|0|||
37781120|NCT00481091|69353238|FG003|Overall Study|Progressive disease other|1|||
37781121|NCT00481091|69353239|FG004|Overall Study|Progressive disease other|1|||
37973470|NCT00561821|69660815|FG002|Overall Study|Other (reason not specified)|0|||
37973471|NCT00561821|69660816|FG003|Overall Study|Other (reason not specified)|0|||
37973472|NCT00561821|69660813|FG000|Overall Study|Adverse Event|2|||
37973473|NCT00561821|69660814|FG001|Overall Study|Adverse Event|3|||
37973474|NCT00561821|69660815|FG002|Overall Study|Adverse Event|1|||
37973475|NCT00561821|69660816|FG003|Overall Study|Adverse Event|1|||
37973476|NCT00558701|69660828|FG000|Overall Study|Protocol Deviations|1|||
37973477|NCT00558701|69660829|FG001|Overall Study|Protocol Deviations|4|||
37973478|NCT03684044|69660837|FG000|Overall Study|Adverse Event|3|||
37973479|NCT03684044|69660838|FG001|Overall Study|Adverse Event|0|||
37973480|NCT03684044|69660837|FG000|Overall Study|Death|4|||
37973481|NCT03684044|69660838|FG001|Overall Study|Death|7|||
37973482|NCT03684044|69660837|FG000|Overall Study|Lost to Follow-up|3|||
37973483|NCT03684044|69660838|FG001|Overall Study|Lost to Follow-up|2|||
37973484|NCT03684044|69660837|FG000|Overall Study|Patient Not Available|0|||
37973485|NCT03684044|69660838|FG001|Overall Study|Patient Not Available|2|||
37973486|NCT03684044|69660837|FG000|Overall Study|Physician Decision|1|||
37973487|NCT03684044|69660838|FG001|Overall Study|Physician Decision|0|||
37973488|NCT03684044|69660837|FG000|Overall Study|Withdrawal by Subject|11|||
37973489|NCT03684044|69660838|FG001|Overall Study|Withdrawal by Subject|9|||
37973490|NCT00510692|69660846|FG000|Overall Study|Adverse Event|1|||
37973491|NCT00510692|69660847|FG001|Overall Study|Adverse Event|3|||
37973492|NCT00510692|69660846|FG000|Overall Study|Withdrawal by Subject|1|||
37973493|NCT00510692|69660847|FG001|Overall Study|Withdrawal by Subject|0|||
37973494|NCT00335452|69660859|FG000|Overall Study|Death|156|||
37973495|NCT00335452|69660860|FG001|Overall Study|Death|144|||
37973496|NCT00335452|69660861|FG002|Overall Study|Death|158|||
37973497|NCT00335452|69660862|FG003|Overall Study|Death|129|||
37973498|NCT00335452|69660859|FG000|Overall Study|Lost to Follow-up|2|||
37973499|NCT00335452|69660860|FG001|Overall Study|Lost to Follow-up|3|||
37973500|NCT00335452|69660861|FG002|Overall Study|Lost to Follow-up|1|||
37973501|NCT00335452|69660862|FG003|Overall Study|Lost to Follow-up|2|||
37973502|NCT00522548|69660879|FG000|Overall Study|Adverse Event|2|||
37973503|NCT00522548|69660880|FG001|Overall Study|Adverse Event|2|||
37973504|NCT00522548|69660879|FG000|Overall Study|Withdrawal by Subject|0|||
37973505|NCT00522548|69660880|FG001|Overall Study|Withdrawal by Subject|2|||
37973506|NCT00522392|69660888|FG000|Overall Study|Disease progression|0|||
37973507|NCT00522392|69660889|FG001|Overall Study|Disease progression|3|||
37973508|NCT00522392|69660888|FG000|Overall Study|Adverse Event|7|||
37973509|NCT00522392|69660889|FG001|Overall Study|Adverse Event|7|||
37973510|NCT00522392|69660888|FG000|Overall Study|Withdrawal by Subject|1|||
37973511|NCT00522392|69660889|FG001|Overall Study|Withdrawal by Subject|1|||
37973512|NCT00522392|69660888|FG000|Overall Study|Physician Decision|0|||
37973513|NCT00522392|69660889|FG001|Overall Study|Physician Decision|1|||
37973514|NCT00522392|69660888|FG000|Overall Study|Non-compliance|0|||
37973515|NCT00522392|69660889|FG001|Overall Study|Non-compliance|1|||
37973516|NCT00309244|69660897|FG000|Overall Study|Adverse Event|29|||
37973517|NCT00309244|69660898|FG001|Overall Study|Adverse Event|12|||
37973518|NCT00309244|69660897|FG000|Overall Study|Lost to Follow-up|6|||
37973519|NCT00309244|69660898|FG001|Overall Study|Lost to Follow-up|22|||
37973520|NCT00309244|69660897|FG000|Overall Study|Physician Decision|5|||
37973521|NCT00309244|69660898|FG001|Overall Study|Physician Decision|8|||
37973522|NCT00309244|69660897|FG000|Overall Study|Protocol Violation|6|||
37973523|NCT00309244|69660898|FG001|Overall Study|Protocol Violation|3|||
37973524|NCT00309244|69660897|FG000|Overall Study|Withdrawal by Subject|50|||
37973525|NCT00309244|69660898|FG001|Overall Study|Withdrawal by Subject|32|||
37973526|NCT00309244|69660897|FG000|Overall Study|Various|7|||
37973527|NCT00309244|69660898|FG001|Overall Study|Various|7|||
37973528|NCT00309244|69660897|FG000|Overall Study|Randomized but not dosed|11|||
37973529|NCT00309244|69660898|FG001|Overall Study|Randomized but not dosed|12|||
37973530|NCT00309244|69660897|FG000|Overall Study|Death|4|||
37973531|NCT00309244|69660898|FG001|Overall Study|Death|1|||
37973532|NCT00483756|69660907|FG000|Overall Study|Death|2|||
37973533|NCT00483756|69660908|FG001|Overall Study|Death|0|||
37973534|NCT00483756|69660909|FG002|Overall Study|Death|1|||
37973535|NCT00483756|69660907|FG000|Overall Study|Adverse Event|19|||
37973536|NCT00483756|69660908|FG001|Overall Study|Adverse Event|38|||
37973537|NCT00483756|69660909|FG002|Overall Study|Adverse Event|40|||
37973538|NCT00483756|69660907|FG000|Overall Study|Lack of Efficacy|1|||
37973539|NCT00483756|69660908|FG001|Overall Study|Lack of Efficacy|0|||
37973540|NCT00483756|69660909|FG002|Overall Study|Lack of Efficacy|0|||
37973541|NCT00483756|69660907|FG000|Overall Study|Lost to Follow-up|3|||
37973542|NCT00483756|69660908|FG001|Overall Study|Lost to Follow-up|1|||
37973543|NCT00483756|69660909|FG002|Overall Study|Lost to Follow-up|0|||
37973544|NCT00483756|69660907|FG000|Overall Study|Withdrawal by Subject|5|||
37973545|NCT00483756|69660908|FG001|Overall Study|Withdrawal by Subject|3|||
37973546|NCT00483756|69660909|FG002|Overall Study|Withdrawal by Subject|4|||
37973547|NCT00483756|69660907|FG000|Overall Study|Other|2|||
37973548|NCT00483756|69660908|FG001|Overall Study|Other|4|||
37973549|NCT00483756|69660909|FG002|Overall Study|Other|3|||
37973550|NCT00483756|69660907|FG000|Overall Study|Randomized, Not Treated|1|||
37973551|NCT00483756|69660908|FG001|Overall Study|Randomized, Not Treated|4|||
37973552|NCT00483756|69660909|FG002|Overall Study|Randomized, Not Treated|4|||
37973553|NCT00309166|69660919|FG000|Overall Study|Adverse event, non-fatal|1|||
37973554|NCT00309166|69660920|FG001|Overall Study|Adverse event, non-fatal|0|||
37973555|NCT00309166|69660919|FG000|Overall Study|Withdrawal by Subject|4|||
37973556|NCT00309166|69660920|FG001|Overall Study|Withdrawal by Subject|3|||
37973557|NCT00501852|69660926|FG000|Overall Study|Adverse Event|3|||
37973558|NCT00501852|69660926|FG000|Overall Study|Withdrawal by Subject|2|||
37973559|NCT00482274|69660940|FG000|Overall Study|Adverse Event|1|||
37973560|NCT00490542|69660946|FG000|Overall Study|Lost to Follow-up|3|||
37973561|NCT00490542|69660947|FG001|Overall Study|Lost to Follow-up|0|||
37973562|NCT00490542|69660946|FG000|Overall Study|Adverse Event|3|||
37973563|NCT00490542|69660947|FG001|Overall Study|Adverse Event|3|||
37973564|NCT00490542|69660946|FG000|Overall Study|Lack of Efficacy|1|||
37973565|NCT00490542|69660947|FG001|Overall Study|Lack of Efficacy|1|||
37973566|NCT00501540|69660953|FG000|Overall Study|Death|5|||
37973567|NCT00322348|69660959|FG000|Overall Study|Adverse Event|0|||
37973568|NCT00322348|69660960|FG001|Overall Study|Adverse Event|1|||
37973569|NCT00322348|69660959|FG000|Overall Study|Withdrawal by Subject|1|||
37973570|NCT00322348|69660960|FG001|Overall Study|Withdrawal by Subject|4|||
37973571|NCT00322348|69660959|FG000|Overall Study|Lost to Follow-up|1|||
37973572|NCT00322348|69660960|FG001|Overall Study|Lost to Follow-up|0|||
37973573|NCT00322348|69660959|FG000|Overall Study|Death|0|||
37973574|NCT00322348|69660960|FG001|Overall Study|Death|2|||
37973575|NCT00322348|69660959|FG000|Overall Study|Disease Progression|30|||
37973576|NCT00322348|69660960|FG001|Overall Study|Disease Progression|25|||
37973577|NCT00322348|69660959|FG000|Overall Study|Reasons not specified|5|||
37973578|NCT00322348|69660960|FG001|Overall Study|Reasons not specified|1|||
37973579|NCT00501228|69660966|FG000|Overall Study|Withdrawal by Subject|1|||
37973580|NCT00308620|69660973|FG000|Overall Study|Death|1|||
37973581|NCT00308620|69660974|FG001|Overall Study|Death|1|||
37973582|NCT00308620|69660975|FG002|Overall Study|Death|0|||
37973583|NCT00308620|69660973|FG000|Overall Study|Lost to Follow-up|0|||
37973584|NCT00308620|69660974|FG001|Overall Study|Lost to Follow-up|0|||
37973585|NCT00308620|69660975|FG002|Overall Study|Lost to Follow-up|1|||
37973586|NCT00492752|69660985|FG000|Double Blind Treatment|Death|13|||
37973587|NCT00492752|69660986|FG001|Double Blind Treatment|Death|0|||
37781122|NCT00481091|69353240|FG005|Overall Study|Progressive disease other|1|||
37781123|NCT00481091|69353241|FG006|Overall Study|Progressive disease other|0|||
37781124|NCT00481091|69353242|FG007|Overall Study|Progressive disease other|2|||
37781125|NCT00481091|69353243|FG008|Overall Study|Progressive disease other|0|||
37781126|NCT00481091|69353244|FG009|Overall Study|Progressive disease other|0|||
37781127|NCT00481091|69353235|FG000|Overall Study|No reason given|0|||
37781128|NCT00481091|69353236|FG001|Overall Study|No reason given|0|||
37781129|NCT00481091|69353237|FG002|Overall Study|No reason given|1|||
37781130|NCT00481091|69353238|FG003|Overall Study|No reason given|1|||
37781131|NCT00481091|69353239|FG004|Overall Study|No reason given|1|||
37781132|NCT00481091|69353240|FG005|Overall Study|No reason given|0|||
37781133|NCT00481091|69353241|FG006|Overall Study|No reason given|1|||
37781134|NCT00481091|69353242|FG007|Overall Study|No reason given|1|||
37781135|NCT00481091|69353243|FG008|Overall Study|No reason given|1|||
37781136|NCT00481091|69353244|FG009|Overall Study|No reason given|4|||
37781137|NCT00003641|69353275|FG000|Overall Study|Withdrawal by Subject|0|||
37781138|NCT00003641|69353276|FG001|Overall Study|Withdrawal by Subject|100|||
37781139|NCT00003641|69353275|FG000|Overall Study|Adverse Event|0|||
37781140|NCT00003641|69353276|FG001|Overall Study|Adverse Event|38|||
37781141|NCT00003641|69353275|FG000|Overall Study|Disease progression|0|||
37781142|NCT00003641|69353276|FG001|Overall Study|Disease progression|2|||
37781143|NCT00003641|69353275|FG000|Overall Study|Unknown/missing|0|||
37781144|NCT00003641|69353276|FG001|Overall Study|Unknown/missing|22|||
37781145|NCT00003641|69353275|FG000|Overall Study|Should not receive interferon therapy|2|||
37781146|NCT00003641|69353276|FG001|Overall Study|Should not receive interferon therapy|0|||
37781147|NCT00003641|69353275|FG000|Overall Study|Never started interferon|567|||
37863988|NCT01253291|69547594|FG000|Overall Study|Withdrawal by Subject|1|||
37973588|NCT00492752|69660987|FG002|Double Blind Treatment|Death|2|||
37973589|NCT00492752|69660988|FG003|Double Blind Treatment|Death|0|||
37973590|NCT00492752|69660985|FG000|Double Blind Treatment|Adverse Event|1|||
37973591|NCT00492752|69660986|FG001|Double Blind Treatment|Adverse Event|0|||
37973592|NCT00492752|69660987|FG002|Double Blind Treatment|Adverse Event|0|||
37973593|NCT00492752|69660988|FG003|Double Blind Treatment|Adverse Event|0|||
37973594|NCT00492752|69660985|FG000|Double Blind Treatment|Protocol Violation|0|||
37973595|NCT00492752|69660986|FG001|Double Blind Treatment|Protocol Violation|0|||
37973596|NCT00492752|69660987|FG002|Double Blind Treatment|Protocol Violation|1|||
37781148|NCT00003641|69353276|FG001|Overall Study|Never started interferon|12|||
37781149|NCT02524158|69353306|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
37781150|NCT02524158|69353307|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
37781151|NCT02524158|69353306|FG000|12-weeks Assessment|Lost to Follow-up|18|||
37781152|NCT02524158|69353307|FG001|12-weeks Assessment|Lost to Follow-up|12|||
37973597|NCT00492752|69660988|FG003|Double Blind Treatment|Protocol Violation|0|||
37973598|NCT00492752|69660985|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
37973599|NCT00492752|69660986|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
37973600|NCT00492752|69660987|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
37973601|NCT00492752|69660988|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
37973602|NCT00492752|69660985|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
37973603|NCT00492752|69660986|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
37973604|NCT00492752|69660987|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
37973605|NCT00492752|69660988|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
37973606|NCT00492752|69660985|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
37973607|NCT00492752|69660986|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
37973608|NCT00492752|69660987|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
37973609|NCT00492752|69660988|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
37973610|NCT00492752|69660985|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
37973611|NCT00492752|69660986|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
37973612|NCT00492752|69660987|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
37973613|NCT00492752|69660988|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
37973614|NCT00492752|69660985|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
37973615|NCT00492752|69660986|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
37973616|NCT00492752|69660987|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
37973617|NCT00492752|69660988|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
37973618|NCT00492752|69660985|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
37973619|NCT00492752|69660986|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
37973620|NCT00492752|69660987|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
37973621|NCT00492752|69660988|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
37973622|NCT00492752|69660985|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
37973623|NCT00492752|69660986|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
37973624|NCT00492752|69660987|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
37973625|NCT00492752|69660988|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
37973626|NCT00492752|69660985|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
37973627|NCT00492752|69660986|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
37973628|NCT00492752|69660987|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
37973629|NCT00492752|69660988|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
37973630|NCT00308308|69660997|FG000|Overall Study|Adverse Event|17|||
37973631|NCT00308308|69660998|FG001|Overall Study|Adverse Event|2|||
37973632|NCT00308308|69660997|FG000|Overall Study|Lost to Follow-up|5|||
37973633|NCT00308308|69660998|FG001|Overall Study|Lost to Follow-up|5|||
37973634|NCT00308308|69660997|FG000|Overall Study|Physician Decision|15|||
37973635|NCT00308308|69660998|FG001|Overall Study|Physician Decision|7|||
37973636|NCT00308308|69660997|FG000|Overall Study|Protocol Violation|3|||
37973637|NCT00308308|69660998|FG001|Overall Study|Protocol Violation|14|||
37973638|NCT00308308|69660997|FG000|Overall Study|Withdrawal by Subject|47|||
37973639|NCT00308308|69660998|FG001|Overall Study|Withdrawal by Subject|19|||
37973640|NCT00308308|69660997|FG000|Overall Study|Various|7|||
37973641|NCT00308308|69660998|FG001|Overall Study|Various|5|||
37973642|NCT00308308|69660997|FG000|Overall Study|Randomized but not dosed|8|||
37973643|NCT00308308|69660998|FG001|Overall Study|Randomized but not dosed|16|||
37973644|NCT00308308|69660997|FG000|Overall Study|Other|1|||
37973645|NCT00308308|69660998|FG001|Overall Study|Other|0|||
37973646|NCT00505934|69661004|FG000|Overall Study|Adverse Event|1|||
37973647|NCT00505934|69661004|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
37973648|NCT00505934|69661004|FG000|Overall Study|Other: IV dose needed to be changed|1|||
37973649|NCT00505778|69661010|FG000|Overall Study|Adverse Event|2|||
37973650|NCT00505778|69661011|FG001|Overall Study|Adverse Event|7|||
37973651|NCT00505778|69661010|FG000|Overall Study|Physician Decision|8|||
37973652|NCT00505778|69661011|FG001|Overall Study|Physician Decision|14|||
37973653|NCT00505778|69661010|FG000|Overall Study|Lost to Follow-up|17|||
37973654|NCT00505778|69661011|FG001|Overall Study|Lost to Follow-up|23|||
37973655|NCT00505778|69661010|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
37973656|NCT00505778|69661011|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
37973657|NCT00505778|69661010|FG000|Overall Study|Protocol Violation|7|||
37973658|NCT00505778|69661011|FG001|Overall Study|Protocol Violation|9|||
37973659|NCT00505778|69661010|FG000|Overall Study|Withdrawal by Subject|29|||
37973660|NCT00505778|69661011|FG001|Overall Study|Withdrawal by Subject|14|||
37973661|NCT00505778|69661010|FG000|Overall Study|Relapse|65|||
37973662|NCT00505778|69661011|FG001|Overall Study|Relapse|65|||
37973663|NCT00505778|69661010|FG000|Overall Study|Took No Study Drug|2|||
37863989|NCT01253291|69547595|FG001|Overall Study|Withdrawal by Subject|1|||
37863990|NCT01253291|69547596|FG002|Overall Study|Withdrawal by Subject|0|||
37863991|NCT01253291|69547597|FG003|Overall Study|Withdrawal by Subject|0|||
37863992|NCT01253291|69547598|FG004|Overall Study|Withdrawal by Subject|0|||
37973664|NCT00505778|69661011|FG001|Overall Study|Took No Study Drug|2|||
37973665|NCT00308074|69661017|FG000|Overall Study|Withdrawal by Subject|1|||
37973666|NCT00500760|69661023|FG000|Overall Study|Death|32|||
37973667|NCT00500760|69661024|FG001|Overall Study|Death|15|||
37973668|NCT00500760|69661023|FG000|Overall Study|Withdrawal by Subject|5|||
37973669|NCT00500760|69661024|FG001|Overall Study|Withdrawal by Subject|7|||
37973670|NCT00500760|69661023|FG000|Overall Study|Administrative decision|2|||
37973671|NCT00500760|69661024|FG001|Overall Study|Administrative decision|0|||
37973672|NCT00500760|69661023|FG000|Overall Study|Lost to Follow-up|3|||
37973673|NCT00500760|69661024|FG001|Overall Study|Lost to Follow-up|0|||
37973674|NCT00500760|69661023|FG000|Overall Study|Other|1|||
37973675|NCT00500760|69661024|FG001|Overall Study|Other|2|||
37973676|NCT00505622|69661033|FG000|Overall Study|Adverse Event|5|||
37973677|NCT00505622|69661034|FG001|Overall Study|Adverse Event|6|||
37973678|NCT00505622|69661035|FG002|Overall Study|Adverse Event|4|||
37973679|NCT00505622|69661033|FG000|Overall Study|Protocol Violation|1|||
37973680|NCT00505622|69661034|FG001|Overall Study|Protocol Violation|1|||
37973681|NCT00505622|69661035|FG002|Overall Study|Protocol Violation|0|||
37973682|NCT00505622|69661033|FG000|Overall Study|Withdrawal by Subject|0|||
37973683|NCT00505622|69661034|FG001|Overall Study|Withdrawal by Subject|3|||
37973684|NCT00505622|69661035|FG002|Overall Study|Withdrawal by Subject|2|||
37973685|NCT00505622|69661033|FG000|Overall Study|Study termination by sponsor|115|||
37973686|NCT00505622|69661034|FG001|Overall Study|Study termination by sponsor|98|||
37973687|NCT00505622|69661035|FG002|Overall Study|Study termination by sponsor|90|||
37973688|NCT03851094|69661045|FG000|Overall Study|Withdrawal by Subject|0|||
37973689|NCT03851094|69661046|FG001|Overall Study|Withdrawal by Subject|1|||
37973690|NCT03851094|69661045|FG000|Overall Study|Participant lost device|0|||
37973691|NCT03851094|69661046|FG001|Overall Study|Participant lost device|1|||
37973692|NCT03851094|69661045|FG000|Overall Study|Participant returned device|0|||
37973693|NCT03851094|69661046|FG001|Overall Study|Participant returned device|2|||
37973694|NCT00505076|69661057|FG000|Overall Study|Adverse Event|1|||
37973695|NCT00505076|69661058|FG001|Overall Study|Adverse Event|0|||
37973696|NCT00505076|69661059|FG002|Overall Study|Adverse Event|1|||
37973697|NCT00505076|69661057|FG000|Overall Study|Protocol Violation|2|||
37973698|NCT00505076|69661058|FG001|Overall Study|Protocol Violation|1|||
37973699|NCT00505076|69661059|FG002|Overall Study|Protocol Violation|2|||
37973700|NCT00505076|69661057|FG000|Overall Study|Withdrawal by Subject|0|||
37973701|NCT00505076|69661058|FG001|Overall Study|Withdrawal by Subject|1|||
37973702|NCT00505076|69661059|FG002|Overall Study|Withdrawal by Subject|2|||
37973703|NCT00307684|69661067|FG000|Open Label Phase|Lack of Efficacy|0|||
37973704|NCT00307684|69661068|FG001|Open Label Phase|Lack of Efficacy|0|||
37973705|NCT00307684|69661069|FG002|Open Label Phase|Lack of Efficacy|3|||
37973706|NCT00307684|69661067|FG000|Open Label Phase|Adverse Event|0|||
37973707|NCT00307684|69661068|FG001|Open Label Phase|Adverse Event|0|||
37973708|NCT00307684|69661069|FG002|Open Label Phase|Adverse Event|16|||
37973709|NCT00307684|69661067|FG000|Open Label Phase|Withdrawal by Subject|0|||
37973710|NCT00307684|69661068|FG001|Open Label Phase|Withdrawal by Subject|0|||
37973711|NCT00307684|69661069|FG002|Open Label Phase|Withdrawal by Subject|15|||
37973712|NCT00307684|69661067|FG000|Open Label Phase|Lost to Follow-up|0|||
37973713|NCT00307684|69661068|FG001|Open Label Phase|Lost to Follow-up|0|||
37973714|NCT00307684|69661069|FG002|Open Label Phase|Lost to Follow-up|11|||
37973715|NCT00307684|69661067|FG000|Open Label Phase|non compliance|0|||
37973716|NCT00307684|69661068|FG001|Open Label Phase|non compliance|0|||
37973717|NCT00307684|69661069|FG002|Open Label Phase|non compliance|5|||
37973718|NCT00307684|69661067|FG000|Open Label Phase|other|0|||
37973719|NCT00307684|69661068|FG001|Open Label Phase|other|0|||
37973720|NCT00307684|69661069|FG002|Open Label Phase|other|6|||
37973721|NCT00307684|69661067|FG000|Double Blind Phase|Lack of Efficacy|2|||
37973722|NCT00307684|69661068|FG001|Double Blind Phase|Lack of Efficacy|5|||
37973723|NCT00307684|69661069|FG002|Double Blind Phase|Lack of Efficacy|0|||
37973724|NCT00489918|69661082|FG000|Overall Study|Withdrawal by Subject|2|||
37973725|NCT00489918|69661083|FG001|Overall Study|Withdrawal by Subject|1|||
37973726|NCT00489918|69661084|FG002|Overall Study|Withdrawal by Subject|1|||
37973727|NCT00489918|69661085|FG003|Overall Study|Withdrawal by Subject|0|||
37973728|NCT00489918|69661086|FG004|Overall Study|Withdrawal by Subject|1|||
37973729|NCT00489918|69661082|FG000|Overall Study|Adverse Event|0|||
37973730|NCT00489918|69661083|FG001|Overall Study|Adverse Event|1|||
37973731|NCT00489918|69661084|FG002|Overall Study|Adverse Event|1|||
37692351|NCT02325739|69168596|FG005|Phase II Part|Subject/guardian decision|0|||
37973732|NCT00489918|69661085|FG003|Overall Study|Adverse Event|0|||
37973733|NCT00489918|69661086|FG004|Overall Study|Adverse Event|0|||
37692352|NCT02325739|69168597|FG006|Phase II Part|Subject/guardian decision|0|||
37692353|NCT02325739|69168598|FG007|Phase II Part|Subject/guardian decision|0|||
37973734|NCT00489918|69661082|FG000|Overall Study|Lost to Follow-up|0|||
37973735|NCT00489918|69661083|FG001|Overall Study|Lost to Follow-up|0|||
37973736|NCT00489918|69661084|FG002|Overall Study|Lost to Follow-up|1|||
37973737|NCT00489918|69661085|FG003|Overall Study|Lost to Follow-up|1|||
37973738|NCT00489918|69661086|FG004|Overall Study|Lost to Follow-up|0|||
37973739|NCT00489918|69661082|FG000|Overall Study|Physician Decision|0|||
37973740|NCT00489918|69661083|FG001|Overall Study|Physician Decision|0|||
37973741|NCT00489918|69661084|FG002|Overall Study|Physician Decision|1|||
37973742|NCT00489918|69661085|FG003|Overall Study|Physician Decision|0|||
37973743|NCT00489918|69661086|FG004|Overall Study|Physician Decision|0|||
37973744|NCT00307294|69661098|FG000|Overall Study|Withdrawal by Subject|1|||
37973745|NCT03963401|69661109|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
37973746|NCT03963401|69661110|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
37973747|NCT03963401|69661111|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
37973748|NCT03963401|69661112|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
37973749|NCT03963401|69661113|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
37973750|NCT03963401|69661114|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
37973751|NCT03963401|69661109|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
37973752|NCT03963401|69661110|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
37973753|NCT03963401|69661111|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
37973754|NCT03963401|69661112|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
37973755|NCT03963401|69661113|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
37973756|NCT03963401|69661114|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
37973757|NCT03963401|69661109|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
37973758|NCT03963401|69661110|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
37973759|NCT03963401|69661111|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
37973760|NCT03963401|69661112|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
37973761|NCT03963401|69661113|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
37973762|NCT03963401|69661114|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
37973763|NCT03963401|69661109|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
37973764|NCT03963401|69661110|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
37973765|NCT03963401|69661111|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
37973766|NCT03963401|69661112|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
37973767|NCT03963401|69661113|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
37973768|NCT03963401|69661114|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
37973769|NCT03963401|69661109|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
37973770|NCT03963401|69661110|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
37973771|NCT03963401|69661111|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
37973772|NCT03963401|69661112|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
37973773|NCT03963401|69661113|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
37973774|NCT03963401|69661114|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
37973775|NCT03963401|69661109|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
37973776|NCT03963401|69661110|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
37973777|NCT03963401|69661111|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
37973778|NCT03963401|69661112|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
37973779|NCT03963401|69661113|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
37973780|NCT03963401|69661114|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
37973781|NCT03963401|69661109|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
37973782|NCT03963401|69661110|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
37973783|NCT03963401|69661111|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
37973784|NCT03963401|69661112|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
37973785|NCT03963401|69661113|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
37973786|NCT03963401|69661114|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
37973787|NCT03963401|69661109|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
37973788|NCT03963401|69661110|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
37973789|NCT03963401|69661111|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
37973790|NCT03963401|69661112|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
37973791|NCT03963401|69661113|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
37973792|NCT03963401|69661114|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
37973793|NCT03963401|69661109|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
37973794|NCT03963401|69661110|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
37973795|NCT03963401|69661111|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
37973796|NCT03963401|69661112|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
37973797|NCT03963401|69661113|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
37973798|NCT03963401|69661114|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
37973799|NCT03963401|69661109|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
37973800|NCT03963401|69661110|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
37973801|NCT03963401|69661111|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
37973802|NCT03963401|69661112|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
37973803|NCT03963401|69661113|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
37973804|NCT03963401|69661114|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
37973805|NCT03963401|69661109|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
37973806|NCT03963401|69661110|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
37973807|NCT03963401|69661111|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
37973808|NCT03963401|69661112|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
37973809|NCT03963401|69661113|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
37973810|NCT03963401|69661114|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
37973811|NCT00334282|69661134|FG000|Overall Study|Lost to Follow-up|11|||
37973812|NCT00334282|69661135|FG001|Overall Study|Lost to Follow-up|5|||
37973813|NCT00334282|69661134|FG000|Overall Study|Withdrawal by Subject|17|||
37973814|NCT00334282|69661135|FG001|Overall Study|Withdrawal by Subject|3|||
37973815|NCT00334282|69661134|FG000|Overall Study|Death|194|||
37973816|NCT00334282|69661135|FG001|Overall Study|Death|100|||
37973817|NCT00306670|69661147|FG000|Overall Study|patients recruited; Genentech, the st|0|||
37973818|NCT00306670|69661148|FG001|Overall Study|patients recruited; Genentech, the st|2|||
37973819|NCT00306592|69661154|FG000|Overall Study|Adverse Event|8|||
37973820|NCT00306592|69661155|FG001|Overall Study|Adverse Event|15|||
37973821|NCT00306592|69661154|FG000|Overall Study|Lost to Follow-up|1|||
37973822|NCT00306592|69661155|FG001|Overall Study|Lost to Follow-up|0|||
37973823|NCT00306592|69661154|FG000|Overall Study|Noncompliance|0|||
37973824|NCT00306592|69661155|FG001|Overall Study|Noncompliance|2|||
37973825|NCT00306592|69661154|FG000|Overall Study|Persistent Antibodies|6|||
37973826|NCT00306592|69661155|FG001|Overall Study|Persistent Antibodies|3|||
37973827|NCT00306592|69661154|FG000|Overall Study|Voluntary|10|||
37973828|NCT00306592|69661155|FG001|Overall Study|Voluntary|6|||
37973829|NCT00306592|69661154|FG000|Overall Study|Other|5|||
37973830|NCT00306592|69661155|FG001|Overall Study|Other|10|||
37973831|NCT00306592|69661154|FG000|Overall Study|Other|1|||
37973832|NCT00306592|69661155|FG001|Overall Study|Other|2|||
37973833|NCT00306592|69661154|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
37973834|NCT00306592|69661155|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
37973835|NCT00321646|69661159|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
37973836|NCT00321646|69661159|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
37973837|NCT00321646|69661159|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
37973838|NCT00403767|69661165|FG000|Overall Study|Adverse Event|993|||
37973839|NCT00403767|69661166|FG001|Overall Study|Adverse Event|919|||
37973840|NCT00403767|69661165|FG000|Overall Study|Non-compliant with study medication|134|||
37973841|NCT00403767|69661166|FG001|Overall Study|Non-compliant with study medication|164|||
37973842|NCT00403767|69661165|FG000|Overall Study|Consent withdrawn|671|||
37973843|NCT00403767|69661166|FG001|Overall Study|Consent withdrawn|673|||
37973844|NCT00403767|69661165|FG000|Overall Study|Investigator dec./not protocol-related|191|||
37973845|NCT00403767|69661166|FG001|Overall Study|Investigator dec./not protocol-related|178|||
37973846|NCT00403767|69661165|FG000|Overall Study|Lost to Follow-up|6|||
37973847|NCT00403767|69661166|FG001|Overall Study|Lost to Follow-up|8|||
37973848|NCT00403767|69661165|FG000|Overall Study|Protocol Violation|142|||
37973849|NCT00403767|69661166|FG001|Overall Study|Protocol Violation|124|||
37973850|NCT00403767|69661165|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
37973851|NCT00403767|69661166|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
37973852|NCT00403767|69661165|FG000|Overall Study|Study terminated by sponsor|82|||
37973853|NCT00403767|69661166|FG001|Overall Study|Study terminated by sponsor|69|||
37973854|NCT00403767|69661165|FG000|Overall Study|Missing/incomplete data|1|||
37973855|NCT00403767|69661166|FG001|Overall Study|Missing/incomplete data|1|||
37973856|NCT00492284|69661176|FG000|Overall Study|Adverse Event|0|||
37781153|NCT02524158|69353306|FG000|6-month Assessment|Withdrawal by Subject|1|||
37781154|NCT02524158|69353307|FG001|6-month Assessment|Withdrawal by Subject|1|||
37781155|NCT02524158|69353306|FG000|6-month Assessment|Lost to Follow-up|21|||
37781156|NCT02524158|69353307|FG001|6-month Assessment|Lost to Follow-up|20|||
37781157|NCT02525094|69353327|FG000|Overall Study|Lost to Follow-up|2|||
37781158|NCT02525094|69353328|FG001|Overall Study|Lost to Follow-up|1|||
37781159|NCT02525094|69353327|FG000|Overall Study|Withdrawal by Subject|5|||
37781160|NCT02525094|69353328|FG001|Overall Study|Withdrawal by Subject|6|||
37781161|NCT02525094|69353327|FG000|Overall Study|Not Treated|1|||
37781162|NCT02525094|69353328|FG001|Overall Study|Not Treated|1|||
37781163|NCT01657266|69353485|FG000|Overall Study|Lost to Follow-up|2|||
37781164|NCT01657266|69353486|FG001|Overall Study|Lost to Follow-up|2|||
37781165|NCT01657266|69353485|FG000|Overall Study|Adverse Event|2|||
37781166|NCT01657266|69353486|FG001|Overall Study|Adverse Event|3|||
37781167|NCT01657032|69353565|FG000|Overall Study|Lost to Follow-up|0|||
37781168|NCT01657032|69353566|FG001|Overall Study|Lost to Follow-up|7|||
37781169|NCT01657500|69353694|FG000|Overall Study|set impropperly matched|3|||
37781170|NCT01657500|69353695|FG001|Overall Study|set impropperly matched|3|||
37781171|NCT01657500|69353694|FG000|Overall Study|Lost to Follow-up|2|||
37781172|NCT01657500|69353695|FG001|Overall Study|Lost to Follow-up|2|||
37781173|NCT01658904|69353708|FG000|Overall Study|Principal Investigator discretion|2|||
37781174|NCT01658904|69353709|FG001|Overall Study|Principal Investigator discretion|0|||
37781175|NCT01658904|69353710|FG002|Overall Study|Principal Investigator discretion|0|||
37692354|NCT02325739|69168599|FG008|Phase II Part|Subject/guardian decision|4|||
37692355|NCT02325739|69168600|FG009|Phase II Part|Subject/guardian decision|1|||
37692356|NCT02325739|69168601|FG010|Phase II Part|Subject/guardian decision|1|||
37781176|NCT01658514|69353894|FG000|Overall Study|Protocol Violation|1|||
37781177|NCT01658514|69353895|FG001|Overall Study|Protocol Violation|0|||
37781178|NCT01658514|69353896|FG002|Overall Study|Protocol Violation|2|||
37781179|NCT01658436|69353917|FG000|Overall Study|Adverse Event|6|||
37781180|NCT01658436|69353918|FG001|Overall Study|Adverse Event|5|||
37781181|NCT01658436|69353917|FG000|Overall Study|Physician Decision|1|||
37781182|NCT01658436|69353918|FG001|Overall Study|Physician Decision|0|||
37781183|NCT01658436|69353917|FG000|Overall Study|Progressive disease|12|||
37692357|NCT01903720|69168646|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
37692358|NCT01903720|69168646|FG000|Overall Study|Adverse Event|1|||
37692359|NCT01903720|69168646|FG000|Overall Study|Rescinding of informed consent|2|||
37692360|NCT01903720|69168646|FG000|Overall Study|Lost to Follow-up|2|||
37692361|NCT01903720|69168646|FG000|Overall Study|Treatment with alternative drug|1|||
37692362|NCT02366689|69168653|FG000|Overall Study|Withdrawal by Subject|1|||
37692363|NCT02366689|69168654|FG001|Overall Study|Withdrawal by Subject|0|||
37692364|NCT02366689|69168655|FG002|Overall Study|Withdrawal by Subject|1|||
37692365|NCT02366689|69168653|FG000|Overall Study|Lost to Follow-up|3|||
37692366|NCT02366689|69168654|FG001|Overall Study|Lost to Follow-up|2|||
37692367|NCT02366689|69168655|FG002|Overall Study|Lost to Follow-up|0|||
37863993|NCT01253291|69547594|FG000|Overall Study|Adverse Event|0|||
37863994|NCT01253291|69547595|FG001|Overall Study|Adverse Event|1|||
37692368|NCT02366689|69168653|FG000|Overall Study|Pregnancy|0|||
37692369|NCT02366689|69168654|FG001|Overall Study|Pregnancy|1|||
37863995|NCT01253291|69547596|FG002|Overall Study|Adverse Event|0|||
37863996|NCT01253291|69547597|FG003|Overall Study|Adverse Event|0|||
37692370|NCT02366689|69168655|FG002|Overall Study|Pregnancy|1|||
37781184|NCT01658436|69353918|FG001|Overall Study|Progressive disease|4|||
37781185|NCT01658436|69353917|FG000|Overall Study|Study terminated by sponsor|0|||
37781186|NCT01658436|69353918|FG001|Overall Study|Study terminated by sponsor|1|||
37781187|NCT01658436|69353917|FG000|Overall Study|Subject/guardian decision|0|||
37973857|NCT00492284|69661177|FG001|Overall Study|Adverse Event|1|||
37973858|NCT00492284|69661178|FG002|Overall Study|Adverse Event|1|||
37973859|NCT00492284|69661179|FG003|Overall Study|Adverse Event|2|||
37973860|NCT00492284|69661176|FG000|Overall Study|Lost to Follow-up|0|||
37973861|NCT00492284|69661177|FG001|Overall Study|Lost to Follow-up|0|||
37973862|NCT00492284|69661178|FG002|Overall Study|Lost to Follow-up|3|||
37973863|NCT00492284|69661179|FG003|Overall Study|Lost to Follow-up|1|||
37973864|NCT00492284|69661176|FG000|Overall Study|Death|0|||
37973865|NCT00492284|69661177|FG001|Overall Study|Death|3|||
37973866|NCT00492284|69661178|FG002|Overall Study|Death|2|||
37973867|NCT00492284|69661179|FG003|Overall Study|Death|5|||
37973868|NCT00492284|69661176|FG000|Overall Study|Withdrawal by Subject|1|||
37973869|NCT00492284|69661177|FG001|Overall Study|Withdrawal by Subject|0|||
37973870|NCT00492284|69661178|FG002|Overall Study|Withdrawal by Subject|0|||
37973871|NCT00492284|69661179|FG003|Overall Study|Withdrawal by Subject|2|||
37973872|NCT00510458|69661189|FG000|Overall Study|5 year not evaluable/missed|21|||
37973873|NCT00510458|69661189|FG000|Overall Study|Death|1|||
37973874|NCT00510458|69661189|FG000|Overall Study|Terminated|14|||
37973875|NCT00510458|69661189|FG000|Overall Study|Lost to Follow-up|6|||
37781188|NCT01658436|69353918|FG001|Overall Study|Subject/guardian decision|1|||
37781189|NCT01658436|69353917|FG000|Overall Study|Death|1|||
37973876|NCT00510458|69661189|FG000|Overall Study|Withdrawal by Subject|3|||
37781190|NCT01658436|69353918|FG001|Overall Study|Death|0|||
37781191|NCT01656408|69354463|FG000|Overall Study|Adverse Event|0|||
37781192|NCT01656408|69354464|FG001|Overall Study|Adverse Event|0|||
37781193|NCT01656408|69354465|FG002|Overall Study|Adverse Event|1|||
37781194|NCT01656408|69354466|FG003|Overall Study|Adverse Event|0|||
37781195|NCT01656408|69354467|FG004|Overall Study|Adverse Event|0|||
37781196|NCT01656408|69354468|FG005|Overall Study|Adverse Event|1|||
37781197|NCT01656408|69354469|FG006|Overall Study|Adverse Event|1|||
37781198|NCT01656408|69354470|FG007|Overall Study|Adverse Event|0|||
37781199|NCT01656408|69354471|FG008|Overall Study|Adverse Event|1|||
37781200|NCT01656408|69354472|FG009|Overall Study|Adverse Event|0|||
37781201|NCT01656408|69354463|FG000|Overall Study|Physician Decision|1|||
37781202|NCT01656408|69354464|FG001|Overall Study|Physician Decision|0|||
37781203|NCT01656408|69354465|FG002|Overall Study|Physician Decision|1|||
37781204|NCT01656408|69354466|FG003|Overall Study|Physician Decision|0|||
37781205|NCT01656408|69354467|FG004|Overall Study|Physician Decision|1|||
37781206|NCT01656408|69354468|FG005|Overall Study|Physician Decision|1|||
37781207|NCT01656408|69354469|FG006|Overall Study|Physician Decision|0|||
37781208|NCT01656408|69354470|FG007|Overall Study|Physician Decision|1|||
37781209|NCT01656408|69354471|FG008|Overall Study|Physician Decision|1|||
37973877|NCT00510458|69661189|FG000|Overall Study|Revision|2|||
37973878|NCT00414765|69661196|FG000|Overall Study|Adverse Event|5|||
37973879|NCT00414765|69661197|FG001|Overall Study|Adverse Event|9|||
37973880|NCT00414765|69661196|FG000|Overall Study|Withdrawal by Subject|1|||
37863997|NCT01253291|69547598|FG004|Overall Study|Adverse Event|0|||
37781210|NCT01656408|69354472|FG009|Overall Study|Physician Decision|3|||
37973881|NCT00414765|69661197|FG001|Overall Study|Withdrawal by Subject|1|||
37781211|NCT01364298|69354924|FG000|Overall Study|Adverse Event|3|||
37781212|NCT01364298|69354925|FG001|Overall Study|Adverse Event|4|||
37781213|NCT01364298|69354924|FG000|Overall Study|Lack of adherence to treatment|1|||
37973882|NCT00414765|69661196|FG000|Overall Study|Disease Progression|0|||
37973883|NCT00414765|69661197|FG001|Overall Study|Disease Progression|1|||
37973884|NCT00500682|69661205|FG000|Overall Study|Adverse Event|37|||
37973885|NCT00500682|69661206|FG001|Overall Study|Adverse Event|29|||
37973886|NCT00500682|69661205|FG000|Overall Study|Death|25|||
37781214|NCT01364298|69354925|FG001|Overall Study|Lack of adherence to treatment|3|||
37781215|NCT01364298|69354924|FG000|Overall Study|Lack of Efficacy|1|||
37973887|NCT00500682|69661206|FG001|Overall Study|Death|16|||
37973888|NCT00500682|69661205|FG000|Overall Study|Lost to Follow-up|11|||
37973889|NCT00500682|69661206|FG001|Overall Study|Lost to Follow-up|11|||
37973890|NCT00500682|69661205|FG000|Overall Study|Physician Decision|6|||
37973891|NCT00500682|69661206|FG001|Overall Study|Physician Decision|10|||
37973892|NCT00500682|69661205|FG000|Overall Study|Pregnancy|2|||
37973893|NCT00500682|69661206|FG001|Overall Study|Pregnancy|0|||
37973894|NCT00500682|69661205|FG000|Overall Study|Protocol Violation|1|||
37973895|NCT00500682|69661206|FG001|Overall Study|Protocol Violation|3|||
37973896|NCT00500682|69661205|FG000|Overall Study|Withdrawal by Subject|80|||
37973897|NCT00500682|69661206|FG001|Overall Study|Withdrawal by Subject|74|||
37973898|NCT00500682|69661205|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
37973899|NCT00500682|69661206|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
37973900|NCT00500370|69661214|FG000|Overall Study|Adverse Event|9|||
37973901|NCT00500370|69661215|FG001|Overall Study|Adverse Event|3|||
37973902|NCT00500370|69661214|FG000|Overall Study|Lost to Follow-up|10|||
37973903|NCT00500370|69661215|FG001|Overall Study|Lost to Follow-up|10|||
37973904|NCT00500370|69661214|FG000|Overall Study|Protocol Violation|2|||
37973905|NCT00500370|69661215|FG001|Overall Study|Protocol Violation|4|||
37973906|NCT00500370|69661214|FG000|Overall Study|Sponsor Decision|2|||
37973907|NCT00500370|69661215|FG001|Overall Study|Sponsor Decision|0|||
37973908|NCT00500370|69661214|FG000|Overall Study|Subject Decision|10|||
37973909|NCT00500370|69661215|FG001|Overall Study|Subject Decision|17|||
37973910|NCT00320788|69661226|FG000|Overall Study|Adverse Event|0|||
37973911|NCT00320788|69661227|FG001|Overall Study|Adverse Event|0|||
37973912|NCT00320788|69661228|FG002|Overall Study|Adverse Event|0|||
37973913|NCT00320788|69661229|FG003|Overall Study|Adverse Event|1|||
37973914|NCT00320788|69661230|FG004|Overall Study|Adverse Event|0|||
37973915|NCT00320788|69661226|FG000|Overall Study|Death|0|||
37973916|NCT00320788|69661227|FG001|Overall Study|Death|0|||
37973917|NCT00320788|69661228|FG002|Overall Study|Death|1|||
37973918|NCT00320788|69661229|FG003|Overall Study|Death|0|||
37973919|NCT00320788|69661230|FG004|Overall Study|Death|1|||
37973920|NCT00320788|69661226|FG000|Overall Study|Lost to Follow-up|0|||
37973921|NCT00320788|69661227|FG001|Overall Study|Lost to Follow-up|2|||
37973922|NCT00320788|69661228|FG002|Overall Study|Lost to Follow-up|1|||
37692371|NCT01903252|69168665|FG000|Double-Blind Induction|Adverse Event|20|||
37863998|NCT01253291|69547594|FG000|Overall Study|Lack of Efficacy|1|||
37973923|NCT00320788|69661229|FG003|Overall Study|Lost to Follow-up|0|||
37973924|NCT00320788|69661230|FG004|Overall Study|Lost to Follow-up|0|||
37973925|NCT00320788|69661226|FG000|Overall Study|Decision by the Sponsor|1|||
37973926|NCT00320788|69661227|FG001|Overall Study|Decision by the Sponsor|1|||
37973927|NCT00320788|69661228|FG002|Overall Study|Decision by the Sponsor|0|||
37973928|NCT00320788|69661229|FG003|Overall Study|Decision by the Sponsor|0|||
37973929|NCT00320788|69661230|FG004|Overall Study|Decision by the Sponsor|1|||
37973930|NCT00320788|69661226|FG000|Overall Study|Other|1|||
37973931|NCT00320788|69661227|FG001|Overall Study|Other|2|||
37973932|NCT00320788|69661228|FG002|Overall Study|Other|1|||
37973933|NCT00320788|69661229|FG003|Overall Study|Other|1|||
37973934|NCT00320788|69661230|FG004|Overall Study|Other|1|||
37973935|NCT00320788|69661226|FG000|Overall Study|Physician Decision|1|||
37973936|NCT00320788|69661227|FG001|Overall Study|Physician Decision|1|||
37973937|NCT00320788|69661228|FG002|Overall Study|Physician Decision|0|||
37973938|NCT00320788|69661229|FG003|Overall Study|Physician Decision|0|||
37973939|NCT00320788|69661230|FG004|Overall Study|Physician Decision|0|||
37973940|NCT00320788|69661226|FG000|Overall Study|Protocol Violation|0|||
37973941|NCT00320788|69661227|FG001|Overall Study|Protocol Violation|0|||
37973942|NCT00320788|69661228|FG002|Overall Study|Protocol Violation|0|||
37973943|NCT00320788|69661229|FG003|Overall Study|Protocol Violation|0|||
37973944|NCT00320788|69661230|FG004|Overall Study|Protocol Violation|1|||
37973945|NCT00320788|69661226|FG000|Overall Study|Withdrawal by Subject|3|||
37973946|NCT00320788|69661227|FG001|Overall Study|Withdrawal by Subject|0|||
37973947|NCT00320788|69661228|FG002|Overall Study|Withdrawal by Subject|0|||
37973948|NCT00320788|69661229|FG003|Overall Study|Withdrawal by Subject|3|||
37973949|NCT00320788|69661230|FG004|Overall Study|Withdrawal by Subject|1|||
37973950|NCT00503984|69661250|FG000|Overall Study|Protocol Violation|0|||
37973951|NCT00503984|69661251|FG001|Overall Study|Protocol Violation|1|||
37973952|NCT00503984|69661252|FG002|Overall Study|Protocol Violation|0|||
37973953|NCT00503984|69661253|FG003|Overall Study|Protocol Violation|0|||
37973954|NCT00503984|69661254|FG004|Overall Study|Protocol Violation|0|||
37973955|NCT00503984|69661255|FG005|Overall Study|Protocol Violation|0|||
37973956|NCT00503984|69661250|FG000|Overall Study|Adverse Event|0|||
37973957|NCT00503984|69661251|FG001|Overall Study|Adverse Event|1|||
37973958|NCT00503984|69661252|FG002|Overall Study|Adverse Event|0|||
37973959|NCT00503984|69661253|FG003|Overall Study|Adverse Event|0|||
37973960|NCT00503984|69661254|FG004|Overall Study|Adverse Event|0|||
37973961|NCT00503984|69661255|FG005|Overall Study|Adverse Event|0|||
37973962|NCT00503984|69661250|FG000|Overall Study|Death|0|||
37973963|NCT00503984|69661251|FG001|Overall Study|Death|0|||
37973964|NCT00503984|69661252|FG002|Overall Study|Death|0|||
37973965|NCT00503984|69661253|FG003|Overall Study|Death|0|||
37973966|NCT00503984|69661254|FG004|Overall Study|Death|1|||
37973967|NCT00503984|69661255|FG005|Overall Study|Death|0|||
37973968|NCT00565409|69661279|FG000|Period 1 Open Label|Adverse Event|17|||
37973969|NCT00565409|69661280|FG001|Period 1 Open Label|Adverse Event|0|||
37973970|NCT00565409|69661281|FG002|Period 1 Open Label|Adverse Event|0|||
37973971|NCT00565409|69661282|FG003|Period 1 Open Label|Adverse Event|0|||
37973972|NCT00565409|69661279|FG000|Period 1 Open Label|Death|2|||
37973973|NCT00565409|69661280|FG001|Period 1 Open Label|Death|0|||
37973974|NCT00565409|69661281|FG002|Period 1 Open Label|Death|0|||
37973975|NCT00565409|69661282|FG003|Period 1 Open Label|Death|0|||
37973976|NCT00565409|69661279|FG000|Period 1 Open Label|Lost to Follow-up|1|||
37973977|NCT00565409|69661280|FG001|Period 1 Open Label|Lost to Follow-up|0|||
37973978|NCT00565409|69661281|FG002|Period 1 Open Label|Lost to Follow-up|0|||
37973979|NCT00565409|69661282|FG003|Period 1 Open Label|Lost to Follow-up|0|||
37973980|NCT00565409|69661279|FG000|Period 1 Open Label|Other|21|||
37973981|NCT00565409|69661280|FG001|Period 1 Open Label|Other|0|||
37973982|NCT00565409|69661281|FG002|Period 1 Open Label|Other|0|||
37973983|NCT00565409|69661282|FG003|Period 1 Open Label|Other|0|||
37973984|NCT00565409|69661279|FG000|Period 1 Open Label|Protocol Violation|14|||
37973985|NCT00565409|69661280|FG001|Period 1 Open Label|Protocol Violation|0|||
37973986|NCT00565409|69661281|FG002|Period 1 Open Label|Protocol Violation|0|||
37973987|NCT00565409|69661282|FG003|Period 1 Open Label|Protocol Violation|0|||
37973988|NCT00565409|69661279|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
37973989|NCT00565409|69661280|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
37973990|NCT00565409|69661281|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
37973991|NCT00565409|69661282|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
37973992|NCT00565409|69661279|FG000|Period 1 Open Label|no conclusion of participation record|1|||
37973993|NCT00565409|69661280|FG001|Period 1 Open Label|no conclusion of participation record|0|||
37973994|NCT00565409|69661281|FG002|Period 1 Open Label|no conclusion of participation record|0|||
37973995|NCT00565409|69661282|FG003|Period 1 Open Label|no conclusion of participation record|0|||
37973996|NCT00565409|69661279|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
37973997|NCT00565409|69661280|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
37973998|NCT00565409|69661281|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
37973999|NCT00565409|69661282|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
37974000|NCT00565409|69661279|FG000|Period 2 Double-Blind|Adverse Event|0|||
37974001|NCT00565409|69661280|FG001|Period 2 Double-Blind|Adverse Event|7|||
37974002|NCT00565409|69661281|FG002|Period 2 Double-Blind|Adverse Event|4|||
37974003|NCT00565409|69661282|FG003|Period 2 Double-Blind|Adverse Event|5|||
37974004|NCT00565409|69661279|FG000|Period 2 Double-Blind|Death|0|||
37781216|NCT01364298|69354925|FG001|Overall Study|Lack of Efficacy|0|||
37974005|NCT00565409|69661280|FG001|Period 2 Double-Blind|Death|2|||
37974006|NCT00565409|69661281|FG002|Period 2 Double-Blind|Death|0|||
37974007|NCT00565409|69661282|FG003|Period 2 Double-Blind|Death|0|||
37974008|NCT00565409|69661279|FG000|Period 2 Double-Blind|Protocol Violation|0|||
37974009|NCT00565409|69661280|FG001|Period 2 Double-Blind|Protocol Violation|4|||
37974010|NCT00565409|69661281|FG002|Period 2 Double-Blind|Protocol Violation|6|||
37974011|NCT00565409|69661282|FG003|Period 2 Double-Blind|Protocol Violation|2|||
37974012|NCT00565409|69661279|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
37974013|NCT00565409|69661280|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
37974014|NCT00565409|69661281|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
37974015|NCT00565409|69661282|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
37974016|NCT00565409|69661279|FG000|Period 2 Double-Blind|Other|0|||
37974017|NCT00565409|69661280|FG001|Period 2 Double-Blind|Other|4|||
37974018|NCT00565409|69661281|FG002|Period 2 Double-Blind|Other|5|||
37974019|NCT00565409|69661282|FG003|Period 2 Double-Blind|Other|9|||
37974020|NCT00565409|69661279|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
37974021|NCT00565409|69661280|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
37974022|NCT00565409|69661281|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
37974023|NCT00565409|69661282|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
37974024|NCT00394251|69661294|FG000|Overall Study|Adverse Event|7|||
37974025|NCT00394251|69661295|FG001|Overall Study|Adverse Event|5|||
37974026|NCT00394251|69661294|FG000|Overall Study|Unacceptable Toxicity|20|||
37974027|NCT00394251|69661295|FG001|Overall Study|Unacceptable Toxicity|18|||
37974028|NCT00394251|69661294|FG000|Overall Study|Physician Decision|1|||
37974029|NCT00394251|69661295|FG001|Overall Study|Physician Decision|1|||
37974030|NCT00394251|69661294|FG000|Overall Study|Protocol Violation|0|||
37974031|NCT00394251|69661295|FG001|Overall Study|Protocol Violation|1|||
37974032|NCT00394251|69661294|FG000|Overall Study|Withdrawal by Subject|7|||
37974033|NCT00394251|69661295|FG001|Overall Study|Withdrawal by Subject|11|||
37974034|NCT00394251|69661294|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
37974035|NCT00394251|69661295|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
37974036|NCT00394095|69661307|FG000|Overall Study|Adverse Event|1|||
37974037|NCT00394095|69661308|FG001|Overall Study|Adverse Event|0|||
37974038|NCT00503906|69661315|FG000|Overall Study|Withdrawal by Subject|1|||
37974039|NCT00305110|69661320|FG000|Overall Study|Missing data|29|||
37974040|NCT00491894|69661324|FG000|Overall Study|Adverse Event|14|||
37974041|NCT00491894|69661324|FG000|Overall Study|Withdrawal by Subject|5|||
37974042|NCT00491894|69661324|FG000|Overall Study|Death|3|||
37974043|NCT00491894|69661324|FG000|Overall Study|Lost to Follow-up|3|||
37974044|NCT00491894|69661324|FG000|Overall Study|Lack of Efficacy|2|||
37974045|NCT00491894|69661324|FG000|Overall Study|Other-Failed to meet any criteria|2|||
37974046|NCT00491894|69661324|FG000|Overall Study|Physician Decision|2|||
37974047|NCT00491894|69661324|FG000|Overall Study|Protocol Violation|2|||
37974048|NCT00491894|69661324|FG000|Overall Study|Other-Intake of prohibited medication|1|||
37974049|NCT00491504|69661332|FG000|Overall Study|Adverse Event|0|||
37974050|NCT00491504|69661333|FG001|Overall Study|Adverse Event|1|||
37974051|NCT00491504|69661334|FG002|Overall Study|Adverse Event|0|||
37974052|NCT00491504|69661335|FG003|Overall Study|Adverse Event|0|||
37974053|NCT00491504|69661332|FG000|Overall Study|Withdrawal by Subject|0|||
37974054|NCT00491504|69661333|FG001|Overall Study|Withdrawal by Subject|0|||
37974055|NCT00491504|69661334|FG002|Overall Study|Withdrawal by Subject|1|||
37974056|NCT00491504|69661335|FG003|Overall Study|Withdrawal by Subject|2|||
37974057|NCT00491504|69661332|FG000|Overall Study|Protocol Violation|0|||
37974058|NCT00491504|69661333|FG001|Overall Study|Protocol Violation|0|||
37974059|NCT00491504|69661334|FG002|Overall Study|Protocol Violation|3|||
37974060|NCT00491504|69661335|FG003|Overall Study|Protocol Violation|2|||
37974061|NCT00500292|69661346|FG000|Overall Study|Adverse Event|3|||
37974062|NCT00500292|69661347|FG001|Overall Study|Adverse Event|6|||
37974063|NCT00500292|69661348|FG002|Overall Study|Adverse Event|4|||
37974064|NCT00500292|69661346|FG000|Overall Study|Condition under investigation worsened|21|||
37974065|NCT00500292|69661347|FG001|Overall Study|Condition under investigation worsened|23|||
37974066|NCT00500292|69661348|FG002|Overall Study|Condition under investigation worsened|19|||
37974067|NCT00500292|69661346|FG000|Overall Study|Withdrawal by Subject|0|||
37974068|NCT00500292|69661347|FG001|Overall Study|Withdrawal by Subject|1|||
37974069|NCT00500292|69661348|FG002|Overall Study|Withdrawal by Subject|0|||
37974070|NCT00500292|69661346|FG000|Overall Study|Other|1|||
37974071|NCT00500292|69661347|FG001|Overall Study|Other|1|||
37974072|NCT00500292|69661348|FG002|Overall Study|Other|4|||
37974073|NCT00499746|69661356|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
37974074|NCT00499746|69661356|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
37974075|NCT00499746|69661356|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
37974076|NCT00499746|69661356|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
37974077|NCT00489216|69661370|FG000|Overall Study|Adverse Event|1|||
37974078|NCT00499590|69661377|FG000|Overall Study|Study Terminated|112|||
37974079|NCT00499590|69661378|FG001|Overall Study|Study Terminated|112|||
37974080|NCT00499590|69661379|FG002|Overall Study|Study Terminated|112|||
37974081|NCT00499590|69661377|FG000|Overall Study|Not treated|1|||
37974082|NCT00499590|69661378|FG001|Overall Study|Not treated|0|||
37974083|NCT00499590|69661379|FG002|Overall Study|Not treated|1|||
37974084|NCT00510146|69661390|FG000|Double-Blind Treatment|Adverse Event|30|||
37974085|NCT00510146|69661391|FG001|Double-Blind Treatment|Adverse Event|13|||
37974086|NCT00510146|69661390|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
37974087|NCT00510146|69661391|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
37974088|NCT00510146|69661390|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
37974089|NCT00510146|69661391|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
37974090|NCT00510146|69661390|FG000|Double-Blind Treatment|Physician Decision|6|||
37974091|NCT00510146|69661391|FG001|Double-Blind Treatment|Physician Decision|0|||
37974092|NCT00510146|69661390|FG000|Double-Blind Treatment|Protocol Violation|1|||
37974093|NCT00510146|69661391|FG001|Double-Blind Treatment|Protocol Violation|2|||
37974094|NCT00510146|69661390|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
37974095|NCT00510146|69661391|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
37974096|NCT00510146|69661390|FG000|Double-Blind Treatment|Clinical Relapse|0|||
37863999|NCT01253291|69547595|FG001|Overall Study|Lack of Efficacy|0|||
37692372|NCT01903252|69168666|FG001|Double-Blind Induction|Adverse Event|18|||
37974097|NCT00510146|69661391|FG001|Double-Blind Treatment|Clinical Relapse|1|||
37974098|NCT00510146|69661390|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
37974099|NCT00510146|69661391|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
37974100|NCT00510146|69661390|FG000|Open-Label Treatment|Adverse Event|22|||
37974101|NCT00510146|69661391|FG001|Open-Label Treatment|Adverse Event|8|||
37974102|NCT00510146|69661390|FG000|Open-Label Treatment|Death|1|||
37974103|NCT00510146|69661391|FG001|Open-Label Treatment|Death|1|||
37974104|NCT00510146|69661390|FG000|Open-Label Treatment|Lack of Efficacy|4|||
37974105|NCT00510146|69661391|FG001|Open-Label Treatment|Lack of Efficacy|0|||
37974106|NCT00510146|69661390|FG000|Open-Label Treatment|Lost to Follow-up|10|||
37974107|NCT00510146|69661391|FG001|Open-Label Treatment|Lost to Follow-up|1|||
37974108|NCT00510146|69661390|FG000|Open-Label Treatment|Physician Decision|3|||
37974109|NCT00510146|69661391|FG001|Open-Label Treatment|Physician Decision|1|||
37974110|NCT00510146|69661390|FG000|Open-Label Treatment|Protocol Violation|4|||
37974111|NCT00510146|69661391|FG001|Open-Label Treatment|Protocol Violation|2|||
37974112|NCT00510146|69661390|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
37974113|NCT00510146|69661391|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
37974114|NCT00510146|69661390|FG000|Open-Label Treatment|Clinical Relapse|1|||
37974115|NCT00510146|69661391|FG001|Open-Label Treatment|Clinical Relapse|1|||
37974116|NCT00510146|69661390|FG000|Open-Label Treatment|Sponsor Decision|2|||
37974117|NCT00510146|69661391|FG001|Open-Label Treatment|Sponsor Decision|0|||
37974118|NCT00480636|69661399|FG000|Overall Study|Death|12|||
37974119|NCT00480636|69661399|FG000|Overall Study|Lost to Follow-up|4|||
37974120|NCT00480636|69661399|FG000|Overall Study|Other|2|||
37974121|NCT00480636|69661399|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
37974122|NCT00499122|69661403|FG000|Overall Study|Withdrawal by Subject|2|||
37974123|NCT00393939|69661410|FG000|Overall Study|Protocol Violation|1|||
37974124|NCT00393939|69661411|FG001|Overall Study|Protocol Violation|1|||
37974125|NCT00393939|69661410|FG000|Overall Study|Lost to Follow-up|2|||
37974126|NCT00393939|69661411|FG001|Overall Study|Lost to Follow-up|4|||
37974127|NCT00393939|69661410|FG000|Overall Study|Death|10|||
37692373|NCT01903252|69168667|FG002|Double-Blind Induction|Adverse Event|0|||
37864000|NCT01253291|69547596|FG002|Overall Study|Lack of Efficacy|0|||
37864001|NCT01253291|69547597|FG003|Overall Study|Lack of Efficacy|0|||
37974128|NCT00393939|69661411|FG001|Overall Study|Death|4|||
37974129|NCT00393939|69661410|FG000|Overall Study|Sponsor|5|||
37974130|NCT00393939|69661411|FG001|Overall Study|Sponsor|13|||
37974131|NCT00393939|69661410|FG000|Overall Study|Objective progression or relapse|239|||
37974132|NCT00393939|69661411|FG001|Overall Study|Objective progression or relapse|223|||
37974133|NCT00393939|69661410|FG000|Overall Study|Withdrawal by Subject|2|||
37974134|NCT00393939|69661411|FG001|Overall Study|Withdrawal by Subject|7|||
37974135|NCT00393939|69661410|FG000|Overall Study|Other|37|||
37974136|NCT00393939|69661411|FG001|Overall Study|Other|45|||
37974137|NCT00488982|69661417|FG000|Course 1|Physician Decision|0|||
37974138|NCT00488982|69661418|FG001|Course 1|Physician Decision|2|||
37974139|NCT00488982|69661419|FG002|Course 1|Physician Decision|4|||
37974140|NCT00488982|69661417|FG000|Course 1|Withdrawal by Subject|0|||
37974141|NCT00488982|69661418|FG001|Course 1|Withdrawal by Subject|8|||
37974142|NCT00488982|69661419|FG002|Course 1|Withdrawal by Subject|2|||
37974143|NCT00488982|69661417|FG000|Course 1|nonprotocol therapy|0|||
37974144|NCT00488982|69661418|FG001|Course 1|nonprotocol therapy|2|||
37974145|NCT00488982|69661419|FG002|Course 1|nonprotocol therapy|2|||
37974146|NCT00488982|69661417|FG000|Course 1|Adverse Event|0|||
37974147|NCT00488982|69661418|FG001|Course 1|Adverse Event|0|||
37974148|NCT00488982|69661419|FG002|Course 1|Adverse Event|6|||
37974149|NCT00488826|69661436|FG000|Overall Study|Withdrawal by Subject|40|||
37974150|NCT00488826|69661437|FG001|Overall Study|Withdrawal by Subject|35|||
37974151|NCT00488826|69661438|FG002|Overall Study|Withdrawal by Subject|19|||
37974152|NCT00488826|69661436|FG000|Overall Study|Protocol Violation|0|||
37974153|NCT00488826|69661437|FG001|Overall Study|Protocol Violation|0|||
37974154|NCT00488826|69661438|FG002|Overall Study|Protocol Violation|2|||
37974155|NCT00488826|69661436|FG000|Overall Study|Adverse Event|9|||
37974156|NCT00488826|69661437|FG001|Overall Study|Adverse Event|15|||
37974157|NCT00488826|69661438|FG002|Overall Study|Adverse Event|4|||
37974158|NCT00488826|69661436|FG000|Overall Study|Lost to Follow-up|5|||
37974159|NCT00488826|69661437|FG001|Overall Study|Lost to Follow-up|1|||
37974160|NCT00488826|69661438|FG002|Overall Study|Lost to Follow-up|0|||
37974161|NCT00488826|69661436|FG000|Overall Study|Protocol Deviations|2|||
37974162|NCT00488826|69661437|FG001|Overall Study|Protocol Deviations|1|||
37974163|NCT00488826|69661438|FG002|Overall Study|Protocol Deviations|1|||
37974164|NCT00393861|69661446|FG000|Overall Study|Adverse Event|2|||
37974165|NCT00393861|69661446|FG000|Overall Study|Disease Progression|24|||
37974166|NCT00480324|69661452|FG000|Overall Study|Adverse Event|1|||
37974167|NCT00480324|69661453|FG001|Overall Study|Adverse Event|1|||
37974168|NCT00480324|69661452|FG000|Overall Study|Protocol Violation|0|||
37974169|NCT00480324|69661453|FG001|Overall Study|Protocol Violation|1|||
37974170|NCT00480324|69661452|FG000|Overall Study|Withdrawal by Subject|14|||
37974171|NCT00480324|69661453|FG001|Overall Study|Withdrawal by Subject|5|||
37974172|NCT00480324|69661452|FG000|Overall Study|Lost to Follow-up|17|||
37974173|NCT00480324|69661453|FG001|Overall Study|Lost to Follow-up|8|||
37974174|NCT00480324|69661452|FG000|Overall Study|Subject's mother pregnant|0|||
37974175|NCT00480324|69661453|FG001|Overall Study|Subject's mother pregnant|1|||
37974176|NCT00488592|69661459|FG000|Overall Study|Withdrawal by Subject|1|||
37974177|NCT00488592|69661459|FG000|Overall Study|Disease progression|1|||
37974178|NCT00488592|69661459|FG000|Overall Study|Enrolled but not treated|1|||
37974179|NCT00488514|69661463|FG000|Overall Study|Adverse Event|41|||
37974180|NCT00488514|69661463|FG000|Overall Study|Lost to Follow-up|44|||
37974181|NCT00488514|69661463|FG000|Overall Study|Protocol Violation|32|||
37974182|NCT00488514|69661463|FG000|Overall Study|Withdrawal by Subject|106|||
37974183|NCT00488514|69661463|FG000|Overall Study|Lack of Efficacy|28|||
37974184|NCT00488514|69661463|FG000|Overall Study|Did not meet criteria for treatment|30|||
37974185|NCT00488514|69661463|FG000|Overall Study|Postive drug screen|1|||
37974186|NCT00488514|69661463|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
37974187|NCT00488514|69661463|FG000|Overall Study|Investigator decision|1|||
37974188|NCT00488514|69661463|FG000|Overall Study|Participant had too few migraines|5|||
37974189|NCT00488514|69661463|FG000|Overall Study|Increase in number of migraines|2|||
37974190|NCT00488514|69661463|FG000|Overall Study|Increased use of concomitant medication|1|||
37974191|NCT00320710|69661487|FG000|Overall Study|Disease progression|24|||
37974192|NCT00320710|69661488|FG001|Overall Study|Disease progression|19|||
37974193|NCT00320710|69661489|FG002|Overall Study|Disease progression|2|||
37974194|NCT00320710|69661487|FG000|Overall Study|Death|10|||
37974195|NCT00320710|69661488|FG001|Overall Study|Death|7|||
37974196|NCT00320710|69661489|FG002|Overall Study|Death|1|||
37974197|NCT00320710|69661487|FG000|Overall Study|Administrative problems|1|||
37974198|NCT00320710|69661488|FG001|Overall Study|Administrative problems|2|||
37974199|NCT00320710|69661489|FG002|Overall Study|Administrative problems|0|||
37974200|NCT00320710|69661487|FG000|Overall Study|Withdrawal by Subject|20|||
37692374|NCT01903252|69168668|FG003|Double-Blind Induction|Adverse Event|0|||
37974201|NCT00320710|69661488|FG001|Overall Study|Withdrawal by Subject|26|||
37974202|NCT00320710|69661489|FG002|Overall Study|Withdrawal by Subject|1|||
37974203|NCT00320710|69661487|FG000|Overall Study|Protocol Violation|6|||
37974204|NCT00320710|69661488|FG001|Overall Study|Protocol Violation|5|||
37974205|NCT00320710|69661489|FG002|Overall Study|Protocol Violation|0|||
37974206|NCT00320710|69661487|FG000|Overall Study|Abnormal test procedure result(s)|2|||
37974207|NCT00320710|69661488|FG001|Overall Study|Abnormal test procedure result(s)|0|||
37974208|NCT00320710|69661489|FG002|Overall Study|Abnormal test procedure result(s)|0|||
37974209|NCT00320710|69661487|FG000|Overall Study|Abnormal laboratory value(s)|12|||
37974210|NCT00320710|69661488|FG001|Overall Study|Abnormal laboratory value(s)|3|||
37974211|NCT00320710|69661489|FG002|Overall Study|Abnormal laboratory value(s)|0|||
37974212|NCT00320710|69661487|FG000|Overall Study|Adverse Event|18|||
37974213|NCT00320710|69661488|FG001|Overall Study|Adverse Event|14|||
37974214|NCT00320710|69661489|FG002|Overall Study|Adverse Event|1|||
37974215|NCT00320710|69661487|FG000|Overall Study|Lost to Follow-up|1|||
37974216|NCT00320710|69661488|FG001|Overall Study|Lost to Follow-up|0|||
37692375|NCT01903252|69168669|FG004|Double-Blind Induction|Adverse Event|0|||
37692376|NCT01903252|69168670|FG005|Double-Blind Induction|Adverse Event|0|||
37974217|NCT00320710|69661489|FG002|Overall Study|Lost to Follow-up|0|||
37974218|NCT00320398|69661498|FG000|Overall Study|Adverse Event|1|||
37974219|NCT00320398|69661499|FG001|Overall Study|Adverse Event|4|||
37974220|NCT00320398|69661498|FG000|Overall Study|Other|1|||
37974221|NCT00320398|69661499|FG001|Overall Study|Other|0|||
37974222|NCT00498186|69661506|FG000|Overall Study|Protocol Violation|10|||
37974223|NCT00498186|69661506|FG000|Overall Study|Lack of Efficacy|31|||
37974224|NCT00498186|69661506|FG000|Overall Study|Adverse Event|89|||
37974225|NCT00498186|69661506|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
37974226|NCT00498186|69661506|FG000|Overall Study|Withdrawal by Subject|18|||
37974227|NCT00498186|69661506|FG000|Overall Study|Lost to Follow-up|3|||
37974228|NCT00498186|69661506|FG000|Overall Study|Other|10|||
37974229|NCT00333970|69661512|FG000|Overall Study|Withdrawal by Subject|13|||
37974230|NCT00333970|69661513|FG001|Overall Study|Withdrawal by Subject|7|||
37974231|NCT00477594|69661521|FG000|Year 1 and Year 2|Adverse Event|4|||
37974232|NCT00477594|69661522|FG001|Year 1 and Year 2|Adverse Event|2|||
37974233|NCT00477594|69661521|FG000|Year 1 and Year 2|Physician Decision|2|||
37974234|NCT00477594|69661522|FG001|Year 1 and Year 2|Physician Decision|1|||
37974235|NCT00477594|69661521|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
37974236|NCT00477594|69661522|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
37974237|NCT00477594|69661521|FG000|Year 1 and Year 2|Other|1|||
37974238|NCT00477594|69661522|FG001|Year 1 and Year 2|Other|0|||
37974239|NCT00477594|69661521|FG000|Year 3|Adverse Event|1|||
37974240|NCT00477594|69661522|FG001|Year 3|Adverse Event|0|||
37974241|NCT00477594|69661521|FG000|Year 3|Withdrawal by Subject|1|||
37974242|NCT00477594|69661522|FG001|Year 3|Withdrawal by Subject|0|||
37974243|NCT00477594|69661521|FG000|Follow-up Period|Withdrawal by Subject|2|||
37974244|NCT00477594|69661522|FG001|Follow-up Period|Withdrawal by Subject|1|||
37974245|NCT00477594|69661521|FG000|Follow-up Period|Other|1|||
37864002|NCT01253291|69547598|FG004|Overall Study|Lack of Efficacy|0|||
37974246|NCT00477594|69661522|FG001|Follow-up Period|Other|0|||
37974247|NCT00475722|69661530|FG000|Overall Study|Withdrawal by Subject|12|||
37974248|NCT00475722|69661531|FG001|Overall Study|Withdrawal by Subject|12|||
37974249|NCT00475722|69661530|FG000|Overall Study|Protocol Violation|3|||
37974250|NCT00475722|69661531|FG001|Overall Study|Protocol Violation|0|||
37974251|NCT00304954|69661541|FG000|Overall Study|Withdrawal by Subject|0|||
37974252|NCT00304954|69661542|FG001|Overall Study|Withdrawal by Subject|0|||
37974253|NCT00304954|69661543|FG002|Overall Study|Withdrawal by Subject|1|||
37974254|NCT00304954|69661544|FG003|Overall Study|Withdrawal by Subject|0|||
37974255|NCT00304954|69661541|FG000|Overall Study|Adverse Event|1|||
37974256|NCT00304954|69661542|FG001|Overall Study|Adverse Event|0|||
37974257|NCT00304954|69661543|FG002|Overall Study|Adverse Event|0|||
37974258|NCT00304954|69661544|FG003|Overall Study|Adverse Event|0|||
37974259|NCT00475176|69661562|FG000|Overall Study|Adverse Event|2|||
37974260|NCT00475176|69661562|FG000|Overall Study|Withdrawal by Subject|1|||
37974261|NCT00475176|69661562|FG000|Overall Study|Protocol Violation|1|||
37974262|NCT00414609|69661568|FG000|Core Study|Adverse Event|9|||
37974263|NCT00414609|69661569|FG001|Core Study|Adverse Event|11|||
37974264|NCT00414609|69661570|FG002|Core Study|Adverse Event|0|||
37974265|NCT00414609|69661568|FG000|Core Study|Abnormal laboratory values|0|||
37974266|NCT00414609|69661569|FG001|Core Study|Abnormal laboratory values|1|||
37974267|NCT00414609|69661570|FG002|Core Study|Abnormal laboratory values|0|||
37974268|NCT00414609|69661568|FG000|Core Study|Abnormal test procedure results|1|||
37974269|NCT00414609|69661569|FG001|Core Study|Abnormal test procedure results|1|||
37974270|NCT00414609|69661570|FG002|Core Study|Abnormal test procedure results|0|||
37974271|NCT00414609|69661568|FG000|Core Study|Protocol deviation|0|||
37974272|NCT00414609|69661569|FG001|Core Study|Protocol deviation|1|||
37974273|NCT00414609|69661570|FG002|Core Study|Protocol deviation|0|||
37974274|NCT00414609|69661568|FG000|Core Study|Patient withdrew consent|10|||
37974275|NCT00414609|69661569|FG001|Core Study|Patient withdrew consent|11|||
37974276|NCT00414609|69661570|FG002|Core Study|Patient withdrew consent|0|||
37974277|NCT00414609|69661568|FG000|Core Study|Lost to Follow-up|7|||
37974278|NCT00414609|69661569|FG001|Core Study|Lost to Follow-up|4|||
37974279|NCT00414609|69661570|FG002|Core Study|Lost to Follow-up|0|||
37974280|NCT00414609|69661568|FG000|Core Study|Administrative problems|0|||
37974281|NCT00414609|69661569|FG001|Core Study|Administrative problems|2|||
37974282|NCT00414609|69661570|FG002|Core Study|Administrative problems|0|||
37974283|NCT00414609|69661568|FG000|Core Study|Death|7|||
37974284|NCT00414609|69661569|FG001|Core Study|Death|14|||
37974285|NCT00414609|69661570|FG002|Core Study|Death|0|||
37974286|NCT00414609|69661568|FG000|Extension Study|Adverse Event|0|||
37974287|NCT00414609|69661569|FG001|Extension Study|Adverse Event|0|||
37974288|NCT00414609|69661570|FG002|Extension Study|Adverse Event|14|||
37974289|NCT00414609|69661568|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
37974290|NCT00414609|69661569|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
37974291|NCT00414609|69661570|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
37974292|NCT00414609|69661568|FG000|Extension Study|Withdrawal by Subject|0|||
37974293|NCT00414609|69661569|FG001|Extension Study|Withdrawal by Subject|0|||
37974294|NCT00414609|69661570|FG002|Extension Study|Withdrawal by Subject|13|||
37974295|NCT00414609|69661568|FG000|Extension Study|Lost to Follow-up|0|||
37974296|NCT00414609|69661569|FG001|Extension Study|Lost to Follow-up|0|||
37974297|NCT00414609|69661570|FG002|Extension Study|Lost to Follow-up|10|||
37974298|NCT00414609|69661568|FG000|Extension Study|Administrative problems|0|||
37974299|NCT00414609|69661569|FG001|Extension Study|Administrative problems|0|||
37974300|NCT00414609|69661570|FG002|Extension Study|Administrative problems|1|||
37974301|NCT00414609|69661568|FG000|Extension Study|Death|0|||
37974302|NCT00414609|69661569|FG001|Extension Study|Death|0|||
37974303|NCT00414609|69661570|FG002|Extension Study|Death|17|||
37974304|NCT00393705|69661581|FG000|Overall Study|Adverse Event|0|||
37974305|NCT00393705|69661582|FG001|Overall Study|Adverse Event|2|||
37974306|NCT00393705|69661581|FG000|Overall Study|Death|0|||
37974307|NCT00393705|69661582|FG001|Overall Study|Death|1|||
37974308|NCT00393705|69661581|FG000|Overall Study|Lost to Follow-up|2|||
37974309|NCT00393705|69661582|FG001|Overall Study|Lost to Follow-up|2|||
37974310|NCT00393705|69661581|FG000|Overall Study|Entry Criteria Not Met|10|||
37974311|NCT00393705|69661582|FG001|Overall Study|Entry Criteria Not Met|10|||
37974312|NCT00393705|69661581|FG000|Overall Study|Protocol Violation|4|||
37974313|NCT00393705|69661582|FG001|Overall Study|Protocol Violation|3|||
37974314|NCT00393705|69661581|FG000|Overall Study|Withdrawal by Subject|5|||
37974315|NCT00393705|69661582|FG001|Overall Study|Withdrawal by Subject|3|||
37974316|NCT00393705|69661581|FG000|Overall Study|Physician Decision|2|||
37974317|NCT00393705|69661582|FG001|Overall Study|Physician Decision|2|||
37974318|NCT00303628|69661590|FG000|Overall Study|Disease progression|0|||
37974319|NCT00303628|69661591|FG001|Overall Study|Disease progression|1|||
37974320|NCT00303628|69661590|FG000|Overall Study|Adverse Event|26|||
37974321|NCT00303628|69661591|FG001|Overall Study|Adverse Event|36|||
37974322|NCT00303628|69661590|FG000|Overall Study|Death|0|||
37974323|NCT00303628|69661591|FG001|Overall Study|Death|1|||
37974324|NCT00303628|69661590|FG000|Overall Study|Withdrawal by Subject|11|||
37974325|NCT00303628|69661591|FG001|Overall Study|Withdrawal by Subject|20|||
37974326|NCT00303628|69661590|FG000|Overall Study|Alternative therapy|2|||
37974327|NCT00303628|69661591|FG001|Overall Study|Alternative therapy|0|||
37974328|NCT00303628|69661590|FG000|Overall Study|Other complicating disease|0|||
37974329|NCT00303628|69661591|FG001|Overall Study|Other complicating disease|1|||
37974330|NCT00303628|69661590|FG000|Overall Study|Not start protocol therapy|3|||
37974331|NCT00303628|69661591|FG001|Overall Study|Not start protocol therapy|5|||
37974332|NCT00303628|69661590|FG000|Overall Study|Other|8|||
37974333|NCT00303628|69661591|FG001|Overall Study|Other|9|||
37974334|NCT00414453|69661597|FG000|Overall Study|Abnormal lab work|16|||
37974335|NCT00332488|69661610|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
37974336|NCT00332488|69661611|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
37974337|NCT00332488|69661612|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
37974338|NCT00332488|69661610|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
37974339|NCT00332488|69661611|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
37974340|NCT00332488|69661612|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
37974341|NCT00332488|69661610|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
37974342|NCT00332488|69661611|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
37974343|NCT00332488|69661612|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
37974344|NCT00332488|69661610|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
37974345|NCT00332488|69661611|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
37974346|NCT00332488|69661612|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
37974347|NCT00332488|69661610|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
37974348|NCT00332488|69661611|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
37974349|NCT00332488|69661612|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
37974350|NCT00332488|69661610|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
37974351|NCT00332488|69661611|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
37974352|NCT00332488|69661612|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
37974353|NCT00332488|69661610|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
37974354|NCT00332488|69661611|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
37974355|NCT00332488|69661612|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
37974356|NCT00332488|69661610|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
37974357|NCT00332488|69661611|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
37974358|NCT00332488|69661612|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
37974359|NCT00332488|69661610|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
37974360|NCT00332488|69661611|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
37974361|NCT00332488|69661612|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
37974362|NCT00332488|69661610|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
37974363|NCT00332488|69661611|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
37974364|NCT00332488|69661612|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
37974365|NCT00332488|69661610|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
37974366|NCT00332488|69661611|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
37974367|NCT00332488|69661612|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
37974368|NCT00332488|69661610|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
37974369|NCT00332488|69661611|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
37974370|NCT00332488|69661612|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
37974371|NCT00332332|69661622|FG000|Overall Study|Adverse Event|13|||
37974372|NCT00332332|69661622|FG000|Overall Study|Death|1|||
37974373|NCT00332332|69661622|FG000|Overall Study|Withdrawal by Subject|8|||
37974374|NCT00332332|69661622|FG000|Overall Study|Physician Decision|1|||
37974375|NCT00332332|69661622|FG000|Overall Study|Lost to Follow-up|3|||
37974376|NCT00332332|69661622|FG000|Overall Study|Protocol deviation|4|||
37974377|NCT00332332|69661622|FG000|Overall Study|Noncompliance|2|||
37974378|NCT00332332|69661622|FG000|Overall Study|Disease progression|2|||
37974379|NCT00332332|69661622|FG000|Overall Study|Other|18|||
37974380|NCT00332332|69661622|FG000|Overall Study|Did not receive study treatment|16|||
37974381|NCT00392925|69661630|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
37974382|NCT00392925|69661631|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
37974383|NCT00392925|69661632|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
37974384|NCT00392925|69661633|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
37974385|NCT00392925|69661630|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
37974386|NCT00392925|69661631|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
37974387|NCT00392925|69661632|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
37974388|NCT00392925|69661633|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
37974389|NCT00392925|69661630|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
37974390|NCT00392925|69661631|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
37974391|NCT00392925|69661632|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
37974392|NCT00392925|69661633|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
37974393|NCT00392925|69661630|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
37974394|NCT00392925|69661631|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
37974395|NCT00392925|69661632|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
37974396|NCT00392925|69661633|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
37974397|NCT00392925|69661630|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
37974398|NCT00392925|69661631|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
37974399|NCT00392925|69661632|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
37974400|NCT00392925|69661633|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
37974401|NCT00392925|69661630|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
37974402|NCT00392925|69661631|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
37974403|NCT00392925|69661632|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
37974404|NCT00392925|69661633|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
37974405|NCT00392925|69661630|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
37974406|NCT00392925|69661631|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
37974407|NCT00392925|69661632|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
37864003|NCT01253291|69547594|FG000|Overall Study|Physician Decision|2|||
37692377|NCT01903252|69168665|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
37692378|NCT01903252|69168666|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
37692379|NCT01903252|69168667|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
37692380|NCT01903252|69168668|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
37692381|NCT01903252|69168669|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
37692382|NCT01903252|69168670|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
37692383|NCT01903252|69168665|FG000|Double-Blind Induction|Physician Decision|2|||
37692384|NCT01903252|69168666|FG001|Double-Blind Induction|Physician Decision|3|||
37692385|NCT01903252|69168667|FG002|Double-Blind Induction|Physician Decision|0|||
37692386|NCT01903252|69168668|FG003|Double-Blind Induction|Physician Decision|0|||
37692387|NCT01903252|69168669|FG004|Double-Blind Induction|Physician Decision|0|||
37692388|NCT01903252|69168670|FG005|Double-Blind Induction|Physician Decision|0|||
37692389|NCT01903252|69168665|FG000|Double-Blind Induction|non-compliance,|7|||
37692390|NCT01903252|69168666|FG001|Double-Blind Induction|non-compliance,|7|||
37692391|NCT01903252|69168667|FG002|Double-Blind Induction|non-compliance,|0|||
37692392|NCT01903252|69168668|FG003|Double-Blind Induction|non-compliance,|0|||
37692393|NCT01903252|69168669|FG004|Double-Blind Induction|non-compliance,|0|||
37692394|NCT01903252|69168670|FG005|Double-Blind Induction|non-compliance,|0|||
37692395|NCT01903252|69168665|FG000|Extended Induction, Open-Label|Adverse Event|0|||
37692396|NCT01903252|69168666|FG001|Extended Induction, Open-Label|Adverse Event|0|||
37692397|NCT01903252|69168667|FG002|Extended Induction, Open-Label|Adverse Event|17|||
37692398|NCT01903252|69168668|FG003|Extended Induction, Open-Label|Adverse Event|0|||
37692399|NCT01903252|69168669|FG004|Extended Induction, Open-Label|Adverse Event|0|||
37692400|NCT01903252|69168670|FG005|Extended Induction, Open-Label|Adverse Event|0|||
37692401|NCT01903252|69168665|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
37692402|NCT01903252|69168666|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
37692403|NCT01903252|69168667|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
37692404|NCT01903252|69168668|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
37692405|NCT01903252|69168669|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
37692406|NCT01903252|69168670|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
37692407|NCT01903252|69168665|FG000|Extended Induction, Open-Label|Physician Decision|0|||
37692408|NCT01903252|69168666|FG001|Extended Induction, Open-Label|Physician Decision|0|||
37692409|NCT01903252|69168667|FG002|Extended Induction, Open-Label|Physician Decision|1|||
37692410|NCT01903252|69168668|FG003|Extended Induction, Open-Label|Physician Decision|0|||
37692411|NCT01903252|69168669|FG004|Extended Induction, Open-Label|Physician Decision|0|||
37692412|NCT01903252|69168670|FG005|Extended Induction, Open-Label|Physician Decision|0|||
37692413|NCT01903252|69168665|FG000|Maintenance, Open-Label|Adverse Event|0|||
37692414|NCT01903252|69168666|FG001|Maintenance, Open-Label|Adverse Event|0|||
37692415|NCT01903252|69168667|FG002|Maintenance, Open-Label|Adverse Event|0|||
37692416|NCT01903252|69168668|FG003|Maintenance, Open-Label|Adverse Event|3|||
37974408|NCT00392925|69661633|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
37974409|NCT00392925|69661630|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
37974410|NCT00392925|69661631|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
37974411|NCT00392925|69661632|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
37974412|NCT00392925|69661633|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
37974413|NCT00392925|69661630|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
37974414|NCT00392925|69661631|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
37974415|NCT00392925|69661632|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
37974416|NCT00392925|69661633|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
37974417|NCT00474786|69661651|FG000|Overall Study|Not Meeting Study Criteria|0|||
37974418|NCT00474786|69661652|FG001|Overall Study|Not Meeting Study Criteria|1|||
37974419|NCT00474786|69661651|FG000|Overall Study|Investigator Request|2|||
37974420|NCT00474786|69661652|FG001|Overall Study|Investigator Request|1|||
37974421|NCT00474786|69661651|FG000|Overall Study|Death|189|||
37974422|NCT00474786|69661652|FG001|Overall Study|Death|170|||
37974423|NCT00474786|69661651|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
37692417|NCT01903252|69168669|FG004|Maintenance, Open-Label|Adverse Event|9|||
37692418|NCT01903252|69168670|FG005|Maintenance, Open-Label|Adverse Event|14|||
37692419|NCT01903252|69168665|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
37974424|NCT00474786|69661652|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
37974425|NCT00474786|69661651|FG000|Overall Study|Lost to Follow-up|4|||
37974426|NCT00474786|69661652|FG001|Overall Study|Lost to Follow-up|7|||
37974427|NCT00474786|69661651|FG000|Overall Study|Protocol Violation|2|||
37974428|NCT00474786|69661652|FG001|Overall Study|Protocol Violation|0|||
37974429|NCT00474786|69661651|FG000|Overall Study|Withdrawal by Subject|15|||
37974430|NCT00474786|69661652|FG001|Overall Study|Withdrawal by Subject|15|||
37974431|NCT00474786|69661651|FG000|Overall Study|Other|5|||
37974432|NCT00474786|69661652|FG001|Overall Study|Other|0|||
37692420|NCT01903252|69168666|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
37864004|NCT01253291|69547595|FG001|Overall Study|Physician Decision|0|||
37974433|NCT00392769|69661658|FG000|Overall Study|Clinical Deterioration|9|||
37974434|NCT00392769|69661658|FG000|Overall Study|Adverse Event|1|||
37974435|NCT00319696|69661662|FG000|Overall Study|Adverse Event|36|||
37974436|NCT00319696|69661662|FG000|Overall Study|withdrawal of consent|14|||
37974437|NCT00319696|69661662|FG000|Overall Study|administrative|7|||
37974438|NCT00319696|69661662|FG000|Overall Study|Lost to Follow-up|3|||
37974439|NCT00474630|69661674|FG000|Overall Study|Adverse Event|98|||
37974440|NCT00474630|69661675|FG001|Overall Study|Adverse Event|26|||
37974441|NCT00474630|69661674|FG000|Overall Study|Lost to Follow-up|22|||
37974442|NCT00474630|69661675|FG001|Overall Study|Lost to Follow-up|15|||
37974443|NCT00474630|69661674|FG000|Overall Study|Withdrawal by Subject|21|||
37974444|NCT00474630|69661675|FG001|Overall Study|Withdrawal by Subject|15|||
37974445|NCT00474630|69661674|FG000|Overall Study|Protocol Violation|3|||
37974446|NCT00474630|69661675|FG001|Overall Study|Protocol Violation|4|||
37974447|NCT00474630|69661674|FG000|Overall Study|Lack of Efficacy|5|||
37974448|NCT00474630|69661675|FG001|Overall Study|Lack of Efficacy|6|||
37974449|NCT00474630|69661674|FG000|Overall Study|Drug noncompliance, other|11|||
37974450|NCT00474630|69661675|FG001|Overall Study|Drug noncompliance, other|4|||
37974451|NCT00392379|69661684|FG000|Overall Study|Withdrawal by Subject|17|||
37974452|NCT00392379|69661685|FG001|Overall Study|Withdrawal by Subject|28|||
37974453|NCT00392379|69661684|FG000|Overall Study|Lost to Follow-up|4|||
37974454|NCT00392379|69661685|FG001|Overall Study|Lost to Follow-up|9|||
37974455|NCT00392379|69661684|FG000|Overall Study|Adverse Event|1|||
37974456|NCT00392379|69661685|FG001|Overall Study|Adverse Event|1|||
37974457|NCT00497874|69661693|FG000|Overall Study|Withdrawal by Subject|48|||
37974458|NCT00497874|69661694|FG001|Overall Study|Withdrawal by Subject|17|||
37974459|NCT00497874|69661693|FG000|Overall Study|Illness|8|||
37974460|NCT00497874|69661694|FG001|Overall Study|Illness|4|||
37974461|NCT00497874|69661693|FG000|Overall Study|Death|2|||
37974462|NCT00497874|69661694|FG001|Overall Study|Death|4|||
37974463|NCT00497874|69661693|FG000|Overall Study|Unable to contact|52|||
37974464|NCT00497874|69661694|FG001|Overall Study|Unable to contact|67|||
37974465|NCT00497874|69661693|FG000|Overall Study|Unable to schedule|37|||
37974466|NCT00497874|69661694|FG001|Overall Study|Unable to schedule|24|||
37974467|NCT00403455|69661702|FG000|Overall Study|Withdrawal by Subject|1|||
37974468|NCT00318370|69661706|FG000|Period 1|Lack of Efficacy|5|||
37864005|NCT01253291|69547596|FG002|Overall Study|Physician Decision|0|||
37974469|NCT00318370|69661707|FG001|Period 1|Lack of Efficacy|0|||
37974470|NCT00318370|69661708|FG002|Period 1|Lack of Efficacy|0|||
37974471|NCT00318370|69661706|FG000|Period 1|Physician Decision|1|||
37974472|NCT00318370|69661707|FG001|Period 1|Physician Decision|0|||
37974473|NCT00318370|69661708|FG002|Period 1|Physician Decision|0|||
37974474|NCT00318370|69661706|FG000|Period 1|Withdrawal by Subject|1|||
37974475|NCT00318370|69661707|FG001|Period 1|Withdrawal by Subject|0|||
37974476|NCT00318370|69661708|FG002|Period 1|Withdrawal by Subject|0|||
37974477|NCT00318370|69661706|FG000|Period 2|Adverse Event|0|||
37974478|NCT00318370|69661707|FG001|Period 2|Adverse Event|3|||
37974479|NCT00318370|69661708|FG002|Period 2|Adverse Event|0|||
37974480|NCT00318370|69661706|FG000|Period 2|Lack of Efficacy|0|||
37974481|NCT00318370|69661707|FG001|Period 2|Lack of Efficacy|5|||
37974482|NCT00318370|69661708|FG002|Period 2|Lack of Efficacy|0|||
37974483|NCT00318370|69661706|FG000|Period 2|Physician Decision|0|||
37974484|NCT00318370|69661707|FG001|Period 2|Physician Decision|1|||
37974485|NCT00318370|69661708|FG002|Period 2|Physician Decision|0|||
37974486|NCT00318370|69661706|FG000|Period 2|Withdrawal by Subject|0|||
37974487|NCT00318370|69661707|FG001|Period 2|Withdrawal by Subject|1|||
37974488|NCT00318370|69661708|FG002|Period 2|Withdrawal by Subject|0|||
37974489|NCT00318370|69661706|FG000|Period 2|Other|0|||
37974490|NCT00318370|69661707|FG001|Period 2|Other|1|||
37974491|NCT00318370|69661708|FG002|Period 2|Other|0|||
37974492|NCT00318370|69661706|FG000|Period 3|Adverse Event|0|||
37974493|NCT00318370|69661707|FG001|Period 3|Adverse Event|0|||
37974494|NCT00318370|69661708|FG002|Period 3|Adverse Event|1|||
37974495|NCT00318370|69661706|FG000|Period 3|Lack of Efficacy|0|||
37974496|NCT00318370|69661707|FG001|Period 3|Lack of Efficacy|0|||
37974497|NCT00318370|69661708|FG002|Period 3|Lack of Efficacy|24|||
37974498|NCT00318370|69661706|FG000|Period 3|Death|0|||
37974499|NCT00318370|69661707|FG001|Period 3|Death|0|||
37974500|NCT00318370|69661708|FG002|Period 3|Death|1|||
37974501|NCT00318370|69661706|FG000|Period 3|Physician Decision|0|||
37974502|NCT00318370|69661707|FG001|Period 3|Physician Decision|0|||
37974503|NCT00318370|69661708|FG002|Period 3|Physician Decision|1|||
37974504|NCT00318370|69661706|FG000|Period 3|Withdrawal by Subject|0|||
37974505|NCT00318370|69661707|FG001|Period 3|Withdrawal by Subject|0|||
37974506|NCT00318370|69661708|FG002|Period 3|Withdrawal by Subject|3|||
37974507|NCT00318370|69661706|FG000|Period 3|Other|0|||
37974508|NCT00318370|69661707|FG001|Period 3|Other|0|||
37974509|NCT00318370|69661708|FG002|Period 3|Other|3|||
37974510|NCT00510068|69661716|FG000|Double-blind Period|Disease progression|98|||
37974511|NCT00510068|69661717|FG001|Double-blind Period|Disease progression|169|||
37974512|NCT00510068|69661716|FG000|Double-blind Period|Final primary analysis|52|||
37974513|NCT00510068|69661717|FG001|Double-blind Period|Final primary analysis|18|||
37974514|NCT00510068|69661716|FG000|Double-blind Period|Adverse Event|37|||
37974515|NCT00510068|69661717|FG001|Double-blind Period|Adverse Event|7|||
37974516|NCT00510068|69661716|FG000|Double-blind Period|Withdrawal by Subject|8|||
37974517|NCT00510068|69661717|FG001|Double-blind Period|Withdrawal by Subject|6|||
37974518|NCT00510068|69661716|FG000|Double-blind Period|Death|4|||
37974519|NCT00510068|69661717|FG001|Double-blind Period|Death|3|||
37974520|NCT00510068|69661716|FG000|Double-blind Period|Abnormal test result (s)|1|||
37974521|NCT00510068|69661717|FG001|Double-blind Period|Abnormal test result (s)|0|||
37974522|NCT00510068|69661716|FG000|Double-blind Period|Lost to Follow-up|1|||
37974523|NCT00510068|69661717|FG001|Double-blind Period|Lost to Follow-up|0|||
37974524|NCT00510068|69661716|FG000|Double-blind Period|Protocol Violation|6|||
37974525|NCT00510068|69661717|FG001|Double-blind Period|Protocol Violation|0|||
37974526|NCT00510068|69661716|FG000|Open-label Period|Disease Progression|124|||
37974527|NCT00510068|69661717|FG001|Open-label Period|Disease Progression|0|||
37974528|NCT00510068|69661716|FG000|Open-label Period|Adverse Event|46|||
37974529|NCT00510068|69661717|FG001|Open-label Period|Adverse Event|0|||
37974530|NCT00510068|69661716|FG000|Open-label Period|Withdrawal by Subject|21|||
37974531|NCT00510068|69661717|FG001|Open-label Period|Withdrawal by Subject|0|||
37974532|NCT00510068|69661716|FG000|Open-label Period|Administrative problems|17|||
37974533|NCT00510068|69661717|FG001|Open-label Period|Administrative problems|0|||
37974534|NCT00510068|69661716|FG000|Open-label Period|Death|7|||
37974535|NCT00510068|69661717|FG001|Open-label Period|Death|0|||
37974536|NCT00510068|69661716|FG000|Open-label Period|New cancer therapy|7|||
37974537|NCT00510068|69661717|FG001|Open-label Period|New cancer therapy|0|||
37974538|NCT00510068|69661716|FG000|Open-label Period|Protocol Violation|2|||
37974539|NCT00510068|69661717|FG001|Open-label Period|Protocol Violation|0|||
37974540|NCT00510068|69661716|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
37974541|NCT00510068|69661717|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
37974542|NCT00509600|69661725|FG000|Overall Study|Adverse Event|1|||
37974543|NCT00402987|69661733|FG000|Overall Study|Lack of Efficacy|0|||
37974544|NCT00402987|69661734|FG001|Overall Study|Lack of Efficacy|0|||
37974545|NCT00402987|69661735|FG002|Overall Study|Lack of Efficacy|1|||
37781217|NCT01364298|69354924|FG000|Overall Study|Lost to Follow-up|5|||
37974546|NCT00402987|69661736|FG003|Overall Study|Lack of Efficacy|0|||
37974547|NCT00501644|69661760|FG000|Overall Study|Adverse Event|4|||
37974548|NCT00501644|69661760|FG000|Overall Study|Withdrawal by Subject|1|||
37974549|NCT00497796|69661766|FG000|Overall Study|Adverse event (not related)|9|||
37974550|NCT00497796|69661767|FG001|Overall Study|Adverse event (not related)|9|||
37974551|NCT00497796|69661766|FG000|Overall Study|Adverse event (related)|5|||
37974552|NCT00497796|69661767|FG001|Overall Study|Adverse event (related)|4|||
37974553|NCT00497796|69661766|FG000|Overall Study|CMV infection or disease treatment|30|||
37974554|NCT00497796|69661767|FG001|Overall Study|CMV infection or disease treatment|4|||
37974555|NCT00497796|69661766|FG000|Overall Study|Consent withdrawn|10|||
37974556|NCT00497796|69661767|FG001|Overall Study|Consent withdrawn|3|||
37974557|NCT00497796|69661766|FG000|Overall Study|Investigator/sponsor discretion|31|||
37974558|NCT00497796|69661767|FG001|Overall Study|Investigator/sponsor discretion|34|||
37974559|NCT00497796|69661766|FG000|Overall Study|Lost to Follow-up|0|||
37974560|NCT00497796|69661767|FG001|Overall Study|Lost to Follow-up|1|||
37974561|NCT00497796|69661766|FG000|Overall Study|Not applicable (randomized not treated)|0|||
37974562|NCT00497796|69661767|FG001|Overall Study|Not applicable (randomized not treated)|4|||
37974563|NCT00496782|69661775|FG000|Overall Study|Protocol Violation|1|||
37974564|NCT00496782|69661776|FG001|Overall Study|Protocol Violation|2|||
37974565|NCT00402831|69661784|FG000|Overall Study|Lost to Follow-up|1|||
37974566|NCT00402831|69661785|FG001|Overall Study|Lost to Follow-up|2|||
37974567|NCT00402831|69661784|FG000|Overall Study|Non-compliance with protocol|0|||
37974568|NCT00402831|69661785|FG001|Overall Study|Non-compliance with protocol|1|||
37974569|NCT00496626|69661795|FG000|Overall Study|Lost to Follow-up|0|||
37974570|NCT00496626|69661796|FG001|Overall Study|Lost to Follow-up|1|||
37974571|NCT00496626|69661795|FG000|Overall Study|Protocol Violation|1|||
37974572|NCT00496626|69661796|FG001|Overall Study|Protocol Violation|0|||
37974573|NCT00496626|69661795|FG000|Overall Study|Withdrawal by Subject|5|||
37974574|NCT00496626|69661796|FG001|Overall Study|Withdrawal by Subject|4|||
37974575|NCT00496626|69661795|FG000|Overall Study|Relocated|0|||
37974576|NCT00496626|69661796|FG001|Overall Study|Relocated|1|||
37974577|NCT00471822|69661806|FG000|Overall Study|Protocol Violation|2|||
37974578|NCT00471276|69661810|FG000|Overall Study|Death|2|||
37974579|NCT00471276|69661810|FG000|Overall Study|Adverse Event|16|||
37974580|NCT00471276|69661810|FG000|Overall Study|Protocol Violation|1|||
37974581|NCT00471276|69661810|FG000|Overall Study|Objective progression or relapse|54|||
37974582|NCT00471276|69661810|FG000|Overall Study|Global deterioration of health status|1|||
37974583|NCT00471276|69661810|FG000|Overall Study|Other|3|||
37974584|NCT00471276|69661810|FG000|Overall Study|Refused treatment|6|||
37974585|NCT00470262|69661816|FG000|Overall Study|Withdrawal by Subject|2|||
37974586|NCT00470262|69661817|FG001|Overall Study|Withdrawal by Subject|0|||
37974587|NCT00496470|69661826|FG000|Overall Study|Adverse Event|8|||
37974588|NCT00496470|69661827|FG001|Overall Study|Adverse Event|10|||
37974589|NCT00496470|69661826|FG000|Overall Study|Withdrawal by Subject|5|||
37974590|NCT00496470|69661827|FG001|Overall Study|Withdrawal by Subject|12|||
37974591|NCT00496470|69661826|FG000|Overall Study|Incorrectly enrolled|13|||
37974592|NCT00496470|69661827|FG001|Overall Study|Incorrectly enrolled|5|||
37974593|NCT00496470|69661826|FG000|Overall Study|Other reason|0|||
37974594|NCT00496470|69661827|FG001|Overall Study|Other reason|2|||
37974595|NCT00496080|69661833|FG000|Overall Study|Lost to Follow-up|9|||
37974596|NCT00496080|69661833|FG000|Overall Study|Surgical re-intervention|7|||
37974597|NCT00496080|69661833|FG000|Overall Study|Withdrawal by Subject|5|||
37974598|NCT00496080|69661833|FG000|Overall Study|Physician Decision|6|||
37974599|NCT00487578|69661840|FG000|Overall Study|Adverse Event|1|||
37974600|NCT00487578|69661841|FG001|Overall Study|Adverse Event|2|||
37974601|NCT00487578|69661840|FG000|Overall Study|Lack of Efficacy|0|||
37974602|NCT00487578|69661841|FG001|Overall Study|Lack of Efficacy|1|||
37974603|NCT00487578|69661840|FG000|Overall Study|Lost to Follow-up|0|||
37974604|NCT00487578|69661841|FG001|Overall Study|Lost to Follow-up|1|||
37974605|NCT00495612|69661849|FG000|Overall Study|Lost to Follow-up|1|||
37974606|NCT00495612|69661850|FG001|Overall Study|Lost to Follow-up|0|||
37974607|NCT00495612|69661849|FG000|Overall Study|Subject's Decision to Withdraw|3|||
37974608|NCT00495612|69661850|FG001|Overall Study|Subject's Decision to Withdraw|0|||
37974609|NCT00487188|69661858|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
37974610|NCT00487188|69661859|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
37974611|NCT00487188|69661860|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
37974612|NCT00487188|69661858|FG000|Induction Phase|Adverse Event|5|||
37974613|NCT00487188|69661859|FG001|Induction Phase|Adverse Event|0|||
37974614|NCT00487188|69661860|FG002|Induction Phase|Adverse Event|0|||
37974615|NCT00487188|69661858|FG000|Induction Phase|Lack of Efficacy|0|||
37974616|NCT00487188|69661859|FG001|Induction Phase|Lack of Efficacy|1|||
37974617|NCT00487188|69661860|FG002|Induction Phase|Lack of Efficacy|0|||
37974618|NCT00487188|69661858|FG000|Induction Phase|Protocol Violation|1|||
37974619|NCT00487188|69661859|FG001|Induction Phase|Protocol Violation|0|||
37974620|NCT00487188|69661860|FG002|Induction Phase|Protocol Violation|0|||
37974621|NCT00487188|69661858|FG000|Induction Phase|Refused Treatment|1|||
37974622|NCT00487188|69661859|FG001|Induction Phase|Refused Treatment|2|||
37974623|NCT00487188|69661860|FG002|Induction Phase|Refused Treatment|0|||
37974624|NCT00487188|69661858|FG000|Induction Phase|Lost to Follow-up|2|||
37974625|NCT00487188|69661859|FG001|Induction Phase|Lost to Follow-up|2|||
37974626|NCT00487188|69661860|FG002|Induction Phase|Lost to Follow-up|0|||
37974627|NCT00487188|69661858|FG000|Induction Phase|Administrative|0|||
37974628|NCT00487188|69661859|FG001|Induction Phase|Administrative|1|||
37974629|NCT00487188|69661860|FG002|Induction Phase|Administrative|0|||
37974630|NCT00487188|69661858|FG000|Maintenance Phase|Adverse Event|1|||
37974631|NCT00487188|69661859|FG001|Maintenance Phase|Adverse Event|0|||
37974632|NCT00487188|69661860|FG002|Maintenance Phase|Adverse Event|0|||
37974633|NCT00487188|69661858|FG000|Maintenance Phase|Death|1|||
37974634|NCT00487188|69661859|FG001|Maintenance Phase|Death|0|||
37974635|NCT00487188|69661860|FG002|Maintenance Phase|Death|0|||
37974636|NCT00487188|69661858|FG000|Maintenance Phase|Lost to Follow-up|1|||
37974637|NCT00487188|69661859|FG001|Maintenance Phase|Lost to Follow-up|0|||
37974638|NCT00487188|69661860|FG002|Maintenance Phase|Lost to Follow-up|0|||
37974639|NCT00487188|69661858|FG000|Maintenance Phase|Administrative|0|||
37974640|NCT00487188|69661859|FG001|Maintenance Phase|Administrative|0|||
37974641|NCT00487188|69661860|FG002|Maintenance Phase|Administrative|1|||
37974642|NCT00509366|69661881|FG000|Overall Study|Not Treated (Screen Failure)|1|||
37974643|NCT00509366|69661882|FG001|Overall Study|Not Treated (Screen Failure)|1|||
37974644|NCT00509366|69661883|FG002|Overall Study|Not Treated (Screen Failure)|1|||
37974645|NCT00509366|69661884|FG003|Overall Study|Not Treated (Screen Failure)|0|||
37974646|NCT00509366|69661885|FG004|Overall Study|Not Treated (Screen Failure)|0|||
37974647|NCT00500318|69661897|FG000|Overall Study|Adverse Event|3|||
37974648|NCT00500318|69661898|FG001|Overall Study|Adverse Event|8|||
37974649|NCT00500318|69661897|FG000|Overall Study|Protocol Violation|1|||
37974650|NCT00500318|69661898|FG001|Overall Study|Protocol Violation|3|||
37974651|NCT00500318|69661897|FG000|Overall Study|Withdrawal by Subject|1|||
37974652|NCT00500318|69661898|FG001|Overall Study|Withdrawal by Subject|2|||
37974653|NCT00500318|69661897|FG000|Overall Study|Lack of Efficacy|0|||
37974654|NCT00500318|69661898|FG001|Overall Study|Lack of Efficacy|3|||
37974655|NCT00500318|69661897|FG000|Overall Study|Other Reason|0|||
37974656|NCT00500318|69661898|FG001|Overall Study|Other Reason|1|||
37974657|NCT00508820|69661906|FG000|Overall Study|Adverse Event|6|||
37974658|NCT00508820|69661907|FG001|Overall Study|Adverse Event|10|||
37974659|NCT00508820|69661906|FG000|Overall Study|Death|6|||
37974660|NCT00508820|69661907|FG001|Overall Study|Death|8|||
37974661|NCT00508820|69661906|FG000|Overall Study|Lost to Follow-up|1|||
37974662|NCT00508820|69661907|FG001|Overall Study|Lost to Follow-up|1|||
37974663|NCT00508820|69661906|FG000|Overall Study|Physician Decision|8|||
37974664|NCT00508820|69661907|FG001|Overall Study|Physician Decision|2|||
37974665|NCT00508820|69661906|FG000|Overall Study|Pregnancy|0|||
37974666|NCT00508820|69661907|FG001|Overall Study|Pregnancy|2|||
37974667|NCT00508820|69661906|FG000|Overall Study|Protocol Violation|2|||
37974668|NCT00508820|69661907|FG001|Overall Study|Protocol Violation|0|||
37974669|NCT00508820|69661906|FG000|Overall Study|Withdrawal by Subject|10|||
37974670|NCT00508820|69661907|FG001|Overall Study|Withdrawal by Subject|12|||
37974671|NCT00508820|69661906|FG000|Overall Study|Other|11|||
37974672|NCT00508820|69661907|FG001|Overall Study|Other|2|||
37974673|NCT00508820|69661906|FG000|Overall Study|Noncompliance|1|||
37974674|NCT00508820|69661907|FG001|Overall Study|Noncompliance|0|||
37974675|NCT00508820|69661906|FG000|Overall Study|Requirement for alternative therapy|7|||
37974676|NCT00508820|69661907|FG001|Overall Study|Requirement for alternative therapy|15|||
37974677|NCT00508820|69661906|FG000|Overall Study|Protocol-specified Criteria|3|||
37974678|NCT00508820|69661907|FG001|Overall Study|Protocol-specified Criteria|12|||
37974679|NCT00499694|69661913|FG000|Overall Study|Patient never received treatment.|1|||
37974680|NCT00486954|69661922|FG000|Pilot Part|Adverse Event|4|||
37974681|NCT00486954|69661923|FG001|Pilot Part|Adverse Event|0|||
37974682|NCT00486954|69661924|FG002|Pilot Part|Adverse Event|5|||
37974683|NCT00486954|69661925|FG003|Pilot Part|Adverse Event|0|||
37974684|NCT00486954|69661926|FG004|Pilot Part|Adverse Event|0|||
37974685|NCT00486954|69661922|FG000|Pilot Part|Disease Progression|2|||
37974686|NCT00486954|69661923|FG001|Pilot Part|Disease Progression|0|||
37974687|NCT00486954|69661924|FG002|Pilot Part|Disease Progression|1|||
37974688|NCT00486954|69661925|FG003|Pilot Part|Disease Progression|0|||
37974689|NCT00486954|69661926|FG004|Pilot Part|Disease Progression|0|||
37974690|NCT00486954|69661922|FG000|Randomized Part|Lost to Follow-up|0|||
37974691|NCT00486954|69661923|FG001|Randomized Part|Lost to Follow-up|0|||
37974692|NCT00486954|69661924|FG002|Randomized Part|Lost to Follow-up|0|||
37974693|NCT00486954|69661925|FG003|Randomized Part|Lost to Follow-up|0|||
37974694|NCT00486954|69661926|FG004|Randomized Part|Lost to Follow-up|1|||
37974695|NCT00486954|69661922|FG000|Randomized Part|Withdrawal by Subject|0|||
37974696|NCT00486954|69661923|FG001|Randomized Part|Withdrawal by Subject|0|||
37974697|NCT00486954|69661924|FG002|Randomized Part|Withdrawal by Subject|0|||
37974698|NCT00486954|69661925|FG003|Randomized Part|Withdrawal by Subject|1|||
37692421|NCT01903252|69168667|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
37974699|NCT00486954|69661926|FG004|Randomized Part|Withdrawal by Subject|0|||
37974700|NCT00486954|69661922|FG000|Randomized Part|Sponsor Terminated Study|0|||
37974701|NCT00486954|69661923|FG001|Randomized Part|Sponsor Terminated Study|0|||
37974702|NCT00486954|69661924|FG002|Randomized Part|Sponsor Terminated Study|0|||
37974703|NCT00486954|69661925|FG003|Randomized Part|Sponsor Terminated Study|19|||
37974704|NCT00486954|69661926|FG004|Randomized Part|Sponsor Terminated Study|13|||
37974705|NCT00494676|69661936|FG000|Allocation|Withdrawal by Subject|2|||
37974706|NCT00494676|69661937|FG001|Allocation|Withdrawal by Subject|4|||
37974707|NCT00494676|69661936|FG000|First Intervention|Withdrawal by Subject|1|||
37974708|NCT00494676|69661937|FG001|First Intervention|Withdrawal by Subject|3|||
37974709|NCT00494676|69661936|FG000|Second Intervention|Withdrawal by Subject|1|||
37974710|NCT00494676|69661937|FG001|Second Intervention|Withdrawal by Subject|1|||
37974711|NCT00486720|69661945|FG000|Overall Study|Adverse Event|1|||
37974712|NCT00486720|69661946|FG001|Overall Study|Adverse Event|2|||
37974713|NCT00486720|69661945|FG000|Overall Study|Lack of Efficacy|4|||
37974714|NCT00486720|69661946|FG001|Overall Study|Lack of Efficacy|6|||
37974715|NCT00486720|69661945|FG000|Overall Study|Physician Decision|1|||
37974716|NCT00486720|69661946|FG001|Overall Study|Physician Decision|2|||
37974717|NCT00486720|69661945|FG000|Overall Study|Protocol Violation|1|||
37974718|NCT00486720|69661946|FG001|Overall Study|Protocol Violation|0|||
37974719|NCT00486720|69661945|FG000|Overall Study|Withdrawal by Subject|3|||
37974720|NCT00486720|69661946|FG001|Overall Study|Withdrawal by Subject|1|||
37974721|NCT00486720|69661945|FG000|Overall Study|Progressive Disease|0|||
37974722|NCT00486720|69661946|FG001|Overall Study|Progressive Disease|1|||
37974723|NCT00486330|69661952|FG000|Overall Study|Adverse Event|2|||
37781218|NCT01364298|69354925|FG001|Overall Study|Lost to Follow-up|10|||
37781219|NCT01364298|69354924|FG000|Overall Study|Withdrawal by Subject|3|||
37781220|NCT01364298|69354925|FG001|Overall Study|Withdrawal by Subject|3|||
37781221|NCT01364298|69354924|FG000|Overall Study|Other|1|||
37692422|NCT01903252|69168668|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
37692423|NCT01903252|69168669|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
37692424|NCT01903252|69168670|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
37692425|NCT01903252|69168665|FG000|Maintenance, Open-Label|Other|0|||
37692426|NCT01903252|69168666|FG001|Maintenance, Open-Label|Other|0|||
37692427|NCT01903252|69168667|FG002|Maintenance, Open-Label|Other|0|||
37692428|NCT01903252|69168668|FG003|Maintenance, Open-Label|Other|2|||
37692429|NCT01903252|69168669|FG004|Maintenance, Open-Label|Other|6|||
37692430|NCT01903252|69168670|FG005|Maintenance, Open-Label|Other|2|||
37692431|NCT01920958|69168688|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
37692432|NCT01613716|69168692|FG000|Overall Study|screen failures|3|||
37692433|NCT01613716|69168692|FG000|Overall Study|Lost to Follow-up|4|||
37692434|NCT01872910|69168702|FG000|Overall Study|Lost to Follow-up|2|||
37692435|NCT01872910|69168703|FG001|Overall Study|Lost to Follow-up|0|||
37692436|NCT01872910|69168704|FG002|Overall Study|Lost to Follow-up|2|||
37692437|NCT01872910|69168705|FG003|Overall Study|Lost to Follow-up|0|||
37692438|NCT01872910|69168706|FG004|Overall Study|Lost to Follow-up|0|||
37692439|NCT01872910|69168707|FG005|Overall Study|Lost to Follow-up|0|||
37692440|NCT01920568|69168722|FG000|Overall Study|Adverse Event|27|||
37692441|NCT01920568|69168723|FG001|Overall Study|Adverse Event|8|||
37692442|NCT01920568|69168722|FG000|Overall Study|Protocol Violation|5|||
37692443|NCT01920568|69168723|FG001|Overall Study|Protocol Violation|3|||
37692444|NCT01920568|69168722|FG000|Overall Study|Lost to Follow-up|2|||
37692445|NCT01920568|69168723|FG001|Overall Study|Lost to Follow-up|2|||
37692446|NCT01920568|69168722|FG000|Overall Study|Physician Decision|13|||
37692447|NCT01920568|69168723|FG001|Overall Study|Physician Decision|4|||
37692448|NCT01920568|69168722|FG000|Overall Study|Withdrawal by Subject|79|||
37692449|NCT01920568|69168723|FG001|Overall Study|Withdrawal by Subject|55|||
37692450|NCT01920568|69168722|FG000|Overall Study|Death due to disease progression|25|||
37692451|NCT01920568|69168723|FG001|Overall Study|Death due to disease progression|12|||
37692452|NCT01902628|69168730|FG000|Overall Study|Withdrawal of participant's consent|7|||
37692453|NCT01902628|69168730|FG000|Overall Study|Adverse Event|41|||
37692454|NCT01902628|69168730|FG000|Overall Study|Lost to Follow-up|35|||
37692455|NCT01920178|69168736|FG000|Overall Study|Lost to Follow-up|2|||
37692456|NCT01920178|69168737|FG001|Overall Study|Lost to Follow-up|1|||
37692457|NCT01901848|69168745|FG000|Randomized and Treated|Lost to Follow-up|3|||
37692458|NCT01901848|69168746|FG001|Randomized and Treated|Lost to Follow-up|6|||
37781222|NCT01364298|69354925|FG001|Overall Study|Other|3|||
37781223|NCT01364922|69354984|FG000|Open-label (OL) Period|Adverse Event|7|||
37692459|NCT01901848|69168745|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
37692460|NCT01901848|69168746|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
37781224|NCT01364922|69354985|FG001|Open-label (OL) Period|Adverse Event|0|||
37974724|NCT00486252|69661956|FG000|Overall Study|Adverse Event|7|||
37692461|NCT01901614|69168754|FG000|Overall Study|Adverse Event|0|||
37692462|NCT01901614|69168755|FG001|Overall Study|Adverse Event|1|||
37692463|NCT01901614|69168754|FG000|Overall Study|Lost to Follow-up|1|||
37781225|NCT01364922|69354986|FG002|Open-label (OL) Period|Adverse Event|0|||
37974725|NCT00486252|69661956|FG000|Overall Study|Lack of Efficacy|9|||
37974726|NCT00486252|69661956|FG000|Overall Study|Lost to Follow-up|24|||
37974727|NCT00486252|69661956|FG000|Overall Study|Other|18|||
37974728|NCT00494442|69661964|FG000|Overall Study|Death|1|||
37974729|NCT00494442|69661965|FG001|Overall Study|Death|1|||
37692464|NCT01901614|69168755|FG001|Overall Study|Lost to Follow-up|0|||
37692465|NCT01901614|69168754|FG000|Overall Study|Screen Fail|1|||
37692466|NCT01901614|69168755|FG001|Overall Study|Screen Fail|0|||
37692467|NCT01901302|69168763|FG000|Overall Study|Adverse Event|2|||
37692468|NCT01901302|69168764|FG001|Overall Study|Adverse Event|1|||
37692469|NCT01901302|69168763|FG000|Overall Study|Lack of Efficacy|0|||
37692470|NCT01901302|69168764|FG001|Overall Study|Lack of Efficacy|2|||
37692471|NCT01901302|69168763|FG000|Overall Study|Study Terminated by Sponsor|23|||
37692472|NCT01901302|69168764|FG001|Overall Study|Study Terminated by Sponsor|20|||
37692473|NCT01901302|69168763|FG000|Overall Study|Withdrawal by Subject|2|||
37692474|NCT01901302|69168764|FG001|Overall Study|Withdrawal by Subject|0|||
37692475|NCT01919398|69168773|FG000|Overall Study|Progressive Disease|0|||
37692476|NCT01919398|69168774|FG001|Overall Study|Progressive Disease|0|||
37692477|NCT01919398|69168775|FG002|Overall Study|Progressive Disease|4|||
37692478|NCT02500043|69168785|FG000|Overall Study|Randomized, but not Treated|2|||
37781226|NCT01364922|69354984|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
37781227|NCT01364922|69354985|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
37692479|NCT02500043|69168786|FG001|Overall Study|Randomized, but not Treated|2|||
37781228|NCT01364922|69354986|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
37781229|NCT01364922|69354984|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
37781230|NCT01364922|69354985|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
37781231|NCT01364922|69354986|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
37781232|NCT01364922|69354984|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
37781233|NCT01364922|69354985|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
37781234|NCT01364922|69354986|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
37781235|NCT01364922|69354984|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
37781236|NCT01364922|69354985|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
37781237|NCT01364922|69354986|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
37781238|NCT01364922|69354984|FG000|Open-label (OL) Period|Other, Unspecified|1|||
37781239|NCT01364922|69354985|FG001|Open-label (OL) Period|Other, Unspecified|0|||
37781240|NCT01364922|69354986|FG002|Open-label (OL) Period|Other, Unspecified|0|||
37781241|NCT01364922|69354984|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
37781242|NCT01364922|69354985|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
37781243|NCT01364922|69354986|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
37781244|NCT01364922|69354984|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
37781245|NCT01364922|69354985|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
37781246|NCT01364922|69354986|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
37781247|NCT01364922|69354984|FG000|Double-Blind (DB) Period|Adverse Event|0|||
37781248|NCT01364922|69354985|FG001|Double-Blind (DB) Period|Adverse Event|0|||
37781249|NCT01364922|69354986|FG002|Double-Blind (DB) Period|Adverse Event|1|||
37781250|NCT01364922|69354984|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
37781251|NCT01364922|69354985|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
37781252|NCT01364922|69354986|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
37781253|NCT02522286|69355160|FG000|Overall Study|Withdrawal by Subject|3|||
37781254|NCT02522286|69355161|FG001|Overall Study|Withdrawal by Subject|0|||
37781255|NCT02522286|69355162|FG002|Overall Study|Withdrawal by Subject|0|||
37781256|NCT02522286|69355163|FG003|Overall Study|Withdrawal by Subject|3|||
37781257|NCT02520726|69355184|FG000|Overall Study|Lost to Follow-up|3|||
37781258|NCT02520726|69355185|FG001|Overall Study|Lost to Follow-up|2|||
37781259|NCT02519712|69355208|FG000|Overall Study|Disease Relapse|1|||
37781260|NCT02519712|69355208|FG000|Overall Study|Disease Progression|1|||
37781261|NCT02519712|69355208|FG000|Overall Study|Accruals are donors|2|||
37781262|NCT02516202|69355451|FG000|Overall Study|Withdrawal by Subject|1|||
37781263|NCT02516202|69355452|FG001|Overall Study|Withdrawal by Subject|0|||
37692480|NCT02500043|69168785|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
37692481|NCT02500043|69168786|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
37692482|NCT02500043|69168785|FG000|Overall Study|Adverse Event|33|||
37692483|NCT02500043|69168786|FG001|Overall Study|Adverse Event|11|||
37692484|NCT02500043|69168785|FG000|Overall Study|Clinical Progression|54|||
37692485|NCT02500043|69168786|FG001|Overall Study|Clinical Progression|35|||
37692486|NCT02500043|69168785|FG000|Overall Study|Radiological Progression|192|||
37781264|NCT02516202|69355453|FG002|Overall Study|Withdrawal by Subject|1|||
37781265|NCT02516202|69355451|FG000|Overall Study|Lost to Follow-up|1|||
37781266|NCT02516202|69355452|FG001|Overall Study|Lost to Follow-up|1|||
37974730|NCT00494442|69661964|FG000|Overall Study|Lack of Efficacy|16|||
37781267|NCT02516202|69355453|FG002|Overall Study|Lost to Follow-up|1|||
37781268|NCT02516202|69355451|FG000|Overall Study|Stopped Follow-up|0|||
37781269|NCT02516202|69355452|FG001|Overall Study|Stopped Follow-up|0|||
37974731|NCT00494442|69661965|FG001|Overall Study|Lack of Efficacy|10|||
37692487|NCT02500043|69168786|FG001|Overall Study|Radiological Progression|110|||
37781270|NCT02516202|69355453|FG002|Overall Study|Stopped Follow-up|1|||
37781271|NCT02518620|69355659|FG000|Overall Study|Adverse Event|23|||
37781272|NCT02518620|69355660|FG001|Overall Study|Adverse Event|11|||
37781273|NCT02518620|69355659|FG000|Overall Study|Lack of Efficacy|2|||
37781274|NCT02518620|69355660|FG001|Overall Study|Lack of Efficacy|0|||
37781275|NCT02518620|69355659|FG000|Overall Study|Non-Compliance with Study Drug|1|||
37781276|NCT02518620|69355660|FG001|Overall Study|Non-Compliance with Study Drug|0|||
37781277|NCT02518620|69355659|FG000|Overall Study|Physician Decision|1|||
37781278|NCT02518620|69355660|FG001|Overall Study|Physician Decision|1|||
37781279|NCT02518620|69355659|FG000|Overall Study|Sponsor's Decision|0|||
37781280|NCT02518620|69355660|FG001|Overall Study|Sponsor's Decision|3|||
37781281|NCT02518620|69355659|FG000|Overall Study|Lost to Follow-up|1|||
37781282|NCT02518620|69355660|FG001|Overall Study|Lost to Follow-up|1|||
37781283|NCT02518620|69355659|FG000|Overall Study|Withdrawal by Subject|17|||
37781284|NCT02518620|69355660|FG001|Overall Study|Withdrawal by Subject|9|||
37974732|NCT00494442|69661964|FG000|Overall Study|Adverse Event|0|||
37974733|NCT00494442|69661965|FG001|Overall Study|Adverse Event|2|||
37974734|NCT00494442|69661964|FG000|Overall Study|Physician Decision|0|||
37692488|NCT02500043|69168785|FG000|Overall Study|Physician's Decision|11|||
37692489|NCT02500043|69168786|FG001|Overall Study|Physician's Decision|3|||
37692490|NCT02500043|69168785|FG000|Overall Study|Withdrawal by Subject|14|||
37692491|NCT02500043|69168786|FG001|Overall Study|Withdrawal by Subject|4|||
37692492|NCT02500043|69168785|FG000|Overall Study|Death|11|||
37692493|NCT02500043|69168786|FG001|Overall Study|Death|2|||
37692494|NCT02500043|69168785|FG000|Overall Study|Protocol Deviation|1|||
37692495|NCT02500043|69168786|FG001|Overall Study|Protocol Deviation|0|||
37692496|NCT02499575|69168794|FG000|Overall Study|Protocol Violation|0|||
37692497|NCT02499575|69168795|FG001|Overall Study|Protocol Violation|1|||
37692498|NCT02065791|69168803|FG000|Overall Study|Closed Site|1|||
37692499|NCT02065791|69168804|FG001|Overall Study|Closed Site|1|||
37781285|NCT02518620|69355659|FG000|Overall Study|Death|1|||
37781286|NCT02518620|69355660|FG001|Overall Study|Death|0|||
37781287|NCT02518620|69355659|FG000|Overall Study|Pregnancy Wish|3|||
37781288|NCT02518620|69355660|FG001|Overall Study|Pregnancy Wish|0|||
37692500|NCT02065791|69168803|FG000|Overall Study|Withdrawal by Subject|11|||
37781289|NCT02518620|69355659|FG000|Overall Study|Pregnancy|1|||
37781290|NCT02518620|69355660|FG001|Overall Study|Pregnancy|0|||
37781291|NCT02518620|69355659|FG000|Overall Study|Relocation|2|||
37781292|NCT02518620|69355660|FG001|Overall Study|Relocation|1|||
37781293|NCT01653912|69355839|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
37781294|NCT01653912|69355840|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
37781295|NCT01653912|69355841|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
37781296|NCT01653912|69355842|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
37781297|NCT01653912|69355843|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
37781298|NCT01653912|69355844|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
37781299|NCT01653912|69355839|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
37781300|NCT01653912|69355840|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
37781301|NCT01653912|69355841|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
37781302|NCT01653912|69355842|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
37692501|NCT02065791|69168804|FG001|Overall Study|Withdrawal by Subject|5|||
37692502|NCT02065791|69168803|FG000|Overall Study|Lost to Follow-up|13|||
37692503|NCT02065791|69168804|FG001|Overall Study|Lost to Follow-up|9|||
37692504|NCT02499263|69168810|FG000|Overall Study|Lost to Follow-up|9|||
37692505|NCT02499263|69168810|FG000|Overall Study|Participant's withdrawal of consent|4|||
37692506|NCT02499263|69168810|FG000|Overall Study|Lack of Efficacy|22|||
37692507|NCT02499263|69168810|FG000|Overall Study|investigator's judgment|12|||
37692508|NCT02499263|69168810|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
37692509|NCT02499263|69168810|FG000|Overall Study|Participant's decision|3|||
37781303|NCT01653912|69355843|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
37781304|NCT01653912|69355844|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
37974735|NCT00494442|69661965|FG001|Overall Study|Physician Decision|1|||
37781305|NCT01653912|69355839|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
37781306|NCT01653912|69355840|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
37781307|NCT01653912|69355841|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
37781308|NCT01653912|69355842|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
37781309|NCT01653912|69355843|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
37781310|NCT01653912|69355844|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
37781311|NCT01653912|69355839|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
37781312|NCT01653912|69355840|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
37781313|NCT01653912|69355841|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
37781314|NCT01653912|69355842|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
37781315|NCT01653912|69355843|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
37781316|NCT01653912|69355844|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
37781317|NCT01653912|69355839|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
37781318|NCT01653912|69355840|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
37781319|NCT01653912|69355841|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
37781320|NCT01653912|69355842|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
37781321|NCT01653912|69355843|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
37781322|NCT01653912|69355844|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
37781323|NCT01653912|69355839|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
37781324|NCT01653912|69355840|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
37781325|NCT01653912|69355841|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
37781326|NCT01653912|69355842|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
37692510|NCT02499263|69168810|FG000|Overall Study|Pregnancy|1|||
37692511|NCT01654289|69168817|FG000|Overall Study|Withdrawal by Subject|10|||
37692512|NCT01654289|69168818|FG001|Overall Study|Withdrawal by Subject|8|||
37781327|NCT01653912|69355843|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
37781328|NCT01653912|69355844|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
37781329|NCT01653912|69355839|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
37781330|NCT01653912|69355840|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
37781331|NCT01653912|69355841|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
37781332|NCT01653912|69355842|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
37781333|NCT01653912|69355843|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
37781334|NCT01653912|69355844|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
37781335|NCT02483520|69355870|FG000|Overall Study|Lost to Follow-up|3|||
37781336|NCT02483520|69355871|FG001|Overall Study|Lost to Follow-up|4|||
37781337|NCT02483520|69355870|FG000|Overall Study|Withdrawal by Subject|4|||
37781338|NCT02483520|69355871|FG001|Overall Study|Withdrawal by Subject|14|||
37781339|NCT02483520|69355870|FG000|Overall Study|Hospitalized|2|||
37781340|NCT02483520|69355871|FG001|Overall Study|Hospitalized|3|||
37781341|NCT02483520|69355870|FG000|Overall Study|Moved to LTC|2|||
37781342|NCT02483520|69355871|FG001|Overall Study|Moved to LTC|3|||
37781343|NCT02514174|69355877|FG000|Overall Study|Patient refused to continue medication|1|||
37781344|NCT02514174|69355877|FG000|Overall Study|Adverse Event|2|||
37781345|NCT02514174|69355877|FG000|Overall Study|Study closed by sponsor|9|||
37781346|NCT02514174|69355877|FG000|Overall Study|Progressive disease|11|||
37781347|NCT02514174|69355877|FG000|Overall Study|Treatment change|1|||
37781348|NCT02514174|69355877|FG000|Overall Study|Treated off study with Afatinib.|1|||
37781349|NCT02482428|69355937|FG000|Overall Study|Lost to Follow-up|4|||
37781350|NCT02482428|69355938|FG001|Overall Study|Lost to Follow-up|9|||
37781351|NCT02482428|69355939|FG002|Overall Study|Lost to Follow-up|1|||
37781352|NCT02482428|69355940|FG003|Overall Study|Lost to Follow-up|2|||
37781353|NCT02482428|69355941|FG004|Overall Study|Lost to Follow-up|4|||
37781354|NCT02482428|69355937|FG000|Overall Study|Physician Decision|0|||
37781355|NCT02482428|69355938|FG001|Overall Study|Physician Decision|0|||
37781356|NCT02482428|69355939|FG002|Overall Study|Physician Decision|0|||
37781357|NCT02482428|69355940|FG003|Overall Study|Physician Decision|0|||
37781358|NCT02482428|69355941|FG004|Overall Study|Physician Decision|1|||
37781359|NCT02482428|69355937|FG000|Overall Study|protocol deviation|1|||
37781360|NCT02482428|69355938|FG001|Overall Study|protocol deviation|1|||
37864006|NCT01253291|69547597|FG003|Overall Study|Physician Decision|0|||
37974736|NCT00494442|69661964|FG000|Overall Study|Non-compliance|0|||
37692513|NCT01654289|69168819|FG002|Overall Study|Withdrawal by Subject|5|||
37692514|NCT01654289|69168817|FG000|Overall Study|Withdrew from intervention only|17|||
37692515|NCT01654289|69168818|FG001|Overall Study|Withdrew from intervention only|20|||
37692516|NCT01654289|69168819|FG002|Overall Study|Withdrew from intervention only|0|||
37692517|NCT02499029|69168829|FG000|Overall Study|Lost to Follow-up|2|||
37692518|NCT02499029|69168830|FG001|Overall Study|Lost to Follow-up|2|||
37692519|NCT02499029|69168829|FG000|Overall Study|Physician Decision|2|||
37692520|NCT02499029|69168830|FG001|Overall Study|Physician Decision|1|||
37692521|NCT02499029|69168829|FG000|Overall Study|Death|1|||
37692522|NCT02499029|69168830|FG001|Overall Study|Death|0|||
37692523|NCT04968353|69168840|FG000|Overall Study|Non-compliance|1|||
37781361|NCT02482428|69355939|FG002|Overall Study|protocol deviation|0|||
37781362|NCT02482428|69355940|FG003|Overall Study|protocol deviation|0|||
37781363|NCT02482428|69355941|FG004|Overall Study|protocol deviation|0|||
37781364|NCT02482428|69355937|FG000|Overall Study|subject/guardian decision|4|||
37864007|NCT01253291|69547598|FG004|Overall Study|Physician Decision|2|||
37781365|NCT02482428|69355938|FG001|Overall Study|subject/guardian decision|2|||
37781366|NCT02482428|69355939|FG002|Overall Study|subject/guardian decision|0|||
37781367|NCT02482428|69355940|FG003|Overall Study|subject/guardian decision|0|||
37781368|NCT02482428|69355941|FG004|Overall Study|subject/guardian decision|2|||
37781369|NCT02480712|69355989|FG000|Overall Study|Enrolled but Never Treated|1|||
37781370|NCT02480712|69355989|FG000|Overall Study|Lost to Follow-up|5|||
37781371|NCT02480712|69355989|FG000|Overall Study|Withdrew Consent|3|||
37781372|NCT02480712|69355989|FG000|Overall Study|Death|1|||
37974737|NCT00494442|69661965|FG001|Overall Study|Non-compliance|1|||
37974738|NCT00494442|69661964|FG000|Overall Study|Intercurrent illness|0|||
37781373|NCT02480712|69355989|FG000|Overall Study|Lack of Efficacy|1|||
37974739|NCT00494442|69661965|FG001|Overall Study|Intercurrent illness|1|||
37974740|NCT03851016|69661973|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
37974741|NCT03851016|69661974|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
37692524|NCT04968353|69168841|FG001|Overall Study|Non-compliance|0|||
37692525|NCT04968353|69168842|FG002|Overall Study|Non-compliance|2|||
37692526|NCT04968353|69168843|FG003|Overall Study|Non-compliance|0|||
37692527|NCT02065713|69168855|FG000|Overall Study|Adverse Event|0|||
37692528|NCT02065713|69168856|FG001|Overall Study|Adverse Event|1|||
37692529|NCT02065713|69168855|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
37692530|NCT02065713|69168856|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
37781374|NCT02513550|69357258|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
37781375|NCT02513550|69357259|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
37781376|NCT02513550|69357260|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
37781377|NCT02513550|69357261|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
37781378|NCT02513550|69357262|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
37781379|NCT02513550|69357263|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
37781380|NCT02513550|69357258|FG000|Double Blind Treatment Period|Adverse Event|5|||
37781381|NCT02513550|69357259|FG001|Double Blind Treatment Period|Adverse Event|13|||
37781382|NCT02513550|69357260|FG002|Double Blind Treatment Period|Adverse Event|17|||
37781383|NCT02513550|69357261|FG003|Double Blind Treatment Period|Adverse Event|0|||
37781384|NCT02513550|69357262|FG004|Double Blind Treatment Period|Adverse Event|1|||
37781385|NCT02513550|69357263|FG005|Double Blind Treatment Period|Adverse Event|0|||
37781386|NCT02513550|69357258|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
37781387|NCT02513550|69357259|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
37781388|NCT02513550|69357260|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
37781389|NCT02513550|69357261|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
37781390|NCT02513550|69357262|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
37692531|NCT02497781|69168864|FG000|Overall Study|Withdrawal by Subject|2|||
37692532|NCT02497781|69168865|FG001|Overall Study|Withdrawal by Subject|0|||
37692533|NCT02497781|69168864|FG000|Overall Study|Lack of Efficacy|0|||
37692534|NCT02497781|69168865|FG001|Overall Study|Lack of Efficacy|1|||
37692535|NCT02497781|69168864|FG000|Overall Study|Randomised but not treated|1|||
37692536|NCT02497781|69168865|FG001|Overall Study|Randomised but not treated|1|||
37692537|NCT02497781|69168864|FG000|Overall Study|Lost to Follow-up|1|||
37692538|NCT02497781|69168865|FG001|Overall Study|Lost to Follow-up|1|||
37692539|NCT02497469|69168873|FG000|Overall Study|Randomized but not Treated|0|||
37692540|NCT02497469|69168874|FG001|Overall Study|Randomized but not Treated|2|||
37692541|NCT02497469|69168873|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
37692542|NCT02497469|69168874|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
37692543|NCT02497469|69168873|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
37692544|NCT02497469|69168874|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
37692545|NCT02497469|69168873|FG000|Overall Study|Significant Protocol Deviation|4|||
37692546|NCT02497469|69168874|FG001|Overall Study|Significant Protocol Deviation|5|||
37692547|NCT02497469|69168873|FG000|Overall Study|Lost to Follow-up|14|||
37692548|NCT02497469|69168874|FG001|Overall Study|Lost to Follow-up|4|||
37692549|NCT02497469|69168873|FG000|Overall Study|Voluntary Withdrawal|39|||
37692550|NCT02497469|69168874|FG001|Overall Study|Voluntary Withdrawal|41|||
37692551|NCT02497469|69168873|FG000|Overall Study|Pregnancy|1|||
37781391|NCT02513550|69357263|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
37781392|NCT02513550|69357258|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
37974742|NCT00493974|69661982|FG000|Overall Study|Death|1|||
37692552|NCT02497469|69168874|FG001|Overall Study|Pregnancy|1|||
37692553|NCT02497469|69168873|FG000|Overall Study|Lack of Efficacy|86|||
37692554|NCT02497469|69168874|FG001|Overall Study|Lack of Efficacy|40|||
37692555|NCT02497469|69168873|FG000|Overall Study|Reason not Specified|6|||
37692556|NCT02497469|69168874|FG001|Overall Study|Reason not Specified|6|||
37692557|NCT02497391|69168880|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
37692558|NCT02497391|69168881|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
37692559|NCT02497391|69168882|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
37692560|NCT02497391|69168883|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
37692561|NCT02497391|69168884|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
37692562|NCT02497391|69168885|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
37692563|NCT02497391|69168880|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
37692564|NCT02497391|69168881|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
37692565|NCT02497391|69168882|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
37692566|NCT02497391|69168883|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
37692567|NCT02497391|69168884|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
37692568|NCT02497391|69168885|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
37692569|NCT02497391|69168880|FG000|Period 3 (14 Days)|Adverse Event|0|||
37692570|NCT02497391|69168881|FG001|Period 3 (14 Days)|Adverse Event|1|||
37692571|NCT02497391|69168882|FG002|Period 3 (14 Days)|Adverse Event|0|||
37692572|NCT02497391|69168883|FG003|Period 3 (14 Days)|Adverse Event|0|||
37692573|NCT02497391|69168884|FG004|Period 3 (14 Days)|Adverse Event|0|||
37692574|NCT02497391|69168885|FG005|Period 3 (14 Days)|Adverse Event|0|||
37692575|NCT02497391|69168880|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
37974743|NCT00493974|69661983|FG001|Overall Study|Death|2|||
37974744|NCT00493974|69661982|FG000|Overall Study|Withdrawal by Subject|8|||
37974745|NCT00493974|69661983|FG001|Overall Study|Withdrawal by Subject|6|||
37974746|NCT00493974|69661982|FG000|Overall Study|Lost to Follow-up|4|||
37974747|NCT00493974|69661983|FG001|Overall Study|Lost to Follow-up|6|||
37974748|NCT00469092|69661991|FG000|Overall Study|Adverse Event|5|||
37974749|NCT00469092|69661992|FG001|Overall Study|Adverse Event|4|||
37974750|NCT00469092|69661991|FG000|Overall Study|Lack of Efficacy|1|||
37974751|NCT00469092|69661992|FG001|Overall Study|Lack of Efficacy|0|||
37692576|NCT02497391|69168881|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
37974752|NCT00469092|69661991|FG000|Overall Study|Lost to Follow-up|1|||
37781393|NCT02513550|69357259|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
37781394|NCT02513550|69357260|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
37781395|NCT02513550|69357261|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
37781396|NCT02513550|69357262|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
37781397|NCT02513550|69357263|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
37781398|NCT02513550|69357258|FG000|Double Blind Treatment Period|Protocol Violation|1|||
37781399|NCT02513550|69357259|FG001|Double Blind Treatment Period|Protocol Violation|1|||
37781400|NCT02513550|69357260|FG002|Double Blind Treatment Period|Protocol Violation|4|||
37781401|NCT02513550|69357261|FG003|Double Blind Treatment Period|Protocol Violation|0|||
37781402|NCT02513550|69357262|FG004|Double Blind Treatment Period|Protocol Violation|0|||
37781403|NCT02513550|69357263|FG005|Double Blind Treatment Period|Protocol Violation|0|||
37781404|NCT02513550|69357258|FG000|Double Blind Treatment Period|Physician Decision|2|||
37781405|NCT02513550|69357259|FG001|Double Blind Treatment Period|Physician Decision|0|||
37781406|NCT02513550|69357260|FG002|Double Blind Treatment Period|Physician Decision|4|||
37781407|NCT02513550|69357261|FG003|Double Blind Treatment Period|Physician Decision|0|||
37781408|NCT02513550|69357262|FG004|Double Blind Treatment Period|Physician Decision|0|||
37781409|NCT02513550|69357263|FG005|Double Blind Treatment Period|Physician Decision|0|||
37781410|NCT02513550|69357258|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
37781411|NCT02513550|69357259|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
37781412|NCT02513550|69357260|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
37781413|NCT02513550|69357261|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
37781414|NCT02513550|69357262|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
37781415|NCT02513550|69357263|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
37781416|NCT02513550|69357258|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
37781417|NCT02513550|69357259|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
37781418|NCT02513550|69357260|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
37781419|NCT02513550|69357261|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
37781420|NCT02513550|69357262|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
37781421|NCT02513550|69357263|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
37781422|NCT02513550|69357258|FG000|Double Blind Treatment Period|Due to personal business|2|||
37781423|NCT02513550|69357259|FG001|Double Blind Treatment Period|Due to personal business|0|||
37781424|NCT02513550|69357260|FG002|Double Blind Treatment Period|Due to personal business|1|||
37781425|NCT02513550|69357261|FG003|Double Blind Treatment Period|Due to personal business|0|||
37864008|NCT01121757|69547613|FG000|First Drug|Death|1|||
37692577|NCT02497391|69168882|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
37692578|NCT02497391|69168883|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
37692579|NCT02497391|69168884|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
37692580|NCT02497391|69168885|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
37692581|NCT02497391|69168880|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
37692582|NCT02497391|69168881|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
37692583|NCT02497391|69168882|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
37692584|NCT02497391|69168883|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
37692585|NCT02497391|69168884|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
37692586|NCT02497391|69168885|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
37781426|NCT02513550|69357262|FG004|Double Blind Treatment Period|Due to personal business|0|||
37781427|NCT02513550|69357263|FG005|Double Blind Treatment Period|Due to personal business|0|||
37781428|NCT02513550|69357258|FG000|Double Blind Treatment Period|Death|1|||
37781429|NCT02513550|69357259|FG001|Double Blind Treatment Period|Death|0|||
37781430|NCT02513550|69357260|FG002|Double Blind Treatment Period|Death|2|||
37781431|NCT02513550|69357261|FG003|Double Blind Treatment Period|Death|0|||
37781432|NCT02513550|69357262|FG004|Double Blind Treatment Period|Death|0|||
37781433|NCT02513550|69357263|FG005|Double Blind Treatment Period|Death|0|||
37781434|NCT02513550|69357258|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
37781435|NCT02513550|69357259|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
37781436|NCT02513550|69357260|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
37781437|NCT02513550|69357261|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
37781438|NCT02513550|69357262|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
37781439|NCT02513550|69357263|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
37781440|NCT02513550|69357258|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
37781441|NCT02513550|69357259|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
37781442|NCT02513550|69357260|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
37781443|NCT02513550|69357261|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
37781444|NCT02513550|69357262|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
37781445|NCT02513550|69357263|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
37781446|NCT02513550|69357258|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
37781447|NCT02513550|69357259|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
37781448|NCT02513550|69357260|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
37781449|NCT02513550|69357261|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
37781450|NCT02513550|69357262|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
37781451|NCT02513550|69357263|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
37781452|NCT02513550|69357258|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
37781453|NCT02513550|69357259|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
37781454|NCT02513550|69357260|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
37781455|NCT02513550|69357261|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
37781456|NCT02513550|69357262|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
37781457|NCT02513550|69357263|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
37781458|NCT02513550|69357258|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
37781459|NCT02513550|69357259|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
37781460|NCT02513550|69357260|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
37781461|NCT02513550|69357261|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
37781462|NCT02513550|69357262|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
37781463|NCT02513550|69357263|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
37781464|NCT02513550|69357258|FG000|Post-Treatment Follow-up Period|Death|0|||
37781465|NCT02513550|69357259|FG001|Post-Treatment Follow-up Period|Death|0|||
37781466|NCT02513550|69357260|FG002|Post-Treatment Follow-up Period|Death|1|||
37781467|NCT02513550|69357261|FG003|Post-Treatment Follow-up Period|Death|0|||
37781468|NCT02513550|69357262|FG004|Post-Treatment Follow-up Period|Death|0|||
37781469|NCT02513550|69357263|FG005|Post-Treatment Follow-up Period|Death|0|||
37781470|NCT02513550|69357258|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
37781471|NCT02513550|69357259|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
37781472|NCT02513550|69357260|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
37974753|NCT00469092|69661992|FG001|Overall Study|Lost to Follow-up|2|||
37974754|NCT00469092|69661991|FG000|Overall Study|Protocol Violation|3|||
37974755|NCT00469092|69661992|FG001|Overall Study|Protocol Violation|3|||
37974756|NCT00469092|69661991|FG000|Overall Study|Withdrawal by Subject|4|||
37974757|NCT00469092|69661992|FG001|Overall Study|Withdrawal by Subject|4|||
37974758|NCT00469092|69661991|FG000|Overall Study|Withdrawal Criteria|3|||
37974759|NCT00469092|69661992|FG001|Overall Study|Withdrawal Criteria|4|||
37974760|NCT00469092|69661991|FG000|Overall Study|Incorrectly Randomised|4|||
37974761|NCT00469092|69661992|FG001|Overall Study|Incorrectly Randomised|3|||
37974762|NCT00469092|69661991|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
37974763|NCT00469092|69661992|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
37974764|NCT00469092|69661991|FG000|Overall Study|Use of lipid lowering drug|1|||
37974765|NCT00469092|69661992|FG001|Overall Study|Use of lipid lowering drug|0|||
37974766|NCT00469092|69661991|FG000|Overall Study|Hypoglycaemic Episodes|1|||
37974767|NCT00469092|69661992|FG001|Overall Study|Hypoglycaemic Episodes|1|||
37974768|NCT00469092|69661991|FG000|Overall Study|Abnormal lab value|1|||
37974769|NCT00469092|69661992|FG001|Overall Study|Abnormal lab value|0|||
37781473|NCT02513550|69357261|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
37781474|NCT02513550|69357262|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
37781475|NCT02513550|69357263|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
37781476|NCT02513550|69357258|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
37781477|NCT02513550|69357259|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
37781478|NCT02513550|69357260|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
37781479|NCT02513550|69357261|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
37781480|NCT02513550|69357262|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
37781481|NCT02513550|69357263|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
37781482|NCT02513550|69357258|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
37781483|NCT02513550|69357259|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
37781484|NCT02513550|69357260|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
37781485|NCT02513550|69357261|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
37781486|NCT02513550|69357262|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
37781487|NCT02513550|69357263|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
37864009|NCT01121757|69547614|FG001|First Drug|Death|0|||
37864010|NCT01121757|69547613|FG000|First Drug|Disease Progression|0|||
37781488|NCT02513472|69357580|FG000|Overall Study|Radiological Disease Progression|45|||
37781489|NCT02513472|69357581|FG001|Overall Study|Radiological Disease Progression|57|||
37781490|NCT02513472|69357580|FG000|Overall Study|Clinical Disease Progression|5|||
37781491|NCT02513472|69357581|FG001|Overall Study|Clinical Disease Progression|13|||
37781492|NCT02513472|69357580|FG000|Overall Study|Adverse Event|8|||
37781493|NCT02513472|69357581|FG001|Overall Study|Adverse Event|11|||
37781494|NCT02513472|69357580|FG000|Overall Study|Withdrawal by Subject|0|||
37781495|NCT02513472|69357581|FG001|Overall Study|Withdrawal by Subject|4|||
37781496|NCT02513472|69357580|FG000|Overall Study|Subject Choice|2|||
37781497|NCT02513472|69357581|FG001|Overall Study|Subject Choice|7|||
37781498|NCT02513472|69357580|FG000|Overall Study|Treatment Completed as per Protocol|3|||
37781499|NCT02513472|69357581|FG001|Overall Study|Treatment Completed as per Protocol|3|||
37781500|NCT02513472|69357580|FG000|Overall Study|Other|3|||
37781501|NCT02513472|69357581|FG001|Overall Study|Other|6|||
37781502|NCT04490395|69357801|FG000|Overall Study|Lost to Follow-up|0|||
37781503|NCT04490395|69357802|FG001|Overall Study|Lost to Follow-up|1|||
37781504|NCT03843541|69358245|FG000|Overall Study|Adverse Event|4|||
37781505|NCT03843541|69358246|FG001|Overall Study|Adverse Event|2|||
37781506|NCT03843541|69358247|FG002|Overall Study|Adverse Event|3|||
37781507|NCT03843541|69358245|FG000|Overall Study|Death|1|||
37781508|NCT03843541|69358246|FG001|Overall Study|Death|0|||
37781509|NCT03843541|69358247|FG002|Overall Study|Death|0|||
37781510|NCT03843541|69358245|FG000|Overall Study|Lack of adherence to study medication|0|||
37781511|NCT03843541|69358246|FG001|Overall Study|Lack of adherence to study medication|0|||
37781512|NCT03843541|69358247|FG002|Overall Study|Lack of adherence to study medication|1|||
37781513|NCT03843541|69358245|FG000|Overall Study|Physician Decision|1|||
37781514|NCT03843541|69358246|FG001|Overall Study|Physician Decision|2|||
37781515|NCT03843541|69358247|FG002|Overall Study|Physician Decision|2|||
37781516|NCT03843541|69358245|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
37781517|NCT03843541|69358246|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
37781518|NCT03843541|69358247|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
37781519|NCT03843541|69358245|FG000|Overall Study|Withdrawal by Subject|6|||
37781520|NCT03843541|69358246|FG001|Overall Study|Withdrawal by Subject|9|||
37781521|NCT03843541|69358247|FG002|Overall Study|Withdrawal by Subject|7|||
37781522|NCT03843541|69358245|FG000|Overall Study|Administration of rescue mucolytic|0|||
37781523|NCT03843541|69358246|FG001|Overall Study|Administration of rescue mucolytic|0|||
37781524|NCT03843541|69358247|FG002|Overall Study|Administration of rescue mucolytic|1|||
37781525|NCT03843541|69358245|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
37781526|NCT03843541|69358246|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
37781527|NCT03843541|69358247|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
37781528|NCT02992418|69359510|FG000|Overall Study|Withdrawal by Subject|11|||
37781529|NCT02992418|69359511|FG001|Overall Study|Withdrawal by Subject|12|||
37781530|NCT02992418|69359510|FG000|Overall Study|Non-compliance with the protocol|308|||
37781531|NCT02992418|69359511|FG001|Overall Study|Non-compliance with the protocol|308|||
37781532|NCT02992418|69359510|FG000|Overall Study|Lost to Follow-up|27|||
37781533|NCT02992418|69359511|FG001|Overall Study|Lost to Follow-up|22|||
37781534|NCT01276106|69359753|FG000|Overall Study|Adverse Event|3|||
37781535|NCT01276106|69359754|FG001|Overall Study|Adverse Event|3|||
37974770|NCT00469092|69661991|FG000|Overall Study|Use of Corticosteroid|1|||
37974771|NCT00469092|69661992|FG001|Overall Study|Use of Corticosteroid|0|||
37974772|NCT00499616|69662002|FG000|Overall Study|Death|1|||
37781536|NCT01276106|69359755|FG002|Overall Study|Adverse Event|11|||
37781537|NCT01276106|69359756|FG003|Overall Study|Adverse Event|3|||
37864011|NCT01121757|69547614|FG001|First Drug|Disease Progression|2|||
37864012|NCT01121757|69547613|FG000|Combination|Physician Decision|0|||
37864013|NCT01121757|69547614|FG001|Combination|Physician Decision|1|||
37864014|NCT01121757|69547613|FG000|Combination|Disease Progression|2|||
37864015|NCT01121757|69547614|FG001|Combination|Disease Progression|0|||
37974773|NCT00499616|69662003|FG001|Overall Study|Death|5|||
37974774|NCT00499616|69662004|FG002|Overall Study|Death|3|||
37974775|NCT00499616|69662005|FG003|Overall Study|Death|1|||
37974776|NCT00499616|69662002|FG000|Overall Study|Lack of Efficacy|5|||
37974777|NCT00499616|69662003|FG001|Overall Study|Lack of Efficacy|0|||
37974778|NCT00499616|69662004|FG002|Overall Study|Lack of Efficacy|19|||
37781538|NCT01276106|69359753|FG000|Overall Study|Withdrawal by Subject|6|||
37781539|NCT01276106|69359754|FG001|Overall Study|Withdrawal by Subject|3|||
37781540|NCT01276106|69359755|FG002|Overall Study|Withdrawal by Subject|1|||
37781541|NCT01276106|69359756|FG003|Overall Study|Withdrawal by Subject|6|||
37781542|NCT01276106|69359753|FG000|Overall Study|Lack of Efficacy|0|||
37781543|NCT01276106|69359754|FG001|Overall Study|Lack of Efficacy|1|||
37781544|NCT01276106|69359755|FG002|Overall Study|Lack of Efficacy|0|||
37781545|NCT01276106|69359756|FG003|Overall Study|Lack of Efficacy|1|||
37781546|NCT01276106|69359753|FG000|Overall Study|Lost to Follow-up|2|||
37781547|NCT01276106|69359754|FG001|Overall Study|Lost to Follow-up|1|||
37781548|NCT01276106|69359755|FG002|Overall Study|Lost to Follow-up|1|||
37781549|NCT01276106|69359756|FG003|Overall Study|Lost to Follow-up|0|||
37781550|NCT01276106|69359753|FG000|Overall Study|Physician Decision|0|||
37781551|NCT01276106|69359754|FG001|Overall Study|Physician Decision|0|||
37781552|NCT01276106|69359755|FG002|Overall Study|Physician Decision|1|||
37781553|NCT01276106|69359756|FG003|Overall Study|Physician Decision|1|||
37781554|NCT01276106|69359753|FG000|Overall Study|Protocol Violation|1|||
37781555|NCT01276106|69359754|FG001|Overall Study|Protocol Violation|1|||
37781556|NCT01276106|69359755|FG002|Overall Study|Protocol Violation|0|||
37781557|NCT01276106|69359756|FG003|Overall Study|Protocol Violation|2|||
37781558|NCT01276106|69359753|FG000|Overall Study|Insufficient therapeutic effects|0|||
37781559|NCT01276106|69359754|FG001|Overall Study|Insufficient therapeutic effects|0|||
37781560|NCT01276106|69359755|FG002|Overall Study|Insufficient therapeutic effects|2|||
37781561|NCT01276106|69359756|FG003|Overall Study|Insufficient therapeutic effects|0|||
37781562|NCT01275170|69359774|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
37781563|NCT01275170|69359775|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
37781564|NCT01275170|69359776|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
37781565|NCT01275170|69359777|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
37781566|NCT01275170|69359778|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
37781567|NCT01275170|69359779|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
37781568|NCT01275170|69359780|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
37781569|NCT01275170|69359781|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
37781570|NCT01273064|69359828|FG000|Overall Study|Adverse Event|5|||
37781571|NCT01273064|69359829|FG001|Overall Study|Adverse Event|1|||
37781572|NCT01273064|69359830|FG002|Overall Study|Adverse Event|3|||
37781573|NCT01273064|69359831|FG003|Overall Study|Adverse Event|2|||
37781574|NCT01273064|69359832|FG004|Overall Study|Adverse Event|1|||
37781575|NCT01273064|69359828|FG000|Overall Study|Withdrawal by Subject|4|||
37781576|NCT01273064|69359829|FG001|Overall Study|Withdrawal by Subject|2|||
37781577|NCT01273064|69359830|FG002|Overall Study|Withdrawal by Subject|2|||
37781578|NCT01273064|69359831|FG003|Overall Study|Withdrawal by Subject|2|||
37781579|NCT01273064|69359832|FG004|Overall Study|Withdrawal by Subject|0|||
37781580|NCT01273064|69359828|FG000|Overall Study|Study Termination|13|||
37781581|NCT01273064|69359829|FG001|Overall Study|Study Termination|27|||
37781582|NCT01273064|69359830|FG002|Overall Study|Study Termination|26|||
37781583|NCT01273064|69359831|FG003|Overall Study|Study Termination|16|||
37781584|NCT01273064|69359832|FG004|Overall Study|Study Termination|8|||
37781585|NCT01273064|69359828|FG000|Overall Study|Lost to Follow-up|1|||
37781586|NCT01273064|69359829|FG001|Overall Study|Lost to Follow-up|0|||
37781587|NCT01273064|69359830|FG002|Overall Study|Lost to Follow-up|0|||
37781588|NCT01273064|69359831|FG003|Overall Study|Lost to Follow-up|0|||
37781589|NCT01273064|69359832|FG004|Overall Study|Lost to Follow-up|0|||
37781590|NCT01273064|69359828|FG000|Overall Study|Physician Decision|0|||
37781591|NCT01273064|69359829|FG001|Overall Study|Physician Decision|0|||
37781592|NCT01273064|69359830|FG002|Overall Study|Physician Decision|0|||
37781593|NCT01273064|69359831|FG003|Overall Study|Physician Decision|0|||
37781594|NCT01273064|69359832|FG004|Overall Study|Physician Decision|1|||
37781595|NCT01272908|69359844|FG000|Initial Treatment Period|Adverse Event|1|||
37781596|NCT01272908|69359844|FG000|Initial Treatment Period|Lack of Efficacy|5|||
37974779|NCT00499616|69662005|FG003|Overall Study|Lack of Efficacy|0|||
37974780|NCT00499616|69662002|FG000|Overall Study|Lost to Follow-up|0|||
37692587|NCT02476175|69168893|FG000|Overall Study|Adverse Event|2|||
37692588|NCT02065557|69168900|FG000|Induction Period|Withdrawal by Subject|2|||
37692589|NCT02065557|69168901|FG001|Induction Period|Withdrawal by Subject|1|||
37692590|NCT02065557|69168902|FG002|Induction Period|Withdrawal by Subject|0|||
37692591|NCT02065557|69168903|FG003|Induction Period|Withdrawal by Subject|0|||
37692592|NCT02065557|69168904|FG004|Induction Period|Withdrawal by Subject|0|||
37692593|NCT02065557|69168905|FG005|Induction Period|Withdrawal by Subject|0|||
37692594|NCT02065557|69168900|FG000|Induction Period|Lack of Efficacy|2|||
37692595|NCT02065557|69168901|FG001|Induction Period|Lack of Efficacy|1|||
37692596|NCT02065557|69168902|FG002|Induction Period|Lack of Efficacy|1|||
37692597|NCT02065557|69168903|FG003|Induction Period|Lack of Efficacy|0|||
37692598|NCT02065557|69168904|FG004|Induction Period|Lack of Efficacy|0|||
37692599|NCT02065557|69168905|FG005|Induction Period|Lack of Efficacy|0|||
37692600|NCT02065557|69168900|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
37692601|NCT02065557|69168901|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
37864016|NCT01253135|69547622|FG000|Original Protocol|Protocol Amendment|15|||
37864017|NCT01253135|69547622|FG000|Amended Protocol|Non-compliance|1|||
37974781|NCT00499616|69662003|FG001|Overall Study|Lost to Follow-up|0|||
37974782|NCT00499616|69662004|FG002|Overall Study|Lost to Follow-up|1|||
37974783|NCT00499616|69662005|FG003|Overall Study|Lost to Follow-up|0|||
37974784|NCT00499616|69662002|FG000|Overall Study|Physician Decision|6|||
37974785|NCT00499616|69662003|FG001|Overall Study|Physician Decision|16|||
37974786|NCT00499616|69662004|FG002|Overall Study|Physician Decision|9|||
37974787|NCT00499616|69662005|FG003|Overall Study|Physician Decision|0|||
37974788|NCT00499616|69662002|FG000|Overall Study|Withdrawal by Subject|1|||
37974789|NCT00499616|69662003|FG001|Overall Study|Withdrawal by Subject|0|||
37692602|NCT02065557|69168902|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
37781597|NCT01272908|69359844|FG000|Initial Treatment Period|Protocol Violation|1|||
37974790|NCT00499616|69662004|FG002|Overall Study|Withdrawal by Subject|1|||
37974791|NCT00499616|69662005|FG003|Overall Study|Withdrawal by Subject|0|||
37974792|NCT00499616|69662002|FG000|Overall Study|Ineligible|1|||
37974793|NCT00499616|69662003|FG001|Overall Study|Ineligible|2|||
37974794|NCT00499616|69662004|FG002|Overall Study|Ineligible|0|||
37974795|NCT00499616|69662005|FG003|Overall Study|Ineligible|15|||
37974796|NCT00499616|69662002|FG000|Overall Study|Not evaluable|0|||
37974797|NCT00499616|69662003|FG001|Overall Study|Not evaluable|0|||
37974798|NCT00499616|69662004|FG002|Overall Study|Not evaluable|0|||
37974799|NCT00499616|69662005|FG003|Overall Study|Not evaluable|41|||
37974800|NCT00499616|69662002|FG000|Overall Study|Patient/Parent Refusal|1|||
37974801|NCT00499616|69662003|FG001|Overall Study|Patient/Parent Refusal|5|||
37974802|NCT00499616|69662004|FG002|Overall Study|Patient/Parent Refusal|3|||
37974803|NCT00499616|69662005|FG003|Overall Study|Patient/Parent Refusal|0|||
37974804|NCT00402597|69662023|FG000|Overall Study|Death|15|||
37974805|NCT00402597|69662024|FG001|Overall Study|Death|7|||
37974806|NCT00402597|69662025|FG002|Overall Study|Death|6|||
37974807|NCT00402597|69662026|FG003|Overall Study|Death|4|||
37974808|NCT00402597|69662027|FG004|Overall Study|Death|6|||
37974809|NCT00402597|69662023|FG000|Overall Study|Adverse Event|81|||
37974810|NCT00402597|69662024|FG001|Overall Study|Adverse Event|18|||
37974811|NCT00402597|69662025|FG002|Overall Study|Adverse Event|106|||
37974812|NCT00402597|69662026|FG003|Overall Study|Adverse Event|39|||
37974813|NCT00402597|69662027|FG004|Overall Study|Adverse Event|71|||
37974814|NCT00402597|69662023|FG000|Overall Study|Lost to Follow-up|8|||
37974815|NCT00402597|69662024|FG001|Overall Study|Lost to Follow-up|1|||
37974816|NCT00402597|69662025|FG002|Overall Study|Lost to Follow-up|8|||
37974817|NCT00402597|69662026|FG003|Overall Study|Lost to Follow-up|2|||
37974818|NCT00402597|69662027|FG004|Overall Study|Lost to Follow-up|3|||
37974819|NCT00402597|69662023|FG000|Overall Study|Withdrawal by Subject|57|||
37974820|NCT00402597|69662024|FG001|Overall Study|Withdrawal by Subject|16|||
37974821|NCT00402597|69662025|FG002|Overall Study|Withdrawal by Subject|65|||
37692603|NCT02065557|69168903|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
37974822|NCT00402597|69662026|FG003|Overall Study|Withdrawal by Subject|15|||
37974823|NCT00402597|69662027|FG004|Overall Study|Withdrawal by Subject|24|||
37974824|NCT00402597|69662023|FG000|Overall Study|reason not specified|30|||
37692604|NCT02065557|69168904|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
37692605|NCT02065557|69168905|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
37692606|NCT02065557|69168900|FG000|Induction Period|Non-Responder at Week 8|4|||
37974825|NCT00402597|69662024|FG001|Overall Study|reason not specified|4|||
37974826|NCT00402597|69662025|FG002|Overall Study|reason not specified|27|||
37974827|NCT00402597|69662026|FG003|Overall Study|reason not specified|14|||
37974828|NCT00402597|69662027|FG004|Overall Study|reason not specified|20|||
37974829|NCT00402363|69662043|FG000|Overall Study|Adverse Event|9|||
37974830|NCT00402363|69662044|FG001|Overall Study|Adverse Event|14|||
37974831|NCT00402363|69662045|FG002|Overall Study|Adverse Event|2|||
37974832|NCT00402363|69662046|FG003|Overall Study|Adverse Event|2|||
37974833|NCT00402363|69662043|FG000|Overall Study|Withdrew Consent|10|||
37974834|NCT00402363|69662044|FG001|Overall Study|Withdrew Consent|5|||
37974835|NCT00402363|69662045|FG002|Overall Study|Withdrew Consent|2|||
37974836|NCT00402363|69662046|FG003|Overall Study|Withdrew Consent|1|||
37974837|NCT00402363|69662043|FG000|Overall Study|Protocol Violation|3|||
37974838|NCT00402363|69662044|FG001|Overall Study|Protocol Violation|5|||
37692607|NCT02065557|69168901|FG001|Induction Period|Non-Responder at Week 8|4|||
37692608|NCT02065557|69168902|FG002|Induction Period|Non-Responder at Week 8|0|||
37974839|NCT00402363|69662045|FG002|Overall Study|Protocol Violation|0|||
37692609|NCT02065557|69168903|FG003|Induction Period|Non-Responder at Week 8|0|||
37974840|NCT00402363|69662046|FG003|Overall Study|Protocol Violation|3|||
37974841|NCT00402363|69662043|FG000|Overall Study|Lost to Follow-up|5|||
37974842|NCT00402363|69662044|FG001|Overall Study|Lost to Follow-up|4|||
37692610|NCT02065557|69168904|FG004|Induction Period|Non-Responder at Week 8|0|||
37781598|NCT01272908|69359844|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
37781599|NCT01272908|69359844|FG000|Re-Treatment Period|Adverse Event|2|||
37781600|NCT01272908|69359844|FG000|Re-Treatment Period|Lack of Efficacy|3|||
37781601|NCT01272908|69359844|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
37781602|NCT01271504|69359854|FG000|Overall Study|Death|7|||
37781603|NCT01271504|69359855|FG001|Overall Study|Death|6|||
37781604|NCT01271504|69359856|FG002|Overall Study|Death|32|||
37781605|NCT01271504|69359857|FG003|Overall Study|Death|32|||
37781606|NCT01271504|69359854|FG000|Overall Study|Lost to Follow-up|0|||
37781607|NCT01271504|69359855|FG001|Overall Study|Lost to Follow-up|1|||
37781608|NCT01271504|69359856|FG002|Overall Study|Lost to Follow-up|3|||
37781609|NCT01271504|69359857|FG003|Overall Study|Lost to Follow-up|1|||
37781610|NCT01271504|69359854|FG000|Overall Study|Protocol Violation|0|||
37781611|NCT01271504|69359855|FG001|Overall Study|Protocol Violation|0|||
37781612|NCT01271504|69359856|FG002|Overall Study|Protocol Violation|0|||
37781613|NCT01271504|69359857|FG003|Overall Study|Protocol Violation|2|||
37781614|NCT01271504|69359854|FG000|Overall Study|Administrative Reasons|0|||
37781615|NCT01271504|69359855|FG001|Overall Study|Administrative Reasons|0|||
37781616|NCT01271504|69359856|FG002|Overall Study|Administrative Reasons|6|||
37781617|NCT01271504|69359857|FG003|Overall Study|Administrative Reasons|5|||
37781618|NCT01271504|69359854|FG000|Overall Study|Withdrawal by Subject|0|||
37864018|NCT00993616|69547630|FG000|Overall Study|No tumor at entry|1|||
37781619|NCT01271504|69359855|FG001|Overall Study|Withdrawal by Subject|0|||
37781620|NCT01271504|69359856|FG002|Overall Study|Withdrawal by Subject|1|||
37781621|NCT01271504|69359857|FG003|Overall Study|Withdrawal by Subject|3|||
37781622|NCT01271504|69359854|FG000|Overall Study|Other|0|||
37781623|NCT01271504|69359855|FG001|Overall Study|Other|1|||
37781624|NCT01271504|69359856|FG002|Overall Study|Other|2|||
37781625|NCT01271504|69359857|FG003|Overall Study|Other|0|||
37781626|NCT01270958|69359900|FG000|Overall Study|Lost to Follow-up|2|||
37781627|NCT01270958|69359900|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
37781628|NCT01270880|69359904|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
37781629|NCT01270802|69359910|FG000|Overall Study|Withdrawal by Subject|1|||
37781630|NCT01270802|69359911|FG001|Overall Study|Withdrawal by Subject|0|||
37781631|NCT01270802|69359910|FG000|Overall Study|Adverse Event|1|||
37781632|NCT01270802|69359911|FG001|Overall Study|Adverse Event|0|||
37781633|NCT01270802|69359910|FG000|Overall Study|Lost to Follow-up|0|||
37781634|NCT01270802|69359911|FG001|Overall Study|Lost to Follow-up|1|||
37781635|NCT01270256|69359920|FG000|Overall Study|Withdrawal by Subject|1|||
37781636|NCT01270256|69359921|FG001|Overall Study|Withdrawal by Subject|0|||
37781637|NCT01279616|69359991|FG000|Overall Study|donor could not be located|5|||
37781638|NCT01279616|69359991|FG000|Overall Study|no signs of sickle cell disease|2|||
37781639|NCT01279070|69360002|FG000|Overall Study|Withdrawal by Subject|2|||
37781640|NCT01279070|69360003|FG001|Overall Study|Withdrawal by Subject|3|||
37781641|NCT01279070|69360002|FG000|Overall Study|Acute exacerbation|3|||
37781642|NCT01279070|69360003|FG001|Overall Study|Acute exacerbation|1|||
37781643|NCT01277744|69360013|FG000|Overall Study|Physician Decision|2|||
37781644|NCT01277822|69360019|FG000|Overall Study|Adverse Event|2|||
37781645|NCT01277822|69360020|FG001|Overall Study|Adverse Event|1|||
37781646|NCT01277822|69360019|FG000|Overall Study|Withdrawal by Subject|6|||
37781647|NCT01277822|69360020|FG001|Overall Study|Withdrawal by Subject|7|||
37781648|NCT01277822|69360019|FG000|Overall Study|Physician Decision|1|||
37781649|NCT01277822|69360020|FG001|Overall Study|Physician Decision|1|||
37781650|NCT01277822|69360019|FG000|Overall Study|Protocol Violation|1|||
37781651|NCT01277822|69360020|FG001|Overall Study|Protocol Violation|0|||
37781652|NCT01277822|69360019|FG000|Overall Study|Lost to Follow-up|2|||
37781653|NCT01277822|69360020|FG001|Overall Study|Lost to Follow-up|1|||
37781654|NCT01277822|69360019|FG000|Overall Study|Contraindicated medication used|2|||
37781655|NCT01277822|69360020|FG001|Overall Study|Contraindicated medication used|1|||
37781656|NCT01277822|69360019|FG000|Overall Study|Participant moved|1|||
37781657|NCT01277822|69360020|FG001|Overall Study|Participant moved|0|||
37781658|NCT01277666|69360029|FG000|Overall Study|Adverse Event|26|||
37781659|NCT01277666|69360030|FG001|Overall Study|Adverse Event|25|||
37781660|NCT01277666|69360031|FG002|Overall Study|Adverse Event|20|||
37781661|NCT01277666|69360029|FG000|Overall Study|Lack of Efficacy|8|||
37781662|NCT01277666|69360030|FG001|Overall Study|Lack of Efficacy|20|||
37781663|NCT01277666|69360031|FG002|Overall Study|Lack of Efficacy|12|||
37781664|NCT01277666|69360029|FG000|Overall Study|Protocol Violation|2|||
37781665|NCT01277666|69360030|FG001|Overall Study|Protocol Violation|3|||
37781666|NCT01277666|69360031|FG002|Overall Study|Protocol Violation|2|||
37781667|NCT01277666|69360029|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
37781668|NCT01277666|69360030|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
37781669|NCT01277666|69360031|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
37781670|NCT01277666|69360029|FG000|Overall Study|Lost to Follow-up|1|||
37781671|NCT01277666|69360030|FG001|Overall Study|Lost to Follow-up|1|||
37781672|NCT01277666|69360031|FG002|Overall Study|Lost to Follow-up|2|||
37781673|NCT01277666|69360029|FG000|Overall Study|Withdrawal by Subject|7|||
37781674|NCT01277666|69360030|FG001|Overall Study|Withdrawal by Subject|8|||
37781675|NCT01277666|69360031|FG002|Overall Study|Withdrawal by Subject|6|||
37781676|NCT01277666|69360029|FG000|Overall Study|Death|0|||
37781677|NCT01277666|69360030|FG001|Overall Study|Death|0|||
37692611|NCT02065557|69168905|FG005|Induction Period|Non-Responder at Week 8|0|||
37692612|NCT02065557|69168900|FG000|Induction Period|Adverse Event|1|||
37692613|NCT02065557|69168901|FG001|Induction Period|Adverse Event|1|||
37692614|NCT02065557|69168902|FG002|Induction Period|Adverse Event|0|||
37692615|NCT02065557|69168903|FG003|Induction Period|Adverse Event|0|||
37692616|NCT02065557|69168904|FG004|Induction Period|Adverse Event|0|||
37692617|NCT02065557|69168905|FG005|Induction Period|Adverse Event|0|||
37692618|NCT02065557|69168900|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
37781678|NCT01277666|69360031|FG002|Overall Study|Death|1|||
37781679|NCT00249002|69360039|FG000|Overall Study|Adverse Event|2|||
37781680|NCT00249002|69360039|FG000|Overall Study|Study cancellation|3|||
37781681|NCT00249002|69360039|FG000|Overall Study|Other|2|||
37781682|NCT01277042|69360045|FG000|Overall Study|Adverse Event|4|||
37781683|NCT01277042|69360046|FG001|Overall Study|Adverse Event|3|||
37692619|NCT02065557|69168901|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
37692620|NCT02065557|69168902|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
37692621|NCT02065557|69168903|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
37692622|NCT02065557|69168904|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
37781684|NCT01277042|69360045|FG000|Overall Study|Lost to Follow-up|2|||
37781685|NCT01277042|69360046|FG001|Overall Study|Lost to Follow-up|2|||
37781686|NCT01277042|69360045|FG000|Overall Study|Withdrawal by Subject|2|||
37781687|NCT01277042|69360046|FG001|Overall Study|Withdrawal by Subject|0|||
37781688|NCT00246740|69360086|FG000|Initial Enrollment|Death|1|||
37781689|NCT00246740|69360087|FG001|Initial Enrollment|Death|0|||
37781690|NCT00246740|69360086|FG000|Initial Enrollment|Additional surgery scheduled|0|||
37781691|NCT00246740|69360087|FG001|Initial Enrollment|Additional surgery scheduled|2|||
37781692|NCT00246740|69360086|FG000|Initial Enrollment|Surgery schedule change|4|||
37781693|NCT00246740|69360087|FG001|Initial Enrollment|Surgery schedule change|4|||
37781694|NCT00246740|69360086|FG000|Initial Enrollment|Other|1|||
37781695|NCT00246740|69360087|FG001|Initial Enrollment|Other|2|||
37692623|NCT02065557|69168905|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
37692624|NCT02065557|69168900|FG000|Maintenance Period|Withdrawal by Subject|0|||
37692625|NCT02065557|69168901|FG001|Maintenance Period|Withdrawal by Subject|0|||
37692626|NCT02065557|69168902|FG002|Maintenance Period|Withdrawal by Subject|0|||
37692627|NCT02065557|69168903|FG003|Maintenance Period|Withdrawal by Subject|0|||
37692628|NCT02065557|69168904|FG004|Maintenance Period|Withdrawal by Subject|2|||
37781696|NCT00245102|69360132|FG000|Overall Study|Not Treated|1|||
37781697|NCT00245102|69360133|FG001|Overall Study|Not Treated|0|||
37781698|NCT00245102|69360134|FG002|Overall Study|Not Treated|1|||
37781699|NCT00245102|69360135|FG003|Overall Study|Not Treated|0|||
37974843|NCT00402363|69662045|FG002|Overall Study|Lost to Follow-up|0|||
37781700|NCT00245102|69360136|FG004|Overall Study|Not Treated|0|||
37781701|NCT00245102|69360137|FG005|Overall Study|Not Treated|0|||
37781702|NCT00245102|69360132|FG000|Overall Study|Protocol Violation|1|||
37974844|NCT00402363|69662046|FG003|Overall Study|Lost to Follow-up|2|||
37974845|NCT00402363|69662043|FG000|Overall Study|"Captured as Other"|6|||
37974846|NCT00402363|69662044|FG001|Overall Study|"Captured as Other"|2|||
37974847|NCT00402363|69662045|FG002|Overall Study|"Captured as Other"|2|||
37781703|NCT00245102|69360133|FG001|Overall Study|Protocol Violation|0|||
37781704|NCT00245102|69360134|FG002|Overall Study|Protocol Violation|0|||
37781705|NCT00245102|69360135|FG003|Overall Study|Protocol Violation|0|||
37781706|NCT00245102|69360136|FG004|Overall Study|Protocol Violation|0|||
37781707|NCT00245102|69360137|FG005|Overall Study|Protocol Violation|0|||
37781708|NCT00245102|69360132|FG000|Overall Study|Death|0|||
37781709|NCT00245102|69360133|FG001|Overall Study|Death|0|||
37781710|NCT00245102|69360134|FG002|Overall Study|Death|0|||
37781711|NCT00245102|69360135|FG003|Overall Study|Death|1|||
37781712|NCT00245102|69360136|FG004|Overall Study|Death|0|||
37781713|NCT00245102|69360137|FG005|Overall Study|Death|0|||
37781714|NCT00245102|69360132|FG000|Overall Study|Adverse Event|4|||
37781715|NCT00245102|69360133|FG001|Overall Study|Adverse Event|2|||
37781716|NCT00245102|69360134|FG002|Overall Study|Adverse Event|5|||
37781717|NCT00245102|69360135|FG003|Overall Study|Adverse Event|1|||
37781718|NCT00245102|69360136|FG004|Overall Study|Adverse Event|0|||
37781719|NCT00245102|69360137|FG005|Overall Study|Adverse Event|2|||
37781720|NCT00245102|69360132|FG000|Overall Study|Decline in performance|0|||
37781721|NCT00245102|69360133|FG001|Overall Study|Decline in performance|2|||
37781722|NCT00245102|69360134|FG002|Overall Study|Decline in performance|0|||
37781723|NCT00245102|69360135|FG003|Overall Study|Decline in performance|1|||
37692629|NCT02065557|69168905|FG005|Maintenance Period|Withdrawal by Subject|1|||
37692630|NCT02065557|69168900|FG000|Maintenance Period|Lack of Efficacy|0|||
37692631|NCT02065557|69168901|FG001|Maintenance Period|Lack of Efficacy|0|||
37692632|NCT02065557|69168902|FG002|Maintenance Period|Lack of Efficacy|0|||
37692633|NCT02065557|69168903|FG003|Maintenance Period|Lack of Efficacy|0|||
37692634|NCT02065557|69168904|FG004|Maintenance Period|Lack of Efficacy|5|||
37692635|NCT02065557|69168905|FG005|Maintenance Period|Lack of Efficacy|2|||
37692636|NCT02065557|69168900|FG000|Maintenance Period|Subject Non-Compliance|0|||
37692637|NCT02065557|69168901|FG001|Maintenance Period|Subject Non-Compliance|0|||
37692638|NCT02065557|69168902|FG002|Maintenance Period|Subject Non-Compliance|0|||
37781724|NCT00245102|69360136|FG004|Overall Study|Decline in performance|0|||
37974848|NCT00402363|69662046|FG003|Overall Study|"Captured as Other"|2|||
37781725|NCT00245102|69360137|FG005|Overall Study|Decline in performance|2|||
37781726|NCT00245102|69360132|FG000|Overall Study|Participant needed surgery|0|||
37781727|NCT00245102|69360133|FG001|Overall Study|Participant needed surgery|0|||
37781728|NCT00245102|69360134|FG002|Overall Study|Participant needed surgery|1|||
37781729|NCT00245102|69360135|FG003|Overall Study|Participant needed surgery|0|||
37781730|NCT00245102|69360136|FG004|Overall Study|Participant needed surgery|0|||
37781731|NCT00245102|69360137|FG005|Overall Study|Participant needed surgery|0|||
37781732|NCT00245102|69360132|FG000|Overall Study|Clinical progression|1|||
37781733|NCT00245102|69360133|FG001|Overall Study|Clinical progression|0|||
37781734|NCT00245102|69360134|FG002|Overall Study|Clinical progression|0|||
37781735|NCT00245102|69360135|FG003|Overall Study|Clinical progression|0|||
37781736|NCT00245102|69360136|FG004|Overall Study|Clinical progression|0|||
37781737|NCT00245102|69360137|FG005|Overall Study|Clinical progression|0|||
37781738|NCT00244712|69360182|FG000|Overall Study|Adverse Event|20|||
37781739|NCT00244712|69360183|FG001|Overall Study|Adverse Event|21|||
37781740|NCT00244712|69360182|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
37781741|NCT00244712|69360183|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
37781742|NCT00244712|69360182|FG000|Overall Study|Lack of Compliance|10|||
37781743|NCT00244712|69360183|FG001|Overall Study|Lack of Compliance|11|||
37781744|NCT00244712|69360182|FG000|Overall Study|Lost to Follow-up|45|||
37781745|NCT00244712|69360183|FG001|Overall Study|Lost to Follow-up|52|||
37781746|NCT00244712|69360182|FG000|Overall Study|Withdrawal by Subject|13|||
37781747|NCT00244712|69360183|FG001|Overall Study|Withdrawal by Subject|23|||
37781748|NCT00244712|69360182|FG000|Overall Study|Protocol Violation, disease progression|13|||
37781749|NCT00244712|69360183|FG001|Overall Study|Protocol Violation, disease progression|11|||
37974849|NCT00469014|69662066|FG000|Initial Phase Randomization|Disease Progression|0|||
37974850|NCT00469014|69662067|FG001|Initial Phase Randomization|Disease Progression|1|||
37692639|NCT02065557|69168903|FG003|Maintenance Period|Subject Non-Compliance|0|||
37692640|NCT02065557|69168904|FG004|Maintenance Period|Subject Non-Compliance|0|||
37692641|NCT02065557|69168905|FG005|Maintenance Period|Subject Non-Compliance|1|||
37692642|NCT02065245|69168937|FG000|Infusion 1|Lost to Follow-up|0|||
37692643|NCT02065245|69168938|FG001|Infusion 1|Lost to Follow-up|0|||
37692644|NCT02065245|69168939|FG002|Infusion 1|Lost to Follow-up|0|||
37692645|NCT02065245|69168940|FG003|Infusion 1|Lost to Follow-up|0|||
37692646|NCT02065245|69168941|FG004|Infusion 1|Lost to Follow-up|0|||
37692647|NCT02065245|69168942|FG005|Infusion 1|Lost to Follow-up|0|||
37692648|NCT02065245|69168943|FG006|Infusion 1|Lost to Follow-up|1|||
37692649|NCT02065245|69168937|FG000|Infusion 1|Death|0|||
37692650|NCT02065245|69168938|FG001|Infusion 1|Death|0|||
37692651|NCT02065245|69168939|FG002|Infusion 1|Death|1|||
37692652|NCT02065245|69168940|FG003|Infusion 1|Death|0|||
37692653|NCT02065245|69168941|FG004|Infusion 1|Death|1|||
37692654|NCT02065245|69168942|FG005|Infusion 1|Death|0|||
37692655|NCT02065245|69168943|FG006|Infusion 1|Death|0|||
37692656|NCT02065245|69168937|FG000|Infusion 2|Death|0|||
37692657|NCT02065245|69168938|FG001|Infusion 2|Death|0|||
37692658|NCT02065245|69168939|FG002|Infusion 2|Death|0|||
37692659|NCT02065245|69168940|FG003|Infusion 2|Death|0|||
37692660|NCT02065245|69168941|FG004|Infusion 2|Death|0|||
37692661|NCT02065245|69168942|FG005|Infusion 2|Death|0|||
37692662|NCT02065245|69168943|FG006|Infusion 2|Death|1|||
37692663|NCT02065245|69168937|FG000|Infusion 3|Lost to Follow-up|1|||
37692664|NCT02065245|69168938|FG001|Infusion 3|Lost to Follow-up|1|||
37692665|NCT02065245|69168939|FG002|Infusion 3|Lost to Follow-up|0|||
37692666|NCT02065245|69168940|FG003|Infusion 3|Lost to Follow-up|0|||
37692667|NCT02065245|69168941|FG004|Infusion 3|Lost to Follow-up|0|||
37692668|NCT02065245|69168942|FG005|Infusion 3|Lost to Follow-up|0|||
37692669|NCT02065245|69168943|FG006|Infusion 3|Lost to Follow-up|0|||
37692670|NCT02043015|69168959|FG000|Overall Study|Lost to Follow-up|4|||
37692671|NCT02043015|69168959|FG000|Overall Study|Withdrawal by Subject|4|||
37781750|NCT00243932|69360201|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
37781751|NCT00243932|69360202|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
37781752|NCT00243932|69360203|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
37692672|NCT02043015|69168959|FG000|Overall Study|Removed once target enrollment reached|15|||
37692673|NCT02043015|69168959|FG000|Overall Study|Participant moved away from study city|4|||
37692674|NCT02043015|69168959|FG000|Overall Study|Incarceration|1|||
37692675|NCT02064231|69168965|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
37692676|NCT02064231|69168966|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
37692677|NCT02064231|69168967|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
37692678|NCT02064231|69168968|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
37781753|NCT00243386|69360211|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
37781754|NCT00243386|69360212|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
37781755|NCT00243386|69360213|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
37781756|NCT00243386|69360211|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
37781757|NCT00243386|69360212|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
37781758|NCT00243386|69360213|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
37781759|NCT00243386|69360211|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
37781760|NCT00243386|69360212|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
37781761|NCT00243386|69360213|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
37781762|NCT00243386|69360211|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
37781763|NCT00243386|69360212|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
37781764|NCT00243386|69360213|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
37781765|NCT00243386|69360211|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
37781766|NCT00243386|69360212|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
37781767|NCT00243386|69360213|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
37781768|NCT00243386|69360211|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
37781769|NCT00243386|69360212|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
37781770|NCT00243386|69360213|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
37781771|NCT00243386|69360211|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
37781772|NCT00243386|69360212|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
37781773|NCT00243386|69360213|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
37781774|NCT00243386|69360211|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
37781775|NCT00243386|69360212|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
37781776|NCT00243386|69360213|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
37781777|NCT00243230|69360272|FG000|Double-Blind Period|Adverse Event|0|||
37781778|NCT00243230|69360273|FG001|Double-Blind Period|Adverse Event|2|||
37781779|NCT00243230|69360274|FG002|Double-Blind Period|Adverse Event|2|||
37781780|NCT00243230|69360275|FG003|Double-Blind Period|Adverse Event|0|||
37781781|NCT00243230|69360272|FG000|Double-Blind Period|Withdrawal by Subject|1|||
37781782|NCT00243230|69360273|FG001|Double-Blind Period|Withdrawal by Subject|0|||
37781783|NCT00243230|69360274|FG002|Double-Blind Period|Withdrawal by Subject|0|||
37781784|NCT00243230|69360275|FG003|Double-Blind Period|Withdrawal by Subject|0|||
37781785|NCT00243230|69360272|FG000|Double-Blind Period|Protocol Violation|0|||
37781786|NCT00243230|69360273|FG001|Double-Blind Period|Protocol Violation|0|||
37781787|NCT00243230|69360274|FG002|Double-Blind Period|Protocol Violation|1|||
37781788|NCT00243230|69360275|FG003|Double-Blind Period|Protocol Violation|0|||
37781789|NCT00243230|69360272|FG000|Double-Blind Period|Randomized but Not Treated|0|||
37781790|NCT00243230|69360273|FG001|Double-Blind Period|Randomized but Not Treated|0|||
37781791|NCT00243230|69360274|FG002|Double-Blind Period|Randomized but Not Treated|2|||
37781792|NCT00243230|69360275|FG003|Double-Blind Period|Randomized but Not Treated|0|||
37781793|NCT00243230|69360272|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
37781794|NCT00243230|69360273|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
37781795|NCT00243230|69360274|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
37781796|NCT00243230|69360275|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
37781797|NCT00243230|69360272|FG000|Open Label Period|Adverse Event|0|||
37781798|NCT00243230|69360273|FG001|Open Label Period|Adverse Event|0|||
37781799|NCT00243230|69360274|FG002|Open Label Period|Adverse Event|0|||
37781800|NCT00243230|69360275|FG003|Open Label Period|Adverse Event|2|||
37781801|NCT00243230|69360272|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
37781802|NCT00243230|69360273|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
37781803|NCT00243230|69360274|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
37781804|NCT00243230|69360275|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
37781805|NCT00243230|69360272|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
37781806|NCT00243230|69360273|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
37781807|NCT00243230|69360274|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
37781808|NCT00243230|69360275|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
37781809|NCT00243230|69360272|FG000|Open Label Period|Lost to Follow-up|0|||
37781810|NCT00243230|69360273|FG001|Open Label Period|Lost to Follow-up|0|||
37781811|NCT00243230|69360274|FG002|Open Label Period|Lost to Follow-up|0|||
37781812|NCT00243230|69360275|FG003|Open Label Period|Lost to Follow-up|2|||
37781813|NCT00243230|69360272|FG000|Open Label Period|Withdrawal by Subject|0|||
37781814|NCT00243230|69360273|FG001|Open Label Period|Withdrawal by Subject|0|||
37781815|NCT00243230|69360274|FG002|Open Label Period|Withdrawal by Subject|0|||
37781816|NCT00243230|69360275|FG003|Open Label Period|Withdrawal by Subject|2|||
37781817|NCT00243230|69360272|FG000|Open Label Period|Protocol Violation|0|||
37781818|NCT00243230|69360273|FG001|Open Label Period|Protocol Violation|0|||
37781819|NCT00243230|69360274|FG002|Open Label Period|Protocol Violation|0|||
37781820|NCT00243230|69360275|FG003|Open Label Period|Protocol Violation|2|||
37781821|NCT00243230|69360272|FG000|Open Label Period|Administrative Reason|0|||
37781822|NCT00243230|69360273|FG001|Open Label Period|Administrative Reason|0|||
37781823|NCT00243230|69360274|FG002|Open Label Period|Administrative Reason|0|||
37781824|NCT00243230|69360275|FG003|Open Label Period|Administrative Reason|63|||
37781825|NCT00243074|69360285|FG000|Overall Study|Ineligible|6|||
37781826|NCT00243074|69360285|FG000|Overall Study|Adverse Event|6|||
37781827|NCT00243074|69360285|FG000|Overall Study|Withdrawal by Subject|2|||
37781828|NCT00243074|69360285|FG000|Overall Study|Lack of Efficacy|36|||
37781829|NCT00243074|69360285|FG000|Overall Study|Death|2|||
37781830|NCT00243074|69360285|FG000|Overall Study|not protocol specified|1|||
37781831|NCT00243074|69360285|FG000|Overall Study|Did not receive any treatment|1|||
37781832|NCT00241358|69360293|FG000|Overall Study|Determined to be not ineligible|0|||
37781833|NCT00241358|69360294|FG001|Overall Study|Determined to be not ineligible|1|||
37781834|NCT00241358|69360295|FG002|Overall Study|Determined to be not ineligible|1|||
37781835|NCT00241280|69360304|FG000|Overall Study|Adverse Event|2|||
37781836|NCT00241280|69360305|FG001|Overall Study|Adverse Event|6|||
37781837|NCT00241280|69360304|FG000|Overall Study|Discomfort|11|||
37781838|NCT00241280|69360305|FG001|Overall Study|Discomfort|16|||
37781839|NCT00241280|69360304|FG000|Overall Study|Pregnancy|1|||
37781840|NCT00241280|69360305|FG001|Overall Study|Pregnancy|5|||
37781841|NCT00241280|69360304|FG000|Overall Study|Lost to Follow-up|5|||
37781842|NCT00241280|69360305|FG001|Overall Study|Lost to Follow-up|8|||
37781843|NCT00241280|69360304|FG000|Overall Study|Withdrawal by Subject|7|||
37781844|NCT00241280|69360305|FG001|Overall Study|Withdrawal by Subject|4|||
37781845|NCT00241280|69360304|FG000|Overall Study|Protocol Violation|4|||
37781846|NCT00241280|69360305|FG001|Overall Study|Protocol Violation|10|||
37781847|NCT00241280|69360304|FG000|Overall Study|Relocation|4|||
37781848|NCT00241280|69360305|FG001|Overall Study|Relocation|4|||
37781849|NCT00241280|69360304|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
37781850|NCT00241280|69360305|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
37781851|NCT00241280|69360304|FG000|Overall Study|Unsatisfactory Visual Response|1|||
37781852|NCT00241280|69360305|FG001|Overall Study|Unsatisfactory Visual Response|1|||
37781853|NCT00241280|69360304|FG000|Overall Study|Diabetic|1|||
37781854|NCT00241280|69360305|FG001|Overall Study|Diabetic|0|||
37692679|NCT02064231|69168965|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
37692680|NCT02064231|69168966|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
37692681|NCT02064231|69168967|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
37692682|NCT02064231|69168968|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
37692683|NCT02064231|69168965|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
37692684|NCT02064231|69168966|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
37692685|NCT02064231|69168967|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
37692686|NCT02064231|69168968|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
37692687|NCT02064231|69168965|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
37692688|NCT02064231|69168966|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
37692689|NCT02064231|69168967|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
37692690|NCT02064231|69168968|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
37692691|NCT02063217|69168983|FG000|Overall Study|Withdrawal by Subject|1|||
37692692|NCT02063217|69168984|FG001|Overall Study|Withdrawal by Subject|0|||
37692693|NCT02063217|69168985|FG002|Overall Study|Withdrawal by Subject|0|||
37692694|NCT02497001|69168997|FG000|Overall Study|Lost to Follow-up|10|||
37692695|NCT02497001|69168998|FG001|Overall Study|Lost to Follow-up|2|||
37692696|NCT02497001|69168999|FG002|Overall Study|Lost to Follow-up|0|||
37781855|NCT00241280|69360304|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
37781856|NCT00241280|69360305|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
37781857|NCT00241280|69360304|FG000|Overall Study|Dispensed incorrect test article|1|||
37781858|NCT00241280|69360305|FG001|Overall Study|Dispensed incorrect test article|2|||
37781859|NCT00241280|69360304|FG000|Overall Study|Unacceptable Fit|0|||
37781860|NCT00241280|69360305|FG001|Overall Study|Unacceptable Fit|1|||
37781861|NCT00241280|69360304|FG000|Overall Study|Scheduling Conflict|0|||
37692697|NCT02497001|69169000|FG003|Overall Study|Lost to Follow-up|2|||
37781862|NCT00241280|69360305|FG001|Overall Study|Scheduling Conflict|2|||
37781863|NCT00241280|69360304|FG000|Overall Study|History of Ocular Surgery|0|||
37781864|NCT00241280|69360305|FG001|Overall Study|History of Ocular Surgery|1|||
37781865|NCT00241280|69360304|FG000|Overall Study|Coating on Lens|1|||
37781866|NCT00241280|69360305|FG001|Overall Study|Coating on Lens|0|||
37781867|NCT00241280|69360304|FG000|Overall Study|Excessive Dryness|0|||
37781868|NCT00241280|69360305|FG001|Overall Study|Excessive Dryness|1|||
37781869|NCT04278872|69360882|FG000|Overall Study|Adverse Event|1|||
37781870|NCT04278872|69360883|FG001|Overall Study|Adverse Event|0|||
37781871|NCT04278872|69360882|FG000|Overall Study|Protocol Violation|0|||
37781872|NCT04278872|69360883|FG001|Overall Study|Protocol Violation|1|||
37781873|NCT04278872|69360882|FG000|Overall Study|Study Termination|2|||
37781874|NCT04278872|69360883|FG001|Overall Study|Study Termination|0|||
37781875|NCT02513160|69363363|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
37781876|NCT02513160|69363364|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
37781877|NCT02513160|69363365|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
37781878|NCT02513160|69363366|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
37781879|NCT02513160|69363363|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
37781880|NCT02513160|69363364|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
37864019|NCT00993616|69547630|FG000|Overall Study|Never treated|1|||
37974851|NCT00469014|69662068|FG002|Initial Phase Randomization|Disease Progression|1|||
37781881|NCT02513160|69363365|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
37781882|NCT02513160|69363366|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
37781883|NCT02513160|69363363|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
37781884|NCT02513160|69363364|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
37781885|NCT02513160|69363365|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
37781886|NCT02513160|69363366|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
37692698|NCT02497001|69168997|FG000|Overall Study|Adverse Event|28|||
37692699|NCT02497001|69168998|FG001|Overall Study|Adverse Event|30|||
37692700|NCT02497001|69168999|FG002|Overall Study|Adverse Event|11|||
37692701|NCT02497001|69169000|FG003|Overall Study|Adverse Event|11|||
37692702|NCT02497001|69168997|FG000|Overall Study|Withdrawal by Subject|14|||
37692703|NCT02497001|69168998|FG001|Overall Study|Withdrawal by Subject|37|||
37692704|NCT02497001|69168999|FG002|Overall Study|Withdrawal by Subject|19|||
37692705|NCT02497001|69169000|FG003|Overall Study|Withdrawal by Subject|15|||
37692706|NCT02497001|69168997|FG000|Overall Study|Physician Decision|5|||
37692707|NCT02497001|69168998|FG001|Overall Study|Physician Decision|11|||
37692708|NCT02497001|69168999|FG002|Overall Study|Physician Decision|5|||
37692709|NCT02497001|69169000|FG003|Overall Study|Physician Decision|1|||
37692710|NCT02497001|69168997|FG000|Overall Study|subjects that were not treated|1|||
37692711|NCT02497001|69168998|FG001|Overall Study|subjects that were not treated|2|||
37692712|NCT02497001|69168999|FG002|Overall Study|subjects that were not treated|2|||
37692713|NCT02497001|69169000|FG003|Overall Study|subjects that were not treated|1|||
37692714|NCT02497001|69168997|FG000|Overall Study|Major Protocol Deviation|3|||
37692715|NCT02497001|69168998|FG001|Overall Study|Major Protocol Deviation|4|||
37692716|NCT02497001|69168999|FG002|Overall Study|Major Protocol Deviation|4|||
37781887|NCT02513160|69363363|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
37781888|NCT02513160|69363364|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
37781889|NCT02513160|69363365|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
37781890|NCT02513160|69363366|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
37781891|NCT02513160|69363363|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
37781892|NCT02513160|69363364|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
37781893|NCT02513160|69363365|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
37781894|NCT02513160|69363366|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
37781895|NCT02513160|69363363|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
37833524|NCT01263496|69517276|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
37833525|NCT01263496|69517268|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
37833526|NCT01263496|69517269|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
37833527|NCT01263496|69517270|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
37833528|NCT01263496|69517271|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
37833529|NCT01263496|69517272|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
37833530|NCT01263496|69517273|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
37833531|NCT01263496|69517274|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
37833532|NCT01263496|69517275|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
37833533|NCT01263496|69517276|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
37833534|NCT01263496|69517268|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
37833535|NCT01263496|69517269|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
37833536|NCT01263496|69517270|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
37833537|NCT01263496|69517271|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
37833538|NCT01263496|69517272|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
37833539|NCT01263496|69517273|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
37833540|NCT01263496|69517274|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
37833541|NCT01263496|69517275|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
37833542|NCT01263496|69517276|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
37833543|NCT01263496|69517268|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
37833544|NCT01263496|69517269|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
37833545|NCT01263496|69517270|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
37781896|NCT02513160|69363364|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
37781897|NCT02513160|69363365|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
37781898|NCT02513160|69363366|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
37781899|NCT02513160|69363363|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
37781900|NCT02513160|69363364|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
37781901|NCT02513160|69363365|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
37781902|NCT02513160|69363366|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
37781903|NCT02513160|69363363|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
37781904|NCT02513160|69363364|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
37781905|NCT02513160|69363365|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
37781906|NCT02513160|69363366|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
37781907|NCT02513160|69363363|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
37781908|NCT02513160|69363364|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
37781909|NCT02513160|69363365|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
37781910|NCT02513160|69363366|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
37781911|NCT02513160|69363363|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
37781912|NCT02513160|69363364|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
37781913|NCT02513160|69363365|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
37781914|NCT02513160|69363366|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
37781915|NCT02513160|69363363|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
37781916|NCT02513160|69363364|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
37781917|NCT02513160|69363365|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
37781918|NCT02513160|69363366|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
37781919|NCT02513160|69363363|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
37781920|NCT02513160|69363364|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
37781921|NCT02513160|69363365|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
37781922|NCT02513160|69363366|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
37781923|NCT02480010|69363401|FG000|Overall Study|Adverse Event|3|||
37781924|NCT02480010|69363402|FG001|Overall Study|Adverse Event|1|||
37781925|NCT02480010|69363401|FG000|Overall Study|Death|1|||
37781926|NCT02480010|69363402|FG001|Overall Study|Death|0|||
37781927|NCT02480010|69363401|FG000|Overall Study|Insufficient therapeutic response|31|||
37781928|NCT02480010|69363402|FG001|Overall Study|Insufficient therapeutic response|29|||
37781929|NCT02480010|69363401|FG000|Overall Study|Refused Treatment|0|||
37781930|NCT02480010|69363402|FG001|Overall Study|Refused Treatment|3|||
37781931|NCT02512302|69363430|FG000|Period 1|Adverse Event|0|||
37781932|NCT02512302|69363431|FG001|Period 1|Adverse Event|1|||
37864020|NCT01120899|69547640|FG000|Overall Study|Withdrawal by Subject|3|||
37864021|NCT01120275|69547644|FG000|Overall Study|Adverse Event|3|||
37692717|NCT02497001|69169000|FG003|Overall Study|Major Protocol Deviation|4|||
37692718|NCT02497001|69168997|FG000|Overall Study|Lack of Efficacy|10|||
37692719|NCT02497001|69168998|FG001|Overall Study|Lack of Efficacy|16|||
37692720|NCT02497001|69168999|FG002|Overall Study|Lack of Efficacy|6|||
37692721|NCT02497001|69169000|FG003|Overall Study|Lack of Efficacy|6|||
37692722|NCT02497001|69168997|FG000|Overall Study|Protocol Violation|3|||
37974852|NCT00469014|69662069|FG003|Initial Phase Randomization|Disease Progression|0|||
37692723|NCT02497001|69168998|FG001|Overall Study|Protocol Violation|1|||
37692724|NCT02497001|69168999|FG002|Overall Study|Protocol Violation|3|||
37781933|NCT02512302|69363432|FG002|Period 1|Adverse Event|0|||
37781934|NCT02512302|69363433|FG003|Period 1|Adverse Event|0|||
37781935|NCT02512302|69363434|FG004|Period 1|Adverse Event|0|||
37781936|NCT02512302|69363435|FG005|Period 1|Adverse Event|0|||
37781937|NCT02512302|69363436|FG006|Period 1|Adverse Event|0|||
37781938|NCT02512302|69363437|FG007|Period 1|Adverse Event|0|||
37781939|NCT02512302|69363438|FG008|Period 1|Adverse Event|0|||
37781940|NCT02512302|69363439|FG009|Period 1|Adverse Event|0|||
37781941|NCT02512302|69363430|FG000|Period 2|Adverse Event|0|||
37781942|NCT02512302|69363431|FG001|Period 2|Adverse Event|0|||
37781943|NCT02512302|69363432|FG002|Period 2|Adverse Event|0|||
37781944|NCT02512302|69363433|FG003|Period 2|Adverse Event|0|||
37781945|NCT02512302|69363434|FG004|Period 2|Adverse Event|0|||
37781946|NCT02512302|69363435|FG005|Period 2|Adverse Event|0|||
37781947|NCT02512302|69363436|FG006|Period 2|Adverse Event|0|||
37781948|NCT02512302|69363437|FG007|Period 2|Adverse Event|0|||
37781949|NCT02512302|69363438|FG008|Period 2|Adverse Event|0|||
37781950|NCT02512302|69363439|FG009|Period 2|Adverse Event|1|||
37781951|NCT02512302|69363430|FG000|Period 3|Lost to Follow-up|0|||
37781952|NCT02512302|69363431|FG001|Period 3|Lost to Follow-up|0|||
37781953|NCT02512302|69363432|FG002|Period 3|Lost to Follow-up|1|||
37781954|NCT02512302|69363433|FG003|Period 3|Lost to Follow-up|0|||
37781955|NCT02512302|69363434|FG004|Period 3|Lost to Follow-up|0|||
37781956|NCT02512302|69363435|FG005|Period 3|Lost to Follow-up|0|||
37781957|NCT02512302|69363436|FG006|Period 3|Lost to Follow-up|0|||
37781958|NCT02512302|69363437|FG007|Period 3|Lost to Follow-up|0|||
37781959|NCT02512302|69363438|FG008|Period 3|Lost to Follow-up|0|||
37781960|NCT02512302|69363439|FG009|Period 3|Lost to Follow-up|0|||
37781961|NCT02512302|69363430|FG000|Period 4|Adverse Event|0|||
37781962|NCT02512302|69363431|FG001|Period 4|Adverse Event|0|||
37692725|NCT02497001|69169000|FG003|Overall Study|Protocol Violation|1|||
37692726|NCT02366143|69169016|FG000|Overall Study|Death|307|||
37692727|NCT02366143|69169017|FG001|Overall Study|Death|278|||
37692728|NCT02366143|69169018|FG002|Overall Study|Death|280|||
37692729|NCT02366143|69169016|FG000|Overall Study|Lost to Follow-up|2|||
37692730|NCT02366143|69169017|FG001|Overall Study|Lost to Follow-up|4|||
37692731|NCT02366143|69169018|FG002|Overall Study|Lost to Follow-up|2|||
37692732|NCT02366143|69169016|FG000|Overall Study|Physician Decision|1|||
37692733|NCT02366143|69169017|FG001|Overall Study|Physician Decision|2|||
37692734|NCT02366143|69169018|FG002|Overall Study|Physician Decision|1|||
37692735|NCT02366143|69169016|FG000|Overall Study|Protocol Violation|0|||
37692736|NCT02366143|69169017|FG001|Overall Study|Protocol Violation|0|||
37692737|NCT02366143|69169018|FG002|Overall Study|Protocol Violation|2|||
37692738|NCT02366143|69169016|FG000|Overall Study|Withdrawal by Subject|16|||
37781963|NCT02512302|69363432|FG002|Period 4|Adverse Event|0|||
37781964|NCT02512302|69363433|FG003|Period 4|Adverse Event|0|||
37781965|NCT02512302|69363434|FG004|Period 4|Adverse Event|0|||
37692739|NCT02366143|69169017|FG001|Overall Study|Withdrawal by Subject|17|||
37692740|NCT02366143|69169018|FG002|Overall Study|Withdrawal by Subject|22|||
37781966|NCT02512302|69363435|FG005|Period 4|Adverse Event|0|||
37781967|NCT02512302|69363436|FG006|Period 4|Adverse Event|1|||
37692741|NCT02366143|69169016|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
37692742|NCT02366143|69169017|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
37692743|NCT02366143|69169018|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
37692744|NCT02366143|69169016|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
37692745|NCT02366143|69169017|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
37692746|NCT02366143|69169018|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
37692747|NCT02366143|69169016|FG000|Overall Study|Randomization Error|1|||
37692748|NCT02366143|69169017|FG001|Overall Study|Randomization Error|0|||
37692749|NCT02366143|69169018|FG002|Overall Study|Randomization Error|0|||
37692750|NCT02366143|69169016|FG000|Overall Study|PI Move and Site Closure|1|||
37692751|NCT02366143|69169017|FG001|Overall Study|PI Move and Site Closure|0|||
37692752|NCT02366143|69169018|FG002|Overall Study|PI Move and Site Closure|1|||
37692753|NCT02366143|69169016|FG000|Overall Study|Study Terminated By Sponsor|0|||
37692754|NCT02366143|69169017|FG001|Overall Study|Study Terminated By Sponsor|0|||
37692755|NCT02366143|69169018|FG002|Overall Study|Study Terminated By Sponsor|2|||
37692756|NCT02366143|69169016|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
37692757|NCT02366143|69169017|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
37692758|NCT02366143|69169018|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
37692759|NCT02366143|69169016|FG000|Overall Study|Patient moved to roll-over study|1|||
37692760|NCT02366143|69169017|FG001|Overall Study|Patient moved to roll-over study|19|||
37692761|NCT02366143|69169018|FG002|Overall Study|Patient moved to roll-over study|28|||
37692762|NCT02366143|69169016|FG000|Overall Study|Patient moved to commercial stock|0|||
37974853|NCT00469014|69662066|FG000|Initial Phase Randomization|No Response|1|||
37974854|NCT00469014|69662067|FG001|Initial Phase Randomization|No Response|0|||
37974855|NCT00469014|69662068|FG002|Initial Phase Randomization|No Response|0|||
37974856|NCT00469014|69662069|FG003|Initial Phase Randomization|No Response|1|||
37974857|NCT00469014|69662066|FG000|Adaptive Randomization|Not Evaluable|1|||
37974858|NCT00469014|69662067|FG001|Adaptive Randomization|Not Evaluable|0|||
37974859|NCT00469014|69662068|FG002|Adaptive Randomization|Not Evaluable|0|||
37974860|NCT00469014|69662069|FG003|Adaptive Randomization|Not Evaluable|1|||
37974861|NCT00469014|69662066|FG000|Adaptive Randomization|No Response|0|||
37974862|NCT00469014|69662067|FG001|Adaptive Randomization|No Response|1|||
37974863|NCT00469014|69662068|FG002|Adaptive Randomization|No Response|0|||
37692763|NCT02366143|69169017|FG001|Overall Study|Patient moved to commercial stock|0|||
37692764|NCT02366143|69169018|FG002|Overall Study|Patient moved to commercial stock|1|||
37692765|NCT02366143|69169016|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
37974864|NCT00469014|69662069|FG003|Adaptive Randomization|No Response|0|||
37974865|NCT00469014|69662066|FG000|Adaptive Randomization|Death|0|||
37692766|NCT02366143|69169017|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
37699583|NCT02011893|69176451|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
37974866|NCT00469014|69662067|FG001|Adaptive Randomization|Death|0|||
37974867|NCT00469014|69662068|FG002|Adaptive Randomization|Death|1|||
37974868|NCT00469014|69662069|FG003|Adaptive Randomization|Death|0|||
37781968|NCT02512302|69363437|FG007|Period 4|Adverse Event|0|||
37781969|NCT02512302|69363438|FG008|Period 4|Adverse Event|0|||
37781970|NCT02512302|69363439|FG009|Period 4|Adverse Event|0|||
37781971|NCT02512068|69363547|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
37781972|NCT02512068|69363548|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
37781973|NCT02512068|69363547|FG000|Overall Study|Major Protocol Deviation|1|||
37781974|NCT02512068|69363548|FG001|Overall Study|Major Protocol Deviation|0|||
37781975|NCT02512068|69363547|FG000|Overall Study|Voluntary Withdrawal|0|||
37781976|NCT02512068|69363548|FG001|Overall Study|Voluntary Withdrawal|1|||
37781977|NCT02512068|69363547|FG000|Overall Study|Lack of Efficacy|0|||
37781978|NCT02512068|69363548|FG001|Overall Study|Lack of Efficacy|1|||
37781979|NCT02512068|69363547|FG000|Overall Study|Reason Not Specified|3|||
37781980|NCT02512068|69363548|FG001|Overall Study|Reason Not Specified|5|||
37781981|NCT02511678|69363563|FG000|Overall Study|Withdrawal by Subject|2|||
37781982|NCT02511678|69363563|FG000|Overall Study|Lost to Follow-up|4|||
37781983|NCT02511678|69363563|FG000|Overall Study|Death|19|||
37781984|NCT02511678|69363563|FG000|Overall Study|Adverse Event|1|||
37781985|NCT02511678|69363563|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
37781986|NCT02511678|69363563|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
37781987|NCT02511678|69363563|FG000|Overall Study|Required Radiofrequency Ablation|1|||
37781988|NCT02511678|69363563|FG000|Overall Study|Biopsy was Negative|1|||
37781989|NCT02511678|69363563|FG000|Overall Study|Protocol Violation|1|||
37781990|NCT02511678|69363563|FG000|Overall Study|Received Radiation Treatment|1|||
37781991|NCT02518464|69363590|FG000|Overall Study|Adverse Event|2|||
37781992|NCT02510820|69363594|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
37781993|NCT02510820|69363595|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
37781994|NCT02510820|69363594|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
37781995|NCT02510820|69363595|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
37781996|NCT02510664|69363605|FG000|Overall Study|Transferred Care|9|||
37781997|NCT02510664|69363606|FG001|Overall Study|Transferred Care|9|||
37781998|NCT02510664|69363607|FG002|Overall Study|Transferred Care|0|||
37974869|NCT00493038|69662081|FG000|Treatment|Adverse Event|8|||
37699584|NCT02011893|69176449|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
37864022|NCT01120275|69547644|FG000|Overall Study|Progression|27|||
37781999|NCT02510664|69363605|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
37782000|NCT02510664|69363606|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
37782001|NCT02510664|69363607|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
37782002|NCT02510664|69363605|FG000|Overall Study|Time Constraints|1|||
37782003|NCT02510664|69363606|FG001|Overall Study|Time Constraints|1|||
37782004|NCT02510664|69363607|FG002|Overall Study|Time Constraints|0|||
37782005|NCT01363986|69363638|FG000|Overall Study|Disease progression|1|||
37782006|NCT02478372|69363672|FG000|Overall Study|Protocol Violation|12|||
37782007|NCT02478372|69363673|FG001|Overall Study|Protocol Violation|8|||
37782008|NCT02478372|69363672|FG000|Overall Study|Lost to Follow-up|1|||
37782009|NCT02478372|69363673|FG001|Overall Study|Lost to Follow-up|4|||
37782010|NCT02478372|69363672|FG000|Overall Study|Death|0|||
37782011|NCT02478372|69363673|FG001|Overall Study|Death|2|||
37782012|NCT01654536|69363685|FG000|Overall Study|Lost to Follow-up|5|||
37782013|NCT01654536|69363686|FG001|Overall Study|Lost to Follow-up|5|||
37782014|NCT01654536|69363685|FG000|Overall Study|Physician Decision|12|||
37782015|NCT01654536|69363686|FG001|Overall Study|Physician Decision|8|||
37782016|NCT01654536|69363685|FG000|Overall Study|Withdrawal by Subject|27|||
37782017|NCT01654536|69363686|FG001|Overall Study|Withdrawal by Subject|25|||
37782018|NCT01654380|69363695|FG000|Part B, Period 1|Physician Decision|0|||
37782019|NCT01654380|69363696|FG001|Part B, Period 1|Physician Decision|0|||
37782020|NCT01654380|69363697|FG002|Part B, Period 1|Physician Decision|1|||
37782021|NCT01654380|69363698|FG003|Part B, Period 1|Physician Decision|0|||
37782022|NCT02477670|69363717|FG000|Stage 1|Adverse Event|2|||
37782023|NCT02477670|69363718|FG001|Stage 1|Adverse Event|7|||
37782024|NCT02477670|69363719|FG002|Stage 1|Adverse Event|0|||
37782025|NCT02477670|69363720|FG003|Stage 1|Adverse Event|0|||
37974870|NCT00493038|69662082|FG001|Treatment|Adverse Event|4|||
37974871|NCT00493038|69662081|FG000|Treatment|Lost to Follow-up|5|||
37974872|NCT00493038|69662082|FG001|Treatment|Lost to Follow-up|3|||
37974873|NCT00493038|69662081|FG000|Treatment|Withdrawal by Subject|11|||
37692767|NCT02366143|69169018|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
37692768|NCT02366143|69169016|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
37692769|NCT02366143|69169017|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
37692770|NCT02366143|69169018|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
37692771|NCT02366143|69169016|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
37692772|NCT02366143|69169017|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
37692773|NCT02366143|69169018|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
37692774|NCT02366143|69169016|FG000|Overall Study|Requester's instructions|1|||
37692775|NCT02366143|69169017|FG001|Overall Study|Requester's instructions|1|||
37692776|NCT02366143|69169018|FG002|Overall Study|Requester's instructions|1|||
37692777|NCT02366143|69169016|FG000|Overall Study|Uneligible|0|||
37692778|NCT02366143|69169017|FG001|Overall Study|Uneligible|1|||
37692779|NCT02366143|69169018|FG002|Overall Study|Uneligible|0|||
37692780|NCT02366143|69169016|FG000|Overall Study|Post Trial Migration|0|||
37692781|NCT02366143|69169017|FG001|Overall Study|Post Trial Migration|1|||
37692782|NCT02366143|69169018|FG002|Overall Study|Post Trial Migration|0|||
37692783|NCT02366143|69169016|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
37692784|NCT02366143|69169017|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
37692785|NCT02366143|69169018|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
37692786|NCT02366143|69169016|FG000|Overall Study|Patient switched to PTAP|0|||
37692787|NCT02366143|69169017|FG001|Overall Study|Patient switched to PTAP|1|||
37692788|NCT02366143|69169018|FG002|Overall Study|Patient switched to PTAP|0|||
37692789|NCT02366143|69169016|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
37692790|NCT02366143|69169017|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
37692791|NCT02366143|69169018|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
37782026|NCT02477670|69363721|FG004|Stage 1|Adverse Event|0|||
37782027|NCT02477670|69363722|FG005|Stage 1|Adverse Event|0|||
37782028|NCT02477670|69363723|FG006|Stage 1|Adverse Event|0|||
37782029|NCT02477670|69363717|FG000|Stage 1|Lost to Follow-up|0|||
37782030|NCT02477670|69363718|FG001|Stage 1|Lost to Follow-up|2|||
37782031|NCT02477670|69363719|FG002|Stage 1|Lost to Follow-up|0|||
37974874|NCT00493038|69662082|FG001|Treatment|Withdrawal by Subject|12|||
37974875|NCT00493038|69662081|FG000|Treatment|Other|0|||
37974876|NCT00493038|69662082|FG001|Treatment|Other|1|||
37974877|NCT00493038|69662081|FG000|Follow-up|Lost to Follow-up|1|||
37974878|NCT00493038|69662082|FG001|Follow-up|Lost to Follow-up|0|||
37974879|NCT00392223|69662090|FG000|Overall Study|Adverse Event|5|||
37974880|NCT00392223|69662091|FG001|Overall Study|Adverse Event|4|||
37974881|NCT00392223|69662090|FG000|Overall Study|Lost to Follow-up|1|||
37974882|NCT00392223|69662091|FG001|Overall Study|Lost to Follow-up|4|||
37782032|NCT02477670|69363720|FG003|Stage 1|Lost to Follow-up|0|||
37782033|NCT02477670|69363721|FG004|Stage 1|Lost to Follow-up|0|||
37692792|NCT02098395|69169034|FG000|Overall Study|Protocol Violation|2|||
37692793|NCT02098395|69169035|FG001|Overall Study|Protocol Violation|2|||
37692794|NCT02098395|69169036|FG002|Overall Study|Protocol Violation|0|||
37692795|NCT02098395|69169037|FG003|Overall Study|Protocol Violation|7|||
37974883|NCT00392223|69662090|FG000|Overall Study|Protocol Violation|0|||
37692796|NCT02098395|69169034|FG000|Overall Study|Withdrawal by Subject|10|||
37782034|NCT02477670|69363722|FG005|Stage 1|Lost to Follow-up|0|||
37782035|NCT02477670|69363723|FG006|Stage 1|Lost to Follow-up|0|||
37782036|NCT02477670|69363717|FG000|Stage 1|Withdrawal by Subject|1|||
37782037|NCT02477670|69363718|FG001|Stage 1|Withdrawal by Subject|2|||
37782038|NCT02477670|69363719|FG002|Stage 1|Withdrawal by Subject|0|||
37782039|NCT02477670|69363720|FG003|Stage 1|Withdrawal by Subject|0|||
37864023|NCT01120275|69547644|FG000|Overall Study|Ineligible|3|||
37782040|NCT02477670|69363721|FG004|Stage 1|Withdrawal by Subject|0|||
37782041|NCT02477670|69363722|FG005|Stage 1|Withdrawal by Subject|0|||
37782042|NCT02477670|69363723|FG006|Stage 1|Withdrawal by Subject|0|||
37974884|NCT00392223|69662091|FG001|Overall Study|Protocol Violation|3|||
37974885|NCT00392223|69662090|FG000|Overall Study|Withdrawal by Subject|3|||
37974886|NCT00392223|69662091|FG001|Overall Study|Withdrawal by Subject|2|||
37974887|NCT00402285|69662100|FG000|Overall Study|insufficient RNA quality|7|||
37974888|NCT00402285|69662101|FG001|Overall Study|insufficient RNA quality|6|||
37974889|NCT00402285|69662102|FG002|Overall Study|insufficient RNA quality|2|||
37974890|NCT00413283|69662112|FG000|Overall Study|Withdrawal by Subject|1|||
37974891|NCT00413283|69662113|FG001|Overall Study|Withdrawal by Subject|0|||
37974892|NCT00413283|69662114|FG002|Overall Study|Withdrawal by Subject|0|||
37974893|NCT00413283|69662115|FG003|Overall Study|Withdrawal by Subject|1|||
37974894|NCT00413283|69662112|FG000|Overall Study|Death|0|||
37974895|NCT00413283|69662113|FG001|Overall Study|Death|0|||
37974896|NCT00413283|69662114|FG002|Overall Study|Death|1|||
37974897|NCT00413283|69662115|FG003|Overall Study|Death|1|||
37782043|NCT02477670|69363717|FG000|Stage 1|Non-compliance with Study Drug|1|||
37782044|NCT02477670|69363718|FG001|Stage 1|Non-compliance with Study Drug|2|||
37782045|NCT02477670|69363719|FG002|Stage 1|Non-compliance with Study Drug|0|||
37782046|NCT02477670|69363720|FG003|Stage 1|Non-compliance with Study Drug|0|||
37782047|NCT02477670|69363721|FG004|Stage 1|Non-compliance with Study Drug|0|||
37782048|NCT02477670|69363722|FG005|Stage 1|Non-compliance with Study Drug|0|||
37782049|NCT02477670|69363723|FG006|Stage 1|Non-compliance with Study Drug|0|||
37782050|NCT02477670|69363717|FG000|Stage 2|Adverse Event|0|||
37782051|NCT02477670|69363718|FG001|Stage 2|Adverse Event|0|||
37782052|NCT02477670|69363719|FG002|Stage 2|Adverse Event|1|||
37782053|NCT02477670|69363720|FG003|Stage 2|Adverse Event|0|||
37782054|NCT02477670|69363721|FG004|Stage 2|Adverse Event|0|||
37782055|NCT02477670|69363722|FG005|Stage 2|Adverse Event|0|||
37782056|NCT02477670|69363723|FG006|Stage 2|Adverse Event|0|||
37782057|NCT02477670|69363717|FG000|Stage 2|Antipsychotic Medication Changed|0|||
37782058|NCT02477670|69363718|FG001|Stage 2|Antipsychotic Medication Changed|0|||
37782059|NCT02477670|69363719|FG002|Stage 2|Antipsychotic Medication Changed|1|||
37782060|NCT02477670|69363720|FG003|Stage 2|Antipsychotic Medication Changed|0|||
37782061|NCT02477670|69363721|FG004|Stage 2|Antipsychotic Medication Changed|0|||
37974898|NCT00413283|69662112|FG000|Overall Study|Adverse Event|0|||
37782062|NCT02477670|69363722|FG005|Stage 2|Antipsychotic Medication Changed|0|||
37782063|NCT02477670|69363723|FG006|Stage 2|Antipsychotic Medication Changed|0|||
37782064|NCT02477670|69363717|FG000|Stage 2|Withdrawal by Subject|0|||
37782065|NCT02477670|69363718|FG001|Stage 2|Withdrawal by Subject|0|||
37782066|NCT02477670|69363719|FG002|Stage 2|Withdrawal by Subject|0|||
37974899|NCT00413283|69662113|FG001|Overall Study|Adverse Event|0|||
37782067|NCT02477670|69363720|FG003|Stage 2|Withdrawal by Subject|1|||
37782068|NCT02477670|69363721|FG004|Stage 2|Withdrawal by Subject|0|||
37782069|NCT02477670|69363722|FG005|Stage 2|Withdrawal by Subject|0|||
37782070|NCT02477670|69363723|FG006|Stage 2|Withdrawal by Subject|0|||
37782071|NCT02509026|69363734|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
37974900|NCT00413283|69662114|FG002|Overall Study|Adverse Event|0|||
37974901|NCT00413283|69662115|FG003|Overall Study|Adverse Event|1|||
37974902|NCT00413283|69662112|FG000|Overall Study|Ineligibility determined|0|||
37692797|NCT02098395|69169035|FG001|Overall Study|Withdrawal by Subject|10|||
37692798|NCT02098395|69169036|FG002|Overall Study|Withdrawal by Subject|5|||
37692799|NCT02098395|69169037|FG003|Overall Study|Withdrawal by Subject|13|||
37692800|NCT02098395|69169034|FG000|Overall Study|Adverse Event|12|||
37692801|NCT02098395|69169035|FG001|Overall Study|Adverse Event|19|||
37692802|NCT02098395|69169036|FG002|Overall Study|Adverse Event|34|||
37782072|NCT02509026|69363734|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
37974903|NCT00413283|69662113|FG001|Overall Study|Ineligibility determined|0|||
37692803|NCT02098395|69169037|FG003|Overall Study|Adverse Event|2|||
37782073|NCT02509026|69363734|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
37692804|NCT02098395|69169034|FG000|Overall Study|Lost to Follow-up|2|||
37782074|NCT02509026|69363734|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
37782075|NCT02509026|69363734|FG000|Induction Period (24 Weeks)|Other|2|||
37782076|NCT02509026|69363734|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
37782077|NCT02509026|69363734|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
37782078|NCT02509026|69363734|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
37782079|NCT02509026|69363734|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
37782080|NCT02509026|69363734|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
37782081|NCT02509026|69363734|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
37782082|NCT02509026|69363734|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
37782083|NCT02509026|69363734|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
37782084|NCT02476968|69364108|FG000|Overall Study|Other|0|||
37782085|NCT02476968|69364109|FG001|Overall Study|Other|2|||
37782086|NCT02476968|69364110|FG002|Overall Study|Other|0|||
37782087|NCT02476968|69364108|FG000|Overall Study|Lost to Follow-up|10|||
37782088|NCT02476968|69364109|FG001|Overall Study|Lost to Follow-up|0|||
37782089|NCT02476968|69364110|FG002|Overall Study|Lost to Follow-up|1|||
37782090|NCT02476968|69364108|FG000|Overall Study|Death|48|||
37782091|NCT02476968|69364109|FG001|Overall Study|Death|8|||
37782092|NCT02476968|69364110|FG002|Overall Study|Death|1|||
37782093|NCT02476968|69364108|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
37782094|NCT02476968|69364109|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
37782095|NCT02476968|69364110|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
37782096|NCT02476968|69364108|FG000|Overall Study|Patient decision|37|||
37782097|NCT02476968|69364109|FG001|Overall Study|Patient decision|8|||
37782098|NCT02476968|69364110|FG002|Overall Study|Patient decision|0|||
37782099|NCT02476578|69364131|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
37782100|NCT02476578|69364132|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
37782101|NCT02476578|69364131|FG000|Overall Study|Lost to Follow-up|6|||
37782102|NCT02476578|69364132|FG001|Overall Study|Lost to Follow-up|13|||
37782103|NCT02504892|69364150|FG000|Overall Study|Adverse event-pneumonitis|2|||
37782104|NCT02504502|69364156|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
37782105|NCT02504502|69364157|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
37782106|NCT02504502|69364156|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
37782107|NCT02504502|69364157|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
37782108|NCT04184622|69364180|FG000|Overall Study|Adverse Event|7|||
37782109|NCT04184622|69364181|FG001|Overall Study|Adverse Event|7|||
37782110|NCT04184622|69364182|FG002|Overall Study|Adverse Event|11|||
37782111|NCT04184622|69364183|FG003|Overall Study|Adverse Event|8|||
37782112|NCT04184622|69364180|FG000|Overall Study|Death|4|||
37782113|NCT04184622|69364181|FG001|Overall Study|Death|4|||
37782114|NCT04184622|69364182|FG002|Overall Study|Death|2|||
37782115|NCT04184622|69364183|FG003|Overall Study|Death|1|||
37782116|NCT04184622|69364180|FG000|Overall Study|Lost to Follow-up|41|||
37782117|NCT04184622|69364181|FG001|Overall Study|Lost to Follow-up|19|||
37782118|NCT04184622|69364182|FG002|Overall Study|Lost to Follow-up|20|||
37782119|NCT04184622|69364183|FG003|Overall Study|Lost to Follow-up|15|||
37782120|NCT04184622|69364180|FG000|Overall Study|Missing Weight at Week 72|1|||
37782121|NCT04184622|69364181|FG001|Overall Study|Missing Weight at Week 72|0|||
37782122|NCT04184622|69364182|FG002|Overall Study|Missing Weight at Week 72|1|||
37782123|NCT04184622|69364183|FG003|Overall Study|Missing Weight at Week 72|0|||
37782124|NCT04184622|69364180|FG000|Overall Study|Other - as reported by the investigator|22|||
37782125|NCT04184622|69364181|FG001|Overall Study|Other - as reported by the investigator|7|||
37782126|NCT04184622|69364182|FG002|Overall Study|Other - as reported by the investigator|5|||
37692805|NCT02098395|69169035|FG001|Overall Study|Lost to Follow-up|1|||
37692806|NCT02098395|69169036|FG002|Overall Study|Lost to Follow-up|0|||
37692807|NCT02098395|69169037|FG003|Overall Study|Lost to Follow-up|3|||
37692808|NCT02098395|69169034|FG000|Overall Study|Unclassified|0|||
37692809|NCT02098395|69169035|FG001|Overall Study|Unclassified|0|||
37692810|NCT02098395|69169036|FG002|Overall Study|Unclassified|3|||
37692811|NCT02098395|69169037|FG003|Overall Study|Unclassified|2|||
37692812|NCT02041923|69169049|FG000|Overall Study|Lost to Follow-up|26|||
37692813|NCT02041923|69169050|FG001|Overall Study|Lost to Follow-up|30|||
37692814|NCT02062437|69169058|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
37692815|NCT02062437|69169058|FG000|Overall Study|Patient not available for the 2y visit|18|||
37692816|NCT02062437|69169058|FG000|Overall Study|Death|2|||
37692817|NCT02062437|69169058|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
37692818|NCT02365519|69169064|FG000|Randomized and Treated|Adverse Event|0|||
37692819|NCT02365519|69169065|FG001|Randomized and Treated|Adverse Event|1|||
37692820|NCT02365519|69169066|FG002|Randomized and Treated|Adverse Event|0|||
37864024|NCT01120275|69547644|FG000|Overall Study|Withdrawal by Subject|1|||
37864025|NCT01120275|69547644|FG000|Overall Study|Refusal|1|||
37692821|NCT02365519|69169064|FG000|Randomized and Treated|Withdrawal by Subject|0|||
37692822|NCT02365519|69169065|FG001|Randomized and Treated|Withdrawal by Subject|1|||
37692823|NCT02365519|69169066|FG002|Randomized and Treated|Withdrawal by Subject|1|||
37692824|NCT02061813|69169075|FG000|Overall Study|Withdrawal by Subject|1|||
37692825|NCT02061813|69169075|FG000|Overall Study|Protocol Violation|2|||
37692826|NCT02096835|69169085|FG000|Overall Study|Withdrawal by Subject|1|||
37864026|NCT01120275|69547644|FG000|Overall Study|Not specific|1|||
37692827|NCT02096835|69169086|FG001|Overall Study|Withdrawal by Subject|0|||
37692828|NCT02096835|69169087|FG002|Overall Study|Withdrawal by Subject|0|||
37692829|NCT02096835|69169085|FG000|Overall Study|converted to open procedures|1|||
37692830|NCT02096835|69169086|FG001|Overall Study|converted to open procedures|0|||
37692831|NCT02096835|69169087|FG002|Overall Study|converted to open procedures|0|||
37864027|NCT00991510|69547651|FG000|Period I (Days 1-14)|Adverse Event|1|||
37692832|NCT02096835|69169085|FG000|Overall Study|Lost to Follow-up|1|||
37692833|NCT02096835|69169086|FG001|Overall Study|Lost to Follow-up|0|||
37692834|NCT02096835|69169087|FG002|Overall Study|Lost to Follow-up|1|||
37692835|NCT02324569|69169097|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
37692836|NCT02324569|69169098|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
37692837|NCT02324569|69169097|FG000|Overall Study|Voluntary Withdrawal|3|||
37692838|NCT02324569|69169098|FG001|Overall Study|Voluntary Withdrawal|6|||
37782127|NCT04184622|69364183|FG003|Overall Study|Other - as reported by the investigator|12|||
37782128|NCT04184622|69364180|FG000|Overall Study|Physician Decision|0|||
37782129|NCT04184622|69364181|FG001|Overall Study|Physician Decision|0|||
37782130|NCT04184622|69364182|FG002|Overall Study|Physician Decision|3|||
37782131|NCT04184622|69364183|FG003|Overall Study|Physician Decision|1|||
37782132|NCT04184622|69364180|FG000|Overall Study|Pregnancy|4|||
37782133|NCT04184622|69364181|FG001|Overall Study|Pregnancy|4|||
37782134|NCT04184622|69364182|FG002|Overall Study|Pregnancy|3|||
37782135|NCT04184622|69364183|FG003|Overall Study|Pregnancy|5|||
37782136|NCT04184622|69364180|FG000|Overall Study|Protocol Deviation|1|||
37864028|NCT00991510|69547652|FG001|Period I (Days 1-14)|Adverse Event|0|||
37782137|NCT04184622|69364181|FG001|Overall Study|Protocol Deviation|0|||
37864029|NCT00991510|69547651|FG000|Period III (Days 29-112)|Adverse Event|1|||
37864030|NCT00991510|69547652|FG001|Period III (Days 29-112)|Adverse Event|1|||
37692839|NCT02324569|69169097|FG000|Overall Study|Lack of Efficacy|2|||
37864031|NCT01119963|69547664|FG000|Overall Study|Lost to Follow-up|1|||
37692840|NCT02324569|69169098|FG001|Overall Study|Lack of Efficacy|3|||
37782138|NCT04184622|69364182|FG002|Overall Study|Protocol Deviation|0|||
37782139|NCT04184622|69364183|FG003|Overall Study|Protocol Deviation|0|||
37692841|NCT02324569|69169097|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
37692842|NCT02324569|69169098|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
37692843|NCT02324569|69169097|FG000|Overall Study|Inconvenient Schedule|2|||
37782140|NCT04184622|69364180|FG000|Overall Study|Withdrawal by Subject|68|||
37782141|NCT04184622|69364181|FG001|Overall Study|Withdrawal by Subject|28|||
37782142|NCT04184622|69364182|FG002|Overall Study|Withdrawal by Subject|29|||
37782143|NCT04184622|69364183|FG003|Overall Study|Withdrawal by Subject|22|||
37782144|NCT03772717|69364216|FG000|Overall Study|Withdrawal by Subject|2|||
37782145|NCT03770403|69364220|FG000|Overall Study|Adverse Event|8|||
37782146|NCT03770403|69364220|FG000|Overall Study|Death|5|||
37782147|NCT03770403|69364220|FG000|Overall Study|Physician Decision|1|||
37782148|NCT03770403|69364220|FG000|Overall Study|Sponsor decision|1|||
37782149|NCT03770403|69364220|FG000|Overall Study|Study terminated by Sponsor|1|||
37782150|NCT03770403|69364220|FG000|Overall Study|Withdrawal by Subject|13|||
37782151|NCT03770403|69364220|FG000|Overall Study|Other|88|||
37782152|NCT03740100|69364224|FG000|Overall Study|Adverse Event|1|||
37782153|NCT03740100|69364224|FG000|Overall Study|Death|1|||
37782154|NCT03499795|69364228|FG000|Overall Study|Adverse Event|1|||
37782155|NCT03499795|69364228|FG000|Overall Study|Lost to Follow-up|1|||
37782156|NCT03456700|69364245|FG000|Overall Study|Withdrawal by Subject|1|||
37782157|NCT03401450|69364251|FG000|Overall Study|Lost to Follow-up|4|||
37782158|NCT03401450|69364252|FG001|Overall Study|Lost to Follow-up|6|||
37782159|NCT03401450|69364251|FG000|Overall Study|Anesthesia plan changed|2|||
37782160|NCT03401450|69364252|FG001|Overall Study|Anesthesia plan changed|2|||
37782161|NCT03401450|69364251|FG000|Overall Study|Did not complete medication diary|4|||
37782162|NCT03401450|69364252|FG001|Overall Study|Did not complete medication diary|2|||
37782163|NCT03401450|69364251|FG000|Overall Study|post surgery medication change|2|||
37782164|NCT03401450|69364252|FG001|Overall Study|post surgery medication change|1|||
37782165|NCT03401450|69364251|FG000|Overall Study|Cancelled surgery|0|||
37782166|NCT03401450|69364252|FG001|Overall Study|Cancelled surgery|2|||
37782167|NCT03326063|69364260|FG000|Overall Study|COVID pandemic: subject recalled to her country|1|||
37782168|NCT03326063|69364261|FG001|Overall Study|COVID pandemic: subject recalled to her country|0|||
37782169|NCT03155997|69364282|FG000|Overall Study|Withdrawal by Subject|119|||
37782170|NCT03155997|69364283|FG001|Overall Study|Withdrawal by Subject|134|||
37782171|NCT03155997|69364282|FG000|Overall Study|Lost to Follow-up|12|||
37782172|NCT03155997|69364283|FG001|Overall Study|Lost to Follow-up|13|||
37782173|NCT03155997|69364282|FG000|Overall Study|Missing disposition data|0|||
37782174|NCT03155997|69364283|FG001|Overall Study|Missing disposition data|1|||
37782175|NCT03155997|69364282|FG000|Overall Study|On study treatment|2027|||
37782176|NCT03155997|69364283|FG001|Overall Study|On study treatment|2074|||
37782177|NCT02764762|69364300|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
37782178|NCT02764762|69364300|FG000|Overall Study|Lost to Follow-up|4|||
37782179|NCT02764762|69364300|FG000|Overall Study|Voluntary Withdrawal|8|||
37782180|NCT02764762|69364300|FG000|Overall Study|Site Termination|1|||
37782181|NCT02764762|69364300|FG000|Overall Study|Lack of Efficacy|16|||
37782182|NCT02764762|69364300|FG000|Overall Study|Reason not Specified|1|||
37782183|NCT02340962|69364310|FG000|Overall Study|Lost to Follow-up|1|||
37782184|NCT02340962|69364311|FG001|Overall Study|Lost to Follow-up|0|||
37782185|NCT02272634|69364331|FG000|Overall Study|Adverse Event|1|||
37782186|NCT02272634|69364332|FG001|Overall Study|Adverse Event|0|||
37782187|NCT02272634|69364333|FG002|Overall Study|Adverse Event|0|||
37782188|NCT02272634|69364331|FG000|Overall Study|Protocol Violation|0|||
37782189|NCT02272634|69364332|FG001|Overall Study|Protocol Violation|0|||
37782190|NCT02272634|69364333|FG002|Overall Study|Protocol Violation|1|||
37782191|NCT02272634|69364331|FG000|Overall Study|Withdrawal by Subject|0|||
37782192|NCT02272634|69364332|FG001|Overall Study|Withdrawal by Subject|1|||
37782193|NCT02272634|69364333|FG002|Overall Study|Withdrawal by Subject|0|||
37782194|NCT00788125|69364344|FG000|Overall Study|Death|6|||
37782195|NCT02504424|69364357|FG000|Overall Study|Withdrawal by Subject|2|||
37782196|NCT02548832|69364687|FG000|Overall Study|Lost to Follow-up|2|||
37782197|NCT02548832|69364688|FG001|Overall Study|Lost to Follow-up|2|||
37782198|NCT02548832|69364689|FG002|Overall Study|Lost to Follow-up|2|||
37782199|NCT03215264|69364878|FG000|Dose Level 2|Adverse Event|0|||
37782200|NCT03215264|69364879|FG001|Dose Level 2|Adverse Event|1|||
37782201|NCT03215264|69364880|FG002|Dose Level 2|Adverse Event|0|||
37692844|NCT02324569|69169098|FG001|Overall Study|Inconvenient Schedule|0|||
37692845|NCT02294773|69169106|FG000|Overall Study|Withdrawal by Subject|0|||
37692846|NCT02294773|69169107|FG001|Overall Study|Withdrawal by Subject|2|||
37782202|NCT03215264|69364878|FG000|Dose Level 3|Withdrawal by Subject|0|||
37782203|NCT03215264|69364879|FG001|Dose Level 3|Withdrawal by Subject|0|||
37782204|NCT03215264|69364880|FG002|Dose Level 3|Withdrawal by Subject|1|||
37782205|NCT02504268|69364951|FG000|Overall Study|Adverse Event|18|||
37782206|NCT02504268|69364952|FG001|Overall Study|Adverse Event|8|||
37782207|NCT02504268|69364953|FG002|Overall Study|Adverse Event|14|||
37782208|NCT02504268|69364954|FG003|Overall Study|Adverse Event|0|||
37782209|NCT02504268|69364955|FG004|Overall Study|Adverse Event|0|||
37782210|NCT02504268|69364956|FG005|Overall Study|Adverse Event|0|||
37782211|NCT02504268|69364957|FG006|Overall Study|Adverse Event|0|||
37782212|NCT02504268|69364958|FG007|Overall Study|Adverse Event|0|||
37782213|NCT02504268|69364959|FG008|Overall Study|Adverse Event|0|||
37782214|NCT02504268|69364951|FG000|Overall Study|Withdrawal of Consent|11|||
37782215|NCT02504268|69364952|FG001|Overall Study|Withdrawal of Consent|10|||
37782216|NCT02504268|69364953|FG002|Overall Study|Withdrawal of Consent|3|||
37782217|NCT02504268|69364954|FG003|Overall Study|Withdrawal of Consent|0|||
37782218|NCT02504268|69364955|FG004|Overall Study|Withdrawal of Consent|0|||
37782219|NCT02504268|69364956|FG005|Overall Study|Withdrawal of Consent|0|||
37782220|NCT02504268|69364957|FG006|Overall Study|Withdrawal of Consent|0|||
37782221|NCT02504268|69364958|FG007|Overall Study|Withdrawal of Consent|0|||
37782222|NCT02504268|69364959|FG008|Overall Study|Withdrawal of Consent|0|||
37782223|NCT02504268|69364951|FG000|Overall Study|Pregnancy|2|||
37782224|NCT02504268|69364952|FG001|Overall Study|Pregnancy|0|||
37782225|NCT02504268|69364953|FG002|Overall Study|Pregnancy|0|||
37782226|NCT02504268|69364954|FG003|Overall Study|Pregnancy|0|||
37782227|NCT02504268|69364955|FG004|Overall Study|Pregnancy|0|||
37782228|NCT02504268|69364956|FG005|Overall Study|Pregnancy|0|||
37782229|NCT02504268|69364957|FG006|Overall Study|Pregnancy|0|||
37782230|NCT02504268|69364958|FG007|Overall Study|Pregnancy|0|||
37782231|NCT02504268|69364959|FG008|Overall Study|Pregnancy|0|||
37782232|NCT02504268|69364951|FG000|Overall Study|Lost to Follow-up|3|||
37782233|NCT02504268|69364952|FG001|Overall Study|Lost to Follow-up|6|||
37782234|NCT02504268|69364953|FG002|Overall Study|Lost to Follow-up|4|||
37782235|NCT02504268|69364954|FG003|Overall Study|Lost to Follow-up|0|||
37782236|NCT02504268|69364955|FG004|Overall Study|Lost to Follow-up|0|||
37782237|NCT02504268|69364956|FG005|Overall Study|Lost to Follow-up|0|||
37782238|NCT02504268|69364957|FG006|Overall Study|Lost to Follow-up|0|||
37782239|NCT02504268|69364958|FG007|Overall Study|Lost to Follow-up|0|||
37782240|NCT02504268|69364959|FG008|Overall Study|Lost to Follow-up|0|||
37692847|NCT02365285|69169117|FG000|Overall Study|Physician Decision|0|||
37692848|NCT02365285|69169118|FG001|Overall Study|Physician Decision|1|||
37692849|NCT02365285|69169119|FG002|Overall Study|Physician Decision|1|||
37692850|NCT02365285|69169120|FG003|Overall Study|Physician Decision|0|||
37692851|NCT02365285|69169117|FG000|Overall Study|Adverse Event|0|||
37692852|NCT02365285|69169118|FG001|Overall Study|Adverse Event|0|||
37692853|NCT02365285|69169119|FG002|Overall Study|Adverse Event|0|||
37782241|NCT02504268|69364951|FG000|Overall Study|Death|1|||
37782242|NCT02504268|69364952|FG001|Overall Study|Death|1|||
37974904|NCT00413283|69662114|FG002|Overall Study|Ineligibility determined|0|||
37692854|NCT02365285|69169120|FG003|Overall Study|Adverse Event|2|||
37692855|NCT02041299|69169134|FG000|Overall Study|Adverse Event|9|||
37692856|NCT02041299|69169135|FG001|Overall Study|Adverse Event|3|||
37692857|NCT02041299|69169134|FG000|Overall Study|Lost to Follow-up|4|||
37782243|NCT02504268|69364953|FG002|Overall Study|Death|0|||
37782244|NCT02504268|69364954|FG003|Overall Study|Death|0|||
37782245|NCT02504268|69364955|FG004|Overall Study|Death|0|||
37782246|NCT02504268|69364956|FG005|Overall Study|Death|0|||
37782247|NCT02504268|69364957|FG006|Overall Study|Death|0|||
37782248|NCT02504268|69364958|FG007|Overall Study|Death|0|||
37782249|NCT02504268|69364959|FG008|Overall Study|Death|0|||
37864032|NCT01119963|69547665|FG001|Overall Study|Lost to Follow-up|1|||
37782250|NCT02504268|69364951|FG000|Overall Study|Subject Request to Discontinue|11|||
37782251|NCT02504268|69364952|FG001|Overall Study|Subject Request to Discontinue|3|||
37782252|NCT02504268|69364953|FG002|Overall Study|Subject Request to Discontinue|6|||
37782253|NCT02504268|69364954|FG003|Overall Study|Subject Request to Discontinue|0|||
37782254|NCT02504268|69364955|FG004|Overall Study|Subject Request to Discontinue|0|||
37782255|NCT02504268|69364956|FG005|Overall Study|Subject Request to Discontinue|0|||
37782256|NCT02504268|69364957|FG006|Overall Study|Subject Request to Discontinue|0|||
37692858|NCT02041299|69169135|FG001|Overall Study|Lost to Follow-up|1|||
37692859|NCT02041299|69169134|FG000|Overall Study|Physician Decision|1|||
37692860|NCT02041299|69169135|FG001|Overall Study|Physician Decision|1|||
37692861|NCT02041299|69169134|FG000|Overall Study|Withdrawal by Subject|13|||
37782257|NCT02504268|69364958|FG007|Overall Study|Subject Request to Discontinue|0|||
37782258|NCT02504268|69364959|FG008|Overall Study|Subject Request to Discontinue|0|||
37782259|NCT02504268|69364951|FG000|Overall Study|No Longer Meets Study Criteria|2|||
37782260|NCT02504268|69364952|FG001|Overall Study|No Longer Meets Study Criteria|3|||
37782261|NCT02504268|69364953|FG002|Overall Study|No Longer Meets Study Criteria|0|||
37782262|NCT02504268|69364954|FG003|Overall Study|No Longer Meets Study Criteria|0|||
37782263|NCT02504268|69364955|FG004|Overall Study|No Longer Meets Study Criteria|0|||
37782264|NCT02504268|69364956|FG005|Overall Study|No Longer Meets Study Criteria|0|||
37782265|NCT02504268|69364957|FG006|Overall Study|No Longer Meets Study Criteria|0|||
37782266|NCT02504268|69364958|FG007|Overall Study|No Longer Meets Study Criteria|0|||
37782267|NCT02504268|69364959|FG008|Overall Study|No Longer Meets Study Criteria|0|||
37782268|NCT02504268|69364951|FG000|Overall Study|Lack of Efficacy|11|||
37782269|NCT02504268|69364952|FG001|Overall Study|Lack of Efficacy|35|||
37782270|NCT02504268|69364953|FG002|Overall Study|Lack of Efficacy|9|||
37782271|NCT02504268|69364954|FG003|Overall Study|Lack of Efficacy|0|||
37782272|NCT02504268|69364955|FG004|Overall Study|Lack of Efficacy|0|||
37782273|NCT02504268|69364956|FG005|Overall Study|Lack of Efficacy|0|||
37782274|NCT02504268|69364957|FG006|Overall Study|Lack of Efficacy|0|||
37782275|NCT02504268|69364958|FG007|Overall Study|Lack of Efficacy|0|||
37782276|NCT02504268|69364959|FG008|Overall Study|Lack of Efficacy|0|||
37782277|NCT02504268|69364951|FG000|Overall Study|Poor/Non-Compliance|3|||
37782278|NCT02504268|69364952|FG001|Overall Study|Poor/Non-Compliance|2|||
37782279|NCT02504268|69364953|FG002|Overall Study|Poor/Non-Compliance|3|||
37782280|NCT02504268|69364954|FG003|Overall Study|Poor/Non-Compliance|0|||
37782281|NCT02504268|69364955|FG004|Overall Study|Poor/Non-Compliance|0|||
37782282|NCT02504268|69364956|FG005|Overall Study|Poor/Non-Compliance|0|||
37782283|NCT02504268|69364957|FG006|Overall Study|Poor/Non-Compliance|0|||
37782284|NCT02504268|69364958|FG007|Overall Study|Poor/Non-Compliance|0|||
37692862|NCT02041299|69169135|FG001|Overall Study|Withdrawal by Subject|7|||
37692863|NCT02041299|69169134|FG000|Overall Study|Protocol Violation|11|||
37692864|NCT02041299|69169135|FG001|Overall Study|Protocol Violation|4|||
37692865|NCT02041299|69169134|FG000|Overall Study|Termination of the study|7|||
37782285|NCT02504268|69364959|FG008|Overall Study|Poor/Non-Compliance|0|||
37782286|NCT02504268|69364951|FG000|Overall Study|Not Disclosed|1|||
37782287|NCT02504268|69364952|FG001|Overall Study|Not Disclosed|0|||
37782288|NCT02504268|69364953|FG002|Overall Study|Not Disclosed|2|||
37782289|NCT02504268|69364954|FG003|Overall Study|Not Disclosed|0|||
37782290|NCT02504268|69364955|FG004|Overall Study|Not Disclosed|0|||
37782291|NCT02504268|69364956|FG005|Overall Study|Not Disclosed|0|||
37692866|NCT02041299|69169135|FG001|Overall Study|Termination of the study|3|||
37782292|NCT02504268|69364957|FG006|Overall Study|Not Disclosed|0|||
37782293|NCT02504268|69364958|FG007|Overall Study|Not Disclosed|0|||
37782294|NCT02504268|69364959|FG008|Overall Study|Not Disclosed|0|||
37782295|NCT01654302|69365003|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
37782296|NCT01654302|69365004|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
37692867|NCT02041299|69169134|FG000|Overall Study|Required bone marrow transplant|0|||
37782297|NCT02476422|69365020|FG000|Overall Study|Subject/guardian decision|0|||
37692868|NCT02041299|69169135|FG001|Overall Study|Required bone marrow transplant|1|||
37692869|NCT02041299|69169134|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
37692870|NCT02041299|69169135|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
37692871|NCT01645735|69169147|FG000|Overall Study|Physician Decision|2|||
37692872|NCT01645735|69169148|FG001|Overall Study|Physician Decision|0|||
37692873|NCT01645735|69169147|FG000|Overall Study|Withdrawal by Subject|1|||
37692874|NCT01645735|69169148|FG001|Overall Study|Withdrawal by Subject|0|||
37692875|NCT01645735|69169147|FG000|Overall Study|Protocol Violation|1|||
37692876|NCT01645735|69169148|FG001|Overall Study|Protocol Violation|0|||
37692877|NCT01645735|69169147|FG000|Overall Study|Adverse Event|0|||
37692878|NCT01645735|69169148|FG001|Overall Study|Adverse Event|1|||
37692879|NCT02365207|69169155|FG000|Overall Study|Withdrawal by Subject|1|||
37692880|NCT02365207|69169155|FG000|Overall Study|Physician Decision|1|||
37692881|NCT01645111|69169159|FG000|Overall Study|Did not require Clevidipine|15|||
37692882|NCT02364037|69169165|FG000|Overall Study|Withdrawal by Subject|7|||
37692883|NCT02364037|69169166|FG001|Overall Study|Withdrawal by Subject|4|||
37692884|NCT02364037|69169165|FG000|Overall Study|Lost to Follow-up|37|||
37782298|NCT02476422|69365021|FG001|Overall Study|Subject/guardian decision|1|||
37782299|NCT02475564|69365051|FG000|Overall Study|Withdrawal by Subject|1|||
37782300|NCT02475564|69365052|FG001|Overall Study|Withdrawal by Subject|0|||
37782301|NCT02475564|69365051|FG000|Overall Study|Lost to Follow-up|2|||
37782302|NCT02475564|69365052|FG001|Overall Study|Lost to Follow-up|1|||
37782303|NCT02475564|69365051|FG000|Overall Study|Intense Menstrual bleeding|1|||
37782304|NCT02475564|69365052|FG001|Overall Study|Intense Menstrual bleeding|0|||
37782305|NCT02503332|69365340|FG000|Overall Study|Adverse Event|17|||
37782306|NCT02503332|69365341|FG001|Overall Study|Adverse Event|5|||
37782307|NCT02503332|69365342|FG002|Overall Study|Adverse Event|3|||
37782308|NCT02503332|69365343|FG003|Overall Study|Adverse Event|1|||
37782309|NCT02503332|69365340|FG000|Overall Study|Investigator's Decision|5|||
37782310|NCT02503332|69365341|FG001|Overall Study|Investigator's Decision|1|||
37782311|NCT02503332|69365342|FG002|Overall Study|Investigator's Decision|0|||
37782312|NCT02503332|69365343|FG003|Overall Study|Investigator's Decision|0|||
37782313|NCT02503332|69365340|FG000|Overall Study|Sponsor's Decision|1|||
37782314|NCT02503332|69365341|FG001|Overall Study|Sponsor's Decision|0|||
37782315|NCT02503332|69365342|FG002|Overall Study|Sponsor's Decision|0|||
37782316|NCT02503332|69365343|FG003|Overall Study|Sponsor's Decision|1|||
37782317|NCT02503332|69365340|FG000|Overall Study|Subject Request|6|||
37692885|NCT02364037|69169166|FG001|Overall Study|Lost to Follow-up|49|||
37692886|NCT01919164|69169177|FG000|Overall Study|Adverse Event|6|||
37692887|NCT01919164|69169178|FG001|Overall Study|Adverse Event|4|||
37692888|NCT01919164|69169179|FG002|Overall Study|Adverse Event|9|||
37692889|NCT01919164|69169180|FG003|Overall Study|Adverse Event|3|||
37782318|NCT02503332|69365341|FG001|Overall Study|Subject Request|5|||
37782319|NCT02503332|69365342|FG002|Overall Study|Subject Request|2|||
37782320|NCT02503332|69365343|FG003|Overall Study|Subject Request|1|||
37782321|NCT02503332|69365340|FG000|Overall Study|Death|0|||
37782322|NCT02503332|69365341|FG001|Overall Study|Death|2|||
37782323|NCT02503332|69365342|FG002|Overall Study|Death|2|||
37782324|NCT02503332|69365343|FG003|Overall Study|Death|0|||
37782325|NCT02503332|69365340|FG000|Overall Study|Other|5|||
37782326|NCT02503332|69365341|FG001|Overall Study|Other|6|||
37782327|NCT02503332|69365342|FG002|Overall Study|Other|1|||
37782328|NCT02503332|69365343|FG003|Overall Study|Other|1|||
37782329|NCT02502864|69365361|FG000|Overall Study|Withdrawal by Subject|1|||
37782330|NCT02474082|69365395|FG000|Overall Study|Adverse Event|2|||
37782331|NCT02474082|69365396|FG001|Overall Study|Adverse Event|32|||
37782332|NCT02474082|69365395|FG000|Overall Study|Withdrawal of informed consent|1|||
37782333|NCT02474082|69365396|FG001|Overall Study|Withdrawal of informed consent|11|||
37782334|NCT02474082|69365395|FG000|Overall Study|Lost to Follow-up|2|||
37782335|NCT02474082|69365396|FG001|Overall Study|Lost to Follow-up|2|||
37782336|NCT02474082|69365395|FG000|Overall Study|Dose tapering not achieved|0|||
37782337|NCT02474082|69365396|FG001|Overall Study|Dose tapering not achieved|4|||
37782338|NCT02474082|69365395|FG000|Overall Study|Participant/guardian decision|1|||
37782339|NCT02474082|69365396|FG001|Overall Study|Participant/guardian decision|2|||
37782340|NCT02474082|69365395|FG000|Overall Study|Non-compliance with study treatment|0|||
37782341|NCT02474082|69365396|FG001|Overall Study|Non-compliance with study treatment|2|||
37782342|NCT02474082|69365395|FG000|Overall Study|Protocol deviation|0|||
37782343|NCT02474082|69365396|FG001|Overall Study|Protocol deviation|1|||
37782344|NCT02501928|69365506|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
37782345|NCT02501928|69365507|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
37782346|NCT02501928|69365508|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
37782347|NCT02501928|69365509|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
37782348|NCT02501928|69365510|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
37782349|NCT02501928|69365511|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
37782350|NCT02473614|69365575|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
37782351|NCT02473614|69365576|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
37782352|NCT02500758|69365598|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
37782353|NCT02500758|69365599|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
37782354|NCT02500758|69365598|FG000|Washout (1 Week)|Lost to Follow-up|2|||
37782355|NCT02500758|69365599|FG001|Washout (1 Week)|Lost to Follow-up|2|||
37782356|NCT02500758|69365598|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
37782357|NCT02500758|69365599|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
37782358|NCT02500758|69365598|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
37782359|NCT02500758|69365599|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
37782360|NCT02500758|69365598|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
37782361|NCT02500758|69365599|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
37782362|NCT02500056|69365613|FG000|Overall Study|Lost to Follow-up|3|||
37782363|NCT02500056|69365614|FG001|Overall Study|Lost to Follow-up|7|||
37782364|NCT02500056|69365613|FG000|Overall Study|Recurrence|1|||
37782365|NCT02500056|69365614|FG001|Overall Study|Recurrence|0|||
37782366|NCT02500056|69365613|FG000|Overall Study|Death|3|||
37782367|NCT02500056|69365614|FG001|Overall Study|Death|1|||
37782368|NCT02472756|69365663|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
37974905|NCT00413283|69662115|FG003|Overall Study|Ineligibility determined|1|||
37974906|NCT00413283|69662112|FG000|Overall Study|Protocol deviation|0|||
37974907|NCT00413283|69662113|FG001|Overall Study|Protocol deviation|1|||
37974908|NCT00413283|69662114|FG002|Overall Study|Protocol deviation|0|||
37974909|NCT00413283|69662115|FG003|Overall Study|Protocol deviation|0|||
37692890|NCT01919164|69169181|FG004|Overall Study|Adverse Event|2|||
37692891|NCT01919164|69169177|FG000|Overall Study|Lost to Follow-up|2|||
37692892|NCT01919164|69169178|FG001|Overall Study|Lost to Follow-up|2|||
37692893|NCT01919164|69169179|FG002|Overall Study|Lost to Follow-up|2|||
37692894|NCT01919164|69169180|FG003|Overall Study|Lost to Follow-up|0|||
37692895|NCT01919164|69169181|FG004|Overall Study|Lost to Follow-up|4|||
37692896|NCT01919164|69169177|FG000|Overall Study|Death|1|||
37692897|NCT01919164|69169178|FG001|Overall Study|Death|0|||
37692898|NCT01919164|69169179|FG002|Overall Study|Death|0|||
37692899|NCT01919164|69169180|FG003|Overall Study|Death|0|||
37692900|NCT01919164|69169181|FG004|Overall Study|Death|0|||
37692901|NCT01919164|69169177|FG000|Overall Study|Protocol Violation|6|||
37692902|NCT01919164|69169178|FG001|Overall Study|Protocol Violation|0|||
37692903|NCT01919164|69169179|FG002|Overall Study|Protocol Violation|3|||
37692904|NCT01919164|69169180|FG003|Overall Study|Protocol Violation|2|||
37692905|NCT01919164|69169181|FG004|Overall Study|Protocol Violation|2|||
37782369|NCT02472756|69365663|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
37782370|NCT02472756|69365663|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
37782371|NCT02472756|69365663|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
37782372|NCT02472756|69365663|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
37782373|NCT02498652|69365673|FG000|Overall Study|Protocol Violation|0|||
37782374|NCT02498652|69365674|FG001|Overall Study|Protocol Violation|1|||
37782375|NCT03213158|69365698|FG000|Overall Study|Withdrawal by Subject|1|||
37692906|NCT01919164|69169177|FG000|Overall Study|Disease progression|2|||
37974910|NCT00413283|69662112|FG000|Overall Study|Requirement for alternative therapy|0|||
37692907|NCT01919164|69169178|FG001|Overall Study|Disease progression|2|||
37692908|NCT01919164|69169179|FG002|Overall Study|Disease progression|1|||
37782376|NCT03213158|69365698|FG000|Overall Study|Physician Decision|2|||
37782377|NCT02498418|69365705|FG000|Overall Study|Lack of Efficacy|0|||
37782378|NCT02498418|69365706|FG001|Overall Study|Lack of Efficacy|0|||
37782379|NCT02498418|69365707|FG002|Overall Study|Lack of Efficacy|1|||
37692909|NCT01919164|69169180|FG003|Overall Study|Disease progression|2|||
37692910|NCT01919164|69169181|FG004|Overall Study|Disease progression|1|||
37692911|NCT01919164|69169177|FG000|Overall Study|Withdrew consent|13|||
37692912|NCT01919164|69169178|FG001|Overall Study|Withdrew consent|13|||
37692913|NCT01919164|69169179|FG002|Overall Study|Withdrew consent|14|||
37692914|NCT01919164|69169180|FG003|Overall Study|Withdrew consent|14|||
37692915|NCT01919164|69169181|FG004|Overall Study|Withdrew consent|9|||
37692916|NCT01919164|69169177|FG000|Overall Study|Other Un-specified|13|||
37692917|NCT01919164|69169178|FG001|Overall Study|Other Un-specified|9|||
37974911|NCT00413283|69662113|FG001|Overall Study|Requirement for alternative therapy|2|||
37782380|NCT02498418|69365705|FG000|Overall Study|Withdrawal by Subject|2|||
37782381|NCT02498418|69365706|FG001|Overall Study|Withdrawal by Subject|0|||
37974912|NCT00413283|69662114|FG002|Overall Study|Requirement for alternative therapy|0|||
37692918|NCT01919164|69169179|FG002|Overall Study|Other Un-specified|8|||
37974913|NCT00413283|69662115|FG003|Overall Study|Requirement for alternative therapy|0|||
37692919|NCT01919164|69169180|FG003|Overall Study|Other Un-specified|7|||
37692920|NCT01919164|69169181|FG004|Overall Study|Other Un-specified|15|||
37692921|NCT01901224|69169193|FG000|Overall Study|study was not funded and terminated|2|||
37692922|NCT01901146|69169199|FG000|Neoadjuvant Phase|Death|1|||
37692923|NCT01901146|69169200|FG001|Neoadjuvant Phase|Death|2|||
37692924|NCT01901146|69169201|FG002|Neoadjuvant Phase|Death|0|||
37692925|NCT01901146|69169202|FG003|Neoadjuvant Phase|Death|0|||
37692926|NCT01901146|69169203|FG004|Neoadjuvant Phase|Death|0|||
37692927|NCT01901146|69169199|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
37692928|NCT01901146|69169200|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
37692929|NCT01901146|69169201|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
37692930|NCT01901146|69169202|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
37692931|NCT01901146|69169203|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
37782382|NCT02498418|69365707|FG002|Overall Study|Withdrawal by Subject|3|||
37782383|NCT02498418|69365705|FG000|Overall Study|Lost to Follow-up|0|||
37782384|NCT02498418|69365706|FG001|Overall Study|Lost to Follow-up|1|||
37782385|NCT02498418|69365707|FG002|Overall Study|Lost to Follow-up|1|||
37782386|NCT02498418|69365705|FG000|Overall Study|Participant taken prohibited medication|0|||
37782387|NCT02498418|69365706|FG001|Overall Study|Participant taken prohibited medication|1|||
37782388|NCT02498418|69365707|FG002|Overall Study|Participant taken prohibited medication|1|||
37782389|NCT02472366|69365725|FG000|Overall Study|Lost to Follow-up|1|||
37782390|NCT02472366|69365726|FG001|Overall Study|Lost to Follow-up|0|||
37782391|NCT03219164|69365734|FG000|Overall Study|Study Terminated by Sponsor|16|||
37782392|NCT03219164|69365735|FG001|Overall Study|Study Terminated by Sponsor|12|||
37782393|NCT03219164|69365734|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
37782394|NCT03219164|69365735|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
37782395|NCT03219164|69365734|FG000|Overall Study|Lost to Follow-up|1|||
37782396|NCT03219164|69365735|FG001|Overall Study|Lost to Follow-up|1|||
37782397|NCT03219164|69365734|FG000|Overall Study|Adverse Event|1|||
37782398|NCT03219164|69365735|FG001|Overall Study|Adverse Event|0|||
37782399|NCT03219164|69365734|FG000|Overall Study|Non-Compliance with Study Drug|1|||
37782400|NCT03219164|69365735|FG001|Overall Study|Non-Compliance with Study Drug|0|||
37782401|NCT03219164|69365734|FG000|Overall Study|Protocol Violation|0|||
37782402|NCT03219164|69365735|FG001|Overall Study|Protocol Violation|1|||
37782403|NCT03219164|69365734|FG000|Overall Study|Withdrew Assent|1|||
37782404|NCT03219164|69365735|FG001|Overall Study|Withdrew Assent|0|||
37782405|NCT02471586|69365753|FG000|Overall Study|Lost to Follow-up|3|||
37782406|NCT02471586|69365754|FG001|Overall Study|Lost to Follow-up|8|||
37782407|NCT02471586|69365755|FG002|Overall Study|Lost to Follow-up|4|||
37782408|NCT02471586|69365753|FG000|Overall Study|Death|2|||
37782409|NCT02471586|69365754|FG001|Overall Study|Death|2|||
37782410|NCT02471586|69365755|FG002|Overall Study|Death|0|||
37782411|NCT02470806|69365906|FG000|Overall Study|Lost to Follow-up|1|||
37782412|NCT02470806|69365907|FG001|Overall Study|Lost to Follow-up|1|||
37782413|NCT02470806|69365906|FG000|Overall Study|Adverse Event|5|||
37782414|NCT02470806|69365907|FG001|Overall Study|Adverse Event|2|||
37782415|NCT02470806|69365906|FG000|Overall Study|Protocol Violation|4|||
37782416|NCT02470806|69365907|FG001|Overall Study|Protocol Violation|11|||
37782417|NCT02470806|69365906|FG000|Overall Study|Physician Decision|0|||
37782418|NCT02470806|69365907|FG001|Overall Study|Physician Decision|3|||
37782419|NCT02470806|69365906|FG000|Overall Study|Withdrawal by Subject|3|||
37782420|NCT02470806|69365907|FG001|Overall Study|Withdrawal by Subject|10|||
37782421|NCT02470806|69365906|FG000|Overall Study|Lack of Efficacy|5|||
37782422|NCT02470806|69365907|FG001|Overall Study|Lack of Efficacy|15|||
37782423|NCT01363908|69365949|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
37782424|NCT01363908|69365950|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
37782425|NCT01363908|69365949|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
37782426|NCT01363908|69365950|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
37782427|NCT01363908|69365949|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
37782428|NCT01363908|69365950|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
37782429|NCT01363908|69365949|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
37782430|NCT01363908|69365950|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
37782431|NCT02497404|69365988|FG000|Overall Study|Adverse Event|1|||
37692932|NCT01901146|69169199|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
37692933|NCT01901146|69169200|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
37692934|NCT01901146|69169201|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
37692935|NCT01901146|69169202|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
37692936|NCT01901146|69169203|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
37692937|NCT01901146|69169199|FG000|Neoadjuvant Phase|Physician Decision|1|||
37692938|NCT01901146|69169200|FG001|Neoadjuvant Phase|Physician Decision|2|||
37692939|NCT01901146|69169201|FG002|Neoadjuvant Phase|Physician Decision|0|||
37692940|NCT01901146|69169202|FG003|Neoadjuvant Phase|Physician Decision|0|||
37692941|NCT01901146|69169203|FG004|Neoadjuvant Phase|Physician Decision|0|||
37692942|NCT01901146|69169199|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
37692943|NCT01901146|69169200|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
37782432|NCT02496702|69366021|FG000|Overall Study|Lost to Follow-up|8|||
37782433|NCT02496702|69366022|FG001|Overall Study|Lost to Follow-up|6|||
37782434|NCT02496702|69366021|FG000|Overall Study|Only partially tested|0|||
37782435|NCT02496702|69366022|FG001|Overall Study|Only partially tested|2|||
37782436|NCT02469246|69366098|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
37782437|NCT02469246|69366099|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
37782438|NCT02469246|69366098|FG000|Double-Blind Phase|Adverse Event|12|||
37782439|NCT02469246|69366099|FG001|Double-Blind Phase|Adverse Event|9|||
37782440|NCT02469246|69366098|FG000|Double-Blind Phase|Death|2|||
37782441|NCT02469246|69366099|FG001|Double-Blind Phase|Death|0|||
37782442|NCT02469246|69366098|FG000|Double-Blind Phase|Lack of Efficacy|2|||
37782443|NCT02469246|69366099|FG001|Double-Blind Phase|Lack of Efficacy|1|||
37782444|NCT02469246|69366098|FG000|Double-Blind Phase|Investigator's Discretion|8|||
37782445|NCT02469246|69366099|FG001|Double-Blind Phase|Investigator's Discretion|8|||
37782446|NCT02469246|69366098|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
37782447|NCT02469246|69366099|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
37782448|NCT02469246|69366098|FG000|Double-Blind Phase|Protocol Violation|1|||
37782449|NCT02469246|69366099|FG001|Double-Blind Phase|Protocol Violation|1|||
37782450|NCT02469246|69366098|FG000|Double-Blind Phase|Withdrew Consent|25|||
37782451|NCT02469246|69366099|FG001|Double-Blind Phase|Withdrew Consent|25|||
37782452|NCT02469246|69366098|FG000|Double-Blind Phase|Lost to Follow-up|9|||
37782453|NCT02469246|69366099|FG001|Double-Blind Phase|Lost to Follow-up|5|||
37782454|NCT02469168|69366118|FG000|Overall Study|Trial closed|1|||
37782455|NCT02469168|69366119|FG001|Overall Study|Trial closed|0|||
37782456|NCT02469090|69366127|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
37782457|NCT02469090|69366128|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
37782458|NCT02469090|69366129|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
37782459|NCT02469090|69366127|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
37782460|NCT02469090|69366128|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
37782461|NCT02469090|69366129|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
37782462|NCT02469090|69366127|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
37782463|NCT02469090|69366128|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
37782464|NCT02469090|69366129|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
37782465|NCT02469090|69366127|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
37782466|NCT02469090|69366128|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
37782467|NCT02469090|69366129|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
37782468|NCT02469090|69366127|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
37782469|NCT02469090|69366128|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
37782470|NCT02469090|69366129|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
37782471|NCT02469090|69366127|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
37782472|NCT02469090|69366128|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
37782473|NCT02469090|69366129|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
37782474|NCT02469090|69366127|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
37782475|NCT02469090|69366128|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
37782476|NCT02469090|69366129|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
37782477|NCT02469090|69366127|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
37782478|NCT02469090|69366128|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
37782479|NCT02469090|69366129|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
37782480|NCT02496000|69366139|FG000|Overall Study|Withdrawal by Subject|1|||
37782481|NCT02496000|69366140|FG001|Overall Study|Withdrawal by Subject|2|||
37782482|NCT02496000|69366141|FG002|Overall Study|Withdrawal by Subject|0|||
37782483|NCT02496000|69366139|FG000|Overall Study|Lost to Follow-up|1|||
37782484|NCT02496000|69366140|FG001|Overall Study|Lost to Follow-up|0|||
37782485|NCT02496000|69366141|FG002|Overall Study|Lost to Follow-up|1|||
37782486|NCT02496000|69366139|FG000|Overall Study|Protocol Violation|0|||
37782487|NCT02496000|69366140|FG001|Overall Study|Protocol Violation|0|||
37782488|NCT02496000|69366141|FG002|Overall Study|Protocol Violation|1|||
37782489|NCT02496000|69366139|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
37782490|NCT02496000|69366140|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
37782491|NCT02496000|69366141|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
37782492|NCT02496000|69366139|FG000|Overall Study|undetermined|0|||
37782493|NCT02496000|69366140|FG001|Overall Study|undetermined|1|||
37782494|NCT02496000|69366141|FG002|Overall Study|undetermined|0|||
37782495|NCT02468934|69366150|FG000|Overall Study|Withdrawal by Subject|4|||
37782496|NCT02468934|69366150|FG000|Overall Study|Screen Failure|3|||
37782497|NCT02517528|69366156|FG000|Overall Study|Withdrawal by Subject|1|||
37782498|NCT02495844|69366162|FG000|Overall Study|Lack of Efficacy|1|||
37782499|NCT02495844|69366163|FG001|Overall Study|Lack of Efficacy|2|||
37782500|NCT02495844|69366162|FG000|Overall Study|AE, non-fatal|0|||
37782501|NCT02495844|69366163|FG001|Overall Study|AE, non-fatal|1|||
37782502|NCT02495844|69366162|FG000|Overall Study|Hepatitis Positivity|0|||
37782503|NCT02495844|69366163|FG001|Overall Study|Hepatitis Positivity|1|||
37782504|NCT02468778|69366174|FG000|Overall Study|Death|2|||
37782505|NCT02468778|69366175|FG001|Overall Study|Death|1|||
37782506|NCT02468778|69366176|FG002|Overall Study|Death|0|||
37782507|NCT02468778|69366174|FG000|Overall Study|Lost to Follow-up|1|||
37782508|NCT02468778|69366175|FG001|Overall Study|Lost to Follow-up|2|||
37782509|NCT02468778|69366176|FG002|Overall Study|Lost to Follow-up|2|||
37782510|NCT02468778|69366174|FG000|Overall Study|Withdrawal by Subject|0|||
37782511|NCT02468778|69366175|FG001|Overall Study|Withdrawal by Subject|1|||
37782512|NCT02468778|69366176|FG002|Overall Study|Withdrawal by Subject|1|||
37782513|NCT01727336|69366190|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
37782514|NCT01727336|69366191|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
37782515|NCT01727336|69366192|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
37782516|NCT01727336|69366193|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
37782517|NCT01727336|69366194|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
37782518|NCT01727336|69366195|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
37782519|NCT01727336|69366190|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
37782520|NCT01727336|69366191|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
37782521|NCT01727336|69366192|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
37782522|NCT01727336|69366193|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
37782523|NCT01727336|69366194|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
37782524|NCT01727336|69366195|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
37692944|NCT01901146|69169201|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
37692945|NCT01901146|69169202|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
37692946|NCT01901146|69169203|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
37692947|NCT01901146|69169199|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
37692948|NCT01901146|69169200|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
37692949|NCT01901146|69169201|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
37692950|NCT01901146|69169202|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
37692951|NCT01901146|69169203|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
37692952|NCT01901146|69169199|FG000|Adjuvant Phase|Other|0|||
37692953|NCT01901146|69169200|FG001|Adjuvant Phase|Other|0|||
37692954|NCT01901146|69169201|FG002|Adjuvant Phase|Other|1|||
37692955|NCT01901146|69169202|FG003|Adjuvant Phase|Other|0|||
37692956|NCT01901146|69169203|FG004|Adjuvant Phase|Other|0|||
37692957|NCT01901146|69169199|FG000|Adjuvant Phase|Death|0|||
37692958|NCT01901146|69169200|FG001|Adjuvant Phase|Death|0|||
37692959|NCT01901146|69169201|FG002|Adjuvant Phase|Death|0|||
37692960|NCT01901146|69169202|FG003|Adjuvant Phase|Death|0|||
37692961|NCT01901146|69169203|FG004|Adjuvant Phase|Death|3|||
37692962|NCT01901146|69169199|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
37692963|NCT01901146|69169200|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
37692964|NCT01901146|69169201|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
37692965|NCT01901146|69169202|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
37692966|NCT01901146|69169203|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
37692967|NCT01901146|69169199|FG000|Adjuvant Phase|Physician Decision|0|||
37692968|NCT01901146|69169200|FG001|Adjuvant Phase|Physician Decision|0|||
37692969|NCT01901146|69169201|FG002|Adjuvant Phase|Physician Decision|9|||
37692970|NCT01901146|69169202|FG003|Adjuvant Phase|Physician Decision|2|||
37692971|NCT01901146|69169203|FG004|Adjuvant Phase|Physician Decision|4|||
37692972|NCT01901146|69169199|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
37692973|NCT01901146|69169200|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
37692974|NCT01901146|69169201|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
37692975|NCT01901146|69169202|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
37692976|NCT01901146|69169203|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
37692977|NCT01644643|69169216|FG000|Overall Study|Death|1|||
37692978|NCT01644643|69169217|FG001|Overall Study|Death|0|||
37692979|NCT01644643|69169218|FG002|Overall Study|Death|3|||
37692980|NCT01644643|69169219|FG003|Overall Study|Death|3|||
37782525|NCT01727336|69366190|FG000|Part 2 Blinded|Death|0|||
37782526|NCT01727336|69366191|FG001|Part 2 Blinded|Death|0|||
37782527|NCT01727336|69366192|FG002|Part 2 Blinded|Death|0|||
37782528|NCT01727336|69366193|FG003|Part 2 Blinded|Death|0|||
37782529|NCT01727336|69366194|FG004|Part 2 Blinded|Death|20|||
37782530|NCT01727336|69366195|FG005|Part 2 Blinded|Death|16|||
37782531|NCT01727336|69366190|FG000|Part 2 Blinded|Lack of Efficacy|0|||
37782532|NCT01727336|69366191|FG001|Part 2 Blinded|Lack of Efficacy|0|||
37782533|NCT01727336|69366192|FG002|Part 2 Blinded|Lack of Efficacy|0|||
37782534|NCT01727336|69366193|FG003|Part 2 Blinded|Lack of Efficacy|0|||
37782535|NCT01727336|69366194|FG004|Part 2 Blinded|Lack of Efficacy|42|||
37782536|NCT01727336|69366195|FG005|Part 2 Blinded|Lack of Efficacy|44|||
37782537|NCT01727336|69366190|FG000|Part 2 Blinded|Lost to Follow-up|0|||
37782538|NCT01727336|69366191|FG001|Part 2 Blinded|Lost to Follow-up|0|||
37782539|NCT01727336|69366192|FG002|Part 2 Blinded|Lost to Follow-up|0|||
37782540|NCT01727336|69366193|FG003|Part 2 Blinded|Lost to Follow-up|0|||
37782541|NCT01727336|69366194|FG004|Part 2 Blinded|Lost to Follow-up|0|||
37782542|NCT01727336|69366195|FG005|Part 2 Blinded|Lost to Follow-up|1|||
37782543|NCT01727336|69366190|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
37782544|NCT01727336|69366191|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
37782545|NCT01727336|69366192|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
37782546|NCT01727336|69366193|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
37782547|NCT01727336|69366194|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
37782548|NCT01727336|69366195|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
37782549|NCT01727336|69366190|FG000|Part 2 Blinded|use of prohibited medications|0|||
37782550|NCT01727336|69366191|FG001|Part 2 Blinded|use of prohibited medications|0|||
37782551|NCT01727336|69366192|FG002|Part 2 Blinded|use of prohibited medications|0|||
37782552|NCT01727336|69366193|FG003|Part 2 Blinded|use of prohibited medications|0|||
37864033|NCT01252667|69547679|FG000|Overall Study|Transplant aborted post-conditioning|0|||
37864034|NCT01252667|69547680|FG001|Overall Study|Transplant aborted post-conditioning|0|||
37692981|NCT01644643|69169216|FG000|Overall Study|Lost to Follow-up|0|||
37692982|NCT01644643|69169217|FG001|Overall Study|Lost to Follow-up|0|||
37692983|NCT01644643|69169218|FG002|Overall Study|Lost to Follow-up|0|||
37692984|NCT01644643|69169219|FG003|Overall Study|Lost to Follow-up|4|||
37692985|NCT01644643|69169216|FG000|Overall Study|Withdrawal by Subject|1|||
37692986|NCT01644643|69169217|FG001|Overall Study|Withdrawal by Subject|0|||
37692987|NCT01644643|69169218|FG002|Overall Study|Withdrawal by Subject|2|||
37692988|NCT01644643|69169219|FG003|Overall Study|Withdrawal by Subject|1|||
37692989|NCT01644643|69169216|FG000|Overall Study|Other Eligibility criteria|0|||
37692990|NCT01644643|69169217|FG001|Overall Study|Other Eligibility criteria|0|||
37692991|NCT01644643|69169218|FG002|Overall Study|Other Eligibility criteria|0|||
37692992|NCT01644643|69169219|FG003|Overall Study|Other Eligibility criteria|2|||
37692993|NCT01864564|69169237|FG000|Overall Study|Lost to Follow-up|17|||
37692994|NCT01864564|69169238|FG001|Overall Study|Lost to Follow-up|23|||
37692995|NCT01864564|69169237|FG000|Overall Study|Withdrawal by Subject|20|||
37692996|NCT01864564|69169238|FG001|Overall Study|Withdrawal by Subject|11|||
37692997|NCT01864564|69169237|FG000|Overall Study|Protocol Violation|0|||
37692998|NCT01864564|69169238|FG001|Overall Study|Protocol Violation|27|||
37692999|NCT01864564|69169237|FG000|Overall Study|not reported|0|||
37693000|NCT01864564|69169238|FG001|Overall Study|not reported|34|||
37693001|NCT01864174|69169246|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
37693002|NCT01864174|69169247|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
37693003|NCT01864174|69169246|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
37693004|NCT01864174|69169247|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
37693005|NCT01864174|69169246|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
37693006|NCT01864174|69169247|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
37693007|NCT01864174|69169246|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
37693008|NCT01864174|69169247|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
37693009|NCT01864174|69169246|FG000|Double Blind - Compliant Randomized|Death|1|||
37693010|NCT01864174|69169247|FG001|Double Blind - Compliant Randomized|Death|0|||
37693011|NCT01864174|69169246|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
37782553|NCT01727336|69366194|FG004|Part 2 Blinded|use of prohibited medications|1|||
37782554|NCT01727336|69366195|FG005|Part 2 Blinded|use of prohibited medications|3|||
37693012|NCT01864174|69169247|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
37782555|NCT02466516|69366229|FG000|Overall Study|Adverse Event|1|||
37782556|NCT02466516|69366230|FG001|Overall Study|Adverse Event|1|||
37782557|NCT02466516|69366231|FG002|Overall Study|Adverse Event|0|||
37782558|NCT02466516|69366232|FG003|Overall Study|Adverse Event|0|||
37864035|NCT01252667|69547681|FG002|Overall Study|Transplant aborted post-conditioning|0|||
37782559|NCT02466516|69366233|FG004|Overall Study|Adverse Event|0|||
37782560|NCT02466516|69366229|FG000|Overall Study|Withdrew Consent|1|||
37782561|NCT02466516|69366230|FG001|Overall Study|Withdrew Consent|0|||
37782562|NCT02466516|69366231|FG002|Overall Study|Withdrew Consent|0|||
37782563|NCT02466516|69366232|FG003|Overall Study|Withdrew Consent|0|||
37782564|NCT02466516|69366233|FG004|Overall Study|Withdrew Consent|0|||
37782565|NCT02466516|69366229|FG000|Overall Study|Lost to Follow-up|2|||
37782566|NCT02466516|69366230|FG001|Overall Study|Lost to Follow-up|0|||
37782567|NCT02466516|69366231|FG002|Overall Study|Lost to Follow-up|1|||
37782568|NCT02466516|69366232|FG003|Overall Study|Lost to Follow-up|0|||
37782569|NCT02466516|69366233|FG004|Overall Study|Lost to Follow-up|0|||
37782570|NCT01725152|69366247|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
37782571|NCT01725152|69366248|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
37782572|NCT01725152|69366247|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
37782573|NCT01725152|69366248|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
37782574|NCT01725152|69366247|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
37782575|NCT01725152|69366248|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
37782576|NCT01725152|69366247|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
37782577|NCT01725152|69366248|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
37782578|NCT01049984|69366264|FG000|Overall Study|Withdrawal by Subject|1|||
37782579|NCT01049984|69366265|FG001|Overall Study|Withdrawal by Subject|5|||
37782580|NCT01049984|69366264|FG000|Overall Study|Protocol Violation|3|||
37782581|NCT01049984|69366265|FG001|Overall Study|Protocol Violation|4|||
37782582|NCT01049984|69366264|FG000|Overall Study|Lost to Follow-up|2|||
37782583|NCT01049984|69366265|FG001|Overall Study|Lost to Follow-up|1|||
37782584|NCT01049984|69366264|FG000|Overall Study|Adverse Event|13|||
37782585|NCT01049984|69366265|FG001|Overall Study|Adverse Event|7|||
37782586|NCT01049984|69366264|FG000|Overall Study|Treatment failure|0|||
37782587|NCT01049984|69366265|FG001|Overall Study|Treatment failure|2|||
37782588|NCT01049360|69366271|FG000|Period 1|Adverse Event|0|||
37782589|NCT01049360|69366272|FG001|Period 1|Adverse Event|1|||
37782590|NCT01049360|69366273|FG002|Period 1|Adverse Event|0|||
37782591|NCT01049360|69366274|FG003|Period 1|Adverse Event|1|||
37782592|NCT01049360|69366275|FG004|Period 1|Adverse Event|0|||
37782593|NCT01049360|69366276|FG005|Period 1|Adverse Event|0|||
37782594|NCT01049360|69366277|FG006|Period 1|Adverse Event|0|||
37782595|NCT01049360|69366278|FG007|Period 1|Adverse Event|1|||
37782596|NCT01049360|69366279|FG008|Period 1|Adverse Event|0|||
37782597|NCT01049360|69366280|FG009|Period 1|Adverse Event|0|||
37782598|NCT01049360|69366281|FG010|Period 1|Adverse Event|0|||
37782599|NCT01049360|69366282|FG011|Period 1|Adverse Event|0|||
37782600|NCT01049360|69366283|FG012|Period 1|Adverse Event|1|||
37782601|NCT01049360|69366284|FG013|Period 1|Adverse Event|1|||
37782602|NCT01049360|69366285|FG014|Period 1|Adverse Event|0|||
37782603|NCT01049360|69366286|FG015|Period 1|Adverse Event|0|||
37782604|NCT01049360|69366287|FG016|Period 1|Adverse Event|1|||
37782605|NCT01049360|69366288|FG017|Period 1|Adverse Event|0|||
37782606|NCT01049360|69366289|FG018|Period 1|Adverse Event|1|||
37782607|NCT01049360|69366290|FG019|Period 1|Adverse Event|0|||
37782608|NCT01049360|69366271|FG000|Period 1|Did not meet inc/exc criteria|0|||
37782609|NCT01049360|69366272|FG001|Period 1|Did not meet inc/exc criteria|0|||
37782610|NCT01049360|69366273|FG002|Period 1|Did not meet inc/exc criteria|0|||
37782611|NCT01049360|69366274|FG003|Period 1|Did not meet inc/exc criteria|0|||
37782612|NCT01049360|69366275|FG004|Period 1|Did not meet inc/exc criteria|0|||
37782613|NCT01049360|69366276|FG005|Period 1|Did not meet inc/exc criteria|0|||
37782614|NCT01049360|69366277|FG006|Period 1|Did not meet inc/exc criteria|0|||
37782615|NCT01049360|69366278|FG007|Period 1|Did not meet inc/exc criteria|1|||
37782616|NCT01049360|69366279|FG008|Period 1|Did not meet inc/exc criteria|1|||
37782617|NCT01049360|69366280|FG009|Period 1|Did not meet inc/exc criteria|0|||
37782618|NCT01049360|69366281|FG010|Period 1|Did not meet inc/exc criteria|0|||
37782619|NCT01049360|69366282|FG011|Period 1|Did not meet inc/exc criteria|0|||
37782620|NCT01049360|69366283|FG012|Period 1|Did not meet inc/exc criteria|0|||
37782621|NCT01049360|69366284|FG013|Period 1|Did not meet inc/exc criteria|0|||
37782622|NCT01049360|69366285|FG014|Period 1|Did not meet inc/exc criteria|0|||
37782623|NCT01049360|69366286|FG015|Period 1|Did not meet inc/exc criteria|0|||
37974914|NCT00413283|69662112|FG000|Overall Study|Other|0|||
37974915|NCT00413283|69662113|FG001|Overall Study|Other|0|||
37782624|NCT01049360|69366287|FG016|Period 1|Did not meet inc/exc criteria|0|||
37782625|NCT01049360|69366288|FG017|Period 1|Did not meet inc/exc criteria|0|||
37782626|NCT01049360|69366289|FG018|Period 1|Did not meet inc/exc criteria|0|||
37782627|NCT01049360|69366290|FG019|Period 1|Did not meet inc/exc criteria|0|||
37782628|NCT01049360|69366271|FG000|Period 1|Withdrawal by Subject|0|||
37782629|NCT01049360|69366272|FG001|Period 1|Withdrawal by Subject|0|||
37782630|NCT01049360|69366273|FG002|Period 1|Withdrawal by Subject|0|||
37782631|NCT01049360|69366274|FG003|Period 1|Withdrawal by Subject|0|||
37782632|NCT01049360|69366275|FG004|Period 1|Withdrawal by Subject|0|||
37782633|NCT01049360|69366276|FG005|Period 1|Withdrawal by Subject|0|||
37782634|NCT01049360|69366277|FG006|Period 1|Withdrawal by Subject|0|||
37782635|NCT01049360|69366278|FG007|Period 1|Withdrawal by Subject|0|||
37974916|NCT00413283|69662114|FG002|Overall Study|Other|1|||
37782636|NCT01049360|69366279|FG008|Period 1|Withdrawal by Subject|1|||
37782637|NCT01049360|69366280|FG009|Period 1|Withdrawal by Subject|0|||
37782638|NCT01049360|69366281|FG010|Period 1|Withdrawal by Subject|1|||
37782639|NCT01049360|69366282|FG011|Period 1|Withdrawal by Subject|0|||
37782640|NCT01049360|69366283|FG012|Period 1|Withdrawal by Subject|1|||
37782641|NCT01049360|69366284|FG013|Period 1|Withdrawal by Subject|0|||
37782642|NCT01049360|69366285|FG014|Period 1|Withdrawal by Subject|0|||
37782643|NCT01049360|69366286|FG015|Period 1|Withdrawal by Subject|0|||
37782644|NCT01049360|69366287|FG016|Period 1|Withdrawal by Subject|0|||
37782645|NCT01049360|69366288|FG017|Period 1|Withdrawal by Subject|0|||
37782646|NCT01049360|69366289|FG018|Period 1|Withdrawal by Subject|0|||
37782647|NCT01049360|69366290|FG019|Period 1|Withdrawal by Subject|0|||
37782648|NCT01049360|69366271|FG000|Period 2|Protocol Violation|0|||
37782649|NCT01049360|69366272|FG001|Period 2|Protocol Violation|0|||
37782650|NCT01049360|69366273|FG002|Period 2|Protocol Violation|0|||
37782651|NCT01049360|69366274|FG003|Period 2|Protocol Violation|1|||
37782652|NCT01049360|69366275|FG004|Period 2|Protocol Violation|0|||
37782653|NCT01049360|69366276|FG005|Period 2|Protocol Violation|0|||
37782654|NCT01049360|69366277|FG006|Period 2|Protocol Violation|0|||
37782655|NCT01049360|69366278|FG007|Period 2|Protocol Violation|0|||
37782656|NCT01049360|69366279|FG008|Period 2|Protocol Violation|0|||
37782657|NCT01049360|69366280|FG009|Period 2|Protocol Violation|0|||
37782658|NCT01049360|69366281|FG010|Period 2|Protocol Violation|0|||
37782659|NCT01049360|69366282|FG011|Period 2|Protocol Violation|0|||
37782660|NCT01049360|69366283|FG012|Period 2|Protocol Violation|0|||
37782661|NCT01049360|69366284|FG013|Period 2|Protocol Violation|0|||
37782662|NCT01049360|69366285|FG014|Period 2|Protocol Violation|1|||
37782663|NCT01049360|69366286|FG015|Period 2|Protocol Violation|1|||
37782664|NCT01049360|69366287|FG016|Period 2|Protocol Violation|0|||
37782665|NCT01049360|69366288|FG017|Period 2|Protocol Violation|0|||
37782666|NCT01049360|69366289|FG018|Period 2|Protocol Violation|0|||
37782667|NCT01049360|69366290|FG019|Period 2|Protocol Violation|0|||
37782668|NCT01049360|69366271|FG000|Period 2|Adverse Event|0|||
37782669|NCT01049360|69366272|FG001|Period 2|Adverse Event|1|||
37782670|NCT01049360|69366273|FG002|Period 2|Adverse Event|0|||
37782671|NCT01049360|69366274|FG003|Period 2|Adverse Event|0|||
37782672|NCT01049360|69366275|FG004|Period 2|Adverse Event|0|||
37782673|NCT01049360|69366276|FG005|Period 2|Adverse Event|0|||
37782674|NCT01049360|69366277|FG006|Period 2|Adverse Event|0|||
37782675|NCT01049360|69366278|FG007|Period 2|Adverse Event|0|||
37782676|NCT01049360|69366279|FG008|Period 2|Adverse Event|1|||
37782677|NCT01049360|69366280|FG009|Period 2|Adverse Event|0|||
37782678|NCT01049360|69366281|FG010|Period 2|Adverse Event|0|||
37782679|NCT01049360|69366282|FG011|Period 2|Adverse Event|0|||
37782680|NCT01049360|69366283|FG012|Period 2|Adverse Event|0|||
37782681|NCT01049360|69366284|FG013|Period 2|Adverse Event|0|||
37782682|NCT01049360|69366285|FG014|Period 2|Adverse Event|0|||
37782683|NCT01049360|69366286|FG015|Period 2|Adverse Event|0|||
37782684|NCT01049360|69366287|FG016|Period 2|Adverse Event|0|||
37782685|NCT01049360|69366288|FG017|Period 2|Adverse Event|0|||
37782686|NCT01049360|69366289|FG018|Period 2|Adverse Event|0|||
37782687|NCT01049360|69366290|FG019|Period 2|Adverse Event|1|||
37864036|NCT01252667|69547682|FG003|Overall Study|Transplant aborted post-conditioning|0|||
37864037|NCT01252667|69547683|FG004|Overall Study|Transplant aborted post-conditioning|0|||
37782688|NCT01049360|69366271|FG000|Period 2|Withdrawal by Subject|0|||
37782689|NCT01049360|69366272|FG001|Period 2|Withdrawal by Subject|0|||
37782690|NCT01049360|69366273|FG002|Period 2|Withdrawal by Subject|0|||
37782691|NCT01049360|69366274|FG003|Period 2|Withdrawal by Subject|1|||
37974917|NCT00413283|69662115|FG003|Overall Study|Other|0|||
37782692|NCT01049360|69366275|FG004|Period 2|Withdrawal by Subject|0|||
37782693|NCT01049360|69366276|FG005|Period 2|Withdrawal by Subject|0|||
37782694|NCT01049360|69366277|FG006|Period 2|Withdrawal by Subject|0|||
37782695|NCT01049360|69366278|FG007|Period 2|Withdrawal by Subject|0|||
37782696|NCT01049360|69366279|FG008|Period 2|Withdrawal by Subject|0|||
37782697|NCT01049360|69366280|FG009|Period 2|Withdrawal by Subject|0|||
37782698|NCT01049360|69366281|FG010|Period 2|Withdrawal by Subject|0|||
37782699|NCT01049360|69366282|FG011|Period 2|Withdrawal by Subject|0|||
37782700|NCT01049360|69366283|FG012|Period 2|Withdrawal by Subject|0|||
37782701|NCT01049360|69366284|FG013|Period 2|Withdrawal by Subject|0|||
37782702|NCT01049360|69366285|FG014|Period 2|Withdrawal by Subject|1|||
37782703|NCT01049360|69366286|FG015|Period 2|Withdrawal by Subject|0|||
37782704|NCT01049360|69366287|FG016|Period 2|Withdrawal by Subject|0|||
37782705|NCT01049360|69366288|FG017|Period 2|Withdrawal by Subject|0|||
37782706|NCT01049360|69366289|FG018|Period 2|Withdrawal by Subject|0|||
37782707|NCT01049360|69366290|FG019|Period 2|Withdrawal by Subject|1|||
37782708|NCT01049360|69366271|FG000|Period 2|Lack of Efficacy|0|||
37782709|NCT01049360|69366272|FG001|Period 2|Lack of Efficacy|0|||
37782710|NCT01049360|69366273|FG002|Period 2|Lack of Efficacy|0|||
37782711|NCT01049360|69366274|FG003|Period 2|Lack of Efficacy|0|||
37782712|NCT01049360|69366275|FG004|Period 2|Lack of Efficacy|0|||
37782713|NCT01049360|69366276|FG005|Period 2|Lack of Efficacy|1|||
37782714|NCT01049360|69366277|FG006|Period 2|Lack of Efficacy|0|||
37782715|NCT01049360|69366278|FG007|Period 2|Lack of Efficacy|0|||
37782716|NCT01049360|69366279|FG008|Period 2|Lack of Efficacy|0|||
37782717|NCT01049360|69366280|FG009|Period 2|Lack of Efficacy|0|||
37782718|NCT01049360|69366281|FG010|Period 2|Lack of Efficacy|0|||
37782719|NCT01049360|69366282|FG011|Period 2|Lack of Efficacy|0|||
37782720|NCT01049360|69366283|FG012|Period 2|Lack of Efficacy|0|||
37782721|NCT01049360|69366284|FG013|Period 2|Lack of Efficacy|0|||
37782722|NCT01049360|69366285|FG014|Period 2|Lack of Efficacy|0|||
37782723|NCT01049360|69366286|FG015|Period 2|Lack of Efficacy|0|||
37782724|NCT01049360|69366287|FG016|Period 2|Lack of Efficacy|0|||
37782725|NCT01049360|69366288|FG017|Period 2|Lack of Efficacy|0|||
37782726|NCT01049360|69366289|FG018|Period 2|Lack of Efficacy|0|||
37782727|NCT01049360|69366290|FG019|Period 2|Lack of Efficacy|0|||
37782728|NCT01049360|69366271|FG000|Period 4|Protocol Violation|0|||
37782729|NCT01049360|69366272|FG001|Period 4|Protocol Violation|0|||
37782730|NCT01049360|69366273|FG002|Period 4|Protocol Violation|0|||
37782731|NCT01049360|69366274|FG003|Period 4|Protocol Violation|0|||
37782732|NCT01049360|69366275|FG004|Period 4|Protocol Violation|0|||
37782733|NCT01049360|69366276|FG005|Period 4|Protocol Violation|0|||
37782734|NCT01049360|69366277|FG006|Period 4|Protocol Violation|0|||
37782735|NCT01049360|69366278|FG007|Period 4|Protocol Violation|0|||
37782736|NCT01049360|69366279|FG008|Period 4|Protocol Violation|0|||
37782737|NCT01049360|69366280|FG009|Period 4|Protocol Violation|0|||
37782738|NCT01049360|69366281|FG010|Period 4|Protocol Violation|0|||
37782739|NCT01049360|69366282|FG011|Period 4|Protocol Violation|0|||
37864038|NCT01252667|69547684|FG005|Overall Study|Transplant aborted post-conditioning|1|||
37974918|NCT00402051|69662127|FG000|Overall Study|Progressive Disease|13|||
37782740|NCT01049360|69366283|FG012|Period 4|Protocol Violation|0|||
37782741|NCT01049360|69366284|FG013|Period 4|Protocol Violation|0|||
37782742|NCT01049360|69366285|FG014|Period 4|Protocol Violation|0|||
37782743|NCT01049360|69366286|FG015|Period 4|Protocol Violation|0|||
37782744|NCT01049360|69366287|FG016|Period 4|Protocol Violation|0|||
37782745|NCT01049360|69366288|FG017|Period 4|Protocol Violation|1|||
37782746|NCT01049360|69366289|FG018|Period 4|Protocol Violation|0|||
37782747|NCT01049360|69366290|FG019|Period 4|Protocol Violation|0|||
37782748|NCT01049360|69366271|FG000|Period 4|Withdrawal by Subject|0|||
37782749|NCT01049360|69366272|FG001|Period 4|Withdrawal by Subject|0|||
37782750|NCT01049360|69366273|FG002|Period 4|Withdrawal by Subject|0|||
37782751|NCT01049360|69366274|FG003|Period 4|Withdrawal by Subject|1|||
37782752|NCT01049360|69366275|FG004|Period 4|Withdrawal by Subject|0|||
37782753|NCT01049360|69366276|FG005|Period 4|Withdrawal by Subject|0|||
37782754|NCT01049360|69366277|FG006|Period 4|Withdrawal by Subject|0|||
37782755|NCT01049360|69366278|FG007|Period 4|Withdrawal by Subject|0|||
37782756|NCT01049360|69366279|FG008|Period 4|Withdrawal by Subject|0|||
37782757|NCT01049360|69366280|FG009|Period 4|Withdrawal by Subject|0|||
37782758|NCT01049360|69366281|FG010|Period 4|Withdrawal by Subject|0|||
37782759|NCT01049360|69366282|FG011|Period 4|Withdrawal by Subject|0|||
37782760|NCT01049360|69366283|FG012|Period 4|Withdrawal by Subject|0|||
37782761|NCT01049360|69366284|FG013|Period 4|Withdrawal by Subject|0|||
37782762|NCT01049360|69366285|FG014|Period 4|Withdrawal by Subject|0|||
37782763|NCT01049360|69366286|FG015|Period 4|Withdrawal by Subject|0|||
37782764|NCT01049360|69366287|FG016|Period 4|Withdrawal by Subject|0|||
37782765|NCT01049360|69366288|FG017|Period 4|Withdrawal by Subject|0|||
37782766|NCT01049360|69366289|FG018|Period 4|Withdrawal by Subject|0|||
37782767|NCT01049360|69366290|FG019|Period 4|Withdrawal by Subject|0|||
37782768|NCT02494596|69366302|FG000|Overall Study|Insufficient Therapeutic Response|3|||
37782769|NCT02494596|69366303|FG001|Overall Study|Insufficient Therapeutic Response|3|||
37782770|NCT02494596|69366304|FG002|Overall Study|Insufficient Therapeutic Response|1|||
37782771|NCT02494596|69366302|FG000|Overall Study|Adverse Event|0|||
37782772|NCT02494596|69366303|FG001|Overall Study|Adverse Event|1|||
37782773|NCT02494596|69366304|FG002|Overall Study|Adverse Event|0|||
37782774|NCT02494596|69366302|FG000|Overall Study|Refused Treatment|0|||
37782775|NCT02494596|69366303|FG001|Overall Study|Refused Treatment|1|||
37782776|NCT02494596|69366304|FG002|Overall Study|Refused Treatment|0|||
37782777|NCT02494206|69366323|FG000|Overall Study|Adverse Event|1|||
37782778|NCT02494206|69366323|FG000|Overall Study|Disease Progression|1|||
37782779|NCT01048502|69366340|FG000|Overall Study|Lost to Follow-up|2|||
37782780|NCT01048502|69366341|FG001|Overall Study|Lost to Follow-up|0|||
37782781|NCT01048502|69366342|FG002|Overall Study|Lost to Follow-up|0|||
37782782|NCT01048502|69366343|FG003|Overall Study|Lost to Follow-up|0|||
37782783|NCT01048502|69366340|FG000|Overall Study|Adverse Event|1|||
37782784|NCT01048502|69366341|FG001|Overall Study|Adverse Event|0|||
37782785|NCT01048502|69366342|FG002|Overall Study|Adverse Event|0|||
37782786|NCT01048502|69366343|FG003|Overall Study|Adverse Event|0|||
37782787|NCT01048502|69366340|FG000|Overall Study|Withdrawal by Subject|1|||
37782788|NCT01048502|69366341|FG001|Overall Study|Withdrawal by Subject|4|||
37782789|NCT01048502|69366342|FG002|Overall Study|Withdrawal by Subject|5|||
37782790|NCT01048502|69366343|FG003|Overall Study|Withdrawal by Subject|3|||
37782791|NCT01048502|69366340|FG000|Overall Study|Physician Decision|0|||
37864039|NCT01119105|69547701|FG000|Overall Study|Withdrawal by Subject|1|||
37782792|NCT01048502|69366341|FG001|Overall Study|Physician Decision|3|||
37782793|NCT01048502|69366342|FG002|Overall Study|Physician Decision|0|||
37782794|NCT01048502|69366343|FG003|Overall Study|Physician Decision|1|||
37782795|NCT02465034|69366356|FG000|Overall Study|Withdrawal by Subject|1|||
37782796|NCT02465034|69366357|FG001|Overall Study|Withdrawal by Subject|1|||
37782797|NCT02465034|69366356|FG000|Overall Study|Screen fail|2|||
37782798|NCT02465034|69366357|FG001|Overall Study|Screen fail|0|||
37782799|NCT02465034|69366356|FG000|Overall Study|Could not be scheduled for study visit|0|||
37782800|NCT02465034|69366357|FG001|Overall Study|Could not be scheduled for study visit|5|||
37782801|NCT02516982|69366384|FG000|Overall Study|Called in to antenatal appointment|32|||
37782802|NCT02516982|69366385|FG001|Overall Study|Called in to antenatal appointment|35|||
37782803|NCT02516982|69366386|FG002|Overall Study|Called in to antenatal appointment|0|||
37782804|NCT02516982|69366387|FG003|Overall Study|Called in to antenatal appointment|0|||
37782805|NCT02516982|69366384|FG000|Overall Study|Withdrawal by Subject|0|||
37782806|NCT02516982|69366385|FG001|Overall Study|Withdrawal by Subject|0|||
37782807|NCT02516982|69366386|FG002|Overall Study|Withdrawal by Subject|1|||
37782808|NCT02516982|69366387|FG003|Overall Study|Withdrawal by Subject|2|||
37782809|NCT02516982|69366384|FG000|Overall Study|Protocol Violation|0|||
37782810|NCT02516982|69366385|FG001|Overall Study|Protocol Violation|0|||
37782811|NCT02516982|69366386|FG002|Overall Study|Protocol Violation|1|||
37782812|NCT02516982|69366387|FG003|Overall Study|Protocol Violation|1|||
37782813|NCT02516982|69366384|FG000|Overall Study|Did not install the app|0|||
37782814|NCT02516982|69366385|FG001|Overall Study|Did not install the app|0|||
37782815|NCT02516982|69366386|FG002|Overall Study|Did not install the app|46|||
37782816|NCT02516982|69366387|FG003|Overall Study|Did not install the app|47|||
37782817|NCT02464410|69366432|FG000|Overall Study|Death|3|||
37782818|NCT02464410|69366433|FG001|Overall Study|Death|4|||
37782819|NCT02464410|69366432|FG000|Overall Study|Lost to Follow-up|7|||
37782820|NCT02464410|69366433|FG001|Overall Study|Lost to Follow-up|9|||
37782821|NCT02464410|69366432|FG000|Overall Study|Withdrawal by Subject|12|||
37782822|NCT02464410|69366433|FG001|Overall Study|Withdrawal by Subject|3|||
37782823|NCT01047332|69366441|FG000|Overall Study|SEMS Obstruction|11|||
37782824|NCT01047332|69366442|FG001|Overall Study|SEMS Obstruction|20|||
37782825|NCT01047332|69366441|FG000|Overall Study|Died Unobstructed|38|||
37782826|NCT01047332|69366442|FG001|Overall Study|Died Unobstructed|41|||
37782827|NCT01047332|69366441|FG000|Overall Study|Lost to Follow-up|8|||
37782828|NCT01047332|69366442|FG001|Overall Study|Lost to Follow-up|3|||
37782829|NCT01046396|69366448|FG000|Overall Study|Withdrawal by Subject|5|||
37782830|NCT01046084|69366474|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
37782831|NCT01046084|69366475|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
37782832|NCT01045694|69366494|FG000|Overall Study|Withdrawal by Subject|2|||
37782833|NCT01044290|69366554|FG000|Follow-up 1|Death|3|||
37782834|NCT01044290|69366555|FG001|Follow-up 1|Death|3|||
37782835|NCT01044290|69366556|FG002|Follow-up 1|Death|1|||
37782836|NCT01044290|69366554|FG000|Follow-up 1|Withdrawal by Subject|2|||
37782837|NCT01044290|69366555|FG001|Follow-up 1|Withdrawal by Subject|2|||
37782838|NCT01044290|69366556|FG002|Follow-up 1|Withdrawal by Subject|0|||
37782839|NCT01044290|69366554|FG000|Follow-Up 2|Death|0|||
37782840|NCT01044290|69366555|FG001|Follow-Up 2|Death|1|||
37782841|NCT01044290|69366556|FG002|Follow-Up 2|Death|1|||
37782842|NCT01044290|69366554|FG000|Follow-Up 2|Withdrawal by Subject|0|||
37782843|NCT01044290|69366555|FG001|Follow-Up 2|Withdrawal by Subject|1|||
37782844|NCT01044290|69366556|FG002|Follow-Up 2|Withdrawal by Subject|1|||
37782845|NCT01041638|69366637|FG000|Overall Study|Adverse Event|4|||
37782846|NCT01041638|69366637|FG000|Overall Study|Death|1|||
37782847|NCT01041638|69366637|FG000|Overall Study|Lack of Efficacy|7|||
37782848|NCT01041638|69366637|FG000|Overall Study|Physician Decision|4|||
37782849|NCT01041638|69366637|FG000|Overall Study|Withdrawal by Subject|11|||
37782850|NCT01045460|69366661|FG000|Overall Study|Physician Decision|3|||
37782851|NCT01045460|69366662|FG001|Overall Study|Physician Decision|2|||
37782852|NCT01045460|69366661|FG000|Overall Study|Lost to Follow-up|0|||
37782853|NCT01045460|69366662|FG001|Overall Study|Lost to Follow-up|1|||
37782854|NCT01045460|69366661|FG000|Overall Study|Lack of Efficacy|3|||
37782855|NCT01045460|69366662|FG001|Overall Study|Lack of Efficacy|0|||
37782856|NCT05014919|69366673|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
37782857|NCT05014919|69366674|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
37782858|NCT05014919|69366675|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
37782859|NCT05014919|69366673|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
37782860|NCT05014919|69366674|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
37782861|NCT05014919|69366675|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
37782862|NCT05014919|69366673|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
37782863|NCT05014919|69366674|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
37782864|NCT05014919|69366675|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
37782865|NCT05014919|69366673|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
37782866|NCT05014919|69366674|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
37782867|NCT05014919|69366675|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
37782868|NCT05014919|69366673|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
37782869|NCT05014919|69366674|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
37782870|NCT05014919|69366675|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
37782871|NCT05014919|69366673|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
37782872|NCT05014919|69366674|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
37782873|NCT05014919|69366675|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
37782874|NCT05014919|69366673|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
37782875|NCT05014919|69366674|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
37782876|NCT05014919|69366675|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
37782877|NCT05014919|69366673|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
37782878|NCT05014919|69366674|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
37782879|NCT05014919|69366675|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
37782880|NCT03409796|69366718|FG000|Overall Study|Adverse Event|2|||
37782881|NCT03409796|69366719|FG001|Overall Study|Adverse Event|0|||
37782882|NCT03409796|69366718|FG000|Overall Study|Other|0|||
37782883|NCT03409796|69366719|FG001|Overall Study|Other|1|||
37782884|NCT02462928|69366728|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
37782885|NCT02462928|69366729|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
37782886|NCT02462928|69366730|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
37782887|NCT02462928|69366728|FG000|Overall Study|Adverse Event|47|||
37782888|NCT02462928|69366729|FG001|Overall Study|Adverse Event|51|||
37782889|NCT02462928|69366730|FG002|Overall Study|Adverse Event|25|||
37782890|NCT02462928|69366728|FG000|Overall Study|Lack of Efficacy|3|||
37782891|NCT02462928|69366729|FG001|Overall Study|Lack of Efficacy|8|||
37782892|NCT02462928|69366730|FG002|Overall Study|Lack of Efficacy|3|||
37782893|NCT02462928|69366728|FG000|Overall Study|Lost to Follow-up|4|||
37782894|NCT02462928|69366729|FG001|Overall Study|Lost to Follow-up|4|||
37782895|NCT02462928|69366730|FG002|Overall Study|Lost to Follow-up|1|||
37782896|NCT02462928|69366728|FG000|Overall Study|Withdrawal by Patient|31|||
37782897|NCT02462928|69366729|FG001|Overall Study|Withdrawal by Patient|21|||
37782898|NCT02462928|69366730|FG002|Overall Study|Withdrawal by Patient|21|||
37782899|NCT02462928|69366728|FG000|Overall Study|Protocol Violation|0|||
37782900|NCT02462928|69366729|FG001|Overall Study|Protocol Violation|1|||
37782901|NCT02462928|69366730|FG002|Overall Study|Protocol Violation|0|||
37782902|NCT02462928|69366728|FG000|Overall Study|Reason not Specified|4|||
37782903|NCT02462928|69366729|FG001|Overall Study|Reason not Specified|6|||
37782904|NCT02462928|69366730|FG002|Overall Study|Reason not Specified|5|||
37782905|NCT00019604|69366747|FG000|Overall Study|Death|1|||
37782906|NCT00019604|69366747|FG000|Overall Study|Progressive disease|23|||
37782907|NCT00019604|69366747|FG000|Overall Study|Refused treatment|1|||
37782908|NCT00019604|69366747|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
37782909|NCT00019604|69366747|FG000|Overall Study|Going to have liver transplant|1|||
37782910|NCT00019604|69366747|FG000|Overall Study|Move to a different study|1|||
37782911|NCT00019604|69366747|FG000|Overall Study|Non compliant on systemic CH|1|||
37782912|NCT00019604|69366747|FG000|Overall Study|Non compliant|1|||
37782913|NCT00019604|69366747|FG000|Overall Study|Resectable disease|1|||
37782914|NCT00019604|69366747|FG000|Overall Study|Started new chemo regimen|1|||
37782915|NCT00019604|69366747|FG000|Overall Study|Pt going to immunotherapy study|1|||
37782916|NCT00019604|69366747|FG000|Overall Study|Too much disease|1|||
37782917|NCT00019604|69366747|FG000|Overall Study|Unable to evaluate|1|||
37782918|NCT00019604|69366747|FG000|Overall Study|Details for other not available|4|||
37782919|NCT02492958|69366763|FG000|Overall Study|Withdrawal by Subject|0|||
37782920|NCT02492958|69366764|FG001|Overall Study|Withdrawal by Subject|0|||
37782921|NCT02492958|69366765|FG002|Overall Study|Withdrawal by Subject|1|||
37782922|NCT02492958|69366766|FG003|Overall Study|Withdrawal by Subject|0|||
37782923|NCT02492958|69366763|FG000|Overall Study|Adverse Event|1|||
37782924|NCT02492958|69366764|FG001|Overall Study|Adverse Event|0|||
37782925|NCT02492958|69366765|FG002|Overall Study|Adverse Event|1|||
37782926|NCT02492958|69366766|FG003|Overall Study|Adverse Event|0|||
37782927|NCT02492880|69366776|FG000|Overall Study|Lost to Follow-up|1|||
37782928|NCT02492880|69366776|FG000|Overall Study|Protocol Violation|1|||
37782929|NCT02516592|69366782|FG000|Overall Study|Patient withdrew consent|5|||
37782930|NCT02516592|69366783|FG001|Overall Study|Patient withdrew consent|2|||
37782931|NCT02516592|69366782|FG000|Overall Study|Protocol deviation|4|||
37782932|NCT02516592|69366783|FG001|Overall Study|Protocol deviation|4|||
37782933|NCT02516592|69366782|FG000|Overall Study|Lost to Follow-up|2|||
37782934|NCT02516592|69366783|FG001|Overall Study|Lost to Follow-up|3|||
37782935|NCT02516592|69366782|FG000|Overall Study|Patient/guardian decision|2|||
37782936|NCT02516592|69366783|FG001|Overall Study|Patient/guardian decision|1|||
37782937|NCT02516592|69366782|FG000|Overall Study|Adverse Event|1|||
37782938|NCT02516592|69366783|FG001|Overall Study|Adverse Event|2|||
37782939|NCT02516592|69366782|FG000|Overall Study|Abnormal test procedure result|1|||
37782940|NCT02516592|69366783|FG001|Overall Study|Abnormal test procedure result|0|||
37782941|NCT02516592|69366782|FG000|Overall Study|Death|1|||
37782942|NCT02516592|69366783|FG001|Overall Study|Death|1|||
37782943|NCT02492100|69366811|FG000|Overall Study|Death|1|||
37782944|NCT02461758|69366834|FG000|Overall Study|Lost to Follow-up|0|||
37782945|NCT02461758|69366835|FG001|Overall Study|Lost to Follow-up|1|||
37782946|NCT02461758|69366836|FG002|Overall Study|Lost to Follow-up|1|||
37782947|NCT02461758|69366837|FG003|Overall Study|Lost to Follow-up|0|||
37782948|NCT02461290|69366859|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
37782949|NCT02461290|69366859|FG000|Overall Study|Lost to Follow-up|3|||
37782950|NCT02461134|69366863|FG000|Overall Study|Adverse Event|1|||
37782951|NCT02460978|69366892|FG000|Overall Study|Adverse Event|17|||
37782952|NCT02460978|69366893|FG001|Overall Study|Adverse Event|11|||
37782953|NCT02460978|69366894|FG002|Overall Study|Adverse Event|11|||
37782954|NCT02460978|69366892|FG000|Overall Study|Withdrawal by Subject|5|||
37782955|NCT02460978|69366893|FG001|Overall Study|Withdrawal by Subject|5|||
37782956|NCT02460978|69366894|FG002|Overall Study|Withdrawal by Subject|14|||
37782957|NCT02460978|69366892|FG000|Overall Study|Lost to Follow-up|2|||
37782958|NCT02460978|69366893|FG001|Overall Study|Lost to Follow-up|3|||
37782959|NCT02460978|69366894|FG002|Overall Study|Lost to Follow-up|1|||
37782960|NCT02460978|69366892|FG000|Overall Study|Protocol Violation|1|||
37782961|NCT02460978|69366893|FG001|Overall Study|Protocol Violation|1|||
37782962|NCT02460978|69366894|FG002|Overall Study|Protocol Violation|1|||
37782963|NCT02460978|69366892|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
37782964|NCT02460978|69366893|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
37782965|NCT02460978|69366894|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
37782966|NCT02460978|69366892|FG000|Overall Study|Pregnancy|0|||
37782967|NCT02460978|69366893|FG001|Overall Study|Pregnancy|0|||
37782968|NCT02460978|69366894|FG002|Overall Study|Pregnancy|2|||
37782969|NCT02489448|69366909|FG000|Overall Study|Death|3|||
37782970|NCT02489448|69366909|FG000|Overall Study|Withdrawal by Subject|2|||
37782971|NCT02488980|69366930|FG000|Overall Study|Protocol Violation|2|||
37782972|NCT02488980|69366931|FG001|Overall Study|Protocol Violation|2|||
37782973|NCT02488980|69366932|FG002|Overall Study|Protocol Violation|2|||
37782974|NCT02460822|69366944|FG000|Overall Study|Withdrawal by Subject|1|||
37782975|NCT02488824|69366950|FG000|Overall Study|Adverse Event|1|||
37782976|NCT02488824|69366951|FG001|Overall Study|Adverse Event|1|||
37782977|NCT02308241|69367063|FG000|Overall Study|Withdrawal by Subject|3|||
37782978|NCT02460198|69367102|FG000|Overall Study|Adverse Event|1|||
37782979|NCT02460198|69367103|FG001|Overall Study|Adverse Event|3|||
37782980|NCT02460198|69367102|FG000|Overall Study|Death|36|||
37782981|NCT02460198|69367103|FG001|Overall Study|Death|28|||
37782982|NCT02460198|69367102|FG000|Overall Study|Lost to Follow-up|1|||
37782983|NCT02460198|69367103|FG001|Overall Study|Lost to Follow-up|1|||
37782984|NCT02460198|69367102|FG000|Overall Study|Transferred to Extension Study|15|||
37782985|NCT02460198|69367103|FG001|Overall Study|Transferred to Extension Study|15|||
37782986|NCT02460198|69367102|FG000|Overall Study|Withdrawal by Subject|2|||
37782987|NCT02460198|69367103|FG001|Overall Study|Withdrawal by Subject|4|||
37782988|NCT02460198|69367102|FG000|Overall Study|Site Terminated By Sponsor|0|||
37782989|NCT02460198|69367103|FG001|Overall Study|Site Terminated By Sponsor|1|||
37782990|NCT02460198|69367102|FG000|Overall Study|Did Not Continue on Extension Study|6|||
37782991|NCT02460198|69367103|FG001|Overall Study|Did Not Continue on Extension Study|11|||
37782992|NCT02487810|69367123|FG000|Overall Study|Withdrawal by Subject|1|||
37782993|NCT02487810|69367124|FG001|Overall Study|Withdrawal by Subject|0|||
37782994|NCT02452320|69367132|FG000|Overall Study|Adverse Event|0|||
37782995|NCT02452320|69367133|FG001|Overall Study|Adverse Event|1|||
37782996|NCT02459964|69367142|FG000|Overall Study|Withdrawal by Subject|0|||
37782997|NCT02459964|69367143|FG001|Overall Study|Withdrawal by Subject|0|||
37782998|NCT02459964|69367144|FG002|Overall Study|Withdrawal by Subject|1|||
37782999|NCT02459964|69367142|FG000|Overall Study|Abnormal EKG changes|0|||
37783000|NCT02459964|69367143|FG001|Overall Study|Abnormal EKG changes|0|||
37783001|NCT02459964|69367144|FG002|Overall Study|Abnormal EKG changes|1|||
37783002|NCT02451930|69367221|FG000|Overall Study|Death|0|||
37783003|NCT02451930|69367222|FG001|Overall Study|Death|15|||
37783004|NCT02451930|69367221|FG000|Overall Study|Lost to Follow-up|0|||
37783005|NCT02451930|69367222|FG001|Overall Study|Lost to Follow-up|3|||
37783006|NCT02451930|69367221|FG000|Overall Study|Sponsor Decision|2|||
37783007|NCT02451930|69367222|FG001|Overall Study|Sponsor Decision|10|||
37783008|NCT02451930|69367221|FG000|Overall Study|Withdrawal by Subject|0|||
37783009|NCT02451930|69367222|FG001|Overall Study|Withdrawal by Subject|1|||
37783010|NCT02451930|69367221|FG000|Overall Study|Other|0|||
37783011|NCT02451930|69367222|FG001|Overall Study|Other|1|||
37783012|NCT02451696|69367258|FG000|Overall Study|Surgery postponed|1|||
37783013|NCT02451696|69367259|FG001|Overall Study|Surgery postponed|0|||
37783014|NCT02459418|69367282|FG000|Overall Study|Exclusion Criteria|4|||
37783015|NCT02459418|69367283|FG001|Overall Study|Exclusion Criteria|0|||
37783016|NCT02459418|69367282|FG000|Overall Study|Protocol Violation|0|||
37783017|NCT02459418|69367283|FG001|Overall Study|Protocol Violation|2|||
37783018|NCT02459418|69367282|FG000|Overall Study|Physician Decision|0|||
37783019|NCT02459418|69367283|FG001|Overall Study|Physician Decision|2|||
37783020|NCT02459418|69367282|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
37783021|NCT02459418|69367283|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
37783022|NCT02459418|69367282|FG000|Overall Study|Adverse Event|0|||
37783023|NCT02459418|69367283|FG001|Overall Study|Adverse Event|1|||
37783024|NCT02459418|69367282|FG000|Overall Study|Withdrawal by Subject|1|||
37783025|NCT02459418|69367283|FG001|Overall Study|Withdrawal by Subject|1|||
37783026|NCT02459418|69367282|FG000|Overall Study|Elevated Creatine Kinase|1|||
37783027|NCT02459418|69367283|FG001|Overall Study|Elevated Creatine Kinase|0|||
37783028|NCT02459418|69367282|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
37783029|NCT02459418|69367283|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
37783030|NCT02487498|69367313|FG000|Period: Period 1|Adverse Event|2|||
37783031|NCT02487498|69367314|FG001|Period: Period 1|Adverse Event|4|||
37783032|NCT02487498|69367313|FG000|Period: Period 1|Subject/guardian decision|2|||
37783033|NCT02487498|69367314|FG001|Period: Period 1|Subject/guardian decision|4|||
37783034|NCT02487498|69367313|FG000|Period: Period 1|Lost to Follow-up|0|||
37783035|NCT02487498|69367314|FG001|Period: Period 1|Lost to Follow-up|2|||
37783036|NCT02487498|69367313|FG000|Period: Period 1|Lack of Efficacy|1|||
37783037|NCT02487498|69367314|FG001|Period: Period 1|Lack of Efficacy|0|||
37783038|NCT02487498|69367313|FG000|Period: Period 1|Physician Decision|0|||
37783039|NCT02487498|69367314|FG001|Period: Period 1|Physician Decision|1|||
37783040|NCT02487498|69367313|FG000|Period: Period 1|Protocol deviation|1|||
37783041|NCT02487498|69367314|FG001|Period: Period 1|Protocol deviation|0|||
37783042|NCT02487498|69367313|FG000|Period: Washout|Subject/guardian decision|0|||
37783043|NCT02487498|69367314|FG001|Period: Washout|Subject/guardian decision|5|||
37783044|NCT02487498|69367313|FG000|Period: Washout|Lack of Efficacy|1|||
37783045|NCT02487498|69367314|FG001|Period: Washout|Lack of Efficacy|1|||
37783046|NCT02487498|69367313|FG000|Period: Washout|Physician Decision|1|||
37783047|NCT02487498|69367314|FG001|Period: Washout|Physician Decision|0|||
37783048|NCT02487498|69367313|FG000|Period: Washout|Non-compliance with study treatment|0|||
37783049|NCT02487498|69367314|FG001|Period: Washout|Non-compliance with study treatment|1|||
37783050|NCT02487498|69367313|FG000|Period: Period 2|Adverse Event|2|||
37783051|NCT02487498|69367314|FG001|Period: Period 2|Adverse Event|2|||
37783052|NCT02487498|69367313|FG000|Period: Period 2|Subject/guardian decision|2|||
37783053|NCT02487498|69367314|FG001|Period: Period 2|Subject/guardian decision|1|||
37783054|NCT02487498|69367313|FG000|Period: Period 2|Lost to Follow-up|1|||
37783055|NCT02487498|69367314|FG001|Period: Period 2|Lost to Follow-up|1|||
37783056|NCT02487498|69367313|FG000|Period: Period 2|Death|0|||
37783057|NCT02487498|69367314|FG001|Period: Period 2|Death|1|||
37783058|NCT02487498|69367313|FG000|Period: Period 2|Physician Decision|1|||
37783059|NCT02487498|69367314|FG001|Period: Period 2|Physician Decision|0|||
37783060|NCT02487108|69367325|FG000|Overall Study|Adverse Event|1|||
37783061|NCT02487108|69367326|FG001|Overall Study|Adverse Event|6|||
37783062|NCT02487108|69367327|FG002|Overall Study|Adverse Event|12|||
37783063|NCT02487108|69367328|FG003|Overall Study|Adverse Event|6|||
37783064|NCT02487108|69367325|FG000|Overall Study|Withdrawal by Subject|8|||
37783065|NCT02487108|69367326|FG001|Overall Study|Withdrawal by Subject|5|||
37783066|NCT02487108|69367327|FG002|Overall Study|Withdrawal by Subject|5|||
37783067|NCT02487108|69367328|FG003|Overall Study|Withdrawal by Subject|0|||
37783068|NCT02487108|69367325|FG000|Overall Study|Non-compliance to study medication|3|||
37783069|NCT02487108|69367326|FG001|Overall Study|Non-compliance to study medication|2|||
37783070|NCT02487108|69367327|FG002|Overall Study|Non-compliance to study medication|5|||
37783071|NCT02487108|69367328|FG003|Overall Study|Non-compliance to study medication|4|||
37783072|NCT02487108|69367325|FG000|Overall Study|Protocol Violation|1|||
37783073|NCT02487108|69367326|FG001|Overall Study|Protocol Violation|1|||
37783074|NCT02487108|69367327|FG002|Overall Study|Protocol Violation|2|||
37783075|NCT02487108|69367328|FG003|Overall Study|Protocol Violation|0|||
37783076|NCT02487108|69367325|FG000|Overall Study|Non-compliance to study procedures|0|||
37783077|NCT02487108|69367326|FG001|Overall Study|Non-compliance to study procedures|0|||
37783078|NCT02487108|69367327|FG002|Overall Study|Non-compliance to study procedures|0|||
37783079|NCT02487108|69367328|FG003|Overall Study|Non-compliance to study procedures|1|||
37783080|NCT02487108|69367325|FG000|Overall Study|Other than specified|3|||
37783081|NCT02487108|69367326|FG001|Overall Study|Other than specified|2|||
37783082|NCT02487108|69367327|FG002|Overall Study|Other than specified|2|||
37693013|NCT01864174|69169246|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
37693014|NCT01864174|69169247|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
37693015|NCT01864174|69169246|FG000|Double Blind - Compliant Randomized|Other|6|||
37693016|NCT01864174|69169247|FG001|Double Blind - Compliant Randomized|Other|10|||
37693017|NCT01864174|69169246|FG000|Off Treatment Follow-Up|Other|2|||
37693018|NCT01864174|69169247|FG001|Off Treatment Follow-Up|Other|0|||
37693019|NCT01864174|69169246|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
37693020|NCT01864174|69169247|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
37693021|NCT01900444|69169253|FG000|Overall Study|Protocol Violation|2|||
37693022|NCT01900444|69169253|FG000|Overall Study|Lost to Follow-up|1|||
37693023|NCT02294227|69169260|FG000|Overall Study|Death|0|||
37693024|NCT02294227|69169261|FG001|Overall Study|Death|0|||
37693025|NCT02294227|69169262|FG002|Overall Study|Death|1|||
37693026|NCT02294227|69169260|FG000|Overall Study|Subject/Guardian Decision|6|||
37693027|NCT02294227|69169261|FG001|Overall Study|Subject/Guardian Decision|3|||
37693028|NCT02294227|69169262|FG002|Overall Study|Subject/Guardian Decision|7|||
37693029|NCT02294227|69169260|FG000|Overall Study|Physician Decision|1|||
37693030|NCT02294227|69169261|FG001|Overall Study|Physician Decision|2|||
37783083|NCT02487108|69367328|FG003|Overall Study|Other than specified|0|||
37974919|NCT00402051|69662128|FG001|Overall Study|Progressive Disease|20|||
37783084|NCT02487030|69367345|FG000|Overall Study|Lack of Efficacy|2|||
37693031|NCT02294227|69169262|FG002|Overall Study|Physician Decision|1|||
37693032|NCT02294227|69169260|FG000|Overall Study|Lost to Follow-up|1|||
37693033|NCT02294227|69169261|FG001|Overall Study|Lost to Follow-up|0|||
37783085|NCT02487030|69367346|FG001|Overall Study|Lack of Efficacy|4|||
37783086|NCT02487030|69367347|FG002|Overall Study|Lack of Efficacy|1|||
37783087|NCT02487030|69367348|FG003|Overall Study|Lack of Efficacy|0|||
37783088|NCT02487030|69367349|FG004|Overall Study|Lack of Efficacy|1|||
37783089|NCT02487030|69367350|FG005|Overall Study|Lack of Efficacy|0|||
37783090|NCT02487030|69367351|FG006|Overall Study|Lack of Efficacy|0|||
37783091|NCT02487030|69367345|FG000|Overall Study|Lost to Follow-up|0|||
37783092|NCT02487030|69367346|FG001|Overall Study|Lost to Follow-up|0|||
37783093|NCT02487030|69367347|FG002|Overall Study|Lost to Follow-up|1|||
37783094|NCT02487030|69367348|FG003|Overall Study|Lost to Follow-up|1|||
37783095|NCT02487030|69367349|FG004|Overall Study|Lost to Follow-up|0|||
37783096|NCT02487030|69367350|FG005|Overall Study|Lost to Follow-up|1|||
37783097|NCT02487030|69367351|FG006|Overall Study|Lost to Follow-up|0|||
37783098|NCT02487030|69367345|FG000|Overall Study|Adverse Event|0|||
37783099|NCT02487030|69367346|FG001|Overall Study|Adverse Event|0|||
37783100|NCT02487030|69367347|FG002|Overall Study|Adverse Event|0|||
37783101|NCT02487030|69367348|FG003|Overall Study|Adverse Event|1|||
37783102|NCT02487030|69367349|FG004|Overall Study|Adverse Event|0|||
37783103|NCT02487030|69367350|FG005|Overall Study|Adverse Event|0|||
37783104|NCT02487030|69367351|FG006|Overall Study|Adverse Event|0|||
37783105|NCT02487030|69367345|FG000|Overall Study|Death|0|||
37783106|NCT02487030|69367346|FG001|Overall Study|Death|0|||
37783107|NCT02487030|69367347|FG002|Overall Study|Death|0|||
37783108|NCT02487030|69367348|FG003|Overall Study|Death|0|||
37783109|NCT02487030|69367349|FG004|Overall Study|Death|1|||
37783110|NCT02487030|69367350|FG005|Overall Study|Death|0|||
37783111|NCT02487030|69367351|FG006|Overall Study|Death|0|||
37783112|NCT02486952|69367368|FG000|Overall Study|Not Started Induction Therapy|3|||
37783113|NCT02486952|69367368|FG000|Overall Study|Adverse Event|1|||
37783114|NCT02486952|69367368|FG000|Overall Study|Death|15|||
37783115|NCT02486952|69367368|FG000|Overall Study|Lack of Efficacy|3|||
37693034|NCT02294227|69169262|FG002|Overall Study|Lost to Follow-up|0|||
37693035|NCT02294227|69169260|FG000|Overall Study|Lack of Efficacy|11|||
37693036|NCT02294227|69169261|FG001|Overall Study|Lack of Efficacy|12|||
37693037|NCT02294227|69169262|FG002|Overall Study|Lack of Efficacy|8|||
37693038|NCT02294227|69169260|FG000|Overall Study|Adverse Event|6|||
37693039|NCT02294227|69169261|FG001|Overall Study|Adverse Event|8|||
37693040|NCT02294227|69169262|FG002|Overall Study|Adverse Event|2|||
37693041|NCT02496767|69169276|FG000|Open-label Lead-in Phase|Adverse Event|176|||
37693042|NCT02496767|69169277|FG001|Open-label Lead-in Phase|Adverse Event|0|||
37693043|NCT02496767|69169278|FG002|Open-label Lead-in Phase|Adverse Event|0|||
37693044|NCT02496767|69169279|FG003|Open-label Lead-in Phase|Adverse Event|0|||
37693045|NCT02496767|69169280|FG004|Open-label Lead-in Phase|Adverse Event|0|||
37693046|NCT02496767|69169281|FG005|Open-label Lead-in Phase|Adverse Event|0|||
37693047|NCT02496767|69169282|FG006|Open-label Lead-in Phase|Adverse Event|0|||
37693048|NCT02496767|69169283|FG007|Open-label Lead-in Phase|Adverse Event|0|||
37693049|NCT02496767|69169276|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
37693050|NCT02496767|69169277|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
37693051|NCT02496767|69169278|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
37693052|NCT02496767|69169279|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
37693053|NCT02496767|69169280|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
37693054|NCT02496767|69169281|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
37693055|NCT02496767|69169282|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
37693056|NCT02496767|69169283|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
37693057|NCT02496767|69169276|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
37693058|NCT02496767|69169277|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
37693059|NCT02496767|69169278|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
37693060|NCT02496767|69169279|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
37783116|NCT02486952|69367368|FG000|Overall Study|Lost to Follow-up|26|||
37783117|NCT02486952|69367368|FG000|Overall Study|Other|2|||
37783118|NCT02486796|69367374|FG000|Overall Study|Withdrawal by Subject|1|||
37783119|NCT02486796|69367375|FG001|Overall Study|Withdrawal by Subject|1|||
37783120|NCT02486796|69367374|FG000|Overall Study|Physician Decision|1|||
37783121|NCT02486796|69367375|FG001|Overall Study|Physician Decision|0|||
37783122|NCT02459262|69367392|FG000|Overall Study|Withdrawal by Subject|0|||
37783123|NCT02459262|69367393|FG001|Overall Study|Withdrawal by Subject|0|||
37783124|NCT02459262|69367394|FG002|Overall Study|Withdrawal by Subject|0|||
37783125|NCT02459262|69367395|FG003|Overall Study|Withdrawal by Subject|0|||
37783126|NCT02459262|69367396|FG004|Overall Study|Withdrawal by Subject|0|||
37783127|NCT02459262|69367397|FG005|Overall Study|Withdrawal by Subject|0|||
37783128|NCT02459262|69367398|FG006|Overall Study|Withdrawal by Subject|0|||
37783129|NCT02459262|69367399|FG007|Overall Study|Withdrawal by Subject|0|||
37783130|NCT02459262|69367400|FG008|Overall Study|Withdrawal by Subject|0|||
37783131|NCT02459262|69367401|FG009|Overall Study|Withdrawal by Subject|1|||
37783132|NCT02459262|69367402|FG010|Overall Study|Withdrawal by Subject|0|||
37783133|NCT02450526|69367486|FG000|DB Period (Cycle 1)|Adverse Event|0|||
37783134|NCT02450526|69367487|FG001|DB Period (Cycle 1)|Adverse Event|0|||
37783135|NCT02450526|69367488|FG002|DB Period (Cycle 1)|Adverse Event|2|||
37783136|NCT02450526|69367489|FG003|DB Period (Cycle 1)|Adverse Event|0|||
37783137|NCT02450526|69367490|FG004|DB Period (Cycle 1)|Adverse Event|0|||
37783138|NCT02450526|69367486|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
37783139|NCT02450526|69367487|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
37783140|NCT02450526|69367488|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
37783141|NCT02450526|69367489|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
37783142|NCT02450526|69367490|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
37783143|NCT02450526|69367486|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
37783144|NCT02450526|69367487|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
37783145|NCT02450526|69367488|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
37783146|NCT02450526|69367489|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
37783147|NCT02450526|69367490|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
37783148|NCT02450526|69367486|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
37783149|NCT02450526|69367487|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
37783150|NCT02450526|69367488|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
37783151|NCT02450526|69367489|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
37783152|NCT02450526|69367490|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
37783153|NCT02450526|69367486|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
37783154|NCT02450526|69367487|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
37783155|NCT02450526|69367488|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
37783156|NCT02450526|69367489|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
37783157|NCT02450526|69367490|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
37783158|NCT02450526|69367486|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
37783159|NCT02450526|69367487|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
37783160|NCT02450526|69367488|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
37783161|NCT02450526|69367489|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
37783162|NCT02450526|69367490|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
37783163|NCT02450526|69367486|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
37783164|NCT02450526|69367487|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
37783165|NCT02450526|69367488|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
37783166|NCT02450526|69367489|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
37783167|NCT02450526|69367490|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
37783168|NCT02450526|69367486|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
37783169|NCT02450526|69367487|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
37783170|NCT02450526|69367488|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
37783171|NCT02450526|69367489|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
37783172|NCT02450526|69367490|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
37783173|NCT02458638|69367557|FG000|Overall Study|Death|309|||
37783174|NCT02458638|69367557|FG000|Overall Study|End of Cohort/End of Study|67|||
37783175|NCT02458638|69367557|FG000|Overall Study|Lost to Follow-up|31|||
37693061|NCT02496767|69169280|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
37693062|NCT02496767|69169281|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
37693063|NCT02496767|69169282|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
37693064|NCT02496767|69169283|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
37693065|NCT02496767|69169276|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
37693066|NCT02496767|69169277|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
37693067|NCT02496767|69169278|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
37693068|NCT02496767|69169279|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
37693069|NCT02496767|69169280|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
37783176|NCT02458638|69367557|FG000|Overall Study|Other Reasons|4|||
37783177|NCT02458638|69367557|FG000|Overall Study|Physician Decision|1|||
37783178|NCT02458638|69367557|FG000|Overall Study|Withdrawal by Subject|47|||
37783179|NCT02458092|69367695|FG000|Overall Study|Withdrawal by Subject|1|||
37783180|NCT02458092|69367696|FG001|Overall Study|Withdrawal by Subject|0|||
37783181|NCT02449902|69367719|FG000|Overall Study|Adverse Event|0|||
37783182|NCT02449902|69367720|FG001|Overall Study|Adverse Event|1|||
37783183|NCT02449902|69367719|FG000|Overall Study|Withdrawal by Subject|0|||
37783184|NCT02449902|69367720|FG001|Overall Study|Withdrawal by Subject|1|||
37783185|NCT02449044|69367728|FG000|Overall Study|Lost to Follow-up|2|||
37783186|NCT02449044|69367728|FG000|Overall Study|Withdrawal by Subject|13|||
37783187|NCT02449044|69367728|FG000|Overall Study|Adverse Event|30|||
37783188|NCT02449044|69367728|FG000|Overall Study|Met Withdrawal Criteria|7|||
37783189|NCT02449044|69367728|FG000|Overall Study|Physician Decision|9|||
37783190|NCT02449044|69367728|FG000|Overall Study|Sponsor Discontinued Trial|3|||
37783191|NCT02448810|69368599|FG000|Overall Study|Adverse Event|0|||
37783192|NCT02448810|69368600|FG001|Overall Study|Adverse Event|0|||
37783193|NCT02448810|69368601|FG002|Overall Study|Adverse Event|1|||
37783194|NCT02448810|69368602|FG003|Overall Study|Adverse Event|0|||
37783195|NCT02448810|69368603|FG004|Overall Study|Adverse Event|0|||
37783196|NCT02448810|69368604|FG005|Overall Study|Adverse Event|0|||
37783197|NCT02448810|69368605|FG006|Overall Study|Adverse Event|0|||
37783198|NCT02448810|69368606|FG007|Overall Study|Adverse Event|0|||
37783199|NCT02448810|69368599|FG000|Overall Study|Withdrawal by Subject|0|||
37783200|NCT02448810|69368600|FG001|Overall Study|Withdrawal by Subject|0|||
37783201|NCT02448810|69368601|FG002|Overall Study|Withdrawal by Subject|1|||
37783202|NCT02448810|69368602|FG003|Overall Study|Withdrawal by Subject|0|||
37783203|NCT02448810|69368603|FG004|Overall Study|Withdrawal by Subject|3|||
37783204|NCT02448810|69368604|FG005|Overall Study|Withdrawal by Subject|5|||
37783205|NCT02448810|69368605|FG006|Overall Study|Withdrawal by Subject|0|||
37783206|NCT02448810|69368606|FG007|Overall Study|Withdrawal by Subject|2|||
37783207|NCT02448810|69368599|FG000|Overall Study|Other (study terminated by sponsor)|0|||
37783208|NCT02448810|69368600|FG001|Overall Study|Other (study terminated by sponsor)|0|||
37783209|NCT02448810|69368601|FG002|Overall Study|Other (study terminated by sponsor)|0|||
37783210|NCT02448810|69368602|FG003|Overall Study|Other (study terminated by sponsor)|0|||
37783211|NCT02448810|69368603|FG004|Overall Study|Other (study terminated by sponsor)|4|||
37783212|NCT02448810|69368604|FG005|Overall Study|Other (study terminated by sponsor)|2|||
37783213|NCT02448810|69368605|FG006|Overall Study|Other (study terminated by sponsor)|2|||
37783214|NCT02448810|69368606|FG007|Overall Study|Other (study terminated by sponsor)|1|||
37783215|NCT02448810|69368599|FG000|Overall Study|Death|1|||
37783216|NCT02448810|69368600|FG001|Overall Study|Death|0|||
37783217|NCT02448810|69368601|FG002|Overall Study|Death|1|||
37783218|NCT02448810|69368602|FG003|Overall Study|Death|0|||
37783219|NCT02448810|69368603|FG004|Overall Study|Death|1|||
37783220|NCT02448810|69368604|FG005|Overall Study|Death|0|||
37783221|NCT02448810|69368605|FG006|Overall Study|Death|0|||
37783222|NCT02448810|69368606|FG007|Overall Study|Death|0|||
37783223|NCT02448810|69368599|FG000|Overall Study|Other (Progressive disease)|2|||
37783224|NCT02448810|69368600|FG001|Overall Study|Other (Progressive disease)|2|||
37783225|NCT02448810|69368601|FG002|Overall Study|Other (Progressive disease)|0|||
37783226|NCT02448810|69368602|FG003|Overall Study|Other (Progressive disease)|3|||
37783227|NCT02448810|69368603|FG004|Overall Study|Other (Progressive disease)|23|||
37783228|NCT02448810|69368604|FG005|Overall Study|Other (Progressive disease)|9|||
37783229|NCT02448810|69368605|FG006|Overall Study|Other (Progressive disease)|14|||
37783230|NCT02448810|69368606|FG007|Overall Study|Other (Progressive disease)|5|||
37783231|NCT02448810|69368599|FG000|Overall Study|Lost to Follow-up|0|||
37783232|NCT02448810|69368600|FG001|Overall Study|Lost to Follow-up|1|||
37783233|NCT02448810|69368601|FG002|Overall Study|Lost to Follow-up|0|||
37783234|NCT02448810|69368602|FG003|Overall Study|Lost to Follow-up|0|||
37783235|NCT02448810|69368603|FG004|Overall Study|Lost to Follow-up|0|||
37783236|NCT02448810|69368604|FG005|Overall Study|Lost to Follow-up|0|||
37974920|NCT00402051|69662127|FG000|Overall Study|Adverse Event|11|||
37974921|NCT00402051|69662128|FG001|Overall Study|Adverse Event|4|||
37974922|NCT00402051|69662127|FG000|Overall Study|Physician Decision|7|||
37974923|NCT00402051|69662128|FG001|Overall Study|Physician Decision|3|||
37693070|NCT02496767|69169281|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
37693071|NCT02496767|69169282|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
37693072|NCT02496767|69169283|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
37693073|NCT02496767|69169276|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
37693074|NCT02496767|69169277|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
37693075|NCT02496767|69169278|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
37693076|NCT02496767|69169279|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
37693077|NCT02496767|69169280|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
37783237|NCT02448810|69368605|FG006|Overall Study|Lost to Follow-up|0|||
37783238|NCT02448810|69368606|FG007|Overall Study|Lost to Follow-up|0|||
37783239|NCT02448810|69368599|FG000|Overall Study|Other (unspecified)|0|||
37783240|NCT02448810|69368600|FG001|Overall Study|Other (unspecified)|0|||
37783241|NCT02448810|69368601|FG002|Overall Study|Other (unspecified)|0|||
37783242|NCT02448810|69368602|FG003|Overall Study|Other (unspecified)|0|||
37783243|NCT02448810|69368603|FG004|Overall Study|Other (unspecified)|0|||
37783244|NCT02448810|69368604|FG005|Overall Study|Other (unspecified)|0|||
37783245|NCT02448810|69368605|FG006|Overall Study|Other (unspecified)|2|||
37783246|NCT02448810|69368606|FG007|Overall Study|Other (unspecified)|0|||
37783247|NCT02457546|69368679|FG000|Overall Study|Other reasons|4|||
37783248|NCT02457546|69368680|FG001|Overall Study|Other reasons|1|||
37783249|NCT02457546|69368679|FG000|Overall Study|Refused to complete study/procedures|1|||
37783250|NCT02457546|69368680|FG001|Overall Study|Refused to complete study/procedures|1|||
37783251|NCT02457546|69368679|FG000|Overall Study|Lost to Follow-up|4|||
37783252|NCT02457546|69368680|FG001|Overall Study|Lost to Follow-up|1|||
37783253|NCT02457546|69368679|FG000|Overall Study|Adverse Event|0|||
37783254|NCT02457546|69368680|FG001|Overall Study|Adverse Event|1|||
37783255|NCT02447952|69368701|FG000|Overall Study|Adverse Event|2|||
37783256|NCT02447952|69368701|FG000|Overall Study|Physician Decision|1|||
37783257|NCT02447952|69368701|FG000|Overall Study|Withdrawal by Subject|4|||
37783258|NCT02447718|69368735|FG000|Overall Study|Lost to Follow-up|8|||
37783259|NCT02447718|69368736|FG001|Overall Study|Lost to Follow-up|0|||
37783260|NCT02447718|69368735|FG000|Overall Study|Withdrawal by Subject|3|||
37783261|NCT02447718|69368736|FG001|Overall Study|Withdrawal by Subject|0|||
37783262|NCT02447718|69368735|FG000|Overall Study|Screen Failure|1|||
37783263|NCT02447718|69368736|FG001|Overall Study|Screen Failure|0|||
37783264|NCT02486406|69368913|FG000|Overall Study|Withdrew consent|1|||
37783265|NCT02486406|69368914|FG001|Overall Study|Withdrew consent|0|||
37783266|NCT02486406|69368915|FG002|Overall Study|Withdrew consent|0|||
37783267|NCT02486406|69368916|FG003|Overall Study|Withdrew consent|1|||
37783268|NCT02486406|69368913|FG000|Overall Study|Lost to Follow-up|1|||
37783269|NCT02486406|69368914|FG001|Overall Study|Lost to Follow-up|3|||
37783270|NCT02486406|69368915|FG002|Overall Study|Lost to Follow-up|1|||
37783271|NCT02486406|69368916|FG003|Overall Study|Lost to Follow-up|3|||
37783272|NCT02486406|69368913|FG000|Overall Study|Other, not specified|0|||
37783273|NCT02486406|69368914|FG001|Overall Study|Other, not specified|0|||
37783274|NCT02486406|69368915|FG002|Overall Study|Other, not specified|1|||
37783275|NCT02486406|69368916|FG003|Overall Study|Other, not specified|0|||
37783276|NCT02485704|69368988|FG000|Overall Study|Lost to Follow-up|4|||
37783277|NCT02485704|69368989|FG001|Overall Study|Lost to Follow-up|5|||
37783278|NCT02485704|69368988|FG000|Overall Study|Withdrawal by Subject|0|||
37783279|NCT02485704|69368989|FG001|Overall Study|Withdrawal by Subject|3|||
37783280|NCT02485704|69368988|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
37783281|NCT02485704|69368989|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
37783282|NCT02485158|69368999|FG000|Overall Study|Withdrawal by Subject|3|||
37783283|NCT02485158|69368999|FG000|Overall Study|expected drug side effect|1|||
37783284|NCT02455518|69369018|FG000|Overall Study|Protocol Violation|0|||
37783285|NCT02455518|69369019|FG001|Overall Study|Protocol Violation|1|||
37783286|NCT02455518|69369020|FG002|Overall Study|Protocol Violation|1|||
37783287|NCT02455518|69369021|FG003|Overall Study|Protocol Violation|3|||
37783288|NCT02240069|69369239|FG000|Overall Study|Withdrawal by Subject|5|||
37783289|NCT02240069|69369240|FG001|Overall Study|Withdrawal by Subject|5|||
37783290|NCT02240069|69369241|FG002|Overall Study|Withdrawal by Subject|2|||
37783291|NCT02484690|69369327|FG000|Overall Study|Adverse Event|1|||
37783292|NCT02484690|69369328|FG001|Overall Study|Adverse Event|3|||
37783293|NCT02484690|69369329|FG002|Overall Study|Adverse Event|0|||
37783294|NCT02484690|69369330|FG003|Overall Study|Adverse Event|0|||
37783295|NCT02484690|69369331|FG004|Overall Study|Adverse Event|5|||
37783296|NCT02484690|69369327|FG000|Overall Study|Death|0|||
37783297|NCT02484690|69369328|FG001|Overall Study|Death|0|||
37783298|NCT02484690|69369329|FG002|Overall Study|Death|0|||
37783299|NCT02484690|69369330|FG003|Overall Study|Death|0|||
37783300|NCT02484690|69369331|FG004|Overall Study|Death|1|||
37783301|NCT02484690|69369327|FG000|Overall Study|Withdrawal by Subject|1|||
37783302|NCT02484690|69369328|FG001|Overall Study|Withdrawal by Subject|3|||
37783303|NCT02484690|69369329|FG002|Overall Study|Withdrawal by Subject|1|||
37783304|NCT02484690|69369330|FG003|Overall Study|Withdrawal by Subject|2|||
37783305|NCT02484690|69369331|FG004|Overall Study|Withdrawal by Subject|0|||
37783306|NCT02484690|69369327|FG000|Overall Study|Physician Decision|2|||
37783307|NCT02484690|69369328|FG001|Overall Study|Physician Decision|0|||
37783308|NCT02484690|69369329|FG002|Overall Study|Physician Decision|1|||
37783309|NCT02484690|69369330|FG003|Overall Study|Physician Decision|0|||
37783310|NCT02484690|69369331|FG004|Overall Study|Physician Decision|0|||
37783311|NCT02484690|69369327|FG000|Overall Study|Lost to Follow-up|0|||
37783312|NCT02484690|69369328|FG001|Overall Study|Lost to Follow-up|0|||
37783313|NCT02484690|69369329|FG002|Overall Study|Lost to Follow-up|1|||
37783314|NCT02484690|69369330|FG003|Overall Study|Lost to Follow-up|0|||
37783315|NCT02484690|69369331|FG004|Overall Study|Lost to Follow-up|0|||
37783316|NCT01654224|69369355|FG000|Overall Study|Lost to Follow-up|2|||
37783317|NCT01654224|69369356|FG001|Overall Study|Lost to Follow-up|2|||
37783318|NCT01654224|69369355|FG000|Overall Study|Did not receive allocation|1|||
37783319|NCT01654224|69369356|FG001|Overall Study|Did not receive allocation|8|||
37783320|NCT01654224|69369355|FG000|Overall Study|Insufficient blood sample|3|||
37783321|NCT01654224|69369356|FG001|Overall Study|Insufficient blood sample|2|||
37783322|NCT02447328|69369362|FG000|Overall Study|Withdrawal by Subject|1|||
37783323|NCT02447250|69369366|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
37783324|NCT02447250|69369366|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
37783325|NCT02447250|69369366|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
37783326|NCT02447172|69369470|FG000|Overall Study|Adverse Event|11|||
37783327|NCT02447172|69369471|FG001|Overall Study|Adverse Event|8|||
37783328|NCT02447172|69369472|FG002|Overall Study|Adverse Event|7|||
37783329|NCT02447172|69369470|FG000|Overall Study|Death|3|||
37783330|NCT02447172|69369471|FG001|Overall Study|Death|1|||
37783331|NCT02447172|69369472|FG002|Overall Study|Death|0|||
37783332|NCT02447172|69369470|FG000|Overall Study|Protocol Violation|2|||
37783333|NCT02447172|69369471|FG001|Overall Study|Protocol Violation|1|||
37783334|NCT02447172|69369472|FG002|Overall Study|Protocol Violation|2|||
37783335|NCT02447172|69369470|FG000|Overall Study|Lost to Follow-up|7|||
37783336|NCT02447172|69369471|FG001|Overall Study|Lost to Follow-up|4|||
37783337|NCT02447172|69369472|FG002|Overall Study|Lost to Follow-up|4|||
37783338|NCT02447172|69369470|FG000|Overall Study|Withdrawal by Subject|5|||
37783339|NCT02447172|69369471|FG001|Overall Study|Withdrawal by Subject|1|||
37783340|NCT02447172|69369472|FG002|Overall Study|Withdrawal by Subject|3|||
37783341|NCT02447172|69369470|FG000|Overall Study|protocol specific treatment unrelated|3|||
37783342|NCT02447172|69369471|FG001|Overall Study|protocol specific treatment unrelated|0|||
37783343|NCT02447172|69369472|FG002|Overall Study|protocol specific treatment unrelated|2|||
37783344|NCT02455050|69369505|FG000|Treatment Period 1|Lost to Follow-up|1|||
37783345|NCT02455050|69369506|FG001|Treatment Period 1|Lost to Follow-up|1|||
37783346|NCT02455050|69369507|FG002|Treatment Period 1|Lost to Follow-up|1|||
37783347|NCT02455050|69369508|FG003|Treatment Period 1|Lost to Follow-up|2|||
37783348|NCT02455050|69369505|FG000|Treatment Period 2|Lost to Follow-up|1|||
37783349|NCT02455050|69369506|FG001|Treatment Period 2|Lost to Follow-up|0|||
37783350|NCT02455050|69369507|FG002|Treatment Period 2|Lost to Follow-up|2|||
37783351|NCT02455050|69369508|FG003|Treatment Period 2|Lost to Follow-up|1|||
37783352|NCT02418468|69369548|FG000|Overall Study|Adverse Event|1|||
37783353|NCT02418468|69369549|FG001|Overall Study|Adverse Event|0|||
37783354|NCT02418468|69369548|FG000|Overall Study|Withdrawal of informed consent|1|||
37783355|NCT02418468|69369549|FG001|Overall Study|Withdrawal of informed consent|1|||
37783356|NCT02418000|69369680|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
37783357|NCT02418000|69369681|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
37783358|NCT02418000|69369682|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
37783359|NCT02418000|69369683|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
37783360|NCT02418000|69369684|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
37783361|NCT02418000|69369680|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
37783362|NCT02418000|69369681|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
37783363|NCT02418000|69369682|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
37783364|NCT02418000|69369683|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
37783365|NCT02418000|69369684|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
37783366|NCT02418000|69369680|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
37783367|NCT02418000|69369681|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
37783368|NCT02418000|69369682|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
37783369|NCT02418000|69369683|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
37783370|NCT02418000|69369684|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
37783371|NCT02418000|69369680|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
37783372|NCT02418000|69369681|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
37783373|NCT02418000|69369682|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
37783374|NCT02418000|69369683|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
37783375|NCT02418000|69369684|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
37783376|NCT02418000|69369680|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
37783377|NCT02418000|69369681|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
37783378|NCT02418000|69369682|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
37783379|NCT02418000|69369683|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
37783380|NCT02418000|69369684|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
37783381|NCT02418000|69369680|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
37783382|NCT02418000|69369681|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
37783383|NCT02418000|69369682|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
37783384|NCT02418000|69369683|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
37783385|NCT02418000|69369684|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
37783386|NCT02418000|69369680|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
37783387|NCT02418000|69369681|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
37783388|NCT02418000|69369682|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
37783389|NCT02418000|69369683|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
37783390|NCT02418000|69369684|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
37783391|NCT02418000|69369680|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
37783392|NCT02418000|69369681|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
37783393|NCT02418000|69369682|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
37783394|NCT02418000|69369683|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
37783395|NCT02418000|69369684|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
37783396|NCT02418000|69369680|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
37783397|NCT02418000|69369681|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
37783398|NCT02418000|69369682|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
37783399|NCT02418000|69369683|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
37783400|NCT02418000|69369684|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
37783401|NCT02417064|69369788|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
37783402|NCT02417064|69369789|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
37783403|NCT02417064|69369790|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
37783404|NCT02417064|69369788|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
37783405|NCT02417064|69369789|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
37783406|NCT02417064|69369790|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
37783407|NCT02417064|69369788|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
37783408|NCT02417064|69369789|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
37783409|NCT02417064|69369790|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
37783410|NCT02417064|69369788|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
37783411|NCT02417064|69369789|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
37783412|NCT02417064|69369790|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
37783413|NCT02417064|69369788|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
37783414|NCT02417064|69369789|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
37783415|NCT02417064|69369790|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
37783416|NCT02417064|69369788|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
37783417|NCT02417064|69369789|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
37783418|NCT02417064|69369790|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
37783419|NCT02417064|69369788|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
37783420|NCT02417064|69369789|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
37783421|NCT02417064|69369790|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
37783422|NCT02417064|69369788|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
37783423|NCT02417064|69369789|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
37783424|NCT02417064|69369790|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
37783425|NCT02417064|69369788|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
37783426|NCT02417064|69369789|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
37783427|NCT02417064|69369790|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
37783428|NCT02417064|69369788|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
37783429|NCT02417064|69369789|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
37783430|NCT02417064|69369790|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
37783431|NCT02417064|69369788|FG000|Follow-up Phase (24 Weeks)|Other|2|||
37783432|NCT02417064|69369789|FG001|Follow-up Phase (24 Weeks)|Other|2|||
37783433|NCT02417064|69369790|FG002|Follow-up Phase (24 Weeks)|Other|3|||
37783434|NCT01653132|69369805|FG000|First Intervention|Protocol Violation|1|||
37693078|NCT02496767|69169281|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
37693079|NCT02496767|69169282|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
37693080|NCT02496767|69169283|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
37693081|NCT02496767|69169276|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
37693082|NCT02496767|69169277|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
37693083|NCT02496767|69169278|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
37693084|NCT02496767|69169279|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
37693085|NCT02496767|69169280|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
37783435|NCT01653132|69369806|FG001|First Intervention|Protocol Violation|0|||
37783436|NCT02453334|69369831|FG000|Overall Study|Death|15|||
37783437|NCT02453334|69369832|FG001|Overall Study|Death|13|||
37783438|NCT02453334|69369831|FG000|Overall Study|Adverse Event|2|||
37783439|NCT02453334|69369832|FG001|Overall Study|Adverse Event|1|||
37783440|NCT02453334|69369831|FG000|Overall Study|Lost to Follow-up|5|||
37783441|NCT02453334|69369832|FG001|Overall Study|Lost to Follow-up|9|||
37783442|NCT02453334|69369831|FG000|Overall Study|Physician Decision|1|||
37783443|NCT02453334|69369832|FG001|Overall Study|Physician Decision|0|||
37783444|NCT02453334|69369831|FG000|Overall Study|Withdrawal by Subject|17|||
37783445|NCT02453334|69369832|FG001|Overall Study|Withdrawal by Subject|13|||
37783446|NCT02453334|69369831|FG000|Overall Study|Other reason|1|||
37783447|NCT02453334|69369832|FG001|Overall Study|Other reason|4|||
37783448|NCT02443740|69369918|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
37783449|NCT02443740|69369919|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
37783450|NCT02443740|69369920|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
37783451|NCT02443740|69369921|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
37783452|NCT02443740|69369922|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
37783453|NCT02443740|69369923|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
37783454|NCT02443740|69369924|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
37783455|NCT02443740|69369925|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
37783456|NCT02443740|69369926|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
37783457|NCT02443740|69369927|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
37783458|NCT02443740|69369928|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
37783459|NCT02443740|69369918|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
37783460|NCT02443740|69369919|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
37783461|NCT02443740|69369920|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
37783462|NCT02443740|69369921|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
37783463|NCT02443740|69369922|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
37783464|NCT02443740|69369923|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
37783465|NCT02443740|69369924|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
37783466|NCT02443740|69369925|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
37693086|NCT02496767|69169281|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
37693087|NCT02496767|69169282|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
37693088|NCT02496767|69169283|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
37693089|NCT02496767|69169276|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
37783467|NCT02443740|69369926|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
37783468|NCT02443740|69369927|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
37693090|NCT02496767|69169277|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
37693091|NCT02496767|69169278|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
37693092|NCT02496767|69169279|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
37693093|NCT02496767|69169280|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
37783469|NCT02443740|69369928|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
37783470|NCT02443740|69369918|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
37783471|NCT02443740|69369919|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
37783472|NCT02443740|69369920|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
37783473|NCT02443740|69369921|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
37783474|NCT02443740|69369922|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
37783475|NCT02443740|69369923|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
37783476|NCT02443740|69369924|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
37783477|NCT02443740|69369925|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
37783478|NCT02443740|69369926|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
37783479|NCT02443740|69369927|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
37783480|NCT02443740|69369928|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
37783481|NCT02416908|69370159|FG000|Dose Escalation Phase|Adverse Event|0|||
37783482|NCT02416908|69370160|FG001|Dose Escalation Phase|Adverse Event|0|||
37783483|NCT02416908|69370161|FG002|Dose Escalation Phase|Adverse Event|3|||
37783484|NCT02416908|69370162|FG003|Dose Escalation Phase|Adverse Event|0|||
37783485|NCT02416908|69370159|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
37783486|NCT02416908|69370160|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
37783487|NCT02416908|69370161|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
37783488|NCT02416908|69370162|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
37783489|NCT02453256|69370252|FG000|Double Blind Period|Death|1|||
37783490|NCT02453256|69370253|FG001|Double Blind Period|Death|1|||
37783491|NCT02453256|69370252|FG000|Double Blind Period|Adverse Event|3|||
37783492|NCT02453256|69370253|FG001|Double Blind Period|Adverse Event|2|||
37783493|NCT02453256|69370252|FG000|Double Blind Period|Withdrawal by Subject|9|||
37783494|NCT02453256|69370253|FG001|Double Blind Period|Withdrawal by Subject|5|||
37783495|NCT02453256|69370252|FG000|Double Blind Period|Other|0|||
37783496|NCT02453256|69370253|FG001|Double Blind Period|Other|1|||
37783497|NCT02453256|69370252|FG000|Open Label Period|Adverse Event|1|||
37783498|NCT02453256|69370253|FG001|Open Label Period|Adverse Event|3|||
37783499|NCT02453256|69370252|FG000|Open Label Period|Death|0|||
37783500|NCT02453256|69370253|FG001|Open Label Period|Death|1|||
37783501|NCT02453256|69370252|FG000|Open Label Period|Lost to Follow-up|1|||
37783502|NCT02453256|69370253|FG001|Open Label Period|Lost to Follow-up|0|||
37783503|NCT02453256|69370252|FG000|Open Label Period|Other|0|||
37783504|NCT02453256|69370253|FG001|Open Label Period|Other|2|||
37783505|NCT02453256|69370252|FG000|Open Label Period|Withdrawal by Subject|5|||
37783506|NCT02453256|69370253|FG001|Open Label Period|Withdrawal by Subject|1|||
37783507|NCT02442804|69370268|FG000|Overall Study|Withdrawal by Subject|0|||
37783508|NCT02442804|69370269|FG001|Overall Study|Withdrawal by Subject|1|||
37783509|NCT02442804|69370268|FG000|Overall Study|Adverse Event|1|||
37783510|NCT02442804|69370269|FG001|Overall Study|Adverse Event|0|||
37783511|NCT02414958|69370358|FG000|Overall Study|Adverse Event|6|||
37783512|NCT02414958|69370359|FG001|Overall Study|Adverse Event|6|||
37783513|NCT02414958|69370360|FG002|Overall Study|Adverse Event|3|||
37783514|NCT02414958|69370358|FG000|Overall Study|Protocol Violation|10|||
37783515|NCT02414958|69370359|FG001|Overall Study|Protocol Violation|3|||
37783516|NCT02414958|69370360|FG002|Overall Study|Protocol Violation|1|||
37783517|NCT02414958|69370358|FG000|Overall Study|Lost to Follow-up|7|||
37783518|NCT02414958|69370359|FG001|Overall Study|Lost to Follow-up|4|||
37783519|NCT02414958|69370360|FG002|Overall Study|Lost to Follow-up|0|||
37783520|NCT02414958|69370358|FG000|Overall Study|Withdrawal by Subject|5|||
37783521|NCT02414958|69370359|FG001|Overall Study|Withdrawal by Subject|3|||
37783522|NCT02414958|69370360|FG002|Overall Study|Withdrawal by Subject|5|||
37783523|NCT02414958|69370358|FG000|Overall Study|Other than specified|4|||
37783524|NCT02414958|69370359|FG001|Overall Study|Other than specified|4|||
37783525|NCT02414958|69370360|FG002|Overall Study|Other than specified|5|||
37783526|NCT02452476|69370433|FG000|Overall Study|Death|4|||
37783527|NCT02452476|69370434|FG001|Overall Study|Death|7|||
37783528|NCT02452476|69370433|FG000|Overall Study|Lost to Follow-up|1|||
37693094|NCT02496767|69169281|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
37693095|NCT02496767|69169282|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
37693096|NCT02496767|69169283|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
37783529|NCT02452476|69370434|FG001|Overall Study|Lost to Follow-up|1|||
37693097|NCT02496767|69169276|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
37974924|NCT00402051|69662127|FG000|Overall Study|Withdrawal by Subject|3|||
37693098|NCT02496767|69169277|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
37693099|NCT02496767|69169278|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
37693100|NCT02496767|69169279|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
37693101|NCT02496767|69169280|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
37693102|NCT02496767|69169281|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
37693103|NCT02496767|69169282|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
37693104|NCT02496767|69169283|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
37693105|NCT02496767|69169276|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
37693106|NCT02496767|69169277|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
37783530|NCT02452476|69370433|FG000|Overall Study|Physician Decision|1|||
37783531|NCT02452476|69370434|FG001|Overall Study|Physician Decision|1|||
37783532|NCT02452476|69370433|FG000|Overall Study|Not treated|5|||
37783533|NCT02452476|69370434|FG001|Overall Study|Not treated|1|||
37783534|NCT02442336|69370449|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
37783535|NCT02442336|69370449|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
37783536|NCT02442336|69370449|FG000|Overall Study|Lost to Follow-up|11|||
37783537|NCT02452398|69370453|FG000|Overall Study|Adverse Event|1|||
37783538|NCT02452398|69370453|FG000|Overall Study|Lost to Follow-up|28|||
37783539|NCT02452398|69370453|FG000|Overall Study|Physician Decision|2|||
37783540|NCT02452398|69370453|FG000|Overall Study|Withdrawal by Subject|6|||
37783541|NCT02452398|69370453|FG000|Overall Study|Moved away|4|||
37783542|NCT02413398|69370459|FG000|Overall Study|Lost to Follow-up|2|||
37783543|NCT02413398|69370460|FG001|Overall Study|Lost to Follow-up|4|||
37783544|NCT02413398|69370459|FG000|Overall Study|Withdrawal by Subject|1|||
37783545|NCT02413398|69370460|FG001|Overall Study|Withdrawal by Subject|1|||
37783546|NCT02413398|69370459|FG000|Overall Study|Other Eligibility criteria|1|||
37783547|NCT02413398|69370460|FG001|Overall Study|Other Eligibility criteria|2|||
37783548|NCT02441946|69370469|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
37783549|NCT02441946|69370470|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
37783550|NCT02441946|69370471|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
37783551|NCT02441946|69370469|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
37783552|NCT02441946|69370470|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
37783553|NCT02441946|69370471|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
37783554|NCT02441946|69370469|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
37783555|NCT02441946|69370470|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
37783556|NCT02441946|69370471|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
37783557|NCT02441946|69370469|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
37783558|NCT02441946|69370470|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
37783559|NCT02441946|69370471|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
37783560|NCT02441946|69370469|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
37783561|NCT02441946|69370470|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
37783562|NCT02441946|69370471|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
37783563|NCT02441946|69370469|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
37783564|NCT02441946|69370470|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
37783565|NCT02441946|69370471|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
37783566|NCT02441946|69370469|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
37783567|NCT02441946|69370470|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
37783568|NCT02441946|69370471|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
37783569|NCT02441946|69370469|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
37783570|NCT02441946|69370470|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
37783571|NCT02441946|69370471|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
37783572|NCT02441946|69370469|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
37783573|NCT02441946|69370470|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
37783574|NCT02441946|69370471|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
37783575|NCT02441946|69370469|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
37783576|NCT02441946|69370470|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
37783577|NCT02441946|69370471|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
37783578|NCT02441946|69370469|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
37783579|NCT02441946|69370470|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
37783580|NCT02441946|69370471|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
37783581|NCT02387580|69370505|FG000|Overall Study|Withdrawal by Subject|0|||
37783582|NCT02387580|69370506|FG001|Overall Study|Withdrawal by Subject|0|||
37783583|NCT02387580|69370507|FG002|Overall Study|Withdrawal by Subject|0|||
37783584|NCT02387580|69370508|FG003|Overall Study|Withdrawal by Subject|1|||
37783585|NCT02387580|69370509|FG004|Overall Study|Withdrawal by Subject|0|||
37783586|NCT02387580|69370510|FG005|Overall Study|Withdrawal by Subject|0|||
37783587|NCT02440854|69370526|FG000|Overall Study|Relocation of patient|1|||
37783588|NCT02440854|69370526|FG000|Overall Study|Death|6|||
37783589|NCT02440854|69370526|FG000|Overall Study|Lost to Follow-up|10|||
37783590|NCT02440854|69370526|FG000|Overall Study|Afatinib discontinuation|46|||
37783591|NCT02440854|69370526|FG000|Overall Study|stopped study at earlier timepoint|14|||
37783592|NCT02440854|69370526|FG000|Overall Study|Study medication not received|1|||
37783593|NCT02440854|69370526|FG000|Overall Study|Violation of inclusion criteria|2|||
37783594|NCT02412852|69370581|FG000|Overall Study|Withdrawal by Subject|0|||
37783595|NCT02412852|69370582|FG001|Overall Study|Withdrawal by Subject|1|||
37783596|NCT02412852|69370583|FG002|Overall Study|Withdrawal by Subject|0|||
37783597|NCT02412852|69370584|FG003|Overall Study|Withdrawal by Subject|0|||
37783598|NCT02412852|69370581|FG000|Overall Study|Physician Decision|0|||
37783599|NCT02412852|69370582|FG001|Overall Study|Physician Decision|0|||
37783600|NCT02412852|69370583|FG002|Overall Study|Physician Decision|0|||
37783601|NCT02412852|69370584|FG003|Overall Study|Physician Decision|1|||
37783602|NCT02386098|69370640|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
37783603|NCT02386098|69370641|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
37783604|NCT02386098|69370642|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
37783605|NCT02386098|69370643|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
37974925|NCT00402051|69662128|FG001|Overall Study|Withdrawal by Subject|3|||
37974926|NCT00402051|69662127|FG000|Overall Study|Death - Related to Study Drug|1|||
37783606|NCT02386098|69370644|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
37974927|NCT00402051|69662128|FG001|Overall Study|Death - Related to Study Drug|2|||
37693107|NCT02496767|69169278|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
37783607|NCT02386098|69370640|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
37783608|NCT02386098|69370641|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
37783609|NCT02386098|69370642|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
37783610|NCT02386098|69370643|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
37783611|NCT02386098|69370644|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
37783612|NCT02386098|69370640|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
37783613|NCT02386098|69370641|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
37783614|NCT02386098|69370642|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
37783615|NCT02386098|69370643|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
37783616|NCT02386098|69370644|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
37783617|NCT02386098|69370640|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
37783618|NCT02386098|69370641|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
37783619|NCT02386098|69370642|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
37783620|NCT02386098|69370643|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
37783621|NCT02386098|69370644|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
37783622|NCT02386098|69370640|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
37783623|NCT02386098|69370641|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
37783624|NCT02386098|69370642|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
37783625|NCT02386098|69370643|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
37783626|NCT02386098|69370644|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
37783627|NCT02386098|69370640|FG000|Stage 1 (96 Weeks)|Other|1|||
37783628|NCT02386098|69370641|FG001|Stage 1 (96 Weeks)|Other|0|||
37783629|NCT02386098|69370642|FG002|Stage 1 (96 Weeks)|Other|0|||
37783630|NCT02386098|69370643|FG003|Stage 1 (96 Weeks)|Other|0|||
37783631|NCT02386098|69370644|FG004|Stage 1 (96 Weeks)|Other|0|||
37783632|NCT02386098|69370640|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
37783633|NCT02386098|69370641|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
37783634|NCT02386098|69370642|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
37783635|NCT02386098|69370643|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
37783636|NCT02386098|69370644|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
37783637|NCT02412618|69370687|FG000|Overall Study|Withdrawal by Subject|1|||
37783638|NCT02412618|69370688|FG001|Overall Study|Withdrawal by Subject|1|||
37783639|NCT02412618|69370687|FG000|Overall Study|Expulsion|1|||
37783640|NCT02412618|69370688|FG001|Overall Study|Expulsion|1|||
37783641|NCT00585195|69370885|FG000|Overall Study|Adverse Event|0|||
37783642|NCT00585195|69370886|FG001|Overall Study|Adverse Event|0|||
37783643|NCT00585195|69370887|FG002|Overall Study|Adverse Event|0|||
37783644|NCT00585195|69370888|FG003|Overall Study|Adverse Event|0|||
37783645|NCT00585195|69370889|FG004|Overall Study|Adverse Event|2|||
37783646|NCT00585195|69370890|FG005|Overall Study|Adverse Event|1|||
37783647|NCT00585195|69370891|FG006|Overall Study|Adverse Event|0|||
37783648|NCT00585195|69370892|FG007|Overall Study|Adverse Event|1|||
37783649|NCT00585195|69370893|FG008|Overall Study|Adverse Event|0|||
37783650|NCT00585195|69370894|FG009|Overall Study|Adverse Event|0|||
37783651|NCT00585195|69370895|FG010|Overall Study|Adverse Event|3|||
37783652|NCT00585195|69370896|FG011|Overall Study|Adverse Event|0|||
37783653|NCT00585195|69370897|FG012|Overall Study|Adverse Event|8|||
37783654|NCT00585195|69370898|FG013|Overall Study|Adverse Event|6|||
37783655|NCT00585195|69370899|FG014|Overall Study|Adverse Event|4|||
37783656|NCT00585195|69370900|FG015|Overall Study|Adverse Event|1|||
37783657|NCT00585195|69370901|FG016|Overall Study|Adverse Event|14|||
37783658|NCT00585195|69370902|FG017|Overall Study|Adverse Event|9|||
37783659|NCT00585195|69370903|FG018|Overall Study|Adverse Event|2|||
37783660|NCT00585195|69370904|FG019|Overall Study|Adverse Event|3|||
37783661|NCT00585195|69370905|FG020|Overall Study|Adverse Event|1|||
37783662|NCT00585195|69370885|FG000|Overall Study|Progressive Disease|2|||
37783663|NCT00585195|69370886|FG001|Overall Study|Progressive Disease|2|||
37693108|NCT02496767|69169279|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
37693109|NCT02496767|69169280|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
37693110|NCT02496767|69169281|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
37693111|NCT02496767|69169282|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
37693112|NCT02496767|69169283|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
37693113|NCT02496767|69169276|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
37693114|NCT02496767|69169277|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
37693115|NCT02496767|69169278|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
37693116|NCT02496767|69169279|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
37693117|NCT02496767|69169280|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
37693118|NCT02496767|69169281|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
37693119|NCT02496767|69169282|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
37783664|NCT00585195|69370887|FG002|Overall Study|Progressive Disease|5|||
37783665|NCT00585195|69370888|FG003|Overall Study|Progressive Disease|4|||
37783666|NCT00585195|69370889|FG004|Overall Study|Progressive Disease|6|||
37783667|NCT00585195|69370890|FG005|Overall Study|Progressive Disease|4|||
37783668|NCT00585195|69370891|FG006|Overall Study|Progressive Disease|6|||
37783669|NCT00585195|69370892|FG007|Overall Study|Progressive Disease|3|||
37783670|NCT00585195|69370893|FG008|Overall Study|Progressive Disease|0|||
37783671|NCT00585195|69370894|FG009|Overall Study|Progressive Disease|5|||
37783672|NCT00585195|69370895|FG010|Overall Study|Progressive Disease|2|||
37783673|NCT00585195|69370896|FG011|Overall Study|Progressive Disease|25|||
37783674|NCT00585195|69370897|FG012|Overall Study|Progressive Disease|29|||
37783675|NCT00585195|69370898|FG013|Overall Study|Progressive Disease|26|||
37783676|NCT00585195|69370899|FG014|Overall Study|Progressive Disease|21|||
37783677|NCT00585195|69370900|FG015|Overall Study|Progressive Disease|12|||
37783678|NCT00585195|69370901|FG016|Overall Study|Progressive Disease|94|||
37783679|NCT00585195|69370902|FG017|Overall Study|Progressive Disease|42|||
37783680|NCT00585195|69370903|FG018|Overall Study|Progressive Disease|4|||
37783681|NCT00585195|69370904|FG019|Overall Study|Progressive Disease|9|||
37783682|NCT00585195|69370905|FG020|Overall Study|Progressive Disease|8|||
37783683|NCT00585195|69370885|FG000|Overall Study|Withdrawal by Subject|1|||
37783684|NCT00585195|69370886|FG001|Overall Study|Withdrawal by Subject|1|||
37783685|NCT00585195|69370887|FG002|Overall Study|Withdrawal by Subject|2|||
37783686|NCT00585195|69370888|FG003|Overall Study|Withdrawal by Subject|2|||
37783687|NCT00585195|69370889|FG004|Overall Study|Withdrawal by Subject|0|||
37783688|NCT00585195|69370890|FG005|Overall Study|Withdrawal by Subject|0|||
37783689|NCT00585195|69370891|FG006|Overall Study|Withdrawal by Subject|0|||
37783690|NCT00585195|69370892|FG007|Overall Study|Withdrawal by Subject|1|||
37783691|NCT00585195|69370893|FG008|Overall Study|Withdrawal by Subject|0|||
37783692|NCT00585195|69370894|FG009|Overall Study|Withdrawal by Subject|0|||
37783693|NCT00585195|69370895|FG010|Overall Study|Withdrawal by Subject|3|||
37783694|NCT00585195|69370896|FG011|Overall Study|Withdrawal by Subject|8|||
37783695|NCT00585195|69370897|FG012|Overall Study|Withdrawal by Subject|15|||
37783696|NCT00585195|69370898|FG013|Overall Study|Withdrawal by Subject|0|||
37783697|NCT00585195|69370899|FG014|Overall Study|Withdrawal by Subject|3|||
37783698|NCT00585195|69370900|FG015|Overall Study|Withdrawal by Subject|0|||
37783699|NCT00585195|69370901|FG016|Overall Study|Withdrawal by Subject|7|||
37783700|NCT00585195|69370902|FG017|Overall Study|Withdrawal by Subject|1|||
37783701|NCT00585195|69370903|FG018|Overall Study|Withdrawal by Subject|2|||
37783702|NCT00585195|69370904|FG019|Overall Study|Withdrawal by Subject|2|||
37783703|NCT00585195|69370905|FG020|Overall Study|Withdrawal by Subject|0|||
37974928|NCT00402051|69662127|FG000|Overall Study|Death Due to Study Disease|2|||
37974929|NCT00402051|69662128|FG001|Overall Study|Death Due to Study Disease|1|||
37974930|NCT00402051|69662127|FG000|Overall Study|Death Due to Adverse Event|0|||
37974931|NCT00402051|69662128|FG001|Overall Study|Death Due to Adverse Event|2|||
37974932|NCT00402051|69662127|FG000|Overall Study|Lost to Follow-up|1|||
37974933|NCT00402051|69662128|FG001|Overall Study|Lost to Follow-up|0|||
37974934|NCT00468858|69662137|FG000|Overall Study|Adverse Event|0|||
37783704|NCT00585195|69370885|FG000|Overall Study|Other|0|||
37974935|NCT00468858|69662138|FG001|Overall Study|Adverse Event|1|||
37783705|NCT00585195|69370886|FG001|Overall Study|Other|1|||
37783706|NCT00585195|69370887|FG002|Overall Study|Other|1|||
37783707|NCT00585195|69370888|FG003|Overall Study|Other|1|||
37783708|NCT00585195|69370889|FG004|Overall Study|Other|0|||
37974936|NCT00468858|69662139|FG002|Overall Study|Adverse Event|0|||
37783709|NCT00585195|69370890|FG005|Overall Study|Other|1|||
37974937|NCT00468858|69662137|FG000|Overall Study|Withdrawal by Subject|7|||
37783710|NCT00585195|69370891|FG006|Overall Study|Other|0|||
37783711|NCT00585195|69370892|FG007|Overall Study|Other|0|||
37783712|NCT00585195|69370893|FG008|Overall Study|Other|2|||
37783713|NCT00585195|69370894|FG009|Overall Study|Other|1|||
37783714|NCT00585195|69370895|FG010|Overall Study|Other|0|||
37783715|NCT00585195|69370896|FG011|Overall Study|Other|19|||
37783716|NCT00585195|69370897|FG012|Overall Study|Other|24|||
37783717|NCT00585195|69370898|FG013|Overall Study|Other|7|||
37783718|NCT00585195|69370899|FG014|Overall Study|Other|11|||
37783719|NCT00585195|69370900|FG015|Overall Study|Other|3|||
37783720|NCT00585195|69370901|FG016|Overall Study|Other|28|||
37783721|NCT00585195|69370902|FG017|Overall Study|Other|12|||
37783722|NCT00585195|69370903|FG018|Overall Study|Other|10|||
37783723|NCT00585195|69370904|FG019|Overall Study|Other|4|||
37783724|NCT00585195|69370905|FG020|Overall Study|Other|2|||
37783725|NCT00585195|69370885|FG000|Overall Study|Randomized not treated|0|||
37783726|NCT00585195|69370886|FG001|Overall Study|Randomized not treated|0|||
37783727|NCT00585195|69370887|FG002|Overall Study|Randomized not treated|1|||
37783728|NCT00585195|69370888|FG003|Overall Study|Randomized not treated|0|||
37783729|NCT00585195|69370889|FG004|Overall Study|Randomized not treated|1|||
37783730|NCT00585195|69370890|FG005|Overall Study|Randomized not treated|0|||
37783731|NCT00585195|69370891|FG006|Overall Study|Randomized not treated|1|||
37783732|NCT00585195|69370892|FG007|Overall Study|Randomized not treated|0|||
37783733|NCT00585195|69370893|FG008|Overall Study|Randomized not treated|0|||
37783734|NCT00585195|69370894|FG009|Overall Study|Randomized not treated|0|||
37974938|NCT00468858|69662138|FG001|Overall Study|Withdrawal by Subject|4|||
37974939|NCT00468858|69662139|FG002|Overall Study|Withdrawal by Subject|5|||
37693120|NCT02496767|69169283|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
37693121|NCT02496767|69169276|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
37693122|NCT02496767|69169277|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
37693123|NCT02496767|69169278|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
37693124|NCT02496767|69169279|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
37693125|NCT02496767|69169280|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
37693126|NCT02496767|69169281|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
37693127|NCT02496767|69169282|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
37693128|NCT02496767|69169283|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
37693129|NCT02496767|69169276|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
37693130|NCT02496767|69169277|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
37693131|NCT02496767|69169278|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
37693132|NCT02496767|69169279|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
37693133|NCT02496767|69169280|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
37693134|NCT02496767|69169281|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
37693135|NCT02496767|69169282|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
37693136|NCT02496767|69169283|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
37693137|NCT02496767|69169276|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
37693138|NCT02496767|69169277|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
37783735|NCT00585195|69370895|FG010|Overall Study|Randomized not treated|2|||
37783736|NCT00585195|69370896|FG011|Overall Study|Randomized not treated|0|||
37783737|NCT00585195|69370897|FG012|Overall Study|Randomized not treated|0|||
37783738|NCT00585195|69370898|FG013|Overall Study|Randomized not treated|0|||
37783739|NCT00585195|69370899|FG014|Overall Study|Randomized not treated|0|||
37974940|NCT00468858|69662137|FG000|Overall Study|Relocation|1|||
37974941|NCT00468858|69662138|FG001|Overall Study|Relocation|3|||
37974942|NCT00468858|69662139|FG002|Overall Study|Relocation|3|||
37974943|NCT00468858|69662137|FG000|Overall Study|Lost to Follow-up|1|||
37974944|NCT00468858|69662138|FG001|Overall Study|Lost to Follow-up|2|||
37783740|NCT00585195|69370900|FG015|Overall Study|Randomized not treated|1|||
37783741|NCT00585195|69370901|FG016|Overall Study|Randomized not treated|0|||
37974945|NCT00468858|69662139|FG002|Overall Study|Lost to Follow-up|5|||
37783742|NCT00585195|69370902|FG017|Overall Study|Randomized not treated|1|||
37783743|NCT00585195|69370903|FG018|Overall Study|Randomized not treated|3|||
37783744|NCT00585195|69370904|FG019|Overall Study|Randomized not treated|0|||
37783745|NCT00585195|69370905|FG020|Overall Study|Randomized not treated|2|||
37783746|NCT00585195|69370885|FG000|Overall Study|Death|0|||
37783747|NCT00585195|69370886|FG001|Overall Study|Death|0|||
37783748|NCT00585195|69370887|FG002|Overall Study|Death|0|||
37783749|NCT00585195|69370888|FG003|Overall Study|Death|0|||
37783750|NCT00585195|69370889|FG004|Overall Study|Death|0|||
37783751|NCT00585195|69370890|FG005|Overall Study|Death|0|||
37783752|NCT00585195|69370891|FG006|Overall Study|Death|0|||
37783753|NCT00585195|69370892|FG007|Overall Study|Death|0|||
37783754|NCT00585195|69370893|FG008|Overall Study|Death|1|||
37783755|NCT00585195|69370894|FG009|Overall Study|Death|0|||
37783756|NCT00585195|69370895|FG010|Overall Study|Death|1|||
37783757|NCT00585195|69370896|FG011|Overall Study|Death|1|||
37783758|NCT00585195|69370897|FG012|Overall Study|Death|7|||
37783759|NCT00585195|69370898|FG013|Overall Study|Death|2|||
37783760|NCT00585195|69370899|FG014|Overall Study|Death|8|||
37783761|NCT00585195|69370900|FG015|Overall Study|Death|2|||
37783762|NCT00585195|69370901|FG016|Overall Study|Death|11|||
37783763|NCT00585195|69370902|FG017|Overall Study|Death|0|||
37783764|NCT00585195|69370903|FG018|Overall Study|Death|0|||
37783765|NCT00585195|69370904|FG019|Overall Study|Death|0|||
37783766|NCT00585195|69370905|FG020|Overall Study|Death|1|||
37783767|NCT00585195|69370885|FG000|Overall Study|Lost to Follow-up|0|||
37783768|NCT00585195|69370886|FG001|Overall Study|Lost to Follow-up|0|||
37783769|NCT00585195|69370887|FG002|Overall Study|Lost to Follow-up|0|||
37783770|NCT00585195|69370888|FG003|Overall Study|Lost to Follow-up|0|||
37783771|NCT00585195|69370889|FG004|Overall Study|Lost to Follow-up|0|||
37783772|NCT00585195|69370890|FG005|Overall Study|Lost to Follow-up|0|||
37783773|NCT00585195|69370891|FG006|Overall Study|Lost to Follow-up|0|||
37783774|NCT00585195|69370892|FG007|Overall Study|Lost to Follow-up|0|||
37783775|NCT00585195|69370893|FG008|Overall Study|Lost to Follow-up|0|||
37783776|NCT00585195|69370894|FG009|Overall Study|Lost to Follow-up|0|||
37783777|NCT00585195|69370895|FG010|Overall Study|Lost to Follow-up|0|||
37783778|NCT00585195|69370896|FG011|Overall Study|Lost to Follow-up|0|||
37783779|NCT00585195|69370897|FG012|Overall Study|Lost to Follow-up|1|||
37783780|NCT00585195|69370898|FG013|Overall Study|Lost to Follow-up|0|||
37783781|NCT00585195|69370899|FG014|Overall Study|Lost to Follow-up|0|||
37783782|NCT00585195|69370900|FG015|Overall Study|Lost to Follow-up|0|||
37783783|NCT00585195|69370901|FG016|Overall Study|Lost to Follow-up|0|||
37783784|NCT00585195|69370902|FG017|Overall Study|Lost to Follow-up|2|||
37783785|NCT00585195|69370903|FG018|Overall Study|Lost to Follow-up|0|||
37783786|NCT00585195|69370904|FG019|Overall Study|Lost to Follow-up|0|||
37783787|NCT00585195|69370905|FG020|Overall Study|Lost to Follow-up|0|||
37783788|NCT00585195|69370885|FG000|Overall Study|Site Terminated by Sponsor|0|||
37783789|NCT00585195|69370886|FG001|Overall Study|Site Terminated by Sponsor|0|||
37783790|NCT00585195|69370887|FG002|Overall Study|Site Terminated by Sponsor|0|||
37783791|NCT00585195|69370888|FG003|Overall Study|Site Terminated by Sponsor|0|||
37783792|NCT00585195|69370889|FG004|Overall Study|Site Terminated by Sponsor|0|||
37783793|NCT00585195|69370890|FG005|Overall Study|Site Terminated by Sponsor|0|||
37783794|NCT00585195|69370891|FG006|Overall Study|Site Terminated by Sponsor|0|||
37783795|NCT00585195|69370892|FG007|Overall Study|Site Terminated by Sponsor|0|||
37783796|NCT00585195|69370893|FG008|Overall Study|Site Terminated by Sponsor|0|||
37783797|NCT00585195|69370894|FG009|Overall Study|Site Terminated by Sponsor|0|||
37783798|NCT00585195|69370895|FG010|Overall Study|Site Terminated by Sponsor|0|||
37974946|NCT00468858|69662137|FG000|Overall Study|Other|0|||
37783799|NCT00585195|69370896|FG011|Overall Study|Site Terminated by Sponsor|0|||
37783800|NCT00585195|69370897|FG012|Overall Study|Site Terminated by Sponsor|1|||
37783801|NCT00585195|69370898|FG013|Overall Study|Site Terminated by Sponsor|0|||
37974947|NCT00468858|69662138|FG001|Overall Study|Other|0|||
37783802|NCT00585195|69370899|FG014|Overall Study|Site Terminated by Sponsor|0|||
37783803|NCT00585195|69370900|FG015|Overall Study|Site Terminated by Sponsor|0|||
37783804|NCT00585195|69370901|FG016|Overall Study|Site Terminated by Sponsor|0|||
37783805|NCT00585195|69370902|FG017|Overall Study|Site Terminated by Sponsor|0|||
37783806|NCT00585195|69370903|FG018|Overall Study|Site Terminated by Sponsor|0|||
37783807|NCT00585195|69370904|FG019|Overall Study|Site Terminated by Sponsor|0|||
37783808|NCT00585195|69370905|FG020|Overall Study|Site Terminated by Sponsor|0|||
37783809|NCT00585195|69370885|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
37783810|NCT00585195|69370886|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
37783811|NCT00585195|69370887|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
37783812|NCT00585195|69370888|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
37783813|NCT00585195|69370889|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
37783814|NCT00585195|69370890|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
37783815|NCT00585195|69370891|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
37783816|NCT00585195|69370892|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
37783817|NCT00585195|69370893|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
37783818|NCT00585195|69370894|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
37783819|NCT00585195|69370895|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
37783820|NCT00585195|69370896|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
37783821|NCT00585195|69370897|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
37783822|NCT00585195|69370898|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
37783823|NCT00585195|69370899|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
37783824|NCT00585195|69370900|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
37783825|NCT00585195|69370901|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
37783826|NCT00585195|69370902|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
37783827|NCT00585195|69370903|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
37783828|NCT00585195|69370904|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
37783829|NCT00585195|69370905|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
37783830|NCT02439216|69371077|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
37783831|NCT02439216|69371078|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
37783832|NCT02439216|69371079|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
37783833|NCT02439216|69371080|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
37783834|NCT02439216|69371081|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
37783835|NCT02439216|69371082|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
37783836|NCT02439216|69371083|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
37783837|NCT02439216|69371084|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
37783838|NCT02439216|69371085|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
37783839|NCT02439216|69371077|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
37783840|NCT02439216|69371078|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
37783841|NCT02439216|69371079|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
37783842|NCT02439216|69371080|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
37783843|NCT02439216|69371081|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
37783844|NCT02439216|69371082|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
37783845|NCT02439216|69371083|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
37783846|NCT02439216|69371084|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
37783847|NCT02439216|69371085|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
37783848|NCT02439216|69371077|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
37783849|NCT02439216|69371078|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
37783850|NCT02439216|69371079|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
37783851|NCT02439216|69371080|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
37783852|NCT02439216|69371081|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
37783853|NCT02439216|69371082|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
37783854|NCT02439216|69371083|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
37783855|NCT02439216|69371084|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
37783856|NCT02439216|69371085|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
37783857|NCT02439216|69371077|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
37783858|NCT02439216|69371078|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
37783859|NCT02439216|69371079|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
37783860|NCT02439216|69371080|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
37783861|NCT02439216|69371081|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
37783862|NCT02439216|69371082|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
37783863|NCT02439216|69371083|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
37783864|NCT02439216|69371084|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
37783865|NCT02439216|69371085|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
37974948|NCT00468858|69662139|FG002|Overall Study|Other|1|||
37974949|NCT00401973|69662204|FG000|Overall Study|Adverse Event|2|||
37693139|NCT02496767|69169278|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
37693140|NCT02496767|69169279|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
37693141|NCT02496767|69169280|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
37974950|NCT00401973|69662205|FG001|Overall Study|Adverse Event|8|||
37974951|NCT00401973|69662206|FG002|Overall Study|Adverse Event|4|||
37974952|NCT00401973|69662204|FG000|Overall Study|Clinical Relapse|0|||
37693142|NCT02496767|69169281|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
37693143|NCT02496767|69169282|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
37693144|NCT02496767|69169283|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
37693145|NCT02496767|69169276|FG000|Double-blind, Withdrawal Phase|Death|0|||
37693146|NCT02496767|69169277|FG001|Double-blind, Withdrawal Phase|Death|0|||
37693147|NCT02496767|69169278|FG002|Double-blind, Withdrawal Phase|Death|0|||
37693148|NCT02496767|69169279|FG003|Double-blind, Withdrawal Phase|Death|0|||
37693149|NCT02496767|69169280|FG004|Double-blind, Withdrawal Phase|Death|0|||
37693150|NCT02496767|69169281|FG005|Double-blind, Withdrawal Phase|Death|0|||
37693151|NCT02496767|69169282|FG006|Double-blind, Withdrawal Phase|Death|1|||
37693152|NCT02496767|69169283|FG007|Double-blind, Withdrawal Phase|Death|2|||
37693153|NCT02496767|69169276|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
37693154|NCT02496767|69169277|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
37693155|NCT02496767|69169278|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
37693156|NCT02496767|69169279|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
37693157|NCT02496767|69169280|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
37693158|NCT02496767|69169281|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
37693159|NCT02496767|69169282|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
37693160|NCT02496767|69169283|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
37693161|NCT02496533|69169299|FG000|Overall Study|Lack of data on outcome|3|||
37693162|NCT02496533|69169300|FG001|Overall Study|Lack of data on outcome|0|||
37693163|NCT02496533|69169299|FG000|Overall Study|Patient did not complete all measures|0|||
37693164|NCT02496533|69169300|FG001|Overall Study|Patient did not complete all measures|4|||
37693165|NCT02496533|69169299|FG000|Overall Study|Late for radiologic testing|0|||
37693166|NCT02496533|69169300|FG001|Overall Study|Late for radiologic testing|2|||
37693167|NCT02496221|69169306|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
37693168|NCT02496221|69169307|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
37693169|NCT02496221|69169306|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
37693170|NCT02496221|69169307|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
37693171|NCT02496221|69169306|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
37693172|NCT02496221|69169307|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
37693173|NCT02475629|69169315|FG000|Overall Study|Adverse Event|1|||
37693174|NCT02475629|69169315|FG000|Overall Study|Death|4|||
37693175|NCT02475629|69169315|FG000|Overall Study|Physician Decision|1|||
37693176|NCT02475629|69169315|FG000|Overall Study|Withdrawal by Subject|1|||
37693177|NCT02475629|69169315|FG000|Overall Study|Lost to Follow-up|1|||
37693178|NCT02475629|69169315|FG000|Overall Study|Subject non-compliance|1|||
37693179|NCT02475395|69169321|FG000|Overall Study|Protocol Violation|30|||
37693180|NCT02475395|69169322|FG001|Overall Study|Protocol Violation|3|||
37974953|NCT00401973|69662205|FG001|Overall Study|Clinical Relapse|1|||
37783866|NCT02439216|69371077|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
37783867|NCT02439216|69371078|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
37783868|NCT02439216|69371079|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
37783869|NCT02439216|69371080|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
37783870|NCT02439216|69371081|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
37783871|NCT02439216|69371082|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
37783872|NCT02439216|69371083|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
37783873|NCT02439216|69371084|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
37783874|NCT02439216|69371085|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
37783875|NCT02439138|69371109|FG000|Overall Study|Adverse Event|1|||
37783876|NCT02439138|69371109|FG000|Overall Study|PI decision to terminate the study|2|||
37783877|NCT02438826|69371485|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
37783878|NCT02438826|69371486|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
37783879|NCT02438826|69371487|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
37783880|NCT02438826|69371488|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
37783881|NCT02438826|69371485|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
37783882|NCT02438826|69371486|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
37783883|NCT02438826|69371487|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
37783884|NCT02438826|69371488|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
37783885|NCT02438826|69371485|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
37783886|NCT02438826|69371486|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
37783887|NCT02438826|69371487|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
37783888|NCT02438826|69371488|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
37783889|NCT02438826|69371485|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
37783890|NCT02438826|69371486|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
37783891|NCT02438826|69371487|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
37783892|NCT02438826|69371488|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
37783893|NCT02438826|69371485|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
37783894|NCT02438826|69371486|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
37783895|NCT02438826|69371487|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
37783896|NCT02438826|69371488|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
37783897|NCT02438826|69371485|FG000|Open-Label Treatment Phase|Adverse Event|11|||
37783898|NCT02438826|69371486|FG001|Open-Label Treatment Phase|Adverse Event|6|||
37783899|NCT02438826|69371487|FG002|Open-Label Treatment Phase|Adverse Event|0|||
37974954|NCT00401973|69662206|FG002|Overall Study|Clinical Relapse|1|||
37974955|NCT00401973|69662204|FG000|Overall Study|Lack of Efficacy|0|||
37974956|NCT00401973|69662205|FG001|Overall Study|Lack of Efficacy|0|||
37974957|NCT00401973|69662206|FG002|Overall Study|Lack of Efficacy|3|||
37974958|NCT00401973|69662204|FG000|Overall Study|Lost to Follow-up|2|||
37974959|NCT00401973|69662205|FG001|Overall Study|Lost to Follow-up|2|||
37974960|NCT00401973|69662206|FG002|Overall Study|Lost to Follow-up|2|||
37974961|NCT00401973|69662204|FG000|Overall Study|Physician Decision|2|||
37974962|NCT00401973|69662205|FG001|Overall Study|Physician Decision|0|||
37974963|NCT00401973|69662206|FG002|Overall Study|Physician Decision|1|||
37974964|NCT00401973|69662204|FG000|Overall Study|Protocol Violation|1|||
37783900|NCT02438826|69371488|FG003|Open-Label Treatment Phase|Adverse Event|0|||
37783901|NCT02438826|69371485|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
37783902|NCT02438826|69371486|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
37783903|NCT02438826|69371487|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
37783904|NCT02438826|69371488|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
37783905|NCT02438826|69371485|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
37783906|NCT02438826|69371486|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
37783907|NCT02438826|69371487|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
37783908|NCT02438826|69371488|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
37783909|NCT02438826|69371485|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
37783910|NCT02438826|69371486|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
37783911|NCT02438826|69371487|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
37783912|NCT02438826|69371488|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
37783913|NCT02438826|69371485|FG000|Post-Treatment Phase|Adverse Event|3|||
37783914|NCT02438826|69371486|FG001|Post-Treatment Phase|Adverse Event|0|||
37783915|NCT02438826|69371487|FG002|Post-Treatment Phase|Adverse Event|0|||
37783916|NCT02438826|69371488|FG003|Post-Treatment Phase|Adverse Event|0|||
37783917|NCT02438826|69371485|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
37783918|NCT02438826|69371486|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
37783919|NCT02438826|69371487|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
37783920|NCT02438826|69371488|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
37783921|NCT02438826|69371485|FG000|Post-Treatment Phase|Physician Decision|1|||
37783922|NCT02438826|69371486|FG001|Post-Treatment Phase|Physician Decision|0|||
37783923|NCT02438826|69371487|FG002|Post-Treatment Phase|Physician Decision|0|||
37783924|NCT02438826|69371488|FG003|Post-Treatment Phase|Physician Decision|0|||
37783925|NCT02438826|69371485|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
37783926|NCT02438826|69371486|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
37783927|NCT02438826|69371487|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
37783928|NCT02438826|69371488|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
37783929|NCT02438280|69371505|FG000|Overall Study|Physician Decision|1|||
37783930|NCT02438280|69371506|FG001|Overall Study|Physician Decision|0|||
37783931|NCT02385708|69371524|FG000|Overall Study|Withdrawal by Subject|0|||
37783932|NCT02385708|69371525|FG001|Overall Study|Withdrawal by Subject|2|||
37783933|NCT02385708|69371524|FG000|Overall Study|Withdrawn - surgery canceled|2|||
37783934|NCT02385708|69371525|FG001|Overall Study|Withdrawn - surgery canceled|5|||
37783935|NCT02385708|69371524|FG000|Overall Study|Investigator decision|5|||
37783936|NCT02385708|69371525|FG001|Overall Study|Investigator decision|7|||
37783937|NCT02385708|69371524|FG000|Overall Study|Protocol Violation|1|||
37783938|NCT02385708|69371525|FG001|Overall Study|Protocol Violation|1|||
37783939|NCT02385084|69372264|FG000|Period 2|Protocol Violation|0|||
37783940|NCT02385084|69372265|FG001|Period 2|Protocol Violation|0|||
37783941|NCT02385084|69372266|FG002|Period 2|Protocol Violation|1|||
37783942|NCT02385084|69372267|FG003|Period 2|Protocol Violation|0|||
37783943|NCT02385084|69372268|FG004|Period 2|Protocol Violation|0|||
37783944|NCT02385084|69372269|FG005|Period 2|Protocol Violation|0|||
37783945|NCT02411292|69372278|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
37783946|NCT02411292|69372278|FG000|Overall Study|Death|2|||
37783947|NCT02411292|69372278|FG000|Overall Study|Lost to Follow-up|3|||
37783948|NCT02384850|69372341|FG000|Overall Study|Withdrawal by Subject|2|||
37783949|NCT02384850|69372342|FG001|Overall Study|Withdrawal by Subject|2|||
37783950|NCT02437890|69372564|FG000|Overall Study|Non-compliance to study drug|0|||
37783951|NCT02437890|69372565|FG001|Overall Study|Non-compliance to study drug|1|||
37783952|NCT02437890|69372566|FG002|Overall Study|Non-compliance to study drug|0|||
37783953|NCT02437890|69372567|FG003|Overall Study|Non-compliance to study drug|0|||
37783954|NCT02437890|69372568|FG004|Overall Study|Non-compliance to study drug|1|||
37783955|NCT02437890|69372564|FG000|Overall Study|Sponsor's decision|1|||
37783956|NCT02437890|69372565|FG001|Overall Study|Sponsor's decision|1|||
37783957|NCT02437890|69372566|FG002|Overall Study|Sponsor's decision|4|||
37783958|NCT02437890|69372567|FG003|Overall Study|Sponsor's decision|0|||
37783959|NCT02437890|69372568|FG004|Overall Study|Sponsor's decision|2|||
37783960|NCT02437890|69372564|FG000|Overall Study|Physician Decision|0|||
37783961|NCT02437890|69372565|FG001|Overall Study|Physician Decision|0|||
37783962|NCT02437890|69372566|FG002|Overall Study|Physician Decision|0|||
37783963|NCT02437890|69372567|FG003|Overall Study|Physician Decision|1|||
37783964|NCT02437890|69372568|FG004|Overall Study|Physician Decision|0|||
37783965|NCT02437890|69372564|FG000|Overall Study|Unable to attend visit(s)|1|||
37974965|NCT00401973|69662205|FG001|Overall Study|Protocol Violation|2|||
37974966|NCT00401973|69662206|FG002|Overall Study|Protocol Violation|3|||
37783966|NCT02437890|69372565|FG001|Overall Study|Unable to attend visit(s)|0|||
37783967|NCT02437890|69372566|FG002|Overall Study|Unable to attend visit(s)|0|||
37783968|NCT02437890|69372567|FG003|Overall Study|Unable to attend visit(s)|0|||
37783969|NCT02437890|69372568|FG004|Overall Study|Unable to attend visit(s)|0|||
37783970|NCT02437890|69372564|FG000|Overall Study|Lack of Efficacy|1|||
37783971|NCT02437890|69372565|FG001|Overall Study|Lack of Efficacy|3|||
37783972|NCT02437890|69372566|FG002|Overall Study|Lack of Efficacy|0|||
37783973|NCT02437890|69372567|FG003|Overall Study|Lack of Efficacy|3|||
37783974|NCT02437890|69372568|FG004|Overall Study|Lack of Efficacy|1|||
37783975|NCT02437890|69372564|FG000|Overall Study|Adverse Event|4|||
37783976|NCT02437890|69372565|FG001|Overall Study|Adverse Event|9|||
37783977|NCT02437890|69372566|FG002|Overall Study|Adverse Event|5|||
37783978|NCT02437890|69372567|FG003|Overall Study|Adverse Event|11|||
37783979|NCT02437890|69372568|FG004|Overall Study|Adverse Event|7|||
37783980|NCT02437890|69372564|FG000|Overall Study|Withdrawal by Subject|1|||
37783981|NCT02437890|69372565|FG001|Overall Study|Withdrawal by Subject|2|||
37783982|NCT02437890|69372566|FG002|Overall Study|Withdrawal by Subject|6|||
37783983|NCT02437890|69372567|FG003|Overall Study|Withdrawal by Subject|5|||
37783984|NCT02437890|69372568|FG004|Overall Study|Withdrawal by Subject|5|||
37783985|NCT02437890|69372564|FG000|Overall Study|Death|0|||
37783986|NCT02437890|69372565|FG001|Overall Study|Death|0|||
37783987|NCT02437890|69372566|FG002|Overall Study|Death|0|||
37783988|NCT02437890|69372567|FG003|Overall Study|Death|2|||
37783989|NCT02437890|69372568|FG004|Overall Study|Death|0|||
37783990|NCT02384538|69372629|FG000|Overall Study|Adverse Event|1|||
37783991|NCT02384538|69372630|FG001|Overall Study|Adverse Event|4|||
37783992|NCT02384538|69372629|FG000|Overall Study|Lack of Efficacy|4|||
37783993|NCT02384538|69372630|FG001|Overall Study|Lack of Efficacy|4|||
37783994|NCT02384538|69372629|FG000|Overall Study|Withdrew Consent|0|||
37783995|NCT02384538|69372630|FG001|Overall Study|Withdrew Consent|4|||
37783996|NCT02384538|69372629|FG000|Overall Study|Other|1|||
37783997|NCT02384538|69372630|FG001|Overall Study|Other|3|||
37783998|NCT02410824|69372654|FG000|First Intervention (One Week)|Headache|0|||
37783999|NCT02410824|69372655|FG001|First Intervention (One Week)|Headache|1|||
37784000|NCT02384460|69372685|FG000|Overall Study|Protocol Violation|0|||
37784001|NCT02384460|69372686|FG001|Overall Study|Protocol Violation|1|||
37784002|NCT02384460|69372685|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
37784003|NCT02384460|69372686|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
37784004|NCT02384460|69372685|FG000|Overall Study|Adverse Event|5|||
37784005|NCT02384460|69372686|FG001|Overall Study|Adverse Event|2|||
37784006|NCT02384460|69372685|FG000|Overall Study|Withdrawal by Subject|0|||
37974967|NCT00401973|69662204|FG000|Overall Study|Sponsor Decision|0|||
37974968|NCT00401973|69662205|FG001|Overall Study|Sponsor Decision|1|||
37784007|NCT02384460|69372686|FG001|Overall Study|Withdrawal by Subject|3|||
37784008|NCT02384460|69372685|FG000|Overall Study|Elective medical treatment|1|||
37784009|NCT02384460|69372686|FG001|Overall Study|Elective medical treatment|0|||
37864040|NCT01119105|69547702|FG001|Overall Study|Withdrawal by Subject|1|||
37784010|NCT02384460|69372685|FG000|Overall Study|Non-compliance|1|||
37784011|NCT02384460|69372686|FG001|Overall Study|Non-compliance|0|||
37784012|NCT02384382|69372709|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
37864041|NCT01119105|69547703|FG002|Overall Study|Withdrawal by Subject|1|||
37864042|NCT01119105|69547701|FG000|Overall Study|Lost to Follow-up|0|||
37784013|NCT02384382|69372709|FG000|Overall Study|Death|1|||
37784014|NCT02384382|69372709|FG000|Overall Study|Adverse Event|1|||
37784015|NCT02384382|69372709|FG000|Overall Study|Disease progression|16|||
37784016|NCT02437188|69372729|FG000|Overall Study|Randomized but did not receive surgery|4|||
37784017|NCT02437188|69372730|FG001|Overall Study|Randomized but did not receive surgery|8|||
37784018|NCT02437188|69372729|FG000|Overall Study|Adverse Event|0|||
37784019|NCT02437188|69372730|FG001|Overall Study|Adverse Event|1|||
37784020|NCT02383758|69372752|FG000|Overall Study|Withdrawal by Subject|0|||
37784021|NCT02383758|69372753|FG001|Overall Study|Withdrawal by Subject|2|||
37784022|NCT02410278|69372803|FG000|Run-in Period|Adverse Event|5|||
37784023|NCT02410278|69372804|FG001|Run-in Period|Adverse Event|0|||
37784024|NCT02410278|69372805|FG002|Run-in Period|Adverse Event|0|||
37784025|NCT02410278|69372803|FG000|Run-in Period|GSRS Threshold Not Met|30|||
37784026|NCT02410278|69372804|FG001|Run-in Period|GSRS Threshold Not Met|0|||
37784027|NCT02410278|69372805|FG002|Run-in Period|GSRS Threshold Not Met|0|||
37784028|NCT02410278|69372803|FG000|Run-in Period|Lost to Follow-up|1|||
37784029|NCT02410278|69372804|FG001|Run-in Period|Lost to Follow-up|0|||
37784030|NCT02410278|69372805|FG002|Run-in Period|Lost to Follow-up|0|||
37784031|NCT02410278|69372803|FG000|Run-in Period|Withdrawal by Subject|1|||
37784032|NCT02410278|69372804|FG001|Run-in Period|Withdrawal by Subject|0|||
37784033|NCT02410278|69372805|FG002|Run-in Period|Withdrawal by Subject|0|||
37784034|NCT02410278|69372803|FG000|Run-in Period|Pregnancy|1|||
37784035|NCT02410278|69372804|FG001|Run-in Period|Pregnancy|0|||
37784036|NCT02410278|69372805|FG002|Run-in Period|Pregnancy|0|||
37784037|NCT02410278|69372803|FG000|Study Treatment Period|Adverse Event|0|||
37784038|NCT02410278|69372804|FG001|Study Treatment Period|Adverse Event|6|||
37784039|NCT02410278|69372805|FG002|Study Treatment Period|Adverse Event|3|||
37784040|NCT02410278|69372803|FG000|Study Treatment Period|Physician Decision|0|||
37784041|NCT02410278|69372804|FG001|Study Treatment Period|Physician Decision|0|||
37784042|NCT02410278|69372805|FG002|Study Treatment Period|Physician Decision|1|||
37784043|NCT02410278|69372803|FG000|Study Treatment Period|Withdrawal by Subject|0|||
37784044|NCT02410278|69372804|FG001|Study Treatment Period|Withdrawal by Subject|1|||
37784045|NCT02410278|69372805|FG002|Study Treatment Period|Withdrawal by Subject|0|||
37784046|NCT02410278|69372803|FG000|Study Treatment Period|Other|0|||
37784047|NCT02410278|69372804|FG001|Study Treatment Period|Other|3|||
37784048|NCT02410278|69372805|FG002|Study Treatment Period|Other|0|||
37784049|NCT02410278|69372803|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
37784050|NCT02410278|69372804|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
37784051|NCT02410278|69372805|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
37784052|NCT02410200|69372838|FG000|Overall Study|Adverse Event|2|||
37784053|NCT02383056|69372857|FG000|Overall Study|Adverse Event|1|||
37784054|NCT02383056|69372858|FG001|Overall Study|Adverse Event|0|||
37784055|NCT02383056|69372857|FG000|Overall Study|Lost to Follow-up|0|||
37784056|NCT02383056|69372858|FG001|Overall Study|Lost to Follow-up|2|||
37784057|NCT02409732|69372864|FG000|Overall Study|Withdrawal by Subject|4|||
37784058|NCT02409732|69372864|FG000|Overall Study|Lost to Follow-up|2|||
37784059|NCT01650636|69372875|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
37693181|NCT01653743|69169330|FG000|Overall Study|Withdrawal by Subject|1|||
37693182|NCT01653743|69169331|FG001|Overall Study|Withdrawal by Subject|0|||
37693183|NCT01653743|69169330|FG000|Overall Study|Investigator discretion|3|||
37693184|NCT01653743|69169331|FG001|Overall Study|Investigator discretion|0|||
37693185|NCT02293993|69169341|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
37693186|NCT02293993|69169342|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
37693187|NCT02293993|69169343|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
37693188|NCT02293993|69169344|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
37693189|NCT02293993|69169341|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
37784060|NCT01650636|69372876|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
37784061|NCT01650636|69372875|FG000|Washout up to 5 Months|Physician Decision|2|||
37784062|NCT01650636|69372876|FG001|Washout up to 5 Months|Physician Decision|2|||
37784063|NCT01650636|69372875|FG000|Washout up to 5 Months|Death|1|||
37784064|NCT01650636|69372876|FG001|Washout up to 5 Months|Death|0|||
37784065|NCT01650636|69372875|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
37784066|NCT01650636|69372876|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
37784067|NCT01650636|69372875|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
37784068|NCT01650636|69372876|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
37784069|NCT01650636|69372875|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
37784070|NCT01650636|69372876|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
37784071|NCT02436876|69372886|FG000|Overall Study|Lost to Follow-up|0|||
37784072|NCT02436876|69372887|FG001|Overall Study|Lost to Follow-up|1|||
37784073|NCT02436876|69372888|FG002|Overall Study|Lost to Follow-up|1|||
37784074|NCT02436876|69372889|FG003|Overall Study|Lost to Follow-up|1|||
37784075|NCT02436876|69372886|FG000|Overall Study|Withdrawal by Subject|1|||
37784076|NCT02436876|69372887|FG001|Overall Study|Withdrawal by Subject|0|||
37784077|NCT02436876|69372888|FG002|Overall Study|Withdrawal by Subject|0|||
37784078|NCT02436876|69372889|FG003|Overall Study|Withdrawal by Subject|1|||
37784079|NCT02436876|69372886|FG000|Overall Study|Physician Decision|0|||
37784080|NCT02436876|69372887|FG001|Overall Study|Physician Decision|2|||
37784081|NCT02436876|69372888|FG002|Overall Study|Physician Decision|1|||
37784082|NCT02436876|69372889|FG003|Overall Study|Physician Decision|0|||
37784083|NCT02436876|69372886|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
37784084|NCT02436876|69372887|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
37784085|NCT02436876|69372888|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
37784086|NCT02436876|69372889|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
37784087|NCT02382276|69372918|FG000|Overall Study|Withdrawal by Subject|4|||
37784088|NCT02382276|69372919|FG001|Overall Study|Withdrawal by Subject|8|||
37784089|NCT02382276|69372920|FG002|Overall Study|Withdrawal by Subject|5|||
37784090|NCT02382276|69372918|FG000|Overall Study|Adverse Event|7|||
37784091|NCT02382276|69372919|FG001|Overall Study|Adverse Event|2|||
37784092|NCT02382276|69372920|FG002|Overall Study|Adverse Event|32|||
37784093|NCT02382276|69372918|FG000|Overall Study|Physician Decision|0|||
37784094|NCT02382276|69372919|FG001|Overall Study|Physician Decision|0|||
37784095|NCT02382276|69372920|FG002|Overall Study|Physician Decision|2|||
37784096|NCT02436408|69372961|FG000|Overall Study|Death|1|||
37784097|NCT02436330|69372984|FG000|Cohort 1|Lost to Follow-up|5|||
37784098|NCT02436330|69372985|FG001|Cohort 1|Lost to Follow-up|2|||
37784099|NCT02436330|69372984|FG000|Cohort 1|Withdrawal by Subject|0|||
37784100|NCT02436330|69372985|FG001|Cohort 1|Withdrawal by Subject|1|||
37784101|NCT02436330|69372984|FG000|Cohort 2|Lost to Follow-up|2|||
37784102|NCT02436330|69372985|FG001|Cohort 2|Lost to Follow-up|0|||
37784103|NCT02436330|69372984|FG000|Cohort 2|Withdrawal by Subject|2|||
37784104|NCT02436330|69372985|FG001|Cohort 2|Withdrawal by Subject|3|||
37784105|NCT02436330|69372984|FG000|Cohort 3|Lost to Follow-up|1|||
37784106|NCT02436330|69372985|FG001|Cohort 3|Lost to Follow-up|0|||
37784107|NCT02436330|69372984|FG000|Cohort 3|Withdrawal by Subject|4|||
37784108|NCT02436330|69372985|FG001|Cohort 3|Withdrawal by Subject|0|||
37784109|NCT02436330|69372984|FG000|Cohort 4|Lost to Follow-up|1|||
37784110|NCT02436330|69372985|FG001|Cohort 4|Lost to Follow-up|0|||
37784111|NCT02436330|69372984|FG000|Cohort 4|Withdrawal by Subject|1|||
37784112|NCT02436330|69372985|FG001|Cohort 4|Withdrawal by Subject|0|||
37784113|NCT02436330|69372984|FG000|Cohort 5|Lost to Follow-up|3|||
37784114|NCT02436330|69372985|FG001|Cohort 5|Lost to Follow-up|2|||
37784115|NCT02436330|69372984|FG000|Cohort 5|Withdrawal by Subject|3|||
37784116|NCT02436330|69372985|FG001|Cohort 5|Withdrawal by Subject|2|||
37784117|NCT02436330|69372984|FG000|Cohort 6|Lost to Follow-up|2|||
37784118|NCT02436330|69372985|FG001|Cohort 6|Lost to Follow-up|0|||
37784119|NCT02436330|69372984|FG000|Cohort 6|Withdrawal by Subject|1|||
37784120|NCT02436330|69372985|FG001|Cohort 6|Withdrawal by Subject|1|||
37784121|NCT01650558|69373022|FG000|Overall Study|Migration out of study area|61|||
37784122|NCT01650558|69373023|FG001|Overall Study|Migration out of study area|71|||
37784123|NCT01650558|69373024|FG002|Overall Study|Migration out of study area|56|||
37784124|NCT01650558|69373022|FG000|Overall Study|Lost to Follow-up|10|||
37784125|NCT01650558|69373023|FG001|Overall Study|Lost to Follow-up|13|||
37784126|NCT01650558|69373024|FG002|Overall Study|Lost to Follow-up|6|||
37784127|NCT01650558|69373022|FG000|Overall Study|Death|10|||
37784128|NCT01650558|69373023|FG001|Overall Study|Death|6|||
37784129|NCT01650558|69373024|FG002|Overall Study|Death|8|||
37784130|NCT01650558|69373022|FG000|Overall Study|Withdrawal by Subject|1|||
37784131|NCT01650558|69373023|FG001|Overall Study|Withdrawal by Subject|1|||
37784132|NCT01650558|69373024|FG002|Overall Study|Withdrawal by Subject|3|||
37784133|NCT01650558|69373022|FG000|Overall Study|Non-compliant participant|1|||
37784134|NCT01650558|69373023|FG001|Overall Study|Non-compliant participant|0|||
37784135|NCT01650558|69373024|FG002|Overall Study|Non-compliant participant|2|||
37784136|NCT01650558|69373022|FG000|Overall Study|Physician Decision|0|||
37784137|NCT01650558|69373023|FG001|Overall Study|Physician Decision|1|||
37784138|NCT01650558|69373024|FG002|Overall Study|Physician Decision|0|||
37784139|NCT02408484|69373063|FG000|Overall Study|Withdrawal by Subject|3|||
37784140|NCT02408484|69373063|FG000|Overall Study|Not treated during study period|1|||
37784141|NCT02380248|69373091|FG000|Overall Study|Lost to Follow-up|11|||
37784142|NCT02380248|69373091|FG000|Overall Study|Withdrawal by Subject|3|||
37784143|NCT02408016|69373138|FG000|Overall Study|Death|6|||
37784144|NCT02408016|69373139|FG001|Overall Study|Death|1|||
37784145|NCT02408016|69373140|FG002|Overall Study|Death|0|||
37784146|NCT02408016|69373138|FG000|Overall Study|Physician Decision|0|||
37784147|NCT02408016|69373139|FG001|Overall Study|Physician Decision|2|||
37784148|NCT02408016|69373140|FG002|Overall Study|Physician Decision|0|||
37784149|NCT02407704|69373204|FG000|Overall Study|Lost to Follow-up|0|||
37784150|NCT02407704|69373205|FG001|Overall Study|Lost to Follow-up|0|||
37784151|NCT02407704|69373206|FG002|Overall Study|Lost to Follow-up|0|||
37784152|NCT02407704|69373207|FG003|Overall Study|Lost to Follow-up|2|||
37784153|NCT02407704|69373204|FG000|Overall Study|Protocol Violation|0|||
37784154|NCT02407704|69373205|FG001|Overall Study|Protocol Violation|0|||
37784155|NCT02407704|69373206|FG002|Overall Study|Protocol Violation|0|||
37784156|NCT02407704|69373207|FG003|Overall Study|Protocol Violation|1|||
37784157|NCT02407704|69373204|FG000|Overall Study|Withdrawal by Subject|0|||
37784158|NCT02407704|69373205|FG001|Overall Study|Withdrawal by Subject|0|||
37784159|NCT02407704|69373206|FG002|Overall Study|Withdrawal by Subject|1|||
37784160|NCT02407704|69373207|FG003|Overall Study|Withdrawal by Subject|0|||
37784161|NCT02406612|69373228|FG000|Overall Study|Screening Failure|3|||
37784162|NCT02406612|69373229|FG001|Overall Study|Screening Failure|0|||
37784163|NCT02406612|69373228|FG000|Overall Study|Intra-procedural Exclusion|1|||
37784164|NCT02406612|69373229|FG001|Overall Study|Intra-procedural Exclusion|3|||
37784165|NCT02406612|69373228|FG000|Overall Study|Guidewire Failure|0|||
37784166|NCT02406612|69373229|FG001|Overall Study|Guidewire Failure|1|||
37784167|NCT02405442|69373373|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
37784168|NCT02405442|69373374|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
37784169|NCT02405442|69373375|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
37784170|NCT02405442|69373376|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
37784171|NCT02405442|69373373|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
37784172|NCT02405442|69373374|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
37784173|NCT02405442|69373375|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
37784174|NCT02405442|69373376|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
37784175|NCT02405442|69373373|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
37784176|NCT02405442|69373374|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
37784177|NCT02405442|69373375|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
37784178|NCT02405442|69373376|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
37784179|NCT02405442|69373373|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
37784180|NCT02405442|69373374|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
37784181|NCT02405442|69373375|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
37784182|NCT02405442|69373376|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
37784183|NCT02405442|69373373|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
37784184|NCT02405442|69373374|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
37784185|NCT02405442|69373375|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
37784186|NCT02405442|69373376|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
37864043|NCT01119105|69547702|FG001|Overall Study|Lost to Follow-up|2|||
37693190|NCT02293993|69169342|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
37693191|NCT02293993|69169343|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
37693192|NCT02293993|69169344|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
37784187|NCT02405442|69373373|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
37784188|NCT02405442|69373374|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
37784189|NCT02405442|69373375|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
37784190|NCT02405442|69373376|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
37784191|NCT02405442|69373373|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
37784192|NCT02405442|69373374|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
37784193|NCT02405442|69373375|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
37784194|NCT02405442|69373376|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
37784195|NCT02405442|69373373|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
37784196|NCT02405442|69373374|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
37784197|NCT02405442|69373375|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
37784198|NCT02405442|69373376|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
37784199|NCT02405442|69373373|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
37784200|NCT02405442|69373374|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
37784201|NCT02405442|69373375|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
37784202|NCT02405442|69373376|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
37784203|NCT02405442|69373373|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
37784204|NCT02405442|69373374|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
37784205|NCT02405442|69373375|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
37784206|NCT02405442|69373376|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
37784207|NCT02405442|69373373|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
37784208|NCT02405442|69373374|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
37784209|NCT02405442|69373375|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
37784210|NCT02405442|69373376|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
37974969|NCT00401973|69662206|FG002|Overall Study|Sponsor Decision|0|||
37974970|NCT00401973|69662204|FG000|Overall Study|Withdrawal by Subject|4|||
37974971|NCT00401973|69662205|FG001|Overall Study|Withdrawal by Subject|12|||
37693193|NCT02293993|69169341|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
37693194|NCT02293993|69169342|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
37693195|NCT02293993|69169343|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
37693196|NCT02293993|69169344|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
37693197|NCT02293993|69169341|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
37693198|NCT02293993|69169342|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
37693199|NCT02293993|69169343|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
37693200|NCT02293993|69169344|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
37693201|NCT02293993|69169341|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
37693202|NCT02293993|69169342|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
37693203|NCT02293993|69169343|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
37693204|NCT02293993|69169344|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
37693205|NCT02322775|69169364|FG000|Overall Study|Adverse Event|1|||
37693206|NCT02322775|69169365|FG001|Overall Study|Adverse Event|0|||
37693207|NCT02322775|69169364|FG000|Overall Study|Lost to Follow-up|0|||
37974972|NCT00401973|69662206|FG002|Overall Study|Withdrawal by Subject|9|||
37784211|NCT02405442|69373373|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
37784212|NCT02405442|69373374|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
37784213|NCT02405442|69373375|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
37784214|NCT02405442|69373376|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
37784215|NCT02405442|69373373|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
37784216|NCT02405442|69373374|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
37784217|NCT02405442|69373375|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
37784218|NCT02405442|69373376|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
37784219|NCT02405442|69373373|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
37784220|NCT02405442|69373374|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
37784221|NCT02405442|69373375|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
37784222|NCT02405442|69373376|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
37784223|NCT02404350|69373492|FG000|Overall Study|Adverse Event|2|||
37784224|NCT02404350|69373493|FG001|Overall Study|Adverse Event|2|||
37784225|NCT02404350|69373494|FG002|Overall Study|Adverse Event|3|||
37784226|NCT02404350|69373495|FG003|Overall Study|Adverse Event|9|||
37784227|NCT02404350|69373492|FG000|Overall Study|Lack of Efficacy|3|||
37784228|NCT02404350|69373493|FG001|Overall Study|Lack of Efficacy|1|||
37784229|NCT02404350|69373494|FG002|Overall Study|Lack of Efficacy|0|||
37784230|NCT02404350|69373495|FG003|Overall Study|Lack of Efficacy|3|||
37784231|NCT02404350|69373492|FG000|Overall Study|Lost to Follow-up|2|||
37784232|NCT02404350|69373493|FG001|Overall Study|Lost to Follow-up|0|||
37784233|NCT02404350|69373494|FG002|Overall Study|Lost to Follow-up|0|||
37784234|NCT02404350|69373495|FG003|Overall Study|Lost to Follow-up|1|||
37784235|NCT02404350|69373492|FG000|Overall Study|Physician Decision|1|||
37784236|NCT02404350|69373493|FG001|Overall Study|Physician Decision|0|||
37784237|NCT02404350|69373494|FG002|Overall Study|Physician Decision|0|||
37784238|NCT02404350|69373495|FG003|Overall Study|Physician Decision|2|||
37784239|NCT02404350|69373492|FG000|Overall Study|Pregnancy|0|||
37784240|NCT02404350|69373493|FG001|Overall Study|Pregnancy|0|||
37784241|NCT02404350|69373494|FG002|Overall Study|Pregnancy|0|||
37784242|NCT02404350|69373495|FG003|Overall Study|Pregnancy|1|||
37784243|NCT02404350|69373492|FG000|Overall Study|Withdrawal by Subject|7|||
37784244|NCT02404350|69373493|FG001|Overall Study|Withdrawal by Subject|3|||
37784245|NCT02404350|69373494|FG002|Overall Study|Withdrawal by Subject|3|||
37784246|NCT02404350|69373495|FG003|Overall Study|Withdrawal by Subject|19|||
37784247|NCT02404350|69373492|FG000|Overall Study|Due to Non-compliance with treatment|0|||
37784248|NCT02404350|69373493|FG001|Overall Study|Due to Non-compliance with treatment|0|||
37784249|NCT02404350|69373494|FG002|Overall Study|Due to Non-compliance with treatment|0|||
37784250|NCT02404350|69373495|FG003|Overall Study|Due to Non-compliance with treatment|1|||
37784251|NCT02404350|69373492|FG000|Overall Study|Due to Technical problems|0|||
37784252|NCT02404350|69373493|FG001|Overall Study|Due to Technical problems|0|||
37784253|NCT02404350|69373494|FG002|Overall Study|Due to Technical problems|0|||
37784254|NCT02404350|69373495|FG003|Overall Study|Due to Technical problems|1|||
37784255|NCT02434770|69373794|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
37784256|NCT02434770|69373795|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
37784257|NCT02434770|69373796|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
37784258|NCT02434770|69373794|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
37784259|NCT02434770|69373795|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
37784260|NCT02434770|69373796|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
37784261|NCT02434770|69373794|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
37784262|NCT02434770|69373795|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
37784263|NCT02434770|69373796|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
37784264|NCT02434770|69373794|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
37784265|NCT02434770|69373795|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
37784266|NCT02434770|69373796|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
37784267|NCT02434770|69373794|FG000|Week 1 to Week 18|Death|1|||
37784268|NCT02434770|69373795|FG001|Week 1 to Week 18|Death|0|||
37784269|NCT02434770|69373796|FG002|Week 1 to Week 18|Death|0|||
37784270|NCT02434770|69373794|FG000|Week 18 to Week|Lost to Follow-up|2|||
37784271|NCT02434770|69373795|FG001|Week 18 to Week|Lost to Follow-up|2|||
37784272|NCT02434770|69373796|FG002|Week 18 to Week|Lost to Follow-up|1|||
37784273|NCT02434770|69373794|FG000|Week 18 to Week|Withdrawal by Subject|0|||
37784274|NCT02434770|69373795|FG001|Week 18 to Week|Withdrawal by Subject|0|||
37784275|NCT02434770|69373796|FG002|Week 18 to Week|Withdrawal by Subject|2|||
37784276|NCT02434770|69373794|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
37784277|NCT02434770|69373795|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
37784278|NCT02434770|69373796|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
37974973|NCT00401193|69662219|FG000|Overall Study|Adverse Event|1|||
37784279|NCT02433834|69373827|FG000|Overall Study|Protocol-specified criteria|7|||
37784280|NCT02433834|69373827|FG000|Overall Study|Protocol Violation|3|||
37784281|NCT02433834|69373827|FG000|Overall Study|Lost to Follow-up|6|||
37784282|NCT02433834|69373827|FG000|Overall Study|Withdrawal by Subject|14|||
37784283|NCT02433834|69373827|FG000|Overall Study|Adverse Event|6|||
37784284|NCT02433834|69373827|FG000|Overall Study|Physician Decision|1|||
37784285|NCT02433678|69373871|FG000|Overall Study|Lost to Follow-up|1|||
37784286|NCT02433678|69373872|FG001|Overall Study|Lost to Follow-up|2|||
37784287|NCT02433288|69373885|FG000|Overall Study|Severe non-compliance to protocol|13|||
37784288|NCT02433288|69373886|FG001|Overall Study|Severe non-compliance to protocol|7|||
37784289|NCT02433288|69373885|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
37784290|NCT02433288|69373886|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
37784291|NCT02433288|69373885|FG000|Overall Study|Withdrawal by Subject|101|||
37784292|NCT02433288|69373886|FG001|Overall Study|Withdrawal by Subject|99|||
37784293|NCT02433288|69373885|FG000|Overall Study|Lost to Follow-up|2|||
37784294|NCT02433288|69373886|FG001|Overall Study|Lost to Follow-up|14|||
37784295|NCT02433288|69373885|FG000|Overall Study|Death|0|||
37784296|NCT02433288|69373886|FG001|Overall Study|Death|3|||
37784297|NCT02433210|69373906|FG000|Overall Study|Physician Decision|1|||
37784298|NCT02433210|69373907|FG001|Overall Study|Physician Decision|0|||
37784299|NCT02433210|69373908|FG002|Overall Study|Physician Decision|0|||
37784300|NCT02432040|69374043|FG000|Overall Study|Lack of Efficacy|3|||
37784301|NCT02432040|69374044|FG001|Overall Study|Lack of Efficacy|0|||
37784302|NCT02432040|69374043|FG000|Overall Study|Lost to Follow-up|4|||
37784303|NCT02432040|69374044|FG001|Overall Study|Lost to Follow-up|5|||
37784304|NCT02432040|69374043|FG000|Overall Study|Physician Decision|1|||
37784305|NCT02432040|69374044|FG001|Overall Study|Physician Decision|1|||
37784306|NCT04418076|69374090|FG000|Overall Study|Death|1|||
37784307|NCT04418076|69374091|FG001|Overall Study|Death|0|||
37784308|NCT04418076|69374092|FG002|Overall Study|Death|0|||
37784309|NCT04418076|69374093|FG003|Overall Study|Death|0|||
37784310|NCT04418076|69374090|FG000|Overall Study|Lost to Follow-up|2|||
37784311|NCT04418076|69374091|FG001|Overall Study|Lost to Follow-up|5|||
37784312|NCT04418076|69374092|FG002|Overall Study|Lost to Follow-up|1|||
37784313|NCT04418076|69374093|FG003|Overall Study|Lost to Follow-up|2|||
37784314|NCT04418076|69374090|FG000|Overall Study|Withdrawal by Subject|1|||
37784315|NCT04418076|69374091|FG001|Overall Study|Withdrawal by Subject|0|||
37784316|NCT04418076|69374092|FG002|Overall Study|Withdrawal by Subject|1|||
37784317|NCT04418076|69374093|FG003|Overall Study|Withdrawal by Subject|1|||
37784318|NCT04418076|69374090|FG000|Overall Study|Dropped out after receiving pillbox and phone|2|||
37784319|NCT04418076|69374091|FG001|Overall Study|Dropped out after receiving pillbox and phone|0|||
37784320|NCT04418076|69374092|FG002|Overall Study|Dropped out after receiving pillbox and phone|2|||
37784321|NCT04418076|69374093|FG003|Overall Study|Dropped out after receiving pillbox and phone|3|||
37693208|NCT02322775|69169365|FG001|Overall Study|Lost to Follow-up|1|||
37693209|NCT02322775|69169364|FG000|Overall Study|Protocol Violation|1|||
37693210|NCT02322775|69169365|FG001|Overall Study|Protocol Violation|0|||
37784322|NCT04165824|69374103|FG000|Overall Study|Adverse Event|23|||
37784323|NCT04165824|69374103|FG000|Overall Study|Physician Decision|1|||
37784324|NCT04165824|69374103|FG000|Overall Study|Withdrawal by Subject|17|||
37784325|NCT04165824|69374103|FG000|Overall Study|Other|5|||
37784326|NCT03809039|69374116|FG000|Part 1|Withdrawal by Subject|1|||
37784327|NCT03809039|69374117|FG001|Part 1|Withdrawal by Subject|0|||
37784328|NCT03809039|69374118|FG002|Part 1|Withdrawal by Subject|0|||
37784329|NCT03809039|69374119|FG003|Part 1|Withdrawal by Subject|1|||
37784330|NCT03809039|69374120|FG004|Part 1|Withdrawal by Subject|0|||
37784331|NCT03809039|69374121|FG005|Part 1|Withdrawal by Subject|0|||
37784332|NCT03809039|69374122|FG006|Part 1|Withdrawal by Subject|0|||
37784333|NCT03809039|69374123|FG007|Part 1|Withdrawal by Subject|0|||
37784334|NCT03809039|69374124|FG008|Part 1|Withdrawal by Subject|0|||
37784335|NCT03809039|69374116|FG000|Part 3|Withdrawn by study termination|0|||
37784336|NCT03809039|69374117|FG001|Part 3|Withdrawn by study termination|0|||
37784337|NCT03809039|69374118|FG002|Part 3|Withdrawn by study termination|0|||
37784338|NCT03809039|69374119|FG003|Part 3|Withdrawn by study termination|0|||
37974974|NCT00401193|69662220|FG001|Overall Study|Adverse Event|3|||
37974975|NCT00401193|69662221|FG002|Overall Study|Adverse Event|1|||
37693211|NCT02322775|69169364|FG000|Overall Study|Withdrawal by Subject|3|||
37693212|NCT02322775|69169365|FG001|Overall Study|Withdrawal by Subject|4|||
37693213|NCT02322775|69169364|FG000|Overall Study|Not willing to perform all FU visits|0|||
37693214|NCT02322775|69169365|FG001|Overall Study|Not willing to perform all FU visits|1|||
37693215|NCT02322229|69169371|FG000|Overall Study|Physician Decision|2|||
37693216|NCT02362789|69169378|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
37693217|NCT02362789|69169379|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
37784339|NCT03809039|69374120|FG004|Part 3|Withdrawn by study termination|0|||
37784340|NCT03809039|69374121|FG005|Part 3|Withdrawn by study termination|0|||
37784341|NCT03809039|69374122|FG006|Part 3|Withdrawn by study termination|0|||
37784342|NCT03809039|69374123|FG007|Part 3|Withdrawn by study termination|2|||
37784343|NCT03809039|69374124|FG008|Part 3|Withdrawn by study termination|6|||
37784344|NCT03541200|69374157|FG000|Overall Study|Adverse Event|19|||
37784345|NCT03541200|69374157|FG000|Overall Study|Death|1|||
37784346|NCT03541200|69374157|FG000|Overall Study|Lost to Follow-up|10|||
37784347|NCT03541200|69374157|FG000|Overall Study|Physician Decision|1|||
37784348|NCT03541200|69374157|FG000|Overall Study|Protocol Violation|51|||
37784349|NCT03541200|69374157|FG000|Overall Study|Withdrawal by Subject|23|||
37784350|NCT03541200|69374157|FG000|Overall Study|other|8|||
37693218|NCT02362789|69169380|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
37693219|NCT02362789|69169378|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
37693220|NCT02362789|69169379|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
37693221|NCT02362789|69169380|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
37693222|NCT02362789|69169378|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
37693223|NCT02362789|69169379|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
37693224|NCT02362789|69169380|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
37693225|NCT02362789|69169378|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
37693226|NCT02362789|69169379|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
37693227|NCT02362789|69169380|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
37693228|NCT02362789|69169378|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
37693229|NCT02362789|69169379|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
37693230|NCT02362789|69169380|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
37693231|NCT01646827|69169389|FG000|Overall Study|Lost to Follow-up|0|||
37693232|NCT01646827|69169390|FG001|Overall Study|Lost to Follow-up|3|||
37693233|NCT01646827|69169389|FG000|Overall Study|Physician Decision|1|||
37693234|NCT01646827|69169390|FG001|Overall Study|Physician Decision|2|||
37693235|NCT01646827|69169389|FG000|Overall Study|Withdrawal by Subject|1|||
37693236|NCT01646827|69169390|FG001|Overall Study|Withdrawal by Subject|0|||
37693237|NCT02293837|69169400|FG000|Overall Study|Lost to Follow-up|0|||
37693238|NCT02293837|69169401|FG001|Overall Study|Lost to Follow-up|2|||
37693239|NCT02293837|69169402|FG002|Overall Study|Lost to Follow-up|1|||
37693240|NCT02293837|69169403|FG003|Overall Study|Lost to Follow-up|0|||
37693241|NCT02293837|69169400|FG000|Overall Study|Withdrawal by Subject|2|||
37693242|NCT02293837|69169401|FG001|Overall Study|Withdrawal by Subject|1|||
37693243|NCT02293837|69169402|FG002|Overall Study|Withdrawal by Subject|2|||
37693244|NCT02293837|69169403|FG003|Overall Study|Withdrawal by Subject|1|||
37693245|NCT02293837|69169400|FG000|Overall Study|COVID-19 Related|1|||
37693246|NCT02293837|69169401|FG001|Overall Study|COVID-19 Related|1|||
37693247|NCT02293837|69169402|FG002|Overall Study|COVID-19 Related|0|||
37693248|NCT02293837|69169403|FG003|Overall Study|COVID-19 Related|0|||
37693249|NCT02293837|69169400|FG000|Overall Study|Participant ill and could not be infused|0|||
37693250|NCT02293837|69169401|FG001|Overall Study|Participant ill and could not be infused|0|||
37693251|NCT02293837|69169402|FG002|Overall Study|Participant ill and could not be infused|1|||
37693252|NCT02293837|69169403|FG003|Overall Study|Participant ill and could not be infused|0|||
37693253|NCT02361307|69169419|FG000|Overall Study|Unstable medical condition.|0|||
37693254|NCT02361307|69169420|FG001|Overall Study|Unstable medical condition.|1|||
37693255|NCT02320903|69169429|FG000|Overall Study|Withdrawal by Subject|0|||
37693256|NCT02320903|69169430|FG001|Overall Study|Withdrawal by Subject|9|||
37693257|NCT02320903|69169431|FG002|Overall Study|Withdrawal by Subject|9|||
37693258|NCT02320903|69169429|FG000|Overall Study|Exited therapy; no longer eligible|8|||
37693259|NCT02320903|69169430|FG001|Overall Study|Exited therapy; no longer eligible|2|||
37693260|NCT02320903|69169431|FG002|Overall Study|Exited therapy; no longer eligible|2|||
37693261|NCT02320903|69169429|FG000|Overall Study|Lost to Follow-up|0|||
37693262|NCT02320903|69169430|FG001|Overall Study|Lost to Follow-up|5|||
37693263|NCT02320903|69169431|FG002|Overall Study|Lost to Follow-up|5|||
37693264|NCT02320123|69169442|FG000|Overall Study|Lost to Follow-up|4|||
37693265|NCT02320123|69169443|FG001|Overall Study|Lost to Follow-up|6|||
37693266|NCT02320123|69169442|FG000|Overall Study|Death|6|||
37784351|NCT03520036|69374164|FG000|Overall Study|Adverse Event|1|||
37693267|NCT02320123|69169443|FG001|Overall Study|Death|5|||
37693268|NCT02360995|69169456|FG000|Overall Study|Lost to Follow-up|2|||
37693269|NCT02360995|69169457|FG001|Overall Study|Lost to Follow-up|0|||
37784352|NCT03520036|69374165|FG001|Overall Study|Adverse Event|2|||
37784353|NCT03520036|69374166|FG002|Overall Study|Adverse Event|0|||
37784354|NCT03520036|69374164|FG000|Overall Study|Protocol Violation|1|||
37784355|NCT03520036|69374165|FG001|Overall Study|Protocol Violation|0|||
37784356|NCT03520036|69374166|FG002|Overall Study|Protocol Violation|0|||
37784357|NCT03520036|69374164|FG000|Overall Study|Withdrawal by Subject|0|||
37784358|NCT03520036|69374165|FG001|Overall Study|Withdrawal by Subject|1|||
37784359|NCT03520036|69374166|FG002|Overall Study|Withdrawal by Subject|4|||
37784360|NCT03520036|69374164|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
37784361|NCT03520036|69374165|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
37784362|NCT03520036|69374166|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
37784363|NCT03505710|69374177|FG000|Overall Study|Progressive Disease|22|||
37784364|NCT03505710|69374178|FG001|Overall Study|Progressive Disease|9|||
37784365|NCT03505710|69374179|FG002|Overall Study|Progressive Disease|34|||
37784366|NCT03505710|69374177|FG000|Overall Study|Clinical Progression|6|||
37784367|NCT03505710|69374178|FG001|Overall Study|Clinical Progression|6|||
37974976|NCT00401193|69662219|FG000|Overall Study|Protocol Violation|3|||
37974977|NCT00401193|69662220|FG001|Overall Study|Protocol Violation|1|||
37974978|NCT00401193|69662221|FG002|Overall Study|Protocol Violation|1|||
37974979|NCT00401193|69662219|FG000|Overall Study|Lost to Follow-up|6|||
37974980|NCT00401193|69662220|FG001|Overall Study|Lost to Follow-up|5|||
37693270|NCT02360995|69169458|FG002|Overall Study|Lost to Follow-up|2|||
37693271|NCT02360995|69169456|FG000|Overall Study|Withdrawal by Subject|0|||
37693272|NCT02360995|69169457|FG001|Overall Study|Withdrawal by Subject|1|||
37693273|NCT02360995|69169458|FG002|Overall Study|Withdrawal by Subject|0|||
37693274|NCT02360605|69169468|FG000|Overall Study|Withdrawal by Subject|4|||
37693275|NCT02360605|69169469|FG001|Overall Study|Withdrawal by Subject|9|||
37693276|NCT02360605|69169468|FG000|Overall Study|Lost to Follow-up|7|||
37693277|NCT02360605|69169469|FG001|Overall Study|Lost to Follow-up|8|||
37693278|NCT02360605|69169468|FG000|Overall Study|Death|0|||
37693279|NCT02360605|69169469|FG001|Overall Study|Death|1|||
37693280|NCT02360293|69169479|FG000|Overall Study|Lost to Follow-up|73|||
37693281|NCT02360293|69169480|FG001|Overall Study|Lost to Follow-up|95|||
37693282|NCT02360293|69169479|FG000|Overall Study|Withdrawal by Subject|2|||
37693283|NCT02360293|69169480|FG001|Overall Study|Withdrawal by Subject|1|||
37693284|NCT02360293|69169479|FG000|Overall Study|Excluded|1|||
37693285|NCT02360293|69169480|FG001|Overall Study|Excluded|0|||
37693286|NCT02359903|69169488|FG000|Overall Study|Adverse Event|0|||
37693287|NCT02359903|69169489|FG001|Overall Study|Adverse Event|2|||
37693288|NCT02291419|69169497|FG000|Overall Study|Early study termination|1|||
37693289|NCT02291419|69169498|FG001|Overall Study|Early study termination|5|||
37693290|NCT02319031|69169506|FG000|Treatment Period|Death|1|||
37693291|NCT02319031|69169507|FG001|Treatment Period|Death|0|||
37693292|NCT02318797|69169515|FG000|Overall Study|Death|3|||
37693293|NCT02318797|69169516|FG001|Overall Study|Death|6|||
37693294|NCT02318797|69169515|FG000|Overall Study|Lost to Follow-up|85|||
37693295|NCT02318797|69169516|FG001|Overall Study|Lost to Follow-up|96|||
37693296|NCT02359435|69169524|FG000|Overall Study|Lost to Follow-up|4|||
37693297|NCT02359435|69169525|FG001|Overall Study|Lost to Follow-up|4|||
37693298|NCT02318719|69169535|FG000|Double-blind Phase|Adverse Event|7|||
37693299|NCT02318719|69169536|FG001|Double-blind Phase|Adverse Event|6|||
37693300|NCT02318719|69169537|FG002|Double-blind Phase|Adverse Event|12|||
37693301|NCT02318719|69169538|FG003|Double-blind Phase|Adverse Event|4|||
37693302|NCT02318719|69169539|FG004|Double-blind Phase|Adverse Event|0|||
37693303|NCT02318719|69169535|FG000|Double-blind Phase|Lack of Efficacy|5|||
37693304|NCT02318719|69169536|FG001|Double-blind Phase|Lack of Efficacy|0|||
37693305|NCT02318719|69169537|FG002|Double-blind Phase|Lack of Efficacy|1|||
37693306|NCT02318719|69169538|FG003|Double-blind Phase|Lack of Efficacy|1|||
37693307|NCT02318719|69169539|FG004|Double-blind Phase|Lack of Efficacy|0|||
37693308|NCT02318719|69169535|FG000|Double-blind Phase|Protocol Violation|0|||
37693309|NCT02318719|69169536|FG001|Double-blind Phase|Protocol Violation|1|||
37693310|NCT02318719|69169537|FG002|Double-blind Phase|Protocol Violation|3|||
37693311|NCT02318719|69169538|FG003|Double-blind Phase|Protocol Violation|0|||
37693312|NCT02318719|69169539|FG004|Double-blind Phase|Protocol Violation|0|||
37693313|NCT02318719|69169535|FG000|Double-blind Phase|Withdrawal by Subject|25|||
37693314|NCT02318719|69169536|FG001|Double-blind Phase|Withdrawal by Subject|7|||
37693315|NCT02318719|69169537|FG002|Double-blind Phase|Withdrawal by Subject|9|||
37693316|NCT02318719|69169538|FG003|Double-blind Phase|Withdrawal by Subject|10|||
37693317|NCT02318719|69169539|FG004|Double-blind Phase|Withdrawal by Subject|0|||
37693318|NCT02318719|69169535|FG000|Double-blind Phase|Other|1|||
37693319|NCT02318719|69169536|FG001|Double-blind Phase|Other|2|||
37693320|NCT02318719|69169537|FG002|Double-blind Phase|Other|0|||
37693321|NCT02318719|69169538|FG003|Double-blind Phase|Other|0|||
37693322|NCT02318719|69169539|FG004|Double-blind Phase|Other|0|||
37693323|NCT02318719|69169535|FG000|Open-label Extension Phase|Adverse Event|0|||
37693324|NCT02318719|69169536|FG001|Open-label Extension Phase|Adverse Event|0|||
37693325|NCT02318719|69169537|FG002|Open-label Extension Phase|Adverse Event|0|||
37693326|NCT02318719|69169538|FG003|Open-label Extension Phase|Adverse Event|0|||
37974981|NCT00401193|69662221|FG002|Overall Study|Lost to Follow-up|1|||
37784368|NCT03505710|69374179|FG002|Overall Study|Clinical Progression|3|||
37784369|NCT03505710|69374177|FG000|Overall Study|Adverse Event|12|||
37784370|NCT03505710|69374178|FG001|Overall Study|Adverse Event|5|||
37784371|NCT03505710|69374179|FG002|Overall Study|Adverse Event|27|||
37784372|NCT03505710|69374177|FG000|Overall Study|Withdrawal by Subject|1|||
37784373|NCT03505710|69374178|FG001|Overall Study|Withdrawal by Subject|3|||
37784374|NCT03505710|69374179|FG002|Overall Study|Withdrawal by Subject|3|||
37784375|NCT03505710|69374177|FG000|Overall Study|Physician Decision|1|||
37784376|NCT03505710|69374178|FG001|Overall Study|Physician Decision|0|||
37784377|NCT03505710|69374179|FG002|Overall Study|Physician Decision|2|||
37784378|NCT03505710|69374177|FG000|Overall Study|Death|4|||
37784379|NCT03505710|69374178|FG001|Overall Study|Death|3|||
37784380|NCT03505710|69374179|FG002|Overall Study|Death|6|||
37784381|NCT03505710|69374177|FG000|Overall Study|Other Reasons|1|||
37784382|NCT03505710|69374178|FG001|Overall Study|Other Reasons|1|||
37784383|NCT03505710|69374179|FG002|Overall Study|Other Reasons|1|||
37784384|NCT03459729|69374187|FG000|Overall Study|Physician Decision|2|||
37784385|NCT03291067|69374195|FG000|Overall Study|Adverse Event|0|||
37784386|NCT03291067|69374196|FG001|Overall Study|Adverse Event|2|||
37784387|NCT03291067|69374197|FG002|Overall Study|Adverse Event|17|||
37784388|NCT03291067|69374198|FG003|Overall Study|Adverse Event|3|||
37784389|NCT03291067|69374195|FG000|Overall Study|Lost to Follow-up|2|||
37784390|NCT03291067|69374196|FG001|Overall Study|Lost to Follow-up|1|||
37784391|NCT03291067|69374197|FG002|Overall Study|Lost to Follow-up|0|||
37784392|NCT03291067|69374198|FG003|Overall Study|Lost to Follow-up|1|||
37784393|NCT03291067|69374195|FG000|Overall Study|Physician Decision|0|||
37784394|NCT03291067|69374196|FG001|Overall Study|Physician Decision|0|||
37784395|NCT03291067|69374197|FG002|Overall Study|Physician Decision|1|||
37784396|NCT03291067|69374198|FG003|Overall Study|Physician Decision|0|||
37784397|NCT03291067|69374195|FG000|Overall Study|Protocol Violation|5|||
37784398|NCT03291067|69374196|FG001|Overall Study|Protocol Violation|3|||
37784399|NCT03291067|69374197|FG002|Overall Study|Protocol Violation|4|||
37784400|NCT03291067|69374198|FG003|Overall Study|Protocol Violation|2|||
37784401|NCT03291067|69374195|FG000|Overall Study|Withdrawal by Subject|3|||
37784402|NCT03291067|69374196|FG001|Overall Study|Withdrawal by Subject|4|||
37784403|NCT03291067|69374197|FG002|Overall Study|Withdrawal by Subject|7|||
37784404|NCT03291067|69374198|FG003|Overall Study|Withdrawal by Subject|5|||
37784405|NCT03291067|69374195|FG000|Overall Study|Other|0|||
37784406|NCT03291067|69374196|FG001|Overall Study|Other|4|||
37784407|NCT03291067|69374197|FG002|Overall Study|Other|4|||
37784408|NCT03291067|69374198|FG003|Overall Study|Other|6|||
37784409|NCT02841280|69374210|FG000|Overall Study|Adverse Event|2|||
37784410|NCT02841280|69374211|FG001|Overall Study|Adverse Event|1|||
37784411|NCT02841280|69374210|FG000|Overall Study|Death|1|||
37784412|NCT02841280|69374211|FG001|Overall Study|Death|0|||
37784413|NCT02841280|69374210|FG000|Overall Study|Lost to Follow-up|2|||
37784414|NCT02841280|69374211|FG001|Overall Study|Lost to Follow-up|2|||
37784415|NCT02841280|69374210|FG000|Overall Study|Withdrawal by Subject|7|||
37784416|NCT02841280|69374211|FG001|Overall Study|Withdrawal by Subject|3|||
37784417|NCT02841280|69374210|FG000|Overall Study|Stop Point: BP above threshold|2|||
37784418|NCT02841280|69374211|FG001|Overall Study|Stop Point: BP above threshold|0|||
37784419|NCT02345330|69374225|FG000|Overall Study|Death|1|||
37784420|NCT02345330|69374225|FG000|Overall Study|Progressive Disease|2|||
37784421|NCT01513343|69374240|FG000|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|8|||
37784422|NCT01513343|69374241|FG001|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|0|||
37784423|NCT01513343|69374240|FG000|Post Data Collection|Dropped/withdrew from study|7|||
37784424|NCT01513343|69374241|FG001|Post Data Collection|Dropped/withdrew from study|1|||
37784425|NCT01513343|69374240|FG000|Post Data Collection|Lost to Follow-up|10|||
37784426|NCT01513343|69374241|FG001|Post Data Collection|Lost to Follow-up|23|||
37784427|NCT01513343|69374240|FG000|6-month Follow-up|Lost to Follow-up|28|||
37784428|NCT01513343|69374241|FG001|6-month Follow-up|Lost to Follow-up|17|||
37784429|NCT01513343|69374240|FG000|12-month Follow-up|Lost to Follow-up|10|||
37784430|NCT01513343|69374241|FG001|12-month Follow-up|Lost to Follow-up|3|||
37784431|NCT01440816|69374268|FG000|Overall Study|Disease Progression|0|||
37784432|NCT01440816|69374269|FG001|Overall Study|Disease Progression|9|||
37974982|NCT00401193|69662219|FG000|Overall Study|Withdrawal by Subject|2|||
37974983|NCT00401193|69662220|FG001|Overall Study|Withdrawal by Subject|0|||
37784433|NCT01440816|69374268|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
37784434|NCT01440816|69374269|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
37784435|NCT01348919|69374280|FG000|Overall Study|Adverse Event|3|||
37784436|NCT01348919|69374281|FG001|Overall Study|Adverse Event|1|||
37784437|NCT01348919|69374282|FG002|Overall Study|Adverse Event|0|||
37784438|NCT01348919|69374280|FG000|Overall Study|Withdrawal by Subject|0|||
37784439|NCT01348919|69374281|FG001|Overall Study|Withdrawal by Subject|1|||
37784440|NCT01348919|69374282|FG002|Overall Study|Withdrawal by Subject|0|||
37784441|NCT01348919|69374280|FG000|Overall Study|Disease progression|0|||
37784442|NCT01348919|69374281|FG001|Overall Study|Disease progression|1|||
37784443|NCT01348919|69374282|FG002|Overall Study|Disease progression|1|||
37784444|NCT00966381|69374294|FG000|Overall Study|Withdrawal by Subject|2|||
37784445|NCT00966381|69374295|FG001|Overall Study|Withdrawal by Subject|2|||
37784446|NCT02431806|69374307|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
37784447|NCT02431806|69374308|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
37784448|NCT02431806|69374309|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
37784449|NCT02431806|69374310|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
37784450|NCT02431806|69374307|FG000|Double-blind Treatment Period|Adverse Event|4|||
37784451|NCT02431806|69374308|FG001|Double-blind Treatment Period|Adverse Event|7|||
37784452|NCT02431806|69374309|FG002|Double-blind Treatment Period|Adverse Event|11|||
37784453|NCT02431806|69374310|FG003|Double-blind Treatment Period|Adverse Event|7|||
37784454|NCT02431806|69374307|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
37784455|NCT02431806|69374308|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
37784456|NCT02431806|69374309|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
37784457|NCT02431806|69374310|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
37784458|NCT02431806|69374307|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
37784459|NCT02431806|69374308|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
37784460|NCT02431806|69374309|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
37784461|NCT02431806|69374310|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
37784462|NCT02431806|69374307|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
37784463|NCT02431806|69374308|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
37784464|NCT02431806|69374309|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
37784465|NCT02431806|69374310|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
37784466|NCT02431806|69374307|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
37784467|NCT02431806|69374308|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
37784468|NCT02431806|69374309|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
37784469|NCT02431806|69374310|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
37784470|NCT02431806|69374307|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
37784471|NCT02431806|69374308|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
37784472|NCT02431806|69374309|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
37784473|NCT02431806|69374310|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
37784474|NCT01650246|69374351|FG000|Overall Study|Adverse Event|23|||
37784475|NCT01650246|69374351|FG000|Overall Study|Protocol Violation|5|||
37784476|NCT01650246|69374351|FG000|Overall Study|Sponsor terminated study|53|||
37784477|NCT01650246|69374351|FG000|Overall Study|Lost to Follow-up|5|||
37784478|NCT01650246|69374351|FG000|Overall Study|Withdrawal by Subject|26|||
37784479|NCT01650246|69374351|FG000|Overall Study|Death|1|||
37784480|NCT01650246|69374351|FG000|Overall Study|Lack of Efficacy|30|||
37784481|NCT01652664|69374370|FG000|Overall Study|Treatment Failure|5|||
37784482|NCT01652664|69374371|FG001|Overall Study|Treatment Failure|1|||
37784483|NCT01652664|69374370|FG000|Overall Study|Inadequate IOP control|1|||
37784484|NCT01652664|69374371|FG001|Overall Study|Inadequate IOP control|0|||
37784485|NCT02379390|69374411|FG000|Overall Study|Adverse Event|1|||
37784486|NCT02379390|69374412|FG001|Overall Study|Adverse Event|1|||
37784487|NCT02379390|69374411|FG000|Overall Study|Investigator's decision|1|||
37784488|NCT02379390|69374412|FG001|Overall Study|Investigator's decision|0|||
37784489|NCT02379390|69374411|FG000|Overall Study|Study Termination|0|||
37784490|NCT02379390|69374412|FG001|Overall Study|Study Termination|1|||
37784491|NCT02379078|69374423|FG000|Overall Study|Lost to Follow-up|33|||
37784492|NCT02379078|69374424|FG001|Overall Study|Lost to Follow-up|30|||
37784493|NCT02379078|69374423|FG000|Overall Study|Withdrawal by Subject|6|||
37784494|NCT02379078|69374424|FG001|Overall Study|Withdrawal by Subject|5|||
37784495|NCT01714739|69374517|FG000|Overall Study|Disease progression|3|||
37784496|NCT01714739|69374518|FG001|Overall Study|Disease progression|5|||
37784497|NCT01714739|69374519|FG002|Overall Study|Disease progression|5|||
37784498|NCT01714739|69374520|FG003|Overall Study|Disease progression|204|||
37784499|NCT01714739|69374521|FG004|Overall Study|Disease progression|1|||
37784500|NCT01714739|69374522|FG005|Overall Study|Disease progression|3|||
37784501|NCT01714739|69374523|FG006|Overall Study|Disease progression|5|||
37784502|NCT01714739|69374517|FG000|Overall Study|Study drug toxicity|1|||
37784503|NCT01714739|69374518|FG001|Overall Study|Study drug toxicity|1|||
37784504|NCT01714739|69374519|FG002|Overall Study|Study drug toxicity|1|||
37784505|NCT01714739|69374520|FG003|Overall Study|Study drug toxicity|15|||
37784506|NCT01714739|69374521|FG004|Overall Study|Study drug toxicity|0|||
37784507|NCT01714739|69374522|FG005|Overall Study|Study drug toxicity|0|||
37784508|NCT01714739|69374523|FG006|Overall Study|Study drug toxicity|5|||
37784509|NCT01714739|69374517|FG000|Overall Study|Death|0|||
37784510|NCT01714739|69374518|FG001|Overall Study|Death|0|||
37784511|NCT01714739|69374519|FG002|Overall Study|Death|0|||
37784512|NCT01714739|69374520|FG003|Overall Study|Death|1|||
37784513|NCT01714739|69374521|FG004|Overall Study|Death|0|||
37784514|NCT01714739|69374522|FG005|Overall Study|Death|0|||
37784515|NCT01714739|69374523|FG006|Overall Study|Death|0|||
37784516|NCT01714739|69374517|FG000|Overall Study|Adverse Event unrelated to drug|0|||
37784517|NCT01714739|69374518|FG001|Overall Study|Adverse Event unrelated to drug|0|||
37784518|NCT01714739|69374519|FG002|Overall Study|Adverse Event unrelated to drug|3|||
37784519|NCT01714739|69374520|FG003|Overall Study|Adverse Event unrelated to drug|21|||
37784520|NCT01714739|69374521|FG004|Overall Study|Adverse Event unrelated to drug|0|||
37784521|NCT01714739|69374522|FG005|Overall Study|Adverse Event unrelated to drug|0|||
37784522|NCT01714739|69374523|FG006|Overall Study|Adverse Event unrelated to drug|0|||
37784523|NCT01714739|69374517|FG000|Overall Study|Participant request to stop therapy|0|||
37784524|NCT01714739|69374518|FG001|Overall Study|Participant request to stop therapy|1|||
37784525|NCT01714739|69374519|FG002|Overall Study|Participant request to stop therapy|0|||
37784526|NCT01714739|69374520|FG003|Overall Study|Participant request to stop therapy|6|||
37784527|NCT01714739|69374521|FG004|Overall Study|Participant request to stop therapy|0|||
37784528|NCT01714739|69374522|FG005|Overall Study|Participant request to stop therapy|0|||
37784529|NCT01714739|69374523|FG006|Overall Study|Participant request to stop therapy|0|||
37784530|NCT01714739|69374517|FG000|Overall Study|Participant withdrew consent|0|||
37784531|NCT01714739|69374518|FG001|Overall Study|Participant withdrew consent|1|||
37784532|NCT01714739|69374519|FG002|Overall Study|Participant withdrew consent|0|||
37784533|NCT01714739|69374520|FG003|Overall Study|Participant withdrew consent|8|||
37784534|NCT01714739|69374521|FG004|Overall Study|Participant withdrew consent|0|||
37784535|NCT01714739|69374522|FG005|Overall Study|Participant withdrew consent|0|||
37784536|NCT01714739|69374523|FG006|Overall Study|Participant withdrew consent|0|||
37784537|NCT01714739|69374517|FG000|Overall Study|Lost to Follow-up|0|||
37784538|NCT01714739|69374518|FG001|Overall Study|Lost to Follow-up|0|||
37784539|NCT01714739|69374519|FG002|Overall Study|Lost to Follow-up|0|||
37784540|NCT01714739|69374520|FG003|Overall Study|Lost to Follow-up|1|||
37784541|NCT01714739|69374521|FG004|Overall Study|Lost to Follow-up|0|||
37784542|NCT01714739|69374522|FG005|Overall Study|Lost to Follow-up|0|||
37784543|NCT01714739|69374523|FG006|Overall Study|Lost to Follow-up|0|||
37784544|NCT01714739|69374517|FG000|Overall Study|Maximum clinical benefit|0|||
37784545|NCT01714739|69374518|FG001|Overall Study|Maximum clinical benefit|1|||
37784546|NCT01714739|69374519|FG002|Overall Study|Maximum clinical benefit|1|||
37784547|NCT01714739|69374520|FG003|Overall Study|Maximum clinical benefit|3|||
37784548|NCT01714739|69374521|FG004|Overall Study|Maximum clinical benefit|0|||
37784549|NCT01714739|69374522|FG005|Overall Study|Maximum clinical benefit|0|||
37784550|NCT01714739|69374523|FG006|Overall Study|Maximum clinical benefit|0|||
37784551|NCT01714739|69374517|FG000|Overall Study|Poor/non-comliance|0|||
37784552|NCT01714739|69374518|FG001|Overall Study|Poor/non-comliance|1|||
37784553|NCT01714739|69374519|FG002|Overall Study|Poor/non-comliance|0|||
37784554|NCT01714739|69374520|FG003|Overall Study|Poor/non-comliance|1|||
37784555|NCT01714739|69374521|FG004|Overall Study|Poor/non-comliance|0|||
37784556|NCT01714739|69374522|FG005|Overall Study|Poor/non-comliance|0|||
37784557|NCT01714739|69374523|FG006|Overall Study|Poor/non-comliance|0|||
37784558|NCT01714739|69374517|FG000|Overall Study|No longer meets study criteria|0|||
37784559|NCT01714739|69374518|FG001|Overall Study|No longer meets study criteria|0|||
37784560|NCT01714739|69374519|FG002|Overall Study|No longer meets study criteria|0|||
37784561|NCT01714739|69374520|FG003|Overall Study|No longer meets study criteria|1|||
37784562|NCT01714739|69374521|FG004|Overall Study|No longer meets study criteria|0|||
37784563|NCT01714739|69374522|FG005|Overall Study|No longer meets study criteria|0|||
37784564|NCT01714739|69374523|FG006|Overall Study|No longer meets study criteria|0|||
37784565|NCT01714739|69374517|FG000|Overall Study|Other reason|0|||
37784566|NCT01714739|69374518|FG001|Overall Study|Other reason|0|||
37784567|NCT01714739|69374519|FG002|Overall Study|Other reason|0|||
37784568|NCT01714739|69374520|FG003|Overall Study|Other reason|3|||
37784569|NCT01714739|69374521|FG004|Overall Study|Other reason|1|||
37784570|NCT01714739|69374522|FG005|Overall Study|Other reason|0|||
37784571|NCT01714739|69374523|FG006|Overall Study|Other reason|0|||
37784572|NCT03823287|69376514|FG000|Overall Study|Withdrawal by Subject|25|||
37784573|NCT03823287|69376515|FG001|Overall Study|Withdrawal by Subject|17|||
37784574|NCT03823287|69376514|FG000|Overall Study|Death|13|||
37784575|NCT03823287|69376515|FG001|Overall Study|Death|7|||
37784576|NCT03823287|69376514|FG000|Overall Study|Lost to Follow-up|7|||
37784577|NCT03823287|69376515|FG001|Overall Study|Lost to Follow-up|8|||
37784578|NCT03823287|69376514|FG000|Overall Study|Adverse Event|6|||
37784579|NCT03823287|69376515|FG001|Overall Study|Adverse Event|8|||
37784580|NCT03823287|69376514|FG000|Overall Study|Physician Decision|5|||
37784581|NCT03823287|69376515|FG001|Overall Study|Physician Decision|2|||
37784582|NCT03823287|69376514|FG000|Overall Study|Lack of Efficacy|2|||
37784583|NCT03823287|69376515|FG001|Overall Study|Lack of Efficacy|0|||
37784584|NCT03823287|69376514|FG000|Overall Study|Other|2|||
37784585|NCT03823287|69376515|FG001|Overall Study|Other|4|||
37784586|NCT03707925|69376676|FG000|Overall Study|Inevaluable|1|||
37784587|NCT03461757|69376736|FG000|Overall Study|Adverse Event|1|||
37784588|NCT03461757|69376737|FG001|Overall Study|Adverse Event|0|||
37784589|NCT03461757|69376736|FG000|Overall Study|Lost to Follow-up|13|||
37784590|NCT03461757|69376737|FG001|Overall Study|Lost to Follow-up|7|||
37784591|NCT03461757|69376736|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
37784592|NCT03461757|69376737|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
37784593|NCT03461757|69376736|FG000|Overall Study|Non-compliance with study treatment|0|||
37784594|NCT03461757|69376737|FG001|Overall Study|Non-compliance with study treatment|1|||
37784595|NCT03461757|69376736|FG000|Overall Study|Pregnancy|2|||
37784596|NCT03461757|69376737|FG001|Overall Study|Pregnancy|0|||
37784597|NCT03461757|69376736|FG000|Overall Study|Protocol Violation|1|||
37784598|NCT03461757|69376737|FG001|Overall Study|Protocol Violation|1|||
37784599|NCT03461757|69376736|FG000|Overall Study|Withdrawal by Subject|7|||
37784600|NCT03461757|69376737|FG001|Overall Study|Withdrawal by Subject|7|||
37784601|NCT03461757|69376736|FG000|Overall Study|Other Reasons|1|||
37784602|NCT03461757|69376737|FG001|Overall Study|Other Reasons|4|||
37784603|NCT03235479|69377225|FG000|Overall Study|Lost to Follow-up|8|||
37784604|NCT03235479|69377226|FG001|Overall Study|Lost to Follow-up|11|||
37784605|NCT03235479|69377225|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
37784606|NCT03235479|69377226|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
37784607|NCT03235479|69377225|FG000|Overall Study|Pregnancy|1|||
37784608|NCT03235479|69377226|FG001|Overall Study|Pregnancy|0|||
37784609|NCT03235479|69377225|FG000|Overall Study|Protocol Deviation|1|||
37784610|NCT03235479|69377226|FG001|Overall Study|Protocol Deviation|3|||
37784611|NCT03235479|69377225|FG000|Overall Study|Technical Problems|3|||
37784612|NCT03235479|69377226|FG001|Overall Study|Technical Problems|2|||
37784613|NCT03235479|69377225|FG000|Overall Study|Withdrawal by Subject|2|||
37784614|NCT03235479|69377226|FG001|Overall Study|Withdrawal by Subject|2|||
37784615|NCT03235479|69377225|FG000|Overall Study|Other Reasons|3|||
37784616|NCT03235479|69377226|FG001|Overall Study|Other Reasons|5|||
37784617|NCT03193437|69377282|FG000|Overall Study|Adverse Event|4|||
37784618|NCT03193437|69377282|FG000|Overall Study|Withdrawal by Subject|2|||
37784619|NCT03193437|69377282|FG000|Overall Study|Disease Progression|2|||
37784620|NCT02906787|69377324|FG000|Overall Study|Withdrawal by Subject|12|||
37784621|NCT02906787|69377325|FG001|Overall Study|Withdrawal by Subject|10|||
37784622|NCT02906787|69377324|FG000|Overall Study|Missed|24|||
37784623|NCT02906787|69377325|FG001|Overall Study|Missed|22|||
37784624|NCT02107443|69377898|FG000|Overall Study|Death|42|||
37784625|NCT02107443|69377899|FG001|Overall Study|Death|30|||
37864044|NCT01119105|69547703|FG002|Overall Study|Lost to Follow-up|5|||
37784626|NCT02107443|69377898|FG000|Overall Study|Study Protocol Violation|3|||
37784627|NCT02107443|69377899|FG001|Overall Study|Study Protocol Violation|1|||
37784628|NCT02107443|69377898|FG000|Overall Study|Registered but Not Eligible|0|||
37784629|NCT02107443|69377899|FG001|Overall Study|Registered but Not Eligible|1|||
37784630|NCT02107443|69377898|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
37784631|NCT02107443|69377899|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
37784632|NCT02107443|69377898|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
37784633|NCT02107443|69377899|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
37784634|NCT02107443|69377898|FG000|Overall Study|Withdrawal: Changed Mind|2|||
37784635|NCT02107443|69377899|FG001|Overall Study|Withdrawal: Changed Mind|0|||
37784636|NCT02107443|69377898|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
37784637|NCT02107443|69377899|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
37784638|NCT02107443|69377898|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
37784639|NCT02107443|69377899|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
37784640|NCT02107443|69377898|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
37784641|NCT02107443|69377899|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
37784642|NCT02107443|69377898|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
37784643|NCT02107443|69377899|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
37784644|NCT02107443|69377898|FG000|Overall Study|Withdrawal: Other Medical|9|||
37784645|NCT02107443|69377899|FG001|Overall Study|Withdrawal: Other Medical|5|||
37784646|NCT02107443|69377898|FG000|Overall Study|Withdrawal: Disease Progression|4|||
37784647|NCT02107443|69377899|FG001|Overall Study|Withdrawal: Disease Progression|2|||
37784648|NCT02107443|69377898|FG000|Overall Study|Withdrawal: Personal Issues|0|||
37784649|NCT02107443|69377899|FG001|Overall Study|Withdrawal: Personal Issues|3|||
37784650|NCT00559949|69378816|FG000|Overall Study|Progressive Disease during cycle 1|1|||
37784651|NCT00559949|69378816|FG000|Overall Study|Adverse Event|1|||
37784652|NCT00559949|69378816|FG000|Overall Study|Withdrawal by Subject|4|||
37784653|NCT00559949|69378816|FG000|Overall Study|No disease evaluation per protocol|1|||
37784654|NCT00559637|69378868|FG000|Overall Study|Adverse Event|22|||
37784655|NCT00559637|69378868|FG000|Overall Study|Withdrawal by Subject|4|||
37784656|NCT00559637|69378868|FG000|Overall Study|Protocol Violation|6|||
37693327|NCT02318719|69169539|FG004|Open-label Extension Phase|Adverse Event|15|||
37693328|NCT02318719|69169535|FG000|Open-label Extension Phase|Death|0|||
37693329|NCT02318719|69169536|FG001|Open-label Extension Phase|Death|0|||
37693330|NCT02318719|69169537|FG002|Open-label Extension Phase|Death|0|||
37693331|NCT02318719|69169538|FG003|Open-label Extension Phase|Death|0|||
37693332|NCT02318719|69169539|FG004|Open-label Extension Phase|Death|1|||
37693333|NCT02318719|69169535|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
37693334|NCT02318719|69169536|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
37693335|NCT02318719|69169537|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
37693336|NCT02318719|69169538|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
37784657|NCT00559637|69378868|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
37784658|NCT00559637|69378868|FG000|Overall Study|Failure to return|6|||
37784659|NCT00559637|69378868|FG000|Overall Study|Insufficient response|3|||
37784660|NCT00559637|69378868|FG000|Overall Study|Started requiring dialysis after month 7|2|||
37784661|NCT00559637|69378868|FG000|Overall Study|Suspected lung cancer|1|||
37784662|NCT00559637|69378868|FG000|Overall Study|Participation in another study|1|||
37784663|NCT00559637|69378868|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
37784664|NCT00559637|69378868|FG000|Overall Study|Change of center|1|||
37784665|NCT00559637|69378868|FG000|Overall Study|Change of home|1|||
37784666|NCT00559637|69378868|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
37784667|NCT02578641|69378941|FG000|Overall Study|Adverse Event|5|||
37784668|NCT02578641|69378942|FG001|Overall Study|Adverse Event|15|||
37784669|NCT02578641|69378941|FG000|Overall Study|Death|16|||
37784670|NCT02578641|69378942|FG001|Overall Study|Death|8|||
37784671|NCT02578641|69378941|FG000|Overall Study|Lost to Follow-up|0|||
37784672|NCT02578641|69378942|FG001|Overall Study|Lost to Follow-up|1|||
37784673|NCT02578641|69378941|FG000|Overall Study|Withdrawal by Subject|14|||
37784674|NCT02578641|69378942|FG001|Overall Study|Withdrawal by Subject|7|||
37784675|NCT02578641|69378941|FG000|Overall Study|Progressive Disease|69|||
37784676|NCT02578641|69378942|FG001|Overall Study|Progressive Disease|21|||
37784677|NCT02578641|69378941|FG000|Overall Study|No Study Drug|2|||
37784678|NCT02578641|69378942|FG001|Overall Study|No Study Drug|0|||
37784679|NCT02578641|69378941|FG000|Overall Study|Randomized by Mistake with Study Treatment|0|||
37784680|NCT02578641|69378942|FG001|Overall Study|Randomized by Mistake with Study Treatment|1|||
37784681|NCT02578641|69378941|FG000|Overall Study|Non-compliance with Study Schedule|1|||
37784682|NCT02578641|69378942|FG001|Overall Study|Non-compliance with Study Schedule|0|||
37784683|NCT02578641|69378941|FG000|Overall Study|Other|1|||
37784684|NCT02578641|69378942|FG001|Overall Study|Other|10|||
37784685|NCT02578641|69378941|FG000|Overall Study|Not treated|1|||
37784686|NCT02578641|69378942|FG001|Overall Study|Not treated|4|||
37784687|NCT02431260|69378970|FG000|Overall Study|Subject Decision|0|||
37784688|NCT02431260|69378971|FG001|Overall Study|Subject Decision|1|||
37784689|NCT02431260|69378972|FG002|Overall Study|Subject Decision|1|||
37784690|NCT02431260|69378973|FG003|Overall Study|Subject Decision|0|||
37784691|NCT02431260|69378974|FG004|Overall Study|Subject Decision|0|||
37784692|NCT02431260|69378975|FG005|Overall Study|Subject Decision|0|||
37784693|NCT02431260|69378976|FG006|Overall Study|Subject Decision|0|||
37784694|NCT02431260|69378977|FG007|Overall Study|Subject Decision|0|||
37784695|NCT02431260|69378978|FG008|Overall Study|Subject Decision|1|||
37784696|NCT02431260|69378979|FG009|Overall Study|Subject Decision|1|||
37784697|NCT02431260|69378980|FG010|Overall Study|Subject Decision|0|||
37784698|NCT02431260|69378981|FG011|Overall Study|Subject Decision|1|||
37784699|NCT02431260|69378982|FG012|Overall Study|Subject Decision|0|||
37784700|NCT02431260|69378983|FG013|Overall Study|Subject Decision|0|||
37784701|NCT02431260|69378970|FG000|Overall Study|Death|4|||
37784702|NCT02431260|69378971|FG001|Overall Study|Death|4|||
37784703|NCT02431260|69378972|FG002|Overall Study|Death|3|||
37784704|NCT02431260|69378973|FG003|Overall Study|Death|4|||
37864045|NCT01119105|69547701|FG000|Overall Study|Adverse Event|1|||
37784705|NCT02431260|69378974|FG004|Overall Study|Death|2|||
37784706|NCT02431260|69378975|FG005|Overall Study|Death|2|||
37864046|NCT01119105|69547702|FG001|Overall Study|Adverse Event|0|||
37784707|NCT02431260|69378976|FG006|Overall Study|Death|3|||
37784708|NCT02431260|69378977|FG007|Overall Study|Death|1|||
37784709|NCT02431260|69378978|FG008|Overall Study|Death|6|||
37784710|NCT02431260|69378979|FG009|Overall Study|Death|6|||
37784711|NCT02431260|69378980|FG010|Overall Study|Death|3|||
37784712|NCT02431260|69378981|FG011|Overall Study|Death|2|||
37784713|NCT02431260|69378982|FG012|Overall Study|Death|5|||
37784714|NCT02431260|69378983|FG013|Overall Study|Death|1|||
37784715|NCT02431260|69378970|FG000|Overall Study|Lost to Follow-up|0|||
37784716|NCT02431260|69378971|FG001|Overall Study|Lost to Follow-up|0|||
37784717|NCT02431260|69378972|FG002|Overall Study|Lost to Follow-up|0|||
37784718|NCT02431260|69378973|FG003|Overall Study|Lost to Follow-up|0|||
37784719|NCT02431260|69378974|FG004|Overall Study|Lost to Follow-up|0|||
37784720|NCT02431260|69378975|FG005|Overall Study|Lost to Follow-up|1|||
37784721|NCT02431260|69378976|FG006|Overall Study|Lost to Follow-up|0|||
37784722|NCT02431260|69378977|FG007|Overall Study|Lost to Follow-up|0|||
37784723|NCT02431260|69378978|FG008|Overall Study|Lost to Follow-up|0|||
37784724|NCT02431260|69378979|FG009|Overall Study|Lost to Follow-up|0|||
37784725|NCT02431260|69378980|FG010|Overall Study|Lost to Follow-up|0|||
37784726|NCT02431260|69378981|FG011|Overall Study|Lost to Follow-up|0|||
37784727|NCT02431260|69378982|FG012|Overall Study|Lost to Follow-up|0|||
37784728|NCT02431260|69378983|FG013|Overall Study|Lost to Follow-up|0|||
37693337|NCT02318719|69169539|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
37693338|NCT02318719|69169535|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
37693339|NCT02318719|69169536|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
37693340|NCT02318719|69169537|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
37693341|NCT02318719|69169538|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
37693342|NCT02318719|69169539|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
37693343|NCT02318719|69169535|FG000|Open-label Extension Phase|Other|0|||
37693344|NCT02318719|69169536|FG001|Open-label Extension Phase|Other|0|||
37693345|NCT02318719|69169537|FG002|Open-label Extension Phase|Other|0|||
37693346|NCT02318719|69169538|FG003|Open-label Extension Phase|Other|0|||
37693347|NCT02318719|69169539|FG004|Open-label Extension Phase|Other|7|||
37693348|NCT01870726|69169558|FG000|Overall Study|Withdrawal of informed consent|0|||
37693349|NCT01870726|69169559|FG001|Overall Study|Withdrawal of informed consent|0|||
37693350|NCT01870726|69169560|FG002|Overall Study|Withdrawal of informed consent|0|||
37693351|NCT01870726|69169561|FG003|Overall Study|Withdrawal of informed consent|1|||
37693352|NCT01870726|69169562|FG004|Overall Study|Withdrawal of informed consent|0|||
37693353|NCT01870726|69169563|FG005|Overall Study|Withdrawal of informed consent|0|||
37693354|NCT01870726|69169564|FG006|Overall Study|Withdrawal of informed consent|0|||
37693355|NCT01870726|69169558|FG000|Overall Study|Withdrawal by Subject|0|||
37693356|NCT01870726|69169559|FG001|Overall Study|Withdrawal by Subject|1|||
37693357|NCT01870726|69169560|FG002|Overall Study|Withdrawal by Subject|0|||
37693358|NCT01870726|69169561|FG003|Overall Study|Withdrawal by Subject|0|||
37693359|NCT01870726|69169562|FG004|Overall Study|Withdrawal by Subject|0|||
37693360|NCT01870726|69169563|FG005|Overall Study|Withdrawal by Subject|0|||
37693361|NCT01870726|69169564|FG006|Overall Study|Withdrawal by Subject|0|||
37693362|NCT01870726|69169558|FG000|Overall Study|Adverse Event|0|||
37693363|NCT01870726|69169559|FG001|Overall Study|Adverse Event|0|||
37693364|NCT01870726|69169560|FG002|Overall Study|Adverse Event|0|||
37693365|NCT01870726|69169561|FG003|Overall Study|Adverse Event|0|||
37693366|NCT01870726|69169562|FG004|Overall Study|Adverse Event|1|||
37693367|NCT01870726|69169563|FG005|Overall Study|Adverse Event|1|||
37693368|NCT01870726|69169564|FG006|Overall Study|Adverse Event|0|||
37693369|NCT01870726|69169558|FG000|Overall Study|Progressive disease|5|||
37693370|NCT01870726|69169559|FG001|Overall Study|Progressive disease|5|||
37693371|NCT01870726|69169560|FG002|Overall Study|Progressive disease|4|||
37693372|NCT01870726|69169561|FG003|Overall Study|Progressive disease|5|||
37693373|NCT01870726|69169562|FG004|Overall Study|Progressive disease|6|||
37693374|NCT01870726|69169563|FG005|Overall Study|Progressive disease|4|||
37693375|NCT01870726|69169564|FG006|Overall Study|Progressive disease|10|||
37693376|NCT01900054|69169589|FG000|Overall Study|Physician Decision|1|||
37693377|NCT01900054|69169589|FG000|Overall Study|Withdrawal by Subject|1|||
37693378|NCT01612156|69169595|FG000|Overall Study|Protocol Violation|2|||
37693379|NCT01612156|69169596|FG001|Overall Study|Protocol Violation|0|||
37693380|NCT01899742|69169604|FG000|Overall Study|Adverse Event|5|||
37693381|NCT01899742|69169605|FG001|Overall Study|Adverse Event|4|||
37693382|NCT01899742|69169604|FG000|Overall Study|Lack of Efficacy|1|||
37693383|NCT01899742|69169605|FG001|Overall Study|Lack of Efficacy|5|||
37693384|NCT01899742|69169604|FG000|Overall Study|Protocol Violation|2|||
37693385|NCT01899742|69169605|FG001|Overall Study|Protocol Violation|2|||
37693386|NCT01899742|69169604|FG000|Overall Study|Withdrawal by Subject|9|||
37693387|NCT01899742|69169605|FG001|Overall Study|Withdrawal by Subject|5|||
37693388|NCT01615822|69169614|FG000|Period 1|Withdrawal by Subject|0|||
37693389|NCT01615822|69169615|FG001|Period 1|Withdrawal by Subject|1|||
37693390|NCT01615822|69169616|FG002|Period 1|Withdrawal by Subject|0|||
37693391|NCT01615822|69169614|FG000|Period 1|Adverse Event|1|||
37693392|NCT01615822|69169615|FG001|Period 1|Adverse Event|1|||
37693393|NCT01615822|69169616|FG002|Period 1|Adverse Event|0|||
37784729|NCT02431260|69378970|FG000|Overall Study|Study Terminated by the Sponsor|0|||
37784730|NCT02431260|69378971|FG001|Overall Study|Study Terminated by the Sponsor|0|||
37784731|NCT02431260|69378972|FG002|Overall Study|Study Terminated by the Sponsor|2|||
37784732|NCT02431260|69378973|FG003|Overall Study|Study Terminated by the Sponsor|1|||
37784733|NCT02431260|69378974|FG004|Overall Study|Study Terminated by the Sponsor|1|||
37784734|NCT02431260|69378975|FG005|Overall Study|Study Terminated by the Sponsor|0|||
37784735|NCT02431260|69378976|FG006|Overall Study|Study Terminated by the Sponsor|1|||
37784736|NCT02431260|69378977|FG007|Overall Study|Study Terminated by the Sponsor|2|||
37784737|NCT02431260|69378978|FG008|Overall Study|Study Terminated by the Sponsor|1|||
37784738|NCT02431260|69378979|FG009|Overall Study|Study Terminated by the Sponsor|1|||
37693394|NCT01615822|69169614|FG000|Period 2|Lost to Follow-up|0|||
37693395|NCT01615822|69169615|FG001|Period 2|Lost to Follow-up|1|||
37693396|NCT01615822|69169616|FG002|Period 2|Lost to Follow-up|2|||
37693397|NCT01898884|69169632|FG000|Multiple Dose Period|Adverse Event|0|||
37693398|NCT01898884|69169633|FG001|Multiple Dose Period|Adverse Event|0|||
37693399|NCT01898884|69169634|FG002|Multiple Dose Period|Adverse Event|0|||
37693400|NCT01898884|69169635|FG003|Multiple Dose Period|Adverse Event|0|||
37693401|NCT01898884|69169636|FG004|Multiple Dose Period|Adverse Event|0|||
37693402|NCT01898884|69169637|FG005|Multiple Dose Period|Adverse Event|0|||
37693403|NCT01898884|69169638|FG006|Multiple Dose Period|Adverse Event|1|||
37693404|NCT01898884|69169639|FG007|Multiple Dose Period|Adverse Event|0|||
37693405|NCT01898884|69169640|FG008|Multiple Dose Period|Adverse Event|0|||
37693406|NCT01898884|69169632|FG000|Multiple Dose Period|Randomized Not Treated|0|||
37693407|NCT01898884|69169633|FG001|Multiple Dose Period|Randomized Not Treated|0|||
37693408|NCT01898884|69169634|FG002|Multiple Dose Period|Randomized Not Treated|0|||
37693409|NCT01898884|69169635|FG003|Multiple Dose Period|Randomized Not Treated|0|||
37693410|NCT01898884|69169636|FG004|Multiple Dose Period|Randomized Not Treated|0|||
37693411|NCT01898884|69169637|FG005|Multiple Dose Period|Randomized Not Treated|0|||
37693412|NCT01898884|69169638|FG006|Multiple Dose Period|Randomized Not Treated|0|||
37693413|NCT01898884|69169639|FG007|Multiple Dose Period|Randomized Not Treated|0|||
37693414|NCT01898884|69169640|FG008|Multiple Dose Period|Randomized Not Treated|1|||
37693415|NCT01613326|69169678|FG000|Overall Study|Adverse Event|7|||
37693416|NCT01613326|69169679|FG001|Overall Study|Adverse Event|5|||
37693417|NCT01613326|69169678|FG000|Overall Study|Withdrawal by Subject|3|||
37693418|NCT01613326|69169679|FG001|Overall Study|Withdrawal by Subject|4|||
37693419|NCT01613326|69169678|FG000|Overall Study|Abnormal test procedure result(s)|2|||
37693420|NCT01613326|69169679|FG001|Overall Study|Abnormal test procedure result(s)|0|||
37693421|NCT01613326|69169678|FG000|Overall Study|inability to use device|1|||
37693422|NCT01613326|69169679|FG001|Overall Study|inability to use device|0|||
37693423|NCT01613326|69169678|FG000|Overall Study|Lack of Efficacy|0|||
37693424|NCT01613326|69169679|FG001|Overall Study|Lack of Efficacy|1|||
37693425|NCT01613326|69169678|FG000|Overall Study|Lost to Follow-up|0|||
37693426|NCT01613326|69169679|FG001|Overall Study|Lost to Follow-up|1|||
37693427|NCT01613326|69169678|FG000|Overall Study|Administrative|0|||
37693428|NCT01613326|69169679|FG001|Overall Study|Administrative|2|||
37693429|NCT01613326|69169678|FG000|Overall Study|Protocol Violation|0|||
37693430|NCT01613326|69169679|FG001|Overall Study|Protocol Violation|1|||
37693431|NCT01613248|69169691|FG000|Overall Study|Adverse Event|0|||
37693432|NCT01613248|69169692|FG001|Overall Study|Adverse Event|0|||
37693433|NCT01613248|69169693|FG002|Overall Study|Adverse Event|0|||
37693434|NCT01613248|69169694|FG003|Overall Study|Adverse Event|1|||
37693435|NCT01613248|69169695|FG004|Overall Study|Adverse Event|0|||
37693436|NCT01613248|69169696|FG005|Overall Study|Adverse Event|0|||
37693437|NCT01613248|69169691|FG000|Overall Study|Withdrawal by Subject|3|||
37693438|NCT01613248|69169692|FG001|Overall Study|Withdrawal by Subject|2|||
37693439|NCT01613248|69169693|FG002|Overall Study|Withdrawal by Subject|2|||
37693440|NCT01613248|69169694|FG003|Overall Study|Withdrawal by Subject|5|||
37693441|NCT01613248|69169695|FG004|Overall Study|Withdrawal by Subject|0|||
37693442|NCT01613248|69169696|FG005|Overall Study|Withdrawal by Subject|1|||
37693443|NCT01613248|69169691|FG000|Overall Study|Lost to Follow-up|5|||
37693444|NCT01613248|69169692|FG001|Overall Study|Lost to Follow-up|7|||
37784739|NCT02431260|69378980|FG010|Overall Study|Study Terminated by the Sponsor|1|||
37784740|NCT02431260|69378981|FG011|Overall Study|Study Terminated by the Sponsor|0|||
37693445|NCT01613248|69169693|FG002|Overall Study|Lost to Follow-up|4|||
37693446|NCT01613248|69169694|FG003|Overall Study|Lost to Follow-up|8|||
37693447|NCT01613248|69169695|FG004|Overall Study|Lost to Follow-up|4|||
37693448|NCT01613248|69169696|FG005|Overall Study|Lost to Follow-up|2|||
37693449|NCT01613248|69169691|FG000|Overall Study|Study Terminated by Sponsor|4|||
37693450|NCT01613248|69169692|FG001|Overall Study|Study Terminated by Sponsor|6|||
37693451|NCT01613248|69169693|FG002|Overall Study|Study Terminated by Sponsor|8|||
37693452|NCT01613248|69169694|FG003|Overall Study|Study Terminated by Sponsor|8|||
37693453|NCT01613248|69169695|FG004|Overall Study|Study Terminated by Sponsor|9|||
37784741|NCT02431260|69378982|FG012|Overall Study|Study Terminated by the Sponsor|4|||
37784742|NCT02431260|69378983|FG013|Overall Study|Study Terminated by the Sponsor|0|||
37784743|NCT02431260|69378970|FG000|Overall Study|Physician Decision|0|||
37784744|NCT02431260|69378971|FG001|Overall Study|Physician Decision|0|||
37784745|NCT02431260|69378972|FG002|Overall Study|Physician Decision|0|||
37784746|NCT02431260|69378973|FG003|Overall Study|Physician Decision|0|||
37784747|NCT02431260|69378974|FG004|Overall Study|Physician Decision|0|||
37784748|NCT02431260|69378975|FG005|Overall Study|Physician Decision|1|||
37784749|NCT02431260|69378976|FG006|Overall Study|Physician Decision|0|||
37784750|NCT02431260|69378977|FG007|Overall Study|Physician Decision|0|||
37784751|NCT02431260|69378978|FG008|Overall Study|Physician Decision|0|||
37784752|NCT02431260|69378979|FG009|Overall Study|Physician Decision|0|||
37784753|NCT02431260|69378980|FG010|Overall Study|Physician Decision|0|||
37784754|NCT02431260|69378981|FG011|Overall Study|Physician Decision|0|||
37784755|NCT02431260|69378982|FG012|Overall Study|Physician Decision|0|||
37784756|NCT02431260|69378983|FG013|Overall Study|Physician Decision|0|||
37784757|NCT02431260|69378970|FG000|Overall Study|Other Unspecified|0|||
37784758|NCT02431260|69378971|FG001|Overall Study|Other Unspecified|0|||
37784759|NCT02431260|69378972|FG002|Overall Study|Other Unspecified|0|||
37784760|NCT02431260|69378973|FG003|Overall Study|Other Unspecified|0|||
37784761|NCT02431260|69378974|FG004|Overall Study|Other Unspecified|0|||
37784762|NCT02431260|69378975|FG005|Overall Study|Other Unspecified|0|||
37784763|NCT02431260|69378976|FG006|Overall Study|Other Unspecified|0|||
37784764|NCT02431260|69378977|FG007|Overall Study|Other Unspecified|0|||
37784765|NCT02431260|69378978|FG008|Overall Study|Other Unspecified|0|||
37784766|NCT02431260|69378979|FG009|Overall Study|Other Unspecified|0|||
37784767|NCT02431260|69378980|FG010|Overall Study|Other Unspecified|0|||
37784768|NCT02431260|69378981|FG011|Overall Study|Other Unspecified|1|||
37784769|NCT02431260|69378982|FG012|Overall Study|Other Unspecified|1|||
37784770|NCT02431260|69378983|FG013|Overall Study|Other Unspecified|0|||
37784771|NCT02430870|69379178|FG000|Part 2|Voluntary Withdrawal|0|||
37784772|NCT02430870|69379179|FG001|Part 2|Voluntary Withdrawal|0|||
37784773|NCT02430870|69379180|FG002|Part 2|Voluntary Withdrawal|0|||
37784774|NCT02430870|69379181|FG003|Part 2|Voluntary Withdrawal|0|||
37784775|NCT02430870|69379182|FG004|Part 2|Voluntary Withdrawal|0|||
37784776|NCT02430870|69379183|FG005|Part 2|Voluntary Withdrawal|0|||
37784777|NCT02430870|69379184|FG006|Part 2|Voluntary Withdrawal|1|||
37784778|NCT02430870|69379185|FG007|Part 2|Voluntary Withdrawal|0|||
37784779|NCT02430870|69379178|FG000|Part 2|Other Reason Not Specified|0|||
37784780|NCT02430870|69379179|FG001|Part 2|Other Reason Not Specified|0|||
37784781|NCT02430870|69379180|FG002|Part 2|Other Reason Not Specified|0|||
37784782|NCT02430870|69379181|FG003|Part 2|Other Reason Not Specified|0|||
37784783|NCT02430870|69379182|FG004|Part 2|Other Reason Not Specified|0|||
37784784|NCT02430870|69379183|FG005|Part 2|Other Reason Not Specified|0|||
37784785|NCT02430870|69379184|FG006|Part 2|Other Reason Not Specified|0|||
37784786|NCT02430870|69379185|FG007|Part 2|Other Reason Not Specified|1|||
37784787|NCT02429934|69379251|FG000|Overall Study|Withdrawal by Subject|0|||
37784788|NCT02429934|69379252|FG001|Overall Study|Withdrawal by Subject|2|||
37784789|NCT02429934|69379251|FG000|Overall Study|Adverse Event|2|||
37784790|NCT02429934|69379252|FG001|Overall Study|Adverse Event|0|||
37784791|NCT02429934|69379251|FG000|Overall Study|Lost to Follow-up|1|||
37784792|NCT02429934|69379252|FG001|Overall Study|Lost to Follow-up|1|||
37784793|NCT02429934|69379251|FG000|Overall Study|Physician Decision|1|||
37784794|NCT02429934|69379252|FG001|Overall Study|Physician Decision|0|||
37784795|NCT02429856|69379266|FG000|Overall Study|Death|12|||
37784796|NCT02429856|69379267|FG001|Overall Study|Death|13|||
37784797|NCT02429856|69379266|FG000|Overall Study|Lost to Follow-up|6|||
37693454|NCT01613248|69169696|FG005|Overall Study|Study Terminated by Sponsor|11|||
37693455|NCT01613248|69169691|FG000|Overall Study|Physician Decision|8|||
37693456|NCT01613248|69169692|FG001|Overall Study|Physician Decision|8|||
37693457|NCT01613248|69169693|FG002|Overall Study|Physician Decision|9|||
37693458|NCT01613248|69169694|FG003|Overall Study|Physician Decision|4|||
37693459|NCT01613248|69169695|FG004|Overall Study|Physician Decision|7|||
37693460|NCT01613248|69169696|FG005|Overall Study|Physician Decision|6|||
37693461|NCT01613248|69169691|FG000|Overall Study|Lack of Qualifying Event|9|||
37693462|NCT01613248|69169692|FG001|Overall Study|Lack of Qualifying Event|11|||
37693463|NCT01613248|69169693|FG002|Overall Study|Lack of Qualifying Event|10|||
37693464|NCT01613248|69169694|FG003|Overall Study|Lack of Qualifying Event|11|||
37784798|NCT02429856|69379267|FG001|Overall Study|Lost to Follow-up|5|||
37784799|NCT02429856|69379266|FG000|Overall Study|Withdrawal by Subject|1|||
37784800|NCT02429856|69379267|FG001|Overall Study|Withdrawal by Subject|1|||
37784801|NCT02429778|69379277|FG000|Overall Study|Lost to Follow-up|2|||
37784802|NCT02429778|69379278|FG001|Overall Study|Lost to Follow-up|0|||
37693465|NCT01613248|69169695|FG004|Overall Study|Lack of Qualifying Event|15|||
37784803|NCT02429778|69379277|FG000|Overall Study|Withdrawal by Subject|5|||
37784804|NCT02429778|69379278|FG001|Overall Study|Withdrawal by Subject|0|||
37784805|NCT02403180|69379286|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
37693466|NCT01613248|69169696|FG005|Overall Study|Lack of Qualifying Event|18|||
37864047|NCT01119105|69547703|FG002|Overall Study|Adverse Event|1|||
37784806|NCT02403180|69379287|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
37784807|NCT02403180|69379286|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
37693467|NCT01613248|69169691|FG000|Overall Study|Pregnancy|0|||
37693468|NCT01613248|69169692|FG001|Overall Study|Pregnancy|0|||
37784808|NCT02403180|69379287|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
37784809|NCT00558467|69379321|FG000|Overall Study|Adverse Event|1|||
37784810|NCT00558467|69379322|FG001|Overall Study|Adverse Event|2|||
37784811|NCT00558467|69379321|FG000|Overall Study|Lack of Efficacy|0|||
37784812|NCT00558467|69379322|FG001|Overall Study|Lack of Efficacy|1|||
37784813|NCT00558467|69379321|FG000|Overall Study|Patient moving out of state|0|||
37784814|NCT00558467|69379322|FG001|Overall Study|Patient moving out of state|1|||
37784815|NCT02402166|69379328|FG000|Overall Study|Adverse Event|2|||
37784816|NCT02402166|69379328|FG000|Overall Study|Withdrawal by Subject|2|||
37784817|NCT02402166|69379328|FG000|Overall Study|Lost to Follow-up|1|||
37784818|NCT02378220|69379348|FG000|Overall Study|Death|6|||
37784819|NCT02378220|69379349|FG001|Overall Study|Death|1|||
37784820|NCT02401308|69379358|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
37784821|NCT02401308|69379359|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
37784822|NCT02401230|69379368|FG000|Overall Study|Adverse Event|3|||
37784823|NCT02401230|69379369|FG001|Overall Study|Adverse Event|2|||
37784824|NCT02401230|69379370|FG002|Overall Study|Adverse Event|0|||
37784825|NCT02401230|69379368|FG000|Overall Study|Withdrawal by Subject|2|||
37784826|NCT02401230|69379369|FG001|Overall Study|Withdrawal by Subject|1|||
37784827|NCT02401230|69379370|FG002|Overall Study|Withdrawal by Subject|1|||
37784828|NCT02401230|69379368|FG000|Overall Study|Lost to Follow-up|1|||
37784829|NCT02401230|69379369|FG001|Overall Study|Lost to Follow-up|3|||
37784830|NCT02401230|69379370|FG002|Overall Study|Lost to Follow-up|3|||
37784831|NCT02429310|69379411|FG000|Overall Study|Lost to Follow-up|1|||
37784832|NCT02429310|69379412|FG001|Overall Study|Lost to Follow-up|2|||
37784833|NCT02429310|69379411|FG000|Overall Study|Protocol Violation|1|||
37784834|NCT02429310|69379412|FG001|Overall Study|Protocol Violation|1|||
37784835|NCT02428608|69379438|FG000|Overall Study|Pregnancy|2|||
37784836|NCT02428608|69379438|FG000|Overall Study|Lost to Follow-up|37|||
37784837|NCT02428608|69379438|FG000|Overall Study|Withdrawal by Subject|2|||
37784838|NCT02428608|69379438|FG000|Overall Study|scheduling conflicts|15|||
37784839|NCT02428608|69379438|FG000|Overall Study|moved away|10|||
37784840|NCT02428608|69379438|FG000|Overall Study|Death|1|||
37784841|NCT02428608|69379438|FG000|Overall Study|various|16|||
37784842|NCT02428296|69379458|FG000|Overall Study|Adverse Event|7|||
37784843|NCT02428296|69379458|FG000|Overall Study|Withdrawal by Subject|2|||
37784844|NCT02427984|69379472|FG000|Overall Study|Lost to Follow-up|13|||
37784845|NCT02427984|69379473|FG001|Overall Study|Lost to Follow-up|5|||
37784846|NCT02427984|69379474|FG002|Overall Study|Lost to Follow-up|18|||
37784847|NCT00556673|69379692|FG000|Overall Study|Protocol deviation|3|||
37784848|NCT00556673|69379693|FG001|Overall Study|Protocol deviation|2|||
37784849|NCT02402322|69379717|FG000|Pretreatment|Withdrawal by Subject|3|||
37784850|NCT02402322|69379718|FG001|Pretreatment|Withdrawal by Subject|1|||
37784851|NCT02402322|69379719|FG002|Pretreatment|Withdrawal by Subject|1|||
37784852|NCT02402322|69379717|FG000|Follow-up|Withdrawal by Subject|6|||
37784853|NCT02402322|69379718|FG001|Follow-up|Withdrawal by Subject|3|||
37693469|NCT01613248|69169693|FG002|Overall Study|Pregnancy|0|||
37693470|NCT01613248|69169694|FG003|Overall Study|Pregnancy|1|||
37693471|NCT01613248|69169695|FG004|Overall Study|Pregnancy|0|||
37693472|NCT01613248|69169696|FG005|Overall Study|Pregnancy|0|||
37693473|NCT01898806|69169710|FG000|Overall Study|Withdrawal by Subject|2|||
37693474|NCT01898806|69169710|FG000|Overall Study|Physician Decision|1|||
37693475|NCT02291029|69169720|FG000|Overall Study|Withdrawal by Subject|0|||
37693476|NCT02291029|69169721|FG001|Overall Study|Withdrawal by Subject|0|||
37693477|NCT02291029|69169722|FG002|Overall Study|Withdrawal by Subject|1|||
37784854|NCT02402322|69379719|FG002|Follow-up|Withdrawal by Subject|24|||
37784855|NCT00555425|69379835|FG000|Overall Study|Missed Medication > 1 wk|34|||
37784856|NCT00555425|69379836|FG001|Overall Study|Missed Medication > 1 wk|15|||
37784857|NCT00555425|69379835|FG000|Overall Study|Missed 3 physician management visits|1|||
37693478|NCT02291029|69169723|FG003|Overall Study|Withdrawal by Subject|0|||
37693479|NCT02291029|69169724|FG004|Overall Study|Withdrawal by Subject|0|||
37693480|NCT02291029|69169725|FG005|Overall Study|Withdrawal by Subject|0|||
37784858|NCT00555425|69379836|FG001|Overall Study|Missed 3 physician management visits|0|||
37784859|NCT00555425|69379835|FG000|Overall Study|Met criteria for protective transfer|16|||
37693481|NCT02291029|69169720|FG000|Overall Study|Adverse Event|0|||
37693482|NCT02291029|69169721|FG001|Overall Study|Adverse Event|1|||
37784860|NCT00555425|69379836|FG001|Overall Study|Met criteria for protective transfer|3|||
37784861|NCT00555425|69379835|FG000|Overall Study|Became pregnant and transferred care|0|||
37784862|NCT00555425|69379836|FG001|Overall Study|Became pregnant and transferred care|1|||
37784863|NCT00554099|69380017|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
37784864|NCT00554099|69380018|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
37784865|NCT00554099|69380019|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
37784866|NCT00554099|69380017|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
37784867|NCT00554099|69380018|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
37784868|NCT00554099|69380019|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
37784869|NCT00554099|69380017|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
37784870|NCT00554099|69380018|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
37784871|NCT00554099|69380019|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
37784872|NCT00554099|69380017|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
37784873|NCT00554099|69380018|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
37784874|NCT00554099|69380019|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
37784875|NCT00554099|69380017|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
37784876|NCT00554099|69380018|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
37784877|NCT00554099|69380019|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
37784878|NCT00554099|69380017|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
37784879|NCT00554099|69380018|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
37784880|NCT00554099|69380019|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
37784881|NCT00554099|69380017|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
37784882|NCT00554099|69380018|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
37784883|NCT00554099|69380019|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
37784884|NCT00554099|69380017|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
37693483|NCT02291029|69169722|FG002|Overall Study|Adverse Event|0|||
37693484|NCT02291029|69169723|FG003|Overall Study|Adverse Event|0|||
37693485|NCT02291029|69169724|FG004|Overall Study|Adverse Event|0|||
37693486|NCT02291029|69169725|FG005|Overall Study|Adverse Event|0|||
37693487|NCT02290873|69169742|FG000|Overall Study|Withdrawal by Subject|0|||
37693488|NCT02290873|69169743|FG001|Overall Study|Withdrawal by Subject|1|||
37693489|NCT02290873|69169744|FG002|Overall Study|Withdrawal by Subject|1|||
37693490|NCT02290873|69169742|FG000|Overall Study|Nellcor device error|1|||
37693491|NCT02290873|69169743|FG001|Overall Study|Nellcor device error|0|||
37693492|NCT02290873|69169744|FG002|Overall Study|Nellcor device error|0|||
37784885|NCT00554099|69380018|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
37784886|NCT00554099|69380019|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
37784887|NCT00554099|69380017|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
37784888|NCT00554099|69380018|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
37784889|NCT00554099|69380019|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
37784890|NCT02377362|69380053|FG000|Part A Second Treatment|Protocol Violation|0|||
37693493|NCT02290873|69169742|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
37693494|NCT02290873|69169743|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
37693495|NCT02290873|69169744|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
37693496|NCT02290873|69169742|FG000|Overall Study|Protocol Violation|0|||
37693497|NCT02290873|69169743|FG001|Overall Study|Protocol Violation|0|||
37693498|NCT02290873|69169744|FG002|Overall Study|Protocol Violation|1|||
37693499|NCT02290405|69169755|FG000|Overall Study|Withdrawal by Subject|1|||
37693500|NCT02290405|69169756|FG001|Overall Study|Withdrawal by Subject|0|||
37693501|NCT02359045|69169764|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
37693502|NCT02359045|69169765|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
37693503|NCT02359045|69169764|FG000|Overall Study|Lost to Follow-up|1|||
37693504|NCT02359045|69169765|FG001|Overall Study|Lost to Follow-up|1|||
37693505|NCT02359045|69169764|FG000|Overall Study|Adverse Event|0|||
37693506|NCT02359045|69169765|FG001|Overall Study|Adverse Event|1|||
37693507|NCT02358343|69169786|FG000|Screening Intervention|Death|0|||
37693508|NCT02358343|69169787|FG001|Screening Intervention|Death|2|||
37693509|NCT02358343|69169788|FG002|Screening Intervention|Death|0|||
37693510|NCT02358343|69169789|FG003|Screening Intervention|Death|0|||
37693511|NCT02358343|69169790|FG004|Screening Intervention|Death|0|||
37693512|NCT02358343|69169786|FG000|Screening Intervention|Withdrawal by Subject|1|||
37693513|NCT02358343|69169787|FG001|Screening Intervention|Withdrawal by Subject|0|||
37693514|NCT02358343|69169788|FG002|Screening Intervention|Withdrawal by Subject|0|||
37693515|NCT02358343|69169789|FG003|Screening Intervention|Withdrawal by Subject|0|||
37693516|NCT02358343|69169790|FG004|Screening Intervention|Withdrawal by Subject|0|||
37693517|NCT02358343|69169786|FG000|Screening Intervention|Determined Ineligible|5|||
37693518|NCT02358343|69169787|FG001|Screening Intervention|Determined Ineligible|6|||
37693519|NCT02358343|69169788|FG002|Screening Intervention|Determined Ineligible|0|||
37693520|NCT02358343|69169789|FG003|Screening Intervention|Determined Ineligible|0|||
37693521|NCT02358343|69169790|FG004|Screening Intervention|Determined Ineligible|0|||
37693522|NCT02358343|69169786|FG000|Comparative Efficacy Trial / Observation|Death|0|||
37693523|NCT02358343|69169787|FG001|Comparative Efficacy Trial / Observation|Death|0|||
37693524|NCT02358343|69169788|FG002|Comparative Efficacy Trial / Observation|Death|2|||
37693525|NCT02358343|69169789|FG003|Comparative Efficacy Trial / Observation|Death|0|||
37693526|NCT02358343|69169790|FG004|Comparative Efficacy Trial / Observation|Death|0|||
37693527|NCT02358343|69169786|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
37693528|NCT02358343|69169787|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
37693529|NCT02358343|69169788|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
37693530|NCT02358343|69169789|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
37693531|NCT02358343|69169790|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
37693532|NCT02358343|69169786|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
37693533|NCT02358343|69169787|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
37693534|NCT02358343|69169788|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
37693535|NCT02358343|69169789|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
37693536|NCT02358343|69169790|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
37693537|NCT02356783|69169803|FG000|Overall Study|Lost to Follow-up|1|||
37693538|NCT02356783|69169804|FG001|Overall Study|Lost to Follow-up|3|||
37693539|NCT02289469|69169812|FG000|Overall Study|Unable to match a control|6|||
37693540|NCT02289469|69169813|FG001|Overall Study|Unable to match a control|0|||
37693541|NCT02318095|69169819|FG000|Overall Study|Adverse Event|1|||
37693542|NCT02317705|69169824|FG000|Overall Study|Withdrawal by Subject|3|||
37693543|NCT02317705|69169824|FG000|Overall Study|Physician Decision|1|||
37693544|NCT02317705|69169824|FG000|Overall Study|Drug not usable|1|||
37693545|NCT02474069|69169828|FG000|Selection Phase (SP)|Adverse Event|8|||
37693546|NCT02474069|69169829|FG001|Selection Phase (SP)|Adverse Event|0|||
37693547|NCT02474069|69169830|FG002|Selection Phase (SP)|Adverse Event|0|||
37693548|NCT02474069|69169828|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
37693549|NCT02474069|69169829|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
37693550|NCT02474069|69169830|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
37784891|NCT02377362|69380054|FG001|Part A Second Treatment|Protocol Violation|0|||
37784892|NCT02377362|69380055|FG002|Part A Second Treatment|Protocol Violation|0|||
37784893|NCT02377362|69380056|FG003|Part A Second Treatment|Protocol Violation|0|||
37784894|NCT02377362|69380057|FG004|Part A Second Treatment|Protocol Violation|1|||
37784895|NCT02377362|69380058|FG005|Part A Second Treatment|Protocol Violation|0|||
37784896|NCT02377362|69380059|FG006|Part A Second Treatment|Protocol Violation|0|||
37784897|NCT02377362|69380060|FG007|Part A Second Treatment|Protocol Violation|0|||
37784898|NCT02377362|69380061|FG008|Part A Second Treatment|Protocol Violation|0|||
37784899|NCT02377362|69380062|FG009|Part A Second Treatment|Protocol Violation|0|||
37784900|NCT02377362|69380063|FG010|Part A Second Treatment|Protocol Violation|0|||
37784901|NCT02377362|69380064|FG011|Part A Second Treatment|Protocol Violation|0|||
37784902|NCT02377362|69380065|FG012|Part A Second Treatment|Protocol Violation|0|||
37784903|NCT02377362|69380053|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
37784904|NCT02377362|69380054|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
37784905|NCT02377362|69380055|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
37784906|NCT02377362|69380056|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
37784907|NCT02377362|69380057|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
37784908|NCT02377362|69380058|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
37784909|NCT02377362|69380059|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
37784910|NCT02377362|69380060|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
37784911|NCT02377362|69380061|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
37784912|NCT02377362|69380062|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
37784913|NCT02377362|69380063|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
37784914|NCT02377362|69380064|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
37784915|NCT02377362|69380065|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
37784916|NCT02377362|69380053|FG000|Part B Overall|Protocol Violation|0|||
37784917|NCT02377362|69380054|FG001|Part B Overall|Protocol Violation|0|||
37784918|NCT02377362|69380055|FG002|Part B Overall|Protocol Violation|0|||
37784919|NCT02377362|69380056|FG003|Part B Overall|Protocol Violation|0|||
37784920|NCT02377362|69380057|FG004|Part B Overall|Protocol Violation|0|||
37784921|NCT02377362|69380058|FG005|Part B Overall|Protocol Violation|0|||
37784922|NCT02377362|69380059|FG006|Part B Overall|Protocol Violation|0|||
37784923|NCT02377362|69380060|FG007|Part B Overall|Protocol Violation|0|||
37784924|NCT02377362|69380061|FG008|Part B Overall|Protocol Violation|0|||
37784925|NCT02377362|69380062|FG009|Part B Overall|Protocol Violation|1|||
37784926|NCT02377362|69380063|FG010|Part B Overall|Protocol Violation|0|||
37784927|NCT02377362|69380064|FG011|Part B Overall|Protocol Violation|0|||
37784928|NCT02377362|69380065|FG012|Part B Overall|Protocol Violation|0|||
37784929|NCT02377362|69380053|FG000|Part B Overall|Adverse Event|0|||
37784930|NCT02377362|69380054|FG001|Part B Overall|Adverse Event|0|||
37784931|NCT02377362|69380055|FG002|Part B Overall|Adverse Event|0|||
37784932|NCT02377362|69380056|FG003|Part B Overall|Adverse Event|0|||
37784933|NCT02377362|69380057|FG004|Part B Overall|Adverse Event|0|||
37784934|NCT02377362|69380058|FG005|Part B Overall|Adverse Event|0|||
37784935|NCT02377362|69380059|FG006|Part B Overall|Adverse Event|1|||
37784936|NCT02377362|69380060|FG007|Part B Overall|Adverse Event|1|||
37784937|NCT02377362|69380061|FG008|Part B Overall|Adverse Event|0|||
37784938|NCT02377362|69380062|FG009|Part B Overall|Adverse Event|0|||
37784939|NCT02377362|69380063|FG010|Part B Overall|Adverse Event|0|||
37784940|NCT02377362|69380064|FG011|Part B Overall|Adverse Event|0|||
37784941|NCT02377362|69380065|FG012|Part B Overall|Adverse Event|0|||
37784942|NCT02377362|69380053|FG000|Part B Overall|Withdrawal by Subject|0|||
37784943|NCT02377362|69380054|FG001|Part B Overall|Withdrawal by Subject|0|||
37784944|NCT02377362|69380055|FG002|Part B Overall|Withdrawal by Subject|0|||
37784945|NCT02377362|69380056|FG003|Part B Overall|Withdrawal by Subject|0|||
37784946|NCT02377362|69380057|FG004|Part B Overall|Withdrawal by Subject|0|||
37784947|NCT02377362|69380058|FG005|Part B Overall|Withdrawal by Subject|0|||
37784948|NCT02377362|69380059|FG006|Part B Overall|Withdrawal by Subject|1|||
37784949|NCT02377362|69380060|FG007|Part B Overall|Withdrawal by Subject|0|||
37784950|NCT02377362|69380061|FG008|Part B Overall|Withdrawal by Subject|0|||
37784951|NCT02377362|69380062|FG009|Part B Overall|Withdrawal by Subject|0|||
37784952|NCT02377362|69380063|FG010|Part B Overall|Withdrawal by Subject|0|||
37693551|NCT02474069|69169828|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
37693552|NCT02474069|69169829|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
37693553|NCT02474069|69169830|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
37693554|NCT02474069|69169828|FG000|Selection Phase (SP)|Physician Decision|1|||
37693555|NCT02474069|69169829|FG001|Selection Phase (SP)|Physician Decision|0|||
37693556|NCT02474069|69169830|FG002|Selection Phase (SP)|Physician Decision|0|||
37693557|NCT02474069|69169828|FG000|Selection Phase (SP)|Protocol Violation|1|||
37693558|NCT02474069|69169829|FG001|Selection Phase (SP)|Protocol Violation|0|||
37693559|NCT02474069|69169830|FG002|Selection Phase (SP)|Protocol Violation|0|||
37784953|NCT02377362|69380064|FG011|Part B Overall|Withdrawal by Subject|1|||
37784954|NCT02377362|69380065|FG012|Part B Overall|Withdrawal by Subject|0|||
37784955|NCT00553631|69380105|FG000|Overall Study|Withdrawal by Subject|0|||
37784956|NCT00553631|69380106|FG001|Overall Study|Withdrawal by Subject|1|||
37784957|NCT00553631|69380105|FG000|Overall Study|Lost to Follow-up|1|||
37784958|NCT00553631|69380106|FG001|Overall Study|Lost to Follow-up|0|||
37974984|NCT00401193|69662221|FG002|Overall Study|Withdrawal by Subject|1|||
37974985|NCT00401193|69662219|FG000|Overall Study|Other Event|3|||
37974986|NCT00401193|69662220|FG001|Overall Study|Other Event|2|||
37974987|NCT00401193|69662221|FG002|Overall Study|Other Event|2|||
37974988|NCT00400569|69662230|FG000|Overall Study|Death|1|||
37974989|NCT00413049|69662239|FG000|Overall Study|Adverse Event|10|||
37693560|NCT02474069|69169828|FG000|Selection Phase (SP)|No longer requires treatment|1|||
37693561|NCT02474069|69169829|FG001|Selection Phase (SP)|No longer requires treatment|0|||
37974990|NCT00413049|69662240|FG001|Overall Study|Adverse Event|8|||
37974991|NCT00413049|69662239|FG000|Overall Study|Withdrawal by Subject|7|||
37974992|NCT00413049|69662240|FG001|Overall Study|Withdrawal by Subject|5|||
37974993|NCT00413049|69662239|FG000|Overall Study|Lost to Follow-up|2|||
37974994|NCT00413049|69662240|FG001|Overall Study|Lost to Follow-up|3|||
37974995|NCT00413049|69662239|FG000|Overall Study|Protocol Violation|3|||
37974996|NCT00413049|69662240|FG001|Overall Study|Protocol Violation|1|||
37974997|NCT00413049|69662239|FG000|Overall Study|Subject no longer requires study drug|0|||
37974998|NCT00413049|69662240|FG001|Overall Study|Subject no longer requires study drug|1|||
37974999|NCT00413049|69662239|FG000|Overall Study|Abnormal laboratory value(s)|1|||
37975000|NCT00413049|69662240|FG001|Overall Study|Abnormal laboratory value(s)|0|||
37975001|NCT00413049|69662239|FG000|Overall Study|Lack of Efficacy|1|||
37975002|NCT00413049|69662240|FG001|Overall Study|Lack of Efficacy|0|||
37975003|NCT00454194|69662248|FG000|Overall Study|Adverse Event|7|||
37975004|NCT00454194|69662249|FG001|Overall Study|Adverse Event|2|||
37975005|NCT00454194|69662248|FG000|Overall Study|Withdrawal by Subject|12|||
37975006|NCT00454194|69662249|FG001|Overall Study|Withdrawal by Subject|8|||
37975007|NCT00454194|69662248|FG000|Overall Study|Other Medical Problems|1|||
37975008|NCT00454194|69662249|FG001|Overall Study|Other Medical Problems|2|||
37975009|NCT00454194|69662248|FG000|Overall Study|Other Unspecified Reason|2|||
37975010|NCT00454194|69662249|FG001|Overall Study|Other Unspecified Reason|2|||
37975011|NCT00412971|69662257|FG000|Overall Study|Lost to Follow-up|17|||
37975012|NCT00412971|69662258|FG001|Overall Study|Lost to Follow-up|9|||
37975013|NCT00412971|69662257|FG000|Overall Study|Protocol Violation|13|||
37975014|NCT00412971|69662258|FG001|Overall Study|Protocol Violation|1|||
37693562|NCT02474069|69169830|FG002|Selection Phase (SP)|No longer requires treatment|0|||
37693563|NCT02474069|69169828|FG000|Selection Phase (SP)|Technical Problem|1|||
37693564|NCT02474069|69169829|FG001|Selection Phase (SP)|Technical Problem|0|||
37693565|NCT02474069|69169830|FG002|Selection Phase (SP)|Technical Problem|0|||
37693566|NCT02474069|69169828|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
37693567|NCT02474069|69169829|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
37693568|NCT02474069|69169830|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
37784959|NCT00553319|69380115|FG000|Overall Study|Lost to Follow-up|10|||
37975015|NCT00303472|69662271|FG000|Treatment Period|Adverse Event|0|||
37784960|NCT00553319|69380116|FG001|Overall Study|Lost to Follow-up|9|||
37975016|NCT00303472|69662272|FG001|Treatment Period|Adverse Event|0|||
37784961|NCT00553319|69380117|FG002|Overall Study|Lost to Follow-up|5|||
37784962|NCT00553319|69380115|FG000|Overall Study|wanted treatment elsewhere|2|||
37784963|NCT00553319|69380116|FG001|Overall Study|wanted treatment elsewhere|1|||
37784964|NCT00553319|69380117|FG002|Overall Study|wanted treatment elsewhere|1|||
37784965|NCT00553319|69380115|FG000|Overall Study|non-compliance|0|||
37784966|NCT00553319|69380116|FG001|Overall Study|non-compliance|0|||
37784967|NCT00553319|69380117|FG002|Overall Study|non-compliance|2|||
37784968|NCT00553319|69380115|FG000|Overall Study|incarceration|1|||
37784969|NCT00553319|69380116|FG001|Overall Study|incarceration|0|||
37784970|NCT00553319|69380117|FG002|Overall Study|incarceration|0|||
37784971|NCT00553319|69380115|FG000|Overall Study|moved|1|||
37784972|NCT00553319|69380116|FG001|Overall Study|moved|0|||
37784973|NCT00553319|69380117|FG002|Overall Study|moved|1|||
37784974|NCT01649856|69380303|FG000|Overall Study|Withdrawal by Subject|14|||
37784975|NCT01649856|69380304|FG001|Overall Study|Withdrawal by Subject|14|||
37784976|NCT01649856|69380303|FG000|Overall Study|Protocol Violation|4|||
37784977|NCT01649856|69380304|FG001|Overall Study|Protocol Violation|4|||
37784978|NCT01649856|69380303|FG000|Overall Study|Treatment Failure|1|||
37784979|NCT01649856|69380304|FG001|Overall Study|Treatment Failure|1|||
37784980|NCT01649856|69380303|FG000|Overall Study|Death|69|||
37784981|NCT01649856|69380304|FG001|Overall Study|Death|34|||
37784982|NCT01649856|69380303|FG000|Overall Study|Stable or Progressed Disease|5|||
37784983|NCT01649856|69380304|FG001|Overall Study|Stable or Progressed Disease|3|||
37784984|NCT01649856|69380303|FG000|Overall Study|Lost to Follow-up|20|||
37784985|NCT01649856|69380304|FG001|Overall Study|Lost to Follow-up|16|||
37784986|NCT01649856|69380303|FG000|Overall Study|Lack of Compliance|6|||
37784987|NCT01649856|69380304|FG001|Overall Study|Lack of Compliance|1|||
37784988|NCT01649856|69380303|FG000|Overall Study|Other|20|||
37784989|NCT01649856|69380304|FG001|Overall Study|Other|5|||
37784990|NCT02375724|69380325|FG000|Overall Study|Lack of Efficacy|1|||
37784991|NCT02375724|69380326|FG001|Overall Study|Lack of Efficacy|1|||
37784992|NCT02375724|69380325|FG000|Overall Study|Withdrawal by Subject|1|||
37784993|NCT02375724|69380326|FG001|Overall Study|Withdrawal by Subject|1|||
37784994|NCT02375724|69380325|FG000|Overall Study|Lost to Follow-up|1|||
37784995|NCT02375724|69380326|FG001|Overall Study|Lost to Follow-up|0|||
37784996|NCT02375724|69380325|FG000|Overall Study|Protocol Violation|1|||
37784997|NCT02375724|69380326|FG001|Overall Study|Protocol Violation|0|||
37784998|NCT02375724|69380325|FG000|Overall Study|Adverse Event|2|||
37784999|NCT02375724|69380326|FG001|Overall Study|Adverse Event|4|||
37785000|NCT02398188|69380334|FG000|Overall Study|Adverse Event|2|||
37785001|NCT02398188|69380335|FG001|Overall Study|Adverse Event|3|||
37785002|NCT02398188|69380334|FG000|Overall Study|Lost to Follow-up|5|||
37785003|NCT02398188|69380335|FG001|Overall Study|Lost to Follow-up|0|||
37785004|NCT02398188|69380334|FG000|Overall Study|Non-compliance|4|||
37785005|NCT02398188|69380335|FG001|Overall Study|Non-compliance|4|||
37785006|NCT02398188|69380334|FG000|Overall Study|Protocol Violation|6|||
37785007|NCT02398188|69380335|FG001|Overall Study|Protocol Violation|10|||
37785008|NCT02398188|69380334|FG000|Overall Study|Sponsor Decision|2|||
37785009|NCT02398188|69380335|FG001|Overall Study|Sponsor Decision|1|||
37785010|NCT02398188|69380334|FG000|Overall Study|Pregnancy|1|||
37785011|NCT02398188|69380335|FG001|Overall Study|Pregnancy|0|||
37785012|NCT02398188|69380334|FG000|Overall Study|Withdrawal by Subject|7|||
37785013|NCT02398188|69380335|FG001|Overall Study|Withdrawal by Subject|16|||
37785014|NCT02426580|69380343|FG000|Overall Study|Death|2|||
37785015|NCT02426580|69380344|FG001|Overall Study|Death|2|||
37785016|NCT02426580|69380343|FG000|Overall Study|Lost to Follow-up|0|||
37785017|NCT02426580|69380344|FG001|Overall Study|Lost to Follow-up|9|||
37785018|NCT02426580|69380343|FG000|Overall Study|transfer to hemodialysis|5|||
37785019|NCT02426580|69380344|FG001|Overall Study|transfer to hemodialysis|5|||
37785020|NCT02426580|69380343|FG000|Overall Study|Kidney transplant|3|||
37785021|NCT02426580|69380344|FG001|Overall Study|Kidney transplant|0|||
37785022|NCT02426580|69380343|FG000|Overall Study|Allergic to egg white|1|||
37785023|NCT02426580|69380344|FG001|Overall Study|Allergic to egg white|0|||
37785024|NCT01651260|69380350|FG000|Overall Study|unable to apply product|3|||
37785025|NCT02425098|69380370|FG000|Overall Study|Lost to Follow-up|7|||
37785026|NCT02425098|69380371|FG001|Overall Study|Lost to Follow-up|7|||
37785027|NCT02425098|69380370|FG000|Overall Study|Withdrawal by Subject|4|||
37785028|NCT02425098|69380371|FG001|Overall Study|Withdrawal by Subject|8|||
37785029|NCT02425098|69380370|FG000|Overall Study|Pregnancy|2|||
37785030|NCT02425098|69380371|FG001|Overall Study|Pregnancy|0|||
37785031|NCT02425098|69380370|FG000|Overall Study|Reason not Specified|0|||
37785032|NCT02425098|69380371|FG001|Overall Study|Reason not Specified|1|||
37785033|NCT02424630|69380379|FG000|Overall Study|No rotator cuff tear|1|||
37785034|NCT02424630|69380380|FG001|Overall Study|No rotator cuff tear|2|||
37785035|NCT02424630|69380379|FG000|Overall Study|Open procedure|0|||
37785036|NCT02424630|69380380|FG001|Overall Study|Open procedure|1|||
37785037|NCT02397408|69380386|FG000|Overall Study|Physician Decision|4|||
37785038|NCT02397408|69380386|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
37785039|NCT02397096|69380392|FG000|Day 1 to Week 24|Adverse Event|7|||
37785040|NCT02397096|69380393|FG001|Day 1 to Week 24|Adverse Event|1|||
37785041|NCT02397096|69380392|FG000|Day 1 to Week 24|Death|1|||
37785042|NCT02397096|69380393|FG001|Day 1 to Week 24|Death|0|||
37785043|NCT02397096|69380392|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
37785044|NCT02397096|69380393|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
37785045|NCT02397096|69380392|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
37785046|NCT02397096|69380393|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
37785047|NCT02397096|69380392|FG000|Day 1 to Week 24|Physician Decision|2|||
37785048|NCT02397096|69380393|FG001|Day 1 to Week 24|Physician Decision|3|||
37785049|NCT02397096|69380392|FG000|Day 1 to Week 24|Protocol Violation|1|||
37785050|NCT02397096|69380393|FG001|Day 1 to Week 24|Protocol Violation|4|||
37785051|NCT02397096|69380392|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
37785052|NCT02397096|69380393|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
37785053|NCT02397096|69380392|FG000|Week 24 to Week 48|Adverse Event|6|||
37785054|NCT02397096|69380393|FG001|Week 24 to Week 48|Adverse Event|2|||
37785055|NCT02397096|69380392|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
37785056|NCT02397096|69380393|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
37785057|NCT02397096|69380392|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
37785058|NCT02397096|69380393|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
37785059|NCT02397096|69380392|FG000|Week 24 to Week 48|Physician Decision|2|||
37785060|NCT02397096|69380393|FG001|Week 24 to Week 48|Physician Decision|1|||
37785061|NCT02397096|69380392|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
37785062|NCT02397096|69380393|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
37785063|NCT02397096|69380392|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
37785064|NCT02397096|69380393|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
37785065|NCT02397096|69380392|FG000|Study Extensions|Ongoing|399|||
37785066|NCT02397096|69380393|FG001|Study Extensions|Ongoing|202|||
37785067|NCT02372058|69380403|FG000|Overall Study|Withdrawal by Subject|3|||
37785068|NCT02396316|69380411|FG000|Overall Study|Physician Decision|1|||
37785069|NCT02396316|69380412|FG001|Overall Study|Physician Decision|0|||
37785070|NCT02396316|69380411|FG000|Overall Study|Progressive disease|6|||
37785071|NCT02396316|69380412|FG001|Overall Study|Progressive disease|3|||
37785072|NCT02396316|69380411|FG000|Overall Study|Protocol Violation|0|||
37785073|NCT02396316|69380412|FG001|Overall Study|Protocol Violation|1|||
37785074|NCT02396316|69380411|FG000|Overall Study|Treatment unblinded|0|||
37785075|NCT02396316|69380412|FG001|Overall Study|Treatment unblinded|1|||
37785076|NCT02395536|69380422|FG000|Overall Study|Lost to Follow-up|4|||
37785077|NCT02395536|69380423|FG001|Overall Study|Lost to Follow-up|4|||
37785078|NCT02395536|69380422|FG000|Overall Study|Death|2|||
37785079|NCT02395536|69380423|FG001|Overall Study|Death|0|||
37785080|NCT02395536|69380422|FG000|Overall Study|Physician Decision|4|||
37785081|NCT02395536|69380423|FG001|Overall Study|Physician Decision|6|||
37785082|NCT02395536|69380422|FG000|Overall Study|Withdrawal by Subject|9|||
37785083|NCT02395536|69380423|FG001|Overall Study|Withdrawal by Subject|17|||
37785084|NCT02395536|69380422|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
37785085|NCT02395536|69380423|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
37785086|NCT02395536|69380422|FG000|Overall Study|Insurance issue|0|||
37785087|NCT02395536|69380423|FG001|Overall Study|Insurance issue|1|||
37785088|NCT00552929|69380439|FG000|Overall Study|Lost to Follow-up|0|||
37785089|NCT00552929|69380440|FG001|Overall Study|Lost to Follow-up|0|||
37975017|NCT00303472|69662273|FG002|Treatment Period|Adverse Event|0|||
37975018|NCT00303472|69662274|FG003|Treatment Period|Adverse Event|0|||
37975019|NCT00303472|69662275|FG004|Treatment Period|Adverse Event|1|||
37975020|NCT00303472|69662276|FG005|Treatment Period|Adverse Event|0|||
37975021|NCT00303472|69662277|FG006|Treatment Period|Adverse Event|0|||
37975022|NCT00303472|69662271|FG000|Treatment Period|Death|0|||
37785090|NCT00552929|69380441|FG002|Overall Study|Lost to Follow-up|0|||
37785091|NCT00552929|69380442|FG003|Overall Study|Lost to Follow-up|0|||
37785092|NCT00552929|69380443|FG004|Overall Study|Lost to Follow-up|0|||
37785093|NCT00552929|69380444|FG005|Overall Study|Lost to Follow-up|0|||
37785094|NCT00552929|69380445|FG006|Overall Study|Lost to Follow-up|0|||
37785095|NCT00552929|69380446|FG007|Overall Study|Lost to Follow-up|0|||
37785096|NCT00552929|69380447|FG008|Overall Study|Lost to Follow-up|1|||
37975023|NCT00303472|69662272|FG001|Treatment Period|Death|0|||
37785097|NCT00552929|69380448|FG009|Overall Study|Lost to Follow-up|0|||
37785098|NCT00552929|69380439|FG000|Overall Study|Not Eligible|0|||
37785099|NCT00552929|69380440|FG001|Overall Study|Not Eligible|0|||
37785100|NCT00552929|69380441|FG002|Overall Study|Not Eligible|0|||
37785101|NCT00552929|69380442|FG003|Overall Study|Not Eligible|0|||
37785102|NCT00552929|69380443|FG004|Overall Study|Not Eligible|0|||
37785103|NCT00552929|69380444|FG005|Overall Study|Not Eligible|1|||
37785104|NCT00552929|69380445|FG006|Overall Study|Not Eligible|0|||
37785105|NCT00552929|69380446|FG007|Overall Study|Not Eligible|0|||
37785106|NCT00552929|69380447|FG008|Overall Study|Not Eligible|0|||
37785107|NCT00552929|69380448|FG009|Overall Study|Not Eligible|0|||
37785108|NCT02395302|69380470|FG000|Overall Study|Screen Failure|3|||
37785109|NCT02395302|69380470|FG000|Overall Study|Run In Failure|7|||
37785110|NCT02395302|69380470|FG000|Overall Study|Withdrawal by Subject|2|||
37785111|NCT02395302|69380470|FG000|Overall Study|Physician Decision|2|||
37785112|NCT02371980|69380504|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
37785113|NCT02371980|69380505|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
37785114|NCT02371980|69380506|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
37785115|NCT02371980|69380507|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
37785116|NCT02371980|69380508|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
37785117|NCT02371980|69380504|FG000|Open-label Period|Significant Protocol Deviation|19|||
37785118|NCT02371980|69380505|FG001|Open-label Period|Significant Protocol Deviation|0|||
37785119|NCT02371980|69380506|FG002|Open-label Period|Significant Protocol Deviation|0|||
37785120|NCT02371980|69380507|FG003|Open-label Period|Significant Protocol Deviation|0|||
37785121|NCT02371980|69380508|FG004|Open-label Period|Significant Protocol Deviation|0|||
37785122|NCT02371980|69380504|FG000|Open-label Period|Noncompliance with Study Drug|10|||
37785123|NCT02371980|69380505|FG001|Open-label Period|Noncompliance with Study Drug|0|||
37785124|NCT02371980|69380506|FG002|Open-label Period|Noncompliance with Study Drug|0|||
37785125|NCT02371980|69380507|FG003|Open-label Period|Noncompliance with Study Drug|0|||
37785126|NCT02371980|69380508|FG004|Open-label Period|Noncompliance with Study Drug|0|||
37785127|NCT02371980|69380504|FG000|Open-label Period|Lost to Follow-up|55|||
37785128|NCT02371980|69380505|FG001|Open-label Period|Lost to Follow-up|0|||
37785129|NCT02371980|69380506|FG002|Open-label Period|Lost to Follow-up|0|||
37785130|NCT02371980|69380507|FG003|Open-label Period|Lost to Follow-up|0|||
37785131|NCT02371980|69380508|FG004|Open-label Period|Lost to Follow-up|0|||
37785132|NCT02371980|69380504|FG000|Open-label Period|Voluntary Withdrawal|91|||
37785133|NCT02371980|69380505|FG001|Open-label Period|Voluntary Withdrawal|0|||
37785134|NCT02371980|69380506|FG002|Open-label Period|Voluntary Withdrawal|0|||
37785135|NCT02371980|69380507|FG003|Open-label Period|Voluntary Withdrawal|0|||
37785136|NCT02371980|69380508|FG004|Open-label Period|Voluntary Withdrawal|0|||
37785137|NCT02371980|69380504|FG000|Open-label Period|Pregnancy|1|||
37785138|NCT02371980|69380505|FG001|Open-label Period|Pregnancy|0|||
37785139|NCT02371980|69380506|FG002|Open-label Period|Pregnancy|0|||
37785140|NCT02371980|69380507|FG003|Open-label Period|Pregnancy|0|||
37785141|NCT02371980|69380508|FG004|Open-label Period|Pregnancy|0|||
37785142|NCT02371980|69380504|FG000|Open-label Period|Lack of Efficacy|116|||
37785143|NCT02371980|69380505|FG001|Open-label Period|Lack of Efficacy|0|||
37785144|NCT02371980|69380506|FG002|Open-label Period|Lack of Efficacy|0|||
37785145|NCT02371980|69380507|FG003|Open-label Period|Lack of Efficacy|0|||
37785146|NCT02371980|69380508|FG004|Open-label Period|Lack of Efficacy|0|||
37785147|NCT02371980|69380504|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
37785148|NCT02371980|69380505|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
37785149|NCT02371980|69380506|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
37785150|NCT02371980|69380507|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
37785151|NCT02371980|69380508|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
37785152|NCT02371980|69380504|FG000|Open-label Period|Reason not Specified|9|||
37785153|NCT02371980|69380505|FG001|Open-label Period|Reason not Specified|0|||
37785154|NCT02371980|69380506|FG002|Open-label Period|Reason not Specified|0|||
37785155|NCT02371980|69380507|FG003|Open-label Period|Reason not Specified|0|||
37785156|NCT02371980|69380508|FG004|Open-label Period|Reason not Specified|0|||
37785157|NCT02371980|69380504|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
37785158|NCT02371980|69380505|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
37785159|NCT02371980|69380506|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
37785160|NCT02371980|69380507|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
37785161|NCT02371980|69380508|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
37785162|NCT02371980|69380504|FG000|Double-blind Period|Significant Protocol Deviation|0|||
37785163|NCT02371980|69380505|FG001|Double-blind Period|Significant Protocol Deviation|2|||
37785164|NCT02371980|69380506|FG002|Double-blind Period|Significant Protocol Deviation|7|||
37785165|NCT02371980|69380507|FG003|Double-blind Period|Significant Protocol Deviation|3|||
37785166|NCT02371980|69380508|FG004|Double-blind Period|Significant Protocol Deviation|3|||
37785167|NCT02371980|69380504|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
37785168|NCT02371980|69380505|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
37785169|NCT02371980|69380506|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
37785170|NCT02371980|69380507|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
37785171|NCT02371980|69380508|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
37785172|NCT02371980|69380504|FG000|Double-blind Period|Lost to Follow-up|0|||
37785173|NCT02371980|69380505|FG001|Double-blind Period|Lost to Follow-up|8|||
37785174|NCT02371980|69380506|FG002|Double-blind Period|Lost to Follow-up|8|||
37785175|NCT02371980|69380507|FG003|Double-blind Period|Lost to Follow-up|6|||
37785176|NCT02371980|69380508|FG004|Double-blind Period|Lost to Follow-up|5|||
37785177|NCT02371980|69380504|FG000|Double-blind Period|Voluntary Withdrawal|0|||
37785178|NCT02371980|69380505|FG001|Double-blind Period|Voluntary Withdrawal|12|||
37785179|NCT02371980|69380506|FG002|Double-blind Period|Voluntary Withdrawal|8|||
37785180|NCT02371980|69380507|FG003|Double-blind Period|Voluntary Withdrawal|9|||
37785181|NCT02371980|69380508|FG004|Double-blind Period|Voluntary Withdrawal|11|||
37785182|NCT02371980|69380504|FG000|Double-blind Period|Relapse|0|||
37785183|NCT02371980|69380505|FG001|Double-blind Period|Relapse|50|||
37785184|NCT02371980|69380506|FG002|Double-blind Period|Relapse|25|||
37785185|NCT02371980|69380507|FG003|Double-blind Period|Relapse|25|||
37785186|NCT02371980|69380508|FG004|Double-blind Period|Relapse|26|||
37785187|NCT02371980|69380504|FG000|Double-blind Period|Reason not Specified|0|||
37785188|NCT02371980|69380505|FG001|Double-blind Period|Reason not Specified|3|||
37785189|NCT02371980|69380506|FG002|Double-blind Period|Reason not Specified|3|||
37785190|NCT02371980|69380507|FG003|Double-blind Period|Reason not Specified|2|||
37785191|NCT02371980|69380508|FG004|Double-blind Period|Reason not Specified|1|||
37785192|NCT02371980|69380504|FG000|Double-blind Period|Missing|0|||
37785193|NCT02371980|69380505|FG001|Double-blind Period|Missing|1|||
37785194|NCT02371980|69380506|FG002|Double-blind Period|Missing|0|||
37785195|NCT02371980|69380507|FG003|Double-blind Period|Missing|0|||
37785196|NCT02371980|69380508|FG004|Double-blind Period|Missing|0|||
37785197|NCT02371746|69380648|FG000|Overall Study|Consent withdrawn|0|||
37785198|NCT02371746|69380649|FG001|Overall Study|Consent withdrawn|0|||
37785199|NCT02371746|69380650|FG002|Overall Study|Consent withdrawn|0|||
37785200|NCT02371746|69380651|FG003|Overall Study|Consent withdrawn|0|||
37785201|NCT02371746|69380652|FG004|Overall Study|Consent withdrawn|0|||
37785202|NCT02371746|69380653|FG005|Overall Study|Consent withdrawn|0|||
37785203|NCT02371746|69380654|FG006|Overall Study|Consent withdrawn|1|||
37785204|NCT02421666|69380702|FG000|6-month Follow-up|Lost to Follow-up|8|||
37785205|NCT02421666|69380703|FG001|6-month Follow-up|Lost to Follow-up|7|||
37785206|NCT02421666|69380702|FG000|6-month Follow-up|Withdrawal by Subject|5|||
37785207|NCT02421666|69380703|FG001|6-month Follow-up|Withdrawal by Subject|6|||
37785208|NCT02421666|69380702|FG000|12-month Follow-up|Lost to Follow-up|5|||
37785209|NCT02421666|69380703|FG001|12-month Follow-up|Lost to Follow-up|5|||
37785210|NCT02421666|69380702|FG000|12-month Follow-up|Withdrawal by Subject|6|||
37785211|NCT02421666|69380703|FG001|12-month Follow-up|Withdrawal by Subject|11|||
37785212|NCT02394756|69380713|FG000|Period 1|Lens Discomfort|0|||
37785213|NCT02394756|69380714|FG001|Period 1|Lens Discomfort|0|||
37785214|NCT02394756|69380715|FG002|Period 1|Lens Discomfort|0|||
37785215|NCT02394756|69380716|FG003|Period 1|Lens Discomfort|0|||
37975024|NCT00303472|69662273|FG002|Treatment Period|Death|0|||
37975025|NCT00303472|69662274|FG003|Treatment Period|Death|1|||
37975026|NCT00303472|69662275|FG004|Treatment Period|Death|0|||
37975027|NCT00303472|69662276|FG005|Treatment Period|Death|0|||
37693569|NCT02474069|69169828|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
37693570|NCT02474069|69169829|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
37693571|NCT02474069|69169830|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
37693572|NCT02474069|69169828|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
37693573|NCT02474069|69169829|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
37693574|NCT02474069|69169830|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
37693575|NCT02474069|69169828|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
37693576|NCT02474069|69169829|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
37785216|NCT02394756|69380717|FG004|Period 1|Lens Discomfort|0|||
37785217|NCT02394756|69380718|FG005|Period 1|Lens Discomfort|1|||
37975028|NCT00303472|69662277|FG006|Treatment Period|Death|1|||
37975029|NCT00303472|69662271|FG000|Treatment Period|Withdrawal by Subject|0|||
37785218|NCT02394756|69380713|FG000|Period 1|Withdrawal by Subject|0|||
37785219|NCT02394756|69380714|FG001|Period 1|Withdrawal by Subject|1|||
37785220|NCT02394756|69380715|FG002|Period 1|Withdrawal by Subject|1|||
37785221|NCT02394756|69380716|FG003|Period 1|Withdrawal by Subject|1|||
37785222|NCT02394756|69380717|FG004|Period 1|Withdrawal by Subject|0|||
37785223|NCT02394756|69380718|FG005|Period 1|Withdrawal by Subject|0|||
37785224|NCT02394756|69380713|FG000|Period 2|Unsatisfactory Visual Response|0|||
37785225|NCT02394756|69380714|FG001|Period 2|Unsatisfactory Visual Response|0|||
37785226|NCT02394756|69380715|FG002|Period 2|Unsatisfactory Visual Response|0|||
37785227|NCT02394756|69380716|FG003|Period 2|Unsatisfactory Visual Response|0|||
37785228|NCT02394756|69380717|FG004|Period 2|Unsatisfactory Visual Response|1|||
37785229|NCT02394756|69380718|FG005|Period 2|Unsatisfactory Visual Response|0|||
37785230|NCT02370888|69380739|FG000|Overall Study|disease progression|2|||
37785231|NCT02370888|69380739|FG000|Overall Study|did not meet chimerism criteria|6|||
37785232|NCT02394600|69380763|FG000|Overall Study|Adverse Event|3|||
37785233|NCT02394600|69380764|FG001|Overall Study|Adverse Event|0|||
37785234|NCT02394600|69380763|FG000|Overall Study|Lost to Follow-up|0|||
37785235|NCT02394600|69380764|FG001|Overall Study|Lost to Follow-up|1|||
37785236|NCT02394600|69380763|FG000|Overall Study|Withdrawal by Subject|0|||
37785237|NCT02394600|69380764|FG001|Overall Study|Withdrawal by Subject|1|||
37785238|NCT02394600|69380763|FG000|Overall Study|Protocol Violation|1|||
37785239|NCT02394600|69380764|FG001|Overall Study|Protocol Violation|0|||
37785240|NCT04685499|69380780|FG000|Overall Study|Study Terminated Early|1|||
37785241|NCT02421588|69380856|FG000|Overall Study|Non-treatment-related AE|8|||
37785242|NCT02421588|69380857|FG001|Overall Study|Non-treatment-related AE|8|||
37785243|NCT02421588|69380856|FG000|Overall Study|Progressive disease|152|||
37785244|NCT02421588|69380857|FG001|Overall Study|Progressive disease|135|||
37785245|NCT02421588|69380856|FG000|Overall Study|Death|11|||
37975030|NCT00303472|69662272|FG001|Treatment Period|Withdrawal by Subject|0|||
37975031|NCT00303472|69662273|FG002|Treatment Period|Withdrawal by Subject|0|||
37785246|NCT02421588|69380857|FG001|Overall Study|Death|3|||
37785247|NCT02421588|69380856|FG000|Overall Study|Physician Decision|8|||
37975032|NCT00303472|69662274|FG003|Treatment Period|Withdrawal by Subject|1|||
37975033|NCT00303472|69662275|FG004|Treatment Period|Withdrawal by Subject|0|||
37693577|NCT02474069|69169830|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
37693578|NCT02474069|69169828|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
37693579|NCT02474069|69169829|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
37693580|NCT02474069|69169830|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
37693581|NCT02474069|69169828|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
37693582|NCT02474069|69169829|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
37693583|NCT02474069|69169830|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
37693584|NCT02317627|69169843|FG000|Overall Study|Withdrawal by Subject|0|||
37693585|NCT02317627|69169844|FG001|Overall Study|Withdrawal by Subject|1|||
37693586|NCT02317627|69169845|FG002|Overall Study|Withdrawal by Subject|1|||
37693587|NCT02317627|69169843|FG000|Overall Study|Lost to Follow-up|2|||
37693588|NCT02317627|69169844|FG001|Overall Study|Lost to Follow-up|0|||
37693589|NCT02317627|69169845|FG002|Overall Study|Lost to Follow-up|0|||
37693590|NCT02317627|69169843|FG000|Overall Study|Stopped by Investigator|0|||
37693591|NCT02317627|69169844|FG001|Overall Study|Stopped by Investigator|1|||
37693592|NCT02317627|69169845|FG002|Overall Study|Stopped by Investigator|0|||
37693593|NCT02317627|69169843|FG000|Overall Study|Adverse Event|0|||
37693594|NCT02317627|69169844|FG001|Overall Study|Adverse Event|2|||
37785248|NCT02421588|69380857|FG001|Overall Study|Physician Decision|17|||
37785249|NCT02421588|69380856|FG000|Overall Study|Other reason not specified|3|||
37785250|NCT02421588|69380857|FG001|Overall Study|Other reason not specified|1|||
37785251|NCT02421588|69380856|FG000|Overall Study|Symptomatic deterioration|13|||
37785252|NCT02421588|69380857|FG001|Overall Study|Symptomatic deterioration|19|||
37785253|NCT02421588|69380856|FG000|Overall Study|Treatment-related AE|10|||
37785254|NCT02421588|69380857|FG001|Overall Study|Treatment-related AE|14|||
37785255|NCT02421588|69380856|FG000|Overall Study|Withdrawal by Subject|14|||
37785256|NCT02421588|69380857|FG001|Overall Study|Withdrawal by Subject|16|||
37785257|NCT02421588|69380856|FG000|Overall Study|Not treated|2|||
37785258|NCT02421588|69380857|FG001|Overall Study|Not treated|8|||
37785259|NCT02421510|69380866|FG000|Overall Study|Other|4|||
37785260|NCT02421510|69380867|FG001|Overall Study|Other|2|||
37785261|NCT02421510|69380868|FG002|Overall Study|Other|3|||
37785262|NCT02421510|69380866|FG000|Overall Study|Protocol Violation|1|||
37785263|NCT02421510|69380867|FG001|Overall Study|Protocol Violation|2|||
37785264|NCT02421510|69380868|FG002|Overall Study|Protocol Violation|0|||
37785265|NCT02421510|69380866|FG000|Overall Study|Death|1|||
37785266|NCT02421510|69380867|FG001|Overall Study|Death|0|||
37785267|NCT02421510|69380868|FG002|Overall Study|Death|0|||
37785268|NCT02421510|69380866|FG000|Overall Study|Noncompliance with study drug|1|||
37785269|NCT02421510|69380867|FG001|Overall Study|Noncompliance with study drug|0|||
37785270|NCT02421510|69380868|FG002|Overall Study|Noncompliance with study drug|0|||
37785271|NCT02421510|69380866|FG000|Overall Study|Physician Decision|1|||
37785272|NCT02421510|69380867|FG001|Overall Study|Physician Decision|1|||
37785273|NCT02421510|69380868|FG002|Overall Study|Physician Decision|3|||
37785274|NCT02421510|69380866|FG000|Overall Study|Adverse Event|9|||
37785275|NCT02421510|69380867|FG001|Overall Study|Adverse Event|10|||
37785276|NCT02421510|69380868|FG002|Overall Study|Adverse Event|18|||
37785277|NCT02421510|69380866|FG000|Overall Study|Pregnancy|1|||
37785278|NCT02421510|69380867|FG001|Overall Study|Pregnancy|1|||
37785279|NCT02421510|69380868|FG002|Overall Study|Pregnancy|0|||
37785280|NCT02421510|69380866|FG000|Overall Study|Withdrawal by Subject|14|||
37785281|NCT02421510|69380867|FG001|Overall Study|Withdrawal by Subject|18|||
37785282|NCT02421510|69380868|FG002|Overall Study|Withdrawal by Subject|12|||
37785283|NCT02421510|69380866|FG000|Overall Study|Lost to Follow-up|1|||
37785284|NCT02421510|69380867|FG001|Overall Study|Lost to Follow-up|1|||
37785285|NCT02421510|69380868|FG002|Overall Study|Lost to Follow-up|0|||
37785286|NCT00552617|69380886|FG000|Overall Study|Not Treated|0|||
37785287|NCT00552617|69380887|FG001|Overall Study|Not Treated|0|||
37785288|NCT00552617|69380888|FG002|Overall Study|Not Treated|1|||
37785289|NCT00552617|69380889|FG003|Overall Study|Not Treated|0|||
37785290|NCT00552617|69380890|FG004|Overall Study|Not Treated|0|||
37785291|NCT00552617|69380891|FG005|Overall Study|Not Treated|0|||
37785292|NCT00552617|69380892|FG006|Overall Study|Not Treated|0|||
37785293|NCT00552617|69380893|FG007|Overall Study|Not Treated|0|||
37785294|NCT00552617|69380894|FG008|Overall Study|Not Treated|0|||
37785295|NCT00552617|69380895|FG009|Overall Study|Not Treated|1|||
37785296|NCT00552617|69380886|FG000|Overall Study|Lost to Follow-up|0|||
37785297|NCT00552617|69380887|FG001|Overall Study|Lost to Follow-up|0|||
37785298|NCT00552617|69380888|FG002|Overall Study|Lost to Follow-up|0|||
37785299|NCT00552617|69380889|FG003|Overall Study|Lost to Follow-up|1|||
37785300|NCT00552617|69380890|FG004|Overall Study|Lost to Follow-up|0|||
37785301|NCT00552617|69380891|FG005|Overall Study|Lost to Follow-up|2|||
37975034|NCT00303472|69662276|FG005|Treatment Period|Withdrawal by Subject|1|||
37975035|NCT00303472|69662277|FG006|Treatment Period|Withdrawal by Subject|0|||
37975036|NCT00303472|69662271|FG000|Treatment Period|Other|0|||
37975037|NCT00303472|69662272|FG001|Treatment Period|Other|0|||
37975038|NCT00303472|69662273|FG002|Treatment Period|Other|0|||
37975039|NCT00303472|69662274|FG003|Treatment Period|Other|0|||
37975040|NCT00303472|69662275|FG004|Treatment Period|Other|1|||
37975041|NCT00303472|69662276|FG005|Treatment Period|Other|0|||
37785302|NCT00552617|69380892|FG006|Overall Study|Lost to Follow-up|0|||
37975042|NCT00303472|69662277|FG006|Treatment Period|Other|1|||
37785303|NCT00552617|69380893|FG007|Overall Study|Lost to Follow-up|0|||
37785304|NCT00552617|69380894|FG008|Overall Study|Lost to Follow-up|2|||
37785305|NCT00552617|69380895|FG009|Overall Study|Lost to Follow-up|0|||
37785306|NCT02421120|69380917|FG000|Overall Study|Adverse Event|1|||
37785307|NCT02420262|69380923|FG000|Overall Study|Adverse Event|1|||
37785308|NCT02420262|69380924|FG001|Overall Study|Adverse Event|0|||
37975043|NCT00303472|69662271|FG000|Treatment Period|Disease Progression (to AML)|0|||
37785309|NCT02420262|69380923|FG000|Overall Study|Withdrawal by Subject|1|||
37785310|NCT02420262|69380924|FG001|Overall Study|Withdrawal by Subject|4|||
37785311|NCT02420262|69380923|FG000|Overall Study|Unclassified|0|||
37785312|NCT02420262|69380924|FG001|Overall Study|Unclassified|1|||
37785313|NCT00552305|69380930|FG000|Overall Study|Adverse Event|43|||
37785314|NCT00552305|69380930|FG000|Overall Study|Lack of Efficacy|120|||
37785315|NCT00552305|69380930|FG000|Overall Study|Lost to Follow-up|4|||
37785316|NCT00552305|69380930|FG000|Overall Study|Protocol Violation|3|||
37785317|NCT00552305|69380930|FG000|Overall Study|Withdrawal by Subject|44|||
37785318|NCT00552305|69380930|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
37785319|NCT00552305|69380930|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
37785320|NCT00552305|69380930|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
37785321|NCT00552305|69380930|FG000|Overall Study|Unsatisfactory compliance|11|||
37785322|NCT00552305|69380930|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
37785323|NCT00552305|69380930|FG000|Overall Study|AE/Other: prohibited drug required|1|||
37785324|NCT00552305|69380930|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
37785325|NCT00552305|69380930|FG000|Overall Study|Other: Site closed|4|||
37785326|NCT00552305|69380930|FG000|Overall Study|Other: Personal problems|1|||
37785327|NCT00552305|69380930|FG000|Overall Study|Other: Unable to attend visits|1|||
37785328|NCT00552305|69380930|FG000|Overall Study|Other: Subject underwent surgery|4|||
37785329|NCT00552305|69380930|FG000|Overall Study|Other: Subject became pregnant|1|||
37785330|NCT00552305|69380930|FG000|Overall Study|Other: Health problems, not drug related|1|||
37785331|NCT00552305|69380930|FG000|Overall Study|Other: Subject moved from area|2|||
37785332|NCT00552305|69380930|FG000|Overall Study|Other: Subject incarcerated|1|||
37785333|NCT00552305|69380930|FG000|Overall Study|Other: Subject went to rehab|1|||
37785334|NCT00552071|69380956|FG000|Overall Study|Adverse Event|1|||
37785335|NCT00552071|69380957|FG001|Overall Study|Adverse Event|0|||
37785336|NCT00552071|69380956|FG000|Overall Study|Lack of Efficacy|1|||
37785337|NCT00552071|69380957|FG001|Overall Study|Lack of Efficacy|0|||
37785338|NCT00552071|69380956|FG000|Overall Study|Physician Decision|1|||
37785339|NCT00552071|69380957|FG001|Overall Study|Physician Decision|0|||
37785340|NCT00552071|69380956|FG000|Overall Study|Pregnancy|1|||
37785341|NCT00552071|69380957|FG001|Overall Study|Pregnancy|0|||
37864048|NCT01119105|69547701|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
37785342|NCT00552071|69380956|FG000|Overall Study|Death|0|||
37785343|NCT00552071|69380957|FG001|Overall Study|Death|1|||
37785344|NCT00552071|69380956|FG000|Overall Study|Withdrawal by Subject|0|||
37785345|NCT00552071|69380957|FG001|Overall Study|Withdrawal by Subject|1|||
37785346|NCT00551525|69380965|FG000|Overall Study|Protocol Violation|5|||
37785347|NCT02370498|69380992|FG000|Overall Study|Adverse Event|10|||
37785348|NCT02370498|69380993|FG001|Overall Study|Adverse Event|8|||
37785349|NCT02370498|69380992|FG000|Overall Study|Death|263|||
37785350|NCT02370498|69380993|FG001|Overall Study|Death|265|||
37785351|NCT02370498|69380992|FG000|Overall Study|Protocol Violation|1|||
37785352|NCT02370498|69380993|FG001|Overall Study|Protocol Violation|2|||
37785353|NCT02370498|69380992|FG000|Overall Study|Withdrawal by Subject|7|||
37785354|NCT02370498|69380993|FG001|Overall Study|Withdrawal by Subject|12|||
37785355|NCT02370498|69380992|FG000|Overall Study|Sponsor's decision|15|||
37785356|NCT02370498|69380993|FG001|Overall Study|Sponsor's decision|9|||
37785357|NCT02347332|69381018|FG000|Overall Study|Not treated|5|||
37785358|NCT02347332|69381019|FG001|Overall Study|Not treated|2|||
37785359|NCT02347332|69381018|FG000|Overall Study|Progressive disease|141|||
37785360|NCT02347332|69381019|FG001|Overall Study|Progressive disease|159|||
37785361|NCT02347332|69381018|FG000|Overall Study|Adverse Event|50|||
37785362|NCT02347332|69381019|FG001|Overall Study|Adverse Event|41|||
37785363|NCT02347332|69381018|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
37785364|NCT02347332|69381019|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
37785365|NCT02347332|69381018|FG000|Overall Study|Protocol Violation|1|||
37785366|NCT02347332|69381019|FG001|Overall Study|Protocol Violation|1|||
37785367|NCT02347332|69381018|FG000|Overall Study|Lost to Follow-up|2|||
37785368|NCT02347332|69381019|FG001|Overall Study|Lost to Follow-up|1|||
37785369|NCT02347332|69381018|FG000|Overall Study|Physician Decision|4|||
37785370|NCT02347332|69381019|FG001|Overall Study|Physician Decision|3|||
37785371|NCT02347332|69381018|FG000|Overall Study|Withdrawal by Subject|20|||
37785372|NCT02347332|69381019|FG001|Overall Study|Withdrawal by Subject|14|||
37785373|NCT02347332|69381018|FG000|Overall Study|Protocol requirement|1|||
37785374|NCT02347332|69381019|FG001|Overall Study|Protocol requirement|1|||
37785375|NCT02347332|69381018|FG000|Overall Study|Switch Post-Trial program|0|||
37785376|NCT02347332|69381019|FG001|Overall Study|Switch Post-Trial program|1|||
37785377|NCT02347176|69381042|FG000|Overall Study|Lost to Follow-up|2|||
37785378|NCT02347176|69381043|FG001|Overall Study|Lost to Follow-up|3|||
37785379|NCT02347176|69381044|FG002|Overall Study|Lost to Follow-up|1|||
37785380|NCT02347176|69381045|FG003|Overall Study|Lost to Follow-up|1|||
37785381|NCT02347176|69381042|FG000|Overall Study|Withdrawal by Subject|9|||
37785382|NCT02347176|69381043|FG001|Overall Study|Withdrawal by Subject|5|||
37785383|NCT02347176|69381044|FG002|Overall Study|Withdrawal by Subject|5|||
37785384|NCT02347176|69381045|FG003|Overall Study|Withdrawal by Subject|3|||
37785385|NCT02347176|69381042|FG000|Overall Study|Other|1|||
37785386|NCT02347176|69381043|FG001|Overall Study|Other|2|||
37785387|NCT02347176|69381044|FG002|Overall Study|Other|2|||
37785388|NCT02347176|69381045|FG003|Overall Study|Other|0|||
37785389|NCT02370420|69381057|FG000|Overall Study|Physician Decision|3|||
37785390|NCT02370420|69381058|FG001|Overall Study|Physician Decision|3|||
37785391|NCT02370420|69381057|FG000|Overall Study|Lost to Follow-up|11|||
37785392|NCT02370420|69381058|FG001|Overall Study|Lost to Follow-up|9|||
37785393|NCT02347098|69381080|FG000|Overall Study|Death|1|||
37785394|NCT02347098|69381081|FG001|Overall Study|Death|0|||
37785395|NCT02347098|69381080|FG000|Overall Study|Withdrawal by Subject|1|||
37785396|NCT02347098|69381081|FG001|Overall Study|Withdrawal by Subject|0|||
37785397|NCT02347098|69381080|FG000|Overall Study|Lost to Follow-up|2|||
37785398|NCT02347098|69381081|FG001|Overall Study|Lost to Follow-up|2|||
37785399|NCT02347098|69381080|FG000|Overall Study|Refuse Follow-up Visit|1|||
37785400|NCT02347098|69381081|FG001|Overall Study|Refuse Follow-up Visit|5|||
37785401|NCT02347098|69381080|FG000|Overall Study|no visit due to illness|2|||
37975044|NCT00303472|69662272|FG001|Treatment Period|Disease Progression (to AML)|0|||
37975045|NCT00303472|69662273|FG002|Treatment Period|Disease Progression (to AML)|0|||
37975046|NCT00303472|69662274|FG003|Treatment Period|Disease Progression (to AML)|0|||
37975047|NCT00303472|69662275|FG004|Treatment Period|Disease Progression (to AML)|1|||
37975048|NCT00303472|69662276|FG005|Treatment Period|Disease Progression (to AML)|0|||
37785402|NCT02347098|69381081|FG001|Overall Study|no visit due to illness|1|||
37785403|NCT02346708|69381098|FG000|Overall Study|Adverse Event|2|||
37785404|NCT02346708|69381099|FG001|Overall Study|Adverse Event|0|||
37975049|NCT00303472|69662277|FG006|Treatment Period|Disease Progression (to AML)|0|||
37785405|NCT02346708|69381098|FG000|Overall Study|Protocol Violation|0|||
37785406|NCT02346708|69381099|FG001|Overall Study|Protocol Violation|1|||
37785407|NCT02346240|69381589|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
37975050|NCT00303472|69662271|FG000|Treatment Extension (Optional)|Adverse Event|1|||
37785408|NCT02346240|69381590|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
37785409|NCT02346240|69381591|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
37785410|NCT02346240|69381592|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
37785411|NCT02346240|69381593|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
37785412|NCT02346240|69381594|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
37785413|NCT02346240|69381595|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
37785414|NCT02346240|69381596|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
37785415|NCT02346240|69381597|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
37785416|NCT02346240|69381598|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
37785417|NCT02346240|69381599|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
37785418|NCT02346240|69381600|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
37785419|NCT02346240|69381601|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
37785420|NCT02346240|69381602|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
37785421|NCT02346240|69381603|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
37785422|NCT02346240|69381604|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
37785423|NCT02346240|69381605|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
37785424|NCT02346240|69381606|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
37785425|NCT02346240|69381607|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
37785426|NCT02346240|69381608|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
37785427|NCT02346240|69381609|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
37785428|NCT02346240|69381610|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
37785429|NCT02346240|69381611|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
37785430|NCT02346240|69381612|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
37785431|NCT02346240|69381589|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
37785432|NCT02346240|69381590|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
37785433|NCT02346240|69381591|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
37785434|NCT02346240|69381592|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
37785435|NCT02346240|69381593|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
37785436|NCT02346240|69381594|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
37785437|NCT02346240|69381595|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
37785438|NCT02346240|69381596|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
37785439|NCT02346240|69381597|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
37785440|NCT02346240|69381598|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
37785441|NCT02346240|69381599|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
37785442|NCT02346240|69381600|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
37785443|NCT02346240|69381601|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
37785444|NCT02346240|69381602|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
37785445|NCT02346240|69381603|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
37785446|NCT02346240|69381604|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
37785447|NCT02346240|69381605|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
37785448|NCT02346240|69381606|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
37785449|NCT02346240|69381607|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
37785450|NCT02346240|69381608|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
37785451|NCT02346240|69381609|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
37785452|NCT02346240|69381610|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
37785453|NCT02346240|69381611|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
37785454|NCT02346240|69381612|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
37975051|NCT00303472|69662272|FG001|Treatment Extension (Optional)|Adverse Event|0|||
37975052|NCT00303472|69662273|FG002|Treatment Extension (Optional)|Adverse Event|1|||
37975053|NCT00303472|69662274|FG003|Treatment Extension (Optional)|Adverse Event|0|||
37975054|NCT00303472|69662275|FG004|Treatment Extension (Optional)|Adverse Event|0|||
37693595|NCT02317627|69169845|FG002|Overall Study|Adverse Event|3|||
37975055|NCT00303472|69662276|FG005|Treatment Extension (Optional)|Adverse Event|0|||
37975056|NCT00303472|69662277|FG006|Treatment Extension (Optional)|Adverse Event|0|||
37975057|NCT00303472|69662271|FG000|Treatment Extension (Optional)|Death|2|||
37975058|NCT00303472|69662272|FG001|Treatment Extension (Optional)|Death|0|||
37975059|NCT00303472|69662273|FG002|Treatment Extension (Optional)|Death|1|||
37975060|NCT00303472|69662274|FG003|Treatment Extension (Optional)|Death|0|||
37975061|NCT00303472|69662275|FG004|Treatment Extension (Optional)|Death|0|||
37975062|NCT00303472|69662276|FG005|Treatment Extension (Optional)|Death|0|||
37975063|NCT00303472|69662277|FG006|Treatment Extension (Optional)|Death|0|||
37975064|NCT00303472|69662271|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
37975065|NCT00303472|69662272|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
37975066|NCT00303472|69662273|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
37975067|NCT00303472|69662274|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
37975068|NCT00303472|69662275|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
37975069|NCT00303472|69662276|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
37785455|NCT02346240|69381589|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
37785456|NCT02346240|69381590|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
37785457|NCT02346240|69381591|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
37975070|NCT00303472|69662277|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
37975071|NCT00303472|69662271|FG000|Treatment Extension (Optional)|Physician Decision|0|||
37975072|NCT00303472|69662272|FG001|Treatment Extension (Optional)|Physician Decision|4|||
37975073|NCT00303472|69662273|FG002|Treatment Extension (Optional)|Physician Decision|2|||
37975074|NCT00303472|69662274|FG003|Treatment Extension (Optional)|Physician Decision|3|||
37975075|NCT00303472|69662275|FG004|Treatment Extension (Optional)|Physician Decision|2|||
37785458|NCT02346240|69381592|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
37785459|NCT02346240|69381593|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
37785460|NCT02346240|69381594|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
37785461|NCT02346240|69381595|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
37785462|NCT02346240|69381596|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
37785463|NCT02346240|69381597|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
37785464|NCT02346240|69381598|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
37785465|NCT02346240|69381599|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
37785466|NCT02346240|69381600|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
37785467|NCT02346240|69381601|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
37785468|NCT02346240|69381602|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
37785469|NCT02346240|69381603|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
37785470|NCT02346240|69381604|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
37785471|NCT02346240|69381605|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
37785472|NCT02346240|69381606|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
37785473|NCT02346240|69381607|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
37785474|NCT02346240|69381608|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
37785475|NCT02346240|69381609|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
37785476|NCT02346240|69381610|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
37785477|NCT02346240|69381611|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
37975076|NCT00303472|69662276|FG005|Treatment Extension (Optional)|Physician Decision|0|||
37975077|NCT00303472|69662277|FG006|Treatment Extension (Optional)|Physician Decision|0|||
37975078|NCT00303472|69662271|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
37975079|NCT00303472|69662272|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
37975080|NCT00303472|69662273|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
37975081|NCT00303472|69662274|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
37975082|NCT00303472|69662275|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
37975083|NCT00303472|69662276|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
37975084|NCT00303472|69662277|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
37975085|NCT00303472|69662271|FG000|Treatment Extension (Optional)|Other|0|||
37785478|NCT02346240|69381612|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
37785479|NCT02346240|69381589|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
37975086|NCT00303472|69662272|FG001|Treatment Extension (Optional)|Other|2|||
37975087|NCT00303472|69662273|FG002|Treatment Extension (Optional)|Other|4|||
37864049|NCT01119105|69547702|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
37975088|NCT00303472|69662274|FG003|Treatment Extension (Optional)|Other|2|||
37975089|NCT00303472|69662275|FG004|Treatment Extension (Optional)|Other|1|||
37785480|NCT02346240|69381590|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
37785481|NCT02346240|69381591|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
37785482|NCT02346240|69381592|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
37785483|NCT02346240|69381593|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
37785484|NCT02346240|69381594|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
37785485|NCT02346240|69381595|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
37785486|NCT02346240|69381596|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
37785487|NCT02346240|69381597|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
37785488|NCT02346240|69381598|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
37785489|NCT02346240|69381599|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
37785490|NCT02346240|69381600|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
37785491|NCT02346240|69381601|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
37785492|NCT02346240|69381602|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
37785493|NCT02346240|69381603|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
37785494|NCT02346240|69381604|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
37785495|NCT02346240|69381605|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
37785496|NCT02346240|69381606|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
37785497|NCT02346240|69381607|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
37785498|NCT02346240|69381608|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
37785499|NCT02346240|69381609|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
37785500|NCT02346240|69381610|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
37785501|NCT02346240|69381611|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
37785502|NCT02346240|69381612|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
37785503|NCT02346240|69381589|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
37785504|NCT02346240|69381590|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
37785505|NCT02346240|69381591|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
37785506|NCT02346240|69381592|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
37785507|NCT02346240|69381593|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
37785508|NCT02346240|69381594|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
37785509|NCT02346240|69381595|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
37785510|NCT02346240|69381596|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
37785511|NCT02346240|69381597|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
37785512|NCT02346240|69381598|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
37785513|NCT02346240|69381599|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
37785514|NCT02346240|69381600|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
37785515|NCT02346240|69381601|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
37785516|NCT02346240|69381602|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
37785517|NCT02346240|69381603|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
37785518|NCT02346240|69381604|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
37785519|NCT02346240|69381605|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
37785520|NCT02346240|69381606|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
37785521|NCT02346240|69381607|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
37785522|NCT02346240|69381608|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
37785523|NCT02346240|69381609|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
37785524|NCT02346240|69381610|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
37785525|NCT02346240|69381611|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
37785526|NCT02346240|69381612|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
37785527|NCT02346240|69381589|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
37785528|NCT02346240|69381590|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
37785529|NCT02346240|69381591|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
37785530|NCT02346240|69381592|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
37785531|NCT02346240|69381593|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
37785532|NCT02346240|69381594|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
37864050|NCT01119105|69547703|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
37864051|NCT01119105|69547701|FG000|Overall Study|Other|1|||
37785533|NCT02346240|69381595|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
37785534|NCT02346240|69381596|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
37785535|NCT02346240|69381597|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
37785536|NCT02346240|69381598|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
37785537|NCT02346240|69381599|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
37785538|NCT02346240|69381600|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
37785539|NCT02346240|69381601|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
37785540|NCT02346240|69381602|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
37785541|NCT02346240|69381603|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
37785542|NCT02346240|69381604|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
37785543|NCT02346240|69381605|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
37785544|NCT02346240|69381606|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
37785545|NCT02346240|69381607|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
37785546|NCT02346240|69381608|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
37785547|NCT02346240|69381609|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
37785548|NCT02346240|69381610|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
37785549|NCT02346240|69381611|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
37785550|NCT02346240|69381612|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
37785551|NCT02346240|69381589|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
37785552|NCT02346240|69381590|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
37785553|NCT02346240|69381591|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
37785554|NCT02346240|69381592|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
37785555|NCT02346240|69381593|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
37785556|NCT02346240|69381594|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
37785557|NCT02346240|69381595|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
37785558|NCT02346240|69381596|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
37785559|NCT02346240|69381597|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
37785560|NCT02346240|69381598|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
37785561|NCT02346240|69381599|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
37785562|NCT02346240|69381600|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
37785563|NCT02346240|69381601|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
37785564|NCT02346240|69381602|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
37785565|NCT02346240|69381603|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
37785566|NCT02346240|69381604|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
37785567|NCT02346240|69381605|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
37975090|NCT00303472|69662276|FG005|Treatment Extension (Optional)|Other|0|||
37975091|NCT00303472|69662277|FG006|Treatment Extension (Optional)|Other|0|||
37864052|NCT01119105|69547702|FG001|Overall Study|Other|1|||
37864053|NCT01119105|69547703|FG002|Overall Study|Other|0|||
37864054|NCT01118949|69547711|FG000|Overall Study|Adverse Event|5|||
37864055|NCT01118949|69547711|FG000|Overall Study|Withdrawal by Subject|4|||
37864056|NCT01252355|69547718|FG000|Overall Study|Adverse Event|9|||
37864057|NCT01252355|69547719|FG001|Overall Study|Adverse Event|17|||
37864058|NCT01252355|69547720|FG002|Overall Study|Adverse Event|22|||
37864059|NCT01252355|69547718|FG000|Overall Study|Lack of Efficacy|6|||
37864060|NCT01252355|69547719|FG001|Overall Study|Lack of Efficacy|4|||
37864061|NCT01252355|69547720|FG002|Overall Study|Lack of Efficacy|2|||
37864062|NCT01252355|69547718|FG000|Overall Study|Lost to Follow-up|0|||
37864063|NCT01252355|69547719|FG001|Overall Study|Lost to Follow-up|0|||
37975092|NCT00303472|69662271|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
37975093|NCT00303472|69662272|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
37785568|NCT02346240|69381606|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
37785569|NCT02346240|69381607|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
37864064|NCT01252355|69547720|FG002|Overall Study|Lost to Follow-up|1|||
37864065|NCT01252355|69547718|FG000|Overall Study|Poor Compliance to Protocol|1|||
37785570|NCT02346240|69381608|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
37785571|NCT02346240|69381609|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
37785572|NCT02346240|69381610|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
37785573|NCT02346240|69381611|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
37785574|NCT02346240|69381612|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
37785575|NCT02346240|69381589|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
37785576|NCT02346240|69381590|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
37785577|NCT02346240|69381591|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
37785578|NCT02346240|69381592|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
37785579|NCT02346240|69381593|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
37785580|NCT02346240|69381594|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
37785581|NCT02346240|69381595|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
37785582|NCT02346240|69381596|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
37785583|NCT02346240|69381597|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
37785584|NCT02346240|69381598|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
37785585|NCT02346240|69381599|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
37785586|NCT02346240|69381600|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
37785587|NCT02346240|69381601|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
37785588|NCT02346240|69381602|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
37785589|NCT02346240|69381603|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
37785590|NCT02346240|69381604|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
37785591|NCT02346240|69381605|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
37785592|NCT02346240|69381606|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
37785593|NCT02346240|69381607|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
37785594|NCT02346240|69381608|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
37785595|NCT02346240|69381609|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
37785596|NCT02346240|69381610|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
37785597|NCT02346240|69381611|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
37785598|NCT02346240|69381612|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
37785599|NCT02346240|69381589|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
37785600|NCT02346240|69381590|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
37785601|NCT02346240|69381591|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
37785602|NCT02346240|69381592|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
37785603|NCT02346240|69381593|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
37785604|NCT02346240|69381594|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
37785605|NCT02346240|69381595|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
37785606|NCT02346240|69381596|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
37785607|NCT02346240|69381597|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
37785608|NCT02346240|69381598|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
37785609|NCT02346240|69381599|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
37785610|NCT02346240|69381600|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
37785611|NCT02346240|69381601|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
37785612|NCT02346240|69381602|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
37785613|NCT02346240|69381603|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
37785614|NCT02346240|69381604|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
37785615|NCT02346240|69381605|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
37785616|NCT02346240|69381606|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
37785617|NCT02346240|69381607|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
37785618|NCT02346240|69381608|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
37785619|NCT02346240|69381609|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
37785620|NCT02346240|69381610|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
37785621|NCT02346240|69381611|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
37785622|NCT02346240|69381612|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
37975094|NCT00303472|69662273|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
37975095|NCT00303472|69662274|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
37975096|NCT00303472|69662275|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
37975097|NCT00303472|69662276|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
37975098|NCT00303472|69662277|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
37975099|NCT00468546|69662295|FG000|Week 24 Analysis|Lack of Efficacy|83|||
37975100|NCT00468546|69662296|FG001|Week 24 Analysis|Lack of Efficacy|37|||
37975101|NCT00468546|69662295|FG000|Week 24 Analysis|Refused treatment|5|||
37975102|NCT00468546|69662296|FG001|Week 24 Analysis|Refused treatment|5|||
37975103|NCT00468546|69662295|FG000|Week 24 Analysis|Adverse Event|1|||
37975104|NCT00468546|69662296|FG001|Week 24 Analysis|Adverse Event|8|||
37785623|NCT02346240|69381589|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
37975105|NCT00468546|69662295|FG000|Week 24 Analysis|Failure to return|3|||
37785624|NCT02346240|69381590|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
37785625|NCT02346240|69381591|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
37785626|NCT02346240|69381592|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
37785627|NCT02346240|69381593|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
37785628|NCT02346240|69381594|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
37785629|NCT02346240|69381595|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
37785630|NCT02346240|69381596|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
37785631|NCT02346240|69381597|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
37785632|NCT02346240|69381598|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
37785633|NCT02346240|69381599|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
37785634|NCT02346240|69381600|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
37785635|NCT02346240|69381601|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
37785636|NCT02346240|69381602|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
37785637|NCT02346240|69381603|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
37785638|NCT02346240|69381604|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
37785639|NCT02346240|69381605|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
37785640|NCT02346240|69381606|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
37785641|NCT02346240|69381607|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
37785642|NCT02346240|69381608|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
37785643|NCT02346240|69381609|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
37785644|NCT02346240|69381610|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
37785645|NCT02346240|69381611|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
37785646|NCT02346240|69381612|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
37785647|NCT02346240|69381589|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
37785648|NCT02346240|69381590|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
37785649|NCT02346240|69381591|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
37785650|NCT02346240|69381592|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
37785651|NCT02346240|69381593|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
37785652|NCT02346240|69381594|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
37785653|NCT02346240|69381595|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
37785654|NCT02346240|69381596|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
37785655|NCT02346240|69381597|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
37785656|NCT02346240|69381598|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
37785657|NCT02346240|69381599|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
37785658|NCT02346240|69381600|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
37785659|NCT02346240|69381601|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
37785660|NCT02346240|69381602|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
37785661|NCT02346240|69381603|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
37785662|NCT02346240|69381604|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
37785663|NCT02346240|69381605|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
37785664|NCT02346240|69381606|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
37785665|NCT02346240|69381607|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
37785666|NCT02346240|69381608|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
37785667|NCT02346240|69381609|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
37785668|NCT02346240|69381610|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
37785669|NCT02346240|69381611|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
37785670|NCT02346240|69381612|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
37785671|NCT02346240|69381589|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
37785672|NCT02346240|69381590|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
37785673|NCT02346240|69381591|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
37785674|NCT02346240|69381592|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
37785675|NCT02346240|69381593|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
37785676|NCT02346240|69381594|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
37785677|NCT02346240|69381595|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
37785678|NCT02346240|69381596|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
37785679|NCT02346240|69381597|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
37785680|NCT02346240|69381598|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
37785681|NCT02346240|69381599|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
37785682|NCT02346240|69381600|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
37785683|NCT02346240|69381601|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
37785684|NCT02346240|69381602|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
37785685|NCT02346240|69381603|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
37785686|NCT02346240|69381604|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
37785687|NCT02346240|69381605|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
37785688|NCT02346240|69381606|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
37785689|NCT02346240|69381607|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
37785690|NCT02346240|69381608|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
37785691|NCT02346240|69381609|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
37785692|NCT02346240|69381610|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
37785693|NCT02346240|69381611|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
37785694|NCT02346240|69381612|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
37785695|NCT02346240|69381589|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
37785696|NCT02346240|69381590|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
37785697|NCT02346240|69381591|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
37785698|NCT02346240|69381592|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
37785699|NCT02346240|69381593|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
37785700|NCT02346240|69381594|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
37785701|NCT02346240|69381595|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
37785702|NCT02346240|69381596|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
37785703|NCT02346240|69381597|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
37785704|NCT02346240|69381598|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
37785705|NCT02346240|69381599|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
37785706|NCT02346240|69381600|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
37785707|NCT02346240|69381601|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
37785708|NCT02346240|69381602|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
37785709|NCT02346240|69381603|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
37785710|NCT02346240|69381604|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
37785711|NCT02346240|69381605|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
37785712|NCT02346240|69381606|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
37785713|NCT02346240|69381607|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
37785714|NCT02346240|69381608|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
37785715|NCT02346240|69381609|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
37785716|NCT02346240|69381610|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
37785717|NCT02346240|69381611|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
37785718|NCT02346240|69381612|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
37785719|NCT02346240|69381589|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
37785720|NCT02346240|69381590|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
37785721|NCT02346240|69381591|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
37785722|NCT02346240|69381592|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
37785723|NCT02346240|69381593|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
37785724|NCT02346240|69381594|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
37785725|NCT02346240|69381595|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
37785726|NCT02346240|69381596|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
37785727|NCT02346240|69381597|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
37785728|NCT02346240|69381598|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
37785729|NCT02346240|69381599|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
37975106|NCT00468546|69662296|FG001|Week 24 Analysis|Failure to return|4|||
37975107|NCT00468546|69662295|FG000|Week 24 Analysis|Rescue therapy|2|||
37975108|NCT00468546|69662296|FG001|Week 24 Analysis|Rescue therapy|0|||
37975109|NCT00468546|69662295|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
37975110|NCT00468546|69662296|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
37975111|NCT00468546|69662295|FG000|Week 24 Analysis|Due to clinical hold|1|||
37975112|NCT00468546|69662296|FG001|Week 24 Analysis|Due to clinical hold|0|||
37975113|NCT00468546|69662295|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
37975114|NCT00468546|69662296|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
37975115|NCT00468546|69662295|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
37975116|NCT00468546|69662296|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
37975117|NCT00468546|69662295|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
37975118|NCT00468546|69662296|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
37975119|NCT00468546|69662295|FG000|Week 24 to Week 104 Analysis|Death|1|||
37975120|NCT00468546|69662296|FG001|Week 24 to Week 104 Analysis|Death|0|||
37975121|NCT00468546|69662295|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
37785730|NCT02346240|69381600|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
37785731|NCT02346240|69381601|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
37785732|NCT02346240|69381602|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
37785733|NCT02346240|69381603|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
37975122|NCT00468546|69662296|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
37975123|NCT00468546|69662295|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
37975124|NCT00468546|69662296|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
37975125|NCT00468546|69662295|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
37975126|NCT00468546|69662296|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
37975127|NCT00468546|69662295|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
37975128|NCT00468546|69662296|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
37975129|NCT00468546|69662295|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
37975130|NCT00468546|69662296|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
37975131|NCT00468546|69662295|FG000|Week 24 to Week 104 Analysis|Other|17|||
37975132|NCT00468546|69662296|FG001|Week 24 to Week 104 Analysis|Other|14|||
37785734|NCT02346240|69381604|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
37785735|NCT02346240|69381605|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
37785736|NCT02346240|69381606|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
37785737|NCT02346240|69381607|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
37785738|NCT02346240|69381608|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
37785739|NCT02346240|69381609|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
37785740|NCT02346240|69381610|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
37785741|NCT02346240|69381611|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
37785742|NCT02346240|69381612|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
37785743|NCT02346240|69381589|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
37785744|NCT02346240|69381590|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
37785745|NCT02346240|69381591|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
37785746|NCT02346240|69381592|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
37785747|NCT02346240|69381593|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
37785748|NCT02346240|69381594|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
37785749|NCT02346240|69381595|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
37785750|NCT02346240|69381596|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
37785751|NCT02346240|69381597|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
37785752|NCT02346240|69381598|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
37785753|NCT02346240|69381599|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
37785754|NCT02346240|69381600|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
37785755|NCT02346240|69381601|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
37785756|NCT02346240|69381602|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
37785757|NCT02346240|69381603|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
37785758|NCT02346240|69381604|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
37785759|NCT02346240|69381605|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
37785760|NCT02346240|69381606|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
37975133|NCT00303316|69662304|FG000|Overall Study|Protocol Violation|1|||
37975134|NCT00303316|69662305|FG001|Overall Study|Protocol Violation|0|||
37975135|NCT00303316|69662304|FG000|Overall Study|Lost to Follow-up|0|||
37785761|NCT02346240|69381607|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
37785762|NCT02346240|69381608|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
37785763|NCT02346240|69381609|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
37785764|NCT02346240|69381610|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
37785765|NCT02346240|69381611|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
37785766|NCT02346240|69381612|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
37785767|NCT02346240|69381589|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
37785768|NCT02346240|69381590|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
37785769|NCT02346240|69381591|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
37785770|NCT02346240|69381592|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
37785771|NCT02346240|69381593|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
37785772|NCT02346240|69381594|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
37785773|NCT02346240|69381595|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
37785774|NCT02346240|69381596|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
37785775|NCT02346240|69381597|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
37785776|NCT02346240|69381598|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
37785777|NCT02346240|69381599|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
37785778|NCT02346240|69381600|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
37785779|NCT02346240|69381601|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
37785780|NCT02346240|69381602|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
37785781|NCT02346240|69381603|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
37785782|NCT02346240|69381604|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
37785783|NCT02346240|69381605|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
37785784|NCT02346240|69381606|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
37785785|NCT02346240|69381607|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
37785786|NCT02346240|69381608|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
37785787|NCT02346240|69381609|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
37785788|NCT02346240|69381610|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
37785789|NCT02346240|69381611|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
37785790|NCT02346240|69381612|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
37785791|NCT02346240|69381589|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
37785792|NCT02346240|69381590|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
37785793|NCT02346240|69381591|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
37785794|NCT02346240|69381592|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
37785795|NCT02346240|69381593|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
37785796|NCT02346240|69381594|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
37785797|NCT02346240|69381595|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
37785798|NCT02346240|69381596|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
37785799|NCT02346240|69381597|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
37785800|NCT02346240|69381598|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
37785801|NCT02346240|69381599|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
37785802|NCT02346240|69381600|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
37975136|NCT00303316|69662305|FG001|Overall Study|Lost to Follow-up|1|||
37785803|NCT02346240|69381601|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
37785804|NCT02346240|69381602|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
37785805|NCT02346240|69381603|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
37785806|NCT02346240|69381604|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
37785807|NCT02346240|69381605|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
37785808|NCT02346240|69381606|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
37785809|NCT02346240|69381607|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
37785810|NCT02346240|69381608|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
37785811|NCT02346240|69381609|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
37785812|NCT02346240|69381610|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
37785813|NCT02346240|69381611|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
37785814|NCT02346240|69381612|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
37785815|NCT02346240|69381589|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
37785816|NCT02346240|69381590|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
37785817|NCT02346240|69381591|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
37785818|NCT02346240|69381592|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
37785819|NCT02346240|69381593|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
37785820|NCT02346240|69381594|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
37785821|NCT02346240|69381595|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
37785822|NCT02346240|69381596|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
37785823|NCT02346240|69381597|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
37785824|NCT02346240|69381598|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
37785825|NCT02346240|69381599|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
37785826|NCT02346240|69381600|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
37785827|NCT02346240|69381601|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
37785828|NCT02346240|69381602|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
37975137|NCT00303316|69662304|FG000|Overall Study|Withdrawal by Subject|1|||
37785829|NCT02346240|69381603|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
37864066|NCT01252355|69547719|FG001|Overall Study|Poor Compliance to Protocol|1|||
37975138|NCT00303316|69662305|FG001|Overall Study|Withdrawal by Subject|2|||
37975139|NCT00468312|69662313|FG000|Overall Study|Adverse Event|2|||
37785830|NCT02346240|69381604|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
37785831|NCT02346240|69381605|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
37785832|NCT02346240|69381606|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
37785833|NCT02346240|69381607|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
37785834|NCT02346240|69381608|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
37785835|NCT02346240|69381609|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
37785836|NCT02346240|69381610|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
37785837|NCT02346240|69381611|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
37785838|NCT02346240|69381612|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
37785839|NCT02346240|69381589|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
37785840|NCT02346240|69381590|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
37785841|NCT02346240|69381591|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
37785842|NCT02346240|69381592|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
37785843|NCT02346240|69381593|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
37785844|NCT02346240|69381594|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
37785845|NCT02346240|69381595|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
37785846|NCT02346240|69381596|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
37785847|NCT02346240|69381597|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
37785848|NCT02346240|69381598|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
37785849|NCT02346240|69381599|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
37785850|NCT02346240|69381600|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
37785851|NCT02346240|69381601|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
37785852|NCT02346240|69381602|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
37785853|NCT02346240|69381603|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
37785854|NCT02346240|69381604|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
37785855|NCT02346240|69381605|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
37785856|NCT02346240|69381606|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
37785857|NCT02346240|69381607|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
37785858|NCT02346240|69381608|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
37785859|NCT02346240|69381609|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
37785860|NCT02346240|69381610|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
37785861|NCT02346240|69381611|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
37785862|NCT02346240|69381612|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
37785863|NCT02346240|69381589|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
37785864|NCT02346240|69381590|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
37785865|NCT02346240|69381591|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
37785866|NCT02346240|69381592|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
37785867|NCT02346240|69381593|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
37785868|NCT02346240|69381594|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
37785869|NCT02346240|69381595|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
37785870|NCT02346240|69381596|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
37785871|NCT02346240|69381597|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
37785872|NCT02346240|69381598|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
37785873|NCT02346240|69381599|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
37785874|NCT02346240|69381600|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
37785875|NCT02346240|69381601|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
37785876|NCT02346240|69381602|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
37785877|NCT02346240|69381603|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
37785878|NCT02346240|69381604|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
37785879|NCT02346240|69381605|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
37693596|NCT02317627|69169843|FG000|Overall Study|Non-compliance with study drug|0|||
37693597|NCT02317627|69169844|FG001|Overall Study|Non-compliance with study drug|1|||
37693598|NCT02317627|69169845|FG002|Overall Study|Non-compliance with study drug|0|||
37693599|NCT02517905|69169861|FG000|Overall Study|Lost to Follow-up|4|||
37693600|NCT02517905|69169862|FG001|Overall Study|Lost to Follow-up|0|||
37693601|NCT02517905|69169861|FG000|Overall Study|Withdrawal by Subject|4|||
37693602|NCT02517905|69169862|FG001|Overall Study|Withdrawal by Subject|0|||
37693603|NCT02517905|69169861|FG000|Overall Study|Screen failure|2|||
37693604|NCT02517905|69169862|FG001|Overall Study|Screen failure|2|||
37693605|NCT02473913|69169870|FG000|Overall Study|Lost to Follow-up|3|||
37693606|NCT02473913|69169871|FG001|Overall Study|Lost to Follow-up|3|||
37693607|NCT02316847|69169879|FG000|Overall Study|Adverse Event|0|||
37693608|NCT02316847|69169880|FG001|Overall Study|Adverse Event|3|||
37975140|NCT00468312|69662314|FG001|Overall Study|Adverse Event|1|||
37975141|NCT00468312|69662313|FG000|Overall Study|Lack of Efficacy|0|||
37975142|NCT00468312|69662314|FG001|Overall Study|Lack of Efficacy|1|||
37975143|NCT00468312|69662313|FG000|Overall Study|Withdrawal by Subject|0|||
37975144|NCT00468312|69662314|FG001|Overall Study|Withdrawal by Subject|1|||
37975145|NCT00468312|69662313|FG000|Overall Study|Protocol Violation|2|||
37975146|NCT00468312|69662314|FG001|Overall Study|Protocol Violation|1|||
37975147|NCT00468312|69662313|FG000|Overall Study|Did not meet protocol eligibility|0|||
37975148|NCT00468312|69662314|FG001|Overall Study|Did not meet protocol eligibility|1|||
37975149|NCT00331864|69662322|FG000|Overall Study|Adverse Event|30|||
37693609|NCT02316847|69169879|FG000|Overall Study|Lost to Follow-up|0|||
37693610|NCT02316847|69169880|FG001|Overall Study|Lost to Follow-up|2|||
37693611|NCT02316847|69169879|FG000|Overall Study|Physician Decision|0|||
37975150|NCT00331864|69662323|FG001|Overall Study|Adverse Event|1|||
37975151|NCT00331864|69662322|FG000|Overall Study|Lack of Efficacy|4|||
37785880|NCT02346240|69381606|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
37785881|NCT02346240|69381607|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
37785882|NCT02346240|69381608|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
37785883|NCT02346240|69381609|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
37785884|NCT02346240|69381610|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
37785885|NCT02346240|69381611|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
37785886|NCT02346240|69381612|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
37785887|NCT02346240|69381589|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
37785888|NCT02346240|69381590|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
37785889|NCT02346240|69381591|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
37785890|NCT02346240|69381592|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
37785891|NCT02346240|69381593|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
37785892|NCT02346240|69381594|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
37785893|NCT02346240|69381595|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
37785894|NCT02346240|69381596|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
37785895|NCT02346240|69381597|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
37785896|NCT02346240|69381598|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
37785897|NCT02346240|69381599|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
37785898|NCT02346240|69381600|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
37785899|NCT02346240|69381601|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
37785900|NCT02346240|69381602|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
37785901|NCT02346240|69381603|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
37785902|NCT02346240|69381604|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
37785903|NCT02346240|69381605|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
37785904|NCT02346240|69381606|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
37785905|NCT02346240|69381607|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
37785906|NCT02346240|69381608|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
37785907|NCT02346240|69381609|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
37785908|NCT02346240|69381610|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
37785909|NCT02346240|69381611|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
37785910|NCT02346240|69381612|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
37785911|NCT02346240|69381589|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
37785912|NCT02346240|69381590|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
37785913|NCT02346240|69381591|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
37785914|NCT02346240|69381592|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
37785915|NCT02346240|69381593|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
37785916|NCT02346240|69381594|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
37785917|NCT02346240|69381595|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
37785918|NCT02346240|69381596|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
37975152|NCT00331864|69662323|FG001|Overall Study|Lack of Efficacy|0|||
37975153|NCT00331864|69662322|FG000|Overall Study|Protocol Violation|3|||
37975154|NCT00331864|69662323|FG001|Overall Study|Protocol Violation|0|||
37975155|NCT00331864|69662322|FG000|Overall Study|Withdrawal by Subject|10|||
37975156|NCT00331864|69662323|FG001|Overall Study|Withdrawal by Subject|0|||
37693612|NCT02316847|69169880|FG001|Overall Study|Physician Decision|1|||
37785919|NCT02346240|69381597|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
37785920|NCT02346240|69381598|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
37785921|NCT02346240|69381599|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
37785922|NCT02346240|69381600|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
37975157|NCT00331864|69662322|FG000|Overall Study|Lost to Follow-up|4|||
37975158|NCT00331864|69662323|FG001|Overall Study|Lost to Follow-up|3|||
37975159|NCT00331864|69662322|FG000|Overall Study|Administrative Problems|1|||
37693613|NCT02316847|69169879|FG000|Overall Study|Pregnancy|0|||
37785923|NCT02346240|69381601|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
37785924|NCT02346240|69381602|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
37785925|NCT02346240|69381603|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
37785926|NCT02346240|69381604|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
37785927|NCT02346240|69381605|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
37785928|NCT02346240|69381606|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
37785929|NCT02346240|69381607|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
37785930|NCT02346240|69381608|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
37785931|NCT02346240|69381609|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
37785932|NCT02346240|69381610|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
37785933|NCT02346240|69381611|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
37785934|NCT02346240|69381612|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
37785935|NCT02346240|69381589|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
37785936|NCT02346240|69381590|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
37785937|NCT02346240|69381591|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
37785938|NCT02346240|69381592|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
37785939|NCT02346240|69381593|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
37785940|NCT02346240|69381594|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
37785941|NCT02346240|69381595|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
37785942|NCT02346240|69381596|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
37785943|NCT02346240|69381597|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
37785944|NCT02346240|69381598|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
37785945|NCT02346240|69381599|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
37785946|NCT02346240|69381600|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
37785947|NCT02346240|69381601|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
37785948|NCT02346240|69381602|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
37785949|NCT02346240|69381603|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
37785950|NCT02346240|69381604|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
37785951|NCT02346240|69381605|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
37785952|NCT02346240|69381606|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
37785953|NCT02346240|69381607|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
37785954|NCT02346240|69381608|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
37785955|NCT02346240|69381609|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
37785956|NCT02346240|69381610|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
37785957|NCT02346240|69381611|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
37785958|NCT02346240|69381612|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
37785959|NCT02346240|69381589|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
37785960|NCT02346240|69381590|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
37785961|NCT02346240|69381591|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
37785962|NCT02346240|69381592|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
37785963|NCT02346240|69381593|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
37785964|NCT02346240|69381594|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
37785965|NCT02346240|69381595|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
37785966|NCT02346240|69381596|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
37785967|NCT02346240|69381597|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
37785968|NCT02346240|69381598|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
37785969|NCT02346240|69381599|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
37785970|NCT02346240|69381600|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
37785971|NCT02346240|69381601|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
37785972|NCT02346240|69381602|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
37785973|NCT02346240|69381603|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
37785974|NCT02346240|69381604|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
37785975|NCT02346240|69381605|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
37785976|NCT02346240|69381606|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
37785977|NCT02346240|69381607|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
37785978|NCT02346240|69381608|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
37785979|NCT02346240|69381609|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
37785980|NCT02346240|69381610|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
37785981|NCT02346240|69381611|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
37785982|NCT02346240|69381612|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
37785983|NCT02346240|69381589|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
37975160|NCT00331864|69662323|FG001|Overall Study|Administrative Problems|0|||
37975161|NCT00331864|69662322|FG000|Overall Study|Death|6|||
37975162|NCT00331864|69662323|FG001|Overall Study|Death|0|||
37785984|NCT02346240|69381590|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
37785985|NCT02346240|69381591|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
37785986|NCT02346240|69381592|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
37785987|NCT02346240|69381593|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
37785988|NCT02346240|69381594|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
37785989|NCT02346240|69381595|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
37785990|NCT02346240|69381596|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
37785991|NCT02346240|69381597|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
37785992|NCT02346240|69381598|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
37785993|NCT02346240|69381599|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
37785994|NCT02346240|69381600|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
37785995|NCT02346240|69381601|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
37785996|NCT02346240|69381602|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
37785997|NCT02346240|69381603|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
37785998|NCT02346240|69381604|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
37785999|NCT02346240|69381605|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
37786000|NCT02346240|69381606|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
37786001|NCT02346240|69381607|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
37786002|NCT02346240|69381608|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
37786003|NCT02346240|69381609|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
37786004|NCT02346240|69381610|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
37786005|NCT02346240|69381611|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
37786006|NCT02346240|69381612|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
37786007|NCT02346240|69381589|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
37786008|NCT02346240|69381590|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
37786009|NCT02346240|69381591|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
37786010|NCT02346240|69381592|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
37786011|NCT02346240|69381593|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
37786012|NCT02346240|69381594|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
37786013|NCT02346240|69381595|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
37786014|NCT02346240|69381596|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
37786015|NCT02346240|69381597|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
37786016|NCT02346240|69381598|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
37786017|NCT02346240|69381599|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
37786018|NCT02346240|69381600|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
37786019|NCT02346240|69381601|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
37786020|NCT02346240|69381602|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
37786021|NCT02346240|69381603|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
37786022|NCT02346240|69381604|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
37786023|NCT02346240|69381605|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
37786024|NCT02346240|69381606|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
37786025|NCT02346240|69381607|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
37786026|NCT02346240|69381608|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
37786027|NCT02346240|69381609|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
37786028|NCT02346240|69381610|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
37786029|NCT02346240|69381611|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
37786030|NCT02346240|69381612|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
37786031|NCT02346240|69381589|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
37786032|NCT02346240|69381590|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
37786033|NCT02346240|69381591|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
37786034|NCT02346240|69381592|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
37975163|NCT00331630|69662329|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
37975164|NCT00331630|69662329|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
37786035|NCT02346240|69381593|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
37786036|NCT02346240|69381594|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
37786037|NCT02346240|69381595|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
37786038|NCT02346240|69381596|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
37786039|NCT02346240|69381597|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
37786040|NCT02346240|69381598|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
37786041|NCT02346240|69381599|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
37786042|NCT02346240|69381600|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
37786043|NCT02346240|69381601|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
37786044|NCT02346240|69381602|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
37786045|NCT02346240|69381603|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
37786046|NCT02346240|69381604|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
37786047|NCT02346240|69381605|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
37786048|NCT02346240|69381606|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
37786049|NCT02346240|69381607|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
37786050|NCT02346240|69381608|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
37786051|NCT02346240|69381609|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
37786052|NCT02346240|69381610|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
37786053|NCT02346240|69381611|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
37786054|NCT02346240|69381612|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
37786055|NCT02392104|69381663|FG000|Overall Study|discontinuation of warfarin|3|||
37786056|NCT02392104|69381663|FG000|Overall Study|bleeding event|1|||
37786057|NCT02392104|69381663|FG000|Overall Study|transferred care to another doctor|2|||
37786058|NCT02392104|69381663|FG000|Overall Study|INR goal range changed|1|||
37786059|NCT02392104|69381663|FG000|Overall Study|admitted to skilled nursing facility|3|||
37786060|NCT02392104|69381663|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
37786061|NCT02391948|69381681|FG000|6-month Assessment|Death|0|||
37786062|NCT02391948|69381682|FG001|6-month Assessment|Death|0|||
37786063|NCT02391948|69381683|FG002|6-month Assessment|Death|0|||
37786064|NCT02391948|69381684|FG003|6-month Assessment|Death|0|||
37786065|NCT02391948|69381685|FG004|6-month Assessment|Death|1|||
37786066|NCT02391948|69381681|FG000|6-month Assessment|Withdrawal by Subject|0|||
37786067|NCT02391948|69381682|FG001|6-month Assessment|Withdrawal by Subject|0|||
37786068|NCT02391948|69381683|FG002|6-month Assessment|Withdrawal by Subject|1|||
37786069|NCT02391948|69381684|FG003|6-month Assessment|Withdrawal by Subject|2|||
37786070|NCT02391948|69381685|FG004|6-month Assessment|Withdrawal by Subject|0|||
37786071|NCT02391948|69381681|FG000|6-month Assessment|Lost to Follow-up|4|||
37786072|NCT02391948|69381682|FG001|6-month Assessment|Lost to Follow-up|5|||
37786073|NCT02391948|69381683|FG002|6-month Assessment|Lost to Follow-up|2|||
37786074|NCT02391948|69381684|FG003|6-month Assessment|Lost to Follow-up|3|||
37786075|NCT02391948|69381685|FG004|6-month Assessment|Lost to Follow-up|1|||
37786076|NCT02391948|69381681|FG000|6-month Assessment|Medical issue/illness|1|||
37786077|NCT02391948|69381682|FG001|6-month Assessment|Medical issue/illness|1|||
37786078|NCT02391948|69381683|FG002|6-month Assessment|Medical issue/illness|0|||
37786079|NCT02391948|69381684|FG003|6-month Assessment|Medical issue/illness|0|||
37786080|NCT02391948|69381685|FG004|6-month Assessment|Medical issue/illness|0|||
37786081|NCT02391948|69381681|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
37786082|NCT02391948|69381682|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
37786083|NCT02391948|69381683|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
37786084|NCT02391948|69381684|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
37786085|NCT02391948|69381685|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
37786086|NCT02391948|69381681|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
37786087|NCT02391948|69381682|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
37786088|NCT02391948|69381683|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
37786089|NCT02391948|69381684|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
37864067|NCT01252355|69547720|FG002|Overall Study|Poor Compliance to Protocol|1|||
37864068|NCT01252355|69547718|FG000|Overall Study|Progressive Disease|2|||
37864069|NCT01252355|69547719|FG001|Overall Study|Progressive Disease|0|||
37864070|NCT01252355|69547720|FG002|Overall Study|Progressive Disease|0|||
37864071|NCT01252355|69547718|FG000|Overall Study|Sponsor Early Termination of Study|149|||
37864072|NCT01252355|69547719|FG001|Overall Study|Sponsor Early Termination of Study|149|||
37864073|NCT01252355|69547720|FG002|Overall Study|Sponsor Early Termination of Study|146|||
37786090|NCT02391948|69381685|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
37864074|NCT01252355|69547718|FG000|Overall Study|Randomized but not Treated|2|||
37786091|NCT02391948|69381681|FG000|12-month Assessment|Death|0|||
37786092|NCT02391948|69381682|FG001|12-month Assessment|Death|0|||
37786093|NCT02391948|69381683|FG002|12-month Assessment|Death|0|||
37786094|NCT02391948|69381684|FG003|12-month Assessment|Death|1|||
37864075|NCT01252355|69547719|FG001|Overall Study|Randomized but not Treated|0|||
37786095|NCT02391948|69381685|FG004|12-month Assessment|Death|0|||
37786096|NCT02391948|69381681|FG000|12-month Assessment|Withdrawal by Subject|1|||
37786097|NCT02391948|69381682|FG001|12-month Assessment|Withdrawal by Subject|0|||
37786098|NCT02391948|69381683|FG002|12-month Assessment|Withdrawal by Subject|0|||
37786099|NCT02391948|69381684|FG003|12-month Assessment|Withdrawal by Subject|1|||
37786100|NCT02391948|69381685|FG004|12-month Assessment|Withdrawal by Subject|0|||
37786101|NCT02391948|69381681|FG000|12-month Assessment|Lost to Follow-up|5|||
37786102|NCT02391948|69381682|FG001|12-month Assessment|Lost to Follow-up|4|||
37786103|NCT02391948|69381683|FG002|12-month Assessment|Lost to Follow-up|4|||
37786104|NCT02391948|69381684|FG003|12-month Assessment|Lost to Follow-up|4|||
37786105|NCT02391948|69381685|FG004|12-month Assessment|Lost to Follow-up|5|||
37786106|NCT02391948|69381681|FG000|12-month Assessment|Medical issue/illness|0|||
37786107|NCT02391948|69381682|FG001|12-month Assessment|Medical issue/illness|1|||
37786108|NCT02391948|69381683|FG002|12-month Assessment|Medical issue/illness|0|||
37786109|NCT02391948|69381684|FG003|12-month Assessment|Medical issue/illness|1|||
37786110|NCT02391948|69381685|FG004|12-month Assessment|Medical issue/illness|0|||
37786111|NCT02391948|69381681|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
37786112|NCT02391948|69381682|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
37786113|NCT02391948|69381683|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
37786114|NCT02391948|69381684|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
37786115|NCT02391948|69381685|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
37786116|NCT02391948|69381681|FG000|18-month Assessment|Death|0|||
37786117|NCT02391948|69381682|FG001|18-month Assessment|Death|0|||
37786118|NCT02391948|69381683|FG002|18-month Assessment|Death|0|||
37786119|NCT02391948|69381684|FG003|18-month Assessment|Death|1|||
37786120|NCT02391948|69381685|FG004|18-month Assessment|Death|1|||
37786121|NCT02391948|69381681|FG000|18-month Assessment|Withdrawal by Subject|1|||
37786122|NCT02391948|69381682|FG001|18-month Assessment|Withdrawal by Subject|0|||
37786123|NCT02391948|69381683|FG002|18-month Assessment|Withdrawal by Subject|0|||
37786124|NCT02391948|69381684|FG003|18-month Assessment|Withdrawal by Subject|1|||
37786125|NCT02391948|69381685|FG004|18-month Assessment|Withdrawal by Subject|0|||
37786126|NCT02391948|69381681|FG000|18-month Assessment|Lost to Follow-up|2|||
37786127|NCT02391948|69381682|FG001|18-month Assessment|Lost to Follow-up|6|||
37786128|NCT02391948|69381683|FG002|18-month Assessment|Lost to Follow-up|2|||
37786129|NCT02391948|69381684|FG003|18-month Assessment|Lost to Follow-up|2|||
37786130|NCT02391948|69381685|FG004|18-month Assessment|Lost to Follow-up|3|||
37786131|NCT02391948|69381681|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
37786132|NCT02391948|69381682|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
37786133|NCT02391948|69381683|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
37786134|NCT02391948|69381684|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
37786135|NCT02391948|69381685|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
37786136|NCT02391948|69381681|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
37786137|NCT02391948|69381682|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
37786138|NCT02391948|69381683|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
37786139|NCT02391948|69381684|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
37786140|NCT02391948|69381685|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
37786141|NCT02391948|69381681|FG000|24-month Assessment|Death|0|||
37786142|NCT02391948|69381682|FG001|24-month Assessment|Death|0|||
37786143|NCT02391948|69381683|FG002|24-month Assessment|Death|0|||
37786144|NCT02391948|69381684|FG003|24-month Assessment|Death|0|||
37786145|NCT02391948|69381685|FG004|24-month Assessment|Death|1|||
37786146|NCT02391948|69381681|FG000|24-month Assessment|Withdrawal by Subject|1|||
37786147|NCT02391948|69381682|FG001|24-month Assessment|Withdrawal by Subject|1|||
37786148|NCT02391948|69381683|FG002|24-month Assessment|Withdrawal by Subject|0|||
37786149|NCT02391948|69381684|FG003|24-month Assessment|Withdrawal by Subject|0|||
37975165|NCT00331630|69662329|FG000|Follow up for 5 Years|Death|5|||
37975166|NCT00331630|69662329|FG000|Follow up for 5 Years|Data collection was stopped|24|||
37975167|NCT00331552|69662335|FG000|Period 3: Phase II|Neurological Symptoms|1|||
37975168|NCT00331552|69662336|FG001|Period 3: Phase II|Neurological Symptoms|0|||
37786150|NCT02391948|69381685|FG004|24-month Assessment|Withdrawal by Subject|1|||
37786151|NCT02391948|69381681|FG000|24-month Assessment|Lost to Follow-up|5|||
37786152|NCT02391948|69381682|FG001|24-month Assessment|Lost to Follow-up|4|||
37786153|NCT02391948|69381683|FG002|24-month Assessment|Lost to Follow-up|0|||
37786154|NCT02391948|69381684|FG003|24-month Assessment|Lost to Follow-up|0|||
37786155|NCT02391948|69381685|FG004|24-month Assessment|Lost to Follow-up|0|||
37786156|NCT02391948|69381681|FG000|24-month Assessment|Medical issue/illness|0|||
37786157|NCT02391948|69381682|FG001|24-month Assessment|Medical issue/illness|0|||
37786158|NCT02391948|69381683|FG002|24-month Assessment|Medical issue/illness|1|||
37786159|NCT02391948|69381684|FG003|24-month Assessment|Medical issue/illness|0|||
37786160|NCT02391948|69381685|FG004|24-month Assessment|Medical issue/illness|0|||
37786161|NCT02391948|69381681|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
37786162|NCT02391948|69381682|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
37786163|NCT02391948|69381683|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
37786164|NCT02391948|69381684|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
37786165|NCT02391948|69381685|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
37786166|NCT02369874|69381928|FG000|Overall Study|Lost to Follow-up|2|||
37786167|NCT02369874|69381929|FG001|Overall Study|Lost to Follow-up|2|||
37786168|NCT02369874|69381930|FG002|Overall Study|Lost to Follow-up|2|||
37786169|NCT02369874|69381928|FG000|Overall Study|Withdrawal by Subject|7|||
37786170|NCT02369874|69381929|FG001|Overall Study|Withdrawal by Subject|9|||
37786171|NCT02369874|69381930|FG002|Overall Study|Withdrawal by Subject|27|||
37786172|NCT02369874|69381928|FG000|Overall Study|Miscellaneous|1|||
37786173|NCT02369874|69381929|FG001|Overall Study|Miscellaneous|1|||
37786174|NCT02369874|69381930|FG002|Overall Study|Miscellaneous|0|||
37786175|NCT02369874|69381928|FG000|Overall Study|On Treatment/Off Study|34|||
37786176|NCT02369874|69381929|FG001|Overall Study|On Treatment/Off Study|45|||
37786177|NCT02369874|69381930|FG002|Overall Study|On Treatment/Off Study|32|||
37786178|NCT02368314|69382073|FG000|Overall Study|Withdrawal by Subject|2|||
37786179|NCT02368314|69382074|FG001|Overall Study|Withdrawal by Subject|1|||
37786180|NCT02368314|69382073|FG000|Overall Study|Adverse Event|1|||
37786181|NCT02368314|69382074|FG001|Overall Study|Adverse Event|2|||
37786182|NCT02366910|69382084|FG000|Overall Study|Withdrawal by Subject|2|||
37786183|NCT02366910|69382084|FG000|Overall Study|Screen Failure|3|||
37786184|NCT02345226|69382388|FG000|Double-Blind Phase|Adverse Event|5|||
37786185|NCT02345226|69382389|FG001|Double-Blind Phase|Adverse Event|6|||
37786186|NCT02345226|69382388|FG000|Double-Blind Phase|Death|3|||
37786187|NCT02345226|69382389|FG001|Double-Blind Phase|Death|0|||
37786188|NCT02345226|69382388|FG000|Double-Blind Phase|Pregnancy|0|||
37786189|NCT02345226|69382389|FG001|Double-Blind Phase|Pregnancy|1|||
37786190|NCT02345226|69382388|FG000|Double-Blind Phase|Lack of Efficacy|1|||
37786191|NCT02345226|69382389|FG001|Double-Blind Phase|Lack of Efficacy|0|||
37786192|NCT02345226|69382388|FG000|Double-Blind Phase|Investigator's Discretion|4|||
37786193|NCT02345226|69382389|FG001|Double-Blind Phase|Investigator's Discretion|3|||
37786194|NCT02345226|69382388|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
37786195|NCT02345226|69382389|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
37786196|NCT02345226|69382388|FG000|Double-Blind Phase|Withdrew Consent|41|||
37786197|NCT02345226|69382389|FG001|Double-Blind Phase|Withdrew Consent|39|||
37786198|NCT02345226|69382388|FG000|Double-Blind Phase|Lost to Follow-up|12|||
37786199|NCT02345226|69382389|FG001|Double-Blind Phase|Lost to Follow-up|16|||
37786200|NCT02345226|69382388|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
37786201|NCT02345226|69382389|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
37786202|NCT02345226|69382388|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
37786203|NCT02345226|69382389|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
37786204|NCT00551369|69382960|FG000|Overall Study|Protocol Violation|5|||
37786205|NCT00551369|69382960|FG000|Overall Study|Withdrawal by Subject|1|||
37786206|NCT00551369|69382960|FG000|Overall Study|Not treated per protocol and re|1|||
37786207|NCT00551291|69382973|FG000|Overall Study|Physician Decision|1|||
37786208|NCT00551213|69383079|FG000|Overall Study|Adverse Event|6|||
37786209|NCT00551213|69383080|FG001|Overall Study|Adverse Event|3|||
37786210|NCT00551213|69383079|FG000|Overall Study|Progressive Disease|41|||
37786211|NCT00551213|69383080|FG001|Overall Study|Progressive Disease|12|||
37786212|NCT00551213|69383079|FG000|Overall Study|Withdrawal by Subject|2|||
37786213|NCT00551213|69383080|FG001|Overall Study|Withdrawal by Subject|0|||
37786214|NCT00551213|69383079|FG000|Overall Study|Not Treated|1|||
37786215|NCT00551213|69383080|FG001|Overall Study|Not Treated|2|||
37786216|NCT00550043|69383217|FG000|Overall Study|Adverse Event|0|||
37786217|NCT00550043|69383218|FG001|Overall Study|Adverse Event|0|||
37786218|NCT00550043|69383219|FG002|Overall Study|Adverse Event|0|||
37786219|NCT00550043|69383220|FG003|Overall Study|Adverse Event|1|||
37786220|NCT00550043|69383221|FG004|Overall Study|Adverse Event|1|||
37786221|NCT00550043|69383217|FG000|Overall Study|Subject Withdrew Consent|0|||
37786222|NCT00550043|69383218|FG001|Overall Study|Subject Withdrew Consent|2|||
37786223|NCT00550043|69383219|FG002|Overall Study|Subject Withdrew Consent|1|||
37786224|NCT00550043|69383220|FG003|Overall Study|Subject Withdrew Consent|0|||
37786225|NCT00550043|69383221|FG004|Overall Study|Subject Withdrew Consent|0|||
37786226|NCT00550043|69383217|FG000|Overall Study|Other Reasons- Unspecified|0|||
37786227|NCT00550043|69383218|FG001|Overall Study|Other Reasons- Unspecified|1|||
37786228|NCT00550043|69383219|FG002|Overall Study|Other Reasons- Unspecified|0|||
37786229|NCT00550043|69383220|FG003|Overall Study|Other Reasons- Unspecified|1|||
37786230|NCT00550043|69383221|FG004|Overall Study|Other Reasons- Unspecified|0|||
37786231|NCT03188822|69383949|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
37786232|NCT03188822|69383949|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
37786233|NCT04976777|69384092|FG000|Overall Study|COVID-19 Infection|1|||
37786234|NCT04976777|69384093|FG001|Overall Study|COVID-19 Infection|0|||
37786235|NCT00555971|69384267|FG000|Overall Study|Adverse Event|1|||
37786236|NCT00555971|69384268|FG001|Overall Study|Adverse Event|1|||
37786237|NCT02343120|69385144|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
37786238|NCT02343120|69385145|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
37693614|NCT02316847|69169880|FG001|Overall Study|Pregnancy|1|||
37786239|NCT02343120|69385146|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
37786240|NCT02343120|69385147|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
37786241|NCT02343120|69385148|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
37786242|NCT02343120|69385144|FG000|Part 1: Dose Escalation|Death|1|||
37786243|NCT02343120|69385145|FG001|Part 1: Dose Escalation|Death|2|||
37786244|NCT02343120|69385146|FG002|Part 1: Dose Escalation|Death|2|||
37786245|NCT02343120|69385147|FG003|Part 1: Dose Escalation|Death|2|||
37786246|NCT02343120|69385148|FG004|Part 1: Dose Escalation|Death|1|||
37786247|NCT02343120|69385144|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
37786248|NCT02343120|69385145|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
37786249|NCT02343120|69385146|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
37786250|NCT02343120|69385147|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
37786251|NCT02343120|69385148|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
37786252|NCT02343120|69385144|FG000|Part 2: Expansion|Sponsor decision|0|||
37786253|NCT02343120|69385145|FG001|Part 2: Expansion|Sponsor decision|0|||
37975169|NCT00331552|69662335|FG000|Period 3: Phase II|Severe Nausea|1|||
37975170|NCT00331552|69662336|FG001|Period 3: Phase II|Severe Nausea|0|||
37975171|NCT00317356|69662351|FG000|Overall Study|Adverse Event|0|||
37786254|NCT02343120|69385146|FG002|Part 2: Expansion|Sponsor decision|0|||
37786255|NCT02343120|69385147|FG003|Part 2: Expansion|Sponsor decision|165|||
37786256|NCT02343120|69385148|FG004|Part 2: Expansion|Sponsor decision|67|||
37786257|NCT02343120|69385144|FG000|Part 2: Expansion|Death|0|||
37786258|NCT02343120|69385145|FG001|Part 2: Expansion|Death|0|||
37786259|NCT02343120|69385146|FG002|Part 2: Expansion|Death|0|||
37786260|NCT02343120|69385147|FG003|Part 2: Expansion|Death|74|||
37786261|NCT02343120|69385148|FG004|Part 2: Expansion|Death|17|||
37786262|NCT02343120|69385144|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
37786263|NCT02343120|69385145|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
37786264|NCT02343120|69385146|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
37786265|NCT02343120|69385147|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
37786266|NCT02343120|69385148|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
37786267|NCT02343120|69385144|FG000|Part 2: Expansion|Lost to Follow-up|0|||
37786268|NCT02343120|69385145|FG001|Part 2: Expansion|Lost to Follow-up|0|||
37786269|NCT02343120|69385146|FG002|Part 2: Expansion|Lost to Follow-up|0|||
37786270|NCT02343120|69385147|FG003|Part 2: Expansion|Lost to Follow-up|5|||
37786271|NCT02343120|69385148|FG004|Part 2: Expansion|Lost to Follow-up|2|||
37786272|NCT02343120|69385144|FG000|Part 2: Expansion|Other|0|||
37786273|NCT02343120|69385145|FG001|Part 2: Expansion|Other|0|||
37786274|NCT02343120|69385146|FG002|Part 2: Expansion|Other|0|||
37786275|NCT02343120|69385147|FG003|Part 2: Expansion|Other|1|||
37786276|NCT02343120|69385148|FG004|Part 2: Expansion|Other|5|||
37786277|NCT02343120|69385144|FG000|Part 2: Expansion|Adverse Event|0|||
37786278|NCT02343120|69385145|FG001|Part 2: Expansion|Adverse Event|0|||
37786279|NCT02343120|69385146|FG002|Part 2: Expansion|Adverse Event|0|||
37786280|NCT02343120|69385147|FG003|Part 2: Expansion|Adverse Event|1|||
37786281|NCT02343120|69385148|FG004|Part 2: Expansion|Adverse Event|1|||
37786282|NCT02342886|69385405|FG000|Overall Study|Treatment non-compliance|1|||
37786283|NCT02342886|69385406|FG001|Overall Study|Treatment non-compliance|0|||
37786284|NCT02342886|69385407|FG002|Overall Study|Treatment non-compliance|0|||
37786285|NCT02342886|69385408|FG003|Overall Study|Treatment non-compliance|1|||
37786286|NCT02342886|69385409|FG004|Overall Study|Treatment non-compliance|0|||
37786287|NCT02342886|69385405|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
37786288|NCT02342886|69385406|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
37786289|NCT02342886|69385407|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
37975172|NCT00317356|69662352|FG001|Overall Study|Adverse Event|0|||
37975173|NCT00317356|69662353|FG002|Overall Study|Adverse Event|1|||
37786290|NCT02342886|69385408|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
37786291|NCT02342886|69385409|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
37786292|NCT02342886|69385405|FG000|Overall Study|Adverse event/specific toxicity|4|||
37786293|NCT02342886|69385406|FG001|Overall Study|Adverse event/specific toxicity|3|||
37786294|NCT02342886|69385407|FG002|Overall Study|Adverse event/specific toxicity|11|||
37786295|NCT02342886|69385408|FG003|Overall Study|Adverse event/specific toxicity|2|||
37786296|NCT02342886|69385409|FG004|Overall Study|Adverse event/specific toxicity|1|||
37786297|NCT02342886|69385405|FG000|Overall Study|Lost to Follow-up|1|||
37975174|NCT00317356|69662354|FG003|Overall Study|Adverse Event|0|||
37975175|NCT00317356|69662351|FG000|Overall Study|Lack of Efficacy|1|||
37975176|NCT00317356|69662352|FG001|Overall Study|Lack of Efficacy|1|||
37975177|NCT00317356|69662353|FG002|Overall Study|Lack of Efficacy|0|||
37975178|NCT00317356|69662354|FG003|Overall Study|Lack of Efficacy|3|||
37786298|NCT02342886|69385406|FG001|Overall Study|Lost to Follow-up|0|||
37975179|NCT00317356|69662351|FG000|Overall Study|Physician Decision|0|||
37975180|NCT00317356|69662352|FG001|Overall Study|Physician Decision|1|||
37786299|NCT02342886|69385407|FG002|Overall Study|Lost to Follow-up|0|||
37786300|NCT02342886|69385408|FG003|Overall Study|Lost to Follow-up|0|||
37786301|NCT02342886|69385409|FG004|Overall Study|Lost to Follow-up|0|||
37975181|NCT00317356|69662353|FG002|Overall Study|Physician Decision|0|||
37786302|NCT02342886|69385405|FG000|Overall Study|Death|1|||
37786303|NCT02342886|69385406|FG001|Overall Study|Death|2|||
37786304|NCT02342886|69385407|FG002|Overall Study|Death|1|||
37786305|NCT02342886|69385408|FG003|Overall Study|Death|0|||
37786306|NCT02342886|69385409|FG004|Overall Study|Death|1|||
37786307|NCT02342886|69385405|FG000|Overall Study|Withdrawal by Subject|0|||
37786308|NCT02342886|69385406|FG001|Overall Study|Withdrawal by Subject|1|||
37786309|NCT02342886|69385407|FG002|Overall Study|Withdrawal by Subject|0|||
37786310|NCT02342886|69385408|FG003|Overall Study|Withdrawal by Subject|1|||
37786311|NCT02342886|69385409|FG004|Overall Study|Withdrawal by Subject|0|||
37786312|NCT02342886|69385405|FG000|Overall Study|Investigator/sponsor decision|0|||
37786313|NCT02342886|69385406|FG001|Overall Study|Investigator/sponsor decision|2|||
37786314|NCT02342886|69385407|FG002|Overall Study|Investigator/sponsor decision|0|||
37786315|NCT02342886|69385408|FG003|Overall Study|Investigator/sponsor decision|3|||
37786316|NCT02342886|69385409|FG004|Overall Study|Investigator/sponsor decision|1|||
37786317|NCT02342886|69385405|FG000|Overall Study|Pregnancy|0|||
37786318|NCT02342886|69385406|FG001|Overall Study|Pregnancy|0|||
37786319|NCT02342886|69385407|FG002|Overall Study|Pregnancy|2|||
37786320|NCT02342886|69385408|FG003|Overall Study|Pregnancy|0|||
37786321|NCT02342886|69385409|FG004|Overall Study|Pregnancy|0|||
37786322|NCT02342886|69385405|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
37786323|NCT02342886|69385406|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
37786324|NCT02342886|69385407|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
37786325|NCT02342886|69385408|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
37786326|NCT02342886|69385409|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
37786327|NCT02342886|69385405|FG000|Overall Study|Protocol Violation|0|||
37786328|NCT02342886|69385406|FG001|Overall Study|Protocol Violation|0|||
37786329|NCT02342886|69385407|FG002|Overall Study|Protocol Violation|0|||
37786330|NCT02342886|69385408|FG003|Overall Study|Protocol Violation|2|||
37786331|NCT02342886|69385409|FG004|Overall Study|Protocol Violation|0|||
37786332|NCT02390076|69385445|FG000|Overall Study|Lost to Follow-up|2|||
37786333|NCT02390076|69385446|FG001|Overall Study|Lost to Follow-up|1|||
37786334|NCT02390076|69385447|FG002|Overall Study|Lost to Follow-up|4|||
37786335|NCT02389998|69385466|FG000|Overall Study|car accident|1|||
37786336|NCT02389998|69385467|FG001|Overall Study|car accident|0|||
37786337|NCT02389764|69385493|FG000|Overall Study|Lack of Efficacy|9|||
37786338|NCT02366130|69385564|FG000|Overall Study|Withdrawal by Subject|3|||
37786339|NCT02366130|69385564|FG000|Overall Study|Ineligible|6|||
37786340|NCT02389452|69385626|FG000|Overall Study|Lost to Follow-up|13|||
37786341|NCT02389452|69385626|FG000|Overall Study|Adverse Event|1|||
37786342|NCT02389452|69385626|FG000|Overall Study|Withdrawal by Subject|5|||
37786343|NCT02389452|69385626|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
37786344|NCT02365584|69385664|FG000|Overall Study|Adverse Event|2|||
37786345|NCT02365584|69385665|FG001|Overall Study|Adverse Event|2|||
37786346|NCT02365584|69385664|FG000|Overall Study|Withdrawal by Subject|1|||
37786347|NCT02365584|69385665|FG001|Overall Study|Withdrawal by Subject|0|||
37786348|NCT02365584|69385664|FG000|Overall Study|Disease Progression|9|||
37786349|NCT02365584|69385665|FG001|Overall Study|Disease Progression|12|||
37786350|NCT02342418|69385677|FG000|Overall Study|Adverse Event|0|||
37786351|NCT02342418|69385678|FG001|Overall Study|Adverse Event|1|||
37786352|NCT02365506|69385719|FG000|Overall Study|Investigator's Discretion|0|||
37786353|NCT02365506|69385720|FG001|Overall Study|Investigator's Discretion|0|||
37786354|NCT02365506|69385721|FG002|Overall Study|Investigator's Discretion|1|||
37786355|NCT02312934|69385758|FG000|Overall Study|Lost to Follow-up|1|||
37786356|NCT02312934|69385759|FG001|Overall Study|Lost to Follow-up|0|||
37786357|NCT02312934|69385758|FG000|Overall Study|Physician Decision|1|||
37786358|NCT02312934|69385759|FG001|Overall Study|Physician Decision|0|||
37786359|NCT02341482|69385793|FG000|Overall Study|Adverse Event|1|||
37786360|NCT02312856|69385833|FG000|Overall Study|Death|1|||
37786361|NCT02312856|69385833|FG000|Overall Study|Lost to Follow-up|3|||
37786362|NCT01602120|69386298|FG000|Overall Study|Adverse Event|3|||
37786363|NCT01602120|69386299|FG001|Overall Study|Adverse Event|6|||
37786364|NCT01602120|69386300|FG002|Overall Study|Adverse Event|0|||
37786365|NCT01602120|69386301|FG003|Overall Study|Adverse Event|2|||
37786366|NCT01602120|69386298|FG000|Overall Study|Death|0|||
37786367|NCT01602120|69386299|FG001|Overall Study|Death|4|||
37786368|NCT01602120|69386300|FG002|Overall Study|Death|0|||
37786369|NCT01602120|69386301|FG003|Overall Study|Death|0|||
37786370|NCT01602120|69386298|FG000|Overall Study|Lost to Follow-up|0|||
37786371|NCT01602120|69386299|FG001|Overall Study|Lost to Follow-up|1|||
37786372|NCT01602120|69386300|FG002|Overall Study|Lost to Follow-up|0|||
37786373|NCT01602120|69386301|FG003|Overall Study|Lost to Follow-up|1|||
37786374|NCT01602120|69386298|FG000|Overall Study|Protocol Violation|1|||
37786375|NCT01602120|69386299|FG001|Overall Study|Protocol Violation|1|||
37786376|NCT01602120|69386300|FG002|Overall Study|Protocol Violation|0|||
37786377|NCT01602120|69386301|FG003|Overall Study|Protocol Violation|0|||
37786378|NCT01602120|69386298|FG000|Overall Study|Non-compliance|0|||
37786379|NCT01602120|69386299|FG001|Overall Study|Non-compliance|3|||
37786380|NCT01602120|69386300|FG002|Overall Study|Non-compliance|0|||
37786381|NCT01602120|69386301|FG003|Overall Study|Non-compliance|1|||
37786382|NCT01602120|69386298|FG000|Overall Study|Withdrawal by Subject|8|||
37786383|NCT01602120|69386299|FG001|Overall Study|Withdrawal by Subject|17|||
37786384|NCT01602120|69386300|FG002|Overall Study|Withdrawal by Subject|0|||
37786385|NCT01602120|69386301|FG003|Overall Study|Withdrawal by Subject|3|||
37786386|NCT01602120|69386298|FG000|Overall Study|Study Terminated by Sponsor|12|||
37786387|NCT01602120|69386299|FG001|Overall Study|Study Terminated by Sponsor|24|||
37786388|NCT01602120|69386300|FG002|Overall Study|Study Terminated by Sponsor|17|||
37786389|NCT01602120|69386301|FG003|Overall Study|Study Terminated by Sponsor|44|||
37786390|NCT01602120|69386298|FG000|Overall Study|Physician Decision|2|||
37786391|NCT01602120|69386299|FG001|Overall Study|Physician Decision|3|||
37786392|NCT01602120|69386300|FG002|Overall Study|Physician Decision|0|||
37786393|NCT01602120|69386301|FG003|Overall Study|Physician Decision|0|||
37786394|NCT01602120|69386298|FG000|Overall Study|Unspecified Reason|3|||
37786395|NCT01602120|69386299|FG001|Overall Study|Unspecified Reason|1|||
37786396|NCT01602120|69386300|FG002|Overall Study|Unspecified Reason|0|||
37786397|NCT01602120|69386301|FG003|Overall Study|Unspecified Reason|2|||
37786398|NCT04543955|69387108|FG000|Overall Study|Company cancelled study|1|||
37786399|NCT04543955|69387109|FG001|Overall Study|Company cancelled study|0|||
37786400|NCT04436744|69387659|FG000|Overall Study|Adverse Event|1|||
37786401|NCT04436744|69387660|FG001|Overall Study|Adverse Event|1|||
37786402|NCT04436744|69387659|FG000|Overall Study|Death|1|||
37786403|NCT04436744|69387660|FG001|Overall Study|Death|0|||
37786404|NCT04436744|69387659|FG000|Overall Study|Lost to Follow-up|0|||
37786405|NCT04436744|69387660|FG001|Overall Study|Lost to Follow-up|2|||
37786406|NCT04436744|69387659|FG000|Overall Study|Physician Decision|0|||
37786407|NCT04436744|69387660|FG001|Overall Study|Physician Decision|1|||
37786408|NCT04436744|69387659|FG000|Overall Study|Progressive Disease|0|||
37786409|NCT04436744|69387660|FG001|Overall Study|Progressive Disease|4|||
37786410|NCT04436744|69387659|FG000|Overall Study|Protocol Deviation|1|||
37786411|NCT04436744|69387660|FG001|Overall Study|Protocol Deviation|1|||
37786412|NCT04436744|69387659|FG000|Overall Study|Withdrawal by Subject|1|||
37786413|NCT04436744|69387660|FG001|Overall Study|Withdrawal by Subject|2|||
37786414|NCT02243306|69387807|FG000|Overall Study|Adverse Event|0|||
37786415|NCT02243306|69387808|FG001|Overall Study|Adverse Event|1|||
37786416|NCT02243306|69387807|FG000|Overall Study|Other: Reached stopping criteria|0|||
37786417|NCT02243306|69387808|FG001|Overall Study|Other: Reached stopping criteria|1|||
37786418|NCT02243306|69387807|FG000|Overall Study|Physician Decision|0|||
37786419|NCT02243306|69387808|FG001|Overall Study|Physician Decision|1|||
37786420|NCT03214679|69387964|FG000|Overall Study|Lost to Follow-up|12|||
37786421|NCT03214679|69387965|FG001|Overall Study|Lost to Follow-up|14|||
37786422|NCT03214679|69387964|FG000|Overall Study|not eligible|2|||
37786423|NCT03214679|69387965|FG001|Overall Study|not eligible|0|||
37786424|NCT01602380|69388312|FG000|Overall Study|Death|63|||
37786425|NCT01602380|69388313|FG001|Overall Study|Death|68|||
37786426|NCT01602380|69388312|FG000|Overall Study|Withdrawal by Subject|22|||
37786427|NCT01602380|69388313|FG001|Overall Study|Withdrawal by Subject|29|||
37786428|NCT01602380|69388312|FG000|Overall Study|Lost to Follow-up|6|||
37786429|NCT01602380|69388313|FG001|Overall Study|Lost to Follow-up|1|||
37786430|NCT01602380|69388312|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
37786431|NCT01602380|69388313|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
37786432|NCT01349465|69389247|FG000|Overall Study|Adverse Event|1|||
37786433|NCT01349465|69389248|FG001|Overall Study|Adverse Event|0|||
37786434|NCT01349465|69389247|FG000|Overall Study|Death|3|||
37786435|NCT01349465|69389248|FG001|Overall Study|Death|0|||
37786436|NCT01349465|69389247|FG000|Overall Study|Lost to Follow-up|10|||
37786437|NCT01349465|69389248|FG001|Overall Study|Lost to Follow-up|1|||
37786438|NCT01349465|69389247|FG000|Overall Study|Withdrawal by Subject|4|||
37786439|NCT01349465|69389248|FG001|Overall Study|Withdrawal by Subject|2|||
37786440|NCT01349465|69389247|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
37786441|NCT01349465|69389248|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
37786442|NCT01648764|69390367|FG000|Overall Study|Progressive Disease|0|||
37786443|NCT01648764|69390368|FG001|Overall Study|Progressive Disease|1|||
37786444|NCT01648764|69390369|FG002|Overall Study|Progressive Disease|0|||
37786445|NCT01648764|69390370|FG003|Overall Study|Progressive Disease|0|||
37786446|NCT01648764|69390371|FG004|Overall Study|Progressive Disease|0|||
37786447|NCT01648764|69390372|FG005|Overall Study|Progressive Disease|1|||
37786448|NCT01648764|69390373|FG006|Overall Study|Progressive Disease|1|||
37786449|NCT01648764|69390374|FG007|Overall Study|Progressive Disease|0|||
37786450|NCT01648764|69390375|FG008|Overall Study|Progressive Disease|0|||
37786451|NCT01648764|69390376|FG009|Overall Study|Progressive Disease|2|||
37786452|NCT01648764|69390377|FG010|Overall Study|Progressive Disease|0|||
37786453|NCT01648764|69390378|FG011|Overall Study|Progressive Disease|1|||
37786454|NCT01648764|69390379|FG012|Overall Study|Progressive Disease|2|||
37786455|NCT01648764|69390380|FG013|Overall Study|Progressive Disease|1|||
37786456|NCT01648764|69390367|FG000|Overall Study|Adverse Event|0|||
37693615|NCT02316847|69169879|FG000|Overall Study|Withdrawal by Subject|2|||
37693616|NCT02316847|69169880|FG001|Overall Study|Withdrawal by Subject|9|||
37786457|NCT01648764|69390368|FG001|Overall Study|Adverse Event|0|||
37786458|NCT01648764|69390369|FG002|Overall Study|Adverse Event|0|||
37786459|NCT01648764|69390370|FG003|Overall Study|Adverse Event|0|||
37786460|NCT01648764|69390371|FG004|Overall Study|Adverse Event|0|||
37786461|NCT01648764|69390372|FG005|Overall Study|Adverse Event|1|||
37786462|NCT01648764|69390373|FG006|Overall Study|Adverse Event|0|||
37786463|NCT01648764|69390374|FG007|Overall Study|Adverse Event|0|||
37975182|NCT00317356|69662354|FG003|Overall Study|Physician Decision|0|||
37975183|NCT00331006|69662364|FG000|Screening Phase|Withdrawal by Subject|1|||
37975184|NCT00331006|69662364|FG000|Screening Phase|enrollment halted|1|||
37975185|NCT00331006|69662364|FG000|Screening Phase|Lost to Follow-up|1|||
37975186|NCT00331006|69662364|FG000|Screening Phase|Ineligible for treatment phase|4|||
37975187|NCT00331006|69662364|FG000|Treatment Phase|Withdrawal by Subject|1|||
37975188|NCT00331006|69662364|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
37975189|NCT00331006|69662364|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
37975190|NCT00302458|69662368|FG000|Overall Study|Lost to Follow-up|1|||
37975191|NCT00302458|69662368|FG000|Overall Study|Ineligible after screening|1|||
37975192|NCT00302458|69662368|FG000|Overall Study|Withdrawal by Subject|1|||
37975193|NCT00391053|69662380|FG000|Overall Study|Serious Adverse Events|1|||
37975194|NCT00391053|69662381|FG001|Overall Study|Serious Adverse Events|0|||
37975195|NCT00391053|69662382|FG002|Overall Study|Serious Adverse Events|1|||
37975196|NCT00391053|69662383|FG003|Overall Study|Serious Adverse Events|4|||
37975197|NCT00391053|69662380|FG000|Overall Study|Protocol Violation|2|||
37975198|NCT00391053|69662381|FG001|Overall Study|Protocol Violation|0|||
37975199|NCT00391053|69662382|FG002|Overall Study|Protocol Violation|0|||
37786464|NCT01648764|69390375|FG008|Overall Study|Adverse Event|0|||
37786465|NCT01648764|69390376|FG009|Overall Study|Adverse Event|1|||
37786466|NCT01648764|69390377|FG010|Overall Study|Adverse Event|0|||
37786467|NCT01648764|69390378|FG011|Overall Study|Adverse Event|3|||
37786468|NCT01648764|69390379|FG012|Overall Study|Adverse Event|1|||
37975200|NCT00391053|69662383|FG003|Overall Study|Protocol Violation|0|||
37975201|NCT00391053|69662380|FG000|Overall Study|Lost to Follow-up|1|||
37975202|NCT00391053|69662381|FG001|Overall Study|Lost to Follow-up|0|||
37786469|NCT01648764|69390380|FG013|Overall Study|Adverse Event|1|||
37786470|NCT01648764|69390367|FG000|Overall Study|Death|0|||
37975203|NCT00391053|69662382|FG002|Overall Study|Lost to Follow-up|0|||
37975204|NCT00391053|69662383|FG003|Overall Study|Lost to Follow-up|5|||
37975205|NCT00391053|69662380|FG000|Overall Study|Withdrawal by Subject|5|||
37786471|NCT01648764|69390368|FG001|Overall Study|Death|0|||
37786472|NCT01648764|69390369|FG002|Overall Study|Death|0|||
37786473|NCT01648764|69390370|FG003|Overall Study|Death|0|||
37786474|NCT01648764|69390371|FG004|Overall Study|Death|0|||
37786475|NCT01648764|69390372|FG005|Overall Study|Death|0|||
37786476|NCT01648764|69390373|FG006|Overall Study|Death|1|||
37786477|NCT01648764|69390374|FG007|Overall Study|Death|0|||
37786478|NCT01648764|69390375|FG008|Overall Study|Death|0|||
37786479|NCT01648764|69390376|FG009|Overall Study|Death|0|||
37786480|NCT01648764|69390377|FG010|Overall Study|Death|0|||
37786481|NCT01648764|69390378|FG011|Overall Study|Death|0|||
37786482|NCT01648764|69390379|FG012|Overall Study|Death|0|||
37786483|NCT01648764|69390380|FG013|Overall Study|Death|1|||
37786484|NCT01648764|69390367|FG000|Overall Study|Withdrawal by Subject|0|||
37786485|NCT01648764|69390368|FG001|Overall Study|Withdrawal by Subject|0|||
37786486|NCT01648764|69390369|FG002|Overall Study|Withdrawal by Subject|0|||
37786487|NCT01648764|69390370|FG003|Overall Study|Withdrawal by Subject|0|||
37786488|NCT01648764|69390371|FG004|Overall Study|Withdrawal by Subject|0|||
37786489|NCT01648764|69390372|FG005|Overall Study|Withdrawal by Subject|0|||
37786490|NCT01648764|69390373|FG006|Overall Study|Withdrawal by Subject|2|||
37786491|NCT01648764|69390374|FG007|Overall Study|Withdrawal by Subject|0|||
37786492|NCT01648764|69390375|FG008|Overall Study|Withdrawal by Subject|0|||
37786493|NCT01648764|69390376|FG009|Overall Study|Withdrawal by Subject|0|||
37786494|NCT01648764|69390377|FG010|Overall Study|Withdrawal by Subject|0|||
37786495|NCT01648764|69390378|FG011|Overall Study|Withdrawal by Subject|0|||
37786496|NCT01648764|69390379|FG012|Overall Study|Withdrawal by Subject|1|||
37786497|NCT01648764|69390380|FG013|Overall Study|Withdrawal by Subject|0|||
37786498|NCT01648764|69390367|FG000|Overall Study|Investigator Decision|0|||
37786499|NCT01648764|69390368|FG001|Overall Study|Investigator Decision|0|||
37786500|NCT01648764|69390369|FG002|Overall Study|Investigator Decision|0|||
37786501|NCT01648764|69390370|FG003|Overall Study|Investigator Decision|0|||
37786502|NCT01648764|69390371|FG004|Overall Study|Investigator Decision|0|||
37786503|NCT01648764|69390372|FG005|Overall Study|Investigator Decision|0|||
37786504|NCT01648764|69390373|FG006|Overall Study|Investigator Decision|1|||
37786505|NCT01648764|69390374|FG007|Overall Study|Investigator Decision|0|||
37786506|NCT01648764|69390375|FG008|Overall Study|Investigator Decision|0|||
37786507|NCT01648764|69390376|FG009|Overall Study|Investigator Decision|0|||
37786508|NCT01648764|69390377|FG010|Overall Study|Investigator Decision|0|||
37786509|NCT01648764|69390378|FG011|Overall Study|Investigator Decision|1|||
37786510|NCT01648764|69390379|FG012|Overall Study|Investigator Decision|0|||
37786511|NCT01648764|69390380|FG013|Overall Study|Investigator Decision|0|||
37786512|NCT02364336|69390416|FG000|Overall Study|Adverse Event|0|||
37786513|NCT02364336|69390417|FG001|Overall Study|Adverse Event|1|||
37786514|NCT02810951|69390648|FG000|Overall Study|Adverse Event|1|||
37786515|NCT02310906|69390744|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
37786516|NCT02310906|69390745|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
37786517|NCT02310906|69390746|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
37786518|NCT02310906|69390747|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
37786519|NCT02310906|69390744|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
37786520|NCT02310906|69390745|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
37786521|NCT02310906|69390746|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
37786522|NCT02310906|69390747|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
37786523|NCT02310906|69390744|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
37786524|NCT02310906|69390745|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
37786525|NCT02310906|69390746|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
37786526|NCT02310906|69390747|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
37693617|NCT02316847|69169879|FG000|Overall Study|Noncompliance with study drug|0|||
37693618|NCT02316847|69169880|FG001|Overall Study|Noncompliance with study drug|3|||
37975206|NCT00391053|69662381|FG001|Overall Study|Withdrawal by Subject|1|||
37975207|NCT00391053|69662382|FG002|Overall Study|Withdrawal by Subject|1|||
37786527|NCT02310906|69390744|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
37786528|NCT02310906|69390745|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
37786529|NCT02310906|69390746|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
37786530|NCT02310906|69390747|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
37786531|NCT02340078|69390797|FG000|Overall Study|Protocol Violation|1|||
37975208|NCT00391053|69662383|FG003|Overall Study|Withdrawal by Subject|1|||
37786532|NCT02340000|69390813|FG000|Time Period 1|Withdrawal by Subject|6|||
37786533|NCT02340000|69390814|FG001|Time Period 1|Withdrawal by Subject|8|||
37786534|NCT02340000|69390813|FG000|Time Period 1|Lost to Follow-up|6|||
37786535|NCT02340000|69390814|FG001|Time Period 1|Lost to Follow-up|7|||
37786536|NCT02340000|69390813|FG000|Time Period 2|Withdrawal by Subject|9|||
37786537|NCT02340000|69390814|FG001|Time Period 2|Withdrawal by Subject|7|||
37786538|NCT02340000|69390813|FG000|Time Period 2|Lost to Follow-up|10|||
37786539|NCT02340000|69390814|FG001|Time Period 2|Lost to Follow-up|8|||
37786540|NCT02364180|69390845|FG000|Overall Study|Screen Fail|1|||
37786541|NCT02310750|69391483|FG000|HP Period 1|Lost to Follow-up|0|||
37786542|NCT02310750|69391484|FG001|HP Period 1|Lost to Follow-up|0|||
37786543|NCT02310750|69391485|FG002|HP Period 1|Lost to Follow-up|0|||
37786544|NCT02310750|69391486|FG003|HP Period 1|Lost to Follow-up|0|||
37786545|NCT02310750|69391487|FG004|HP Period 1|Lost to Follow-up|0|||
37786546|NCT02310750|69391488|FG005|HP Period 1|Lost to Follow-up|0|||
37786547|NCT02310750|69391489|FG006|HP Period 1|Lost to Follow-up|1|||
37786548|NCT02310750|69391490|FG007|HP Period 1|Lost to Follow-up|0|||
37786549|NCT02310750|69391491|FG008|HP Period 1|Lost to Follow-up|0|||
37786550|NCT02310750|69391492|FG009|HP Period 1|Lost to Follow-up|0|||
37786551|NCT02310750|69391493|FG010|HP Period 1|Lost to Follow-up|0|||
37786552|NCT02310750|69391494|FG011|HP Period 1|Lost to Follow-up|0|||
37786553|NCT02310750|69391495|FG012|HP Period 1|Lost to Follow-up|0|||
37786554|NCT02310750|69391496|FG013|HP Period 1|Lost to Follow-up|0|||
37786555|NCT02310750|69391497|FG014|HP Period 1|Lost to Follow-up|0|||
37786556|NCT02310750|69391498|FG015|HP Period 1|Lost to Follow-up|0|||
37786557|NCT02310750|69391483|FG000|HP Period 1|Withdrawal by Subject|1|||
37786558|NCT02310750|69391484|FG001|HP Period 1|Withdrawal by Subject|0|||
37786559|NCT02310750|69391485|FG002|HP Period 1|Withdrawal by Subject|0|||
37786560|NCT02310750|69391486|FG003|HP Period 1|Withdrawal by Subject|1|||
37786561|NCT02310750|69391487|FG004|HP Period 1|Withdrawal by Subject|0|||
37786562|NCT02310750|69391488|FG005|HP Period 1|Withdrawal by Subject|0|||
37786563|NCT02310750|69391489|FG006|HP Period 1|Withdrawal by Subject|0|||
37786564|NCT02310750|69391490|FG007|HP Period 1|Withdrawal by Subject|0|||
37786565|NCT02310750|69391491|FG008|HP Period 1|Withdrawal by Subject|0|||
37975209|NCT00317044|69662396|FG000|Overall Study|Protocol Violation|28|||
37975210|NCT00317044|69662397|FG001|Overall Study|Protocol Violation|22|||
37786566|NCT02310750|69391492|FG009|HP Period 1|Withdrawal by Subject|0|||
37786567|NCT02310750|69391493|FG010|HP Period 1|Withdrawal by Subject|0|||
37786568|NCT02310750|69391494|FG011|HP Period 1|Withdrawal by Subject|0|||
37786569|NCT02310750|69391495|FG012|HP Period 1|Withdrawal by Subject|0|||
37786570|NCT02310750|69391496|FG013|HP Period 1|Withdrawal by Subject|0|||
37786571|NCT02310750|69391497|FG014|HP Period 1|Withdrawal by Subject|0|||
37786572|NCT02310750|69391498|FG015|HP Period 1|Withdrawal by Subject|0|||
37786573|NCT02310750|69391483|FG000|HP Washout 1|Lost to Follow-up|0|||
37786574|NCT02310750|69391484|FG001|HP Washout 1|Lost to Follow-up|0|||
37786575|NCT02310750|69391485|FG002|HP Washout 1|Lost to Follow-up|1|||
37786576|NCT02310750|69391486|FG003|HP Washout 1|Lost to Follow-up|1|||
37786577|NCT02310750|69391487|FG004|HP Washout 1|Lost to Follow-up|2|||
37693619|NCT02316847|69169879|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
37693620|NCT02316847|69169880|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
37693621|NCT02473523|69169888|FG000|Overall Study|Death|1|||
37975211|NCT00317044|69662398|FG002|Overall Study|Protocol Violation|20|||
37975212|NCT00317044|69662396|FG000|Overall Study|Adverse Event|4|||
37975213|NCT00317044|69662397|FG001|Overall Study|Adverse Event|7|||
37975214|NCT00317044|69662398|FG002|Overall Study|Adverse Event|4|||
37975215|NCT00317044|69662396|FG000|Overall Study|Withdrawal by Subject|10|||
37975216|NCT00317044|69662397|FG001|Overall Study|Withdrawal by Subject|7|||
37975217|NCT00317044|69662398|FG002|Overall Study|Withdrawal by Subject|12|||
37975218|NCT00317044|69662396|FG000|Overall Study|Lost to Follow-up|0|||
37975219|NCT00317044|69662397|FG001|Overall Study|Lost to Follow-up|2|||
37975220|NCT00317044|69662398|FG002|Overall Study|Lost to Follow-up|3|||
37975221|NCT00317044|69662396|FG000|Overall Study|Multiple Reasons|6|||
37975222|NCT00317044|69662397|FG001|Overall Study|Multiple Reasons|2|||
37975223|NCT00317044|69662398|FG002|Overall Study|Multiple Reasons|6|||
37975224|NCT00301834|69662406|FG000|Overall Study|Death|1|||
37975225|NCT00301366|69662413|FG000|Overall Study|Adverse Event|1|||
37975226|NCT00330928|69662417|FG000|Overall Study|Lost to Follow-up|6|||
37975227|NCT00330928|69662417|FG000|Overall Study|Physician Decision|9|||
37975228|NCT00330928|69662417|FG000|Overall Study|Death|1|||
37975229|NCT00330928|69662417|FG000|Overall Study|IVUS could not be performed.|1|||
37975230|NCT00330616|69662421|FG000|Overall Study|Adverse Event|13|||
37975231|NCT00330616|69662421|FG000|Overall Study|Lack of Efficacy|1|||
37975232|NCT00330616|69662421|FG000|Overall Study|Lost to Follow-up|2|||
37975233|NCT00330616|69662421|FG000|Overall Study|Withdrawal by Subject|4|||
37975234|NCT00330616|69662421|FG000|Overall Study|Other|1|||
37975235|NCT00466440|69662428|FG000|Overall Study|Adverse Event|0|||
37975236|NCT00466440|69662429|FG001|Overall Study|Adverse Event|3|||
37975237|NCT00466440|69662430|FG002|Overall Study|Adverse Event|1|||
37975238|NCT00466440|69662428|FG000|Overall Study|Death|1|||
37975239|NCT00466440|69662429|FG001|Overall Study|Death|1|||
37975240|NCT00466440|69662430|FG002|Overall Study|Death|0|||
37786578|NCT02310750|69391488|FG005|HP Washout 1|Lost to Follow-up|2|||
37786579|NCT02310750|69391489|FG006|HP Washout 1|Lost to Follow-up|3|||
37786580|NCT02310750|69391490|FG007|HP Washout 1|Lost to Follow-up|0|||
37786581|NCT02310750|69391491|FG008|HP Washout 1|Lost to Follow-up|0|||
37693622|NCT02473523|69169888|FG000|Overall Study|Lost to Follow-up|1|||
37693623|NCT02316769|69169894|FG000|Overall Study|Physician Decision|1|||
37975241|NCT00466440|69662428|FG000|Overall Study|Progressive disease|13|||
37975242|NCT00466440|69662429|FG001|Overall Study|Progressive disease|5|||
37975243|NCT00466440|69662430|FG002|Overall Study|Progressive disease|4|||
37693624|NCT02316769|69169895|FG001|Overall Study|Physician Decision|0|||
37975244|NCT00466440|69662428|FG000|Overall Study|Lost to Follow-up|0|||
37975245|NCT00466440|69662429|FG001|Overall Study|Lost to Follow-up|1|||
37975246|NCT00466440|69662430|FG002|Overall Study|Lost to Follow-up|0|||
37975247|NCT00466440|69662428|FG000|Overall Study|Physician Decision|0|||
37975248|NCT00466440|69662429|FG001|Overall Study|Physician Decision|1|||
37975249|NCT00466440|69662430|FG002|Overall Study|Physician Decision|2|||
37975250|NCT00466440|69662428|FG000|Overall Study|Protocol entry criteria not met|0|||
37975251|NCT00466440|69662429|FG001|Overall Study|Protocol entry criteria not met|0|||
37975252|NCT00466440|69662430|FG002|Overall Study|Protocol entry criteria not met|4|||
37975253|NCT00466440|69662428|FG000|Overall Study|Withdrawal by Subject|0|||
37693625|NCT02316769|69169894|FG000|Overall Study|Withdrawal by Subject|1|||
37975254|NCT00466440|69662429|FG001|Overall Study|Withdrawal by Subject|1|||
37975255|NCT00466440|69662430|FG002|Overall Study|Withdrawal by Subject|0|||
37864076|NCT01252355|69547720|FG002|Overall Study|Randomized but not Treated|0|||
37864077|NCT01252355|69547718|FG000|Overall Study|Other Than Above|8|||
37864078|NCT01252355|69547719|FG001|Overall Study|Other Than Above|7|||
37864079|NCT01252355|69547720|FG002|Overall Study|Other Than Above|7|||
37864080|NCT01118325|69547731|FG000|Overall Study|Adverse Event|1|||
37864081|NCT01118325|69547732|FG001|Overall Study|Adverse Event|0|||
37975256|NCT00466440|69662428|FG000|Overall Study|Sponsor decision|0|||
37864082|NCT01118325|69547733|FG002|Overall Study|Adverse Event|1|||
37864083|NCT01117857|69547754|FG000|Overall Study|Lost to Follow-up|4|||
37975257|NCT00466440|69662429|FG001|Overall Study|Sponsor decision|0|||
37786582|NCT02310750|69391492|FG009|HP Washout 1|Lost to Follow-up|0|||
37786583|NCT02310750|69391493|FG010|HP Washout 1|Lost to Follow-up|0|||
37693626|NCT02316769|69169895|FG001|Overall Study|Withdrawal by Subject|0|||
37975258|NCT00466440|69662430|FG002|Overall Study|Sponsor decision|1|||
37786584|NCT02310750|69391494|FG011|HP Washout 1|Lost to Follow-up|0|||
37693627|NCT02473445|69169901|FG000|Overall Study|Withdrawal by Subject|2|||
37693628|NCT02473445|69169901|FG000|Overall Study|Sponsor Decision|20|||
37786585|NCT02310750|69391495|FG012|HP Washout 1|Lost to Follow-up|0|||
37786586|NCT02310750|69391496|FG013|HP Washout 1|Lost to Follow-up|0|||
37786587|NCT02310750|69391497|FG014|HP Washout 1|Lost to Follow-up|0|||
37786588|NCT02310750|69391498|FG015|HP Washout 1|Lost to Follow-up|0|||
37786589|NCT02310750|69391483|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
37786590|NCT02310750|69391484|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
37786591|NCT02310750|69391485|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
37786592|NCT02310750|69391486|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
37786593|NCT02310750|69391487|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
37693629|NCT02473367|69169905|FG000|Wait 1|Withdrawal by Subject|1|||
37693630|NCT02473367|69169905|FG000|Period 4|Lost to Follow-up|1|||
37693631|NCT02316613|69169915|FG000|Overall Study|Death|63|||
37693632|NCT02316613|69169915|FG000|Overall Study|Lost to Follow-up|9|||
37693633|NCT02316613|69169915|FG000|Overall Study|Lymphoma transformation|2|||
37975259|NCT00465972|69662449|FG000|Overall Study|Withdrawal by Subject|2|||
37975260|NCT00465972|69662450|FG001|Overall Study|Withdrawal by Subject|1|||
37693634|NCT02316613|69169915|FG000|Overall Study|Participant moved/changed medical team|11|||
37786594|NCT02310750|69391488|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
37975261|NCT00465894|69662460|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
37786595|NCT02310750|69391489|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
37786596|NCT02310750|69391490|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
37786597|NCT02310750|69391491|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
37786598|NCT02310750|69391492|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
37786599|NCT02310750|69391493|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
37786600|NCT02310750|69391494|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
37786601|NCT02310750|69391495|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
37786602|NCT02310750|69391496|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
37786603|NCT02310750|69391497|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
37786604|NCT02310750|69391498|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
37786605|NCT02310750|69391483|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
37786606|NCT02310750|69391484|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
37786607|NCT02310750|69391485|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
37786608|NCT02310750|69391486|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
37786609|NCT02310750|69391487|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
37786610|NCT02310750|69391488|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
37786611|NCT02310750|69391489|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
37786612|NCT02310750|69391490|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
37786613|NCT02310750|69391491|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
37786614|NCT02310750|69391492|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
37786615|NCT02310750|69391493|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
37786616|NCT02310750|69391494|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
37786617|NCT02310750|69391495|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
37786618|NCT02310750|69391496|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
37786619|NCT02310750|69391497|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
37786620|NCT02310750|69391498|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
37786621|NCT02310750|69391483|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
37786622|NCT02310750|69391484|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
37786623|NCT02310750|69391485|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
37786624|NCT02310750|69391486|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
37786625|NCT02310750|69391487|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
37786626|NCT02310750|69391488|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
37786627|NCT02310750|69391489|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
37786628|NCT02310750|69391490|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
37786629|NCT02310750|69391491|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
37786630|NCT02310750|69391492|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
37786631|NCT02310750|69391493|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
37786632|NCT02310750|69391494|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
37786633|NCT02310750|69391495|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
37786634|NCT02310750|69391496|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
37786635|NCT02310750|69391497|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
37786636|NCT02310750|69391498|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
37786637|NCT02310750|69391483|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
37786638|NCT02310750|69391484|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
37786639|NCT02310750|69391485|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
37786640|NCT02310750|69391486|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
37786641|NCT02310750|69391487|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
37786642|NCT02310750|69391488|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
37786643|NCT02310750|69391489|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
37786644|NCT02310750|69391490|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
37786645|NCT02310750|69391491|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
37786646|NCT02310750|69391492|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
37975262|NCT00465894|69662461|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
37975263|NCT00465894|69662460|FG000|Treatment For 12 Weeks|Family Issues|1|||
37975264|NCT00465894|69662461|FG001|Treatment For 12 Weeks|Family Issues|1|||
37975265|NCT00465894|69662460|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
37975266|NCT00465894|69662461|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
37975267|NCT00330460|69662485|FG000|Overall Study|Physician Decision|1|||
37975268|NCT00330460|69662486|FG001|Overall Study|Physician Decision|0|||
37975269|NCT00330460|69662485|FG000|Overall Study|Adverse Event|10|||
37975270|NCT00330460|69662486|FG001|Overall Study|Adverse Event|8|||
37975271|NCT00330460|69662485|FG000|Overall Study|Withdrawal by Subject|18|||
37975272|NCT00330460|69662486|FG001|Overall Study|Withdrawal by Subject|17|||
37975273|NCT00330460|69662485|FG000|Overall Study|Death|1|||
37975274|NCT00330460|69662486|FG001|Overall Study|Death|1|||
37975275|NCT00330460|69662485|FG000|Overall Study|Ineligibility determined|1|||
37975276|NCT00330460|69662486|FG001|Overall Study|Ineligibility determined|3|||
37975277|NCT00330460|69662485|FG000|Overall Study|Lost to Follow-up|8|||
37975278|NCT00330460|69662486|FG001|Overall Study|Lost to Follow-up|3|||
37693635|NCT02316613|69169915|FG000|Overall Study|No data and duplicate cases|5|||
37975279|NCT00330460|69662485|FG000|Overall Study|Noncompliance|2|||
37975280|NCT00330460|69662486|FG001|Overall Study|Noncompliance|1|||
37975281|NCT00330460|69662485|FG000|Overall Study|Other|1|||
37975282|NCT00330460|69662486|FG001|Overall Study|Other|0|||
37975283|NCT00454116|69662495|FG000|Overall Study|Adverse Event|5|||
37975284|NCT00454116|69662496|FG001|Overall Study|Adverse Event|11|||
37975285|NCT00454116|69662497|FG002|Overall Study|Adverse Event|9|||
37975286|NCT00454116|69662495|FG000|Overall Study|Condition under investigation worsened|17|||
37975287|NCT00454116|69662496|FG001|Overall Study|Condition under investigation worsened|13|||
37975288|NCT00454116|69662497|FG002|Overall Study|Condition under investigation worsened|18|||
37975289|NCT00454116|69662495|FG000|Overall Study|Withdrawal by Subject|3|||
37786647|NCT02310750|69391493|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
37975290|NCT00454116|69662496|FG001|Overall Study|Withdrawal by Subject|3|||
37693636|NCT02316613|69169915|FG000|Overall Study|Did not met selection criteria|14|||
37693637|NCT02492165|69169934|FG000|Overall Study|Withdrawal by Subject|0|||
37693638|NCT02492165|69169935|FG001|Overall Study|Withdrawal by Subject|1|||
37786648|NCT02310750|69391494|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
37975291|NCT00454116|69662497|FG002|Overall Study|Withdrawal by Subject|1|||
37786649|NCT02310750|69391495|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
37975292|NCT00454116|69662495|FG000|Overall Study|Other|2|||
37975293|NCT00454116|69662496|FG001|Overall Study|Other|2|||
37975294|NCT00454116|69662497|FG002|Overall Study|Other|0|||
37975295|NCT00465816|69662508|FG000|Overall Study|Lost to Follow-up|0|||
37975296|NCT00465816|69662509|FG001|Overall Study|Lost to Follow-up|0|||
37975297|NCT00465816|69662510|FG002|Overall Study|Lost to Follow-up|2|||
37975298|NCT00465738|69662521|FG000|Overall Study|Lost to Follow-up|2|||
37975299|NCT00465738|69662522|FG001|Overall Study|Lost to Follow-up|0|||
37975300|NCT00465738|69662521|FG000|Overall Study|Adverse Event|0|||
37975301|NCT00465738|69662522|FG001|Overall Study|Adverse Event|1|||
37975302|NCT00465738|69662521|FG000|Overall Study|Withdrawal by Subject|2|||
37975303|NCT00465738|69662522|FG001|Overall Study|Withdrawal by Subject|0|||
37975304|NCT00465738|69662521|FG000|Overall Study|Other|2|||
37975305|NCT00465738|69662522|FG001|Overall Study|Other|5|||
37975306|NCT00400179|69662530|FG000|Overall Study|Adverse Event|2|||
37975307|NCT00400179|69662531|FG001|Overall Study|Adverse Event|2|||
37975308|NCT00400179|69662530|FG000|Overall Study|Death|1|||
37975309|NCT00400179|69662531|FG001|Overall Study|Death|2|||
37975310|NCT00400179|69662530|FG000|Overall Study|Withdrew Consent|1|||
37975311|NCT00400179|69662531|FG001|Overall Study|Withdrew Consent|5|||
37975312|NCT00400179|69662530|FG000|Overall Study|Disease progression|1|||
37975313|NCT00400179|69662531|FG001|Overall Study|Disease progression|1|||
37975314|NCT00400179|69662530|FG000|Overall Study|Intercurrent illness|0|||
37975315|NCT00400179|69662531|FG001|Overall Study|Intercurrent illness|1|||
37975316|NCT00400179|69662530|FG000|Overall Study|Investigator judgment|0|||
37975317|NCT00400179|69662531|FG001|Overall Study|Investigator judgment|1|||
37975318|NCT00400179|69662530|FG000|Overall Study|Randomization error/patient ineligible|1|||
37786650|NCT02310750|69391496|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
37786651|NCT02310750|69391497|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
37786652|NCT02310750|69391498|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
37786653|NCT02310750|69391483|FG000|HP Washout 2|Lost to Follow-up|0|||
37786654|NCT02310750|69391484|FG001|HP Washout 2|Lost to Follow-up|0|||
37786655|NCT02310750|69391485|FG002|HP Washout 2|Lost to Follow-up|0|||
37786656|NCT02310750|69391486|FG003|HP Washout 2|Lost to Follow-up|0|||
37786657|NCT02310750|69391487|FG004|HP Washout 2|Lost to Follow-up|1|||
37786658|NCT02310750|69391488|FG005|HP Washout 2|Lost to Follow-up|0|||
37786659|NCT02310750|69391489|FG006|HP Washout 2|Lost to Follow-up|7|||
37786660|NCT02310750|69391490|FG007|HP Washout 2|Lost to Follow-up|0|||
37975319|NCT00400179|69662531|FG001|Overall Study|Randomization error/patient ineligible|6|||
37786661|NCT02310750|69391491|FG008|HP Washout 2|Lost to Follow-up|0|||
37975320|NCT00465270|69662539|FG000|Overall Study|Death|7|||
37786662|NCT02310750|69391492|FG009|HP Washout 2|Lost to Follow-up|0|||
37786663|NCT02310750|69391493|FG010|HP Washout 2|Lost to Follow-up|0|||
37693639|NCT02492165|69169936|FG002|Overall Study|Withdrawal by Subject|0|||
37786664|NCT02310750|69391494|FG011|HP Washout 2|Lost to Follow-up|0|||
37786665|NCT02310750|69391495|FG012|HP Washout 2|Lost to Follow-up|0|||
37786666|NCT02310750|69391496|FG013|HP Washout 2|Lost to Follow-up|0|||
37786667|NCT02310750|69391497|FG014|HP Washout 2|Lost to Follow-up|0|||
37786668|NCT02310750|69391498|FG015|HP Washout 2|Lost to Follow-up|0|||
37786669|NCT02310672|69391603|FG000|Overall Study|Death|1|||
37786670|NCT02310672|69391603|FG000|Overall Study|Lost to Follow-up|1|||
37786671|NCT02310672|69391603|FG000|Overall Study|Withdrawal by Subject|1|||
37786672|NCT02310672|69391603|FG000|Overall Study|Sponsor's decision|12|||
37786673|NCT02363946|69391749|FG000|Overall Study|Lost to Follow-up|0|||
37786674|NCT02363946|69391750|FG001|Overall Study|Lost to Follow-up|0|||
37786675|NCT02363946|69391751|FG002|Overall Study|Lost to Follow-up|0|||
37786676|NCT02363946|69391752|FG003|Overall Study|Lost to Follow-up|0|||
37786677|NCT02363946|69391753|FG004|Overall Study|Lost to Follow-up|0|||
37786678|NCT02363946|69391754|FG005|Overall Study|Lost to Follow-up|0|||
37786679|NCT02363946|69391755|FG006|Overall Study|Lost to Follow-up|0|||
37786680|NCT02363946|69391756|FG007|Overall Study|Lost to Follow-up|1|||
37786681|NCT02363946|69391757|FG008|Overall Study|Lost to Follow-up|0|||
37786682|NCT02363946|69391758|FG009|Overall Study|Lost to Follow-up|0|||
37786683|NCT02363946|69391759|FG010|Overall Study|Lost to Follow-up|0|||
37786684|NCT02363946|69391760|FG011|Overall Study|Lost to Follow-up|0|||
37786685|NCT02363946|69391761|FG012|Overall Study|Lost to Follow-up|0|||
37786686|NCT02363478|69391789|FG000|Overall Study|Lost to Follow-up|4|||
37786687|NCT02363478|69391789|FG000|Overall Study|Adverse Event|4|||
37786688|NCT02310126|69391796|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
37786689|NCT02310126|69391797|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
37786690|NCT02310126|69391796|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
37786691|NCT02310126|69391797|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
37786692|NCT02338362|69391805|FG000|Overall Study|Withdrawal by Subject|1|||
37786693|NCT02338362|69391806|FG001|Overall Study|Withdrawal by Subject|1|||
37786694|NCT02363322|69391814|FG000|Overall Study|Lost to Follow-up|1|||
37786695|NCT02363322|69391815|FG001|Overall Study|Lost to Follow-up|0|||
37786696|NCT02361762|69391823|FG000|Overall Study|Withdrawal by Subject|0|||
37786697|NCT02361762|69391824|FG001|Overall Study|Withdrawal by Subject|1|||
37786698|NCT02361762|69391823|FG000|Overall Study|Lost to Follow-up|0|||
37786699|NCT02361762|69391824|FG001|Overall Study|Lost to Follow-up|1|||
37786700|NCT02337738|69391833|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
37786701|NCT02337738|69391834|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
37786702|NCT02337738|69391835|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
37786703|NCT02337738|69391833|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
37786704|NCT02337738|69391834|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
37786705|NCT02337738|69391835|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
37786706|NCT02337738|69391833|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
37786707|NCT02337738|69391834|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
37786708|NCT02337738|69391835|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
37786709|NCT02337738|69391833|FG000|Overall Study|Voluntary Withdrawal|10|||
37786710|NCT02337738|69391834|FG001|Overall Study|Voluntary Withdrawal|5|||
37786711|NCT02337738|69391835|FG002|Overall Study|Voluntary Withdrawal|2|||
37786712|NCT02337738|69391833|FG000|Overall Study|Lack of Efficacy|2|||
37786713|NCT02337738|69391834|FG001|Overall Study|Lack of Efficacy|4|||
37786714|NCT02337738|69391835|FG002|Overall Study|Lack of Efficacy|0|||
37786715|NCT02337738|69391833|FG000|Overall Study|Investigator's Judgment|1|||
37786716|NCT02337738|69391834|FG001|Overall Study|Investigator's Judgment|1|||
37786717|NCT02337738|69391835|FG002|Overall Study|Investigator's Judgment|3|||
37786718|NCT02309112|69391846|FG000|Overall Study|Withdrawal by Subject|1|||
37786719|NCT02309112|69391847|FG001|Overall Study|Withdrawal by Subject|0|||
37786720|NCT02309112|69391848|FG002|Overall Study|Withdrawal by Subject|1|||
37786721|NCT02309112|69391846|FG000|Overall Study|Lost to Follow-up|0|||
37786722|NCT02309112|69391847|FG001|Overall Study|Lost to Follow-up|1|||
37786723|NCT02309112|69391848|FG002|Overall Study|Lost to Follow-up|0|||
37786724|NCT02361216|69391860|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
37786725|NCT02361216|69391861|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
37786726|NCT02361216|69391860|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
37786727|NCT02361216|69391861|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
37786728|NCT02361216|69391860|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
37786729|NCT02361216|69391861|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
37975321|NCT00465270|69662540|FG001|Overall Study|Death|11|||
37975322|NCT00465270|69662539|FG000|Overall Study|Withdrawal by Subject|34|||
37786730|NCT02361216|69391860|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
37786731|NCT02361216|69391861|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
37786732|NCT02361216|69391860|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
37786733|NCT02361216|69391861|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
37786734|NCT02361216|69391860|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
37786735|NCT02361216|69391861|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
37786736|NCT00559988|69392294|FG000|Overall Study|Death|147|||
37786737|NCT00559988|69392295|FG001|Overall Study|Death|140|||
37786738|NCT00559988|69392294|FG000|Overall Study|Withdrawal by Subject|152|||
37786739|NCT00559988|69392295|FG001|Overall Study|Withdrawal by Subject|139|||
37786740|NCT00559988|69392294|FG000|Overall Study|Lost to Follow-up|42|||
37786741|NCT00559988|69392295|FG001|Overall Study|Lost to Follow-up|56|||
37786742|NCT00559988|69392294|FG000|Overall Study|ICD device explanted|10|||
37786743|NCT00559988|69392295|FG001|Overall Study|ICD device explanted|17|||
37786744|NCT00559754|69392357|FG000|Overall Study|Disease progression|1|||
37786745|NCT00559754|69392357|FG000|Overall Study|Adverse Event|5|||
37786746|NCT00559754|69392357|FG000|Overall Study|Protocol Violation|1|||
37786747|NCT00559754|69392357|FG000|Overall Study|Investigator criteria|2|||
37786748|NCT00559754|69392357|FG000|Overall Study|Withdrawal by Subject|2|||
37786749|NCT00559364|69392471|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
37786750|NCT00559364|69392472|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
37786751|NCT02308020|69392535|FG000|Overall Study|Lost to Follow-up|1|||
37786752|NCT02308020|69392536|FG001|Overall Study|Lost to Follow-up|7|||
37786753|NCT02308020|69392537|FG002|Overall Study|Lost to Follow-up|0|||
37786754|NCT02308020|69392538|FG003|Overall Study|Lost to Follow-up|0|||
37786755|NCT02308020|69392539|FG004|Overall Study|Lost to Follow-up|1|||
37975323|NCT00465270|69662540|FG001|Overall Study|Withdrawal by Subject|78|||
37975324|NCT00465270|69662539|FG000|Overall Study|Lost to Follow-up|60|||
37786756|NCT02308020|69392540|FG005|Overall Study|Lost to Follow-up|2|||
37786757|NCT02308020|69392535|FG000|Overall Study|Sponsor Decision|0|||
37786758|NCT02308020|69392536|FG001|Overall Study|Sponsor Decision|8|||
37786759|NCT02308020|69392537|FG002|Overall Study|Sponsor Decision|0|||
37786760|NCT02308020|69392538|FG003|Overall Study|Sponsor Decision|2|||
37786761|NCT02308020|69392539|FG004|Overall Study|Sponsor Decision|2|||
37786762|NCT02308020|69392540|FG005|Overall Study|Sponsor Decision|1|||
37786763|NCT02308020|69392535|FG000|Overall Study|Withdrawal by Subject|3|||
37786764|NCT02308020|69392536|FG001|Overall Study|Withdrawal by Subject|5|||
37786765|NCT02308020|69392537|FG002|Overall Study|Withdrawal by Subject|3|||
37786766|NCT02308020|69392538|FG003|Overall Study|Withdrawal by Subject|2|||
37786767|NCT02308020|69392539|FG004|Overall Study|Withdrawal by Subject|1|||
37786768|NCT02308020|69392540|FG005|Overall Study|Withdrawal by Subject|2|||
37786769|NCT02359890|69392560|FG000|Overall Study|Not meeting eligibility|4|||
37786770|NCT02359890|69392560|FG000|Overall Study|Never treated with study catheter|6|||
37786771|NCT02306850|69392564|FG000|Overall Study|Lack of Efficacy|2|||
37786772|NCT02306694|69392569|FG000|Overall Study|Withdrawal by Subject|3|||
37786773|NCT02306694|69392569|FG000|Overall Study|Lost to Follow-up|1|||
37786774|NCT01648140|69392581|FG000|Overall Study|Physician Decision|1|||
37786775|NCT01648140|69392582|FG001|Overall Study|Physician Decision|0|||
37786776|NCT01648140|69392583|FG002|Overall Study|Physician Decision|0|||
37786777|NCT01648140|69392584|FG003|Overall Study|Physician Decision|0|||
37786778|NCT01648140|69392581|FG000|Overall Study|Lack of Efficacy|4|||
37786779|NCT01648140|69392582|FG001|Overall Study|Lack of Efficacy|7|||
37786780|NCT01648140|69392583|FG002|Overall Study|Lack of Efficacy|1|||
37786781|NCT01648140|69392584|FG003|Overall Study|Lack of Efficacy|0|||
37786782|NCT01648140|69392581|FG000|Overall Study|Adverse Event|3|||
37786783|NCT01648140|69392582|FG001|Overall Study|Adverse Event|1|||
37786784|NCT01648140|69392583|FG002|Overall Study|Adverse Event|2|||
37786785|NCT01648140|69392584|FG003|Overall Study|Adverse Event|0|||
37786786|NCT01648140|69392581|FG000|Overall Study|Withdrawal by Subject|2|||
37786787|NCT01648140|69392582|FG001|Overall Study|Withdrawal by Subject|3|||
37786788|NCT01648140|69392583|FG002|Overall Study|Withdrawal by Subject|3|||
37786789|NCT01648140|69392584|FG003|Overall Study|Withdrawal by Subject|2|||
37786790|NCT01648140|69392581|FG000|Overall Study|Lost to Follow-up|2|||
37786791|NCT01648140|69392582|FG001|Overall Study|Lost to Follow-up|1|||
37786792|NCT01648140|69392583|FG002|Overall Study|Lost to Follow-up|2|||
37786793|NCT01648140|69392584|FG003|Overall Study|Lost to Follow-up|0|||
37786794|NCT02336178|69392603|FG000|Overall Study|Lost to Follow-up|1|||
37786795|NCT02336178|69392603|FG000|Overall Study|Protocol Violation|1|||
37786796|NCT02336178|69392603|FG000|Overall Study|Withdrawal by Subject|1|||
37786797|NCT02336178|69392603|FG000|Overall Study|Other|1|||
37786798|NCT02357940|69392617|FG000|Overall Study|Adverse Event|0|||
37786799|NCT02357940|69392618|FG001|Overall Study|Adverse Event|1|||
37786800|NCT02357940|69392617|FG000|Overall Study|Investigator's judgement|0|||
37786801|NCT02357940|69392618|FG001|Overall Study|Investigator's judgement|1|||
37786802|NCT02335242|69392626|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
37786803|NCT02335242|69392627|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
37786804|NCT02335242|69392626|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
37786805|NCT02335242|69392627|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
37786806|NCT02335242|69392626|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
37786807|NCT02335242|69392627|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
37786808|NCT02334384|69392639|FG000|Overall Study|Lost to Follow-up|1|||
37786809|NCT02334384|69392640|FG001|Overall Study|Lost to Follow-up|1|||
37786810|NCT02334306|69392648|FG000|Double-blind Period|Adverse Event|0|||
37786811|NCT02334306|69392649|FG001|Double-blind Period|Adverse Event|1|||
37786812|NCT02334306|69392648|FG000|Double-blind Period|Withdrawal by Subject|1|||
37786813|NCT02334306|69392649|FG001|Double-blind Period|Withdrawal by Subject|1|||
37786814|NCT02305758|69392658|FG000|Overall Study|Death|27|||
37786815|NCT02305758|69392659|FG001|Overall Study|Death|27|||
37786816|NCT02305758|69392658|FG000|Overall Study|Withdrew consent|9|||
37786817|NCT02305758|69392659|FG001|Overall Study|Withdrew consent|2|||
37786818|NCT02305758|69392658|FG000|Overall Study|Lost to Follow-up|6|||
37786819|NCT02305758|69392659|FG001|Overall Study|Lost to Follow-up|1|||
37786820|NCT02305758|69392658|FG000|Overall Study|Study Terminated by Sponsor|21|||
37786821|NCT02305758|69392659|FG001|Overall Study|Study Terminated by Sponsor|34|||
37786822|NCT02305758|69392658|FG000|Overall Study|Other, not specified|2|||
37786823|NCT02305758|69392659|FG001|Overall Study|Other, not specified|1|||
37786824|NCT02305446|69392665|FG000|Overall Study|Adverse Event|1|||
37786825|NCT02303574|69392802|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
37786826|NCT02303574|69392803|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
37786827|NCT02303574|69392804|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
37786828|NCT02303574|69392805|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
37786829|NCT02303574|69392806|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
37786830|NCT02303574|69392807|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
37975325|NCT00465270|69662540|FG001|Overall Study|Lost to Follow-up|67|||
37786831|NCT02303574|69392808|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
37786832|NCT02303574|69392809|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
37786833|NCT02303574|69392810|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
37786834|NCT02303574|69392811|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
37786835|NCT02303574|69392802|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
37786836|NCT02303574|69392803|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
37786837|NCT02303574|69392804|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
37786838|NCT02303574|69392805|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
37786839|NCT02303574|69392806|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
37786840|NCT02303574|69392807|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
37975326|NCT00465270|69662539|FG000|Overall Study|Investigator request|3|||
37786841|NCT02303574|69392808|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
37786842|NCT02303574|69392809|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
37786843|NCT02303574|69392810|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
37786844|NCT02303574|69392811|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
37786845|NCT02354976|69392847|FG000|Overall Study|Other - reason not specified|1|||
37786846|NCT02354976|69392848|FG001|Overall Study|Other - reason not specified|0|||
37786847|NCT02354976|69392849|FG002|Overall Study|Other - reason not specified|1|||
37786848|NCT02354976|69392847|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
37786849|NCT02354976|69392848|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
37786850|NCT02354976|69392849|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
37786851|NCT02354976|69392847|FG000|Overall Study|Adverse Event|1|||
37786852|NCT02354976|69392848|FG001|Overall Study|Adverse Event|0|||
37786853|NCT02354976|69392849|FG002|Overall Study|Adverse Event|2|||
37786854|NCT02303262|69392857|FG000|Overall Study|Withdrawal by Subject|2|||
37786855|NCT00558896|69392868|FG000|Overall Study|Adverse Event|1|||
37786856|NCT00558896|69392869|FG001|Overall Study|Adverse Event|1|||
37786857|NCT00558896|69392870|FG002|Overall Study|Adverse Event|1|||
37786858|NCT00558896|69392871|FG003|Overall Study|Adverse Event|3|||
37786859|NCT00558896|69392872|FG004|Overall Study|Adverse Event|4|||
37786860|NCT00558896|69392873|FG005|Overall Study|Adverse Event|10|||
37786861|NCT00558896|69392874|FG006|Overall Study|Adverse Event|3|||
37786862|NCT00558896|69392868|FG000|Overall Study|Death|3|||
37786863|NCT00558896|69392869|FG001|Overall Study|Death|0|||
37786864|NCT00558896|69392870|FG002|Overall Study|Death|2|||
37786865|NCT00558896|69392871|FG003|Overall Study|Death|3|||
37786866|NCT00558896|69392872|FG004|Overall Study|Death|2|||
37786867|NCT00558896|69392873|FG005|Overall Study|Death|2|||
37786868|NCT00558896|69392874|FG006|Overall Study|Death|6|||
37786869|NCT00558896|69392868|FG000|Overall Study|Withdrawal by Subject|2|||
37786870|NCT00558896|69392869|FG001|Overall Study|Withdrawal by Subject|1|||
37786871|NCT00558896|69392870|FG002|Overall Study|Withdrawal by Subject|1|||
37786872|NCT00558896|69392871|FG003|Overall Study|Withdrawal by Subject|1|||
37786873|NCT00558896|69392872|FG004|Overall Study|Withdrawal by Subject|1|||
37786874|NCT00558896|69392873|FG005|Overall Study|Withdrawal by Subject|5|||
37786875|NCT00558896|69392874|FG006|Overall Study|Withdrawal by Subject|5|||
37786876|NCT00558896|69392868|FG000|Overall Study|Alternative Treatment|2|||
37786877|NCT00558896|69392869|FG001|Overall Study|Alternative Treatment|2|||
37786878|NCT00558896|69392870|FG002|Overall Study|Alternative Treatment|0|||
37786879|NCT00558896|69392871|FG003|Overall Study|Alternative Treatment|2|||
37786880|NCT00558896|69392872|FG004|Overall Study|Alternative Treatment|6|||
37975327|NCT00465270|69662540|FG001|Overall Study|Investigator request|4|||
37975328|NCT00464568|69662546|FG000|Overall Study|Adverse Event|2|||
37975329|NCT00464490|69662565|FG000|Overall Study|Physician Decision|11|||
37975330|NCT00464490|69662566|FG001|Overall Study|Physician Decision|11|||
37975331|NCT03849300|69662576|FG000|Overall Study|move out to different area|1|||
37975332|NCT03849300|69662577|FG001|Overall Study|move out to different area|3|||
37975333|NCT03849300|69662578|FG002|Overall Study|move out to different area|1|||
37786881|NCT00558896|69392873|FG005|Overall Study|Alternative Treatment|7|||
37786882|NCT00558896|69392874|FG006|Overall Study|Alternative Treatment|1|||
37786883|NCT00558896|69392868|FG000|Overall Study|Physician discretion|3|||
37786884|NCT00558896|69392869|FG001|Overall Study|Physician discretion|2|||
37786885|NCT00558896|69392870|FG002|Overall Study|Physician discretion|1|||
37786886|NCT00558896|69392871|FG003|Overall Study|Physician discretion|2|||
37786887|NCT00558896|69392872|FG004|Overall Study|Physician discretion|1|||
37786888|NCT00558896|69392873|FG005|Overall Study|Physician discretion|3|||
37786889|NCT00558896|69392874|FG006|Overall Study|Physician discretion|3|||
37786890|NCT00558896|69392868|FG000|Overall Study|Continues on treatment|10|||
37786891|NCT00558896|69392869|FG001|Overall Study|Continues on treatment|1|||
37786892|NCT00558896|69392870|FG002|Overall Study|Continues on treatment|0|||
37786893|NCT00558896|69392871|FG003|Overall Study|Continues on treatment|1|||
37786894|NCT00558896|69392872|FG004|Overall Study|Continues on treatment|9|||
37786895|NCT00558896|69392873|FG005|Overall Study|Continues on treatment|25|||
37786896|NCT00558896|69392874|FG006|Overall Study|Continues on treatment|6|||
37786897|NCT00558428|69393008|FG000|Overall Study|Adverse Event|6|||
37786898|NCT00558428|69393009|FG001|Overall Study|Adverse Event|22|||
37786899|NCT00558428|69393010|FG002|Overall Study|Adverse Event|3|||
37786900|NCT00558428|69393011|FG003|Overall Study|Adverse Event|4|||
37786901|NCT00558428|69393008|FG000|Overall Study|Lost to Follow-up|0|||
37786902|NCT00558428|69393009|FG001|Overall Study|Lost to Follow-up|1|||
37786903|NCT00558428|69393010|FG002|Overall Study|Lost to Follow-up|0|||
37786904|NCT00558428|69393011|FG003|Overall Study|Lost to Follow-up|0|||
37786905|NCT00558428|69393008|FG000|Overall Study|Lack of Efficacy|0|||
37786906|NCT00558428|69393009|FG001|Overall Study|Lack of Efficacy|0|||
37786907|NCT00558428|69393010|FG002|Overall Study|Lack of Efficacy|1|||
37786908|NCT00558428|69393011|FG003|Overall Study|Lack of Efficacy|2|||
37786909|NCT00558428|69393008|FG000|Overall Study|Non compliant with protocol|1|||
37786910|NCT00558428|69393009|FG001|Overall Study|Non compliant with protocol|0|||
37786911|NCT00558428|69393010|FG002|Overall Study|Non compliant with protocol|0|||
37786912|NCT00558428|69393011|FG003|Overall Study|Non compliant with protocol|3|||
37786913|NCT00558428|69393008|FG000|Overall Study|Consent withdrawn|2|||
37786914|NCT00558428|69393009|FG001|Overall Study|Consent withdrawn|1|||
37786915|NCT00558428|69393010|FG002|Overall Study|Consent withdrawn|0|||
37786916|NCT00558428|69393011|FG003|Overall Study|Consent withdrawn|1|||
37786917|NCT00558428|69393008|FG000|Overall Study|Other|3|||
37786918|NCT00558428|69393009|FG001|Overall Study|Other|0|||
37786919|NCT00558428|69393010|FG002|Overall Study|Other|0|||
37786920|NCT00558428|69393011|FG003|Overall Study|Other|1|||
37786921|NCT00558272|69393050|FG000|Overall Study|Adverse Event|10|||
37786922|NCT00558272|69393051|FG001|Overall Study|Adverse Event|0|||
37786923|NCT00558272|69393050|FG000|Overall Study|Death|1|||
37786924|NCT00558272|69393051|FG001|Overall Study|Death|0|||
37786925|NCT00558272|69393050|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
37786926|NCT00558272|69393051|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
37786927|NCT00558272|69393050|FG000|Overall Study|AZ study team decision|0|||
37786928|NCT00558272|69393051|FG001|Overall Study|AZ study team decision|1|||
37786929|NCT00558272|69393050|FG000|Overall Study|Incorrectly enrolled|1|||
37786930|NCT00558272|69393051|FG001|Overall Study|Incorrectly enrolled|0|||
37786931|NCT00558272|69393050|FG000|Overall Study|Withdrawal by Subject|0|||
37786932|NCT00558272|69393051|FG001|Overall Study|Withdrawal by Subject|1|||
37786933|NCT00557492|69393196|FG000|Overall Study|Change in health insurance|1|||
37786934|NCT02354586|69393299|FG000|Overall Study|Death|230|||
37786935|NCT02354586|69393299|FG000|Overall Study|Withdrawal by Subject|59|||
37786936|NCT02354586|69393299|FG000|Overall Study|Lost to Follow-up|11|||
37786937|NCT02354586|69393299|FG000|Overall Study|Sponsor decision|51|||
37786938|NCT02354586|69393299|FG000|Overall Study|Site closure|2|||
37786939|NCT02354586|69393299|FG000|Overall Study|Intercurrent illness|1|||
37786940|NCT02354586|69393299|FG000|Overall Study|Protocol Violation|3|||
37786941|NCT02354586|69393299|FG000|Overall Study|Physician Decision|13|||
37786942|NCT02354586|69393299|FG000|Overall Study|Lack of Efficacy|86|||
37786943|NCT02354586|69393299|FG000|Overall Study|Adverse Event|7|||
37786944|NCT02332824|69393324|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
37786945|NCT02332824|69393325|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
37786946|NCT02332824|69393326|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
37786947|NCT02332824|69393327|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
37786948|NCT02332824|69393328|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
37786949|NCT02332824|69393329|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
37786950|NCT02332824|69393324|FG000|Overall Study|Voluntary Withdrawal|1|||
37786951|NCT02332824|69393325|FG001|Overall Study|Voluntary Withdrawal|0|||
37786952|NCT02332824|69393326|FG002|Overall Study|Voluntary Withdrawal|0|||
37786953|NCT02332824|69393327|FG003|Overall Study|Voluntary Withdrawal|0|||
37786954|NCT02332824|69393328|FG004|Overall Study|Voluntary Withdrawal|0|||
37786955|NCT02332824|69393329|FG005|Overall Study|Voluntary Withdrawal|0|||
37786956|NCT02332824|69393324|FG000|Overall Study|Inconvenient schedule|1|||
37786957|NCT02332824|69393325|FG001|Overall Study|Inconvenient schedule|1|||
37786958|NCT02332824|69393326|FG002|Overall Study|Inconvenient schedule|0|||
37786959|NCT02332824|69393327|FG003|Overall Study|Inconvenient schedule|0|||
37786960|NCT02332824|69393328|FG004|Overall Study|Inconvenient schedule|0|||
37786961|NCT02332824|69393329|FG005|Overall Study|Inconvenient schedule|0|||
37786962|NCT02332824|69393324|FG000|Overall Study|Transfer|0|||
37786963|NCT02332824|69393325|FG001|Overall Study|Transfer|0|||
37786964|NCT02332824|69393326|FG002|Overall Study|Transfer|1|||
37786965|NCT02332824|69393327|FG003|Overall Study|Transfer|1|||
37786966|NCT02332824|69393328|FG004|Overall Study|Transfer|0|||
37786967|NCT02332824|69393329|FG005|Overall Study|Transfer|0|||
37786968|NCT00556712|69393476|FG000|Overall Study|Adverse Event|7|||
37786969|NCT00556712|69393477|FG001|Overall Study|Adverse Event|19|||
37786970|NCT00556712|69393476|FG000|Overall Study|Death|5|||
37786971|NCT00556712|69393477|FG001|Overall Study|Death|10|||
37786972|NCT00556712|69393476|FG000|Overall Study|Progressive Disease|383|||
37786973|NCT00556712|69393477|FG001|Overall Study|Progressive Disease|320|||
37786974|NCT00556712|69393476|FG000|Overall Study|Protocol Violation|3|||
37786975|NCT00556712|69393477|FG001|Overall Study|Protocol Violation|2|||
37786976|NCT00556712|69393476|FG000|Overall Study|Refused Treatment|17|||
37786977|NCT00556712|69393477|FG001|Overall Study|Refused Treatment|16|||
37786978|NCT00556712|69393476|FG000|Overall Study|Failure to Return|2|||
37786979|NCT00556712|69393477|FG001|Overall Study|Failure to Return|3|||
37786980|NCT00556712|69393476|FG000|Overall Study|Other|2|||
37786981|NCT00556712|69393477|FG001|Overall Study|Other|2|||
37786982|NCT00556712|69393476|FG000|Overall Study|Ongoing at Data Cutoff|32|||
37786983|NCT00556712|69393477|FG001|Overall Study|Ongoing at Data Cutoff|66|||
37786984|NCT00556322|69393551|FG000|Overall Study|Insufficient therapeutic response|158|||
37786985|NCT00556322|69393552|FG001|Overall Study|Insufficient therapeutic response|168|||
37786986|NCT00556322|69393551|FG000|Overall Study|Adverse Event|7|||
37786987|NCT00556322|69393552|FG001|Overall Study|Adverse Event|4|||
37786988|NCT00556322|69393551|FG000|Overall Study|Other|4|||
37786989|NCT00556322|69393552|FG001|Overall Study|Other|1|||
37786990|NCT00556322|69393551|FG000|Overall Study|Lost to Follow-up|5|||
37786991|NCT00556322|69393552|FG001|Overall Study|Lost to Follow-up|3|||
37786992|NCT00556322|69393551|FG000|Overall Study|Withdrawal by Subject|19|||
37786993|NCT00556322|69393552|FG001|Overall Study|Withdrawal by Subject|7|||
37786994|NCT00556322|69393551|FG000|Overall Study|Protocol Violation|5|||
37786995|NCT00556322|69393552|FG001|Overall Study|Protocol Violation|1|||
37786996|NCT00556322|69393551|FG000|Overall Study|Ongoing at data cutoff|3|||
37786997|NCT00556322|69393552|FG001|Overall Study|Ongoing at data cutoff|5|||
37786998|NCT00556322|69393551|FG000|Overall Study|Death|20|||
37786999|NCT00556322|69393552|FG001|Overall Study|Death|14|||
37787000|NCT00556166|69393570|FG000|Overall Study|Withdrawal by Subject|1|||
37787001|NCT02332590|69393730|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
37787002|NCT02332590|69393731|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
37787003|NCT02332590|69393730|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
37787004|NCT02332590|69393731|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
37787005|NCT02332590|69393730|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
37787006|NCT02332590|69393731|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
37787007|NCT02332590|69393730|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
37787008|NCT02332590|69393731|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
37787009|NCT02332590|69393730|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
37787010|NCT02332590|69393731|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
37787011|NCT02332590|69393730|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
37787012|NCT02332590|69393731|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
37787013|NCT02332590|69393730|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
37787014|NCT02332590|69393731|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
37787015|NCT02332590|69393730|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
37787016|NCT02332590|69393731|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
37787017|NCT02332590|69393730|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
37787018|NCT02332590|69393731|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
37787019|NCT00554840|69393802|FG000|Overall Study|Physician Decision|0|||
37787020|NCT00554840|69393803|FG001|Overall Study|Physician Decision|1|||
37787021|NCT02302716|69393828|FG000|Overall Study|Adverse Event|1|||
37787022|NCT02302716|69393829|FG001|Overall Study|Adverse Event|1|||
37787023|NCT02302716|69393828|FG000|Overall Study|Death|0|||
37787024|NCT02302716|69393829|FG001|Overall Study|Death|1|||
37787025|NCT02302716|69393828|FG000|Overall Study|Lack of Efficacy|0|||
37787026|NCT02302716|69393829|FG001|Overall Study|Lack of Efficacy|1|||
37787027|NCT02302716|69393828|FG000|Overall Study|Lost to Follow-up|2|||
37787028|NCT02302716|69393829|FG001|Overall Study|Lost to Follow-up|4|||
37787029|NCT02302716|69393828|FG000|Overall Study|Physician Decision|3|||
37787030|NCT02302716|69393829|FG001|Overall Study|Physician Decision|4|||
37787031|NCT02302716|69393828|FG000|Overall Study|Withdrawal by Subject|13|||
37787032|NCT02302716|69393829|FG001|Overall Study|Withdrawal by Subject|7|||
37787033|NCT02302716|69393828|FG000|Overall Study|Protocol Violation|0|||
37787034|NCT02302716|69393829|FG001|Overall Study|Protocol Violation|1|||
37787035|NCT00554606|69393858|FG000|Overall Study|Adverse Event|3|||
37787036|NCT00554606|69393858|FG000|Overall Study|Abnormal laboratory values|1|||
37787037|NCT00554606|69393858|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
37787038|NCT00554606|69393858|FG000|Overall Study|Subject withdrew consent|2|||
37787039|NCT00554606|69393858|FG000|Overall Study|Lost to Follow-up|2|||
37787040|NCT00554606|69393858|FG000|Overall Study|Administrative problems|60|||
37787041|NCT00554606|69393858|FG000|Overall Study|Death|1|||
37787042|NCT00554606|69393858|FG000|Overall Study|Protocol deviation|2|||
37787043|NCT02354508|69393894|FG000|Period 1: Core Phase|Adverse Event|1|||
37787044|NCT02354508|69393895|FG001|Period 1: Core Phase|Adverse Event|1|||
37787045|NCT02354508|69393896|FG002|Period 1: Core Phase|Adverse Event|2|||
37787046|NCT02354508|69393894|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
37787047|NCT02354508|69393895|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
37787048|NCT02354508|69393896|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
37787049|NCT02354508|69393894|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
37787050|NCT02354508|69393895|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
37787051|NCT02354508|69393896|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
37787052|NCT02354508|69393894|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
37787053|NCT02354508|69393895|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
37787054|NCT02354508|69393896|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
37787055|NCT02354508|69393894|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
37787056|NCT02354508|69393895|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
37787057|NCT02354508|69393896|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
37787058|NCT02354508|69393894|FG000|Period 2: Extension Phase|Physician Decision|5|||
37787059|NCT02354508|69393895|FG001|Period 2: Extension Phase|Physician Decision|0|||
37787060|NCT02354508|69393896|FG002|Period 2: Extension Phase|Physician Decision|1|||
37787061|NCT02354508|69393894|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
37787062|NCT02354508|69393895|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
37787063|NCT02354508|69393896|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
37787064|NCT02354508|69393894|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
37787065|NCT02354508|69393895|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
37787066|NCT02354508|69393896|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
37787067|NCT02354508|69393894|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
37787068|NCT02354508|69393895|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
37787069|NCT02354508|69393896|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
37787070|NCT00554216|69393948|FG000|Overall Study|Lost to Follow-up|92|||
37787071|NCT00554216|69393949|FG001|Overall Study|Lost to Follow-up|31|||
37787072|NCT00554216|69393950|FG002|Overall Study|Lost to Follow-up|63|||
37787073|NCT00554216|69393948|FG000|Overall Study|Adverse Event|16|||
37787074|NCT00554216|69393949|FG001|Overall Study|Adverse Event|16|||
37787075|NCT00554216|69393950|FG002|Overall Study|Adverse Event|36|||
37787076|NCT00554216|69393948|FG000|Overall Study|Withdrawal by Subject|92|||
37787077|NCT00554216|69393949|FG001|Overall Study|Withdrawal by Subject|31|||
37787078|NCT00554216|69393950|FG002|Overall Study|Withdrawal by Subject|43|||
37787079|NCT00554216|69393948|FG000|Overall Study|Non compliance|10|||
37787080|NCT00554216|69393949|FG001|Overall Study|Non compliance|4|||
37787081|NCT00554216|69393950|FG002|Overall Study|Non compliance|5|||
37787082|NCT00554216|69393948|FG000|Overall Study|Pregnancy|2|||
37787083|NCT00554216|69393949|FG001|Overall Study|Pregnancy|1|||
37787084|NCT00554216|69393950|FG002|Overall Study|Pregnancy|14|||
37787085|NCT00554216|69393948|FG000|Overall Study|Restricted med|3|||
37787086|NCT00554216|69393949|FG001|Overall Study|Restricted med|1|||
37787087|NCT00554216|69393950|FG002|Overall Study|Restricted med|1|||
37787088|NCT00554216|69393948|FG000|Overall Study|Other|12|||
37787089|NCT00554216|69393949|FG001|Overall Study|Other|7|||
37787090|NCT00554216|69393950|FG002|Overall Study|Other|10|||
37787091|NCT00554216|69393948|FG000|Overall Study|Lack of Efficacy|15|||
37787092|NCT00554216|69393949|FG001|Overall Study|Lack of Efficacy|3|||
37787093|NCT00554216|69393950|FG002|Overall Study|Lack of Efficacy|0|||
37787094|NCT02353572|69393975|FG000|Overall Study|Withdrawal by Subject|1|||
37787095|NCT02353572|69393975|FG000|Overall Study|Study terminated|2|||
37787096|NCT00552578|69393987|FG000|Overall Study|Lost to Follow-up|1|||
37787097|NCT00552578|69393988|FG001|Overall Study|Lost to Follow-up|1|||
37787098|NCT02301936|69393996|FG000|Overall Study|Lost to Follow-up|1|||
37787099|NCT02301936|69393997|FG001|Overall Study|Lost to Follow-up|0|||
37693640|NCT02492165|69169937|FG003|Overall Study|Withdrawal by Subject|0|||
37693641|NCT02355691|69169949|FG000|Overall Study|Loss of Research Personnel|7|||
37693642|NCT02355691|69169950|FG001|Overall Study|Loss of Research Personnel|9|||
37693643|NCT02473289|69169958|FG000|Overall Study|Adverse Event|2|||
37693644|NCT02473289|69169959|FG001|Overall Study|Adverse Event|3|||
37693645|NCT02473289|69169958|FG000|Overall Study|Lost to Follow-up|1|||
37693646|NCT02473289|69169959|FG001|Overall Study|Lost to Follow-up|1|||
37787100|NCT00552344|69394036|FG000|Overall Study|Lack of Efficacy|55|||
37787101|NCT00552344|69394036|FG000|Overall Study|Loss of efficacy|75|||
37787102|NCT00552344|69394036|FG000|Overall Study|Lost to Follow-up|8|||
37787103|NCT00552344|69394036|FG000|Overall Study|Withdrawal by Subject|48|||
37787104|NCT00552344|69394036|FG000|Overall Study|SAE, non-fatal|6|||
37787105|NCT00552344|69394036|FG000|Overall Study|AE, non-serious non-fatal|38|||
37787106|NCT00552344|69394036|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
37787107|NCT00552344|69394036|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
37787108|NCT00552344|69394036|FG000|Overall Study|Other Reason|22|||
37787109|NCT00553514|69394073|FG000|Overall Study|Protocol deviation|0|||
37787110|NCT00553514|69394074|FG001|Overall Study|Protocol deviation|0|||
37787111|NCT00553514|69394075|FG002|Overall Study|Protocol deviation|0|||
37787112|NCT00553514|69394076|FG003|Overall Study|Protocol deviation|1|||
37787113|NCT00553514|69394077|FG004|Overall Study|Protocol deviation|0|||
37787114|NCT00553514|69394073|FG000|Overall Study|Lack of ovarian response|4|||
37787115|NCT00553514|69394074|FG001|Overall Study|Lack of ovarian response|5|||
37787116|NCT00553514|69394075|FG002|Overall Study|Lack of ovarian response|5|||
37787117|NCT00553514|69394076|FG003|Overall Study|Lack of ovarian response|5|||
37787118|NCT00553514|69394077|FG004|Overall Study|Lack of ovarian response|6|||
37787119|NCT00553514|69394073|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
37787120|NCT00553514|69394074|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
37787121|NCT00553514|69394075|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
37787122|NCT00553514|69394076|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
37787123|NCT00553514|69394077|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
37787124|NCT00553514|69394073|FG000|Overall Study|Risk of multiple pregnancy|0|||
37787125|NCT00553514|69394074|FG001|Overall Study|Risk of multiple pregnancy|2|||
37787126|NCT00553514|69394075|FG002|Overall Study|Risk of multiple pregnancy|0|||
37787127|NCT00553514|69394076|FG003|Overall Study|Risk of multiple pregnancy|1|||
37787128|NCT00553514|69394077|FG004|Overall Study|Risk of multiple pregnancy|0|||
37787129|NCT00553514|69394073|FG000|Overall Study|Other|1|||
37787130|NCT00553514|69394074|FG001|Overall Study|Other|1|||
37787131|NCT00553514|69394075|FG002|Overall Study|Other|0|||
37787132|NCT00553514|69394076|FG003|Overall Study|Other|0|||
37787133|NCT00553514|69394077|FG004|Overall Study|Other|1|||
37787134|NCT00553436|69394101|FG000|Overall Study|Conversion to another procedure|1|||
37787135|NCT00553202|69394132|FG000|Overall Study|Death|16|||
37787136|NCT00553202|69394132|FG000|Overall Study|Lost to Follow-up|1|||
37787137|NCT00553202|69394132|FG000|Overall Study|Physician Decision|28|||
37787138|NCT00553202|69394132|FG000|Overall Study|Withdrawal by Subject|1|||
37787139|NCT00553202|69394132|FG000|Overall Study|No donor identified|16|||
37787140|NCT00553202|69394132|FG000|Overall Study|Fails to meet organ function|6|||
37787141|NCT00552188|69394156|FG000|Overall Study|Adverse Event|0|||
37787142|NCT00552188|69394157|FG001|Overall Study|Adverse Event|2|||
37787143|NCT00552188|69394156|FG000|Overall Study|Lost to Follow-up|2|||
37787144|NCT00552188|69394157|FG001|Overall Study|Lost to Follow-up|1|||
37787145|NCT00552188|69394156|FG000|Overall Study|Withdrawal of consent|0|||
37787146|NCT00552188|69394157|FG001|Overall Study|Withdrawal of consent|1|||
37787147|NCT00552188|69394156|FG000|Overall Study|Subject returned to home country|0|||
37787148|NCT00552188|69394157|FG001|Overall Study|Subject returned to home country|1|||
37787149|NCT00552110|69394177|FG000|Overall Study|Serious or Life-Threatening AE|0|||
37787150|NCT00552110|69394178|FG001|Overall Study|Serious or Life-Threatening AE|0|||
37787151|NCT00552110|69394179|FG002|Overall Study|Serious or Life-Threatening AE|1|||
37787152|NCT00552110|69394180|FG003|Overall Study|Serious or Life-Threatening AE|0|||
37787153|NCT00552110|69394181|FG004|Overall Study|Serious or Life-Threatening AE|0|||
37787154|NCT00552110|69394177|FG000|Overall Study|Lack of Efficacy|1|||
37787155|NCT00552110|69394178|FG001|Overall Study|Lack of Efficacy|0|||
37787156|NCT00552110|69394179|FG002|Overall Study|Lack of Efficacy|0|||
37787157|NCT00552110|69394180|FG003|Overall Study|Lack of Efficacy|1|||
37787158|NCT00552110|69394181|FG004|Overall Study|Lack of Efficacy|4|||
37787159|NCT00552110|69394177|FG000|Overall Study|Withdrawal by Subject|0|||
37787160|NCT00552110|69394178|FG001|Overall Study|Withdrawal by Subject|2|||
37787161|NCT00552110|69394179|FG002|Overall Study|Withdrawal by Subject|0|||
37787162|NCT00552110|69394180|FG003|Overall Study|Withdrawal by Subject|3|||
37787163|NCT00552110|69394181|FG004|Overall Study|Withdrawal by Subject|2|||
37787164|NCT00552110|69394177|FG000|Overall Study|Lost to Follow-up|0|||
37787165|NCT00552110|69394178|FG001|Overall Study|Lost to Follow-up|0|||
37787166|NCT00552110|69394179|FG002|Overall Study|Lost to Follow-up|0|||
37787167|NCT00552110|69394180|FG003|Overall Study|Lost to Follow-up|1|||
37787168|NCT00552110|69394181|FG004|Overall Study|Lost to Follow-up|1|||
37787169|NCT00552110|69394177|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
37787170|NCT00552110|69394178|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
37787171|NCT00552110|69394179|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
37787172|NCT00552110|69394180|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
37787173|NCT00552110|69394181|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
37787174|NCT00552110|69394177|FG000|Overall Study|Withdrawn per Sponsor|0|||
37787175|NCT00552110|69394178|FG001|Overall Study|Withdrawn per Sponsor|1|||
37787176|NCT00552110|69394179|FG002|Overall Study|Withdrawn per Sponsor|0|||
37787177|NCT00552110|69394180|FG003|Overall Study|Withdrawn per Sponsor|0|||
37787178|NCT00552110|69394181|FG004|Overall Study|Withdrawn per Sponsor|1|||
37787179|NCT00552110|69394177|FG000|Overall Study|Use of Prohibited Medication|1|||
37787180|NCT00552110|69394178|FG001|Overall Study|Use of Prohibited Medication|1|||
37787181|NCT00552110|69394179|FG002|Overall Study|Use of Prohibited Medication|0|||
37787182|NCT00552110|69394180|FG003|Overall Study|Use of Prohibited Medication|0|||
37787183|NCT00552110|69394181|FG004|Overall Study|Use of Prohibited Medication|0|||
37787184|NCT00552110|69394177|FG000|Overall Study|Delay of Study due to Relabeling|0|||
37787185|NCT00552110|69394178|FG001|Overall Study|Delay of Study due to Relabeling|0|||
37787186|NCT00552110|69394179|FG002|Overall Study|Delay of Study due to Relabeling|0|||
37787187|NCT00552110|69394180|FG003|Overall Study|Delay of Study due to Relabeling|1|||
37787188|NCT00552110|69394181|FG004|Overall Study|Delay of Study due to Relabeling|0|||
37787189|NCT00552110|69394177|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
37787190|NCT00552110|69394178|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
37787191|NCT00552110|69394179|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
37787192|NCT00552110|69394180|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
37787193|NCT00552110|69394181|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
37787194|NCT00552110|69394177|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
37787195|NCT00552110|69394178|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
37787196|NCT00552110|69394179|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
37787197|NCT00552110|69394180|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
37787198|NCT00552110|69394181|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
37787199|NCT02301624|69394204|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
37787200|NCT02301624|69394205|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
37787201|NCT02301624|69394204|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
37787202|NCT02301624|69394205|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
37787203|NCT02301624|69394204|FG000|Open-label Maintenance Phase|Adverse Event|2|||
37787204|NCT02301624|69394205|FG001|Open-label Maintenance Phase|Adverse Event|5|||
37787205|NCT02301624|69394204|FG000|Open-label Maintenance Phase|Physician Decision|3|||
37787206|NCT02301624|69394205|FG001|Open-label Maintenance Phase|Physician Decision|3|||
37787207|NCT02301624|69394204|FG000|Open-label Maintenance Phase|Death|2|||
37787208|NCT02301624|69394205|FG001|Open-label Maintenance Phase|Death|1|||
37787209|NCT02301624|69394204|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
37787210|NCT02301624|69394205|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
37787211|NCT02301546|69394246|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
37787212|NCT02301546|69394247|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
37787213|NCT02301546|69394246|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
37975334|NCT03849300|69662579|FG003|Overall Study|move out to different area|4|||
37975335|NCT03849300|69662576|FG000|Overall Study|scheduling/transportation conflict|4|||
37975336|NCT03849300|69662577|FG001|Overall Study|scheduling/transportation conflict|4|||
37975337|NCT03849300|69662578|FG002|Overall Study|scheduling/transportation conflict|3|||
37975338|NCT03849300|69662579|FG003|Overall Study|scheduling/transportation conflict|2|||
37975339|NCT00412893|69662593|FG000|Overall Study|Adverse Event|31|||
37975340|NCT00412893|69662594|FG001|Overall Study|Adverse Event|53|||
37975341|NCT00412893|69662593|FG000|Overall Study|Death|17|||
37975342|NCT00412893|69662594|FG001|Overall Study|Death|21|||
37975343|NCT00412893|69662593|FG000|Overall Study|Insufficient Therapeutic Response|39|||
37975344|NCT00412893|69662594|FG001|Overall Study|Insufficient Therapeutic Response|23|||
37975345|NCT00412893|69662593|FG000|Overall Study|Lost to Follow-up|2|||
37975346|NCT00412893|69662594|FG001|Overall Study|Lost to Follow-up|1|||
37975347|NCT00412893|69662593|FG000|Overall Study|Violation of Selection at Entry|17|||
37975348|NCT00412893|69662594|FG001|Overall Study|Violation of Selection at Entry|10|||
37975349|NCT00412893|69662593|FG000|Overall Study|Other Protocol Violation|10|||
37975350|NCT00412893|69662594|FG001|Overall Study|Other Protocol Violation|6|||
37975351|NCT00412893|69662593|FG000|Overall Study|Did Not Cooperate|12|||
37975352|NCT00412893|69662594|FG001|Overall Study|Did Not Cooperate|9|||
37975353|NCT00412893|69662593|FG000|Overall Study|Administrative Reason|12|||
37787214|NCT02301546|69394247|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
37787215|NCT02301546|69394246|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
37787216|NCT02301546|69394247|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
37787217|NCT02301546|69394246|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
37787218|NCT02301546|69394247|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
37787219|NCT02301546|69394246|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
37787220|NCT02301546|69394247|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
37787221|NCT02301546|69394246|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
37787222|NCT02301546|69394247|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
37787223|NCT02301546|69394246|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
37787224|NCT02301546|69394247|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
37787225|NCT02351934|69394271|FG000|Allocation|POD weight<pre-op weight|3|||
37787226|NCT02351934|69394272|FG001|Allocation|POD weight<pre-op weight|0|||
37787227|NCT02351934|69394271|FG000|Allocation|Hypotension preventing administration|2|||
37787228|NCT02351934|69394272|FG001|Allocation|Hypotension preventing administration|0|||
37787229|NCT02351934|69394271|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
37787230|NCT02351934|69394272|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
37787231|NCT02351934|69394271|FG000|Follow-Up|POD weight<pre-op weight|3|||
37787232|NCT02351934|69394272|FG001|Follow-Up|POD weight<pre-op weight|0|||
37787233|NCT02351934|69394271|FG000|Follow-Up|Acute Kidney Injury|1|||
37787234|NCT02351934|69394272|FG001|Follow-Up|Acute Kidney Injury|0|||
37787235|NCT02351934|69394271|FG000|Follow-Up|Early dismissal|3|||
37787236|NCT02351934|69394272|FG001|Follow-Up|Early dismissal|0|||
37787237|NCT02351934|69394271|FG000|Follow-Up|Hypotension|3|||
37787238|NCT02351934|69394272|FG001|Follow-Up|Hypotension|0|||
37787239|NCT02351934|69394271|FG000|Follow-Up|No documentation|2|||
37787240|NCT02351934|69394272|FG001|Follow-Up|No documentation|0|||
37787241|NCT02351934|69394271|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
37787242|NCT02351934|69394272|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
37787243|NCT02351934|69394271|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
37787244|NCT02351934|69394272|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
37787245|NCT02351856|69394312|FG000|Overall Study|Adverse Event|2|||
37787246|NCT02351856|69394312|FG000|Overall Study|Physician Decision|5|||
37787247|NCT02351856|69394312|FG000|Overall Study|Study terminated by sponsor|1|||
37787248|NCT02349360|69394352|FG000|Overall Study|Withdrawal by Subject|0|||
37787249|NCT02349360|69394353|FG001|Overall Study|Withdrawal by Subject|1|||
37787250|NCT00551642|69394378|FG000|Treatment Period|Protocol Deviation|6|||
37787251|NCT00551642|69394379|FG001|Treatment Period|Protocol Deviation|11|||
37787252|NCT00551642|69394378|FG000|Treatment Period|Delivery device failure|1|||
37787253|NCT00551642|69394379|FG001|Treatment Period|Delivery device failure|3|||
37787254|NCT00551642|69394378|FG000|Treatment Period|Physician Decision|0|||
37787255|NCT00551642|69394379|FG001|Treatment Period|Physician Decision|1|||
37787256|NCT00551642|69394378|FG000|Treatment Period|Death|33|||
37787257|NCT00551642|69394379|FG001|Treatment Period|Death|31|||
37787258|NCT00551642|69394378|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
37787259|NCT00551642|69394379|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
37787260|NCT00551642|69394378|FG000|Treatment Period|Adverse Event|15|||
37787261|NCT00551642|69394379|FG001|Treatment Period|Adverse Event|12|||
37787262|NCT00551642|69394378|FG000|Treatment Period|Withdrawal by Subject|2|||
37787263|NCT00551642|69394379|FG001|Treatment Period|Withdrawal by Subject|1|||
37787264|NCT00550550|69394473|FG000|Overall Study|Adverse Event|13|||
37787265|NCT00550550|69394474|FG001|Overall Study|Adverse Event|5|||
37787266|NCT00550550|69394473|FG000|Overall Study|Treatment Failure|0|||
37787267|NCT00550550|69394474|FG001|Overall Study|Treatment Failure|1|||
37787268|NCT00550550|69394473|FG000|Overall Study|Lost to Follow-up|4|||
37787269|NCT00550550|69394474|FG001|Overall Study|Lost to Follow-up|0|||
37787270|NCT00550550|69394473|FG000|Overall Study|Withdrawal by Subject|10|||
37787271|NCT00550550|69394474|FG001|Overall Study|Withdrawal by Subject|8|||
37787272|NCT00550550|69394473|FG000|Overall Study|Protocol Violation|5|||
37787273|NCT00550550|69394474|FG001|Overall Study|Protocol Violation|14|||
37787274|NCT00550550|69394473|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
37787275|NCT00550550|69394474|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
37787276|NCT00550550|69394473|FG000|Overall Study|Randomized But Not Treated|1|||
37787277|NCT00550550|69394474|FG001|Overall Study|Randomized But Not Treated|0|||
37787278|NCT02301156|69394525|FG000|Overall Study|Adverse Event|13|||
37787279|NCT02301156|69394526|FG001|Overall Study|Adverse Event|14|||
37787280|NCT02301156|69394525|FG000|Overall Study|Death|1|||
37787281|NCT02301156|69394526|FG001|Overall Study|Death|5|||
37975354|NCT00412893|69662594|FG001|Overall Study|Administrative Reason|15|||
37787282|NCT02301156|69394525|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
37787283|NCT02301156|69394526|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
37787284|NCT02301156|69394525|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
37787285|NCT02301156|69394526|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
37787286|NCT02301156|69394525|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
37787287|NCT02301156|69394526|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
37787288|NCT02301156|69394525|FG000|Overall Study|Reason not Specified|6|||
37787289|NCT02301156|69394526|FG001|Overall Study|Reason not Specified|3|||
37787290|NCT02301390|69394607|FG000|Overall Study|Withdrawal by Subject|3|||
37787291|NCT02301390|69394608|FG001|Overall Study|Withdrawal by Subject|5|||
37787292|NCT02301390|69394607|FG000|Overall Study|Protocol Violation|1|||
37787293|NCT02301390|69394608|FG001|Overall Study|Protocol Violation|0|||
37787294|NCT02301390|69394607|FG000|Overall Study|Physician Decision|1|||
37787295|NCT02301390|69394608|FG001|Overall Study|Physician Decision|0|||
37787296|NCT02301390|69394607|FG000|Overall Study|Lost to Follow-up|0|||
37787297|NCT02301390|69394608|FG001|Overall Study|Lost to Follow-up|1|||
37787298|NCT02301390|69394607|FG000|Overall Study|Death|2|||
37787299|NCT02301390|69394608|FG001|Overall Study|Death|2|||
37787300|NCT02301390|69394607|FG000|Overall Study|Procedure not completed|0|||
37787301|NCT02301390|69394608|FG001|Overall Study|Procedure not completed|4|||
37787302|NCT02301390|69394607|FG000|Overall Study|Missed multiple visits|1|||
37787303|NCT02301390|69394608|FG001|Overall Study|Missed multiple visits|1|||
37787304|NCT02301390|69394607|FG000|Overall Study|study terminated|2|||
37787305|NCT02301390|69394608|FG001|Overall Study|study terminated|0|||
37787306|NCT02300610|69394725|FG000|Overall Study|Withdrawal by Subject|1|||
37787307|NCT02300610|69394726|FG001|Overall Study|Withdrawal by Subject|0|||
37787308|NCT02300610|69394727|FG002|Overall Study|Withdrawal by Subject|1|||
37787309|NCT02300298|69394772|FG000|Disposition for Nintedanib|Progressive disease|10|||
37787310|NCT02300298|69394773|FG001|Disposition for Nintedanib|Progressive disease|0|||
37787311|NCT02300298|69394772|FG000|Disposition for Docetaxel|Progressive disease|0|||
37787312|NCT02300298|69394773|FG001|Disposition for Docetaxel|Progressive disease|6|||
37787313|NCT02300298|69394772|FG000|Disposition for Docetaxel|other adverse event|0|||
37787314|NCT02300298|69394773|FG001|Disposition for Docetaxel|other adverse event|4|||
37787315|NCT02300220|69394779|FG000|Overall Study|Lost to Follow-up|1|||
37787316|NCT02300220|69394780|FG001|Overall Study|Lost to Follow-up|2|||
37787317|NCT02300220|69394779|FG000|Overall Study|Death|1|||
37787318|NCT02300220|69394780|FG001|Overall Study|Death|1|||
37787319|NCT02300220|69394779|FG000|Overall Study|Adverse Event|1|||
37787320|NCT02300220|69394780|FG001|Overall Study|Adverse Event|1|||
37787321|NCT02300220|69394779|FG000|Overall Study|Protocol Violation|1|||
37787322|NCT02300220|69394780|FG001|Overall Study|Protocol Violation|0|||
37787323|NCT02300220|69394779|FG000|Overall Study|Withdrawal by Subject|0|||
37787324|NCT02300220|69394780|FG001|Overall Study|Withdrawal by Subject|2|||
37787325|NCT02300220|69394779|FG000|Overall Study|Did not tolerate IMP|0|||
37787326|NCT02300220|69394780|FG001|Overall Study|Did not tolerate IMP|1|||
37787327|NCT02327130|69394804|FG000|Overall Study|Discharged in less than 5 days|5|||
37787328|NCT02327130|69394804|FG000|Overall Study|Physician Decision|2|||
37787329|NCT02327130|69394804|FG000|Overall Study|Unable to provide breath sample|1|||
37787330|NCT02327130|69394804|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
37787331|NCT02327130|69394804|FG000|Overall Study|Met exclusion criteria|3|||
37787332|NCT02326272|69394859|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
37787333|NCT02326272|69394860|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
37787334|NCT02326272|69394861|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
37787335|NCT02326272|69394862|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
37787336|NCT02326272|69394863|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
37787337|NCT02326272|69394864|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
37787338|NCT02326272|69394865|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
37787339|NCT02326272|69394866|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
37787340|NCT02326272|69394867|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
37787341|NCT02326272|69394868|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
37787342|NCT02326272|69394869|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
37787343|NCT02326272|69394870|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
37787344|NCT02326272|69394871|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
37787345|NCT02326272|69394872|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
37787346|NCT02326272|69394873|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
37787347|NCT02326272|69394859|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
37787348|NCT02326272|69394860|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
37787349|NCT02326272|69394861|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
37787350|NCT02326272|69394862|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
37787351|NCT02326272|69394863|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
37787352|NCT02326272|69394864|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
37787353|NCT02326272|69394865|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
37787354|NCT02326272|69394866|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
37787355|NCT02326272|69394867|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
37787356|NCT02326272|69394868|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
37787357|NCT02326272|69394869|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
37787358|NCT02326272|69394870|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
37787359|NCT02326272|69394871|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
37787360|NCT02326272|69394872|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
37787361|NCT02326272|69394873|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
37787362|NCT02326272|69394859|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
37787363|NCT02326272|69394860|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
37787364|NCT02326272|69394861|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
37787365|NCT02326272|69394862|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
37787366|NCT02326272|69394863|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
37787367|NCT02326272|69394864|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
37787368|NCT02326272|69394865|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
37787369|NCT02326272|69394866|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
37787370|NCT02326272|69394867|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
37787371|NCT02326272|69394868|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
37975355|NCT00412893|69662593|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
37975356|NCT00412893|69662594|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
37975357|NCT00412737|69662602|FG000|Overall Study|Death|1|||
37975358|NCT00412737|69662603|FG001|Overall Study|Death|0|||
37975359|NCT00412737|69662602|FG000|Overall Study|Adverse Event|3|||
37975360|NCT00412737|69662603|FG001|Overall Study|Adverse Event|2|||
37975361|NCT00412737|69662602|FG000|Overall Study|Refused Treatment|6|||
37975362|NCT00412737|69662603|FG001|Overall Study|Refused Treatment|2|||
37975363|NCT00412737|69662602|FG000|Overall Study|Failure to Return|6|||
37975364|NCT00412737|69662603|FG001|Overall Study|Failure to Return|2|||
37975365|NCT00508742|69662611|FG000|Period 1: Infant Series|Adverse Event|5|||
37975366|NCT00508742|69662612|FG001|Period 1: Infant Series|Adverse Event|4|||
37975367|NCT00508742|69662611|FG000|Period 1: Infant Series|Protocol Violation|1|||
37975368|NCT00508742|69662612|FG001|Period 1: Infant Series|Protocol Violation|0|||
37787372|NCT02326272|69394869|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
37975369|NCT00508742|69662611|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
37787373|NCT02326272|69394870|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
37787374|NCT02326272|69394871|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
37975370|NCT00508742|69662612|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
37975371|NCT00508742|69662611|FG000|Period 1: Infant Series|Physician Decision|1|||
37975372|NCT00508742|69662612|FG001|Period 1: Infant Series|Physician Decision|0|||
37787375|NCT02326272|69394872|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
37787376|NCT02326272|69394873|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
37787377|NCT02326272|69394859|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
37787378|NCT02326272|69394860|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
37787379|NCT02326272|69394861|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
37787380|NCT02326272|69394862|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
37787381|NCT02326272|69394863|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
37787382|NCT02326272|69394864|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
37787383|NCT02326272|69394865|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
37787384|NCT02326272|69394866|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
37787385|NCT02326272|69394867|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
37787386|NCT02326272|69394868|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
37787387|NCT02326272|69394869|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
37787388|NCT02326272|69394870|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
37787389|NCT02326272|69394871|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
37787390|NCT02326272|69394872|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
37787391|NCT02326272|69394873|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
37787392|NCT02326272|69394859|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
37787393|NCT02326272|69394860|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
37787394|NCT02326272|69394861|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
37787395|NCT02326272|69394862|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
37787396|NCT02326272|69394863|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
37787397|NCT02326272|69394864|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
37787398|NCT02326272|69394865|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
37787399|NCT02326272|69394866|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
37787400|NCT02326272|69394867|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
37787401|NCT02326272|69394868|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
37787402|NCT02326272|69394869|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
37693647|NCT02473289|69169958|FG000|Overall Study|Protocol Violation|0|||
37787403|NCT02326272|69394870|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
37787404|NCT02326272|69394871|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
37787405|NCT02326272|69394872|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
37787406|NCT02326272|69394873|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
37787407|NCT02326272|69394859|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
37787408|NCT02326272|69394860|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
37787409|NCT02326272|69394861|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
37787410|NCT02326272|69394862|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
37787411|NCT02326272|69394863|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
37787412|NCT02326272|69394864|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
37787413|NCT02326272|69394865|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
37787414|NCT02326272|69394866|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
37787415|NCT02326272|69394867|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
37787416|NCT02326272|69394868|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
37787417|NCT02326272|69394869|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
37787418|NCT02326272|69394870|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
37787419|NCT02326272|69394871|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
37787420|NCT02326272|69394872|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
37787421|NCT02326272|69394873|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
37787422|NCT02326272|69394859|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
37787423|NCT02326272|69394860|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
37787424|NCT02326272|69394861|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
37787425|NCT02326272|69394862|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
37787426|NCT02326272|69394863|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
37787427|NCT02326272|69394864|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
37787428|NCT02326272|69394865|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
37787429|NCT02326272|69394866|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
37787430|NCT02326272|69394867|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
37975373|NCT00508742|69662611|FG000|Period 1: Infant Series|Other|4|||
37975374|NCT00508742|69662612|FG001|Period 1: Infant Series|Other|1|||
37975375|NCT00508742|69662611|FG000|Period 2: After Infant Series|Adverse Event|2|||
37975376|NCT00508742|69662612|FG001|Period 2: After Infant Series|Adverse Event|6|||
37975377|NCT00508742|69662611|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
37975378|NCT00508742|69662612|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
37975379|NCT00508742|69662611|FG000|Period 2: After Infant Series|Protocol Violation|1|||
37975380|NCT00508742|69662612|FG001|Period 2: After Infant Series|Protocol Violation|0|||
37975381|NCT00508742|69662611|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
37975382|NCT00508742|69662612|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
37975383|NCT00508742|69662611|FG000|Period 2: After Infant Series|Failed to Return|1|||
37975384|NCT00508742|69662612|FG001|Period 2: After Infant Series|Failed to Return|0|||
37975385|NCT00508742|69662611|FG000|Period 2: After Infant Series|Other|2|||
37787431|NCT02326272|69394868|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
37787432|NCT02326272|69394869|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
37787433|NCT02326272|69394870|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
37787434|NCT02326272|69394871|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
37787435|NCT02326272|69394872|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
37787436|NCT02326272|69394873|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
37787437|NCT02326272|69394859|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
37787438|NCT02326272|69394860|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
37787439|NCT02326272|69394861|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
37787440|NCT02326272|69394862|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
37787441|NCT02326272|69394863|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
37787442|NCT02326272|69394864|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
37787443|NCT02326272|69394865|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
37787444|NCT02326272|69394866|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
37787445|NCT02326272|69394867|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
37787446|NCT02326272|69394868|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
37787447|NCT02326272|69394869|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
37787448|NCT02326272|69394870|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
37787449|NCT02326272|69394871|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
37787450|NCT02326272|69394872|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
37787451|NCT02326272|69394873|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
37787452|NCT02326272|69394859|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
37787453|NCT02326272|69394860|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
37787454|NCT02326272|69394861|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
37787455|NCT02326272|69394862|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
37787456|NCT02326272|69394863|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
37787457|NCT02326272|69394864|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
37787458|NCT02326272|69394865|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
37787459|NCT02326272|69394866|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
37787460|NCT02326272|69394867|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
37787461|NCT02326272|69394868|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
37787462|NCT02326272|69394869|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
37787463|NCT02326272|69394870|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
37787464|NCT02326272|69394871|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
37787465|NCT02326272|69394872|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
37787466|NCT02326272|69394873|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
37787467|NCT02326272|69394859|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
37787468|NCT02326272|69394860|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
37787469|NCT02326272|69394861|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
37787470|NCT02326272|69394862|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
37787471|NCT02326272|69394863|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
37787472|NCT02326272|69394864|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
37787473|NCT02326272|69394865|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
37787474|NCT02326272|69394866|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
37787475|NCT02326272|69394867|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
37787476|NCT02326272|69394868|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
37787477|NCT02326272|69394869|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
37787478|NCT02326272|69394870|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
37787479|NCT02326272|69394871|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
37787480|NCT02326272|69394872|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
37787481|NCT02326272|69394873|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
37787482|NCT02326272|69394859|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
37787483|NCT02326272|69394860|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
37787484|NCT02326272|69394861|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
37787485|NCT02326272|69394862|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
37787486|NCT02326272|69394863|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
37787487|NCT02326272|69394864|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
37787488|NCT02326272|69394865|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
37787489|NCT02326272|69394866|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
37787490|NCT02326272|69394867|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
37787491|NCT02326272|69394868|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
37787492|NCT02326272|69394869|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
37787493|NCT02326272|69394870|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
37787494|NCT02326272|69394871|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
37787495|NCT02326272|69394872|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
37787496|NCT02326272|69394873|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
37787497|NCT02326272|69394859|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
37787498|NCT02326272|69394860|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
37787499|NCT02326272|69394861|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
37787500|NCT02326272|69394862|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
37787501|NCT02326272|69394863|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
37787502|NCT02326272|69394864|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
37787503|NCT02326272|69394865|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
37787504|NCT02326272|69394866|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
37787505|NCT02326272|69394867|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
37787506|NCT02326272|69394868|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
37787507|NCT02326272|69394869|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
37787508|NCT02326272|69394870|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
37787509|NCT02326272|69394871|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
37787510|NCT02326272|69394872|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
37787511|NCT02326272|69394873|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
37787512|NCT02326272|69394859|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
37787513|NCT02326272|69394860|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
37787514|NCT02326272|69394861|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
37787515|NCT02326272|69394862|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
37787516|NCT02326272|69394863|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
37787517|NCT02326272|69394864|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
37787518|NCT02326272|69394865|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
37787519|NCT02326272|69394866|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
37787520|NCT02326272|69394867|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
37787521|NCT02326272|69394868|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
37787522|NCT02326272|69394869|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
37787523|NCT02326272|69394870|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
37787524|NCT02326272|69394871|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
37787525|NCT02326272|69394872|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
37975386|NCT00508742|69662612|FG001|Period 2: After Infant Series|Other|1|||
37975387|NCT00508742|69662611|FG000|Period 3: Toddler Dose|Adverse Event|1|||
37787526|NCT02326272|69394873|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
37787527|NCT02326272|69394859|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
37787528|NCT02326272|69394860|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
37787529|NCT02326272|69394861|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
37787530|NCT02326272|69394862|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
37787531|NCT02326272|69394863|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
37787532|NCT02326272|69394864|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
37787533|NCT02326272|69394865|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
37787534|NCT02326272|69394866|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
37787535|NCT02326272|69394867|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
37787536|NCT02326272|69394868|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
37787537|NCT02326272|69394869|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
37787538|NCT02326272|69394870|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
37787539|NCT02326272|69394871|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
37787540|NCT02326272|69394872|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
37787541|NCT02326272|69394873|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
37787542|NCT02326272|69394859|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
37787543|NCT02326272|69394860|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
37787544|NCT02326272|69394861|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
37787545|NCT02326272|69394862|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
37787546|NCT02326272|69394863|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
37787547|NCT02326272|69394864|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
37787548|NCT02326272|69394865|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
37787549|NCT02326272|69394866|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
37787550|NCT02326272|69394867|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
37787551|NCT02326272|69394868|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
37787552|NCT02326272|69394869|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
37787553|NCT02326272|69394870|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
37787554|NCT02326272|69394871|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
37787555|NCT02326272|69394872|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
37787556|NCT02326272|69394873|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
37787557|NCT02326272|69394859|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
37787558|NCT02326272|69394860|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
37787559|NCT02326272|69394861|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
37787560|NCT02326272|69394862|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
37787561|NCT02326272|69394863|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
37787562|NCT02326272|69394864|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
37787563|NCT02326272|69394865|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
37787564|NCT02326272|69394866|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
37787565|NCT02326272|69394867|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
37787566|NCT02326272|69394868|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
37787567|NCT02326272|69394869|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
37787568|NCT02326272|69394870|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
37787569|NCT02326272|69394871|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
37787570|NCT02326272|69394872|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
37787571|NCT02326272|69394873|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
37787572|NCT02326272|69394859|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
37787573|NCT02326272|69394860|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
37787574|NCT02326272|69394861|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
37787575|NCT02326272|69394862|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
37787576|NCT02326272|69394863|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
37787577|NCT02326272|69394864|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
37787578|NCT02326272|69394865|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
37787579|NCT02326272|69394866|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
37787580|NCT02326272|69394867|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
37787581|NCT02326272|69394868|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
37787582|NCT02326272|69394869|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
37787583|NCT02326272|69394870|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
37787584|NCT02326272|69394871|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
37787585|NCT02326272|69394872|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
37787586|NCT02326272|69394873|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
37787587|NCT02326272|69394859|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
37787588|NCT02326272|69394860|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
37787589|NCT02326272|69394861|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
37787590|NCT02326272|69394862|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
37787591|NCT02326272|69394863|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
37787592|NCT02326272|69394864|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
37787593|NCT02326272|69394865|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
37787594|NCT02326272|69394866|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
37787595|NCT02326272|69394867|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
37787596|NCT02326272|69394868|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
37787597|NCT02326272|69394869|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
37787598|NCT02326272|69394870|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
37787599|NCT02326272|69394871|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
37787600|NCT02326272|69394872|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
37787601|NCT02326272|69394873|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
37787602|NCT02326272|69394859|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
37787603|NCT02326272|69394860|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
37787604|NCT02326272|69394861|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
37787605|NCT02326272|69394862|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
37787606|NCT02326272|69394863|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
37787607|NCT02326272|69394864|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
37787608|NCT02326272|69394865|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
37787609|NCT02326272|69394866|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
37787610|NCT02326272|69394867|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
37787611|NCT02326272|69394868|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
37787612|NCT02326272|69394869|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
37787613|NCT02326272|69394870|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
37787614|NCT02326272|69394871|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
37787615|NCT02326272|69394872|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
37787616|NCT02326272|69394873|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
37787617|NCT02326272|69394859|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
37787618|NCT02326272|69394860|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
37787619|NCT02326272|69394861|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
37787620|NCT02326272|69394862|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
37787621|NCT02326272|69394863|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
37787622|NCT02326272|69394864|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
37787623|NCT02326272|69394865|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
37787624|NCT02326272|69394866|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
37787625|NCT02326272|69394867|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
37787626|NCT02326272|69394868|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
37787627|NCT02326272|69394869|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
37787628|NCT02326272|69394870|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
37787629|NCT02326272|69394871|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
37787630|NCT02326272|69394872|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
37787631|NCT02326272|69394873|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
37787632|NCT02326272|69394859|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
37787633|NCT02326272|69394860|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
37787634|NCT02326272|69394861|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
37787635|NCT02326272|69394862|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
37787636|NCT02326272|69394863|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
37787637|NCT02326272|69394864|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
37787638|NCT02326272|69394865|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
37787639|NCT02326272|69394866|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
37787640|NCT02326272|69394867|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
37787641|NCT02326272|69394868|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
37787642|NCT02326272|69394869|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
37787643|NCT02326272|69394870|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
37787644|NCT02326272|69394871|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
37787645|NCT02326272|69394872|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
37787646|NCT02326272|69394873|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
37787647|NCT02326272|69394859|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
37787648|NCT02326272|69394860|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
37787649|NCT02326272|69394861|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
37787650|NCT02326272|69394862|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
37787651|NCT02326272|69394863|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
37787652|NCT02326272|69394864|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
37787653|NCT02326272|69394865|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
37787654|NCT02326272|69394866|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
37787655|NCT02326272|69394867|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
37787656|NCT02326272|69394868|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
37787657|NCT02326272|69394869|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
37787658|NCT02326272|69394870|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
37787659|NCT02326272|69394871|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
37787660|NCT02326272|69394872|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
37787661|NCT02326272|69394873|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
37787662|NCT02326272|69394859|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
37787663|NCT02326272|69394860|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
37787664|NCT02326272|69394861|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
37787665|NCT02326272|69394862|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
37787666|NCT02326272|69394863|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
37787667|NCT02326272|69394864|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
37787668|NCT02326272|69394865|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
37787669|NCT02326272|69394866|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
37787670|NCT02326272|69394867|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
37787671|NCT02326272|69394868|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
37787672|NCT02326272|69394869|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
37787673|NCT02326272|69394870|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
37787674|NCT02326272|69394871|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
37787675|NCT02326272|69394872|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
37787676|NCT02326272|69394873|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
37787677|NCT02326272|69394859|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
37787678|NCT02326272|69394860|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
37787679|NCT02326272|69394861|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
37787680|NCT02326272|69394862|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
37787681|NCT02326272|69394863|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
37787682|NCT02326272|69394864|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
37787683|NCT02326272|69394865|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
37787684|NCT02326272|69394866|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
37787685|NCT02326272|69394867|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
37787686|NCT02326272|69394868|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
37787687|NCT02326272|69394869|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
37787688|NCT02326272|69394870|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
37787689|NCT02326272|69394871|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
37693648|NCT02473289|69169959|FG001|Overall Study|Protocol Violation|1|||
37693649|NCT02473289|69169958|FG000|Overall Study|Withdrawal of consent|6|||
37787690|NCT02326272|69394872|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
37787691|NCT02326272|69394873|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
37787692|NCT02326272|69394859|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
37787693|NCT02326272|69394860|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
37787694|NCT02326272|69394861|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
37787695|NCT02326272|69394862|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
37787696|NCT02326272|69394863|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
37787697|NCT02326272|69394864|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
37787698|NCT02326272|69394865|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
37787699|NCT02326272|69394866|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
37787700|NCT02326272|69394867|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
37787701|NCT02326272|69394868|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
37787702|NCT02326272|69394869|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
37787703|NCT02326272|69394870|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
37787704|NCT02326272|69394871|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
37787705|NCT02326272|69394872|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
37787706|NCT02326272|69394873|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
37787707|NCT02326272|69394859|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
37787708|NCT02326272|69394860|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
37787709|NCT02326272|69394861|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
37787710|NCT02326272|69394862|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
37787711|NCT02326272|69394863|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
37787712|NCT02326272|69394864|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
37787713|NCT02326272|69394865|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
37787714|NCT02326272|69394866|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
37787715|NCT02326272|69394867|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
37787716|NCT02326272|69394868|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
37787717|NCT02326272|69394869|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
37787718|NCT02326272|69394870|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
37787719|NCT02326272|69394871|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
37787720|NCT02326272|69394872|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
37787721|NCT02326272|69394873|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
37787722|NCT02325414|69394910|FG000|Overall Study|Withdrawal by Subject|3|||
37787723|NCT02325414|69394911|FG001|Overall Study|Withdrawal by Subject|1|||
37787724|NCT02325414|69394910|FG000|Overall Study|Lost to Follow-up|5|||
37787725|NCT02325414|69394911|FG001|Overall Study|Lost to Follow-up|5|||
37787726|NCT02349048|69394929|FG000|Overall Study|Withdrawal by Subject|4|||
37787727|NCT02349048|69394930|FG001|Overall Study|Withdrawal by Subject|0|||
37787728|NCT02349048|69394929|FG000|Overall Study|Lost to Follow-up|1|||
37787729|NCT02349048|69394930|FG001|Overall Study|Lost to Follow-up|0|||
37787730|NCT02299206|69394977|FG000|Overall Study|Lost to Follow-up|1|||
37787731|NCT02299206|69394977|FG000|Overall Study|Withdrawal by Subject|1|||
37787732|NCT02298192|69394996|FG000|Overall Study|Unclassified|3|||
37787733|NCT02298192|69394997|FG001|Overall Study|Unclassified|2|||
37787734|NCT02298192|69394996|FG000|Overall Study|Withdrawal criteria|2|||
37787735|NCT02298192|69394997|FG001|Overall Study|Withdrawal criteria|0|||
37787736|NCT02298192|69394996|FG000|Overall Study|Withdrawal by Subject|6|||
37787737|NCT02298192|69394997|FG001|Overall Study|Withdrawal by Subject|1|||
37787738|NCT02298192|69394996|FG000|Overall Study|Lost to Follow-up|2|||
37787739|NCT02298192|69394997|FG001|Overall Study|Lost to Follow-up|1|||
37787740|NCT02298192|69394996|FG000|Overall Study|Adverse Event|6|||
37787741|NCT02298192|69394997|FG001|Overall Study|Adverse Event|2|||
37787742|NCT02280408|69395123|FG000|Overall Study|Lost to Follow-up|0|||
37787743|NCT02280408|69395124|FG001|Overall Study|Lost to Follow-up|2|||
37787744|NCT02280408|69395125|FG002|Overall Study|Lost to Follow-up|0|||
37787745|NCT02280408|69395126|FG003|Overall Study|Lost to Follow-up|0|||
37787746|NCT02296476|69395202|FG000|Overall Study|Disease Progression|6|||
37787747|NCT02296476|69395203|FG001|Overall Study|Disease Progression|4|||
37787748|NCT02296476|69395204|FG002|Overall Study|Disease Progression|2|||
37787749|NCT00552032|69395245|FG000|Overall Study|Withdrawal by Subject|2|||
37787750|NCT00552032|69395246|FG001|Overall Study|Withdrawal by Subject|2|||
37787751|NCT00552032|69395245|FG000|Overall Study|Protocol Violation|7|||
37787752|NCT00552032|69395246|FG001|Overall Study|Protocol Violation|12|||
37787753|NCT00552032|69395245|FG000|Overall Study|Lost to Follow-up|8|||
37787754|NCT00552032|69395246|FG001|Overall Study|Lost to Follow-up|5|||
37787755|NCT03312530|69396040|FG000|Overall Study|Death|5|||
37787756|NCT03312530|69396041|FG001|Overall Study|Death|5|||
37787757|NCT03312530|69396042|FG002|Overall Study|Death|4|||
37787758|NCT03312530|69396043|FG003|Overall Study|Death|10|||
37787759|NCT03312530|69396044|FG004|Overall Study|Death|8|||
37787760|NCT03312530|69396040|FG000|Overall Study|Lost to Follow-up|0|||
37787761|NCT03312530|69396041|FG001|Overall Study|Lost to Follow-up|0|||
37787762|NCT03312530|69396042|FG002|Overall Study|Lost to Follow-up|0|||
37787763|NCT03312530|69396043|FG003|Overall Study|Lost to Follow-up|1|||
37787764|NCT03312530|69396044|FG004|Overall Study|Lost to Follow-up|0|||
37787765|NCT03312530|69396040|FG000|Overall Study|Participant in another sponsor study.|0|||
37787766|NCT03312530|69396041|FG001|Overall Study|Participant in another sponsor study.|0|||
37787767|NCT03312530|69396042|FG002|Overall Study|Participant in another sponsor study.|0|||
37787768|NCT03312530|69396043|FG003|Overall Study|Participant in another sponsor study.|1|||
37787769|NCT03312530|69396044|FG004|Overall Study|Participant in another sponsor study.|0|||
37787770|NCT03312530|69396040|FG000|Overall Study|Study terminated by sponsor|1|||
37787771|NCT03312530|69396041|FG001|Overall Study|Study terminated by sponsor|0|||
37787772|NCT03312530|69396042|FG002|Overall Study|Study terminated by sponsor|2|||
37787773|NCT03312530|69396043|FG003|Overall Study|Study terminated by sponsor|3|||
37787774|NCT03312530|69396044|FG004|Overall Study|Study terminated by sponsor|7|||
37787775|NCT03312530|69396040|FG000|Overall Study|Withdrawal by Subject|0|||
37787776|NCT03312530|69396041|FG001|Overall Study|Withdrawal by Subject|1|||
37787777|NCT03312530|69396042|FG002|Overall Study|Withdrawal by Subject|0|||
37787778|NCT03312530|69396043|FG003|Overall Study|Withdrawal by Subject|0|||
37787779|NCT03312530|69396044|FG004|Overall Study|Withdrawal by Subject|0|||
37787780|NCT03312530|69396040|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
37787781|NCT03312530|69396041|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
37787782|NCT03312530|69396042|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
37787783|NCT03312530|69396043|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
37787784|NCT03312530|69396044|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
37787785|NCT02296320|69396166|FG000|Overall Study|Withdrawal by Subject|4|||
37787786|NCT02296320|69396167|FG001|Overall Study|Withdrawal by Subject|0|||
37787787|NCT02296320|69396168|FG002|Overall Study|Withdrawal by Subject|2|||
37787788|NCT02296320|69396166|FG000|Overall Study|Death|24|||
37787789|NCT02296320|69396167|FG001|Overall Study|Death|3|||
37787790|NCT02296320|69396168|FG002|Overall Study|Death|27|||
37787791|NCT02296320|69396166|FG000|Overall Study|Lost to Follow-up|5|||
37787792|NCT02296320|69396167|FG001|Overall Study|Lost to Follow-up|2|||
37787793|NCT02296320|69396168|FG002|Overall Study|Lost to Follow-up|7|||
37787794|NCT02296320|69396166|FG000|Overall Study|Not treated|2|||
37787795|NCT02296320|69396167|FG001|Overall Study|Not treated|0|||
37787796|NCT02296320|69396168|FG002|Overall Study|Not treated|0|||
37787797|NCT02296320|69396166|FG000|Overall Study|Not - specified|0|||
37787798|NCT02296320|69396167|FG001|Overall Study|Not - specified|0|||
37787799|NCT02296320|69396168|FG002|Overall Study|Not - specified|1|||
37787800|NCT02296242|69396207|FG000|Overall Study|Death|1|||
37787801|NCT02296242|69396208|FG001|Overall Study|Death|1|||
37787802|NCT02296242|69396209|FG002|Overall Study|Death|1|||
37787803|NCT02296242|69396210|FG003|Overall Study|Death|1|||
37787804|NCT02296242|69396211|FG004|Overall Study|Death|1|||
37787805|NCT02296242|69396207|FG000|Overall Study|Withdrawal by Subject|0|||
37787806|NCT02296242|69396208|FG001|Overall Study|Withdrawal by Subject|0|||
37787807|NCT02296242|69396209|FG002|Overall Study|Withdrawal by Subject|1|||
37787808|NCT02296242|69396210|FG003|Overall Study|Withdrawal by Subject|1|||
37787809|NCT02296242|69396211|FG004|Overall Study|Withdrawal by Subject|3|||
37787810|NCT02296242|69396207|FG000|Overall Study|Disease Progression|1|||
37787811|NCT02296242|69396208|FG001|Overall Study|Disease Progression|3|||
37787812|NCT02296242|69396209|FG002|Overall Study|Disease Progression|2|||
37787813|NCT02296242|69396210|FG003|Overall Study|Disease Progression|8|||
37787814|NCT02296242|69396211|FG004|Overall Study|Disease Progression|11|||
37787815|NCT02296242|69396207|FG000|Overall Study|Unacceptable Toxicity|0|||
37787816|NCT02296242|69396208|FG001|Overall Study|Unacceptable Toxicity|0|||
37787817|NCT02296242|69396209|FG002|Overall Study|Unacceptable Toxicity|0|||
37787818|NCT02296242|69396210|FG003|Overall Study|Unacceptable Toxicity|0|||
37787819|NCT02296242|69396211|FG004|Overall Study|Unacceptable Toxicity|1|||
37787820|NCT02296242|69396207|FG000|Overall Study|Patient Condition Changed|0|||
37787821|NCT02296242|69396208|FG001|Overall Study|Patient Condition Changed|0|||
37787822|NCT02296242|69396209|FG002|Overall Study|Patient Condition Changed|2|||
37787823|NCT02296242|69396210|FG003|Overall Study|Patient Condition Changed|0|||
37787824|NCT02296242|69396211|FG004|Overall Study|Patient Condition Changed|1|||
37787825|NCT02296242|69396207|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
37787826|NCT02296242|69396208|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
37787827|NCT02296242|69396209|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
37787828|NCT02296242|69396210|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
37787829|NCT02296242|69396211|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
37787830|NCT02296242|69396207|FG000|Overall Study|Lost to Follow-up|1|||
37787831|NCT02296242|69396208|FG001|Overall Study|Lost to Follow-up|0|||
37787832|NCT02296242|69396209|FG002|Overall Study|Lost to Follow-up|0|||
37787833|NCT02296242|69396210|FG003|Overall Study|Lost to Follow-up|0|||
37787834|NCT02296242|69396211|FG004|Overall Study|Lost to Follow-up|0|||
37787835|NCT02296242|69396207|FG000|Overall Study|Need for Hydroxyurea|2|||
37787836|NCT02296242|69396208|FG001|Overall Study|Need for Hydroxyurea|0|||
37787837|NCT02296242|69396209|FG002|Overall Study|Need for Hydroxyurea|0|||
37787838|NCT02296242|69396210|FG003|Overall Study|Need for Hydroxyurea|0|||
37787839|NCT02296242|69396211|FG004|Overall Study|Need for Hydroxyurea|0|||
37787840|NCT02296242|69396207|FG000|Overall Study|Screened for Other Protocol|0|||
37787841|NCT02296242|69396208|FG001|Overall Study|Screened for Other Protocol|1|||
37787842|NCT02296242|69396209|FG002|Overall Study|Screened for Other Protocol|0|||
37787843|NCT02296242|69396210|FG003|Overall Study|Screened for Other Protocol|0|||
37787844|NCT02296242|69396211|FG004|Overall Study|Screened for Other Protocol|0|||
37787845|NCT02296242|69396207|FG000|Overall Study|Physician Decision|0|||
37787846|NCT02296242|69396208|FG001|Overall Study|Physician Decision|1|||
37787847|NCT02296242|69396209|FG002|Overall Study|Physician Decision|0|||
37787848|NCT02296242|69396210|FG003|Overall Study|Physician Decision|1|||
37787849|NCT02296242|69396211|FG004|Overall Study|Physician Decision|0|||
37787850|NCT02296242|69396207|FG000|Overall Study|Alternative Treatment|0|||
37787851|NCT02296242|69396208|FG001|Overall Study|Alternative Treatment|0|||
37787852|NCT02296242|69396209|FG002|Overall Study|Alternative Treatment|0|||
37787853|NCT02296242|69396210|FG003|Overall Study|Alternative Treatment|1|||
37787854|NCT02296242|69396211|FG004|Overall Study|Alternative Treatment|0|||
37787855|NCT02296242|69396207|FG000|Overall Study|Adverse Event|0|||
37787856|NCT02296242|69396208|FG001|Overall Study|Adverse Event|0|||
37787857|NCT02296242|69396209|FG002|Overall Study|Adverse Event|0|||
37693650|NCT02473289|69169959|FG001|Overall Study|Withdrawal of consent|7|||
37787858|NCT02296242|69396210|FG003|Overall Study|Adverse Event|1|||
37787859|NCT02296242|69396211|FG004|Overall Study|Adverse Event|0|||
37787860|NCT02296242|69396207|FG000|Overall Study|Lack of Efficacy|0|||
37787861|NCT02296242|69396208|FG001|Overall Study|Lack of Efficacy|0|||
37787862|NCT02296242|69396209|FG002|Overall Study|Lack of Efficacy|0|||
37787863|NCT02296242|69396210|FG003|Overall Study|Lack of Efficacy|0|||
37787864|NCT02296242|69396211|FG004|Overall Study|Lack of Efficacy|3|||
37787865|NCT02295774|69396231|FG000|Overall Study|Physician Decision|1|||
37787866|NCT02295774|69396231|FG000|Overall Study|Withdrawal by Subject|2|||
37787867|NCT02294682|69396246|FG000|Overall Study|Could not swallow pills|1|||
37787868|NCT02294682|69396247|FG001|Overall Study|Could not swallow pills|0|||
37787869|NCT02294604|69396256|FG000|Overall Study|Did not provide samples for culture|0|||
37787870|NCT02294604|69396257|FG001|Overall Study|Did not provide samples for culture|1|||
37787871|NCT02294604|69396258|FG002|Overall Study|Did not provide samples for culture|0|||
37787872|NCT02294604|69396256|FG000|Overall Study|Culture contamination|1|||
37787873|NCT02294604|69396257|FG001|Overall Study|Culture contamination|2|||
37787874|NCT02294604|69396258|FG002|Overall Study|Culture contamination|0|||
37787875|NCT01645176|69396277|FG000|Overall Study|Lack of Efficacy|4|||
37787876|NCT01645176|69396277|FG000|Overall Study|did not complete final MRI|1|||
37787877|NCT02322216|69396292|FG000|Overall Study|Adverse Event|1|||
37787878|NCT02322216|69396293|FG001|Overall Study|Adverse Event|0|||
37787879|NCT02322216|69396292|FG000|Overall Study|Withdrawal by Subject|1|||
37787880|NCT02322216|69396293|FG001|Overall Study|Withdrawal by Subject|4|||
37787881|NCT01647516|69396334|FG000|Induction Period (IP)|Physician Decision|2|||
37787882|NCT01647516|69396335|FG001|Induction Period (IP)|Physician Decision|0|||
37787883|NCT01647516|69396336|FG002|Induction Period (IP)|Physician Decision|0|||
37787884|NCT01647516|69396337|FG003|Induction Period (IP)|Physician Decision|0|||
37787885|NCT01647516|69396338|FG004|Induction Period (IP)|Physician Decision|0|||
37787886|NCT01647516|69396339|FG005|Induction Period (IP)|Physician Decision|0|||
37787887|NCT01647516|69396334|FG000|Induction Period (IP)|Adverse Event|1|||
37787888|NCT01647516|69396335|FG001|Induction Period (IP)|Adverse Event|2|||
37787889|NCT01647516|69396336|FG002|Induction Period (IP)|Adverse Event|0|||
37787890|NCT01647516|69396337|FG003|Induction Period (IP)|Adverse Event|0|||
37787891|NCT01647516|69396338|FG004|Induction Period (IP)|Adverse Event|0|||
37787892|NCT01647516|69396339|FG005|Induction Period (IP)|Adverse Event|0|||
37787893|NCT01647516|69396334|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
37787894|NCT01647516|69396335|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
37787895|NCT01647516|69396336|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
37787896|NCT01647516|69396337|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
37787897|NCT01647516|69396338|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
37693651|NCT02473289|69169958|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
37693652|NCT02473289|69169959|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
37693653|NCT02473289|69169958|FG000|Overall Study|Other|2|||
37693654|NCT02473289|69169959|FG001|Overall Study|Other|0|||
37787898|NCT01647516|69396339|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
37787899|NCT01647516|69396334|FG000|Induction Period (IP)|Participant Choice|0|||
37787900|NCT01647516|69396335|FG001|Induction Period (IP)|Participant Choice|0|||
37787901|NCT01647516|69396336|FG002|Induction Period (IP)|Participant Choice|1|||
37787902|NCT01647516|69396337|FG003|Induction Period (IP)|Participant Choice|0|||
37787903|NCT01647516|69396338|FG004|Induction Period (IP)|Participant Choice|0|||
37787904|NCT01647516|69396339|FG005|Induction Period (IP)|Participant Choice|0|||
37787905|NCT01647516|69396334|FG000|Induction Period (IP)|Lack of Efficacy|1|||
37787906|NCT01647516|69396335|FG001|Induction Period (IP)|Lack of Efficacy|0|||
37787907|NCT01647516|69396336|FG002|Induction Period (IP)|Lack of Efficacy|0|||
37787908|NCT01647516|69396337|FG003|Induction Period (IP)|Lack of Efficacy|0|||
37787909|NCT01647516|69396338|FG004|Induction Period (IP)|Lack of Efficacy|0|||
37693655|NCT02354599|69169971|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
37787910|NCT01647516|69396339|FG005|Induction Period (IP)|Lack of Efficacy|0|||
37787911|NCT01647516|69396334|FG000|Induction Period (IP)|No study drug received|1|||
37787912|NCT01647516|69396335|FG001|Induction Period (IP)|No study drug received|1|||
37787913|NCT01647516|69396336|FG002|Induction Period (IP)|No study drug received|0|||
37787914|NCT01647516|69396337|FG003|Induction Period (IP)|No study drug received|0|||
37787915|NCT01647516|69396338|FG004|Induction Period (IP)|No study drug received|0|||
37787916|NCT01647516|69396339|FG005|Induction Period (IP)|No study drug received|0|||
37787917|NCT01647516|69396334|FG000|Maintenance Period (MP)|Adverse Event|2|||
37787918|NCT01647516|69396335|FG001|Maintenance Period (MP)|Adverse Event|1|||
37787919|NCT01647516|69396336|FG002|Maintenance Period (MP)|Adverse Event|0|||
37787920|NCT01647516|69396337|FG003|Maintenance Period (MP)|Adverse Event|0|||
37787921|NCT01647516|69396338|FG004|Maintenance Period (MP)|Adverse Event|0|||
37787922|NCT01647516|69396339|FG005|Maintenance Period (MP)|Adverse Event|0|||
37787923|NCT01647516|69396334|FG000|Maintenance Period (MP)|Non-compliance|1|||
37787924|NCT01647516|69396335|FG001|Maintenance Period (MP)|Non-compliance|0|||
37787925|NCT01647516|69396336|FG002|Maintenance Period (MP)|Non-compliance|0|||
37787926|NCT01647516|69396337|FG003|Maintenance Period (MP)|Non-compliance|0|||
37787927|NCT01647516|69396338|FG004|Maintenance Period (MP)|Non-compliance|0|||
37787928|NCT01647516|69396339|FG005|Maintenance Period (MP)|Non-compliance|0|||
37787929|NCT01647516|69396334|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
37787930|NCT01647516|69396335|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
37787931|NCT01647516|69396336|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
37787932|NCT01647516|69396337|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
37787933|NCT01647516|69396338|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
37787934|NCT01647516|69396339|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
37787935|NCT01647516|69396334|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
37787936|NCT01647516|69396335|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
37787937|NCT01647516|69396336|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
37787938|NCT01647516|69396337|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
37787939|NCT01647516|69396338|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
37787940|NCT01647516|69396339|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
37787941|NCT01647516|69396334|FG000|Open-Label Period|Adverse Event|0|||
37787942|NCT01647516|69396335|FG001|Open-Label Period|Adverse Event|0|||
37787943|NCT01647516|69396336|FG002|Open-Label Period|Adverse Event|0|||
37787944|NCT01647516|69396337|FG003|Open-Label Period|Adverse Event|5|||
37787945|NCT01647516|69396338|FG004|Open-Label Period|Adverse Event|6|||
37787946|NCT01647516|69396339|FG005|Open-Label Period|Adverse Event|3|||
37787947|NCT01647516|69396334|FG000|Open-Label Period|Pregnancy|0|||
37787948|NCT01647516|69396335|FG001|Open-Label Period|Pregnancy|0|||
37787949|NCT01647516|69396336|FG002|Open-Label Period|Pregnancy|0|||
37787950|NCT01647516|69396337|FG003|Open-Label Period|Pregnancy|0|||
37787951|NCT01647516|69396338|FG004|Open-Label Period|Pregnancy|0|||
37787952|NCT01647516|69396339|FG005|Open-Label Period|Pregnancy|1|||
37787953|NCT01647516|69396334|FG000|Open-Label Period|Non-compliance|0|||
37787954|NCT01647516|69396335|FG001|Open-Label Period|Non-compliance|0|||
37787955|NCT01647516|69396336|FG002|Open-Label Period|Non-compliance|0|||
37787956|NCT01647516|69396337|FG003|Open-Label Period|Non-compliance|1|||
37787957|NCT01647516|69396338|FG004|Open-Label Period|Non-compliance|0|||
37787958|NCT01647516|69396339|FG005|Open-Label Period|Non-compliance|1|||
37787959|NCT01647516|69396334|FG000|Open-Label Period|Physician Decision|0|||
37787960|NCT01647516|69396335|FG001|Open-Label Period|Physician Decision|0|||
37787961|NCT01647516|69396336|FG002|Open-Label Period|Physician Decision|0|||
37787962|NCT01647516|69396337|FG003|Open-Label Period|Physician Decision|1|||
37787963|NCT01647516|69396338|FG004|Open-Label Period|Physician Decision|1|||
37787964|NCT01647516|69396339|FG005|Open-Label Period|Physician Decision|0|||
37787965|NCT01647516|69396334|FG000|Open-Label Period|Withdrawal by Subject|0|||
37787966|NCT01647516|69396335|FG001|Open-Label Period|Withdrawal by Subject|0|||
37787967|NCT01647516|69396336|FG002|Open-Label Period|Withdrawal by Subject|0|||
37787968|NCT01647516|69396337|FG003|Open-Label Period|Withdrawal by Subject|9|||
37787969|NCT01647516|69396338|FG004|Open-Label Period|Withdrawal by Subject|11|||
37787970|NCT01647516|69396339|FG005|Open-Label Period|Withdrawal by Subject|6|||
37787971|NCT01647516|69396334|FG000|Open-Label Period|Lost to Follow-up|0|||
37787972|NCT01647516|69396335|FG001|Open-Label Period|Lost to Follow-up|0|||
37787973|NCT01647516|69396336|FG002|Open-Label Period|Lost to Follow-up|0|||
37787974|NCT01647516|69396337|FG003|Open-Label Period|Lost to Follow-up|1|||
37787975|NCT01647516|69396338|FG004|Open-Label Period|Lost to Follow-up|0|||
37787976|NCT01647516|69396339|FG005|Open-Label Period|Lost to Follow-up|1|||
37787977|NCT01647516|69396334|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
37787978|NCT01647516|69396335|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
37787979|NCT01647516|69396336|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
37787980|NCT01647516|69396337|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
37787981|NCT01647516|69396338|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
37787982|NCT01647516|69396339|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
37787983|NCT01647516|69396334|FG000|Open-Label Period|Lack of Efficacy|0|||
37787984|NCT01647516|69396335|FG001|Open-Label Period|Lack of Efficacy|0|||
37787985|NCT01647516|69396336|FG002|Open-Label Period|Lack of Efficacy|0|||
37787986|NCT01647516|69396337|FG003|Open-Label Period|Lack of Efficacy|7|||
37787987|NCT01647516|69396338|FG004|Open-Label Period|Lack of Efficacy|9|||
37787988|NCT01647516|69396339|FG005|Open-Label Period|Lack of Efficacy|10|||
37787989|NCT01647516|69396334|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
37787990|NCT01647516|69396335|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
37787991|NCT01647516|69396336|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
37787992|NCT01647516|69396337|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
37787993|NCT01647516|69396338|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
37787994|NCT01647516|69396339|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
37787995|NCT01647516|69396334|FG000|Open-Label Period|No completion / discontinuation visit|0|||
37787996|NCT01647516|69396335|FG001|Open-Label Period|No completion / discontinuation visit|0|||
37787997|NCT01647516|69396336|FG002|Open-Label Period|No completion / discontinuation visit|0|||
37787998|NCT01647516|69396337|FG003|Open-Label Period|No completion / discontinuation visit|0|||
37787999|NCT01647516|69396338|FG004|Open-Label Period|No completion / discontinuation visit|2|||
37788000|NCT01647516|69396339|FG005|Open-Label Period|No completion / discontinuation visit|1|||
37788001|NCT01647282|69396356|FG000|Overall Study|Physician Decision|7|||
37788002|NCT01647282|69396357|FG001|Overall Study|Physician Decision|5|||
37788003|NCT02321436|69396365|FG000|Overall Study|Withdrawal by Subject|1|||
37788004|NCT02321436|69396366|FG001|Overall Study|Withdrawal by Subject|0|||
37788005|NCT02321436|69396365|FG000|Overall Study|Lost to Follow-up|0|||
37788006|NCT02321436|69396366|FG001|Overall Study|Lost to Follow-up|1|||
37788007|NCT02319642|69396375|FG000|Overall Study|Adverse Event|2|||
37788008|NCT02319642|69396376|FG001|Overall Study|Adverse Event|4|||
37788009|NCT02319642|69396375|FG000|Overall Study|Lack of Efficacy|1|||
37788010|NCT02319642|69396376|FG001|Overall Study|Lack of Efficacy|1|||
37788011|NCT02319642|69396375|FG000|Overall Study|Withdrawal by Subject|1|||
37788012|NCT02319642|69396376|FG001|Overall Study|Withdrawal by Subject|1|||
37788013|NCT02280096|69396386|FG000|Overall Study|Pregnancy|1|||
37788014|NCT02280096|69396387|FG001|Overall Study|Pregnancy|0|||
37788015|NCT02280096|69396386|FG000|Overall Study|Functional neurological disorder|1|||
37788016|NCT02280096|69396387|FG001|Overall Study|Functional neurological disorder|0|||
37788017|NCT02280096|69396386|FG000|Overall Study|Lack of attachment|0|||
37788018|NCT02280096|69396387|FG001|Overall Study|Lack of attachment|1|||
37788019|NCT02279862|69396404|FG000|Overall Study|Study drug toxicity|3|||
37788020|NCT02279862|69396405|FG001|Overall Study|Study drug toxicity|6|||
37788021|NCT02279862|69396404|FG000|Overall Study|No longer meets criteria|0|||
37788022|NCT02279862|69396405|FG001|Overall Study|No longer meets criteria|1|||
37788023|NCT02279862|69396404|FG000|Overall Study|Administrative reason by sponsor|0|||
37788024|NCT02279862|69396405|FG001|Overall Study|Administrative reason by sponsor|1|||
37788025|NCT02279862|69396404|FG000|Overall Study|Disease progression|5|||
37788026|NCT02279862|69396405|FG001|Overall Study|Disease progression|2|||
37788027|NCT02279862|69396404|FG000|Overall Study|Study closed by sponsor|16|||
37788028|NCT02279862|69396405|FG001|Overall Study|Study closed by sponsor|13|||
37788029|NCT02279862|69396404|FG000|Overall Study|Other|1|||
37788030|NCT02279862|69396405|FG001|Overall Study|Other|2|||
37788031|NCT02279862|69396404|FG000|Overall Study|Withdrawal by Subject|1|||
37788032|NCT02279862|69396405|FG001|Overall Study|Withdrawal by Subject|0|||
37788033|NCT02318940|69396413|FG000|Overall Study|lost the record|1|||
37788034|NCT02318940|69396414|FG001|Overall Study|lost the record|0|||
37788035|NCT02294058|69396423|FG000|Overall Study|Adverse Event|16|||
37788036|NCT02294058|69396424|FG001|Overall Study|Adverse Event|7|||
37788037|NCT02294058|69396425|FG002|Overall Study|Adverse Event|13|||
37788038|NCT02294058|69396423|FG000|Overall Study|Lack of Efficacy|3|||
37788039|NCT02294058|69396424|FG001|Overall Study|Lack of Efficacy|3|||
37788040|NCT02294058|69396425|FG002|Overall Study|Lack of Efficacy|0|||
37788041|NCT02294058|69396423|FG000|Overall Study|Lost to Follow-up|1|||
37788042|NCT02294058|69396424|FG001|Overall Study|Lost to Follow-up|0|||
37788043|NCT02294058|69396425|FG002|Overall Study|Lost to Follow-up|2|||
37788044|NCT02294058|69396423|FG000|Overall Study|Withdrawal by Subject|10|||
37788045|NCT02294058|69396424|FG001|Overall Study|Withdrawal by Subject|14|||
37788046|NCT02294058|69396425|FG002|Overall Study|Withdrawal by Subject|13|||
37788047|NCT02294058|69396423|FG000|Overall Study|Physician Decision|2|||
37788048|NCT02294058|69396424|FG001|Overall Study|Physician Decision|1|||
37788049|NCT02294058|69396425|FG002|Overall Study|Physician Decision|0|||
37788050|NCT02294058|69396423|FG000|Overall Study|Miscellaneous|4|||
37788051|NCT02294058|69396424|FG001|Overall Study|Miscellaneous|1|||
37788052|NCT02294058|69396425|FG002|Overall Study|Miscellaneous|1|||
37788053|NCT02293902|69396437|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
37788054|NCT02293902|69396438|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
37788055|NCT02293902|69396439|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
37788056|NCT02293902|69396440|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
37788057|NCT02293902|69396441|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
37788058|NCT02293902|69396437|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
37788059|NCT02293902|69396438|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
37788060|NCT02293902|69396439|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
37788061|NCT02293902|69396440|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
37788062|NCT02293902|69396441|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
37788063|NCT02293902|69396437|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
37788064|NCT02293902|69396438|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
37788065|NCT02293902|69396439|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
37788066|NCT02293902|69396440|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
37788067|NCT02293902|69396441|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
37788068|NCT02293902|69396437|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
37788069|NCT02293902|69396438|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
37788070|NCT02293902|69396439|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
37788071|NCT02293902|69396440|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
37788072|NCT02293902|69396441|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
37788073|NCT02293902|69396437|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
37788074|NCT02293902|69396438|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
37788075|NCT02293902|69396439|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
37788076|NCT02293902|69396440|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
37788077|NCT02293902|69396441|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
37788078|NCT02278614|69396461|FG000|Overall Study|Withdrawal by Subject|3|||
37788079|NCT02278614|69396462|FG001|Overall Study|Withdrawal by Subject|5|||
37788080|NCT02278614|69396461|FG000|Overall Study|Adverse Event|1|||
37788081|NCT02278614|69396462|FG001|Overall Study|Adverse Event|0|||
37788082|NCT02278614|69396461|FG000|Overall Study|left eye was not eligible|1|||
37788083|NCT02278614|69396462|FG001|Overall Study|left eye was not eligible|0|||
37788084|NCT02318706|69396472|FG000|Double-blind Phase|Adverse Event|7|||
37788085|NCT02318706|69396473|FG001|Double-blind Phase|Adverse Event|4|||
37788086|NCT02318706|69396474|FG002|Double-blind Phase|Adverse Event|3|||
37788087|NCT02318706|69396475|FG003|Double-blind Phase|Adverse Event|10|||
37788088|NCT02318706|69396476|FG004|Double-blind Phase|Adverse Event|0|||
37788089|NCT02318706|69396472|FG000|Double-blind Phase|Lost to Follow-up|1|||
37788090|NCT02318706|69396473|FG001|Double-blind Phase|Lost to Follow-up|0|||
37788091|NCT02318706|69396474|FG002|Double-blind Phase|Lost to Follow-up|0|||
37788092|NCT02318706|69396475|FG003|Double-blind Phase|Lost to Follow-up|0|||
37788093|NCT02318706|69396476|FG004|Double-blind Phase|Lost to Follow-up|0|||
37788094|NCT02318706|69396472|FG000|Double-blind Phase|Protocol Violation|4|||
37788095|NCT02318706|69396473|FG001|Double-blind Phase|Protocol Violation|2|||
37788096|NCT02318706|69396474|FG002|Double-blind Phase|Protocol Violation|4|||
37788097|NCT02318706|69396475|FG003|Double-blind Phase|Protocol Violation|3|||
37788098|NCT02318706|69396476|FG004|Double-blind Phase|Protocol Violation|0|||
37788099|NCT02318706|69396472|FG000|Double-blind Phase|Withdrawal by Subject|9|||
37788100|NCT02318706|69396473|FG001|Double-blind Phase|Withdrawal by Subject|5|||
37788101|NCT02318706|69396474|FG002|Double-blind Phase|Withdrawal by Subject|7|||
37788102|NCT02318706|69396475|FG003|Double-blind Phase|Withdrawal by Subject|10|||
37788103|NCT02318706|69396476|FG004|Double-blind Phase|Withdrawal by Subject|0|||
37788104|NCT02318706|69396472|FG000|Double-blind Phase|Other|4|||
37788105|NCT02318706|69396473|FG001|Double-blind Phase|Other|1|||
37788106|NCT02318706|69396474|FG002|Double-blind Phase|Other|2|||
37788107|NCT02318706|69396475|FG003|Double-blind Phase|Other|1|||
37788108|NCT02318706|69396476|FG004|Double-blind Phase|Other|0|||
37788109|NCT02318706|69396472|FG000|Double-blind Phase|Death|0|||
37788110|NCT02318706|69396473|FG001|Double-blind Phase|Death|0|||
37788111|NCT02318706|69396474|FG002|Double-blind Phase|Death|2|||
37788112|NCT02318706|69396475|FG003|Double-blind Phase|Death|0|||
37788113|NCT02318706|69396476|FG004|Double-blind Phase|Death|0|||
37788114|NCT02318706|69396472|FG000|Open-label Extension Phase|Adverse Event|0|||
37975388|NCT00508742|69662612|FG001|Period 3: Toddler Dose|Adverse Event|0|||
37975389|NCT00508742|69662611|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
37975390|NCT00508742|69662612|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
37788115|NCT02318706|69396473|FG001|Open-label Extension Phase|Adverse Event|0|||
37788116|NCT02318706|69396474|FG002|Open-label Extension Phase|Adverse Event|0|||
37788117|NCT02318706|69396475|FG003|Open-label Extension Phase|Adverse Event|0|||
37788118|NCT02318706|69396476|FG004|Open-label Extension Phase|Adverse Event|21|||
37788119|NCT02318706|69396472|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
37788120|NCT02318706|69396473|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
37788121|NCT02318706|69396474|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
37788122|NCT02318706|69396475|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
37788123|NCT02318706|69396476|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
37788124|NCT02318706|69396472|FG000|Open-label Extension Phase|Death|0|||
37788125|NCT02318706|69396473|FG001|Open-label Extension Phase|Death|0|||
37788126|NCT02318706|69396474|FG002|Open-label Extension Phase|Death|0|||
37788127|NCT02318706|69396475|FG003|Open-label Extension Phase|Death|0|||
37788128|NCT02318706|69396476|FG004|Open-label Extension Phase|Death|1|||
37788129|NCT02318706|69396472|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
37788130|NCT02318706|69396473|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
37788131|NCT02318706|69396474|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
37788132|NCT02318706|69396475|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
37788133|NCT02318706|69396476|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
37788134|NCT04583280|69396527|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
37788135|NCT04583280|69396528|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
37788136|NCT04489940|69396547|FG000|Overall Study|Other|2|||
37788137|NCT04489940|69396547|FG000|Overall Study|Withdrawal by Subject|2|||
37788138|NCT04489940|69396547|FG000|Overall Study|Death|5|||
37788139|NCT04489940|69396547|FG000|Overall Study|Lost to Follow-up|1|||
37788140|NCT04365257|69396553|FG000|Overall Study|Physician Decision|1|||
37788141|NCT04365257|69396554|FG001|Overall Study|Physician Decision|0|||
37788142|NCT04365257|69396553|FG000|Overall Study|Patient Noncompliance|1|||
37788143|NCT04365257|69396554|FG001|Overall Study|Patient Noncompliance|0|||
37788144|NCT04365257|69396553|FG000|Overall Study|Withdrawal by Subject|0|||
37788145|NCT04365257|69396554|FG001|Overall Study|Withdrawal by Subject|1|||
37788146|NCT03395223|69396586|FG000|Overall Study|Lost to Follow-up|3|||
37788147|NCT03395223|69396586|FG000|Overall Study|Other|1|||
37788148|NCT02864940|69396616|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
37788149|NCT02864940|69396617|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
37788150|NCT02756611|69396636|FG000|Overall Study|Death|70|||
37788151|NCT02756611|69396636|FG000|Overall Study|Withdrawal by Subject|2|||
37788152|NCT02756611|69396636|FG000|Overall Study|Lost to Follow-up|3|||
37788153|NCT02756611|69396636|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
37788154|NCT02756611|69396636|FG000|Overall Study|Other|10|||
37788155|NCT02624518|69396640|FG000|Overall Study|Physician Decision|1|||
37788156|NCT02287623|69396646|FG000|Overall Study|Protocol Violation|0|||
37788157|NCT02287623|69396647|FG001|Overall Study|Protocol Violation|1|||
37788158|NCT01794520|69396669|FG000|Overall Study|Adverse events- related to progression|0|||
37788159|NCT01794520|69396670|FG001|Overall Study|Adverse events- related to progression|0|||
37788160|NCT01794520|69396671|FG002|Overall Study|Adverse events- related to progression|1|||
37788161|NCT01794520|69396672|FG003|Overall Study|Adverse events- related to progression|2|||
37788162|NCT01794520|69396673|FG004|Overall Study|Adverse events- related to progression|0|||
37864084|NCT01117857|69547754|FG000|Overall Study|Withdrawal by Subject|4|||
37864085|NCT01117857|69547754|FG000|Overall Study|Physician Decision|1|||
37864086|NCT01251887|69547761|FG000|Overall Study|Scheduling conflict|1|||
37864087|NCT01251887|69547762|FG001|Overall Study|Scheduling conflict|2|||
37864088|NCT01251887|69547763|FG002|Overall Study|Scheduling conflict|2|||
37864089|NCT01251887|69547761|FG000|Overall Study|Physician Decision|0|||
37864090|NCT01251887|69547762|FG001|Overall Study|Physician Decision|1|||
37975391|NCT00508742|69662611|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
37788163|NCT01794520|69396674|FG005|Overall Study|Adverse events- related to progression|1|||
37788164|NCT01794520|69396675|FG006|Overall Study|Adverse events- related to progression|0|||
37788165|NCT01794520|69396669|FG000|Overall Study|Adverse event- not related to progression|1|||
37788166|NCT01794520|69396670|FG001|Overall Study|Adverse event- not related to progression|1|||
37788167|NCT01794520|69396671|FG002|Overall Study|Adverse event- not related to progression|0|||
37788168|NCT01794520|69396672|FG003|Overall Study|Adverse event- not related to progression|0|||
37788169|NCT01794520|69396673|FG004|Overall Study|Adverse event- not related to progression|2|||
37788170|NCT01794520|69396674|FG005|Overall Study|Adverse event- not related to progression|0|||
37788171|NCT01794520|69396675|FG006|Overall Study|Adverse event- not related to progression|0|||
37788172|NCT01794520|69396669|FG000|Overall Study|Progressive disease|5|||
37788173|NCT01794520|69396670|FG001|Overall Study|Progressive disease|6|||
37788174|NCT01794520|69396671|FG002|Overall Study|Progressive disease|2|||
37788175|NCT01794520|69396672|FG003|Overall Study|Progressive disease|5|||
37788176|NCT01794520|69396673|FG004|Overall Study|Progressive disease|27|||
37788177|NCT01794520|69396674|FG005|Overall Study|Progressive disease|18|||
37788178|NCT01794520|69396675|FG006|Overall Study|Progressive disease|0|||
37788179|NCT01794520|69396669|FG000|Overall Study|Withdrew consent|0|||
37788180|NCT01794520|69396670|FG001|Overall Study|Withdrew consent|0|||
37788181|NCT01794520|69396671|FG002|Overall Study|Withdrew consent|1|||
37788182|NCT01794520|69396672|FG003|Overall Study|Withdrew consent|1|||
37788183|NCT01794520|69396673|FG004|Overall Study|Withdrew consent|0|||
37788184|NCT01794520|69396674|FG005|Overall Study|Withdrew consent|0|||
37788185|NCT01794520|69396675|FG006|Overall Study|Withdrew consent|0|||
37788186|NCT01794520|69396669|FG000|Overall Study|Lost to Follow-up|0|||
37788187|NCT01794520|69396670|FG001|Overall Study|Lost to Follow-up|0|||
37788188|NCT01794520|69396671|FG002|Overall Study|Lost to Follow-up|0|||
37788189|NCT01794520|69396672|FG003|Overall Study|Lost to Follow-up|0|||
37788190|NCT01794520|69396673|FG004|Overall Study|Lost to Follow-up|1|||
37788191|NCT01794520|69396674|FG005|Overall Study|Lost to Follow-up|0|||
37788192|NCT01794520|69396675|FG006|Overall Study|Lost to Follow-up|0|||
37788193|NCT01794520|69396669|FG000|Overall Study|Toxicity|0|||
37788194|NCT01794520|69396670|FG001|Overall Study|Toxicity|2|||
37788195|NCT01794520|69396671|FG002|Overall Study|Toxicity|0|||
37788196|NCT01794520|69396672|FG003|Overall Study|Toxicity|0|||
37788197|NCT01794520|69396673|FG004|Overall Study|Toxicity|0|||
37788198|NCT01794520|69396674|FG005|Overall Study|Toxicity|0|||
37788199|NCT01794520|69396675|FG006|Overall Study|Toxicity|0|||
37788200|NCT01794520|69396669|FG000|Overall Study|Study terminated by sponsor|0|||
37788201|NCT01794520|69396670|FG001|Overall Study|Study terminated by sponsor|0|||
37788202|NCT01794520|69396671|FG002|Overall Study|Study terminated by sponsor|1|||
37788203|NCT01794520|69396672|FG003|Overall Study|Study terminated by sponsor|0|||
37788204|NCT01794520|69396673|FG004|Overall Study|Study terminated by sponsor|1|||
37788205|NCT01794520|69396674|FG005|Overall Study|Study terminated by sponsor|0|||
37788206|NCT01794520|69396675|FG006|Overall Study|Study terminated by sponsor|7|||
37788207|NCT01794520|69396669|FG000|Overall Study|Death|0|||
37788208|NCT01794520|69396670|FG001|Overall Study|Death|0|||
37788209|NCT01794520|69396671|FG002|Overall Study|Death|0|||
37788210|NCT01794520|69396672|FG003|Overall Study|Death|0|||
37788211|NCT01794520|69396673|FG004|Overall Study|Death|1|||
37788212|NCT01794520|69396674|FG005|Overall Study|Death|0|||
37788213|NCT01794520|69396675|FG006|Overall Study|Death|22|||
37788214|NCT01794520|69396669|FG000|Overall Study|Other, not specified|0|||
37788215|NCT01794520|69396670|FG001|Overall Study|Other, not specified|0|||
37788216|NCT01794520|69396671|FG002|Overall Study|Other, not specified|1|||
37788217|NCT01794520|69396672|FG003|Overall Study|Other, not specified|1|||
37788218|NCT01794520|69396673|FG004|Overall Study|Other, not specified|4|||
37788219|NCT01794520|69396674|FG005|Overall Study|Other, not specified|1|||
37788220|NCT01794520|69396675|FG006|Overall Study|Other, not specified|2|||
37788221|NCT01774019|69396698|FG000|Overall Study|No longer meets protocol criteria|2|||
37788222|NCT01774019|69396699|FG001|Overall Study|No longer meets protocol criteria|0|||
37788223|NCT01774019|69396698|FG000|Overall Study|Withdrawal by Subject|1|||
37788224|NCT01774019|69396699|FG001|Overall Study|Withdrawal by Subject|0|||
37788225|NCT01774019|69396698|FG000|Overall Study|Surgery delayed > 120 days|1|||
37788226|NCT01774019|69396699|FG001|Overall Study|Surgery delayed > 120 days|0|||
37788227|NCT01774019|69396698|FG000|Overall Study|Patient refused surgery|1|||
37788228|NCT01774019|69396699|FG001|Overall Study|Patient refused surgery|1|||
37788229|NCT01774019|69396698|FG000|Overall Study|Unable to implant study device|1|||
37788230|NCT01774019|69396699|FG001|Overall Study|Unable to implant study device|0|||
37788231|NCT01774019|69396698|FG000|Overall Study|Lost to Follow-up|0|||
37788232|NCT01774019|69396699|FG001|Overall Study|Lost to Follow-up|3|||
37788233|NCT03251924|69397052|FG000|Overall Study|Disease Progression|6|||
37788234|NCT03251924|69397053|FG001|Overall Study|Disease Progression|6|||
37788235|NCT03251924|69397054|FG002|Overall Study|Disease Progression|7|||
37788236|NCT03251924|69397055|FG003|Overall Study|Disease Progression|8|||
37788237|NCT03251924|69397056|FG004|Overall Study|Disease Progression|8|||
37788238|NCT03251924|69397057|FG005|Overall Study|Disease Progression|7|||
37788239|NCT03251924|69397058|FG006|Overall Study|Disease Progression|6|||
37788240|NCT03251924|69397059|FG007|Overall Study|Disease Progression|10|||
37788241|NCT03251924|69397060|FG008|Overall Study|Disease Progression|6|||
37788242|NCT03251924|69397052|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
37788243|NCT03251924|69397053|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
37788244|NCT03251924|69397054|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
37788245|NCT03251924|69397055|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
37788246|NCT03251924|69397056|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
37788247|NCT03251924|69397057|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
37788248|NCT03251924|69397058|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
37788249|NCT03251924|69397059|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
37788250|NCT03251924|69397060|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
37788251|NCT03251924|69397052|FG000|Overall Study|Death|0|||
37788252|NCT03251924|69397053|FG001|Overall Study|Death|1|||
37788253|NCT03251924|69397054|FG002|Overall Study|Death|0|||
37788254|NCT03251924|69397055|FG003|Overall Study|Death|1|||
37788255|NCT03251924|69397056|FG004|Overall Study|Death|1|||
37788256|NCT03251924|69397057|FG005|Overall Study|Death|1|||
37788257|NCT03251924|69397058|FG006|Overall Study|Death|0|||
37788258|NCT03251924|69397059|FG007|Overall Study|Death|0|||
37788259|NCT03251924|69397060|FG008|Overall Study|Death|0|||
37788260|NCT03251924|69397052|FG000|Overall Study|Study Drug Toxicity|0|||
37788261|NCT03251924|69397053|FG001|Overall Study|Study Drug Toxicity|0|||
37788262|NCT03251924|69397054|FG002|Overall Study|Study Drug Toxicity|0|||
37788263|NCT03251924|69397055|FG003|Overall Study|Study Drug Toxicity|1|||
37788264|NCT03251924|69397056|FG004|Overall Study|Study Drug Toxicity|0|||
37788265|NCT03251924|69397057|FG005|Overall Study|Study Drug Toxicity|0|||
37788266|NCT03251924|69397058|FG006|Overall Study|Study Drug Toxicity|0|||
37788267|NCT03251924|69397059|FG007|Overall Study|Study Drug Toxicity|0|||
37788268|NCT03251924|69397060|FG008|Overall Study|Study Drug Toxicity|1|||
37788269|NCT03251924|69397052|FG000|Overall Study|Other Reasons|0|||
37788270|NCT03251924|69397053|FG001|Overall Study|Other Reasons|0|||
37788271|NCT03251924|69397054|FG002|Overall Study|Other Reasons|0|||
37788272|NCT03251924|69397055|FG003|Overall Study|Other Reasons|0|||
37788273|NCT03251924|69397056|FG004|Overall Study|Other Reasons|0|||
37788274|NCT03251924|69397057|FG005|Overall Study|Other Reasons|0|||
37788275|NCT03251924|69397058|FG006|Overall Study|Other Reasons|0|||
37788276|NCT03251924|69397059|FG007|Overall Study|Other Reasons|0|||
37788277|NCT03251924|69397060|FG008|Overall Study|Other Reasons|1|||
37788278|NCT03251924|69397052|FG000|Overall Study|Participant request to discontinue study treatment|0|||
37788279|NCT03251924|69397053|FG001|Overall Study|Participant request to discontinue study treatment|0|||
37788280|NCT03251924|69397054|FG002|Overall Study|Participant request to discontinue study treatment|0|||
37788281|NCT03251924|69397055|FG003|Overall Study|Participant request to discontinue study treatment|0|||
37788282|NCT03251924|69397056|FG004|Overall Study|Participant request to discontinue study treatment|0|||
37788283|NCT03251924|69397057|FG005|Overall Study|Participant request to discontinue study treatment|0|||
37788284|NCT03251924|69397058|FG006|Overall Study|Participant request to discontinue study treatment|0|||
37788285|NCT03251924|69397059|FG007|Overall Study|Participant request to discontinue study treatment|1|||
37788286|NCT03251924|69397060|FG008|Overall Study|Participant request to discontinue study treatment|0|||
37788287|NCT03723707|69397154|FG000|Overall Study|Death|32|||
37788288|NCT03723707|69397155|FG001|Overall Study|Death|32|||
37788289|NCT03723707|69397154|FG000|Overall Study|Admitted to long term care|12|||
37788290|NCT03723707|69397155|FG001|Overall Study|Admitted to long term care|12|||
37788291|NCT03723707|69397154|FG000|Overall Study|No longer receiving care at NYU Langone Health|15|||
37788292|NCT03723707|69397155|FG001|Overall Study|No longer receiving care at NYU Langone Health|8|||
37788293|NCT03723707|69397154|FG000|Overall Study|Lost to Follow-up|40|||
37788294|NCT03723707|69397155|FG001|Overall Study|Lost to Follow-up|22|||
37788295|NCT03723707|69397154|FG000|Overall Study|Discontinued after study closure|24|||
37788296|NCT03723707|69397155|FG001|Overall Study|Discontinued after study closure|12|||
37788297|NCT01350141|69397265|FG000|Overall Study|Lost to Follow-up|1|||
37788298|NCT01350141|69397266|FG001|Overall Study|Lost to Follow-up|0|||
37788299|NCT01350141|69397267|FG002|Overall Study|Lost to Follow-up|1|||
37788300|NCT01350141|69397265|FG000|Overall Study|Withdrawal by Subject|1|||
37788301|NCT01350141|69397266|FG001|Overall Study|Withdrawal by Subject|0|||
37788302|NCT01350141|69397267|FG002|Overall Study|Withdrawal by Subject|0|||
37788303|NCT01350141|69397265|FG000|Overall Study|Randomized but not treated|1|||
37788304|NCT01350141|69397266|FG001|Overall Study|Randomized but not treated|0|||
37788305|NCT01350141|69397267|FG002|Overall Study|Randomized but not treated|0|||
37788306|NCT05045625|69397806|FG000|Overall Study|Lost to Follow-up|3|||
37788307|NCT04830969|69398188|FG000|Overall Study|Withdrawal by Subject|6|||
37788308|NCT04830969|69398189|FG001|Overall Study|Withdrawal by Subject|2|||
37788309|NCT04830969|69398188|FG000|Overall Study|Protocol Violation|3|||
37788310|NCT04830969|69398189|FG001|Overall Study|Protocol Violation|9|||
37788311|NCT04830969|69398188|FG000|Overall Study|Lost to Follow-up|4|||
37788312|NCT04830969|69398189|FG001|Overall Study|Lost to Follow-up|4|||
37788313|NCT02384993|69398500|FG000|Overall Study|Adverse Event|0|||
37788314|NCT02384993|69398501|FG001|Overall Study|Adverse Event|1|||
37788315|NCT01352117|69398545|FG000|Overall Study|Death|15|||
37788316|NCT01352117|69398546|FG001|Overall Study|Death|16|||
37788317|NCT01352117|69398545|FG000|Overall Study|Withdrawal by Subject|1|||
37788318|NCT01352117|69398546|FG001|Overall Study|Withdrawal by Subject|0|||
37788319|NCT01352117|69398545|FG000|Overall Study|Lost to Follow-up|2|||
37788320|NCT01352117|69398546|FG001|Overall Study|Lost to Follow-up|7|||
37788321|NCT01352117|69398545|FG000|Overall Study|Non-adherent to study requirements|1|||
37788322|NCT01352117|69398546|FG001|Overall Study|Non-adherent to study requirements|1|||
37788323|NCT01352117|69398545|FG000|Overall Study|Did not initiate study treatment|1|||
37788324|NCT01352117|69398546|FG001|Overall Study|Did not initiate study treatment|0|||
37788325|NCT01352117|69398545|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
37788326|NCT01352117|69398546|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
37788327|NCT03578237|69398617|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
37788328|NCT03578237|69398618|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
37788329|NCT04173507|69398697|FG000|Overall Study|On Treatment|3|||
37788330|NCT04173507|69398697|FG000|Overall Study|Adverse Event|3|||
37788331|NCT04173507|69398697|FG000|Overall Study|Progression/Relapse|34|||
37788332|NCT04173507|69398697|FG000|Overall Study|Death|2|||
37788333|NCT02220725|69398705|FG000|Overall Study|Lost to Follow-up|0|||
37788334|NCT02220725|69398706|FG001|Overall Study|Lost to Follow-up|0|||
37788335|NCT02220725|69398707|FG002|Overall Study|Lost to Follow-up|0|||
37788336|NCT02220725|69398708|FG003|Overall Study|Lost to Follow-up|1|||
37788337|NCT02220725|69398705|FG000|Overall Study|Withdrawal by Subject|0|||
37788338|NCT02220725|69398706|FG001|Overall Study|Withdrawal by Subject|0|||
37788339|NCT02220725|69398707|FG002|Overall Study|Withdrawal by Subject|0|||
37788340|NCT02220725|69398708|FG003|Overall Study|Withdrawal by Subject|1|||
37788341|NCT02259517|69398750|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
37788342|NCT02259517|69398751|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
37788343|NCT02259517|69398752|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
37788344|NCT02259517|69398750|FG000|Overall Study|Withdrawal by Subject|0|||
37788345|NCT02259517|69398751|FG001|Overall Study|Withdrawal by Subject|0|||
37788346|NCT02259517|69398752|FG002|Overall Study|Withdrawal by Subject|3|||
37788347|NCT02277990|69398795|FG000|Overall Study|Death|170|||
37788348|NCT02277990|69398796|FG001|Overall Study|Death|188|||
37788349|NCT02277990|69398795|FG000|Overall Study|Withdrawal by Subject|64|||
37788350|NCT02277990|69398796|FG001|Overall Study|Withdrawal by Subject|53|||
37788351|NCT02277990|69398795|FG000|Overall Study|Physician Decision|40|||
37788352|NCT02277990|69398796|FG001|Overall Study|Physician Decision|34|||
37788353|NCT02277990|69398795|FG000|Overall Study|Lost to Follow-up|66|||
37788354|NCT02277990|69398796|FG001|Overall Study|Lost to Follow-up|69|||
37788355|NCT02277990|69398795|FG000|Overall Study|Had other reason|26|||
37788356|NCT02277990|69398796|FG001|Overall Study|Had other reason|32|||
37788357|NCT02317614|69398818|FG000|Overall Study|Lost to Follow-up|1|||
37788358|NCT02317614|69398819|FG001|Overall Study|Lost to Follow-up|1|||
37788359|NCT02317614|69398818|FG000|Overall Study|Withdrawal by Subject|1|||
37788360|NCT02317614|69398819|FG001|Overall Study|Withdrawal by Subject|0|||
37788361|NCT02317614|69398818|FG000|Overall Study|Death|1|||
37788362|NCT02317614|69398819|FG001|Overall Study|Death|1|||
37788363|NCT02276040|69398832|FG000|Overall Study|Physician Decision|15|||
37788364|NCT02315664|69398838|FG000|Overall Study|Lost to Follow-up|1|||
37788365|NCT02315664|69398839|FG001|Overall Study|Lost to Follow-up|1|||
37788366|NCT02315664|69398838|FG000|Overall Study|Withdrawal by Subject|0|||
37788367|NCT02315664|69398839|FG001|Overall Study|Withdrawal by Subject|3|||
37788368|NCT02314728|69398867|FG000|Overall Study|Protocol Violation|1|||
37788369|NCT02314728|69398868|FG001|Overall Study|Protocol Violation|0|||
37788370|NCT02314728|69398867|FG000|Overall Study|Lost to Follow-up|0|||
37788371|NCT02314728|69398868|FG001|Overall Study|Lost to Follow-up|1|||
37788372|NCT02275338|69398887|FG000|Overall Study|Adverse Event|15|||
37788373|NCT02275338|69398887|FG000|Overall Study|Lack of Efficacy|3|||
37788374|NCT02275338|69398887|FG000|Overall Study|Withdrawal by Subject|4|||
37788375|NCT02275338|69398887|FG000|Overall Study|Disease progression (death)|1|||
37788376|NCT02275338|69398887|FG000|Overall Study|Ineligible to start Phase 2|4|||
37788377|NCT02275338|69398887|FG000|Overall Study|Reason not specified|5|||
37788378|NCT02275338|69398887|FG000|Overall Study|Does not meet entry criteria|1|||
37788379|NCT02313558|69398894|FG000|Overall Study|Withdrawal by Subject|2|||
37788380|NCT02313558|69398895|FG001|Overall Study|Withdrawal by Subject|0|||
37788381|NCT02313558|69398894|FG000|Overall Study|Lost to Follow-up|4|||
37788382|NCT02313558|69398895|FG001|Overall Study|Lost to Follow-up|4|||
37788383|NCT01646268|69398923|FG000|Overall Study|Adverse Event|6|||
37788384|NCT01646268|69398924|FG001|Overall Study|Adverse Event|7|||
37788385|NCT01646268|69398923|FG000|Overall Study|Lack of Efficacy|1|||
37788386|NCT01646268|69398924|FG001|Overall Study|Lack of Efficacy|3|||
37788387|NCT01646268|69398923|FG000|Overall Study|Protocol Violation|0|||
37788388|NCT01646268|69398924|FG001|Overall Study|Protocol Violation|1|||
37788389|NCT01646268|69398923|FG000|Overall Study|Withdrawal by Subject|2|||
37788390|NCT01646268|69398924|FG001|Overall Study|Withdrawal by Subject|5|||
37788391|NCT01646268|69398923|FG000|Overall Study|Other|2|||
37788392|NCT01646268|69398924|FG001|Overall Study|Other|0|||
37788393|NCT02275026|69398930|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
37788394|NCT02275026|69398930|FG000|Overall Study|Withdrawal by Subject|4|||
37788395|NCT02275026|69398930|FG000|Overall Study|Ineligible due to medical history|13|||
37788396|NCT02275026|69398930|FG000|Overall Study|MRI malfunction precluded testing|1|||
37788397|NCT02275026|69398930|FG000|Overall Study|Ineligible after MRI findings|1|||
37788398|NCT02275026|69398930|FG000|Overall Study|Lost to Follow-up|2|||
37788399|NCT02275026|69398930|FG000|Overall Study|Scanner failure|1|||
37788400|NCT04579250|69399033|FG000|Overall Study|Withdrawal by Subject|1|||
37788401|NCT04579250|69399034|FG001|Overall Study|Withdrawal by Subject|1|||
37788402|NCT04579250|69399035|FG002|Overall Study|Withdrawal by Subject|0|||
37788403|NCT04579250|69399033|FG000|Overall Study|Lost to Follow-up|1|||
37788404|NCT04579250|69399034|FG001|Overall Study|Lost to Follow-up|1|||
37788405|NCT04579250|69399035|FG002|Overall Study|Lost to Follow-up|0|||
37788406|NCT04579250|69399033|FG000|Overall Study|Moved from area|0|||
37788407|NCT04579250|69399034|FG001|Overall Study|Moved from area|1|||
37788408|NCT04579250|69399035|FG002|Overall Study|Moved from area|2|||
37788409|NCT03175367|69399062|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
37788410|NCT03175367|69399063|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
37788411|NCT03175367|69399064|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
37788412|NCT03175367|69399065|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
37788413|NCT03175367|69399066|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
37788414|NCT03175367|69399067|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
37788415|NCT03175367|69399068|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
37788416|NCT03175367|69399062|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
37788417|NCT03175367|69399063|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
37788418|NCT03175367|69399064|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
37788419|NCT03175367|69399065|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
37788420|NCT03175367|69399066|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
37788421|NCT03175367|69399067|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
37788422|NCT03175367|69399068|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
37788423|NCT03175367|69399062|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
37788424|NCT03175367|69399063|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
37788425|NCT03175367|69399064|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
37788426|NCT03175367|69399065|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
37788427|NCT03175367|69399066|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
37788428|NCT03175367|69399067|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
37788429|NCT03175367|69399068|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
37788430|NCT03175367|69399062|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
37788431|NCT03175367|69399063|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
37788432|NCT03175367|69399064|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
37788433|NCT03175367|69399065|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
37788434|NCT03175367|69399066|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
37788435|NCT03175367|69399067|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
37788436|NCT03175367|69399068|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
37788437|NCT03175367|69399062|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
37788438|NCT03175367|69399063|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
37788439|NCT03175367|69399064|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
37788440|NCT03175367|69399065|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
37788441|NCT03175367|69399066|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
37788442|NCT03175367|69399067|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
37788443|NCT03175367|69399068|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
37788444|NCT03175367|69399062|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
37788445|NCT03175367|69399063|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
37788446|NCT03175367|69399064|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
37788447|NCT03175367|69399065|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
37788448|NCT03175367|69399066|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
37788449|NCT03175367|69399067|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
37788450|NCT03175367|69399068|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
37788451|NCT03175367|69399062|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
37788452|NCT03175367|69399063|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
37788453|NCT03175367|69399064|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
37788454|NCT03175367|69399065|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
37788455|NCT03175367|69399066|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
37788456|NCT03175367|69399067|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
37788457|NCT03175367|69399068|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
37788458|NCT03174275|69399125|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
37788459|NCT03174275|69399125|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
37788460|NCT03174275|69399125|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
37788461|NCT03174275|69399125|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
37788462|NCT03174275|69399125|FG000|Adjuvant Chemotherapy|Progression|1|||
37788463|NCT03174275|69399125|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
37788464|NCT03174275|69399125|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
37788465|NCT03174275|69399125|FG000|Adjuvant Durvalumab|Progression|1|||
37788466|NCT03174275|69399125|FG000|Adjuvant Durvalumab|Adverse Event|3|||
37788467|NCT03174275|69399125|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
37788468|NCT03174275|69399125|FG000|Adjuvant Radiotherapy|Progression|1|||
37693656|NCT02354599|69169972|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
37693657|NCT02354599|69169973|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
37693658|NCT02354599|69169974|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
37788469|NCT03174275|69399125|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
37788470|NCT03990363|69399217|FG000|Overall Study|Withdrawal by Subject|10|||
37788471|NCT03990363|69399218|FG001|Overall Study|Withdrawal by Subject|9|||
37788472|NCT03990363|69399219|FG002|Overall Study|Withdrawal by Subject|18|||
37788473|NCT03990363|69399220|FG003|Overall Study|Withdrawal by Subject|11|||
37788474|NCT03990363|69399221|FG004|Overall Study|Withdrawal by Subject|9|||
37788475|NCT03990363|69399217|FG000|Overall Study|Physician Decision|1|||
37788476|NCT03990363|69399218|FG001|Overall Study|Physician Decision|0|||
37788477|NCT03990363|69399219|FG002|Overall Study|Physician Decision|0|||
37788478|NCT03990363|69399220|FG003|Overall Study|Physician Decision|0|||
37788479|NCT03990363|69399221|FG004|Overall Study|Physician Decision|0|||
37788480|NCT03990363|69399217|FG000|Overall Study|Adverse Event|1|||
37788481|NCT03990363|69399218|FG001|Overall Study|Adverse Event|3|||
37788482|NCT03990363|69399219|FG002|Overall Study|Adverse Event|2|||
37788483|NCT03990363|69399220|FG003|Overall Study|Adverse Event|2|||
37788484|NCT03990363|69399221|FG004|Overall Study|Adverse Event|0|||
37788485|NCT03990363|69399217|FG000|Overall Study|Death|14|||
37788486|NCT03990363|69399218|FG001|Overall Study|Death|8|||
37788487|NCT03990363|69399219|FG002|Overall Study|Death|14|||
37788488|NCT03990363|69399220|FG003|Overall Study|Death|10|||
37788489|NCT03990363|69399221|FG004|Overall Study|Death|11|||
37788490|NCT03990363|69399217|FG000|Overall Study|Failure to meet randomization criteria|0|||
37788491|NCT03990363|69399218|FG001|Overall Study|Failure to meet randomization criteria|1|||
37788492|NCT03990363|69399219|FG002|Overall Study|Failure to meet randomization criteria|1|||
37788493|NCT03990363|69399220|FG003|Overall Study|Failure to meet randomization criteria|0|||
37788494|NCT03990363|69399221|FG004|Overall Study|Failure to meet randomization criteria|0|||
37788495|NCT03990363|69399217|FG000|Overall Study|Lost to Follow-up|0|||
37788496|NCT03990363|69399218|FG001|Overall Study|Lost to Follow-up|0|||
37788497|NCT03990363|69399219|FG002|Overall Study|Lost to Follow-up|0|||
37788498|NCT03990363|69399220|FG003|Overall Study|Lost to Follow-up|1|||
37788499|NCT03990363|69399221|FG004|Overall Study|Lost to Follow-up|2|||
37788500|NCT03990363|69399217|FG000|Overall Study|Non-compliance with study drug|2|||
37788501|NCT03990363|69399218|FG001|Overall Study|Non-compliance with study drug|1|||
37788502|NCT03990363|69399219|FG002|Overall Study|Non-compliance with study drug|2|||
37788503|NCT03990363|69399220|FG003|Overall Study|Non-compliance with study drug|0|||
37788504|NCT03990363|69399221|FG004|Overall Study|Non-compliance with study drug|0|||
37788505|NCT03990363|69399217|FG000|Overall Study|Study terminated by sponsor|0|||
37788506|NCT03990363|69399218|FG001|Overall Study|Study terminated by sponsor|1|||
37788507|NCT03990363|69399219|FG002|Overall Study|Study terminated by sponsor|0|||
37788508|NCT03990363|69399220|FG003|Overall Study|Study terminated by sponsor|0|||
37788509|NCT03990363|69399221|FG004|Overall Study|Study terminated by sponsor|0|||
37788510|NCT03990363|69399217|FG000|Overall Study|Site terminated by sponsor|2|||
37788511|NCT03990363|69399218|FG001|Overall Study|Site terminated by sponsor|1|||
37788512|NCT03990363|69399219|FG002|Overall Study|Site terminated by sponsor|2|||
37788513|NCT03990363|69399220|FG003|Overall Study|Site terminated by sponsor|0|||
37788514|NCT03990363|69399221|FG004|Overall Study|Site terminated by sponsor|2|||
37788515|NCT03990363|69399217|FG000|Overall Study|Not categorized|5|||
37788516|NCT03990363|69399218|FG001|Overall Study|Not categorized|5|||
37788517|NCT03990363|69399219|FG002|Overall Study|Not categorized|3|||
37788518|NCT03990363|69399220|FG003|Overall Study|Not categorized|2|||
37788519|NCT03990363|69399221|FG004|Overall Study|Not categorized|2|||
37788520|NCT04661839|69399291|FG000|Overall Study|Not Treated|0|||
37788521|NCT04661839|69399292|FG001|Overall Study|Not Treated|0|||
37788522|NCT04661839|69399293|FG002|Overall Study|Not Treated|1|||
37788523|NCT04661839|69399294|FG003|Overall Study|Not Treated|0|||
37788524|NCT04661839|69399291|FG000|Overall Study|Lost to Follow-up|1|||
37788525|NCT04661839|69399292|FG001|Overall Study|Lost to Follow-up|0|||
37788526|NCT04661839|69399293|FG002|Overall Study|Lost to Follow-up|0|||
37788527|NCT04661839|69399294|FG003|Overall Study|Lost to Follow-up|1|||
37788528|NCT02240485|69399395|FG000|3 Months Post-admission|Lost to Follow-up|1|||
37788529|NCT02240485|69399396|FG001|3 Months Post-admission|Lost to Follow-up|5|||
37788530|NCT02240485|69399395|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
37788531|NCT02240485|69399396|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
37788532|NCT02240485|69399395|FG000|9 Months Post-admission|Lost to Follow-up|3|||
37788533|NCT02240485|69399396|FG001|9 Months Post-admission|Lost to Follow-up|1|||
37788534|NCT02240485|69399395|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
37788535|NCT02240485|69399396|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
37788536|NCT02240485|69399395|FG000|18 Months Post-admission|Lost to Follow-up|1|||
37788537|NCT02240485|69399396|FG001|18 Months Post-admission|Lost to Follow-up|1|||
37788538|NCT02240485|69399395|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
37788539|NCT02240485|69399396|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
37788540|NCT04149535|69399419|FG000|Overall Study|Death|11|||
37788541|NCT04149535|69399420|FG001|Overall Study|Death|7|||
37788542|NCT04149535|69399419|FG000|Overall Study|Physician Decision|10|||
37788543|NCT04149535|69399420|FG001|Overall Study|Physician Decision|4|||
37788544|NCT04149535|69399419|FG000|Overall Study|Withdrawal by Subject|6|||
37788545|NCT04149535|69399420|FG001|Overall Study|Withdrawal by Subject|7|||
37788546|NCT04149535|69399419|FG000|Overall Study|Not described|2|||
37788547|NCT04149535|69399420|FG001|Overall Study|Not described|0|||
37788548|NCT02210559|69399438|FG000|Overall Study|Progressive Disease|3|||
37788549|NCT02210559|69399439|FG001|Overall Study|Progressive Disease|2|||
37788550|NCT02210559|69399438|FG000|Overall Study|Adverse Event|2|||
37788551|NCT02210559|69399439|FG001|Overall Study|Adverse Event|2|||
37788552|NCT02210559|69399438|FG000|Overall Study|Physician Decision|1|||
37788553|NCT02210559|69399439|FG001|Overall Study|Physician Decision|0|||
37788554|NCT02210559|69399438|FG000|Overall Study|Withdrawal by Subject|0|||
37788555|NCT02210559|69399439|FG001|Overall Study|Withdrawal by Subject|1|||
37788556|NCT02210559|69399438|FG000|Overall Study|Other than specified|0|||
37788557|NCT02210559|69399439|FG001|Overall Study|Other than specified|1|||
37788558|NCT02073279|69399596|FG000|Double-blind Period|Adverse Event|1|||
37788559|NCT02073279|69399597|FG001|Double-blind Period|Adverse Event|1|||
37788560|NCT02073279|69399596|FG000|Double-blind Period|Switched to another treatment|1|||
37788561|NCT02073279|69399597|FG001|Double-blind Period|Switched to another treatment|2|||
37788562|NCT02073279|69399596|FG000|Double-blind Period|Protocol Violation|0|||
37788563|NCT02073279|69399597|FG001|Double-blind Period|Protocol Violation|1|||
37788564|NCT02073279|69399596|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
37788565|NCT02073279|69399597|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
37788566|NCT02073279|69399596|FG000|Double-blind Period|Withdrawal by Subject|2|||
37788567|NCT02073279|69399597|FG001|Double-blind Period|Withdrawal by Subject|2|||
37788568|NCT02073279|69399596|FG000|Open-label Extension Period|Adverse Event|1|||
37864091|NCT01251887|69547763|FG002|Overall Study|Physician Decision|0|||
37788569|NCT02073279|69399597|FG001|Open-label Extension Period|Adverse Event|0|||
37788570|NCT02073279|69399596|FG000|Open-label Extension Period|Lack of Efficacy|1|||
37788571|NCT02073279|69399597|FG001|Open-label Extension Period|Lack of Efficacy|0|||
37788572|NCT02073279|69399596|FG000|Open-label Extension Period|Lost to Follow-up|0|||
37788573|NCT02073279|69399597|FG001|Open-label Extension Period|Lost to Follow-up|4|||
37788574|NCT02073279|69399596|FG000|Open-label Extension Period|Switched to another treatment|1|||
37788575|NCT02073279|69399597|FG001|Open-label Extension Period|Switched to another treatment|4|||
37788576|NCT02073279|69399596|FG000|Open-label Extension Period|Protocol Violation|0|||
37788577|NCT02073279|69399597|FG001|Open-label Extension Period|Protocol Violation|1|||
37788578|NCT02073279|69399596|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
37788579|NCT02073279|69399597|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
37788580|NCT02073279|69399596|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
37788581|NCT02073279|69399597|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
37788582|NCT01673867|69399853|FG000|Randomization|Adverse event unrelated to study drug|1|||
37788583|NCT01673867|69399854|FG001|Randomization|Adverse event unrelated to study drug|0|||
37788584|NCT01673867|69399853|FG000|Randomization|Participant request to discontinue study treatment|0|||
37788585|NCT01673867|69399854|FG001|Randomization|Participant request to discontinue study treatment|4|||
37788586|NCT01673867|69399853|FG000|Randomization|Withdrawal by participant|0|||
37788587|NCT01673867|69399854|FG001|Randomization|Withdrawal by participant|12|||
37788588|NCT01673867|69399853|FG000|Randomization|Lost to Follow-up|0|||
37788589|NCT01673867|69399854|FG001|Randomization|Lost to Follow-up|1|||
37788590|NCT01673867|69399853|FG000|Randomization|Participant no longer meets study criteria|4|||
37788591|NCT01673867|69399854|FG001|Randomization|Participant no longer meets study criteria|5|||
37788592|NCT01673867|69399853|FG000|Treatment|Disease Progression|208|||
37788593|NCT01673867|69399854|FG001|Treatment|Disease Progression|178|||
37788594|NCT01673867|69399853|FG000|Treatment|Study Drug Toxicity|23|||
37788595|NCT01673867|69399854|FG001|Treatment|Study Drug Toxicity|43|||
37788596|NCT01673867|69399853|FG000|Treatment|Death|2|||
37788597|NCT01673867|69399854|FG001|Treatment|Death|3|||
37788598|NCT01673867|69399853|FG000|Treatment|Adverse event unrelated to study drug|23|||
37788599|NCT01673867|69399854|FG001|Treatment|Adverse event unrelated to study drug|10|||
37788600|NCT01673867|69399853|FG000|Treatment|Participant request to discontinue study treatment|7|||
37788601|NCT01673867|69399854|FG001|Treatment|Participant request to discontinue study treatment|17|||
37788602|NCT01673867|69399853|FG000|Treatment|Withdrawal by participant|5|||
37788603|NCT01673867|69399854|FG001|Treatment|Withdrawal by participant|5|||
37788604|NCT01673867|69399853|FG000|Treatment|Maximum clinical benefit|1|||
37788605|NCT01673867|69399854|FG001|Treatment|Maximum clinical benefit|10|||
37788606|NCT01673867|69399853|FG000|Treatment|Participant no longer meets study criteria|2|||
37788607|NCT01673867|69399854|FG001|Treatment|Participant no longer meets study criteria|0|||
37788608|NCT01673867|69399853|FG000|Treatment|Administrative reason by sponsor|3|||
37788609|NCT01673867|69399854|FG001|Treatment|Administrative reason by sponsor|0|||
37788610|NCT01673867|69399853|FG000|Treatment|Other reason|11|||
37788611|NCT01673867|69399854|FG001|Treatment|Other reason|2|||
37788612|NCT02041533|69399950|FG000|Pre-Treatment Period|Disease Progression|1|||
37788613|NCT02041533|69399951|FG001|Pre-Treatment Period|Disease Progression|1|||
37788614|NCT02041533|69399950|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
37788615|NCT02041533|69399951|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
37788616|NCT02041533|69399950|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
37788617|NCT02041533|69399951|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
37788618|NCT02041533|69399950|FG000|Treatment Period|Disease progression|189|||
37788619|NCT02041533|69399951|FG001|Treatment Period|Disease progression|146|||
37788620|NCT02041533|69399950|FG000|Treatment Period|Study drug toxicity|30|||
37788621|NCT02041533|69399951|FG001|Treatment Period|Study drug toxicity|34|||
37788622|NCT02041533|69399950|FG000|Treatment Period|Death|1|||
37788623|NCT02041533|69399951|FG001|Treatment Period|Death|0|||
37788624|NCT02041533|69399950|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
37788625|NCT02041533|69399951|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
37864092|NCT00991276|69547777|FG000|First Intervention Period|Adverse Event|0|||
37864093|NCT00991276|69547778|FG001|First Intervention Period|Adverse Event|1|||
37693659|NCT02354599|69169975|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
37693660|NCT02354599|69169976|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
37693661|NCT02354599|69169971|FG000|Overall Study|Withdrawal by Subject|1|||
37693662|NCT02354599|69169972|FG001|Overall Study|Withdrawal by Subject|1|||
37693663|NCT02354599|69169973|FG002|Overall Study|Withdrawal by Subject|0|||
37693664|NCT02354599|69169974|FG003|Overall Study|Withdrawal by Subject|0|||
37693665|NCT02354599|69169975|FG004|Overall Study|Withdrawal by Subject|0|||
37693666|NCT02354599|69169976|FG005|Overall Study|Withdrawal by Subject|0|||
37693667|NCT02316223|69169999|FG000|Overall Study|Lack of Efficacy|0|||
37693668|NCT02316223|69170000|FG001|Overall Study|Lack of Efficacy|1|||
37693669|NCT02316223|69170001|FG002|Overall Study|Lack of Efficacy|1|||
37693670|NCT02316223|69169999|FG000|Overall Study|Lost to Follow-up|27|||
37693671|NCT02316223|69170000|FG001|Overall Study|Lost to Follow-up|34|||
37788626|NCT02041533|69399950|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
37788627|NCT02041533|69399951|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
37788628|NCT02041533|69399950|FG000|Treatment Period|Participant withdrew consent|2|||
37788629|NCT02041533|69399951|FG001|Treatment Period|Participant withdrew consent|2|||
37788630|NCT02041533|69399950|FG000|Treatment Period|Maximum clinical benefit|0|||
37788631|NCT02041533|69399951|FG001|Treatment Period|Maximum clinical benefit|18|||
37788632|NCT02041533|69399950|FG000|Treatment Period|Poor/Non-compliance|1|||
37788633|NCT02041533|69399951|FG001|Treatment Period|Poor/Non-compliance|0|||
37788634|NCT02041533|69399950|FG000|Treatment Period|Administrative reason by sponsor|1|||
37788635|NCT02041533|69399951|FG001|Treatment Period|Administrative reason by sponsor|0|||
37788636|NCT02041533|69399950|FG000|Treatment Period|Other reasons|9|||
37788637|NCT02041533|69399951|FG001|Treatment Period|Other reasons|2|||
37788638|NCT02041533|69399950|FG000|Treatment Period|Not Reported|0|||
37788639|NCT02041533|69399951|FG001|Treatment Period|Not Reported|1|||
37788640|NCT02907203|69399958|FG000|Overall Study|Death|1|||
37788641|NCT02907203|69399958|FG000|Overall Study|Lost to Follow-up|3|||
37788642|NCT02907203|69399958|FG000|Overall Study|Withdrawal by Subject|3|||
37788643|NCT02907203|69399958|FG000|Overall Study|Surgical bypass|1|||
37788644|NCT00559585|69401071|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
37788645|NCT00559585|69401072|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
37788646|NCT00559585|69401071|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
37788647|NCT00559585|69401072|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
37788648|NCT00559585|69401071|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
37788649|NCT00559585|69401072|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
37788650|NCT00559585|69401071|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
37788651|NCT00559585|69401072|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
37788652|NCT00559585|69401071|FG000|Double Blind ST Period Main Study|Death|1|||
37788653|NCT00559585|69401072|FG001|Double Blind ST Period Main Study|Death|1|||
37788654|NCT00559585|69401071|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
37788655|NCT00559585|69401072|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
37788656|NCT00559585|69401071|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
37788657|NCT00559585|69401072|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
37788658|NCT00559585|69401071|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
37788659|NCT00559585|69401072|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
37788660|NCT00559585|69401071|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
37788661|NCT00559585|69401072|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
37864094|NCT00991276|69547779|FG002|First Intervention Period|Adverse Event|0|||
37693672|NCT02316223|69170001|FG002|Overall Study|Lost to Follow-up|36|||
37693673|NCT02316223|69169999|FG000|Overall Study|COPD Diagnosis|3|||
37693674|NCT02316223|69170000|FG001|Overall Study|COPD Diagnosis|2|||
37693675|NCT02316223|69170001|FG002|Overall Study|COPD Diagnosis|3|||
37693676|NCT02316223|69169999|FG000|Overall Study|Reside outside study area|1|||
37693677|NCT02316223|69170000|FG001|Overall Study|Reside outside study area|1|||
37693678|NCT02316223|69170001|FG002|Overall Study|Reside outside study area|1|||
37693679|NCT02316223|69169999|FG000|Overall Study|No asthma|2|||
37693680|NCT02316223|69170000|FG001|Overall Study|No asthma|0|||
37693681|NCT02316223|69170001|FG002|Overall Study|No asthma|0|||
37693682|NCT02316223|69169999|FG000|Overall Study|Discontinued by PI|11|||
37693683|NCT02316223|69170000|FG001|Overall Study|Discontinued by PI|19|||
37693684|NCT02316223|69170001|FG002|Overall Study|Discontinued by PI|3|||
37693685|NCT02286895|69170011|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
37693686|NCT02286895|69170012|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
37788662|NCT00559585|69401071|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
37788663|NCT00559585|69401072|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
37788664|NCT00559585|69401071|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
37788665|NCT00559585|69401072|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
37788666|NCT00559585|69401071|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
37788667|NCT00559585|69401072|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
37788668|NCT00559585|69401071|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
37788669|NCT00559585|69401072|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
37788670|NCT00559585|69401071|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
37788671|NCT00559585|69401072|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
37788672|NCT00559585|69401071|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
37788673|NCT00559585|69401072|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
37788674|NCT00559585|69401071|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
37788675|NCT00559585|69401072|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
37788676|NCT00559585|69401071|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
37788677|NCT00559585|69401072|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
37788678|NCT00559585|69401071|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
37788679|NCT00559585|69401072|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
37788680|NCT00559585|69401071|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
37788681|NCT00559585|69401072|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
37788682|NCT00559585|69401071|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
37788683|NCT00559585|69401072|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
37788684|NCT00559585|69401071|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
37788685|NCT00559585|69401072|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
37788686|NCT00559585|69401071|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
37788687|NCT00559585|69401072|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
37788688|NCT00559585|69401071|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
37788689|NCT00559585|69401072|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
37788690|NCT00559585|69401071|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
37788691|NCT00559585|69401072|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
37788692|NCT00559585|69401071|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
37788693|NCT00559585|69401072|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
37788694|NCT00559585|69401071|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
37788695|NCT00559585|69401072|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
37788696|NCT00559585|69401071|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
37788697|NCT00559585|69401072|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
37788698|NCT00559585|69401071|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
37788699|NCT00559585|69401072|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
37788700|NCT00559507|69401112|FG000|Overall Study|Not treated, patient ineligible|3|||
37788701|NCT00559273|69401368|FG000|Correction Period (20 Weeks)|Death|3|||
37788702|NCT00559273|69401369|FG001|Correction Period (20 Weeks)|Death|4|||
37788703|NCT00559273|69401368|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
37788704|NCT00559273|69401369|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
37788705|NCT00559273|69401368|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
37788706|NCT00559273|69401369|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
37788707|NCT00559273|69401368|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
37788708|NCT00559273|69401369|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
37788709|NCT00559273|69401368|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
37788710|NCT00559273|69401369|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
37788711|NCT00559273|69401368|FG000|Evaluation Period (8 Weeks)|Death|1|||
37788712|NCT00559273|69401369|FG001|Evaluation Period (8 Weeks)|Death|3|||
37788713|NCT00559273|69401368|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
37788714|NCT00559273|69401369|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
37788715|NCT00559273|69401368|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
37788716|NCT00559273|69401369|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
37788717|NCT00559273|69401368|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
37788718|NCT00559273|69401369|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
37788719|NCT00558259|69401424|FG000|Overall Study|Adverse Event|50|||
37788720|NCT00558259|69401425|FG001|Overall Study|Adverse Event|81|||
37788721|NCT00558259|69401424|FG000|Overall Study|Protocol Violation|9|||
37788722|NCT00558259|69401425|FG001|Overall Study|Protocol Violation|5|||
37975392|NCT00508742|69662612|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
37788723|NCT00558259|69401424|FG000|Overall Study|Withdrawal by Subject|12|||
37788724|NCT00558259|69401425|FG001|Overall Study|Withdrawal by Subject|13|||
37788725|NCT00558103|69401572|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
37693687|NCT02286895|69170011|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
37693688|NCT02286895|69170012|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
37693689|NCT02286895|69170011|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
37693690|NCT02286895|69170012|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
37788726|NCT00558103|69401573|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
37788727|NCT00558103|69401574|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
37788728|NCT00558103|69401575|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
37788729|NCT00558103|69401576|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
37788730|NCT00558103|69401577|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
37788731|NCT00558103|69401572|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
37788732|NCT00558103|69401573|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
37693691|NCT02472977|69170021|FG000|Overall Study|Disease progression|4|||
37693692|NCT02472977|69170022|FG001|Overall Study|Disease progression|25|||
37693693|NCT02472977|69170023|FG002|Overall Study|Disease progression|6|||
37693694|NCT02472977|69170021|FG000|Overall Study|Withdrawal by Subject|0|||
37693695|NCT02472977|69170022|FG001|Overall Study|Withdrawal by Subject|1|||
37693696|NCT02472977|69170023|FG002|Overall Study|Withdrawal by Subject|0|||
37693697|NCT02472977|69170021|FG000|Overall Study|Study drug toxicity|2|||
37693698|NCT02472977|69170022|FG001|Overall Study|Study drug toxicity|0|||
37693699|NCT02472977|69170023|FG002|Overall Study|Study drug toxicity|2|||
37693700|NCT02472977|69170021|FG000|Overall Study|Subject request to discontinue treatment|0|||
37693701|NCT02472977|69170022|FG001|Overall Study|Subject request to discontinue treatment|1|||
37788733|NCT00558103|69401574|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
37788734|NCT00558103|69401575|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
37788735|NCT00558103|69401576|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
37788736|NCT00558103|69401577|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
37788737|NCT00558103|69401572|FG000|Randomized Treatment Phase|Disease Progression|1|||
37788738|NCT00558103|69401573|FG001|Randomized Treatment Phase|Disease Progression|0|||
37788739|NCT00558103|69401574|FG002|Randomized Treatment Phase|Disease Progression|1|||
37788740|NCT00558103|69401575|FG003|Randomized Treatment Phase|Disease Progression|0|||
37788741|NCT00558103|69401576|FG004|Randomized Treatment Phase|Disease Progression|0|||
37788742|NCT00558103|69401577|FG005|Randomized Treatment Phase|Disease Progression|0|||
37788743|NCT00558103|69401572|FG000|Randomized Treatment Phase|Adverse Event|0|||
37788744|NCT00558103|69401573|FG001|Randomized Treatment Phase|Adverse Event|0|||
37788745|NCT00558103|69401574|FG002|Randomized Treatment Phase|Adverse Event|0|||
37788746|NCT00558103|69401575|FG003|Randomized Treatment Phase|Adverse Event|1|||
37788747|NCT00558103|69401576|FG004|Randomized Treatment Phase|Adverse Event|1|||
37693702|NCT02472977|69170023|FG002|Overall Study|Subject request to discontinue treatment|0|||
37693703|NCT02060487|69170034|FG000|Overall Study|Other|1|||
37788748|NCT00558103|69401577|FG005|Randomized Treatment Phase|Adverse Event|0|||
37788749|NCT00558103|69401572|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
37788750|NCT00558103|69401573|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
37788751|NCT00558103|69401574|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
37788752|NCT00558103|69401575|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
37788753|NCT00558103|69401576|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
37788754|NCT00558103|69401577|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
37788755|NCT00558103|69401572|FG000|Monotherapy Extension Phase|Disease Progression|0|||
37788756|NCT00558103|69401573|FG001|Monotherapy Extension Phase|Disease Progression|0|||
37788757|NCT00558103|69401574|FG002|Monotherapy Extension Phase|Disease Progression|0|||
37788758|NCT00558103|69401575|FG003|Monotherapy Extension Phase|Disease Progression|0|||
37788759|NCT00558103|69401576|FG004|Monotherapy Extension Phase|Disease Progression|0|||
37788760|NCT00558103|69401577|FG005|Monotherapy Extension Phase|Disease Progression|8|||
37788761|NCT00558025|69401614|FG000|Overall Study|Adverse Event|1|||
37788762|NCT00558025|69401615|FG001|Overall Study|Adverse Event|1|||
37788763|NCT00558025|69401614|FG000|Overall Study|Withdrawal by Subject|2|||
37788764|NCT00558025|69401615|FG001|Overall Study|Withdrawal by Subject|2|||
37788765|NCT00558025|69401614|FG000|Overall Study|Protocol Violation|1|||
37788766|NCT00558025|69401615|FG001|Overall Study|Protocol Violation|0|||
37788767|NCT00557323|69401668|FG000|Overall Study|Death|3|||
37788768|NCT00557323|69401668|FG000|Overall Study|Withdrawal by Subject|2|||
37788769|NCT00557323|69401668|FG000|Overall Study|Administrative change|2|||
37788770|NCT00557245|69401702|FG000|Overall Study|Lost to Follow-up|7|||
37788771|NCT00557245|69401703|FG001|Overall Study|Lost to Follow-up|8|||
37788772|NCT00557245|69401704|FG002|Overall Study|Lost to Follow-up|10|||
37788773|NCT00557245|69401702|FG000|Overall Study|Ineligible|5|||
37788774|NCT00557245|69401703|FG001|Overall Study|Ineligible|4|||
37788775|NCT00557245|69401704|FG002|Overall Study|Ineligible|2|||
37788776|NCT00556075|69401765|FG000|Overall Study|Lost to Follow-up|3|||
37788777|NCT00556075|69401766|FG001|Overall Study|Lost to Follow-up|0|||
37788778|NCT00556075|69401767|FG002|Overall Study|Lost to Follow-up|3|||
37788779|NCT00556075|69401765|FG000|Overall Study|Withdrawal by Subject|3|||
37788780|NCT00556075|69401766|FG001|Overall Study|Withdrawal by Subject|3|||
37788781|NCT00556075|69401767|FG002|Overall Study|Withdrawal by Subject|0|||
37788782|NCT00556075|69401765|FG000|Overall Study|Protocol Violation|1|||
37788783|NCT00556075|69401766|FG001|Overall Study|Protocol Violation|1|||
37788784|NCT00556075|69401767|FG002|Overall Study|Protocol Violation|3|||
37788785|NCT00556075|69401765|FG000|Overall Study|Not eligible|1|||
37788786|NCT00556075|69401766|FG001|Overall Study|Not eligible|1|||
37788787|NCT00556075|69401767|FG002|Overall Study|Not eligible|2|||
37788788|NCT00556075|69401765|FG000|Overall Study|Adverse Event|1|||
37788789|NCT00556075|69401766|FG001|Overall Study|Adverse Event|2|||
37788790|NCT00556075|69401767|FG002|Overall Study|Adverse Event|0|||
37788791|NCT00556075|69401765|FG000|Overall Study|Personal issues|4|||
37788792|NCT00556075|69401766|FG001|Overall Study|Personal issues|1|||
37788793|NCT00556075|69401767|FG002|Overall Study|Personal issues|0|||
37788794|NCT00556075|69401765|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
37788795|NCT00556075|69401766|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
37788796|NCT00556075|69401767|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
37788797|NCT02289690|69401798|FG000|Overall Study|Adverse Event Related to Progression|0|||
37788798|NCT02289690|69401799|FG001|Overall Study|Adverse Event Related to Progression|1|||
37788799|NCT02289690|69401800|FG002|Overall Study|Adverse Event Related to Progression|1|||
37788800|NCT02289690|69401801|FG003|Overall Study|Adverse Event Related to Progression|0|||
37788801|NCT02289690|69401802|FG004|Overall Study|Adverse Event Related to Progression|1|||
37788802|NCT02289690|69401803|FG005|Overall Study|Adverse Event Related to Progression|0|||
37788803|NCT02289690|69401804|FG006|Overall Study|Adverse Event Related to Progression|1|||
37788804|NCT02289690|69401805|FG007|Overall Study|Adverse Event Related to Progression|0|||
37788805|NCT02289690|69401806|FG008|Overall Study|Adverse Event Related to Progression|0|||
37788806|NCT02289690|69401807|FG009|Overall Study|Adverse Event Related to Progression|0|||
37788807|NCT02289690|69401798|FG000|Overall Study|Withdrawal by Subject|1|||
37788808|NCT02289690|69401799|FG001|Overall Study|Withdrawal by Subject|0|||
37788809|NCT02289690|69401800|FG002|Overall Study|Withdrawal by Subject|0|||
37788810|NCT02289690|69401801|FG003|Overall Study|Withdrawal by Subject|0|||
37788811|NCT02289690|69401802|FG004|Overall Study|Withdrawal by Subject|1|||
37788812|NCT02289690|69401803|FG005|Overall Study|Withdrawal by Subject|1|||
37788813|NCT02289690|69401804|FG006|Overall Study|Withdrawal by Subject|0|||
37788814|NCT02289690|69401805|FG007|Overall Study|Withdrawal by Subject|0|||
37788815|NCT02289690|69401806|FG008|Overall Study|Withdrawal by Subject|4|||
37788816|NCT02289690|69401807|FG009|Overall Study|Withdrawal by Subject|2|||
37788817|NCT02289690|69401798|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
37788818|NCT02289690|69401799|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
37788819|NCT02289690|69401800|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
37788820|NCT02289690|69401801|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
37788821|NCT02289690|69401802|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
37788822|NCT02289690|69401803|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
37788823|NCT02289690|69401804|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
37788824|NCT02289690|69401805|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
37788825|NCT02289690|69401806|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
37788826|NCT02289690|69401807|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
37788827|NCT02289690|69401798|FG000|Overall Study|Lost to Follow-up|0|||
37975393|NCT00508742|69662611|FG000|Period 3: Toddler Dose|Other|5|||
37975394|NCT00508742|69662612|FG001|Period 3: Toddler Dose|Other|4|||
37788828|NCT02289690|69401799|FG001|Overall Study|Lost to Follow-up|0|||
37788829|NCT02289690|69401800|FG002|Overall Study|Lost to Follow-up|0|||
37788830|NCT02289690|69401801|FG003|Overall Study|Lost to Follow-up|0|||
37788831|NCT02289690|69401802|FG004|Overall Study|Lost to Follow-up|0|||
37788832|NCT02289690|69401803|FG005|Overall Study|Lost to Follow-up|0|||
37788833|NCT02289690|69401804|FG006|Overall Study|Lost to Follow-up|0|||
37788834|NCT02289690|69401805|FG007|Overall Study|Lost to Follow-up|1|||
37788835|NCT02289690|69401806|FG008|Overall Study|Lost to Follow-up|0|||
37788836|NCT02289690|69401807|FG009|Overall Study|Lost to Follow-up|2|||
37788837|NCT02289690|69401798|FG000|Overall Study|Death|0|||
37788838|NCT02289690|69401799|FG001|Overall Study|Death|0|||
37788839|NCT02289690|69401800|FG002|Overall Study|Death|0|||
37788840|NCT02289690|69401801|FG003|Overall Study|Death|0|||
37788841|NCT02289690|69401802|FG004|Overall Study|Death|0|||
37788842|NCT02289690|69401803|FG005|Overall Study|Death|0|||
37788843|NCT02289690|69401804|FG006|Overall Study|Death|0|||
37788844|NCT02289690|69401805|FG007|Overall Study|Death|49|||
37788845|NCT02289690|69401806|FG008|Overall Study|Death|45|||
37788846|NCT02289690|69401807|FG009|Overall Study|Death|41|||
37788847|NCT02289690|69401798|FG000|Overall Study|Sponsor Discontinued Study|0|||
37788848|NCT02289690|69401799|FG001|Overall Study|Sponsor Discontinued Study|0|||
37788849|NCT02289690|69401800|FG002|Overall Study|Sponsor Discontinued Study|0|||
37788850|NCT02289690|69401801|FG003|Overall Study|Sponsor Discontinued Study|0|||
37788851|NCT02289690|69401802|FG004|Overall Study|Sponsor Discontinued Study|0|||
37788852|NCT02289690|69401803|FG005|Overall Study|Sponsor Discontinued Study|0|||
37788853|NCT02289690|69401804|FG006|Overall Study|Sponsor Discontinued Study|0|||
37788854|NCT02289690|69401805|FG007|Overall Study|Sponsor Discontinued Study|9|||
37788855|NCT02289690|69401806|FG008|Overall Study|Sponsor Discontinued Study|7|||
37788856|NCT02289690|69401807|FG009|Overall Study|Sponsor Discontinued Study|15|||
37788857|NCT02289690|69401798|FG000|Overall Study|Other|0|||
37788858|NCT02289690|69401799|FG001|Overall Study|Other|0|||
37788859|NCT02289690|69401800|FG002|Overall Study|Other|0|||
37788860|NCT02289690|69401801|FG003|Overall Study|Other|1|||
37788861|NCT02289690|69401802|FG004|Overall Study|Other|1|||
37788862|NCT02289690|69401803|FG005|Overall Study|Other|0|||
37788863|NCT02289690|69401804|FG006|Overall Study|Other|1|||
37788864|NCT02289690|69401805|FG007|Overall Study|Other|2|||
37788865|NCT02289690|69401806|FG008|Overall Study|Other|3|||
37788866|NCT02289690|69401807|FG009|Overall Study|Other|1|||
37788867|NCT02289456|69401910|FG000|Induction Period|Death|2|||
37788868|NCT02289456|69401910|FG000|Induction Period|Adverse Event|11|||
37788869|NCT02289456|69401910|FG000|Induction Period|Progressive Disease (PD)|4|||
37788870|NCT02289456|69401910|FG000|Induction Period|Symptomatic Deterioration|4|||
37788871|NCT02289456|69401910|FG000|Induction Period|Withdrawal by Subject|2|||
37788872|NCT02289456|69401910|FG000|Induction Period|Miscellaneous|1|||
37788873|NCT02289456|69401910|FG000|Monotherapy Period|Death|1|||
37788874|NCT02289456|69401910|FG000|Monotherapy Period|Adverse Event|1|||
37788875|NCT02289456|69401910|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
37788876|NCT02289456|69401910|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
37788877|NCT02289456|69401910|FG000|Monotherapy Period|Withdrawal by Subject|2|||
37788878|NCT02289456|69401910|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
37788879|NCT02289456|69401910|FG000|Monotherapy Period|Miscellaneous|1|||
37788880|NCT02274948|69401959|FG000|Overall Study|Lost to Follow-up|28|||
37788881|NCT02274948|69401960|FG001|Overall Study|Lost to Follow-up|25|||
37788882|NCT02274948|69401959|FG000|Overall Study|Withdrawal by Subject|64|||
37788883|NCT02274948|69401960|FG001|Overall Study|Withdrawal by Subject|58|||
37788884|NCT02274948|69401959|FG000|Overall Study|Stopped on family Practitioner advice|2|||
37788885|NCT02274948|69401960|FG001|Overall Study|Stopped on family Practitioner advice|5|||
37788886|NCT02274948|69401959|FG000|Overall Study|Left the area|4|||
37788887|NCT02274948|69401960|FG001|Overall Study|Left the area|3|||
37788888|NCT02274792|69401976|FG000|Overall Study|Withdrawal by Subject|13|||
37788889|NCT02274792|69401976|FG000|Overall Study|Lost to Follow-up|8|||
37788890|NCT02274792|69401976|FG000|Overall Study|Protocol Specified Criteria|2|||
37693704|NCT02060487|69170035|FG001|Overall Study|Other|2|||
37693705|NCT02060487|69170036|FG002|Overall Study|Other|1|||
37788891|NCT02274792|69401976|FG000|Overall Study|Sponsor Decision|2|||
37788892|NCT02274558|69402006|FG000|Overall Study|Adverse Event|2|||
37788893|NCT02274558|69402007|FG001|Overall Study|Adverse Event|4|||
37788894|NCT02274558|69402008|FG002|Overall Study|Adverse Event|2|||
37788895|NCT02274558|69402006|FG000|Overall Study|Non-compliance|2|||
37788896|NCT02274558|69402007|FG001|Overall Study|Non-compliance|1|||
37788897|NCT02274558|69402008|FG002|Overall Study|Non-compliance|0|||
37788898|NCT02274558|69402006|FG000|Overall Study|Withdrawal by Subject|1|||
37788899|NCT02274558|69402007|FG001|Overall Study|Withdrawal by Subject|5|||
37975395|NCT00508274|69662633|FG000|Overall Study|Adverse Event|5|||
37693706|NCT02060487|69170034|FG000|Overall Study|Lack of Efficacy|0|||
37788900|NCT02274558|69402008|FG002|Overall Study|Withdrawal by Subject|4|||
37788901|NCT02274558|69402006|FG000|Overall Study|Death|0|||
37788902|NCT02274558|69402007|FG001|Overall Study|Death|0|||
37788903|NCT02274558|69402008|FG002|Overall Study|Death|1|||
37788904|NCT02274558|69402006|FG000|Overall Study|Lost to Follow-up|2|||
37788905|NCT02274558|69402007|FG001|Overall Study|Lost to Follow-up|1|||
37788906|NCT02274558|69402008|FG002|Overall Study|Lost to Follow-up|1|||
37788907|NCT02274558|69402006|FG000|Overall Study|Physician Decision|0|||
37788908|NCT02274558|69402007|FG001|Overall Study|Physician Decision|2|||
37788909|NCT02274558|69402008|FG002|Overall Study|Physician Decision|1|||
37788910|NCT02287896|69402025|FG000|Second Injection Visit|Withdrawal by Subject|0|||
37788911|NCT02287896|69402026|FG001|Second Injection Visit|Withdrawal by Subject|1|||
37788912|NCT00553501|69402084|FG000|Overall Study|Adverse Event|2|||
37788913|NCT00553501|69402084|FG000|Overall Study|Death|1|||
37788914|NCT00553501|69402084|FG000|Overall Study|Progression|1|||
37788915|NCT02287584|69402112|FG000|the Double-blind Phase|Adverse Event|17|||
37788916|NCT02287584|69402113|FG001|the Double-blind Phase|Adverse Event|17|||
37788917|NCT02287584|69402114|FG002|the Double-blind Phase|Adverse Event|12|||
37788918|NCT02287584|69402115|FG003|the Double-blind Phase|Adverse Event|0|||
37788919|NCT02287584|69402116|FG004|the Double-blind Phase|Adverse Event|0|||
37788920|NCT02287584|69402117|FG005|the Double-blind Phase|Adverse Event|0|||
37788921|NCT02287584|69402112|FG000|the Double-blind Phase|Lack of Efficacy|18|||
37788922|NCT02287584|69402113|FG001|the Double-blind Phase|Lack of Efficacy|8|||
37788923|NCT02287584|69402114|FG002|the Double-blind Phase|Lack of Efficacy|8|||
37788924|NCT02287584|69402115|FG003|the Double-blind Phase|Lack of Efficacy|0|||
37788925|NCT02287584|69402116|FG004|the Double-blind Phase|Lack of Efficacy|0|||
37788926|NCT02287584|69402117|FG005|the Double-blind Phase|Lack of Efficacy|0|||
37788927|NCT02287584|69402112|FG000|the Double-blind Phase|Lost to Follow-up|0|||
37788928|NCT02287584|69402113|FG001|the Double-blind Phase|Lost to Follow-up|1|||
37788929|NCT02287584|69402114|FG002|the Double-blind Phase|Lost to Follow-up|1|||
37788930|NCT02287584|69402115|FG003|the Double-blind Phase|Lost to Follow-up|0|||
37788931|NCT02287584|69402116|FG004|the Double-blind Phase|Lost to Follow-up|0|||
37788932|NCT02287584|69402117|FG005|the Double-blind Phase|Lost to Follow-up|0|||
37788933|NCT02287584|69402112|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
37788934|NCT02287584|69402113|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
37788935|NCT02287584|69402114|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
37788936|NCT02287584|69402115|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
37788937|NCT02287584|69402116|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
37788938|NCT02287584|69402117|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
37788939|NCT02287584|69402112|FG000|the Double-blind Phase|Pregnancy|0|||
37788940|NCT02287584|69402113|FG001|the Double-blind Phase|Pregnancy|1|||
37788941|NCT02287584|69402114|FG002|the Double-blind Phase|Pregnancy|0|||
37788942|NCT02287584|69402115|FG003|the Double-blind Phase|Pregnancy|0|||
37788943|NCT02287584|69402116|FG004|the Double-blind Phase|Pregnancy|0|||
37693707|NCT02060487|69170035|FG001|Overall Study|Lack of Efficacy|1|||
37788944|NCT02287584|69402117|FG005|the Double-blind Phase|Pregnancy|0|||
37788945|NCT02287584|69402112|FG000|the Double-blind Phase|Protocol Violation|0|||
37693708|NCT02060487|69170036|FG002|Overall Study|Lack of Efficacy|0|||
37788946|NCT02287584|69402113|FG001|the Double-blind Phase|Protocol Violation|3|||
37788947|NCT02287584|69402114|FG002|the Double-blind Phase|Protocol Violation|0|||
37788948|NCT02287584|69402115|FG003|the Double-blind Phase|Protocol Violation|0|||
37788949|NCT02287584|69402116|FG004|the Double-blind Phase|Protocol Violation|0|||
37788950|NCT02287584|69402117|FG005|the Double-blind Phase|Protocol Violation|0|||
37788951|NCT02287584|69402112|FG000|the Double-blind Phase|other reasons|0|||
37788952|NCT02287584|69402113|FG001|the Double-blind Phase|other reasons|0|||
37788953|NCT02287584|69402114|FG002|the Double-blind Phase|other reasons|1|||
37788954|NCT02287584|69402115|FG003|the Double-blind Phase|other reasons|0|||
37788955|NCT02287584|69402116|FG004|the Double-blind Phase|other reasons|0|||
37788956|NCT02287584|69402117|FG005|the Double-blind Phase|other reasons|0|||
37975396|NCT00508274|69662633|FG000|Overall Study|Death|7|||
37975397|NCT00508274|69662633|FG000|Overall Study|Disease progression|32|||
37975398|NCT00508274|69662633|FG000|Overall Study|Withdrawal by Subject|1|||
37975399|NCT00508274|69662633|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
37975400|NCT00508274|69662633|FG000|Overall Study|Missing|3|||
37975401|NCT00499460|69662639|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
37975402|NCT00499460|69662640|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
37975403|NCT00499460|69662639|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
37975404|NCT00499460|69662640|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
37975405|NCT00499460|69662639|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
37975406|NCT00499460|69662640|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
37975407|NCT00412113|69662658|FG000|Overall Study|Adverse Event|11|||
37975408|NCT00412113|69662659|FG001|Overall Study|Adverse Event|15|||
37975409|NCT00412113|69662658|FG000|Overall Study|did not receive treatment|1|||
37975410|NCT00412113|69662659|FG001|Overall Study|did not receive treatment|0|||
37975411|NCT00411645|69662667|FG000|Overall Study|Consent Withdrawn|13|||
37975412|NCT00411645|69662668|FG001|Overall Study|Consent Withdrawn|22|||
37975413|NCT00411645|69662667|FG000|Overall Study|Death|56|||
37975414|NCT00411645|69662668|FG001|Overall Study|Death|135|||
37788957|NCT02287584|69402112|FG000|the Open-label Phase|Did not receive drug|0|||
37788958|NCT02287584|69402113|FG001|the Open-label Phase|Did not receive drug|0|||
37788959|NCT02287584|69402114|FG002|the Open-label Phase|Did not receive drug|0|||
37788960|NCT02287584|69402115|FG003|the Open-label Phase|Did not receive drug|7|||
37788961|NCT02287584|69402116|FG004|the Open-label Phase|Did not receive drug|6|||
37788962|NCT02287584|69402117|FG005|the Open-label Phase|Did not receive drug|4|||
37788963|NCT02287584|69402112|FG000|the Open-label Phase|Adverse Event|0|||
37975415|NCT00411645|69662667|FG000|Overall Study|Investigator/Sponsor Decision|10|||
37975416|NCT00411645|69662668|FG001|Overall Study|Investigator/Sponsor Decision|7|||
37975417|NCT00411645|69662667|FG000|Overall Study|Lost to Follow-up|2|||
37975418|NCT00411645|69662668|FG001|Overall Study|Lost to Follow-up|0|||
37788964|NCT02287584|69402113|FG001|the Open-label Phase|Adverse Event|0|||
37788965|NCT02287584|69402114|FG002|the Open-label Phase|Adverse Event|0|||
37788966|NCT02287584|69402115|FG003|the Open-label Phase|Adverse Event|15|||
37788967|NCT02287584|69402116|FG004|the Open-label Phase|Adverse Event|12|||
37788968|NCT02287584|69402117|FG005|the Open-label Phase|Adverse Event|16|||
37788969|NCT02287584|69402112|FG000|the Open-label Phase|Lack of Efficacy|0|||
37788970|NCT02287584|69402113|FG001|the Open-label Phase|Lack of Efficacy|0|||
37788971|NCT02287584|69402114|FG002|the Open-label Phase|Lack of Efficacy|0|||
37788972|NCT02287584|69402115|FG003|the Open-label Phase|Lack of Efficacy|8|||
37788973|NCT02287584|69402116|FG004|the Open-label Phase|Lack of Efficacy|3|||
37788974|NCT02287584|69402117|FG005|the Open-label Phase|Lack of Efficacy|7|||
37788975|NCT02287584|69402112|FG000|the Open-label Phase|Lost to Follow-up|0|||
37788976|NCT02287584|69402113|FG001|the Open-label Phase|Lost to Follow-up|0|||
37788977|NCT02287584|69402114|FG002|the Open-label Phase|Lost to Follow-up|0|||
37788978|NCT02287584|69402115|FG003|the Open-label Phase|Lost to Follow-up|4|||
37788979|NCT02287584|69402116|FG004|the Open-label Phase|Lost to Follow-up|1|||
37788980|NCT02287584|69402117|FG005|the Open-label Phase|Lost to Follow-up|2|||
37788981|NCT02287584|69402112|FG000|the Open-label Phase|Withdrawal by Subject|0|||
37788982|NCT02287584|69402113|FG001|the Open-label Phase|Withdrawal by Subject|0|||
37788983|NCT02287584|69402114|FG002|the Open-label Phase|Withdrawal by Subject|0|||
37788984|NCT02287584|69402115|FG003|the Open-label Phase|Withdrawal by Subject|18|||
37788985|NCT02287584|69402116|FG004|the Open-label Phase|Withdrawal by Subject|29|||
37788986|NCT02287584|69402117|FG005|the Open-label Phase|Withdrawal by Subject|21|||
37788987|NCT02287584|69402112|FG000|the Open-label Phase|non-compliance|0|||
37788988|NCT02287584|69402113|FG001|the Open-label Phase|non-compliance|0|||
37788989|NCT02287584|69402114|FG002|the Open-label Phase|non-compliance|0|||
37788990|NCT02287584|69402115|FG003|the Open-label Phase|non-compliance|2|||
37788991|NCT02287584|69402116|FG004|the Open-label Phase|non-compliance|5|||
37788992|NCT02287584|69402117|FG005|the Open-label Phase|non-compliance|1|||
37788993|NCT02287584|69402112|FG000|the Open-label Phase|other reasons|0|||
37788994|NCT02287584|69402113|FG001|the Open-label Phase|other reasons|0|||
37788995|NCT02287584|69402114|FG002|the Open-label Phase|other reasons|0|||
37788996|NCT02287584|69402115|FG003|the Open-label Phase|other reasons|3|||
37788997|NCT02287584|69402116|FG004|the Open-label Phase|other reasons|6|||
37788998|NCT02287584|69402117|FG005|the Open-label Phase|other reasons|6|||
37788999|NCT00553267|69402150|FG000|Overall Study|Adverse Event|8|||
37789000|NCT00553267|69402151|FG001|Overall Study|Adverse Event|10|||
37789001|NCT00553267|69402152|FG002|Overall Study|Adverse Event|5|||
37789002|NCT00553267|69402150|FG000|Overall Study|Non compliant with protocol|3|||
37789003|NCT00553267|69402151|FG001|Overall Study|Non compliant with protocol|3|||
37789004|NCT00553267|69402152|FG002|Overall Study|Non compliant with protocol|2|||
37789005|NCT00553267|69402150|FG000|Overall Study|Lost to Follow-up|0|||
37789006|NCT00553267|69402151|FG001|Overall Study|Lost to Follow-up|0|||
37789007|NCT00553267|69402152|FG002|Overall Study|Lost to Follow-up|1|||
37789008|NCT00553267|69402150|FG000|Overall Study|Consent withdrawn|2|||
37789009|NCT00553267|69402151|FG001|Overall Study|Consent withdrawn|3|||
37789010|NCT00553267|69402152|FG002|Overall Study|Consent withdrawn|1|||
37789011|NCT00553267|69402150|FG000|Overall Study|Specified category|1|||
37789012|NCT00553267|69402151|FG001|Overall Study|Specified category|2|||
37789013|NCT00553267|69402152|FG002|Overall Study|Specified category|1|||
37789014|NCT02271984|69402166|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
37789015|NCT02271984|69402167|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
37789016|NCT02271984|69402168|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
37789017|NCT02271984|69402169|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
37789018|NCT02271984|69402170|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
37789019|NCT02271984|69402171|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
37789020|NCT02271984|69402172|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
37789021|NCT02271984|69402173|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
37789022|NCT02271984|69402174|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
37789023|NCT02271984|69402175|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
37789024|NCT02271984|69402176|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
37975419|NCT00490724|69662678|FG000|Period I|Physician Decision|0|||
37789025|NCT02271984|69402177|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
37789026|NCT02287038|69402228|FG000|Overall Study|Stopped attending appointments|3|||
37789027|NCT02287038|69402229|FG001|Overall Study|Stopped attending appointments|2|||
37789028|NCT02287038|69402228|FG000|Overall Study|Anxiety after starting medication|0|||
37789029|NCT02287038|69402229|FG001|Overall Study|Anxiety after starting medication|1|||
37789030|NCT02287038|69402228|FG000|Overall Study|Nausea after starting medication|1|||
37789031|NCT02287038|69402229|FG001|Overall Study|Nausea after starting medication|0|||
37789032|NCT02287038|69402228|FG000|Overall Study|Abnormal ECG after starting medication|1|||
37789033|NCT02287038|69402229|FG001|Overall Study|Abnormal ECG after starting medication|0|||
37789034|NCT02286960|69402239|FG000|Overall Study|Lost to Follow-up|3|||
37789035|NCT02286960|69402240|FG001|Overall Study|Lost to Follow-up|3|||
37789036|NCT02286102|69402257|FG000|Overall Study|Screen Failure|1|||
37789037|NCT02286102|69402258|FG001|Overall Study|Screen Failure|1|||
37789038|NCT02285166|69402264|FG000|Overall Study|Case Report Forms Uncollected|564|||
37789039|NCT02285166|69402264|FG000|Overall Study|Protocol Deviation|402|||
37789040|NCT00555061|69402327|FG000|Overall Study|Adverse Event|3|||
37789041|NCT00555061|69402327|FG000|Overall Study|Protocol Violation|1|||
37789042|NCT00555061|69402327|FG000|Overall Study|Lost to Follow-up|2|||
37789043|NCT00555061|69402327|FG000|Overall Study|Withdrawal by Subject|2|||
37789044|NCT00555061|69402327|FG000|Overall Study|Participant enrolled, but never treated|1|||
37789045|NCT01642212|69402345|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
37789046|NCT01642212|69402346|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
37789047|NCT01642212|69402347|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
37789048|NCT01642212|69402348|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
37789049|NCT01642212|69402349|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
37789050|NCT01642212|69402345|FG000|Double-blind Treatment|Other|0|||
37789051|NCT01642212|69402346|FG001|Double-blind Treatment|Other|2|||
37789052|NCT01642212|69402347|FG002|Double-blind Treatment|Other|1|||
37789053|NCT01642212|69402348|FG003|Double-blind Treatment|Other|0|||
37789054|NCT01642212|69402349|FG004|Double-blind Treatment|Other|0|||
37789055|NCT01642212|69402345|FG000|Double-blind Treatment|Non-compliance|0|||
37789056|NCT01642212|69402346|FG001|Double-blind Treatment|Non-compliance|1|||
37789057|NCT01642212|69402347|FG002|Double-blind Treatment|Non-compliance|0|||
37789058|NCT01642212|69402348|FG003|Double-blind Treatment|Non-compliance|0|||
37789059|NCT01642212|69402349|FG004|Double-blind Treatment|Non-compliance|0|||
37789060|NCT01642212|69402345|FG000|Double-blind Treatment|Adverse Event|0|||
37789061|NCT01642212|69402346|FG001|Double-blind Treatment|Adverse Event|0|||
37789062|NCT01642212|69402347|FG002|Double-blind Treatment|Adverse Event|1|||
37789063|NCT01642212|69402348|FG003|Double-blind Treatment|Adverse Event|0|||
37789064|NCT01642212|69402349|FG004|Double-blind Treatment|Adverse Event|0|||
37975420|NCT00490724|69662679|FG001|Period I|Physician Decision|0|||
37789065|NCT01642212|69402345|FG000|Open-label Extension|Adverse Event|0|||
37789066|NCT01642212|69402346|FG001|Open-label Extension|Adverse Event|0|||
37975421|NCT00490724|69662680|FG002|Period I|Physician Decision|1|||
37789067|NCT01642212|69402347|FG002|Open-label Extension|Adverse Event|0|||
37789068|NCT01642212|69402348|FG003|Open-label Extension|Adverse Event|3|||
37789069|NCT01642212|69402349|FG004|Open-label Extension|Adverse Event|0|||
37789070|NCT01642212|69402345|FG000|Open-label Extension|Sponsor Decision|0|||
37789071|NCT01642212|69402346|FG001|Open-label Extension|Sponsor Decision|0|||
37789072|NCT01642212|69402347|FG002|Open-label Extension|Sponsor Decision|0|||
37789073|NCT01642212|69402348|FG003|Open-label Extension|Sponsor Decision|7|||
37789074|NCT01642212|69402349|FG004|Open-label Extension|Sponsor Decision|4|||
37789075|NCT01642212|69402345|FG000|Open-label Extension|Consent Withdrawn|0|||
37789076|NCT01642212|69402346|FG001|Open-label Extension|Consent Withdrawn|0|||
37789077|NCT01642212|69402347|FG002|Open-label Extension|Consent Withdrawn|0|||
37789078|NCT01642212|69402348|FG003|Open-label Extension|Consent Withdrawn|0|||
37789079|NCT01642212|69402349|FG004|Open-label Extension|Consent Withdrawn|2|||
37789080|NCT01642212|69402345|FG000|Open-label Extension|Lost to Follow-up|0|||
37789081|NCT01642212|69402346|FG001|Open-label Extension|Lost to Follow-up|0|||
37789082|NCT01642212|69402347|FG002|Open-label Extension|Lost to Follow-up|0|||
37789083|NCT01642212|69402348|FG003|Open-label Extension|Lost to Follow-up|0|||
37789084|NCT01642212|69402349|FG004|Open-label Extension|Lost to Follow-up|1|||
37789085|NCT01642212|69402345|FG000|Open-label Extension|Other|0|||
37789086|NCT01642212|69402346|FG001|Open-label Extension|Other|0|||
37789087|NCT01642212|69402347|FG002|Open-label Extension|Other|0|||
37975422|NCT00490724|69662678|FG000|Period II|Treatment Discontinuation|3|||
37975423|NCT00490724|69662679|FG001|Period II|Treatment Discontinuation|1|||
37789088|NCT01642212|69402348|FG003|Open-label Extension|Other|0|||
37789089|NCT01642212|69402349|FG004|Open-label Extension|Other|1|||
37789090|NCT00552175|69402374|FG000|Overall Study|Lack of Efficacy|2|||
37789091|NCT00552175|69402375|FG001|Overall Study|Lack of Efficacy|0|||
37789092|NCT00552175|69402376|FG002|Overall Study|Lack of Efficacy|1|||
37789093|NCT00552175|69402374|FG000|Overall Study|Adverse Event|9|||
37789094|NCT00552175|69402375|FG001|Overall Study|Adverse Event|9|||
37789095|NCT00552175|69402376|FG002|Overall Study|Adverse Event|10|||
37789096|NCT00552175|69402374|FG000|Overall Study|Withdrawal by Subject|2|||
37789097|NCT00552175|69402375|FG001|Overall Study|Withdrawal by Subject|2|||
37789098|NCT00552175|69402376|FG002|Overall Study|Withdrawal by Subject|1|||
37789099|NCT00552175|69402374|FG000|Overall Study|Lost to Follow-up|0|||
37789100|NCT00552175|69402375|FG001|Overall Study|Lost to Follow-up|0|||
37789101|NCT00552175|69402376|FG002|Overall Study|Lost to Follow-up|1|||
37789102|NCT00552175|69402374|FG000|Overall Study|Entry Criteria Not Met|1|||
37789103|NCT00552175|69402375|FG001|Overall Study|Entry Criteria Not Met|1|||
37789104|NCT00552175|69402376|FG002|Overall Study|Entry Criteria Not Met|0|||
37693709|NCT02060487|69170034|FG000|Overall Study|Withdrawal by Subject|3|||
37789105|NCT00552175|69402374|FG000|Overall Study|Reason Not Specified|3|||
37789106|NCT00552175|69402375|FG001|Overall Study|Reason Not Specified|1|||
37789107|NCT00552175|69402376|FG002|Overall Study|Reason Not Specified|1|||
37975424|NCT00490724|69662680|FG002|Period II|Treatment Discontinuation|3|||
37975425|NCT03835221|69662688|FG000|Methafilcon A|Withdrawal by Subject|1|||
37975426|NCT00398073|69662696|FG000|Overall Study|Withdrawal by Subject|1|||
37789108|NCT01644474|69402387|FG000|Overall Study|Poor compliance to protocol|1|||
37789109|NCT01644474|69402388|FG001|Overall Study|Poor compliance to protocol|0|||
37789110|NCT01644474|69402387|FG000|Overall Study|Consent withdrawn by participant|0|||
37789111|NCT01644474|69402388|FG001|Overall Study|Consent withdrawn by participant|1|||
37789112|NCT01644474|69402387|FG000|Overall Study|Participant moved|0|||
37789113|NCT01644474|69402388|FG001|Overall Study|Participant moved|1|||
37789114|NCT01644474|69402387|FG000|Overall Study|Adverse Event|4|||
37789115|NCT01644474|69402388|FG001|Overall Study|Adverse Event|5|||
37789116|NCT01644474|69402387|FG000|Overall Study|Site scheduling error|1|||
37789117|NCT01644474|69402388|FG001|Overall Study|Site scheduling error|1|||
37789118|NCT01644474|69402387|FG000|Overall Study|Protocol Violation|1|||
37789119|NCT01644474|69402388|FG001|Overall Study|Protocol Violation|0|||
37789120|NCT02285010|69402423|FG000|Overall Study|not abdominal hysterectomy|2|||
37789121|NCT02285010|69402424|FG001|Overall Study|not abdominal hysterectomy|0|||
37789122|NCT02285010|69402423|FG000|Overall Study|Not spinal anesthesia|3|||
37789123|NCT02285010|69402424|FG001|Overall Study|Not spinal anesthesia|1|||
37789124|NCT00551161|69402468|FG000|Overall Study|Withdrawal by Subject|1|||
37789125|NCT00550771|69402504|FG000|Overall Study|Adverse Event|11|||
37789126|NCT00550771|69402505|FG001|Overall Study|Adverse Event|3|||
37789127|NCT00550771|69402504|FG000|Overall Study|Discontinued for study-related reasons|0|||
37789128|NCT00550771|69402505|FG001|Overall Study|Discontinued for study-related reasons|1|||
37789129|NCT00550771|69402504|FG000|Overall Study|Physician Decision|2|||
37789130|NCT00550771|69402505|FG001|Overall Study|Physician Decision|0|||
37789131|NCT00550771|69402504|FG000|Overall Study|Withdrawal by Subject|0|||
37789132|NCT00550771|69402505|FG001|Overall Study|Withdrawal by Subject|1|||
37789133|NCT00550771|69402504|FG000|Overall Study|Protocol Violation|4|||
37789134|NCT00550771|69402505|FG001|Overall Study|Protocol Violation|5|||
37789135|NCT00550537|69402538|FG000|Overall Study|Death|18|||
37789136|NCT00550537|69402538|FG000|Overall Study|Adverse Event|20|||
37789137|NCT00550537|69402538|FG000|Overall Study|Disease progression before|46|||
37789138|NCT00550537|69402538|FG000|Overall Study|Withdrawal by Subject|7|||
37789139|NCT00550537|69402538|FG000|Overall Study|Change in treatment plan|4|||
37789140|NCT00550537|69402538|FG000|Overall Study|Other complicating ilness|3|||
37789141|NCT00550537|69402538|FG000|Overall Study|Declining performance status|2|||
37789142|NCT00550537|69402538|FG000|Overall Study|Treated closer to home|4|||
37789143|NCT00550147|69402556|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
37789144|NCT00550147|69402556|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
37789145|NCT00550147|69402556|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
37789146|NCT00550147|69402556|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
37789147|NCT00550147|69402556|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
37789148|NCT00550459|69402767|FG000|Overall Study|Adverse Event|0|||
37789149|NCT00550459|69402768|FG001|Overall Study|Adverse Event|2|||
37789150|NCT00550459|69402767|FG000|Overall Study|Withdrawal by Subject|1|||
37789151|NCT00550459|69402768|FG001|Overall Study|Withdrawal by Subject|1|||
37789152|NCT02823145|69402803|FG000|Enrollment|Other|1|||
37789153|NCT02823145|69402804|FG001|Enrollment|Other|0|||
37789154|NCT02823145|69402803|FG000|Treatment|Adverse Event|0|||
37789155|NCT02823145|69402804|FG001|Treatment|Adverse Event|11|||
37789156|NCT02823145|69402803|FG000|Treatment|Death|0|||
37789157|NCT02823145|69402804|FG001|Treatment|Death|3|||
37789158|NCT02823145|69402803|FG000|Treatment|Family Decision|0|||
37789159|NCT02823145|69402804|FG001|Treatment|Family Decision|1|||
37789160|NCT02823145|69402803|FG000|Treatment|IP approved and subject moved to commercial drug|0|||
37789161|NCT02823145|69402804|FG001|Treatment|IP approved and subject moved to commercial drug|1|||
37789162|NCT02823145|69402803|FG000|Treatment|Lack of Efficacy|0|||
37789163|NCT02823145|69402804|FG001|Treatment|Lack of Efficacy|48|||
37789164|NCT02823145|69402803|FG000|Treatment|Non-Compliance With E-Diary|0|||
37789165|NCT02823145|69402804|FG001|Treatment|Non-Compliance With E-Diary|1|||
37789166|NCT02823145|69402803|FG000|Treatment|Physician Decision|0|||
37789167|NCT02823145|69402804|FG001|Treatment|Physician Decision|2|||
37789168|NCT02823145|69402803|FG000|Treatment|Subject has transitioned to study 1900 OLE study|0|||
37789169|NCT02823145|69402804|FG001|Treatment|Subject has transitioned to study 1900 OLE study|225|||
37789170|NCT02823145|69402803|FG000|Treatment|Subject needed to take prohibited medication|0|||
37789171|NCT02823145|69402804|FG001|Treatment|Subject needed to take prohibited medication|1|||
37789172|NCT02823145|69402803|FG000|Treatment|Subject transferred to direct access programme|0|||
37789173|NCT02823145|69402804|FG001|Treatment|Subject transferred to direct access programme|1|||
37789174|NCT02823145|69402803|FG000|Treatment|Switching to commercially available drug|0|||
37789175|NCT02823145|69402804|FG001|Treatment|Switching to commercially available drug|11|||
37789176|NCT02823145|69402803|FG000|Treatment|Transitioned to commercial supply of medication|0|||
37789177|NCT02823145|69402804|FG001|Treatment|Transitioned to commercial supply of medication|1|||
37789178|NCT02823145|69402803|FG000|Treatment|Withdrawal By Caregiver|0|||
37789179|NCT02823145|69402804|FG001|Treatment|Withdrawal By Caregiver|1|||
37789180|NCT02823145|69402803|FG000|Treatment|Withdrawal by sponsor due to lack of compliance|0|||
37789181|NCT02823145|69402804|FG001|Treatment|Withdrawal by sponsor due to lack of compliance|1|||
37789182|NCT02823145|69402803|FG000|Treatment|Withdrawal by Subject|0|||
37789183|NCT02823145|69402804|FG001|Treatment|Withdrawal by Subject|16|||
37789184|NCT02823145|69402803|FG000|Treatment|Reason unknown|0|||
37789185|NCT02823145|69402804|FG001|Treatment|Reason unknown|1|||
37789186|NCT01643928|69403072|FG000|Overall Study|Lost to Follow-up|1|||
37789187|NCT01643928|69403073|FG001|Overall Study|Lost to Follow-up|0|||
37789188|NCT01643928|69403074|FG002|Overall Study|Lost to Follow-up|2|||
37789189|NCT01643928|69403075|FG003|Overall Study|Lost to Follow-up|0|||
37789190|NCT01643928|69403076|FG004|Overall Study|Lost to Follow-up|0|||
37789191|NCT01643928|69403072|FG000|Overall Study|Withdrawal by Subject|2|||
37789192|NCT01643928|69403073|FG001|Overall Study|Withdrawal by Subject|0|||
37789193|NCT01643928|69403074|FG002|Overall Study|Withdrawal by Subject|0|||
37789194|NCT01643928|69403075|FG003|Overall Study|Withdrawal by Subject|1|||
37789195|NCT01643928|69403076|FG004|Overall Study|Withdrawal by Subject|0|||
37789196|NCT01643928|69403072|FG000|Overall Study|Pregnancy|0|||
37789197|NCT01643928|69403073|FG001|Overall Study|Pregnancy|0|||
37789198|NCT01643928|69403074|FG002|Overall Study|Pregnancy|0|||
37789199|NCT01643928|69403075|FG003|Overall Study|Pregnancy|1|||
37789200|NCT01643928|69403076|FG004|Overall Study|Pregnancy|0|||
37789201|NCT01643928|69403072|FG000|Overall Study|Other|5|||
37789202|NCT01643928|69403073|FG001|Overall Study|Other|1|||
37789203|NCT01643928|69403074|FG002|Overall Study|Other|1|||
37789204|NCT01643928|69403075|FG003|Overall Study|Other|0|||
37789205|NCT01643928|69403076|FG004|Overall Study|Other|0|||
37789206|NCT01643928|69403072|FG000|Overall Study|Adverse Event|2|||
37789207|NCT01643928|69403073|FG001|Overall Study|Adverse Event|1|||
37789208|NCT01643928|69403074|FG002|Overall Study|Adverse Event|0|||
37789209|NCT01643928|69403075|FG003|Overall Study|Adverse Event|1|||
37789210|NCT01643928|69403076|FG004|Overall Study|Adverse Event|2|||
37789211|NCT03237845|69403287|FG000|Overall Study|Adverse Event|0|||
37789212|NCT03237845|69403288|FG001|Overall Study|Adverse Event|1|||
37789213|NCT03237845|69403287|FG000|Overall Study|Lost to Follow-up|13|||
37789214|NCT03237845|69403288|FG001|Overall Study|Lost to Follow-up|10|||
37789215|NCT03237845|69403287|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
37789216|NCT03237845|69403288|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
37789217|NCT03237845|69403287|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
37789218|NCT03237845|69403288|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
37789219|NCT03237845|69403287|FG000|Overall Study|Physician Decision|1|||
37789220|NCT03237845|69403288|FG001|Overall Study|Physician Decision|2|||
37789221|NCT03237845|69403287|FG000|Overall Study|Pregnancy|1|||
37789222|NCT03237845|69403288|FG001|Overall Study|Pregnancy|0|||
37789223|NCT03237845|69403287|FG000|Overall Study|Protocol Deviation|0|||
37789224|NCT03237845|69403288|FG001|Overall Study|Protocol Deviation|1|||
37789225|NCT03237845|69403287|FG000|Overall Study|Technical Problems|8|||
37789226|NCT03237845|69403288|FG001|Overall Study|Technical Problems|1|||
37789227|NCT03237845|69403287|FG000|Overall Study|Withdrawal by Subject|3|||
37789228|NCT03237845|69403288|FG001|Overall Study|Withdrawal by Subject|3|||
37789229|NCT03237845|69403287|FG000|Overall Study|Other Reasons|4|||
37789230|NCT03237845|69403288|FG001|Overall Study|Other Reasons|0|||
37789231|NCT01643850|69403375|FG000|Overall Study|Withdrawal by Subject|0|||
37789232|NCT01643850|69403376|FG001|Overall Study|Withdrawal by Subject|0|||
37789233|NCT01643850|69403377|FG002|Overall Study|Withdrawal by Subject|0|||
37789234|NCT01643850|69403378|FG003|Overall Study|Withdrawal by Subject|0|||
37789235|NCT01643850|69403379|FG004|Overall Study|Withdrawal by Subject|1|||
37789236|NCT01643850|69403380|FG005|Overall Study|Withdrawal by Subject|0|||
37789237|NCT01643850|69403381|FG006|Overall Study|Withdrawal by Subject|0|||
37789238|NCT01643850|69403382|FG007|Overall Study|Withdrawal by Subject|0|||
37789239|NCT01643850|69403383|FG008|Overall Study|Withdrawal by Subject|0|||
37789240|NCT01643850|69403375|FG000|Overall Study|Lost to Follow-up|0|||
37789241|NCT01643850|69403376|FG001|Overall Study|Lost to Follow-up|0|||
37789242|NCT01643850|69403377|FG002|Overall Study|Lost to Follow-up|0|||
37789243|NCT01643850|69403378|FG003|Overall Study|Lost to Follow-up|0|||
37789244|NCT01643850|69403379|FG004|Overall Study|Lost to Follow-up|0|||
37789245|NCT01643850|69403380|FG005|Overall Study|Lost to Follow-up|0|||
37789246|NCT01643850|69403381|FG006|Overall Study|Lost to Follow-up|1|||
37789247|NCT01643850|69403382|FG007|Overall Study|Lost to Follow-up|0|||
37789248|NCT01643850|69403383|FG008|Overall Study|Lost to Follow-up|1|||
37789249|NCT01643850|69403375|FG000|Overall Study|Adverse Event|0|||
37789250|NCT01643850|69403376|FG001|Overall Study|Adverse Event|0|||
37789251|NCT01643850|69403377|FG002|Overall Study|Adverse Event|0|||
37789252|NCT01643850|69403378|FG003|Overall Study|Adverse Event|0|||
37789253|NCT01643850|69403379|FG004|Overall Study|Adverse Event|1|||
37789254|NCT01643850|69403380|FG005|Overall Study|Adverse Event|0|||
37789255|NCT01643850|69403381|FG006|Overall Study|Adverse Event|0|||
37789256|NCT01643850|69403382|FG007|Overall Study|Adverse Event|0|||
37789257|NCT01643850|69403383|FG008|Overall Study|Adverse Event|0|||
37789258|NCT01643850|69403375|FG000|Overall Study|Administrative Problems|0|||
37789259|NCT01643850|69403376|FG001|Overall Study|Administrative Problems|0|||
37789260|NCT01643850|69403377|FG002|Overall Study|Administrative Problems|1|||
37789261|NCT01643850|69403378|FG003|Overall Study|Administrative Problems|0|||
37789262|NCT01643850|69403379|FG004|Overall Study|Administrative Problems|1|||
37789263|NCT01643850|69403380|FG005|Overall Study|Administrative Problems|0|||
37789264|NCT01643850|69403381|FG006|Overall Study|Administrative Problems|0|||
37789265|NCT01643850|69403382|FG007|Overall Study|Administrative Problems|0|||
37789266|NCT01643850|69403383|FG008|Overall Study|Administrative Problems|0|||
37789267|NCT02271594|69403451|FG000|Overall Study|Study closed; recruiting failure|19|||
37789268|NCT02271594|69403452|FG001|Overall Study|Study closed; recruiting failure|12|||
37789269|NCT02535923|69403471|FG000|Overall Study|Lost to Follow-up|5|||
37789270|NCT02535923|69403472|FG001|Overall Study|Lost to Follow-up|5|||
37789271|NCT02535923|69403471|FG000|Overall Study|Withdrawal by Subject|4|||
37789272|NCT02535923|69403472|FG001|Overall Study|Withdrawal by Subject|3|||
37789273|NCT02270736|69403481|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
37789274|NCT02270736|69403482|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
37789275|NCT02270736|69403483|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
37789276|NCT02270736|69403484|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
37789277|NCT02270736|69403485|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
37789278|NCT02270736|69403481|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
37789279|NCT02270736|69403482|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
37789280|NCT02270736|69403483|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
37789281|NCT02270736|69403484|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
37789282|NCT02270736|69403485|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
37789283|NCT02270736|69403481|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
37789284|NCT02270736|69403482|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
37789285|NCT02270736|69403483|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
37789286|NCT02270736|69403484|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
37789287|NCT02270736|69403485|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
37789288|NCT02270736|69403481|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
37789289|NCT02270736|69403482|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
37789290|NCT02270736|69403483|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
37789291|NCT02270736|69403484|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
37789292|NCT02270736|69403485|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
37789293|NCT02270736|69403481|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
37789294|NCT02270736|69403482|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
37789295|NCT02270736|69403483|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
37789296|NCT02270736|69403484|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
37789297|NCT02270736|69403485|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
37789298|NCT02270736|69403481|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
37789299|NCT02270736|69403482|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
37789300|NCT02270736|69403483|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
37789301|NCT02270736|69403484|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
37789302|NCT02270736|69403485|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
37789303|NCT02270736|69403481|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
37789304|NCT02270736|69403482|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
37789305|NCT02270736|69403483|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
37789306|NCT02270736|69403484|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
37789307|NCT02270736|69403485|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
37789308|NCT02270736|69403481|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
37789309|NCT02270736|69403482|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
37789310|NCT02270736|69403483|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
37789311|NCT02270736|69403484|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
37789312|NCT02270736|69403485|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
37789313|NCT02270736|69403481|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
37789314|NCT02270736|69403482|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
37789315|NCT02270736|69403483|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
37789316|NCT02270736|69403484|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
37789317|NCT02270736|69403485|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
37789318|NCT02269098|69403500|FG000|Overall Study|Lost to Follow-up|14|||
37789319|NCT02269098|69403501|FG001|Overall Study|Lost to Follow-up|9|||
37789320|NCT02283762|69403629|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
37789321|NCT02283762|69403630|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
37789322|NCT02283762|69403629|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
37789323|NCT02283762|69403630|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
37789324|NCT02283762|69403629|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
37789325|NCT02283762|69403630|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
37789326|NCT02283762|69403629|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
37789327|NCT02283762|69403630|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
37789328|NCT02283762|69403629|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
37789329|NCT02283762|69403630|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
37789330|NCT02283762|69403629|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
37789331|NCT02283762|69403630|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
37789332|NCT02283762|69403629|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
37789333|NCT02283762|69403630|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
37789334|NCT02283762|69403629|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
37789335|NCT02283762|69403630|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
37789336|NCT02283762|69403629|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
37789337|NCT02283762|69403630|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
37789338|NCT02283762|69403629|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
37789339|NCT02283762|69403630|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
37789340|NCT02283762|69403629|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
37789341|NCT02283762|69403630|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
37789342|NCT02283762|69403629|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
37789343|NCT02283762|69403630|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
37789344|NCT02283294|69403730|FG000|Overall Study|Lost to Follow-up|1|||
37789345|NCT02283294|69403731|FG001|Overall Study|Lost to Follow-up|1|||
37789346|NCT02283294|69403730|FG000|Overall Study|Withdrawal by Subject|1|||
37789347|NCT02283294|69403731|FG001|Overall Study|Withdrawal by Subject|6|||
37789348|NCT02283294|69403730|FG000|Overall Study|Protocol Violation|1|||
37789349|NCT02283294|69403731|FG001|Overall Study|Protocol Violation|0|||
37789350|NCT02283294|69403730|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
37789351|NCT02283294|69403731|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
37789352|NCT02282982|69403747|FG000|Overall Study|Lost to Follow-up|15|||
37789353|NCT02282982|69403747|FG000|Overall Study|Withdrew consent|2|||
37789354|NCT02282982|69403747|FG000|Overall Study|Death|4|||
37789355|NCT02282982|69403747|FG000|Overall Study|Lack of product|156|||
37789356|NCT02282982|69403747|FG000|Overall Study|Palivizumab is ended|11|||
37789357|NCT02282982|69403747|FG000|Overall Study|Other, not specified|18|||
37789358|NCT02268864|69403789|FG000|Overall Study|Withdrawal by Subject|2|||
37789359|NCT02268864|69403790|FG001|Overall Study|Withdrawal by Subject|0|||
37789360|NCT02268864|69403791|FG002|Overall Study|Withdrawal by Subject|0|||
37789361|NCT02268864|69403789|FG000|Overall Study|Death|0|||
37789362|NCT02268864|69403790|FG001|Overall Study|Death|1|||
37789363|NCT02268864|69403791|FG002|Overall Study|Death|0|||
37789364|NCT02268786|69403820|FG000|Overall Study|No Euploid Embryos available|42|||
37789365|NCT02268786|69403821|FG001|Overall Study|No Euploid Embryos available|0|||
37789366|NCT02268786|69403820|FG000|Overall Study|Withdrawal by Subject|7|||
37789367|NCT02268786|69403821|FG001|Overall Study|Withdrawal by Subject|14|||
37789368|NCT02268786|69403820|FG000|Overall Study|Thaw Failure|6|||
37789369|NCT02268786|69403821|FG001|Overall Study|Thaw Failure|4|||
37789370|NCT02268786|69403820|FG000|Overall Study|Protocol Violation|1|||
37789371|NCT02268786|69403821|FG001|Overall Study|Protocol Violation|0|||
37789372|NCT02268396|69403836|FG000|Overall Study|Adverse Event|3|||
37789373|NCT02268396|69403836|FG000|Overall Study|Administrative|2|||
37789374|NCT02268396|69403836|FG000|Overall Study|Withdrawal by Subject|1|||
37789375|NCT02268396|69403836|FG000|Overall Study|Lost to Follow-up|2|||
37789376|NCT02268396|69403836|FG000|Overall Study|Protocol-Specified Criteria|2|||
37789377|NCT02268396|69403836|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
37789378|NCT02268084|69403842|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
37789379|NCT02268084|69403843|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
37789380|NCT02268084|69403842|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
37789381|NCT02268084|69403843|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
37789382|NCT01643772|69403872|FG000|Overall Study|Protocol Violation|0|||
37789383|NCT01643772|69403873|FG001|Overall Study|Protocol Violation|0|||
37789384|NCT01643772|69403874|FG002|Overall Study|Protocol Violation|0|||
37789385|NCT01643772|69403875|FG003|Overall Study|Protocol Violation|1|||
37789386|NCT01643772|69403872|FG000|Overall Study|Adverse Event|0|||
37789387|NCT01643772|69403873|FG001|Overall Study|Adverse Event|0|||
37789388|NCT01643772|69403874|FG002|Overall Study|Adverse Event|0|||
37789389|NCT01643772|69403875|FG003|Overall Study|Adverse Event|1|||
37789390|NCT02265744|69403978|FG000|Overall Study|Poor/Non-compliance|1|||
37789391|NCT02265744|69403979|FG001|Overall Study|Poor/Non-compliance|1|||
37789392|NCT02265744|69403980|FG002|Overall Study|Poor/Non-compliance|0|||
37789393|NCT02265744|69403981|FG003|Overall Study|Poor/Non-compliance|0|||
37789394|NCT02265744|69403982|FG004|Overall Study|Poor/Non-compliance|2|||
37789395|NCT02265744|69403978|FG000|Overall Study|Lost to Follow-up|0|||
37789396|NCT02265744|69403979|FG001|Overall Study|Lost to Follow-up|0|||
37789397|NCT02265744|69403980|FG002|Overall Study|Lost to Follow-up|0|||
37789398|NCT02265744|69403981|FG003|Overall Study|Lost to Follow-up|1|||
37789399|NCT02265744|69403982|FG004|Overall Study|Lost to Follow-up|0|||
37789400|NCT02265744|69403978|FG000|Overall Study|Death|0|||
37789401|NCT02265744|69403979|FG001|Overall Study|Death|0|||
37789402|NCT02265744|69403980|FG002|Overall Study|Death|0|||
37789403|NCT02265744|69403981|FG003|Overall Study|Death|2|||
37789404|NCT02265744|69403982|FG004|Overall Study|Death|0|||
37789405|NCT02265744|69403978|FG000|Overall Study|Withdrawal by Subject|2|||
37789406|NCT02265744|69403979|FG001|Overall Study|Withdrawal by Subject|0|||
37789407|NCT02265744|69403980|FG002|Overall Study|Withdrawal by Subject|0|||
37789408|NCT02265744|69403981|FG003|Overall Study|Withdrawal by Subject|2|||
37789409|NCT02265744|69403982|FG004|Overall Study|Withdrawal by Subject|0|||
37789410|NCT02265744|69403978|FG000|Overall Study|Participant request to discontinue|2|||
37789411|NCT02265744|69403979|FG001|Overall Study|Participant request to discontinue|2|||
37789412|NCT02265744|69403980|FG002|Overall Study|Participant request to discontinue|2|||
37789413|NCT02265744|69403981|FG003|Overall Study|Participant request to discontinue|0|||
37789414|NCT02265744|69403982|FG004|Overall Study|Participant request to discontinue|0|||
37789415|NCT02265744|69403978|FG000|Overall Study|Adverse Event|8|||
37789416|NCT02265744|69403979|FG001|Overall Study|Adverse Event|4|||
37789417|NCT02265744|69403980|FG002|Overall Study|Adverse Event|9|||
37789418|NCT02265744|69403981|FG003|Overall Study|Adverse Event|8|||
37789419|NCT02265744|69403982|FG004|Overall Study|Adverse Event|2|||
37789420|NCT02265744|69403978|FG000|Overall Study|Lack of Efficacy|2|||
37789421|NCT02265744|69403979|FG001|Overall Study|Lack of Efficacy|4|||
37789422|NCT02265744|69403980|FG002|Overall Study|Lack of Efficacy|3|||
37789423|NCT02265744|69403981|FG003|Overall Study|Lack of Efficacy|4|||
37789424|NCT02265744|69403982|FG004|Overall Study|Lack of Efficacy|5|||
37789425|NCT02265744|69403978|FG000|Overall Study|Reason not provided by Investigator|1|||
37789426|NCT02265744|69403979|FG001|Overall Study|Reason not provided by Investigator|0|||
37789427|NCT02265744|69403980|FG002|Overall Study|Reason not provided by Investigator|0|||
37789428|NCT02265744|69403981|FG003|Overall Study|Reason not provided by Investigator|2|||
37789429|NCT02265744|69403982|FG004|Overall Study|Reason not provided by Investigator|0|||
37789430|NCT02265744|69403978|FG000|Overall Study|Administrative reason by sponsor|3|||
37789431|NCT02265744|69403979|FG001|Overall Study|Administrative reason by sponsor|2|||
37789432|NCT02265744|69403980|FG002|Overall Study|Administrative reason by sponsor|2|||
37789433|NCT02265744|69403981|FG003|Overall Study|Administrative reason by sponsor|3|||
37789434|NCT02265744|69403982|FG004|Overall Study|Administrative reason by sponsor|3|||
37789435|NCT02265744|69403978|FG000|Overall Study|Subject no longer meets study criteria|0|||
37789436|NCT02265744|69403979|FG001|Overall Study|Subject no longer meets study criteria|0|||
37789437|NCT02265744|69403980|FG002|Overall Study|Subject no longer meets study criteria|0|||
37789438|NCT02265744|69403981|FG003|Overall Study|Subject no longer meets study criteria|0|||
37789439|NCT02265744|69403982|FG004|Overall Study|Subject no longer meets study criteria|1|||
37789440|NCT02265744|69403978|FG000|Overall Study|Pregnancy|1|||
37789441|NCT02265744|69403979|FG001|Overall Study|Pregnancy|2|||
37789442|NCT02265744|69403980|FG002|Overall Study|Pregnancy|1|||
37789443|NCT02265744|69403981|FG003|Overall Study|Pregnancy|1|||
37789444|NCT02265744|69403982|FG004|Overall Study|Pregnancy|0|||
37789445|NCT00085735|69404011|FG000|Overall Study|Adverse Event|1|||
37789446|NCT00085735|69404012|FG001|Overall Study|Adverse Event|0|||
37789447|NCT00085735|69404013|FG002|Overall Study|Adverse Event|0|||
37789448|NCT00085735|69404014|FG003|Overall Study|Adverse Event|0|||
37789449|NCT00085735|69404015|FG004|Overall Study|Adverse Event|0|||
37789450|NCT00085735|69404016|FG005|Overall Study|Adverse Event|0|||
37789451|NCT00085735|69404011|FG000|Overall Study|Lack of Efficacy|2|||
37789452|NCT00085735|69404012|FG001|Overall Study|Lack of Efficacy|4|||
37789453|NCT00085735|69404013|FG002|Overall Study|Lack of Efficacy|6|||
37789454|NCT00085735|69404014|FG003|Overall Study|Lack of Efficacy|3|||
37789455|NCT00085735|69404015|FG004|Overall Study|Lack of Efficacy|4|||
37789456|NCT00085735|69404016|FG005|Overall Study|Lack of Efficacy|3|||
37789457|NCT00085735|69404011|FG000|Overall Study|Lost to Follow-up|0|||
37789458|NCT00085735|69404012|FG001|Overall Study|Lost to Follow-up|1|||
37789459|NCT00085735|69404013|FG002|Overall Study|Lost to Follow-up|0|||
37789460|NCT00085735|69404014|FG003|Overall Study|Lost to Follow-up|0|||
37789461|NCT00085735|69404015|FG004|Overall Study|Lost to Follow-up|1|||
37789462|NCT00085735|69404016|FG005|Overall Study|Lost to Follow-up|0|||
37789463|NCT00085735|69404011|FG000|Overall Study|Physician Decision|2|||
37789464|NCT00085735|69404012|FG001|Overall Study|Physician Decision|3|||
37789465|NCT00085735|69404013|FG002|Overall Study|Physician Decision|2|||
37789466|NCT00085735|69404014|FG003|Overall Study|Physician Decision|3|||
37789467|NCT00085735|69404015|FG004|Overall Study|Physician Decision|11|||
37789468|NCT00085735|69404016|FG005|Overall Study|Physician Decision|8|||
37789469|NCT00085735|69404011|FG000|Overall Study|Protocol Violation|1|||
37789470|NCT00085735|69404012|FG001|Overall Study|Protocol Violation|0|||
37789471|NCT00085735|69404013|FG002|Overall Study|Protocol Violation|0|||
37789472|NCT00085735|69404014|FG003|Overall Study|Protocol Violation|0|||
37789473|NCT00085735|69404015|FG004|Overall Study|Protocol Violation|0|||
37789474|NCT00085735|69404016|FG005|Overall Study|Protocol Violation|0|||
37789475|NCT00085735|69404011|FG000|Overall Study|Withdrawal by Subject|1|||
37789476|NCT00085735|69404012|FG001|Overall Study|Withdrawal by Subject|0|||
37789477|NCT00085735|69404013|FG002|Overall Study|Withdrawal by Subject|4|||
37789478|NCT00085735|69404014|FG003|Overall Study|Withdrawal by Subject|5|||
37789479|NCT00085735|69404015|FG004|Overall Study|Withdrawal by Subject|7|||
37789480|NCT00085735|69404016|FG005|Overall Study|Withdrawal by Subject|8|||
37789481|NCT00085735|69404011|FG000|Overall Study|Patient ineligible|1|||
37789482|NCT00085735|69404012|FG001|Overall Study|Patient ineligible|0|||
37789483|NCT00085735|69404013|FG002|Overall Study|Patient ineligible|3|||
37789484|NCT00085735|69404014|FG003|Overall Study|Patient ineligible|7|||
37789485|NCT00085735|69404015|FG004|Overall Study|Patient ineligible|17|||
37789486|NCT00085735|69404016|FG005|Overall Study|Patient ineligible|8|||
37789487|NCT00085735|69404011|FG000|Overall Study|Excess residual disease|2|||
37789488|NCT00085735|69404012|FG001|Overall Study|Excess residual disease|2|||
37789489|NCT00085735|69404013|FG002|Overall Study|Excess residual disease|1|||
37789490|NCT00085735|69404014|FG003|Overall Study|Excess residual disease|1|||
37789491|NCT00085735|69404015|FG004|Overall Study|Excess residual disease|1|||
37789492|NCT00085735|69404016|FG005|Overall Study|Excess residual disease|4|||
37789493|NCT00085735|69404011|FG000|Overall Study|Reason not documented|1|||
37789494|NCT00085735|69404012|FG001|Overall Study|Reason not documented|0|||
37789495|NCT00085735|69404013|FG002|Overall Study|Reason not documented|1|||
37789496|NCT00085735|69404014|FG003|Overall Study|Reason not documented|0|||
37789497|NCT00085735|69404015|FG004|Overall Study|Reason not documented|1|||
37789498|NCT00085735|69404016|FG005|Overall Study|Reason not documented|0|||
37789499|NCT00085735|69404011|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
37789500|NCT00085735|69404012|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
37789501|NCT00085735|69404013|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
37789502|NCT00085735|69404014|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
37789503|NCT00085735|69404015|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
37789504|NCT00085735|69404016|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
37789505|NCT04537793|69404318|FG000|Part B (24 Weeks)|Adverse Event|0|||
37789506|NCT04537793|69404319|FG001|Part B (24 Weeks)|Adverse Event|1|||
37789507|NCT01938001|69405577|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
37789508|NCT01938001|69405578|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
37789509|NCT01938001|69405577|FG000|Pre-Treatment|Death|1|||
37789510|NCT01938001|69405578|FG001|Pre-Treatment|Death|0|||
37789511|NCT01938001|69405577|FG000|Treatment|Death|2|||
37789512|NCT01938001|69405578|FG001|Treatment|Death|0|||
37789513|NCT01938001|69405577|FG000|Treatment|Adverse Event|14|||
37789514|NCT01938001|69405578|FG001|Treatment|Adverse Event|8|||
37789515|NCT01938001|69405577|FG000|Treatment|Progressive Disease|21|||
37789516|NCT01938001|69405578|FG001|Treatment|Progressive Disease|54|||
37789517|NCT01938001|69405577|FG000|Treatment|Withdrawal by Subject|13|||
37789518|NCT01938001|69405578|FG001|Treatment|Withdrawal by Subject|7|||
37789519|NCT01938001|69405577|FG000|Treatment|Other reasons|2|||
37789520|NCT01938001|69405578|FG001|Treatment|Other reasons|1|||
37789521|NCT01066663|69405739|FG000|Overall Study|Adverse Event|0|||
37789522|NCT01066663|69405740|FG001|Overall Study|Adverse Event|0|||
37789523|NCT01066663|69405741|FG002|Overall Study|Adverse Event|1|||
37789524|NCT03930745|69407947|FG000|Overall Study|Lost to Follow-up|10|||
37789525|NCT03930745|69407948|FG001|Overall Study|Lost to Follow-up|5|||
37789526|NCT03930745|69407947|FG000|Overall Study|Withdrawal by Subject|1|||
37789527|NCT03930745|69407948|FG001|Overall Study|Withdrawal by Subject|2|||
37789528|NCT03930745|69407947|FG000|Overall Study|Protocol Violation|2|||
37789529|NCT03930745|69407948|FG001|Overall Study|Protocol Violation|2|||
37789530|NCT03930745|69407947|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
37789531|NCT03930745|69407948|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
37789532|NCT03930745|69407947|FG000|Overall Study|Adverse Event|0|||
37789533|NCT03930745|69407948|FG001|Overall Study|Adverse Event|1|||
37789534|NCT03930745|69407947|FG000|Overall Study|Pregnancy|0|||
37789535|NCT03930745|69407948|FG001|Overall Study|Pregnancy|1|||
37789536|NCT04473326|69410693|FG000|Overall Study|Death|0|||
37789537|NCT04473326|69410694|FG001|Overall Study|Death|1|||
37789538|NCT04473326|69410693|FG000|Overall Study|Withdrawal by Subject|1|||
37789539|NCT04473326|69410694|FG001|Overall Study|Withdrawal by Subject|2|||
37789540|NCT05993299|69411045|FG000|Overall Study|Did not meet treatment eligibility criteria|2|||
37789541|NCT05993299|69411045|FG000|Overall Study|Ongoing|4|||
37789542|NCT05239598|69411102|FG000|Phase II (Open Label)|Lost to Follow-up|1|||
37789543|NCT05239598|69411103|FG001|Phase II (Open Label)|Lost to Follow-up|0|||
37789544|NCT05239598|69411102|FG000|Phase II (Open Label)|Withdrawal by Subject|1|||
37789545|NCT05239598|69411103|FG001|Phase II (Open Label)|Withdrawal by Subject|0|||
37789546|NCT05010070|69411146|FG000|Overall Study|Lost to Follow-up|1|||
37789547|NCT05010070|69411146|FG000|Overall Study|Withdrawal by Subject|1|||
37789548|NCT04523480|69411175|FG000|Overall Study|Lost to Follow-up|30|||
37789549|NCT04523480|69411176|FG001|Overall Study|Lost to Follow-up|35|||
37789550|NCT04523480|69411177|FG002|Overall Study|Lost to Follow-up|0|||
37789551|NCT04454125|69411187|FG000|Overall Study|Lost to Follow-up|0|||
37789552|NCT04454125|69411188|FG001|Overall Study|Lost to Follow-up|1|||
37789553|NCT04307446|69411200|FG000|Overall Study|Lost to Follow-up|2|||
37789554|NCT04307446|69411201|FG001|Overall Study|Lost to Follow-up|0|||
37975427|NCT00398073|69662697|FG001|Overall Study|Withdrawal by Subject|0|||
37975428|NCT00490646|69662705|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
37789555|NCT04143009|69411223|FG000|Pilot Trial|Lost to Follow-up|0|||
37789556|NCT04143009|69411224|FG001|Pilot Trial|Lost to Follow-up|1|||
37789557|NCT04143009|69411225|FG002|Pilot Trial|Lost to Follow-up|1|||
37789558|NCT04126317|69411235|FG000|Overall Study|Adverse Event|0|||
37789559|NCT04126317|69411236|FG001|Overall Study|Adverse Event|1|||
37789560|NCT04126317|69411235|FG000|Overall Study|Withdrawal by Subject|4|||
37789561|NCT04126317|69411236|FG001|Overall Study|Withdrawal by Subject|1|||
37789562|NCT04066894|69411242|FG000|Overall Study|Lack of Efficacy|1|||
37789563|NCT04066894|69411242|FG000|Overall Study|Screen Failure|1|||
37789564|NCT03929913|69411268|FG000|Overall Study|Death|4|||
37789565|NCT03929913|69411268|FG000|Overall Study|Lost to Follow-up|1|||
37789566|NCT03929913|69411268|FG000|Overall Study|Failed Procedure|2|||
37789567|NCT03832192|69411283|FG000|Overall Study|Participants are disenrolled upon hospital discharge.|152|||
37789568|NCT03832192|69411284|FG001|Overall Study|Participants are disenrolled upon hospital discharge.|149|||
37975429|NCT00490646|69662706|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
37789569|NCT03738800|69411300|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
37975430|NCT00490646|69662705|FG000|Overall Study|Never Treated (had an adverse event)|1|||
37975431|NCT00490646|69662706|FG001|Overall Study|Never Treated (had an adverse event)|0|||
37975432|NCT00490646|69662705|FG000|Overall Study|Never Treated (withdrew consent)|0|||
37975433|NCT00490646|69662706|FG001|Overall Study|Never Treated (withdrew consent)|1|||
37975434|NCT00388947|69662712|FG000|Overall Study|Protocol Violation|47|||
37975435|NCT00490568|69662716|FG000|Overall Study|Adverse Event|116|||
37975436|NCT00490568|69662716|FG000|Overall Study|Lost to Follow-up|13|||
37975437|NCT00490568|69662716|FG000|Overall Study|Protocol Violation|45|||
37975438|NCT00490568|69662716|FG000|Overall Study|Withdrawal by Subject|135|||
37975439|NCT00490568|69662716|FG000|Overall Study|Still in the study at termination|974|||
37975440|NCT00490568|69662716|FG000|Overall Study|Other|1|||
37975441|NCT00490568|69662716|FG000|Overall Study|Exclusion criteria met|1|||
37975442|NCT00490568|69662716|FG000|Overall Study|Caregiver related|20|||
37975443|NCT00490568|69662716|FG000|Overall Study|Abnormal ECG|25|||
37975444|NCT00490568|69662716|FG000|Overall Study|Participant refused follow-up|9|||
37975445|NCT00490568|69662716|FG000|Overall Study|Legal representative withdrew consent|1|||
37975446|NCT00490568|69662716|FG000|Overall Study|Disease progression|4|||
37975447|NCT00490568|69662716|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
37975448|NCT00490568|69662716|FG000|Overall Study|Investigator decision|3|||
37975449|NCT00490568|69662716|FG000|Overall Study|Non-Compliance|7|||
37975450|NCT00490568|69662716|FG000|Overall Study|Efficacy related|3|||
37975451|NCT00490568|69662716|FG000|Overall Study|Participant died|1|||
37975452|NCT00490568|69662716|FG000|Overall Study|Participant withdrawal due to surgery|1|||
37975453|NCT00561353|69662731|FG000|Overall Study|Subject reached a virologic endpoint|2|||
37975454|NCT00561353|69662732|FG001|Overall Study|Subject reached a virologic endpoint|1|||
37975455|NCT00561353|69662733|FG002|Overall Study|Subject reached a virologic endpoint|1|||
37975456|NCT00561353|69662734|FG003|Overall Study|Subject reached a virologic endpoint|4|||
37975457|NCT00561353|69662735|FG004|Overall Study|Subject reached a virologic endpoint|1|||
37975458|NCT00561353|69662736|FG005|Overall Study|Subject reached a virologic endpoint|3|||
37789570|NCT03738800|69411301|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
37789571|NCT03738800|69411302|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
37789572|NCT03738800|69411300|FG000|Double-blind Treatment Period|Study Discontinued By Sponsor|5|||
37789573|NCT03738800|69411301|FG001|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
37789574|NCT03738800|69411302|FG002|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
37789575|NCT03738800|69411300|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
37789576|NCT03738800|69411301|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
37789577|NCT03738800|69411302|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
37789578|NCT03682055|69411321|FG000|Overall Study|Lack of Efficacy|1|||
37789579|NCT03682055|69411322|FG001|Overall Study|Lack of Efficacy|2|||
37789580|NCT03682055|69411323|FG002|Overall Study|Lack of Efficacy|1|||
37789581|NCT03682055|69411324|FG003|Overall Study|Lack of Efficacy|2|||
37789582|NCT03682055|69411325|FG004|Overall Study|Lack of Efficacy|1|||
37789583|NCT03682055|69411326|FG005|Overall Study|Lack of Efficacy|3|||
37789584|NCT03682055|69411321|FG000|Overall Study|Withdrawal by Subject|0|||
37789585|NCT03682055|69411322|FG001|Overall Study|Withdrawal by Subject|0|||
37789586|NCT03682055|69411323|FG002|Overall Study|Withdrawal by Subject|0|||
37789587|NCT03682055|69411324|FG003|Overall Study|Withdrawal by Subject|0|||
37789588|NCT03682055|69411325|FG004|Overall Study|Withdrawal by Subject|0|||
37789589|NCT03682055|69411326|FG005|Overall Study|Withdrawal by Subject|1|||
37789590|NCT03682055|69411321|FG000|Overall Study|Termination of Study by Sponsor|0|||
37789591|NCT03682055|69411322|FG001|Overall Study|Termination of Study by Sponsor|0|||
37789592|NCT03682055|69411323|FG002|Overall Study|Termination of Study by Sponsor|0|||
37789593|NCT03682055|69411324|FG003|Overall Study|Termination of Study by Sponsor|0|||
37789594|NCT03682055|69411325|FG004|Overall Study|Termination of Study by Sponsor|0|||
37789595|NCT03682055|69411326|FG005|Overall Study|Termination of Study by Sponsor|3|||
37789596|NCT03547518|69411342|FG000|Overall Study|Lost to Follow-up|2|||
37975459|NCT00561353|69662737|FG006|Overall Study|Subject reached a virologic endpoint|4|||
37789597|NCT03547518|69411343|FG001|Overall Study|Lost to Follow-up|0|||
37789598|NCT03519347|69411354|FG000|Interventional Crossover Period 1|Death|0|||
37789599|NCT03519347|69411355|FG001|Interventional Crossover Period 1|Death|0|||
37789600|NCT03519347|69411356|FG002|Interventional Crossover Period 1|Death|0|||
37789601|NCT03519347|69411357|FG003|Interventional Crossover Period 1|Death|1|||
37789602|NCT03199638|69411395|FG000|Overall Study|inability to drink glutamine during regularly|0|||
37789603|NCT03199638|69411396|FG001|Overall Study|inability to drink glutamine during regularly|2|||
37789604|NCT03015194|69411415|FG000|Overall Study|Death|10|||
37789605|NCT03015194|69411415|FG000|Overall Study|Withdrawal by Subject|2|||
37789606|NCT02873715|69411426|FG000|Overall Study|Lost to Follow-up|84|||
37789607|NCT02873715|69411427|FG001|Overall Study|Lost to Follow-up|94|||
37789608|NCT02873715|69411426|FG000|Overall Study|Withdrawal by Subject|7|||
37975460|NCT00561353|69662738|FG007|Overall Study|Subject reached a virologic endpoint|4|||
37975461|NCT00561353|69662739|FG008|Overall Study|Subject reached a virologic endpoint|5|||
37789609|NCT02873715|69411427|FG001|Overall Study|Withdrawal by Subject|26|||
37789610|NCT02536300|69411445|FG000|Overall Study|Investigator's Discretion|17|||
37789611|NCT02536300|69411446|FG001|Overall Study|Investigator's Discretion|11|||
37789612|NCT02536300|69411447|FG002|Overall Study|Investigator's Discretion|2|||
37789613|NCT02536300|69411445|FG000|Overall Study|Progressive Disease|11|||
37789614|NCT02536300|69411446|FG001|Overall Study|Progressive Disease|7|||
37789615|NCT02536300|69411447|FG002|Overall Study|Progressive Disease|6|||
37789616|NCT02536300|69411445|FG000|Overall Study|Study Terminated by Sponsor|6|||
37789617|NCT02536300|69411446|FG001|Overall Study|Study Terminated by Sponsor|4|||
37789618|NCT02536300|69411447|FG002|Overall Study|Study Terminated by Sponsor|7|||
37789619|NCT02536300|69411445|FG000|Overall Study|Death|7|||
37789620|NCT02536300|69411446|FG001|Overall Study|Death|0|||
37789621|NCT02536300|69411447|FG002|Overall Study|Death|5|||
37789622|NCT02536300|69411445|FG000|Overall Study|Withdrew Consent|4|||
37789623|NCT02536300|69411446|FG001|Overall Study|Withdrew Consent|2|||
37789624|NCT02536300|69411447|FG002|Overall Study|Withdrew Consent|0|||
37789625|NCT02536300|69411445|FG000|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
37789626|NCT02536300|69411446|FG001|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|2|||
37789627|NCT02536300|69411447|FG002|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
37789628|NCT02536300|69411445|FG000|Overall Study|Enrolled but Never Treated|0|||
37789629|NCT02536300|69411446|FG001|Overall Study|Enrolled but Never Treated|0|||
37789630|NCT02536300|69411447|FG002|Overall Study|Enrolled but Never Treated|1|||
37789631|NCT02536300|69411445|FG000|Overall Study|Non-compliance With Study Drug|1|||
37789632|NCT02536300|69411446|FG001|Overall Study|Non-compliance With Study Drug|0|||
37789633|NCT02536300|69411447|FG002|Overall Study|Non-compliance With Study Drug|0|||
37789634|NCT02536300|69411445|FG000|Overall Study|Protocol Violation|0|||
37789635|NCT02536300|69411446|FG001|Overall Study|Protocol Violation|1|||
37789636|NCT02536300|69411447|FG002|Overall Study|Protocol Violation|0|||
37789637|NCT02499354|69411466|FG000|Overall Study|Withdrawal by Subject|1|||
37789638|NCT02499354|69411467|FG001|Overall Study|Withdrawal by Subject|0|||
37789639|NCT02365649|69411479|FG000|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
37789640|NCT02365649|69411480|FG001|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
37789641|NCT02365649|69411481|FG002|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
37789642|NCT02365649|69411482|FG003|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|1|||
37789643|NCT02365649|69411483|FG004|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
37789644|NCT02365649|69411484|FG005|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
37789645|NCT02365649|69411485|FG006|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
37789646|NCT02365649|69411486|FG007|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
37789647|NCT02365649|69411487|FG008|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
37789648|NCT02365649|69411488|FG009|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
37789649|NCT02365649|69411479|FG000|Double-Blind Induction (Weeks 1-16)|Adverse Event|3|||
37789650|NCT02365649|69411480|FG001|Double-Blind Induction (Weeks 1-16)|Adverse Event|4|||
37789651|NCT02365649|69411481|FG002|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
37789652|NCT02365649|69411482|FG003|Double-Blind Induction (Weeks 1-16)|Adverse Event|7|||
37789653|NCT02365649|69411483|FG004|Double-Blind Induction (Weeks 1-16)|Adverse Event|1|||
37789654|NCT02365649|69411484|FG005|Double-Blind Induction (Weeks 1-16)|Adverse Event|2|||
37789655|NCT02365649|69411485|FG006|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
37789656|NCT02365649|69411486|FG007|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
37789657|NCT02365649|69411487|FG008|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
37789658|NCT02365649|69411488|FG009|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
37789659|NCT02365649|69411479|FG000|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|3|||
37789660|NCT02365649|69411480|FG001|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
37789661|NCT02365649|69411481|FG002|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
37789662|NCT02365649|69411482|FG003|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
37789663|NCT02365649|69411483|FG004|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|2|||
37789664|NCT02365649|69411484|FG005|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
37789665|NCT02365649|69411485|FG006|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
37789666|NCT02365649|69411486|FG007|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
37789667|NCT02365649|69411487|FG008|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
37789668|NCT02365649|69411488|FG009|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
37789669|NCT02365649|69411479|FG000|Double-Blind Induction (Weeks 1-16)|Other|1|||
37789670|NCT02365649|69411480|FG001|Double-Blind Induction (Weeks 1-16)|Other|0|||
37789671|NCT02365649|69411481|FG002|Double-Blind Induction (Weeks 1-16)|Other|1|||
37789672|NCT02365649|69411482|FG003|Double-Blind Induction (Weeks 1-16)|Other|0|||
37789673|NCT02365649|69411483|FG004|Double-Blind Induction (Weeks 1-16)|Other|1|||
37789674|NCT02365649|69411484|FG005|Double-Blind Induction (Weeks 1-16)|Other|1|||
37789675|NCT02365649|69411485|FG006|Double-Blind Induction (Weeks 1-16)|Other|0|||
37789676|NCT02365649|69411486|FG007|Double-Blind Induction (Weeks 1-16)|Other|0|||
37789677|NCT02365649|69411487|FG008|Double-Blind Induction (Weeks 1-16)|Other|0|||
37789678|NCT02365649|69411488|FG009|Double-Blind Induction (Weeks 1-16)|Other|0|||
37789679|NCT02365649|69411479|FG000|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
37789680|NCT02365649|69411480|FG001|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
37789681|NCT02365649|69411481|FG002|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|1|||
37789682|NCT02365649|69411482|FG003|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
37789683|NCT02365649|69411483|FG004|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
37789684|NCT02365649|69411484|FG005|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
37789685|NCT02365649|69411485|FG006|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
37789686|NCT02365649|69411486|FG007|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
37789687|NCT02365649|69411487|FG008|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
37789688|NCT02365649|69411488|FG009|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
37789689|NCT02365649|69411479|FG000|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
37789690|NCT02365649|69411480|FG001|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
37789691|NCT02365649|69411481|FG002|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
37789692|NCT02365649|69411482|FG003|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
37789693|NCT02365649|69411483|FG004|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
37975462|NCT00561353|69662740|FG009|Overall Study|Subject reached a virologic endpoint|0|||
37975463|NCT00561353|69662731|FG000|Overall Study|Subject ineligible to continue the trial|0|||
37975464|NCT00561353|69662732|FG001|Overall Study|Subject ineligible to continue the trial|0|||
37975465|NCT00561353|69662733|FG002|Overall Study|Subject ineligible to continue the trial|0|||
37975466|NCT00561353|69662734|FG003|Overall Study|Subject ineligible to continue the trial|0|||
37975467|NCT00561353|69662735|FG004|Overall Study|Subject ineligible to continue the trial|0|||
37975468|NCT00561353|69662736|FG005|Overall Study|Subject ineligible to continue the trial|1|||
37975469|NCT00561353|69662737|FG006|Overall Study|Subject ineligible to continue the trial|1|||
37975470|NCT00561353|69662738|FG007|Overall Study|Subject ineligible to continue the trial|0|||
37975471|NCT00561353|69662739|FG008|Overall Study|Subject ineligible to continue the trial|2|||
37975472|NCT00561353|69662740|FG009|Overall Study|Subject ineligible to continue the trial|1|||
37975473|NCT00561353|69662731|FG000|Overall Study|Other|1|||
37975474|NCT00561353|69662732|FG001|Overall Study|Other|0|||
37975475|NCT00561353|69662733|FG002|Overall Study|Other|1|||
37975476|NCT00561353|69662734|FG003|Overall Study|Other|0|||
37975477|NCT00561353|69662735|FG004|Overall Study|Other|0|||
37975478|NCT00561353|69662736|FG005|Overall Study|Other|2|||
37975479|NCT00561353|69662737|FG006|Overall Study|Other|0|||
37975480|NCT00561353|69662738|FG007|Overall Study|Other|0|||
37789694|NCT02365649|69411484|FG005|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
37789695|NCT02365649|69411485|FG006|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
37975481|NCT00561353|69662739|FG008|Overall Study|Other|0|||
37975482|NCT00561353|69662740|FG009|Overall Study|Other|0|||
37789696|NCT02365649|69411486|FG007|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
37789697|NCT02365649|69411487|FG008|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
37789698|NCT02365649|69411488|FG009|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
37789699|NCT02365649|69411479|FG000|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
37789700|NCT02365649|69411480|FG001|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
37789701|NCT02365649|69411481|FG002|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|1|||
37789702|NCT02365649|69411482|FG003|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
37789703|NCT02365649|69411483|FG004|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
37789704|NCT02365649|69411484|FG005|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
37789705|NCT02365649|69411485|FG006|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
37789706|NCT02365649|69411486|FG007|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
37789707|NCT02365649|69411487|FG008|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
37789708|NCT02365649|69411488|FG009|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
37789709|NCT02365649|69411479|FG000|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
37789710|NCT02365649|69411480|FG001|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
37789711|NCT02365649|69411481|FG002|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
37789712|NCT02365649|69411482|FG003|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
37789713|NCT02365649|69411483|FG004|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
37789714|NCT02365649|69411484|FG005|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
37789715|NCT02365649|69411485|FG006|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|2|||
37789716|NCT02365649|69411486|FG007|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
37789717|NCT02365649|69411487|FG008|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
37789718|NCT02365649|69411488|FG009|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
37789719|NCT02365649|69411479|FG000|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
37789720|NCT02365649|69411480|FG001|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
37789721|NCT02365649|69411481|FG002|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
37789722|NCT02365649|69411482|FG003|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
37789723|NCT02365649|69411483|FG004|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
37789724|NCT02365649|69411484|FG005|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
37789725|NCT02365649|69411485|FG006|Double-Blind Extension (Weeks 16-52)|Adverse Event|6|||
37789726|NCT02365649|69411486|FG007|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
37789727|NCT02365649|69411487|FG008|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
37789728|NCT02365649|69411488|FG009|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
37789729|NCT02365649|69411479|FG000|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
37789730|NCT02365649|69411480|FG001|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
37789731|NCT02365649|69411481|FG002|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
37789732|NCT02365649|69411482|FG003|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
37789733|NCT02365649|69411483|FG004|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
37789734|NCT02365649|69411484|FG005|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
37789735|NCT02365649|69411485|FG006|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|7|||
37789736|NCT02365649|69411486|FG007|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|2|||
37789737|NCT02365649|69411487|FG008|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|8|||
37789738|NCT02365649|69411488|FG009|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|10|||
37789739|NCT02365649|69411479|FG000|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
37789740|NCT02365649|69411480|FG001|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
37789741|NCT02365649|69411481|FG002|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
37789742|NCT02365649|69411482|FG003|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
37789743|NCT02365649|69411483|FG004|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
37789744|NCT02365649|69411484|FG005|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
37789745|NCT02365649|69411485|FG006|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
37789746|NCT02365649|69411486|FG007|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
37789747|NCT02365649|69411487|FG008|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|2|||
37789748|NCT02365649|69411488|FG009|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
37789749|NCT02365649|69411479|FG000|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
37789750|NCT02365649|69411480|FG001|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
37789751|NCT02365649|69411481|FG002|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
37789752|NCT02365649|69411482|FG003|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
37975483|NCT00561353|69662731|FG000|Overall Study|Adverse Event|0|||
37789753|NCT02365649|69411483|FG004|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
37789754|NCT02365649|69411484|FG005|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
37789755|NCT02365649|69411485|FG006|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
37789756|NCT02365649|69411486|FG007|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
37789757|NCT02365649|69411487|FG008|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
37789758|NCT02365649|69411488|FG009|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
37789759|NCT01949662|69411518|FG000|Overall Study|Death|9|||
37789760|NCT01949662|69411519|FG001|Overall Study|Death|7|||
37789761|NCT01949662|69411518|FG000|Overall Study|Discharged before an agitation event|8|||
37789762|NCT01949662|69411519|FG001|Overall Study|Discharged before an agitation event|3|||
37789763|NCT01949662|69411518|FG000|Overall Study|Dropped out|1|||
37789764|NCT01949662|69411519|FG001|Overall Study|Dropped out|3|||
37789765|NCT01949662|69411518|FG000|Overall Study|Ineligible|0|||
37789766|NCT01949662|69411519|FG001|Overall Study|Ineligible|1|||
37789767|NCT01856686|69411527|FG000|Overall Study|Lost to Follow-up|5|||
37789768|NCT01856686|69411528|FG001|Overall Study|Lost to Follow-up|11|||
37789769|NCT01770145|69411534|FG000|Baseline|Adverse Event|20|||
37789770|NCT01770145|69411534|FG000|Baseline|Withdrawal by Subject|1|||
37789771|NCT01770145|69411534|FG000|Baseline|Lost to Follow-up|1|||
37789772|NCT01770145|69411534|FG000|Baseline|Unable to define optimal dose|4|||
37789773|NCT01770145|69411534|FG000|Treatment|Adverse Event|3|||
37789774|NCT01770145|69411534|FG000|Treatment|Withdrawal by Subject|1|||
37789775|NCT01749137|69411540|FG000|Overall Study|Adverse Event|4|||
37789776|NCT01749137|69411541|FG001|Overall Study|Adverse Event|4|||
37789777|NCT01749137|69411540|FG000|Overall Study|Lost to Follow-up|2|||
37789778|NCT01749137|69411541|FG001|Overall Study|Lost to Follow-up|3|||
37789779|NCT01749137|69411540|FG000|Overall Study|Physician Decision|1|||
37789780|NCT01749137|69411541|FG001|Overall Study|Physician Decision|0|||
37789781|NCT01749137|69411540|FG000|Overall Study|Withdrawal by Subject|8|||
37789782|NCT01749137|69411541|FG001|Overall Study|Withdrawal by Subject|4|||
37789783|NCT01726582|69411547|FG000|Overall Study|Physician Decision|99|||
37789784|NCT01726582|69411547|FG000|Overall Study|Death|85|||
37789785|NCT00794339|69411562|FG000|Overall Study|Withdrawal by Subject|3|||
37789786|NCT00794339|69411562|FG000|Overall Study|Ineligible|4|||
37789787|NCT00794339|69411562|FG000|Overall Study|Tx prior to ATSM|3|||
37789788|NCT00794339|69411562|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
37789789|NCT00794339|69411562|FG000|Overall Study|Tx not per protocol|1|||
37789790|NCT00506662|69411589|FG000|Overall Study|Adverse Event|0|||
37789791|NCT00506662|69411590|FG001|Overall Study|Adverse Event|2|||
37789792|NCT00506662|69411589|FG000|Overall Study|Lack of Efficacy|1|||
37789793|NCT00506662|69411590|FG001|Overall Study|Lack of Efficacy|0|||
37789794|NCT00506662|69411589|FG000|Overall Study|Protocol Violation|2|||
37789795|NCT00506662|69411590|FG001|Overall Study|Protocol Violation|4|||
37789796|NCT00506662|69411589|FG000|Overall Study|Trial terminated|10|||
37789797|NCT00506662|69411590|FG001|Overall Study|Trial terminated|16|||
37789798|NCT00506662|69411589|FG000|Overall Study|Not recorded|4|||
37789799|NCT00506662|69411590|FG001|Overall Study|Not recorded|6|||
37789800|NCT00161213|69411596|FG000|Overall Study|Withdrawal by Subject|1|||
37789801|NCT00161213|69411596|FG000|Overall Study|Evaluable for toxicity but not response|1|||
37789802|NCT00006436|69411604|FG000|Overall Study|Refused further treatment|2|||
37789803|NCT00006436|69411604|FG000|Overall Study|Declined to participate (before treatment started)|1|||
37789804|NCT03838484|69411827|FG000|Overall Study|Lost to Follow-up|0|||
37789805|NCT03838484|69411828|FG001|Overall Study|Lost to Follow-up|1|||
37789806|NCT03838484|69411829|FG002|Overall Study|Lost to Follow-up|0|||
37789807|NCT03838484|69411830|FG003|Overall Study|Lost to Follow-up|0|||
37789808|NCT01349192|69412062|FG000|Overall Study|Protocol Violation|0|||
37789809|NCT01349192|69412063|FG001|Overall Study|Protocol Violation|1|||
37789810|NCT01349192|69412062|FG000|Overall Study|Withdrawal by Subject|0|||
37789811|NCT01349192|69412063|FG001|Overall Study|Withdrawal by Subject|2|||
37789812|NCT01349192|69412062|FG000|Overall Study|Lost to Follow-up|1|||
37789813|NCT01349192|69412063|FG001|Overall Study|Lost to Follow-up|3|||
37789814|NCT01349192|69412062|FG000|Overall Study|Failure to adhere to Protocol|2|||
37789815|NCT01349192|69412063|FG001|Overall Study|Failure to adhere to Protocol|0|||
37789816|NCT01721876|69412418|FG000|Overall Study|Not treated|1|||
37789817|NCT01721876|69412419|FG001|Overall Study|Not treated|4|||
37789818|NCT01721876|69412418|FG000|Overall Study|Disease progression / relapse|123|||
37789819|NCT01721876|69412419|FG001|Overall Study|Disease progression / relapse|156|||
37789820|NCT01721876|69412418|FG000|Overall Study|Death|6|||
37789821|NCT01721876|69412419|FG001|Overall Study|Death|13|||
37789822|NCT01721876|69412418|FG000|Overall Study|Adverse Event|41|||
37789823|NCT01721876|69412419|FG001|Overall Study|Adverse Event|165|||
37789824|NCT01721876|69412418|FG000|Overall Study|Protocol Violation|2|||
37789825|NCT01721876|69412419|FG001|Overall Study|Protocol Violation|1|||
37789826|NCT01721876|69412418|FG000|Overall Study|Withdrawal by Subject|15|||
37789827|NCT01721876|69412419|FG001|Overall Study|Withdrawal by Subject|38|||
37789828|NCT01721876|69412418|FG000|Overall Study|Reason not listed|34|||
37789829|NCT01721876|69412419|FG001|Overall Study|Reason not listed|63|||
37789830|NCT01721876|69412418|FG000|Overall Study|Sponsor terminated trial|0|||
37693710|NCT02060487|69170035|FG001|Overall Study|Withdrawal by Subject|10|||
37693711|NCT02060487|69170036|FG002|Overall Study|Withdrawal by Subject|4|||
37693712|NCT02060487|69170034|FG000|Overall Study|Study Terminated By Sponsor|87|||
37693713|NCT02060487|69170035|FG001|Overall Study|Study Terminated By Sponsor|89|||
37693714|NCT02060487|69170036|FG002|Overall Study|Study Terminated By Sponsor|100|||
37789831|NCT01721876|69412419|FG001|Overall Study|Sponsor terminated trial|4|||
37789832|NCT02265510|69412650|FG000|Overall Study|Withdrawal by Subject|1|||
37789833|NCT02265510|69412651|FG001|Overall Study|Withdrawal by Subject|1|||
37789834|NCT02265510|69412652|FG002|Overall Study|Withdrawal by Subject|2|||
37789835|NCT02265510|69412653|FG003|Overall Study|Withdrawal by Subject|1|||
37789836|NCT02265510|69412654|FG004|Overall Study|Withdrawal by Subject|0|||
37789837|NCT02265510|69412655|FG005|Overall Study|Withdrawal by Subject|2|||
37789838|NCT02265510|69412656|FG006|Overall Study|Withdrawal by Subject|0|||
37789839|NCT02265510|69412657|FG007|Overall Study|Withdrawal by Subject|2|||
37789840|NCT02265510|69412658|FG008|Overall Study|Withdrawal by Subject|0|||
37789841|NCT02265510|69412659|FG009|Overall Study|Withdrawal by Subject|0|||
37789842|NCT02265510|69412660|FG010|Overall Study|Withdrawal by Subject|0|||
37864095|NCT00991276|69547780|FG003|First Intervention Period|Adverse Event|1|||
37864096|NCT00991276|69547781|FG004|First Intervention Period|Adverse Event|0|||
37864097|NCT00991276|69547782|FG005|First Intervention Period|Adverse Event|0|||
37864098|NCT00991276|69547777|FG000|First Intervention Period|Protocol Violation|0|||
37864099|NCT00991276|69547778|FG001|First Intervention Period|Protocol Violation|0|||
37864100|NCT00991276|69547779|FG002|First Intervention Period|Protocol Violation|0|||
37864101|NCT00991276|69547780|FG003|First Intervention Period|Protocol Violation|0|||
37864102|NCT00991276|69547781|FG004|First Intervention Period|Protocol Violation|2|||
37864103|NCT00991276|69547782|FG005|First Intervention Period|Protocol Violation|0|||
37864104|NCT00991276|69547777|FG000|First Intervention Period|Insufficient clinical response|0|||
37864105|NCT00991276|69547778|FG001|First Intervention Period|Insufficient clinical response|0|||
37789843|NCT02265510|69412661|FG011|Overall Study|Withdrawal by Subject|0|||
37789844|NCT02265510|69412662|FG012|Overall Study|Withdrawal by Subject|1|||
37789845|NCT02265510|69412663|FG013|Overall Study|Withdrawal by Subject|0|||
37789846|NCT02265510|69412650|FG000|Overall Study|Disease Progression|0|||
37789847|NCT02265510|69412651|FG001|Overall Study|Disease Progression|1|||
37789848|NCT02265510|69412652|FG002|Overall Study|Disease Progression|2|||
37789849|NCT02265510|69412653|FG003|Overall Study|Disease Progression|1|||
37789850|NCT02265510|69412654|FG004|Overall Study|Disease Progression|1|||
37789851|NCT02265510|69412655|FG005|Overall Study|Disease Progression|0|||
37789852|NCT02265510|69412656|FG006|Overall Study|Disease Progression|0|||
37789853|NCT02265510|69412657|FG007|Overall Study|Disease Progression|0|||
37789854|NCT02265510|69412658|FG008|Overall Study|Disease Progression|0|||
37789855|NCT02265510|69412659|FG009|Overall Study|Disease Progression|0|||
37789856|NCT02265510|69412660|FG010|Overall Study|Disease Progression|0|||
37789857|NCT02265510|69412661|FG011|Overall Study|Disease Progression|0|||
37789858|NCT02265510|69412662|FG012|Overall Study|Disease Progression|0|||
37789859|NCT02265510|69412663|FG013|Overall Study|Disease Progression|0|||
37789860|NCT02265510|69412650|FG000|Overall Study|Death|2|||
37789861|NCT02265510|69412651|FG001|Overall Study|Death|0|||
37789862|NCT02265510|69412652|FG002|Overall Study|Death|2|||
37789863|NCT02265510|69412653|FG003|Overall Study|Death|2|||
37789864|NCT02265510|69412654|FG004|Overall Study|Death|1|||
37789865|NCT02265510|69412655|FG005|Overall Study|Death|3|||
37789866|NCT02265510|69412656|FG006|Overall Study|Death|2|||
37789867|NCT02265510|69412657|FG007|Overall Study|Death|1|||
37789868|NCT02265510|69412658|FG008|Overall Study|Death|3|||
37789869|NCT02265510|69412659|FG009|Overall Study|Death|3|||
37789870|NCT02265510|69412660|FG010|Overall Study|Death|4|||
37789871|NCT02265510|69412661|FG011|Overall Study|Death|12|||
37789872|NCT02265510|69412662|FG012|Overall Study|Death|7|||
37789873|NCT02265510|69412663|FG013|Overall Study|Death|6|||
37789874|NCT02265510|69412650|FG000|Overall Study|Lost to Follow-up|0|||
37789875|NCT02265510|69412651|FG001|Overall Study|Lost to Follow-up|0|||
37789876|NCT02265510|69412652|FG002|Overall Study|Lost to Follow-up|0|||
37789877|NCT02265510|69412653|FG003|Overall Study|Lost to Follow-up|0|||
37789878|NCT02265510|69412654|FG004|Overall Study|Lost to Follow-up|1|||
37789879|NCT02265510|69412655|FG005|Overall Study|Lost to Follow-up|0|||
37789880|NCT02265510|69412656|FG006|Overall Study|Lost to Follow-up|0|||
37864106|NCT00991276|69547779|FG002|First Intervention Period|Insufficient clinical response|0|||
37789881|NCT02265510|69412657|FG007|Overall Study|Lost to Follow-up|0|||
37789882|NCT02265510|69412658|FG008|Overall Study|Lost to Follow-up|0|||
37789883|NCT02265510|69412659|FG009|Overall Study|Lost to Follow-up|2|||
37789884|NCT02265510|69412660|FG010|Overall Study|Lost to Follow-up|0|||
37789885|NCT02265510|69412661|FG011|Overall Study|Lost to Follow-up|0|||
37789886|NCT02265510|69412662|FG012|Overall Study|Lost to Follow-up|0|||
37789887|NCT02265510|69412663|FG013|Overall Study|Lost to Follow-up|2|||
37789888|NCT02265510|69412650|FG000|Overall Study|Other|0|||
37789889|NCT02265510|69412651|FG001|Overall Study|Other|1|||
37789890|NCT02265510|69412652|FG002|Overall Study|Other|0|||
37789891|NCT02265510|69412653|FG003|Overall Study|Other|0|||
37789892|NCT02265510|69412654|FG004|Overall Study|Other|0|||
37789893|NCT02265510|69412655|FG005|Overall Study|Other|0|||
37975484|NCT00561353|69662732|FG001|Overall Study|Adverse Event|0|||
37975485|NCT00561353|69662733|FG002|Overall Study|Adverse Event|0|||
37975486|NCT00561353|69662734|FG003|Overall Study|Adverse Event|2|||
37975487|NCT00561353|69662735|FG004|Overall Study|Adverse Event|0|||
37975488|NCT00561353|69662736|FG005|Overall Study|Adverse Event|0|||
37975489|NCT00561353|69662737|FG006|Overall Study|Adverse Event|1|||
37975490|NCT00561353|69662738|FG007|Overall Study|Adverse Event|0|||
37975491|NCT00561353|69662739|FG008|Overall Study|Adverse Event|0|||
37975492|NCT00561353|69662740|FG009|Overall Study|Adverse Event|1|||
37975493|NCT00561353|69662731|FG000|Overall Study|Lost to Follow-up|2|||
37975494|NCT00561353|69662732|FG001|Overall Study|Lost to Follow-up|0|||
37975495|NCT00561353|69662733|FG002|Overall Study|Lost to Follow-up|1|||
37975496|NCT00561353|69662734|FG003|Overall Study|Lost to Follow-up|0|||
37975497|NCT00561353|69662735|FG004|Overall Study|Lost to Follow-up|0|||
37975498|NCT00561353|69662736|FG005|Overall Study|Lost to Follow-up|0|||
37975499|NCT00561353|69662737|FG006|Overall Study|Lost to Follow-up|0|||
37975500|NCT00561353|69662738|FG007|Overall Study|Lost to Follow-up|0|||
37975501|NCT00561353|69662739|FG008|Overall Study|Lost to Follow-up|0|||
37975502|NCT00561353|69662740|FG009|Overall Study|Lost to Follow-up|0|||
37975503|NCT00561353|69662731|FG000|Overall Study|Withdrawal by Subject|0|||
37975504|NCT00561353|69662732|FG001|Overall Study|Withdrawal by Subject|2|||
37975505|NCT00561353|69662733|FG002|Overall Study|Withdrawal by Subject|0|||
37975506|NCT00561353|69662734|FG003|Overall Study|Withdrawal by Subject|0|||
37975507|NCT00561353|69662735|FG004|Overall Study|Withdrawal by Subject|0|||
37975508|NCT00561353|69662736|FG005|Overall Study|Withdrawal by Subject|0|||
37975509|NCT00561353|69662737|FG006|Overall Study|Withdrawal by Subject|0|||
37693715|NCT02060487|69170034|FG000|Overall Study|Randomized in error|1|||
37789894|NCT02265510|69412656|FG006|Overall Study|Other|0|||
37975510|NCT00561353|69662738|FG007|Overall Study|Withdrawal by Subject|0|||
37789895|NCT02265510|69412657|FG007|Overall Study|Other|0|||
37789896|NCT02265510|69412658|FG008|Overall Study|Other|0|||
37789897|NCT02265510|69412659|FG009|Overall Study|Other|0|||
37789898|NCT02265510|69412660|FG010|Overall Study|Other|0|||
37789899|NCT02265510|69412661|FG011|Overall Study|Other|0|||
37789900|NCT02265510|69412662|FG012|Overall Study|Other|0|||
37789901|NCT02265510|69412663|FG013|Overall Study|Other|0|||
37975511|NCT00561353|69662739|FG008|Overall Study|Withdrawal by Subject|0|||
37975512|NCT00561353|69662740|FG009|Overall Study|Withdrawal by Subject|0|||
37975513|NCT00560885|69662807|FG000|Overall Study|Death|7|||
37975514|NCT00560885|69662807|FG000|Overall Study|Withdrawal by Subject|1|||
37975515|NCT00397215|69662815|FG000|Month 0 (Day 0)|Adverse Event|0|||
37975516|NCT00397215|69662816|FG001|Month 0 (Day 0)|Adverse Event|1|||
37975517|NCT00397215|69662817|FG002|Month 0 (Day 0)|Adverse Event|0|||
37693716|NCT02060487|69170035|FG001|Overall Study|Randomized in error|0|||
37693717|NCT02060487|69170036|FG002|Overall Study|Randomized in error|0|||
37789902|NCT02265510|69412650|FG000|Overall Study|Study Terminated by Sponsor|0|||
37789903|NCT02265510|69412651|FG001|Overall Study|Study Terminated by Sponsor|0|||
37789904|NCT02265510|69412652|FG002|Overall Study|Study Terminated by Sponsor|0|||
37789905|NCT02265510|69412653|FG003|Overall Study|Study Terminated by Sponsor|0|||
37789906|NCT02265510|69412654|FG004|Overall Study|Study Terminated by Sponsor|0|||
37789907|NCT02265510|69412655|FG005|Overall Study|Study Terminated by Sponsor|1|||
37789908|NCT02265510|69412656|FG006|Overall Study|Study Terminated by Sponsor|1|||
37789909|NCT02265510|69412657|FG007|Overall Study|Study Terminated by Sponsor|1|||
37789910|NCT02265510|69412658|FG008|Overall Study|Study Terminated by Sponsor|1|||
37789911|NCT02265510|69412659|FG009|Overall Study|Study Terminated by Sponsor|2|||
37789912|NCT02265510|69412660|FG010|Overall Study|Study Terminated by Sponsor|1|||
37789913|NCT02265510|69412661|FG011|Overall Study|Study Terminated by Sponsor|4|||
37789914|NCT02265510|69412662|FG012|Overall Study|Study Terminated by Sponsor|1|||
37789915|NCT02265510|69412663|FG013|Overall Study|Study Terminated by Sponsor|2|||
37789916|NCT01238211|69412764|FG000|Overall Study|Continues active treatment|31|||
37789917|NCT01238211|69412764|FG000|Overall Study|Adverse Event|7|||
37789918|NCT01238211|69412764|FG000|Overall Study|Death|4|||
37789919|NCT01238211|69412764|FG000|Overall Study|Relapse/Progression|2|||
37789920|NCT01238211|69412764|FG000|Overall Study|Withdrawal by Subject|7|||
37789921|NCT01238211|69412764|FG000|Overall Study|Non-protocol treatment|4|||
37789922|NCT01238211|69412764|FG000|Overall Study|Investigator/Patient Decision|3|||
37789923|NCT02264574|69412940|FG000|Overall Study|Death|21|||
37789924|NCT02264574|69412941|FG001|Overall Study|Death|21|||
37789925|NCT02264574|69412940|FG000|Overall Study|Withdrawal by Subject|8|||
37789926|NCT02264574|69412941|FG001|Overall Study|Withdrawal by Subject|6|||
37789927|NCT02264574|69412940|FG000|Overall Study|Other, Not Specified|0|||
37789928|NCT02264574|69412941|FG001|Overall Study|Other, Not Specified|3|||
37789929|NCT01641900|69412981|FG000|Overall Study|Withdrawal by Subject|2|||
37789930|NCT01641900|69412982|FG001|Overall Study|Withdrawal by Subject|2|||
37789931|NCT01640808|69413055|FG000|Overall Study|Unable to continue dynamic CT|14|||
37789932|NCT01640808|69413056|FG001|Overall Study|Unable to continue dynamic CT|4|||
37789933|NCT01640808|69413055|FG000|Overall Study|Withdrawal by Subject|12|||
37789934|NCT01640808|69413056|FG001|Overall Study|Withdrawal by Subject|4|||
37789935|NCT01640808|69413055|FG000|Overall Study|Lost to Follow-up|4|||
37789936|NCT01640808|69413056|FG001|Overall Study|Lost to Follow-up|0|||
37789937|NCT01640808|69413055|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
37789938|NCT01640808|69413056|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
37789939|NCT01640808|69413055|FG000|Overall Study|Administration of anticancer drugs|2|||
37789940|NCT01640808|69413056|FG001|Overall Study|Administration of anticancer drugs|1|||
37789941|NCT01640808|69413055|FG000|Overall Study|Physician Decision|19|||
37789942|NCT01640808|69413056|FG001|Overall Study|Physician Decision|5|||
37789943|NCT01640808|69413055|FG000|Overall Study|Randomized but not treated|4|||
37789944|NCT01640808|69413056|FG001|Overall Study|Randomized but not treated|2|||
37789945|NCT02263326|69413077|FG000|Overall Study|Lost to Follow-up|1|||
37789946|NCT02263326|69413078|FG001|Overall Study|Lost to Follow-up|1|||
37789947|NCT02260986|69413184|FG000|Overall Study|Adverse Event|24|||
37789948|NCT02260986|69413185|FG001|Overall Study|Adverse Event|0|||
37789949|NCT02260986|69413186|FG002|Overall Study|Adverse Event|11|||
37789950|NCT02260986|69413184|FG000|Overall Study|Lack of Efficacy|27|||
37789951|NCT02260986|69413185|FG001|Overall Study|Lack of Efficacy|3|||
37789952|NCT02260986|69413186|FG002|Overall Study|Lack of Efficacy|0|||
37789953|NCT02260986|69413184|FG000|Overall Study|Protocol Violation|14|||
37789954|NCT02260986|69413185|FG001|Overall Study|Protocol Violation|5|||
37789955|NCT02260986|69413186|FG002|Overall Study|Protocol Violation|16|||
37789956|NCT02260986|69413184|FG000|Overall Study|Car accident|0|||
37789957|NCT02260986|69413185|FG001|Overall Study|Car accident|0|||
37789958|NCT02260986|69413186|FG002|Overall Study|Car accident|1|||
37789959|NCT02260986|69413184|FG000|Overall Study|Withdrawal by Subject|17|||
37789960|NCT02260986|69413185|FG001|Overall Study|Withdrawal by Subject|4|||
37789961|NCT02260986|69413186|FG002|Overall Study|Withdrawal by Subject|9|||
37789962|NCT02260986|69413184|FG000|Overall Study|Incorrect randomization|0|||
37789963|NCT02260986|69413185|FG001|Overall Study|Incorrect randomization|1|||
37789964|NCT02260986|69413186|FG002|Overall Study|Incorrect randomization|0|||
37789965|NCT02260986|69413184|FG000|Overall Study|Lack of investigation product supply|2|||
37789966|NCT02260986|69413185|FG001|Overall Study|Lack of investigation product supply|0|||
37789967|NCT02260986|69413186|FG002|Overall Study|Lack of investigation product supply|1|||
37789968|NCT02260986|69413184|FG000|Overall Study|Lost to Follow-up|4|||
37789969|NCT02260986|69413185|FG001|Overall Study|Lost to Follow-up|0|||
37789970|NCT02260986|69413186|FG002|Overall Study|Lost to Follow-up|3|||
37789971|NCT02260986|69413184|FG000|Overall Study|Pregnancy|2|||
37789972|NCT02260986|69413185|FG001|Overall Study|Pregnancy|0|||
37789973|NCT02260986|69413186|FG002|Overall Study|Pregnancy|0|||
37789974|NCT02259582|69413202|FG000|Overall Study|Physician Decision|0|||
37789975|NCT02259582|69413203|FG001|Overall Study|Physician Decision|1|||
37789976|NCT02259582|69413204|FG002|Overall Study|Physician Decision|0|||
37789977|NCT02259582|69413202|FG000|Overall Study|Death|0|||
37789978|NCT02259582|69413203|FG001|Overall Study|Death|0|||
37789979|NCT02259582|69413204|FG002|Overall Study|Death|1|||
37789980|NCT02259582|69413202|FG000|Overall Study|Adverse Event|1|||
37789981|NCT02259582|69413203|FG001|Overall Study|Adverse Event|0|||
37789982|NCT02259582|69413204|FG002|Overall Study|Adverse Event|1|||
37789983|NCT02259582|69413202|FG000|Overall Study|Withdrawal by Subject|0|||
37789984|NCT02259582|69413203|FG001|Overall Study|Withdrawal by Subject|0|||
37789985|NCT02259582|69413204|FG002|Overall Study|Withdrawal by Subject|1|||
37789986|NCT02259582|69413202|FG000|Overall Study|Disease progression|14|||
37789987|NCT02259582|69413203|FG001|Overall Study|Disease progression|15|||
37789988|NCT02259582|69413204|FG002|Overall Study|Disease progression|17|||
37789989|NCT02259582|69413202|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
37789990|NCT02259582|69413203|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
37789991|NCT02259582|69413204|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
37789992|NCT03238651|69413217|FG000|Overall Study|Other|0|||
37789993|NCT03238651|69413218|FG001|Overall Study|Other|0|||
37789994|NCT03238651|69413219|FG002|Overall Study|Other|0|||
37789995|NCT03238651|69413220|FG003|Overall Study|Other|0|||
37789996|NCT03238651|69413221|FG004|Overall Study|Other|1|||
37789997|NCT03238651|69413217|FG000|Overall Study|Progressive Disease|2|||
37789998|NCT03238651|69413218|FG001|Overall Study|Progressive Disease|2|||
37789999|NCT03238651|69413219|FG002|Overall Study|Progressive Disease|2|||
37790000|NCT03238651|69413220|FG003|Overall Study|Progressive Disease|2|||
37790001|NCT03238651|69413221|FG004|Overall Study|Progressive Disease|0|||
37790002|NCT03238651|69413217|FG000|Overall Study|Withdrawal by Subject|0|||
37790003|NCT03238651|69413218|FG001|Overall Study|Withdrawal by Subject|1|||
37790004|NCT03238651|69413219|FG002|Overall Study|Withdrawal by Subject|0|||
37790005|NCT03238651|69413220|FG003|Overall Study|Withdrawal by Subject|1|||
37790006|NCT03238651|69413221|FG004|Overall Study|Withdrawal by Subject|0|||
37790007|NCT03238651|69413217|FG000|Overall Study|Adverse Event|1|||
37790008|NCT03238651|69413218|FG001|Overall Study|Adverse Event|3|||
37790009|NCT03238651|69413219|FG002|Overall Study|Adverse Event|2|||
37790010|NCT03238651|69413220|FG003|Overall Study|Adverse Event|0|||
37790011|NCT03238651|69413221|FG004|Overall Study|Adverse Event|0|||
37790012|NCT05490771|69413245|FG000|Overall Study|Disease progression|18|||
37790013|NCT05490771|69413245|FG000|Overall Study|Adverse Event|3|||
37790014|NCT05490771|69413245|FG000|Overall Study|Other complicating disease|1|||
37790015|NCT05490771|69413245|FG000|Overall Study|Withdrawal by Subject|3|||
37790016|NCT05490771|69413245|FG000|Overall Study|Physician Decision|1|||
37790017|NCT05490771|69413245|FG000|Overall Study|Still on treatment|2|||
37790018|NCT05490771|69413245|FG000|Overall Study|Never start protocol therapy|5|||
37790019|NCT05490771|69413245|FG000|Overall Study|Ineligible|2|||
37790020|NCT05346055|69413249|FG000|Overall Study|Withdrawal by Subject|1|||
37790021|NCT05346055|69413249|FG000|Overall Study|Protocol Violation|1|||
37790022|NCT05346055|69413249|FG000|Overall Study|Therapist decision|1|||
37790023|NCT05211739|69413259|FG000|First Wear Period (Approx 30 Days)|Adverse Event|0|||
37790024|NCT05211739|69413260|FG001|First Wear Period (Approx 30 Days)|Adverse Event|1|||
37790025|NCT05211739|69413259|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|1|||
37790026|NCT05211739|69413260|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|0|||
37790027|NCT05211739|69413259|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
37790028|NCT05211739|69413260|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
37790029|NCT05211739|69413259|FG000|Second Wear Period (Approx 30 Days)|Adverse Event|1|||
37790030|NCT05211739|69413260|FG001|Second Wear Period (Approx 30 Days)|Adverse Event|0|||
37790031|NCT05085405|69413288|FG000|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
37790032|NCT05085405|69413289|FG001|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
37790033|NCT05085405|69413290|FG002|Overall Study|Patient closed to the anticoagulation clinic monitoring service|1|||
37790034|NCT05085405|69413291|FG003|Overall Study|Patient closed to the anticoagulation clinic monitoring service|2|||
37790035|NCT05085405|69413292|FG004|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
37790036|NCT05085405|69413293|FG005|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
37790037|NCT05085405|69413288|FG000|Overall Study|Patient started PPI prior to intervention delivery.|0|||
37790038|NCT05085405|69413289|FG001|Overall Study|Patient started PPI prior to intervention delivery.|0|||
37790039|NCT05085405|69413290|FG002|Overall Study|Patient started PPI prior to intervention delivery.|0|||
37790040|NCT05085405|69413291|FG003|Overall Study|Patient started PPI prior to intervention delivery.|1|||
37790041|NCT05085405|69413292|FG004|Overall Study|Patient started PPI prior to intervention delivery.|0|||
37790042|NCT05085405|69413293|FG005|Overall Study|Patient started PPI prior to intervention delivery.|0|||
37790043|NCT04932941|69413305|FG000|Overall Study|Lost to Follow-up|3|||
37790044|NCT04932941|69413306|FG001|Overall Study|Lost to Follow-up|1|||
37790045|NCT04932941|69413305|FG000|Overall Study|Withdrawal by Subject|7|||
37790046|NCT04932941|69413306|FG001|Overall Study|Withdrawal by Subject|4|||
37790047|NCT04932941|69413305|FG000|Overall Study|Other|4|||
37693718|NCT02060487|69170034|FG000|Overall Study|Protocol Violation|0|||
37790048|NCT04932941|69413306|FG001|Overall Study|Other|2|||
37790049|NCT04662073|69413366|FG000|Overall Study|Withdrawal by Subject|1|||
37790050|NCT04662073|69413367|FG001|Overall Study|Withdrawal by Subject|0|||
37790051|NCT04656418|69413375|FG000|Overall Study|Withdrawal by Subject|1|||
37790052|NCT04656418|69413376|FG001|Overall Study|Withdrawal by Subject|3|||
37790053|NCT04622306|69413383|FG000|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
37790054|NCT04622306|69413384|FG001|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
37790055|NCT04622306|69413385|FG002|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
37790056|NCT04622306|69413386|FG003|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
37790057|NCT04622306|69413387|FG004|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
37790058|NCT04622306|69413388|FG005|Couples Used First Assigned Condom Set|Withdrawal by Subject|5|||
37790059|NCT04622306|69413383|FG000|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
37790060|NCT04622306|69413384|FG001|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
37790061|NCT04622306|69413385|FG002|Couples Used Third Assigned Condom Set|Withdrawal by Subject|2|||
37790062|NCT04622306|69413386|FG003|Couples Used Third Assigned Condom Set|Withdrawal by Subject|3|||
37790063|NCT04622306|69413387|FG004|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
37790064|NCT04622306|69413388|FG005|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
37790065|NCT04601103|69413400|FG000|Overall Study|Needed crown & cleaning|0|||
37790066|NCT04601103|69413401|FG001|Overall Study|Needed crown & cleaning|0|||
37790067|NCT04601103|69413402|FG002|Overall Study|Needed crown & cleaning|1|||
37790068|NCT04601103|69413400|FG000|Overall Study|study was terminated|18|||
37790069|NCT04601103|69413401|FG001|Overall Study|study was terminated|18|||
37790070|NCT04601103|69413402|FG002|Overall Study|study was terminated|16|||
37790071|NCT04575597|69413416|FG000|Overall Study|Death|0|||
37790072|NCT04575597|69413417|FG001|Overall Study|Death|0|||
37790073|NCT04575597|69413418|FG002|Overall Study|Death|0|||
37790074|NCT04575597|69413419|FG003|Overall Study|Death|1|||
37790075|NCT04575597|69413420|FG004|Overall Study|Death|3|||
37790076|NCT04575597|69413421|FG005|Overall Study|Death|14|||
37790077|NCT04575597|69413416|FG000|Overall Study|Lost to Follow-up|2|||
37790078|NCT04575597|69413417|FG001|Overall Study|Lost to Follow-up|1|||
37790079|NCT04575597|69413418|FG002|Overall Study|Lost to Follow-up|1|||
37790080|NCT04575597|69413419|FG003|Overall Study|Lost to Follow-up|2|||
37790081|NCT04575597|69413420|FG004|Overall Study|Lost to Follow-up|10|||
37790082|NCT04575597|69413421|FG005|Overall Study|Lost to Follow-up|8|||
37790083|NCT04575597|69413416|FG000|Overall Study|Withdrawal by Subject|2|||
37790084|NCT04575597|69413417|FG001|Overall Study|Withdrawal by Subject|2|||
37790085|NCT04575597|69413418|FG002|Overall Study|Withdrawal by Subject|4|||
37790086|NCT04575597|69413419|FG003|Overall Study|Withdrawal by Subject|2|||
37790087|NCT04575597|69413420|FG004|Overall Study|Withdrawal by Subject|25|||
37790088|NCT04575597|69413421|FG005|Overall Study|Withdrawal by Subject|28|||
37790089|NCT04575597|69413416|FG000|Overall Study|Not Recorded|0|||
37790090|NCT04575597|69413417|FG001|Overall Study|Not Recorded|0|||
37790091|NCT04575597|69413418|FG002|Overall Study|Not Recorded|0|||
37790092|NCT04575597|69413419|FG003|Overall Study|Not Recorded|0|||
37790093|NCT04575597|69413420|FG004|Overall Study|Not Recorded|0|||
37790094|NCT04575597|69413421|FG005|Overall Study|Not Recorded|2|||
37790095|NCT04575597|69413416|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
37790096|NCT04575597|69413417|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
37790097|NCT04575597|69413418|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
37790098|NCT04575597|69413419|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
37790099|NCT04575597|69413420|FG004|Overall Study|Randomized By Mistake Without Study Treatment|3|||
37790100|NCT04575597|69413421|FG005|Overall Study|Randomized By Mistake Without Study Treatment|2|||
37790101|NCT04546724|69413443|FG000|Overall Study|Withdrawal by Subject|145|||
37790102|NCT04546724|69413444|FG001|Overall Study|Withdrawal by Subject|41|||
37790103|NCT04546724|69413443|FG000|Overall Study|Adverse Event|1|||
37790104|NCT04546724|69413444|FG001|Overall Study|Adverse Event|1|||
37790105|NCT04546724|69413443|FG000|Overall Study|Lost to Follow-up|186|||
37790106|NCT04546724|69413444|FG001|Overall Study|Lost to Follow-up|63|||
37790107|NCT04546724|69413443|FG000|Overall Study|Physician Decision|8|||
37790108|NCT04546724|69413444|FG001|Overall Study|Physician Decision|2|||
37790109|NCT04546724|69413443|FG000|Overall Study|Death|2|||
37790110|NCT04546724|69413444|FG001|Overall Study|Death|1|||
37790111|NCT04546724|69413443|FG000|Overall Study|subject has been out of town|1|||
37790112|NCT04546724|69413444|FG001|Overall Study|subject has been out of town|0|||
37790113|NCT04546724|69413443|FG000|Overall Study|subject is incarcerated|2|||
37790114|NCT04546724|69413444|FG001|Overall Study|subject is incarcerated|0|||
37790115|NCT04546724|69413443|FG000|Overall Study|subject is relocating|12|||
37790116|NCT04546724|69413444|FG001|Overall Study|subject is relocating|4|||
37790117|NCT04546724|69413443|FG000|Overall Study|Subject in another study|1|||
37790118|NCT04546724|69413444|FG001|Overall Study|Subject in another study|1|||
37790119|NCT04514510|69413456|FG000|Overall Study|Lost to Follow-up|0|||
37790120|NCT04514510|69413457|FG001|Overall Study|Lost to Follow-up|1|||
37790121|NCT04514510|69413456|FG000|Overall Study|Randomized but did not receive Isoquercetin|1|||
37790122|NCT04514510|69413457|FG001|Overall Study|Randomized but did not receive Isoquercetin|0|||
37790128|NCT04391842|69413473|FG000|Overall Study|Withdrawal by Subject|2|||
37790129|NCT04327024|69413496|FG000|Overall Study|Death|1|||
37790130|NCT04327024|69413497|FG001|Overall Study|Death|2|||
37790131|NCT04327024|69413498|FG002|Overall Study|Death|1|||
37790132|NCT04327024|69413496|FG000|Overall Study|Non-compliance with study drug|0|||
37790133|NCT04327024|69413497|FG001|Overall Study|Non-compliance with study drug|1|||
37790134|NCT04327024|69413498|FG002|Overall Study|Non-compliance with study drug|0|||
37790135|NCT04327024|69413496|FG000|Overall Study|Withdrawal by Subject|1|||
37790136|NCT04327024|69413497|FG001|Overall Study|Withdrawal by Subject|1|||
37790137|NCT04327024|69413498|FG002|Overall Study|Withdrawal by Subject|2|||
37790138|NCT04322149|69413511|FG000|Overall Study|Adverse Event|1|||
37790139|NCT04322149|69413512|FG001|Overall Study|Adverse Event|1|||
37790140|NCT04322149|69413513|FG002|Overall Study|Adverse Event|0|||
37790141|NCT04322149|69413514|FG003|Overall Study|Adverse Event|0|||
37790142|NCT04322149|69413511|FG000|Overall Study|Withdrawal by Subject|0|||
37790143|NCT04322149|69413512|FG001|Overall Study|Withdrawal by Subject|0|||
37790144|NCT04322149|69413513|FG002|Overall Study|Withdrawal by Subject|0|||
37790145|NCT04322149|69413514|FG003|Overall Study|Withdrawal by Subject|2|||
37790146|NCT04322149|69413511|FG000|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
37864107|NCT00991276|69547780|FG003|First Intervention Period|Insufficient clinical response|0|||
37693719|NCT02060487|69170035|FG001|Overall Study|Protocol Violation|1|||
37790147|NCT04322149|69413512|FG001|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|1|||
37790148|NCT04322149|69413513|FG002|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
37790149|NCT04322149|69413514|FG003|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
37790150|NCT04294459|69413535|FG000|Overall Study|Adverse Event|0|||
37790151|NCT04294459|69413536|FG001|Overall Study|Adverse Event|1|||
37790152|NCT04226742|69413545|FG000|Overall Study|Lost to Follow-up|16|||
37790153|NCT04226742|69413546|FG001|Overall Study|Lost to Follow-up|13|||
37790154|NCT04226742|69413545|FG000|Overall Study|Withdrawal by Subject|5|||
37790155|NCT04226742|69413546|FG001|Overall Study|Withdrawal by Subject|3|||
37790156|NCT04194528|69413552|FG000|Overall Study|Adverse Event|1|||
37790157|NCT04146012|69413584|FG000|Overall Study|Study Terminated|30|||
37790158|NCT04146012|69413585|FG001|Overall Study|Study Terminated|15|||
37975518|NCT00397215|69662818|FG003|Month 0 (Day 0)|Adverse Event|0|||
37693720|NCT02060487|69170036|FG002|Overall Study|Protocol Violation|1|||
37790159|NCT04085458|69413591|FG000|Overall Study|Other|1|||
37790160|NCT04085458|69413591|FG000|Overall Study|Withdrawal by Subject|2|||
37790161|NCT04085458|69413591|FG000|Overall Study|Adverse Event|2|||
37790162|NCT04033159|69413597|FG000|Washout Period|Physician Decision|0|||
37790163|NCT04033159|69413598|FG001|Washout Period|Physician Decision|1|||
37790164|NCT04033159|69413599|FG002|Washout Period|Physician Decision|0|||
37790165|NCT04033159|69413597|FG000|Washout Period|Study terminated by Sponsor|0|||
37790166|NCT04033159|69413598|FG001|Washout Period|Study terminated by Sponsor|7|||
37790167|NCT04033159|69413599|FG002|Washout Period|Study terminated by Sponsor|0|||
37790168|NCT04033159|69413597|FG000|Multiple Ascending Dose Period|Study terminated by Sponsor|6|||
37790169|NCT04033159|69413598|FG001|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
37790170|NCT04033159|69413599|FG002|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
37790171|NCT03969888|69413615|FG000|Overall Study|Never Received Study Drug|0|||
37790172|NCT03969888|69413616|FG001|Overall Study|Never Received Study Drug|0|||
37790173|NCT03969888|69413617|FG002|Overall Study|Never Received Study Drug|1|||
37790174|NCT03969888|69413618|FG003|Overall Study|Never Received Study Drug|0|||
37790175|NCT03969888|69413619|FG004|Overall Study|Never Received Study Drug|0|||
37790176|NCT03969888|69413620|FG005|Overall Study|Never Received Study Drug|0|||
37790177|NCT03969888|69413621|FG006|Overall Study|Never Received Study Drug|1|||
37790178|NCT03969888|69413622|FG007|Overall Study|Never Received Study Drug|0|||
37790179|NCT03969888|69413615|FG000|Overall Study|Reason Not Specified|0|||
37790180|NCT03969888|69413616|FG001|Overall Study|Reason Not Specified|0|||
37790181|NCT03969888|69413617|FG002|Overall Study|Reason Not Specified|0|||
37790182|NCT03969888|69413618|FG003|Overall Study|Reason Not Specified|0|||
37790183|NCT03969888|69413619|FG004|Overall Study|Reason Not Specified|0|||
37790184|NCT03969888|69413620|FG005|Overall Study|Reason Not Specified|0|||
37790185|NCT03969888|69413621|FG006|Overall Study|Reason Not Specified|0|||
37790186|NCT03969888|69413622|FG007|Overall Study|Reason Not Specified|1|||
37790187|NCT03952559|69413646|FG000|Double Blind Treatment Period|Adverse Event|0|||
37790188|NCT03952559|69413647|FG001|Double Blind Treatment Period|Adverse Event|2|||
37790189|NCT03952559|69413648|FG002|Double Blind Treatment Period|Adverse Event|1|||
37790190|NCT03952559|69413649|FG003|Double Blind Treatment Period|Adverse Event|0|||
37790191|NCT03952559|69413650|FG004|Double Blind Treatment Period|Adverse Event|1|||
37790192|NCT03952559|69413646|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
37790193|NCT03952559|69413647|FG001|Double Blind Treatment Period|Lack of Efficacy|4|||
37790194|NCT03952559|69413648|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
37790195|NCT03952559|69413649|FG003|Double Blind Treatment Period|Lack of Efficacy|1|||
37790196|NCT03952559|69413650|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
37790197|NCT03952559|69413646|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
37790198|NCT03952559|69413647|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
37693721|NCT02060487|69170034|FG000|Overall Study|Lost to Follow-up|3|||
37790199|NCT03952559|69413648|FG002|Double Blind Treatment Period|Withdrawal by Subject|2|||
37790200|NCT03952559|69413649|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
37790201|NCT03952559|69413650|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
37693722|NCT02060487|69170035|FG001|Overall Study|Lost to Follow-up|0|||
37790202|NCT03952559|69413646|FG000|Double Blind Treatment Period|Inadvertently randomized|0|||
37790203|NCT03952559|69413647|FG001|Double Blind Treatment Period|Inadvertently randomized|0|||
37790204|NCT03952559|69413648|FG002|Double Blind Treatment Period|Inadvertently randomized|1|||
37790205|NCT03952559|69413649|FG003|Double Blind Treatment Period|Inadvertently randomized|0|||
37790206|NCT03952559|69413650|FG004|Double Blind Treatment Period|Inadvertently randomized|0|||
37790207|NCT03945175|69413686|FG000|Overall Study|Did not meet inclusion criteria|31|||
37790208|NCT03945175|69413686|FG000|Overall Study|Withdrew consent|2|||
37790209|NCT03945175|69413686|FG000|Overall Study|Responded to Placebo Treatment and was not Allocated to Mydayis|1|||
37790210|NCT03945175|69413686|FG000|Overall Study|Early termination during Mydayis treatment|1|||
37790211|NCT03942406|69413697|FG000|Overall Study|Lost to Follow-up|4|||
37790212|NCT03942406|69413698|FG001|Overall Study|Lost to Follow-up|5|||
37790213|NCT03942406|69413699|FG002|Overall Study|Lost to Follow-up|3|||
37790214|NCT03942406|69413700|FG003|Overall Study|Lost to Follow-up|7|||
37790215|NCT03942406|69413701|FG004|Overall Study|Lost to Follow-up|1|||
37790216|NCT03942406|69413702|FG005|Overall Study|Lost to Follow-up|0|||
37790217|NCT03942406|69413703|FG006|Overall Study|Lost to Follow-up|0|||
37790218|NCT03942406|69413697|FG000|Overall Study|Withdrawal by Subject|3|||
37790219|NCT03942406|69413698|FG001|Overall Study|Withdrawal by Subject|1|||
37790220|NCT03942406|69413699|FG002|Overall Study|Withdrawal by Subject|1|||
37790221|NCT03942406|69413700|FG003|Overall Study|Withdrawal by Subject|3|||
37790222|NCT03942406|69413701|FG004|Overall Study|Withdrawal by Subject|0|||
37790223|NCT03942406|69413702|FG005|Overall Study|Withdrawal by Subject|0|||
37790224|NCT03942406|69413703|FG006|Overall Study|Withdrawal by Subject|0|||
37790225|NCT03942406|69413697|FG000|Overall Study|Other: early termination, telemedicine visits|4|||
37790226|NCT03942406|69413698|FG001|Overall Study|Other: early termination, telemedicine visits|1|||
37790227|NCT03942406|69413699|FG002|Overall Study|Other: early termination, telemedicine visits|1|||
37790228|NCT03942406|69413700|FG003|Overall Study|Other: early termination, telemedicine visits|0|||
37790229|NCT03942406|69413701|FG004|Overall Study|Other: early termination, telemedicine visits|1|||
37790230|NCT03942406|69413702|FG005|Overall Study|Other: early termination, telemedicine visits|1|||
37790231|NCT03942406|69413703|FG006|Overall Study|Other: early termination, telemedicine visits|0|||
37790232|NCT03909100|69413737|FG000|Overall Study|Protocol Deviation|2|||
37790233|NCT03909100|69413737|FG000|Overall Study|Technical Problems|4|||
37790234|NCT03909100|69413737|FG000|Overall Study|Withdrawal by Subject|4|||
37790235|NCT03909100|69413737|FG000|Overall Study|Lost to Follow-up|1|||
37790236|NCT03909100|69413737|FG000|Overall Study|Reason not Specified|4|||
37790237|NCT03896295|69413759|FG000|Overall Study|Adverse Event|0|||
37790238|NCT03896295|69413760|FG001|Overall Study|Adverse Event|1|||
37790239|NCT03896295|69413759|FG000|Overall Study|COVID-19|7|||
37790240|NCT03896295|69413760|FG001|Overall Study|COVID-19|29|||
37790241|NCT03734666|69413801|FG000|Overall Study|Other|7|||
37790242|NCT03734666|69413802|FG001|Overall Study|Other|4|||
37790243|NCT03734666|69413801|FG000|Overall Study|Lost to Follow-up|12|||
37790244|NCT03734666|69413802|FG001|Overall Study|Lost to Follow-up|12|||
37790245|NCT03635489|69413815|FG000|Overall Study|Death|6|||
37790246|NCT03635489|69413816|FG001|Overall Study|Death|3|||
37790247|NCT03635489|69413815|FG000|Overall Study|Lost to Follow-up|0|||
37790248|NCT03635489|69413816|FG001|Overall Study|Lost to Follow-up|1|||
37790249|NCT03635489|69413815|FG000|Overall Study|Withdrawal by Subject|1|||
37790250|NCT03635489|69413816|FG001|Overall Study|Withdrawal by Subject|2|||
37790251|NCT03633617|69413827|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
37790252|NCT03633617|69413828|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
37790253|NCT03633617|69413829|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
37790254|NCT03633617|69413830|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
37790255|NCT03633617|69413831|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
37790256|NCT03633617|69413832|FG005|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
37790257|NCT03633617|69413833|FG006|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
37790258|NCT03633617|69413834|FG007|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
37790259|NCT03633617|69413835|FG008|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
37790260|NCT03633617|69413836|FG009|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
37790261|NCT03633617|69413837|FG010|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
37790262|NCT03633617|69413827|FG000|Part A|Unconfirmed early termination visit|1|||
37790263|NCT03633617|69413828|FG001|Part A|Unconfirmed early termination visit|0|||
37790264|NCT03633617|69413829|FG002|Part A|Unconfirmed early termination visit|0|||
37790265|NCT03633617|69413830|FG003|Part A|Unconfirmed early termination visit|0|||
37790266|NCT03633617|69413831|FG004|Part A|Unconfirmed early termination visit|0|||
37790267|NCT03633617|69413832|FG005|Part A|Unconfirmed early termination visit|0|||
37790268|NCT03633617|69413833|FG006|Part A|Unconfirmed early termination visit|0|||
37790269|NCT03633617|69413834|FG007|Part A|Unconfirmed early termination visit|0|||
37790270|NCT03633617|69413835|FG008|Part A|Unconfirmed early termination visit|0|||
37790271|NCT03633617|69413836|FG009|Part A|Unconfirmed early termination visit|0|||
37790272|NCT03633617|69413837|FG010|Part A|Unconfirmed early termination visit|0|||
37790273|NCT03633617|69413827|FG000|Part A|Adverse Event|0|||
37790274|NCT03633617|69413828|FG001|Part A|Adverse Event|1|||
37790275|NCT03633617|69413829|FG002|Part A|Adverse Event|0|||
37790276|NCT03633617|69413830|FG003|Part A|Adverse Event|0|||
37790277|NCT03633617|69413831|FG004|Part A|Adverse Event|0|||
37790278|NCT03633617|69413832|FG005|Part A|Adverse Event|0|||
37790279|NCT03633617|69413833|FG006|Part A|Adverse Event|0|||
37790280|NCT03633617|69413834|FG007|Part A|Adverse Event|0|||
37790281|NCT03633617|69413835|FG008|Part A|Adverse Event|0|||
37790282|NCT03633617|69413836|FG009|Part A|Adverse Event|0|||
37790283|NCT03633617|69413837|FG010|Part A|Adverse Event|0|||
37790284|NCT03633617|69413827|FG000|Part A|Pregnancy|1|||
37790285|NCT03633617|69413828|FG001|Part A|Pregnancy|0|||
37790286|NCT03633617|69413829|FG002|Part A|Pregnancy|0|||
37790287|NCT03633617|69413830|FG003|Part A|Pregnancy|0|||
37790288|NCT03633617|69413831|FG004|Part A|Pregnancy|0|||
37790289|NCT03633617|69413832|FG005|Part A|Pregnancy|0|||
37790290|NCT03633617|69413833|FG006|Part A|Pregnancy|0|||
37790291|NCT03633617|69413834|FG007|Part A|Pregnancy|0|||
37790292|NCT03633617|69413835|FG008|Part A|Pregnancy|0|||
37790293|NCT03633617|69413836|FG009|Part A|Pregnancy|0|||
37790294|NCT03633617|69413837|FG010|Part A|Pregnancy|0|||
37790295|NCT03633617|69413827|FG000|Part A|Withdrawal by Subject|0|||
37790296|NCT03633617|69413828|FG001|Part A|Withdrawal by Subject|1|||
37790297|NCT03633617|69413829|FG002|Part A|Withdrawal by Subject|0|||
37790298|NCT03633617|69413830|FG003|Part A|Withdrawal by Subject|0|||
37790299|NCT03633617|69413831|FG004|Part A|Withdrawal by Subject|0|||
37790300|NCT03633617|69413832|FG005|Part A|Withdrawal by Subject|0|||
37790301|NCT03633617|69413833|FG006|Part A|Withdrawal by Subject|0|||
37790302|NCT03633617|69413834|FG007|Part A|Withdrawal by Subject|0|||
37790303|NCT03633617|69413835|FG008|Part A|Withdrawal by Subject|0|||
37790304|NCT03633617|69413836|FG009|Part A|Withdrawal by Subject|0|||
37790305|NCT03633617|69413837|FG010|Part A|Withdrawal by Subject|0|||
37790306|NCT03633617|69413827|FG000|Part B|Adverse Event|0|||
37790307|NCT03633617|69413828|FG001|Part B|Adverse Event|0|||
37790308|NCT03633617|69413829|FG002|Part B|Adverse Event|2|||
37790309|NCT03633617|69413830|FG003|Part B|Adverse Event|2|||
37790310|NCT03633617|69413831|FG004|Part B|Adverse Event|1|||
37790311|NCT03633617|69413832|FG005|Part B|Adverse Event|0|||
37790312|NCT03633617|69413833|FG006|Part B|Adverse Event|0|||
37790313|NCT03633617|69413834|FG007|Part B|Adverse Event|0|||
37790314|NCT03633617|69413835|FG008|Part B|Adverse Event|0|||
37790315|NCT03633617|69413836|FG009|Part B|Adverse Event|0|||
37790316|NCT03633617|69413837|FG010|Part B|Adverse Event|0|||
37790317|NCT03633617|69413827|FG000|Part B|Withdrawal by Subject|0|||
37790318|NCT03633617|69413828|FG001|Part B|Withdrawal by Subject|0|||
37790319|NCT03633617|69413829|FG002|Part B|Withdrawal by Subject|1|||
37790320|NCT03633617|69413830|FG003|Part B|Withdrawal by Subject|0|||
37790321|NCT03633617|69413831|FG004|Part B|Withdrawal by Subject|2|||
37790322|NCT03633617|69413832|FG005|Part B|Withdrawal by Subject|0|||
37790323|NCT03633617|69413833|FG006|Part B|Withdrawal by Subject|0|||
37693723|NCT02060487|69170036|FG002|Overall Study|Lost to Follow-up|2|||
37693724|NCT02060487|69170034|FG000|Overall Study|Death|34|||
37790324|NCT03633617|69413834|FG007|Part B|Withdrawal by Subject|0|||
37790325|NCT03633617|69413835|FG008|Part B|Withdrawal by Subject|0|||
37790326|NCT03633617|69413836|FG009|Part B|Withdrawal by Subject|0|||
37790327|NCT03633617|69413837|FG010|Part B|Withdrawal by Subject|0|||
37790328|NCT03633617|69413827|FG000|Part B|Lost to Follow-up|0|||
37790329|NCT03633617|69413828|FG001|Part B|Lost to Follow-up|0|||
37790330|NCT03633617|69413829|FG002|Part B|Lost to Follow-up|0|||
37790331|NCT03633617|69413830|FG003|Part B|Lost to Follow-up|0|||
37790332|NCT03633617|69413831|FG004|Part B|Lost to Follow-up|1|||
37790333|NCT03633617|69413832|FG005|Part B|Lost to Follow-up|0|||
37790334|NCT03633617|69413833|FG006|Part B|Lost to Follow-up|0|||
37790335|NCT03633617|69413834|FG007|Part B|Lost to Follow-up|0|||
37790336|NCT03633617|69413835|FG008|Part B|Lost to Follow-up|0|||
37790337|NCT03633617|69413836|FG009|Part B|Lost to Follow-up|0|||
37790338|NCT03633617|69413837|FG010|Part B|Lost to Follow-up|0|||
37790339|NCT03633617|69413827|FG000|Part B|Physician Decision|0|||
37790340|NCT03633617|69413828|FG001|Part B|Physician Decision|0|||
37790341|NCT03633617|69413829|FG002|Part B|Physician Decision|0|||
37790342|NCT03633617|69413830|FG003|Part B|Physician Decision|0|||
37790343|NCT03633617|69413831|FG004|Part B|Physician Decision|1|||
37790344|NCT03633617|69413832|FG005|Part B|Physician Decision|0|||
37693725|NCT02060487|69170035|FG001|Overall Study|Death|25|||
37790345|NCT03633617|69413833|FG006|Part B|Physician Decision|0|||
37790346|NCT03633617|69413834|FG007|Part B|Physician Decision|0|||
37790347|NCT03633617|69413835|FG008|Part B|Physician Decision|0|||
37790348|NCT03633617|69413836|FG009|Part B|Physician Decision|0|||
37790349|NCT03633617|69413837|FG010|Part B|Physician Decision|0|||
37790350|NCT03633617|69413827|FG000|Part B|COVID-19 Restrictions|0|||
37790351|NCT03633617|69413828|FG001|Part B|COVID-19 Restrictions|0|||
37790352|NCT03633617|69413829|FG002|Part B|COVID-19 Restrictions|1|||
37790353|NCT03633617|69413830|FG003|Part B|COVID-19 Restrictions|0|||
37790354|NCT03633617|69413831|FG004|Part B|COVID-19 Restrictions|0|||
37790355|NCT03633617|69413832|FG005|Part B|COVID-19 Restrictions|0|||
37790356|NCT03633617|69413833|FG006|Part B|COVID-19 Restrictions|0|||
37790357|NCT03633617|69413834|FG007|Part B|COVID-19 Restrictions|0|||
37790358|NCT03633617|69413835|FG008|Part B|COVID-19 Restrictions|0|||
37790359|NCT03633617|69413836|FG009|Part B|COVID-19 Restrictions|0|||
37790360|NCT03633617|69413837|FG010|Part B|COVID-19 Restrictions|0|||
37790361|NCT03633617|69413827|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
37790362|NCT03633617|69413828|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
37790363|NCT03633617|69413829|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
37790364|NCT03633617|69413830|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
37790365|NCT03633617|69413831|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
37790366|NCT03633617|69413832|FG005|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
37790367|NCT03633617|69413833|FG006|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
37790368|NCT03633617|69413834|FG007|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
37790369|NCT03633617|69413835|FG008|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
37790370|NCT03633617|69413836|FG009|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
37790371|NCT03633617|69413837|FG010|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
37790372|NCT03633617|69413827|FG000|Part C (& Follow-up)|Adverse Event|0|||
37790373|NCT03633617|69413828|FG001|Part C (& Follow-up)|Adverse Event|0|||
37790374|NCT03633617|69413829|FG002|Part C (& Follow-up)|Adverse Event|0|||
37790375|NCT03633617|69413830|FG003|Part C (& Follow-up)|Adverse Event|0|||
37790376|NCT03633617|69413831|FG004|Part C (& Follow-up)|Adverse Event|0|||
37790377|NCT03633617|69413832|FG005|Part C (& Follow-up)|Adverse Event|1|||
37790378|NCT03633617|69413833|FG006|Part C (& Follow-up)|Adverse Event|0|||
37790379|NCT03633617|69413834|FG007|Part C (& Follow-up)|Adverse Event|1|||
37790380|NCT03633617|69413835|FG008|Part C (& Follow-up)|Adverse Event|0|||
37790381|NCT03633617|69413836|FG009|Part C (& Follow-up)|Adverse Event|0|||
37790382|NCT03633617|69413837|FG010|Part C (& Follow-up)|Adverse Event|0|||
37790383|NCT03633617|69413827|FG000|Part C (& Follow-up)|Pregnancy|0|||
37790384|NCT03633617|69413828|FG001|Part C (& Follow-up)|Pregnancy|0|||
37790385|NCT03633617|69413829|FG002|Part C (& Follow-up)|Pregnancy|0|||
37790386|NCT03633617|69413830|FG003|Part C (& Follow-up)|Pregnancy|0|||
37790387|NCT03633617|69413831|FG004|Part C (& Follow-up)|Pregnancy|0|||
37790388|NCT03633617|69413832|FG005|Part C (& Follow-up)|Pregnancy|0|||
37790389|NCT03633617|69413833|FG006|Part C (& Follow-up)|Pregnancy|0|||
37790390|NCT03633617|69413834|FG007|Part C (& Follow-up)|Pregnancy|0|||
37790391|NCT03633617|69413835|FG008|Part C (& Follow-up)|Pregnancy|0|||
37790392|NCT03633617|69413836|FG009|Part C (& Follow-up)|Pregnancy|1|||
37790393|NCT03633617|69413837|FG010|Part C (& Follow-up)|Pregnancy|0|||
37790394|NCT03633617|69413827|FG000|Part C (& Follow-up)|Withdrawal by Subject|0|||
37790395|NCT03633617|69413828|FG001|Part C (& Follow-up)|Withdrawal by Subject|0|||
37790396|NCT03633617|69413829|FG002|Part C (& Follow-up)|Withdrawal by Subject|0|||
37790397|NCT03633617|69413830|FG003|Part C (& Follow-up)|Withdrawal by Subject|0|||
37790398|NCT03633617|69413831|FG004|Part C (& Follow-up)|Withdrawal by Subject|0|||
37790399|NCT03633617|69413832|FG005|Part C (& Follow-up)|Withdrawal by Subject|2|||
37790400|NCT03633617|69413833|FG006|Part C (& Follow-up)|Withdrawal by Subject|2|||
37790401|NCT03633617|69413834|FG007|Part C (& Follow-up)|Withdrawal by Subject|0|||
37790402|NCT03633617|69413835|FG008|Part C (& Follow-up)|Withdrawal by Subject|1|||
37790403|NCT03633617|69413836|FG009|Part C (& Follow-up)|Withdrawal by Subject|1|||
37790404|NCT03633617|69413837|FG010|Part C (& Follow-up)|Withdrawal by Subject|6|||
37790405|NCT03633617|69413827|FG000|Part C (& Follow-up)|Lost to Follow-up|0|||
37790406|NCT03633617|69413828|FG001|Part C (& Follow-up)|Lost to Follow-up|0|||
37790407|NCT03633617|69413829|FG002|Part C (& Follow-up)|Lost to Follow-up|0|||
37790408|NCT03633617|69413830|FG003|Part C (& Follow-up)|Lost to Follow-up|0|||
37790409|NCT03633617|69413831|FG004|Part C (& Follow-up)|Lost to Follow-up|0|||
37790410|NCT03633617|69413832|FG005|Part C (& Follow-up)|Lost to Follow-up|3|||
37790411|NCT03633617|69413833|FG006|Part C (& Follow-up)|Lost to Follow-up|3|||
37790412|NCT03633617|69413834|FG007|Part C (& Follow-up)|Lost to Follow-up|1|||
37790413|NCT03633617|69413835|FG008|Part C (& Follow-up)|Lost to Follow-up|0|||
37790414|NCT03633617|69413836|FG009|Part C (& Follow-up)|Lost to Follow-up|7|||
37790415|NCT03633617|69413837|FG010|Part C (& Follow-up)|Lost to Follow-up|2|||
37790416|NCT03633617|69413827|FG000|Part C (& Follow-up)|Physician Decision|0|||
37790417|NCT03633617|69413828|FG001|Part C (& Follow-up)|Physician Decision|0|||
37790418|NCT03633617|69413829|FG002|Part C (& Follow-up)|Physician Decision|0|||
37790419|NCT03633617|69413830|FG003|Part C (& Follow-up)|Physician Decision|0|||
37790420|NCT03633617|69413831|FG004|Part C (& Follow-up)|Physician Decision|0|||
37790421|NCT03633617|69413832|FG005|Part C (& Follow-up)|Physician Decision|0|||
37790422|NCT03633617|69413833|FG006|Part C (& Follow-up)|Physician Decision|0|||
37790423|NCT03633617|69413834|FG007|Part C (& Follow-up)|Physician Decision|1|||
37790424|NCT03633617|69413835|FG008|Part C (& Follow-up)|Physician Decision|0|||
37790425|NCT03633617|69413836|FG009|Part C (& Follow-up)|Physician Decision|0|||
37790426|NCT03633617|69413837|FG010|Part C (& Follow-up)|Physician Decision|1|||
37790427|NCT03633617|69413827|FG000|Part C (& Follow-up)|COVID-19 related|0|||
37790428|NCT03633617|69413828|FG001|Part C (& Follow-up)|COVID-19 related|0|||
37790429|NCT03633617|69413829|FG002|Part C (& Follow-up)|COVID-19 related|0|||
37790430|NCT03633617|69413830|FG003|Part C (& Follow-up)|COVID-19 related|0|||
37790431|NCT03633617|69413831|FG004|Part C (& Follow-up)|COVID-19 related|0|||
37790432|NCT03633617|69413832|FG005|Part C (& Follow-up)|COVID-19 related|1|||
37790433|NCT03633617|69413833|FG006|Part C (& Follow-up)|COVID-19 related|0|||
37790434|NCT03633617|69413834|FG007|Part C (& Follow-up)|COVID-19 related|0|||
37790435|NCT03633617|69413835|FG008|Part C (& Follow-up)|COVID-19 related|0|||
37790436|NCT03633617|69413836|FG009|Part C (& Follow-up)|COVID-19 related|0|||
37790437|NCT03633617|69413837|FG010|Part C (& Follow-up)|COVID-19 related|0|||
37790438|NCT03633617|69413827|FG000|Part C (& Follow-up)|Protocol Violation|0|||
37790439|NCT03633617|69413828|FG001|Part C (& Follow-up)|Protocol Violation|0|||
37790440|NCT03633617|69413829|FG002|Part C (& Follow-up)|Protocol Violation|0|||
37790441|NCT03633617|69413830|FG003|Part C (& Follow-up)|Protocol Violation|0|||
37790442|NCT03633617|69413831|FG004|Part C (& Follow-up)|Protocol Violation|0|||
37790443|NCT03633617|69413832|FG005|Part C (& Follow-up)|Protocol Violation|0|||
37790444|NCT03633617|69413833|FG006|Part C (& Follow-up)|Protocol Violation|0|||
37790445|NCT03633617|69413834|FG007|Part C (& Follow-up)|Protocol Violation|0|||
37790446|NCT03633617|69413835|FG008|Part C (& Follow-up)|Protocol Violation|0|||
37790447|NCT03633617|69413836|FG009|Part C (& Follow-up)|Protocol Violation|3|||
37790448|NCT03633617|69413837|FG010|Part C (& Follow-up)|Protocol Violation|1|||
37790449|NCT03633617|69413827|FG000|Part C (& Follow-up)|Lack of Efficacy|0|||
37790450|NCT03633617|69413828|FG001|Part C (& Follow-up)|Lack of Efficacy|0|||
37790451|NCT03633617|69413829|FG002|Part C (& Follow-up)|Lack of Efficacy|0|||
37790452|NCT03633617|69413830|FG003|Part C (& Follow-up)|Lack of Efficacy|0|||
37790453|NCT03633617|69413831|FG004|Part C (& Follow-up)|Lack of Efficacy|0|||
37790454|NCT03633617|69413832|FG005|Part C (& Follow-up)|Lack of Efficacy|0|||
37790455|NCT03633617|69413833|FG006|Part C (& Follow-up)|Lack of Efficacy|0|||
37790456|NCT03633617|69413834|FG007|Part C (& Follow-up)|Lack of Efficacy|1|||
37790457|NCT03633617|69413835|FG008|Part C (& Follow-up)|Lack of Efficacy|0|||
37790458|NCT03633617|69413836|FG009|Part C (& Follow-up)|Lack of Efficacy|0|||
37790459|NCT03633617|69413837|FG010|Part C (& Follow-up)|Lack of Efficacy|0|||
37790460|NCT03631784|69413867|FG000|Overall Study|Death|48|||
37790461|NCT03631784|69413868|FG001|Overall Study|Death|28|||
37790462|NCT03631784|69413867|FG000|Overall Study|Lost to Follow-up|1|||
37790463|NCT03631784|69413868|FG001|Overall Study|Lost to Follow-up|0|||
37790464|NCT03631784|69413867|FG000|Overall Study|Withdrawal by Subject|0|||
37790465|NCT03631784|69413868|FG001|Overall Study|Withdrawal by Subject|3|||
37790466|NCT03631784|69413867|FG000|Overall Study|Participants Ongoing|63|||
37790467|NCT03631784|69413868|FG001|Overall Study|Participants Ongoing|71|||
37790468|NCT03617705|69413874|FG000|Overall Study|Withdrawal by Subject|2|||
37790469|NCT03617705|69413874|FG000|Overall Study|lost contact after screening due to covid pandemic|6|||
37790470|NCT03617705|69413874|FG000|Overall Study|withdrawal by study team due to non-compliance|1|||
37790471|NCT03607422|69413884|FG000|Overall Study|Adverse Event|7|||
37790472|NCT03607422|69413885|FG001|Overall Study|Adverse Event|3|||
37790473|NCT03607422|69413886|FG002|Overall Study|Adverse Event|2|||
37790474|NCT03607422|69413887|FG003|Overall Study|Adverse Event|0|||
37790475|NCT03607422|69413888|FG004|Overall Study|Adverse Event|2|||
37790476|NCT03607422|69413889|FG005|Overall Study|Adverse Event|0|||
37790477|NCT03607422|69413884|FG000|Overall Study|Withdrawal by Subject|11|||
37790478|NCT03607422|69413885|FG001|Overall Study|Withdrawal by Subject|3|||
37790479|NCT03607422|69413886|FG002|Overall Study|Withdrawal by Subject|6|||
37790480|NCT03607422|69413887|FG003|Overall Study|Withdrawal by Subject|2|||
37790481|NCT03607422|69413888|FG004|Overall Study|Withdrawal by Subject|0|||
37790482|NCT03607422|69413889|FG005|Overall Study|Withdrawal by Subject|0|||
37790483|NCT03607422|69413884|FG000|Overall Study|Lost to Follow-up|0|||
37790484|NCT03607422|69413885|FG001|Overall Study|Lost to Follow-up|0|||
37790485|NCT03607422|69413886|FG002|Overall Study|Lost to Follow-up|1|||
37790486|NCT03607422|69413887|FG003|Overall Study|Lost to Follow-up|0|||
37790487|NCT03607422|69413888|FG004|Overall Study|Lost to Follow-up|0|||
37790488|NCT03607422|69413889|FG005|Overall Study|Lost to Follow-up|0|||
37790489|NCT03607422|69413884|FG000|Overall Study|Other|12|||
37790490|NCT03607422|69413885|FG001|Overall Study|Other|4|||
37790491|NCT03607422|69413886|FG002|Overall Study|Other|1|||
37790492|NCT03607422|69413887|FG003|Overall Study|Other|2|||
37790493|NCT03607422|69413888|FG004|Overall Study|Other|0|||
37790494|NCT03607422|69413889|FG005|Overall Study|Other|2|||
37790495|NCT03607422|69413884|FG000|Overall Study|Ongoing at Time of Analysis|8|||
37790496|NCT03607422|69413885|FG001|Overall Study|Ongoing at Time of Analysis|0|||
37790497|NCT03607422|69413886|FG002|Overall Study|Ongoing at Time of Analysis|2|||
37790498|NCT03607422|69413887|FG003|Overall Study|Ongoing at Time of Analysis|1|||
37790499|NCT03607422|69413888|FG004|Overall Study|Ongoing at Time of Analysis|1|||
37790500|NCT03607422|69413889|FG005|Overall Study|Ongoing at Time of Analysis|1|||
37790501|NCT03568318|69413927|FG000|Overall Study|Adverse Event|3|||
37790502|NCT03568318|69413928|FG001|Overall Study|Adverse Event|1|||
37790503|NCT03568318|69413929|FG002|Overall Study|Adverse Event|1|||
37864108|NCT00991276|69547781|FG004|First Intervention Period|Insufficient clinical response|1|||
37864109|NCT00991276|69547782|FG005|First Intervention Period|Insufficient clinical response|0|||
37790504|NCT03568318|69413930|FG003|Overall Study|Adverse Event|0|||
37790505|NCT03568318|69413931|FG004|Overall Study|Adverse Event|1|||
37790506|NCT03568318|69413932|FG005|Overall Study|Adverse Event|0|||
37790507|NCT03568318|69413927|FG000|Overall Study|Withdrawal by Subject|6|||
37790508|NCT03568318|69413928|FG001|Overall Study|Withdrawal by Subject|5|||
37790509|NCT03568318|69413929|FG002|Overall Study|Withdrawal by Subject|2|||
37790510|NCT03568318|69413930|FG003|Overall Study|Withdrawal by Subject|1|||
37790511|NCT03568318|69413931|FG004|Overall Study|Withdrawal by Subject|0|||
37790512|NCT03568318|69413932|FG005|Overall Study|Withdrawal by Subject|0|||
37790513|NCT03568318|69413927|FG000|Overall Study|Lost to Follow-up|3|||
37790514|NCT03568318|69413928|FG001|Overall Study|Lost to Follow-up|2|||
37790515|NCT03568318|69413929|FG002|Overall Study|Lost to Follow-up|2|||
37790516|NCT03568318|69413930|FG003|Overall Study|Lost to Follow-up|2|||
37790517|NCT03568318|69413931|FG004|Overall Study|Lost to Follow-up|1|||
37790518|NCT03568318|69413932|FG005|Overall Study|Lost to Follow-up|0|||
37790519|NCT03568318|69413927|FG000|Overall Study|Other|3|||
37693726|NCT02060487|69170036|FG002|Overall Study|Death|19|||
37693727|NCT02060487|69170034|FG000|Overall Study|Adverse Event|0|||
37790520|NCT03568318|69413928|FG001|Overall Study|Other|1|||
37790521|NCT03568318|69413929|FG002|Overall Study|Other|3|||
37790522|NCT03568318|69413930|FG003|Overall Study|Other|0|||
37790523|NCT03568318|69413931|FG004|Overall Study|Other|0|||
37790524|NCT03568318|69413932|FG005|Overall Study|Other|0|||
37790525|NCT03568318|69413927|FG000|Overall Study|Ongoing at Time of Analysis|5|||
37790526|NCT03568318|69413928|FG001|Overall Study|Ongoing at Time of Analysis|3|||
37790527|NCT03568318|69413929|FG002|Overall Study|Ongoing at Time of Analysis|2|||
37790528|NCT03568318|69413930|FG003|Overall Study|Ongoing at Time of Analysis|1|||
37790529|NCT03568318|69413931|FG004|Overall Study|Ongoing at Time of Analysis|0|||
37790530|NCT03568318|69413932|FG005|Overall Study|Ongoing at Time of Analysis|0|||
37790531|NCT03550794|69413948|FG000|Overall Study|No longer met inclusion criteria|1|||
37790532|NCT03550794|69413949|FG001|Overall Study|No longer met inclusion criteria|2|||
37790533|NCT03550794|69413948|FG000|Overall Study|Goals of care changed|1|||
37790534|NCT03550794|69413949|FG001|Overall Study|Goals of care changed|0|||
37790535|NCT03550794|69413948|FG000|Overall Study|Withdrawal by Subject|2|||
37790536|NCT03550794|69413949|FG001|Overall Study|Withdrawal by Subject|0|||
37790537|NCT03550794|69413948|FG000|Overall Study|Death|0|||
37790538|NCT03550794|69413949|FG001|Overall Study|Death|1|||
37790539|NCT03427125|69413992|FG000|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
37790540|NCT03427125|69413993|FG001|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|995|||
37790541|NCT03427125|69413994|FG002|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
37790542|NCT03341273|69414009|FG000|Overall Study|Lost to Follow-up|7|||
37790543|NCT03341273|69414010|FG001|Overall Study|Lost to Follow-up|7|||
37790544|NCT03341273|69414009|FG000|Overall Study|Withdrawal by Subject|4|||
37790545|NCT03341273|69414010|FG001|Overall Study|Withdrawal by Subject|2|||
37790546|NCT03341273|69414009|FG000|Overall Study|Physician Decision|1|||
37790547|NCT03341273|69414010|FG001|Overall Study|Physician Decision|0|||
37790548|NCT03341273|69414009|FG000|Overall Study|Protocol Violation|0|||
37790549|NCT03341273|69414010|FG001|Overall Study|Protocol Violation|1|||
37790550|NCT03341273|69414009|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
37790551|NCT03341273|69414010|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
37790552|NCT03341273|69414009|FG000|Overall Study|Became ineligible after enrollment|1|||
37790553|NCT03341273|69414010|FG001|Overall Study|Became ineligible after enrollment|0|||
37790554|NCT03341273|69414009|FG000|Overall Study|Not Eligible at Enrollment|0|||
37790555|NCT03341273|69414010|FG001|Overall Study|Not Eligible at Enrollment|1|||
37790556|NCT03341273|69414009|FG000|Overall Study|Participant incarcerated|1|||
37790557|NCT03341273|69414010|FG001|Overall Study|Participant incarcerated|0|||
37790558|NCT03307785|69414027|FG000|Part A: Up to 28.5 Months|Disease progression|2|||
37790559|NCT03307785|69414028|FG001|Part A: Up to 28.5 Months|Disease progression|0|||
37790560|NCT03307785|69414029|FG002|Part A: Up to 28.5 Months|Disease progression|0|||
37790561|NCT03307785|69414030|FG003|Part A: Up to 28.5 Months|Disease progression|0|||
37790562|NCT03307785|69414031|FG004|Part A: Up to 28.5 Months|Disease progression|0|||
37790563|NCT03307785|69414032|FG005|Part A: Up to 28.5 Months|Disease progression|0|||
37790564|NCT03307785|69414033|FG006|Part A: Up to 28.5 Months|Disease progression|0|||
37790565|NCT03307785|69414034|FG007|Part A: Up to 28.5 Months|Disease progression|0|||
37790566|NCT03307785|69414035|FG008|Part A: Up to 28.5 Months|Disease progression|0|||
37790567|NCT03307785|69414036|FG009|Part A: Up to 28.5 Months|Disease progression|0|||
37790568|NCT03307785|69414037|FG010|Part A: Up to 28.5 Months|Disease progression|0|||
37790569|NCT03307785|69414027|FG000|Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
37693728|NCT02060487|69170035|FG001|Overall Study|Adverse Event|0|||
37790570|NCT03307785|69414028|FG001|Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
37790571|NCT03307785|69414029|FG002|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
37790572|NCT03307785|69414030|FG003|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
37790573|NCT03307785|69414031|FG004|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
37790574|NCT03307785|69414032|FG005|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
37790575|NCT03307785|69414033|FG006|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
37693729|NCT02060487|69170036|FG002|Overall Study|Adverse Event|1|||
37790576|NCT03307785|69414034|FG007|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
37790577|NCT03307785|69414035|FG008|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
37790578|NCT03307785|69414036|FG009|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
37790579|NCT03307785|69414037|FG010|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
37790580|NCT03307785|69414027|FG000|Part A: Up to 28.5 Months|Death|4|||
37790581|NCT03307785|69414028|FG001|Part A: Up to 28.5 Months|Death|4|||
37790582|NCT03307785|69414029|FG002|Part A: Up to 28.5 Months|Death|0|||
37790583|NCT03307785|69414030|FG003|Part A: Up to 28.5 Months|Death|0|||
37790584|NCT03307785|69414031|FG004|Part A: Up to 28.5 Months|Death|0|||
37790585|NCT03307785|69414032|FG005|Part A: Up to 28.5 Months|Death|0|||
37790586|NCT03307785|69414033|FG006|Part A: Up to 28.5 Months|Death|0|||
37790587|NCT03307785|69414034|FG007|Part A: Up to 28.5 Months|Death|0|||
37790588|NCT03307785|69414035|FG008|Part A: Up to 28.5 Months|Death|0|||
37790589|NCT03307785|69414036|FG009|Part A: Up to 28.5 Months|Death|0|||
37790590|NCT03307785|69414037|FG010|Part A: Up to 28.5 Months|Death|0|||
37790591|NCT03307785|69414027|FG000|Part A: Up to 28.5 Months|Physician Decision|3|||
37790592|NCT03307785|69414028|FG001|Part A: Up to 28.5 Months|Physician Decision|1|||
37790593|NCT03307785|69414029|FG002|Part A: Up to 28.5 Months|Physician Decision|0|||
37790594|NCT03307785|69414030|FG003|Part A: Up to 28.5 Months|Physician Decision|0|||
37790595|NCT03307785|69414031|FG004|Part A: Up to 28.5 Months|Physician Decision|0|||
37790596|NCT03307785|69414032|FG005|Part A: Up to 28.5 Months|Physician Decision|0|||
37790597|NCT03307785|69414033|FG006|Part A: Up to 28.5 Months|Physician Decision|0|||
37790598|NCT03307785|69414034|FG007|Part A: Up to 28.5 Months|Physician Decision|0|||
37790599|NCT03307785|69414035|FG008|Part A: Up to 28.5 Months|Physician Decision|0|||
37790600|NCT03307785|69414036|FG009|Part A: Up to 28.5 Months|Physician Decision|0|||
37790601|NCT03307785|69414037|FG010|Part A: Up to 28.5 Months|Physician Decision|0|||
37790602|NCT03307785|69414027|FG000|Part B: Up to 28.5 Months|Disease progression|0|||
37790603|NCT03307785|69414028|FG001|Part B: Up to 28.5 Months|Disease progression|0|||
37790604|NCT03307785|69414029|FG002|Part B: Up to 28.5 Months|Disease progression|1|||
37790605|NCT03307785|69414030|FG003|Part B: Up to 28.5 Months|Disease progression|0|||
37790606|NCT03307785|69414031|FG004|Part B: Up to 28.5 Months|Disease progression|0|||
37790607|NCT03307785|69414032|FG005|Part B: Up to 28.5 Months|Disease progression|0|||
37790608|NCT03307785|69414033|FG006|Part B: Up to 28.5 Months|Disease progression|0|||
37790609|NCT03307785|69414034|FG007|Part B: Up to 28.5 Months|Disease progression|0|||
37790610|NCT03307785|69414035|FG008|Part B: Up to 28.5 Months|Disease progression|0|||
37790611|NCT03307785|69414036|FG009|Part B: Up to 28.5 Months|Disease progression|0|||
37790612|NCT03307785|69414037|FG010|Part B: Up to 28.5 Months|Disease progression|0|||
37790613|NCT03307785|69414027|FG000|Part B: Up to 28.5 Months|Physician Decision|0|||
37790614|NCT03307785|69414028|FG001|Part B: Up to 28.5 Months|Physician Decision|0|||
37790615|NCT03307785|69414029|FG002|Part B: Up to 28.5 Months|Physician Decision|1|||
37790616|NCT03307785|69414030|FG003|Part B: Up to 28.5 Months|Physician Decision|0|||
37790617|NCT03307785|69414031|FG004|Part B: Up to 28.5 Months|Physician Decision|0|||
37790618|NCT03307785|69414032|FG005|Part B: Up to 28.5 Months|Physician Decision|0|||
37790619|NCT03307785|69414033|FG006|Part B: Up to 28.5 Months|Physician Decision|0|||
37790620|NCT03307785|69414034|FG007|Part B: Up to 28.5 Months|Physician Decision|0|||
37790621|NCT03307785|69414035|FG008|Part B: Up to 28.5 Months|Physician Decision|0|||
37790622|NCT03307785|69414036|FG009|Part B: Up to 28.5 Months|Physician Decision|0|||
37790623|NCT03307785|69414037|FG010|Part B: Up to 28.5 Months|Physician Decision|0|||
37790624|NCT03307785|69414027|FG000|Part B: Up to 28.5 Months|Death|0|||
37790625|NCT03307785|69414028|FG001|Part B: Up to 28.5 Months|Death|0|||
37790626|NCT03307785|69414029|FG002|Part B: Up to 28.5 Months|Death|7|||
37790627|NCT03307785|69414030|FG003|Part B: Up to 28.5 Months|Death|0|||
37790628|NCT03307785|69414031|FG004|Part B: Up to 28.5 Months|Death|0|||
37790629|NCT03307785|69414032|FG005|Part B: Up to 28.5 Months|Death|0|||
37790630|NCT03307785|69414033|FG006|Part B: Up to 28.5 Months|Death|0|||
37790631|NCT03307785|69414034|FG007|Part B: Up to 28.5 Months|Death|0|||
37790632|NCT03307785|69414035|FG008|Part B: Up to 28.5 Months|Death|0|||
37790633|NCT03307785|69414036|FG009|Part B: Up to 28.5 Months|Death|0|||
37790634|NCT03307785|69414037|FG010|Part B: Up to 28.5 Months|Death|0|||
37790635|NCT03307785|69414027|FG000|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
37790636|NCT03307785|69414028|FG001|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
37790637|NCT03307785|69414029|FG002|Part B: Up to 28.5 Months|Withdrawal by Subject|1|||
37790638|NCT03307785|69414030|FG003|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
37790639|NCT03307785|69414031|FG004|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
37790640|NCT03307785|69414032|FG005|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
37790641|NCT03307785|69414033|FG006|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
37790642|NCT03307785|69414034|FG007|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
37790643|NCT03307785|69414035|FG008|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
37790644|NCT03307785|69414036|FG009|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
37790645|NCT03307785|69414037|FG010|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
37790646|NCT03307785|69414027|FG000|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
37790647|NCT03307785|69414028|FG001|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
37790648|NCT03307785|69414029|FG002|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|4|||
37790649|NCT03307785|69414030|FG003|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
37790650|NCT03307785|69414031|FG004|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
37790651|NCT03307785|69414032|FG005|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
37790652|NCT03307785|69414033|FG006|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
37790653|NCT03307785|69414034|FG007|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
37790654|NCT03307785|69414035|FG008|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
37790655|NCT03307785|69414036|FG009|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
37790656|NCT03307785|69414037|FG010|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
37790657|NCT03307785|69414027|FG000|Part C: Up to 22.5 Months|Disease progression|0|||
37790658|NCT03307785|69414028|FG001|Part C: Up to 22.5 Months|Disease progression|0|||
37790659|NCT03307785|69414029|FG002|Part C: Up to 22.5 Months|Disease progression|0|||
37790660|NCT03307785|69414030|FG003|Part C: Up to 22.5 Months|Disease progression|0|||
37790661|NCT03307785|69414031|FG004|Part C: Up to 22.5 Months|Disease progression|1|||
37790662|NCT03307785|69414032|FG005|Part C: Up to 22.5 Months|Disease progression|0|||
37790663|NCT03307785|69414033|FG006|Part C: Up to 22.5 Months|Disease progression|0|||
37790664|NCT03307785|69414034|FG007|Part C: Up to 22.5 Months|Disease progression|0|||
37790665|NCT03307785|69414035|FG008|Part C: Up to 22.5 Months|Disease progression|0|||
37790666|NCT03307785|69414036|FG009|Part C: Up to 22.5 Months|Disease progression|0|||
37790667|NCT03307785|69414037|FG010|Part C: Up to 22.5 Months|Disease progression|0|||
37790668|NCT03307785|69414027|FG000|Part C: Up to 22.5 Months|Physician Decision|0|||
37790669|NCT03307785|69414028|FG001|Part C: Up to 22.5 Months|Physician Decision|0|||
37790670|NCT03307785|69414029|FG002|Part C: Up to 22.5 Months|Physician Decision|0|||
37790671|NCT03307785|69414030|FG003|Part C: Up to 22.5 Months|Physician Decision|3|||
37790672|NCT03307785|69414031|FG004|Part C: Up to 22.5 Months|Physician Decision|1|||
37790673|NCT03307785|69414032|FG005|Part C: Up to 22.5 Months|Physician Decision|0|||
37790674|NCT03307785|69414033|FG006|Part C: Up to 22.5 Months|Physician Decision|0|||
37790675|NCT03307785|69414034|FG007|Part C: Up to 22.5 Months|Physician Decision|0|||
37790676|NCT03307785|69414035|FG008|Part C: Up to 22.5 Months|Physician Decision|0|||
37790677|NCT03307785|69414036|FG009|Part C: Up to 22.5 Months|Physician Decision|0|||
37790678|NCT03307785|69414037|FG010|Part C: Up to 22.5 Months|Physician Decision|0|||
37790679|NCT03307785|69414027|FG000|Part C: Up to 22.5 Months|Death|0|||
37790680|NCT03307785|69414028|FG001|Part C: Up to 22.5 Months|Death|0|||
37790681|NCT03307785|69414029|FG002|Part C: Up to 22.5 Months|Death|0|||
37790682|NCT03307785|69414030|FG003|Part C: Up to 22.5 Months|Death|1|||
37790683|NCT03307785|69414031|FG004|Part C: Up to 22.5 Months|Death|4|||
37790684|NCT03307785|69414032|FG005|Part C: Up to 22.5 Months|Death|0|||
37790685|NCT03307785|69414033|FG006|Part C: Up to 22.5 Months|Death|0|||
37790686|NCT03307785|69414034|FG007|Part C: Up to 22.5 Months|Death|0|||
37790687|NCT03307785|69414035|FG008|Part C: Up to 22.5 Months|Death|0|||
37790688|NCT03307785|69414036|FG009|Part C: Up to 22.5 Months|Death|0|||
37790689|NCT03307785|69414037|FG010|Part C: Up to 22.5 Months|Death|0|||
37790690|NCT03307785|69414027|FG000|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
37790691|NCT03307785|69414028|FG001|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
37790692|NCT03307785|69414029|FG002|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
37790693|NCT03307785|69414030|FG003|Part C: Up to 22.5 Months|Withdrawal by Subject|1|||
37790694|NCT03307785|69414031|FG004|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
37790695|NCT03307785|69414032|FG005|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
37790696|NCT03307785|69414033|FG006|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
37790697|NCT03307785|69414034|FG007|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
37790698|NCT03307785|69414035|FG008|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
37790699|NCT03307785|69414036|FG009|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
37790700|NCT03307785|69414037|FG010|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
37790701|NCT03307785|69414027|FG000|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
37790702|NCT03307785|69414028|FG001|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
37790703|NCT03307785|69414029|FG002|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
37790704|NCT03307785|69414030|FG003|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|1|||
37790705|NCT03307785|69414031|FG004|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|1|||
37790706|NCT03307785|69414032|FG005|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
37790707|NCT03307785|69414033|FG006|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
37790708|NCT03307785|69414034|FG007|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
37790709|NCT03307785|69414035|FG008|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
37790710|NCT03307785|69414036|FG009|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
37790711|NCT03307785|69414037|FG010|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
37790712|NCT03307785|69414027|FG000|Part D: Up to 9.5 Months|Physician Decision|0|||
37790713|NCT03307785|69414028|FG001|Part D: Up to 9.5 Months|Physician Decision|0|||
37790714|NCT03307785|69414029|FG002|Part D: Up to 9.5 Months|Physician Decision|0|||
37790715|NCT03307785|69414030|FG003|Part D: Up to 9.5 Months|Physician Decision|0|||
37790716|NCT03307785|69414031|FG004|Part D: Up to 9.5 Months|Physician Decision|0|||
37790717|NCT03307785|69414032|FG005|Part D: Up to 9.5 Months|Physician Decision|1|||
37790718|NCT03307785|69414033|FG006|Part D: Up to 9.5 Months|Physician Decision|0|||
37790719|NCT03307785|69414034|FG007|Part D: Up to 9.5 Months|Physician Decision|0|||
37790720|NCT03307785|69414035|FG008|Part D: Up to 9.5 Months|Physician Decision|0|||
37790721|NCT03307785|69414036|FG009|Part D: Up to 9.5 Months|Physician Decision|0|||
37790722|NCT03307785|69414037|FG010|Part D: Up to 9.5 Months|Physician Decision|0|||
37790723|NCT03307785|69414027|FG000|Part D: Up to 9.5 Months|Death|0|||
37790724|NCT03307785|69414028|FG001|Part D: Up to 9.5 Months|Death|0|||
37790725|NCT03307785|69414029|FG002|Part D: Up to 9.5 Months|Death|0|||
37790726|NCT03307785|69414030|FG003|Part D: Up to 9.5 Months|Death|0|||
37790727|NCT03307785|69414031|FG004|Part D: Up to 9.5 Months|Death|0|||
37790728|NCT03307785|69414032|FG005|Part D: Up to 9.5 Months|Death|1|||
37790729|NCT03307785|69414033|FG006|Part D: Up to 9.5 Months|Death|0|||
37790730|NCT03307785|69414034|FG007|Part D: Up to 9.5 Months|Death|0|||
37790731|NCT03307785|69414035|FG008|Part D: Up to 9.5 Months|Death|0|||
37790732|NCT03307785|69414036|FG009|Part D: Up to 9.5 Months|Death|0|||
37790733|NCT03307785|69414037|FG010|Part D: Up to 9.5 Months|Death|0|||
37790734|NCT03307785|69414027|FG000|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
37790735|NCT03307785|69414028|FG001|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
37790736|NCT03307785|69414029|FG002|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
37790737|NCT03307785|69414030|FG003|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
37790738|NCT03307785|69414031|FG004|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
37790739|NCT03307785|69414032|FG005|Part D: Up to 9.5 Months|Withdrawal by Subject|1|||
37790740|NCT03307785|69414033|FG006|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
37790741|NCT03307785|69414034|FG007|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
37790742|NCT03307785|69414035|FG008|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
37790743|NCT03307785|69414036|FG009|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
37790744|NCT03307785|69414037|FG010|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
37790745|NCT03307785|69414027|FG000|Part E: Up to 4.4 Months|Death|0|||
37790746|NCT03307785|69414028|FG001|Part E: Up to 4.4 Months|Death|0|||
37790747|NCT03307785|69414029|FG002|Part E: Up to 4.4 Months|Death|0|||
37790748|NCT03307785|69414030|FG003|Part E: Up to 4.4 Months|Death|0|||
37790749|NCT03307785|69414031|FG004|Part E: Up to 4.4 Months|Death|0|||
37790750|NCT03307785|69414032|FG005|Part E: Up to 4.4 Months|Death|0|||
37790751|NCT03307785|69414033|FG006|Part E: Up to 4.4 Months|Death|1|||
37790752|NCT03307785|69414034|FG007|Part E: Up to 4.4 Months|Death|0|||
37790753|NCT03307785|69414035|FG008|Part E: Up to 4.4 Months|Death|0|||
37790754|NCT03307785|69414036|FG009|Part E: Up to 4.4 Months|Death|0|||
37790755|NCT03307785|69414037|FG010|Part E: Up to 4.4 Months|Death|0|||
37790756|NCT03307785|69414027|FG000|Part E: Up to 4.4 Months|Physician Decision|0|||
37790757|NCT03307785|69414028|FG001|Part E: Up to 4.4 Months|Physician Decision|0|||
37790758|NCT03307785|69414029|FG002|Part E: Up to 4.4 Months|Physician Decision|0|||
37790759|NCT03307785|69414030|FG003|Part E: Up to 4.4 Months|Physician Decision|0|||
37790760|NCT03307785|69414031|FG004|Part E: Up to 4.4 Months|Physician Decision|0|||
37790761|NCT03307785|69414032|FG005|Part E: Up to 4.4 Months|Physician Decision|0|||
37790762|NCT03307785|69414033|FG006|Part E: Up to 4.4 Months|Physician Decision|1|||
37790763|NCT03307785|69414034|FG007|Part E: Up to 4.4 Months|Physician Decision|0|||
37790764|NCT03307785|69414035|FG008|Part E: Up to 4.4 Months|Physician Decision|0|||
37790765|NCT03307785|69414036|FG009|Part E: Up to 4.4 Months|Physician Decision|0|||
37790766|NCT03307785|69414037|FG010|Part E: Up to 4.4 Months|Physician Decision|0|||
37790767|NCT03307785|69414027|FG000|Part F: Up to 3.5 Months|Physician Decision|0|||
37790768|NCT03307785|69414028|FG001|Part F: Up to 3.5 Months|Physician Decision|0|||
37790769|NCT03307785|69414029|FG002|Part F: Up to 3.5 Months|Physician Decision|0|||
37790770|NCT03307785|69414030|FG003|Part F: Up to 3.5 Months|Physician Decision|0|||
37790771|NCT03307785|69414031|FG004|Part F: Up to 3.5 Months|Physician Decision|0|||
37790772|NCT03307785|69414032|FG005|Part F: Up to 3.5 Months|Physician Decision|0|||
37790773|NCT03307785|69414033|FG006|Part F: Up to 3.5 Months|Physician Decision|0|||
37790774|NCT03307785|69414034|FG007|Part F: Up to 3.5 Months|Physician Decision|1|||
37790775|NCT03307785|69414035|FG008|Part F: Up to 3.5 Months|Physician Decision|0|||
37790776|NCT03307785|69414036|FG009|Part F: Up to 3.5 Months|Physician Decision|0|||
37790777|NCT03307785|69414037|FG010|Part F: Up to 3.5 Months|Physician Decision|0|||
37790778|NCT03284710|69414062|FG000|Overall Study|Withdrawal by Subject|1|||
37790779|NCT03284710|69414063|FG001|Overall Study|Withdrawal by Subject|0|||
37790780|NCT03284710|69414064|FG002|Overall Study|Withdrawal by Subject|1|||
37790781|NCT03284710|69414065|FG003|Overall Study|Withdrawal by Subject|6|||
37790782|NCT03284710|69414062|FG000|Overall Study|Lost to Follow-up|3|||
37790783|NCT03284710|69414063|FG001|Overall Study|Lost to Follow-up|3|||
37790784|NCT03284710|69414064|FG002|Overall Study|Lost to Follow-up|1|||
37790785|NCT03284710|69414065|FG003|Overall Study|Lost to Follow-up|0|||
37790786|NCT03284710|69414062|FG000|Overall Study|Physician Decision|1|||
37790787|NCT03284710|69414063|FG001|Overall Study|Physician Decision|0|||
37790788|NCT03284710|69414064|FG002|Overall Study|Physician Decision|0|||
37790789|NCT03284710|69414065|FG003|Overall Study|Physician Decision|0|||
37790790|NCT03284710|69414062|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
37790791|NCT03284710|69414063|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
37790792|NCT03284710|69414064|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
37790793|NCT03284710|69414065|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
37790794|NCT03284710|69414062|FG000|Overall Study|HIV Infection|0|||
37790795|NCT03284710|69414063|FG001|Overall Study|HIV Infection|2|||
37790796|NCT03284710|69414064|FG002|Overall Study|HIV Infection|2|||
37790797|NCT03284710|69414065|FG003|Overall Study|HIV Infection|1|||
37790798|NCT03248167|69414084|FG000|Overall Study|Withdrawal by Subject|2|||
37790799|NCT03248167|69414085|FG001|Overall Study|Withdrawal by Subject|2|||
37790800|NCT03248167|69414084|FG000|Overall Study|Physician Decision|0|||
37790801|NCT03248167|69414085|FG001|Overall Study|Physician Decision|1|||
37790802|NCT03248167|69414084|FG000|Overall Study|Institution Mandated COVID-19 Research Pause|2|||
37790803|NCT03248167|69414085|FG001|Overall Study|Institution Mandated COVID-19 Research Pause|1|||
37790804|NCT03248167|69414084|FG000|Overall Study|Lost to Follow-up|1|||
37790805|NCT03248167|69414085|FG001|Overall Study|Lost to Follow-up|0|||
37790806|NCT03220737|69414099|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
37790807|NCT03220737|69414100|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
37790808|NCT03220737|69414101|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
37790809|NCT03220737|69414102|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
37790810|NCT03220737|69414103|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
37790811|NCT03220737|69414104|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
37790812|NCT03220737|69414105|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
37790813|NCT03220737|69414099|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
37790814|NCT03220737|69414100|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
37790815|NCT03220737|69414101|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
37790816|NCT03220737|69414102|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
37790817|NCT03220737|69414103|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
37790818|NCT03220737|69414104|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
37790819|NCT03220737|69414105|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
37790820|NCT03220737|69414099|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
37790821|NCT03220737|69414100|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
37790822|NCT03220737|69414101|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
37790823|NCT03220737|69414102|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
37790824|NCT03220737|69414103|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
37790825|NCT03220737|69414104|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
37790826|NCT03220737|69414105|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
37790827|NCT03220737|69414099|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
37790828|NCT03220737|69414100|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
37790829|NCT03220737|69414101|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
37790830|NCT03220737|69414102|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
37790831|NCT03220737|69414103|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
37790832|NCT03220737|69414104|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
37790833|NCT03220737|69414105|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
37790834|NCT03220737|69414099|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
37790835|NCT03220737|69414100|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
37790836|NCT03220737|69414101|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
37790837|NCT03220737|69414102|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
37790838|NCT03220737|69414103|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
37790839|NCT03220737|69414104|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
37790840|NCT03220737|69414105|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
37790841|NCT03220737|69414099|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
37790842|NCT03220737|69414100|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
37790843|NCT03220737|69414101|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
37790844|NCT03220737|69414102|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
37790845|NCT03220737|69414103|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
37790846|NCT03220737|69414104|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
37790847|NCT03220737|69414105|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
37790848|NCT03220737|69414099|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
37790849|NCT03220737|69414100|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
37790850|NCT03220737|69414101|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
37790851|NCT03220737|69414102|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
37790852|NCT03220737|69414103|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
37790853|NCT03220737|69414104|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
37790854|NCT03220737|69414105|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
37790855|NCT03220737|69414099|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
37790856|NCT03220737|69414100|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
37790857|NCT03220737|69414101|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
37790858|NCT03220737|69414102|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
37790859|NCT03220737|69414103|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
37790860|NCT03220737|69414104|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
37790861|NCT03220737|69414105|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
37790862|NCT03198728|69414129|FG000|Overall Study|Adverse Event|10|||
37790863|NCT03198728|69414130|FG001|Overall Study|Adverse Event|5|||
37790864|NCT03198728|69414129|FG000|Overall Study|Lost to Follow-up|21|||
37790865|NCT03198728|69414130|FG001|Overall Study|Lost to Follow-up|7|||
37790866|NCT03198728|69414129|FG000|Overall Study|Physician Decision|7|||
37790867|NCT03198728|69414130|FG001|Overall Study|Physician Decision|2|||
37790868|NCT03198728|69414129|FG000|Overall Study|Withdrawal by Subject|14|||
37790869|NCT03198728|69414130|FG001|Overall Study|Withdrawal by Subject|10|||
37790870|NCT03144804|69414162|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
37790871|NCT03142334|69414168|FG000|Overall Study|Death|18|||
37790872|NCT03142334|69414169|FG001|Overall Study|Death|33|||
37790873|NCT03142334|69414168|FG000|Overall Study|Withdrawal by Subject|15|||
37790874|NCT03142334|69414169|FG001|Overall Study|Withdrawal by Subject|11|||
37790875|NCT03142334|69414168|FG000|Overall Study|Ongoing on trial follow up|463|||
37790876|NCT03142334|69414169|FG001|Overall Study|Ongoing on trial follow up|454|||
37790877|NCT03126539|69414177|FG000|Overall Study|Lost to Follow-up|1|||
37790878|NCT03126539|69414178|FG001|Overall Study|Lost to Follow-up|1|||
37790879|NCT03126539|69414179|FG002|Overall Study|Lost to Follow-up|1|||
37790880|NCT03126539|69414180|FG003|Overall Study|Lost to Follow-up|0|||
37790881|NCT03126539|69414181|FG004|Overall Study|Lost to Follow-up|0|||
37790882|NCT03123250|69414194|FG000|60 Months Follow Up|Withdrawal by Subject|2|||
37790883|NCT03099096|69414198|FG000|Overall Study|Adverse Event|1|||
37790884|NCT03099096|69414198|FG000|Overall Study|Physician Decision|1|||
37790885|NCT03043664|69414202|FG000|Overall Study|Lost to Follow-up|1|||
37790886|NCT03041467|69414208|FG000|Overall Study|Death|40|||
37790887|NCT03041467|69414209|FG001|Overall Study|Death|36|||
37790888|NCT03041467|69414208|FG000|Overall Study|Withdrawal by Subject|36|||
37790889|NCT03041467|69414209|FG001|Overall Study|Withdrawal by Subject|37|||
37790890|NCT03041467|69414208|FG000|Overall Study|Lost to Follow-up|6|||
37790891|NCT03041467|69414209|FG001|Overall Study|Lost to Follow-up|7|||
37790892|NCT03041467|69414208|FG000|Overall Study|Declined consent for study extension|21|||
37790893|NCT03041467|69414209|FG001|Overall Study|Declined consent for study extension|33|||
37790894|NCT03041467|69414208|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
37790895|NCT03041467|69414209|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
37790896|NCT03041467|69414208|FG000|Overall Study|48 Month visit not completed|9|||
37790897|NCT03041467|69414209|FG001|Overall Study|48 Month visit not completed|4|||
37790898|NCT03019406|69414221|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
37790899|NCT03019406|69414222|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
37790900|NCT03019406|69414223|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
37790901|NCT03019406|69414224|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
37790902|NCT02972593|69414239|FG000|Overall Study|Lost to Follow-up|19|||
37790903|NCT02972593|69414240|FG001|Overall Study|Lost to Follow-up|15|||
37790904|NCT02972593|69414239|FG000|Overall Study|Protocol Violation|1|||
37790905|NCT02972593|69414240|FG001|Overall Study|Protocol Violation|0|||
37790906|NCT02949700|69414252|FG000|Phase I|Withdrawal by Subject|1|||
37790907|NCT02949700|69414253|FG001|Phase I|Withdrawal by Subject|1|||
37790908|NCT02949700|69414254|FG002|Phase I|Withdrawal by Subject|0|||
37790909|NCT02949700|69414255|FG003|Phase I|Withdrawal by Subject|0|||
37790910|NCT02949700|69414252|FG000|Phase I|Protocol Violation|1|||
37790911|NCT02949700|69414253|FG001|Phase I|Protocol Violation|0|||
37975519|NCT00397215|69662815|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
37790912|NCT02949700|69414254|FG002|Phase I|Protocol Violation|0|||
37790913|NCT02949700|69414255|FG003|Phase I|Protocol Violation|0|||
37693730|NCT02059395|69170046|FG000|Overall Study|Lost to Follow-up|2|||
37790914|NCT02949700|69414252|FG000|Phase II|Withdrawal by Subject|0|||
37790915|NCT02949700|69414253|FG001|Phase II|Withdrawal by Subject|0|||
37790916|NCT02949700|69414254|FG002|Phase II|Withdrawal by Subject|0|||
37790917|NCT02949700|69414255|FG003|Phase II|Withdrawal by Subject|2|||
37790918|NCT02949700|69414252|FG000|Phase II|Protocol Violation|0|||
37790919|NCT02949700|69414253|FG001|Phase II|Protocol Violation|0|||
37790920|NCT02949700|69414254|FG002|Phase II|Protocol Violation|1|||
37790921|NCT02949700|69414255|FG003|Phase II|Protocol Violation|3|||
37790922|NCT02947087|69414266|FG000|Overall Study|Withdrawal by Subject|3|||
37790923|NCT02947087|69414267|FG001|Overall Study|Withdrawal by Subject|2|||
37790924|NCT02879448|69414275|FG000|Overall Study|No implant attempt|17|||
37790925|NCT02879448|69414276|FG001|Overall Study|No implant attempt|28|||
37790926|NCT02879448|69414275|FG000|Overall Study|Withdrawal by Subject|20|||
37790927|NCT02879448|69414276|FG001|Overall Study|Withdrawal by Subject|46|||
37790928|NCT02879448|69414275|FG000|Overall Study|Death|63|||
37790929|NCT02879448|69414276|FG001|Overall Study|Death|85|||
37790930|NCT02879448|69414275|FG000|Overall Study|Lost to Follow-up|3|||
37790931|NCT02879448|69414276|FG001|Overall Study|Lost to Follow-up|4|||
37790932|NCT02879448|69414275|FG000|Overall Study|Missing visit|34|||
37790933|NCT02879448|69414276|FG001|Overall Study|Missing visit|39|||
37790934|NCT02879448|69414275|FG000|Overall Study|Pending evaluation|1|||
37790935|NCT02879448|69414276|FG001|Overall Study|Pending evaluation|0|||
37790936|NCT02868216|69414284|FG000|Overall Study|Death|0|||
37790937|NCT02868216|69414285|FG001|Overall Study|Death|1|||
37790938|NCT02868216|69414284|FG000|Overall Study|coronary artery bypass|1|||
37790939|NCT02868216|69414285|FG001|Overall Study|coronary artery bypass|0|||
37790940|NCT02868216|69414284|FG000|Overall Study|Withdrawal by Subject|7|||
37790941|NCT02868216|69414285|FG001|Overall Study|Withdrawal by Subject|5|||
37790942|NCT02841995|69414294|FG000|Overall Study|Disease progression|5|||
37790943|NCT02841995|69414295|FG001|Overall Study|Disease progression|11|||
37790944|NCT02841995|69414296|FG002|Overall Study|Disease progression|8|||
37790945|NCT02841995|69414294|FG000|Overall Study|Withdrawal by Subject|2|||
37790946|NCT02841995|69414295|FG001|Overall Study|Withdrawal by Subject|4|||
37790947|NCT02841995|69414296|FG002|Overall Study|Withdrawal by Subject|4|||
37790948|NCT02841995|69414294|FG000|Overall Study|Adverse Event|2|||
37790949|NCT02841995|69414295|FG001|Overall Study|Adverse Event|0|||
37790950|NCT02841995|69414296|FG002|Overall Study|Adverse Event|1|||
37790951|NCT02841995|69414294|FG000|Overall Study|Investigator decision|2|||
37790952|NCT02841995|69414295|FG001|Overall Study|Investigator decision|0|||
37790953|NCT02841995|69414296|FG002|Overall Study|Investigator decision|1|||
37790954|NCT02841995|69414294|FG000|Overall Study|Death|0|||
37790955|NCT02841995|69414295|FG001|Overall Study|Death|0|||
37790956|NCT02841995|69414296|FG002|Overall Study|Death|2|||
37790957|NCT02841995|69414294|FG000|Overall Study|Noncompliance to protocol|1|||
37790958|NCT02841995|69414295|FG001|Overall Study|Noncompliance to protocol|0|||
37790959|NCT02841995|69414296|FG002|Overall Study|Noncompliance to protocol|0|||
37790960|NCT02841995|69414294|FG000|Overall Study|Sponsor decision|1|||
37790961|NCT02841995|69414295|FG001|Overall Study|Sponsor decision|0|||
37790962|NCT02841995|69414296|FG002|Overall Study|Sponsor decision|0|||
37790963|NCT02841995|69414294|FG000|Overall Study|Other|4|||
37790964|NCT02841995|69414295|FG001|Overall Study|Other|1|||
37790965|NCT02841995|69414296|FG002|Overall Study|Other|5|||
37790966|NCT02643966|69414313|FG000|First Screening Round|ineligible|1|||
37790967|NCT02643966|69414313|FG000|First Screening Round|excluded from analysis|2|||
37790968|NCT02643966|69414313|FG000|First Screening Round|Lost to Follow-up|56|||
37790969|NCT02643966|69414313|FG000|First Screening Round|Withdrawal by Subject|28|||
37790970|NCT02643966|69414313|FG000|First Screening Round|Death|1|||
37790971|NCT02643966|69414313|FG000|Between First and Second Screening|Lost to Follow-up|65|||
37790972|NCT02643966|69414313|FG000|Between First and Second Screening|Withdrawal by Subject|82|||
37790973|NCT02643966|69414313|FG000|Between First and Second Screening|women who skipped year 2 exam|11|||
37790974|NCT02643966|69414313|FG000|Second Screening Round|Withdrawal by Subject|20|||
37790975|NCT02643966|69414313|FG000|Second Screening Round|Lost to Follow-up|57|||
37790976|NCT02643966|69414313|FG000|Second Screening Round|Physician Decision|2|||
37790977|NCT02643966|69414313|FG000|Second Screening Round|Death|4|||
37790978|NCT02643966|69414313|FG000|Between Second and Third Screening|Lost to Follow-up|75|||
37790979|NCT02643966|69414313|FG000|Between Second and Third Screening|Death|1|||
37790980|NCT02643966|69414313|FG000|Between Second and Third Screening|Withdrawal by Subject|181|||
37790981|NCT02643966|69414313|FG000|Third Screening Round|PI excluded|2|||
37790982|NCT02643966|69414313|FG000|Third Screening Round|Lost to Follow-up|241|||
37790983|NCT02554383|69414342|FG000|Overall Study|Ineligible|3|||
37790984|NCT02554383|69414343|FG001|Overall Study|Ineligible|2|||
37790985|NCT02554383|69414342|FG000|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|8|||
37790986|NCT02554383|69414343|FG001|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|6|||
37790987|NCT02554383|69414342|FG000|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|0|||
37790988|NCT02554383|69414343|FG001|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|2|||
37790989|NCT02554383|69414342|FG000|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|12|||
37790990|NCT02554383|69414343|FG001|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|9|||
37790991|NCT02522871|69414351|FG000|Overall Study|Protocol Violation|1|||
37790992|NCT02522871|69414352|FG001|Overall Study|Protocol Violation|4|||
37790993|NCT02522871|69414351|FG000|Overall Study|Treated without randomization|1|||
37790994|NCT02522871|69414352|FG001|Overall Study|Treated without randomization|0|||
37790995|NCT02522871|69414351|FG000|Overall Study|Death|9|||
37790996|NCT02522871|69414352|FG001|Overall Study|Death|9|||
37790997|NCT02522871|69414351|FG000|Overall Study|Died in operating room prior to transplant|0|||
37790998|NCT02522871|69414352|FG001|Overall Study|Died in operating room prior to transplant|1|||
37790999|NCT02519439|69414367|FG000|Overall Study|Study Termination|19|||
37791000|NCT02519439|69414367|FG000|Overall Study|Withdrawal by Subject|1|||
37791001|NCT02519439|69414367|FG000|Overall Study|Adverse Event|1|||
37791002|NCT02147184|69414377|FG000|Overall Study|Lost to Follow-up|28|||
37791003|NCT02147184|69414378|FG001|Overall Study|Lost to Follow-up|15|||
37791004|NCT02147184|69414377|FG000|Overall Study|Study Burden|11|||
37791005|NCT02147184|69414378|FG001|Overall Study|Study Burden|7|||
37791006|NCT02147184|69414377|FG000|Overall Study|Pregnancy|6|||
37791007|NCT02147184|69414378|FG001|Overall Study|Pregnancy|0|||
37791008|NCT02147184|69414377|FG000|Overall Study|Moved out of state|3|||
37791009|NCT02147184|69414378|FG001|Overall Study|Moved out of state|3|||
37791010|NCT02147184|69414377|FG000|Overall Study|Physician Decision|0|||
37791011|NCT02147184|69414378|FG001|Overall Study|Physician Decision|2|||
37791012|NCT02147184|69414377|FG000|Overall Study|Other|1|||
37791013|NCT02147184|69414378|FG001|Overall Study|Other|0|||
37791014|NCT02101021|69414389|FG000|Overall Study|Death|4|||
37791015|NCT02101021|69414390|FG001|Overall Study|Death|3|||
37791016|NCT02101021|69414391|FG002|Overall Study|Death|6|||
37791017|NCT02101021|69414392|FG003|Overall Study|Death|0|||
37791018|NCT02101021|69414393|FG004|Overall Study|Death|3|||
37791019|NCT02101021|69414389|FG000|Overall Study|Withdrew Consent from study|1|||
37791020|NCT02101021|69414390|FG001|Overall Study|Withdrew Consent from study|1|||
37791021|NCT02101021|69414391|FG002|Overall Study|Withdrew Consent from study|0|||
37791022|NCT02101021|69414392|FG003|Overall Study|Withdrew Consent from study|2|||
37791023|NCT02101021|69414393|FG004|Overall Study|Withdrew Consent from study|0|||
37791024|NCT02101021|69414389|FG000|Overall Study|Lost to Follow-up|1|||
37791025|NCT02101021|69414390|FG001|Overall Study|Lost to Follow-up|0|||
37791026|NCT02101021|69414391|FG002|Overall Study|Lost to Follow-up|0|||
37791027|NCT02101021|69414392|FG003|Overall Study|Lost to Follow-up|0|||
37975520|NCT00397215|69662816|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
37975521|NCT00397215|69662817|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
37791028|NCT02101021|69414393|FG004|Overall Study|Lost to Follow-up|0|||
37791029|NCT02101021|69414389|FG000|Overall Study|Study Terminated by Sponsor|1|||
37975522|NCT00397215|69662818|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
37791030|NCT02101021|69414390|FG001|Overall Study|Study Terminated by Sponsor|0|||
37791031|NCT02101021|69414391|FG002|Overall Study|Study Terminated by Sponsor|1|||
37791032|NCT02101021|69414392|FG003|Overall Study|Study Terminated by Sponsor|1|||
37791033|NCT02101021|69414393|FG004|Overall Study|Study Terminated by Sponsor|1|||
37791034|NCT02031536|69414418|FG000|Overall Study|ineligible|1|||
37791035|NCT02031536|69414419|FG001|Overall Study|ineligible|0|||
37791036|NCT02028455|69414433|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
37791037|NCT02028455|69414434|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
37791038|NCT02028455|69414435|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
37791039|NCT02028455|69414436|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
37791040|NCT02028455|69414437|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
37791041|NCT02028455|69414438|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
37791042|NCT02028455|69414439|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
37791043|NCT02028455|69414440|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
37791044|NCT02028455|69414433|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
37791045|NCT02028455|69414434|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
37791046|NCT02028455|69414435|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
37791047|NCT02028455|69414436|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
37791048|NCT02028455|69414437|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
37791049|NCT02028455|69414438|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
37791050|NCT02028455|69414439|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
37791051|NCT02028455|69414440|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
37791052|NCT02028455|69414433|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
37791053|NCT02028455|69414434|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
37791054|NCT02028455|69414435|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
37791055|NCT02028455|69414436|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
37791056|NCT02028455|69414437|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
37791057|NCT02028455|69414438|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
37791058|NCT02028455|69414439|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
37791059|NCT02028455|69414440|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
37791060|NCT02028455|69414433|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
37791061|NCT02028455|69414434|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
37791062|NCT02028455|69414435|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
37864110|NCT00991276|69547777|FG000|First Intervention Period|Other|0|||
37975523|NCT00397215|69662815|FG000|Month 0 (Day 0)|Other|4|||
37791063|NCT02028455|69414436|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
37791064|NCT02028455|69414437|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
37791065|NCT02028455|69414438|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
37791066|NCT02028455|69414439|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
37791067|NCT02028455|69414440|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
37791068|NCT02019641|69414464|FG000|10-Week Follow up|Withdrawal by investigator|2|||
37791069|NCT02019641|69414465|FG001|10-Week Follow up|Withdrawal by investigator|0|||
37791070|NCT02019641|69414466|FG002|10-Week Follow up|Withdrawal by investigator|0|||
37791071|NCT02019641|69414464|FG000|10-Week Follow up|Withdrawal by Subject|1|||
37791072|NCT02019641|69414465|FG001|10-Week Follow up|Withdrawal by Subject|1|||
37791073|NCT02019641|69414466|FG002|10-Week Follow up|Withdrawal by Subject|0|||
37791074|NCT02019641|69414464|FG000|20-Week Follow up|Withdrawal by investigator|0|||
37791075|NCT02019641|69414465|FG001|20-Week Follow up|Withdrawal by investigator|0|||
37693731|NCT02059395|69170047|FG001|Overall Study|Lost to Follow-up|4|||
37693732|NCT02059239|69170055|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
37791076|NCT02019641|69414466|FG002|20-Week Follow up|Withdrawal by investigator|1|||
37791077|NCT01964430|69414475|FG000|Pre-Treatment (Randomization) Period|Protocol Deviation|0|||
37791078|NCT01964430|69414476|FG001|Pre-Treatment (Randomization) Period|Protocol Deviation|2|||
37791079|NCT01964430|69414475|FG000|Pre-Treatment (Randomization) Period|Withdrawal by Subject|2|||
37791080|NCT01964430|69414476|FG001|Pre-Treatment (Randomization) Period|Withdrawal by Subject|9|||
37791081|NCT01964430|69414475|FG000|Pre-Treatment (Randomization) Period|Adverse Event|1|||
37791082|NCT01964430|69414476|FG001|Pre-Treatment (Randomization) Period|Adverse Event|0|||
37791083|NCT01964430|69414475|FG000|Treatment Period|Adverse Event|71|||
37791084|NCT01964430|69414476|FG001|Treatment Period|Adverse Event|37|||
37791085|NCT01964430|69414475|FG000|Treatment Period|Withdrawal by Subject|36|||
37791086|NCT01964430|69414476|FG001|Treatment Period|Withdrawal by Subject|27|||
37791087|NCT01964430|69414475|FG000|Treatment Period|Death|1|||
37791088|NCT01964430|69414476|FG001|Treatment Period|Death|3|||
37864111|NCT00991276|69547778|FG001|First Intervention Period|Other|0|||
37864112|NCT00991276|69547779|FG002|First Intervention Period|Other|0|||
37864113|NCT00991276|69547780|FG003|First Intervention Period|Other|1|||
37864114|NCT00991276|69547781|FG004|First Intervention Period|Other|1|||
37864115|NCT00991276|69547782|FG005|First Intervention Period|Other|0|||
37864116|NCT00991276|69547777|FG000|First Intervention Period|Withdrawal by Subject|0|||
37864117|NCT00991276|69547778|FG001|First Intervention Period|Withdrawal by Subject|1|||
37864118|NCT00991276|69547779|FG002|First Intervention Period|Withdrawal by Subject|0|||
37864119|NCT00991276|69547780|FG003|First Intervention Period|Withdrawal by Subject|1|||
37864120|NCT00991276|69547781|FG004|First Intervention Period|Withdrawal by Subject|0|||
37864121|NCT00991276|69547782|FG005|First Intervention Period|Withdrawal by Subject|1|||
37864122|NCT00991276|69547777|FG000|First Intervention Period|Lost to Follow-up|0|||
37864123|NCT00991276|69547778|FG001|First Intervention Period|Lost to Follow-up|1|||
37791089|NCT01964430|69414475|FG000|Treatment Period|Protocol Deviation|0|||
37791090|NCT01964430|69414476|FG001|Treatment Period|Protocol Deviation|1|||
37791091|NCT01964430|69414475|FG000|Treatment Period|Physician Decision|5|||
37791092|NCT01964430|69414476|FG001|Treatment Period|Physician Decision|4|||
37791093|NCT01964430|69414475|FG000|Treatment Period|Disease Relapse|28|||
37791094|NCT01964430|69414476|FG001|Treatment Period|Disease Relapse|38|||
37791095|NCT01964430|69414475|FG000|Treatment Period|Other reasons|1|||
37791096|NCT01964430|69414476|FG001|Treatment Period|Other reasons|3|||
37791097|NCT01898494|69414486|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
37791098|NCT01898494|69414487|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
37791099|NCT01898494|69414488|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
37791100|NCT01898494|69414489|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
37791101|NCT01898494|69414490|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
37791102|NCT01898494|69414486|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
37791103|NCT01898494|69414487|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
37791104|NCT01898494|69414488|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
37791105|NCT01898494|69414489|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
37791106|NCT01898494|69414490|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
37791107|NCT01898494|69414486|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
37791108|NCT01898494|69414487|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
37791109|NCT01898494|69414488|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
37791110|NCT01898494|69414489|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
37791111|NCT01898494|69414490|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
37791112|NCT01898494|69414486|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
37791113|NCT01898494|69414487|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
37791114|NCT01898494|69414488|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
37791115|NCT01898494|69414489|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
37791116|NCT01898494|69414490|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
37791117|NCT01898494|69414486|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
37791118|NCT01898494|69414487|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
37791119|NCT01898494|69414488|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
37791120|NCT01898494|69414489|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
37791121|NCT01898494|69414490|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
37791122|NCT01898494|69414486|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
37791123|NCT01898494|69414487|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
37791124|NCT01898494|69414488|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
37791125|NCT01898494|69414489|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
37791126|NCT01898494|69414490|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
37791127|NCT01898494|69414486|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
37791128|NCT01898494|69414487|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
37791129|NCT01898494|69414488|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
37791130|NCT01898494|69414489|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
37864124|NCT00991276|69547779|FG002|First Intervention Period|Lost to Follow-up|0|||
37864125|NCT00991276|69547780|FG003|First Intervention Period|Lost to Follow-up|1|||
37791131|NCT01898494|69414490|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
37791132|NCT01898494|69414486|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
37791133|NCT01898494|69414487|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
37791134|NCT01898494|69414488|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
37791135|NCT01898494|69414489|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
37791136|NCT01898494|69414490|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
37791137|NCT01898494|69414486|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
37791138|NCT01898494|69414487|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
37791139|NCT01898494|69414488|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
37791140|NCT01898494|69414489|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
37791141|NCT01898494|69414490|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
37791142|NCT01898494|69414486|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
37791143|NCT01898494|69414487|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
37791144|NCT01898494|69414488|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
37791145|NCT01898494|69414489|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
37791146|NCT01898494|69414490|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
37791147|NCT01898494|69414486|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
37791148|NCT01898494|69414487|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
37791149|NCT01898494|69414488|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
37791150|NCT01898494|69414489|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
37791151|NCT01898494|69414490|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
37791152|NCT01898494|69414486|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
37791153|NCT01898494|69414487|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
37791154|NCT01898494|69414488|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
37791155|NCT01898494|69414489|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
37791156|NCT01898494|69414490|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
37791157|NCT01898494|69414486|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
37791158|NCT01898494|69414487|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
37791159|NCT01898494|69414488|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
37791160|NCT01898494|69414489|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
37791161|NCT01898494|69414490|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
37791162|NCT01898494|69414486|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
37791163|NCT01898494|69414487|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
37791164|NCT01898494|69414488|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
37791165|NCT01898494|69414489|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
37791166|NCT01898494|69414490|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
37791167|NCT01863043|69414508|FG000|Overall Study|Death|6|||
37791168|NCT01863043|69414509|FG001|Overall Study|Death|1|||
37791169|NCT01863043|69414508|FG000|Overall Study|Withdrawal by Subject|0|||
37791170|NCT01863043|69414509|FG001|Overall Study|Withdrawal by Subject|2|||
37791171|NCT01863043|69414508|FG000|Overall Study|Adverse Event|7|||
37693733|NCT02059239|69170056|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
37693734|NCT02059239|69170055|FG000|Overall Study|Physician Decision|1|||
37791172|NCT01863043|69414509|FG001|Overall Study|Adverse Event|8|||
37791173|NCT01863043|69414508|FG000|Overall Study|exclusion criteria found after enrollment|0|||
37791174|NCT01863043|69414509|FG001|Overall Study|exclusion criteria found after enrollment|1|||
37791175|NCT01841359|69414515|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
37791176|NCT01841359|69414515|FG000|Overall Study|Concommitant medical issues|2|||
37791177|NCT01841359|69414515|FG000|Overall Study|Adverse Event|3|||
37791178|NCT01841359|69414515|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
37791179|NCT01660451|69414525|FG000|Overall Study|Protocol Violation|0|||
37791180|NCT01660451|69414526|FG001|Overall Study|Protocol Violation|1|||
37693735|NCT02059239|69170056|FG001|Overall Study|Physician Decision|0|||
37791181|NCT01660451|69414527|FG002|Overall Study|Protocol Violation|1|||
37791182|NCT01660451|69414525|FG000|Overall Study|Adverse Event (AE) without Clinical PD|11|||
37791183|NCT01660451|69414526|FG001|Overall Study|Adverse Event (AE) without Clinical PD|8|||
37791184|NCT01660451|69414527|FG002|Overall Study|Adverse Event (AE) without Clinical PD|26|||
37791185|NCT01660451|69414525|FG000|Overall Study|AE with Clinical PD|1|||
37791186|NCT01660451|69414526|FG001|Overall Study|AE with Clinical PD|3|||
37791187|NCT01660451|69414527|FG002|Overall Study|AE with Clinical PD|9|||
37791188|NCT01660451|69414525|FG000|Overall Study|Sponsor Decision|0|||
37791189|NCT01660451|69414526|FG001|Overall Study|Sponsor Decision|0|||
37791190|NCT01660451|69414527|FG002|Overall Study|Sponsor Decision|1|||
37791191|NCT01660451|69414525|FG000|Overall Study|Protocol Deviation|0|||
37791192|NCT01660451|69414526|FG001|Overall Study|Protocol Deviation|0|||
37791193|NCT01660451|69414527|FG002|Overall Study|Protocol Deviation|1|||
37791194|NCT01660451|69414525|FG000|Overall Study|Physician Decision|1|||
37791195|NCT01660451|69414526|FG001|Overall Study|Physician Decision|2|||
37791196|NCT01660451|69414527|FG002|Overall Study|Physician Decision|5|||
37791197|NCT01660451|69414525|FG000|Overall Study|Withdrawal by Subject|1|||
37791198|NCT01660451|69414526|FG001|Overall Study|Withdrawal by Subject|0|||
37791199|NCT01660451|69414527|FG002|Overall Study|Withdrawal by Subject|16|||
37791200|NCT01660451|69414525|FG000|Overall Study|Ongoing with treatment|3|||
37791201|NCT01660451|69414526|FG001|Overall Study|Ongoing with treatment|3|||
37791202|NCT01660451|69414527|FG002|Overall Study|Ongoing with treatment|46|||
37791203|NCT01390584|69414546|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
37791204|NCT01390584|69414547|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
37791205|NCT01390584|69414548|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
37791206|NCT01242800|69414559|FG000|Overall Study|Patient refusal|0|||
37791207|NCT01242800|69414560|FG001|Overall Study|Patient refusal|10|||
37791208|NCT01242800|69414559|FG000|Overall Study|Physician Decision|0|||
37791209|NCT01242800|69414560|FG001|Overall Study|Physician Decision|1|||
37791210|NCT01242800|69414559|FG000|Overall Study|Disease progression|0|||
37791211|NCT01242800|69414560|FG001|Overall Study|Disease progression|3|||
37791212|NCT01242800|69414559|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
37791213|NCT01242800|69414560|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
37791214|NCT01242800|69414559|FG000|Overall Study|Reasons not reported|0|||
37791215|NCT01242800|69414560|FG001|Overall Study|Reasons not reported|4|||
37791216|NCT01216683|69414569|FG000|Induction|Never started treatment|0|||
37791217|NCT01216683|69414570|FG001|Induction|Never started treatment|6|||
37791218|NCT01216683|69414571|FG002|Induction|Never started treatment|3|||
37791219|NCT01216683|69414569|FG000|Induction|Lack of Efficacy|4|||
37791220|NCT01216683|69414570|FG001|Induction|Lack of Efficacy|3|||
37791221|NCT01216683|69414571|FG002|Induction|Lack of Efficacy|7|||
37791222|NCT01216683|69414569|FG000|Induction|Adverse Event|0|||
37791223|NCT01216683|69414570|FG001|Induction|Adverse Event|5|||
37791224|NCT01216683|69414571|FG002|Induction|Adverse Event|5|||
37791225|NCT01216683|69414569|FG000|Induction|Death|0|||
37791226|NCT01216683|69414570|FG001|Induction|Death|0|||
37693736|NCT02059161|69170065|FG000|Overall Study|Pregnancy|0|||
37693737|NCT02059161|69170066|FG001|Overall Study|Pregnancy|2|||
37693738|NCT02059161|69170065|FG000|Overall Study|Adverse Event|2|||
37693739|NCT02059161|69170066|FG001|Overall Study|Adverse Event|6|||
37791227|NCT01216683|69414571|FG002|Induction|Death|2|||
37791228|NCT01216683|69414569|FG000|Induction|Withdrawal by Subject|0|||
37791229|NCT01216683|69414570|FG001|Induction|Withdrawal by Subject|4|||
37791230|NCT01216683|69414571|FG002|Induction|Withdrawal by Subject|2|||
37791231|NCT01216683|69414569|FG000|Induction|Other disease|0|||
37791232|NCT01216683|69414570|FG001|Induction|Other disease|1|||
37791233|NCT01216683|69414571|FG002|Induction|Other disease|2|||
37791234|NCT01216683|69414569|FG000|Continuation|Lack of Efficacy|3|||
37791235|NCT01216683|69414570|FG001|Continuation|Lack of Efficacy|2|||
37791236|NCT01216683|69414571|FG002|Continuation|Lack of Efficacy|7|||
37791237|NCT01216683|69414569|FG000|Continuation|Adverse Event|5|||
37791238|NCT01216683|69414570|FG001|Continuation|Adverse Event|3|||
37791239|NCT01216683|69414571|FG002|Continuation|Adverse Event|16|||
37791240|NCT01216683|69414569|FG000|Continuation|Death|1|||
37791241|NCT01216683|69414570|FG001|Continuation|Death|0|||
37791242|NCT01216683|69414571|FG002|Continuation|Death|2|||
37791243|NCT01216683|69414569|FG000|Continuation|Withdrawal by Subject|4|||
37791244|NCT01216683|69414570|FG001|Continuation|Withdrawal by Subject|5|||
37791245|NCT01216683|69414571|FG002|Continuation|Withdrawal by Subject|9|||
37791246|NCT01216683|69414569|FG000|Continuation|Other diseases|0|||
37791247|NCT01216683|69414570|FG001|Continuation|Other diseases|2|||
37791248|NCT01216683|69414571|FG002|Continuation|Other diseases|1|||
37791249|NCT01216683|69414569|FG000|Continuation|Physician Decision|1|||
37791250|NCT01216683|69414570|FG001|Continuation|Physician Decision|0|||
37791251|NCT01216683|69414571|FG002|Continuation|Physician Decision|1|||
37791252|NCT01216683|69414569|FG000|Continuation|Non-compliance|1|||
37791253|NCT01216683|69414570|FG001|Continuation|Non-compliance|0|||
37791254|NCT01216683|69414571|FG002|Continuation|Non-compliance|1|||
37791255|NCT01216683|69414569|FG000|Continuation|Insurance change|0|||
37791256|NCT01216683|69414570|FG001|Continuation|Insurance change|1|||
37791257|NCT01216683|69414571|FG002|Continuation|Insurance change|0|||
37791258|NCT01216683|69414569|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
37791259|NCT01216683|69414570|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
37791260|NCT01216683|69414571|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
37791261|NCT01216683|69414569|FG000|Continuation|Not reported|0|||
37791262|NCT01216683|69414570|FG001|Continuation|Not reported|0|||
37791263|NCT01216683|69414571|FG002|Continuation|Not reported|1|||
37791264|NCT01216683|69414569|FG000|Continuation|Never started treatment|0|||
37791265|NCT01216683|69414570|FG001|Continuation|Never started treatment|1|||
37791266|NCT01216683|69414571|FG002|Continuation|Never started treatment|5|||
37791267|NCT01145495|69414592|FG000|Overall Study|Adverse Event|6|||
37791268|NCT01145495|69414592|FG000|Overall Study|Withdrawal by Subject|6|||
37791269|NCT01145495|69414592|FG000|Overall Study|Disease progression after respone|2|||
37791270|NCT01124695|69414598|FG000|Overall Study|Disease progression|77|||
37791271|NCT01124695|69414598|FG000|Overall Study|Adverse Event|11|||
37791272|NCT01124695|69414598|FG000|Overall Study|Death|1|||
37791273|NCT01124695|69414598|FG000|Overall Study|Withdrawal by Subject|7|||
37791274|NCT01124695|69414598|FG000|Overall Study|Physician Decision|3|||
37791275|NCT01124695|69414598|FG000|Overall Study|Alternative therapy|9|||
37791276|NCT01124695|69414598|FG000|Overall Study|No documentation that patient went off treatment|4|||
37791277|NCT01124695|69414598|FG000|Overall Study|Ineligible|9|||
37791278|NCT01124695|69414598|FG000|Overall Study|Ineligible and never start treatment|2|||
37791279|NCT01084083|69414609|FG000|Overall Study|Adverse Event|5|||
37791280|NCT01084083|69414609|FG000|Overall Study|Death|1|||
37791281|NCT01084083|69414609|FG000|Overall Study|Withdrawal by Subject|2|||
37791282|NCT01084083|69414609|FG000|Overall Study|Complicating disease|1|||
37791283|NCT01084083|69414609|FG000|Overall Study|Other|2|||
37791284|NCT01084083|69414609|FG000|Overall Study|Never started assigned therapy|1|||
37791285|NCT01079780|69414617|FG000|Overall Study|Disease progression|43|||
37791286|NCT01079780|69414618|FG001|Overall Study|Disease progression|7|||
37791287|NCT01079780|69414619|FG002|Overall Study|Disease progression|31|||
37791288|NCT01079780|69414617|FG000|Overall Study|Adverse Event|13|||
37791289|NCT01079780|69414618|FG001|Overall Study|Adverse Event|5|||
37791290|NCT01079780|69414619|FG002|Overall Study|Adverse Event|7|||
37791291|NCT01079780|69414617|FG000|Overall Study|Death|2|||
37791292|NCT01079780|69414618|FG001|Overall Study|Death|0|||
37791293|NCT01079780|69414619|FG002|Overall Study|Death|2|||
37791294|NCT01079780|69414617|FG000|Overall Study|Withdrawal by Subject|6|||
37791295|NCT01079780|69414618|FG001|Overall Study|Withdrawal by Subject|4|||
37791296|NCT01079780|69414619|FG002|Overall Study|Withdrawal by Subject|4|||
37791297|NCT01079780|69414617|FG000|Overall Study|Alternative therapy|2|||
37791298|NCT01079780|69414618|FG001|Overall Study|Alternative therapy|0|||
37791299|NCT01079780|69414619|FG002|Overall Study|Alternative therapy|2|||
37791300|NCT01079780|69414617|FG000|Overall Study|Physician Decision|1|||
37791301|NCT01079780|69414618|FG001|Overall Study|Physician Decision|0|||
37791302|NCT01079780|69414619|FG002|Overall Study|Physician Decision|1|||
37693740|NCT02059161|69170065|FG000|Overall Study|Lost to Follow-up|20|||
37791303|NCT01079780|69414617|FG000|Overall Study|Error made in lesion measurement|1|||
37791304|NCT01079780|69414618|FG001|Overall Study|Error made in lesion measurement|0|||
37791305|NCT01079780|69414619|FG002|Overall Study|Error made in lesion measurement|0|||
37791306|NCT01079780|69414617|FG000|Overall Study|Patient had surgery|1|||
37791307|NCT01079780|69414618|FG001|Overall Study|Patient had surgery|0|||
37791308|NCT01079780|69414619|FG002|Overall Study|Patient had surgery|0|||
37791309|NCT01079780|69414617|FG000|Overall Study|Treatment cycle delay|0|||
37791310|NCT01079780|69414618|FG001|Overall Study|Treatment cycle delay|0|||
37791311|NCT01079780|69414619|FG002|Overall Study|Treatment cycle delay|1|||
37791312|NCT01079780|69414617|FG000|Overall Study|Never started treatment|1|||
37791313|NCT01079780|69414618|FG001|Overall Study|Never started treatment|0|||
37693741|NCT02059161|69170066|FG001|Overall Study|Lost to Follow-up|12|||
37791314|NCT01079780|69414619|FG002|Overall Study|Never started treatment|2|||
37791315|NCT01013961|69414629|FG000|Overall Study|Adverse Event|2|||
37791316|NCT01013961|69414630|FG001|Overall Study|Adverse Event|2|||
37791317|NCT01013961|69414629|FG000|Overall Study|Withdrawal by Subject|1|||
37791318|NCT01013961|69414630|FG001|Overall Study|Withdrawal by Subject|0|||
37791319|NCT01013961|69414629|FG000|Overall Study|Physician Decision|0|||
37791320|NCT01013961|69414630|FG001|Overall Study|Physician Decision|1|||
37791321|NCT00834093|69414645|FG000|Overall Study|Progressive Disease|3|||
37791322|NCT00834093|69414645|FG000|Overall Study|Withdrawal by subject or MD Decision|5|||
37791323|NCT00606294|69414651|FG000|Overall Study|Withdrawal by Subject|36|||
37791324|NCT00606294|69414652|FG001|Overall Study|Withdrawal by Subject|0|||
37791325|NCT00583596|69414658|FG000|Overall Study|Lost to Follow-up|110|||
37791326|NCT00583596|69414658|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
37791327|NCT00583596|69414658|FG000|Overall Study|Death|2|||
37791328|NCT00583596|69414658|FG000|Overall Study|Withdrawal by Subject|6|||
37791329|NCT00583596|69414658|FG000|Overall Study|Lost to Follow-up|94|||
37791330|NCT00583596|69414658|FG000|Overall Study|Data not complete|1|||
37791331|NCT00583596|69414658|FG000|Overall Study|Not consented|15|||
37791332|NCT00583596|69414658|FG000|Overall Study|Outside f-up window|26|||
37791333|NCT00316888|69414669|FG000|Overall Study|Adverse Event|4|||
37791334|NCT00316888|69414670|FG001|Overall Study|Adverse Event|5|||
37791335|NCT00316888|69414669|FG000|Overall Study|Withdrawal by Subject|2|||
37791336|NCT00316888|69414670|FG001|Overall Study|Withdrawal by Subject|2|||
37791337|NCT00316888|69414669|FG000|Overall Study|Not start protocol therapy|0|||
37791338|NCT00316888|69414670|FG001|Overall Study|Not start protocol therapy|1|||
37791339|NCT00274924|69414679|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
37791340|NCT00274924|69414680|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
37791341|NCT00274924|69414681|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
37791342|NCT00274924|69414679|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
37791343|NCT00274924|69414680|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
37791344|NCT00274924|69414681|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
37791345|NCT00274924|69414679|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
37791346|NCT00274924|69414680|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
37791347|NCT00274924|69414681|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
37791348|NCT00274924|69414679|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
37791349|NCT00274924|69414680|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
37791350|NCT00274924|69414681|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
37791351|NCT00274924|69414679|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
37791352|NCT00274924|69414680|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
37791353|NCT00274924|69414681|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
37791354|NCT00274924|69414679|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
37791355|NCT00274924|69414680|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
37791356|NCT00274924|69414681|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
37791357|NCT00274924|69414679|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
37791358|NCT00274924|69414680|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
37791359|NCT00274924|69414681|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
37791360|NCT00274924|69414679|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
37791361|NCT00274924|69414680|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
37791362|NCT00274924|69414681|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
37791363|NCT00274924|69414679|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
37791364|NCT00274924|69414680|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
37791365|NCT00274924|69414681|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
37791366|NCT00274924|69414679|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
37791367|NCT00274924|69414680|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
37791368|NCT00274924|69414681|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
37791369|NCT00274924|69414679|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
37791370|NCT00274924|69414680|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
37791371|NCT00274924|69414681|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
37791372|NCT00274924|69414679|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
37791373|NCT00274924|69414680|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
37791374|NCT00274924|69414681|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
37791375|NCT00274924|69414679|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
37791376|NCT00274924|69414680|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
37791377|NCT00274924|69414681|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
37791378|NCT00104884|69414688|FG000|Overall Study|Disease progression|4|||
37791379|NCT00096174|69414692|FG000|Overall Study|Lack of Efficacy|9|||
37791380|NCT00096174|69414692|FG000|Overall Study|Adverse Event|15|||
37791381|NCT00096174|69414692|FG000|Overall Study|Death|6|||
37791382|NCT00096174|69414692|FG000|Overall Study|Withdrawal by Subject|15|||
37791383|NCT00096174|69414692|FG000|Overall Study|Not started protocol therapy|3|||
37791384|NCT00096174|69414692|FG000|Overall Study|Ineligible|6|||
37791385|NCT00096174|69414692|FG000|Overall Study|other reason|8|||
37791386|NCT00080938|69414696|FG000|Overall Study|Adverse Event|3|||
37791387|NCT00080938|69414696|FG000|Overall Study|Withdrawal by Subject|6|||
37693742|NCT02059161|69170065|FG000|Overall Study|Physician Decision|4|||
37693743|NCT02059161|69170066|FG001|Overall Study|Physician Decision|4|||
37693744|NCT02059161|69170065|FG000|Overall Study|Protocol Violation|1|||
37693745|NCT02059161|69170066|FG001|Overall Study|Protocol Violation|1|||
37693746|NCT02059161|69170065|FG000|Overall Study|Withdrawal by Subject|16|||
37693747|NCT02059161|69170066|FG001|Overall Study|Withdrawal by Subject|13|||
37693748|NCT02059161|69170065|FG000|Overall Study|Randomized in error, no study drug|0|||
37693749|NCT02059161|69170066|FG001|Overall Study|Randomized in error, no study drug|1|||
37693750|NCT02059161|69170065|FG000|Overall Study|Non-compliance with study drug|6|||
37693751|NCT02059161|69170066|FG001|Overall Study|Non-compliance with study drug|2|||
37693752|NCT01897714|69170078|FG000|Phase I (Dose Escalation)|Disease progression|3|||
37693753|NCT01897714|69170079|FG001|Phase I (Dose Escalation)|Disease progression|5|||
37693754|NCT01897714|69170080|FG002|Phase I (Dose Escalation)|Disease progression|1|||
37693755|NCT01897714|69170081|FG003|Phase I (Dose Escalation)|Disease progression|3|||
37693756|NCT01897714|69170082|FG004|Phase I (Dose Escalation)|Disease progression|0|||
37791388|NCT00080938|69414696|FG000|Overall Study|Death|2|||
37791389|NCT00080938|69414696|FG000|Overall Study|Lack of Efficacy|7|||
37791390|NCT00080938|69414696|FG000|Overall Study|other disease|1|||
37791391|NCT00080938|69414696|FG000|Overall Study|Not started protocol therapy|1|||
37791392|NCT00080938|69414696|FG000|Overall Study|Ineligible|4|||
37791393|NCT00074282|69414700|FG000|Step 1|Adverse Event|32|||
37791394|NCT00074282|69414701|FG001|Step 1|Adverse Event|0|||
37791395|NCT00074282|69414702|FG002|Step 1|Adverse Event|0|||
37791396|NCT00074282|69414700|FG000|Step 1|Death|6|||
37791397|NCT00074282|69414701|FG001|Step 1|Death|0|||
37791398|NCT00074282|69414702|FG002|Step 1|Death|0|||
37791399|NCT00074282|69414700|FG000|Step 1|Withdrawal by Subject|7|||
37791400|NCT00074282|69414701|FG001|Step 1|Withdrawal by Subject|0|||
37791401|NCT00074282|69414702|FG002|Step 1|Withdrawal by Subject|0|||
37791402|NCT00074282|69414700|FG000|Step 1|Disease progression|2|||
37791403|NCT00074282|69414701|FG001|Step 1|Disease progression|0|||
37791404|NCT00074282|69414702|FG002|Step 1|Disease progression|0|||
37791405|NCT00074282|69414700|FG000|Step 1|Alternative therapy|2|||
37791406|NCT00074282|69414701|FG001|Step 1|Alternative therapy|0|||
37791407|NCT00074282|69414702|FG002|Step 1|Alternative therapy|0|||
37791408|NCT00074282|69414700|FG000|Step 1|Other complicating disease|2|||
37791409|NCT00074282|69414701|FG001|Step 1|Other complicating disease|0|||
37791410|NCT00074282|69414702|FG002|Step 1|Other complicating disease|0|||
37791411|NCT00074282|69414700|FG000|Step 1|Physician Decision|1|||
37791412|NCT00074282|69414701|FG001|Step 1|Physician Decision|0|||
37791413|NCT00074282|69414702|FG002|Step 1|Physician Decision|0|||
37791414|NCT00074282|69414700|FG000|Step 1|Ineligible|4|||
37791415|NCT00074282|69414701|FG001|Step 1|Ineligible|0|||
37791416|NCT00074282|69414702|FG002|Step 1|Ineligible|0|||
37791417|NCT00074282|69414700|FG000|Step 1|Never started treatment|2|||
37791418|NCT00074282|69414701|FG001|Step 1|Never started treatment|0|||
37791419|NCT00074282|69414702|FG002|Step 1|Never started treatment|0|||
37791420|NCT00074282|69414700|FG000|Step 2|Adverse Event|0|||
37791421|NCT00074282|69414701|FG001|Step 2|Adverse Event|2|||
37791422|NCT00074282|69414702|FG002|Step 2|Adverse Event|12|||
37791423|NCT00074282|69414700|FG000|Step 2|Disease progression|0|||
37791424|NCT00074282|69414701|FG001|Step 2|Disease progression|0|||
37791425|NCT00074282|69414702|FG002|Step 2|Disease progression|5|||
37791426|NCT00074282|69414700|FG000|Step 2|Death|0|||
37791427|NCT00074282|69414701|FG001|Step 2|Death|0|||
37791428|NCT00074282|69414702|FG002|Step 2|Death|3|||
37791429|NCT00074282|69414700|FG000|Step 2|Withdrawal by Subject|0|||
37791430|NCT00074282|69414701|FG001|Step 2|Withdrawal by Subject|0|||
37791431|NCT00074282|69414702|FG002|Step 2|Withdrawal by Subject|2|||
37791432|NCT00074282|69414700|FG000|Step 2|Physician Decision|0|||
37791433|NCT00074282|69414701|FG001|Step 2|Physician Decision|0|||
37791434|NCT00074282|69414702|FG002|Step 2|Physician Decision|1|||
37791435|NCT00074282|69414700|FG000|Step 2|Ineligible|0|||
37791436|NCT00074282|69414701|FG001|Step 2|Ineligible|0|||
37791437|NCT00074282|69414702|FG002|Step 2|Ineligible|1|||
37791438|NCT00071981|69414714|FG000|Overall Study|Lack of Efficacy|37|||
37791439|NCT00071981|69414715|FG001|Overall Study|Lack of Efficacy|29|||
37791440|NCT00071981|69414716|FG002|Overall Study|Lack of Efficacy|30|||
37791441|NCT00071981|69414717|FG003|Overall Study|Lack of Efficacy|43|||
37791442|NCT00071981|69414714|FG000|Overall Study|Adverse Event|4|||
37791443|NCT00071981|69414715|FG001|Overall Study|Adverse Event|4|||
37791444|NCT00071981|69414716|FG002|Overall Study|Adverse Event|3|||
37791445|NCT00071981|69414717|FG003|Overall Study|Adverse Event|1|||
37791446|NCT00071981|69414714|FG000|Overall Study|Death|0|||
37791447|NCT00071981|69414715|FG001|Overall Study|Death|0|||
37791448|NCT00071981|69414716|FG002|Overall Study|Death|1|||
37791449|NCT00071981|69414717|FG003|Overall Study|Death|1|||
37791450|NCT00071981|69414714|FG000|Overall Study|Withdrawal by Subject|3|||
37791451|NCT00071981|69414715|FG001|Overall Study|Withdrawal by Subject|1|||
37791452|NCT00071981|69414716|FG002|Overall Study|Withdrawal by Subject|0|||
37791453|NCT00071981|69414717|FG003|Overall Study|Withdrawal by Subject|0|||
37791454|NCT00071981|69414714|FG000|Overall Study|No protocol therapy|2|||
37791455|NCT00071981|69414715|FG001|Overall Study|No protocol therapy|5|||
37791456|NCT00071981|69414716|FG002|Overall Study|No protocol therapy|1|||
37791457|NCT00071981|69414717|FG003|Overall Study|No protocol therapy|0|||
37791458|NCT00071981|69414714|FG000|Overall Study|others (not specified in the study)|0|||
37791459|NCT00071981|69414715|FG001|Overall Study|others (not specified in the study)|2|||
37791460|NCT00071981|69414716|FG002|Overall Study|others (not specified in the study)|2|||
37791461|NCT00071981|69414717|FG003|Overall Study|others (not specified in the study)|0|||
37791462|NCT00070291|69414727|FG000|Step 1|Withdrawal by Subject|1|||
37791463|NCT00070291|69414727|FG000|Step 1|Adverse Event|1|||
37791464|NCT00070291|69414727|FG000|Step 2|Adverse Event|1|||
37791465|NCT00064350|69414734|FG000|Induction Treatment|Disease Progression|5|||
37791466|NCT00064350|69414735|FG001|Induction Treatment|Disease Progression|1|||
37791467|NCT00064350|69414736|FG002|Induction Treatment|Disease Progression|110|||
37791468|NCT00064350|69414734|FG000|Induction Treatment|Adverse Event|0|||
37791469|NCT00064350|69414735|FG001|Induction Treatment|Adverse Event|2|||
37791470|NCT00064350|69414736|FG002|Induction Treatment|Adverse Event|49|||
37791471|NCT00064350|69414734|FG000|Induction Treatment|Death|0|||
37791472|NCT00064350|69414735|FG001|Induction Treatment|Death|0|||
37791473|NCT00064350|69414736|FG002|Induction Treatment|Death|9|||
37791474|NCT00064350|69414734|FG000|Induction Treatment|Withdrawal by Subject|0|||
37791475|NCT00064350|69414735|FG001|Induction Treatment|Withdrawal by Subject|0|||
37791476|NCT00064350|69414736|FG002|Induction Treatment|Withdrawal by Subject|21|||
37791477|NCT00064350|69414734|FG000|Induction Treatment|Ineligible or never started treatment|3|||
37791478|NCT00064350|69414735|FG001|Induction Treatment|Ineligible or never started treatment|6|||
37791479|NCT00064350|69414736|FG002|Induction Treatment|Ineligible or never started treatment|34|||
37791480|NCT00064350|69414734|FG000|Induction Treatment|Other|0|||
37791481|NCT00064350|69414735|FG001|Induction Treatment|Other|0|||
37791482|NCT00064350|69414736|FG002|Induction Treatment|Other|13|||
37791483|NCT00064350|69414734|FG000|Randomization|Adverse Event|8|||
37791484|NCT00064350|69414735|FG001|Randomization|Adverse Event|3|||
37791485|NCT00064350|69414736|FG002|Randomization|Adverse Event|0|||
37791486|NCT00064350|69414734|FG000|Randomization|Death|3|||
37791487|NCT00064350|69414735|FG001|Randomization|Death|0|||
37791488|NCT00064350|69414736|FG002|Randomization|Death|0|||
37791489|NCT00064350|69414734|FG000|Randomization|Withdrawal by Subject|1|||
37791490|NCT00064350|69414735|FG001|Randomization|Withdrawal by Subject|0|||
37791491|NCT00064350|69414736|FG002|Randomization|Withdrawal by Subject|0|||
37791492|NCT00064350|69414734|FG000|Randomization|Ineligible or never started treatment|9|||
37791493|NCT00064350|69414735|FG001|Randomization|Ineligible or never started treatment|15|||
37791494|NCT00064350|69414736|FG002|Randomization|Ineligible or never started treatment|0|||
37791495|NCT00064350|69414734|FG000|Randomization|Other|5|||
37791496|NCT00064350|69414735|FG001|Randomization|Other|0|||
37791497|NCT00064350|69414736|FG002|Randomization|Other|0|||
37791498|NCT00064350|69414734|FG000|Cross-Over|Adverse Event|0|||
37791499|NCT00064350|69414735|FG001|Cross-Over|Adverse Event|1|||
37791500|NCT00064350|69414736|FG002|Cross-Over|Adverse Event|0|||
37791501|NCT00064350|69414734|FG000|Cross-Over|Death|1|||
37791502|NCT00064350|69414735|FG001|Cross-Over|Death|3|||
37791503|NCT00064350|69414736|FG002|Cross-Over|Death|0|||
37791504|NCT00064350|69414734|FG000|Cross-Over|Withdrawal by Subject|2|||
37791505|NCT00064350|69414735|FG001|Cross-Over|Withdrawal by Subject|2|||
37791506|NCT00064350|69414736|FG002|Cross-Over|Withdrawal by Subject|0|||
37791507|NCT00064350|69414734|FG000|Cross-Over|Ineligible or never started treatment|3|||
37791508|NCT00064350|69414735|FG001|Cross-Over|Ineligible or never started treatment|6|||
37791509|NCT00064350|69414736|FG002|Cross-Over|Ineligible or never started treatment|0|||
37791510|NCT00064350|69414734|FG000|Cross-Over|Other|0|||
37791511|NCT00064350|69414735|FG001|Cross-Over|Other|2|||
37791512|NCT00064350|69414736|FG002|Cross-Over|Other|0|||
37791513|NCT00063986|69414745|FG000|Overall Study|Withdrawal by Subject|1|||
37791514|NCT00063986|69414745|FG000|Overall Study|Ineligible|1|||
37791515|NCT00063986|69414745|FG000|Overall Study|Intra-operatively ineligible|4|||
37791516|NCT00057954|69414753|FG000|Overall Study|Death|1|||
37791517|NCT00057954|69414753|FG000|Overall Study|Disease progression|1|||
37791518|NCT00049530|69414757|FG000|Overall Study|Lack of Efficacy|25|||
37791519|NCT00049530|69414757|FG000|Overall Study|Adverse Event|2|||
37791520|NCT00049530|69414757|FG000|Overall Study|Death|1|||
37791521|NCT00049530|69414757|FG000|Overall Study|symptomatic deterioration|1|||
37791522|NCT00049530|69414757|FG000|Overall Study|ineligible|3|||
37791523|NCT00045305|69414761|FG000|Overall Study|Lack of Efficacy|6|||
37791524|NCT00045305|69414761|FG000|Overall Study|Adverse Event|3|||
37791525|NCT00045305|69414761|FG000|Overall Study|Death|3|||
37791526|NCT00045305|69414761|FG000|Overall Study|site error|2|||
37791527|NCT00033657|69414767|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
37791528|NCT00033657|69414768|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
37791529|NCT00033657|69414767|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
37791530|NCT00033657|69414768|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
37791531|NCT00033657|69414767|FG000|Neoadjuvant Chemotherapy|Death|1|||
37791532|NCT00033657|69414768|FG001|Neoadjuvant Chemotherapy|Death|1|||
37791533|NCT00033657|69414767|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
37791534|NCT00033657|69414768|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
37791535|NCT00033657|69414767|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
37791536|NCT00033657|69414768|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
37791537|NCT00033657|69414767|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
37791538|NCT00033657|69414768|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
37791539|NCT00033657|69414767|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
37791540|NCT00033657|69414768|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
37791541|NCT00033657|69414767|FG000|Surgical Resection|not complete resection|0|||
37791542|NCT00033657|69414768|FG001|Surgical Resection|not complete resection|3|||
37791543|NCT00033657|69414767|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
37791544|NCT00033657|69414768|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
37791545|NCT00033657|69414767|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
37791546|NCT00033657|69414768|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
37791547|NCT00033657|69414767|FG000|Adjuvant Chemotherapy|Death|2|||
37791548|NCT00033657|69414768|FG001|Adjuvant Chemotherapy|Death|1|||
37791549|NCT00033657|69414767|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
37791550|NCT00033657|69414768|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
37791551|NCT00033657|69414767|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
37791552|NCT00033657|69414768|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
37791553|NCT00033657|69414767|FG000|Adjuvant Chemotherapy|Other|0|||
37791554|NCT00033657|69414768|FG001|Adjuvant Chemotherapy|Other|2|||
37791555|NCT00003389|69414778|FG000|Overall Study|Disease progression|6|||
37791556|NCT00003389|69414779|FG001|Overall Study|Disease progression|1|||
37791557|NCT00003389|69414778|FG000|Overall Study|Adverse Event|13|||
37791558|NCT00003389|69414779|FG001|Overall Study|Adverse Event|2|||
37791559|NCT00003389|69414778|FG000|Overall Study|Death|0|||
37791560|NCT00003389|69414779|FG001|Overall Study|Death|3|||
37791561|NCT00003389|69414778|FG000|Overall Study|Withdrawal by Subject|12|||
37791562|NCT00003389|69414779|FG001|Overall Study|Withdrawal by Subject|5|||
37791563|NCT00003389|69414778|FG000|Overall Study|Alternative therapy|2|||
37791564|NCT00003389|69414779|FG001|Overall Study|Alternative therapy|1|||
37791565|NCT00003389|69414778|FG000|Overall Study|Complicating disease|1|||
37791566|NCT00003389|69414779|FG001|Overall Study|Complicating disease|0|||
37791567|NCT00003389|69414778|FG000|Overall Study|Off-treatment reason missing|31|||
37791568|NCT00003389|69414779|FG001|Overall Study|Off-treatment reason missing|21|||
37791569|NCT00003389|69414778|FG000|Overall Study|Ineligible|33|||
37791570|NCT00003389|69414779|FG001|Overall Study|Ineligible|27|||
37791571|NCT00003138|69414787|FG000|Step 1|Reasons off treatment not documented|60|||
37791572|NCT00003138|69414788|FG001|Step 1|Reasons off treatment not documented|57|||
37791573|NCT00003138|69414787|FG000|Step 1|Never started treatment|1|||
37791574|NCT00003138|69414788|FG001|Step 1|Never started treatment|0|||
37791575|NCT00003138|69414787|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
37791576|NCT00003138|69414788|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
37791577|NCT00003138|69414787|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
37791578|NCT00003138|69414788|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
37791579|NCT00003138|69414787|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
37791580|NCT00003138|69414788|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
37791581|NCT00003138|69414787|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
37791582|NCT00003138|69414788|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
37791583|NCT00002525|69414799|FG000|Overall Study|Adverse Event|36|||
37791584|NCT00002525|69414800|FG001|Overall Study|Adverse Event|0|||
37791585|NCT00002525|69414799|FG000|Overall Study|Death|5|||
37791586|NCT00002525|69414800|FG001|Overall Study|Death|0|||
37791587|NCT00002525|69414799|FG000|Overall Study|Withdrawal by Subject|11|||
37791588|NCT00002525|69414800|FG001|Overall Study|Withdrawal by Subject|0|||
37791589|NCT00002525|69414799|FG000|Overall Study|Start non-protocol therapy|1|||
37791590|NCT00002525|69414800|FG001|Overall Study|Start non-protocol therapy|0|||
37791591|NCT00002525|69414799|FG000|Overall Study|Other complicating disease|1|||
37791592|NCT00002525|69414800|FG001|Overall Study|Other complicating disease|0|||
37791593|NCT00002525|69414799|FG000|Overall Study|Duke's A, B1, D disease|92|||
37791594|NCT00002525|69414800|FG001|Overall Study|Duke's A, B1, D disease|0|||
37791595|NCT00002525|69414799|FG000|Overall Study|Error|6|||
37791596|NCT00002525|69414800|FG001|Overall Study|Error|0|||
37791597|NCT00002525|69414799|FG000|Overall Study|Other|26|||
37791598|NCT00002525|69414800|FG001|Overall Study|Other|0|||
37791599|NCT00002525|69414799|FG000|Overall Study|Never start protocol therapy|8|||
37791600|NCT00002525|69414800|FG001|Overall Study|Never start protocol therapy|0|||
37791601|NCT02259348|69414808|FG000|Overall Study|Donors|6|||
37791602|NCT02259348|69414808|FG000|Overall Study|Death|4|||
37791603|NCT02259114|69415065|FG000|Overall Study|Progressive Disease|14|||
37791604|NCT02259114|69415066|FG001|Overall Study|Progressive Disease|2|||
37791605|NCT02259114|69415067|FG002|Overall Study|Progressive Disease|10|||
37791606|NCT02259114|69415068|FG003|Overall Study|Progressive Disease|2|||
37791607|NCT02259114|69415069|FG004|Overall Study|Progressive Disease|5|||
37791608|NCT02259114|69415065|FG000|Overall Study|Adverse Event|2|||
37791609|NCT02259114|69415066|FG001|Overall Study|Adverse Event|1|||
37791610|NCT02259114|69415067|FG002|Overall Study|Adverse Event|0|||
37791611|NCT02259114|69415068|FG003|Overall Study|Adverse Event|0|||
37791612|NCT02259114|69415069|FG004|Overall Study|Adverse Event|1|||
37791613|NCT02259114|69415065|FG000|Overall Study|Death|3|||
37791614|NCT02259114|69415066|FG001|Overall Study|Death|0|||
37791615|NCT02259114|69415067|FG002|Overall Study|Death|1|||
37791616|NCT02259114|69415068|FG003|Overall Study|Death|0|||
37791617|NCT02259114|69415069|FG004|Overall Study|Death|0|||
37791618|NCT02259114|69415065|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
37791619|NCT02259114|69415066|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
37791620|NCT02259114|69415067|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
37791621|NCT02259114|69415068|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
37975524|NCT00397215|69662816|FG001|Month 0 (Day 0)|Other|1|||
37975525|NCT00397215|69662817|FG002|Month 0 (Day 0)|Other|3|||
37975526|NCT00397215|69662818|FG003|Month 0 (Day 0)|Other|3|||
37975527|NCT00397215|69662815|FG000|Month 6 (Day 180)|Adverse Event|0|||
37975528|NCT00397215|69662816|FG001|Month 6 (Day 180)|Adverse Event|3|||
37791622|NCT02259114|69415069|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
37791623|NCT02259114|69415065|FG000|Overall Study|Withdrawal by Subject|0|||
37791624|NCT02259114|69415066|FG001|Overall Study|Withdrawal by Subject|0|||
37791625|NCT02259114|69415067|FG002|Overall Study|Withdrawal by Subject|1|||
37791626|NCT02259114|69415068|FG003|Overall Study|Withdrawal by Subject|1|||
37791627|NCT02259114|69415069|FG004|Overall Study|Withdrawal by Subject|0|||
37791628|NCT02259114|69415065|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
37791629|NCT02259114|69415066|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
37975529|NCT00397215|69662817|FG002|Month 6 (Day 180)|Adverse Event|2|||
37791630|NCT02259114|69415067|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
37791631|NCT02259114|69415068|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
37791632|NCT02259114|69415069|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
37791633|NCT02259114|69415065|FG000|Overall Study|Not Treated|1|||
37791634|NCT02259114|69415066|FG001|Overall Study|Not Treated|0|||
37791635|NCT02259114|69415067|FG002|Overall Study|Not Treated|0|||
37791636|NCT02259114|69415068|FG003|Overall Study|Not Treated|0|||
37791637|NCT02259114|69415069|FG004|Overall Study|Not Treated|0|||
37791638|NCT02258334|69415124|FG000|Overall Study|Adverse Event|1|||
37791639|NCT02258334|69415125|FG001|Overall Study|Adverse Event|0|||
37791640|NCT02258334|69415126|FG002|Overall Study|Adverse Event|0|||
37791641|NCT02258334|69415127|FG003|Overall Study|Adverse Event|0|||
37791642|NCT04960202|69415164|FG000|Overall Study|Other|12|||
37791643|NCT04960202|69415165|FG001|Overall Study|Other|10|||
37791644|NCT04960202|69415164|FG000|Overall Study|Withdrawal by Subject|43|||
37791645|NCT04960202|69415165|FG001|Overall Study|Withdrawal by Subject|45|||
37791646|NCT04960202|69415164|FG000|Overall Study|Lost to Follow-up|20|||
37791647|NCT04960202|69415165|FG001|Overall Study|Lost to Follow-up|17|||
37791648|NCT04960202|69415164|FG000|Overall Study|Death|0|||
37791649|NCT04960202|69415165|FG001|Overall Study|Death|15|||
37791650|NCT02257632|69415235|FG000|Overall Study|Withdrawal by Subject|0|||
37791651|NCT02257632|69415236|FG001|Overall Study|Withdrawal by Subject|1|||
37791652|NCT02257632|69415235|FG000|Overall Study|Adverse Event|1|||
37791653|NCT02257632|69415236|FG001|Overall Study|Adverse Event|2|||
37791654|NCT01642914|69415270|FG000|Overall Study|Adverse Event|11|||
37791655|NCT01642914|69415271|FG001|Overall Study|Adverse Event|7|||
37791656|NCT01642914|69415272|FG002|Overall Study|Adverse Event|15|||
37791657|NCT01642914|69415270|FG000|Overall Study|Lack of Efficacy|9|||
37791658|NCT01642914|69415271|FG001|Overall Study|Lack of Efficacy|4|||
37791659|NCT01642914|69415272|FG002|Overall Study|Lack of Efficacy|2|||
37791660|NCT01642914|69415270|FG000|Overall Study|Protocol Violation|15|||
37791661|NCT01642914|69415271|FG001|Overall Study|Protocol Violation|13|||
37791662|NCT01642914|69415272|FG002|Overall Study|Protocol Violation|6|||
37791663|NCT01642914|69415270|FG000|Overall Study|Withdrawal by Subject|5|||
37791664|NCT01642914|69415271|FG001|Overall Study|Withdrawal by Subject|5|||
37791665|NCT01642914|69415272|FG002|Overall Study|Withdrawal by Subject|10|||
37791666|NCT01642914|69415270|FG000|Overall Study|Lost to Follow-up|5|||
37791667|NCT01642914|69415271|FG001|Overall Study|Lost to Follow-up|3|||
37791668|NCT01642914|69415272|FG002|Overall Study|Lost to Follow-up|7|||
37791669|NCT01642914|69415270|FG000|Overall Study|Other Reason|1|||
37791670|NCT01642914|69415271|FG001|Overall Study|Other Reason|0|||
37791671|NCT01642914|69415272|FG002|Overall Study|Other Reason|0|||
37791672|NCT01642602|69415331|FG000|Overall Study|Adverse Event|2|||
37791673|NCT02256540|69415397|FG000|Overall Study|Withdrawal by Subject|0|||
37791674|NCT02256540|69415398|FG001|Overall Study|Withdrawal by Subject|1|||
37791675|NCT02256540|69415399|FG002|Overall Study|Withdrawal by Subject|1|||
37791676|NCT02256540|69415397|FG000|Overall Study|Back pain preventing exercise|0|||
37791677|NCT02256540|69415398|FG001|Overall Study|Back pain preventing exercise|0|||
37791678|NCT02256540|69415399|FG002|Overall Study|Back pain preventing exercise|1|||
37791679|NCT01640184|69415423|FG000|Overall Study|Death|1|||
37791680|NCT01640184|69415424|FG001|Overall Study|Death|0|||
37791681|NCT01640184|69415425|FG002|Overall Study|Death|0|||
37791682|NCT01640184|69415423|FG000|Overall Study|Lost to Follow-up|4|||
37791683|NCT01640184|69415424|FG001|Overall Study|Lost to Follow-up|1|||
37791684|NCT01640184|69415425|FG002|Overall Study|Lost to Follow-up|0|||
37791685|NCT01640184|69415423|FG000|Overall Study|Physician Decision|3|||
37791686|NCT01640184|69415424|FG001|Overall Study|Physician Decision|0|||
37791687|NCT01640184|69415425|FG002|Overall Study|Physician Decision|0|||
37791688|NCT01640184|69415423|FG000|Overall Study|Withdrawal by Subject|0|||
37791689|NCT01640184|69415424|FG001|Overall Study|Withdrawal by Subject|1|||
37791690|NCT01640184|69415425|FG002|Overall Study|Withdrawal by Subject|1|||
37791691|NCT01640184|69415423|FG000|Overall Study|Protocol Violation|0|||
37791692|NCT01640184|69415424|FG001|Overall Study|Protocol Violation|0|||
37791693|NCT01640184|69415425|FG002|Overall Study|Protocol Violation|1|||
37791694|NCT02256384|69415445|FG000|Overall Study|Withdrawal by Subject|12|||
37791695|NCT02256384|69415445|FG000|Overall Study|Equipment not capturing data|2|||
37791696|NCT02255760|69415488|FG000|Overall Study|Lost to Follow-up|0|||
37791697|NCT02255760|69415489|FG001|Overall Study|Lost to Follow-up|1|||
37791698|NCT02255760|69415490|FG002|Overall Study|Lost to Follow-up|0|||
37791699|NCT02255760|69415491|FG003|Overall Study|Lost to Follow-up|0|||
37791700|NCT02255760|69415492|FG004|Overall Study|Lost to Follow-up|0|||
37791701|NCT01641822|69415588|FG000|Run-in Phase|Noncompliance with study drug|1|||
37791702|NCT01641822|69415589|FG001|Run-in Phase|Noncompliance with study drug|0|||
37791703|NCT01641822|69415590|FG002|Run-in Phase|Noncompliance with study drug|0|||
37791704|NCT01641822|69415588|FG000|Run-in Phase|Adverse Event|3|||
37791705|NCT01641822|69415589|FG001|Run-in Phase|Adverse Event|0|||
37791706|NCT01641822|69415590|FG002|Run-in Phase|Adverse Event|0|||
37791707|NCT01641822|69415588|FG000|Run-in Phase|Withdrew consent|1|||
37791708|NCT01641822|69415589|FG001|Run-in Phase|Withdrew consent|0|||
37791709|NCT01641822|69415590|FG002|Run-in Phase|Withdrew consent|0|||
37791710|NCT01641822|69415588|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
37791711|NCT01641822|69415589|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
37791712|NCT01641822|69415590|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
37791713|NCT01641822|69415588|FG000|Comparative Phase|Noncompliance with study drug|0|||
37791714|NCT01641822|69415589|FG001|Comparative Phase|Noncompliance with study drug|1|||
37791715|NCT01641822|69415590|FG002|Comparative Phase|Noncompliance with study drug|0|||
37791716|NCT01641822|69415588|FG000|Comparative Phase|Investigator's discretion|0|||
37791717|NCT01641822|69415589|FG001|Comparative Phase|Investigator's discretion|0|||
37791718|NCT01641822|69415590|FG002|Comparative Phase|Investigator's discretion|1|||
37791719|NCT01641822|69415588|FG000|Comparative Phase|Pregnancy|0|||
37791720|NCT01641822|69415589|FG001|Comparative Phase|Pregnancy|0|||
37791721|NCT01641822|69415590|FG002|Comparative Phase|Pregnancy|1|||
37791722|NCT01641822|69415588|FG000|Comparative Phase|Adverse event, serious fatal|0|||
37791723|NCT01641822|69415589|FG001|Comparative Phase|Adverse event, serious fatal|1|||
37791724|NCT01641822|69415590|FG002|Comparative Phase|Adverse event, serious fatal|0|||
37791725|NCT01641822|69415588|FG000|Comparative Phase|Withdrew consent|0|||
37791726|NCT01641822|69415589|FG001|Comparative Phase|Withdrew consent|3|||
37791727|NCT01641822|69415590|FG002|Comparative Phase|Withdrew consent|7|||
37791728|NCT01641822|69415588|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
37791729|NCT01641822|69415589|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
37791730|NCT01641822|69415590|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
37791731|NCT01641198|69415670|FG000|After 12 Months of Function|Lost to Follow-up|3|||
37791732|NCT01641198|69415671|FG001|After 12 Months of Function|Lost to Follow-up|2|||
37791733|NCT01641198|69415672|FG002|After 12 Months of Function|Lost to Follow-up|2|||
37791734|NCT01641198|69415670|FG000|After 12 Months of Function|Protocol Violation|1|||
37791735|NCT01641198|69415671|FG001|After 12 Months of Function|Protocol Violation|0|||
37791736|NCT01641198|69415672|FG002|After 12 Months of Function|Protocol Violation|0|||
37791737|NCT01641198|69415670|FG000|After 12 Months of Function|Adverse Event|0|||
37791738|NCT01641198|69415671|FG001|After 12 Months of Function|Adverse Event|1|||
37791739|NCT01641198|69415672|FG002|After 12 Months of Function|Adverse Event|0|||
37791740|NCT01641198|69415670|FG000|After 24 Months of Function|Lost to Follow-up|4|||
37791741|NCT01641198|69415671|FG001|After 24 Months of Function|Lost to Follow-up|9|||
37791742|NCT01641198|69415672|FG002|After 24 Months of Function|Lost to Follow-up|6|||
37791743|NCT01641198|69415670|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
37791744|NCT01641198|69415671|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
37791745|NCT01641198|69415672|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
37791746|NCT01641198|69415670|FG000|At 15-20 Years of Function|Death|1|||
37791747|NCT01641198|69415671|FG001|At 15-20 Years of Function|Death|0|||
37791748|NCT01641198|69415672|FG002|At 15-20 Years of Function|Death|1|||
37791749|NCT01639560|69415757|FG000|Overall Study|Withdrawal by Subject|9|||
37791750|NCT01639560|69415758|FG001|Overall Study|Withdrawal by Subject|14|||
37791751|NCT01639560|69415757|FG000|Overall Study|Lack of Efficacy|1|||
37791752|NCT01639560|69415758|FG001|Overall Study|Lack of Efficacy|2|||
37791753|NCT01639560|69415757|FG000|Overall Study|Lost to Follow-up|9|||
37791754|NCT01639560|69415758|FG001|Overall Study|Lost to Follow-up|11|||
37791755|NCT01639560|69415757|FG000|Overall Study|Adverse Event|0|||
37791756|NCT01639560|69415758|FG001|Overall Study|Adverse Event|2|||
37791757|NCT01601652|69415780|FG000|Overall Study|Death|1|||
37791758|NCT03952130|69415818|FG000|Overall Study|Adverse Event|0|||
37791759|NCT03952130|69415819|FG001|Overall Study|Adverse Event|1|||
37791760|NCT03952130|69415818|FG000|Overall Study|Lost to Follow-up|1|||
37791761|NCT03952130|69415819|FG001|Overall Study|Lost to Follow-up|0|||
37791762|NCT03952130|69415818|FG000|Overall Study|Withdrawal by Subject|1|||
37791763|NCT03952130|69415819|FG001|Overall Study|Withdrawal by Subject|5|||
37791764|NCT01640964|69415863|FG000|Overall Study|Lost to Follow-up|0|||
37791765|NCT01640964|69415864|FG001|Overall Study|Lost to Follow-up|0|||
37791766|NCT01640964|69415865|FG002|Overall Study|Lost to Follow-up|1|||
37791767|NCT01640964|69415863|FG000|Overall Study|Protocol Deviation|1|||
37791768|NCT01640964|69415864|FG001|Overall Study|Protocol Deviation|1|||
37791769|NCT01640964|69415865|FG002|Overall Study|Protocol Deviation|2|||
37791770|NCT01638390|69415976|FG000|Overall Study|screening failures|21|||
37791771|NCT01600716|69416007|FG000|Overall Study|Other Reasons|3|||
37791772|NCT01600716|69416008|FG001|Overall Study|Other Reasons|1|||
37791773|NCT01600716|69416007|FG000|Overall Study|Personal Reasons|0|||
37791774|NCT01600716|69416008|FG001|Overall Study|Personal Reasons|2|||
37791775|NCT01600716|69416007|FG000|Overall Study|Lost to Follow-up|0|||
37791776|NCT01600716|69416008|FG001|Overall Study|Lost to Follow-up|2|||
37791777|NCT01600716|69416007|FG000|Overall Study|Pregnancy|1|||
37791778|NCT01600716|69416008|FG001|Overall Study|Pregnancy|0|||
37791779|NCT01600716|69416007|FG000|Overall Study|Lack of Efficacy|2|||
37791780|NCT01600716|69416008|FG001|Overall Study|Lack of Efficacy|1|||
37791781|NCT01600716|69416007|FG000|Overall Study|Adverse Event|1|||
37791782|NCT01600716|69416008|FG001|Overall Study|Adverse Event|1|||
37791783|NCT01600326|69416120|FG000|Overall Study|Lost to Follow-up|1|||
37791784|NCT01600326|69416121|FG001|Overall Study|Lost to Follow-up|1|||
37791785|NCT01637142|69416257|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
37791786|NCT01636986|69416275|FG000|Overall Study|Withdrawal by Subject|0|||
37791787|NCT01636986|69416276|FG001|Overall Study|Withdrawal by Subject|1|||
37791788|NCT01636986|69416275|FG000|Overall Study|Corneal Staining|0|||
37791789|NCT01636986|69416276|FG001|Overall Study|Corneal Staining|1|||
37791790|NCT01601496|69416366|FG000|Overall Study|Physician Decision|1|||
37791791|NCT01601496|69416366|FG000|Overall Study|Withdrawal by Subject|1|||
37791792|NCT01601496|69416366|FG000|Overall Study|Lost to Follow-up|6|||
37791793|NCT01601496|69416366|FG000|Overall Study|Death|4|||
37791794|NCT01601496|69416366|FG000|Overall Study|Other: patient refusal to continue|3|||
37791795|NCT03211832|69416372|FG000|Overall Study|No longer with agency|32|||
37791796|NCT03211832|69416373|FG001|Overall Study|No longer with agency|49|||
37791797|NCT03211832|69416374|FG002|Overall Study|No longer with agency|30|||
37791798|NCT03211832|69416372|FG000|Overall Study|Declined survey|3|||
37791799|NCT03211832|69416373|FG001|Overall Study|Declined survey|3|||
37791800|NCT03211832|69416374|FG002|Overall Study|Declined survey|2|||
37791801|NCT03211832|69416372|FG000|Overall Study|Not available during data collection|1|||
37791802|NCT03211832|69416373|FG001|Overall Study|Not available during data collection|0|||
37791803|NCT03211832|69416374|FG002|Overall Study|Not available during data collection|2|||
37791804|NCT04887948|69416383|FG000|Overall Study|Death|1|||
37791805|NCT04887948|69416384|FG001|Overall Study|Death|0|||
37791806|NCT04887948|69416385|FG002|Overall Study|Death|0|||
37791807|NCT04887948|69416383|FG000|Overall Study|Lost to Follow-up|1|||
37791808|NCT04887948|69416384|FG001|Overall Study|Lost to Follow-up|0|||
37791809|NCT04887948|69416385|FG002|Overall Study|Lost to Follow-up|3|||
37791810|NCT04887948|69416383|FG000|Overall Study|Physician Decision|0|||
37791811|NCT04887948|69416384|FG001|Overall Study|Physician Decision|4|||
37791812|NCT04887948|69416385|FG002|Overall Study|Physician Decision|1|||
37791813|NCT04887948|69416383|FG000|Overall Study|Protocol Violation|1|||
37791814|NCT04887948|69416384|FG001|Overall Study|Protocol Violation|1|||
37791815|NCT04887948|69416385|FG002|Overall Study|Protocol Violation|0|||
37791816|NCT04887948|69416383|FG000|Overall Study|Withdrawal by Subject|0|||
37791817|NCT04887948|69416384|FG001|Overall Study|Withdrawal by Subject|6|||
37791818|NCT04887948|69416385|FG002|Overall Study|Withdrawal by Subject|1|||
37791819|NCT04887948|69416383|FG000|Overall Study|No longer met eligibility criteria|1|||
37791820|NCT04887948|69416384|FG001|Overall Study|No longer met eligibility criteria|2|||
37791821|NCT04887948|69416385|FG002|Overall Study|No longer met eligibility criteria|1|||
37693757|NCT01897714|69170083|FG005|Phase I (Dose Escalation)|Disease progression|0|||
37791822|NCT04887948|69416383|FG000|Overall Study|Other|2|||
37791823|NCT04887948|69416384|FG001|Overall Study|Other|1|||
37791824|NCT04887948|69416385|FG002|Overall Study|Other|1|||
37791825|NCT01638000|69416523|FG000|Overall Study|Randomized but Never Received Drug|7|||
37791826|NCT01638000|69416524|FG001|Overall Study|Randomized but Never Received Drug|10|||
37791827|NCT01638000|69416523|FG000|Overall Study|Adverse Event|14|||
37791828|NCT01638000|69416524|FG001|Overall Study|Adverse Event|16|||
37791829|NCT01638000|69416523|FG000|Overall Study|Lack of Efficacy|5|||
37791830|NCT01638000|69416524|FG001|Overall Study|Lack of Efficacy|6|||
37791831|NCT01638000|69416523|FG000|Overall Study|Protocol Violation|11|||
37791832|NCT01638000|69416524|FG001|Overall Study|Protocol Violation|13|||
37791833|NCT01638000|69416523|FG000|Overall Study|Withdrawal by Subject|21|||
37791834|NCT01638000|69416524|FG001|Overall Study|Withdrawal by Subject|24|||
37791835|NCT01638000|69416523|FG000|Overall Study|Miscellaneous|2|||
37791836|NCT01638000|69416524|FG001|Overall Study|Miscellaneous|2|||
37791837|NCT01637922|69416583|FG000|Overall Study|Adverse Event|0|||
37791838|NCT01637922|69416584|FG001|Overall Study|Adverse Event|1|||
37791839|NCT01637922|69416583|FG000|Overall Study|Protocol Violation|0|||
37791840|NCT01637922|69416584|FG001|Overall Study|Protocol Violation|1|||
37791841|NCT01637922|69416583|FG000|Overall Study|Withdrawal by Subject|0|||
37791842|NCT01637922|69416584|FG001|Overall Study|Withdrawal by Subject|3|||
37791843|NCT01637922|69416583|FG000|Overall Study|Lost to Follow-up|2|||
37791844|NCT01637922|69416584|FG001|Overall Study|Lost to Follow-up|0|||
37791845|NCT03496662|69416789|FG000|Overall Study|Adverse Event|1|||
37791846|NCT03496662|69416790|FG001|Overall Study|Adverse Event|0|||
37791847|NCT03496662|69416791|FG002|Overall Study|Adverse Event|1|||
37791848|NCT03496662|69416789|FG000|Overall Study|Physician Decision|1|||
37791849|NCT03496662|69416790|FG001|Overall Study|Physician Decision|0|||
37791850|NCT03496662|69416791|FG002|Overall Study|Physician Decision|3|||
37791851|NCT03496662|69416789|FG000|Overall Study|Withdrawal by Subject|0|||
37791852|NCT03496662|69416790|FG001|Overall Study|Withdrawal by Subject|0|||
37791853|NCT03496662|69416791|FG002|Overall Study|Withdrawal by Subject|2|||
37791854|NCT03496662|69416789|FG000|Overall Study|Death|0|||
37791855|NCT03496662|69416790|FG001|Overall Study|Death|0|||
37791856|NCT03496662|69416791|FG002|Overall Study|Death|2|||
37791857|NCT03496662|69416789|FG000|Overall Study|Noncompliance|0|||
37791858|NCT03496662|69416790|FG001|Overall Study|Noncompliance|0|||
37791859|NCT03496662|69416791|FG002|Overall Study|Noncompliance|1|||
37791860|NCT01638546|69416801|FG000|Overall Study|Adverse Event|1|||
37791861|NCT01638546|69416802|FG001|Overall Study|Adverse Event|3|||
37791862|NCT03172494|69416822|FG000|Overall Study|Adverse Event|5|||
37791863|NCT03172494|69416823|FG001|Overall Study|Adverse Event|1|||
37791864|NCT03172494|69416824|FG002|Overall Study|Adverse Event|15|||
37791865|NCT03172494|69416822|FG000|Overall Study|Protocol Violation|3|||
37791866|NCT03172494|69416823|FG001|Overall Study|Protocol Violation|2|||
37791867|NCT03172494|69416824|FG002|Overall Study|Protocol Violation|1|||
37791868|NCT03172494|69416822|FG000|Overall Study|Lack of Efficacy|0|||
37791869|NCT03172494|69416823|FG001|Overall Study|Lack of Efficacy|0|||
37791870|NCT03172494|69416824|FG002|Overall Study|Lack of Efficacy|4|||
37791871|NCT03172494|69416822|FG000|Overall Study|Pregnancy|0|||
37791872|NCT03172494|69416823|FG001|Overall Study|Pregnancy|1|||
37791873|NCT03172494|69416824|FG002|Overall Study|Pregnancy|0|||
37791874|NCT03172494|69416822|FG000|Overall Study|Withdrawal by Subject|10|||
37791875|NCT03172494|69416823|FG001|Overall Study|Withdrawal by Subject|8|||
37791876|NCT03172494|69416824|FG002|Overall Study|Withdrawal by Subject|8|||
37791877|NCT03172494|69416822|FG000|Overall Study|Severe hypoglycaemic episode|0|||
37791878|NCT03172494|69416823|FG001|Overall Study|Severe hypoglycaemic episode|0|||
37791879|NCT03172494|69416824|FG002|Overall Study|Severe hypoglycaemic episode|1|||
37791880|NCT03172494|69416822|FG000|Overall Study|Non-compliance towards treatment|2|||
37791881|NCT03172494|69416823|FG001|Overall Study|Non-compliance towards treatment|0|||
37791882|NCT03172494|69416824|FG002|Overall Study|Non-compliance towards treatment|0|||
37791883|NCT01636362|69416925|FG000|Overall Study|Physician Decision|6|||
37791884|NCT01636362|69416925|FG000|Overall Study|Subject healed, not returning|1|||
37791885|NCT01636362|69416925|FG000|Overall Study|Withdrawal by Subject|1|||
37791886|NCT02797184|69416954|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
37791887|NCT02797184|69416955|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
37791888|NCT03042468|69416997|FG000|Overall Study|Death|0|||
37791889|NCT03042468|69416998|FG001|Overall Study|Death|1|||
37791890|NCT03042468|69416999|FG002|Overall Study|Death|1|||
37791891|NCT03042468|69417000|FG003|Overall Study|Death|0|||
37791892|NCT03042468|69417001|FG004|Overall Study|Death|0|||
37791893|NCT03042468|69417002|FG005|Overall Study|Death|0|||
37791894|NCT03042468|69416997|FG000|Overall Study|Withdrawal by Subject|0|||
37791895|NCT03042468|69416998|FG001|Overall Study|Withdrawal by Subject|0|||
37791896|NCT03042468|69416999|FG002|Overall Study|Withdrawal by Subject|0|||
37791897|NCT03042468|69417000|FG003|Overall Study|Withdrawal by Subject|0|||
37791898|NCT03042468|69417001|FG004|Overall Study|Withdrawal by Subject|0|||
37791899|NCT03042468|69417002|FG005|Overall Study|Withdrawal by Subject|1|||
37791900|NCT03042468|69416997|FG000|Overall Study|Lost to Follow-up|0|||
37791901|NCT03042468|69416998|FG001|Overall Study|Lost to Follow-up|0|||
37791902|NCT03042468|69416999|FG002|Overall Study|Lost to Follow-up|0|||
37791903|NCT03042468|69417000|FG003|Overall Study|Lost to Follow-up|0|||
37791904|NCT03042468|69417001|FG004|Overall Study|Lost to Follow-up|1|||
37791905|NCT03042468|69417002|FG005|Overall Study|Lost to Follow-up|1|||
37791906|NCT01634178|69417020|FG000|Treatment Period 1|Adverse Event|0|||
37791907|NCT01634178|69417021|FG001|Treatment Period 1|Adverse Event|1|||
37791908|NCT01634178|69417020|FG000|Treatment Period 2|Adverse Event|1|||
37791909|NCT01634178|69417021|FG001|Treatment Period 2|Adverse Event|0|||
37791910|NCT02412306|69417063|FG000|Overall Study|Lost to Follow-up|0|||
37791911|NCT02412306|69417064|FG001|Overall Study|Lost to Follow-up|1|||
37791912|NCT02412306|69417065|FG002|Overall Study|Lost to Follow-up|0|||
37791913|NCT02412306|69417066|FG003|Overall Study|Lost to Follow-up|0|||
37791914|NCT02412306|69417067|FG004|Overall Study|Lost to Follow-up|0|||
37791915|NCT02412306|69417063|FG000|Overall Study|Withdrawal by Subject|0|||
37791916|NCT02412306|69417064|FG001|Overall Study|Withdrawal by Subject|0|||
37791917|NCT02412306|69417065|FG002|Overall Study|Withdrawal by Subject|1|||
37791918|NCT02412306|69417066|FG003|Overall Study|Withdrawal by Subject|0|||
37791919|NCT02412306|69417067|FG004|Overall Study|Withdrawal by Subject|0|||
37791920|NCT02412306|69417063|FG000|Overall Study|Death|5|||
37791921|NCT02412306|69417064|FG001|Overall Study|Death|7|||
37791922|NCT02412306|69417065|FG002|Overall Study|Death|15|||
37791923|NCT02412306|69417066|FG003|Overall Study|Death|0|||
37791924|NCT02412306|69417067|FG004|Overall Study|Death|2|||
37791925|NCT04285723|69417090|FG000|Overall Study|Subject decision|1|||
37791926|NCT04285723|69417091|FG001|Overall Study|Subject decision|2|||
37791927|NCT04285723|69417090|FG000|Overall Study|Physician Decision|1|||
37791928|NCT04285723|69417091|FG001|Overall Study|Physician Decision|0|||
37791929|NCT04285723|69417090|FG000|Overall Study|No efficiency|1|||
37791930|NCT04285723|69417091|FG001|Overall Study|No efficiency|0|||
37791931|NCT01352221|69417105|FG000|Double-blind Phase|Adverse Event|6|||
37791932|NCT01352221|69417106|FG001|Double-blind Phase|Adverse Event|4|||
37791933|NCT01352221|69417107|FG002|Double-blind Phase|Adverse Event|0|||
37791934|NCT01352221|69417108|FG003|Double-blind Phase|Adverse Event|0|||
37791935|NCT01352221|69417105|FG000|Double-blind Phase|Withdrawal by Subject|3|||
37791936|NCT01352221|69417106|FG001|Double-blind Phase|Withdrawal by Subject|5|||
37791937|NCT01352221|69417107|FG002|Double-blind Phase|Withdrawal by Subject|0|||
37791938|NCT01352221|69417108|FG003|Double-blind Phase|Withdrawal by Subject|0|||
37791939|NCT01352221|69417105|FG000|Double-blind Phase|Lost to Follow-up|0|||
37791940|NCT01352221|69417106|FG001|Double-blind Phase|Lost to Follow-up|1|||
37791941|NCT01352221|69417107|FG002|Double-blind Phase|Lost to Follow-up|0|||
37791942|NCT01352221|69417108|FG003|Double-blind Phase|Lost to Follow-up|0|||
37791943|NCT01352221|69417105|FG000|Double-blind Phase|Protocol Violation|0|||
37791944|NCT01352221|69417106|FG001|Double-blind Phase|Protocol Violation|1|||
37791945|NCT01352221|69417107|FG002|Double-blind Phase|Protocol Violation|0|||
37791946|NCT01352221|69417108|FG003|Double-blind Phase|Protocol Violation|0|||
37791947|NCT01352221|69417105|FG000|Open-label Phase|Physician Decision|0|||
37791948|NCT01352221|69417106|FG001|Open-label Phase|Physician Decision|0|||
37791949|NCT01352221|69417107|FG002|Open-label Phase|Physician Decision|2|||
37791950|NCT01352221|69417108|FG003|Open-label Phase|Physician Decision|1|||
37791951|NCT01352221|69417105|FG000|Open-label Phase|Pregnancy|0|||
37791952|NCT01352221|69417106|FG001|Open-label Phase|Pregnancy|0|||
37791953|NCT01352221|69417107|FG002|Open-label Phase|Pregnancy|1|||
37791954|NCT01352221|69417108|FG003|Open-label Phase|Pregnancy|0|||
37791955|NCT01352221|69417105|FG000|Open-label Phase|Adverse Event|0|||
37791956|NCT01352221|69417106|FG001|Open-label Phase|Adverse Event|0|||
37791957|NCT01352221|69417107|FG002|Open-label Phase|Adverse Event|8|||
37791958|NCT01352221|69417108|FG003|Open-label Phase|Adverse Event|4|||
37791959|NCT01352221|69417105|FG000|Open-label Phase|Withdrawal by Subject|0|||
37791960|NCT01352221|69417106|FG001|Open-label Phase|Withdrawal by Subject|0|||
37791961|NCT01352221|69417107|FG002|Open-label Phase|Withdrawal by Subject|1|||
37791962|NCT01352221|69417108|FG003|Open-label Phase|Withdrawal by Subject|6|||
37791963|NCT01352221|69417105|FG000|Open-label Phase|Worsening of IBD|0|||
37791964|NCT01352221|69417106|FG001|Open-label Phase|Worsening of IBD|0|||
37791965|NCT01352221|69417107|FG002|Open-label Phase|Worsening of IBD|1|||
37791966|NCT01352221|69417108|FG003|Open-label Phase|Worsening of IBD|0|||
37791967|NCT01634100|69417134|FG000|Overall Study|Withdrawal by Subject|1|||
37791968|NCT01634100|69417135|FG001|Overall Study|Withdrawal by Subject|0|||
37791969|NCT01634100|69417136|FG002|Overall Study|Withdrawal by Subject|1|||
37791970|NCT01634100|69417137|FG003|Overall Study|Withdrawal by Subject|0|||
37791971|NCT01634100|69417138|FG004|Overall Study|Withdrawal by Subject|0|||
37791972|NCT01634100|69417139|FG005|Overall Study|Withdrawal by Subject|0|||
37791973|NCT01633944|69417149|FG000|Open-label Titration Phase|Adverse Event|109|||
37791974|NCT01633944|69417150|FG001|Open-label Titration Phase|Adverse Event|0|||
37791975|NCT01633944|69417151|FG002|Open-label Titration Phase|Adverse Event|0|||
37791976|NCT01633944|69417149|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
37791977|NCT01633944|69417150|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
37791978|NCT01633944|69417151|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
37791979|NCT01633944|69417149|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
37791980|NCT01633944|69417150|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
37791981|NCT01633944|69417151|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
37791982|NCT01633944|69417149|FG000|Open-label Titration Phase|Protocol Violation|24|||
37791983|NCT01633944|69417150|FG001|Open-label Titration Phase|Protocol Violation|0|||
37975530|NCT00397215|69662818|FG003|Month 6 (Day 180)|Adverse Event|0|||
37791984|NCT01633944|69417151|FG002|Open-label Titration Phase|Protocol Violation|0|||
37791985|NCT01633944|69417149|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
37791986|NCT01633944|69417150|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
37791987|NCT01633944|69417151|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
37975531|NCT00397215|69662815|FG000|Month 6 (Day 180)|Other|2|||
37975532|NCT00397215|69662816|FG001|Month 6 (Day 180)|Other|0|||
37975533|NCT00397215|69662817|FG002|Month 6 (Day 180)|Other|3|||
37975534|NCT00397215|69662818|FG003|Month 6 (Day 180)|Other|0|||
37975535|NCT00556439|69662835|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
37975536|NCT00556439|69662836|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
37975537|NCT00556439|69662837|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
37975538|NCT00556439|69662838|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
37975539|NCT00556439|69662835|FG000|Study Entry to Week 12|Physician Decision|1|||
37975540|NCT00556439|69662836|FG001|Study Entry to Week 12|Physician Decision|0|||
37975541|NCT00556439|69662837|FG002|Study Entry to Week 12|Physician Decision|0|||
37975542|NCT00556439|69662838|FG003|Study Entry to Week 12|Physician Decision|0|||
37975543|NCT00556439|69662835|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
37975544|NCT00556439|69662836|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
37791988|NCT01633944|69417149|FG000|Open-label Titration Phase|Other|68|||
37791989|NCT01633944|69417150|FG001|Open-label Titration Phase|Other|0|||
37791990|NCT01633944|69417151|FG002|Open-label Titration Phase|Other|0|||
37791991|NCT01633944|69417149|FG000|Double-blind Treatment Phase|Adverse Event|0|||
37791992|NCT01633944|69417150|FG001|Double-blind Treatment Phase|Adverse Event|13|||
37791993|NCT01633944|69417151|FG002|Double-blind Treatment Phase|Adverse Event|7|||
37791994|NCT01633944|69417149|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
37791995|NCT01633944|69417150|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
37791996|NCT01633944|69417151|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
37791997|NCT01633944|69417149|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
37791998|NCT01633944|69417150|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
37791999|NCT01633944|69417151|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
37792000|NCT01633944|69417149|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
37792001|NCT01633944|69417150|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
37792002|NCT01633944|69417151|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
37792003|NCT01633944|69417149|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
37792004|NCT01633944|69417150|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
37792005|NCT01633944|69417151|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
37792006|NCT01633944|69417149|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
37792007|NCT01633944|69417150|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
37792008|NCT01633944|69417151|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
37792009|NCT01633944|69417149|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
37792010|NCT01633944|69417150|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
37792011|NCT01633944|69417151|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
37792012|NCT01633944|69417149|FG000|Double-blind Treatment Phase|Other|0|||
37792013|NCT01633944|69417150|FG001|Double-blind Treatment Phase|Other|7|||
37792014|NCT01633944|69417151|FG002|Double-blind Treatment Phase|Other|0|||
37792015|NCT01633788|69417196|FG000|Overall Study|Adverse Event|1|||
37792016|NCT01633788|69417197|FG001|Overall Study|Adverse Event|3|||
37792017|NCT01633788|69417198|FG002|Overall Study|Adverse Event|3|||
37792018|NCT01633788|69417199|FG003|Overall Study|Adverse Event|3|||
37792019|NCT01633788|69417196|FG000|Overall Study|Lost to Follow-up|2|||
37792020|NCT01633788|69417197|FG001|Overall Study|Lost to Follow-up|2|||
37792021|NCT01633788|69417198|FG002|Overall Study|Lost to Follow-up|2|||
37792022|NCT01633788|69417199|FG003|Overall Study|Lost to Follow-up|0|||
37792023|NCT01633788|69417196|FG000|Overall Study|Personal Reasons|3|||
37792024|NCT01633788|69417197|FG001|Overall Study|Personal Reasons|1|||
37792025|NCT01633788|69417198|FG002|Overall Study|Personal Reasons|1|||
37792026|NCT01633788|69417199|FG003|Overall Study|Personal Reasons|3|||
37792027|NCT01633788|69417196|FG000|Overall Study|Protocol Violation|1|||
37792028|NCT01633788|69417197|FG001|Overall Study|Protocol Violation|0|||
37792029|NCT01633788|69417198|FG002|Overall Study|Protocol Violation|1|||
37975545|NCT00556439|69662837|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
37975546|NCT00556439|69662838|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
37792030|NCT01633788|69417199|FG003|Overall Study|Protocol Violation|0|||
37792031|NCT01633788|69417196|FG000|Overall Study|Other Reasons|0|||
37792032|NCT01633788|69417197|FG001|Overall Study|Other Reasons|2|||
37792033|NCT01633788|69417198|FG002|Overall Study|Other Reasons|3|||
37792034|NCT01633788|69417199|FG003|Overall Study|Other Reasons|7|||
37975547|NCT00556439|69662835|FG000|Study Entry to Week 12|Recurrent infection|1|||
37792035|NCT04154943|69417209|FG000|Overall Study|Study Ongoing|68|||
37792036|NCT04154943|69417209|FG000|Overall Study|Lost to Follow-up|1|||
37792037|NCT04154943|69417209|FG000|Overall Study|Decision by the Investigator|1|||
37975548|NCT00556439|69662836|FG001|Study Entry to Week 12|Recurrent infection|0|||
37975549|NCT00556439|69662837|FG002|Study Entry to Week 12|Recurrent infection|0|||
37792038|NCT04154943|69417209|FG000|Overall Study|Death|5|||
37792039|NCT04154943|69417209|FG000|Overall Study|Withdrawal by Subject|4|||
37792040|NCT03476239|69417230|FG000|Overall Study|Withdrawal by Subject|10|||
37792041|NCT03476239|69417230|FG000|Overall Study|Death|80|||
37792042|NCT03476239|69417230|FG000|Overall Study|Lost to Follow-up|8|||
37792043|NCT02678312|69417239|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
37792044|NCT02678312|69417240|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
37792045|NCT02678312|69417241|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
37792046|NCT02678312|69417242|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
37792047|NCT02678312|69417243|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
37792048|NCT02678312|69417239|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
37792049|NCT02678312|69417240|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
37792050|NCT02678312|69417241|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
37792051|NCT02678312|69417242|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
37792052|NCT02678312|69417243|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
37792053|NCT02678312|69417239|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
37792054|NCT02678312|69417240|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
37792055|NCT02678312|69417241|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
37792056|NCT02678312|69417242|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
37792057|NCT02678312|69417243|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
37792058|NCT02678312|69417239|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
37792059|NCT02678312|69417240|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
37792060|NCT02678312|69417241|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
37792061|NCT02678312|69417242|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
37792062|NCT02678312|69417243|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
37792063|NCT02678312|69417239|FG000|Part 2 Double Blind Epoch|Death|0|||
37792064|NCT02678312|69417240|FG001|Part 2 Double Blind Epoch|Death|0|||
37792065|NCT02678312|69417241|FG002|Part 2 Double Blind Epoch|Death|0|||
37792066|NCT02678312|69417242|FG003|Part 2 Double Blind Epoch|Death|8|||
37792067|NCT02678312|69417243|FG004|Part 2 Double Blind Epoch|Death|12|||
37792068|NCT02678312|69417239|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
37792069|NCT02678312|69417240|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
37792070|NCT02678312|69417241|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
37792071|NCT02678312|69417242|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
37792072|NCT02678312|69417243|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
37792073|NCT02678312|69417239|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
37792074|NCT02678312|69417240|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
37792075|NCT02678312|69417241|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
37792076|NCT02678312|69417242|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
37792077|NCT02678312|69417243|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
37792078|NCT02678312|69417239|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
37792079|NCT02678312|69417240|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
37792080|NCT02678312|69417241|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
37792081|NCT02678312|69417242|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
37792082|NCT02678312|69417243|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
37792083|NCT02256631|69417490|FG000|Overall Study|Lost to Follow-up|1|||
37792084|NCT02256631|69417491|FG001|Overall Study|Lost to Follow-up|1|||
37792085|NCT02256631|69417492|FG002|Overall Study|Lost to Follow-up|0|||
37792086|NCT02256631|69417493|FG003|Overall Study|Lost to Follow-up|2|||
37792087|NCT02256631|69417494|FG004|Overall Study|Lost to Follow-up|0|||
37792088|NCT02256631|69417495|FG005|Overall Study|Lost to Follow-up|4|||
37792089|NCT02256631|69417496|FG006|Overall Study|Lost to Follow-up|1|||
37792090|NCT02256631|69417490|FG000|Overall Study|Withdrawal by Subject|0|||
37792091|NCT02256631|69417491|FG001|Overall Study|Withdrawal by Subject|0|||
37792092|NCT02256631|69417492|FG002|Overall Study|Withdrawal by Subject|0|||
37792093|NCT02256631|69417493|FG003|Overall Study|Withdrawal by Subject|1|||
37792094|NCT02256631|69417494|FG004|Overall Study|Withdrawal by Subject|1|||
37792095|NCT02256631|69417495|FG005|Overall Study|Withdrawal by Subject|0|||
37975550|NCT00556439|69662838|FG003|Study Entry to Week 12|Recurrent infection|0|||
37975551|NCT00556439|69662835|FG000|Study Entry to Week 12|Malignancy|0|||
37975552|NCT00556439|69662836|FG001|Study Entry to Week 12|Malignancy|0|||
37975553|NCT00556439|69662837|FG002|Study Entry to Week 12|Malignancy|1|||
37792096|NCT02256631|69417496|FG006|Overall Study|Withdrawal by Subject|1|||
37792097|NCT02256631|69417490|FG000|Overall Study|Unable to get to clinic|0|||
37792098|NCT02256631|69417491|FG001|Overall Study|Unable to get to clinic|2|||
37792099|NCT02256631|69417492|FG002|Overall Study|Unable to get to clinic|0|||
37792100|NCT02256631|69417493|FG003|Overall Study|Unable to get to clinic|1|||
37792101|NCT02256631|69417494|FG004|Overall Study|Unable to get to clinic|0|||
37792102|NCT02256631|69417495|FG005|Overall Study|Unable to get to clinic|1|||
37975554|NCT00556439|69662838|FG003|Study Entry to Week 12|Malignancy|0|||
37792103|NCT02256631|69417496|FG006|Overall Study|Unable to get to clinic|2|||
37792104|NCT02163733|69417594|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
37792105|NCT02163733|69417595|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
37792106|NCT02163733|69417596|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
37792107|NCT02163733|69417594|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
37792108|NCT02163733|69417595|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
37792109|NCT02163733|69417596|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
37792110|NCT02279745|69417626|FG000|Overall Study|Adverse Event|7|||
37792111|NCT02279745|69417626|FG000|Overall Study|Death|6|||
37792112|NCT02279745|69417626|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
37792113|NCT02279745|69417626|FG000|Overall Study|Withdrawal by Subject|2|||
37792114|NCT02279745|69417626|FG000|Overall Study|Pregnancy|1|||
37792115|NCT02279745|69417626|FG000|Overall Study|Study Non-compliance|1|||
37792116|NCT02279745|69417626|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
37693758|NCT01897714|69170078|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
37693759|NCT01897714|69170079|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
37792117|NCT01761877|69417665|FG000|Overall Study|Adverse Event|7|||
37792118|NCT01761877|69417666|FG001|Overall Study|Adverse Event|0|||
37792119|NCT01761877|69417665|FG000|Overall Study|Withdrawal by Subject|6|||
37792120|NCT01761877|69417666|FG001|Overall Study|Withdrawal by Subject|4|||
37792121|NCT01761877|69417665|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
37792122|NCT01761877|69417666|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
37792123|NCT01761877|69417665|FG000|Overall Study|Death|0|||
37792124|NCT01761877|69417666|FG001|Overall Study|Death|1|||
37792125|NCT01761877|69417665|FG000|Overall Study|MRI intolerant|1|||
37792126|NCT01761877|69417666|FG001|Overall Study|MRI intolerant|6|||
37792127|NCT00588523|69417746|FG000|Overall Study|Not treated|3|||
37792128|NCT03093259|69417920|FG000|Overall Study|Adverse Event|1|||
37792129|NCT03093259|69417921|FG001|Overall Study|Adverse Event|0|||
37792130|NCT03093259|69417920|FG000|Overall Study|Withdrawal by Subject|1|||
37792131|NCT03093259|69417921|FG001|Overall Study|Withdrawal by Subject|0|||
37792132|NCT02997865|69418213|FG000|Overall Study|Death|2|||
37792133|NCT02997865|69418214|FG001|Overall Study|Death|1|||
37792134|NCT02997865|69418213|FG000|Overall Study|Lost to Follow-up|6|||
37792135|NCT02997865|69418214|FG001|Overall Study|Lost to Follow-up|3|||
37792136|NCT02997865|69418213|FG000|Overall Study|Withdrawal by Subject|5|||
37792137|NCT02997865|69418214|FG001|Overall Study|Withdrawal by Subject|0|||
37792138|NCT01575834|69419443|FG000|Overall Study|Withdrawal by Subject|352|||
37792139|NCT01575834|69419444|FG001|Overall Study|Withdrawal by Subject|390|||
37792140|NCT01575834|69419443|FG000|Overall Study|Death|81|||
37792141|NCT01575834|69419444|FG001|Overall Study|Death|74|||
37792142|NCT01575834|69419443|FG000|Overall Study|Other|70|||
37792143|NCT01575834|69419444|FG001|Overall Study|Other|70|||
37792144|NCT01575834|69419443|FG000|Overall Study|Adverse Event|63|||
37792145|NCT01575834|69419444|FG001|Overall Study|Adverse Event|61|||
37792146|NCT01575834|69419443|FG000|Overall Study|Lost to Follow-up|55|||
37792147|NCT01575834|69419444|FG001|Overall Study|Lost to Follow-up|68|||
37792148|NCT01575834|69419443|FG000|Overall Study|Noncompliance|52|||
37792149|NCT01575834|69419444|FG001|Overall Study|Noncompliance|27|||
37792150|NCT01575834|69419443|FG000|Overall Study|Administrative decision|15|||
37792151|NCT01575834|69419444|FG001|Overall Study|Administrative decision|33|||
37792152|NCT01575834|69419443|FG000|Overall Study|Ineligibility Determined|5|||
37792153|NCT01575834|69419444|FG001|Overall Study|Ineligibility Determined|8|||
37792154|NCT01575834|69419443|FG000|Overall Study|Protocol Deviation|4|||
37864126|NCT00991276|69547781|FG004|First Intervention Period|Lost to Follow-up|0|||
37864127|NCT00991276|69547782|FG005|First Intervention Period|Lost to Follow-up|0|||
37864128|NCT00991276|69547777|FG000|Second Intervention Period|Adverse Event|0|||
37693760|NCT01897714|69170080|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
37864129|NCT00991276|69547778|FG001|Second Intervention Period|Adverse Event|2|||
37864130|NCT00991276|69547779|FG002|Second Intervention Period|Adverse Event|0|||
37693761|NCT01897714|69170081|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
37792155|NCT01575834|69419444|FG001|Overall Study|Protocol Deviation|3|||
37792156|NCT01575834|69419443|FG000|Overall Study|Requirement for Alternative Therapy|2|||
37792157|NCT01575834|69419444|FG001|Overall Study|Requirement for Alternative Therapy|4|||
37792158|NCT02253654|69419556|FG000|Overall Study|Withdrawal by Subject|12|||
37864131|NCT00991276|69547780|FG003|Second Intervention Period|Adverse Event|1|||
37792159|NCT02253654|69419557|FG001|Overall Study|Withdrawal by Subject|4|||
37792160|NCT02253654|69419556|FG000|Overall Study|Decision by Sponsor|1|||
37792161|NCT02253654|69419557|FG001|Overall Study|Decision by Sponsor|1|||
37792162|NCT02253654|69419556|FG000|Overall Study|Lost to Follow-up|2|||
37792163|NCT02253654|69419557|FG001|Overall Study|Lost to Follow-up|5|||
37792164|NCT02253654|69419556|FG000|Overall Study|Death|4|||
37792165|NCT02253654|69419557|FG001|Overall Study|Death|7|||
37792166|NCT02253654|69419556|FG000|Overall Study|Did Not Receive Study Treatment|4|||
37792167|NCT02253654|69419557|FG001|Overall Study|Did Not Receive Study Treatment|1|||
37792168|NCT02252406|69419565|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
37792169|NCT02252406|69419566|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
37792170|NCT02252406|69419565|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
37792171|NCT02252406|69419566|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
37792172|NCT02252406|69419565|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
37792173|NCT02252406|69419566|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
37792174|NCT02252406|69419565|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
37792175|NCT02252406|69419566|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
37792176|NCT02252406|69419565|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
37792177|NCT02252406|69419566|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
37792178|NCT02246478|69419576|FG000|Multiple-dose Phase|Protocol Violation|1|||
37792179|NCT02246478|69419577|FG001|Multiple-dose Phase|Protocol Violation|0|||
37792180|NCT02246478|69419578|FG002|Multiple-dose Phase|Protocol Violation|0|||
37792181|NCT02246478|69419579|FG003|Multiple-dose Phase|Protocol Violation|1|||
37792182|NCT02252016|69419598|FG000|Overall Study|Lost to Follow-up|2|||
37792183|NCT02252016|69419599|FG001|Overall Study|Lost to Follow-up|1|||
37792184|NCT02252016|69419598|FG000|Overall Study|Physician Decision|1|||
37792185|NCT02252016|69419599|FG001|Overall Study|Physician Decision|0|||
37792186|NCT02252016|69419598|FG000|Overall Study|Withdrawal by Subject|0|||
37792187|NCT02252016|69419599|FG001|Overall Study|Withdrawal by Subject|2|||
37792188|NCT02249832|69419605|FG000|Overall Study|Withdrawal by Subject|3|||
37792189|NCT02249832|69419605|FG000|Overall Study|Lost to Follow-up|10|||
37792190|NCT02248974|69419616|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
37792191|NCT02248974|69419617|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
37792192|NCT02248974|69419616|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
37792193|NCT02248974|69419617|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
37792194|NCT02248974|69419616|FG000|1-Day Follow-Up|Enrolled in another study|1|||
37792195|NCT02248974|69419617|FG001|1-Day Follow-Up|Enrolled in another study|0|||
37792196|NCT02248974|69419616|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
37792197|NCT02248974|69419617|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
37792198|NCT02248974|69419616|FG000|1-Week Follow-Up|Enrolled in another study|1|||
37792199|NCT02248974|69419617|FG001|1-Week Follow-Up|Enrolled in another study|1|||
37792200|NCT02248974|69419616|FG000|1-Week Follow-Up|Transferred to another facility|1|||
37792201|NCT02248974|69419617|FG001|1-Week Follow-Up|Transferred to another facility|0|||
37792202|NCT02248974|69419616|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
37792203|NCT02248974|69419617|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
37792204|NCT02248974|69419616|FG000|1-Week Follow-Up|Death|1|||
37792205|NCT02248974|69419617|FG001|1-Week Follow-Up|Death|1|||
37792206|NCT02248974|69419616|FG000|1-Week Follow-Up|Excluded because of age|0|||
37792207|NCT02248974|69419617|FG001|1-Week Follow-Up|Excluded because of age|1|||
37792208|NCT02248974|69419616|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
37792209|NCT02248974|69419617|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
37792210|NCT02248974|69419616|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
37693762|NCT01897714|69170082|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
37693763|NCT01897714|69170083|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
37792211|NCT02248974|69419617|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
37792212|NCT02248974|69419616|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
37693764|NCT01897714|69170078|FG000|Phase I (Dose Escalation)|Other|0|||
37792213|NCT02248974|69419617|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
37792214|NCT02248974|69419616|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
37792215|NCT02248974|69419617|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
37792216|NCT02248974|69419616|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
37693765|NCT01897714|69170079|FG001|Phase I (Dose Escalation)|Other|1|||
37792217|NCT02248974|69419617|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
37792218|NCT02246166|69419625|FG000|Overall Study|Protocol Violation|1|||
37792219|NCT02246166|69419626|FG001|Overall Study|Protocol Violation|0|||
37792220|NCT02706847|69419635|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
37792221|NCT02706847|69419636|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
37792222|NCT02706847|69419637|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
37792223|NCT02706847|69419638|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
37792224|NCT02706847|69419635|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
37792225|NCT02706847|69419636|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
37792226|NCT02706847|69419637|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
37792227|NCT02706847|69419638|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
37792228|NCT02706847|69419635|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
37792229|NCT02706847|69419636|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
37792230|NCT02706847|69419637|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
37792231|NCT02706847|69419638|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
37792232|NCT02706847|69419635|FG000|Period 1: Day 1 to Week 12|Other|4|||
37792233|NCT02706847|69419636|FG001|Period 1: Day 1 to Week 12|Other|4|||
37792234|NCT02706847|69419637|FG002|Period 1: Day 1 to Week 12|Other|2|||
37792235|NCT02706847|69419638|FG003|Period 1: Day 1 to Week 12|Other|2|||
37792236|NCT02706847|69419635|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
37792237|NCT02706847|69419636|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
37792238|NCT02706847|69419637|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
37792239|NCT02706847|69419638|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
37792240|NCT02706847|69419635|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
37792241|NCT02706847|69419636|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
37792242|NCT02706847|69419637|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
37792243|NCT02706847|69419638|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
37792244|NCT02706847|69419635|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
37792245|NCT02706847|69419636|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
37792246|NCT02706847|69419637|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
37792247|NCT02706847|69419638|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
37792248|NCT02706847|69419635|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
37792249|NCT02706847|69419636|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
37792250|NCT02706847|69419637|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
37792251|NCT02706847|69419638|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
37792252|NCT02706847|69419635|FG000|Period 1: Week 12 to Week 24|Other|1|||
37792253|NCT02706847|69419636|FG001|Period 1: Week 12 to Week 24|Other|0|||
37975555|NCT00556439|69662835|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
37975556|NCT00556439|69662836|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
37792254|NCT02706847|69419637|FG002|Period 1: Week 12 to Week 24|Other|1|||
37693766|NCT01897714|69170080|FG002|Phase I (Dose Escalation)|Other|0|||
37792255|NCT02706847|69419638|FG003|Period 1: Week 12 to Week 24|Other|4|||
37792256|NCT02706847|69419635|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
37693767|NCT01897714|69170081|FG003|Phase I (Dose Escalation)|Other|0|||
37792257|NCT02706847|69419636|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
37792258|NCT02706847|69419637|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
37792259|NCT02706847|69419638|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
37792260|NCT02706847|69419635|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
37792261|NCT02706847|69419636|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
37792262|NCT02706847|69419637|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
37792263|NCT02706847|69419638|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
37792264|NCT02706847|69419635|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
37792265|NCT02706847|69419636|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
37792266|NCT02706847|69419637|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
37792267|NCT02706847|69419638|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
37792268|NCT02706847|69419635|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
37792269|NCT02706847|69419636|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
37792270|NCT02706847|69419637|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
37792271|NCT02706847|69419638|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
37792272|NCT02706847|69419635|FG000|Period 2: Week 24 to Week 260|Other|8|||
37792273|NCT02706847|69419636|FG001|Period 2: Week 24 to Week 260|Other|5|||
37792274|NCT02706847|69419637|FG002|Period 2: Week 24 to Week 260|Other|15|||
37792275|NCT02706847|69419638|FG003|Period 2: Week 24 to Week 260|Other|15|||
37792276|NCT02245620|69419651|FG000|Overall Study|Physician Decision|1|||
37792277|NCT02245620|69419652|FG001|Overall Study|Physician Decision|1|||
37792278|NCT02244996|69419660|FG000|Overall Study|Lack of Efficacy|2|||
37792279|NCT02244996|69419661|FG001|Overall Study|Lack of Efficacy|6|||
37792280|NCT02243280|69419696|FG000|Treated|Adverse Event|1|||
37792281|NCT02243280|69419697|FG001|Treated|Adverse Event|0|||
37792282|NCT02243280|69419698|FG002|Treated|Adverse Event|0|||
37792283|NCT02243280|69419699|FG003|Treated|Adverse Event|0|||
37792284|NCT02243280|69419700|FG004|Treated|Adverse Event|0|||
37792285|NCT02243280|69419701|FG005|Treated|Adverse Event|0|||
37792286|NCT02243280|69419702|FG006|Treated|Adverse Event|0|||
37792287|NCT02243280|69419703|FG007|Treated|Adverse Event|0|||
37792288|NCT02243280|69419704|FG008|Treated|Adverse Event|0|||
37792289|NCT02243280|69419705|FG009|Treated|Adverse Event|0|||
37792290|NCT02243280|69419706|FG010|Treated|Adverse Event|1|||
37792291|NCT02243280|69419696|FG000|Treated|Lost to Follow-up|0|||
37792292|NCT02243280|69419697|FG001|Treated|Lost to Follow-up|0|||
37792293|NCT02243280|69419698|FG002|Treated|Lost to Follow-up|0|||
37792294|NCT02243280|69419699|FG003|Treated|Lost to Follow-up|0|||
37792295|NCT02243280|69419700|FG004|Treated|Lost to Follow-up|0|||
37792296|NCT02243280|69419701|FG005|Treated|Lost to Follow-up|0|||
37792297|NCT02243280|69419702|FG006|Treated|Lost to Follow-up|0|||
37792298|NCT02243280|69419703|FG007|Treated|Lost to Follow-up|0|||
37792299|NCT02243280|69419704|FG008|Treated|Lost to Follow-up|1|||
37792300|NCT02243280|69419705|FG009|Treated|Lost to Follow-up|0|||
37792301|NCT02243280|69419706|FG010|Treated|Lost to Follow-up|2|||
37792302|NCT02248818|69419764|FG000|Screening|Protocol Violation|0|||
37792303|NCT02248818|69419765|FG001|Screening|Protocol Violation|0|||
37792304|NCT02248818|69419766|FG002|Screening|Protocol Violation|0|||
37792305|NCT02248818|69419767|FG003|Screening|Protocol Violation|0|||
37792306|NCT02248818|69419768|FG004|Screening|Protocol Violation|0|||
37792307|NCT02248818|69419769|FG005|Screening|Protocol Violation|0|||
37792308|NCT02248818|69419770|FG006|Screening|Protocol Violation|0|||
37792309|NCT02248818|69419771|FG007|Screening|Protocol Violation|0|||
37792310|NCT02248818|69419772|FG008|Screening|Protocol Violation|7|||
37792311|NCT02248818|69419764|FG000|Screening|Study fully enrolled|0|||
37792312|NCT02248818|69419765|FG001|Screening|Study fully enrolled|0|||
37792313|NCT02248818|69419766|FG002|Screening|Study fully enrolled|0|||
37792314|NCT02248818|69419767|FG003|Screening|Study fully enrolled|0|||
37792315|NCT02248818|69419768|FG004|Screening|Study fully enrolled|0|||
37693768|NCT01897714|69170082|FG004|Phase I (Dose Escalation)|Other|0|||
37792316|NCT02248818|69419769|FG005|Screening|Study fully enrolled|0|||
37792317|NCT02248818|69419770|FG006|Screening|Study fully enrolled|0|||
37792318|NCT02248818|69419771|FG007|Screening|Study fully enrolled|0|||
37792319|NCT02248818|69419772|FG008|Screening|Study fully enrolled|14|||
37792320|NCT02248818|69419764|FG000|Screening|Physician Decision|0|||
37792321|NCT02248818|69419765|FG001|Screening|Physician Decision|0|||
37792322|NCT02248818|69419766|FG002|Screening|Physician Decision|0|||
37792323|NCT02248818|69419767|FG003|Screening|Physician Decision|0|||
37792324|NCT02248818|69419768|FG004|Screening|Physician Decision|0|||
37792325|NCT02248818|69419769|FG005|Screening|Physician Decision|0|||
37792326|NCT02248818|69419770|FG006|Screening|Physician Decision|0|||
37792327|NCT02248818|69419771|FG007|Screening|Physician Decision|0|||
37792328|NCT02248818|69419772|FG008|Screening|Physician Decision|73|||
37792329|NCT02248818|69419764|FG000|Screening|Withdrawal by Subject|0|||
37792330|NCT02248818|69419765|FG001|Screening|Withdrawal by Subject|0|||
37792331|NCT02248818|69419766|FG002|Screening|Withdrawal by Subject|0|||
37792332|NCT02248818|69419767|FG003|Screening|Withdrawal by Subject|0|||
37792333|NCT02248818|69419768|FG004|Screening|Withdrawal by Subject|0|||
37792334|NCT02248818|69419769|FG005|Screening|Withdrawal by Subject|0|||
37792335|NCT02248818|69419770|FG006|Screening|Withdrawal by Subject|0|||
37792336|NCT02248818|69419771|FG007|Screening|Withdrawal by Subject|0|||
37792337|NCT02248818|69419772|FG008|Screening|Withdrawal by Subject|6|||
37792338|NCT02248818|69419764|FG000|Screening|Lost to Follow-up|0|||
37792339|NCT02248818|69419765|FG001|Screening|Lost to Follow-up|0|||
37792340|NCT02248818|69419766|FG002|Screening|Lost to Follow-up|0|||
37792341|NCT02248818|69419767|FG003|Screening|Lost to Follow-up|0|||
37792342|NCT02248818|69419768|FG004|Screening|Lost to Follow-up|0|||
37792343|NCT02248818|69419769|FG005|Screening|Lost to Follow-up|0|||
37792344|NCT02248818|69419770|FG006|Screening|Lost to Follow-up|0|||
37792345|NCT02248818|69419771|FG007|Screening|Lost to Follow-up|0|||
37792346|NCT02248818|69419772|FG008|Screening|Lost to Follow-up|7|||
37792347|NCT02248818|69419764|FG000|Randomised Study|Administrative - randomization error|0|||
37792348|NCT02248818|69419765|FG001|Randomised Study|Administrative - randomization error|0|||
37792349|NCT02248818|69419766|FG002|Randomised Study|Administrative - randomization error|0|||
37792350|NCT02248818|69419767|FG003|Randomised Study|Administrative - randomization error|0|||
37792351|NCT02248818|69419768|FG004|Randomised Study|Administrative - randomization error|0|||
37792352|NCT02248818|69419769|FG005|Randomised Study|Administrative - randomization error|8|||
37792353|NCT02248818|69419770|FG006|Randomised Study|Administrative - randomization error|0|||
37792354|NCT02248818|69419771|FG007|Randomised Study|Administrative - randomization error|0|||
37792355|NCT02248818|69419772|FG008|Randomised Study|Administrative - randomization error|0|||
37792356|NCT02247960|69419801|FG000|Patient Consent and Randomization|Physician Decision|2|||
37792357|NCT02247960|69419802|FG001|Patient Consent and Randomization|Physician Decision|2|||
37792358|NCT02247960|69419801|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
37792359|NCT02247960|69419802|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
37792360|NCT02247960|69419801|FG000|Catheter Removed|Lost to Follow-up|7|||
37792361|NCT02247960|69419802|FG001|Catheter Removed|Lost to Follow-up|10|||
37792362|NCT02247804|69419891|FG000|Treatment Period 1|Adverse Event|9|||
37792363|NCT02247804|69419892|FG001|Treatment Period 1|Adverse Event|2|||
37792364|NCT02247804|69419893|FG002|Treatment Period 1|Adverse Event|0|||
37792365|NCT02247804|69419891|FG000|Treatment Period 1|Lack of Efficacy|0|||
37792366|NCT02247804|69419892|FG001|Treatment Period 1|Lack of Efficacy|0|||
37792367|NCT02247804|69419893|FG002|Treatment Period 1|Lack of Efficacy|2|||
37792368|NCT02247804|69419891|FG000|Treatment Period 1|Lost to Follow-up|1|||
37792369|NCT02247804|69419892|FG001|Treatment Period 1|Lost to Follow-up|0|||
37792370|NCT02247804|69419893|FG002|Treatment Period 1|Lost to Follow-up|2|||
37792371|NCT02247804|69419891|FG000|Treatment Period 1|Personal Reasons|7|||
37792372|NCT02247804|69419892|FG001|Treatment Period 1|Personal Reasons|1|||
37792373|NCT02247804|69419893|FG002|Treatment Period 1|Personal Reasons|2|||
37792374|NCT02247804|69419891|FG000|Treatment Period 1|Protocol Deviation|0|||
37792375|NCT02247804|69419892|FG001|Treatment Period 1|Protocol Deviation|0|||
37792376|NCT02247804|69419893|FG002|Treatment Period 1|Protocol Deviation|1|||
37792377|NCT02247804|69419891|FG000|Treatment Period 1|Randomized but not Treated|5|||
37792378|NCT02247804|69419892|FG001|Treatment Period 1|Randomized but not Treated|1|||
37792379|NCT02247804|69419893|FG002|Treatment Period 1|Randomized but not Treated|1|||
37792380|NCT02247804|69419891|FG000|Treatment Period 2|Adverse Event|6|||
37792381|NCT02247804|69419892|FG001|Treatment Period 2|Adverse Event|3|||
37792382|NCT02247804|69419893|FG002|Treatment Period 2|Adverse Event|3|||
37792383|NCT02247804|69419891|FG000|Treatment Period 2|Lack of Efficacy|0|||
37693769|NCT01897714|69170083|FG005|Phase I (Dose Escalation)|Other|0|||
37792384|NCT02247804|69419892|FG001|Treatment Period 2|Lack of Efficacy|0|||
37792385|NCT02247804|69419893|FG002|Treatment Period 2|Lack of Efficacy|1|||
37792386|NCT02247804|69419891|FG000|Treatment Period 2|Lost to Follow-up|0|||
37792387|NCT02247804|69419892|FG001|Treatment Period 2|Lost to Follow-up|1|||
37792388|NCT02247804|69419893|FG002|Treatment Period 2|Lost to Follow-up|1|||
37792389|NCT02247804|69419891|FG000|Treatment Period 2|Personal Reasons|2|||
37792390|NCT02247804|69419892|FG001|Treatment Period 2|Personal Reasons|1|||
37792391|NCT02247804|69419893|FG002|Treatment Period 2|Personal Reasons|1|||
37792392|NCT02247804|69419891|FG000|Treatment Period 2|Reason not Specified|0|||
37792393|NCT02247804|69419892|FG001|Treatment Period 2|Reason not Specified|0|||
37792394|NCT02247804|69419893|FG002|Treatment Period 2|Reason not Specified|2|||
37792395|NCT02247804|69419891|FG000|Treatment Period 3|Adverse Event|4|||
37792396|NCT02247804|69419892|FG001|Treatment Period 3|Adverse Event|3|||
37792397|NCT02247804|69419893|FG002|Treatment Period 3|Adverse Event|3|||
37792398|NCT02247804|69419891|FG000|Treatment Period 3|Lack of Efficacy|0|||
37792399|NCT02247804|69419892|FG001|Treatment Period 3|Lack of Efficacy|1|||
37792400|NCT02247804|69419893|FG002|Treatment Period 3|Lack of Efficacy|0|||
37792401|NCT02247804|69419891|FG000|Treatment Period 3|Lost to Follow-up|1|||
37792402|NCT02247804|69419892|FG001|Treatment Period 3|Lost to Follow-up|2|||
37792403|NCT02247804|69419893|FG002|Treatment Period 3|Lost to Follow-up|2|||
37792404|NCT02247804|69419891|FG000|Treatment Period 3|Personal Reasons|4|||
37792405|NCT02247804|69419892|FG001|Treatment Period 3|Personal Reasons|3|||
37792406|NCT02247804|69419893|FG002|Treatment Period 3|Personal Reasons|2|||
37792407|NCT02247804|69419891|FG000|Treatment Period 3|Reason not Specified|2|||
37792408|NCT02247804|69419892|FG001|Treatment Period 3|Reason not Specified|1|||
37792409|NCT02247804|69419893|FG002|Treatment Period 3|Reason not Specified|3|||
37792410|NCT02243202|69419918|FG000|Overall Study|Adverse Event|5|||
37792411|NCT02243202|69419919|FG001|Overall Study|Adverse Event|6|||
37792412|NCT02243202|69419920|FG002|Overall Study|Adverse Event|10|||
37792413|NCT02243202|69419921|FG003|Overall Study|Adverse Event|4|||
37792414|NCT02243202|69419918|FG000|Overall Study|Lost to Follow-up|9|||
37792415|NCT02243202|69419919|FG001|Overall Study|Lost to Follow-up|9|||
37792416|NCT02243202|69419920|FG002|Overall Study|Lost to Follow-up|14|||
37792417|NCT02243202|69419921|FG003|Overall Study|Lost to Follow-up|11|||
37792418|NCT02243202|69419918|FG000|Overall Study|Protocol Violation|3|||
37792419|NCT02243202|69419919|FG001|Overall Study|Protocol Violation|1|||
37792420|NCT02243202|69419920|FG002|Overall Study|Protocol Violation|2|||
37792421|NCT02243202|69419921|FG003|Overall Study|Protocol Violation|1|||
37792422|NCT02243202|69419918|FG000|Overall Study|Withdrawal by Subject|7|||
37792423|NCT02243202|69419919|FG001|Overall Study|Withdrawal by Subject|6|||
37792424|NCT02243202|69419920|FG002|Overall Study|Withdrawal by Subject|4|||
37792425|NCT02243202|69419921|FG003|Overall Study|Withdrawal by Subject|4|||
37792426|NCT02243202|69419918|FG000|Overall Study|Other|1|||
37792427|NCT02243202|69419919|FG001|Overall Study|Other|3|||
37792428|NCT02243202|69419920|FG002|Overall Study|Other|1|||
37792429|NCT02243202|69419921|FG003|Overall Study|Other|2|||
37792430|NCT02243202|69419918|FG000|Overall Study|Randomized but not received treatment|0|||
37792431|NCT02243202|69419919|FG001|Overall Study|Randomized but not received treatment|0|||
37792432|NCT02243202|69419920|FG002|Overall Study|Randomized but not received treatment|0|||
37792433|NCT02243202|69419921|FG003|Overall Study|Randomized but not received treatment|1|||
37792434|NCT02243046|69419934|FG000|Overall Study|Lost to Follow-up|1|||
37792435|NCT02243046|69419935|FG001|Overall Study|Lost to Follow-up|1|||
37792436|NCT02243046|69419936|FG002|Overall Study|Lost to Follow-up|4|||
37792437|NCT02207946|69419946|FG000|Overall Study|Lost to Follow-up|1|||
37792438|NCT02207946|69419947|FG001|Overall Study|Lost to Follow-up|0|||
37792439|NCT02207946|69419946|FG000|Overall Study|Adverse Event|0|||
37792440|NCT02207946|69419947|FG001|Overall Study|Adverse Event|1|||
37792441|NCT03976076|69419954|FG000|Overall Study|Withdrawal by Subject|2|||
37792442|NCT03551210|69420153|FG000|Overall Study|Adverse Event|5|||
37792443|NCT03551210|69420154|FG001|Overall Study|Adverse Event|6|||
37792444|NCT03551210|69420153|FG000|Overall Study|Withdrawal by Subject|1|||
37792445|NCT03551210|69420154|FG001|Overall Study|Withdrawal by Subject|7|||
37792446|NCT03551210|69420153|FG000|Overall Study|Needed in other antibiotic treatment|2|||
37792447|NCT03551210|69420154|FG001|Overall Study|Needed in other antibiotic treatment|5|||
37792448|NCT03551210|69420153|FG000|Overall Study|Lost to Follow-up|1|||
37792449|NCT03551210|69420154|FG001|Overall Study|Lost to Follow-up|1|||
37792450|NCT03551210|69420153|FG000|Overall Study|Absence of visit 4 and 5|1|||
37792451|NCT03551210|69420154|FG001|Overall Study|Absence of visit 4 and 5|0|||
37792452|NCT03551210|69420153|FG000|Overall Study|No drug for dispensing|0|||
37792453|NCT03551210|69420154|FG001|Overall Study|No drug for dispensing|1|||
37792454|NCT02207634|69420291|FG000|Overall Study|Withdrawal by Subject|21|||
37792455|NCT02207634|69420292|FG001|Overall Study|Withdrawal by Subject|31|||
37792456|NCT02207634|69420291|FG000|Overall Study|Lost to Follow-up|1|||
37792457|NCT02207634|69420292|FG001|Overall Study|Lost to Follow-up|0|||
37792458|NCT03452228|69420335|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
37792459|NCT03452228|69420336|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
37792460|NCT03452228|69420337|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
37792461|NCT03452228|69420335|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
37792462|NCT03452228|69420336|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
37792463|NCT03452228|69420337|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
37792464|NCT03452228|69420335|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
37792465|NCT03452228|69420336|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
37792466|NCT03452228|69420337|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
37792467|NCT03452228|69420335|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
37792468|NCT03452228|69420336|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
37792469|NCT03452228|69420337|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
37792470|NCT02207556|69420400|FG000|Overall Study|Physician Decision|1|||
37792471|NCT02207556|69420401|FG001|Overall Study|Physician Decision|0|||
37792472|NCT02207556|69420400|FG000|Overall Study|Withdrawal by Subject|1|||
37792473|NCT02207556|69420401|FG001|Overall Study|Withdrawal by Subject|0|||
37792474|NCT02207556|69420400|FG000|Overall Study|Death|0|||
37792475|NCT02207556|69420401|FG001|Overall Study|Death|5|||
37792476|NCT03732638|69420416|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
37792477|NCT03732638|69420417|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
37792478|NCT03732638|69420416|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
37792479|NCT03732638|69420417|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
37792480|NCT03732638|69420416|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
37792481|NCT03732638|69420417|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
37792482|NCT03732638|69420416|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
37792483|NCT03732638|69420417|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
37792484|NCT03732638|69420416|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
37792485|NCT03732638|69420417|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
37792486|NCT03732638|69420416|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
37792487|NCT03732638|69420417|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
37792488|NCT03732638|69420416|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
37792489|NCT03732638|69420417|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
37792490|NCT03732638|69420416|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
37792491|NCT03732638|69420417|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
37792492|NCT03732638|69420416|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
37792493|NCT03732638|69420417|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
37792494|NCT03732638|69420416|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
37792495|NCT03732638|69420417|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
37792496|NCT03732638|69420416|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
37792497|NCT03732638|69420417|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
37792498|NCT03732638|69420416|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
37792499|NCT03732638|69420417|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
37792500|NCT03732638|69420416|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
37864132|NCT00991276|69547781|FG004|Second Intervention Period|Adverse Event|1|||
37792501|NCT03732638|69420417|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
37792502|NCT03732638|69420416|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
37792503|NCT03732638|69420417|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
37792504|NCT03732638|69420416|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
37864133|NCT00991276|69547782|FG005|Second Intervention Period|Adverse Event|0|||
37864134|NCT00991276|69547777|FG000|Second Intervention Period|Protocol Violation|1|||
37792505|NCT03732638|69420417|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
37792506|NCT03732638|69420416|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
37792507|NCT03732638|69420417|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
37792508|NCT03732638|69420416|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
37792509|NCT03732638|69420417|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
37792510|NCT03732638|69420416|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
37792511|NCT03732638|69420417|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
37792512|NCT03732638|69420416|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
37792513|NCT03732638|69420417|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
37792514|NCT03732638|69420416|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
37792515|NCT03732638|69420417|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
37792516|NCT03732638|69420416|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
37792517|NCT03732638|69420417|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
37792518|NCT03732638|69420416|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
37792519|NCT03732638|69420417|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
37792520|NCT03732638|69420416|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
37792521|NCT03732638|69420417|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
37792522|NCT03732638|69420416|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
37792523|NCT03732638|69420417|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
37792524|NCT03266588|69420456|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
37792525|NCT03266588|69420457|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
37792526|NCT03266588|69420458|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
37792527|NCT03266588|69420456|FG000|Observational Period|Withdrawal by Subject|44|||
37792528|NCT03266588|69420457|FG001|Observational Period|Withdrawal by Subject|22|||
37792529|NCT03266588|69420458|FG002|Observational Period|Withdrawal by Subject|13|||
37792530|NCT03266588|69420456|FG000|Observational Period|Non-compliance|18|||
37792531|NCT03266588|69420457|FG001|Observational Period|Non-compliance|12|||
37792532|NCT03266588|69420458|FG002|Observational Period|Non-compliance|10|||
37792533|NCT03266588|69420456|FG000|Observational Period|Lost to Follow-up|8|||
37792534|NCT03266588|69420457|FG001|Observational Period|Lost to Follow-up|12|||
37792535|NCT03266588|69420458|FG002|Observational Period|Lost to Follow-up|4|||
37792536|NCT03266588|69420456|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
37792537|NCT03266588|69420457|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
37792538|NCT03266588|69420458|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
37792539|NCT03266588|69420456|FG000|Observational Period|Protocol Deviation|1|||
37792540|NCT03266588|69420457|FG001|Observational Period|Protocol Deviation|0|||
37792541|NCT03266588|69420458|FG002|Observational Period|Protocol Deviation|0|||
37792542|NCT03266588|69420456|FG000|Observational Period|Other Reasons|3|||
37792543|NCT03266588|69420457|FG001|Observational Period|Other Reasons|0|||
37792544|NCT03266588|69420458|FG002|Observational Period|Other Reasons|1|||
37792545|NCT03266588|69420456|FG000|Long-term Treatment Period|Adverse Event|33|||
37792546|NCT03266588|69420457|FG001|Long-term Treatment Period|Adverse Event|17|||
37975557|NCT00556439|69662837|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
37693770|NCT01897714|69170078|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
37792547|NCT03266588|69420458|FG002|Long-term Treatment Period|Adverse Event|8|||
37792548|NCT03266588|69420456|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
37792549|NCT03266588|69420457|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
37792550|NCT03266588|69420458|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
37792551|NCT03266588|69420456|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
37792552|NCT03266588|69420457|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
37792553|NCT03266588|69420458|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
37792554|NCT03266588|69420456|FG000|Long-term Treatment Period|Non-Compliance|126|||
37792555|NCT03266588|69420457|FG001|Long-term Treatment Period|Non-Compliance|57|||
37792556|NCT03266588|69420458|FG002|Long-term Treatment Period|Non-Compliance|7|||
37792557|NCT03266588|69420456|FG000|Long-term Treatment Period|Pregnancy|11|||
37792558|NCT03266588|69420457|FG001|Long-term Treatment Period|Pregnancy|5|||
37792559|NCT03266588|69420458|FG002|Long-term Treatment Period|Pregnancy|0|||
37792560|NCT03266588|69420456|FG000|Long-term Treatment Period|Protocol Deviation|17|||
37792561|NCT03266588|69420457|FG001|Long-term Treatment Period|Protocol Deviation|10|||
37792562|NCT03266588|69420458|FG002|Long-term Treatment Period|Protocol Deviation|4|||
37792563|NCT03266588|69420456|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
37792564|NCT03266588|69420457|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
37792565|NCT03266588|69420458|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
37792566|NCT03266588|69420456|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
37792567|NCT03266588|69420457|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
37792568|NCT03266588|69420458|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
37792569|NCT03266588|69420456|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
37792570|NCT03266588|69420457|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
37792571|NCT03266588|69420458|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
37792572|NCT03266588|69420456|FG000|Long-term Treatment Period|Other Reasons|5|||
37792573|NCT03266588|69420457|FG001|Long-term Treatment Period|Other Reasons|0|||
37792574|NCT03266588|69420458|FG002|Long-term Treatment Period|Other Reasons|0|||
37792575|NCT03266588|69420456|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
37792576|NCT03266588|69420457|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
37792577|NCT03266588|69420458|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
37792578|NCT03238196|69420522|FG000|Overall Study|Adverse Event|3|||
37792579|NCT03238196|69420523|FG001|Overall Study|Adverse Event|0|||
37792580|NCT03238196|69420524|FG002|Overall Study|Adverse Event|2|||
37792581|NCT03238196|69420525|FG003|Overall Study|Adverse Event|2|||
37792582|NCT03238196|69420522|FG000|Overall Study|Withdrawal by Subject|4|||
37792583|NCT03238196|69420523|FG001|Overall Study|Withdrawal by Subject|1|||
37792584|NCT03238196|69420524|FG002|Overall Study|Withdrawal by Subject|1|||
37792585|NCT03238196|69420525|FG003|Overall Study|Withdrawal by Subject|0|||
37792586|NCT03238196|69420522|FG000|Overall Study|Disease progression|14|||
37792587|NCT03238196|69420523|FG001|Overall Study|Disease progression|2|||
37792588|NCT03238196|69420524|FG002|Overall Study|Disease progression|3|||
37792589|NCT03238196|69420525|FG003|Overall Study|Disease progression|2|||
37792590|NCT03238196|69420522|FG000|Overall Study|Still on treatment|1|||
37792591|NCT03238196|69420523|FG001|Overall Study|Still on treatment|0|||
37792592|NCT03238196|69420524|FG002|Overall Study|Still on treatment|0|||
37792593|NCT03238196|69420525|FG003|Overall Study|Still on treatment|0|||
37792594|NCT03019640|69420544|FG000|Overall Study|Screen Failures|4|||
37792595|NCT03019640|69420544|FG000|Overall Study|Adverse Event|3|||
37792596|NCT03019640|69420544|FG000|Overall Study|Participant Relapsed|1|||
37792597|NCT02240706|69420612|FG000|Overall Study|Lack of Efficacy|2|||
37792598|NCT02240706|69420613|FG001|Overall Study|Lack of Efficacy|2|||
37792599|NCT02240706|69420614|FG002|Overall Study|Lack of Efficacy|2|||
37792600|NCT02240706|69420615|FG003|Overall Study|Lack of Efficacy|2|||
37792601|NCT02240706|69420616|FG004|Overall Study|Lack of Efficacy|5|||
37792602|NCT02240706|69420617|FG005|Overall Study|Lack of Efficacy|0|||
37792603|NCT02240706|69420618|FG006|Overall Study|Lack of Efficacy|0|||
37792604|NCT02240706|69420612|FG000|Overall Study|Adverse Event|1|||
37792605|NCT02240706|69420613|FG001|Overall Study|Adverse Event|0|||
37792606|NCT02240706|69420614|FG002|Overall Study|Adverse Event|1|||
37792607|NCT02240706|69420615|FG003|Overall Study|Adverse Event|0|||
37792608|NCT02240706|69420616|FG004|Overall Study|Adverse Event|2|||
37792609|NCT02240706|69420617|FG005|Overall Study|Adverse Event|0|||
37792610|NCT02240706|69420618|FG006|Overall Study|Adverse Event|0|||
37792611|NCT02240706|69420612|FG000|Overall Study|Progressive disease|0|||
37792612|NCT02240706|69420613|FG001|Overall Study|Progressive disease|0|||
37792613|NCT02240706|69420614|FG002|Overall Study|Progressive disease|0|||
37792614|NCT02240706|69420615|FG003|Overall Study|Progressive disease|0|||
37792615|NCT02240706|69420616|FG004|Overall Study|Progressive disease|1|||
37792616|NCT02240706|69420617|FG005|Overall Study|Progressive disease|0|||
37792617|NCT02240706|69420618|FG006|Overall Study|Progressive disease|0|||
37792618|NCT02240706|69420612|FG000|Overall Study|Dose limiting toxicity|0|||
37792619|NCT02240706|69420613|FG001|Overall Study|Dose limiting toxicity|0|||
37792620|NCT02240706|69420614|FG002|Overall Study|Dose limiting toxicity|0|||
37792621|NCT02240706|69420615|FG003|Overall Study|Dose limiting toxicity|0|||
37792622|NCT02240706|69420616|FG004|Overall Study|Dose limiting toxicity|1|||
37792623|NCT02240706|69420617|FG005|Overall Study|Dose limiting toxicity|0|||
37792624|NCT02240706|69420618|FG006|Overall Study|Dose limiting toxicity|0|||
37792625|NCT02240706|69420612|FG000|Overall Study|Refused to continue taking medication|0|||
37792626|NCT02240706|69420613|FG001|Overall Study|Refused to continue taking medication|1|||
37792627|NCT02240706|69420614|FG002|Overall Study|Refused to continue taking medication|3|||
37792628|NCT02240706|69420615|FG003|Overall Study|Refused to continue taking medication|1|||
37792629|NCT02240706|69420616|FG004|Overall Study|Refused to continue taking medication|2|||
37792630|NCT02240706|69420617|FG005|Overall Study|Refused to continue taking medication|0|||
37792631|NCT02240706|69420618|FG006|Overall Study|Refused to continue taking medication|0|||
37792632|NCT02240706|69420612|FG000|Overall Study|Insurance billing concerns|0|||
37792633|NCT02240706|69420613|FG001|Overall Study|Insurance billing concerns|0|||
37792634|NCT02240706|69420614|FG002|Overall Study|Insurance billing concerns|0|||
37792635|NCT02240706|69420615|FG003|Overall Study|Insurance billing concerns|1|||
37792636|NCT02240706|69420616|FG004|Overall Study|Insurance billing concerns|0|||
37792637|NCT02240706|69420617|FG005|Overall Study|Insurance billing concerns|0|||
37792638|NCT02240706|69420618|FG006|Overall Study|Insurance billing concerns|0|||
37792639|NCT01600092|69420643|FG000|Overall Study|Adverse Event|2|||
37792640|NCT01600092|69420644|FG001|Overall Study|Adverse Event|0|||
37792641|NCT01600092|69420643|FG000|Overall Study|Lost to Follow-up|4|||
37792642|NCT01600092|69420644|FG001|Overall Study|Lost to Follow-up|6|||
37792643|NCT01600092|69420643|FG000|Overall Study|Withdrawal by parent/guardian|8|||
37792644|NCT01600092|69420644|FG001|Overall Study|Withdrawal by parent/guardian|6|||
37792645|NCT01600092|69420643|FG000|Overall Study|Physician Decision|1|||
37792646|NCT01600092|69420644|FG001|Overall Study|Physician Decision|1|||
37792647|NCT01600092|69420643|FG000|Overall Study|Randomized but not vaccinated|3|||
37792648|NCT01600092|69420644|FG001|Overall Study|Randomized but not vaccinated|3|||
37792649|NCT02240628|69420656|FG000|Overall Study|Physician Decision|6|||
37792650|NCT02240628|69420657|FG001|Overall Study|Physician Decision|5|||
37792651|NCT02207400|69420679|FG000|Overall Study|Adverse Event|1|||
37792652|NCT02207400|69420680|FG001|Overall Study|Adverse Event|1|||
37792653|NCT02207400|69420679|FG000|Overall Study|Lost to Follow-up|6|||
37792654|NCT02207400|69420680|FG001|Overall Study|Lost to Follow-up|7|||
37792655|NCT02207400|69420679|FG000|Overall Study|Protocol Violation|1|||
37792656|NCT02207400|69420680|FG001|Overall Study|Protocol Violation|1|||
37792657|NCT02207400|69420679|FG000|Overall Study|Withdrawal by Subject|8|||
37792658|NCT02207400|69420680|FG001|Overall Study|Withdrawal by Subject|4|||
37792659|NCT02207400|69420679|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
37792660|NCT02207400|69420680|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
37792661|NCT02207244|69421039|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
37792662|NCT02207244|69421040|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
37792663|NCT02207244|69421041|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
37792664|NCT02207244|69421042|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
37792665|NCT02207244|69421043|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
37792666|NCT02207244|69421044|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
37792667|NCT02207244|69421045|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
37792668|NCT02207244|69421046|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
37792669|NCT02207244|69421047|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
37792670|NCT02207244|69421048|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
37792671|NCT02207244|69421049|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
37792672|NCT02207244|69421039|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
37792673|NCT02207244|69421040|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
37792674|NCT02207244|69421041|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
37792675|NCT02207244|69421042|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
37792676|NCT02207244|69421043|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
37792677|NCT02207244|69421044|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
37792678|NCT02207244|69421045|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
37792679|NCT02207244|69421046|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
37792680|NCT02207244|69421047|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
37792681|NCT02207244|69421048|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
37792682|NCT02207244|69421049|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
37792683|NCT02207244|69421039|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
37792684|NCT02207244|69421040|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
37792685|NCT02207244|69421041|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
37792686|NCT02207244|69421042|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
37792687|NCT02207244|69421043|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
37792688|NCT02207244|69421044|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
37792689|NCT02207244|69421045|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
37792690|NCT02207244|69421046|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
37792691|NCT02207244|69421047|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
37792692|NCT02207244|69421048|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
37792693|NCT02207244|69421049|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
37792694|NCT02207244|69421039|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
37792695|NCT02207244|69421040|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
37792696|NCT02207244|69421041|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
37792697|NCT02207244|69421042|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
37792698|NCT02207244|69421043|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
37792699|NCT02207244|69421044|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
37792700|NCT02207244|69421045|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
37792701|NCT02207244|69421046|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
37792702|NCT02207244|69421047|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
37792703|NCT02207244|69421048|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
37792704|NCT02207244|69421049|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
37792705|NCT02207244|69421039|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
37792706|NCT02207244|69421040|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
37792707|NCT02207244|69421041|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
37792708|NCT02207244|69421042|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
37792709|NCT02207244|69421043|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
37792710|NCT02207244|69421044|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
37792711|NCT02207244|69421045|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
37792712|NCT02207244|69421046|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
37792713|NCT02207244|69421047|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
37792714|NCT02207244|69421048|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
37792715|NCT02207244|69421049|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
37792716|NCT02207244|69421039|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
37792717|NCT02207244|69421040|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
37792718|NCT02207244|69421041|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
37792719|NCT02207244|69421042|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
37792720|NCT02207244|69421043|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
37792721|NCT02207244|69421044|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
37792722|NCT02207244|69421045|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
37792723|NCT02207244|69421046|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
37792724|NCT02207244|69421047|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
37792725|NCT02207244|69421048|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
37792726|NCT02207244|69421049|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
37792727|NCT02207244|69421039|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
37792728|NCT02207244|69421040|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
37792729|NCT02207244|69421041|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
37792730|NCT02207244|69421042|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
37792731|NCT02207244|69421043|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
37792732|NCT02207244|69421044|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
37792733|NCT02207244|69421045|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
37792734|NCT02207244|69421046|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
37792735|NCT02207244|69421047|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
37792736|NCT02207244|69421048|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
37792737|NCT02207244|69421049|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
37792738|NCT02207244|69421039|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
37792739|NCT02207244|69421040|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
37792740|NCT02207244|69421041|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
37792741|NCT02207244|69421042|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
37792742|NCT02207244|69421043|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
37792743|NCT02207244|69421044|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
37792744|NCT02207244|69421045|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
37792745|NCT02207244|69421046|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
37792746|NCT02207244|69421047|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
37792747|NCT02207244|69421048|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
37792748|NCT02207244|69421049|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
37792749|NCT02207244|69421039|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
37792750|NCT02207244|69421040|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
37792751|NCT02207244|69421041|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
37792752|NCT02207244|69421042|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
37792753|NCT02207244|69421043|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
37792754|NCT02207244|69421044|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
37792755|NCT02207244|69421045|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
37792756|NCT02207244|69421046|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
37792757|NCT02207244|69421047|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
37792758|NCT02207244|69421048|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
37792759|NCT02207244|69421049|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
37792760|NCT02207244|69421039|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
37792761|NCT02207244|69421040|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
37792762|NCT02207244|69421041|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
37792763|NCT02207244|69421042|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
37792764|NCT02207244|69421043|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
37792765|NCT02207244|69421044|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
37792766|NCT02207244|69421045|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
37792767|NCT02207244|69421046|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
37792768|NCT02207244|69421047|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
37792769|NCT02207244|69421048|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
37792770|NCT02207244|69421049|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
37792771|NCT02207244|69421039|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
37792772|NCT02207244|69421040|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
37792773|NCT02207244|69421041|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
37792774|NCT02207244|69421042|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
37792775|NCT02207244|69421043|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
37792776|NCT02207244|69421044|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
37792777|NCT02207244|69421045|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
37792778|NCT02207244|69421046|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
37792779|NCT02207244|69421047|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
37792780|NCT02207244|69421048|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
37792781|NCT02207244|69421049|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
37792782|NCT02207244|69421039|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
37792783|NCT02207244|69421040|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
37792784|NCT02207244|69421041|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
37792785|NCT02207244|69421042|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
37792786|NCT02207244|69421043|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
37792787|NCT02207244|69421044|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
37792788|NCT02207244|69421045|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
37792789|NCT02207244|69421046|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
37792790|NCT02207244|69421047|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
37792791|NCT02207244|69421048|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
37792792|NCT02207244|69421049|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
37792793|NCT02207244|69421039|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
37792794|NCT02207244|69421040|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
37792795|NCT02207244|69421041|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
37792796|NCT02207244|69421042|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
37792797|NCT02207244|69421043|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
37792798|NCT02207244|69421044|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
37792799|NCT02207244|69421045|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
37792800|NCT02207244|69421046|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
37792801|NCT02207244|69421047|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
37792802|NCT02207244|69421048|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
37792803|NCT02207244|69421049|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
37792804|NCT02207244|69421039|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
37792805|NCT02207244|69421040|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
37792806|NCT02207244|69421041|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
37792807|NCT02207244|69421042|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
37792808|NCT02207244|69421043|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
37792809|NCT02207244|69421044|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
37792810|NCT02207244|69421045|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
37792811|NCT02207244|69421046|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
37792812|NCT02207244|69421047|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
37792813|NCT02207244|69421048|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
37792814|NCT02207244|69421049|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
37792815|NCT02207244|69421039|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
37792816|NCT02207244|69421040|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
37792817|NCT02207244|69421041|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
37792818|NCT02207244|69421042|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
37792819|NCT02207244|69421043|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
37792820|NCT02207244|69421044|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
37792821|NCT02207244|69421045|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
37792822|NCT02207244|69421046|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
37792823|NCT02207244|69421047|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
37792824|NCT02207244|69421048|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
37792825|NCT02207244|69421049|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
37693771|NCT01897714|69170079|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
37792826|NCT02207244|69421039|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
37792827|NCT02207244|69421040|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
37792828|NCT02207244|69421041|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
37792829|NCT02207244|69421042|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
37792830|NCT02207244|69421043|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
37792831|NCT02207244|69421044|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
37792832|NCT02207244|69421045|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
37792833|NCT02207244|69421046|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
37792834|NCT02207244|69421047|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
37792835|NCT02207244|69421048|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
37792836|NCT02207244|69421049|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
37792837|NCT02207244|69421039|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
37792838|NCT02207244|69421040|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
37792839|NCT02207244|69421041|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
37792840|NCT02207244|69421042|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
37792841|NCT02207244|69421043|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
37792842|NCT02207244|69421044|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
37792843|NCT02207244|69421045|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
37792844|NCT02207244|69421046|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
37792845|NCT02207244|69421047|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
37792846|NCT02207244|69421048|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
37792847|NCT02207244|69421049|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
37792848|NCT02207244|69421039|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
37792849|NCT02207244|69421040|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
37792850|NCT02207244|69421041|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
37792851|NCT02207244|69421042|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
37792852|NCT02207244|69421043|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
37792853|NCT02207244|69421044|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
37792854|NCT02207244|69421045|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
37792855|NCT02207244|69421046|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
37792856|NCT02207244|69421047|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
37792857|NCT02207244|69421048|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
37792858|NCT02207244|69421049|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
37792859|NCT02207244|69421039|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
37792860|NCT02207244|69421040|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
37792861|NCT02207244|69421041|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
37792862|NCT02207244|69421042|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
37792863|NCT02207244|69421043|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
37792864|NCT02207244|69421044|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
37792865|NCT02207244|69421045|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
37792866|NCT02207244|69421046|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
37792867|NCT02207244|69421047|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
37792868|NCT02207244|69421048|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
37792869|NCT02207244|69421049|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
37792870|NCT02207244|69421039|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
37792871|NCT02207244|69421040|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
37792872|NCT02207244|69421041|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
37792873|NCT02207244|69421042|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
37792874|NCT02207244|69421043|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
37792875|NCT02207244|69421044|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
37792876|NCT02207244|69421045|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
37792877|NCT02207244|69421046|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
37792878|NCT02207244|69421047|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
37792879|NCT02207244|69421048|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
37792880|NCT02207244|69421049|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
37792881|NCT02207244|69421039|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
37792882|NCT02207244|69421040|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
37864135|NCT00991276|69547778|FG001|Second Intervention Period|Protocol Violation|0|||
37864136|NCT00991276|69547779|FG002|Second Intervention Period|Protocol Violation|0|||
37792883|NCT02207244|69421041|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
37792884|NCT02207244|69421042|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
37792885|NCT02207244|69421043|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
37792886|NCT02207244|69421044|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
37792887|NCT02207244|69421045|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
37792888|NCT02207244|69421046|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
37792889|NCT02207244|69421047|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
37792890|NCT02207244|69421048|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
37792891|NCT02207244|69421049|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
37792892|NCT02207244|69421039|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
37792893|NCT02207244|69421040|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
37792894|NCT02207244|69421041|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
37792895|NCT02207244|69421042|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
37792896|NCT02207244|69421043|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
37792897|NCT02207244|69421044|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
37792898|NCT02207244|69421045|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
37792899|NCT02207244|69421046|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
37792900|NCT02207244|69421047|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
37792901|NCT02207244|69421048|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
37792902|NCT02207244|69421049|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
37792903|NCT02207244|69421039|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
37792904|NCT02207244|69421040|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
37792905|NCT02207244|69421041|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
37792906|NCT02207244|69421042|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
37792907|NCT02207244|69421043|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
37792908|NCT02207244|69421044|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
37792909|NCT02207244|69421045|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
37792910|NCT02207244|69421046|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
37792911|NCT02207244|69421047|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
37792912|NCT02207244|69421048|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
37792913|NCT02207244|69421049|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
37792914|NCT02207244|69421039|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
37792915|NCT02207244|69421040|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
37792916|NCT02207244|69421041|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
37792917|NCT02207244|69421042|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
37792918|NCT02207244|69421043|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
37792919|NCT02207244|69421044|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
37792920|NCT02207244|69421045|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
37792921|NCT02207244|69421046|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
37792922|NCT02207244|69421047|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
37792923|NCT02207244|69421048|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
37792924|NCT02207244|69421049|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
37792925|NCT02207244|69421039|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
37792926|NCT02207244|69421040|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
37792927|NCT02207244|69421041|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
37792928|NCT02207244|69421042|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
37792929|NCT02207244|69421043|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
37792930|NCT02207244|69421044|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
37792931|NCT02207244|69421045|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
37792932|NCT02207244|69421046|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
37792933|NCT02207244|69421047|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
37792934|NCT02207244|69421048|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
37792935|NCT02207244|69421049|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
37792936|NCT02207244|69421039|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
37792937|NCT02207244|69421040|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
37792938|NCT02207244|69421041|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
37792939|NCT02207244|69421042|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
37792940|NCT02207244|69421043|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
37792941|NCT02207244|69421044|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
37792942|NCT02207244|69421045|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
37792943|NCT02207244|69421046|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
37792944|NCT02207244|69421047|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
37792945|NCT02207244|69421048|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
37792946|NCT02207244|69421049|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
37792947|NCT02207244|69421039|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
37792948|NCT02207244|69421040|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
37792949|NCT02207244|69421041|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
37792950|NCT02207244|69421042|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
37792951|NCT02207244|69421043|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
37792952|NCT02207244|69421044|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
37792953|NCT02207244|69421045|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
37792954|NCT02207244|69421046|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
37792955|NCT02207244|69421047|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
37792956|NCT02207244|69421048|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
37792957|NCT02207244|69421049|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
37792958|NCT02207244|69421039|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
37792959|NCT02207244|69421040|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
37792960|NCT02207244|69421041|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
37792961|NCT02207244|69421042|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
37792962|NCT02207244|69421043|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
37792963|NCT02207244|69421044|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
37792964|NCT02207244|69421045|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
37792965|NCT02207244|69421046|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
37792966|NCT02207244|69421047|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
37792967|NCT02207244|69421048|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
37792968|NCT02207244|69421049|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
37792969|NCT02207244|69421039|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
37792970|NCT02207244|69421040|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
37792971|NCT02207244|69421041|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
37792972|NCT02207244|69421042|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
37792973|NCT02207244|69421043|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
37792974|NCT02207244|69421044|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
37792975|NCT02207244|69421045|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
37792976|NCT02207244|69421046|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
37792977|NCT02207244|69421047|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
37792978|NCT02207244|69421048|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
37792979|NCT02207244|69421049|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
37792980|NCT02207088|69421102|FG000|Overall Study|Adverse Event|2|||
37792981|NCT02206620|69421117|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
37792982|NCT02206620|69421118|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
37792983|NCT02206620|69421117|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
37792984|NCT02206620|69421118|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
37792985|NCT02239926|69421132|FG000|Overall Study|Withdrawal by Subject|0|||
37792986|NCT02239926|69421133|FG001|Overall Study|Withdrawal by Subject|1|||
37792987|NCT02239692|69421141|FG000|Overall Study|Incomplete colonoscopy|1|||
37792988|NCT02239692|69421142|FG001|Overall Study|Incomplete colonoscopy|2|||
37792989|NCT02239692|69421141|FG000|Overall Study|Adverse Event|0|||
37792990|NCT02239692|69421142|FG001|Overall Study|Adverse Event|1|||
37792991|NCT02239692|69421141|FG000|Overall Study|Physician Decision|0|||
37792992|NCT02239692|69421142|FG001|Overall Study|Physician Decision|1|||
37792993|NCT02239692|69421141|FG000|Overall Study|Lost to Follow-up|1|||
37792994|NCT02239692|69421142|FG001|Overall Study|Lost to Follow-up|4|||
37792995|NCT02239692|69421141|FG000|Overall Study|Withdrawal by Subject|3|||
37792996|NCT02239692|69421142|FG001|Overall Study|Withdrawal by Subject|5|||
37792997|NCT02239692|69421141|FG000|Overall Study|Other reason|1|||
37792998|NCT02239692|69421142|FG001|Overall Study|Other reason|0|||
37792999|NCT02206152|69421170|FG000|Pre-Randomization|Withdrawal by Subject|2|||
37793000|NCT02239536|69421178|FG000|Overall Study|Non-neoplastic polyp|23|||
37793001|NCT02239536|69421179|FG001|Overall Study|Non-neoplastic polyp|17|||
37793002|NCT02239224|69421189|FG000|Overall Study|Administrative|0|||
37793003|NCT02239224|69421190|FG001|Overall Study|Administrative|0|||
37793004|NCT02239224|69421191|FG002|Overall Study|Administrative|3|||
37793005|NCT02239224|69421192|FG003|Overall Study|Administrative|1|||
37793006|NCT01600014|69421202|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
37793007|NCT01600014|69421203|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
37793008|NCT01600014|69421202|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
37793009|NCT01600014|69421203|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
37793010|NCT01600014|69421202|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
37793011|NCT01600014|69421203|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
37793012|NCT01600014|69421202|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
37793013|NCT01600014|69421203|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
37793014|NCT01600014|69421202|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
37793015|NCT01600014|69421203|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
37793016|NCT01600014|69421202|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
37793017|NCT01600014|69421203|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
37793018|NCT01600014|69421202|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
37793019|NCT01600014|69421203|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
37793020|NCT01600014|69421202|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
37793021|NCT01600014|69421203|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
37793022|NCT01600014|69421202|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
37793023|NCT01600014|69421203|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
37793024|NCT01600014|69421202|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
37793025|NCT01600014|69421203|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
37793026|NCT01600014|69421202|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
37793027|NCT01600014|69421203|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
37793028|NCT01600014|69421202|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
37793029|NCT01600014|69421203|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
37793030|NCT01600014|69421202|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
37793031|NCT01600014|69421203|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
37793032|NCT01600014|69421202|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
37793033|NCT01600014|69421203|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
37793034|NCT01600014|69421202|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
37793035|NCT01600014|69421203|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
37793036|NCT01600014|69421202|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
37793037|NCT01600014|69421203|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
37793038|NCT01600014|69421202|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
37793039|NCT01600014|69421203|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
37793040|NCT02237196|69421225|FG000|Overall Study|Adverse Event|0|||
37793041|NCT02237196|69421226|FG001|Overall Study|Adverse Event|1|||
37793042|NCT02237196|69421227|FG002|Overall Study|Adverse Event|1|||
37793043|NCT02237196|69421228|FG003|Overall Study|Adverse Event|0|||
37793044|NCT02237196|69421225|FG000|Overall Study|Lost to Follow-up|4|||
37793045|NCT02237196|69421226|FG001|Overall Study|Lost to Follow-up|2|||
37793046|NCT02237196|69421227|FG002|Overall Study|Lost to Follow-up|4|||
37793047|NCT02237196|69421228|FG003|Overall Study|Lost to Follow-up|6|||
37793048|NCT02237196|69421225|FG000|Overall Study|Physician Decision|2|||
37793049|NCT02237196|69421226|FG001|Overall Study|Physician Decision|0|||
37793050|NCT02237196|69421227|FG002|Overall Study|Physician Decision|0|||
37793051|NCT02237196|69421228|FG003|Overall Study|Physician Decision|1|||
37793052|NCT02237196|69421225|FG000|Overall Study|Pregnancy|0|||
37793053|NCT02237196|69421226|FG001|Overall Study|Pregnancy|0|||
37793054|NCT02237196|69421227|FG002|Overall Study|Pregnancy|1|||
37793055|NCT02237196|69421228|FG003|Overall Study|Pregnancy|1|||
37793056|NCT02237196|69421225|FG000|Overall Study|Withdrawal by Subject|1|||
37864137|NCT00991276|69547780|FG003|Second Intervention Period|Protocol Violation|0|||
37864138|NCT00991276|69547781|FG004|Second Intervention Period|Protocol Violation|0|||
37864139|NCT00991276|69547782|FG005|Second Intervention Period|Protocol Violation|0|||
37864140|NCT00991276|69547777|FG000|Second Intervention Period|Other|0|||
37864141|NCT00991276|69547778|FG001|Second Intervention Period|Other|0|||
37864142|NCT00991276|69547779|FG002|Second Intervention Period|Other|0|||
37864143|NCT00991276|69547780|FG003|Second Intervention Period|Other|1|||
37864144|NCT00991276|69547781|FG004|Second Intervention Period|Other|0|||
37793057|NCT02237196|69421226|FG001|Overall Study|Withdrawal by Subject|1|||
37793058|NCT02237196|69421227|FG002|Overall Study|Withdrawal by Subject|4|||
37793059|NCT02237196|69421228|FG003|Overall Study|Withdrawal by Subject|1|||
37793060|NCT02237196|69421225|FG000|Overall Study|Site Error|1|||
37793061|NCT02237196|69421226|FG001|Overall Study|Site Error|2|||
37864145|NCT00991276|69547782|FG005|Second Intervention Period|Other|1|||
37864146|NCT00991276|69547777|FG000|Third Intervention Period|Protocol Violation|1|||
37864147|NCT00991276|69547778|FG001|Third Intervention Period|Protocol Violation|0|||
37864148|NCT00991276|69547779|FG002|Third Intervention Period|Protocol Violation|0|||
37975558|NCT00556439|69662838|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
37793062|NCT02237196|69421227|FG002|Overall Study|Site Error|0|||
37793063|NCT02237196|69421228|FG003|Overall Study|Site Error|2|||
37793064|NCT02237118|69421244|FG000|Overall Study|Protocol Violation|0|||
37793065|NCT02237118|69421245|FG001|Overall Study|Protocol Violation|1|||
37793066|NCT02237118|69421244|FG000|Overall Study|consent withdrawn|1|||
37793067|NCT02237118|69421245|FG001|Overall Study|consent withdrawn|0|||
37793068|NCT02234622|69421261|FG000|Overall Study|Withdrawal by Subject|16|||
37793069|NCT02234622|69421262|FG001|Overall Study|Withdrawal by Subject|22|||
37975559|NCT00556439|69662835|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
37793070|NCT02234622|69421261|FG000|Overall Study|Lost to Follow-up|27|||
37793071|NCT02234622|69421262|FG001|Overall Study|Lost to Follow-up|14|||
37793072|NCT02203032|69421270|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
37793073|NCT02203032|69421271|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
37793074|NCT02203032|69421272|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
37793075|NCT02203032|69421273|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
37793076|NCT02203032|69421270|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
37793077|NCT02203032|69421271|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
37793078|NCT02203032|69421272|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
37793079|NCT02203032|69421273|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
37793080|NCT02203032|69421270|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
37793081|NCT02203032|69421271|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
37793082|NCT02203032|69421272|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
37793083|NCT02203032|69421273|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
37793084|NCT02203032|69421270|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
37793085|NCT02203032|69421271|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
37793086|NCT02203032|69421272|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
37793087|NCT02203032|69421273|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
37793088|NCT02203032|69421270|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
37793089|NCT02203032|69421271|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
37793090|NCT02203032|69421272|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
37793091|NCT02203032|69421273|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
37793092|NCT02203032|69421270|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
37793093|NCT02203032|69421271|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
37793094|NCT02203032|69421272|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
37793095|NCT02203032|69421273|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
37793096|NCT02203032|69421270|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
37793097|NCT02203032|69421271|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
37793098|NCT02203032|69421272|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
37793099|NCT02203032|69421273|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
37793100|NCT02203032|69421270|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
37793101|NCT02203032|69421271|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
37793102|NCT02203032|69421272|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
37793103|NCT02203032|69421273|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
37793104|NCT02203032|69421270|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
37793105|NCT02203032|69421271|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
37793106|NCT02203032|69421272|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
37793107|NCT02203032|69421273|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
37793108|NCT02203032|69421270|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
37793109|NCT02203032|69421271|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
37975560|NCT00556439|69662836|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
37975561|NCT00556439|69662837|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
37975562|NCT00556439|69662838|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
37864149|NCT00991276|69547780|FG003|Third Intervention Period|Protocol Violation|0|||
37864150|NCT00991276|69547781|FG004|Third Intervention Period|Protocol Violation|0|||
37793110|NCT02203032|69421272|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
37793111|NCT02203032|69421273|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
37793112|NCT02203032|69421270|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
37793113|NCT02203032|69421271|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
37793114|NCT02203032|69421272|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
37793115|NCT02203032|69421273|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
37793116|NCT02203032|69421270|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
37793117|NCT02203032|69421271|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
37793118|NCT02203032|69421272|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
37793119|NCT02203032|69421273|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
37793120|NCT02169414|69421285|FG000|Overall Study|Withdrawal by Subject|1|||
37864151|NCT00991276|69547782|FG005|Third Intervention Period|Protocol Violation|0|||
37864152|NCT00991276|69547777|FG000|Third Intervention Period|Other|0|||
37793121|NCT02169414|69421286|FG001|Overall Study|Withdrawal by Subject|0|||
37793122|NCT02169414|69421287|FG002|Overall Study|Withdrawal by Subject|0|||
37793123|NCT02169414|69421288|FG003|Overall Study|Withdrawal by Subject|0|||
37793124|NCT02169414|69421285|FG000|Overall Study|Adverse Event|0|||
37793125|NCT02169414|69421286|FG001|Overall Study|Adverse Event|1|||
37793126|NCT02169414|69421287|FG002|Overall Study|Adverse Event|0|||
37793127|NCT02169414|69421288|FG003|Overall Study|Adverse Event|0|||
37793128|NCT03213457|69421305|FG000|Overall Study|Not Treated|1|||
37793129|NCT03213457|69421306|FG001|Overall Study|Not Treated|1|||
37793130|NCT03213457|69421307|FG002|Overall Study|Not Treated|0|||
37793131|NCT03213457|69421305|FG000|Overall Study|Adverse Event|16|||
37793132|NCT03213457|69421306|FG001|Overall Study|Adverse Event|9|||
37793133|NCT03213457|69421307|FG002|Overall Study|Adverse Event|41|||
37793134|NCT03213457|69421305|FG000|Overall Study|Non-Compliance With Study Drug|1|||
37793135|NCT03213457|69421306|FG001|Overall Study|Non-Compliance With Study Drug|2|||
37793136|NCT03213457|69421307|FG002|Overall Study|Non-Compliance With Study Drug|7|||
37793137|NCT03213457|69421305|FG000|Overall Study|Non-Compliance Other, Not Specified|0|||
37793138|NCT03213457|69421306|FG001|Overall Study|Non-Compliance Other, Not Specified|1|||
37793139|NCT03213457|69421307|FG002|Overall Study|Non-Compliance Other, Not Specified|5|||
37793140|NCT03213457|69421305|FG000|Overall Study|Withdrawal by Subject|18|||
37793141|NCT03213457|69421306|FG001|Overall Study|Withdrawal by Subject|7|||
37793142|NCT03213457|69421307|FG002|Overall Study|Withdrawal by Subject|35|||
37793143|NCT03213457|69421305|FG000|Overall Study|Lost to Follow-up|12|||
37793144|NCT03213457|69421306|FG001|Overall Study|Lost to Follow-up|12|||
37793145|NCT03213457|69421307|FG002|Overall Study|Lost to Follow-up|33|||
37793146|NCT03213457|69421305|FG000|Overall Study|Pregnancy|11|||
37793147|NCT03213457|69421306|FG001|Overall Study|Pregnancy|0|||
37793148|NCT03213457|69421307|FG002|Overall Study|Pregnancy|7|||
37793149|NCT03213457|69421305|FG000|Overall Study|Protocol Violation|1|||
37793150|NCT03213457|69421306|FG001|Overall Study|Protocol Violation|1|||
37793151|NCT03213457|69421307|FG002|Overall Study|Protocol Violation|6|||
37793152|NCT03213457|69421305|FG000|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|4|||
37793153|NCT03213457|69421306|FG001|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|0|||
37793154|NCT03213457|69421307|FG002|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|2|||
37793155|NCT03213457|69421305|FG000|Overall Study|Dual Energy X-Ray Absorptiometry Finding|1|||
37793156|NCT03213457|69421306|FG001|Overall Study|Dual Energy X-Ray Absorptiometry Finding|1|||
37793157|NCT03213457|69421307|FG002|Overall Study|Dual Energy X-Ray Absorptiometry Finding|3|||
37793158|NCT03213457|69421305|FG000|Overall Study|Lack of Efficacy|12|||
37793159|NCT03213457|69421306|FG001|Overall Study|Lack of Efficacy|2|||
37793160|NCT03213457|69421307|FG002|Overall Study|Lack of Efficacy|9|||
37793161|NCT03213457|69421305|FG000|Overall Study|Other, Not Specified|11|||
37793162|NCT03213457|69421306|FG001|Overall Study|Other, Not Specified|3|||
37793163|NCT03213457|69421307|FG002|Overall Study|Other, Not Specified|26|||
37793164|NCT02201940|69421317|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
37793165|NCT02201940|69421318|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
37793166|NCT02201940|69421317|FG000|Overall Study|Lack of Efficacy|2|||
37793167|NCT02201940|69421318|FG001|Overall Study|Lack of Efficacy|113|||
37793168|NCT02201940|69421317|FG000|Overall Study|Lost to Follow-up|5|||
37793169|NCT02201940|69421318|FG001|Overall Study|Lost to Follow-up|0|||
37793170|NCT02201940|69421317|FG000|Overall Study|Withdrew Consent|2|||
37793171|NCT02201940|69421318|FG001|Overall Study|Withdrew Consent|1|||
37793172|NCT02201940|69421317|FG000|Overall Study|Investigator's Discretion|1|||
37793173|NCT02201940|69421318|FG001|Overall Study|Investigator's Discretion|1|||
37793174|NCT02201940|69421317|FG000|Overall Study|Death|1|||
37793175|NCT02201940|69421318|FG001|Overall Study|Death|0|||
37793176|NCT02201940|69421317|FG000|Overall Study|Adverse Event|0|||
37793177|NCT02201940|69421318|FG001|Overall Study|Adverse Event|1|||
37793178|NCT02232984|69421324|FG000|Overall Study|Withdrawal by Subject|5|||
37793179|NCT02232984|69421324|FG000|Overall Study|Death|1|||
37793180|NCT02232984|69421324|FG000|Overall Study|Investigator withdrawal|10|||
37793181|NCT02232984|69421324|FG000|Overall Study|Device implant unsuccessful|53|||
37793182|NCT02232984|69421324|FG000|Overall Study|not disclosed by site|7|||
37793183|NCT02232984|69421324|FG000|Overall Study|Protocol Violation|1|||
37793184|NCT02169336|69421334|FG000|Overall Study|Lack of Efficacy|1|||
37793185|NCT02169336|69421335|FG001|Overall Study|Lack of Efficacy|1|||
37793186|NCT02169336|69421336|FG002|Overall Study|Lack of Efficacy|0|||
37793187|NCT02169336|69421334|FG000|Overall Study|Adverse Event|2|||
37793188|NCT02169336|69421335|FG001|Overall Study|Adverse Event|3|||
37793189|NCT02169336|69421336|FG002|Overall Study|Adverse Event|1|||
37793190|NCT02169336|69421334|FG000|Overall Study|Withdrawal by Subject|1|||
37793191|NCT02169336|69421335|FG001|Overall Study|Withdrawal by Subject|0|||
37793192|NCT02169336|69421336|FG002|Overall Study|Withdrawal by Subject|0|||
37793193|NCT02169336|69421334|FG000|Overall Study|Physician Decision|0|||
37793194|NCT02169336|69421335|FG001|Overall Study|Physician Decision|0|||
37793195|NCT02169336|69421336|FG002|Overall Study|Physician Decision|1|||
37793196|NCT02169336|69421334|FG000|Overall Study|Subject declined to continue dosing|0|||
37793197|NCT02169336|69421335|FG001|Overall Study|Subject declined to continue dosing|0|||
37793198|NCT02169336|69421336|FG002|Overall Study|Subject declined to continue dosing|1|||
37793199|NCT02609828|69421352|FG000|Overall Study|Adverse Event|8|||
37793200|NCT02609828|69421353|FG001|Overall Study|Adverse Event|1|||
37793201|NCT02609828|69421354|FG002|Overall Study|Adverse Event|0|||
37793202|NCT02609828|69421355|FG003|Overall Study|Adverse Event|6|||
37793203|NCT02609828|69421352|FG000|Overall Study|Death|15|||
37793204|NCT02609828|69421353|FG001|Overall Study|Death|1|||
37793205|NCT02609828|69421354|FG002|Overall Study|Death|1|||
37793206|NCT02609828|69421355|FG003|Overall Study|Death|19|||
37793207|NCT02609828|69421352|FG000|Overall Study|Insufficient clinical response|2|||
37793208|NCT02609828|69421353|FG001|Overall Study|Insufficient clinical response|1|||
37793209|NCT02609828|69421354|FG002|Overall Study|Insufficient clinical response|0|||
37793210|NCT02609828|69421355|FG003|Overall Study|Insufficient clinical response|0|||
37793211|NCT02609828|69421352|FG000|Overall Study|Lost to Follow-up|0|||
37793212|NCT02609828|69421353|FG001|Overall Study|Lost to Follow-up|0|||
37793213|NCT02609828|69421354|FG002|Overall Study|Lost to Follow-up|0|||
37793214|NCT02609828|69421355|FG003|Overall Study|Lost to Follow-up|1|||
37793215|NCT02609828|69421352|FG000|Overall Study|Protocol Violation|2|||
37793216|NCT02609828|69421353|FG001|Overall Study|Protocol Violation|0|||
37793217|NCT02609828|69421354|FG002|Overall Study|Protocol Violation|0|||
37793218|NCT02609828|69421355|FG003|Overall Study|Protocol Violation|1|||
37793219|NCT02609828|69421352|FG000|Overall Study|Withdrawal by Subject|12|||
37793220|NCT02609828|69421353|FG001|Overall Study|Withdrawal by Subject|1|||
37793221|NCT02609828|69421354|FG002|Overall Study|Withdrawal by Subject|0|||
37793222|NCT02609828|69421355|FG003|Overall Study|Withdrawal by Subject|10|||
37793223|NCT02609828|69421352|FG000|Overall Study|Other|3|||
37793224|NCT02609828|69421353|FG001|Overall Study|Other|0|||
37793225|NCT02609828|69421354|FG002|Overall Study|Other|0|||
37793226|NCT02609828|69421355|FG003|Overall Study|Other|6|||
37793227|NCT02609828|69421352|FG000|Overall Study|Randomized but not treated|1|||
37693772|NCT01897714|69170080|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
37793228|NCT02609828|69421353|FG001|Overall Study|Randomized but not treated|0|||
37793229|NCT02609828|69421354|FG002|Overall Study|Randomized but not treated|0|||
37793230|NCT02609828|69421355|FG003|Overall Study|Randomized but not treated|0|||
37793231|NCT01632306|69421371|FG000|Overall Study|Protocol Violation|1|||
37793232|NCT01632306|69421372|FG001|Overall Study|Protocol Violation|0|||
37793233|NCT01632306|69421373|FG002|Overall Study|Protocol Violation|0|||
37793234|NCT02201784|69421381|FG000|Overall Study|Failure to achieve adequate block|2|||
37793235|NCT02201784|69421382|FG001|Overall Study|Failure to achieve adequate block|0|||
37793236|NCT02201472|69421388|FG000|Overall Study|Lack of Efficacy|2|||
37793237|NCT02168946|69421433|FG000|Overall Study|Adverse Event|8|||
37793238|NCT02168946|69421434|FG001|Overall Study|Adverse Event|5|||
37793239|NCT02168946|69421433|FG000|Overall Study|Lost to Follow-up|3|||
37793240|NCT02168946|69421434|FG001|Overall Study|Lost to Follow-up|0|||
37793241|NCT02168946|69421433|FG000|Overall Study|Subject unable to come back for visits|1|||
37793242|NCT02168946|69421434|FG001|Overall Study|Subject unable to come back for visits|0|||
37793243|NCT02168478|69421455|FG000|Overall Study|Withdrawal by Subject|1|||
37793244|NCT02168478|69421455|FG000|Overall Study|Did Not Consent to Participation|2|||
37793245|NCT02168478|69421455|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
37793246|NCT02200614|69422606|FG000|Double Blind Treatment|Adverse Event|86|||
37793247|NCT02200614|69422607|FG001|Double Blind Treatment|Adverse Event|48|||
37793248|NCT02200614|69422606|FG000|Double Blind Treatment|Confirmed metastasis|120|||
37793249|NCT02200614|69422607|FG001|Double Blind Treatment|Confirmed metastasis|140|||
37793250|NCT02200614|69422606|FG000|Double Blind Treatment|Judgment of the investigator|59|||
37793251|NCT02200614|69422607|FG001|Double Blind Treatment|Judgment of the investigator|99|||
37793252|NCT02200614|69422606|FG000|Double Blind Treatment|Metastasis by local reading|1|||
37793253|NCT02200614|69422607|FG001|Double Blind Treatment|Metastasis by local reading|3|||
37793254|NCT02200614|69422606|FG000|Double Blind Treatment|Other reason|6|||
37793255|NCT02200614|69422607|FG001|Double Blind Treatment|Other reason|2|||
37793256|NCT02200614|69422606|FG000|Double Blind Treatment|Personal reason|77|||
37793257|NCT02200614|69422607|FG001|Double Blind Treatment|Personal reason|85|||
37793258|NCT02200614|69422606|FG000|Double Blind Treatment|Protocol deviation|14|||
37793259|NCT02200614|69422607|FG001|Double Blind Treatment|Protocol deviation|7|||
37793260|NCT02200614|69422606|FG000|Double Blind Treatment|Not treated|1|||
37793261|NCT02200614|69422607|FG001|Double Blind Treatment|Not treated|0|||
37793262|NCT02200614|69422606|FG000|Open Label|Adverse Event|41|||
37793263|NCT02200614|69422607|FG001|Open Label|Adverse Event|11|||
37793264|NCT02200614|69422606|FG000|Open Label|Confirmed metastasis|1|||
37793265|NCT02200614|69422607|FG001|Open Label|Confirmed metastasis|0|||
37793266|NCT02200614|69422606|FG000|Open Label|Judgment of the investigator|29|||
37793267|NCT02200614|69422607|FG001|Open Label|Judgment of the investigator|2|||
37793268|NCT02200614|69422606|FG000|Open Label|Metastasis by local reading|138|||
37793269|NCT02200614|69422607|FG001|Open Label|Metastasis by local reading|27|||
37793270|NCT02200614|69422606|FG000|Open Label|Other reason|22|||
37793271|NCT02200614|69422607|FG001|Open Label|Other reason|4|||
37793272|NCT02200614|69422606|FG000|Open Label|Personal reason|60|||
37793273|NCT02200614|69422607|FG001|Open Label|Personal reason|8|||
37793274|NCT02200614|69422606|FG000|Open Label|Protocol deviation|3|||
37793275|NCT02200614|69422607|FG001|Open Label|Protocol deviation|2|||
37793276|NCT02200614|69422606|FG000|Open Label|Missing|2|||
37793277|NCT02200614|69422607|FG001|Open Label|Missing|2|||
37793278|NCT02231892|69422618|FG000|Overall Study|Lost to Follow-up|1|||
37793279|NCT02231892|69422619|FG001|Overall Study|Lost to Follow-up|0|||
37793280|NCT02231892|69422620|FG002|Overall Study|Lost to Follow-up|3|||
37793281|NCT02231892|69422618|FG000|Overall Study|Withdrawal by Subject|4|||
37793282|NCT02231892|69422619|FG001|Overall Study|Withdrawal by Subject|3|||
37793283|NCT02231892|69422620|FG002|Overall Study|Withdrawal by Subject|15|||
37793284|NCT02231892|69422618|FG000|Overall Study|Physician Decision|0|||
37793285|NCT02231892|69422619|FG001|Overall Study|Physician Decision|2|||
37793286|NCT02231892|69422620|FG002|Overall Study|Physician Decision|4|||
37793287|NCT02231892|69422618|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
37793288|NCT02231892|69422619|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
37793289|NCT02231892|69422620|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
37793290|NCT02231892|69422618|FG000|Overall Study|Participant motor threshold was >83%|0|||
37793291|NCT02231892|69422619|FG001|Overall Study|Participant motor threshold was >83%|0|||
37793292|NCT02231892|69422620|FG002|Overall Study|Participant motor threshold was >83%|9|||
37793293|NCT02231892|69422618|FG000|Overall Study|Could not find motor threshold|2|||
37793294|NCT02231892|69422619|FG001|Overall Study|Could not find motor threshold|0|||
37793295|NCT02231892|69422620|FG002|Overall Study|Could not find motor threshold|1|||
37793296|NCT02231892|69422618|FG000|Overall Study|Could not find reliable motor hotspot|0|||
37793297|NCT02231892|69422619|FG001|Overall Study|Could not find reliable motor hotspot|0|||
37793298|NCT02231892|69422620|FG002|Overall Study|Could not find reliable motor hotspot|1|||
37793299|NCT02231580|69422636|FG000|Overall Study|Adverse Event|5|||
37793300|NCT02231580|69422637|FG001|Overall Study|Adverse Event|0|||
37793301|NCT02166606|69422645|FG000|Overall Study|Adverse Event|3|||
37793302|NCT02166606|69422645|FG000|Overall Study|Death|31|||
37793303|NCT02166606|69422645|FG000|Overall Study|Protocol Violation|7|||
37793304|NCT02166606|69422645|FG000|Overall Study|Lost to Follow-up|30|||
37793305|NCT02166606|69422645|FG000|Overall Study|Withdrawal by Subject|1|||
37793306|NCT02166606|69422645|FG000|Overall Study|Physician Decision|1|||
37793307|NCT02166606|69422645|FG000|Overall Study|Device upgrade|1|||
37793308|NCT02166606|69422645|FG000|Overall Study|Enrolled after End of Enrollment|4|||
37793309|NCT02230956|69422652|FG000|Overall Study|Adverse Event|1|||
37793310|NCT02230956|69422653|FG001|Overall Study|Adverse Event|1|||
37793311|NCT02230956|69422654|FG002|Overall Study|Adverse Event|0|||
37793312|NCT02230956|69422652|FG000|Overall Study|Lack of Efficacy|1|||
37793313|NCT02230956|69422653|FG001|Overall Study|Lack of Efficacy|1|||
37793314|NCT02230956|69422654|FG002|Overall Study|Lack of Efficacy|1|||
37793315|NCT02230956|69422652|FG000|Overall Study|Lost to Follow-up|1|||
37793316|NCT02230956|69422653|FG001|Overall Study|Lost to Follow-up|1|||
37793317|NCT02230956|69422654|FG002|Overall Study|Lost to Follow-up|2|||
37793318|NCT02230956|69422652|FG000|Overall Study|Personal Reasons|2|||
37793319|NCT02230956|69422653|FG001|Overall Study|Personal Reasons|1|||
37793320|NCT02230956|69422654|FG002|Overall Study|Personal Reasons|1|||
37793321|NCT02230956|69422652|FG000|Overall Study|Protocol Violation|0|||
37793322|NCT02230956|69422653|FG001|Overall Study|Protocol Violation|1|||
37793323|NCT02230956|69422654|FG002|Overall Study|Protocol Violation|1|||
37793324|NCT02230956|69422652|FG000|Overall Study|Other Miscellaneous Reason|0|||
37793325|NCT02230956|69422653|FG001|Overall Study|Other Miscellaneous Reason|1|||
37793326|NCT02230956|69422654|FG002|Overall Study|Other Miscellaneous Reason|2|||
37793327|NCT02230410|69422662|FG000|Overall Study|Screen Failure|3|||
37793328|NCT02230332|69422668|FG000|Overall Study|Adverse Event|2|||
37793329|NCT02230332|69422669|FG001|Overall Study|Adverse Event|1|||
37793330|NCT02230332|69422668|FG000|Overall Study|Lost to Follow-up|1|||
37793331|NCT02230332|69422669|FG001|Overall Study|Lost to Follow-up|0|||
37793332|NCT02230332|69422668|FG000|Overall Study|Protocol Violation|1|||
37793333|NCT02230332|69422669|FG001|Overall Study|Protocol Violation|0|||
37793334|NCT02230254|69422675|FG000|Overall Study|Lost to Follow-up|3|||
37793335|NCT02198664|69422681|FG000|Overall Study|Adverse Event|2|||
37793336|NCT02198664|69422682|FG001|Overall Study|Adverse Event|0|||
37793337|NCT02198664|69422681|FG000|Overall Study|Withdrawal by Subject|11|||
37793338|NCT02198664|69422682|FG001|Overall Study|Withdrawal by Subject|8|||
37793339|NCT02198664|69422681|FG000|Overall Study|Failure to tolerate|2|||
37793340|NCT02198664|69422682|FG001|Overall Study|Failure to tolerate|0|||
37793341|NCT02198664|69422681|FG000|Overall Study|Not stated|1|||
37793342|NCT02198664|69422682|FG001|Overall Study|Not stated|0|||
37793343|NCT02165826|69422693|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
37793344|NCT02165826|69422694|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
37793345|NCT02165826|69422695|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
37793346|NCT02165826|69422693|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
37793347|NCT02165826|69422694|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
37793348|NCT02165826|69422695|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
37793349|NCT02165826|69422693|FG000|Main Treatment Period|Lost to Follow-up|4|||
37793350|NCT02165826|69422694|FG001|Main Treatment Period|Lost to Follow-up|2|||
37793351|NCT02165826|69422695|FG002|Main Treatment Period|Lost to Follow-up|1|||
37793352|NCT02165826|69422693|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
37793353|NCT02165826|69422694|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
37793354|NCT02165826|69422695|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
37793355|NCT02165826|69422693|FG000|Main Treatment Period|Lack of Efficacy|2|||
37793356|NCT02165826|69422694|FG001|Main Treatment Period|Lack of Efficacy|0|||
37793357|NCT02165826|69422695|FG002|Main Treatment Period|Lack of Efficacy|0|||
37793358|NCT02165826|69422693|FG000|Main Treatment Period|Reason Not Specified|8|||
37793359|NCT02165826|69422694|FG001|Main Treatment Period|Reason Not Specified|5|||
37793360|NCT02165826|69422695|FG002|Main Treatment Period|Reason Not Specified|16|||
37793361|NCT02165826|69422693|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
37793362|NCT02165826|69422694|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
37793363|NCT02165826|69422695|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
37793364|NCT02165826|69422693|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
37793365|NCT02165826|69422694|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
37793366|NCT02165826|69422695|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
37793367|NCT02165826|69422693|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
37793368|NCT02165826|69422694|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
37793369|NCT02165826|69422695|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
37793370|NCT02165826|69422693|FG000|Down-Titration Period|Reason Not Specified|1|||
37793371|NCT02165826|69422694|FG001|Down-Titration Period|Reason Not Specified|0|||
37793372|NCT02165826|69422695|FG002|Down-Titration Period|Reason Not Specified|2|||
37793373|NCT02198040|69422732|FG000|Overall Study|Work reasons|0|||
37793374|NCT02198040|69422733|FG001|Overall Study|Work reasons|1|||
37793375|NCT02198040|69422734|FG002|Overall Study|Work reasons|0|||
37793376|NCT02198040|69422732|FG000|Overall Study|Withdrawal by Subject|0|||
37793377|NCT02198040|69422733|FG001|Overall Study|Withdrawal by Subject|0|||
37793378|NCT02198040|69422734|FG002|Overall Study|Withdrawal by Subject|1|||
37793379|NCT02197806|69422748|FG000|Overall Study|Adverse Event|0|||
37793380|NCT02197806|69422749|FG001|Overall Study|Adverse Event|1|||
37793381|NCT02197806|69422750|FG002|Overall Study|Adverse Event|0|||
37793382|NCT02197806|69422751|FG003|Overall Study|Adverse Event|1|||
37793383|NCT02229864|69422798|FG000|Overall Study|Death|2|||
37793384|NCT02229864|69422798|FG000|Overall Study|Lost to Follow-up|1|||
37793385|NCT02229552|69422802|FG000|Baseline|Withdrawal by Subject|6|||
37793386|NCT02229552|69422802|FG000|1-year Follow up|Withdrawal by Subject|7|||
37793387|NCT02229552|69422802|FG000|1-year Follow up|Lost to Follow-up|18|||
37793388|NCT02229552|69422802|FG000|2-Year Follow up|Withdrawal by Subject|9|||
37793389|NCT02229552|69422802|FG000|2-Year Follow up|Lost to Follow-up|17|||
37793390|NCT02229396|69422809|FG000|Overall Study|Adverse Event|6|||
37793391|NCT02229396|69422810|FG001|Overall Study|Adverse Event|12|||
37793392|NCT02229396|69422811|FG002|Overall Study|Adverse Event|12|||
37864153|NCT00991276|69547778|FG001|Third Intervention Period|Other|0|||
37864154|NCT00991276|69547779|FG002|Third Intervention Period|Other|0|||
37975563|NCT00556439|69662835|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
37975564|NCT00556439|69662836|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
37793393|NCT02229396|69422809|FG000|Overall Study|Death|2|||
37793394|NCT02229396|69422810|FG001|Overall Study|Death|3|||
37793395|NCT02229396|69422811|FG002|Overall Study|Death|1|||
37793396|NCT02229396|69422809|FG000|Overall Study|Lost to Follow-up|14|||
37793397|NCT02229396|69422810|FG001|Overall Study|Lost to Follow-up|14|||
37864155|NCT00991276|69547780|FG003|Third Intervention Period|Other|0|||
37864156|NCT00991276|69547781|FG004|Third Intervention Period|Other|0|||
37793398|NCT02229396|69422811|FG002|Overall Study|Lost to Follow-up|21|||
37793399|NCT02229396|69422809|FG000|Overall Study|Protocol Violation|2|||
37793400|NCT02229396|69422810|FG001|Overall Study|Protocol Violation|1|||
37793401|NCT02229396|69422811|FG002|Overall Study|Protocol Violation|0|||
37793402|NCT02229396|69422809|FG000|Overall Study|Patient Incorrectly Randomized|0|||
37793403|NCT02229396|69422810|FG001|Overall Study|Patient Incorrectly Randomized|0|||
37793404|NCT02229396|69422811|FG002|Overall Study|Patient Incorrectly Randomized|1|||
37793405|NCT02229396|69422809|FG000|Overall Study|Other|10|||
37793406|NCT02229396|69422810|FG001|Overall Study|Other|18|||
37793407|NCT02229396|69422811|FG002|Overall Study|Other|15|||
37793408|NCT02229396|69422809|FG000|Overall Study|Withdrawal by Subject|42|||
37793409|NCT02229396|69422810|FG001|Overall Study|Withdrawal by Subject|28|||
37793410|NCT02229396|69422811|FG002|Overall Study|Withdrawal by Subject|41|||
37793411|NCT02229396|69422809|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
37793412|NCT02229396|69422810|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
37793413|NCT02229396|69422811|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
37793414|NCT02229396|69422809|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
37793415|NCT02229396|69422810|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
37793416|NCT02229396|69422811|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
37793417|NCT02197416|69422826|FG000|Overall Study|Other reasons|0|||
37793418|NCT02197416|69422827|FG001|Overall Study|Other reasons|2|||
37793419|NCT02197416|69422828|FG002|Overall Study|Other reasons|5|||
37793420|NCT02197416|69422826|FG000|Overall Study|Withdrawal by Subject|0|||
37793421|NCT02197416|69422827|FG001|Overall Study|Withdrawal by Subject|2|||
37793422|NCT02197416|69422828|FG002|Overall Study|Withdrawal by Subject|1|||
37793423|NCT02197416|69422826|FG000|Overall Study|Protocol Violation|1|||
37793424|NCT02197416|69422827|FG001|Overall Study|Protocol Violation|0|||
37793425|NCT02197416|69422828|FG002|Overall Study|Protocol Violation|1|||
37793426|NCT02197416|69422826|FG000|Overall Study|Adverse Event|0|||
37793427|NCT02197416|69422827|FG001|Overall Study|Adverse Event|0|||
37793428|NCT02197416|69422828|FG002|Overall Study|Adverse Event|1|||
37793429|NCT02165202|69422836|FG000|Oral Phase|Refused further participation|5|||
37793430|NCT02165202|69422837|FG001|Oral Phase|Refused further participation|1|||
37793431|NCT02165202|69422836|FG000|Oral Phase|Study product Related Toxicity|1|||
37793432|NCT02165202|69422837|FG001|Oral Phase|Study product Related Toxicity|0|||
37793433|NCT02165202|69422836|FG000|Oral Phase|Unable to contact Participant|1|||
37793434|NCT02165202|69422837|FG001|Oral Phase|Unable to contact Participant|1|||
37793435|NCT02165202|69422836|FG000|Oral Phase|Clinical reasons|1|||
37793436|NCT02165202|69422837|FG001|Oral Phase|Clinical reasons|0|||
37793437|NCT02165202|69422836|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
37793438|NCT02165202|69422837|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
37793439|NCT02165202|69422836|FG000|Oral Phase|CMC advised termination|1|||
37793440|NCT02165202|69422837|FG001|Oral Phase|CMC advised termination|0|||
37793441|NCT02165202|69422836|FG000|Oral Phase|Relocated, no follow-up planned|1|||
37793442|NCT02165202|69422837|FG001|Oral Phase|Relocated, no follow-up planned|0|||
37793443|NCT02165202|69422836|FG000|Oral Phase|Abnormal EKG|0|||
37793444|NCT02165202|69422837|FG001|Oral Phase|Abnormal EKG|1|||
37793445|NCT02165202|69422836|FG000|Injection Phase|Abnormal Lab Value|5|||
37793446|NCT02165202|69422837|FG001|Injection Phase|Abnormal Lab Value|1|||
37793447|NCT02165202|69422836|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
37793448|NCT02165202|69422837|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
37793449|NCT02165202|69422836|FG000|Injection Phase|Unable to attend within Visit Window|1|||
37793450|NCT02165202|69422837|FG001|Injection Phase|Unable to attend within Visit Window|0|||
37793451|NCT02165202|69422836|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
37793452|NCT02165202|69422837|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
37793453|NCT02165202|69422836|FG000|Injection Phase|End of Study|2|||
37793454|NCT02165202|69422837|FG001|Injection Phase|End of Study|1|||
37793455|NCT02165202|69422836|FG000|Injection Phase|Study Product related Toxicity|1|||
37793456|NCT02165202|69422837|FG001|Injection Phase|Study Product related Toxicity|0|||
37793457|NCT02165202|69422836|FG000|Injection Phase|No longer interested|0|||
37793458|NCT02165202|69422837|FG001|Injection Phase|No longer interested|1|||
37793459|NCT02165202|69422836|FG000|Injection Phase|Participant unwilling to comply|1|||
37793460|NCT02165202|69422837|FG001|Injection Phase|Participant unwilling to comply|0|||
37793461|NCT01628874|69422845|FG000|Overall Study|Physician Decision|1|||
37793462|NCT01628874|69422846|FG001|Overall Study|Physician Decision|1|||
37793463|NCT01628874|69422845|FG000|Overall Study|Age >4 months|4|||
37793464|NCT01628874|69422846|FG001|Overall Study|Age >4 months|2|||
37793465|NCT02196714|69422871|FG000|Overall Study|Protocol Violation|0|||
37793466|NCT02196714|69422872|FG001|Overall Study|Protocol Violation|0|||
37793467|NCT02196714|69422873|FG002|Overall Study|Protocol Violation|1|||
37793468|NCT02196714|69422874|FG003|Overall Study|Protocol Violation|0|||
37793469|NCT02196558|69422898|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
37793470|NCT02196558|69422899|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
37793471|NCT02196558|69422900|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
37793472|NCT02196558|69422898|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
37793473|NCT02196558|69422899|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
37793474|NCT02196558|69422900|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
37793475|NCT02196558|69422898|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
37793476|NCT02196558|69422899|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
37793477|NCT02196558|69422900|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
37793478|NCT02196558|69422898|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
37793479|NCT02196558|69422899|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
37793480|NCT02196558|69422900|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
37793481|NCT02196558|69422898|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
37793482|NCT02196558|69422899|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
37793483|NCT02196558|69422900|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
37793484|NCT02196324|69422921|FG000|Overall Study|Withdrawal by Subject|8|||
37793485|NCT02196324|69422922|FG001|Overall Study|Withdrawal by Subject|4|||
37793486|NCT02196324|69422921|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
37793487|NCT02196324|69422922|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
37793488|NCT02196324|69422921|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
37793489|NCT02196324|69422922|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
37793490|NCT02196324|69422921|FG000|Overall Study|Other|1|||
37793491|NCT02196324|69422922|FG001|Overall Study|Other|0|||
37793492|NCT02195700|69422930|FG000|Overall Study|Protocol Violation|0|||
37793493|NCT02195700|69422931|FG001|Overall Study|Protocol Violation|2|||
37793494|NCT02195700|69422930|FG000|Overall Study|Noncompliance|1|||
37793495|NCT02195700|69422931|FG001|Overall Study|Noncompliance|0|||
37793496|NCT02195700|69422930|FG000|Overall Study|Adverse Event|1|||
37793497|NCT02195700|69422931|FG001|Overall Study|Adverse Event|2|||
37793498|NCT02195700|69422930|FG000|Overall Study|Withdrawal by Subject|3|||
37793499|NCT02195700|69422931|FG001|Overall Study|Withdrawal by Subject|2|||
37793500|NCT02195700|69422930|FG000|Overall Study|Lost to Follow-up|1|||
37793501|NCT02195700|69422931|FG001|Overall Study|Lost to Follow-up|1|||
37793502|NCT02228460|69422946|FG000|Overall Study|Adverse Event|1|||
37793503|NCT02228460|69422946|FG000|Overall Study|Lost to Follow-up|1|||
37793504|NCT02227446|69422962|FG000|Overall Study|not eligible post randomization|18|||
37793505|NCT02227446|69422963|FG001|Overall Study|not eligible post randomization|29|||
37793506|NCT02227446|69422962|FG000|Overall Study|Withdrawal by Subject|4|||
37793507|NCT02227446|69422963|FG001|Overall Study|Withdrawal by Subject|5|||
37793508|NCT02227368|69422971|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
37793509|NCT02227368|69422972|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
37793510|NCT02227368|69422971|FG000|Overall Study|Lost to Follow-up|1|||
37793511|NCT02227368|69422972|FG001|Overall Study|Lost to Follow-up|0|||
37793512|NCT02227368|69422971|FG000|Overall Study|Adverse Event|1|||
37793513|NCT02227368|69422972|FG001|Overall Study|Adverse Event|0|||
37793514|NCT02162862|69422981|FG000|Overall Study|Lost to Follow-up|0|||
37793515|NCT02162862|69422982|FG001|Overall Study|Lost to Follow-up|11|||
37793516|NCT02162862|69422983|FG002|Overall Study|Lost to Follow-up|0|||
37793517|NCT02162862|69422981|FG000|Overall Study|Subject did not feel the med was needed|0|||
37793518|NCT02162862|69422982|FG001|Overall Study|Subject did not feel the med was needed|0|||
37793519|NCT02162862|69422983|FG002|Overall Study|Subject did not feel the med was needed|4|||
37793520|NCT02226198|69423021|FG000|Lead-in Phase|Protocol Violation|1|||
37793521|NCT02226198|69423022|FG001|Lead-in Phase|Protocol Violation|0|||
37793522|NCT02226198|69423023|FG002|Lead-in Phase|Protocol Violation|0|||
37793523|NCT02226198|69423021|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
37793524|NCT02226198|69423022|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
37793525|NCT02226198|69423023|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
37793526|NCT02226120|69423194|FG000|Overall Study|Adverse Event|60|||
37793527|NCT02226120|69423194|FG000|Overall Study|Death|172|||
37793528|NCT02226120|69423194|FG000|Overall Study|Study terminated by sponsor|1|||
37793529|NCT02226120|69423194|FG000|Overall Study|Technical problems|4|||
37793530|NCT02226120|69423194|FG000|Overall Study|Lost to Follow-up|13|||
37793531|NCT02226120|69423194|FG000|Overall Study|Physician Decision|21|||
37793532|NCT02226120|69423194|FG000|Overall Study|Withdrawal by parent/guardian|36|||
37793533|NCT02226120|69423194|FG000|Overall Study|Non-compliance with study drug|10|||
37793534|NCT02226120|69423194|FG000|Overall Study|Protocol deviation|1|||
37793535|NCT02226120|69423194|FG000|Overall Study|missing treatment disposition pages|2|||
37793536|NCT02194998|69423359|FG000|On-HCV Treatment|Did not pick up study medication|0|||
37793537|NCT02194998|69423360|FG001|On-HCV Treatment|Did not pick up study medication|1|||
37793538|NCT02194998|69423361|FG002|On-HCV Treatment|Did not pick up study medication|0|||
37793539|NCT02194998|69423362|FG003|On-HCV Treatment|Did not pick up study medication|0|||
37793540|NCT02194998|69423359|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
37793541|NCT02194998|69423360|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
37793542|NCT02194998|69423361|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
37793543|NCT02194998|69423362|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
37793544|NCT02194062|69423375|FG000|Overall Study|Lost to Follow-up|2|||
37793545|NCT02194062|69423376|FG001|Overall Study|Lost to Follow-up|2|||
37793546|NCT02194062|69423377|FG002|Overall Study|Lost to Follow-up|5|||
37793547|NCT02193828|69423398|FG000|Overall Study|Withdrawal by Subject|0|||
37793548|NCT02193828|69423399|FG001|Overall Study|Withdrawal by Subject|0|||
37793549|NCT02193828|69423400|FG002|Overall Study|Withdrawal by Subject|1|||
37793550|NCT02193828|69423401|FG003|Overall Study|Withdrawal by Subject|1|||
37793551|NCT02192970|69423422|FG000|Overall Study|Lost to Follow-up|6|||
37793552|NCT02192970|69423423|FG001|Overall Study|Lost to Follow-up|0|||
37793553|NCT02192190|69423607|FG000|Overall Study|Adverse Event|1|||
37793554|NCT02192190|69423608|FG001|Overall Study|Adverse Event|1|||
37793555|NCT02192190|69423609|FG002|Overall Study|Adverse Event|0|||
37793556|NCT02192190|69423610|FG003|Overall Study|Adverse Event|0|||
37793557|NCT02192190|69423611|FG004|Overall Study|Adverse Event|0|||
37793558|NCT02192190|69423612|FG005|Overall Study|Adverse Event|0|||
37793559|NCT02192190|69423607|FG000|Overall Study|Lost to Follow-up|3|||
37793560|NCT02192190|69423608|FG001|Overall Study|Lost to Follow-up|3|||
37793561|NCT02192190|69423609|FG002|Overall Study|Lost to Follow-up|2|||
37793562|NCT02192190|69423610|FG003|Overall Study|Lost to Follow-up|1|||
37793563|NCT02192190|69423611|FG004|Overall Study|Lost to Follow-up|4|||
37793564|NCT02192190|69423612|FG005|Overall Study|Lost to Follow-up|3|||
37793565|NCT02192190|69423607|FG000|Overall Study|Physician Decision|2|||
37793566|NCT02192190|69423608|FG001|Overall Study|Physician Decision|0|||
37793567|NCT02192190|69423609|FG002|Overall Study|Physician Decision|0|||
37793568|NCT02192190|69423610|FG003|Overall Study|Physician Decision|0|||
37793569|NCT02192190|69423611|FG004|Overall Study|Physician Decision|0|||
37793570|NCT02192190|69423612|FG005|Overall Study|Physician Decision|0|||
37793571|NCT02192190|69423607|FG000|Overall Study|Terminated by Sponsor|43|||
37793572|NCT02192190|69423608|FG001|Overall Study|Terminated by Sponsor|23|||
37793573|NCT02192190|69423609|FG002|Overall Study|Terminated by Sponsor|20|||
37793574|NCT02192190|69423610|FG003|Overall Study|Terminated by Sponsor|23|||
37793575|NCT02192190|69423611|FG004|Overall Study|Terminated by Sponsor|21|||
37793576|NCT02192190|69423612|FG005|Overall Study|Terminated by Sponsor|23|||
37793577|NCT02192190|69423607|FG000|Overall Study|Withdrawal by Subject|4|||
37793578|NCT02192190|69423608|FG001|Overall Study|Withdrawal by Subject|1|||
37793579|NCT02192190|69423609|FG002|Overall Study|Withdrawal by Subject|2|||
37864157|NCT00991276|69547782|FG005|Third Intervention Period|Other|1|||
37793580|NCT02192190|69423610|FG003|Overall Study|Withdrawal by Subject|1|||
37793581|NCT02192190|69423611|FG004|Overall Study|Withdrawal by Subject|5|||
37793582|NCT02192190|69423612|FG005|Overall Study|Withdrawal by Subject|3|||
37793583|NCT02192190|69423607|FG000|Overall Study|Could not Keep Visit Schedule|1|||
37793584|NCT02192190|69423608|FG001|Overall Study|Could not Keep Visit Schedule|0|||
37793585|NCT02192190|69423609|FG002|Overall Study|Could not Keep Visit Schedule|0|||
37793586|NCT02192190|69423610|FG003|Overall Study|Could not Keep Visit Schedule|0|||
37793587|NCT02192190|69423611|FG004|Overall Study|Could not Keep Visit Schedule|0|||
37793588|NCT02192190|69423612|FG005|Overall Study|Could not Keep Visit Schedule|0|||
37793589|NCT02192190|69423607|FG000|Overall Study|Positive Drug Screen|0|||
37793590|NCT02192190|69423608|FG001|Overall Study|Positive Drug Screen|0|||
37793591|NCT02192190|69423609|FG002|Overall Study|Positive Drug Screen|0|||
37793592|NCT02192190|69423610|FG003|Overall Study|Positive Drug Screen|1|||
37793593|NCT02192190|69423611|FG004|Overall Study|Positive Drug Screen|0|||
37793594|NCT02192190|69423612|FG005|Overall Study|Positive Drug Screen|0|||
37793595|NCT02192190|69423607|FG000|Overall Study|Inadequate Pain Relief|0|||
37793596|NCT02192190|69423608|FG001|Overall Study|Inadequate Pain Relief|1|||
37793597|NCT02192190|69423609|FG002|Overall Study|Inadequate Pain Relief|1|||
37793598|NCT02192190|69423610|FG003|Overall Study|Inadequate Pain Relief|0|||
37793599|NCT02192190|69423611|FG004|Overall Study|Inadequate Pain Relief|0|||
37793600|NCT02192190|69423612|FG005|Overall Study|Inadequate Pain Relief|0|||
37793601|NCT02224638|69423640|FG000|Overall Study|Adverse Event|1|||
37793602|NCT02224638|69423641|FG001|Overall Study|Adverse Event|1|||
37793603|NCT02224560|69423656|FG000|Overall Study|Protocol Deviation|1|||
37793604|NCT02224560|69423657|FG001|Overall Study|Protocol Deviation|0|||
37793605|NCT02224560|69423658|FG002|Overall Study|Protocol Deviation|0|||
37793606|NCT02224560|69423656|FG000|Overall Study|Withdrawal by Subject|2|||
37793607|NCT02224560|69423657|FG001|Overall Study|Withdrawal by Subject|0|||
37793608|NCT02224560|69423658|FG002|Overall Study|Withdrawal by Subject|1|||
37793609|NCT02224560|69423656|FG000|Overall Study|Met Withdrawal Criteria|1|||
37793610|NCT02224560|69423657|FG001|Overall Study|Met Withdrawal Criteria|0|||
37793611|NCT02224560|69423658|FG002|Overall Study|Met Withdrawal Criteria|0|||
37793612|NCT02224560|69423656|FG000|Overall Study|Adverse Event|4|||
37793613|NCT02224560|69423657|FG001|Overall Study|Adverse Event|1|||
37793614|NCT02224560|69423658|FG002|Overall Study|Adverse Event|1|||
37793615|NCT02224560|69423656|FG000|Overall Study|Withdrawn by Investigator|1|||
37793616|NCT02224560|69423657|FG001|Overall Study|Withdrawn by Investigator|1|||
37793617|NCT02224560|69423658|FG002|Overall Study|Withdrawn by Investigator|0|||
37793618|NCT02161458|69423670|FG000|Overall Study|Withdrawal by Subject|0|||
37793619|NCT02161458|69423671|FG001|Overall Study|Withdrawal by Subject|4|||
37793620|NCT02161458|69423672|FG002|Overall Study|Withdrawal by Subject|4|||
37793621|NCT02161458|69423673|FG003|Overall Study|Withdrawal by Subject|0|||
37793622|NCT02161458|69423670|FG000|Overall Study|Lost to Follow-up|0|||
37793623|NCT02161458|69423671|FG001|Overall Study|Lost to Follow-up|2|||
37793624|NCT02161458|69423672|FG002|Overall Study|Lost to Follow-up|1|||
37793625|NCT02161458|69423673|FG003|Overall Study|Lost to Follow-up|0|||
37793626|NCT02223858|69423685|FG000|Overall Study|Death|1|||
37793627|NCT02223858|69423686|FG001|Overall Study|Death|1|||
37793628|NCT02223858|69423685|FG000|Overall Study|Lost to Follow-up|6|||
37793629|NCT02223858|69423686|FG001|Overall Study|Lost to Follow-up|11|||
37793630|NCT02223858|69423685|FG000|Overall Study|Withdrawal by Subject|8|||
37793631|NCT02223858|69423686|FG001|Overall Study|Withdrawal by Subject|5|||
37793632|NCT02223858|69423685|FG000|Overall Study|Refused|9|||
37793633|NCT02223858|69423686|FG001|Overall Study|Refused|9|||
37793634|NCT02223390|69423694|FG000|Overall Study|Lost to Follow-up|9|||
37793635|NCT02223390|69423695|FG001|Overall Study|Lost to Follow-up|4|||
37793636|NCT04914000|69425579|FG000|Overall Study|Lost to Follow-up|8|||
37793637|NCT04914000|69425579|FG000|Overall Study|Withdrawal by Subject|1|||
37793638|NCT04530825|69425596|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
37793639|NCT04530825|69425597|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
37793640|NCT04530825|69425598|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
37793641|NCT04530825|69425599|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
37793642|NCT04530825|69425596|FG000|Overall Study|Did not complete follow-up|3|||
37793643|NCT04530825|69425597|FG001|Overall Study|Did not complete follow-up|0|||
37793644|NCT04530825|69425598|FG002|Overall Study|Did not complete follow-up|0|||
37793645|NCT04530825|69425599|FG003|Overall Study|Did not complete follow-up|0|||
37793646|NCT04169373|69425613|FG000|Week 1 to Week 14|Adverse Event|1|||
37793647|NCT04169373|69425614|FG001|Week 1 to Week 14|Adverse Event|0|||
37793648|NCT04169373|69425615|FG002|Week 1 to Week 14|Adverse Event|1|||
37793649|NCT04169373|69425616|FG003|Week 1 to Week 14|Adverse Event|2|||
37793650|NCT04169373|69425613|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
37793651|NCT04169373|69425614|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
37793652|NCT04169373|69425615|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
37793653|NCT04169373|69425616|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
37793654|NCT04169373|69425613|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
37793655|NCT04169373|69425614|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
37793656|NCT04169373|69425615|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
37793657|NCT04169373|69425616|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
37793658|NCT04169373|69425613|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
37793659|NCT04169373|69425614|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
37793660|NCT04169373|69425615|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
37793661|NCT04169373|69425616|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
37793662|NCT04169373|69425613|FG000|Week 1 to Week 14|Other|1|||
37793663|NCT04169373|69425614|FG001|Week 1 to Week 14|Other|3|||
37793664|NCT04169373|69425615|FG002|Week 1 to Week 14|Other|3|||
37793665|NCT04169373|69425616|FG003|Week 1 to Week 14|Other|5|||
37793666|NCT04169373|69425613|FG000|Week 14 to Week 52|Adverse Event|1|||
37793667|NCT04169373|69425614|FG001|Week 14 to Week 52|Adverse Event|0|||
37793668|NCT04169373|69425615|FG002|Week 14 to Week 52|Adverse Event|0|||
37793669|NCT04169373|69425616|FG003|Week 14 to Week 52|Adverse Event|1|||
37793670|NCT04169373|69425613|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
37793671|NCT04169373|69425614|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
37793672|NCT04169373|69425615|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
37793673|NCT04169373|69425616|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
37793674|NCT04169373|69425613|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
37793675|NCT04169373|69425614|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
37793676|NCT04169373|69425615|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
37793677|NCT04169373|69425616|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
37793678|NCT04169373|69425613|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
37793679|NCT04169373|69425614|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
37793680|NCT04169373|69425615|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
37793681|NCT04169373|69425616|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
37793682|NCT04169373|69425613|FG000|Week 14 to Week 52|Other|4|||
37793683|NCT04169373|69425614|FG001|Week 14 to Week 52|Other|5|||
37793684|NCT04169373|69425615|FG002|Week 14 to Week 52|Other|4|||
37793685|NCT04169373|69425616|FG003|Week 14 to Week 52|Other|5|||
37793686|NCT04169373|69425613|FG000|Week 14 to Week 52|Ongoing|0|||
37793687|NCT04169373|69425614|FG001|Week 14 to Week 52|Ongoing|1|||
37793688|NCT04169373|69425615|FG002|Week 14 to Week 52|Ongoing|0|||
37793689|NCT04169373|69425616|FG003|Week 14 to Week 52|Ongoing|0|||
37793690|NCT04154930|69425631|FG000|Overall Study|Withdrawal by Subject|15|||
37793691|NCT04154930|69425632|FG001|Overall Study|Withdrawal by Subject|6|||
37793692|NCT04154930|69425631|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
37793693|NCT04154930|69425632|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
37793694|NCT04154930|69425631|FG000|Overall Study|Lost to Follow-up|14|||
37793695|NCT04154930|69425632|FG001|Overall Study|Lost to Follow-up|6|||
37793696|NCT04154930|69425631|FG000|Overall Study|Other|6|||
37793697|NCT04154930|69425632|FG001|Overall Study|Other|0|||
37793698|NCT04124471|69425638|FG000|Overall Study|screen failure|1|||
37793699|NCT04093024|69425644|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
37793700|NCT04093024|69425645|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
37793701|NCT04093024|69425644|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
37793702|NCT04093024|69425645|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
37793703|NCT04093024|69425644|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
37793704|NCT04093024|69425645|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
37793705|NCT04093024|69425644|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
37793706|NCT04093024|69425645|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
37793707|NCT03971474|69425681|FG000|Overall Study|Adverse Event|11|||
37793708|NCT03971474|69425682|FG001|Overall Study|Adverse Event|7|||
37793709|NCT03971474|69425681|FG000|Overall Study|Refusal unrelated to adverse event|5|||
37793710|NCT03971474|69425682|FG001|Overall Study|Refusal unrelated to adverse event|1|||
37793711|NCT03971474|69425681|FG000|Overall Study|Progression/relapse|40|||
37793712|NCT03971474|69425682|FG001|Overall Study|Progression/relapse|47|||
37793713|NCT03971474|69425681|FG000|Overall Study|Death|6|||
37793714|NCT03971474|69425682|FG001|Overall Study|Death|3|||
37793715|NCT03971474|69425681|FG000|Overall Study|Other - not protocol specified|5|||
37793716|NCT03971474|69425682|FG001|Overall Study|Other - not protocol specified|4|||
37793717|NCT03971474|69425681|FG000|Overall Study|On treatment|0|||
37793718|NCT03971474|69425682|FG001|Overall Study|On treatment|7|||
37793719|NCT03633929|69425689|FG000|Overall Study|Lost to Follow-up|1|||
37793720|NCT03633929|69425689|FG000|Overall Study|Did not login to software. Did not participate|3|||
37793721|NCT03625687|69425693|FG000|Overall Study|Death|1|||
37793722|NCT02785952|69425716|FG000|Overall Study|Adverse Event|31|||
37793723|NCT02785952|69425717|FG001|Overall Study|Adverse Event|19|||
37793724|NCT02785952|69425716|FG000|Overall Study|Refusal unrelated to adverse events|10|||
37793725|NCT02785952|69425717|FG001|Overall Study|Refusal unrelated to adverse events|5|||
37793726|NCT02785952|69425716|FG000|Overall Study|Disease progression/relapse|61|||
37793727|NCT02785952|69425717|FG001|Overall Study|Disease progression/relapse|89|||
37793728|NCT02785952|69425716|FG000|Overall Study|Death|11|||
37793729|NCT02785952|69425717|FG001|Overall Study|Death|7|||
37793730|NCT02785952|69425716|FG000|Overall Study|Other- not protocol specified|6|||
37793731|NCT02785952|69425717|FG001|Overall Study|Other- not protocol specified|4|||
37793732|NCT02785952|69425716|FG000|Overall Study|On protocol treatment|6|||
37793733|NCT02785952|69425717|FG001|Overall Study|On protocol treatment|3|||
37793734|NCT02674685|69425725|FG000|Overall Study|Withdrawal by Subject|4|||
37793735|NCT02654236|69425732|FG000|Overall Study|Withdrawal by Subject|0|||
37793736|NCT02654236|69425733|FG001|Overall Study|Withdrawal by Subject|0|||
37793737|NCT02654236|69425734|FG002|Overall Study|Withdrawal by Subject|2|||
37793738|NCT02372136|69425744|FG000|Overall Study|Death|3|||
37793739|NCT02372136|69425745|FG001|Overall Study|Death|1|||
37793740|NCT02194829|69425755|FG000|Overall Study|Adverse Event|2|||
37793741|NCT02194829|69425756|FG001|Overall Study|Adverse Event|2|||
37793742|NCT02194829|69425755|FG000|Overall Study|Death|0|||
37793743|NCT02194829|69425756|FG001|Overall Study|Death|1|||
37793744|NCT02194829|69425755|FG000|Overall Study|Disease progression|0|||
37793745|NCT02194829|69425756|FG001|Overall Study|Disease progression|1|||
37793746|NCT02194829|69425755|FG000|Overall Study|Withdrawal by Subject|0|||
37793747|NCT02194829|69425756|FG001|Overall Study|Withdrawal by Subject|1|||
37793748|NCT02194829|69425755|FG000|Overall Study|Never started protocol therapy|0|||
37793749|NCT02194829|69425756|FG001|Overall Study|Never started protocol therapy|1|||
37864158|NCT00991276|69547777|FG000|Third Intervention Period|Adverse Event|0|||
37693773|NCT01897714|69170081|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
37693774|NCT01897714|69170082|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
37864159|NCT00991276|69547778|FG001|Third Intervention Period|Adverse Event|0|||
37793750|NCT02087046|69425763|FG000|Overall Study|Adverse Event|4|||
37793751|NCT02087046|69425763|FG000|Overall Study|Death|1|||
37793752|NCT02087046|69425763|FG000|Overall Study|Lost to Follow-up|3|||
37793753|NCT02087046|69425763|FG000|Overall Study|Withdrawal by Subject|2|||
37793754|NCT02087046|69425763|FG000|Overall Study|Physician Decision|1|||
37793755|NCT01390038|69425772|FG000|Overall Study|Death|1|||
37793756|NCT01390038|69425772|FG000|Overall Study|Lost to Follow-up|1|||
37793757|NCT01390038|69425772|FG000|Overall Study|Withdrawal by Subject|4|||
37793758|NCT01390038|69425772|FG000|Overall Study|Simpliciti System Removal|2|||
37864160|NCT00991276|69547779|FG002|Third Intervention Period|Adverse Event|1|||
37793759|NCT00621192|69425790|FG000|Overall Study|Withdrawal by Subject|0|||
37793760|NCT00621192|69425791|FG001|Overall Study|Withdrawal by Subject|0|||
37793761|NCT00621192|69425792|FG002|Overall Study|Withdrawal by Subject|2|||
37793762|NCT00621192|69425793|FG003|Overall Study|Withdrawal by Subject|0|||
37793763|NCT00621192|69425790|FG000|Overall Study|Physician Decision|1|||
37793764|NCT00621192|69425791|FG001|Overall Study|Physician Decision|3|||
37793765|NCT00621192|69425792|FG002|Overall Study|Physician Decision|0|||
37793766|NCT00621192|69425793|FG003|Overall Study|Physician Decision|0|||
37793767|NCT00621192|69425790|FG000|Overall Study|Protocol Violation|1|||
37793768|NCT00621192|69425791|FG001|Overall Study|Protocol Violation|0|||
37793769|NCT00621192|69425792|FG002|Overall Study|Protocol Violation|0|||
37793770|NCT00621192|69425793|FG003|Overall Study|Protocol Violation|1|||
37793771|NCT00621192|69425790|FG000|Overall Study|Adverse Event|0|||
37793772|NCT00621192|69425791|FG001|Overall Study|Adverse Event|1|||
37793773|NCT00621192|69425792|FG002|Overall Study|Adverse Event|0|||
37793774|NCT00621192|69425793|FG003|Overall Study|Adverse Event|1|||
37793775|NCT00621192|69425790|FG000|Overall Study|Death|2|||
37793776|NCT00621192|69425791|FG001|Overall Study|Death|5|||
37793777|NCT00621192|69425792|FG002|Overall Study|Death|0|||
37793778|NCT00621192|69425793|FG003|Overall Study|Death|0|||
37793779|NCT00621192|69425790|FG000|Overall Study|Final Assessments not Completed|0|||
37793780|NCT00621192|69425791|FG001|Overall Study|Final Assessments not Completed|0|||
37793781|NCT00621192|69425792|FG002|Overall Study|Final Assessments not Completed|3|||
37793782|NCT00621192|69425793|FG003|Overall Study|Final Assessments not Completed|1|||
37793783|NCT00364286|69425803|FG000|Overall Study|Withdrawal by Subject|1|||
37793784|NCT00364286|69425803|FG000|Overall Study|Adverse Event|2|||
37793785|NCT00278200|69425809|FG000|Overall Study|Death|1|||
37793786|NCT00278200|69425810|FG001|Overall Study|Death|3|||
37793787|NCT00278200|69425809|FG000|Overall Study|Physician Decision|0|||
37793788|NCT00278200|69425810|FG001|Overall Study|Physician Decision|1|||
37793789|NCT00255346|69425821|FG000|Overall Study|Adverse Event|1|||
37793790|NCT00255346|69425822|FG001|Overall Study|Adverse Event|0|||
37793791|NCT00255346|69425823|FG002|Overall Study|Adverse Event|0|||
37793792|NCT00255346|69425824|FG003|Overall Study|Adverse Event|0|||
37793793|NCT00255346|69425825|FG004|Overall Study|Adverse Event|0|||
37793794|NCT02222922|69427966|FG000|Overall Study|Death|0|||
37793795|NCT02222922|69427967|FG001|Overall Study|Death|0|||
37793796|NCT02222922|69427968|FG002|Overall Study|Death|0|||
37793797|NCT02222922|69427969|FG003|Overall Study|Death|0|||
37793798|NCT02222922|69427970|FG004|Overall Study|Death|13|||
37793799|NCT02222922|69427971|FG005|Overall Study|Death|0|||
37793800|NCT02222922|69427972|FG006|Overall Study|Death|0|||
37793801|NCT02222922|69427973|FG007|Overall Study|Death|0|||
37793802|NCT02222922|69427974|FG008|Overall Study|Death|2|||
37793803|NCT02222922|69427966|FG000|Overall Study|Lost to Follow-up|0|||
37793804|NCT02222922|69427967|FG001|Overall Study|Lost to Follow-up|0|||
37793805|NCT02222922|69427968|FG002|Overall Study|Lost to Follow-up|1|||
37793806|NCT02222922|69427969|FG003|Overall Study|Lost to Follow-up|0|||
37793807|NCT02222922|69427970|FG004|Overall Study|Lost to Follow-up|9|||
37793808|NCT02222922|69427971|FG005|Overall Study|Lost to Follow-up|1|||
37793809|NCT02222922|69427972|FG006|Overall Study|Lost to Follow-up|0|||
37793810|NCT02222922|69427973|FG007|Overall Study|Lost to Follow-up|0|||
37793811|NCT02222922|69427974|FG008|Overall Study|Lost to Follow-up|0|||
37793812|NCT02222922|69427966|FG000|Overall Study|Other|0|||
37793813|NCT02222922|69427967|FG001|Overall Study|Other|0|||
37793814|NCT02222922|69427968|FG002|Overall Study|Other|0|||
37793815|NCT02222922|69427969|FG003|Overall Study|Other|2|||
37793816|NCT02222922|69427970|FG004|Overall Study|Other|10|||
37793817|NCT02222922|69427971|FG005|Overall Study|Other|2|||
37793818|NCT02222922|69427972|FG006|Overall Study|Other|2|||
37793819|NCT02222922|69427973|FG007|Overall Study|Other|4|||
37793820|NCT02222922|69427974|FG008|Overall Study|Other|1|||
37793821|NCT02222922|69427966|FG000|Overall Study|Participant refused further follow-up|1|||
37693775|NCT01897714|69170083|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
37693776|NCT01897714|69170078|FG000|Phase II (MTD)|Lost to Follow-up|0|||
37793822|NCT02222922|69427967|FG001|Overall Study|Participant refused further follow-up|0|||
37793823|NCT02222922|69427968|FG002|Overall Study|Participant refused further follow-up|0|||
37793824|NCT02222922|69427969|FG003|Overall Study|Participant refused further follow-up|1|||
37793825|NCT02222922|69427970|FG004|Overall Study|Participant refused further follow-up|6|||
37793826|NCT02222922|69427971|FG005|Overall Study|Participant refused further follow-up|0|||
37793827|NCT02222922|69427972|FG006|Overall Study|Participant refused further follow-up|0|||
37793828|NCT02222922|69427973|FG007|Overall Study|Participant refused further follow-up|0|||
37793829|NCT02222922|69427974|FG008|Overall Study|Participant refused further follow-up|3|||
37793830|NCT02161146|69428026|FG000|Overall Study|Adverse Event|1|||
37793831|NCT02161146|69428027|FG001|Overall Study|Adverse Event|1|||
37793832|NCT02161146|69428028|FG002|Overall Study|Adverse Event|0|||
37793833|NCT02161146|69428029|FG003|Overall Study|Adverse Event|1|||
37793834|NCT02161146|69428030|FG004|Overall Study|Adverse Event|0|||
37793835|NCT02161146|69428026|FG000|Overall Study|Lost to Follow-up|0|||
37793836|NCT02161146|69428027|FG001|Overall Study|Lost to Follow-up|1|||
37793837|NCT02161146|69428028|FG002|Overall Study|Lost to Follow-up|0|||
37793838|NCT02161146|69428029|FG003|Overall Study|Lost to Follow-up|0|||
37793839|NCT02161146|69428030|FG004|Overall Study|Lost to Follow-up|0|||
37793840|NCT02161146|69428026|FG000|Overall Study|Personal Reasons|0|||
37793841|NCT02161146|69428027|FG001|Overall Study|Personal Reasons|1|||
37793842|NCT02161146|69428028|FG002|Overall Study|Personal Reasons|0|||
37793843|NCT02161146|69428029|FG003|Overall Study|Personal Reasons|2|||
37793844|NCT02161146|69428030|FG004|Overall Study|Personal Reasons|1|||
37793845|NCT02161146|69428026|FG000|Overall Study|Other Miscellaneous Reasons|0|||
37793846|NCT02161146|69428027|FG001|Overall Study|Other Miscellaneous Reasons|1|||
37793847|NCT02161146|69428028|FG002|Overall Study|Other Miscellaneous Reasons|0|||
37793848|NCT02161146|69428029|FG003|Overall Study|Other Miscellaneous Reasons|0|||
37793849|NCT02161146|69428030|FG004|Overall Study|Other Miscellaneous Reasons|0|||
37793850|NCT02222688|69428265|FG000|Overall Study|Withdrawal by Subject|0|||
37793851|NCT02222688|69428266|FG001|Overall Study|Withdrawal by Subject|0|||
37793852|NCT02222688|69428267|FG002|Overall Study|Withdrawal by Subject|0|||
37793853|NCT02222688|69428268|FG003|Overall Study|Withdrawal by Subject|2|||
37793854|NCT02222688|69428269|FG004|Overall Study|Withdrawal by Subject|1|||
37793855|NCT02222688|69428270|FG005|Overall Study|Withdrawal by Subject|0|||
37793856|NCT02222688|69428271|FG006|Overall Study|Withdrawal by Subject|1|||
37793857|NCT02222688|69428265|FG000|Overall Study|Disease progression|1|||
37793858|NCT02222688|69428266|FG001|Overall Study|Disease progression|0|||
37793859|NCT02222688|69428267|FG002|Overall Study|Disease progression|0|||
37793860|NCT02222688|69428268|FG003|Overall Study|Disease progression|0|||
37793861|NCT02222688|69428269|FG004|Overall Study|Disease progression|0|||
37793862|NCT02222688|69428270|FG005|Overall Study|Disease progression|0|||
37793863|NCT02222688|69428271|FG006|Overall Study|Disease progression|0|||
37793864|NCT02159352|69428323|FG000|Overall Study|Adverse Event|3|||
37793865|NCT02159352|69428324|FG001|Overall Study|Adverse Event|1|||
37793866|NCT02159352|69428323|FG000|Overall Study|Withdrawal by Subject|0|||
37793867|NCT02159352|69428324|FG001|Overall Study|Withdrawal by Subject|1|||
37793868|NCT02187744|69428361|FG000|Study|Participant refused further follow-up|1|||
37793869|NCT02187744|69428362|FG001|Study|Participant refused further follow-up|0|||
37793870|NCT02187744|69428361|FG000|Study|Other|2|||
37793871|NCT02187744|69428362|FG001|Study|Other|1|||
37793872|NCT02187744|69428361|FG000|Study|Lost to Follow-up|0|||
37793873|NCT02187744|69428362|FG001|Study|Lost to Follow-up|2|||
37793874|NCT02187744|69428361|FG000|Study|Related adverse event, not serious|0|||
37793875|NCT02187744|69428362|FG001|Study|Related adverse event, not serious|2|||
37793876|NCT02187744|69428361|FG000|Study|Death|1|||
37793877|NCT02187744|69428362|FG001|Study|Death|0|||
37793878|NCT02187744|69428361|FG000|Study|Related adverse event, serious non-fatal|0|||
37793879|NCT02187744|69428362|FG001|Study|Related adverse event, serious non-fatal|1|||
37793880|NCT02187744|69428361|FG000|Treatment|Death|1|||
37793881|NCT02187744|69428362|FG001|Treatment|Death|0|||
37793882|NCT02187744|69428361|FG000|Treatment|Related adverse event, serious non-fatal|0|||
37793883|NCT02187744|69428362|FG001|Treatment|Related adverse event, serious non-fatal|1|||
37793884|NCT02187744|69428361|FG000|Treatment|Related adverse event, not serious|0|||
37793885|NCT02187744|69428362|FG001|Treatment|Related adverse event, not serious|2|||
37793886|NCT02187744|69428361|FG000|Treatment|Lost to Follow-up|0|||
37793887|NCT02187744|69428362|FG001|Treatment|Lost to Follow-up|1|||
37793888|NCT02187744|69428361|FG000|Treatment|Other|2|||
37793889|NCT02187744|69428362|FG001|Treatment|Other|0|||
37793890|NCT02187744|69428361|FG000|Treatment|Participant refused continued treatment|1|||
37793891|NCT02187744|69428362|FG001|Treatment|Participant refused continued treatment|1|||
37975565|NCT00556439|69662837|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
37975566|NCT00556439|69662838|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
37975567|NCT00556439|69662835|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
37975568|NCT00556439|69662836|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
37975569|NCT00556439|69662837|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
37793892|NCT02186652|69428543|FG000|Overall Study|Lost to Follow-up|2|||
37793893|NCT02186652|69428544|FG001|Overall Study|Lost to Follow-up|0|||
37793894|NCT02185794|69428580|FG000|Overall Study|Enrolled but Never Dosed|1|||
37793895|NCT02185794|69428581|FG001|Overall Study|Enrolled but Never Dosed|6|||
37793896|NCT02185794|69428582|FG002|Overall Study|Enrolled but Never Dosed|3|||
37793897|NCT02185794|69428583|FG003|Overall Study|Enrolled but Never Dosed|1|||
37793898|NCT02185794|69428584|FG004|Overall Study|Enrolled but Never Dosed|1|||
37793899|NCT02185794|69428585|FG005|Overall Study|Enrolled but Never Dosed|0|||
37793900|NCT02185794|69428580|FG000|Overall Study|Investigator's Discretion|1|||
37793901|NCT02185794|69428581|FG001|Overall Study|Investigator's Discretion|0|||
37793902|NCT02185794|69428582|FG002|Overall Study|Investigator's Discretion|1|||
37793903|NCT02185794|69428583|FG003|Overall Study|Investigator's Discretion|2|||
37793904|NCT02185794|69428584|FG004|Overall Study|Investigator's Discretion|2|||
37793905|NCT02185794|69428585|FG005|Overall Study|Investigator's Discretion|15|||
37793906|NCT02185794|69428580|FG000|Overall Study|Withdrew Consent|2|||
37793907|NCT02185794|69428581|FG001|Overall Study|Withdrew Consent|5|||
37793908|NCT02185794|69428582|FG002|Overall Study|Withdrew Consent|10|||
37793909|NCT02185794|69428583|FG003|Overall Study|Withdrew Consent|2|||
37793910|NCT02185794|69428584|FG004|Overall Study|Withdrew Consent|0|||
37793911|NCT02185794|69428585|FG005|Overall Study|Withdrew Consent|0|||
37793912|NCT02185794|69428580|FG000|Overall Study|Lost to Follow-up|1|||
37793913|NCT02185794|69428581|FG001|Overall Study|Lost to Follow-up|2|||
37793914|NCT02185794|69428582|FG002|Overall Study|Lost to Follow-up|2|||
37793915|NCT02185794|69428583|FG003|Overall Study|Lost to Follow-up|3|||
37793916|NCT02185794|69428584|FG004|Overall Study|Lost to Follow-up|0|||
37793917|NCT02185794|69428585|FG005|Overall Study|Lost to Follow-up|1|||
37793918|NCT02221674|69428616|FG000|Overall Study|Lost to Follow-up|1|||
37793919|NCT02221674|69428617|FG001|Overall Study|Lost to Follow-up|0|||
37793920|NCT02221674|69428618|FG002|Overall Study|Lost to Follow-up|0|||
37793921|NCT02221284|69428633|FG000|Overall Study|Case Report Forms Uncollected|56|||
37793922|NCT02221284|69428633|FG000|Overall Study|Protocol Deviation|5|||
37793923|NCT02187042|69428794|FG000|Overall Study|Death|1|||
37793924|NCT02187042|69428795|FG001|Overall Study|Death|1|||
37793925|NCT02187042|69428794|FG000|Overall Study|Toxicity|6|||
37793926|NCT02187042|69428795|FG001|Overall Study|Toxicity|5|||
37793927|NCT02187042|69428794|FG000|Overall Study|Participant choice|1|||
37793928|NCT02187042|69428795|FG001|Overall Study|Participant choice|0|||
37793929|NCT02187042|69428794|FG000|Overall Study|Doctor choice|1|||
37793930|NCT02187042|69428795|FG001|Overall Study|Doctor choice|0|||
37793931|NCT02187042|69428794|FG000|Overall Study|Progressive disease|4|||
37793932|NCT02187042|69428795|FG001|Overall Study|Progressive disease|8|||
37793933|NCT02219334|69428978|FG000|Overall Study|Withdrawal by Subject|1|||
37793934|NCT02219334|69428979|FG001|Overall Study|Withdrawal by Subject|0|||
37793935|NCT02219334|69428978|FG000|Overall Study|Protocol Violation|7|||
37793936|NCT02219334|69428979|FG001|Overall Study|Protocol Violation|3|||
37793937|NCT02159040|69428997|FG000|Overall Study|Death|1|||
37793938|NCT02218008|69429022|FG000|Stage 1 (S1)|Adverse Event|6|||
37793939|NCT02218008|69429023|FG001|Stage 1 (S1)|Adverse Event|5|||
37793940|NCT02218008|69429024|FG002|Stage 1 (S1)|Adverse Event|11|||
37793941|NCT02218008|69429025|FG003|Stage 1 (S1)|Adverse Event|0|||
37793942|NCT02218008|69429026|FG004|Stage 1 (S1)|Adverse Event|0|||
37793943|NCT02218008|69429027|FG005|Stage 1 (S1)|Adverse Event|0|||
37793944|NCT02218008|69429022|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
37793945|NCT02218008|69429023|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
37793946|NCT02218008|69429024|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
37793947|NCT02218008|69429025|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
37793948|NCT02218008|69429026|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
37793949|NCT02218008|69429027|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
37793950|NCT02218008|69429022|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
37793951|NCT02218008|69429023|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
37793952|NCT02218008|69429024|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
37793953|NCT02218008|69429025|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
37793954|NCT02218008|69429026|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
37793955|NCT02218008|69429027|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
37793956|NCT02218008|69429022|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
37793957|NCT02218008|69429023|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
37793958|NCT02218008|69429024|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
37793959|NCT02218008|69429025|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
37793960|NCT02218008|69429026|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
37793961|NCT02218008|69429027|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
37793962|NCT02218008|69429022|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
37793963|NCT02218008|69429023|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
37793964|NCT02218008|69429024|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
37793965|NCT02218008|69429025|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
37975570|NCT00556439|69662838|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
37975571|NCT00387465|69662851|FG000|Overall Study|Withdrawal by Subject|0|||
37975572|NCT00387465|69662852|FG001|Overall Study|Withdrawal by Subject|1|||
37793966|NCT02218008|69429026|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
37793967|NCT02218008|69429027|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
37793968|NCT02218008|69429022|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
37793969|NCT02218008|69429023|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
37793970|NCT02218008|69429024|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
37793971|NCT02218008|69429025|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
37793972|NCT02218008|69429026|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
37793973|NCT02218008|69429027|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
37793974|NCT02218008|69429022|FG000|Stage 1 (S1)|Pregnancy|0|||
37793975|NCT02218008|69429023|FG001|Stage 1 (S1)|Pregnancy|0|||
37793976|NCT02218008|69429024|FG002|Stage 1 (S1)|Pregnancy|1|||
37793977|NCT02218008|69429025|FG003|Stage 1 (S1)|Pregnancy|0|||
37975573|NCT00387465|69662853|FG002|Overall Study|Withdrawal by Subject|0|||
37793978|NCT02218008|69429026|FG004|Stage 1 (S1)|Pregnancy|0|||
37793979|NCT02218008|69429027|FG005|Stage 1 (S1)|Pregnancy|0|||
37793980|NCT02218008|69429022|FG000|Stage 1 (S1)|Protocol Violation|0|||
37793981|NCT02218008|69429023|FG001|Stage 1 (S1)|Protocol Violation|0|||
37793982|NCT02218008|69429024|FG002|Stage 1 (S1)|Protocol Violation|1|||
37793983|NCT02218008|69429025|FG003|Stage 1 (S1)|Protocol Violation|0|||
37793984|NCT02218008|69429026|FG004|Stage 1 (S1)|Protocol Violation|0|||
37793985|NCT02218008|69429027|FG005|Stage 1 (S1)|Protocol Violation|0|||
37793986|NCT02218008|69429022|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
37793987|NCT02218008|69429023|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
37793988|NCT02218008|69429024|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
37793989|NCT02218008|69429025|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
37793990|NCT02218008|69429026|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
37793991|NCT02218008|69429027|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
37793992|NCT02218008|69429022|FG000|Stage 2 (S2)|Adverse Event|0|||
37793993|NCT02218008|69429023|FG001|Stage 2 (S2)|Adverse Event|0|||
37793994|NCT02218008|69429024|FG002|Stage 2 (S2)|Adverse Event|0|||
37793995|NCT02218008|69429025|FG003|Stage 2 (S2)|Adverse Event|2|||
37793996|NCT02218008|69429026|FG004|Stage 2 (S2)|Adverse Event|3|||
37793997|NCT02218008|69429027|FG005|Stage 2 (S2)|Adverse Event|3|||
37793998|NCT02218008|69429022|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
37793999|NCT02218008|69429023|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
37794000|NCT02218008|69429024|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
37794001|NCT02218008|69429025|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
37794002|NCT02218008|69429026|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
37794003|NCT02218008|69429027|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
37794004|NCT02218008|69429022|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
37794005|NCT02218008|69429023|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
37794006|NCT02218008|69429024|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
37794007|NCT02218008|69429025|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
37794008|NCT02218008|69429026|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
37794009|NCT02218008|69429027|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
37794010|NCT02218008|69429022|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
37794011|NCT02218008|69429023|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
37794012|NCT02218008|69429024|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
37794013|NCT02218008|69429025|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
37794014|NCT02218008|69429026|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
37794015|NCT02218008|69429027|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
37794016|NCT02218008|69429022|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
37794017|NCT02218008|69429023|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
37794018|NCT02218008|69429024|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
37794019|NCT02218008|69429025|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
37794020|NCT02218008|69429026|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
37794021|NCT02218008|69429027|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
37794022|NCT01632150|69429124|FG000|Overall Study|Disease progression|27|||
37794023|NCT01632150|69429124|FG000|Overall Study|Study drug toxicity|1|||
37864161|NCT00991276|69547780|FG003|Third Intervention Period|Adverse Event|0|||
37794024|NCT01632150|69429124|FG000|Overall Study|Unrelated adverse event|7|||
37794025|NCT01632150|69429124|FG000|Overall Study|Withdrawal by Subject|2|||
37794026|NCT01632150|69429124|FG000|Overall Study|Patient underwent autologous transplant|1|||
37794027|NCT01632150|69429124|FG000|Overall Study|Moved to compassionate program|2|||
37794028|NCT02185014|69429149|FG000|Overall Study|Adverse Event|18|||
37794029|NCT02185014|69429149|FG000|Overall Study|Withdrew Consent|8|||
37794030|NCT02185014|69429149|FG000|Overall Study|Lost to Follow-up|4|||
37794031|NCT02185014|69429149|FG000|Overall Study|Lack of Efficacy|14|||
37864162|NCT00991276|69547781|FG004|Third Intervention Period|Adverse Event|0|||
37794032|NCT02185014|69429149|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
37794033|NCT02185014|69429149|FG000|Overall Study|Subject Noncompliance|1|||
37794034|NCT02185014|69429149|FG000|Overall Study|Other|4|||
37794035|NCT02184156|69429199|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
37794036|NCT02184156|69429200|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
37794037|NCT02184156|69429199|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
37794038|NCT02184156|69429200|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
37794039|NCT02158884|69429223|FG000|Baseline Assessment|Missed performance assessment|3|||
37794040|NCT02158884|69429223|FG000|Baseline Assessment|Missed SMFA|1|||
37794041|NCT02158884|69429223|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
37975574|NCT00387153|69662870|FG000|Overall Study|Adverse Event|1|||
37794042|NCT02158884|69429223|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
37794043|NCT02158884|69429223|FG000|6 Month Assessment|Missed SMFA|20|||
37794044|NCT02158884|69429223|FG000|12 Month Assessment|Missed SMFA|17|||
37794045|NCT02158806|69429266|FG000|Overall Study|Death|2|||
37794046|NCT02158806|69429267|FG001|Overall Study|Death|0|||
37794047|NCT02158806|69429266|FG000|Overall Study|Withdrawal by Subject|2|||
37794048|NCT02158806|69429267|FG001|Overall Study|Withdrawal by Subject|0|||
37794049|NCT02158806|69429266|FG000|Overall Study|Lost to Follow-up|0|||
37794050|NCT02158806|69429267|FG001|Overall Study|Lost to Follow-up|3|||
37794051|NCT02158806|69429266|FG000|Overall Study|Moved out of area|0|||
37794052|NCT02158806|69429267|FG001|Overall Study|Moved out of area|1|||
37794053|NCT02158806|69429266|FG000|Overall Study|Transferred to palliative care|0|||
37794054|NCT02158806|69429267|FG001|Overall Study|Transferred to palliative care|1|||
37794055|NCT02158728|69429298|FG000|Overall Study|no procedure according to CIP done|3|||
37794056|NCT02158728|69429298|FG000|Overall Study|no qualified dataset|24|||
37794057|NCT02157948|69429343|FG000|Overall Study|Withdrawal by Subject|4|||
37794058|NCT02157948|69429344|FG001|Overall Study|Withdrawal by Subject|5|||
37794059|NCT02157948|69429343|FG000|Overall Study|Lost to Follow-up|3|||
37794060|NCT02157948|69429344|FG001|Overall Study|Lost to Follow-up|2|||
37794061|NCT02157948|69429343|FG000|Overall Study|Protocol Specified Criteria|2|||
37794062|NCT02157948|69429344|FG001|Overall Study|Protocol Specified Criteria|1|||
37794063|NCT02157948|69429343|FG000|Overall Study|Decision by Sponsor|0|||
37794064|NCT02157948|69429344|FG001|Overall Study|Decision by Sponsor|1|||
37794065|NCT02182830|69429385|FG000|Overall Study|Not Treated|1|||
37794066|NCT02182830|69429386|FG001|Overall Study|Not Treated|1|||
37794067|NCT02182830|69429385|FG000|Overall Study|Trial stopped, reason missing|3|||
37794068|NCT02182830|69429386|FG001|Overall Study|Trial stopped, reason missing|3|||
37794069|NCT02182830|69429385|FG000|Overall Study|Consent withdrawn|8|||
37794070|NCT02182830|69429386|FG001|Overall Study|Consent withdrawn|8|||
37794071|NCT02182830|69429385|FG000|Overall Study|Lost to Follow-up|3|||
37794072|NCT02182830|69429386|FG001|Overall Study|Lost to Follow-up|3|||
37794073|NCT02182440|69429960|FG000|Overall Study|Adverse Event|0|||
37794074|NCT02182440|69429961|FG001|Overall Study|Adverse Event|1|||
37794075|NCT02182440|69429962|FG002|Overall Study|Adverse Event|0|||
37794076|NCT02182440|69429963|FG003|Overall Study|Adverse Event|0|||
37794077|NCT02182440|69429960|FG000|Overall Study|Death|31|||
37794078|NCT02182440|69429961|FG001|Overall Study|Death|8|||
37794079|NCT02182440|69429962|FG002|Overall Study|Death|5|||
37794080|NCT02182440|69429963|FG003|Overall Study|Death|16|||
37794081|NCT02182440|69429960|FG000|Overall Study|Protocol Violation|0|||
37794082|NCT02182440|69429961|FG001|Overall Study|Protocol Violation|1|||
37794083|NCT02182440|69429962|FG002|Overall Study|Protocol Violation|0|||
37794084|NCT02182440|69429963|FG003|Overall Study|Protocol Violation|0|||
37794085|NCT02182440|69429960|FG000|Overall Study|Physician Decision|1|||
37794086|NCT02182440|69429961|FG001|Overall Study|Physician Decision|0|||
37794087|NCT02182440|69429962|FG002|Overall Study|Physician Decision|0|||
37794088|NCT02182440|69429963|FG003|Overall Study|Physician Decision|0|||
37794089|NCT02182440|69429960|FG000|Overall Study|Withdrawal by Subject|1|||
37794090|NCT02182440|69429961|FG001|Overall Study|Withdrawal by Subject|1|||
37794091|NCT02182440|69429962|FG002|Overall Study|Withdrawal by Subject|3|||
37794092|NCT02182440|69429963|FG003|Overall Study|Withdrawal by Subject|4|||
37794093|NCT02182440|69429960|FG000|Overall Study|different, e.g adm other hospital|12|||
37794094|NCT02182440|69429961|FG001|Overall Study|different, e.g adm other hospital|3|||
37794095|NCT02182440|69429962|FG002|Overall Study|different, e.g adm other hospital|3|||
37794096|NCT02182440|69429963|FG003|Overall Study|different, e.g adm other hospital|10|||
37794097|NCT02181816|69430005|FG000|Overall Study|Case Report Forms Uncollected|38|||
37794098|NCT02181816|69430005|FG000|Overall Study|Protocol Deviation|21|||
37794099|NCT02156466|69430161|FG000|Overall Study|Adverse Event|0|||
37794100|NCT02156466|69430162|FG001|Overall Study|Adverse Event|0|||
37794101|NCT02156466|69430163|FG002|Overall Study|Adverse Event|1|||
37794102|NCT02156466|69430164|FG003|Overall Study|Adverse Event|1|||
37794103|NCT02156466|69430165|FG004|Overall Study|Adverse Event|0|||
37794104|NCT02156466|69430161|FG000|Overall Study|Quantiferon Positivity|0|||
37794105|NCT02156466|69430162|FG001|Overall Study|Quantiferon Positivity|0|||
37794106|NCT02156466|69430163|FG002|Overall Study|Quantiferon Positivity|0|||
37794107|NCT02156466|69430164|FG003|Overall Study|Quantiferon Positivity|1|||
37794108|NCT02156466|69430165|FG004|Overall Study|Quantiferon Positivity|0|||
37794109|NCT02216526|69430204|FG000|Overall Study|Adverse Event|1|||
37794110|NCT02216526|69430205|FG001|Overall Study|Adverse Event|1|||
37794111|NCT02216526|69430206|FG002|Overall Study|Adverse Event|0|||
37794112|NCT02216526|69430204|FG000|Overall Study|Death|0|||
37794113|NCT02216526|69430205|FG001|Overall Study|Death|1|||
37794114|NCT02216526|69430206|FG002|Overall Study|Death|3|||
37794115|NCT02216526|69430204|FG000|Overall Study|Protocol Violation|2|||
37794116|NCT02216526|69430205|FG001|Overall Study|Protocol Violation|0|||
37794117|NCT02216526|69430206|FG002|Overall Study|Protocol Violation|2|||
37794118|NCT02216526|69430204|FG000|Overall Study|Hospitalization|2|||
37794119|NCT02216526|69430205|FG001|Overall Study|Hospitalization|1|||
37794120|NCT02216526|69430206|FG002|Overall Study|Hospitalization|3|||
37794121|NCT02216214|69430246|FG000|Overall Study|Randomized Never Received Study Drug|1|||
37794122|NCT02216214|69430247|FG001|Overall Study|Randomized Never Received Study Drug|0|||
37794123|NCT02216214|69430246|FG000|Overall Study|Adverse Event|10|||
37794124|NCT02216214|69430247|FG001|Overall Study|Adverse Event|8|||
37794125|NCT02216214|69430246|FG000|Overall Study|Lack of Efficacy|2|||
37794126|NCT02216214|69430247|FG001|Overall Study|Lack of Efficacy|2|||
37794127|NCT02216214|69430246|FG000|Overall Study|Lost to Follow-up|3|||
37794128|NCT02216214|69430247|FG001|Overall Study|Lost to Follow-up|2|||
37794129|NCT02216214|69430246|FG000|Overall Study|Protocol Violation|4|||
37693777|NCT01897714|69170079|FG001|Phase II (MTD)|Lost to Follow-up|0|||
37794130|NCT02216214|69430247|FG001|Overall Study|Protocol Violation|2|||
37794131|NCT02216214|69430246|FG000|Overall Study|Withdrawal by Subject|22|||
37794132|NCT02216214|69430247|FG001|Overall Study|Withdrawal by Subject|20|||
37794133|NCT02216214|69430246|FG000|Overall Study|Study Terminated By Sponsor|0|||
37794134|NCT02216214|69430247|FG001|Overall Study|Study Terminated By Sponsor|1|||
37794135|NCT02216214|69430246|FG000|Overall Study|Miscellaneous|1|||
37794136|NCT02216214|69430247|FG001|Overall Study|Miscellaneous|1|||
37794137|NCT02214186|69430278|FG000|Overall Study|Lost to Follow-up|1|||
37794138|NCT02214186|69430279|FG001|Overall Study|Lost to Follow-up|1|||
37794139|NCT02214186|69430278|FG000|Overall Study|Protocol Violation|1|||
37794140|NCT02214186|69430279|FG001|Overall Study|Protocol Violation|1|||
37794141|NCT02181504|69430335|FG000|Overall Study|Adverse Event|1|||
37794142|NCT02181504|69430336|FG001|Overall Study|Adverse Event|1|||
37794143|NCT02181504|69430337|FG002|Overall Study|Adverse Event|1|||
37794144|NCT02179398|69430367|FG000|Overall Study|Lack of obligatory data|3|||
37794145|NCT02179398|69430368|FG001|Overall Study|Lack of obligatory data|3|||
37794146|NCT02179398|69430367|FG000|Overall Study|Lost to Follow-up|0|||
37794147|NCT02179398|69430368|FG001|Overall Study|Lost to Follow-up|1|||
37794148|NCT02156076|69430382|FG000|Treatment Period|no longer meets study criteria|0|||
37794149|NCT02156076|69430383|FG001|Treatment Period|no longer meets study criteria|0|||
37794150|NCT02156076|69430384|FG002|Treatment Period|no longer meets study criteria|1|||
37794151|NCT02156076|69430385|FG003|Treatment Period|no longer meets study criteria|0|||
37794152|NCT02156076|69430382|FG000|Treatment Period|Poor/non-compliance|0|||
37794153|NCT02156076|69430383|FG001|Treatment Period|Poor/non-compliance|1|||
37794154|NCT02156076|69430384|FG002|Treatment Period|Poor/non-compliance|0|||
37794155|NCT02156076|69430385|FG003|Treatment Period|Poor/non-compliance|0|||
37794156|NCT02156076|69430382|FG000|Treatment Period|Lost to Follow-up|0|||
37794157|NCT02156076|69430383|FG001|Treatment Period|Lost to Follow-up|0|||
37794158|NCT02156076|69430384|FG002|Treatment Period|Lost to Follow-up|0|||
37794159|NCT02156076|69430385|FG003|Treatment Period|Lost to Follow-up|1|||
37794160|NCT02156076|69430382|FG000|Treatment Period|Withdrawal by Subject|0|||
37794161|NCT02156076|69430383|FG001|Treatment Period|Withdrawal by Subject|0|||
37794162|NCT02156076|69430384|FG002|Treatment Period|Withdrawal by Subject|1|||
37794163|NCT02156076|69430385|FG003|Treatment Period|Withdrawal by Subject|0|||
37794164|NCT02156076|69430382|FG000|Treatment Period|Subject request to discontinue treatment|0|||
37794165|NCT02156076|69430383|FG001|Treatment Period|Subject request to discontinue treatment|1|||
37794166|NCT02156076|69430384|FG002|Treatment Period|Subject request to discontinue treatment|0|||
37794167|NCT02156076|69430385|FG003|Treatment Period|Subject request to discontinue treatment|0|||
37794168|NCT02156076|69430382|FG000|Treatment Period|Adverse Event|0|||
37794169|NCT02156076|69430383|FG001|Treatment Period|Adverse Event|0|||
37794170|NCT02156076|69430384|FG002|Treatment Period|Adverse Event|0|||
37794171|NCT02156076|69430385|FG003|Treatment Period|Adverse Event|1|||
37794172|NCT02156076|69430382|FG000|Follow-up Period|Withdrawal by Subject|1|||
37794173|NCT02156076|69430383|FG001|Follow-up Period|Withdrawal by Subject|0|||
37794174|NCT02156076|69430384|FG002|Follow-up Period|Withdrawal by Subject|0|||
37794175|NCT02156076|69430385|FG003|Follow-up Period|Withdrawal by Subject|0|||
37794176|NCT02213094|69430397|FG000|Overall Study|Adverse Event|1|||
37794177|NCT02213094|69430398|FG001|Overall Study|Adverse Event|0|||
37794178|NCT02155608|69430406|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
37794179|NCT02155608|69430407|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
37794180|NCT02155608|69430406|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
37794181|NCT02155608|69430407|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
37975575|NCT00387153|69662870|FG000|Overall Study|Disease Progression|3|||
37975576|NCT00387153|69662870|FG000|Overall Study|Lack of Response|4|||
37975577|NCT00386607|69662874|FG000|Core|Adverse Event|40|||
37975578|NCT00386607|69662875|FG001|Core|Adverse Event|0|||
37975579|NCT00386607|69662874|FG000|Core|Abnormal laboratory value(s)|3|||
37794182|NCT01629966|69430422|FG000|Overall Study|Pregnancy|0|||
37794183|NCT01629966|69430423|FG001|Overall Study|Pregnancy|1|||
37794184|NCT01629966|69430424|FG002|Overall Study|Pregnancy|0|||
37794185|NCT01629966|69430422|FG000|Overall Study|Lost to Follow-up|10|||
37794186|NCT01629966|69430423|FG001|Overall Study|Lost to Follow-up|13|||
37794187|NCT01629966|69430424|FG002|Overall Study|Lost to Follow-up|9|||
37794188|NCT01629966|69430422|FG000|Overall Study|Withdrawal by Subject|8|||
37794189|NCT01629966|69430423|FG001|Overall Study|Withdrawal by Subject|9|||
37794190|NCT01629966|69430424|FG002|Overall Study|Withdrawal by Subject|16|||
37794191|NCT01629966|69430422|FG000|Overall Study|Protocol Violation|7|||
37794192|NCT01629966|69430423|FG001|Overall Study|Protocol Violation|9|||
37794193|NCT01629966|69430424|FG002|Overall Study|Protocol Violation|7|||
37794194|NCT01629966|69430422|FG000|Overall Study|Lack of Efficacy|5|||
37794195|NCT01629966|69430423|FG001|Overall Study|Lack of Efficacy|2|||
37794196|NCT01629966|69430424|FG002|Overall Study|Lack of Efficacy|4|||
37794197|NCT01629966|69430422|FG000|Overall Study|Adverse Event|11|||
37794198|NCT01629966|69430423|FG001|Overall Study|Adverse Event|18|||
37794199|NCT01629966|69430424|FG002|Overall Study|Adverse Event|30|||
37794200|NCT02177838|69430464|FG000|Overall Study|Withdrawal by Subject|1|||
37794201|NCT02177838|69430464|FG000|Overall Study|Physician Decision|1|||
37794202|NCT02177838|69430464|FG000|Overall Study|Death|1|||
37794203|NCT02177136|69430561|FG000|DB Phase|Withdrawal by Subject|2|||
37794204|NCT02177136|69430562|FG001|DB Phase|Withdrawal by Subject|0|||
37794205|NCT02177136|69430563|FG002|DB Phase|Withdrawal by Subject|0|||
37975580|NCT00386607|69662875|FG001|Core|Abnormal laboratory value(s)|0|||
37975581|NCT00386607|69662874|FG000|Core|Unsatisfactory therapeutic effect|23|||
37794206|NCT02177136|69430564|FG003|DB Phase|Withdrawal by Subject|0|||
37794207|NCT02177136|69430561|FG000|DB Phase|Discontinued Due to Pruritus|1|||
37975582|NCT00386607|69662875|FG001|Core|Unsatisfactory therapeutic effect|0|||
37794208|NCT02177136|69430562|FG001|DB Phase|Discontinued Due to Pruritus|3|||
37794209|NCT02177136|69430563|FG002|DB Phase|Discontinued Due to Pruritus|0|||
37794210|NCT02177136|69430564|FG003|DB Phase|Discontinued Due to Pruritus|0|||
37794211|NCT02177136|69430561|FG000|DB Phase|Adverse Event|3|||
37794212|NCT02177136|69430562|FG001|DB Phase|Adverse Event|2|||
37794213|NCT02177136|69430563|FG002|DB Phase|Adverse Event|3|||
37794214|NCT02177136|69430564|FG003|DB Phase|Adverse Event|0|||
37794215|NCT02177136|69430561|FG000|DB Phase|Protocol Violation|0|||
37794216|NCT02177136|69430562|FG001|DB Phase|Protocol Violation|0|||
37794217|NCT02177136|69430563|FG002|DB Phase|Protocol Violation|1|||
37794218|NCT02177136|69430564|FG003|DB Phase|Protocol Violation|0|||
37794219|NCT02177136|69430561|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
37794220|NCT02177136|69430562|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
37794221|NCT02177136|69430563|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
37794222|NCT02177136|69430564|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
37794223|NCT02177136|69430561|FG000|LTSE Phase|Withdrawal by Subject|0|||
37794224|NCT02177136|69430562|FG001|LTSE Phase|Withdrawal by Subject|0|||
37794225|NCT02177136|69430563|FG002|LTSE Phase|Withdrawal by Subject|0|||
37794226|NCT02177136|69430564|FG003|LTSE Phase|Withdrawal by Subject|6|||
37794227|NCT02177136|69430561|FG000|LTSE Phase|Adverse Event|0|||
37794228|NCT02177136|69430562|FG001|LTSE Phase|Adverse Event|0|||
37794229|NCT02177136|69430563|FG002|LTSE Phase|Adverse Event|0|||
37794230|NCT02177136|69430564|FG003|LTSE Phase|Adverse Event|10|||
37794231|NCT02177136|69430561|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
37794232|NCT02177136|69430562|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
37794233|NCT02177136|69430563|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
37794234|NCT02177136|69430564|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
37794235|NCT02177136|69430561|FG000|LTSE Phase|Physician Decision|0|||
37794236|NCT02177136|69430562|FG001|LTSE Phase|Physician Decision|0|||
37794237|NCT02177136|69430563|FG002|LTSE Phase|Physician Decision|0|||
37794238|NCT02177136|69430564|FG003|LTSE Phase|Physician Decision|2|||
37794239|NCT02177136|69430561|FG000|LTSE Phase|Lost to Follow-up|0|||
37794240|NCT02177136|69430562|FG001|LTSE Phase|Lost to Follow-up|0|||
37794241|NCT02177136|69430563|FG002|LTSE Phase|Lost to Follow-up|0|||
37794242|NCT02177136|69430564|FG003|LTSE Phase|Lost to Follow-up|1|||
37794243|NCT02177136|69430561|FG000|LTSE Phase|Participant Moved|0|||
37794244|NCT02177136|69430562|FG001|LTSE Phase|Participant Moved|0|||
37794245|NCT02177136|69430563|FG002|LTSE Phase|Participant Moved|0|||
37794246|NCT02177136|69430564|FG003|LTSE Phase|Participant Moved|1|||
37794247|NCT02176356|69430592|FG000|Overall Study|Screen Failure|14|||
37794248|NCT02176356|69430592|FG000|Overall Study|Lost to Follow-up|4|||
37794249|NCT02176356|69430592|FG000|Overall Study|Personal Reasons|3|||
37794250|NCT02176356|69430592|FG000|Overall Study|Other Miscellaneous Reasons|2|||
37794251|NCT02210208|69430602|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
37794252|NCT02210208|69430602|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
37794253|NCT02210208|69430602|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
37794254|NCT02209506|69430622|FG000|Overall Study|Withdrawal by Subject|0|||
37794255|NCT02209506|69430623|FG001|Overall Study|Withdrawal by Subject|0|||
37794256|NCT02209506|69430624|FG002|Overall Study|Withdrawal by Subject|0|||
37794257|NCT02209506|69430625|FG003|Overall Study|Withdrawal by Subject|0|||
37794258|NCT02209506|69430626|FG004|Overall Study|Withdrawal by Subject|1|||
37794259|NCT02153736|69430643|FG000|Overall Study|Lost to Follow-up|1|||
37794260|NCT02153736|69430644|FG001|Overall Study|Lost to Follow-up|0|||
37794261|NCT02153736|69430643|FG000|Overall Study|Medical status change made ineligible|1|||
37794262|NCT02153736|69430644|FG001|Overall Study|Medical status change made ineligible|0|||
37794263|NCT02153736|69430643|FG000|Overall Study|Death|0|||
37794264|NCT02153736|69430644|FG001|Overall Study|Death|1|||
37794265|NCT02153736|69430643|FG000|Overall Study|Withdrawal by Subject|0|||
37794266|NCT02153736|69430644|FG001|Overall Study|Withdrawal by Subject|1|||
37794267|NCT02175966|69430652|FG000|Follow-up Period|Lack of Efficacy|10|||
37794268|NCT02175966|69430653|FG001|Follow-up Period|Lack of Efficacy|6|||
37794269|NCT02153346|69430659|FG000|Overall Study|Lost to Follow-up|11|||
37794270|NCT02174562|69430666|FG000|Overall Study|Withdrawal by Subject|7|||
37794271|NCT02174562|69430667|FG001|Overall Study|Withdrawal by Subject|2|||
37794272|NCT02174562|69430666|FG000|Overall Study|Death|2|||
37794273|NCT02174562|69430667|FG001|Overall Study|Death|0|||
37794274|NCT02174562|69430666|FG000|Overall Study|Lost to Follow-up|0|||
37794275|NCT02174562|69430667|FG001|Overall Study|Lost to Follow-up|3|||
37794276|NCT02136576|69430676|FG000|Overall Study|Lost to Follow-up|2|||
37794277|NCT02136576|69430677|FG001|Overall Study|Lost to Follow-up|0|||
37794278|NCT02136576|69430678|FG002|Overall Study|Lost to Follow-up|0|||
37794279|NCT02153112|69430935|FG000|Overall Study|Adverse Event|0|||
37794280|NCT02153112|69430936|FG001|Overall Study|Adverse Event|0|||
37794281|NCT02153112|69430937|FG002|Overall Study|Adverse Event|1|||
37794282|NCT02153112|69430938|FG003|Overall Study|Adverse Event|0|||
37794283|NCT02153112|69430939|FG004|Overall Study|Adverse Event|0|||
37794284|NCT02153112|69430940|FG005|Overall Study|Adverse Event|0|||
37794285|NCT02153112|69430941|FG006|Overall Study|Adverse Event|0|||
37794286|NCT02153112|69430942|FG007|Overall Study|Adverse Event|0|||
37794287|NCT02153112|69430943|FG008|Overall Study|Adverse Event|0|||
37794288|NCT02153112|69430944|FG009|Overall Study|Adverse Event|0|||
37794289|NCT02153112|69430935|FG000|Overall Study|Lost to Follow-up|1|||
37794290|NCT02153112|69430936|FG001|Overall Study|Lost to Follow-up|1|||
37794291|NCT02153112|69430937|FG002|Overall Study|Lost to Follow-up|0|||
37794292|NCT02153112|69430938|FG003|Overall Study|Lost to Follow-up|0|||
37794293|NCT02153112|69430939|FG004|Overall Study|Lost to Follow-up|2|||
37794294|NCT02153112|69430940|FG005|Overall Study|Lost to Follow-up|1|||
37794295|NCT02153112|69430941|FG006|Overall Study|Lost to Follow-up|1|||
37794296|NCT02153112|69430942|FG007|Overall Study|Lost to Follow-up|0|||
37794297|NCT02153112|69430943|FG008|Overall Study|Lost to Follow-up|1|||
37794298|NCT02153112|69430944|FG009|Overall Study|Lost to Follow-up|1|||
37794299|NCT02153112|69430935|FG000|Overall Study|Withdrawal by Subject|3|||
37794300|NCT02153112|69430936|FG001|Overall Study|Withdrawal by Subject|1|||
37794301|NCT02153112|69430937|FG002|Overall Study|Withdrawal by Subject|2|||
37794302|NCT02153112|69430938|FG003|Overall Study|Withdrawal by Subject|2|||
37794303|NCT02153112|69430939|FG004|Overall Study|Withdrawal by Subject|1|||
37794304|NCT02153112|69430940|FG005|Overall Study|Withdrawal by Subject|1|||
37794305|NCT02153112|69430941|FG006|Overall Study|Withdrawal by Subject|7|||
37794306|NCT02153112|69430942|FG007|Overall Study|Withdrawal by Subject|2|||
37794307|NCT02153112|69430943|FG008|Overall Study|Withdrawal by Subject|13|||
37794308|NCT02153112|69430944|FG009|Overall Study|Withdrawal by Subject|12|||
37794309|NCT02153112|69430935|FG000|Overall Study|Reason not Specified|0|||
37794310|NCT02153112|69430936|FG001|Overall Study|Reason not Specified|0|||
37794311|NCT02153112|69430937|FG002|Overall Study|Reason not Specified|0|||
37794312|NCT02153112|69430938|FG003|Overall Study|Reason not Specified|0|||
37794313|NCT02153112|69430939|FG004|Overall Study|Reason not Specified|0|||
37794314|NCT02153112|69430940|FG005|Overall Study|Reason not Specified|0|||
37794315|NCT02153112|69430941|FG006|Overall Study|Reason not Specified|0|||
37794316|NCT02153112|69430942|FG007|Overall Study|Reason not Specified|0|||
37794317|NCT02153112|69430943|FG008|Overall Study|Reason not Specified|1|||
37794318|NCT02153112|69430944|FG009|Overall Study|Reason not Specified|1|||
37794319|NCT02133924|69430994|FG000|Overall Study|Death|38|||
37794320|NCT02133924|69430994|FG000|Overall Study|Physician Decision|1|||
37794321|NCT02133924|69430994|FG000|Overall Study|Withdrawal by Subject|3|||
37794322|NCT02173704|69431085|FG000|Overall Study|Adverse Event|1|||
37794323|NCT02173704|69431086|FG001|Overall Study|Adverse Event|0|||
37794324|NCT02173704|69431085|FG000|Overall Study|Lost to Follow-up|1|||
37794325|NCT02173704|69431086|FG001|Overall Study|Lost to Follow-up|0|||
37794326|NCT02173704|69431085|FG000|Overall Study|Other|1|||
37794327|NCT02173704|69431086|FG001|Overall Study|Other|0|||
37794328|NCT02173704|69431085|FG000|Overall Study|Protocol Violation|1|||
37794329|NCT02173704|69431086|FG001|Overall Study|Protocol Violation|0|||
37794330|NCT02173704|69431085|FG000|Overall Study|Withdrawal by Subject|9|||
37794331|NCT02173704|69431086|FG001|Overall Study|Withdrawal by Subject|4|||
37794332|NCT02173548|69431107|FG000|Overall Study|Lost to Follow-up|0|||
37794333|NCT02173548|69431108|FG001|Overall Study|Lost to Follow-up|2|||
37794334|NCT02173548|69431107|FG000|Overall Study|Withdrawal by Subject|1|||
37794335|NCT02173548|69431108|FG001|Overall Study|Withdrawal by Subject|0|||
37794336|NCT02173158|69431124|FG000|Efficacy Phase|Adverse Event|1|||
37794337|NCT02152566|69431146|FG000|Overall Study|Lost to Follow-up|1|||
37794338|NCT02152566|69431146|FG000|Overall Study|Withdrawal by Subject|2|||
37794339|NCT02171130|69431175|FG000|Overall Study|Death|1|||
37794340|NCT02171130|69431175|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
37794341|NCT02171130|69431175|FG000|Overall Study|Discontinued; Site Termination|5|||
37794342|NCT02171130|69431175|FG000|Overall Study|Withdrawal by Subject|3|||
37794343|NCT02171130|69431175|FG000|Overall Study|Physician Decision|1|||
37794344|NCT02171130|69431175|FG000|Overall Study|Lost to Follow-up|1|||
37794345|NCT02171130|69431175|FG000|Overall Study|Met Exclusion Criteria|1|||
37693778|NCT01897714|69170080|FG002|Phase II (MTD)|Lost to Follow-up|0|||
37794346|NCT03603314|69437030|FG000|Overall Study|Lost to Follow-up|0|||
37794347|NCT03603314|69437031|FG001|Overall Study|Lost to Follow-up|3|||
37794348|NCT03603314|69437032|FG002|Overall Study|Lost to Follow-up|0|||
37794349|NCT03603314|69437030|FG000|Overall Study|Protocol Violation|0|||
37794350|NCT03603314|69437031|FG001|Overall Study|Protocol Violation|1|||
37794351|NCT03603314|69437032|FG002|Overall Study|Protocol Violation|0|||
37794352|NCT03603314|69437030|FG000|Overall Study|Adverse Event|2|||
37794353|NCT03603314|69437031|FG001|Overall Study|Adverse Event|0|||
37794354|NCT03603314|69437032|FG002|Overall Study|Adverse Event|0|||
37794355|NCT03603314|69437030|FG000|Overall Study|Physician Decision|1|||
37794356|NCT03603314|69437031|FG001|Overall Study|Physician Decision|1|||
37794357|NCT03603314|69437032|FG002|Overall Study|Physician Decision|0|||
37794358|NCT03603314|69437030|FG000|Overall Study|Withdrawal by Subject|4|||
37794359|NCT03603314|69437031|FG001|Overall Study|Withdrawal by Subject|5|||
37794360|NCT03603314|69437032|FG002|Overall Study|Withdrawal by Subject|3|||
37794361|NCT03603314|69437030|FG000|Overall Study|Other|0|||
37794362|NCT03603314|69437031|FG001|Overall Study|Other|1|||
37794363|NCT03603314|69437032|FG002|Overall Study|Other|0|||
37794364|NCT04302350|69437047|FG000|Overall Study|Physician Decision|1|||
37794365|NCT04302350|69437048|FG001|Overall Study|Physician Decision|1|||
37794366|NCT04302350|69437049|FG002|Overall Study|Physician Decision|2|||
37794367|NCT04302350|69437047|FG000|Overall Study|Lack of Efficacy|1|||
37794368|NCT04302350|69437048|FG001|Overall Study|Lack of Efficacy|1|||
37794369|NCT04302350|69437049|FG002|Overall Study|Lack of Efficacy|4|||
37794370|NCT04302350|69437047|FG000|Overall Study|Adverse Event|0|||
37794371|NCT04302350|69437048|FG001|Overall Study|Adverse Event|1|||
37794372|NCT04302350|69437049|FG002|Overall Study|Adverse Event|2|||
37794373|NCT02335424|69437084|FG000|Overall Study|Withdrawal by Subject|19|||
37794374|NCT02335424|69437084|FG000|Overall Study|Adverse Event|25|||
37794375|NCT02335424|69437084|FG000|Overall Study|Death|273|||
37794376|NCT02335424|69437084|FG000|Overall Study|Lost to Follow-up|3|||
37794377|NCT02335424|69437084|FG000|Overall Study|Physician Decision|13|||
37794378|NCT02335424|69437084|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
37794379|NCT02335424|69437084|FG000|Overall Study|Protocol Violation|1|||
37794380|NCT02335424|69437084|FG000|Overall Study|Screen failure|1|||
37794381|NCT03805412|69437091|FG000|Overall Study|Lost to Follow-up|0|||
37794382|NCT03805412|69437092|FG001|Overall Study|Lost to Follow-up|1|||
37794383|NCT04791319|69437112|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
37794384|NCT04791319|69437113|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
37794385|NCT04791319|69437114|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
37794386|NCT04791319|69437115|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
37794387|NCT04791319|69437116|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
37794388|NCT04791319|69437117|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
37794389|NCT04791319|69437118|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
37794390|NCT04791319|69437119|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
37794391|NCT04791319|69437120|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
37794392|NCT04791319|69437121|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
37794393|NCT04791319|69437122|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
37794394|NCT04791319|69437112|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
37794395|NCT04791319|69437113|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
37693779|NCT01897714|69170081|FG003|Phase II (MTD)|Lost to Follow-up|0|||
37693780|NCT01897714|69170082|FG004|Phase II (MTD)|Lost to Follow-up|1|||
37693781|NCT01897714|69170083|FG005|Phase II (MTD)|Lost to Follow-up|0|||
37693782|NCT01897714|69170078|FG000|Phase II (MTD)|Death|0|||
37693783|NCT01897714|69170079|FG001|Phase II (MTD)|Death|0|||
37693784|NCT01897714|69170080|FG002|Phase II (MTD)|Death|0|||
37693785|NCT01897714|69170081|FG003|Phase II (MTD)|Death|0|||
37693786|NCT01897714|69170082|FG004|Phase II (MTD)|Death|25|||
37693787|NCT01897714|69170083|FG005|Phase II (MTD)|Death|10|||
37693788|NCT01897714|69170078|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
37693789|NCT01897714|69170079|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
37693790|NCT01897714|69170080|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
37693791|NCT01897714|69170081|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
37693792|NCT01897714|69170082|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
37693793|NCT01897714|69170083|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
37693794|NCT01897714|69170078|FG000|Phase II (MTD)|Other|0|||
37693795|NCT01897714|69170079|FG001|Phase II (MTD)|Other|0|||
37693796|NCT01897714|69170080|FG002|Phase II (MTD)|Other|0|||
37693797|NCT01897714|69170081|FG003|Phase II (MTD)|Other|0|||
37693798|NCT01897714|69170082|FG004|Phase II (MTD)|Other|3|||
37693799|NCT01897714|69170083|FG005|Phase II (MTD)|Other|0|||
37794396|NCT04791319|69437114|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
37794397|NCT04791319|69437115|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
37794398|NCT04791319|69437116|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
37693800|NCT01861522|69170101|FG000|Overall Study|Adverse Event|1|||
37693801|NCT01861522|69170102|FG001|Overall Study|Adverse Event|0|||
37794399|NCT04791319|69437117|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
37693802|NCT01861522|69170101|FG000|Overall Study|Withdrawal by Subject|2|||
37693803|NCT01861522|69170102|FG001|Overall Study|Withdrawal by Subject|0|||
37794400|NCT04791319|69437118|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
37794401|NCT04791319|69437119|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
37794402|NCT04791319|69437120|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
37794403|NCT04791319|69437121|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
37794404|NCT04791319|69437122|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
37794405|NCT04791319|69437112|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
37794406|NCT04791319|69437113|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
37794407|NCT04791319|69437114|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
37794408|NCT04791319|69437115|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
37794409|NCT04791319|69437116|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
37794410|NCT04791319|69437117|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
37794411|NCT04791319|69437118|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
37794412|NCT04791319|69437119|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
37794413|NCT04791319|69437120|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
37794414|NCT04791319|69437121|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
37794415|NCT04791319|69437122|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
37794416|NCT04791319|69437112|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
37794417|NCT04791319|69437113|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
37794418|NCT04791319|69437114|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
37794419|NCT04791319|69437115|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
37794420|NCT04791319|69437116|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
37794421|NCT04791319|69437117|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
37794422|NCT04791319|69437118|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
37794423|NCT04791319|69437119|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
37794424|NCT04791319|69437120|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
37794425|NCT04791319|69437121|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
37794426|NCT04791319|69437122|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
37794427|NCT04791319|69437112|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
37794428|NCT04791319|69437113|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
37794429|NCT04791319|69437114|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
37794430|NCT04791319|69437115|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
37794431|NCT04791319|69437116|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
37794432|NCT04791319|69437117|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
37794433|NCT04791319|69437118|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
37794434|NCT04791319|69437119|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
37794435|NCT04791319|69437120|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
37794436|NCT04791319|69437121|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
37794437|NCT04791319|69437122|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
37794438|NCT04791319|69437112|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
37794439|NCT04791319|69437113|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
37794440|NCT04791319|69437114|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
37794441|NCT04791319|69437115|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
37794442|NCT04791319|69437116|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
37794443|NCT04791319|69437117|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
37794444|NCT04791319|69437118|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
37794445|NCT04791319|69437119|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
37794446|NCT04791319|69437120|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
37794447|NCT04791319|69437121|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
37794448|NCT04791319|69437122|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
37794449|NCT04791319|69437112|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
37794450|NCT04791319|69437113|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
37794451|NCT04791319|69437114|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
37794452|NCT04791319|69437115|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
37794453|NCT04791319|69437116|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
37794454|NCT04791319|69437117|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
37794455|NCT04791319|69437118|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
37794456|NCT04791319|69437119|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
37975583|NCT00386607|69662874|FG000|Core|Condition no longer requires study drug|4|||
37975584|NCT00386607|69662875|FG001|Core|Condition no longer requires study drug|0|||
37975585|NCT00386607|69662874|FG000|Core|Patient withdrew consent|15|||
37975586|NCT00386607|69662875|FG001|Core|Patient withdrew consent|0|||
37693804|NCT01860976|69170110|FG000|Blinded Treatment|Adverse Event|1|||
37975587|NCT00386607|69662874|FG000|Core|Lost to Follow-up|23|||
37975588|NCT00386607|69662875|FG001|Core|Lost to Follow-up|0|||
37794457|NCT04791319|69437120|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
37794458|NCT04791319|69437121|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
37794459|NCT04791319|69437122|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
37794460|NCT04791319|69437112|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
37794461|NCT04791319|69437113|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
37794462|NCT04791319|69437114|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
37794463|NCT04791319|69437115|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
37794464|NCT04791319|69437116|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
37794465|NCT04791319|69437117|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
37794466|NCT04791319|69437118|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
37794467|NCT04791319|69437119|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
37794468|NCT04791319|69437120|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
37794469|NCT04791319|69437121|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
37794470|NCT04791319|69437122|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
37794471|NCT04791319|69437112|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
37794472|NCT04791319|69437113|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
37794473|NCT04791319|69437114|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
37794474|NCT04791319|69437115|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
37794475|NCT04791319|69437116|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
37794476|NCT04791319|69437117|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
37794477|NCT04791319|69437118|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
37794478|NCT04791319|69437119|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
37794479|NCT04791319|69437120|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
37794480|NCT04791319|69437121|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
37794481|NCT04791319|69437122|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
37794482|NCT03472495|69437179|FG000|Overall Study|Treatment no longer indicated|1|||
37794483|NCT03472495|69437180|FG001|Overall Study|Treatment no longer indicated|2|||
37794484|NCT03472495|69437179|FG000|Overall Study|Physician Decision|0|||
37794485|NCT03472495|69437180|FG001|Overall Study|Physician Decision|2|||
37794486|NCT03234907|69437188|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
37794487|NCT03234907|69437189|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
37794488|NCT03234907|69437190|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
37794489|NCT03234907|69437191|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
37794490|NCT03234907|69437192|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
37794491|NCT03234907|69437193|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
37794492|NCT03234907|69437188|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
37794493|NCT03234907|69437189|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
37794494|NCT03234907|69437190|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
37794495|NCT03234907|69437191|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
37794496|NCT03234907|69437192|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
37794497|NCT03234907|69437193|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
37794498|NCT03234907|69437188|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
37794499|NCT03234907|69437189|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
37794500|NCT03234907|69437190|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
37794501|NCT03234907|69437191|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
37794502|NCT03234907|69437192|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
37794503|NCT03234907|69437193|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
37794504|NCT03234907|69437188|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
37794505|NCT03234907|69437189|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
37794506|NCT03234907|69437190|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
37794507|NCT03234907|69437191|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
37794508|NCT03234907|69437192|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
37794509|NCT03234907|69437193|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
37794510|NCT03234907|69437188|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
37794511|NCT03234907|69437189|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
37794512|NCT03234907|69437190|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
37794513|NCT03234907|69437191|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
37794514|NCT03234907|69437192|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
37794515|NCT03234907|69437193|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
37794516|NCT03234907|69437188|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
37794517|NCT03234907|69437189|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
37794518|NCT03234907|69437190|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
37794519|NCT03234907|69437191|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
37794520|NCT03234907|69437192|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
37794521|NCT03234907|69437193|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
37794522|NCT03234907|69437188|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
37794523|NCT03234907|69437189|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
37794524|NCT03234907|69437190|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
37794525|NCT03234907|69437191|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
37794526|NCT03234907|69437192|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
37794527|NCT03234907|69437193|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
37794528|NCT03818581|69437207|FG000|Overall Study|Adverse Event|1|||
37794529|NCT03818581|69437208|FG001|Overall Study|Adverse Event|0|||
37794530|NCT03818581|69437209|FG002|Overall Study|Adverse Event|0|||
37794531|NCT03818581|69437210|FG003|Overall Study|Adverse Event|0|||
37794532|NCT03818581|69437211|FG004|Overall Study|Adverse Event|0|||
37794533|NCT03818581|69437207|FG000|Overall Study|Covid-19|2|||
37794534|NCT03818581|69437208|FG001|Overall Study|Covid-19|0|||
37794535|NCT03818581|69437209|FG002|Overall Study|Covid-19|0|||
37794536|NCT03818581|69437210|FG003|Overall Study|Covid-19|0|||
37794537|NCT03818581|69437211|FG004|Overall Study|Covid-19|1|||
37794538|NCT03818581|69437207|FG000|Overall Study|Withdrawal by Subject|0|||
37794539|NCT03818581|69437208|FG001|Overall Study|Withdrawal by Subject|0|||
37794540|NCT03818581|69437209|FG002|Overall Study|Withdrawal by Subject|0|||
37794541|NCT03818581|69437210|FG003|Overall Study|Withdrawal by Subject|0|||
37794542|NCT03818581|69437211|FG004|Overall Study|Withdrawal by Subject|1|||
37794543|NCT03818581|69437207|FG000|Overall Study|No longer met study criteria|1|||
37794544|NCT03818581|69437208|FG001|Overall Study|No longer met study criteria|0|||
37794545|NCT03818581|69437209|FG002|Overall Study|No longer met study criteria|0|||
37794546|NCT03818581|69437210|FG003|Overall Study|No longer met study criteria|0|||
37794547|NCT03818581|69437211|FG004|Overall Study|No longer met study criteria|2|||
37794548|NCT03736447|69437225|FG000|Overall Study|Adverse Event|5|||
37794549|NCT03736447|69437226|FG001|Overall Study|Adverse Event|1|||
37794550|NCT03736447|69437225|FG000|Overall Study|Withdrawal by Subject|5|||
37794551|NCT03736447|69437226|FG001|Overall Study|Withdrawal by Subject|1|||
37794552|NCT03736447|69437225|FG000|Overall Study|Lost to Follow-up|1|||
37794553|NCT03736447|69437226|FG001|Overall Study|Lost to Follow-up|0|||
37794554|NCT03736447|69437225|FG000|Overall Study|Physician Decision|1|||
37794555|NCT03736447|69437226|FG001|Overall Study|Physician Decision|0|||
37794556|NCT03736447|69437225|FG000|Overall Study|Continued commitment to study treatment|3|||
37794557|NCT03736447|69437226|FG001|Overall Study|Continued commitment to study treatment|0|||
37794558|NCT03736447|69437225|FG000|Overall Study|Taste aversion to study product|0|||
37794559|NCT03736447|69437226|FG001|Overall Study|Taste aversion to study product|1|||
37794560|NCT02132754|69437275|FG000|Overall Study|Adverse Event|0|||
37794561|NCT02132754|69437276|FG001|Overall Study|Adverse Event|0|||
37794562|NCT02132754|69437277|FG002|Overall Study|Adverse Event|0|||
37794563|NCT02132754|69437278|FG003|Overall Study|Adverse Event|0|||
37794564|NCT02132754|69437279|FG004|Overall Study|Adverse Event|0|||
37794565|NCT02132754|69437280|FG005|Overall Study|Adverse Event|0|||
37794566|NCT02132754|69437281|FG006|Overall Study|Adverse Event|0|||
37794567|NCT02132754|69437282|FG007|Overall Study|Adverse Event|0|||
37794568|NCT02132754|69437283|FG008|Overall Study|Adverse Event|0|||
37794569|NCT02132754|69437284|FG009|Overall Study|Adverse Event|0|||
37794570|NCT02132754|69437285|FG010|Overall Study|Adverse Event|0|||
37794571|NCT02132754|69437286|FG011|Overall Study|Adverse Event|0|||
37794572|NCT02132754|69437287|FG012|Overall Study|Adverse Event|0|||
37794573|NCT02132754|69437288|FG013|Overall Study|Adverse Event|0|||
37794574|NCT02132754|69437289|FG014|Overall Study|Adverse Event|0|||
37794575|NCT02132754|69437290|FG015|Overall Study|Adverse Event|0|||
37864163|NCT00991276|69547782|FG005|Third Intervention Period|Adverse Event|0|||
37794576|NCT02132754|69437291|FG016|Overall Study|Adverse Event|0|||
37794577|NCT02132754|69437292|FG017|Overall Study|Adverse Event|1|||
37794578|NCT02132754|69437293|FG018|Overall Study|Adverse Event|0|||
37794579|NCT02132754|69437294|FG019|Overall Study|Adverse Event|0|||
37794580|NCT02132754|69437295|FG020|Overall Study|Adverse Event|0|||
37794581|NCT02132754|69437296|FG021|Overall Study|Adverse Event|0|||
37794582|NCT02132754|69437297|FG022|Overall Study|Adverse Event|0|||
37794583|NCT02132754|69437298|FG023|Overall Study|Adverse Event|0|||
37794584|NCT02132754|69437299|FG024|Overall Study|Adverse Event|0|||
37794585|NCT02132754|69437300|FG025|Overall Study|Adverse Event|1|||
37794586|NCT02132754|69437301|FG026|Overall Study|Adverse Event|1|||
37794587|NCT02132754|69437302|FG027|Overall Study|Adverse Event|0|||
37794588|NCT02132754|69437303|FG028|Overall Study|Adverse Event|0|||
37794589|NCT02132754|69437304|FG029|Overall Study|Adverse Event|0|||
37794590|NCT02132754|69437305|FG030|Overall Study|Adverse Event|1|||
37693805|NCT01860976|69170111|FG001|Blinded Treatment|Adverse Event|3|||
37794591|NCT02132754|69437306|FG031|Overall Study|Adverse Event|0|||
37794592|NCT02132754|69437307|FG032|Overall Study|Adverse Event|1|||
37794593|NCT02132754|69437308|FG033|Overall Study|Adverse Event|1|||
37794594|NCT02132754|69437275|FG000|Overall Study|Clinical Progression|0|||
37794595|NCT02132754|69437276|FG001|Overall Study|Clinical Progression|0|||
37794596|NCT02132754|69437277|FG002|Overall Study|Clinical Progression|0|||
37794597|NCT02132754|69437278|FG003|Overall Study|Clinical Progression|0|||
37794598|NCT02132754|69437279|FG004|Overall Study|Clinical Progression|0|||
37794599|NCT02132754|69437280|FG005|Overall Study|Clinical Progression|0|||
37794600|NCT02132754|69437281|FG006|Overall Study|Clinical Progression|0|||
37794601|NCT02132754|69437282|FG007|Overall Study|Clinical Progression|0|||
37794602|NCT02132754|69437283|FG008|Overall Study|Clinical Progression|0|||
37794603|NCT02132754|69437284|FG009|Overall Study|Clinical Progression|1|||
37794604|NCT02132754|69437285|FG010|Overall Study|Clinical Progression|0|||
37794605|NCT02132754|69437286|FG011|Overall Study|Clinical Progression|0|||
37794606|NCT02132754|69437287|FG012|Overall Study|Clinical Progression|0|||
37794607|NCT02132754|69437288|FG013|Overall Study|Clinical Progression|0|||
37794608|NCT02132754|69437289|FG014|Overall Study|Clinical Progression|0|||
37794609|NCT02132754|69437290|FG015|Overall Study|Clinical Progression|0|||
37794610|NCT02132754|69437291|FG016|Overall Study|Clinical Progression|1|||
37794611|NCT02132754|69437292|FG017|Overall Study|Clinical Progression|1|||
37794612|NCT02132754|69437293|FG018|Overall Study|Clinical Progression|0|||
37794613|NCT02132754|69437294|FG019|Overall Study|Clinical Progression|1|||
37794614|NCT02132754|69437295|FG020|Overall Study|Clinical Progression|0|||
37794615|NCT02132754|69437296|FG021|Overall Study|Clinical Progression|0|||
37794616|NCT02132754|69437297|FG022|Overall Study|Clinical Progression|1|||
37794617|NCT02132754|69437298|FG023|Overall Study|Clinical Progression|0|||
37794618|NCT02132754|69437299|FG024|Overall Study|Clinical Progression|1|||
37794619|NCT02132754|69437300|FG025|Overall Study|Clinical Progression|1|||
37794620|NCT02132754|69437301|FG026|Overall Study|Clinical Progression|0|||
37794621|NCT02132754|69437302|FG027|Overall Study|Clinical Progression|1|||
37794622|NCT02132754|69437303|FG028|Overall Study|Clinical Progression|1|||
37794623|NCT02132754|69437304|FG029|Overall Study|Clinical Progression|0|||
37794624|NCT02132754|69437305|FG030|Overall Study|Clinical Progression|1|||
37794625|NCT02132754|69437306|FG031|Overall Study|Clinical Progression|0|||
37794626|NCT02132754|69437307|FG032|Overall Study|Clinical Progression|0|||
37794627|NCT02132754|69437308|FG033|Overall Study|Clinical Progression|2|||
37794628|NCT02132754|69437275|FG000|Overall Study|Death|0|||
37794629|NCT02132754|69437276|FG001|Overall Study|Death|0|||
37794630|NCT02132754|69437277|FG002|Overall Study|Death|0|||
37794631|NCT02132754|69437278|FG003|Overall Study|Death|0|||
37975589|NCT00386607|69662874|FG000|Core|Administrative problems|1|||
37794632|NCT02132754|69437279|FG004|Overall Study|Death|0|||
37794633|NCT02132754|69437280|FG005|Overall Study|Death|0|||
37794634|NCT02132754|69437281|FG006|Overall Study|Death|0|||
37794635|NCT02132754|69437282|FG007|Overall Study|Death|0|||
37794636|NCT02132754|69437283|FG008|Overall Study|Death|0|||
37794637|NCT02132754|69437284|FG009|Overall Study|Death|0|||
37794638|NCT02132754|69437285|FG010|Overall Study|Death|0|||
37794639|NCT02132754|69437286|FG011|Overall Study|Death|0|||
37794640|NCT02132754|69437287|FG012|Overall Study|Death|0|||
37794641|NCT02132754|69437288|FG013|Overall Study|Death|0|||
37794642|NCT02132754|69437289|FG014|Overall Study|Death|0|||
37794643|NCT02132754|69437290|FG015|Overall Study|Death|1|||
37794644|NCT02132754|69437291|FG016|Overall Study|Death|0|||
37794645|NCT02132754|69437292|FG017|Overall Study|Death|0|||
37794646|NCT02132754|69437293|FG018|Overall Study|Death|0|||
37794647|NCT02132754|69437294|FG019|Overall Study|Death|1|||
37794648|NCT02132754|69437295|FG020|Overall Study|Death|0|||
37794649|NCT02132754|69437296|FG021|Overall Study|Death|1|||
37794650|NCT02132754|69437297|FG022|Overall Study|Death|0|||
37794651|NCT02132754|69437298|FG023|Overall Study|Death|0|||
37794652|NCT02132754|69437299|FG024|Overall Study|Death|0|||
37794653|NCT02132754|69437300|FG025|Overall Study|Death|0|||
37794654|NCT02132754|69437301|FG026|Overall Study|Death|1|||
37794655|NCT02132754|69437302|FG027|Overall Study|Death|0|||
37794656|NCT02132754|69437303|FG028|Overall Study|Death|0|||
37794657|NCT02132754|69437304|FG029|Overall Study|Death|0|||
37794658|NCT02132754|69437305|FG030|Overall Study|Death|0|||
37794659|NCT02132754|69437306|FG031|Overall Study|Death|0|||
37794660|NCT02132754|69437307|FG032|Overall Study|Death|0|||
37794661|NCT02132754|69437308|FG033|Overall Study|Death|2|||
37794662|NCT02132754|69437275|FG000|Overall Study|Excluded Medication|0|||
37794663|NCT02132754|69437276|FG001|Overall Study|Excluded Medication|0|||
37794664|NCT02132754|69437277|FG002|Overall Study|Excluded Medication|0|||
37794665|NCT02132754|69437278|FG003|Overall Study|Excluded Medication|0|||
37794666|NCT02132754|69437279|FG004|Overall Study|Excluded Medication|0|||
37794667|NCT02132754|69437280|FG005|Overall Study|Excluded Medication|0|||
37794668|NCT02132754|69437281|FG006|Overall Study|Excluded Medication|0|||
37794669|NCT02132754|69437282|FG007|Overall Study|Excluded Medication|0|||
37794670|NCT02132754|69437283|FG008|Overall Study|Excluded Medication|0|||
37794671|NCT02132754|69437284|FG009|Overall Study|Excluded Medication|0|||
37794672|NCT02132754|69437285|FG010|Overall Study|Excluded Medication|0|||
37794673|NCT02132754|69437286|FG011|Overall Study|Excluded Medication|0|||
37794674|NCT02132754|69437287|FG012|Overall Study|Excluded Medication|0|||
37794675|NCT02132754|69437288|FG013|Overall Study|Excluded Medication|0|||
37794676|NCT02132754|69437289|FG014|Overall Study|Excluded Medication|0|||
37794677|NCT02132754|69437290|FG015|Overall Study|Excluded Medication|0|||
37794678|NCT02132754|69437291|FG016|Overall Study|Excluded Medication|0|||
37794679|NCT02132754|69437292|FG017|Overall Study|Excluded Medication|0|||
37794680|NCT02132754|69437293|FG018|Overall Study|Excluded Medication|0|||
37794681|NCT02132754|69437294|FG019|Overall Study|Excluded Medication|0|||
37794682|NCT02132754|69437295|FG020|Overall Study|Excluded Medication|1|||
37794683|NCT02132754|69437296|FG021|Overall Study|Excluded Medication|0|||
37794684|NCT02132754|69437297|FG022|Overall Study|Excluded Medication|0|||
37794685|NCT02132754|69437298|FG023|Overall Study|Excluded Medication|0|||
37794686|NCT02132754|69437299|FG024|Overall Study|Excluded Medication|0|||
37794687|NCT02132754|69437300|FG025|Overall Study|Excluded Medication|0|||
37794688|NCT02132754|69437301|FG026|Overall Study|Excluded Medication|0|||
37794689|NCT02132754|69437302|FG027|Overall Study|Excluded Medication|0|||
37794690|NCT02132754|69437303|FG028|Overall Study|Excluded Medication|0|||
37794691|NCT02132754|69437304|FG029|Overall Study|Excluded Medication|0|||
37794692|NCT02132754|69437305|FG030|Overall Study|Excluded Medication|0|||
37794693|NCT02132754|69437306|FG031|Overall Study|Excluded Medication|0|||
37794694|NCT02132754|69437307|FG032|Overall Study|Excluded Medication|0|||
37794695|NCT02132754|69437308|FG033|Overall Study|Excluded Medication|1|||
37794696|NCT02132754|69437275|FG000|Overall Study|Physician Decision|0|||
37794697|NCT02132754|69437276|FG001|Overall Study|Physician Decision|0|||
37794698|NCT02132754|69437277|FG002|Overall Study|Physician Decision|0|||
37794699|NCT02132754|69437278|FG003|Overall Study|Physician Decision|0|||
37794700|NCT02132754|69437279|FG004|Overall Study|Physician Decision|0|||
37794701|NCT02132754|69437280|FG005|Overall Study|Physician Decision|0|||
37794702|NCT02132754|69437281|FG006|Overall Study|Physician Decision|0|||
37794703|NCT02132754|69437282|FG007|Overall Study|Physician Decision|0|||
37794704|NCT02132754|69437283|FG008|Overall Study|Physician Decision|0|||
37794705|NCT02132754|69437284|FG009|Overall Study|Physician Decision|1|||
37794706|NCT02132754|69437285|FG010|Overall Study|Physician Decision|0|||
37794707|NCT02132754|69437286|FG011|Overall Study|Physician Decision|1|||
37794708|NCT02132754|69437287|FG012|Overall Study|Physician Decision|1|||
37794709|NCT02132754|69437288|FG013|Overall Study|Physician Decision|0|||
37794710|NCT02132754|69437289|FG014|Overall Study|Physician Decision|0|||
37794711|NCT02132754|69437290|FG015|Overall Study|Physician Decision|1|||
37794712|NCT02132754|69437291|FG016|Overall Study|Physician Decision|0|||
37794713|NCT02132754|69437292|FG017|Overall Study|Physician Decision|0|||
37794714|NCT02132754|69437293|FG018|Overall Study|Physician Decision|0|||
37794715|NCT02132754|69437294|FG019|Overall Study|Physician Decision|0|||
37794716|NCT02132754|69437295|FG020|Overall Study|Physician Decision|0|||
37794717|NCT02132754|69437296|FG021|Overall Study|Physician Decision|0|||
37794718|NCT02132754|69437297|FG022|Overall Study|Physician Decision|0|||
37794719|NCT02132754|69437298|FG023|Overall Study|Physician Decision|0|||
37794720|NCT02132754|69437299|FG024|Overall Study|Physician Decision|1|||
37794721|NCT02132754|69437300|FG025|Overall Study|Physician Decision|0|||
37794722|NCT02132754|69437301|FG026|Overall Study|Physician Decision|0|||
37794723|NCT02132754|69437302|FG027|Overall Study|Physician Decision|0|||
37794724|NCT02132754|69437303|FG028|Overall Study|Physician Decision|0|||
37794725|NCT02132754|69437304|FG029|Overall Study|Physician Decision|0|||
37794726|NCT02132754|69437305|FG030|Overall Study|Physician Decision|0|||
37794727|NCT02132754|69437306|FG031|Overall Study|Physician Decision|1|||
37794728|NCT02132754|69437307|FG032|Overall Study|Physician Decision|0|||
37794729|NCT02132754|69437308|FG033|Overall Study|Physician Decision|3|||
37794730|NCT02132754|69437275|FG000|Overall Study|Progressive Disease|1|||
37794731|NCT02132754|69437276|FG001|Overall Study|Progressive Disease|1|||
37794732|NCT02132754|69437277|FG002|Overall Study|Progressive Disease|1|||
37794733|NCT02132754|69437278|FG003|Overall Study|Progressive Disease|1|||
37794734|NCT02132754|69437279|FG004|Overall Study|Progressive Disease|1|||
37794735|NCT02132754|69437280|FG005|Overall Study|Progressive Disease|1|||
37794736|NCT02132754|69437281|FG006|Overall Study|Progressive Disease|1|||
37794737|NCT02132754|69437282|FG007|Overall Study|Progressive Disease|1|||
37794738|NCT02132754|69437283|FG008|Overall Study|Progressive Disease|1|||
37794739|NCT02132754|69437284|FG009|Overall Study|Progressive Disease|3|||
37794740|NCT02132754|69437285|FG010|Overall Study|Progressive Disease|3|||
37794741|NCT02132754|69437286|FG011|Overall Study|Progressive Disease|2|||
37794742|NCT02132754|69437287|FG012|Overall Study|Progressive Disease|2|||
37794743|NCT02132754|69437288|FG013|Overall Study|Progressive Disease|3|||
37794744|NCT02132754|69437289|FG014|Overall Study|Progressive Disease|2|||
37794745|NCT02132754|69437290|FG015|Overall Study|Progressive Disease|1|||
37794746|NCT02132754|69437291|FG016|Overall Study|Progressive Disease|2|||
37794747|NCT02132754|69437292|FG017|Overall Study|Progressive Disease|1|||
37794748|NCT02132754|69437293|FG018|Overall Study|Progressive Disease|3|||
37794749|NCT02132754|69437294|FG019|Overall Study|Progressive Disease|1|||
37794750|NCT02132754|69437295|FG020|Overall Study|Progressive Disease|1|||
37794751|NCT02132754|69437296|FG021|Overall Study|Progressive Disease|3|||
37794752|NCT02132754|69437297|FG022|Overall Study|Progressive Disease|2|||
37794753|NCT02132754|69437298|FG023|Overall Study|Progressive Disease|3|||
37794754|NCT02132754|69437299|FG024|Overall Study|Progressive Disease|0|||
37794755|NCT02132754|69437300|FG025|Overall Study|Progressive Disease|1|||
37794756|NCT02132754|69437301|FG026|Overall Study|Progressive Disease|2|||
37794757|NCT02132754|69437302|FG027|Overall Study|Progressive Disease|1|||
37794758|NCT02132754|69437303|FG028|Overall Study|Progressive Disease|2|||
37794759|NCT02132754|69437304|FG029|Overall Study|Progressive Disease|3|||
37794760|NCT02132754|69437305|FG030|Overall Study|Progressive Disease|1|||
37794761|NCT02132754|69437306|FG031|Overall Study|Progressive Disease|1|||
37794762|NCT02132754|69437307|FG032|Overall Study|Progressive Disease|3|||
37794763|NCT02132754|69437308|FG033|Overall Study|Progressive Disease|6|||
37794764|NCT02132754|69437275|FG000|Overall Study|Screen Failure|0|||
37794765|NCT02132754|69437276|FG001|Overall Study|Screen Failure|0|||
37794766|NCT02132754|69437277|FG002|Overall Study|Screen Failure|0|||
37794767|NCT02132754|69437278|FG003|Overall Study|Screen Failure|0|||
37794768|NCT02132754|69437279|FG004|Overall Study|Screen Failure|0|||
37794769|NCT02132754|69437280|FG005|Overall Study|Screen Failure|0|||
37794770|NCT02132754|69437281|FG006|Overall Study|Screen Failure|0|||
37794771|NCT02132754|69437282|FG007|Overall Study|Screen Failure|0|||
37794772|NCT02132754|69437283|FG008|Overall Study|Screen Failure|0|||
37794773|NCT02132754|69437284|FG009|Overall Study|Screen Failure|0|||
37794774|NCT02132754|69437285|FG010|Overall Study|Screen Failure|0|||
37794775|NCT02132754|69437286|FG011|Overall Study|Screen Failure|0|||
37794776|NCT02132754|69437287|FG012|Overall Study|Screen Failure|0|||
37794777|NCT02132754|69437288|FG013|Overall Study|Screen Failure|0|||
37794778|NCT02132754|69437289|FG014|Overall Study|Screen Failure|0|||
37794779|NCT02132754|69437290|FG015|Overall Study|Screen Failure|0|||
37794780|NCT02132754|69437291|FG016|Overall Study|Screen Failure|0|||
37794781|NCT02132754|69437292|FG017|Overall Study|Screen Failure|0|||
37794782|NCT02132754|69437293|FG018|Overall Study|Screen Failure|0|||
37794783|NCT02132754|69437294|FG019|Overall Study|Screen Failure|1|||
37794784|NCT02132754|69437295|FG020|Overall Study|Screen Failure|0|||
37794785|NCT02132754|69437296|FG021|Overall Study|Screen Failure|1|||
37794786|NCT02132754|69437297|FG022|Overall Study|Screen Failure|0|||
37975590|NCT00386607|69662875|FG001|Core|Administrative problems|0|||
37794787|NCT02132754|69437298|FG023|Overall Study|Screen Failure|0|||
37794788|NCT02132754|69437299|FG024|Overall Study|Screen Failure|0|||
37794789|NCT02132754|69437300|FG025|Overall Study|Screen Failure|0|||
37794790|NCT02132754|69437301|FG026|Overall Study|Screen Failure|0|||
37794791|NCT02132754|69437302|FG027|Overall Study|Screen Failure|0|||
37794792|NCT02132754|69437303|FG028|Overall Study|Screen Failure|0|||
37794793|NCT02132754|69437304|FG029|Overall Study|Screen Failure|0|||
37794794|NCT02132754|69437305|FG030|Overall Study|Screen Failure|0|||
37975591|NCT00386607|69662874|FG000|Core|Protocol Deviation|6|||
37794795|NCT02132754|69437306|FG031|Overall Study|Screen Failure|0|||
37794796|NCT02132754|69437307|FG032|Overall Study|Screen Failure|0|||
37794797|NCT02132754|69437308|FG033|Overall Study|Screen Failure|0|||
37794798|NCT02132754|69437275|FG000|Overall Study|Transferred to Extension Study|0|||
37794799|NCT02132754|69437276|FG001|Overall Study|Transferred to Extension Study|0|||
37794800|NCT02132754|69437277|FG002|Overall Study|Transferred to Extension Study|0|||
37794801|NCT02132754|69437278|FG003|Overall Study|Transferred to Extension Study|0|||
37794802|NCT02132754|69437279|FG004|Overall Study|Transferred to Extension Study|0|||
37794803|NCT02132754|69437280|FG005|Overall Study|Transferred to Extension Study|0|||
37794804|NCT02132754|69437281|FG006|Overall Study|Transferred to Extension Study|0|||
37794805|NCT02132754|69437282|FG007|Overall Study|Transferred to Extension Study|0|||
37794806|NCT02132754|69437283|FG008|Overall Study|Transferred to Extension Study|0|||
37794807|NCT02132754|69437284|FG009|Overall Study|Transferred to Extension Study|0|||
37794808|NCT02132754|69437285|FG010|Overall Study|Transferred to Extension Study|0|||
37794809|NCT02132754|69437286|FG011|Overall Study|Transferred to Extension Study|0|||
37794810|NCT02132754|69437287|FG012|Overall Study|Transferred to Extension Study|0|||
37794811|NCT02132754|69437288|FG013|Overall Study|Transferred to Extension Study|0|||
37794812|NCT02132754|69437289|FG014|Overall Study|Transferred to Extension Study|0|||
37794813|NCT02132754|69437290|FG015|Overall Study|Transferred to Extension Study|0|||
37794814|NCT02132754|69437291|FG016|Overall Study|Transferred to Extension Study|0|||
37794815|NCT02132754|69437292|FG017|Overall Study|Transferred to Extension Study|0|||
37794816|NCT02132754|69437293|FG018|Overall Study|Transferred to Extension Study|0|||
37794817|NCT02132754|69437294|FG019|Overall Study|Transferred to Extension Study|0|||
37794818|NCT02132754|69437295|FG020|Overall Study|Transferred to Extension Study|0|||
37794819|NCT02132754|69437296|FG021|Overall Study|Transferred to Extension Study|0|||
37794820|NCT02132754|69437297|FG022|Overall Study|Transferred to Extension Study|0|||
37794821|NCT02132754|69437298|FG023|Overall Study|Transferred to Extension Study|0|||
37794822|NCT02132754|69437299|FG024|Overall Study|Transferred to Extension Study|0|||
37794823|NCT02132754|69437300|FG025|Overall Study|Transferred to Extension Study|0|||
37794824|NCT02132754|69437301|FG026|Overall Study|Transferred to Extension Study|0|||
37975592|NCT00386607|69662875|FG001|Core|Protocol Deviation|0|||
37975593|NCT00386607|69662874|FG000|Extension|Adverse Event|0|||
37975594|NCT00386607|69662875|FG001|Extension|Adverse Event|6|||
37975595|NCT00386607|69662874|FG000|Extension|Abnormal laboratory value(s)|0|||
37975596|NCT00386607|69662875|FG001|Extension|Abnormal laboratory value(s)|1|||
37975597|NCT00386607|69662874|FG000|Extension|Administrative problems|0|||
37975598|NCT00386607|69662875|FG001|Extension|Administrative problems|1|||
37975599|NCT00386607|69662874|FG000|Extension|Lost to Follow-up|0|||
37975600|NCT00386607|69662875|FG001|Extension|Lost to Follow-up|3|||
37975601|NCT00386607|69662874|FG000|Extension|Patient withdrew consent|0|||
37975602|NCT00386607|69662875|FG001|Extension|Patient withdrew consent|5|||
37975603|NCT00386607|69662874|FG000|Extension|Unsatisfactory therapeutic effect|0|||
37975604|NCT00386607|69662875|FG001|Extension|Unsatisfactory therapeutic effect|1|||
37975605|NCT00410163|69662889|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
37975606|NCT00410163|69662890|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
37975607|NCT00410163|69662889|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
37975608|NCT00410163|69662890|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
37975609|NCT00410163|69662889|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
37975610|NCT00410163|69662890|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
37975611|NCT00410163|69662889|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
37975612|NCT00410163|69662890|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
37794825|NCT02132754|69437302|FG027|Overall Study|Transferred to Extension Study|0|||
37794826|NCT02132754|69437303|FG028|Overall Study|Transferred to Extension Study|0|||
37794827|NCT02132754|69437304|FG029|Overall Study|Transferred to Extension Study|0|||
37794828|NCT02132754|69437305|FG030|Overall Study|Transferred to Extension Study|0|||
37794829|NCT02132754|69437306|FG031|Overall Study|Transferred to Extension Study|0|||
37794830|NCT02132754|69437307|FG032|Overall Study|Transferred to Extension Study|0|||
37794831|NCT02132754|69437308|FG033|Overall Study|Transferred to Extension Study|6|||
37794832|NCT02132754|69437275|FG000|Overall Study|Withdrawal by Subject|0|||
37794833|NCT02132754|69437276|FG001|Overall Study|Withdrawal by Subject|0|||
37794834|NCT02132754|69437277|FG002|Overall Study|Withdrawal by Subject|0|||
37794835|NCT02132754|69437278|FG003|Overall Study|Withdrawal by Subject|0|||
37794836|NCT02132754|69437279|FG004|Overall Study|Withdrawal by Subject|0|||
37794837|NCT02132754|69437280|FG005|Overall Study|Withdrawal by Subject|0|||
37794838|NCT02132754|69437281|FG006|Overall Study|Withdrawal by Subject|0|||
37794839|NCT02132754|69437282|FG007|Overall Study|Withdrawal by Subject|0|||
37794840|NCT02132754|69437283|FG008|Overall Study|Withdrawal by Subject|0|||
37794841|NCT02132754|69437284|FG009|Overall Study|Withdrawal by Subject|1|||
37794842|NCT02132754|69437285|FG010|Overall Study|Withdrawal by Subject|0|||
37794843|NCT02132754|69437286|FG011|Overall Study|Withdrawal by Subject|0|||
37975613|NCT00410163|69662889|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
37975614|NCT00410163|69662890|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
37794844|NCT02132754|69437287|FG012|Overall Study|Withdrawal by Subject|1|||
37794845|NCT02132754|69437288|FG013|Overall Study|Withdrawal by Subject|0|||
37794846|NCT02132754|69437289|FG014|Overall Study|Withdrawal by Subject|1|||
37794847|NCT02132754|69437290|FG015|Overall Study|Withdrawal by Subject|2|||
37794848|NCT02132754|69437291|FG016|Overall Study|Withdrawal by Subject|1|||
37794849|NCT02132754|69437292|FG017|Overall Study|Withdrawal by Subject|0|||
37794850|NCT02132754|69437293|FG018|Overall Study|Withdrawal by Subject|0|||
37794851|NCT02132754|69437294|FG019|Overall Study|Withdrawal by Subject|0|||
37794852|NCT02132754|69437295|FG020|Overall Study|Withdrawal by Subject|1|||
37794853|NCT02132754|69437296|FG021|Overall Study|Withdrawal by Subject|0|||
37794854|NCT02132754|69437297|FG022|Overall Study|Withdrawal by Subject|0|||
37794855|NCT02132754|69437298|FG023|Overall Study|Withdrawal by Subject|0|||
37794856|NCT02132754|69437299|FG024|Overall Study|Withdrawal by Subject|1|||
37794857|NCT02132754|69437300|FG025|Overall Study|Withdrawal by Subject|0|||
37794858|NCT02132754|69437301|FG026|Overall Study|Withdrawal by Subject|0|||
37794859|NCT02132754|69437302|FG027|Overall Study|Withdrawal by Subject|1|||
37794860|NCT02132754|69437303|FG028|Overall Study|Withdrawal by Subject|0|||
37794861|NCT02132754|69437304|FG029|Overall Study|Withdrawal by Subject|0|||
37794862|NCT02132754|69437305|FG030|Overall Study|Withdrawal by Subject|0|||
37794863|NCT02132754|69437306|FG031|Overall Study|Withdrawal by Subject|1|||
37794864|NCT02132754|69437307|FG032|Overall Study|Withdrawal by Subject|0|||
37794865|NCT02132754|69437308|FG033|Overall Study|Withdrawal by Subject|2|||
37794866|NCT02151786|69437418|FG000|Overall Study|Unavailability of Case Report Form|26|||
37794867|NCT02151786|69437418|FG000|Overall Study|Outside the Contract Period|1|||
37794868|NCT02151786|69437418|FG000|Overall Study|Randomized, not Treated|1|||
37794869|NCT02151786|69437418|FG000|Overall Study|Unavailability of Information|8|||
37794870|NCT02132130|69437426|FG000|Overall Study|Lost to Follow-up|0|||
37794871|NCT02132130|69437427|FG001|Overall Study|Lost to Follow-up|2|||
37794872|NCT02132130|69437428|FG002|Overall Study|Lost to Follow-up|0|||
37794873|NCT02132130|69437429|FG003|Overall Study|Lost to Follow-up|0|||
37794874|NCT02132130|69437426|FG000|Overall Study|Withdrawal by Subject|0|||
37794875|NCT02132130|69437427|FG001|Overall Study|Withdrawal by Subject|0|||
37794876|NCT02132130|69437428|FG002|Overall Study|Withdrawal by Subject|0|||
37794877|NCT02132130|69437429|FG003|Overall Study|Withdrawal by Subject|1|||
37794878|NCT02131662|69437448|FG000|Overall Study|Protocol Violation|1|||
37794879|NCT02131662|69437449|FG001|Overall Study|Protocol Violation|0|||
37794880|NCT02131662|69437450|FG002|Overall Study|Protocol Violation|0|||
37794881|NCT02131662|69437451|FG003|Overall Study|Protocol Violation|0|||
37794882|NCT02131662|69437452|FG004|Overall Study|Protocol Violation|0|||
37794883|NCT02131662|69437448|FG000|Overall Study|Other|2|||
37794884|NCT02131662|69437449|FG001|Overall Study|Other|4|||
37794885|NCT02131662|69437450|FG002|Overall Study|Other|3|||
37794886|NCT02131662|69437451|FG003|Overall Study|Other|3|||
37794887|NCT02131662|69437452|FG004|Overall Study|Other|4|||
37794888|NCT02131662|69437448|FG000|Overall Study|Adverse Event|0|||
37794889|NCT02131662|69437449|FG001|Overall Study|Adverse Event|1|||
37794890|NCT02131662|69437450|FG002|Overall Study|Adverse Event|1|||
37794891|NCT02131662|69437451|FG003|Overall Study|Adverse Event|1|||
37794892|NCT02131662|69437452|FG004|Overall Study|Adverse Event|3|||
37794893|NCT02131662|69437448|FG000|Overall Study|Pregnancy|0|||
37794894|NCT02131662|69437449|FG001|Overall Study|Pregnancy|1|||
37794895|NCT02131662|69437450|FG002|Overall Study|Pregnancy|0|||
37794896|NCT02131662|69437451|FG003|Overall Study|Pregnancy|1|||
37794897|NCT02131662|69437452|FG004|Overall Study|Pregnancy|0|||
37794898|NCT02131662|69437448|FG000|Overall Study|Wish for pregnancy|0|||
37794899|NCT02131662|69437449|FG001|Overall Study|Wish for pregnancy|0|||
37794900|NCT02131662|69437450|FG002|Overall Study|Wish for pregnancy|0|||
37794901|NCT02131662|69437451|FG003|Overall Study|Wish for pregnancy|0|||
37794902|NCT02131662|69437452|FG004|Overall Study|Wish for pregnancy|1|||
37794903|NCT02131662|69437448|FG000|Overall Study|Lack of Efficacy|1|||
37794904|NCT02131662|69437449|FG001|Overall Study|Lack of Efficacy|0|||
37794905|NCT02131662|69437450|FG002|Overall Study|Lack of Efficacy|0|||
37794906|NCT02131662|69437451|FG003|Overall Study|Lack of Efficacy|0|||
37794907|NCT02131662|69437452|FG004|Overall Study|Lack of Efficacy|1|||
37794908|NCT02131662|69437448|FG000|Overall Study|Withdrawal by Subject|1|||
37794909|NCT02131662|69437449|FG001|Overall Study|Withdrawal by Subject|5|||
37794910|NCT02131662|69437450|FG002|Overall Study|Withdrawal by Subject|1|||
37794911|NCT02131662|69437451|FG003|Overall Study|Withdrawal by Subject|5|||
37794912|NCT02131662|69437452|FG004|Overall Study|Withdrawal by Subject|6|||
37794913|NCT02131662|69437448|FG000|Overall Study|Lost to Follow-up|1|||
37794914|NCT02131662|69437449|FG001|Overall Study|Lost to Follow-up|3|||
37794915|NCT02131662|69437450|FG002|Overall Study|Lost to Follow-up|0|||
37794916|NCT02131662|69437451|FG003|Overall Study|Lost to Follow-up|9|||
37794917|NCT02131662|69437452|FG004|Overall Study|Lost to Follow-up|0|||
37794918|NCT02131662|69437448|FG000|Overall Study|Not treated|2|||
37794919|NCT02131662|69437449|FG001|Overall Study|Not treated|0|||
37794920|NCT02131662|69437450|FG002|Overall Study|Not treated|2|||
37794921|NCT02131662|69437451|FG003|Overall Study|Not treated|2|||
37794922|NCT02131662|69437452|FG004|Overall Study|Not treated|3|||
37794923|NCT02106156|69437471|FG000|Overall Study|Patient Died|19|||
37794924|NCT02106156|69437472|FG001|Overall Study|Patient Died|0|||
37794925|NCT02106156|69437473|FG002|Overall Study|Patient Died|0|||
37794926|NCT02106156|69437471|FG000|Overall Study|Lack of Tolerability|305|||
37794927|NCT02106156|69437472|FG001|Overall Study|Lack of Tolerability|3|||
37794928|NCT02106156|69437473|FG002|Overall Study|Lack of Tolerability|0|||
37794929|NCT02106156|69437471|FG000|Overall Study|Lack of Virological Response|1044|||
37794930|NCT02106156|69437472|FG001|Overall Study|Lack of Virological Response|8|||
37794931|NCT02106156|69437473|FG002|Overall Study|Lack of Virological Response|0|||
37794932|NCT02106156|69437471|FG000|Overall Study|Concomitant Disease|74|||
37794933|NCT02106156|69437472|FG001|Overall Study|Concomitant Disease|2|||
37794934|NCT02106156|69437473|FG002|Overall Study|Concomitant Disease|0|||
37794935|NCT02106156|69437471|FG000|Overall Study|Lack of Compliance|211|||
37794936|NCT02106156|69437472|FG001|Overall Study|Lack of Compliance|7|||
37794937|NCT02106156|69437473|FG002|Overall Study|Lack of Compliance|0|||
37794938|NCT02106156|69437471|FG000|Overall Study|Patients Request|307|||
37794939|NCT02106156|69437472|FG001|Overall Study|Patients Request|9|||
37794940|NCT02106156|69437473|FG002|Overall Study|Patients Request|0|||
37794941|NCT02106156|69437471|FG000|Overall Study|Lost to Follow-up|451|||
37794942|NCT02106156|69437472|FG001|Overall Study|Lost to Follow-up|8|||
37794943|NCT02106156|69437473|FG002|Overall Study|Lost to Follow-up|0|||
37794944|NCT02106156|69437471|FG000|Overall Study|Unplanned Event|82|||
37794945|NCT02106156|69437472|FG001|Overall Study|Unplanned Event|2|||
37794946|NCT02106156|69437473|FG002|Overall Study|Unplanned Event|0|||
37794947|NCT02106156|69437471|FG000|Overall Study|Change of Laboratory Parameter|10|||
37794948|NCT02106156|69437472|FG001|Overall Study|Change of Laboratory Parameter|0|||
37794949|NCT02106156|69437473|FG002|Overall Study|Change of Laboratory Parameter|0|||
37794950|NCT02106156|69437471|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
37794951|NCT02106156|69437472|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
37794952|NCT02106156|69437473|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
37794953|NCT02106156|69437471|FG000|Overall Study|Relocation/Change of Physician|40|||
37794954|NCT02106156|69437472|FG001|Overall Study|Relocation/Change of Physician|1|||
37794955|NCT02106156|69437473|FG002|Overall Study|Relocation/Change of Physician|0|||
37794956|NCT01598610|69437499|FG000|Overall Study|Adverse Event|1|||
37794957|NCT01625988|69437505|FG000|Overall Study|Lost to Follow-up|5|||
37794958|NCT01625988|69437506|FG001|Overall Study|Lost to Follow-up|6|||
37794959|NCT01625988|69437505|FG000|Overall Study|Withdrawal by Subject|8|||
37794960|NCT01625988|69437506|FG001|Overall Study|Withdrawal by Subject|3|||
37794961|NCT01625988|69437505|FG000|Overall Study|Adverse Event|0|||
37794962|NCT01625988|69437506|FG001|Overall Study|Adverse Event|1|||
37794963|NCT01625988|69437505|FG000|Overall Study|Lack of Efficacy|0|||
37794964|NCT01625988|69437506|FG001|Overall Study|Lack of Efficacy|1|||
37794965|NCT01625988|69437505|FG000|Overall Study|Randomized Inappropriately|1|||
37794966|NCT01625988|69437506|FG001|Overall Study|Randomized Inappropriately|0|||
37794967|NCT01625988|69437505|FG000|Overall Study|Protocol Violation|0|||
37794968|NCT01625988|69437506|FG001|Overall Study|Protocol Violation|2|||
37794969|NCT02131272|69437517|FG000|Overall Study|Withdrawal by parent|0|||
37794970|NCT02131272|69437518|FG001|Overall Study|Withdrawal by parent|1|||
37794971|NCT02131272|69437517|FG000|Overall Study|Withdrawal by Subject|0|||
37794972|NCT02131272|69437518|FG001|Overall Study|Withdrawal by Subject|1|||
37794973|NCT02131272|69437517|FG000|Overall Study|Withdrawal Criteria|1|||
37794974|NCT02131272|69437518|FG001|Overall Study|Withdrawal Criteria|0|||
37794975|NCT02130882|69437526|FG000|Overall Study|Withdrawal by Subject|0|||
37794976|NCT02130882|69437527|FG001|Overall Study|Withdrawal by Subject|1|||
37794977|NCT02130570|69437535|FG000|Overall Study|Death|3|||
37794978|NCT02130570|69437536|FG001|Overall Study|Death|5|||
37794979|NCT02130570|69437535|FG000|Overall Study|Withdrawal by Subject|6|||
37794980|NCT02130570|69437536|FG001|Overall Study|Withdrawal by Subject|3|||
37794981|NCT02130570|69437535|FG000|Overall Study|Part of practice that discontinued study|0|||
37794982|NCT02130570|69437536|FG001|Overall Study|Part of practice that discontinued study|5|||
37794983|NCT02149836|69437543|FG000|Overall Study|Withdrawal by Subject|1|||
37794984|NCT02130024|69437549|FG000|Overall Study|Adverse Event|10|||
37794985|NCT02130024|69437550|FG001|Overall Study|Adverse Event|11|||
37794986|NCT02130024|69437549|FG000|Overall Study|Death|2|||
37794987|NCT02130024|69437550|FG001|Overall Study|Death|2|||
37794988|NCT02130024|69437549|FG000|Overall Study|Lost to Follow-up|1|||
37794989|NCT02130024|69437550|FG001|Overall Study|Lost to Follow-up|1|||
37794990|NCT02130024|69437549|FG000|Overall Study|Physician Decision|1|||
37794991|NCT02130024|69437550|FG001|Overall Study|Physician Decision|3|||
37794992|NCT02130024|69437549|FG000|Overall Study|Protocol Deviation|4|||
37794993|NCT02130024|69437550|FG001|Overall Study|Protocol Deviation|0|||
37794994|NCT02130024|69437549|FG000|Overall Study|Site Administration Problems|1|||
37794995|NCT02130024|69437550|FG001|Overall Study|Site Administration Problems|0|||
37794996|NCT02130024|69437549|FG000|Overall Study|Subject Withdrew Consent|6|||
37794997|NCT02130024|69437550|FG001|Overall Study|Subject Withdrew Consent|14|||
37794998|NCT02105688|69437558|FG000|Part A: Double-Blind|Adverse Event|1|||
37794999|NCT02105688|69437559|FG001|Part A: Double-Blind|Adverse Event|0|||
37795000|NCT02105688|69437558|FG000|Part A: Double-Blind|Death|0|||
37795001|NCT02105688|69437559|FG001|Part A: Double-Blind|Death|1|||
37795002|NCT02105688|69437558|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
37795003|NCT02105688|69437559|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
37795004|NCT02105688|69437558|FG000|Part A: Double-Blind|Physician Decision|0|||
37795005|NCT02105688|69437559|FG001|Part A: Double-Blind|Physician Decision|1|||
37795006|NCT02105688|69437558|FG000|Part A: Double-Blind|Status Unknown|0|||
37795007|NCT02105688|69437559|FG001|Part A: Double-Blind|Status Unknown|2|||
37795008|NCT02105688|69437558|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
37795009|NCT02105688|69437559|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
37975615|NCT00410163|69662889|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
37975616|NCT00410163|69662890|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
37975617|NCT00410163|69662889|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
37795010|NCT02105688|69437558|FG000|Part B: Observational Follow-up|Death|2|||
37795011|NCT02105688|69437559|FG001|Part B: Observational Follow-up|Death|1|||
37795012|NCT02105688|69437558|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
37795013|NCT02105688|69437559|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
37795014|NCT02105688|69437558|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
37795015|NCT02105688|69437559|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
37795016|NCT02105688|69437558|FG000|Part B: Observational Follow-up|Physician Decision|3|||
37795017|NCT02105688|69437559|FG001|Part B: Observational Follow-up|Physician Decision|1|||
37795018|NCT02105454|69437566|FG000|Overall Study|Withdrawal by Subject|1|||
37795019|NCT01625910|69437572|FG000|Overall Study|Lost to Follow-up|3|||
37795020|NCT01625910|69437573|FG001|Overall Study|Lost to Follow-up|4|||
37795021|NCT02104752|69437583|FG000|Overall Study|Withdrawal by Subject|1|||
37795022|NCT02104752|69437584|FG001|Overall Study|Withdrawal by Subject|0|||
37795023|NCT02104752|69437583|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
37795024|NCT02104752|69437584|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
37795025|NCT02102724|69437592|FG000|Overall Study|Lost to Follow-up|1|||
37795026|NCT02102724|69437593|FG001|Overall Study|Lost to Follow-up|0|||
37795027|NCT02102724|69437592|FG000|Overall Study|surgery for brain aneurysm|1|||
37795028|NCT02102724|69437593|FG001|Overall Study|surgery for brain aneurysm|1|||
37795029|NCT02102490|69437599|FG000|Overall Study|Death|6|||
37795030|NCT02102490|69437599|FG000|Overall Study|Lost to Follow-up|1|||
37795031|NCT02101554|69437606|FG000|Overall Study|Protocol Violation|0|||
37795032|NCT02101554|69437607|FG001|Overall Study|Protocol Violation|1|||
37795033|NCT02101554|69437608|FG002|Overall Study|Protocol Violation|0|||
37795034|NCT02101554|69437606|FG000|Overall Study|Insufficient Clinical Response|0|||
37795035|NCT02101554|69437607|FG001|Overall Study|Insufficient Clinical Response|2|||
37795036|NCT02101554|69437608|FG002|Overall Study|Insufficient Clinical Response|0|||
37795037|NCT02101554|69437606|FG000|Overall Study|Adverse Event|2|||
37795038|NCT02101554|69437607|FG001|Overall Study|Adverse Event|1|||
37795039|NCT02101554|69437608|FG002|Overall Study|Adverse Event|1|||
37795040|NCT02101554|69437606|FG000|Overall Study|Lost to Follow-up|0|||
37795041|NCT02101554|69437607|FG001|Overall Study|Lost to Follow-up|1|||
37795042|NCT02101554|69437608|FG002|Overall Study|Lost to Follow-up|0|||
37795043|NCT02101554|69437606|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
37795044|NCT02101554|69437607|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
37795045|NCT02101554|69437608|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
37795046|NCT02128932|69437619|FG000|Overall Study|Withdrawal by Subject|11|||
37795047|NCT02128932|69437620|FG001|Overall Study|Withdrawal by Subject|7|||
37795048|NCT02128932|69437621|FG002|Overall Study|Withdrawal by Subject|8|||
37795049|NCT02128932|69437619|FG000|Overall Study|Death|2|||
37795050|NCT02128932|69437620|FG001|Overall Study|Death|0|||
37795051|NCT02128932|69437621|FG002|Overall Study|Death|2|||
37795052|NCT02128932|69437619|FG000|Overall Study|Lost to Follow-up|2|||
37795053|NCT02128932|69437620|FG001|Overall Study|Lost to Follow-up|1|||
37795054|NCT02128932|69437621|FG002|Overall Study|Lost to Follow-up|1|||
37795055|NCT02128932|69437619|FG000|Overall Study|No reason for withdrawal|12|||
37795056|NCT02128932|69437620|FG001|Overall Study|No reason for withdrawal|11|||
37795057|NCT02128932|69437621|FG002|Overall Study|No reason for withdrawal|7|||
37795058|NCT02128542|69437631|FG000|Overall Study|Lost to Follow-up|3|||
37795059|NCT02128542|69437632|FG001|Overall Study|Lost to Follow-up|0|||
37795060|NCT02128542|69437631|FG000|Overall Study|Withdrew Consent|1|||
37795061|NCT02128542|69437632|FG001|Overall Study|Withdrew Consent|0|||
37795062|NCT02127372|69437642|FG000|Overall Study|Withdrawal by Subject|1|||
37795063|NCT02127372|69437643|FG001|Overall Study|Withdrawal by Subject|0|||
37795064|NCT02126826|69437657|FG000|Overall Study|Withdrawal by Subject|0|||
37795065|NCT02126826|69437658|FG001|Overall Study|Withdrawal by Subject|0|||
37795066|NCT02126826|69437659|FG002|Overall Study|Withdrawal by Subject|0|||
37693806|NCT01860976|69170110|FG000|Blinded Treatment|Lack of Efficacy|5|||
37693807|NCT01860976|69170111|FG001|Blinded Treatment|Lack of Efficacy|12|||
37795067|NCT02126826|69437660|FG003|Overall Study|Withdrawal by Subject|1|||
37795068|NCT02126826|69437661|FG004|Overall Study|Withdrawal by Subject|0|||
37795069|NCT02126826|69437662|FG005|Overall Study|Withdrawal by Subject|0|||
37795070|NCT02126826|69437663|FG006|Overall Study|Withdrawal by Subject|0|||
37795071|NCT02126670|69437688|FG000|Overall Study|Withdrawal by Subject|1|||
37795072|NCT02126670|69437689|FG001|Overall Study|Withdrawal by Subject|0|||
37795073|NCT02126670|69437690|FG002|Overall Study|Withdrawal by Subject|0|||
37795074|NCT02126670|69437691|FG003|Overall Study|Withdrawal by Subject|1|||
37795075|NCT02125734|69437703|FG000|Period 2|Adverse Event|0|||
37795076|NCT02125734|69437704|FG001|Period 2|Adverse Event|1|||
37795077|NCT02124798|69437710|FG000|Overall Study|Adverse Event|3|||
37795078|NCT02124798|69437710|FG000|Overall Study|Lost to Follow-up|1|||
37795079|NCT02146326|69437718|FG000|Overall Study|Lost to Follow-up|3|||
37795080|NCT02146326|69437719|FG001|Overall Study|Lost to Follow-up|3|||
37795081|NCT02146326|69437720|FG002|Overall Study|Lost to Follow-up|11|||
37795082|NCT02146326|69437721|FG003|Overall Study|Lost to Follow-up|19|||
37795083|NCT02146326|69437718|FG000|Overall Study|Withdrawal by Subject|2|||
37795084|NCT02146326|69437719|FG001|Overall Study|Withdrawal by Subject|1|||
37795085|NCT02146326|69437720|FG002|Overall Study|Withdrawal by Subject|15|||
37795086|NCT02146326|69437721|FG003|Overall Study|Withdrawal by Subject|11|||
37795087|NCT02146326|69437718|FG000|Overall Study|Separated from mental health center|23|||
37795088|NCT02146326|69437719|FG001|Overall Study|Separated from mental health center|33|||
37795089|NCT02146326|69437720|FG002|Overall Study|Separated from mental health center|0|||
37795090|NCT02146326|69437721|FG003|Overall Study|Separated from mental health center|0|||
37795091|NCT02146326|69437718|FG000|Overall Study|Incarcerated|0|||
37795092|NCT02146326|69437719|FG001|Overall Study|Incarcerated|0|||
37795093|NCT02146326|69437720|FG002|Overall Study|Incarcerated|3|||
37795094|NCT02146326|69437721|FG003|Overall Study|Incarcerated|8|||
37795095|NCT02146326|69437718|FG000|Overall Study|Death|0|||
37795096|NCT02146326|69437719|FG001|Overall Study|Death|0|||
37795097|NCT02146326|69437720|FG002|Overall Study|Death|4|||
37795098|NCT02146326|69437721|FG003|Overall Study|Death|4|||
37795099|NCT02146326|69437718|FG000|Overall Study|Unable to complete interview|0|||
37795100|NCT02146326|69437719|FG001|Overall Study|Unable to complete interview|0|||
37795101|NCT02146326|69437720|FG002|Overall Study|Unable to complete interview|10|||
37795102|NCT02146326|69437721|FG003|Overall Study|Unable to complete interview|6|||
37795103|NCT02146248|69437737|FG000|Overall Study|Withdrawal by Subject|2|||
37795104|NCT02145468|69437747|FG000|Overall Study|Withdrawal by Subject|5|||
37795105|NCT02145468|69437748|FG001|Overall Study|Withdrawal by Subject|8|||
37795106|NCT02124564|69437754|FG000|Treatment Period|Adverse Event|2|||
37795107|NCT02124564|69437754|FG000|Treatment Period|Lack of Efficacy|3|||
37795108|NCT02124564|69437754|FG000|Treatment Period|Withdrawal by Subject|2|||
37795109|NCT02145390|69437759|FG000|Overall Study|Withdrawal by Subject|1|||
37795110|NCT02100696|69437769|FG000|Induction Phase|Adverse Event|0|||
37795111|NCT02100696|69437770|FG001|Induction Phase|Adverse Event|0|||
37795112|NCT02100696|69437771|FG002|Induction Phase|Adverse Event|1|||
37795113|NCT02100696|69437772|FG003|Induction Phase|Adverse Event|0|||
37795114|NCT02100696|69437773|FG004|Induction Phase|Adverse Event|0|||
37795115|NCT02100696|69437774|FG005|Induction Phase|Adverse Event|0|||
37795116|NCT02100696|69437769|FG000|Induction Phase|Lost to Follow-up|1|||
37795117|NCT02100696|69437770|FG001|Induction Phase|Lost to Follow-up|0|||
37795118|NCT02100696|69437771|FG002|Induction Phase|Lost to Follow-up|1|||
37795119|NCT02100696|69437772|FG003|Induction Phase|Lost to Follow-up|0|||
37795120|NCT02100696|69437773|FG004|Induction Phase|Lost to Follow-up|0|||
37795121|NCT02100696|69437774|FG005|Induction Phase|Lost to Follow-up|0|||
37795122|NCT02100696|69437769|FG000|Induction Phase|Protocol Violation|0|||
37795123|NCT02100696|69437770|FG001|Induction Phase|Protocol Violation|1|||
37795124|NCT02100696|69437771|FG002|Induction Phase|Protocol Violation|1|||
37795125|NCT02100696|69437772|FG003|Induction Phase|Protocol Violation|0|||
37795126|NCT02100696|69437773|FG004|Induction Phase|Protocol Violation|0|||
37795127|NCT02100696|69437774|FG005|Induction Phase|Protocol Violation|0|||
37795128|NCT02100696|69437769|FG000|Induction Phase|Withdrawal by Subject|8|||
37795129|NCT02100696|69437770|FG001|Induction Phase|Withdrawal by Subject|2|||
37795130|NCT02100696|69437771|FG002|Induction Phase|Withdrawal by Subject|13|||
37795131|NCT02100696|69437772|FG003|Induction Phase|Withdrawal by Subject|0|||
37795132|NCT02100696|69437773|FG004|Induction Phase|Withdrawal by Subject|0|||
37795133|NCT02100696|69437774|FG005|Induction Phase|Withdrawal by Subject|0|||
37795134|NCT02100696|69437769|FG000|Induction Phase|Physician Decision|1|||
37795135|NCT02100696|69437770|FG001|Induction Phase|Physician Decision|0|||
37795136|NCT02100696|69437771|FG002|Induction Phase|Physician Decision|2|||
37795137|NCT02100696|69437772|FG003|Induction Phase|Physician Decision|0|||
37795138|NCT02100696|69437773|FG004|Induction Phase|Physician Decision|0|||
37795139|NCT02100696|69437774|FG005|Induction Phase|Physician Decision|0|||
37795140|NCT02100696|69437769|FG000|Induction Phase|Multiple Reasons|5|||
37795141|NCT02100696|69437770|FG001|Induction Phase|Multiple Reasons|2|||
37795142|NCT02100696|69437771|FG002|Induction Phase|Multiple Reasons|8|||
37795143|NCT02100696|69437772|FG003|Induction Phase|Multiple Reasons|0|||
37795144|NCT02100696|69437773|FG004|Induction Phase|Multiple Reasons|0|||
37795145|NCT02100696|69437774|FG005|Induction Phase|Multiple Reasons|0|||
37795146|NCT02100696|69437769|FG000|Maintenance Phase|Adverse Event|0|||
37795147|NCT02100696|69437770|FG001|Maintenance Phase|Adverse Event|0|||
37795148|NCT02100696|69437771|FG002|Maintenance Phase|Adverse Event|0|||
37795149|NCT02100696|69437772|FG003|Maintenance Phase|Adverse Event|0|||
37795150|NCT02100696|69437773|FG004|Maintenance Phase|Adverse Event|0|||
37795151|NCT02100696|69437774|FG005|Maintenance Phase|Adverse Event|2|||
37795152|NCT02100696|69437769|FG000|Maintenance Phase|Lost to Follow-up|0|||
37795153|NCT02100696|69437770|FG001|Maintenance Phase|Lost to Follow-up|0|||
37795154|NCT02100696|69437771|FG002|Maintenance Phase|Lost to Follow-up|0|||
37795155|NCT02100696|69437772|FG003|Maintenance Phase|Lost to Follow-up|0|||
37795156|NCT02100696|69437773|FG004|Maintenance Phase|Lost to Follow-up|1|||
37795157|NCT02100696|69437774|FG005|Maintenance Phase|Lost to Follow-up|0|||
37795158|NCT02100696|69437769|FG000|Maintenance Phase|Protocol Violation|0|||
37795159|NCT02100696|69437770|FG001|Maintenance Phase|Protocol Violation|0|||
37795160|NCT02100696|69437771|FG002|Maintenance Phase|Protocol Violation|0|||
37795161|NCT02100696|69437772|FG003|Maintenance Phase|Protocol Violation|0|||
37795162|NCT02100696|69437773|FG004|Maintenance Phase|Protocol Violation|1|||
37795163|NCT02100696|69437774|FG005|Maintenance Phase|Protocol Violation|0|||
37795164|NCT02100696|69437769|FG000|Maintenance Phase|Withdrawal by Subject|0|||
37795165|NCT02100696|69437770|FG001|Maintenance Phase|Withdrawal by Subject|0|||
37795166|NCT02100696|69437771|FG002|Maintenance Phase|Withdrawal by Subject|0|||
37795167|NCT02100696|69437772|FG003|Maintenance Phase|Withdrawal by Subject|1|||
37795168|NCT02100696|69437773|FG004|Maintenance Phase|Withdrawal by Subject|4|||
37795169|NCT02100696|69437774|FG005|Maintenance Phase|Withdrawal by Subject|2|||
37795170|NCT02100696|69437769|FG000|Maintenance Phase|Physician Decision|0|||
37795171|NCT02100696|69437770|FG001|Maintenance Phase|Physician Decision|0|||
37795172|NCT02100696|69437771|FG002|Maintenance Phase|Physician Decision|0|||
37795173|NCT02100696|69437772|FG003|Maintenance Phase|Physician Decision|0|||
37795174|NCT02100696|69437773|FG004|Maintenance Phase|Physician Decision|1|||
37795175|NCT02100696|69437774|FG005|Maintenance Phase|Physician Decision|0|||
37795176|NCT02100696|69437769|FG000|Maintenance Phase|Multiple Reasons|0|||
37795177|NCT02100696|69437770|FG001|Maintenance Phase|Multiple Reasons|0|||
37795178|NCT02100696|69437771|FG002|Maintenance Phase|Multiple Reasons|0|||
37795179|NCT02100696|69437772|FG003|Maintenance Phase|Multiple Reasons|0|||
37795180|NCT02100696|69437773|FG004|Maintenance Phase|Multiple Reasons|2|||
37795181|NCT02100696|69437774|FG005|Maintenance Phase|Multiple Reasons|1|||
37795182|NCT02145156|69437798|FG000|Overall Study|No match to vaccination records|60|||
37795183|NCT02145156|69437799|FG001|Overall Study|No match to vaccination records|52|||
37795184|NCT02145156|69437800|FG002|Overall Study|No match to vaccination records|41|||
37795185|NCT02123472|69437808|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
37795186|NCT02123472|69437809|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
37795187|NCT02145078|69437815|FG000|Overall Study|Death|1|||
37795188|NCT02145078|69437815|FG000|Overall Study|Reason not given|3|||
37795189|NCT02144610|69437821|FG000|Overall Study|Physician Decision|1|||
37795190|NCT02144610|69437822|FG001|Overall Study|Physician Decision|0|||
37795191|NCT02144610|69437821|FG000|Overall Study|Withdrawal by Subject|1|||
37795192|NCT02144610|69437822|FG001|Overall Study|Withdrawal by Subject|5|||
37795193|NCT02144610|69437821|FG000|Overall Study|Death|2|||
37795194|NCT02144610|69437822|FG001|Overall Study|Death|2|||
37795195|NCT02144610|69437821|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
37795196|NCT02144610|69437822|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
37795197|NCT02144610|69437821|FG000|Overall Study|Other|0|||
37795198|NCT02144610|69437822|FG001|Overall Study|Other|1|||
37795199|NCT02100228|69437830|FG000|Overall Study|Other|19|||
37795200|NCT02100228|69437831|FG001|Overall Study|Other|19|||
37795201|NCT02100228|69437830|FG000|Overall Study|Administrative reason|0|||
37795202|NCT02100228|69437831|FG001|Overall Study|Administrative reason|1|||
37795203|NCT02100228|69437830|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
37795204|NCT02100228|69437831|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
37795205|NCT02100228|69437830|FG000|Overall Study|Non-compliance|0|||
37795206|NCT02100228|69437831|FG001|Overall Study|Non-compliance|3|||
37795207|NCT02100228|69437830|FG000|Overall Study|Lost to Follow-up|0|||
37795208|NCT02100228|69437831|FG001|Overall Study|Lost to Follow-up|1|||
37795209|NCT02100228|69437830|FG000|Overall Study|Withdrawal by Subject|27|||
37795210|NCT02100228|69437831|FG001|Overall Study|Withdrawal by Subject|37|||
37795211|NCT02100228|69437830|FG000|Overall Study|Adverse Event|16|||
37795212|NCT02100228|69437831|FG001|Overall Study|Adverse Event|12|||
37795213|NCT02100228|69437830|FG000|Overall Study|Death|1|||
37795214|NCT02100228|69437831|FG001|Overall Study|Death|1|||
37795215|NCT02099838|69437839|FG000|Overall Study|Death|1|||
37795216|NCT02099838|69437840|FG001|Overall Study|Death|0|||
37795217|NCT02099838|69437839|FG000|Overall Study|Lost to Follow-up|3|||
37795218|NCT02099838|69437840|FG001|Overall Study|Lost to Follow-up|1|||
37795219|NCT02099838|69437839|FG000|Overall Study|Withdrawal by Subject|0|||
37795220|NCT02099838|69437840|FG001|Overall Study|Withdrawal by Subject|1|||
37795221|NCT02144220|69437846|FG000|Overall Study|technology incompatibility|9|||
37795222|NCT02144220|69437846|FG000|Overall Study|Lack of Efficacy|4|||
37795223|NCT02144220|69437846|FG000|Overall Study|Physician Decision|3|||
37795224|NCT02144220|69437846|FG000|Overall Study|Withdrawal by Subject|2|||
37795225|NCT02144220|69437846|FG000|Overall Study|Protocol Violation|1|||
37795226|NCT02099682|69437850|FG000|Overall Study|Data Not Available|51|||
37795227|NCT02099682|69437850|FG000|Overall Study|Lost to Follow-up|31|||
37795228|NCT02099682|69437850|FG000|Overall Study|Other|29|||
37795229|NCT02142894|69437854|FG000|Overall Study|Protocol Violation|8|||
37795230|NCT02098746|69437858|FG000|Overall Study|Changes of Investigator|2|||
37795231|NCT02098746|69437858|FG000|Overall Study|Other Miscellaneous Reasons|1|||
37795232|NCT02098746|69437858|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
37795233|NCT02098746|69437858|FG000|Overall Study|Data Not Available After Treatment|1|||
37795234|NCT02122770|69437866|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
37795235|NCT02122770|69437867|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
37795236|NCT02122770|69437868|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
37795237|NCT02122770|69437869|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
37795238|NCT02122770|69437870|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
37795239|NCT02122770|69437871|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
37795240|NCT02122770|69437866|FG000|Part A: Drug-drug Interaction 2|Other|0|||
37795241|NCT02122770|69437867|FG001|Part A: Drug-drug Interaction 2|Other|0|||
37795242|NCT02122770|69437868|FG002|Part A: Drug-drug Interaction 2|Other|1|||
37795243|NCT02122770|69437869|FG003|Part A: Drug-drug Interaction 2|Other|0|||
37795244|NCT02122770|69437870|FG004|Part A: Drug-drug Interaction 2|Other|0|||
37795245|NCT02122770|69437871|FG005|Part A: Drug-drug Interaction 2|Other|0|||
37795246|NCT02122770|69437866|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
37795247|NCT02122770|69437867|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
37795248|NCT02122770|69437868|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
37795249|NCT02122770|69437869|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
37795250|NCT02122770|69437870|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
37795251|NCT02122770|69437871|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
37795252|NCT02122770|69437866|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
37795253|NCT02122770|69437867|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
37795254|NCT02122770|69437868|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
37795255|NCT02122770|69437869|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
37795256|NCT02122770|69437870|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
37795257|NCT02122770|69437871|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
37795258|NCT02122770|69437866|FG000|Part B: Standard of Care|Adverse Event|0|||
37795259|NCT02122770|69437867|FG001|Part B: Standard of Care|Adverse Event|0|||
37795260|NCT02122770|69437868|FG002|Part B: Standard of Care|Adverse Event|0|||
37795261|NCT02122770|69437869|FG003|Part B: Standard of Care|Adverse Event|0|||
37795262|NCT02122770|69437870|FG004|Part B: Standard of Care|Adverse Event|4|||
37795263|NCT02122770|69437871|FG005|Part B: Standard of Care|Adverse Event|1|||
37795264|NCT02122770|69437866|FG000|Part B: Standard of Care|Other|0|||
37795265|NCT02122770|69437867|FG001|Part B: Standard of Care|Other|0|||
37795266|NCT02122770|69437868|FG002|Part B: Standard of Care|Other|0|||
37795267|NCT02122770|69437869|FG003|Part B: Standard of Care|Other|0|||
37795268|NCT02122770|69437870|FG004|Part B: Standard of Care|Other|0|||
37795269|NCT02122770|69437871|FG005|Part B: Standard of Care|Other|2|||
37795270|NCT02122770|69437866|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
37795271|NCT02122770|69437867|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
37795272|NCT02122770|69437868|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
37795273|NCT02122770|69437869|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
37795274|NCT02122770|69437870|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
37795275|NCT02122770|69437871|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
37795276|NCT02122770|69437866|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
37795277|NCT02122770|69437867|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
37795278|NCT02122770|69437868|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
37795279|NCT02122770|69437869|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
37795280|NCT02122770|69437870|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
37795281|NCT02122770|69437871|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
37795282|NCT02122770|69437866|FG000|Part B: Standard of Care|Progressive Disease|0|||
37795283|NCT02122770|69437867|FG001|Part B: Standard of Care|Progressive Disease|0|||
37795284|NCT02122770|69437868|FG002|Part B: Standard of Care|Progressive Disease|0|||
37795285|NCT02122770|69437869|FG003|Part B: Standard of Care|Progressive Disease|0|||
37795286|NCT02122770|69437870|FG004|Part B: Standard of Care|Progressive Disease|10|||
37795287|NCT02122770|69437871|FG005|Part B: Standard of Care|Progressive Disease|8|||
37795288|NCT02122380|69437896|FG000|First Intervention (30 Days)|Adverse Event|1|||
37795289|NCT02122380|69437897|FG001|First Intervention (30 Days)|Adverse Event|0|||
37795290|NCT02122380|69437896|FG000|First Intervention (30 Days)|Physician Decision|0|||
37795291|NCT02122380|69437897|FG001|First Intervention (30 Days)|Physician Decision|1|||
37795292|NCT02122380|69437896|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
37795293|NCT02122380|69437897|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
37795294|NCT02122380|69437896|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
37795295|NCT02122380|69437897|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
37795296|NCT02122380|69437896|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
37795297|NCT02122380|69437897|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
37795298|NCT02122146|69437912|FG000|Part 1: Dose Escalation|Death|0|||
37795299|NCT02122146|69437913|FG001|Part 1: Dose Escalation|Death|1|||
37795300|NCT02122146|69437914|FG002|Part 1: Dose Escalation|Death|1|||
37795301|NCT02122146|69437915|FG003|Part 1: Dose Escalation|Death|0|||
37795302|NCT02122146|69437916|FG004|Part 1: Dose Escalation|Death|0|||
37795303|NCT02122146|69437917|FG005|Part 1: Dose Escalation|Death|0|||
37795304|NCT02122146|69437918|FG006|Part 1: Dose Escalation|Death|0|||
37795305|NCT02122146|69437919|FG007|Part 1: Dose Escalation|Death|0|||
37795306|NCT02122146|69437912|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
37795307|NCT02122146|69437913|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
37795308|NCT02122146|69437914|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
37795309|NCT02122146|69437915|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
37795310|NCT02122146|69437916|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
37795311|NCT02122146|69437917|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
37795312|NCT02122146|69437918|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
37795313|NCT02122146|69437919|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
37795314|NCT02122146|69437912|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
37795315|NCT02122146|69437913|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
37795316|NCT02122146|69437914|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
37795317|NCT02122146|69437915|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
37795318|NCT02122146|69437916|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
37795319|NCT02122146|69437917|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
37795320|NCT02122146|69437918|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
37795321|NCT02122146|69437919|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
37795322|NCT02122146|69437912|FG000|Part 1: Dose Escalation|Other|1|||
37795323|NCT02122146|69437913|FG001|Part 1: Dose Escalation|Other|0|||
37795324|NCT02122146|69437914|FG002|Part 1: Dose Escalation|Other|0|||
37795325|NCT02122146|69437915|FG003|Part 1: Dose Escalation|Other|0|||
37795326|NCT02122146|69437916|FG004|Part 1: Dose Escalation|Other|0|||
37795327|NCT02122146|69437917|FG005|Part 1: Dose Escalation|Other|1|||
37795328|NCT02122146|69437918|FG006|Part 1: Dose Escalation|Other|1|||
37795329|NCT02122146|69437919|FG007|Part 1: Dose Escalation|Other|2|||
37795330|NCT02121834|69437945|FG000|Overall Study|Protocol Violation|0|||
37795331|NCT02121834|69437946|FG001|Overall Study|Protocol Violation|1|||
37795332|NCT02121834|69437947|FG002|Overall Study|Protocol Violation|0|||
37795333|NCT02121834|69437948|FG003|Overall Study|Protocol Violation|0|||
37795334|NCT02121834|69437949|FG004|Overall Study|Protocol Violation|0|||
37795335|NCT02121834|69437950|FG005|Overall Study|Protocol Violation|0|||
37795336|NCT02121834|69437951|FG006|Overall Study|Protocol Violation|0|||
37795337|NCT02121834|69437945|FG000|Overall Study|Withdrawal by Subject|0|||
37795338|NCT02121834|69437946|FG001|Overall Study|Withdrawal by Subject|1|||
37795339|NCT02121834|69437947|FG002|Overall Study|Withdrawal by Subject|1|||
37795340|NCT02121834|69437948|FG003|Overall Study|Withdrawal by Subject|0|||
37795341|NCT02121834|69437949|FG004|Overall Study|Withdrawal by Subject|0|||
37795342|NCT02121834|69437950|FG005|Overall Study|Withdrawal by Subject|0|||
37795343|NCT02121834|69437951|FG006|Overall Study|Withdrawal by Subject|0|||
37795344|NCT02121834|69437945|FG000|Overall Study|Lost to Follow-up|0|||
37795345|NCT02121834|69437946|FG001|Overall Study|Lost to Follow-up|0|||
37795346|NCT02121834|69437947|FG002|Overall Study|Lost to Follow-up|1|||
37795347|NCT02121834|69437948|FG003|Overall Study|Lost to Follow-up|0|||
37795348|NCT02121834|69437949|FG004|Overall Study|Lost to Follow-up|0|||
37864164|NCT00991276|69547777|FG000|Third Intervention Period|Withdrawal by Subject|0|||
37795349|NCT02121834|69437950|FG005|Overall Study|Lost to Follow-up|0|||
37795350|NCT02121834|69437951|FG006|Overall Study|Lost to Follow-up|0|||
37795351|NCT02121756|69437979|FG000|Overall Study|Adverse Event|3|||
37795352|NCT02121756|69437980|FG001|Overall Study|Adverse Event|0|||
37795353|NCT02121756|69437979|FG000|Overall Study|Protocol Violation|1|||
37795354|NCT02121756|69437980|FG001|Overall Study|Protocol Violation|1|||
37795355|NCT02121756|69437979|FG000|Overall Study|Physician Decision|2|||
37795356|NCT02121756|69437980|FG001|Overall Study|Physician Decision|1|||
37795357|NCT02142504|69437992|FG000|Overall Study|Protocol Violation|2|||
37795358|NCT02142504|69437993|FG001|Overall Study|Protocol Violation|1|||
37795359|NCT02142504|69437994|FG002|Overall Study|Protocol Violation|2|||
37795360|NCT02142504|69437992|FG000|Overall Study|Adverse Event|2|||
37795361|NCT02142504|69437993|FG001|Overall Study|Adverse Event|3|||
37795362|NCT02142504|69437994|FG002|Overall Study|Adverse Event|4|||
37795363|NCT02142504|69437992|FG000|Overall Study|Lost to Follow-up|12|||
37795364|NCT02142504|69437993|FG001|Overall Study|Lost to Follow-up|19|||
37795365|NCT02142504|69437994|FG002|Overall Study|Lost to Follow-up|17|||
37795366|NCT02142504|69437992|FG000|Overall Study|Withdrawal by Subject|7|||
37795367|NCT02142504|69437993|FG001|Overall Study|Withdrawal by Subject|9|||
37795368|NCT02142504|69437994|FG002|Overall Study|Withdrawal by Subject|11|||
37795369|NCT02142504|69437992|FG000|Overall Study|Pregnancy|4|||
37795370|NCT02142504|69437993|FG001|Overall Study|Pregnancy|4|||
37795371|NCT02142504|69437994|FG002|Overall Study|Pregnancy|2|||
37795372|NCT02142504|69437992|FG000|Overall Study|Physician Decision|0|||
37795373|NCT02142504|69437993|FG001|Overall Study|Physician Decision|1|||
37795374|NCT02142504|69437994|FG002|Overall Study|Physician Decision|3|||
37795375|NCT02142504|69437992|FG000|Overall Study|Reason Not Specified|4|||
37795376|NCT02142504|69437993|FG001|Overall Study|Reason Not Specified|5|||
37795377|NCT02142504|69437994|FG002|Overall Study|Reason Not Specified|4|||
37795378|NCT02121522|69438002|FG000|Overall Study|Adverse Event|1|||
37795379|NCT02121210|69438008|FG000|Overall Study|Adverse Event|5|||
37795380|NCT02121210|69438009|FG001|Overall Study|Adverse Event|7|||
37795381|NCT02121210|69438008|FG000|Overall Study|Lack of Efficacy|2|||
37795382|NCT02121210|69438009|FG001|Overall Study|Lack of Efficacy|0|||
37795383|NCT02121210|69438008|FG000|Overall Study|Other than specified above|0|||
37795384|NCT02121210|69438009|FG001|Overall Study|Other than specified above|2|||
37795385|NCT02141490|69438018|FG000|Overall Study|Screening failures|4|||
37795386|NCT02141490|69438019|FG001|Overall Study|Screening failures|0|||
37795387|NCT02141490|69438020|FG002|Overall Study|Screening failures|0|||
37795388|NCT02097108|69438030|FG000|Overall Study|Adverse Event|1|||
37795389|NCT02097108|69438030|FG000|Overall Study|patient was abroad for 6 months|1|||
37795390|NCT02097030|69438036|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
37795391|NCT02097030|69438037|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
37795392|NCT02097030|69438036|FG000|First Intervention (3 Days)|Visual Acuity|0|||
37795393|NCT02097030|69438037|FG001|First Intervention (3 Days)|Visual Acuity|1|||
37795394|NCT02096952|69438047|FG000|Overall Study|Adverse Event|1|||
37795395|NCT02120898|69438054|FG000|Overall Study|Withdrawal by Subject|4|||
37795396|NCT02120898|69438055|FG001|Overall Study|Withdrawal by Subject|2|||
37795397|NCT02120898|69438056|FG002|Overall Study|Withdrawal by Subject|2|||
37795398|NCT02120898|69438054|FG000|Overall Study|Non-compliance with study drug|3|||
37795399|NCT02120898|69438055|FG001|Overall Study|Non-compliance with study drug|0|||
37795400|NCT02120898|69438056|FG002|Overall Study|Non-compliance with study drug|0|||
37795401|NCT02120898|69438054|FG000|Overall Study|Adverse Event|1|||
37795402|NCT02120898|69438055|FG001|Overall Study|Adverse Event|2|||
37795403|NCT02120898|69438056|FG002|Overall Study|Adverse Event|1|||
37795404|NCT02120898|69438054|FG000|Overall Study|Protocol Violation|1|||
37795405|NCT02120898|69438055|FG001|Overall Study|Protocol Violation|2|||
37795406|NCT02120898|69438056|FG002|Overall Study|Protocol Violation|0|||
37795407|NCT02120898|69438054|FG000|Overall Study|Lost to Follow-up|0|||
37795408|NCT02120898|69438055|FG001|Overall Study|Lost to Follow-up|0|||
37795409|NCT02120898|69438056|FG002|Overall Study|Lost to Follow-up|1|||
37795410|NCT02120664|69438069|FG000|Overall Study|Withdrawal by Subject|0|||
37795411|NCT02120664|69438070|FG001|Overall Study|Withdrawal by Subject|0|||
37795412|NCT02120664|69438071|FG002|Overall Study|Withdrawal by Subject|0|||
37795413|NCT02120664|69438072|FG003|Overall Study|Withdrawal by Subject|1|||
37795414|NCT02120664|69438073|FG004|Overall Study|Withdrawal by Subject|0|||
37795415|NCT01627860|69438088|FG000|Overall Study|Adverse Event|9|||
37795416|NCT01627860|69438089|FG001|Overall Study|Adverse Event|4|||
37795417|NCT01627860|69438088|FG000|Overall Study|Withdrawal by Subject|2|||
37795418|NCT01627860|69438089|FG001|Overall Study|Withdrawal by Subject|1|||
37864165|NCT00991276|69547778|FG001|Third Intervention Period|Withdrawal by Subject|0|||
37795419|NCT01627860|69438088|FG000|Overall Study|Seizure frequency doubled|0|||
37795420|NCT01627860|69438089|FG001|Overall Study|Seizure frequency doubled|1|||
37795421|NCT01627860|69438088|FG000|Overall Study|Protocol Violation|1|||
37795422|NCT01627860|69438089|FG001|Overall Study|Protocol Violation|0|||
37795423|NCT01627782|69438099|FG000|Overall Study|Adverse Event|1|||
37795424|NCT01627782|69438100|FG001|Overall Study|Adverse Event|2|||
37795425|NCT01627782|69438101|FG002|Overall Study|Adverse Event|0|||
37795426|NCT01627782|69438102|FG003|Overall Study|Adverse Event|1|||
37795427|NCT01627782|69438099|FG000|Overall Study|Lack of Efficacy|11|||
37795428|NCT01627782|69438100|FG001|Overall Study|Lack of Efficacy|1|||
37795429|NCT01627782|69438101|FG002|Overall Study|Lack of Efficacy|15|||
37795430|NCT01627782|69438102|FG003|Overall Study|Lack of Efficacy|2|||
37795431|NCT01627782|69438099|FG000|Overall Study|Protocol Violation|1|||
37795432|NCT01627782|69438100|FG001|Overall Study|Protocol Violation|0|||
37795433|NCT01627782|69438101|FG002|Overall Study|Protocol Violation|0|||
37795434|NCT01627782|69438102|FG003|Overall Study|Protocol Violation|0|||
37795435|NCT01627782|69438099|FG000|Overall Study|Withdrawal by Subject|2|||
37795436|NCT01627782|69438100|FG001|Overall Study|Withdrawal by Subject|1|||
37795437|NCT01627782|69438101|FG002|Overall Study|Withdrawal by Subject|0|||
37795438|NCT01627782|69438102|FG003|Overall Study|Withdrawal by Subject|0|||
37795439|NCT01627782|69438099|FG000|Overall Study|Other|0|||
37795440|NCT01627782|69438100|FG001|Overall Study|Other|2|||
37795441|NCT01627782|69438101|FG002|Overall Study|Other|0|||
37795442|NCT01627782|69438102|FG003|Overall Study|Other|3|||
37795443|NCT01627782|69438099|FG000|Overall Study|Randomized But Not Treated|1|||
37795444|NCT01627782|69438100|FG001|Overall Study|Randomized But Not Treated|0|||
37795445|NCT01627782|69438101|FG002|Overall Study|Randomized But Not Treated|0|||
37795446|NCT01627782|69438102|FG003|Overall Study|Randomized But Not Treated|0|||
37795447|NCT01598532|69438114|FG000|Overall Study|Lost to Follow-up|3|||
37795448|NCT01598532|69438114|FG000|Overall Study|Did not meet inclusion criteria|8|||
37795449|NCT02119650|69438123|FG000|Overall Study|Adverse Event|3|||
37795450|NCT02119650|69438124|FG001|Overall Study|Adverse Event|4|||
37795451|NCT02119650|69438123|FG000|Overall Study|Subject decision|2|||
37795452|NCT02119650|69438124|FG001|Overall Study|Subject decision|3|||
37795453|NCT02119650|69438123|FG000|Overall Study|Disease progression|11|||
37795454|NCT02119650|69438124|FG001|Overall Study|Disease progression|14|||
37795455|NCT02119650|69438123|FG000|Overall Study|Death|5|||
37795456|NCT02119650|69438124|FG001|Overall Study|Death|1|||
37795457|NCT02119650|69438123|FG000|Overall Study|Noncompliance with study treatment|1|||
37795458|NCT02119650|69438124|FG001|Overall Study|Noncompliance with study treatment|1|||
37795459|NCT02119650|69438123|FG000|Overall Study|Study terminated by the sponsor|1|||
37795460|NCT02119650|69438124|FG001|Overall Study|Study terminated by the sponsor|0|||
38043669|NCT02180867|69731807|FG003|Overall Study|Refusal of further protocol therapy|6|||
37795461|NCT02119650|69438123|FG000|Overall Study|Physician Decision|0|||
37795462|NCT02119650|69438124|FG001|Overall Study|Physician Decision|2|||
37795463|NCT02119650|69438123|FG000|Overall Study|Multiple reasons for termination|2|||
37795464|NCT02119650|69438124|FG001|Overall Study|Multiple reasons for termination|1|||
37833546|NCT01263496|69517271|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
37833547|NCT01263496|69517272|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
37833548|NCT01263496|69517273|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
38043670|NCT02180867|69731808|FG004|Overall Study|Refusal of further protocol therapy|4|||
38043671|NCT02180867|69731809|FG005|Overall Study|Refusal of further protocol therapy|0|||
38043672|NCT02180867|69731810|FG006|Overall Study|Refusal of further protocol therapy|0|||
38043673|NCT02152982|69731840|FG000|Overall Study|Ineligible|4|||
38043674|NCT02152982|69731841|FG001|Overall Study|Ineligible|4|||
38043675|NCT02152982|69731840|FG000|Overall Study|Did not start treatment|12|||
38043676|NCT02152982|69731841|FG001|Overall Study|Did not start treatment|6|||
38043677|NCT02115282|69731863|FG000|Overall Study|Disease progression during treatment|216|||
38043678|NCT02115282|69731864|FG001|Overall Study|Disease progression during treatment|229|||
38043679|NCT02115282|69731863|FG000|Overall Study|Adverse Event|49|||
38043680|NCT02115282|69731864|FG001|Overall Study|Adverse Event|23|||
38043681|NCT02115282|69731863|FG000|Overall Study|Death|1|||
38043682|NCT02115282|69731864|FG001|Overall Study|Death|3|||
38043683|NCT02115282|69731863|FG000|Overall Study|Alternative therapy|1|||
38043684|NCT02115282|69731864|FG001|Overall Study|Alternative therapy|1|||
38043685|NCT02115282|69731863|FG000|Overall Study|Complicating disease|0|||
38043686|NCT02115282|69731864|FG001|Overall Study|Complicating disease|3|||
38043687|NCT02115282|69731863|FG000|Overall Study|Withdrawal by Subject|12|||
38043688|NCT02115282|69731864|FG001|Overall Study|Withdrawal by Subject|10|||
38043689|NCT02115282|69731863|FG000|Overall Study|Symptomatic progression/deterioration|7|||
38043690|NCT02115282|69731864|FG001|Overall Study|Symptomatic progression/deterioration|18|||
38043691|NCT02115282|69731863|FG000|Overall Study|Non-compliance|5|||
37795465|NCT02119416|69438133|FG000|Overall Study|Protocol Violation|1|||
37795466|NCT02119416|69438134|FG001|Overall Study|Protocol Violation|1|||
37795467|NCT02119416|69438135|FG002|Overall Study|Protocol Violation|1|||
37795468|NCT02119416|69438133|FG000|Overall Study|wrong pubertal stage|1|||
37795469|NCT02119416|69438134|FG001|Overall Study|wrong pubertal stage|0|||
37795470|NCT02119416|69438135|FG002|Overall Study|wrong pubertal stage|1|||
37795471|NCT02140164|69438146|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
37795472|NCT02119260|69438157|FG000|Overall Study|Adverse Event|1|||
37795473|NCT02119260|69438158|FG001|Overall Study|Adverse Event|0|||
37795474|NCT02119260|69438159|FG002|Overall Study|Adverse Event|0|||
37795475|NCT02119260|69438160|FG003|Overall Study|Adverse Event|0|||
37795476|NCT02119260|69438161|FG004|Overall Study|Adverse Event|0|||
37795477|NCT02119260|69438162|FG005|Overall Study|Adverse Event|0|||
37795478|NCT02119260|69438163|FG006|Overall Study|Adverse Event|0|||
37795479|NCT02119260|69438157|FG000|Overall Study|Withdrew consent|0|||
37795480|NCT02119260|69438158|FG001|Overall Study|Withdrew consent|1|||
37795481|NCT02119260|69438159|FG002|Overall Study|Withdrew consent|1|||
37795482|NCT02119260|69438160|FG003|Overall Study|Withdrew consent|0|||
37795483|NCT02119260|69438161|FG004|Overall Study|Withdrew consent|0|||
37795484|NCT02119260|69438162|FG005|Overall Study|Withdrew consent|0|||
37795485|NCT02119260|69438163|FG006|Overall Study|Withdrew consent|0|||
37795486|NCT02119104|69438188|FG000|Overall Study|Protocol Violation|16|||
37795487|NCT02119026|69438194|FG000|1st-line Treatment|Adverse Event|9|||
37795488|NCT02119026|69438195|FG001|1st-line Treatment|Adverse Event|14|||
37795489|NCT02119026|69438194|FG000|1st-line Treatment|Physician Decision|3|||
37795490|NCT02119026|69438195|FG001|1st-line Treatment|Physician Decision|8|||
37795491|NCT02119026|69438194|FG000|1st-line Treatment|Withdrawal by Subject|4|||
37795492|NCT02119026|69438195|FG001|1st-line Treatment|Withdrawal by Subject|10|||
37795493|NCT02119026|69438194|FG000|1st-line Treatment|Patient condition or compliance|6|||
37795494|NCT02119026|69438195|FG001|1st-line Treatment|Patient condition or compliance|4|||
37795495|NCT02119026|69438194|FG000|1st-line Treatment|Surgery of metastases|2|||
37795496|NCT02119026|69438195|FG001|1st-line Treatment|Surgery of metastases|1|||
37795497|NCT02119026|69438194|FG000|1st-line Treatment|Death|2|||
37693808|NCT01860976|69170110|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
37693809|NCT01860976|69170111|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
37795498|NCT02119026|69438195|FG001|1st-line Treatment|Death|1|||
37795499|NCT02119026|69438194|FG000|2nd-line Treatment|Lost to Follow-up|2|||
37795500|NCT02119026|69438195|FG001|2nd-line Treatment|Lost to Follow-up|0|||
37795501|NCT02119026|69438194|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
37795502|NCT02119026|69438195|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
37795503|NCT02119026|69438194|FG000|2nd-line Treatment|Adverse Event|4|||
37795504|NCT02119026|69438195|FG001|2nd-line Treatment|Adverse Event|1|||
37795505|NCT02095158|69438201|FG000|Overall Study|Adverse Event|14|||
37795506|NCT02095158|69438201|FG000|Overall Study|Lack of Efficacy|3|||
37795507|NCT02095158|69438201|FG000|Overall Study|Pregnancy|1|||
37795508|NCT02095158|69438201|FG000|Overall Study|Lost to Follow-up|20|||
37795509|NCT02095158|69438201|FG000|Overall Study|Personal Reasons|35|||
37795510|NCT02095158|69438201|FG000|Overall Study|Protocol Violation|1|||
37795511|NCT02095158|69438201|FG000|Overall Study|Other Miscellaneous Reasons|1|||
37795512|NCT02094612|69438207|FG000|Overall Study|Lost to Follow-up|47|||
37795513|NCT02094612|69438208|FG001|Overall Study|Lost to Follow-up|47|||
37795514|NCT02094612|69438207|FG000|Overall Study|Never started ADHD medication|32|||
37795515|NCT02094612|69438208|FG001|Overall Study|Never started ADHD medication|23|||
37795516|NCT02139306|69438216|FG000|Overall Study|Withdrawal by Subject|4|||
37795517|NCT02139306|69438217|FG001|Overall Study|Withdrawal by Subject|6|||
37795518|NCT02139306|69438216|FG000|Overall Study|Adverse Event|3|||
37795519|NCT02139306|69438217|FG001|Overall Study|Adverse Event|4|||
37795520|NCT02139306|69438216|FG000|Overall Study|Physician Decision|0|||
37795521|NCT02139306|69438217|FG001|Overall Study|Physician Decision|1|||
37795522|NCT02139306|69438216|FG000|Overall Study|Other Unspecified|2|||
37795523|NCT02139306|69438217|FG001|Overall Study|Other Unspecified|3|||
37795524|NCT02139306|69438216|FG000|Overall Study|Protocol Violation|4|||
37795525|NCT02139306|69438217|FG001|Overall Study|Protocol Violation|0|||
37795526|NCT02094300|69438224|FG000|Overall Study|Death|7|||
37795527|NCT02094300|69438224|FG000|Overall Study|Lost to Follow-up|10|||
37795528|NCT02094300|69438224|FG000|Overall Study|Still be eligible for follow-up|3|||
37795529|NCT02118792|69438230|FG000|Overall Study|Withdrawal by Subject|6|||
37795530|NCT02118792|69438231|FG001|Overall Study|Withdrawal by Subject|3|||
37795531|NCT02118792|69438230|FG000|Overall Study|Lost to Follow-up|4|||
37795532|NCT02118792|69438231|FG001|Overall Study|Lost to Follow-up|4|||
37795533|NCT02118792|69438230|FG000|Overall Study|Adverse Event|5|||
37795534|NCT02118792|69438231|FG001|Overall Study|Adverse Event|4|||
37795535|NCT02118792|69438230|FG000|Overall Study|Withdrawal by parent/guardian|14|||
37795536|NCT02118792|69438231|FG001|Overall Study|Withdrawal by parent/guardian|20|||
37795537|NCT02118792|69438230|FG000|Overall Study|Other|1|||
37795538|NCT02118792|69438231|FG001|Overall Study|Other|6|||
37795539|NCT02118792|69438230|FG000|Overall Study|Randomised but not treated|1|||
37795540|NCT02118792|69438231|FG001|Overall Study|Randomised but not treated|0|||
37795541|NCT02118714|69438239|FG000|Overall Study|Lost to Follow-up|2|||
37795542|NCT02118714|69438239|FG000|Overall Study|Protocol Violation|1|||
37795543|NCT02138916|69438246|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
37795544|NCT02138916|69438247|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
37795545|NCT02138916|69438248|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
37795546|NCT02138916|69438246|FG000|Overall Study|Death|14|||
37795547|NCT02138916|69438247|FG001|Overall Study|Death|11|||
37795548|NCT02138916|69438248|FG002|Overall Study|Death|12|||
37795549|NCT02138916|69438246|FG000|Overall Study|Withdrawal by Subject|27|||
37795550|NCT02138916|69438247|FG001|Overall Study|Withdrawal by Subject|31|||
37795551|NCT02138916|69438248|FG002|Overall Study|Withdrawal by Subject|32|||
37795552|NCT02138916|69438246|FG000|Overall Study|Study specific withdrawal criteria|0|||
37795553|NCT02138916|69438247|FG001|Overall Study|Study specific withdrawal criteria|0|||
37795554|NCT02138916|69438248|FG002|Overall Study|Study specific withdrawal criteria|1|||
37795555|NCT02138916|69438246|FG000|Overall Study|incorrect enrolment|1|||
37795556|NCT02138916|69438247|FG001|Overall Study|incorrect enrolment|1|||
37795557|NCT02138916|69438248|FG002|Overall Study|incorrect enrolment|0|||
37795558|NCT02138916|69438246|FG000|Overall Study|Severe non-compliance|1|||
37795559|NCT02138916|69438247|FG001|Overall Study|Severe non-compliance|2|||
37795560|NCT02138916|69438248|FG002|Overall Study|Severe non-compliance|1|||
37795561|NCT02138916|69438246|FG000|Overall Study|Lost to Follow-up|4|||
37795562|NCT02138916|69438247|FG001|Overall Study|Lost to Follow-up|2|||
37795563|NCT02138916|69438248|FG002|Overall Study|Lost to Follow-up|3|||
37795564|NCT02138916|69438246|FG000|Overall Study|Adverse Event|4|||
37795565|NCT02138916|69438247|FG001|Overall Study|Adverse Event|4|||
37795566|NCT02138916|69438248|FG002|Overall Study|Adverse Event|3|||
37795567|NCT02118012|69438258|FG000|Overall Study|Adverse Event|0|||
37795568|NCT02118012|69438259|FG001|Overall Study|Adverse Event|1|||
37795569|NCT02118012|69438258|FG000|Overall Study|Physician Decision|0|||
37795570|NCT02118012|69438259|FG001|Overall Study|Physician Decision|1|||
37795571|NCT02093520|69438267|FG000|Overall Study|Not treated|6|||
37795572|NCT02093520|69438268|FG001|Overall Study|Not treated|22|||
37795573|NCT02138838|69438276|FG000|Overall Study|Study Closure|7|||
37795574|NCT02138838|69438277|FG001|Overall Study|Study Closure|6|||
37795575|NCT02138838|69438276|FG000|Overall Study|Withdrawal by Subject|1|||
37795576|NCT02138838|69438277|FG001|Overall Study|Withdrawal by Subject|5|||
37795577|NCT02138214|69438286|FG000|Overall Study|Withdrawal by Subject|0|||
37795578|NCT02138214|69438287|FG001|Overall Study|Withdrawal by Subject|1|||
37795579|NCT02138214|69438288|FG002|Overall Study|Withdrawal by Subject|0|||
37795580|NCT02138214|69438286|FG000|Overall Study|Lost to Follow-up|0|||
37795581|NCT02138214|69438287|FG001|Overall Study|Lost to Follow-up|2|||
37795582|NCT02138214|69438288|FG002|Overall Study|Lost to Follow-up|4|||
37795583|NCT02138214|69438286|FG000|Overall Study|Screen Failure|0|||
37795584|NCT02138214|69438287|FG001|Overall Study|Screen Failure|1|||
37795585|NCT02138214|69438288|FG002|Overall Study|Screen Failure|0|||
37795586|NCT02092662|69438297|FG000|Overall Study|Lost to Follow-up|13|||
37795587|NCT02092662|69438298|FG001|Overall Study|Lost to Follow-up|0|||
37795588|NCT02092350|69438307|FG000|Overall Study|Adverse Event|0|||
37795589|NCT02092350|69438308|FG001|Overall Study|Adverse Event|3|||
37795590|NCT02092350|69438307|FG000|Overall Study|Death|2|||
37795591|NCT02092350|69438308|FG001|Overall Study|Death|5|||
37795592|NCT02092350|69438307|FG000|Overall Study|Lost to Follow-up|3|||
37795593|NCT02092350|69438308|FG001|Overall Study|Lost to Follow-up|1|||
37795594|NCT02092350|69438307|FG000|Overall Study|Protocol Violation|1|||
37795595|NCT02092350|69438308|FG001|Overall Study|Protocol Violation|0|||
37795596|NCT02092350|69438307|FG000|Overall Study|Physician Decision|1|||
37795597|NCT02092350|69438308|FG001|Overall Study|Physician Decision|1|||
37795598|NCT02092350|69438307|FG000|Overall Study|Screen Failure|1|||
37795599|NCT02092350|69438308|FG001|Overall Study|Screen Failure|0|||
37795600|NCT02092350|69438307|FG000|Overall Study|Withdrawal by Subject|2|||
37795601|NCT02092350|69438308|FG001|Overall Study|Withdrawal by Subject|2|||
37795602|NCT02117544|69438316|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
37795603|NCT02117544|69438317|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
37795604|NCT02138136|69438324|FG000|Overall Study|Protocol Violation|4|||
37795605|NCT02138136|69438324|FG000|Overall Study|Physician Decision|7|||
37795606|NCT02138136|69438324|FG000|Overall Study|Lack of Efficacy|35|||
37795607|NCT02138136|69438324|FG000|Overall Study|Pregnancy|2|||
37795608|NCT02138136|69438324|FG000|Overall Study|Adverse Event|18|||
37795609|NCT02138136|69438324|FG000|Overall Study|Withdrawal by Subject|36|||
37795610|NCT02138136|69438324|FG000|Overall Study|Lost to Follow-up|32|||
37795611|NCT02138136|69438324|FG000|Overall Study|Withdrawn by Sponsor|5|||
37795612|NCT01626690|69438331|FG000|Overall Study|Protocol Violation|1|||
37795613|NCT01626690|69438332|FG001|Overall Study|Protocol Violation|0|||
37795614|NCT01626690|69438331|FG000|Overall Study|Adverse Event|1|||
37795615|NCT01626690|69438332|FG001|Overall Study|Adverse Event|0|||
37795616|NCT01626456|69438342|FG000|Overall Study|Withdrawal by Subject|21|||
37795617|NCT01626456|69438343|FG001|Overall Study|Withdrawal by Subject|46|||
37795618|NCT01626456|69438342|FG000|Overall Study|Adverse Event|2|||
37795619|NCT01626456|69438343|FG001|Overall Study|Adverse Event|27|||
37795620|NCT01626456|69438342|FG000|Overall Study|Lost to Follow-up|2|||
37795621|NCT01626456|69438343|FG001|Overall Study|Lost to Follow-up|27|||
37795622|NCT01626456|69438342|FG000|Overall Study|Lack of Efficacy|6|||
37795623|NCT01626456|69438343|FG001|Overall Study|Lack of Efficacy|7|||
37795624|NCT01626456|69438342|FG000|Overall Study|Physician Decision|1|||
37795625|NCT01626456|69438343|FG001|Overall Study|Physician Decision|4|||
37795626|NCT01626456|69438342|FG000|Overall Study|Protocol Violation|1|||
37795627|NCT01626456|69438343|FG001|Overall Study|Protocol Violation|1|||
37795628|NCT01626456|69438342|FG000|Overall Study|Site Closure|2|||
37795629|NCT01626456|69438343|FG001|Overall Study|Site Closure|3|||
37795630|NCT01626456|69438342|FG000|Overall Study|Incarceration|0|||
37795631|NCT01626456|69438343|FG001|Overall Study|Incarceration|2|||
37795632|NCT02116608|69438361|FG000|Overall Study|Lost to Follow-up|0|||
37795633|NCT02116608|69438362|FG001|Overall Study|Lost to Follow-up|0|||
37795634|NCT02116608|69438363|FG002|Overall Study|Lost to Follow-up|1|||
37795635|NCT02116608|69438361|FG000|Overall Study|Physician Decision|0|||
37795636|NCT02116608|69438362|FG001|Overall Study|Physician Decision|1|||
37795637|NCT02116608|69438363|FG002|Overall Study|Physician Decision|0|||
37795638|NCT02116608|69438361|FG000|Overall Study|Death|0|||
37795639|NCT02116608|69438362|FG001|Overall Study|Death|1|||
37795640|NCT02116608|69438363|FG002|Overall Study|Death|0|||
37795641|NCT02092116|69438373|FG000|Overall Study|Withdrawal by Subject|0|||
37795642|NCT02092116|69438374|FG001|Overall Study|Withdrawal by Subject|3|||
37795643|NCT02092116|69438373|FG000|Overall Study|Adverse Event|0|||
37795644|NCT02092116|69438374|FG001|Overall Study|Adverse Event|1|||
37795645|NCT02091726|69438380|FG000|Overall Study|Lost to Follow-up|6|||
37795646|NCT02091414|69438384|FG000|Overall Study|Withdrawal by Subject|2|||
37795647|NCT02091414|69438384|FG000|Overall Study|Death|2|||
37795648|NCT02116530|69438390|FG000|Overall Study|Withdrawal by Subject|1|||
37795649|NCT02116530|69438391|FG001|Overall Study|Withdrawal by Subject|2|||
37795650|NCT02116530|69438390|FG000|Overall Study|Adverse Event|4|||
37795651|NCT02116530|69438391|FG001|Overall Study|Adverse Event|0|||
37795652|NCT02116530|69438390|FG000|Overall Study|Physician Decision|1|||
37795653|NCT02116530|69438391|FG001|Overall Study|Physician Decision|0|||
37795654|NCT02116530|69438390|FG000|Overall Study|Lost to Follow-up|1|||
37795655|NCT02116530|69438391|FG001|Overall Study|Lost to Follow-up|0|||
37795656|NCT02116530|69438390|FG000|Overall Study|Other Medical Problems|2|||
37795657|NCT02116530|69438391|FG001|Overall Study|Other Medical Problems|2|||
37795658|NCT02072226|69438399|FG000|Overall Study|Lost to Follow-up|11|||
37795659|NCT02072226|69438400|FG001|Overall Study|Lost to Follow-up|7|||
37795660|NCT02072226|69438399|FG000|Overall Study|Patient Non-compliance|2|||
37795661|NCT02072226|69438400|FG001|Overall Study|Patient Non-compliance|3|||
37795662|NCT02072226|69438399|FG000|Overall Study|Death|1|||
37795663|NCT02072226|69438400|FG001|Overall Study|Death|0|||
37795664|NCT02072226|69438399|FG000|Overall Study|Patient Withdrawal of Consent|1|||
37795665|NCT02072226|69438400|FG001|Overall Study|Patient Withdrawal of Consent|0|||
37795666|NCT02090634|69438408|FG000|Overall Study|Lost to Follow-up|0|||
37795667|NCT02090634|69438409|FG001|Overall Study|Lost to Follow-up|1|||
37795668|NCT02090634|69438408|FG000|Overall Study|Death|0|||
37795669|NCT02090634|69438409|FG001|Overall Study|Death|1|||
37795670|NCT02090634|69438408|FG000|Overall Study|Protocol Violation|3|||
37795671|NCT02090634|69438409|FG001|Overall Study|Protocol Violation|1|||
37795672|NCT02090634|69438408|FG000|Overall Study|Adverse Event|2|||
37795673|NCT02090634|69438409|FG001|Overall Study|Adverse Event|0|||
37795674|NCT02114892|69438417|FG000|Overall Study|Lost to Follow-up|1|||
37795675|NCT02114892|69438418|FG001|Overall Study|Lost to Follow-up|2|||
37795676|NCT02070978|69438427|FG000|Overall Study|Adverse Event|6|||
37795677|NCT02070978|69438428|FG001|Overall Study|Adverse Event|2|||
37795678|NCT02070978|69438429|FG002|Overall Study|Adverse Event|0|||
37795679|NCT02070978|69438427|FG000|Overall Study|Lost to Follow-up|1|||
37795680|NCT02070978|69438428|FG001|Overall Study|Lost to Follow-up|3|||
37795681|NCT02070978|69438429|FG002|Overall Study|Lost to Follow-up|4|||
37795682|NCT02070978|69438427|FG000|Overall Study|Withdrawal by Subject|3|||
37795683|NCT02070978|69438428|FG001|Overall Study|Withdrawal by Subject|5|||
37795684|NCT02070978|69438429|FG002|Overall Study|Withdrawal by Subject|3|||
37795685|NCT02070978|69438427|FG000|Overall Study|Protocol Violation|1|||
37795686|NCT02070978|69438428|FG001|Overall Study|Protocol Violation|0|||
37795687|NCT02070978|69438429|FG002|Overall Study|Protocol Violation|3|||
37795688|NCT02070978|69438427|FG000|Overall Study|Lack of Efficacy|0|||
37795689|NCT02070978|69438428|FG001|Overall Study|Lack of Efficacy|1|||
37795690|NCT02070978|69438429|FG002|Overall Study|Lack of Efficacy|0|||
37795691|NCT02070978|69438427|FG000|Overall Study|Death|0|||
37795692|NCT02070978|69438428|FG001|Overall Study|Death|0|||
37795693|NCT02070978|69438429|FG002|Overall Study|Death|2|||
37795694|NCT02070978|69438427|FG000|Overall Study|Un-specified|3|||
37795695|NCT02070978|69438428|FG001|Overall Study|Un-specified|2|||
37795696|NCT02070978|69438429|FG002|Overall Study|Un-specified|2|||
37795697|NCT02070978|69438427|FG000|Overall Study|Terminated by Sponsor|33|||
37795698|NCT02070978|69438428|FG001|Overall Study|Terminated by Sponsor|40|||
37795699|NCT02070978|69438429|FG002|Overall Study|Terminated by Sponsor|39|||
37795700|NCT02114268|69438443|FG000|Overall Study|Lost to Follow-up|4|||
37795701|NCT02114268|69438444|FG001|Overall Study|Lost to Follow-up|1|||
37795702|NCT02114268|69438445|FG002|Overall Study|Lost to Follow-up|1|||
37693810|NCT01860976|69170110|FG000|Blinded Treatment|Withdrawal by Subject|3|||
37693811|NCT01860976|69170111|FG001|Blinded Treatment|Withdrawal by Subject|5|||
37693812|NCT01860976|69170110|FG000|Blinded Treatment|Subject no longer met criteria|1|||
37693813|NCT01860976|69170111|FG001|Blinded Treatment|Subject no longer met criteria|0|||
37693814|NCT01860976|69170110|FG000|Blinded Treatment|Entered Open-Label in error|0|||
37693815|NCT01860976|69170111|FG001|Blinded Treatment|Entered Open-Label in error|1|||
37693816|NCT01860976|69170110|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
37693817|NCT01860976|69170111|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
37693818|NCT01860976|69170110|FG000|Open-Label|Adverse Event|2|||
37693819|NCT01860976|69170111|FG001|Open-Label|Adverse Event|4|||
37693820|NCT01860976|69170110|FG000|Open-Label|Lack of Efficacy|16|||
37693821|NCT01860976|69170111|FG001|Open-Label|Lack of Efficacy|8|||
37693822|NCT01860976|69170110|FG000|Open-Label|Lost to Follow-up|1|||
37693823|NCT01860976|69170111|FG001|Open-Label|Lost to Follow-up|2|||
37693824|NCT01860976|69170110|FG000|Open-Label|Subject request discontinue treatment|4|||
37693825|NCT01860976|69170111|FG001|Open-Label|Subject request discontinue treatment|3|||
37693826|NCT01860976|69170110|FG000|Open-Label|Withdrawal by Subject|4|||
37693827|NCT01860976|69170111|FG001|Open-Label|Withdrawal by Subject|1|||
37693828|NCT01860976|69170110|FG000|Open-Label|Other Reasons|1|||
37693829|NCT01860976|69170111|FG001|Open-Label|Other Reasons|1|||
37693830|NCT01860976|69170110|FG000|Long Term Extension|Adverse Event|4|||
37693831|NCT01860976|69170111|FG001|Long Term Extension|Adverse Event|0|||
37693832|NCT01860976|69170110|FG000|Long Term Extension|Lack of Efficacy|2|||
37693833|NCT01860976|69170111|FG001|Long Term Extension|Lack of Efficacy|0|||
37795703|NCT02114268|69438446|FG003|Overall Study|Lost to Follow-up|0|||
37795704|NCT02114268|69438447|FG004|Overall Study|Lost to Follow-up|0|||
37795705|NCT02114268|69438448|FG005|Overall Study|Lost to Follow-up|2|||
37693834|NCT01860976|69170110|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
37693835|NCT01860976|69170111|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
37693836|NCT01860976|69170110|FG000|Long Term Extension|Lost to Follow-up|2|||
37693837|NCT01860976|69170111|FG001|Long Term Extension|Lost to Follow-up|0|||
37693838|NCT01860976|69170110|FG000|Long Term Extension|subject withdrew consent|7|||
37795706|NCT02114268|69438443|FG000|Overall Study|Withdrawal by Subject|1|||
37795707|NCT02114268|69438444|FG001|Overall Study|Withdrawal by Subject|0|||
37795708|NCT02114268|69438445|FG002|Overall Study|Withdrawal by Subject|0|||
37795709|NCT02114268|69438446|FG003|Overall Study|Withdrawal by Subject|0|||
37795710|NCT02114268|69438447|FG004|Overall Study|Withdrawal by Subject|0|||
37795711|NCT02114268|69438448|FG005|Overall Study|Withdrawal by Subject|1|||
37795712|NCT02114268|69438443|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
37795713|NCT02114268|69438444|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
37795714|NCT02114268|69438445|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
37795715|NCT02114268|69438446|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
37795716|NCT02114268|69438447|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
37795717|NCT02114268|69438448|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
37795718|NCT02089230|69438470|FG000|Overall Study|Death|0|||
37795719|NCT02089230|69438471|FG001|Overall Study|Death|0|||
37795720|NCT02089230|69438472|FG002|Overall Study|Death|2|||
37795721|NCT02089230|69438470|FG000|Overall Study|Seeking Alternative Therapy|0|||
37795722|NCT02089230|69438471|FG001|Overall Study|Seeking Alternative Therapy|0|||
37795723|NCT02089230|69438472|FG002|Overall Study|Seeking Alternative Therapy|4|||
37795724|NCT02070744|69438484|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
37795725|NCT02070744|69438485|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
37795726|NCT02070744|69438486|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
37795727|NCT02070744|69438487|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
37795728|NCT02070744|69438488|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
37795729|NCT02070744|69438484|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
37795730|NCT02070744|69438485|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
37795731|NCT02070744|69438486|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
37795732|NCT02070744|69438487|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
37795733|NCT02070744|69438488|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
37795734|NCT02070744|69438484|FG000|OLE Phase (48 Weeks)|Other|0|||
37795735|NCT02070744|69438485|FG001|OLE Phase (48 Weeks)|Other|0|||
37795736|NCT02070744|69438486|FG002|OLE Phase (48 Weeks)|Other|0|||
37795737|NCT02070744|69438487|FG003|OLE Phase (48 Weeks)|Other|0|||
37795738|NCT02070744|69438488|FG004|OLE Phase (48 Weeks)|Other|1|||
37795739|NCT02113956|69438505|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
37795740|NCT02113956|69438506|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
37795741|NCT02113956|69438505|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
37795742|NCT02113956|69438506|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
37795743|NCT02113956|69438505|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
37795744|NCT02113956|69438506|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
37795745|NCT02070588|69438515|FG000|Overall Study|Withdrawal by Subject|29|||
37795746|NCT02070588|69438516|FG001|Overall Study|Withdrawal by Subject|1|||
37795747|NCT02070588|69438517|FG002|Overall Study|Withdrawal by Subject|0|||
37795748|NCT02070588|69438515|FG000|Overall Study|Writhdrawal due to early termination|9|||
37795749|NCT02070588|69438516|FG001|Overall Study|Writhdrawal due to early termination|0|||
37795750|NCT02070588|69438517|FG002|Overall Study|Writhdrawal due to early termination|0|||
37795751|NCT02070588|69438515|FG000|Overall Study|Adverse Event|1|||
37795752|NCT02070588|69438516|FG001|Overall Study|Adverse Event|0|||
37795753|NCT02070588|69438517|FG002|Overall Study|Adverse Event|0|||
37795754|NCT02111850|69438536|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
37795755|NCT02111850|69438537|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
37795756|NCT02111850|69438538|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
37795757|NCT02111850|69438539|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
37795758|NCT02111850|69438540|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
37795759|NCT02111850|69438541|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
37795760|NCT02111850|69438542|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
37795761|NCT02111850|69438543|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
37795762|NCT02111850|69438544|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
37795763|NCT02111850|69438545|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
37795764|NCT02111850|69438546|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
37795765|NCT02087904|69438576|FG000|Overall Study|Did Not Receive Study Drug|0|||
37795766|NCT02087904|69438577|FG001|Overall Study|Did Not Receive Study Drug|0|||
37795767|NCT02087904|69438578|FG002|Overall Study|Did Not Receive Study Drug|2|||
37795768|NCT02087904|69438579|FG003|Overall Study|Did Not Receive Study Drug|1|||
37795769|NCT02087904|69438576|FG000|Overall Study|Adverse Event|8|||
37795770|NCT02087904|69438577|FG001|Overall Study|Adverse Event|4|||
37795771|NCT02087904|69438578|FG002|Overall Study|Adverse Event|4|||
37795772|NCT02087904|69438579|FG003|Overall Study|Adverse Event|12|||
37795773|NCT02087904|69438576|FG000|Overall Study|Lack of Efficacy|3|||
37795774|NCT02087904|69438577|FG001|Overall Study|Lack of Efficacy|6|||
37795775|NCT02087904|69438578|FG002|Overall Study|Lack of Efficacy|3|||
37795776|NCT02087904|69438579|FG003|Overall Study|Lack of Efficacy|2|||
37795777|NCT02087904|69438576|FG000|Overall Study|Other|6|||
37795778|NCT02087904|69438577|FG001|Overall Study|Other|2|||
37795779|NCT02087904|69438578|FG002|Overall Study|Other|4|||
37795780|NCT02087904|69438579|FG003|Overall Study|Other|4|||
37795781|NCT02087904|69438576|FG000|Overall Study|Withdrawal by Subject|8|||
37795782|NCT02087904|69438577|FG001|Overall Study|Withdrawal by Subject|3|||
37795783|NCT02087904|69438578|FG002|Overall Study|Withdrawal by Subject|7|||
37795784|NCT02087904|69438579|FG003|Overall Study|Withdrawal by Subject|4|||
37795785|NCT02087904|69438576|FG000|Overall Study|Lost to Follow-up|0|||
37795786|NCT02087904|69438577|FG001|Overall Study|Lost to Follow-up|4|||
37795787|NCT02087904|69438578|FG002|Overall Study|Lost to Follow-up|2|||
37795788|NCT02087904|69438579|FG003|Overall Study|Lost to Follow-up|2|||
37795789|NCT02087670|69438591|FG000|Overall Study|Withdrawal by Subject|3|||
37795790|NCT02087670|69438592|FG001|Overall Study|Withdrawal by Subject|2|||
37795791|NCT02086968|69438600|FG000|Overall Study|Adverse Event|1|||
37795792|NCT02086968|69438601|FG001|Overall Study|Adverse Event|5|||
37795793|NCT02086968|69438600|FG000|Overall Study|Lost to Follow-up|2|||
37795794|NCT02086968|69438601|FG001|Overall Study|Lost to Follow-up|3|||
37795795|NCT02086968|69438600|FG000|Overall Study|Study drug received outside protocol|0|||
37795796|NCT02086968|69438601|FG001|Overall Study|Study drug received outside protocol|1|||
37795797|NCT02086968|69438600|FG000|Overall Study|Physician Decision|4|||
37795798|NCT02086968|69438601|FG001|Overall Study|Physician Decision|0|||
37795799|NCT02086968|69438600|FG000|Overall Study|Withdrawal by Subject|1|||
37795800|NCT02086968|69438601|FG001|Overall Study|Withdrawal by Subject|4|||
37795801|NCT02086110|69438609|FG000|Overall Study|Withdrawal by Subject|1|||
37795802|NCT02086110|69438610|FG001|Overall Study|Withdrawal by Subject|1|||
37795803|NCT02085252|69438619|FG000|Overall Study|Withdrawal of Consent|1|||
37795804|NCT02085252|69438620|FG001|Overall Study|Withdrawal of Consent|0|||
37795805|NCT02085252|69438619|FG000|Overall Study|Adverse Event|0|||
37795806|NCT02085252|69438620|FG001|Overall Study|Adverse Event|1|||
37795807|NCT02085252|69438619|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
37795808|NCT02085252|69438620|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
37795809|NCT02085252|69438619|FG000|Overall Study|Reason Not Specified|0|||
37795810|NCT02085252|69438620|FG001|Overall Study|Reason Not Specified|1|||
37795811|NCT02085252|69438619|FG000|Overall Study|Reason Unknown|0|||
37795812|NCT02085252|69438620|FG001|Overall Study|Reason Unknown|1|||
37795813|NCT02084238|69438626|FG000|Overall Study|Lost to Follow-up|2|||
37795814|NCT02084082|69438639|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
37795815|NCT02084082|69438640|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
37795816|NCT02084082|69438641|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
37795817|NCT02084082|69438642|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
37795818|NCT02084082|69438639|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
37795819|NCT02084082|69438640|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
37795820|NCT02084082|69438641|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
37795821|NCT02084082|69438642|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
37795822|NCT02083926|69438654|FG000|Overall Study|Withdrawal by Subject|1|||
37795823|NCT02083926|69438655|FG001|Overall Study|Withdrawal by Subject|0|||
37795824|NCT02083380|69438665|FG000|Overall Study|Lack of Efficacy|68|||
37795825|NCT02083380|69438666|FG001|Overall Study|Lack of Efficacy|79|||
37795826|NCT02083380|69438667|FG002|Overall Study|Lack of Efficacy|64|||
37795827|NCT02083380|69438665|FG000|Overall Study|Withdrawal by Subject|9|||
37795828|NCT02083380|69438666|FG001|Overall Study|Withdrawal by Subject|3|||
37795829|NCT02083380|69438667|FG002|Overall Study|Withdrawal by Subject|7|||
37795830|NCT02083380|69438665|FG000|Overall Study|Physician Decision|1|||
37795831|NCT02083380|69438666|FG001|Overall Study|Physician Decision|6|||
37795832|NCT02083380|69438667|FG002|Overall Study|Physician Decision|3|||
37795833|NCT02083380|69438665|FG000|Overall Study|Adverse Event|0|||
37693839|NCT01860976|69170111|FG001|Long Term Extension|subject withdrew consent|0|||
37693840|NCT01860040|69170122|FG000|Overall Study|Withdrawal by Subject|1|||
37693841|NCT01860040|69170123|FG001|Overall Study|Withdrawal by Subject|0|||
37693842|NCT01896934|69170128|FG000|Overall Study|Adverse Event|1|||
37693843|NCT01896934|69170128|FG000|Overall Study|Withdrawal by Subject|1|||
37693844|NCT02039505|69170135|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
37693845|NCT02039505|69170136|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
37693846|NCT02039505|69170137|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
37693847|NCT02039505|69170138|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
37693848|NCT02039505|69170139|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
37693849|NCT02039505|69170140|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
37693850|NCT02039505|69170141|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
37795834|NCT02083380|69438666|FG001|Overall Study|Adverse Event|0|||
37795835|NCT02083380|69438667|FG002|Overall Study|Adverse Event|1|||
37795836|NCT02083380|69438665|FG000|Overall Study|Lost to Follow-up|5|||
37795837|NCT02083380|69438666|FG001|Overall Study|Lost to Follow-up|3|||
37795838|NCT02083380|69438667|FG002|Overall Study|Lost to Follow-up|3|||
37795839|NCT02083380|69438665|FG000|Overall Study|Other|8|||
37795840|NCT02083380|69438666|FG001|Overall Study|Other|4|||
37864166|NCT00991276|69547779|FG002|Third Intervention Period|Withdrawal by Subject|0|||
37795841|NCT02083380|69438667|FG002|Overall Study|Other|6|||
37795842|NCT02109744|69438682|FG000|Overall Study|Death|1|||
37795843|NCT02109744|69438683|FG001|Overall Study|Death|1|||
37795844|NCT02109744|69438682|FG000|Overall Study|no marrow exam|1|||
37795845|NCT02109744|69438683|FG001|Overall Study|no marrow exam|0|||
37795846|NCT02109432|69438689|FG000|Overall Study|Withdrawal by Subject|1|||
37795847|NCT02109042|69438693|FG000|Overall Study|Sponsor Decision|15|||
37795848|NCT02066922|69438698|FG000|Overall Study|Adverse Event|1|||
37795849|NCT02108262|69438709|FG000|Overall Study|Non-compliance|0|||
37795850|NCT02108262|69438710|FG001|Overall Study|Non-compliance|2|||
37795851|NCT02108262|69438711|FG002|Overall Study|Non-compliance|1|||
37795852|NCT02108262|69438712|FG003|Overall Study|Non-compliance|1|||
37795853|NCT02108262|69438709|FG000|Overall Study|Randomized by error/screen failure|0|||
37795854|NCT02108262|69438710|FG001|Overall Study|Randomized by error/screen failure|0|||
37795855|NCT02108262|69438711|FG002|Overall Study|Randomized by error/screen failure|1|||
37795856|NCT02108262|69438712|FG003|Overall Study|Randomized by error/screen failure|0|||
37795857|NCT02108262|69438709|FG000|Overall Study|Distance to center|0|||
37795858|NCT02108262|69438710|FG001|Overall Study|Distance to center|1|||
37795859|NCT02108262|69438711|FG002|Overall Study|Distance to center|1|||
37795860|NCT02108262|69438712|FG003|Overall Study|Distance to center|0|||
37795861|NCT02108262|69438709|FG000|Overall Study|Adverse Event|0|||
37795862|NCT02108262|69438710|FG001|Overall Study|Adverse Event|11|||
37795863|NCT02108262|69438711|FG002|Overall Study|Adverse Event|6|||
37795864|NCT02108262|69438712|FG003|Overall Study|Adverse Event|12|||
37795865|NCT02108262|69438709|FG000|Overall Study|Death|0|||
37795866|NCT02108262|69438710|FG001|Overall Study|Death|2|||
37795867|NCT02108262|69438711|FG002|Overall Study|Death|2|||
37795868|NCT02108262|69438712|FG003|Overall Study|Death|1|||
37795869|NCT02108262|69438709|FG000|Overall Study|Lost to Follow-up|0|||
37795870|NCT02108262|69438710|FG001|Overall Study|Lost to Follow-up|0|||
37795871|NCT02108262|69438711|FG002|Overall Study|Lost to Follow-up|1|||
37795872|NCT02108262|69438712|FG003|Overall Study|Lost to Follow-up|0|||
37795873|NCT02108262|69438709|FG000|Overall Study|Physician Decision|0|||
37795874|NCT02108262|69438710|FG001|Overall Study|Physician Decision|0|||
37795875|NCT02108262|69438711|FG002|Overall Study|Physician Decision|2|||
37795876|NCT02108262|69438712|FG003|Overall Study|Physician Decision|0|||
37795877|NCT02108262|69438709|FG000|Overall Study|Withdrawal by Subject|0|||
37795878|NCT02108262|69438710|FG001|Overall Study|Withdrawal by Subject|7|||
37693851|NCT02039505|69170135|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
37693852|NCT02039505|69170136|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
37795879|NCT02108262|69438711|FG002|Overall Study|Withdrawal by Subject|3|||
37795880|NCT02108262|69438712|FG003|Overall Study|Withdrawal by Subject|4|||
37795881|NCT02108262|69438709|FG000|Overall Study|Due to key hepatic values|0|||
37795882|NCT02108262|69438710|FG001|Overall Study|Due to key hepatic values|1|||
37795883|NCT02108262|69438711|FG002|Overall Study|Due to key hepatic values|0|||
37795884|NCT02108262|69438712|FG003|Overall Study|Due to key hepatic values|0|||
37795885|NCT02108262|69438709|FG000|Overall Study|Unable to contact patient|0|||
37795886|NCT02108262|69438710|FG001|Overall Study|Unable to contact patient|3|||
37795887|NCT02108262|69438711|FG002|Overall Study|Unable to contact patient|1|||
37795888|NCT02108262|69438712|FG003|Overall Study|Unable to contact patient|2|||
37795889|NCT02108262|69438709|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
37795890|NCT02108262|69438710|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
37795891|NCT02108262|69438711|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
37795892|NCT02108262|69438712|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
37795893|NCT02108262|69438709|FG000|Overall Study|Patient did not want another infusion|0|||
37795894|NCT02108262|69438710|FG001|Overall Study|Patient did not want another infusion|3|||
37795895|NCT02108262|69438711|FG002|Overall Study|Patient did not want another infusion|3|||
37795896|NCT02108262|69438712|FG003|Overall Study|Patient did not want another infusion|2|||
37795897|NCT02108262|69438709|FG000|Overall Study|Vacation|0|||
37795898|NCT02108262|69438710|FG001|Overall Study|Vacation|1|||
37795899|NCT02108262|69438711|FG002|Overall Study|Vacation|0|||
37795900|NCT02108262|69438712|FG003|Overall Study|Vacation|0|||
37795901|NCT02108262|69438709|FG000|Overall Study|Patient decision|0|||
37795902|NCT02108262|69438710|FG001|Overall Study|Patient decision|7|||
37795903|NCT02108262|69438711|FG002|Overall Study|Patient decision|9|||
37795904|NCT02108262|69438712|FG003|Overall Study|Patient decision|14|||
37795905|NCT02108262|69438709|FG000|Overall Study|Missed IV due to pharmacy error|0|||
37795906|NCT02108262|69438710|FG001|Overall Study|Missed IV due to pharmacy error|0|||
37795907|NCT02108262|69438711|FG002|Overall Study|Missed IV due to pharmacy error|1|||
37795908|NCT02108262|69438712|FG003|Overall Study|Missed IV due to pharmacy error|0|||
37795909|NCT02107482|69438721|FG000|Overall Study|inconveinence|2|||
37795910|NCT02107482|69438721|FG000|Overall Study|Lost to Follow-up|1|||
37795911|NCT02107482|69438721|FG000|Overall Study|Lack of Efficacy|1|||
37795912|NCT02066298|69438731|FG000|Overall Study|Lost to Follow-up|3|||
37975618|NCT00410163|69662890|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
37975619|NCT00410163|69662889|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
37795913|NCT02066298|69438732|FG001|Overall Study|Lost to Follow-up|2|||
37795914|NCT02066298|69438733|FG002|Overall Study|Lost to Follow-up|3|||
37795915|NCT02066298|69438734|FG003|Overall Study|Lost to Follow-up|2|||
37795916|NCT02066298|69438735|FG004|Overall Study|Lost to Follow-up|3|||
37795917|NCT02066298|69438736|FG005|Overall Study|Lost to Follow-up|4|||
37795918|NCT02066298|69438731|FG000|Overall Study|Withdrawal by Subject|6|||
37795919|NCT02066298|69438732|FG001|Overall Study|Withdrawal by Subject|6|||
37795920|NCT02066298|69438733|FG002|Overall Study|Withdrawal by Subject|6|||
37795921|NCT02066298|69438734|FG003|Overall Study|Withdrawal by Subject|4|||
37795922|NCT02066298|69438735|FG004|Overall Study|Withdrawal by Subject|5|||
37795923|NCT02066298|69438736|FG005|Overall Study|Withdrawal by Subject|8|||
37795924|NCT02066298|69438731|FG000|Overall Study|Physician Decision|0|||
37795925|NCT02066298|69438732|FG001|Overall Study|Physician Decision|0|||
37795926|NCT02066298|69438733|FG002|Overall Study|Physician Decision|1|||
37795927|NCT02066298|69438734|FG003|Overall Study|Physician Decision|0|||
37795928|NCT02066298|69438735|FG004|Overall Study|Physician Decision|1|||
37795929|NCT02066298|69438736|FG005|Overall Study|Physician Decision|0|||
37795930|NCT02082912|69438750|FG000|Overall Study|Physician Decision|0|||
37795931|NCT02082912|69438751|FG001|Overall Study|Physician Decision|1|||
37795932|NCT02082522|69438759|FG000|Overall Study|Sponsor termination|5|||
37795933|NCT02082522|69438760|FG001|Overall Study|Sponsor termination|3|||
37795934|NCT02082522|69438759|FG000|Overall Study|Withdrawal by Subject|2|||
37795935|NCT02082522|69438760|FG001|Overall Study|Withdrawal by Subject|4|||
37795936|NCT02082522|69438759|FG000|Overall Study|Death|1|||
37795937|NCT02082522|69438760|FG001|Overall Study|Death|0|||
37795938|NCT02082522|69438759|FG000|Overall Study|Lost to Follow-up|1|||
37795939|NCT02082522|69438760|FG001|Overall Study|Lost to Follow-up|0|||
37795940|NCT02082522|69438759|FG000|Overall Study|Physician Decision|3|||
37795941|NCT02082522|69438760|FG001|Overall Study|Physician Decision|1|||
37795942|NCT02082522|69438759|FG000|Overall Study|Disease progression|2|||
37795943|NCT02082522|69438760|FG001|Overall Study|Disease progression|2|||
37795944|NCT02082522|69438759|FG000|Overall Study|Chemotherapy change|1|||
37795945|NCT02082522|69438760|FG001|Overall Study|Chemotherapy change|3|||
37795946|NCT02082210|69438772|FG000|Overall Study|Death|0|||
37795947|NCT02082210|69438773|FG001|Overall Study|Death|0|||
37795948|NCT02082210|69438774|FG002|Overall Study|Death|1|||
37795949|NCT02082210|69438775|FG003|Overall Study|Death|1|||
37795950|NCT02082210|69438776|FG004|Overall Study|Death|1|||
37795951|NCT02082210|69438777|FG005|Overall Study|Death|0|||
37795952|NCT02082210|69438772|FG000|Overall Study|Withdrawal by Subject|0|||
37795953|NCT02082210|69438773|FG001|Overall Study|Withdrawal by Subject|0|||
37795954|NCT02082210|69438774|FG002|Overall Study|Withdrawal by Subject|0|||
37795955|NCT02082210|69438775|FG003|Overall Study|Withdrawal by Subject|1|||
37795956|NCT02082210|69438776|FG004|Overall Study|Withdrawal by Subject|2|||
37795957|NCT02082210|69438777|FG005|Overall Study|Withdrawal by Subject|2|||
37795958|NCT02082210|69438772|FG000|Overall Study|Clinical Progression|0|||
37795959|NCT02082210|69438773|FG001|Overall Study|Clinical Progression|0|||
37795960|NCT02082210|69438774|FG002|Overall Study|Clinical Progression|0|||
37795961|NCT02082210|69438775|FG003|Overall Study|Clinical Progression|1|||
37795962|NCT02082210|69438776|FG004|Overall Study|Clinical Progression|0|||
37795963|NCT02082210|69438777|FG005|Overall Study|Clinical Progression|0|||
37795964|NCT02082210|69438772|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
37795965|NCT02082210|69438773|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
37795966|NCT02082210|69438774|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
37795967|NCT02082210|69438775|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
37795968|NCT02082210|69438776|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
37795969|NCT02082210|69438777|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
37795970|NCT02082210|69438772|FG000|Overall Study|Physician Decision|0|||
37795971|NCT02082210|69438773|FG001|Overall Study|Physician Decision|0|||
37795972|NCT02082210|69438774|FG002|Overall Study|Physician Decision|1|||
37795973|NCT02082210|69438775|FG003|Overall Study|Physician Decision|1|||
37795974|NCT02082210|69438776|FG004|Overall Study|Physician Decision|0|||
37795975|NCT02082210|69438777|FG005|Overall Study|Physician Decision|0|||
37795976|NCT02107092|69438803|FG000|Overall Study|Miscellaneous|3|||
37795977|NCT02107092|69438803|FG000|Overall Study|Subject compliance|3|||
37795978|NCT02107092|69438803|FG000|Overall Study|Hypo-or hyperkalemia|2|||
37795979|NCT02107092|69438803|FG000|Overall Study|Met ECG withdrawal criteria|3|||
37795980|NCT02107092|69438803|FG000|Overall Study|Physician Decision|3|||
37795981|NCT02107092|69438803|FG000|Overall Study|Lost to Follow-up|2|||
37795982|NCT02107092|69438803|FG000|Overall Study|Withdrawal by Subject|9|||
37795983|NCT02107092|69438803|FG000|Overall Study|Adverse Event|7|||
37795984|NCT02107092|69438803|FG000|Overall Study|Expected progression of CKD|12|||
37795985|NCT02107014|69438807|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
37795986|NCT01624974|69438813|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
37795987|NCT01624974|69438814|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
37795988|NCT01624974|69438813|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
37795989|NCT01624974|69438814|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
37795990|NCT01624974|69438813|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
37795991|NCT01624974|69438814|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
37795992|NCT01624974|69438813|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
37795993|NCT01624974|69438814|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
37795994|NCT01624974|69438813|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
37795995|NCT01624974|69438814|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
37795996|NCT01624974|69438813|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
37795997|NCT01624974|69438814|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
37795998|NCT01624974|69438813|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
37795999|NCT01624974|69438814|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
37796000|NCT01624974|69438813|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
37796001|NCT01624974|69438814|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
37796002|NCT01624974|69438813|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
37796003|NCT01624974|69438814|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
37796004|NCT01624974|69438813|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
37796005|NCT01624974|69438814|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
37796006|NCT01624974|69438813|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
37796007|NCT01624974|69438814|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
37796008|NCT01624974|69438813|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
37796009|NCT01624974|69438814|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
37796010|NCT02065518|69438825|FG000|Overall Study|Lost to Follow-up|3|||
37796011|NCT02065518|69438826|FG001|Overall Study|Lost to Follow-up|4|||
37796012|NCT02065518|69438827|FG002|Overall Study|Lost to Follow-up|0|||
37796013|NCT02065518|69438828|FG003|Overall Study|Lost to Follow-up|3|||
37796014|NCT02065518|69438825|FG000|Overall Study|Withdrawal by Subject|3|||
37796015|NCT02065518|69438826|FG001|Overall Study|Withdrawal by Subject|4|||
37796016|NCT02065518|69438827|FG002|Overall Study|Withdrawal by Subject|9|||
37796017|NCT02065518|69438828|FG003|Overall Study|Withdrawal by Subject|2|||
37796018|NCT01624662|69438842|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
37796019|NCT01624662|69438843|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
37796020|NCT01624662|69438844|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
37796021|NCT01624662|69438845|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
37796022|NCT01624662|69438842|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
37796023|NCT01624662|69438843|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
37796024|NCT01624662|69438844|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
37796025|NCT01624662|69438845|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
37796026|NCT01624662|69438842|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
37796027|NCT01624662|69438843|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
37796028|NCT01624662|69438844|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
37796029|NCT01624662|69438845|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
37796030|NCT01624662|69438842|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
37796031|NCT01624662|69438843|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
37796032|NCT01624662|69438844|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
37796033|NCT01624662|69438845|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
37796034|NCT01624662|69438842|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
37796035|NCT01624662|69438843|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
37796036|NCT01624662|69438844|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
37796037|NCT01624662|69438845|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
37796038|NCT01624662|69438842|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
37796039|NCT01624662|69438843|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
37796040|NCT01624662|69438844|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
37796041|NCT01624662|69438845|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
37796042|NCT01624662|69438842|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
37796043|NCT01624662|69438843|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
37796044|NCT01624662|69438844|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
37796045|NCT01624662|69438845|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
37796046|NCT01624506|69438868|FG000|Overall Study|Lost to Follow-up|29|||
37796047|NCT01624506|69438869|FG001|Overall Study|Lost to Follow-up|15|||
37796048|NCT01624506|69438868|FG000|Overall Study|Withdrawal by Subject|9|||
37796049|NCT01624506|69438869|FG001|Overall Study|Withdrawal by Subject|2|||
37796050|NCT01624506|69438868|FG000|Overall Study|Death|1|||
37796051|NCT01624506|69438869|FG001|Overall Study|Death|0|||
37796052|NCT01624506|69438868|FG000|Overall Study|LINX explants|23|||
37796053|NCT01624506|69438869|FG001|Overall Study|LINX explants|0|||
37796054|NCT01624506|69438868|FG000|Overall Study|Adverse Event|3|||
37796055|NCT01624506|69438869|FG001|Overall Study|Adverse Event|0|||
37796056|NCT02106390|69438878|FG000|Overall Study|Withdrawal by Subject|15|||
37796057|NCT02106390|69438879|FG001|Overall Study|Withdrawal by Subject|16|||
37796058|NCT02106390|69438880|FG002|Overall Study|Withdrawal by Subject|15|||
37796059|NCT02106390|69438878|FG000|Overall Study|Lost to Follow-up|25|||
37796060|NCT02106390|69438879|FG001|Overall Study|Lost to Follow-up|20|||
37796061|NCT02106390|69438880|FG002|Overall Study|Lost to Follow-up|13|||
37796062|NCT02106390|69438878|FG000|Overall Study|Other: Administrative Reason|8|||
37796063|NCT02106390|69438879|FG001|Overall Study|Other: Administrative Reason|5|||
37796064|NCT02106390|69438880|FG002|Overall Study|Other: Administrative Reason|12|||
37796065|NCT02106390|69438878|FG000|Overall Study|Other: Unspecified|1|||
37796066|NCT02106390|69438879|FG001|Overall Study|Other: Unspecified|4|||
37796067|NCT02106390|69438880|FG002|Overall Study|Other: Unspecified|2|||
37796068|NCT02106390|69438878|FG000|Overall Study|Adverse Event|0|||
37796069|NCT02106390|69438879|FG001|Overall Study|Adverse Event|2|||
37796070|NCT02106390|69438880|FG002|Overall Study|Adverse Event|1|||
37796071|NCT02106390|69438878|FG000|Overall Study|Protocol Violation|0|||
37796072|NCT02106390|69438879|FG001|Overall Study|Protocol Violation|1|||
37796073|NCT02106390|69438880|FG002|Overall Study|Protocol Violation|0|||
37796074|NCT02064894|69438894|FG000|Overall Study|Withdrawal by Subject|43|||
37796075|NCT02064894|69438895|FG001|Overall Study|Withdrawal by Subject|102|||
37796076|NCT02064894|69438896|FG002|Overall Study|Withdrawal by Subject|115|||
37796077|NCT02081586|69438908|FG000|Overall Study|Lost to Follow-up|0|||
37796078|NCT02081586|69438909|FG001|Overall Study|Lost to Follow-up|1|||
37796079|NCT02081586|69438910|FG002|Overall Study|Lost to Follow-up|0|||
37796080|NCT02081586|69438911|FG003|Overall Study|Lost to Follow-up|1|||
37796081|NCT02081586|69438908|FG000|Overall Study|Head injury not related to study|0|||
37796082|NCT02081586|69438909|FG001|Overall Study|Head injury not related to study|0|||
37796083|NCT02081586|69438910|FG002|Overall Study|Head injury not related to study|1|||
37796084|NCT02081586|69438911|FG003|Overall Study|Head injury not related to study|0|||
37796085|NCT02081196|69438923|FG000|Overall Study|Lost to Follow-up|1|||
37796086|NCT02064816|69438931|FG000|Overall Study|Adverse Event|3|||
37796087|NCT02064816|69438932|FG001|Overall Study|Adverse Event|2|||
37796088|NCT02064816|69438931|FG000|Overall Study|Withdrawal by Subject|2|||
37796089|NCT02064816|69438932|FG001|Overall Study|Withdrawal by Subject|1|||
37796090|NCT02064816|69438931|FG000|Overall Study|Lost to Follow-up|2|||
37796091|NCT02064816|69438932|FG001|Overall Study|Lost to Follow-up|1|||
37796092|NCT02064816|69438931|FG000|Overall Study|Therapeutic failure|0|||
37796093|NCT02064816|69438932|FG001|Overall Study|Therapeutic failure|1|||
37796094|NCT02064816|69438931|FG000|Overall Study|Other|1|||
37796095|NCT02064816|69438932|FG001|Overall Study|Other|3|||
37796096|NCT02080260|69438938|FG000|Overall Study|Death|18|||
37796097|NCT02080260|69438938|FG000|Overall Study|Withdrawal by Subject|1|||
37796098|NCT01624194|69438944|FG000|Overall Study|Lost to Follow-up|1|||
37796099|NCT01624194|69438945|FG001|Overall Study|Lost to Follow-up|0|||
37796100|NCT01624194|69438944|FG000|Overall Study|Withdrawal by Subject|1|||
37796101|NCT01624194|69438945|FG001|Overall Study|Withdrawal by Subject|0|||
37796102|NCT02079636|69438967|FG000|Overall Study|Death|2|||
37796103|NCT02079636|69438968|FG001|Overall Study|Death|1|||
37796104|NCT02079636|69438969|FG002|Overall Study|Death|0|||
37796105|NCT02079636|69438970|FG003|Overall Study|Death|5|||
37796106|NCT02079636|69438971|FG004|Overall Study|Death|1|||
37796107|NCT02079636|69438972|FG005|Overall Study|Death|2|||
37796108|NCT02079636|69438973|FG006|Overall Study|Death|1|||
37796109|NCT02079636|69438974|FG007|Overall Study|Death|0|||
37796110|NCT02079636|69438975|FG008|Overall Study|Death|0|||
37796111|NCT02079636|69438976|FG009|Overall Study|Death|0|||
37796112|NCT02079636|69438977|FG010|Overall Study|Death|0|||
37796113|NCT02079636|69438978|FG011|Overall Study|Death|1|||
37796114|NCT02079636|69438979|FG012|Overall Study|Death|1|||
37796115|NCT02079636|69438980|FG013|Overall Study|Death|0|||
37796116|NCT02079636|69438981|FG014|Overall Study|Death|2|||
37796117|NCT02079636|69438967|FG000|Overall Study|Adverse Event|1|||
37796118|NCT02079636|69438968|FG001|Overall Study|Adverse Event|1|||
37796119|NCT02079636|69438969|FG002|Overall Study|Adverse Event|0|||
37796120|NCT02079636|69438970|FG003|Overall Study|Adverse Event|1|||
37796121|NCT02079636|69438971|FG004|Overall Study|Adverse Event|1|||
37796122|NCT02079636|69438972|FG005|Overall Study|Adverse Event|2|||
37796123|NCT02079636|69438973|FG006|Overall Study|Adverse Event|0|||
37796124|NCT02079636|69438974|FG007|Overall Study|Adverse Event|0|||
37796125|NCT02079636|69438975|FG008|Overall Study|Adverse Event|0|||
37796126|NCT02079636|69438976|FG009|Overall Study|Adverse Event|0|||
37796127|NCT02079636|69438977|FG010|Overall Study|Adverse Event|0|||
37796128|NCT02079636|69438978|FG011|Overall Study|Adverse Event|0|||
37796129|NCT02079636|69438979|FG012|Overall Study|Adverse Event|0|||
37796130|NCT02079636|69438980|FG013|Overall Study|Adverse Event|0|||
37796131|NCT02079636|69438981|FG014|Overall Study|Adverse Event|0|||
37796132|NCT02079636|69438967|FG000|Overall Study|Progressive disease|0|||
37796133|NCT02079636|69438968|FG001|Overall Study|Progressive disease|0|||
37796134|NCT02079636|69438969|FG002|Overall Study|Progressive disease|0|||
37796135|NCT02079636|69438970|FG003|Overall Study|Progressive disease|2|||
37796136|NCT02079636|69438971|FG004|Overall Study|Progressive disease|0|||
37796137|NCT02079636|69438972|FG005|Overall Study|Progressive disease|0|||
37796138|NCT02079636|69438973|FG006|Overall Study|Progressive disease|0|||
37796139|NCT02079636|69438974|FG007|Overall Study|Progressive disease|0|||
37796140|NCT02079636|69438975|FG008|Overall Study|Progressive disease|0|||
37796141|NCT02079636|69438976|FG009|Overall Study|Progressive disease|0|||
37796142|NCT02079636|69438977|FG010|Overall Study|Progressive disease|0|||
37796143|NCT02079636|69438978|FG011|Overall Study|Progressive disease|0|||
37796144|NCT02079636|69438979|FG012|Overall Study|Progressive disease|1|||
37796145|NCT02079636|69438980|FG013|Overall Study|Progressive disease|0|||
37796146|NCT02079636|69438981|FG014|Overall Study|Progressive disease|0|||
37796147|NCT02079636|69438967|FG000|Overall Study|Withdrawal by Subject|0|||
37796148|NCT02079636|69438968|FG001|Overall Study|Withdrawal by Subject|0|||
37796149|NCT02079636|69438969|FG002|Overall Study|Withdrawal by Subject|0|||
37796150|NCT02079636|69438970|FG003|Overall Study|Withdrawal by Subject|4|||
37796151|NCT02079636|69438971|FG004|Overall Study|Withdrawal by Subject|0|||
37796152|NCT02079636|69438972|FG005|Overall Study|Withdrawal by Subject|1|||
37796153|NCT02079636|69438973|FG006|Overall Study|Withdrawal by Subject|0|||
37796154|NCT02079636|69438974|FG007|Overall Study|Withdrawal by Subject|0|||
37796155|NCT02079636|69438975|FG008|Overall Study|Withdrawal by Subject|0|||
37796156|NCT02079636|69438976|FG009|Overall Study|Withdrawal by Subject|2|||
37796157|NCT02079636|69438977|FG010|Overall Study|Withdrawal by Subject|1|||
37796158|NCT02079636|69438978|FG011|Overall Study|Withdrawal by Subject|1|||
37796159|NCT02079636|69438979|FG012|Overall Study|Withdrawal by Subject|1|||
37796160|NCT02079636|69438980|FG013|Overall Study|Withdrawal by Subject|0|||
37796161|NCT02079636|69438981|FG014|Overall Study|Withdrawal by Subject|2|||
37796162|NCT02079636|69438967|FG000|Overall Study|Physician Decision|0|||
37796163|NCT02079636|69438968|FG001|Overall Study|Physician Decision|0|||
37796164|NCT02079636|69438969|FG002|Overall Study|Physician Decision|0|||
37796165|NCT02079636|69438970|FG003|Overall Study|Physician Decision|0|||
37796166|NCT02079636|69438971|FG004|Overall Study|Physician Decision|0|||
37796167|NCT02079636|69438972|FG005|Overall Study|Physician Decision|1|||
37796168|NCT02079636|69438973|FG006|Overall Study|Physician Decision|0|||
37796169|NCT02079636|69438974|FG007|Overall Study|Physician Decision|0|||
37796170|NCT02079636|69438975|FG008|Overall Study|Physician Decision|0|||
37796171|NCT02079636|69438976|FG009|Overall Study|Physician Decision|1|||
37796172|NCT02079636|69438977|FG010|Overall Study|Physician Decision|1|||
37796173|NCT02079636|69438978|FG011|Overall Study|Physician Decision|0|||
37796174|NCT02079636|69438979|FG012|Overall Study|Physician Decision|0|||
37796175|NCT02079636|69438980|FG013|Overall Study|Physician Decision|0|||
37796176|NCT02079636|69438981|FG014|Overall Study|Physician Decision|1|||
37796177|NCT02079636|69438967|FG000|Overall Study|Lost to Follow-up|0|||
37796178|NCT02079636|69438968|FG001|Overall Study|Lost to Follow-up|0|||
37796179|NCT02079636|69438969|FG002|Overall Study|Lost to Follow-up|0|||
37796180|NCT02079636|69438970|FG003|Overall Study|Lost to Follow-up|0|||
37796181|NCT02079636|69438971|FG004|Overall Study|Lost to Follow-up|0|||
37796182|NCT02079636|69438972|FG005|Overall Study|Lost to Follow-up|0|||
37796183|NCT02079636|69438973|FG006|Overall Study|Lost to Follow-up|0|||
37796184|NCT02079636|69438974|FG007|Overall Study|Lost to Follow-up|1|||
37796185|NCT02079636|69438975|FG008|Overall Study|Lost to Follow-up|0|||
37796186|NCT02079636|69438976|FG009|Overall Study|Lost to Follow-up|0|||
37796187|NCT02079636|69438977|FG010|Overall Study|Lost to Follow-up|0|||
37796188|NCT02079636|69438978|FG011|Overall Study|Lost to Follow-up|0|||
37796189|NCT02079636|69438979|FG012|Overall Study|Lost to Follow-up|0|||
37796190|NCT02079636|69438980|FG013|Overall Study|Lost to Follow-up|0|||
37796191|NCT02079636|69438981|FG014|Overall Study|Lost to Follow-up|0|||
37796192|NCT02079246|69439045|FG000|OLEX|Withdrawal before treatment|1|||
37796193|NCT02079246|69439046|FG001|OLEX|Withdrawal before treatment|0|||
37796194|NCT02079246|69439045|FG000|OLEX|Death|11|||
37796195|NCT02079246|69439046|FG001|OLEX|Death|0|||
37796196|NCT02079246|69439045|FG000|OLEX|Adverse Event|66|||
37796197|NCT02079246|69439046|FG001|OLEX|Adverse Event|0|||
37796198|NCT02079246|69439045|FG000|OLEX|Withdrawal by Subject|60|||
37796199|NCT02079246|69439046|FG001|OLEX|Withdrawal by Subject|0|||
37796200|NCT02079246|69439045|FG000|OLEX|Lost to Follow-up|6|||
37796201|NCT02079246|69439046|FG001|OLEX|Lost to Follow-up|0|||
37796202|NCT02079246|69439045|FG000|OLEX|Protocol Violation|6|||
37796203|NCT02079246|69439046|FG001|OLEX|Protocol Violation|0|||
37796204|NCT02079246|69439045|FG000|OLEX|Lack of Efficacy|3|||
37796205|NCT02079246|69439046|FG001|OLEX|Lack of Efficacy|0|||
37796206|NCT02079246|69439045|FG000|OLEX|Results of the lead-in studies|58|||
37796207|NCT02079246|69439046|FG001|OLEX|Results of the lead-in studies|0|||
37796208|NCT02079246|69439045|FG000|OLEX|Other: Disallowed medication|8|||
37796209|NCT02079246|69439046|FG001|OLEX|Other: Disallowed medication|0|||
37796210|NCT02079246|69439045|FG000|OLEX|Other: Insufficient compliance|2|||
37796211|NCT02079246|69439046|FG001|OLEX|Other: Insufficient compliance|0|||
37796212|NCT02079246|69439045|FG000|OLEX|Other: Caregiver unavailable|3|||
37796213|NCT02079246|69439046|FG001|OLEX|Other: Caregiver unavailable|0|||
37796214|NCT02079246|69439045|FG000|OLEX|Other: Coordinator decision|1|||
37796215|NCT02079246|69439046|FG001|OLEX|Other: Coordinator decision|0|||
37796216|NCT02079246|69439045|FG000|OLEX|Other: Worsening of condition|1|||
37796217|NCT02079246|69439046|FG001|OLEX|Other: Worsening of condition|0|||
37796218|NCT02079246|69439045|FG000|OLEX|Other: Moved to nursing home|1|||
37796219|NCT02079246|69439046|FG001|OLEX|Other: Moved to nursing home|0|||
37796220|NCT02079246|69439045|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
37796221|NCT02079246|69439046|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
37796222|NCT02079246|69439045|FG000|OLEX-MEM|Adverse Event|0|||
37796223|NCT02079246|69439046|FG001|OLEX-MEM|Adverse Event|6|||
37796224|NCT02079246|69439045|FG000|OLEX-MEM|Withdrawal by Subject|0|||
37796225|NCT02079246|69439046|FG001|OLEX-MEM|Withdrawal by Subject|7|||
37796226|NCT02079246|69439045|FG000|OLEX-MEM|Protocol Violation|0|||
37796227|NCT02079246|69439046|FG001|OLEX-MEM|Protocol Violation|2|||
37796228|NCT02079246|69439045|FG000|OLEX-MEM|Lost to Follow-up|0|||
37796229|NCT02079246|69439046|FG001|OLEX-MEM|Lost to Follow-up|1|||
37796230|NCT02079246|69439045|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
37796231|NCT02079246|69439046|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
37796232|NCT02077374|69439057|FG000|Overall Study|Withdrawal by Subject|0|||
37796233|NCT02077374|69439058|FG001|Overall Study|Withdrawal by Subject|1|||
37796234|NCT02077374|69439057|FG000|Overall Study|Protocol Violation|0|||
37796235|NCT02077374|69439058|FG001|Overall Study|Protocol Violation|1|||
37796236|NCT02077140|69439072|FG000|Overall Study|Lost to Follow-up|4|||
37796237|NCT02077140|69439073|FG001|Overall Study|Lost to Follow-up|1|||
37796238|NCT02077140|69439074|FG002|Overall Study|Lost to Follow-up|2|||
37796239|NCT02077140|69439075|FG003|Overall Study|Lost to Follow-up|2|||
37796240|NCT02077140|69439076|FG004|Overall Study|Lost to Follow-up|3|||
37975620|NCT00410163|69662890|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
37796241|NCT02077140|69439072|FG000|Overall Study|Withdrawal by Subject|0|||
37796242|NCT02077140|69439073|FG001|Overall Study|Withdrawal by Subject|1|||
37796243|NCT02077140|69439074|FG002|Overall Study|Withdrawal by Subject|0|||
37796244|NCT02077140|69439075|FG003|Overall Study|Withdrawal by Subject|2|||
37796245|NCT02077140|69439076|FG004|Overall Study|Withdrawal by Subject|2|||
37796246|NCT02047110|69439095|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
37796247|NCT02047110|69439096|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
37796248|NCT02047110|69439097|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
37796249|NCT02047110|69439098|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
37975621|NCT00410163|69662889|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
37796250|NCT02047110|69439095|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
37796251|NCT02047110|69439096|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
37796252|NCT02047110|69439097|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
37796253|NCT02047110|69439098|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
37796254|NCT02047110|69439095|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
37796255|NCT02047110|69439096|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
37796256|NCT02047110|69439097|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
37796257|NCT02047110|69439098|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
37796258|NCT02047110|69439095|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
37796259|NCT02047110|69439096|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
37796260|NCT02047110|69439097|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
37796261|NCT02047110|69439098|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
37796262|NCT02047110|69439095|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
37796263|NCT02047110|69439096|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
37796264|NCT02047110|69439097|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
37796265|NCT02047110|69439098|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
37796266|NCT02047110|69439095|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
37796267|NCT02047110|69439096|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
37796268|NCT02047110|69439097|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
37796269|NCT02047110|69439098|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
37796270|NCT02047110|69439095|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
37796271|NCT02047110|69439096|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
37796272|NCT02047110|69439097|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
37796273|NCT02047110|69439098|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
37796274|NCT02047110|69439095|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
37796275|NCT02047110|69439096|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
37796276|NCT02047110|69439097|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
37796277|NCT02047110|69439098|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
37796278|NCT02047110|69439095|FG000|Escape Treatment Period|Adverse Event|1|||
37796279|NCT02047110|69439096|FG001|Escape Treatment Period|Adverse Event|2|||
37796280|NCT02047110|69439097|FG002|Escape Treatment Period|Adverse Event|2|||
37796281|NCT02047110|69439098|FG003|Escape Treatment Period|Adverse Event|0|||
37796282|NCT02047110|69439095|FG000|Escape Treatment Period|Other than specified|1|||
37796283|NCT02047110|69439096|FG001|Escape Treatment Period|Other than specified|2|||
37796284|NCT02047110|69439097|FG002|Escape Treatment Period|Other than specified|0|||
37796285|NCT02047110|69439098|FG003|Escape Treatment Period|Other than specified|1|||
37796286|NCT02047110|69439095|FG000|OLE Treatment Period|Other than specified|0|||
37796287|NCT02047110|69439096|FG001|OLE Treatment Period|Other than specified|0|||
37796288|NCT02047110|69439097|FG002|OLE Treatment Period|Other than specified|1|||
37796289|NCT02047110|69439098|FG003|OLE Treatment Period|Other than specified|0|||
37796290|NCT02046564|69439117|FG000|Overall Study|Adverse Event|6|||
37796291|NCT02046564|69439118|FG001|Overall Study|Adverse Event|3|||
37796292|NCT02046564|69439117|FG000|Overall Study|Physician Decision|0|||
37796293|NCT02046564|69439118|FG001|Overall Study|Physician Decision|1|||
37796294|NCT02046564|69439117|FG000|Overall Study|Protocol Violation|3|||
37796295|NCT02046564|69439118|FG001|Overall Study|Protocol Violation|1|||
37796296|NCT02046564|69439117|FG000|Overall Study|Withdrawal by Subject|4|||
37796297|NCT02046564|69439118|FG001|Overall Study|Withdrawal by Subject|10|||
37796298|NCT02046564|69439117|FG000|Overall Study|Subject met withdrawal criteria|2|||
37796299|NCT02046564|69439118|FG001|Overall Study|Subject met withdrawal criteria|5|||
37796300|NCT02046174|69439124|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
37796301|NCT02046174|69439125|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
37796302|NCT02045862|69439213|FG000|Overall Study|Death|0|||
37796303|NCT02045862|69439214|FG001|Overall Study|Death|0|||
37796304|NCT02045862|69439215|FG002|Overall Study|Death|1|||
37796305|NCT02045862|69439213|FG000|Overall Study|Miscellaneous|5|||
37796306|NCT02045862|69439214|FG001|Overall Study|Miscellaneous|0|||
37796307|NCT02045862|69439215|FG002|Overall Study|Miscellaneous|8|||
37796308|NCT02045862|69439213|FG000|Overall Study|Withdrawal by Patient|18|||
37796309|NCT02045862|69439214|FG001|Overall Study|Withdrawal by Patient|27|||
37796310|NCT02045862|69439215|FG002|Overall Study|Withdrawal by Patient|57|||
37796311|NCT02045862|69439213|FG000|Overall Study|Protocol Violation|0|||
37796312|NCT02045862|69439214|FG001|Overall Study|Protocol Violation|0|||
37796313|NCT02045862|69439215|FG002|Overall Study|Protocol Violation|6|||
37796314|NCT02045862|69439213|FG000|Overall Study|Lack of Efficacy|8|||
37796315|NCT02045862|69439214|FG001|Overall Study|Lack of Efficacy|4|||
37796316|NCT02045862|69439215|FG002|Overall Study|Lack of Efficacy|13|||
37796317|NCT02045862|69439213|FG000|Overall Study|Randomized but not Received Study Drug|0|||
37796318|NCT02045862|69439214|FG001|Overall Study|Randomized but not Received Study Drug|2|||
37796319|NCT02045862|69439215|FG002|Overall Study|Randomized but not Received Study Drug|8|||
37796320|NCT02045862|69439213|FG000|Overall Study|Adverse Event|7|||
37796321|NCT02045862|69439214|FG001|Overall Study|Adverse Event|5|||
37796322|NCT02045862|69439215|FG002|Overall Study|Adverse Event|27|||
37796323|NCT02045862|69439213|FG000|Overall Study|Lost to Follow-up|1|||
37796324|NCT02045862|69439214|FG001|Overall Study|Lost to Follow-up|2|||
37796325|NCT02045862|69439215|FG002|Overall Study|Lost to Follow-up|6|||
37796326|NCT02075658|69439225|FG000|Overall Study|Physician Decision|2|||
37796327|NCT02075658|69439226|FG001|Overall Study|Physician Decision|2|||
37796328|NCT02063880|69439234|FG000|Overall Study|Death|21|||
37796329|NCT02063880|69439235|FG001|Overall Study|Death|18|||
37796330|NCT02063880|69439234|FG000|Overall Study|Lost to Follow-up|7|||
37796331|NCT02063880|69439235|FG001|Overall Study|Lost to Follow-up|7|||
37796332|NCT02063880|69439234|FG000|Overall Study|Ineligible|0|||
37796333|NCT02063880|69439235|FG001|Overall Study|Ineligible|2|||
37796334|NCT02044848|69439243|FG000|Overall Study|Administrative Problems|2|||
37796335|NCT02044848|69439244|FG001|Overall Study|Administrative Problems|3|||
37796336|NCT02044458|69439252|FG000|Overall Study|Protocol Violation|3|||
37796337|NCT02044458|69439253|FG001|Overall Study|Protocol Violation|8|||
37796338|NCT02044302|69439261|FG000|Overall Study|study terminated|2|||
37796339|NCT02044302|69439262|FG001|Overall Study|study terminated|0|||
37796340|NCT02062944|69439266|FG000|Overall Study|Lost to Follow-up|1|||
37796341|NCT02062944|69439266|FG000|Overall Study|New hemotological disorder identified|1|||
37796342|NCT02062944|69439266|FG000|Overall Study|Uncontrolled Hypertension|1|||
37796343|NCT02062944|69439266|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
37796344|NCT02062632|69439271|FG000|Overall Study|No treatment data|1|||
37796345|NCT02062398|69439275|FG000|Overall Study|Implant removal|1|||
37796346|NCT02061540|69439279|FG000|Overall Study|Adverse Event|2|||
37796347|NCT02061540|69439279|FG000|Overall Study|Withdrawal by Subject|2|||
37796348|NCT02043366|69439294|FG000|Overall Study|Lost to Follow-up|2|||
37796349|NCT02043366|69439295|FG001|Overall Study|Lost to Follow-up|2|||
37796350|NCT02043366|69439296|FG002|Overall Study|Lost to Follow-up|2|||
37796351|NCT02043366|69439297|FG003|Overall Study|Lost to Follow-up|2|||
37796352|NCT02043366|69439298|FG004|Overall Study|Lost to Follow-up|2|||
37796353|NCT02043366|69439299|FG005|Overall Study|Lost to Follow-up|2|||
37796354|NCT02060370|69439315|FG000|Overall Study|Physician Decision|1|||
37796355|NCT01622088|69439319|FG000|Overall Study|Adverse Event|20|||
37796356|NCT01622088|69439319|FG000|Overall Study|Lost to Follow-up|1|||
37796357|NCT01622088|69439319|FG000|Overall Study|Withdrawal by Subject|20|||
37796358|NCT01622088|69439319|FG000|Overall Study|Investigator Decision|1|||
37796359|NCT01622088|69439319|FG000|Overall Study|Death|53|||
37796360|NCT01622088|69439319|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
37796361|NCT01621542|69439330|FG000|Overall Study|Adverse Event|0|||
37796362|NCT01621542|69439331|FG001|Overall Study|Adverse Event|0|||
37796363|NCT01621542|69439332|FG002|Overall Study|Adverse Event|1|||
37796364|NCT01621542|69439333|FG003|Overall Study|Adverse Event|3|||
37796365|NCT01621542|69439334|FG004|Overall Study|Adverse Event|0|||
37796366|NCT01621542|69439335|FG005|Overall Study|Adverse Event|0|||
37796367|NCT01621542|69439330|FG000|Overall Study|Death|0|||
37796368|NCT01621542|69439331|FG001|Overall Study|Death|1|||
37796369|NCT01621542|69439332|FG002|Overall Study|Death|0|||
37796370|NCT01621542|69439333|FG003|Overall Study|Death|0|||
37796371|NCT01621542|69439334|FG004|Overall Study|Death|0|||
37796372|NCT01621542|69439335|FG005|Overall Study|Death|0|||
37796373|NCT01621542|69439330|FG000|Overall Study|Physician Decision|1|||
37796374|NCT01621542|69439331|FG001|Overall Study|Physician Decision|0|||
37796375|NCT01621542|69439332|FG002|Overall Study|Physician Decision|1|||
37796376|NCT01621542|69439333|FG003|Overall Study|Physician Decision|13|||
37796377|NCT01621542|69439334|FG004|Overall Study|Physician Decision|3|||
37796378|NCT01621542|69439335|FG005|Overall Study|Physician Decision|1|||
37796379|NCT01621542|69439330|FG000|Overall Study|Withdrawal by Subject|2|||
37796380|NCT01621542|69439331|FG001|Overall Study|Withdrawal by Subject|0|||
37796381|NCT01621542|69439332|FG002|Overall Study|Withdrawal by Subject|1|||
37796382|NCT01621542|69439333|FG003|Overall Study|Withdrawal by Subject|3|||
37796383|NCT01621542|69439334|FG004|Overall Study|Withdrawal by Subject|3|||
37796384|NCT01621542|69439335|FG005|Overall Study|Withdrawal by Subject|3|||
37796385|NCT01621542|69439330|FG000|Overall Study|progression/treatment failure|2|||
37796386|NCT01621542|69439331|FG001|Overall Study|progression/treatment failure|4|||
37796387|NCT01621542|69439332|FG002|Overall Study|progression/treatment failure|3|||
37796388|NCT01621542|69439333|FG003|Overall Study|progression/treatment failure|7|||
37796389|NCT01621542|69439334|FG004|Overall Study|progression/treatment failure|3|||
37796390|NCT01621542|69439335|FG005|Overall Study|progression/treatment failure|5|||
37796391|NCT01621542|69439330|FG000|Overall Study|Protocol Violation|0|||
37796392|NCT01621542|69439331|FG001|Overall Study|Protocol Violation|0|||
37796393|NCT01621542|69439332|FG002|Overall Study|Protocol Violation|0|||
37796394|NCT01621542|69439333|FG003|Overall Study|Protocol Violation|1|||
37796395|NCT01621542|69439334|FG004|Overall Study|Protocol Violation|0|||
37796396|NCT01621542|69439335|FG005|Overall Study|Protocol Violation|0|||
37796397|NCT01621542|69439330|FG000|Overall Study|study stopped by sponsor|0|||
37796398|NCT01621542|69439331|FG001|Overall Study|study stopped by sponsor|0|||
37796399|NCT01621542|69439332|FG002|Overall Study|study stopped by sponsor|0|||
37796400|NCT01621542|69439333|FG003|Overall Study|study stopped by sponsor|1|||
37796401|NCT01621542|69439334|FG004|Overall Study|study stopped by sponsor|0|||
37796402|NCT01621542|69439335|FG005|Overall Study|study stopped by sponsor|0|||
37796403|NCT02021292|69439351|FG000|Overall Study|Physician Decision|0|||
37796404|NCT02021292|69439352|FG001|Overall Study|Physician Decision|1|||
37796405|NCT02021292|69439351|FG000|Overall Study|Lost to Follow-up|0|||
37796406|NCT02021292|69439352|FG001|Overall Study|Lost to Follow-up|1|||
37796407|NCT02021292|69439351|FG000|Overall Study|Death|0|||
37796408|NCT02021292|69439352|FG001|Overall Study|Death|1|||
37796409|NCT02059980|69439362|FG000|Overall Study|Lost to Follow-up|2|||
37796410|NCT02059980|69439363|FG001|Overall Study|Lost to Follow-up|1|||
37796411|NCT02043132|69439371|FG000|Overall Study|Lost to Follow-up|1|||
37796412|NCT02043132|69439372|FG001|Overall Study|Lost to Follow-up|1|||
37796413|NCT02043132|69439371|FG000|Overall Study|screen failures|4|||
37796414|NCT02043132|69439372|FG001|Overall Study|screen failures|8|||
37796415|NCT02059434|69439387|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
37796416|NCT02059434|69439388|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
37796417|NCT02059434|69439389|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
37796418|NCT02059434|69439390|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
37796419|NCT02059434|69439391|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
37796420|NCT02059434|69439392|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
37796421|NCT02059434|69439393|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
37796422|NCT02059434|69439394|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
37796423|NCT02059434|69439395|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
37796424|NCT02059434|69439387|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
37796425|NCT02059434|69439388|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
37796426|NCT02059434|69439389|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
37796427|NCT02059434|69439390|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
37796428|NCT02059434|69439391|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
37796429|NCT02059434|69439392|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
37796430|NCT02059434|69439393|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
37796431|NCT02059434|69439394|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
37796432|NCT02059434|69439395|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
37796433|NCT02059434|69439387|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
37796434|NCT02059434|69439388|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
37796435|NCT02059434|69439389|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
37796436|NCT02059434|69439390|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
37796437|NCT02059434|69439391|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
37796438|NCT02059434|69439392|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
37796439|NCT02059434|69439393|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
37796440|NCT02059434|69439394|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
37796441|NCT02059434|69439395|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
37796442|NCT02059434|69439387|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
37796443|NCT02059434|69439388|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
37796444|NCT02059434|69439389|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
37796445|NCT02059434|69439390|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
37796446|NCT02059434|69439391|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
37796447|NCT02059434|69439392|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
37796448|NCT02059434|69439393|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
37796449|NCT02059434|69439394|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
37796450|NCT02059434|69439395|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
37796451|NCT02059434|69439387|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
37796452|NCT02059434|69439388|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
37796453|NCT02059434|69439389|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
37796454|NCT02059434|69439390|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
37796455|NCT02059434|69439391|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
37796456|NCT02059434|69439392|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
37796457|NCT02059434|69439393|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
37796458|NCT02059434|69439394|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
37796459|NCT02059434|69439395|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
37796460|NCT02059278|69439425|FG000|Overall Study|Adverse Event|1|||
37796461|NCT02059278|69439426|FG001|Overall Study|Adverse Event|1|||
37796462|NCT02059278|69439425|FG000|Overall Study|Lost to Follow-up|1|||
37796463|NCT02059278|69439426|FG001|Overall Study|Lost to Follow-up|0|||
37693853|NCT02039505|69170137|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
37796464|NCT02059278|69439425|FG000|Overall Study|Withdrawal by Subject|0|||
37693854|NCT02039505|69170138|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
37796465|NCT02059278|69439426|FG001|Overall Study|Withdrawal by Subject|3|||
37796466|NCT02059278|69439425|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
37796467|NCT02059278|69439426|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
37796468|NCT02020512|69439432|FG000|Overall Study|Adverse Event|1|||
37693855|NCT02039505|69170139|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
37796469|NCT02020512|69439432|FG000|Overall Study|Lost to Follow-up|3|||
37796470|NCT02020512|69439432|FG000|Overall Study|Protocol Violation|4|||
37796471|NCT02041962|69439438|FG000|Overall Study|Lost Aetna Coverage|43|||
37796472|NCT02041962|69439439|FG001|Overall Study|Lost Aetna Coverage|40|||
37796473|NCT02041962|69439438|FG000|Overall Study|Death|1|||
37796474|NCT02041962|69439439|FG001|Overall Study|Death|1|||
37796475|NCT02041962|69439438|FG000|Overall Study|Lost to Follow-up|37|||
37796476|NCT02041962|69439439|FG001|Overall Study|Lost to Follow-up|32|||
37796477|NCT02041962|69439438|FG000|Overall Study|Withdrawal by Subject|0|||
37796478|NCT02041962|69439439|FG001|Overall Study|Withdrawal by Subject|11|||
37796479|NCT02041494|69439447|FG000|Overall Study|Death|1|||
37796480|NCT02041494|69439448|FG001|Overall Study|Death|3|||
37796481|NCT02041494|69439447|FG000|Overall Study|Lost to Follow-up|2|||
37796482|NCT02041494|69439448|FG001|Overall Study|Lost to Follow-up|6|||
37796483|NCT02041494|69439447|FG000|Overall Study|study terminated|16|||
37796484|NCT02041494|69439448|FG001|Overall Study|study terminated|11|||
37796485|NCT02041104|69439479|FG000|Overall Study|Lost to Follow-up|1|||
37796486|NCT02041104|69439480|FG001|Overall Study|Lost to Follow-up|4|||
37796487|NCT02041104|69439479|FG000|Overall Study|discomfort during OGTT|0|||
37796488|NCT02041104|69439480|FG001|Overall Study|discomfort during OGTT|3|||
37796489|NCT02019420|69439490|FG000|Overall Study|Did not receive study drug|2|||
37796490|NCT02019420|69439491|FG001|Overall Study|Did not receive study drug|2|||
37796491|NCT02019420|69439490|FG000|Overall Study|Withdrawal by Subject|1|||
37796492|NCT02019420|69439491|FG001|Overall Study|Withdrawal by Subject|3|||
37796493|NCT02019420|69439490|FG000|Overall Study|At request of sponsor or investigator|0|||
37796494|NCT02019420|69439491|FG001|Overall Study|At request of sponsor or investigator|1|||
37796495|NCT02019420|69439490|FG000|Overall Study|Death|104|||
37796496|NCT02019420|69439491|FG001|Overall Study|Death|99|||
37796497|NCT02019420|69439490|FG000|Overall Study|Transferred to other care facility|1|||
37796498|NCT02019420|69439491|FG001|Overall Study|Transferred to other care facility|1|||
37796499|NCT02019264|69439499|FG000|Overall Study|Not treated|6|||
37796500|NCT02019264|69439500|FG001|Overall Study|Not treated|4|||
37796501|NCT02019264|69439499|FG000|Overall Study|Lost to Follow-up|50|||
37796502|NCT02019264|69439500|FG001|Overall Study|Lost to Follow-up|47|||
37796503|NCT02019264|69439499|FG000|Overall Study|Withdrawal by Subject|142|||
37796504|NCT02019264|69439500|FG001|Overall Study|Withdrawal by Subject|117|||
37796505|NCT02019264|69439499|FG000|Overall Study|Administrative reason|36|||
37796506|NCT02019264|69439500|FG001|Overall Study|Administrative reason|28|||
37796507|NCT02019264|69439499|FG000|Overall Study|Missing|14|||
37796508|NCT02019264|69439500|FG001|Overall Study|Missing|11|||
37796509|NCT02019108|69439508|FG000|Overall Study|Lost to Follow-up|5|||
37796510|NCT02019108|69439509|FG001|Overall Study|Lost to Follow-up|7|||
37796511|NCT02018562|69439517|FG000|Overall Study|Withdrawal by Subject|2|||
37796512|NCT02018562|69439518|FG001|Overall Study|Withdrawal by Subject|0|||
37796513|NCT02018562|69439517|FG000|Overall Study|Discharged prior to study completion|1|||
37796514|NCT02018562|69439518|FG001|Overall Study|Discharged prior to study completion|0|||
37796515|NCT02058966|69439524|FG000|Open-Label Methamphetamine|Adverse Event|1|||
37796516|NCT02058966|69439524|FG000|First Intervention|Withdrawal by Subject|1|||
37796517|NCT02017860|69439536|FG000|Overall Study|Adverse Event|1|||
37796518|NCT02017860|69439536|FG000|Overall Study|Withdrawal by Subject|1|||
37796519|NCT02040870|69439540|FG000|Overall Study|Completed treatment phase|6|||
37796520|NCT02040870|69439540|FG000|Overall Study|Adverse Event|7|||
37796521|NCT02040870|69439540|FG000|Overall Study|Progressive disease|58|||
37796522|NCT02040870|69439540|FG000|Overall Study|Physician Decision|6|||
37796523|NCT02040870|69439540|FG000|Overall Study|Subject/guardian decision|10|||
37796524|NCT02040870|69439540|FG000|Overall Study|Lost to Follow-up|3|||
37796525|NCT02040870|69439540|FG000|Overall Study|Death|13|||
37796526|NCT02016690|69439544|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
37796527|NCT02016690|69439544|FG000|Overall Study|Excluded from SAS: Duplication|2|||
37975622|NCT00410163|69662890|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
37975623|NCT00410163|69662889|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
37796528|NCT02016690|69439544|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
37796529|NCT02016690|69439544|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
37796530|NCT02016690|69439544|FG000|Overall Study|Did not meet inclusion criteria|13|||
37796531|NCT02016690|69439544|FG000|Overall Study|Hospitalized for RSV at study start|3|||
37796532|NCT02016300|69439550|FG000|Overall Study|Lost to Follow-up|0|||
37796533|NCT02016300|69439551|FG001|Overall Study|Lost to Follow-up|3|||
37796534|NCT02040090|69439559|FG000|Overall Study|Adverse Event|2|||
37796535|NCT02040090|69439560|FG001|Overall Study|Adverse Event|0|||
37796536|NCT02040090|69439559|FG000|Overall Study|Physician Decision|1|||
37796537|NCT02040090|69439560|FG001|Overall Study|Physician Decision|0|||
37796538|NCT02040090|69439559|FG000|Overall Study|Withdrawal by Subject|0|||
37796539|NCT02040090|69439560|FG001|Overall Study|Withdrawal by Subject|1|||
37796540|NCT02040090|69439559|FG000|Overall Study|Lost to Follow-up|0|||
37796541|NCT02040090|69439560|FG001|Overall Study|Lost to Follow-up|1|||
37796542|NCT02058498|69439566|FG000|Overall Study|Withdrawal by Subject|4|||
37796543|NCT02039778|69439570|FG000|Overall Study|Death|2|||
37796544|NCT02039778|69439570|FG000|Overall Study|Withdrawal by Subject|1|||
37796545|NCT02039778|69439570|FG000|Overall Study|Never started the protocol treatment|1|||
37796546|NCT02015754|69439574|FG000|Overall Study|Disease progression|5|||
37796547|NCT02015754|69439574|FG000|Overall Study|Change in treatment modality|5|||
37796548|NCT02015754|69439574|FG000|Overall Study|Lost to Follow-up|1|||
37796549|NCT02015676|69439581|FG000|Overall Study|Adverse Event|2|||
37796550|NCT02015676|69439582|FG001|Overall Study|Adverse Event|18|||
37796551|NCT02015676|69439583|FG002|Overall Study|Adverse Event|0|||
37796552|NCT02015676|69439581|FG000|Overall Study|Lack of Efficacy|2|||
37796553|NCT02015676|69439582|FG001|Overall Study|Lack of Efficacy|4|||
37796554|NCT02015676|69439583|FG002|Overall Study|Lack of Efficacy|0|||
37796555|NCT02015676|69439581|FG000|Overall Study|Protocol Violation|1|||
37796556|NCT02015676|69439582|FG001|Overall Study|Protocol Violation|0|||
37796557|NCT02015676|69439583|FG002|Overall Study|Protocol Violation|0|||
37796558|NCT02015676|69439581|FG000|Overall Study|Withdrawal by Subject|1|||
37796559|NCT02015676|69439582|FG001|Overall Study|Withdrawal by Subject|7|||
37796560|NCT02015676|69439583|FG002|Overall Study|Withdrawal by Subject|1|||
37796561|NCT02015676|69439581|FG000|Overall Study|Administrative reasons|0|||
37796562|NCT02015676|69439582|FG001|Overall Study|Administrative reasons|3|||
37796563|NCT02015676|69439583|FG002|Overall Study|Administrative reasons|1|||
37796564|NCT02015676|69439581|FG000|Overall Study|Death|0|||
37796565|NCT02015676|69439582|FG001|Overall Study|Death|1|||
37796566|NCT02015676|69439583|FG002|Overall Study|Death|0|||
37796567|NCT02015676|69439581|FG000|Overall Study|Disease progression|3|||
37796568|NCT02015676|69439582|FG001|Overall Study|Disease progression|1|||
37796569|NCT02015676|69439583|FG002|Overall Study|Disease progression|1|||
37796570|NCT02015520|69439591|FG000|Overall Study|Lack of Efficacy|1|||
37796571|NCT02015520|69439592|FG001|Overall Study|Lack of Efficacy|0|||
37796572|NCT02015520|69439593|FG002|Overall Study|Lack of Efficacy|3|||
37796573|NCT02015520|69439594|FG003|Overall Study|Lack of Efficacy|2|||
37796574|NCT02015520|69439591|FG000|Overall Study|Adverse Event|0|||
37796575|NCT02015520|69439592|FG001|Overall Study|Adverse Event|0|||
37796576|NCT02015520|69439593|FG002|Overall Study|Adverse Event|0|||
37796577|NCT02015520|69439594|FG003|Overall Study|Adverse Event|1|||
37796578|NCT02015520|69439591|FG000|Overall Study|Withdrawal by Subject|2|||
37796579|NCT02015520|69439592|FG001|Overall Study|Withdrawal by Subject|2|||
37796580|NCT02015520|69439593|FG002|Overall Study|Withdrawal by Subject|1|||
37796581|NCT02015520|69439594|FG003|Overall Study|Withdrawal by Subject|0|||
37796582|NCT02015520|69439591|FG000|Overall Study|Death|1|||
37796583|NCT02015520|69439592|FG001|Overall Study|Death|0|||
37796584|NCT02015520|69439593|FG002|Overall Study|Death|0|||
37796585|NCT02015520|69439594|FG003|Overall Study|Death|0|||
37796586|NCT02015520|69439591|FG000|Overall Study|Lost to Follow-up|0|||
37796587|NCT02015520|69439592|FG001|Overall Study|Lost to Follow-up|0|||
37796588|NCT02015520|69439593|FG002|Overall Study|Lost to Follow-up|1|||
37796589|NCT02015520|69439594|FG003|Overall Study|Lost to Follow-up|0|||
37796590|NCT02015520|69439591|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
37796591|NCT02015520|69439592|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
37796592|NCT02015520|69439593|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
37796593|NCT02015520|69439594|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
37796594|NCT02015520|69439591|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
37796595|NCT02015520|69439592|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
37796596|NCT02015520|69439593|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
37796597|NCT02015520|69439594|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
37796598|NCT02058108|69439606|FG000|Overall Study|Abnormal Laboratory Values|0|||
37796599|NCT02058108|69439607|FG001|Overall Study|Abnormal Laboratory Values|1|||
37796600|NCT02058108|69439606|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
37796601|NCT02058108|69439607|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
37796602|NCT02058108|69439606|FG000|Overall Study|No longer requires study drug|0|||
37796603|NCT02058108|69439607|FG001|Overall Study|No longer requires study drug|1|||
37796604|NCT02058108|69439606|FG000|Overall Study|Withdrawal by Subject|1|||
37796605|NCT02058108|69439607|FG001|Overall Study|Withdrawal by Subject|0|||
37796606|NCT02058108|69439606|FG000|Overall Study|Administrative problems|3|||
37796607|NCT02058108|69439607|FG001|Overall Study|Administrative problems|3|||
37796608|NCT02058108|69439606|FG000|Overall Study|Protocol Violation|0|||
37796609|NCT02058108|69439607|FG001|Overall Study|Protocol Violation|1|||
37796610|NCT02057874|69439615|FG000|Overall Study|participant did not return for scan|1|||
37796611|NCT02038920|69439622|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
37796612|NCT02038920|69439623|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
37796613|NCT02038920|69439624|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
37796614|NCT02038920|69439625|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
37796615|NCT02038920|69439626|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
37796616|NCT02038920|69439627|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
37796617|NCT02038920|69439622|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
37796618|NCT02038920|69439623|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
37796619|NCT02038920|69439624|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
37796620|NCT02038920|69439625|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
37796621|NCT02038920|69439626|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
37796622|NCT02038920|69439627|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
37796623|NCT02038920|69439622|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
37796624|NCT02038920|69439623|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
37796625|NCT02038920|69439624|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
37796626|NCT02038920|69439625|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
37796627|NCT02038920|69439626|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
37796628|NCT02038920|69439627|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
37796629|NCT02038920|69439622|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
37796630|NCT02038920|69439623|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
37796631|NCT02038920|69439624|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
37796632|NCT02038920|69439625|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
37796633|NCT02038920|69439626|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
37796634|NCT02038920|69439627|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
37796635|NCT02038920|69439622|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
37796636|NCT02038920|69439623|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
37796637|NCT02038920|69439624|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
37796638|NCT02038920|69439625|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
37796639|NCT02038920|69439626|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
37796640|NCT02038920|69439627|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
37796641|NCT02038920|69439622|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
37796642|NCT02038920|69439623|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
37796643|NCT02038920|69439624|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
37796644|NCT02038920|69439625|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
37796645|NCT02038920|69439626|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
37796646|NCT02038920|69439627|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
37796647|NCT02038920|69439622|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
37796648|NCT02038920|69439623|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
37796649|NCT02038920|69439624|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
37796650|NCT02038920|69439625|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
37796651|NCT02038920|69439626|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
37796652|NCT02038920|69439627|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
37796653|NCT02038920|69439622|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
37796654|NCT02038920|69439623|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
37796655|NCT02038920|69439624|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
37796656|NCT02038920|69439625|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
37796657|NCT02038920|69439626|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
37796658|NCT02038920|69439627|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
37796659|NCT02038920|69439622|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
37796660|NCT02038920|69439623|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
37796661|NCT02038920|69439624|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
37796662|NCT02038920|69439625|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
37796663|NCT02038920|69439626|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
37796664|NCT02038920|69439627|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
37796665|NCT02038920|69439622|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
37796666|NCT02038920|69439623|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
37796667|NCT02038920|69439624|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
37796668|NCT02038920|69439625|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
37796669|NCT02038920|69439626|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
37796670|NCT02038920|69439627|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
37796671|NCT02038920|69439622|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
37796672|NCT02038920|69439623|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
37796673|NCT02038920|69439624|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
37796674|NCT02038920|69439625|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
37796675|NCT02038920|69439626|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
37796676|NCT02038920|69439627|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
37796677|NCT02038920|69439622|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
37796678|NCT02038920|69439623|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
37975624|NCT00410163|69662890|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
38043692|NCT02115282|69731864|FG001|Overall Study|Non-compliance|1|||
38043693|NCT02115282|69731863|FG000|Overall Study|Protocol Violation|2|||
37693856|NCT02039505|69170140|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
37796679|NCT02038920|69439624|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
37796680|NCT02038920|69439625|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
37796681|NCT02038920|69439626|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
37796682|NCT02038920|69439627|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
37796683|NCT02038764|69439649|FG000|Overall Study|Adverse Event|0|||
37796684|NCT02038764|69439650|FG001|Overall Study|Adverse Event|0|||
37796685|NCT02038764|69439651|FG002|Overall Study|Adverse Event|1|||
37796686|NCT02038764|69439652|FG003|Overall Study|Adverse Event|0|||
37796687|NCT02038764|69439653|FG004|Overall Study|Adverse Event|0|||
37796688|NCT02038764|69439649|FG000|Overall Study|Lost to Follow-up|0|||
37796689|NCT02038764|69439650|FG001|Overall Study|Lost to Follow-up|1|||
37796690|NCT02038764|69439651|FG002|Overall Study|Lost to Follow-up|0|||
37796691|NCT02038764|69439652|FG003|Overall Study|Lost to Follow-up|0|||
37796692|NCT02038764|69439653|FG004|Overall Study|Lost to Follow-up|0|||
37796693|NCT02038764|69439649|FG000|Overall Study|Withdrawal by Subject|0|||
37796694|NCT02038764|69439650|FG001|Overall Study|Withdrawal by Subject|0|||
37796695|NCT02038764|69439651|FG002|Overall Study|Withdrawal by Subject|0|||
37796696|NCT02038764|69439652|FG003|Overall Study|Withdrawal by Subject|0|||
37796697|NCT02038764|69439653|FG004|Overall Study|Withdrawal by Subject|1|||
37796698|NCT02038764|69439649|FG000|Overall Study|Other|1|||
37796699|NCT02038764|69439650|FG001|Overall Study|Other|0|||
37796700|NCT02038764|69439651|FG002|Overall Study|Other|1|||
37796701|NCT02038764|69439652|FG003|Overall Study|Other|0|||
37796702|NCT02038764|69439653|FG004|Overall Study|Other|0|||
37796703|NCT02014740|69439671|FG000|Overall Study|Lost to Follow-up|4|||
37796704|NCT02014740|69439672|FG001|Overall Study|Lost to Follow-up|4|||
37796705|NCT02014740|69439671|FG000|Overall Study|Withdrawal by Subject|2|||
37796706|NCT02014740|69439672|FG001|Overall Study|Withdrawal by Subject|1|||
37796707|NCT02014584|69439680|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
37796708|NCT02014584|69439681|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
37796709|NCT02014584|69439682|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
37796710|NCT02014584|69439683|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
37796711|NCT02014584|69439684|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
37796712|NCT02014584|69439685|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
37796713|NCT02014584|69439680|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
37796714|NCT02014584|69439681|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
37796715|NCT02014584|69439682|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
37796716|NCT02014584|69439683|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
37796717|NCT02014584|69439684|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
37796718|NCT02014584|69439685|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
37796719|NCT02014584|69439680|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
37796720|NCT02014584|69439681|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
37796721|NCT02014584|69439682|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
37796722|NCT02014584|69439683|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
37796723|NCT02014584|69439684|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
37796724|NCT02014584|69439685|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
37796725|NCT02014584|69439680|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
37796726|NCT02014584|69439681|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
37796727|NCT02014584|69439682|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
37796728|NCT02014584|69439683|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
37796729|NCT02014584|69439684|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
37796730|NCT02014584|69439685|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
37796731|NCT02014584|69439680|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
37975625|NCT00410163|69662889|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
37975626|NCT00410163|69662890|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
37796732|NCT02014584|69439681|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
37796733|NCT02014584|69439682|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
37796734|NCT02014584|69439683|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
37796735|NCT02014584|69439684|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
37796736|NCT02014584|69439685|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
37796737|NCT02014272|69439697|FG000|Intervention Period 1|Withdrawal by Subject|1|||
37796738|NCT02014272|69439698|FG001|Intervention Period 1|Withdrawal by Subject|0|||
37796739|NCT02014272|69439697|FG000|Intervention Period 1|Adverse Event|0|||
37796740|NCT02014272|69439698|FG001|Intervention Period 1|Adverse Event|1|||
37796741|NCT02037984|69439712|FG000|Overall Study|Lack of Efficacy|0|||
37796742|NCT02037984|69439713|FG001|Overall Study|Lack of Efficacy|0|||
37796743|NCT02037984|69439714|FG002|Overall Study|Lack of Efficacy|3|||
37796744|NCT02037984|69439715|FG003|Overall Study|Lack of Efficacy|10|||
37796745|NCT02037984|69439716|FG004|Overall Study|Lack of Efficacy|2|||
37796746|NCT02037984|69439717|FG005|Overall Study|Lack of Efficacy|2|||
37796747|NCT02037984|69439718|FG006|Overall Study|Lack of Efficacy|4|||
37796748|NCT02037984|69439719|FG007|Overall Study|Lack of Efficacy|3|||
37796749|NCT02037984|69439712|FG000|Overall Study|Lost to Follow-up|1|||
37796750|NCT02037984|69439713|FG001|Overall Study|Lost to Follow-up|0|||
37796751|NCT02037984|69439714|FG002|Overall Study|Lost to Follow-up|3|||
37796752|NCT02037984|69439715|FG003|Overall Study|Lost to Follow-up|5|||
37796753|NCT02037984|69439716|FG004|Overall Study|Lost to Follow-up|2|||
37796754|NCT02037984|69439717|FG005|Overall Study|Lost to Follow-up|2|||
37796755|NCT02037984|69439718|FG006|Overall Study|Lost to Follow-up|2|||
37796756|NCT02037984|69439719|FG007|Overall Study|Lost to Follow-up|4|||
37796757|NCT02037984|69439712|FG000|Overall Study|Physician Decision|0|||
37796758|NCT02037984|69439713|FG001|Overall Study|Physician Decision|0|||
37796759|NCT02037984|69439714|FG002|Overall Study|Physician Decision|0|||
37796760|NCT02037984|69439715|FG003|Overall Study|Physician Decision|0|||
37796761|NCT02037984|69439716|FG004|Overall Study|Physician Decision|0|||
37796762|NCT02037984|69439717|FG005|Overall Study|Physician Decision|0|||
37796763|NCT02037984|69439718|FG006|Overall Study|Physician Decision|1|||
37796764|NCT02037984|69439719|FG007|Overall Study|Physician Decision|0|||
37796765|NCT02037984|69439712|FG000|Overall Study|Protocol Violation|0|||
37796766|NCT02037984|69439713|FG001|Overall Study|Protocol Violation|0|||
37796767|NCT02037984|69439714|FG002|Overall Study|Protocol Violation|0|||
37796768|NCT02037984|69439715|FG003|Overall Study|Protocol Violation|0|||
37796769|NCT02037984|69439716|FG004|Overall Study|Protocol Violation|0|||
37796770|NCT02037984|69439717|FG005|Overall Study|Protocol Violation|1|||
37796771|NCT02037984|69439718|FG006|Overall Study|Protocol Violation|2|||
37796772|NCT02037984|69439719|FG007|Overall Study|Protocol Violation|0|||
37796773|NCT02037984|69439712|FG000|Overall Study|Technical Problems|0|||
37796774|NCT02037984|69439713|FG001|Overall Study|Technical Problems|0|||
37796775|NCT02037984|69439714|FG002|Overall Study|Technical Problems|3|||
37796776|NCT02037984|69439715|FG003|Overall Study|Technical Problems|3|||
37796777|NCT02037984|69439716|FG004|Overall Study|Technical Problems|2|||
37796778|NCT02037984|69439717|FG005|Overall Study|Technical Problems|3|||
37796779|NCT02037984|69439718|FG006|Overall Study|Technical Problems|4|||
37796780|NCT02037984|69439719|FG007|Overall Study|Technical Problems|2|||
37796781|NCT02037984|69439712|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
37796782|NCT02037984|69439713|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
37796783|NCT02037984|69439714|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
37796784|NCT02037984|69439715|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
37796785|NCT02037984|69439716|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
37796786|NCT02037984|69439717|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
37796787|NCT02037984|69439718|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
37796788|NCT02037984|69439719|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
37796789|NCT02037984|69439712|FG000|Overall Study|Withdrawal by Subject|0|||
37796790|NCT02037984|69439713|FG001|Overall Study|Withdrawal by Subject|0|||
37796791|NCT02037984|69439714|FG002|Overall Study|Withdrawal by Subject|0|||
37796792|NCT02037984|69439715|FG003|Overall Study|Withdrawal by Subject|1|||
37796793|NCT02037984|69439716|FG004|Overall Study|Withdrawal by Subject|1|||
37796794|NCT02037984|69439717|FG005|Overall Study|Withdrawal by Subject|3|||
37796795|NCT02037984|69439718|FG006|Overall Study|Withdrawal by Subject|0|||
37796796|NCT02037984|69439719|FG007|Overall Study|Withdrawal by Subject|1|||
37796797|NCT02057406|69439750|FG000|Overall Study|Physician Decision|0|||
37796798|NCT02057406|69439751|FG001|Overall Study|Physician Decision|0|||
37796799|NCT02057406|69439752|FG002|Overall Study|Physician Decision|2|||
37693857|NCT02039505|69170141|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
37693858|NCT02039505|69170135|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
37796800|NCT02057406|69439750|FG000|Overall Study|Withdrawal by Subject|0|||
37864167|NCT00991276|69547780|FG003|Third Intervention Period|Withdrawal by Subject|1|||
37796801|NCT02057406|69439751|FG001|Overall Study|Withdrawal by Subject|2|||
37796802|NCT02057406|69439752|FG002|Overall Study|Withdrawal by Subject|0|||
37796803|NCT02057406|69439750|FG000|Overall Study|Lost to Follow-up|0|||
37796804|NCT02057406|69439751|FG001|Overall Study|Lost to Follow-up|0|||
37796805|NCT02057406|69439752|FG002|Overall Study|Lost to Follow-up|1|||
37796806|NCT02057406|69439750|FG000|Overall Study|Death|1|||
37796807|NCT02057406|69439751|FG001|Overall Study|Death|0|||
37796808|NCT02057406|69439752|FG002|Overall Study|Death|0|||
37796809|NCT02057406|69439750|FG000|Overall Study|Protocol Violation|0|||
37796810|NCT02057406|69439751|FG001|Overall Study|Protocol Violation|1|||
37796811|NCT02057406|69439752|FG002|Overall Study|Protocol Violation|0|||
37796812|NCT02057406|69439750|FG000|Overall Study|Patient transportation issues|0|||
37796813|NCT02057406|69439751|FG001|Overall Study|Patient transportation issues|0|||
37796814|NCT02057406|69439752|FG002|Overall Study|Patient transportation issues|1|||
37796815|NCT02036580|69439763|FG000|Overall Study|Withdrawal by Subject|0|||
37796816|NCT02036580|69439764|FG001|Overall Study|Withdrawal by Subject|1|||
37796817|NCT02036580|69439765|FG002|Overall Study|Withdrawal by Subject|0|||
37796818|NCT02036580|69439763|FG000|Overall Study|Adverse Event|1|||
37796819|NCT02036580|69439764|FG001|Overall Study|Adverse Event|0|||
37796820|NCT02036580|69439765|FG002|Overall Study|Adverse Event|0|||
37796821|NCT02014116|69439782|FG000|Overall Study|Progressive Disease|3|||
37796822|NCT02014116|69439783|FG001|Overall Study|Progressive Disease|4|||
37796823|NCT02014116|69439784|FG002|Overall Study|Progressive Disease|2|||
37796824|NCT02014116|69439785|FG003|Overall Study|Progressive Disease|6|||
37796825|NCT02014116|69439786|FG004|Overall Study|Progressive Disease|1|||
37796826|NCT02014116|69439787|FG005|Overall Study|Progressive Disease|13|||
37796827|NCT02014116|69439788|FG006|Overall Study|Progressive Disease|1|||
37796828|NCT02014116|69439789|FG007|Overall Study|Progressive Disease|3|||
37796829|NCT02014116|69439790|FG008|Overall Study|Progressive Disease|7|||
37796830|NCT02014116|69439782|FG000|Overall Study|Adverse Event|0|||
37796831|NCT02014116|69439783|FG001|Overall Study|Adverse Event|0|||
37796832|NCT02014116|69439784|FG002|Overall Study|Adverse Event|0|||
37796833|NCT02014116|69439785|FG003|Overall Study|Adverse Event|0|||
37796834|NCT02014116|69439786|FG004|Overall Study|Adverse Event|1|||
37796835|NCT02014116|69439787|FG005|Overall Study|Adverse Event|0|||
37796836|NCT02014116|69439788|FG006|Overall Study|Adverse Event|0|||
37796837|NCT02014116|69439789|FG007|Overall Study|Adverse Event|1|||
37796838|NCT02014116|69439790|FG008|Overall Study|Adverse Event|0|||
37796839|NCT02014116|69439782|FG000|Overall Study|Lost to Follow-up|0|||
37796840|NCT02014116|69439783|FG001|Overall Study|Lost to Follow-up|0|||
37796841|NCT02014116|69439784|FG002|Overall Study|Lost to Follow-up|0|||
37796842|NCT02014116|69439785|FG003|Overall Study|Lost to Follow-up|0|||
37796843|NCT02014116|69439786|FG004|Overall Study|Lost to Follow-up|0|||
37796844|NCT02014116|69439787|FG005|Overall Study|Lost to Follow-up|1|||
37796845|NCT02014116|69439788|FG006|Overall Study|Lost to Follow-up|0|||
37796846|NCT02014116|69439789|FG007|Overall Study|Lost to Follow-up|0|||
37796847|NCT02014116|69439790|FG008|Overall Study|Lost to Follow-up|1|||
37796848|NCT02014116|69439782|FG000|Overall Study|Death|0|||
37796849|NCT02014116|69439783|FG001|Overall Study|Death|0|||
37796850|NCT02014116|69439784|FG002|Overall Study|Death|0|||
37796851|NCT02014116|69439785|FG003|Overall Study|Death|0|||
37796852|NCT02014116|69439786|FG004|Overall Study|Death|0|||
37796853|NCT02014116|69439787|FG005|Overall Study|Death|0|||
37796854|NCT02014116|69439788|FG006|Overall Study|Death|0|||
37796855|NCT02014116|69439789|FG007|Overall Study|Death|1|||
37796856|NCT02014116|69439790|FG008|Overall Study|Death|1|||
37796857|NCT02014116|69439782|FG000|Overall Study|Withdrawal by Subject|0|||
37796858|NCT02014116|69439783|FG001|Overall Study|Withdrawal by Subject|0|||
37796859|NCT02014116|69439784|FG002|Overall Study|Withdrawal by Subject|1|||
37796860|NCT02014116|69439785|FG003|Overall Study|Withdrawal by Subject|1|||
37796861|NCT02014116|69439786|FG004|Overall Study|Withdrawal by Subject|0|||
37796862|NCT02014116|69439787|FG005|Overall Study|Withdrawal by Subject|1|||
37796863|NCT02014116|69439788|FG006|Overall Study|Withdrawal by Subject|0|||
37796864|NCT02014116|69439789|FG007|Overall Study|Withdrawal by Subject|0|||
37796865|NCT02014116|69439790|FG008|Overall Study|Withdrawal by Subject|0|||
37796866|NCT02014116|69439782|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
37796867|NCT02014116|69439783|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
37796868|NCT02014116|69439784|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
37796869|NCT02014116|69439785|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
37796870|NCT02014116|69439786|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
37796871|NCT02014116|69439787|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
37796872|NCT02014116|69439788|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
37796873|NCT02014116|69439789|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
37796874|NCT02014116|69439790|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
37796875|NCT02014116|69439782|FG000|Overall Study|Physician Decision|0|||
37796876|NCT02014116|69439783|FG001|Overall Study|Physician Decision|0|||
37796877|NCT02014116|69439784|FG002|Overall Study|Physician Decision|0|||
37796878|NCT02014116|69439785|FG003|Overall Study|Physician Decision|0|||
37796879|NCT02014116|69439786|FG004|Overall Study|Physician Decision|0|||
37796880|NCT02014116|69439787|FG005|Overall Study|Physician Decision|0|||
37796881|NCT02014116|69439788|FG006|Overall Study|Physician Decision|0|||
37796882|NCT02014116|69439789|FG007|Overall Study|Physician Decision|0|||
37796883|NCT02014116|69439790|FG008|Overall Study|Physician Decision|1|||
37796884|NCT02057250|69439817|FG000|AID Assessment Phase|Adverse Event|3|||
37796885|NCT02057250|69439818|FG001|AID Assessment Phase|Adverse Event|2|||
37796886|NCT02057250|69439819|FG002|AID Assessment Phase|Adverse Event|6|||
37796887|NCT02057250|69439820|FG003|AID Assessment Phase|Adverse Event|1|||
37796888|NCT02057250|69439821|FG004|AID Assessment Phase|Adverse Event|0|||
37796889|NCT02057250|69439817|FG000|AID Assessment Phase|Other than specified above|1|||
37796890|NCT02057250|69439818|FG001|AID Assessment Phase|Other than specified above|1|||
37796891|NCT02057250|69439819|FG002|AID Assessment Phase|Other than specified above|1|||
37796892|NCT02057250|69439820|FG003|AID Assessment Phase|Other than specified above|1|||
37796893|NCT02057250|69439821|FG004|AID Assessment Phase|Other than specified above|0|||
37796894|NCT02057250|69439817|FG000|Extension Phase|Adverse Event|0|||
37796895|NCT02057250|69439818|FG001|Extension Phase|Adverse Event|0|||
37796896|NCT02057250|69439819|FG002|Extension Phase|Adverse Event|0|||
37796897|NCT02057250|69439820|FG003|Extension Phase|Adverse Event|0|||
37796898|NCT02057250|69439821|FG004|Extension Phase|Adverse Event|15|||
37796899|NCT02057250|69439817|FG000|Extension Phase|Lack of Efficacy|0|||
37796900|NCT02057250|69439818|FG001|Extension Phase|Lack of Efficacy|0|||
37796901|NCT02057250|69439819|FG002|Extension Phase|Lack of Efficacy|0|||
37796902|NCT02057250|69439820|FG003|Extension Phase|Lack of Efficacy|0|||
37796903|NCT02057250|69439821|FG004|Extension Phase|Lack of Efficacy|10|||
37796904|NCT02057250|69439817|FG000|Extension Phase|Entered in this period but not treated|0|||
37796905|NCT02057250|69439818|FG001|Extension Phase|Entered in this period but not treated|0|||
37796906|NCT02057250|69439819|FG002|Extension Phase|Entered in this period but not treated|0|||
37796907|NCT02057250|69439820|FG003|Extension Phase|Entered in this period but not treated|0|||
37796908|NCT02057250|69439821|FG004|Extension Phase|Entered in this period but not treated|4|||
37796909|NCT02057250|69439817|FG000|Extension Phase|Other than specified above|0|||
37796910|NCT02057250|69439818|FG001|Extension Phase|Other than specified above|0|||
37796911|NCT02057250|69439819|FG002|Extension Phase|Other than specified above|0|||
37796912|NCT02057250|69439820|FG003|Extension Phase|Other than specified above|0|||
37796913|NCT02057250|69439821|FG004|Extension Phase|Other than specified above|7|||
37796914|NCT02036502|69439841|FG000|Part 1:Dose Determination/Escalation|Death|3|||
37796915|NCT02036502|69439842|FG001|Part 1:Dose Determination/Escalation|Death|2|||
37796916|NCT02036502|69439843|FG002|Part 1:Dose Determination/Escalation|Death|0|||
37796917|NCT02036502|69439844|FG003|Part 1:Dose Determination/Escalation|Death|0|||
37796918|NCT02036502|69439845|FG004|Part 1:Dose Determination/Escalation|Death|0|||
37796919|NCT02036502|69439846|FG005|Part 1:Dose Determination/Escalation|Death|0|||
37796920|NCT02036502|69439847|FG006|Part 1:Dose Determination/Escalation|Death|0|||
37796921|NCT02036502|69439848|FG007|Part 1:Dose Determination/Escalation|Death|0|||
37796922|NCT02036502|69439841|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
37796923|NCT02036502|69439842|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
37796924|NCT02036502|69439843|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
37796925|NCT02036502|69439844|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
37796926|NCT02036502|69439845|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
37796927|NCT02036502|69439846|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
37796928|NCT02036502|69439847|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
37796929|NCT02036502|69439848|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
37796930|NCT02036502|69439841|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
37796931|NCT02036502|69439842|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
37796932|NCT02036502|69439843|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
37796933|NCT02036502|69439844|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
37796934|NCT02036502|69439845|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
37796935|NCT02036502|69439846|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
37796936|NCT02036502|69439847|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
37796937|NCT02036502|69439848|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
37796938|NCT02036502|69439841|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
37796939|NCT02036502|69439842|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
37796940|NCT02036502|69439843|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
37796941|NCT02036502|69439844|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
37796942|NCT02036502|69439845|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
37796943|NCT02036502|69439846|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
37796944|NCT02036502|69439847|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
37796945|NCT02036502|69439848|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
37796946|NCT02036502|69439841|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
37796947|NCT02036502|69439842|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
37796948|NCT02036502|69439843|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
37796949|NCT02036502|69439844|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
37796950|NCT02036502|69439845|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
37796951|NCT02036502|69439846|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
37796952|NCT02036502|69439847|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
37796953|NCT02036502|69439848|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
37796954|NCT02036502|69439841|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
37796955|NCT02036502|69439842|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
37796956|NCT02036502|69439843|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
37796957|NCT02036502|69439844|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
37796958|NCT02036502|69439845|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
37796959|NCT02036502|69439846|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
37796960|NCT02036502|69439847|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
37796961|NCT02036502|69439848|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
37796962|NCT02036502|69439841|FG000|Part 2:Dose Confirmation|Death|0|||
37796963|NCT02036502|69439842|FG001|Part 2:Dose Confirmation|Death|0|||
37796964|NCT02036502|69439843|FG002|Part 2:Dose Confirmation|Death|1|||
37796965|NCT02036502|69439844|FG003|Part 2:Dose Confirmation|Death|0|||
37796966|NCT02036502|69439845|FG004|Part 2:Dose Confirmation|Death|0|||
37796967|NCT02036502|69439846|FG005|Part 2:Dose Confirmation|Death|0|||
37796968|NCT02036502|69439847|FG006|Part 2:Dose Confirmation|Death|0|||
37796969|NCT02036502|69439848|FG007|Part 2:Dose Confirmation|Death|0|||
37796970|NCT02036502|69439841|FG000|Part 2:Dose Confirmation|Not treated|0|||
37796971|NCT02036502|69439842|FG001|Part 2:Dose Confirmation|Not treated|0|||
37796972|NCT02036502|69439843|FG002|Part 2:Dose Confirmation|Not treated|0|||
37796973|NCT02036502|69439844|FG003|Part 2:Dose Confirmation|Not treated|1|||
37796974|NCT02036502|69439845|FG004|Part 2:Dose Confirmation|Not treated|0|||
37796975|NCT02036502|69439846|FG005|Part 2:Dose Confirmation|Not treated|0|||
37796976|NCT02036502|69439847|FG006|Part 2:Dose Confirmation|Not treated|0|||
37796977|NCT02036502|69439848|FG007|Part 2:Dose Confirmation|Not treated|0|||
37796978|NCT02036502|69439841|FG000|Part 3:Dose Expansion|Adverse Event|0|||
37796979|NCT02036502|69439842|FG001|Part 3:Dose Expansion|Adverse Event|0|||
37796980|NCT02036502|69439843|FG002|Part 3:Dose Expansion|Adverse Event|0|||
37796981|NCT02036502|69439844|FG003|Part 3:Dose Expansion|Adverse Event|0|||
37796982|NCT02036502|69439845|FG004|Part 3:Dose Expansion|Adverse Event|0|||
37796983|NCT02036502|69439846|FG005|Part 3:Dose Expansion|Adverse Event|4|||
37796984|NCT02036502|69439847|FG006|Part 3:Dose Expansion|Adverse Event|0|||
37796985|NCT02036502|69439848|FG007|Part 3:Dose Expansion|Adverse Event|2|||
37796986|NCT02036502|69439841|FG000|Part 3:Dose Expansion|Death|0|||
37796987|NCT02036502|69439842|FG001|Part 3:Dose Expansion|Death|0|||
37796988|NCT02036502|69439843|FG002|Part 3:Dose Expansion|Death|0|||
37796989|NCT02036502|69439844|FG003|Part 3:Dose Expansion|Death|0|||
37796990|NCT02036502|69439845|FG004|Part 3:Dose Expansion|Death|0|||
37796991|NCT02036502|69439846|FG005|Part 3:Dose Expansion|Death|24|||
37796992|NCT02036502|69439847|FG006|Part 3:Dose Expansion|Death|0|||
37796993|NCT02036502|69439848|FG007|Part 3:Dose Expansion|Death|3|||
37796994|NCT02036502|69439841|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
37796995|NCT02036502|69439842|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
37796996|NCT02036502|69439843|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
37796997|NCT02036502|69439844|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
37796998|NCT02036502|69439845|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
37796999|NCT02036502|69439846|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
37797000|NCT02036502|69439847|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
37797001|NCT02036502|69439848|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
37797002|NCT02036502|69439841|FG000|Part 3:Dose Expansion|Physician Decision|0|||
37797003|NCT02036502|69439842|FG001|Part 3:Dose Expansion|Physician Decision|0|||
37797004|NCT02036502|69439843|FG002|Part 3:Dose Expansion|Physician Decision|0|||
37797005|NCT02036502|69439844|FG003|Part 3:Dose Expansion|Physician Decision|0|||
37797006|NCT02036502|69439845|FG004|Part 3:Dose Expansion|Physician Decision|0|||
37797007|NCT02036502|69439846|FG005|Part 3:Dose Expansion|Physician Decision|1|||
37797008|NCT02036502|69439847|FG006|Part 3:Dose Expansion|Physician Decision|0|||
37797009|NCT02036502|69439848|FG007|Part 3:Dose Expansion|Physician Decision|0|||
37797010|NCT02036502|69439841|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
37797011|NCT02036502|69439842|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
37797012|NCT02036502|69439843|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
37797013|NCT02036502|69439844|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
37797014|NCT02036502|69439845|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
37797015|NCT02036502|69439846|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
37797016|NCT02036502|69439847|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
37797017|NCT02036502|69439848|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
37797018|NCT02036502|69439841|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
37797019|NCT02036502|69439842|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
37797020|NCT02036502|69439843|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
37797021|NCT02036502|69439844|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
37797022|NCT02036502|69439845|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
37975627|NCT00410163|69662889|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
37797023|NCT02036502|69439846|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
37797024|NCT02036502|69439847|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
37975628|NCT00410163|69662890|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
37797025|NCT02036502|69439848|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
37797026|NCT02036502|69439841|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
37797027|NCT02036502|69439842|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
37797028|NCT02036502|69439843|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
37797029|NCT02036502|69439844|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
37797030|NCT02036502|69439845|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
37797031|NCT02036502|69439846|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
37797032|NCT02036502|69439847|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
37797033|NCT02036502|69439848|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
37797034|NCT02036502|69439841|FG000|Part 3:Dose Expansion|Not Treated|0|||
37797035|NCT02036502|69439842|FG001|Part 3:Dose Expansion|Not Treated|0|||
37797036|NCT02036502|69439843|FG002|Part 3:Dose Expansion|Not Treated|0|||
37797037|NCT02036502|69439844|FG003|Part 3:Dose Expansion|Not Treated|0|||
37797038|NCT02036502|69439845|FG004|Part 3:Dose Expansion|Not Treated|0|||
37797039|NCT02036502|69439846|FG005|Part 3:Dose Expansion|Not Treated|2|||
37797040|NCT02036502|69439847|FG006|Part 3:Dose Expansion|Not Treated|0|||
37797041|NCT02036502|69439848|FG007|Part 3:Dose Expansion|Not Treated|0|||
37797042|NCT02056626|69439872|FG000|Overall Study|patient did not follow directions|3|||
37797043|NCT02056626|69439873|FG001|Overall Study|patient did not follow directions|1|||
37797044|NCT02056626|69439874|FG002|Overall Study|patient did not follow directions|0|||
37797045|NCT02056626|69439875|FG003|Overall Study|patient did not follow directions|0|||
37797046|NCT02035332|69439885|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
37797047|NCT02056392|69439895|FG000|Overall Study|Lost to Follow-up|0|||
37797048|NCT02056392|69439896|FG001|Overall Study|Lost to Follow-up|1|||
37797049|NCT02056392|69439897|FG002|Overall Study|Lost to Follow-up|2|||
37797050|NCT02056392|69439898|FG003|Overall Study|Lost to Follow-up|0|||
37797051|NCT02056392|69439899|FG004|Overall Study|Lost to Follow-up|0|||
37797052|NCT02056392|69439900|FG005|Overall Study|Lost to Follow-up|0|||
37797053|NCT02056392|69439895|FG000|Overall Study|Protocol Violation|1|||
37797054|NCT02056392|69439896|FG001|Overall Study|Protocol Violation|0|||
37797055|NCT02056392|69439897|FG002|Overall Study|Protocol Violation|1|||
37797056|NCT02056392|69439898|FG003|Overall Study|Protocol Violation|0|||
37797057|NCT02056392|69439899|FG004|Overall Study|Protocol Violation|0|||
37797058|NCT02056392|69439900|FG005|Overall Study|Protocol Violation|0|||
37797059|NCT02056392|69439895|FG000|Overall Study|Withdrawal by Subject|1|||
37797060|NCT02056392|69439896|FG001|Overall Study|Withdrawal by Subject|0|||
37797061|NCT02056392|69439897|FG002|Overall Study|Withdrawal by Subject|0|||
37797062|NCT02056392|69439898|FG003|Overall Study|Withdrawal by Subject|0|||
37797063|NCT02056392|69439899|FG004|Overall Study|Withdrawal by Subject|1|||
37797064|NCT02056392|69439900|FG005|Overall Study|Withdrawal by Subject|0|||
37797065|NCT02034708|69439910|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
37797066|NCT02034708|69439911|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
37797067|NCT02034708|69439910|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
37797068|NCT02034708|69439911|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
37797069|NCT02034708|69439910|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
37797070|NCT02034708|69439911|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
37797071|NCT02034708|69439910|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
37797072|NCT02034708|69439911|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
37797073|NCT02034552|69439925|FG000|Overall Study|Never treated|3|||
37797074|NCT02034552|69439926|FG001|Overall Study|Never treated|2|||
37797075|NCT02034552|69439927|FG002|Overall Study|Never treated|0|||
37797076|NCT02034552|69439925|FG000|Overall Study|Radiological progression|3|||
37797077|NCT02034552|69439926|FG001|Overall Study|Radiological progression|5|||
37797078|NCT02034552|69439927|FG002|Overall Study|Radiological progression|4|||
37797079|NCT02034552|69439925|FG000|Overall Study|AE not assoc. with disease progression|1|||
37797080|NCT02034552|69439926|FG001|Overall Study|AE not assoc. with disease progression|4|||
37797081|NCT02034552|69439927|FG002|Overall Study|AE not assoc. with disease progression|2|||
37797082|NCT02034552|69439925|FG000|Overall Study|AE associated with disease progression|0|||
37797083|NCT02034552|69439926|FG001|Overall Study|AE associated with disease progression|1|||
37797084|NCT02034552|69439927|FG002|Overall Study|AE associated with disease progression|0|||
37975629|NCT00410163|69662889|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
37797085|NCT02034552|69439925|FG000|Overall Study|Withdrawal by Subject|2|||
37797086|NCT02034552|69439926|FG001|Overall Study|Withdrawal by Subject|1|||
37797087|NCT02034552|69439927|FG002|Overall Study|Withdrawal by Subject|1|||
37797088|NCT02034552|69439925|FG000|Overall Study|Non-compliance with study drug|0|||
37797089|NCT02034552|69439926|FG001|Overall Study|Non-compliance with study drug|0|||
37797090|NCT02034552|69439927|FG002|Overall Study|Non-compliance with study drug|1|||
37797091|NCT02034552|69439925|FG000|Overall Study|Clinical progression|5|||
37797092|NCT02034552|69439926|FG001|Overall Study|Clinical progression|7|||
37797093|NCT02034552|69439927|FG002|Overall Study|Clinical progression|9|||
37797094|NCT02034474|69439937|FG000|Overall Study|Adverse Event|3|||
37797095|NCT02034474|69439938|FG001|Overall Study|Adverse Event|2|||
37797096|NCT02034474|69439937|FG000|Overall Study|Withdrawal by Subject|1|||
37797097|NCT02034474|69439938|FG001|Overall Study|Withdrawal by Subject|2|||
37797098|NCT02011542|69439946|FG000|Overall Study|Physician Decision|1|||
37797099|NCT02011386|69439950|FG000|Overall Study|Non-compliance|2|||
37797100|NCT02011386|69439950|FG000|Overall Study|Lack of Efficacy|3|||
37797101|NCT02010684|69439956|FG000|Overall Study|Lost to Follow-up|8|||
37797102|NCT02010684|69439957|FG001|Overall Study|Lost to Follow-up|18|||
37797103|NCT02010684|69439956|FG000|Overall Study|Withdrawal by Subject|4|||
37797104|NCT02010684|69439957|FG001|Overall Study|Withdrawal by Subject|5|||
37797105|NCT02034162|69439965|FG000|Double-blind|Lost to Follow-up|3|||
37797106|NCT02034162|69439966|FG001|Double-blind|Lost to Follow-up|0|||
37797107|NCT02034162|69439967|FG002|Double-blind|Lost to Follow-up|0|||
37797108|NCT02034162|69439965|FG000|Double-blind|Physician Decision|1|||
37797109|NCT02034162|69439966|FG001|Double-blind|Physician Decision|0|||
37797110|NCT02034162|69439967|FG002|Double-blind|Physician Decision|0|||
37797111|NCT02034162|69439965|FG000|Double-blind|Protocol Violation|0|||
37797112|NCT02034162|69439966|FG001|Double-blind|Protocol Violation|1|||
37797113|NCT02034162|69439967|FG002|Double-blind|Protocol Violation|0|||
37797114|NCT02034162|69439965|FG000|Double-blind|Withdrawal by Subject|5|||
37797115|NCT02034162|69439966|FG001|Double-blind|Withdrawal by Subject|7|||
37797116|NCT02034162|69439967|FG002|Double-blind|Withdrawal by Subject|0|||
37797117|NCT02034006|69439980|FG000|Overall Study|Withdrawal by Subject|7|||
37797118|NCT02034006|69439980|FG000|Overall Study|Lost to Follow-up|5|||
37797119|NCT02034006|69439980|FG000|Overall Study|Death|1|||
37797120|NCT02034006|69439980|FG000|Overall Study|Pregnancy|1|||
37797121|NCT02054910|69439989|FG000|Overall Study|Lost to Follow-up|4|||
37797122|NCT02054910|69439990|FG001|Overall Study|Lost to Follow-up|1|||
37797123|NCT02033850|69440000|FG000|Overall Study|Death|1|||
37797124|NCT02033850|69440001|FG001|Overall Study|Death|0|||
37797125|NCT02033850|69440000|FG000|Overall Study|unrelated medical reason|1|||
37797126|NCT02033850|69440001|FG001|Overall Study|unrelated medical reason|1|||
37797127|NCT02054130|69440011|FG000|Overall Study|Withdrawal by Subject|4|||
37797128|NCT02054130|69440012|FG001|Overall Study|Withdrawal by Subject|4|||
37797129|NCT02054130|69440013|FG002|Overall Study|Withdrawal by Subject|7|||
37797130|NCT02054130|69440014|FG003|Overall Study|Withdrawal by Subject|10|||
37797131|NCT02054130|69440011|FG000|Overall Study|Death|0|||
37797132|NCT02054130|69440012|FG001|Overall Study|Death|1|||
37797133|NCT02054130|69440013|FG002|Overall Study|Death|0|||
37797134|NCT02054130|69440014|FG003|Overall Study|Death|0|||
37797135|NCT02054130|69440011|FG000|Overall Study|Lost to Follow-up|0|||
37797136|NCT02054130|69440012|FG001|Overall Study|Lost to Follow-up|0|||
37797137|NCT02054130|69440013|FG002|Overall Study|Lost to Follow-up|1|||
37797138|NCT02054130|69440014|FG003|Overall Study|Lost to Follow-up|2|||
37797139|NCT02054130|69440011|FG000|Overall Study|Missed dose|4|||
37797140|NCT02054130|69440012|FG001|Overall Study|Missed dose|6|||
37864168|NCT00991276|69547781|FG004|Third Intervention Period|Withdrawal by Subject|0|||
37864169|NCT00991276|69547782|FG005|Third Intervention Period|Withdrawal by Subject|0|||
37797141|NCT02054130|69440013|FG002|Overall Study|Missed dose|7|||
37864170|NCT00990652|69547791|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
37797142|NCT02054130|69440014|FG003|Overall Study|Missed dose|10|||
37797143|NCT02009046|69440029|FG000|Overall Study|Lost to Follow-up|256|||
37797144|NCT02009046|69440030|FG001|Overall Study|Lost to Follow-up|206|||
37797145|NCT02052960|69440046|FG000|Overall Study|Adverse Event|19|||
37797146|NCT02052960|69440047|FG001|Overall Study|Adverse Event|17|||
37797147|NCT02052960|69440046|FG000|Overall Study|Protocol Violation|4|||
37797148|NCT02052960|69440047|FG001|Overall Study|Protocol Violation|3|||
37797149|NCT02052960|69440046|FG000|Overall Study|Withdrawal by Subject|6|||
37797150|NCT02052960|69440047|FG001|Overall Study|Withdrawal by Subject|11|||
37797151|NCT02052960|69440046|FG000|Overall Study|Other|25|||
37797152|NCT02052960|69440047|FG001|Overall Study|Other|15|||
37797153|NCT02008890|69440059|FG000|Period 1|Withdrawal by Subject|7|||
37797154|NCT02008890|69440060|FG001|Period 1|Withdrawal by Subject|7|||
37797155|NCT02008890|69440061|FG002|Period 1|Withdrawal by Subject|5|||
37797156|NCT02008890|69440062|FG003|Period 1|Withdrawal by Subject|0|||
37797157|NCT02008890|69440063|FG004|Period 1|Withdrawal by Subject|0|||
37797158|NCT02008890|69440059|FG000|Period 1|Pregnancy|1|||
37797159|NCT02008890|69440060|FG001|Period 1|Pregnancy|0|||
37797160|NCT02008890|69440061|FG002|Period 1|Pregnancy|0|||
37797161|NCT02008890|69440062|FG003|Period 1|Pregnancy|0|||
37797162|NCT02008890|69440063|FG004|Period 1|Pregnancy|0|||
37797163|NCT02008890|69440059|FG000|Period 1|Physician Decision|1|||
37797164|NCT02008890|69440060|FG001|Period 1|Physician Decision|0|||
37797165|NCT02008890|69440061|FG002|Period 1|Physician Decision|1|||
37797166|NCT02008890|69440062|FG003|Period 1|Physician Decision|0|||
37797167|NCT02008890|69440063|FG004|Period 1|Physician Decision|0|||
37797168|NCT02008890|69440059|FG000|Period 1|Adverse Event|6|||
37797169|NCT02008890|69440060|FG001|Period 1|Adverse Event|8|||
37797170|NCT02008890|69440061|FG002|Period 1|Adverse Event|6|||
37797171|NCT02008890|69440062|FG003|Period 1|Adverse Event|0|||
37797172|NCT02008890|69440063|FG004|Period 1|Adverse Event|0|||
37797173|NCT02008890|69440059|FG000|Period 2|Adverse Event|12|||
37797174|NCT02008890|69440060|FG001|Period 2|Adverse Event|7|||
37797175|NCT02008890|69440061|FG002|Period 2|Adverse Event|0|||
37797176|NCT02008890|69440062|FG003|Period 2|Adverse Event|5|||
37797177|NCT02008890|69440063|FG004|Period 2|Adverse Event|5|||
37797178|NCT02008890|69440059|FG000|Period 2|Withdrawal by Subject|11|||
37797179|NCT02008890|69440060|FG001|Period 2|Withdrawal by Subject|8|||
37797180|NCT02008890|69440061|FG002|Period 2|Withdrawal by Subject|0|||
37797181|NCT02008890|69440062|FG003|Period 2|Withdrawal by Subject|7|||
37797182|NCT02008890|69440063|FG004|Period 2|Withdrawal by Subject|2|||
37797183|NCT02008890|69440059|FG000|Period 2|Physician Decision|4|||
37797184|NCT02008890|69440060|FG001|Period 2|Physician Decision|0|||
37797185|NCT02008890|69440061|FG002|Period 2|Physician Decision|0|||
37797186|NCT02008890|69440062|FG003|Period 2|Physician Decision|2|||
37797187|NCT02008890|69440063|FG004|Period 2|Physician Decision|1|||
37797188|NCT02008890|69440059|FG000|Period 2|Lost to Follow-up|0|||
37797189|NCT02008890|69440060|FG001|Period 2|Lost to Follow-up|0|||
37797190|NCT02008890|69440061|FG002|Period 2|Lost to Follow-up|1|||
37797191|NCT02008890|69440062|FG003|Period 2|Lost to Follow-up|0|||
37797192|NCT02008890|69440063|FG004|Period 2|Lost to Follow-up|0|||
37797193|NCT02008890|69440059|FG000|Extension Period|Withdrawal by Subject|3|||
37797194|NCT02008890|69440060|FG001|Extension Period|Withdrawal by Subject|2|||
37797195|NCT02008890|69440061|FG002|Extension Period|Withdrawal by Subject|0|||
37797196|NCT02008890|69440062|FG003|Extension Period|Withdrawal by Subject|4|||
37797197|NCT02008890|69440063|FG004|Extension Period|Withdrawal by Subject|2|||
37797198|NCT02008890|69440059|FG000|Extension Period|Lost to Follow-up|1|||
37797199|NCT02008890|69440060|FG001|Extension Period|Lost to Follow-up|0|||
37797200|NCT02008890|69440061|FG002|Extension Period|Lost to Follow-up|0|||
37797201|NCT02008890|69440062|FG003|Extension Period|Lost to Follow-up|0|||
37797202|NCT02008890|69440063|FG004|Extension Period|Lost to Follow-up|0|||
37797203|NCT02008890|69440059|FG000|Extension Period|Adverse Event|1|||
37797204|NCT02008890|69440060|FG001|Extension Period|Adverse Event|3|||
37975630|NCT00410163|69662890|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
37797205|NCT02008890|69440061|FG002|Extension Period|Adverse Event|0|||
37797206|NCT02008890|69440062|FG003|Extension Period|Adverse Event|0|||
37864171|NCT00990652|69547791|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
37975631|NCT00410163|69662889|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
37975632|NCT00410163|69662890|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
37975633|NCT00409617|69662926|FG000|Overall Study|Adverse Event|57|||
37975634|NCT00409617|69662926|FG000|Overall Study|Lack of Efficacy|54|||
37797207|NCT02008890|69440063|FG004|Extension Period|Adverse Event|2|||
37797208|NCT02052414|69440078|FG000|Overall Study|Adverse Event|12|||
37797209|NCT02052414|69440078|FG000|Overall Study|Lack of Efficacy|2|||
37797210|NCT02052414|69440078|FG000|Overall Study|Withdrawal by Subject|3|||
37797211|NCT02007954|69440083|FG000|Overall Study|Received liver transplant|3|||
37797212|NCT02007954|69440083|FG000|Overall Study|Switch in treatment modality|2|||
37797213|NCT02007954|69440083|FG000|Overall Study|Disease progression and unrelated AE|1|||
37797214|NCT02007954|69440083|FG000|Overall Study|Death|1|||
37797215|NCT02049450|69440087|FG000|Overall Study|Adverse Event|2|||
37797216|NCT02049450|69440087|FG000|Overall Study|Withdrawal by Subject|1|||
37797217|NCT02049450|69440087|FG000|Overall Study|Patients/guardian decision|1|||
37797218|NCT02031432|69440098|FG000|Overall Study|Protocol Violation|1|||
37797219|NCT02031432|69440098|FG000|Overall Study|Lack of Efficacy|5|||
37797220|NCT02031432|69440098|FG000|Overall Study|Cancer Progression|2|||
37797221|NCT02031432|69440098|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
37797222|NCT02031432|69440098|FG000|Overall Study|Adverse Event|8|||
37797223|NCT02031432|69440098|FG000|Overall Study|Withdrawal by Subject|5|||
37797224|NCT02031432|69440098|FG000|Overall Study|Lost to Follow-up|1|||
37797225|NCT02031432|69440098|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
37797226|NCT02031432|69440098|FG000|Overall Study|Death|10|||
37797227|NCT02031276|69440105|FG000|Period 1 Double-blind IV|Adverse Event|6|||
37797228|NCT02031276|69440106|FG001|Period 1 Double-blind IV|Adverse Event|5|||
37797229|NCT02031276|69440107|FG002|Period 1 Double-blind IV|Adverse Event|1|||
37797230|NCT02031276|69440105|FG000|Period 1 Double-blind IV|Other|0|||
37797231|NCT02031276|69440106|FG001|Period 1 Double-blind IV|Other|1|||
37797232|NCT02031276|69440107|FG002|Period 1 Double-blind IV|Other|0|||
37797233|NCT02031276|69440105|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
37797234|NCT02031276|69440106|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
37797235|NCT02031276|69440107|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
37797236|NCT02031276|69440105|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
37797237|NCT02031276|69440106|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
37797238|NCT02031276|69440107|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
37797239|NCT02031276|69440105|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
37797240|NCT02031276|69440106|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
37797241|NCT02031276|69440107|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
37797242|NCT02031276|69440105|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
37797243|NCT02031276|69440106|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
37797244|NCT02031276|69440107|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
37797245|NCT02031276|69440105|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
37797246|NCT02031276|69440106|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
37797247|NCT02031276|69440107|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
37797248|NCT02031276|69440105|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
37797249|NCT02031276|69440106|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
37797250|NCT02031276|69440107|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
37797251|NCT02031276|69440105|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
37797252|NCT02031276|69440106|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
37797253|NCT02031276|69440107|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
37797254|NCT02007720|69440121|FG000|Overall Study|Withdrawal by Subject|9|||
37797255|NCT02007720|69440122|FG001|Overall Study|Withdrawal by Subject|11|||
37797256|NCT02007720|69440121|FG000|Overall Study|study terminated by sponsor|58|||
37797257|NCT02007720|69440122|FG001|Overall Study|study terminated by sponsor|54|||
37797258|NCT02007720|69440121|FG000|Overall Study|technical problem|4|||
37797259|NCT02007720|69440122|FG001|Overall Study|technical problem|2|||
37797260|NCT02007720|69440121|FG000|Overall Study|patient followd less than 165 days|11|||
37797261|NCT02007720|69440122|FG001|Overall Study|patient followd less than 165 days|5|||
37797262|NCT01363440|69440132|FG000|Overall Study|Adverse Event|5|||
37797263|NCT01363440|69440133|FG001|Overall Study|Adverse Event|4|||
37797264|NCT01363440|69440134|FG002|Overall Study|Adverse Event|4|||
37797265|NCT01363440|69440132|FG000|Overall Study|Death|3|||
37797266|NCT01363440|69440133|FG001|Overall Study|Death|7|||
37797267|NCT01363440|69440134|FG002|Overall Study|Death|5|||
37797268|NCT01363440|69440132|FG000|Overall Study|Withdrawal by Subject|9|||
37797269|NCT01363440|69440133|FG001|Overall Study|Withdrawal by Subject|11|||
37797270|NCT01363440|69440134|FG002|Overall Study|Withdrawal by Subject|11|||
37797271|NCT01363440|69440132|FG000|Overall Study|Lost to Follow-up|2|||
37797272|NCT01363440|69440133|FG001|Overall Study|Lost to Follow-up|4|||
37797273|NCT01363440|69440134|FG002|Overall Study|Lost to Follow-up|5|||
37797274|NCT01363440|69440132|FG000|Overall Study|Other|4|||
37797275|NCT01363440|69440133|FG001|Overall Study|Other|5|||
37797276|NCT01363440|69440134|FG002|Overall Study|Other|2|||
37797277|NCT02007252|69440147|FG000|Overall Study|Administrative problems|3|||
37797278|NCT02007252|69440148|FG001|Overall Study|Administrative problems|7|||
37797279|NCT02007252|69440147|FG000|Overall Study|Abnormal laboratory value(s)|1|||
37797280|NCT02007252|69440148|FG001|Overall Study|Abnormal laboratory value(s)|0|||
37797281|NCT02007252|69440147|FG000|Overall Study|Adverse Event|7|||
37975635|NCT00409617|69662926|FG000|Overall Study|Lost to Follow-up|2|||
37975636|NCT00409617|69662926|FG000|Overall Study|Protocol Violation|24|||
37975637|NCT00409617|69662926|FG000|Overall Study|Withdrawal by Subject|8|||
37797282|NCT02007252|69440148|FG001|Overall Study|Adverse Event|4|||
37797283|NCT02007096|69440156|FG000|Overall Study|medication not available|2|||
37797284|NCT02007096|69440157|FG001|Overall Study|medication not available|0|||
37797285|NCT02007096|69440156|FG000|Overall Study|did not inject saline|0|||
37797286|NCT02007096|69440157|FG001|Overall Study|did not inject saline|3|||
37797287|NCT02007096|69440156|FG000|Overall Study|did not follow postoperative protocol|8|||
37797288|NCT02007096|69440157|FG001|Overall Study|did not follow postoperative protocol|11|||
37797289|NCT02007096|69440156|FG000|Overall Study|converted to open surgery|1|||
37797290|NCT02007096|69440157|FG001|Overall Study|converted to open surgery|1|||
37797291|NCT02007096|69440156|FG000|Overall Study|no mesh placed|0|||
37797292|NCT02007096|69440157|FG001|Overall Study|no mesh placed|1|||
37797293|NCT02006706|69440163|FG000|Overall Study|Lost to Follow-up|1|||
37797294|NCT02049138|69440170|FG000|Overall Study|Adverse Event|46|||
37797295|NCT02049138|69440171|FG001|Overall Study|Adverse Event|25|||
37797296|NCT02049138|69440172|FG002|Overall Study|Adverse Event|1|||
37797297|NCT02049138|69440170|FG000|Overall Study|Withdrawal by Subject|57|||
37797298|NCT02049138|69440171|FG001|Overall Study|Withdrawal by Subject|21|||
37797299|NCT02049138|69440172|FG002|Overall Study|Withdrawal by Subject|5|||
37797300|NCT02049138|69440170|FG000|Overall Study|Lost to Follow-up|18|||
37797301|NCT02049138|69440171|FG001|Overall Study|Lost to Follow-up|5|||
37797302|NCT02049138|69440172|FG002|Overall Study|Lost to Follow-up|1|||
37797303|NCT02049138|69440170|FG000|Overall Study|Lack of Efficacy|10|||
37797304|NCT02049138|69440171|FG001|Overall Study|Lack of Efficacy|26|||
37797305|NCT02049138|69440172|FG002|Overall Study|Lack of Efficacy|1|||
37797306|NCT02049138|69440170|FG000|Overall Study|Non-Compliance|15|||
37797307|NCT02049138|69440171|FG001|Overall Study|Non-Compliance|6|||
37797308|NCT02049138|69440172|FG002|Overall Study|Non-Compliance|0|||
37797309|NCT02049138|69440170|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
37797310|NCT02049138|69440171|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
37797311|NCT02049138|69440172|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
37797312|NCT02049138|69440170|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
37797313|NCT02049138|69440171|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
37797314|NCT02049138|69440172|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
37797315|NCT02049138|69440170|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
37797316|NCT02049138|69440171|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
37797317|NCT02049138|69440172|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
37797318|NCT02049138|69440170|FG000|Overall Study|Other|15|||
37797319|NCT02049138|69440171|FG001|Overall Study|Other|13|||
37797320|NCT02049138|69440172|FG002|Overall Study|Other|0|||
37797321|NCT02049138|69440170|FG000|Overall Study|Missing|0|||
37797322|NCT02049138|69440171|FG001|Overall Study|Missing|1|||
37797323|NCT02049138|69440172|FG002|Overall Study|Missing|0|||
37797324|NCT02048904|69440183|FG000|Overall Study|Withdrawal by Subject|7|||
37797325|NCT02048904|69440183|FG000|Overall Study|Physician Decision|70|||
37797326|NCT02006628|69440189|FG000|Overall Study|Adverse Event|1|||
37797327|NCT02006628|69440190|FG001|Overall Study|Adverse Event|1|||
37797328|NCT02006628|69440189|FG000|Overall Study|Withdrawal by Subject|2|||
37797329|NCT02006628|69440190|FG001|Overall Study|Withdrawal by Subject|1|||
37797330|NCT02048826|69440198|FG000|Overall Study|Withdrawal by Subject|1|||
37797331|NCT02048826|69440199|FG001|Overall Study|Withdrawal by Subject|0|||
37797332|NCT02006472|69440210|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
37797333|NCT02006472|69440211|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
37797334|NCT02006472|69440212|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
37797335|NCT02006472|69440213|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
37797336|NCT02006472|69440214|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
37797337|NCT02006472|69440210|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
37797338|NCT02006472|69440211|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
37797339|NCT02006472|69440212|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
37797340|NCT02006472|69440213|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
37797341|NCT02006472|69440214|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
37797342|NCT02006472|69440210|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
37797343|NCT02006472|69440211|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
37797344|NCT02006472|69440212|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
37797345|NCT02006472|69440213|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
37797346|NCT02006472|69440214|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
37797347|NCT02006472|69440210|FG000|Period 1 (Through Week 26)|Other|1|||
37797348|NCT02006472|69440211|FG001|Period 1 (Through Week 26)|Other|5|||
37797349|NCT02006472|69440212|FG002|Period 1 (Through Week 26)|Other|0|||
37797350|NCT02006472|69440213|FG003|Period 1 (Through Week 26)|Other|2|||
37797351|NCT02006472|69440214|FG004|Period 1 (Through Week 26)|Other|3|||
37797352|NCT02006472|69440210|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
37797353|NCT02006472|69440211|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
37797354|NCT02006472|69440212|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
37797355|NCT02006472|69440213|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
37797356|NCT02006472|69440214|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
37797357|NCT02006472|69440210|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
38043694|NCT02115282|69731864|FG001|Overall Study|Protocol Violation|2|||
37797358|NCT02006472|69440211|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
37797359|NCT02006472|69440212|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
37797360|NCT02006472|69440213|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
37797361|NCT02006472|69440214|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
37797362|NCT02006472|69440210|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
37797363|NCT02006472|69440211|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
37797364|NCT02006472|69440212|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
37797365|NCT02006472|69440213|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
37797366|NCT02006472|69440214|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
37797367|NCT02006472|69440210|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
37797368|NCT02006472|69440211|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
37797369|NCT02006472|69440212|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
37797370|NCT02006472|69440213|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
37797371|NCT02006472|69440214|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
37797372|NCT02006472|69440210|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
37797373|NCT02006472|69440211|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
37797374|NCT02006472|69440212|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
37797375|NCT02006472|69440213|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
37797376|NCT02006472|69440214|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
37797377|NCT02006472|69440210|FG000|Period 2 (Through Week 52)|Other|0|||
37797378|NCT02006472|69440211|FG001|Period 2 (Through Week 52)|Other|1|||
37797379|NCT02006472|69440212|FG002|Period 2 (Through Week 52)|Other|0|||
37797380|NCT02006472|69440213|FG003|Period 2 (Through Week 52)|Other|1|||
37797381|NCT02006472|69440214|FG004|Period 2 (Through Week 52)|Other|0|||
37797382|NCT02006472|69440210|FG000|Period 2 (Through Week 52)|Not treated|0|||
37797383|NCT02006472|69440211|FG001|Period 2 (Through Week 52)|Not treated|0|||
37797384|NCT02006472|69440212|FG002|Period 2 (Through Week 52)|Not treated|2|||
37797385|NCT02006472|69440213|FG003|Period 2 (Through Week 52)|Not treated|0|||
37797386|NCT02006472|69440214|FG004|Period 2 (Through Week 52)|Not treated|0|||
37797387|NCT02006472|69440210|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
37797388|NCT02006472|69440211|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
37797389|NCT02006472|69440212|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
37797390|NCT02006472|69440213|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
37797391|NCT02006472|69440214|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
37797392|NCT02006472|69440210|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
37797393|NCT02006472|69440211|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
37797394|NCT02006472|69440212|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
37797395|NCT02006472|69440213|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
37797396|NCT02006472|69440214|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
37797397|NCT02005692|69440231|FG000|Overall Study|Protocol Violation|1|||
37797398|NCT02005692|69440231|FG000|Overall Study|Withdrawal by Subject|1|||
37797399|NCT02005692|69440231|FG000|Overall Study|Discharged earlier than anticipated|5|||
37797400|NCT02029638|69440239|FG000|Overall Study|Death|0|||
37797401|NCT02029638|69440240|FG001|Overall Study|Death|0|||
37797402|NCT02029638|69440241|FG002|Overall Study|Death|1|||
37797403|NCT02029638|69440239|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
37797404|NCT02029638|69440240|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
37797405|NCT02029638|69440241|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
37797406|NCT02047734|69440252|FG000|Overall Study|Adverse Event|18|||
37797407|NCT02047734|69440253|FG001|Overall Study|Adverse Event|13|||
37797408|NCT02047734|69440254|FG002|Overall Study|Adverse Event|13|||
37797409|NCT02047734|69440252|FG000|Overall Study|Lack of Efficacy|4|||
37797410|NCT02047734|69440253|FG001|Overall Study|Lack of Efficacy|5|||
37797411|NCT02047734|69440254|FG002|Overall Study|Lack of Efficacy|1|||
37797412|NCT02047734|69440252|FG000|Overall Study|Protocol Violation|3|||
37797413|NCT02047734|69440253|FG001|Overall Study|Protocol Violation|1|||
37797414|NCT02047734|69440254|FG002|Overall Study|Protocol Violation|1|||
37864172|NCT00990340|69547798|FG000|First 14-day Treatment|Not Compliant|2|||
37797415|NCT02047734|69440252|FG000|Overall Study|Lost to Follow-up|1|||
37797416|NCT02047734|69440253|FG001|Overall Study|Lost to Follow-up|4|||
37797417|NCT02047734|69440254|FG002|Overall Study|Lost to Follow-up|0|||
37797418|NCT02047734|69440252|FG000|Overall Study|Death|0|||
37797419|NCT02047734|69440253|FG001|Overall Study|Death|1|||
37797420|NCT02047734|69440254|FG002|Overall Study|Death|0|||
37797421|NCT02047734|69440252|FG000|Overall Study|Withdrawal by Subject|30|||
37797422|NCT02047734|69440253|FG001|Overall Study|Withdrawal by Subject|31|||
37797423|NCT02047734|69440254|FG002|Overall Study|Withdrawal by Subject|19|||
37797424|NCT02047734|69440252|FG000|Overall Study|Physician Decision|7|||
37797425|NCT02047734|69440253|FG001|Overall Study|Physician Decision|6|||
37797426|NCT02047734|69440254|FG002|Overall Study|Physician Decision|5|||
37797427|NCT02047734|69440252|FG000|Overall Study|Miscellaneous|2|||
37797428|NCT02047734|69440253|FG001|Overall Study|Miscellaneous|4|||
37797429|NCT02047734|69440254|FG002|Overall Study|Miscellaneous|6|||
37975638|NCT00409617|69662926|FG000|Overall Study|Administrative reasons|1|||
37797430|NCT02047734|69440252|FG000|Overall Study|Did Not Receive Study Drug|2|||
37797431|NCT02047734|69440253|FG001|Overall Study|Did Not Receive Study Drug|4|||
37975639|NCT00409617|69662926|FG000|Overall Study|Not described|14|||
37797432|NCT02047734|69440254|FG002|Overall Study|Did Not Receive Study Drug|1|||
37864173|NCT00990340|69547799|FG001|First 14-day Treatment|Not Compliant|1|||
37864174|NCT00990340|69547798|FG000|First 14-day Treatment|Lost to Follow-up|2|||
37864175|NCT00990340|69547799|FG001|First 14-day Treatment|Lost to Follow-up|1|||
37693859|NCT02039505|69170136|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
37693860|NCT02039505|69170137|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
37797433|NCT02053350|69440262|FG000|Overall Study|Withdrawal by Subject|1|||
37797434|NCT02053350|69440262|FG000|Overall Study|Adverse Event|4|||
37797435|NCT01994850|69440266|FG000|Overall Study|Physician Decision|1|||
37797436|NCT01994850|69440266|FG000|Overall Study|Withdrawal by Subject|1|||
37797437|NCT02027844|69440273|FG000|Overall Study|Withdrawal by Subject|3|||
37864176|NCT00990340|69547798|FG000|First 14-day Treatment|Protocol Violation|2|||
37864177|NCT00990340|69547799|FG001|First 14-day Treatment|Protocol Violation|2|||
37864178|NCT01207440|69547814|FG000|Overall Study|Adverse Event|46|||
37864179|NCT01207440|69547815|FG001|Overall Study|Adverse Event|11|||
37864180|NCT01207440|69547816|FG002|Overall Study|Adverse Event|7|||
37864181|NCT01207440|69547817|FG003|Overall Study|Adverse Event|2|||
37864182|NCT01207440|69547818|FG004|Overall Study|Adverse Event|6|||
37864183|NCT01207440|69547819|FG005|Overall Study|Adverse Event|6|||
37864184|NCT01207440|69547820|FG006|Overall Study|Adverse Event|2|||
37975640|NCT00300274|69662933|FG000|Overall Study|Withdrawal by Subject|12|||
37975641|NCT00300274|69662934|FG001|Overall Study|Withdrawal by Subject|3|||
37975642|NCT00300274|69662935|FG002|Overall Study|Withdrawal by Subject|14|||
37975643|NCT00300274|69662933|FG000|Overall Study|Lost to Follow-up|3|||
37975644|NCT00300274|69662934|FG001|Overall Study|Lost to Follow-up|4|||
37975645|NCT00300274|69662935|FG002|Overall Study|Lost to Follow-up|5|||
37975646|NCT00300274|69662933|FG000|Overall Study|Death|31|||
37975647|NCT00300274|69662934|FG001|Overall Study|Death|20|||
37975648|NCT00300274|69662935|FG002|Overall Study|Death|25|||
37797438|NCT02027844|69440274|FG001|Overall Study|Withdrawal by Subject|2|||
37693861|NCT02039505|69170138|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
37797439|NCT02027844|69440275|FG002|Overall Study|Withdrawal by Subject|1|||
37797440|NCT02027844|69440273|FG000|Overall Study|Lost to Follow-up|0|||
37864185|NCT01207440|69547814|FG000|Overall Study|Death|6|||
37864186|NCT01207440|69547815|FG001|Overall Study|Death|3|||
37864187|NCT01207440|69547816|FG002|Overall Study|Death|2|||
37864188|NCT01207440|69547817|FG003|Overall Study|Death|2|||
37864189|NCT01207440|69547818|FG004|Overall Study|Death|7|||
37864190|NCT01207440|69547819|FG005|Overall Study|Death|5|||
37864191|NCT01207440|69547820|FG006|Overall Study|Death|1|||
37864192|NCT01207440|69547814|FG000|Overall Study|Lack of Efficacy|13|||
37864193|NCT01207440|69547815|FG001|Overall Study|Lack of Efficacy|2|||
37864194|NCT01207440|69547816|FG002|Overall Study|Lack of Efficacy|5|||
37975649|NCT00300274|69662933|FG000|Overall Study|Re-transplant|0|||
37975650|NCT00300274|69662934|FG001|Overall Study|Re-transplant|0|||
37797441|NCT02027844|69440274|FG001|Overall Study|Lost to Follow-up|2|||
37797442|NCT02027844|69440275|FG002|Overall Study|Lost to Follow-up|1|||
37797443|NCT02027844|69440273|FG000|Overall Study|Protocol Violation|0|||
37797444|NCT02027844|69440274|FG001|Overall Study|Protocol Violation|2|||
37797445|NCT02027844|69440275|FG002|Overall Study|Protocol Violation|0|||
37797446|NCT02027844|69440273|FG000|Overall Study|Incomlete data|2|||
37797447|NCT02027844|69440274|FG001|Overall Study|Incomlete data|0|||
37797448|NCT02027844|69440275|FG002|Overall Study|Incomlete data|0|||
37797449|NCT01994382|69440300|FG000|Overall Study|Informed consent withdrawn|0|||
37797450|NCT01994382|69440301|FG001|Overall Study|Informed consent withdrawn|0|||
37797451|NCT01994382|69440302|FG002|Overall Study|Informed consent withdrawn|0|||
37797452|NCT01994382|69440303|FG003|Overall Study|Informed consent withdrawn|0|||
37797453|NCT01994382|69440304|FG004|Overall Study|Informed consent withdrawn|0|||
37797454|NCT01994382|69440305|FG005|Overall Study|Informed consent withdrawn|0|||
37797455|NCT01994382|69440306|FG006|Overall Study|Informed consent withdrawn|1|||
37797456|NCT01994382|69440307|FG007|Overall Study|Informed consent withdrawn|0|||
37797457|NCT01994382|69440308|FG008|Overall Study|Informed consent withdrawn|0|||
37797458|NCT01994382|69440309|FG009|Overall Study|Informed consent withdrawn|0|||
37797459|NCT01994382|69440310|FG010|Overall Study|Informed consent withdrawn|0|||
37797460|NCT01994382|69440311|FG011|Overall Study|Informed consent withdrawn|0|||
37797461|NCT01994382|69440312|FG012|Overall Study|Informed consent withdrawn|0|||
37797462|NCT01994382|69440313|FG013|Overall Study|Informed consent withdrawn|0|||
37797463|NCT01994382|69440314|FG014|Overall Study|Informed consent withdrawn|0|||
37797464|NCT01994382|69440315|FG015|Overall Study|Informed consent withdrawn|0|||
37797465|NCT01994382|69440316|FG016|Overall Study|Informed consent withdrawn|0|||
37797466|NCT01994382|69440300|FG000|Overall Study|Progressive disease|3|||
37797467|NCT01994382|69440301|FG001|Overall Study|Progressive disease|4|||
37797468|NCT01994382|69440302|FG002|Overall Study|Progressive disease|4|||
37797469|NCT01994382|69440303|FG003|Overall Study|Progressive disease|3|||
37797470|NCT01994382|69440304|FG004|Overall Study|Progressive disease|2|||
37797471|NCT01994382|69440305|FG005|Overall Study|Progressive disease|3|||
37797472|NCT01994382|69440306|FG006|Overall Study|Progressive disease|3|||
37797473|NCT01994382|69440307|FG007|Overall Study|Progressive disease|6|||
37797474|NCT01994382|69440308|FG008|Overall Study|Progressive disease|2|||
37797475|NCT01994382|69440309|FG009|Overall Study|Progressive disease|2|||
37797476|NCT01994382|69440310|FG010|Overall Study|Progressive disease|13|||
37797477|NCT01994382|69440311|FG011|Overall Study|Progressive disease|8|||
37797478|NCT01994382|69440312|FG012|Overall Study|Progressive disease|7|||
37797479|NCT01994382|69440313|FG013|Overall Study|Progressive disease|3|||
37797480|NCT01994382|69440314|FG014|Overall Study|Progressive disease|6|||
37797481|NCT01994382|69440315|FG015|Overall Study|Progressive disease|44|||
37797482|NCT01994382|69440316|FG016|Overall Study|Progressive disease|28|||
37797483|NCT01994382|69440300|FG000|Overall Study|Physician Decision|0|||
37797484|NCT01994382|69440301|FG001|Overall Study|Physician Decision|1|||
37797485|NCT01994382|69440302|FG002|Overall Study|Physician Decision|0|||
37797486|NCT01994382|69440303|FG003|Overall Study|Physician Decision|0|||
37797487|NCT01994382|69440304|FG004|Overall Study|Physician Decision|0|||
37797488|NCT01994382|69440305|FG005|Overall Study|Physician Decision|0|||
37797489|NCT01994382|69440306|FG006|Overall Study|Physician Decision|0|||
37797490|NCT01994382|69440307|FG007|Overall Study|Physician Decision|0|||
37797491|NCT01994382|69440308|FG008|Overall Study|Physician Decision|0|||
37797492|NCT01994382|69440309|FG009|Overall Study|Physician Decision|0|||
37797493|NCT01994382|69440310|FG010|Overall Study|Physician Decision|3|||
37797494|NCT01994382|69440311|FG011|Overall Study|Physician Decision|1|||
37797495|NCT01994382|69440312|FG012|Overall Study|Physician Decision|1|||
37797496|NCT01994382|69440313|FG013|Overall Study|Physician Decision|0|||
37797497|NCT01994382|69440314|FG014|Overall Study|Physician Decision|1|||
37797498|NCT01994382|69440315|FG015|Overall Study|Physician Decision|4|||
37797499|NCT01994382|69440316|FG016|Overall Study|Physician Decision|2|||
37797500|NCT01994382|69440300|FG000|Overall Study|Death|0|||
37797501|NCT01994382|69440301|FG001|Overall Study|Death|0|||
37797502|NCT01994382|69440302|FG002|Overall Study|Death|0|||
37797503|NCT01994382|69440303|FG003|Overall Study|Death|0|||
37797504|NCT01994382|69440304|FG004|Overall Study|Death|1|||
37797505|NCT01994382|69440305|FG005|Overall Study|Death|0|||
37797506|NCT01994382|69440306|FG006|Overall Study|Death|0|||
37797507|NCT01994382|69440307|FG007|Overall Study|Death|0|||
37797508|NCT01994382|69440308|FG008|Overall Study|Death|1|||
37797509|NCT01994382|69440309|FG009|Overall Study|Death|1|||
37797510|NCT01994382|69440310|FG010|Overall Study|Death|0|||
37797511|NCT01994382|69440311|FG011|Overall Study|Death|0|||
37797512|NCT01994382|69440312|FG012|Overall Study|Death|0|||
37797513|NCT01994382|69440313|FG013|Overall Study|Death|0|||
37797514|NCT01994382|69440314|FG014|Overall Study|Death|0|||
37797515|NCT01994382|69440315|FG015|Overall Study|Death|1|||
37797516|NCT01994382|69440316|FG016|Overall Study|Death|0|||
37797517|NCT01994382|69440300|FG000|Overall Study|Adverse Event|0|||
37797518|NCT01994382|69440301|FG001|Overall Study|Adverse Event|1|||
37797519|NCT01994382|69440302|FG002|Overall Study|Adverse Event|2|||
37797520|NCT01994382|69440303|FG003|Overall Study|Adverse Event|0|||
37797521|NCT01994382|69440304|FG004|Overall Study|Adverse Event|0|||
37797522|NCT01994382|69440305|FG005|Overall Study|Adverse Event|0|||
37797523|NCT01994382|69440306|FG006|Overall Study|Adverse Event|0|||
37797524|NCT01994382|69440307|FG007|Overall Study|Adverse Event|0|||
37797525|NCT01994382|69440308|FG008|Overall Study|Adverse Event|0|||
37797526|NCT01994382|69440309|FG009|Overall Study|Adverse Event|0|||
37797527|NCT01994382|69440310|FG010|Overall Study|Adverse Event|15|||
37797528|NCT01994382|69440311|FG011|Overall Study|Adverse Event|2|||
37797529|NCT01994382|69440312|FG012|Overall Study|Adverse Event|7|||
37797530|NCT01994382|69440313|FG013|Overall Study|Adverse Event|3|||
37797531|NCT01994382|69440314|FG014|Overall Study|Adverse Event|17|||
37797532|NCT01994382|69440315|FG015|Overall Study|Adverse Event|6|||
37797533|NCT01994382|69440316|FG016|Overall Study|Adverse Event|3|||
37797534|NCT01994382|69440300|FG000|Overall Study|Other than specified|0|||
37797535|NCT01994382|69440301|FG001|Overall Study|Other than specified|0|||
37797536|NCT01994382|69440302|FG002|Overall Study|Other than specified|0|||
37797537|NCT01994382|69440303|FG003|Overall Study|Other than specified|0|||
37797538|NCT01994382|69440304|FG004|Overall Study|Other than specified|0|||
37797539|NCT01994382|69440305|FG005|Overall Study|Other than specified|0|||
37797540|NCT01994382|69440306|FG006|Overall Study|Other than specified|0|||
37797541|NCT01994382|69440307|FG007|Overall Study|Other than specified|0|||
37797542|NCT01994382|69440308|FG008|Overall Study|Other than specified|0|||
37797543|NCT01994382|69440309|FG009|Overall Study|Other than specified|0|||
37797544|NCT01994382|69440310|FG010|Overall Study|Other than specified|2|||
37797545|NCT01994382|69440311|FG011|Overall Study|Other than specified|0|||
37797546|NCT01994382|69440312|FG012|Overall Study|Other than specified|2|||
37797547|NCT01994382|69440313|FG013|Overall Study|Other than specified|0|||
37797548|NCT01994382|69440314|FG014|Overall Study|Other than specified|0|||
37797549|NCT01994382|69440315|FG015|Overall Study|Other than specified|4|||
37797550|NCT01994382|69440316|FG016|Overall Study|Other than specified|4|||
37797551|NCT01994382|69440300|FG000|Overall Study|Withdrawal by Subject|0|||
37797552|NCT01994382|69440301|FG001|Overall Study|Withdrawal by Subject|0|||
37797553|NCT01994382|69440302|FG002|Overall Study|Withdrawal by Subject|0|||
37797554|NCT01994382|69440303|FG003|Overall Study|Withdrawal by Subject|0|||
37797555|NCT01994382|69440304|FG004|Overall Study|Withdrawal by Subject|0|||
37797556|NCT01994382|69440305|FG005|Overall Study|Withdrawal by Subject|0|||
37797557|NCT01994382|69440306|FG006|Overall Study|Withdrawal by Subject|0|||
37797558|NCT01994382|69440307|FG007|Overall Study|Withdrawal by Subject|0|||
37797559|NCT01994382|69440308|FG008|Overall Study|Withdrawal by Subject|0|||
37797560|NCT01994382|69440309|FG009|Overall Study|Withdrawal by Subject|0|||
37797561|NCT01994382|69440310|FG010|Overall Study|Withdrawal by Subject|6|||
37797562|NCT01994382|69440311|FG011|Overall Study|Withdrawal by Subject|0|||
37797563|NCT01994382|69440312|FG012|Overall Study|Withdrawal by Subject|2|||
37797564|NCT01994382|69440313|FG013|Overall Study|Withdrawal by Subject|0|||
37797565|NCT01994382|69440314|FG014|Overall Study|Withdrawal by Subject|4|||
37797566|NCT01994382|69440315|FG015|Overall Study|Withdrawal by Subject|3|||
37797567|NCT01994382|69440316|FG016|Overall Study|Withdrawal by Subject|0|||
37797568|NCT01994382|69440300|FG000|Overall Study|Lost to Follow-up|0|||
37797569|NCT01994382|69440301|FG001|Overall Study|Lost to Follow-up|0|||
37797570|NCT01994382|69440302|FG002|Overall Study|Lost to Follow-up|0|||
37797571|NCT01994382|69440303|FG003|Overall Study|Lost to Follow-up|0|||
37797572|NCT01994382|69440304|FG004|Overall Study|Lost to Follow-up|0|||
37797573|NCT01994382|69440305|FG005|Overall Study|Lost to Follow-up|0|||
37797574|NCT01994382|69440306|FG006|Overall Study|Lost to Follow-up|0|||
37797575|NCT01994382|69440307|FG007|Overall Study|Lost to Follow-up|0|||
37797576|NCT01994382|69440308|FG008|Overall Study|Lost to Follow-up|0|||
37797577|NCT01994382|69440309|FG009|Overall Study|Lost to Follow-up|0|||
37797578|NCT01994382|69440310|FG010|Overall Study|Lost to Follow-up|1|||
37797579|NCT01994382|69440311|FG011|Overall Study|Lost to Follow-up|0|||
37797580|NCT01994382|69440312|FG012|Overall Study|Lost to Follow-up|0|||
37797581|NCT01994382|69440313|FG013|Overall Study|Lost to Follow-up|0|||
37797582|NCT01994382|69440314|FG014|Overall Study|Lost to Follow-up|0|||
37797583|NCT01994382|69440315|FG015|Overall Study|Lost to Follow-up|0|||
37797584|NCT01994382|69440316|FG016|Overall Study|Lost to Follow-up|0|||
37797585|NCT01994382|69440300|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
37797586|NCT01994382|69440301|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
37797587|NCT01994382|69440302|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
37797588|NCT01994382|69440303|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
37797589|NCT01994382|69440304|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
37797590|NCT01994382|69440305|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
37797591|NCT01994382|69440306|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
37797592|NCT01994382|69440307|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
37797593|NCT01994382|69440308|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
37797594|NCT01994382|69440309|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
37797595|NCT01994382|69440310|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
37797596|NCT01994382|69440311|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
37797597|NCT01994382|69440312|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
37797598|NCT01994382|69440313|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
37797599|NCT01994382|69440314|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
37797600|NCT01994382|69440315|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
37797601|NCT01994382|69440316|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
37797602|NCT01994382|69440300|FG000|Overall Study|Protocol violation/noncompliance|0|||
37797603|NCT01994382|69440301|FG001|Overall Study|Protocol violation/noncompliance|0|||
37797604|NCT01994382|69440302|FG002|Overall Study|Protocol violation/noncompliance|0|||
37797605|NCT01994382|69440303|FG003|Overall Study|Protocol violation/noncompliance|0|||
37797606|NCT01994382|69440304|FG004|Overall Study|Protocol violation/noncompliance|0|||
37797607|NCT01994382|69440305|FG005|Overall Study|Protocol violation/noncompliance|0|||
37797608|NCT01994382|69440306|FG006|Overall Study|Protocol violation/noncompliance|0|||
37797609|NCT01994382|69440307|FG007|Overall Study|Protocol violation/noncompliance|0|||
37797610|NCT01994382|69440308|FG008|Overall Study|Protocol violation/noncompliance|0|||
37797611|NCT01994382|69440309|FG009|Overall Study|Protocol violation/noncompliance|0|||
37797612|NCT01994382|69440310|FG010|Overall Study|Protocol violation/noncompliance|0|||
37797613|NCT01994382|69440311|FG011|Overall Study|Protocol violation/noncompliance|1|||
37797614|NCT01994382|69440312|FG012|Overall Study|Protocol violation/noncompliance|0|||
37797615|NCT01994382|69440313|FG013|Overall Study|Protocol violation/noncompliance|0|||
37797616|NCT01994382|69440314|FG014|Overall Study|Protocol violation/noncompliance|0|||
37797617|NCT01994382|69440315|FG015|Overall Study|Protocol violation/noncompliance|0|||
37797618|NCT01994382|69440316|FG016|Overall Study|Protocol violation/noncompliance|2|||
37797619|NCT01994382|69440300|FG000|Overall Study|Rolled over to Phase 2a|0|||
37797620|NCT01994382|69440301|FG001|Overall Study|Rolled over to Phase 2a|0|||
37797621|NCT01994382|69440302|FG002|Overall Study|Rolled over to Phase 2a|1|||
37797622|NCT01994382|69440303|FG003|Overall Study|Rolled over to Phase 2a|0|||
37797623|NCT01994382|69440304|FG004|Overall Study|Rolled over to Phase 2a|0|||
37797624|NCT01994382|69440305|FG005|Overall Study|Rolled over to Phase 2a|0|||
37797625|NCT01994382|69440306|FG006|Overall Study|Rolled over to Phase 2a|0|||
37797626|NCT01994382|69440307|FG007|Overall Study|Rolled over to Phase 2a|0|||
37797627|NCT01994382|69440308|FG008|Overall Study|Rolled over to Phase 2a|0|||
37797628|NCT01994382|69440309|FG009|Overall Study|Rolled over to Phase 2a|2|||
37797629|NCT01994382|69440310|FG010|Overall Study|Rolled over to Phase 2a|0|||
37797630|NCT01994382|69440311|FG011|Overall Study|Rolled over to Phase 2a|0|||
37797631|NCT01994382|69440312|FG012|Overall Study|Rolled over to Phase 2a|0|||
37797632|NCT01994382|69440313|FG013|Overall Study|Rolled over to Phase 2a|0|||
37797633|NCT01994382|69440314|FG014|Overall Study|Rolled over to Phase 2a|0|||
37797634|NCT01994382|69440315|FG015|Overall Study|Rolled over to Phase 2a|0|||
37797635|NCT01994382|69440316|FG016|Overall Study|Rolled over to Phase 2a|0|||
37797636|NCT02003898|69440359|FG000|Overall Study|Death|3|||
37797637|NCT02003898|69440359|FG000|Overall Study|Lost to Follow-up|12|||
37797638|NCT02003898|69440359|FG000|Overall Study|Withdrawal by Subject|52|||
37797639|NCT01994226|69440365|FG000|Overall Study|Protocol Violation|13|||
37797640|NCT01994226|69440366|FG001|Overall Study|Protocol Violation|10|||
37797641|NCT01994226|69440365|FG000|Overall Study|Early Cessation of treatment|6|||
37797642|NCT01994226|69440366|FG001|Overall Study|Early Cessation of treatment|11|||
37797643|NCT02002884|69440375|FG000|Main Period (MP)|Other|0|||
37797644|NCT02002884|69440376|FG001|Main Period (MP)|Other|3|||
37797645|NCT02002884|69440377|FG002|Main Period (MP)|Other|3|||
37797646|NCT02002884|69440378|FG003|Main Period (MP)|Other|0|||
37797647|NCT02002884|69440375|FG000|Main Period (MP)|Adverse Event|0|||
37797648|NCT02002884|69440376|FG001|Main Period (MP)|Adverse Event|1|||
37797649|NCT02002884|69440377|FG002|Main Period (MP)|Adverse Event|1|||
37797650|NCT02002884|69440378|FG003|Main Period (MP)|Adverse Event|0|||
37797651|NCT02002884|69440375|FG000|Main Period (MP)|Withdrawal by Subject|6|||
37797652|NCT02002884|69440376|FG001|Main Period (MP)|Withdrawal by Subject|2|||
37797653|NCT02002884|69440377|FG002|Main Period (MP)|Withdrawal by Subject|2|||
37797654|NCT02002884|69440378|FG003|Main Period (MP)|Withdrawal by Subject|0|||
37797655|NCT02002884|69440375|FG000|Main Period (MP)|Lost to Follow-up|0|||
37797656|NCT02002884|69440376|FG001|Main Period (MP)|Lost to Follow-up|0|||
37797657|NCT02002884|69440377|FG002|Main Period (MP)|Lost to Follow-up|2|||
37797658|NCT02002884|69440378|FG003|Main Period (MP)|Lost to Follow-up|0|||
37797659|NCT02002884|69440375|FG000|Open-Label Extension Period (OLEX)|Other|0|||
37797660|NCT02002884|69440376|FG001|Open-Label Extension Period (OLEX)|Other|0|||
37797661|NCT02002884|69440377|FG002|Open-Label Extension Period (OLEX)|Other|0|||
37797662|NCT02002884|69440378|FG003|Open-Label Extension Period (OLEX)|Other|24|||
37797663|NCT02002884|69440375|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
37797664|NCT02002884|69440376|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
37797665|NCT02002884|69440377|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
37797666|NCT02002884|69440378|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
37797667|NCT02002884|69440375|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
37797668|NCT02002884|69440376|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
37797669|NCT02002884|69440377|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
37797670|NCT02002884|69440378|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
37797671|NCT02002884|69440375|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
37797672|NCT02002884|69440376|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
37797673|NCT02002884|69440377|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
37797674|NCT02002884|69440378|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
37797675|NCT02002884|69440375|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
37797676|NCT02002884|69440376|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
37797677|NCT02002884|69440377|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
37797678|NCT02002884|69440378|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
37797679|NCT02002182|69440390|FG000|Overall Study|Withdraw from study|3|||
37797680|NCT02002182|69440391|FG001|Overall Study|Withdraw from study|1|||
37797681|NCT02002182|69440390|FG000|Overall Study|Health Reasons|1|||
37797682|NCT02002182|69440391|FG001|Overall Study|Health Reasons|0|||
37797683|NCT02002182|69440390|FG000|Overall Study|Death|1|||
37797684|NCT02002182|69440391|FG001|Overall Study|Death|0|||
37797685|NCT01990950|69440397|FG000|Overall Study|Death|3|||
37797686|NCT01990950|69440397|FG000|Overall Study|Lost to Follow-up|2|||
37797687|NCT01990950|69440397|FG000|Overall Study|Withdrawal by Subject|6|||
37797688|NCT02001558|69440403|FG000|Overall Study|Lost to Follow-up|8|||
37797689|NCT02001558|69440404|FG001|Overall Study|Lost to Follow-up|14|||
37797690|NCT02023866|69440410|FG000|Overall Study|Non-compliance|2|||
37797691|NCT02023866|69440410|FG000|Overall Study|Adverse Event|3|||
37797692|NCT02023866|69440410|FG000|Overall Study|Withdrawal by Subject|1|||
37797693|NCT02023242|69440416|FG000|Overall Study|Lost to Follow-up|3|||
37797694|NCT02023242|69440417|FG001|Overall Study|Lost to Follow-up|1|||
37797695|NCT02023242|69440416|FG000|Overall Study|Death|0|||
37797696|NCT02023242|69440417|FG001|Overall Study|Death|1|||
37864195|NCT01207440|69547817|FG003|Overall Study|Lack of Efficacy|1|||
37864196|NCT01207440|69547818|FG004|Overall Study|Lack of Efficacy|2|||
37864197|NCT01207440|69547819|FG005|Overall Study|Lack of Efficacy|3|||
37797697|NCT01967940|69440426|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
37797698|NCT01967940|69440427|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
37797699|NCT01967940|69440428|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
37797700|NCT01967940|69440429|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
37797701|NCT01967940|69440426|FG000|Part 2|Adverse Event|0|||
37797702|NCT01967940|69440427|FG001|Part 2|Adverse Event|0|||
37797703|NCT01967940|69440428|FG002|Part 2|Adverse Event|0|||
37797704|NCT01967940|69440429|FG003|Part 2|Adverse Event|1|||
37797705|NCT01967940|69440426|FG000|Part 2|Unknown Reason|0|||
37797706|NCT01967940|69440427|FG001|Part 2|Unknown Reason|0|||
37797707|NCT01967940|69440428|FG002|Part 2|Unknown Reason|0|||
37864198|NCT01207440|69547820|FG006|Overall Study|Lack of Efficacy|0|||
37797708|NCT01967940|69440429|FG003|Part 2|Unknown Reason|1|||
37797709|NCT01990560|69440439|FG000|Overall Study|Withdrawal by Subject|1|||
37797710|NCT01998984|69440447|FG000|Overall Study|Adverse Event|0|||
37797711|NCT01998984|69440448|FG001|Overall Study|Adverse Event|0|||
37797712|NCT01998984|69440449|FG002|Overall Study|Adverse Event|0|||
37797713|NCT01998984|69440450|FG003|Overall Study|Adverse Event|1|||
37797714|NCT01998984|69440447|FG000|Overall Study|Lost to Follow-up|0|||
37797715|NCT01998984|69440448|FG001|Overall Study|Lost to Follow-up|1|||
37797716|NCT01998984|69440449|FG002|Overall Study|Lost to Follow-up|0|||
37797717|NCT01998984|69440450|FG003|Overall Study|Lost to Follow-up|1|||
37797718|NCT01998984|69440447|FG000|Overall Study|Withdrawal by Subject|0|||
37797719|NCT01998984|69440448|FG001|Overall Study|Withdrawal by Subject|0|||
37797720|NCT01998984|69440449|FG002|Overall Study|Withdrawal by Subject|1|||
37797721|NCT01998984|69440450|FG003|Overall Study|Withdrawal by Subject|0|||
37797722|NCT01998984|69440447|FG000|Overall Study|Other|0|||
37797723|NCT01998984|69440448|FG001|Overall Study|Other|0|||
37797724|NCT01998984|69440449|FG002|Overall Study|Other|0|||
37797725|NCT01998984|69440450|FG003|Overall Study|Other|1|||
37797726|NCT01967706|69440462|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
37797727|NCT01967706|69440463|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
37797728|NCT01967706|69440464|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
37797729|NCT01967706|69440465|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
37797730|NCT01967628|69440476|FG000|Overall Study|Withdrawal by Subject|2|||
37797731|NCT01967628|69440477|FG001|Overall Study|Withdrawal by Subject|0|||
37797732|NCT01967628|69440476|FG000|Overall Study|Unable to complete bronchoscopy|4|||
37797733|NCT01967628|69440477|FG001|Overall Study|Unable to complete bronchoscopy|6|||
37797734|NCT01967628|69440476|FG000|Overall Study|Lost to Follow-up|1|||
37797735|NCT01967628|69440477|FG001|Overall Study|Lost to Follow-up|0|||
37797736|NCT01967628|69440476|FG000|Overall Study|Low protein concentration in sample|20|||
37797737|NCT01967628|69440477|FG001|Overall Study|Low protein concentration in sample|25|||
37797738|NCT01998906|69440486|FG000|Overall Study|Participants ongoing in follow-up|77|||
37797739|NCT01998906|69440487|FG001|Overall Study|Participants ongoing in follow-up|60|||
37797740|NCT01998906|69440488|FG002|Overall Study|Participants ongoing in follow-up|58|||
37797741|NCT01998906|69440486|FG000|Overall Study|Death|21|||
37797742|NCT01998906|69440487|FG001|Overall Study|Death|30|||
37797743|NCT01998906|69440488|FG002|Overall Study|Death|17|||
37797744|NCT01998906|69440486|FG000|Overall Study|Lack of Efficacy|10|||
37797745|NCT01998906|69440487|FG001|Overall Study|Lack of Efficacy|9|||
37797746|NCT01998906|69440488|FG002|Overall Study|Lack of Efficacy|8|||
37797747|NCT01998906|69440486|FG000|Overall Study|Failure to return|0|||
37797748|NCT01998906|69440487|FG001|Overall Study|Failure to return|2|||
37797749|NCT01998906|69440488|FG002|Overall Study|Failure to return|4|||
37797750|NCT01998906|69440486|FG000|Overall Study|Violation of Selection Criteria|0|||
37864199|NCT01207440|69547814|FG000|Overall Study|Lost to Follow-up|0|||
37864200|NCT01207440|69547815|FG001|Overall Study|Lost to Follow-up|0|||
37864201|NCT01207440|69547816|FG002|Overall Study|Lost to Follow-up|2|||
37864202|NCT01207440|69547817|FG003|Overall Study|Lost to Follow-up|1|||
37864203|NCT01207440|69547818|FG004|Overall Study|Lost to Follow-up|0|||
37864204|NCT01207440|69547819|FG005|Overall Study|Lost to Follow-up|0|||
37864205|NCT01207440|69547820|FG006|Overall Study|Lost to Follow-up|0|||
37864206|NCT01207440|69547814|FG000|Overall Study|Non-compliance with Study Drug|3|||
37797751|NCT01998906|69440487|FG001|Overall Study|Violation of Selection Criteria|0|||
37797752|NCT01998906|69440488|FG002|Overall Study|Violation of Selection Criteria|1|||
37797753|NCT01998906|69440486|FG000|Overall Study|Withdrawal by Subject|1|||
37864207|NCT01207440|69547815|FG001|Overall Study|Non-compliance with Study Drug|0|||
37864208|NCT01207440|69547816|FG002|Overall Study|Non-compliance with Study Drug|1|||
37797754|NCT01998906|69440487|FG001|Overall Study|Withdrawal by Subject|4|||
37797755|NCT01998906|69440488|FG002|Overall Study|Withdrawal by Subject|3|||
37864209|NCT01207440|69547817|FG003|Overall Study|Non-compliance with Study Drug|0|||
37864210|NCT01207440|69547818|FG004|Overall Study|Non-compliance with Study Drug|0|||
37975651|NCT00300274|69662935|FG002|Overall Study|Re-transplant|1|||
37797756|NCT01998906|69440486|FG000|Overall Study|Administrative/Other|2|||
37797757|NCT01998906|69440487|FG001|Overall Study|Administrative/Other|1|||
37797758|NCT01998906|69440488|FG002|Overall Study|Administrative/Other|3|||
37797759|NCT01998906|69440486|FG000|Overall Study|Other|3|||
37797760|NCT01998906|69440487|FG001|Overall Study|Other|8|||
37797761|NCT01998906|69440488|FG002|Overall Study|Other|4|||
37864211|NCT01207440|69547819|FG005|Overall Study|Non-compliance with Study Drug|0|||
37864212|NCT01207440|69547820|FG006|Overall Study|Non-compliance with Study Drug|0|||
37864213|NCT01207440|69547814|FG000|Overall Study|Physician Decision|6|||
37864214|NCT01207440|69547815|FG001|Overall Study|Physician Decision|5|||
37864215|NCT01207440|69547816|FG002|Overall Study|Physician Decision|5|||
37864216|NCT01207440|69547817|FG003|Overall Study|Physician Decision|0|||
37864217|NCT01207440|69547818|FG004|Overall Study|Physician Decision|1|||
37864218|NCT01207440|69547819|FG005|Overall Study|Physician Decision|0|||
37864219|NCT01207440|69547820|FG006|Overall Study|Physician Decision|0|||
37864220|NCT01207440|69547814|FG000|Overall Study|Progressive Disease|19|||
37864221|NCT01207440|69547815|FG001|Overall Study|Progressive Disease|10|||
37864222|NCT01207440|69547816|FG002|Overall Study|Progressive Disease|19|||
37864223|NCT01207440|69547817|FG003|Overall Study|Progressive Disease|7|||
37864224|NCT01207440|69547818|FG004|Overall Study|Progressive Disease|23|||
37864225|NCT01207440|69547819|FG005|Overall Study|Progressive Disease|27|||
37864226|NCT01207440|69547820|FG006|Overall Study|Progressive Disease|0|||
37864227|NCT01207440|69547814|FG000|Overall Study|Protocol Violation|2|||
37975652|NCT00299728|69662945|FG000|Overall Study|Lost to Follow-up|0|||
37975653|NCT00299728|69662946|FG001|Overall Study|Lost to Follow-up|1|||
37693862|NCT02039505|69170139|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
37693863|NCT02039505|69170140|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
37693864|NCT02039505|69170141|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
37693865|NCT02039505|69170135|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
37693866|NCT02039505|69170136|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
37864228|NCT01207440|69547815|FG001|Overall Study|Protocol Violation|0|||
37864229|NCT01207440|69547816|FG002|Overall Study|Protocol Violation|0|||
37797762|NCT01967550|69440501|FG000|Overall Study|Withdrawal by Subject|1|||
37797763|NCT01967550|69440502|FG001|Overall Study|Withdrawal by Subject|0|||
37797764|NCT01967550|69440501|FG000|Overall Study|Adverse Event|2|||
37797765|NCT01967550|69440502|FG001|Overall Study|Adverse Event|0|||
37797766|NCT01967550|69440501|FG000|Overall Study|Protocol Violation|2|||
37797767|NCT01967550|69440502|FG001|Overall Study|Protocol Violation|1|||
37797768|NCT01967550|69440501|FG000|Overall Study|Non Compliance|0|||
37797769|NCT01967550|69440502|FG001|Overall Study|Non Compliance|1|||
37797770|NCT01989546|69440508|FG000|Overall Study|Clinical Progression|1|||
37797771|NCT01989546|69440508|FG000|Overall Study|Disease progression on study|8|||
37797772|NCT01997892|69440512|FG000|Overall Study|Physician Decision|2|||
37797773|NCT01997892|69440512|FG000|Overall Study|Lost to Follow-up|6|||
37797774|NCT01997892|69440512|FG000|Overall Study|Death|14|||
37797775|NCT01997892|69440512|FG000|Overall Study|Renal transplant|8|||
37797776|NCT01997892|69440512|FG000|Overall Study|Other|3|||
37797777|NCT01997892|69440512|FG000|Overall Study|Study completion data not recorded|35|||
37797778|NCT01989468|69440524|FG000|Overall Study|Adverse Event|10|||
37797779|NCT01989468|69440525|FG001|Overall Study|Adverse Event|15|||
37797780|NCT01989468|69440526|FG002|Overall Study|Adverse Event|4|||
37797781|NCT01989468|69440527|FG003|Overall Study|Adverse Event|5|||
37797782|NCT01989468|69440528|FG004|Overall Study|Adverse Event|4|||
37797783|NCT01989468|69440524|FG000|Overall Study|Lack of Efficacy|11|||
37797784|NCT01989468|69440525|FG001|Overall Study|Lack of Efficacy|11|||
37797785|NCT01989468|69440526|FG002|Overall Study|Lack of Efficacy|7|||
37797786|NCT01989468|69440527|FG003|Overall Study|Lack of Efficacy|4|||
37797787|NCT01989468|69440528|FG004|Overall Study|Lack of Efficacy|2|||
37797788|NCT01989468|69440524|FG000|Overall Study|Lost to Follow-up|5|||
37797789|NCT01989468|69440525|FG001|Overall Study|Lost to Follow-up|2|||
37797790|NCT01989468|69440526|FG002|Overall Study|Lost to Follow-up|0|||
37797791|NCT01989468|69440527|FG003|Overall Study|Lost to Follow-up|1|||
37797792|NCT01989468|69440528|FG004|Overall Study|Lost to Follow-up|1|||
37797793|NCT01989468|69440524|FG000|Overall Study|Physician Decision|4|||
37797794|NCT01989468|69440525|FG001|Overall Study|Physician Decision|1|||
37797795|NCT01989468|69440526|FG002|Overall Study|Physician Decision|0|||
37797796|NCT01989468|69440527|FG003|Overall Study|Physician Decision|1|||
37797797|NCT01989468|69440528|FG004|Overall Study|Physician Decision|0|||
37797798|NCT01989468|69440524|FG000|Overall Study|Pregnancy|0|||
37797799|NCT01989468|69440525|FG001|Overall Study|Pregnancy|1|||
37797800|NCT01989468|69440526|FG002|Overall Study|Pregnancy|0|||
37797801|NCT01989468|69440527|FG003|Overall Study|Pregnancy|0|||
37797802|NCT01989468|69440528|FG004|Overall Study|Pregnancy|0|||
37797803|NCT01989468|69440524|FG000|Overall Study|Technical Problems|3|||
37797804|NCT01989468|69440525|FG001|Overall Study|Technical Problems|1|||
37797805|NCT01989468|69440526|FG002|Overall Study|Technical Problems|3|||
37797806|NCT01989468|69440527|FG003|Overall Study|Technical Problems|1|||
37797807|NCT01989468|69440528|FG004|Overall Study|Technical Problems|0|||
37797808|NCT01989468|69440524|FG000|Overall Study|Subject Guardian Decision|11|||
37797809|NCT01989468|69440525|FG001|Overall Study|Subject Guardian Decision|6|||
37797810|NCT01989468|69440526|FG002|Overall Study|Subject Guardian Decision|4|||
37797811|NCT01989468|69440527|FG003|Overall Study|Subject Guardian Decision|4|||
37797812|NCT01989468|69440528|FG004|Overall Study|Subject Guardian Decision|1|||
37797813|NCT01989468|69440524|FG000|Overall Study|Death|3|||
37797814|NCT01989468|69440525|FG001|Overall Study|Death|0|||
37797815|NCT01989468|69440526|FG002|Overall Study|Death|1|||
37797816|NCT01989468|69440527|FG003|Overall Study|Death|0|||
37797817|NCT01989468|69440528|FG004|Overall Study|Death|0|||
37797818|NCT01989156|69440544|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
37797819|NCT01989156|69440545|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
37797820|NCT01989156|69440546|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
37797821|NCT01989156|69440544|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
37797822|NCT01989156|69440545|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
37797823|NCT01989156|69440546|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
37797824|NCT01989156|69440544|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
37797825|NCT01989156|69440545|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
37797826|NCT01989156|69440546|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
37797827|NCT01989156|69440544|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
37797828|NCT01989156|69440545|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
37797829|NCT01989156|69440546|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
37797830|NCT01989156|69440544|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
37797831|NCT01989156|69440545|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
37797832|NCT01989156|69440546|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
37797833|NCT01989156|69440544|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
37797834|NCT01989156|69440545|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
37797835|NCT01989156|69440546|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
37797836|NCT01989156|69440544|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
37797837|NCT01989156|69440545|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
37797838|NCT01989156|69440546|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
37797839|NCT01989156|69440544|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
37797840|NCT01989156|69440545|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
37864230|NCT01207440|69547817|FG003|Overall Study|Protocol Violation|0|||
37797841|NCT01989156|69440546|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
37797842|NCT01620762|69440557|FG000|Overall Study|Protocol Violation|1|||
37797843|NCT01620762|69440558|FG001|Overall Study|Protocol Violation|1|||
37797844|NCT01620762|69440559|FG002|Overall Study|Protocol Violation|1|||
37797845|NCT01620762|69440557|FG000|Overall Study|Adverse Event|9|||
37797846|NCT01620762|69440558|FG001|Overall Study|Adverse Event|5|||
37797847|NCT01620762|69440559|FG002|Overall Study|Adverse Event|2|||
37797848|NCT01620762|69440557|FG000|Overall Study|Withdrawal by Subject|23|||
37797849|NCT01620762|69440558|FG001|Overall Study|Withdrawal by Subject|26|||
37797850|NCT01620762|69440559|FG002|Overall Study|Withdrawal by Subject|27|||
37797851|NCT01620762|69440557|FG000|Overall Study|Lost to Follow-up|11|||
37797852|NCT01620762|69440558|FG001|Overall Study|Lost to Follow-up|17|||
37797853|NCT01620762|69440559|FG002|Overall Study|Lost to Follow-up|10|||
37797854|NCT01620762|69440557|FG000|Overall Study|Protocol deviation|1|||
37797855|NCT01620762|69440558|FG001|Overall Study|Protocol deviation|1|||
37797856|NCT01620762|69440559|FG002|Overall Study|Protocol deviation|6|||
37797857|NCT01620762|69440557|FG000|Overall Study|Subject deterioration|0|||
37797858|NCT01620762|69440558|FG001|Overall Study|Subject deterioration|1|||
37797859|NCT01620762|69440559|FG002|Overall Study|Subject deterioration|1|||
37797860|NCT01620762|69440557|FG000|Overall Study|Non-specified|3|||
37797861|NCT01620762|69440558|FG001|Overall Study|Non-specified|6|||
37797862|NCT01620762|69440559|FG002|Overall Study|Non-specified|5|||
37797863|NCT01620762|69440557|FG000|Overall Study|Use of prohibted therapies|0|||
37797864|NCT01620762|69440558|FG001|Overall Study|Use of prohibted therapies|1|||
37797865|NCT01620762|69440559|FG002|Overall Study|Use of prohibted therapies|1|||
37797866|NCT01966068|69440569|FG000|Overall Study|Withdrawal by Subject|57|||
37797867|NCT01966068|69440569|FG000|Overall Study|Lost to Follow-up|81|||
37797868|NCT01620528|69440577|FG000|Treatment Period|Did Not Receive Study Drug|0|||
37797869|NCT01620528|69440578|FG001|Treatment Period|Did Not Receive Study Drug|0|||
37797870|NCT01620528|69440579|FG002|Treatment Period|Did Not Receive Study Drug|1|||
37797871|NCT01620528|69440577|FG000|Treatment Period|Withdrawal by Subject|35|||
37797872|NCT01620528|69440578|FG001|Treatment Period|Withdrawal by Subject|21|||
37797873|NCT01620528|69440579|FG002|Treatment Period|Withdrawal by Subject|16|||
37797874|NCT01620528|69440577|FG000|Treatment Period|Adverse Event|17|||
37797875|NCT01620528|69440578|FG001|Treatment Period|Adverse Event|13|||
37797876|NCT01620528|69440579|FG002|Treatment Period|Adverse Event|21|||
37797877|NCT01620528|69440577|FG000|Treatment Period|Lost to Follow-up|16|||
37797878|NCT01620528|69440578|FG001|Treatment Period|Lost to Follow-up|8|||
37797879|NCT01620528|69440579|FG002|Treatment Period|Lost to Follow-up|14|||
37797880|NCT01620528|69440577|FG000|Treatment Period|Other|9|||
37797881|NCT01620528|69440578|FG001|Treatment Period|Other|5|||
37797882|NCT01620528|69440579|FG002|Treatment Period|Other|7|||
37797883|NCT01620528|69440577|FG000|Treatment Period|Subject Noncompliant|11|||
37797884|NCT01620528|69440578|FG001|Treatment Period|Subject Noncompliant|2|||
37797885|NCT01620528|69440579|FG002|Treatment Period|Subject Noncompliant|2|||
37797886|NCT01620528|69440577|FG000|Treatment Period|Pregnancy|7|||
37797887|NCT01620528|69440578|FG001|Treatment Period|Pregnancy|2|||
37797888|NCT01620528|69440579|FG002|Treatment Period|Pregnancy|2|||
37797889|NCT01620528|69440577|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
37797890|NCT01620528|69440578|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
37797891|NCT01620528|69440579|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
37797892|NCT01620528|69440577|FG000|Treatment Period|Exclusionary Medication Received|0|||
37797893|NCT01620528|69440578|FG001|Treatment Period|Exclusionary Medication Received|1|||
37797894|NCT01620528|69440579|FG002|Treatment Period|Exclusionary Medication Received|0|||
37797895|NCT01620528|69440577|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
37797896|NCT01620528|69440578|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
37797897|NCT01620528|69440579|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
37797898|NCT01620528|69440577|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
37797899|NCT01620528|69440578|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
37797900|NCT01620528|69440579|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
37797901|NCT01620528|69440577|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
37797902|NCT01620528|69440578|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
37797903|NCT01620528|69440579|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
37797904|NCT01620528|69440577|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
37797905|NCT01620528|69440578|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
37797906|NCT01620528|69440579|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
37797907|NCT01620528|69440577|FG000|Post-Treatment Follow-Up Period|Other|6|||
37797908|NCT01620528|69440578|FG001|Post-Treatment Follow-Up Period|Other|4|||
37797909|NCT01620528|69440579|FG002|Post-Treatment Follow-Up Period|Other|2|||
37797910|NCT01965834|69440587|FG000|Overall Study|Lack of Efficacy|4|||
37797911|NCT01965600|69440591|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
37797912|NCT01965600|69440592|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
37797913|NCT01965600|69440593|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
37797914|NCT01965600|69440594|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
37797915|NCT01965600|69440591|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
37797916|NCT01965600|69440592|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
37797917|NCT01965600|69440593|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
37975654|NCT00299728|69662945|FG000|Overall Study|Withdrawal by Subject|0|||
37975655|NCT00299728|69662946|FG001|Overall Study|Withdrawal by Subject|1|||
37975656|NCT00299728|69662945|FG000|Overall Study|Progressive disease|0|||
37975657|NCT00299728|69662946|FG001|Overall Study|Progressive disease|1|||
37975658|NCT00396591|69662952|FG000|Overall Study|Disease Progression|13|||
37975659|NCT00396591|69662952|FG000|Overall Study|Adverse Event|2|||
37975660|NCT00396591|69662952|FG000|Overall Study|Participant request|1|||
37797918|NCT01965600|69440594|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
37975661|NCT00316264|69662959|FG000|Overall Study|Lost to Follow-up|0|||
37975662|NCT00316264|69662960|FG001|Overall Study|Lost to Follow-up|1|||
37975663|NCT00316264|69662961|FG002|Overall Study|Lost to Follow-up|0|||
37797919|NCT01965600|69440591|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
37797920|NCT01965600|69440592|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
37975664|NCT00316264|69662959|FG000|Overall Study|Withdrawal of Consent|3|||
37975665|NCT00316264|69662960|FG001|Overall Study|Withdrawal of Consent|5|||
37797921|NCT01965600|69440593|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
37797922|NCT01965600|69440594|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
37797923|NCT01965600|69440591|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
37797924|NCT01965600|69440592|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
37797925|NCT01965600|69440593|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
37797926|NCT01965600|69440594|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
37797927|NCT01965600|69440591|FG000|Second Intervention|Study terminated by Sponsor|0|||
37797928|NCT01965600|69440592|FG001|Second Intervention|Study terminated by Sponsor|0|||
37797929|NCT01965600|69440593|FG002|Second Intervention|Study terminated by Sponsor|2|||
37797930|NCT01965600|69440594|FG003|Second Intervention|Study terminated by Sponsor|2|||
37797931|NCT01996332|69440602|FG000|Overall Study|Adverse Event|117|||
37797932|NCT01996332|69440602|FG000|Overall Study|Lack of Efficacy|1245|||
37797933|NCT01996332|69440602|FG000|Overall Study|Death|264|||
37797934|NCT01996332|69440602|FG000|Overall Study|Protocol Violation|9|||
37797935|NCT01996332|69440602|FG000|Overall Study|Withdrawal by Subject|71|||
37797936|NCT01996332|69440602|FG000|Overall Study|Other|20|||
37797937|NCT01996332|69440602|FG000|Overall Study|Clinical Deterioration|28|||
37797938|NCT01996332|69440602|FG000|Overall Study|Physician Decision|17|||
37797939|NCT01996332|69440602|FG000|Overall Study|Lost to Follow-up|34|||
37797940|NCT01996254|69440608|FG000|Overall Study|Change in Eligibility|0|||
37797941|NCT01996254|69440609|FG001|Overall Study|Change in Eligibility|2|||
37797942|NCT01996254|69440610|FG002|Overall Study|Change in Eligibility|0|||
37797943|NCT01996254|69440608|FG000|Overall Study|Withdrawal by Subject|0|||
37797944|NCT01996254|69440609|FG001|Overall Study|Withdrawal by Subject|3|||
37797945|NCT01996254|69440610|FG002|Overall Study|Withdrawal by Subject|4|||
37797946|NCT01996254|69440608|FG000|Overall Study|Lost to Follow-up|1|||
37797947|NCT01996254|69440609|FG001|Overall Study|Lost to Follow-up|0|||
37797948|NCT01996254|69440610|FG002|Overall Study|Lost to Follow-up|4|||
37797949|NCT01987986|69440624|FG000|Overall Study|Lost to Follow-up|1|||
37797950|NCT01987986|69440625|FG001|Overall Study|Lost to Follow-up|0|||
37797951|NCT01987986|69440626|FG002|Overall Study|Lost to Follow-up|0|||
37797952|NCT01987986|69440627|FG003|Overall Study|Lost to Follow-up|0|||
37797953|NCT01987986|69440624|FG000|Overall Study|Adverse Event|1|||
37797954|NCT01987986|69440625|FG001|Overall Study|Adverse Event|0|||
37797955|NCT01987986|69440626|FG002|Overall Study|Adverse Event|2|||
37797956|NCT01987986|69440627|FG003|Overall Study|Adverse Event|0|||
37797957|NCT01987908|69440637|FG000|Placebo Lead-in Period|Adverse Event|2|||
37797958|NCT01987908|69440638|FG001|Placebo Lead-in Period|Adverse Event|0|||
37797959|NCT01987908|69440639|FG002|Placebo Lead-in Period|Adverse Event|0|||
37797960|NCT01987908|69440637|FG000|Placebo Lead-in Period|Physician Decision|2|||
37797961|NCT01987908|69440638|FG001|Placebo Lead-in Period|Physician Decision|0|||
37797962|NCT01987908|69440639|FG002|Placebo Lead-in Period|Physician Decision|0|||
37797963|NCT01987908|69440637|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
37797964|NCT01987908|69440638|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
37797965|NCT01987908|69440639|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
37797966|NCT01987908|69440637|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
37797967|NCT01987908|69440638|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
37797968|NCT01987908|69440639|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
37797969|NCT01987908|69440637|FG000|Treatment Period|Adverse Event|0|||
37797970|NCT01987908|69440638|FG001|Treatment Period|Adverse Event|1|||
37797971|NCT01987908|69440639|FG002|Treatment Period|Adverse Event|1|||
37797972|NCT01987908|69440637|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
37797973|NCT01987908|69440638|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
37797974|NCT01987908|69440639|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
37797975|NCT01987908|69440637|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
37797976|NCT01987908|69440638|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
37797977|NCT01987908|69440639|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
37797978|NCT01995552|69440663|FG000|Overall Study|Protocol Violation|1|||
37797979|NCT01995552|69440663|FG000|Overall Study|Lack of Efficacy|15|||
37797980|NCT01995552|69440663|FG000|Overall Study|Death|1|||
37797981|NCT01987830|69440669|FG000|Overall Study|Never received baseline scan|1|||
37797982|NCT01987596|69440675|FG000|Overall Study|Physician Decision|1|||
37797983|NCT01987596|69440676|FG001|Overall Study|Physician Decision|0|||
37797984|NCT01987596|69440675|FG000|Overall Study|Progressive Disease; missing all period|0|||
37797985|NCT01987596|69440676|FG001|Overall Study|Progressive Disease; missing all period|1|||
37797986|NCT01964976|69440690|FG000|Overall Study|Protocol Violation|31|||
37797987|NCT01964898|69440699|FG000|Overall Study|ineligible post-randomization|1|||
37797988|NCT01964898|69440700|FG001|Overall Study|ineligible post-randomization|1|||
37797989|NCT01964898|69440699|FG000|Overall Study|did not receive the allocated interventi|2|||
37797990|NCT01964898|69440700|FG001|Overall Study|did not receive the allocated interventi|1|||
37797991|NCT01964898|69440699|FG000|Overall Study|Lost to Follow-up|3|||
37797992|NCT01964898|69440700|FG001|Overall Study|Lost to Follow-up|5|||
37797993|NCT01964898|69440699|FG000|Overall Study|Withdrawal by Subject|1|||
37797994|NCT01964898|69440700|FG001|Overall Study|Withdrawal by Subject|0|||
37797995|NCT01964352|69440710|FG000|Overall Study|Adverse Event|13|||
37797996|NCT01964352|69440711|FG001|Overall Study|Adverse Event|3|||
37797997|NCT01964352|69440712|FG002|Overall Study|Adverse Event|4|||
37797998|NCT01964352|69440713|FG003|Overall Study|Adverse Event|3|||
37797999|NCT01964352|69440710|FG000|Overall Study|Lack of Efficacy|6|||
37798000|NCT01964352|69440711|FG001|Overall Study|Lack of Efficacy|0|||
37798001|NCT01964352|69440712|FG002|Overall Study|Lack of Efficacy|0|||
37798002|NCT01964352|69440713|FG003|Overall Study|Lack of Efficacy|0|||
37798003|NCT01964352|69440710|FG000|Overall Study|Protocol Violation|2|||
37798004|NCT01964352|69440711|FG001|Overall Study|Protocol Violation|4|||
37798005|NCT01964352|69440712|FG002|Overall Study|Protocol Violation|0|||
37798006|NCT01964352|69440713|FG003|Overall Study|Protocol Violation|2|||
37798007|NCT01964352|69440710|FG000|Overall Study|Lost to Follow-up|1|||
37798008|NCT01964352|69440711|FG001|Overall Study|Lost to Follow-up|0|||
37798009|NCT01964352|69440712|FG002|Overall Study|Lost to Follow-up|0|||
37798010|NCT01964352|69440713|FG003|Overall Study|Lost to Follow-up|1|||
37798011|NCT01964352|69440710|FG000|Overall Study|Withdrawal by Subject|4|||
37798012|NCT01964352|69440711|FG001|Overall Study|Withdrawal by Subject|2|||
37798013|NCT01964352|69440712|FG002|Overall Study|Withdrawal by Subject|1|||
37798014|NCT01964352|69440713|FG003|Overall Study|Withdrawal by Subject|0|||
37798015|NCT01964352|69440710|FG000|Overall Study|Other than stated above|0|||
37798016|NCT01964352|69440711|FG001|Overall Study|Other than stated above|2|||
37798017|NCT01964352|69440712|FG002|Overall Study|Other than stated above|1|||
37798018|NCT01964352|69440713|FG003|Overall Study|Other than stated above|2|||
37798019|NCT01946412|69440723|FG000|Overall Study|Adverse Event|1|||
37798020|NCT01946412|69440723|FG000|Overall Study|Non-Compliance|1|||
37798021|NCT01946412|69440723|FG000|Overall Study|Continued with commercial Kalydeco|2|||
37798022|NCT01946412|69440723|FG000|Overall Study|Difficulty in swallowing|1|||
37798023|NCT01946178|69440729|FG000|Overall Study|Pregnancy|1|||
37798024|NCT01946178|69440729|FG000|Overall Study|Lost to Follow-up|1|||
37798025|NCT01945944|69440739|FG000|Overall Study|Adverse Event|0|||
37798026|NCT01945944|69440740|FG001|Overall Study|Adverse Event|2|||
37798027|NCT01945944|69440739|FG000|Overall Study|Physician Decision|1|||
37798028|NCT01945944|69440740|FG001|Overall Study|Physician Decision|0|||
37798029|NCT01945944|69440739|FG000|Overall Study|Withdrawal by Subject|0|||
37798030|NCT01945944|69440740|FG001|Overall Study|Withdrawal by Subject|1|||
37798031|NCT01945866|69440750|FG000|Overall Study|Eyes did not complete or were dropped|2|||
37798032|NCT01945866|69440751|FG001|Overall Study|Eyes did not complete or were dropped|0|||
37798033|NCT01986114|69440758|FG000|Overall Study|Adverse Event|59|||
37798034|NCT01986114|69440758|FG000|Overall Study|Lack of Efficacy|23|||
37798035|NCT01986114|69440758|FG000|Overall Study|Withdrawal by Subject|58|||
37798036|NCT01986114|69440758|FG000|Overall Study|Noncompliance|3|||
37798037|NCT01986114|69440758|FG000|Overall Study|Protocol Violation|1|||
37798038|NCT01986114|69440758|FG000|Overall Study|Lost to Follow-up|5|||
37798039|NCT01986114|69440758|FG000|Overall Study|Other reason|7|||
37798040|NCT01945710|69440771|FG000|Overall Study|Progressive Disease|5|||
37798041|NCT01945710|69440772|FG001|Overall Study|Progressive Disease|4|||
37798042|NCT01945710|69440773|FG002|Overall Study|Progressive Disease|3|||
37798043|NCT01945710|69440774|FG003|Overall Study|Progressive Disease|2|||
37798044|NCT01945710|69440775|FG004|Overall Study|Progressive Disease|7|||
37798045|NCT01945710|69440776|FG005|Overall Study|Progressive Disease|3|||
37798046|NCT01945710|69440777|FG006|Overall Study|Progressive Disease|19|||
37798047|NCT01945710|69440771|FG000|Overall Study|Adverse Event|0|||
37798048|NCT01945710|69440772|FG001|Overall Study|Adverse Event|1|||
37798049|NCT01945710|69440773|FG002|Overall Study|Adverse Event|0|||
37798050|NCT01945710|69440774|FG003|Overall Study|Adverse Event|0|||
37798051|NCT01945710|69440775|FG004|Overall Study|Adverse Event|0|||
37798052|NCT01945710|69440776|FG005|Overall Study|Adverse Event|0|||
37798053|NCT01945710|69440777|FG006|Overall Study|Adverse Event|0|||
37798054|NCT01945710|69440771|FG000|Overall Study|Other|2|||
37798055|NCT01945710|69440772|FG001|Overall Study|Other|0|||
37798056|NCT01945710|69440773|FG002|Overall Study|Other|3|||
37798057|NCT01945710|69440774|FG003|Overall Study|Other|1|||
37975666|NCT00316264|69662961|FG002|Overall Study|Withdrawal of Consent|6|||
37798058|NCT01945710|69440775|FG004|Overall Study|Other|1|||
37798059|NCT01945710|69440776|FG005|Overall Study|Other|0|||
37798060|NCT01945710|69440777|FG006|Overall Study|Other|4|||
37798061|NCT01945710|69440771|FG000|Overall Study|Withdrawal by Subject|0|||
37798062|NCT01945710|69440772|FG001|Overall Study|Withdrawal by Subject|1|||
37798063|NCT01945710|69440773|FG002|Overall Study|Withdrawal by Subject|1|||
37798064|NCT01945710|69440774|FG003|Overall Study|Withdrawal by Subject|0|||
37798065|NCT01945710|69440775|FG004|Overall Study|Withdrawal by Subject|1|||
37798066|NCT01945710|69440776|FG005|Overall Study|Withdrawal by Subject|0|||
37798067|NCT01945710|69440777|FG006|Overall Study|Withdrawal by Subject|0|||
37798068|NCT01945242|69440797|FG000|Overall Study|Physician Decision|3|||
37798069|NCT01945242|69440798|FG001|Overall Study|Physician Decision|3|||
37798070|NCT01945086|69440808|FG000|Overall Study|Withdrawal by Subject|1|||
37798071|NCT01945086|69440809|FG001|Overall Study|Withdrawal by Subject|0|||
37798072|NCT01945086|69440810|FG002|Overall Study|Withdrawal by Subject|1|||
37798073|NCT01945086|69440808|FG000|Overall Study|Adverse Event|0|||
37798074|NCT01945086|69440809|FG001|Overall Study|Adverse Event|0|||
37798075|NCT01945086|69440810|FG002|Overall Study|Adverse Event|1|||
37798076|NCT01963728|69440820|FG000|Overall Study|Study terminated early|0|||
37798077|NCT01963728|69440821|FG001|Overall Study|Study terminated early|1|||
37798078|NCT01963260|69440837|FG000|Overall Study|Withdrawal by Subject|2|||
37798079|NCT01963260|69440838|FG001|Overall Study|Withdrawal by Subject|0|||
37798080|NCT01963260|69440839|FG002|Overall Study|Withdrawal by Subject|0|||
37798081|NCT01963260|69440840|FG003|Overall Study|Withdrawal by Subject|1|||
37798082|NCT01963260|69440841|FG004|Overall Study|Withdrawal by Subject|2|||
37798083|NCT01963260|69440842|FG005|Overall Study|Withdrawal by Subject|0|||
37798084|NCT01963260|69440843|FG006|Overall Study|Withdrawal by Subject|0|||
37798085|NCT01963260|69440844|FG007|Overall Study|Withdrawal by Subject|0|||
37798086|NCT01963260|69440845|FG008|Overall Study|Withdrawal by Subject|0|||
37798087|NCT01963260|69440846|FG009|Overall Study|Withdrawal by Subject|0|||
37798088|NCT01962948|69440879|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
37798089|NCT01962948|69440880|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
37798090|NCT01962948|69440881|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
37798091|NCT01962948|69440882|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
37798092|NCT01985334|69440897|FG000|Overall Study|Administrative problems|1|||
37798093|NCT01985334|69440898|FG001|Overall Study|Administrative problems|1|||
37798094|NCT01985334|69440899|FG002|Overall Study|Administrative problems|0|||
37798095|NCT01985334|69440900|FG003|Overall Study|Administrative problems|2|||
37798096|NCT01985334|69440901|FG004|Overall Study|Administrative problems|0|||
37798097|NCT01985334|69440902|FG005|Overall Study|Administrative problems|1|||
37798098|NCT01985334|69440903|FG006|Overall Study|Administrative problems|1|||
37798099|NCT01985334|69440904|FG007|Overall Study|Administrative problems|3|||
37798100|NCT01985334|69440897|FG000|Overall Study|Death|1|||
37798101|NCT01985334|69440898|FG001|Overall Study|Death|0|||
37798102|NCT01985334|69440899|FG002|Overall Study|Death|0|||
37798103|NCT01985334|69440900|FG003|Overall Study|Death|3|||
37798104|NCT01985334|69440901|FG004|Overall Study|Death|0|||
37798105|NCT01985334|69440902|FG005|Overall Study|Death|0|||
37798106|NCT01985334|69440903|FG006|Overall Study|Death|1|||
37798107|NCT01985334|69440904|FG007|Overall Study|Death|2|||
37798108|NCT01985334|69440897|FG000|Overall Study|Worsening of disease|0|||
37798109|NCT01985334|69440898|FG001|Overall Study|Worsening of disease|0|||
37798110|NCT01985334|69440899|FG002|Overall Study|Worsening of disease|0|||
37798111|NCT01985334|69440900|FG003|Overall Study|Worsening of disease|1|||
37798112|NCT01985334|69440901|FG004|Overall Study|Worsening of disease|0|||
37798113|NCT01985334|69440902|FG005|Overall Study|Worsening of disease|3|||
37798114|NCT01985334|69440903|FG006|Overall Study|Worsening of disease|0|||
37798115|NCT01985334|69440904|FG007|Overall Study|Worsening of disease|1|||
37798116|NCT01985334|69440897|FG000|Overall Study|Other|2|||
37798117|NCT01985334|69440898|FG001|Overall Study|Other|9|||
37798118|NCT01985334|69440899|FG002|Overall Study|Other|7|||
37798119|NCT01985334|69440900|FG003|Overall Study|Other|17|||
37798120|NCT01985334|69440901|FG004|Overall Study|Other|4|||
37798121|NCT01985334|69440902|FG005|Overall Study|Other|8|||
37798122|NCT01985334|69440903|FG006|Overall Study|Other|4|||
37798123|NCT01985334|69440904|FG007|Overall Study|Other|7|||
37798124|NCT01985334|69440897|FG000|Overall Study|Protocol deviation|6|||
37798125|NCT01985334|69440898|FG001|Overall Study|Protocol deviation|31|||
37798126|NCT01985334|69440899|FG002|Overall Study|Protocol deviation|25|||
37798127|NCT01985334|69440900|FG003|Overall Study|Protocol deviation|84|||
37798128|NCT01985334|69440901|FG004|Overall Study|Protocol deviation|17|||
37798129|NCT01985334|69440902|FG005|Overall Study|Protocol deviation|47|||
37798130|NCT01985334|69440903|FG006|Overall Study|Protocol deviation|15|||
37798131|NCT01985334|69440904|FG007|Overall Study|Protocol deviation|42|||
37798132|NCT01985334|69440897|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
37798133|NCT01985334|69440898|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
37798134|NCT01985334|69440899|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
37798135|NCT01985334|69440900|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
37798136|NCT01985334|69440901|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
37798137|NCT01985334|69440902|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
37798138|NCT01985334|69440903|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
37798139|NCT01985334|69440904|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
37798140|NCT01985334|69440897|FG000|Overall Study|Subject withdrawal of consent|3|||
37798141|NCT01985334|69440898|FG001|Overall Study|Subject withdrawal of consent|6|||
37798142|NCT01985334|69440899|FG002|Overall Study|Subject withdrawal of consent|2|||
37798143|NCT01985334|69440900|FG003|Overall Study|Subject withdrawal of consent|28|||
37798144|NCT01985334|69440901|FG004|Overall Study|Subject withdrawal of consent|4|||
37798145|NCT01985334|69440902|FG005|Overall Study|Subject withdrawal of consent|19|||
37798146|NCT01985334|69440903|FG006|Overall Study|Subject withdrawal of consent|0|||
37798147|NCT01985334|69440904|FG007|Overall Study|Subject withdrawal of consent|20|||
37798148|NCT01985334|69440897|FG000|Overall Study|Adverse Event|0|||
37798149|NCT01985334|69440898|FG001|Overall Study|Adverse Event|8|||
37798150|NCT01985334|69440899|FG002|Overall Study|Adverse Event|2|||
37798151|NCT01985334|69440900|FG003|Overall Study|Adverse Event|26|||
37798152|NCT01985334|69440901|FG004|Overall Study|Adverse Event|3|||
37798153|NCT01985334|69440902|FG005|Overall Study|Adverse Event|18|||
37798154|NCT01985334|69440903|FG006|Overall Study|Adverse Event|3|||
37798155|NCT01985334|69440904|FG007|Overall Study|Adverse Event|15|||
37798156|NCT01985334|69440897|FG000|Overall Study|Other|4|||
37798157|NCT01985334|69440898|FG001|Overall Study|Other|2|||
37798158|NCT01985334|69440899|FG002|Overall Study|Other|3|||
37798159|NCT01985334|69440900|FG003|Overall Study|Other|10|||
37798160|NCT01985334|69440901|FG004|Overall Study|Other|1|||
37798161|NCT01985334|69440902|FG005|Overall Study|Other|6|||
37798162|NCT01985334|69440903|FG006|Overall Study|Other|2|||
37798163|NCT01985334|69440904|FG007|Overall Study|Other|2|||
37798164|NCT01985334|69440897|FG000|Overall Study|Medication non-compliance|0|||
37798165|NCT01985334|69440898|FG001|Overall Study|Medication non-compliance|4|||
37798166|NCT01985334|69440899|FG002|Overall Study|Medication non-compliance|1|||
37798167|NCT01985334|69440900|FG003|Overall Study|Medication non-compliance|6|||
37798168|NCT01985334|69440901|FG004|Overall Study|Medication non-compliance|2|||
37798169|NCT01985334|69440902|FG005|Overall Study|Medication non-compliance|3|||
37798170|NCT01985334|69440903|FG006|Overall Study|Medication non-compliance|1|||
37798171|NCT01985334|69440904|FG007|Overall Study|Medication non-compliance|3|||
37798172|NCT01985334|69440897|FG000|Overall Study|Use of prohibited treatment|1|||
37798173|NCT01985334|69440898|FG001|Overall Study|Use of prohibited treatment|4|||
37798174|NCT01985334|69440899|FG002|Overall Study|Use of prohibited treatment|1|||
37798175|NCT01985334|69440900|FG003|Overall Study|Use of prohibited treatment|2|||
37798176|NCT01985334|69440901|FG004|Overall Study|Use of prohibited treatment|1|||
37798177|NCT01985334|69440902|FG005|Overall Study|Use of prohibited treatment|6|||
37798178|NCT01985334|69440903|FG006|Overall Study|Use of prohibited treatment|2|||
37798179|NCT01985334|69440904|FG007|Overall Study|Use of prohibited treatment|0|||
37798180|NCT01985334|69440897|FG000|Overall Study|Investigator decision|0|||
37798181|NCT01985334|69440898|FG001|Overall Study|Investigator decision|3|||
37798182|NCT01985334|69440899|FG002|Overall Study|Investigator decision|0|||
37798183|NCT01985334|69440900|FG003|Overall Study|Investigator decision|7|||
37798184|NCT01985334|69440901|FG004|Overall Study|Investigator decision|1|||
37798185|NCT01985334|69440902|FG005|Overall Study|Investigator decision|1|||
37798186|NCT01985334|69440903|FG006|Overall Study|Investigator decision|0|||
37798187|NCT01985334|69440904|FG007|Overall Study|Investigator decision|4|||
37798188|NCT01985334|69440897|FG000|Overall Study|Lost to Follow-up|0|||
37798189|NCT01985334|69440898|FG001|Overall Study|Lost to Follow-up|2|||
37798190|NCT01985334|69440899|FG002|Overall Study|Lost to Follow-up|0|||
37798191|NCT01985334|69440900|FG003|Overall Study|Lost to Follow-up|3|||
37798192|NCT01985334|69440901|FG004|Overall Study|Lost to Follow-up|1|||
37798193|NCT01985334|69440902|FG005|Overall Study|Lost to Follow-up|4|||
37798194|NCT01985334|69440903|FG006|Overall Study|Lost to Follow-up|0|||
37798195|NCT01985334|69440904|FG007|Overall Study|Lost to Follow-up|3|||
37798196|NCT01944774|69440939|FG000|Overall Study|Withdrawal by Subject|2|||
37798197|NCT01944774|69440940|FG001|Overall Study|Withdrawal by Subject|3|||
37798198|NCT01944774|69440941|FG002|Overall Study|Withdrawal by Subject|3|||
37798199|NCT01944774|69440939|FG000|Overall Study|Adverse Event|3|||
37798200|NCT01944774|69440940|FG001|Overall Study|Adverse Event|2|||
37798201|NCT01944774|69440941|FG002|Overall Study|Adverse Event|3|||
37975667|NCT00316264|69662959|FG000|Overall Study|Death|2|||
37864231|NCT01207440|69547818|FG004|Overall Study|Protocol Violation|0|||
37864232|NCT01207440|69547819|FG005|Overall Study|Protocol Violation|0|||
37798202|NCT01944774|69440939|FG000|Overall Study|Lack of Efficacy|1|||
37798203|NCT01944774|69440940|FG001|Overall Study|Lack of Efficacy|2|||
37798204|NCT01944774|69440941|FG002|Overall Study|Lack of Efficacy|2|||
37798205|NCT01944774|69440939|FG000|Overall Study|Lost to Follow-up|0|||
37798206|NCT01944774|69440940|FG001|Overall Study|Lost to Follow-up|1|||
37798207|NCT01944774|69440941|FG002|Overall Study|Lost to Follow-up|0|||
37798208|NCT01944462|69440952|FG000|PPPP Educational Program|Lost to Follow-up|60|||
37975668|NCT00316264|69662960|FG001|Overall Study|Death|0|||
37798209|NCT01943292|69440960|FG000|Overall Study|Withdrawal by Subject|1|||
37798210|NCT01943292|69440961|FG001|Overall Study|Withdrawal by Subject|0|||
37798211|NCT01943292|69440962|FG002|Overall Study|Withdrawal by Subject|0|||
37798212|NCT01961544|69440970|FG000|Overall Study|Protocol Violation|1|||
37798213|NCT01961544|69440970|FG000|Overall Study|Withdrawal by Subject|7|||
37798214|NCT01961544|69440970|FG000|Overall Study|Adverse Event|1|||
37798215|NCT01961544|69440970|FG000|Overall Study|Physician Decision|2|||
37798216|NCT01961544|69440970|FG000|Overall Study|Poor Tolerance|1|||
37798217|NCT01961544|69440970|FG000|Overall Study|Aggravation of Steral Pain|1|||
37798218|NCT01942590|69440976|FG000|Overall Study|Withdrawal by Subject|0|||
37798219|NCT01942590|69440977|FG001|Overall Study|Withdrawal by Subject|1|||
37798220|NCT01942590|69440976|FG000|Overall Study|Adverse Event|1|||
37798221|NCT01942590|69440977|FG001|Overall Study|Adverse Event|0|||
37798222|NCT01984242|69440987|FG000|Overall Study|Death|52|||
37798223|NCT01984242|69440988|FG001|Overall Study|Death|50|||
37798224|NCT01984242|69440989|FG002|Overall Study|Death|52|||
37798225|NCT01984242|69440987|FG000|Overall Study|Withdrawal by Subject|5|||
37798226|NCT01984242|69440988|FG001|Overall Study|Withdrawal by Subject|3|||
37798227|NCT01984242|69440989|FG002|Overall Study|Withdrawal by Subject|10|||
37798228|NCT01984242|69440987|FG000|Overall Study|Physician Decision|0|||
37798229|NCT01984242|69440988|FG001|Overall Study|Physician Decision|0|||
37798230|NCT01984242|69440989|FG002|Overall Study|Physician Decision|1|||
37798231|NCT01984242|69440987|FG000|Overall Study|Lost to Follow-up|4|||
37798232|NCT01984242|69440988|FG001|Overall Study|Lost to Follow-up|0|||
37798233|NCT01984242|69440989|FG002|Overall Study|Lost to Follow-up|3|||
37798234|NCT01984242|69440987|FG000|Overall Study|Sponsor Decision|1|||
37798235|NCT01984242|69440988|FG001|Overall Study|Sponsor Decision|0|||
37798236|NCT01984242|69440989|FG002|Overall Study|Sponsor Decision|0|||
37798237|NCT01984242|69440987|FG000|Overall Study|Non-Compliance|1|||
37798238|NCT01984242|69440988|FG001|Overall Study|Non-Compliance|0|||
37798239|NCT01984242|69440989|FG002|Overall Study|Non-Compliance|0|||
37798240|NCT01984242|69440987|FG000|Overall Study|Study terminated by Sponsor|38|||
37798241|NCT01984242|69440988|FG001|Overall Study|Study terminated by Sponsor|50|||
37798242|NCT01984242|69440989|FG002|Overall Study|Study terminated by Sponsor|34|||
37798243|NCT01984242|69440987|FG000|Overall Study|Disease Progression|0|||
37798244|NCT01984242|69440988|FG001|Overall Study|Disease Progression|0|||
37798245|NCT01984242|69440989|FG002|Overall Study|Disease Progression|1|||
37798246|NCT01941498|69441005|FG000|Overall Study|Relocated out of state|1|||
37798247|NCT01960998|69441026|FG000|Overall Study|Lost to Follow-up|3|||
37798248|NCT01960998|69441027|FG001|Overall Study|Lost to Follow-up|7|||
37798249|NCT01960998|69441026|FG000|Overall Study|Death|0|||
37798250|NCT01960998|69441027|FG001|Overall Study|Death|1|||
37798251|NCT01960998|69441026|FG000|Overall Study|Withdrawal by Subject|8|||
37798252|NCT01960998|69441027|FG001|Overall Study|Withdrawal by Subject|2|||
37798253|NCT01960998|69441026|FG000|Overall Study|lost computer access|0|||
37798254|NCT01960998|69441027|FG001|Overall Study|lost computer access|1|||
37798255|NCT01941186|69441037|FG000|Follow-up|Lost to Follow-up|1|||
37798256|NCT01941186|69441038|FG001|Follow-up|Lost to Follow-up|0|||
37798257|NCT01960842|69441057|FG000|Overall Study|Adverse Event|1|||
37798258|NCT01960842|69441057|FG000|Overall Study|Withdrawal by Subject|2|||
37798259|NCT01984164|69441063|FG000|Overall Study|Withdrawal by Subject|4|||
37798260|NCT01984164|69441064|FG001|Overall Study|Withdrawal by Subject|3|||
37798261|NCT01984164|69441063|FG000|Overall Study|Adverse Event|5|||
37798262|NCT01984164|69441064|FG001|Overall Study|Adverse Event|19|||
37798263|NCT01984164|69441063|FG000|Overall Study|Lost to Follow-up|1|||
37798264|NCT01984164|69441064|FG001|Overall Study|Lost to Follow-up|3|||
37798265|NCT01983930|69441072|FG000|Overall Study|Withdrawal by Subject|9|||
37798266|NCT01983930|69441073|FG001|Overall Study|Withdrawal by Subject|8|||
37798267|NCT01983930|69441072|FG000|Overall Study|Adverse Event|0|||
37798268|NCT01983930|69441073|FG001|Overall Study|Adverse Event|1|||
37798269|NCT01983774|69441086|FG000|Overall Study|Lung Transplant|0|||
37798270|NCT01983774|69441087|FG001|Overall Study|Lung Transplant|1|||
37798271|NCT01983774|69441086|FG000|Overall Study|Lost to Follow-up|1|||
37798272|NCT01983774|69441087|FG001|Overall Study|Lost to Follow-up|0|||
37798273|NCT01982682|69441095|FG000|Overall Study|Physician Decision|1|||
37798274|NCT01940484|69441100|FG000|Overall Study|Withdrawal by Subject|3|||
37798275|NCT01940484|69441100|FG000|Overall Study|Underwent transplantation|4|||
37798276|NCT01940484|69441100|FG000|Overall Study|Death|2|||
37798277|NCT01940484|69441100|FG000|Overall Study|Adverse Event|1|||
37798278|NCT01939548|69441107|FG000|Overall Study|Non compliance|0|||
37798279|NCT01939548|69441108|FG001|Overall Study|Non compliance|2|||
37798280|NCT01939548|69441109|FG002|Overall Study|Non compliance|0|||
37798281|NCT01939548|69441107|FG000|Overall Study|Study Terminated by Sponsor|17|||
37798282|NCT01939548|69441108|FG001|Overall Study|Study Terminated by Sponsor|19|||
37798283|NCT01939548|69441109|FG002|Overall Study|Study Terminated by Sponsor|12|||
37798284|NCT01939548|69441107|FG000|Overall Study|Insufficient Clinical Response|1|||
37798285|NCT01939548|69441108|FG001|Overall Study|Insufficient Clinical Response|0|||
37798286|NCT01939548|69441109|FG002|Overall Study|Insufficient Clinical Response|0|||
37798287|NCT01939548|69441107|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
37798288|NCT01939548|69441108|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
37798289|NCT01939548|69441109|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
37798290|NCT01939548|69441107|FG000|Overall Study|Withdrawal by Subject|4|||
37798291|NCT01939548|69441108|FG001|Overall Study|Withdrawal by Subject|4|||
37798292|NCT01939548|69441109|FG002|Overall Study|Withdrawal by Subject|1|||
37798293|NCT01939548|69441107|FG000|Overall Study|Protocol Violation|7|||
37798294|NCT01939548|69441108|FG001|Overall Study|Protocol Violation|6|||
37798295|NCT01939548|69441109|FG002|Overall Study|Protocol Violation|5|||
37798296|NCT01939548|69441107|FG000|Overall Study|Lost to Follow-up|5|||
37798297|NCT01939548|69441108|FG001|Overall Study|Lost to Follow-up|5|||
37798298|NCT01939548|69441109|FG002|Overall Study|Lost to Follow-up|3|||
37798299|NCT01939548|69441107|FG000|Overall Study|Adverse Event|2|||
37798300|NCT01939548|69441108|FG001|Overall Study|Adverse Event|9|||
37798301|NCT01939548|69441109|FG002|Overall Study|Adverse Event|7|||
37798302|NCT01939548|69441107|FG000|Overall Study|Death|0|||
37798303|NCT01939548|69441108|FG001|Overall Study|Death|0|||
37798304|NCT01939548|69441109|FG002|Overall Study|Death|1|||
37798305|NCT01939548|69441107|FG000|Overall Study|Participant dropped|0|||
37798306|NCT01939548|69441108|FG001|Overall Study|Participant dropped|0|||
37798307|NCT01939548|69441109|FG002|Overall Study|Participant dropped|1|||
37798308|NCT01939548|69441107|FG000|Overall Study|Participant unwilling to continue|0|||
37798309|NCT01939548|69441108|FG001|Overall Study|Participant unwilling to continue|1|||
37798310|NCT01939548|69441109|FG002|Overall Study|Participant unwilling to continue|0|||
37798311|NCT01939548|69441107|FG000|Overall Study|Participant withdrew consent|0|||
37798312|NCT01939548|69441108|FG001|Overall Study|Participant withdrew consent|2|||
37798313|NCT01939548|69441109|FG002|Overall Study|Participant withdrew consent|0|||
37798314|NCT01939548|69441107|FG000|Overall Study|Did not complete follow-up|0|||
37798315|NCT01939548|69441108|FG001|Overall Study|Did not complete follow-up|1|||
37798316|NCT01939548|69441109|FG002|Overall Study|Did not complete follow-up|0|||
37798317|NCT01960296|69441119|FG000|Overall Study|Postponed surgery|1|||
37798318|NCT01960296|69441120|FG001|Overall Study|Postponed surgery|0|||
37798319|NCT01960296|69441119|FG000|Overall Study|Received different procedure|1|||
37798320|NCT01960296|69441120|FG001|Overall Study|Received different procedure|3|||
37798321|NCT01982292|69441128|FG000|Overall Study|Adverse Event|2|||
37798322|NCT01982292|69441129|FG001|Overall Study|Adverse Event|0|||
37798323|NCT01982292|69441128|FG000|Overall Study|Death|1|||
37798324|NCT01982292|69441129|FG001|Overall Study|Death|0|||
37798325|NCT01982292|69441128|FG000|Overall Study|Lost to Follow-up|2|||
37798326|NCT01982292|69441129|FG001|Overall Study|Lost to Follow-up|0|||
37798327|NCT01982292|69441128|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
37798328|NCT01982292|69441129|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
37798329|NCT01982292|69441128|FG000|Overall Study|Protocol Deviation|1|||
37798330|NCT01982292|69441129|FG001|Overall Study|Protocol Deviation|0|||
37798331|NCT01982292|69441128|FG000|Overall Study|Patient/Guardian Decision|3|||
37798332|NCT01982292|69441129|FG001|Overall Study|Patient/Guardian Decision|1|||
37798333|NCT01982292|69441128|FG000|Overall Study|Technical Problems|2|||
37798334|NCT01982292|69441129|FG001|Overall Study|Technical Problems|0|||
37798335|NCT01939314|69441137|FG000|Overall Study|Withdrawal by Subject|3|||
37798336|NCT01939314|69441138|FG001|Overall Study|Withdrawal by Subject|1|||
37798337|NCT01939314|69441137|FG000|Overall Study|Protocol Violation|1|||
37798338|NCT01939314|69441138|FG001|Overall Study|Protocol Violation|0|||
37798339|NCT01939314|69441137|FG000|Overall Study|Pregnancy|0|||
37798340|NCT01939314|69441138|FG001|Overall Study|Pregnancy|1|||
37798341|NCT01939314|69441137|FG000|Overall Study|Lost to Follow-up|5|||
37798342|NCT01939314|69441138|FG001|Overall Study|Lost to Follow-up|6|||
37798343|NCT01939158|69441150|FG000|Overall Study|Adverse Event|1|||
37798344|NCT01939158|69441151|FG001|Overall Study|Adverse Event|0|||
37798345|NCT01939158|69441152|FG002|Overall Study|Adverse Event|0|||
37798346|NCT01939158|69441153|FG003|Overall Study|Adverse Event|0|||
37798347|NCT01939158|69441150|FG000|Overall Study|Withdrawal by Subject|22|||
37798348|NCT01939158|69441151|FG001|Overall Study|Withdrawal by Subject|25|||
37798349|NCT01939158|69441152|FG002|Overall Study|Withdrawal by Subject|15|||
37798350|NCT01939158|69441153|FG003|Overall Study|Withdrawal by Subject|17|||
37798351|NCT01939158|69441150|FG000|Overall Study|Migrated/moved from study area|5|||
37798352|NCT01939158|69441151|FG001|Overall Study|Migrated/moved from study area|7|||
37798353|NCT01939158|69441152|FG002|Overall Study|Migrated/moved from study area|3|||
37798354|NCT01939158|69441153|FG003|Overall Study|Migrated/moved from study area|6|||
37798355|NCT01939158|69441150|FG000|Overall Study|Lost to Follow-up|18|||
37798356|NCT01939158|69441151|FG001|Overall Study|Lost to Follow-up|17|||
37798357|NCT01939158|69441152|FG002|Overall Study|Lost to Follow-up|17|||
37798358|NCT01939158|69441153|FG003|Overall Study|Lost to Follow-up|17|||
37798359|NCT01939158|69441150|FG000|Overall Study|Death|0|||
37798360|NCT01939158|69441151|FG001|Overall Study|Death|0|||
37798361|NCT01939158|69441152|FG002|Overall Study|Death|1|||
37798362|NCT01939158|69441153|FG003|Overall Study|Death|1|||
37798363|NCT01939158|69441150|FG000|Overall Study|No longer meets eligibility criteria|0|||
37798364|NCT01939158|69441151|FG001|Overall Study|No longer meets eligibility criteria|0|||
37798365|NCT01939158|69441152|FG002|Overall Study|No longer meets eligibility criteria|1|||
37798366|NCT01939158|69441153|FG003|Overall Study|No longer meets eligibility criteria|0|||
37798367|NCT01939158|69441150|FG000|Overall Study|Other|1|||
37798368|NCT01939158|69441151|FG001|Overall Study|Other|3|||
37798369|NCT01939158|69441152|FG002|Overall Study|Other|4|||
37798370|NCT01939158|69441153|FG003|Overall Study|Other|3|||
37798371|NCT01939002|69441169|FG000|Overall Study|Adverse Event|13|||
37798372|NCT01939002|69441170|FG001|Overall Study|Adverse Event|13|||
37798373|NCT01939002|69441169|FG000|Overall Study|Withdrawal by Subject|5|||
37798374|NCT01939002|69441170|FG001|Overall Study|Withdrawal by Subject|3|||
37798375|NCT01939002|69441169|FG000|Overall Study|Other|1|||
37798376|NCT01939002|69441170|FG001|Overall Study|Other|2|||
37798377|NCT01938846|69441184|FG000|Overall Study|Progressive disease|26|||
37798378|NCT01938846|69441185|FG001|Overall Study|Progressive disease|18|||
37798379|NCT01938846|69441186|FG002|Overall Study|Progressive disease|16|||
37798380|NCT01938846|69441184|FG000|Overall Study|Adverse Event|8|||
37798381|NCT01938846|69441185|FG001|Overall Study|Adverse Event|4|||
37798382|NCT01938846|69441186|FG002|Overall Study|Adverse Event|3|||
37798383|NCT01938846|69441184|FG000|Overall Study|Withdrawal by Subject|2|||
37798384|NCT01938846|69441185|FG001|Overall Study|Withdrawal by Subject|2|||
37798385|NCT01938846|69441186|FG002|Overall Study|Withdrawal by Subject|1|||
37798386|NCT01938846|69441184|FG000|Overall Study|Other than listed|5|||
37798387|NCT01938846|69441185|FG001|Overall Study|Other than listed|1|||
37798388|NCT01938846|69441186|FG002|Overall Study|Other than listed|4|||
37798389|NCT01960140|69441227|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
37798390|NCT01981356|69441237|FG000|Overall Study|Lost to Follow-up|4|||
37798391|NCT01981356|69441238|FG001|Overall Study|Lost to Follow-up|1|||
37798392|NCT01981356|69441237|FG000|Overall Study|Withdrawal by Subject|1|||
37798393|NCT01981356|69441238|FG001|Overall Study|Withdrawal by Subject|1|||
37798394|NCT01981356|69441237|FG000|Overall Study|Protocol Violation|2|||
37798395|NCT01981356|69441238|FG001|Overall Study|Protocol Violation|0|||
37798396|NCT01981122|69441247|FG000|Overall Study|Withdrawal by Subject|0|||
37798397|NCT01981122|69441248|FG001|Overall Study|Withdrawal by Subject|2|||
37798398|NCT01981122|69441247|FG000|Overall Study|Protocol Violation|0|||
37798399|NCT01981122|69441248|FG001|Overall Study|Protocol Violation|1|||
37798400|NCT01981122|69441247|FG000|Overall Study|Lost to Follow-up|0|||
37798401|NCT01981122|69441248|FG001|Overall Study|Lost to Follow-up|1|||
37798402|NCT01981122|69441247|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
37798403|NCT01981122|69441248|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
37798404|NCT01981122|69441247|FG000|Overall Study|Death|14|||
37798405|NCT01981122|69441248|FG001|Overall Study|Death|15|||
37798406|NCT01980888|69441256|FG000|Overall Study|Study Terminated by Sponsor|116|||
37798407|NCT01980888|69441257|FG001|Overall Study|Study Terminated by Sponsor|122|||
37798408|NCT01980888|69441256|FG000|Overall Study|Withdrew Consent|17|||
37798409|NCT01980888|69441257|FG001|Overall Study|Withdrew Consent|6|||
37798410|NCT01980888|69441256|FG000|Overall Study|Investigator's Discretion|8|||
37975669|NCT00316264|69662961|FG002|Overall Study|Death|0|||
37798411|NCT01980888|69441257|FG001|Overall Study|Investigator's Discretion|3|||
37798412|NCT01980888|69441256|FG000|Overall Study|Non-Compliance with Study Drug|3|||
37798413|NCT01980888|69441257|FG001|Overall Study|Non-Compliance with Study Drug|2|||
37798414|NCT01937364|69441274|FG000|Overall Study|Adverse Event|2|||
37798415|NCT01937364|69441275|FG001|Overall Study|Adverse Event|1|||
37798416|NCT01979952|69441283|FG000|Overall Study|Adverse Event|4|||
37798417|NCT01979952|69441284|FG001|Overall Study|Adverse Event|5|||
37798418|NCT01979952|69441283|FG000|Overall Study|Protocol Violation|1|||
37798419|NCT01979952|69441284|FG001|Overall Study|Protocol Violation|0|||
37798420|NCT01979952|69441283|FG000|Overall Study|Withdrawal by Subject|2|||
37798421|NCT01979952|69441284|FG001|Overall Study|Withdrawal by Subject|1|||
37798422|NCT01979952|69441283|FG000|Overall Study|Other than specified above|1|||
37798423|NCT01979952|69441284|FG001|Overall Study|Other than specified above|0|||
37798424|NCT01999218|69441293|FG000|Overall Study|Hyperglycemia|18|||
37798425|NCT01999218|69441294|FG001|Overall Study|Hyperglycemia|17|||
37798426|NCT01999218|69441295|FG002|Overall Study|Hyperglycemia|17|||
37798427|NCT01999218|69441293|FG000|Overall Study|Lack of Efficacy|1|||
37798428|NCT01999218|69441294|FG001|Overall Study|Lack of Efficacy|0|||
37798429|NCT01999218|69441295|FG002|Overall Study|Lack of Efficacy|1|||
37798430|NCT01999218|69441293|FG000|Overall Study|Lost to Follow-up|22|||
37798431|NCT01999218|69441294|FG001|Overall Study|Lost to Follow-up|17|||
37798432|NCT01999218|69441295|FG002|Overall Study|Lost to Follow-up|18|||
37798433|NCT01999218|69441293|FG000|Overall Study|Non-Compliance With Study Drug|6|||
37798434|NCT01999218|69441294|FG001|Overall Study|Non-Compliance With Study Drug|4|||
37798435|NCT01999218|69441295|FG002|Overall Study|Non-Compliance With Study Drug|1|||
37798436|NCT01999218|69441293|FG000|Overall Study|Physician Decision|1|||
37798437|NCT01999218|69441294|FG001|Overall Study|Physician Decision|4|||
37798438|NCT01999218|69441295|FG002|Overall Study|Physician Decision|6|||
37798439|NCT01999218|69441293|FG000|Overall Study|Protocol Violation|4|||
37798440|NCT01999218|69441294|FG001|Overall Study|Protocol Violation|5|||
37798441|NCT01999218|69441295|FG002|Overall Study|Protocol Violation|4|||
37798442|NCT01999218|69441293|FG000|Overall Study|Screen failure|0|||
37798443|NCT01999218|69441294|FG001|Overall Study|Screen failure|1|||
37798444|NCT01999218|69441295|FG002|Overall Study|Screen failure|0|||
37798445|NCT01999218|69441293|FG000|Overall Study|Study Terminated By Sponsor|7|||
37798446|NCT01999218|69441294|FG001|Overall Study|Study Terminated By Sponsor|5|||
37798447|NCT01999218|69441295|FG002|Overall Study|Study Terminated By Sponsor|12|||
37798448|NCT01999218|69441293|FG000|Overall Study|Participant moves|2|||
37798449|NCT01999218|69441294|FG001|Overall Study|Participant moves|5|||
37798450|NCT01999218|69441295|FG002|Overall Study|Participant moves|3|||
37798451|NCT01999218|69441293|FG000|Overall Study|Withdrawal by Subject|28|||
37798452|NCT01999218|69441294|FG001|Overall Study|Withdrawal by Subject|29|||
37798453|NCT01999218|69441295|FG002|Overall Study|Withdrawal by Subject|34|||
37798454|NCT01999218|69441293|FG000|Overall Study|Creatinine/eGFR|0|||
37798455|NCT01999218|69441294|FG001|Overall Study|Creatinine/eGFR|0|||
37798456|NCT01999218|69441295|FG002|Overall Study|Creatinine/eGFR|1|||
37798457|NCT01999218|69441293|FG000|Overall Study|Death|7|||
37798458|NCT01999218|69441294|FG001|Overall Study|Death|1|||
37798459|NCT01999218|69441295|FG002|Overall Study|Death|2|||
37798460|NCT01999218|69441293|FG000|Overall Study|Excluded Medication|1|||
37798461|NCT01999218|69441294|FG001|Overall Study|Excluded Medication|1|||
37798462|NCT01999218|69441295|FG002|Overall Study|Excluded Medication|2|||
37798463|NCT01999218|69441293|FG000|Overall Study|Adverse Event|9|||
37798464|NCT01999218|69441294|FG001|Overall Study|Adverse Event|7|||
37798465|NCT01999218|69441295|FG002|Overall Study|Adverse Event|7|||
37798466|NCT01999218|69441293|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
37798467|NCT01999218|69441294|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
37798468|NCT01999218|69441295|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
37798469|NCT01937130|69441307|FG000|Overall Study|Withdrawal by Subject|0|||
37798470|NCT01937130|69441308|FG001|Overall Study|Withdrawal by Subject|0|||
37798471|NCT01937130|69441309|FG002|Overall Study|Withdrawal by Subject|0|||
37798472|NCT01937130|69441310|FG003|Overall Study|Withdrawal by Subject|1|||
37798473|NCT01937130|69441307|FG000|Overall Study|Adverse Event|0|||
37798474|NCT01937130|69441308|FG001|Overall Study|Adverse Event|1|||
37798475|NCT01937130|69441309|FG002|Overall Study|Adverse Event|0|||
37798476|NCT01937130|69441310|FG003|Overall Study|Adverse Event|1|||
37798477|NCT01937130|69441307|FG000|Overall Study|Death|1|||
37798478|NCT01937130|69441308|FG001|Overall Study|Death|1|||
37798479|NCT01937130|69441309|FG002|Overall Study|Death|1|||
37798480|NCT01937130|69441310|FG003|Overall Study|Death|0|||
37798481|NCT01937130|69441307|FG000|Overall Study|Lost to Follow-up|2|||
37798482|NCT01937130|69441308|FG001|Overall Study|Lost to Follow-up|0|||
37798483|NCT01937130|69441309|FG002|Overall Study|Lost to Follow-up|2|||
37798484|NCT01937130|69441310|FG003|Overall Study|Lost to Follow-up|0|||
37798485|NCT01937130|69441307|FG000|Overall Study|Physician Decision|0|||
37798486|NCT01937130|69441308|FG001|Overall Study|Physician Decision|1|||
37798487|NCT01937130|69441309|FG002|Overall Study|Physician Decision|0|||
37798488|NCT01937130|69441310|FG003|Overall Study|Physician Decision|0|||
37693867|NCT02039505|69170137|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
37693868|NCT02039505|69170138|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
37798489|NCT01937130|69441307|FG000|Overall Study|Patients unable to swallow|0|||
37798490|NCT01937130|69441308|FG001|Overall Study|Patients unable to swallow|1|||
37798491|NCT01937130|69441309|FG002|Overall Study|Patients unable to swallow|0|||
37798492|NCT01937130|69441310|FG003|Overall Study|Patients unable to swallow|0|||
37798493|NCT01937130|69441307|FG000|Overall Study|Patient lost to FU due to death|2|||
37798494|NCT01937130|69441308|FG001|Overall Study|Patient lost to FU due to death|0|||
37798495|NCT01937130|69441309|FG002|Overall Study|Patient lost to FU due to death|0|||
37798496|NCT01937130|69441310|FG003|Overall Study|Patient lost to FU due to death|0|||
37798497|NCT01936974|69441322|FG000|Overall Study|Physician Decision|2|||
37798498|NCT01936974|69441323|FG001|Overall Study|Physician Decision|5|||
37798499|NCT01959516|69441329|FG000|Epoch 1|Adverse Event|4|||
37798500|NCT01959516|69441330|FG001|Epoch 1|Adverse Event|1|||
37798501|NCT01959516|69441329|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
37798502|NCT01959516|69441330|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
37798503|NCT01959516|69441329|FG000|Epoch 1|Subject withdrew consent|3|||
37798504|NCT01959516|69441330|FG001|Epoch 1|Subject withdrew consent|2|||
37798505|NCT01959516|69441329|FG000|Epoch 1|Administrative problems|1|||
37798506|NCT01959516|69441330|FG001|Epoch 1|Administrative problems|0|||
37798507|NCT01959516|69441329|FG000|Epoch 1|Use of prohibited treatment|1|||
37798508|NCT01959516|69441330|FG001|Epoch 1|Use of prohibited treatment|0|||
37798509|NCT01959516|69441329|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
37798510|NCT01959516|69441330|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
37798511|NCT01959516|69441329|FG000|Epoch 1|Protocol deviation|0|||
37798512|NCT01959516|69441330|FG001|Epoch 1|Protocol deviation|1|||
37798513|NCT01959516|69441329|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
37798514|NCT01959516|69441330|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
37798515|NCT01959516|69441329|FG000|Epoch 2|Subject withdrew consent|1|||
37798516|NCT01959516|69441330|FG001|Epoch 2|Subject withdrew consent|0|||
37798517|NCT01959516|69441329|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
37798518|NCT01959516|69441330|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
37798519|NCT01979016|69441338|FG000|Overall Study|Withdrawal by Subject|2|||
37798520|NCT01979016|69441339|FG001|Overall Study|Withdrawal by Subject|0|||
37798521|NCT01979016|69441338|FG000|Overall Study|Adverse Event|0|||
37798522|NCT01979016|69441339|FG001|Overall Study|Adverse Event|1|||
37693869|NCT02039505|69170139|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
37693870|NCT02039505|69170140|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
37693871|NCT02039505|69170141|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
37693872|NCT02039505|69170135|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
37798523|NCT01935336|69441349|FG000|Overall Study|Adverse Event|1|||
37798524|NCT01935336|69441350|FG001|Overall Study|Adverse Event|0|||
37798525|NCT01935336|69441351|FG002|Overall Study|Adverse Event|0|||
37798526|NCT01935336|69441352|FG003|Overall Study|Adverse Event|0|||
37798527|NCT01935336|69441349|FG000|Overall Study|Progressive disease|5|||
37798528|NCT01935336|69441350|FG001|Overall Study|Progressive disease|3|||
37798529|NCT01935336|69441351|FG002|Overall Study|Progressive disease|47|||
37798530|NCT01935336|69441352|FG003|Overall Study|Progressive disease|66|||
37798531|NCT01978236|69441368|FG000|Overall Study|Discontinued due to study close|2|||
37798532|NCT01977846|69441374|FG000|Total Study - Prospective|Death|0|||
37798533|NCT01977846|69441375|FG001|Total Study - Prospective|Death|1|||
37798534|NCT01977846|69441374|FG000|Total Study - Prospective|Lost to Follow-up|0|||
37798535|NCT01977846|69441375|FG001|Total Study - Prospective|Lost to Follow-up|8|||
37798536|NCT01977846|69441374|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
37798537|NCT01977846|69441375|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
37798538|NCT01977846|69441374|FG000|Total Study - Prospective|Not available at time of visit|0|||
37798539|NCT01977846|69441375|FG001|Total Study - Prospective|Not available at time of visit|5|||
37798540|NCT01977846|69441374|FG000|Total Study - Prospective|No show|0|||
37798541|NCT01977846|69441375|FG001|Total Study - Prospective|No show|1|||
37798542|NCT01977846|69441374|FG000|Total Study - Prospective|Protocol Violation|0|||
37798543|NCT01977846|69441375|FG001|Total Study - Prospective|Protocol Violation|1|||
37798544|NCT01934790|69441382|FG000|Treatment|Adverse Event|3|||
37798545|NCT01934790|69441382|FG000|Treatment|Clinical progression|6|||
37798546|NCT01934790|69441382|FG000|Treatment|Radiological progression|4|||
37798547|NCT01934790|69441382|FG000|Treatment|Withdrawal by Subject|2|||
37798548|NCT01934790|69441382|FG000|Treatment|Study drug never administered|1|||
37798549|NCT01934790|69441382|FG000|Active Follow up|Death|20|||
37798550|NCT01934790|69441382|FG000|Active Follow up|Physician Decision|2|||
37798551|NCT01934790|69441382|FG000|Active Follow up|Progressive disease|1|||
37798552|NCT01934790|69441382|FG000|Active Follow up|Other reason|1|||
37798553|NCT01934556|69441389|FG000|Overall Study|Withdrawal by Subject|0|||
37798554|NCT01934556|69441390|FG001|Overall Study|Withdrawal by Subject|1|||
37798555|NCT01934556|69441391|FG002|Overall Study|Withdrawal by Subject|1|||
37798556|NCT01934556|69441389|FG000|Overall Study|Lost to Follow-up|4|||
37975670|NCT00316264|69662959|FG000|Overall Study|Other|1|||
37693873|NCT02039505|69170136|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
37798557|NCT01934556|69441390|FG001|Overall Study|Lost to Follow-up|10|||
37798558|NCT01934556|69441391|FG002|Overall Study|Lost to Follow-up|7|||
37798559|NCT01934556|69441389|FG000|Overall Study|Death|1|||
37798560|NCT01934556|69441390|FG001|Overall Study|Death|5|||
37798561|NCT01934556|69441391|FG002|Overall Study|Death|2|||
37798562|NCT01977690|69441401|FG000|Overall Study|Withdrawal by Subject|0|||
37798563|NCT01977690|69441402|FG001|Overall Study|Withdrawal by Subject|4|||
37798564|NCT01934010|69441477|FG000|Overall Study|Adverse Event|1|||
37798565|NCT01934010|69441478|FG001|Overall Study|Adverse Event|1|||
37798566|NCT01934010|69441479|FG002|Overall Study|Adverse Event|0|||
37798567|NCT01934010|69441477|FG000|Overall Study|Withdrawal by Subject|15|||
37975671|NCT00316264|69662960|FG001|Overall Study|Other|1|||
37798568|NCT01934010|69441478|FG001|Overall Study|Withdrawal by Subject|6|||
37798569|NCT01934010|69441479|FG002|Overall Study|Withdrawal by Subject|2|||
37798570|NCT01934010|69441477|FG000|Overall Study|Lost to Follow-up|7|||
37798571|NCT01934010|69441478|FG001|Overall Study|Lost to Follow-up|4|||
37798572|NCT01934010|69441479|FG002|Overall Study|Lost to Follow-up|0|||
37798573|NCT01620138|69441498|FG000|Overall Study|Withdrawal by Subject|3|||
37798574|NCT01620138|69441499|FG001|Overall Study|Withdrawal by Subject|0|||
37798575|NCT01620138|69441498|FG000|Overall Study|Lack of Efficacy|1|||
37798576|NCT01620138|69441499|FG001|Overall Study|Lack of Efficacy|0|||
37798577|NCT01620138|69441498|FG000|Overall Study|Adverse Event|2|||
37798578|NCT01620138|69441499|FG001|Overall Study|Adverse Event|0|||
37798579|NCT01977612|69441507|FG000|Overall Study|Lost to Follow-up|1|||
37798580|NCT01977612|69441508|FG001|Overall Study|Lost to Follow-up|1|||
37798581|NCT01932996|69441516|FG000|Overall Study|Protocol Violation|2|||
37798582|NCT01932996|69441517|FG001|Overall Study|Protocol Violation|0|||
37798583|NCT01932762|69441527|FG000|Overall Study|Withdrawal by Subject|1|||
37798584|NCT01932762|69441528|FG001|Overall Study|Withdrawal by Subject|2|||
37798585|NCT01932762|69441529|FG002|Overall Study|Withdrawal by Subject|0|||
37798586|NCT01932762|69441530|FG003|Overall Study|Withdrawal by Subject|0|||
37798587|NCT01932762|69441527|FG000|Overall Study|Lost to Follow-up|4|||
37798588|NCT01932762|69441528|FG001|Overall Study|Lost to Follow-up|0|||
37798589|NCT01932762|69441529|FG002|Overall Study|Lost to Follow-up|0|||
37798590|NCT01932762|69441530|FG003|Overall Study|Lost to Follow-up|1|||
37798591|NCT01932762|69441527|FG000|Overall Study|Physician Decision|1|||
37798592|NCT01932762|69441528|FG001|Overall Study|Physician Decision|0|||
37798593|NCT01932762|69441529|FG002|Overall Study|Physician Decision|0|||
37798594|NCT01932762|69441530|FG003|Overall Study|Physician Decision|0|||
37798595|NCT01618968|69441544|FG000|Overall Study|Adverse Event|1|||
37798596|NCT01618968|69441545|FG001|Overall Study|Adverse Event|0|||
37798597|NCT01618968|69441546|FG002|Overall Study|Adverse Event|0|||
37798598|NCT01618968|69441547|FG003|Overall Study|Adverse Event|0|||
37798599|NCT01618968|69441544|FG000|Overall Study|Death|0|||
37798600|NCT01618968|69441545|FG001|Overall Study|Death|0|||
37798601|NCT01618968|69441546|FG002|Overall Study|Death|0|||
37798602|NCT01618968|69441547|FG003|Overall Study|Death|1|||
37798603|NCT01932294|69441556|FG000|Overall Study|Death|43|||
37798604|NCT01932294|69441556|FG000|Overall Study|Lost to Follow-up|8|||
37798605|NCT01932294|69441556|FG000|Overall Study|VAD Implantation|20|||
37798606|NCT01932294|69441556|FG000|Overall Study|Heart Transplantation|16|||
37798607|NCT01932294|69441556|FG000|Overall Study|Transferred to other hospitals|12|||
37798608|NCT01931670|69441564|FG000|Treatment Period|Exclusionary Medication Received|1|||
37798609|NCT01931670|69441565|FG001|Treatment Period|Exclusionary Medication Received|1|||
37798610|NCT01931670|69441566|FG002|Treatment Period|Exclusionary Medication Received|1|||
37798611|NCT01931670|69441564|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
37798612|NCT01931670|69441565|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
37798613|NCT01931670|69441566|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
37798614|NCT01931670|69441564|FG000|Treatment Period|Subject Noncompliant|4|||
37798615|NCT01931670|69441565|FG001|Treatment Period|Subject Noncompliant|9|||
37798616|NCT01931670|69441566|FG002|Treatment Period|Subject Noncompliant|5|||
37798617|NCT01931670|69441564|FG000|Treatment Period|Adverse Event|19|||
37798618|NCT01931670|69441565|FG001|Treatment Period|Adverse Event|8|||
37798619|NCT01931670|69441566|FG002|Treatment Period|Adverse Event|21|||
37798620|NCT01931670|69441564|FG000|Treatment Period|Lack of Efficacy|11|||
37798621|NCT01931670|69441565|FG001|Treatment Period|Lack of Efficacy|2|||
37798622|NCT01931670|69441566|FG002|Treatment Period|Lack of Efficacy|2|||
37798623|NCT01931670|69441564|FG000|Treatment Period|Pregnancy|7|||
37798624|NCT01931670|69441565|FG001|Treatment Period|Pregnancy|2|||
37798625|NCT01931670|69441566|FG002|Treatment Period|Pregnancy|0|||
37798626|NCT01931670|69441564|FG000|Treatment Period|Other|8|||
37798627|NCT01931670|69441565|FG001|Treatment Period|Other|7|||
37798628|NCT01931670|69441566|FG002|Treatment Period|Other|2|||
37798629|NCT01931670|69441564|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
37798630|NCT01931670|69441565|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
37798631|NCT01931670|69441566|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
37798632|NCT01931670|69441564|FG000|Treatment Period|Lost to Follow-up|19|||
37798633|NCT01931670|69441565|FG001|Treatment Period|Lost to Follow-up|5|||
37798634|NCT01931670|69441566|FG002|Treatment Period|Lost to Follow-up|7|||
37798635|NCT01931670|69441564|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
37798636|NCT01931670|69441565|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
37798637|NCT01931670|69441566|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
37798638|NCT01931670|69441564|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
37798639|NCT01931670|69441565|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
37798640|NCT01931670|69441566|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
37798641|NCT01931670|69441564|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
37798642|NCT01931670|69441565|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
37798643|NCT01931670|69441566|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
37798644|NCT01931670|69441564|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
37798645|NCT01931670|69441565|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
37798646|NCT01931670|69441566|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
37798647|NCT01931670|69441564|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
37798648|NCT01931670|69441565|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
37798649|NCT01931670|69441566|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
37798650|NCT01931670|69441564|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
37798651|NCT01931670|69441565|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
37798652|NCT01931670|69441566|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
37798653|NCT01977456|69441574|FG000|Overall Study|Death|5|||
37798654|NCT01957644|69441583|FG000|Overall Study|Adverse Event|4|||
37798655|NCT01957644|69441584|FG001|Overall Study|Adverse Event|2|||
37798656|NCT01957644|69441585|FG002|Overall Study|Adverse Event|0|||
37798657|NCT01957644|69441586|FG003|Overall Study|Adverse Event|0|||
37798658|NCT01957644|69441587|FG004|Overall Study|Adverse Event|1|||
37798659|NCT01957644|69441583|FG000|Overall Study|Progressive disease / relapse|0|||
37798660|NCT01957644|69441584|FG001|Overall Study|Progressive disease / relapse|1|||
37798661|NCT01957644|69441585|FG002|Overall Study|Progressive disease / relapse|0|||
37798662|NCT01957644|69441586|FG003|Overall Study|Progressive disease / relapse|1|||
37798663|NCT01957644|69441587|FG004|Overall Study|Progressive disease / relapse|0|||
37798664|NCT01957644|69441583|FG000|Overall Study|Other reason|1|||
37798665|NCT01957644|69441584|FG001|Overall Study|Other reason|2|||
37798666|NCT01957644|69441585|FG002|Overall Study|Other reason|1|||
37798667|NCT01957644|69441586|FG003|Overall Study|Other reason|1|||
37798668|NCT01957644|69441587|FG004|Overall Study|Other reason|0|||
37798669|NCT01957644|69441583|FG000|Overall Study|Withdrawal by Subject|1|||
37798670|NCT01957644|69441584|FG001|Overall Study|Withdrawal by Subject|0|||
37864233|NCT01207440|69547820|FG006|Overall Study|Protocol Violation|0|||
37864234|NCT01207440|69547814|FG000|Overall Study|Site Terminated by Sponsor|69|||
37864235|NCT01207440|69547815|FG001|Overall Study|Site Terminated by Sponsor|19|||
37798671|NCT01957644|69441585|FG002|Overall Study|Withdrawal by Subject|0|||
37798672|NCT01957644|69441586|FG003|Overall Study|Withdrawal by Subject|0|||
37798673|NCT01957644|69441587|FG004|Overall Study|Withdrawal by Subject|0|||
37798674|NCT01957644|69441583|FG000|Overall Study|Protocol Violation|0|||
37798675|NCT01957644|69441584|FG001|Overall Study|Protocol Violation|1|||
37864236|NCT01207440|69547816|FG002|Overall Study|Site Terminated by Sponsor|12|||
37798676|NCT01957644|69441585|FG002|Overall Study|Protocol Violation|0|||
37798677|NCT01957644|69441586|FG003|Overall Study|Protocol Violation|0|||
37798678|NCT01957644|69441587|FG004|Overall Study|Protocol Violation|0|||
37798679|NCT01931202|69441604|FG000|Overall Study|Withdrawal by Subject|0|||
37864237|NCT01207440|69547817|FG003|Overall Study|Site Terminated by Sponsor|2|||
37864238|NCT01207440|69547818|FG004|Overall Study|Site Terminated by Sponsor|3|||
37864239|NCT01207440|69547819|FG005|Overall Study|Site Terminated by Sponsor|0|||
37864240|NCT01207440|69547820|FG006|Overall Study|Site Terminated by Sponsor|2|||
37864241|NCT01207440|69547814|FG000|Overall Study|Withdrawal by Subject|29|||
37864242|NCT01207440|69547815|FG001|Overall Study|Withdrawal by Subject|4|||
37864243|NCT01207440|69547816|FG002|Overall Study|Withdrawal by Subject|5|||
37864244|NCT01207440|69547817|FG003|Overall Study|Withdrawal by Subject|3|||
37864245|NCT01207440|69547818|FG004|Overall Study|Withdrawal by Subject|2|||
37864246|NCT01207440|69547819|FG005|Overall Study|Withdrawal by Subject|2|||
37864247|NCT01207440|69547820|FG006|Overall Study|Withdrawal by Subject|0|||
37864248|NCT01207440|69547814|FG000|Overall Study|Reason Not Specified|10|||
37864249|NCT01207440|69547815|FG001|Overall Study|Reason Not Specified|10|||
37864250|NCT01207440|69547816|FG002|Overall Study|Reason Not Specified|7|||
37693874|NCT02039505|69170137|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
37693875|NCT02039505|69170138|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
37693876|NCT02039505|69170139|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
37798680|NCT01931202|69441605|FG001|Overall Study|Withdrawal by Subject|0|||
37798681|NCT01931202|69441606|FG002|Overall Study|Withdrawal by Subject|2|||
37864251|NCT01207440|69547817|FG003|Overall Study|Reason Not Specified|0|||
37864252|NCT01207440|69547818|FG004|Overall Study|Reason Not Specified|4|||
37864253|NCT01207440|69547819|FG005|Overall Study|Reason Not Specified|3|||
37798682|NCT01931202|69441604|FG000|Overall Study|Lost to Follow-up|0|||
37798683|NCT01931202|69441605|FG001|Overall Study|Lost to Follow-up|5|||
37798684|NCT01931202|69441606|FG002|Overall Study|Lost to Follow-up|2|||
37798685|NCT01930890|69441621|FG000|Overall Study|Study Termination|14|||
37798686|NCT01930890|69441622|FG001|Overall Study|Study Termination|28|||
37798687|NCT01930890|69441623|FG002|Overall Study|Study Termination|13|||
37798688|NCT01930890|69441624|FG003|Overall Study|Study Termination|25|||
37798689|NCT01930890|69441621|FG000|Overall Study|Death|0|||
37798690|NCT01930890|69441622|FG001|Overall Study|Death|0|||
37798691|NCT01930890|69441623|FG002|Overall Study|Death|0|||
37693877|NCT02039505|69170140|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
37798692|NCT01930890|69441624|FG003|Overall Study|Death|1|||
37798693|NCT01930890|69441621|FG000|Overall Study|Investigator Decision|0|||
37798694|NCT01930890|69441622|FG001|Overall Study|Investigator Decision|1|||
37798695|NCT01930890|69441623|FG002|Overall Study|Investigator Decision|0|||
37798696|NCT01930890|69441624|FG003|Overall Study|Investigator Decision|0|||
37798697|NCT01930890|69441621|FG000|Overall Study|Consent Withdrawn|0|||
37798698|NCT01930890|69441622|FG001|Overall Study|Consent Withdrawn|3|||
37798699|NCT01930890|69441623|FG002|Overall Study|Consent Withdrawn|0|||
37798700|NCT01930890|69441624|FG003|Overall Study|Consent Withdrawn|1|||
37798701|NCT01930890|69441621|FG000|Overall Study|Adverse Event|0|||
37798702|NCT01930890|69441622|FG001|Overall Study|Adverse Event|1|||
37798703|NCT01930890|69441623|FG002|Overall Study|Adverse Event|0|||
37798704|NCT01930890|69441624|FG003|Overall Study|Adverse Event|0|||
37798705|NCT01930188|69441637|FG000|Overall Study|unclassified|4|||
37798706|NCT01930188|69441638|FG001|Overall Study|unclassified|5|||
37798707|NCT01930188|69441639|FG002|Overall Study|unclassified|3|||
37798708|NCT01930188|69441637|FG000|Overall Study|Missing follow-up information|2|||
37798709|NCT01930188|69441638|FG001|Overall Study|Missing follow-up information|2|||
37798710|NCT01930188|69441639|FG002|Overall Study|Missing follow-up information|3|||
37798711|NCT01930188|69441637|FG000|Overall Study|Lost to Follow-up|5|||
37798712|NCT01930188|69441638|FG001|Overall Study|Lost to Follow-up|2|||
37798713|NCT01930188|69441639|FG002|Overall Study|Lost to Follow-up|2|||
37798714|NCT01930188|69441637|FG000|Overall Study|Death|2|||
37798715|NCT01930188|69441638|FG001|Overall Study|Death|1|||
37798716|NCT01930188|69441639|FG002|Overall Study|Death|3|||
37798717|NCT01930188|69441637|FG000|Overall Study|Withdrawal by Subject|9|||
37798718|NCT01930188|69441638|FG001|Overall Study|Withdrawal by Subject|11|||
37798719|NCT01930188|69441639|FG002|Overall Study|Withdrawal by Subject|8|||
37798720|NCT01977222|69441648|FG000|Overall Study|Withdrawal by Subject|1|||
37798721|NCT01957488|69441652|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
37798722|NCT01957488|69441653|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
37798723|NCT01957488|69441654|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
37798724|NCT01957488|69441655|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
37798725|NCT01957488|69441656|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
37798726|NCT01957488|69441657|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
37798727|NCT01957488|69441652|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
37798728|NCT01957488|69441653|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
37798729|NCT01957488|69441654|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
37798730|NCT01957488|69441655|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
37693878|NCT02039505|69170141|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
37693879|NCT02039505|69170135|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
37693880|NCT02039505|69170136|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
37693881|NCT02039505|69170137|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
37693882|NCT02039505|69170138|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
37693883|NCT02039505|69170139|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
37693884|NCT02039505|69170140|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
37693885|NCT02039505|69170141|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
37693886|NCT02039505|69170135|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
37693887|NCT02039505|69170136|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
37693888|NCT02039505|69170137|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
37693889|NCT02039505|69170138|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
37693890|NCT02039505|69170139|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
37693891|NCT02039505|69170140|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
37798731|NCT01957488|69441656|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
37798732|NCT01957488|69441657|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
37798733|NCT01957488|69441652|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
37798734|NCT01957488|69441653|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
37798735|NCT01957488|69441654|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
37798736|NCT01957488|69441655|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
37798737|NCT01957488|69441656|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
37798738|NCT01957488|69441657|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
37798739|NCT01957488|69441652|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
37798740|NCT01957488|69441653|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
37798741|NCT01957488|69441654|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
37798742|NCT01957488|69441655|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
37798743|NCT01957488|69441656|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
37798744|NCT01957488|69441657|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
37798745|NCT01957488|69441652|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
37798746|NCT01957488|69441653|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
37798747|NCT01957488|69441654|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
37798748|NCT01957488|69441655|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
37798749|NCT01957488|69441656|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
37798750|NCT01957488|69441657|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
37798751|NCT01957488|69441652|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
37798752|NCT01957488|69441653|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
37798753|NCT01957488|69441654|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
37798754|NCT01957488|69441655|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
37798755|NCT01957488|69441656|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
37798756|NCT01957488|69441657|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
37798757|NCT01957488|69441652|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
37798758|NCT01957488|69441653|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
37798759|NCT01957488|69441654|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
37798760|NCT01957488|69441655|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
37798761|NCT01957488|69441656|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
37798762|NCT01957488|69441657|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
37798763|NCT01957488|69441652|FG000|Test Period 2 (2 Weeks)|Other|1|||
37798764|NCT01957488|69441653|FG001|Test Period 2 (2 Weeks)|Other|0|||
37798765|NCT01957488|69441654|FG002|Test Period 2 (2 Weeks)|Other|0|||
37798766|NCT01957488|69441655|FG003|Test Period 2 (2 Weeks)|Other|0|||
37798767|NCT01957488|69441656|FG004|Test Period 2 (2 Weeks)|Other|0|||
37798768|NCT01957488|69441657|FG005|Test Period 2 (2 Weeks)|Other|0|||
37798769|NCT01957488|69441652|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
37798770|NCT01957488|69441653|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
37798771|NCT01957488|69441654|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
37798772|NCT01957488|69441655|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
37798773|NCT01957488|69441656|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
37798774|NCT01957488|69441657|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
37798775|NCT01957488|69441652|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
37798776|NCT01957488|69441653|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
37798777|NCT01957488|69441654|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
37798778|NCT01957488|69441655|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
37798779|NCT01957488|69441656|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
37798780|NCT01957488|69441657|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
37798781|NCT01957488|69441652|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
37798782|NCT01957488|69441653|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
37798783|NCT01957488|69441654|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
37798784|NCT01957488|69441655|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
37798785|NCT01957488|69441656|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
37798786|NCT01957488|69441657|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
37798787|NCT01957488|69441652|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
37798788|NCT01957488|69441653|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
37798789|NCT01957488|69441654|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
37798790|NCT01957488|69441655|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
37798791|NCT01957488|69441656|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
37798792|NCT01957488|69441657|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
37798793|NCT01957488|69441652|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
37798794|NCT01957488|69441653|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
37798795|NCT01957488|69441654|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
37798796|NCT01957488|69441655|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
37798797|NCT01957488|69441656|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
37798798|NCT01957488|69441657|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
37798799|NCT01976364|69441665|FG000|Main Study (36 Months)|Adverse Event|63|||
37798800|NCT01976364|69441666|FG001|Main Study (36 Months)|Adverse Event|0|||
37798801|NCT01976364|69441667|FG002|Main Study (36 Months)|Adverse Event|0|||
37798802|NCT01976364|69441665|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
37798803|NCT01976364|69441666|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
37798804|NCT01976364|69441667|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
37798805|NCT01976364|69441665|FG000|Main Study (36 Months)|Other|13|||
37798806|NCT01976364|69441666|FG001|Main Study (36 Months)|Other|0|||
37798807|NCT01976364|69441667|FG002|Main Study (36 Months)|Other|0|||
37798808|NCT01976364|69441665|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
37798809|NCT01976364|69441666|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
37798810|NCT01976364|69441667|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
37798811|NCT01976364|69441665|FG000|Main Study (36 Months)|Medication error|1|||
37798812|NCT01976364|69441666|FG001|Main Study (36 Months)|Medication error|0|||
37798813|NCT01976364|69441667|FG002|Main Study (36 Months)|Medication error|0|||
37798814|NCT01976364|69441665|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
37798815|NCT01976364|69441666|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
37798816|NCT01976364|69441667|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
37798817|NCT01976364|69441665|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
37798818|NCT01976364|69441666|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
37798819|NCT01976364|69441667|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
37798820|NCT01976364|69441665|FG000|Main Study (36 Months)|Protocol Violation|13|||
37798821|NCT01976364|69441666|FG001|Main Study (36 Months)|Protocol Violation|0|||
37798822|NCT01976364|69441667|FG002|Main Study (36 Months)|Protocol Violation|0|||
37798823|NCT01976364|69441665|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
37798824|NCT01976364|69441666|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
37798825|NCT01976364|69441667|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
37798826|NCT01976364|69441665|FG000|Main Study (36 Months)|Death|5|||
37798827|NCT01976364|69441666|FG001|Main Study (36 Months)|Death|0|||
37798828|NCT01976364|69441667|FG002|Main Study (36 Months)|Death|0|||
37798829|NCT01976364|69441665|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
37798830|NCT01976364|69441666|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
37798831|NCT01976364|69441667|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
37798832|NCT01976364|69441665|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
37798833|NCT01976364|69441666|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
37798834|NCT01976364|69441667|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
37798835|NCT01976364|69441665|FG000|Sub-study (12 Months)|Protocol Violation|0|||
37798836|NCT01976364|69441666|FG001|Sub-study (12 Months)|Protocol Violation|1|||
37798837|NCT01976364|69441667|FG002|Sub-study (12 Months)|Protocol Violation|1|||
37798838|NCT01976364|69441665|FG000|Sub-study (12 Months)|Adverse Event|0|||
37798839|NCT01976364|69441666|FG001|Sub-study (12 Months)|Adverse Event|4|||
37798840|NCT01976364|69441667|FG002|Sub-study (12 Months)|Adverse Event|3|||
37798841|NCT01956240|69441678|FG000|Overall Study|Lost to Follow-up|6|||
37798842|NCT01956240|69441679|FG001|Overall Study|Lost to Follow-up|20|||
37798843|NCT01956240|69441678|FG000|Overall Study|Adverse Event|17|||
37798844|NCT01956240|69441679|FG001|Overall Study|Adverse Event|4|||
37798845|NCT01929876|69441685|FG000|Period 2|Non-Compliance|1|||
37798846|NCT01929408|69441689|FG000|Overall Study|received HCT as initial treatment|8|||
37798847|NCT01929018|69441695|FG000|Overall Study|Lost to Follow-up|1|||
37798848|NCT01929018|69441696|FG001|Overall Study|Lost to Follow-up|0|||
37798849|NCT01929018|69441695|FG000|Overall Study|Hospitalization|0|||
37798850|NCT01929018|69441696|FG001|Overall Study|Hospitalization|1|||
37798851|NCT01928940|69441704|FG000|Overall Study|Adverse Event|0|||
37798852|NCT01928940|69441705|FG001|Overall Study|Adverse Event|1|||
37798853|NCT01928862|69441717|FG000|Overall Study|Lost to Follow-up|1|||
37798854|NCT01928862|69441718|FG001|Overall Study|Lost to Follow-up|0|||
37798855|NCT01928862|69441719|FG002|Overall Study|Lost to Follow-up|0|||
37798856|NCT01928862|69441720|FG003|Overall Study|Lost to Follow-up|0|||
37798857|NCT01928862|69441721|FG004|Overall Study|Lost to Follow-up|1|||
37798858|NCT01954056|69441736|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
37798859|NCT01954056|69441737|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
37798860|NCT01953354|69441745|FG000|Overall Study|Withdrawal by Subject|0|||
37798861|NCT01953354|69441746|FG001|Overall Study|Withdrawal by Subject|1|||
37798862|NCT01953354|69441745|FG000|Overall Study|Decision of Sponsor|0|||
37798863|NCT01953354|69441746|FG001|Overall Study|Decision of Sponsor|1|||
37798864|NCT01953354|69441745|FG000|Overall Study|Disease Exacerbation|1|||
37798865|NCT01953354|69441746|FG001|Overall Study|Disease Exacerbation|0|||
37798866|NCT01975272|69441755|FG000|Overall Study|Excluded after protocol amendment|1|||
37798867|NCT01975272|69441756|FG001|Overall Study|Excluded after protocol amendment|1|||
37798868|NCT01975272|69441757|FG002|Overall Study|Excluded after protocol amendment|2|||
37798869|NCT01951638|69441770|FG000|Treatment Period|Protocol Violation|0|||
37798870|NCT01951638|69441771|FG001|Treatment Period|Protocol Violation|0|||
37798871|NCT01951638|69441772|FG002|Treatment Period|Protocol Violation|0|||
37798872|NCT01951638|69441773|FG003|Treatment Period|Protocol Violation|2|||
37798873|NCT01951638|69441774|FG004|Treatment Period|Protocol Violation|0|||
37798874|NCT01951638|69441770|FG000|Treatment Period|Protocol-driven decision point|1|||
37798875|NCT01951638|69441771|FG001|Treatment Period|Protocol-driven decision point|3|||
37798876|NCT01951638|69441772|FG002|Treatment Period|Protocol-driven decision point|0|||
37798877|NCT01951638|69441773|FG003|Treatment Period|Protocol-driven decision point|0|||
37798878|NCT01951638|69441774|FG004|Treatment Period|Protocol-driven decision point|0|||
37798879|NCT01951638|69441770|FG000|Treatment Period|Logistical difficulties|0|||
37798880|NCT01951638|69441771|FG001|Treatment Period|Logistical difficulties|1|||
37798881|NCT01951638|69441772|FG002|Treatment Period|Logistical difficulties|1|||
37798882|NCT01951638|69441773|FG003|Treatment Period|Logistical difficulties|0|||
37798883|NCT01951638|69441774|FG004|Treatment Period|Logistical difficulties|0|||
37798884|NCT01951638|69441770|FG000|Treatment Period|Withdrawal by Subject|9|||
37798885|NCT01951638|69441771|FG001|Treatment Period|Withdrawal by Subject|6|||
37798886|NCT01951638|69441772|FG002|Treatment Period|Withdrawal by Subject|4|||
37798887|NCT01951638|69441773|FG003|Treatment Period|Withdrawal by Subject|5|||
37798888|NCT01951638|69441774|FG004|Treatment Period|Withdrawal by Subject|4|||
37798889|NCT01951638|69441770|FG000|Treatment Period|Death|0|||
37798890|NCT01951638|69441771|FG001|Treatment Period|Death|0|||
37798891|NCT01951638|69441772|FG002|Treatment Period|Death|0|||
37798892|NCT01951638|69441773|FG003|Treatment Period|Death|3|||
37798893|NCT01951638|69441774|FG004|Treatment Period|Death|1|||
37798894|NCT01951638|69441770|FG000|Treatment Period|Adverse Event|3|||
37798895|NCT01951638|69441771|FG001|Treatment Period|Adverse Event|4|||
37798896|NCT01951638|69441772|FG002|Treatment Period|Adverse Event|8|||
37798897|NCT01951638|69441773|FG003|Treatment Period|Adverse Event|6|||
37798898|NCT01951638|69441774|FG004|Treatment Period|Adverse Event|5|||
37798899|NCT01951638|69441770|FG000|Follow-up Period|Protocol Violation|0|||
37798900|NCT01951638|69441771|FG001|Follow-up Period|Protocol Violation|0|||
37798901|NCT01951638|69441772|FG002|Follow-up Period|Protocol Violation|0|||
37798902|NCT01951638|69441773|FG003|Follow-up Period|Protocol Violation|1|||
37798903|NCT01951638|69441774|FG004|Follow-up Period|Protocol Violation|0|||
37798904|NCT01951638|69441770|FG000|Follow-up Period|Logistical difficulties|0|||
37798905|NCT01951638|69441771|FG001|Follow-up Period|Logistical difficulties|2|||
37798906|NCT01951638|69441772|FG002|Follow-up Period|Logistical difficulties|0|||
37798907|NCT01951638|69441773|FG003|Follow-up Period|Logistical difficulties|0|||
37798908|NCT01951638|69441774|FG004|Follow-up Period|Logistical difficulties|1|||
37798909|NCT01951638|69441770|FG000|Follow-up Period|Withdrawal by Subject|1|||
37798910|NCT01951638|69441771|FG001|Follow-up Period|Withdrawal by Subject|5|||
37798911|NCT01951638|69441772|FG002|Follow-up Period|Withdrawal by Subject|2|||
37798912|NCT01951638|69441773|FG003|Follow-up Period|Withdrawal by Subject|1|||
37798913|NCT01951638|69441774|FG004|Follow-up Period|Withdrawal by Subject|2|||
37798914|NCT01951638|69441770|FG000|Follow-up Period|Lost to Follow-up|0|||
37798915|NCT01951638|69441771|FG001|Follow-up Period|Lost to Follow-up|1|||
37798916|NCT01951638|69441772|FG002|Follow-up Period|Lost to Follow-up|0|||
37798917|NCT01951638|69441773|FG003|Follow-up Period|Lost to Follow-up|1|||
37798918|NCT01951638|69441774|FG004|Follow-up Period|Lost to Follow-up|0|||
37798919|NCT01951638|69441770|FG000|Follow-up Period|Death|1|||
37798920|NCT01951638|69441771|FG001|Follow-up Period|Death|0|||
37798921|NCT01951638|69441772|FG002|Follow-up Period|Death|1|||
37798922|NCT01951638|69441773|FG003|Follow-up Period|Death|4|||
37798923|NCT01951638|69441774|FG004|Follow-up Period|Death|1|||
37798924|NCT01951638|69441770|FG000|Follow-up Period|Adverse Event|0|||
37798925|NCT01951638|69441771|FG001|Follow-up Period|Adverse Event|1|||
37798926|NCT01951638|69441772|FG002|Follow-up Period|Adverse Event|2|||
37798927|NCT01951638|69441773|FG003|Follow-up Period|Adverse Event|1|||
37798928|NCT01951638|69441774|FG004|Follow-up Period|Adverse Event|1|||
37798929|NCT01928472|69441790|FG000|Overall Study|Death|0|||
37798930|NCT01928472|69441791|FG001|Overall Study|Death|0|||
37798931|NCT01928472|69441792|FG002|Overall Study|Death|1|||
37798932|NCT01928472|69441793|FG003|Overall Study|Death|0|||
37798933|NCT01928472|69441790|FG000|Overall Study|Withdrawal by Subject|4|||
37798934|NCT01928472|69441791|FG001|Overall Study|Withdrawal by Subject|4|||
37798935|NCT01928472|69441792|FG002|Overall Study|Withdrawal by Subject|1|||
37693892|NCT02039505|69170141|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
37798936|NCT01928472|69441793|FG003|Overall Study|Withdrawal by Subject|2|||
37798937|NCT01928472|69441790|FG000|Overall Study|Lost to Follow-up|2|||
37798938|NCT01928472|69441791|FG001|Overall Study|Lost to Follow-up|3|||
37798939|NCT01928472|69441792|FG002|Overall Study|Lost to Follow-up|4|||
37798940|NCT01928472|69441793|FG003|Overall Study|Lost to Follow-up|0|||
37798941|NCT01928472|69441790|FG000|Overall Study|Administrative Reason|2|||
37798942|NCT01928472|69441791|FG001|Overall Study|Administrative Reason|1|||
37798943|NCT01928472|69441792|FG002|Overall Study|Administrative Reason|0|||
37798944|NCT01928472|69441793|FG003|Overall Study|Administrative Reason|0|||
37798945|NCT01928472|69441790|FG000|Overall Study|Unclassified|0|||
37798946|NCT01928472|69441791|FG001|Overall Study|Unclassified|0|||
37798947|NCT01928472|69441792|FG002|Overall Study|Unclassified|1|||
37798948|NCT01928472|69441793|FG003|Overall Study|Unclassified|0|||
37798949|NCT01351415|69443654|FG000|Overall Study|Withdrawal by Subject|15|||
37798950|NCT01351415|69443655|FG001|Overall Study|Withdrawal by Subject|17|||
37798951|NCT01351415|69443654|FG000|Overall Study|Trial termination by the Sponsor|28|||
37798952|NCT01351415|69443655|FG001|Overall Study|Trial termination by the Sponsor|19|||
37798953|NCT01351415|69443654|FG000|Overall Study|Lost to Follow-up|5|||
37798954|NCT01351415|69443655|FG001|Overall Study|Lost to Follow-up|7|||
37798955|NCT01351415|69443654|FG000|Overall Study|Death|190|||
37798956|NCT01351415|69443655|FG001|Overall Study|Death|187|||
37798957|NCT01351415|69443654|FG000|Overall Study|Physician Decision|2|||
37798958|NCT01351415|69443655|FG001|Overall Study|Physician Decision|3|||
37798959|NCT01351415|69443654|FG000|Overall Study|Reason unknown|0|||
37798960|NCT01351415|69443655|FG001|Overall Study|Reason unknown|2|||
37798961|NCT01351415|69443654|FG000|Overall Study|Never Started|5|||
37798962|NCT01351415|69443655|FG001|Overall Study|Never Started|5|||
37798963|NCT04811339|69443763|FG000|Overall Study|lack of transportation not wanting to return|4|||
37798964|NCT04811339|69443764|FG001|Overall Study|lack of transportation not wanting to return|8|||
37798965|NCT04811339|69443765|FG002|Overall Study|lack of transportation not wanting to return|0|||
37798966|NCT04811339|69443763|FG000|Overall Study|Adverse Event|3|||
37798967|NCT04811339|69443764|FG001|Overall Study|Adverse Event|0|||
37798968|NCT04811339|69443765|FG002|Overall Study|Adverse Event|0|||
37798969|NCT04811339|69443763|FG000|Overall Study|Lost to Follow-up|1|||
37798970|NCT04811339|69443764|FG001|Overall Study|Lost to Follow-up|0|||
37798971|NCT04811339|69443765|FG002|Overall Study|Lost to Follow-up|0|||
37798972|NCT04811339|69443763|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
37798973|NCT04811339|69443764|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
37798974|NCT04811339|69443765|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
37798975|NCT04811339|69443763|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
37798976|NCT04811339|69443764|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
37798977|NCT04811339|69443765|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
37798978|NCT04811339|69443763|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
37798979|NCT04811339|69443764|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
37798980|NCT04811339|69443765|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
37798981|NCT04811339|69443763|FG000|Overall Study|Withdrawal by Subject|0|||
37798982|NCT04811339|69443764|FG001|Overall Study|Withdrawal by Subject|3|||
37798983|NCT04811339|69443765|FG002|Overall Study|Withdrawal by Subject|0|||
37798984|NCT04811339|69443763|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
37798985|NCT04811339|69443764|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
37798986|NCT04811339|69443765|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
37798987|NCT04811339|69443763|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
37798988|NCT04811339|69443764|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
37798989|NCT04811339|69443765|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
37798990|NCT04332107|69443777|FG000|Day 3|Lost to Follow-up|23|||
37798991|NCT04332107|69443778|FG001|Day 3|Lost to Follow-up|14|||
37798992|NCT04332107|69443777|FG000|Day 3|Missing outcome data|3|||
37798993|NCT04332107|69443778|FG001|Day 3|Missing outcome data|6|||
37798994|NCT04332107|69443777|FG000|Day 14|Lost to Follow-up|13|||
37798995|NCT04332107|69443778|FG001|Day 14|Lost to Follow-up|4|||
37798996|NCT04332107|69443777|FG000|Day 14|Missing outcome data|4|||
37798997|NCT04332107|69443778|FG001|Day 14|Missing outcome data|4|||
37798998|NCT04332107|69443777|FG000|Day 21|Lost to Follow-up|10|||
37798999|NCT04332107|69443778|FG001|Day 21|Lost to Follow-up|2|||
37799000|NCT03375203|69443793|FG000|Overall Study|Protocol Violation|0|||
37799001|NCT03375203|69443794|FG001|Overall Study|Protocol Violation|0|||
37799002|NCT03375203|69443795|FG002|Overall Study|Protocol Violation|1|||
37799003|NCT03375203|69443796|FG003|Overall Study|Protocol Violation|0|||
37799004|NCT03375203|69443797|FG004|Overall Study|Protocol Violation|0|||
37799005|NCT03375203|69443793|FG000|Overall Study|Adverse Event|2|||
37799006|NCT03375203|69443794|FG001|Overall Study|Adverse Event|3|||
37799007|NCT03375203|69443795|FG002|Overall Study|Adverse Event|0|||
37799008|NCT03375203|69443796|FG003|Overall Study|Adverse Event|2|||
37799009|NCT03375203|69443797|FG004|Overall Study|Adverse Event|2|||
37799010|NCT03375203|69443793|FG000|Overall Study|Withdrawal by Subject|3|||
37799011|NCT03375203|69443794|FG001|Overall Study|Withdrawal by Subject|0|||
37799012|NCT03375203|69443795|FG002|Overall Study|Withdrawal by Subject|1|||
37799013|NCT03375203|69443796|FG003|Overall Study|Withdrawal by Subject|0|||
37799014|NCT03375203|69443797|FG004|Overall Study|Withdrawal by Subject|2|||
37799015|NCT03375203|69443793|FG000|Overall Study|Non-compliance with study drug|1|||
37799016|NCT03375203|69443794|FG001|Overall Study|Non-compliance with study drug|0|||
37799017|NCT03375203|69443795|FG002|Overall Study|Non-compliance with study drug|0|||
37799018|NCT03375203|69443796|FG003|Overall Study|Non-compliance with study drug|0|||
37799019|NCT03375203|69443797|FG004|Overall Study|Non-compliance with study drug|0|||
37799020|NCT03375203|69443793|FG000|Overall Study|Randomized, not treated.|0|||
37799021|NCT03375203|69443794|FG001|Overall Study|Randomized, not treated.|1|||
37799022|NCT03375203|69443795|FG002|Overall Study|Randomized, not treated.|0|||
37799023|NCT03375203|69443796|FG003|Overall Study|Randomized, not treated.|0|||
37799024|NCT03375203|69443797|FG004|Overall Study|Randomized, not treated.|0|||
37799025|NCT03075839|69443819|FG000|Overall Study|Lost to Follow-up|4|||
37799026|NCT02919683|69443825|FG000|Post-Surgery Follow-Up|Death|2|||
37799027|NCT02919683|69443826|FG001|Post-Surgery Follow-Up|Death|2|||
37799028|NCT02919683|69443825|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
37799029|NCT02919683|69443826|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
37799030|NCT01928082|69443833|FG000|Overall Study|Study terminated.|1|||
37799031|NCT01972776|69443843|FG000|Part 1|Withdrawal by Subject|0|||
37799032|NCT01972776|69443844|FG001|Part 1|Withdrawal by Subject|0|||
37799033|NCT01972776|69443845|FG002|Part 1|Withdrawal by Subject|1|||
37799034|NCT01972776|69443846|FG003|Part 1|Withdrawal by Subject|0|||
37799035|NCT01972776|69443847|FG004|Part 1|Withdrawal by Subject|0|||
37799036|NCT01972776|69443848|FG005|Part 1|Withdrawal by Subject|0|||
37799037|NCT01972776|69443843|FG000|Part 1|Adverse Event|0|||
37799038|NCT01972776|69443844|FG001|Part 1|Adverse Event|0|||
37799039|NCT01972776|69443845|FG002|Part 1|Adverse Event|1|||
37799040|NCT01972776|69443846|FG003|Part 1|Adverse Event|1|||
37799041|NCT01972776|69443847|FG004|Part 1|Adverse Event|0|||
37799042|NCT01972776|69443848|FG005|Part 1|Adverse Event|0|||
37799043|NCT01972776|69443843|FG000|Part 2|Adverse Event|0|||
37799044|NCT01972776|69443844|FG001|Part 2|Adverse Event|0|||
37799045|NCT01972776|69443845|FG002|Part 2|Adverse Event|0|||
37799046|NCT01972776|69443846|FG003|Part 2|Adverse Event|0|||
37799047|NCT01972776|69443847|FG004|Part 2|Adverse Event|3|||
37799048|NCT01972776|69443848|FG005|Part 2|Adverse Event|0|||
37799049|NCT01972776|69443843|FG000|Part 2|Administrative problems|0|||
37799050|NCT01972776|69443844|FG001|Part 2|Administrative problems|0|||
37799051|NCT01972776|69443845|FG002|Part 2|Administrative problems|0|||
37799052|NCT01972776|69443846|FG003|Part 2|Administrative problems|0|||
37799053|NCT01972776|69443847|FG004|Part 2|Administrative problems|10|||
37799054|NCT01972776|69443848|FG005|Part 2|Administrative problems|7|||
37799055|NCT03763331|69443864|FG000|Overall Study|Lost to Follow-up|1|||
37799056|NCT03763331|69443865|FG001|Overall Study|Lost to Follow-up|0|||
37799057|NCT03763331|69443864|FG000|Overall Study|Withdrawal by Subject|1|||
37799058|NCT03763331|69443865|FG001|Overall Study|Withdrawal by Subject|0|||
37799059|NCT03763331|69443864|FG000|Overall Study|Non-compliance|0|||
37799060|NCT03763331|69443865|FG001|Overall Study|Non-compliance|3|||
37799061|NCT00001259|69443892|FG000|Study 2|Adverse Event|0|||
37799062|NCT00001259|69443893|FG001|Study 2|Adverse Event|0|||
37799063|NCT00001259|69443894|FG002|Study 2|Adverse Event|0|||
37799064|NCT00001259|69443895|FG003|Study 2|Adverse Event|0|||
37799065|NCT00001259|69443896|FG004|Study 2|Adverse Event|2|||
37799066|NCT00001259|69443897|FG005|Study 2|Adverse Event|0|||
37799067|NCT00001259|69443898|FG006|Study 2|Adverse Event|0|||
37799068|NCT01926444|69443912|FG000|Overall Study|Colonoscopy not performed|0|||
37799069|NCT01926444|69443913|FG001|Overall Study|Colonoscopy not performed|0|||
37799070|NCT01926444|69443914|FG002|Overall Study|Colonoscopy not performed|4|||
37799071|NCT01926444|69443915|FG003|Overall Study|Colonoscopy not performed|2|||
37799072|NCT05003167|69443925|FG000|Overall Study|Withdrawal by Subject|1|||
37799073|NCT04988035|69443931|FG000|Overall Study|Death|19|||
37799074|NCT04988035|69443932|FG001|Overall Study|Death|13|||
37799075|NCT04988035|69443931|FG000|Overall Study|Lost to Follow-up|12|||
37799076|NCT04988035|69443932|FG001|Overall Study|Lost to Follow-up|6|||
37799077|NCT04988035|69443931|FG000|Overall Study|Protocol Violation|0|||
37799078|NCT04988035|69443932|FG001|Overall Study|Protocol Violation|1|||
37799079|NCT04988035|69443931|FG000|Overall Study|Withdrawal by Subject|2|||
37799080|NCT04988035|69443932|FG001|Overall Study|Withdrawal by Subject|4|||
37799081|NCT04988035|69443931|FG000|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
37799082|NCT04988035|69443932|FG001|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
37799083|NCT04847674|69443950|FG000|Overall Study|Withdrawal by Subject|0|||
37799084|NCT04847674|69443951|FG001|Overall Study|Withdrawal by Subject|1|||
37799085|NCT04847674|69443952|FG002|Overall Study|Withdrawal by Subject|0|||
37799086|NCT04847674|69443950|FG000|Overall Study|Lost to Follow-up|0|||
37799087|NCT04847674|69443951|FG001|Overall Study|Lost to Follow-up|0|||
37799088|NCT04847674|69443952|FG002|Overall Study|Lost to Follow-up|2|||
37799089|NCT04847674|69443950|FG000|Overall Study|Other than specified|21|||
37799090|NCT04847674|69443951|FG001|Overall Study|Other than specified|20|||
37799091|NCT04847674|69443952|FG002|Overall Study|Other than specified|20|||
37799092|NCT04649060|69443964|FG000|Arm A/Arm B Treatment|Adverse Event|0|||
37799093|NCT04649060|69443965|FG001|Arm A/Arm B Treatment|Adverse Event|3|||
37799094|NCT04649060|69443964|FG000|Arm A/Arm B Treatment|Physician Decision|1|||
37799095|NCT04649060|69443965|FG001|Arm A/Arm B Treatment|Physician Decision|1|||
37799096|NCT04649060|69443964|FG000|Arm A/Arm B Treatment|Progressive Disease|3|||
37799097|NCT04649060|69443965|FG001|Arm A/Arm B Treatment|Progressive Disease|12|||
37799098|NCT04649060|69443964|FG000|Arm A/Arm B Treatment|Study Terminated by Sponsor|17|||
37799099|NCT04649060|69443965|FG001|Arm A/Arm B Treatment|Study Terminated by Sponsor|10|||
37799100|NCT04649060|69443964|FG000|Arm A/Arm B Treatment|Patient Request|1|||
37799101|NCT04649060|69443965|FG001|Arm A/Arm B Treatment|Patient Request|0|||
37799102|NCT04649060|69443964|FG000|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|4|||
37799103|NCT04649060|69443965|FG001|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|1|||
37799104|NCT04649060|69443964|FG000|Arm A/Arm B Treatment|Other|1|||
37799105|NCT04649060|69443965|FG001|Arm A/Arm B Treatment|Other|0|||
37799106|NCT04649060|69443964|FG000|Crossover (Arm B)|Adverse Event|0|||
37799107|NCT04649060|69443965|FG001|Crossover (Arm B)|Adverse Event|1|||
37799108|NCT04649060|69443964|FG000|Crossover (Arm B)|Lost to Follow-up|0|||
37799109|NCT04649060|69443965|FG001|Crossover (Arm B)|Lost to Follow-up|1|||
37799110|NCT04640272|69443972|FG000|Overall Study|Subject moved out of area|1|||
37799111|NCT04511650|69443979|FG000|Overall Study|Lost to Follow-up|1|||
37799112|NCT04511650|69443980|FG001|Overall Study|Lost to Follow-up|0|||
37799113|NCT04511650|69443981|FG002|Overall Study|Lost to Follow-up|0|||
37799114|NCT04511650|69443979|FG000|Overall Study|Withdrawal by Subject|1|||
37799115|NCT04511650|69443980|FG001|Overall Study|Withdrawal by Subject|0|||
37799116|NCT04511650|69443981|FG002|Overall Study|Withdrawal by Subject|0|||
37799117|NCT04511650|69443979|FG000|Overall Study|reason not provided|0|||
37799118|NCT04511650|69443980|FG001|Overall Study|reason not provided|0|||
37799119|NCT04511650|69443981|FG002|Overall Study|reason not provided|1|||
37799120|NCT04511650|69443979|FG000|Overall Study|Death|1|||
37799121|NCT04511650|69443980|FG001|Overall Study|Death|1|||
37799122|NCT04511650|69443981|FG002|Overall Study|Death|1|||
37799123|NCT04285580|69444013|FG000|Overall Study|Protocol Violation|0|||
37799124|NCT04285580|69444014|FG001|Overall Study|Protocol Violation|1|||
37799125|NCT04200248|69444032|FG000|Overall Study|Personal reasons|0|||
37799126|NCT04200248|69444033|FG001|Overall Study|Personal reasons|0|||
37799127|NCT04200248|69444034|FG002|Overall Study|Personal reasons|1|||
37799128|NCT04200248|69444032|FG000|Overall Study|Discontinued prior to treatment|3|||
37799129|NCT04200248|69444033|FG001|Overall Study|Discontinued prior to treatment|3|||
37799130|NCT04200248|69444034|FG002|Overall Study|Discontinued prior to treatment|2|||
37799131|NCT04137887|69444044|FG000|Overall Study|Death|102|||
37799132|NCT04137887|69444045|FG001|Overall Study|Death|92|||
37799133|NCT04137887|69444044|FG000|Overall Study|Withdrawal by Subject|2|||
37799134|NCT04137887|69444045|FG001|Overall Study|Withdrawal by Subject|3|||
37799135|NCT04137887|69444044|FG000|Overall Study|Randomized but not treated|0|||
37799136|NCT04137887|69444045|FG001|Overall Study|Randomized but not treated|1|||
37799137|NCT04074590|69444053|FG000|Overall Study|Adverse Event|1|||
37799138|NCT04074590|69444054|FG001|Overall Study|Adverse Event|0|||
37799139|NCT04074590|69444053|FG000|Overall Study|Physician Decision|1|||
37799140|NCT04074590|69444054|FG001|Overall Study|Physician Decision|0|||
37799141|NCT04074590|69444053|FG000|Overall Study|Withdrawal by Subject|2|||
37799142|NCT04074590|69444054|FG001|Overall Study|Withdrawal by Subject|0|||
37799143|NCT03557008|69444091|FG000|Overall Study|Withdrawal by Subject|2|||
37799144|NCT03557008|69444092|FG001|Overall Study|Withdrawal by Subject|2|||
37799145|NCT03557008|69444091|FG000|Overall Study|Early termination from study|3|||
37799146|NCT03557008|69444092|FG001|Overall Study|Early termination from study|1|||
37799147|NCT03040999|69444100|FG000|Overall Study|Lost to Follow-up|1|||
37799148|NCT03040999|69444101|FG001|Overall Study|Lost to Follow-up|0|||
37799149|NCT03040999|69444100|FG000|Overall Study|Withdrawal by Subject|7|||
37799150|NCT03040999|69444101|FG001|Overall Study|Withdrawal by Subject|12|||
37799151|NCT03040999|69444100|FG000|Overall Study|Death|128|||
37799152|NCT03040999|69444101|FG001|Overall Study|Death|138|||
37799153|NCT03040999|69444100|FG000|Overall Study|Participants Ongoing in Trial|266|||
37799154|NCT03040999|69444101|FG001|Overall Study|Participants Ongoing in Trial|252|||
37799155|NCT02366728|69444110|FG000|Overall Study|Death|0|||
37799156|NCT02366728|69444111|FG001|Overall Study|Death|0|||
37799157|NCT02366728|69444112|FG002|Overall Study|Death|1|||
37799158|NCT02366728|69444110|FG000|Overall Study|Adverse Event|1|||
37799159|NCT02366728|69444111|FG001|Overall Study|Adverse Event|0|||
37799160|NCT02366728|69444112|FG002|Overall Study|Adverse Event|0|||
37799161|NCT02366728|69444110|FG000|Overall Study|Screen Failure|2|||
37799162|NCT02366728|69444111|FG001|Overall Study|Screen Failure|1|||
37799163|NCT02366728|69444112|FG002|Overall Study|Screen Failure|0|||
37799164|NCT02366728|69444110|FG000|Overall Study|Only yielded 2 vaccines|1|||
37799165|NCT02366728|69444111|FG001|Overall Study|Only yielded 2 vaccines|0|||
37799166|NCT02366728|69444112|FG002|Overall Study|Only yielded 2 vaccines|0|||
37799167|NCT02355002|69444122|FG000|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|1|||
37799168|NCT02355002|69444123|FG001|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|0|||
37799169|NCT02355002|69444122|FG000|Period 1: Phase 1, Randomized-Controlled|Adverse Event|1|||
37799170|NCT02355002|69444123|FG001|Period 1: Phase 1, Randomized-Controlled|Adverse Event|0|||
37799171|NCT02355002|69444122|FG000|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
37799172|NCT02355002|69444123|FG001|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
37799173|NCT02355002|69444122|FG000|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|0|||
37799174|NCT02355002|69444123|FG001|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|1|||
37799175|NCT02355002|69444122|FG000|Period 2: Phase 2 Open-Label|Withdrawal by Subject|2|||
37799176|NCT02355002|69444123|FG001|Period 2: Phase 2 Open-Label|Withdrawal by Subject|0|||
37799177|NCT02355002|69444122|FG000|Period 2: Phase 2 Open-Label|Participant left country|1|||
37799178|NCT02355002|69444123|FG001|Period 2: Phase 2 Open-Label|Participant left country|0|||
37799179|NCT02355002|69444122|FG000|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
37799180|NCT02355002|69444123|FG001|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
37799181|NCT02246920|69444133|FG000|Overall Study|Adverse Event|3|||
37799182|NCT02246920|69444134|FG001|Overall Study|Adverse Event|1|||
37799183|NCT02246920|69444135|FG002|Overall Study|Adverse Event|1|||
37799184|NCT02246920|69444133|FG000|Overall Study|Lost to Follow-up|2|||
37799185|NCT02246920|69444134|FG001|Overall Study|Lost to Follow-up|1|||
37799186|NCT02246920|69444135|FG002|Overall Study|Lost to Follow-up|0|||
37799187|NCT02246920|69444133|FG000|Overall Study|Protocol Violation|2|||
37799188|NCT02246920|69444134|FG001|Overall Study|Protocol Violation|5|||
37799189|NCT02246920|69444135|FG002|Overall Study|Protocol Violation|1|||
37799190|NCT02246920|69444133|FG000|Overall Study|Withdrawal by Subject|0|||
37799191|NCT02246920|69444134|FG001|Overall Study|Withdrawal by Subject|0|||
37799192|NCT02246920|69444135|FG002|Overall Study|Withdrawal by Subject|1|||
37799193|NCT01832402|69444145|FG000|Overall Study|Lost to Follow-up|2|||
37799194|NCT01832402|69444146|FG001|Overall Study|Lost to Follow-up|0|||
37799195|NCT01832402|69444145|FG000|Overall Study|Withdrawal by Subject|3|||
37799196|NCT01832402|69444146|FG001|Overall Study|Withdrawal by Subject|3|||
37799197|NCT01832402|69444145|FG000|Overall Study|Declining Performance status|2|||
37799198|NCT01832402|69444146|FG001|Overall Study|Declining Performance status|1|||
37799199|NCT01661881|69444156|FG000|Overall Study|Disease Progression|1|||
37799200|NCT00667628|69444167|FG000|Overall Study|Lost to Follow-up|1|||
37799201|NCT00667628|69444168|FG001|Overall Study|Lost to Follow-up|0|||
37799202|NCT00667628|69444167|FG000|Overall Study|Death|6|||
37799203|NCT00667628|69444168|FG001|Overall Study|Death|6|||
37799204|NCT00667628|69444167|FG000|Overall Study|Investigator Considers in Best Interest|1|||
37799205|NCT00667628|69444168|FG001|Overall Study|Investigator Considers in Best Interest|0|||
37799206|NCT00667628|69444167|FG000|Overall Study|Sponsor Terminated Study|17|||
37799207|NCT00667628|69444168|FG001|Overall Study|Sponsor Terminated Study|21|||
37799208|NCT01597908|69444180|FG000|Randomized Phase|Death|217|||
37799209|NCT01597908|69444181|FG001|Randomized Phase|Death|238|||
37799210|NCT01597908|69444182|FG002|Randomized Phase|Death|0|||
37799211|NCT01597908|69444180|FG000|Randomized Phase|Sponsor Decision|93|||
37799212|NCT01597908|69444181|FG001|Randomized Phase|Sponsor Decision|39|||
37799213|NCT01597908|69444182|FG002|Randomized Phase|Sponsor Decision|0|||
37799214|NCT01597908|69444180|FG000|Randomized Phase|Lost to Follow-up|9|||
37799215|NCT01597908|69444181|FG001|Randomized Phase|Lost to Follow-up|16|||
37799216|NCT01597908|69444182|FG002|Randomized Phase|Lost to Follow-up|0|||
37799217|NCT01597908|69444180|FG000|Randomized Phase|Physician Decision|6|||
37799218|NCT01597908|69444181|FG001|Randomized Phase|Physician Decision|3|||
37799219|NCT01597908|69444182|FG002|Randomized Phase|Physician Decision|0|||
37799220|NCT01597908|69444180|FG000|Randomized Phase|Withdrawal by Subject|26|||
37799221|NCT01597908|69444181|FG001|Randomized Phase|Withdrawal by Subject|22|||
37799222|NCT01597908|69444182|FG002|Randomized Phase|Withdrawal by Subject|0|||
37799223|NCT01597908|69444180|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
37799224|NCT01597908|69444181|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
37799225|NCT01597908|69444182|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
37799226|NCT01597908|69444180|FG000|Crossover Phase|Death|0|||
37799227|NCT01597908|69444181|FG001|Crossover Phase|Death|0|||
37799228|NCT01597908|69444182|FG002|Crossover Phase|Death|11|||
37799229|NCT01597908|69444180|FG000|Crossover Phase|Withdrawal by Subject|0|||
37799230|NCT01597908|69444181|FG001|Crossover Phase|Withdrawal by Subject|0|||
37799231|NCT01597908|69444182|FG002|Crossover Phase|Withdrawal by Subject|3|||
37799232|NCT01597908|69444180|FG000|Crossover Phase|Sponsor Decision|0|||
37799233|NCT01597908|69444181|FG001|Crossover Phase|Sponsor Decision|0|||
37799234|NCT01597908|69444182|FG002|Crossover Phase|Sponsor Decision|20|||
37799235|NCT01951170|69444191|FG000|Overall Study|Investigator decision|1|||
37799236|NCT01951092|69444195|FG000|Overall Study|Lost to Follow-up|10|||
37799237|NCT01951092|69444195|FG000|Overall Study|Incarceration|1|||
37799238|NCT01951092|69444195|FG000|Overall Study|Transfer of Care|1|||
37799239|NCT01949532|69444201|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
37799240|NCT01949532|69444202|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
37799241|NCT01949142|69444210|FG000|Overall Study|Withdrawal of consent|1|||
37799242|NCT01949142|69444211|FG001|Overall Study|Withdrawal of consent|0|||
37799243|NCT01949142|69444210|FG000|Overall Study|Lost to Follow-up|1|||
37799244|NCT01949142|69444211|FG001|Overall Study|Lost to Follow-up|1|||
37799245|NCT01949142|69444210|FG000|Overall Study|Parent changed their mind|1|||
37799246|NCT01949142|69444211|FG001|Overall Study|Parent changed their mind|0|||
37799247|NCT01948908|69444221|FG000|Overall Study|Protocol Violation|1|||
37799248|NCT01948908|69444222|FG001|Overall Study|Protocol Violation|0|||
37799249|NCT01948908|69444223|FG002|Overall Study|Protocol Violation|2|||
37799250|NCT01925274|69444234|FG000|Overall Study|Death|1|||
37799251|NCT01925274|69444235|FG001|Overall Study|Death|0|||
37799252|NCT01925274|69444236|FG002|Overall Study|Death|0|||
37799253|NCT01925274|69444234|FG000|Overall Study|Lost to Follow-up|0|||
37799254|NCT01925274|69444235|FG001|Overall Study|Lost to Follow-up|1|||
37799255|NCT01925274|69444236|FG002|Overall Study|Lost to Follow-up|0|||
37799256|NCT01925274|69444234|FG000|Overall Study|Withdrawal by Subject|1|||
37799257|NCT01925274|69444235|FG001|Overall Study|Withdrawal by Subject|2|||
37799258|NCT01925274|69444236|FG002|Overall Study|Withdrawal by Subject|0|||
37799259|NCT01925274|69444234|FG000|Overall Study|Study terminated by sponsor|4|||
37799260|NCT01925274|69444235|FG001|Overall Study|Study terminated by sponsor|0|||
37799261|NCT01925274|69444236|FG002|Overall Study|Study terminated by sponsor|0|||
37799262|NCT01925274|69444234|FG000|Overall Study|Protocol amendment|1|||
37799263|NCT01925274|69444235|FG001|Overall Study|Protocol amendment|3|||
37799264|NCT01925274|69444236|FG002|Overall Study|Protocol amendment|6|||
37799265|NCT01948830|69444248|FG000|Overall Study|Physician Decision|1|||
37799266|NCT01948830|69444249|FG001|Overall Study|Physician Decision|3|||
37799267|NCT01948830|69444248|FG000|Overall Study|Protocol deviation|1|||
37799268|NCT01948830|69444249|FG001|Overall Study|Protocol deviation|2|||
37799269|NCT01948830|69444248|FG000|Overall Study|Lost to Follow-up|5|||
37799270|NCT01948830|69444249|FG001|Overall Study|Lost to Follow-up|4|||
37799271|NCT01948830|69444248|FG000|Overall Study|Withdrawal by Subject|14|||
37799272|NCT01948830|69444249|FG001|Overall Study|Withdrawal by Subject|17|||
37799273|NCT01948830|69444248|FG000|Overall Study|Adverse Event|9|||
37799274|NCT01948830|69444249|FG001|Overall Study|Adverse Event|2|||
37799275|NCT01948830|69444248|FG000|Overall Study|Death|3|||
37799276|NCT01948830|69444249|FG001|Overall Study|Death|4|||
37799277|NCT01972464|69444257|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
37799278|NCT01972464|69444258|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
37799279|NCT01972464|69444257|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
37799280|NCT01972464|69444258|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
37799281|NCT01972464|69444257|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
37799282|NCT01972464|69444258|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
37799283|NCT01972464|69444257|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
37799284|NCT01972464|69444258|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
37799285|NCT01948050|69444267|FG000|Overall Study|Withdrawal by Subject|0|||
37799286|NCT01948050|69444268|FG001|Overall Study|Withdrawal by Subject|1|||
37799287|NCT01947894|69444277|FG000|Overall Study|Other|3|||
37799288|NCT01947894|69444278|FG001|Overall Study|Other|4|||
37799289|NCT01947894|69444279|FG002|Overall Study|Other|3|||
37799290|NCT01947894|69444277|FG000|Overall Study|Withdrawal by Subject|12|||
37799291|NCT01947894|69444278|FG001|Overall Study|Withdrawal by Subject|4|||
37799292|NCT01947894|69444279|FG002|Overall Study|Withdrawal by Subject|1|||
37799293|NCT01947894|69444277|FG000|Overall Study|Death|12|||
37799294|NCT01947894|69444278|FG001|Overall Study|Death|1|||
37799295|NCT01947894|69444279|FG002|Overall Study|Death|0|||
37799296|NCT01947894|69444277|FG000|Overall Study|Physician Decision|2|||
37799297|NCT01947894|69444278|FG001|Overall Study|Physician Decision|0|||
37799298|NCT01947894|69444279|FG002|Overall Study|Physician Decision|0|||
37799299|NCT01947894|69444277|FG000|Overall Study|Adverse Event|5|||
37799300|NCT01947894|69444278|FG001|Overall Study|Adverse Event|1|||
37799301|NCT01947894|69444279|FG002|Overall Study|Adverse Event|0|||
37799302|NCT01947894|69444277|FG000|Overall Study|Switched to other growth hormone brand|53|||
37799303|NCT01947894|69444278|FG001|Overall Study|Switched to other growth hormone brand|8|||
37799304|NCT01947894|69444279|FG002|Overall Study|Switched to other growth hormone brand|23|||
37799305|NCT01947582|69444287|FG000|Overall Study|Withdrawal by Subject|1|||
37799306|NCT01924806|69444293|FG000|Overall Study|Physician Decision|2|||
37799307|NCT01924806|69444294|FG001|Overall Study|Physician Decision|1|||
37799308|NCT01924182|69444302|FG000|Overall Study|Withdrawal by Subject|1|||
37799309|NCT01924182|69444303|FG001|Overall Study|Withdrawal by Subject|0|||
37799310|NCT01972308|69444311|FG000|Overall Study|Withdrawal by Subject|0|||
37799311|NCT01972308|69444312|FG001|Overall Study|Withdrawal by Subject|1|||
37799312|NCT01972308|69444311|FG000|Overall Study|Lost to Follow-up|4|||
37799313|NCT01972308|69444312|FG001|Overall Study|Lost to Follow-up|6|||
37799314|NCT01972308|69444311|FG000|Overall Study|Death|4|||
37799315|NCT01972308|69444312|FG001|Overall Study|Death|1|||
37799316|NCT01946880|69444322|FG000|Overall Study|Lost to Follow-up|1|||
37799317|NCT01946880|69444323|FG001|Overall Study|Lost to Follow-up|0|||
37799318|NCT01946880|69444322|FG000|Overall Study|Physician Decision|1|||
37799319|NCT01946880|69444323|FG001|Overall Study|Physician Decision|1|||
37799320|NCT01946880|69444322|FG000|Overall Study|Withdrawal by Subject|3|||
37799321|NCT01946880|69444323|FG001|Overall Study|Withdrawal by Subject|2|||
37975672|NCT00316264|69662961|FG002|Overall Study|Other|0|||
37799322|NCT01946880|69444322|FG000|Overall Study|Met Primary Endpoint|1|||
37799323|NCT01946880|69444323|FG001|Overall Study|Met Primary Endpoint|0|||
37799324|NCT01946880|69444322|FG000|Overall Study|Personal and Family Issues|1|||
37799325|NCT01946880|69444323|FG001|Overall Study|Personal and Family Issues|0|||
37799326|NCT01972152|69444329|FG000|First Treatment Visit|Lost to Follow-up|0|||
37799327|NCT01972152|69444330|FG001|First Treatment Visit|Lost to Follow-up|1|||
37799328|NCT01972152|69444331|FG002|First Treatment Visit|Lost to Follow-up|0|||
37799329|NCT01972152|69444332|FG003|First Treatment Visit|Lost to Follow-up|0|||
37799330|NCT01972152|69444333|FG004|First Treatment Visit|Lost to Follow-up|0|||
37799331|NCT01972152|69444334|FG005|First Treatment Visit|Lost to Follow-up|0|||
37799332|NCT01972152|69444329|FG000|Second Treatment Visit|Protocol Violation|0|||
37799333|NCT01972152|69444330|FG001|Second Treatment Visit|Protocol Violation|1|||
37799334|NCT01972152|69444331|FG002|Second Treatment Visit|Protocol Violation|0|||
37799335|NCT01972152|69444332|FG003|Second Treatment Visit|Protocol Violation|0|||
37799336|NCT01972152|69444333|FG004|Second Treatment Visit|Protocol Violation|0|||
37799337|NCT01972152|69444334|FG005|Second Treatment Visit|Protocol Violation|0|||
37799338|NCT01972074|69444348|FG000|Overall Study|Adverse Event|4|||
37799339|NCT01972074|69444349|FG001|Overall Study|Adverse Event|1|||
37799340|NCT01972074|69444350|FG002|Overall Study|Adverse Event|0|||
37799341|NCT01972074|69444348|FG000|Overall Study|Lack of Efficacy|1|||
37799342|NCT01972074|69444349|FG001|Overall Study|Lack of Efficacy|1|||
37799343|NCT01972074|69444350|FG002|Overall Study|Lack of Efficacy|0|||
37799344|NCT01972074|69444348|FG000|Overall Study|Lost to Follow-up|0|||
37799345|NCT01972074|69444349|FG001|Overall Study|Lost to Follow-up|1|||
37799346|NCT01972074|69444350|FG002|Overall Study|Lost to Follow-up|1|||
37799347|NCT01972074|69444348|FG000|Overall Study|Withdrawal by Subject|1|||
37799348|NCT01972074|69444349|FG001|Overall Study|Withdrawal by Subject|1|||
37799349|NCT01972074|69444350|FG002|Overall Study|Withdrawal by Subject|1|||
37799350|NCT01972074|69444348|FG000|Overall Study|Scanner Unavailable|0|||
37799351|NCT01972074|69444349|FG001|Overall Study|Scanner Unavailable|0|||
37799352|NCT01972074|69444350|FG002|Overall Study|Scanner Unavailable|1|||
37799353|NCT01970982|69444360|FG000|Overall Study|Withdrawal by Subject|0|||
37799354|NCT01970982|69444361|FG001|Overall Study|Withdrawal by Subject|0|||
37799355|NCT01970982|69444362|FG002|Overall Study|Withdrawal by Subject|2|||
37799356|NCT01946802|69444371|FG000|Overall Study|Death|1|||
37799357|NCT01946802|69444371|FG000|Overall Study|Withdrawal by Subject|2|||
37799358|NCT01946802|69444371|FG000|Overall Study|Combined septic shock|1|||
37799359|NCT01946802|69444371|FG000|Overall Study|Protocol Violation|1|||
37799360|NCT01618266|69444375|FG000|Overall Study|Lost to Follow-up|9|||
37799361|NCT01618266|69444375|FG000|Overall Study|Treatment satisfaction|10|||
37799362|NCT01618266|69444375|FG000|Overall Study|Other reasons|11|||
37799363|NCT01618266|69444375|FG000|Overall Study|Lack of Efficacy|23|||
37799364|NCT01618266|69444375|FG000|Overall Study|Protocol Violation|43|||
37799365|NCT01919112|69444382|FG000|Secondary Analysis-day 30|Death|1|||
37799366|NCT01919112|69444383|FG001|Secondary Analysis-day 30|Death|1|||
37799367|NCT01919112|69444384|FG002|Secondary Analysis-day 30|Death|1|||
37799368|NCT01919112|69444382|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
37799369|NCT01919112|69444383|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
37799370|NCT01919112|69444384|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
37799371|NCT01918332|69444396|FG000|Overall Study|Adverse Event|0|||
37799372|NCT01918332|69444397|FG001|Overall Study|Adverse Event|0|||
37799373|NCT01918332|69444398|FG002|Overall Study|Adverse Event|0|||
37799374|NCT01918332|69444399|FG003|Overall Study|Adverse Event|1|||
37799375|NCT01918332|69444396|FG000|Overall Study|Withdrawal by Subject|2|||
37799376|NCT01918332|69444397|FG001|Overall Study|Withdrawal by Subject|3|||
37799377|NCT01918332|69444398|FG002|Overall Study|Withdrawal by Subject|2|||
37799378|NCT01918332|69444399|FG003|Overall Study|Withdrawal by Subject|3|||
37799379|NCT01918332|69444396|FG000|Overall Study|Protocol Violation|6|||
37799380|NCT01918332|69444397|FG001|Overall Study|Protocol Violation|2|||
37799381|NCT01918332|69444398|FG002|Overall Study|Protocol Violation|6|||
37799382|NCT01918332|69444399|FG003|Overall Study|Protocol Violation|3|||
37799383|NCT01918332|69444396|FG000|Overall Study|lipid result by central lab did not meet|0|||
37799384|NCT01918332|69444397|FG001|Overall Study|lipid result by central lab did not meet|0|||
37799385|NCT01918332|69444398|FG002|Overall Study|lipid result by central lab did not meet|1|||
37799386|NCT01918332|69444399|FG003|Overall Study|lipid result by central lab did not meet|0|||
37799387|NCT01922934|69444411|FG000|Eligible Patients|Death|0|||
37799388|NCT01922934|69444412|FG001|Eligible Patients|Death|7|||
37799389|NCT01922934|69444411|FG000|Eligible Patients|Physician Decision|17|||
37799390|NCT01922934|69444412|FG001|Eligible Patients|Physician Decision|0|||
37799391|NCT01922934|69444411|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
37799392|NCT01922934|69444412|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
37799393|NCT01922934|69444411|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
37799394|NCT01922934|69444412|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
37799395|NCT01922934|69444411|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
37799396|NCT01922934|69444412|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
37799397|NCT01922934|69444411|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
37799398|NCT01922934|69444412|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
37799399|NCT01970592|69444420|FG000|Overall Study|Withdrawal by Subject|4|||
37799400|NCT01970592|69444420|FG000|Overall Study|Physician Decision|1|||
37799401|NCT01970592|69444420|FG000|Overall Study|Adverse Event|1|||
37799402|NCT01920594|69444426|FG000|Overall Study|Adverse Event|4|||
37799403|NCT01920594|69444427|FG001|Overall Study|Adverse Event|2|||
37799404|NCT01920594|69444426|FG000|Overall Study|Lost to Follow-up|1|||
37799405|NCT01920594|69444427|FG001|Overall Study|Lost to Follow-up|0|||
37799406|NCT01920594|69444426|FG000|Overall Study|Recovery|2|||
37799407|NCT01920594|69444427|FG001|Overall Study|Recovery|0|||
37799408|NCT01920594|69444426|FG000|Overall Study|Investigator discretion|0|||
37799409|NCT01920594|69444427|FG001|Overall Study|Investigator discretion|1|||
37799410|NCT01917084|69444433|FG000|Overall Study|Withdrawal by Subject|1|||
37799411|NCT01917006|69444444|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
37799412|NCT01917006|69444445|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
37799413|NCT01917006|69444446|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
37799414|NCT01917006|69444447|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
37799415|NCT01917006|69444448|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
37799416|NCT01917006|69444449|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
37799417|NCT01917006|69444450|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
37799418|NCT01917006|69444451|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
37799419|NCT01917006|69444444|FG000|Randomized-treatment Period|Personal Reasons|0|||
37799420|NCT01917006|69444445|FG001|Randomized-treatment Period|Personal Reasons|0|||
37799421|NCT01917006|69444446|FG002|Randomized-treatment Period|Personal Reasons|0|||
37799422|NCT01917006|69444447|FG003|Randomized-treatment Period|Personal Reasons|0|||
37693893|NCT02039505|69170135|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
37693894|NCT02039505|69170136|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
37693895|NCT02039505|69170137|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
37693896|NCT02039505|69170138|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
37693897|NCT02039505|69170139|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
37693898|NCT02039505|69170140|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
37975673|NCT00385827|69662972|FG000|Part 1|Adverse Event|1|||
37975674|NCT00385827|69662973|FG001|Part 1|Adverse Event|0|||
37975675|NCT00385827|69662974|FG002|Part 1|Adverse Event|0|||
37975676|NCT00385827|69662972|FG000|Part 1|Death|2|||
37975677|NCT00385827|69662973|FG001|Part 1|Death|0|||
37975678|NCT00385827|69662974|FG002|Part 1|Death|0|||
37975679|NCT00385827|69662972|FG000|Part 1|Lack of Efficacy|5|||
37693899|NCT02039505|69170141|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
37693900|NCT02039505|69170135|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
37693901|NCT02039505|69170136|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
37693902|NCT02039505|69170137|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
37693903|NCT02039505|69170138|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
37693904|NCT02039505|69170139|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
37693905|NCT02039505|69170140|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
37693906|NCT02039505|69170141|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
37693907|NCT02039505|69170135|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
37693908|NCT02039505|69170136|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
37693909|NCT02039505|69170137|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
37693910|NCT02039505|69170138|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
37693911|NCT02039505|69170139|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
37693912|NCT02039505|69170140|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
37693913|NCT02039505|69170141|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
37693914|NCT02039505|69170135|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
37693915|NCT02039505|69170136|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
37693916|NCT02039505|69170137|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
37693917|NCT02039505|69170138|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
37693918|NCT02039505|69170139|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
37693919|NCT02039505|69170140|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
37693920|NCT02039505|69170141|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
37693921|NCT02095197|69170163|FG000|Overall Study|Lost to Follow-up|0|||
37693922|NCT02095197|69170164|FG001|Overall Study|Lost to Follow-up|3|||
37693923|NCT02039427|69170174|FG000|Overall Study|Duration of surgery > 3h|1|||
37693924|NCT02039427|69170175|FG001|Overall Study|Duration of surgery > 3h|1|||
37693925|NCT02039427|69170176|FG002|Overall Study|Duration of surgery > 3h|0|||
37975680|NCT00385827|69662973|FG001|Part 1|Lack of Efficacy|0|||
37693926|NCT02039427|69170177|FG003|Overall Study|Duration of surgery > 3h|0|||
37693927|NCT02039427|69170174|FG000|Overall Study|Withdrawal on concent|0|||
37975681|NCT00385827|69662974|FG002|Part 1|Lack of Efficacy|0|||
37975682|NCT00385827|69662972|FG000|Part 1|Other|1|||
37975683|NCT00385827|69662973|FG001|Part 1|Other|0|||
37799423|NCT01917006|69444448|FG004|Randomized-treatment Period|Personal Reasons|0|||
37799424|NCT01917006|69444449|FG005|Randomized-treatment Period|Personal Reasons|1|||
37799425|NCT01917006|69444450|FG006|Randomized-treatment Period|Personal Reasons|0|||
37799426|NCT01917006|69444451|FG007|Randomized-treatment Period|Personal Reasons|0|||
37799427|NCT01917006|69444444|FG000|Randomized-treatment Period|Protocol Violation|1|||
37799428|NCT01917006|69444445|FG001|Randomized-treatment Period|Protocol Violation|0|||
37799429|NCT01917006|69444446|FG002|Randomized-treatment Period|Protocol Violation|0|||
37799430|NCT01917006|69444447|FG003|Randomized-treatment Period|Protocol Violation|0|||
37799431|NCT01917006|69444448|FG004|Randomized-treatment Period|Protocol Violation|0|||
37799432|NCT01917006|69444449|FG005|Randomized-treatment Period|Protocol Violation|0|||
37799433|NCT01917006|69444450|FG006|Randomized-treatment Period|Protocol Violation|0|||
37799434|NCT01917006|69444451|FG007|Randomized-treatment Period|Protocol Violation|0|||
37799435|NCT01917006|69444444|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
37799436|NCT01917006|69444445|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
37799437|NCT01917006|69444446|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
37799438|NCT01917006|69444447|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
37799439|NCT01917006|69444448|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
37799440|NCT01917006|69444449|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
37799441|NCT01917006|69444450|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
37799442|NCT01917006|69444451|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
37799443|NCT01917006|69444444|FG000|Open-label Period|Adverse Event|0|||
37799444|NCT01917006|69444445|FG001|Open-label Period|Adverse Event|0|||
37799445|NCT01917006|69444446|FG002|Open-label Period|Adverse Event|0|||
37799446|NCT01917006|69444447|FG003|Open-label Period|Adverse Event|0|||
37799447|NCT01917006|69444448|FG004|Open-label Period|Adverse Event|0|||
37799448|NCT01917006|69444449|FG005|Open-label Period|Adverse Event|0|||
37799449|NCT01917006|69444450|FG006|Open-label Period|Adverse Event|0|||
37693928|NCT02039427|69170175|FG001|Overall Study|Withdrawal on concent|0|||
37693929|NCT02039427|69170176|FG002|Overall Study|Withdrawal on concent|0|||
37693930|NCT02039427|69170177|FG003|Overall Study|Withdrawal on concent|1|||
37693931|NCT02039427|69170174|FG000|Overall Study|Cancellation of surgery|0|||
37693932|NCT02039427|69170175|FG001|Overall Study|Cancellation of surgery|0|||
37693933|NCT02039427|69170176|FG002|Overall Study|Cancellation of surgery|1|||
37693934|NCT02039427|69170177|FG003|Overall Study|Cancellation of surgery|0|||
37693935|NCT02039427|69170174|FG000|Overall Study|Loss of follow - up|1|||
37693936|NCT02039427|69170175|FG001|Overall Study|Loss of follow - up|0|||
37693937|NCT02039427|69170176|FG002|Overall Study|Loss of follow - up|2|||
37799450|NCT01917006|69444451|FG007|Open-label Period|Adverse Event|1|||
37799451|NCT01917006|69444444|FG000|Open-label Period|Lost to Follow-up|0|||
37799452|NCT01917006|69444445|FG001|Open-label Period|Lost to Follow-up|0|||
37693938|NCT02039427|69170177|FG003|Overall Study|Loss of follow - up|4|||
37693939|NCT02039427|69170174|FG000|Overall Study|Steroid Use|1|||
37693940|NCT02039427|69170175|FG001|Overall Study|Steroid Use|0|||
37693941|NCT02039427|69170176|FG002|Overall Study|Steroid Use|0|||
37799453|NCT01917006|69444446|FG002|Open-label Period|Lost to Follow-up|0|||
37799454|NCT01917006|69444447|FG003|Open-label Period|Lost to Follow-up|0|||
37799455|NCT01917006|69444448|FG004|Open-label Period|Lost to Follow-up|0|||
37799456|NCT01917006|69444449|FG005|Open-label Period|Lost to Follow-up|0|||
37799457|NCT01917006|69444450|FG006|Open-label Period|Lost to Follow-up|0|||
37799458|NCT01917006|69444451|FG007|Open-label Period|Lost to Follow-up|1|||
37799459|NCT01916304|69444468|FG000|Overall Study|Screening failure|17|||
37799460|NCT01916226|69444476|FG000|Overall Study|Adverse Event|1|||
37799461|NCT01916226|69444477|FG001|Overall Study|Adverse Event|0|||
37799462|NCT01916226|69444478|FG002|Overall Study|Adverse Event|1|||
37799463|NCT01916226|69444479|FG003|Overall Study|Adverse Event|1|||
37799464|NCT01916226|69444476|FG000|Overall Study|Lack of Efficacy|0|||
37799465|NCT01916226|69444477|FG001|Overall Study|Lack of Efficacy|0|||
37799466|NCT01916226|69444478|FG002|Overall Study|Lack of Efficacy|2|||
37799467|NCT01916226|69444479|FG003|Overall Study|Lack of Efficacy|1|||
37799468|NCT01916226|69444476|FG000|Overall Study|Protocol Violation|0|||
37799469|NCT01916226|69444477|FG001|Overall Study|Protocol Violation|1|||
37799470|NCT01916226|69444478|FG002|Overall Study|Protocol Violation|0|||
37799471|NCT01916226|69444479|FG003|Overall Study|Protocol Violation|1|||
37799472|NCT01916226|69444476|FG000|Overall Study|Physician Decision|0|||
37799473|NCT01916226|69444477|FG001|Overall Study|Physician Decision|0|||
37799474|NCT01916226|69444478|FG002|Overall Study|Physician Decision|0|||
37799475|NCT01916226|69444479|FG003|Overall Study|Physician Decision|1|||
37799476|NCT01969500|69444492|FG000|Overall Study|Death|0|||
37799477|NCT01969500|69444493|FG001|Overall Study|Death|1|||
37799478|NCT01969500|69444492|FG000|Overall Study|extended hospitalization|1|||
37799479|NCT01969500|69444493|FG001|Overall Study|extended hospitalization|1|||
37799480|NCT01915914|69444499|FG000|Acute Phase|Withdrawal by Subject|4|||
37799481|NCT01915914|69444500|FG001|Acute Phase|Withdrawal by Subject|0|||
37799482|NCT01915914|69444501|FG002|Acute Phase|Withdrawal by Subject|0|||
37799483|NCT01915914|69444502|FG003|Acute Phase|Withdrawal by Subject|0|||
37799484|NCT01915914|69444499|FG000|Acute Phase|Lost to Follow-up|4|||
37799485|NCT01915914|69444500|FG001|Acute Phase|Lost to Follow-up|0|||
37799486|NCT01915914|69444501|FG002|Acute Phase|Lost to Follow-up|0|||
37799487|NCT01915914|69444502|FG003|Acute Phase|Lost to Follow-up|0|||
37799488|NCT01915914|69444499|FG000|Acute Phase|Physician Decision|1|||
37799489|NCT01915914|69444500|FG001|Acute Phase|Physician Decision|0|||
37799490|NCT01915914|69444501|FG002|Acute Phase|Physician Decision|0|||
37799491|NCT01915914|69444502|FG003|Acute Phase|Physician Decision|0|||
37799492|NCT01915914|69444499|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
37799493|NCT01915914|69444500|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
37799494|NCT01915914|69444501|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
37799495|NCT01915914|69444502|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
37799496|NCT01915914|69444499|FG000|Acute Phase|"Not Achieved treatment success"|1|||
37799497|NCT01915914|69444500|FG001|Acute Phase|"Not Achieved treatment success"|0|||
37799498|NCT01915914|69444501|FG002|Acute Phase|"Not Achieved treatment success"|0|||
37799499|NCT01915914|69444502|FG003|Acute Phase|"Not Achieved treatment success"|0|||
37799500|NCT01915914|69444499|FG000|Acute Phase|Missing|1|||
37799501|NCT01915914|69444500|FG001|Acute Phase|Missing|0|||
37799502|NCT01915914|69444501|FG002|Acute Phase|Missing|0|||
37799503|NCT01915914|69444502|FG003|Acute Phase|Missing|0|||
37799504|NCT01915914|69444499|FG000|Maintenance Phase|Withdrawal by Subject|0|||
37799505|NCT01915914|69444500|FG001|Maintenance Phase|Withdrawal by Subject|1|||
37799506|NCT01915914|69444501|FG002|Maintenance Phase|Withdrawal by Subject|1|||
37799507|NCT01915914|69444502|FG003|Maintenance Phase|Withdrawal by Subject|0|||
37799508|NCT01915914|69444499|FG000|Maintenance Phase|Lost to Follow-up|0|||
37799509|NCT01915914|69444500|FG001|Maintenance Phase|Lost to Follow-up|4|||
37799510|NCT01915914|69444501|FG002|Maintenance Phase|Lost to Follow-up|1|||
37799511|NCT01915914|69444502|FG003|Maintenance Phase|Lost to Follow-up|0|||
37799512|NCT01915914|69444499|FG000|Maintenance Phase|Missing|0|||
37799513|NCT01915914|69444500|FG001|Maintenance Phase|Missing|1|||
37799514|NCT01915914|69444501|FG002|Maintenance Phase|Missing|0|||
37799515|NCT01915914|69444502|FG003|Maintenance Phase|Missing|0|||
37799516|NCT01915914|69444499|FG000|Follow-up Phase|Withdrawal by Subject|0|||
37975684|NCT00385827|69662974|FG002|Part 1|Other|0|||
37799517|NCT01915914|69444500|FG001|Follow-up Phase|Withdrawal by Subject|0|||
37799518|NCT01915914|69444501|FG002|Follow-up Phase|Withdrawal by Subject|0|||
37799519|NCT01915914|69444502|FG003|Follow-up Phase|Withdrawal by Subject|1|||
37799520|NCT01915914|69444499|FG000|Follow-up Phase|Physician Decision|0|||
37799521|NCT01915914|69444500|FG001|Follow-up Phase|Physician Decision|0|||
37799522|NCT01915914|69444501|FG002|Follow-up Phase|Physician Decision|0|||
37799523|NCT01915914|69444502|FG003|Follow-up Phase|Physician Decision|1|||
37799524|NCT01919970|69444522|FG000|Overall Study|Withdrawal by Subject|3|||
37799525|NCT01919970|69444523|FG001|Overall Study|Withdrawal by Subject|0|||
37799526|NCT01919814|69444529|FG000|Overall Study|Adverse Event|1|||
37799527|NCT01919814|69444530|FG001|Overall Study|Adverse Event|0|||
37975685|NCT00385827|69662972|FG000|Part 2|Adverse Event|0|||
37799528|NCT01919814|69444529|FG000|Overall Study|Protocol Violation|1|||
37799529|NCT01919814|69444530|FG001|Overall Study|Protocol Violation|0|||
37799530|NCT01919814|69444529|FG000|Overall Study|Withdrawal by Subject|1|||
37799531|NCT01919814|69444530|FG001|Overall Study|Withdrawal by Subject|0|||
37799532|NCT01968954|69444538|FG000|Overall Study|Adverse Event|6|||
37799533|NCT01968954|69444539|FG001|Overall Study|Adverse Event|3|||
37799534|NCT01968954|69444538|FG000|Overall Study|Death|1|||
37799535|NCT01968954|69444539|FG001|Overall Study|Death|2|||
37799536|NCT01968954|69444538|FG000|Overall Study|Lost to Follow-up|6|||
37799537|NCT01968954|69444539|FG001|Overall Study|Lost to Follow-up|4|||
37799538|NCT01968954|69444538|FG000|Overall Study|Withdrawal by Subject|20|||
37799539|NCT01968954|69444539|FG001|Overall Study|Withdrawal by Subject|23|||
37799540|NCT01968954|69444538|FG000|Overall Study|Other|7|||
37799541|NCT01968954|69444539|FG001|Overall Study|Other|8|||
37799542|NCT01968954|69444538|FG000|Overall Study|Protocol Violation|0|||
37799543|NCT01968954|69444539|FG001|Overall Study|Protocol Violation|1|||
37799544|NCT01968954|69444538|FG000|Overall Study|Did not met inclusion criteria|0|||
37799545|NCT01968954|69444539|FG001|Overall Study|Did not met inclusion criteria|2|||
37799546|NCT01919190|69444548|FG000|Overall Study|Intra-op findings, etc.|3|||
37799547|NCT01919190|69444549|FG001|Overall Study|Intra-op findings, etc.|0|||
37799548|NCT01620060|69444556|FG000|Overall Study|Adverse Event|9|||
37975686|NCT00385827|69662973|FG001|Part 2|Adverse Event|6|||
37799549|NCT01620060|69444556|FG000|Overall Study|Protocol Violation|1|||
37799550|NCT01620060|69444556|FG000|Overall Study|Withdrawal by Subject|1|||
37799551|NCT01620060|69444556|FG000|Overall Study|Did not comply with Study Produre|1|||
37799552|NCT01620060|69444556|FG000|Overall Study|Family emergency|1|||
37799553|NCT01620060|69444556|FG000|Overall Study|Per Sponsor Decision|2|||
37799554|NCT01914666|69444563|FG000|Treatment Period|Lack of Efficacy|0|||
37799555|NCT01914666|69444564|FG001|Treatment Period|Lack of Efficacy|0|||
37799556|NCT01914666|69444565|FG002|Treatment Period|Lack of Efficacy|2|||
37799557|NCT01914666|69444563|FG000|Treatment Period|Adverse Event|10|||
37799558|NCT01914666|69444564|FG001|Treatment Period|Adverse Event|4|||
37799559|NCT01914666|69444565|FG002|Treatment Period|Adverse Event|2|||
37799560|NCT01914666|69444563|FG000|Treatment Period|Withdrawal by Subject|3|||
37799561|NCT01914666|69444564|FG001|Treatment Period|Withdrawal by Subject|2|||
37799562|NCT01914666|69444565|FG002|Treatment Period|Withdrawal by Subject|2|||
37799563|NCT01914666|69444563|FG000|Treatment Period|Physician Decision|0|||
37799564|NCT01914666|69444564|FG001|Treatment Period|Physician Decision|0|||
37799565|NCT01914666|69444565|FG002|Treatment Period|Physician Decision|2|||
37799566|NCT01913340|69444573|FG000|Overall Study|Death|2|||
37799567|NCT01913340|69444574|FG001|Overall Study|Death|5|||
37799568|NCT01913340|69444573|FG000|Overall Study|Lost to Follow-up|1|||
37799569|NCT01913340|69444574|FG001|Overall Study|Lost to Follow-up|1|||
37799570|NCT01864200|69444582|FG000|Overall Study|Lost to Follow-up|1|||
37799571|NCT01864200|69444583|FG001|Overall Study|Lost to Follow-up|3|||
37799572|NCT01864200|69444582|FG000|Overall Study|Protocol Violation|1|||
37799573|NCT01864200|69444583|FG001|Overall Study|Protocol Violation|0|||
37799574|NCT01912872|69444593|FG000|Overall Study|Lost to Follow-up|2|||
37799575|NCT01912872|69444594|FG001|Overall Study|Lost to Follow-up|3|||
37799576|NCT01912872|69444595|FG002|Overall Study|Lost to Follow-up|5|||
37799577|NCT01912872|69444596|FG003|Overall Study|Lost to Follow-up|5|||
37799578|NCT01912872|69444593|FG000|Overall Study|Other unspecified|3|||
37799579|NCT01912872|69444594|FG001|Overall Study|Other unspecified|1|||
37799580|NCT01912872|69444595|FG002|Overall Study|Other unspecified|3|||
37799581|NCT01912872|69444596|FG003|Overall Study|Other unspecified|0|||
37799582|NCT01912872|69444593|FG000|Overall Study|Informed consent withdrawn|0|||
37799583|NCT01912872|69444594|FG001|Overall Study|Informed consent withdrawn|0|||
37799584|NCT01912872|69444595|FG002|Overall Study|Informed consent withdrawn|1|||
37799585|NCT01912872|69444596|FG003|Overall Study|Informed consent withdrawn|1|||
37799586|NCT01912872|69444593|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
37799587|NCT01912872|69444594|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
37799588|NCT01912872|69444595|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
37799589|NCT01912872|69444596|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
37799590|NCT01912872|69444593|FG000|Overall Study|Protocol Violation|0|||
37799591|NCT01912872|69444594|FG001|Overall Study|Protocol Violation|0|||
37799592|NCT01912872|69444595|FG002|Overall Study|Protocol Violation|1|||
37799593|NCT01912872|69444596|FG003|Overall Study|Protocol Violation|0|||
37799594|NCT01912872|69444593|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
37799595|NCT01912872|69444594|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
37799596|NCT01912872|69444595|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
37799597|NCT01912872|69444596|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
37799598|NCT01912872|69444593|FG000|Overall Study|Withdrawal of study medication|0|||
37799599|NCT01912872|69444594|FG001|Overall Study|Withdrawal of study medication|0|||
37799600|NCT01912872|69444595|FG002|Overall Study|Withdrawal of study medication|0|||
37799601|NCT01912872|69444596|FG003|Overall Study|Withdrawal of study medication|2|||
37799602|NCT01912872|69444593|FG000|Overall Study|Missing|0|||
37799603|NCT01912872|69444594|FG001|Overall Study|Missing|0|||
37799604|NCT01912872|69444595|FG002|Overall Study|Missing|0|||
37799605|NCT01912872|69444596|FG003|Overall Study|Missing|1|||
37799606|NCT01912404|69444609|FG000|Overall Study|Due to personal reasons|1|||
37799607|NCT01912404|69444610|FG001|Overall Study|Due to personal reasons|0|||
37799608|NCT01911780|69444618|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
37799609|NCT01911780|69444619|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
37799610|NCT01911780|69444618|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
37799611|NCT01911780|69444619|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
37799612|NCT01911780|69444618|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
37799613|NCT01911780|69444619|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
37799614|NCT01911780|69444618|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
37799615|NCT01911780|69444619|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
37799616|NCT01911780|69444618|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
37799617|NCT01911780|69444619|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
37799618|NCT01911780|69444618|FG000|Extension Period (52 Weeks)|Personal reason|1|||
37799619|NCT01911780|69444619|FG001|Extension Period (52 Weeks)|Personal reason|1|||
37799620|NCT01911546|69444629|FG000|Overall Study|Lost to Follow-up|1|||
37799621|NCT01911546|69444629|FG000|Overall Study|Everolimus was discontinued|5|||
37799622|NCT01910298|69444635|FG000|Overall Study|Adverse Event|1|||
37799623|NCT01910298|69444636|FG001|Overall Study|Adverse Event|0|||
37799624|NCT01910298|69444635|FG000|Overall Study|Withdrawal by Subject|2|||
37799625|NCT01910298|69444636|FG001|Overall Study|Withdrawal by Subject|7|||
37799626|NCT01910298|69444635|FG000|Overall Study|Protocol Deviation|0|||
37799627|NCT01910298|69444636|FG001|Overall Study|Protocol Deviation|5|||
37799628|NCT01910298|69444635|FG000|Overall Study|Lost to Follow-up|1|||
37799629|NCT01910298|69444636|FG001|Overall Study|Lost to Follow-up|1|||
37799630|NCT01910298|69444635|FG000|Overall Study|Study Terminated by Sponsor|1|||
37799631|NCT01910298|69444636|FG001|Overall Study|Study Terminated by Sponsor|17|||
37799632|NCT01910298|69444635|FG000|Overall Study|Other Miscellaneous Reasons|0|||
37799633|NCT01910298|69444636|FG001|Overall Study|Other Miscellaneous Reasons|2|||
37799634|NCT01909674|69444644|FG000|Overall Study|Withdrawal by Subject|5|||
37799635|NCT01909674|69444645|FG001|Overall Study|Withdrawal by Subject|2|||
37799636|NCT01908816|69444655|FG000|Overall Study|Subject's no longer requires study drug|0|||
37799637|NCT01908816|69444656|FG001|Overall Study|Subject's no longer requires study drug|0|||
37799638|NCT01908816|69444657|FG002|Overall Study|Subject's no longer requires study drug|0|||
37799639|NCT01908816|69444658|FG003|Overall Study|Subject's no longer requires study drug|1|||
37799640|NCT01908816|69444655|FG000|Overall Study|Protocol deviation|1|||
37799641|NCT01908816|69444656|FG001|Overall Study|Protocol deviation|2|||
37799642|NCT01908816|69444657|FG002|Overall Study|Protocol deviation|1|||
37799643|NCT01908816|69444658|FG003|Overall Study|Protocol deviation|1|||
37799644|NCT01908816|69444655|FG000|Overall Study|Withdrawal by Subject|0|||
37799645|NCT01908816|69444656|FG001|Overall Study|Withdrawal by Subject|4|||
37799646|NCT01908816|69444657|FG002|Overall Study|Withdrawal by Subject|2|||
37799647|NCT01908816|69444658|FG003|Overall Study|Withdrawal by Subject|2|||
37799648|NCT01908816|69444655|FG000|Overall Study|Lost to Follow-up|3|||
37799649|NCT01908816|69444656|FG001|Overall Study|Lost to Follow-up|5|||
37799650|NCT01908816|69444657|FG002|Overall Study|Lost to Follow-up|4|||
37799651|NCT01908816|69444658|FG003|Overall Study|Lost to Follow-up|2|||
37799652|NCT01908816|69444655|FG000|Overall Study|Death|1|||
37799653|NCT01908816|69444656|FG001|Overall Study|Death|0|||
37799654|NCT01908816|69444657|FG002|Overall Study|Death|7|||
37799655|NCT01908816|69444658|FG003|Overall Study|Death|1|||
37799656|NCT01908816|69444655|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
37799657|NCT01908816|69444656|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
37799658|NCT01908816|69444657|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
37799659|NCT01908816|69444658|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
37799660|NCT01908816|69444655|FG000|Overall Study|Early termination|87|||
37799661|NCT01908816|69444656|FG001|Overall Study|Early termination|60|||
37799662|NCT01908816|69444657|FG002|Overall Study|Early termination|43|||
37799663|NCT01908816|69444658|FG003|Overall Study|Early termination|28|||
37799664|NCT01908582|69444671|FG000|Period 2|Physician Decision|1|||
37799665|NCT01908582|69444671|FG000|Period 2|Withdrawal by Subject|1|||
37799666|NCT01908426|69444680|FG000|Overall Study|Adverse Event|98|||
37799667|NCT01908426|69444681|FG001|Overall Study|Adverse Event|11|||
37799668|NCT01908426|69444680|FG000|Overall Study|Clinical Deterioration|72|||
37799669|NCT01908426|69444681|FG001|Overall Study|Clinical Deterioration|38|||
37799670|NCT01908426|69444680|FG000|Overall Study|Lack of Efficacy|3|||
37799671|NCT01908426|69444681|FG001|Overall Study|Lack of Efficacy|0|||
37975687|NCT00385827|69662974|FG002|Part 2|Adverse Event|10|||
37975688|NCT00385827|69662972|FG000|Part 2|Death|0|||
37799672|NCT01908426|69444680|FG000|Overall Study|Lost to Follow-up|0|||
37799673|NCT01908426|69444681|FG001|Overall Study|Lost to Follow-up|1|||
37799674|NCT01908426|69444680|FG000|Overall Study|Physician Decision|3|||
37799675|NCT01908426|69444681|FG001|Overall Study|Physician Decision|3|||
37975689|NCT00385827|69662973|FG001|Part 2|Death|0|||
37975690|NCT00385827|69662974|FG002|Part 2|Death|2|||
37975691|NCT00385827|69662972|FG000|Part 2|Lack of Efficacy|0|||
37975692|NCT00385827|69662973|FG001|Part 2|Lack of Efficacy|14|||
37799676|NCT01908426|69444680|FG000|Overall Study|Withdrawal by Subject|11|||
37799677|NCT01908426|69444681|FG001|Overall Study|Withdrawal by Subject|6|||
37799678|NCT01908426|69444680|FG000|Overall Study|Progressive Disease|206|||
37799679|NCT01908426|69444681|FG001|Overall Study|Progressive Disease|152|||
37799680|NCT01908426|69444680|FG000|Overall Study|Protocol Violation|1|||
37799681|NCT01908426|69444681|FG001|Overall Study|Protocol Violation|0|||
37975693|NCT00385827|69662974|FG002|Part 2|Lack of Efficacy|13|||
37975694|NCT00385827|69662972|FG000|Part 2|Randomized but not treated|0|||
37799682|NCT01908426|69444680|FG000|Overall Study|No Study Treatment Given|3|||
37799683|NCT01908426|69444681|FG001|Overall Study|No Study Treatment Given|0|||
37799684|NCT01907100|69444691|FG000|Overall Study|PD based on modified RECIST criteria|31|||
37799685|NCT01907100|69444692|FG001|Overall Study|PD based on modified RECIST criteria|32|||
37799686|NCT01907100|69444693|FG002|Overall Study|PD based on modified RECIST criteria|95|||
37799687|NCT01907100|69444694|FG003|Overall Study|PD based on modified RECIST criteria|92|||
37799688|NCT01907100|69444691|FG000|Overall Study|Withdrawal by Subject|2|||
37799689|NCT01907100|69444692|FG001|Overall Study|Withdrawal by Subject|5|||
37799690|NCT01907100|69444693|FG002|Overall Study|Withdrawal by Subject|10|||
37799691|NCT01907100|69444694|FG003|Overall Study|Withdrawal by Subject|13|||
37799692|NCT01907100|69444691|FG000|Overall Study|Protocol Violation|0|||
37799693|NCT01907100|69444692|FG001|Overall Study|Protocol Violation|0|||
37799694|NCT01907100|69444693|FG002|Overall Study|Protocol Violation|1|||
37799695|NCT01907100|69444694|FG003|Overall Study|Protocol Violation|1|||
37799696|NCT01907100|69444691|FG000|Overall Study|Lost to Follow-up|0|||
37799697|NCT01907100|69444692|FG001|Overall Study|Lost to Follow-up|0|||
37799698|NCT01907100|69444693|FG002|Overall Study|Lost to Follow-up|0|||
37799699|NCT01907100|69444694|FG003|Overall Study|Lost to Follow-up|1|||
37799700|NCT01907100|69444691|FG000|Overall Study|Not treated|2|||
37799701|NCT01907100|69444692|FG001|Overall Study|Not treated|0|||
37799702|NCT01907100|69444693|FG002|Overall Study|Not treated|1|||
37799703|NCT01907100|69444694|FG003|Overall Study|Not treated|2|||
37799704|NCT01907100|69444691|FG000|Overall Study|Other than reasons specified|1|||
37799705|NCT01907100|69444692|FG001|Overall Study|Other than reasons specified|0|||
37799706|NCT01907100|69444693|FG002|Overall Study|Other than reasons specified|10|||
37799707|NCT01907100|69444694|FG003|Overall Study|Other than reasons specified|6|||
37799708|NCT01907100|69444691|FG000|Overall Study|Adverse event (AE)|6|||
37799709|NCT01907100|69444692|FG001|Overall Study|Adverse event (AE)|3|||
37799710|NCT01907100|69444693|FG002|Overall Study|Adverse event (AE)|22|||
37799711|NCT01907100|69444694|FG003|Overall Study|Adverse event (AE)|23|||
37799712|NCT01907100|69444691|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
37799713|NCT01907100|69444692|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
37799714|NCT01907100|69444693|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
37799715|NCT01907100|69444694|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
37799716|NCT01889862|69444702|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
37799717|NCT01889862|69444703|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
37799718|NCT01889862|69444704|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
37799719|NCT01889862|69444705|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
37799720|NCT01889862|69444706|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
37799721|NCT01889862|69444702|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
37799722|NCT01889862|69444703|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
37799723|NCT01889862|69444704|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
37799724|NCT01889862|69444705|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
37799725|NCT01889862|69444706|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
37799726|NCT01889862|69444702|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
37799727|NCT01889862|69444703|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
37799728|NCT01889862|69444704|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
37799729|NCT01889862|69444705|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
37799730|NCT01889862|69444706|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
37799731|NCT01889862|69444702|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
37799732|NCT01889862|69444703|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
37799733|NCT01889862|69444704|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
37799734|NCT01889862|69444705|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
37799735|NCT01889862|69444706|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
37799736|NCT01889862|69444702|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
37975695|NCT00385827|69662973|FG001|Part 2|Randomized but not treated|2|||
37799737|NCT01889862|69444703|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
37799738|NCT01889862|69444704|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
37799739|NCT01889862|69444705|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
37799740|NCT01889862|69444706|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
37799741|NCT01889862|69444702|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
37799742|NCT01889862|69444703|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
37799743|NCT01889862|69444704|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
37799744|NCT01889862|69444705|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
37799745|NCT01889862|69444706|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
37799746|NCT01889862|69444702|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
37799747|NCT01889862|69444703|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
37799748|NCT01889862|69444704|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
37799749|NCT01889862|69444705|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
37799750|NCT01889862|69444706|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
37799751|NCT01889862|69444702|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
37799752|NCT01889862|69444703|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
37799753|NCT01889862|69444704|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
37799754|NCT01889862|69444705|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
37799755|NCT01889862|69444706|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
37799756|NCT01889862|69444702|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
37799757|NCT01889862|69444703|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
37799758|NCT01889862|69444704|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
37799759|NCT01889862|69444705|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
37799760|NCT01889862|69444706|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
37799761|NCT01889862|69444702|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
37799762|NCT01889862|69444703|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
37799763|NCT01889862|69444704|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
37799764|NCT01889862|69444705|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
37799765|NCT01889862|69444706|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
37799766|NCT01887912|69444733|FG000|Overall Study|Serious adverse event|400|||
37799767|NCT01887912|69444734|FG001|Overall Study|Serious adverse event|198|||
37799768|NCT01887912|69444733|FG000|Overall Study|Other Adverse Event|34|||
37799769|NCT01887912|69444734|FG001|Overall Study|Other Adverse Event|15|||
37799770|NCT01887912|69444733|FG000|Overall Study|Protocol Violation|67|||
37799771|NCT01887912|69444734|FG001|Overall Study|Protocol Violation|37|||
37799772|NCT01887912|69444733|FG000|Overall Study|Lost to Follow-up|163|||
37799773|NCT01887912|69444734|FG001|Overall Study|Lost to Follow-up|74|||
37799774|NCT01887912|69444733|FG000|Overall Study|Withdrawal by Subject|606|||
37799775|NCT01887912|69444734|FG001|Overall Study|Withdrawal by Subject|349|||
37799776|NCT01887912|69444733|FG000|Overall Study|Other|122|||
37799777|NCT01887912|69444734|FG001|Overall Study|Other|58|||
37799778|NCT01887678|69444742|FG000|Overall Study|Adverse Event|4|||
37799779|NCT01887678|69444743|FG001|Overall Study|Adverse Event|6|||
37799780|NCT01887678|69444742|FG000|Overall Study|Exceeded rescue medication dosage|4|||
37799781|NCT01887678|69444743|FG001|Overall Study|Exceeded rescue medication dosage|5|||
37799782|NCT01887678|69444742|FG000|Overall Study|Withdrawal of consent|3|||
37799783|NCT01887678|69444743|FG001|Overall Study|Withdrawal of consent|4|||
37799784|NCT01887678|69444742|FG000|Overall Study|Lost to Follow-up|4|||
37799785|NCT01887678|69444743|FG001|Overall Study|Lost to Follow-up|2|||
37799786|NCT01887678|69444742|FG000|Overall Study|Deterioration of clinical condition|0|||
37799787|NCT01887678|69444743|FG001|Overall Study|Deterioration of clinical condition|4|||
37799788|NCT01887678|69444742|FG000|Overall Study|Lack of Efficacy|1|||
37799789|NCT01887678|69444743|FG001|Overall Study|Lack of Efficacy|2|||
37799790|NCT01887678|69444742|FG000|Overall Study|Non-compliance|0|||
37799791|NCT01887678|69444743|FG001|Overall Study|Non-compliance|3|||
37799792|NCT01887678|69444742|FG000|Overall Study|Specified|1|||
37799793|NCT01887678|69444743|FG001|Overall Study|Specified|2|||
37799794|NCT01887600|69444751|FG000|Overall Study|Death|39|||
37799795|NCT01887600|69444752|FG001|Overall Study|Death|16|||
37799796|NCT01887600|69444751|FG000|Overall Study|Lack of Efficacy|3|||
37799797|NCT01887600|69444752|FG001|Overall Study|Lack of Efficacy|26|||
37799798|NCT01887600|69444751|FG000|Overall Study|Lost to Follow-up|5|||
37799799|NCT01887600|69444752|FG001|Overall Study|Lost to Follow-up|1|||
37799800|NCT01887600|69444751|FG000|Overall Study|Physician Decision|7|||
37799801|NCT01887600|69444752|FG001|Overall Study|Physician Decision|8|||
37799802|NCT01887600|69444751|FG000|Overall Study|Protocol Deviation|3|||
37799803|NCT01887600|69444752|FG001|Overall Study|Protocol Deviation|0|||
37799804|NCT01887600|69444751|FG000|Overall Study|Withdrawal by Subject|58|||
37799805|NCT01887600|69444752|FG001|Overall Study|Withdrawal by Subject|52|||
37799806|NCT01887600|69444751|FG000|Overall Study|Adverse Event|21|||
37799807|NCT01887600|69444752|FG001|Overall Study|Adverse Event|9|||
37799808|NCT01887600|69444751|FG000|Overall Study|Non-compliance with study drug|3|||
37799809|NCT01887600|69444752|FG001|Overall Study|Non-compliance with study drug|0|||
37799810|NCT01887600|69444751|FG000|Overall Study|Miscellaneous|6|||
37799811|NCT01887600|69444752|FG001|Overall Study|Miscellaneous|2|||
37799812|NCT01887600|69444751|FG000|Overall Study|Progressive Disease|1|||
37799813|NCT01887600|69444752|FG001|Overall Study|Progressive Disease|0|||
37799814|NCT01887288|69444759|FG000|Overall Study|The study was terminated and the PI has|16|||
37799815|NCT01887210|69444765|FG000|Overall Study|Withdrawal by Subject|1|||
37799816|NCT01887210|69444766|FG001|Overall Study|Withdrawal by Subject|3|||
37799817|NCT01887210|69444765|FG000|Overall Study|Lost to Follow-up|0|||
37799818|NCT01887210|69444766|FG001|Overall Study|Lost to Follow-up|1|||
37799819|NCT01885182|69444797|FG000|Overall Study|Adverse Event|11|||
37799820|NCT01885182|69444798|FG001|Overall Study|Adverse Event|13|||
37799821|NCT01885182|69444797|FG000|Overall Study|Withdrawal by Subject|13|||
37799822|NCT01885182|69444798|FG001|Overall Study|Withdrawal by Subject|6|||
37799823|NCT01885182|69444797|FG000|Overall Study|Lost to Follow-up|2|||
37799824|NCT01885182|69444798|FG001|Overall Study|Lost to Follow-up|2|||
37799825|NCT01885182|69444797|FG000|Overall Study|Lack of Efficacy|8|||
37799826|NCT01885182|69444798|FG001|Overall Study|Lack of Efficacy|1|||
37799827|NCT01885104|69444808|FG000|Overall Study|Withdrawal of Consent|1|||
37799828|NCT01885104|69444809|FG001|Overall Study|Withdrawal of Consent|0|||
37799829|NCT01885104|69444808|FG000|Overall Study|Lost to Follow-up|0|||
37799830|NCT01885104|69444809|FG001|Overall Study|Lost to Follow-up|1|||
37799831|NCT01885104|69444808|FG000|Overall Study|Physician Decision|1|||
37799832|NCT01885104|69444809|FG001|Overall Study|Physician Decision|0|||
37799833|NCT01881750|69444817|FG000|Overall Study|Changes in concomitant therapies|2|||
37799834|NCT01881750|69444818|FG001|Overall Study|Changes in concomitant therapies|3|||
37799835|NCT01881750|69444817|FG000|Overall Study|Lost to Follow-up|0|||
37799836|NCT01881750|69444818|FG001|Overall Study|Lost to Follow-up|1|||
37799837|NCT01906008|69444828|FG000|Overall Study|Lost to Follow-up|2|||
37799838|NCT01906008|69444829|FG001|Overall Study|Lost to Follow-up|0|||
37799839|NCT01906008|69444828|FG000|Overall Study|Oxaliplatin toxicity|2|||
37799840|NCT01906008|69444829|FG001|Overall Study|Oxaliplatin toxicity|0|||
37799841|NCT01906008|69444828|FG000|Overall Study|Protocol Violation|0|||
37799842|NCT01906008|69444829|FG001|Overall Study|Protocol Violation|1|||
37799843|NCT01906008|69444828|FG000|Overall Study|Withdrawal by Subject|1|||
37799844|NCT01906008|69444829|FG001|Overall Study|Withdrawal by Subject|5|||
37799845|NCT01906008|69444828|FG000|Overall Study|Did not start study med|3|||
37799846|NCT01906008|69444829|FG001|Overall Study|Did not start study med|4|||
37799847|NCT01906008|69444828|FG000|Overall Study|Oxaliplatin stops|10|||
37799848|NCT01906008|69444829|FG001|Overall Study|Oxaliplatin stops|8|||
37799849|NCT01906008|69444828|FG000|Overall Study|Hospice|1|||
37799850|NCT01906008|69444829|FG001|Overall Study|Hospice|0|||
37799851|NCT01906008|69444828|FG000|Overall Study|Physician Decision|3|||
37799852|NCT01906008|69444829|FG001|Overall Study|Physician Decision|3|||
37799853|NCT01906008|69444828|FG000|Overall Study|Lack of compliance of study med|5|||
37799854|NCT01906008|69444829|FG001|Overall Study|Lack of compliance of study med|3|||
37799855|NCT01906008|69444828|FG000|Overall Study|Adverse Event|0|||
37799856|NCT01906008|69444829|FG001|Overall Study|Adverse Event|3|||
37799857|NCT01863732|69444839|FG000|Overall Study|Adverse Event|2|||
37799858|NCT01863732|69444840|FG001|Overall Study|Adverse Event|0|||
37799859|NCT01863732|69444841|FG002|Overall Study|Adverse Event|3|||
37799860|NCT01863732|69444842|FG003|Overall Study|Adverse Event|3|||
37799861|NCT01863732|69444839|FG000|Overall Study|Lack of Efficacy|1|||
37799862|NCT01863732|69444840|FG001|Overall Study|Lack of Efficacy|0|||
37799863|NCT01863732|69444841|FG002|Overall Study|Lack of Efficacy|2|||
37799864|NCT01863732|69444842|FG003|Overall Study|Lack of Efficacy|1|||
37799865|NCT01863732|69444839|FG000|Overall Study|Lost to Follow-up|2|||
37799866|NCT01863732|69444840|FG001|Overall Study|Lost to Follow-up|2|||
37799867|NCT01863732|69444841|FG002|Overall Study|Lost to Follow-up|1|||
37799868|NCT01863732|69444842|FG003|Overall Study|Lost to Follow-up|1|||
37799869|NCT01863732|69444839|FG000|Overall Study|Physician Decision|1|||
37799870|NCT01863732|69444840|FG001|Overall Study|Physician Decision|0|||
37799871|NCT01863732|69444841|FG002|Overall Study|Physician Decision|1|||
37799872|NCT01863732|69444842|FG003|Overall Study|Physician Decision|0|||
37799873|NCT01863732|69444839|FG000|Overall Study|Pregnancy|0|||
37799874|NCT01863732|69444840|FG001|Overall Study|Pregnancy|0|||
37799875|NCT01863732|69444841|FG002|Overall Study|Pregnancy|0|||
37799876|NCT01863732|69444842|FG003|Overall Study|Pregnancy|1|||
37799877|NCT01863732|69444839|FG000|Overall Study|Technical problems|0|||
37975696|NCT00385827|69662974|FG002|Part 2|Randomized but not treated|2|||
37975697|NCT00385827|69662972|FG000|Part 2|Other|0|||
37975698|NCT00385827|69662973|FG001|Part 2|Other|11|||
37799878|NCT01863732|69444840|FG001|Overall Study|Technical problems|1|||
37799879|NCT01863732|69444841|FG002|Overall Study|Technical problems|1|||
37799880|NCT01863732|69444842|FG003|Overall Study|Technical problems|0|||
37799881|NCT01863732|69444839|FG000|Overall Study|Subject/guardian decision|6|||
37799882|NCT01863732|69444840|FG001|Overall Study|Subject/guardian decision|9|||
37799883|NCT01863732|69444841|FG002|Overall Study|Subject/guardian decision|3|||
37799884|NCT01863732|69444842|FG003|Overall Study|Subject/guardian decision|1|||
37799885|NCT01863732|69444839|FG000|Overall Study|Death|1|||
37799886|NCT01863732|69444840|FG001|Overall Study|Death|0|||
37799887|NCT01863732|69444841|FG002|Overall Study|Death|0|||
37799888|NCT01863732|69444842|FG003|Overall Study|Death|1|||
37799889|NCT01905540|69444855|FG000|Period 3|Other|1|||
37799890|NCT01905540|69444856|FG001|Period 3|Other|0|||
37799891|NCT01905540|69444857|FG002|Period 3|Other|1|||
37799892|NCT01905540|69444858|FG003|Period 3|Other|1|||
37799893|NCT01904760|69444870|FG000|Overall Study|Protocol Violation|1|||
37799894|NCT01904760|69444871|FG001|Overall Study|Protocol Violation|0|||
37799895|NCT01904604|69444880|FG000|Overall Study|Withdrew before receiving dosing|0|||
37799896|NCT01904604|69444881|FG001|Overall Study|Withdrew before receiving dosing|1|||
37799897|NCT01904604|69444882|FG002|Overall Study|Withdrew before receiving dosing|0|||
37799898|NCT01904604|69444880|FG000|Overall Study|Non-compliance|1|||
37799899|NCT01904604|69444881|FG001|Overall Study|Non-compliance|0|||
37799900|NCT01904604|69444882|FG002|Overall Study|Non-compliance|0|||
37799901|NCT01904604|69444880|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
37799902|NCT01904604|69444881|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
37799903|NCT01904604|69444882|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
37799904|NCT01904604|69444880|FG000|Overall Study|Patch site reactions|1|||
37799905|NCT01904604|69444881|FG001|Overall Study|Patch site reactions|1|||
37799906|NCT01904604|69444882|FG002|Overall Study|Patch site reactions|0|||
37799907|NCT01904604|69444880|FG000|Overall Study|Increased syncope|0|||
37799908|NCT01904604|69444881|FG001|Overall Study|Increased syncope|1|||
37799909|NCT01904604|69444882|FG002|Overall Study|Increased syncope|0|||
37799910|NCT01904604|69444880|FG000|Overall Study|Unrelated illness|0|||
37799911|NCT01904604|69444881|FG001|Overall Study|Unrelated illness|1|||
37799912|NCT01904604|69444882|FG002|Overall Study|Unrelated illness|0|||
37799913|NCT01904604|69444880|FG000|Overall Study|Passed Week 52 OFC|1|||
37799914|NCT01904604|69444881|FG001|Overall Study|Passed Week 52 OFC|0|||
37799915|NCT01904604|69444882|FG002|Overall Study|Passed Week 52 OFC|0|||
37799916|NCT01904604|69444880|FG000|Overall Study|Withdrawal by Subject|1|||
37799917|NCT01904604|69444881|FG001|Overall Study|Withdrawal by Subject|2|||
37799918|NCT01904604|69444882|FG002|Overall Study|Withdrawal by Subject|0|||
37799919|NCT01904604|69444880|FG000|Overall Study|Participant Relocated|1|||
37799920|NCT01904604|69444881|FG001|Overall Study|Participant Relocated|1|||
37799921|NCT01904604|69444882|FG002|Overall Study|Participant Relocated|1|||
37799922|NCT01904604|69444880|FG000|Overall Study|Lost to Follow-up|0|||
37799923|NCT01904604|69444881|FG001|Overall Study|Lost to Follow-up|0|||
37799924|NCT01904604|69444882|FG002|Overall Study|Lost to Follow-up|1|||
37799925|NCT01904058|69444897|FG000|Overall Study|Adverse Event|2|||
37799926|NCT01904058|69444898|FG001|Overall Study|Adverse Event|0|||
37799927|NCT01904058|69444899|FG002|Overall Study|Adverse Event|0|||
37799928|NCT01904058|69444900|FG003|Overall Study|Adverse Event|0|||
37799929|NCT01904058|69444897|FG000|Overall Study|Withdrawal by Subject|1|||
37799930|NCT01904058|69444898|FG001|Overall Study|Withdrawal by Subject|0|||
37799931|NCT01904058|69444899|FG002|Overall Study|Withdrawal by Subject|1|||
37799932|NCT01904058|69444900|FG003|Overall Study|Withdrawal by Subject|0|||
37799933|NCT01904058|69444897|FG000|Overall Study|Pregnancy|0|||
37799934|NCT01904058|69444898|FG001|Overall Study|Pregnancy|0|||
37799935|NCT01904058|69444899|FG002|Overall Study|Pregnancy|0|||
37799936|NCT01904058|69444900|FG003|Overall Study|Pregnancy|1|||
37799937|NCT01881126|69444918|FG000|Overall Study|Non-compliance|1|||
37799938|NCT01881126|69444919|FG001|Overall Study|Non-compliance|1|||
37799939|NCT01881126|69444918|FG000|Overall Study|Adverse Event|0|||
37799940|NCT01881126|69444919|FG001|Overall Study|Adverse Event|1|||
37799941|NCT01614600|69444925|FG000|Overall Study|Unacceptable fit|1|||
37799942|NCT01614600|69444925|FG000|Overall Study|Discomfort|1|||
37799943|NCT01614600|69444925|FG000|Overall Study|Unable to remove lens at the end of day|1|||
37799944|NCT01614600|69444925|FG000|Overall Study|Protocol deviation|1|||
37799945|NCT01880736|69444933|FG000|Overall Study|Adverse Event|0|||
37799946|NCT01880736|69444934|FG001|Overall Study|Adverse Event|0|||
37799947|NCT01880736|69444935|FG002|Overall Study|Adverse Event|0|||
37799948|NCT01880736|69444936|FG003|Overall Study|Adverse Event|1|||
37799949|NCT01880736|69444933|FG000|Overall Study|Withdrawal Criteria|1|||
37799950|NCT01880736|69444934|FG001|Overall Study|Withdrawal Criteria|2|||
37799951|NCT01880736|69444935|FG002|Overall Study|Withdrawal Criteria|1|||
37799952|NCT01880736|69444936|FG003|Overall Study|Withdrawal Criteria|5|||
37799953|NCT01880424|69444948|FG000|Overall Study|Adverse Event|7|||
37799954|NCT01880424|69444949|FG001|Overall Study|Adverse Event|6|||
37799955|NCT01880424|69444948|FG000|Overall Study|Lack of Efficacy|1|||
37799956|NCT01880424|69444949|FG001|Overall Study|Lack of Efficacy|4|||
37799957|NCT01880424|69444948|FG000|Overall Study|Lost to Follow-up|3|||
37799958|NCT01880424|69444949|FG001|Overall Study|Lost to Follow-up|2|||
37799959|NCT01880424|69444948|FG000|Overall Study|Protocol Violation|11|||
37799960|NCT01880424|69444949|FG001|Overall Study|Protocol Violation|13|||
37799961|NCT01880424|69444948|FG000|Overall Study|Withdrawal by Subject|10|||
37799962|NCT01880424|69444949|FG001|Overall Study|Withdrawal by Subject|30|||
37799963|NCT01880424|69444948|FG000|Overall Study|Other|1|||
37799964|NCT01880424|69444949|FG001|Overall Study|Other|0|||
37799965|NCT01862874|69444957|FG000|Overall Study|Randomized not treated|1|||
37799966|NCT01862874|69444958|FG001|Overall Study|Randomized not treated|0|||
37799967|NCT01862874|69444957|FG000|Overall Study|Adverse Event|0|||
37799968|NCT01862874|69444958|FG001|Overall Study|Adverse Event|3|||
37799969|NCT01862874|69444957|FG000|Overall Study|Lost to Follow-up|26|||
37799970|NCT01862874|69444958|FG001|Overall Study|Lost to Follow-up|29|||
37799971|NCT01862874|69444957|FG000|Overall Study|Physician Decision|5|||
37799972|NCT01862874|69444958|FG001|Overall Study|Physician Decision|3|||
37799973|NCT01862874|69444957|FG000|Overall Study|Withdrawn by parent/guardian|1|||
37799974|NCT01862874|69444958|FG001|Overall Study|Withdrawn by parent/guardian|1|||
37799975|NCT01862874|69444957|FG000|Overall Study|Withdrawal by Subject|46|||
37799976|NCT01862874|69444958|FG001|Overall Study|Withdrawal by Subject|40|||
37799977|NCT01862874|69444957|FG000|Overall Study|Death|0|||
37799978|NCT01862874|69444958|FG001|Overall Study|Death|1|||
37799979|NCT01879722|69444974|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
37799980|NCT01879722|69444975|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
37799981|NCT01879722|69444976|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
37799982|NCT01879722|69444977|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
37799983|NCT01879722|69444978|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
37799984|NCT01879722|69444979|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
37799985|NCT01879722|69444980|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
37799986|NCT01879722|69444981|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
37799987|NCT01879722|69444982|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
37799988|NCT01879722|69444983|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
37799989|NCT01879722|69444974|FG000|Overall Study|Voluntary Withdrawal|0|||
37799990|NCT01879722|69444975|FG001|Overall Study|Voluntary Withdrawal|0|||
37799991|NCT01879722|69444976|FG002|Overall Study|Voluntary Withdrawal|0|||
37799992|NCT01879722|69444977|FG003|Overall Study|Voluntary Withdrawal|0|||
37799993|NCT01879722|69444978|FG004|Overall Study|Voluntary Withdrawal|0|||
37799994|NCT01879722|69444979|FG005|Overall Study|Voluntary Withdrawal|0|||
37799995|NCT01879722|69444980|FG006|Overall Study|Voluntary Withdrawal|0|||
37799996|NCT01879722|69444981|FG007|Overall Study|Voluntary Withdrawal|0|||
37799997|NCT01879722|69444982|FG008|Overall Study|Voluntary Withdrawal|1|||
37799998|NCT01879722|69444983|FG009|Overall Study|Voluntary Withdrawal|0|||
37799999|NCT01879410|69445010|FG000|Overall Study|Adverse Event|9|||
37800000|NCT01879410|69445011|FG001|Overall Study|Adverse Event|14|||
37800001|NCT01879410|69445010|FG000|Overall Study|Lack of Efficacy|4|||
37800002|NCT01879410|69445011|FG001|Overall Study|Lack of Efficacy|6|||
37800003|NCT01879410|69445010|FG000|Overall Study|Protocol Violation|1|||
37800004|NCT01879410|69445011|FG001|Overall Study|Protocol Violation|7|||
37800005|NCT01879410|69445010|FG000|Overall Study|Lost to Follow-up|2|||
37800006|NCT01879410|69445011|FG001|Overall Study|Lost to Follow-up|1|||
37800007|NCT01879410|69445010|FG000|Overall Study|Withdrawal by Subject|7|||
37800008|NCT01879410|69445011|FG001|Overall Study|Withdrawal by Subject|8|||
37800009|NCT01879410|69445010|FG000|Overall Study|Randomised in Error|1|||
37800010|NCT01879410|69445011|FG001|Overall Study|Randomised in Error|2|||
37800011|NCT01903434|69445017|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
37800012|NCT01903434|69445018|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
37800013|NCT01903434|69445017|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
37800014|NCT01903434|69445018|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
37800015|NCT01903356|69445024|FG000|Overall Study|Lost to Follow-up|7|||
37800016|NCT01903356|69445024|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
37800017|NCT01903356|69445024|FG000|Overall Study|Violated the dosage and administration|3|||
37800018|NCT01862796|69445031|FG000|Overall Study|Prohibited medications|0|||
37800019|NCT01862796|69445032|FG001|Overall Study|Prohibited medications|0|||
37800020|NCT01862796|69445033|FG002|Overall Study|Prohibited medications|1|||
37800021|NCT01878084|69445041|FG000|Overall Study|Physician Decision|2|||
37800022|NCT01862640|69445050|FG000|Overall Study|Adverse Event|4|||
37800023|NCT01862640|69445051|FG001|Overall Study|Adverse Event|10|||
37800024|NCT01862640|69445052|FG002|Overall Study|Adverse Event|6|||
37800025|NCT01862640|69445053|FG003|Overall Study|Adverse Event|8|||
37800026|NCT01862640|69445050|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
37800027|NCT01862640|69445051|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
37800028|NCT01862640|69445052|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
37800029|NCT01862640|69445053|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
37975699|NCT00385827|69662974|FG002|Part 2|Other|21|||
37800030|NCT01862640|69445050|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
37800031|NCT01862640|69445051|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
37800032|NCT01862640|69445052|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
37975700|NCT00498602|69662991|FG000|Overall Study|Death|0|||
37975701|NCT00498602|69662992|FG001|Overall Study|Death|0|||
37975702|NCT00498602|69662993|FG002|Overall Study|Death|0|||
37800033|NCT01862640|69445053|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
37800034|NCT01862640|69445050|FG000|Overall Study|Withdrawal by Subject|2|||
37800035|NCT01862640|69445051|FG001|Overall Study|Withdrawal by Subject|4|||
37800036|NCT01862640|69445052|FG002|Overall Study|Withdrawal by Subject|8|||
37800037|NCT01862640|69445053|FG003|Overall Study|Withdrawal by Subject|5|||
37800038|NCT01862640|69445050|FG000|Overall Study|Protocol Deviation|0|||
37800039|NCT01862640|69445051|FG001|Overall Study|Protocol Deviation|0|||
37800040|NCT01862640|69445052|FG002|Overall Study|Protocol Deviation|1|||
37800041|NCT01862640|69445053|FG003|Overall Study|Protocol Deviation|0|||
37800042|NCT01902966|69445062|FG000|Overall Study|Death|1|||
37800043|NCT01902966|69445062|FG000|Overall Study|Physician Decision|1|||
37800044|NCT01902966|69445062|FG000|Overall Study|Withdrawal by Subject|1|||
37800045|NCT01862484|69445068|FG000|Overall Study|Lack of Efficacy|1|||
37800046|NCT01862484|69445069|FG001|Overall Study|Lack of Efficacy|1|||
37800047|NCT01862484|69445068|FG000|Overall Study|Lost to Follow-up|1|||
37800048|NCT01862484|69445069|FG001|Overall Study|Lost to Follow-up|2|||
37800049|NCT01862484|69445068|FG000|Overall Study|Protocol Violation|0|||
37800050|NCT01862484|69445069|FG001|Overall Study|Protocol Violation|2|||
37800051|NCT01862484|69445068|FG000|Overall Study|Withdrawal by Subject|0|||
37800052|NCT01862484|69445069|FG001|Overall Study|Withdrawal by Subject|3|||
37800053|NCT01902888|69445075|FG000|Overall Study|Study Terminated|3|||
37800054|NCT01862328|69445086|FG000|Overall Study|Progressive Disease|3|||
37800055|NCT01862328|69445087|FG001|Overall Study|Progressive Disease|11|||
37800056|NCT01862328|69445088|FG002|Overall Study|Progressive Disease|5|||
37800057|NCT01862328|69445089|FG003|Overall Study|Progressive Disease|6|||
37800058|NCT01862328|69445090|FG004|Overall Study|Progressive Disease|7|||
37800059|NCT01862328|69445091|FG005|Overall Study|Progressive Disease|4|||
37800060|NCT01862328|69445092|FG006|Overall Study|Progressive Disease|3|||
37800061|NCT01862328|69445086|FG000|Overall Study|Adverse Event|0|||
37800062|NCT01862328|69445087|FG001|Overall Study|Adverse Event|4|||
37800063|NCT01862328|69445088|FG002|Overall Study|Adverse Event|0|||
37800064|NCT01862328|69445089|FG003|Overall Study|Adverse Event|1|||
37800065|NCT01862328|69445090|FG004|Overall Study|Adverse Event|0|||
37800066|NCT01862328|69445091|FG005|Overall Study|Adverse Event|2|||
37800067|NCT01862328|69445092|FG006|Overall Study|Adverse Event|4|||
37800068|NCT01862328|69445086|FG000|Overall Study|Other|0|||
37800069|NCT01862328|69445087|FG001|Overall Study|Other|2|||
37800070|NCT01862328|69445088|FG002|Overall Study|Other|1|||
37800071|NCT01862328|69445089|FG003|Overall Study|Other|0|||
37800072|NCT01862328|69445090|FG004|Overall Study|Other|4|||
37800073|NCT01862328|69445091|FG005|Overall Study|Other|0|||
37800074|NCT01862328|69445092|FG006|Overall Study|Other|1|||
37800075|NCT01862328|69445086|FG000|Overall Study|Withdrawal by Subject|1|||
37800076|NCT01862328|69445087|FG001|Overall Study|Withdrawal by Subject|1|||
37800077|NCT01862328|69445088|FG002|Overall Study|Withdrawal by Subject|0|||
37800078|NCT01862328|69445089|FG003|Overall Study|Withdrawal by Subject|0|||
37800079|NCT01862328|69445090|FG004|Overall Study|Withdrawal by Subject|1|||
37800080|NCT01862328|69445091|FG005|Overall Study|Withdrawal by Subject|1|||
37800081|NCT01862328|69445092|FG006|Overall Study|Withdrawal by Subject|1|||
37800082|NCT01862328|69445086|FG000|Overall Study|Symptomatic Deterioration|0|||
37800083|NCT01862328|69445087|FG001|Overall Study|Symptomatic Deterioration|0|||
37800084|NCT01862328|69445088|FG002|Overall Study|Symptomatic Deterioration|0|||
37800085|NCT01862328|69445089|FG003|Overall Study|Symptomatic Deterioration|0|||
37800086|NCT01862328|69445090|FG004|Overall Study|Symptomatic Deterioration|0|||
37800087|NCT01862328|69445091|FG005|Overall Study|Symptomatic Deterioration|0|||
37800088|NCT01862328|69445092|FG006|Overall Study|Symptomatic Deterioration|1|||
37800089|NCT01862250|69445114|FG000|Overall Study|Adverse Event|4|||
37800090|NCT01860846|69445118|FG000|Overall Study|Lost to Follow-up|33|||
37800091|NCT01901874|69445122|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
37800092|NCT01901874|69445122|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
37800093|NCT01901874|69445122|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
37800094|NCT01901874|69445122|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
37800095|NCT01901874|69445122|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
37800096|NCT01901874|69445122|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
37800097|NCT01860534|69445128|FG000|ROP #1|Needed treatment for ROP|0|||
37800098|NCT01860534|69445129|FG001|ROP #1|Needed treatment for ROP|1|||
37800099|NCT01860534|69445128|FG000|ROP #2|discharged prior to ROP #2|1|||
37800100|NCT01860534|69445129|FG001|ROP #2|discharged prior to ROP #2|0|||
37800101|NCT01901328|69445139|FG000|Overall Study|Lost to Follow-up|1|||
37975703|NCT00498602|69662994|FG003|Overall Study|Death|0|||
37800102|NCT01901328|69445140|FG001|Overall Study|Lost to Follow-up|0|||
37800103|NCT01901328|69445139|FG000|Overall Study|Physician Decision|0|||
37800104|NCT01901328|69445140|FG001|Overall Study|Physician Decision|1|||
37800105|NCT01901328|69445139|FG000|Overall Study|Protocol Violation|1|||
37800106|NCT01901328|69445140|FG001|Overall Study|Protocol Violation|1|||
37800107|NCT01901328|69445139|FG000|Overall Study|Study Terminated by Sponsor|19|||
37800108|NCT01901328|69445140|FG001|Overall Study|Study Terminated by Sponsor|16|||
37800109|NCT01901328|69445139|FG000|Overall Study|Withdrawal by Subject|1|||
37975704|NCT00498602|69662995|FG004|Overall Study|Death|0|||
37800110|NCT01901328|69445140|FG001|Overall Study|Withdrawal by Subject|2|||
37800111|NCT01901328|69445139|FG000|Overall Study|Lack of Efficacy|0|||
37800112|NCT01901328|69445140|FG001|Overall Study|Lack of Efficacy|1|||
37800113|NCT01859988|69445153|FG000|Overall Study|Withdrawal by Subject|6|||
37800114|NCT01859988|69445154|FG001|Overall Study|Withdrawal by Subject|3|||
37800115|NCT01859988|69445155|FG002|Overall Study|Withdrawal by Subject|4|||
37800116|NCT01859988|69445156|FG003|Overall Study|Withdrawal by Subject|3|||
37800117|NCT01859988|69445157|FG004|Overall Study|Withdrawal by Subject|2|||
37800118|NCT01859988|69445158|FG005|Overall Study|Withdrawal by Subject|2|||
37800119|NCT01859988|69445153|FG000|Overall Study|Lack of Efficacy|1|||
37800120|NCT01859988|69445154|FG001|Overall Study|Lack of Efficacy|1|||
37800121|NCT01859988|69445155|FG002|Overall Study|Lack of Efficacy|5|||
37800122|NCT01859988|69445156|FG003|Overall Study|Lack of Efficacy|0|||
37800123|NCT01859988|69445157|FG004|Overall Study|Lack of Efficacy|7|||
37800124|NCT01859988|69445158|FG005|Overall Study|Lack of Efficacy|9|||
37800125|NCT01859988|69445153|FG000|Overall Study|Physician Decision|1|||
37800126|NCT01859988|69445154|FG001|Overall Study|Physician Decision|3|||
37800127|NCT01859988|69445155|FG002|Overall Study|Physician Decision|1|||
37800128|NCT01859988|69445156|FG003|Overall Study|Physician Decision|3|||
37800129|NCT01859988|69445157|FG004|Overall Study|Physician Decision|4|||
37800130|NCT01859988|69445158|FG005|Overall Study|Physician Decision|1|||
37800131|NCT01859988|69445153|FG000|Overall Study|Adverse Event|2|||
37800132|NCT01859988|69445154|FG001|Overall Study|Adverse Event|1|||
37800133|NCT01859988|69445155|FG002|Overall Study|Adverse Event|3|||
37800134|NCT01859988|69445156|FG003|Overall Study|Adverse Event|1|||
37800135|NCT01859988|69445157|FG004|Overall Study|Adverse Event|2|||
37800136|NCT01859988|69445158|FG005|Overall Study|Adverse Event|2|||
37800137|NCT01859988|69445153|FG000|Overall Study|Lost to Follow-up|1|||
37800138|NCT01859988|69445154|FG001|Overall Study|Lost to Follow-up|2|||
37800139|NCT01859988|69445155|FG002|Overall Study|Lost to Follow-up|3|||
37800140|NCT01859988|69445156|FG003|Overall Study|Lost to Follow-up|0|||
37800141|NCT01859988|69445157|FG004|Overall Study|Lost to Follow-up|3|||
37800142|NCT01859988|69445158|FG005|Overall Study|Lost to Follow-up|2|||
37800143|NCT01859988|69445153|FG000|Overall Study|Protocol Violation|0|||
37800144|NCT01859988|69445154|FG001|Overall Study|Protocol Violation|0|||
37800145|NCT01859988|69445155|FG002|Overall Study|Protocol Violation|1|||
37800146|NCT01859988|69445156|FG003|Overall Study|Protocol Violation|0|||
37800147|NCT01859988|69445157|FG004|Overall Study|Protocol Violation|0|||
37800148|NCT01859988|69445158|FG005|Overall Study|Protocol Violation|0|||
37800149|NCT01859988|69445153|FG000|Overall Study|Other than specified above|0|||
37800150|NCT01859988|69445154|FG001|Overall Study|Other than specified above|2|||
37800151|NCT01859988|69445155|FG002|Overall Study|Other than specified above|11|||
37800152|NCT01859988|69445156|FG003|Overall Study|Other than specified above|3|||
37800153|NCT01859988|69445157|FG004|Overall Study|Other than specified above|5|||
37800154|NCT01859988|69445158|FG005|Overall Study|Other than specified above|3|||
37800155|NCT01859598|69445172|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
37800156|NCT01876446|69445180|FG000|Overall Study|Death|0|||
37800157|NCT01876446|69445181|FG001|Overall Study|Death|1|||
37800158|NCT01876446|69445180|FG000|Overall Study|Withdrawal by Subject|1|||
37800159|NCT01876446|69445181|FG001|Overall Study|Withdrawal by Subject|2|||
37800160|NCT01876446|69445180|FG000|Overall Study|Physician Decision|1|||
37800161|NCT01876446|69445181|FG001|Overall Study|Physician Decision|3|||
37800162|NCT01900626|69445189|FG000|Overall Study|study was closed due to low enrollment|1|||
37800163|NCT01900626|69445190|FG001|Overall Study|study was closed due to low enrollment|1|||
37800164|NCT01900314|69445200|FG000|Overall Study|Lost to Follow-up|1|||
37800165|NCT01900314|69445201|FG001|Overall Study|Lost to Follow-up|0|||
37800166|NCT01900314|69445200|FG000|Overall Study|Protocol Violation|0|||
37800167|NCT01900314|69445201|FG001|Overall Study|Protocol Violation|1|||
37800168|NCT01900314|69445200|FG000|Overall Study|Withdrawal by Subject|3|||
37800169|NCT01900314|69445201|FG001|Overall Study|Withdrawal by Subject|3|||
37800170|NCT01899768|69445208|FG000|Part A|Adverse Event|2|||
37800171|NCT01899768|69445208|FG000|Part A|Withdrawal by Subject|1|||
37800172|NCT01899768|69445208|FG000|Part B|Adverse Event|1|||
37800173|NCT01899768|69445208|FG000|Part B|Withdrawal by Subject|1|||
37800174|NCT01898598|69445218|FG000|Overall Study|Adverse Event|1|||
37800175|NCT01898598|69445219|FG001|Overall Study|Adverse Event|0|||
37800176|NCT01898598|69445218|FG000|Overall Study|Withdrawal by Subject|3|||
37800177|NCT01898598|69445219|FG001|Overall Study|Withdrawal by Subject|0|||
37800178|NCT01898598|69445218|FG000|Overall Study|Lost to Follow-up|0|||
37800179|NCT01898598|69445219|FG001|Overall Study|Lost to Follow-up|1|||
37975705|NCT00498602|69662996|FG005|Overall Study|Death|1|||
37975706|NCT00498602|69662997|FG006|Overall Study|Death|0|||
37800180|NCT01898598|69445218|FG000|Overall Study|Other|0|||
37800181|NCT01898598|69445219|FG001|Overall Study|Other|1|||
37800182|NCT01898442|69445228|FG000|Overall Study|Hemolysis/technical problems|1|||
37975707|NCT00498602|69662991|FG000|Overall Study|Lack of Efficacy|1|||
37800183|NCT01898442|69445229|FG001|Overall Study|Hemolysis/technical problems|2|||
37800184|NCT01898442|69445230|FG002|Overall Study|Hemolysis/technical problems|2|||
37800185|NCT01898442|69445228|FG000|Overall Study|Patient vomited pills|0|||
37800186|NCT01898442|69445229|FG001|Overall Study|Patient vomited pills|0|||
37800187|NCT01898442|69445230|FG002|Overall Study|Patient vomited pills|1|||
37800188|NCT01898286|69445238|FG000|Overall Study|Withdrawal by Subject|1|||
37800189|NCT01898286|69445238|FG000|Overall Study|Protocol Violation|1|||
37800190|NCT01898286|69445238|FG000|Overall Study|Lost to Follow-up|1|||
37800191|NCT01898208|69445245|FG000|Overall Study|Positive blood culture|17|||
37800192|NCT01898208|69445246|FG001|Overall Study|Positive blood culture|23|||
37800193|NCT01898208|69445247|FG002|Overall Study|Positive blood culture|15|||
37800194|NCT01898208|69445245|FG000|Overall Study|Death/comfort care within 24 hours|10|||
37800195|NCT01898208|69445246|FG001|Overall Study|Death/comfort care within 24 hours|9|||
37800196|NCT01898208|69445247|FG002|Overall Study|Death/comfort care within 24 hours|8|||
37800197|NCT01898208|69445245|FG000|Overall Study|Negative Gram Stain|6|||
37800198|NCT01898208|69445246|FG001|Overall Study|Negative Gram Stain|9|||
37800199|NCT01898208|69445247|FG002|Overall Study|Negative Gram Stain|6|||
37800200|NCT01898208|69445245|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
37800201|NCT01898208|69445246|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
37800202|NCT01898208|69445247|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
37800203|NCT01898208|69445245|FG000|Overall Study|System/Technical Error|1|||
37800204|NCT01898208|69445246|FG001|Overall Study|System/Technical Error|2|||
37800205|NCT01898208|69445247|FG002|Overall Study|System/Technical Error|3|||
37800206|NCT01898208|69445245|FG000|Overall Study|Lost to Follow-up|3|||
37800207|NCT01898208|69445246|FG001|Overall Study|Lost to Follow-up|1|||
37800208|NCT01898208|69445247|FG002|Overall Study|Lost to Follow-up|1|||
37800209|NCT01898130|69445255|FG000|Treatment|Withdrawal by Subject|2|||
37800210|NCT01898130|69445255|FG000|Treatment|Progressive Disease|4|||
37800211|NCT01898130|69445255|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
37800212|NCT01876368|69445261|FG000|Overall Study|Adverse Event|2|||
37800213|NCT01876368|69445262|FG001|Overall Study|Adverse Event|5|||
37800214|NCT01876368|69445261|FG000|Overall Study|Lack of Efficacy|1|||
37800215|NCT01876368|69445262|FG001|Overall Study|Lack of Efficacy|0|||
37800216|NCT01876368|69445261|FG000|Overall Study|Lost to Follow-up|0|||
37800217|NCT01876368|69445262|FG001|Overall Study|Lost to Follow-up|1|||
37800218|NCT01876368|69445261|FG000|Overall Study|Non-compliance with study treatment|0|||
37800219|NCT01876368|69445262|FG001|Overall Study|Non-compliance with study treatment|1|||
37800220|NCT01876368|69445261|FG000|Overall Study|Physician Decision|0|||
37800221|NCT01876368|69445262|FG001|Overall Study|Physician Decision|2|||
37800222|NCT01876368|69445261|FG000|Overall Study|Protocol deviation|3|||
37800223|NCT01876368|69445262|FG001|Overall Study|Protocol deviation|3|||
37800224|NCT01876368|69445261|FG000|Overall Study|Subject/guardian decision|3|||
37800225|NCT01876368|69445262|FG001|Overall Study|Subject/guardian decision|1|||
37800226|NCT01874340|69445272|FG000|Overall Study|Study terminated by Sponsor|6|||
37800227|NCT01874340|69445273|FG001|Overall Study|Study terminated by Sponsor|8|||
37800228|NCT01874340|69445274|FG002|Overall Study|Study terminated by Sponsor|8|||
37800229|NCT01874340|69445275|FG003|Overall Study|Study terminated by Sponsor|4|||
37800230|NCT01874340|69445272|FG000|Overall Study|Withdrawal by Subject|0|||
37800231|NCT01874340|69445273|FG001|Overall Study|Withdrawal by Subject|0|||
37800232|NCT01874340|69445274|FG002|Overall Study|Withdrawal by Subject|0|||
37800233|NCT01874340|69445275|FG003|Overall Study|Withdrawal by Subject|1|||
37800234|NCT01897896|69445287|FG000|Overall Study|Death|1|||
37800235|NCT01897896|69445288|FG001|Overall Study|Death|0|||
37800236|NCT01897896|69445287|FG000|Overall Study|Adverse Event|11|||
37800237|NCT01897896|69445288|FG001|Overall Study|Adverse Event|1|||
37800238|NCT01897896|69445287|FG000|Overall Study|Lost to Follow-up|1|||
37800239|NCT01897896|69445288|FG001|Overall Study|Lost to Follow-up|0|||
37800240|NCT01897896|69445287|FG000|Overall Study|Non-compliance with study drug dosing|1|||
37800241|NCT01897896|69445288|FG001|Overall Study|Non-compliance with study drug dosing|1|||
37800242|NCT01897896|69445287|FG000|Overall Study|Withdrawal by Subject|7|||
37800243|NCT01897896|69445288|FG001|Overall Study|Withdrawal by Subject|1|||
37800244|NCT01897896|69445287|FG000|Overall Study|Require drug that interfere with study|1|||
37800245|NCT01897896|69445288|FG001|Overall Study|Require drug that interfere with study|4|||
37800246|NCT01897896|69445287|FG000|Overall Study|Protocol Violation|1|||
37800247|NCT01897896|69445288|FG001|Overall Study|Protocol Violation|1|||
37800248|NCT01897896|69445287|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
37800249|NCT01897896|69445288|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
37800250|NCT01897896|69445287|FG000|Overall Study|Caregiver can no longer participate|0|||
37800251|NCT01897896|69445288|FG001|Overall Study|Caregiver can no longer participate|2|||
37800252|NCT01897896|69445287|FG000|Overall Study|Other than specified|2|||
37800253|NCT01897896|69445288|FG001|Overall Study|Other than specified|1|||
37693942|NCT02039427|69170177|FG003|Overall Study|Steroid Use|0|||
37800254|NCT01858194|69445298|FG000|Overall Study|Total Artificial Heart Implant|0|||
37800255|NCT01858194|69445299|FG001|Overall Study|Total Artificial Heart Implant|1|||
37800256|NCT01858194|69445298|FG000|Overall Study|Lost to Follow-up|0|||
37800257|NCT01858194|69445299|FG001|Overall Study|Lost to Follow-up|1|||
37800258|NCT01873950|69445307|FG000|Period 5|Withdrawal by Subject|0|||
37800259|NCT01873950|69445308|FG001|Period 5|Withdrawal by Subject|0|||
37800260|NCT01873950|69445309|FG002|Period 5|Withdrawal by Subject|0|||
37800261|NCT01873950|69445310|FG003|Period 5|Withdrawal by Subject|1|||
37800262|NCT01873950|69445311|FG004|Period 5|Withdrawal by Subject|0|||
37800263|NCT01857102|69445325|FG000|Period 1|No longer meets Eligibility Criteria|0|||
37800264|NCT01857102|69445326|FG001|Period 1|No longer meets Eligibility Criteria|2|||
37800265|NCT01857102|69445325|FG000|Period 1|Lost to Follow-up|0|||
37800266|NCT01857102|69445326|FG001|Period 1|Lost to Follow-up|3|||
37800267|NCT01857102|69445325|FG000|Period 1|Unsatisfactory Lens Fit|1|||
37800268|NCT01857102|69445326|FG001|Period 1|Unsatisfactory Lens Fit|0|||
37800269|NCT01857102|69445325|FG000|Period 1|Unsatisfactory Visual Response|1|||
37800270|NCT01857102|69445326|FG001|Period 1|Unsatisfactory Visual Response|0|||
37800271|NCT01857102|69445325|FG000|Period 1|Physician Decision|1|||
37800272|NCT01857102|69445326|FG001|Period 1|Physician Decision|0|||
37800273|NCT01857102|69445325|FG000|Period 2|Lens Discomfort|1|||
37800274|NCT01857102|69445326|FG001|Period 2|Lens Discomfort|0|||
37800275|NCT01857102|69445325|FG000|Period 2|Unsatisfactory Lens Fit|1|||
37800276|NCT01857102|69445326|FG001|Period 2|Unsatisfactory Lens Fit|0|||
37800277|NCT01872078|69445338|FG000|Overall Study|Adverse Event|0|||
37800278|NCT01872078|69445339|FG001|Overall Study|Adverse Event|0|||
37800279|NCT01872078|69445340|FG002|Overall Study|Adverse Event|1|||
37800280|NCT01872078|69445341|FG003|Overall Study|Adverse Event|0|||
37800281|NCT01872078|69445338|FG000|Overall Study|Dose administration non-compliance|0|||
37800282|NCT01872078|69445339|FG001|Overall Study|Dose administration non-compliance|0|||
37800283|NCT01872078|69445340|FG002|Overall Study|Dose administration non-compliance|0|||
37800284|NCT01872078|69445341|FG003|Overall Study|Dose administration non-compliance|1|||
37800285|NCT01872078|69445338|FG000|Overall Study|Protocol Violation|0|||
37800286|NCT01872078|69445339|FG001|Overall Study|Protocol Violation|0|||
37800287|NCT01872078|69445340|FG002|Overall Study|Protocol Violation|1|||
37800288|NCT01872078|69445341|FG003|Overall Study|Protocol Violation|0|||
37800289|NCT01872078|69445338|FG000|Overall Study|Withdrawal by Subject|0|||
37800290|NCT01872078|69445339|FG001|Overall Study|Withdrawal by Subject|0|||
37800291|NCT01872078|69445340|FG002|Overall Study|Withdrawal by Subject|1|||
37800292|NCT01872078|69445341|FG003|Overall Study|Withdrawal by Subject|0|||
37800293|NCT01872078|69445338|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
37800294|NCT01872078|69445339|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
37800295|NCT01872078|69445340|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
37800296|NCT01872078|69445341|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
37800297|NCT01896726|69445351|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
37800298|NCT01896726|69445351|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
37800299|NCT01856790|69445358|FG000|Closed Loop Control|Withdrawal by Subject|2|||
37800300|NCT01856790|69445358|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
37800301|NCT01856322|69445372|FG000|Overall Study|off study due to lack of accrual|0|||
37800302|NCT01856322|69445373|FG001|Overall Study|off study due to lack of accrual|0|||
37800303|NCT01856322|69445374|FG002|Overall Study|off study due to lack of accrual|3|||
37800304|NCT01896102|69445381|FG000|Overall Study|Death|1|||
37800305|NCT01896102|69445381|FG000|Overall Study|Participant to receive allogenic transplant|2|||
37800306|NCT01871532|69445388|FG000|Overall Study|Withdrawal by Subject|1|||
37800307|NCT01871532|69445389|FG001|Overall Study|Withdrawal by Subject|2|||
37800308|NCT01855074|69445395|FG000|Overall Study|Adverse Event|1|||
37800309|NCT01855074|69445395|FG000|Overall Study|Lost to Follow-up|4|||
37800310|NCT01855074|69445395|FG000|Overall Study|Withdrawal by Subject|8|||
37800311|NCT01855074|69445395|FG000|Overall Study|Started but not treated|1|||
37800312|NCT01871142|69445399|FG000|Overall Study|Adverse Event|1|||
37800313|NCT01895322|69445413|FG000|Overall Study|Adverse Event|1|||
37800314|NCT01895322|69445413|FG000|Overall Study|Withdrawal by Subject|2|||
37800315|NCT01895322|69445413|FG000|Overall Study|Protocol Violation|10|||
37800316|NCT01894776|69445418|FG000|Overall Study|Withdrawal by Subject|1|||
37800317|NCT01894620|69445424|FG000|Overall Study|Withdrawal by Subject|0|||
37800318|NCT01894620|69445425|FG001|Overall Study|Withdrawal by Subject|1|||
37800319|NCT01854918|69445435|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
37800320|NCT01854918|69445436|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
37800321|NCT01854918|69445435|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
37800322|NCT01854918|69445436|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
37800323|NCT01854918|69445435|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
37800324|NCT01854918|69445436|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
37800325|NCT01854918|69445435|FG000|SOC-controlled Period (Year 1)|Death|5|||
37800326|NCT01854918|69445436|FG001|SOC-controlled Period (Year 1)|Death|5|||
37800327|NCT01854918|69445435|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
37800328|NCT01854918|69445436|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
37800329|NCT01854918|69445435|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
37800330|NCT01854918|69445436|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
37800331|NCT01854918|69445435|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
37800332|NCT01854918|69445436|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
37800333|NCT01854918|69445435|FG000|All-IP Period (Years 2 and 3)|Death|5|||
37800334|NCT01854918|69445436|FG001|All-IP Period (Years 2 and 3)|Death|16|||
37800335|NCT01894230|69445451|FG000|Overall Study|Lost to Follow-up|2|||
37800336|NCT01894230|69445452|FG001|Overall Study|Lost to Follow-up|2|||
37800337|NCT01894230|69445451|FG000|Overall Study|Withdrawal by Subject|4|||
37800338|NCT01894230|69445452|FG001|Overall Study|Withdrawal by Subject|4|||
37800339|NCT01894230|69445451|FG000|Overall Study|Non-adherent|0|||
37800340|NCT01894230|69445452|FG001|Overall Study|Non-adherent|1|||
37800341|NCT01894230|69445451|FG000|Overall Study|Death|1|||
37800342|NCT01894230|69445452|FG001|Overall Study|Death|0|||
37800343|NCT01894152|69445458|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
37800344|NCT01854528|69445464|FG000|Overall Study|Adverse Event|0|||
37800345|NCT01854528|69445465|FG001|Overall Study|Adverse Event|4|||
37800346|NCT01854528|69445464|FG000|Overall Study|Withdrawal by Subject|0|||
37800347|NCT01854528|69445465|FG001|Overall Study|Withdrawal by Subject|2|||
37800348|NCT01854528|69445464|FG000|Overall Study|Virologic Failure|0|||
37800349|NCT01854528|69445465|FG001|Overall Study|Virologic Failure|9|||
37800350|NCT01853982|69445473|FG000|Overall Study|Withdrawal by Subject|1|||
37800351|NCT01853982|69445474|FG001|Overall Study|Withdrawal by Subject|0|||
37800352|NCT01853982|69445473|FG000|Overall Study|Death|1|||
37800353|NCT01853982|69445474|FG001|Overall Study|Death|0|||
37800354|NCT01853982|69445473|FG000|Overall Study|Lost to Follow-up|0|||
37800355|NCT01853982|69445474|FG001|Overall Study|Lost to Follow-up|1|||
37800356|NCT01853280|69445482|FG000|Overall Study|Lack of Efficacy|2|||
37800357|NCT01853280|69445483|FG001|Overall Study|Lack of Efficacy|2|||
37800358|NCT01853280|69445482|FG000|Overall Study|Lost to Follow-up|0|||
37800359|NCT01853280|69445483|FG001|Overall Study|Lost to Follow-up|1|||
37800360|NCT01853280|69445482|FG000|Overall Study|Physician Decision|0|||
37800361|NCT01853280|69445483|FG001|Overall Study|Physician Decision|1|||
37800362|NCT01853280|69445482|FG000|Overall Study|Withdrawal by Subject|0|||
37800363|NCT01853280|69445483|FG001|Overall Study|Withdrawal by Subject|1|||
37800364|NCT01853280|69445482|FG000|Overall Study|Ineligible|0|||
37800365|NCT01853280|69445483|FG001|Overall Study|Ineligible|1|||
37800366|NCT01892436|69445493|FG000|Overall Study|Withdrawal by Subject|8|||
37800367|NCT01892436|69445494|FG001|Overall Study|Withdrawal by Subject|15|||
37800368|NCT01892436|69445495|FG002|Overall Study|Withdrawal by Subject|4|||
37800369|NCT01892436|69445496|FG003|Overall Study|Withdrawal by Subject|4|||
37800370|NCT01892436|69445493|FG000|Overall Study|Death|1|||
37800371|NCT01892436|69445494|FG001|Overall Study|Death|1|||
37800372|NCT01892436|69445495|FG002|Overall Study|Death|0|||
37800373|NCT01892436|69445496|FG003|Overall Study|Death|0|||
37800374|NCT01892436|69445493|FG000|Overall Study|Physician Decision|2|||
37800375|NCT01892436|69445494|FG001|Overall Study|Physician Decision|1|||
37800376|NCT01892436|69445495|FG002|Overall Study|Physician Decision|0|||
37800377|NCT01892436|69445496|FG003|Overall Study|Physician Decision|1|||
37800378|NCT01892436|69445493|FG000|Overall Study|Pregnancy|0|||
37800379|NCT01892436|69445494|FG001|Overall Study|Pregnancy|2|||
37800380|NCT01892436|69445495|FG002|Overall Study|Pregnancy|1|||
37800381|NCT01892436|69445496|FG003|Overall Study|Pregnancy|0|||
37800382|NCT01892436|69445493|FG000|Overall Study|Technical problems|2|||
37800383|NCT01892436|69445494|FG001|Overall Study|Technical problems|1|||
37800384|NCT01892436|69445495|FG002|Overall Study|Technical problems|1|||
37800385|NCT01892436|69445496|FG003|Overall Study|Technical problems|1|||
37800386|NCT01892436|69445493|FG000|Overall Study|Lack of Efficacy|1|||
37800387|NCT01892436|69445494|FG001|Overall Study|Lack of Efficacy|2|||
37800388|NCT01892436|69445495|FG002|Overall Study|Lack of Efficacy|2|||
37800389|NCT01892436|69445496|FG003|Overall Study|Lack of Efficacy|2|||
37693943|NCT02094885|69170193|FG000|Overall Study|Death|1|||
37800390|NCT01892436|69445493|FG000|Overall Study|Lost to Follow-up|1|||
37800391|NCT01892436|69445494|FG001|Overall Study|Lost to Follow-up|1|||
37800392|NCT01892436|69445495|FG002|Overall Study|Lost to Follow-up|1|||
37800393|NCT01892436|69445496|FG003|Overall Study|Lost to Follow-up|3|||
37800394|NCT01892436|69445493|FG000|Overall Study|non-compliance with treatment|1|||
37800395|NCT01892436|69445494|FG001|Overall Study|non-compliance with treatment|0|||
37800396|NCT01892436|69445495|FG002|Overall Study|non-compliance with treatment|0|||
37800397|NCT01892436|69445496|FG003|Overall Study|non-compliance with treatment|0|||
37800398|NCT01892436|69445493|FG000|Overall Study|Adverse Event|7|||
37800399|NCT01892436|69445494|FG001|Overall Study|Adverse Event|6|||
37800400|NCT01892436|69445495|FG002|Overall Study|Adverse Event|2|||
37800401|NCT01892436|69445496|FG003|Overall Study|Adverse Event|3|||
37800402|NCT01853046|69445508|FG000|Overall Study|Withdrawal by Subject|1|||
37800403|NCT01853046|69445509|FG001|Overall Study|Withdrawal by Subject|1|||
37800404|NCT01853046|69445508|FG000|Overall Study|Adverse Event|4|||
37800405|NCT01853046|69445509|FG001|Overall Study|Adverse Event|2|||
37800406|NCT01853046|69445508|FG000|Overall Study|Disease progression|13|||
37800407|NCT01853046|69445509|FG001|Overall Study|Disease progression|3|||
37800408|NCT01891890|69445519|FG000|Overall Study|Lost to Follow-up|0|||
37800409|NCT01891890|69445520|FG001|Overall Study|Lost to Follow-up|0|||
37800410|NCT01891890|69445521|FG002|Overall Study|Lost to Follow-up|1|||
37800411|NCT01891890|69445519|FG000|Overall Study|Study ended before endpoint reached|7|||
37800412|NCT01891890|69445520|FG001|Overall Study|Study ended before endpoint reached|3|||
37800413|NCT01891890|69445521|FG002|Overall Study|Study ended before endpoint reached|6|||
37800414|NCT01852812|69445532|FG000|Overall Study|Adverse Event|0|||
37800415|NCT01852812|69445533|FG001|Overall Study|Adverse Event|0|||
37800416|NCT01852812|69445534|FG002|Overall Study|Adverse Event|1|||
37800417|NCT01852812|69445532|FG000|Overall Study|Non-compliance With Study Drug|0|||
37800418|NCT01852812|69445533|FG001|Overall Study|Non-compliance With Study Drug|1|||
37800419|NCT01852812|69445534|FG002|Overall Study|Non-compliance With Study Drug|0|||
37800420|NCT01869348|69445544|FG000|Overall Study|Withdrawal by Subject|1|||
37800421|NCT01869348|69445545|FG001|Overall Study|Withdrawal by Subject|1|||
37800422|NCT01869192|69445553|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
37800423|NCT01869192|69445554|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
37800424|NCT01869192|69445553|FG000|Postoperative Chemotherapy|Physician Decision|0|||
37800425|NCT01869192|69445554|FG001|Postoperative Chemotherapy|Physician Decision|2|||
37800426|NCT01868646|69445562|FG000|Overall Study|Do not meet inclusion criteria|3|||
37800427|NCT01868646|69445563|FG001|Overall Study|Do not meet inclusion criteria|5|||
37800428|NCT01852110|69445571|FG000|Overall Study|Adverse Event|12|||
37800429|NCT01852110|69445572|FG001|Overall Study|Adverse Event|5|||
37800430|NCT01852110|69445573|FG002|Overall Study|Adverse Event|0|||
37800431|NCT01852110|69445574|FG003|Overall Study|Adverse Event|0|||
37800432|NCT01852110|69445575|FG004|Overall Study|Adverse Event|0|||
37800433|NCT01852110|69445576|FG005|Overall Study|Adverse Event|0|||
37975708|NCT00498602|69662992|FG001|Overall Study|Lack of Efficacy|0|||
37975709|NCT00498602|69662993|FG002|Overall Study|Lack of Efficacy|0|||
37975710|NCT00498602|69662994|FG003|Overall Study|Lack of Efficacy|0|||
37800434|NCT01852110|69445571|FG000|Overall Study|Lost to Follow-up|1|||
37800435|NCT01852110|69445572|FG001|Overall Study|Lost to Follow-up|3|||
37800436|NCT01852110|69445573|FG002|Overall Study|Lost to Follow-up|0|||
37800437|NCT01852110|69445574|FG003|Overall Study|Lost to Follow-up|0|||
37800438|NCT01852110|69445575|FG004|Overall Study|Lost to Follow-up|0|||
37800439|NCT01852110|69445576|FG005|Overall Study|Lost to Follow-up|0|||
37800440|NCT01852110|69445571|FG000|Overall Study|Non-compliance with Study Drug|2|||
37800441|NCT01852110|69445572|FG001|Overall Study|Non-compliance with Study Drug|1|||
37800442|NCT01852110|69445573|FG002|Overall Study|Non-compliance with Study Drug|0|||
37800443|NCT01852110|69445574|FG003|Overall Study|Non-compliance with Study Drug|0|||
37800444|NCT01852110|69445575|FG004|Overall Study|Non-compliance with Study Drug|0|||
37800445|NCT01852110|69445576|FG005|Overall Study|Non-compliance with Study Drug|0|||
37800446|NCT01852110|69445571|FG000|Overall Study|Physician Decision|1|||
37800447|NCT01852110|69445572|FG001|Overall Study|Physician Decision|0|||
37800448|NCT01852110|69445573|FG002|Overall Study|Physician Decision|0|||
37800449|NCT01852110|69445574|FG003|Overall Study|Physician Decision|0|||
37800450|NCT01852110|69445575|FG004|Overall Study|Physician Decision|0|||
37800451|NCT01852110|69445576|FG005|Overall Study|Physician Decision|0|||
37800452|NCT01852110|69445571|FG000|Overall Study|Protocol Violation|0|||
37800453|NCT01852110|69445572|FG001|Overall Study|Protocol Violation|1|||
37800454|NCT01852110|69445573|FG002|Overall Study|Protocol Violation|0|||
37800455|NCT01852110|69445574|FG003|Overall Study|Protocol Violation|0|||
37800456|NCT01852110|69445575|FG004|Overall Study|Protocol Violation|0|||
37800457|NCT01852110|69445576|FG005|Overall Study|Protocol Violation|0|||
37800458|NCT01852110|69445571|FG000|Overall Study|Study Terminated by Sponsor|30|||
37800459|NCT01852110|69445572|FG001|Overall Study|Study Terminated by Sponsor|32|||
37800460|NCT01852110|69445573|FG002|Overall Study|Study Terminated by Sponsor|0|||
37800461|NCT01852110|69445574|FG003|Overall Study|Study Terminated by Sponsor|0|||
37800462|NCT01852110|69445575|FG004|Overall Study|Study Terminated by Sponsor|0|||
37800463|NCT01852110|69445576|FG005|Overall Study|Study Terminated by Sponsor|0|||
37800464|NCT01852110|69445571|FG000|Overall Study|Withdrawal by Subject|4|||
37800465|NCT01852110|69445572|FG001|Overall Study|Withdrawal by Subject|4|||
37800466|NCT01852110|69445573|FG002|Overall Study|Withdrawal by Subject|0|||
37800467|NCT01852110|69445574|FG003|Overall Study|Withdrawal by Subject|0|||
37800468|NCT01852110|69445575|FG004|Overall Study|Withdrawal by Subject|0|||
37800469|NCT01852110|69445576|FG005|Overall Study|Withdrawal by Subject|0|||
37800470|NCT01851720|69445592|FG000|Overall Study|Lost to Follow-up|0|||
37800471|NCT01851720|69445593|FG001|Overall Study|Lost to Follow-up|1|||
37800472|NCT01851330|69445602|FG000|Overall Study|Lack of Efficacy|10|||
37800473|NCT01851330|69445603|FG001|Overall Study|Lack of Efficacy|9|||
37800474|NCT01851330|69445604|FG002|Overall Study|Lack of Efficacy|2|||
37800475|NCT01851330|69445602|FG000|Overall Study|Lost to Follow-up|1|||
37800476|NCT01851330|69445603|FG001|Overall Study|Lost to Follow-up|6|||
37800477|NCT01851330|69445604|FG002|Overall Study|Lost to Follow-up|9|||
37800478|NCT01851330|69445602|FG000|Overall Study|Withdrew Consent|2|||
37800479|NCT01851330|69445603|FG001|Overall Study|Withdrew Consent|1|||
37800480|NCT01851330|69445604|FG002|Overall Study|Withdrew Consent|0|||
37800481|NCT01851330|69445602|FG000|Overall Study|Investigator's Discretion|0|||
37800482|NCT01851330|69445603|FG001|Overall Study|Investigator's Discretion|0|||
37800483|NCT01851330|69445604|FG002|Overall Study|Investigator's Discretion|1|||
37800484|NCT01868022|69445621|FG000|Overall Study|Withdrawal by Subject|0|||
37800485|NCT01868022|69445622|FG001|Overall Study|Withdrawal by Subject|0|||
37800486|NCT01868022|69445623|FG002|Overall Study|Withdrawal by Subject|1|||
37800487|NCT01868022|69445624|FG003|Overall Study|Withdrawal by Subject|1|||
37800488|NCT01868022|69445625|FG004|Overall Study|Withdrawal by Subject|0|||
37800489|NCT01868022|69445626|FG005|Overall Study|Withdrawal by Subject|0|||
37800490|NCT01868022|69445627|FG006|Overall Study|Withdrawal by Subject|0|||
37800491|NCT01868022|69445628|FG007|Overall Study|Withdrawal by Subject|1|||
37975711|NCT00498602|69662995|FG004|Overall Study|Lack of Efficacy|0|||
37975712|NCT00498602|69662996|FG005|Overall Study|Lack of Efficacy|0|||
37975713|NCT00498602|69662997|FG006|Overall Study|Lack of Efficacy|0|||
37800492|NCT01868022|69445629|FG008|Overall Study|Withdrawal by Subject|0|||
37800493|NCT01868022|69445621|FG000|Overall Study|Adverse Event|0|||
37800494|NCT01868022|69445622|FG001|Overall Study|Adverse Event|0|||
37800495|NCT01868022|69445623|FG002|Overall Study|Adverse Event|0|||
37800496|NCT01868022|69445624|FG003|Overall Study|Adverse Event|0|||
37800497|NCT01868022|69445625|FG004|Overall Study|Adverse Event|2|||
37800498|NCT01868022|69445626|FG005|Overall Study|Adverse Event|0|||
37800499|NCT01868022|69445627|FG006|Overall Study|Adverse Event|0|||
37800500|NCT01868022|69445628|FG007|Overall Study|Adverse Event|2|||
37800501|NCT01868022|69445629|FG008|Overall Study|Adverse Event|2|||
37800502|NCT01868022|69445621|FG000|Overall Study|Physician Decision|0|||
37800503|NCT01868022|69445622|FG001|Overall Study|Physician Decision|0|||
37800504|NCT01868022|69445623|FG002|Overall Study|Physician Decision|0|||
37800505|NCT01868022|69445624|FG003|Overall Study|Physician Decision|0|||
37800506|NCT01868022|69445625|FG004|Overall Study|Physician Decision|0|||
37800507|NCT01868022|69445626|FG005|Overall Study|Physician Decision|1|||
37800508|NCT01868022|69445627|FG006|Overall Study|Physician Decision|0|||
37800509|NCT01868022|69445628|FG007|Overall Study|Physician Decision|2|||
37800510|NCT01868022|69445629|FG008|Overall Study|Physician Decision|0|||
37800511|NCT01868022|69445621|FG000|Overall Study|Study closed/terminated|0|||
37800512|NCT01868022|69445622|FG001|Overall Study|Study closed/terminated|0|||
37800513|NCT01868022|69445623|FG002|Overall Study|Study closed/terminated|0|||
37800514|NCT01868022|69445624|FG003|Overall Study|Study closed/terminated|0|||
37800515|NCT01868022|69445625|FG004|Overall Study|Study closed/terminated|0|||
37800516|NCT01868022|69445626|FG005|Overall Study|Study closed/terminated|0|||
37800517|NCT01868022|69445627|FG006|Overall Study|Study closed/terminated|0|||
37800518|NCT01868022|69445628|FG007|Overall Study|Study closed/terminated|1|||
37800519|NCT01868022|69445629|FG008|Overall Study|Study closed/terminated|0|||
37800520|NCT01868022|69445621|FG000|Overall Study|Ongoing|0|||
37800521|NCT01868022|69445622|FG001|Overall Study|Ongoing|0|||
37800522|NCT01868022|69445623|FG002|Overall Study|Ongoing|0|||
37800523|NCT01868022|69445624|FG003|Overall Study|Ongoing|0|||
37800524|NCT01868022|69445625|FG004|Overall Study|Ongoing|0|||
37800525|NCT01868022|69445626|FG005|Overall Study|Ongoing|0|||
37800526|NCT01868022|69445627|FG006|Overall Study|Ongoing|0|||
37800527|NCT01868022|69445628|FG007|Overall Study|Ongoing|3|||
37800528|NCT01868022|69445629|FG008|Overall Study|Ongoing|0|||
37800529|NCT01850004|69445655|FG000|Overall Study|Poor/Non-compliance|1|||
37800530|NCT01850004|69445655|FG000|Overall Study|Participant Withdrew Consent|9|||
37800531|NCT01850004|69445655|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
37800532|NCT01850004|69445655|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
37800533|NCT01850004|69445655|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
37800534|NCT01850004|69445655|FG000|Overall Study|Other Reasons|2|||
37800535|NCT01850004|69445655|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
37800536|NCT01850004|69445655|FG000|Overall Study|Maximum Clinical Benefit|4|||
37800537|NCT01867710|69445663|FG000|Overall Study|Death|25|||
37800538|NCT01867710|69445664|FG001|Overall Study|Death|15|||
37800539|NCT01867710|69445665|FG002|Overall Study|Death|27|||
37800540|NCT01867710|69445666|FG003|Overall Study|Death|20|||
37800541|NCT01867710|69445663|FG000|Overall Study|Lost to Follow-up|3|||
37800542|NCT01867710|69445664|FG001|Overall Study|Lost to Follow-up|4|||
37800543|NCT01867710|69445665|FG002|Overall Study|Lost to Follow-up|3|||
37800544|NCT01867710|69445666|FG003|Overall Study|Lost to Follow-up|2|||
37800545|NCT01867710|69445663|FG000|Overall Study|Withdrawal of consent|2|||
37800546|NCT01867710|69445664|FG001|Overall Study|Withdrawal of consent|5|||
37800547|NCT01867710|69445665|FG002|Overall Study|Withdrawal of consent|1|||
37800548|NCT01867710|69445666|FG003|Overall Study|Withdrawal of consent|2|||
37800549|NCT01867710|69445663|FG000|Overall Study|Study Terminated by Sponsor|9|||
37693944|NCT02094885|69170194|FG001|Overall Study|Death|5|||
37693945|NCT02094885|69170193|FG000|Overall Study|Withdrawn due to age|1|||
37800550|NCT01867710|69445664|FG001|Overall Study|Study Terminated by Sponsor|13|||
37800551|NCT01867710|69445665|FG002|Overall Study|Study Terminated by Sponsor|8|||
37800552|NCT01867710|69445666|FG003|Overall Study|Study Terminated by Sponsor|16|||
37800553|NCT01867710|69445663|FG000|Overall Study|Biochemical progression|0|||
37800554|NCT01867710|69445664|FG001|Overall Study|Biochemical progression|1|||
37800555|NCT01867710|69445665|FG002|Overall Study|Biochemical progression|0|||
37800556|NCT01867710|69445666|FG003|Overall Study|Biochemical progression|0|||
37800557|NCT01867710|69445663|FG000|Overall Study|Clinical progression|0|||
37800558|NCT01867710|69445664|FG001|Overall Study|Clinical progression|0|||
37800559|NCT01867710|69445665|FG002|Overall Study|Clinical progression|1|||
37800560|NCT01867710|69445666|FG003|Overall Study|Clinical progression|0|||
37800561|NCT01867710|69445663|FG000|Overall Study|Disease progression|1|||
37800562|NCT01867710|69445664|FG001|Overall Study|Disease progression|0|||
37800563|NCT01867710|69445665|FG002|Overall Study|Disease progression|0|||
37800564|NCT01867710|69445666|FG003|Overall Study|Disease progression|0|||
37800565|NCT01867710|69445663|FG000|Overall Study|Patient decision|0|||
37800566|NCT01867710|69445664|FG001|Overall Study|Patient decision|0|||
37800567|NCT01867710|69445665|FG002|Overall Study|Patient decision|0|||
37800568|NCT01867710|69445666|FG003|Overall Study|Patient decision|1|||
37800569|NCT01867710|69445663|FG000|Overall Study|Patient to follow subsequent treatment|0|||
37800570|NCT01867710|69445664|FG001|Overall Study|Patient to follow subsequent treatment|1|||
37800571|NCT01867710|69445665|FG002|Overall Study|Patient to follow subsequent treatment|0|||
37800572|NCT01867710|69445666|FG003|Overall Study|Patient to follow subsequent treatment|0|||
37800573|NCT01867710|69445663|FG000|Overall Study|Progressive disease|1|||
37800574|NCT01867710|69445664|FG001|Overall Study|Progressive disease|0|||
37800575|NCT01867710|69445665|FG002|Overall Study|Progressive disease|0|||
37800576|NCT01867710|69445666|FG003|Overall Study|Progressive disease|0|||
37800577|NCT01867710|69445663|FG000|Overall Study|Protocol Violation|0|||
37800578|NCT01867710|69445664|FG001|Overall Study|Protocol Violation|0|||
37800579|NCT01867710|69445665|FG002|Overall Study|Protocol Violation|0|||
37800580|NCT01867710|69445666|FG003|Overall Study|Protocol Violation|1|||
37800581|NCT01867710|69445663|FG000|Overall Study|PSA-progression|0|||
37800582|NCT01867710|69445664|FG001|Overall Study|PSA-progression|1|||
37800583|NCT01867710|69445665|FG002|Overall Study|PSA-progression|0|||
37800584|NCT01867710|69445666|FG003|Overall Study|PSA-progression|0|||
37800585|NCT01867710|69445663|FG000|Overall Study|Study medication no longer effective|0|||
37800586|NCT01867710|69445664|FG001|Overall Study|Study medication no longer effective|1|||
37693946|NCT02094885|69170194|FG001|Overall Study|Withdrawn due to age|0|||
37693947|NCT01896856|69170206|FG000|Overall Study|Transportation issues / Non-compliance|0|||
37800587|NCT01867710|69445665|FG002|Overall Study|Study medication no longer effective|0|||
37800588|NCT01867710|69445666|FG003|Overall Study|Study medication no longer effective|0|||
37800589|NCT01849848|69445676|FG000|Overall Study|Physician Decision|1|||
37800590|NCT01849848|69445676|FG000|Overall Study|Progression of the primary disease|3|||
37693948|NCT01896856|69170207|FG001|Overall Study|Transportation issues / Non-compliance|0|||
37693949|NCT01896856|69170208|FG002|Overall Study|Transportation issues / Non-compliance|1|||
37693950|NCT01896856|69170209|FG003|Overall Study|Transportation issues / Non-compliance|0|||
37693951|NCT01896856|69170210|FG004|Overall Study|Transportation issues / Non-compliance|0|||
37693952|NCT01896856|69170211|FG005|Overall Study|Transportation issues / Non-compliance|0|||
37693953|NCT02038959|69170228|FG000|Overall Study|Withdrawal by Subject|6|||
37693954|NCT02038959|69170229|FG001|Overall Study|Withdrawal by Subject|8|||
37693955|NCT01896700|69170237|FG000|Overall Study|Adverse Event|4|||
37693956|NCT01896700|69170238|FG001|Overall Study|Adverse Event|5|||
37693957|NCT01896700|69170237|FG000|Overall Study|Withdrawal by Subject|0|||
37800591|NCT01849458|69445680|FG000|Overall Study|Lost to Follow-up|4|||
37800592|NCT01832766|69445684|FG000|Washout|Lost to Follow-up|0|||
37800593|NCT01832766|69445685|FG001|Washout|Lost to Follow-up|1|||
37800594|NCT01832532|69445693|FG000|Overall Study|Withdrawal by Subject|5|||
37800595|NCT01832532|69445694|FG001|Overall Study|Withdrawal by Subject|2|||
37800596|NCT01848990|69445703|FG000|Overall Study|Adverse Event|6|||
37800597|NCT01848990|69445704|FG001|Overall Study|Adverse Event|2|||
37800598|NCT01848990|69445705|FG002|Overall Study|Adverse Event|0|||
37800599|NCT01848990|69445703|FG000|Overall Study|Lost to Follow-up|6|||
37800600|NCT01848990|69445704|FG001|Overall Study|Lost to Follow-up|2|||
37800601|NCT01848990|69445705|FG002|Overall Study|Lost to Follow-up|2|||
37800602|NCT01848990|69445703|FG000|Overall Study|Protocol Violation|1|||
37800603|NCT01848990|69445704|FG001|Overall Study|Protocol Violation|1|||
37800604|NCT01848990|69445705|FG002|Overall Study|Protocol Violation|0|||
37800605|NCT01848990|69445703|FG000|Overall Study|Withdrawal by Subject|29|||
37800606|NCT01848990|69445704|FG001|Overall Study|Withdrawal by Subject|10|||
37800607|NCT01848990|69445705|FG002|Overall Study|Withdrawal by Subject|11|||
37800608|NCT01848990|69445703|FG000|Overall Study|Physician Decision|1|||
37800609|NCT01848990|69445704|FG001|Overall Study|Physician Decision|1|||
37800610|NCT01848990|69445705|FG002|Overall Study|Physician Decision|0|||
37800611|NCT01848990|69445703|FG000|Overall Study|Non Compliance|1|||
37800612|NCT01848990|69445704|FG001|Overall Study|Non Compliance|0|||
37800613|NCT01848990|69445705|FG002|Overall Study|Non Compliance|0|||
37800614|NCT01848990|69445703|FG000|Overall Study|Death|1|||
37800615|NCT01848990|69445704|FG001|Overall Study|Death|0|||
37800616|NCT01848990|69445705|FG002|Overall Study|Death|1|||
37800617|NCT01848990|69445703|FG000|Overall Study|Other|1|||
37800618|NCT01848990|69445704|FG001|Overall Study|Other|4|||
37800619|NCT01848990|69445705|FG002|Overall Study|Other|2|||
37800620|NCT01867086|69445717|FG000|Overall Study|Disease Progression|1|||
37800621|NCT01831596|69445721|FG000|Overall Study|Other|8|||
37800622|NCT01848834|69445730|FG000|Overall Study|Adverse Event|3|||
37800623|NCT01848834|69445731|FG001|Overall Study|Adverse Event|11|||
37800624|NCT01848834|69445732|FG002|Overall Study|Adverse Event|3|||
37800625|NCT01848834|69445733|FG003|Overall Study|Adverse Event|5|||
37800626|NCT01848834|69445734|FG004|Overall Study|Adverse Event|9|||
37800627|NCT01848834|69445730|FG000|Overall Study|Death|2|||
37800628|NCT01848834|69445731|FG001|Overall Study|Death|11|||
37800629|NCT01848834|69445732|FG002|Overall Study|Death|1|||
37800630|NCT01848834|69445733|FG003|Overall Study|Death|8|||
37800631|NCT01848834|69445734|FG004|Overall Study|Death|27|||
37800632|NCT01848834|69445730|FG000|Overall Study|Excluded Medication|5|||
37800633|NCT01848834|69445731|FG001|Overall Study|Excluded Medication|4|||
37800634|NCT01848834|69445732|FG002|Overall Study|Excluded Medication|3|||
37800635|NCT01848834|69445733|FG003|Overall Study|Excluded Medication|6|||
37800636|NCT01848834|69445734|FG004|Overall Study|Excluded Medication|6|||
37800637|NCT01848834|69445730|FG000|Overall Study|Lost to Follow-up|5|||
37800638|NCT01848834|69445731|FG001|Overall Study|Lost to Follow-up|5|||
37800639|NCT01848834|69445732|FG002|Overall Study|Lost to Follow-up|3|||
37800640|NCT01848834|69445733|FG003|Overall Study|Lost to Follow-up|0|||
37693958|NCT01896700|69170238|FG001|Overall Study|Withdrawal by Subject|1|||
37800641|NCT01848834|69445734|FG004|Overall Study|Lost to Follow-up|3|||
37800642|NCT01848834|69445730|FG000|Overall Study|Physician Decision|1|||
37800643|NCT01848834|69445731|FG001|Overall Study|Physician Decision|3|||
37800644|NCT01848834|69445732|FG002|Overall Study|Physician Decision|4|||
37800645|NCT01848834|69445733|FG003|Overall Study|Physician Decision|0|||
37800646|NCT01848834|69445734|FG004|Overall Study|Physician Decision|11|||
37800647|NCT01848834|69445730|FG000|Overall Study|Protocol Violation|0|||
37800648|NCT01848834|69445731|FG001|Overall Study|Protocol Violation|0|||
37800649|NCT01848834|69445732|FG002|Overall Study|Protocol Violation|0|||
37800650|NCT01848834|69445733|FG003|Overall Study|Protocol Violation|0|||
37693959|NCT02352493|69170262|FG000|Overall Study|Pregnancy|0|||
37693960|NCT02352493|69170263|FG001|Overall Study|Pregnancy|0|||
37800651|NCT01848834|69445734|FG004|Overall Study|Protocol Violation|1|||
37800652|NCT01848834|69445730|FG000|Overall Study|Sponsor Decision|1|||
37800653|NCT01848834|69445731|FG001|Overall Study|Sponsor Decision|1|||
37800654|NCT01848834|69445732|FG002|Overall Study|Sponsor Decision|0|||
37800655|NCT01848834|69445733|FG003|Overall Study|Sponsor Decision|1|||
37800656|NCT01848834|69445734|FG004|Overall Study|Sponsor Decision|1|||
37800657|NCT01848834|69445730|FG000|Overall Study|Withdrawal by Subject|2|||
37800658|NCT01848834|69445731|FG001|Overall Study|Withdrawal by Subject|13|||
37800659|NCT01848834|69445732|FG002|Overall Study|Withdrawal by Subject|10|||
37800660|NCT01848834|69445733|FG003|Overall Study|Withdrawal by Subject|6|||
37800661|NCT01848834|69445734|FG004|Overall Study|Withdrawal by Subject|36|||
37800662|NCT01867008|69445750|FG000|Overall Study|Withdrawal by Subject|1|||
37800663|NCT01848756|69445754|FG000|Overall Study|Adverse Event|1|||
37800664|NCT01848756|69445754|FG000|Overall Study|Withdrawal by Subject|1|||
37800665|NCT01848756|69445754|FG000|Overall Study|Enrolled in Error|1|||
37800666|NCT01830972|69445761|FG000|Part II|Withdrawal by Subject|2|||
37800667|NCT01830972|69445762|FG001|Part II|Withdrawal by Subject|2|||
37800668|NCT01830972|69445761|FG000|Part III|Withdrawal by Subject|1|||
37800669|NCT01830972|69445762|FG001|Part III|Withdrawal by Subject|0|||
37800670|NCT01830972|69445761|FG000|Part III|Noncompliance|1|||
37800671|NCT01830972|69445762|FG001|Part III|Noncompliance|0|||
37800672|NCT01830972|69445761|FG000|Part IV|Withdrawal by Subject|2|||
37800673|NCT01830972|69445762|FG001|Part IV|Withdrawal by Subject|1|||
37800674|NCT01830972|69445761|FG000|Part IV|Non-Compliance|1|||
37800675|NCT01830972|69445762|FG001|Part IV|Non-Compliance|0|||
37800676|NCT01848288|69445778|FG000|Overall Study|Death|1|||
37800677|NCT01848288|69445778|FG000|Overall Study|Protocol Violation|1|||
37800678|NCT01848288|69445778|FG000|Overall Study|Withdrawal by Subject|1|||
37800679|NCT01848210|69445785|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
37800680|NCT01848210|69445786|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
37800681|NCT01848210|69445785|FG000|Overall Study|Lost to Follow-up|24|||
37800682|NCT01848210|69445786|FG001|Overall Study|Lost to Follow-up|12|||
37800683|NCT01848210|69445785|FG000|Overall Study|Protocol Violation|3|||
37800684|NCT01848210|69445786|FG001|Overall Study|Protocol Violation|5|||
37800685|NCT01848210|69445785|FG000|Overall Study|Use of Forbidden Drugs|9|||
37800686|NCT01848210|69445786|FG001|Overall Study|Use of Forbidden Drugs|10|||
37800687|NCT01848210|69445785|FG000|Overall Study|Impedition Condition|5|||
37800688|NCT01848210|69445786|FG001|Overall Study|Impedition Condition|9|||
37800689|NCT01848210|69445785|FG000|Overall Study|Adverse Event|7|||
37800690|NCT01848210|69445786|FG001|Overall Study|Adverse Event|9|||
37800691|NCT01848210|69445785|FG000|Overall Study|Discontinuation Criterion|5|||
37800692|NCT01848210|69445786|FG001|Overall Study|Discontinuation Criterion|7|||
37800693|NCT01848210|69445785|FG000|Overall Study|Hypesensitivity|1|||
37800694|NCT01848210|69445786|FG001|Overall Study|Hypesensitivity|0|||
37800695|NCT01848210|69445785|FG000|Overall Study|Hepatic Function Alteration|4|||
37800696|NCT01848210|69445786|FG001|Overall Study|Hepatic Function Alteration|0|||
37800697|NCT01848210|69445785|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
37800698|NCT01848210|69445786|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
37800699|NCT01848210|69445785|FG000|Overall Study|Administrative|1|||
37800700|NCT01848210|69445786|FG001|Overall Study|Administrative|0|||
37800701|NCT01830816|69445795|FG000|Overall Study|Progressive Disease|12|||
37800702|NCT01830816|69445796|FG001|Overall Study|Progressive Disease|7|||
37800703|NCT01830816|69445797|FG002|Overall Study|Progressive Disease|7|||
37800704|NCT01830816|69445795|FG000|Overall Study|Adverse Event|3|||
37800705|NCT01830816|69445796|FG001|Overall Study|Adverse Event|4|||
37800706|NCT01830816|69445797|FG002|Overall Study|Adverse Event|0|||
37800707|NCT01830816|69445795|FG000|Overall Study|Study Terminated by Sponsor|1|||
37800708|NCT01830816|69445796|FG001|Overall Study|Study Terminated by Sponsor|1|||
37800709|NCT01830816|69445797|FG002|Overall Study|Study Terminated by Sponsor|0|||
37800710|NCT01830816|69445795|FG000|Overall Study|Withdrawal by Subject|1|||
37800711|NCT01830816|69445796|FG001|Overall Study|Withdrawal by Subject|1|||
37800712|NCT01830816|69445797|FG002|Overall Study|Withdrawal by Subject|0|||
37800713|NCT01830816|69445795|FG000|Overall Study|Lost to Follow-up|0|||
37800714|NCT01830816|69445796|FG001|Overall Study|Lost to Follow-up|1|||
37800715|NCT01830816|69445797|FG002|Overall Study|Lost to Follow-up|0|||
37800716|NCT01830816|69445795|FG000|Overall Study|Symptomatic Deterioration|1|||
37800717|NCT01830816|69445796|FG001|Overall Study|Symptomatic Deterioration|0|||
37800718|NCT01830816|69445797|FG002|Overall Study|Symptomatic Deterioration|0|||
37693961|NCT02352493|69170264|FG002|Overall Study|Pregnancy|0|||
37800719|NCT01830816|69445795|FG000|Overall Study|Reason not Specified|2|||
37800720|NCT01830816|69445796|FG001|Overall Study|Reason not Specified|0|||
37975714|NCT00498602|69662991|FG000|Overall Study|Lost to Follow-up|0|||
37800721|NCT01830816|69445797|FG002|Overall Study|Reason not Specified|0|||
37800722|NCT01846416|69445811|FG000|Treatment Phase|Death|2|||
37800723|NCT01846416|69445812|FG001|Treatment Phase|Death|9|||
37800724|NCT01846416|69445813|FG002|Treatment Phase|Death|1|||
37800725|NCT01846416|69445811|FG000|Treatment Phase|Withdrawal by Subject|2|||
37800726|NCT01846416|69445812|FG001|Treatment Phase|Withdrawal by Subject|4|||
37975715|NCT00498602|69662992|FG001|Overall Study|Lost to Follow-up|2|||
37800727|NCT01846416|69445813|FG002|Treatment Phase|Withdrawal by Subject|2|||
37800728|NCT01846416|69445811|FG000|Treatment Phase|Other|1|||
37800729|NCT01846416|69445812|FG001|Treatment Phase|Other|5|||
37800730|NCT01846416|69445813|FG002|Treatment Phase|Other|1|||
37800731|NCT01846416|69445811|FG000|Treatment Phase|Physician Decision|1|||
37800732|NCT01846416|69445812|FG001|Treatment Phase|Physician Decision|2|||
37800733|NCT01846416|69445813|FG002|Treatment Phase|Physician Decision|0|||
37800734|NCT01846416|69445811|FG000|Treatment Phase|Adverse Event|3|||
37800735|NCT01846416|69445812|FG001|Treatment Phase|Adverse Event|4|||
37800736|NCT01846416|69445813|FG002|Treatment Phase|Adverse Event|0|||
37800737|NCT01846416|69445811|FG000|Treatment Phase|Non-compliance|0|||
37800738|NCT01846416|69445812|FG001|Treatment Phase|Non-compliance|2|||
37800739|NCT01846416|69445813|FG002|Treatment Phase|Non-compliance|0|||
37800740|NCT01846416|69445811|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
37800741|NCT01846416|69445812|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
37800742|NCT01846416|69445813|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
37800743|NCT01846416|69445811|FG000|Treatment Phase|Progressive Disease|21|||
37800744|NCT01846416|69445812|FG001|Treatment Phase|Progressive Disease|63|||
37800745|NCT01846416|69445813|FG002|Treatment Phase|Progressive Disease|9|||
37800746|NCT01846416|69445811|FG000|Survival Follow-up|Death|21|||
37800747|NCT01846416|69445812|FG001|Survival Follow-up|Death|62|||
37800748|NCT01846416|69445813|FG002|Survival Follow-up|Death|9|||
37800749|NCT01846416|69445811|FG000|Survival Follow-up|Lost to Follow-up|0|||
37800750|NCT01846416|69445812|FG001|Survival Follow-up|Lost to Follow-up|2|||
37800751|NCT01846416|69445813|FG002|Survival Follow-up|Lost to Follow-up|2|||
37800752|NCT01846416|69445811|FG000|Survival Follow-up|Withdrawal by Subject|2|||
37800753|NCT01846416|69445812|FG001|Survival Follow-up|Withdrawal by Subject|7|||
37800754|NCT01846416|69445813|FG002|Survival Follow-up|Withdrawal by Subject|0|||
37800755|NCT01846416|69445811|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
37800756|NCT01846416|69445812|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
37800757|NCT01846416|69445813|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
37800758|NCT01846416|69445811|FG000|Survival Follow-up|Other|3|||
37800759|NCT01846416|69445812|FG001|Survival Follow-up|Other|1|||
37800760|NCT01846416|69445813|FG002|Survival Follow-up|Other|1|||
37800761|NCT01865448|69445824|FG000|Overall Study|Adverse Event|1|||
37800762|NCT01865448|69445825|FG001|Overall Study|Adverse Event|1|||
37800763|NCT01865448|69445824|FG000|Overall Study|Pregnancy|0|||
37800764|NCT01865448|69445825|FG001|Overall Study|Pregnancy|1|||
37800765|NCT01865448|69445824|FG000|Overall Study|dropout unrelated to study|1|||
37800766|NCT01865448|69445825|FG001|Overall Study|dropout unrelated to study|1|||
37800767|NCT01804140|69445832|FG000|Overall Study|No sampling or biopsy procedures done|114|||
37800768|NCT01846104|69445836|FG000|Overall Study|Withdrawal by Subject|1|||
37800769|NCT01803282|69445852|FG000|Overall Study|Progressive Disease|4|||
37800770|NCT01803282|69445853|FG001|Overall Study|Progressive Disease|3|||
37800771|NCT01803282|69445854|FG002|Overall Study|Progressive Disease|6|||
37800772|NCT01803282|69445855|FG003|Overall Study|Progressive Disease|22|||
37800773|NCT01803282|69445856|FG004|Overall Study|Progressive Disease|5|||
37800774|NCT01803282|69445857|FG005|Overall Study|Progressive Disease|8|||
37800775|NCT01803282|69445858|FG006|Overall Study|Progressive Disease|23|||
37800776|NCT01803282|69445859|FG007|Overall Study|Progressive Disease|24|||
37800777|NCT01803282|69445860|FG008|Overall Study|Progressive Disease|3|||
37800778|NCT01803282|69445861|FG009|Overall Study|Progressive Disease|29|||
37800779|NCT01803282|69445862|FG010|Overall Study|Progressive Disease|6|||
37800780|NCT01803282|69445863|FG011|Overall Study|Progressive Disease|11|||
37975716|NCT00498602|69662993|FG002|Overall Study|Lost to Follow-up|0|||
37975717|NCT00498602|69662994|FG003|Overall Study|Lost to Follow-up|2|||
37975718|NCT00498602|69662995|FG004|Overall Study|Lost to Follow-up|0|||
37800781|NCT01803282|69445852|FG000|Overall Study|Death|0|||
37800782|NCT01803282|69445853|FG001|Overall Study|Death|0|||
37800783|NCT01803282|69445854|FG002|Overall Study|Death|0|||
37800784|NCT01803282|69445855|FG003|Overall Study|Death|0|||
37800785|NCT01803282|69445856|FG004|Overall Study|Death|2|||
37975719|NCT00498602|69662996|FG005|Overall Study|Lost to Follow-up|0|||
37800786|NCT01803282|69445857|FG005|Overall Study|Death|1|||
37800787|NCT01803282|69445858|FG006|Overall Study|Death|1|||
37800788|NCT01803282|69445859|FG007|Overall Study|Death|5|||
37975720|NCT00498602|69662997|FG006|Overall Study|Lost to Follow-up|0|||
37975721|NCT00498602|69662991|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
37800789|NCT01803282|69445860|FG008|Overall Study|Death|1|||
37800790|NCT01803282|69445861|FG009|Overall Study|Death|1|||
37800791|NCT01803282|69445862|FG010|Overall Study|Death|0|||
37800792|NCT01803282|69445863|FG011|Overall Study|Death|0|||
37800793|NCT01803282|69445852|FG000|Overall Study|Withdrew Consent|0|||
37800794|NCT01803282|69445853|FG001|Overall Study|Withdrew Consent|0|||
37800795|NCT01803282|69445854|FG002|Overall Study|Withdrew Consent|0|||
37800796|NCT01803282|69445855|FG003|Overall Study|Withdrew Consent|6|||
37800797|NCT01803282|69445856|FG004|Overall Study|Withdrew Consent|1|||
37800798|NCT01803282|69445857|FG005|Overall Study|Withdrew Consent|0|||
37800799|NCT01803282|69445858|FG006|Overall Study|Withdrew Consent|8|||
37800800|NCT01803282|69445859|FG007|Overall Study|Withdrew Consent|3|||
37800801|NCT01803282|69445860|FG008|Overall Study|Withdrew Consent|1|||
37800802|NCT01803282|69445861|FG009|Overall Study|Withdrew Consent|5|||
37800803|NCT01803282|69445862|FG010|Overall Study|Withdrew Consent|0|||
37800804|NCT01803282|69445863|FG011|Overall Study|Withdrew Consent|1|||
37800805|NCT01803282|69445852|FG000|Overall Study|Investigator's Discretion|0|||
37800806|NCT01803282|69445853|FG001|Overall Study|Investigator's Discretion|0|||
37800807|NCT01803282|69445854|FG002|Overall Study|Investigator's Discretion|0|||
37800808|NCT01803282|69445855|FG003|Overall Study|Investigator's Discretion|7|||
37800809|NCT01803282|69445856|FG004|Overall Study|Investigator's Discretion|2|||
37800810|NCT01803282|69445857|FG005|Overall Study|Investigator's Discretion|1|||
37800811|NCT01803282|69445858|FG006|Overall Study|Investigator's Discretion|7|||
37800812|NCT01803282|69445859|FG007|Overall Study|Investigator's Discretion|10|||
37800813|NCT01803282|69445860|FG008|Overall Study|Investigator's Discretion|6|||
37800814|NCT01803282|69445861|FG009|Overall Study|Investigator's Discretion|7|||
37800815|NCT01803282|69445862|FG010|Overall Study|Investigator's Discretion|1|||
37800816|NCT01803282|69445863|FG011|Overall Study|Investigator's Discretion|0|||
37800817|NCT01803282|69445852|FG000|Overall Study|Adverse Event|0|||
37800818|NCT01803282|69445853|FG001|Overall Study|Adverse Event|0|||
37800819|NCT01803282|69445854|FG002|Overall Study|Adverse Event|0|||
37800820|NCT01803282|69445855|FG003|Overall Study|Adverse Event|0|||
37800821|NCT01803282|69445856|FG004|Overall Study|Adverse Event|0|||
37800822|NCT01803282|69445857|FG005|Overall Study|Adverse Event|0|||
37800823|NCT01803282|69445858|FG006|Overall Study|Adverse Event|1|||
37800824|NCT01803282|69445859|FG007|Overall Study|Adverse Event|2|||
37800825|NCT01803282|69445860|FG008|Overall Study|Adverse Event|0|||
37800826|NCT01803282|69445861|FG009|Overall Study|Adverse Event|1|||
37800827|NCT01803282|69445862|FG010|Overall Study|Adverse Event|0|||
37800828|NCT01803282|69445863|FG011|Overall Study|Adverse Event|3|||
37800829|NCT01803282|69445852|FG000|Overall Study|Non-Compliance with Study Drug|0|||
37800830|NCT01803282|69445853|FG001|Overall Study|Non-Compliance with Study Drug|0|||
37800831|NCT01803282|69445854|FG002|Overall Study|Non-Compliance with Study Drug|0|||
37800832|NCT01803282|69445855|FG003|Overall Study|Non-Compliance with Study Drug|1|||
37800833|NCT01803282|69445856|FG004|Overall Study|Non-Compliance with Study Drug|0|||
37800834|NCT01803282|69445857|FG005|Overall Study|Non-Compliance with Study Drug|0|||
37800835|NCT01803282|69445858|FG006|Overall Study|Non-Compliance with Study Drug|0|||
37800836|NCT01803282|69445859|FG007|Overall Study|Non-Compliance with Study Drug|0|||
37800837|NCT01803282|69445860|FG008|Overall Study|Non-Compliance with Study Drug|0|||
37800838|NCT01803282|69445861|FG009|Overall Study|Non-Compliance with Study Drug|0|||
37800839|NCT01803282|69445862|FG010|Overall Study|Non-Compliance with Study Drug|0|||
37800840|NCT01803282|69445863|FG011|Overall Study|Non-Compliance with Study Drug|0|||
37800841|NCT01803282|69445852|FG000|Overall Study|Unknown Reason|0|||
37800842|NCT01803282|69445853|FG001|Overall Study|Unknown Reason|0|||
37800843|NCT01803282|69445854|FG002|Overall Study|Unknown Reason|0|||
37800844|NCT01803282|69445855|FG003|Overall Study|Unknown Reason|0|||
37800845|NCT01803282|69445856|FG004|Overall Study|Unknown Reason|0|||
37800846|NCT01803282|69445857|FG005|Overall Study|Unknown Reason|0|||
37800847|NCT01803282|69445858|FG006|Overall Study|Unknown Reason|0|||
37800848|NCT01803282|69445859|FG007|Overall Study|Unknown Reason|1|||
37800849|NCT01803282|69445860|FG008|Overall Study|Unknown Reason|0|||
37800850|NCT01803282|69445861|FG009|Overall Study|Unknown Reason|0|||
37800851|NCT01803282|69445862|FG010|Overall Study|Unknown Reason|0|||
37800852|NCT01803282|69445863|FG011|Overall Study|Unknown Reason|0|||
37800853|NCT01803282|69445852|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
37800854|NCT01803282|69445853|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
37800855|NCT01803282|69445854|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
37800856|NCT01803282|69445855|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
37800857|NCT01803282|69445856|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
37800858|NCT01803282|69445857|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
37800859|NCT01803282|69445858|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
37800860|NCT01803282|69445859|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
37800861|NCT01803282|69445860|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
37800862|NCT01803282|69445861|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
37800863|NCT01803282|69445862|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
37800864|NCT01803282|69445863|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
37800865|NCT01803282|69445852|FG000|Overall Study|Enrolled but Never Treated|0|||
37800866|NCT01803282|69445853|FG001|Overall Study|Enrolled but Never Treated|0|||
37800867|NCT01803282|69445854|FG002|Overall Study|Enrolled but Never Treated|0|||
37800868|NCT01803282|69445855|FG003|Overall Study|Enrolled but Never Treated|0|||
37800869|NCT01803282|69445856|FG004|Overall Study|Enrolled but Never Treated|1|||
37800870|NCT01803282|69445857|FG005|Overall Study|Enrolled but Never Treated|0|||
37800871|NCT01803282|69445858|FG006|Overall Study|Enrolled but Never Treated|1|||
37800872|NCT01803282|69445859|FG007|Overall Study|Enrolled but Never Treated|1|||
37800873|NCT01803282|69445860|FG008|Overall Study|Enrolled but Never Treated|0|||
37800874|NCT01803282|69445861|FG009|Overall Study|Enrolled but Never Treated|1|||
37800875|NCT01803282|69445862|FG010|Overall Study|Enrolled but Never Treated|0|||
37800876|NCT01803282|69445863|FG011|Overall Study|Enrolled but Never Treated|0|||
37800877|NCT01844778|69445892|FG000|Overall Study|Protocol deviation|0|||
37800878|NCT01844778|69445893|FG001|Overall Study|Protocol deviation|1|||
37800879|NCT01844778|69445894|FG002|Overall Study|Protocol deviation|2|||
37800880|NCT01844778|69445892|FG000|Overall Study|Withdrawal by Subject|2|||
37800881|NCT01844778|69445893|FG001|Overall Study|Withdrawal by Subject|0|||
37800882|NCT01844778|69445894|FG002|Overall Study|Withdrawal by Subject|0|||
37800883|NCT01844778|69445892|FG000|Overall Study|Adverse Event|0|||
37800884|NCT01844778|69445893|FG001|Overall Study|Adverse Event|2|||
37800885|NCT01844778|69445894|FG002|Overall Study|Adverse Event|2|||
37800886|NCT01802580|69445908|FG000|Overall Study|Physician Decision|1|||
37800887|NCT01802580|69445909|FG001|Overall Study|Physician Decision|0|||
37800888|NCT01802580|69445908|FG000|Overall Study|Protocol Violation|2|||
37800889|NCT01802580|69445909|FG001|Overall Study|Protocol Violation|0|||
37800890|NCT01802580|69445908|FG000|Overall Study|Withdrawal by Subject|5|||
37800891|NCT01802580|69445909|FG001|Overall Study|Withdrawal by Subject|6|||
37800892|NCT01802580|69445908|FG000|Overall Study|Other|1|||
37800893|NCT01802580|69445909|FG001|Overall Study|Other|3|||
37800894|NCT01802580|69445908|FG000|Overall Study|Lack of Efficacy|0|||
37800895|NCT01802580|69445909|FG001|Overall Study|Lack of Efficacy|2|||
37800896|NCT01611090|69445917|FG000|Randomized Period|Lost to Follow-up|8|||
37800897|NCT01611090|69445918|FG001|Randomized Period|Lost to Follow-up|3|||
37800898|NCT01611090|69445919|FG002|Randomized Period|Lost to Follow-up|0|||
37800899|NCT01611090|69445917|FG000|Randomized Period|Withdrawal by Subject|22|||
37800900|NCT01611090|69445918|FG001|Randomized Period|Withdrawal by Subject|26|||
37800901|NCT01611090|69445919|FG002|Randomized Period|Withdrawal by Subject|0|||
37800902|NCT01611090|69445917|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
37800903|NCT01611090|69445918|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
37800904|NCT01611090|69445919|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
37800905|NCT01611090|69445917|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
37800906|NCT01611090|69445918|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
37800907|NCT01611090|69445919|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
37800908|NCT01844700|69445928|FG000|Overall Study|Lack of Efficacy|1|||
37800909|NCT01844700|69445929|FG001|Overall Study|Lack of Efficacy|0|||
37800910|NCT01844700|69445928|FG000|Overall Study|refused medication switch|1|||
37800911|NCT01844700|69445929|FG001|Overall Study|refused medication switch|0|||
37800912|NCT01844700|69445928|FG000|Overall Study|Withdrawal by Subject|1|||
37800913|NCT01844700|69445929|FG001|Overall Study|Withdrawal by Subject|0|||
37800914|NCT01844700|69445928|FG000|Overall Study|stopped taking meds|0|||
37800915|NCT01844700|69445929|FG001|Overall Study|stopped taking meds|1|||
37800916|NCT01844076|69445939|FG000|Overall Study|Adverse Event|1|||
37800917|NCT01844076|69445940|FG001|Overall Study|Adverse Event|0|||
37800918|NCT01844076|69445941|FG002|Overall Study|Adverse Event|0|||
37800919|NCT01844076|69445942|FG003|Overall Study|Adverse Event|0|||
37800920|NCT01844076|69445939|FG000|Overall Study|Withdrawal by Subject|1|||
37800921|NCT01844076|69445940|FG001|Overall Study|Withdrawal by Subject|0|||
37800922|NCT01844076|69445941|FG002|Overall Study|Withdrawal by Subject|0|||
37800923|NCT01844076|69445942|FG003|Overall Study|Withdrawal by Subject|0|||
37800924|NCT01826604|69445954|FG000|Overall Study|Lost to Follow-up|8|||
37800925|NCT01826604|69445955|FG001|Overall Study|Lost to Follow-up|9|||
37800926|NCT01843842|69445963|FG000|Overall Study|Do not meet inclusion criteria|1|||
37800927|NCT01843842|69445964|FG001|Overall Study|Do not meet inclusion criteria|1|||
37800928|NCT01826448|69445972|FG000|Overall Study|Adverse Event|1|||
37800929|NCT01826448|69445973|FG001|Overall Study|Adverse Event|3|||
37800930|NCT01826448|69445972|FG000|Overall Study|Disease progression|2|||
37800931|NCT01826448|69445973|FG001|Overall Study|Disease progression|4|||
37800932|NCT01826448|69445972|FG000|Overall Study|Withdrawal by Subject|1|||
37800933|NCT01826448|69445973|FG001|Overall Study|Withdrawal by Subject|0|||
37800934|NCT01826448|69445972|FG000|Overall Study|Physician Decision|0|||
37800935|NCT01826448|69445973|FG001|Overall Study|Physician Decision|1|||
37800936|NCT01826448|69445972|FG000|Overall Study|2 active cancers|0|||
37800937|NCT01826448|69445973|FG001|Overall Study|2 active cancers|1|||
37800938|NCT01826370|69445979|FG000|Overall Study|Protocol Violation|6|||
37800939|NCT01826370|69445979|FG000|Overall Study|Lost to Follow-up|12|||
37800940|NCT01826370|69445979|FG000|Overall Study|Other reason not defined above|2|||
37800941|NCT01826214|69445985|FG000|Overall Study|Adverse Event|7|||
37800942|NCT01826214|69445986|FG001|Overall Study|Adverse Event|6|||
37800943|NCT01826214|69445985|FG000|Overall Study|Death|3|||
37800944|NCT01826214|69445986|FG001|Overall Study|Death|1|||
37800945|NCT01826214|69445985|FG000|Overall Study|Lost to Follow-up|1|||
37800946|NCT01826214|69445986|FG001|Overall Study|Lost to Follow-up|0|||
37800947|NCT01826214|69445985|FG000|Overall Study|Physician Decision|0|||
37800948|NCT01826214|69445986|FG001|Overall Study|Physician Decision|2|||
37800949|NCT01826214|69445985|FG000|Overall Study|Progressive disease|22|||
37800950|NCT01826214|69445986|FG001|Overall Study|Progressive disease|21|||
37800951|NCT01826214|69445985|FG000|Overall Study|Study terminated by Sponsor|0|||
37800952|NCT01826214|69445986|FG001|Overall Study|Study terminated by Sponsor|1|||
37800953|NCT01826214|69445985|FG000|Overall Study|Subject/guardian decision|2|||
37800954|NCT01826214|69445986|FG001|Overall Study|Subject/guardian decision|3|||
37800955|NCT01843062|69445994|FG000|Overall Study|Protocol Violation|1|||
37800956|NCT01843062|69445995|FG001|Overall Study|Protocol Violation|0|||
37800957|NCT01843062|69445994|FG000|Overall Study|New treatment following progression|2|||
37800958|NCT01843062|69445995|FG001|Overall Study|New treatment following progression|0|||
37800959|NCT01843062|69445994|FG000|Overall Study|Pregnancy|1|||
37800960|NCT01843062|69445995|FG001|Overall Study|Pregnancy|0|||
37800961|NCT01843062|69445994|FG000|Overall Study|Adverse Event|2|||
37800962|NCT01843062|69445995|FG001|Overall Study|Adverse Event|0|||
37800963|NCT01843062|69445994|FG000|Overall Study|Incorrect randomisation|1|||
37800964|NCT01843062|69445995|FG001|Overall Study|Incorrect randomisation|0|||
37693962|NCT02352493|69170265|FG003|Overall Study|Pregnancy|0|||
37800965|NCT01843062|69445994|FG000|Overall Study|Withdrawal by Subject|12|||
37800966|NCT01843062|69445995|FG001|Overall Study|Withdrawal by Subject|3|||
37800967|NCT01843062|69445994|FG000|Overall Study|Death|1|||
37800968|NCT01843062|69445995|FG001|Overall Study|Death|2|||
37800969|NCT01843062|69445994|FG000|Overall Study|Lost to Follow-up|2|||
37800970|NCT01843062|69445995|FG001|Overall Study|Lost to Follow-up|4|||
37800971|NCT01842438|69446003|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
37800972|NCT01842438|69446004|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
37800973|NCT01842438|69446003|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
37800974|NCT01842438|69446004|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
37800975|NCT01842438|69446003|FG000|T2: 6month Follow-up|Death|0|||
37800976|NCT01842438|69446004|FG001|T2: 6month Follow-up|Death|1|||
37800977|NCT01799226|69446016|FG000|Overall Study|Withdrawal by Subject|1|||
37800978|NCT01799226|69446017|FG001|Overall Study|Withdrawal by Subject|0|||
37800979|NCT01799226|69446016|FG000|Overall Study|Disqualified at Day 14|1|||
37800980|NCT01799226|69446017|FG001|Overall Study|Disqualified at Day 14|0|||
37800993|NCT01825200|69446041|FG000|Overall Study|Lost to Follow-up|5|||
37800994|NCT01825200|69446042|FG001|Overall Study|Lost to Follow-up|6|||
37800995|NCT01825200|69446041|FG000|Overall Study|Withdrawal by Subject|0|||
37800996|NCT01825200|69446042|FG001|Overall Study|Withdrawal by Subject|1|||
37800997|NCT01824576|69446048|FG000|Overall Study|Device deficiency|2|||
37800998|NCT01824498|69446058|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
37800999|NCT01824498|69446059|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
37801000|NCT01824498|69446060|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
37801001|NCT01824498|69446061|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
37801002|NCT01824498|69446062|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
37801003|NCT01824498|69446063|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
37801004|NCT01798134|69446071|FG000|Overall Study|Lost to Follow-up|1|||
37801005|NCT01798134|69446071|FG000|Overall Study|Withdrawal by Subject|3|||
37801006|NCT01798134|69446071|FG000|Overall Study|Death|2|||
37801007|NCT01798134|69446071|FG000|Overall Study|Adverse Event|3|||
37801008|NCT01798134|69446071|FG000|Overall Study|Physician Decision|3|||
37801009|NCT01798134|69446071|FG000|Overall Study|Liver transplant/surgery|4|||
37801010|NCT01798056|69446077|FG000|Overall Study|Serious Adverse Event|13|||
37801011|NCT01798056|69446078|FG001|Overall Study|Serious Adverse Event|12|||
37801012|NCT01798056|69446077|FG000|Overall Study|Withdrawal by Subject|12|||
37801013|NCT01798056|69446078|FG001|Overall Study|Withdrawal by Subject|9|||
37801014|NCT01798056|69446077|FG000|Overall Study|Migrated/moved from study area|1|||
37801015|NCT01798056|69446078|FG001|Overall Study|Migrated/moved from study area|1|||
37801016|NCT01798056|69446077|FG000|Overall Study|Lost to Follow-up|1|||
37801017|NCT01798056|69446078|FG001|Overall Study|Lost to Follow-up|1|||
37801018|NCT01798056|69446077|FG000|Overall Study|Other|0|||
37801019|NCT01798056|69446078|FG001|Overall Study|Other|2|||
37801020|NCT01824342|69446088|FG000|Overall Study|Withdrawal by Subject|0|||
37801021|NCT01824342|69446089|FG001|Overall Study|Withdrawal by Subject|3|||
37801022|NCT01824342|69446088|FG000|Overall Study|Adverse Event|1|||
37801023|NCT01824342|69446089|FG001|Overall Study|Adverse Event|1|||
37801024|NCT01824342|69446088|FG000|Overall Study|Disease Progression|1|||
37801025|NCT01824342|69446089|FG001|Overall Study|Disease Progression|1|||
37801026|NCT01824342|69446088|FG000|Overall Study|Physician Decision|5|||
37801027|NCT01824342|69446089|FG001|Overall Study|Physician Decision|0|||
37801028|NCT01824342|69446088|FG000|Overall Study|Death|2|||
37801029|NCT01824342|69446089|FG001|Overall Study|Death|0|||
37801030|NCT01841970|69446095|FG000|Overall Study|Withdrawal by Subject|1|||
37801031|NCT01841970|69446095|FG000|Overall Study|Physician Decision|2|||
37801032|NCT01841970|69446095|FG000|Overall Study|Lost to Follow-up|8|||
37801033|NCT01823328|69446104|FG000|Overall Study|Withdrawal by Subject|8|||
37801034|NCT01823328|69446105|FG001|Overall Study|Withdrawal by Subject|6|||
37801035|NCT01840410|69446113|FG000|Overall Study|Physician Decision|1|||
37801036|NCT01840410|69446114|FG001|Overall Study|Physician Decision|2|||
37801037|NCT01840410|69446113|FG000|Overall Study|Pregnancy|1|||
37801038|NCT01840410|69446114|FG001|Overall Study|Pregnancy|0|||
37801039|NCT01840410|69446113|FG000|Overall Study|Protocol deviation|1|||
37975722|NCT00498602|69662992|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
37801040|NCT01840410|69446114|FG001|Overall Study|Protocol deviation|0|||
37975723|NCT00498602|69662993|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
37975724|NCT00498602|69662994|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
37975725|NCT00498602|69662995|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
37801041|NCT01840410|69446113|FG000|Overall Study|Lost to Follow-up|1|||
37801042|NCT01840410|69446114|FG001|Overall Study|Lost to Follow-up|0|||
37975726|NCT00498602|69662996|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
37801043|NCT01840410|69446113|FG000|Overall Study|Withdrawal by Subject|2|||
37801044|NCT01840410|69446114|FG001|Overall Study|Withdrawal by Subject|1|||
37801045|NCT01840410|69446113|FG000|Overall Study|Adverse Event|1|||
37801046|NCT01840410|69446114|FG001|Overall Study|Adverse Event|1|||
37801047|NCT01797432|69446122|FG000|Overall Study|Lost to Follow-up|1|||
37801048|NCT01797432|69446122|FG000|Overall Study|Adverse Event|1|||
37801049|NCT01797432|69446122|FG000|Overall Study|Withdrawal by Subject|1|||
37801050|NCT01797432|69446122|FG000|Overall Study|lived too far from study site|1|||
37801051|NCT01797120|69446128|FG000|Overall Study|Disesae progression|37|||
37801052|NCT01797120|69446129|FG001|Overall Study|Disesae progression|49|||
37801053|NCT01797120|69446128|FG000|Overall Study|Adverse Event|13|||
37801054|NCT01797120|69446129|FG001|Overall Study|Adverse Event|5|||
37801055|NCT01797120|69446128|FG000|Overall Study|Withdrawal by Subject|6|||
37801056|NCT01797120|69446129|FG001|Overall Study|Withdrawal by Subject|6|||
37801057|NCT01797120|69446128|FG000|Overall Study|Symptomatic progression|2|||
37801058|NCT01797120|69446129|FG001|Overall Study|Symptomatic progression|1|||
37801059|NCT01797120|69446128|FG000|Overall Study|Non-compliance|1|||
37801060|NCT01797120|69446129|FG001|Overall Study|Non-compliance|0|||
37801061|NCT01797120|69446128|FG000|Overall Study|Physician Decision|3|||
37801062|NCT01797120|69446129|FG001|Overall Study|Physician Decision|0|||
37801063|NCT01797120|69446128|FG000|Overall Study|still on treatment|2|||
37801064|NCT01797120|69446129|FG001|Overall Study|still on treatment|4|||
37801065|NCT01797120|69446128|FG000|Overall Study|never start protocol therapy|2|||
37801066|NCT01797120|69446129|FG001|Overall Study|never start protocol therapy|0|||
37801067|NCT01796964|69446137|FG000|Overall Study|Adverse Event|1|||
37801068|NCT01796964|69446138|FG001|Overall Study|Adverse Event|1|||
37801069|NCT01796964|69446137|FG000|Overall Study|Death|1|||
37801070|NCT01796964|69446138|FG001|Overall Study|Death|0|||
37801071|NCT01796964|69446137|FG000|Overall Study|Protocol Violation|0|||
37801072|NCT01796964|69446138|FG001|Overall Study|Protocol Violation|1|||
37801073|NCT01796964|69446137|FG000|Overall Study|Withdrawal by Subject|1|||
37801074|NCT01796964|69446138|FG001|Overall Study|Withdrawal by Subject|1|||
37801075|NCT01838694|69446147|FG000|Overall Study|Adverse Event|0|||
37801076|NCT01838694|69446148|FG001|Overall Study|Adverse Event|1|||
37801077|NCT01795638|69446159|FG000|Overall Study|Death|0|||
37801078|NCT01795638|69446160|FG001|Overall Study|Death|3|||
37801079|NCT01795638|69446159|FG000|Overall Study|transferred to quaternary hospital|2|||
37801080|NCT01795638|69446160|FG001|Overall Study|transferred to quaternary hospital|3|||
37801081|NCT01795638|69446159|FG000|Overall Study|Protocol Violation|3|||
37801082|NCT01795638|69446160|FG001|Overall Study|Protocol Violation|0|||
37801083|NCT01795638|69446159|FG000|Overall Study|discharged from hospital|7|||
37801084|NCT01795638|69446160|FG001|Overall Study|discharged from hospital|5|||
37801085|NCT01795638|69446159|FG000|Overall Study|Withdrawal by Subject|1|||
37801086|NCT01795638|69446160|FG001|Overall Study|Withdrawal by Subject|0|||
37801087|NCT01794780|69446174|FG000|Overall Study|Adverse Event|0|||
37801088|NCT01794780|69446175|FG001|Overall Study|Adverse Event|1|||
37801089|NCT01794780|69446176|FG002|Overall Study|Adverse Event|2|||
37801090|NCT01794780|69446177|FG003|Overall Study|Adverse Event|0|||
37801091|NCT01794780|69446178|FG004|Overall Study|Adverse Event|0|||
37801092|NCT01794780|69446179|FG005|Overall Study|Adverse Event|0|||
37801093|NCT01794780|69446180|FG006|Overall Study|Adverse Event|0|||
37801094|NCT01794780|69446181|FG007|Overall Study|Adverse Event|0|||
37801095|NCT01794780|69446174|FG000|Overall Study|Death|0|||
37801096|NCT01794780|69446175|FG001|Overall Study|Death|2|||
37801097|NCT01794780|69446176|FG002|Overall Study|Death|14|||
37801098|NCT01794780|69446177|FG003|Overall Study|Death|1|||
37801099|NCT01794780|69446178|FG004|Overall Study|Death|0|||
37801100|NCT01794780|69446179|FG005|Overall Study|Death|9|||
37801101|NCT01794780|69446180|FG006|Overall Study|Death|4|||
37801102|NCT01794780|69446181|FG007|Overall Study|Death|0|||
37801103|NCT01794780|69446174|FG000|Overall Study|Lost to Follow-up|10|||
37801104|NCT01794780|69446175|FG001|Overall Study|Lost to Follow-up|64|||
37801105|NCT01794780|69446176|FG002|Overall Study|Lost to Follow-up|165|||
37801106|NCT01794780|69446177|FG003|Overall Study|Lost to Follow-up|53|||
37801107|NCT01794780|69446178|FG004|Overall Study|Lost to Follow-up|2|||
37801108|NCT01794780|69446179|FG005|Overall Study|Lost to Follow-up|99|||
37801109|NCT01794780|69446180|FG006|Overall Study|Lost to Follow-up|30|||
37801110|NCT01794780|69446181|FG007|Overall Study|Lost to Follow-up|5|||
37801111|NCT01794780|69446174|FG000|Overall Study|Withdrew informed consent|7|||
37801112|NCT01794780|69446175|FG001|Overall Study|Withdrew informed consent|17|||
37801113|NCT01794780|69446176|FG002|Overall Study|Withdrew informed consent|36|||
37801114|NCT01794780|69446177|FG003|Overall Study|Withdrew informed consent|9|||
37801115|NCT01794780|69446178|FG004|Overall Study|Withdrew informed consent|0|||
37801116|NCT01794780|69446179|FG005|Overall Study|Withdrew informed consent|48|||
37801117|NCT01794780|69446180|FG006|Overall Study|Withdrew informed consent|4|||
37801118|NCT01794780|69446181|FG007|Overall Study|Withdrew informed consent|3|||
37801119|NCT01794780|69446174|FG000|Overall Study|Other|0|||
37801120|NCT01794780|69446175|FG001|Overall Study|Other|12|||
37801121|NCT01794780|69446176|FG002|Overall Study|Other|25|||
37801122|NCT01794780|69446177|FG003|Overall Study|Other|20|||
37801123|NCT01794780|69446178|FG004|Overall Study|Other|1|||
37801124|NCT01794780|69446179|FG005|Overall Study|Other|24|||
37801125|NCT01794780|69446180|FG006|Overall Study|Other|4|||
37801126|NCT01794780|69446181|FG007|Overall Study|Other|1|||
37801127|NCT01838616|69446208|FG000|Titration Period|Adverse Event|18|||
37801128|NCT01838616|69446209|FG001|Titration Period|Adverse Event|48|||
37801129|NCT01838616|69446208|FG000|Titration Period|Lack of Efficacy|5|||
37801130|NCT01838616|69446209|FG001|Titration Period|Lack of Efficacy|12|||
37801131|NCT01838616|69446208|FG000|Titration Period|Withdrawal by Subject|5|||
37801132|NCT01838616|69446209|FG001|Titration Period|Withdrawal by Subject|5|||
37801133|NCT01838616|69446208|FG000|Titration Period|Technical problems|1|||
37801134|NCT01838616|69446209|FG001|Titration Period|Technical problems|0|||
37801135|NCT01838616|69446208|FG000|Titration Period|Other|1|||
37801136|NCT01838616|69446209|FG001|Titration Period|Other|0|||
37801137|NCT01838616|69446208|FG000|Titration Period|Protocol Violation|0|||
37801138|NCT01838616|69446209|FG001|Titration Period|Protocol Violation|1|||
37801139|NCT01838616|69446208|FG000|Continuation Period|Lack of Efficacy|3|||
37801140|NCT01838616|69446209|FG001|Continuation Period|Lack of Efficacy|5|||
37801141|NCT01838616|69446208|FG000|Continuation Period|Adverse Event|8|||
37801142|NCT01838616|69446209|FG001|Continuation Period|Adverse Event|4|||
37801143|NCT01838616|69446208|FG000|Continuation Period|Protocol Violation|2|||
37801144|NCT01838616|69446209|FG001|Continuation Period|Protocol Violation|0|||
37801145|NCT01838616|69446208|FG000|Continuation Period|Lost to Follow-up|1|||
37801146|NCT01838616|69446209|FG001|Continuation Period|Lost to Follow-up|0|||
37801147|NCT01838616|69446208|FG000|Continuation Period|Withdrawal by Subject|0|||
37801148|NCT01838616|69446209|FG001|Continuation Period|Withdrawal by Subject|4|||
37801149|NCT01838616|69446208|FG000|Continuation Period|Technical problems|0|||
37801150|NCT01838616|69446209|FG001|Continuation Period|Technical problems|1|||
37801151|NCT01838616|69446208|FG000|Pick-up Arm|Lack of Efficacy|4|||
37801152|NCT01838616|69446209|FG001|Pick-up Arm|Lack of Efficacy|0|||
37801153|NCT01838616|69446208|FG000|Pick-up Arm|Adverse Event|9|||
37801154|NCT01838616|69446209|FG001|Pick-up Arm|Adverse Event|0|||
37801155|NCT01838616|69446208|FG000|Pick-up Arm|Withdrawal by Subject|1|||
37801156|NCT01838616|69446209|FG001|Pick-up Arm|Withdrawal by Subject|0|||
37801157|NCT01838616|69446208|FG000|Pick-up Arm|Technical problems|1|||
37801158|NCT01838616|69446209|FG001|Pick-up Arm|Technical problems|0|||
37801159|NCT01611792|69446222|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
37801160|NCT01611792|69446223|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
37801161|NCT01611792|69446222|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
37801162|NCT01611792|69446223|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
37801163|NCT01820364|69446230|FG000|Part I: LGX818|Death|1|||
37801164|NCT01820364|69446231|FG001|Part I: LGX818|Death|0|||
37801165|NCT01820364|69446230|FG000|Part I: LGX818|Administrative Problems|3|||
37801166|NCT01820364|69446231|FG001|Part I: LGX818|Administrative Problems|0|||
37801167|NCT01820364|69446230|FG000|Part I: LGX818|Adverse Event|6|||
37801168|NCT01820364|69446231|FG001|Part I: LGX818|Adverse Event|0|||
37801169|NCT01820364|69446230|FG000|Part I: LGX818|Disease Progression|4|||
37801170|NCT01820364|69446231|FG001|Part I: LGX818|Disease Progression|0|||
37801171|NCT01820364|69446230|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
37801172|NCT01820364|69446231|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
37801173|NCT01819506|69446239|FG000|Overall Study|Physician Decision|5|||
37801174|NCT01819506|69446240|FG001|Overall Study|Physician Decision|2|||
37801175|NCT01819506|69446239|FG000|Overall Study|Withdrawal by Subject|3|||
37801176|NCT01819506|69446240|FG001|Overall Study|Withdrawal by Subject|3|||
37801177|NCT01794000|69446248|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
37801178|NCT01794000|69446249|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
37801179|NCT01794000|69446248|FG000|Double-Blind Phase (DBP)|Death|1|||
37801180|NCT01794000|69446249|FG001|Double-Blind Phase (DBP)|Death|2|||
37801181|NCT01794000|69446248|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
37801182|NCT01794000|69446249|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
37801183|NCT01794000|69446248|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
37801184|NCT01794000|69446249|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
37801185|NCT01794000|69446248|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
37801186|NCT01794000|69446249|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
37801187|NCT01794000|69446248|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
37801188|NCT01794000|69446249|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
37801189|NCT01794000|69446248|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
37801190|NCT01794000|69446249|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
37801191|NCT01794000|69446248|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
37801192|NCT01794000|69446249|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
37801193|NCT01609296|69446256|FG000|Overall Study|Death|253|||
37801194|NCT01609296|69446256|FG000|Overall Study|Withdrawal by Subject|151|||
37801195|NCT01609296|69446256|FG000|Overall Study|Lost to Follow-up|21|||
37801196|NCT01609296|69446256|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
37801197|NCT01609296|69446256|FG000|Overall Study|missed visit but known to be alive|28|||
37801198|NCT01609218|69446264|FG000|Period 1|Adverse Event|3|||
37801199|NCT01609218|69446265|FG001|Period 1|Adverse Event|5|||
37801200|NCT01609218|69446264|FG000|Period 1|Sponsor Decision|0|||
37975727|NCT00498602|69662997|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
37975728|NCT00498602|69662991|FG000|Overall Study|AE not related to Study Drug|1|||
37975729|NCT00498602|69662992|FG001|Overall Study|AE not related to Study Drug|3|||
37975730|NCT00498602|69662993|FG002|Overall Study|AE not related to Study Drug|0|||
37975731|NCT00498602|69662994|FG003|Overall Study|AE not related to Study Drug|0|||
37801201|NCT01609218|69446265|FG001|Period 1|Sponsor Decision|1|||
37801202|NCT01609218|69446264|FG000|Period 2|Adverse Event|1|||
37801203|NCT01609218|69446265|FG001|Period 2|Adverse Event|0|||
37801204|NCT01609062|69446273|FG000|Extension Phase|Terminated by Sponsor|14|||
37801205|NCT01609062|69446274|FG001|Extension Phase|Terminated by Sponsor|9|||
37801206|NCT01609062|69446273|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
37801207|NCT01609062|69446274|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
37801208|NCT01609062|69446273|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
37801209|NCT01609062|69446274|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
37801210|NCT01819272|69446287|FG000|Overall Study|Adverse Event|1|||
37801211|NCT01819272|69446288|FG001|Overall Study|Adverse Event|0|||
37801212|NCT01819272|69446289|FG002|Overall Study|Adverse Event|0|||
37801213|NCT01819272|69446290|FG003|Overall Study|Adverse Event|2|||
37801214|NCT01819272|69446291|FG004|Overall Study|Adverse Event|0|||
37801215|NCT01819272|69446292|FG005|Overall Study|Adverse Event|0|||
37801216|NCT01819272|69446287|FG000|Overall Study|Lost to Follow-up|3|||
37801217|NCT01819272|69446288|FG001|Overall Study|Lost to Follow-up|0|||
37801218|NCT01819272|69446289|FG002|Overall Study|Lost to Follow-up|1|||
37801219|NCT01819272|69446290|FG003|Overall Study|Lost to Follow-up|0|||
37801220|NCT01819272|69446291|FG004|Overall Study|Lost to Follow-up|0|||
37801221|NCT01819272|69446292|FG005|Overall Study|Lost to Follow-up|3|||
37801222|NCT01819272|69446287|FG000|Overall Study|Protocol Violation|0|||
37801223|NCT01819272|69446288|FG001|Overall Study|Protocol Violation|0|||
37801224|NCT01819272|69446289|FG002|Overall Study|Protocol Violation|0|||
37801225|NCT01819272|69446290|FG003|Overall Study|Protocol Violation|1|||
37801226|NCT01819272|69446291|FG004|Overall Study|Protocol Violation|2|||
37801227|NCT01819272|69446292|FG005|Overall Study|Protocol Violation|3|||
37801228|NCT01819272|69446287|FG000|Overall Study|Physician Decision|0|||
37801229|NCT01819272|69446288|FG001|Overall Study|Physician Decision|1|||
37801230|NCT01819272|69446289|FG002|Overall Study|Physician Decision|0|||
37801231|NCT01819272|69446290|FG003|Overall Study|Physician Decision|0|||
37801232|NCT01819272|69446291|FG004|Overall Study|Physician Decision|0|||
37801233|NCT01819272|69446292|FG005|Overall Study|Physician Decision|0|||
37801234|NCT01819272|69446287|FG000|Overall Study|Withdrawal of Consent|0|||
37801235|NCT01819272|69446288|FG001|Overall Study|Withdrawal of Consent|1|||
37801236|NCT01819272|69446289|FG002|Overall Study|Withdrawal of Consent|2|||
37801237|NCT01819272|69446290|FG003|Overall Study|Withdrawal of Consent|1|||
37801238|NCT01819272|69446291|FG004|Overall Study|Withdrawal of Consent|0|||
37801239|NCT01819272|69446292|FG005|Overall Study|Withdrawal of Consent|1|||
37801240|NCT01819272|69446287|FG000|Overall Study|Loss of Glucose Control|2|||
37801241|NCT01819272|69446288|FG001|Overall Study|Loss of Glucose Control|1|||
37801242|NCT01819272|69446289|FG002|Overall Study|Loss of Glucose Control|0|||
37801243|NCT01819272|69446290|FG003|Overall Study|Loss of Glucose Control|1|||
37801244|NCT01819272|69446291|FG004|Overall Study|Loss of Glucose Control|2|||
37801245|NCT01819272|69446292|FG005|Overall Study|Loss of Glucose Control|0|||
37801246|NCT01819194|69446306|FG000|Overall Study|Loss of study articles|2|||
37801247|NCT01611558|69446310|FG000|Induction Phase|Study drug toxicity|15|||
37801248|NCT01611558|69446310|FG000|Induction Phase|Disease progression|18|||
37801249|NCT01611558|69446310|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
37801250|NCT01611558|69446310|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
37801251|NCT01611558|69446310|FG000|Induction Phase|Death|1|||
37801252|NCT01611558|69446310|FG000|Maintenance Phase|Withdrawal by Subject|1|||
37801253|NCT01611558|69446310|FG000|Maintenance Phase|Elevated Uric acid|1|||
37801254|NCT01818726|69446317|FG000|Overall Study|Administrative reasons|5|||
37801255|NCT01818726|69446318|FG001|Overall Study|Administrative reasons|1|||
37975732|NCT00498602|69662995|FG004|Overall Study|AE not related to Study Drug|2|||
37801256|NCT01818726|69446317|FG000|Overall Study|Withdrawal by Subject|0|||
37801257|NCT01818726|69446318|FG001|Overall Study|Withdrawal by Subject|1|||
37801258|NCT01818726|69446317|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
37801259|NCT01818726|69446318|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
37801260|NCT01818336|69446324|FG000|Overall Study|Declined retest visit|0|||
37801261|NCT01818336|69446325|FG001|Overall Study|Declined retest visit|11|||
37801262|NCT01818336|69446324|FG000|Overall Study|Lost to Follow-up|0|||
37801263|NCT01818336|69446325|FG001|Overall Study|Lost to Follow-up|1|||
37801264|NCT01818258|69446333|FG000|Overall Study|Death|3|||
37801265|NCT01818258|69446334|FG001|Overall Study|Death|0|||
37801266|NCT01818258|69446333|FG000|Overall Study|Withdrawal by Subject|0|||
37801267|NCT01818258|69446334|FG001|Overall Study|Withdrawal by Subject|1|||
37801268|NCT01818258|69446333|FG000|Overall Study|Lost to Follow-up|0|||
37693963|NCT02352493|69170266|FG004|Overall Study|Pregnancy|0|||
37801269|NCT01818258|69446334|FG001|Overall Study|Lost to Follow-up|1|||
37801270|NCT01818258|69446333|FG000|Overall Study|Unable to Travel to Clinic|0|||
37801271|NCT01818258|69446334|FG001|Overall Study|Unable to Travel to Clinic|1|||
37801272|NCT01817790|69446343|FG000|Overall Study|Adverse Event|0|||
37801273|NCT01817790|69446344|FG001|Overall Study|Adverse Event|2|||
37801274|NCT01817790|69446343|FG000|Overall Study|Lost to Follow-up|0|||
37801275|NCT01817790|69446344|FG001|Overall Study|Lost to Follow-up|1|||
37801276|NCT01817790|69446343|FG000|Overall Study|Protocol Violation|2|||
37801277|NCT01817790|69446344|FG001|Overall Study|Protocol Violation|1|||
37801278|NCT01817790|69446343|FG000|Overall Study|Withdrawal by Subject|1|||
37801279|NCT01817790|69446344|FG001|Overall Study|Withdrawal by Subject|3|||
37801280|NCT01817790|69446343|FG000|Overall Study|Other: Could not attend appointment|1|||
37801281|NCT01817790|69446344|FG001|Overall Study|Other: Could not attend appointment|1|||
37801282|NCT01793688|69446352|FG000|Overall Study|Protocol Violation|2|||
37801283|NCT01793142|69446356|FG000|Overall Study|Randomized not treated|7|||
37801284|NCT01792830|69446371|FG000|Overall Study|Withdrawal by Subject|22|||
37801285|NCT01792830|69446372|FG001|Overall Study|Withdrawal by Subject|0|||
37801286|NCT01792830|69446373|FG002|Overall Study|Withdrawal by Subject|0|||
37801287|NCT01792830|69446374|FG003|Overall Study|Withdrawal by Subject|2|||
37801288|NCT01792830|69446375|FG004|Overall Study|Withdrawal by Subject|1|||
37801289|NCT01792830|69446376|FG005|Overall Study|Withdrawal by Subject|1|||
37801290|NCT01792830|69446377|FG006|Overall Study|Withdrawal by Subject|1|||
37801291|NCT01792830|69446378|FG007|Overall Study|Withdrawal by Subject|1|||
37801292|NCT01792830|69446379|FG008|Overall Study|Withdrawal by Subject|7|||
37801293|NCT01792830|69446380|FG009|Overall Study|Withdrawal by Subject|0|||
37801294|NCT01792830|69446381|FG010|Overall Study|Withdrawal by Subject|2|||
37801295|NCT01792830|69446371|FG000|Overall Study|Death|3|||
37801296|NCT01792830|69446372|FG001|Overall Study|Death|0|||
37801297|NCT01792830|69446373|FG002|Overall Study|Death|0|||
37801298|NCT01792830|69446374|FG003|Overall Study|Death|1|||
37801299|NCT01792830|69446375|FG004|Overall Study|Death|0|||
37801300|NCT01792830|69446376|FG005|Overall Study|Death|0|||
37801301|NCT01792830|69446377|FG006|Overall Study|Death|1|||
37801302|NCT01792830|69446378|FG007|Overall Study|Death|0|||
37801303|NCT01792830|69446379|FG008|Overall Study|Death|1|||
37801304|NCT01792830|69446380|FG009|Overall Study|Death|0|||
37801305|NCT01792830|69446381|FG010|Overall Study|Death|1|||
37801306|NCT01792830|69446371|FG000|Overall Study|Adverse Event|0|||
37801307|NCT01792830|69446372|FG001|Overall Study|Adverse Event|0|||
37801308|NCT01792830|69446373|FG002|Overall Study|Adverse Event|0|||
37801309|NCT01792830|69446374|FG003|Overall Study|Adverse Event|0|||
37801310|NCT01792830|69446375|FG004|Overall Study|Adverse Event|0|||
37801311|NCT01792830|69446376|FG005|Overall Study|Adverse Event|0|||
37801312|NCT01792830|69446377|FG006|Overall Study|Adverse Event|0|||
37801313|NCT01792830|69446378|FG007|Overall Study|Adverse Event|0|||
37801314|NCT01792830|69446379|FG008|Overall Study|Adverse Event|1|||
37801315|NCT01792830|69446380|FG009|Overall Study|Adverse Event|0|||
37801316|NCT01792830|69446381|FG010|Overall Study|Adverse Event|0|||
37801317|NCT01792518|69446413|FG000|Overall Study|Adverse Event|3|||
37801318|NCT01792518|69446414|FG001|Overall Study|Adverse Event|4|||
37801319|NCT01792518|69446413|FG000|Overall Study|Protocol Violation|0|||
37801320|NCT01792518|69446414|FG001|Overall Study|Protocol Violation|1|||
37801321|NCT01792518|69446413|FG000|Overall Study|Lost to Follow-up|3|||
37801322|NCT01792518|69446414|FG001|Overall Study|Lost to Follow-up|1|||
37801323|NCT01792518|69446413|FG000|Overall Study|Withdrawal by Subject|2|||
37801324|NCT01792518|69446414|FG001|Overall Study|Withdrawal by Subject|0|||
37801325|NCT01792518|69446413|FG000|Overall Study|Other Reason|0|||
37801326|NCT01792518|69446414|FG001|Overall Study|Other Reason|1|||
37801327|NCT01792284|69446420|FG000|Lead-in Period|Adverse Event|15|||
37801328|NCT01792284|69446421|FG001|Lead-in Period|Adverse Event|0|||
37801329|NCT01792284|69446422|FG002|Lead-in Period|Adverse Event|0|||
37801330|NCT01792284|69446420|FG000|Lead-in Period|Lost to Follow-up|2|||
37801331|NCT01792284|69446421|FG001|Lead-in Period|Lost to Follow-up|0|||
37801332|NCT01792284|69446422|FG002|Lead-in Period|Lost to Follow-up|0|||
37801333|NCT01792284|69446420|FG000|Lead-in Period|Protocol Violation|1|||
37801334|NCT01792284|69446421|FG001|Lead-in Period|Protocol Violation|0|||
37801335|NCT01792284|69446422|FG002|Lead-in Period|Protocol Violation|0|||
37801336|NCT01792284|69446420|FG000|Lead-in Period|Withdrawal by Subject|10|||
37801337|NCT01792284|69446421|FG001|Lead-in Period|Withdrawal by Subject|0|||
37801338|NCT01792284|69446422|FG002|Lead-in Period|Withdrawal by Subject|0|||
37801339|NCT01792284|69446420|FG000|Lead-in Period|Physician Decision|1|||
37801340|NCT01792284|69446421|FG001|Lead-in Period|Physician Decision|0|||
37801341|NCT01792284|69446422|FG002|Lead-in Period|Physician Decision|0|||
37801342|NCT01792284|69446420|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
37801343|NCT01792284|69446421|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
37801344|NCT01792284|69446422|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
37801345|NCT01792284|69446420|FG000|Randomization Period 1|Withdrawal by Subject|0|||
37801346|NCT01792284|69446421|FG001|Randomization Period 1|Withdrawal by Subject|1|||
37801347|NCT01792284|69446422|FG002|Randomization Period 1|Withdrawal by Subject|1|||
37801348|NCT01792284|69446420|FG000|Randomization Period 1|Physician Decision|0|||
37801349|NCT01792284|69446421|FG001|Randomization Period 1|Physician Decision|1|||
37801350|NCT01792284|69446422|FG002|Randomization Period 1|Physician Decision|1|||
37801351|NCT01792284|69446420|FG000|Randomization Period 1|Adverse Event|0|||
37801352|NCT01792284|69446421|FG001|Randomization Period 1|Adverse Event|0|||
37801353|NCT01792284|69446422|FG002|Randomization Period 1|Adverse Event|2|||
37801354|NCT01792284|69446420|FG000|Randomization Period 1|Lost to Follow-up|0|||
37801355|NCT01792284|69446421|FG001|Randomization Period 1|Lost to Follow-up|0|||
37801356|NCT01792284|69446422|FG002|Randomization Period 1|Lost to Follow-up|1|||
37801357|NCT01792284|69446420|FG000|Randomization Period 2|Protocol Violation|0|||
37801358|NCT01792284|69446421|FG001|Randomization Period 2|Protocol Violation|1|||
37801359|NCT01792284|69446422|FG002|Randomization Period 2|Protocol Violation|0|||
37801360|NCT01792284|69446420|FG000|Randomization Period 2|Withdrawal by Subject|0|||
37801361|NCT01792284|69446421|FG001|Randomization Period 2|Withdrawal by Subject|2|||
37801362|NCT01792284|69446422|FG002|Randomization Period 2|Withdrawal by Subject|0|||
37801363|NCT01791894|69446430|FG000|Overall Study|Adverse Event|1|||
37801364|NCT01837680|69446437|FG000|Overall Study|Lost to Follow-up|2|||
37801365|NCT01837680|69446438|FG001|Overall Study|Lost to Follow-up|2|||
37801366|NCT01837680|69446437|FG000|Overall Study|lack of insurance|0|||
37801367|NCT01837680|69446438|FG001|Overall Study|lack of insurance|2|||
37801368|NCT01837680|69446437|FG000|Overall Study|allergic reaction|6|||
37801369|NCT01837680|69446438|FG001|Overall Study|allergic reaction|0|||
37801370|NCT01837680|69446437|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
37801371|NCT01837680|69446438|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
37801372|NCT01836276|69446446|FG000|Overall Study|Lost to Follow-up|28|||
37801373|NCT01836276|69446447|FG001|Overall Study|Lost to Follow-up|51|||
37801374|NCT01790568|69446453|FG000|Overall Study|Progression prior to transplant|0|||
37801375|NCT01790568|69446454|FG001|Overall Study|Progression prior to transplant|1|||
37693964|NCT02352493|69170267|FG005|Overall Study|Pregnancy|0|||
37693965|NCT02352493|69170268|FG006|Overall Study|Pregnancy|1|||
37693966|NCT02352493|69170269|FG007|Overall Study|Pregnancy|0|||
37801376|NCT01610076|69446460|FG000|Overall Study|Technical issue with video|0|||
37801377|NCT01610076|69446461|FG001|Overall Study|Technical issue with video|1|||
37801378|NCT01610076|69446460|FG000|Overall Study|Lost to Follow-up|3|||
37801379|NCT01610076|69446461|FG001|Overall Study|Lost to Follow-up|4|||
37801380|NCT01836198|69446470|FG000|Part A, Period 2|Protocol Violation|0|||
37801381|NCT01836198|69446471|FG001|Part A, Period 2|Protocol Violation|1|||
37801382|NCT01836198|69446472|FG002|Part A, Period 2|Protocol Violation|0|||
37801383|NCT01816074|69446492|FG000|Phase 1|Time commitment issues|0|||
37801384|NCT01816074|69446493|FG001|Phase 1|Time commitment issues|0|||
37801385|NCT01816074|69446494|FG002|Phase 1|Time commitment issues|1|||
37801386|NCT01816074|69446495|FG003|Phase 1|Time commitment issues|0|||
37801387|NCT01816074|69446492|FG000|Phase 2|Time commitment Issues|0|||
37801388|NCT01816074|69446493|FG001|Phase 2|Time commitment Issues|2|||
37801389|NCT01816074|69446494|FG002|Phase 2|Time commitment Issues|0|||
37801390|NCT01816074|69446495|FG003|Phase 2|Time commitment Issues|0|||
37801391|NCT01816074|69446492|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
37801392|NCT01816074|69446493|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
37801393|NCT01816074|69446494|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
37801394|NCT01816074|69446495|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
37801395|NCT01816074|69446492|FG000|Phase 2|Physician Decision|0|||
37801396|NCT01816074|69446493|FG001|Phase 2|Physician Decision|0|||
37801397|NCT01816074|69446494|FG002|Phase 2|Physician Decision|0|||
37801398|NCT01816074|69446495|FG003|Phase 2|Physician Decision|1|||
37801399|NCT01816074|69446492|FG000|Phase 2|Withdrawal by Subject|1|||
37801400|NCT01816074|69446493|FG001|Phase 2|Withdrawal by Subject|0|||
37801401|NCT01816074|69446494|FG002|Phase 2|Withdrawal by Subject|0|||
37801402|NCT01816074|69446495|FG003|Phase 2|Withdrawal by Subject|0|||
37801403|NCT01815918|69446521|FG000|Overall Study|Patient samples not analyzable|3|||
37801404|NCT01815918|69446522|FG001|Overall Study|Patient samples not analyzable|4|||
37801405|NCT01815918|69446521|FG000|Overall Study|Lack of Efficacy|15|||
37801406|NCT01815918|69446522|FG001|Overall Study|Lack of Efficacy|15|||
37801407|NCT01789476|69446534|FG000|Overall Study|Lack of Efficacy|6|||
37801408|NCT01789476|69446535|FG001|Overall Study|Lack of Efficacy|2|||
37801409|NCT01789476|69446534|FG000|Overall Study|Adverse Event|1|||
37801410|NCT01789476|69446535|FG001|Overall Study|Adverse Event|0|||
37801411|NCT01789476|69446534|FG000|Overall Study|Unable to get IV access|1|||
37801412|NCT01789476|69446535|FG001|Overall Study|Unable to get IV access|0|||
37801413|NCT01789320|69446541|FG000|Overall Study|Re-enrolled into study|1|||
37801414|NCT01789320|69446541|FG000|Overall Study|Lost to Follow-up|1|||
37801415|NCT01815840|69446547|FG000|Overall Study|Missing|1|||
37801416|NCT01815840|69446548|FG001|Overall Study|Missing|0|||
37801417|NCT01815840|69446547|FG000|Overall Study|Withdrew Consent|31|||
37801418|NCT01815840|69446548|FG001|Overall Study|Withdrew Consent|30|||
37801419|NCT01815840|69446547|FG000|Overall Study|Administrative/Other|1|||
37801420|NCT01815840|69446548|FG001|Overall Study|Administrative/Other|3|||
37801421|NCT01815840|69446547|FG000|Overall Study|Adverse Event|10|||
37801422|NCT01815840|69446548|FG001|Overall Study|Adverse Event|16|||
37801423|NCT01815840|69446547|FG000|Overall Study|Death|2|||
37801424|NCT01815840|69446548|FG001|Overall Study|Death|2|||
37801425|NCT01815840|69446547|FG000|Overall Study|Disease progression|3|||
37801426|NCT01815840|69446548|FG001|Overall Study|Disease progression|2|||
37801427|NCT01815840|69446547|FG000|Overall Study|Investigators Decision|2|||
37801428|NCT01815840|69446548|FG001|Overall Study|Investigators Decision|3|||
37801429|NCT01815840|69446547|FG000|Overall Study|Lost to Follow-up|3|||
37801430|NCT01815840|69446548|FG001|Overall Study|Lost to Follow-up|6|||
37801431|NCT01815840|69446547|FG000|Overall Study|Refused Treatment|5|||
37801432|NCT01815840|69446548|FG001|Overall Study|Refused Treatment|1|||
37801433|NCT01815840|69446547|FG000|Overall Study|Sponsor Termination Treatment|1|||
37801434|NCT01815840|69446548|FG001|Overall Study|Sponsor Termination Treatment|0|||
37801435|NCT01774110|69446554|FG000|Overall Study|Lost to Follow-up|7|||
37801436|NCT01788228|69446561|FG000|Overall Study|Migrated/moved from study area|1|||
37801437|NCT01788228|69446562|FG001|Overall Study|Migrated/moved from study area|0|||
37801438|NCT01607346|69446571|FG000|Overall Study|Adverse Event|3|||
37801439|NCT01787838|69446575|FG000|Overall Study|refused|1413|||
37801440|NCT01787760|69446582|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
37801441|NCT01787760|69446583|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
37801442|NCT01787760|69446584|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
37975733|NCT00498602|69662996|FG005|Overall Study|AE not related to Study Drug|2|||
37975734|NCT00498602|69662997|FG006|Overall Study|AE not related to Study Drug|1|||
37801443|NCT01787760|69446582|FG000|Overall Study|Decompensated on left exotropia|0|||
37801444|NCT01787760|69446583|FG001|Overall Study|Decompensated on left exotropia|0|||
37975735|NCT00498602|69662991|FG000|Overall Study|Caregiver Request|2|||
37975736|NCT00498602|69662992|FG001|Overall Study|Caregiver Request|2|||
37975737|NCT00498602|69662993|FG002|Overall Study|Caregiver Request|2|||
37975738|NCT00498602|69662994|FG003|Overall Study|Caregiver Request|0|||
37801445|NCT01787760|69446584|FG002|Overall Study|Decompensated on left exotropia|1|||
37801446|NCT01787760|69446582|FG000|Overall Study|Dryness|0|||
37801447|NCT01787760|69446583|FG001|Overall Study|Dryness|1|||
37801448|NCT01787760|69446584|FG002|Overall Study|Dryness|0|||
37801449|NCT01787760|69446582|FG000|Overall Study|Relocation|1|||
37801450|NCT01787760|69446583|FG001|Overall Study|Relocation|1|||
37801451|NCT01787760|69446584|FG002|Overall Study|Relocation|0|||
37801452|NCT01787760|69446582|FG000|Overall Study|Lens discomfort|3|||
37801453|NCT01787760|69446583|FG001|Overall Study|Lens discomfort|0|||
37801454|NCT01787760|69446584|FG002|Overall Study|Lens discomfort|0|||
37801455|NCT01787760|69446582|FG000|Overall Study|Lens handling difficulty|1|||
37801456|NCT01787760|69446583|FG001|Overall Study|Lens handling difficulty|2|||
37801457|NCT01787760|69446584|FG002|Overall Study|Lens handling difficulty|0|||
37801458|NCT01787760|69446582|FG000|Overall Study|Protocol Violation|6|||
37801459|NCT01787760|69446583|FG001|Overall Study|Protocol Violation|0|||
37801460|NCT01787760|69446584|FG002|Overall Study|Protocol Violation|1|||
37801461|NCT01787760|69446582|FG000|Overall Study|Withdrawal by Subject|5|||
37801462|NCT01787760|69446583|FG001|Overall Study|Withdrawal by Subject|1|||
37801463|NCT01787760|69446584|FG002|Overall Study|Withdrawal by Subject|2|||
37801464|NCT01787760|69446582|FG000|Overall Study|Lost to Follow-up|1|||
37801465|NCT01787760|69446583|FG001|Overall Study|Lost to Follow-up|0|||
37801466|NCT01787760|69446584|FG002|Overall Study|Lost to Follow-up|1|||
37801467|NCT01787760|69446582|FG000|Overall Study|Stroke|1|||
37801468|NCT01787760|69446583|FG001|Overall Study|Stroke|0|||
37801469|NCT01787760|69446584|FG002|Overall Study|Stroke|0|||
37801470|NCT01787760|69446582|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
37801471|NCT01787760|69446583|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
37801472|NCT01787760|69446584|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
37801473|NCT01787760|69446582|FG000|Overall Study|Unsatisfactory physiological response|2|||
37801474|NCT01787760|69446583|FG001|Overall Study|Unsatisfactory physiological response|4|||
37801475|NCT01787760|69446584|FG002|Overall Study|Unsatisfactory physiological response|0|||
37801476|NCT01787760|69446582|FG000|Overall Study|Unsatisfactory visual response|1|||
37801477|NCT01787760|69446583|FG001|Overall Study|Unsatisfactory visual response|1|||
37801478|NCT01787760|69446584|FG002|Overall Study|Unsatisfactory visual response|0|||
37801479|NCT01787760|69446582|FG000|Overall Study|Near vision blur|1|||
37801480|NCT01787760|69446583|FG001|Overall Study|Near vision blur|0|||
37801481|NCT01787760|69446584|FG002|Overall Study|Near vision blur|0|||
37801482|NCT01815138|69446595|FG000|Overall Study|Withdrawal by Subject|0|||
37801483|NCT01815138|69446596|FG001|Overall Study|Withdrawal by Subject|1|||
37801484|NCT01815138|69446595|FG000|Overall Study|Physician Decision|8|||
37801485|NCT01815138|69446596|FG001|Overall Study|Physician Decision|5|||
37801486|NCT01606800|69446604|FG000|Overall Study|Adverse Event|3|||
37801487|NCT01606800|69446605|FG001|Overall Study|Adverse Event|1|||
37801488|NCT01606800|69446604|FG000|Overall Study|Participant withdrew consent|0|||
37801489|NCT01606800|69446605|FG001|Overall Study|Participant withdrew consent|1|||
37801490|NCT01606800|69446604|FG000|Overall Study|Missing completion status|2|||
37801491|NCT01606800|69446605|FG001|Overall Study|Missing completion status|0|||
37801492|NCT01772550|69446614|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
37801493|NCT01772550|69446615|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
37801494|NCT01772550|69446616|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
37801495|NCT01772550|69446614|FG000|Overall Study|Adverse Event|0|||
37801496|NCT01772550|69446615|FG001|Overall Study|Adverse Event|0|||
37801497|NCT01772550|69446616|FG002|Overall Study|Adverse Event|1|||
37801498|NCT01787292|69446624|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
37801499|NCT01787292|69446625|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
37801500|NCT01787292|69446624|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
37864254|NCT01207440|69547820|FG006|Overall Study|Reason Not Specified|0|||
37801501|NCT01787292|69446625|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
37801502|NCT01814748|69446638|FG000|Overall Study|Lost to Follow-up|1|||
37801503|NCT01814748|69446639|FG001|Overall Study|Lost to Follow-up|2|||
37801504|NCT01814748|69446638|FG000|Overall Study|Study site terminated by sponsor|1|||
37801505|NCT01814748|69446639|FG001|Overall Study|Study site terminated by sponsor|1|||
37801506|NCT01814748|69446638|FG000|Overall Study|Withdrawal by Subject|6|||
37693967|NCT02352493|69170270|FG008|Overall Study|Pregnancy|1|||
37801507|NCT01814748|69446639|FG001|Overall Study|Withdrawal by Subject|4|||
37801508|NCT01814670|69446645|FG000|Overall Study|Protocol Violation|12|||
37801509|NCT01814046|69446651|FG000|Drug Administration|Death due to complications of RSV|1|||
37801510|NCT01814046|69446652|FG001|Drug Administration|Death due to complications of RSV|0|||
37801511|NCT01814046|69446653|FG002|Drug Administration|Death due to complications of RSV|0|||
37801512|NCT01813890|69446663|FG000|Overall Study|Adverse Event|0|||
37801513|NCT01813890|69446664|FG001|Overall Study|Adverse Event|3|||
37801514|NCT01813890|69446665|FG002|Overall Study|Adverse Event|4|||
37801515|NCT01813890|69446663|FG000|Overall Study|Lack of Efficacy|9|||
37801516|NCT01813890|69446664|FG001|Overall Study|Lack of Efficacy|1|||
37801517|NCT01813890|69446665|FG002|Overall Study|Lack of Efficacy|2|||
37801518|NCT01772316|69446673|FG000|Overall Study|Serious adverse event|1|||
37801519|NCT01772316|69446673|FG000|Overall Study|Inform consent withdrawn|1|||
37801520|NCT01772316|69446673|FG000|Overall Study|Withdrawn by sponsor decision|5|||
37801521|NCT01813422|69446679|FG000|Overall Study|Withdrawal by Subject|14|||
37801522|NCT01813422|69446680|FG001|Overall Study|Withdrawal by Subject|8|||
37801523|NCT01813422|69446679|FG000|Overall Study|Death|2|||
37801524|NCT01813422|69446680|FG001|Overall Study|Death|3|||
37801525|NCT01813422|69446679|FG000|Overall Study|Sponsor Decision|2|||
37801526|NCT01813422|69446680|FG001|Overall Study|Sponsor Decision|1|||
37801527|NCT01813422|69446679|FG000|Overall Study|Lost to Follow-up|2|||
37801528|NCT01813422|69446680|FG001|Overall Study|Lost to Follow-up|4|||
37801529|NCT01786668|69446690|FG000|Overall Study|Adverse Event|0|||
37801530|NCT01786668|69446691|FG001|Overall Study|Adverse Event|1|||
37801531|NCT01786668|69446692|FG002|Overall Study|Adverse Event|1|||
37801532|NCT01786668|69446693|FG003|Overall Study|Adverse Event|2|||
37801533|NCT01786668|69446690|FG000|Overall Study|Withdrawal by Subject|0|||
37801534|NCT01786668|69446691|FG001|Overall Study|Withdrawal by Subject|0|||
37801535|NCT01786668|69446692|FG002|Overall Study|Withdrawal by Subject|3|||
37801536|NCT01786668|69446693|FG003|Overall Study|Withdrawal by Subject|1|||
37801537|NCT01786668|69446690|FG000|Overall Study|Pregnancy|0|||
37801538|NCT01786668|69446691|FG001|Overall Study|Pregnancy|0|||
37801539|NCT01786668|69446692|FG002|Overall Study|Pregnancy|0|||
37801540|NCT01786668|69446693|FG003|Overall Study|Pregnancy|1|||
37801541|NCT01786668|69446690|FG000|Overall Study|Lost to Follow-up|1|||
37801542|NCT01786668|69446691|FG001|Overall Study|Lost to Follow-up|0|||
37801543|NCT01786668|69446692|FG002|Overall Study|Lost to Follow-up|1|||
37801544|NCT01786668|69446693|FG003|Overall Study|Lost to Follow-up|0|||
37801545|NCT01786512|69446714|FG000|Overall Study|Lost to Follow-up|0|||
37801546|NCT01786512|69446715|FG001|Overall Study|Lost to Follow-up|0|||
37801547|NCT01786512|69446716|FG002|Overall Study|Lost to Follow-up|0|||
37801548|NCT01786512|69446717|FG003|Overall Study|Lost to Follow-up|0|||
37801549|NCT01786512|69446718|FG004|Overall Study|Lost to Follow-up|0|||
37801550|NCT01786512|69446719|FG005|Overall Study|Lost to Follow-up|0|||
37801551|NCT01786512|69446720|FG006|Overall Study|Lost to Follow-up|0|||
37801552|NCT01786512|69446721|FG007|Overall Study|Lost to Follow-up|0|||
37801553|NCT01786512|69446722|FG008|Overall Study|Lost to Follow-up|0|||
37801554|NCT01786512|69446723|FG009|Overall Study|Lost to Follow-up|1|||
37693968|NCT02352493|69170271|FG009|Overall Study|Pregnancy|0|||
37801555|NCT01786512|69446724|FG010|Overall Study|Lost to Follow-up|0|||
37801556|NCT01786512|69446714|FG000|Overall Study|Decision by sponsor|0|||
37801557|NCT01786512|69446715|FG001|Overall Study|Decision by sponsor|0|||
37801558|NCT01786512|69446716|FG002|Overall Study|Decision by sponsor|0|||
37801559|NCT01786512|69446717|FG003|Overall Study|Decision by sponsor|0|||
37801560|NCT01786512|69446718|FG004|Overall Study|Decision by sponsor|0|||
37801561|NCT01786512|69446719|FG005|Overall Study|Decision by sponsor|0|||
37801562|NCT01786512|69446720|FG006|Overall Study|Decision by sponsor|0|||
37693969|NCT02352493|69170272|FG010|Overall Study|Pregnancy|0|||
37801563|NCT01786512|69446721|FG007|Overall Study|Decision by sponsor|0|||
37801564|NCT01786512|69446722|FG008|Overall Study|Decision by sponsor|0|||
37801565|NCT01786512|69446723|FG009|Overall Study|Decision by sponsor|0|||
37801566|NCT01786512|69446724|FG010|Overall Study|Decision by sponsor|2|||
37801567|NCT01786512|69446714|FG000|Overall Study|Withdrawal by Subject|0|||
37801568|NCT01786512|69446715|FG001|Overall Study|Withdrawal by Subject|1|||
37801569|NCT01786512|69446716|FG002|Overall Study|Withdrawal by Subject|0|||
37801570|NCT01786512|69446717|FG003|Overall Study|Withdrawal by Subject|0|||
37801571|NCT01786512|69446718|FG004|Overall Study|Withdrawal by Subject|0|||
37801572|NCT01786512|69446719|FG005|Overall Study|Withdrawal by Subject|0|||
37801573|NCT01786512|69446720|FG006|Overall Study|Withdrawal by Subject|1|||
37801574|NCT01786512|69446721|FG007|Overall Study|Withdrawal by Subject|0|||
37801575|NCT01786512|69446722|FG008|Overall Study|Withdrawal by Subject|0|||
37801576|NCT01786512|69446723|FG009|Overall Study|Withdrawal by Subject|3|||
37801577|NCT01786512|69446724|FG010|Overall Study|Withdrawal by Subject|7|||
37801578|NCT01786512|69446714|FG000|Overall Study|Death|0|||
37801579|NCT01786512|69446715|FG001|Overall Study|Death|0|||
37801580|NCT01786512|69446716|FG002|Overall Study|Death|0|||
37801581|NCT01786512|69446717|FG003|Overall Study|Death|0|||
37801582|NCT01786512|69446718|FG004|Overall Study|Death|0|||
37801583|NCT01786512|69446719|FG005|Overall Study|Death|0|||
37801584|NCT01786512|69446720|FG006|Overall Study|Death|0|||
37801585|NCT01786512|69446721|FG007|Overall Study|Death|0|||
37801586|NCT01786512|69446722|FG008|Overall Study|Death|4|||
37801587|NCT01786512|69446723|FG009|Overall Study|Death|1|||
37801588|NCT01786512|69446724|FG010|Overall Study|Death|3|||
37801589|NCT01772160|69446756|FG000|Overall Study|Death|3|||
37801590|NCT01772160|69446756|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
37801591|NCT01772160|69446756|FG000|Overall Study|Consent withdrawal|3|||
37801592|NCT01772160|69446756|FG000|Overall Study|Migrated / moved from the study area|4|||
37801593|NCT01772160|69446756|FG000|Overall Study|Lost to Follow-up|30|||
37801594|NCT01772160|69446756|FG000|Overall Study|Other|5|||
37801595|NCT01770912|69446762|FG000|Overall Study|Lost to Follow-up|2|||
37801596|NCT01770912|69446763|FG001|Overall Study|Lost to Follow-up|0|||
37801597|NCT01811706|69446769|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
37801598|NCT01811706|69446770|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
37801599|NCT01811472|69446781|FG000|Overall Study|Adverse Event|1|||
37801600|NCT01811472|69446782|FG001|Overall Study|Adverse Event|0|||
37801601|NCT01811472|69446783|FG002|Overall Study|Adverse Event|4|||
37801602|NCT01811472|69446781|FG000|Overall Study|Lost to Follow-up|0|||
37801603|NCT01811472|69446782|FG001|Overall Study|Lost to Follow-up|0|||
37801604|NCT01811472|69446783|FG002|Overall Study|Lost to Follow-up|1|||
37801605|NCT01811472|69446781|FG000|Overall Study|Subject/guardian decision|1|||
37801606|NCT01811472|69446782|FG001|Overall Study|Subject/guardian decision|0|||
37801607|NCT01811472|69446783|FG002|Overall Study|Subject/guardian decision|0|||
37801608|NCT01811238|69446792|FG000|Overall Study|Withdrawal by Subject|42|||
37801609|NCT01811238|69446792|FG000|Overall Study|Adverse Event|25|||
37801610|NCT01811238|69446792|FG000|Overall Study|Protocol Violation|4|||
37801611|NCT01811238|69446792|FG000|Overall Study|Lack of Efficacy|4|||
37801612|NCT01811238|69446792|FG000|Overall Study|subject refused study medication|6|||
37801613|NCT01769508|69446797|FG000|Overall Study|Death|3|||
37801614|NCT01769508|69446797|FG000|Overall Study|Withdrawal by Subject|1|||
37801615|NCT01769508|69446797|FG000|Overall Study|Adverse Event|1|||
37801616|NCT01769508|69446797|FG000|Overall Study|Lost to Follow-up|1|||
37801617|NCT01810380|69446804|FG000|Overall Study|Randomised not treated|2|||
37801618|NCT01810380|69446805|FG001|Overall Study|Randomised not treated|1|||
37801619|NCT01810380|69446806|FG002|Overall Study|Randomised not treated|1|||
37801620|NCT01810380|69446804|FG000|Overall Study|Adverse Event|11|||
37801621|NCT01810380|69446805|FG001|Overall Study|Adverse Event|14|||
37801622|NCT01810380|69446806|FG002|Overall Study|Adverse Event|4|||
37801623|NCT01810380|69446804|FG000|Overall Study|Lack of Efficacy|24|||
37801624|NCT01810380|69446805|FG001|Overall Study|Lack of Efficacy|10|||
37801625|NCT01810380|69446806|FG002|Overall Study|Lack of Efficacy|11|||
37801626|NCT01810380|69446804|FG000|Overall Study|Protocol Violation|1|||
37801627|NCT01810380|69446805|FG001|Overall Study|Protocol Violation|0|||
37801628|NCT01810380|69446806|FG002|Overall Study|Protocol Violation|1|||
37801629|NCT01810380|69446804|FG000|Overall Study|Withdrawal by Subject|6|||
37864255|NCT00990184|69547842|FG000|Overall Study|Physician Decision|1|||
37801630|NCT01810380|69446805|FG001|Overall Study|Withdrawal by Subject|0|||
37801631|NCT01810380|69446806|FG002|Overall Study|Withdrawal by Subject|6|||
37801632|NCT01810380|69446804|FG000|Overall Study|Administrative or other reasons|11|||
37801633|NCT01810380|69446805|FG001|Overall Study|Administrative or other reasons|13|||
37801634|NCT01810380|69446806|FG002|Overall Study|Administrative or other reasons|9|||
37801635|NCT01769196|69446816|FG000|Overall Study|Adverse Event|24|||
37801636|NCT01769196|69446817|FG001|Overall Study|Adverse Event|20|||
37801637|NCT01769196|69446816|FG000|Overall Study|Death|21|||
37801638|NCT01769196|69446817|FG001|Overall Study|Death|26|||
37801639|NCT01769196|69446816|FG000|Overall Study|Investigator Discretion|7|||
37801640|NCT01769196|69446817|FG001|Overall Study|Investigator Discretion|3|||
37801641|NCT01769196|69446816|FG000|Overall Study|Lack of Efficacy|3|||
37801642|NCT01769196|69446817|FG001|Overall Study|Lack of Efficacy|2|||
37801643|NCT01769196|69446816|FG000|Overall Study|Progressive disease|11|||
37693970|NCT02352493|69170273|FG011|Overall Study|Pregnancy|0|||
37693971|NCT02352493|69170274|FG012|Overall Study|Pregnancy|0|||
37693972|NCT02352493|69170275|FG013|Overall Study|Pregnancy|0|||
37693973|NCT02352493|69170276|FG014|Overall Study|Pregnancy|0|||
37693974|NCT02352493|69170277|FG015|Overall Study|Pregnancy|0|||
37693975|NCT02352493|69170278|FG016|Overall Study|Pregnancy|0|||
37693976|NCT02352493|69170279|FG017|Overall Study|Pregnancy|0|||
37693977|NCT02352493|69170262|FG000|Overall Study|Withdrawal by Subject|0|||
37693978|NCT02352493|69170263|FG001|Overall Study|Withdrawal by Subject|0|||
37693979|NCT02352493|69170264|FG002|Overall Study|Withdrawal by Subject|0|||
37693980|NCT02352493|69170265|FG003|Overall Study|Withdrawal by Subject|0|||
37693981|NCT02352493|69170266|FG004|Overall Study|Withdrawal by Subject|0|||
37693982|NCT02352493|69170267|FG005|Overall Study|Withdrawal by Subject|0|||
37693983|NCT02352493|69170268|FG006|Overall Study|Withdrawal by Subject|0|||
37693984|NCT02352493|69170269|FG007|Overall Study|Withdrawal by Subject|0|||
37693985|NCT02352493|69170270|FG008|Overall Study|Withdrawal by Subject|1|||
37693986|NCT02352493|69170271|FG009|Overall Study|Withdrawal by Subject|0|||
37693987|NCT02352493|69170272|FG010|Overall Study|Withdrawal by Subject|0|||
37801644|NCT01769196|69446817|FG001|Overall Study|Progressive disease|6|||
37801645|NCT01769196|69446816|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
37801646|NCT01769196|69446817|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
37801647|NCT01769196|69446816|FG000|Overall Study|Protocol Violation|0|||
37693988|NCT02352493|69170273|FG011|Overall Study|Withdrawal by Subject|0|||
37801648|NCT01769196|69446817|FG001|Overall Study|Protocol Violation|3|||
37801649|NCT01769196|69446816|FG000|Overall Study|Study terminated by sponsor|160|||
37801650|NCT01769196|69446817|FG001|Overall Study|Study terminated by sponsor|161|||
37801651|NCT01769196|69446816|FG000|Overall Study|Participant never dosed with study drug|1|||
37801652|NCT01769196|69446817|FG001|Overall Study|Participant never dosed with study drug|0|||
37801653|NCT01769196|69446816|FG000|Overall Study|Withdrew consent|36|||
37801654|NCT01769196|69446817|FG001|Overall Study|Withdrew consent|40|||
37801655|NCT01810302|69446825|FG000|Overall Study|Death|1|||
37801656|NCT01810302|69446826|FG001|Overall Study|Death|0|||
37801657|NCT01810302|69446825|FG000|Overall Study|Physician Decision|0|||
37801658|NCT01810302|69446826|FG001|Overall Study|Physician Decision|1|||
37801659|NCT01783938|69446834|FG000|Overall Study|Disease Progression|18|||
37801660|NCT01783938|69446835|FG001|Overall Study|Disease Progression|41|||
37801661|NCT01783938|69446834|FG000|Overall Study|Study Drug Toxicity|27|||
37801662|NCT01783938|69446835|FG001|Overall Study|Study Drug Toxicity|14|||
37801663|NCT01783938|69446834|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
37801664|NCT01783938|69446835|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
37801665|NCT01783938|69446834|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
37801666|NCT01783938|69446835|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
37801667|NCT01783938|69446834|FG000|Overall Study|Participant Withdrew Consent|2|||
37801668|NCT01783938|69446835|FG001|Overall Study|Participant Withdrew Consent|0|||
37801669|NCT01783938|69446834|FG000|Overall Study|Maximum Clinical Benefit|1|||
37801670|NCT01783938|69446835|FG001|Overall Study|Maximum Clinical Benefit|0|||
37801671|NCT01783938|69446834|FG000|Overall Study|Other Reasons|3|||
37801672|NCT01783938|69446835|FG001|Overall Study|Other Reasons|1|||
37801673|NCT01768572|69446844|FG000|Overall Study|Adverse Event|7|||
37801674|NCT01768572|69446845|FG001|Overall Study|Adverse Event|8|||
37801675|NCT01768572|69446846|FG002|Overall Study|Adverse Event|4|||
37801676|NCT01768572|69446844|FG000|Overall Study|Lack of Efficacy|1|||
37801677|NCT01768572|69446845|FG001|Overall Study|Lack of Efficacy|3|||
37801678|NCT01768572|69446846|FG002|Overall Study|Lack of Efficacy|1|||
37801679|NCT01768572|69446844|FG000|Overall Study|Other, Not due to an adverse event|1|||
37801680|NCT01768572|69446845|FG001|Overall Study|Other, Not due to an adverse event|1|||
37801681|NCT01768572|69446846|FG002|Overall Study|Other, Not due to an adverse event|1|||
37801682|NCT01783548|69446856|FG000|Overall Study|Adverse Event|8|||
37801683|NCT01783548|69446857|FG001|Overall Study|Adverse Event|4|||
37801684|NCT01783548|69446856|FG000|Overall Study|Withdrawal by Subject|11|||
37801685|NCT01783548|69446857|FG001|Overall Study|Withdrawal by Subject|8|||
37801686|NCT01783548|69446856|FG000|Overall Study|Non-compliance|4|||
37801687|NCT01783548|69446857|FG001|Overall Study|Non-compliance|0|||
37801688|NCT01783548|69446856|FG000|Overall Study|Protocol Violation|2|||
37801689|NCT01783548|69446857|FG001|Overall Study|Protocol Violation|2|||
37801690|NCT01783548|69446856|FG000|Overall Study|Lost to Follow-up|8|||
37801691|NCT01783548|69446857|FG001|Overall Study|Lost to Follow-up|3|||
37801692|NCT01783548|69446856|FG000|Overall Study|Lack of Efficacy|1|||
37801693|NCT01783548|69446857|FG001|Overall Study|Lack of Efficacy|1|||
37801694|NCT01809210|69446870|FG000|Overall Study|Withdrawal by Subject|0|||
37801695|NCT01809210|69446871|FG001|Overall Study|Withdrawal by Subject|0|||
37801696|NCT01809210|69446872|FG002|Overall Study|Withdrawal by Subject|1|||
37801697|NCT01809210|69446873|FG003|Overall Study|Withdrawal by Subject|1|||
37801698|NCT01809210|69446874|FG004|Overall Study|Withdrawal by Subject|1|||
37801699|NCT01809210|69446875|FG005|Overall Study|Withdrawal by Subject|0|||
37801700|NCT01809210|69446876|FG006|Overall Study|Withdrawal by Subject|4|||
37801701|NCT01809210|69446870|FG000|Overall Study|Death|1|||
37801702|NCT01809210|69446871|FG001|Overall Study|Death|1|||
37801703|NCT01809210|69446872|FG002|Overall Study|Death|2|||
37801704|NCT01809210|69446873|FG003|Overall Study|Death|0|||
37801705|NCT01809210|69446874|FG004|Overall Study|Death|1|||
37801706|NCT01809210|69446875|FG005|Overall Study|Death|3|||
37801707|NCT01809210|69446876|FG006|Overall Study|Death|1|||
37801708|NCT01809132|69446895|FG000|Overall Study|Withdrawal by Subject|0|||
37801709|NCT01809132|69446896|FG001|Overall Study|Withdrawal by Subject|0|||
37801710|NCT01809132|69446897|FG002|Overall Study|Withdrawal by Subject|1|||
37801711|NCT01808508|69446908|FG000|Overall Study|Lost to Follow-up|1|||
37801712|NCT01808508|69446909|FG001|Overall Study|Lost to Follow-up|0|||
37801713|NCT01808508|69446910|FG002|Overall Study|Lost to Follow-up|0|||
37801714|NCT01766778|69446920|FG000|Overall Study|Adverse Event|4|||
37801715|NCT01766778|69446921|FG001|Overall Study|Adverse Event|4|||
37801716|NCT01766778|69446920|FG000|Overall Study|Withdrawal by Subject|1|||
37864256|NCT00986830|69547848|FG000|Overall Study|Death|1|||
37975739|NCT00498602|69662995|FG004|Overall Study|Caregiver Request|1|||
37975740|NCT00498602|69662996|FG005|Overall Study|Caregiver Request|2|||
37975741|NCT00498602|69662997|FG006|Overall Study|Caregiver Request|0|||
37801717|NCT01766778|69446921|FG001|Overall Study|Withdrawal by Subject|0|||
37801718|NCT01808196|69446927|FG000|Overall Study|Lost to Follow-up|1|||
37801719|NCT01808118|69446931|FG000|Period 1|Adverse Event|15|||
37864257|NCT00986830|69547848|FG000|Overall Study|Lost to Follow-up|1|||
37801720|NCT01808118|69446932|FG001|Period 1|Adverse Event|0|||
37801721|NCT01808118|69446933|FG002|Period 1|Adverse Event|0|||
37801722|NCT01808118|69446931|FG000|Period 1|Withdrew consent|24|||
37801723|NCT01808118|69446932|FG001|Period 1|Withdrew consent|0|||
37801724|NCT01808118|69446933|FG002|Period 1|Withdrew consent|0|||
37801725|NCT01808118|69446931|FG000|Period 1|Lost to Follow-up|9|||
37801726|NCT01808118|69446932|FG001|Period 1|Lost to Follow-up|0|||
37801727|NCT01808118|69446933|FG002|Period 1|Lost to Follow-up|0|||
37801728|NCT01808118|69446931|FG000|Period 1|Did not meet criteria for remission|303|||
37801729|NCT01808118|69446932|FG001|Period 1|Did not meet criteria for remission|0|||
37801730|NCT01808118|69446933|FG002|Period 1|Did not meet criteria for remission|0|||
37801731|NCT01808118|69446931|FG000|Period 1|Enrolled in error|7|||
37801732|NCT01808118|69446932|FG001|Period 1|Enrolled in error|0|||
37801733|NCT01808118|69446933|FG002|Period 1|Enrolled in error|0|||
37801734|NCT01808118|69446931|FG000|Period 1|Did not meet inclusion criteria|3|||
37801735|NCT01808118|69446932|FG001|Period 1|Did not meet inclusion criteria|0|||
37801736|NCT01808118|69446933|FG002|Period 1|Did not meet inclusion criteria|0|||
37801737|NCT01808118|69446931|FG000|Period 1|Non-conformance with inclusion criteria|3|||
37801738|NCT01808118|69446932|FG001|Period 1|Non-conformance with inclusion criteria|0|||
37801739|NCT01808118|69446933|FG002|Period 1|Non-conformance with inclusion criteria|0|||
37801740|NCT01808118|69446931|FG000|Period 1|Investigator decision: site closure|2|||
37801741|NCT01808118|69446932|FG001|Period 1|Investigator decision: site closure|0|||
37801742|NCT01808118|69446933|FG002|Period 1|Investigator decision: site closure|0|||
37801743|NCT01808118|69446931|FG000|Period 1|Non-compliance per sponsor|1|||
37801744|NCT01808118|69446932|FG001|Period 1|Non-compliance per sponsor|0|||
37801745|NCT01808118|69446933|FG002|Period 1|Non-compliance per sponsor|0|||
37801746|NCT01808118|69446931|FG000|Period 1|Lack of Efficacy|1|||
37801747|NCT01808118|69446932|FG001|Period 1|Lack of Efficacy|0|||
37801748|NCT01808118|69446933|FG002|Period 1|Lack of Efficacy|0|||
37801749|NCT01808118|69446931|FG000|Period 2|Adverse Event|0|||
37801750|NCT01808118|69446932|FG001|Period 2|Adverse Event|4|||
37801751|NCT01808118|69446933|FG002|Period 2|Adverse Event|0|||
37801752|NCT01808118|69446931|FG000|Period 2|Withdrew consent|0|||
37801753|NCT01808118|69446932|FG001|Period 2|Withdrew consent|7|||
37801754|NCT01808118|69446933|FG002|Period 2|Withdrew consent|6|||
37801755|NCT01808118|69446931|FG000|Period 2|Lost to Follow-up|0|||
37801756|NCT01808118|69446932|FG001|Period 2|Lost to Follow-up|0|||
37801757|NCT01808118|69446933|FG002|Period 2|Lost to Follow-up|2|||
37801758|NCT01808118|69446931|FG000|Period 2|Investigator no longer conducting trials|0|||
37801759|NCT01808118|69446932|FG001|Period 2|Investigator no longer conducting trials|1|||
37801760|NCT01808118|69446933|FG002|Period 2|Investigator no longer conducting trials|0|||
37801761|NCT01808118|69446931|FG000|Period 2|Switched to other therapy|0|||
37801762|NCT01808118|69446932|FG001|Period 2|Switched to other therapy|1|||
37801763|NCT01808118|69446933|FG002|Period 2|Switched to other therapy|0|||
37801764|NCT01807650|69446947|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
37801765|NCT01807650|69446947|FG000|Overall Study|Adverse Event|5|||
37801766|NCT01807650|69446947|FG000|Overall Study|Other|2|||
37801767|NCT01782690|69446988|FG000|Overall Study|Not reported|7|||
37801768|NCT01782690|69446988|FG000|Overall Study|Toxicity of gemcitabine|1|||
37801769|NCT01782690|69446988|FG000|Overall Study|Toxicity of erlotinib|1|||
37801770|NCT01782690|69446988|FG000|Overall Study|Lost to Follow-up|31|||
37801771|NCT01782690|69446988|FG000|Overall Study|Withdrawal of informed consent|2|||
37801772|NCT01782690|69446988|FG000|Overall Study|Absent rash|9|||
37801773|NCT01782690|69446988|FG000|Overall Study|Physician Decision|13|||
37801774|NCT01782690|69446988|FG000|Overall Study|Patient's wish|21|||
37801775|NCT01782690|69446988|FG000|Overall Study|Tumor progression|74|||
37801776|NCT01782690|69446988|FG000|Overall Study|Death|133|||
37801777|NCT01782690|69446988|FG000|Overall Study|Study completion unknown|7|||
37801778|NCT01782378|69446994|FG000|First Series|Lost to Follow-up|7|||
37801779|NCT01782378|69446995|FG001|First Series|Lost to Follow-up|8|||
37801780|NCT01782378|69446994|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
37801781|NCT01782378|69446995|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
37801782|NCT01782378|69446994|FG000|Second Series|Lost to Follow-up|8|||
37801783|NCT01782378|69446995|FG001|Second Series|Lost to Follow-up|7|||
37801784|NCT01782378|69446994|FG000|Second Series|Did not choose to complete S2 Optional|18|||
37801785|NCT01782378|69446995|FG001|Second Series|Did not choose to complete S2 Optional|0|||
37801786|NCT01766310|69447003|FG000|Overall Study|Lost to Follow-up|1|||
37801787|NCT01766310|69447004|FG001|Overall Study|Lost to Follow-up|3|||
37801788|NCT01765920|69447012|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
37801789|NCT01765920|69447013|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
37801790|NCT01765920|69447012|FG000|Overall Study|Patient code disclosure|0|||
37801791|NCT01765920|69447013|FG001|Overall Study|Patient code disclosure|1|||
37801792|NCT01782222|69447022|FG000|Overall Study|Adverse Event|4|||
37801793|NCT01782222|69447023|FG001|Overall Study|Adverse Event|5|||
37801794|NCT01782222|69447024|FG002|Overall Study|Adverse Event|3|||
37801795|NCT01782222|69447022|FG000|Overall Study|Lack of Efficacy|2|||
37801796|NCT01782222|69447023|FG001|Overall Study|Lack of Efficacy|1|||
37801797|NCT01782222|69447024|FG002|Overall Study|Lack of Efficacy|0|||
37801798|NCT01782222|69447022|FG000|Overall Study|Protocol Violation|1|||
37801799|NCT01782222|69447023|FG001|Overall Study|Protocol Violation|0|||
37801800|NCT01782222|69447024|FG002|Overall Study|Protocol Violation|0|||
37801801|NCT01782222|69447022|FG000|Overall Study|Withdrawal by Subject|1|||
37801802|NCT01782222|69447023|FG001|Overall Study|Withdrawal by Subject|4|||
37801803|NCT01782222|69447024|FG002|Overall Study|Withdrawal by Subject|1|||
37801804|NCT01782222|69447022|FG000|Overall Study|Moved to other state|0|||
37801805|NCT01782222|69447023|FG001|Overall Study|Moved to other state|1|||
37801806|NCT01782222|69447024|FG002|Overall Study|Moved to other state|0|||
37801807|NCT01781832|69447032|FG000|Overall Study|Withdrawal by Subject|1|||
37801808|NCT01807182|69447036|FG000|Overall Study|Death|1|||
37801809|NCT01807182|69447036|FG000|Overall Study|New therapy|1|||
37801810|NCT01807182|69447036|FG000|Overall Study|Moved to hospice care|1|||
37801811|NCT01806714|69447042|FG000|Overall Study|No functioning phone number|200|||
37801812|NCT01806714|69447043|FG001|Overall Study|No functioning phone number|170|||
37801813|NCT01765764|69447052|FG000|Treatment Period|Adverse Event|1|||
37801814|NCT01765764|69447053|FG001|Treatment Period|Adverse Event|2|||
37801815|NCT01765764|69447054|FG002|Treatment Period|Adverse Event|1|||
37801816|NCT01765764|69447052|FG000|Treatment Period|Lost to Follow-up|0|||
37801817|NCT01765764|69447053|FG001|Treatment Period|Lost to Follow-up|3|||
37801818|NCT01765764|69447054|FG002|Treatment Period|Lost to Follow-up|2|||
37801819|NCT01765764|69447052|FG000|Treatment Period|Personal Reasons|1|||
37801820|NCT01765764|69447053|FG001|Treatment Period|Personal Reasons|2|||
37801821|NCT01765764|69447054|FG002|Treatment Period|Personal Reasons|1|||
37801822|NCT01765764|69447052|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
37801823|NCT01765764|69447053|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
37801824|NCT01765764|69447054|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
37801825|NCT01806168|69447065|FG000|Overall Study|Adverse Event|1|||
37801826|NCT01806168|69447066|FG001|Overall Study|Adverse Event|0|||
37801827|NCT01806168|69447067|FG002|Overall Study|Adverse Event|0|||
37801828|NCT01806168|69447065|FG000|Overall Study|Withdrawal by Subject|0|||
37801829|NCT01806168|69447066|FG001|Overall Study|Withdrawal by Subject|1|||
37801830|NCT01806168|69447067|FG002|Overall Study|Withdrawal by Subject|2|||
37801831|NCT01806168|69447065|FG000|Overall Study|Protocol Violation|0|||
37801832|NCT01806168|69447066|FG001|Overall Study|Protocol Violation|0|||
37801833|NCT01806168|69447067|FG002|Overall Study|Protocol Violation|1|||
37801834|NCT01804842|69447081|FG000|Overall Study|Adverse Event|1|||
37801835|NCT01804842|69447082|FG001|Overall Study|Adverse Event|1|||
37801836|NCT01804842|69447083|FG002|Overall Study|Adverse Event|0|||
37801837|NCT01804842|69447081|FG000|Overall Study|Lost to Follow-up|1|||
37801838|NCT01804842|69447082|FG001|Overall Study|Lost to Follow-up|0|||
37801839|NCT01804842|69447083|FG002|Overall Study|Lost to Follow-up|0|||
37801840|NCT01804842|69447081|FG000|Overall Study|Non-Compliance|1|||
37801841|NCT01804842|69447082|FG001|Overall Study|Non-Compliance|1|||
37801842|NCT01804842|69447083|FG002|Overall Study|Non-Compliance|0|||
37801843|NCT01804842|69447081|FG000|Overall Study|Personal Reason|0|||
37801844|NCT01804842|69447082|FG001|Overall Study|Personal Reason|0|||
37801845|NCT01804842|69447083|FG002|Overall Study|Personal Reason|1|||
37801846|NCT01781286|69447091|FG000|Overall Study|Lost to Follow-up|0|||
37801847|NCT01781286|69447092|FG001|Overall Study|Lost to Follow-up|0|||
37801848|NCT01781286|69447093|FG002|Overall Study|Lost to Follow-up|0|||
37801849|NCT01781286|69447094|FG003|Overall Study|Lost to Follow-up|0|||
37801850|NCT01781286|69447095|FG004|Overall Study|Lost to Follow-up|0|||
37801851|NCT01781286|69447096|FG005|Overall Study|Lost to Follow-up|1|||
37801852|NCT01781286|69447091|FG000|Overall Study|Time Constraints|2|||
37801853|NCT01781286|69447092|FG001|Overall Study|Time Constraints|0|||
37801854|NCT01781286|69447093|FG002|Overall Study|Time Constraints|2|||
37801855|NCT01781286|69447094|FG003|Overall Study|Time Constraints|0|||
37801856|NCT01781286|69447095|FG004|Overall Study|Time Constraints|0|||
37801857|NCT01781286|69447096|FG005|Overall Study|Time Constraints|0|||
37801858|NCT01781286|69447091|FG000|Overall Study|Noncompliance|0|||
37801859|NCT01781286|69447092|FG001|Overall Study|Noncompliance|0|||
37801860|NCT01781286|69447093|FG002|Overall Study|Noncompliance|0|||
37975742|NCT00498602|69662991|FG000|Overall Study|Investigator Request|0|||
37975743|NCT00498602|69662992|FG001|Overall Study|Investigator Request|0|||
37801861|NCT01781286|69447094|FG003|Overall Study|Noncompliance|1|||
37801862|NCT01781286|69447095|FG004|Overall Study|Noncompliance|0|||
37801863|NCT01781286|69447096|FG005|Overall Study|Noncompliance|0|||
37801864|NCT01780974|69447108|FG000|Overall Study|Death|1|||
37801865|NCT01780974|69447109|FG001|Overall Study|Death|0|||
37801866|NCT01780974|69447108|FG000|Overall Study|Adverse Event|1|||
37801867|NCT01780974|69447109|FG001|Overall Study|Adverse Event|3|||
37801868|NCT01780662|69447118|FG000|Overall Study|Adverse Event|1|||
37801869|NCT01780662|69447119|FG001|Overall Study|Adverse Event|0|||
37801870|NCT01780662|69447120|FG002|Overall Study|Adverse Event|2|||
37801871|NCT01780662|69447118|FG000|Overall Study|Physician Decision|0|||
37801872|NCT01780662|69447119|FG001|Overall Study|Physician Decision|5|||
37801873|NCT01780662|69447120|FG002|Overall Study|Physician Decision|7|||
37801874|NCT01780662|69447118|FG000|Overall Study|Protocol Violation|0|||
37801875|NCT01780662|69447119|FG001|Overall Study|Protocol Violation|1|||
37801876|NCT01780662|69447120|FG002|Overall Study|Protocol Violation|0|||
37801877|NCT01780662|69447118|FG000|Overall Study|Ineligible|0|||
37801878|NCT01780662|69447119|FG001|Overall Study|Ineligible|0|||
37801879|NCT01780662|69447120|FG002|Overall Study|Ineligible|1|||
37801880|NCT01780584|69447132|FG000|Overall Study|Death|1|||
37801881|NCT01780584|69447133|FG001|Overall Study|Death|0|||
37801882|NCT01780584|69447134|FG002|Overall Study|Death|1|||
37801883|NCT01780584|69447132|FG000|Overall Study|Adverse Event|0|||
37801884|NCT01780584|69447133|FG001|Overall Study|Adverse Event|1|||
37801885|NCT01780584|69447134|FG002|Overall Study|Adverse Event|0|||
37801886|NCT01780584|69447132|FG000|Overall Study|Protocol Violation|0|||
37801887|NCT01780584|69447133|FG001|Overall Study|Protocol Violation|0|||
37801888|NCT01780584|69447134|FG002|Overall Study|Protocol Violation|1|||
37801889|NCT01780506|69447144|FG000|Double-Blind Phase|Randomized but not Treated|3|||
37801890|NCT01780506|69447145|FG001|Double-Blind Phase|Randomized but not Treated|2|||
37801891|NCT01780506|69447144|FG000|Double-Blind Phase|Adverse Event|4|||
37801892|NCT01780506|69447145|FG001|Double-Blind Phase|Adverse Event|14|||
37801893|NCT01780506|69447144|FG000|Double-Blind Phase|Death|1|||
37801894|NCT01780506|69447145|FG001|Double-Blind Phase|Death|2|||
37801895|NCT01780506|69447144|FG000|Double-Blind Phase|Pregnancy|2|||
37801896|NCT01780506|69447145|FG001|Double-Blind Phase|Pregnancy|1|||
37801897|NCT01780506|69447144|FG000|Double-Blind Phase|Lack of Efficacy|1|||
37801898|NCT01780506|69447145|FG001|Double-Blind Phase|Lack of Efficacy|1|||
37801899|NCT01780506|69447144|FG000|Double-Blind Phase|Investigator's Discretion|5|||
37801900|NCT01780506|69447145|FG001|Double-Blind Phase|Investigator's Discretion|2|||
37801901|NCT01780506|69447144|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
37801902|NCT01780506|69447145|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
37801903|NCT01780506|69447144|FG000|Double-Blind Phase|Protocol Violation|4|||
37801904|NCT01780506|69447145|FG001|Double-Blind Phase|Protocol Violation|3|||
37801905|NCT01780506|69447144|FG000|Double-Blind Phase|Withdrew Consent|23|||
37801906|NCT01780506|69447145|FG001|Double-Blind Phase|Withdrew Consent|24|||
37801907|NCT01780506|69447144|FG000|Double-Blind Phase|Lost to Follow-up|23|||
37801908|NCT01780506|69447145|FG001|Double-Blind Phase|Lost to Follow-up|26|||
37801909|NCT01780506|69447144|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
37801910|NCT01780506|69447145|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
37801911|NCT01779648|69447155|FG000|Overall Study|Protocol Violation|1|||
37801912|NCT01779648|69447156|FG001|Overall Study|Protocol Violation|0|||
37801913|NCT01762800|69447164|FG000|Overall Study|Adverse Event|8|||
37801914|NCT01762800|69447165|FG001|Overall Study|Adverse Event|13|||
37801915|NCT01762800|69447164|FG000|Overall Study|Lack of Efficacy|3|||
37801916|NCT01762800|69447165|FG001|Overall Study|Lack of Efficacy|2|||
37801917|NCT01762800|69447164|FG000|Overall Study|Study Closed/Terminated|0|||
37801918|NCT01762800|69447165|FG001|Overall Study|Study Closed/Terminated|1|||
37801919|NCT01762800|69447164|FG000|Overall Study|Physician Decision|1|||
37801920|NCT01762800|69447165|FG001|Overall Study|Physician Decision|1|||
37801921|NCT01762800|69447164|FG000|Overall Study|Withdrawal by Subject|7|||
37801922|NCT01762800|69447165|FG001|Overall Study|Withdrawal by Subject|4|||
37801923|NCT01597596|69447179|FG000|Overall Study|Study terminated by sponsor|1|||
37801924|NCT01597596|69447180|FG001|Overall Study|Study terminated by sponsor|0|||
37801925|NCT01597596|69447179|FG000|Overall Study|Physician Decision|0|||
37801926|NCT01597596|69447180|FG001|Overall Study|Physician Decision|1|||
37801927|NCT01778556|69447188|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
37801928|NCT01778556|69447189|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
37801929|NCT01778556|69447188|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
37801930|NCT01778556|69447189|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
37801931|NCT01778556|69447188|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
37801932|NCT01778556|69447189|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
37801933|NCT01778556|69447188|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
37801934|NCT01778556|69447189|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
37801935|NCT01761162|69447198|FG000|Overall Study|Withdrawal by Subject|3|||
37801936|NCT01778010|69447202|FG000|Overall Study|Withdrawal by Subject|2|||
37801937|NCT01778010|69447202|FG000|Overall Study|abnormal ECG before meds|1|||
37801938|NCT01778010|69447202|FG000|Overall Study|Arrested|1|||
37801939|NCT01778010|69447202|FG000|Overall Study|rash while on placebo|1|||
37801940|NCT01777932|69447219|FG000|Overall Study|Disease progression|136|||
37801941|NCT01777932|69447219|FG000|Overall Study|Death|3|||
37801942|NCT01777932|69447219|FG000|Overall Study|Adverse Event|34|||
37801943|NCT01777932|69447219|FG000|Overall Study|Lost to Follow-up|3|||
37801944|NCT01777932|69447219|FG000|Overall Study|Investigator decision|10|||
37801945|NCT01777932|69447219|FG000|Overall Study|Reimbursement limit|9|||
37801946|NCT01777932|69447219|FG000|Overall Study|Patient refused further treatment|10|||
37801947|NCT01777854|69447223|FG000|Overall Study|Physician Decision|3|||
37801948|NCT01777854|69447224|FG001|Overall Study|Physician Decision|3|||
37801949|NCT01777776|69447232|FG000|Overall Study|Adverse Event|2|||
37801950|NCT01777776|69447233|FG001|Overall Study|Adverse Event|4|||
37801951|NCT01777776|69447234|FG002|Overall Study|Adverse Event|0|||
37801952|NCT01777776|69447235|FG003|Overall Study|Adverse Event|0|||
37801953|NCT01777776|69447232|FG000|Overall Study|Disease Progression|4|||
37801954|NCT01777776|69447233|FG001|Overall Study|Disease Progression|8|||
37801955|NCT01777776|69447234|FG002|Overall Study|Disease Progression|6|||
37801956|NCT01777776|69447235|FG003|Overall Study|Disease Progression|3|||
37801957|NCT01777776|69447232|FG000|Overall Study|Withdrawal by Subject|0|||
37801958|NCT01777776|69447233|FG001|Overall Study|Withdrawal by Subject|0|||
37801959|NCT01777776|69447234|FG002|Overall Study|Withdrawal by Subject|0|||
37801960|NCT01777776|69447235|FG003|Overall Study|Withdrawal by Subject|1|||
37801961|NCT01777620|69447256|FG000|Overall Study|Subject Withdrawal|1|||
37801962|NCT01777620|69447257|FG001|Overall Study|Subject Withdrawal|0|||
37801963|NCT01777542|69447263|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
37801964|NCT01777542|69447264|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
37801965|NCT01736124|69447273|FG000|Post-intervention Assessment|Death|2|||
37801966|NCT01736124|69447274|FG001|Post-intervention Assessment|Death|2|||
37801967|NCT01736124|69447273|FG000|Post-intervention Assessment|lost computer access|1|||
37801968|NCT01736124|69447274|FG001|Post-intervention Assessment|lost computer access|1|||
37801969|NCT01736124|69447273|FG000|Post-intervention Assessment|Moved away|3|||
37801970|NCT01736124|69447274|FG001|Post-intervention Assessment|Moved away|1|||
37801971|NCT01736124|69447273|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
37801972|NCT01736124|69447274|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
37801973|NCT01736124|69447273|FG000|Post-intervention Assessment|Illness|3|||
37801974|NCT01736124|69447274|FG001|Post-intervention Assessment|Illness|2|||
37801975|NCT01736124|69447273|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
37801976|NCT01736124|69447274|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
37801977|NCT01736124|69447273|FG000|Post-intervention Assessment|Temporarily away|3|||
37801978|NCT01736124|69447274|FG001|Post-intervention Assessment|Temporarily away|1|||
37801979|NCT01736124|69447273|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
37801980|NCT01736124|69447274|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
37801981|NCT01736124|69447273|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
37801982|NCT01736124|69447274|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
37801983|NCT01736124|69447273|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
37801984|NCT01736124|69447274|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
37801985|NCT01736124|69447273|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
37801986|NCT01736124|69447274|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
37801987|NCT01736124|69447273|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
37801988|NCT01736124|69447274|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
37801989|NCT01736124|69447273|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
37801990|NCT01736124|69447274|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
37801991|NCT01736124|69447273|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
37801992|NCT01736124|69447274|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
37801993|NCT01736124|69447273|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
37801994|NCT01736124|69447274|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
37801995|NCT01736124|69447273|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
37801996|NCT01736124|69447274|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
37801997|NCT01759446|69447287|FG000|Overall Study|Protocol Violation|1|||
37801998|NCT01759446|69447288|FG001|Overall Study|Protocol Violation|0|||
37801999|NCT01759446|69447289|FG002|Overall Study|Protocol Violation|1|||
37802000|NCT01759446|69447290|FG003|Overall Study|Protocol Violation|0|||
37802001|NCT01759446|69447291|FG004|Overall Study|Protocol Violation|0|||
37802002|NCT01759446|69447287|FG000|Overall Study|Withdrawal by Subject|0|||
37864258|NCT00986830|69547848|FG000|Overall Study|Lack of Efficacy|1|||
37802003|NCT01759446|69447288|FG001|Overall Study|Withdrawal by Subject|1|||
37802004|NCT01759446|69447289|FG002|Overall Study|Withdrawal by Subject|0|||
37802005|NCT01759446|69447290|FG003|Overall Study|Withdrawal by Subject|1|||
37802006|NCT01759446|69447291|FG004|Overall Study|Withdrawal by Subject|0|||
37802007|NCT01777308|69447305|FG000|Overall Study|Withdrawal by Subject|5|||
37802008|NCT01777308|69447306|FG001|Overall Study|Withdrawal by Subject|1|||
37802009|NCT01777308|69447305|FG000|Overall Study|Migrated/moved from study area|1|||
37802010|NCT01777308|69447306|FG001|Overall Study|Migrated/moved from study area|0|||
37802011|NCT01777308|69447305|FG000|Overall Study|Lost to Follow-up|7|||
37802012|NCT01777308|69447306|FG001|Overall Study|Lost to Follow-up|2|||
37802013|NCT01777308|69447305|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
37802014|NCT01777308|69447306|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
37802015|NCT01759368|69447315|FG000|Overall Study|Lost to Follow-up|1|||
37802016|NCT01759368|69447316|FG001|Overall Study|Lost to Follow-up|0|||
37802017|NCT01777152|69447326|FG000|Overall Study|Withdrawal by Subject|22|||
37802018|NCT01777152|69447327|FG001|Overall Study|Withdrawal by Subject|16|||
37802019|NCT01777152|69447326|FG000|Overall Study|Lost to Follow-up|3|||
37802020|NCT01777152|69447327|FG001|Overall Study|Lost to Follow-up|5|||
37802021|NCT01777152|69447326|FG000|Overall Study|Death|68|||
37802022|NCT01777152|69447327|FG001|Overall Study|Death|89|||
37802023|NCT01777152|69447326|FG000|Overall Study|Not eligible, no study drug received|1|||
37802024|NCT01777152|69447327|FG001|Overall Study|Not eligible, no study drug received|0|||
37802025|NCT01777152|69447326|FG000|Overall Study|Change of diagnosis|1|||
37802026|NCT01777152|69447327|FG001|Overall Study|Change of diagnosis|0|||
37802027|NCT01759290|69447334|FG000|Overall Study|Subjects withdrawn consent|5|||
37802028|NCT01759290|69447334|FG000|Overall Study|Physician Decision|2|||
37802029|NCT01759290|69447334|FG000|Overall Study|Death|17|||
37802030|NCT01759290|69447334|FG000|Overall Study|Lost to Follow-up|53|||
37802031|NCT01759290|69447334|FG000|Overall Study|Unknown reason|4|||
37802032|NCT01758900|69447340|FG000|Overall Study|difficulty for further intubation|7|||
37802033|NCT01758900|69447341|FG001|Overall Study|difficulty for further intubation|8|||
37802034|NCT01757184|69447349|FG000|Double-blind Period|Adverse Event|1|||
37802035|NCT01757184|69447350|FG001|Double-blind Period|Adverse Event|0|||
37802036|NCT01757184|69447351|FG002|Double-blind Period|Adverse Event|0|||
37802037|NCT01757184|69447352|FG003|Double-blind Period|Adverse Event|0|||
37802038|NCT01757184|69447349|FG000|Open-label Period|Lost to Follow-up|0|||
37802039|NCT01757184|69447350|FG001|Open-label Period|Lost to Follow-up|0|||
37802040|NCT01757184|69447351|FG002|Open-label Period|Lost to Follow-up|2|||
37802041|NCT01757184|69447352|FG003|Open-label Period|Lost to Follow-up|0|||
37802042|NCT01757184|69447349|FG000|Open-label Period|Withdrawal by Subject|0|||
37802043|NCT01757184|69447350|FG001|Open-label Period|Withdrawal by Subject|0|||
37802044|NCT01757184|69447351|FG002|Open-label Period|Withdrawal by Subject|1|||
37802045|NCT01757184|69447352|FG003|Open-label Period|Withdrawal by Subject|1|||
37802046|NCT01757184|69447349|FG000|Open-label Period|Discontinued by Sponsor|0|||
37802047|NCT01757184|69447350|FG001|Open-label Period|Discontinued by Sponsor|0|||
37802048|NCT01757184|69447351|FG002|Open-label Period|Discontinued by Sponsor|1|||
37802049|NCT01757184|69447352|FG003|Open-label Period|Discontinued by Sponsor|2|||
37802050|NCT01775904|69447366|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
37802051|NCT01775904|69447366|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
37802052|NCT01775670|69447378|FG000|Overall Study|Lost to Follow-up|1|||
37802053|NCT01775670|69447379|FG001|Overall Study|Lost to Follow-up|1|||
37802054|NCT01775124|69447387|FG000|Core Period|Disease Progression|0|||
37802055|NCT01775124|69447388|FG001|Core Period|Disease Progression|1|||
37802056|NCT01775124|69447387|FG000|Core Period|Physician Decision|1|||
37802057|NCT01775124|69447388|FG001|Core Period|Physician Decision|1|||
37802058|NCT01775124|69447387|FG000|Core Period|Death|0|||
37802059|NCT01775124|69447388|FG001|Core Period|Death|1|||
37802060|NCT01775124|69447387|FG000|Core Period|Administrative problems|1|||
37802061|NCT01775124|69447388|FG001|Core Period|Administrative problems|0|||
37802062|NCT01775124|69447387|FG000|Core Period|Withdrawal by Subject|4|||
37802063|NCT01775124|69447388|FG001|Core Period|Withdrawal by Subject|2|||
37802064|NCT01775124|69447387|FG000|Core Period|Adverse Event|5|||
37802065|NCT01775124|69447388|FG001|Core Period|Adverse Event|5|||
37802066|NCT01775124|69447387|FG000|Extension Period|Adverse Event|3|||
37802067|NCT01775124|69447388|FG001|Extension Period|Adverse Event|2|||
37802068|NCT01775124|69447387|FG000|Extension Period|Physician Decision|0|||
37802069|NCT01775124|69447388|FG001|Extension Period|Physician Decision|2|||
37802070|NCT01775124|69447387|FG000|Extension Period|Administrative problems|0|||
37802071|NCT01775124|69447388|FG001|Extension Period|Administrative problems|1|||
37802072|NCT01775124|69447387|FG000|Extension Period|Lost to Follow-up|0|||
37975744|NCT00498602|69662993|FG002|Overall Study|Investigator Request|1|||
37975745|NCT00498602|69662994|FG003|Overall Study|Investigator Request|0|||
37975746|NCT00498602|69662995|FG004|Overall Study|Investigator Request|0|||
37975747|NCT00498602|69662996|FG005|Overall Study|Investigator Request|0|||
37975748|NCT00498602|69662997|FG006|Overall Study|Investigator Request|0|||
37802073|NCT01775124|69447388|FG001|Extension Period|Lost to Follow-up|1|||
37802074|NCT01775124|69447387|FG000|Extension Period|Withdrawal by Subject|9|||
37802075|NCT01775124|69447388|FG001|Extension Period|Withdrawal by Subject|12|||
37802076|NCT01733316|69447395|FG000|RP103 Phase|Non-compliance|1|||
37802077|NCT01733316|69447395|FG000|Long Term Extension Phase|Adverse Event|1|||
37802078|NCT01733316|69447395|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
37802079|NCT01733316|69447395|FG000|Long Term Extension Phase|Sponsor Decision|2|||
37802080|NCT01732926|69447408|FG000|Overall Study|Study Terminated by Sponsor|168|||
37802081|NCT01732926|69447409|FG001|Overall Study|Study Terminated by Sponsor|80|||
37802082|NCT01732926|69447408|FG000|Overall Study|Withdrawal by Subject|46|||
37802083|NCT01732926|69447409|FG001|Overall Study|Withdrawal by Subject|8|||
37802084|NCT01732926|69447408|FG000|Overall Study|Physician Decision|24|||
37802085|NCT01732926|69447409|FG001|Overall Study|Physician Decision|11|||
37802086|NCT01732926|69447408|FG000|Overall Study|Other Reason|21|||
37802087|NCT01732926|69447409|FG001|Overall Study|Other Reason|4|||
37802088|NCT01732926|69447408|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
37802089|NCT01732926|69447409|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
37802090|NCT01732926|69447408|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
37802091|NCT01732926|69447409|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
37802092|NCT01755858|69447417|FG000|Overall Study|Adverse Event|1|||
37802093|NCT01755858|69447418|FG001|Overall Study|Adverse Event|1|||
37802094|NCT01732770|69447428|FG000|Overall Study|Lost to Follow-up|2|||
37802095|NCT01732770|69447429|FG001|Overall Study|Lost to Follow-up|3|||
37802096|NCT01732770|69447428|FG000|Overall Study|Withdrawal by Subject|5|||
37802097|NCT01732770|69447429|FG001|Overall Study|Withdrawal by Subject|3|||
37802098|NCT01732770|69447428|FG000|Overall Study|Decision by Sponsor|2|||
37802099|NCT01732770|69447429|FG001|Overall Study|Decision by Sponsor|2|||
37802100|NCT01732770|69447428|FG000|Overall Study|Death|1|||
37802101|NCT01732770|69447429|FG001|Overall Study|Death|0|||
37802102|NCT01732692|69447437|FG000|Overall Study|Adverse Event|0|||
37802103|NCT01732692|69447438|FG001|Overall Study|Adverse Event|1|||
37802104|NCT01774968|69447446|FG000|Overall Study|Adverse Event|4|||
37802105|NCT01774968|69447447|FG001|Overall Study|Adverse Event|4|||
37802106|NCT01774968|69447446|FG000|Overall Study|Death|0|||
37802107|NCT01774968|69447447|FG001|Overall Study|Death|1|||
37802108|NCT01774968|69447446|FG000|Overall Study|Lost to Follow-up|1|||
37802109|NCT01774968|69447447|FG001|Overall Study|Lost to Follow-up|3|||
37802110|NCT01774968|69447446|FG000|Overall Study|Physician Decision|5|||
37802111|NCT01774968|69447447|FG001|Overall Study|Physician Decision|1|||
37802112|NCT01774968|69447446|FG000|Overall Study|Protocol Violation|14|||
37802113|NCT01774968|69447447|FG001|Overall Study|Protocol Violation|13|||
37802114|NCT01774968|69447446|FG000|Overall Study|Sponsor Decision|0|||
37802115|NCT01774968|69447447|FG001|Overall Study|Sponsor Decision|2|||
37802116|NCT01774968|69447446|FG000|Overall Study|Withdrawal by Subject|6|||
37802117|NCT01774968|69447447|FG001|Overall Study|Withdrawal by Subject|11|||
37802118|NCT01774344|69447455|FG000|Overall Study|Withdrawal by Subject|3|||
37802119|NCT01774344|69447456|FG001|Overall Study|Withdrawal by Subject|10|||
37802120|NCT01774344|69447455|FG000|Overall Study|Protocol Violation|0|||
37802121|NCT01774344|69447456|FG001|Overall Study|Protocol Violation|1|||
37802122|NCT01774344|69447455|FG000|Overall Study|Lost to Follow-up|4|||
37802123|NCT01774344|69447456|FG001|Overall Study|Lost to Follow-up|10|||
37802124|NCT01774344|69447455|FG000|Overall Study|End of survival follow-up not available|2|||
37802125|NCT01774344|69447456|FG001|Overall Study|End of survival follow-up not available|2|||
37802126|NCT01774344|69447455|FG000|Overall Study|Data collection finished|4|||
37802127|NCT01774344|69447456|FG001|Overall Study|Data collection finished|14|||
37802128|NCT01774344|69447455|FG000|Overall Study|Other|0|||
37802129|NCT01774344|69447456|FG001|Overall Study|Other|1|||
37802130|NCT01774344|69447455|FG000|Overall Study|Did not enter Survival Follow up|49|||
37802131|NCT01774344|69447456|FG001|Overall Study|Did not enter Survival Follow up|83|||
37802132|NCT01732536|69447464|FG000|Overall Study|Withdrawal by Subject|1|||
37802133|NCT01732536|69447465|FG001|Overall Study|Withdrawal by Subject|1|||
37802134|NCT01755702|69447474|FG000|Wash Out Period I|Other Reason|3|||
37802135|NCT01755702|69447474|FG000|Washout Period II|Other Reason|5|||
37802136|NCT01732458|69447488|FG000|Overall Study|Lost to Follow-up|0|||
37802137|NCT01732458|69447489|FG001|Overall Study|Lost to Follow-up|2|||
37802138|NCT01732458|69447490|FG002|Overall Study|Lost to Follow-up|0|||
37802139|NCT01732458|69447491|FG003|Overall Study|Lost to Follow-up|0|||
37802140|NCT01732458|69447488|FG000|Overall Study|Non-Compliance With Study Drug|0|||
37802141|NCT01732458|69447489|FG001|Overall Study|Non-Compliance With Study Drug|0|||
37802142|NCT01732458|69447490|FG002|Overall Study|Non-Compliance With Study Drug|1|||
37802143|NCT01732458|69447491|FG003|Overall Study|Non-Compliance With Study Drug|0|||
37802144|NCT01732458|69447488|FG000|Overall Study|Physician Decision|1|||
37802145|NCT01732458|69447489|FG001|Overall Study|Physician Decision|2|||
37802146|NCT01732458|69447490|FG002|Overall Study|Physician Decision|2|||
37802147|NCT01732458|69447491|FG003|Overall Study|Physician Decision|0|||
37802148|NCT01732458|69447488|FG000|Overall Study|Protocol Violation|2|||
37802149|NCT01732458|69447489|FG001|Overall Study|Protocol Violation|0|||
37802150|NCT01732458|69447490|FG002|Overall Study|Protocol Violation|0|||
37802151|NCT01732458|69447491|FG003|Overall Study|Protocol Violation|2|||
37802152|NCT01732458|69447488|FG000|Overall Study|Screen Failure|0|||
37802153|NCT01732458|69447489|FG001|Overall Study|Screen Failure|1|||
37802154|NCT01732458|69447490|FG002|Overall Study|Screen Failure|0|||
37802155|NCT01732458|69447491|FG003|Overall Study|Screen Failure|0|||
37802156|NCT01731990|69447515|FG000|Overall Study|Adverse Event|1|||
37802157|NCT01731990|69447516|FG001|Overall Study|Adverse Event|5|||
37802158|NCT01731990|69447515|FG000|Overall Study|Withdrawal by Subject|1|||
37802159|NCT01731990|69447516|FG001|Overall Study|Withdrawal by Subject|1|||
37802160|NCT01731990|69447515|FG000|Overall Study|Protocol deviation|1|||
37802161|NCT01731990|69447516|FG001|Overall Study|Protocol deviation|2|||
37802162|NCT01731990|69447515|FG000|Overall Study|Death|1|||
37802163|NCT01731990|69447516|FG001|Overall Study|Death|0|||
37802164|NCT01708902|69447529|FG000|Overall Study|Adverse Event|3|||
37802165|NCT01708902|69447530|FG001|Overall Study|Adverse Event|4|||
37802166|NCT01708902|69447531|FG002|Overall Study|Adverse Event|9|||
37802167|NCT01708902|69447532|FG003|Overall Study|Adverse Event|2|||
37802168|NCT01708902|69447533|FG004|Overall Study|Adverse Event|7|||
37802169|NCT01708902|69447534|FG005|Overall Study|Adverse Event|3|||
37802170|NCT01708902|69447535|FG006|Overall Study|Adverse Event|5|||
37802171|NCT01708902|69447529|FG000|Overall Study|Lack of Efficacy|3|||
37802172|NCT01708902|69447530|FG001|Overall Study|Lack of Efficacy|1|||
37802173|NCT01708902|69447531|FG002|Overall Study|Lack of Efficacy|0|||
37802174|NCT01708902|69447532|FG003|Overall Study|Lack of Efficacy|0|||
37802175|NCT01708902|69447533|FG004|Overall Study|Lack of Efficacy|0|||
37802176|NCT01708902|69447534|FG005|Overall Study|Lack of Efficacy|1|||
37802177|NCT01708902|69447535|FG006|Overall Study|Lack of Efficacy|0|||
37802178|NCT01708902|69447529|FG000|Overall Study|Non compliance with protocol|0|||
37802179|NCT01708902|69447530|FG001|Overall Study|Non compliance with protocol|2|||
37802180|NCT01708902|69447531|FG002|Overall Study|Non compliance with protocol|1|||
37802181|NCT01708902|69447532|FG003|Overall Study|Non compliance with protocol|3|||
37802182|NCT01708902|69447533|FG004|Overall Study|Non compliance with protocol|0|||
37802183|NCT01708902|69447534|FG005|Overall Study|Non compliance with protocol|0|||
37802184|NCT01708902|69447535|FG006|Overall Study|Non compliance with protocol|0|||
37802185|NCT01708902|69447529|FG000|Overall Study|Lost to Follow-up|2|||
37802186|NCT01708902|69447530|FG001|Overall Study|Lost to Follow-up|1|||
37802187|NCT01708902|69447531|FG002|Overall Study|Lost to Follow-up|2|||
37802188|NCT01708902|69447532|FG003|Overall Study|Lost to Follow-up|2|||
37802189|NCT01708902|69447533|FG004|Overall Study|Lost to Follow-up|0|||
37802190|NCT01708902|69447534|FG005|Overall Study|Lost to Follow-up|0|||
37802191|NCT01708902|69447535|FG006|Overall Study|Lost to Follow-up|1|||
37802192|NCT01708902|69447529|FG000|Overall Study|Refused to continue trial medication|8|||
37802193|NCT01708902|69447530|FG001|Overall Study|Refused to continue trial medication|0|||
37802194|NCT01708902|69447531|FG002|Overall Study|Refused to continue trial medication|4|||
37802195|NCT01708902|69447532|FG003|Overall Study|Refused to continue trial medication|2|||
37802196|NCT01708902|69447533|FG004|Overall Study|Refused to continue trial medication|8|||
37802197|NCT01708902|69447534|FG005|Overall Study|Refused to continue trial medication|1|||
37802198|NCT01708902|69447535|FG006|Overall Study|Refused to continue trial medication|1|||
37802199|NCT01708902|69447529|FG000|Overall Study|Other Reason|1|||
37802200|NCT01708902|69447530|FG001|Overall Study|Other Reason|0|||
37802201|NCT01708902|69447531|FG002|Overall Study|Other Reason|1|||
37802202|NCT01708902|69447532|FG003|Overall Study|Other Reason|1|||
37802203|NCT01708902|69447533|FG004|Overall Study|Other Reason|1|||
37802204|NCT01708902|69447534|FG005|Overall Study|Other Reason|2|||
37802205|NCT01708902|69447535|FG006|Overall Study|Other Reason|0|||
37802206|NCT01755546|69447554|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
37802207|NCT01755546|69447554|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
37802208|NCT01755546|69447554|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
37802209|NCT01755546|69447554|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
37802210|NCT01755546|69447554|FG000|Titration Phase|Adverse Event|11|||
37802211|NCT01755546|69447554|FG000|Titration Phase|Lack of Efficacy|18|||
37802212|NCT01755546|69447554|FG000|Titration Phase|Protocol Violation|9|||
37802213|NCT01755546|69447554|FG000|Titration Phase|Lost to Follow-up|2|||
37802214|NCT01755546|69447554|FG000|Titration Phase|Other and Continuing|22|||
37802215|NCT01755546|69447554|FG000|Titration Phase|Withdrawal by Subject|8|||
37802216|NCT01755546|69447554|FG000|Long Term Treatment|Adverse Event|12|||
37802217|NCT01755546|69447554|FG000|Long Term Treatment|Lack of Efficacy|6|||
37802218|NCT01755546|69447554|FG000|Long Term Treatment|Protocol Violation|10|||
37802219|NCT01755546|69447554|FG000|Long Term Treatment|Withdrawal by Subject|35|||
37802220|NCT01755546|69447554|FG000|Long Term Treatment|Lost to Follow-up|17|||
37802221|NCT01755546|69447554|FG000|Long Term Treatment|other and ongoing|41|||
37802222|NCT01755234|69447560|FG000|Overall Study|Lost to Follow-up|11|||
37802223|NCT01755234|69447561|FG001|Overall Study|Lost to Follow-up|6|||
37802224|NCT01755234|69447560|FG000|Overall Study|Change in surgical case|2|||
37802225|NCT01755234|69447561|FG001|Overall Study|Change in surgical case|1|||
37802226|NCT01755234|69447560|FG000|Overall Study|case cancelled|1|||
37802227|NCT01755234|69447561|FG001|Overall Study|case cancelled|0|||
37802228|NCT01755234|69447560|FG000|Overall Study|Withdrawal by Subject|0|||
37802229|NCT01755234|69447561|FG001|Overall Study|Withdrawal by Subject|1|||
37802230|NCT01755234|69447560|FG000|Overall Study|unblinded|1|||
37802231|NCT01755234|69447561|FG001|Overall Study|unblinded|0|||
37802232|NCT01731912|69447567|FG000|Overall Study|noncompliance|2|||
37802233|NCT01731678|69447571|FG000|Overall Study|Withdrawal by Subject|3|||
37802234|NCT01731678|69447571|FG000|Overall Study|Did not meet inclusion criteria|1|||
37802235|NCT01731678|69447571|FG000|Overall Study|RMT too high, making TMS difficult|3|||
37802236|NCT01731600|69447577|FG000|Overall Study|Adverse Event|2|||
37802237|NCT01731600|69447578|FG001|Overall Study|Adverse Event|0|||
37802238|NCT01731600|69447577|FG000|Overall Study|Withdrawal criteria|1|||
37802239|NCT01731600|69447578|FG001|Overall Study|Withdrawal criteria|0|||
37802240|NCT01731600|69447577|FG000|Overall Study|Other reasons|3|||
37802241|NCT01731600|69447578|FG001|Overall Study|Other reasons|0|||
37802242|NCT01730586|69447588|FG000|Overall Study|Progressive Disease|2|||
37802243|NCT01730586|69447588|FG000|Overall Study|Inadequate Trial|8|||
37802244|NCT01730586|69447588|FG000|Overall Study|Adverse Event|2|||
37802245|NCT01730586|69447588|FG000|Overall Study|Hospice|1|||
37802246|NCT01707030|69447596|FG000|Overall Study|Death|1|||
37802247|NCT01707030|69447597|FG001|Overall Study|Death|1|||
37802248|NCT01707030|69447596|FG000|Overall Study|Withdrawal by Subject|2|||
37802249|NCT01707030|69447597|FG001|Overall Study|Withdrawal by Subject|3|||
37802250|NCT01707030|69447596|FG000|Overall Study|Lost to Follow-up|8|||
37802251|NCT01707030|69447597|FG001|Overall Study|Lost to Follow-up|13|||
37802252|NCT01755156|69447609|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
37802253|NCT01755156|69447610|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
37802254|NCT01755156|69447609|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
37802255|NCT01755156|69447610|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
37802256|NCT01755156|69447609|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
37802257|NCT01755156|69447610|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
37802258|NCT01755156|69447609|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
37802259|NCT01755156|69447610|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
37693989|NCT02352493|69170274|FG012|Overall Study|Withdrawal by Subject|0|||
37693990|NCT02352493|69170275|FG013|Overall Study|Withdrawal by Subject|0|||
37693991|NCT02352493|69170276|FG014|Overall Study|Withdrawal by Subject|1|||
37693992|NCT02352493|69170277|FG015|Overall Study|Withdrawal by Subject|0|||
37693993|NCT02352493|69170278|FG016|Overall Study|Withdrawal by Subject|0|||
37693994|NCT02352493|69170279|FG017|Overall Study|Withdrawal by Subject|0|||
37802260|NCT01755156|69447609|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
37802261|NCT01755156|69447610|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
37802262|NCT01755156|69447609|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
37802263|NCT01755156|69447610|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
37802264|NCT01755156|69447609|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
37802265|NCT01755156|69447610|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
37802266|NCT01755156|69447609|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
37802267|NCT01755156|69447610|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
37802268|NCT01755156|69447609|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
37802269|NCT01755156|69447610|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
37802270|NCT01755156|69447609|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
37802271|NCT01755156|69447610|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
37802272|NCT01755156|69447609|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
37802273|NCT01755156|69447610|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
37802274|NCT01754922|69447622|FG000|Overall Study|Adverse Event|0|||
37802275|NCT01754922|69447623|FG001|Overall Study|Adverse Event|1|||
37802276|NCT01754766|69447633|FG000|Overall Study|Personal reasons|1|||
37802277|NCT01754766|69447634|FG001|Overall Study|Personal reasons|1|||
37802278|NCT01754766|69447635|FG002|Overall Study|Personal reasons|0|||
37802279|NCT01754376|69447643|FG000|Overall Study|Adverse Event|1|||
37802280|NCT01754376|69447643|FG000|Overall Study|Lack of Efficacy|2|||
37802281|NCT01605396|69447650|FG000|Overall Study|Adverse Event|5|||
37802282|NCT01605396|69447651|FG001|Overall Study|Adverse Event|3|||
37802283|NCT01605396|69447650|FG000|Overall Study|Lost to Follow-up|1|||
37802284|NCT01605396|69447651|FG001|Overall Study|Lost to Follow-up|0|||
37802285|NCT01605396|69447650|FG000|Overall Study|Non-Compliance With Study Drug|1|||
37802286|NCT01605396|69447651|FG001|Overall Study|Non-Compliance With Study Drug|1|||
37802287|NCT01605396|69447650|FG000|Overall Study|Physician Decision|2|||
37802288|NCT01605396|69447651|FG001|Overall Study|Physician Decision|2|||
37802289|NCT01605396|69447650|FG000|Overall Study|Progressive Disease|23|||
37802290|NCT01605396|69447651|FG001|Overall Study|Progressive Disease|27|||
37802291|NCT01605396|69447650|FG000|Overall Study|Withdrawal by Subject|4|||
37802292|NCT01605396|69447651|FG001|Overall Study|Withdrawal by Subject|2|||
37802293|NCT01605396|69447650|FG000|Overall Study|Transfer Off Study|4|||
37802294|NCT01605396|69447651|FG001|Overall Study|Transfer Off Study|5|||
37802295|NCT01730118|69447664|FG000|Dose Escalation|Death on study|5|||
37802296|NCT01730118|69447665|FG001|Dose Escalation|Death on study|7|||
37802297|NCT01730118|69447666|FG002|Dose Escalation|Death on study|2|||
37802298|NCT01730118|69447667|FG003|Dose Escalation|Death on study|6|||
37802299|NCT01730118|69447668|FG004|Dose Escalation|Death on study|0|||
37802300|NCT01730118|69447669|FG005|Dose Escalation|Death on study|0|||
37802301|NCT01730118|69447670|FG006|Dose Escalation|Death on study|0|||
37802302|NCT01730118|69447664|FG000|Dose Escalation|Died before treatment|0|||
37802303|NCT01730118|69447665|FG001|Dose Escalation|Died before treatment|0|||
37802304|NCT01730118|69447666|FG002|Dose Escalation|Died before treatment|0|||
37802305|NCT01730118|69447667|FG003|Dose Escalation|Died before treatment|0|||
37802306|NCT01730118|69447668|FG004|Dose Escalation|Died before treatment|0|||
37802307|NCT01730118|69447669|FG005|Dose Escalation|Died before treatment|0|||
37802308|NCT01730118|69447670|FG006|Dose Escalation|Died before treatment|1|||
37802309|NCT01730118|69447664|FG000|Dose Escalation|Chose to start a different treatment|1|||
37802310|NCT01730118|69447665|FG001|Dose Escalation|Chose to start a different treatment|0|||
37802311|NCT01730118|69447666|FG002|Dose Escalation|Chose to start a different treatment|0|||
37802312|NCT01730118|69447667|FG003|Dose Escalation|Chose to start a different treatment|0|||
37802313|NCT01730118|69447668|FG004|Dose Escalation|Chose to start a different treatment|0|||
37802314|NCT01730118|69447669|FG005|Dose Escalation|Chose to start a different treatment|0|||
37802315|NCT01730118|69447670|FG006|Dose Escalation|Chose to start a different treatment|0|||
37802316|NCT01730118|69447664|FG000|Dose Escalation|Withdrawal by Subject|0|||
37802317|NCT01730118|69447665|FG001|Dose Escalation|Withdrawal by Subject|0|||
37802318|NCT01730118|69447666|FG002|Dose Escalation|Withdrawal by Subject|1|||
37802319|NCT01730118|69447667|FG003|Dose Escalation|Withdrawal by Subject|0|||
37802320|NCT01730118|69447668|FG004|Dose Escalation|Withdrawal by Subject|0|||
37802321|NCT01730118|69447669|FG005|Dose Escalation|Withdrawal by Subject|0|||
37802322|NCT01730118|69447670|FG006|Dose Escalation|Withdrawal by Subject|0|||
37802323|NCT01730118|69447664|FG000|Dose Escalation|Disease progression prior to treatment|0|||
37802324|NCT01730118|69447665|FG001|Dose Escalation|Disease progression prior to treatment|0|||
37802325|NCT01730118|69447666|FG002|Dose Escalation|Disease progression prior to treatment|0|||
37802326|NCT01730118|69447667|FG003|Dose Escalation|Disease progression prior to treatment|0|||
37802327|NCT01730118|69447668|FG004|Dose Escalation|Disease progression prior to treatment|0|||
37802328|NCT01730118|69447669|FG005|Dose Escalation|Disease progression prior to treatment|0|||
37802329|NCT01730118|69447670|FG006|Dose Escalation|Disease progression prior to treatment|1|||
37802330|NCT01730118|69447664|FG000|Dose Expansion|Death|0|||
37802331|NCT01730118|69447665|FG001|Dose Expansion|Death|0|||
37802332|NCT01730118|69447666|FG002|Dose Expansion|Death|0|||
37802333|NCT01730118|69447667|FG003|Dose Expansion|Death|0|||
37802334|NCT01730118|69447668|FG004|Dose Expansion|Death|1|||
37802335|NCT01730118|69447669|FG005|Dose Expansion|Death|0|||
37802336|NCT01730118|69447670|FG006|Dose Expansion|Death|0|||
37802337|NCT01730118|69447664|FG000|Dose Expansion|Other medical condition|0|||
37802338|NCT01730118|69447665|FG001|Dose Expansion|Other medical condition|0|||
37802339|NCT01730118|69447666|FG002|Dose Expansion|Other medical condition|0|||
37802340|NCT01730118|69447667|FG003|Dose Expansion|Other medical condition|0|||
37802341|NCT01730118|69447668|FG004|Dose Expansion|Other medical condition|1|||
37802342|NCT01730118|69447669|FG005|Dose Expansion|Other medical condition|0|||
37802343|NCT01730118|69447670|FG006|Dose Expansion|Other medical condition|0|||
37802344|NCT01730118|69447664|FG000|Dose Expansion|Withdrawal by Subject|0|||
37802345|NCT01730118|69447665|FG001|Dose Expansion|Withdrawal by Subject|0|||
37802346|NCT01730118|69447666|FG002|Dose Expansion|Withdrawal by Subject|0|||
37802347|NCT01730118|69447667|FG003|Dose Expansion|Withdrawal by Subject|0|||
37802348|NCT01730118|69447668|FG004|Dose Expansion|Withdrawal by Subject|1|||
37802349|NCT01730118|69447669|FG005|Dose Expansion|Withdrawal by Subject|0|||
37802350|NCT01730118|69447670|FG006|Dose Expansion|Withdrawal by Subject|0|||
37802351|NCT01730118|69447664|FG000|Dose Expansion|Disease progression|0|||
37802352|NCT01730118|69447665|FG001|Dose Expansion|Disease progression|0|||
37802353|NCT01730118|69447666|FG002|Dose Expansion|Disease progression|0|||
37802354|NCT01730118|69447667|FG003|Dose Expansion|Disease progression|0|||
37802355|NCT01730118|69447668|FG004|Dose Expansion|Disease progression|0|||
37802356|NCT01730118|69447669|FG005|Dose Expansion|Disease progression|1|||
37802357|NCT01730118|69447670|FG006|Dose Expansion|Disease progression|0|||
37975749|NCT00498602|69662991|FG000|Overall Study|Subject Request|3|||
37802358|NCT01730118|69447664|FG000|Dose Expansion|Inability to return|0|||
37802359|NCT01730118|69447665|FG001|Dose Expansion|Inability to return|0|||
37802360|NCT01730118|69447666|FG002|Dose Expansion|Inability to return|0|||
37802361|NCT01730118|69447667|FG003|Dose Expansion|Inability to return|0|||
37802362|NCT01730118|69447668|FG004|Dose Expansion|Inability to return|0|||
37802363|NCT01730118|69447669|FG005|Dose Expansion|Inability to return|1|||
37802364|NCT01730118|69447670|FG006|Dose Expansion|Inability to return|0|||
37802365|NCT01730118|69447664|FG000|Dose Expansion|Physician Decision|0|||
37802366|NCT01730118|69447665|FG001|Dose Expansion|Physician Decision|0|||
37802367|NCT01730118|69447666|FG002|Dose Expansion|Physician Decision|0|||
37802368|NCT01730118|69447667|FG003|Dose Expansion|Physician Decision|0|||
37802369|NCT01730118|69447668|FG004|Dose Expansion|Physician Decision|0|||
37802370|NCT01730118|69447669|FG005|Dose Expansion|Physician Decision|1|||
37802371|NCT01730118|69447670|FG006|Dose Expansion|Physician Decision|0|||
37802372|NCT01730040|69447694|FG000|Overall Study|Randomized but not treated|0|||
37802373|NCT01730040|69447695|FG001|Overall Study|Randomized but not treated|0|||
37802374|NCT01730040|69447696|FG002|Overall Study|Randomized but not treated|0|||
37802375|NCT01730040|69447697|FG003|Overall Study|Randomized but not treated|0|||
37802376|NCT01730040|69447698|FG004|Overall Study|Randomized but not treated|0|||
37802377|NCT01730040|69447699|FG005|Overall Study|Randomized but not treated|1|||
37802378|NCT01730040|69447700|FG006|Overall Study|Randomized but not treated|0|||
37802379|NCT01730040|69447694|FG000|Overall Study|Subject moved|0|||
37802380|NCT01730040|69447695|FG001|Overall Study|Subject moved|0|||
37802381|NCT01730040|69447696|FG002|Overall Study|Subject moved|1|||
37802382|NCT01730040|69447697|FG003|Overall Study|Subject moved|0|||
37802383|NCT01730040|69447698|FG004|Overall Study|Subject moved|0|||
37802384|NCT01730040|69447699|FG005|Overall Study|Subject moved|0|||
37802385|NCT01730040|69447700|FG006|Overall Study|Subject moved|1|||
37802386|NCT01730040|69447694|FG000|Overall Study|Physician Decision|0|||
37802387|NCT01730040|69447695|FG001|Overall Study|Physician Decision|0|||
37802388|NCT01730040|69447696|FG002|Overall Study|Physician Decision|0|||
37802389|NCT01730040|69447697|FG003|Overall Study|Physician Decision|0|||
37802390|NCT01730040|69447698|FG004|Overall Study|Physician Decision|0|||
37802391|NCT01730040|69447699|FG005|Overall Study|Physician Decision|1|||
37802392|NCT01730040|69447700|FG006|Overall Study|Physician Decision|1|||
37802393|NCT01730040|69447694|FG000|Overall Study|Other than specified|7|||
37802394|NCT01730040|69447695|FG001|Overall Study|Other than specified|8|||
37802395|NCT01730040|69447696|FG002|Overall Study|Other than specified|5|||
37802396|NCT01730040|69447697|FG003|Overall Study|Other than specified|5|||
37802397|NCT01730040|69447698|FG004|Overall Study|Other than specified|5|||
37802398|NCT01730040|69447699|FG005|Overall Study|Other than specified|4|||
37802399|NCT01730040|69447700|FG006|Overall Study|Other than specified|4|||
37802400|NCT01730040|69447694|FG000|Overall Study|Adverse Event|4|||
37802401|NCT01730040|69447695|FG001|Overall Study|Adverse Event|3|||
37802402|NCT01730040|69447696|FG002|Overall Study|Adverse Event|5|||
37802403|NCT01730040|69447697|FG003|Overall Study|Adverse Event|3|||
37802404|NCT01730040|69447698|FG004|Overall Study|Adverse Event|1|||
37802405|NCT01730040|69447699|FG005|Overall Study|Adverse Event|1|||
37802406|NCT01730040|69447700|FG006|Overall Study|Adverse Event|2|||
37802407|NCT01730040|69447694|FG000|Overall Study|Poor compliance to protocol|2|||
37802408|NCT01730040|69447695|FG001|Overall Study|Poor compliance to protocol|4|||
37802409|NCT01730040|69447696|FG002|Overall Study|Poor compliance to protocol|0|||
37802410|NCT01730040|69447697|FG003|Overall Study|Poor compliance to protocol|0|||
37802411|NCT01730040|69447698|FG004|Overall Study|Poor compliance to protocol|0|||
37802412|NCT01730040|69447699|FG005|Overall Study|Poor compliance to protocol|0|||
37802413|NCT01730040|69447700|FG006|Overall Study|Poor compliance to protocol|1|||
37802414|NCT01706328|69447718|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
37975750|NCT00498602|69662992|FG001|Overall Study|Subject Request|0|||
37975751|NCT00498602|69662993|FG002|Overall Study|Subject Request|1|||
37802415|NCT01706328|69447719|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
37802416|NCT01706328|69447720|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
37802417|NCT01706328|69447718|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
37802418|NCT01706328|69447719|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
37802419|NCT01706328|69447720|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
37802420|NCT01706328|69447718|FG000|2-week Run-in Period|Physician Decision|4|||
37802421|NCT01706328|69447719|FG001|2-week Run-in Period|Physician Decision|0|||
37975752|NCT00498602|69662994|FG003|Overall Study|Subject Request|1|||
37802422|NCT01706328|69447720|FG002|2-week Run-in Period|Physician Decision|0|||
37802423|NCT01706328|69447718|FG000|2-week Run-in Period|Adverse Event|4|||
37802424|NCT01706328|69447719|FG001|2-week Run-in Period|Adverse Event|0|||
37802425|NCT01706328|69447720|FG002|2-week Run-in Period|Adverse Event|0|||
37802426|NCT01706328|69447718|FG000|2-week Run-in Period|Lost to Follow-up|2|||
37802427|NCT01706328|69447719|FG001|2-week Run-in Period|Lost to Follow-up|0|||
37802428|NCT01706328|69447720|FG002|2-week Run-in Period|Lost to Follow-up|0|||
37802429|NCT01706328|69447718|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
37802430|NCT01706328|69447719|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
37802431|NCT01706328|69447720|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
37802432|NCT01706328|69447718|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
37802433|NCT01706328|69447719|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
37802434|NCT01706328|69447720|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
37802435|NCT01706328|69447718|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
37802436|NCT01706328|69447719|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
37802437|NCT01706328|69447720|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
37802438|NCT01706328|69447718|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
37802439|NCT01706328|69447719|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
37802440|NCT01706328|69447720|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
37802441|NCT01706328|69447718|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
37802442|NCT01706328|69447719|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
37802443|NCT01706328|69447720|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
37802444|NCT01706328|69447718|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
37802445|NCT01706328|69447719|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
37802446|NCT01706328|69447720|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
37802447|NCT01706328|69447718|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
37802448|NCT01706328|69447719|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
37802449|NCT01706328|69447720|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
37802450|NCT01753518|69447728|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
37802451|NCT01753518|69447729|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
37802452|NCT01753518|69447728|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
37802453|NCT01753518|69447729|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
37802454|NCT01753518|69447728|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
37802455|NCT01753518|69447729|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
37802456|NCT01753518|69447728|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
37802457|NCT01753518|69447729|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
37802458|NCT01706250|69447735|FG000|Overall Study|Lost to Follow-up|2|||
37802459|NCT01729728|69447747|FG000|Overall Study|Adverse Event|0|||
37802460|NCT01729728|69447748|FG001|Overall Study|Adverse Event|6|||
37802461|NCT01729728|69447749|FG002|Overall Study|Adverse Event|0|||
37802462|NCT01729728|69447747|FG000|Overall Study|Protocol Violation|1|||
37802463|NCT01729728|69447748|FG001|Overall Study|Protocol Violation|0|||
37802464|NCT01729728|69447749|FG002|Overall Study|Protocol Violation|1|||
37802465|NCT01729026|69447882|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
37802466|NCT01729026|69447883|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
37802467|NCT01729026|69447882|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
37802468|NCT01729026|69447883|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
37802469|NCT01728792|69447897|FG000|Overall Study|Withdrawal of Consent|1|||
37802470|NCT01728792|69447898|FG001|Overall Study|Withdrawal of Consent|1|||
37802471|NCT01728792|69447899|FG002|Overall Study|Withdrawal of Consent|0|||
37802472|NCT01728792|69447900|FG003|Overall Study|Withdrawal of Consent|1|||
37802473|NCT01728792|69447901|FG004|Overall Study|Withdrawal of Consent|0|||
37802474|NCT01728792|69447897|FG000|Overall Study|Lost to Follow-up|2|||
37802475|NCT01728792|69447898|FG001|Overall Study|Lost to Follow-up|1|||
37802476|NCT01728792|69447899|FG002|Overall Study|Lost to Follow-up|4|||
37802477|NCT01728792|69447900|FG003|Overall Study|Lost to Follow-up|2|||
37802478|NCT01728792|69447901|FG004|Overall Study|Lost to Follow-up|0|||
37802479|NCT01752036|69447913|FG000|Overall Study|Death|2|||
37802480|NCT01728324|69447921|FG000|Termination of DBV|Adverse Event|14|||
37802481|NCT01728324|69447922|FG001|Termination of DBV|Adverse Event|13|||
37802482|NCT01728324|69447923|FG002|Termination of DBV|Adverse Event|4|||
37975753|NCT00498602|69662995|FG004|Overall Study|Subject Request|1|||
37802483|NCT01728324|69447921|FG000|Termination of DBV|Lack of Efficacy|14|||
37802484|NCT01728324|69447922|FG001|Termination of DBV|Lack of Efficacy|12|||
37802485|NCT01728324|69447923|FG002|Termination of DBV|Lack of Efficacy|8|||
37802486|NCT01728324|69447921|FG000|Termination of DBV|Withdrawal by Subject|9|||
37802487|NCT01728324|69447922|FG001|Termination of DBV|Withdrawal by Subject|6|||
37802488|NCT01728324|69447923|FG002|Termination of DBV|Withdrawal by Subject|2|||
37802489|NCT01728324|69447921|FG000|Termination of DBV|Other than stated|1|||
37802490|NCT01728324|69447922|FG001|Termination of DBV|Other than stated|3|||
37802491|NCT01728324|69447923|FG002|Termination of DBV|Other than stated|0|||
37802492|NCT01728324|69447921|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
37802493|NCT01728324|69447922|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
37802494|NCT01728324|69447923|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
37802495|NCT01728324|69447921|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
37802496|NCT01728324|69447922|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
37802497|NCT01728324|69447923|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
37802498|NCT01728324|69447921|FG000|Termination of FDV|Adverse Event|14|||
37802499|NCT01728324|69447922|FG001|Termination of FDV|Adverse Event|13|||
37802500|NCT01728324|69447923|FG002|Termination of FDV|Adverse Event|4|||
37802501|NCT01728324|69447921|FG000|Termination of FDV|Lack of Efficacy|14|||
37802502|NCT01728324|69447922|FG001|Termination of FDV|Lack of Efficacy|12|||
37802503|NCT01728324|69447923|FG002|Termination of FDV|Lack of Efficacy|8|||
37802504|NCT01728324|69447921|FG000|Termination of FDV|Withdrawal by Subject|9|||
37802505|NCT01728324|69447922|FG001|Termination of FDV|Withdrawal by Subject|6|||
37802506|NCT01728324|69447923|FG002|Termination of FDV|Withdrawal by Subject|2|||
37802507|NCT01728324|69447921|FG000|Termination of FDV|Other than stated|1|||
37802508|NCT01728324|69447922|FG001|Termination of FDV|Other than stated|3|||
37802509|NCT01728324|69447923|FG002|Termination of FDV|Other than stated|0|||
37802510|NCT01728324|69447921|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
37802511|NCT01728324|69447922|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
37802512|NCT01728324|69447923|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
37802513|NCT01728324|69447921|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
37802514|NCT01728324|69447922|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
37975754|NCT00498602|69662996|FG005|Overall Study|Subject Request|4|||
37802515|NCT01728324|69447923|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
37802516|NCT01728324|69447921|FG000|Termination of RBV|Adverse Event|15|||
37802517|NCT01728324|69447922|FG001|Termination of RBV|Adverse Event|16|||
37802518|NCT01728324|69447923|FG002|Termination of RBV|Adverse Event|5|||
37802519|NCT01728324|69447921|FG000|Termination of RBV|Lack of Efficacy|14|||
37802520|NCT01728324|69447922|FG001|Termination of RBV|Lack of Efficacy|11|||
37802521|NCT01728324|69447923|FG002|Termination of RBV|Lack of Efficacy|7|||
37802522|NCT01728324|69447921|FG000|Termination of RBV|Withdrawal by Subject|9|||
37802523|NCT01728324|69447922|FG001|Termination of RBV|Withdrawal by Subject|5|||
37802524|NCT01728324|69447923|FG002|Termination of RBV|Withdrawal by Subject|2|||
37802525|NCT01728324|69447921|FG000|Termination of RBV|Other than stated|1|||
37802526|NCT01728324|69447922|FG001|Termination of RBV|Other than stated|3|||
37802527|NCT01728324|69447923|FG002|Termination of RBV|Other than stated|1|||
37802528|NCT01728324|69447921|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
37802529|NCT01728324|69447922|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
37802530|NCT01728324|69447923|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
37802531|NCT01728324|69447921|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
37802532|NCT01728324|69447922|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
37802533|NCT01728324|69447923|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
37802534|NCT01728246|69447935|FG000|Overall Study|Participant needed rescue medication|1|||
37802535|NCT01728246|69447936|FG001|Overall Study|Participant needed rescue medication|5|||
37802536|NCT01728246|69447935|FG000|Overall Study|Protocol Violation|1|||
37802537|NCT01728246|69447936|FG001|Overall Study|Protocol Violation|0|||
37802538|NCT01728246|69447935|FG000|Overall Study|Withdrawal by Subject|2|||
37802539|NCT01728246|69447936|FG001|Overall Study|Withdrawal by Subject|3|||
37802540|NCT01728246|69447935|FG000|Overall Study|Lost to Follow-up|23|||
37802541|NCT01728246|69447936|FG001|Overall Study|Lost to Follow-up|22|||
37802542|NCT01728246|69447935|FG000|Overall Study|Lack of Efficacy|1|||
37802543|NCT01728246|69447936|FG001|Overall Study|Lack of Efficacy|1|||
37802544|NCT01728246|69447935|FG000|Overall Study|Adverse Event|8|||
37802545|NCT01728246|69447936|FG001|Overall Study|Adverse Event|5|||
37802546|NCT01705236|69447942|FG000|Overall Study|Lost to Follow-up|1|||
37802547|NCT01705236|69447942|FG000|Overall Study|Administrative problems|2|||
37802548|NCT01705236|69447942|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
37802549|NCT01705236|69447942|FG000|Overall Study|Protocol Violation|3|||
37802550|NCT01705236|69447942|FG000|Overall Study|Abnormal test procedure result(s)|4|||
37802551|NCT01705236|69447942|FG000|Overall Study|Abnormal laboratory value(s)|4|||
37802552|NCT01705236|69447942|FG000|Overall Study|Withdrawal by Subject|5|||
37802553|NCT01705236|69447942|FG000|Overall Study|Adverse Event|5|||
37802554|NCT01705080|69447949|FG000|Overall Study|Missed visit|10|||
37802555|NCT01705080|69447950|FG001|Overall Study|Missed visit|4|||
37802556|NCT01705080|69447951|FG002|Overall Study|Missed visit|1|||
37802557|NCT01705080|69447949|FG000|Overall Study|Death|4|||
37802558|NCT01705080|69447950|FG001|Overall Study|Death|4|||
37802559|NCT01705080|69447951|FG002|Overall Study|Death|6|||
37802560|NCT01705080|69447949|FG000|Overall Study|Withdrawal by Subject|61|||
37802561|NCT01705080|69447950|FG001|Overall Study|Withdrawal by Subject|44|||
37802562|NCT01705080|69447951|FG002|Overall Study|Withdrawal by Subject|9|||
37802563|NCT01704846|69447961|FG000|Treatment Period 2|Withdrawal by Subject|0|||
37802564|NCT01704846|69447962|FG001|Treatment Period 2|Withdrawal by Subject|1|||
37802565|NCT01751802|69447970|FG000|Overall Study|Adverse Event|4|||
37802566|NCT01751802|69447971|FG001|Overall Study|Adverse Event|2|||
37802567|NCT01704456|69447985|FG000|Overall Study|Lost to Follow-up|8|||
37802568|NCT01704456|69447986|FG001|Overall Study|Lost to Follow-up|14|||
37802569|NCT01703988|69447996|FG000|Overall Study|Investigator Judgment|0|||
37802570|NCT01703988|69447997|FG001|Overall Study|Investigator Judgment|0|||
37802571|NCT01703988|69447998|FG002|Overall Study|Investigator Judgment|0|||
37802572|NCT01703988|69447999|FG003|Overall Study|Investigator Judgment|1|||
37802573|NCT01703832|69448012|FG000|Overall Study|Withdrawal by Subject|1|||
37802574|NCT01703832|69448013|FG001|Overall Study|Withdrawal by Subject|0|||
37802575|NCT01703286|69448019|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
37802576|NCT01703286|69448020|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
37802577|NCT01703286|69448021|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
37802578|NCT01703286|69448022|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
37802579|NCT01703286|69448023|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
37802580|NCT01703286|69448024|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
37802581|NCT01703286|69448019|FG000|Period 2 Including Washout|Adverse Event|0|||
37802582|NCT01703286|69448020|FG001|Period 2 Including Washout|Adverse Event|0|||
37802583|NCT01703286|69448021|FG002|Period 2 Including Washout|Adverse Event|0|||
37802584|NCT01703286|69448022|FG003|Period 2 Including Washout|Adverse Event|1|||
37802585|NCT01703286|69448023|FG004|Period 2 Including Washout|Adverse Event|0|||
37802586|NCT01703286|69448024|FG005|Period 2 Including Washout|Adverse Event|0|||
37802587|NCT01703208|69448037|FG000|Overall Study|Death|61|||
37802588|NCT01703208|69448038|FG001|Overall Study|Death|48|||
37802589|NCT01703208|69448037|FG000|Overall Study|Lack of Efficacy|1|||
37802590|NCT01703208|69448038|FG001|Overall Study|Lack of Efficacy|2|||
37802591|NCT01703208|69448037|FG000|Overall Study|Lost to Follow-up|68|||
37802592|NCT01703208|69448038|FG001|Overall Study|Lost to Follow-up|62|||
37802593|NCT01703208|69448037|FG000|Overall Study|Non-Compliance with Study Drug|1|||
37802594|NCT01703208|69448038|FG001|Overall Study|Non-Compliance with Study Drug|0|||
37802595|NCT01703208|69448037|FG000|Overall Study|Excluded Medication|1|||
37802596|NCT01703208|69448038|FG001|Overall Study|Excluded Medication|2|||
37802597|NCT01703208|69448037|FG000|Overall Study|Site Discontinued Study Participation|23|||
37802598|NCT01703208|69448038|FG001|Overall Study|Site Discontinued Study Participation|27|||
37802599|NCT01703208|69448037|FG000|Overall Study|Physician Decision|11|||
37802600|NCT01703208|69448038|FG001|Overall Study|Physician Decision|13|||
37802601|NCT01703208|69448037|FG000|Overall Study|Progressive disease|2|||
37802602|NCT01703208|69448038|FG001|Overall Study|Progressive disease|2|||
37802603|NCT01703208|69448037|FG000|Overall Study|Protocol Violation|1|||
37802604|NCT01703208|69448038|FG001|Overall Study|Protocol Violation|1|||
37802605|NCT01703208|69448037|FG000|Overall Study|Study Terminated by Sponsor|1710|||
37802606|NCT01703208|69448038|FG001|Overall Study|Study Terminated by Sponsor|1716|||
37802607|NCT01703208|69448037|FG000|Overall Study|Withdrawal by Subject|205|||
37802608|NCT01703208|69448038|FG001|Overall Study|Withdrawal by Subject|209|||
37802609|NCT01703208|69448037|FG000|Overall Study|Adverse Event|14|||
37802610|NCT01703208|69448038|FG001|Overall Study|Adverse Event|19|||
37802611|NCT01703208|69448037|FG000|Overall Study|Technical Problems|0|||
37802612|NCT01703208|69448038|FG001|Overall Study|Technical Problems|1|||
37802613|NCT01703208|69448037|FG000|Overall Study|Protocol Deviation|2|||
37802614|NCT01703208|69448038|FG001|Overall Study|Protocol Deviation|0|||
37802615|NCT01727700|69448047|FG000|Overall Study|Adverse Event|0|||
37802616|NCT01727700|69448048|FG001|Overall Study|Adverse Event|7|||
37802617|NCT01727700|69448049|FG002|Overall Study|Adverse Event|1|||
37802618|NCT01727700|69448047|FG000|Overall Study|Particpant withdrew consent|0|||
37802619|NCT01727700|69448048|FG001|Overall Study|Particpant withdrew consent|3|||
37802620|NCT01727700|69448049|FG002|Overall Study|Particpant withdrew consent|1|||
37802621|NCT01727700|69448047|FG000|Overall Study|Protocol Violation|2|||
37802622|NCT01727700|69448048|FG001|Overall Study|Protocol Violation|0|||
37802623|NCT01727700|69448049|FG002|Overall Study|Protocol Violation|0|||
37802624|NCT01727154|69448057|FG000|Overall Study|Death|17|||
37802625|NCT01727154|69448057|FG000|Overall Study|Withdrawal by Subject|14|||
37802626|NCT01727154|69448057|FG000|Overall Study|Subject Withdrew Consent|18|||
37802627|NCT01727154|69448057|FG000|Overall Study|Study Terminated|6|||
37802628|NCT01727154|69448057|FG000|Overall Study|No Discontinuation Documentation|4|||
37802629|NCT01725750|69448063|FG000|Overall Study|Adverse Event|1|||
37802630|NCT01725750|69448064|FG001|Overall Study|Adverse Event|0|||
37802631|NCT01725750|69448063|FG000|Overall Study|Lost to Follow-up|1|||
37802632|NCT01725750|69448064|FG001|Overall Study|Lost to Follow-up|1|||
37802633|NCT01725750|69448063|FG000|Overall Study|Withdrawal by Subject|0|||
37802634|NCT01725750|69448064|FG001|Overall Study|Withdrawal by Subject|9|||
37802635|NCT01725282|69448076|FG000|Overall Study|Adverse Event|1|||
37693995|NCT02352493|69170262|FG000|Overall Study|Lost to Follow-up|0|||
37693996|NCT02352493|69170263|FG001|Overall Study|Lost to Follow-up|0|||
37693997|NCT02352493|69170264|FG002|Overall Study|Lost to Follow-up|0|||
37802636|NCT01725282|69448077|FG001|Overall Study|Adverse Event|3|||
37802637|NCT01725282|69448078|FG002|Overall Study|Adverse Event|6|||
37802638|NCT01725282|69448079|FG003|Overall Study|Adverse Event|4|||
37802639|NCT01725282|69448076|FG000|Overall Study|Exacerbation of Target Disease|1|||
37802640|NCT01725282|69448077|FG001|Overall Study|Exacerbation of Target Disease|0|||
37693998|NCT02352493|69170265|FG003|Overall Study|Lost to Follow-up|0|||
37802641|NCT01725282|69448078|FG002|Overall Study|Exacerbation of Target Disease|0|||
37802642|NCT01725282|69448079|FG003|Overall Study|Exacerbation of Target Disease|1|||
37802643|NCT01725282|69448076|FG000|Overall Study|Met Exclusion Criteria|0|||
37802644|NCT01725282|69448077|FG001|Overall Study|Met Exclusion Criteria|0|||
37802645|NCT01725282|69448078|FG002|Overall Study|Met Exclusion Criteria|1|||
37802646|NCT01725282|69448079|FG003|Overall Study|Met Exclusion Criteria|0|||
37802647|NCT01725282|69448076|FG000|Overall Study|Study Site Withdrawal|0|||
37802648|NCT01725282|69448077|FG001|Overall Study|Study Site Withdrawal|1|||
37802649|NCT01725282|69448078|FG002|Overall Study|Study Site Withdrawal|0|||
37802650|NCT01725282|69448079|FG003|Overall Study|Study Site Withdrawal|0|||
37802651|NCT01725282|69448076|FG000|Overall Study|Withdrawal by Subject|0|||
37802652|NCT01725282|69448077|FG001|Overall Study|Withdrawal by Subject|0|||
37802653|NCT01725282|69448078|FG002|Overall Study|Withdrawal by Subject|1|||
37802654|NCT01725282|69448079|FG003|Overall Study|Withdrawal by Subject|1|||
37802655|NCT01725282|69448076|FG000|Overall Study|Lack of Efficacy|0|||
37802656|NCT01725282|69448077|FG001|Overall Study|Lack of Efficacy|1|||
37802657|NCT01725282|69448078|FG002|Overall Study|Lack of Efficacy|0|||
37802658|NCT01725282|69448079|FG003|Overall Study|Lack of Efficacy|1|||
37802659|NCT01725126|69448095|FG000|Overall Study|Protocol Violation|0|||
37802660|NCT01725126|69448096|FG001|Overall Study|Protocol Violation|1|||
37802661|NCT01725126|69448097|FG002|Overall Study|Protocol Violation|0|||
37802662|NCT01725126|69448098|FG003|Overall Study|Protocol Violation|0|||
37802663|NCT01725126|69448099|FG004|Overall Study|Protocol Violation|0|||
37802664|NCT01725126|69448100|FG005|Overall Study|Protocol Violation|0|||
37802665|NCT01725126|69448095|FG000|Overall Study|Withdrawal by Subject|0|||
37802666|NCT01725126|69448096|FG001|Overall Study|Withdrawal by Subject|0|||
37802667|NCT01725126|69448097|FG002|Overall Study|Withdrawal by Subject|0|||
37802668|NCT01725126|69448098|FG003|Overall Study|Withdrawal by Subject|1|||
37802669|NCT01725126|69448099|FG004|Overall Study|Withdrawal by Subject|0|||
37802670|NCT01725126|69448100|FG005|Overall Study|Withdrawal by Subject|0|||
37802671|NCT01751724|69448125|FG000|Overall Study|extubated bef.start assigned treatment|1|||
37802672|NCT01751724|69448126|FG001|Overall Study|extubated bef.start assigned treatment|0|||
37802673|NCT01751724|69448125|FG000|Overall Study|withdrawn by parent|0|||
37802674|NCT01751724|69448126|FG001|Overall Study|withdrawn by parent|2|||
37802675|NCT01751646|69448134|FG000|Overall Study|Lost to Follow-up|5|||
37802676|NCT01751646|69448135|FG001|Overall Study|Lost to Follow-up|1|||
37802677|NCT01751646|69448134|FG000|Overall Study|Withdrawal by Subject|0|||
37802678|NCT01751646|69448135|FG001|Overall Study|Withdrawal by Subject|4|||
37802679|NCT01751646|69448134|FG000|Overall Study|Starting hormone therapy|1|||
37802680|NCT01751646|69448135|FG001|Overall Study|Starting hormone therapy|0|||
37802681|NCT01751646|69448134|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
37802682|NCT01751646|69448135|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
37802683|NCT01751646|69448134|FG000|Overall Study|Inadvertent enrollment|1|||
37802684|NCT01751646|69448135|FG001|Overall Study|Inadvertent enrollment|1|||
37802685|NCT01751646|69448134|FG000|Overall Study|Moved out of the area|1|||
37802686|NCT01751646|69448135|FG001|Overall Study|Moved out of the area|5|||
37802687|NCT01751646|69448134|FG000|Overall Study|Inability to attend required visits|0|||
37802688|NCT01751646|69448135|FG001|Overall Study|Inability to attend required visits|1|||
37802689|NCT01751646|69448134|FG000|Overall Study|Off study due to multiple obligations|0|||
37802690|NCT01751646|69448135|FG001|Overall Study|Off study due to multiple obligations|1|||
37802691|NCT01751646|69448134|FG000|Overall Study|Fails to comply with study requirements|0|||
37802692|NCT01751646|69448135|FG001|Overall Study|Fails to comply with study requirements|1|||
37802693|NCT01751646|69448134|FG000|Overall Study|Childcare issues|1|||
37975755|NCT00498602|69662997|FG006|Overall Study|Subject Request|1|||
37975756|NCT00498602|69662991|FG000|Overall Study|Other|2|||
37975757|NCT00498602|69662992|FG001|Overall Study|Other|3|||
37975758|NCT00498602|69662993|FG002|Overall Study|Other|1|||
37975759|NCT00498602|69662994|FG003|Overall Study|Other|0|||
37975760|NCT00498602|69662995|FG004|Overall Study|Other|0|||
37975761|NCT00498602|69662996|FG005|Overall Study|Other|3|||
37802694|NCT01751646|69448135|FG001|Overall Study|Childcare issues|1|||
37802695|NCT01751568|69448148|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
37802696|NCT01751568|69448149|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
37802697|NCT01751568|69448150|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
37802698|NCT01751412|69448158|FG000|Overall Study|Disease Progression Before Treatment|1|||
37802699|NCT01751178|69448165|FG000|Overall Study|Adverse Event|2|||
37802700|NCT01751178|69448166|FG001|Overall Study|Adverse Event|0|||
37802701|NCT01751178|69448167|FG002|Overall Study|Adverse Event|0|||
37802702|NCT01751178|69448165|FG000|Overall Study|Other Reason (unknown)|1|||
37802703|NCT01751178|69448166|FG001|Overall Study|Other Reason (unknown)|0|||
37802704|NCT01751178|69448167|FG002|Overall Study|Other Reason (unknown)|2|||
37975762|NCT00498602|69662997|FG006|Overall Study|Other|0|||
37975763|NCT00507728|69663016|FG000|Randomization to Month 3|Lost to Follow-up|15|||
37975764|NCT00507728|69663017|FG001|Randomization to Month 3|Lost to Follow-up|14|||
37975765|NCT00507728|69663018|FG002|Randomization to Month 3|Lost to Follow-up|20|||
37975766|NCT00507728|69663016|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
37975767|NCT00507728|69663017|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
37802705|NCT01606254|69448183|FG000|Overall Study|Withdrawal by Subject|1|||
37802706|NCT01606254|69448184|FG001|Overall Study|Withdrawal by Subject|3|||
37802707|NCT01606254|69448185|FG002|Overall Study|Withdrawal by Subject|0|||
37802708|NCT01606254|69448186|FG003|Overall Study|Withdrawal by Subject|2|||
37802709|NCT01606254|69448183|FG000|Overall Study|Adverse Event|1|||
37802710|NCT01606254|69448184|FG001|Overall Study|Adverse Event|1|||
37802711|NCT01606254|69448185|FG002|Overall Study|Adverse Event|0|||
37802712|NCT01606254|69448186|FG003|Overall Study|Adverse Event|1|||
37802713|NCT01750242|69448196|FG000|Overall Study|Unreadable Images|3|||
37802714|NCT01723254|69448209|FG000|Overall Study|Conflict with work schedule|0|||
37802715|NCT01723254|69448210|FG001|Overall Study|Conflict with work schedule|0|||
37802716|NCT01723254|69448211|FG002|Overall Study|Conflict with work schedule|0|||
37802717|NCT01723254|69448212|FG003|Overall Study|Conflict with work schedule|0|||
37802718|NCT01723254|69448213|FG004|Overall Study|Conflict with work schedule|0|||
37802719|NCT01723254|69448214|FG005|Overall Study|Conflict with work schedule|0|||
37802720|NCT01723254|69448215|FG006|Overall Study|Conflict with work schedule|0|||
37802721|NCT01723254|69448216|FG007|Overall Study|Conflict with work schedule|1|||
37802722|NCT01723254|69448209|FG000|Overall Study|Personal issues|0|||
37802723|NCT01723254|69448210|FG001|Overall Study|Personal issues|0|||
37802724|NCT01723254|69448211|FG002|Overall Study|Personal issues|0|||
37802725|NCT01723254|69448212|FG003|Overall Study|Personal issues|0|||
37802726|NCT01723254|69448213|FG004|Overall Study|Personal issues|0|||
37802727|NCT01723254|69448214|FG005|Overall Study|Personal issues|1|||
37802728|NCT01723254|69448215|FG006|Overall Study|Personal issues|0|||
37802729|NCT01723254|69448216|FG007|Overall Study|Personal issues|0|||
37802730|NCT01723254|69448209|FG000|Overall Study|No longer have time to participate|0|||
37802731|NCT01723254|69448210|FG001|Overall Study|No longer have time to participate|0|||
37802732|NCT01723254|69448211|FG002|Overall Study|No longer have time to participate|0|||
37802733|NCT01723254|69448212|FG003|Overall Study|No longer have time to participate|1|||
37802734|NCT01723254|69448213|FG004|Overall Study|No longer have time to participate|0|||
37802735|NCT01723254|69448214|FG005|Overall Study|No longer have time to participate|0|||
37802736|NCT01723254|69448215|FG006|Overall Study|No longer have time to participate|0|||
37802737|NCT01723254|69448216|FG007|Overall Study|No longer have time to participate|0|||
37802738|NCT01723254|69448209|FG000|Overall Study|Move/Left to another country/city|0|||
37802739|NCT01723254|69448210|FG001|Overall Study|Move/Left to another country/city|0|||
37802740|NCT01723254|69448211|FG002|Overall Study|Move/Left to another country/city|2|||
37802741|NCT01723254|69448212|FG003|Overall Study|Move/Left to another country/city|1|||
37802742|NCT01723254|69448213|FG004|Overall Study|Move/Left to another country/city|1|||
37802743|NCT01723254|69448214|FG005|Overall Study|Move/Left to another country/city|0|||
37802744|NCT01723254|69448215|FG006|Overall Study|Move/Left to another country/city|0|||
37802745|NCT01723254|69448216|FG007|Overall Study|Move/Left to another country/city|0|||
37802746|NCT01723254|69448209|FG000|Overall Study|Protocol Violation|0|||
37802747|NCT01723254|69448210|FG001|Overall Study|Protocol Violation|1|||
37802748|NCT01723254|69448211|FG002|Overall Study|Protocol Violation|0|||
37802749|NCT01723254|69448212|FG003|Overall Study|Protocol Violation|0|||
37802750|NCT01723254|69448213|FG004|Overall Study|Protocol Violation|0|||
37802751|NCT01723254|69448214|FG005|Overall Study|Protocol Violation|0|||
37802752|NCT01723254|69448215|FG006|Overall Study|Protocol Violation|0|||
37802753|NCT01723254|69448216|FG007|Overall Study|Protocol Violation|0|||
37802754|NCT01723254|69448209|FG000|Overall Study|Withdrawal by Subject|1|||
37802755|NCT01723254|69448210|FG001|Overall Study|Withdrawal by Subject|2|||
37802756|NCT01723254|69448211|FG002|Overall Study|Withdrawal by Subject|1|||
37802757|NCT01723254|69448212|FG003|Overall Study|Withdrawal by Subject|0|||
37802758|NCT01723254|69448213|FG004|Overall Study|Withdrawal by Subject|1|||
37802759|NCT01723254|69448214|FG005|Overall Study|Withdrawal by Subject|1|||
37802760|NCT01723254|69448215|FG006|Overall Study|Withdrawal by Subject|1|||
37802761|NCT01723254|69448216|FG007|Overall Study|Withdrawal by Subject|2|||
37975768|NCT00507728|69663018|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
37975769|NCT00498368|69663034|FG000|Overall Study|Withdrawal by Subject|3|||
37975770|NCT00498368|69663035|FG001|Overall Study|Withdrawal by Subject|2|||
37975771|NCT00385671|69663044|FG000|Overall Study|Adverse Event|14|||
37975772|NCT00385671|69663045|FG001|Overall Study|Adverse Event|27|||
37802762|NCT01722162|69448236|FG000|Overall Study|Withdrawal by Subject|1|||
37802763|NCT01722162|69448237|FG001|Overall Study|Withdrawal by Subject|1|||
37802764|NCT01722162|69448236|FG000|Overall Study|Found ineligible|1|||
37802765|NCT01722162|69448237|FG001|Overall Study|Found ineligible|0|||
37802766|NCT01722162|69448236|FG000|Overall Study|Unrelated to study adverse event|2|||
37802767|NCT01722162|69448237|FG001|Overall Study|Unrelated to study adverse event|2|||
37802768|NCT01722162|69448236|FG000|Overall Study|Adverse Event|1|||
37802769|NCT01722162|69448237|FG001|Overall Study|Adverse Event|1|||
37802770|NCT01722162|69448236|FG000|Overall Study|Insurance denial post enrollment|0|||
37802771|NCT01722162|69448237|FG001|Overall Study|Insurance denial post enrollment|1|||
37975773|NCT00385671|69663046|FG002|Overall Study|Adverse Event|18|||
37802772|NCT01722162|69448236|FG000|Overall Study|Noncompliance|0|||
37802773|NCT01722162|69448237|FG001|Overall Study|Noncompliance|1|||
37802774|NCT01721772|69448245|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
37802775|NCT01721772|69448246|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
37802776|NCT01721772|69448245|FG000|Pre-Treatment|Poor/non-compliance|0|||
37802777|NCT01721772|69448246|FG001|Pre-Treatment|Poor/non-compliance|1|||
37802778|NCT01721772|69448245|FG000|Pre-Treatment|Participant withdrew consent|0|||
37802779|NCT01721772|69448246|FG001|Pre-Treatment|Participant withdrew consent|1|||
37802780|NCT01721772|69448245|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
37802781|NCT01721772|69448246|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
37802782|NCT01721772|69448245|FG000|Treatment|Disease progression|119|||
37802783|NCT01721772|69448246|FG001|Treatment|Disease progression|168|||
37802784|NCT01721772|69448245|FG000|Treatment|Study drug toxicity|19|||
37802785|NCT01721772|69448246|FG001|Treatment|Study drug toxicity|10|||
37802786|NCT01721772|69448245|FG000|Treatment|Adverse event unrelated to study drug|7|||
37802787|NCT01721772|69448246|FG001|Treatment|Adverse event unrelated to study drug|7|||
37802788|NCT01721772|69448245|FG000|Treatment|Maximum clinical benefit|16|||
37802789|NCT01721772|69448246|FG001|Treatment|Maximum clinical benefit|4|||
37802790|NCT01721772|69448245|FG000|Treatment|Other|19|||
37802791|NCT01721772|69448246|FG001|Treatment|Other|2|||
37802792|NCT01721772|69448245|FG000|Treatment|Participant withdrew consent|2|||
37802793|NCT01721772|69448246|FG001|Treatment|Participant withdrew consent|5|||
37802794|NCT01721772|69448245|FG000|Treatment|Participant request to discontinue study treatment|21|||
37802795|NCT01721772|69448246|FG001|Treatment|Participant request to discontinue study treatment|8|||
37802796|NCT01721772|69448245|FG000|Treatment|Death|1|||
37802797|NCT01721772|69448246|FG001|Treatment|Death|0|||
37802798|NCT01721772|69448245|FG000|Treatment|Not reported|1|||
37802799|NCT01721772|69448246|FG001|Treatment|Not reported|0|||
37802800|NCT01721772|69448245|FG000|Treatment|Poor/non-compliance|1|||
37802801|NCT01721772|69448246|FG001|Treatment|Poor/non-compliance|0|||
37802802|NCT01721772|69448245|FG000|Treatment|Lost to Follow-up|0|||
37802803|NCT01721772|69448246|FG001|Treatment|Lost to Follow-up|1|||
37802804|NCT01702428|69448256|FG000|Overall Study|Adverse Event|2|||
37802805|NCT01702428|69448257|FG001|Overall Study|Adverse Event|0|||
37802806|NCT01702428|69448258|FG002|Overall Study|Adverse Event|0|||
37802807|NCT01702428|69448259|FG003|Overall Study|Adverse Event|0|||
37802808|NCT01702428|69448256|FG000|Overall Study|Lost to Follow-up|33|||
37802809|NCT01702428|69448257|FG001|Overall Study|Lost to Follow-up|41|||
37802810|NCT01702428|69448258|FG002|Overall Study|Lost to Follow-up|37|||
37802811|NCT01702428|69448259|FG003|Overall Study|Lost to Follow-up|44|||
37802812|NCT01702428|69448256|FG000|Overall Study|Parents cannot assist to site|1|||
37802813|NCT01702428|69448257|FG001|Overall Study|Parents cannot assist to site|0|||
37802814|NCT01702428|69448258|FG002|Overall Study|Parents cannot assist to site|1|||
37802815|NCT01702428|69448259|FG003|Overall Study|Parents cannot assist to site|0|||
37802816|NCT01702428|69448256|FG000|Overall Study|Lost Coverage|0|||
37802817|NCT01702428|69448257|FG001|Overall Study|Lost Coverage|0|||
37802818|NCT01702428|69448258|FG002|Overall Study|Lost Coverage|0|||
37802819|NCT01702428|69448259|FG003|Overall Study|Lost Coverage|1|||
37802820|NCT01702428|69448256|FG000|Overall Study|Lost Health Plan|3|||
37802821|NCT01702428|69448257|FG001|Overall Study|Lost Health Plan|5|||
37802822|NCT01702428|69448258|FG002|Overall Study|Lost Health Plan|0|||
37802823|NCT01702428|69448259|FG003|Overall Study|Lost Health Plan|2|||
37802824|NCT01702428|69448256|FG000|Overall Study|Mother transferred care|0|||
37802825|NCT01702428|69448257|FG001|Overall Study|Mother transferred care|1|||
37802826|NCT01702428|69448258|FG002|Overall Study|Mother transferred care|0|||
37802827|NCT01702428|69448259|FG003|Overall Study|Mother transferred care|0|||
37802828|NCT01702428|69448256|FG000|Overall Study|Parents too busy|1|||
37802829|NCT01702428|69448257|FG001|Overall Study|Parents too busy|0|||
37802830|NCT01702428|69448258|FG002|Overall Study|Parents too busy|0|||
37802831|NCT01702428|69448259|FG003|Overall Study|Parents too busy|0|||
37802832|NCT01702428|69448256|FG000|Overall Study|Protocol Violation|3|||
37802833|NCT01702428|69448257|FG001|Overall Study|Protocol Violation|0|||
37802834|NCT01702428|69448258|FG002|Overall Study|Protocol Violation|1|||
37802835|NCT01702428|69448259|FG003|Overall Study|Protocol Violation|0|||
37802836|NCT01702428|69448256|FG000|Overall Study|Withdrawal by Subject|21|||
37802837|NCT01702428|69448257|FG001|Overall Study|Withdrawal by Subject|23|||
37802838|NCT01702428|69448258|FG002|Overall Study|Withdrawal by Subject|14|||
37802839|NCT01702428|69448259|FG003|Overall Study|Withdrawal by Subject|10|||
37802840|NCT01701258|69448280|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
37802841|NCT01701258|69448281|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
37802842|NCT01701258|69448282|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
37975774|NCT00385671|69663044|FG000|Overall Study|Lack of Efficacy|5|||
37802843|NCT01701258|69448283|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
37802844|NCT01701258|69448284|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
37802845|NCT01701258|69448285|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
37802846|NCT01701258|69448286|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
37802847|NCT01701258|69448287|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
37802848|NCT01701258|69448288|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
37802849|NCT01701258|69448289|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
37802850|NCT01701258|69448290|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
37802851|NCT01701258|69448291|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
37802852|NCT01701258|69448292|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
37802853|NCT01701258|69448280|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
37802854|NCT01701258|69448281|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
37802855|NCT01701258|69448282|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
37802856|NCT01701258|69448283|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
37802857|NCT01701258|69448284|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
37802858|NCT01701258|69448285|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
37802859|NCT01701258|69448286|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
37802860|NCT01701258|69448287|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
37802861|NCT01701258|69448288|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
37802862|NCT01701258|69448289|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
37802863|NCT01701258|69448290|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
37802864|NCT01701258|69448291|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
37802865|NCT01701258|69448292|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
37802866|NCT01701258|69448280|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
37802867|NCT01701258|69448281|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
37802868|NCT01701258|69448282|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
37802869|NCT01701258|69448283|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
37802870|NCT01701258|69448284|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
37802871|NCT01701258|69448285|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
37802872|NCT01701258|69448286|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
37802873|NCT01701258|69448287|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
37802874|NCT01701258|69448288|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
37802875|NCT01701258|69448289|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
37802876|NCT01701258|69448290|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
37802877|NCT01701258|69448291|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
37802878|NCT01701258|69448292|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
37802879|NCT01701258|69448280|FG000|Assessment and Scheduling|Investigator Terminated|2|||
37802880|NCT01701258|69448281|FG001|Assessment and Scheduling|Investigator Terminated|0|||
37802881|NCT01701258|69448282|FG002|Assessment and Scheduling|Investigator Terminated|0|||
37802882|NCT01701258|69448283|FG003|Assessment and Scheduling|Investigator Terminated|0|||
37802883|NCT01701258|69448284|FG004|Assessment and Scheduling|Investigator Terminated|0|||
37802884|NCT01701258|69448285|FG005|Assessment and Scheduling|Investigator Terminated|0|||
37802885|NCT01701258|69448286|FG006|Assessment and Scheduling|Investigator Terminated|0|||
37802886|NCT01701258|69448287|FG007|Assessment and Scheduling|Investigator Terminated|0|||
37802887|NCT01701258|69448288|FG008|Assessment and Scheduling|Investigator Terminated|0|||
37802888|NCT01701258|69448289|FG009|Assessment and Scheduling|Investigator Terminated|0|||
37802889|NCT01701258|69448290|FG010|Assessment and Scheduling|Investigator Terminated|0|||
37802890|NCT01701258|69448291|FG011|Assessment and Scheduling|Investigator Terminated|0|||
37802891|NCT01701258|69448292|FG012|Assessment and Scheduling|Investigator Terminated|0|||
37802892|NCT01700946|69448322|FG000|Overall Study|Lost to Follow-up|1|||
37802893|NCT01700946|69448323|FG001|Overall Study|Lost to Follow-up|0|||
37802894|NCT01700946|69448322|FG000|Overall Study|Physician Decision|7|||
37802895|NCT01700946|69448323|FG001|Overall Study|Physician Decision|12|||
37802896|NCT01700946|69448322|FG000|Overall Study|Withdrawal by Subject|0|||
37802897|NCT01700946|69448323|FG001|Overall Study|Withdrawal by Subject|2|||
37802898|NCT01700946|69448322|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
37802899|NCT01700946|69448323|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
37802900|NCT01700946|69448322|FG000|Overall Study|Relapse|2|||
37802901|NCT01700946|69448323|FG001|Overall Study|Relapse|1|||
37802902|NCT01700946|69448322|FG000|Overall Study|Unacceptable toxicity|1|||
37802903|NCT01700946|69448323|FG001|Overall Study|Unacceptable toxicity|0|||
37802904|NCT01748994|69448335|FG000|Overall Study|Lost to Follow-up|8|||
37802905|NCT01748994|69448336|FG001|Overall Study|Lost to Follow-up|6|||
37802906|NCT01721070|69448342|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
37802907|NCT01748760|69448351|FG000|Overall Study|Withdrawal by Subject|1|||
37802908|NCT01748760|69448352|FG001|Overall Study|Withdrawal by Subject|1|||
37802909|NCT01748760|69448351|FG000|Overall Study|Lost to Follow-up|5|||
37802910|NCT01748760|69448352|FG001|Overall Study|Lost to Follow-up|1|||
37802911|NCT01748292|69448360|FG000|Overall Study|Adverse Event|2|||
37802912|NCT01748292|69448361|FG001|Overall Study|Adverse Event|4|||
37802913|NCT01748292|69448360|FG000|Overall Study|Lost to Follow-up|0|||
37802914|NCT01748292|69448361|FG001|Overall Study|Lost to Follow-up|3|||
37802915|NCT01748292|69448360|FG000|Overall Study|Death|0|||
37802916|NCT01748292|69448361|FG001|Overall Study|Death|3|||
37802917|NCT01748292|69448360|FG000|Overall Study|Withdrawal by Subject|0|||
37802918|NCT01748292|69448361|FG001|Overall Study|Withdrawal by Subject|2|||
37802919|NCT01720602|69448367|FG000|Overall Study|Adverse Event|3|||
37802920|NCT01720602|69448367|FG000|Overall Study|Progressive disease on therapy|2|||
37802921|NCT01746732|69448371|FG000|Lead-In Period|Withdrawal by Subject|1|||
37802922|NCT01746732|69448372|FG001|Lead-In Period|Withdrawal by Subject|0|||
37802923|NCT01746732|69448373|FG002|Lead-In Period|Withdrawal by Subject|0|||
37802924|NCT01746732|69448371|FG000|Period 1|Physician Decision|0|||
37802925|NCT01746732|69448372|FG001|Period 1|Physician Decision|1|||
37802926|NCT01746732|69448373|FG002|Period 1|Physician Decision|0|||
37802927|NCT01746732|69448371|FG000|Period 2|Withdrawal by Subject|0|||
37802928|NCT01746732|69448372|FG001|Period 2|Withdrawal by Subject|0|||
37802929|NCT01746732|69448373|FG002|Period 2|Withdrawal by Subject|2|||
37802930|NCT01746732|69448371|FG000|Period 2|Adverse Event|0|||
37802931|NCT01746732|69448372|FG001|Period 2|Adverse Event|0|||
37802932|NCT01746732|69448373|FG002|Period 2|Adverse Event|1|||
37802933|NCT01746732|69448371|FG000|Period 2|Lost to Follow-up|0|||
37802934|NCT01746732|69448372|FG001|Period 2|Lost to Follow-up|0|||
37802935|NCT01746732|69448373|FG002|Period 2|Lost to Follow-up|1|||
37802936|NCT01720524|69448383|FG000|Part A|Insufficient Clinical Response|2|||
37802937|NCT01720524|69448384|FG001|Part A|Insufficient Clinical Response|4|||
37802938|NCT01720524|69448383|FG000|Part A|Adverse Event|2|||
37802939|NCT01720524|69448384|FG001|Part A|Adverse Event|2|||
37802940|NCT01720524|69448383|FG000|Part A|Death|2|||
37802941|NCT01720524|69448384|FG001|Part A|Death|1|||
37802942|NCT01720524|69448383|FG000|Part A|Lost to Follow-up|0|||
37802943|NCT01720524|69448384|FG001|Part A|Lost to Follow-up|1|||
37802944|NCT01720524|69448383|FG000|Part A|Missed 28 day follow-up visit|1|||
37802945|NCT01720524|69448384|FG001|Part A|Missed 28 day follow-up visit|1|||
37802946|NCT01720524|69448383|FG000|Part A|Withdrawal by Subject|0|||
37802947|NCT01720524|69448384|FG001|Part A|Withdrawal by Subject|1|||
37802948|NCT01720524|69448383|FG000|Part A|Other|0|||
37802949|NCT01720524|69448384|FG001|Part A|Other|1|||
37802950|NCT01720524|69448383|FG000|Part A|Lost to Follow-up|0|||
37802951|NCT01720524|69448384|FG001|Part A|Lost to Follow-up|1|||
37802952|NCT01720524|69448383|FG000|Part B|No longer willing to participate in study|1|||
37802953|NCT01720524|69448384|FG001|Part B|No longer willing to participate in study|4|||
37802954|NCT01720524|69448383|FG000|Part B|Other|2|||
37802955|NCT01720524|69448384|FG001|Part B|Other|0|||
37802956|NCT01720524|69448383|FG000|Part B|Lost to Follow-up|2|||
37802957|NCT01720524|69448384|FG001|Part B|Lost to Follow-up|3|||
37802958|NCT01720524|69448383|FG000|Part B|Death|0|||
37802959|NCT01720524|69448384|FG001|Part B|Death|2|||
37802960|NCT01720446|69448396|FG000|Overall Study|Lost to Follow-up|12|||
37802961|NCT01720446|69448397|FG001|Overall Study|Lost to Follow-up|6|||
37802962|NCT01720446|69448398|FG002|Overall Study|Lost to Follow-up|16|||
37802963|NCT01720446|69448399|FG003|Overall Study|Lost to Follow-up|16|||
37802964|NCT01720446|69448396|FG000|Overall Study|Withdrawal by Subject|2|||
37802965|NCT01720446|69448397|FG001|Overall Study|Withdrawal by Subject|5|||
37802966|NCT01720446|69448398|FG002|Overall Study|Withdrawal by Subject|4|||
37802967|NCT01720446|69448399|FG003|Overall Study|Withdrawal by Subject|4|||
37802968|NCT01746108|69448415|FG000|Overall Study|Migrated /moved from study area|0|||
37802969|NCT01746108|69448416|FG001|Overall Study|Migrated /moved from study area|1|||
37802970|NCT01746108|69448417|FG002|Overall Study|Migrated /moved from study area|0|||
37802971|NCT01746108|69448415|FG000|Overall Study|Adverse event, non-fatal|0|||
37802972|NCT01746108|69448416|FG001|Overall Study|Adverse event, non-fatal|1|||
37802973|NCT01746108|69448417|FG002|Overall Study|Adverse event, non-fatal|0|||
37802974|NCT01746108|69448415|FG000|Overall Study|Withdrawal by Subject|0|||
37802975|NCT01746108|69448416|FG001|Overall Study|Withdrawal by Subject|1|||
37802976|NCT01746108|69448417|FG002|Overall Study|Withdrawal by Subject|0|||
37802977|NCT01746108|69448415|FG000|Overall Study|Lost to Follow-up|0|||
37802978|NCT01746108|69448416|FG001|Overall Study|Lost to Follow-up|1|||
37802979|NCT01746108|69448417|FG002|Overall Study|Lost to Follow-up|0|||
37802980|NCT01717638|69448446|FG000|Overall Study|Lost to Follow-up|0|||
37802981|NCT01717638|69448447|FG001|Overall Study|Lost to Follow-up|0|||
37802982|NCT01717638|69448448|FG002|Overall Study|Lost to Follow-up|0|||
37802983|NCT01717638|69448449|FG003|Overall Study|Lost to Follow-up|0|||
37802984|NCT01717638|69448450|FG004|Overall Study|Lost to Follow-up|0|||
37802985|NCT01717638|69448451|FG005|Overall Study|Lost to Follow-up|1|||
37802986|NCT01717638|69448452|FG006|Overall Study|Lost to Follow-up|0|||
37802987|NCT01717638|69448453|FG007|Overall Study|Lost to Follow-up|0|||
37802988|NCT01717638|69448454|FG008|Overall Study|Lost to Follow-up|0|||
37802989|NCT01717638|69448455|FG009|Overall Study|Lost to Follow-up|0|||
37802990|NCT01717638|69448456|FG010|Overall Study|Lost to Follow-up|0|||
37802991|NCT01717638|69448457|FG011|Overall Study|Lost to Follow-up|0|||
37802992|NCT01717638|69448458|FG012|Overall Study|Lost to Follow-up|0|||
37802993|NCT01717638|69448446|FG000|Overall Study|Father in hospital|0|||
37802994|NCT01717638|69448447|FG001|Overall Study|Father in hospital|0|||
37802995|NCT01717638|69448448|FG002|Overall Study|Father in hospital|0|||
37802996|NCT01717638|69448449|FG003|Overall Study|Father in hospital|0|||
37802997|NCT01717638|69448450|FG004|Overall Study|Father in hospital|0|||
37802998|NCT01717638|69448451|FG005|Overall Study|Father in hospital|0|||
37802999|NCT01717638|69448452|FG006|Overall Study|Father in hospital|0|||
37803000|NCT01717638|69448453|FG007|Overall Study|Father in hospital|0|||
37803001|NCT01717638|69448454|FG008|Overall Study|Father in hospital|0|||
37803002|NCT01717638|69448455|FG009|Overall Study|Father in hospital|0|||
37803003|NCT01717638|69448456|FG010|Overall Study|Father in hospital|0|||
37803004|NCT01717638|69448457|FG011|Overall Study|Father in hospital|0|||
37803005|NCT01717638|69448458|FG012|Overall Study|Father in hospital|1|||
37803006|NCT01717638|69448446|FG000|Overall Study|Withdrawal by Subject|0|||
37803007|NCT01717638|69448447|FG001|Overall Study|Withdrawal by Subject|1|||
37803008|NCT01717638|69448448|FG002|Overall Study|Withdrawal by Subject|1|||
37803009|NCT01717638|69448449|FG003|Overall Study|Withdrawal by Subject|0|||
37803010|NCT01717638|69448450|FG004|Overall Study|Withdrawal by Subject|1|||
37803011|NCT01717638|69448451|FG005|Overall Study|Withdrawal by Subject|0|||
37803012|NCT01717638|69448452|FG006|Overall Study|Withdrawal by Subject|2|||
37803013|NCT01717638|69448453|FG007|Overall Study|Withdrawal by Subject|1|||
37803014|NCT01717638|69448454|FG008|Overall Study|Withdrawal by Subject|2|||
37803015|NCT01717638|69448455|FG009|Overall Study|Withdrawal by Subject|1|||
37803016|NCT01717638|69448456|FG010|Overall Study|Withdrawal by Subject|0|||
37803017|NCT01717638|69448457|FG011|Overall Study|Withdrawal by Subject|0|||
37803018|NCT01717638|69448458|FG012|Overall Study|Withdrawal by Subject|18|||
37803019|NCT01745094|69448496|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
37803020|NCT01745094|69448497|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
37803021|NCT01745094|69448498|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
37803022|NCT01745094|69448499|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
37803023|NCT01745094|69448496|FG000|Overall Study|Adverse Event|0|||
37803024|NCT01745094|69448497|FG001|Overall Study|Adverse Event|0|||
37803025|NCT01745094|69448498|FG002|Overall Study|Adverse Event|3|||
37803026|NCT01745094|69448499|FG003|Overall Study|Adverse Event|0|||
37803027|NCT01745094|69448496|FG000|Overall Study|Withdrawal by Subject|2|||
37803028|NCT01745094|69448497|FG001|Overall Study|Withdrawal by Subject|0|||
37803029|NCT01745094|69448498|FG002|Overall Study|Withdrawal by Subject|1|||
37803030|NCT01745094|69448499|FG003|Overall Study|Withdrawal by Subject|2|||
37803031|NCT01745094|69448496|FG000|Overall Study|Protocol Violation|1|||
37803032|NCT01745094|69448497|FG001|Overall Study|Protocol Violation|0|||
37803033|NCT01745094|69448498|FG002|Overall Study|Protocol Violation|3|||
37803034|NCT01745094|69448499|FG003|Overall Study|Protocol Violation|1|||
37803035|NCT01745094|69448496|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
37803036|NCT01745094|69448497|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
37803037|NCT01745094|69448498|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
37803038|NCT01745094|69448499|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
37803039|NCT01745094|69448496|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
37803040|NCT01745094|69448497|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
37803041|NCT01745094|69448498|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
37803042|NCT01745094|69448499|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
37803043|NCT01745094|69448496|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
37803044|NCT01745094|69448497|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
37803045|NCT01745094|69448498|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
37803046|NCT01745094|69448499|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
37803047|NCT01697748|69448514|FG000|Overall Study|ineligible skin incision|1|||
37803048|NCT01697748|69448515|FG001|Overall Study|ineligible skin incision|2|||
37803049|NCT01697748|69448514|FG000|Overall Study|ineligible uterine incision|4|||
37803050|NCT01697748|69448515|FG001|Overall Study|ineligible uterine incision|1|||
37803051|NCT01697748|69448514|FG000|Overall Study|Lost to Follow-up|53|||
37803052|NCT01697748|69448515|FG001|Overall Study|Lost to Follow-up|65|||
37803053|NCT01717326|69448541|FG000|Overall Study|Death|0|||
37803054|NCT01717326|69448542|FG001|Overall Study|Death|0|||
37803055|NCT01717326|69448543|FG002|Overall Study|Death|0|||
37803056|NCT01717326|69448544|FG003|Overall Study|Death|0|||
37803057|NCT01717326|69448545|FG004|Overall Study|Death|0|||
37803058|NCT01717326|69448546|FG005|Overall Study|Death|0|||
37803059|NCT01717326|69448547|FG006|Overall Study|Death|0|||
37803060|NCT01717326|69448548|FG007|Overall Study|Death|0|||
37803061|NCT01717326|69448549|FG008|Overall Study|Death|0|||
37803062|NCT01717326|69448550|FG009|Overall Study|Death|0|||
37803063|NCT01717326|69448551|FG010|Overall Study|Death|1|||
37803064|NCT01717326|69448552|FG011|Overall Study|Death|0|||
37803065|NCT01717326|69448553|FG012|Overall Study|Death|0|||
37803066|NCT01717326|69448554|FG013|Overall Study|Death|0|||
37803067|NCT01717326|69448555|FG014|Overall Study|Death|0|||
37803068|NCT01717326|69448556|FG015|Overall Study|Death|0|||
37803069|NCT01717326|69448557|FG016|Overall Study|Death|0|||
37803070|NCT01717326|69448558|FG017|Overall Study|Death|0|||
37693999|NCT02352493|69170266|FG004|Overall Study|Lost to Follow-up|0|||
37694000|NCT02352493|69170267|FG005|Overall Study|Lost to Follow-up|0|||
37803071|NCT01717326|69448559|FG018|Overall Study|Death|0|||
37803072|NCT01717326|69448560|FG019|Overall Study|Death|0|||
37803073|NCT01717326|69448541|FG000|Overall Study|Lost to Follow-up|3|||
37694001|NCT02352493|69170268|FG006|Overall Study|Lost to Follow-up|0|||
37694002|NCT02352493|69170269|FG007|Overall Study|Lost to Follow-up|0|||
37803074|NCT01717326|69448542|FG001|Overall Study|Lost to Follow-up|0|||
37803075|NCT01717326|69448543|FG002|Overall Study|Lost to Follow-up|0|||
37803076|NCT01717326|69448544|FG003|Overall Study|Lost to Follow-up|2|||
37803077|NCT01717326|69448545|FG004|Overall Study|Lost to Follow-up|1|||
37803078|NCT01717326|69448546|FG005|Overall Study|Lost to Follow-up|0|||
37803079|NCT01717326|69448547|FG006|Overall Study|Lost to Follow-up|1|||
37803080|NCT01717326|69448548|FG007|Overall Study|Lost to Follow-up|0|||
37803081|NCT01717326|69448549|FG008|Overall Study|Lost to Follow-up|0|||
37803082|NCT01717326|69448550|FG009|Overall Study|Lost to Follow-up|0|||
37803083|NCT01717326|69448551|FG010|Overall Study|Lost to Follow-up|1|||
37803084|NCT01717326|69448552|FG011|Overall Study|Lost to Follow-up|0|||
37803085|NCT01717326|69448553|FG012|Overall Study|Lost to Follow-up|0|||
37803086|NCT01717326|69448554|FG013|Overall Study|Lost to Follow-up|0|||
37803087|NCT01717326|69448555|FG014|Overall Study|Lost to Follow-up|0|||
37803088|NCT01717326|69448556|FG015|Overall Study|Lost to Follow-up|2|||
37803089|NCT01717326|69448557|FG016|Overall Study|Lost to Follow-up|1|||
37803090|NCT01717326|69448558|FG017|Overall Study|Lost to Follow-up|0|||
37803091|NCT01717326|69448559|FG018|Overall Study|Lost to Follow-up|2|||
37803092|NCT01717326|69448560|FG019|Overall Study|Lost to Follow-up|3|||
37803093|NCT01717326|69448541|FG000|Overall Study|Physician Decision|0|||
37803094|NCT01717326|69448542|FG001|Overall Study|Physician Decision|0|||
37803095|NCT01717326|69448543|FG002|Overall Study|Physician Decision|0|||
37803096|NCT01717326|69448544|FG003|Overall Study|Physician Decision|0|||
37803097|NCT01717326|69448545|FG004|Overall Study|Physician Decision|0|||
37803098|NCT01717326|69448546|FG005|Overall Study|Physician Decision|0|||
37803099|NCT01717326|69448547|FG006|Overall Study|Physician Decision|0|||
37803100|NCT01717326|69448548|FG007|Overall Study|Physician Decision|0|||
37803101|NCT01717326|69448549|FG008|Overall Study|Physician Decision|0|||
37803102|NCT01717326|69448550|FG009|Overall Study|Physician Decision|1|||
37803103|NCT01717326|69448551|FG010|Overall Study|Physician Decision|0|||
37803104|NCT01717326|69448552|FG011|Overall Study|Physician Decision|0|||
37803105|NCT01717326|69448553|FG012|Overall Study|Physician Decision|0|||
37803106|NCT01717326|69448554|FG013|Overall Study|Physician Decision|0|||
37803107|NCT01717326|69448555|FG014|Overall Study|Physician Decision|0|||
37803108|NCT01717326|69448556|FG015|Overall Study|Physician Decision|0|||
37803109|NCT01717326|69448557|FG016|Overall Study|Physician Decision|0|||
37803110|NCT01717326|69448558|FG017|Overall Study|Physician Decision|0|||
37803111|NCT01717326|69448559|FG018|Overall Study|Physician Decision|0|||
37803112|NCT01717326|69448560|FG019|Overall Study|Physician Decision|0|||
37975775|NCT00385671|69663045|FG001|Overall Study|Lack of Efficacy|9|||
37975776|NCT00385671|69663046|FG002|Overall Study|Lack of Efficacy|5|||
37975777|NCT00385671|69663044|FG000|Overall Study|Lost to Follow-up|6|||
37975778|NCT00385671|69663045|FG001|Overall Study|Lost to Follow-up|6|||
37975779|NCT00385671|69663046|FG002|Overall Study|Lost to Follow-up|5|||
37975780|NCT00385671|69663044|FG000|Overall Study|Physician Decision|2|||
37975781|NCT00385671|69663045|FG001|Overall Study|Physician Decision|1|||
37975782|NCT00385671|69663046|FG002|Overall Study|Physician Decision|2|||
37975783|NCT00385671|69663044|FG000|Overall Study|Protocol Violation|5|||
37975784|NCT00385671|69663045|FG001|Overall Study|Protocol Violation|2|||
37975785|NCT00385671|69663046|FG002|Overall Study|Protocol Violation|1|||
37975786|NCT00385671|69663044|FG000|Overall Study|Sponsor Decision|2|||
37975787|NCT00385671|69663045|FG001|Overall Study|Sponsor Decision|2|||
37975788|NCT00385671|69663046|FG002|Overall Study|Sponsor Decision|1|||
37694003|NCT02352493|69170270|FG008|Overall Study|Lost to Follow-up|0|||
37803113|NCT01717326|69448541|FG000|Overall Study|Protocol Violation|0|||
37803114|NCT01717326|69448542|FG001|Overall Study|Protocol Violation|0|||
37803115|NCT01717326|69448543|FG002|Overall Study|Protocol Violation|0|||
37803116|NCT01717326|69448544|FG003|Overall Study|Protocol Violation|0|||
37803117|NCT01717326|69448545|FG004|Overall Study|Protocol Violation|1|||
37803118|NCT01717326|69448546|FG005|Overall Study|Protocol Violation|0|||
37803119|NCT01717326|69448547|FG006|Overall Study|Protocol Violation|0|||
37803120|NCT01717326|69448548|FG007|Overall Study|Protocol Violation|0|||
37803121|NCT01717326|69448549|FG008|Overall Study|Protocol Violation|0|||
37803122|NCT01717326|69448550|FG009|Overall Study|Protocol Violation|0|||
37803123|NCT01717326|69448551|FG010|Overall Study|Protocol Violation|0|||
37975789|NCT00385671|69663044|FG000|Overall Study|Withdrawal by Subject|4|||
37975790|NCT00385671|69663045|FG001|Overall Study|Withdrawal by Subject|4|||
37975791|NCT00385671|69663046|FG002|Overall Study|Withdrawal by Subject|4|||
37864259|NCT00986830|69547848|FG000|Overall Study|Unable to access sinus with device|5|||
37803124|NCT01717326|69448552|FG011|Overall Study|Protocol Violation|0|||
37803125|NCT01717326|69448553|FG012|Overall Study|Protocol Violation|0|||
37803126|NCT01717326|69448554|FG013|Overall Study|Protocol Violation|0|||
37803127|NCT01717326|69448555|FG014|Overall Study|Protocol Violation|0|||
37803128|NCT01717326|69448556|FG015|Overall Study|Protocol Violation|0|||
37803129|NCT01717326|69448557|FG016|Overall Study|Protocol Violation|0|||
37803130|NCT01717326|69448558|FG017|Overall Study|Protocol Violation|0|||
37803131|NCT01717326|69448559|FG018|Overall Study|Protocol Violation|0|||
37803132|NCT01717326|69448560|FG019|Overall Study|Protocol Violation|0|||
37975792|NCT00497198|69663058|FG000|Overall Study|Adverse Event|4|||
37975793|NCT00497198|69663059|FG001|Overall Study|Adverse Event|2|||
37803133|NCT01717326|69448541|FG000|Overall Study|Withdrawal by Subject|0|||
37975794|NCT00497198|69663058|FG000|Overall Study|Physician Decision|1|||
37975795|NCT00497198|69663059|FG001|Overall Study|Physician Decision|2|||
37803134|NCT01717326|69448542|FG001|Overall Study|Withdrawal by Subject|1|||
37803135|NCT01717326|69448543|FG002|Overall Study|Withdrawal by Subject|0|||
37803136|NCT01717326|69448544|FG003|Overall Study|Withdrawal by Subject|0|||
37803137|NCT01717326|69448545|FG004|Overall Study|Withdrawal by Subject|0|||
37803138|NCT01717326|69448546|FG005|Overall Study|Withdrawal by Subject|0|||
37803139|NCT01717326|69448547|FG006|Overall Study|Withdrawal by Subject|0|||
37803140|NCT01717326|69448548|FG007|Overall Study|Withdrawal by Subject|0|||
37803141|NCT01717326|69448549|FG008|Overall Study|Withdrawal by Subject|0|||
37803142|NCT01717326|69448550|FG009|Overall Study|Withdrawal by Subject|1|||
37803143|NCT01717326|69448551|FG010|Overall Study|Withdrawal by Subject|0|||
37803144|NCT01717326|69448552|FG011|Overall Study|Withdrawal by Subject|0|||
37803145|NCT01717326|69448553|FG012|Overall Study|Withdrawal by Subject|1|||
37803146|NCT01717326|69448554|FG013|Overall Study|Withdrawal by Subject|0|||
37803147|NCT01717326|69448555|FG014|Overall Study|Withdrawal by Subject|0|||
37803148|NCT01717326|69448556|FG015|Overall Study|Withdrawal by Subject|1|||
37803149|NCT01717326|69448557|FG016|Overall Study|Withdrawal by Subject|0|||
37803150|NCT01717326|69448558|FG017|Overall Study|Withdrawal by Subject|0|||
37803151|NCT01717326|69448559|FG018|Overall Study|Withdrawal by Subject|2|||
37803152|NCT01717326|69448560|FG019|Overall Study|Withdrawal by Subject|3|||
37803153|NCT01697592|69448612|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
37803154|NCT01697592|69448613|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
37803155|NCT01697592|69448614|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
37803156|NCT01697592|69448615|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
37803157|NCT01697592|69448616|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
37803158|NCT01697592|69448617|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
37803159|NCT01697592|69448618|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
37803160|NCT01697592|69448619|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
37803161|NCT01697592|69448620|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
37803162|NCT01697592|69448621|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
37803163|NCT01697592|69448612|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
37803164|NCT01697592|69448613|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
37803165|NCT01697592|69448614|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
37803166|NCT01697592|69448615|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
37803167|NCT01697592|69448616|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
37803168|NCT01697592|69448617|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
37803169|NCT01697592|69448618|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
37803170|NCT01697592|69448619|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
37803171|NCT01697592|69448620|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
37803172|NCT01697592|69448621|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
37803173|NCT01697592|69448612|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
37803174|NCT01697592|69448613|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
37803175|NCT01697592|69448614|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
37803176|NCT01697592|69448615|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
37803177|NCT01697592|69448616|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
37803178|NCT01697592|69448617|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
37803179|NCT01697592|69448618|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
37803180|NCT01697592|69448619|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
37803181|NCT01697592|69448620|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
37803182|NCT01697592|69448621|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
37803183|NCT01697592|69448612|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
37803184|NCT01697592|69448613|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
37803185|NCT01697592|69448614|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
37803186|NCT01697592|69448615|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
37803187|NCT01697592|69448616|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
37803188|NCT01697592|69448617|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
37803189|NCT01697592|69448618|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
37975796|NCT00497198|69663058|FG000|Overall Study|Withdrawal by Subject|0|||
37975797|NCT00497198|69663059|FG001|Overall Study|Withdrawal by Subject|1|||
37975798|NCT00496964|69663067|FG000|Overall Study|Withdrawal by Subject|0|||
37975799|NCT00496964|69663068|FG001|Overall Study|Withdrawal by Subject|1|||
37975800|NCT00490490|69663076|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
37975801|NCT00490490|69663076|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
37975802|NCT00385593|69663082|FG000|Overall Study|Adverse Event|3|||
37975803|NCT00385593|69663083|FG001|Overall Study|Adverse Event|2|||
37975804|NCT00385593|69663082|FG000|Overall Study|Withdrawal by Subject|17|||
37975805|NCT00385593|69663083|FG001|Overall Study|Withdrawal by Subject|7|||
37975806|NCT00385593|69663082|FG000|Overall Study|Lost to Follow-up|12|||
37975807|NCT00385593|69663083|FG001|Overall Study|Lost to Follow-up|8|||
37975808|NCT00385593|69663082|FG000|Overall Study|Protocol Violation|7|||
37975809|NCT00385593|69663083|FG001|Overall Study|Protocol Violation|4|||
37975810|NCT00385593|69663082|FG000|Overall Study|Several reasons|17|||
37975811|NCT00385593|69663083|FG001|Overall Study|Several reasons|15|||
37975812|NCT00385593|69663082|FG000|Overall Study|Incorrect inclusion|2|||
37975813|NCT00385593|69663083|FG001|Overall Study|Incorrect inclusion|0|||
37975814|NCT00385593|69663082|FG000|Overall Study|Incorrect randomization|0|||
37975815|NCT00385593|69663083|FG001|Overall Study|Incorrect randomization|1|||
37975816|NCT00495794|69663091|FG000|Overall Study|Pharmacist did not activate patient|522|||
37975817|NCT00495794|69663092|FG001|Overall Study|Pharmacist did not activate patient|0|||
37975818|NCT00495170|69663098|FG000|Overall Study|Lost to Follow-up|9|||
37803190|NCT01697592|69448619|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
37803191|NCT01697592|69448620|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
37803192|NCT01697592|69448621|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
37803193|NCT01697592|69448612|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
37803194|NCT01697592|69448613|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
37803195|NCT01697592|69448614|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
37803196|NCT01697592|69448615|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
37803197|NCT01697592|69448616|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
37803198|NCT01697592|69448617|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
37803199|NCT01697592|69448618|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
37803200|NCT01697592|69448619|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
37803201|NCT01697592|69448620|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
37803202|NCT01697592|69448621|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
37803203|NCT01697592|69448612|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
37803204|NCT01697592|69448613|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
37803205|NCT01697592|69448614|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
37803206|NCT01697592|69448615|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
37803207|NCT01697592|69448616|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
37803208|NCT01697592|69448617|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
37803209|NCT01697592|69448618|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
37803210|NCT01697592|69448619|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
37803211|NCT01697592|69448620|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
37803212|NCT01697592|69448621|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
37803213|NCT01697592|69448612|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
37803214|NCT01697592|69448613|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
37803215|NCT01697592|69448614|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
37803216|NCT01697592|69448615|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
37803217|NCT01697592|69448616|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
37803218|NCT01697592|69448617|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
37803219|NCT01697592|69448618|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
37803220|NCT01697592|69448619|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
37803221|NCT01697592|69448620|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
37803222|NCT01697592|69448621|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
37803223|NCT01697592|69448612|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
37803224|NCT01697592|69448613|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
37803225|NCT01697592|69448614|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
37803226|NCT01697592|69448615|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
37803227|NCT01697592|69448616|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
37803228|NCT01697592|69448617|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
37803229|NCT01697592|69448618|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
37803230|NCT01697592|69448619|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
37803231|NCT01697592|69448620|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
37803232|NCT01697592|69448621|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
37803233|NCT01744782|69448657|FG000|Overall Study|Death|1|||
37803234|NCT01744392|69448661|FG000|Overall Study|Physician Decision|1|||
37803235|NCT01604850|69448668|FG000|Overall Study|Enrolled but never treated|0|||
37803236|NCT01604850|69448669|FG001|Overall Study|Enrolled but never treated|1|||
37803237|NCT01604850|69448668|FG000|Overall Study|Efficacy Failure|50|||
37803238|NCT01604850|69448669|FG001|Overall Study|Efficacy Failure|29|||
37803239|NCT01604850|69448668|FG000|Overall Study|Lost to Follow-up|1|||
37803240|NCT01604850|69448669|FG001|Overall Study|Lost to Follow-up|0|||
37803241|NCT01604850|69448668|FG000|Overall Study|Subject withdrew consent|1|||
37803242|NCT01604850|69448669|FG001|Overall Study|Subject withdrew consent|0|||
37803243|NCT01742286|69448682|FG000|Escalation Phase|Administrative problems|1|||
37803244|NCT01742286|69448683|FG001|Escalation Phase|Administrative problems|1|||
37803245|NCT01742286|69448684|FG002|Escalation Phase|Administrative problems|0|||
37803246|NCT01742286|69448685|FG003|Escalation Phase|Administrative problems|0|||
37803247|NCT01742286|69448686|FG004|Escalation Phase|Administrative problems|0|||
37803248|NCT01742286|69448687|FG005|Escalation Phase|Administrative problems|0|||
37803249|NCT01742286|69448688|FG006|Escalation Phase|Administrative problems|2|||
37803250|NCT01742286|69448682|FG000|Escalation Phase|Adverse Event|0|||
37803251|NCT01742286|69448683|FG001|Escalation Phase|Adverse Event|1|||
37803252|NCT01742286|69448684|FG002|Escalation Phase|Adverse Event|2|||
37803253|NCT01742286|69448685|FG003|Escalation Phase|Adverse Event|0|||
37803254|NCT01742286|69448686|FG004|Escalation Phase|Adverse Event|0|||
37803255|NCT01742286|69448687|FG005|Escalation Phase|Adverse Event|1|||
37803256|NCT01742286|69448688|FG006|Escalation Phase|Adverse Event|0|||
37803257|NCT01742286|69448682|FG000|Escalation Phase|Disease progression|3|||
37803258|NCT01742286|69448683|FG001|Escalation Phase|Disease progression|7|||
37803259|NCT01742286|69448684|FG002|Escalation Phase|Disease progression|4|||
37803260|NCT01742286|69448685|FG003|Escalation Phase|Disease progression|1|||
37803261|NCT01742286|69448686|FG004|Escalation Phase|Disease progression|4|||
37803262|NCT01742286|69448687|FG005|Escalation Phase|Disease progression|3|||
37803263|NCT01742286|69448688|FG006|Escalation Phase|Disease progression|2|||
37803264|NCT01742286|69448682|FG000|Escalation Phase|Death|0|||
37803265|NCT01742286|69448683|FG001|Escalation Phase|Death|0|||
37803266|NCT01742286|69448684|FG002|Escalation Phase|Death|0|||
37803267|NCT01742286|69448685|FG003|Escalation Phase|Death|0|||
37803268|NCT01742286|69448686|FG004|Escalation Phase|Death|0|||
37803269|NCT01742286|69448687|FG005|Escalation Phase|Death|1|||
37803270|NCT01742286|69448688|FG006|Escalation Phase|Death|0|||
37803271|NCT01742286|69448682|FG000|Escalation Phase|Physician Decision|0|||
37803272|NCT01742286|69448683|FG001|Escalation Phase|Physician Decision|3|||
37803273|NCT01742286|69448684|FG002|Escalation Phase|Physician Decision|0|||
37803274|NCT01742286|69448685|FG003|Escalation Phase|Physician Decision|1|||
37803275|NCT01742286|69448686|FG004|Escalation Phase|Physician Decision|0|||
37803276|NCT01742286|69448687|FG005|Escalation Phase|Physician Decision|0|||
37803277|NCT01742286|69448688|FG006|Escalation Phase|Physician Decision|2|||
37803278|NCT01742286|69448682|FG000|Escalation Phase|Subject/guardian decision|1|||
37803279|NCT01742286|69448683|FG001|Escalation Phase|Subject/guardian decision|0|||
37803280|NCT01742286|69448684|FG002|Escalation Phase|Subject/guardian decision|0|||
37803281|NCT01742286|69448685|FG003|Escalation Phase|Subject/guardian decision|0|||
37803282|NCT01742286|69448686|FG004|Escalation Phase|Subject/guardian decision|0|||
37803283|NCT01742286|69448687|FG005|Escalation Phase|Subject/guardian decision|0|||
37803284|NCT01742286|69448688|FG006|Escalation Phase|Subject/guardian decision|0|||
37803285|NCT01742286|69448682|FG000|Expansion Phase|Administrative problems|0|||
37803286|NCT01742286|69448683|FG001|Expansion Phase|Administrative problems|0|||
37803287|NCT01742286|69448684|FG002|Expansion Phase|Administrative problems|0|||
37803288|NCT01742286|69448685|FG003|Expansion Phase|Administrative problems|0|||
37803289|NCT01742286|69448686|FG004|Expansion Phase|Administrative problems|0|||
37803290|NCT01742286|69448687|FG005|Expansion Phase|Administrative problems|0|||
37803291|NCT01742286|69448688|FG006|Expansion Phase|Administrative problems|5|||
37803292|NCT01742286|69448682|FG000|Expansion Phase|Physician Decision|0|||
37803293|NCT01742286|69448683|FG001|Expansion Phase|Physician Decision|0|||
37803294|NCT01742286|69448684|FG002|Expansion Phase|Physician Decision|4|||
37803295|NCT01742286|69448685|FG003|Expansion Phase|Physician Decision|0|||
37803296|NCT01742286|69448686|FG004|Expansion Phase|Physician Decision|0|||
37803297|NCT01742286|69448687|FG005|Expansion Phase|Physician Decision|0|||
37803298|NCT01742286|69448688|FG006|Expansion Phase|Physician Decision|9|||
37803299|NCT01742286|69448682|FG000|Expansion Phase|Adverse Event|0|||
37803300|NCT01742286|69448683|FG001|Expansion Phase|Adverse Event|0|||
37803301|NCT01742286|69448684|FG002|Expansion Phase|Adverse Event|0|||
37803302|NCT01742286|69448685|FG003|Expansion Phase|Adverse Event|0|||
37803303|NCT01742286|69448686|FG004|Expansion Phase|Adverse Event|0|||
37803304|NCT01742286|69448687|FG005|Expansion Phase|Adverse Event|0|||
37803305|NCT01742286|69448688|FG006|Expansion Phase|Adverse Event|6|||
37803306|NCT01742286|69448682|FG000|Expansion Phase|Disease progression|0|||
37803307|NCT01742286|69448683|FG001|Expansion Phase|Disease progression|0|||
37803308|NCT01742286|69448684|FG002|Expansion Phase|Disease progression|3|||
37803309|NCT01742286|69448685|FG003|Expansion Phase|Disease progression|0|||
37803310|NCT01742286|69448686|FG004|Expansion Phase|Disease progression|0|||
37975819|NCT00495170|69663098|FG000|Overall Study|Withdrawal by Subject|3|||
37803311|NCT01742286|69448687|FG005|Expansion Phase|Disease progression|0|||
37803312|NCT01742286|69448688|FG006|Expansion Phase|Disease progression|15|||
37803313|NCT01742286|69448682|FG000|Expansion Phase|Withdrawal by Subject|0|||
37803314|NCT01742286|69448683|FG001|Expansion Phase|Withdrawal by Subject|0|||
37803315|NCT01742286|69448684|FG002|Expansion Phase|Withdrawal by Subject|0|||
37803316|NCT01742286|69448685|FG003|Expansion Phase|Withdrawal by Subject|0|||
37803317|NCT01742286|69448686|FG004|Expansion Phase|Withdrawal by Subject|0|||
37803318|NCT01742286|69448687|FG005|Expansion Phase|Withdrawal by Subject|0|||
37803319|NCT01742286|69448688|FG006|Expansion Phase|Withdrawal by Subject|1|||
37803320|NCT01697358|69448713|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
37803321|NCT01697358|69448714|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
37803322|NCT01697358|69448713|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
37803323|NCT01697358|69448714|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
37803324|NCT01697358|69448713|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
37803325|NCT01697358|69448714|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
37803326|NCT01697358|69448713|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
37803327|NCT01697358|69448714|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
37803328|NCT01697358|69448713|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
37803329|NCT01697358|69448714|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
37803330|NCT01697358|69448713|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
37803331|NCT01697358|69448714|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
37803332|NCT01697358|69448713|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
37803333|NCT01697358|69448714|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
37803334|NCT01697358|69448713|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
37803335|NCT01697358|69448714|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
37803336|NCT01697358|69448713|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
37803337|NCT01697358|69448714|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
37803338|NCT01697358|69448713|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
37803339|NCT01697358|69448714|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
37803340|NCT01716234|69448727|FG000|Overall Study|Protocol Violation|0|||
37803341|NCT01716234|69448728|FG001|Overall Study|Protocol Violation|0|||
37803342|NCT01716234|69448729|FG002|Overall Study|Protocol Violation|0|||
37803343|NCT01716234|69448730|FG003|Overall Study|Protocol Violation|1|||
37803344|NCT01716234|69448731|FG004|Overall Study|Protocol Violation|1|||
37803345|NCT01716234|69448732|FG005|Overall Study|Protocol Violation|1|||
37803346|NCT01716234|69448733|FG006|Overall Study|Protocol Violation|0|||
37803347|NCT01716234|69448727|FG000|Overall Study|Lack of Efficacy|0|||
37803348|NCT01716234|69448728|FG001|Overall Study|Lack of Efficacy|0|||
37803349|NCT01716234|69448729|FG002|Overall Study|Lack of Efficacy|0|||
37803350|NCT01716234|69448730|FG003|Overall Study|Lack of Efficacy|1|||
37803351|NCT01716234|69448731|FG004|Overall Study|Lack of Efficacy|0|||
37803352|NCT01716234|69448732|FG005|Overall Study|Lack of Efficacy|0|||
37803353|NCT01716234|69448733|FG006|Overall Study|Lack of Efficacy|0|||
37803354|NCT01716234|69448727|FG000|Overall Study|Did not meet protocol eligibility|0|||
37803355|NCT01716234|69448728|FG001|Overall Study|Did not meet protocol eligibility|0|||
37803356|NCT01716234|69448729|FG002|Overall Study|Did not meet protocol eligibility|1|||
37803357|NCT01716234|69448730|FG003|Overall Study|Did not meet protocol eligibility|0|||
37803358|NCT01716234|69448731|FG004|Overall Study|Did not meet protocol eligibility|0|||
37803359|NCT01716234|69448732|FG005|Overall Study|Did not meet protocol eligibility|4|||
37803360|NCT01716234|69448733|FG006|Overall Study|Did not meet protocol eligibility|0|||
37803361|NCT01716234|69448727|FG000|Overall Study|Adverse Event|7|||
37803362|NCT01716234|69448728|FG001|Overall Study|Adverse Event|10|||
37803363|NCT01716234|69448729|FG002|Overall Study|Adverse Event|2|||
37803364|NCT01716234|69448730|FG003|Overall Study|Adverse Event|8|||
37803365|NCT01716234|69448731|FG004|Overall Study|Adverse Event|3|||
37803366|NCT01716234|69448732|FG005|Overall Study|Adverse Event|6|||
37803367|NCT01716234|69448733|FG006|Overall Study|Adverse Event|0|||
37803368|NCT01716234|69448727|FG000|Overall Study|Withdrawal by Subject|3|||
37803369|NCT01716234|69448728|FG001|Overall Study|Withdrawal by Subject|0|||
37803370|NCT01716234|69448729|FG002|Overall Study|Withdrawal by Subject|2|||
37803371|NCT01716234|69448730|FG003|Overall Study|Withdrawal by Subject|2|||
37803372|NCT01716234|69448731|FG004|Overall Study|Withdrawal by Subject|1|||
37803373|NCT01716234|69448732|FG005|Overall Study|Withdrawal by Subject|3|||
37803374|NCT01716234|69448733|FG006|Overall Study|Withdrawal by Subject|0|||
37803375|NCT01716156|69448752|FG000|Overall Study|Protocol Violation|1|||
37803376|NCT01716156|69448753|FG001|Overall Study|Protocol Violation|0|||
37803377|NCT01716156|69448754|FG002|Overall Study|Protocol Violation|0|||
37803378|NCT01716156|69448752|FG000|Overall Study|Withdrawal by Subject|0|||
37803379|NCT01716156|69448753|FG001|Overall Study|Withdrawal by Subject|1|||
37803380|NCT01716156|69448754|FG002|Overall Study|Withdrawal by Subject|2|||
37803381|NCT01716156|69448752|FG000|Overall Study|Lost to Follow-up|1|||
37803382|NCT01716156|69448753|FG001|Overall Study|Lost to Follow-up|0|||
37803383|NCT01716156|69448754|FG002|Overall Study|Lost to Follow-up|0|||
37803384|NCT01739790|69448768|FG000|Overall Study|Early Trial Termination|2|||
37803385|NCT01739790|69448769|FG001|Overall Study|Early Trial Termination|4|||
37864260|NCT00990106|69547854|FG000|Overall Study|"too busy to continue"|1|||
37864261|NCT00990106|69547855|FG001|Overall Study|"too busy to continue"|2|||
37864262|NCT00990106|69547854|FG000|Overall Study|Lost to Follow-up|1|||
37864263|NCT00990106|69547855|FG001|Overall Study|Lost to Follow-up|3|||
37803386|NCT01696032|69448779|FG000|Overall Study|Withdrawal by Subject|0|||
37803387|NCT01696032|69448780|FG001|Overall Study|Withdrawal by Subject|0|||
37803388|NCT01696032|69448781|FG002|Overall Study|Withdrawal by Subject|1|||
37803389|NCT01696032|69448782|FG003|Overall Study|Withdrawal by Subject|2|||
37803390|NCT01696032|69448779|FG000|Overall Study|Death|14|||
37803391|NCT01696032|69448780|FG001|Overall Study|Death|4|||
37803392|NCT01696032|69448781|FG002|Overall Study|Death|43|||
37864264|NCT00990106|69547854|FG000|Overall Study|Withdrawal by Subject|2|||
37864265|NCT00990106|69547855|FG001|Overall Study|Withdrawal by Subject|1|||
37803393|NCT01696032|69448782|FG003|Overall Study|Death|18|||
37803394|NCT01696032|69448779|FG000|Overall Study|Lost to Follow-up|0|||
37803395|NCT01696032|69448780|FG001|Overall Study|Lost to Follow-up|1|||
37803396|NCT01696032|69448781|FG002|Overall Study|Lost to Follow-up|0|||
37803397|NCT01696032|69448782|FG003|Overall Study|Lost to Follow-up|0|||
37803398|NCT01696032|69448779|FG000|Overall Study|Database lock|0|||
37803399|NCT01696032|69448780|FG001|Overall Study|Database lock|1|||
37803400|NCT01696032|69448781|FG002|Overall Study|Database lock|7|||
37803401|NCT01696032|69448782|FG003|Overall Study|Database lock|2|||
37803402|NCT01695954|69448798|FG000|Overall Study|Withdrawal by Subject|4|||
37803403|NCT01695954|69448799|FG001|Overall Study|Withdrawal by Subject|0|||
37803404|NCT01695954|69448798|FG000|Overall Study|Adverse Event|0|||
37803405|NCT01695954|69448799|FG001|Overall Study|Adverse Event|2|||
37803406|NCT01694706|69448807|FG000|Overall Study|Adverse Event|0|||
37803407|NCT01694706|69448808|FG001|Overall Study|Adverse Event|1|||
37803408|NCT01694706|69448809|FG002|Overall Study|Adverse Event|0|||
37803409|NCT01694706|69448807|FG000|Overall Study|other reason not defined above|1|||
37803410|NCT01694706|69448808|FG001|Overall Study|other reason not defined above|0|||
37803411|NCT01694706|69448809|FG002|Overall Study|other reason not defined above|0|||
37803412|NCT01693692|69448821|FG000|Overall Study|Withdrawal by Subject|12|||
37803413|NCT01693692|69448822|FG001|Overall Study|Withdrawal by Subject|10|||
37803414|NCT01693692|69448823|FG002|Overall Study|Withdrawal by Subject|11|||
37803415|NCT01693692|69448821|FG000|Overall Study|Adverse Event|7|||
37803416|NCT01693692|69448822|FG001|Overall Study|Adverse Event|14|||
37803417|NCT01693692|69448823|FG002|Overall Study|Adverse Event|9|||
37803418|NCT01693692|69448821|FG000|Overall Study|Physician Decision|0|||
37803419|NCT01693692|69448822|FG001|Overall Study|Physician Decision|0|||
37803420|NCT01693692|69448823|FG002|Overall Study|Physician Decision|1|||
37803421|NCT01693692|69448821|FG000|Overall Study|Protocol Violation|5|||
37803422|NCT01693692|69448822|FG001|Overall Study|Protocol Violation|4|||
37803423|NCT01693692|69448823|FG002|Overall Study|Protocol Violation|6|||
37803424|NCT01693692|69448821|FG000|Overall Study|Lost to Follow-up|2|||
37803425|NCT01693692|69448822|FG001|Overall Study|Lost to Follow-up|2|||
37803426|NCT01693692|69448823|FG002|Overall Study|Lost to Follow-up|3|||
37803427|NCT01693692|69448821|FG000|Overall Study|Other|4|||
37803428|NCT01693692|69448822|FG001|Overall Study|Other|4|||
37803429|NCT01693692|69448823|FG002|Overall Study|Other|6|||
37803430|NCT01693614|69448834|FG000|Overall Study|Adverse Event|7|||
37803431|NCT01693614|69448835|FG001|Overall Study|Adverse Event|11|||
37803432|NCT01693614|69448836|FG002|Overall Study|Adverse Event|5|||
37803433|NCT01693614|69448834|FG000|Overall Study|Disease progression|11|||
37803434|NCT01693614|69448835|FG001|Overall Study|Disease progression|8|||
37803435|NCT01693614|69448836|FG002|Overall Study|Disease progression|7|||
37803436|NCT01693614|69448834|FG000|Overall Study|Protocol Violation|5|||
37803437|NCT01693614|69448835|FG001|Overall Study|Protocol Violation|2|||
37803438|NCT01693614|69448836|FG002|Overall Study|Protocol Violation|1|||
37803439|NCT01693614|69448834|FG000|Overall Study|Death|1|||
37803440|NCT01693614|69448835|FG001|Overall Study|Death|0|||
37803441|NCT01693614|69448836|FG002|Overall Study|Death|0|||
37803442|NCT01693614|69448834|FG000|Overall Study|Physician Decision|1|||
37803443|NCT01693614|69448835|FG001|Overall Study|Physician Decision|1|||
37803444|NCT01693614|69448836|FG002|Overall Study|Physician Decision|4|||
37803445|NCT01693614|69448834|FG000|Overall Study|Withdrawal by subject/guardian|0|||
37803446|NCT01693614|69448835|FG001|Overall Study|Withdrawal by subject/guardian|0|||
37803447|NCT01693614|69448836|FG002|Overall Study|Withdrawal by subject/guardian|2|||
37803448|NCT01693614|69448834|FG000|Overall Study|Withdrawal by Subject|1|||
37803449|NCT01693614|69448835|FG001|Overall Study|Withdrawal by Subject|0|||
37803450|NCT01693614|69448836|FG002|Overall Study|Withdrawal by Subject|5|||
37803451|NCT01715298|69448847|FG000|Overall Study|Lost to Follow-up|0|||
37803452|NCT01715298|69448848|FG001|Overall Study|Lost to Follow-up|2|||
37803453|NCT01715298|69448847|FG000|Overall Study|Patient/guardian decision|7|||
37803454|NCT01715298|69448848|FG001|Overall Study|Patient/guardian decision|9|||
37803455|NCT01713582|69448875|FG000|Overall Study|Disease progression|3|||
37803456|NCT01713582|69448876|FG001|Overall Study|Disease progression|3|||
37803457|NCT01713582|69448877|FG002|Overall Study|Disease progression|3|||
37803458|NCT01713582|69448878|FG003|Overall Study|Disease progression|2|||
37803459|NCT01713582|69448879|FG004|Overall Study|Disease progression|3|||
37803460|NCT01713582|69448880|FG005|Overall Study|Disease progression|3|||
37803461|NCT01713582|69448881|FG006|Overall Study|Disease progression|3|||
37803462|NCT01713582|69448882|FG007|Overall Study|Disease progression|3|||
37803463|NCT01713582|69448883|FG008|Overall Study|Disease progression|3|||
37803464|NCT01713582|69448884|FG009|Overall Study|Disease progression|11|||
37803465|NCT01713582|69448885|FG010|Overall Study|Disease progression|10|||
37803466|NCT01713582|69448886|FG011|Overall Study|Disease progression|5|||
37803467|NCT01713582|69448887|FG012|Overall Study|Disease progression|3|||
37803468|NCT01713582|69448888|FG013|Overall Study|Disease progression|3|||
37803469|NCT01713582|69448889|FG014|Overall Study|Disease progression|6|||
37803470|NCT01713582|69448890|FG015|Overall Study|Disease progression|6|||
37803471|NCT01713582|69448891|FG016|Overall Study|Disease progression|5|||
37803472|NCT01713582|69448892|FG017|Overall Study|Disease progression|2|||
37803473|NCT01713582|69448893|FG018|Overall Study|Disease progression|3|||
37803474|NCT01713582|69448894|FG019|Overall Study|Disease progression|5|||
37803475|NCT01713582|69448895|FG020|Overall Study|Disease progression|15|||
37803476|NCT01713582|69448875|FG000|Overall Study|Death|0|||
37803477|NCT01713582|69448876|FG001|Overall Study|Death|0|||
37803478|NCT01713582|69448877|FG002|Overall Study|Death|0|||
37803479|NCT01713582|69448878|FG003|Overall Study|Death|1|||
37803480|NCT01713582|69448879|FG004|Overall Study|Death|1|||
37803481|NCT01713582|69448880|FG005|Overall Study|Death|3|||
37803482|NCT01713582|69448881|FG006|Overall Study|Death|3|||
37803483|NCT01713582|69448882|FG007|Overall Study|Death|2|||
37803484|NCT01713582|69448883|FG008|Overall Study|Death|3|||
37803485|NCT01713582|69448884|FG009|Overall Study|Death|4|||
37803486|NCT01713582|69448885|FG010|Overall Study|Death|3|||
37803487|NCT01713582|69448886|FG011|Overall Study|Death|0|||
37803488|NCT01713582|69448887|FG012|Overall Study|Death|0|||
37803489|NCT01713582|69448888|FG013|Overall Study|Death|0|||
37803490|NCT01713582|69448889|FG014|Overall Study|Death|0|||
37803491|NCT01713582|69448890|FG015|Overall Study|Death|0|||
37803492|NCT01713582|69448891|FG016|Overall Study|Death|0|||
37803493|NCT01713582|69448892|FG017|Overall Study|Death|0|||
37803494|NCT01713582|69448893|FG018|Overall Study|Death|0|||
37803495|NCT01713582|69448894|FG019|Overall Study|Death|0|||
37803496|NCT01713582|69448895|FG020|Overall Study|Death|0|||
37803497|NCT01713582|69448875|FG000|Overall Study|Adverse event-related|0|||
37803498|NCT01713582|69448876|FG001|Overall Study|Adverse event-related|0|||
37803499|NCT01713582|69448877|FG002|Overall Study|Adverse event-related|0|||
37803500|NCT01713582|69448878|FG003|Overall Study|Adverse event-related|0|||
37803501|NCT01713582|69448879|FG004|Overall Study|Adverse event-related|0|||
37803502|NCT01713582|69448880|FG005|Overall Study|Adverse event-related|0|||
37803503|NCT01713582|69448881|FG006|Overall Study|Adverse event-related|0|||
37803504|NCT01713582|69448882|FG007|Overall Study|Adverse event-related|0|||
37803505|NCT01713582|69448883|FG008|Overall Study|Adverse event-related|0|||
37803506|NCT01713582|69448884|FG009|Overall Study|Adverse event-related|1|||
37803507|NCT01713582|69448885|FG010|Overall Study|Adverse event-related|1|||
37803508|NCT01713582|69448886|FG011|Overall Study|Adverse event-related|0|||
37803509|NCT01713582|69448887|FG012|Overall Study|Adverse event-related|0|||
37803510|NCT01713582|69448888|FG013|Overall Study|Adverse event-related|0|||
37803511|NCT01713582|69448889|FG014|Overall Study|Adverse event-related|0|||
37803512|NCT01713582|69448890|FG015|Overall Study|Adverse event-related|0|||
37803513|NCT01713582|69448891|FG016|Overall Study|Adverse event-related|0|||
37803514|NCT01713582|69448892|FG017|Overall Study|Adverse event-related|0|||
37803515|NCT01713582|69448893|FG018|Overall Study|Adverse event-related|1|||
37803516|NCT01713582|69448894|FG019|Overall Study|Adverse event-related|0|||
37803517|NCT01713582|69448895|FG020|Overall Study|Adverse event-related|0|||
37803518|NCT01713582|69448875|FG000|Overall Study|Adverse event-unrelated|0|||
37803519|NCT01713582|69448876|FG001|Overall Study|Adverse event-unrelated|0|||
37803520|NCT01713582|69448877|FG002|Overall Study|Adverse event-unrelated|0|||
37803521|NCT01713582|69448878|FG003|Overall Study|Adverse event-unrelated|0|||
37803522|NCT01713582|69448879|FG004|Overall Study|Adverse event-unrelated|0|||
37803523|NCT01713582|69448880|FG005|Overall Study|Adverse event-unrelated|1|||
37803524|NCT01713582|69448881|FG006|Overall Study|Adverse event-unrelated|1|||
37803525|NCT01713582|69448882|FG007|Overall Study|Adverse event-unrelated|1|||
37803526|NCT01713582|69448883|FG008|Overall Study|Adverse event-unrelated|0|||
37803527|NCT01713582|69448884|FG009|Overall Study|Adverse event-unrelated|0|||
37803528|NCT01713582|69448885|FG010|Overall Study|Adverse event-unrelated|0|||
37803529|NCT01713582|69448886|FG011|Overall Study|Adverse event-unrelated|0|||
37803530|NCT01713582|69448887|FG012|Overall Study|Adverse event-unrelated|0|||
37803531|NCT01713582|69448888|FG013|Overall Study|Adverse event-unrelated|1|||
37803532|NCT01713582|69448889|FG014|Overall Study|Adverse event-unrelated|1|||
37803533|NCT01713582|69448890|FG015|Overall Study|Adverse event-unrelated|0|||
37803534|NCT01713582|69448891|FG016|Overall Study|Adverse event-unrelated|0|||
37803535|NCT01713582|69448892|FG017|Overall Study|Adverse event-unrelated|0|||
37803536|NCT01713582|69448893|FG018|Overall Study|Adverse event-unrelated|0|||
37803537|NCT01713582|69448894|FG019|Overall Study|Adverse event-unrelated|0|||
37803538|NCT01713582|69448895|FG020|Overall Study|Adverse event-unrelated|0|||
37803539|NCT01713582|69448875|FG000|Overall Study|Withdrawal of consent|0|||
37803540|NCT01713582|69448876|FG001|Overall Study|Withdrawal of consent|0|||
37803541|NCT01713582|69448877|FG002|Overall Study|Withdrawal of consent|1|||
37803542|NCT01713582|69448878|FG003|Overall Study|Withdrawal of consent|0|||
37803543|NCT01713582|69448879|FG004|Overall Study|Withdrawal of consent|0|||
37803544|NCT01713582|69448880|FG005|Overall Study|Withdrawal of consent|1|||
37803545|NCT01713582|69448881|FG006|Overall Study|Withdrawal of consent|0|||
37803546|NCT01713582|69448882|FG007|Overall Study|Withdrawal of consent|0|||
37803547|NCT01713582|69448883|FG008|Overall Study|Withdrawal of consent|0|||
37803548|NCT01713582|69448884|FG009|Overall Study|Withdrawal of consent|1|||
37803549|NCT01713582|69448885|FG010|Overall Study|Withdrawal of consent|0|||
37803550|NCT01713582|69448886|FG011|Overall Study|Withdrawal of consent|0|||
37803551|NCT01713582|69448887|FG012|Overall Study|Withdrawal of consent|0|||
37803552|NCT01713582|69448888|FG013|Overall Study|Withdrawal of consent|0|||
37803553|NCT01713582|69448889|FG014|Overall Study|Withdrawal of consent|0|||
37803554|NCT01713582|69448890|FG015|Overall Study|Withdrawal of consent|0|||
37803555|NCT01713582|69448891|FG016|Overall Study|Withdrawal of consent|0|||
37803556|NCT01713582|69448892|FG017|Overall Study|Withdrawal of consent|0|||
37803557|NCT01713582|69448893|FG018|Overall Study|Withdrawal of consent|1|||
37803558|NCT01713582|69448894|FG019|Overall Study|Withdrawal of consent|0|||
37803559|NCT01713582|69448895|FG020|Overall Study|Withdrawal of consent|0|||
37803560|NCT01713582|69448875|FG000|Overall Study|Lack of Efficacy|0|||
37803561|NCT01713582|69448876|FG001|Overall Study|Lack of Efficacy|0|||
37803562|NCT01713582|69448877|FG002|Overall Study|Lack of Efficacy|0|||
37803563|NCT01713582|69448878|FG003|Overall Study|Lack of Efficacy|0|||
37803564|NCT01713582|69448879|FG004|Overall Study|Lack of Efficacy|0|||
37803565|NCT01713582|69448880|FG005|Overall Study|Lack of Efficacy|0|||
37803566|NCT01713582|69448881|FG006|Overall Study|Lack of Efficacy|0|||
37803567|NCT01713582|69448882|FG007|Overall Study|Lack of Efficacy|0|||
37803568|NCT01713582|69448883|FG008|Overall Study|Lack of Efficacy|0|||
37803569|NCT01713582|69448884|FG009|Overall Study|Lack of Efficacy|1|||
37803570|NCT01713582|69448885|FG010|Overall Study|Lack of Efficacy|2|||
37803571|NCT01713582|69448886|FG011|Overall Study|Lack of Efficacy|0|||
37803572|NCT01713582|69448887|FG012|Overall Study|Lack of Efficacy|0|||
37803573|NCT01713582|69448888|FG013|Overall Study|Lack of Efficacy|0|||
37803574|NCT01713582|69448889|FG014|Overall Study|Lack of Efficacy|0|||
37803575|NCT01713582|69448890|FG015|Overall Study|Lack of Efficacy|0|||
37803576|NCT01713582|69448891|FG016|Overall Study|Lack of Efficacy|0|||
37803577|NCT01713582|69448892|FG017|Overall Study|Lack of Efficacy|0|||
37803578|NCT01713582|69448893|FG018|Overall Study|Lack of Efficacy|0|||
37803579|NCT01713582|69448894|FG019|Overall Study|Lack of Efficacy|0|||
37803580|NCT01713582|69448895|FG020|Overall Study|Lack of Efficacy|0|||
37803581|NCT01713582|69448875|FG000|Overall Study|Withdrawal by Subject|0|||
37803582|NCT01713582|69448876|FG001|Overall Study|Withdrawal by Subject|0|||
37803583|NCT01713582|69448877|FG002|Overall Study|Withdrawal by Subject|0|||
37803584|NCT01713582|69448878|FG003|Overall Study|Withdrawal by Subject|0|||
37803585|NCT01713582|69448879|FG004|Overall Study|Withdrawal by Subject|0|||
37803586|NCT01713582|69448880|FG005|Overall Study|Withdrawal by Subject|0|||
37803587|NCT01713582|69448881|FG006|Overall Study|Withdrawal by Subject|0|||
37803588|NCT01713582|69448882|FG007|Overall Study|Withdrawal by Subject|0|||
37803589|NCT01713582|69448883|FG008|Overall Study|Withdrawal by Subject|0|||
37803590|NCT01713582|69448884|FG009|Overall Study|Withdrawal by Subject|0|||
37803591|NCT01713582|69448885|FG010|Overall Study|Withdrawal by Subject|0|||
37803592|NCT01713582|69448886|FG011|Overall Study|Withdrawal by Subject|0|||
37803593|NCT01713582|69448887|FG012|Overall Study|Withdrawal by Subject|0|||
37803594|NCT01713582|69448888|FG013|Overall Study|Withdrawal by Subject|0|||
37803595|NCT01713582|69448889|FG014|Overall Study|Withdrawal by Subject|0|||
37803596|NCT01713582|69448890|FG015|Overall Study|Withdrawal by Subject|0|||
37803597|NCT01713582|69448891|FG016|Overall Study|Withdrawal by Subject|0|||
37803598|NCT01713582|69448892|FG017|Overall Study|Withdrawal by Subject|1|||
37803599|NCT01713582|69448893|FG018|Overall Study|Withdrawal by Subject|0|||
37803600|NCT01713582|69448894|FG019|Overall Study|Withdrawal by Subject|0|||
37803601|NCT01713582|69448895|FG020|Overall Study|Withdrawal by Subject|0|||
37803602|NCT01713582|69448875|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
37803603|NCT01713582|69448876|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
37803604|NCT01713582|69448877|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
37803605|NCT01713582|69448878|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
37803606|NCT01713582|69448879|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
37803607|NCT01713582|69448880|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
37803608|NCT01713582|69448881|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
37803609|NCT01713582|69448882|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
37803610|NCT01713582|69448883|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
37803611|NCT01713582|69448884|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
37803612|NCT01713582|69448885|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
37803613|NCT01713582|69448886|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
37803614|NCT01713582|69448887|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
37803615|NCT01713582|69448888|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
37803616|NCT01713582|69448889|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
37803617|NCT01713582|69448890|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
37803618|NCT01713582|69448891|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
37803619|NCT01713582|69448892|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
37803620|NCT01713582|69448893|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
37803621|NCT01713582|69448894|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
37803622|NCT01713582|69448895|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
37803623|NCT01713582|69448875|FG000|Overall Study|Disease progression and adverse event|0|||
37803624|NCT01713582|69448876|FG001|Overall Study|Disease progression and adverse event|0|||
37803625|NCT01713582|69448877|FG002|Overall Study|Disease progression and adverse event|0|||
37803626|NCT01713582|69448878|FG003|Overall Study|Disease progression and adverse event|0|||
37803627|NCT01713582|69448879|FG004|Overall Study|Disease progression and adverse event|0|||
37803628|NCT01713582|69448880|FG005|Overall Study|Disease progression and adverse event|0|||
37803629|NCT01713582|69448881|FG006|Overall Study|Disease progression and adverse event|0|||
37803630|NCT01713582|69448882|FG007|Overall Study|Disease progression and adverse event|0|||
37803631|NCT01713582|69448883|FG008|Overall Study|Disease progression and adverse event|0|||
37803632|NCT01713582|69448884|FG009|Overall Study|Disease progression and adverse event|0|||
37803633|NCT01713582|69448885|FG010|Overall Study|Disease progression and adverse event|0|||
37803634|NCT01713582|69448886|FG011|Overall Study|Disease progression and adverse event|0|||
37803635|NCT01713582|69448887|FG012|Overall Study|Disease progression and adverse event|0|||
37803636|NCT01713582|69448888|FG013|Overall Study|Disease progression and adverse event|0|||
37803637|NCT01713582|69448889|FG014|Overall Study|Disease progression and adverse event|0|||
37803638|NCT01713582|69448890|FG015|Overall Study|Disease progression and adverse event|0|||
37803639|NCT01713582|69448891|FG016|Overall Study|Disease progression and adverse event|1|||
37803640|NCT01713582|69448892|FG017|Overall Study|Disease progression and adverse event|0|||
37803641|NCT01713582|69448893|FG018|Overall Study|Disease progression and adverse event|0|||
37803642|NCT01713582|69448894|FG019|Overall Study|Disease progression and adverse event|0|||
37803643|NCT01713582|69448895|FG020|Overall Study|Disease progression and adverse event|0|||
37803644|NCT01739400|69448955|FG000|Overall Study|Physician Decision|3|||
37803645|NCT01739400|69448956|FG001|Overall Study|Physician Decision|0|||
37803646|NCT01739400|69448955|FG000|Overall Study|Lost to Follow-up|2|||
37803647|NCT01739400|69448956|FG001|Overall Study|Lost to Follow-up|0|||
37803648|NCT01739400|69448955|FG000|Overall Study|Death|5|||
37803649|NCT01739400|69448956|FG001|Overall Study|Death|2|||
37803650|NCT01739400|69448955|FG000|Overall Study|Withdrawal by Subject|7|||
37803651|NCT01739400|69448956|FG001|Overall Study|Withdrawal by Subject|7|||
37803652|NCT01713348|69448965|FG000|Overall Study|Withdrawal by Subject|3|||
37803653|NCT01713348|69448966|FG001|Overall Study|Withdrawal by Subject|2|||
37803654|NCT01713348|69448967|FG002|Overall Study|Withdrawal by Subject|2|||
37803655|NCT01713348|69448968|FG003|Overall Study|Withdrawal by Subject|0|||
37803656|NCT01713348|69448965|FG000|Overall Study|Lost to Follow-up|1|||
37803657|NCT01713348|69448966|FG001|Overall Study|Lost to Follow-up|0|||
37803658|NCT01713348|69448967|FG002|Overall Study|Lost to Follow-up|0|||
37803659|NCT01713348|69448968|FG003|Overall Study|Lost to Follow-up|0|||
37803660|NCT01737996|69448981|FG000|Overall Study|Adverse Event|0|||
37803661|NCT01737996|69448982|FG001|Overall Study|Adverse Event|1|||
37803662|NCT01737996|69448983|FG002|Overall Study|Adverse Event|1|||
37803663|NCT01737996|69448981|FG000|Overall Study|Withdrawal by Subject|0|||
37803664|NCT01737996|69448982|FG001|Overall Study|Withdrawal by Subject|0|||
37694004|NCT02352493|69170271|FG009|Overall Study|Lost to Follow-up|1|||
37694005|NCT02352493|69170272|FG010|Overall Study|Lost to Follow-up|0|||
37803665|NCT01737996|69448983|FG002|Overall Study|Withdrawal by Subject|1|||
37803666|NCT01713036|69448991|FG000|Overall Study|Death|1|||
37803667|NCT01712334|69449001|FG000|Treatment Period 1|Randomized in Error|0|||
37694006|NCT02352493|69170273|FG011|Overall Study|Lost to Follow-up|0|||
37694007|NCT02352493|69170274|FG012|Overall Study|Lost to Follow-up|1|||
37803668|NCT01712334|69449002|FG001|Treatment Period 1|Randomized in Error|2|||
37803669|NCT01712256|69449008|FG000|Overall Study|Lost to Follow-up|1|||
37803670|NCT01712178|69449014|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
37803671|NCT01712178|69449015|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
37803672|NCT01712178|69449014|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
37803673|NCT01712178|69449015|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
37803674|NCT01712178|69449014|FG000|Overall Study|Lost to Follow-up|0|||
37803675|NCT01712178|69449015|FG001|Overall Study|Lost to Follow-up|1|||
37803676|NCT01693068|69449023|FG000|Randomization Period|On-study|2|||
37803677|NCT01693068|69449024|FG001|Randomization Period|On-study|5|||
37803678|NCT01693068|69449025|FG002|Randomization Period|On-study|0|||
37803679|NCT01693068|69449023|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
37803680|NCT01693068|69449024|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
37803681|NCT01693068|69449025|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
37803682|NCT01691898|69449039|FG000|Overall Study|Death|34|||
37803683|NCT01691898|69449040|FG001|Overall Study|Death|32|||
37803684|NCT01691898|69449041|FG002|Overall Study|Death|6|||
37803685|NCT01691898|69449042|FG003|Overall Study|Death|3|||
37803686|NCT01691898|69449043|FG004|Overall Study|Death|8|||
37803687|NCT01691898|69449044|FG005|Overall Study|Death|31|||
37803688|NCT01691898|69449039|FG000|Overall Study|Adverse Event|0|||
37803689|NCT01691898|69449040|FG001|Overall Study|Adverse Event|1|||
37803690|NCT01691898|69449041|FG002|Overall Study|Adverse Event|0|||
37803691|NCT01691898|69449042|FG003|Overall Study|Adverse Event|1|||
37803692|NCT01691898|69449043|FG004|Overall Study|Adverse Event|1|||
37803693|NCT01691898|69449044|FG005|Overall Study|Adverse Event|0|||
37803694|NCT01691898|69449039|FG000|Overall Study|Progression of Disease|1|||
37803695|NCT01691898|69449040|FG001|Overall Study|Progression of Disease|2|||
37803696|NCT01691898|69449041|FG002|Overall Study|Progression of Disease|1|||
37803697|NCT01691898|69449042|FG003|Overall Study|Progression of Disease|0|||
37803698|NCT01691898|69449043|FG004|Overall Study|Progression of Disease|0|||
37803699|NCT01691898|69449044|FG005|Overall Study|Progression of Disease|1|||
37803700|NCT01691898|69449039|FG000|Overall Study|Lost to Follow-up|3|||
37694008|NCT02352493|69170275|FG013|Overall Study|Lost to Follow-up|2|||
37803701|NCT01691898|69449040|FG001|Overall Study|Lost to Follow-up|1|||
37803702|NCT01691898|69449041|FG002|Overall Study|Lost to Follow-up|0|||
37803703|NCT01691898|69449042|FG003|Overall Study|Lost to Follow-up|0|||
37803704|NCT01691898|69449043|FG004|Overall Study|Lost to Follow-up|1|||
37803705|NCT01691898|69449044|FG005|Overall Study|Lost to Follow-up|0|||
37803706|NCT01691898|69449039|FG000|Overall Study|Withdrawal by Subject|9|||
37803707|NCT01691898|69449040|FG001|Overall Study|Withdrawal by Subject|8|||
37803708|NCT01691898|69449041|FG002|Overall Study|Withdrawal by Subject|2|||
37803709|NCT01691898|69449042|FG003|Overall Study|Withdrawal by Subject|1|||
37803710|NCT01691898|69449043|FG004|Overall Study|Withdrawal by Subject|3|||
37803711|NCT01691898|69449044|FG005|Overall Study|Withdrawal by Subject|3|||
37803712|NCT01691898|69449039|FG000|Overall Study|Non-Compliance|0|||
37803713|NCT01691898|69449040|FG001|Overall Study|Non-Compliance|0|||
37803714|NCT01691898|69449041|FG002|Overall Study|Non-Compliance|0|||
37803715|NCT01691898|69449042|FG003|Overall Study|Non-Compliance|0|||
37803716|NCT01691898|69449043|FG004|Overall Study|Non-Compliance|1|||
37803717|NCT01691898|69449044|FG005|Overall Study|Non-Compliance|0|||
37803718|NCT01737840|69449078|FG000|Overall Study|Diagnosed with an other pathology|2|||
37803719|NCT01737840|69449079|FG001|Overall Study|Diagnosed with an other pathology|2|||
37803720|NCT01691820|69449089|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
37803721|NCT01691820|69449090|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
37694009|NCT02352493|69170276|FG014|Overall Study|Lost to Follow-up|0|||
37803722|NCT01691820|69449089|FG000|Overall Study|Migrated/moved from study area|7|||
37803723|NCT01691820|69449090|FG001|Overall Study|Migrated/moved from study area|4|||
37803724|NCT01691820|69449089|FG000|Overall Study|Lost to Follow-up|6|||
37803725|NCT01691820|69449090|FG001|Overall Study|Lost to Follow-up|17|||
37803726|NCT01691820|69449089|FG000|Overall Study|Other (unspecified)|4|||
37803727|NCT01691820|69449090|FG001|Overall Study|Other (unspecified)|1|||
37803728|NCT01711866|69449100|FG000|Overall Study|Noncompliant|3|||
37803729|NCT01711866|69449100|FG000|Overall Study|Withdrawal by Subject|3|||
37803730|NCT01711866|69449100|FG000|Overall Study|Adverse Event|2|||
37803731|NCT01737762|69449106|FG000|Overall Study|Adverse Event|2|||
37803732|NCT01737762|69449107|FG001|Overall Study|Adverse Event|2|||
37803733|NCT01737762|69449106|FG000|Overall Study|Lost to Follow-up|1|||
37803734|NCT01737762|69449107|FG001|Overall Study|Lost to Follow-up|0|||
37803735|NCT01737762|69449106|FG000|Overall Study|Withdrawal by Subject|2|||
37803736|NCT01737762|69449107|FG001|Overall Study|Withdrawal by Subject|2|||
37803737|NCT01737762|69449106|FG000|Overall Study|Progressive disease|1|||
37803738|NCT01737762|69449107|FG001|Overall Study|Progressive disease|2|||
37803739|NCT01737762|69449106|FG000|Overall Study|Physician Decision|1|||
37803740|NCT01737762|69449107|FG001|Overall Study|Physician Decision|1|||
37803741|NCT01737762|69449106|FG000|Overall Study|Moved from area|2|||
37803742|NCT01737762|69449107|FG001|Overall Study|Moved from area|1|||
37803743|NCT01737762|69449106|FG000|Overall Study|Trial termination|11|||
37803744|NCT01737762|69449107|FG001|Overall Study|Trial termination|9|||
37803745|NCT01691508|69449115|FG000|Overall Study|Adverse Event|3|||
37803746|NCT01691508|69449116|FG001|Overall Study|Adverse Event|3|||
37803747|NCT01691508|69449115|FG000|Overall Study|Withdrawal by Subject|1|||
37803748|NCT01691508|69449116|FG001|Overall Study|Withdrawal by Subject|0|||
37803749|NCT01682460|69449122|FG000|Overall Study|Withdrawal by Subject|2|||
37803750|NCT01682460|69449122|FG000|Overall Study|Did not meet inclusion criteria|2|||
37803751|NCT01691430|69449128|FG000|Overall Study|Death|17|||
37803752|NCT01691430|69449129|FG001|Overall Study|Death|16|||
37803753|NCT01691430|69449128|FG000|Overall Study|Withdrawal by Subject|5|||
37803754|NCT01691430|69449129|FG001|Overall Study|Withdrawal by Subject|1|||
37803755|NCT01691430|69449128|FG000|Overall Study|Lost to Follow-up|0|||
37803756|NCT01691430|69449129|FG001|Overall Study|Lost to Follow-up|3|||
37803757|NCT01709838|69449135|FG000|Overall Study|Withdrawal by Subject|21|||
37803758|NCT01709838|69449135|FG000|Overall Study|Lost to Follow-up|16|||
37803759|NCT01709838|69449135|FG000|Overall Study|Pregnancy|10|||
37803760|NCT01709838|69449135|FG000|Overall Study|Subject/guardian decision|8|||
37803761|NCT01709838|69449135|FG000|Overall Study|Adverse Event|4|||
37803762|NCT01709838|69449135|FG000|Overall Study|Physician Decision|4|||
37803763|NCT01709838|69449135|FG000|Overall Study|Death|3|||
37803764|NCT01709838|69449135|FG000|Overall Study|Protocol Violation|1|||
37803765|NCT01682226|69449141|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
37803766|NCT01682226|69449141|FG000|Overall Study|Participants did not receive treatment|2|||
37803767|NCT01682226|69449141|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
37803768|NCT04167618|69449147|FG000|Overall Study|Trial terminated by sponsor|1|||
37694010|NCT02352493|69170277|FG015|Overall Study|Lost to Follow-up|0|||
37803769|NCT04167618|69449148|FG001|Overall Study|Trial terminated by sponsor|1|||
37803770|NCT01688466|69449156|FG000|Overall Study|Withdrawal by Subject|2|||
37803771|NCT01688466|69449157|FG001|Overall Study|Withdrawal by Subject|1|||
37803772|NCT01688466|69449156|FG000|Overall Study|Death|0|||
37803773|NCT01688466|69449157|FG001|Overall Study|Death|1|||
37803774|NCT01688466|69449156|FG000|Overall Study|Adverse Event|0|||
37803775|NCT01688466|69449157|FG001|Overall Study|Adverse Event|4|||
37803776|NCT01688466|69449156|FG000|Overall Study|Not evaluable|0|||
37803777|NCT01688466|69449157|FG001|Overall Study|Not evaluable|1|||
37803778|NCT01682148|69449165|FG000|Overall Study|Withdrawal by Subject|2|||
37803779|NCT01682148|69449166|FG001|Overall Study|Withdrawal by Subject|0|||
37803780|NCT01682148|69449165|FG000|Overall Study|Lost to Follow-up|1|||
37803781|NCT01682148|69449166|FG001|Overall Study|Lost to Follow-up|2|||
37803782|NCT01682148|69449165|FG000|Overall Study|Protocol Violation|1|||
37803783|NCT01682148|69449166|FG001|Overall Study|Protocol Violation|1|||
37803784|NCT01681992|69449180|FG000|Overall Study|Adverse Event|3|||
37803785|NCT01681992|69449181|FG001|Overall Study|Adverse Event|2|||
37803786|NCT01681992|69449182|FG002|Overall Study|Adverse Event|3|||
37803787|NCT01681992|69449180|FG000|Overall Study|Lost to Follow-up|36|||
37803788|NCT01681992|69449181|FG001|Overall Study|Lost to Follow-up|38|||
37803789|NCT01681992|69449182|FG002|Overall Study|Lost to Follow-up|53|||
37803790|NCT01681992|69449180|FG000|Overall Study|As Per Sponsor Decision|0|||
37803791|NCT01681992|69449181|FG001|Overall Study|As Per Sponsor Decision|0|||
37803792|NCT01681992|69449182|FG002|Overall Study|As Per Sponsor Decision|1|||
37803793|NCT01681992|69449180|FG000|Overall Study|Protocol Violation|0|||
37803794|NCT01681992|69449181|FG001|Overall Study|Protocol Violation|0|||
37803795|NCT01681992|69449182|FG002|Overall Study|Protocol Violation|1|||
37803796|NCT01681992|69449180|FG000|Overall Study|Withdrawal by Subject|27|||
37803797|NCT01681992|69449181|FG001|Overall Study|Withdrawal by Subject|30|||
37803798|NCT01681992|69449182|FG002|Overall Study|Withdrawal by Subject|25|||
37803799|NCT01687998|69449192|FG000|Overall Study|Withdrawal by Subject|49|||
37803800|NCT01687998|69449193|FG001|Overall Study|Withdrawal by Subject|51|||
37803801|NCT01687998|69449192|FG000|Overall Study|Known to be Alive at Study End|54|||
37803802|NCT01687998|69449193|FG001|Overall Study|Known to be Alive at Study End|62|||
37803803|NCT01687998|69449192|FG000|Overall Study|Lost to Follow-up|9|||
37803804|NCT01687998|69449193|FG001|Overall Study|Lost to Follow-up|7|||
37803805|NCT01681836|69449199|FG000|Second Intervention|Withdrawal by Subject|0|||
37803806|NCT01681836|69449200|FG001|Second Intervention|Withdrawal by Subject|1|||
37803807|NCT01681368|69449206|FG000|Overall Study|Refused further treatment|1|||
37803808|NCT01681368|69449206|FG000|Overall Study|Refused further follow up|1|||
37803809|NCT01681212|69449210|FG000|Overall Study|No longer met study criteria|5|||
37803810|NCT01681212|69449210|FG000|Overall Study|Administrative reason by sponsor|1|||
37803811|NCT01687296|69449216|FG000|Overall Study|Lack of Efficacy|1|||
37803812|NCT01687296|69449217|FG001|Overall Study|Lack of Efficacy|1|||
37803813|NCT01687296|69449216|FG000|Overall Study|Protocol Violation|0|||
37803814|NCT01687296|69449217|FG001|Overall Study|Protocol Violation|1|||
37803815|NCT01687296|69449216|FG000|Overall Study|Withdrawal by Subject|6|||
37803816|NCT01687296|69449217|FG001|Overall Study|Withdrawal by Subject|3|||
37803817|NCT01568892|69449238|FG000|Open-label Phase|Adverse Event|2|||
37803818|NCT01568892|69449239|FG001|Open-label Phase|Adverse Event|0|||
37803819|NCT01568892|69449238|FG000|Open-label Phase|Lack of Efficacy|4|||
37803820|NCT01568892|69449239|FG001|Open-label Phase|Lack of Efficacy|2|||
37803821|NCT01568892|69449238|FG000|Open-label Phase|Lost to Follow-up|0|||
37803822|NCT01568892|69449239|FG001|Open-label Phase|Lost to Follow-up|1|||
37803823|NCT01568112|69449250|FG000|Overall Study|Randomized But Not Treated|0|||
37803824|NCT01568112|69449251|FG001|Overall Study|Randomized But Not Treated|1|||
37803825|NCT01568112|69449252|FG002|Overall Study|Randomized But Not Treated|0|||
37803826|NCT01568112|69449253|FG003|Overall Study|Randomized But Not Treated|0|||
37803827|NCT01568112|69449250|FG000|Overall Study|Withdrew due to Adverse Event|2|||
37803828|NCT01568112|69449251|FG001|Overall Study|Withdrew due to Adverse Event|4|||
37803829|NCT01568112|69449252|FG002|Overall Study|Withdrew due to Adverse Event|6|||
37803830|NCT01568112|69449253|FG003|Overall Study|Withdrew due to Adverse Event|3|||
37803831|NCT01568112|69449250|FG000|Overall Study|Lost to Follow-up|0|||
37803832|NCT01568112|69449251|FG001|Overall Study|Lost to Follow-up|0|||
37803833|NCT01568112|69449252|FG002|Overall Study|Lost to Follow-up|0|||
37803834|NCT01568112|69449253|FG003|Overall Study|Lost to Follow-up|1|||
37803835|NCT01568112|69449250|FG000|Overall Study|Withdrawal by Subject|2|||
37803836|NCT01568112|69449251|FG001|Overall Study|Withdrawal by Subject|3|||
37803837|NCT01568112|69449252|FG002|Overall Study|Withdrawal by Subject|0|||
37803838|NCT01568112|69449253|FG003|Overall Study|Withdrawal by Subject|7|||
37803839|NCT01568112|69449250|FG000|Overall Study|Withdrawal by Physician|1|||
37803840|NCT01568112|69449251|FG001|Overall Study|Withdrawal by Physician|0|||
37803841|NCT01568112|69449252|FG002|Overall Study|Withdrawal by Physician|1|||
37803842|NCT01568112|69449253|FG003|Overall Study|Withdrawal by Physician|1|||
37803843|NCT01568034|69449264|FG000|Overall Study|Withdrawal by Subject|1|||
37803844|NCT01568034|69449265|FG001|Overall Study|Withdrawal by Subject|0|||
37803845|NCT01568034|69449266|FG002|Overall Study|Withdrawal by Subject|0|||
37803846|NCT01568034|69449267|FG003|Overall Study|Withdrawal by Subject|0|||
37803847|NCT01687218|69449283|FG000|Overall Study|Withdrawal by Subject|2|||
37803848|NCT01687218|69449284|FG001|Overall Study|Withdrawal by Subject|3|||
37803849|NCT01687218|69449285|FG002|Overall Study|Withdrawal by Subject|0|||
37803850|NCT01687218|69449286|FG003|Overall Study|Withdrawal by Subject|1|||
37803851|NCT01687218|69449287|FG004|Overall Study|Withdrawal by Subject|1|||
37803852|NCT01687218|69449288|FG005|Overall Study|Withdrawal by Subject|0|||
37803853|NCT01687218|69449283|FG000|Overall Study|Relocated, no follow-up planned|1|||
37803854|NCT01687218|69449284|FG001|Overall Study|Relocated, no follow-up planned|0|||
37803855|NCT01687218|69449285|FG002|Overall Study|Relocated, no follow-up planned|1|||
37803856|NCT01687218|69449286|FG003|Overall Study|Relocated, no follow-up planned|1|||
37803857|NCT01687218|69449287|FG004|Overall Study|Relocated, no follow-up planned|0|||
37803858|NCT01687218|69449288|FG005|Overall Study|Relocated, no follow-up planned|0|||
37803859|NCT01686828|69449300|FG000|Overall Study|Physician Decision|1|||
37803860|NCT01686828|69449301|FG001|Overall Study|Physician Decision|0|||
37803861|NCT01686828|69449302|FG002|Overall Study|Physician Decision|0|||
37803862|NCT01686828|69449303|FG003|Overall Study|Physician Decision|0|||
37803863|NCT01686828|69449300|FG000|Overall Study|New Job|0|||
37803864|NCT01686828|69449301|FG001|Overall Study|New Job|1|||
37803865|NCT01686828|69449302|FG002|Overall Study|New Job|0|||
37803866|NCT01686828|69449303|FG003|Overall Study|New Job|0|||
37803867|NCT01686828|69449300|FG000|Overall Study|Weight Loss|0|||
37803868|NCT01686828|69449301|FG001|Overall Study|Weight Loss|0|||
37803869|NCT01686828|69449302|FG002|Overall Study|Weight Loss|1|||
37803870|NCT01686828|69449303|FG003|Overall Study|Weight Loss|0|||
37803871|NCT01686438|69449320|FG000|Overall Study|Lost to Follow-up|8|||
37803872|NCT01686438|69449321|FG001|Overall Study|Lost to Follow-up|9|||
37803873|NCT01686438|69449322|FG002|Overall Study|Lost to Follow-up|10|||
37803874|NCT01686438|69449320|FG000|Overall Study|Adverse Event|0|||
37803875|NCT01686438|69449321|FG001|Overall Study|Adverse Event|0|||
37803876|NCT01686438|69449322|FG002|Overall Study|Adverse Event|1|||
37803877|NCT01686438|69449320|FG000|Overall Study|Protocol Violation|0|||
37803878|NCT01686438|69449321|FG001|Overall Study|Protocol Violation|0|||
37803879|NCT01686438|69449322|FG002|Overall Study|Protocol Violation|1|||
37803880|NCT01686438|69449320|FG000|Overall Study|Withdrawal by Subject|0|||
37803881|NCT01686438|69449321|FG001|Overall Study|Withdrawal by Subject|0|||
37803882|NCT01686438|69449322|FG002|Overall Study|Withdrawal by Subject|1|||
37803883|NCT01593696|69449336|FG000|Dose Escalation|Progressive Disease|2|||
37803884|NCT01593696|69449337|FG001|Dose Escalation|Progressive Disease|0|||
37803885|NCT01593696|69449338|FG002|Dose Escalation|Progressive Disease|0|||
37803886|NCT01593696|69449339|FG003|Dose Escalation|Progressive Disease|0|||
37803887|NCT01593696|69449336|FG000|Dose Expansion|Fungal infection|0|||
37803888|NCT01593696|69449337|FG001|Dose Expansion|Fungal infection|0|||
37803889|NCT01593696|69449338|FG002|Dose Expansion|Fungal infection|1|||
37803890|NCT01593696|69449339|FG003|Dose Expansion|Fungal infection|0|||
37803891|NCT01592760|69449352|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
37803892|NCT01592760|69449353|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
37803893|NCT01592760|69449354|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
37803894|NCT01696188|69449367|FG000|Overall Study|Protocol Violation|1|||
37803895|NCT01696188|69449368|FG001|Overall Study|Protocol Violation|1|||
37803896|NCT01603602|69449377|FG000|Overall Study|Adverse Event|1|||
37803897|NCT01603602|69449378|FG001|Overall Study|Adverse Event|0|||
37803898|NCT01603602|69449379|FG002|Overall Study|Adverse Event|0|||
37803899|NCT01603602|69449377|FG000|Overall Study|Personal Reasons|1|||
37803900|NCT01603602|69449378|FG001|Overall Study|Personal Reasons|0|||
37803901|NCT01603602|69449379|FG002|Overall Study|Personal Reasons|1|||
37803902|NCT01684878|69449391|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
37803903|NCT01684878|69449392|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
37803904|NCT01684878|69449393|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
37803905|NCT01684878|69449394|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
37803906|NCT01684878|69449391|FG000|Part 1: Safety Run in Phase|Death|15|||
37803907|NCT01684878|69449392|FG001|Part 1: Safety Run in Phase|Death|20|||
37803908|NCT01684878|69449393|FG002|Part 1: Safety Run in Phase|Death|0|||
37803909|NCT01684878|69449394|FG003|Part 1: Safety Run in Phase|Death|0|||
37803910|NCT01684878|69449391|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
37803911|NCT01684878|69449392|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
37803912|NCT01684878|69449393|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
37803913|NCT01684878|69449394|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
37803914|NCT01684878|69449391|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
37803915|NCT01684878|69449392|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
37803916|NCT01684878|69449393|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
37803917|NCT01684878|69449394|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
37803918|NCT01684878|69449391|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
37803919|NCT01684878|69449392|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
37803920|NCT01684878|69449393|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
37803921|NCT01684878|69449394|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
37803922|NCT01684878|69449391|FG000|Part 2: Randomized Phase|Death|0|||
37803923|NCT01684878|69449392|FG001|Part 2: Randomized Phase|Death|0|||
37803924|NCT01684878|69449393|FG002|Part 2: Randomized Phase|Death|62|||
37803925|NCT01684878|69449394|FG003|Part 2: Randomized Phase|Death|68|||
37803926|NCT01684878|69449391|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
37803927|NCT01684878|69449392|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
37803928|NCT01684878|69449393|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
37803929|NCT01684878|69449394|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
37803930|NCT01684878|69449391|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
37803931|NCT01684878|69449392|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
37803932|NCT01684878|69449393|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
37803933|NCT01684878|69449394|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
37803934|NCT01684722|69449408|FG000|Overall Study|Lost to Follow-up|78|||
37803935|NCT01684722|69449409|FG001|Overall Study|Lost to Follow-up|56|||
37803936|NCT01684722|69449410|FG002|Overall Study|Lost to Follow-up|75|||
37803937|NCT01684722|69449411|FG003|Overall Study|Lost to Follow-up|89|||
37803938|NCT01684722|69449408|FG000|Overall Study|Death|19|||
37803939|NCT01684722|69449409|FG001|Overall Study|Death|21|||
37803940|NCT01684722|69449410|FG002|Overall Study|Death|19|||
37803941|NCT01684722|69449411|FG003|Overall Study|Death|21|||
37803942|NCT01592292|69449428|FG000|Overall Study|Follow-up loss|3|||
37803943|NCT01592292|69449429|FG001|Overall Study|Follow-up loss|3|||
37803944|NCT01592292|69449430|FG002|Overall Study|Follow-up loss|1|||
37803945|NCT01592292|69449431|FG003|Overall Study|Follow-up loss|0|||
37803946|NCT01592292|69449428|FG000|Overall Study|Withdrew consent|2|||
37803947|NCT01592292|69449429|FG001|Overall Study|Withdrew consent|1|||
37803948|NCT01592292|69449430|FG002|Overall Study|Withdrew consent|0|||
37803949|NCT01592292|69449431|FG003|Overall Study|Withdrew consent|0|||
37803950|NCT01592292|69449428|FG000|Overall Study|Other|1|||
37803951|NCT01592292|69449429|FG001|Overall Study|Other|1|||
37803952|NCT01592292|69449430|FG002|Overall Study|Other|2|||
37803953|NCT01592292|69449431|FG003|Overall Study|Other|1|||
37803954|NCT01590888|69449440|FG000|Overall Study|Adverse Event|3|||
37803955|NCT01590888|69449441|FG001|Overall Study|Adverse Event|0|||
37803956|NCT01590888|69449442|FG002|Overall Study|Adverse Event|1|||
37803957|NCT01590888|69449440|FG000|Overall Study|Lost to Follow-up|1|||
37803958|NCT01590888|69449441|FG001|Overall Study|Lost to Follow-up|0|||
37803959|NCT01590888|69449442|FG002|Overall Study|Lost to Follow-up|0|||
37803960|NCT01565928|69449450|FG000|Overall Study|Adverse Event|3|||
37803961|NCT01565928|69449450|FG000|Overall Study|Other|3|||
37803962|NCT01565928|69449450|FG000|Overall Study|Progressive Disease|13|||
37803963|NCT01565928|69449450|FG000|Overall Study|Withdrawal by Subject|1|||
37803964|NCT01565928|69449450|FG000|Overall Study|Death|2|||
37803965|NCT01565850|69449459|FG000|Overall Study|Adverse Event|0|||
37803966|NCT01565850|69449460|FG001|Overall Study|Adverse Event|1|||
37803967|NCT01565850|69449459|FG000|Overall Study|Lost to Follow-up|12|||
37803968|NCT01565850|69449460|FG001|Overall Study|Lost to Follow-up|4|||
37803969|NCT01565850|69449459|FG000|Overall Study|Investigator's Discretion|2|||
37803970|NCT01565850|69449460|FG001|Overall Study|Investigator's Discretion|1|||
37803971|NCT01565850|69449459|FG000|Overall Study|Participant noncompliance|2|||
37803972|NCT01565850|69449460|FG001|Overall Study|Participant noncompliance|0|||
37803973|NCT01565850|69449459|FG000|Overall Study|Withdrew Consent|4|||
37803974|NCT01565850|69449460|FG001|Overall Study|Withdrew Consent|2|||
37803975|NCT01565694|69449466|FG000|Dose-Titration Period|Adverse Event|4|||
37803976|NCT01565694|69449466|FG000|Dose-Titration Period|Protocol Violation|10|||
37803977|NCT01565694|69449466|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
37803978|NCT01543152|69449475|FG000|Overall Study|Withdrawal by Subject|0|||
37803979|NCT01543152|69449476|FG001|Overall Study|Withdrawal by Subject|2|||
37803980|NCT01543152|69449477|FG002|Overall Study|Withdrawal by Subject|0|||
37803981|NCT01543152|69449478|FG003|Overall Study|Withdrawal by Subject|0|||
37803982|NCT01543152|69449479|FG004|Overall Study|Withdrawal by Subject|0|||
37803983|NCT01590810|69449496|FG000|Overall Study|Physician Decision|0|||
37803984|NCT01590810|69449497|FG001|Overall Study|Physician Decision|1|||
37803985|NCT01590810|69449498|FG002|Overall Study|Physician Decision|1|||
37803986|NCT01590810|69449499|FG003|Overall Study|Physician Decision|0|||
37803987|NCT01590810|69449500|FG004|Overall Study|Physician Decision|0|||
37803988|NCT01542528|69449535|FG000|Overall Study|Lost to Follow-up|2|||
37803989|NCT01542528|69449536|FG001|Overall Study|Lost to Follow-up|1|||
37803990|NCT01542528|69449535|FG000|Overall Study|Physician Decision|1|||
37803991|NCT01542528|69449536|FG001|Overall Study|Physician Decision|0|||
37803992|NCT01542528|69449535|FG000|Overall Study|Withdrawal by Subject|9|||
37803993|NCT01542528|69449536|FG001|Overall Study|Withdrawal by Subject|6|||
37803994|NCT01565148|69449546|FG000|Overall Study|Withdrawal by Subject|1|||
37803995|NCT01565148|69449547|FG001|Overall Study|Withdrawal by Subject|1|||
37803996|NCT01565148|69449548|FG002|Overall Study|Withdrawal by Subject|1|||
37803997|NCT01565148|69449549|FG003|Overall Study|Withdrawal by Subject|2|||
37803998|NCT01565148|69449546|FG000|Overall Study|Lost to Follow-up|4|||
37803999|NCT01565148|69449547|FG001|Overall Study|Lost to Follow-up|4|||
37804000|NCT01565148|69449548|FG002|Overall Study|Lost to Follow-up|0|||
37804001|NCT01565148|69449549|FG003|Overall Study|Lost to Follow-up|3|||
37804002|NCT01565148|69449546|FG000|Overall Study|Rescue Therapy|8|||
37804003|NCT01565148|69449547|FG001|Overall Study|Rescue Therapy|5|||
37804004|NCT01565148|69449548|FG002|Overall Study|Rescue Therapy|5|||
37804005|NCT01565148|69449549|FG003|Overall Study|Rescue Therapy|8|||
37804006|NCT01565148|69449546|FG000|Overall Study|Death|0|||
37804007|NCT01565148|69449547|FG001|Overall Study|Death|0|||
37804008|NCT01565148|69449548|FG002|Overall Study|Death|1|||
37804009|NCT01565148|69449549|FG003|Overall Study|Death|0|||
37804010|NCT01565148|69449546|FG000|Overall Study|Physician Decision|2|||
37804011|NCT01565148|69449547|FG001|Overall Study|Physician Decision|5|||
37804012|NCT01565148|69449548|FG002|Overall Study|Physician Decision|0|||
37804013|NCT01565148|69449549|FG003|Overall Study|Physician Decision|0|||
37804014|NCT01564758|69449563|FG000|Overall Study|Death|8|||
37804015|NCT01564758|69449563|FG000|Overall Study|Adverse Event|3|||
37804016|NCT01564758|69449563|FG000|Overall Study|Other|3|||
37804017|NCT01541826|69449570|FG000|Overall Study|Lost to Follow-up|2|||
37804018|NCT01541826|69449571|FG001|Overall Study|Lost to Follow-up|3|||
37804019|NCT01541826|69449572|FG002|Overall Study|Lost to Follow-up|0|||
37804020|NCT01541826|69449570|FG000|Overall Study|Withdrawal by Subject|2|||
37804021|NCT01541826|69449571|FG001|Overall Study|Withdrawal by Subject|0|||
37804022|NCT01541826|69449572|FG002|Overall Study|Withdrawal by Subject|0|||
37804023|NCT01541748|69449580|FG000|Overall Study|Lost to Follow-up|17|||
37975820|NCT00495170|69663098|FG000|Overall Study|Inappropriate staging|8|||
37975821|NCT03853148|69663106|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
37975822|NCT03853148|69663107|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
38043764|NCT02101853|69731877|FG005|Post Induction Randomization|Death|0|||
37804024|NCT01541748|69449580|FG000|Overall Study|Moved out of state|1|||
37804025|NCT01541748|69449580|FG000|Overall Study|Withdrawal by Subject|7|||
37804026|NCT01541748|69449580|FG000|Overall Study|Screen failure|5|||
37804027|NCT01541748|69449580|FG000|Overall Study|Did not receive study device|1|||
37804028|NCT01589094|69449593|FG000|Overall Study|Did not receive treatment|2|||
37804029|NCT01563978|69449599|FG000|Overall Study|Physician Decision|1|||
37804030|NCT01563978|69449600|FG001|Overall Study|Physician Decision|0|||
37804031|NCT01563978|69449599|FG000|Overall Study|Lost to Follow-up|1|||
37804032|NCT01563978|69449600|FG001|Overall Study|Lost to Follow-up|0|||
37804033|NCT01563978|69449599|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
37804034|NCT01563978|69449600|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
37804035|NCT01563978|69449599|FG000|Overall Study|Adverse Event|1|||
37804036|NCT01563978|69449600|FG001|Overall Study|Adverse Event|2|||
37804037|NCT01563354|69449609|FG000|Core Phase|Adverse Event|5|||
37804038|NCT01563354|69449610|FG001|Core Phase|Adverse Event|15|||
37804039|NCT01563354|69449611|FG002|Core Phase|Adverse Event|13|||
37804040|NCT01563354|69449609|FG000|Core Phase|Withdrawal by Subject|1|||
37804041|NCT01563354|69449610|FG001|Core Phase|Withdrawal by Subject|0|||
37804042|NCT01563354|69449611|FG002|Core Phase|Withdrawal by Subject|3|||
37804043|NCT01563354|69449609|FG000|Core Phase|Lost to Follow-up|1|||
37804044|NCT01563354|69449610|FG001|Core Phase|Lost to Follow-up|0|||
37804045|NCT01563354|69449611|FG002|Core Phase|Lost to Follow-up|0|||
37804046|NCT01563354|69449609|FG000|Core Phase|Death|1|||
37804047|NCT01563354|69449610|FG001|Core Phase|Death|5|||
37804048|NCT01563354|69449611|FG002|Core Phase|Death|2|||
37804049|NCT01563354|69449609|FG000|Core Phase|Diseasse progression|18|||
37804050|NCT01563354|69449610|FG001|Core Phase|Diseasse progression|7|||
37804051|NCT01563354|69449611|FG002|Core Phase|Diseasse progression|8|||
37804052|NCT01563354|69449609|FG000|Core Phase|Protocol deviation|2|||
37804053|NCT01563354|69449610|FG001|Core Phase|Protocol deviation|0|||
37804054|NCT01563354|69449611|FG002|Core Phase|Protocol deviation|0|||
37804055|NCT01563354|69449609|FG000|Core Phase|PI decision - did not enter extension|0|||
37804056|NCT01563354|69449610|FG001|Core Phase|PI decision - did not enter extension|1|||
37804057|NCT01563354|69449611|FG002|Core Phase|PI decision - did not enter extension|0|||
37804058|NCT01563354|69449609|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
37804059|NCT01563354|69449610|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
37804060|NCT01563354|69449611|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
37804061|NCT01563354|69449609|FG000|Extension Phase|Adverse Event|0|||
37804062|NCT01563354|69449610|FG001|Extension Phase|Adverse Event|3|||
37804063|NCT01563354|69449611|FG002|Extension Phase|Adverse Event|2|||
37804064|NCT01563354|69449609|FG000|Extension Phase|Withdrawal by Subject|0|||
37804065|NCT01563354|69449610|FG001|Extension Phase|Withdrawal by Subject|1|||
37804066|NCT01563354|69449611|FG002|Extension Phase|Withdrawal by Subject|0|||
38043765|NCT02101853|69731872|FG000|Post Induction Randomization|Lack of Efficacy|0|||
37804067|NCT01563354|69449609|FG000|Extension Phase|Administration problems|3|||
37804068|NCT01563354|69449610|FG001|Extension Phase|Administration problems|2|||
37804069|NCT01563354|69449611|FG002|Extension Phase|Administration problems|3|||
37804070|NCT01563354|69449609|FG000|Extension Phase|Disease progression|9|||
37804071|NCT01563354|69449610|FG001|Extension Phase|Disease progression|8|||
38043766|NCT02101853|69731873|FG001|Post Induction Randomization|Lack of Efficacy|14|||
38043767|NCT02101853|69731874|FG002|Post Induction Randomization|Lack of Efficacy|23|||
38043768|NCT02101853|69731875|FG003|Post Induction Randomization|Lack of Efficacy|18|||
38043769|NCT02101853|69731876|FG004|Post Induction Randomization|Lack of Efficacy|21|||
37804072|NCT01563354|69449611|FG002|Extension Phase|Disease progression|10|||
37804073|NCT01588548|69449625|FG000|Overall Study|Withdrawal by Subject|0|||
37804074|NCT01588548|69449626|FG001|Overall Study|Withdrawal by Subject|1|||
37804075|NCT01588548|69449627|FG002|Overall Study|Withdrawal by Subject|1|||
37804076|NCT01588548|69449628|FG003|Overall Study|Withdrawal by Subject|1|||
37804077|NCT01588548|69449629|FG004|Overall Study|Withdrawal by Subject|2|||
37804078|NCT01588548|69449630|FG005|Overall Study|Withdrawal by Subject|3|||
37804079|NCT01588548|69449625|FG000|Overall Study|Adverse Event|0|||
37804080|NCT01588548|69449626|FG001|Overall Study|Adverse Event|0|||
37804081|NCT01588548|69449627|FG002|Overall Study|Adverse Event|1|||
37804082|NCT01588548|69449628|FG003|Overall Study|Adverse Event|2|||
37804083|NCT01588548|69449629|FG004|Overall Study|Adverse Event|1|||
37804084|NCT01588548|69449630|FG005|Overall Study|Adverse Event|0|||
37804085|NCT01588548|69449625|FG000|Overall Study|Condition Under Investigation Worsened|3|||
37804086|NCT01588548|69449626|FG001|Overall Study|Condition Under Investigation Worsened|6|||
37804087|NCT01588548|69449627|FG002|Overall Study|Condition Under Investigation Worsened|4|||
37804088|NCT01588548|69449628|FG003|Overall Study|Condition Under Investigation Worsened|4|||
37804089|NCT01588548|69449629|FG004|Overall Study|Condition Under Investigation Worsened|3|||
37804090|NCT01588548|69449630|FG005|Overall Study|Condition Under Investigation Worsened|3|||
37804091|NCT01587924|69449648|FG000|Overall Study|Adverse Event|0|||
37804092|NCT01587924|69449649|FG001|Overall Study|Adverse Event|2|||
37804093|NCT01587924|69449650|FG002|Overall Study|Adverse Event|0|||
37804094|NCT01587924|69449651|FG003|Overall Study|Adverse Event|0|||
37804095|NCT01587924|69449648|FG000|Overall Study|Protocol Violation|2|||
37804096|NCT01587924|69449649|FG001|Overall Study|Protocol Violation|1|||
37804097|NCT01587924|69449650|FG002|Overall Study|Protocol Violation|2|||
37804098|NCT01587924|69449651|FG003|Overall Study|Protocol Violation|1|||
37804099|NCT01587924|69449648|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
37804100|NCT01587924|69449649|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
37804101|NCT01587924|69449650|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
37804102|NCT01587924|69449651|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
37804103|NCT01587924|69449648|FG000|Overall Study|Withdrawal by Subject|0|||
37804104|NCT01587924|69449649|FG001|Overall Study|Withdrawal by Subject|1|||
37804105|NCT01587924|69449650|FG002|Overall Study|Withdrawal by Subject|1|||
37804106|NCT01587924|69449651|FG003|Overall Study|Withdrawal by Subject|0|||
37804107|NCT01539642|69449663|FG000|Overall Study|Lack of Efficacy|20|||
37804108|NCT01539642|69449664|FG001|Overall Study|Lack of Efficacy|18|||
37804109|NCT01539642|69449663|FG000|Overall Study|Patient ready for early discharge|8|||
37804110|NCT01539642|69449664|FG001|Overall Study|Patient ready for early discharge|7|||
37804111|NCT01539642|69449663|FG000|Overall Study|Adverse Event|6|||
37804112|NCT01539642|69449664|FG001|Overall Study|Adverse Event|4|||
37804113|NCT01539642|69449663|FG000|Overall Study|Withdrawal by Subject|2|||
37804114|NCT01539642|69449664|FG001|Overall Study|Withdrawal by Subject|2|||
37864266|NCT00990106|69547854|FG000|Overall Study|opted for open label prazosin|1|||
37864267|NCT00990106|69547855|FG001|Overall Study|opted for open label prazosin|1|||
37804115|NCT01586364|69449670|FG000|Overall Study|Withdrawal by Subject|40|||
37804116|NCT01586364|69449670|FG000|Overall Study|Adverse Event|37|||
37804117|NCT01586364|69449670|FG000|Overall Study|Lost to Follow-up|17|||
37804118|NCT01586364|69449670|FG000|Overall Study|Protocol Violation|16|||
37804119|NCT01586364|69449670|FG000|Overall Study|Lack of Efficacy|1|||
37804120|NCT01586364|69449670|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
37864268|NCT00990106|69547854|FG000|Overall Study|relocation/deployment|4|||
37804121|NCT01586364|69449670|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
37804122|NCT01586364|69449670|FG000|Overall Study|Other-Site closure due to PI illness|1|||
37804123|NCT01586364|69449670|FG000|Overall Study|Other-PI discretion, site closing|2|||
37804124|NCT01586364|69449670|FG000|Overall Study|Other-Not specified|1|||
37804125|NCT01538628|69449676|FG000|Overall Study|Withdrawal by Subject|1|||
37804126|NCT01538628|69449677|FG001|Overall Study|Withdrawal by Subject|1|||
37804127|NCT01538628|69449676|FG000|Overall Study|Lost to Follow-up|0|||
37804128|NCT01538628|69449677|FG001|Overall Study|Lost to Follow-up|1|||
37804129|NCT01538472|69449684|FG000|Overall Study|Disease Progression|3|||
37804130|NCT01538472|69449684|FG000|Overall Study|Death|1|||
37804131|NCT01562028|69449690|FG000|Overall Study|Withdrawal by Subject|1|||
37804132|NCT01562028|69449691|FG001|Overall Study|Withdrawal by Subject|1|||
37804133|NCT01562028|69449690|FG000|Overall Study|Lost to Follow-up|2|||
37804134|NCT01562028|69449691|FG001|Overall Study|Lost to Follow-up|1|||
37804135|NCT01585584|69449697|FG000|Overall Study|Lack of Efficacy|1|||
37804136|NCT01585584|69449697|FG000|Overall Study|Withdrawal by Subject|1|||
37804137|NCT01585584|69449697|FG000|Overall Study|Physician Decision|2|||
37804138|NCT01561560|69449701|FG000|First Two Weeks of Wear|Time/job conflict|0|||
37804139|NCT01561560|69449702|FG001|First Two Weeks of Wear|Time/job conflict|1|||
37804140|NCT01561560|69449701|FG000|First Two Weeks of Wear|Adverse Event|0|||
37804141|NCT01561560|69449702|FG001|First Two Weeks of Wear|Adverse Event|1|||
37804142|NCT01561560|69449701|FG000|Second Two Weeks of Wear|Adverse Event|0|||
37804143|NCT01561560|69449702|FG001|Second Two Weeks of Wear|Adverse Event|1|||
37804144|NCT01537068|69449710|FG000|Overall Study|Lost to Follow-up|2|||
37804145|NCT01537068|69449711|FG001|Overall Study|Lost to Follow-up|1|||
37804146|NCT01537068|69449710|FG000|Overall Study|Adverse Event|0|||
37804147|NCT01537068|69449711|FG001|Overall Study|Adverse Event|1|||
37804148|NCT01537068|69449710|FG000|Overall Study|Withdrawal by Subject|1|||
37804149|NCT01537068|69449711|FG001|Overall Study|Withdrawal by Subject|1|||
37804150|NCT01537068|69449710|FG000|Overall Study|Lack of Efficacy|1|||
37804151|NCT01537068|69449711|FG001|Overall Study|Lack of Efficacy|0|||
37804152|NCT01585428|69449719|FG000|Overall Study|Death during treatment|1|||
37804153|NCT01585428|69449720|FG001|Overall Study|Death during treatment|0|||
37804154|NCT01585272|69449727|FG000|Overall Study|Adverse Event|22|||
37804155|NCT01585272|69449727|FG000|Overall Study|Protocol Violation|7|||
37804156|NCT01585272|69449727|FG000|Overall Study|Withdrawal by Subject|10|||
37804157|NCT01560780|69449733|FG000|Overall Study|Death|2|||
37804158|NCT01560780|69449734|FG001|Overall Study|Death|1|||
37804159|NCT01560780|69449733|FG000|Overall Study|Patient Preference|11|||
37804160|NCT01560780|69449734|FG001|Overall Study|Patient Preference|11|||
37804161|NCT01585038|69449742|FG000|Overall Study|Adverse Event|2|||
37804162|NCT01585038|69449743|FG001|Overall Study|Adverse Event|2|||
37804163|NCT01560234|69449757|FG000|Overall Study|Lost to Follow-up|3|||
37804164|NCT01560234|69449758|FG001|Overall Study|Lost to Follow-up|0|||
37804165|NCT01560234|69449759|FG002|Overall Study|Lost to Follow-up|1|||
37804166|NCT01560234|69449760|FG003|Overall Study|Lost to Follow-up|0|||
37804167|NCT01560234|69449761|FG004|Overall Study|Lost to Follow-up|0|||
37804168|NCT01560234|69449762|FG005|Overall Study|Lost to Follow-up|2|||
37804169|NCT01560234|69449763|FG006|Overall Study|Lost to Follow-up|0|||
37804170|NCT01560234|69449764|FG007|Overall Study|Lost to Follow-up|2|||
37804171|NCT01559844|69449782|FG000|Overall Study|Consent Withdrawn|7|||
37804172|NCT01559844|69449782|FG000|Overall Study|Death|5|||
37804173|NCT01559844|69449782|FG000|Overall Study|Efficacy Failure|10|||
37975823|NCT03853148|69663108|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
37804174|NCT01559844|69449782|FG000|Overall Study|No Longer A Transplant Candidate|3|||
37804175|NCT01584648|69449788|FG000|Overall Study|Death|136|||
37804176|NCT01584648|69449789|FG001|Overall Study|Death|146|||
37804177|NCT01584648|69449788|FG000|Overall Study|Lost to Follow-up|9|||
37804178|NCT01584648|69449789|FG001|Overall Study|Lost to Follow-up|9|||
37804179|NCT01584648|69449788|FG000|Overall Study|Investigator discretion|3|||
37804180|NCT01584648|69449789|FG001|Overall Study|Investigator discretion|2|||
37804181|NCT01584648|69449788|FG000|Overall Study|Withdrew consent|13|||
37804182|NCT01584648|69449789|FG001|Overall Study|Withdrew consent|4|||
37804183|NCT01584648|69449788|FG000|Overall Study|Study closed/terminated|50|||
37804184|NCT01584648|69449789|FG001|Overall Study|Study closed/terminated|23|||
37804185|NCT01584648|69449788|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
37804186|NCT01584648|69449789|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
37804187|NCT01559454|69449800|FG000|Overall Study|Lost to Follow-up|3|||
37804188|NCT01559454|69449801|FG001|Overall Study|Lost to Follow-up|2|||
37804189|NCT01559454|69449800|FG000|Overall Study|Withdrawal by Subject|0|||
37694011|NCT02352493|69170278|FG016|Overall Study|Lost to Follow-up|0|||
37694012|NCT02352493|69170279|FG017|Overall Study|Lost to Follow-up|0|||
37804190|NCT01559454|69449801|FG001|Overall Study|Withdrawal by Subject|1|||
37804191|NCT01559454|69449800|FG000|Overall Study|Physician Decision|0|||
37804192|NCT01559454|69449801|FG001|Overall Study|Physician Decision|1|||
37804193|NCT01559454|69449800|FG000|Overall Study|Protocol Violation|0|||
37804194|NCT01559454|69449801|FG001|Overall Study|Protocol Violation|1|||
37804195|NCT01559454|69449800|FG000|Overall Study|Lack of Efficacy|0|||
37804196|NCT01559454|69449801|FG001|Overall Study|Lack of Efficacy|1|||
37804197|NCT01584024|69449807|FG000|Overall Study|Lost to Follow-up|10|||
37804198|NCT01584024|69449807|FG000|Overall Study|Withdrawal by Subject|3|||
37804199|NCT01583166|69449814|FG000|Overall Study|Withdrawal by Subject|4|||
37804200|NCT01583166|69449815|FG001|Overall Study|Withdrawal by Subject|6|||
37804201|NCT01535274|69449823|FG000|Overall Study|Determined to be ineligible|0|||
37804202|NCT01535274|69449824|FG001|Overall Study|Determined to be ineligible|1|||
37804203|NCT01535274|69449823|FG000|Overall Study|Misallocated to propofol intervention|0|||
37804204|NCT01535274|69449824|FG001|Overall Study|Misallocated to propofol intervention|1|||
37804205|NCT01558752|69449834|FG000|Overall Study|Physician Decision|2|||
37804206|NCT01558752|69449835|FG001|Overall Study|Physician Decision|0|||
37804207|NCT01582854|69449843|FG000|Overall Study|Death|8|||
37804208|NCT01582854|69449844|FG001|Overall Study|Death|5|||
37804209|NCT01582854|69449843|FG000|Overall Study|Adverse Event|2|||
37804210|NCT01582854|69449844|FG001|Overall Study|Adverse Event|3|||
37804211|NCT01582854|69449843|FG000|Overall Study|Withdrawal by Participant|8|||
37804212|NCT01582854|69449844|FG001|Overall Study|Withdrawal by Participant|11|||
37804213|NCT01582854|69449843|FG000|Overall Study|Lost to Follow-up|1|||
37804214|NCT01582854|69449844|FG001|Overall Study|Lost to Follow-up|2|||
37804215|NCT01582854|69449843|FG000|Overall Study|Physician Decision|0|||
37694013|NCT02286193|69170334|FG000|Overall Study|Referred: CRS unable to make contact|62|||
37804216|NCT01582854|69449844|FG001|Overall Study|Physician Decision|1|||
37804217|NCT01582854|69449843|FG000|Overall Study|Recurrent Stroke|13|||
37804218|NCT01582854|69449844|FG001|Overall Study|Recurrent Stroke|8|||
37804219|NCT01582854|69449843|FG000|Overall Study|Disallowed Concomitant Medication|3|||
37804220|NCT01582854|69449844|FG001|Overall Study|Disallowed Concomitant Medication|2|||
37804221|NCT01582854|69449843|FG000|Overall Study|Carotid or Neurosurgery|0|||
37804222|NCT01582854|69449844|FG001|Overall Study|Carotid or Neurosurgery|1|||
37804223|NCT01582854|69449843|FG000|Overall Study|General Anaesthesia|0|||
37804224|NCT01582854|69449844|FG001|Overall Study|General Anaesthesia|1|||
37804225|NCT01582854|69449843|FG000|Overall Study|Other Miscellaneous Reason|1|||
37804226|NCT01582854|69449844|FG001|Overall Study|Other Miscellaneous Reason|0|||
37804227|NCT01582308|69449850|FG000|Period 1|Withdrawal by Subject|0|||
37804228|NCT01582308|69449851|FG001|Period 1|Withdrawal by Subject|0|||
37804229|NCT01582308|69449852|FG002|Period 1|Withdrawal by Subject|0|||
37804230|NCT01582308|69449853|FG003|Period 1|Withdrawal by Subject|0|||
37804231|NCT01582308|69449854|FG004|Period 1|Withdrawal by Subject|0|||
37804232|NCT01582308|69449855|FG005|Period 1|Withdrawal by Subject|0|||
37804233|NCT01582308|69449856|FG006|Period 1|Withdrawal by Subject|1|||
37804234|NCT01582308|69449857|FG007|Period 1|Withdrawal by Subject|0|||
37804235|NCT01582308|69449858|FG008|Period 1|Withdrawal by Subject|0|||
37804236|NCT01582308|69449859|FG009|Period 1|Withdrawal by Subject|0|||
37804237|NCT01582308|69449850|FG000|10-day Washout Following Period 1|Physician Decision|0|||
37804238|NCT01582308|69449851|FG001|10-day Washout Following Period 1|Physician Decision|0|||
37804239|NCT01582308|69449852|FG002|10-day Washout Following Period 1|Physician Decision|0|||
37804240|NCT01582308|69449853|FG003|10-day Washout Following Period 1|Physician Decision|0|||
37804241|NCT01582308|69449854|FG004|10-day Washout Following Period 1|Physician Decision|1|||
37804242|NCT01582308|69449855|FG005|10-day Washout Following Period 1|Physician Decision|0|||
37804243|NCT01582308|69449856|FG006|10-day Washout Following Period 1|Physician Decision|0|||
37804244|NCT01582308|69449857|FG007|10-day Washout Following Period 1|Physician Decision|0|||
37804245|NCT01582308|69449858|FG008|10-day Washout Following Period 1|Physician Decision|0|||
37804246|NCT01582308|69449859|FG009|10-day Washout Following Period 1|Physician Decision|0|||
37804247|NCT01582308|69449850|FG000|Period 4|Physician Decision|1|||
37804248|NCT01582308|69449851|FG001|Period 4|Physician Decision|0|||
37804249|NCT01582308|69449852|FG002|Period 4|Physician Decision|0|||
37804250|NCT01582308|69449853|FG003|Period 4|Physician Decision|0|||
37804251|NCT01582308|69449854|FG004|Period 4|Physician Decision|0|||
37804252|NCT01582308|69449855|FG005|Period 4|Physician Decision|1|||
37804253|NCT01582308|69449856|FG006|Period 4|Physician Decision|0|||
37694014|NCT02286193|69170334|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
37694015|NCT02286193|69170334|FG000|Overall Study|Referred: Declined service|38|||
37694016|NCT01896232|69170341|FG000|Overall Study|Death|6|||
37804254|NCT01582308|69449857|FG007|Period 4|Physician Decision|0|||
37804255|NCT01582308|69449858|FG008|Period 4|Physician Decision|0|||
37804256|NCT01582308|69449859|FG009|Period 4|Physician Decision|1|||
37804257|NCT01558674|69449874|FG000|Part 1|Study Terminated by Sponsor|10|||
37804258|NCT01558674|69449875|FG001|Part 1|Study Terminated by Sponsor|0|||
37804259|NCT01558674|69449874|FG000|Part 1|Withdrawal by Subject|1|||
37694017|NCT01896232|69170342|FG001|Overall Study|Death|10|||
37804260|NCT01558674|69449875|FG001|Part 1|Withdrawal by Subject|0|||
37804261|NCT01558596|69449896|FG000|Overall Study|Withdrawal by Subject|1|||
37804262|NCT01558596|69449897|FG001|Overall Study|Withdrawal by Subject|0|||
37804263|NCT01558596|69449896|FG000|Overall Study|surgery elsewhere or cancelled|1|||
37804264|NCT01558596|69449897|FG001|Overall Study|surgery elsewhere or cancelled|1|||
37804265|NCT01558596|69449896|FG000|Overall Study|Protocol Violation|1|||
37804266|NCT01558596|69449897|FG001|Overall Study|Protocol Violation|0|||
37804267|NCT01535040|69449905|FG000|Overall Study|Physician Decision|0|||
37804268|NCT01535040|69449906|FG001|Overall Study|Physician Decision|1|||
37804269|NCT01535040|69449905|FG000|Overall Study|Withdrawal by Subject|13|||
37804270|NCT01535040|69449906|FG001|Overall Study|Withdrawal by Subject|10|||
37804271|NCT01535040|69449905|FG000|Overall Study|Never Started|9|||
37804272|NCT01535040|69449906|FG001|Overall Study|Never Started|4|||
37804273|NCT01535040|69449905|FG000|Overall Study|Toxicity|7|||
37804274|NCT01535040|69449906|FG001|Overall Study|Toxicity|5|||
37804275|NCT01535040|69449905|FG000|Overall Study|Multiple Reasons|1|||
37804276|NCT01535040|69449906|FG001|Overall Study|Multiple Reasons|1|||
37804277|NCT01534962|69449916|FG000|Overall Study|Randomized but did not start treatment|2|||
37804278|NCT01534962|69449917|FG001|Overall Study|Randomized but did not start treatment|0|||
37804279|NCT01534962|69449918|FG002|Overall Study|Randomized but did not start treatment|0|||
37804280|NCT01534962|69449919|FG003|Overall Study|Randomized but did not start treatment|1|||
37804281|NCT01534962|69449916|FG000|Overall Study|Discontinued at AF recurrence|35|||
37804282|NCT01534962|69449917|FG001|Overall Study|Discontinued at AF recurrence|26|||
37804283|NCT01534962|69449918|FG002|Overall Study|Discontinued at AF recurrence|24|||
37804284|NCT01534962|69449919|FG003|Overall Study|Discontinued at AF recurrence|31|||
37804285|NCT01582152|69449931|FG000|Overall Study|Disease Progression|4|||
37804286|NCT01582152|69449932|FG001|Overall Study|Disease Progression|5|||
37804287|NCT01582152|69449931|FG000|Overall Study|Adverse Event|2|||
37804288|NCT01582152|69449932|FG001|Overall Study|Adverse Event|1|||
37804289|NCT01581684|69449948|FG000|Overall Study|Other reason not defined|0|||
37804290|NCT01581684|69449949|FG001|Overall Study|Other reason not defined|0|||
37804291|NCT01581684|69449950|FG002|Overall Study|Other reason not defined|0|||
37804292|NCT01581684|69449951|FG003|Overall Study|Other reason not defined|0|||
37804293|NCT01581684|69449952|FG004|Overall Study|Other reason not defined|0|||
37804294|NCT01581684|69449953|FG005|Overall Study|Other reason not defined|0|||
37804295|NCT01581684|69449954|FG006|Overall Study|Other reason not defined|0|||
37804296|NCT01581684|69449955|FG007|Overall Study|Other reason not defined|0|||
37804297|NCT01581684|69449956|FG008|Overall Study|Other reason not defined|1|||
37804298|NCT01581684|69449957|FG009|Overall Study|Other reason not defined|0|||
37804299|NCT01557582|69449990|FG000|Overall Study|Protocol Violation|4|||
37804300|NCT01557582|69449990|FG000|Overall Study|Operator error|2|||
37804301|NCT01557504|69449996|FG000|Overall Study|Physician Decision|1|||
37804302|NCT01557504|69449997|FG001|Overall Study|Physician Decision|0|||
37804303|NCT01557348|69450011|FG000|Overall Study|Adverse Event|6|||
37804304|NCT01557348|69450012|FG001|Overall Study|Adverse Event|16|||
37804305|NCT01557348|69450011|FG000|Overall Study|Infusion reaction event|5|||
37804306|NCT01557348|69450012|FG001|Overall Study|Infusion reaction event|5|||
37804307|NCT01557348|69450011|FG000|Overall Study|Death|7|||
37804308|NCT01557348|69450012|FG001|Overall Study|Death|4|||
37804309|NCT01557348|69450011|FG000|Overall Study|Insufficient Therapeutic Response|13|||
37804310|NCT01557348|69450012|FG001|Overall Study|Insufficient Therapeutic Response|28|||
37804311|NCT01557348|69450011|FG000|Overall Study|Withdrawal by Subject|5|||
37804312|NCT01557348|69450012|FG001|Overall Study|Withdrawal by Subject|4|||
37804313|NCT01557348|69450011|FG000|Overall Study|Lost to Follow-up|26|||
37804314|NCT01557348|69450012|FG001|Overall Study|Lost to Follow-up|22|||
37804315|NCT01557348|69450011|FG000|Overall Study|Administrative|18|||
37804316|NCT01557348|69450012|FG001|Overall Study|Administrative|11|||
37804317|NCT01580670|69450019|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
37804318|NCT01580670|69450019|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
37804319|NCT01534260|69450025|FG000|Overall Study|Adverse Event|1|||
37804320|NCT01534260|69450026|FG001|Overall Study|Adverse Event|8|||
38043770|NCT02101853|69731877|FG005|Post Induction Randomization|Lack of Efficacy|0|||
38043771|NCT02101853|69731872|FG000|Post Induction Randomization|Physician Decision|0|||
38043772|NCT02101853|69731873|FG001|Post Induction Randomization|Physician Decision|43|||
38043773|NCT02101853|69731874|FG002|Post Induction Randomization|Physician Decision|23|||
38043774|NCT02101853|69731875|FG003|Post Induction Randomization|Physician Decision|14|||
38043775|NCT02101853|69731876|FG004|Post Induction Randomization|Physician Decision|14|||
38043776|NCT02101853|69731877|FG005|Post Induction Randomization|Physician Decision|0|||
38043777|NCT02101853|69731872|FG000|Post Induction Randomization|Protocol Violation|0|||
37804321|NCT01534260|69450025|FG000|Overall Study|Death|2|||
37804322|NCT01534260|69450026|FG001|Overall Study|Death|0|||
37804323|NCT01534260|69450025|FG000|Overall Study|Lack of Efficacy|1|||
37804324|NCT01534260|69450026|FG001|Overall Study|Lack of Efficacy|1|||
37804325|NCT01534260|69450025|FG000|Overall Study|Withdrawal by Subject|1|||
37804326|NCT01534260|69450026|FG001|Overall Study|Withdrawal by Subject|3|||
37804327|NCT01534260|69450025|FG000|Overall Study|Disease Progression|8|||
37804328|NCT01534260|69450026|FG001|Overall Study|Disease Progression|6|||
37804329|NCT01534260|69450025|FG000|Overall Study|Physician Decision|3|||
37804330|NCT01534260|69450026|FG001|Overall Study|Physician Decision|1|||
37804331|NCT01534260|69450025|FG000|Overall Study|No treatment, per protocol|0|||
37804332|NCT01534260|69450026|FG001|Overall Study|No treatment, per protocol|1|||
37804333|NCT01534182|69450034|FG000|Overall Study|Administrative problems|1|||
37804334|NCT01534182|69450035|FG001|Overall Study|Administrative problems|0|||
37804335|NCT01534182|69450034|FG000|Overall Study|Withdrawal by Subject|4|||
37804336|NCT01534182|69450035|FG001|Overall Study|Withdrawal by Subject|7|||
37804337|NCT01534182|69450034|FG000|Overall Study|Adverse Event|7|||
37804338|NCT01534182|69450035|FG001|Overall Study|Adverse Event|3|||
37804339|NCT01579812|69450042|FG000|Overall Study|Ineligible after treatment start|40|||
37804340|NCT01579812|69450042|FG000|Overall Study|Patient choice|3|||
37804341|NCT01579812|69450042|FG000|Overall Study|Noncompliance|3|||
37804342|NCT01579812|69450042|FG000|Overall Study|Withdrawal by Subject|6|||
37804343|NCT01533714|69450055|FG000|Overall Study|Adverse Event|0|||
37804344|NCT01533714|69450056|FG001|Overall Study|Adverse Event|1|||
37804345|NCT01533714|69450057|FG002|Overall Study|Adverse Event|2|||
37804346|NCT01533714|69450058|FG003|Overall Study|Adverse Event|2|||
37804347|NCT01533714|69450059|FG004|Overall Study|Adverse Event|2|||
37804348|NCT01533714|69450060|FG005|Overall Study|Adverse Event|1|||
37804349|NCT01533714|69450055|FG000|Overall Study|Lack of Efficacy|0|||
37804350|NCT01533714|69450056|FG001|Overall Study|Lack of Efficacy|0|||
37804351|NCT01533714|69450057|FG002|Overall Study|Lack of Efficacy|0|||
37804352|NCT01533714|69450058|FG003|Overall Study|Lack of Efficacy|0|||
37804353|NCT01533714|69450059|FG004|Overall Study|Lack of Efficacy|0|||
37804354|NCT01533714|69450060|FG005|Overall Study|Lack of Efficacy|1|||
37694018|NCT01896232|69170341|FG000|Overall Study|Withdrawal by Subject|32|||
37804355|NCT01533714|69450055|FG000|Overall Study|Withdrawal by Subject|0|||
37804356|NCT01533714|69450056|FG001|Overall Study|Withdrawal by Subject|1|||
37804357|NCT01533714|69450057|FG002|Overall Study|Withdrawal by Subject|0|||
37804358|NCT01533714|69450058|FG003|Overall Study|Withdrawal by Subject|1|||
37804359|NCT01533714|69450059|FG004|Overall Study|Withdrawal by Subject|1|||
37804360|NCT01533714|69450060|FG005|Overall Study|Withdrawal by Subject|0|||
37804361|NCT01533714|69450055|FG000|Overall Study|Exclusion criteria|0|||
37804362|NCT01533714|69450056|FG001|Overall Study|Exclusion criteria|1|||
37804363|NCT01533714|69450057|FG002|Overall Study|Exclusion criteria|0|||
37804364|NCT01533714|69450058|FG003|Overall Study|Exclusion criteria|0|||
37804365|NCT01533714|69450059|FG004|Overall Study|Exclusion criteria|0|||
37804366|NCT01533714|69450060|FG005|Overall Study|Exclusion criteria|0|||
37804367|NCT01533714|69450055|FG000|Overall Study|Positive for purified protein derivative|0|||
37804368|NCT01533714|69450056|FG001|Overall Study|Positive for purified protein derivative|0|||
37804369|NCT01533714|69450057|FG002|Overall Study|Positive for purified protein derivative|1|||
37804370|NCT01533714|69450058|FG003|Overall Study|Positive for purified protein derivative|0|||
37804371|NCT01533714|69450059|FG004|Overall Study|Positive for purified protein derivative|1|||
37804372|NCT01533714|69450060|FG005|Overall Study|Positive for purified protein derivative|0|||
37804373|NCT01533714|69450055|FG000|Overall Study|Withdrawal criteria|0|||
37804374|NCT01533714|69450056|FG001|Overall Study|Withdrawal criteria|0|||
37804375|NCT01533714|69450057|FG002|Overall Study|Withdrawal criteria|1|||
37804376|NCT01533714|69450058|FG003|Overall Study|Withdrawal criteria|0|||
37804377|NCT01533714|69450059|FG004|Overall Study|Withdrawal criteria|3|||
37804378|NCT01533714|69450060|FG005|Overall Study|Withdrawal criteria|1|||
37804379|NCT01533714|69450055|FG000|Overall Study|Ineligibility reason|0|||
37694019|NCT01896232|69170342|FG001|Overall Study|Withdrawal by Subject|31|||
37804380|NCT01533714|69450056|FG001|Overall Study|Ineligibility reason|0|||
37804381|NCT01533714|69450057|FG002|Overall Study|Ineligibility reason|0|||
37804382|NCT01533714|69450058|FG003|Overall Study|Ineligibility reason|1|||
37804383|NCT01533714|69450059|FG004|Overall Study|Ineligibility reason|0|||
37694020|NCT01896232|69170341|FG000|Overall Study|Sponsor Decision|2|||
37804384|NCT01533714|69450060|FG005|Overall Study|Ineligibility reason|0|||
37804385|NCT01533246|69450074|FG000|Overall Study|Adverse Event|1|||
37804386|NCT01533246|69450074|FG000|Overall Study|Withdrawal by Subject|1|||
37804387|NCT01579578|69450080|FG000|Overall Study|Death|4|||
37804388|NCT01579578|69450081|FG001|Overall Study|Death|1|||
37804389|NCT01579578|69450080|FG000|Overall Study|Lost to Follow-up|1|||
37804390|NCT01579578|69450081|FG001|Overall Study|Lost to Follow-up|1|||
37804391|NCT01579578|69450080|FG000|Overall Study|Withdrawal by Subject|2|||
37804392|NCT01579578|69450081|FG001|Overall Study|Withdrawal by Subject|1|||
37804393|NCT01579578|69450080|FG000|Overall Study|Eligibility criteria|3|||
37804394|NCT01579578|69450081|FG001|Overall Study|Eligibility criteria|9|||
37804395|NCT01579578|69450080|FG000|Overall Study|Ongoing|3|||
37804396|NCT01579578|69450081|FG001|Overall Study|Ongoing|0|||
37804397|NCT01578486|69450087|FG000|Overall Study|Physician Decision|3|||
37804398|NCT01578486|69450087|FG000|Overall Study|Withdrawal by Subject|2|||
37804399|NCT01532934|69450093|FG000|Overall Study|Lost to Follow-up|11|||
37804400|NCT01532934|69450094|FG001|Overall Study|Lost to Follow-up|11|||
37804401|NCT01532934|69450093|FG000|Overall Study|In controlled environment|3|||
37804402|NCT01532934|69450094|FG001|Overall Study|In controlled environment|2|||
37804403|NCT01555164|69450104|FG000|Overall Study|Adverse Event|5|||
37804404|NCT01555164|69450105|FG001|Overall Study|Adverse Event|7|||
37804405|NCT01555164|69450104|FG000|Overall Study|Hyperglycemia|0|||
37804406|NCT01555164|69450105|FG001|Overall Study|Hyperglycemia|1|||
37804407|NCT01555164|69450104|FG000|Overall Study|Investigator's Discretion|2|||
37804408|NCT01555164|69450105|FG001|Overall Study|Investigator's Discretion|2|||
37804409|NCT01555164|69450104|FG000|Overall Study|Lost to Follow-up|4|||
37804410|NCT01555164|69450105|FG001|Overall Study|Lost to Follow-up|3|||
37804411|NCT01555164|69450104|FG000|Overall Study|Protocol Violation|9|||
37804412|NCT01555164|69450105|FG001|Overall Study|Protocol Violation|5|||
37804413|NCT01555164|69450104|FG000|Overall Study|Subject Non-compliance|14|||
37804414|NCT01555164|69450105|FG001|Overall Study|Subject Non-compliance|6|||
37804415|NCT01555164|69450104|FG000|Overall Study|Subject Withdrew Consent|6|||
37804416|NCT01555164|69450105|FG001|Overall Study|Subject Withdrew Consent|11|||
37804417|NCT01578330|69450111|FG000|Overall Study|Adverse Event|2|||
37804418|NCT01578330|69450111|FG000|Overall Study|Protocol Violation|5|||
37804419|NCT01577160|69450115|FG000|Overall Study|Adverse Event|9|||
37804420|NCT01577160|69450115|FG000|Overall Study|Lack of Efficacy|15|||
37804421|NCT01577160|69450115|FG000|Overall Study|Lost to Follow-up|40|||
37804422|NCT01577160|69450115|FG000|Overall Study|Withdrawal by Subject|18|||
37804423|NCT01577160|69450115|FG000|Overall Study|Subject Uncooperative|7|||
37804424|NCT01577160|69450115|FG000|Overall Study|Other|9|||
37804425|NCT01554618|69450121|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
37804426|NCT01554618|69450122|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
37804427|NCT01554618|69450121|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
37804428|NCT01554618|69450122|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
37804429|NCT01554618|69450121|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
37804430|NCT01554618|69450122|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
37804431|NCT01554618|69450121|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
37804432|NCT01554618|69450122|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
37804433|NCT01554618|69450121|FG000|Open-Label Extension Period|Physician Decision|0|||
37804434|NCT01554618|69450122|FG001|Open-Label Extension Period|Physician Decision|1|||
37804435|NCT01554618|69450121|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
37804436|NCT01554618|69450122|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
37804437|NCT01531998|69450132|FG000|Overall Study|Withdrawal by Subject|3|||
37804438|NCT01576146|69450136|FG000|Extension Period 1|Adverse Event|2|||
37804439|NCT01576146|69450136|FG000|Extension Period 1|Death|2|||
37804440|NCT01576146|69450136|FG000|Extension Period 1|Physician Decision|2|||
37804441|NCT01576146|69450136|FG000|Extension Period 1|Withdrawal by Subject|1|||
37804442|NCT01576146|69450136|FG000|Extension Period 1|Lost to Follow-up|1|||
37804443|NCT01576146|69450136|FG000|Extension Period 1|Parathyroidectomy|1|||
37804444|NCT01576146|69450136|FG000|Extension Period 1|Renal Transplant|1|||
37804445|NCT01576146|69450136|FG000|Extension Period 2|Sponsor Decision|13|||
37804446|NCT01576146|69450136|FG000|Extension Period 2|Death|1|||
37804447|NCT01576146|69450136|FG000|Extension Period 2|Adverse Event|1|||
37804448|NCT01576146|69450136|FG000|Extension Period 2|Renal Transplant|1|||
37804449|NCT01576146|69450136|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
37804450|NCT01553916|69450140|FG000|Overall Study|Withdrawal by Subject|2|||
37804451|NCT01553916|69450140|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
37804452|NCT01553136|69450146|FG000|Overall Study|Adverse Event|3|||
37804453|NCT01553136|69450147|FG001|Overall Study|Adverse Event|2|||
37804454|NCT01553136|69450146|FG000|Overall Study|Withdrawal by Subject|2|||
37694021|NCT01896232|69170342|FG001|Overall Study|Sponsor Decision|0|||
37804455|NCT01553136|69450147|FG001|Overall Study|Withdrawal by Subject|3|||
37804456|NCT01553136|69450146|FG000|Overall Study|Lost to Follow-up|4|||
37804457|NCT01553136|69450147|FG001|Overall Study|Lost to Follow-up|10|||
37804458|NCT01553136|69450146|FG000|Overall Study|Physician Decision|2|||
37804459|NCT01553136|69450147|FG001|Overall Study|Physician Decision|3|||
37804460|NCT01553136|69450146|FG000|Overall Study|Scheduling Difficulties|5|||
37804461|NCT01553136|69450147|FG001|Overall Study|Scheduling Difficulties|4|||
37804462|NCT01552902|69450156|FG000|Overall Study|Adverse Event|1|||
37804463|NCT01552902|69450157|FG001|Overall Study|Adverse Event|15|||
37804464|NCT01552902|69450158|FG002|Overall Study|Adverse Event|14|||
37804465|NCT01552902|69450156|FG000|Overall Study|Protocol Violation|3|||
37804466|NCT01552902|69450157|FG001|Overall Study|Protocol Violation|3|||
37804467|NCT01552902|69450158|FG002|Overall Study|Protocol Violation|3|||
37804468|NCT01552902|69450156|FG000|Overall Study|Lack of Efficacy|4|||
37804469|NCT01552902|69450157|FG001|Overall Study|Lack of Efficacy|3|||
37804470|NCT01552902|69450158|FG002|Overall Study|Lack of Efficacy|1|||
37804471|NCT01552902|69450156|FG000|Overall Study|Withdrawal by Subject|1|||
37804472|NCT01552902|69450157|FG001|Overall Study|Withdrawal by Subject|9|||
37804473|NCT01552902|69450158|FG002|Overall Study|Withdrawal by Subject|6|||
37804474|NCT01552902|69450156|FG000|Overall Study|Lost to Follow-up|1|||
37804475|NCT01552902|69450157|FG001|Overall Study|Lost to Follow-up|3|||
37804476|NCT01552902|69450158|FG002|Overall Study|Lost to Follow-up|6|||
37804477|NCT01552902|69450156|FG000|Overall Study|Other|3|||
37804478|NCT01552902|69450157|FG001|Overall Study|Other|4|||
37804479|NCT01552902|69450158|FG002|Overall Study|Other|3|||
37804480|NCT01529346|69450184|FG000|Overall Study|Lost to Follow-up|2|||
37804481|NCT01529346|69450185|FG001|Overall Study|Lost to Follow-up|0|||
37804482|NCT01529346|69450186|FG002|Overall Study|Lost to Follow-up|1|||
37804483|NCT01529346|69450187|FG003|Overall Study|Lost to Follow-up|0|||
37804484|NCT01529346|69450188|FG004|Overall Study|Lost to Follow-up|0|||
37804485|NCT01529346|69450184|FG000|Overall Study|Other|0|||
37804486|NCT01529346|69450185|FG001|Overall Study|Other|1|||
37804487|NCT01529346|69450186|FG002|Overall Study|Other|1|||
37804488|NCT01529346|69450187|FG003|Overall Study|Other|0|||
37804489|NCT01529346|69450188|FG004|Overall Study|Other|0|||
37804490|NCT01529268|69450212|FG000|Overall Study|Lost to Follow-up|9|||
37804491|NCT01529268|69450213|FG001|Overall Study|Lost to Follow-up|3|||
37804492|NCT01529268|69450212|FG000|Overall Study|Moved|3|||
37804493|NCT01529268|69450213|FG001|Overall Study|Moved|0|||
37804494|NCT01529112|69450221|FG000|Overall Study|Adverse Event|2|||
37804495|NCT01529112|69450222|FG001|Overall Study|Adverse Event|0|||
37804496|NCT01529112|69450221|FG000|Overall Study|Death|59|||
37804497|NCT01529112|69450222|FG001|Overall Study|Death|38|||
37804498|NCT01529112|69450221|FG000|Overall Study|Protocol Violation|1|||
37804499|NCT01529112|69450222|FG001|Overall Study|Protocol Violation|0|||
37804500|NCT01529112|69450221|FG000|Overall Study|Withdrawal by Subject|7|||
37804501|NCT01529112|69450222|FG001|Overall Study|Withdrawal by Subject|3|||
37804502|NCT01551420|69450230|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
37804503|NCT01551420|69450231|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
37804504|NCT01551420|69450230|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
37804505|NCT01551420|69450231|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
37804506|NCT01551420|69450230|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
37804507|NCT01551420|69450231|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
37804508|NCT01551420|69450230|FG000|Screened for Part B Eligibility|Declined participation|8|||
37804509|NCT01551420|69450231|FG001|Screened for Part B Eligibility|Declined participation|1|||
37804510|NCT01551420|69450230|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
37804511|NCT01551420|69450231|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
37804512|NCT01551420|69450230|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
37804513|NCT01551420|69450231|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
37804514|NCT01551420|69450230|FG000|Home Use (Part B)|Withdrawal by staff|0|||
37804515|NCT01551420|69450231|FG001|Home Use (Part B)|Withdrawal by staff|1|||
37804516|NCT01575054|69450239|FG000|Overall Study|Other Reasons|5|||
37804517|NCT01575054|69450240|FG001|Overall Study|Other Reasons|3|||
37804518|NCT01575054|69450239|FG000|Overall Study|Protocol Violation|2|||
37804519|NCT01575054|69450240|FG001|Overall Study|Protocol Violation|1|||
37804520|NCT01575054|69450239|FG000|Overall Study|Personal Reasons|10|||
37804521|NCT01575054|69450240|FG001|Overall Study|Personal Reasons|11|||
37804522|NCT01575054|69450239|FG000|Overall Study|Lost to Follow-up|3|||
37804523|NCT01575054|69450240|FG001|Overall Study|Lost to Follow-up|3|||
37804524|NCT01575054|69450239|FG000|Overall Study|Adverse Event|9|||
37804525|NCT01575054|69450240|FG001|Overall Study|Adverse Event|8|||
37804526|NCT01528254|69450248|FG000|Overall Study|Administrative problems|96|||
37804527|NCT01528254|69450249|FG001|Overall Study|Administrative problems|94|||
37804528|NCT01528254|69450248|FG000|Overall Study|Adverse Event|28|||
37804529|NCT01528254|69450249|FG001|Overall Study|Adverse Event|44|||
37804530|NCT01528254|69450248|FG000|Overall Study|Lost to Follow-up|17|||
37804531|NCT01528254|69450249|FG001|Overall Study|Lost to Follow-up|24|||
37804532|NCT01528254|69450248|FG000|Overall Study|Death|13|||
37804533|NCT01528254|69450249|FG001|Overall Study|Death|9|||
37804534|NCT01528254|69450248|FG000|Overall Study|Protocol deviation|9|||
37804535|NCT01528254|69450249|FG001|Overall Study|Protocol deviation|19|||
37804536|NCT01528254|69450248|FG000|Overall Study|New therapy for study indication|8|||
37804537|NCT01528254|69450249|FG001|Overall Study|New therapy for study indication|6|||
37804538|NCT01528254|69450248|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
37804539|NCT01528254|69450249|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
37804540|NCT01528254|69450248|FG000|Overall Study|Withdrawal by Subject|5|||
37804541|NCT01528254|69450249|FG001|Overall Study|Withdrawal by Subject|4|||
37975824|NCT03853148|69663109|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
37975825|NCT00385203|69663121|FG000|Overall Study|Adverse Event|5|||
37975826|NCT00385203|69663122|FG001|Overall Study|Adverse Event|4|||
37975827|NCT00385203|69663121|FG000|Overall Study|Death|1|||
37975828|NCT00385203|69663122|FG001|Overall Study|Death|0|||
37975829|NCT00385203|69663121|FG000|Overall Study|Condition under investigation worsened|18|||
37975830|NCT00385203|69663122|FG001|Overall Study|Condition under investigation worsened|3|||
37975831|NCT00385203|69663121|FG000|Overall Study|Incorrect enrollment|2|||
37975832|NCT00385203|69663122|FG001|Overall Study|Incorrect enrollment|0|||
37975833|NCT00408993|69663131|FG000|Overall Study|Adverse Event|15|||
37975834|NCT00408993|69663132|FG001|Overall Study|Adverse Event|4|||
37804542|NCT01528254|69450248|FG000|Overall Study|Abnormal laboratory value(s)|3|||
37804543|NCT01528254|69450249|FG001|Overall Study|Abnormal laboratory value(s)|7|||
37804544|NCT01528254|69450248|FG000|Overall Study|Abnormal test procedure result(s)|1|||
37804545|NCT01528254|69450249|FG001|Overall Study|Abnormal test procedure result(s)|0|||
37804546|NCT01528254|69450248|FG000|Overall Study|No longer requires study drug|1|||
37804547|NCT01528254|69450249|FG001|Overall Study|No longer requires study drug|1|||
37804548|NCT01574352|69450258|FG000|Overall Study|Withdrawal by Subject|6|||
37804549|NCT01574352|69450259|FG001|Overall Study|Withdrawal by Subject|13|||
37804550|NCT01574352|69450258|FG000|Overall Study|Injury in non-camp related sport|1|||
37804551|NCT01574352|69450259|FG001|Overall Study|Injury in non-camp related sport|0|||
37804552|NCT01527006|69450267|FG000|Core Study|Adverse Event|0|||
37804553|NCT01527006|69450268|FG001|Core Study|Adverse Event|2|||
37804554|NCT01527006|69450267|FG000|Core Study|Lost to Follow-up|0|||
37804555|NCT01527006|69450268|FG001|Core Study|Lost to Follow-up|1|||
37804556|NCT01527006|69450267|FG000|Core Study|Subject Choice|1|||
37804557|NCT01527006|69450268|FG001|Core Study|Subject Choice|0|||
37804558|NCT01527006|69450267|FG000|Core Study|Inadequate Therapeutic Effect|1|||
37804559|NCT01527006|69450268|FG001|Core Study|Inadequate Therapeutic Effect|0|||
37804560|NCT01527006|69450267|FG000|Core Study|Withdrawal by Subject|0|||
37804561|NCT01527006|69450268|FG001|Core Study|Withdrawal by Subject|1|||
37804562|NCT01527006|69450267|FG000|Core Study|Other|0|||
37804563|NCT01527006|69450268|FG001|Core Study|Other|2|||
37804564|NCT01527006|69450267|FG000|Extension Phase|Adverse Event|4|||
37804565|NCT01527006|69450268|FG001|Extension Phase|Adverse Event|2|||
37804566|NCT01527006|69450267|FG000|Extension Phase|Lost to Follow-up|0|||
37804567|NCT01527006|69450268|FG001|Extension Phase|Lost to Follow-up|1|||
37975835|NCT00408993|69663131|FG000|Overall Study|Protocol Violation|1|||
37804568|NCT01527006|69450267|FG000|Extension Phase|Subject Choice|1|||
37804569|NCT01527006|69450268|FG001|Extension Phase|Subject Choice|1|||
37804570|NCT01527006|69450267|FG000|Extension Phase|Inadequate therapeutic effect|1|||
37804571|NCT01527006|69450268|FG001|Extension Phase|Inadequate therapeutic effect|1|||
37804572|NCT01527006|69450267|FG000|Extension Phase|Other|0|||
37804573|NCT01527006|69450268|FG001|Extension Phase|Other|3|||
37804574|NCT01526928|69450286|FG000|Overall Study|Progressive Disease|35|||
37804575|NCT01526928|69450287|FG001|Overall Study|Progressive Disease|17|||
37804576|NCT01526928|69450288|FG002|Overall Study|Progressive Disease|150|||
37804577|NCT01526928|69450289|FG003|Overall Study|Progressive Disease|182|||
37804578|NCT01526928|69450290|FG004|Overall Study|Progressive Disease|76|||
37975836|NCT00408993|69663132|FG001|Overall Study|Protocol Violation|6|||
37975837|NCT00408993|69663131|FG000|Overall Study|Lack of Efficacy|1|||
37804579|NCT01526928|69450291|FG005|Overall Study|Progressive Disease|4|||
37804580|NCT01526928|69450286|FG000|Overall Study|Adverse Event|2|||
37804581|NCT01526928|69450287|FG001|Overall Study|Adverse Event|1|||
37804582|NCT01526928|69450288|FG002|Overall Study|Adverse Event|29|||
37804583|NCT01526928|69450289|FG003|Overall Study|Adverse Event|40|||
37804584|NCT01526928|69450290|FG004|Overall Study|Adverse Event|13|||
37804585|NCT01526928|69450291|FG005|Overall Study|Adverse Event|2|||
37804586|NCT01526928|69450286|FG000|Overall Study|Death|0|||
37804587|NCT01526928|69450287|FG001|Overall Study|Death|0|||
37804588|NCT01526928|69450288|FG002|Overall Study|Death|3|||
37804589|NCT01526928|69450289|FG003|Overall Study|Death|0|||
37804590|NCT01526928|69450290|FG004|Overall Study|Death|0|||
37804591|NCT01526928|69450291|FG005|Overall Study|Death|0|||
37804592|NCT01526928|69450286|FG000|Overall Study|Withdrawal by Subject|1|||
37804593|NCT01526928|69450287|FG001|Overall Study|Withdrawal by Subject|0|||
37804594|NCT01526928|69450288|FG002|Overall Study|Withdrawal by Subject|13|||
37804595|NCT01526928|69450289|FG003|Overall Study|Withdrawal by Subject|11|||
37804596|NCT01526928|69450290|FG004|Overall Study|Withdrawal by Subject|3|||
37804597|NCT01526928|69450291|FG005|Overall Study|Withdrawal by Subject|0|||
37804598|NCT01526928|69450286|FG000|Overall Study|Physician Decision|0|||
37804599|NCT01526928|69450287|FG001|Overall Study|Physician Decision|0|||
37804600|NCT01526928|69450288|FG002|Overall Study|Physician Decision|2|||
37804601|NCT01526928|69450289|FG003|Overall Study|Physician Decision|5|||
37804602|NCT01526928|69450290|FG004|Overall Study|Physician Decision|0|||
37804603|NCT01526928|69450291|FG005|Overall Study|Physician Decision|0|||
37804604|NCT01526928|69450286|FG000|Overall Study|Other Reason|0|||
37804605|NCT01526928|69450287|FG001|Overall Study|Other Reason|1|||
37804606|NCT01526928|69450288|FG002|Overall Study|Other Reason|11|||
37804607|NCT01526928|69450289|FG003|Overall Study|Other Reason|4|||
37804608|NCT01526928|69450290|FG004|Overall Study|Other Reason|1|||
37804609|NCT01526928|69450291|FG005|Overall Study|Other Reason|0|||
37804610|NCT01526928|69450286|FG000|Overall Study|Lost to Follow-up|0|||
37804611|NCT01526928|69450287|FG001|Overall Study|Lost to Follow-up|0|||
37804612|NCT01526928|69450288|FG002|Overall Study|Lost to Follow-up|0|||
37804613|NCT01526928|69450289|FG003|Overall Study|Lost to Follow-up|1|||
37804614|NCT01526928|69450290|FG004|Overall Study|Lost to Follow-up|0|||
37804615|NCT01526928|69450291|FG005|Overall Study|Lost to Follow-up|0|||
37804616|NCT01526928|69450286|FG000|Overall Study|Protocol Deviation|0|||
37804617|NCT01526928|69450287|FG001|Overall Study|Protocol Deviation|0|||
37804618|NCT01526928|69450288|FG002|Overall Study|Protocol Deviation|0|||
37804619|NCT01526928|69450289|FG003|Overall Study|Protocol Deviation|2|||
37804620|NCT01526928|69450290|FG004|Overall Study|Protocol Deviation|0|||
37804621|NCT01526928|69450291|FG005|Overall Study|Protocol Deviation|0|||
37804622|NCT01526928|69450286|FG000|Overall Study|Missing|0|||
37804623|NCT01526928|69450287|FG001|Overall Study|Missing|0|||
37804624|NCT01526928|69450288|FG002|Overall Study|Missing|1|||
37804625|NCT01526928|69450289|FG003|Overall Study|Missing|0|||
37804626|NCT01526928|69450290|FG004|Overall Study|Missing|2|||
37804627|NCT01526928|69450291|FG005|Overall Study|Missing|0|||
37804628|NCT01549860|69450349|FG000|Overall Study|Withdrawal by Subject|1|||
37804629|NCT01549860|69450350|FG001|Overall Study|Withdrawal by Subject|0|||
37804630|NCT01549860|69450349|FG000|Overall Study|Physician Decision|1|||
37804631|NCT01549860|69450350|FG001|Overall Study|Physician Decision|1|||
37804632|NCT01549392|69450358|FG000|Overall Study|Withdrawal by Subject|1|||
37804633|NCT01549392|69450359|FG001|Overall Study|Withdrawal by Subject|0|||
37804634|NCT01526148|69450367|FG000|Overall Study|Adverse Event|6|||
37804635|NCT01526148|69450368|FG001|Overall Study|Adverse Event|5|||
37804636|NCT01526148|69450367|FG000|Overall Study|Lost to Follow-up|3|||
37804637|NCT01526148|69450368|FG001|Overall Study|Lost to Follow-up|6|||
37804638|NCT01526148|69450367|FG000|Overall Study|Withdrawal by Subject|2|||
37804639|NCT01526148|69450368|FG001|Overall Study|Withdrawal by Subject|0|||
37804640|NCT01526148|69450367|FG000|Overall Study|Unstable Medical Condition|1|||
37804641|NCT01526148|69450368|FG001|Overall Study|Unstable Medical Condition|0|||
37804642|NCT01526148|69450367|FG000|Overall Study|Unable to discontinue concomitant med|1|||
37804643|NCT01526148|69450368|FG001|Overall Study|Unable to discontinue concomitant med|0|||
37694022|NCT01896232|69170341|FG000|Overall Study|Lost to Follow-up|9|||
37804644|NCT01526148|69450367|FG000|Overall Study|Moved out of state|1|||
37804645|NCT01526148|69450368|FG001|Overall Study|Moved out of state|0|||
37804646|NCT01526148|69450367|FG000|Overall Study|Incarcerated|0|||
37804647|NCT01526148|69450368|FG001|Overall Study|Incarcerated|2|||
37804648|NCT01572948|69450376|FG000|Overall Study|Lost to Follow-up|1|||
37804649|NCT01572948|69450377|FG001|Overall Study|Lost to Follow-up|0|||
37804650|NCT01572948|69450376|FG000|Overall Study|unable to contact|0|||
37804651|NCT01572948|69450377|FG001|Overall Study|unable to contact|1|||
37804652|NCT01525602|69450395|FG000|Overall Study|Adverse Event|1|||
37804653|NCT01525602|69450396|FG001|Overall Study|Adverse Event|0|||
37804654|NCT01525602|69450397|FG002|Overall Study|Adverse Event|1|||
37804655|NCT01525602|69450398|FG003|Overall Study|Adverse Event|1|||
37804656|NCT01525602|69450399|FG004|Overall Study|Adverse Event|3|||
37804657|NCT01525602|69450400|FG005|Overall Study|Adverse Event|3|||
37804658|NCT01525602|69450401|FG006|Overall Study|Adverse Event|0|||
37804659|NCT01525602|69450402|FG007|Overall Study|Adverse Event|1|||
37804660|NCT01525602|69450395|FG000|Overall Study|Disease progression|6|||
37804661|NCT01525602|69450396|FG001|Overall Study|Disease progression|3|||
37804662|NCT01525602|69450397|FG002|Overall Study|Disease progression|2|||
37804663|NCT01525602|69450398|FG003|Overall Study|Disease progression|5|||
37804664|NCT01525602|69450399|FG004|Overall Study|Disease progression|22|||
37804665|NCT01525602|69450400|FG005|Overall Study|Disease progression|2|||
37804666|NCT01525602|69450401|FG006|Overall Study|Disease progression|3|||
37804667|NCT01525602|69450402|FG007|Overall Study|Disease progression|3|||
37804668|NCT01525602|69450395|FG000|Overall Study|Clinical progression|2|||
37804669|NCT01525602|69450396|FG001|Overall Study|Clinical progression|0|||
37804670|NCT01525602|69450397|FG002|Overall Study|Clinical progression|0|||
37804671|NCT01525602|69450398|FG003|Overall Study|Clinical progression|0|||
37804672|NCT01525602|69450399|FG004|Overall Study|Clinical progression|0|||
37804673|NCT01525602|69450400|FG005|Overall Study|Clinical progression|0|||
37804674|NCT01525602|69450401|FG006|Overall Study|Clinical progression|1|||
37804675|NCT01525602|69450402|FG007|Overall Study|Clinical progression|1|||
37804676|NCT01525602|69450395|FG000|Overall Study|Non-compliance|0|||
37804677|NCT01525602|69450396|FG001|Overall Study|Non-compliance|0|||
37804678|NCT01525602|69450397|FG002|Overall Study|Non-compliance|0|||
37804679|NCT01525602|69450398|FG003|Overall Study|Non-compliance|0|||
37804680|NCT01525602|69450399|FG004|Overall Study|Non-compliance|1|||
37804681|NCT01525602|69450400|FG005|Overall Study|Non-compliance|0|||
37804682|NCT01525602|69450401|FG006|Overall Study|Non-compliance|0|||
37804683|NCT01525602|69450402|FG007|Overall Study|Non-compliance|0|||
37804684|NCT01525602|69450395|FG000|Overall Study|Withdrawal by Subject|0|||
37804685|NCT01525602|69450396|FG001|Overall Study|Withdrawal by Subject|0|||
37804686|NCT01525602|69450397|FG002|Overall Study|Withdrawal by Subject|0|||
37804687|NCT01525602|69450398|FG003|Overall Study|Withdrawal by Subject|0|||
37804688|NCT01525602|69450399|FG004|Overall Study|Withdrawal by Subject|3|||
37804689|NCT01525602|69450400|FG005|Overall Study|Withdrawal by Subject|1|||
37804690|NCT01525602|69450401|FG006|Overall Study|Withdrawal by Subject|0|||
37804691|NCT01525602|69450402|FG007|Overall Study|Withdrawal by Subject|1|||
37804692|NCT01525602|69450395|FG000|Overall Study|Physician Decision|0|||
37804693|NCT01525602|69450396|FG001|Overall Study|Physician Decision|0|||
37804694|NCT01525602|69450397|FG002|Overall Study|Physician Decision|0|||
37804695|NCT01525602|69450398|FG003|Overall Study|Physician Decision|0|||
37804696|NCT01525602|69450399|FG004|Overall Study|Physician Decision|3|||
37804697|NCT01525602|69450400|FG005|Overall Study|Physician Decision|0|||
37804698|NCT01525602|69450401|FG006|Overall Study|Physician Decision|1|||
37975838|NCT00408993|69663132|FG001|Overall Study|Lack of Efficacy|4|||
37804699|NCT01525602|69450402|FG007|Overall Study|Physician Decision|0|||
37804700|NCT01525602|69450395|FG000|Overall Study|Death|0|||
37804701|NCT01525602|69450396|FG001|Overall Study|Death|0|||
37804702|NCT01525602|69450397|FG002|Overall Study|Death|0|||
37804703|NCT01525602|69450398|FG003|Overall Study|Death|0|||
37804704|NCT01525602|69450399|FG004|Overall Study|Death|1|||
37804705|NCT01525602|69450400|FG005|Overall Study|Death|1|||
37804706|NCT01525602|69450401|FG006|Overall Study|Death|0|||
37804707|NCT01525602|69450402|FG007|Overall Study|Death|0|||
37804708|NCT01525602|69450395|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
37804709|NCT01525602|69450396|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
37804710|NCT01525602|69450397|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
37804711|NCT01525602|69450398|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
37804712|NCT01525602|69450399|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
37804713|NCT01525602|69450400|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
37804714|NCT01525602|69450401|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
37804715|NCT01525602|69450402|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
37804716|NCT01549002|69450429|FG000|Overall Study|Excessive pain|0|||
37804717|NCT01549002|69450430|FG001|Overall Study|Excessive pain|2|||
37804718|NCT01549002|69450429|FG000|Overall Study|Moderate sedation required|0|||
37804719|NCT01549002|69450430|FG001|Overall Study|Moderate sedation required|2|||
37804720|NCT01548768|69450440|FG000|Overall Study|Withdrawal by Subject|0|||
37804721|NCT01548768|69450441|FG001|Overall Study|Withdrawal by Subject|2|||
37804722|NCT01548768|69450442|FG002|Overall Study|Withdrawal by Subject|1|||
37804723|NCT01548768|69450443|FG003|Overall Study|Withdrawal by Subject|0|||
37804724|NCT01548768|69450440|FG000|Overall Study|Physician Decision|1|||
37804725|NCT01548768|69450441|FG001|Overall Study|Physician Decision|0|||
37804726|NCT01548768|69450442|FG002|Overall Study|Physician Decision|0|||
37804727|NCT01548768|69450443|FG003|Overall Study|Physician Decision|0|||
37804728|NCT01548768|69450440|FG000|Overall Study|Adverse Event|0|||
37804729|NCT01548768|69450441|FG001|Overall Study|Adverse Event|0|||
37804730|NCT01548768|69450442|FG002|Overall Study|Adverse Event|0|||
37804731|NCT01548768|69450443|FG003|Overall Study|Adverse Event|1|||
37804732|NCT01548768|69450440|FG000|Overall Study|Non-Compliance|0|||
37804733|NCT01548768|69450441|FG001|Overall Study|Non-Compliance|0|||
37804734|NCT01548768|69450442|FG002|Overall Study|Non-Compliance|0|||
37804735|NCT01548768|69450443|FG003|Overall Study|Non-Compliance|3|||
37804736|NCT01572792|69450460|FG000|Lead-in Study|Lost to Follow-up|5|||
37804737|NCT01572792|69450461|FG001|Lead-in Study|Lost to Follow-up|9|||
37804738|NCT01572792|69450462|FG002|Lead-in Study|Lost to Follow-up|4|||
37804739|NCT01572792|69450463|FG003|Lead-in Study|Lost to Follow-up|2|||
37804740|NCT01572792|69450464|FG004|Lead-in Study|Lost to Follow-up|4|||
37804741|NCT01572792|69450460|FG000|Lead-in Study|Withdrawal by Subject|22|||
37804742|NCT01572792|69450461|FG001|Lead-in Study|Withdrawal by Subject|11|||
37804743|NCT01572792|69450462|FG002|Lead-in Study|Withdrawal by Subject|12|||
37804744|NCT01572792|69450463|FG003|Lead-in Study|Withdrawal by Subject|24|||
37804745|NCT01572792|69450464|FG004|Lead-in Study|Withdrawal by Subject|11|||
37804746|NCT01572792|69450460|FG000|Lead-in Study|Protocol Violation|19|||
37804747|NCT01572792|69450461|FG001|Lead-in Study|Protocol Violation|10|||
37804748|NCT01572792|69450462|FG002|Lead-in Study|Protocol Violation|12|||
37804749|NCT01572792|69450463|FG003|Lead-in Study|Protocol Violation|13|||
37804750|NCT01572792|69450464|FG004|Lead-in Study|Protocol Violation|21|||
37804751|NCT01572792|69450460|FG000|Lead-in Study|Lack of Efficacy|20|||
37804752|NCT01572792|69450461|FG001|Lead-in Study|Lack of Efficacy|5|||
37804753|NCT01572792|69450462|FG002|Lead-in Study|Lack of Efficacy|4|||
37804754|NCT01572792|69450463|FG003|Lead-in Study|Lack of Efficacy|8|||
37804755|NCT01572792|69450464|FG004|Lead-in Study|Lack of Efficacy|10|||
37804756|NCT01572792|69450460|FG000|Lead-in Study|Adverse Event|21|||
37804757|NCT01572792|69450461|FG001|Lead-in Study|Adverse Event|21|||
37804758|NCT01572792|69450462|FG002|Lead-in Study|Adverse Event|22|||
37804759|NCT01572792|69450463|FG003|Lead-in Study|Adverse Event|16|||
37804760|NCT01572792|69450464|FG004|Lead-in Study|Adverse Event|14|||
37804761|NCT01572792|69450460|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
37804762|NCT01572792|69450461|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
37804763|NCT01572792|69450462|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
37804764|NCT01572792|69450463|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
37804765|NCT01572792|69450464|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
37804766|NCT01572792|69450460|FG000|Extension Study|Lost to Follow-up|6|||
37804767|NCT01572792|69450461|FG001|Extension Study|Lost to Follow-up|2|||
37804768|NCT01572792|69450462|FG002|Extension Study|Lost to Follow-up|0|||
37804769|NCT01572792|69450463|FG003|Extension Study|Lost to Follow-up|3|||
37804770|NCT01572792|69450464|FG004|Extension Study|Lost to Follow-up|3|||
37804771|NCT01572792|69450460|FG000|Extension Study|Withdrawal by Subject|7|||
37804772|NCT01572792|69450461|FG001|Extension Study|Withdrawal by Subject|6|||
37804773|NCT01572792|69450462|FG002|Extension Study|Withdrawal by Subject|11|||
37804774|NCT01572792|69450463|FG003|Extension Study|Withdrawal by Subject|8|||
37804775|NCT01572792|69450464|FG004|Extension Study|Withdrawal by Subject|14|||
37804776|NCT01572792|69450460|FG000|Extension Study|Protocol Violation|0|||
37804777|NCT01572792|69450461|FG001|Extension Study|Protocol Violation|4|||
37804778|NCT01572792|69450462|FG002|Extension Study|Protocol Violation|3|||
37804779|NCT01572792|69450463|FG003|Extension Study|Protocol Violation|4|||
37804780|NCT01572792|69450464|FG004|Extension Study|Protocol Violation|3|||
37804781|NCT01572792|69450460|FG000|Extension Study|Lack of Efficacy|2|||
37804782|NCT01572792|69450461|FG001|Extension Study|Lack of Efficacy|3|||
37804783|NCT01572792|69450462|FG002|Extension Study|Lack of Efficacy|3|||
37804784|NCT01572792|69450463|FG003|Extension Study|Lack of Efficacy|2|||
37804785|NCT01572792|69450464|FG004|Extension Study|Lack of Efficacy|2|||
37804786|NCT01572792|69450460|FG000|Extension Study|Adverse Event|7|||
37804787|NCT01572792|69450461|FG001|Extension Study|Adverse Event|6|||
37804788|NCT01572792|69450462|FG002|Extension Study|Adverse Event|5|||
37804789|NCT01572792|69450463|FG003|Extension Study|Adverse Event|6|||
37804790|NCT01572792|69450464|FG004|Extension Study|Adverse Event|4|||
37804791|NCT01572792|69450460|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
37804792|NCT01572792|69450461|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
37804793|NCT01572792|69450462|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
37804794|NCT01572792|69450463|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
37804795|NCT01572792|69450464|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
37804796|NCT01547598|69450479|FG000|Overall Study|Withdrew consent|1|||
37804797|NCT01547598|69450480|FG001|Overall Study|Withdrew consent|1|||
37804798|NCT01547598|69450479|FG000|Overall Study|Lost to Follow-up|1|||
37804799|NCT01547598|69450480|FG001|Overall Study|Lost to Follow-up|1|||
37804800|NCT01547598|69450479|FG000|Overall Study|Adverse Event|1|||
37804801|NCT01547598|69450480|FG001|Overall Study|Adverse Event|1|||
37804802|NCT01547598|69450479|FG000|Overall Study|Protocol Violation|1|||
37804803|NCT01547598|69450480|FG001|Overall Study|Protocol Violation|1|||
37804804|NCT01547598|69450479|FG000|Overall Study|Other Miscellaneous Reasons|2|||
37804805|NCT01547598|69450480|FG001|Overall Study|Other Miscellaneous Reasons|1|||
37804806|NCT01547286|69450487|FG000|Overall Study|Did not meet all eligibility criteria|1|||
37804807|NCT01547286|69450487|FG000|Overall Study|Physician Decision|1|||
37804808|NCT01547130|69450494|FG000|Overall Study|Lost to Follow-up|9|||
37804809|NCT01547130|69450495|FG001|Overall Study|Lost to Follow-up|5|||
37804810|NCT01524978|69450520|FG000|Overall Study|Other|16|||
37804811|NCT01524978|69450521|FG001|Overall Study|Other|2|||
37804812|NCT01524978|69450522|FG002|Overall Study|Other|1|||
37804813|NCT01524978|69450523|FG003|Overall Study|Other|2|||
37804814|NCT01524978|69450524|FG004|Overall Study|Other|1|||
37804815|NCT01524978|69450525|FG005|Overall Study|Other|3|||
37804816|NCT01524978|69450526|FG006|Overall Study|Other|17|||
37804817|NCT01524978|69450527|FG007|Overall Study|Other|1|||
37804818|NCT01524978|69450528|FG008|Overall Study|Other|2|||
37804819|NCT01524978|69450529|FG009|Overall Study|Other|2|||
37804820|NCT01524978|69450530|FG010|Overall Study|Other|5|||
37804821|NCT01524978|69450520|FG000|Overall Study|Withdrawal by Subject|12|||
37804822|NCT01524978|69450521|FG001|Overall Study|Withdrawal by Subject|0|||
37804823|NCT01524978|69450522|FG002|Overall Study|Withdrawal by Subject|1|||
37804824|NCT01524978|69450523|FG003|Overall Study|Withdrawal by Subject|1|||
37804825|NCT01524978|69450524|FG004|Overall Study|Withdrawal by Subject|3|||
37804826|NCT01524978|69450525|FG005|Overall Study|Withdrawal by Subject|1|||
37804827|NCT01524978|69450526|FG006|Overall Study|Withdrawal by Subject|6|||
37804828|NCT01524978|69450527|FG007|Overall Study|Withdrawal by Subject|2|||
37804829|NCT01524978|69450528|FG008|Overall Study|Withdrawal by Subject|4|||
37804830|NCT01524978|69450529|FG009|Overall Study|Withdrawal by Subject|0|||
37804831|NCT01524978|69450530|FG010|Overall Study|Withdrawal by Subject|5|||
37804832|NCT01524978|69450520|FG000|Overall Study|Lost to Follow-up|0|||
37804833|NCT01524978|69450521|FG001|Overall Study|Lost to Follow-up|0|||
37804834|NCT01524978|69450522|FG002|Overall Study|Lost to Follow-up|3|||
37804835|NCT01524978|69450523|FG003|Overall Study|Lost to Follow-up|0|||
37804836|NCT01524978|69450524|FG004|Overall Study|Lost to Follow-up|1|||
37804837|NCT01524978|69450525|FG005|Overall Study|Lost to Follow-up|1|||
37804838|NCT01524978|69450526|FG006|Overall Study|Lost to Follow-up|2|||
37804839|NCT01524978|69450527|FG007|Overall Study|Lost to Follow-up|0|||
37804840|NCT01524978|69450528|FG008|Overall Study|Lost to Follow-up|1|||
37804841|NCT01524978|69450529|FG009|Overall Study|Lost to Follow-up|1|||
37804842|NCT01524978|69450530|FG010|Overall Study|Lost to Follow-up|1|||
37804843|NCT01524978|69450520|FG000|Overall Study|Death|34|||
37804844|NCT01524978|69450521|FG001|Overall Study|Death|2|||
37804845|NCT01524978|69450522|FG002|Overall Study|Death|5|||
37804846|NCT01524978|69450523|FG003|Overall Study|Death|24|||
37804847|NCT01524978|69450524|FG004|Overall Study|Death|4|||
37804848|NCT01524978|69450525|FG005|Overall Study|Death|4|||
37804849|NCT01524978|69450526|FG006|Overall Study|Death|1|||
37804850|NCT01524978|69450527|FG007|Overall Study|Death|9|||
37804851|NCT01524978|69450528|FG008|Overall Study|Death|5|||
37804852|NCT01524978|69450529|FG009|Overall Study|Death|6|||
37804853|NCT01524978|69450530|FG010|Overall Study|Death|17|||
37804854|NCT01524900|69450550|FG000|Overall Study|Lost to Follow-up|3|||
37804855|NCT01524900|69450551|FG001|Overall Study|Lost to Follow-up|12|||
37804856|NCT01524900|69450552|FG002|Overall Study|Lost to Follow-up|1|||
37804857|NCT01524900|69450553|FG003|Overall Study|Lost to Follow-up|0|||
37804858|NCT01524900|69450554|FG004|Overall Study|Lost to Follow-up|0|||
37804859|NCT01524900|69450550|FG000|Overall Study|Other reason than stated above|1|||
37804860|NCT01524900|69450551|FG001|Overall Study|Other reason than stated above|1|||
37804861|NCT01524900|69450552|FG002|Overall Study|Other reason than stated above|0|||
37804862|NCT01524900|69450553|FG003|Overall Study|Other reason than stated above|0|||
37804863|NCT01524900|69450554|FG004|Overall Study|Other reason than stated above|0|||
37804864|NCT01524900|69450550|FG000|Overall Study|No reason documented|2|||
37804865|NCT01524900|69450551|FG001|Overall Study|No reason documented|1|||
37804866|NCT01524900|69450552|FG002|Overall Study|No reason documented|0|||
37804867|NCT01524900|69450553|FG003|Overall Study|No reason documented|1|||
37804868|NCT01524900|69450554|FG004|Overall Study|No reason documented|0|||
37804869|NCT01524198|69450569|FG000|Overall Study|Protocol Violation|8|||
37804870|NCT01524198|69450570|FG001|Overall Study|Protocol Violation|6|||
37804871|NCT01524198|69450569|FG000|Overall Study|Withdrawal by Subject|15|||
37804872|NCT01524198|69450570|FG001|Overall Study|Withdrawal by Subject|10|||
37804873|NCT01523886|69450578|FG000|Overall Study|surgery cancelled|0|||
37804874|NCT01523886|69450579|FG001|Overall Study|surgery cancelled|1|||
37804875|NCT01546038|69450591|FG000|Overall Study|Death|15|||
37804876|NCT01546038|69450592|FG001|Overall Study|Death|6|||
37804877|NCT01546038|69450593|FG002|Overall Study|Death|4|||
37975839|NCT00408993|69663131|FG000|Overall Study|Withdrawal by Subject|2|||
37975840|NCT00408993|69663132|FG001|Overall Study|Withdrawal by Subject|3|||
37975841|NCT00395967|69663142|FG000|Treatment Period|Failed Mobilization|1|||
37975842|NCT00395967|69663142|FG000|Follow-up Period|Death|1|||
37975843|NCT00395967|69663142|FG000|Follow-up Period|Lost to Follow-up|1|||
37975844|NCT00395733|69663148|FG000|Period 2|Withdrawal by Subject|1|||
37975845|NCT00395733|69663149|FG001|Period 2|Withdrawal by Subject|2|||
37975846|NCT00395733|69663148|FG000|Period 2|Protocol Violation|0|||
37975847|NCT00395733|69663149|FG001|Period 2|Protocol Violation|1|||
37975848|NCT00395733|69663148|FG000|Period 2|Adverse Event|0|||
37975849|NCT00395733|69663149|FG001|Period 2|Adverse Event|2|||
37975850|NCT00395733|69663148|FG000|Period 2|Technical problems|1|||
37975851|NCT00395733|69663149|FG001|Period 2|Technical problems|0|||
37975852|NCT00395343|69663157|FG000|Overall Study|Adverse Event|13|||
37975853|NCT00395343|69663158|FG001|Overall Study|Adverse Event|5|||
37975854|NCT00395343|69663157|FG000|Overall Study|Lack of Efficacy|0|||
37975855|NCT00395343|69663158|FG001|Overall Study|Lack of Efficacy|1|||
37975856|NCT00395343|69663157|FG000|Overall Study|Lost to Follow-up|4|||
37804878|NCT01546038|69450594|FG003|Overall Study|Death|2|||
37804879|NCT01546038|69450595|FG004|Overall Study|Death|9|||
37804880|NCT01546038|69450596|FG005|Overall Study|Death|3|||
37804881|NCT01546038|69450597|FG006|Overall Study|Death|46|||
37804882|NCT01546038|69450598|FG007|Overall Study|Death|76|||
37804883|NCT01546038|69450599|FG008|Overall Study|Death|39|||
37804884|NCT01546038|69450591|FG000|Overall Study|Lost to Follow-up|0|||
37804885|NCT01546038|69450592|FG001|Overall Study|Lost to Follow-up|0|||
37804886|NCT01546038|69450593|FG002|Overall Study|Lost to Follow-up|0|||
37804887|NCT01546038|69450594|FG003|Overall Study|Lost to Follow-up|0|||
37804888|NCT01546038|69450595|FG004|Overall Study|Lost to Follow-up|1|||
37804889|NCT01546038|69450596|FG005|Overall Study|Lost to Follow-up|0|||
37804890|NCT01546038|69450597|FG006|Overall Study|Lost to Follow-up|2|||
37804891|NCT01546038|69450598|FG007|Overall Study|Lost to Follow-up|1|||
37804892|NCT01546038|69450599|FG008|Overall Study|Lost to Follow-up|0|||
37804893|NCT01546038|69450591|FG000|Overall Study|Withdrawal by Subject|1|||
37804894|NCT01546038|69450592|FG001|Overall Study|Withdrawal by Subject|0|||
37804895|NCT01546038|69450593|FG002|Overall Study|Withdrawal by Subject|0|||
37804896|NCT01546038|69450594|FG003|Overall Study|Withdrawal by Subject|1|||
37804897|NCT01546038|69450595|FG004|Overall Study|Withdrawal by Subject|0|||
37804898|NCT01546038|69450596|FG005|Overall Study|Withdrawal by Subject|1|||
37804899|NCT01546038|69450597|FG006|Overall Study|Withdrawal by Subject|3|||
37804900|NCT01546038|69450598|FG007|Overall Study|Withdrawal by Subject|3|||
37804901|NCT01546038|69450599|FG008|Overall Study|Withdrawal by Subject|1|||
37804902|NCT01546038|69450591|FG000|Overall Study|: Randomized, not treated|0|||
37804903|NCT01546038|69450592|FG001|Overall Study|: Randomized, not treated|0|||
37804904|NCT01546038|69450593|FG002|Overall Study|: Randomized, not treated|0|||
37804905|NCT01546038|69450594|FG003|Overall Study|: Randomized, not treated|0|||
37804906|NCT01546038|69450595|FG004|Overall Study|: Randomized, not treated|0|||
37804907|NCT01546038|69450596|FG005|Overall Study|: Randomized, not treated|0|||
37804908|NCT01546038|69450597|FG006|Overall Study|: Randomized, not treated|2|||
37804909|NCT01546038|69450598|FG007|Overall Study|: Randomized, not treated|4|||
37804910|NCT01546038|69450599|FG008|Overall Study|: Randomized, not treated|3|||
37804911|NCT01571232|69450651|FG000|Overall Study|Lost to Follow-up|0|||
37804912|NCT01571232|69450652|FG001|Overall Study|Lost to Follow-up|1|||
37804913|NCT01571232|69450651|FG000|Overall Study|Withdrawal by Subject|1|||
37804914|NCT01571232|69450652|FG001|Overall Study|Withdrawal by Subject|0|||
37804915|NCT01544478|69450659|FG000|Overall Study|Adverse Event|1|||
37804916|NCT01544478|69450659|FG000|Overall Study|Death|1|||
37804917|NCT01544478|69450659|FG000|Overall Study|Lost to Follow-up|48|||
37804918|NCT01544478|69450659|FG000|Overall Study|Physician Decision|15|||
37804919|NCT01544478|69450659|FG000|Overall Study|Pregnancy|1|||
37804920|NCT01544478|69450659|FG000|Overall Study|Withdrawal by Subject|52|||
37804921|NCT01522950|69450666|FG000|Overall Study|Withdrawal by Subject|3|||
37804922|NCT01522950|69450667|FG001|Overall Study|Withdrawal by Subject|2|||
37804923|NCT01522950|69450668|FG002|Overall Study|Withdrawal by Subject|1|||
37804924|NCT01522950|69450666|FG000|Overall Study|Adverse Event|3|||
37804925|NCT01522950|69450667|FG001|Overall Study|Adverse Event|1|||
37804926|NCT01522950|69450668|FG002|Overall Study|Adverse Event|1|||
37804927|NCT01522950|69450666|FG000|Overall Study|Protocol Violation|0|||
37804928|NCT01522950|69450667|FG001|Overall Study|Protocol Violation|0|||
37804929|NCT01522950|69450668|FG002|Overall Study|Protocol Violation|2|||
37804930|NCT01522950|69450666|FG000|Overall Study|Death|0|||
37804931|NCT01522950|69450667|FG001|Overall Study|Death|1|||
37804932|NCT01522950|69450668|FG002|Overall Study|Death|1|||
37804933|NCT01522950|69450666|FG000|Overall Study|Study Medication Sensitivity|0|||
37804934|NCT01522950|69450667|FG001|Overall Study|Study Medication Sensitivity|1|||
37804935|NCT01522950|69450668|FG002|Overall Study|Study Medication Sensitivity|0|||
37804936|NCT01522404|69450678|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
37804937|NCT01522404|69450679|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
37804938|NCT01522404|69450678|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
37804939|NCT01522404|69450679|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
37804940|NCT01522404|69450678|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
37804941|NCT01522404|69450679|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
37804942|NCT01570686|69450695|FG000|Overall Study|Abnormal test procedure result(s)|1|||
37804943|NCT01570686|69450696|FG001|Overall Study|Abnormal test procedure result(s)|1|||
37804944|NCT01570686|69450695|FG000|Overall Study|Administrative problems|0|||
37804945|NCT01570686|69450696|FG001|Overall Study|Administrative problems|1|||
37804946|NCT01570686|69450695|FG000|Overall Study|Adverse Event|8|||
37804947|NCT01570686|69450696|FG001|Overall Study|Adverse Event|6|||
37804948|NCT01570686|69450695|FG000|Overall Study|Lost to Follow-up|4|||
37804949|NCT01570686|69450696|FG001|Overall Study|Lost to Follow-up|3|||
37804950|NCT01570686|69450695|FG000|Overall Study|Protocol Deviation|3|||
37804951|NCT01570686|69450696|FG001|Overall Study|Protocol Deviation|0|||
37804952|NCT01570686|69450695|FG000|Overall Study|Withdrawal by Subject|4|||
37804953|NCT01570686|69450696|FG001|Overall Study|Withdrawal by Subject|4|||
37804954|NCT01570686|69450695|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
37804955|NCT01570686|69450696|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
37804956|NCT01522248|69450704|FG000|Overall Study|Lost to Follow-up|1|||
37804957|NCT01522248|69450705|FG001|Overall Study|Lost to Follow-up|0|||
37804958|NCT01543776|69450718|FG000|Overall Study|Withdrawal by Subject|2|||
37804959|NCT01543776|69450719|FG001|Overall Study|Withdrawal by Subject|2|||
37804960|NCT01518192|69450728|FG000|Overall Study|Lost to Follow-up|29|||
37804961|NCT01518192|69450729|FG001|Overall Study|Lost to Follow-up|26|||
37804962|NCT01518192|69450730|FG002|Overall Study|Lost to Follow-up|35|||
37804963|NCT01517802|69450744|FG000|Overall Study|Death|1|||
37804964|NCT01520922|69450750|FG000|Treatment Phase|Physician Decision|2|||
37804965|NCT01520922|69450751|FG001|Treatment Phase|Physician Decision|1|||
37804966|NCT01520922|69450750|FG000|Treatment Phase|Progression|0|||
37804967|NCT01520922|69450751|FG001|Treatment Phase|Progression|2|||
37804968|NCT01520922|69450750|FG000|Treatment Phase|Adverse Event|3|||
37804969|NCT01520922|69450751|FG001|Treatment Phase|Adverse Event|5|||
37804970|NCT01520922|69450750|FG000|Follow up|Lost to Follow-up|0|||
37804971|NCT01520922|69450751|FG001|Follow up|Lost to Follow-up|1|||
37804972|NCT01520922|69450750|FG000|Survival Follow-up|Withdrawal by Subject|1|||
37804973|NCT01520922|69450751|FG001|Survival Follow-up|Withdrawal by Subject|0|||
37804974|NCT01569438|69450759|FG000|Overall Study|Lack of Efficacy|1|||
37804975|NCT01569438|69450760|FG001|Overall Study|Lack of Efficacy|2|||
37804976|NCT01569438|69450759|FG000|Overall Study|Withdrawal by Subject|0|||
37804977|NCT01569438|69450760|FG001|Overall Study|Withdrawal by Subject|3|||
37804978|NCT01569438|69450759|FG000|Overall Study|Adverse Event|2|||
37804979|NCT01569438|69450760|FG001|Overall Study|Adverse Event|15|||
37804980|NCT01569438|69450759|FG000|Overall Study|Protocol Violation|2|||
37804981|NCT01569438|69450760|FG001|Overall Study|Protocol Violation|0|||
37804982|NCT01569438|69450759|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
37804983|NCT01569438|69450760|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
37804984|NCT01569438|69450759|FG000|Overall Study|Sponsor/Physician decision|1|||
37804985|NCT01569438|69450760|FG001|Overall Study|Sponsor/Physician decision|1|||
37804986|NCT01569438|69450759|FG000|Overall Study|Unable to adhere to study schedule|0|||
37804987|NCT01569438|69450760|FG001|Overall Study|Unable to adhere to study schedule|1|||
37804988|NCT01517412|69450768|FG000|Overall Study|Adverse Event|10|||
37804989|NCT01517412|69450769|FG001|Overall Study|Adverse Event|11|||
37804990|NCT01517412|69450768|FG000|Overall Study|Lack of Efficacy|10|||
37804991|NCT01517412|69450769|FG001|Overall Study|Lack of Efficacy|5|||
37804992|NCT01517412|69450768|FG000|Overall Study|Poor compliance to protocol|8|||
37804993|NCT01517412|69450769|FG001|Overall Study|Poor compliance to protocol|3|||
37804994|NCT01517412|69450768|FG000|Overall Study|Other than specified above|8|||
37804995|NCT01517412|69450769|FG001|Overall Study|Other than specified above|5|||
37804996|NCT01517178|69450775|FG000|Period 1|Adverse Event|1|||
37804997|NCT01517178|69450776|FG001|Period 1|Adverse Event|2|||
37804998|NCT01517178|69450775|FG000|Period 1|Lack of Efficacy|0|||
37804999|NCT01517178|69450776|FG001|Period 1|Lack of Efficacy|1|||
37805000|NCT01517178|69450775|FG000|Period 1|E.g. study termination|3|||
37805001|NCT01517178|69450776|FG001|Period 1|E.g. study termination|1|||
37805002|NCT01517178|69450775|FG000|Period 1|Withdrawal by Subject|0|||
37805003|NCT01517178|69450776|FG001|Period 1|Withdrawal by Subject|1|||
37805004|NCT01517178|69450775|FG000|Period 2|Adverse Event|1|||
37805005|NCT01517178|69450776|FG001|Period 2|Adverse Event|0|||
37805006|NCT01517178|69450775|FG000|Period 2|Withdrawal by Subject|3|||
37805007|NCT01517178|69450776|FG001|Period 2|Withdrawal by Subject|0|||
37805008|NCT01517178|69450775|FG000|Period 2|E.g. study termination|2|||
37805009|NCT01517178|69450776|FG001|Period 2|E.g. study termination|2|||
37805010|NCT01489956|69450784|FG000|Overall Study|Lost to Follow-up|1|||
37805011|NCT01489956|69450785|FG001|Overall Study|Lost to Follow-up|0|||
37805012|NCT01489956|69450786|FG002|Overall Study|Lost to Follow-up|0|||
37805013|NCT01489956|69450784|FG000|Overall Study|Withdrawal by Subject|0|||
37805014|NCT01489956|69450785|FG001|Overall Study|Withdrawal by Subject|0|||
37805015|NCT01489956|69450786|FG002|Overall Study|Withdrawal by Subject|1|||
37805016|NCT01516008|69450797|FG000|Overall Study|Adverse Event|0|||
37805017|NCT01516008|69450798|FG001|Overall Study|Adverse Event|2|||
37805018|NCT01516008|69450799|FG002|Overall Study|Adverse Event|7|||
37805019|NCT01516008|69450797|FG000|Overall Study|Lack of Efficacy|44|||
37805020|NCT01516008|69450798|FG001|Overall Study|Lack of Efficacy|14|||
37805021|NCT01516008|69450799|FG002|Overall Study|Lack of Efficacy|10|||
37805022|NCT01516008|69450797|FG000|Overall Study|Protocol Violation|1|||
37864269|NCT00990106|69547855|FG001|Overall Study|relocation/deployment|1|||
37864270|NCT00990106|69547854|FG000|Overall Study|started exclusionary medication|0|||
37864271|NCT00990106|69547855|FG001|Overall Study|started exclusionary medication|1|||
37805023|NCT01516008|69450798|FG001|Overall Study|Protocol Violation|0|||
37805024|NCT01516008|69450799|FG002|Overall Study|Protocol Violation|0|||
37805025|NCT01516008|69450797|FG000|Overall Study|Reason not specified|0|||
37805026|NCT01516008|69450798|FG001|Overall Study|Reason not specified|0|||
37805027|NCT01516008|69450799|FG002|Overall Study|Reason not specified|1|||
37805028|NCT01489254|69450810|FG000|Double-blind Part|Adverse Event|7|||
37805029|NCT01489254|69450811|FG001|Double-blind Part|Adverse Event|2|||
37805030|NCT01489254|69450812|FG002|Double-blind Part|Adverse Event|2|||
37805031|NCT01489254|69450813|FG003|Double-blind Part|Adverse Event|0|||
37805032|NCT01489254|69450810|FG000|Double-blind Part|Pregnancy|1|||
37805033|NCT01489254|69450811|FG001|Double-blind Part|Pregnancy|3|||
37805034|NCT01489254|69450812|FG002|Double-blind Part|Pregnancy|0|||
37805035|NCT01489254|69450813|FG003|Double-blind Part|Pregnancy|0|||
37805036|NCT01489254|69450810|FG000|Double-blind Part|Withdrawal by Subject|12|||
37805037|NCT01489254|69450811|FG001|Double-blind Part|Withdrawal by Subject|20|||
37805038|NCT01489254|69450812|FG002|Double-blind Part|Withdrawal by Subject|1|||
37805039|NCT01489254|69450813|FG003|Double-blind Part|Withdrawal by Subject|0|||
37805040|NCT01489254|69450810|FG000|Double-blind Part|Lost to Follow-up|1|||
37805041|NCT01489254|69450811|FG001|Double-blind Part|Lost to Follow-up|2|||
37805042|NCT01489254|69450812|FG002|Double-blind Part|Lost to Follow-up|0|||
37805043|NCT01489254|69450813|FG003|Double-blind Part|Lost to Follow-up|0|||
37805044|NCT01489254|69450810|FG000|Double-blind Part|Other reasons for not completing study|4|||
37805045|NCT01489254|69450811|FG001|Double-blind Part|Other reasons for not completing study|6|||
37805046|NCT01489254|69450812|FG002|Double-blind Part|Other reasons for not completing study|0|||
37805047|NCT01489254|69450813|FG003|Double-blind Part|Other reasons for not completing study|0|||
37805048|NCT01489254|69450810|FG000|Open-label Extension Part|Adverse Event|0|||
37805049|NCT01489254|69450811|FG001|Open-label Extension Part|Adverse Event|0|||
37805050|NCT01489254|69450812|FG002|Open-label Extension Part|Adverse Event|0|||
37805051|NCT01489254|69450813|FG003|Open-label Extension Part|Adverse Event|10|||
37805052|NCT01489254|69450810|FG000|Open-label Extension Part|Pregnancy|0|||
37805053|NCT01489254|69450811|FG001|Open-label Extension Part|Pregnancy|0|||
37805054|NCT01489254|69450812|FG002|Open-label Extension Part|Pregnancy|0|||
37805055|NCT01489254|69450813|FG003|Open-label Extension Part|Pregnancy|3|||
37805056|NCT01489254|69450810|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
37805057|NCT01489254|69450811|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
37805058|NCT01489254|69450812|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
37805059|NCT01489254|69450813|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
37805060|NCT01489254|69450810|FG000|Open-label Extension Part|Protocol Violation|0|||
37805061|NCT01489254|69450811|FG001|Open-label Extension Part|Protocol Violation|0|||
37805062|NCT01489254|69450812|FG002|Open-label Extension Part|Protocol Violation|0|||
37805063|NCT01489254|69450813|FG003|Open-label Extension Part|Protocol Violation|1|||
37805064|NCT01489254|69450810|FG000|Open-label Extension Part|Lost to Follow-up|0|||
37805065|NCT01489254|69450811|FG001|Open-label Extension Part|Lost to Follow-up|0|||
37805066|NCT01489254|69450812|FG002|Open-label Extension Part|Lost to Follow-up|0|||
37805067|NCT01489254|69450813|FG003|Open-label Extension Part|Lost to Follow-up|9|||
37805068|NCT01489254|69450810|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
37805069|NCT01489254|69450811|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
37805070|NCT01489254|69450812|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
37805071|NCT01489254|69450813|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
37805072|NCT01489020|69450828|FG000|Overall Study|Withdrawal by Subject|1|||
37805073|NCT01489020|69450829|FG001|Overall Study|Withdrawal by Subject|0|||
37805074|NCT01489020|69450830|FG002|Overall Study|Withdrawal by Subject|0|||
37805075|NCT01489020|69450831|FG003|Overall Study|Withdrawal by Subject|0|||
37805076|NCT01489020|69450832|FG004|Overall Study|Withdrawal by Subject|0|||
37805077|NCT01489020|69450833|FG005|Overall Study|Withdrawal by Subject|0|||
37805078|NCT01489020|69450828|FG000|Overall Study|Adverse Event|0|||
37805079|NCT01489020|69450829|FG001|Overall Study|Adverse Event|0|||
37805080|NCT01489020|69450830|FG002|Overall Study|Adverse Event|3|||
37805081|NCT01489020|69450831|FG003|Overall Study|Adverse Event|0|||
37805082|NCT01489020|69450832|FG004|Overall Study|Adverse Event|3|||
37805083|NCT01489020|69450833|FG005|Overall Study|Adverse Event|0|||
37805084|NCT01489020|69450828|FG000|Overall Study|Concomitant disease|0|||
37805085|NCT01489020|69450829|FG001|Overall Study|Concomitant disease|0|||
37805086|NCT01489020|69450830|FG002|Overall Study|Concomitant disease|0|||
37805087|NCT01489020|69450831|FG003|Overall Study|Concomitant disease|0|||
37805088|NCT01489020|69450832|FG004|Overall Study|Concomitant disease|3|||
37805089|NCT01489020|69450833|FG005|Overall Study|Concomitant disease|0|||
37805090|NCT01514760|69450853|FG000|Overall Study|Lost to Follow-up|2|||
37805091|NCT01514682|69450859|FG000|Overall Study|Withdrawal by Subject|2|||
37805092|NCT01514682|69450860|FG001|Overall Study|Withdrawal by Subject|3|||
37805093|NCT01514682|69450859|FG000|Overall Study|Physician Decision|4|||
37805094|NCT01514682|69450860|FG001|Overall Study|Physician Decision|3|||
37805095|NCT01514448|69450868|FG000|Overall Study|Death|7|||
37805096|NCT01514448|69450869|FG001|Overall Study|Death|8|||
37805097|NCT01514448|69450868|FG000|Overall Study|Withdrawal by Subject|2|||
37805098|NCT01514448|69450869|FG001|Overall Study|Withdrawal by Subject|0|||
37805099|NCT01514448|69450868|FG000|Overall Study|Lost to Follow-up|2|||
37805100|NCT01514448|69450869|FG001|Overall Study|Lost to Follow-up|0|||
37805101|NCT01514448|69450868|FG000|Overall Study|New Cancer Therapy|1|||
37805102|NCT01514448|69450869|FG001|Overall Study|New Cancer Therapy|0|||
37805103|NCT01514370|69450878|FG000|Overall Study|Protocol Violation|2|||
37805104|NCT01514370|69450879|FG001|Overall Study|Protocol Violation|3|||
37805105|NCT01514370|69450878|FG000|Overall Study|Lost to Follow-up|0|||
37805106|NCT01514370|69450879|FG001|Overall Study|Lost to Follow-up|2|||
37805107|NCT01514370|69450878|FG000|Overall Study|Withdrawal by Subject|2|||
37805108|NCT01514370|69450879|FG001|Overall Study|Withdrawal by Subject|1|||
37805109|NCT01514370|69450878|FG000|Overall Study|Adverse Event|1|||
37805110|NCT01514370|69450879|FG001|Overall Study|Adverse Event|3|||
37805111|NCT01514370|69450878|FG000|Overall Study|Other|6|||
37805112|NCT01514370|69450879|FG001|Overall Study|Other|7|||
37805113|NCT01519674|69450889|FG000|Overall Study|Adverse Event|3|||
37805114|NCT01519674|69450890|FG001|Overall Study|Adverse Event|3|||
37805115|NCT01519674|69450891|FG002|Overall Study|Adverse Event|0|||
37805116|NCT01519674|69450889|FG000|Overall Study|Lack of Efficacy|1|||
37805117|NCT01519674|69450890|FG001|Overall Study|Lack of Efficacy|1|||
37805118|NCT01519674|69450891|FG002|Overall Study|Lack of Efficacy|1|||
37805119|NCT01519674|69450889|FG000|Overall Study|Protocol Violation|0|||
37805120|NCT01519674|69450890|FG001|Overall Study|Protocol Violation|3|||
37805121|NCT01519674|69450891|FG002|Overall Study|Protocol Violation|1|||
37805122|NCT01519674|69450889|FG000|Overall Study|Withdrawal Criteria|7|||
37805123|NCT01519674|69450890|FG001|Overall Study|Withdrawal Criteria|2|||
37805124|NCT01519674|69450891|FG002|Overall Study|Withdrawal Criteria|7|||
37805125|NCT01519674|69450889|FG000|Overall Study|Unsclassified|10|||
37805126|NCT01519674|69450890|FG001|Overall Study|Unsclassified|4|||
37805127|NCT01519674|69450891|FG002|Overall Study|Unsclassified|3|||
37805128|NCT01519518|69450901|FG000|Overall Study|Consent not available|7|||
37805129|NCT01519518|69450902|FG001|Overall Study|Consent not available|10|||
37805130|NCT01519206|69450908|FG000|Overall Study|Lost to Follow-up|3|||
37805131|NCT01519206|69450908|FG000|Overall Study|Missed Visit|2|||
37805132|NCT01518972|69450921|FG000|Overall Study|Lost to Follow-up|2|||
37805133|NCT01518972|69450922|FG001|Overall Study|Lost to Follow-up|1|||
37805134|NCT01518972|69450921|FG000|Overall Study|Withdrawal by Subject|1|||
37805135|NCT01518972|69450922|FG001|Overall Study|Withdrawal by Subject|0|||
37805136|NCT01518972|69450921|FG000|Overall Study|Moved from area|1|||
37805137|NCT01518972|69450922|FG001|Overall Study|Moved from area|0|||
37805138|NCT01518972|69450921|FG000|Overall Study|Transportation problems|1|||
37805139|NCT01518972|69450922|FG001|Overall Study|Transportation problems|0|||
37805140|NCT01518972|69450921|FG000|Overall Study|Exclusionary medical condition|1|||
37805141|NCT01518972|69450922|FG001|Overall Study|Exclusionary medical condition|0|||
37805142|NCT01518972|69450921|FG000|Overall Study|Missed safety visits|0|||
37805143|NCT01518972|69450922|FG001|Overall Study|Missed safety visits|1|||
37805144|NCT01518972|69450921|FG000|Overall Study|Exclusionary medication|0|||
37805145|NCT01518972|69450922|FG001|Overall Study|Exclusionary medication|1|||
37805146|NCT01518972|69450921|FG000|Overall Study|Declined medication starting on day 12|0|||
37805147|NCT01518972|69450922|FG001|Overall Study|Declined medication starting on day 12|1|||
37805148|NCT01514136|69450930|FG000|Test Period 1; Test A|Protocol Violation|1|||
37805149|NCT01514136|69450931|FG001|Test Period 1; Test A|Protocol Violation|0|||
37805150|NCT01514136|69450932|FG002|Test Period 1; Test A|Protocol Violation|0|||
37805151|NCT01514136|69450933|FG003|Test Period 1; Test A|Protocol Violation|0|||
37805152|NCT01514136|69450934|FG004|Test Period 1; Test A|Protocol Violation|0|||
37805153|NCT01514136|69450935|FG005|Test Period 1; Test A|Protocol Violation|0|||
37805154|NCT01514136|69450936|FG006|Test Period 1; Test A|Protocol Violation|0|||
37805155|NCT01514136|69450937|FG007|Test Period 1; Test A|Protocol Violation|0|||
37805156|NCT01514136|69450930|FG000|Test Period 1; Test A|Break from study holiday|2|||
37805157|NCT01514136|69450931|FG001|Test Period 1; Test A|Break from study holiday|0|||
37805158|NCT01514136|69450932|FG002|Test Period 1; Test A|Break from study holiday|0|||
37805159|NCT01514136|69450933|FG003|Test Period 1; Test A|Break from study holiday|0|||
37805160|NCT01514136|69450934|FG004|Test Period 1; Test A|Break from study holiday|0|||
37805161|NCT01514136|69450935|FG005|Test Period 1; Test A|Break from study holiday|0|||
37805162|NCT01514136|69450936|FG006|Test Period 1; Test A|Break from study holiday|0|||
37805163|NCT01514136|69450937|FG007|Test Period 1; Test A|Break from study holiday|0|||
37805164|NCT01514136|69450930|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
37805165|NCT01514136|69450931|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
37805166|NCT01514136|69450932|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
37805167|NCT01514136|69450933|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
37805168|NCT01514136|69450934|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
37805169|NCT01514136|69450935|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
37805170|NCT01514136|69450936|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
37805171|NCT01514136|69450937|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
37805172|NCT01514136|69450930|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
37805173|NCT01514136|69450931|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
37805174|NCT01514136|69450932|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
37805175|NCT01514136|69450933|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
37805176|NCT01514136|69450934|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
37805177|NCT01514136|69450935|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
37805178|NCT01514136|69450936|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
37805179|NCT01514136|69450937|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
37805180|NCT01514136|69450930|FG000|Test Period 2; Test A*|Adverse Event|0|||
37805181|NCT01514136|69450931|FG001|Test Period 2; Test A*|Adverse Event|0|||
37805182|NCT01514136|69450932|FG002|Test Period 2; Test A*|Adverse Event|0|||
37805183|NCT01514136|69450933|FG003|Test Period 2; Test A*|Adverse Event|0|||
37805184|NCT01514136|69450934|FG004|Test Period 2; Test A*|Adverse Event|1|||
37805185|NCT01514136|69450935|FG005|Test Period 2; Test A*|Adverse Event|0|||
37805186|NCT01514136|69450936|FG006|Test Period 2; Test A*|Adverse Event|0|||
37805187|NCT01514136|69450937|FG007|Test Period 2; Test A*|Adverse Event|0|||
37805188|NCT01514136|69450930|FG000|Test Period 2; Test A*|Holiday|0|||
37805189|NCT01514136|69450931|FG001|Test Period 2; Test A*|Holiday|0|||
37805190|NCT01514136|69450932|FG002|Test Period 2; Test A*|Holiday|0|||
37805191|NCT01514136|69450933|FG003|Test Period 2; Test A*|Holiday|0|||
37805192|NCT01514136|69450934|FG004|Test Period 2; Test A*|Holiday|1|||
37805193|NCT01514136|69450935|FG005|Test Period 2; Test A*|Holiday|0|||
37805194|NCT01514136|69450936|FG006|Test Period 2; Test A*|Holiday|0|||
37805195|NCT01514136|69450937|FG007|Test Period 2; Test A*|Holiday|0|||
37805196|NCT01514136|69450930|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
37805197|NCT01514136|69450931|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
37805198|NCT01514136|69450932|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
37805199|NCT01514136|69450933|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
37805200|NCT01514136|69450934|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
37805201|NCT01514136|69450935|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
37805202|NCT01514136|69450936|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
37805203|NCT01514136|69450937|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
37805204|NCT01514136|69450930|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
37805205|NCT01514136|69450931|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
37805206|NCT01514136|69450932|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
37805207|NCT01514136|69450933|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
37805208|NCT01514136|69450934|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
37805209|NCT01514136|69450935|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
37805210|NCT01514136|69450936|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
37805211|NCT01514136|69450937|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
37805212|NCT01514136|69450930|FG000|Test Period 2; Test C*|holiday|0|||
37805213|NCT01514136|69450931|FG001|Test Period 2; Test C*|holiday|0|||
37805214|NCT01514136|69450932|FG002|Test Period 2; Test C*|holiday|0|||
37805215|NCT01514136|69450933|FG003|Test Period 2; Test C*|holiday|0|||
37805216|NCT01514136|69450934|FG004|Test Period 2; Test C*|holiday|0|||
37805217|NCT01514136|69450935|FG005|Test Period 2; Test C*|holiday|0|||
37805218|NCT01514136|69450936|FG006|Test Period 2; Test C*|holiday|1|||
37805219|NCT01514136|69450937|FG007|Test Period 2; Test C*|holiday|0|||
37805220|NCT01514136|69450930|FG000|Test Period 2; Test C*|Protocol Violation|0|||
37805221|NCT01514136|69450931|FG001|Test Period 2; Test C*|Protocol Violation|0|||
37805222|NCT01514136|69450932|FG002|Test Period 2; Test C*|Protocol Violation|0|||
37805223|NCT01514136|69450933|FG003|Test Period 2; Test C*|Protocol Violation|0|||
37805224|NCT01514136|69450934|FG004|Test Period 2; Test C*|Protocol Violation|0|||
37805225|NCT01514136|69450935|FG005|Test Period 2; Test C*|Protocol Violation|0|||
37805226|NCT01514136|69450936|FG006|Test Period 2; Test C*|Protocol Violation|1|||
37805227|NCT01514136|69450937|FG007|Test Period 2; Test C*|Protocol Violation|0|||
37805228|NCT01513590|69450965|FG000|Overall Study|Adverse Event|2|||
37805229|NCT01513590|69450966|FG001|Overall Study|Adverse Event|3|||
37805230|NCT01513590|69450965|FG000|Overall Study|Withdrawal Criteria|3|||
37805231|NCT01513590|69450966|FG001|Overall Study|Withdrawal Criteria|0|||
37805232|NCT01513590|69450965|FG000|Overall Study|Unclassified|5|||
37805233|NCT01513590|69450966|FG001|Overall Study|Unclassified|10|||
37805234|NCT01512264|69450976|FG000|Overall Study|Lost to Follow-up|0|||
37805235|NCT01512264|69450977|FG001|Overall Study|Lost to Follow-up|0|||
37864272|NCT00990106|69547854|FG000|Overall Study|planned major surgery|0|||
37975857|NCT00395343|69663158|FG001|Overall Study|Lost to Follow-up|4|||
37975858|NCT00395343|69663157|FG000|Overall Study|Physician Decision|2|||
37975859|NCT00395343|69663158|FG001|Overall Study|Physician Decision|4|||
37805236|NCT01512264|69450978|FG002|Overall Study|Lost to Follow-up|0|||
37975860|NCT00395343|69663157|FG000|Overall Study|Protocol Violation|6|||
37975861|NCT00395343|69663158|FG001|Overall Study|Protocol Violation|8|||
37975862|NCT00395343|69663157|FG000|Overall Study|Withdrawal by Subject|11|||
37975863|NCT00395343|69663158|FG001|Overall Study|Withdrawal by Subject|12|||
37975864|NCT00395343|69663157|FG000|Overall Study|Other|5|||
37805237|NCT01512264|69450979|FG003|Overall Study|Lost to Follow-up|1|||
37805238|NCT01512108|69450991|FG000|Overall Study|Adverse Event|9|||
37805239|NCT01512108|69450992|FG001|Overall Study|Adverse Event|4|||
37864273|NCT00990106|69547855|FG001|Overall Study|planned major surgery|1|||
37864274|NCT00990106|69547854|FG000|Overall Study|scheduling conflicts|0|||
37975865|NCT00395343|69663158|FG001|Overall Study|Other|2|||
37805240|NCT01512108|69450991|FG000|Overall Study|Protocol Violation|1|||
37805241|NCT01512108|69450992|FG001|Overall Study|Protocol Violation|2|||
37805242|NCT01512108|69450991|FG000|Overall Study|Withdrawal Criteria|1|||
37975866|NCT00560573|69663164|FG000|Overall Study|Death|4|||
37975867|NCT00560573|69663165|FG001|Overall Study|Death|1|||
37975868|NCT00560573|69663166|FG002|Overall Study|Death|4|||
37805243|NCT01512108|69450992|FG001|Overall Study|Withdrawal Criteria|0|||
37805244|NCT01512108|69450991|FG000|Overall Study|Unclassified|11|||
37805245|NCT01512108|69450992|FG001|Overall Study|Unclassified|3|||
37805246|NCT01486758|69451000|FG000|Overall Study|Lost to Follow-up|0|||
37805247|NCT01486758|69451001|FG001|Overall Study|Lost to Follow-up|1|||
37805248|NCT01463982|69451012|FG000|Overall Study|Withdrawal by Subject|0|||
37805249|NCT01463982|69451013|FG001|Overall Study|Withdrawal by Subject|1|||
37805250|NCT01463982|69451014|FG002|Overall Study|Withdrawal by Subject|1|||
37805251|NCT01463982|69451015|FG003|Overall Study|Withdrawal by Subject|0|||
37805252|NCT01463982|69451012|FG000|Overall Study|Treatment delay over 5 week|0|||
37805253|NCT01463982|69451013|FG001|Overall Study|Treatment delay over 5 week|0|||
37805254|NCT01463982|69451014|FG002|Overall Study|Treatment delay over 5 week|1|||
37805255|NCT01463982|69451015|FG003|Overall Study|Treatment delay over 5 week|0|||
37805256|NCT01486446|69451027|FG000|Overall Study|Adverse Event|1|||
37805257|NCT01486446|69451028|FG001|Overall Study|Adverse Event|0|||
37805258|NCT01485354|69451034|FG000|Overall Study|Withdrawal by Subject|5|||
37805259|NCT01510158|69451041|FG000|Overall Study|Adverse Event|7|||
37805260|NCT01510158|69451042|FG001|Overall Study|Adverse Event|8|||
37805261|NCT01510158|69451043|FG002|Overall Study|Adverse Event|5|||
37805262|NCT01510158|69451041|FG000|Overall Study|Gout flare|1|||
37805263|NCT01510158|69451042|FG001|Overall Study|Gout flare|0|||
37805264|NCT01510158|69451043|FG002|Overall Study|Gout flare|0|||
37805265|NCT01510158|69451041|FG000|Overall Study|Protocol Violation|17|||
37805266|NCT01510158|69451042|FG001|Overall Study|Protocol Violation|16|||
37805267|NCT01510158|69451043|FG002|Overall Study|Protocol Violation|24|||
37805268|NCT01510158|69451041|FG000|Overall Study|Sponsor terminated study.|2|||
37805269|NCT01510158|69451042|FG001|Overall Study|Sponsor terminated study.|0|||
37805270|NCT01510158|69451043|FG002|Overall Study|Sponsor terminated study.|2|||
37805271|NCT01510158|69451041|FG000|Overall Study|Lost to Follow-up|13|||
37805272|NCT01510158|69451042|FG001|Overall Study|Lost to Follow-up|16|||
37805273|NCT01510158|69451043|FG002|Overall Study|Lost to Follow-up|9|||
37805274|NCT01510158|69451041|FG000|Overall Study|Withdrawal by Subject|10|||
37805275|NCT01510158|69451042|FG001|Overall Study|Withdrawal by Subject|13|||
37805276|NCT01510158|69451043|FG002|Overall Study|Withdrawal by Subject|10|||
37805277|NCT01510158|69451041|FG000|Overall Study|Death|1|||
37805278|NCT01510158|69451042|FG001|Overall Study|Death|0|||
37805279|NCT01510158|69451043|FG002|Overall Study|Death|0|||
37805280|NCT01485120|69451060|FG000|Overall Study|Withdrawal by Subject|2|||
37805281|NCT01484496|69451067|FG000|Period 1|Protocol Violation|3|||
37805282|NCT01484496|69451068|FG001|Period 1|Protocol Violation|4|||
37805283|NCT01484496|69451069|FG002|Period 1|Protocol Violation|0|||
37805284|NCT01484496|69451070|FG003|Period 1|Protocol Violation|0|||
37805285|NCT01484496|69451067|FG000|Period 1|Physician Decision|5|||
37805286|NCT01484496|69451068|FG001|Period 1|Physician Decision|1|||
37805287|NCT01484496|69451069|FG002|Period 1|Physician Decision|0|||
37805288|NCT01484496|69451070|FG003|Period 1|Physician Decision|0|||
37805289|NCT01484496|69451067|FG000|Period 1|Lack of Efficacy|10|||
37805290|NCT01484496|69451068|FG001|Period 1|Lack of Efficacy|15|||
37805291|NCT01484496|69451069|FG002|Period 1|Lack of Efficacy|0|||
37805292|NCT01484496|69451070|FG003|Period 1|Lack of Efficacy|0|||
37805293|NCT01484496|69451067|FG000|Period 1|Adverse Event|25|||
37805294|NCT01484496|69451068|FG001|Period 1|Adverse Event|40|||
37805295|NCT01484496|69451069|FG002|Period 1|Adverse Event|0|||
37805296|NCT01484496|69451070|FG003|Period 1|Adverse Event|0|||
37805297|NCT01484496|69451067|FG000|Period 1|Withdrawal by Subject|15|||
37805298|NCT01484496|69451068|FG001|Period 1|Withdrawal by Subject|12|||
37805299|NCT01484496|69451069|FG002|Period 1|Withdrawal by Subject|0|||
37805300|NCT01484496|69451070|FG003|Period 1|Withdrawal by Subject|0|||
37805301|NCT01484496|69451067|FG000|Period 1|Lost to Follow-up|2|||
37805302|NCT01484496|69451068|FG001|Period 1|Lost to Follow-up|6|||
37805303|NCT01484496|69451069|FG002|Period 1|Lost to Follow-up|0|||
37805304|NCT01484496|69451070|FG003|Period 1|Lost to Follow-up|0|||
37805305|NCT01484496|69451067|FG000|Period 1|Positive Pregnancy|1|||
37805306|NCT01484496|69451068|FG001|Period 1|Positive Pregnancy|6|||
37805307|NCT01484496|69451069|FG002|Period 1|Positive Pregnancy|0|||
37975869|NCT00560573|69663167|FG003|Overall Study|Death|5|||
37975870|NCT00560573|69663168|FG004|Overall Study|Death|1|||
37805308|NCT01484496|69451070|FG003|Period 1|Positive Pregnancy|0|||
37805309|NCT01484496|69451067|FG000|Period 1|Treatment Failure|3|||
37805310|NCT01484496|69451068|FG001|Period 1|Treatment Failure|6|||
37805311|NCT01484496|69451069|FG002|Period 1|Treatment Failure|0|||
37805312|NCT01484496|69451070|FG003|Period 1|Treatment Failure|0|||
37805313|NCT01484496|69451067|FG000|Period 1|Lack of Compliance|2|||
37805314|NCT01484496|69451068|FG001|Period 1|Lack of Compliance|1|||
37805315|NCT01484496|69451069|FG002|Period 1|Lack of Compliance|0|||
37805316|NCT01484496|69451070|FG003|Period 1|Lack of Compliance|0|||
37805317|NCT01484496|69451067|FG000|Period 1|Unable to Visit Site|0|||
37805318|NCT01484496|69451068|FG001|Period 1|Unable to Visit Site|2|||
37975871|NCT00560573|69663169|FG005|Overall Study|Death|10|||
37805319|NCT01484496|69451069|FG002|Period 1|Unable to Visit Site|0|||
37805320|NCT01484496|69451070|FG003|Period 1|Unable to Visit Site|0|||
37805321|NCT01484496|69451067|FG000|Period 2|Lack of Efficacy|0|||
37805322|NCT01484496|69451068|FG001|Period 2|Lack of Efficacy|0|||
37975872|NCT00560573|69663164|FG000|Overall Study|Lost to Follow-up|0|||
37975873|NCT00560573|69663165|FG001|Overall Study|Lost to Follow-up|0|||
37975874|NCT00560573|69663166|FG002|Overall Study|Lost to Follow-up|0|||
37975875|NCT00560573|69663167|FG003|Overall Study|Lost to Follow-up|1|||
37975876|NCT00560573|69663168|FG004|Overall Study|Lost to Follow-up|1|||
37975877|NCT00560573|69663169|FG005|Overall Study|Lost to Follow-up|0|||
37975878|NCT00560573|69663164|FG000|Overall Study|Withdrawal by Subject|0|||
37975879|NCT00560573|69663165|FG001|Overall Study|Withdrawal by Subject|0|||
37975880|NCT00560573|69663166|FG002|Overall Study|Withdrawal by Subject|0|||
37975881|NCT00560573|69663167|FG003|Overall Study|Withdrawal by Subject|1|||
37975882|NCT00560573|69663168|FG004|Overall Study|Withdrawal by Subject|1|||
37975883|NCT00560573|69663169|FG005|Overall Study|Withdrawal by Subject|0|||
37975884|NCT00560573|69663164|FG000|Overall Study|Other|2|||
37975885|NCT00560573|69663165|FG001|Overall Study|Other|2|||
37975886|NCT00560573|69663166|FG002|Overall Study|Other|2|||
37975887|NCT00560573|69663167|FG003|Overall Study|Other|3|||
37975888|NCT00560573|69663168|FG004|Overall Study|Other|3|||
37975889|NCT00560573|69663169|FG005|Overall Study|Other|3|||
37975890|NCT00560573|69663164|FG000|Overall Study|Enrolled, not treated|0|||
37975891|NCT00560573|69663165|FG001|Overall Study|Enrolled, not treated|0|||
37805323|NCT01484496|69451069|FG002|Period 2|Lack of Efficacy|1|||
37975892|NCT00560573|69663166|FG002|Overall Study|Enrolled, not treated|0|||
37975893|NCT00560573|69663167|FG003|Overall Study|Enrolled, not treated|0|||
37805324|NCT01484496|69451070|FG003|Period 2|Lack of Efficacy|3|||
37805325|NCT01484496|69451067|FG000|Period 2|Adverse Event|0|||
37805326|NCT01484496|69451068|FG001|Period 2|Adverse Event|0|||
37805327|NCT01484496|69451069|FG002|Period 2|Adverse Event|5|||
37805328|NCT01484496|69451070|FG003|Period 2|Adverse Event|13|||
37805329|NCT01484496|69451067|FG000|Period 2|Other|0|||
37805330|NCT01484496|69451068|FG001|Period 2|Other|0|||
37805331|NCT01484496|69451069|FG002|Period 2|Other|9|||
37805332|NCT01484496|69451070|FG003|Period 2|Other|6|||
37805333|NCT01509846|69451083|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
37805334|NCT01509846|69451084|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
37805335|NCT01509846|69451085|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
37805336|NCT01509846|69451086|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
37805337|NCT01509846|69451087|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
37805338|NCT01509846|69451083|FG000|Received Vaccination 2|Illness|0|||
37805339|NCT01509846|69451084|FG001|Received Vaccination 2|Illness|0|||
37805340|NCT01509846|69451085|FG002|Received Vaccination 2|Illness|0|||
37805341|NCT01509846|69451086|FG003|Received Vaccination 2|Illness|0|||
37805342|NCT01509846|69451087|FG004|Received Vaccination 2|Illness|1|||
37805343|NCT01509846|69451083|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
37805344|NCT01509846|69451084|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
37805345|NCT01509846|69451085|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
37805346|NCT01509846|69451086|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
37805347|NCT01509846|69451087|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
37805348|NCT01509846|69451083|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
37805349|NCT01509846|69451084|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
37805350|NCT01509846|69451085|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
37805351|NCT01509846|69451086|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
37805352|NCT01509846|69451087|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
37805353|NCT01509846|69451083|FG000|Received Vaccination 3|Pregnancy|0|||
37805354|NCT01509846|69451084|FG001|Received Vaccination 3|Pregnancy|0|||
37805355|NCT01509846|69451085|FG002|Received Vaccination 3|Pregnancy|0|||
37805356|NCT01509846|69451086|FG003|Received Vaccination 3|Pregnancy|1|||
37805357|NCT01509846|69451087|FG004|Received Vaccination 3|Pregnancy|0|||
37805358|NCT01509846|69451083|FG000|Received Vaccination 3|Lost to Follow-up|0|||
37805359|NCT01509846|69451084|FG001|Received Vaccination 3|Lost to Follow-up|0|||
37805360|NCT01509846|69451085|FG002|Received Vaccination 3|Lost to Follow-up|1|||
37864275|NCT00990106|69547855|FG001|Overall Study|scheduling conflicts|2|||
37805361|NCT01509846|69451086|FG003|Received Vaccination 3|Lost to Follow-up|0|||
37805362|NCT01509846|69451087|FG004|Received Vaccination 3|Lost to Follow-up|0|||
37805363|NCT01462344|69451108|FG000|Overall Study|Withdrawal by Subject|245|||
37805364|NCT01462344|69451109|FG001|Overall Study|Withdrawal by Subject|226|||
37864276|NCT00983476|69547864|FG000|Overall Study|Did not receive intervention|17|||
37805365|NCT01462344|69451108|FG000|Overall Study|Adverse Event|24|||
37975894|NCT00560573|69663168|FG004|Overall Study|Enrolled, not treated|1|||
37975895|NCT00560573|69663169|FG005|Overall Study|Enrolled, not treated|0|||
37975896|NCT03961529|69663202|FG000|Overall Study|Adverse Event|13|||
37975897|NCT03961529|69663203|FG001|Overall Study|Adverse Event|5|||
37975898|NCT03961529|69663204|FG002|Overall Study|Adverse Event|2|||
37805366|NCT01462344|69451109|FG001|Overall Study|Adverse Event|23|||
37805367|NCT01462344|69451108|FG000|Overall Study|Asthma Exacerbation|34|||
37805368|NCT01462344|69451109|FG001|Overall Study|Asthma Exacerbation|35|||
37805369|NCT01462344|69451108|FG000|Overall Study|Lack of Efficacy|5|||
37805370|NCT01462344|69451109|FG001|Overall Study|Lack of Efficacy|6|||
37805371|NCT01462344|69451108|FG000|Overall Study|Protocol Violation|68|||
37805372|NCT01462344|69451109|FG001|Overall Study|Protocol Violation|53|||
37805373|NCT01462344|69451108|FG000|Overall Study|Lost to Follow-up|7|||
37805374|NCT01462344|69451109|FG001|Overall Study|Lost to Follow-up|7|||
37805375|NCT01484028|69451115|FG000|Period 1|Lost to Follow-up|0|||
37805376|NCT01484028|69451116|FG001|Period 1|Lost to Follow-up|1|||
37805377|NCT01484028|69451117|FG002|Period 1|Lost to Follow-up|0|||
37805378|NCT01484028|69451118|FG003|Period 1|Lost to Follow-up|0|||
37805379|NCT01484028|69451115|FG000|Period 1|Non-Compliance to Protocol|0|||
37805380|NCT01484028|69451116|FG001|Period 1|Non-Compliance to Protocol|1|||
37805381|NCT01484028|69451117|FG002|Period 1|Non-Compliance to Protocol|0|||
37805382|NCT01484028|69451118|FG003|Period 1|Non-Compliance to Protocol|1|||
37805383|NCT01484028|69451115|FG000|Period 1|Lens Discomfort|0|||
37805384|NCT01484028|69451116|FG001|Period 1|Lens Discomfort|1|||
37805385|NCT01484028|69451117|FG002|Period 1|Lens Discomfort|0|||
37805386|NCT01484028|69451118|FG003|Period 1|Lens Discomfort|0|||
37805387|NCT01462266|69451128|FG000|Overall Study|Adverse Event|7|||
37805388|NCT01462266|69451129|FG001|Overall Study|Adverse Event|6|||
37805389|NCT01462266|69451128|FG000|Overall Study|Death|2|||
37805390|NCT01462266|69451129|FG001|Overall Study|Death|1|||
37805391|NCT01462266|69451128|FG000|Overall Study|Lack of Efficacy|0|||
37805392|NCT01462266|69451129|FG001|Overall Study|Lack of Efficacy|2|||
37805393|NCT01462266|69451128|FG000|Overall Study|Lost to Follow-up|4|||
37805394|NCT01462266|69451129|FG001|Overall Study|Lost to Follow-up|3|||
37805395|NCT01462266|69451128|FG000|Overall Study|Non-compliance with study drug|3|||
37805396|NCT01462266|69451129|FG001|Overall Study|Non-compliance with study drug|0|||
37805397|NCT01462266|69451128|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
37805398|NCT01462266|69451129|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
37805399|NCT01462266|69451128|FG000|Overall Study|Physician Decision|2|||
37805400|NCT01462266|69451129|FG001|Overall Study|Physician Decision|5|||
37975899|NCT03961529|69663202|FG000|Overall Study|Withdrawal by Subject|17|||
37975900|NCT03961529|69663203|FG001|Overall Study|Withdrawal by Subject|2|||
37975901|NCT03961529|69663204|FG002|Overall Study|Withdrawal by Subject|1|||
37805401|NCT01462266|69451128|FG000|Overall Study|Protocol Violation|1|||
37805402|NCT01462266|69451129|FG001|Overall Study|Protocol Violation|3|||
37805403|NCT01462266|69451128|FG000|Overall Study|Withdrawal by Subject|7|||
37805404|NCT01462266|69451129|FG001|Overall Study|Withdrawal by Subject|2|||
37805405|NCT01462266|69451128|FG000|Overall Study|Screen failure|1|||
37805406|NCT01462266|69451129|FG001|Overall Study|Screen failure|1|||
37805407|NCT01508910|69451138|FG000|Treatment|Death|2|||
37805408|NCT01508910|69451139|FG001|Treatment|Death|3|||
37805409|NCT01508910|69451140|FG002|Treatment|Death|2|||
37805410|NCT01508910|69451141|FG003|Treatment|Death|0|||
37805411|NCT01508910|69451138|FG000|Treatment|Lost to Follow-up|0|||
37805412|NCT01508910|69451139|FG001|Treatment|Lost to Follow-up|0|||
37805413|NCT01508910|69451140|FG002|Treatment|Lost to Follow-up|2|||
37805414|NCT01508910|69451141|FG003|Treatment|Lost to Follow-up|1|||
37805415|NCT01508910|69451138|FG000|Treatment|Withdrawal by Subject|0|||
37805416|NCT01508910|69451139|FG001|Treatment|Withdrawal by Subject|1|||
37805417|NCT01508910|69451140|FG002|Treatment|Withdrawal by Subject|6|||
37975902|NCT03961529|69663202|FG000|Overall Study|Withdrawal by parent/guardian|0|||
37975903|NCT03961529|69663203|FG001|Overall Study|Withdrawal by parent/guardian|7|||
37975904|NCT03961529|69663204|FG002|Overall Study|Withdrawal by parent/guardian|0|||
37975905|NCT03961529|69663202|FG000|Overall Study|Physician Decision|2|||
37805418|NCT01508910|69451141|FG003|Treatment|Withdrawal by Subject|1|||
37805419|NCT01508910|69451138|FG000|Treatment|Sponsor Decision|0|||
37805420|NCT01508910|69451139|FG001|Treatment|Sponsor Decision|0|||
37805421|NCT01508910|69451140|FG002|Treatment|Sponsor Decision|0|||
37805422|NCT01508910|69451141|FG003|Treatment|Sponsor Decision|1|||
37805423|NCT01462110|69451155|FG000|Overall Study|Adverse Event|1|||
37805424|NCT01462110|69451156|FG001|Overall Study|Adverse Event|0|||
37805425|NCT01508676|69451164|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
37805426|NCT01508676|69451165|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
37805427|NCT01508676|69451164|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
37975906|NCT03961529|69663203|FG001|Overall Study|Physician Decision|1|||
37975907|NCT03961529|69663204|FG002|Overall Study|Physician Decision|1|||
37805428|NCT01508676|69451165|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
37975908|NCT03961529|69663202|FG000|Overall Study|Lost to Follow-up|2|||
37975909|NCT03961529|69663203|FG001|Overall Study|Lost to Follow-up|1|||
37975910|NCT03961529|69663204|FG002|Overall Study|Lost to Follow-up|0|||
37975911|NCT03961529|69663202|FG000|Overall Study|Lack of Efficacy|2|||
37975912|NCT03961529|69663203|FG001|Overall Study|Lack of Efficacy|0|||
37975913|NCT03961529|69663204|FG002|Overall Study|Lack of Efficacy|1|||
37805429|NCT01508676|69451164|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
37805430|NCT01508676|69451165|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
37805431|NCT01508676|69451164|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
37805432|NCT01508676|69451165|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
37975914|NCT03961529|69663202|FG000|Overall Study|Other|6|||
37805433|NCT01508676|69451164|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
37805434|NCT01508676|69451165|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
37975915|NCT03961529|69663203|FG001|Overall Study|Other|1|||
37975916|NCT03961529|69663204|FG002|Overall Study|Other|0|||
37975917|NCT00494780|69663214|FG000|Overall Study|Adverse Event|1|||
37975918|NCT00494780|69663215|FG001|Overall Study|Adverse Event|0|||
37805435|NCT01508130|69451174|FG000|Overall Study|Adverse Event|81|||
37805436|NCT01508130|69451175|FG001|Overall Study|Adverse Event|28|||
37805437|NCT01508130|69451174|FG000|Overall Study|Death|3|||
37805438|NCT01508130|69451175|FG001|Overall Study|Death|1|||
37975919|NCT00494780|69663214|FG000|Overall Study|Withdrew before Dosed|0|||
37975920|NCT00494780|69663215|FG001|Overall Study|Withdrew before Dosed|1|||
37975921|NCT00494780|69663214|FG000|Overall Study|Progression of Study Disease|7|||
37975922|NCT00494780|69663215|FG001|Overall Study|Progression of Study Disease|8|||
37805439|NCT01508130|69451174|FG000|Overall Study|Protocol Violation|2|||
37805440|NCT01508130|69451175|FG001|Overall Study|Protocol Violation|0|||
37975923|NCT00494780|69663214|FG000|Overall Study|New Treatment|2|||
37805441|NCT01508130|69451174|FG000|Overall Study|Lost to Follow-up|25|||
37805442|NCT01508130|69451175|FG001|Overall Study|Lost to Follow-up|2|||
37805443|NCT01508130|69451174|FG000|Overall Study|Withdrawal by Subject|3|||
37805444|NCT01508130|69451175|FG001|Overall Study|Withdrawal by Subject|3|||
37805445|NCT01508130|69451174|FG000|Overall Study|Subject's substantial non-compliance|25|||
37805446|NCT01508130|69451175|FG001|Overall Study|Subject's substantial non-compliance|9|||
37805447|NCT01508130|69451174|FG000|Overall Study|Insufficient therapeutic response|74|||
37805448|NCT01508130|69451175|FG001|Overall Study|Insufficient therapeutic response|23|||
37805449|NCT01508130|69451174|FG000|Overall Study|Administrative|14|||
37805450|NCT01508130|69451175|FG001|Overall Study|Administrative|3|||
37805451|NCT01482312|69451183|FG000|Period 1, 90 Minutes of Wear|Other|1|||
37805452|NCT01482312|69451184|FG001|Period 1, 90 Minutes of Wear|Other|0|||
37805453|NCT01482312|69451185|FG002|Period 1, 90 Minutes of Wear|Other|0|||
37805454|NCT01482312|69451183|FG000|Period 2, 90 Minutes of Wear|Other|1|||
37805455|NCT01482312|69451184|FG001|Period 2, 90 Minutes of Wear|Other|0|||
37805456|NCT01482312|69451185|FG002|Period 2, 90 Minutes of Wear|Other|0|||
37805457|NCT01461096|69451195|FG000|Overall Study|Death|3|||
37805458|NCT01461096|69451196|FG001|Overall Study|Death|6|||
37805459|NCT01461096|69451195|FG000|Overall Study|Severe debilitation, unable to continue|1|||
37805460|NCT01461096|69451196|FG001|Overall Study|Severe debilitation, unable to continue|1|||
37805461|NCT01461096|69451195|FG000|Overall Study|Subj not able to get to clinic|15|||
37805462|NCT01461096|69451196|FG001|Overall Study|Subj not able to get to clinic|13|||
37805463|NCT01461096|69451195|FG000|Overall Study|Site is closing|27|||
37805464|NCT01461096|69451196|FG001|Overall Study|Site is closing|30|||
37805465|NCT01461096|69451195|FG000|Overall Study|Withdrawal by Subject|5|||
37805466|NCT01461096|69451196|FG001|Overall Study|Withdrawal by Subject|3|||
37805467|NCT01461096|69451195|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
37805468|NCT01461096|69451196|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
37805469|NCT01461096|69451195|FG000|Overall Study|Lost to Follow-up|8|||
37805470|NCT01461096|69451196|FG001|Overall Study|Lost to Follow-up|4|||
37805471|NCT01507896|69451203|FG000|Overall Study|Withdrawal by Subject|1|||
37805472|NCT01507896|69451203|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
37805473|NCT01507662|69451218|FG000|Overall Study|Death|26|||
37805474|NCT01507662|69451219|FG001|Overall Study|Death|18|||
37805475|NCT01507662|69451218|FG000|Overall Study|Withdrawal by Subject|290|||
37805476|NCT01507662|69451219|FG001|Overall Study|Withdrawal by Subject|287|||
37805477|NCT01507662|69451218|FG000|Overall Study|Lost to Follow-up|498|||
37805478|NCT01507662|69451219|FG001|Overall Study|Lost to Follow-up|523|||
37805479|NCT01507662|69451218|FG000|Overall Study|Proxy interview done|2|||
37805480|NCT01507662|69451219|FG001|Overall Study|Proxy interview done|3|||
37805481|NCT01506960|69451225|FG000|Overall Study|Did not meet angiographic criteria|47|||
37975924|NCT00494780|69663215|FG001|Overall Study|New Treatment|2|||
37975925|NCT00494780|69663214|FG000|Overall Study|Non-compliance|1|||
37975926|NCT00494780|69663215|FG001|Overall Study|Non-compliance|0|||
37805482|NCT01480674|69451231|FG000|Overall Study|Death|23|||
37805483|NCT01480674|69451231|FG000|Overall Study|Lost to Follow-up|2|||
37805484|NCT01480674|69451231|FG000|Overall Study|visit not done|10|||
37805485|NCT01506882|69451237|FG000|Overall Study|Lack of Efficacy|4|||
37805486|NCT01506882|69451238|FG001|Overall Study|Lack of Efficacy|3|||
37805487|NCT01506882|69451237|FG000|Overall Study|Lost to Follow-up|1|||
37975927|NCT00494780|69663214|FG000|Overall Study|Residual Tumour Mass|0|||
37805488|NCT01506882|69451238|FG001|Overall Study|Lost to Follow-up|0|||
37805489|NCT01506882|69451237|FG000|Overall Study|Withdrawal by Subject|9|||
37975928|NCT00494780|69663215|FG001|Overall Study|Residual Tumour Mass|1|||
37975929|NCT00494780|69663214|FG000|Overall Study|Insurance Issues|0|||
37805490|NCT01506882|69451238|FG001|Overall Study|Withdrawal by Subject|3|||
37805491|NCT01506882|69451237|FG000|Overall Study|SAE, non-fatal|2|||
37805492|NCT01506882|69451238|FG001|Overall Study|SAE, non-fatal|0|||
37805493|NCT01506882|69451237|FG000|Overall Study|AE, non-serious non-fatal|3|||
37805494|NCT01506882|69451238|FG001|Overall Study|AE, non-serious non-fatal|1|||
37805495|NCT01506882|69451237|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
37805496|NCT01506882|69451238|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
37805497|NCT01506882|69451237|FG000|Overall Study|Other Reason|2|||
37805498|NCT01506882|69451238|FG001|Overall Study|Other Reason|0|||
37805499|NCT01506726|69451248|FG000|Overall Study|Adverse Event|1|||
37805500|NCT01506726|69451249|FG001|Overall Study|Adverse Event|2|||
37805501|NCT01505868|69451260|FG000|Overall Study|Withdrawal by Subject|1|||
37805502|NCT01505868|69451261|FG001|Overall Study|Withdrawal by Subject|0|||
37805503|NCT01505868|69451262|FG002|Overall Study|Withdrawal by Subject|0|||
37805504|NCT01505868|69451263|FG003|Overall Study|Withdrawal by Subject|0|||
37805505|NCT01505868|69451264|FG004|Overall Study|Withdrawal by Subject|0|||
37805506|NCT01505634|69451279|FG000|Overall Study|Withdrawal by Subject|2|||
37805507|NCT01505634|69451280|FG001|Overall Study|Withdrawal by Subject|5|||
37805508|NCT01505634|69451281|FG002|Overall Study|Withdrawal by Subject|1|||
37805509|NCT01505634|69451279|FG000|Overall Study|Physician Decision|1|||
37805510|NCT01505634|69451280|FG001|Overall Study|Physician Decision|1|||
37805511|NCT01505634|69451281|FG002|Overall Study|Physician Decision|0|||
37805512|NCT01505634|69451279|FG000|Overall Study|Adverse Event|1|||
37975930|NCT00494780|69663215|FG001|Overall Study|Insurance Issues|1|||
37975931|NCT00490022|69663225|FG000|Overall Study|Adverse Event|0|||
37975932|NCT00490022|69663226|FG001|Overall Study|Adverse Event|2|||
37805513|NCT01505634|69451280|FG001|Overall Study|Adverse Event|0|||
37805514|NCT01505634|69451281|FG002|Overall Study|Adverse Event|0|||
37805515|NCT01505634|69451279|FG000|Overall Study|Insufficient supply of drug at site|1|||
37805516|NCT01505634|69451280|FG001|Overall Study|Insufficient supply of drug at site|0|||
37805517|NCT01505634|69451281|FG002|Overall Study|Insufficient supply of drug at site|0|||
37805518|NCT01505634|69451279|FG000|Overall Study|Protocol Violation|2|||
37805519|NCT01505634|69451280|FG001|Overall Study|Protocol Violation|0|||
37805520|NCT01505634|69451281|FG002|Overall Study|Protocol Violation|0|||
37805521|NCT01505634|69451279|FG000|Overall Study|Lost to Follow-up|1|||
37805522|NCT01505634|69451280|FG001|Overall Study|Lost to Follow-up|4|||
37805523|NCT01505634|69451281|FG002|Overall Study|Lost to Follow-up|4|||
37805524|NCT01505634|69451279|FG000|Overall Study|Death|1|||
37805525|NCT01505634|69451280|FG001|Overall Study|Death|0|||
37805526|NCT01505634|69451281|FG002|Overall Study|Death|0|||
37805527|NCT01505634|69451279|FG000|Overall Study|In a conflict zone|0|||
37805528|NCT01505634|69451280|FG001|Overall Study|In a conflict zone|0|||
37805529|NCT01505634|69451281|FG002|Overall Study|In a conflict zone|1|||
37805530|NCT01460628|69451289|FG000|Overall Study|Adverse Event|3|||
37805531|NCT01460628|69451289|FG000|Overall Study|Withdrawal by Subject|2|||
37805532|NCT01480596|69451295|FG000|Overall Study|Adverse Event|3|||
37805533|NCT01480596|69451296|FG001|Overall Study|Adverse Event|0|||
37805534|NCT01480596|69451295|FG000|Overall Study|MG exacerbation or change in medication|2|||
37805535|NCT01480596|69451296|FG001|Overall Study|MG exacerbation or change in medication|2|||
37805536|NCT01480284|69451304|FG000|Overall Study|Withdrawal by Subject|2|||
37805537|NCT01480284|69451305|FG001|Overall Study|Withdrawal by Subject|0|||
37805538|NCT01480284|69451304|FG000|Overall Study|Adverse Event|1|||
37805539|NCT01480284|69451305|FG001|Overall Study|Adverse Event|0|||
37805540|NCT01480284|69451304|FG000|Overall Study|Study closed/terminated|3|||
37805541|NCT01480284|69451305|FG001|Overall Study|Study closed/terminated|0|||
37805542|NCT01480284|69451304|FG000|Overall Study|Lost to Follow-up|1|||
37805543|NCT01480284|69451305|FG001|Overall Study|Lost to Follow-up|0|||
37805544|NCT01480284|69451304|FG000|Overall Study|Physician Decision|1|||
37805545|NCT01480284|69451305|FG001|Overall Study|Physician Decision|0|||
37805546|NCT01459614|69451313|FG000|Overall Study|Adverse Event|1|||
37805547|NCT01459614|69451314|FG001|Overall Study|Adverse Event|0|||
37805548|NCT01458522|69451322|FG000|Overall Study|Withdrawal by Subject|2|||
37805549|NCT01458522|69451323|FG001|Overall Study|Withdrawal by Subject|2|||
37805550|NCT01458522|69451322|FG000|Overall Study|Physician Decision|1|||
37805551|NCT01458522|69451323|FG001|Overall Study|Physician Decision|9|||
37805552|NCT01505010|69451337|FG000|Overall Study|Protocol Violation|0|||
37805553|NCT01505010|69451338|FG001|Overall Study|Protocol Violation|1|||
37805554|NCT01505010|69451337|FG000|Overall Study|Lost to Follow-up|0|||
37805555|NCT01505010|69451338|FG001|Overall Study|Lost to Follow-up|1|||
37864277|NCT00983476|69547865|FG001|Overall Study|Did not receive intervention|22|||
37805556|NCT01458366|69451349|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
37805557|NCT01458366|69451350|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
37805558|NCT01458366|69451351|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
37805559|NCT01458366|69451352|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
37864278|NCT00983476|69547866|FG002|Overall Study|Did not receive intervention|0|||
37805560|NCT01458366|69451353|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
37805561|NCT01458366|69451349|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
37805562|NCT01458366|69451350|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
37805563|NCT01458366|69451351|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
37805564|NCT01458366|69451352|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
37805565|NCT01458366|69451353|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
37975933|NCT00490022|69663225|FG000|Overall Study|Withdrawal by Subject|1|||
37805566|NCT01458210|69451361|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
37805567|NCT01458210|69451361|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
37805568|NCT01458210|69451361|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
37805569|NCT01458210|69451361|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
37805570|NCT01478958|69451371|FG000|Overall Study|Withdrawal by Subject|1|||
37805571|NCT01478958|69451372|FG001|Overall Study|Withdrawal by Subject|1|||
37805572|NCT01478958|69451373|FG002|Overall Study|Withdrawal by Subject|1|||
37805573|NCT01478958|69451371|FG000|Overall Study|Weight loss|1|||
37805574|NCT01478958|69451372|FG001|Overall Study|Weight loss|0|||
37805575|NCT01478958|69451373|FG002|Overall Study|Weight loss|0|||
37805576|NCT01478958|69451371|FG000|Overall Study|Re-located|0|||
37975934|NCT00490022|69663226|FG001|Overall Study|Withdrawal by Subject|0|||
37975935|NCT00490022|69663225|FG000|Overall Study|Subject failed to disclose concommitant|0|||
37975936|NCT00490022|69663226|FG001|Overall Study|Subject failed to disclose concommitant|1|||
37975937|NCT00493454|69663232|FG000|Overall Study|Withdrawal by Subject|1|||
37975938|NCT00493220|69663242|FG000|Third Intervention|Withdrawal by Subject|1|||
37975939|NCT00493220|69663243|FG001|Third Intervention|Withdrawal by Subject|0|||
37975940|NCT00493220|69663244|FG002|Third Intervention|Withdrawal by Subject|0|||
37975941|NCT00493220|69663245|FG003|Third Intervention|Withdrawal by Subject|0|||
37975942|NCT00493220|69663246|FG004|Third Intervention|Withdrawal by Subject|0|||
37975943|NCT00493220|69663247|FG005|Third Intervention|Withdrawal by Subject|0|||
37975944|NCT00394953|69663259|FG000|First Treatment Period|Adverse Event|1|||
37975945|NCT00394953|69663260|FG001|First Treatment Period|Adverse Event|2|||
37975946|NCT00394953|69663259|FG000|First Treatment Period|Death|6|||
37975947|NCT00394953|69663260|FG001|First Treatment Period|Death|7|||
37975948|NCT00394953|69663259|FG000|First Treatment Period|Lack of Efficacy|1|||
37975949|NCT00394953|69663260|FG001|First Treatment Period|Lack of Efficacy|1|||
37805577|NCT01478958|69451372|FG001|Overall Study|Re-located|1|||
37805578|NCT01478958|69451373|FG002|Overall Study|Re-located|0|||
37805579|NCT01478958|69451371|FG000|Overall Study|Unable to comply|0|||
37975950|NCT00394953|69663259|FG000|First Treatment Period|Withdrawal by Subject|6|||
37975951|NCT00394953|69663260|FG001|First Treatment Period|Withdrawal by Subject|3|||
37975952|NCT00394953|69663259|FG000|First Treatment Period|Lost to Follow-up|0|||
37975953|NCT00394953|69663260|FG001|First Treatment Period|Lost to Follow-up|1|||
37975954|NCT00394953|69663259|FG000|First Treatment Period|Renal transplant|11|||
37975955|NCT00394953|69663260|FG001|First Treatment Period|Renal transplant|7|||
37975956|NCT00394953|69663259|FG000|First Treatment Period|Not defined|4|||
37975957|NCT00394953|69663260|FG001|First Treatment Period|Not defined|1|||
37975958|NCT00394953|69663259|FG000|Second Treatment Period|Adverse Event|2|||
37975959|NCT00394953|69663260|FG001|Second Treatment Period|Adverse Event|5|||
37975960|NCT00394953|69663259|FG000|Second Treatment Period|Death|8|||
37975961|NCT00394953|69663260|FG001|Second Treatment Period|Death|4|||
37805580|NCT01478958|69451372|FG001|Overall Study|Unable to comply|0|||
37805581|NCT01478958|69451373|FG002|Overall Study|Unable to comply|2|||
37805582|NCT01458132|69451383|FG000|Overall Study|Other|15|||
37805583|NCT01458132|69451384|FG001|Overall Study|Other|3|||
37805584|NCT01457352|69451392|FG000|Period 1|Adverse Event|2|||
37805585|NCT01457352|69451393|FG001|Period 1|Adverse Event|0|||
37805586|NCT01457352|69451392|FG000|Period 1|Withdrawal by Subject|2|||
37805587|NCT01457352|69451393|FG001|Period 1|Withdrawal by Subject|0|||
37864279|NCT00982228|69547910|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
37975962|NCT00394953|69663259|FG000|Second Treatment Period|Lack of Efficacy|9|||
37805588|NCT01457352|69451392|FG000|Period 1|Physician Decision|2|||
37805589|NCT01457352|69451393|FG001|Period 1|Physician Decision|0|||
37975963|NCT00394953|69663260|FG001|Second Treatment Period|Lack of Efficacy|47|||
37975964|NCT00394953|69663259|FG000|Second Treatment Period|Withdrawal by Subject|3|||
37975965|NCT00394953|69663260|FG001|Second Treatment Period|Withdrawal by Subject|3|||
37975966|NCT00394953|69663259|FG000|Second Treatment Period|Lost to Follow-up|0|||
37975967|NCT00394953|69663260|FG001|Second Treatment Period|Lost to Follow-up|1|||
37975968|NCT00394953|69663259|FG000|Second Treatment Period|Renal transplant|4|||
37694023|NCT01896232|69170342|FG001|Overall Study|Lost to Follow-up|12|||
37805590|NCT01457352|69451392|FG000|Period 1|MS related disease progression|1|||
37805591|NCT01457352|69451393|FG001|Period 1|MS related disease progression|0|||
37805592|NCT01457352|69451392|FG000|Period 1|Withdrawn|1|||
37805593|NCT01457352|69451393|FG001|Period 1|Withdrawn|0|||
37805594|NCT01457352|69451392|FG000|Period 1|withdrew per sponsor|1|||
37805595|NCT01457352|69451393|FG001|Period 1|withdrew per sponsor|0|||
37805596|NCT01457352|69451392|FG000|Period 1|Protocol Violation|4|||
37805597|NCT01457352|69451393|FG001|Period 1|Protocol Violation|0|||
37805598|NCT01457352|69451392|FG000|Period 1|Did not meet eligibility criteria|3|||
37805599|NCT01457352|69451393|FG001|Period 1|Did not meet eligibility criteria|0|||
37805600|NCT01457352|69451392|FG000|Period 2|Withdrawal by Subject|23|||
37805601|NCT01457352|69451393|FG001|Period 2|Withdrawal by Subject|0|||
37805602|NCT01457352|69451392|FG000|Period 2|Adverse Event|22|||
37805603|NCT01457352|69451393|FG001|Period 2|Adverse Event|0|||
37805604|NCT01457352|69451392|FG000|Period 2|no analysis|10|||
37805605|NCT01457352|69451393|FG001|Period 2|no analysis|0|||
37805606|NCT01457352|69451392|FG000|Period 2|Lack of Efficacy|8|||
37805607|NCT01457352|69451393|FG001|Period 2|Lack of Efficacy|0|||
37805608|NCT01457352|69451392|FG000|Period 2|Protocol Violation|4|||
37805609|NCT01457352|69451393|FG001|Period 2|Protocol Violation|0|||
37805610|NCT01457352|69451392|FG000|Period 2|Sponsor's withdrawal|7|||
37805611|NCT01457352|69451393|FG001|Period 2|Sponsor's withdrawal|0|||
37975969|NCT00394953|69663260|FG001|Second Treatment Period|Renal transplant|6|||
37975970|NCT00394953|69663259|FG000|Second Treatment Period|Not defined|3|||
37975971|NCT00394953|69663260|FG001|Second Treatment Period|Not defined|8|||
37975972|NCT00485732|69663268|FG000|Overall Study|Protocol Violation|1|||
37975973|NCT00485732|69663269|FG001|Overall Study|Protocol Violation|3|||
37975974|NCT00485732|69663268|FG000|Overall Study|Withdrawal by Subject|5|||
37975975|NCT00485732|69663269|FG001|Overall Study|Withdrawal by Subject|4|||
37975976|NCT00485732|69663268|FG000|Overall Study|Lost to Follow-up|2|||
37975977|NCT00485732|69663269|FG001|Overall Study|Lost to Follow-up|2|||
37975978|NCT00489554|69663275|FG000|Overall Study|Adverse Event|2|||
37975979|NCT00489554|69663275|FG000|Overall Study|Withdrawal by Subject|1|||
37975980|NCT00489554|69663275|FG000|Overall Study|Lost to Follow-up|1|||
37975981|NCT00408681|69663279|FG000|Overall Study|Lack of Efficacy|2|||
37975982|NCT00408681|69663279|FG000|Overall Study|Adverse Event|7|||
37975983|NCT00560417|69663286|FG000|Overall Study|Adverse Event|3|||
37975984|NCT00560417|69663287|FG001|Overall Study|Adverse Event|2|||
37975985|NCT00560417|69663286|FG000|Overall Study|Entry Criteria Not Met|1|||
37975986|NCT00560417|69663287|FG001|Overall Study|Entry Criteria Not Met|0|||
37975987|NCT00560417|69663286|FG000|Overall Study|Lost to Follow-up|0|||
37975988|NCT00560417|69663287|FG001|Overall Study|Lost to Follow-up|1|||
37694024|NCT02460224|69170377|FG000|Overall Study|Adverse Event|0|||
37805612|NCT01457352|69451392|FG000|Period 2|Lost to Follow-up|1|||
37694025|NCT02460224|69170378|FG001|Overall Study|Adverse Event|0|||
37805613|NCT01457352|69451393|FG001|Period 2|Lost to Follow-up|0|||
37805614|NCT01457352|69451392|FG000|Period 2|dose change|1|||
37975989|NCT00560417|69663286|FG000|Overall Study|Physician Decision|2|||
37975990|NCT00560417|69663287|FG001|Overall Study|Physician Decision|6|||
37975991|NCT00560417|69663286|FG000|Overall Study|Protocol Violation|6|||
37975992|NCT00560417|69663287|FG001|Overall Study|Protocol Violation|5|||
37975993|NCT00560417|69663286|FG000|Overall Study|Sponsor Decision|2|||
37805615|NCT01457352|69451393|FG001|Period 2|dose change|0|||
37805616|NCT01457352|69451392|FG000|Period 2|Physician Decision|1|||
37805617|NCT01457352|69451393|FG001|Period 2|Physician Decision|0|||
37805618|NCT01457352|69451392|FG000|Period 2|Did not meet eligibility criteria|3|||
37805619|NCT01457352|69451393|FG001|Period 2|Did not meet eligibility criteria|0|||
37805620|NCT01457352|69451392|FG000|Period 3|Adverse Event|1|||
37805621|NCT01457352|69451393|FG001|Period 3|Adverse Event|1|||
37805622|NCT01457352|69451392|FG000|Period 3|Withdrawal by Subject|0|||
37805623|NCT01457352|69451393|FG001|Period 3|Withdrawal by Subject|2|||
37805624|NCT01457352|69451392|FG000|Period 3|incorrect treatment|0|||
37805625|NCT01457352|69451393|FG001|Period 3|incorrect treatment|1|||
37805626|NCT01457352|69451392|FG000|Period 3|Sponsor's withdrawal|0|||
37805627|NCT01457352|69451393|FG001|Period 3|Sponsor's withdrawal|1|||
37805628|NCT01457118|69451407|FG000|Overall Study|Adverse Event|1|||
37805629|NCT01457118|69451408|FG001|Overall Study|Adverse Event|0|||
37805630|NCT01457118|69451409|FG002|Overall Study|Adverse Event|0|||
37805631|NCT01457118|69451410|FG003|Overall Study|Adverse Event|1|||
37805632|NCT01457118|69451407|FG000|Overall Study|Clinical Progression|0|||
37805633|NCT01457118|69451408|FG001|Overall Study|Clinical Progression|1|||
37805634|NCT01457118|69451409|FG002|Overall Study|Clinical Progression|0|||
37805635|NCT01457118|69451410|FG003|Overall Study|Clinical Progression|1|||
37805636|NCT01457118|69451407|FG000|Overall Study|Physician Decision|2|||
37805637|NCT01457118|69451408|FG001|Overall Study|Physician Decision|0|||
37805638|NCT01457118|69451409|FG002|Overall Study|Physician Decision|0|||
37805639|NCT01457118|69451410|FG003|Overall Study|Physician Decision|0|||
37805640|NCT01457118|69451407|FG000|Overall Study|Progressive Disease by RECIST|12|||
37805641|NCT01457118|69451408|FG001|Overall Study|Progressive Disease by RECIST|3|||
37805642|NCT01457118|69451409|FG002|Overall Study|Progressive Disease by RECIST|1|||
37805643|NCT01457118|69451410|FG003|Overall Study|Progressive Disease by RECIST|0|||
37805644|NCT01457118|69451407|FG000|Overall Study|Withdrawal by Subject|5|||
37805645|NCT01457118|69451408|FG001|Overall Study|Withdrawal by Subject|0|||
37805646|NCT01457118|69451409|FG002|Overall Study|Withdrawal by Subject|0|||
37805647|NCT01457118|69451410|FG003|Overall Study|Withdrawal by Subject|0|||
37805648|NCT01456962|69451422|FG000|Overall Study|Lost to Follow-up|2|||
37805649|NCT01456962|69451423|FG001|Overall Study|Lost to Follow-up|1|||
37805650|NCT01501110|69451431|FG000|Overall Study|Death|0|||
37805651|NCT01501110|69451432|FG001|Overall Study|Death|1|||
37805652|NCT01500720|69451440|FG000|Overall Study|Randomized But Not Treated|1|||
37805653|NCT01500720|69451441|FG001|Overall Study|Randomized But Not Treated|1|||
37805654|NCT01500720|69451440|FG000|Overall Study|Other|4|||
37805655|NCT01500720|69451441|FG001|Overall Study|Other|8|||
37805656|NCT01500252|69451449|FG000|Overall Study|Death|4|||
37805657|NCT01500252|69451450|FG001|Overall Study|Death|2|||
37805658|NCT01500252|69451449|FG000|Overall Study|Lost to Follow-up|5|||
37805659|NCT01500252|69451450|FG001|Overall Study|Lost to Follow-up|4|||
37805660|NCT01476696|69451457|FG000|Overall Study|Sponsor decision|2|||
37805661|NCT01476696|69451458|FG001|Overall Study|Sponsor decision|1|||
37805662|NCT01476696|69451459|FG002|Overall Study|Sponsor decision|0|||
37805663|NCT01476696|69451457|FG000|Overall Study|Withdrawal by Subject|1|||
37805664|NCT01476696|69451458|FG001|Overall Study|Withdrawal by Subject|0|||
37805665|NCT01476696|69451459|FG002|Overall Study|Withdrawal by Subject|0|||
37805666|NCT01500096|69451476|FG000|Overall Study|Lost to Follow-up|1|||
37805667|NCT01500096|69451477|FG001|Overall Study|Lost to Follow-up|0|||
37805668|NCT01500096|69451478|FG002|Overall Study|Lost to Follow-up|0|||
37805669|NCT01500096|69451479|FG003|Overall Study|Lost to Follow-up|2|||
37805670|NCT01455012|69451491|FG000|Overall Study|Adverse Event|0|||
37805671|NCT01455012|69451492|FG001|Overall Study|Adverse Event|2|||
37805672|NCT01455012|69451491|FG000|Overall Study|Lack of Efficacy|6|||
37805673|NCT01455012|69451492|FG001|Overall Study|Lack of Efficacy|1|||
37805674|NCT01455012|69451491|FG000|Overall Study|Withdrawal by Subject|3|||
37805675|NCT01455012|69451492|FG001|Overall Study|Withdrawal by Subject|1|||
37805676|NCT01455012|69451491|FG000|Overall Study|Unknown reason|2|||
37805677|NCT01455012|69451492|FG001|Overall Study|Unknown reason|0|||
37805678|NCT01454778|69451498|FG000|Overall Study|Lost to Follow-up|2|||
37805679|NCT01454778|69451498|FG000|Overall Study|Death|1|||
37805680|NCT01454076|69451507|FG000|Overall Study|Other|2|||
37805681|NCT01454076|69451508|FG001|Overall Study|Other|0|||
37805682|NCT01454076|69451509|FG002|Overall Study|Other|0|||
37805683|NCT01454076|69451510|FG003|Overall Study|Other|1|||
37805684|NCT01454076|69451511|FG004|Overall Study|Other|2|||
37805685|NCT01454076|69451507|FG000|Overall Study|Withdrawal by Subject|3|||
37805686|NCT01454076|69451508|FG001|Overall Study|Withdrawal by Subject|4|||
37805687|NCT01454076|69451509|FG002|Overall Study|Withdrawal by Subject|2|||
37805688|NCT01454076|69451510|FG003|Overall Study|Withdrawal by Subject|1|||
37805689|NCT01454076|69451511|FG004|Overall Study|Withdrawal by Subject|2|||
37805690|NCT01454076|69451507|FG000|Overall Study|Adverse Event|8|||
37805691|NCT01454076|69451508|FG001|Overall Study|Adverse Event|2|||
37805692|NCT01454076|69451509|FG002|Overall Study|Adverse Event|7|||
37805693|NCT01454076|69451510|FG003|Overall Study|Adverse Event|0|||
37805694|NCT01454076|69451511|FG004|Overall Study|Adverse Event|2|||
37805695|NCT01453998|69451535|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
37805696|NCT01453998|69451536|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
37805697|NCT01453998|69451537|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
37805698|NCT01453374|69451548|FG000|Overall Study|Adverse Event|7|||
37805699|NCT01453374|69451548|FG000|Overall Study|Lack of Efficacy|1|||
37805700|NCT01453374|69451548|FG000|Overall Study|Lost to Follow-up|3|||
37805701|NCT01453374|69451548|FG000|Overall Study|Withdrawal by Subject|5|||
37805702|NCT01453374|69451548|FG000|Overall Study|Incarcerated|2|||
37805703|NCT01453296|69451554|FG000|Treatment Period 1|Adverse Event|0|||
37805704|NCT01453296|69451555|FG001|Treatment Period 1|Adverse Event|1|||
37805705|NCT01453296|69451554|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
37805706|NCT01453296|69451555|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
37805707|NCT01453296|69451554|FG000|Treatment Period 2|Adverse Event|1|||
37805708|NCT01453296|69451555|FG001|Treatment Period 2|Adverse Event|0|||
37805709|NCT01453296|69451554|FG000|Treatment Period 2|Withdrawal by Subject|1|||
37805710|NCT01453296|69451555|FG001|Treatment Period 2|Withdrawal by Subject|0|||
37805711|NCT01453140|69451561|FG000|Overall Study|Adverse Event|3|||
37805712|NCT01499940|69451569|FG000|Overall Study|Study was withdrawn before completion.|9|||
37805713|NCT01499160|69451573|FG000|Overall Study|Adverse Event|1|||
37805714|NCT01499160|69451573|FG000|Overall Study|Withdrawal by Subject|1|||
37805715|NCT01498692|69451578|FG000|Overall Study|Death|4|||
37805716|NCT01498692|69451578|FG000|Overall Study|Withdrawal by Subject|1|||
37805717|NCT01498692|69451578|FG000|Overall Study|Missed 12-month visit|3|||
37805718|NCT01498068|69451584|FG000|Overall Study|Withdrawal by Subject|1|||
37805719|NCT01498068|69451585|FG001|Overall Study|Withdrawal by Subject|1|||
37805720|NCT01497366|69451593|FG000|Overall Study|Virologic failure|2|||
37805721|NCT01497366|69451594|FG001|Overall Study|Virologic failure|50|||
37805722|NCT01497366|69451593|FG000|Overall Study|Lost to Follow-up|11|||
37805723|NCT01497366|69451594|FG001|Overall Study|Lost to Follow-up|10|||
37805724|NCT01497366|69451593|FG000|Overall Study|Withdrawal by Subject|6|||
37805725|NCT01497366|69451594|FG001|Overall Study|Withdrawal by Subject|6|||
37805726|NCT01497366|69451593|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
37805727|NCT01497366|69451594|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
37805728|NCT01497366|69451593|FG000|Overall Study|Other|5|||
37805729|NCT01497366|69451594|FG001|Overall Study|Other|0|||
37805730|NCT01497366|69451593|FG000|Overall Study|Death|1|||
37805731|NCT01497366|69451594|FG001|Overall Study|Death|1|||
37805732|NCT01497366|69451593|FG000|Overall Study|Randomized but not treated|7|||
37805733|NCT01497366|69451594|FG001|Overall Study|Randomized but not treated|21|||
37805734|NCT01475838|69451603|FG000|Randomized Phase|Randomized but Not Treated|0|||
37805735|NCT01475838|69451604|FG001|Randomized Phase|Randomized but Not Treated|5|||
37805736|NCT01475838|69451603|FG000|Randomized Phase|Adverse Event|6|||
37805737|NCT01475838|69451604|FG001|Randomized Phase|Adverse Event|1|||
37805738|NCT01475838|69451603|FG000|Randomized Phase|Pregnancy|0|||
37805739|NCT01475838|69451604|FG001|Randomized Phase|Pregnancy|1|||
37805740|NCT01475838|69451603|FG000|Randomized Phase|Investigators Discretion|1|||
37805741|NCT01475838|69451604|FG001|Randomized Phase|Investigators Discretion|2|||
37805742|NCT01475838|69451603|FG000|Randomized Phase|Withdrew Consent|10|||
37805743|NCT01475838|69451604|FG001|Randomized Phase|Withdrew Consent|14|||
37805744|NCT01475838|69451603|FG000|Randomized Phase|Lost to Follow-up|3|||
37805745|NCT01475838|69451604|FG001|Randomized Phase|Lost to Follow-up|4|||
37805746|NCT01475838|69451603|FG000|Randomized Phase|Participant Noncompliance|1|||
37805747|NCT01475838|69451604|FG001|Randomized Phase|Participant Noncompliance|5|||
37805748|NCT01475838|69451603|FG000|Randomized Phase|Protocol Violation|9|||
37975994|NCT00560417|69663287|FG001|Overall Study|Sponsor Decision|0|||
37805749|NCT01475838|69451604|FG001|Randomized Phase|Protocol Violation|4|||
37805750|NCT01475838|69451603|FG000|Extension Phase|Participant Noncompliance|1|||
37805751|NCT01475838|69451604|FG001|Extension Phase|Participant Noncompliance|0|||
37805752|NCT01451814|69451613|FG000|Overall Study|Withdrawal by Subject|1|||
37805753|NCT01451814|69451614|FG001|Overall Study|Withdrawal by Subject|1|||
37805754|NCT01451814|69451613|FG000|Overall Study|Lost to Follow-up|5|||
37805755|NCT01451814|69451614|FG001|Overall Study|Lost to Follow-up|4|||
37805756|NCT01475370|69451623|FG000|Overall Study|Exacerbation of primary disease|2|||
37805757|NCT01475370|69451624|FG001|Overall Study|Exacerbation of primary disease|2|||
37805758|NCT01475370|69451625|FG002|Overall Study|Exacerbation of primary disease|2|||
37805759|NCT01475370|69451623|FG000|Overall Study|Study drug administration difficult|0|||
37805760|NCT01475370|69451624|FG001|Overall Study|Study drug administration difficult|1|||
37805761|NCT01475370|69451625|FG002|Overall Study|Study drug administration difficult|1|||
37805762|NCT01475370|69451623|FG000|Overall Study|Other than specified|1|||
37805763|NCT01475370|69451624|FG001|Overall Study|Other than specified|0|||
37805764|NCT01475370|69451625|FG002|Overall Study|Other than specified|0|||
37805765|NCT01496430|69451636|FG000|Overall Study|Adverse Event|0|||
37805766|NCT01496430|69451637|FG001|Overall Study|Adverse Event|0|||
37805767|NCT01496430|69451638|FG002|Overall Study|Adverse Event|1|||
37805768|NCT01496430|69451636|FG000|Overall Study|Major Protocol Deviation|0|||
37805769|NCT01496430|69451637|FG001|Overall Study|Major Protocol Deviation|0|||
37805770|NCT01496430|69451638|FG002|Overall Study|Major Protocol Deviation|1|||
37805771|NCT01496430|69451636|FG000|Overall Study|Lost to Follow-up|2|||
37805772|NCT01496430|69451637|FG001|Overall Study|Lost to Follow-up|3|||
37805773|NCT01496430|69451638|FG002|Overall Study|Lost to Follow-up|1|||
37805774|NCT01496430|69451636|FG000|Overall Study|Voluntary Withdrawal|2|||
37805775|NCT01496430|69451637|FG001|Overall Study|Voluntary Withdrawal|1|||
37805776|NCT01496430|69451638|FG002|Overall Study|Voluntary Withdrawal|6|||
37805777|NCT01496430|69451636|FG000|Overall Study|Principal Investigator Discretion|0|||
37805778|NCT01496430|69451637|FG001|Overall Study|Principal Investigator Discretion|1|||
37805779|NCT01496430|69451638|FG002|Overall Study|Principal Investigator Discretion|1|||
37805780|NCT01496430|69451636|FG000|Overall Study|Other|2|||
37805781|NCT01496430|69451637|FG001|Overall Study|Other|0|||
37805782|NCT01496430|69451638|FG002|Overall Study|Other|0|||
37805783|NCT01451424|69451650|FG000|Overall Study|Withdrawal by Subject|1|||
37805784|NCT01451424|69451651|FG001|Overall Study|Withdrawal by Subject|1|||
37805785|NCT01451424|69451652|FG002|Overall Study|Withdrawal by Subject|0|||
37805786|NCT01451424|69451653|FG003|Overall Study|Withdrawal by Subject|2|||
37805787|NCT01451424|69451650|FG000|Overall Study|Lost to Follow-up|0|||
37805788|NCT01451424|69451651|FG001|Overall Study|Lost to Follow-up|1|||
37805789|NCT01451424|69451652|FG002|Overall Study|Lost to Follow-up|0|||
37805790|NCT01451424|69451653|FG003|Overall Study|Lost to Follow-up|1|||
37805791|NCT01451424|69451650|FG000|Overall Study|Physician Decision|0|||
37805792|NCT01451424|69451651|FG001|Overall Study|Physician Decision|0|||
37805793|NCT01451424|69451652|FG002|Overall Study|Physician Decision|1|||
37805794|NCT01451424|69451653|FG003|Overall Study|Physician Decision|1|||
37805795|NCT01451424|69451650|FG000|Overall Study|Adverse Event|0|||
37805796|NCT01451424|69451651|FG001|Overall Study|Adverse Event|0|||
37805797|NCT01451424|69451652|FG002|Overall Study|Adverse Event|0|||
37805798|NCT01451424|69451653|FG003|Overall Study|Adverse Event|1|||
37805799|NCT01475214|69451671|FG000|Overall Study|Lost to Follow-up|1|||
37805800|NCT01475214|69451672|FG001|Overall Study|Lost to Follow-up|0|||
37805801|NCT01475214|69451673|FG002|Overall Study|Lost to Follow-up|1|||
37805802|NCT01475214|69451671|FG000|Overall Study|Physician Decision|2|||
37805803|NCT01475214|69451672|FG001|Overall Study|Physician Decision|0|||
37805804|NCT01475214|69451673|FG002|Overall Study|Physician Decision|0|||
37805805|NCT01475214|69451671|FG000|Overall Study|Withdrawal by Subject|2|||
37805806|NCT01475214|69451672|FG001|Overall Study|Withdrawal by Subject|4|||
37805807|NCT01475214|69451673|FG002|Overall Study|Withdrawal by Subject|1|||
37805808|NCT01496274|69451684|FG000|Overall Study|Protocol Violation|0|||
37805809|NCT01496274|69451685|FG001|Overall Study|Protocol Violation|1|||
37805810|NCT01496274|69451684|FG000|Overall Study|Adverse Event|1|||
37805811|NCT01496274|69451685|FG001|Overall Study|Adverse Event|1|||
37805812|NCT01496274|69451684|FG000|Overall Study|Withdrawal by Subject|2|||
37694026|NCT02460224|69170379|FG002|Overall Study|Adverse Event|0|||
37805813|NCT01496274|69451685|FG001|Overall Study|Withdrawal by Subject|0|||
37805814|NCT01496274|69451684|FG000|Overall Study|Lost to Follow-up|0|||
37805815|NCT01496274|69451685|FG001|Overall Study|Lost to Follow-up|3|||
37805816|NCT01475136|69451710|FG000|Overall Study|Sponsor Decision|0|||
37805817|NCT01475136|69451711|FG001|Overall Study|Sponsor Decision|1|||
37805818|NCT01475136|69451712|FG002|Overall Study|Sponsor Decision|0|||
37805819|NCT01475136|69451713|FG003|Overall Study|Sponsor Decision|0|||
37805820|NCT01475136|69451710|FG000|Overall Study|Entry Criteria Not Met|0|||
37805821|NCT01475136|69451711|FG001|Overall Study|Entry Criteria Not Met|2|||
37805822|NCT01475136|69451712|FG002|Overall Study|Entry Criteria Not Met|3|||
37805823|NCT01475136|69451713|FG003|Overall Study|Entry Criteria Not Met|1|||
37805824|NCT01475136|69451710|FG000|Overall Study|Withdrawal by Subject|0|||
37805825|NCT01475136|69451711|FG001|Overall Study|Withdrawal by Subject|0|||
37805826|NCT01475136|69451712|FG002|Overall Study|Withdrawal by Subject|0|||
37805827|NCT01475136|69451713|FG003|Overall Study|Withdrawal by Subject|2|||
37805828|NCT01475136|69451710|FG000|Overall Study|Adverse Event|1|||
37805829|NCT01475136|69451711|FG001|Overall Study|Adverse Event|0|||
37805830|NCT01475136|69451712|FG002|Overall Study|Adverse Event|0|||
37805831|NCT01475136|69451713|FG003|Overall Study|Adverse Event|1|||
37805832|NCT01475136|69451710|FG000|Overall Study|Death|0|||
37805833|NCT01475136|69451711|FG001|Overall Study|Death|0|||
37805834|NCT01475136|69451712|FG002|Overall Study|Death|0|||
37805835|NCT01475136|69451713|FG003|Overall Study|Death|1|||
37805836|NCT01474746|69451725|FG000|Overall Study|Lost to Follow-up|1|||
37805837|NCT01474746|69451726|FG001|Overall Study|Lost to Follow-up|1|||
37805838|NCT01474746|69451725|FG000|Overall Study|Withdrawal by Subject|2|||
37805839|NCT01474746|69451726|FG001|Overall Study|Withdrawal by Subject|1|||
37805840|NCT01450800|69451734|FG000|Overall Study|Protocol Violation|1|||
37805841|NCT01450800|69451735|FG001|Overall Study|Protocol Violation|3|||
37805842|NCT01474512|69451746|FG000|Induction Period|Adverse Event|6|||
37805843|NCT01474512|69451747|FG001|Induction Period|Adverse Event|10|||
37805844|NCT01474512|69451748|FG002|Induction Period|Adverse Event|10|||
37805845|NCT01474512|69451749|FG003|Induction Period|Adverse Event|0|||
37805846|NCT01474512|69451750|FG004|Induction Period|Adverse Event|0|||
37805847|NCT01474512|69451751|FG005|Induction Period|Adverse Event|0|||
37805848|NCT01474512|69451752|FG006|Induction Period|Adverse Event|0|||
37805849|NCT01474512|69451753|FG007|Induction Period|Adverse Event|0|||
37805850|NCT01474512|69451754|FG008|Induction Period|Adverse Event|0|||
37805851|NCT01474512|69451755|FG009|Induction Period|Adverse Event|0|||
37805852|NCT01474512|69451756|FG010|Induction Period|Adverse Event|0|||
37805853|NCT01474512|69451757|FG011|Induction Period|Adverse Event|0|||
37805854|NCT01474512|69451758|FG012|Induction Period|Adverse Event|0|||
37805855|NCT01474512|69451759|FG013|Induction Period|Adverse Event|0|||
37805856|NCT01474512|69451760|FG014|Induction Period|Adverse Event|0|||
37805857|NCT01474512|69451761|FG015|Induction Period|Adverse Event|0|||
37805858|NCT01474512|69451762|FG016|Induction Period|Adverse Event|0|||
37805859|NCT01474512|69451763|FG017|Induction Period|Adverse Event|0|||
37805860|NCT01474512|69451746|FG000|Induction Period|Lack of Efficacy|7|||
37805861|NCT01474512|69451747|FG001|Induction Period|Lack of Efficacy|1|||
37805862|NCT01474512|69451748|FG002|Induction Period|Lack of Efficacy|0|||
37805863|NCT01474512|69451749|FG003|Induction Period|Lack of Efficacy|0|||
37805864|NCT01474512|69451750|FG004|Induction Period|Lack of Efficacy|0|||
37805865|NCT01474512|69451751|FG005|Induction Period|Lack of Efficacy|0|||
37805866|NCT01474512|69451752|FG006|Induction Period|Lack of Efficacy|0|||
37805867|NCT01474512|69451753|FG007|Induction Period|Lack of Efficacy|0|||
37805868|NCT01474512|69451754|FG008|Induction Period|Lack of Efficacy|0|||
37805869|NCT01474512|69451755|FG009|Induction Period|Lack of Efficacy|0|||
37805870|NCT01474512|69451756|FG010|Induction Period|Lack of Efficacy|0|||
37805871|NCT01474512|69451757|FG011|Induction Period|Lack of Efficacy|0|||
37805872|NCT01474512|69451758|FG012|Induction Period|Lack of Efficacy|0|||
37975995|NCT00560417|69663286|FG000|Overall Study|Withdrawal by Subject|3|||
37975996|NCT00560417|69663287|FG001|Overall Study|Withdrawal by Subject|3|||
37975997|NCT03968159|69663300|FG000|Overall Study|Adverse Event|4|||
37975998|NCT03968159|69663301|FG001|Overall Study|Adverse Event|4|||
37975999|NCT03968159|69663300|FG000|Overall Study|Lost to Follow-up|1|||
37976000|NCT03968159|69663301|FG001|Overall Study|Lost to Follow-up|1|||
37805873|NCT01474512|69451759|FG013|Induction Period|Lack of Efficacy|0|||
37805874|NCT01474512|69451760|FG014|Induction Period|Lack of Efficacy|0|||
37805875|NCT01474512|69451761|FG015|Induction Period|Lack of Efficacy|0|||
37805876|NCT01474512|69451762|FG016|Induction Period|Lack of Efficacy|0|||
37805877|NCT01474512|69451763|FG017|Induction Period|Lack of Efficacy|0|||
37805878|NCT01474512|69451746|FG000|Induction Period|Withdrawal by Subject|6|||
37805879|NCT01474512|69451747|FG001|Induction Period|Withdrawal by Subject|6|||
37805880|NCT01474512|69451748|FG002|Induction Period|Withdrawal by Subject|5|||
37805881|NCT01474512|69451749|FG003|Induction Period|Withdrawal by Subject|0|||
37805882|NCT01474512|69451750|FG004|Induction Period|Withdrawal by Subject|0|||
37805883|NCT01474512|69451751|FG005|Induction Period|Withdrawal by Subject|0|||
37805884|NCT01474512|69451752|FG006|Induction Period|Withdrawal by Subject|0|||
37805885|NCT01474512|69451753|FG007|Induction Period|Withdrawal by Subject|0|||
37805886|NCT01474512|69451754|FG008|Induction Period|Withdrawal by Subject|0|||
37976001|NCT03968159|69663300|FG000|Overall Study|Use of prohibited medication|0|||
37976002|NCT03968159|69663301|FG001|Overall Study|Use of prohibited medication|1|||
37976003|NCT03968159|69663300|FG000|Overall Study|Protocol Violation|2|||
37976004|NCT03968159|69663301|FG001|Overall Study|Protocol Violation|2|||
37976005|NCT03968159|69663300|FG000|Overall Study|Withdrawal by Subject|4|||
37976006|NCT03968159|69663301|FG001|Overall Study|Withdrawal by Subject|6|||
37805887|NCT01474512|69451755|FG009|Induction Period|Withdrawal by Subject|0|||
37976007|NCT03968159|69663300|FG000|Overall Study|Lack of Efficacy|0|||
37805888|NCT01474512|69451756|FG010|Induction Period|Withdrawal by Subject|0|||
37805889|NCT01474512|69451757|FG011|Induction Period|Withdrawal by Subject|0|||
37805890|NCT01474512|69451758|FG012|Induction Period|Withdrawal by Subject|0|||
37805891|NCT01474512|69451759|FG013|Induction Period|Withdrawal by Subject|0|||
37805892|NCT01474512|69451760|FG014|Induction Period|Withdrawal by Subject|0|||
37805893|NCT01474512|69451761|FG015|Induction Period|Withdrawal by Subject|0|||
37805894|NCT01474512|69451762|FG016|Induction Period|Withdrawal by Subject|0|||
37805895|NCT01474512|69451763|FG017|Induction Period|Withdrawal by Subject|0|||
37805896|NCT01474512|69451746|FG000|Induction Period|Protocol Violation|3|||
37805897|NCT01474512|69451747|FG001|Induction Period|Protocol Violation|6|||
37805898|NCT01474512|69451748|FG002|Induction Period|Protocol Violation|0|||
37805899|NCT01474512|69451749|FG003|Induction Period|Protocol Violation|0|||
37805900|NCT01474512|69451750|FG004|Induction Period|Protocol Violation|0|||
37805901|NCT01474512|69451751|FG005|Induction Period|Protocol Violation|0|||
37805902|NCT01474512|69451752|FG006|Induction Period|Protocol Violation|0|||
37805903|NCT01474512|69451753|FG007|Induction Period|Protocol Violation|0|||
37805904|NCT01474512|69451754|FG008|Induction Period|Protocol Violation|0|||
37805905|NCT01474512|69451755|FG009|Induction Period|Protocol Violation|0|||
37805906|NCT01474512|69451756|FG010|Induction Period|Protocol Violation|0|||
37805907|NCT01474512|69451757|FG011|Induction Period|Protocol Violation|0|||
37805908|NCT01474512|69451758|FG012|Induction Period|Protocol Violation|0|||
37805909|NCT01474512|69451759|FG013|Induction Period|Protocol Violation|0|||
37805910|NCT01474512|69451760|FG014|Induction Period|Protocol Violation|0|||
37805911|NCT01474512|69451761|FG015|Induction Period|Protocol Violation|0|||
37805912|NCT01474512|69451762|FG016|Induction Period|Protocol Violation|0|||
37805913|NCT01474512|69451763|FG017|Induction Period|Protocol Violation|0|||
37805914|NCT01474512|69451746|FG000|Induction Period|Sponsor Decision|1|||
37805915|NCT01474512|69451747|FG001|Induction Period|Sponsor Decision|1|||
37805916|NCT01474512|69451748|FG002|Induction Period|Sponsor Decision|1|||
37805917|NCT01474512|69451749|FG003|Induction Period|Sponsor Decision|0|||
37805918|NCT01474512|69451750|FG004|Induction Period|Sponsor Decision|0|||
37805919|NCT01474512|69451751|FG005|Induction Period|Sponsor Decision|0|||
37805920|NCT01474512|69451752|FG006|Induction Period|Sponsor Decision|0|||
37805921|NCT01474512|69451753|FG007|Induction Period|Sponsor Decision|0|||
37805922|NCT01474512|69451754|FG008|Induction Period|Sponsor Decision|0|||
37805923|NCT01474512|69451755|FG009|Induction Period|Sponsor Decision|0|||
37805924|NCT01474512|69451756|FG010|Induction Period|Sponsor Decision|0|||
37805925|NCT01474512|69451757|FG011|Induction Period|Sponsor Decision|0|||
37805926|NCT01474512|69451758|FG012|Induction Period|Sponsor Decision|0|||
37805927|NCT01474512|69451759|FG013|Induction Period|Sponsor Decision|0|||
37805928|NCT01474512|69451760|FG014|Induction Period|Sponsor Decision|0|||
37805929|NCT01474512|69451761|FG015|Induction Period|Sponsor Decision|0|||
37805930|NCT01474512|69451762|FG016|Induction Period|Sponsor Decision|0|||
37805931|NCT01474512|69451763|FG017|Induction Period|Sponsor Decision|0|||
37805932|NCT01474512|69451746|FG000|Induction Period|Lost to Follow-up|1|||
37805933|NCT01474512|69451747|FG001|Induction Period|Lost to Follow-up|0|||
37805934|NCT01474512|69451748|FG002|Induction Period|Lost to Follow-up|2|||
37805935|NCT01474512|69451749|FG003|Induction Period|Lost to Follow-up|0|||
37805936|NCT01474512|69451750|FG004|Induction Period|Lost to Follow-up|0|||
37805937|NCT01474512|69451751|FG005|Induction Period|Lost to Follow-up|0|||
37805938|NCT01474512|69451752|FG006|Induction Period|Lost to Follow-up|0|||
37805939|NCT01474512|69451753|FG007|Induction Period|Lost to Follow-up|0|||
37805940|NCT01474512|69451754|FG008|Induction Period|Lost to Follow-up|0|||
37805941|NCT01474512|69451755|FG009|Induction Period|Lost to Follow-up|0|||
37805942|NCT01474512|69451756|FG010|Induction Period|Lost to Follow-up|0|||
37805943|NCT01474512|69451757|FG011|Induction Period|Lost to Follow-up|0|||
37805944|NCT01474512|69451758|FG012|Induction Period|Lost to Follow-up|0|||
37805945|NCT01474512|69451759|FG013|Induction Period|Lost to Follow-up|0|||
37805946|NCT01474512|69451760|FG014|Induction Period|Lost to Follow-up|0|||
37805947|NCT01474512|69451761|FG015|Induction Period|Lost to Follow-up|0|||
37805948|NCT01474512|69451762|FG016|Induction Period|Lost to Follow-up|0|||
37805949|NCT01474512|69451763|FG017|Induction Period|Lost to Follow-up|0|||
37805950|NCT01474512|69451746|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
37805951|NCT01474512|69451747|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
37805952|NCT01474512|69451748|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
37805953|NCT01474512|69451749|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
37805954|NCT01474512|69451750|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
37805955|NCT01474512|69451751|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
37805956|NCT01474512|69451752|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
37805957|NCT01474512|69451753|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
37805958|NCT01474512|69451754|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
37805959|NCT01474512|69451755|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
37805960|NCT01474512|69451756|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
37805961|NCT01474512|69451757|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
37805962|NCT01474512|69451758|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
37805963|NCT01474512|69451759|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
37805964|NCT01474512|69451760|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
37805965|NCT01474512|69451761|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
37805966|NCT01474512|69451762|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
37976008|NCT03968159|69663301|FG001|Overall Study|Lack of Efficacy|1|||
37805967|NCT01474512|69451763|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
37805968|NCT01474512|69451746|FG000|Maintenance Period|Adverse Event|0|||
37805969|NCT01474512|69451747|FG001|Maintenance Period|Adverse Event|0|||
37805970|NCT01474512|69451748|FG002|Maintenance Period|Adverse Event|0|||
37805971|NCT01474512|69451749|FG003|Maintenance Period|Adverse Event|4|||
37805972|NCT01474512|69451750|FG004|Maintenance Period|Adverse Event|2|||
37805973|NCT01474512|69451751|FG005|Maintenance Period|Adverse Event|7|||
37976009|NCT03968159|69663300|FG000|Overall Study|Not further specified|2|||
37976010|NCT03968159|69663301|FG001|Overall Study|Not further specified|0|||
37976011|NCT03966911|69663309|FG000|Overall Study|Adverse Event|1|||
37976012|NCT03966911|69663310|FG001|Overall Study|Adverse Event|1|||
37805974|NCT01474512|69451752|FG006|Maintenance Period|Adverse Event|0|||
37805975|NCT01474512|69451753|FG007|Maintenance Period|Adverse Event|19|||
37805976|NCT01474512|69451754|FG008|Maintenance Period|Adverse Event|1|||
37805977|NCT01474512|69451755|FG009|Maintenance Period|Adverse Event|3|||
37805978|NCT01474512|69451756|FG010|Maintenance Period|Adverse Event|0|||
37805979|NCT01474512|69451757|FG011|Maintenance Period|Adverse Event|0|||
37805980|NCT01474512|69451758|FG012|Maintenance Period|Adverse Event|0|||
37805981|NCT01474512|69451759|FG013|Maintenance Period|Adverse Event|0|||
37805982|NCT01474512|69451760|FG014|Maintenance Period|Adverse Event|0|||
37805983|NCT01474512|69451761|FG015|Maintenance Period|Adverse Event|0|||
37805984|NCT01474512|69451762|FG016|Maintenance Period|Adverse Event|0|||
37805985|NCT01474512|69451763|FG017|Maintenance Period|Adverse Event|0|||
37805986|NCT01474512|69451746|FG000|Maintenance Period|Withdrawal by Subject|0|||
37805987|NCT01474512|69451747|FG001|Maintenance Period|Withdrawal by Subject|0|||
37805988|NCT01474512|69451748|FG002|Maintenance Period|Withdrawal by Subject|0|||
37805989|NCT01474512|69451749|FG003|Maintenance Period|Withdrawal by Subject|6|||
37805990|NCT01474512|69451750|FG004|Maintenance Period|Withdrawal by Subject|2|||
37805991|NCT01474512|69451751|FG005|Maintenance Period|Withdrawal by Subject|3|||
37805992|NCT01474512|69451752|FG006|Maintenance Period|Withdrawal by Subject|1|||
37805993|NCT01474512|69451753|FG007|Maintenance Period|Withdrawal by Subject|6|||
37805994|NCT01474512|69451754|FG008|Maintenance Period|Withdrawal by Subject|3|||
37805995|NCT01474512|69451755|FG009|Maintenance Period|Withdrawal by Subject|1|||
37805996|NCT01474512|69451756|FG010|Maintenance Period|Withdrawal by Subject|0|||
37805997|NCT01474512|69451757|FG011|Maintenance Period|Withdrawal by Subject|0|||
37805998|NCT01474512|69451758|FG012|Maintenance Period|Withdrawal by Subject|0|||
37805999|NCT01474512|69451759|FG013|Maintenance Period|Withdrawal by Subject|0|||
37806000|NCT01474512|69451760|FG014|Maintenance Period|Withdrawal by Subject|0|||
37806001|NCT01474512|69451761|FG015|Maintenance Period|Withdrawal by Subject|0|||
37806002|NCT01474512|69451762|FG016|Maintenance Period|Withdrawal by Subject|0|||
37806003|NCT01474512|69451763|FG017|Maintenance Period|Withdrawal by Subject|0|||
37806004|NCT01474512|69451746|FG000|Maintenance Period|Lost to Follow-up|0|||
37806005|NCT01474512|69451747|FG001|Maintenance Period|Lost to Follow-up|0|||
37806006|NCT01474512|69451748|FG002|Maintenance Period|Lost to Follow-up|0|||
37806007|NCT01474512|69451749|FG003|Maintenance Period|Lost to Follow-up|3|||
37806008|NCT01474512|69451750|FG004|Maintenance Period|Lost to Follow-up|3|||
37806009|NCT01474512|69451751|FG005|Maintenance Period|Lost to Follow-up|0|||
37806010|NCT01474512|69451752|FG006|Maintenance Period|Lost to Follow-up|0|||
37806011|NCT01474512|69451753|FG007|Maintenance Period|Lost to Follow-up|2|||
37806012|NCT01474512|69451754|FG008|Maintenance Period|Lost to Follow-up|1|||
37806013|NCT01474512|69451755|FG009|Maintenance Period|Lost to Follow-up|1|||
37806014|NCT01474512|69451756|FG010|Maintenance Period|Lost to Follow-up|0|||
37806015|NCT01474512|69451757|FG011|Maintenance Period|Lost to Follow-up|0|||
37806016|NCT01474512|69451758|FG012|Maintenance Period|Lost to Follow-up|0|||
37806017|NCT01474512|69451759|FG013|Maintenance Period|Lost to Follow-up|0|||
37806018|NCT01474512|69451760|FG014|Maintenance Period|Lost to Follow-up|0|||
37806019|NCT01474512|69451761|FG015|Maintenance Period|Lost to Follow-up|0|||
37806020|NCT01474512|69451762|FG016|Maintenance Period|Lost to Follow-up|0|||
37806021|NCT01474512|69451763|FG017|Maintenance Period|Lost to Follow-up|0|||
37864280|NCT00982228|69547911|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
37976013|NCT03966911|69663309|FG000|Overall Study|Withdrawal by Subject|8|||
37976014|NCT03966911|69663310|FG001|Overall Study|Withdrawal by Subject|2|||
37694027|NCT02460224|69170380|FG003|Overall Study|Adverse Event|0|||
37694028|NCT02460224|69170381|FG004|Overall Study|Adverse Event|0|||
37806022|NCT01474512|69451746|FG000|Maintenance Period|Death|0|||
37806023|NCT01474512|69451747|FG001|Maintenance Period|Death|0|||
37806024|NCT01474512|69451748|FG002|Maintenance Period|Death|0|||
37806025|NCT01474512|69451749|FG003|Maintenance Period|Death|0|||
37806026|NCT01474512|69451750|FG004|Maintenance Period|Death|0|||
37806027|NCT01474512|69451751|FG005|Maintenance Period|Death|2|||
37806028|NCT01474512|69451752|FG006|Maintenance Period|Death|0|||
37806029|NCT01474512|69451753|FG007|Maintenance Period|Death|0|||
37806030|NCT01474512|69451754|FG008|Maintenance Period|Death|0|||
37806031|NCT01474512|69451755|FG009|Maintenance Period|Death|0|||
37806032|NCT01474512|69451756|FG010|Maintenance Period|Death|0|||
37976015|NCT03966911|69663309|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
37976016|NCT03966911|69663310|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
37806033|NCT01474512|69451757|FG011|Maintenance Period|Death|0|||
37806034|NCT01474512|69451758|FG012|Maintenance Period|Death|0|||
37806035|NCT01474512|69451759|FG013|Maintenance Period|Death|0|||
37806036|NCT01474512|69451760|FG014|Maintenance Period|Death|0|||
37806037|NCT01474512|69451761|FG015|Maintenance Period|Death|0|||
37806038|NCT01474512|69451762|FG016|Maintenance Period|Death|0|||
37806039|NCT01474512|69451763|FG017|Maintenance Period|Death|0|||
37806040|NCT01474512|69451746|FG000|Maintenance Period|Physician Decision|0|||
37806041|NCT01474512|69451747|FG001|Maintenance Period|Physician Decision|0|||
37806042|NCT01474512|69451748|FG002|Maintenance Period|Physician Decision|0|||
37806043|NCT01474512|69451749|FG003|Maintenance Period|Physician Decision|0|||
37806044|NCT01474512|69451750|FG004|Maintenance Period|Physician Decision|0|||
37806045|NCT01474512|69451751|FG005|Maintenance Period|Physician Decision|1|||
37806046|NCT01474512|69451752|FG006|Maintenance Period|Physician Decision|0|||
37806047|NCT01474512|69451753|FG007|Maintenance Period|Physician Decision|2|||
37806048|NCT01474512|69451754|FG008|Maintenance Period|Physician Decision|0|||
37806049|NCT01474512|69451755|FG009|Maintenance Period|Physician Decision|0|||
37806050|NCT01474512|69451756|FG010|Maintenance Period|Physician Decision|0|||
37806051|NCT01474512|69451757|FG011|Maintenance Period|Physician Decision|0|||
37806052|NCT01474512|69451758|FG012|Maintenance Period|Physician Decision|0|||
37806053|NCT01474512|69451759|FG013|Maintenance Period|Physician Decision|0|||
37806054|NCT01474512|69451760|FG014|Maintenance Period|Physician Decision|0|||
37806055|NCT01474512|69451761|FG015|Maintenance Period|Physician Decision|0|||
37806056|NCT01474512|69451762|FG016|Maintenance Period|Physician Decision|0|||
37806057|NCT01474512|69451763|FG017|Maintenance Period|Physician Decision|0|||
37806058|NCT01474512|69451746|FG000|Maintenance Period|Clinical Relapse|0|||
37806059|NCT01474512|69451747|FG001|Maintenance Period|Clinical Relapse|0|||
37806060|NCT01474512|69451748|FG002|Maintenance Period|Clinical Relapse|0|||
37806061|NCT01474512|69451749|FG003|Maintenance Period|Clinical Relapse|1|||
37806062|NCT01474512|69451750|FG004|Maintenance Period|Clinical Relapse|0|||
37806063|NCT01474512|69451751|FG005|Maintenance Period|Clinical Relapse|0|||
37806064|NCT01474512|69451752|FG006|Maintenance Period|Clinical Relapse|0|||
37806065|NCT01474512|69451753|FG007|Maintenance Period|Clinical Relapse|0|||
37806066|NCT01474512|69451754|FG008|Maintenance Period|Clinical Relapse|0|||
37806067|NCT01474512|69451755|FG009|Maintenance Period|Clinical Relapse|0|||
37806068|NCT01474512|69451756|FG010|Maintenance Period|Clinical Relapse|0|||
37806069|NCT01474512|69451757|FG011|Maintenance Period|Clinical Relapse|0|||
37806070|NCT01474512|69451758|FG012|Maintenance Period|Clinical Relapse|0|||
37806071|NCT01474512|69451759|FG013|Maintenance Period|Clinical Relapse|0|||
37806072|NCT01474512|69451760|FG014|Maintenance Period|Clinical Relapse|0|||
37806073|NCT01474512|69451761|FG015|Maintenance Period|Clinical Relapse|0|||
37806074|NCT01474512|69451762|FG016|Maintenance Period|Clinical Relapse|0|||
37806075|NCT01474512|69451763|FG017|Maintenance Period|Clinical Relapse|0|||
37806076|NCT01474512|69451746|FG000|Maintenance Period|Lack of Efficacy|0|||
37806077|NCT01474512|69451747|FG001|Maintenance Period|Lack of Efficacy|0|||
37806078|NCT01474512|69451748|FG002|Maintenance Period|Lack of Efficacy|0|||
37806079|NCT01474512|69451749|FG003|Maintenance Period|Lack of Efficacy|1|||
37806080|NCT01474512|69451750|FG004|Maintenance Period|Lack of Efficacy|0|||
37806081|NCT01474512|69451751|FG005|Maintenance Period|Lack of Efficacy|0|||
37806082|NCT01474512|69451752|FG006|Maintenance Period|Lack of Efficacy|0|||
37806083|NCT01474512|69451753|FG007|Maintenance Period|Lack of Efficacy|11|||
37806084|NCT01474512|69451754|FG008|Maintenance Period|Lack of Efficacy|11|||
37806085|NCT01474512|69451755|FG009|Maintenance Period|Lack of Efficacy|12|||
37806086|NCT01474512|69451756|FG010|Maintenance Period|Lack of Efficacy|0|||
37806087|NCT01474512|69451757|FG011|Maintenance Period|Lack of Efficacy|0|||
37806088|NCT01474512|69451758|FG012|Maintenance Period|Lack of Efficacy|0|||
37806089|NCT01474512|69451759|FG013|Maintenance Period|Lack of Efficacy|0|||
37806090|NCT01474512|69451760|FG014|Maintenance Period|Lack of Efficacy|0|||
37806091|NCT01474512|69451761|FG015|Maintenance Period|Lack of Efficacy|0|||
37806092|NCT01474512|69451762|FG016|Maintenance Period|Lack of Efficacy|0|||
37806093|NCT01474512|69451763|FG017|Maintenance Period|Lack of Efficacy|0|||
37806094|NCT01474512|69451746|FG000|Maintenance Period|Protocol Violation|0|||
37806095|NCT01474512|69451747|FG001|Maintenance Period|Protocol Violation|0|||
37806096|NCT01474512|69451748|FG002|Maintenance Period|Protocol Violation|0|||
37806097|NCT01474512|69451749|FG003|Maintenance Period|Protocol Violation|1|||
37806098|NCT01474512|69451750|FG004|Maintenance Period|Protocol Violation|0|||
37806099|NCT01474512|69451751|FG005|Maintenance Period|Protocol Violation|0|||
37806100|NCT01474512|69451752|FG006|Maintenance Period|Protocol Violation|0|||
37806101|NCT01474512|69451753|FG007|Maintenance Period|Protocol Violation|1|||
37806102|NCT01474512|69451754|FG008|Maintenance Period|Protocol Violation|0|||
37806103|NCT01474512|69451755|FG009|Maintenance Period|Protocol Violation|1|||
37806104|NCT01474512|69451756|FG010|Maintenance Period|Protocol Violation|0|||
37806105|NCT01474512|69451757|FG011|Maintenance Period|Protocol Violation|0|||
37806106|NCT01474512|69451758|FG012|Maintenance Period|Protocol Violation|0|||
37806107|NCT01474512|69451759|FG013|Maintenance Period|Protocol Violation|0|||
37806108|NCT01474512|69451760|FG014|Maintenance Period|Protocol Violation|0|||
37806109|NCT01474512|69451761|FG015|Maintenance Period|Protocol Violation|0|||
37806110|NCT01474512|69451762|FG016|Maintenance Period|Protocol Violation|0|||
37806111|NCT01474512|69451763|FG017|Maintenance Period|Protocol Violation|0|||
37806112|NCT01474512|69451746|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
37806113|NCT01474512|69451747|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
37806114|NCT01474512|69451748|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
37806115|NCT01474512|69451749|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
37806116|NCT01474512|69451750|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
37806117|NCT01474512|69451751|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
37806118|NCT01474512|69451752|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
37806119|NCT01474512|69451753|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
37806120|NCT01474512|69451754|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
37806121|NCT01474512|69451755|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
37806122|NCT01474512|69451756|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
37806123|NCT01474512|69451757|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
37806124|NCT01474512|69451758|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
37806125|NCT01474512|69451759|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
37806126|NCT01474512|69451760|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
37806127|NCT01474512|69451761|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
37806128|NCT01474512|69451762|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
37806129|NCT01474512|69451763|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
37806130|NCT01474512|69451746|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
37806131|NCT01474512|69451747|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
37806132|NCT01474512|69451748|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
37806133|NCT01474512|69451749|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
37806134|NCT01474512|69451750|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
37806135|NCT01474512|69451751|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
37806136|NCT01474512|69451752|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
37806137|NCT01474512|69451753|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
37806138|NCT01474512|69451754|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
37806139|NCT01474512|69451755|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
37806140|NCT01474512|69451756|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
37806141|NCT01474512|69451757|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
37806142|NCT01474512|69451758|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
37806143|NCT01474512|69451759|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
37806144|NCT01474512|69451760|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
37806145|NCT01474512|69451761|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
37806146|NCT01474512|69451762|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
37806147|NCT01474512|69451763|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
37806148|NCT01474512|69451746|FG000|Long-Term Extension Period|Adverse Event|0|||
37806149|NCT01474512|69451747|FG001|Long-Term Extension Period|Adverse Event|0|||
37806150|NCT01474512|69451748|FG002|Long-Term Extension Period|Adverse Event|0|||
37806151|NCT01474512|69451749|FG003|Long-Term Extension Period|Adverse Event|0|||
37806152|NCT01474512|69451750|FG004|Long-Term Extension Period|Adverse Event|0|||
37806153|NCT01474512|69451751|FG005|Long-Term Extension Period|Adverse Event|0|||
37806154|NCT01474512|69451752|FG006|Long-Term Extension Period|Adverse Event|0|||
37806155|NCT01474512|69451753|FG007|Long-Term Extension Period|Adverse Event|0|||
37806156|NCT01474512|69451754|FG008|Long-Term Extension Period|Adverse Event|0|||
37806157|NCT01474512|69451755|FG009|Long-Term Extension Period|Adverse Event|0|||
37806158|NCT01474512|69451756|FG010|Long-Term Extension Period|Adverse Event|0|||
37806159|NCT01474512|69451757|FG011|Long-Term Extension Period|Adverse Event|1|||
37806160|NCT01474512|69451758|FG012|Long-Term Extension Period|Adverse Event|57|||
37806161|NCT01474512|69451759|FG013|Long-Term Extension Period|Adverse Event|58|||
37806162|NCT01474512|69451760|FG014|Long-Term Extension Period|Adverse Event|0|||
37806163|NCT01474512|69451761|FG015|Long-Term Extension Period|Adverse Event|0|||
37806164|NCT01474512|69451762|FG016|Long-Term Extension Period|Adverse Event|0|||
37806165|NCT01474512|69451763|FG017|Long-Term Extension Period|Adverse Event|0|||
37806166|NCT01474512|69451746|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
37806167|NCT01474512|69451747|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
37976017|NCT03966365|69663320|FG000|Overall Study|Protocol Violation|1|||
37976018|NCT03966365|69663321|FG001|Overall Study|Protocol Violation|0|||
37976019|NCT00375219|69663330|FG000|Overall Study|Failure to achieve a response|16|||
37806168|NCT01474512|69451748|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
37806169|NCT01474512|69451749|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
37806170|NCT01474512|69451750|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
37806171|NCT01474512|69451751|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
37806172|NCT01474512|69451752|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
37806173|NCT01474512|69451753|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
37806174|NCT01474512|69451754|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
37806175|NCT01474512|69451755|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
37806176|NCT01474512|69451756|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
37806177|NCT01474512|69451757|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
37806178|NCT01474512|69451758|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
37806179|NCT01474512|69451759|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
37806180|NCT01474512|69451760|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
37806181|NCT01474512|69451761|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
37806182|NCT01474512|69451762|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
37806183|NCT01474512|69451763|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
37806184|NCT01474512|69451746|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
37806185|NCT01474512|69451747|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
37806186|NCT01474512|69451748|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
37806187|NCT01474512|69451749|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
37806188|NCT01474512|69451750|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
37976020|NCT00375219|69663331|FG001|Overall Study|Failure to achieve a response|2|||
37976021|NCT00375219|69663332|FG002|Overall Study|Failure to achieve a response|0|||
37976022|NCT00375219|69663330|FG000|Overall Study|Adverse Event|8|||
37976023|NCT00375219|69663331|FG001|Overall Study|Adverse Event|2|||
37806189|NCT01474512|69451751|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
37806190|NCT01474512|69451752|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
37806191|NCT01474512|69451753|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
37806192|NCT01474512|69451754|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
37806193|NCT01474512|69451755|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
37806194|NCT01474512|69451756|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
37806195|NCT01474512|69451757|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
37806196|NCT01474512|69451758|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
37806197|NCT01474512|69451759|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
37806198|NCT01474512|69451760|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
37806199|NCT01474512|69451761|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
37806200|NCT01474512|69451762|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
37806201|NCT01474512|69451763|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
37806202|NCT01474512|69451746|FG000|Long-Term Extension Period|Physician Decision|0|||
37806203|NCT01474512|69451747|FG001|Long-Term Extension Period|Physician Decision|0|||
37806204|NCT01474512|69451748|FG002|Long-Term Extension Period|Physician Decision|0|||
37806205|NCT01474512|69451749|FG003|Long-Term Extension Period|Physician Decision|0|||
37806206|NCT01474512|69451750|FG004|Long-Term Extension Period|Physician Decision|0|||
37806207|NCT01474512|69451751|FG005|Long-Term Extension Period|Physician Decision|0|||
37976024|NCT00375219|69663332|FG002|Overall Study|Adverse Event|1|||
37806208|NCT01474512|69451752|FG006|Long-Term Extension Period|Physician Decision|0|||
37806209|NCT01474512|69451753|FG007|Long-Term Extension Period|Physician Decision|0|||
37976025|NCT00375219|69663330|FG000|Overall Study|Protocol Violation|1|||
37976026|NCT00375219|69663331|FG001|Overall Study|Protocol Violation|0|||
37806210|NCT01474512|69451754|FG008|Long-Term Extension Period|Physician Decision|0|||
37806211|NCT01474512|69451755|FG009|Long-Term Extension Period|Physician Decision|0|||
37806212|NCT01474512|69451756|FG010|Long-Term Extension Period|Physician Decision|0|||
37806213|NCT01474512|69451757|FG011|Long-Term Extension Period|Physician Decision|0|||
37806214|NCT01474512|69451758|FG012|Long-Term Extension Period|Physician Decision|21|||
37806215|NCT01474512|69451759|FG013|Long-Term Extension Period|Physician Decision|21|||
37806216|NCT01474512|69451760|FG014|Long-Term Extension Period|Physician Decision|0|||
37976027|NCT00375219|69663332|FG002|Overall Study|Protocol Violation|1|||
37976028|NCT00375219|69663330|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
37976029|NCT00375219|69663331|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
37976030|NCT00375219|69663332|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
37976031|NCT00375219|69663330|FG000|Overall Study|Lost to Follow-up|1|||
37976032|NCT00375219|69663331|FG001|Overall Study|Lost to Follow-up|1|||
37976033|NCT00375219|69663332|FG002|Overall Study|Lost to Follow-up|0|||
37976034|NCT00375219|69663330|FG000|Overall Study|Disease progression|18|||
37976035|NCT00375219|69663331|FG001|Overall Study|Disease progression|9|||
37976036|NCT00375219|69663332|FG002|Overall Study|Disease progression|12|||
37976037|NCT00375219|69663330|FG000|Overall Study|Death|4|||
37976038|NCT00375219|69663331|FG001|Overall Study|Death|3|||
37976039|NCT00375219|69663332|FG002|Overall Study|Death|7|||
37976040|NCT00375219|69663330|FG000|Overall Study|Hematologic resistance|1|||
37976041|NCT00375219|69663331|FG001|Overall Study|Hematologic resistance|0|||
37976042|NCT00375219|69663332|FG002|Overall Study|Hematologic resistance|0|||
37806217|NCT01474512|69451761|FG015|Long-Term Extension Period|Physician Decision|0|||
37806218|NCT01474512|69451762|FG016|Long-Term Extension Period|Physician Decision|0|||
37806219|NCT01474512|69451763|FG017|Long-Term Extension Period|Physician Decision|0|||
37806220|NCT01474512|69451746|FG000|Long-Term Extension Period|Clinical Relapse|0|||
37806221|NCT01474512|69451747|FG001|Long-Term Extension Period|Clinical Relapse|0|||
37806222|NCT01474512|69451748|FG002|Long-Term Extension Period|Clinical Relapse|0|||
37806223|NCT01474512|69451749|FG003|Long-Term Extension Period|Clinical Relapse|0|||
37806224|NCT01474512|69451750|FG004|Long-Term Extension Period|Clinical Relapse|0|||
37806225|NCT01474512|69451751|FG005|Long-Term Extension Period|Clinical Relapse|0|||
37806226|NCT01474512|69451752|FG006|Long-Term Extension Period|Clinical Relapse|0|||
37806227|NCT01474512|69451753|FG007|Long-Term Extension Period|Clinical Relapse|0|||
37806228|NCT01474512|69451754|FG008|Long-Term Extension Period|Clinical Relapse|0|||
37806229|NCT01474512|69451755|FG009|Long-Term Extension Period|Clinical Relapse|0|||
37806230|NCT01474512|69451756|FG010|Long-Term Extension Period|Clinical Relapse|0|||
37806231|NCT01474512|69451757|FG011|Long-Term Extension Period|Clinical Relapse|0|||
37806232|NCT01474512|69451758|FG012|Long-Term Extension Period|Clinical Relapse|9|||
37806233|NCT01474512|69451759|FG013|Long-Term Extension Period|Clinical Relapse|9|||
37806234|NCT01474512|69451760|FG014|Long-Term Extension Period|Clinical Relapse|0|||
37806235|NCT01474512|69451761|FG015|Long-Term Extension Period|Clinical Relapse|0|||
37806236|NCT01474512|69451762|FG016|Long-Term Extension Period|Clinical Relapse|0|||
37806237|NCT01474512|69451763|FG017|Long-Term Extension Period|Clinical Relapse|0|||
37806238|NCT01474512|69451746|FG000|Long-Term Extension Period|Death|0|||
37806239|NCT01474512|69451747|FG001|Long-Term Extension Period|Death|0|||
37806240|NCT01474512|69451748|FG002|Long-Term Extension Period|Death|0|||
37806241|NCT01474512|69451749|FG003|Long-Term Extension Period|Death|0|||
37806242|NCT01474512|69451750|FG004|Long-Term Extension Period|Death|0|||
37806243|NCT01474512|69451751|FG005|Long-Term Extension Period|Death|0|||
37806244|NCT01474512|69451752|FG006|Long-Term Extension Period|Death|0|||
37806245|NCT01474512|69451753|FG007|Long-Term Extension Period|Death|0|||
37806246|NCT01474512|69451754|FG008|Long-Term Extension Period|Death|0|||
37806247|NCT01474512|69451755|FG009|Long-Term Extension Period|Death|0|||
37806248|NCT01474512|69451756|FG010|Long-Term Extension Period|Death|0|||
37806249|NCT01474512|69451757|FG011|Long-Term Extension Period|Death|0|||
37806250|NCT01474512|69451758|FG012|Long-Term Extension Period|Death|9|||
37806251|NCT01474512|69451759|FG013|Long-Term Extension Period|Death|9|||
37806252|NCT01474512|69451760|FG014|Long-Term Extension Period|Death|0|||
37806253|NCT01474512|69451761|FG015|Long-Term Extension Period|Death|0|||
37976043|NCT00375219|69663330|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
37976044|NCT00375219|69663331|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
37976045|NCT00375219|69663332|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
37976046|NCT00375219|69663330|FG000|Overall Study|Allograft|2|||
37976047|NCT00375219|69663331|FG001|Overall Study|Allograft|0|||
37976048|NCT00375219|69663332|FG002|Overall Study|Allograft|0|||
37806254|NCT01474512|69451762|FG016|Long-Term Extension Period|Death|0|||
37806255|NCT01474512|69451763|FG017|Long-Term Extension Period|Death|0|||
37806256|NCT01474512|69451746|FG000|Long-Term Extension Period|Sponsor Decision|0|||
37806257|NCT01474512|69451747|FG001|Long-Term Extension Period|Sponsor Decision|0|||
37806258|NCT01474512|69451748|FG002|Long-Term Extension Period|Sponsor Decision|0|||
37806259|NCT01474512|69451749|FG003|Long-Term Extension Period|Sponsor Decision|0|||
37806260|NCT01474512|69451750|FG004|Long-Term Extension Period|Sponsor Decision|0|||
37806261|NCT01474512|69451751|FG005|Long-Term Extension Period|Sponsor Decision|0|||
37806262|NCT01474512|69451752|FG006|Long-Term Extension Period|Sponsor Decision|0|||
37806263|NCT01474512|69451753|FG007|Long-Term Extension Period|Sponsor Decision|0|||
37806264|NCT01474512|69451754|FG008|Long-Term Extension Period|Sponsor Decision|0|||
37806265|NCT01474512|69451755|FG009|Long-Term Extension Period|Sponsor Decision|0|||
37806266|NCT01474512|69451756|FG010|Long-Term Extension Period|Sponsor Decision|0|||
37806267|NCT01474512|69451757|FG011|Long-Term Extension Period|Sponsor Decision|0|||
37806268|NCT01474512|69451758|FG012|Long-Term Extension Period|Sponsor Decision|6|||
37806269|NCT01474512|69451759|FG013|Long-Term Extension Period|Sponsor Decision|6|||
37806270|NCT01474512|69451760|FG014|Long-Term Extension Period|Sponsor Decision|0|||
37806271|NCT01474512|69451761|FG015|Long-Term Extension Period|Sponsor Decision|0|||
37806272|NCT01474512|69451762|FG016|Long-Term Extension Period|Sponsor Decision|0|||
37806273|NCT01474512|69451763|FG017|Long-Term Extension Period|Sponsor Decision|0|||
37806274|NCT01474512|69451746|FG000|Long-Term Extension Period|Protocol Violation|0|||
37806275|NCT01474512|69451747|FG001|Long-Term Extension Period|Protocol Violation|0|||
37806276|NCT01474512|69451748|FG002|Long-Term Extension Period|Protocol Violation|0|||
37806277|NCT01474512|69451749|FG003|Long-Term Extension Period|Protocol Violation|0|||
37806278|NCT01474512|69451750|FG004|Long-Term Extension Period|Protocol Violation|0|||
37806279|NCT01474512|69451751|FG005|Long-Term Extension Period|Protocol Violation|0|||
37806280|NCT01474512|69451752|FG006|Long-Term Extension Period|Protocol Violation|0|||
37806281|NCT01474512|69451753|FG007|Long-Term Extension Period|Protocol Violation|0|||
37806282|NCT01474512|69451754|FG008|Long-Term Extension Period|Protocol Violation|0|||
37806283|NCT01474512|69451755|FG009|Long-Term Extension Period|Protocol Violation|0|||
37806284|NCT01474512|69451756|FG010|Long-Term Extension Period|Protocol Violation|0|||
37806285|NCT01474512|69451757|FG011|Long-Term Extension Period|Protocol Violation|0|||
37806286|NCT01474512|69451758|FG012|Long-Term Extension Period|Protocol Violation|5|||
37806287|NCT01474512|69451759|FG013|Long-Term Extension Period|Protocol Violation|5|||
37806288|NCT01474512|69451760|FG014|Long-Term Extension Period|Protocol Violation|0|||
37806289|NCT01474512|69451761|FG015|Long-Term Extension Period|Protocol Violation|0|||
37806290|NCT01474512|69451762|FG016|Long-Term Extension Period|Protocol Violation|0|||
37864281|NCT00982228|69547910|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
37864282|NCT00982228|69547911|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
37864283|NCT00982228|69547910|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
37806291|NCT01474512|69451763|FG017|Long-Term Extension Period|Protocol Violation|0|||
37806292|NCT01474512|69451746|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
37806293|NCT01474512|69451747|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
37806294|NCT01474512|69451748|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
37806295|NCT01474512|69451749|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
37806296|NCT01474512|69451750|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
37806297|NCT01474512|69451751|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
37806298|NCT01474512|69451752|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
37806299|NCT01474512|69451753|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
37806300|NCT01474512|69451754|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
37806301|NCT01474512|69451755|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
37806302|NCT01474512|69451756|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
37806303|NCT01474512|69451757|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
37806304|NCT01474512|69451758|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
37806305|NCT01474512|69451759|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
37806306|NCT01474512|69451760|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
37806307|NCT01474512|69451761|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
37806308|NCT01474512|69451762|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
37806309|NCT01474512|69451763|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
37806310|NCT01474512|69451746|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
37806311|NCT01474512|69451747|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
37806312|NCT01474512|69451748|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
37806313|NCT01474512|69451749|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
37806314|NCT01474512|69451750|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
37806315|NCT01474512|69451751|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
37806316|NCT01474512|69451752|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
37806317|NCT01474512|69451753|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
37806318|NCT01474512|69451754|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
37976049|NCT00375219|69663330|FG000|Overall Study|Cord blood transplantation|1|||
37976050|NCT00375219|69663331|FG001|Overall Study|Cord blood transplantation|0|||
37976051|NCT00375219|69663332|FG002|Overall Study|Cord blood transplantation|0|||
37806319|NCT01474512|69451755|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
37806320|NCT01474512|69451756|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
37806321|NCT01474512|69451757|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
37806322|NCT01474512|69451758|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
37806323|NCT01474512|69451759|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
37806324|NCT01474512|69451760|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
37806325|NCT01474512|69451761|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
37806326|NCT01474512|69451762|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
37806327|NCT01474512|69451763|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
37806328|NCT01474512|69451746|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
37806329|NCT01474512|69451747|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
37806330|NCT01474512|69451748|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
37806331|NCT01474512|69451749|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
37806332|NCT01474512|69451750|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
37806333|NCT01474512|69451751|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
37806334|NCT01474512|69451752|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
37806335|NCT01474512|69451753|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
37806336|NCT01474512|69451754|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
37806337|NCT01474512|69451755|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
37806338|NCT01474512|69451756|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
37806339|NCT01474512|69451757|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
37806340|NCT01474512|69451758|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
37806341|NCT01474512|69451759|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
37806342|NCT01474512|69451760|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
37806343|NCT01474512|69451761|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
37806344|NCT01474512|69451762|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
37806345|NCT01474512|69451763|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
37806346|NCT01474512|69451746|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
37806347|NCT01474512|69451747|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
37806348|NCT01474512|69451748|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
37806349|NCT01474512|69451749|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
37806350|NCT01474512|69451750|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
37806351|NCT01474512|69451751|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
37806352|NCT01474512|69451752|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
37806353|NCT01474512|69451753|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
37806354|NCT01474512|69451754|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
37806355|NCT01474512|69451755|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
37806356|NCT01474512|69451756|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
37806357|NCT01474512|69451757|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
37806358|NCT01474512|69451758|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
37806359|NCT01474512|69451759|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
37806360|NCT01474512|69451760|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
37806361|NCT01474512|69451761|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
37806362|NCT01474512|69451762|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
37806363|NCT01474512|69451763|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
37976052|NCT00375219|69663330|FG000|Overall Study|Withdrawal by Subject|1|||
37976053|NCT00375219|69663331|FG001|Overall Study|Withdrawal by Subject|0|||
37806364|NCT01474512|69451746|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
37806365|NCT01474512|69451747|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
37976054|NCT00375219|69663332|FG002|Overall Study|Withdrawal by Subject|0|||
37806366|NCT01474512|69451748|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
37806367|NCT01474512|69451749|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
37806368|NCT01474512|69451750|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
37806369|NCT01474512|69451751|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
37806370|NCT01474512|69451752|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
37806371|NCT01474512|69451753|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
37976055|NCT03965351|69663341|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
37806372|NCT01474512|69451754|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
37806373|NCT01474512|69451755|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
37806374|NCT01474512|69451756|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
37806375|NCT01474512|69451757|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
37806376|NCT01474512|69451758|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
37806377|NCT01474512|69451759|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
37806378|NCT01474512|69451760|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
37806379|NCT01474512|69451761|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
37806380|NCT01474512|69451762|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
37806381|NCT01474512|69451763|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
37806382|NCT01474512|69451746|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
37806383|NCT01474512|69451747|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
37806384|NCT01474512|69451748|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
37806385|NCT01474512|69451749|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
37806386|NCT01474512|69451750|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
37806387|NCT01474512|69451751|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
37806388|NCT01474512|69451752|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
37806389|NCT01474512|69451753|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
37976056|NCT03965351|69663342|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
37976057|NCT03965351|69663341|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
37976058|NCT03965351|69663342|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
37976059|NCT00554801|69663350|FG000|Overall Study|left area before completion|5|||
37976060|NCT00554801|69663351|FG001|Overall Study|left area before completion|0|||
37976061|NCT00554801|69663350|FG000|Overall Study|Withdrawal by Subject|14|||
37976062|NCT00554801|69663351|FG001|Overall Study|Withdrawal by Subject|0|||
37976063|NCT00374907|69663361|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
37976064|NCT00374907|69663362|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
37976065|NCT00374907|69663361|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
37976066|NCT00374907|69663362|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
37976067|NCT00374907|69663361|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
37976068|NCT00374907|69663362|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
37806390|NCT01474512|69451754|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
37976069|NCT00374907|69663361|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
37976070|NCT00374907|69663362|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
37976071|NCT00374907|69663361|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
37976072|NCT00374907|69663362|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
37976073|NCT00374127|69663370|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
37976074|NCT00374127|69663370|FG000|Overall Study|Blood could not be drawn.|2|||
37976075|NCT00374127|69663370|FG000|Overall Study|Protocol Violation|5|||
37976076|NCT00374127|69663370|FG000|Overall Study|Pregnancy|1|||
37976077|NCT00553787|69663383|FG000|Overall Study|Adverse Event|34|||
37976078|NCT00553787|69663384|FG001|Overall Study|Adverse Event|21|||
37976079|NCT00553787|69663385|FG002|Overall Study|Adverse Event|67|||
37806391|NCT01474512|69451755|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
37806392|NCT01474512|69451756|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
37806393|NCT01474512|69451757|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
37806394|NCT01474512|69451758|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
37976080|NCT00553787|69663383|FG000|Overall Study|Lost to Follow-up|132|||
37976081|NCT00553787|69663384|FG001|Overall Study|Lost to Follow-up|44|||
37976082|NCT00553787|69663385|FG002|Overall Study|Lost to Follow-up|78|||
37976083|NCT00553787|69663383|FG000|Overall Study|Withdrawal by Subject|151|||
37806395|NCT01474512|69451759|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
37806396|NCT01474512|69451760|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
37806397|NCT01474512|69451761|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
37806398|NCT01474512|69451762|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
37806399|NCT01474512|69451763|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
37806400|NCT01474512|69451746|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
37806401|NCT01474512|69451747|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
37806402|NCT01474512|69451748|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
37806403|NCT01474512|69451749|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
37976084|NCT00553787|69663384|FG001|Overall Study|Withdrawal by Subject|40|||
37806404|NCT01474512|69451750|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
37806405|NCT01474512|69451751|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
37806406|NCT01474512|69451752|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
37976085|NCT00553787|69663385|FG002|Overall Study|Withdrawal by Subject|83|||
37976086|NCT00553787|69663383|FG000|Overall Study|Lack of Efficacy|31|||
37976087|NCT00553787|69663384|FG001|Overall Study|Lack of Efficacy|1|||
37976088|NCT00553787|69663385|FG002|Overall Study|Lack of Efficacy|3|||
37976089|NCT00553787|69663383|FG000|Overall Study|Pregnancy|0|||
37976090|NCT00553787|69663384|FG001|Overall Study|Pregnancy|1|||
37976091|NCT00553787|69663385|FG002|Overall Study|Pregnancy|2|||
37976092|NCT00553787|69663383|FG000|Overall Study|non compliance|4|||
37976093|NCT00553787|69663384|FG001|Overall Study|non compliance|0|||
37976094|NCT00553787|69663385|FG002|Overall Study|non compliance|11|||
37976095|NCT00553787|69663383|FG000|Overall Study|Requirement for restricted medication|8|||
37976096|NCT00553787|69663384|FG001|Overall Study|Requirement for restricted medication|7|||
37976097|NCT00553787|69663385|FG002|Overall Study|Requirement for restricted medication|5|||
37976098|NCT00553787|69663383|FG000|Overall Study|Other|18|||
37976099|NCT00553787|69663384|FG001|Overall Study|Other|10|||
37976100|NCT00553787|69663385|FG002|Overall Study|Other|13|||
37976101|NCT00407745|69663395|FG000|Overall Study|Lack of Efficacy|1|||
37976102|NCT00407745|69663396|FG001|Overall Study|Lack of Efficacy|2|||
37976103|NCT00407745|69663395|FG000|Overall Study|Withdrawal by Subject|3|||
37976104|NCT00407745|69663396|FG001|Overall Study|Withdrawal by Subject|3|||
37976105|NCT00407745|69663395|FG000|Overall Study|Protocol Violation|5|||
37976106|NCT00407745|69663396|FG001|Overall Study|Protocol Violation|3|||
37976107|NCT00407745|69663395|FG000|Overall Study|Adverse Event|8|||
37976108|NCT00407745|69663396|FG001|Overall Study|Adverse Event|8|||
37976109|NCT00407745|69663395|FG000|Overall Study|Other|2|||
37976110|NCT00407745|69663396|FG001|Overall Study|Other|0|||
37976111|NCT00407745|69663395|FG000|Overall Study|Randomized, unknown if treated|0|||
37976112|NCT00407745|69663396|FG001|Overall Study|Randomized, unknown if treated|1|||
37976113|NCT03958955|69663402|FG000|Overall Study|Adverse Event|1|||
37976114|NCT00464334|69663419|FG000|Overall Study|Adverse Event|0|||
37976115|NCT00464334|69663420|FG001|Overall Study|Adverse Event|0|||
37976116|NCT00464334|69663421|FG002|Overall Study|Adverse Event|0|||
37806407|NCT01474512|69451753|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
37806408|NCT01474512|69451754|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
37806409|NCT01474512|69451755|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
37806410|NCT01474512|69451756|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
37806411|NCT01474512|69451757|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
37806412|NCT01474512|69451758|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
37806413|NCT01474512|69451759|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
37806414|NCT01474512|69451760|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
37806415|NCT01474512|69451761|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
37806416|NCT01474512|69451762|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
37806417|NCT01474512|69451763|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
37806418|NCT01474512|69451746|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
37806419|NCT01474512|69451747|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
37806420|NCT01474512|69451748|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
37806421|NCT01474512|69451749|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
37806422|NCT01474512|69451750|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
37806423|NCT01474512|69451751|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
37806424|NCT01474512|69451752|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
37806425|NCT01474512|69451753|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
37806426|NCT01474512|69451754|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
37806427|NCT01474512|69451755|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
37806428|NCT01474512|69451756|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
37806429|NCT01474512|69451757|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
37806430|NCT01474512|69451758|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
37806431|NCT01474512|69451759|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
37806432|NCT01474512|69451760|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
37806433|NCT01474512|69451761|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
37806434|NCT01474512|69451762|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
37806435|NCT01474512|69451763|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
37806436|NCT01474512|69451746|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
37806437|NCT01474512|69451747|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
37976117|NCT00464334|69663422|FG003|Overall Study|Adverse Event|1|||
37976118|NCT00464334|69663423|FG004|Overall Study|Adverse Event|1|||
37976119|NCT00464334|69663424|FG005|Overall Study|Adverse Event|1|||
37976120|NCT00464334|69663425|FG006|Overall Study|Adverse Event|0|||
37976121|NCT00464334|69663426|FG007|Overall Study|Adverse Event|0|||
37976122|NCT00464334|69663427|FG008|Overall Study|Adverse Event|2|||
37806438|NCT01474512|69451748|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
37806439|NCT01474512|69451749|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
37806440|NCT01474512|69451750|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
37976123|NCT00464334|69663428|FG009|Overall Study|Adverse Event|1|||
37976124|NCT00464334|69663429|FG010|Overall Study|Adverse Event|2|||
37806441|NCT01474512|69451751|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
37806442|NCT01474512|69451752|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
37806443|NCT01474512|69451753|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
37806444|NCT01474512|69451754|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
37806445|NCT01474512|69451755|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
37806446|NCT01474512|69451756|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
37806447|NCT01474512|69451757|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
37806448|NCT01474512|69451758|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
37806449|NCT01474512|69451759|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
37806450|NCT01474512|69451760|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
37806451|NCT01474512|69451761|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
37806452|NCT01474512|69451762|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
37806453|NCT01474512|69451763|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
37806454|NCT01474512|69451746|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
37806455|NCT01474512|69451747|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
37806456|NCT01474512|69451748|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
37806457|NCT01474512|69451749|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
37806458|NCT01474512|69451750|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
37806459|NCT01474512|69451751|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
37806460|NCT01474512|69451752|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
37806461|NCT01474512|69451753|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
37806462|NCT01474512|69451754|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
37806463|NCT01474512|69451755|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
37806464|NCT01474512|69451756|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
37806465|NCT01474512|69451757|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
37806466|NCT01474512|69451758|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
37806467|NCT01474512|69451759|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
37806468|NCT01474512|69451760|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
37976125|NCT00464334|69663419|FG000|Overall Study|Lack of Efficacy|0|||
37976126|NCT00464334|69663420|FG001|Overall Study|Lack of Efficacy|1|||
37976127|NCT00464334|69663421|FG002|Overall Study|Lack of Efficacy|0|||
37976128|NCT00464334|69663422|FG003|Overall Study|Lack of Efficacy|0|||
37976129|NCT00464334|69663423|FG004|Overall Study|Lack of Efficacy|0|||
37976130|NCT00464334|69663424|FG005|Overall Study|Lack of Efficacy|0|||
37976131|NCT00464334|69663425|FG006|Overall Study|Lack of Efficacy|0|||
37976132|NCT00464334|69663426|FG007|Overall Study|Lack of Efficacy|0|||
37976133|NCT00464334|69663427|FG008|Overall Study|Lack of Efficacy|0|||
37976134|NCT00464334|69663428|FG009|Overall Study|Lack of Efficacy|0|||
37976135|NCT00464334|69663429|FG010|Overall Study|Lack of Efficacy|0|||
37976136|NCT00464334|69663419|FG000|Overall Study|Lost to Follow-up|0|||
37976137|NCT00464334|69663420|FG001|Overall Study|Lost to Follow-up|0|||
37976138|NCT00464334|69663421|FG002|Overall Study|Lost to Follow-up|1|||
37976139|NCT00464334|69663422|FG003|Overall Study|Lost to Follow-up|0|||
37976140|NCT00464334|69663423|FG004|Overall Study|Lost to Follow-up|1|||
37806469|NCT01474512|69451761|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
37806470|NCT01474512|69451762|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
37864284|NCT00982228|69547911|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
37976141|NCT00464334|69663424|FG005|Overall Study|Lost to Follow-up|0|||
37976142|NCT00464334|69663425|FG006|Overall Study|Lost to Follow-up|1|||
37976143|NCT00464334|69663426|FG007|Overall Study|Lost to Follow-up|0|||
37976144|NCT00464334|69663427|FG008|Overall Study|Lost to Follow-up|0|||
37694029|NCT02460224|69170382|FG005|Overall Study|Adverse Event|0|||
37806471|NCT01474512|69451763|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
37806472|NCT01474512|69451746|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
37806473|NCT01474512|69451747|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
37806474|NCT01474512|69451748|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
37806475|NCT01474512|69451749|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
37806476|NCT01474512|69451750|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
37806477|NCT01474512|69451751|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
37806478|NCT01474512|69451752|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
37806479|NCT01474512|69451753|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
37806480|NCT01474512|69451754|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
37806481|NCT01474512|69451755|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
37806482|NCT01474512|69451756|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
37806483|NCT01474512|69451757|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
37806484|NCT01474512|69451758|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
37806485|NCT01474512|69451759|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
37806486|NCT01474512|69451760|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
37806487|NCT01474512|69451761|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
37806488|NCT01474512|69451762|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
37806489|NCT01474512|69451763|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
37806490|NCT01474512|69451746|FG000|Post-Treatment Follow-Up|Death|0|||
37806491|NCT01474512|69451747|FG001|Post-Treatment Follow-Up|Death|0|||
37806492|NCT01474512|69451748|FG002|Post-Treatment Follow-Up|Death|0|||
37806493|NCT01474512|69451749|FG003|Post-Treatment Follow-Up|Death|0|||
37806494|NCT01474512|69451750|FG004|Post-Treatment Follow-Up|Death|0|||
37806495|NCT01474512|69451751|FG005|Post-Treatment Follow-Up|Death|0|||
37806496|NCT01474512|69451752|FG006|Post-Treatment Follow-Up|Death|0|||
37806497|NCT01474512|69451753|FG007|Post-Treatment Follow-Up|Death|0|||
37806498|NCT01474512|69451754|FG008|Post-Treatment Follow-Up|Death|0|||
37806499|NCT01474512|69451755|FG009|Post-Treatment Follow-Up|Death|0|||
37806500|NCT01474512|69451756|FG010|Post-Treatment Follow-Up|Death|0|||
37806501|NCT01474512|69451757|FG011|Post-Treatment Follow-Up|Death|0|||
37806502|NCT01474512|69451758|FG012|Post-Treatment Follow-Up|Death|0|||
37806503|NCT01474512|69451759|FG013|Post-Treatment Follow-Up|Death|0|||
37806504|NCT01474512|69451760|FG014|Post-Treatment Follow-Up|Death|0|||
37806505|NCT01474512|69451761|FG015|Post-Treatment Follow-Up|Death|0|||
37806506|NCT01474512|69451762|FG016|Post-Treatment Follow-Up|Death|1|||
37806507|NCT01474512|69451763|FG017|Post-Treatment Follow-Up|Death|0|||
37806508|NCT01474434|69451797|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
37806509|NCT01474434|69451798|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
37806510|NCT01474434|69451799|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
37806511|NCT01474434|69451800|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
37806512|NCT01474434|69451797|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
37806513|NCT01474434|69451798|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
37806514|NCT01474434|69451799|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
37806515|NCT01474434|69451800|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
37806516|NCT01474434|69451797|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
37806517|NCT01474434|69451798|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
37806518|NCT01474434|69451799|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
37806519|NCT01474434|69451800|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
37806520|NCT01473732|69451816|FG000|Overall Study|Adverse Event|1|||
37806521|NCT01473732|69451817|FG001|Overall Study|Adverse Event|0|||
37806522|NCT01473732|69451816|FG000|Overall Study|Death|1|||
37806523|NCT01473732|69451817|FG001|Overall Study|Death|0|||
37806524|NCT01450098|69451825|FG000|Period 3|Protocol Violation|0|||
37806525|NCT01450098|69451826|FG001|Period 3|Protocol Violation|1|||
37806526|NCT01450098|69451825|FG000|Period 3|Withdrawal by Subject|0|||
37806527|NCT01450098|69451826|FG001|Period 3|Withdrawal by Subject|2|||
37806528|NCT01449708|69451841|FG000|Overall Study|Protocol Violation|0|||
37806529|NCT01449708|69451842|FG001|Overall Study|Protocol Violation|1|||
37806530|NCT01449708|69451841|FG000|Overall Study|surgical complication|1|||
37806531|NCT01449708|69451842|FG001|Overall Study|surgical complication|2|||
37806532|NCT01449708|69451841|FG000|Overall Study|respiratory failure|1|||
37806533|NCT01449708|69451842|FG001|Overall Study|respiratory failure|0|||
37806534|NCT01449630|69451860|FG000|Period 1|Physician Decision|1|||
37806535|NCT01449630|69451861|FG001|Period 1|Physician Decision|0|||
37806536|NCT01449630|69451862|FG002|Period 1|Physician Decision|0|||
37806537|NCT01449630|69451863|FG003|Period 1|Physician Decision|1|||
37806538|NCT01449630|69451864|FG004|Period 1|Physician Decision|0|||
37806539|NCT01449630|69451865|FG005|Period 1|Physician Decision|0|||
37806540|NCT01449630|69451866|FG006|Period 1|Physician Decision|0|||
37806541|NCT01449630|69451867|FG007|Period 1|Physician Decision|0|||
37806542|NCT01449630|69451868|FG008|Period 1|Physician Decision|0|||
37806543|NCT01449630|69451860|FG000|Period 1|Sponsor Decision|0|||
37806544|NCT01449630|69451861|FG001|Period 1|Sponsor Decision|0|||
37976145|NCT00464334|69663428|FG009|Overall Study|Lost to Follow-up|0|||
37976146|NCT00464334|69663429|FG010|Overall Study|Lost to Follow-up|2|||
37976147|NCT00464334|69663419|FG000|Overall Study|Progressive Disease|0|||
37976148|NCT00464334|69663420|FG001|Overall Study|Progressive Disease|0|||
37976149|NCT00464334|69663421|FG002|Overall Study|Progressive Disease|0|||
37976150|NCT00464334|69663422|FG003|Overall Study|Progressive Disease|0|||
37976151|NCT00464334|69663423|FG004|Overall Study|Progressive Disease|0|||
37976152|NCT00464334|69663424|FG005|Overall Study|Progressive Disease|1|||
37976153|NCT00464334|69663425|FG006|Overall Study|Progressive Disease|0|||
37976154|NCT00464334|69663426|FG007|Overall Study|Progressive Disease|0|||
37976155|NCT00464334|69663427|FG008|Overall Study|Progressive Disease|1|||
37976156|NCT00464334|69663428|FG009|Overall Study|Progressive Disease|0|||
37976157|NCT00464334|69663429|FG010|Overall Study|Progressive Disease|0|||
37976158|NCT00464334|69663419|FG000|Overall Study|Study Terminated by Sponsor|0|||
37976159|NCT00464334|69663420|FG001|Overall Study|Study Terminated by Sponsor|0|||
37976160|NCT00464334|69663421|FG002|Overall Study|Study Terminated by Sponsor|0|||
37976161|NCT00464334|69663422|FG003|Overall Study|Study Terminated by Sponsor|1|||
37976162|NCT00464334|69663423|FG004|Overall Study|Study Terminated by Sponsor|0|||
37976163|NCT00464334|69663424|FG005|Overall Study|Study Terminated by Sponsor|0|||
37976164|NCT00464334|69663425|FG006|Overall Study|Study Terminated by Sponsor|0|||
37976165|NCT00464334|69663426|FG007|Overall Study|Study Terminated by Sponsor|0|||
37976166|NCT00464334|69663427|FG008|Overall Study|Study Terminated by Sponsor|0|||
37976167|NCT00464334|69663428|FG009|Overall Study|Study Terminated by Sponsor|0|||
37976168|NCT00464334|69663429|FG010|Overall Study|Study Terminated by Sponsor|0|||
37976169|NCT00464334|69663419|FG000|Overall Study|Withdrawal by Subject|1|||
37976170|NCT00464334|69663420|FG001|Overall Study|Withdrawal by Subject|7|||
37976171|NCT00464334|69663421|FG002|Overall Study|Withdrawal by Subject|4|||
37976172|NCT00464334|69663422|FG003|Overall Study|Withdrawal by Subject|2|||
37976173|NCT00464334|69663423|FG004|Overall Study|Withdrawal by Subject|2|||
37976174|NCT00464334|69663424|FG005|Overall Study|Withdrawal by Subject|2|||
37976175|NCT00464334|69663425|FG006|Overall Study|Withdrawal by Subject|2|||
37806545|NCT01449630|69451862|FG002|Period 1|Sponsor Decision|0|||
37806546|NCT01449630|69451863|FG003|Period 1|Sponsor Decision|0|||
37806547|NCT01449630|69451864|FG004|Period 1|Sponsor Decision|0|||
37806548|NCT01449630|69451865|FG005|Period 1|Sponsor Decision|1|||
37806549|NCT01449630|69451866|FG006|Period 1|Sponsor Decision|0|||
37806550|NCT01449630|69451867|FG007|Period 1|Sponsor Decision|0|||
37806551|NCT01449630|69451868|FG008|Period 1|Sponsor Decision|0|||
37806552|NCT01449630|69451860|FG000|Period 2|Sponsor Decision|0|||
37806553|NCT01449630|69451861|FG001|Period 2|Sponsor Decision|0|||
37806554|NCT01449630|69451862|FG002|Period 2|Sponsor Decision|0|||
37806555|NCT01449630|69451863|FG003|Period 2|Sponsor Decision|0|||
37806556|NCT01449630|69451864|FG004|Period 2|Sponsor Decision|0|||
37806557|NCT01449630|69451865|FG005|Period 2|Sponsor Decision|0|||
37806558|NCT01449630|69451866|FG006|Period 2|Sponsor Decision|1|||
37806559|NCT01449630|69451867|FG007|Period 2|Sponsor Decision|0|||
37806560|NCT01449630|69451868|FG008|Period 2|Sponsor Decision|0|||
37806561|NCT01493778|69451890|FG000|Overall Study|Withdrawal by Subject|8|||
37806562|NCT01473420|69451905|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
37806563|NCT01473420|69451906|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
37806564|NCT01473420|69451905|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
37806565|NCT01473420|69451906|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
37806566|NCT01473420|69451905|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
37806567|NCT01473420|69451906|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
37806568|NCT01473420|69451905|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
37806569|NCT01473420|69451906|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
37806570|NCT01473420|69451905|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
37806571|NCT01473420|69451906|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
37806572|NCT01473420|69451905|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
37806573|NCT01473420|69451906|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
37806574|NCT01473420|69451905|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
37976176|NCT00464334|69663426|FG007|Overall Study|Withdrawal by Subject|1|||
37976177|NCT00464334|69663427|FG008|Overall Study|Withdrawal by Subject|3|||
37976178|NCT00464334|69663428|FG009|Overall Study|Withdrawal by Subject|0|||
37976179|NCT00464334|69663429|FG010|Overall Study|Withdrawal by Subject|0|||
37976180|NCT00299494|69663470|FG000|Overall Study|Withdrawal by Subject|0|||
37976181|NCT00299494|69663471|FG001|Overall Study|Withdrawal by Subject|0|||
37806575|NCT01473420|69451906|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
37806576|NCT01473420|69451905|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
37806577|NCT01473420|69451906|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
37806578|NCT01473420|69451905|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
37806579|NCT01473420|69451906|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
37806580|NCT01473420|69451905|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
37806581|NCT01473420|69451906|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
37806582|NCT01473420|69451905|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
37806583|NCT01473420|69451906|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
37806584|NCT01473420|69451905|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
37976182|NCT00299494|69663472|FG002|Overall Study|Withdrawal by Subject|0|||
37976183|NCT00299494|69663473|FG003|Overall Study|Withdrawal by Subject|3|||
37976184|NCT00299494|69663474|FG004|Overall Study|Withdrawal by Subject|1|||
37976185|NCT00299494|69663475|FG005|Overall Study|Withdrawal by Subject|4|||
37976186|NCT00299494|69663470|FG000|Overall Study|Physician Decision|0|||
37976187|NCT00299494|69663471|FG001|Overall Study|Physician Decision|0|||
37976188|NCT00299494|69663472|FG002|Overall Study|Physician Decision|0|||
37976189|NCT00299494|69663473|FG003|Overall Study|Physician Decision|0|||
37976190|NCT00299494|69663474|FG004|Overall Study|Physician Decision|1|||
37976191|NCT00299494|69663475|FG005|Overall Study|Physician Decision|0|||
37976192|NCT00299494|69663470|FG000|Overall Study|Death|3|||
37976193|NCT00299494|69663471|FG001|Overall Study|Death|1|||
37976194|NCT00299494|69663472|FG002|Overall Study|Death|4|||
37976195|NCT00299494|69663473|FG003|Overall Study|Death|6|||
37976196|NCT00299494|69663474|FG004|Overall Study|Death|18|||
37976197|NCT00299494|69663475|FG005|Overall Study|Death|19|||
37976198|NCT00299494|69663470|FG000|Overall Study|Lost to Follow-up|0|||
37976199|NCT00299494|69663471|FG001|Overall Study|Lost to Follow-up|0|||
37976200|NCT00299494|69663472|FG002|Overall Study|Lost to Follow-up|0|||
37976201|NCT00299494|69663473|FG003|Overall Study|Lost to Follow-up|0|||
37976202|NCT00299494|69663474|FG004|Overall Study|Lost to Follow-up|3|||
37976203|NCT00299494|69663475|FG005|Overall Study|Lost to Follow-up|1|||
37976204|NCT00299494|69663470|FG000|Overall Study|Other - Unspecified|0|||
37976205|NCT00299494|69663471|FG001|Overall Study|Other - Unspecified|0|||
37976206|NCT00299494|69663472|FG002|Overall Study|Other - Unspecified|0|||
37976207|NCT00299494|69663473|FG003|Overall Study|Other - Unspecified|0|||
37976208|NCT00299494|69663474|FG004|Overall Study|Other - Unspecified|3|||
37976209|NCT00299494|69663475|FG005|Overall Study|Other - Unspecified|1|||
37976210|NCT00299494|69663470|FG000|Overall Study|Other - site closure|0|||
37976211|NCT00299494|69663471|FG001|Overall Study|Other - site closure|0|||
37976212|NCT00299494|69663472|FG002|Overall Study|Other - site closure|0|||
37976213|NCT00299494|69663473|FG003|Overall Study|Other - site closure|1|||
37976214|NCT00299494|69663474|FG004|Overall Study|Other - site closure|1|||
37976215|NCT00299494|69663475|FG005|Overall Study|Other - site closure|1|||
37976216|NCT00453180|69663502|FG000|Overall Study|Lost to Follow-up|2|||
37976217|NCT00453180|69663503|FG001|Overall Study|Lost to Follow-up|1|||
37806585|NCT01473420|69451906|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
37806586|NCT01473420|69451905|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
37806587|NCT01473420|69451906|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
37806588|NCT01492686|69451920|FG000|Double-blind Phase|Adverse Event|0|||
37806589|NCT01492686|69451921|FG001|Double-blind Phase|Adverse Event|2|||
37806590|NCT01492686|69451920|FG000|Double-blind Phase|Physician Decision|0|||
37806591|NCT01492686|69451921|FG001|Double-blind Phase|Physician Decision|1|||
37806592|NCT01492686|69451920|FG000|Double-blind Phase|Withdrawal by Subject|0|||
37806593|NCT01492686|69451921|FG001|Double-blind Phase|Withdrawal by Subject|2|||
37806594|NCT01492686|69451920|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
37806595|NCT01492686|69451921|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
37806596|NCT01492686|69451920|FG000|Open-label Phase|Adverse Event|1|||
37806597|NCT01492686|69451921|FG001|Open-label Phase|Adverse Event|2|||
37806598|NCT01492686|69451920|FG000|Open-label Phase|Physician Decision|1|||
37806599|NCT01492686|69451921|FG001|Open-label Phase|Physician Decision|0|||
37806600|NCT01492686|69451920|FG000|Open-label Phase|Withdrawal by Subject|6|||
37806601|NCT01492686|69451921|FG001|Open-label Phase|Withdrawal by Subject|7|||
37806602|NCT01492686|69451920|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
37806603|NCT01492686|69451921|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
37806604|NCT01449006|69451931|FG000|Overall Study|Lost to Follow-up|1|||
37806605|NCT01449006|69451932|FG001|Overall Study|Lost to Follow-up|0|||
37806606|NCT01449006|69451931|FG000|Overall Study|Withdrawal by Subject|1|||
37976218|NCT00453180|69663502|FG000|Overall Study|Adverse Event|1|||
37694030|NCT02460224|69170383|FG006|Overall Study|Adverse Event|1|||
37976219|NCT00453180|69663503|FG001|Overall Study|Adverse Event|2|||
37976220|NCT00464178|69663509|FG000|Overall Study|Protocol Violation|1|||
37976221|NCT00464178|69663509|FG000|Overall Study|Withdrawal by Subject|1|||
37976222|NCT00560105|69663516|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
37976223|NCT00560105|69663517|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
37976224|NCT00467610|69663523|FG000|Overall Study|Withdrawal by Subject|1|||
37806607|NCT01449006|69451932|FG001|Overall Study|Withdrawal by Subject|0|||
37806608|NCT01449006|69451931|FG000|Overall Study|Protocol Violation|1|||
37806609|NCT01449006|69451932|FG001|Overall Study|Protocol Violation|0|||
37806610|NCT01448850|69451940|FG000|Overall Study|Death|3|||
37976225|NCT00316186|69663527|FG000|Overall Study|Adverse Event|6|||
37976226|NCT00316186|69663527|FG000|Overall Study|Disease Progression|4|||
37976227|NCT00316186|69663527|FG000|Overall Study|Lost to Follow-up|1|||
37806611|NCT01448850|69451941|FG001|Overall Study|Death|6|||
37806612|NCT01448850|69451940|FG000|Overall Study|Withdrawal by Subject|13|||
37806613|NCT01448850|69451941|FG001|Overall Study|Withdrawal by Subject|21|||
37806614|NCT01448850|69451940|FG000|Overall Study|Lost to Follow-up|3|||
37806615|NCT01448850|69451941|FG001|Overall Study|Lost to Follow-up|1|||
37806616|NCT01448850|69451940|FG000|Overall Study|Other|15|||
37806617|NCT01448850|69451941|FG001|Overall Study|Other|12|||
37806618|NCT01491672|69451951|FG000|Overall Study|Lost to Follow-up|0|||
37806619|NCT01491672|69451952|FG001|Overall Study|Lost to Follow-up|4|||
37806620|NCT01491672|69451953|FG002|Overall Study|Lost to Follow-up|1|||
37806621|NCT01491672|69451951|FG000|Overall Study|Withdrawal by Subject|6|||
37806622|NCT01491672|69451952|FG001|Overall Study|Withdrawal by Subject|7|||
37806623|NCT01491672|69451953|FG002|Overall Study|Withdrawal by Subject|0|||
37806624|NCT01491672|69451951|FG000|Overall Study|Adverse Event|8|||
37806625|NCT01491672|69451952|FG001|Overall Study|Adverse Event|10|||
37806626|NCT01491672|69451953|FG002|Overall Study|Adverse Event|4|||
37806627|NCT01491672|69451951|FG000|Overall Study|Disease progression|42|||
37806628|NCT01491672|69451952|FG001|Overall Study|Disease progression|34|||
37806629|NCT01491672|69451953|FG002|Overall Study|Disease progression|6|||
37806630|NCT01491672|69451951|FG000|Overall Study|Protocol deviation|0|||
37806631|NCT01491672|69451952|FG001|Overall Study|Protocol deviation|1|||
37806632|NCT01491672|69451953|FG002|Overall Study|Protocol deviation|0|||
37806633|NCT01491672|69451951|FG000|Overall Study|Death|0|||
37806634|NCT01491672|69451952|FG001|Overall Study|Death|4|||
37806635|NCT01491672|69451953|FG002|Overall Study|Death|0|||
37806636|NCT01447446|69451969|FG000|Overall Study|Death|6|||
37806637|NCT01447446|69451970|FG001|Overall Study|Death|3|||
37806638|NCT01447446|69451971|FG002|Overall Study|Death|2|||
37806639|NCT01447446|69451972|FG003|Overall Study|Death|1|||
37806640|NCT01447446|69451973|FG004|Overall Study|Death|7|||
37806641|NCT01447446|69451974|FG005|Overall Study|Death|0|||
37806642|NCT01447446|69451969|FG000|Overall Study|Adverse Event|3|||
37806643|NCT01447446|69451970|FG001|Overall Study|Adverse Event|0|||
37806644|NCT01447446|69451971|FG002|Overall Study|Adverse Event|1|||
37806645|NCT01447446|69451972|FG003|Overall Study|Adverse Event|0|||
37806646|NCT01447446|69451973|FG004|Overall Study|Adverse Event|2|||
37806647|NCT01447446|69451974|FG005|Overall Study|Adverse Event|0|||
37806648|NCT01447446|69451969|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
37806649|NCT01447446|69451970|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
37806650|NCT01447446|69451971|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
37806651|NCT01447446|69451972|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
37806652|NCT01447446|69451973|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
37806653|NCT01447446|69451974|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
37806654|NCT01447446|69451969|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
37806655|NCT01447446|69451970|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
37806656|NCT01447446|69451971|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
37806657|NCT01447446|69451972|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
37806658|NCT01447446|69451973|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
37806659|NCT01447446|69451974|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
37806660|NCT01447446|69451969|FG000|Overall Study|Administrative/Other|34|||
37806661|NCT01447446|69451970|FG001|Overall Study|Administrative/Other|9|||
37806662|NCT01447446|69451971|FG002|Overall Study|Administrative/Other|10|||
37806663|NCT01447446|69451972|FG003|Overall Study|Administrative/Other|2|||
37806664|NCT01447446|69451973|FG004|Overall Study|Administrative/Other|33|||
37806665|NCT01447446|69451974|FG005|Overall Study|Administrative/Other|4|||
37806666|NCT01447446|69451969|FG000|Overall Study|SVR12 Assessment|13|||
37806667|NCT01447446|69451970|FG001|Overall Study|SVR12 Assessment|1|||
37806668|NCT01447446|69451971|FG002|Overall Study|SVR12 Assessment|2|||
37806669|NCT01447446|69451972|FG003|Overall Study|SVR12 Assessment|1|||
37806670|NCT01447446|69451973|FG004|Overall Study|SVR12 Assessment|5|||
37806671|NCT01447446|69451974|FG005|Overall Study|SVR12 Assessment|5|||
37806672|NCT01447446|69451969|FG000|Overall Study|New Treatment Started|8|||
37806673|NCT01447446|69451970|FG001|Overall Study|New Treatment Started|2|||
37806674|NCT01447446|69451971|FG002|Overall Study|New Treatment Started|1|||
37806675|NCT01447446|69451972|FG003|Overall Study|New Treatment Started|0|||
37806676|NCT01447446|69451973|FG004|Overall Study|New Treatment Started|2|||
37806677|NCT01447446|69451974|FG005|Overall Study|New Treatment Started|0|||
37806678|NCT01447446|69451969|FG000|Overall Study|Reason not Specified|1|||
37806679|NCT01447446|69451970|FG001|Overall Study|Reason not Specified|1|||
37806680|NCT01447446|69451971|FG002|Overall Study|Reason not Specified|1|||
37806681|NCT01447446|69451972|FG003|Overall Study|Reason not Specified|1|||
37806682|NCT01447446|69451973|FG004|Overall Study|Reason not Specified|1|||
37806683|NCT01447446|69451974|FG005|Overall Study|Reason not Specified|0|||
37806684|NCT01490814|69451996|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
37806685|NCT01490814|69451997|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
37806686|NCT01490814|69451996|FG000|Overall Study|Physician Decision|1|||
37806687|NCT01490814|69451997|FG001|Overall Study|Physician Decision|0|||
37806688|NCT01490814|69451996|FG000|Overall Study|Withdrawal by Subject|0|||
37806689|NCT01490814|69451997|FG001|Overall Study|Withdrawal by Subject|5|||
37806690|NCT01471782|69452009|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
37806691|NCT01471782|69452010|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
37806692|NCT01471782|69452011|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
37806693|NCT01471782|69452012|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
37806694|NCT01471782|69452013|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
37806695|NCT01471782|69452014|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
37806696|NCT01471782|69452009|FG000|Overall Study|Lack of Efficacy|1|||
37806697|NCT01471782|69452010|FG001|Overall Study|Lack of Efficacy|2|||
37806698|NCT01471782|69452011|FG002|Overall Study|Lack of Efficacy|1|||
37806699|NCT01471782|69452012|FG003|Overall Study|Lack of Efficacy|1|||
37806700|NCT01471782|69452013|FG004|Overall Study|Lack of Efficacy|5|||
37806701|NCT01471782|69452014|FG005|Overall Study|Lack of Efficacy|18|||
37806702|NCT01471782|69452009|FG000|Overall Study|Adverse Event|1|||
37806703|NCT01471782|69452010|FG001|Overall Study|Adverse Event|1|||
37806704|NCT01471782|69452011|FG002|Overall Study|Adverse Event|2|||
37806705|NCT01471782|69452012|FG003|Overall Study|Adverse Event|2|||
37806706|NCT01471782|69452013|FG004|Overall Study|Adverse Event|3|||
37806707|NCT01471782|69452014|FG005|Overall Study|Adverse Event|1|||
37806708|NCT01471782|69452009|FG000|Overall Study|Other|0|||
37806709|NCT01471782|69452010|FG001|Overall Study|Other|0|||
37806710|NCT01471782|69452011|FG002|Overall Study|Other|1|||
37806711|NCT01471782|69452012|FG003|Overall Study|Other|1|||
37806712|NCT01471782|69452013|FG004|Overall Study|Other|6|||
37806713|NCT01471782|69452014|FG005|Overall Study|Other|5|||
37806714|NCT01471782|69452009|FG000|Overall Study|Change of Chemotherapy|1|||
37806715|NCT01471782|69452010|FG001|Overall Study|Change of Chemotherapy|1|||
37976228|NCT00316186|69663527|FG000|Overall Study|Other|1|||
37976229|NCT00453102|69663531|FG000|Overall Study|Withdrawal by Subject|2|||
37976230|NCT00299182|69663542|FG000|Overall Study|Withdrawal by Subject|0|||
37976231|NCT00299182|69663543|FG001|Overall Study|Withdrawal by Subject|0|||
37976232|NCT00299182|69663544|FG002|Overall Study|Withdrawal by Subject|1|||
37976233|NCT00299182|69663545|FG003|Overall Study|Withdrawal by Subject|0|||
37976234|NCT00299182|69663546|FG004|Overall Study|Withdrawal by Subject|1|||
37976235|NCT00299182|69663547|FG005|Overall Study|Withdrawal by Subject|2|||
37976236|NCT00299182|69663548|FG006|Overall Study|Withdrawal by Subject|0|||
37976237|NCT00299182|69663542|FG000|Overall Study|Chemotherapy Changed|0|||
37976238|NCT00299182|69663543|FG001|Overall Study|Chemotherapy Changed|0|||
37976239|NCT00299182|69663544|FG002|Overall Study|Chemotherapy Changed|1|||
37976240|NCT00299182|69663545|FG003|Overall Study|Chemotherapy Changed|0|||
37976241|NCT00299182|69663546|FG004|Overall Study|Chemotherapy Changed|1|||
37976242|NCT00299182|69663547|FG005|Overall Study|Chemotherapy Changed|0|||
37976243|NCT00299182|69663548|FG006|Overall Study|Chemotherapy Changed|1|||
37976244|NCT00299182|69663542|FG000|Overall Study|Adverse Event|0|||
37976245|NCT00299182|69663543|FG001|Overall Study|Adverse Event|0|||
37976246|NCT00299182|69663544|FG002|Overall Study|Adverse Event|0|||
37976247|NCT00299182|69663545|FG003|Overall Study|Adverse Event|0|||
37864285|NCT00982228|69547910|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
37976248|NCT00299182|69663546|FG004|Overall Study|Adverse Event|0|||
37976249|NCT00299182|69663547|FG005|Overall Study|Adverse Event|1|||
37806716|NCT01471782|69452011|FG002|Overall Study|Change of Chemotherapy|0|||
37806717|NCT01471782|69452012|FG003|Overall Study|Change of Chemotherapy|0|||
37806718|NCT01471782|69452013|FG004|Overall Study|Change of Chemotherapy|1|||
37806719|NCT01471782|69452014|FG005|Overall Study|Change of Chemotherapy|4|||
37806720|NCT01471782|69452009|FG000|Overall Study|Disease Relapse|0|||
37806721|NCT01471782|69452010|FG001|Overall Study|Disease Relapse|0|||
37976250|NCT00299182|69663548|FG006|Overall Study|Adverse Event|0|||
37976251|NCT00299182|69663542|FG000|Overall Study|Not Eligible|0|||
37976252|NCT00299182|69663543|FG001|Overall Study|Not Eligible|0|||
37806722|NCT01471782|69452011|FG002|Overall Study|Disease Relapse|0|||
37806723|NCT01471782|69452012|FG003|Overall Study|Disease Relapse|1|||
37806724|NCT01471782|69452013|FG004|Overall Study|Disease Relapse|2|||
37806725|NCT01471782|69452014|FG005|Overall Study|Disease Relapse|1|||
37806726|NCT01471782|69452009|FG000|Overall Study|Physician Decision|0|||
37806727|NCT01471782|69452010|FG001|Overall Study|Physician Decision|0|||
37806728|NCT01471782|69452011|FG002|Overall Study|Physician Decision|0|||
37806729|NCT01471782|69452012|FG003|Overall Study|Physician Decision|0|||
37806730|NCT01471782|69452013|FG004|Overall Study|Physician Decision|3|||
37806731|NCT01471782|69452014|FG005|Overall Study|Physician Decision|8|||
37806732|NCT01471782|69452009|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
37806733|NCT01471782|69452010|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
37806734|NCT01471782|69452011|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
37806735|NCT01471782|69452012|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
37806736|NCT01471782|69452013|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
37806737|NCT01471782|69452014|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
37806738|NCT01471782|69452009|FG000|Overall Study|Death|0|||
37806739|NCT01471782|69452010|FG001|Overall Study|Death|0|||
37806740|NCT01471782|69452011|FG002|Overall Study|Death|0|||
37806741|NCT01471782|69452012|FG003|Overall Study|Death|0|||
37976253|NCT00299182|69663544|FG002|Overall Study|Not Eligible|0|||
37976254|NCT00299182|69663545|FG003|Overall Study|Not Eligible|0|||
37976255|NCT00299182|69663546|FG004|Overall Study|Not Eligible|1|||
37976256|NCT00299182|69663547|FG005|Overall Study|Not Eligible|0|||
37976257|NCT00299182|69663548|FG006|Overall Study|Not Eligible|0|||
37976258|NCT00467142|69663566|FG000|Overall Study|Withdrawal by Subject|1|||
37976259|NCT00467142|69663566|FG000|Overall Study|Adverse Event|1|||
37976260|NCT00467142|69663566|FG000|Overall Study|Protocol Violation|1|||
37976261|NCT00553475|69663573|FG000|Overall Study|Adverse Event|7|||
37976262|NCT00553475|69663574|FG001|Overall Study|Adverse Event|17|||
37976263|NCT00553475|69663575|FG002|Overall Study|Adverse Event|13|||
37976264|NCT00553475|69663573|FG000|Overall Study|Lack of Efficacy|7|||
37976265|NCT00553475|69663574|FG001|Overall Study|Lack of Efficacy|1|||
37976266|NCT00553475|69663575|FG002|Overall Study|Lack of Efficacy|0|||
37976267|NCT00553475|69663573|FG000|Overall Study|Withdrawal by Subject|1|||
37976268|NCT00553475|69663574|FG001|Overall Study|Withdrawal by Subject|1|||
37976269|NCT00553475|69663575|FG002|Overall Study|Withdrawal by Subject|0|||
37976270|NCT00553475|69663573|FG000|Overall Study|Physician Decision|1|||
37976271|NCT00553475|69663574|FG001|Overall Study|Physician Decision|0|||
37976272|NCT00553475|69663575|FG002|Overall Study|Physician Decision|0|||
37976273|NCT00553475|69663573|FG000|Overall Study|Due to moving|0|||
37976274|NCT00553475|69663574|FG001|Overall Study|Due to moving|1|||
37976275|NCT00553475|69663575|FG002|Overall Study|Due to moving|0|||
37976276|NCT00329602|69663587|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
37806742|NCT01471782|69452013|FG004|Overall Study|Death|0|||
37806743|NCT01471782|69452014|FG005|Overall Study|Death|1|||
37806744|NCT01490580|69452041|FG000|Overall Study|Parents withdrew consent|0|||
37806745|NCT01490580|69452042|FG001|Overall Study|Parents withdrew consent|2|||
37806746|NCT01490190|69452052|FG000|Overall Study|Withdrawal by Subject|9|||
37806747|NCT01490190|69452052|FG000|Overall Study|Adverse Event|17|||
37806748|NCT01490190|69452052|FG000|Overall Study|Protocol Violation|5|||
37806749|NCT01490190|69452052|FG000|Overall Study|Lost to Follow-up|13|||
37806750|NCT01490190|69452052|FG000|Overall Study|Relocation|1|||
37806751|NCT01490190|69452052|FG000|Overall Study|Inconvenience|1|||
37806752|NCT01490190|69452052|FG000|Overall Study|Ring expulsion|2|||
37806753|NCT01446042|69452059|FG000|Overall Study|Withdrawal by Subject|12|||
37806754|NCT01446042|69452060|FG001|Overall Study|Withdrawal by Subject|2|||
37806755|NCT01446042|69452061|FG002|Overall Study|Withdrawal by Subject|4|||
37806756|NCT01446042|69452059|FG000|Overall Study|Adverse Event|1|||
37806757|NCT01446042|69452060|FG001|Overall Study|Adverse Event|0|||
37864286|NCT00982228|69547911|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
37806758|NCT01446042|69452061|FG002|Overall Study|Adverse Event|4|||
37806759|NCT01446042|69452059|FG000|Overall Study|Lost to Follow-up|5|||
37806760|NCT01446042|69452060|FG001|Overall Study|Lost to Follow-up|0|||
37806761|NCT01446042|69452061|FG002|Overall Study|Lost to Follow-up|0|||
37806762|NCT01446042|69452059|FG000|Overall Study|Other reasons|2|||
37806763|NCT01446042|69452060|FG001|Overall Study|Other reasons|1|||
37806764|NCT01446042|69452061|FG002|Overall Study|Other reasons|1|||
37806765|NCT01445886|69452069|FG000|Overall Study|Lost to Follow-up|2|||
37806766|NCT01445886|69452069|FG000|Overall Study|Protocol Violation|3|||
37806767|NCT01470612|69452077|FG000|Overall Study|Adverse Event|20|||
37806768|NCT01470612|69452078|FG001|Overall Study|Adverse Event|80|||
37976277|NCT00329602|69663588|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
37976278|NCT00329602|69663589|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
37976279|NCT00329602|69663587|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
37976280|NCT00329602|69663588|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
37976281|NCT00329602|69663589|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
37976282|NCT00329602|69663587|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
37976283|NCT00329602|69663588|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
37976284|NCT00329602|69663589|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
37976285|NCT00329602|69663587|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
37976286|NCT00329602|69663588|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
37976287|NCT00329602|69663589|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
37976288|NCT00329602|69663587|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
37806769|NCT01470612|69452077|FG000|Overall Study|Death|0|||
37806770|NCT01470612|69452078|FG001|Overall Study|Death|1|||
37806771|NCT01470612|69452077|FG000|Overall Study|Lack of Efficacy|20|||
37806772|NCT01470612|69452078|FG001|Overall Study|Lack of Efficacy|326|||
37806773|NCT01470612|69452077|FG000|Overall Study|Lost to Follow-up|2|||
37806774|NCT01470612|69452078|FG001|Overall Study|Lost to Follow-up|5|||
37806775|NCT01470612|69452077|FG000|Overall Study|Did not meet entrance criteria|0|||
37806776|NCT01470612|69452078|FG001|Overall Study|Did not meet entrance criteria|1|||
37806777|NCT01470612|69452077|FG000|Overall Study|Pregnancy|2|||
37806778|NCT01470612|69452078|FG001|Overall Study|Pregnancy|10|||
37806779|NCT01470612|69452077|FG000|Overall Study|Protocol Violation|2|||
37806780|NCT01470612|69452078|FG001|Overall Study|Protocol Violation|7|||
37806781|NCT01470612|69452077|FG000|Overall Study|Withdrawal by Subject|24|||
37806782|NCT01470612|69452078|FG001|Overall Study|Withdrawal by Subject|79|||
37806783|NCT01470612|69452077|FG000|Overall Study|Other|14|||
37806784|NCT01470612|69452078|FG001|Overall Study|Other|156|||
37806785|NCT01445730|69452084|FG000|Overall Study|Adverse Event|1|||
37806786|NCT01445730|69452084|FG000|Overall Study|For the advice of a dentist|1|||
37806787|NCT01445730|69452084|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
37806788|NCT01445652|69452090|FG000|Overall Study|Not comfortable in lenses|5|||
37806789|NCT01445652|69452091|FG001|Overall Study|Not comfortable in lenses|0|||
37806790|NCT01445652|69452090|FG000|Overall Study|Failed to attend scheduled visit|2|||
37806791|NCT01445652|69452091|FG001|Overall Study|Failed to attend scheduled visit|3|||
37806792|NCT01445652|69452090|FG000|Overall Study|Failed teach session|2|||
37806793|NCT01445652|69452091|FG001|Overall Study|Failed teach session|0|||
37806794|NCT01445652|69452090|FG000|Overall Study|Adverse Event|1|||
37806795|NCT01445652|69452091|FG001|Overall Study|Adverse Event|0|||
37806796|NCT01470144|69452097|FG000|Overall Study|Adverse Event|2|||
37806797|NCT01470144|69452097|FG000|Overall Study|Death|1|||
37806798|NCT01470144|69452097|FG000|Overall Study|Lung transplant|6|||
37806799|NCT01470144|69452097|FG000|Overall Study|Patient's and investigator's decision|1|||
37806800|NCT01443858|69452104|FG000|Overall Study|Withdrawal by Subject|9|||
37806801|NCT01443858|69452105|FG001|Overall Study|Withdrawal by Subject|8|||
37806802|NCT01443858|69452106|FG002|Overall Study|Withdrawal by Subject|5|||
37806803|NCT01443858|69452104|FG000|Overall Study|Lack of Efficacy|1|||
37806804|NCT01443858|69452105|FG001|Overall Study|Lack of Efficacy|0|||
37806805|NCT01443858|69452106|FG002|Overall Study|Lack of Efficacy|0|||
37806806|NCT01443858|69452104|FG000|Overall Study|Lost to Follow-up|5|||
37806807|NCT01443858|69452105|FG001|Overall Study|Lost to Follow-up|5|||
37806808|NCT01443858|69452106|FG002|Overall Study|Lost to Follow-up|2|||
37806809|NCT01443078|69452114|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
37806810|NCT01443078|69452114|FG000|Overall Study|Withdrawal by Subject|1|||
37806811|NCT01443078|69452114|FG000|Overall Study|Patient had brain mets|1|||
37806812|NCT01439880|69452120|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
37806813|NCT01439880|69452121|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
37806814|NCT01439880|69452120|FG000|SOC-controlled Period (Year 1)|Death|2|||
37806815|NCT01439880|69452121|FG001|SOC-controlled Period (Year 1)|Death|1|||
37806816|NCT01439880|69452120|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
37806817|NCT01439880|69452121|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
37806818|NCT01439880|69452120|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
37806819|NCT01439880|69452121|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
37976289|NCT00329602|69663588|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
37976290|NCT00329602|69663589|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
37806820|NCT01439880|69452120|FG000|SOC-controlled Period (Year 1)|Other|8|||
37806821|NCT01439880|69452121|FG001|SOC-controlled Period (Year 1)|Other|13|||
37806822|NCT01439880|69452120|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
37806823|NCT01439880|69452121|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
37976291|NCT00329602|69663587|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
37976292|NCT00329602|69663588|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
37806824|NCT01439880|69452120|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
37806825|NCT01439880|69452121|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
37806826|NCT01439880|69452120|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
37976293|NCT00329602|69663589|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
37976294|NCT00463866|69663607|FG000|Overall Study|Adverse Event|70|||
37806827|NCT01439880|69452121|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
37806828|NCT01439880|69452120|FG000|All-IP Period (Years 2 to 5)|Death|3|||
37806829|NCT01439880|69452121|FG001|All-IP Period (Years 2 to 5)|Death|13|||
37806830|NCT01439880|69452120|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
37806831|NCT01439880|69452121|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
37806832|NCT01439880|69452120|FG000|All-IP Period (Years 2 to 5)|Other|14|||
37806833|NCT01439880|69452121|FG001|All-IP Period (Years 2 to 5)|Other|31|||
37806834|NCT01439880|69452120|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
37806835|NCT01439880|69452121|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
37806836|NCT01469364|69452138|FG000|Overall Study|Adverse Event|1|||
37806837|NCT01469364|69452138|FG000|Overall Study|Withdrawal by Subject|1|||
37806838|NCT01439724|69452144|FG000|Overall Study|missing consultation|9|||
37806839|NCT01439724|69452145|FG001|Overall Study|missing consultation|8|||
37806840|NCT01439568|69452153|FG000|Overall Study|Lost to Follow-up|1|||
37806841|NCT01439568|69452154|FG001|Overall Study|Lost to Follow-up|0|||
37806842|NCT01439568|69452153|FG000|Overall Study|Withdrawal by Subject|2|||
37806843|NCT01439568|69452154|FG001|Overall Study|Withdrawal by Subject|2|||
37806844|NCT01469052|69452166|FG000|Overall Study|Adverse Event|2|||
37806845|NCT01469052|69452167|FG001|Overall Study|Adverse Event|3|||
37806846|NCT01469052|69452168|FG002|Overall Study|Adverse Event|0|||
37806847|NCT01469052|69452169|FG003|Overall Study|Adverse Event|2|||
37806848|NCT01469052|69452170|FG004|Overall Study|Adverse Event|0|||
37806849|NCT01469052|69452171|FG005|Overall Study|Adverse Event|1|||
37806850|NCT01469052|69452166|FG000|Overall Study|Progressive disease|3|||
37806851|NCT01469052|69452167|FG001|Overall Study|Progressive disease|0|||
37806852|NCT01469052|69452168|FG002|Overall Study|Progressive disease|5|||
37806853|NCT01469052|69452169|FG003|Overall Study|Progressive disease|3|||
37806854|NCT01469052|69452170|FG004|Overall Study|Progressive disease|7|||
37806855|NCT01469052|69452171|FG005|Overall Study|Progressive disease|2|||
37806856|NCT01469052|69452166|FG000|Overall Study|Lack of Efficacy|0|||
37806857|NCT01469052|69452167|FG001|Overall Study|Lack of Efficacy|0|||
37806858|NCT01469052|69452168|FG002|Overall Study|Lack of Efficacy|0|||
37806859|NCT01469052|69452169|FG003|Overall Study|Lack of Efficacy|0|||
37806860|NCT01469052|69452170|FG004|Overall Study|Lack of Efficacy|0|||
37806861|NCT01469052|69452171|FG005|Overall Study|Lack of Efficacy|2|||
37806862|NCT01469052|69452166|FG000|Overall Study|Moved to rollover protocol|1|||
37806863|NCT01469052|69452167|FG001|Overall Study|Moved to rollover protocol|0|||
37806864|NCT01469052|69452168|FG002|Overall Study|Moved to rollover protocol|1|||
37806865|NCT01469052|69452169|FG003|Overall Study|Moved to rollover protocol|0|||
37806866|NCT01469052|69452170|FG004|Overall Study|Moved to rollover protocol|0|||
37806867|NCT01469052|69452171|FG005|Overall Study|Moved to rollover protocol|1|||
37806868|NCT01469052|69452166|FG000|Overall Study|Other|0|||
37806869|NCT01469052|69452167|FG001|Overall Study|Other|1|||
37806870|NCT01469052|69452168|FG002|Overall Study|Other|0|||
37806871|NCT01469052|69452169|FG003|Overall Study|Other|0|||
37806872|NCT01469052|69452170|FG004|Overall Study|Other|1|||
37806873|NCT01469052|69452171|FG005|Overall Study|Other|0|||
37806874|NCT01468818|69452183|FG000|Overall Study|Death during treatment|2|||
37806875|NCT01442376|69452190|FG000|Overall Study|Adverse Event|0|||
37806876|NCT01442376|69452191|FG001|Overall Study|Adverse Event|3|||
37806877|NCT01442376|69452192|FG002|Overall Study|Adverse Event|2|||
37806878|NCT01442376|69452190|FG000|Overall Study|Death|0|||
37806879|NCT01442376|69452191|FG001|Overall Study|Death|1|||
37806880|NCT01442376|69452192|FG002|Overall Study|Death|1|||
37806881|NCT01442376|69452190|FG000|Overall Study|Withdrawal of consent|0|||
37806882|NCT01442376|69452191|FG001|Overall Study|Withdrawal of consent|0|||
37806883|NCT01442376|69452192|FG002|Overall Study|Withdrawal of consent|1|||
37806884|NCT01442376|69452190|FG000|Overall Study|Patients not treated|2|||
37806885|NCT01442376|69452191|FG001|Overall Study|Patients not treated|3|||
37806886|NCT01442376|69452192|FG002|Overall Study|Patients not treated|1|||
37806887|NCT01442376|69452190|FG000|Overall Study|Not eligible for subsequent cycles|1|||
37806888|NCT01442376|69452191|FG001|Overall Study|Not eligible for subsequent cycles|2|||
37806889|NCT01442376|69452192|FG002|Overall Study|Not eligible for subsequent cycles|0|||
37806890|NCT01442064|69452206|FG000|Overall Study|Adverse Event|2|||
37806891|NCT01442064|69452207|FG001|Overall Study|Adverse Event|2|||
37806892|NCT01442064|69452208|FG002|Overall Study|Adverse Event|2|||
37806893|NCT01442064|69452209|FG003|Overall Study|Adverse Event|1|||
37806894|NCT01442064|69452210|FG004|Overall Study|Adverse Event|2|||
37806895|NCT01442064|69452211|FG005|Overall Study|Adverse Event|0|||
37806896|NCT01442064|69452206|FG000|Overall Study|Death|0|||
37806897|NCT01442064|69452207|FG001|Overall Study|Death|1|||
37806898|NCT01442064|69452208|FG002|Overall Study|Death|3|||
37806899|NCT01442064|69452209|FG003|Overall Study|Death|3|||
37806900|NCT01442064|69452210|FG004|Overall Study|Death|1|||
37806901|NCT01442064|69452211|FG005|Overall Study|Death|3|||
37806902|NCT01442064|69452206|FG000|Overall Study|Lost to Follow-up|5|||
37806903|NCT01442064|69452207|FG001|Overall Study|Lost to Follow-up|5|||
37806904|NCT01442064|69452208|FG002|Overall Study|Lost to Follow-up|1|||
37806905|NCT01442064|69452209|FG003|Overall Study|Lost to Follow-up|1|||
37806906|NCT01442064|69452210|FG004|Overall Study|Lost to Follow-up|3|||
37806907|NCT01442064|69452211|FG005|Overall Study|Lost to Follow-up|3|||
37806908|NCT01442064|69452206|FG000|Overall Study|Physician Decision|1|||
37806909|NCT01442064|69452207|FG001|Overall Study|Physician Decision|1|||
37806910|NCT01442064|69452208|FG002|Overall Study|Physician Decision|2|||
37806911|NCT01442064|69452209|FG003|Overall Study|Physician Decision|3|||
37806912|NCT01442064|69452210|FG004|Overall Study|Physician Decision|3|||
37806913|NCT01442064|69452211|FG005|Overall Study|Physician Decision|1|||
37806914|NCT01442064|69452206|FG000|Overall Study|Withdrawal by Subject|6|||
37806915|NCT01442064|69452207|FG001|Overall Study|Withdrawal by Subject|3|||
37806916|NCT01442064|69452208|FG002|Overall Study|Withdrawal by Subject|2|||
37806917|NCT01442064|69452209|FG003|Overall Study|Withdrawal by Subject|2|||
37806918|NCT01442064|69452210|FG004|Overall Study|Withdrawal by Subject|2|||
37806919|NCT01442064|69452211|FG005|Overall Study|Withdrawal by Subject|1|||
37806920|NCT01442064|69452206|FG000|Overall Study|Sponsor decision|82|||
37806921|NCT01442064|69452207|FG001|Overall Study|Sponsor decision|88|||
37806922|NCT01442064|69452208|FG002|Overall Study|Sponsor decision|92|||
37806923|NCT01442064|69452209|FG003|Overall Study|Sponsor decision|88|||
37806924|NCT01442064|69452210|FG004|Overall Study|Sponsor decision|95|||
37806925|NCT01442064|69452211|FG005|Overall Study|Sponsor decision|87|||
37806926|NCT01442064|69452206|FG000|Overall Study|Subject non-compliance|0|||
37806927|NCT01442064|69452207|FG001|Overall Study|Subject non-compliance|0|||
37806928|NCT01442064|69452208|FG002|Overall Study|Subject non-compliance|0|||
37806929|NCT01442064|69452209|FG003|Overall Study|Subject non-compliance|0|||
37806930|NCT01442064|69452210|FG004|Overall Study|Subject non-compliance|0|||
37806931|NCT01442064|69452211|FG005|Overall Study|Subject non-compliance|2|||
37806932|NCT01442064|69452206|FG000|Overall Study|Condition mandated other intervention|1|||
37806933|NCT01442064|69452207|FG001|Overall Study|Condition mandated other intervention|1|||
37806934|NCT01442064|69452208|FG002|Overall Study|Condition mandated other intervention|2|||
37806935|NCT01442064|69452209|FG003|Overall Study|Condition mandated other intervention|0|||
37806936|NCT01442064|69452210|FG004|Overall Study|Condition mandated other intervention|0|||
37806937|NCT01442064|69452211|FG005|Overall Study|Condition mandated other intervention|2|||
37806938|NCT01467960|69452234|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
37806939|NCT01467960|69452235|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
37806940|NCT01467960|69452236|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
37806941|NCT01467960|69452237|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
37806942|NCT01467960|69452238|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
37806943|NCT01467960|69452239|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
37806944|NCT01441596|69452256|FG000|Overall Study|Other reason not defined below|0|||
37806945|NCT01441596|69452257|FG001|Overall Study|Other reason not defined below|2|||
37806946|NCT01441596|69452258|FG002|Overall Study|Other reason not defined below|1|||
37806947|NCT01441596|69452256|FG000|Overall Study|Withdrawal by Subject|4|||
37806948|NCT01441596|69452257|FG001|Overall Study|Withdrawal by Subject|0|||
37806949|NCT01441596|69452258|FG002|Overall Study|Withdrawal by Subject|2|||
37806950|NCT01441596|69452256|FG000|Overall Study|Not treated|0|||
37806951|NCT01441596|69452257|FG001|Overall Study|Not treated|1|||
37976295|NCT00463866|69663608|FG001|Overall Study|Adverse Event|93|||
37806952|NCT01441596|69452258|FG002|Overall Study|Not treated|1|||
37806953|NCT01441440|69452269|FG000|Overall Study|Death|1|||
37806954|NCT01441440|69452270|FG001|Overall Study|Death|0|||
37806955|NCT01441440|69452271|FG002|Overall Study|Death|1|||
37806956|NCT01441440|69452269|FG000|Overall Study|Adverse Event|2|||
37806957|NCT01441440|69452270|FG001|Overall Study|Adverse Event|9|||
37806958|NCT01441440|69452271|FG002|Overall Study|Adverse Event|9|||
37806959|NCT01441440|69452269|FG000|Overall Study|Lost to Follow-up|0|||
37806960|NCT01441440|69452270|FG001|Overall Study|Lost to Follow-up|2|||
37806961|NCT01441440|69452271|FG002|Overall Study|Lost to Follow-up|1|||
37806962|NCT01441440|69452269|FG000|Overall Study|Withdrawal by Subject|11|||
37806963|NCT01441440|69452270|FG001|Overall Study|Withdrawal by Subject|9|||
37806964|NCT01441440|69452271|FG002|Overall Study|Withdrawal by Subject|9|||
37806965|NCT01441440|69452269|FG000|Overall Study|Pregnancy|1|||
37806966|NCT01441440|69452270|FG001|Overall Study|Pregnancy|0|||
37806967|NCT01441440|69452271|FG002|Overall Study|Pregnancy|0|||
37806968|NCT01441440|69452269|FG000|Overall Study|Lack of Efficacy|1|||
37806969|NCT01441440|69452270|FG001|Overall Study|Lack of Efficacy|0|||
37806970|NCT01441440|69452271|FG002|Overall Study|Lack of Efficacy|1|||
37806971|NCT01441440|69452269|FG000|Overall Study|Moving|0|||
37806972|NCT01441440|69452270|FG001|Overall Study|Moving|1|||
37806973|NCT01441440|69452271|FG002|Overall Study|Moving|1|||
37806974|NCT01441440|69452269|FG000|Overall Study|Work-related matter|0|||
37806975|NCT01441440|69452270|FG001|Overall Study|Work-related matter|1|||
37806976|NCT01441440|69452271|FG002|Overall Study|Work-related matter|0|||
37806977|NCT01441440|69452269|FG000|Overall Study|Difficllty in keeping the schedule|1|||
37806978|NCT01441440|69452270|FG001|Overall Study|Difficllty in keeping the schedule|1|||
37806979|NCT01441440|69452271|FG002|Overall Study|Difficllty in keeping the schedule|0|||
37806980|NCT01438476|69452281|FG000|Overall Study|Protocol Violation|1|||
37806981|NCT01438476|69452282|FG001|Overall Study|Protocol Violation|0|||
37806982|NCT01438476|69452281|FG000|Overall Study|Withdrawal by Subject|1|||
37806983|NCT01438476|69452282|FG001|Overall Study|Withdrawal by Subject|0|||
37806984|NCT01438476|69452281|FG000|Overall Study|No Surgery- Disease|8|||
37806985|NCT01438476|69452282|FG001|Overall Study|No Surgery- Disease|10|||
37806986|NCT01438476|69452281|FG000|Overall Study|Communication barrier|0|||
37806987|NCT01438476|69452282|FG001|Overall Study|Communication barrier|1|||
37806988|NCT01467570|69452290|FG000|Overall Study|Lost to Follow-up|8|||
37806989|NCT01467570|69452291|FG001|Overall Study|Lost to Follow-up|9|||
37806990|NCT01437540|69452301|FG000|Overall Study|Not listed below|7|||
37806991|NCT01437540|69452302|FG001|Overall Study|Not listed below|6|||
37806992|NCT01437540|69452301|FG000|Overall Study|COPD exacerbation|13|||
37806993|NCT01437540|69452302|FG001|Overall Study|COPD exacerbation|3|||
37806994|NCT01437540|69452301|FG000|Overall Study|Lost to Follow-up|3|||
37806995|NCT01437540|69452302|FG001|Overall Study|Lost to Follow-up|5|||
37806996|NCT01437540|69452301|FG000|Overall Study|Lack of Efficacy|23|||
37806997|NCT01437540|69452302|FG001|Overall Study|Lack of Efficacy|11|||
37806998|NCT01437540|69452301|FG000|Overall Study|Protocol Violation|24|||
37806999|NCT01437540|69452302|FG001|Overall Study|Protocol Violation|12|||
37807000|NCT01437540|69452301|FG000|Overall Study|Adverse Event|26|||
37807001|NCT01437540|69452302|FG001|Overall Study|Adverse Event|13|||
37807002|NCT01437540|69452301|FG000|Overall Study|Withdrawal by Subject|31|||
37807003|NCT01437540|69452302|FG001|Overall Study|Withdrawal by Subject|15|||
37807004|NCT01440972|69452310|FG000|Overall Study|Withdrawal by Subject|3|||
37807005|NCT01440972|69452311|FG001|Overall Study|Withdrawal by Subject|2|||
37807006|NCT01420536|69452319|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
37807007|NCT01420536|69452320|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
37807008|NCT01420068|69452330|FG000|Overall Study|Administrative problems|1|||
37807009|NCT01420068|69452331|FG001|Overall Study|Administrative problems|3|||
37807010|NCT01420068|69452330|FG000|Overall Study|Withdrawal by Subject|1|||
37807011|NCT01420068|69452331|FG001|Overall Study|Withdrawal by Subject|2|||
37807012|NCT01467492|69452339|FG000|Overall Study|Withdrawal by Subject|6|||
37807013|NCT01467492|69452340|FG001|Overall Study|Withdrawal by Subject|4|||
37807014|NCT01467492|69452339|FG000|Overall Study|Study Terminated by Sponsor|6|||
37807015|NCT01467492|69452340|FG001|Overall Study|Study Terminated by Sponsor|4|||
37807016|NCT01467492|69452339|FG000|Overall Study|Adverse Event|4|||
37807017|NCT01467492|69452340|FG001|Overall Study|Adverse Event|3|||
37807018|NCT01467492|69452339|FG000|Overall Study|Lost to Follow-up|3|||
37807019|NCT01467492|69452340|FG001|Overall Study|Lost to Follow-up|2|||
37807020|NCT01467492|69452339|FG000|Overall Study|Undefined|2|||
37807021|NCT01467492|69452340|FG001|Overall Study|Undefined|0|||
37807022|NCT01467492|69452339|FG000|Overall Study|Enrolled But Not Treated|1|||
37807023|NCT01467492|69452340|FG001|Overall Study|Enrolled But Not Treated|0|||
37807024|NCT01466790|69452355|FG000|Overall Study|Adverse Event|1|||
37807025|NCT01466790|69452356|FG001|Overall Study|Adverse Event|0|||
37807026|NCT01466790|69452357|FG002|Overall Study|Adverse Event|0|||
37807027|NCT01466790|69452358|FG003|Overall Study|Adverse Event|0|||
37807028|NCT01466790|69452359|FG004|Overall Study|Adverse Event|2|||
37807029|NCT01466790|69452360|FG005|Overall Study|Adverse Event|0|||
37807030|NCT01466790|69452361|FG006|Overall Study|Adverse Event|0|||
37807031|NCT01466790|69452362|FG007|Overall Study|Adverse Event|0|||
37807032|NCT01466790|69452355|FG000|Overall Study|Lost to Follow-up|2|||
37807033|NCT01466790|69452356|FG001|Overall Study|Lost to Follow-up|0|||
37807034|NCT01466790|69452357|FG002|Overall Study|Lost to Follow-up|0|||
37807035|NCT01466790|69452358|FG003|Overall Study|Lost to Follow-up|0|||
37807036|NCT01466790|69452359|FG004|Overall Study|Lost to Follow-up|0|||
37807037|NCT01466790|69452360|FG005|Overall Study|Lost to Follow-up|0|||
37807038|NCT01466790|69452361|FG006|Overall Study|Lost to Follow-up|0|||
37976296|NCT00463866|69663607|FG000|Overall Study|Withdrawal by Subject|81|||
37976297|NCT00463866|69663608|FG001|Overall Study|Withdrawal by Subject|79|||
37976298|NCT00463866|69663607|FG000|Overall Study|Lost to Follow-up|46|||
37976299|NCT00463866|69663608|FG001|Overall Study|Lost to Follow-up|55|||
37976300|NCT00463866|69663607|FG000|Overall Study|Incorrect Enrolment|64|||
37976301|NCT00463866|69663608|FG001|Overall Study|Incorrect Enrolment|66|||
37976302|NCT00463866|69663607|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
37976303|NCT00463866|69663608|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
37976304|NCT00463866|69663607|FG000|Overall Study|Safety Reason|1|||
37807039|NCT01466790|69452362|FG007|Overall Study|Lost to Follow-up|0|||
37807040|NCT01466790|69452355|FG000|Overall Study|Withdrawal by Subject|1|||
37807041|NCT01466790|69452356|FG001|Overall Study|Withdrawal by Subject|1|||
37807042|NCT01466790|69452357|FG002|Overall Study|Withdrawal by Subject|0|||
37807043|NCT01466790|69452358|FG003|Overall Study|Withdrawal by Subject|0|||
37807044|NCT01466790|69452359|FG004|Overall Study|Withdrawal by Subject|1|||
37807045|NCT01466790|69452360|FG005|Overall Study|Withdrawal by Subject|0|||
37807046|NCT01466790|69452361|FG006|Overall Study|Withdrawal by Subject|1|||
37807047|NCT01466790|69452362|FG007|Overall Study|Withdrawal by Subject|1|||
37807048|NCT01418352|69452380|FG000|Overall Study|Lost to Follow-up|2|||
37807049|NCT01418352|69452381|FG001|Overall Study|Lost to Follow-up|0|||
37807050|NCT01418352|69452382|FG002|Overall Study|Lost to Follow-up|0|||
37807051|NCT01418352|69452383|FG003|Overall Study|Lost to Follow-up|0|||
37807052|NCT01418352|69452380|FG000|Overall Study|Adverse Event|0|||
37807053|NCT01418352|69452381|FG001|Overall Study|Adverse Event|1|||
37807054|NCT01418352|69452382|FG002|Overall Study|Adverse Event|0|||
37807055|NCT01418352|69452383|FG003|Overall Study|Adverse Event|0|||
37807056|NCT01418352|69452380|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
37807057|NCT01418352|69452381|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
37807058|NCT01418352|69452382|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
37807059|NCT01418352|69452383|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
37807060|NCT01418352|69452380|FG000|Overall Study|Subject Withdrew Consent|0|||
37807061|NCT01418352|69452381|FG001|Overall Study|Subject Withdrew Consent|1|||
37807062|NCT01418352|69452382|FG002|Overall Study|Subject Withdrew Consent|2|||
37807063|NCT01418352|69452383|FG003|Overall Study|Subject Withdrew Consent|1|||
37807064|NCT01418352|69452380|FG000|Overall Study|Protocol Deviation|0|||
37807065|NCT01418352|69452381|FG001|Overall Study|Protocol Deviation|0|||
37807066|NCT01418352|69452382|FG002|Overall Study|Protocol Deviation|1|||
37807067|NCT01418352|69452383|FG003|Overall Study|Protocol Deviation|0|||
37807068|NCT01418352|69452380|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
37807069|NCT01418352|69452381|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
37807070|NCT01418352|69452382|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
37807071|NCT01418352|69452383|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
37807072|NCT01436370|69452401|FG000|Overall Study|Lost to Follow-up|0|||
37807073|NCT01436370|69452402|FG001|Overall Study|Lost to Follow-up|0|||
37807074|NCT01436370|69452403|FG002|Overall Study|Lost to Follow-up|0|||
37807075|NCT01436370|69452404|FG003|Overall Study|Lost to Follow-up|0|||
37807076|NCT01436370|69452405|FG004|Overall Study|Lost to Follow-up|1|||
37807077|NCT01436370|69452406|FG005|Overall Study|Lost to Follow-up|0|||
37807078|NCT01436370|69452407|FG006|Overall Study|Lost to Follow-up|0|||
37807079|NCT01436370|69452408|FG007|Overall Study|Lost to Follow-up|0|||
37807080|NCT01465464|69452436|FG000|Overall Study|Adverse Event|96|||
37807081|NCT01465464|69452437|FG001|Overall Study|Adverse Event|49|||
37807082|NCT01465464|69452436|FG000|Overall Study|Lack of Efficacy|139|||
37807083|NCT01465464|69452437|FG001|Overall Study|Lack of Efficacy|190|||
37864287|NCT00982228|69547910|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
37976305|NCT00463866|69663608|FG001|Overall Study|Safety Reason|3|||
37807084|NCT01465464|69452436|FG000|Overall Study|Physician Decision|13|||
37807085|NCT01465464|69452437|FG001|Overall Study|Physician Decision|5|||
37807086|NCT01465464|69452436|FG000|Overall Study|Protocol Violation|1|||
37807087|NCT01465464|69452437|FG001|Overall Study|Protocol Violation|1|||
37807088|NCT01465464|69452436|FG000|Overall Study|Withdrawal by Subject|46|||
37807089|NCT01465464|69452437|FG001|Overall Study|Withdrawal by Subject|30|||
37976306|NCT00463866|69663607|FG000|Overall Study|Mis-Randomization of subject|0|||
37976307|NCT00463866|69663608|FG001|Overall Study|Mis-Randomization of subject|1|||
37807090|NCT01465464|69452436|FG000|Overall Study|Other|9|||
37807091|NCT01465464|69452437|FG001|Overall Study|Other|3|||
37807092|NCT01465464|69452436|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
37807093|NCT01465464|69452437|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
37807094|NCT01417104|69452445|FG000|Overall Study|Withdrawal by Subject|5|||
37807095|NCT01417104|69452446|FG001|Overall Study|Withdrawal by Subject|1|||
37807096|NCT01417104|69452445|FG000|Overall Study|Failure to make contact|0|||
37807097|NCT01417104|69452446|FG001|Overall Study|Failure to make contact|1|||
37807098|NCT01417104|69452445|FG000|Overall Study|Adverse Event|1|||
37807099|NCT01417104|69452446|FG001|Overall Study|Adverse Event|0|||
37807100|NCT01465386|69452452|FG000|Overall Study|Lack of Efficacy|3|||
37807101|NCT01465386|69452452|FG000|Overall Study|Adverse Event|1|||
37807102|NCT01465230|69452456|FG000|Overall Study|Withdrawal by Subject|2|||
37807103|NCT01435356|69452462|FG000|Overall Study|Adverse Event|2|||
37807104|NCT01435356|69452463|FG001|Overall Study|Adverse Event|0|||
37976308|NCT00463866|69663607|FG000|Overall Study|Other|22|||
37976309|NCT00463866|69663608|FG001|Overall Study|Other|22|||
37976310|NCT00313846|69663616|FG000|Overall Study|Withdrawal by Subject|2|||
37976311|NCT00313846|69663617|FG001|Overall Study|Withdrawal by Subject|0|||
37976312|NCT00313846|69663616|FG000|Overall Study|Adverse Event|1|||
37976313|NCT00313846|69663617|FG001|Overall Study|Adverse Event|8|||
37976314|NCT00313846|69663616|FG000|Overall Study|Administrative|2|||
37976315|NCT00313846|69663617|FG001|Overall Study|Administrative|3|||
37976316|NCT00551135|69663628|FG000|Overall Study|Adverse Event|1|||
37976317|NCT00551135|69663629|FG001|Overall Study|Adverse Event|0|||
37807105|NCT01435356|69452462|FG000|Overall Study|Disease progression/recurrence|17|||
37807106|NCT01435356|69452463|FG001|Overall Study|Disease progression/recurrence|10|||
37807107|NCT01435356|69452462|FG000|Overall Study|Protocol Violation|0|||
37807108|NCT01435356|69452463|FG001|Overall Study|Protocol Violation|1|||
37807109|NCT01435356|69452462|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
37807110|NCT01435356|69452463|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
37807111|NCT01435356|69452462|FG000|Overall Study|Withdrawal by Subject|1|||
37807112|NCT01435356|69452463|FG001|Overall Study|Withdrawal by Subject|1|||
37807113|NCT01435356|69452462|FG000|Overall Study|Facial palsy|1|||
37807114|NCT01435356|69452463|FG001|Overall Study|Facial palsy|0|||
37807115|NCT01435356|69452462|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
37807116|NCT01435356|69452463|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
37807117|NCT01435356|69452462|FG000|Overall Study|Physician Decision|1|||
37807118|NCT01435356|69452463|FG001|Overall Study|Physician Decision|0|||
37807119|NCT01435356|69452462|FG000|Overall Study|Patient decision|3|||
37807120|NCT01435356|69452463|FG001|Overall Study|Patient decision|0|||
37807121|NCT01435356|69452462|FG000|Overall Study|Patient moved to another city|1|||
37807122|NCT01435356|69452463|FG001|Overall Study|Patient moved to another city|1|||
37807123|NCT01435122|69452469|FG000|Overall Study|Early withdrawal due to toxicity|8|||
37976318|NCT00551135|69663630|FG002|Overall Study|Adverse Event|1|||
37976319|NCT00551135|69663631|FG003|Overall Study|Adverse Event|1|||
37976320|NCT00551135|69663628|FG000|Overall Study|Lost to Follow-up|0|||
37976321|NCT00551135|69663629|FG001|Overall Study|Lost to Follow-up|0|||
37976322|NCT00551135|69663630|FG002|Overall Study|Lost to Follow-up|0|||
37807124|NCT01434810|69452484|FG000|Overall Study|Did not receive treatment|11|||
37807125|NCT01434810|69452485|FG001|Overall Study|Did not receive treatment|3|||
37807126|NCT01434810|69452484|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
37807127|NCT01434810|69452485|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
37976323|NCT00551135|69663631|FG003|Overall Study|Lost to Follow-up|1|||
37976324|NCT00551135|69663628|FG000|Overall Study|Other|3|||
37976325|NCT00551135|69663629|FG001|Overall Study|Other|2|||
37807128|NCT01393626|69452495|FG000|Overall Study|Adverse Event|2|||
37807129|NCT01393626|69452496|FG001|Overall Study|Adverse Event|1|||
37807130|NCT01393626|69452497|FG002|Overall Study|Adverse Event|5|||
37807131|NCT01393626|69452498|FG003|Overall Study|Adverse Event|0|||
37807132|NCT01393626|69452495|FG000|Overall Study|Did not meet entrance criteria|1|||
37807133|NCT01393626|69452496|FG001|Overall Study|Did not meet entrance criteria|0|||
37807134|NCT01393626|69452497|FG002|Overall Study|Did not meet entrance criteria|0|||
37807135|NCT01393626|69452498|FG003|Overall Study|Did not meet entrance criteria|0|||
37976326|NCT00551135|69663630|FG002|Overall Study|Other|1|||
37976327|NCT00551135|69663631|FG003|Overall Study|Other|2|||
37807136|NCT01393626|69452495|FG000|Overall Study|Lack of Efficacy|6|||
37976328|NCT00551135|69663628|FG000|Overall Study|Withdrawal by Subject|1|||
37807137|NCT01393626|69452496|FG001|Overall Study|Lack of Efficacy|6|||
37807138|NCT01393626|69452497|FG002|Overall Study|Lack of Efficacy|4|||
37807139|NCT01393626|69452498|FG003|Overall Study|Lack of Efficacy|1|||
37976329|NCT00551135|69663629|FG001|Overall Study|Withdrawal by Subject|0|||
37976330|NCT00551135|69663630|FG002|Overall Study|Withdrawal by Subject|3|||
37807140|NCT01393626|69452495|FG000|Overall Study|Lost to Follow-up|1|||
37807141|NCT01393626|69452496|FG001|Overall Study|Lost to Follow-up|1|||
37807142|NCT01393626|69452497|FG002|Overall Study|Lost to Follow-up|1|||
37807143|NCT01393626|69452498|FG003|Overall Study|Lost to Follow-up|0|||
37807144|NCT01393626|69452495|FG000|Overall Study|Withdrawal by Subject|6|||
37807145|NCT01393626|69452496|FG001|Overall Study|Withdrawal by Subject|4|||
37976331|NCT00551135|69663631|FG003|Overall Study|Withdrawal by Subject|1|||
37807146|NCT01393626|69452497|FG002|Overall Study|Withdrawal by Subject|0|||
37807147|NCT01393626|69452498|FG003|Overall Study|Withdrawal by Subject|0|||
37807148|NCT01393626|69452495|FG000|Overall Study|Other|1|||
37807149|NCT01393626|69452496|FG001|Overall Study|Other|0|||
37807150|NCT01393626|69452497|FG002|Overall Study|Other|0|||
37807151|NCT01393626|69452498|FG003|Overall Study|Other|0|||
37807152|NCT01393626|69452495|FG000|Overall Study|Protocol Violation|1|||
37807153|NCT01393626|69452496|FG001|Overall Study|Protocol Violation|0|||
37807154|NCT01393626|69452497|FG002|Overall Study|Protocol Violation|2|||
37807155|NCT01393626|69452498|FG003|Overall Study|Protocol Violation|0|||
37807156|NCT01434654|69452517|FG000|Overall Study|Withdrawal by Subject|1|||
37807157|NCT01434654|69452518|FG001|Overall Study|Withdrawal by Subject|0|||
37807158|NCT01434654|69452517|FG000|Overall Study|Lost to Follow-up|1|||
37807159|NCT01434654|69452518|FG001|Overall Study|Lost to Follow-up|0|||
37807160|NCT01393158|69452528|FG000|Overall Study|Adverse Event|1|||
37807161|NCT01393158|69452529|FG001|Overall Study|Adverse Event|0|||
37807162|NCT01413360|69452541|FG000|Overall Study|Lost to Follow-up|2|||
37807163|NCT01413360|69452541|FG000|Overall Study|Adverse Event|1|||
37807164|NCT01413204|69452548|FG000|Overall Study|Adverse Event|1|||
37807165|NCT01413204|69452549|FG001|Overall Study|Adverse Event|2|||
37807166|NCT01413204|69452550|FG002|Overall Study|Adverse Event|2|||
37807167|NCT01413204|69452548|FG000|Overall Study|Physician Decision|3|||
37807168|NCT01413204|69452549|FG001|Overall Study|Physician Decision|0|||
37807169|NCT01413204|69452550|FG002|Overall Study|Physician Decision|2|||
37807170|NCT01413204|69452548|FG000|Overall Study|Withdrawal by Subject|1|||
37807171|NCT01413204|69452549|FG001|Overall Study|Withdrawal by Subject|4|||
37807172|NCT01413204|69452550|FG002|Overall Study|Withdrawal by Subject|4|||
37807173|NCT01413204|69452548|FG000|Overall Study|Clearly not eligible for the study|0|||
37807174|NCT01413204|69452549|FG001|Overall Study|Clearly not eligible for the study|0|||
37807175|NCT01413204|69452550|FG002|Overall Study|Clearly not eligible for the study|1|||
37807176|NCT01413204|69452548|FG000|Overall Study|Fasting plasma glucose level increased|1|||
37807177|NCT01413204|69452549|FG001|Overall Study|Fasting plasma glucose level increased|0|||
37807178|NCT01413204|69452550|FG002|Overall Study|Fasting plasma glucose level increased|10|||
37807179|NCT01392378|69452563|FG000|Infant Series|Adverse Event|0|||
37807180|NCT01392378|69452564|FG001|Infant Series|Adverse Event|0|||
37807181|NCT01392378|69452565|FG002|Infant Series|Adverse Event|0|||
37807182|NCT01392378|69452566|FG003|Infant Series|Adverse Event|1|||
37807183|NCT01392378|69452567|FG004|Infant Series|Adverse Event|0|||
37807184|NCT01392378|69452563|FG000|Infant Series|Lost to Follow-up|0|||
37807185|NCT01392378|69452564|FG001|Infant Series|Lost to Follow-up|0|||
37807186|NCT01392378|69452565|FG002|Infant Series|Lost to Follow-up|0|||
37807187|NCT01392378|69452566|FG003|Infant Series|Lost to Follow-up|1|||
37807188|NCT01392378|69452567|FG004|Infant Series|Lost to Follow-up|0|||
37807189|NCT01392378|69452563|FG000|Infant Series|Protocol Violation|0|||
37807190|NCT01392378|69452564|FG001|Infant Series|Protocol Violation|1|||
37807191|NCT01392378|69452565|FG002|Infant Series|Protocol Violation|0|||
37807192|NCT01392378|69452566|FG003|Infant Series|Protocol Violation|0|||
37807193|NCT01392378|69452567|FG004|Infant Series|Protocol Violation|0|||
37807194|NCT01392378|69452563|FG000|Infant Series|Withdrawal by Parent|4|||
37807195|NCT01392378|69452564|FG001|Infant Series|Withdrawal by Parent|1|||
37976332|NCT00299104|69663644|FG000|Treatment Period|Adverse Event|14|||
37807196|NCT01392378|69452565|FG002|Infant Series|Withdrawal by Parent|0|||
37807197|NCT01392378|69452566|FG003|Infant Series|Withdrawal by Parent|0|||
37807198|NCT01392378|69452567|FG004|Infant Series|Withdrawal by Parent|0|||
37807199|NCT01392378|69452563|FG000|After Infant Series|Lost to Follow-up|0|||
37807200|NCT01392378|69452564|FG001|After Infant Series|Lost to Follow-up|0|||
37807201|NCT01392378|69452565|FG002|After Infant Series|Lost to Follow-up|1|||
37807202|NCT01392378|69452566|FG003|After Infant Series|Lost to Follow-up|0|||
37807203|NCT01392378|69452567|FG004|After Infant Series|Lost to Follow-up|0|||
37807204|NCT01392378|69452563|FG000|After Infant Series|Withdrawal by Parent|0|||
37807205|NCT01392378|69452564|FG001|After Infant Series|Withdrawal by Parent|1|||
37807206|NCT01392378|69452565|FG002|After Infant Series|Withdrawal by Parent|1|||
37807207|NCT01392378|69452566|FG003|After Infant Series|Withdrawal by Parent|0|||
37807208|NCT01392378|69452567|FG004|After Infant Series|Withdrawal by Parent|1|||
37807209|NCT01392378|69452563|FG000|Toddler Dose|Lost to Follow-up|0|||
37807210|NCT01392378|69452564|FG001|Toddler Dose|Lost to Follow-up|0|||
37807211|NCT01392378|69452565|FG002|Toddler Dose|Lost to Follow-up|0|||
37807212|NCT01392378|69452566|FG003|Toddler Dose|Lost to Follow-up|1|||
37807213|NCT01392378|69452567|FG004|Toddler Dose|Lost to Follow-up|0|||
37807214|NCT01392378|69452563|FG000|Toddler Dose|Withdrawal by Parent|0|||
37807215|NCT01392378|69452564|FG001|Toddler Dose|Withdrawal by Parent|1|||
37807216|NCT01392378|69452565|FG002|Toddler Dose|Withdrawal by Parent|0|||
37807217|NCT01392378|69452566|FG003|Toddler Dose|Withdrawal by Parent|1|||
37807218|NCT01392378|69452567|FG004|Toddler Dose|Withdrawal by Parent|1|||
37976333|NCT00299104|69663645|FG001|Treatment Period|Adverse Event|9|||
37807219|NCT01412424|69452589|FG000|Core Treatment Period|Treatment Failure|24|||
37807220|NCT01412424|69452589|FG000|Core Treatment Period|Adverse Event|21|||
37807221|NCT01412424|69452589|FG000|Core Treatment Period|Patient Request|5|||
37807222|NCT01412424|69452589|FG000|Core Treatment Period|Lost to Follow-up|2|||
37807223|NCT01412424|69452589|FG000|Core Treatment Period|Sponsor Request|1|||
37807224|NCT01412424|69452589|FG000|Extension Treatment Period|Adverse Event|2|||
37807225|NCT01412424|69452589|FG000|Extension Treatment Period|Treatment Failure|2|||
37807226|NCT01412424|69452589|FG000|Extension Treatment Period|Patient Request|2|||
37807227|NCT01433250|69452601|FG000|Overall Study|Protocol Violation|0|||
37807228|NCT01433250|69452602|FG001|Overall Study|Protocol Violation|1|||
37807229|NCT01433250|69452601|FG000|Overall Study|Withdrawal by Subject|3|||
37807230|NCT01433250|69452602|FG001|Overall Study|Withdrawal by Subject|2|||
37807231|NCT01433172|69452611|FG000|Overall Study|Withdrawal by Subject|0|||
37807232|NCT01433172|69452612|FG001|Overall Study|Withdrawal by Subject|1|||
37807233|NCT01433172|69452613|FG002|Overall Study|Withdrawal by Subject|0|||
37807234|NCT01433172|69452611|FG000|Overall Study|Disease Progression|0|||
37807235|NCT01433172|69452612|FG001|Overall Study|Disease Progression|0|||
37807236|NCT01433172|69452613|FG002|Overall Study|Disease Progression|1|||
37807237|NCT01433172|69452611|FG000|Overall Study|Death|0|||
37807238|NCT01433172|69452612|FG001|Overall Study|Death|2|||
37807239|NCT01433172|69452613|FG002|Overall Study|Death|0|||
37807240|NCT01432938|69452621|FG000|First Intervention|Protocol Violation|1|||
37807241|NCT01432938|69452622|FG001|First Intervention|Protocol Violation|0|||
37807242|NCT01432938|69452621|FG000|First Intervention|Physician Decision|1|||
37807243|NCT01432938|69452622|FG001|First Intervention|Physician Decision|0|||
37807244|NCT01432938|69452621|FG000|Second Intervention|Adverse Event|1|||
37807245|NCT01432938|69452622|FG001|Second Intervention|Adverse Event|0|||
37807246|NCT01392300|69452631|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
37807247|NCT01392300|69452632|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
37807248|NCT01392300|69452633|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
37807249|NCT01392300|69452631|FG000|Main Period (MP)|Withdrawal by Subject|5|||
37807250|NCT01392300|69452632|FG001|Main Period (MP)|Withdrawal by Subject|1|||
37807251|NCT01392300|69452633|FG002|Main Period (MP)|Withdrawal by Subject|0|||
37807252|NCT01392300|69452631|FG000|Main Period (MP)|Lost to Follow-up|3|||
37807253|NCT01392300|69452632|FG001|Main Period (MP)|Lost to Follow-up|3|||
37807254|NCT01392300|69452633|FG002|Main Period (MP)|Lost to Follow-up|0|||
37807255|NCT01392300|69452631|FG000|Main Period (MP)|Non-compliance|1|||
37976334|NCT00299104|69663646|FG002|Treatment Period|Adverse Event|7|||
37976335|NCT00299104|69663644|FG000|Treatment Period|Death|1|||
37807256|NCT01392300|69452632|FG001|Main Period (MP)|Non-compliance|0|||
37807257|NCT01392300|69452633|FG002|Main Period (MP)|Non-compliance|0|||
37976336|NCT00299104|69663645|FG001|Treatment Period|Death|1|||
37807258|NCT01392300|69452631|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
37807259|NCT01392300|69452632|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
37807260|NCT01392300|69452633|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
37807261|NCT01392300|69452631|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
37807262|NCT01392300|69452632|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
37807263|NCT01392300|69452633|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
37807264|NCT01392300|69452631|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
37807265|NCT01392300|69452632|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
37807266|NCT01392300|69452633|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
37807267|NCT01392300|69452631|FG000|Open Label Extension (OLEX) Period|Death|0|||
37807268|NCT01392300|69452632|FG001|Open Label Extension (OLEX) Period|Death|0|||
37807269|NCT01392300|69452633|FG002|Open Label Extension (OLEX) Period|Death|4|||
37807270|NCT01392300|69452631|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
37807271|NCT01392300|69452632|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
37807272|NCT01392300|69452633|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
37807273|NCT01392300|69452631|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
37976337|NCT00299104|69663646|FG002|Treatment Period|Death|1|||
37807274|NCT01392300|69452632|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
37807275|NCT01392300|69452633|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
37807276|NCT01392300|69452631|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
37807277|NCT01392300|69452632|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
37807278|NCT01392300|69452633|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
37807279|NCT01432626|69452640|FG000|Overall Study|LV function recovered|2|||
37807280|NCT01432626|69452640|FG000|Overall Study|Withdrawal by Subject|2|||
37807281|NCT01432626|69452640|FG000|Overall Study|Only 1 image competed|2|||
37807282|NCT01432626|69452640|FG000|Overall Study|Imaging agent not available|1|||
37807283|NCT01391832|69452646|FG000|Overall Study|Withdrawal by Subject|21|||
37807284|NCT01391832|69452647|FG001|Overall Study|Withdrawal by Subject|22|||
37807285|NCT01391832|69452646|FG000|Overall Study|Lost to Follow-up|0|||
37807286|NCT01391832|69452647|FG001|Overall Study|Lost to Follow-up|1|||
37807287|NCT01410474|69452655|FG000|Overall Study|Withdrawal by Subject|0|||
37807288|NCT01410474|69452656|FG001|Overall Study|Withdrawal by Subject|1|||
37807289|NCT01391130|69452671|FG000|Overall Study|Withdrawal by Subject|3|||
37807290|NCT01391130|69452672|FG001|Overall Study|Withdrawal by Subject|2|||
37807291|NCT01391130|69452671|FG000|Overall Study|Physician Decision|2|||
37807292|NCT01391130|69452672|FG001|Overall Study|Physician Decision|3|||
37807293|NCT01391130|69452671|FG000|Overall Study|Did not Receive Drug|1|||
37807294|NCT01391130|69452672|FG001|Overall Study|Did not Receive Drug|1|||
37807295|NCT01410240|69452681|FG000|Overall Study|Physician Decision|0|||
37807296|NCT01410240|69452682|FG001|Overall Study|Physician Decision|0|||
37807297|NCT01410240|69452683|FG002|Overall Study|Physician Decision|1|||
37807298|NCT01410240|69452681|FG000|Overall Study|Missed week 6 assessments|1|||
37807299|NCT01410240|69452682|FG001|Overall Study|Missed week 6 assessments|1|||
37807300|NCT01410240|69452683|FG002|Overall Study|Missed week 6 assessments|1|||
37807301|NCT01409928|69452692|FG000|Overall Study|Physician Decision|12|||
37807302|NCT01431534|69452699|FG000|Treatment Phase|Adverse Event|0|||
37807303|NCT01431534|69452700|FG001|Treatment Phase|Adverse Event|0|||
37807304|NCT01431534|69452701|FG002|Treatment Phase|Adverse Event|1|||
37807305|NCT01431534|69452699|FG000|Treatment Phase|Progressive Disease|4|||
37807306|NCT01431534|69452700|FG001|Treatment Phase|Progressive Disease|3|||
37807307|NCT01431534|69452701|FG002|Treatment Phase|Progressive Disease|10|||
37807308|NCT01409382|69452711|FG000|Overall Study|Lost to Follow-up|1|||
37807309|NCT01409382|69452712|FG001|Overall Study|Lost to Follow-up|1|||
37807310|NCT01409382|69452711|FG000|Overall Study|Protocol Violation|0|||
37807311|NCT01409382|69452712|FG001|Overall Study|Protocol Violation|3|||
37807312|NCT01409382|69452711|FG000|Overall Study|Multiple pregnancy|2|||
37807313|NCT01409382|69452712|FG001|Overall Study|Multiple pregnancy|4|||
37807314|NCT01409382|69452711|FG000|Overall Study|Still pregnant when study ended|13|||
37807315|NCT01409382|69452712|FG001|Overall Study|Still pregnant when study ended|2|||
37807316|NCT01409382|69452711|FG000|Overall Study|Did not manage to get pregnant|64|||
37807317|NCT01409382|69452712|FG001|Overall Study|Did not manage to get pregnant|70|||
37807318|NCT01409382|69452711|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
37807319|NCT01409382|69452712|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
37807320|NCT01408914|69452725|FG000|Overall Study|Could not complete tx in protocol period|5|||
37807321|NCT01408914|69452726|FG001|Overall Study|Could not complete tx in protocol period|5|||
37807322|NCT01408914|69452727|FG002|Overall Study|Could not complete tx in protocol period|6|||
37807323|NCT01408914|69452725|FG000|Overall Study|Lost to Follow-up|4|||
37807324|NCT01408914|69452726|FG001|Overall Study|Lost to Follow-up|1|||
37807325|NCT01408914|69452727|FG002|Overall Study|Lost to Follow-up|2|||
37807326|NCT01408914|69452725|FG000|Overall Study|Physician Decision|1|||
37807327|NCT01408914|69452726|FG001|Overall Study|Physician Decision|1|||
37807328|NCT01408914|69452727|FG002|Overall Study|Physician Decision|0|||
37807329|NCT01408914|69452725|FG000|Overall Study|Withdrawal by Subject|1|||
37807330|NCT01408914|69452726|FG001|Overall Study|Withdrawal by Subject|0|||
37807331|NCT01408914|69452727|FG002|Overall Study|Withdrawal by Subject|1|||
37807332|NCT01408914|69452725|FG000|Overall Study|Moved out of study jurisdiction|1|||
37807333|NCT01408914|69452726|FG001|Overall Study|Moved out of study jurisdiction|1|||
37807334|NCT01408914|69452727|FG002|Overall Study|Moved out of study jurisdiction|0|||
37807335|NCT01408914|69452725|FG000|Overall Study|Late exclusion|0|||
37807336|NCT01408914|69452726|FG001|Overall Study|Late exclusion|3|||
37694031|NCT02460224|69170384|FG007|Overall Study|Adverse Event|0|||
37807337|NCT01408914|69452727|FG002|Overall Study|Late exclusion|3|||
37807338|NCT01408914|69452725|FG000|Overall Study|Change in local TB/HIV norms|0|||
37807339|NCT01408914|69452726|FG001|Overall Study|Change in local TB/HIV norms|1|||
37807340|NCT01408914|69452727|FG002|Overall Study|Change in local TB/HIV norms|1|||
37807341|NCT01431144|69452737|FG000|Overall Study|Implant mobility and removal|2|||
37807342|NCT01431144|69452738|FG001|Overall Study|Implant mobility and removal|0|||
37976338|NCT00299104|69663644|FG000|Treatment Period|Insufficient therapeutic response|34|||
37976339|NCT00299104|69663645|FG001|Treatment Period|Insufficient therapeutic response|13|||
37976340|NCT00299104|69663646|FG002|Treatment Period|Insufficient therapeutic response|8|||
37976341|NCT00299104|69663644|FG000|Treatment Period|Failure to return|9|||
37976342|NCT00299104|69663645|FG001|Treatment Period|Failure to return|8|||
37976343|NCT00299104|69663646|FG002|Treatment Period|Failure to return|8|||
37976344|NCT00299104|69663644|FG000|Treatment Period|Violation of selection criteria|1|||
37976345|NCT00299104|69663645|FG001|Treatment Period|Violation of selection criteria|2|||
37976346|NCT00299104|69663646|FG002|Treatment Period|Violation of selection criteria|0|||
37976347|NCT00299104|69663644|FG000|Treatment Period|Protocol Violation|1|||
37976348|NCT00299104|69663645|FG001|Treatment Period|Protocol Violation|1|||
37976349|NCT00299104|69663646|FG002|Treatment Period|Protocol Violation|0|||
37807343|NCT01430754|69452747|FG000|Run-In Phase|Circadian Period Ineligible|24|||
37807344|NCT01430754|69452748|FG001|Run-In Phase|Circadian Period Ineligible|0|||
37807345|NCT01430754|69452747|FG000|Run-In Phase|Protocol Violation|6|||
37807346|NCT01430754|69452748|FG001|Run-In Phase|Protocol Violation|0|||
37807347|NCT01430754|69452747|FG000|Run-In Phase|Adverse Event|2|||
37807348|NCT01430754|69452748|FG001|Run-In Phase|Adverse Event|0|||
37807349|NCT01430754|69452747|FG000|Run-In Phase|Other|2|||
37807350|NCT01430754|69452748|FG001|Run-In Phase|Other|0|||
37807351|NCT01430754|69452747|FG000|Run-In Phase|Withdrawal by Subject|2|||
37864288|NCT00982228|69547911|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
37864289|NCT00982228|69547910|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
37864290|NCT00982228|69547911|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
37864291|NCT00982228|69547910|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
37864292|NCT00982228|69547911|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
37864293|NCT00982228|69547910|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
37864294|NCT00982228|69547911|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
37864295|NCT00982228|69547910|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
37864296|NCT00982228|69547911|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
37864297|NCT00982228|69547910|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
37864298|NCT00982228|69547911|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
37864299|NCT01260350|69547937|FG000|Overall Study|Lack of Efficacy|0|||
37864300|NCT01260350|69547938|FG001|Overall Study|Lack of Efficacy|0|||
37864301|NCT01260350|69547939|FG002|Overall Study|Lack of Efficacy|0|||
37864302|NCT01260350|69547940|FG003|Overall Study|Lack of Efficacy|0|||
37864303|NCT01260350|69547941|FG004|Overall Study|Lack of Efficacy|0|||
37864304|NCT01260350|69547942|FG005|Overall Study|Lack of Efficacy|0|||
37864305|NCT01260350|69547943|FG006|Overall Study|Lack of Efficacy|0|||
37864306|NCT01260350|69547944|FG007|Overall Study|Lack of Efficacy|0|||
37976350|NCT00299104|69663644|FG000|Treatment Period|Refused treatment|9|||
37807352|NCT01430754|69452748|FG001|Run-In Phase|Withdrawal by Subject|0|||
37807353|NCT01430754|69452747|FG000|Run-In Phase|Lost to Follow-up|1|||
37807354|NCT01430754|69452748|FG001|Run-In Phase|Lost to Follow-up|0|||
37807355|NCT01390428|69452762|FG000|Overall Study|Elective Surgery|0|||
37807356|NCT01390428|69452763|FG001|Overall Study|Elective Surgery|0|||
37807357|NCT01390428|69452764|FG002|Overall Study|Elective Surgery|0|||
37807358|NCT01390428|69452765|FG003|Overall Study|Elective Surgery|0|||
37807359|NCT01390428|69452766|FG004|Overall Study|Elective Surgery|1|||
37807360|NCT01390428|69452767|FG005|Overall Study|Elective Surgery|0|||
37807361|NCT01390428|69452762|FG000|Overall Study|Withdrawal by Subject|0|||
37807362|NCT01390428|69452763|FG001|Overall Study|Withdrawal by Subject|0|||
37807363|NCT01390428|69452764|FG002|Overall Study|Withdrawal by Subject|1|||
37807364|NCT01390428|69452765|FG003|Overall Study|Withdrawal by Subject|0|||
37807365|NCT01390428|69452766|FG004|Overall Study|Withdrawal by Subject|0|||
37807366|NCT01390428|69452767|FG005|Overall Study|Withdrawal by Subject|0|||
37807367|NCT01430130|69452781|FG000|Overall Study|Lost to Follow-up|1|||
37807368|NCT01430130|69452781|FG000|Overall Study|Infection on Control Side of Incision|1|||
37807369|NCT01407354|69452787|FG000|First Intervention|Withdrawal by Subject|0|||
37807370|NCT01407354|69452788|FG001|First Intervention|Withdrawal by Subject|2|||
37807371|NCT01407354|69452787|FG000|First Intervention|Adverse Event|1|||
37807372|NCT01407354|69452788|FG001|First Intervention|Adverse Event|0|||
37807373|NCT01407354|69452787|FG000|First Intervention|Physician Decision|1|||
37807374|NCT01407354|69452788|FG001|First Intervention|Physician Decision|0|||
37807375|NCT01407276|69452803|FG000|Overall Study|Withdrawal by Subject|0|||
37807376|NCT01407276|69452804|FG001|Overall Study|Withdrawal by Subject|0|||
37807377|NCT01407276|69452805|FG002|Overall Study|Withdrawal by Subject|0|||
37807378|NCT01407276|69452806|FG003|Overall Study|Withdrawal by Subject|0|||
37807379|NCT01407276|69452807|FG004|Overall Study|Withdrawal by Subject|0|||
37807380|NCT01407276|69452808|FG005|Overall Study|Withdrawal by Subject|0|||
37807381|NCT01407276|69452809|FG006|Overall Study|Withdrawal by Subject|0|||
37807382|NCT01407276|69452810|FG007|Overall Study|Withdrawal by Subject|1|||
37807383|NCT01390272|69452837|FG000|Overall Study|Death|3|||
37807384|NCT01390272|69452838|FG001|Overall Study|Death|2|||
37807385|NCT01390272|69452837|FG000|Overall Study|Withdrawal by Subject|9|||
37807386|NCT01390272|69452838|FG001|Overall Study|Withdrawal by Subject|5|||
37807387|NCT01390272|69452837|FG000|Overall Study|Patient moved, no longer eligible|5|||
37807388|NCT01390272|69452838|FG001|Overall Study|Patient moved, no longer eligible|8|||
37807389|NCT01429584|69452846|FG000|Overall Study|Withdrawal by Subject|1|||
37807390|NCT01429584|69452847|FG001|Overall Study|Withdrawal by Subject|0|||
37807391|NCT01429584|69452846|FG000|Overall Study|Protocol Violation|0|||
37807392|NCT01429584|69452847|FG001|Overall Study|Protocol Violation|1|||
37807393|NCT01406652|69452855|FG000|Overall Study|Lost-to-follow-up|3|||
37807394|NCT01406652|69452856|FG001|Overall Study|Lost-to-follow-up|4|||
37807395|NCT01406652|69452855|FG000|Overall Study|Withdrawal by Subject|2|||
37807396|NCT01406652|69452856|FG001|Overall Study|Withdrawal by Subject|2|||
37807397|NCT01406652|69452855|FG000|Overall Study|Insufficient follow-up|5|||
37807398|NCT01406652|69452856|FG001|Overall Study|Insufficient follow-up|4|||
37807399|NCT01406652|69452855|FG000|Overall Study|Infection not sure|10|||
37807400|NCT01406652|69452856|FG001|Overall Study|Infection not sure|10|||
37807401|NCT01406574|69452864|FG000|Overall Study|Adverse Event|0|||
37807402|NCT01406574|69452865|FG001|Overall Study|Adverse Event|0|||
37976351|NCT00299104|69663645|FG001|Treatment Period|Refused treatment|2|||
37976352|NCT00299104|69663646|FG002|Treatment Period|Refused treatment|2|||
37976353|NCT00299104|69663644|FG000|Treatment Period|Withdrew consent|14|||
37976354|NCT00299104|69663645|FG001|Treatment Period|Withdrew consent|19|||
37976355|NCT00299104|69663646|FG002|Treatment Period|Withdrew consent|9|||
37976356|NCT00299104|69663644|FG000|Treatment Period|Administrative reasons|106|||
37976357|NCT00299104|69663645|FG001|Treatment Period|Administrative reasons|120|||
37807403|NCT01406574|69452866|FG002|Overall Study|Adverse Event|1|||
37807404|NCT01406574|69452867|FG003|Overall Study|Adverse Event|3|||
37807405|NCT01406574|69452864|FG000|Overall Study|Physician Decision|0|||
37807406|NCT01406574|69452865|FG001|Overall Study|Physician Decision|0|||
37807407|NCT01406574|69452866|FG002|Overall Study|Physician Decision|0|||
37807408|NCT01406574|69452867|FG003|Overall Study|Physician Decision|1|||
37807409|NCT01406574|69452864|FG000|Overall Study|Withdrawal by Subject|0|||
37807410|NCT01406574|69452865|FG001|Overall Study|Withdrawal by Subject|1|||
37807411|NCT01406574|69452866|FG002|Overall Study|Withdrawal by Subject|0|||
37807412|NCT01406574|69452867|FG003|Overall Study|Withdrawal by Subject|0|||
37807413|NCT01406574|69452864|FG000|Overall Study|Definite progression of primary disease|1|||
37807414|NCT01406574|69452865|FG001|Overall Study|Definite progression of primary disease|0|||
37807415|NCT01406574|69452866|FG002|Overall Study|Definite progression of primary disease|0|||
37807416|NCT01406574|69452867|FG003|Overall Study|Definite progression of primary disease|0|||
37807417|NCT01405950|69452880|FG000|Overall Study|Withdrawal by Subject|1|||
37807418|NCT01405950|69452881|FG001|Overall Study|Withdrawal by Subject|0|||
37807419|NCT01405950|69452882|FG002|Overall Study|Withdrawal by Subject|0|||
37807420|NCT01405950|69452883|FG003|Overall Study|Withdrawal by Subject|0|||
37807421|NCT01405560|69452891|FG000|Overall Study|Physician Decision|1|||
37807422|NCT01428882|69452897|FG000|Overall Study|Lack of Efficacy|2|||
37807423|NCT01428882|69452898|FG001|Overall Study|Lack of Efficacy|7|||
37807424|NCT01428882|69452897|FG000|Overall Study|Protocol Violation|4|||
37807425|NCT01428882|69452898|FG001|Overall Study|Protocol Violation|3|||
37807426|NCT01428258|69452906|FG000|Intervention 1|Withdrawal by Subject|2|||
37807427|NCT01428258|69452907|FG001|Intervention 1|Withdrawal by Subject|0|||
37807428|NCT01389882|69452923|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
37807429|NCT01389882|69452924|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
37807430|NCT01389882|69452923|FG000|Overall Study|Withdrawal by Subject|0|||
37807431|NCT01389882|69452924|FG001|Overall Study|Withdrawal by Subject|1|||
37807432|NCT01442688|69452932|FG000|First Intervention|Withdrawal by Subject|1|||
37976358|NCT00299104|69663646|FG002|Treatment Period|Administrative reasons|137|||
37807433|NCT01442688|69452933|FG001|First Intervention|Withdrawal by Subject|0|||
37807434|NCT01442688|69452932|FG000|First Intervention|subject incarcerated|1|||
37807435|NCT01442688|69452933|FG001|First Intervention|subject incarcerated|0|||
37807436|NCT01442688|69452932|FG000|Second Intervention|Adverse Event|1|||
37807437|NCT01442688|69452933|FG001|Second Intervention|Adverse Event|0|||
37807438|NCT01466166|69452939|FG000|Overall Study|Death|1|||
37807439|NCT01466166|69452939|FG000|Overall Study|Lost to Follow-up|7|||
37807440|NCT01466166|69452939|FG000|Overall Study|Infusion Reaction (IR)|27|||
37807441|NCT01466166|69452939|FG000|Overall Study|Adverse Event (Other than IR)|11|||
37807442|NCT01466166|69452939|FG000|Overall Study|Elevated Serum Uric Acid|78|||
37807443|NCT01466166|69452939|FG000|Overall Study|Withdrawal by Subject|13|||
37807444|NCT01466166|69452939|FG000|Overall Study|Sponsor Decision|4|||
37807445|NCT01466166|69452939|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
37807446|NCT01466166|69452939|FG000|Overall Study|Other|20|||
37807447|NCT01426854|69452945|FG000|Overall Study|Adverse Event|1|||
37807448|NCT01426854|69452946|FG001|Overall Study|Adverse Event|5|||
37807449|NCT01426854|69452945|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
37807450|NCT01426854|69452946|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
37807451|NCT01426854|69452945|FG000|Overall Study|Lost to Follow-up|3|||
37807452|NCT01426854|69452946|FG001|Overall Study|Lost to Follow-up|0|||
37807453|NCT01426854|69452945|FG000|Overall Study|Noncompliance|0|||
37807454|NCT01426854|69452946|FG001|Overall Study|Noncompliance|1|||
37807455|NCT01426854|69452945|FG000|Overall Study|Treatment Failure|0|||
37807456|NCT01426854|69452946|FG001|Overall Study|Treatment Failure|16|||
37807457|NCT01426854|69452945|FG000|Overall Study|Protocol Deviation|0|||
37807458|NCT01426854|69452946|FG001|Overall Study|Protocol Deviation|1|||
37807459|NCT01426854|69452945|FG000|Overall Study|Other|3|||
37807460|NCT01426854|69452946|FG001|Overall Study|Other|2|||
37807461|NCT01426386|69452958|FG000|Overall Study|Adverse Event|0|||
37807462|NCT01426386|69452959|FG001|Overall Study|Adverse Event|1|||
37807463|NCT01426386|69452960|FG002|Overall Study|Adverse Event|0|||
37807464|NCT01426386|69452961|FG003|Overall Study|Adverse Event|0|||
37807465|NCT01426386|69452962|FG004|Overall Study|Adverse Event|0|||
37807466|NCT01426386|69452963|FG005|Overall Study|Adverse Event|0|||
37807467|NCT01426386|69452958|FG000|Overall Study|Did not attend scheduled visit|1|||
37807468|NCT01426386|69452959|FG001|Overall Study|Did not attend scheduled visit|4|||
37807469|NCT01426386|69452960|FG002|Overall Study|Did not attend scheduled visit|0|||
37807470|NCT01426386|69452961|FG003|Overall Study|Did not attend scheduled visit|0|||
37807471|NCT01426386|69452962|FG004|Overall Study|Did not attend scheduled visit|2|||
37807472|NCT01426386|69452963|FG005|Overall Study|Did not attend scheduled visit|1|||
37807473|NCT01426386|69452958|FG000|Overall Study|Poor response|2|||
37807474|NCT01426386|69452959|FG001|Overall Study|Poor response|1|||
37807475|NCT01426386|69452960|FG002|Overall Study|Poor response|2|||
37807476|NCT01426386|69452961|FG003|Overall Study|Poor response|0|||
37807477|NCT01426386|69452962|FG004|Overall Study|Poor response|1|||
37807478|NCT01426386|69452963|FG005|Overall Study|Poor response|0|||
37807479|NCT01426386|69452958|FG000|Overall Study|Personal reasons|0|||
37807480|NCT01426386|69452959|FG001|Overall Study|Personal reasons|0|||
37807481|NCT01426386|69452960|FG002|Overall Study|Personal reasons|0|||
37807482|NCT01426386|69452961|FG003|Overall Study|Personal reasons|0|||
37807483|NCT01426386|69452962|FG004|Overall Study|Personal reasons|1|||
37807484|NCT01426386|69452963|FG005|Overall Study|Personal reasons|0|||
37807485|NCT01404234|69452977|FG000|Overall Study|Withdrawal by Subject|2|||
37807486|NCT01403610|69452985|FG000|Overall Study|Withdrawal by Subject|2|||
37807487|NCT01403610|69452986|FG001|Overall Study|Withdrawal by Subject|0|||
37807488|NCT01403610|69452987|FG002|Overall Study|Withdrawal by Subject|0|||
37807489|NCT01403610|69452988|FG003|Overall Study|Withdrawal by Subject|0|||
37807490|NCT01403610|69452985|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
37807491|NCT01403610|69452986|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
37807492|NCT01403610|69452987|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
37807493|NCT01403610|69452988|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
37807494|NCT01403064|69453002|FG000|Overall Study|Death|0|||
37807495|NCT01403064|69453003|FG001|Overall Study|Death|0|||
37807496|NCT01403064|69453004|FG002|Overall Study|Death|1|||
37807497|NCT01403064|69453005|FG003|Overall Study|Death|1|||
37976359|NCT00299104|69663644|FG000|Safety Follow-Up (SFU) Period|Death|3|||
37976360|NCT00299104|69663645|FG001|Safety Follow-Up (SFU) Period|Death|2|||
37976361|NCT00299104|69663646|FG002|Safety Follow-Up (SFU) Period|Death|1|||
37976362|NCT00299104|69663644|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
37807498|NCT01403064|69453002|FG000|Overall Study|Withdrawal by Subject|0|||
37807499|NCT01403064|69453003|FG001|Overall Study|Withdrawal by Subject|0|||
37807500|NCT01403064|69453004|FG002|Overall Study|Withdrawal by Subject|1|||
37807501|NCT01403064|69453005|FG003|Overall Study|Withdrawal by Subject|1|||
37807502|NCT01403064|69453002|FG000|Overall Study|Other|1|||
37694032|NCT02460224|69170385|FG008|Overall Study|Adverse Event|0|||
37807503|NCT01403064|69453003|FG001|Overall Study|Other|0|||
37807504|NCT01403064|69453004|FG002|Overall Study|Other|2|||
37807505|NCT01403064|69453005|FG003|Overall Study|Other|1|||
37807506|NCT01402986|69453024|FG000|Overall Study|Withdrawal by Subject|7|||
37807507|NCT01402986|69453025|FG001|Overall Study|Withdrawal by Subject|10|||
37807508|NCT01402986|69453026|FG002|Overall Study|Withdrawal by Subject|7|||
37807509|NCT01402986|69453027|FG003|Overall Study|Withdrawal by Subject|13|||
37976363|NCT00299104|69663645|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
37976364|NCT00299104|69663646|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
37976365|NCT00299104|69663644|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
37976366|NCT00299104|69663645|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
37976367|NCT00299104|69663646|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
37976368|NCT00299104|69663644|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
37976369|NCT00299104|69663645|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
37976370|NCT00299104|69663646|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
37976371|NCT00299104|69663644|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
37976372|NCT00299104|69663645|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
37976373|NCT00299104|69663646|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
37976374|NCT00299104|69663644|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
37976375|NCT00299104|69663645|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
37976376|NCT00299104|69663646|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
37976377|NCT00299104|69663644|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
37976378|NCT00299104|69663645|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
37976379|NCT00299104|69663646|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
37976380|NCT00299104|69663644|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
37976381|NCT00299104|69663645|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
37976382|NCT00299104|69663646|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
37976383|NCT00313612|69663656|FG000|Overall Study|Patient never received treatment|0|||
37976384|NCT00313612|69663657|FG001|Overall Study|Patient never received treatment|1|||
37976385|NCT00507416|69663666|FG000|Overall Study|Adverse Event|58|||
37976386|NCT00507416|69663667|FG001|Overall Study|Adverse Event|67|||
37976387|NCT00507416|69663668|FG002|Overall Study|Adverse Event|65|||
37976388|NCT00507416|69663666|FG000|Overall Study|Protocol Violation|1|||
37976389|NCT00507416|69663667|FG001|Overall Study|Protocol Violation|2|||
37976390|NCT00507416|69663668|FG002|Overall Study|Protocol Violation|0|||
37976391|NCT00507416|69663666|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
37976392|NCT00507416|69663667|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
37976393|NCT00507416|69663668|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
37976394|NCT00507416|69663666|FG000|Overall Study|Progressive Disease|20|||
37976395|NCT00507416|69663667|FG001|Overall Study|Progressive Disease|10|||
37976396|NCT00507416|69663668|FG002|Overall Study|Progressive Disease|13|||
37976397|NCT00507416|69663666|FG000|Overall Study|Patient declined further treatment|18|||
37976398|NCT00507416|69663667|FG001|Overall Study|Patient declined further treatment|14|||
37976399|NCT00507416|69663668|FG002|Overall Study|Patient declined further treatment|11|||
37976400|NCT00507416|69663666|FG000|Overall Study|Other|11|||
37976401|NCT00507416|69663667|FG001|Overall Study|Other|16|||
37976402|NCT00507416|69663668|FG002|Overall Study|Other|13|||
37976403|NCT00507416|69663666|FG000|Overall Study|Did not Receive Study Treatment|3|||
37976404|NCT00507416|69663667|FG001|Overall Study|Did not Receive Study Treatment|9|||
37976405|NCT00507416|69663668|FG002|Overall Study|Did not Receive Study Treatment|4|||
37976406|NCT00489476|69663680|FG000|Overall Study|Lost to Follow-up|0|||
37976407|NCT00489476|69663681|FG001|Overall Study|Lost to Follow-up|1|||
37976408|NCT00489476|69663682|FG002|Overall Study|Lost to Follow-up|0|||
37976409|NCT00489476|69663683|FG003|Overall Study|Lost to Follow-up|0|||
37976410|NCT00550745|69663695|FG000|Overall Study|Death|20|||
37976411|NCT00550745|69663696|FG001|Overall Study|Death|16|||
37976412|NCT00550745|69663695|FG000|Overall Study|Lost to Follow-up|45|||
37976413|NCT00550745|69663696|FG001|Overall Study|Lost to Follow-up|30|||
37976414|NCT00550745|69663695|FG000|Overall Study|Physician Decision|0|||
37976415|NCT00550745|69663696|FG001|Overall Study|Physician Decision|2|||
37976416|NCT00550745|69663695|FG000|Overall Study|Protocol Violation|4|||
37976417|NCT00550745|69663696|FG001|Overall Study|Protocol Violation|2|||
37807510|NCT01402986|69453024|FG000|Overall Study|Death|0|||
37807511|NCT01402986|69453025|FG001|Overall Study|Death|0|||
37807512|NCT01402986|69453026|FG002|Overall Study|Death|0|||
37976418|NCT00550745|69663695|FG000|Overall Study|Withdrawal by Subject|17|||
37976419|NCT00550745|69663696|FG001|Overall Study|Withdrawal by Subject|10|||
37976420|NCT00550745|69663695|FG000|Overall Study|Screen failure|1|||
37976421|NCT00550745|69663696|FG001|Overall Study|Screen failure|0|||
37976422|NCT00452790|69663704|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
37807513|NCT01402986|69453027|FG003|Overall Study|Death|2|||
37807514|NCT01402986|69453024|FG000|Overall Study|Lost to Follow-up|0|||
37976423|NCT00452790|69663705|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
37976424|NCT00452790|69663704|FG000|Infant Series|Parent/legal guardian request|8|||
37976425|NCT00452790|69663705|FG001|Infant Series|Parent/legal guardian request|6|||
37976426|NCT00452790|69663704|FG000|Infant Series|Failed to return|4|||
37976427|NCT00452790|69663705|FG001|Infant Series|Failed to return|1|||
37976428|NCT00452790|69663704|FG000|Infant Series|Protocol Violation|1|||
37976429|NCT00452790|69663705|FG001|Infant Series|Protocol Violation|3|||
37976430|NCT00452790|69663704|FG000|Infant Series|Lost to Follow-up|2|||
37976431|NCT00452790|69663705|FG001|Infant Series|Lost to Follow-up|2|||
37976432|NCT00452790|69663704|FG000|Infant Series|Adverse Event|1|||
37807515|NCT01402986|69453025|FG001|Overall Study|Lost to Follow-up|0|||
37807516|NCT01402986|69453026|FG002|Overall Study|Lost to Follow-up|0|||
37807517|NCT01402986|69453027|FG003|Overall Study|Lost to Follow-up|1|||
37807518|NCT01402986|69453024|FG000|Overall Study|Other|2|||
37807519|NCT01402986|69453025|FG001|Overall Study|Other|5|||
37807520|NCT01402986|69453026|FG002|Overall Study|Other|1|||
37807521|NCT01402986|69453027|FG003|Overall Study|Other|6|||
37807522|NCT01402908|69453039|FG000|Overall Study|Withdrawal by Subject|30|||
37807523|NCT01402908|69453040|FG001|Overall Study|Withdrawal by Subject|17|||
37807524|NCT01402908|69453039|FG000|Overall Study|Lost to Follow-up|3|||
37807525|NCT01402908|69453040|FG001|Overall Study|Lost to Follow-up|1|||
37807526|NCT01402908|69453039|FG000|Overall Study|Physician Decision|1|||
37807527|NCT01402908|69453040|FG001|Overall Study|Physician Decision|0|||
37807528|NCT01389258|69453046|FG000|Overall Study|Lost to Follow-up|5|||
37807529|NCT01389102|69453056|FG000|Overall Study|Adverse Event|1|||
37807530|NCT01389102|69453057|FG001|Overall Study|Adverse Event|3|||
37807531|NCT01389102|69453058|FG002|Overall Study|Adverse Event|2|||
37807532|NCT01389102|69453059|FG003|Overall Study|Adverse Event|2|||
37807533|NCT01389102|69453060|FG004|Overall Study|Adverse Event|2|||
37807534|NCT01389102|69453061|FG005|Overall Study|Adverse Event|2|||
37807535|NCT01389102|69453056|FG000|Overall Study|Hurricane Katrina|4|||
37807536|NCT01389102|69453057|FG001|Overall Study|Hurricane Katrina|2|||
37807537|NCT01389102|69453058|FG002|Overall Study|Hurricane Katrina|3|||
37807538|NCT01389102|69453059|FG003|Overall Study|Hurricane Katrina|0|||
37807539|NCT01389102|69453060|FG004|Overall Study|Hurricane Katrina|3|||
37807540|NCT01389102|69453061|FG005|Overall Study|Hurricane Katrina|1|||
37807541|NCT01389102|69453056|FG000|Overall Study|Lost to Follow-up|4|||
37807542|NCT01389102|69453057|FG001|Overall Study|Lost to Follow-up|1|||
37807543|NCT01389102|69453058|FG002|Overall Study|Lost to Follow-up|1|||
37807544|NCT01389102|69453059|FG003|Overall Study|Lost to Follow-up|2|||
37807545|NCT01389102|69453060|FG004|Overall Study|Lost to Follow-up|4|||
37807546|NCT01389102|69453061|FG005|Overall Study|Lost to Follow-up|1|||
37807547|NCT01389102|69453056|FG000|Overall Study|Protocol Violation|0|||
37807548|NCT01389102|69453057|FG001|Overall Study|Protocol Violation|0|||
37807549|NCT01389102|69453058|FG002|Overall Study|Protocol Violation|3|||
37807550|NCT01389102|69453059|FG003|Overall Study|Protocol Violation|0|||
37807551|NCT01389102|69453060|FG004|Overall Study|Protocol Violation|1|||
37807552|NCT01389102|69453061|FG005|Overall Study|Protocol Violation|1|||
37807553|NCT01389102|69453056|FG000|Overall Study|Withdrawal by Subject|7|||
37807554|NCT01389102|69453057|FG001|Overall Study|Withdrawal by Subject|4|||
37807555|NCT01389102|69453058|FG002|Overall Study|Withdrawal by Subject|9|||
37807556|NCT01389102|69453059|FG003|Overall Study|Withdrawal by Subject|2|||
37807557|NCT01389102|69453060|FG004|Overall Study|Withdrawal by Subject|3|||
37807558|NCT01389102|69453061|FG005|Overall Study|Withdrawal by Subject|3|||
37807559|NCT01389102|69453056|FG000|Overall Study|Subject Traveling Out of Country|0|||
37807560|NCT01389102|69453057|FG001|Overall Study|Subject Traveling Out of Country|0|||
37807561|NCT01389102|69453058|FG002|Overall Study|Subject Traveling Out of Country|0|||
37807562|NCT01389102|69453059|FG003|Overall Study|Subject Traveling Out of Country|1|||
37807563|NCT01389102|69453060|FG004|Overall Study|Subject Traveling Out of Country|0|||
37807564|NCT01389102|69453061|FG005|Overall Study|Subject Traveling Out of Country|0|||
37807565|NCT01389102|69453056|FG000|Overall Study|Subject Moved|2|||
37807566|NCT01389102|69453057|FG001|Overall Study|Subject Moved|0|||
37807567|NCT01389102|69453058|FG002|Overall Study|Subject Moved|1|||
37807568|NCT01389102|69453059|FG003|Overall Study|Subject Moved|0|||
37807569|NCT01389102|69453060|FG004|Overall Study|Subject Moved|0|||
37807570|NCT01389102|69453061|FG005|Overall Study|Subject Moved|0|||
37807571|NCT01389102|69453056|FG000|Overall Study|Unavailable due to husband's illness|0|||
37807572|NCT01389102|69453057|FG001|Overall Study|Unavailable due to husband's illness|1|||
37807573|NCT01389102|69453058|FG002|Overall Study|Unavailable due to husband's illness|0|||
37807574|NCT01389102|69453059|FG003|Overall Study|Unavailable due to husband's illness|0|||
37807575|NCT01389102|69453060|FG004|Overall Study|Unavailable due to husband's illness|0|||
37694033|NCT02460224|69170386|FG009|Overall Study|Adverse Event|0|||
37807576|NCT01389102|69453061|FG005|Overall Study|Unavailable due to husband's illness|0|||
37807577|NCT01389102|69453056|FG000|Overall Study|Investigator Judgement|0|||
37807578|NCT01389102|69453057|FG001|Overall Study|Investigator Judgement|1|||
37807579|NCT01389102|69453058|FG002|Overall Study|Investigator Judgement|0|||
37807580|NCT01389102|69453059|FG003|Overall Study|Investigator Judgement|0|||
37807581|NCT01389102|69453060|FG004|Overall Study|Investigator Judgement|0|||
37807582|NCT01389102|69453061|FG005|Overall Study|Investigator Judgement|0|||
37807583|NCT01402284|69453081|FG000|Overall Study|Withdrawal consent|2|||
37807584|NCT01402284|69453081|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
37807585|NCT01402284|69453081|FG000|Overall Study|Physician Decision|1|||
37807586|NCT01402284|69453081|FG000|Overall Study|Disease progression on study|10|||
37807587|NCT01388790|69453085|FG000|Overall Study|Ongoing at data cut-off date|8|||
37807588|NCT01388478|69453089|FG000|Overall Study|Adverse Event|4|||
37807589|NCT01388478|69453089|FG000|Overall Study|Withdrawal by Subject|1|||
37864307|NCT01260350|69547945|FG008|Overall Study|Lack of Efficacy|0|||
37807590|NCT01424670|69453095|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
37807591|NCT01424670|69453096|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
37807592|NCT01424670|69453095|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
37807593|NCT01424670|69453096|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
37807594|NCT01424670|69453095|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
37807595|NCT01424670|69453096|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
37807596|NCT01424670|69453095|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
37807597|NCT01424670|69453096|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
37694034|NCT02460224|69170387|FG010|Overall Study|Adverse Event|0|||
37694035|NCT02460224|69170388|FG011|Overall Study|Adverse Event|0|||
37694036|NCT02460224|69170389|FG012|Overall Study|Adverse Event|1|||
37807598|NCT01424670|69453095|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
37807599|NCT01424670|69453096|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
37807600|NCT01424670|69453095|FG000|Continuation Period|Adverse Event|13|||
37807601|NCT01424670|69453096|FG001|Continuation Period|Adverse Event|5|||
37807602|NCT01424670|69453095|FG000|Continuation Period|Lost to Follow-up|2|||
37807603|NCT01424670|69453096|FG001|Continuation Period|Lost to Follow-up|0|||
37807604|NCT01424670|69453095|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
37807605|NCT01424670|69453096|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
37807606|NCT01424670|69453095|FG000|Continuation Period|Physician Decision|5|||
37807607|NCT01424670|69453096|FG001|Continuation Period|Physician Decision|4|||
37807608|NCT01424670|69453095|FG000|Continuation Period|Withdrawal by Subject|13|||
37807609|NCT01424670|69453096|FG001|Continuation Period|Withdrawal by Subject|4|||
37807610|NCT01424514|69453104|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
37807611|NCT01424514|69453105|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
37807612|NCT01424514|69453104|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
37807613|NCT01424514|69453105|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
37807614|NCT01400958|69453118|FG000|Overall Study|Physician Decision|0|||
37807615|NCT01400958|69453119|FG001|Overall Study|Physician Decision|1|||
37807616|NCT01400958|69453118|FG000|Overall Study|Withdrawal by Subject|0|||
37807617|NCT01400958|69453119|FG001|Overall Study|Withdrawal by Subject|1|||
37807618|NCT01400958|69453118|FG000|Overall Study|Adverse Event|1|||
37807619|NCT01400958|69453119|FG001|Overall Study|Adverse Event|0|||
37807620|NCT01388166|69453125|FG000|Overall Study|Adverse Event|16|||
37807621|NCT01388166|69453125|FG000|Overall Study|Lost to Follow-up|30|||
37807622|NCT01388166|69453125|FG000|Overall Study|Others than specified above|13|||
37807623|NCT01400412|69453131|FG000|Overall Study|Lost to Follow-up|4|||
37807624|NCT01400412|69453132|FG001|Overall Study|Lost to Follow-up|7|||
37807625|NCT01400412|69453131|FG000|Overall Study|Withdrawal by Subject|3|||
37807626|NCT01400412|69453132|FG001|Overall Study|Withdrawal by Subject|4|||
37807627|NCT01400412|69453131|FG000|Overall Study|Unable to complete|3|||
37807628|NCT01400412|69453132|FG001|Overall Study|Unable to complete|3|||
37807629|NCT01400412|69453131|FG000|Overall Study|Never started study treatment|0|||
37807630|NCT01400412|69453132|FG001|Overall Study|Never started study treatment|3|||
37807631|NCT01422876|69453150|FG000|Week 24|Lost to Follow-up|1|||
37807632|NCT01422876|69453151|FG001|Week 24|Lost to Follow-up|1|||
37807633|NCT01422876|69453152|FG002|Week 24|Lost to Follow-up|2|||
37807634|NCT01422876|69453153|FG003|Week 24|Lost to Follow-up|4|||
37807635|NCT01422876|69453154|FG004|Week 24|Lost to Follow-up|2|||
37807636|NCT01422876|69453155|FG005|Week 24|Lost to Follow-up|0|||
37807637|NCT01422876|69453156|FG006|Week 24|Lost to Follow-up|1|||
37807638|NCT01422876|69453157|FG007|Week 24|Lost to Follow-up|3|||
37807639|NCT01422876|69453158|FG008|Week 24|Lost to Follow-up|3|||
37807640|NCT01422876|69453159|FG009|Week 24|Lost to Follow-up|4|||
37807641|NCT01422876|69453150|FG000|Week 24|Consent withdrawn|5|||
37807642|NCT01422876|69453151|FG001|Week 24|Consent withdrawn|1|||
37807643|NCT01422876|69453152|FG002|Week 24|Consent withdrawn|3|||
37807644|NCT01422876|69453153|FG003|Week 24|Consent withdrawn|4|||
37807645|NCT01422876|69453154|FG004|Week 24|Consent withdrawn|5|||
37807646|NCT01422876|69453155|FG005|Week 24|Consent withdrawn|6|||
37976433|NCT00452790|69663705|FG001|Infant Series|Adverse Event|2|||
37807647|NCT01422876|69453156|FG006|Week 24|Consent withdrawn|5|||
37807648|NCT01422876|69453157|FG007|Week 24|Consent withdrawn|4|||
37807649|NCT01422876|69453158|FG008|Week 24|Consent withdrawn|3|||
37807650|NCT01422876|69453159|FG009|Week 24|Consent withdrawn|6|||
37864308|NCT01260350|69547946|FG009|Overall Study|Lack of Efficacy|0|||
37864309|NCT01260350|69547947|FG010|Overall Study|Lack of Efficacy|0|||
37807651|NCT01422876|69453150|FG000|Week 24|Death|0|||
37807652|NCT01422876|69453151|FG001|Week 24|Death|1|||
37807653|NCT01422876|69453152|FG002|Week 24|Death|0|||
37807654|NCT01422876|69453153|FG003|Week 24|Death|0|||
37807655|NCT01422876|69453154|FG004|Week 24|Death|0|||
37807656|NCT01422876|69453155|FG005|Week 24|Death|0|||
37807657|NCT01422876|69453156|FG006|Week 24|Death|0|||
37807658|NCT01422876|69453157|FG007|Week 24|Death|0|||
37807659|NCT01422876|69453158|FG008|Week 24|Death|0|||
37807660|NCT01422876|69453159|FG009|Week 24|Death|0|||
37807661|NCT01422876|69453150|FG000|Week 52|Lost to Follow-up|3|||
37807662|NCT01422876|69453151|FG001|Week 52|Lost to Follow-up|5|||
37807663|NCT01422876|69453152|FG002|Week 52|Lost to Follow-up|7|||
37807664|NCT01422876|69453153|FG003|Week 52|Lost to Follow-up|5|||
37807665|NCT01422876|69453154|FG004|Week 52|Lost to Follow-up|8|||
37807666|NCT01422876|69453155|FG005|Week 52|Lost to Follow-up|5|||
37807667|NCT01422876|69453156|FG006|Week 52|Lost to Follow-up|5|||
37807668|NCT01422876|69453157|FG007|Week 52|Lost to Follow-up|8|||
37976434|NCT00452790|69663704|FG000|Infant Series|Other reasons|1|||
37807669|NCT01422876|69453158|FG008|Week 52|Lost to Follow-up|7|||
37807670|NCT01422876|69453159|FG009|Week 52|Lost to Follow-up|8|||
37807671|NCT01422876|69453150|FG000|Week 52|Consent withdrawn|9|||
37807672|NCT01422876|69453151|FG001|Week 52|Consent withdrawn|4|||
37807673|NCT01422876|69453152|FG002|Week 52|Consent withdrawn|6|||
37807674|NCT01422876|69453153|FG003|Week 52|Consent withdrawn|12|||
37807675|NCT01422876|69453154|FG004|Week 52|Consent withdrawn|7|||
37807676|NCT01422876|69453155|FG005|Week 52|Consent withdrawn|12|||
37807677|NCT01422876|69453156|FG006|Week 52|Consent withdrawn|10|||
37807678|NCT01422876|69453157|FG007|Week 52|Consent withdrawn|12|||
37807679|NCT01422876|69453158|FG008|Week 52|Consent withdrawn|13|||
37807680|NCT01422876|69453159|FG009|Week 52|Consent withdrawn|9|||
37807681|NCT01422876|69453150|FG000|Week 52|Death|0|||
37807682|NCT01422876|69453151|FG001|Week 52|Death|1|||
37807683|NCT01422876|69453152|FG002|Week 52|Death|0|||
37807684|NCT01422876|69453153|FG003|Week 52|Death|1|||
37807685|NCT01422876|69453154|FG004|Week 52|Death|0|||
37807686|NCT01422876|69453155|FG005|Week 52|Death|0|||
37807687|NCT01422876|69453156|FG006|Week 52|Death|1|||
37807688|NCT01422876|69453157|FG007|Week 52|Death|3|||
37807689|NCT01422876|69453158|FG008|Week 52|Death|1|||
37807690|NCT01422876|69453159|FG009|Week 52|Death|0|||
37807691|NCT01422720|69453177|FG000|Overall Study|Adverse Event|16|||
37976435|NCT00452790|69663705|FG001|Infant Series|Other reasons|2|||
37807692|NCT01422720|69453177|FG000|Overall Study|Lack of Efficacy|1|||
37807693|NCT01422720|69453177|FG000|Overall Study|Withdrawal by Subject|4|||
37807694|NCT01422720|69453177|FG000|Overall Study|Ineligibility|1|||
37807695|NCT01387932|69453187|FG000|Randomized and Treated|Physician Decision|3|||
37807696|NCT01387932|69453188|FG001|Randomized and Treated|Physician Decision|2|||
37807697|NCT01387932|69453187|FG000|Randomized and Treated|Withdrawal by Subject|4|||
37807698|NCT01387932|69453188|FG001|Randomized and Treated|Withdrawal by Subject|2|||
37807699|NCT01387932|69453187|FG000|Survival Follow-up|Liver Transplant|24|||
37807700|NCT01387932|69453188|FG001|Survival Follow-up|Liver Transplant|28|||
37807701|NCT01387932|69453187|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
37807702|NCT01387932|69453188|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
37807703|NCT01387932|69453187|FG000|Survival Follow-up|Withdrawal by Subject|2|||
37807704|NCT01387932|69453188|FG001|Survival Follow-up|Withdrawal by Subject|4|||
37807705|NCT01387932|69453187|FG000|Survival Follow-up|Lost to Follow-up|6|||
37807706|NCT01387932|69453188|FG001|Survival Follow-up|Lost to Follow-up|5|||
37807707|NCT01422408|69453196|FG000|Overall Study|Adverse Event|1|||
37807708|NCT01422408|69453196|FG000|Overall Study|Withdrawal by Subject|3|||
37807709|NCT01399788|69453200|FG000|First Intervention Period|Adverse Event|1|||
37807710|NCT01399788|69453201|FG001|First Intervention Period|Adverse Event|0|||
37807711|NCT01387542|69453207|FG000|Overall Study|Adverse Event|3|||
37807712|NCT01387542|69453207|FG000|Overall Study|Withdrawal by Subject|1|||
37807713|NCT01387542|69453207|FG000|Overall Study|Changed diagnosis|1|||
37807714|NCT01387542|69453207|FG000|Overall Study|Insufficient response|1|||
37807715|NCT01387542|69453207|FG000|Overall Study|Non-compliant|1|||
37807716|NCT01387542|69453207|FG000|Overall Study|Lost to Follow-up|1|||
37976436|NCT00452790|69663704|FG000|Infant Series|Investigator request|0|||
37807717|NCT01387230|69453214|FG000|Overall Study|Adverse Event|0|||
37807718|NCT01387230|69453215|FG001|Overall Study|Adverse Event|1|||
37807719|NCT01387230|69453216|FG002|Overall Study|Adverse Event|3|||
37807720|NCT01387230|69453214|FG000|Overall Study|Lack of Efficacy|8|||
37807721|NCT01387230|69453215|FG001|Overall Study|Lack of Efficacy|5|||
37807722|NCT01387230|69453216|FG002|Overall Study|Lack of Efficacy|4|||
37807723|NCT01387230|69453214|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
37807724|NCT01387230|69453215|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
37807725|NCT01387230|69453216|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
37807726|NCT01387230|69453214|FG000|Overall Study|Lost to Follow-up|0|||
37807727|NCT01387230|69453215|FG001|Overall Study|Lost to Follow-up|0|||
37807728|NCT01387230|69453216|FG002|Overall Study|Lost to Follow-up|1|||
37807729|NCT01387230|69453214|FG000|Overall Study|Withdrawal by Subject|4|||
37807730|NCT01387230|69453215|FG001|Overall Study|Withdrawal by Subject|1|||
37807731|NCT01387230|69453216|FG002|Overall Study|Withdrawal by Subject|0|||
37976437|NCT00452790|69663705|FG001|Infant Series|Investigator request|1|||
37976438|NCT00452790|69663704|FG000|Infant Series|Death|0|||
37976439|NCT00452790|69663705|FG001|Infant Series|Death|1|||
37807732|NCT01387074|69453224|FG000|Overall Study|Lost to Follow-up|7|||
37807733|NCT01387074|69453224|FG000|Overall Study|Lack of Efficacy|1|||
37807734|NCT01386606|69453232|FG000|Overall Study|Adverse Event|0|||
37807735|NCT01386606|69453233|FG001|Overall Study|Adverse Event|1|||
37807736|NCT01386606|69453234|FG002|Overall Study|Adverse Event|0|||
37807737|NCT01386606|69453235|FG003|Overall Study|Adverse Event|0|||
37807738|NCT01386606|69453232|FG000|Overall Study|Withdrawal by Subject|0|||
37807739|NCT01386606|69453233|FG001|Overall Study|Withdrawal by Subject|1|||
37807740|NCT01386606|69453234|FG002|Overall Study|Withdrawal by Subject|1|||
37807741|NCT01386606|69453235|FG003|Overall Study|Withdrawal by Subject|0|||
37807742|NCT01386606|69453232|FG000|Overall Study|Protocol Violation|1|||
37807743|NCT01386606|69453233|FG001|Overall Study|Protocol Violation|0|||
37807744|NCT01386606|69453234|FG002|Overall Study|Protocol Violation|1|||
37807745|NCT01386606|69453235|FG003|Overall Study|Protocol Violation|1|||
37807746|NCT01386606|69453232|FG000|Overall Study|Lost to Follow-up|2|||
37807747|NCT01386606|69453233|FG001|Overall Study|Lost to Follow-up|0|||
37807748|NCT01386606|69453234|FG002|Overall Study|Lost to Follow-up|0|||
37807749|NCT01386606|69453235|FG003|Overall Study|Lost to Follow-up|0|||
37807750|NCT01386606|69453232|FG000|Overall Study|Subject incarcerated|0|||
37807751|NCT01386606|69453233|FG001|Overall Study|Subject incarcerated|1|||
37807752|NCT01386606|69453234|FG002|Overall Study|Subject incarcerated|0|||
37807753|NCT01386606|69453235|FG003|Overall Study|Subject incarcerated|0|||
37807754|NCT01386606|69453232|FG000|Overall Study|Unable to draw PK|1|||
37807755|NCT01386606|69453233|FG001|Overall Study|Unable to draw PK|0|||
37807756|NCT01386606|69453234|FG002|Overall Study|Unable to draw PK|0|||
37807757|NCT01386606|69453235|FG003|Overall Study|Unable to draw PK|0|||
37807758|NCT01386606|69453232|FG000|Overall Study|T levels too high|0|||
37807759|NCT01386606|69453233|FG001|Overall Study|T levels too high|1|||
37807760|NCT01386606|69453234|FG002|Overall Study|T levels too high|1|||
37807761|NCT01386606|69453235|FG003|Overall Study|T levels too high|0|||
37807762|NCT01385748|69453252|FG000|Overall Study|Withdrawal by Subject|7|||
37976440|NCT00452790|69663704|FG000|After Infant Series|Investigator request|10|||
37976441|NCT00452790|69663705|FG001|After Infant Series|Investigator request|10|||
37807763|NCT01385748|69453253|FG001|Overall Study|Withdrawal by Subject|4|||
37807764|NCT01385748|69453254|FG002|Overall Study|Withdrawal by Subject|5|||
37807765|NCT01385748|69453252|FG000|Overall Study|Noncompliance|3|||
37807766|NCT01385748|69453253|FG001|Overall Study|Noncompliance|1|||
37807767|NCT01385748|69453254|FG002|Overall Study|Noncompliance|6|||
37807768|NCT01385748|69453252|FG000|Overall Study|Other|1|||
37807769|NCT01385748|69453253|FG001|Overall Study|Other|7|||
37807770|NCT01385748|69453254|FG002|Overall Study|Other|1|||
37807771|NCT01385748|69453252|FG000|Overall Study|Adverse Event|4|||
37807772|NCT01385748|69453253|FG001|Overall Study|Adverse Event|2|||
37807773|NCT01385748|69453254|FG002|Overall Study|Adverse Event|1|||
37807774|NCT01397448|69453269|FG000|Overall Study|Adverse Event|4|||
37807775|NCT01397448|69453270|FG001|Overall Study|Adverse Event|4|||
37807776|NCT01397448|69453271|FG002|Overall Study|Adverse Event|6|||
37807777|NCT01397448|69453269|FG000|Overall Study|Withdrawal by Subject|4|||
37807778|NCT01397448|69453270|FG001|Overall Study|Withdrawal by Subject|4|||
37807779|NCT01397448|69453271|FG002|Overall Study|Withdrawal by Subject|3|||
37807780|NCT01397448|69453269|FG000|Overall Study|Lack of Efficacy|2|||
37807781|NCT01397448|69453270|FG001|Overall Study|Lack of Efficacy|0|||
37807782|NCT01397448|69453271|FG002|Overall Study|Lack of Efficacy|5|||
37807783|NCT01397448|69453269|FG000|Overall Study|Other|8|||
37807784|NCT01397448|69453270|FG001|Overall Study|Other|7|||
37694037|NCT02460224|69170390|FG013|Overall Study|Adverse Event|0|||
37694038|NCT02460224|69170391|FG014|Overall Study|Adverse Event|0|||
37694039|NCT02460224|69170392|FG015|Overall Study|Adverse Event|0|||
37807785|NCT01397448|69453271|FG002|Overall Study|Other|4|||
37807786|NCT01385202|69453279|FG000|Overall Study|Lost to Follow-up|6|||
37807787|NCT01385202|69453279|FG000|Overall Study|Not Eligible|11|||
37807788|NCT01385202|69453279|FG000|Overall Study|Withdrawn|1|||
37807789|NCT01384734|69453290|FG000|Overall Study|Adverse Event|0|||
37807790|NCT01384734|69453291|FG001|Overall Study|Adverse Event|3|||
37807791|NCT01384734|69453292|FG002|Overall Study|Adverse Event|0|||
37807792|NCT01384734|69453293|FG003|Overall Study|Adverse Event|2|||
37807793|NCT01384734|69453294|FG004|Overall Study|Adverse Event|7|||
37807794|NCT01384734|69453290|FG000|Overall Study|Death|1|||
37807795|NCT01384734|69453291|FG001|Overall Study|Death|0|||
37807796|NCT01384734|69453292|FG002|Overall Study|Death|1|||
37807797|NCT01384734|69453293|FG003|Overall Study|Death|0|||
37807798|NCT01384734|69453294|FG004|Overall Study|Death|0|||
37807799|NCT01384734|69453290|FG000|Overall Study|Continuation criteria not met|0|||
37807800|NCT01384734|69453291|FG001|Overall Study|Continuation criteria not met|0|||
37807801|NCT01384734|69453292|FG002|Overall Study|Continuation criteria not met|1|||
37807802|NCT01384734|69453293|FG003|Overall Study|Continuation criteria not met|1|||
37807803|NCT01384734|69453294|FG004|Overall Study|Continuation criteria not met|0|||
37807804|NCT01384734|69453290|FG000|Overall Study|Lack of Efficacy|3|||
37807805|NCT01384734|69453291|FG001|Overall Study|Lack of Efficacy|7|||
37807806|NCT01384734|69453292|FG002|Overall Study|Lack of Efficacy|4|||
37807807|NCT01384734|69453293|FG003|Overall Study|Lack of Efficacy|4|||
37807808|NCT01384734|69453294|FG004|Overall Study|Lack of Efficacy|2|||
37807809|NCT01384734|69453290|FG000|Overall Study|Lost to Follow-up|5|||
37807810|NCT01384734|69453291|FG001|Overall Study|Lost to Follow-up|3|||
37807811|NCT01384734|69453292|FG002|Overall Study|Lost to Follow-up|3|||
37807812|NCT01384734|69453293|FG003|Overall Study|Lost to Follow-up|8|||
37807813|NCT01384734|69453294|FG004|Overall Study|Lost to Follow-up|5|||
37807814|NCT01384734|69453290|FG000|Overall Study|Non-compliance with study drug|1|||
37807815|NCT01384734|69453291|FG001|Overall Study|Non-compliance with study drug|2|||
37807816|NCT01384734|69453292|FG002|Overall Study|Non-compliance with study drug|6|||
37807817|NCT01384734|69453293|FG003|Overall Study|Non-compliance with study drug|0|||
37807818|NCT01384734|69453294|FG004|Overall Study|Non-compliance with study drug|2|||
37807819|NCT01384734|69453290|FG000|Overall Study|Pregnancy|0|||
37807820|NCT01384734|69453291|FG001|Overall Study|Pregnancy|1|||
37807821|NCT01384734|69453292|FG002|Overall Study|Pregnancy|0|||
37807822|NCT01384734|69453293|FG003|Overall Study|Pregnancy|0|||
37807823|NCT01384734|69453294|FG004|Overall Study|Pregnancy|1|||
37807824|NCT01384734|69453290|FG000|Overall Study|Sponsor terminated|0|||
37807825|NCT01384734|69453291|FG001|Overall Study|Sponsor terminated|0|||
37807826|NCT01384734|69453292|FG002|Overall Study|Sponsor terminated|0|||
37807827|NCT01384734|69453293|FG003|Overall Study|Sponsor terminated|0|||
37807828|NCT01384734|69453294|FG004|Overall Study|Sponsor terminated|1|||
37807829|NCT01384734|69453290|FG000|Overall Study|Withdrawal by Subject|5|||
37807830|NCT01384734|69453291|FG001|Overall Study|Withdrawal by Subject|5|||
37807831|NCT01384734|69453292|FG002|Overall Study|Withdrawal by Subject|6|||
37807832|NCT01384734|69453293|FG003|Overall Study|Withdrawal by Subject|7|||
37807833|NCT01384734|69453294|FG004|Overall Study|Withdrawal by Subject|9|||
37807834|NCT01384734|69453290|FG000|Overall Study|Investigator relocating|0|||
37807835|NCT01384734|69453291|FG001|Overall Study|Investigator relocating|2|||
37807836|NCT01384734|69453292|FG002|Overall Study|Investigator relocating|0|||
37807837|NCT01384734|69453293|FG003|Overall Study|Investigator relocating|3|||
37807838|NCT01384734|69453294|FG004|Overall Study|Investigator relocating|1|||
37807839|NCT01384734|69453290|FG000|Overall Study|Unable to come back for visit|1|||
37807840|NCT01384734|69453291|FG001|Overall Study|Unable to come back for visit|0|||
37807841|NCT01384734|69453292|FG002|Overall Study|Unable to come back for visit|1|||
37807842|NCT01384734|69453293|FG003|Overall Study|Unable to come back for visit|1|||
37807843|NCT01384734|69453294|FG004|Overall Study|Unable to come back for visit|0|||
37807844|NCT01384734|69453290|FG000|Overall Study|Prison|0|||
37807845|NCT01384734|69453291|FG001|Overall Study|Prison|0|||
37807846|NCT01384734|69453292|FG002|Overall Study|Prison|1|||
37807847|NCT01384734|69453293|FG003|Overall Study|Prison|0|||
37807848|NCT01384734|69453294|FG004|Overall Study|Prison|0|||
37807849|NCT01384734|69453290|FG000|Overall Study|As per Exclusion criteria|0|||
37807850|NCT01384734|69453291|FG001|Overall Study|As per Exclusion criteria|1|||
37807851|NCT01384734|69453292|FG002|Overall Study|As per Exclusion criteria|0|||
37807852|NCT01384734|69453293|FG003|Overall Study|As per Exclusion criteria|0|||
37807853|NCT01384734|69453294|FG004|Overall Study|As per Exclusion criteria|0|||
37807854|NCT01384734|69453290|FG000|Overall Study|Missed End of treatment visit|0|||
37807855|NCT01384734|69453291|FG001|Overall Study|Missed End of treatment visit|0|||
37807856|NCT01384734|69453292|FG002|Overall Study|Missed End of treatment visit|0|||
37807857|NCT01384734|69453293|FG003|Overall Study|Missed End of treatment visit|1|||
37807858|NCT01384734|69453294|FG004|Overall Study|Missed End of treatment visit|0|||
37807859|NCT01384734|69453290|FG000|Overall Study|Adhesion problem|0|||
37807860|NCT01384734|69453291|FG001|Overall Study|Adhesion problem|0|||
37807861|NCT01384734|69453292|FG002|Overall Study|Adhesion problem|0|||
37807862|NCT01384734|69453293|FG003|Overall Study|Adhesion problem|1|||
37807863|NCT01384734|69453294|FG004|Overall Study|Adhesion problem|0|||
37807864|NCT01384734|69453290|FG000|Overall Study|Early termination|0|||
37807865|NCT01384734|69453291|FG001|Overall Study|Early termination|0|||
37807866|NCT01384734|69453292|FG002|Overall Study|Early termination|0|||
37694040|NCT02460224|69170393|FG016|Overall Study|Adverse Event|1|||
37694041|NCT02460224|69170394|FG017|Overall Study|Adverse Event|0|||
37807867|NCT01384734|69453293|FG003|Overall Study|Early termination|0|||
37807868|NCT01384734|69453294|FG004|Overall Study|Early termination|1|||
37807869|NCT01384734|69453290|FG000|Overall Study|Physician Decision|1|||
37807870|NCT01384734|69453291|FG001|Overall Study|Physician Decision|0|||
37807871|NCT01384734|69453292|FG002|Overall Study|Physician Decision|0|||
37807872|NCT01384734|69453293|FG003|Overall Study|Physician Decision|0|||
37807873|NCT01384734|69453294|FG004|Overall Study|Physician Decision|0|||
37807874|NCT01396512|69453305|FG000|Overall Study|Withdrawal by Subject|0|||
37807875|NCT01396512|69453306|FG001|Overall Study|Withdrawal by Subject|1|||
37807876|NCT01396434|69453315|FG000|Overall Study|Lost to Follow-up|1|||
37807877|NCT01396434|69453316|FG001|Overall Study|Lost to Follow-up|0|||
37807878|NCT01396434|69453317|FG002|Overall Study|Lost to Follow-up|0|||
37807879|NCT01396434|69453315|FG000|Overall Study|Other|10|||
37807880|NCT01396434|69453316|FG001|Overall Study|Other|0|||
37807881|NCT01396434|69453317|FG002|Overall Study|Other|0|||
37807882|NCT01383954|69453325|FG000|Overall Study|Lack of Efficacy|2|||
37807883|NCT01383954|69453325|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
37807884|NCT01383954|69453325|FG000|Overall Study|Adverse Event|1|||
37807885|NCT01383954|69453325|FG000|Overall Study|Reason Not Specified|9|||
37807886|NCT01383486|69453329|FG000|Overall Study|Lost to Follow-up|10|||
37807887|NCT01383486|69453329|FG000|Overall Study|Incomplete information for analysis|2|||
37807888|NCT01383486|69453329|FG000|Overall Study|Did not take any product|6|||
37807889|NCT01383174|69453336|FG000|3 Month Assessment|Death|0|||
37807890|NCT01383174|69453337|FG001|3 Month Assessment|Death|1|||
37807891|NCT01383174|69453336|FG000|3 Month Assessment|Lost to Follow-up|2|||
37807892|NCT01383174|69453337|FG001|3 Month Assessment|Lost to Follow-up|0|||
37807893|NCT01383174|69453336|FG000|3 Month Assessment|Refused to complete|4|||
37807894|NCT01383174|69453337|FG001|3 Month Assessment|Refused to complete|0|||
37807895|NCT01383174|69453336|FG000|6 Month Assessment|Lost to Follow-up|1|||
37807896|NCT01383174|69453337|FG001|6 Month Assessment|Lost to Follow-up|1|||
37807897|NCT01383174|69453336|FG000|6 Month Assessment|Refused to complete|4|||
37807898|NCT01383174|69453337|FG001|6 Month Assessment|Refused to complete|0|||
37807899|NCT01396278|69453348|FG000|Overall Study|Adverse Event|0|||
37807900|NCT01396278|69453349|FG001|Overall Study|Adverse Event|0|||
37807901|NCT01396278|69453350|FG002|Overall Study|Adverse Event|0|||
37807902|NCT01396278|69453351|FG003|Overall Study|Adverse Event|2|||
37807903|NCT01396278|69453352|FG004|Overall Study|Adverse Event|0|||
37807904|NCT01396278|69453348|FG000|Overall Study|Withdraw due to trial termination|2|||
37807905|NCT01396278|69453349|FG001|Overall Study|Withdraw due to trial termination|1|||
37807906|NCT01396278|69453350|FG002|Overall Study|Withdraw due to trial termination|1|||
37807907|NCT01396278|69453351|FG003|Overall Study|Withdraw due to trial termination|0|||
37807908|NCT01396278|69453352|FG004|Overall Study|Withdraw due to trial termination|2|||
37807909|NCT01383096|69453367|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
37807910|NCT01383096|69453368|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
37807911|NCT01383096|69453369|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
37807912|NCT01383096|69453367|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
37807913|NCT01383096|69453368|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
37807914|NCT01383096|69453369|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
37807915|NCT01383096|69453367|FG000|Third Intervention (8 Days)|Elevated AST|0|||
37807916|NCT01383096|69453368|FG001|Third Intervention (8 Days)|Elevated AST|1|||
37807917|NCT01383096|69453369|FG002|Third Intervention (8 Days)|Elevated AST|0|||
37807918|NCT01383096|69453367|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
37807919|NCT01383096|69453368|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
37807920|NCT01383096|69453369|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
37807921|NCT01383096|69453367|FG000|Third Intervention (8 Days)|Adverse Event|1|||
37807922|NCT01383096|69453368|FG001|Third Intervention (8 Days)|Adverse Event|0|||
37807923|NCT01383096|69453369|FG002|Third Intervention (8 Days)|Adverse Event|0|||
37807924|NCT01383096|69453367|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
37807925|NCT01383096|69453368|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
37807926|NCT01383096|69453369|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
37807927|NCT01383096|69453367|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
37807928|NCT01383096|69453368|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
37807929|NCT01383096|69453369|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
37694042|NCT02460224|69170395|FG018|Overall Study|Adverse Event|1|||
37694043|NCT02460224|69170396|FG019|Overall Study|Adverse Event|0|||
37694044|NCT02460224|69170397|FG020|Overall Study|Adverse Event|1|||
37694045|NCT02460224|69170398|FG021|Overall Study|Adverse Event|1|||
37694046|NCT02460224|69170399|FG022|Overall Study|Adverse Event|1|||
37694047|NCT02460224|69170400|FG023|Overall Study|Adverse Event|0|||
37694048|NCT02460224|69170401|FG024|Overall Study|Adverse Event|0|||
37694049|NCT02460224|69170402|FG025|Overall Study|Adverse Event|0|||
37694050|NCT02460224|69170403|FG026|Overall Study|Adverse Event|11|||
37694051|NCT02460224|69170404|FG027|Overall Study|Adverse Event|1|||
37694052|NCT02460224|69170405|FG028|Overall Study|Adverse Event|6|||
37694053|NCT02460224|69170377|FG000|Overall Study|Death|0|||
37694054|NCT02460224|69170378|FG001|Overall Study|Death|0|||
37694055|NCT02460224|69170379|FG002|Overall Study|Death|0|||
37694056|NCT02460224|69170380|FG003|Overall Study|Death|0|||
37694057|NCT02460224|69170381|FG004|Overall Study|Death|0|||
37807930|NCT01383096|69453367|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
37807931|NCT01383096|69453368|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
37807932|NCT01383096|69453369|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
37807933|NCT01383096|69453367|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
37694058|NCT02460224|69170382|FG005|Overall Study|Death|2|||
37694059|NCT02460224|69170383|FG006|Overall Study|Death|1|||
37694060|NCT02460224|69170384|FG007|Overall Study|Death|0|||
37694061|NCT02460224|69170385|FG008|Overall Study|Death|0|||
37694062|NCT02460224|69170386|FG009|Overall Study|Death|1|||
37694063|NCT02460224|69170387|FG010|Overall Study|Death|0|||
37694064|NCT02460224|69170388|FG011|Overall Study|Death|0|||
37694065|NCT02460224|69170389|FG012|Overall Study|Death|0|||
37694066|NCT02460224|69170390|FG013|Overall Study|Death|1|||
37694067|NCT02460224|69170391|FG014|Overall Study|Death|0|||
37694068|NCT02460224|69170392|FG015|Overall Study|Death|0|||
37694069|NCT02460224|69170393|FG016|Overall Study|Death|2|||
37807934|NCT01383096|69453368|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
37807935|NCT01383096|69453369|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
37807936|NCT01383096|69453367|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
37807937|NCT01383096|69453368|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
37807938|NCT01383096|69453369|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
37694070|NCT02460224|69170394|FG017|Overall Study|Death|1|||
37694071|NCT02460224|69170395|FG018|Overall Study|Death|0|||
37694072|NCT02460224|69170396|FG019|Overall Study|Death|2|||
37807939|NCT01383096|69453367|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
37807940|NCT01383096|69453368|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
37807941|NCT01383096|69453369|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
37807942|NCT01383018|69453410|FG000|Overall Study|Adverse Event|14|||
37807943|NCT01383018|69453410|FG000|Overall Study|Death|10|||
37807944|NCT01383018|69453410|FG000|Overall Study|Lost to Follow-up|5|||
37807945|NCT01383018|69453410|FG000|Overall Study|Physician Decision|5|||
37807946|NCT01383018|69453410|FG000|Overall Study|Withdrawal by Subject|9|||
37807947|NCT01383018|69453410|FG000|Overall Study|Subject not implanted|76|||
37694073|NCT02460224|69170397|FG020|Overall Study|Death|0|||
37694074|NCT02460224|69170398|FG021|Overall Study|Death|0|||
37694075|NCT02460224|69170399|FG022|Overall Study|Death|0|||
37694076|NCT02460224|69170400|FG023|Overall Study|Death|0|||
37694077|NCT02460224|69170401|FG024|Overall Study|Death|1|||
37694078|NCT02460224|69170402|FG025|Overall Study|Death|1|||
37694079|NCT02460224|69170403|FG026|Overall Study|Death|5|||
37694080|NCT02460224|69170404|FG027|Overall Study|Death|0|||
37694081|NCT02460224|69170405|FG028|Overall Study|Death|1|||
37694082|NCT02460224|69170377|FG000|Overall Study|Lost to Follow-up|0|||
37694083|NCT02460224|69170378|FG001|Overall Study|Lost to Follow-up|0|||
37694084|NCT02460224|69170379|FG002|Overall Study|Lost to Follow-up|0|||
37694085|NCT02460224|69170380|FG003|Overall Study|Lost to Follow-up|0|||
37807948|NCT01383018|69453410|FG000|Overall Study|Missed Visit|247|||
37807949|NCT01383018|69453410|FG000|Overall Study|Site closed early-not compliance related|7|||
37807950|NCT01383018|69453410|FG000|Overall Study|Patient moved away from site|1|||
37807951|NCT01383018|69453410|FG000|Overall Study|Subject Incarcerated|1|||
37807952|NCT01382940|69453424|FG000|Overall Study|Adverse Event|19|||
37807953|NCT01382940|69453424|FG000|Overall Study|Lost to Follow-up|4|||
37694086|NCT02460224|69170381|FG004|Overall Study|Lost to Follow-up|0|||
37694087|NCT02460224|69170382|FG005|Overall Study|Lost to Follow-up|0|||
37694088|NCT02460224|69170383|FG006|Overall Study|Lost to Follow-up|0|||
37694089|NCT02460224|69170384|FG007|Overall Study|Lost to Follow-up|0|||
37694090|NCT02460224|69170385|FG008|Overall Study|Lost to Follow-up|0|||
37694091|NCT02460224|69170386|FG009|Overall Study|Lost to Follow-up|0|||
37694092|NCT02460224|69170387|FG010|Overall Study|Lost to Follow-up|0|||
37807954|NCT01382940|69453424|FG000|Overall Study|Physician Decision|7|||
37807955|NCT01382940|69453424|FG000|Overall Study|Withdrawal by Subject|23|||
37807956|NCT01382940|69453424|FG000|Overall Study|Protocol Violation|20|||
37807957|NCT01381926|69453430|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
37976442|NCT00452790|69663704|FG000|After Infant Series|Adverse Event|4|||
37976443|NCT00452790|69663705|FG001|After Infant Series|Adverse Event|1|||
37976444|NCT00452790|69663704|FG000|After Infant Series|Parent/legal guardian request|1|||
37807958|NCT01381926|69453431|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
37807959|NCT01381926|69453430|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
37807960|NCT01381926|69453431|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
37807961|NCT01395888|69453441|FG000|2-week Run-in Period|Adverse Event|2|||
37976445|NCT00452790|69663705|FG001|After Infant Series|Parent/legal guardian request|3|||
37976446|NCT00452790|69663704|FG000|After Infant Series|Lost to Follow-up|4|||
37976447|NCT00452790|69663705|FG001|After Infant Series|Lost to Follow-up|0|||
37694093|NCT02460224|69170388|FG011|Overall Study|Lost to Follow-up|0|||
37694094|NCT02460224|69170389|FG012|Overall Study|Lost to Follow-up|0|||
37694095|NCT02460224|69170390|FG013|Overall Study|Lost to Follow-up|0|||
37694096|NCT02460224|69170391|FG014|Overall Study|Lost to Follow-up|0|||
37694097|NCT02460224|69170392|FG015|Overall Study|Lost to Follow-up|0|||
37694098|NCT02460224|69170393|FG016|Overall Study|Lost to Follow-up|0|||
37976448|NCT00452790|69663704|FG000|After Infant Series|Failed to return|1|||
37694099|NCT02460224|69170394|FG017|Overall Study|Lost to Follow-up|0|||
37694100|NCT02460224|69170395|FG018|Overall Study|Lost to Follow-up|0|||
37694101|NCT02460224|69170396|FG019|Overall Study|Lost to Follow-up|0|||
37694102|NCT02460224|69170397|FG020|Overall Study|Lost to Follow-up|0|||
37807962|NCT01395888|69453442|FG001|2-week Run-in Period|Adverse Event|0|||
37807963|NCT01395888|69453443|FG002|2-week Run-in Period|Adverse Event|0|||
37807964|NCT01395888|69453441|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
37807965|NCT01395888|69453442|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
37807966|NCT01395888|69453443|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
37807967|NCT01395888|69453441|FG000|2-week Run-in Period|Lost to Follow-up|1|||
37807968|NCT01395888|69453442|FG001|2-week Run-in Period|Lost to Follow-up|0|||
37976449|NCT00452790|69663705|FG001|After Infant Series|Failed to return|0|||
37976450|NCT00452790|69663704|FG000|After Infant Series|Other reasons|1|||
37976451|NCT00452790|69663705|FG001|After Infant Series|Other reasons|0|||
37976452|NCT00452790|69663704|FG000|Toddler Dose|Failed to return|0|||
37976453|NCT00452790|69663705|FG001|Toddler Dose|Failed to return|1|||
37976454|NCT00452790|69663704|FG000|Toddler Dose|Parent/legal guardian request|0|||
37976455|NCT00452790|69663705|FG001|Toddler Dose|Parent/legal guardian request|1|||
37976456|NCT00463788|69663717|FG000|Overall Study|Progressive Disease|86|||
37976457|NCT00463788|69663718|FG001|Overall Study|Progressive Disease|42|||
37976458|NCT00463788|69663717|FG000|Overall Study|Adverse Event|6|||
37807969|NCT01395888|69453443|FG002|2-week Run-in Period|Lost to Follow-up|0|||
37807970|NCT01395888|69453441|FG000|2-week Run-in Period|Protocol Violation|2|||
37807971|NCT01395888|69453442|FG001|2-week Run-in Period|Protocol Violation|0|||
37807972|NCT01395888|69453443|FG002|2-week Run-in Period|Protocol Violation|0|||
37807973|NCT01395888|69453441|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
37807974|NCT01395888|69453442|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
37807975|NCT01395888|69453443|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
37807976|NCT01395888|69453441|FG000|Treatment Period (TP)|Adverse Event|0|||
37807977|NCT01395888|69453442|FG001|Treatment Period (TP)|Adverse Event|7|||
37807978|NCT01395888|69453443|FG002|Treatment Period (TP)|Adverse Event|6|||
37807979|NCT01395888|69453441|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
37807980|NCT01395888|69453442|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
37807981|NCT01395888|69453443|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
37807982|NCT01395888|69453441|FG000|Treatment Period (TP)|Protocol Violation|0|||
37807983|NCT01395888|69453442|FG001|Treatment Period (TP)|Protocol Violation|1|||
37807984|NCT01395888|69453443|FG002|Treatment Period (TP)|Protocol Violation|5|||
37807985|NCT01395888|69453441|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
37807986|NCT01395888|69453442|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
37807987|NCT01395888|69453443|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
37807988|NCT01395888|69453441|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
37807989|NCT01395888|69453442|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
37807990|NCT01395888|69453443|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
37807991|NCT01395810|69453453|FG000|Overall Study|Adverse Event|0|||
37807992|NCT01395810|69453454|FG001|Overall Study|Adverse Event|1|||
37807993|NCT01395810|69453455|FG002|Overall Study|Adverse Event|0|||
37807994|NCT01395810|69453456|FG003|Overall Study|Adverse Event|0|||
37807995|NCT01395810|69453453|FG000|Overall Study|Lack of Efficacy|0|||
37807996|NCT01395810|69453454|FG001|Overall Study|Lack of Efficacy|1|||
37807997|NCT01395810|69453455|FG002|Overall Study|Lack of Efficacy|0|||
37807998|NCT01395810|69453456|FG003|Overall Study|Lack of Efficacy|0|||
37807999|NCT01395810|69453453|FG000|Overall Study|Withdrawal criteria|0|||
37808000|NCT01395810|69453454|FG001|Overall Study|Withdrawal criteria|2|||
37808001|NCT01395810|69453455|FG002|Overall Study|Withdrawal criteria|0|||
37808002|NCT01395810|69453456|FG003|Overall Study|Withdrawal criteria|0|||
37808003|NCT01395810|69453453|FG000|Overall Study|Unclassified|2|||
37808004|NCT01395810|69453454|FG001|Overall Study|Unclassified|0|||
37808005|NCT01395810|69453455|FG002|Overall Study|Unclassified|0|||
37808006|NCT01395810|69453456|FG003|Overall Study|Unclassified|0|||
37808007|NCT01381692|69453469|FG000|Overall Study|Adverse Event|1|||
37808008|NCT01381692|69453470|FG001|Overall Study|Adverse Event|0|||
37808009|NCT01381692|69453471|FG002|Overall Study|Adverse Event|0|||
37808010|NCT01381692|69453472|FG003|Overall Study|Adverse Event|0|||
37808011|NCT01381692|69453473|FG004|Overall Study|Adverse Event|0|||
37808012|NCT01381692|69453474|FG005|Overall Study|Adverse Event|0|||
37808013|NCT01395030|69453482|FG000|Overall Study|Did not complete FCH PET/CT|7|||
37808014|NCT01381068|69453490|FG000|Overall Study|Death|1|||
37808015|NCT01381068|69453491|FG001|Overall Study|Death|0|||
37808016|NCT01394952|69453499|FG000|Overall Study|Lost to Follow-up|0|||
37808017|NCT01394952|69453500|FG001|Overall Study|Lost to Follow-up|5|||
37808018|NCT01394952|69453499|FG000|Overall Study|Withdrawal by Subject|10|||
37808019|NCT01394952|69453500|FG001|Overall Study|Withdrawal by Subject|5|||
37808020|NCT01394952|69453499|FG000|Overall Study|Physician Decision|2|||
37808021|NCT01394952|69453500|FG001|Overall Study|Physician Decision|0|||
37808022|NCT01394952|69453499|FG000|Overall Study|Sponsor Decision|5|||
37808023|NCT01394952|69453500|FG001|Overall Study|Sponsor Decision|7|||
37808024|NCT01394718|69453508|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
37808025|NCT01394718|69453509|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
37808026|NCT01394250|69453517|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
37976459|NCT00463788|69663718|FG001|Overall Study|Adverse Event|2|||
37808027|NCT01394250|69453518|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
37808028|NCT01394250|69453517|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
37976460|NCT00463788|69663717|FG000|Overall Study|Withdrawal by Subject|6|||
37976461|NCT00463788|69663718|FG001|Overall Study|Withdrawal by Subject|2|||
37976462|NCT00463788|69663717|FG000|Overall Study|Death|4|||
37976463|NCT00463788|69663718|FG001|Overall Study|Death|3|||
37976464|NCT00463788|69663717|FG000|Overall Study|Symptomatic Deterioration|2|||
37976465|NCT00463788|69663718|FG001|Overall Study|Symptomatic Deterioration|3|||
37976466|NCT00463788|69663717|FG000|Overall Study|Lost to Follow-up|1|||
37976467|NCT00463788|69663718|FG001|Overall Study|Lost to Follow-up|0|||
37976468|NCT00463788|69663717|FG000|Overall Study|Protocol Violation|0|||
37976469|NCT00463788|69663718|FG001|Overall Study|Protocol Violation|1|||
37976470|NCT00463788|69663717|FG000|Overall Study|Other|3|||
37976471|NCT00463788|69663718|FG001|Overall Study|Other|0|||
37976472|NCT00463788|69663717|FG000|Overall Study|Randomized but not treated|1|||
37976473|NCT00463788|69663718|FG001|Overall Study|Randomized but not treated|1|||
37976474|NCT00548249|69663730|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
37976475|NCT00548249|69663731|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
37976476|NCT00548249|69663732|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
37976477|NCT00548249|69663733|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
37976478|NCT00548249|69663734|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
37976479|NCT00548249|69663730|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
37976480|NCT00548249|69663731|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
37976481|NCT00548249|69663732|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
37976482|NCT00548249|69663733|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
37976483|NCT00548249|69663734|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
37976484|NCT00548249|69663730|FG000|Overall Study|Protocol Violation|1|||
37976485|NCT00548249|69663731|FG001|Overall Study|Protocol Violation|1|||
37976486|NCT00548249|69663732|FG002|Overall Study|Protocol Violation|4|||
37976487|NCT00548249|69663733|FG003|Overall Study|Protocol Violation|0|||
37976488|NCT00548249|69663734|FG004|Overall Study|Protocol Violation|3|||
37976489|NCT00548249|69663730|FG000|Overall Study|Miscellaneous|2|||
37976490|NCT00548249|69663731|FG001|Overall Study|Miscellaneous|3|||
37976491|NCT00548249|69663732|FG002|Overall Study|Miscellaneous|2|||
37976492|NCT00548249|69663733|FG003|Overall Study|Miscellaneous|0|||
37976493|NCT00548249|69663734|FG004|Overall Study|Miscellaneous|2|||
37976494|NCT00548249|69663730|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
37976495|NCT00548249|69663731|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
37976496|NCT00548249|69663732|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
37976497|NCT00548249|69663733|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
37808029|NCT01394250|69453518|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
37808030|NCT01380990|69453526|FG000|Overall Study|Treatment Failure|1|||
37808031|NCT01380990|69453527|FG001|Overall Study|Treatment Failure|0|||
37808032|NCT01380990|69453526|FG000|Overall Study|Death|0|||
37808033|NCT01380990|69453527|FG001|Overall Study|Death|1|||
37808034|NCT01380834|69453539|FG000|Overall Study|Physician Decision|1|||
37808035|NCT01380834|69453540|FG001|Overall Study|Physician Decision|0|||
37808036|NCT00214422|69453549|FG000|Overall Study|Physician Decision|2|||
37808037|NCT00214422|69453550|FG001|Overall Study|Physician Decision|0|||
37808038|NCT00214422|69453551|FG002|Overall Study|Physician Decision|0|||
37808039|NCT00214422|69453549|FG000|Overall Study|Developed esophageal ca|1|||
37808040|NCT00214422|69453550|FG001|Overall Study|Developed esophageal ca|0|||
37808041|NCT00214422|69453551|FG002|Overall Study|Developed esophageal ca|0|||
37808042|NCT00214422|69453549|FG000|Overall Study|Pt taken off study|1|||
37808043|NCT00214422|69453550|FG001|Overall Study|Pt taken off study|1|||
37808044|NCT00214422|69453551|FG002|Overall Study|Pt taken off study|0|||
37808045|NCT00214422|69453549|FG000|Overall Study|Disease progression on study|1|||
37808046|NCT00214422|69453550|FG001|Overall Study|Disease progression on study|0|||
37976498|NCT00548249|69663734|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
37976499|NCT00548249|69663730|FG000|Overall Study|Adverse Event|2|||
37976500|NCT00548249|69663731|FG001|Overall Study|Adverse Event|2|||
37976501|NCT00548249|69663732|FG002|Overall Study|Adverse Event|0|||
37976502|NCT00548249|69663733|FG003|Overall Study|Adverse Event|1|||
37976503|NCT00548249|69663734|FG004|Overall Study|Adverse Event|1|||
37976504|NCT00548249|69663730|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
37976505|NCT00548249|69663731|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
37976506|NCT00548249|69663732|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
37976507|NCT00548249|69663733|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
37976508|NCT00548249|69663734|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
37976509|NCT00548249|69663730|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
37808047|NCT00214422|69453551|FG002|Overall Study|Disease progression on study|0|||
37808048|NCT00214422|69453549|FG000|Overall Study|Unable to make a radiation treatment|0|||
37808049|NCT00214422|69453550|FG001|Overall Study|Unable to make a radiation treatment|0|||
37976510|NCT00548249|69663731|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
37808050|NCT00214422|69453551|FG002|Overall Study|Unable to make a radiation treatment|1|||
37808051|NCT00218634|69453565|FG000|Overall Study|Lost to Follow-up|8|||
37808052|NCT00218634|69453566|FG001|Overall Study|Lost to Follow-up|15|||
37808053|NCT00217620|69453575|FG000|Overall Study|Adverse Event|2|||
37808054|NCT00217620|69453575|FG000|Overall Study|Progression|31|||
37808055|NCT00217620|69453575|FG000|Overall Study|Not Protocol Specified|4|||
37808056|NCT00217620|69453575|FG000|Overall Study|Ineligible|13|||
37808057|NCT00217620|69453575|FG000|Overall Study|Never received treatment|1|||
37808058|NCT00217464|69453583|FG000|Overall Study|Progression|15|||
37808059|NCT00217464|69453583|FG000|Overall Study|Other|2|||
37808060|NCT00214500|69453587|FG000|Treatment Period|Adverse Event|1|||
37808061|NCT00214500|69453587|FG000|Extension Period|Withdrawal by Subject|2|||
37808062|NCT00211536|69453596|FG000|Overall Study|Withdrawal by Subject|2|||
37808063|NCT00211536|69453597|FG001|Overall Study|Withdrawal by Subject|2|||
37808064|NCT00211536|69453596|FG000|Overall Study|Physician Decision|0|||
37808065|NCT00211536|69453597|FG001|Overall Study|Physician Decision|5|||
37808066|NCT00211536|69453596|FG000|Overall Study|Adverse Event|2|||
37808067|NCT00211536|69453597|FG001|Overall Study|Adverse Event|0|||
37808068|NCT03192462|69453660|FG000|Overall Study|Death|13|||
37808069|NCT03192462|69453661|FG001|Overall Study|Death|11|||
37808070|NCT03192462|69453662|FG002|Overall Study|Death|9|||
37976511|NCT00548249|69663732|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
37976512|NCT00548249|69663733|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
37976513|NCT00548249|69663734|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
37976514|NCT00548249|69663730|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
37808071|NCT03192462|69453660|FG000|Overall Study|Lost to Follow-up|0|||
37808072|NCT03192462|69453661|FG001|Overall Study|Lost to Follow-up|1|||
37976515|NCT00548249|69663731|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
37976516|NCT00548249|69663732|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
37976517|NCT00548249|69663733|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
37976518|NCT00548249|69663734|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
37976519|NCT00548249|69663730|FG000|Overall Study|Prolonged hospitalization|0|||
37976520|NCT00548249|69663731|FG001|Overall Study|Prolonged hospitalization|0|||
37976521|NCT00548249|69663732|FG002|Overall Study|Prolonged hospitalization|2|||
37976522|NCT00548249|69663733|FG003|Overall Study|Prolonged hospitalization|1|||
37976523|NCT00548249|69663734|FG004|Overall Study|Prolonged hospitalization|0|||
37976524|NCT00548249|69663730|FG000|Overall Study|Withdrawal by Subject|2|||
37976525|NCT00548249|69663731|FG001|Overall Study|Withdrawal by Subject|0|||
37976526|NCT00548249|69663732|FG002|Overall Study|Withdrawal by Subject|0|||
37976527|NCT00548249|69663733|FG003|Overall Study|Withdrawal by Subject|0|||
37976528|NCT00548249|69663734|FG004|Overall Study|Withdrawal by Subject|0|||
37976529|NCT00548249|69663730|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
37976530|NCT00548249|69663731|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
37976531|NCT00548249|69663732|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
37976532|NCT00548249|69663733|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
37976533|NCT00548249|69663734|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
37976534|NCT00548249|69663730|FG000|Overall Study|Sponsor's request|0|||
37976535|NCT00548249|69663731|FG001|Overall Study|Sponsor's request|0|||
37976536|NCT00548249|69663732|FG002|Overall Study|Sponsor's request|0|||
37976537|NCT00548249|69663733|FG003|Overall Study|Sponsor's request|1|||
37976538|NCT00548249|69663734|FG004|Overall Study|Sponsor's request|0|||
37808073|NCT03192462|69453662|FG002|Overall Study|Lost to Follow-up|0|||
37808074|NCT03192462|69453660|FG000|Overall Study|On follow up|0|||
37976539|NCT00463476|69663748|FG000|Overall Study|Withdrawal by Subject|1|||
37976540|NCT00463476|69663749|FG001|Overall Study|Withdrawal by Subject|2|||
37976541|NCT00463476|69663748|FG000|Overall Study|Lost to Follow-up|1|||
37976542|NCT00463476|69663749|FG001|Overall Study|Lost to Follow-up|1|||
37976543|NCT03839940|69663757|FG000|Overall Study|Withdrawal by Subject|3|||
37976544|NCT03839940|69663758|FG001|Overall Study|Withdrawal by Subject|0|||
37808075|NCT03192462|69453661|FG001|Overall Study|On follow up|0|||
37808076|NCT03192462|69453662|FG002|Overall Study|On follow up|3|||
37808077|NCT03589326|69453672|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|135|||
37976545|NCT03839940|69663757|FG000|Overall Study|Protocol Violation|0|||
37976546|NCT03839940|69663758|FG001|Overall Study|Protocol Violation|1|||
37976547|NCT03839940|69663757|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
37976548|NCT03839940|69663758|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
37808078|NCT03589326|69453673|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|63|||
37808079|NCT03589326|69453672|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|21|||
37808080|NCT03589326|69453673|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|13|||
37808081|NCT03589326|69453672|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|0|||
37808082|NCT03589326|69453673|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|1|||
37808083|NCT03589326|69453672|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|6|||
37808084|NCT03589326|69453673|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|4|||
37808085|NCT03589326|69453672|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|2|||
37808086|NCT03589326|69453673|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|0|||
37808087|NCT03028740|69453694|FG000|Overall Study|Did not Receive Study Drug|4|||
37808088|NCT03028740|69453695|FG001|Overall Study|Did not Receive Study Drug|5|||
37808089|NCT03028740|69453694|FG000|Overall Study|Adverse Event|8|||
37808090|NCT03028740|69453695|FG001|Overall Study|Adverse Event|26|||
37976549|NCT03839628|69663766|FG000|Overall Study|Withdrawal by Subject|1|||
37976550|NCT00462462|69663772|FG000|Overall Study|Physician Decision|0|||
37976551|NCT00462462|69663773|FG001|Overall Study|Physician Decision|1|||
37976552|NCT00462384|69663781|FG000|Overall Study|Adverse Event|2|||
37976553|NCT00462384|69663781|FG000|Overall Study|Death|2|||
37976554|NCT00462384|69663781|FG000|Overall Study|Withdrawal by Subject|1|||
37976555|NCT00462384|69663781|FG000|Overall Study|Other|4|||
37976556|NCT00452400|69663790|FG000|Overall Study|Adverse Event|1|||
37976557|NCT00452400|69663791|FG001|Overall Study|Adverse Event|1|||
37976558|NCT00452400|69663792|FG002|Overall Study|Adverse Event|5|||
37976559|NCT00452400|69663793|FG003|Overall Study|Adverse Event|0|||
37976560|NCT00452400|69663794|FG004|Overall Study|Adverse Event|2|||
37976561|NCT00452400|69663790|FG000|Overall Study|Protocol Violation|0|||
37976562|NCT00452400|69663791|FG001|Overall Study|Protocol Violation|0|||
37976563|NCT00452400|69663792|FG002|Overall Study|Protocol Violation|1|||
37976564|NCT00452400|69663793|FG003|Overall Study|Protocol Violation|0|||
37976565|NCT00452400|69663794|FG004|Overall Study|Protocol Violation|0|||
37976566|NCT00452400|69663790|FG000|Overall Study|Lost to Follow-up|1|||
37976567|NCT00452400|69663791|FG001|Overall Study|Lost to Follow-up|0|||
37976568|NCT00452400|69663792|FG002|Overall Study|Lost to Follow-up|0|||
37976569|NCT00452400|69663793|FG003|Overall Study|Lost to Follow-up|0|||
37976570|NCT00452400|69663794|FG004|Overall Study|Lost to Follow-up|0|||
37976571|NCT00452400|69663790|FG000|Overall Study|Withdrawal by Subject|1|||
37976572|NCT00452400|69663791|FG001|Overall Study|Withdrawal by Subject|0|||
37976573|NCT00452400|69663792|FG002|Overall Study|Withdrawal by Subject|1|||
37976574|NCT00452400|69663793|FG003|Overall Study|Withdrawal by Subject|0|||
37976575|NCT00452400|69663794|FG004|Overall Study|Withdrawal by Subject|0|||
37976576|NCT00452400|69663790|FG000|Overall Study|Lack of Efficacy|2|||
37976577|NCT00452400|69663791|FG001|Overall Study|Lack of Efficacy|0|||
37976578|NCT00452400|69663792|FG002|Overall Study|Lack of Efficacy|0|||
37976579|NCT00452400|69663793|FG003|Overall Study|Lack of Efficacy|0|||
37976580|NCT00452400|69663794|FG004|Overall Study|Lack of Efficacy|0|||
37976581|NCT00452400|69663790|FG000|Overall Study|Other reasons not listed above|0|||
37976582|NCT00452400|69663791|FG001|Overall Study|Other reasons not listed above|0|||
37976583|NCT00452400|69663792|FG002|Overall Study|Other reasons not listed above|0|||
37976584|NCT00452400|69663793|FG003|Overall Study|Other reasons not listed above|1|||
37976585|NCT00452400|69663794|FG004|Overall Study|Other reasons not listed above|1|||
37976586|NCT00462306|69663808|FG000|Overall Study|insufficient data|0|||
37976587|NCT00462306|69663809|FG001|Overall Study|insufficient data|13|||
37976588|NCT00461682|69663817|FG000|Overall Study|Protocol Violation|1|||
37808091|NCT03028740|69453694|FG000|Overall Study|Lack of Efficacy|0|||
37808092|NCT03028740|69453695|FG001|Overall Study|Lack of Efficacy|1|||
37808093|NCT03028740|69453694|FG000|Overall Study|Withdrawal by Subject|48|||
37808094|NCT03028740|69453695|FG001|Overall Study|Withdrawal by Subject|101|||
37808095|NCT03028740|69453694|FG000|Overall Study|Lost to Follow-up|30|||
37808096|NCT03028740|69453695|FG001|Overall Study|Lost to Follow-up|54|||
37808097|NCT03028740|69453694|FG000|Overall Study|Physician Decision|4|||
37808098|NCT03028740|69453695|FG001|Overall Study|Physician Decision|11|||
37808099|NCT03028740|69453694|FG000|Overall Study|Protocol Violation|4|||
37808100|NCT03028740|69453695|FG001|Overall Study|Protocol Violation|8|||
37864310|NCT01260350|69547948|FG011|Overall Study|Lack of Efficacy|0|||
37976589|NCT00443430|69663825|FG000|Overall Study|Lack of Efficacy|3|||
37976590|NCT00443430|69663826|FG001|Overall Study|Lack of Efficacy|3|||
37976591|NCT00443430|69663825|FG000|Overall Study|Adverse Event|1|||
37976592|NCT00443430|69663826|FG001|Overall Study|Adverse Event|1|||
37976593|NCT00460746|69663832|FG000|Overall Study|Adverse Event|1|||
37976594|NCT00460746|69663832|FG000|Overall Study|Lost to Follow-up|1|||
37976595|NCT00443118|69663839|FG000|Overall Study|unknown primary outcome|3|||
37976596|NCT00443118|69663840|FG001|Overall Study|unknown primary outcome|1|||
37976597|NCT00443118|69663841|FG002|Overall Study|unknown primary outcome|0|||
37976598|NCT00443118|69663839|FG000|Overall Study|Withdrawal by Subject|1|||
37976599|NCT00443118|69663840|FG001|Overall Study|Withdrawal by Subject|0|||
37976600|NCT00443118|69663841|FG002|Overall Study|Withdrawal by Subject|0|||
37808101|NCT03028740|69453694|FG000|Overall Study|Non-compliance with Study Drug|0|||
37808102|NCT03028740|69453695|FG001|Overall Study|Non-compliance with Study Drug|2|||
37808103|NCT03028740|69453694|FG000|Overall Study|Study Terminated by Sponsor|467|||
37976601|NCT00460434|69663869|FG000|Overall Study|Lost to Follow-up|3|||
37976602|NCT00460434|69663870|FG001|Overall Study|Lost to Follow-up|7|||
37976603|NCT00373425|69663881|FG000|Overall Study|Relapse of NSCLC|116|||
37976604|NCT00373425|69663882|FG001|Overall Study|Relapse of NSCLC|104|||
37808104|NCT03028740|69453695|FG001|Overall Study|Study Terminated by Sponsor|917|||
37808105|NCT03028740|69453694|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
37808106|NCT03028740|69453695|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
37808107|NCT03028740|69453694|FG000|Overall Study|Reason not Specified|1|||
37808108|NCT03028740|69453695|FG001|Overall Study|Reason not Specified|5|||
37808109|NCT02980692|69453718|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
37808110|NCT02980692|69453719|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
37808111|NCT02980692|69453720|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
37808112|NCT02980692|69453721|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
37808113|NCT02980692|69453722|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
37808114|NCT02980692|69453718|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
37808115|NCT02980692|69453719|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
37808116|NCT02980692|69453720|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
37808117|NCT02980692|69453721|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
37808118|NCT02980692|69453722|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
37808119|NCT02980692|69453718|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
37808120|NCT02980692|69453719|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
37808121|NCT02980692|69453720|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
37808122|NCT02980692|69453721|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
37808123|NCT02980692|69453722|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
37808124|NCT02980692|69453718|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
37808125|NCT02980692|69453719|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
37808126|NCT02980692|69453720|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
37808127|NCT02980692|69453721|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
37808128|NCT02980692|69453722|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
37808129|NCT02980692|69453718|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
37864311|NCT01260350|69547949|FG012|Overall Study|Lack of Efficacy|0|||
37976605|NCT00373425|69663883|FG002|Overall Study|Relapse of NSCLC|19|||
37976606|NCT00373425|69663884|FG003|Overall Study|Relapse of NSCLC|2|||
37976607|NCT00373425|69663885|FG004|Overall Study|Relapse of NSCLC|26|||
37808130|NCT02980692|69453719|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
37808131|NCT02980692|69453720|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
37864312|NCT01260350|69547950|FG013|Overall Study|Lack of Efficacy|0|||
37976608|NCT00373425|69663881|FG000|Overall Study|Adverse Event|191|||
37976609|NCT00373425|69663882|FG001|Overall Study|Adverse Event|22|||
37976610|NCT00373425|69663883|FG002|Overall Study|Adverse Event|59|||
37976611|NCT00373425|69663884|FG003|Overall Study|Adverse Event|0|||
37976612|NCT00373425|69663885|FG004|Overall Study|Adverse Event|34|||
37976613|NCT00373425|69663881|FG000|Overall Study|Patient request|35|||
37976614|NCT00373425|69663882|FG001|Overall Study|Patient request|18|||
37976615|NCT00373425|69663883|FG002|Overall Study|Patient request|43|||
37976616|NCT00373425|69663884|FG003|Overall Study|Patient request|6|||
37976617|NCT00373425|69663885|FG004|Overall Study|Patient request|7|||
37864313|NCT01260350|69547951|FG014|Overall Study|Lack of Efficacy|0|||
37976618|NCT00373425|69663881|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
37808132|NCT02980692|69453721|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
37808133|NCT02980692|69453722|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
37808134|NCT02980692|69453718|FG000|Double Blind Placebo Controlled Period|Other|1|||
37808135|NCT02980692|69453719|FG001|Double Blind Placebo Controlled Period|Other|0|||
37808136|NCT02980692|69453720|FG002|Double Blind Placebo Controlled Period|Other|0|||
37808137|NCT02980692|69453721|FG003|Double Blind Placebo Controlled Period|Other|0|||
37808138|NCT02980692|69453722|FG004|Double Blind Placebo Controlled Period|Other|1|||
37808139|NCT02980692|69453718|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
37808140|NCT02980692|69453719|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
37808141|NCT02980692|69453720|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
37808142|NCT02980692|69453721|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
37808143|NCT02980692|69453722|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
37808144|NCT02980692|69453718|FG000|Double-blind Follow-up Period|Adverse Event|0|||
37808145|NCT02980692|69453719|FG001|Double-blind Follow-up Period|Adverse Event|0|||
37808146|NCT02980692|69453720|FG002|Double-blind Follow-up Period|Adverse Event|0|||
37808147|NCT02980692|69453721|FG003|Double-blind Follow-up Period|Adverse Event|1|||
37808148|NCT02980692|69453722|FG004|Double-blind Follow-up Period|Adverse Event|1|||
37808149|NCT02980692|69453718|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
37976619|NCT00373425|69663882|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
37976620|NCT00373425|69663883|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
37808150|NCT02980692|69453719|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
37808151|NCT02980692|69453720|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
37808152|NCT02980692|69453721|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
37808153|NCT02980692|69453722|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
37808154|NCT02980692|69453718|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
37808155|NCT02980692|69453719|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
37808156|NCT02980692|69453720|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
37808157|NCT02980692|69453721|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
37808158|NCT02980692|69453722|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
37808159|NCT02980692|69453718|FG000|Double-blind Follow-up Period|Pregnancy|0|||
37808160|NCT02980692|69453719|FG001|Double-blind Follow-up Period|Pregnancy|0|||
37808161|NCT02980692|69453720|FG002|Double-blind Follow-up Period|Pregnancy|1|||
37808162|NCT02980692|69453721|FG003|Double-blind Follow-up Period|Pregnancy|1|||
37808163|NCT02980692|69453722|FG004|Double-blind Follow-up Period|Pregnancy|0|||
37808164|NCT02980692|69453718|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
37808165|NCT02980692|69453719|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
37808166|NCT02980692|69453720|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
37976621|NCT00373425|69663884|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
37976622|NCT00373425|69663885|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
37976623|NCT00373425|69663881|FG000|Overall Study|Death|7|||
37976624|NCT00373425|69663882|FG001|Overall Study|Death|0|||
37808167|NCT02980692|69453721|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
37808168|NCT02980692|69453722|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
37808169|NCT02980692|69453718|FG000|Double-blind Follow-up Period|Other|0|||
37808170|NCT02980692|69453719|FG001|Double-blind Follow-up Period|Other|0|||
37808171|NCT02980692|69453720|FG002|Double-blind Follow-up Period|Other|1|||
37808172|NCT02980692|69453721|FG003|Double-blind Follow-up Period|Other|1|||
37808173|NCT02980692|69453722|FG004|Double-blind Follow-up Period|Other|3|||
37976625|NCT00373425|69663883|FG002|Overall Study|Death|3|||
37976626|NCT00373425|69663884|FG003|Overall Study|Death|1|||
37976627|NCT00373425|69663885|FG004|Overall Study|Death|0|||
37976628|NCT00459342|69663894|FG000|Overall Study|Not eligible|1|||
37808174|NCT04439279|69454003|FG000|Overall Study|Adverse Event|7|||
37808175|NCT04439279|69454003|FG000|Overall Study|Death|4|||
37808176|NCT04439279|69454003|FG000|Overall Study|Disease progression|17|||
37808177|NCT04439279|69454003|FG000|Overall Study|Complicating disease|3|||
37808178|NCT04439279|69454003|FG000|Overall Study|Withdrawal by Subject|2|||
37808179|NCT04439279|69454003|FG000|Overall Study|Ineligible|1|||
37808180|NCT04439279|69454003|FG000|Overall Study|Treatment still ongoing|1|||
37808181|NCT04123548|69454033|FG000|Overall Study|Withdrawal by Subject|1|||
37808182|NCT04123548|69454033|FG000|Overall Study|Lost to Follow-up|8|||
37808183|NCT04123548|69454033|FG000|Overall Study|Death|4|||
37808184|NCT04123548|69454033|FG000|Overall Study|Reason Not Specified|1|||
37864314|NCT01260350|69547952|FG015|Overall Study|Lack of Efficacy|0|||
37808185|NCT04022733|69454039|FG000|Overall Study|conversion to open surgery|3|||
37808186|NCT04022733|69454040|FG001|Overall Study|conversion to open surgery|2|||
37808187|NCT04022733|69454039|FG000|Overall Study|bradycardia|0|||
37864315|NCT01260350|69547953|FG016|Overall Study|Lack of Efficacy|0|||
37808188|NCT04022733|69454040|FG001|Overall Study|bradycardia|1|||
37976629|NCT00443040|69663901|FG000|Overall Study|Withdrawal by Subject|1|||
37976630|NCT00443040|69663902|FG001|Overall Study|Withdrawal by Subject|0|||
37808189|NCT03818035|69454063|FG000|Part 1 (Up to 28 Weeks)|Death|1|||
37976631|NCT00443040|69663903|FG002|Overall Study|Withdrawal by Subject|0|||
37808190|NCT03818035|69454064|FG001|Part 1 (Up to 28 Weeks)|Death|0|||
37808191|NCT03818035|69454065|FG002|Part 1 (Up to 28 Weeks)|Death|0|||
37808192|NCT03818035|69454066|FG003|Part 1 (Up to 28 Weeks)|Death|0|||
37808193|NCT03818035|69454063|FG000|Part 1 (Up to 28 Weeks)|Lack of Efficacy|3|||
37808194|NCT03818035|69454064|FG001|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
37808195|NCT03818035|69454065|FG002|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
37808196|NCT03818035|69454066|FG003|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
37808197|NCT03818035|69454063|FG000|Part 1 (Up to 28 Weeks)|Lost to Follow-up|10|||
37808198|NCT03818035|69454064|FG001|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
37808199|NCT03818035|69454065|FG002|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
37808200|NCT03818035|69454066|FG003|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
37808201|NCT03818035|69454063|FG000|Part 1 (Up to 28 Weeks)|Protocol Violation|10|||
37808202|NCT03818035|69454064|FG001|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
37808203|NCT03818035|69454065|FG002|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
37808204|NCT03818035|69454066|FG003|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
37808205|NCT03818035|69454063|FG000|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|8|||
37808206|NCT03818035|69454064|FG001|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
37808207|NCT03818035|69454065|FG002|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
37808208|NCT03818035|69454066|FG003|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
37808209|NCT03818035|69454063|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|1|||
37808210|NCT03818035|69454064|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
37808211|NCT03818035|69454065|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
37808212|NCT03818035|69454066|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
37808213|NCT03818035|69454063|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Other|16|||
37808214|NCT03818035|69454064|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
37808215|NCT03818035|69454065|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
37808216|NCT03818035|69454066|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
37808217|NCT03818035|69454063|FG000|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|1|||
37864316|NCT01260350|69547954|FG017|Overall Study|Lack of Efficacy|1|||
37976632|NCT00443040|69663901|FG000|Overall Study|Converted to an open laparotomy|3|||
37976633|NCT00443040|69663902|FG001|Overall Study|Converted to an open laparotomy|0|||
37808218|NCT03818035|69454064|FG001|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
37808219|NCT03818035|69454065|FG002|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
37808220|NCT03818035|69454066|FG003|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
37808221|NCT03818035|69454063|FG000|Part 1 (Up to 28 Weeks)|Other|7|||
37808222|NCT03818035|69454064|FG001|Part 1 (Up to 28 Weeks)|Other|0|||
37976634|NCT00443040|69663903|FG002|Overall Study|Converted to an open laparotomy|1|||
37808223|NCT03818035|69454065|FG002|Part 1 (Up to 28 Weeks)|Other|0|||
37808224|NCT03818035|69454066|FG003|Part 1 (Up to 28 Weeks)|Other|0|||
37808225|NCT03818035|69454063|FG000|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
37808226|NCT03818035|69454064|FG001|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
37808227|NCT03818035|69454065|FG002|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
37808228|NCT03818035|69454066|FG003|Part 2 (Week 28 to Week 68)|Lack of Efficacy|4|||
37808229|NCT03818035|69454063|FG000|Part 2 (Week 28 to Week 68)|Lost to Follow-up|0|||
37808230|NCT03818035|69454064|FG001|Part 2 (Week 28 to Week 68)|Lost to Follow-up|6|||
37808231|NCT03818035|69454065|FG002|Part 2 (Week 28 to Week 68)|Lost to Follow-up|1|||
37808232|NCT03818035|69454066|FG003|Part 2 (Week 28 to Week 68)|Lost to Follow-up|9|||
37976635|NCT00442962|69663911|FG000|Overall Study|Pregnancy|1|||
37976636|NCT00442962|69663911|FG000|Overall Study|Lost to Follow-up|7|||
37976637|NCT00313300|69663920|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
37976638|NCT00313300|69663921|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
37976639|NCT00313300|69663922|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
37976640|NCT00313300|69663923|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
37976641|NCT00313300|69663924|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
37976642|NCT00313300|69663920|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
37976643|NCT00313300|69663921|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
37976644|NCT00313300|69663922|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
37976645|NCT00313300|69663923|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
37976646|NCT00313300|69663924|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
37976647|NCT00313300|69663920|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
37976648|NCT00313300|69663921|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
37976649|NCT00313300|69663922|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
37976650|NCT00313300|69663923|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
37808233|NCT03818035|69454063|FG000|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
37808234|NCT03818035|69454064|FG001|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
37808235|NCT03818035|69454065|FG002|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
37808236|NCT03818035|69454066|FG003|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|8|||
37808237|NCT03818035|69454063|FG000|Part 2 (Week 28 to Week 68)|Other Adverse Events|0|||
37808238|NCT03818035|69454064|FG001|Part 2 (Week 28 to Week 68)|Other Adverse Events|3|||
37808239|NCT03818035|69454065|FG002|Part 2 (Week 28 to Week 68)|Other Adverse Events|4|||
37808240|NCT03818035|69454066|FG003|Part 2 (Week 28 to Week 68)|Other Adverse Events|7|||
37808241|NCT03818035|69454063|FG000|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
37808242|NCT03818035|69454064|FG001|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|1|||
37808243|NCT03818035|69454065|FG002|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|2|||
37808244|NCT03818035|69454066|FG003|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
37808245|NCT03818035|69454063|FG000|Part 2 (Week 28 to Week 68)|Other|0|||
37808246|NCT03818035|69454064|FG001|Part 2 (Week 28 to Week 68)|Other|1|||
37808247|NCT03818035|69454065|FG002|Part 2 (Week 28 to Week 68)|Other|1|||
37808248|NCT03818035|69454066|FG003|Part 2 (Week 28 to Week 68)|Other|1|||
37808249|NCT03593915|69454081|FG000|Overall Study|Adverse Event|0|||
37808250|NCT03593915|69454082|FG001|Overall Study|Adverse Event|0|||
37808251|NCT03593915|69454083|FG002|Overall Study|Adverse Event|0|||
37808252|NCT03593915|69454084|FG003|Overall Study|Adverse Event|1|||
37808253|NCT03593915|69454085|FG004|Overall Study|Adverse Event|0|||
37808254|NCT03593915|69454086|FG005|Overall Study|Adverse Event|0|||
37808255|NCT03593915|69454081|FG000|Overall Study|Physician Decision|0|||
37808256|NCT03593915|69454082|FG001|Overall Study|Physician Decision|0|||
37808257|NCT03593915|69454083|FG002|Overall Study|Physician Decision|0|||
37808258|NCT03593915|69454084|FG003|Overall Study|Physician Decision|0|||
37808259|NCT03593915|69454085|FG004|Overall Study|Physician Decision|0|||
37808260|NCT03593915|69454086|FG005|Overall Study|Physician Decision|1|||
37808261|NCT03563716|69454112|FG000|Overall Study|Death|20|||
37808262|NCT03563716|69454113|FG001|Overall Study|Death|14|||
37808263|NCT03563716|69454112|FG000|Overall Study|Withdrawal by Subject|3|||
37808264|NCT03563716|69454113|FG001|Overall Study|Withdrawal by Subject|3|||
37808265|NCT03563716|69454112|FG000|Overall Study|Still on Study|45|||
37808266|NCT03563716|69454113|FG001|Overall Study|Still on Study|50|||
37808267|NCT03492177|69454122|FG000|Overall Study|Adverse Event|1|||
37808268|NCT03492177|69454123|FG001|Overall Study|Adverse Event|0|||
37808269|NCT03492177|69454124|FG002|Overall Study|Adverse Event|0|||
37808270|NCT03492177|69454122|FG000|Overall Study|Death|3|||
37808271|NCT03492177|69454123|FG001|Overall Study|Death|0|||
37808272|NCT03492177|69454124|FG002|Overall Study|Death|3|||
37976651|NCT00313300|69663924|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
37808273|NCT03492177|69454122|FG000|Overall Study|Lack of Efficacy|1|||
37808274|NCT03492177|69454123|FG001|Overall Study|Lack of Efficacy|2|||
37808275|NCT03492177|69454124|FG002|Overall Study|Lack of Efficacy|0|||
37808276|NCT03492177|69454122|FG000|Overall Study|Other|1|||
37808277|NCT03492177|69454123|FG001|Overall Study|Other|0|||
37808278|NCT03492177|69454124|FG002|Overall Study|Other|0|||
37808279|NCT03492177|69454122|FG000|Overall Study|Ongoing|16|||
37864317|NCT01260350|69547955|FG018|Overall Study|Lack of Efficacy|0|||
37808280|NCT03492177|69454123|FG001|Overall Study|Ongoing|19|||
37808281|NCT03492177|69454124|FG002|Overall Study|Ongoing|17|||
37808282|NCT03462719|69454134|FG000|Overall Study|Withdrawal by Subject|4|||
37808283|NCT03462719|69454135|FG001|Overall Study|Withdrawal by Subject|3|||
37808284|NCT03462719|69454134|FG000|Overall Study|Ongoing|87|||
37808285|NCT03462719|69454135|FG001|Overall Study|Ongoing|72|||
37808286|NCT03462030|69454143|FG000|Overall Study|Withdrawal by Subject|1|||
37808287|NCT03462030|69454144|FG001|Overall Study|Withdrawal by Subject|1|||
37808288|NCT03336333|69454153|FG000|Overall Study|Remained on study at time of data cut-off|202|||
37808289|NCT03336333|69454154|FG001|Overall Study|Remained on study at time of data cut-off|219|||
37808290|NCT03336333|69454155|FG002|Overall Study|Remained on study at time of data cut-off|102|||
37808291|NCT03336333|69454153|FG000|Overall Study|Death|14|||
37808292|NCT03336333|69454154|FG001|Overall Study|Death|16|||
37808293|NCT03336333|69454155|FG002|Overall Study|Death|8|||
37808294|NCT03336333|69454153|FG000|Overall Study|Withdrawal by Subject|16|||
37808295|NCT03336333|69454154|FG001|Overall Study|Withdrawal by Subject|5|||
37808296|NCT03336333|69454155|FG002|Overall Study|Withdrawal by Subject|1|||
37808297|NCT03336333|69454153|FG000|Overall Study|Physician Decision|5|||
37808298|NCT03336333|69454154|FG001|Overall Study|Physician Decision|1|||
37808299|NCT03336333|69454155|FG002|Overall Study|Physician Decision|0|||
37808300|NCT03336333|69454153|FG000|Overall Study|Lost to Follow-up|1|||
37808301|NCT03336333|69454154|FG001|Overall Study|Lost to Follow-up|0|||
37808302|NCT03336333|69454155|FG002|Overall Study|Lost to Follow-up|0|||
37808303|NCT03275285|69454164|FG000|Overall Study|Ongoing|61|||
37808304|NCT03275285|69454165|FG001|Overall Study|Ongoing|105|||
37808305|NCT03240874|69454179|FG000|Overall Study|Lost to Follow-up|0|||
37976652|NCT00313300|69663920|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
37976653|NCT00313300|69663921|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
37976654|NCT00313300|69663922|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
37976655|NCT00313300|69663923|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
37976656|NCT00313300|69663924|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
37976657|NCT00313300|69663920|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
37976658|NCT00313300|69663921|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
37976659|NCT00313300|69663922|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
37976660|NCT00313300|69663923|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
37976661|NCT00313300|69663924|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
37976662|NCT00313300|69663920|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
37976663|NCT00313300|69663921|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
37976664|NCT00313300|69663922|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
37976665|NCT00313300|69663923|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
37976666|NCT00313300|69663924|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
37976667|NCT00313300|69663920|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
37976668|NCT00313300|69663921|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
37808306|NCT03240874|69454180|FG001|Overall Study|Lost to Follow-up|2|||
37808307|NCT03240874|69454181|FG002|Overall Study|Lost to Follow-up|4|||
37808308|NCT03240874|69454182|FG003|Overall Study|Lost to Follow-up|1|||
37808309|NCT03201965|69454193|FG000|Overall Study|Death|5|||
37808310|NCT03201965|69454194|FG001|Overall Study|Death|27|||
37808311|NCT03201965|69454195|FG002|Overall Study|Death|27|||
37808312|NCT03201965|69454193|FG000|Overall Study|Lost to Follow-up|0|||
37808313|NCT03201965|69454194|FG001|Overall Study|Lost to Follow-up|1|||
37808314|NCT03201965|69454195|FG002|Overall Study|Lost to Follow-up|0|||
37808315|NCT03201965|69454193|FG000|Overall Study|Withdrawal by Subject|3|||
37808316|NCT03201965|69454194|FG001|Overall Study|Withdrawal by Subject|13|||
37808317|NCT03201965|69454195|FG002|Overall Study|Withdrawal by Subject|4|||
37808318|NCT03201965|69454193|FG000|Overall Study|Ongoing|20|||
37808319|NCT03201965|69454194|FG001|Overall Study|Ongoing|152|||
37808320|NCT03201965|69454195|FG002|Overall Study|Ongoing|164|||
37808321|NCT03083665|69454205|FG000|Double-Blind Period|Adverse Event|5|||
37808322|NCT03083665|69454206|FG001|Double-Blind Period|Adverse Event|4|||
37808323|NCT03083665|69454207|FG002|Double-Blind Period|Adverse Event|5|||
37808324|NCT03083665|69454208|FG003|Double-Blind Period|Adverse Event|0|||
37808325|NCT03083665|69454209|FG004|Double-Blind Period|Adverse Event|0|||
37808326|NCT03083665|69454210|FG005|Double-Blind Period|Adverse Event|0|||
37808327|NCT03083665|69454205|FG000|Double-Blind Period|Lack of Efficacy|0|||
37808328|NCT03083665|69454206|FG001|Double-Blind Period|Lack of Efficacy|0|||
37808329|NCT03083665|69454207|FG002|Double-Blind Period|Lack of Efficacy|1|||
37808330|NCT03083665|69454208|FG003|Double-Blind Period|Lack of Efficacy|0|||
37808331|NCT03083665|69454209|FG004|Double-Blind Period|Lack of Efficacy|0|||
37808332|NCT03083665|69454210|FG005|Double-Blind Period|Lack of Efficacy|0|||
37864318|NCT01260350|69547956|FG019|Overall Study|Lack of Efficacy|0|||
37808333|NCT03083665|69454205|FG000|Double-Blind Period|Protocol Violation|1|||
37808334|NCT03083665|69454206|FG001|Double-Blind Period|Protocol Violation|0|||
37808335|NCT03083665|69454207|FG002|Double-Blind Period|Protocol Violation|1|||
37808336|NCT03083665|69454208|FG003|Double-Blind Period|Protocol Violation|0|||
37808337|NCT03083665|69454209|FG004|Double-Blind Period|Protocol Violation|0|||
37808338|NCT03083665|69454210|FG005|Double-Blind Period|Protocol Violation|0|||
37808339|NCT03083665|69454205|FG000|Double-Blind Period|Lost to Follow-up|1|||
37808340|NCT03083665|69454206|FG001|Double-Blind Period|Lost to Follow-up|0|||
37808341|NCT03083665|69454207|FG002|Double-Blind Period|Lost to Follow-up|1|||
37808342|NCT03083665|69454208|FG003|Double-Blind Period|Lost to Follow-up|0|||
37808343|NCT03083665|69454209|FG004|Double-Blind Period|Lost to Follow-up|0|||
37808344|NCT03083665|69454210|FG005|Double-Blind Period|Lost to Follow-up|0|||
37808345|NCT03083665|69454205|FG000|Double-Blind Period|Withdrawal by Subject|3|||
37808346|NCT03083665|69454206|FG001|Double-Blind Period|Withdrawal by Subject|0|||
37808347|NCT03083665|69454207|FG002|Double-Blind Period|Withdrawal by Subject|0|||
37808348|NCT03083665|69454208|FG003|Double-Blind Period|Withdrawal by Subject|0|||
37808349|NCT03083665|69454209|FG004|Double-Blind Period|Withdrawal by Subject|0|||
37808350|NCT03083665|69454210|FG005|Double-Blind Period|Withdrawal by Subject|0|||
37808351|NCT03083665|69454205|FG000|Double-Blind Period|Consent withdrawn by subject due to concern on AE|1|||
37808352|NCT03083665|69454206|FG001|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
37808353|NCT03083665|69454207|FG002|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
37808354|NCT03083665|69454208|FG003|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
37808355|NCT03083665|69454209|FG004|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
37808356|NCT03083665|69454210|FG005|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
37808357|NCT03083665|69454205|FG000|Double-Blind Period|Subjects were able to never take a study drug|0|||
37808358|NCT03083665|69454206|FG001|Double-Blind Period|Subjects were able to never take a study drug|1|||
37808359|NCT03083665|69454207|FG002|Double-Blind Period|Subjects were able to never take a study drug|0|||
37808360|NCT03083665|69454208|FG003|Double-Blind Period|Subjects were able to never take a study drug|0|||
37808361|NCT03083665|69454209|FG004|Double-Blind Period|Subjects were able to never take a study drug|0|||
37808362|NCT03083665|69454210|FG005|Double-Blind Period|Subjects were able to never take a study drug|0|||
37808363|NCT03083665|69454205|FG000|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
37808364|NCT03083665|69454206|FG001|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
37808365|NCT03083665|69454207|FG002|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
37808366|NCT03083665|69454208|FG003|Open-Label Temporary Period (OLTP)|Adverse Event|2|||
37808367|NCT03083665|69454209|FG004|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
37808368|NCT03083665|69454210|FG005|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
37808369|NCT03083665|69454205|FG000|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
37808370|NCT03083665|69454206|FG001|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
37808371|NCT03083665|69454207|FG002|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
37808372|NCT03083665|69454208|FG003|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
37808373|NCT03083665|69454209|FG004|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
37808374|NCT03083665|69454210|FG005|Open-Label Temporary Period (OLTP)|Lack of Efficacy|2|||
37808375|NCT03083665|69454205|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
37808376|NCT03083665|69454206|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
37808377|NCT03083665|69454207|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
37808378|NCT03083665|69454208|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
37808379|NCT03083665|69454209|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
37808380|NCT03083665|69454210|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
37808381|NCT03083665|69454205|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
37808382|NCT03083665|69454206|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
37808383|NCT03083665|69454207|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
37808384|NCT03083665|69454208|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
37694103|NCT02460224|69170398|FG021|Overall Study|Lost to Follow-up|0|||
37808385|NCT03083665|69454209|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
37808386|NCT03083665|69454210|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|1|||
37864319|NCT01260350|69547957|FG020|Overall Study|Lack of Efficacy|3|||
37808387|NCT03083665|69454205|FG000|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
37976669|NCT00313300|69663922|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
37808388|NCT03083665|69454206|FG001|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
37808389|NCT03083665|69454207|FG002|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
37808390|NCT03083665|69454208|FG003|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|1|||
37808391|NCT03083665|69454209|FG004|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
37976670|NCT00313300|69663923|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
37976671|NCT00313300|69663924|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
37976672|NCT00313300|69663920|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
37976673|NCT00313300|69663921|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
37976674|NCT00313300|69663922|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
37976675|NCT00313300|69663923|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
37976676|NCT00313300|69663924|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
37976677|NCT00313300|69663920|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
37976678|NCT00313300|69663921|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
37808392|NCT03083665|69454210|FG005|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
37808393|NCT03083665|69454205|FG000|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
37808394|NCT03083665|69454206|FG001|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
37808395|NCT03083665|69454207|FG002|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
37808396|NCT03083665|69454208|FG003|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
37808397|NCT03083665|69454209|FG004|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
37808398|NCT03083665|69454210|FG005|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|1|||
37808399|NCT03083665|69454205|FG000|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
37808400|NCT03083665|69454206|FG001|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
37808401|NCT03083665|69454207|FG002|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
37808402|NCT03083665|69454208|FG003|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
37808403|NCT03083665|69454209|FG004|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
37808404|NCT03083665|69454210|FG005|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|1|||
37808405|NCT03045276|69454231|FG000|Intervention Phase|Withdrawal by Subject|7|||
37808406|NCT03045276|69454232|FG001|Intervention Phase|Withdrawal by Subject|2|||
37808407|NCT03045276|69454233|FG002|Intervention Phase|Withdrawal by Subject|3|||
37808408|NCT03045276|69454234|FG003|Intervention Phase|Withdrawal by Subject|7|||
37808409|NCT03045276|69454231|FG000|Intervention Phase|Developed exclusionary criteria|3|||
37808410|NCT03045276|69454232|FG001|Intervention Phase|Developed exclusionary criteria|3|||
37808411|NCT03045276|69454233|FG002|Intervention Phase|Developed exclusionary criteria|0|||
37808412|NCT03045276|69454234|FG003|Intervention Phase|Developed exclusionary criteria|0|||
37808413|NCT03045276|69454231|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
37808414|NCT03045276|69454232|FG001|Follow-Up Phase|Withdrawal by Subject|4|||
37808415|NCT03045276|69454233|FG002|Follow-Up Phase|Withdrawal by Subject|4|||
37808416|NCT03045276|69454234|FG003|Follow-Up Phase|Withdrawal by Subject|4|||
37976679|NCT00313300|69663922|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
37976680|NCT00313300|69663923|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
37976681|NCT00313300|69663924|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
37808417|NCT03045276|69454231|FG000|Follow-Up Phase|Lost to Follow-up|0|||
37808418|NCT03045276|69454232|FG001|Follow-Up Phase|Lost to Follow-up|1|||
37808419|NCT03045276|69454233|FG002|Follow-Up Phase|Lost to Follow-up|0|||
37808420|NCT03045276|69454234|FG003|Follow-Up Phase|Lost to Follow-up|1|||
37808421|NCT03045276|69454231|FG000|Follow-Up Phase|Developed exclusionary criteria|1|||
37808422|NCT03045276|69454232|FG001|Follow-Up Phase|Developed exclusionary criteria|0|||
37808423|NCT03045276|69454233|FG002|Follow-Up Phase|Developed exclusionary criteria|0|||
37808424|NCT03045276|69454234|FG003|Follow-Up Phase|Developed exclusionary criteria|0|||
37808425|NCT02819518|69454266|FG000|Overall Study|Death|9|||
37808426|NCT02819518|69454267|FG001|Overall Study|Death|11|||
37808427|NCT02819518|69454268|FG002|Overall Study|Death|9|||
37808428|NCT02819518|69454269|FG003|Overall Study|Death|447|||
37808429|NCT02819518|69454270|FG004|Overall Study|Death|233|||
37808430|NCT02819518|69454266|FG000|Overall Study|Withdrawal by Subject|0|||
37808431|NCT02819518|69454267|FG001|Overall Study|Withdrawal by Subject|0|||
37808432|NCT02819518|69454268|FG002|Overall Study|Withdrawal by Subject|0|||
37808433|NCT02819518|69454269|FG003|Overall Study|Withdrawal by Subject|21|||
37808434|NCT02819518|69454270|FG004|Overall Study|Withdrawal by Subject|6|||
37808435|NCT02819518|69454266|FG000|Overall Study|Ongoing in Study|2|||
37808436|NCT02819518|69454267|FG001|Overall Study|Ongoing in Study|3|||
37808437|NCT02819518|69454268|FG002|Overall Study|Ongoing in Study|1|||
37808438|NCT02819518|69454269|FG003|Overall Study|Ongoing in Study|98|||
37808439|NCT02819518|69454270|FG004|Overall Study|Ongoing in Study|42|||
37808440|NCT02661022|69454286|FG000|Overall Study|Withdrawal by Subject|3|||
37808441|NCT02661022|69454287|FG001|Overall Study|Withdrawal by Subject|0|||
37808442|NCT02661022|69454286|FG000|Overall Study|Adverse Event|1|||
37808443|NCT02661022|69454287|FG001|Overall Study|Adverse Event|1|||
37808444|NCT02661022|69454286|FG000|Overall Study|Physician Decision|1|||
37808445|NCT02661022|69454287|FG001|Overall Study|Physician Decision|0|||
37808446|NCT02661022|69454286|FG000|Overall Study|Progressive Disease|2|||
37808447|NCT02661022|69454287|FG001|Overall Study|Progressive Disease|1|||
37808448|NCT02475681|69454298|FG000|Overall Study|Death|16|||
37808449|NCT02475681|69454299|FG001|Overall Study|Death|6|||
37808450|NCT02475681|69454300|FG002|Overall Study|Death|9|||
37808451|NCT02475681|69454298|FG000|Overall Study|Physician Decision|0|||
37808452|NCT02475681|69454299|FG001|Overall Study|Physician Decision|3|||
37808453|NCT02475681|69454300|FG002|Overall Study|Physician Decision|1|||
37808454|NCT02475681|69454298|FG000|Overall Study|Withdrawal by Subject|12|||
37808455|NCT02475681|69454299|FG001|Overall Study|Withdrawal by Subject|6|||
37808456|NCT02475681|69454300|FG002|Overall Study|Withdrawal by Subject|9|||
37808457|NCT02475681|69454298|FG000|Overall Study|Lost to Follow-up|2|||
37808458|NCT02475681|69454299|FG001|Overall Study|Lost to Follow-up|1|||
37808459|NCT02475681|69454300|FG002|Overall Study|Lost to Follow-up|3|||
37808460|NCT02475681|69454298|FG000|Overall Study|Ongoing in Study|0|||
37808461|NCT02475681|69454299|FG001|Overall Study|Ongoing in Study|163|||
37808462|NCT02475681|69454300|FG002|Overall Study|Ongoing in Study|157|||
37808463|NCT02475681|69454298|FG000|Overall Study|Reasons other than above listed|2|||
37808464|NCT02475681|69454299|FG001|Overall Study|Reasons other than above listed|0|||
37808465|NCT02475681|69454300|FG002|Overall Study|Reasons other than above listed|0|||
37976682|NCT00313300|69663920|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
37976683|NCT00313300|69663921|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
37976684|NCT00313300|69663922|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
37976685|NCT00313300|69663923|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
37976686|NCT00313300|69663924|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
37976687|NCT00313300|69663920|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
37976688|NCT00313300|69663921|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
37976689|NCT00313300|69663922|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
37976690|NCT00313300|69663923|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
37976691|NCT00313300|69663924|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
37976692|NCT00313300|69663920|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
37976693|NCT00313300|69663921|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
37976694|NCT00313300|69663922|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
37976695|NCT00313300|69663923|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
37976696|NCT00313300|69663924|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
37976697|NCT00313300|69663920|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
37976698|NCT00313300|69663921|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
37976699|NCT00313300|69663922|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
37976700|NCT00313300|69663923|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
37976701|NCT00313300|69663924|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
37976702|NCT00313300|69663920|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
37976703|NCT00313300|69663921|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
37976704|NCT00313300|69663922|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
37976705|NCT00313300|69663923|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
37976706|NCT00313300|69663924|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
37976707|NCT00313300|69663920|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
37976708|NCT00313300|69663921|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
37976709|NCT00313300|69663922|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
37976710|NCT00313300|69663923|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
37976711|NCT00313300|69663924|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
37976712|NCT00313300|69663920|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
37808496|NCT02277444|69454331|FG000|Overall Study|Adverse Event|10|||
37808497|NCT02277444|69454331|FG000|Overall Study|Withdrawal by Subject|3|||
37808498|NCT02277444|69454331|FG000|Overall Study|Other|1|||
37808499|NCT02277444|69454331|FG000|Overall Study|Enrolled and not Treated|3|||
37808500|NCT02277444|69454331|FG000|Overall Study|Ongoing|113|||
37808501|NCT02252172|69454337|FG000|Overall Study|Lost to Follow-up|3|||
37808502|NCT02252172|69454338|FG001|Overall Study|Lost to Follow-up|1|||
37808503|NCT02252172|69454337|FG000|Overall Study|Ongoing|276|||
37808504|NCT02252172|69454338|FG001|Overall Study|Ongoing|298|||
37808505|NCT02195479|69454357|FG000|Overall Study|Lost to Follow-up|3|||
37808506|NCT02195479|69454358|FG001|Overall Study|Lost to Follow-up|0|||
37808507|NCT02195479|69454357|FG000|Overall Study|Death|48|||
37808508|NCT02195479|69454358|FG001|Overall Study|Death|45|||
37808509|NCT02195479|69454357|FG000|Overall Study|Physician Decision|1|||
37808510|NCT02195479|69454358|FG001|Overall Study|Physician Decision|0|||
37808511|NCT02195479|69454357|FG000|Overall Study|Withdrawal by Subject|11|||
37808512|NCT02195479|69454358|FG001|Overall Study|Withdrawal by Subject|6|||
37808513|NCT02195479|69454357|FG000|Overall Study|Other|2|||
37808514|NCT02195479|69454358|FG001|Overall Study|Other|2|||
37808515|NCT02195479|69454357|FG000|Overall Study|Ongoing|291|||
37808516|NCT02195479|69454358|FG001|Overall Study|Ongoing|297|||
37808517|NCT01901562|69454368|FG000|Overall Study|Protocol Violation|5|||
37808518|NCT01901562|69454368|FG000|Overall Study|Excluded intraoperatively|4|||
37808519|NCT01802632|69454378|FG000|Overall Study|Death|28|||
37808520|NCT01802632|69454379|FG001|Overall Study|Death|1|||
37808521|NCT01802632|69454380|FG002|Overall Study|Death|38|||
37808522|NCT01802632|69454381|FG003|Overall Study|Death|0|||
37808523|NCT01802632|69454382|FG004|Overall Study|Death|2|||
37808524|NCT01802632|69454383|FG005|Overall Study|Death|0|||
37808525|NCT01802632|69454378|FG000|Overall Study|Withdrawal by Subject|4|||
37808526|NCT01802632|69454379|FG001|Overall Study|Withdrawal by Subject|2|||
37808527|NCT01802632|69454380|FG002|Overall Study|Withdrawal by Subject|7|||
37808528|NCT01802632|69454381|FG003|Overall Study|Withdrawal by Subject|3|||
37808529|NCT01802632|69454382|FG004|Overall Study|Withdrawal by Subject|0|||
37808530|NCT01802632|69454383|FG005|Overall Study|Withdrawal by Subject|1|||
37808531|NCT01802632|69454378|FG000|Overall Study|Objective Disease Progression|1|||
37808532|NCT01802632|69454379|FG001|Overall Study|Objective Disease Progression|12|||
37808533|NCT01802632|69454380|FG002|Overall Study|Objective Disease Progression|104|||
37808534|NCT01802632|69454381|FG003|Overall Study|Objective Disease Progression|6|||
37808535|NCT01802632|69454382|FG004|Overall Study|Objective Disease Progression|4|||
37976713|NCT00313300|69663921|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
37808536|NCT01802632|69454383|FG005|Overall Study|Objective Disease Progression|4|||
37808537|NCT01802632|69454378|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
37808538|NCT01802632|69454379|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
37808539|NCT01802632|69454380|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
37808540|NCT01802632|69454381|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
37808541|NCT01802632|69454382|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
37808542|NCT01802632|69454383|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
37808543|NCT01802632|69454378|FG000|Overall Study|Other (not specified)|0|||
37808544|NCT01802632|69454379|FG001|Overall Study|Other (not specified)|0|||
37808545|NCT01802632|69454380|FG002|Overall Study|Other (not specified)|7|||
37808546|NCT01802632|69454381|FG003|Overall Study|Other (not specified)|1|||
37808547|NCT01802632|69454382|FG004|Overall Study|Other (not specified)|0|||
37808548|NCT01802632|69454383|FG005|Overall Study|Other (not specified)|1|||
37808549|NCT01776840|69454397|FG000|Overall Study|Lost to Follow-up|4|||
37808550|NCT01776840|69454398|FG001|Overall Study|Lost to Follow-up|4|||
37808551|NCT01776840|69454397|FG000|Overall Study|Withdrawal by Subject|42|||
37808552|NCT01776840|69454398|FG001|Overall Study|Withdrawal by Subject|22|||
37808553|NCT01776840|69454397|FG000|Overall Study|Ongoing|112|||
37808554|NCT01776840|69454398|FG001|Overall Study|Ongoing|129|||
37808555|NCT01615029|69454409|FG000|Overall Study|Adverse Event|0|||
37808556|NCT01615029|69454410|FG001|Overall Study|Adverse Event|0|||
37808557|NCT01615029|69454411|FG002|Overall Study|Adverse Event|0|||
37808558|NCT01615029|69454412|FG003|Overall Study|Adverse Event|0|||
37808559|NCT01615029|69454413|FG004|Overall Study|Adverse Event|1|||
37808560|NCT01615029|69454409|FG000|Overall Study|Death|0|||
37808561|NCT01615029|69454410|FG001|Overall Study|Death|0|||
37808562|NCT01615029|69454411|FG002|Overall Study|Death|0|||
37808563|NCT01615029|69454412|FG003|Overall Study|Death|0|||
37808564|NCT01615029|69454413|FG004|Overall Study|Death|1|||
37808565|NCT01615029|69454409|FG000|Overall Study|Lost to Follow-up|0|||
37808566|NCT01615029|69454410|FG001|Overall Study|Lost to Follow-up|0|||
37808567|NCT01615029|69454411|FG002|Overall Study|Lost to Follow-up|0|||
37808568|NCT01615029|69454412|FG003|Overall Study|Lost to Follow-up|0|||
37808569|NCT01615029|69454413|FG004|Overall Study|Lost to Follow-up|1|||
37808570|NCT01615029|69454409|FG000|Overall Study|Progressive disease|2|||
37808571|NCT01615029|69454410|FG001|Overall Study|Progressive disease|1|||
37808572|NCT01615029|69454411|FG002|Overall Study|Progressive disease|1|||
37808573|NCT01615029|69454412|FG003|Overall Study|Progressive disease|1|||
37808574|NCT01615029|69454413|FG004|Overall Study|Progressive disease|5|||
37808575|NCT01615029|69454409|FG000|Overall Study|Physician Decision|0|||
37808576|NCT01615029|69454410|FG001|Overall Study|Physician Decision|0|||
37808577|NCT01615029|69454411|FG002|Overall Study|Physician Decision|0|||
37808578|NCT01615029|69454412|FG003|Overall Study|Physician Decision|0|||
37808579|NCT01615029|69454413|FG004|Overall Study|Physician Decision|1|||
37808580|NCT01615029|69454409|FG000|Overall Study|Ongoing|1|||
37808581|NCT01615029|69454410|FG001|Overall Study|Ongoing|2|||
37808582|NCT01615029|69454411|FG002|Overall Study|Ongoing|3|||
37808583|NCT01615029|69454412|FG003|Overall Study|Ongoing|2|||
37808584|NCT01615029|69454413|FG004|Overall Study|Ongoing|23|||
37808585|NCT00819247|69454428|FG000|Overall Study|Adverse Event|0|||
37808586|NCT00819247|69454429|FG001|Overall Study|Adverse Event|5|||
37808587|NCT00819247|69454430|FG002|Overall Study|Adverse Event|3|||
37808588|NCT00819247|69454428|FG000|Overall Study|Insufficient testosterone response|5|||
37808589|NCT00819247|69454429|FG001|Overall Study|Insufficient testosterone response|8|||
37808590|NCT00819247|69454430|FG002|Overall Study|Insufficient testosterone response|10|||
37808591|NCT00819247|69454428|FG000|Overall Study|Withdrawal by Subject|1|||
37808592|NCT00819247|69454429|FG001|Overall Study|Withdrawal by Subject|0|||
37808593|NCT00819247|69454430|FG002|Overall Study|Withdrawal by Subject|0|||
37808594|NCT00819247|69454428|FG000|Overall Study|Protocol Violation|1|||
37808595|NCT00819247|69454429|FG001|Overall Study|Protocol Violation|0|||
37808596|NCT00819247|69454430|FG002|Overall Study|Protocol Violation|1|||
37808597|NCT00819247|69454428|FG000|Overall Study|Mistakenly withdrawn|0|||
37808598|NCT00819247|69454429|FG001|Overall Study|Mistakenly withdrawn|1|||
37808599|NCT00819247|69454430|FG002|Overall Study|Mistakenly withdrawn|0|||
37808600|NCT00819247|69454428|FG000|Overall Study|Bad prostate-specific antigen response|3|||
37808601|NCT00819247|69454429|FG001|Overall Study|Bad prostate-specific antigen response|2|||
37808602|NCT00819247|69454430|FG002|Overall Study|Bad prostate-specific antigen response|0|||
37808603|NCT00819247|69454428|FG000|Overall Study|Other|1|||
37808604|NCT00819247|69454429|FG001|Overall Study|Other|0|||
37808605|NCT00819247|69454430|FG002|Overall Study|Other|0|||
37808606|NCT00716976|69454440|FG000|Overall Study|Adverse Event|2|||
37808607|NCT00716976|69454441|FG001|Overall Study|Adverse Event|0|||
37808608|NCT00716976|69454440|FG000|Overall Study|Death|1|||
37808609|NCT00716976|69454441|FG001|Overall Study|Death|0|||
37808610|NCT00716976|69454440|FG000|Overall Study|Physician Decision|2|||
37808611|NCT00716976|69454441|FG001|Overall Study|Physician Decision|2|||
37808612|NCT00716976|69454440|FG000|Overall Study|Withdrawal by Subject|5|||
37808613|NCT00716976|69454441|FG001|Overall Study|Withdrawal by Subject|1|||
37808614|NCT00716976|69454440|FG000|Overall Study|Premature discontinuation cisplatin|5|||
37808615|NCT00716976|69454441|FG001|Overall Study|Premature discontinuation cisplatin|4|||
37808616|NCT00716976|69454440|FG000|Overall Study|Radiation during protocol|1|||
37808617|NCT00716976|69454441|FG001|Overall Study|Radiation during protocol|0|||
37808618|NCT00716976|69454440|FG000|Overall Study|Ineligibles|4|||
37808619|NCT00716976|69454441|FG001|Overall Study|Ineligibles|2|||
37808620|NCT00089778|69454563|FG000|Overall Study|Protocol Violation|0|||
37808621|NCT00089778|69454564|FG001|Overall Study|Protocol Violation|0|||
37808622|NCT00089778|69454565|FG002|Overall Study|Protocol Violation|1|||
37808623|NCT00089544|69454577|FG000|Overall Study|Ineligible|1|||
37808624|NCT00089544|69454578|FG001|Overall Study|Ineligible|0|||
37808625|NCT00089076|69454584|FG000|Overall Study|Alternate Therapy|1|||
37808626|NCT00089076|69454584|FG000|Overall Study|Withdrawal by Subject|2|||
37808627|NCT00089076|69454584|FG000|Overall Study|Progression|7|||
37808628|NCT00088374|69454588|FG000|Overall Study|patient did not receive any 17AAG|1|||
37808629|NCT00088374|69454588|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
37808630|NCT00087594|69454594|FG000|Overall Study|Adverse Event|2|||
37808631|NCT00087594|69454595|FG001|Overall Study|Adverse Event|3|||
37808632|NCT00087594|69454594|FG000|Overall Study|Lost to Follow-up|0|||
37808633|NCT00087594|69454595|FG001|Overall Study|Lost to Follow-up|2|||
37808634|NCT00087594|69454594|FG000|Overall Study|Withdrawal by Subject|4|||
37808635|NCT00087594|69454595|FG001|Overall Study|Withdrawal by Subject|2|||
37808636|NCT00087594|69454594|FG000|Overall Study|Lack of Efficacy|2|||
37808637|NCT00087594|69454595|FG001|Overall Study|Lack of Efficacy|5|||
37808638|NCT00087516|69454604|FG000|Overall Study|Adverse Event|10|||
37808639|NCT00087516|69454605|FG001|Overall Study|Adverse Event|10|||
37808640|NCT00087516|69454606|FG002|Overall Study|Adverse Event|3|||
37976714|NCT00313300|69663922|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
37976715|NCT00313300|69663923|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
37976716|NCT00313300|69663924|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
37976717|NCT00313300|69663920|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
37976718|NCT00313300|69663921|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
37976719|NCT00313300|69663922|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
37976720|NCT00313300|69663923|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
37976721|NCT00313300|69663924|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
37976722|NCT00313300|69663920|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
37976723|NCT00313300|69663921|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
37976724|NCT00313300|69663922|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
37976725|NCT00313300|69663923|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
37976726|NCT00313300|69663924|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
37976727|NCT00313300|69663920|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
37976728|NCT00313300|69663921|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
37808641|NCT00087516|69454607|FG003|Overall Study|Adverse Event|6|||
37808642|NCT00087516|69454604|FG000|Overall Study|Lack of Efficacy|82|||
37808643|NCT00087516|69454605|FG001|Overall Study|Lack of Efficacy|80|||
37808644|NCT00087516|69454606|FG002|Overall Study|Lack of Efficacy|39|||
37808645|NCT00087516|69454607|FG003|Overall Study|Lack of Efficacy|29|||
37808646|NCT00087516|69454604|FG000|Overall Study|Lost to Follow-up|8|||
37808647|NCT00087516|69454605|FG001|Overall Study|Lost to Follow-up|6|||
37808648|NCT00087516|69454606|FG002|Overall Study|Lost to Follow-up|5|||
37808649|NCT00087516|69454607|FG003|Overall Study|Lost to Follow-up|5|||
37808650|NCT00087516|69454604|FG000|Overall Study|Protocol Violation|4|||
37808651|NCT00087516|69454605|FG001|Overall Study|Protocol Violation|8|||
37808652|NCT00087516|69454606|FG002|Overall Study|Protocol Violation|3|||
37808653|NCT00087516|69454607|FG003|Overall Study|Protocol Violation|6|||
37808654|NCT00087516|69454604|FG000|Overall Study|Withdrawal by Subject|16|||
37808655|NCT00087516|69454605|FG001|Overall Study|Withdrawal by Subject|27|||
37808656|NCT00087516|69454606|FG002|Overall Study|Withdrawal by Subject|11|||
37808657|NCT00087516|69454607|FG003|Overall Study|Withdrawal by Subject|12|||
37808658|NCT00087516|69454604|FG000|Overall Study|Site terminated|0|||
37808659|NCT00087516|69454605|FG001|Overall Study|Site terminated|2|||
37808660|NCT00087516|69454606|FG002|Overall Study|Site terminated|1|||
37808661|NCT00087516|69454607|FG003|Overall Study|Site terminated|0|||
37808662|NCT00087516|69454604|FG000|Overall Study|Protocol specified discontinuation|35|||
37808663|NCT00087516|69454605|FG001|Overall Study|Protocol specified discontinuation|33|||
37808664|NCT00087516|69454606|FG002|Overall Study|Protocol specified discontinuation|33|||
37808665|NCT00087516|69454607|FG003|Overall Study|Protocol specified discontinuation|26|||
37808666|NCT00087516|69454604|FG000|Overall Study|Patient moved|3|||
37808667|NCT00087516|69454605|FG001|Overall Study|Patient moved|2|||
37808668|NCT00087516|69454606|FG002|Overall Study|Patient moved|1|||
37808669|NCT00087516|69454607|FG003|Overall Study|Patient moved|0|||
37808670|NCT00087516|69454604|FG000|Overall Study|Patient was non-compliant|3|||
37808671|NCT00087516|69454605|FG001|Overall Study|Patient was non-compliant|1|||
37808672|NCT00087516|69454606|FG002|Overall Study|Patient was non-compliant|0|||
37808673|NCT00087516|69454607|FG003|Overall Study|Patient was non-compliant|0|||
37808674|NCT00087516|69454604|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
37808675|NCT00087516|69454605|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
37808676|NCT00087516|69454606|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
37808677|NCT00087516|69454607|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
37976729|NCT00313300|69663922|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
37976730|NCT00313300|69663923|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
37976731|NCT00313300|69663924|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
37976732|NCT00313300|69663920|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
37808678|NCT00087516|69454604|FG000|Overall Study|Other|0|||
37808679|NCT00087516|69454605|FG001|Overall Study|Other|0|||
37808680|NCT00087516|69454606|FG002|Overall Study|Other|1|||
37808681|NCT00087516|69454607|FG003|Overall Study|Other|0|||
37808682|NCT00087126|69454621|FG000|Overall Study|Ineligible - second primary|1|||
37808683|NCT00087126|69454621|FG000|Overall Study|Never treated|1|||
37808684|NCT03490734|69454634|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
37808685|NCT03490734|69454635|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
37808686|NCT03490734|69454636|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
37808687|NCT03490734|69454637|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
37808688|NCT03490734|69454634|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
37808689|NCT03490734|69454635|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
37808690|NCT03490734|69454636|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
37808691|NCT03490734|69454637|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
37808692|NCT03490734|69454634|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
37808693|NCT03490734|69454635|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
37808694|NCT03490734|69454636|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
37808695|NCT03490734|69454637|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
37808696|NCT03490734|69454634|FG000|Post-intervention Scan Visit|Adverse Event|2|||
37808697|NCT03490734|69454635|FG001|Post-intervention Scan Visit|Adverse Event|0|||
37808698|NCT03490734|69454636|FG002|Post-intervention Scan Visit|Adverse Event|0|||
37808699|NCT03490734|69454637|FG003|Post-intervention Scan Visit|Adverse Event|0|||
37808700|NCT03490734|69454634|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
37808701|NCT03490734|69454635|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
37808702|NCT03490734|69454636|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
37808703|NCT03490734|69454637|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
37808704|NCT03490734|69454634|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
37976733|NCT00313300|69663921|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
37976734|NCT00313300|69663922|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
37976735|NCT00313300|69663923|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
37976736|NCT00313300|69663924|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
37976737|NCT00313300|69663920|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
37976738|NCT00313300|69663921|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
37976739|NCT00313300|69663922|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
37976740|NCT00313300|69663923|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
37976741|NCT00313300|69663924|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
37976742|NCT00459186|69663942|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
37976743|NCT00459186|69663942|FG000|PET Imaging and Assessment|Adverse Event|3|||
37976744|NCT00328510|69663948|FG000|Overall Study|Gag disorder, could not use frame|4|||
37808705|NCT03490734|69454635|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
37808706|NCT03490734|69454636|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
37808707|NCT03490734|69454637|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
37808708|NCT00086346|69454648|FG000|Randomization|Did not receive test article|4|||
37808709|NCT00086346|69454649|FG001|Randomization|Did not receive test article|4|||
37808710|NCT00086346|69454648|FG000|Patients Dosed With Test Article|Adverse Event|94|||
37808711|NCT00086346|69454649|FG001|Patients Dosed With Test Article|Adverse Event|11|||
37808712|NCT00086346|69454648|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
37808713|NCT00086346|69454649|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
37808714|NCT00086346|69454648|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
37808715|NCT00086346|69454649|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
37808716|NCT00086346|69454648|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
37808717|NCT00086346|69454649|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
37808718|NCT00086346|69454648|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
37808719|NCT00086346|69454649|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
37808720|NCT00086346|69454648|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
37808721|NCT00086346|69454649|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
37808722|NCT00085566|69454658|FG000|Overall Study|Adverse Event|0|||
37808723|NCT00085566|69454659|FG001|Overall Study|Adverse Event|0|||
37808724|NCT00085566|69454660|FG002|Overall Study|Adverse Event|10|||
37808725|NCT00085566|69454658|FG000|Overall Study|Patient Not treated|0|||
37808726|NCT00085566|69454659|FG001|Overall Study|Patient Not treated|0|||
37808727|NCT00085566|69454660|FG002|Overall Study|Patient Not treated|3|||
37808728|NCT00085566|69454658|FG000|Overall Study|Clinical progression|0|||
37808729|NCT00085566|69454659|FG001|Overall Study|Clinical progression|0|||
37808730|NCT00085566|69454660|FG002|Overall Study|Clinical progression|1|||
37808731|NCT00085098|69454670|FG000|Overall Study|Withdrawal by Subject|0|||
37808732|NCT00085098|69454671|FG001|Overall Study|Withdrawal by Subject|1|||
37808733|NCT00085098|69454670|FG000|Overall Study|Ineligible|1|||
37864320|NCT01260350|69547958|FG021|Overall Study|Lack of Efficacy|0|||
37694104|NCT02460224|69170399|FG022|Overall Study|Lost to Follow-up|1|||
37808734|NCT00085098|69454671|FG001|Overall Study|Ineligible|1|||
37808735|NCT00084864|69454684|FG000|Overall Study|Adverse Event|1|||
37808736|NCT00084864|69454685|FG001|Overall Study|Adverse Event|0|||
37808737|NCT00084864|69454686|FG002|Overall Study|Adverse Event|0|||
37808738|NCT00084864|69454687|FG003|Overall Study|Adverse Event|0|||
37694105|NCT02460224|69170400|FG023|Overall Study|Lost to Follow-up|0|||
37808739|NCT00084318|69454699|FG000|Overall Study|Withdrawal by Subject|5|||
37808740|NCT00084318|69454700|FG001|Overall Study|Withdrawal by Subject|2|||
37808741|NCT00084318|69454699|FG000|Overall Study|Protocol Violation|15|||
37808742|NCT00084318|69454700|FG001|Overall Study|Protocol Violation|11|||
37808743|NCT00084318|69454699|FG000|Overall Study|No protocol treatment|2|||
37808744|NCT00084318|69454700|FG001|Overall Study|No protocol treatment|0|||
37808745|NCT00084084|69454708|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
37808746|NCT00084084|69454708|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
37808747|NCT00083616|69454713|FG000|Overall Study|Disease Progression|16|||
37808748|NCT00083616|69454713|FG000|Overall Study|Lost to Follow-up|1|||
37808749|NCT00083616|69454713|FG000|Overall Study|Physician Decision|2|||
37808750|NCT00083616|69454713|FG000|Overall Study|Withdrawal by Subject|3|||
37808751|NCT00083616|69454713|FG000|Overall Study|Ineligibility determined|2|||
37808752|NCT00083616|69454713|FG000|Overall Study|Non-compliance|1|||
37808753|NCT00083616|69454713|FG000|Overall Study|Other|6|||
37808754|NCT00083226|69454717|FG000|Overall Study|Lack of Efficacy|19|||
37808755|NCT00083226|69454717|FG000|Overall Study|Adverse Event|9|||
37808756|NCT00083226|69454717|FG000|Overall Study|Death|4|||
37808757|NCT00083226|69454717|FG000|Overall Study|Withdrawal by Subject|4|||
37808758|NCT00083226|69454717|FG000|Overall Study|Other|2|||
37808759|NCT00083226|69454717|FG000|Overall Study|ineligible or not receiving treatment|4|||
37808760|NCT00082758|69454724|FG000|Overall Study|Adverse Event|0|||
37808761|NCT00082758|69454725|FG001|Overall Study|Adverse Event|2|||
37808762|NCT00082758|69454726|FG002|Overall Study|Adverse Event|0|||
37808763|NCT00082758|69454724|FG000|Overall Study|Lack of Efficacy|12|||
37808764|NCT00082758|69454725|FG001|Overall Study|Lack of Efficacy|13|||
37808765|NCT00082758|69454726|FG002|Overall Study|Lack of Efficacy|0|||
37808766|NCT00082758|69454724|FG000|Overall Study|Physician Decision|0|||
37808767|NCT00082758|69454725|FG001|Overall Study|Physician Decision|1|||
37808768|NCT00082758|69454726|FG002|Overall Study|Physician Decision|0|||
37808769|NCT00082758|69454724|FG000|Overall Study|Withdrawal by Subject|3|||
37694106|NCT02460224|69170401|FG024|Overall Study|Lost to Follow-up|0|||
37808770|NCT00082758|69454725|FG001|Overall Study|Withdrawal by Subject|0|||
37808771|NCT00082758|69454726|FG002|Overall Study|Withdrawal by Subject|0|||
37808772|NCT00082758|69454724|FG000|Overall Study|Protocol Violation|0|||
37808773|NCT00082758|69454725|FG001|Overall Study|Protocol Violation|1|||
37808774|NCT00082758|69454726|FG002|Overall Study|Protocol Violation|0|||
37808775|NCT00088452|69454737|FG000|Overall Study|Did not receive intervention|1|||
37808776|NCT00088452|69454738|FG001|Overall Study|Did not receive intervention|0|||
37808777|NCT00088452|69454739|FG002|Overall Study|Did not receive intervention|1|||
37808778|NCT04686084|69454829|FG000|Overall Study|Lost to Follow-up|1|||
37808779|NCT04685538|69454836|FG000|Overall Study|Adverse Event|0|||
37808780|NCT04685538|69454837|FG001|Overall Study|Adverse Event|1|||
37808781|NCT04685538|69454836|FG000|Overall Study|Lost to Follow-up|0|||
37808782|NCT04685538|69454837|FG001|Overall Study|Lost to Follow-up|2|||
37808783|NCT04213326|69454849|FG000|Overall Study|Consent withdrawn|51|||
37808784|NCT04213326|69454850|FG001|Overall Study|Consent withdrawn|241|||
37808785|NCT04213326|69454849|FG000|Overall Study|Lost to Follow-up|50|||
37808786|NCT04213326|69454850|FG001|Overall Study|Lost to Follow-up|902|||
37808787|NCT04213326|69454849|FG000|Overall Study|Protocol Violation|3|||
37808788|NCT04213326|69454850|FG001|Overall Study|Protocol Violation|25|||
37808789|NCT04213326|69454849|FG000|Overall Study|Participant eligibility changed|106|||
37808790|NCT04213326|69454850|FG001|Overall Study|Participant eligibility changed|19|||
37808791|NCT04213326|69454849|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
37808792|NCT04213326|69454850|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
37808793|NCT04213326|69454849|FG000|Overall Study|Incomplete study visit|0|||
37808794|NCT04213326|69454850|FG001|Overall Study|Incomplete study visit|367|||
37808795|NCT01625286|69454863|FG000|Overall Study|Adverse Event|0|||
37808796|NCT01625286|69454864|FG001|Overall Study|Adverse Event|0|||
37808797|NCT01625286|69454865|FG002|Overall Study|Adverse Event|0|||
37808798|NCT01625286|69454866|FG003|Overall Study|Adverse Event|0|||
37976745|NCT00328510|69663949|FG001|Overall Study|Gag disorder, could not use frame|0|||
37976746|NCT00328510|69663948|FG000|Overall Study|Dentition problems, could not use frame|1|||
37976747|NCT00328510|69663949|FG001|Overall Study|Dentition problems, could not use frame|0|||
37976748|NCT00328510|69663948|FG000|Overall Study|Withdrawal by Subject|4|||
37976749|NCT00328510|69663949|FG001|Overall Study|Withdrawal by Subject|2|||
37976750|NCT00328510|69663948|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
37808799|NCT01625286|69454867|FG004|Overall Study|Adverse Event|1|||
37808800|NCT01625286|69454868|FG005|Overall Study|Adverse Event|2|||
37808801|NCT01625286|69454869|FG006|Overall Study|Adverse Event|1|||
37808802|NCT01625286|69454863|FG000|Overall Study|Death|0|||
37976751|NCT00328510|69663949|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
37808803|NCT01625286|69454864|FG001|Overall Study|Death|0|||
37808804|NCT01625286|69454865|FG002|Overall Study|Death|1|||
37808805|NCT01625286|69454866|FG003|Overall Study|Death|1|||
37808806|NCT01625286|69454867|FG004|Overall Study|Death|0|||
37808807|NCT01625286|69454868|FG005|Overall Study|Death|11|||
37808808|NCT01625286|69454869|FG006|Overall Study|Death|16|||
37808809|NCT01625286|69454863|FG000|Overall Study|Withdrawal by Subject|0|||
37808810|NCT01625286|69454864|FG001|Overall Study|Withdrawal by Subject|1|||
37808811|NCT01625286|69454865|FG002|Overall Study|Withdrawal by Subject|0|||
37808812|NCT01625286|69454866|FG003|Overall Study|Withdrawal by Subject|1|||
37808813|NCT01625286|69454867|FG004|Overall Study|Withdrawal by Subject|0|||
37808814|NCT01625286|69454868|FG005|Overall Study|Withdrawal by Subject|0|||
37808815|NCT01625286|69454869|FG006|Overall Study|Withdrawal by Subject|1|||
37808816|NCT01625286|69454863|FG000|Overall Study|Any reason not specifically recorded|0|||
37808817|NCT01625286|69454864|FG001|Overall Study|Any reason not specifically recorded|0|||
37808818|NCT01625286|69454865|FG002|Overall Study|Any reason not specifically recorded|0|||
37808819|NCT01625286|69454866|FG003|Overall Study|Any reason not specifically recorded|0|||
37808820|NCT01625286|69454867|FG004|Overall Study|Any reason not specifically recorded|0|||
37808821|NCT01625286|69454868|FG005|Overall Study|Any reason not specifically recorded|1|||
37808822|NCT01625286|69454869|FG006|Overall Study|Any reason not specifically recorded|0|||
37808823|NCT01625286|69454863|FG000|Overall Study|Progressive disease|6|||
37808824|NCT01625286|69454864|FG001|Overall Study|Progressive disease|3|||
37808825|NCT01625286|69454865|FG002|Overall Study|Progressive disease|4|||
37808826|NCT01625286|69454866|FG003|Overall Study|Progressive disease|5|||
37808827|NCT01625286|69454867|FG004|Overall Study|Progressive disease|5|||
37808828|NCT01625286|69454868|FG005|Overall Study|Progressive disease|0|||
37808829|NCT01625286|69454869|FG006|Overall Study|Progressive disease|0|||
37808830|NCT01625286|69454863|FG000|Overall Study|Lost to Follow-up|0|||
37864321|NCT01260350|69547937|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
37864322|NCT01260350|69547938|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
37808831|NCT01625286|69454864|FG001|Overall Study|Lost to Follow-up|0|||
37808832|NCT01625286|69454865|FG002|Overall Study|Lost to Follow-up|0|||
37808833|NCT01625286|69454866|FG003|Overall Study|Lost to Follow-up|0|||
37808834|NCT01625286|69454867|FG004|Overall Study|Lost to Follow-up|0|||
37808835|NCT01625286|69454868|FG005|Overall Study|Lost to Follow-up|0|||
37808836|NCT01625286|69454869|FG006|Overall Study|Lost to Follow-up|1|||
37808837|NCT04083222|69454914|FG000|Overall Study|Voluntary Withdrawal|0|||
37808838|NCT04083222|69454915|FG001|Overall Study|Voluntary Withdrawal|1|||
37808839|NCT04083222|69454914|FG000|Overall Study|Reason not Specified|0|||
37808840|NCT04083222|69454915|FG001|Overall Study|Reason not Specified|1|||
37808841|NCT03286842|69454921|FG000|Overall Study|Patients rolled over to another study|80|||
37808842|NCT03037476|69454929|FG000|Overall Study|Lost to Follow-up|63|||
37808843|NCT03037476|69454930|FG001|Overall Study|Lost to Follow-up|46|||
37808844|NCT00639678|69454945|FG000|Overall Study|Withdrawal by Subject|3|||
37808845|NCT00639678|69454946|FG001|Overall Study|Withdrawal by Subject|0|||
37808846|NCT00639678|69454947|FG002|Overall Study|Withdrawal by Subject|4|||
37808847|NCT00639678|69454948|FG003|Overall Study|Withdrawal by Subject|0|||
37808848|NCT00639678|69454945|FG000|Overall Study|Lost to Follow-up|1|||
37808849|NCT00639678|69454946|FG001|Overall Study|Lost to Follow-up|0|||
37808850|NCT00639678|69454947|FG002|Overall Study|Lost to Follow-up|6|||
37808851|NCT00639678|69454948|FG003|Overall Study|Lost to Follow-up|0|||
37808852|NCT00639678|69454945|FG000|Overall Study|Adverse Event|0|||
37808853|NCT00639678|69454946|FG001|Overall Study|Adverse Event|1|||
37808854|NCT00639678|69454947|FG002|Overall Study|Adverse Event|0|||
37808855|NCT00639678|69454948|FG003|Overall Study|Adverse Event|0|||
37808856|NCT00639678|69454945|FG000|Overall Study|Lack of Compliance|0|||
37808857|NCT00639678|69454946|FG001|Overall Study|Lack of Compliance|0|||
37808858|NCT00639678|69454947|FG002|Overall Study|Lack of Compliance|1|||
37808859|NCT00639678|69454948|FG003|Overall Study|Lack of Compliance|0|||
37808860|NCT00638508|69454973|FG000|Overall Study|Physician Decision|5|||
37808861|NCT00638508|69454974|FG001|Overall Study|Physician Decision|2|||
37808862|NCT00637806|69454987|FG000|Double-blind Phase|Study Discontinued|2|||
37808863|NCT00637806|69454988|FG001|Double-blind Phase|Study Discontinued|0|||
37808864|NCT00637806|69454989|FG002|Double-blind Phase|Study Discontinued|1|||
37808865|NCT00637806|69454990|FG003|Double-blind Phase|Study Discontinued|0|||
37808866|NCT00637806|69454987|FG000|Extension Phase|Study Discontinued|0|||
37808867|NCT00637806|69454988|FG001|Extension Phase|Study Discontinued|0|||
37808868|NCT00637806|69454989|FG002|Extension Phase|Study Discontinued|0|||
37808869|NCT00637806|69454990|FG003|Extension Phase|Study Discontinued|1|||
37808870|NCT00637728|69455001|FG000|Double-blind Phase|Adverse Event|1|||
37808871|NCT00637728|69455002|FG001|Double-blind Phase|Adverse Event|0|||
37808872|NCT00637728|69455003|FG002|Double-blind Phase|Adverse Event|0|||
37808873|NCT00637728|69455001|FG000|Double-blind Phase|Non-compliance|2|||
37808874|NCT00637728|69455002|FG001|Double-blind Phase|Non-compliance|0|||
37808875|NCT00637728|69455003|FG002|Double-blind Phase|Non-compliance|0|||
37808876|NCT00637728|69455001|FG000|Double-blind Phase|Study Discontinued|1|||
37808877|NCT00637728|69455002|FG001|Double-blind Phase|Study Discontinued|1|||
37808878|NCT00637728|69455003|FG002|Double-blind Phase|Study Discontinued|0|||
37808879|NCT00637572|69455012|FG000|Overall Study|Adverse Event|1|||
37808880|NCT00637572|69455013|FG001|Overall Study|Adverse Event|2|||
37808881|NCT00637572|69455012|FG000|Overall Study|Death|0|||
37808882|NCT00637572|69455013|FG001|Overall Study|Death|1|||
37808883|NCT00637572|69455012|FG000|Overall Study|Lost to Follow-up|0|||
37808884|NCT00637572|69455013|FG001|Overall Study|Lost to Follow-up|1|||
37808885|NCT00637572|69455012|FG000|Overall Study|Physician Decision|1|||
37808886|NCT00637572|69455013|FG001|Overall Study|Physician Decision|1|||
37808887|NCT00637572|69455012|FG000|Overall Study|Withdrawal by Subject|0|||
37808888|NCT00637572|69455013|FG001|Overall Study|Withdrawal by Subject|2|||
37808889|NCT00637572|69455012|FG000|Overall Study|Illicit Drug Use|1|||
37808890|NCT00637572|69455013|FG001|Overall Study|Illicit Drug Use|0|||
37808891|NCT00637416|69455021|FG000|Overall Study|Lost to Follow-up|1|||
37808892|NCT00637416|69455022|FG001|Overall Study|Lost to Follow-up|1|||
37808893|NCT00637416|69455021|FG000|Overall Study|Unable to take study drug|0|||
37808894|NCT00637416|69455022|FG001|Overall Study|Unable to take study drug|1|||
37808895|NCT00636792|69455028|FG000|Overall Study|Adverse Event|16|||
37808896|NCT00636792|69455028|FG000|Overall Study|Physician Decision|7|||
37808897|NCT00636792|69455028|FG000|Overall Study|Progressive Disease|4|||
37808898|NCT00636792|69455028|FG000|Overall Study|Withdrawal by Subject|3|||
37808899|NCT00636792|69455028|FG000|Overall Study|Other|3|||
37808900|NCT00636636|69455060|FG000|Overall Study|Other reason|4|||
37808901|NCT00636636|69455061|FG001|Overall Study|Other reason|6|||
37808902|NCT00636636|69455060|FG000|Overall Study|Adverse Event|19|||
37808903|NCT00636636|69455061|FG001|Overall Study|Adverse Event|8|||
37808904|NCT00636636|69455060|FG000|Overall Study|Lack of Efficacy|7|||
37808905|NCT00636636|69455061|FG001|Overall Study|Lack of Efficacy|12|||
37808906|NCT00636636|69455060|FG000|Overall Study|Protocol Violation|2|||
37808907|NCT00636636|69455061|FG001|Overall Study|Protocol Violation|2|||
37808908|NCT00636636|69455060|FG000|Overall Study|Lost to Follow-up|0|||
37808909|NCT00636636|69455061|FG001|Overall Study|Lost to Follow-up|1|||
37808910|NCT00636636|69455060|FG000|Overall Study|Death|0|||
37808911|NCT00636636|69455061|FG001|Overall Study|Death|1|||
37808912|NCT00636636|69455060|FG000|Overall Study|Withdrawal by Subject|4|||
37808913|NCT00636636|69455061|FG001|Overall Study|Withdrawal by Subject|9|||
37808914|NCT00635778|69455074|FG000|Overall Study|Adverse Event|1|||
37808915|NCT00635778|69455075|FG001|Overall Study|Adverse Event|0|||
37808916|NCT00635778|69455076|FG002|Overall Study|Adverse Event|0|||
37808917|NCT00635778|69455077|FG003|Overall Study|Adverse Event|3|||
37808918|NCT00635778|69455078|FG004|Overall Study|Adverse Event|3|||
37808919|NCT00635778|69455079|FG005|Overall Study|Adverse Event|6|||
37808920|NCT00635778|69455080|FG006|Overall Study|Adverse Event|1|||
37808921|NCT00635778|69455074|FG000|Overall Study|Withdrawal by Subject|0|||
37808922|NCT00635778|69455075|FG001|Overall Study|Withdrawal by Subject|0|||
37808923|NCT00635778|69455076|FG002|Overall Study|Withdrawal by Subject|0|||
37808924|NCT00635778|69455077|FG003|Overall Study|Withdrawal by Subject|1|||
37808925|NCT00635778|69455078|FG004|Overall Study|Withdrawal by Subject|0|||
37808926|NCT00635778|69455079|FG005|Overall Study|Withdrawal by Subject|1|||
37808927|NCT00635778|69455080|FG006|Overall Study|Withdrawal by Subject|1|||
37808928|NCT00635778|69455074|FG000|Overall Study|Progressive disease|0|||
37808929|NCT00635778|69455075|FG001|Overall Study|Progressive disease|3|||
37808930|NCT00635778|69455076|FG002|Overall Study|Progressive disease|3|||
37808931|NCT00635778|69455077|FG003|Overall Study|Progressive disease|4|||
37808932|NCT00635778|69455078|FG004|Overall Study|Progressive disease|5|||
37808933|NCT00635778|69455079|FG005|Overall Study|Progressive disease|14|||
37694107|NCT02460224|69170402|FG025|Overall Study|Lost to Follow-up|0|||
37694108|NCT02460224|69170403|FG026|Overall Study|Lost to Follow-up|0|||
37808934|NCT00635778|69455080|FG006|Overall Study|Progressive disease|4|||
37808935|NCT00634920|69455100|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
37808936|NCT00634920|69455101|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
37808937|NCT00634920|69455102|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
37808938|NCT00634920|69455100|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
37808939|NCT00634920|69455101|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
37808940|NCT00634920|69455102|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
37808941|NCT00634920|69455100|FG000|Period 1 - Pre-Randomization|Rejections|0|||
37808942|NCT00634920|69455101|FG001|Period 1 - Pre-Randomization|Rejections|0|||
37976752|NCT00328510|69663948|FG000|Overall Study|Treatment changed to a single fraction|1|||
37976753|NCT00328510|69663949|FG001|Overall Study|Treatment changed to a single fraction|1|||
37808943|NCT00634920|69455102|FG002|Period 1 - Pre-Randomization|Rejections|55|||
37808944|NCT00634920|69455100|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
37808945|NCT00634920|69455101|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
37808946|NCT00634920|69455102|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
37808947|NCT00634920|69455100|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
37808948|NCT00634920|69455101|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
37808949|NCT00634920|69455102|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
37808950|NCT00634920|69455100|FG000|Period 1 - Pre-Randomization|Other issues|0|||
37808951|NCT00634920|69455101|FG001|Period 1 - Pre-Randomization|Other issues|0|||
37808952|NCT00634920|69455102|FG002|Period 1 - Pre-Randomization|Other issues|6|||
37808953|NCT00634920|69455100|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
37808954|NCT00634920|69455101|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
37808955|NCT00634920|69455102|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
37808956|NCT00634920|69455100|FG000|Period 2 - Post-Randomization|Rejection|11|||
37808957|NCT00634920|69455101|FG001|Period 2 - Post-Randomization|Rejection|5|||
37808958|NCT00634920|69455102|FG002|Period 2 - Post-Randomization|Rejection|0|||
37808959|NCT00634920|69455100|FG000|Period 2 - Post-Randomization|Death|2|||
37808960|NCT00634920|69455101|FG001|Period 2 - Post-Randomization|Death|5|||
37808961|NCT00634920|69455102|FG002|Period 2 - Post-Randomization|Death|0|||
37808962|NCT00634920|69455100|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
37808963|NCT00634920|69455101|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
37808964|NCT00634920|69455102|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
37808965|NCT00634920|69455100|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
37808966|NCT00634920|69455101|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
37808967|NCT00634920|69455102|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
37808968|NCT00634842|69455110|FG000|Overall Study|Adverse Event|2|||
37808969|NCT00634842|69455111|FG001|Overall Study|Adverse Event|3|||
37808970|NCT00634842|69455110|FG000|Overall Study|Protocol Violation|8|||
37808971|NCT00634842|69455111|FG001|Overall Study|Protocol Violation|4|||
37808972|NCT00634842|69455110|FG000|Overall Study|Move to another state|1|||
37808973|NCT00634842|69455111|FG001|Overall Study|Move to another state|0|||
37808974|NCT00634842|69455110|FG000|Overall Study|Inclusion criteria were not met|1|||
37808975|NCT00634842|69455111|FG001|Overall Study|Inclusion criteria were not met|0|||
37808976|NCT00634842|69455110|FG000|Overall Study|Lost to Follow-up|1|||
37808977|NCT00634842|69455111|FG001|Overall Study|Lost to Follow-up|2|||
37808978|NCT00634842|69455110|FG000|Overall Study|Physician Decision|1|||
37808979|NCT00634842|69455111|FG001|Overall Study|Physician Decision|0|||
37808980|NCT00634842|69455110|FG000|Overall Study|Withdrawal by Subject|1|||
37808981|NCT00634842|69455111|FG001|Overall Study|Withdrawal by Subject|3|||
37808982|NCT00634842|69455110|FG000|Overall Study|Lack of time and intolerance to drug|0|||
37808983|NCT00634842|69455111|FG001|Overall Study|Lack of time and intolerance to drug|1|||
37808984|NCT00634842|69455110|FG000|Overall Study|Discontinued due to injection|0|||
37808985|NCT00634842|69455111|FG001|Overall Study|Discontinued due to injection|2|||
37808986|NCT00634842|69455110|FG000|Overall Study|No need of study drug to treat diabetes|0|||
37808987|NCT00634842|69455111|FG001|Overall Study|No need of study drug to treat diabetes|1|||
37808988|NCT00634842|69455110|FG000|Overall Study|No wish to keep taking Avandia|0|||
37808989|NCT00634842|69455111|FG001|Overall Study|No wish to keep taking Avandia|1|||
37808990|NCT00634842|69455110|FG000|Overall Study|Subject off study drug for too long|0|||
37808991|NCT00634842|69455111|FG001|Overall Study|Subject off study drug for too long|1|||
37808992|NCT00633984|69455119|FG000|Overall Study|Lost to Follow-up|0|||
37808993|NCT00633984|69455120|FG001|Overall Study|Lost to Follow-up|6|||
37808994|NCT00633984|69455119|FG000|Overall Study|Withdrawal by Subject|8|||
37808995|NCT00633984|69455120|FG001|Overall Study|Withdrawal by Subject|7|||
37808996|NCT00633984|69455119|FG000|Overall Study|Hospitalized|1|||
37808997|NCT00633984|69455120|FG001|Overall Study|Hospitalized|0|||
37808998|NCT01921218|69455148|FG000|Overall Study|Death|2|||
37808999|NCT01921218|69455149|FG001|Overall Study|Death|1|||
37809000|NCT01921218|69455148|FG000|Overall Study|Withdrawal by Subject|0|||
37809001|NCT01921218|69455149|FG001|Overall Study|Withdrawal by Subject|2|||
37809002|NCT01921218|69455148|FG000|Overall Study|Kidney transplant|1|||
37809003|NCT01921218|69455149|FG001|Overall Study|Kidney transplant|1|||
37809004|NCT00633750|69455155|FG000|Overall Study|Adverse Event|2|||
37976754|NCT00313144|69663955|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
37809005|NCT00633750|69455155|FG000|Overall Study|Withdrawal by Subject|3|||
37976755|NCT00313144|69663955|FG000|Overall Study|Death|7|||
37976756|NCT00313144|69663955|FG000|Overall Study|Lost to Follow-up|5|||
37976757|NCT00313144|69663955|FG000|Overall Study|Withdrawal by Subject|4|||
37809006|NCT00633360|69455163|FG000|Overall Study|Lost to Follow-up|1|||
37809007|NCT00633360|69455164|FG001|Overall Study|Lost to Follow-up|1|||
37809008|NCT00633360|69455163|FG000|Overall Study|Adverse Event|3|||
37809009|NCT00633360|69455164|FG001|Overall Study|Adverse Event|1|||
37809010|NCT00633360|69455163|FG000|Overall Study|Protocol Violation|0|||
37976758|NCT00313144|69663955|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
37809011|NCT00633360|69455164|FG001|Overall Study|Protocol Violation|1|||
37809012|NCT00633126|69455172|FG000|Overall Study|Did not receive full dose|1|||
37809013|NCT00989664|69455176|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
37809014|NCT00989664|69455176|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
37809015|NCT00989664|69455176|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
37809016|NCT00989664|69455176|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
37809017|NCT00989664|69455176|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
37809018|NCT00989664|69455176|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
37809019|NCT00989664|69455176|FG000|Long-Term Follow-Up|Death|3|||
37809020|NCT00632736|69455182|FG000|Overall Study|Adverse Event|104|||
37809021|NCT00632736|69455182|FG000|Overall Study|Lost to Follow-up|15|||
37809022|NCT00632736|69455182|FG000|Overall Study|Protocol Violation|14|||
37809023|NCT00632736|69455182|FG000|Overall Study|Withdrawal by Subject|99|||
37809024|NCT00632736|69455182|FG000|Overall Study|Lack of Efficacy|5|||
37809025|NCT00632736|69455182|FG000|Overall Study|Sponsor terminated study|5|||
37809026|NCT00632736|69455182|FG000|Overall Study|Non-compliance|10|||
37809027|NCT00632736|69455182|FG000|Overall Study|Other|16|||
37809028|NCT00989196|69455186|FG000|Treatment Period|Lost to Follow-up|1|||
37809029|NCT00989196|69455187|FG001|Treatment Period|Lost to Follow-up|0|||
37809030|NCT00632502|69455195|FG000|Overall Study|Adverse Event|0|||
37809031|NCT00632502|69455196|FG001|Overall Study|Adverse Event|1|||
37809032|NCT00632502|69455195|FG000|Overall Study|Randomized not treated|3|||
37809033|NCT00632502|69455196|FG001|Overall Study|Randomized not treated|0|||
37809034|NCT00632424|69455206|FG000|Overall Study|Disease Progression|17|||
37809035|NCT00632424|69455206|FG000|Overall Study|Study Drug Toxicity|1|||
37809036|NCT00631488|69455223|FG000|Overall Study|Adverse Event|1|||
37809037|NCT00631488|69455224|FG001|Overall Study|Adverse Event|0|||
37809038|NCT00631488|69455225|FG002|Overall Study|Adverse Event|0|||
37809039|NCT00631488|69455223|FG000|Overall Study|Lost to Follow-up|2|||
37809040|NCT00631488|69455224|FG001|Overall Study|Lost to Follow-up|2|||
37976759|NCT00313144|69663955|FG000|Overall Study|Physician Decision|4|||
37976760|NCT00313144|69663955|FG000|Overall Study|Adverse event - transient|5|||
37976761|NCT00313144|69663955|FG000|Overall Study|Liver transplant|1|||
37976762|NCT00313144|69663955|FG000|Overall Study|Insurance (homecare provider) change|1|||
37976763|NCT00313144|69663955|FG000|Overall Study|Change to different product|1|||
37976764|NCT00313144|69663955|FG000|Overall Study|Due to termination of the study|66|||
37976765|NCT00459108|69663968|FG000|Overall Study|Withdrawal by Subject|5|||
37976766|NCT00459108|69663968|FG000|Overall Study|Adverse Event|3|||
37976767|NCT00459108|69663968|FG000|Overall Study|Death|2|||
37976768|NCT00459108|69663968|FG000|Overall Study|Progression|1|||
37976769|NCT00458484|69663980|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
37976770|NCT00458484|69663981|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
37976771|NCT00458484|69663982|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
37976772|NCT00458484|69663983|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
37976773|NCT00458484|69663984|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
37976774|NCT00458484|69663985|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
37976775|NCT00458484|69663986|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
37976776|NCT00328198|69664011|FG000|Treatment|Adverse Event|21|||
37976777|NCT00328198|69664011|FG000|Treatment|Death|1|||
37976778|NCT00328198|69664011|FG000|Treatment|Physician Decision|5|||
37976779|NCT00328198|69664011|FG000|Treatment|Withdrawal by Subject|5|||
37976780|NCT00328198|69664011|FG000|Treatment|Evidence of disease progression|2|||
37976781|NCT00328198|69664011|FG000|Treatment|Non-compliance|1|||
37976782|NCT00328198|69664011|FG000|Treatment|Confirmed complete response, MRD -|3|||
37976783|NCT00328198|69664011|FG000|Follow-up|Lost to Follow-up|4|||
37976784|NCT00328198|69664011|FG000|Follow-up|Death|31|||
37976785|NCT00450450|69664017|FG000|Overall Study|Death|1|||
37809041|NCT00631488|69455225|FG002|Overall Study|Lost to Follow-up|0|||
37809042|NCT00631488|69455223|FG000|Overall Study|Physician Decision|1|||
37809043|NCT00631488|69455224|FG001|Overall Study|Physician Decision|0|||
37809044|NCT00631488|69455225|FG002|Overall Study|Physician Decision|1|||
37809045|NCT00631488|69455223|FG000|Overall Study|Protocol Violation|0|||
37809046|NCT00631488|69455224|FG001|Overall Study|Protocol Violation|0|||
37976786|NCT00450450|69664018|FG001|Overall Study|Death|3|||
37809047|NCT00631488|69455225|FG002|Overall Study|Protocol Violation|1|||
37809048|NCT00988884|69455235|FG000|Overall Study|Adverse Event|0|||
37809049|NCT00988884|69455236|FG001|Overall Study|Adverse Event|1|||
37976787|NCT00450450|69664017|FG000|Overall Study|Relapse|2|||
37976788|NCT00450450|69664018|FG001|Overall Study|Relapse|0|||
37976789|NCT00450450|69664017|FG000|Overall Study|Missing Data|2|||
37976790|NCT00450450|69664018|FG001|Overall Study|Missing Data|0|||
37976791|NCT00442572|69664026|FG000|Overall Study|Relapse|8|||
37976792|NCT00442572|69664027|FG001|Overall Study|Relapse|1|||
37976793|NCT00442572|69664026|FG000|Overall Study|Lost to Follow-up|0|||
37809050|NCT00988884|69455235|FG000|Overall Study|Lost to Follow-up|20|||
37809051|NCT00988884|69455236|FG001|Overall Study|Lost to Follow-up|16|||
37809052|NCT00988884|69455235|FG000|Overall Study|Protocol Violation|0|||
37809053|NCT00988884|69455236|FG001|Overall Study|Protocol Violation|1|||
37809054|NCT00988884|69455235|FG000|Overall Study|Withdrawal by Subject|15|||
37809055|NCT00988884|69455236|FG001|Overall Study|Withdrawal by Subject|18|||
37809056|NCT00631020|69455242|FG000|Overall Study|Lost to Follow-up|7|||
37809057|NCT00631020|69455242|FG000|Overall Study|Incarcerated|1|||
37809058|NCT00987402|69455248|FG000|Overall Study|Insufficient data entry|86|||
37809059|NCT00987402|69455249|FG001|Overall Study|Insufficient data entry|98|||
37809060|NCT00630864|69455255|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
37809061|NCT00630864|69455255|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
37809062|NCT00630786|69455262|FG000|Overall Study|Physician Decision|0|||
37809063|NCT00630786|69455263|FG001|Overall Study|Physician Decision|0|||
37809064|NCT00630786|69455264|FG002|Overall Study|Physician Decision|1|||
37809065|NCT00630786|69455262|FG000|Overall Study|Withdrawal by Subject|0|||
37809066|NCT00630786|69455263|FG001|Overall Study|Withdrawal by Subject|1|||
37809067|NCT00630786|69455264|FG002|Overall Study|Withdrawal by Subject|1|||
37809068|NCT00630786|69455262|FG000|Overall Study|Lost to Follow-up|0|||
37809069|NCT00630786|69455263|FG001|Overall Study|Lost to Follow-up|1|||
37809070|NCT00630786|69455264|FG002|Overall Study|Lost to Follow-up|0|||
37809071|NCT00630786|69455262|FG000|Overall Study|Other|1|||
37809072|NCT00630786|69455263|FG001|Overall Study|Other|0|||
37809073|NCT00630786|69455264|FG002|Overall Study|Other|0|||
37809074|NCT00630396|69455270|FG000|Overall Study|Death|4|||
37809075|NCT00630396|69455270|FG000|Overall Study|Lost to Follow-up|3|||
37809076|NCT00985686|69455278|FG000|Overall Study|Lost to Follow-up|1|||
37809077|NCT00985686|69455279|FG001|Overall Study|Lost to Follow-up|1|||
37809078|NCT00985686|69455280|FG002|Overall Study|Lost to Follow-up|0|||
37809079|NCT00985686|69455281|FG003|Overall Study|Lost to Follow-up|2|||
37809080|NCT03098394|69455291|FG000|Overall Study|Pregnancy|0|||
37809081|NCT03098394|69455292|FG001|Overall Study|Pregnancy|1|||
37809082|NCT00984594|69455303|FG000|Overall Study|Lost to Follow-up|1|||
37809083|NCT00984594|69455304|FG001|Overall Study|Lost to Follow-up|0|||
37809084|NCT00984594|69455303|FG000|Overall Study|Withdrawal by Subject|0|||
37809085|NCT00984594|69455304|FG001|Overall Study|Withdrawal by Subject|1|||
37809086|NCT00984204|69455312|FG000|Overall Study|Death|1|||
37809087|NCT00984204|69455312|FG000|Overall Study|Lost to Follow-up|4|||
37809088|NCT00984204|69455312|FG000|Overall Study|Lack of Efficacy|10|||
37809089|NCT00983892|69455318|FG000|Overall Study|Withdrawal by Subject|10|||
37809090|NCT00983892|69455319|FG001|Overall Study|Withdrawal by Subject|12|||
37809091|NCT00983580|69455327|FG000|Overall Study|Cancel Prior to treatment|1|||
37809092|NCT00983580|69455328|FG001|Overall Study|Cancel Prior to treatment|3|||
37809093|NCT00983580|69455327|FG000|Overall Study|Protocol Violation|1|||
37809094|NCT00983580|69455328|FG001|Overall Study|Protocol Violation|1|||
37809095|NCT00983580|69455327|FG000|Overall Study|Ineligible|3|||
37809096|NCT00983580|69455328|FG001|Overall Study|Ineligible|0|||
37809097|NCT00982878|69455335|FG000|Overall Study|Physician Decision|1|||
37694109|NCT02460224|69170404|FG027|Overall Study|Lost to Follow-up|0|||
37809098|NCT00982488|69455344|FG000|Overall Study|Administrative reason by sponsor|81|||
37976794|NCT00442572|69664027|FG001|Overall Study|Lost to Follow-up|1|||
37809099|NCT00982488|69455345|FG001|Overall Study|Administrative reason by sponsor|3|||
37976795|NCT00442572|69664026|FG000|Overall Study|Withdrawal by Subject|0|||
37809100|NCT00982488|69455346|FG002|Overall Study|Administrative reason by sponsor|11|||
37809101|NCT00982488|69455347|FG003|Overall Study|Administrative reason by sponsor|0|||
37809102|NCT00982488|69455348|FG004|Overall Study|Administrative reason by sponsor|0|||
37864323|NCT01260350|69547939|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
37864324|NCT01260350|69547940|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
37864325|NCT01260350|69547941|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
37864326|NCT01260350|69547942|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
37864327|NCT01260350|69547943|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
37864328|NCT01260350|69547944|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
37864329|NCT01260350|69547945|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
37864330|NCT01260350|69547946|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
37864331|NCT01260350|69547947|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
37864332|NCT01260350|69547948|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
37864333|NCT01260350|69547949|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
37864334|NCT01260350|69547950|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
37864335|NCT01260350|69547951|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
37864336|NCT01260350|69547952|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
37864337|NCT01260350|69547953|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
37864338|NCT01260350|69547954|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
37864339|NCT01260350|69547955|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
37864340|NCT01260350|69547956|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
37864341|NCT01260350|69547957|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
37864342|NCT01260350|69547958|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
37864343|NCT01260194|69548012|FG000|Overall Study|Withdrawal of Consent|1|||
37864344|NCT01259726|69548020|FG000|Overall Study|Death|1|||
37864345|NCT01259726|69548021|FG001|Overall Study|Death|0|||
37864346|NCT01259726|69548022|FG002|Overall Study|Death|0|||
37864347|NCT01259726|69548023|FG003|Overall Study|Death|0|||
37864348|NCT01259726|69548020|FG000|Overall Study|Physician Decision|2|||
37864349|NCT01259726|69548021|FG001|Overall Study|Physician Decision|0|||
37864350|NCT01259726|69548022|FG002|Overall Study|Physician Decision|1|||
37864351|NCT01259726|69548023|FG003|Overall Study|Physician Decision|1|||
37864352|NCT01259726|69548020|FG000|Overall Study|Withdrawal by Subject|1|||
37809103|NCT00982488|69455344|FG000|Overall Study|Adverse event unrelated to study drug|5|||
37809104|NCT00982488|69455345|FG001|Overall Study|Adverse event unrelated to study drug|1|||
37809105|NCT00982488|69455346|FG002|Overall Study|Adverse event unrelated to study drug|0|||
37809106|NCT00982488|69455347|FG003|Overall Study|Adverse event unrelated to study drug|0|||
37809107|NCT00982488|69455348|FG004|Overall Study|Adverse event unrelated to study drug|0|||
37809108|NCT00982488|69455344|FG000|Overall Study|Death|11|||
37809109|NCT00982488|69455345|FG001|Overall Study|Death|0|||
37809110|NCT00982488|69455346|FG002|Overall Study|Death|2|||
37809111|NCT00982488|69455347|FG003|Overall Study|Death|0|||
37809112|NCT00982488|69455348|FG004|Overall Study|Death|0|||
37809113|NCT00982488|69455344|FG000|Overall Study|Disease progression|30|||
37864353|NCT01259726|69548021|FG001|Overall Study|Withdrawal by Subject|3|||
37809114|NCT00982488|69455345|FG001|Overall Study|Disease progression|5|||
37809115|NCT00982488|69455346|FG002|Overall Study|Disease progression|10|||
37809116|NCT00982488|69455347|FG003|Overall Study|Disease progression|1|||
37809117|NCT00982488|69455348|FG004|Overall Study|Disease progression|1|||
37809118|NCT00982488|69455344|FG000|Overall Study|Lost to Follow-up|1|||
37809119|NCT00982488|69455345|FG001|Overall Study|Lost to Follow-up|0|||
37809120|NCT00982488|69455346|FG002|Overall Study|Lost to Follow-up|0|||
37809121|NCT00982488|69455347|FG003|Overall Study|Lost to Follow-up|0|||
37809122|NCT00982488|69455348|FG004|Overall Study|Lost to Follow-up|0|||
37809123|NCT00982488|69455344|FG000|Overall Study|Maximum clinical benefit|1|||
37809124|NCT00982488|69455345|FG001|Overall Study|Maximum clinical benefit|1|||
37809125|NCT00982488|69455346|FG002|Overall Study|Maximum clinical benefit|1|||
37809126|NCT00982488|69455347|FG003|Overall Study|Maximum clinical benefit|0|||
37809127|NCT00982488|69455348|FG004|Overall Study|Maximum clinical benefit|0|||
37809128|NCT00982488|69455344|FG000|Overall Study|Other|15|||
37976796|NCT00442572|69664027|FG001|Overall Study|Withdrawal by Subject|1|||
37976797|NCT00442416|69664036|FG000|Overall Study|Adverse Event|4|||
37976798|NCT00442416|69664037|FG001|Overall Study|Adverse Event|1|||
37976799|NCT00442416|69664036|FG000|Overall Study|Death|1|||
37976800|NCT00442416|69664037|FG001|Overall Study|Death|0|||
37976801|NCT00442416|69664036|FG000|Overall Study|Lack of Efficacy|2|||
37809129|NCT00982488|69455345|FG001|Overall Study|Other|1|||
37809130|NCT00982488|69455346|FG002|Overall Study|Other|3|||
37809131|NCT00982488|69455347|FG003|Overall Study|Other|1|||
37809132|NCT00982488|69455348|FG004|Overall Study|Other|0|||
37976802|NCT00442416|69664037|FG001|Overall Study|Lack of Efficacy|0|||
37976803|NCT00442416|69664036|FG000|Overall Study|Protocol Violation|2|||
37809133|NCT00982488|69455344|FG000|Overall Study|Poor compliance/noncompliance|0|||
37809134|NCT00982488|69455345|FG001|Overall Study|Poor compliance/noncompliance|1|||
37809135|NCT00982488|69455346|FG002|Overall Study|Poor compliance/noncompliance|0|||
37809136|NCT00982488|69455347|FG003|Overall Study|Poor compliance/noncompliance|0|||
37809137|NCT00982488|69455348|FG004|Overall Study|Poor compliance/noncompliance|0|||
37809138|NCT00982488|69455344|FG000|Overall Study|Stem cell transplant|2|||
37809139|NCT00982488|69455345|FG001|Overall Study|Stem cell transplant|0|||
37809140|NCT00982488|69455346|FG002|Overall Study|Stem cell transplant|0|||
37809141|NCT00982488|69455347|FG003|Overall Study|Stem cell transplant|1|||
37809142|NCT00982488|69455348|FG004|Overall Study|Stem cell transplant|0|||
37809143|NCT00982488|69455344|FG000|Overall Study|Study drug toxicity|34|||
37809144|NCT00982488|69455345|FG001|Overall Study|Study drug toxicity|1|||
37809145|NCT00982488|69455346|FG002|Overall Study|Study drug toxicity|6|||
37809146|NCT00982488|69455347|FG003|Overall Study|Study drug toxicity|0|||
37809147|NCT00982488|69455348|FG004|Overall Study|Study drug toxicity|0|||
37809148|NCT00982488|69455344|FG000|Overall Study|Withdrawal by Subject|5|||
37809149|NCT00982488|69455345|FG001|Overall Study|Withdrawal by Subject|1|||
37809150|NCT00982488|69455346|FG002|Overall Study|Withdrawal by Subject|1|||
37809151|NCT00982488|69455347|FG003|Overall Study|Withdrawal by Subject|0|||
37809152|NCT00982488|69455348|FG004|Overall Study|Withdrawal by Subject|0|||
37809153|NCT00982410|69455362|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
37809154|NCT00982410|69455363|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
37809155|NCT00982410|69455362|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
37809156|NCT00982410|69455363|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
37809157|NCT00982410|69455362|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
37809158|NCT00982410|69455363|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
37809159|NCT00982410|69455362|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
37809160|NCT00982410|69455363|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
37809161|NCT00982410|69455362|FG000|6-month Follow-up Assessment|participant no transportation|1|||
37809162|NCT00982410|69455363|FG001|6-month Follow-up Assessment|participant no transportation|0|||
37809163|NCT00982410|69455362|FG000|6-month Follow-up Assessment|incarceration|0|||
37809164|NCT00982410|69455363|FG001|6-month Follow-up Assessment|incarceration|2|||
37809165|NCT00982410|69455362|FG000|6-month Follow-up Assessment|patent surgery|0|||
37809166|NCT00982410|69455363|FG001|6-month Follow-up Assessment|patent surgery|1|||
37809167|NCT00982410|69455362|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
37809168|NCT00982410|69455363|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
37809169|NCT00982410|69455362|FG000|12-month Follow-up Assessment|Death|0|||
37809170|NCT00982410|69455363|FG001|12-month Follow-up Assessment|Death|2|||
37809171|NCT00982410|69455362|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
37809172|NCT00982410|69455363|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
37809173|NCT00982410|69455362|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
37809174|NCT00982410|69455363|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
37809175|NCT00982410|69455362|FG000|12-month Follow-up Assessment|incarceration|2|||
37809176|NCT00982410|69455363|FG001|12-month Follow-up Assessment|incarceration|1|||
37809177|NCT00982410|69455362|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
37809178|NCT00982410|69455363|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
37809179|NCT00982020|69455372|FG000|Overall Study|Adverse Event|19|||
37809180|NCT00982020|69455373|FG001|Overall Study|Adverse Event|15|||
37809181|NCT00982020|69455372|FG000|Overall Study|Withdrawal by Subject|11|||
37809182|NCT00982020|69455373|FG001|Overall Study|Withdrawal by Subject|14|||
37809183|NCT00982020|69455372|FG000|Overall Study|Lost to Follow-up|5|||
37809184|NCT00982020|69455373|FG001|Overall Study|Lost to Follow-up|11|||
37809185|NCT00982020|69455372|FG000|Overall Study|Lack of Efficacy|10|||
37809186|NCT00982020|69455373|FG001|Overall Study|Lack of Efficacy|4|||
37809187|NCT00982020|69455372|FG000|Overall Study|Parent/Caregiver Decision|5|||
37809188|NCT00982020|69455373|FG001|Overall Study|Parent/Caregiver Decision|5|||
37809189|NCT00982020|69455372|FG000|Overall Study|Treatment Non-compliance|3|||
37809190|NCT00982020|69455373|FG001|Overall Study|Treatment Non-compliance|6|||
37809191|NCT00982020|69455372|FG000|Overall Study|Physician Decision|2|||
37809192|NCT00982020|69455373|FG001|Overall Study|Physician Decision|5|||
37809193|NCT00982020|69455372|FG000|Overall Study|Entry Criteria Not Met|2|||
37809194|NCT00982020|69455373|FG001|Overall Study|Entry Criteria Not Met|1|||
37809195|NCT00982020|69455372|FG000|Overall Study|Protocol Violation|0|||
37809196|NCT00982020|69455373|FG001|Overall Study|Protocol Violation|2|||
37809197|NCT00982020|69455372|FG000|Overall Study|Clinical Relapse|0|||
37809198|NCT00982020|69455373|FG001|Overall Study|Clinical Relapse|1|||
37809199|NCT00981084|69455386|FG000|Post Intervention (Data Analysis)|poor effort|1|||
37809200|NCT00981084|69455387|FG001|Post Intervention (Data Analysis)|poor effort|1|||
37809201|NCT00981084|69455386|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
37809202|NCT00981084|69455387|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
37809203|NCT00980148|69455397|FG000|Overall Study|Discharged from facility|89|||
37809204|NCT00980148|69455398|FG001|Overall Study|Discharged from facility|96|||
37809205|NCT00980148|69455397|FG000|Overall Study|Received other antichlamydia treatment|20|||
37809206|NCT00980148|69455398|FG001|Overall Study|Received other antichlamydia treatment|14|||
37809207|NCT00980148|69455397|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
37809208|NCT00980148|69455398|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
37809209|NCT00980148|69455397|FG000|Overall Study|Various other reasons|8|||
37809210|NCT00980148|69455398|FG001|Overall Study|Various other reasons|9|||
37809211|NCT04553406|69455435|FG000|Overall Study|Study Discontinuation|0|||
37809212|NCT04553406|69455436|FG001|Overall Study|Study Discontinuation|1|||
37809213|NCT03033576|69455444|FG000|Overall Study|Ineligible|1|||
37809214|NCT03033576|69455445|FG001|Overall Study|Ineligible|1|||
37809215|NCT03033576|69455444|FG000|Overall Study|Adverse Event|4|||
37809216|NCT03033576|69455445|FG001|Overall Study|Adverse Event|20|||
37809217|NCT03033576|69455444|FG000|Overall Study|Progression/relapse|9|||
37809218|NCT03033576|69455445|FG001|Overall Study|Progression/relapse|36|||
37809219|NCT03033576|69455444|FG000|Overall Study|Death|1|||
37809220|NCT03033576|69455445|FG001|Overall Study|Death|1|||
37809221|NCT03033576|69455444|FG000|Overall Study|Patient refusal|1|||
37809222|NCT03033576|69455445|FG001|Overall Study|Patient refusal|6|||
37809223|NCT03033576|69455444|FG000|Overall Study|Other, unspecified reasons|0|||
37809224|NCT03033576|69455445|FG001|Overall Study|Other, unspecified reasons|4|||
37809225|NCT03033576|69455444|FG000|Overall Study|Currently on protocol therapy|0|||
37809226|NCT03033576|69455445|FG001|Overall Study|Currently on protocol therapy|2|||
37809227|NCT04129944|69455455|FG000|Overall Study|Death|0|||
37809228|NCT04129944|69455456|FG001|Overall Study|Death|0|||
37809229|NCT04129944|69455457|FG002|Overall Study|Death|0|||
37809230|NCT04129944|69455458|FG003|Overall Study|Death|1|||
37809231|NCT04129944|69455455|FG000|Overall Study|Lost to Follow-up|1|||
37809232|NCT04129944|69455456|FG001|Overall Study|Lost to Follow-up|0|||
37809233|NCT04129944|69455457|FG002|Overall Study|Lost to Follow-up|0|||
37809234|NCT04129944|69455458|FG003|Overall Study|Lost to Follow-up|0|||
37809235|NCT04129944|69455455|FG000|Overall Study|Withdrawal by Subject|1|||
37809236|NCT04129944|69455456|FG001|Overall Study|Withdrawal by Subject|0|||
37809237|NCT04129944|69455457|FG002|Overall Study|Withdrawal by Subject|1|||
37809238|NCT04129944|69455458|FG003|Overall Study|Withdrawal by Subject|2|||
37809239|NCT03829332|69455522|FG000|Overall Study|Death|145|||
37809240|NCT03829332|69455523|FG001|Overall Study|Death|135|||
37809241|NCT03829332|69455522|FG000|Overall Study|Withdrawal by Subject|10|||
37809242|NCT03829332|69455523|FG001|Overall Study|Withdrawal by Subject|4|||
37809243|NCT03829332|69455522|FG000|Overall Study|Ongoing in Study|154|||
37809244|NCT03829332|69455523|FG001|Overall Study|Ongoing in Study|175|||
37809245|NCT02914314|69455543|FG000|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
37809246|NCT02914314|69455544|FG001|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
37809247|NCT02914314|69455545|FG002|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
37809248|NCT02914314|69455546|FG003|Core Phase (Up to 20 Weeks)|Lost to Follow-up|1|||
37809249|NCT02914314|69455543|FG000|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
37809250|NCT02914314|69455544|FG001|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
37694110|NCT02460224|69170405|FG028|Overall Study|Lost to Follow-up|0|||
37809251|NCT02914314|69455545|FG002|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
37809252|NCT02914314|69455546|FG003|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|1|||
37809253|NCT02914314|69455543|FG000|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
37809254|NCT02914314|69455544|FG001|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
37809255|NCT02914314|69455545|FG002|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|1|||
37864354|NCT01259726|69548022|FG002|Overall Study|Withdrawal by Subject|2|||
37809256|NCT02914314|69455546|FG003|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
37809257|NCT02914314|69455543|FG000|Extension Phase (Up to 32 Weeks)|Participant choice|0|||
37809258|NCT02914314|69455544|FG001|Extension Phase (Up to 32 Weeks)|Participant choice|0|||
37864355|NCT01259726|69548023|FG003|Overall Study|Withdrawal by Subject|1|||
37809259|NCT02914314|69455545|FG002|Extension Phase (Up to 32 Weeks)|Participant choice|1|||
37809260|NCT02914314|69455546|FG003|Extension Phase (Up to 32 Weeks)|Participant choice|0|||
37809261|NCT02914314|69455543|FG000|Extension Phase (Up to 32 Weeks)|Withdrawal by Subject|0|||
37809262|NCT02914314|69455544|FG001|Extension Phase (Up to 32 Weeks)|Withdrawal by Subject|0|||
37809263|NCT02914314|69455545|FG002|Extension Phase (Up to 32 Weeks)|Withdrawal by Subject|1|||
37809264|NCT02914314|69455546|FG003|Extension Phase (Up to 32 Weeks)|Withdrawal by Subject|0|||
37976804|NCT00442416|69664037|FG001|Overall Study|Protocol Violation|3|||
37976805|NCT00442416|69664036|FG000|Overall Study|Withdrew consent|1|||
37976806|NCT00442416|69664037|FG001|Overall Study|Withdrew consent|2|||
37976807|NCT00442416|69664036|FG000|Overall Study|Administrative/Other|27|||
37976808|NCT00442416|69664037|FG001|Overall Study|Administrative/Other|33|||
37976809|NCT00441792|69664045|FG000|Overall Study|Lost to Follow-up|0|||
37809265|NCT01899144|69457161|FG000|Treatment Period 2|Other|1|||
37809266|NCT01899144|69457161|FG000|Treatment Period 3|Other|2|||
37809267|NCT01899144|69457161|FG000|Treatment Period 5|Other|1|||
37809268|NCT03821844|69457775|FG000|Overall Study|Death|37|||
37809269|NCT03821844|69457776|FG001|Overall Study|Death|31|||
37809270|NCT03821844|69457775|FG000|Overall Study|Discharged|10|||
37809271|NCT03821844|69457776|FG001|Overall Study|Discharged|14|||
37809272|NCT03821844|69457775|FG000|Overall Study|Not present in facility at followup|2|||
37809273|NCT03821844|69457776|FG001|Overall Study|Not present in facility at followup|3|||
37809274|NCT01796106|69459227|FG000|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|5|||
37809275|NCT01796106|69459228|FG001|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|7|||
37809276|NCT01168219|69460416|FG000|Overall Study|off study before starting treatment|2|||
37809277|NCT01168219|69460416|FG000|Overall Study|withdrew before transplant|1|||
37809278|NCT01168219|69460416|FG000|Overall Study|ineligible due to CML|2|||
37976810|NCT00441792|69664046|FG001|Overall Study|Lost to Follow-up|2|||
37976811|NCT00312208|69664054|FG000|Overall Study|Adverse Event|97|||
37809279|NCT01115803|69460427|FG000|Overall Study|Withdrawal by Subject|0|||
37809280|NCT01115803|69460428|FG001|Overall Study|Withdrawal by Subject|0|||
37809281|NCT01115803|69460429|FG002|Overall Study|Withdrawal by Subject|0|||
37809282|NCT01115803|69460430|FG003|Overall Study|Withdrawal by Subject|0|||
37809283|NCT01115803|69460431|FG004|Overall Study|Withdrawal by Subject|0|||
37809284|NCT01115803|69460432|FG005|Overall Study|Withdrawal by Subject|0|||
37976812|NCT00312208|69664055|FG001|Overall Study|Adverse Event|61|||
37976813|NCT00312208|69664054|FG000|Overall Study|Protocol Violation|5|||
37976814|NCT00312208|69664055|FG001|Overall Study|Protocol Violation|3|||
37976815|NCT00312208|69664054|FG000|Overall Study|Death|2|||
37976816|NCT00312208|69664055|FG001|Overall Study|Death|1|||
37976817|NCT00312208|69664054|FG000|Overall Study|Lack of Efficacy|7|||
37809285|NCT01115803|69460433|FG006|Overall Study|Withdrawal by Subject|1|||
37809286|NCT01115803|69460427|FG000|Overall Study|Lost to Follow-up|0|||
37976818|NCT00312208|69664055|FG001|Overall Study|Lack of Efficacy|4|||
37976819|NCT00312208|69664054|FG000|Overall Study|Lost to Follow-up|3|||
37976820|NCT00312208|69664055|FG001|Overall Study|Lost to Follow-up|5|||
37976821|NCT00312208|69664054|FG000|Overall Study|Withdrawal by Subject|53|||
37976822|NCT00312208|69664055|FG001|Overall Study|Withdrawal by Subject|42|||
37976823|NCT00312208|69664054|FG000|Overall Study|Other|5|||
37809287|NCT01115803|69460428|FG001|Overall Study|Lost to Follow-up|0|||
37809288|NCT01115803|69460429|FG002|Overall Study|Lost to Follow-up|1|||
37809289|NCT01115803|69460430|FG003|Overall Study|Lost to Follow-up|0|||
37809290|NCT01115803|69460431|FG004|Overall Study|Lost to Follow-up|0|||
37809291|NCT01115803|69460432|FG005|Overall Study|Lost to Follow-up|0|||
37976824|NCT00312208|69664055|FG001|Overall Study|Other|7|||
37976825|NCT00297778|69664063|FG000|Overall Study|Adverse Event|16|||
37976826|NCT00297778|69664064|FG001|Overall Study|Adverse Event|10|||
37809292|NCT01115803|69460433|FG006|Overall Study|Lost to Follow-up|0|||
37809293|NCT01115803|69460427|FG000|Overall Study|Progressive Disease during Cycle1|0|||
37809294|NCT01115803|69460428|FG001|Overall Study|Progressive Disease during Cycle1|0|||
37976827|NCT00297778|69664063|FG000|Overall Study|Withdrawal by Subject|1|||
37976828|NCT00297778|69664064|FG001|Overall Study|Withdrawal by Subject|5|||
37809295|NCT01115803|69460429|FG002|Overall Study|Progressive Disease during Cycle1|0|||
37809296|NCT01115803|69460430|FG003|Overall Study|Progressive Disease during Cycle1|0|||
37694111|NCT02460224|69170377|FG000|Overall Study|Physician Decision|0|||
37809297|NCT01115803|69460431|FG004|Overall Study|Progressive Disease during Cycle1|0|||
37809298|NCT01115803|69460432|FG005|Overall Study|Progressive Disease during Cycle1|0|||
37694112|NCT02460224|69170378|FG001|Overall Study|Physician Decision|1|||
37694113|NCT02460224|69170379|FG002|Overall Study|Physician Decision|0|||
37694114|NCT02460224|69170380|FG003|Overall Study|Physician Decision|0|||
37694115|NCT02460224|69170381|FG004|Overall Study|Physician Decision|1|||
37694116|NCT02460224|69170382|FG005|Overall Study|Physician Decision|0|||
37694117|NCT02460224|69170383|FG006|Overall Study|Physician Decision|0|||
37694118|NCT02460224|69170384|FG007|Overall Study|Physician Decision|1|||
37694119|NCT02460224|69170385|FG008|Overall Study|Physician Decision|0|||
37694120|NCT02460224|69170386|FG009|Overall Study|Physician Decision|0|||
37694121|NCT02460224|69170387|FG010|Overall Study|Physician Decision|0|||
37694122|NCT02460224|69170388|FG011|Overall Study|Physician Decision|1|||
37694123|NCT02460224|69170389|FG012|Overall Study|Physician Decision|0|||
37694124|NCT02460224|69170390|FG013|Overall Study|Physician Decision|1|||
37694125|NCT02460224|69170391|FG014|Overall Study|Physician Decision|0|||
37694126|NCT02460224|69170392|FG015|Overall Study|Physician Decision|0|||
37694127|NCT02460224|69170393|FG016|Overall Study|Physician Decision|2|||
37694128|NCT02460224|69170394|FG017|Overall Study|Physician Decision|1|||
37694129|NCT02460224|69170395|FG018|Overall Study|Physician Decision|1|||
37694130|NCT02460224|69170396|FG019|Overall Study|Physician Decision|2|||
37694131|NCT02460224|69170397|FG020|Overall Study|Physician Decision|1|||
37694132|NCT02460224|69170398|FG021|Overall Study|Physician Decision|1|||
37694133|NCT02460224|69170399|FG022|Overall Study|Physician Decision|0|||
37694134|NCT02460224|69170400|FG023|Overall Study|Physician Decision|0|||
37694135|NCT02460224|69170401|FG024|Overall Study|Physician Decision|1|||
37809299|NCT01115803|69460433|FG006|Overall Study|Progressive Disease during Cycle1|1|||
37809300|NCT01115569|69460454|FG000|Conversion/Titration Phase|Adverse Event|59|||
37809301|NCT01115569|69460455|FG001|Conversion/Titration Phase|Adverse Event|0|||
37809302|NCT01115569|69460454|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
37809303|NCT01115569|69460455|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
37809304|NCT01115569|69460454|FG000|Conversion/Titration Phase|Physician Decision|5|||
37809305|NCT01115569|69460455|FG001|Conversion/Titration Phase|Physician Decision|0|||
37809306|NCT01115569|69460454|FG000|Conversion/Titration Phase|Protocol Violation|68|||
37809307|NCT01115569|69460455|FG001|Conversion/Titration Phase|Protocol Violation|0|||
37809308|NCT01115569|69460454|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
37809309|NCT01115569|69460455|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
37809310|NCT01115569|69460454|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
37976829|NCT00297778|69664063|FG000|Overall Study|Lack of Efficacy|2|||
37976830|NCT00297778|69664064|FG001|Overall Study|Lack of Efficacy|1|||
37809311|NCT01115569|69460455|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
37809312|NCT01115569|69460454|FG000|Maintenance Phase|Adverse Event|0|||
37809313|NCT01115569|69460455|FG001|Maintenance Phase|Adverse Event|43|||
37809314|NCT01115569|69460454|FG000|Maintenance Phase|Lost to Follow-up|0|||
37809315|NCT01115569|69460455|FG001|Maintenance Phase|Lost to Follow-up|8|||
37694136|NCT02460224|69170402|FG025|Overall Study|Physician Decision|0|||
37694137|NCT02460224|69170403|FG026|Overall Study|Physician Decision|14|||
37694138|NCT02460224|69170404|FG027|Overall Study|Physician Decision|1|||
37694139|NCT02460224|69170405|FG028|Overall Study|Physician Decision|6|||
37694140|NCT02460224|69170377|FG000|Overall Study|Progressive disease|15|||
37694141|NCT02460224|69170378|FG001|Overall Study|Progressive disease|11|||
37694142|NCT02460224|69170379|FG002|Overall Study|Progressive disease|5|||
37694143|NCT02460224|69170380|FG003|Overall Study|Progressive disease|6|||
37694144|NCT02460224|69170381|FG004|Overall Study|Progressive disease|3|||
37809316|NCT01115569|69460454|FG000|Maintenance Phase|Physician Decision|0|||
37809317|NCT01115569|69460455|FG001|Maintenance Phase|Physician Decision|3|||
37809318|NCT01115569|69460454|FG000|Maintenance Phase|Protocol Violation|0|||
37809319|NCT01115569|69460455|FG001|Maintenance Phase|Protocol Violation|9|||
37809320|NCT01115569|69460454|FG000|Maintenance Phase|Withdrawal by Subject|0|||
37809321|NCT01115569|69460455|FG001|Maintenance Phase|Withdrawal by Subject|27|||
37809322|NCT01115569|69460454|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
37809323|NCT01115569|69460455|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
37809324|NCT01115569|69460454|FG000|Maintenance Phase|Administrative|0|||
37809325|NCT01115569|69460455|FG001|Maintenance Phase|Administrative|1|||
37809326|NCT01107886|69460462|FG000|Overall Study|Lost to Follow-up|15|||
37809327|NCT01107886|69460463|FG001|Overall Study|Lost to Follow-up|13|||
37809328|NCT01107886|69460462|FG000|Overall Study|Withdrawal by Subject|180|||
37809329|NCT01107886|69460463|FG001|Overall Study|Withdrawal by Subject|196|||
37809330|NCT01107886|69460462|FG000|Overall Study|Administrative withdrawal of consent|7|||
37809331|NCT01107886|69460463|FG001|Overall Study|Administrative withdrawal of consent|5|||
37809332|NCT01107457|69460474|FG000|Part A|Adverse Event|1|||
37809333|NCT01107457|69460475|FG001|Part A|Adverse Event|2|||
37809334|NCT01107457|69460476|FG002|Part A|Adverse Event|1|||
37809335|NCT01107457|69460477|FG003|Part A|Adverse Event|0|||
37809336|NCT01107457|69460478|FG004|Part A|Adverse Event|0|||
37809337|NCT01107457|69460479|FG005|Part A|Adverse Event|0|||
37809338|NCT01107457|69460474|FG000|Part A|Withdrawal by Subject|3|||
37809339|NCT01107457|69460475|FG001|Part A|Withdrawal by Subject|3|||
37809340|NCT01107457|69460476|FG002|Part A|Withdrawal by Subject|0|||
37809341|NCT01107457|69460477|FG003|Part A|Withdrawal by Subject|3|||
37809342|NCT01107457|69460478|FG004|Part A|Withdrawal by Subject|1|||
37809343|NCT01107457|69460479|FG005|Part A|Withdrawal by Subject|0|||
37809344|NCT01107457|69460474|FG000|Part A|Lost to Follow-up|0|||
37809345|NCT01107457|69460475|FG001|Part A|Lost to Follow-up|1|||
37809346|NCT01107457|69460476|FG002|Part A|Lost to Follow-up|0|||
37809347|NCT01107457|69460477|FG003|Part A|Lost to Follow-up|0|||
37809348|NCT01107457|69460478|FG004|Part A|Lost to Follow-up|0|||
37809349|NCT01107457|69460479|FG005|Part A|Lost to Follow-up|0|||
37809350|NCT01107457|69460474|FG000|Part A|Lack of Efficacy|1|||
37809351|NCT01107457|69460475|FG001|Part A|Lack of Efficacy|0|||
37809352|NCT01107457|69460476|FG002|Part A|Lack of Efficacy|0|||
37809353|NCT01107457|69460477|FG003|Part A|Lack of Efficacy|0|||
37809354|NCT01107457|69460478|FG004|Part A|Lack of Efficacy|0|||
37809355|NCT01107457|69460479|FG005|Part A|Lack of Efficacy|0|||
37809356|NCT01107457|69460474|FG000|Part A|Protocol Violation|0|||
37809357|NCT01107457|69460475|FG001|Part A|Protocol Violation|1|||
37809358|NCT01107457|69460476|FG002|Part A|Protocol Violation|0|||
37809359|NCT01107457|69460477|FG003|Part A|Protocol Violation|0|||
37809360|NCT01107457|69460478|FG004|Part A|Protocol Violation|0|||
37809361|NCT01107457|69460479|FG005|Part A|Protocol Violation|0|||
37809362|NCT01107457|69460474|FG000|Part B and C|Adverse Event|0|||
37809363|NCT01107457|69460475|FG001|Part B and C|Adverse Event|0|||
37976831|NCT00297778|69664063|FG000|Overall Study|Non-compliant with trial protocol|0|||
37976832|NCT00297778|69664064|FG001|Overall Study|Non-compliant with trial protocol|3|||
37976833|NCT00297778|69664063|FG000|Overall Study|Other|0|||
37976834|NCT00297778|69664064|FG001|Overall Study|Other|1|||
37976835|NCT03848832|69664073|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
37976836|NCT03848832|69664074|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
37976837|NCT03848832|69664075|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
37976838|NCT03848832|69664073|FG000|Overall Study|Withdrawal by Subject|0|||
37976839|NCT03848832|69664074|FG001|Overall Study|Withdrawal by Subject|0|||
37976840|NCT03848832|69664075|FG002|Overall Study|Withdrawal by Subject|1|||
37976841|NCT03848832|69664073|FG000|Overall Study|Withdrawal (Covid-19)|0|||
37809364|NCT01107457|69460476|FG002|Part B and C|Adverse Event|0|||
37976842|NCT03848832|69664074|FG001|Overall Study|Withdrawal (Covid-19)|2|||
37976843|NCT03848832|69664075|FG002|Overall Study|Withdrawal (Covid-19)|0|||
37976844|NCT03848832|69664073|FG000|Overall Study|Physician Decision|2|||
37809365|NCT01107457|69460477|FG003|Part B and C|Adverse Event|0|||
37809366|NCT01107457|69460478|FG004|Part B and C|Adverse Event|0|||
37809367|NCT01107457|69460479|FG005|Part B and C|Adverse Event|12|||
37809368|NCT01107457|69460474|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
37809369|NCT01107457|69460475|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
37809370|NCT01107457|69460476|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
37809371|NCT01107457|69460477|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
37809372|NCT01107457|69460478|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
37809373|NCT01107457|69460479|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
37809374|NCT01107457|69460474|FG000|Part B and C|Physician Decision|0|||
37809375|NCT01107457|69460475|FG001|Part B and C|Physician Decision|0|||
37809376|NCT01107457|69460476|FG002|Part B and C|Physician Decision|0|||
37809377|NCT01107457|69460477|FG003|Part B and C|Physician Decision|0|||
37809378|NCT01107457|69460478|FG004|Part B and C|Physician Decision|0|||
37809379|NCT01107457|69460479|FG005|Part B and C|Physician Decision|3|||
37809380|NCT01107457|69460474|FG000|Part B and C|Lack of Efficacy|0|||
37809381|NCT01107457|69460475|FG001|Part B and C|Lack of Efficacy|0|||
37809382|NCT01107457|69460476|FG002|Part B and C|Lack of Efficacy|0|||
37809383|NCT01107457|69460477|FG003|Part B and C|Lack of Efficacy|0|||
37809384|NCT01107457|69460478|FG004|Part B and C|Lack of Efficacy|0|||
37809385|NCT01107457|69460479|FG005|Part B and C|Lack of Efficacy|7|||
37809386|NCT01107457|69460474|FG000|Part B and C|Lost to Follow-up|0|||
37809387|NCT01107457|69460475|FG001|Part B and C|Lost to Follow-up|0|||
37809388|NCT01107457|69460476|FG002|Part B and C|Lost to Follow-up|0|||
37809389|NCT01107457|69460477|FG003|Part B and C|Lost to Follow-up|0|||
37809390|NCT01107457|69460478|FG004|Part B and C|Lost to Follow-up|0|||
37809391|NCT01107457|69460479|FG005|Part B and C|Lost to Follow-up|10|||
37809392|NCT01107457|69460474|FG000|Part B and C|Protocol Violation|0|||
37809393|NCT01107457|69460475|FG001|Part B and C|Protocol Violation|0|||
37809394|NCT01107457|69460476|FG002|Part B and C|Protocol Violation|0|||
37809395|NCT01107457|69460477|FG003|Part B and C|Protocol Violation|0|||
37809396|NCT01107457|69460478|FG004|Part B and C|Protocol Violation|0|||
37809397|NCT01107457|69460479|FG005|Part B and C|Protocol Violation|1|||
37809398|NCT01107457|69460474|FG000|Part B and C|Sponsor Decision|0|||
37809399|NCT01107457|69460475|FG001|Part B and C|Sponsor Decision|0|||
37809400|NCT01107457|69460476|FG002|Part B and C|Sponsor Decision|0|||
37809401|NCT01107457|69460477|FG003|Part B and C|Sponsor Decision|0|||
37809402|NCT01107457|69460478|FG004|Part B and C|Sponsor Decision|0|||
37809403|NCT01107457|69460479|FG005|Part B and C|Sponsor Decision|66|||
37809404|NCT01107457|69460474|FG000|Part B and C|Withdrawal by Subject|0|||
37809405|NCT01107457|69460475|FG001|Part B and C|Withdrawal by Subject|0|||
37809406|NCT01107457|69460476|FG002|Part B and C|Withdrawal by Subject|0|||
37809407|NCT01107457|69460477|FG003|Part B and C|Withdrawal by Subject|0|||
37809408|NCT01107457|69460478|FG004|Part B and C|Withdrawal by Subject|0|||
37809409|NCT01107457|69460479|FG005|Part B and C|Withdrawal by Subject|16|||
37809410|NCT01107457|69460474|FG000|Part B and C|Clinical Relapse|0|||
37809411|NCT01107457|69460475|FG001|Part B and C|Clinical Relapse|0|||
37809412|NCT01107457|69460476|FG002|Part B and C|Clinical Relapse|0|||
37809413|NCT01107457|69460477|FG003|Part B and C|Clinical Relapse|0|||
37809414|NCT01107457|69460478|FG004|Part B and C|Clinical Relapse|0|||
37809415|NCT01107457|69460479|FG005|Part B and C|Clinical Relapse|4|||
37809416|NCT04545385|69460509|FG000|Overall Study|Withdrawal by Subject|2|||
37809417|NCT04545385|69460510|FG001|Overall Study|Withdrawal by Subject|0|||
37809418|NCT04545385|69460509|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
37809419|NCT04545385|69460510|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
37809420|NCT04545385|69460509|FG000|Overall Study|Study termination|10|||
37809421|NCT04545385|69460510|FG001|Overall Study|Study termination|10|||
37809422|NCT04545385|69460509|FG000|Overall Study|Sponsor decision|2|||
37809423|NCT04545385|69460510|FG001|Overall Study|Sponsor decision|2|||
37809424|NCT04545385|69460509|FG000|Overall Study|Other than specified|1|||
37809425|NCT04545385|69460510|FG001|Overall Study|Other than specified|0|||
37809426|NCT03783026|69460525|FG000|Treatment Phase|Adverse Event|15|||
37809427|NCT03783026|69460525|FG000|Treatment Phase|Lack of Efficacy|11|||
37809428|NCT03783026|69460525|FG000|Treatment Phase|Withdrawal by Subject|6|||
37809429|NCT03783026|69460525|FG000|Treatment Phase|Lost to Follow-up|2|||
37976845|NCT03848832|69664074|FG001|Overall Study|Physician Decision|1|||
37976846|NCT03848832|69664075|FG002|Overall Study|Physician Decision|3|||
37976847|NCT03848832|69664073|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
37976848|NCT03848832|69664074|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
37976849|NCT03848832|69664075|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
37976850|NCT03848832|69664073|FG000|Overall Study|Adverse Event|1|||
37809430|NCT03783026|69460525|FG000|Treatment Phase|Protocol Deviation|8|||
37976851|NCT03848832|69664074|FG001|Overall Study|Adverse Event|0|||
37976852|NCT03848832|69664075|FG002|Overall Study|Adverse Event|0|||
37809431|NCT03783026|69460525|FG000|Treatment Phase|Did Not Receive Treatment|1|||
37809432|NCT03783026|69460525|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
37809433|NCT03635112|69460532|FG000|Overall Study|Adverse Event|5|||
37809434|NCT03635112|69460533|FG001|Overall Study|Adverse Event|9|||
37809435|NCT03635112|69460534|FG002|Overall Study|Adverse Event|14|||
37809436|NCT03635112|69460532|FG000|Overall Study|Lost to Follow-up|1|||
37809437|NCT03635112|69460533|FG001|Overall Study|Lost to Follow-up|0|||
37809438|NCT03635112|69460534|FG002|Overall Study|Lost to Follow-up|1|||
37809439|NCT03635112|69460532|FG000|Overall Study|Physician Decision|5|||
37809440|NCT03635112|69460533|FG001|Overall Study|Physician Decision|7|||
37809441|NCT03635112|69460534|FG002|Overall Study|Physician Decision|5|||
37976853|NCT00450372|69664085|FG000|Overall Study|Physician Decision|1|||
37809442|NCT03635112|69460532|FG000|Overall Study|Protocol Violation|0|||
37976854|NCT00327340|69664094|FG000|Overall Study|Withdrawal by Subject|1|||
37976855|NCT00327340|69664095|FG001|Overall Study|Withdrawal by Subject|5|||
37809443|NCT03635112|69460533|FG001|Overall Study|Protocol Violation|0|||
37976856|NCT00327340|69664094|FG000|Overall Study|Physician Decision|1|||
37976857|NCT00327340|69664095|FG001|Overall Study|Physician Decision|1|||
37976858|NCT00327340|69664094|FG000|Overall Study|Disease Progression|10|||
37976859|NCT00327340|69664095|FG001|Overall Study|Disease Progression|19|||
37976860|NCT00327340|69664094|FG000|Overall Study|Symptomatic Disease|0|||
37694145|NCT02460224|69170382|FG005|Overall Study|Progressive disease|26|||
37694146|NCT02460224|69170383|FG006|Overall Study|Progressive disease|28|||
37694147|NCT02460224|69170384|FG007|Overall Study|Progressive disease|4|||
37809444|NCT03635112|69460534|FG002|Overall Study|Protocol Violation|1|||
37809445|NCT03635112|69460532|FG000|Overall Study|Study Terminated by Sponsor|11|||
37809446|NCT03635112|69460533|FG001|Overall Study|Study Terminated by Sponsor|17|||
37809447|NCT03635112|69460534|FG002|Overall Study|Study Terminated by Sponsor|21|||
37809448|NCT03635112|69460532|FG000|Overall Study|Withdrawal by Subject|4|||
37809449|NCT03635112|69460533|FG001|Overall Study|Withdrawal by Subject|9|||
37809450|NCT03635112|69460534|FG002|Overall Study|Withdrawal by Subject|7|||
37809451|NCT03635112|69460532|FG000|Overall Study|Miscellaneous|0|||
37809452|NCT03635112|69460533|FG001|Overall Study|Miscellaneous|0|||
37809453|NCT03635112|69460534|FG002|Overall Study|Miscellaneous|1|||
37809454|NCT03588728|69460547|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
37809455|NCT03588728|69460548|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
37694148|NCT02460224|69170385|FG008|Overall Study|Progressive disease|5|||
37694149|NCT02460224|69170386|FG009|Overall Study|Progressive disease|9|||
37694150|NCT02460224|69170387|FG010|Overall Study|Progressive disease|5|||
37694151|NCT02460224|69170388|FG011|Overall Study|Progressive disease|4|||
37809456|NCT03588728|69460549|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
37809457|NCT03588728|69460550|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
37809458|NCT03588728|69460547|FG000|Overall Study|Lab shut down due to COVID-19|0|||
37809459|NCT03588728|69460548|FG001|Overall Study|Lab shut down due to COVID-19|0|||
37809460|NCT03588728|69460549|FG002|Overall Study|Lab shut down due to COVID-19|0|||
37809461|NCT03588728|69460550|FG003|Overall Study|Lab shut down due to COVID-19|1|||
37809462|NCT03588728|69460547|FG000|Overall Study|multiple technical issues|1|||
37809463|NCT03588728|69460548|FG001|Overall Study|multiple technical issues|0|||
37809464|NCT03588728|69460549|FG002|Overall Study|multiple technical issues|0|||
37809465|NCT03588728|69460550|FG003|Overall Study|multiple technical issues|0|||
37809466|NCT03588728|69460547|FG000|Overall Study|Hospitalized for COVID|1|||
37809467|NCT03588728|69460548|FG001|Overall Study|Hospitalized for COVID|0|||
37809468|NCT03588728|69460549|FG002|Overall Study|Hospitalized for COVID|0|||
37809469|NCT03588728|69460550|FG003|Overall Study|Hospitalized for COVID|0|||
37809470|NCT03588728|69460547|FG000|Overall Study|Schedule change unable to attend sessions|1|||
37809471|NCT03588728|69460548|FG001|Overall Study|Schedule change unable to attend sessions|0|||
37809472|NCT03588728|69460549|FG002|Overall Study|Schedule change unable to attend sessions|0|||
37809473|NCT03588728|69460550|FG003|Overall Study|Schedule change unable to attend sessions|0|||
37809474|NCT02987543|69460572|FG000|Overall Study|Ongoing study at data cut off|49|||
37809475|NCT02987543|69460573|FG001|Overall Study|Ongoing study at data cut off|21|||
37809476|NCT02987543|69460574|FG002|Overall Study|Ongoing study at data cut off|19|||
37809477|NCT02987543|69460575|FG003|Overall Study|Ongoing study at data cut off|12|||
37809478|NCT02987543|69460572|FG000|Overall Study|Death|88|||
37809479|NCT02987543|69460573|FG001|Overall Study|Death|54|||
37809480|NCT02987543|69460574|FG002|Overall Study|Death|67|||
37809481|NCT02987543|69460575|FG003|Overall Study|Death|28|||
37809482|NCT02987543|69460572|FG000|Overall Study|Lost to Follow-up|3|||
37809483|NCT02987543|69460573|FG001|Overall Study|Lost to Follow-up|0|||
37809484|NCT02987543|69460574|FG002|Overall Study|Lost to Follow-up|1|||
37809485|NCT02987543|69460575|FG003|Overall Study|Lost to Follow-up|0|||
37809486|NCT02987543|69460572|FG000|Overall Study|Screen failure|0|||
37809487|NCT02987543|69460573|FG001|Overall Study|Screen failure|0|||
37809488|NCT02987543|69460574|FG002|Overall Study|Screen failure|0|||
37809489|NCT02987543|69460575|FG003|Overall Study|Screen failure|1|||
37809490|NCT02987543|69460572|FG000|Overall Study|Withdrawal by Subject|21|||
37809491|NCT02987543|69460573|FG001|Overall Study|Withdrawal by Subject|7|||
37976861|NCT00327340|69664095|FG001|Overall Study|Symptomatic Disease|2|||
37976862|NCT00327340|69664094|FG000|Overall Study|Adverse Event|3|||
37809492|NCT02987543|69460574|FG002|Overall Study|Withdrawal by Subject|7|||
37809493|NCT02987543|69460575|FG003|Overall Study|Withdrawal by Subject|6|||
37809494|NCT02987543|69460572|FG000|Overall Study|Study terminated by sponsor|1|||
37809495|NCT02987543|69460573|FG001|Overall Study|Study terminated by sponsor|0|||
37809496|NCT02987543|69460574|FG002|Overall Study|Study terminated by sponsor|0|||
37809497|NCT02987543|69460575|FG003|Overall Study|Study terminated by sponsor|0|||
37809498|NCT02987543|69460572|FG000|Overall Study|Investigator decision|0|||
37809499|NCT02987543|69460573|FG001|Overall Study|Investigator decision|1|||
37809500|NCT02987543|69460574|FG002|Overall Study|Investigator decision|0|||
37976863|NCT00327340|69664095|FG001|Overall Study|Adverse Event|3|||
37694152|NCT02460224|69170389|FG012|Overall Study|Progressive disease|5|||
37694153|NCT02460224|69170390|FG013|Overall Study|Progressive disease|4|||
37809501|NCT02987543|69460575|FG003|Overall Study|Investigator decision|0|||
37809502|NCT02987543|69460572|FG000|Overall Study|Disease progression|0|||
37809503|NCT02987543|69460573|FG001|Overall Study|Disease progression|0|||
37809504|NCT02987543|69460574|FG002|Overall Study|Disease progression|0|||
37809505|NCT02987543|69460575|FG003|Overall Study|Disease progression|1|||
37809506|NCT02983045|69460591|FG000|Overall Study|Withdrawal by Subject|0|||
37809507|NCT02983045|69460592|FG001|Overall Study|Withdrawal by Subject|1|||
37809508|NCT02983045|69460593|FG002|Overall Study|Withdrawal by Subject|0|||
37809509|NCT02983045|69460594|FG003|Overall Study|Withdrawal by Subject|5|||
37809510|NCT02983045|69460595|FG004|Overall Study|Withdrawal by Subject|0|||
37809511|NCT02983045|69460596|FG005|Overall Study|Withdrawal by Subject|72|||
37809512|NCT02983045|69460597|FG006|Overall Study|Withdrawal by Subject|0|||
37809513|NCT02983045|69460598|FG007|Overall Study|Withdrawal by Subject|0|||
37809514|NCT02983045|69460599|FG008|Overall Study|Withdrawal by Subject|0|||
37809515|NCT02983045|69460600|FG009|Overall Study|Withdrawal by Subject|2|||
37809516|NCT02983045|69460591|FG000|Overall Study|Lost to Follow-up|0|||
37809517|NCT02983045|69460592|FG001|Overall Study|Lost to Follow-up|0|||
37809518|NCT02983045|69460593|FG002|Overall Study|Lost to Follow-up|0|||
37809519|NCT02983045|69460594|FG003|Overall Study|Lost to Follow-up|0|||
37809520|NCT02983045|69460595|FG004|Overall Study|Lost to Follow-up|0|||
37809521|NCT02983045|69460596|FG005|Overall Study|Lost to Follow-up|10|||
37809522|NCT02983045|69460597|FG006|Overall Study|Lost to Follow-up|0|||
37809523|NCT02983045|69460598|FG007|Overall Study|Lost to Follow-up|0|||
37809524|NCT02983045|69460599|FG008|Overall Study|Lost to Follow-up|0|||
37809525|NCT02983045|69460600|FG009|Overall Study|Lost to Follow-up|0|||
37809526|NCT02564263|69460624|FG000|Overall Study|Adverse Event|31|||
37809527|NCT02564263|69460625|FG001|Overall Study|Adverse Event|29|||
37809528|NCT02564263|69460624|FG000|Overall Study|Death|270|||
37809529|NCT02564263|69460625|FG001|Overall Study|Death|262|||
37809530|NCT02564263|69460624|FG000|Overall Study|Withdrawal by Subject|4|||
37809531|NCT02564263|69460625|FG001|Overall Study|Withdrawal by Subject|19|||
37809532|NCT02564263|69460624|FG000|Overall Study|Sponsor's decision|9|||
37809533|NCT02564263|69460625|FG001|Overall Study|Sponsor's decision|4|||
37809534|NCT02379819|69460632|FG000|Overall Study|Withdrawal by Subject|10|||
37809535|NCT02379819|69460632|FG000|Overall Study|Death|2|||
37809536|NCT02379819|69460632|FG000|Overall Study|Lack of Efficacy|1|||
37809537|NCT02379819|69460632|FG000|Overall Study|Lost to Follow-up|1|||
37809538|NCT02368886|69460640|FG000|Overall Study|Cancel|1|||
37809539|NCT02368886|69460641|FG001|Overall Study|Cancel|1|||
37809540|NCT02368886|69460642|FG002|Overall Study|Cancel|1|||
37809541|NCT02368886|69460643|FG003|Overall Study|Cancel|3|||
37809542|NCT02368886|69460640|FG000|Overall Study|Ineligible|0|||
37809543|NCT02368886|69460641|FG001|Overall Study|Ineligible|0|||
37809544|NCT02368886|69460642|FG002|Overall Study|Ineligible|0|||
37809545|NCT02368886|69460643|FG003|Overall Study|Ineligible|1|||
37809546|NCT02227238|69460657|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
37809547|NCT02227238|69460658|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
37809548|NCT02227238|69460659|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
37809549|NCT02227238|69460657|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
37809550|NCT02227238|69460658|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
37809551|NCT02227238|69460659|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
37809552|NCT02227238|69460657|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
37809553|NCT02227238|69460658|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
37809554|NCT02227238|69460659|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
37809555|NCT02227238|69460657|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
37809556|NCT02227238|69460658|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
37809557|NCT02227238|69460659|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
37809558|NCT02227238|69460657|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
37809559|NCT02227238|69460658|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
37809560|NCT02227238|69460659|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
37809561|NCT02227238|69460657|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
37809562|NCT02227238|69460658|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
37809563|NCT02227238|69460659|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
37864356|NCT01259726|69548020|FG000|Overall Study|Lost to Follow-up|1|||
37809564|NCT02227238|69460657|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
37809565|NCT02227238|69460658|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
37809566|NCT02227238|69460659|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
37809567|NCT02227238|69460657|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
37809568|NCT02227238|69460658|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
37809569|NCT02227238|69460659|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
37809570|NCT02227238|69460657|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
37809571|NCT02227238|69460658|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
37809572|NCT02227238|69460659|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
37809573|NCT02227238|69460657|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
37809574|NCT02227238|69460658|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
37809575|NCT02227238|69460659|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
37809576|NCT02227238|69460657|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
37809577|NCT02227238|69460658|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
37809578|NCT02227238|69460659|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
37809579|NCT02227238|69460657|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
37809580|NCT02227238|69460658|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
37809581|NCT02227238|69460659|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
37809582|NCT02227238|69460657|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
37809583|NCT02227238|69460658|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
37809584|NCT02227238|69460659|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
37809585|NCT02227238|69460657|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
37809586|NCT02227238|69460658|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
37809587|NCT02227238|69460659|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
37809588|NCT02126969|69460680|FG000|Overall Study|Withdrawal by Subject|1|||
37809589|NCT02126969|69460681|FG001|Overall Study|Withdrawal by Subject|2|||
37809590|NCT01715285|69460689|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
37809591|NCT01715285|69460690|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
37809592|NCT01715285|69460691|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
37809593|NCT01715285|69460689|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
37809594|NCT01715285|69460690|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
37809595|NCT01715285|69460691|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
37809596|NCT01715285|69460689|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
37809597|NCT01715285|69460690|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
37809598|NCT01715285|69460691|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
37809599|NCT01715285|69460689|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
37809600|NCT01715285|69460690|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
37809601|NCT01715285|69460691|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
37976864|NCT00548093|69664105|FG000|Overall Study|Death|33|||
37976865|NCT00548093|69664106|FG001|Overall Study|Death|13|||
37976866|NCT00548093|69664105|FG000|Overall Study|Lost to Follow-up|3|||
37976867|NCT00548093|69664106|FG001|Overall Study|Lost to Follow-up|1|||
37976868|NCT00548093|69664105|FG000|Overall Study|Objective progression or relapse|1|||
37976869|NCT00548093|69664106|FG001|Overall Study|Objective progression or relapse|1|||
37976870|NCT00548093|69664105|FG000|Overall Study|Other|11|||
37976871|NCT00548093|69664106|FG001|Overall Study|Other|1|||
37809602|NCT01715285|69460689|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
37809603|NCT01715285|69460690|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
37809604|NCT01715285|69460691|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
37809605|NCT01715285|69460689|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
37809606|NCT01715285|69460690|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
37809607|NCT01715285|69460691|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
37809608|NCT01715285|69460689|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
37809609|NCT01715285|69460690|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
37809610|NCT01715285|69460691|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
37809611|NCT01715285|69460689|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
37809612|NCT01715285|69460690|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
37809613|NCT01715285|69460691|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
37809614|NCT01715285|69460689|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
37809615|NCT01715285|69460690|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
37809616|NCT01715285|69460691|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
37809617|NCT01715285|69460689|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
37809618|NCT01715285|69460690|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
37809619|NCT01715285|69460691|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
37809620|NCT01715285|69460689|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
37809621|NCT01715285|69460690|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
37809622|NCT01715285|69460691|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
37809623|NCT01715285|69460689|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
37809624|NCT01715285|69460690|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
37976872|NCT00548093|69664105|FG000|Overall Study|Withdrawal by Subject|1|||
37976873|NCT00548093|69664106|FG001|Overall Study|Withdrawal by Subject|0|||
37694154|NCT02460224|69170391|FG014|Overall Study|Progressive disease|5|||
37809625|NCT01715285|69460691|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
37809626|NCT01715285|69460689|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
37809627|NCT01715285|69460690|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
37809628|NCT01715285|69460691|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
37809629|NCT01715285|69460689|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
37809630|NCT01715285|69460690|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
37809631|NCT01715285|69460691|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
37809632|NCT01250496|69460700|FG000|Overall Study|Study terminated|124|||
37809633|NCT01250496|69460701|FG001|Overall Study|Study terminated|124|||
37809634|NCT01105975|69460717|FG000|Overall Study|Adverse Event|2|||
37809635|NCT01105975|69460718|FG001|Overall Study|Adverse Event|1|||
37809636|NCT01105975|69460719|FG002|Overall Study|Adverse Event|5|||
37809637|NCT01105975|69460720|FG003|Overall Study|Adverse Event|1|||
37809638|NCT01105975|69460721|FG004|Overall Study|Adverse Event|0|||
37809639|NCT01105975|69460722|FG005|Overall Study|Adverse Event|1|||
37809640|NCT01105975|69460723|FG006|Overall Study|Adverse Event|2|||
37809641|NCT01105975|69460724|FG007|Overall Study|Adverse Event|4|||
37809642|NCT01105975|69460725|FG008|Overall Study|Adverse Event|1|||
37809643|NCT01105975|69460726|FG009|Overall Study|Adverse Event|4|||
37809644|NCT01105975|69460717|FG000|Overall Study|Withdrawal by Subject|2|||
37809645|NCT01105975|69460718|FG001|Overall Study|Withdrawal by Subject|2|||
37809646|NCT01105975|69460719|FG002|Overall Study|Withdrawal by Subject|2|||
37809647|NCT01105975|69460720|FG003|Overall Study|Withdrawal by Subject|0|||
37809648|NCT01105975|69460721|FG004|Overall Study|Withdrawal by Subject|4|||
37809649|NCT01105975|69460722|FG005|Overall Study|Withdrawal by Subject|1|||
37809650|NCT01105975|69460723|FG006|Overall Study|Withdrawal by Subject|2|||
37809651|NCT01105975|69460724|FG007|Overall Study|Withdrawal by Subject|1|||
37809652|NCT01105975|69460725|FG008|Overall Study|Withdrawal by Subject|0|||
37809653|NCT01105975|69460726|FG009|Overall Study|Withdrawal by Subject|3|||
37809654|NCT01105975|69460717|FG000|Overall Study|Lost to Follow-up|1|||
37809655|NCT01105975|69460718|FG001|Overall Study|Lost to Follow-up|0|||
37809656|NCT01105975|69460719|FG002|Overall Study|Lost to Follow-up|0|||
37809657|NCT01105975|69460720|FG003|Overall Study|Lost to Follow-up|1|||
37809658|NCT01105975|69460721|FG004|Overall Study|Lost to Follow-up|1|||
37809659|NCT01105975|69460722|FG005|Overall Study|Lost to Follow-up|0|||
37809660|NCT01105975|69460723|FG006|Overall Study|Lost to Follow-up|0|||
37809661|NCT01105975|69460724|FG007|Overall Study|Lost to Follow-up|0|||
37809662|NCT01105975|69460725|FG008|Overall Study|Lost to Follow-up|1|||
37809663|NCT01105975|69460726|FG009|Overall Study|Lost to Follow-up|0|||
37809664|NCT01105975|69460717|FG000|Overall Study|Physician Decision|0|||
37809665|NCT01105975|69460718|FG001|Overall Study|Physician Decision|0|||
37809666|NCT01105975|69460719|FG002|Overall Study|Physician Decision|0|||
37809667|NCT01105975|69460720|FG003|Overall Study|Physician Decision|0|||
37809668|NCT01105975|69460721|FG004|Overall Study|Physician Decision|0|||
37809669|NCT01105975|69460722|FG005|Overall Study|Physician Decision|0|||
37809670|NCT01105975|69460723|FG006|Overall Study|Physician Decision|2|||
37809671|NCT01105975|69460724|FG007|Overall Study|Physician Decision|0|||
37809672|NCT01105975|69460725|FG008|Overall Study|Physician Decision|0|||
37809673|NCT01105975|69460726|FG009|Overall Study|Physician Decision|0|||
37809674|NCT01105975|69460717|FG000|Overall Study|Protocol Violation|0|||
37809675|NCT01105975|69460718|FG001|Overall Study|Protocol Violation|2|||
37809676|NCT01105975|69460719|FG002|Overall Study|Protocol Violation|2|||
37809677|NCT01105975|69460720|FG003|Overall Study|Protocol Violation|0|||
37809678|NCT01105975|69460721|FG004|Overall Study|Protocol Violation|1|||
37809679|NCT01105975|69460722|FG005|Overall Study|Protocol Violation|1|||
37809680|NCT01105975|69460723|FG006|Overall Study|Protocol Violation|1|||
37809681|NCT01105975|69460724|FG007|Overall Study|Protocol Violation|1|||
37809682|NCT01105975|69460725|FG008|Overall Study|Protocol Violation|2|||
37809683|NCT01105975|69460726|FG009|Overall Study|Protocol Violation|2|||
37809684|NCT01105975|69460717|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
37809685|NCT01105975|69460718|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
37809686|NCT01105975|69460719|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
37809687|NCT01105975|69460720|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
37809688|NCT01105975|69460721|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
37809689|NCT01105975|69460722|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
37809690|NCT01105975|69460723|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
37809691|NCT01105975|69460724|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
37864357|NCT01259726|69548021|FG001|Overall Study|Lost to Follow-up|1|||
37976874|NCT00548093|69664105|FG000|Overall Study|Completed post-treatment follow-up|1|||
37809692|NCT01105975|69460725|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
37809693|NCT01105975|69460726|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
37809694|NCT00831623|69460767|FG000|Overall Study|Withdrawal by Subject|9|||
37864358|NCT01259726|69548022|FG002|Overall Study|Lost to Follow-up|1|||
37976875|NCT00548093|69664106|FG001|Overall Study|Completed post-treatment follow-up|0|||
37809695|NCT00831623|69460767|FG000|Overall Study|Lost to Follow-up|1|||
37809696|NCT00831623|69460767|FG000|Overall Study|Not 2 years post-treatment|12|||
37809697|NCT00079417|69460771|FG000|Overall Study|Physician Decision|2|||
37809698|NCT00079417|69460771|FG000|Overall Study|Ineligible|7|||
37809699|NCT04627038|69465494|FG000|Overall Study|Adverse Event|36|||
37809700|NCT04627038|69465495|FG001|Overall Study|Adverse Event|8|||
37809701|NCT04627038|69465494|FG000|Overall Study|Lost to Follow-up|1|||
37809702|NCT04627038|69465495|FG001|Overall Study|Lost to Follow-up|0|||
37809703|NCT04627038|69465494|FG000|Overall Study|Physician Decision|0|||
37809704|NCT04627038|69465495|FG001|Overall Study|Physician Decision|1|||
37809705|NCT04627038|69465494|FG000|Overall Study|Protocol Violation|3|||
37809706|NCT04627038|69465495|FG001|Overall Study|Protocol Violation|1|||
37809707|NCT04627038|69465494|FG000|Overall Study|Withdrawal by Subject|13|||
37809708|NCT04627038|69465495|FG001|Overall Study|Withdrawal by Subject|3|||
37809709|NCT04627038|69465494|FG000|Overall Study|Non-compliance with study drug|0|||
37809710|NCT04627038|69465495|FG001|Overall Study|Non-compliance with study drug|1|||
37809711|NCT04627038|69465494|FG000|Overall Study|Prohibited Concomitant Medication|1|||
37809712|NCT04627038|69465495|FG001|Overall Study|Prohibited Concomitant Medication|0|||
37809713|NCT05483686|69465709|FG000|Overall Study|Lost to Follow-up|5|||
37809714|NCT05483686|69465710|FG001|Overall Study|Lost to Follow-up|7|||
37809715|NCT05292755|69465718|FG000|Overall Study|Lost to Follow-up|5|||
37809716|NCT05292755|69465719|FG001|Overall Study|Lost to Follow-up|9|||
37809717|NCT04590781|69465733|FG000|Overall Study|Death|0|||
37809718|NCT04590781|69465734|FG001|Overall Study|Death|2|||
37976876|NCT00450216|69664117|FG000|Overall Study|Adverse Event|38|||
37976877|NCT00450216|69664118|FG001|Overall Study|Adverse Event|23|||
37976878|NCT00450216|69664117|FG000|Overall Study|Withdrawal by Subject|48|||
37809719|NCT04590781|69465733|FG000|Overall Study|Withdrawal by Subject|2|||
37809720|NCT04590781|69465734|FG001|Overall Study|Withdrawal by Subject|0|||
37809721|NCT04248868|69465741|FG000|Overall Study|Death|1|||
37809722|NCT04248868|69465741|FG000|Overall Study|Lost to Follow-up|3|||
37809723|NCT04248868|69465741|FG000|Overall Study|Protocol Violation|2|||
37809724|NCT04211831|69465748|FG000|Overall Study|Withdrawal by Subject|4|||
37809725|NCT04211831|69465749|FG001|Overall Study|Withdrawal by Subject|1|||
37809726|NCT04211831|69465750|FG002|Overall Study|Withdrawal by Subject|1|||
37809727|NCT04211831|69465748|FG000|Overall Study|Protocol Violation|0|||
37809728|NCT04211831|69465749|FG001|Overall Study|Protocol Violation|0|||
37809729|NCT04211831|69465750|FG002|Overall Study|Protocol Violation|1|||
37809730|NCT04211831|69465748|FG000|Overall Study|Adverse Event|0|||
37809731|NCT04211831|69465749|FG001|Overall Study|Adverse Event|1|||
37809732|NCT04211831|69465750|FG002|Overall Study|Adverse Event|0|||
37809733|NCT04211831|69465748|FG000|Overall Study|Lack of Efficacy|0|||
37809734|NCT04211831|69465749|FG001|Overall Study|Lack of Efficacy|0|||
37809735|NCT04211831|69465750|FG002|Overall Study|Lack of Efficacy|1|||
37809736|NCT04211831|69465748|FG000|Overall Study|Lost to Follow-up|0|||
37809737|NCT04211831|69465749|FG001|Overall Study|Lost to Follow-up|0|||
37809738|NCT04211831|69465750|FG002|Overall Study|Lost to Follow-up|2|||
37809739|NCT04211831|69465748|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
37809740|NCT04211831|69465749|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
37809741|NCT04211831|69465750|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
37809742|NCT04211831|69465748|FG000|Overall Study|Other|0|||
37809743|NCT04211831|69465749|FG001|Overall Study|Other|1|||
37809744|NCT04211831|69465750|FG002|Overall Study|Other|0|||
37809745|NCT04067518|69465808|FG000|Overall Study|Adverse Event|1|||
37809746|NCT04067518|69465809|FG001|Overall Study|Adverse Event|3|||
37809747|NCT04067518|69465808|FG000|Overall Study|Screen failures|0|||
37809748|NCT04067518|69465809|FG001|Overall Study|Screen failures|1|||
37809749|NCT04067518|69465808|FG000|Overall Study|Enrolled but not treated|0|||
37809750|NCT04067518|69465809|FG001|Overall Study|Enrolled but not treated|1|||
37976879|NCT00450216|69664118|FG001|Overall Study|Withdrawal by Subject|26|||
37976880|NCT00450216|69664117|FG000|Overall Study|Lost to Follow-up|16|||
37976881|NCT00450216|69664118|FG001|Overall Study|Lost to Follow-up|9|||
37976882|NCT00450216|69664117|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
37809751|NCT03912233|69465850|FG000|Overall Study|Adverse Event|1|||
37809752|NCT03912233|69465851|FG001|Overall Study|Adverse Event|0|||
37809753|NCT03912233|69465852|FG002|Overall Study|Adverse Event|0|||
37809754|NCT03912233|69465853|FG003|Overall Study|Adverse Event|0|||
37809755|NCT03912233|69465854|FG004|Overall Study|Adverse Event|0|||
37809756|NCT03912233|69465855|FG005|Overall Study|Adverse Event|0|||
37809757|NCT03912233|69465850|FG000|Overall Study|Physician Decision|1|||
37809758|NCT03912233|69465851|FG001|Overall Study|Physician Decision|0|||
37809759|NCT03912233|69465852|FG002|Overall Study|Physician Decision|0|||
37809760|NCT03912233|69465853|FG003|Overall Study|Physician Decision|0|||
37809761|NCT03912233|69465854|FG004|Overall Study|Physician Decision|0|||
37809762|NCT03912233|69465855|FG005|Overall Study|Physician Decision|0|||
37809763|NCT03912233|69465850|FG000|Overall Study|Other|0|||
37809764|NCT03912233|69465851|FG001|Overall Study|Other|0|||
37809765|NCT03912233|69465852|FG002|Overall Study|Other|0|||
37809766|NCT03912233|69465853|FG003|Overall Study|Other|0|||
37809767|NCT03912233|69465854|FG004|Overall Study|Other|7|||
37809768|NCT03912233|69465855|FG005|Overall Study|Other|12|||
37809769|NCT03546062|69465898|FG000|Overall Study|Adverse Event|6|||
37809770|NCT03546062|69465899|FG001|Overall Study|Adverse Event|5|||
37809771|NCT03546062|69465900|FG002|Overall Study|Adverse Event|8|||
37809772|NCT03539952|69465910|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
37809773|NCT03539952|69465911|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
37809774|NCT03539952|69465910|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
37809775|NCT03539952|69465911|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
37809776|NCT03539952|69465910|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
37809777|NCT03539952|69465911|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
37809778|NCT03539952|69465910|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
37809779|NCT03539952|69465911|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
37809780|NCT03539952|69465910|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
37809781|NCT03539952|69465911|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
37809782|NCT03539952|69465910|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
37809783|NCT03539952|69465911|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
37809784|NCT03539952|69465910|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
37809785|NCT03539952|69465911|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
37809786|NCT02929108|69465943|FG000|Overall Study|Hospice patient death|100|||
37809787|NCT02929108|69465944|FG001|Overall Study|Hospice patient death|64|||
37809788|NCT02929108|69465945|FG002|Overall Study|Hospice patient death|28|||
37809789|NCT02929108|69465946|FG003|Overall Study|Hospice patient death|46|||
37809790|NCT02929108|69465947|FG004|Overall Study|Hospice patient death|55|||
37809791|NCT02929108|69465948|FG005|Overall Study|Hospice patient death|28|||
37809792|NCT02929108|69465949|FG006|Overall Study|Hospice patient death|78|||
37976883|NCT00450216|69664118|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
37976884|NCT00450216|69664117|FG000|Overall Study|misc|21|||
37809793|NCT02661295|69465957|FG000|Overall Study|Death|1|||
37809794|NCT02661295|69465957|FG000|Overall Study|Transferred Out|1|||
37809795|NCT02661295|69465957|FG000|Overall Study|Kidney Transplant|1|||
37809796|NCT02661295|69465957|FG000|Overall Study|Withdrawn due to side effects|8|||
37809797|NCT02661295|69465957|FG000|Overall Study|Withdrawn due to access type|1|||
37809798|NCT02661295|69465957|FG000|Overall Study|Withdrawn due to allergies|1|||
37809799|NCT02661295|69465957|FG000|Overall Study|Withdrawn due to non-compliance|1|||
37976885|NCT00450216|69664118|FG001|Overall Study|misc|20|||
37976886|NCT00441480|69664126|FG000|Overall Study|Protocol Violation|1|||
37976887|NCT00441480|69664127|FG001|Overall Study|Protocol Violation|1|||
37809800|NCT02661295|69465957|FG000|Overall Study|Withdrawal by Subject|3|||
37809801|NCT02661295|69465957|FG000|Overall Study|Failed screening|2|||
37809802|NCT02412748|69465963|FG000|Overall Study|Lost to Follow-up|38|||
37809803|NCT02412748|69465964|FG001|Overall Study|Lost to Follow-up|39|||
37809804|NCT01844726|69465989|FG000|Overall Study|Withdrawal by Subject|0|||
37809805|NCT01844726|69465990|FG001|Overall Study|Withdrawal by Subject|1|||
37809806|NCT01844726|69465989|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
37809807|NCT01844726|69465990|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
37809808|NCT05131451|69470963|FG000|Overall Study|Protocol Violation|1|||
37809809|NCT05131451|69470964|FG001|Overall Study|Protocol Violation|0|||
37976888|NCT00441480|69664126|FG000|Overall Study|Withdrawal by Subject|2|||
37976889|NCT00441480|69664127|FG001|Overall Study|Withdrawal by Subject|3|||
37976890|NCT00547703|69664135|FG000|Overall Study|Lost to Follow-up|1|||
37976891|NCT00547703|69664136|FG001|Overall Study|Lost to Follow-up|0|||
37976892|NCT00297232|69664142|FG000|Overall Study|Lack of Efficacy|7|||
37976893|NCT00297232|69664142|FG000|Overall Study|Lost to Follow-up|10|||
37976894|NCT00297232|69664142|FG000|Overall Study|Adverse Event|63|||
37976895|NCT00297232|69664142|FG000|Overall Study|Voluntary Withdrawal|120|||
37976896|NCT00297232|69664142|FG000|Overall Study|Subject was Noncompliant|9|||
37976897|NCT00297232|69664142|FG000|Overall Study|Death|9|||
37976898|NCT00297232|69664142|FG000|Overall Study|Anti-natalizumab Positive|8|||
37976899|NCT00297232|69664142|FG000|Overall Study|Switched to Commercial Tysabri|22|||
37976900|NCT00297232|69664142|FG000|Overall Study|Disease Progression|8|||
37976901|NCT00297232|69664142|FG000|Overall Study|Fear of PML|10|||
37976902|NCT00297232|69664142|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
37976903|NCT00297232|69664142|FG000|Overall Study|Miscellaneous|5|||
37809810|NCT05108922|69470972|FG000|Overall Study|Adverse Event|0|||
37809811|NCT05108922|69470973|FG001|Overall Study|Adverse Event|1|||
37809812|NCT05108922|69470972|FG000|Overall Study|Physician Decision|1|||
37976904|NCT00297232|69664142|FG000|Overall Study|Sponsor Decision|34|||
37976905|NCT00297232|69664142|FG000|Overall Study|Subject Relocated|7|||
37976906|NCT00297232|69664142|FG000|Overall Study|Subject Withdrew Consent|37|||
37976907|NCT00297232|69664142|FG000|Overall Study|Persistently Positive Antibodies|11|||
37976908|NCT00297232|69664142|FG000|Overall Study|Investigator Withdrew From Program|19|||
37976909|NCT00297232|69664142|FG000|Overall Study|Did Not Enroll to Week 264|34|||
37976910|NCT00297232|69664142|FG000|Overall Study|Did Not Enroll to Week 480|17|||
37976911|NCT00297232|69664142|FG000|Overall Study|No data available after Week 264|161|||
37976912|NCT00297232|69664142|FG000|Overall Study|Other|1|||
37809813|NCT05108922|69470973|FG001|Overall Study|Physician Decision|1|||
37809814|NCT05108922|69470972|FG000|Overall Study|Screen Failure|1|||
37809815|NCT05108922|69470973|FG001|Overall Study|Screen Failure|1|||
37809816|NCT05108922|69470972|FG000|Overall Study|Withdrawal by Subject|7|||
37809817|NCT05108922|69470973|FG001|Overall Study|Withdrawal by Subject|4|||
37809818|NCT04874636|69470989|FG000|Overall Study|Adverse Event|17|||
37809819|NCT04874636|69470990|FG001|Overall Study|Adverse Event|7|||
37809820|NCT04874636|69470989|FG000|Overall Study|Lost to Follow-up|1|||
37809821|NCT04874636|69470990|FG001|Overall Study|Lost to Follow-up|0|||
37809822|NCT04874636|69470989|FG000|Overall Study|Non-Compliance with Study Drug|2|||
37809823|NCT04874636|69470990|FG001|Overall Study|Non-Compliance with Study Drug|0|||
37809824|NCT04874636|69470989|FG000|Overall Study|Physician Decision|1|||
37809825|NCT04874636|69470990|FG001|Overall Study|Physician Decision|0|||
37809826|NCT04874636|69470989|FG000|Overall Study|Withdrawal by Subject|6|||
37809827|NCT04874636|69470990|FG001|Overall Study|Withdrawal by Subject|5|||
37809828|NCT04707157|69471006|FG000|Overall Study|Adverse Event|12|||
37809829|NCT04707157|69471007|FG001|Overall Study|Adverse Event|3|||
37809830|NCT04707157|69471006|FG000|Overall Study|Lost to Follow-up|2|||
37809831|NCT04707157|69471007|FG001|Overall Study|Lost to Follow-up|0|||
37809832|NCT04707157|69471006|FG000|Overall Study|Sponsor's decision|1|||
37809833|NCT04707157|69471007|FG001|Overall Study|Sponsor's decision|0|||
37809834|NCT04707157|69471006|FG000|Overall Study|Physician Decision|8|||
37809835|NCT04707157|69471007|FG001|Overall Study|Physician Decision|5|||
37976913|NCT00449670|69664158|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
37976914|NCT00449670|69664159|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
37976915|NCT00449670|69664158|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
37976916|NCT00449670|69664159|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
37976917|NCT00449670|69664158|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
37976918|NCT00449670|69664159|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
37976919|NCT00449670|69664158|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
37809836|NCT04707157|69471006|FG000|Overall Study|Protocol Deviation|1|||
37809837|NCT04707157|69471007|FG001|Overall Study|Protocol Deviation|0|||
37809838|NCT04707157|69471006|FG000|Overall Study|Withdrawal by Subject|1|||
37809839|NCT04707157|69471007|FG001|Overall Study|Withdrawal by Subject|1|||
37809840|NCT04700449|69471016|FG000|Stage 1: Double-Blind Period|Adverse Event|5|||
37809841|NCT04700449|69471017|FG001|Stage 1: Double-Blind Period|Adverse Event|0|||
37976920|NCT00449670|69664159|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
37976921|NCT00449670|69664158|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
37976922|NCT00449670|69664159|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
37976923|NCT00449670|69664158|FG000|Booster Phase (Study no.109873)|Other|0|||
37976924|NCT00449670|69664159|FG001|Booster Phase (Study no.109873)|Other|2|||
37976925|NCT00296374|69664175|FG000|Overall Study|Adverse Event|14|||
37976926|NCT00296374|69664176|FG001|Overall Study|Adverse Event|10|||
37976927|NCT00296374|69664177|FG002|Overall Study|Adverse Event|7|||
37809842|NCT04700449|69471018|FG002|Stage 1: Double-Blind Period|Adverse Event|1|||
37809843|NCT04700449|69471019|FG003|Stage 1: Double-Blind Period|Adverse Event|0|||
37809844|NCT04700449|69471016|FG000|Stage 1: Double-Blind Period|Protocol Violation|0|||
37809845|NCT04700449|69471017|FG001|Stage 1: Double-Blind Period|Protocol Violation|1|||
37809846|NCT04700449|69471018|FG002|Stage 1: Double-Blind Period|Protocol Violation|0|||
37809847|NCT04700449|69471019|FG003|Stage 1: Double-Blind Period|Protocol Violation|0|||
37809848|NCT04700449|69471016|FG000|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
37809849|NCT04700449|69471017|FG001|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
37809850|NCT04700449|69471018|FG002|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
37809851|NCT04700449|69471019|FG003|Stage 1: Double-Blind Period|Withdrawal by Subject|0|||
37809852|NCT04700449|69471016|FG000|Stage 1: Double-Blind Period|Lack of Efficacy|1|||
37809853|NCT04700449|69471017|FG001|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
37809854|NCT04700449|69471018|FG002|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
37809855|NCT04700449|69471019|FG003|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
37809856|NCT04700449|69471016|FG000|Stage 1: Double-Blind Period|COVID-19 Restriction|3|||
37809857|NCT04700449|69471017|FG001|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
37809858|NCT04700449|69471018|FG002|Stage 1: Double-Blind Period|COVID-19 Restriction|1|||
37809859|NCT04700449|69471019|FG003|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
37976928|NCT00296374|69664175|FG000|Overall Study|Withdrawal by Subject|3|||
37976929|NCT00296374|69664176|FG001|Overall Study|Withdrawal by Subject|5|||
37809860|NCT04700449|69471016|FG000|Stage 1: Double-Blind Period|Other|0|||
37809861|NCT04700449|69471017|FG001|Stage 1: Double-Blind Period|Other|0|||
37809862|NCT04700449|69471018|FG002|Stage 1: Double-Blind Period|Other|1|||
37809863|NCT04700449|69471019|FG003|Stage 1: Double-Blind Period|Other|0|||
37809864|NCT04700449|69471016|FG000|Stage 2 Sub-study 1|Adverse Event|0|||
37809865|NCT04700449|69471017|FG001|Stage 2 Sub-study 1|Adverse Event|1|||
37809866|NCT04700449|69471018|FG002|Stage 2 Sub-study 1|Adverse Event|0|||
37809867|NCT04700449|69471019|FG003|Stage 2 Sub-study 1|Adverse Event|0|||
37809868|NCT04700449|69471016|FG000|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
37809869|NCT04700449|69471017|FG001|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
37809870|NCT04700449|69471018|FG002|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
37809871|NCT04700449|69471019|FG003|Stage 2 Sub-study 1|Withdrawal by Subject|0|||
37809872|NCT04700449|69471016|FG000|Stage 2 Sub-study 1|Lack of Efficacy|0|||
37809873|NCT04700449|69471017|FG001|Stage 2 Sub-study 1|Lack of Efficacy|0|||
37809874|NCT04700449|69471018|FG002|Stage 2 Sub-study 1|Lack of Efficacy|2|||
37809875|NCT04700449|69471019|FG003|Stage 2 Sub-study 1|Lack of Efficacy|0|||
37809876|NCT04700449|69471016|FG000|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
37809877|NCT04700449|69471017|FG001|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
37809878|NCT04700449|69471018|FG002|Stage 2 Sub-study 1|COVID-19 Restriction|1|||
37809879|NCT04700449|69471019|FG003|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
37809880|NCT04700449|69471016|FG000|Stage 2 Sub-study 1|Other|1|||
37809881|NCT04700449|69471017|FG001|Stage 2 Sub-study 1|Other|2|||
37809882|NCT04700449|69471018|FG002|Stage 2 Sub-study 1|Other|0|||
37809883|NCT04700449|69471019|FG003|Stage 2 Sub-study 1|Other|0|||
37809884|NCT04700449|69471016|FG000|Stage 2 Sub-study 2|Adverse Event|0|||
37809885|NCT04700449|69471017|FG001|Stage 2 Sub-study 2|Adverse Event|0|||
37809886|NCT04700449|69471018|FG002|Stage 2 Sub-study 2|Adverse Event|0|||
37809887|NCT04700449|69471019|FG003|Stage 2 Sub-study 2|Adverse Event|7|||
37809888|NCT04700449|69471016|FG000|Stage 2 Sub-study 2|Lost to Follow-up|0|||
37809889|NCT04700449|69471017|FG001|Stage 2 Sub-study 2|Lost to Follow-up|0|||
37809890|NCT04700449|69471018|FG002|Stage 2 Sub-study 2|Lost to Follow-up|0|||
37809891|NCT04700449|69471019|FG003|Stage 2 Sub-study 2|Lost to Follow-up|1|||
37809892|NCT04700449|69471016|FG000|Stage 2 Sub-study 2|Lack of Efficacy|0|||
37809893|NCT04700449|69471017|FG001|Stage 2 Sub-study 2|Lack of Efficacy|0|||
37809894|NCT04700449|69471018|FG002|Stage 2 Sub-study 2|Lack of Efficacy|0|||
37809895|NCT04700449|69471019|FG003|Stage 2 Sub-study 2|Lack of Efficacy|9|||
37809896|NCT04700449|69471016|FG000|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
37809897|NCT04700449|69471017|FG001|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
37809898|NCT04700449|69471018|FG002|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
37809899|NCT04700449|69471019|FG003|Stage 2 Sub-study 2|COVID-19 Restriction|1|||
37809900|NCT04700449|69471016|FG000|Stage 2 Sub-study 2|Other|0|||
37809901|NCT04700449|69471017|FG001|Stage 2 Sub-study 2|Other|0|||
37809902|NCT04700449|69471018|FG002|Stage 2 Sub-study 2|Other|0|||
37976930|NCT00296374|69664177|FG002|Overall Study|Withdrawal by Subject|11|||
37976931|NCT00296374|69664175|FG000|Overall Study|Incorrect enrollment|3|||
37976932|NCT00296374|69664176|FG001|Overall Study|Incorrect enrollment|3|||
37976933|NCT00296374|69664177|FG002|Overall Study|Incorrect enrollment|4|||
37976934|NCT00296374|69664175|FG000|Overall Study|Protocol Violation|1|||
37809903|NCT04700449|69471019|FG003|Stage 2 Sub-study 2|Other|5|||
37809904|NCT04667377|69471043|FG000|Dose Escalation Period|Other not specified below|3|||
37809905|NCT04667377|69471044|FG001|Dose Escalation Period|Other not specified below|3|||
37809906|NCT04667377|69471045|FG002|Dose Escalation Period|Other not specified below|2|||
37809907|NCT04667377|69471046|FG003|Dose Escalation Period|Other not specified below|1|||
37809908|NCT04667377|69471047|FG004|Dose Escalation Period|Other not specified below|3|||
37809909|NCT04667377|69471043|FG000|Dose Escalation Period|Protocol Violation|2|||
37809910|NCT04667377|69471044|FG001|Dose Escalation Period|Protocol Violation|2|||
37809911|NCT04667377|69471045|FG002|Dose Escalation Period|Protocol Violation|0|||
37809912|NCT04667377|69471046|FG003|Dose Escalation Period|Protocol Violation|2|||
37694155|NCT02460224|69170392|FG015|Overall Study|Progressive disease|5|||
37809913|NCT04667377|69471047|FG004|Dose Escalation Period|Protocol Violation|1|||
37809914|NCT04667377|69471043|FG000|Dose Escalation Period|Burden of study procedures|2|||
37976935|NCT00296374|69664176|FG001|Overall Study|Protocol Violation|2|||
37694156|NCT02460224|69170393|FG016|Overall Study|Progressive disease|15|||
37809915|NCT04667377|69471044|FG001|Dose Escalation Period|Burden of study procedures|1|||
37809916|NCT04667377|69471045|FG002|Dose Escalation Period|Burden of study procedures|1|||
37809917|NCT04667377|69471046|FG003|Dose Escalation Period|Burden of study procedures|1|||
37976936|NCT00296374|69664177|FG002|Overall Study|Protocol Violation|3|||
37976937|NCT00296374|69664175|FG000|Overall Study|Lost to Follow-up|3|||
37976938|NCT00296374|69664176|FG001|Overall Study|Lost to Follow-up|1|||
37809918|NCT04667377|69471047|FG004|Dose Escalation Period|Burden of study procedures|5|||
37809919|NCT04667377|69471043|FG000|Dose Escalation Period|Change of residence|0|||
37809920|NCT04667377|69471044|FG001|Dose Escalation Period|Change of residence|0|||
37809921|NCT04667377|69471045|FG002|Dose Escalation Period|Change of residence|1|||
37809922|NCT04667377|69471046|FG003|Dose Escalation Period|Change of residence|0|||
37809923|NCT04667377|69471047|FG004|Dose Escalation Period|Change of residence|0|||
37809924|NCT04667377|69471043|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
37809925|NCT04667377|69471044|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
37809926|NCT04667377|69471045|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
37809927|NCT04667377|69471046|FG003|Dose Escalation Period|Perceived lack of efficacy|0|||
37809928|NCT04667377|69471047|FG004|Dose Escalation Period|Perceived lack of efficacy|6|||
37809929|NCT04667377|69471043|FG000|Dose Escalation Period|Adverse Event|9|||
37809930|NCT04667377|69471044|FG001|Dose Escalation Period|Adverse Event|10|||
37809931|NCT04667377|69471045|FG002|Dose Escalation Period|Adverse Event|12|||
37976939|NCT00296374|69664177|FG002|Overall Study|Lost to Follow-up|1|||
37976940|NCT00296374|69664175|FG000|Overall Study|Relocated to another state|1|||
37976941|NCT00296374|69664176|FG001|Overall Study|Relocated to another state|0|||
37976942|NCT00296374|69664177|FG002|Overall Study|Relocated to another state|0|||
37976943|NCT00296374|69664175|FG000|Overall Study|Stopped drug before end of study visit|0|||
37976944|NCT00296374|69664176|FG001|Overall Study|Stopped drug before end of study visit|1|||
37976945|NCT00296374|69664177|FG002|Overall Study|Stopped drug before end of study visit|0|||
37976946|NCT00296374|69664175|FG000|Overall Study|Nephrologist introduced ACE|0|||
37809932|NCT04667377|69471046|FG003|Dose Escalation Period|Adverse Event|17|||
37809933|NCT04667377|69471047|FG004|Dose Escalation Period|Adverse Event|3|||
37809934|NCT04667377|69471043|FG000|Dose Escalation Period|Adverse event: COVID-infection|4|||
37809935|NCT04667377|69471044|FG001|Dose Escalation Period|Adverse event: COVID-infection|1|||
37809936|NCT04667377|69471045|FG002|Dose Escalation Period|Adverse event: COVID-infection|2|||
37809937|NCT04667377|69471046|FG003|Dose Escalation Period|Adverse event: COVID-infection|1|||
37809938|NCT04667377|69471047|FG004|Dose Escalation Period|Adverse event: COVID-infection|0|||
37809939|NCT04667377|69471043|FG000|Dose Escalation Period|Not treated|1|||
37864359|NCT01259726|69548023|FG003|Overall Study|Lost to Follow-up|3|||
37809940|NCT04667377|69471044|FG001|Dose Escalation Period|Not treated|0|||
37809941|NCT04667377|69471045|FG002|Dose Escalation Period|Not treated|0|||
37809942|NCT04667377|69471046|FG003|Dose Escalation Period|Not treated|0|||
37809943|NCT04667377|69471047|FG004|Dose Escalation Period|Not treated|0|||
37809944|NCT04667377|69471043|FG000|Dose Escalation Period|Withdrawal by Subject|2|||
37809945|NCT04667377|69471044|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
37809946|NCT04667377|69471045|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
37809947|NCT04667377|69471046|FG003|Dose Escalation Period|Withdrawal by Subject|0|||
37809948|NCT04667377|69471047|FG004|Dose Escalation Period|Withdrawal by Subject|2|||
37809949|NCT04667377|69471043|FG000|Dose Escalation Period|Lost to Follow-up|0|||
37809950|NCT04667377|69471044|FG001|Dose Escalation Period|Lost to Follow-up|1|||
37809951|NCT04667377|69471045|FG002|Dose Escalation Period|Lost to Follow-up|0|||
37809952|NCT04667377|69471046|FG003|Dose Escalation Period|Lost to Follow-up|0|||
37809953|NCT04667377|69471047|FG004|Dose Escalation Period|Lost to Follow-up|0|||
37809954|NCT04667377|69471043|FG000|Maintenance Period|Perceived lack of efficacy|0|||
37809955|NCT04667377|69471044|FG001|Maintenance Period|Perceived lack of efficacy|2|||
37809956|NCT04667377|69471045|FG002|Maintenance Period|Perceived lack of efficacy|1|||
37809957|NCT04667377|69471046|FG003|Maintenance Period|Perceived lack of efficacy|0|||
37809958|NCT04667377|69471047|FG004|Maintenance Period|Perceived lack of efficacy|1|||
37809959|NCT04667377|69471043|FG000|Maintenance Period|Adverse Event|2|||
37809960|NCT04667377|69471044|FG001|Maintenance Period|Adverse Event|8|||
37809961|NCT04667377|69471045|FG002|Maintenance Period|Adverse Event|5|||
37809962|NCT04667377|69471046|FG003|Maintenance Period|Adverse Event|4|||
37809963|NCT04667377|69471047|FG004|Maintenance Period|Adverse Event|1|||
37809964|NCT04667377|69471043|FG000|Maintenance Period|Adverse event: COVID infection|0|||
37809965|NCT04667377|69471044|FG001|Maintenance Period|Adverse event: COVID infection|1|||
37809966|NCT04667377|69471045|FG002|Maintenance Period|Adverse event: COVID infection|0|||
37809967|NCT04667377|69471046|FG003|Maintenance Period|Adverse event: COVID infection|0|||
37809968|NCT04667377|69471047|FG004|Maintenance Period|Adverse event: COVID infection|0|||
37809969|NCT04667377|69471043|FG000|Maintenance Period|COVID-related|0|||
37809970|NCT04667377|69471044|FG001|Maintenance Period|COVID-related|0|||
37809971|NCT04667377|69471045|FG002|Maintenance Period|COVID-related|1|||
37809972|NCT04667377|69471046|FG003|Maintenance Period|COVID-related|1|||
37809973|NCT04667377|69471047|FG004|Maintenance Period|COVID-related|0|||
37809974|NCT04667377|69471043|FG000|Maintenance Period|Protocol Violation|1|||
37809975|NCT04667377|69471044|FG001|Maintenance Period|Protocol Violation|0|||
37809976|NCT04667377|69471045|FG002|Maintenance Period|Protocol Violation|0|||
37809977|NCT04667377|69471046|FG003|Maintenance Period|Protocol Violation|0|||
37809978|NCT04667377|69471047|FG004|Maintenance Period|Protocol Violation|1|||
37809979|NCT04667377|69471043|FG000|Maintenance Period|Burden of study procedures|1|||
37809980|NCT04667377|69471044|FG001|Maintenance Period|Burden of study procedures|2|||
37809981|NCT04667377|69471045|FG002|Maintenance Period|Burden of study procedures|0|||
37864360|NCT01259492|69548037|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
37864361|NCT01259492|69548038|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
37864362|NCT01259492|69548039|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
37976947|NCT00296374|69664176|FG001|Overall Study|Nephrologist introduced ACE|1|||
37976948|NCT00296374|69664177|FG002|Overall Study|Nephrologist introduced ACE|0|||
37976949|NCT00296374|69664175|FG000|Overall Study|Pregnancy|0|||
37976950|NCT00296374|69664176|FG001|Overall Study|Pregnancy|0|||
37976951|NCT00296374|69664177|FG002|Overall Study|Pregnancy|2|||
37976952|NCT00296374|69664175|FG000|Overall Study|Other|0|||
37976953|NCT00296374|69664176|FG001|Overall Study|Other|0|||
37976954|NCT00296374|69664177|FG002|Overall Study|Other|1|||
37976955|NCT00326950|69664200|FG000|Overall Study|Progressive Disease|1|||
37976956|NCT00548717|69664206|FG000|Overall Study|Death|5|||
37976957|NCT00548717|69664207|FG001|Overall Study|Death|2|||
37976958|NCT00548717|69664206|FG000|Overall Study|Relapse|3|||
37976959|NCT00548717|69664207|FG001|Overall Study|Relapse|0|||
37694157|NCT02460224|69170394|FG017|Overall Study|Progressive disease|3|||
37694158|NCT02460224|69170395|FG018|Overall Study|Progressive disease|8|||
37694159|NCT02460224|69170396|FG019|Overall Study|Progressive disease|3|||
37694160|NCT02460224|69170397|FG020|Overall Study|Progressive disease|4|||
37694161|NCT02460224|69170398|FG021|Overall Study|Progressive disease|9|||
37694162|NCT02460224|69170399|FG022|Overall Study|Progressive disease|4|||
37694163|NCT02460224|69170400|FG023|Overall Study|Progressive disease|11|||
37694164|NCT02460224|69170401|FG024|Overall Study|Progressive disease|4|||
37694165|NCT02460224|69170402|FG025|Overall Study|Progressive disease|5|||
37694166|NCT02460224|69170403|FG026|Overall Study|Progressive disease|85|||
37694167|NCT02460224|69170404|FG027|Overall Study|Progressive disease|17|||
37694168|NCT02460224|69170405|FG028|Overall Study|Progressive disease|77|||
37694169|NCT02460224|69170377|FG000|Overall Study|Subject/guardian decision|2|||
37694170|NCT02460224|69170378|FG001|Overall Study|Subject/guardian decision|0|||
37864363|NCT01259492|69548040|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
37976960|NCT00548717|69664206|FG000|Overall Study|Alternative treatment for GVHD|1|||
37694171|NCT02460224|69170379|FG002|Overall Study|Subject/guardian decision|1|||
37694172|NCT02460224|69170380|FG003|Overall Study|Subject/guardian decision|0|||
37694173|NCT02460224|69170381|FG004|Overall Study|Subject/guardian decision|2|||
37694174|NCT02460224|69170382|FG005|Overall Study|Subject/guardian decision|2|||
37809982|NCT04667377|69471046|FG003|Maintenance Period|Burden of study procedures|1|||
37809983|NCT04667377|69471047|FG004|Maintenance Period|Burden of study procedures|0|||
37809984|NCT04667377|69471043|FG000|Maintenance Period|Change of residence|0|||
37809985|NCT04667377|69471044|FG001|Maintenance Period|Change of residence|1|||
37809986|NCT04667377|69471045|FG002|Maintenance Period|Change of residence|0|||
37809987|NCT04667377|69471046|FG003|Maintenance Period|Change of residence|0|||
37809988|NCT04667377|69471047|FG004|Maintenance Period|Change of residence|1|||
37809989|NCT04667377|69471043|FG000|Maintenance Period|Missing|1|||
37809990|NCT04667377|69471044|FG001|Maintenance Period|Missing|0|||
37809991|NCT04667377|69471045|FG002|Maintenance Period|Missing|0|||
37809992|NCT04667377|69471046|FG003|Maintenance Period|Missing|0|||
37809993|NCT04667377|69471047|FG004|Maintenance Period|Missing|0|||
37809994|NCT04667377|69471043|FG000|Maintenance Period|Other than listed above|2|||
37809995|NCT04667377|69471044|FG001|Maintenance Period|Other than listed above|0|||
37809996|NCT04667377|69471045|FG002|Maintenance Period|Other than listed above|3|||
37809997|NCT04667377|69471046|FG003|Maintenance Period|Other than listed above|2|||
37809998|NCT04667377|69471047|FG004|Maintenance Period|Other than listed above|6|||
37809999|NCT04667377|69471043|FG000|Maintenance Period|Withdrawal by Subject|0|||
37810000|NCT04667377|69471044|FG001|Maintenance Period|Withdrawal by Subject|1|||
37810001|NCT04667377|69471045|FG002|Maintenance Period|Withdrawal by Subject|0|||
37810002|NCT04667377|69471046|FG003|Maintenance Period|Withdrawal by Subject|0|||
37810003|NCT04667377|69471047|FG004|Maintenance Period|Withdrawal by Subject|0|||
37810004|NCT04667377|69471043|FG000|Maintenance Period|Lost to Follow-up|1|||
37810005|NCT04667377|69471044|FG001|Maintenance Period|Lost to Follow-up|0|||
37810006|NCT04667377|69471045|FG002|Maintenance Period|Lost to Follow-up|1|||
37810007|NCT04667377|69471046|FG003|Maintenance Period|Lost to Follow-up|0|||
37810008|NCT04667377|69471047|FG004|Maintenance Period|Lost to Follow-up|1|||
37810009|NCT04537923|69471067|FG000|Overall Study|Adverse Event|2|||
37810010|NCT04537923|69471068|FG001|Overall Study|Adverse Event|1|||
37810011|NCT04537923|69471069|FG002|Overall Study|Adverse Event|2|||
37810012|NCT04537923|69471070|FG003|Overall Study|Adverse Event|4|||
37810013|NCT04537923|69471067|FG000|Overall Study|Death|3|||
37810014|NCT04537923|69471068|FG001|Overall Study|Death|3|||
37810015|NCT04537923|69471069|FG002|Overall Study|Death|1|||
37810016|NCT04537923|69471070|FG003|Overall Study|Death|11|||
37810017|NCT04537923|69471067|FG000|Overall Study|Lost to Follow-up|1|||
37810018|NCT04537923|69471068|FG001|Overall Study|Lost to Follow-up|2|||
37810019|NCT04537923|69471069|FG002|Overall Study|Lost to Follow-up|1|||
37810020|NCT04537923|69471070|FG003|Overall Study|Lost to Follow-up|6|||
37810021|NCT04537923|69471067|FG000|Overall Study|Physician Decision|1|||
37810022|NCT04537923|69471068|FG001|Overall Study|Physician Decision|0|||
37810023|NCT04537923|69471069|FG002|Overall Study|Physician Decision|2|||
37810024|NCT04537923|69471070|FG003|Overall Study|Physician Decision|5|||
37810025|NCT04537923|69471067|FG000|Overall Study|Pregnancy|1|||
37810026|NCT04537923|69471068|FG001|Overall Study|Pregnancy|0|||
37810027|NCT04537923|69471069|FG002|Overall Study|Pregnancy|0|||
37810028|NCT04537923|69471070|FG003|Overall Study|Pregnancy|0|||
37810029|NCT04537923|69471067|FG000|Overall Study|Withdrawal by Subject|4|||
37810030|NCT04537923|69471068|FG001|Overall Study|Withdrawal by Subject|4|||
37810031|NCT04537923|69471069|FG002|Overall Study|Withdrawal by Subject|4|||
37810032|NCT04537923|69471070|FG003|Overall Study|Withdrawal by Subject|58|||
37810033|NCT04537923|69471067|FG000|Overall Study|Missed study visits|2|||
37810034|NCT04537923|69471068|FG001|Overall Study|Missed study visits|0|||
37810035|NCT04537923|69471069|FG002|Overall Study|Missed study visits|0|||
37810036|NCT04537923|69471070|FG003|Overall Study|Missed study visits|3|||
37810037|NCT04537923|69471067|FG000|Overall Study|Sponsor's decision|0|||
37810038|NCT04537923|69471068|FG001|Overall Study|Sponsor's decision|0|||
37810039|NCT04537923|69471069|FG002|Overall Study|Sponsor's decision|1|||
37810040|NCT04537923|69471070|FG003|Overall Study|Sponsor's decision|1|||
37810041|NCT04537923|69471067|FG000|Overall Study|Safety reasons|1|||
37810042|NCT04537923|69471068|FG001|Overall Study|Safety reasons|0|||
37810043|NCT04537923|69471069|FG002|Overall Study|Safety reasons|0|||
37810044|NCT04537923|69471070|FG003|Overall Study|Safety reasons|0|||
37810045|NCT04428333|69471093|FG000|Overall Study|Physician Decision|2|||
37810046|NCT04428333|69471094|FG001|Overall Study|Physician Decision|0|||
37810047|NCT04428333|69471093|FG000|Overall Study|Withdrawal by Subject|0|||
37810048|NCT04428333|69471094|FG001|Overall Study|Withdrawal by Subject|1|||
37810049|NCT04428333|69471093|FG000|Overall Study|In Follow-Up|5|||
37810050|NCT04428333|69471094|FG001|Overall Study|In Follow-Up|10|||
37810051|NCT04428333|69471093|FG000|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|47|||
37810052|NCT04428333|69471094|FG001|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|47|||
37810053|NCT04160468|69471102|FG000|Overall Study|Lost to Follow-up|19|||
37810054|NCT04160468|69471103|FG001|Overall Study|Lost to Follow-up|4|||
37810055|NCT04160468|69471102|FG000|Overall Study|Randomized but not dosed|6|||
37810056|NCT04160468|69471103|FG001|Overall Study|Randomized but not dosed|0|||
37810057|NCT04160468|69471102|FG000|Overall Study|Withdrawal by Subject|4|||
37810058|NCT04160468|69471103|FG001|Overall Study|Withdrawal by Subject|1|||
37810059|NCT04160468|69471102|FG000|Overall Study|Participant unable/unwilling to adhere to protocol|1|||
37810060|NCT04160468|69471103|FG001|Overall Study|Participant unable/unwilling to adhere to protocol|0|||
37810061|NCT04160468|69471102|FG000|Overall Study|Participant incarcerated|1|||
37810062|NCT04160468|69471103|FG001|Overall Study|Participant incarcerated|0|||
37810063|NCT03761056|69471122|FG000|Overall Study|Still on Study|34|||
37810064|NCT03761056|69471122|FG000|Overall Study|Death|6|||
37810065|NCT03761056|69471122|FG000|Overall Study|Investigator Decision|1|||
37810066|NCT03761056|69471122|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|1|||
37810067|NCT03276572|69471144|FG000|Overall Study|In follow-up|0|||
37810068|NCT03276572|69471145|FG001|Overall Study|In follow-up|0|||
37810069|NCT03276572|69471146|FG002|Overall Study|In follow-up|0|||
37810070|NCT03276572|69471147|FG003|Overall Study|In follow-up|0|||
37810071|NCT03276572|69471148|FG004|Overall Study|In follow-up|0|||
37810072|NCT03276572|69471149|FG005|Overall Study|In follow-up|1|||
37810073|NCT03276572|69471150|FG006|Overall Study|In follow-up|1|||
37810074|NCT03276572|69471144|FG000|Overall Study|Lost to Follow-up|0|||
37810075|NCT03276572|69471145|FG001|Overall Study|Lost to Follow-up|0|||
37810076|NCT03276572|69471146|FG002|Overall Study|Lost to Follow-up|0|||
37810077|NCT03276572|69471147|FG003|Overall Study|Lost to Follow-up|0|||
37810078|NCT03276572|69471148|FG004|Overall Study|Lost to Follow-up|0|||
37810079|NCT03276572|69471149|FG005|Overall Study|Lost to Follow-up|0|||
37810080|NCT03276572|69471150|FG006|Overall Study|Lost to Follow-up|1|||
37810081|NCT02840877|69471176|FG000|Baseline to 12 Weeks|Withdrawal by Subject|11|||
37810082|NCT02840877|69471176|FG000|Baseline to 12 Weeks|Moved/Transferred out|5|||
37810083|NCT02840877|69471176|FG000|Baseline to 12 Weeks|Lost to Follow-up|2|||
37810084|NCT02840877|69471176|FG000|Baseline to 12 Weeks|Death|1|||
37810085|NCT02840877|69471176|FG000|Baseline to 12 Weeks|Changed treatment regimen, no longer on first line drugs.|1|||
37810086|NCT02840877|69471176|FG000|Baseline to 12 Weeks|Treatment extended due to bacterial meningitis.|1|||
37810087|NCT02840877|69471176|FG000|12 Weeks to 6 Months|Withdrawal by Subject|4|||
37810088|NCT02840877|69471176|FG000|12 Weeks to 6 Months|Treatment failure|1|||
37810089|NCT02840877|69471176|FG000|12 Weeks to 6 Months|Moved/transferred out|1|||
37810090|NCT02840877|69471176|FG000|12 Weeks to 6 Months|Lost to Follow-up|4|||
37810091|NCT02840877|69471176|FG000|12 Weeks to 6 Months|Death|1|||
37810092|NCT02840877|69471176|FG000|6 Months to 18 Months|Withdrawal by Subject|1|||
37810093|NCT02840877|69471176|FG000|6 Months to 18 Months|Treatment failure|7|||
37810094|NCT02840877|69471176|FG000|6 Months to 18 Months|Relapse/recurrence of TB|8|||
37810095|NCT02840877|69471176|FG000|6 Months to 18 Months|Moved/transferred out|6|||
37810096|NCT02840877|69471176|FG000|6 Months to 18 Months|Lost to Follow-up|24|||
37810097|NCT02840877|69471176|FG000|6 Months to 18 Months|Death|4|||
37810098|NCT02840877|69471176|FG000|6 Months to 18 Months|Diagnosed with multi-drug resistant tuberculosis.|1|||
37810099|NCT02840877|69471176|FG000|6 Months to 18 Months|Treatment stopped due to liver injury.|1|||
37810100|NCT02840877|69471176|FG000|6 Months to 18 Months|Still in study.|14|||
37810101|NCT02694185|69471182|FG000|Overall Study|Withdrawal by Subject|45|||
37810102|NCT02694185|69471183|FG001|Overall Study|Withdrawal by Subject|0|||
37810103|NCT02684903|69471191|FG000|Overall Study|COVID-19 shutdown of lab|4|||
37810104|NCT02684903|69471192|FG001|Overall Study|COVID-19 shutdown of lab|6|||
37810105|NCT02684903|69471191|FG000|Overall Study|Lost to Follow-up|31|||
37810106|NCT02684903|69471192|FG001|Overall Study|Lost to Follow-up|41|||
37810107|NCT02621424|69471207|FG000|Overall Study|Withdrawal by Subject|1|||
37810108|NCT02621424|69471208|FG001|Overall Study|Withdrawal by Subject|2|||
37810109|NCT02616185|69471223|FG000|Overall Study|Death|0|||
37810110|NCT02616185|69471224|FG001|Overall Study|Death|0|||
37810111|NCT02616185|69471225|FG002|Overall Study|Death|0|||
37810112|NCT02616185|69471226|FG003|Overall Study|Death|1|||
37810113|NCT02616185|69471227|FG004|Overall Study|Death|2|||
37810114|NCT02616185|69471228|FG005|Overall Study|Death|0|||
37810115|NCT02616185|69471229|FG006|Overall Study|Death|0|||
37810116|NCT02616185|69471230|FG007|Overall Study|Death|2|||
37810117|NCT02616185|69471231|FG008|Overall Study|Death|1|||
37810118|NCT02616185|69471223|FG000|Overall Study|Study terminated by sponsor|0|||
37810119|NCT02616185|69471224|FG001|Overall Study|Study terminated by sponsor|0|||
37810120|NCT02616185|69471225|FG002|Overall Study|Study terminated by sponsor|1|||
37810121|NCT02616185|69471226|FG003|Overall Study|Study terminated by sponsor|0|||
37810122|NCT02616185|69471227|FG004|Overall Study|Study terminated by sponsor|0|||
37810123|NCT02616185|69471228|FG005|Overall Study|Study terminated by sponsor|0|||
37810124|NCT02616185|69471229|FG006|Overall Study|Study terminated by sponsor|5|||
37864364|NCT01259492|69548037|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
37864365|NCT01259492|69548038|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
37810125|NCT02616185|69471230|FG007|Overall Study|Study terminated by sponsor|2|||
37810126|NCT02616185|69471231|FG008|Overall Study|Study terminated by sponsor|0|||
37864366|NCT01259492|69548039|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
37810127|NCT02616185|69471223|FG000|Overall Study|Participant refused further follow-up|1|||
37810128|NCT02616185|69471224|FG001|Overall Study|Participant refused further follow-up|1|||
37810129|NCT02616185|69471225|FG002|Overall Study|Participant refused further follow-up|2|||
37810130|NCT02616185|69471226|FG003|Overall Study|Participant refused further follow-up|3|||
37810131|NCT02616185|69471227|FG004|Overall Study|Participant refused further follow-up|4|||
37810132|NCT02616185|69471228|FG005|Overall Study|Participant refused further follow-up|0|||
37810133|NCT02616185|69471229|FG006|Overall Study|Participant refused further follow-up|3|||
37810134|NCT02616185|69471230|FG007|Overall Study|Participant refused further follow-up|4|||
37810135|NCT02616185|69471231|FG008|Overall Study|Participant refused further follow-up|3|||
37810136|NCT02616185|69471223|FG000|Overall Study|Not reported|0|||
37810137|NCT02616185|69471224|FG001|Overall Study|Not reported|0|||
37810138|NCT02616185|69471225|FG002|Overall Study|Not reported|0|||
37810139|NCT02616185|69471226|FG003|Overall Study|Not reported|1|||
37810140|NCT02616185|69471227|FG004|Overall Study|Not reported|3|||
37810141|NCT02616185|69471228|FG005|Overall Study|Not reported|1|||
37810142|NCT02616185|69471229|FG006|Overall Study|Not reported|0|||
37810143|NCT02616185|69471230|FG007|Overall Study|Not reported|5|||
37810144|NCT02616185|69471231|FG008|Overall Study|Not reported|2|||
37810145|NCT01967888|69471297|FG000|Overall Study|Lost to Follow-up|6|||
37810146|NCT01967888|69471298|FG001|Overall Study|Lost to Follow-up|4|||
37810147|NCT01967888|69471297|FG000|Overall Study|Withdrawal by Subject|1|||
37810148|NCT01967888|69471298|FG001|Overall Study|Withdrawal by Subject|1|||
37810149|NCT01967888|69471297|FG000|Overall Study|Did Not Have Transplant|1|||
37810150|NCT01967888|69471298|FG001|Overall Study|Did Not Have Transplant|0|||
37810151|NCT01967888|69471297|FG000|Overall Study|Research visit not done, data recorded|1|||
37694175|NCT02460224|69170383|FG006|Overall Study|Subject/guardian decision|0|||
37694176|NCT02460224|69170384|FG007|Overall Study|Subject/guardian decision|0|||
37694177|NCT02460224|69170385|FG008|Overall Study|Subject/guardian decision|1|||
37694178|NCT02460224|69170386|FG009|Overall Study|Subject/guardian decision|1|||
37810152|NCT01967888|69471298|FG001|Overall Study|Research visit not done, data recorded|0|||
37810153|NCT01967888|69471297|FG000|Overall Study|Subject excluded after randomization|1|||
37810154|NCT01967888|69471298|FG001|Overall Study|Subject excluded after randomization|0|||
37810155|NCT01967888|69471297|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
37810156|NCT01967888|69471298|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
37810157|NCT01967888|69471297|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
37810158|NCT01967888|69471298|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
37810159|NCT00653068|69471321|FG000|Overall Study|Death|9|||
37810160|NCT00653068|69471321|FG000|Overall Study|Lack of Efficacy|34|||
37810161|NCT00653068|69471321|FG000|Overall Study|Physician Decision|4|||
37810162|NCT00653068|69471321|FG000|Overall Study|Withdrawal by Subject|1|||
37810163|NCT00653068|69471321|FG000|Overall Study|Ineligible|2|||
37810164|NCT00414648|69471330|FG000|Overall Study|Adverse Event|5|||
37810165|NCT00414648|69471331|FG001|Overall Study|Adverse Event|5|||
37810166|NCT00414648|69471330|FG000|Overall Study|Death|0|||
37810167|NCT00414648|69471331|FG001|Overall Study|Death|1|||
37810168|NCT00414648|69471330|FG000|Overall Study|Lack of Efficacy|0|||
37810169|NCT00414648|69471331|FG001|Overall Study|Lack of Efficacy|2|||
37810170|NCT00414648|69471330|FG000|Overall Study|Withdrawal by Subject|0|||
37810171|NCT00414648|69471331|FG001|Overall Study|Withdrawal by Subject|1|||
37810172|NCT02538666|69471936|FG000|Pre-Treatment|Disease progression|1|||
37810173|NCT02538666|69471937|FG001|Pre-Treatment|Disease progression|0|||
37810174|NCT02538666|69471938|FG002|Pre-Treatment|Disease progression|0|||
37810175|NCT02538666|69471936|FG000|Pre-Treatment|no longer meets study criteria|1|||
37810176|NCT02538666|69471937|FG001|Pre-Treatment|no longer meets study criteria|0|||
37810177|NCT02538666|69471938|FG002|Pre-Treatment|no longer meets study criteria|0|||
37810178|NCT02538666|69471936|FG000|Pre-Treatment|Withdrew Consent|0|||
37810179|NCT02538666|69471937|FG001|Pre-Treatment|Withdrew Consent|1|||
37864367|NCT01259492|69548040|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
37864368|NCT01259492|69548037|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
37976961|NCT00548717|69664207|FG001|Overall Study|Alternative treatment for GVHD|0|||
37810180|NCT02538666|69471938|FG002|Pre-Treatment|Withdrew Consent|1|||
37810181|NCT02538666|69471936|FG000|Treatment|Disease progression|270|||
37810182|NCT02538666|69471937|FG001|Treatment|Disease progression|227|||
37810183|NCT02538666|69471938|FG002|Treatment|Disease progression|165|||
37810184|NCT02538666|69471936|FG000|Treatment|Study drug toxicity|1|||
37810185|NCT02538666|69471937|FG001|Treatment|Study drug toxicity|29|||
37810186|NCT02538666|69471938|FG002|Treatment|Study drug toxicity|92|||
37810187|NCT02538666|69471936|FG000|Treatment|Death|0|||
37810188|NCT02538666|69471937|FG001|Treatment|Death|2|||
37810189|NCT02538666|69471938|FG002|Treatment|Death|3|||
37810190|NCT02538666|69471936|FG000|Treatment|Adverse event unrelated to study drug|8|||
37810191|NCT02538666|69471937|FG001|Treatment|Adverse event unrelated to study drug|10|||
37810192|NCT02538666|69471938|FG002|Treatment|Adverse event unrelated to study drug|15|||
37810193|NCT02538666|69471936|FG000|Treatment|Participant request to discontinue study treatment|3|||
37694179|NCT02460224|69170387|FG010|Overall Study|Subject/guardian decision|0|||
37810194|NCT02538666|69471937|FG001|Treatment|Participant request to discontinue study treatment|6|||
37810195|NCT02538666|69471938|FG002|Treatment|Participant request to discontinue study treatment|11|||
37810196|NCT02538666|69471936|FG000|Treatment|Participant withdrew consent|2|||
37810197|NCT02538666|69471937|FG001|Treatment|Participant withdrew consent|5|||
37810198|NCT02538666|69471938|FG002|Treatment|Participant withdrew consent|3|||
37810199|NCT02538666|69471936|FG000|Treatment|Lost to Follow-up|0|||
37810200|NCT02538666|69471937|FG001|Treatment|Lost to Follow-up|1|||
37810201|NCT02538666|69471938|FG002|Treatment|Lost to Follow-up|1|||
37810202|NCT02538666|69471936|FG000|Treatment|Maximum clinical benefit|4|||
37810203|NCT02538666|69471937|FG001|Treatment|Maximum clinical benefit|3|||
37810204|NCT02538666|69471938|FG002|Treatment|Maximum clinical benefit|4|||
37810205|NCT02538666|69471936|FG000|Treatment|Poor/non-compliance|0|||
37810206|NCT02538666|69471937|FG001|Treatment|Poor/non-compliance|1|||
37810207|NCT02538666|69471938|FG002|Treatment|Poor/non-compliance|0|||
37810208|NCT02538666|69471936|FG000|Treatment|Participant no longer meets study criteria|0|||
37810209|NCT02538666|69471937|FG001|Treatment|Participant no longer meets study criteria|2|||
37810210|NCT02538666|69471938|FG002|Treatment|Participant no longer meets study criteria|0|||
37810211|NCT02538666|69471936|FG000|Treatment|Administrative reason by sponsor|0|||
37810212|NCT02538666|69471937|FG001|Treatment|Administrative reason by sponsor|0|||
37810213|NCT02538666|69471938|FG002|Treatment|Administrative reason by sponsor|1|||
37810214|NCT02538666|69471936|FG000|Treatment|Other reasons|8|||
37810215|NCT02538666|69471937|FG001|Treatment|Other reasons|15|||
37810216|NCT02538666|69471938|FG002|Treatment|Other reasons|5|||
37810217|NCT02538666|69471936|FG000|Treatment|Not reported|2|||
37810218|NCT02538666|69471937|FG001|Treatment|Not reported|2|||
37810219|NCT02538666|69471938|FG002|Treatment|Not reported|2|||
37810220|NCT02407236|69471992|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
37810221|NCT02407236|69471993|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
37810222|NCT02407236|69471994|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
37810223|NCT02407236|69471995|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
37810224|NCT02407236|69471996|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
37810225|NCT02407236|69471997|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
37810226|NCT02407236|69471998|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
37810227|NCT02407236|69471999|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
37810228|NCT02407236|69472000|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
37810229|NCT02407236|69472001|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
37810230|NCT02407236|69472002|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
37810231|NCT02407236|69472003|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
37810232|NCT02407236|69472004|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
37810233|NCT02407236|69471992|FG000|Induction Study (8 Weeks)|Death|0|||
37810234|NCT02407236|69471993|FG001|Induction Study (8 Weeks)|Death|0|||
37810235|NCT02407236|69471994|FG002|Induction Study (8 Weeks)|Death|1|||
37810236|NCT02407236|69471995|FG003|Induction Study (8 Weeks)|Death|0|||
37810237|NCT02407236|69471996|FG004|Induction Study (8 Weeks)|Death|0|||
37810238|NCT02407236|69471997|FG005|Induction Study (8 Weeks)|Death|0|||
37810239|NCT02407236|69471998|FG006|Induction Study (8 Weeks)|Death|0|||
37810240|NCT02407236|69471999|FG007|Induction Study (8 Weeks)|Death|0|||
37810241|NCT02407236|69472000|FG008|Induction Study (8 Weeks)|Death|0|||
37810242|NCT02407236|69472001|FG009|Induction Study (8 Weeks)|Death|0|||
37810243|NCT02407236|69472002|FG010|Induction Study (8 Weeks)|Death|0|||
37810244|NCT02407236|69472003|FG011|Induction Study (8 Weeks)|Death|0|||
37810245|NCT02407236|69472004|FG012|Induction Study (8 Weeks)|Death|0|||
37864369|NCT01259492|69548038|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
37976962|NCT00441168|69664218|FG000|Treatment Period|Death|3|||
37810246|NCT02407236|69471992|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
37810247|NCT02407236|69471993|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
37810248|NCT02407236|69471994|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
37810249|NCT02407236|69471995|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
37810250|NCT02407236|69471996|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
37810251|NCT02407236|69471997|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
37810252|NCT02407236|69471998|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
37810253|NCT02407236|69471999|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
37810254|NCT02407236|69472000|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
37810255|NCT02407236|69472001|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
37810256|NCT02407236|69472002|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
37810257|NCT02407236|69472003|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
37976963|NCT00441168|69664219|FG001|Treatment Period|Death|0|||
37810258|NCT02407236|69472004|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
37810259|NCT02407236|69471992|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
37810260|NCT02407236|69471993|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
37810261|NCT02407236|69471994|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
37810262|NCT02407236|69471995|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
37976964|NCT00441168|69664218|FG000|Treatment Period|Adverse Event|1|||
37810263|NCT02407236|69471996|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
37810264|NCT02407236|69471997|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
37810265|NCT02407236|69471998|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
37810266|NCT02407236|69471999|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
37810267|NCT02407236|69472000|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
37810268|NCT02407236|69472001|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
37810269|NCT02407236|69472002|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
37810270|NCT02407236|69472003|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
37810271|NCT02407236|69472004|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
37810272|NCT02407236|69471992|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
37810273|NCT02407236|69471993|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
37810274|NCT02407236|69471994|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
37810275|NCT02407236|69471995|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
37810276|NCT02407236|69471996|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
37810277|NCT02407236|69471997|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
37810278|NCT02407236|69471998|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
37810279|NCT02407236|69471999|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
37810280|NCT02407236|69472000|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
37810281|NCT02407236|69472001|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
37810282|NCT02407236|69472002|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
37810283|NCT02407236|69472003|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
37810284|NCT02407236|69472004|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
37810285|NCT02407236|69471992|FG000|Induction Study (8 Weeks)|Other|2|||
37810286|NCT02407236|69471993|FG001|Induction Study (8 Weeks)|Other|1|||
37810287|NCT02407236|69471994|FG002|Induction Study (8 Weeks)|Other|5|||
37810288|NCT02407236|69471995|FG003|Induction Study (8 Weeks)|Other|0|||
37810289|NCT02407236|69471996|FG004|Induction Study (8 Weeks)|Other|0|||
37810290|NCT02407236|69471997|FG005|Induction Study (8 Weeks)|Other|0|||
37810291|NCT02407236|69471998|FG006|Induction Study (8 Weeks)|Other|0|||
37810292|NCT02407236|69471999|FG007|Induction Study (8 Weeks)|Other|0|||
37810293|NCT02407236|69472000|FG008|Induction Study (8 Weeks)|Other|0|||
37810294|NCT02407236|69472001|FG009|Induction Study (8 Weeks)|Other|0|||
37810295|NCT02407236|69472002|FG010|Induction Study (8 Weeks)|Other|0|||
37810296|NCT02407236|69472003|FG011|Induction Study (8 Weeks)|Other|0|||
37810297|NCT02407236|69472004|FG012|Induction Study (8 Weeks)|Other|0|||
37810298|NCT02407236|69471992|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
37810299|NCT02407236|69471993|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
37810300|NCT02407236|69471994|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
37810301|NCT02407236|69471995|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
37810302|NCT02407236|69471996|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
37810303|NCT02407236|69471997|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
37810304|NCT02407236|69471998|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
37810305|NCT02407236|69471999|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
37810306|NCT02407236|69472000|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
37810307|NCT02407236|69472001|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
37810308|NCT02407236|69472002|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
37810309|NCT02407236|69472003|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
37810310|NCT02407236|69472004|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
37810311|NCT02407236|69471992|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
37810312|NCT02407236|69471993|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
37810313|NCT02407236|69471994|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
37810314|NCT02407236|69471995|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
37810315|NCT02407236|69471996|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
37810316|NCT02407236|69471997|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
37810317|NCT02407236|69471998|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
37810318|NCT02407236|69471999|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
37810319|NCT02407236|69472000|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
37810320|NCT02407236|69472001|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
37810321|NCT02407236|69472002|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
37810322|NCT02407236|69472003|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
37810323|NCT02407236|69472004|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
37810324|NCT02407236|69471992|FG000|Maintenance Study (44 Weeks)|Other|0|||
37810325|NCT02407236|69471993|FG001|Maintenance Study (44 Weeks)|Other|0|||
37810326|NCT02407236|69471994|FG002|Maintenance Study (44 Weeks)|Other|0|||
37810327|NCT02407236|69471995|FG003|Maintenance Study (44 Weeks)|Other|5|||
37810328|NCT02407236|69471996|FG004|Maintenance Study (44 Weeks)|Other|7|||
37976965|NCT00441168|69664219|FG001|Treatment Period|Adverse Event|2|||
37976966|NCT00441168|69664218|FG000|Treatment Period|Progressive Disease|0|||
37976967|NCT00441168|69664219|FG001|Treatment Period|Progressive Disease|2|||
37976968|NCT00441168|69664218|FG000|Treatment Period|Protocol Violation|0|||
37976969|NCT00441168|69664219|FG001|Treatment Period|Protocol Violation|1|||
37976970|NCT00441168|69664218|FG000|Treatment Period|Lost to Follow-up|0|||
37976971|NCT00441168|69664219|FG001|Treatment Period|Lost to Follow-up|1|||
37976972|NCT00441168|69664218|FG000|Treatment Period|Withdrawal by Subject|3|||
37976973|NCT00441168|69664219|FG001|Treatment Period|Withdrawal by Subject|0|||
37976974|NCT00441168|69664218|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
37976975|NCT00441168|69664219|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
37976976|NCT00441168|69664218|FG000|Treatment Period|refractory disease|1|||
37976977|NCT00441168|69664219|FG001|Treatment Period|refractory disease|0|||
37976978|NCT00441168|69664218|FG000|Follow-up Period|Death|3|||
37976979|NCT00441168|69664219|FG001|Follow-up Period|Death|0|||
37976980|NCT00441168|69664218|FG000|Follow-up Period|Lost to Follow-up|5|||
37976981|NCT00441168|69664219|FG001|Follow-up Period|Lost to Follow-up|6|||
37976982|NCT00441168|69664218|FG000|Follow-up Period|Withdrawal by Subject|3|||
37976983|NCT00441168|69664219|FG001|Follow-up Period|Withdrawal by Subject|0|||
37976984|NCT00441168|69664218|FG000|Follow-up Period|Other|1|||
37976985|NCT00441168|69664219|FG001|Follow-up Period|Other|3|||
37976986|NCT00296140|69664227|FG000|Overall Study|Lost to Follow-up|1|||
37976987|NCT00296140|69664228|FG001|Overall Study|Lost to Follow-up|0|||
37976988|NCT00296140|69664227|FG000|Overall Study|Withdrawal by Subject|1|||
37976989|NCT00296140|69664228|FG001|Overall Study|Withdrawal by Subject|0|||
37976990|NCT00296140|69664227|FG000|Overall Study|Discharge to Nursing Home|1|||
37810329|NCT02407236|69471997|FG005|Maintenance Study (44 Weeks)|Other|8|||
37810330|NCT02407236|69471998|FG006|Maintenance Study (44 Weeks)|Other|4|||
37976991|NCT00296140|69664228|FG001|Overall Study|Discharge to Nursing Home|0|||
37976992|NCT03958331|69664237|FG000|Overall Study|Withdrawal by Subject|3|||
37976993|NCT03958331|69664238|FG001|Overall Study|Withdrawal by Subject|1|||
37810331|NCT02407236|69471999|FG007|Maintenance Study (44 Weeks)|Other|6|||
37810332|NCT02407236|69472000|FG008|Maintenance Study (44 Weeks)|Other|0|||
37810333|NCT02407236|69472001|FG009|Maintenance Study (44 Weeks)|Other|0|||
37810334|NCT02407236|69472002|FG010|Maintenance Study (44 Weeks)|Other|0|||
37810335|NCT02407236|69472003|FG011|Maintenance Study (44 Weeks)|Other|0|||
37810336|NCT02407236|69472004|FG012|Maintenance Study (44 Weeks)|Other|0|||
37810337|NCT02407236|69471992|FG000|Maintenance Study (44 Weeks)|Death|0|||
37810338|NCT02407236|69471993|FG001|Maintenance Study (44 Weeks)|Death|0|||
37810339|NCT02407236|69471994|FG002|Maintenance Study (44 Weeks)|Death|0|||
37810340|NCT02407236|69471995|FG003|Maintenance Study (44 Weeks)|Death|0|||
37810341|NCT02407236|69471996|FG004|Maintenance Study (44 Weeks)|Death|0|||
37810342|NCT02407236|69471997|FG005|Maintenance Study (44 Weeks)|Death|0|||
37810343|NCT02407236|69471998|FG006|Maintenance Study (44 Weeks)|Death|0|||
37810344|NCT02407236|69471999|FG007|Maintenance Study (44 Weeks)|Death|1|||
37810345|NCT02407236|69472000|FG008|Maintenance Study (44 Weeks)|Death|0|||
37810346|NCT02407236|69472001|FG009|Maintenance Study (44 Weeks)|Death|0|||
37810347|NCT02407236|69472002|FG010|Maintenance Study (44 Weeks)|Death|0|||
37810348|NCT02407236|69472003|FG011|Maintenance Study (44 Weeks)|Death|0|||
37810349|NCT02407236|69472004|FG012|Maintenance Study (44 Weeks)|Death|0|||
37810350|NCT02407236|69471992|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
37810351|NCT02407236|69471993|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
37810352|NCT02407236|69471994|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
37810353|NCT02407236|69471995|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
37810354|NCT02407236|69471996|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
37810355|NCT02407236|69471997|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
37810356|NCT02407236|69471998|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
37810357|NCT02407236|69471999|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
37810358|NCT02407236|69472000|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
37810359|NCT02407236|69472001|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
37810360|NCT02407236|69472002|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
37810361|NCT02407236|69472003|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
37810362|NCT02407236|69472004|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
37810363|NCT02407236|69471992|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
37810364|NCT02407236|69471993|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
37810365|NCT02407236|69471994|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
37810366|NCT02407236|69471995|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
37864370|NCT01259492|69548039|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
37976994|NCT03958331|69664239|FG002|Overall Study|Withdrawal by Subject|5|||
37976995|NCT03958331|69664237|FG000|Overall Study|Weaned from medicine|2|||
37976996|NCT03958331|69664238|FG001|Overall Study|Weaned from medicine|0|||
37976997|NCT03958331|69664239|FG002|Overall Study|Weaned from medicine|0|||
37976998|NCT03958331|69664237|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
37976999|NCT03958331|69664238|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
37977000|NCT03958331|69664239|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
37977001|NCT03956615|69664245|FG000|Overall Study|No multiple myeloma confirmed|2|||
37977002|NCT03956615|69664245|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
37977003|NCT03956615|69664245|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
37977004|NCT03956615|69664245|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
37977005|NCT03956225|69664251|FG000|Overall Study|Lack of Efficacy|1|||
37977006|NCT03956225|69664252|FG001|Overall Study|Lack of Efficacy|1|||
37977007|NCT03956225|69664251|FG000|Overall Study|Lost to Follow-up|0|||
37977008|NCT03956225|69664252|FG001|Overall Study|Lost to Follow-up|1|||
37977009|NCT03956225|69664251|FG000|Overall Study|Withdrawal by Subject|2|||
37977010|NCT03956225|69664252|FG001|Overall Study|Withdrawal by Subject|1|||
37977011|NCT03956225|69664251|FG000|Overall Study|Other Reasons|2|||
37977012|NCT03956225|69664252|FG001|Overall Study|Other Reasons|1|||
37977013|NCT00457626|69664261|FG000|Overall Study|Adverse Event|3|||
37977014|NCT00457626|69664261|FG000|Overall Study|Administrative Problems|2|||
37977015|NCT00457626|69664261|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
37977016|NCT00373113|69664267|FG000|Overall Study|Death|1|||
37977017|NCT00373113|69664268|FG001|Overall Study|Death|7|||
37977018|NCT00373113|69664267|FG000|Overall Study|Adverse Event|38|||
37977019|NCT00373113|69664268|FG001|Overall Study|Adverse Event|24|||
37810367|NCT02407236|69471996|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
37810368|NCT02407236|69471997|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
37810369|NCT02407236|69471998|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
37810370|NCT02407236|69471999|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
37810371|NCT02407236|69472000|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
37810372|NCT02407236|69472001|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
37810373|NCT02407236|69472002|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
37810374|NCT02407236|69472003|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
37810375|NCT02407236|69472004|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
37810376|NCT02407236|69471992|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
37810377|NCT02407236|69471993|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
37810378|NCT02407236|69471994|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
37810379|NCT02407236|69471995|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
37810380|NCT02407236|69471996|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
37810381|NCT02407236|69471997|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
37810382|NCT02407236|69471998|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
37810383|NCT02407236|69471999|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
37810384|NCT02407236|69472000|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
37810385|NCT02407236|69472001|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
37810386|NCT02407236|69472002|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
37810387|NCT02407236|69472003|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
37977020|NCT00373113|69664267|FG000|Overall Study|Study terminated by sponsor|9|||
37977021|NCT00373113|69664268|FG001|Overall Study|Study terminated by sponsor|1|||
37977022|NCT00373113|69664267|FG000|Overall Study|Global deterioration of health status|10|||
37977023|NCT00373113|69664268|FG001|Overall Study|Global deterioration of health status|7|||
37810388|NCT02407236|69472004|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
37810389|NCT02407236|69471992|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
37810390|NCT02407236|69471993|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
37694180|NCT02460224|69170388|FG011|Overall Study|Subject/guardian decision|1|||
37694181|NCT02460224|69170389|FG012|Overall Study|Subject/guardian decision|0|||
37694182|NCT02460224|69170390|FG013|Overall Study|Subject/guardian decision|0|||
37694183|NCT02460224|69170391|FG014|Overall Study|Subject/guardian decision|0|||
37694184|NCT02460224|69170392|FG015|Overall Study|Subject/guardian decision|1|||
37694185|NCT02460224|69170393|FG016|Overall Study|Subject/guardian decision|0|||
37694186|NCT02460224|69170394|FG017|Overall Study|Subject/guardian decision|1|||
37810391|NCT02407236|69471994|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
37810392|NCT02407236|69471995|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
37810393|NCT02407236|69471996|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
37810394|NCT02407236|69471997|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
37810395|NCT02407236|69471998|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
37977024|NCT00373113|69664267|FG000|Overall Study|Lost to Follow-up|1|||
37977025|NCT00373113|69664268|FG001|Overall Study|Lost to Follow-up|3|||
37977026|NCT00373113|69664267|FG000|Overall Study|Objective progression or relapse|150|||
37977027|NCT00373113|69664268|FG001|Overall Study|Objective progression or relapse|169|||
37977028|NCT00373113|69664267|FG000|Overall Study|Other|14|||
37977029|NCT00373113|69664268|FG001|Overall Study|Other|17|||
37977030|NCT00373113|69664267|FG000|Overall Study|Protocol Violation|5|||
37977031|NCT00373113|69664268|FG001|Overall Study|Protocol Violation|1|||
37977032|NCT00373113|69664267|FG000|Overall Study|Withdrawal by Subject|10|||
37977033|NCT00373113|69664268|FG001|Overall Study|Withdrawal by Subject|15|||
37977034|NCT00407511|69664274|FG000|Overall Study|Adverse Event|9|||
37977035|NCT00407511|69664274|FG000|Overall Study|Lost to Follow-up|4|||
37977036|NCT00407511|69664274|FG000|Overall Study|Other|5|||
37977037|NCT00407511|69664274|FG000|Overall Study|Withdrawal by Subject|4|||
37977038|NCT00384189|69664282|FG000|Overall Study|Reason Not Specified|50|||
37977039|NCT00384189|69664283|FG001|Overall Study|Reason Not Specified|57|||
37977040|NCT00384189|69664284|FG002|Overall Study|Reason Not Specified|58|||
37977041|NCT00384189|69664285|FG003|Overall Study|Reason Not Specified|40|||
37977042|NCT00326716|69664297|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
37977043|NCT00326716|69664298|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
37977044|NCT00326716|69664299|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
37977045|NCT00326716|69664300|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
37977046|NCT00548405|69664333|FG000|Overall Study|Adverse Event|6|||
37977047|NCT00548405|69664334|FG001|Overall Study|Adverse Event|2|||
37694187|NCT02460224|69170395|FG018|Overall Study|Subject/guardian decision|2|||
37694188|NCT02460224|69170396|FG019|Overall Study|Subject/guardian decision|0|||
37977048|NCT00548405|69664335|FG002|Overall Study|Adverse Event|0|||
37977049|NCT00548405|69664333|FG000|Overall Study|Lack of Efficacy|6|||
37977050|NCT00548405|69664334|FG001|Overall Study|Lack of Efficacy|0|||
37977051|NCT00548405|69664335|FG002|Overall Study|Lack of Efficacy|0|||
37977052|NCT00548405|69664333|FG000|Overall Study|Physician Decision|3|||
37694189|NCT02460224|69170397|FG020|Overall Study|Subject/guardian decision|0|||
37694190|NCT02460224|69170398|FG021|Overall Study|Subject/guardian decision|1|||
37694191|NCT02460224|69170399|FG022|Overall Study|Subject/guardian decision|0|||
37977053|NCT00548405|69664334|FG001|Overall Study|Physician Decision|4|||
37977054|NCT00548405|69664335|FG002|Overall Study|Physician Decision|1|||
37977055|NCT00548405|69664333|FG000|Overall Study|Pregnancy|1|||
37977056|NCT00548405|69664334|FG001|Overall Study|Pregnancy|0|||
37977057|NCT00548405|69664335|FG002|Overall Study|Pregnancy|0|||
37977058|NCT00548405|69664333|FG000|Overall Study|Protocol Violation|1|||
37694192|NCT02460224|69170400|FG023|Overall Study|Subject/guardian decision|0|||
37694193|NCT02460224|69170401|FG024|Overall Study|Subject/guardian decision|0|||
37810396|NCT02407236|69471999|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
37810397|NCT02407236|69472000|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
37810398|NCT02407236|69472001|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
37810399|NCT02407236|69472002|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
37810400|NCT02407236|69472003|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
37810401|NCT02407236|69472004|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
37810402|NCT01893138|69472032|FG000|Double-Blind Period|Withdrawal by Subject|1|||
37810403|NCT01893138|69472033|FG001|Double-Blind Period|Withdrawal by Subject|1|||
37810404|NCT01893138|69472032|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
37810405|NCT01893138|69472033|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
37810406|NCT01893138|69472032|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
37810407|NCT01893138|69472033|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
37694194|NCT02460224|69170402|FG025|Overall Study|Subject/guardian decision|0|||
37694195|NCT02460224|69170403|FG026|Overall Study|Subject/guardian decision|6|||
37694196|NCT02460224|69170404|FG027|Overall Study|Subject/guardian decision|2|||
37694197|NCT02460224|69170405|FG028|Overall Study|Subject/guardian decision|3|||
37694198|NCT02094573|69170479|FG000|Overall Study|Adverse Event|4|||
37694199|NCT02094573|69170480|FG001|Overall Study|Adverse Event|14|||
37694200|NCT02094573|69170479|FG000|Overall Study|Clinical Progressive Disease|9|||
37694201|NCT02094573|69170480|FG001|Overall Study|Clinical Progressive Disease|13|||
37810408|NCT01893138|69472032|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
37810409|NCT01893138|69472033|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
37810410|NCT01893138|69472032|FG000|Open Label - Unblinded Period|Adverse Event|1|||
37810411|NCT01893138|69472033|FG001|Open Label - Unblinded Period|Adverse Event|0|||
37810412|NCT04309500|69472045|FG000|Overall Study|Lost to Follow-up|1|||
37810413|NCT04309500|69472046|FG001|Overall Study|Lost to Follow-up|0|||
37810414|NCT04309500|69472047|FG002|Overall Study|Lost to Follow-up|0|||
37810415|NCT04309500|69472048|FG003|Overall Study|Lost to Follow-up|0|||
37810416|NCT03671304|69473383|FG000|Overall Study|study terminated|7|||
37810417|NCT03517722|69473389|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
37810418|NCT03517722|69473390|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
37810419|NCT03517722|69473389|FG000|Double Blind Period: Week 0-52|Death|0|||
37810420|NCT03517722|69473390|FG001|Double Blind Period: Week 0-52|Death|4|||
37810421|NCT03517722|69473389|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
37810422|NCT03517722|69473390|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
37810423|NCT03517722|69473389|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
37810424|NCT03517722|69473390|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
37810425|NCT03517722|69473389|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
37810426|NCT03517722|69473390|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
37810427|NCT03517722|69473389|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
37810428|NCT03517722|69473390|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
37810429|NCT03517722|69473389|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
37810430|NCT03517722|69473390|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
37810431|NCT03517722|69473389|FG000|Double Blind Period: Week 0-52|Other|4|||
37810432|NCT03517722|69473390|FG001|Double Blind Period: Week 0-52|Other|3|||
37810433|NCT03517722|69473389|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
37810434|NCT03517722|69473390|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
37810435|NCT03517722|69473389|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
37810436|NCT03517722|69473390|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
37810437|NCT03517722|69473389|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
37810438|NCT03517722|69473390|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
37810439|NCT03517722|69473389|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
37810440|NCT03517722|69473390|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
37977059|NCT00548405|69664334|FG001|Overall Study|Protocol Violation|0|||
37977060|NCT00548405|69664335|FG002|Overall Study|Protocol Violation|0|||
37694202|NCT02094573|69170479|FG000|Overall Study|Death|11|||
37694203|NCT02094573|69170480|FG001|Overall Study|Death|3|||
37977061|NCT00548405|69664333|FG000|Overall Study|Withdrawal by Subject|36|||
37694204|NCT02094573|69170479|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
37810441|NCT03517722|69473389|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
37810442|NCT03517722|69473390|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
37810443|NCT03447990|69473404|FG000|Overall Study|Withdrawal by Subject|0|||
37810444|NCT03447990|69473405|FG001|Overall Study|Withdrawal by Subject|0|||
37810445|NCT03447990|69473406|FG002|Overall Study|Withdrawal by Subject|0|||
37810446|NCT03447990|69473407|FG003|Overall Study|Withdrawal by Subject|0|||
37810447|NCT03447990|69473408|FG004|Overall Study|Withdrawal by Subject|0|||
37810448|NCT03447990|69473409|FG005|Overall Study|Withdrawal by Subject|0|||
37810449|NCT03447990|69473410|FG006|Overall Study|Withdrawal by Subject|1|||
37810450|NCT01376778|69473462|FG000|Overall Study|Lost to Follow-up|3|||
37810451|NCT01376778|69473463|FG001|Overall Study|Lost to Follow-up|2|||
37810452|NCT01074294|69473472|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
37810453|NCT01074294|69473473|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
37810454|NCT01074294|69473474|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
37810455|NCT01074294|69473475|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
37810456|NCT01074294|69473472|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
37810457|NCT01074294|69473473|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
37810458|NCT01074294|69473474|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
37810459|NCT01074294|69473475|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
37810460|NCT01074294|69473472|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
37810461|NCT01074294|69473473|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
37810462|NCT01074294|69473474|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
37810463|NCT01074294|69473475|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
37810464|NCT01074294|69473472|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
37810465|NCT01074294|69473473|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
37810466|NCT01074294|69473474|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
37810467|NCT01074294|69473475|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
37810468|NCT01074294|69473472|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
37810469|NCT01074294|69473473|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
37810470|NCT01074294|69473474|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
37810471|NCT01074294|69473475|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
37810472|NCT01074294|69473472|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
37810473|NCT01074294|69473473|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
37977062|NCT00548405|69664334|FG001|Overall Study|Withdrawal by Subject|12|||
37977063|NCT00548405|69664335|FG002|Overall Study|Withdrawal by Subject|5|||
37977064|NCT00548405|69664333|FG000|Overall Study|Lost to Follow-up|1|||
37977065|NCT00548405|69664334|FG001|Overall Study|Lost to Follow-up|1|||
37977066|NCT00548405|69664335|FG002|Overall Study|Lost to Follow-up|2|||
37810474|NCT01074294|69473474|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
37810475|NCT01074294|69473475|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
37810476|NCT01074294|69473472|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
37810477|NCT01074294|69473473|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
37810478|NCT01074294|69473474|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
37810479|NCT01074294|69473475|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
37810480|NCT01074294|69473472|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
37810481|NCT01074294|69473473|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
37810482|NCT01074294|69473474|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
37810483|NCT01074294|69473475|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
37810484|NCT01074294|69473472|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
37810485|NCT01074294|69473473|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
37977067|NCT00548405|69664333|FG000|Overall Study|Death|0|||
37977068|NCT00548405|69664334|FG001|Overall Study|Death|1|||
37977069|NCT00548405|69664335|FG002|Overall Study|Death|1|||
37977070|NCT00548405|69664333|FG000|Overall Study|Sponsor decision|1|||
37977071|NCT00548405|69664334|FG001|Overall Study|Sponsor decision|0|||
37810486|NCT01074294|69473474|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
37810487|NCT01074294|69473475|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
37810488|NCT01074294|69473472|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
37810489|NCT01074294|69473473|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
37977072|NCT00548405|69664335|FG002|Overall Study|Sponsor decision|0|||
37810490|NCT01074294|69473474|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
37977073|NCT00548405|69664333|FG000|Overall Study|Randomized but not treated|1|||
37977074|NCT00548405|69664334|FG001|Overall Study|Randomized but not treated|0|||
37977075|NCT00548405|69664335|FG002|Overall Study|Randomized but not treated|0|||
37977076|NCT00295750|69664347|FG000|Overall Study|Adverse Event|19|||
37977077|NCT00295750|69664348|FG001|Overall Study|Adverse Event|15|||
37977078|NCT00295750|69664349|FG002|Overall Study|Adverse Event|12|||
37977079|NCT00295750|69664347|FG000|Overall Study|Lack of Efficacy|1|||
37977080|NCT00295750|69664348|FG001|Overall Study|Lack of Efficacy|1|||
37810491|NCT01074294|69473475|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
37810492|NCT01074294|69473472|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
37810493|NCT01074294|69473473|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
37810494|NCT01074294|69473474|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
37810495|NCT01074294|69473475|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
37810496|NCT01074294|69473472|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
37977081|NCT00295750|69664349|FG002|Overall Study|Lack of Efficacy|0|||
37977082|NCT00295750|69664347|FG000|Overall Study|Lost to Follow-up|1|||
37977083|NCT00295750|69664348|FG001|Overall Study|Lost to Follow-up|4|||
37977084|NCT00295750|69664349|FG002|Overall Study|Lost to Follow-up|1|||
37977085|NCT00295750|69664347|FG000|Overall Study|Taking prohibited therapy|2|||
37977086|NCT00295750|69664348|FG001|Overall Study|Taking prohibited therapy|3|||
37977087|NCT00295750|69664349|FG002|Overall Study|Taking prohibited therapy|2|||
37977088|NCT00295750|69664347|FG000|Overall Study|Administrative errors|2|||
37977089|NCT00295750|69664348|FG001|Overall Study|Administrative errors|4|||
37977090|NCT00295750|69664349|FG002|Overall Study|Administrative errors|5|||
37977091|NCT00295750|69664347|FG000|Overall Study|Trial drug errors|1|||
37977092|NCT00295750|69664348|FG001|Overall Study|Trial drug errors|1|||
37977093|NCT00295750|69664349|FG002|Overall Study|Trial drug errors|0|||
37810497|NCT01074294|69473473|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
37810498|NCT01074294|69473474|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
37810499|NCT01074294|69473475|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
37810500|NCT01074294|69473472|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
37810501|NCT01074294|69473473|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
37810502|NCT01074294|69473474|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
37810503|NCT01074294|69473475|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
37810504|NCT04753437|69474464|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
37810505|NCT04753437|69474465|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
37810506|NCT04753437|69474464|FG000|Overall Study|Liver Function Test Abnormalities|2|||
37810507|NCT04753437|69474465|FG001|Overall Study|Liver Function Test Abnormalities|4|||
37810508|NCT04605094|69474473|FG000|Overall Study|Adverse Event|2|||
37810509|NCT04605094|69474474|FG001|Overall Study|Adverse Event|2|||
37810510|NCT04605094|69474473|FG000|Overall Study|Lost to Follow-up|1|||
37810511|NCT04605094|69474474|FG001|Overall Study|Lost to Follow-up|4|||
37810512|NCT04605094|69474473|FG000|Overall Study|Physician Decision|2|||
37810513|NCT04605094|69474474|FG001|Overall Study|Physician Decision|2|||
37810514|NCT04605094|69474473|FG000|Overall Study|Study terminated by Sponsor|31|||
37810515|NCT04605094|69474474|FG001|Overall Study|Study terminated by Sponsor|33|||
37810516|NCT04605094|69474473|FG000|Overall Study|Withdrawal by Subject|22|||
37810517|NCT04605094|69474474|FG001|Overall Study|Withdrawal by Subject|19|||
37810518|NCT04605094|69474473|FG000|Overall Study|Other|1|||
37810519|NCT04605094|69474474|FG001|Overall Study|Other|1|||
37810520|NCT04526210|69474483|FG000|Overall Study|Sponsor decision|7|||
37810521|NCT04526210|69474484|FG001|Overall Study|Sponsor decision|5|||
37810522|NCT04526210|69474483|FG000|Overall Study|Withdrawal by Subject|3|||
37810523|NCT04526210|69474484|FG001|Overall Study|Withdrawal by Subject|2|||
37810524|NCT04149964|69474502|FG000|Overall Study|Lost to Follow-up|19|||
37810525|NCT04149964|69474503|FG001|Overall Study|Lost to Follow-up|18|||
37810526|NCT03842969|69474529|FG000|Overall Study|Participant declined follow-up visit|0|||
37810527|NCT03842969|69474530|FG001|Overall Study|Participant declined follow-up visit|1|||
37810528|NCT03842969|69474531|FG002|Overall Study|Participant declined follow-up visit|0|||
37810529|NCT03842969|69474529|FG000|Overall Study|Sponsor's decision|12|||
37810530|NCT03842969|69474530|FG001|Overall Study|Sponsor's decision|99|||
37810531|NCT03842969|69474531|FG002|Overall Study|Sponsor's decision|61|||
37810532|NCT03842969|69474529|FG000|Overall Study|Pregnancy|0|||
37977094|NCT00295750|69664347|FG000|Overall Study|Disease progression|2|||
37810533|NCT03842969|69474530|FG001|Overall Study|Pregnancy|0|||
37810534|NCT03842969|69474531|FG002|Overall Study|Pregnancy|1|||
37977095|NCT00295750|69664348|FG001|Overall Study|Disease progression|1|||
37977096|NCT00295750|69664349|FG002|Overall Study|Disease progression|0|||
37977097|NCT00295750|69664347|FG000|Overall Study|Personal reasons|0|||
37977098|NCT00295750|69664348|FG001|Overall Study|Personal reasons|1|||
37810535|NCT03842969|69474529|FG000|Overall Study|Death|1|||
37810536|NCT03842969|69474530|FG001|Overall Study|Death|0|||
37810537|NCT03842969|69474531|FG002|Overall Study|Death|1|||
37810538|NCT03842969|69474529|FG000|Overall Study|Withdrawal by Subject|3|||
37810539|NCT03842969|69474530|FG001|Overall Study|Withdrawal by Subject|30|||
37810540|NCT03842969|69474531|FG002|Overall Study|Withdrawal by Subject|18|||
37810541|NCT03842969|69474529|FG000|Overall Study|Protocol Violation|1|||
37810542|NCT03842969|69474530|FG001|Overall Study|Protocol Violation|1|||
37810543|NCT03842969|69474531|FG002|Overall Study|Protocol Violation|0|||
37810544|NCT03842969|69474529|FG000|Overall Study|Physician Decision|0|||
37810545|NCT03842969|69474530|FG001|Overall Study|Physician Decision|3|||
37810546|NCT03842969|69474531|FG002|Overall Study|Physician Decision|0|||
37810547|NCT03842969|69474529|FG000|Overall Study|Lost to Follow-up|0|||
37810548|NCT03842969|69474530|FG001|Overall Study|Lost to Follow-up|2|||
37810549|NCT03842969|69474531|FG002|Overall Study|Lost to Follow-up|0|||
37810550|NCT03842969|69474529|FG000|Overall Study|Adverse Event|0|||
37977099|NCT00295750|69664349|FG002|Overall Study|Personal reasons|0|||
37864371|NCT01259492|69548040|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
37864372|NCT01259492|69548037|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
37864373|NCT01259492|69548038|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
37864374|NCT01259492|69548039|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
37864375|NCT01259492|69548040|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
37864376|NCT01259492|69548037|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
37864377|NCT01259492|69548038|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
37864378|NCT01259492|69548039|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
37977100|NCT00295750|69664347|FG000|Overall Study|Randomized but never received trial drug|4|||
37977101|NCT00295750|69664348|FG001|Overall Study|Randomized but never received trial drug|3|||
37977102|NCT00295750|69664349|FG002|Overall Study|Randomized but never received trial drug|3|||
37977103|NCT00295750|69664347|FG000|Overall Study|Withdrawal by Subject|9|||
37977104|NCT00295750|69664348|FG001|Overall Study|Withdrawal by Subject|4|||
37977105|NCT00295750|69664349|FG002|Overall Study|Withdrawal by Subject|7|||
37810551|NCT03842969|69474530|FG001|Overall Study|Adverse Event|2|||
37810552|NCT03842969|69474531|FG002|Overall Study|Adverse Event|0|||
37810553|NCT02938520|69474554|FG000|Overall Study|On-going at the time of analysis|258|||
37810554|NCT02938520|69474555|FG001|Overall Study|On-going at the time of analysis|261|||
37977106|NCT00295750|69664347|FG000|Overall Study|Protocol Violation|2|||
37977107|NCT00295750|69664348|FG001|Overall Study|Protocol Violation|4|||
37977108|NCT00295750|69664349|FG002|Overall Study|Protocol Violation|2|||
37977109|NCT03948581|69664359|FG000|Overall Study|Lost to Follow-up|0|||
37977110|NCT03948581|69664360|FG001|Overall Study|Lost to Follow-up|1|||
37977111|NCT00548327|69664368|FG000|Overall Study|Adverse Event|0|||
37977112|NCT00548327|69664369|FG001|Overall Study|Adverse Event|1|||
37977113|NCT03953183|69664391|FG000|Overall Study|Physician Decision|0|||
37977114|NCT03953183|69664392|FG001|Overall Study|Physician Decision|1|||
37977115|NCT03953183|69664391|FG000|Overall Study|Withdrawal by Subject|0|||
37977116|NCT03953183|69664392|FG001|Overall Study|Withdrawal by Subject|1|||
37977117|NCT00406653|69664402|FG000|Induction Period|Adverse Event|1|||
37977118|NCT00406653|69664403|FG001|Induction Period|Adverse Event|10|||
37977119|NCT00406653|69664404|FG002|Induction Period|Adverse Event|4|||
37977120|NCT00406653|69664405|FG003|Induction Period|Adverse Event|11|||
37977121|NCT00406653|69664406|FG004|Induction Period|Adverse Event|0|||
37977122|NCT00406653|69664407|FG005|Induction Period|Adverse Event|0|||
37977123|NCT00406653|69664408|FG006|Induction Period|Adverse Event|0|||
37977124|NCT00406653|69664402|FG000|Induction Period|Lack of Efficacy|11|||
37977125|NCT00406653|69664403|FG001|Induction Period|Lack of Efficacy|14|||
37977126|NCT00406653|69664404|FG002|Induction Period|Lack of Efficacy|8|||
37810555|NCT02938520|69474554|FG000|Overall Study|Physician Decision|2|||
37810556|NCT02938520|69474555|FG001|Overall Study|Physician Decision|5|||
37810557|NCT02938520|69474554|FG000|Overall Study|Lost to Follow-up|2|||
37810558|NCT02938520|69474555|FG001|Overall Study|Lost to Follow-up|2|||
37810559|NCT02938520|69474554|FG000|Overall Study|Withdrawal by Subject|7|||
37810560|NCT02938520|69474555|FG001|Overall Study|Withdrawal by Subject|7|||
37810561|NCT02938520|69474554|FG000|Overall Study|Protocol Violation|0|||
37810562|NCT02938520|69474555|FG001|Overall Study|Protocol Violation|1|||
37810563|NCT02938520|69474554|FG000|Overall Study|Lack of Efficacy|5|||
37810564|NCT02938520|69474555|FG001|Overall Study|Lack of Efficacy|3|||
37810565|NCT02938520|69474554|FG000|Overall Study|Adverse Event|9|||
37864379|NCT01259492|69548040|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
37977127|NCT00406653|69664405|FG003|Induction Period|Lack of Efficacy|10|||
37977128|NCT00406653|69664406|FG004|Induction Period|Lack of Efficacy|0|||
37977129|NCT00406653|69664407|FG005|Induction Period|Lack of Efficacy|0|||
37977130|NCT00406653|69664408|FG006|Induction Period|Lack of Efficacy|0|||
37977131|NCT00406653|69664402|FG000|Induction Period|Lost to Follow-up|0|||
37977132|NCT00406653|69664403|FG001|Induction Period|Lost to Follow-up|2|||
37977133|NCT00406653|69664404|FG002|Induction Period|Lost to Follow-up|0|||
37977134|NCT00406653|69664405|FG003|Induction Period|Lost to Follow-up|0|||
37977135|NCT00406653|69664406|FG004|Induction Period|Lost to Follow-up|0|||
37977136|NCT00406653|69664407|FG005|Induction Period|Lost to Follow-up|0|||
37977137|NCT00406653|69664408|FG006|Induction Period|Lost to Follow-up|0|||
37810566|NCT02938520|69474555|FG001|Overall Study|Adverse Event|4|||
37810567|NCT02764541|69474572|FG000|Overall Study|Withdrawal by Subject|0|||
37810568|NCT02764541|69474573|FG001|Overall Study|Withdrawal by Subject|0|||
37810569|NCT02764541|69474574|FG002|Overall Study|Withdrawal by Subject|0|||
37810570|NCT02764541|69474575|FG003|Overall Study|Withdrawal by Subject|0|||
37810571|NCT02764541|69474576|FG004|Overall Study|Withdrawal by Subject|1|||
37810572|NCT02764541|69474577|FG005|Overall Study|Withdrawal by Subject|1|||
37810573|NCT02764541|69474578|FG006|Overall Study|Withdrawal by Subject|0|||
37810574|NCT02764541|69474579|FG007|Overall Study|Withdrawal by Subject|1|||
37810575|NCT02764541|69474572|FG000|Overall Study|Adverse Event|1|||
37810576|NCT02764541|69474573|FG001|Overall Study|Adverse Event|0|||
37810577|NCT02764541|69474574|FG002|Overall Study|Adverse Event|0|||
37810578|NCT02764541|69474575|FG003|Overall Study|Adverse Event|0|||
37810579|NCT02764541|69474576|FG004|Overall Study|Adverse Event|0|||
37810580|NCT02764541|69474577|FG005|Overall Study|Adverse Event|0|||
37810581|NCT02764541|69474578|FG006|Overall Study|Adverse Event|1|||
37810582|NCT02764541|69474579|FG007|Overall Study|Adverse Event|0|||
37810583|NCT02764541|69474572|FG000|Overall Study|Metastasis|1|||
37810584|NCT02764541|69474573|FG001|Overall Study|Metastasis|0|||
37810585|NCT02764541|69474574|FG002|Overall Study|Metastasis|0|||
37810586|NCT02764541|69474575|FG003|Overall Study|Metastasis|0|||
37810587|NCT02764541|69474576|FG004|Overall Study|Metastasis|0|||
37810588|NCT02764541|69474577|FG005|Overall Study|Metastasis|0|||
37810589|NCT02764541|69474578|FG006|Overall Study|Metastasis|0|||
37810590|NCT02764541|69474579|FG007|Overall Study|Metastasis|0|||
37810591|NCT02764541|69474572|FG000|Overall Study|Disease progression|1|||
37810592|NCT02764541|69474573|FG001|Overall Study|Disease progression|1|||
37810593|NCT02764541|69474574|FG002|Overall Study|Disease progression|0|||
37810594|NCT02764541|69474575|FG003|Overall Study|Disease progression|0|||
37810595|NCT02764541|69474576|FG004|Overall Study|Disease progression|0|||
37810596|NCT02764541|69474577|FG005|Overall Study|Disease progression|0|||
37810597|NCT02764541|69474578|FG006|Overall Study|Disease progression|0|||
37810598|NCT02764541|69474579|FG007|Overall Study|Disease progression|1|||
37810599|NCT02764541|69474572|FG000|Overall Study|Protocol Violation|0|||
37810600|NCT02764541|69474573|FG001|Overall Study|Protocol Violation|0|||
37810601|NCT02764541|69474574|FG002|Overall Study|Protocol Violation|0|||
37810602|NCT02764541|69474575|FG003|Overall Study|Protocol Violation|1|||
37810603|NCT02764541|69474576|FG004|Overall Study|Protocol Violation|0|||
37810604|NCT02764541|69474577|FG005|Overall Study|Protocol Violation|1|||
37810605|NCT02764541|69474578|FG006|Overall Study|Protocol Violation|0|||
37810606|NCT02764541|69474579|FG007|Overall Study|Protocol Violation|0|||
37810607|NCT02764541|69474572|FG000|Overall Study|Physician Decision|0|||
37810608|NCT02764541|69474573|FG001|Overall Study|Physician Decision|0|||
37810609|NCT02764541|69474574|FG002|Overall Study|Physician Decision|0|||
37810610|NCT02764541|69474575|FG003|Overall Study|Physician Decision|1|||
37810611|NCT02764541|69474576|FG004|Overall Study|Physician Decision|0|||
37810612|NCT02764541|69474577|FG005|Overall Study|Physician Decision|0|||
37810613|NCT02764541|69474578|FG006|Overall Study|Physician Decision|0|||
37810614|NCT02764541|69474579|FG007|Overall Study|Physician Decision|1|||
37810615|NCT02764541|69474572|FG000|Overall Study|Three Cycles completed before surgery|0|||
37810616|NCT02764541|69474573|FG001|Overall Study|Three Cycles completed before surgery|0|||
37810617|NCT02764541|69474574|FG002|Overall Study|Three Cycles completed before surgery|0|||
37810618|NCT02764541|69474575|FG003|Overall Study|Three Cycles completed before surgery|1|||
37810619|NCT02764541|69474576|FG004|Overall Study|Three Cycles completed before surgery|0|||
37810620|NCT02764541|69474577|FG005|Overall Study|Three Cycles completed before surgery|0|||
37810621|NCT02764541|69474578|FG006|Overall Study|Three Cycles completed before surgery|0|||
37810622|NCT02764541|69474579|FG007|Overall Study|Three Cycles completed before surgery|0|||
37810623|NCT02764541|69474572|FG000|Overall Study|Patient Compliance|0|||
37810624|NCT02764541|69474573|FG001|Overall Study|Patient Compliance|0|||
37810625|NCT02764541|69474574|FG002|Overall Study|Patient Compliance|1|||
37810626|NCT02764541|69474575|FG003|Overall Study|Patient Compliance|0|||
37810627|NCT02764541|69474576|FG004|Overall Study|Patient Compliance|0|||
37810628|NCT02764541|69474577|FG005|Overall Study|Patient Compliance|0|||
37810629|NCT02764541|69474578|FG006|Overall Study|Patient Compliance|0|||
37810630|NCT02764541|69474579|FG007|Overall Study|Patient Compliance|0|||
37810631|NCT02764541|69474572|FG000|Overall Study|Death|0|||
37810632|NCT02764541|69474573|FG001|Overall Study|Death|0|||
37810633|NCT02764541|69474574|FG002|Overall Study|Death|0|||
37810634|NCT02764541|69474575|FG003|Overall Study|Death|0|||
37810635|NCT02764541|69474576|FG004|Overall Study|Death|0|||
37810636|NCT02764541|69474577|FG005|Overall Study|Death|0|||
37810637|NCT02764541|69474578|FG006|Overall Study|Death|1|||
37810638|NCT02764541|69474579|FG007|Overall Study|Death|0|||
37810639|NCT02764541|69474572|FG000|Overall Study|Insurance reasons|0|||
37810640|NCT02764541|69474573|FG001|Overall Study|Insurance reasons|0|||
37810641|NCT02764541|69474574|FG002|Overall Study|Insurance reasons|0|||
37810642|NCT02764541|69474575|FG003|Overall Study|Insurance reasons|0|||
37810643|NCT02764541|69474576|FG004|Overall Study|Insurance reasons|0|||
37810644|NCT02764541|69474577|FG005|Overall Study|Insurance reasons|0|||
37810645|NCT02764541|69474578|FG006|Overall Study|Insurance reasons|1|||
37810646|NCT02764541|69474579|FG007|Overall Study|Insurance reasons|0|||
37810647|NCT02587065|69474599|FG000|Overall Study|Adverse Event|14|||
37810648|NCT02587065|69474599|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
37810649|NCT02587065|69474599|FG000|Overall Study|Non-adherence to the Protocol|3|||
37810650|NCT02587065|69474599|FG000|Overall Study|Discontinuation of Study Medication|2|||
37810651|NCT02587065|69474599|FG000|Overall Study|Reason not Specified|3|||
37810652|NCT02544503|69474609|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
37810653|NCT02544503|69474610|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
37810654|NCT02544503|69474609|FG000|Overall Study|Lost to Follow-up|9|||
37810655|NCT02544503|69474610|FG001|Overall Study|Lost to Follow-up|0|||
37810656|NCT02544503|69474609|FG000|Overall Study|Withdrawal by Subject|1|||
37810657|NCT02544503|69474610|FG001|Overall Study|Withdrawal by Subject|0|||
37810658|NCT01705977|69474618|FG000|Treatment Period (Year 1)|Withdrawal by Subject|128|||
37810659|NCT01705977|69474619|FG001|Treatment Period (Year 1)|Withdrawal by Subject|128|||
37810660|NCT01705977|69474618|FG000|Treatment Period (Year 1)|Adverse Event|57|||
37810661|NCT01705977|69474619|FG001|Treatment Period (Year 1)|Adverse Event|49|||
37810662|NCT01705977|69474618|FG000|Treatment Period (Year 1)|Protocol Violation|2|||
37810663|NCT01705977|69474619|FG001|Treatment Period (Year 1)|Protocol Violation|4|||
37977138|NCT00406653|69664402|FG000|Induction Period|Withdrawal of Consent|2|||
37977139|NCT00406653|69664403|FG001|Induction Period|Withdrawal of Consent|5|||
37977140|NCT00406653|69664404|FG002|Induction Period|Withdrawal of Consent|1|||
37977141|NCT00406653|69664405|FG003|Induction Period|Withdrawal of Consent|2|||
37977142|NCT00406653|69664406|FG004|Induction Period|Withdrawal of Consent|0|||
37977143|NCT00406653|69664407|FG005|Induction Period|Withdrawal of Consent|0|||
37977144|NCT00406653|69664408|FG006|Induction Period|Withdrawal of Consent|0|||
37977145|NCT00406653|69664402|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
37977146|NCT00406653|69664403|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
37977147|NCT00406653|69664404|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
37977148|NCT00406653|69664405|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
37977149|NCT00406653|69664406|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
37810664|NCT01705977|69474618|FG000|Treatment Period (Year 1)|Site closure|3|||
37810665|NCT01705977|69474619|FG001|Treatment Period (Year 1)|Site closure|2|||
37977150|NCT00406653|69664407|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
37977151|NCT00406653|69664408|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
37977152|NCT00406653|69664402|FG000|Induction Period|Pregnancy|1|||
37977153|NCT00406653|69664403|FG001|Induction Period|Pregnancy|0|||
37810666|NCT01705977|69474618|FG000|Treatment Period (Year 1)|Lost to Follow-up|33|||
37810667|NCT01705977|69474619|FG001|Treatment Period (Year 1)|Lost to Follow-up|37|||
37810668|NCT01705977|69474618|FG000|Treatment Period (Year 1)|Physician Decision|48|||
37810669|NCT01705977|69474619|FG001|Treatment Period (Year 1)|Physician Decision|38|||
37810670|NCT01705977|69474618|FG000|Treatment Period (Year 1)|Missing study conclusion form|2|||
37810671|NCT01705977|69474619|FG001|Treatment Period (Year 1)|Missing study conclusion form|2|||
37810672|NCT01705977|69474618|FG000|Treatment Period (Year 1)|Randomized but not treated|7|||
37810673|NCT01705977|69474619|FG001|Treatment Period (Year 1)|Randomized but not treated|9|||
37810674|NCT01705977|69474618|FG000|Follow-up Period (Years 2 to 5)|Death|58|||
37810675|NCT01705977|69474619|FG001|Follow-up Period (Years 2 to 5)|Death|38|||
37810676|NCT01705977|69474618|FG000|Follow-up Period (Years 2 to 5)|Lost to Follow-up|75|||
37810677|NCT01705977|69474619|FG001|Follow-up Period (Years 2 to 5)|Lost to Follow-up|89|||
37810678|NCT01705977|69474618|FG000|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|44|||
37810679|NCT01705977|69474619|FG001|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|36|||
37810680|NCT01705977|69474618|FG000|Follow-up Period (Years 2 to 5)|Missing|19|||
37810681|NCT01705977|69474619|FG001|Follow-up Period (Years 2 to 5)|Missing|18|||
37810682|NCT01474889|69474628|FG000|Overall Study|Physician Decision|1|||
37810683|NCT01474889|69474629|FG001|Overall Study|Physician Decision|0|||
37810684|NCT01474889|69474630|FG002|Overall Study|Physician Decision|0|||
37977154|NCT00406653|69664404|FG002|Induction Period|Pregnancy|0|||
37977155|NCT00406653|69664405|FG003|Induction Period|Pregnancy|0|||
37977156|NCT00406653|69664406|FG004|Induction Period|Pregnancy|0|||
37977157|NCT00406653|69664407|FG005|Induction Period|Pregnancy|0|||
37977158|NCT00406653|69664408|FG006|Induction Period|Pregnancy|0|||
37977159|NCT00406653|69664402|FG000|Induction Period|Declined participation but followup done|0|||
37977160|NCT00406653|69664403|FG001|Induction Period|Declined participation but followup done|2|||
37810685|NCT01474889|69474628|FG000|Overall Study|Did not meet inclusion|1|||
37810686|NCT01474889|69474629|FG001|Overall Study|Did not meet inclusion|0|||
37810687|NCT01474889|69474630|FG002|Overall Study|Did not meet inclusion|0|||
37810688|NCT01474889|69474628|FG000|Overall Study|Withdrawal by Subject|0|||
37810689|NCT01474889|69474629|FG001|Overall Study|Withdrawal by Subject|1|||
37810690|NCT01474889|69474630|FG002|Overall Study|Withdrawal by Subject|0|||
37810691|NCT01231906|69474638|FG000|Overall Study|Lack of Efficacy|75|||
37810692|NCT01231906|69474639|FG001|Overall Study|Lack of Efficacy|68|||
37810693|NCT01231906|69474638|FG000|Overall Study|Lost to Follow-up|1|||
37810694|NCT01231906|69474639|FG001|Overall Study|Lost to Follow-up|0|||
37810695|NCT01231906|69474638|FG000|Overall Study|Physician Decision|34|||
37810696|NCT01231906|69474639|FG001|Overall Study|Physician Decision|24|||
37810697|NCT01231906|69474638|FG000|Overall Study|Withdrawal by Subject|0|||
37810698|NCT01231906|69474639|FG001|Overall Study|Withdrawal by Subject|4|||
37810699|NCT01231906|69474638|FG000|Overall Study|Ineligible|10|||
37810700|NCT01231906|69474639|FG001|Overall Study|Ineligible|3|||
37810701|NCT01231906|69474638|FG000|Overall Study|No treatment|1|||
37810702|NCT01231906|69474639|FG001|Overall Study|No treatment|2|||
37810703|NCT00724048|69474649|FG000|Overall Study|Adverse Event|1|||
37810704|NCT00724048|69474650|FG001|Overall Study|Adverse Event|1|||
37810705|NCT00724048|69474651|FG002|Overall Study|Adverse Event|1|||
37810706|NCT00724048|69474652|FG003|Overall Study|Adverse Event|0|||
37810707|NCT00724048|69474649|FG000|Overall Study|Lost to Follow-up|0|||
37810708|NCT00724048|69474650|FG001|Overall Study|Lost to Follow-up|1|||
37810709|NCT00724048|69474651|FG002|Overall Study|Lost to Follow-up|0|||
37810710|NCT00724048|69474652|FG003|Overall Study|Lost to Follow-up|0|||
37810711|NCT00724048|69474649|FG000|Overall Study|Withdrawal by Subject|1|||
37810712|NCT00724048|69474650|FG001|Overall Study|Withdrawal by Subject|2|||
37810713|NCT00724048|69474651|FG002|Overall Study|Withdrawal by Subject|1|||
37810714|NCT00724048|69474652|FG003|Overall Study|Withdrawal by Subject|2|||
37810715|NCT00724048|69474649|FG000|Overall Study|Investigator decision|0|||
37810716|NCT00724048|69474650|FG001|Overall Study|Investigator decision|0|||
37810717|NCT00724048|69474651|FG002|Overall Study|Investigator decision|1|||
37810718|NCT00724048|69474652|FG003|Overall Study|Investigator decision|0|||
37810719|NCT00724048|69474649|FG000|Overall Study|Did not tolerate study drug|0|||
37810720|NCT00724048|69474650|FG001|Overall Study|Did not tolerate study drug|0|||
37810721|NCT00724048|69474651|FG002|Overall Study|Did not tolerate study drug|0|||
37810722|NCT00724048|69474652|FG003|Overall Study|Did not tolerate study drug|1|||
37810723|NCT00724048|69474649|FG000|Overall Study|Other than specified|1|||
37810724|NCT00724048|69474650|FG001|Overall Study|Other than specified|1|||
37810725|NCT00724048|69474651|FG002|Overall Study|Other than specified|0|||
37810726|NCT00724048|69474652|FG003|Overall Study|Other than specified|0|||
37810727|NCT00304070|69474665|FG000|Overall Study|Death|0|||
37810728|NCT00304070|69474666|FG001|Overall Study|Death|0|||
37810729|NCT00304070|69474667|FG002|Overall Study|Death|3|||
37810730|NCT00304070|69474665|FG000|Overall Study|Lost to Follow-up|0|||
37810731|NCT00304070|69474666|FG001|Overall Study|Lost to Follow-up|0|||
37810732|NCT00304070|69474667|FG002|Overall Study|Lost to Follow-up|1|||
37810733|NCT00304070|69474665|FG000|Overall Study|Physician Decision|0|||
37810734|NCT00304070|69474666|FG001|Overall Study|Physician Decision|0|||
37810735|NCT00304070|69474667|FG002|Overall Study|Physician Decision|3|||
37810736|NCT00304070|69474665|FG000|Overall Study|Withdrawal by Subject|0|||
37810737|NCT00304070|69474666|FG001|Overall Study|Withdrawal by Subject|0|||
37810738|NCT00304070|69474667|FG002|Overall Study|Withdrawal by Subject|1|||
37810739|NCT00304070|69474665|FG000|Overall Study|Progressive Disease|3|||
37810740|NCT00304070|69474666|FG001|Overall Study|Progressive Disease|7|||
37810741|NCT00304070|69474667|FG002|Overall Study|Progressive Disease|4|||
37977161|NCT00406653|69664404|FG002|Induction Period|Declined participation but followup done|1|||
37977162|NCT00406653|69664405|FG003|Induction Period|Declined participation but followup done|1|||
37810742|NCT00160680|69474681|FG000|Overall Study|Adverse Event|0|||
37810743|NCT00160680|69474682|FG001|Overall Study|Adverse Event|1|||
37810744|NCT00160680|69474681|FG000|Overall Study|Lack of Efficacy|2|||
37810745|NCT00160680|69474682|FG001|Overall Study|Lack of Efficacy|1|||
37810746|NCT00160680|69474681|FG000|Overall Study|Lost to Follow-up|3|||
37810747|NCT00160680|69474682|FG001|Overall Study|Lost to Follow-up|2|||
37810748|NCT00160680|69474681|FG000|Overall Study|Withdrawal by Subject|4|||
37810749|NCT00160680|69474682|FG001|Overall Study|Withdrawal by Subject|9|||
37810750|NCT04556838|69475525|FG000|Overall Study|Withdrawal by Subject|3|||
37810751|NCT04556838|69475526|FG001|Overall Study|Withdrawal by Subject|1|||
37977163|NCT00406653|69664406|FG004|Induction Period|Declined participation but followup done|0|||
37810752|NCT04556838|69475527|FG002|Overall Study|Withdrawal by Subject|2|||
37810753|NCT04556838|69475525|FG000|Overall Study|Adverse Event|0|||
37810754|NCT04556838|69475526|FG001|Overall Study|Adverse Event|1|||
37810755|NCT04556838|69475527|FG002|Overall Study|Adverse Event|1|||
37810756|NCT04556838|69475525|FG000|Overall Study|Lost to Follow-up|0|||
37810757|NCT04556838|69475526|FG001|Overall Study|Lost to Follow-up|0|||
37810758|NCT04556838|69475527|FG002|Overall Study|Lost to Follow-up|2|||
37810759|NCT04556838|69475525|FG000|Overall Study|Subject travel|0|||
37810760|NCT04556838|69475526|FG001|Overall Study|Subject travel|1|||
37810761|NCT04556838|69475527|FG002|Overall Study|Subject travel|0|||
37810762|NCT04556838|69475525|FG000|Overall Study|Physician Decision|1|||
37810763|NCT04556838|69475526|FG001|Overall Study|Physician Decision|0|||
37977164|NCT00406653|69664407|FG005|Induction Period|Declined participation but followup done|0|||
37977165|NCT00406653|69664408|FG006|Induction Period|Declined participation but followup done|0|||
37977166|NCT00406653|69664402|FG000|Induction Period|Given prohibited drug|0|||
37977167|NCT00406653|69664403|FG001|Induction Period|Given prohibited drug|1|||
37977168|NCT00406653|69664404|FG002|Induction Period|Given prohibited drug|2|||
37977169|NCT00406653|69664405|FG003|Induction Period|Given prohibited drug|0|||
37810764|NCT04556838|69475527|FG002|Overall Study|Physician Decision|0|||
37810765|NCT03671148|69475550|FG000|Overall Study|Adverse Event|3|||
37810766|NCT03671148|69475551|FG001|Overall Study|Adverse Event|2|||
37810767|NCT03671148|69475550|FG000|Overall Study|Withdrawal by Subject|8|||
37810768|NCT03671148|69475551|FG001|Overall Study|Withdrawal by Subject|2|||
37810769|NCT03671148|69475550|FG000|Overall Study|Lost to Follow-up|1|||
37810770|NCT03671148|69475551|FG001|Overall Study|Lost to Follow-up|2|||
37810771|NCT03671148|69475550|FG000|Overall Study|Lack of Efficacy|7|||
37810772|NCT03671148|69475551|FG001|Overall Study|Lack of Efficacy|2|||
37810773|NCT03671148|69475550|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
37810774|NCT03671148|69475551|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
37810775|NCT03671148|69475550|FG000|Overall Study|Other|1|||
37810776|NCT03671148|69475551|FG001|Overall Study|Other|0|||
37810777|NCT03671148|69475550|FG000|Overall Study|Incomplete Randomization Visit|1|||
37810778|NCT03671148|69475551|FG001|Overall Study|Incomplete Randomization Visit|0|||
37810779|NCT01430442|69475565|FG000|Overall Study|Subject Withdrew Consent|3|||
37810780|NCT01430442|69475566|FG001|Overall Study|Subject Withdrew Consent|0|||
37810781|NCT01430442|69475567|FG002|Overall Study|Subject Withdrew Consent|1|||
37810782|NCT01430442|69475568|FG003|Overall Study|Subject Withdrew Consent|0|||
37810783|NCT01430442|69475569|FG004|Overall Study|Subject Withdrew Consent|2|||
37810784|NCT01430442|69475570|FG005|Overall Study|Subject Withdrew Consent|1|||
37810785|NCT01430442|69475571|FG006|Overall Study|Subject Withdrew Consent|5|||
37810786|NCT01430442|69475572|FG007|Overall Study|Subject Withdrew Consent|2|||
37810787|NCT01430442|69475565|FG000|Overall Study|Lost to Follow-up|2|||
37810788|NCT01430442|69475566|FG001|Overall Study|Lost to Follow-up|0|||
37810789|NCT01430442|69475567|FG002|Overall Study|Lost to Follow-up|1|||
37810790|NCT01430442|69475568|FG003|Overall Study|Lost to Follow-up|2|||
37810791|NCT01430442|69475569|FG004|Overall Study|Lost to Follow-up|2|||
37810792|NCT01430442|69475570|FG005|Overall Study|Lost to Follow-up|1|||
37810793|NCT01430442|69475571|FG006|Overall Study|Lost to Follow-up|5|||
37810794|NCT01430442|69475572|FG007|Overall Study|Lost to Follow-up|1|||
37810795|NCT01430442|69475565|FG000|Overall Study|Pregnancy|1|||
37810796|NCT01430442|69475566|FG001|Overall Study|Pregnancy|0|||
37810797|NCT01430442|69475567|FG002|Overall Study|Pregnancy|0|||
37810798|NCT01430442|69475568|FG003|Overall Study|Pregnancy|0|||
37810799|NCT01430442|69475569|FG004|Overall Study|Pregnancy|0|||
37810800|NCT01430442|69475570|FG005|Overall Study|Pregnancy|1|||
37810801|NCT01430442|69475571|FG006|Overall Study|Pregnancy|0|||
37810802|NCT01430442|69475572|FG007|Overall Study|Pregnancy|0|||
37810803|NCT01430442|69475565|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
37810804|NCT01430442|69475566|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
37810805|NCT01430442|69475567|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
37810806|NCT01430442|69475568|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
37810807|NCT01430442|69475569|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
37810808|NCT01430442|69475570|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
37810809|NCT01430442|69475571|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
37810810|NCT01430442|69475572|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
37810811|NCT01420926|69475592|FG000|Overall Study|Adverse Event|6|||
37810812|NCT01420926|69475593|FG001|Overall Study|Adverse Event|4|||
37810813|NCT01420926|69475592|FG000|Overall Study|Death|18|||
37810814|NCT01420926|69475593|FG001|Overall Study|Death|17|||
37810815|NCT01420926|69475592|FG000|Overall Study|Withdrawal by Subject|11|||
37810816|NCT01420926|69475593|FG001|Overall Study|Withdrawal by Subject|17|||
37810817|NCT01420926|69475592|FG000|Overall Study|Non-protocol treatment|17|||
37810818|NCT01420926|69475593|FG001|Overall Study|Non-protocol treatment|20|||
37810819|NCT01420926|69475592|FG000|Overall Study|Physician Decision|8|||
37810820|NCT01420926|69475593|FG001|Overall Study|Physician Decision|5|||
37810821|NCT04303572|69476149|FG000|Overall Study|Study closed due to poor enrollment|1|||
37810822|NCT03551730|69476181|FG000|Overall Study|Adverse Event|1|||
37810823|NCT03551730|69476182|FG001|Overall Study|Adverse Event|0|||
37810824|NCT03551730|69476183|FG002|Overall Study|Adverse Event|0|||
37810825|NCT03551730|69476184|FG003|Overall Study|Adverse Event|0|||
37810826|NCT02534844|69476196|FG000|Part B|Withdrawal by Subject|0|||
37810827|NCT02534844|69476197|FG001|Part B|Withdrawal by Subject|0|||
37810828|NCT02534844|69476198|FG002|Part B|Withdrawal by Subject|0|||
37810829|NCT02534844|69476199|FG003|Part B|Withdrawal by Subject|0|||
37810830|NCT02534844|69476200|FG004|Part B|Withdrawal by Subject|2|||
37810831|NCT02534844|69476201|FG005|Part B|Withdrawal by Subject|1|||
37810832|NCT01818492|69476218|FG000|Overall Study|Adverse Event|2|||
37810833|NCT01818492|69476218|FG000|Overall Study|Death|3|||
37810834|NCT01818492|69476218|FG000|Overall Study|Withdrawal by Subject|1|||
37810835|NCT01818492|69476218|FG000|Overall Study|Additional therapy when not allowed PP|4|||
37810836|NCT01239030|69476228|FG000|Double Blind|Adverse Event|0|||
37810837|NCT01239030|69476229|FG001|Double Blind|Adverse Event|1|||
37810838|NCT01239030|69476230|FG002|Double Blind|Adverse Event|0|||
37810839|NCT01239030|69476231|FG003|Double Blind|Adverse Event|2|||
37810840|NCT01239030|69476232|FG004|Double Blind|Adverse Event|0|||
37810841|NCT01239030|69476228|FG000|Double Blind|Withdrawal by Subject|0|||
37810842|NCT01239030|69476229|FG001|Double Blind|Withdrawal by Subject|1|||
37810843|NCT01239030|69476230|FG002|Double Blind|Withdrawal by Subject|1|||
37810844|NCT01239030|69476231|FG003|Double Blind|Withdrawal by Subject|0|||
37810845|NCT01239030|69476232|FG004|Double Blind|Withdrawal by Subject|1|||
37810846|NCT01239030|69476228|FG000|Double Blind|Lost to Follow-up|1|||
37810847|NCT01239030|69476229|FG001|Double Blind|Lost to Follow-up|1|||
37810848|NCT01239030|69476230|FG002|Double Blind|Lost to Follow-up|0|||
37810849|NCT01239030|69476231|FG003|Double Blind|Lost to Follow-up|0|||
37810850|NCT01239030|69476232|FG004|Double Blind|Lost to Follow-up|0|||
37810851|NCT01239030|69476228|FG000|Double Blind|Physician Decision|0|||
37810852|NCT01239030|69476229|FG001|Double Blind|Physician Decision|1|||
37810853|NCT01239030|69476230|FG002|Double Blind|Physician Decision|0|||
37810854|NCT01239030|69476231|FG003|Double Blind|Physician Decision|0|||
37810855|NCT01239030|69476232|FG004|Double Blind|Physician Decision|0|||
37810856|NCT01239030|69476228|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
37810857|NCT01239030|69476229|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
37810858|NCT01239030|69476230|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
37810859|NCT01239030|69476231|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
37810860|NCT01239030|69476232|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
37810861|NCT01239030|69476228|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
37810862|NCT01239030|69476229|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
37810863|NCT01239030|69476230|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
37810864|NCT01239030|69476231|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
37977170|NCT00406653|69664406|FG004|Induction Period|Given prohibited drug|0|||
37977171|NCT00406653|69664407|FG005|Induction Period|Given prohibited drug|0|||
37977172|NCT00406653|69664408|FG006|Induction Period|Given prohibited drug|0|||
37810865|NCT01239030|69476232|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
37810866|NCT01239030|69476228|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
37810867|NCT01239030|69476229|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
37810868|NCT01239030|69476230|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
37810869|NCT01239030|69476231|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
37810870|NCT01239030|69476232|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
37810871|NCT01239030|69476228|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
37810872|NCT01239030|69476229|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
37810873|NCT01239030|69476230|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
37810874|NCT01239030|69476231|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
37810875|NCT01239030|69476232|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
37977173|NCT00406653|69664402|FG000|Induction Period|Incarcerated|0|||
37977174|NCT00406653|69664403|FG001|Induction Period|Incarcerated|0|||
37977175|NCT00406653|69664404|FG002|Induction Period|Incarcerated|1|||
37810876|NCT01086540|69476247|FG000|Overall Study|Death|3|||
37810877|NCT01086540|69476248|FG001|Overall Study|Death|1|||
37810878|NCT01086540|69476247|FG000|Overall Study|Physician Decision|2|||
37810879|NCT01086540|69476248|FG001|Overall Study|Physician Decision|1|||
37810880|NCT01086540|69476247|FG000|Overall Study|Addition of new therapy for PAH|1|||
37810881|NCT01086540|69476248|FG001|Overall Study|Addition of new therapy for PAH|0|||
37810882|NCT04567524|69479543|FG000|Overall Study|Adverse Event|1|||
37977176|NCT00406653|69664405|FG003|Induction Period|Incarcerated|0|||
37810883|NCT04567524|69479544|FG001|Overall Study|Adverse Event|1|||
37810884|NCT04567524|69479545|FG002|Overall Study|Adverse Event|0|||
37810885|NCT04567524|69479546|FG003|Overall Study|Adverse Event|0|||
37810886|NCT04567524|69479543|FG000|Overall Study|Withdrawal by Subject|2|||
37810887|NCT04567524|69479544|FG001|Overall Study|Withdrawal by Subject|0|||
37810888|NCT04567524|69479545|FG002|Overall Study|Withdrawal by Subject|0|||
37810889|NCT04567524|69479546|FG003|Overall Study|Withdrawal by Subject|1|||
37810890|NCT03370302|69479582|FG000|Dose Escalation Phase|Other|0|||
37810891|NCT03370302|69479583|FG001|Dose Escalation Phase|Other|1|||
37810892|NCT03370302|69479584|FG002|Dose Escalation Phase|Other|1|||
37810893|NCT03370302|69479585|FG003|Dose Escalation Phase|Other|0|||
37810894|NCT03370302|69479586|FG004|Dose Escalation Phase|Other|0|||
37810895|NCT03370302|69479587|FG005|Dose Escalation Phase|Other|0|||
37810896|NCT03370302|69479582|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
37810897|NCT03370302|69479583|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
37810898|NCT03370302|69479584|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
37810899|NCT03370302|69479585|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
37810900|NCT03370302|69479586|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
37810901|NCT03370302|69479587|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
37810902|NCT03370302|69479582|FG000|Dose Escalation Phase|Adverse Event|1|||
37810903|NCT03370302|69479583|FG001|Dose Escalation Phase|Adverse Event|0|||
37810904|NCT03370302|69479584|FG002|Dose Escalation Phase|Adverse Event|2|||
37810905|NCT03370302|69479585|FG003|Dose Escalation Phase|Adverse Event|0|||
37810906|NCT03370302|69479586|FG004|Dose Escalation Phase|Adverse Event|0|||
37810907|NCT03370302|69479587|FG005|Dose Escalation Phase|Adverse Event|0|||
37810908|NCT03370302|69479582|FG000|Dose Escalation Phase|Progressive Disease|2|||
37810909|NCT03370302|69479583|FG001|Dose Escalation Phase|Progressive Disease|4|||
37810910|NCT03370302|69479584|FG002|Dose Escalation Phase|Progressive Disease|2|||
37810911|NCT03370302|69479585|FG003|Dose Escalation Phase|Progressive Disease|0|||
37810912|NCT03370302|69479586|FG004|Dose Escalation Phase|Progressive Disease|3|||
37810913|NCT03370302|69479587|FG005|Dose Escalation Phase|Progressive Disease|1|||
37810914|NCT03370302|69479582|FG000|Dose Expansion Phase|Progressive Disease|0|||
37810915|NCT03370302|69479583|FG001|Dose Expansion Phase|Progressive Disease|0|||
37810916|NCT03370302|69479584|FG002|Dose Expansion Phase|Progressive Disease|0|||
37810917|NCT03370302|69479585|FG003|Dose Expansion Phase|Progressive Disease|6|||
37810918|NCT03370302|69479586|FG004|Dose Expansion Phase|Progressive Disease|0|||
37810919|NCT03370302|69479587|FG005|Dose Expansion Phase|Progressive Disease|0|||
37810920|NCT03327324|69479611|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
37810921|NCT03327324|69479612|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
37810922|NCT03327324|69479613|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
37810923|NCT03327324|69479614|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
37810924|NCT03327324|69479615|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
37810925|NCT03327324|69479616|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
37810926|NCT03327324|69479611|FG000|Baseline (Month 0-Month 3)|Refused|0|||
37810927|NCT03327324|69479612|FG001|Baseline (Month 0-Month 3)|Refused|0|||
37810928|NCT03327324|69479613|FG002|Baseline (Month 0-Month 3)|Refused|0|||
37810929|NCT03327324|69479614|FG003|Baseline (Month 0-Month 3)|Refused|0|||
37810930|NCT03327324|69479615|FG004|Baseline (Month 0-Month 3)|Refused|1|||
37810931|NCT03327324|69479616|FG005|Baseline (Month 0-Month 3)|Refused|0|||
37810932|NCT03327324|69479611|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
37810933|NCT03327324|69479612|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
37810934|NCT03327324|69479613|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
37810935|NCT03327324|69479614|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
37810936|NCT03327324|69479615|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
37810937|NCT03327324|69479616|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
37810938|NCT03327324|69479611|FG000|Baseline (Month 0-Month 3)|Death|0|||
37810939|NCT03327324|69479612|FG001|Baseline (Month 0-Month 3)|Death|0|||
37810940|NCT03327324|69479613|FG002|Baseline (Month 0-Month 3)|Death|0|||
37810941|NCT03327324|69479614|FG003|Baseline (Month 0-Month 3)|Death|0|||
37810942|NCT03327324|69479615|FG004|Baseline (Month 0-Month 3)|Death|1|||
37810943|NCT03327324|69479616|FG005|Baseline (Month 0-Month 3)|Death|0|||
37810944|NCT03327324|69479611|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
37810945|NCT03327324|69479612|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
37833549|NCT01263496|69517274|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
37810946|NCT03327324|69479613|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
37810947|NCT03327324|69479614|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
37810948|NCT03327324|69479615|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
37810949|NCT03327324|69479616|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
37810950|NCT03327324|69479611|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
37810951|NCT03327324|69479612|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
37810952|NCT03327324|69479613|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
37810953|NCT03327324|69479614|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
37810954|NCT03327324|69479615|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
37810955|NCT03327324|69479616|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
37810956|NCT03327324|69479611|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
37810957|NCT03327324|69479612|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
37810958|NCT03327324|69479613|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
37810959|NCT03327324|69479614|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
37977177|NCT00406653|69664406|FG004|Induction Period|Incarcerated|0|||
37977178|NCT00406653|69664407|FG005|Induction Period|Incarcerated|0|||
37977179|NCT00406653|69664408|FG006|Induction Period|Incarcerated|0|||
37810960|NCT03327324|69479615|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
37810961|NCT03327324|69479616|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
37810962|NCT03327324|69479611|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
37810963|NCT03327324|69479612|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
37810964|NCT03327324|69479613|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
37810965|NCT03327324|69479614|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
37810966|NCT03327324|69479615|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
37810967|NCT03327324|69479616|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
37810968|NCT03327324|69479611|FG000|Intervention (Month 3-Month 6)|Death|1|||
37810969|NCT03327324|69479612|FG001|Intervention (Month 3-Month 6)|Death|0|||
37810970|NCT03327324|69479613|FG002|Intervention (Month 3-Month 6)|Death|1|||
37810971|NCT03327324|69479614|FG003|Intervention (Month 3-Month 6)|Death|1|||
37810972|NCT03327324|69479615|FG004|Intervention (Month 3-Month 6)|Death|1|||
37810973|NCT03327324|69479616|FG005|Intervention (Month 3-Month 6)|Death|0|||
37810974|NCT03327324|69479611|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
37810975|NCT03327324|69479612|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
37810976|NCT03327324|69479613|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
37810977|NCT03327324|69479614|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
37810978|NCT03327324|69479615|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
37810979|NCT03327324|69479616|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
37810980|NCT03327324|69479611|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
37810981|NCT03327324|69479612|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
37810982|NCT03327324|69479613|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
37810983|NCT03327324|69479614|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
37810984|NCT03327324|69479615|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
37810985|NCT03327324|69479616|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
37810986|NCT03327324|69479611|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
37977180|NCT00406653|69664402|FG000|Induction Period|Patient relocated|0|||
37977181|NCT00406653|69664403|FG001|Induction Period|Patient relocated|0|||
37810987|NCT03327324|69479612|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
37810988|NCT03327324|69479613|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
37810989|NCT03327324|69479614|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
37810990|NCT03327324|69479615|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
37810991|NCT03327324|69479616|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
37810992|NCT03327324|69479611|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
37810993|NCT03327324|69479612|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
37810994|NCT03327324|69479613|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
37810995|NCT03327324|69479614|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
37810996|NCT03327324|69479615|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
37810997|NCT03327324|69479616|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
37810998|NCT03327324|69479611|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
37810999|NCT03327324|69479612|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
37811000|NCT03327324|69479613|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
37811001|NCT03327324|69479614|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
37811002|NCT03327324|69479615|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
37811003|NCT03327324|69479616|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
37811004|NCT03327324|69479611|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
37811005|NCT03327324|69479612|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
37811006|NCT03327324|69479613|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
37811007|NCT03327324|69479614|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
37811008|NCT03327324|69479615|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
37811009|NCT03327324|69479616|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
37811010|NCT03327324|69479611|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
37811011|NCT03327324|69479612|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
37811012|NCT03327324|69479613|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
37811013|NCT03327324|69479614|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
37811014|NCT03327324|69479615|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
37811015|NCT03327324|69479616|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
37811016|NCT03252522|69479622|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
37811017|NCT03252522|69479623|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
37811018|NCT03252522|69479624|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
37811019|NCT03252522|69479622|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
37811020|NCT03252522|69479623|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
37811021|NCT03252522|69479624|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
37811022|NCT03252522|69479622|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
37811023|NCT03252522|69479623|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
37811024|NCT03252522|69479624|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
37811025|NCT03252522|69479622|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
37811026|NCT03252522|69479623|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
37811027|NCT03252522|69479624|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
37811028|NCT03252522|69479622|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
37811029|NCT03252522|69479623|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
37811030|NCT03252522|69479624|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
37811031|NCT03252522|69479622|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
37811032|NCT03252522|69479623|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
37811033|NCT03252522|69479624|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
37811034|NCT03252522|69479622|FG000|Phase 2: Open Label|Adverse Event|0|||
37811035|NCT03252522|69479623|FG001|Phase 2: Open Label|Adverse Event|0|||
37811036|NCT03252522|69479624|FG002|Phase 2: Open Label|Adverse Event|2|||
37811037|NCT03252522|69479622|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
37811038|NCT03252522|69479623|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
37811039|NCT03252522|69479624|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
37811040|NCT02756364|69479639|FG000|Overall Study|Site Terminated by Sponsor|24|||
37811041|NCT02756364|69479640|FG001|Overall Study|Site Terminated by Sponsor|30|||
37811042|NCT02756364|69479641|FG002|Overall Study|Site Terminated by Sponsor|21|||
37811043|NCT02756364|69479639|FG000|Overall Study|Death|20|||
37811044|NCT02756364|69479640|FG001|Overall Study|Death|15|||
37811045|NCT02756364|69479641|FG002|Overall Study|Death|18|||
37811046|NCT02756364|69479639|FG000|Overall Study|Withdrawal by Patient|2|||
37811047|NCT02756364|69479640|FG001|Overall Study|Withdrawal by Patient|1|||
37811048|NCT02756364|69479641|FG002|Overall Study|Withdrawal by Patient|8|||
37811049|NCT02756364|69479639|FG000|Overall Study|Lost to Follow-up|0|||
37811050|NCT02756364|69479640|FG001|Overall Study|Lost to Follow-up|1|||
37811051|NCT02756364|69479641|FG002|Overall Study|Lost to Follow-up|1|||
37977182|NCT00406653|69664404|FG002|Induction Period|Patient relocated|1|||
37811052|NCT01906476|69479651|FG000|Overall Study|Lost to Follow-up|17|||
37811053|NCT01906476|69479652|FG001|Overall Study|Lost to Follow-up|16|||
37977183|NCT00406653|69664405|FG003|Induction Period|Patient relocated|0|||
37977184|NCT00406653|69664406|FG004|Induction Period|Patient relocated|0|||
37977185|NCT00406653|69664407|FG005|Induction Period|Patient relocated|0|||
37977186|NCT00406653|69664408|FG006|Induction Period|Patient relocated|0|||
37977187|NCT00406653|69664402|FG000|Maintenance Period|Adverse Event|0|||
37811054|NCT05343624|69479658|FG000|Overall Study|Chart review not completed|1|||
37811055|NCT04208412|69479700|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
37811056|NCT04208412|69479701|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
37811057|NCT04208412|69479700|FG000|Overall Study|Withdrawal by Subject|1|||
37811058|NCT04208412|69479701|FG001|Overall Study|Withdrawal by Subject|0|||
37811059|NCT04208412|69479700|FG000|Overall Study|Lost to Follow-up|0|||
37811060|NCT04208412|69479701|FG001|Overall Study|Lost to Follow-up|1|||
37811061|NCT04095858|69479711|FG000|Overall Study|Death|1|||
37811062|NCT04095858|69479712|FG001|Overall Study|Death|0|||
37811063|NCT04095858|69479711|FG000|Overall Study|Study terminated by Sponsor|2|||
37811064|NCT04095858|69479712|FG001|Overall Study|Study terminated by Sponsor|4|||
37811065|NCT03937986|69479718|FG000|Overall Study|COVID-19 Pandemic|1|||
37811066|NCT03738150|69479733|FG000|Base Study|Withdrawal by Subject|1|||
37811067|NCT03738150|69479733|FG000|Extension Study|Withdrawal by Subject|1|||
37811068|NCT03567174|69479749|FG000|Overall Study|Death|24|||
37811069|NCT03567174|69479750|FG001|Overall Study|Death|31|||
37811070|NCT03567174|69479749|FG000|Overall Study|Lost to Follow-up|165|||
37811071|NCT03567174|69479750|FG001|Overall Study|Lost to Follow-up|174|||
37977188|NCT00406653|69664403|FG001|Maintenance Period|Adverse Event|0|||
37977189|NCT00406653|69664404|FG002|Maintenance Period|Adverse Event|0|||
37977190|NCT00406653|69664405|FG003|Maintenance Period|Adverse Event|0|||
37811072|NCT03529110|69479761|FG000|Overall Study|Progressive Disease|66|||
37811073|NCT03529110|69479762|FG001|Overall Study|Progressive Disease|158|||
37811074|NCT03529110|69479761|FG000|Overall Study|Clinical Progression|4|||
37811075|NCT03529110|69479762|FG001|Overall Study|Clinical Progression|12|||
37811076|NCT03529110|69479761|FG000|Overall Study|Adverse Event|35|||
37811077|NCT03529110|69479762|FG001|Overall Study|Adverse Event|17|||
37811078|NCT03529110|69479761|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
37811079|NCT03529110|69479762|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
37811080|NCT03529110|69479761|FG000|Overall Study|Lack of Efficacy|3|||
37811081|NCT03529110|69479762|FG001|Overall Study|Lack of Efficacy|3|||
37811082|NCT03529110|69479761|FG000|Overall Study|Physician Decision|2|||
37811083|NCT03529110|69479762|FG001|Overall Study|Physician Decision|8|||
37811084|NCT03529110|69479761|FG000|Overall Study|Miscellaneous|2|||
37811085|NCT03529110|69479762|FG001|Overall Study|Miscellaneous|5|||
37811086|NCT02663622|69479793|FG000|Overall Study|Death|3|||
37811087|NCT02663622|69479794|FG001|Overall Study|Death|1|||
37811088|NCT02663622|69479795|FG002|Overall Study|Death|1|||
37811089|NCT02663622|69479796|FG003|Overall Study|Death|8|||
37811090|NCT02663622|69479793|FG000|Overall Study|Protocol Violation|0|||
37811091|NCT02663622|69479794|FG001|Overall Study|Protocol Violation|0|||
37811092|NCT02663622|69479795|FG002|Overall Study|Protocol Violation|0|||
37811093|NCT02663622|69479796|FG003|Overall Study|Protocol Violation|1|||
37811094|NCT02545998|69479822|FG000|Overall Study|Lost to Follow-up|12|||
37811095|NCT02545998|69479823|FG001|Overall Study|Lost to Follow-up|3|||
37811096|NCT02545998|69479822|FG000|Overall Study|Withdrawal by Subject|3|||
37977191|NCT00406653|69664406|FG004|Maintenance Period|Adverse Event|1|||
37977192|NCT00406653|69664407|FG005|Maintenance Period|Adverse Event|1|||
37977193|NCT00406653|69664408|FG006|Maintenance Period|Adverse Event|0|||
37977194|NCT00406653|69664402|FG000|Maintenance Period|Lack of Efficacy|0|||
37977195|NCT00406653|69664403|FG001|Maintenance Period|Lack of Efficacy|0|||
37977196|NCT00406653|69664404|FG002|Maintenance Period|Lack of Efficacy|0|||
37977197|NCT00406653|69664405|FG003|Maintenance Period|Lack of Efficacy|0|||
37694205|NCT02094573|69170480|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
37811097|NCT02545998|69479823|FG001|Overall Study|Withdrawal by Subject|2|||
37811098|NCT02257242|69479847|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
37811099|NCT02257242|69479848|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
37811100|NCT02257242|69479849|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
37811101|NCT02257242|69479850|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
37833550|NCT01263496|69517275|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
37833551|NCT01263496|69517276|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
37833552|NCT01263496|69517268|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
37833553|NCT01263496|69517269|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
37833554|NCT01263496|69517270|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
37811102|NCT02257242|69479851|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
37811103|NCT02257242|69479852|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
37811104|NCT02257242|69479853|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
37811105|NCT02257242|69479854|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
37811106|NCT02257242|69479855|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
37811107|NCT01943916|69479885|FG000|Overall Study|Technically invalid images|10|||
37811108|NCT01943916|69479885|FG000|Overall Study|Enrollment Failure|23|||
37811109|NCT01943916|69479885|FG000|Overall Study|Pilot Phase exclusion|100|||
37811110|NCT01943916|69479885|FG000|Overall Study|Quality Assurance Reader Fail|130|||
37811111|NCT01943916|69479885|FG000|Overall Study|Technical Failure|39|||
37811112|NCT01943916|69479885|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
37811113|NCT01943916|69479885|FG000|Overall Study|No Truth Panel Review|38|||
37811114|NCT01943916|69479885|FG000|Overall Study|Protocol Deviation|1|||
37811115|NCT01564368|69479894|FG000|Overall Study|Ineligible|18|||
37811116|NCT01564368|69479894|FG000|Overall Study|Not Randomized in Parent study|116|||
37811117|NCT01564368|69479894|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
37811118|NCT01564368|69479894|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
37811119|NCT00281658|69479902|FG000|Randomized Phase|Adverse Event|0|||
37811120|NCT00281658|69479903|FG001|Randomized Phase|Adverse Event|2|||
37811121|NCT00281658|69479904|FG002|Randomized Phase|Adverse Event|0|||
37811122|NCT00281658|69479905|FG003|Randomized Phase|Adverse Event|0|||
37811123|NCT00281658|69479902|FG000|Randomized Phase|Lost to Follow-up|34|||
37811124|NCT00281658|69479903|FG001|Randomized Phase|Lost to Follow-up|27|||
37811125|NCT00281658|69479904|FG002|Randomized Phase|Lost to Follow-up|0|||
37811126|NCT00281658|69479905|FG003|Randomized Phase|Lost to Follow-up|0|||
37811127|NCT00281658|69479902|FG000|Randomized Phase|Withdrawal by Subject|8|||
37811128|NCT00281658|69479903|FG001|Randomized Phase|Withdrawal by Subject|7|||
37811129|NCT00281658|69479904|FG002|Randomized Phase|Withdrawal by Subject|0|||
37811130|NCT00281658|69479905|FG003|Randomized Phase|Withdrawal by Subject|0|||
37811131|NCT00281658|69479902|FG000|Randomized Phase|Study closed/terminated|1|||
37811132|NCT00281658|69479903|FG001|Randomized Phase|Study closed/terminated|1|||
37811133|NCT00281658|69479904|FG002|Randomized Phase|Study closed/terminated|0|||
37811134|NCT00281658|69479905|FG003|Randomized Phase|Study closed/terminated|0|||
37811135|NCT00281658|69479902|FG000|Randomized Phase|Disease progression|36|||
37811136|NCT00281658|69479903|FG001|Randomized Phase|Disease progression|27|||
37811137|NCT00281658|69479904|FG002|Randomized Phase|Disease progression|0|||
37811138|NCT00281658|69479905|FG003|Randomized Phase|Disease progression|0|||
37811139|NCT00281658|69479902|FG000|Randomized Phase|Physician Decision|1|||
37811140|NCT00281658|69479903|FG001|Randomized Phase|Physician Decision|1|||
37811141|NCT00281658|69479904|FG002|Randomized Phase|Physician Decision|0|||
37811142|NCT00281658|69479905|FG003|Randomized Phase|Physician Decision|0|||
37811143|NCT00281658|69479902|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
37811144|NCT00281658|69479903|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
37811145|NCT00281658|69479904|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
37811146|NCT00281658|69479905|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
37811147|NCT00281658|69479902|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
37811148|NCT00281658|69479903|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
37811149|NCT00281658|69479904|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
37811150|NCT00281658|69479905|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
37811151|NCT00281658|69479902|FG000|Randomized Phase|Treatment ongoing|1|||
37811152|NCT00281658|69479903|FG001|Randomized Phase|Treatment ongoing|0|||
37811153|NCT00281658|69479904|FG002|Randomized Phase|Treatment ongoing|0|||
37811154|NCT00281658|69479905|FG003|Randomized Phase|Treatment ongoing|0|||
37811155|NCT00281658|69479902|FG000|Open Label Phase|Adverse Event|0|||
37811156|NCT00281658|69479903|FG001|Open Label Phase|Adverse Event|0|||
37811157|NCT00281658|69479904|FG002|Open Label Phase|Adverse Event|1|||
37811158|NCT00281658|69479905|FG003|Open Label Phase|Adverse Event|0|||
37811159|NCT00281658|69479902|FG000|Open Label Phase|Lost to Follow-up|0|||
37811160|NCT00281658|69479903|FG001|Open Label Phase|Lost to Follow-up|0|||
37811161|NCT00281658|69479904|FG002|Open Label Phase|Lost to Follow-up|16|||
37811162|NCT00281658|69479905|FG003|Open Label Phase|Lost to Follow-up|2|||
37811163|NCT00281658|69479902|FG000|Open Label Phase|Withdrawal by Subject|0|||
37811164|NCT00281658|69479903|FG001|Open Label Phase|Withdrawal by Subject|0|||
37811165|NCT00281658|69479904|FG002|Open Label Phase|Withdrawal by Subject|3|||
37811166|NCT00281658|69479905|FG003|Open Label Phase|Withdrawal by Subject|2|||
37811167|NCT00281658|69479902|FG000|Open Label Phase|Disease progression|0|||
37811168|NCT00281658|69479903|FG001|Open Label Phase|Disease progression|0|||
37811169|NCT00281658|69479904|FG002|Open Label Phase|Disease progression|18|||
37811170|NCT00281658|69479905|FG003|Open Label Phase|Disease progression|0|||
37811171|NCT00281658|69479902|FG000|Open Label Phase|Physician Decision|0|||
37811172|NCT00281658|69479903|FG001|Open Label Phase|Physician Decision|0|||
37811173|NCT00281658|69479904|FG002|Open Label Phase|Physician Decision|1|||
37811174|NCT00281658|69479905|FG003|Open Label Phase|Physician Decision|0|||
37811175|NCT00281658|69479902|FG000|Open Label Phase|Relocation of patient|0|||
37977198|NCT00406653|69664406|FG004|Maintenance Period|Lack of Efficacy|20|||
37811176|NCT00281658|69479903|FG001|Open Label Phase|Relocation of patient|0|||
37811177|NCT00281658|69479904|FG002|Open Label Phase|Relocation of patient|1|||
37811178|NCT00281658|69479905|FG003|Open Label Phase|Relocation of patient|0|||
37977199|NCT00406653|69664407|FG005|Maintenance Period|Lack of Efficacy|26|||
37977200|NCT00406653|69664408|FG006|Maintenance Period|Lack of Efficacy|0|||
37977201|NCT00406653|69664402|FG000|Maintenance Period|Lost to Follow-up|0|||
37977202|NCT00406653|69664403|FG001|Maintenance Period|Lost to Follow-up|0|||
37977203|NCT00406653|69664404|FG002|Maintenance Period|Lost to Follow-up|0|||
37977204|NCT00406653|69664405|FG003|Maintenance Period|Lost to Follow-up|0|||
37977205|NCT00406653|69664406|FG004|Maintenance Period|Lost to Follow-up|2|||
37977206|NCT00406653|69664407|FG005|Maintenance Period|Lost to Follow-up|1|||
37977207|NCT00406653|69664408|FG006|Maintenance Period|Lost to Follow-up|0|||
37977208|NCT00406653|69664402|FG000|Maintenance Period|Withdrawal of Consent|0|||
37977209|NCT00406653|69664403|FG001|Maintenance Period|Withdrawal of Consent|0|||
37977210|NCT00406653|69664404|FG002|Maintenance Period|Withdrawal of Consent|0|||
37977211|NCT00406653|69664405|FG003|Maintenance Period|Withdrawal of Consent|0|||
37977212|NCT00406653|69664406|FG004|Maintenance Period|Withdrawal of Consent|2|||
37977213|NCT00406653|69664407|FG005|Maintenance Period|Withdrawal of Consent|0|||
37977214|NCT00406653|69664408|FG006|Maintenance Period|Withdrawal of Consent|0|||
37977215|NCT00406653|69664402|FG000|Maintenance Period|Pregnancy|0|||
37977216|NCT00406653|69664403|FG001|Maintenance Period|Pregnancy|0|||
37977217|NCT00406653|69664404|FG002|Maintenance Period|Pregnancy|0|||
37977218|NCT00406653|69664405|FG003|Maintenance Period|Pregnancy|0|||
37977219|NCT00406653|69664406|FG004|Maintenance Period|Pregnancy|0|||
37977220|NCT00406653|69664407|FG005|Maintenance Period|Pregnancy|1|||
37977221|NCT00406653|69664408|FG006|Maintenance Period|Pregnancy|0|||
37977222|NCT00406653|69664402|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
37977223|NCT00406653|69664403|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
37977224|NCT00406653|69664404|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
37977225|NCT00406653|69664405|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
37977226|NCT00406653|69664406|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
37977227|NCT00406653|69664407|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
37811179|NCT00281658|69479902|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
37811180|NCT00281658|69479903|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
37811181|NCT00281658|69479904|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
37811182|NCT00281658|69479905|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
37811183|NCT02758626|69481298|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
37811184|NCT02758626|69481299|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
37811185|NCT02758626|69481298|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
37811186|NCT02758626|69481299|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
37811187|NCT02758626|69481298|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
37811188|NCT02758626|69481299|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
37811189|NCT02758626|69481298|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
37811190|NCT02758626|69481299|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
37811191|NCT02357784|69481305|FG000|Overall Study|Withdrawal by Subject|1|||
37811192|NCT01448616|69481312|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
37811193|NCT01448616|69481313|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
37811194|NCT01448616|69481314|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
37811195|NCT01448616|69481315|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
37811196|NCT01448616|69481312|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
37977228|NCT00406653|69664408|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
37977229|NCT00406653|69664402|FG000|Maintenance Period|Error in disease score evaluation|0|||
37977230|NCT00406653|69664403|FG001|Maintenance Period|Error in disease score evaluation|0|||
37977231|NCT00406653|69664404|FG002|Maintenance Period|Error in disease score evaluation|0|||
37977232|NCT00406653|69664405|FG003|Maintenance Period|Error in disease score evaluation|0|||
37977233|NCT00406653|69664406|FG004|Maintenance Period|Error in disease score evaluation|1|||
37811197|NCT01448616|69481313|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
37811198|NCT01448616|69481314|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
37811199|NCT01448616|69481315|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
37811200|NCT01448616|69481312|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
37811201|NCT01448616|69481313|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
37811202|NCT01448616|69481314|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
37811203|NCT01448616|69481315|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
37811204|NCT01448616|69481312|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
37811205|NCT01448616|69481313|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
37811206|NCT01448616|69481314|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
37811207|NCT01448616|69481315|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
37811208|NCT01448616|69481312|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
37811209|NCT01448616|69481313|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
37811210|NCT01448616|69481314|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
37811211|NCT01448616|69481315|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
37811212|NCT00074412|69481352|FG000|Overall Study|Death|30|||
37811213|NCT00074412|69481353|FG001|Overall Study|Death|26|||
37811214|NCT00074412|69481352|FG000|Overall Study|Lost to Follow-up|52|||
37811215|NCT00074412|69481353|FG001|Overall Study|Lost to Follow-up|58|||
37811216|NCT04505592|69482359|FG000|Overall Study|Death|2|||
37811217|NCT04505592|69482360|FG001|Overall Study|Death|1|||
37811218|NCT04706793|69482663|FG000|Treatment|Disease worsening|10|||
37811219|NCT04706793|69482664|FG001|Treatment|Disease worsening|10|||
37811220|NCT04706793|69482663|FG000|Follow-up|Lack of Efficacy|1|||
37811221|NCT04706793|69482664|FG001|Follow-up|Lack of Efficacy|0|||
37811222|NCT04706793|69482663|FG000|Follow-up|Disease worsening|8|||
37811223|NCT04706793|69482664|FG001|Follow-up|Disease worsening|10|||
37811224|NCT04706793|69482663|FG000|Follow-up|Adverse Event|1|||
37811225|NCT04706793|69482664|FG001|Follow-up|Adverse Event|0|||
37811226|NCT04607148|69482674|FG000|Overall Study|Withdrawal by Subject|0|||
37811227|NCT04607148|69482675|FG001|Overall Study|Withdrawal by Subject|4|||
37811228|NCT04607148|69482676|FG002|Overall Study|Withdrawal by Subject|2|||
37811229|NCT04607148|69482677|FG003|Overall Study|Withdrawal by Subject|8|||
37811230|NCT04607148|69482674|FG000|Overall Study|Study Terminated by Sponsor|14|||
37811231|NCT04607148|69482675|FG001|Overall Study|Study Terminated by Sponsor|59|||
37811232|NCT04607148|69482676|FG002|Overall Study|Study Terminated by Sponsor|9|||
37811233|NCT04607148|69482677|FG003|Overall Study|Study Terminated by Sponsor|39|||
37811234|NCT04607148|69482674|FG000|Overall Study|Sponsor Decision|0|||
37811235|NCT04607148|69482675|FG001|Overall Study|Sponsor Decision|0|||
37811236|NCT04607148|69482676|FG002|Overall Study|Sponsor Decision|1|||
37811237|NCT04607148|69482677|FG003|Overall Study|Sponsor Decision|0|||
37811238|NCT04607148|69482674|FG000|Overall Study|Non-Compliance With Study Drug|0|||
37811239|NCT04607148|69482675|FG001|Overall Study|Non-Compliance With Study Drug|1|||
37811240|NCT04607148|69482676|FG002|Overall Study|Non-Compliance With Study Drug|0|||
37811241|NCT04607148|69482677|FG003|Overall Study|Non-Compliance With Study Drug|0|||
37811242|NCT04607148|69482674|FG000|Overall Study|Lost to Follow-up|0|||
37811243|NCT04607148|69482675|FG001|Overall Study|Lost to Follow-up|2|||
37811244|NCT04607148|69482676|FG002|Overall Study|Lost to Follow-up|0|||
37811245|NCT04607148|69482677|FG003|Overall Study|Lost to Follow-up|0|||
37811246|NCT04607148|69482674|FG000|Overall Study|Death|0|||
37811247|NCT04607148|69482675|FG001|Overall Study|Death|3|||
37811248|NCT04607148|69482676|FG002|Overall Study|Death|0|||
37811249|NCT04607148|69482677|FG003|Overall Study|Death|1|||
37811250|NCT04607148|69482674|FG000|Overall Study|Adverse Event|0|||
37811251|NCT04607148|69482675|FG001|Overall Study|Adverse Event|1|||
37811252|NCT04607148|69482676|FG002|Overall Study|Adverse Event|0|||
37811253|NCT04607148|69482677|FG003|Overall Study|Adverse Event|0|||
37811254|NCT04542057|69482689|FG000|Overall Study|Death|3|||
37811255|NCT04542057|69482690|FG001|Overall Study|Death|1|||
37811256|NCT04542057|69482689|FG000|Overall Study|COPD exacerbation withdrawal criteria|5|||
37811257|NCT04542057|69482690|FG001|Overall Study|COPD exacerbation withdrawal criteria|6|||
37811258|NCT04542057|69482689|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|10|||
37811259|NCT04542057|69482690|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
37811260|NCT04542057|69482689|FG000|Overall Study|Adverse Event|15|||
37811261|NCT04542057|69482690|FG001|Overall Study|Adverse Event|6|||
37811262|NCT04542057|69482689|FG000|Overall Study|COVID-19 adverse event|6|||
37811263|NCT04542057|69482690|FG001|Overall Study|COVID-19 adverse event|4|||
37811264|NCT04542057|69482689|FG000|Overall Study|Lack of Efficacy|2|||
37811265|NCT04542057|69482690|FG001|Overall Study|Lack of Efficacy|5|||
37811266|NCT04542057|69482689|FG000|Overall Study|Study terminated by sponsor|1|||
37811267|NCT04542057|69482690|FG001|Overall Study|Study terminated by sponsor|0|||
37811268|NCT04542057|69482689|FG000|Overall Study|Investigator discretion|2|||
37811269|NCT04542057|69482690|FG001|Overall Study|Investigator discretion|1|||
37811270|NCT04542057|69482689|FG000|Overall Study|Withdrawal by Subject|52|||
37811271|NCT04542057|69482690|FG001|Overall Study|Withdrawal by Subject|30|||
37811272|NCT04542057|69482689|FG000|Overall Study|Lost to Follow-up|8|||
37811273|NCT04542057|69482690|FG001|Overall Study|Lost to Follow-up|11|||
37811274|NCT04542057|69482689|FG000|Overall Study|Other|2|||
37811275|NCT04542057|69482690|FG001|Overall Study|Other|2|||
37811276|NCT04193527|69482704|FG000|Overall Study|Other|1|||
37811277|NCT04193527|69482705|FG001|Overall Study|Other|1|||
37811278|NCT04193527|69482706|FG002|Overall Study|Other|0|||
37811279|NCT03915470|69482719|FG000|Overall Study|Death|3|||
37811280|NCT03915470|69482720|FG001|Overall Study|Death|1|||
37811281|NCT03915470|69482719|FG000|Overall Study|Adverse Event|1|||
37811282|NCT03915470|69482720|FG001|Overall Study|Adverse Event|0|||
37811283|NCT03915470|69482719|FG000|Overall Study|Physician Decision|1|||
37811284|NCT03915470|69482720|FG001|Overall Study|Physician Decision|0|||
37811285|NCT03915470|69482719|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
37811286|NCT03915470|69482720|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
37811287|NCT03575468|69482728|FG000|Overall Study|Withdrawal by Subject|3|||
37811288|NCT03575468|69482729|FG001|Overall Study|Withdrawal by Subject|0|||
37811289|NCT03575468|69482728|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
37811290|NCT03575468|69482729|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
37811291|NCT03575468|69482728|FG000|Overall Study|Lost to Follow-up|13|||
37811292|NCT03575468|69482729|FG001|Overall Study|Lost to Follow-up|17|||
37811293|NCT03555981|69482737|FG000|Overall Study|Lost to Follow-up|0|||
37811294|NCT03555981|69482738|FG001|Overall Study|Lost to Follow-up|2|||
37811295|NCT03488225|69482744|FG000|Overall Study|Off Protocol Therapy|2|||
37811296|NCT03488225|69482744|FG000|Overall Study|Stem Cell Transplant|2|||
37811297|NCT03382834|69482750|FG000|Overall Study|Lost to Follow-up|1|||
37811298|NCT03382834|69482751|FG001|Overall Study|Lost to Follow-up|0|||
37811299|NCT03382834|69482750|FG000|Overall Study|Withdrawal by Subject|0|||
37811300|NCT03382834|69482751|FG001|Overall Study|Withdrawal by Subject|1|||
37811301|NCT03308942|69482762|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
37811302|NCT03308942|69482763|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
37811303|NCT03308942|69482764|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
37811304|NCT03308942|69482765|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
37977234|NCT00406653|69664407|FG005|Maintenance Period|Error in disease score evaluation|0|||
37977235|NCT00406653|69664408|FG006|Maintenance Period|Error in disease score evaluation|0|||
37977236|NCT00406653|69664402|FG000|Open-Label Period|Death|0|||
37977237|NCT00406653|69664403|FG001|Open-Label Period|Death|0|||
37977238|NCT00406653|69664404|FG002|Open-Label Period|Death|0|||
37977239|NCT00406653|69664405|FG003|Open-Label Period|Death|0|||
37977240|NCT00406653|69664406|FG004|Open-Label Period|Death|0|||
37977241|NCT00406653|69664407|FG005|Open-Label Period|Death|0|||
37977242|NCT00406653|69664408|FG006|Open-Label Period|Death|1|||
37977243|NCT00406653|69664402|FG000|Open-Label Period|Adverse Event|0|||
37977244|NCT00406653|69664403|FG001|Open-Label Period|Adverse Event|0|||
37977245|NCT00406653|69664404|FG002|Open-Label Period|Adverse Event|0|||
37977246|NCT00406653|69664405|FG003|Open-Label Period|Adverse Event|0|||
37977247|NCT00406653|69664406|FG004|Open-Label Period|Adverse Event|0|||
37977248|NCT00406653|69664407|FG005|Open-Label Period|Adverse Event|0|||
37977249|NCT00406653|69664408|FG006|Open-Label Period|Adverse Event|18|||
37977250|NCT00406653|69664402|FG000|Open-Label Period|Lack of Efficacy|0|||
37977251|NCT00406653|69664403|FG001|Open-Label Period|Lack of Efficacy|0|||
37977252|NCT00406653|69664404|FG002|Open-Label Period|Lack of Efficacy|0|||
37977253|NCT00406653|69664405|FG003|Open-Label Period|Lack of Efficacy|0|||
37977254|NCT00406653|69664406|FG004|Open-Label Period|Lack of Efficacy|0|||
37977255|NCT00406653|69664407|FG005|Open-Label Period|Lack of Efficacy|0|||
37977256|NCT00406653|69664408|FG006|Open-Label Period|Lack of Efficacy|160|||
37977257|NCT00406653|69664402|FG000|Open-Label Period|Lost to Follow-up|0|||
37977258|NCT00406653|69664403|FG001|Open-Label Period|Lost to Follow-up|0|||
37977259|NCT00406653|69664404|FG002|Open-Label Period|Lost to Follow-up|0|||
37977260|NCT00406653|69664405|FG003|Open-Label Period|Lost to Follow-up|0|||
37977261|NCT00406653|69664406|FG004|Open-Label Period|Lost to Follow-up|0|||
37977262|NCT00406653|69664407|FG005|Open-Label Period|Lost to Follow-up|0|||
37977263|NCT00406653|69664408|FG006|Open-Label Period|Lost to Follow-up|6|||
37977264|NCT00406653|69664402|FG000|Open-Label Period|Withdrawal of Consent|0|||
37977265|NCT00406653|69664403|FG001|Open-Label Period|Withdrawal of Consent|0|||
37977266|NCT00406653|69664404|FG002|Open-Label Period|Withdrawal of Consent|0|||
37811305|NCT03308942|69482766|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
37977267|NCT00406653|69664405|FG003|Open-Label Period|Withdrawal of Consent|0|||
37977268|NCT00406653|69664406|FG004|Open-Label Period|Withdrawal of Consent|0|||
37811306|NCT03308942|69482762|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
37811307|NCT03308942|69482763|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
37811308|NCT03308942|69482764|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
37977269|NCT00406653|69664407|FG005|Open-Label Period|Withdrawal of Consent|0|||
37977270|NCT00406653|69664408|FG006|Open-Label Period|Withdrawal of Consent|11|||
37977271|NCT00406653|69664402|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
37977272|NCT00406653|69664403|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
37977273|NCT00406653|69664404|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
37977274|NCT00406653|69664405|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
37977275|NCT00406653|69664406|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
37977276|NCT00406653|69664407|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
37977277|NCT00406653|69664408|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
37811309|NCT03308942|69482765|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
37811310|NCT03308942|69482766|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
37811311|NCT03308942|69482762|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
37811312|NCT03308942|69482763|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
37811313|NCT03308942|69482764|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
37811314|NCT03308942|69482765|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
37811315|NCT03308942|69482766|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
37811316|NCT03308942|69482762|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
37811317|NCT03308942|69482763|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
37811318|NCT03308942|69482764|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
37811319|NCT03308942|69482765|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
37811320|NCT03308942|69482766|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
37811321|NCT03308942|69482762|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
37811322|NCT03308942|69482763|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
37811323|NCT03308942|69482764|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
37977278|NCT00406653|69664402|FG000|Open-Label Period|Pregnancy|0|||
37977279|NCT00406653|69664403|FG001|Open-Label Period|Pregnancy|0|||
37977280|NCT00406653|69664404|FG002|Open-Label Period|Pregnancy|0|||
37977281|NCT00406653|69664405|FG003|Open-Label Period|Pregnancy|0|||
37977282|NCT00406653|69664406|FG004|Open-Label Period|Pregnancy|0|||
37977283|NCT00406653|69664407|FG005|Open-Label Period|Pregnancy|0|||
37977284|NCT00406653|69664408|FG006|Open-Label Period|Pregnancy|2|||
37977285|NCT00406653|69664402|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
37977286|NCT00406653|69664403|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
37977287|NCT00406653|69664404|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
37977288|NCT00406653|69664405|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
37977289|NCT00406653|69664406|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
37977290|NCT00406653|69664407|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
37977291|NCT00406653|69664408|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
37977292|NCT00406653|69664402|FG000|Open-Label Period|Declined participation but followup done|0|||
37977293|NCT00406653|69664403|FG001|Open-Label Period|Declined participation but followup done|0|||
37811324|NCT03308942|69482765|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
37811325|NCT03308942|69482766|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
37811326|NCT03308942|69482762|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
37811327|NCT03308942|69482763|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
37811328|NCT03308942|69482764|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
37811329|NCT03308942|69482765|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
37811330|NCT03308942|69482766|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
37811331|NCT03308942|69482762|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
37811332|NCT03308942|69482763|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
37811333|NCT03308942|69482764|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
37811334|NCT03308942|69482765|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
37811335|NCT03308942|69482766|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
37811336|NCT03291431|69482781|FG000|Overall Study|Protocol Violation|2|||
37811337|NCT03291431|69482782|FG001|Overall Study|Protocol Violation|1|||
37811338|NCT03291431|69482781|FG000|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|1|||
37811339|NCT03291431|69482782|FG001|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|0|||
37811340|NCT03291431|69482781|FG000|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|0|||
37811341|NCT03291431|69482782|FG001|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|1|||
37811342|NCT03261401|69482801|FG000|Overall Study|Withdrawal by Subject|0|||
37811343|NCT03261401|69482802|FG001|Overall Study|Withdrawal by Subject|0|||
37811344|NCT03261401|69482803|FG002|Overall Study|Withdrawal by Subject|0|||
37811345|NCT03261401|69482804|FG003|Overall Study|Withdrawal by Subject|0|||
37811346|NCT03261401|69482805|FG004|Overall Study|Withdrawal by Subject|0|||
37811347|NCT03261401|69482806|FG005|Overall Study|Withdrawal by Subject|1|||
37864380|NCT01259492|69548037|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
37977294|NCT00406653|69664404|FG002|Open-Label Period|Declined participation but followup done|0|||
37977295|NCT00406653|69664405|FG003|Open-Label Period|Declined participation but followup done|0|||
37977296|NCT00406653|69664406|FG004|Open-Label Period|Declined participation but followup done|0|||
37811348|NCT03261401|69482807|FG006|Overall Study|Withdrawal by Subject|0|||
37977297|NCT00406653|69664407|FG005|Open-Label Period|Declined participation but followup done|0|||
37977298|NCT00406653|69664408|FG006|Open-Label Period|Declined participation but followup done|8|||
37977299|NCT00406653|69664402|FG000|Open-Label Period|Discontinued by Sponsor|0|||
37977300|NCT00406653|69664403|FG001|Open-Label Period|Discontinued by Sponsor|0|||
37977301|NCT00406653|69664404|FG002|Open-Label Period|Discontinued by Sponsor|0|||
37977302|NCT00406653|69664405|FG003|Open-Label Period|Discontinued by Sponsor|0|||
37977303|NCT00406653|69664406|FG004|Open-Label Period|Discontinued by Sponsor|0|||
37977304|NCT00406653|69664407|FG005|Open-Label Period|Discontinued by Sponsor|0|||
37977305|NCT00406653|69664408|FG006|Open-Label Period|Discontinued by Sponsor|1|||
37811349|NCT03261401|69482808|FG007|Overall Study|Withdrawal by Subject|0|||
37811350|NCT03261401|69482809|FG008|Overall Study|Withdrawal by Subject|0|||
37811351|NCT03261401|69482810|FG009|Overall Study|Withdrawal by Subject|0|||
37811352|NCT03261401|69482811|FG010|Overall Study|Withdrawal by Subject|0|||
37811353|NCT03261401|69482812|FG011|Overall Study|Withdrawal by Subject|0|||
37811354|NCT03261401|69482813|FG012|Overall Study|Withdrawal by Subject|0|||
37811355|NCT03261401|69482801|FG000|Overall Study|Participant Unable To Attend Final Visit|0|||
37811356|NCT03261401|69482802|FG001|Overall Study|Participant Unable To Attend Final Visit|0|||
37811357|NCT03261401|69482803|FG002|Overall Study|Participant Unable To Attend Final Visit|0|||
37811358|NCT03261401|69482804|FG003|Overall Study|Participant Unable To Attend Final Visit|0|||
37811359|NCT03261401|69482805|FG004|Overall Study|Participant Unable To Attend Final Visit|0|||
37811360|NCT03261401|69482806|FG005|Overall Study|Participant Unable To Attend Final Visit|0|||
37694206|NCT02094573|69170479|FG000|Overall Study|Non-compliance with Study Drug|1|||
37694207|NCT02094573|69170480|FG001|Overall Study|Non-compliance with Study Drug|1|||
37694208|NCT02094573|69170479|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
37694209|NCT02094573|69170480|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
37694210|NCT02094573|69170479|FG000|Overall Study|Physician Decision|4|||
37694211|NCT02094573|69170480|FG001|Overall Study|Physician Decision|4|||
37694212|NCT02094573|69170479|FG000|Overall Study|Site Terminated by Sponsor|10|||
37694213|NCT02094573|69170480|FG001|Overall Study|Site Terminated by Sponsor|17|||
37694214|NCT02094573|69170479|FG000|Overall Study|Withdrawal by Subject|6|||
37694215|NCT02094573|69170480|FG001|Overall Study|Withdrawal by Subject|8|||
37694216|NCT02094573|69170479|FG000|Overall Study|Randomized but not Treated|3|||
37811361|NCT03261401|69482807|FG006|Overall Study|Participant Unable To Attend Final Visit|0|||
37811362|NCT03261401|69482808|FG007|Overall Study|Participant Unable To Attend Final Visit|0|||
37977306|NCT00406653|69664402|FG000|Open-Label Period|Refused followup|0|||
37977307|NCT00406653|69664403|FG001|Open-Label Period|Refused followup|0|||
37694217|NCT02094573|69170480|FG001|Overall Study|Randomized but not Treated|0|||
37811363|NCT03261401|69482809|FG008|Overall Study|Participant Unable To Attend Final Visit|0|||
37811364|NCT03261401|69482810|FG009|Overall Study|Participant Unable To Attend Final Visit|0|||
37811365|NCT03261401|69482811|FG010|Overall Study|Participant Unable To Attend Final Visit|0|||
37811366|NCT03261401|69482812|FG011|Overall Study|Participant Unable To Attend Final Visit|0|||
37811367|NCT03261401|69482813|FG012|Overall Study|Participant Unable To Attend Final Visit|1|||
37811368|NCT02998528|69482853|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
37811369|NCT02998528|69482854|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
37811370|NCT02998528|69482855|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
37811371|NCT02998528|69482853|FG000|Randomization Period|Participant withdrew consent|0|||
37811372|NCT02998528|69482854|FG001|Randomization Period|Participant withdrew consent|3|||
37811373|NCT02998528|69482855|FG002|Randomization Period|Participant withdrew consent|0|||
37811374|NCT02998528|69482853|FG000|Randomization Period|Participant no longer meets study criteria|1|||
37811375|NCT02998528|69482854|FG001|Randomization Period|Participant no longer meets study criteria|3|||
37811376|NCT02998528|69482855|FG002|Randomization Period|Participant no longer meets study criteria|2|||
37811377|NCT02998528|69482853|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
37811378|NCT02998528|69482854|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
37811379|NCT02998528|69482855|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
37811380|NCT02998528|69482853|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
37811381|NCT02998528|69482854|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
37811382|NCT02998528|69482855|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
37811383|NCT02998528|69482853|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
37811384|NCT02998528|69482854|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
37811385|NCT02998528|69482855|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
37811386|NCT02998528|69482853|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
37811387|NCT02998528|69482854|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
37811388|NCT02998528|69482855|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
37811389|NCT02998528|69482853|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
37811390|NCT02998528|69482854|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
37811391|NCT02998528|69482855|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
37811392|NCT02998528|69482853|FG000|Neoadjuvant Treatment Period|Death|1|||
37811393|NCT02998528|69482854|FG001|Neoadjuvant Treatment Period|Death|0|||
37811394|NCT02998528|69482855|FG002|Neoadjuvant Treatment Period|Death|0|||
37811395|NCT02998528|69482853|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
37811396|NCT02998528|69482854|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
37811397|NCT02998528|69482855|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
37811398|NCT02998528|69482853|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
37811399|NCT02998528|69482854|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
37811400|NCT02998528|69482855|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
37811401|NCT02998528|69482853|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
37811402|NCT02998528|69482854|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
37811403|NCT02998528|69482855|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
37811404|NCT02998528|69482853|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
37811405|NCT02998528|69482854|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
37811406|NCT02998528|69482855|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
37811407|NCT02998528|69482853|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
37811408|NCT02998528|69482854|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
37811409|NCT02998528|69482855|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
37811410|NCT02998528|69482853|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
37811411|NCT02998528|69482854|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
37811412|NCT02998528|69482855|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
37811413|NCT02718911|69482876|FG000|Overall Study|Adverse Event|0|||
37811414|NCT02718911|69482877|FG001|Overall Study|Adverse Event|0|||
37811415|NCT02718911|69482878|FG002|Overall Study|Adverse Event|0|||
37811416|NCT02718911|69482879|FG003|Overall Study|Adverse Event|0|||
37811417|NCT02718911|69482880|FG004|Overall Study|Adverse Event|0|||
37811418|NCT02718911|69482881|FG005|Overall Study|Adverse Event|0|||
37811419|NCT02718911|69482882|FG006|Overall Study|Adverse Event|0|||
37811420|NCT02718911|69482883|FG007|Overall Study|Adverse Event|0|||
37811421|NCT02718911|69482884|FG008|Overall Study|Adverse Event|0|||
37811422|NCT02718911|69482885|FG009|Overall Study|Adverse Event|2|||
37811423|NCT02718911|69482876|FG000|Overall Study|Death|2|||
37811424|NCT02718911|69482877|FG001|Overall Study|Death|3|||
37811425|NCT02718911|69482878|FG002|Overall Study|Death|1|||
37811426|NCT02718911|69482879|FG003|Overall Study|Death|0|||
37811427|NCT02718911|69482880|FG004|Overall Study|Death|1|||
37811428|NCT02718911|69482881|FG005|Overall Study|Death|3|||
37811429|NCT02718911|69482882|FG006|Overall Study|Death|1|||
37811430|NCT02718911|69482883|FG007|Overall Study|Death|1|||
37811431|NCT02718911|69482884|FG008|Overall Study|Death|4|||
37811432|NCT02718911|69482885|FG009|Overall Study|Death|3|||
37811433|NCT02718911|69482876|FG000|Overall Study|Lost to Follow-up|0|||
37811434|NCT02718911|69482877|FG001|Overall Study|Lost to Follow-up|0|||
37811435|NCT02718911|69482878|FG002|Overall Study|Lost to Follow-up|0|||
37811436|NCT02718911|69482879|FG003|Overall Study|Lost to Follow-up|0|||
37811437|NCT02718911|69482880|FG004|Overall Study|Lost to Follow-up|0|||
37811438|NCT02718911|69482881|FG005|Overall Study|Lost to Follow-up|0|||
37811439|NCT02718911|69482882|FG006|Overall Study|Lost to Follow-up|0|||
37811440|NCT02718911|69482883|FG007|Overall Study|Lost to Follow-up|0|||
37811441|NCT02718911|69482884|FG008|Overall Study|Lost to Follow-up|1|||
37811442|NCT02718911|69482885|FG009|Overall Study|Lost to Follow-up|0|||
37811443|NCT02718911|69482876|FG000|Overall Study|Physician Decision|2|||
37811444|NCT02718911|69482877|FG001|Overall Study|Physician Decision|0|||
37811445|NCT02718911|69482878|FG002|Overall Study|Physician Decision|1|||
37811446|NCT02718911|69482879|FG003|Overall Study|Physician Decision|1|||
37811447|NCT02718911|69482880|FG004|Overall Study|Physician Decision|0|||
37811448|NCT02718911|69482881|FG005|Overall Study|Physician Decision|0|||
37811449|NCT02718911|69482882|FG006|Overall Study|Physician Decision|0|||
37811450|NCT02718911|69482883|FG007|Overall Study|Physician Decision|1|||
37811451|NCT02718911|69482884|FG008|Overall Study|Physician Decision|2|||
37811452|NCT02718911|69482885|FG009|Overall Study|Physician Decision|1|||
37811453|NCT02718911|69482876|FG000|Overall Study|Withdrawal by Subject|0|||
37811454|NCT02718911|69482877|FG001|Overall Study|Withdrawal by Subject|0|||
37811455|NCT02718911|69482878|FG002|Overall Study|Withdrawal by Subject|0|||
37811456|NCT02718911|69482879|FG003|Overall Study|Withdrawal by Subject|0|||
37811457|NCT02718911|69482880|FG004|Overall Study|Withdrawal by Subject|1|||
37811458|NCT02718911|69482881|FG005|Overall Study|Withdrawal by Subject|0|||
37811459|NCT02718911|69482882|FG006|Overall Study|Withdrawal by Subject|0|||
37811460|NCT02718911|69482883|FG007|Overall Study|Withdrawal by Subject|0|||
37811461|NCT02718911|69482884|FG008|Overall Study|Withdrawal by Subject|1|||
37811462|NCT02718911|69482885|FG009|Overall Study|Withdrawal by Subject|4|||
37811463|NCT02718911|69482876|FG000|Overall Study|Reason Not Collected|0|||
37811464|NCT02718911|69482877|FG001|Overall Study|Reason Not Collected|0|||
37811465|NCT02718911|69482878|FG002|Overall Study|Reason Not Collected|1|||
37811466|NCT02718911|69482879|FG003|Overall Study|Reason Not Collected|0|||
37811467|NCT02718911|69482880|FG004|Overall Study|Reason Not Collected|0|||
37811468|NCT02718911|69482881|FG005|Overall Study|Reason Not Collected|0|||
37811469|NCT02718911|69482882|FG006|Overall Study|Reason Not Collected|2|||
37811470|NCT02718911|69482883|FG007|Overall Study|Reason Not Collected|1|||
37811471|NCT02718911|69482884|FG008|Overall Study|Reason Not Collected|4|||
37811472|NCT02718911|69482885|FG009|Overall Study|Reason Not Collected|9|||
37811473|NCT02542267|69482909|FG000|Overall Study|Withdrawal by Subject|10|||
37811474|NCT02542267|69482909|FG000|Overall Study|Physician Decision|6|||
37811475|NCT02542267|69482909|FG000|Overall Study|Lost to Follow-up|4|||
37811476|NCT02542267|69482909|FG000|Overall Study|Death|13|||
37811477|NCT02542267|69482909|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
37811478|NCT02542267|69482909|FG000|Overall Study|Other|9|||
37811479|NCT02017717|69482961|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
37811480|NCT02017717|69482962|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
37811481|NCT02017717|69482963|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
37811482|NCT02017717|69482964|FG003|Before Treatment Period|Adverse Event unrelated to study drug|1|||
37811483|NCT02017717|69482965|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
37811484|NCT02017717|69482966|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
37811485|NCT02017717|69482967|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
37811486|NCT02017717|69482968|FG007|Before Treatment Period|Adverse Event unrelated to study drug|0|||
37811487|NCT02017717|69482969|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
37811488|NCT02017717|69482961|FG000|Before Treatment Period|Participant request to stop therapy|0|||
37811489|NCT02017717|69482962|FG001|Before Treatment Period|Participant request to stop therapy|0|||
37811490|NCT02017717|69482963|FG002|Before Treatment Period|Participant request to stop therapy|0|||
37811491|NCT02017717|69482964|FG003|Before Treatment Period|Participant request to stop therapy|0|||
37811492|NCT02017717|69482965|FG004|Before Treatment Period|Participant request to stop therapy|5|||
37811493|NCT02017717|69482966|FG005|Before Treatment Period|Participant request to stop therapy|0|||
37811494|NCT02017717|69482967|FG006|Before Treatment Period|Participant request to stop therapy|0|||
37811495|NCT02017717|69482968|FG007|Before Treatment Period|Participant request to stop therapy|0|||
37811496|NCT02017717|69482969|FG008|Before Treatment Period|Participant request to stop therapy|0|||
37811497|NCT02017717|69482961|FG000|Before Treatment Period|Participant withdrew consent|0|||
37811498|NCT02017717|69482962|FG001|Before Treatment Period|Participant withdrew consent|0|||
37811499|NCT02017717|69482963|FG002|Before Treatment Period|Participant withdrew consent|0|||
37811500|NCT02017717|69482964|FG003|Before Treatment Period|Participant withdrew consent|0|||
37811501|NCT02017717|69482965|FG004|Before Treatment Period|Participant withdrew consent|11|||
37811502|NCT02017717|69482966|FG005|Before Treatment Period|Participant withdrew consent|0|||
37811503|NCT02017717|69482967|FG006|Before Treatment Period|Participant withdrew consent|0|||
37811504|NCT02017717|69482968|FG007|Before Treatment Period|Participant withdrew consent|0|||
37811505|NCT02017717|69482969|FG008|Before Treatment Period|Participant withdrew consent|2|||
37811506|NCT02017717|69482961|FG000|Before Treatment Period|Lost to Follow-up|0|||
37811507|NCT02017717|69482962|FG001|Before Treatment Period|Lost to Follow-up|0|||
37811508|NCT02017717|69482963|FG002|Before Treatment Period|Lost to Follow-up|0|||
37811509|NCT02017717|69482964|FG003|Before Treatment Period|Lost to Follow-up|0|||
37811510|NCT02017717|69482965|FG004|Before Treatment Period|Lost to Follow-up|1|||
37811511|NCT02017717|69482966|FG005|Before Treatment Period|Lost to Follow-up|0|||
37811512|NCT02017717|69482967|FG006|Before Treatment Period|Lost to Follow-up|0|||
37811513|NCT02017717|69482968|FG007|Before Treatment Period|Lost to Follow-up|0|||
37811514|NCT02017717|69482969|FG008|Before Treatment Period|Lost to Follow-up|0|||
37811515|NCT02017717|69482961|FG000|Before Treatment Period|Participant no longer met criteria|0|||
37811516|NCT02017717|69482962|FG001|Before Treatment Period|Participant no longer met criteria|0|||
37811517|NCT02017717|69482963|FG002|Before Treatment Period|Participant no longer met criteria|0|||
37811518|NCT02017717|69482964|FG003|Before Treatment Period|Participant no longer met criteria|1|||
37811519|NCT02017717|69482965|FG004|Before Treatment Period|Participant no longer met criteria|2|||
37811520|NCT02017717|69482966|FG005|Before Treatment Period|Participant no longer met criteria|0|||
37811521|NCT02017717|69482967|FG006|Before Treatment Period|Participant no longer met criteria|0|||
37811522|NCT02017717|69482968|FG007|Before Treatment Period|Participant no longer met criteria|1|||
37811523|NCT02017717|69482969|FG008|Before Treatment Period|Participant no longer met criteria|0|||
37811524|NCT02017717|69482961|FG000|Before Treatment Period|other reason|0|||
37811525|NCT02017717|69482962|FG001|Before Treatment Period|other reason|0|||
37811526|NCT02017717|69482963|FG002|Before Treatment Period|other reason|0|||
37811527|NCT02017717|69482964|FG003|Before Treatment Period|other reason|0|||
37811528|NCT02017717|69482965|FG004|Before Treatment Period|other reason|1|||
37811529|NCT02017717|69482966|FG005|Before Treatment Period|other reason|0|||
37811530|NCT02017717|69482967|FG006|Before Treatment Period|other reason|0|||
37811531|NCT02017717|69482968|FG007|Before Treatment Period|other reason|0|||
37811532|NCT02017717|69482969|FG008|Before Treatment Period|other reason|0|||
37811533|NCT02017717|69482961|FG000|Treatment Period|Disease progression|7|||
37811534|NCT02017717|69482962|FG001|Treatment Period|Disease progression|9|||
37811535|NCT02017717|69482963|FG002|Treatment Period|Disease progression|12|||
37811536|NCT02017717|69482964|FG003|Treatment Period|Disease progression|165|||
37811537|NCT02017717|69482965|FG004|Treatment Period|Disease progression|134|||
37811538|NCT02017717|69482966|FG005|Treatment Period|Disease progression|20|||
37811539|NCT02017717|69482967|FG006|Treatment Period|Disease progression|26|||
37811540|NCT02017717|69482968|FG007|Treatment Period|Disease progression|17|||
37811541|NCT02017717|69482969|FG008|Treatment Period|Disease progression|22|||
37694218|NCT01859494|69170486|FG000|Overall Study|Adverse Event|1|||
37694219|NCT01858636|69170490|FG000|Overall Study|No Device Deployment Attempted|24|||
37694220|NCT01858636|69170490|FG000|Overall Study|Physician Decision|1|||
37694221|NCT01858636|69170490|FG000|Overall Study|Death|1|||
37694222|NCT01858636|69170490|FG000|Overall Study|Lost to Follow-up|1|||
37694223|NCT01858636|69170490|FG000|Overall Study|Withdrawal by Subject|1|||
37694224|NCT02058849|69170497|FG000|Overall Study|Hospitalization|1|||
37694225|NCT02058849|69170498|FG001|Overall Study|Hospitalization|1|||
37694226|NCT02058849|69170497|FG000|Overall Study|Death|1|||
37694227|NCT02058849|69170498|FG001|Overall Study|Death|0|||
37694228|NCT02058849|69170497|FG000|Overall Study|Lost to Follow-up|1|||
37694229|NCT02058849|69170498|FG001|Overall Study|Lost to Follow-up|0|||
37694230|NCT02058849|69170497|FG000|Overall Study|Withdrawal by Subject|4|||
37694231|NCT02058849|69170498|FG001|Overall Study|Withdrawal by Subject|0|||
37694232|NCT01858558|69170506|FG000|Overall Study|Death|1|||
37694233|NCT01858558|69170507|FG001|Overall Study|Death|1|||
37694234|NCT01858558|69170506|FG000|Overall Study|Lost to Follow-up|1|||
37694235|NCT01858558|69170507|FG001|Overall Study|Lost to Follow-up|0|||
37694236|NCT01858558|69170506|FG000|Overall Study|Disease progression|3|||
37694237|NCT01858558|69170507|FG001|Overall Study|Disease progression|1|||
37694238|NCT01858558|69170506|FG000|Overall Study|Product contamination|2|||
37694239|NCT01858558|69170507|FG001|Overall Study|Product contamination|0|||
37694240|NCT01858558|69170506|FG000|Overall Study|Failed expansion of cell product|2|||
37694241|NCT01858558|69170507|FG001|Overall Study|Failed expansion of cell product|0|||
37694242|NCT02058537|69170513|FG000|Overall Study|Withdrawal by Subject|1|||
37694243|NCT01612000|69170521|FG000|Overall Study|Lost to Follow-up|6|||
37694244|NCT01612000|69170522|FG001|Overall Study|Lost to Follow-up|4|||
37694245|NCT01612000|69170523|FG002|Overall Study|Lost to Follow-up|4|||
37694246|NCT01612000|69170524|FG003|Overall Study|Lost to Follow-up|8|||
37694247|NCT01612000|69170521|FG000|Overall Study|Physician Decision|0|||
37694248|NCT01612000|69170522|FG001|Overall Study|Physician Decision|0|||
37694249|NCT01612000|69170523|FG002|Overall Study|Physician Decision|1|||
37694250|NCT01612000|69170524|FG003|Overall Study|Physician Decision|0|||
37694251|NCT01612000|69170521|FG000|Overall Study|Withdrawal by Subject|3|||
37694252|NCT01612000|69170522|FG001|Overall Study|Withdrawal by Subject|1|||
37694253|NCT01612000|69170523|FG002|Overall Study|Withdrawal by Subject|2|||
37694254|NCT01612000|69170524|FG003|Overall Study|Withdrawal by Subject|2|||
37694255|NCT01895608|69170538|FG000|Overall Study|change in health status|0|||
37694256|NCT01895608|69170539|FG001|Overall Study|change in health status|1|||
37694257|NCT01895608|69170540|FG002|Overall Study|change in health status|1|||
37694258|NCT01895608|69170541|FG003|Overall Study|change in health status|0|||
37694259|NCT01895608|69170538|FG000|Overall Study|Withdrawal by Subject|0|||
37694260|NCT01895608|69170539|FG001|Overall Study|Withdrawal by Subject|0|||
37694261|NCT01895608|69170540|FG002|Overall Study|Withdrawal by Subject|2|||
37694262|NCT01895608|69170541|FG003|Overall Study|Withdrawal by Subject|0|||
37694263|NCT02409680|69170553|FG000|Overall Study|Lost to Follow-up|15|||
37694264|NCT02409680|69170554|FG001|Overall Study|Lost to Follow-up|30|||
37694265|NCT01895452|69170562|FG000|Overall Study|Adverse Event|1|||
37694266|NCT01895452|69170563|FG001|Overall Study|Adverse Event|4|||
37811542|NCT02017717|69482961|FG000|Treatment Period|Study drug toxicity|3|||
37977308|NCT00406653|69664404|FG002|Open-Label Period|Refused followup|0|||
37694267|NCT01895452|69170562|FG000|Overall Study|Lost to Follow-up|1|||
37694268|NCT01895452|69170563|FG001|Overall Study|Lost to Follow-up|5|||
37694269|NCT01895452|69170562|FG000|Overall Study|Pregnancy|0|||
37694270|NCT01895452|69170563|FG001|Overall Study|Pregnancy|1|||
37694271|NCT01895452|69170562|FG000|Overall Study|Withdrawal by Subject|2|||
37977309|NCT00406653|69664405|FG003|Open-Label Period|Refused followup|0|||
37694272|NCT01895452|69170563|FG001|Overall Study|Withdrawal by Subject|14|||
37694273|NCT01895452|69170562|FG000|Overall Study|Underlying disease|0|||
37694274|NCT01895452|69170563|FG001|Overall Study|Underlying disease|3|||
37811543|NCT02017717|69482962|FG001|Treatment Period|Study drug toxicity|0|||
37811544|NCT02017717|69482963|FG002|Treatment Period|Study drug toxicity|1|||
37811545|NCT02017717|69482964|FG003|Treatment Period|Study drug toxicity|7|||
37811546|NCT02017717|69482965|FG004|Treatment Period|Study drug toxicity|11|||
37811547|NCT02017717|69482966|FG005|Treatment Period|Study drug toxicity|4|||
37811548|NCT02017717|69482967|FG006|Treatment Period|Study drug toxicity|4|||
37811549|NCT02017717|69482968|FG007|Treatment Period|Study drug toxicity|5|||
37694275|NCT01895452|69170562|FG000|Overall Study|Noncompliance with study drug|0|||
37694276|NCT01895452|69170563|FG001|Overall Study|Noncompliance with study drug|1|||
37694277|NCT02094417|69170573|FG000|Overall Study|Adverse Event|0|||
37694278|NCT02094417|69170574|FG001|Overall Study|Adverse Event|0|||
37694279|NCT02094417|69170575|FG002|Overall Study|Adverse Event|0|||
37694280|NCT02094417|69170576|FG003|Overall Study|Adverse Event|1|||
37694281|NCT02094417|69170573|FG000|Overall Study|Eligibility criteria|0|||
37694282|NCT02094417|69170574|FG001|Overall Study|Eligibility criteria|1|||
37694283|NCT02094417|69170575|FG002|Overall Study|Eligibility criteria|0|||
37694284|NCT02094417|69170576|FG003|Overall Study|Eligibility criteria|0|||
37694285|NCT02094417|69170573|FG000|Overall Study|No responder|4|||
37694286|NCT02094417|69170574|FG001|Overall Study|No responder|4|||
37694287|NCT02094417|69170575|FG002|Overall Study|No responder|4|||
37694288|NCT02094417|69170576|FG003|Overall Study|No responder|3|||
37694289|NCT02094417|69170573|FG000|Overall Study|Unable to conduct observations or assess|0|||
37694290|NCT02094417|69170574|FG001|Overall Study|Unable to conduct observations or assess|1|||
37694291|NCT02094417|69170575|FG002|Overall Study|Unable to conduct observations or assess|0|||
37694292|NCT02094417|69170576|FG003|Overall Study|Unable to conduct observations or assess|0|||
37694293|NCT02094417|69170573|FG000|Overall Study|Withdrawal by Subject|1|||
37694294|NCT02094417|69170574|FG001|Overall Study|Withdrawal by Subject|2|||
37694295|NCT02094417|69170575|FG002|Overall Study|Withdrawal by Subject|1|||
37694296|NCT02094417|69170576|FG003|Overall Study|Withdrawal by Subject|3|||
37694297|NCT01894984|69170588|FG000|Overall Study|Other|314|||
37811550|NCT02017717|69482969|FG008|Treatment Period|Study drug toxicity|3|||
37811551|NCT02017717|69482961|FG000|Treatment Period|Death|0|||
37811552|NCT02017717|69482962|FG001|Treatment Period|Death|0|||
37811553|NCT02017717|69482963|FG002|Treatment Period|Death|1|||
37811554|NCT02017717|69482964|FG003|Treatment Period|Death|0|||
37811555|NCT02017717|69482965|FG004|Treatment Period|Death|0|||
37811556|NCT02017717|69482966|FG005|Treatment Period|Death|0|||
37811557|NCT02017717|69482967|FG006|Treatment Period|Death|0|||
37811558|NCT02017717|69482968|FG007|Treatment Period|Death|1|||
37811559|NCT02017717|69482969|FG008|Treatment Period|Death|0|||
37811560|NCT02017717|69482961|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
37811561|NCT02017717|69482962|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
37811562|NCT02017717|69482963|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
37811563|NCT02017717|69482964|FG003|Treatment Period|Adverse event unrelated to study drug|4|||
37811564|NCT02017717|69482965|FG004|Treatment Period|Adverse event unrelated to study drug|5|||
37811565|NCT02017717|69482966|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
37811566|NCT02017717|69482967|FG006|Treatment Period|Adverse event unrelated to study drug|0|||
37811567|NCT02017717|69482968|FG007|Treatment Period|Adverse event unrelated to study drug|0|||
37811568|NCT02017717|69482969|FG008|Treatment Period|Adverse event unrelated to study drug|1|||
37811569|NCT02017717|69482961|FG000|Treatment Period|Participant request to stop therapy|0|||
37811570|NCT02017717|69482962|FG001|Treatment Period|Participant request to stop therapy|0|||
37811571|NCT02017717|69482963|FG002|Treatment Period|Participant request to stop therapy|3|||
37811572|NCT02017717|69482964|FG003|Treatment Period|Participant request to stop therapy|4|||
37811573|NCT02017717|69482965|FG004|Treatment Period|Participant request to stop therapy|7|||
37811574|NCT02017717|69482966|FG005|Treatment Period|Participant request to stop therapy|5|||
37811575|NCT02017717|69482967|FG006|Treatment Period|Participant request to stop therapy|0|||
37811576|NCT02017717|69482968|FG007|Treatment Period|Participant request to stop therapy|2|||
37811577|NCT02017717|69482969|FG008|Treatment Period|Participant request to stop therapy|1|||
37811578|NCT02017717|69482961|FG000|Treatment Period|Participant withdrew consent|0|||
37811579|NCT02017717|69482962|FG001|Treatment Period|Participant withdrew consent|0|||
37694298|NCT01894984|69170589|FG001|Overall Study|Other|175|||
37694299|NCT02375672|69170595|FG000|Overall Study|remain on follow up|20|||
37694300|NCT01894516|69170603|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
37694301|NCT01894516|69170604|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
37694302|NCT01894516|69170605|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
37694303|NCT01894516|69170606|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
37811580|NCT02017717|69482963|FG002|Treatment Period|Participant withdrew consent|1|||
37811581|NCT02017717|69482964|FG003|Treatment Period|Participant withdrew consent|1|||
37811582|NCT02017717|69482965|FG004|Treatment Period|Participant withdrew consent|4|||
37811583|NCT02017717|69482966|FG005|Treatment Period|Participant withdrew consent|0|||
37811584|NCT02017717|69482967|FG006|Treatment Period|Participant withdrew consent|0|||
37811585|NCT02017717|69482968|FG007|Treatment Period|Participant withdrew consent|2|||
37811586|NCT02017717|69482969|FG008|Treatment Period|Participant withdrew consent|0|||
37811587|NCT02017717|69482961|FG000|Treatment Period|Participant no longer met criteria|0|||
37811588|NCT02017717|69482962|FG001|Treatment Period|Participant no longer met criteria|0|||
37811589|NCT02017717|69482963|FG002|Treatment Period|Participant no longer met criteria|0|||
37811590|NCT02017717|69482964|FG003|Treatment Period|Participant no longer met criteria|0|||
37811591|NCT02017717|69482965|FG004|Treatment Period|Participant no longer met criteria|1|||
37811592|NCT02017717|69482966|FG005|Treatment Period|Participant no longer met criteria|0|||
37811593|NCT02017717|69482967|FG006|Treatment Period|Participant no longer met criteria|0|||
37811594|NCT02017717|69482968|FG007|Treatment Period|Participant no longer met criteria|0|||
37811595|NCT02017717|69482969|FG008|Treatment Period|Participant no longer met criteria|0|||
37811596|NCT02017717|69482961|FG000|Treatment Period|other reasons|0|||
37811597|NCT02017717|69482962|FG001|Treatment Period|other reasons|0|||
37811598|NCT02017717|69482963|FG002|Treatment Period|other reasons|0|||
37811599|NCT02017717|69482964|FG003|Treatment Period|other reasons|0|||
37811600|NCT02017717|69482965|FG004|Treatment Period|other reasons|1|||
37811601|NCT02017717|69482966|FG005|Treatment Period|other reasons|0|||
37811602|NCT02017717|69482967|FG006|Treatment Period|other reasons|0|||
37811603|NCT02017717|69482968|FG007|Treatment Period|other reasons|1|||
37811604|NCT02017717|69482969|FG008|Treatment Period|other reasons|1|||
37811605|NCT02017717|69482961|FG000|Treatment Period|Maximum clinical benefit|0|||
37811606|NCT02017717|69482962|FG001|Treatment Period|Maximum clinical benefit|0|||
37811607|NCT02017717|69482963|FG002|Treatment Period|Maximum clinical benefit|0|||
37811608|NCT02017717|69482964|FG003|Treatment Period|Maximum clinical benefit|0|||
37811609|NCT02017717|69482965|FG004|Treatment Period|Maximum clinical benefit|1|||
37811610|NCT02017717|69482966|FG005|Treatment Period|Maximum clinical benefit|0|||
37811611|NCT02017717|69482967|FG006|Treatment Period|Maximum clinical benefit|0|||
37811612|NCT02017717|69482968|FG007|Treatment Period|Maximum clinical benefit|0|||
37811613|NCT02017717|69482969|FG008|Treatment Period|Maximum clinical benefit|0|||
37811614|NCT02000622|69482995|FG000|Overall Study|Withdrawal by Subject|5|||
37811615|NCT02000622|69482996|FG001|Overall Study|Withdrawal by Subject|7|||
37811616|NCT02000622|69482995|FG000|Overall Study|Lost to Follow-up|4|||
37811617|NCT02000622|69482996|FG001|Overall Study|Lost to Follow-up|0|||
37811618|NCT02000622|69482995|FG000|Overall Study|Death|159|||
37811619|NCT02000622|69482996|FG001|Overall Study|Death|73|||
37811620|NCT02000622|69482995|FG000|Overall Study|Withdrawn due to site closure|1|||
37811621|NCT02000622|69482996|FG001|Overall Study|Withdrawn due to site closure|0|||
37811622|NCT01539863|69483004|FG000|Overall Study|Lost to Follow-up|5|||
37811623|NCT01539863|69483005|FG001|Overall Study|Lost to Follow-up|4|||
37811624|NCT00942331|69483013|FG000|Overall Study|Did not start treatment|15|||
37811625|NCT00942331|69483014|FG001|Overall Study|Did not start treatment|22|||
37811626|NCT00827372|69483020|FG000|Overall Study|Adverse Event|5|||
37811627|NCT00827372|69483020|FG000|Overall Study|Lack of Efficacy|3|||
37811628|NCT00590902|69483029|FG000|Overall Study|Death|1|||
37811629|NCT00577122|69483035|FG000|Overall Study|Adverse Event|0|||
37811630|NCT00577122|69483036|FG001|Overall Study|Adverse Event|2|||
37811631|NCT00577122|69483035|FG000|Overall Study|Progression, relapse during active trt|6|||
37811632|NCT00577122|69483036|FG001|Overall Study|Progression, relapse during active trt|8|||
37811633|NCT00577122|69483035|FG000|Overall Study|Prog, refract disease during active trt|8|||
37811634|NCT00577122|69483036|FG001|Overall Study|Prog, refract disease during active trt|5|||
37811635|NCT00577122|69483035|FG000|Overall Study|Alternative Therapy|0|||
37811636|NCT00577122|69483036|FG001|Overall Study|Alternative Therapy|1|||
37811637|NCT00419770|69483045|FG000|Overall Study|Withdrawal by Subject|5|||
37811638|NCT00419770|69483046|FG001|Overall Study|Withdrawal by Subject|1|||
37977310|NCT00406653|69664406|FG004|Open-Label Period|Refused followup|0|||
37977311|NCT00406653|69664407|FG005|Open-Label Period|Refused followup|0|||
37977312|NCT00406653|69664408|FG006|Open-Label Period|Refused followup|1|||
37977313|NCT00547157|69664430|FG000|Overall Study|Other|1|||
37977314|NCT00547157|69664431|FG001|Overall Study|Other|0|||
37977315|NCT00547157|69664430|FG000|Overall Study|Death|38|||
37977316|NCT00547157|69664431|FG001|Overall Study|Death|18|||
37977317|NCT00547157|69664430|FG000|Overall Study|Withdrawal by Subject|3|||
37977318|NCT00547157|69664431|FG001|Overall Study|Withdrawal by Subject|1|||
37977319|NCT00547157|69664430|FG000|Overall Study|Administrative decision|3|||
37977320|NCT00547157|69664431|FG001|Overall Study|Administrative decision|2|||
37811639|NCT00129701|69483052|FG000|Overall Study|Withdrawal by Subject|33|||
37811640|NCT04521114|69489091|FG000|Overall Study|Lost to Follow-up|1|||
37811641|NCT04521114|69489092|FG001|Overall Study|Lost to Follow-up|2|||
37811642|NCT04521114|69489093|FG002|Overall Study|Lost to Follow-up|0|||
37977321|NCT00547157|69664430|FG000|Overall Study|Lost to Follow-up|4|||
37977322|NCT00547157|69664431|FG001|Overall Study|Lost to Follow-up|2|||
37977323|NCT00384033|69664441|FG000|Overall Study|Adverse Event|10|||
37811643|NCT04521114|69489091|FG000|Overall Study|Withdrawal by Subject|1|||
37977324|NCT00384033|69664442|FG001|Overall Study|Adverse Event|8|||
37811644|NCT04521114|69489092|FG001|Overall Study|Withdrawal by Subject|2|||
37811645|NCT04521114|69489093|FG002|Overall Study|Withdrawal by Subject|2|||
37811646|NCT04521114|69489091|FG000|Overall Study|Adverse Event|1|||
37811647|NCT04521114|69489092|FG001|Overall Study|Adverse Event|0|||
37811648|NCT04521114|69489093|FG002|Overall Study|Adverse Event|0|||
37811649|NCT04521114|69489091|FG000|Overall Study|Sponsor Wish|1|||
37811650|NCT04521114|69489092|FG001|Overall Study|Sponsor Wish|0|||
37811651|NCT04521114|69489093|FG002|Overall Study|Sponsor Wish|0|||
37811652|NCT04521114|69489091|FG000|Overall Study|Withdrawal of Consent|2|||
37811653|NCT04521114|69489092|FG001|Overall Study|Withdrawal of Consent|2|||
37811654|NCT04521114|69489093|FG002|Overall Study|Withdrawal of Consent|0|||
37811655|NCT04360824|69489115|FG000|Overall Study|Withdrawal by Subject|2|||
37811656|NCT04360824|69489116|FG001|Overall Study|Withdrawal by Subject|1|||
37811657|NCT04360824|69489115|FG000|Overall Study|Did not receive assigned treatment|1|||
37811658|NCT04360824|69489116|FG001|Overall Study|Did not receive assigned treatment|3|||
37811659|NCT03711786|69489125|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
37811660|NCT03711786|69489126|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
37811661|NCT03711786|69489125|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
37811662|NCT03711786|69489126|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
37977325|NCT00384033|69664443|FG002|Overall Study|Adverse Event|11|||
37811663|NCT03711786|69489125|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
37811664|NCT03711786|69489126|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
37811665|NCT03711786|69489125|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
37811666|NCT03711786|69489126|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
37811667|NCT03711786|69489125|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
37811668|NCT03711786|69489126|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
37811669|NCT03711786|69489125|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
37811670|NCT03711786|69489126|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
37811671|NCT03691974|69489136|FG000|Overall Study|Physician Decision|1|||
37811672|NCT03691974|69489137|FG001|Overall Study|Physician Decision|0|||
37811673|NCT03691974|69489136|FG000|Overall Study|Adverse Event|1|||
37811674|NCT03691974|69489137|FG001|Overall Study|Adverse Event|0|||
37811675|NCT03691974|69489136|FG000|Overall Study|Withdrawal by Subject|11|||
37811676|NCT03691974|69489137|FG001|Overall Study|Withdrawal by Subject|9|||
37811677|NCT03691974|69489136|FG000|Overall Study|Protocol Violation|1|||
37811678|NCT03691974|69489137|FG001|Overall Study|Protocol Violation|0|||
37811679|NCT03691974|69489136|FG000|Overall Study|Lost to Follow-up|8|||
37811680|NCT03691974|69489137|FG001|Overall Study|Lost to Follow-up|7|||
37811681|NCT03525678|69489158|FG000|Overall Study|Ongoing at the time of interim analysis|60|||
37811682|NCT03525678|69489159|FG001|Overall Study|Ongoing at the time of interim analysis|65|||
37811683|NCT03525678|69489160|FG002|Overall Study|Ongoing at the time of interim analysis|21|||
37811684|NCT03525678|69489158|FG000|Overall Study|Withdrawal by Subject|3|||
37811685|NCT03525678|69489159|FG001|Overall Study|Withdrawal by Subject|1|||
37811686|NCT03525678|69489160|FG002|Overall Study|Withdrawal by Subject|0|||
37811687|NCT03525678|69489158|FG000|Overall Study|Physician Decision|1|||
37811688|NCT03525678|69489159|FG001|Overall Study|Physician Decision|2|||
37811689|NCT03525678|69489160|FG002|Overall Study|Physician Decision|0|||
37811690|NCT03525678|69489158|FG000|Overall Study|Lost to Follow-up|1|||
37811691|NCT03525678|69489159|FG001|Overall Study|Lost to Follow-up|0|||
37977326|NCT00384033|69664444|FG003|Overall Study|Adverse Event|20|||
37977327|NCT00384033|69664441|FG000|Overall Study|Failed to return|1|||
37977328|NCT00384033|69664442|FG001|Overall Study|Failed to return|3|||
37977329|NCT00384033|69664443|FG002|Overall Study|Failed to return|2|||
37977330|NCT00384033|69664444|FG003|Overall Study|Failed to return|2|||
37811692|NCT03525678|69489160|FG002|Overall Study|Lost to Follow-up|0|||
37811693|NCT03525678|69489158|FG000|Overall Study|Death|32|||
37811694|NCT03525678|69489159|FG001|Overall Study|Death|31|||
37811695|NCT03525678|69489160|FG002|Overall Study|Death|4|||
37977331|NCT00384033|69664441|FG000|Overall Study|Physician Decision|1|||
37811696|NCT02454972|69489177|FG000|Overall Study|Progressive disease|17|||
37811697|NCT02454972|69489178|FG001|Overall Study|Progressive disease|16|||
37811698|NCT02454972|69489179|FG002|Overall Study|Progressive disease|59|||
37977332|NCT00384033|69664442|FG001|Overall Study|Physician Decision|0|||
37977333|NCT00384033|69664443|FG002|Overall Study|Physician Decision|0|||
37977334|NCT00384033|69664444|FG003|Overall Study|Physician Decision|0|||
37977335|NCT00384033|69664441|FG000|Overall Study|Lost to Follow-up|6|||
37977336|NCT00384033|69664442|FG001|Overall Study|Lost to Follow-up|12|||
37977337|NCT00384033|69664443|FG002|Overall Study|Lost to Follow-up|7|||
37977338|NCT00384033|69664444|FG003|Overall Study|Lost to Follow-up|7|||
37977339|NCT00384033|69664441|FG000|Overall Study|Other|2|||
37977340|NCT00384033|69664442|FG001|Overall Study|Other|0|||
37977341|NCT00384033|69664443|FG002|Overall Study|Other|0|||
37811699|NCT02454972|69489180|FG003|Overall Study|Progressive disease|23|||
37811700|NCT02454972|69489181|FG004|Overall Study|Progressive disease|16|||
37811701|NCT02454972|69489182|FG005|Overall Study|Progressive disease|12|||
37811702|NCT02454972|69489183|FG006|Overall Study|Progressive disease|19|||
37811703|NCT02454972|69489184|FG007|Overall Study|Progressive disease|27|||
37811704|NCT02454972|69489185|FG008|Overall Study|Progressive disease|0|||
37811705|NCT02454972|69489177|FG000|Overall Study|Death|0|||
37811706|NCT02454972|69489178|FG001|Overall Study|Death|0|||
37811707|NCT02454972|69489179|FG002|Overall Study|Death|5|||
37811708|NCT02454972|69489180|FG003|Overall Study|Death|1|||
37811709|NCT02454972|69489181|FG004|Overall Study|Death|0|||
37811710|NCT02454972|69489182|FG005|Overall Study|Death|0|||
37811711|NCT02454972|69489183|FG006|Overall Study|Death|0|||
37811712|NCT02454972|69489184|FG007|Overall Study|Death|0|||
37811713|NCT02454972|69489185|FG008|Overall Study|Death|95|||
37811714|NCT02454972|69489177|FG000|Overall Study|Physician Decision|0|||
37811715|NCT02454972|69489178|FG001|Overall Study|Physician Decision|1|||
37811716|NCT02454972|69489179|FG002|Overall Study|Physician Decision|2|||
37811717|NCT02454972|69489180|FG003|Overall Study|Physician Decision|1|||
37811718|NCT02454972|69489181|FG004|Overall Study|Physician Decision|2|||
37811719|NCT02454972|69489182|FG005|Overall Study|Physician Decision|0|||
37811720|NCT02454972|69489183|FG006|Overall Study|Physician Decision|0|||
37811721|NCT02454972|69489184|FG007|Overall Study|Physician Decision|1|||
37811722|NCT02454972|69489185|FG008|Overall Study|Physician Decision|0|||
37811723|NCT02454972|69489177|FG000|Overall Study|Non treatment-related adverse event|2|||
37811724|NCT02454972|69489178|FG001|Overall Study|Non treatment-related adverse event|0|||
37811725|NCT02454972|69489179|FG002|Overall Study|Non treatment-related adverse event|1|||
37811726|NCT02454972|69489180|FG003|Overall Study|Non treatment-related adverse event|0|||
37811727|NCT02454972|69489181|FG004|Overall Study|Non treatment-related adverse event|0|||
37811728|NCT02454972|69489182|FG005|Overall Study|Non treatment-related adverse event|1|||
37811729|NCT02454972|69489183|FG006|Overall Study|Non treatment-related adverse event|0|||
37811730|NCT02454972|69489184|FG007|Overall Study|Non treatment-related adverse event|1|||
37811731|NCT02454972|69489185|FG008|Overall Study|Non treatment-related adverse event|0|||
37811732|NCT02454972|69489177|FG000|Overall Study|Treatment-related adverse events|0|||
37811733|NCT02454972|69489178|FG001|Overall Study|Treatment-related adverse events|1|||
37811734|NCT02454972|69489179|FG002|Overall Study|Treatment-related adverse events|1|||
37811735|NCT02454972|69489180|FG003|Overall Study|Treatment-related adverse events|0|||
37811736|NCT02454972|69489181|FG004|Overall Study|Treatment-related adverse events|2|||
37811737|NCT02454972|69489182|FG005|Overall Study|Treatment-related adverse events|0|||
37811738|NCT02454972|69489183|FG006|Overall Study|Treatment-related adverse events|0|||
37811739|NCT02454972|69489184|FG007|Overall Study|Treatment-related adverse events|2|||
37811740|NCT02454972|69489185|FG008|Overall Study|Treatment-related adverse events|0|||
37811741|NCT02454972|69489177|FG000|Overall Study|Patient moves to compassionate use|0|||
37811742|NCT02454972|69489178|FG001|Overall Study|Patient moves to compassionate use|0|||
37811743|NCT02454972|69489179|FG002|Overall Study|Patient moves to compassionate use|0|||
37811744|NCT02454972|69489180|FG003|Overall Study|Patient moves to compassionate use|0|||
37811745|NCT02454972|69489181|FG004|Overall Study|Patient moves to compassionate use|0|||
37811746|NCT02454972|69489182|FG005|Overall Study|Patient moves to compassionate use|0|||
37811747|NCT02454972|69489183|FG006|Overall Study|Patient moves to compassionate use|2|||
37811748|NCT02454972|69489184|FG007|Overall Study|Patient moves to compassionate use|0|||
37811749|NCT02454972|69489185|FG008|Overall Study|Patient moves to compassionate use|0|||
37811750|NCT02454972|69489177|FG000|Overall Study|Withdrawal by Subject|0|||
37811751|NCT02454972|69489178|FG001|Overall Study|Withdrawal by Subject|1|||
37811752|NCT02454972|69489179|FG002|Overall Study|Withdrawal by Subject|5|||
37811753|NCT02454972|69489180|FG003|Overall Study|Withdrawal by Subject|2|||
37864381|NCT01259492|69548038|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
37977342|NCT00384033|69664444|FG003|Overall Study|Other|0|||
37811754|NCT02454972|69489181|FG004|Overall Study|Withdrawal by Subject|3|||
37811755|NCT02454972|69489182|FG005|Overall Study|Withdrawal by Subject|2|||
37977343|NCT00384033|69664441|FG000|Overall Study|Protocol Violation|5|||
37811756|NCT02454972|69489183|FG006|Overall Study|Withdrawal by Subject|0|||
37811757|NCT02454972|69489184|FG007|Overall Study|Withdrawal by Subject|1|||
37811758|NCT02454972|69489185|FG008|Overall Study|Withdrawal by Subject|2|||
37811759|NCT02454972|69489177|FG000|Overall Study|Multiple delay/holds on treatment|0|||
37811760|NCT02454972|69489178|FG001|Overall Study|Multiple delay/holds on treatment|0|||
37811761|NCT02454972|69489179|FG002|Overall Study|Multiple delay/holds on treatment|0|||
37811762|NCT02454972|69489180|FG003|Overall Study|Multiple delay/holds on treatment|1|||
37811763|NCT02454972|69489181|FG004|Overall Study|Multiple delay/holds on treatment|0|||
37811764|NCT02454972|69489182|FG005|Overall Study|Multiple delay/holds on treatment|0|||
37811765|NCT02454972|69489183|FG006|Overall Study|Multiple delay/holds on treatment|0|||
37811766|NCT02454972|69489184|FG007|Overall Study|Multiple delay/holds on treatment|0|||
37811767|NCT02454972|69489185|FG008|Overall Study|Multiple delay/holds on treatment|0|||
37811768|NCT02454972|69489177|FG000|Overall Study|Never treated|0|||
37811769|NCT02454972|69489178|FG001|Overall Study|Never treated|0|||
37811770|NCT02454972|69489179|FG002|Overall Study|Never treated|3|||
37811771|NCT02454972|69489180|FG003|Overall Study|Never treated|1|||
37811772|NCT02454972|69489181|FG004|Overall Study|Never treated|1|||
37811773|NCT02454972|69489182|FG005|Overall Study|Never treated|0|||
37811774|NCT02454972|69489183|FG006|Overall Study|Never treated|0|||
37811775|NCT02454972|69489184|FG007|Overall Study|Never treated|0|||
37811776|NCT02454972|69489185|FG008|Overall Study|Never treated|5|||
37811777|NCT02454972|69489177|FG000|Overall Study|Lost to Follow-up|0|||
37811778|NCT02454972|69489178|FG001|Overall Study|Lost to Follow-up|0|||
37811779|NCT02454972|69489179|FG002|Overall Study|Lost to Follow-up|0|||
37811780|NCT02454972|69489180|FG003|Overall Study|Lost to Follow-up|0|||
37811781|NCT02454972|69489181|FG004|Overall Study|Lost to Follow-up|0|||
37811782|NCT02454972|69489182|FG005|Overall Study|Lost to Follow-up|0|||
37811783|NCT02454972|69489183|FG006|Overall Study|Lost to Follow-up|0|||
37811784|NCT02454972|69489184|FG007|Overall Study|Lost to Follow-up|0|||
37811785|NCT02454972|69489185|FG008|Overall Study|Lost to Follow-up|2|||
37811786|NCT02454972|69489177|FG000|Overall Study|Study termination|0|||
37811787|NCT02454972|69489178|FG001|Overall Study|Study termination|0|||
37811788|NCT02454972|69489179|FG002|Overall Study|Study termination|0|||
37811789|NCT02454972|69489180|FG003|Overall Study|Study termination|0|||
37811790|NCT02454972|69489181|FG004|Overall Study|Study termination|0|||
37811791|NCT02454972|69489182|FG005|Overall Study|Study termination|0|||
37811792|NCT02454972|69489183|FG006|Overall Study|Study termination|0|||
37811793|NCT02454972|69489184|FG007|Overall Study|Study termination|0|||
37811794|NCT02454972|69489185|FG008|Overall Study|Study termination|6|||
37811795|NCT00063882|69489203|FG000|Overall Study|Protocol Violation|3|||
37811796|NCT00063882|69489204|FG001|Overall Study|Protocol Violation|3|||
37811797|NCT00063882|69489203|FG000|Overall Study|Withdrawal by Subject|2|||
37977344|NCT00384033|69664442|FG001|Overall Study|Protocol Violation|0|||
37811798|NCT00063882|69489204|FG001|Overall Study|Withdrawal by Subject|1|||
37811799|NCT01279044|69489213|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
37811800|NCT01279044|69489214|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
37811801|NCT01279044|69489215|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
37811802|NCT01279044|69489213|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
37811803|NCT01279044|69489214|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
37811804|NCT01279044|69489215|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
37811805|NCT01279044|69489213|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
37811806|NCT01279044|69489214|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
37811807|NCT01279044|69489215|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
37811808|NCT01278342|69489224|FG000|Overall Study|Physician Decision|0|||
37811809|NCT01278342|69489225|FG001|Overall Study|Physician Decision|1|||
37811810|NCT01278342|69489226|FG002|Overall Study|Physician Decision|0|||
37811811|NCT01278342|69489224|FG000|Overall Study|Lost to Follow-up|1|||
37811812|NCT01278342|69489225|FG001|Overall Study|Lost to Follow-up|0|||
37811813|NCT01278342|69489226|FG002|Overall Study|Lost to Follow-up|0|||
37977345|NCT00384033|69664443|FG002|Overall Study|Protocol Violation|5|||
37977346|NCT00384033|69664444|FG003|Overall Study|Protocol Violation|6|||
37977347|NCT00384033|69664441|FG000|Overall Study|Withdrawal by Subject|6|||
37977348|NCT00384033|69664442|FG001|Overall Study|Withdrawal by Subject|2|||
37977349|NCT00384033|69664443|FG002|Overall Study|Withdrawal by Subject|5|||
37977350|NCT00384033|69664444|FG003|Overall Study|Withdrawal by Subject|2|||
37977351|NCT00384033|69664441|FG000|Overall Study|Lack of Efficacy|7|||
37977352|NCT00384033|69664442|FG001|Overall Study|Lack of Efficacy|3|||
37977353|NCT00384033|69664443|FG002|Overall Study|Lack of Efficacy|3|||
37977354|NCT00384033|69664444|FG003|Overall Study|Lack of Efficacy|1|||
37977355|NCT00384033|69664441|FG000|Overall Study|Randomized but not treated|3|||
37977356|NCT00384033|69664442|FG001|Overall Study|Randomized but not treated|7|||
37977357|NCT00384033|69664443|FG002|Overall Study|Randomized but not treated|10|||
37977358|NCT00384033|69664444|FG003|Overall Study|Randomized but not treated|2|||
37977359|NCT00546377|69664454|FG000|Overall Study|Deemed ineligible|1|||
37977360|NCT00546377|69664454|FG000|Overall Study|Adverse Event|6|||
37977361|NCT00545753|69664461|FG000|Overall Study|Withdrawal by Subject|0|||
37977362|NCT00545753|69664462|FG001|Overall Study|Withdrawal by Subject|1|||
37811814|NCT01278342|69489224|FG000|Overall Study|Administrative problems|2|||
37811815|NCT01278342|69489225|FG001|Overall Study|Administrative problems|0|||
37811816|NCT01278342|69489226|FG002|Overall Study|Administrative problems|0|||
37811817|NCT01278342|69489224|FG000|Overall Study|Other|1|||
37811818|NCT01278342|69489225|FG001|Overall Study|Other|0|||
37811819|NCT01278342|69489226|FG002|Overall Study|Other|0|||
37811820|NCT01278030|69489236|FG000|Overall Study|Withdrawal by Subject|8|||
37811821|NCT01278030|69489237|FG001|Overall Study|Withdrawal by Subject|4|||
37811822|NCT01277718|69489243|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
37811823|NCT01277718|69489244|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
37811824|NCT01277718|69489243|FG000|Period 2 - Second Intervention|Physician Decision|0|||
37811825|NCT01277718|69489244|FG001|Period 2 - Second Intervention|Physician Decision|2|||
37811826|NCT01276236|69489252|FG000|Overall Study|Lack of Efficacy|2|||
37811827|NCT01276236|69489252|FG000|Overall Study|Withdrawal by Subject|4|||
37811828|NCT01275222|69489262|FG000|Phase l by Treatment|Adverse Event|1|||
37811829|NCT01275222|69489263|FG001|Phase l by Treatment|Adverse Event|4|||
37811830|NCT01275222|69489264|FG002|Phase l by Treatment|Adverse Event|2|||
37811831|NCT01275222|69489265|FG003|Phase l by Treatment|Adverse Event|3|||
37811832|NCT01275222|69489266|FG004|Phase l by Treatment|Adverse Event|0|||
37977363|NCT00545753|69664463|FG002|Overall Study|Withdrawal by Subject|10|||
37977364|NCT00545753|69664461|FG000|Overall Study|Lost to Follow-up|13|||
37977365|NCT00545753|69664462|FG001|Overall Study|Lost to Follow-up|3|||
37811833|NCT01275222|69489267|FG005|Phase l by Treatment|Adverse Event|0|||
37811834|NCT01275222|69489262|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
37811835|NCT01275222|69489263|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
37811836|NCT01275222|69489264|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
37811837|NCT01275222|69489265|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
37977366|NCT00545753|69664463|FG002|Overall Study|Lost to Follow-up|12|||
37977367|NCT00545753|69664461|FG000|Overall Study|Protocol Violation|3|||
37977368|NCT00545753|69664462|FG001|Overall Study|Protocol Violation|1|||
37977369|NCT00545753|69664463|FG002|Overall Study|Protocol Violation|4|||
37811838|NCT01275222|69489266|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
37811839|NCT01275222|69489267|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
37811840|NCT01275222|69489262|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
37977370|NCT00406419|69664475|FG000|Overall Study|Death|3|||
37977371|NCT00406419|69664476|FG001|Overall Study|Death|1|||
37977372|NCT00406419|69664477|FG002|Overall Study|Death|4|||
37977373|NCT00406419|69664475|FG000|Overall Study|Protocol Violation|6|||
37977374|NCT00406419|69664476|FG001|Overall Study|Protocol Violation|2|||
37977375|NCT00406419|69664477|FG002|Overall Study|Protocol Violation|5|||
37977376|NCT00406419|69664475|FG000|Overall Study|Study Terminated by Sponsor|260|||
37977377|NCT00406419|69664476|FG001|Overall Study|Study Terminated by Sponsor|288|||
37977378|NCT00406419|69664477|FG002|Overall Study|Study Terminated by Sponsor|282|||
37977379|NCT00406419|69664475|FG000|Overall Study|Withdrawal by Subject|17|||
37977380|NCT00406419|69664476|FG001|Overall Study|Withdrawal by Subject|24|||
37811841|NCT01275222|69489263|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
37977381|NCT00406419|69664477|FG002|Overall Study|Withdrawal by Subject|26|||
37977382|NCT00406419|69664475|FG000|Overall Study|Lack of Efficacy|12|||
37977383|NCT00406419|69664476|FG001|Overall Study|Lack of Efficacy|1|||
37977384|NCT00406419|69664477|FG002|Overall Study|Lack of Efficacy|6|||
37977385|NCT00406419|69664475|FG000|Overall Study|Non-Compliance with Study Drug|5|||
37977386|NCT00406419|69664476|FG001|Overall Study|Non-Compliance with Study Drug|6|||
37811842|NCT01275222|69489264|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
37811843|NCT01275222|69489265|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
37811844|NCT01275222|69489266|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
37811845|NCT01275222|69489267|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
37811846|NCT01275222|69489262|FG000|Phase l by Treatment|Disease progression|12|||
37811847|NCT01275222|69489263|FG001|Phase l by Treatment|Disease progression|8|||
37811848|NCT01275222|69489264|FG002|Phase l by Treatment|Disease progression|2|||
37811849|NCT01275222|69489265|FG003|Phase l by Treatment|Disease progression|5|||
37811850|NCT01275222|69489266|FG004|Phase l by Treatment|Disease progression|0|||
37811851|NCT01275222|69489267|FG005|Phase l by Treatment|Disease progression|0|||
37811852|NCT01275222|69489262|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
37811853|NCT01275222|69489263|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
37811854|NCT01275222|69489264|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
37811855|NCT01275222|69489265|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
37811856|NCT01275222|69489266|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
37811857|NCT01275222|69489267|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
37811858|NCT01275222|69489262|FG000|Phase l by Treatment|Death|0|||
37811859|NCT01275222|69489263|FG001|Phase l by Treatment|Death|1|||
37811860|NCT01275222|69489264|FG002|Phase l by Treatment|Death|0|||
37811861|NCT01275222|69489265|FG003|Phase l by Treatment|Death|1|||
37811862|NCT01275222|69489266|FG004|Phase l by Treatment|Death|0|||
37811863|NCT01275222|69489267|FG005|Phase l by Treatment|Death|0|||
37811864|NCT01275222|69489262|FG000|Phase ll by Stratum|Adverse Event|0|||
37811865|NCT01275222|69489263|FG001|Phase ll by Stratum|Adverse Event|0|||
37811866|NCT01275222|69489264|FG002|Phase ll by Stratum|Adverse Event|0|||
37811867|NCT01275222|69489265|FG003|Phase ll by Stratum|Adverse Event|0|||
37811868|NCT01275222|69489266|FG004|Phase ll by Stratum|Adverse Event|2|||
37811869|NCT01275222|69489267|FG005|Phase ll by Stratum|Adverse Event|10|||
37811870|NCT01275222|69489262|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
37811871|NCT01275222|69489263|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
37811872|NCT01275222|69489264|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
37811873|NCT01275222|69489265|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
37811874|NCT01275222|69489266|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
37811875|NCT01275222|69489267|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
37811876|NCT01275222|69489262|FG000|Phase ll by Stratum|Disease progression|0|||
37811877|NCT01275222|69489263|FG001|Phase ll by Stratum|Disease progression|0|||
37811878|NCT01275222|69489264|FG002|Phase ll by Stratum|Disease progression|0|||
37811879|NCT01275222|69489265|FG003|Phase ll by Stratum|Disease progression|0|||
37811880|NCT01275222|69489266|FG004|Phase ll by Stratum|Disease progression|23|||
37811881|NCT01275222|69489267|FG005|Phase ll by Stratum|Disease progression|31|||
37811882|NCT01275222|69489262|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
37811883|NCT01275222|69489263|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
37977387|NCT00406419|69664477|FG002|Overall Study|Non-Compliance with Study Drug|3|||
37811884|NCT01275222|69489264|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
37811885|NCT01275222|69489265|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
37811886|NCT01275222|69489266|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
37811887|NCT01275222|69489267|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
37811888|NCT01275222|69489262|FG000|Phase ll by Stratum|Death|0|||
37864382|NCT01259492|69548039|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
37864383|NCT01259492|69548040|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
37977388|NCT00406419|69664475|FG000|Overall Study|Adverse Event|10|||
37977389|NCT00406419|69664476|FG001|Overall Study|Adverse Event|12|||
37977390|NCT00406419|69664477|FG002|Overall Study|Adverse Event|16|||
37977391|NCT00406419|69664475|FG000|Overall Study|Lost to Follow-up|11|||
37977392|NCT00406419|69664476|FG001|Overall Study|Lost to Follow-up|10|||
37811889|NCT01275222|69489263|FG001|Phase ll by Stratum|Death|0|||
37811890|NCT01275222|69489264|FG002|Phase ll by Stratum|Death|0|||
37811891|NCT01275222|69489265|FG003|Phase ll by Stratum|Death|0|||
37811892|NCT01275222|69489266|FG004|Phase ll by Stratum|Death|1|||
37811893|NCT01275222|69489267|FG005|Phase ll by Stratum|Death|1|||
37811894|NCT01275144|69489285|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
37811895|NCT01275144|69489286|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
37811896|NCT01275066|69489297|FG000|Overall Study|Withdrawal by Subject|0|||
37811897|NCT01275066|69489298|FG001|Overall Study|Withdrawal by Subject|0|||
37811898|NCT01275066|69489299|FG002|Overall Study|Withdrawal by Subject|1|||
37811899|NCT01275066|69489297|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
37811900|NCT01275066|69489298|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
37811901|NCT01275066|69489299|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
37811902|NCT01273038|69489309|FG000|Second Intervention (14 Days)|Adverse Event|0|||
37811903|NCT01273038|69489310|FG001|Second Intervention (14 Days)|Adverse Event|1|||
37811904|NCT01273038|69489309|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
37811905|NCT01273038|69489310|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
37811906|NCT01272180|69489320|FG000|Overall Study|Adverse Event|0|||
37811907|NCT01272180|69489321|FG001|Overall Study|Adverse Event|0|||
37811908|NCT01272180|69489322|FG002|Overall Study|Adverse Event|1|||
37811909|NCT01272180|69489323|FG003|Overall Study|Adverse Event|0|||
37811910|NCT01272180|69489320|FG000|Overall Study|Withdrawal by Subject|2|||
37811911|NCT01272180|69489321|FG001|Overall Study|Withdrawal by Subject|6|||
37811912|NCT01272180|69489322|FG002|Overall Study|Withdrawal by Subject|3|||
37811913|NCT01272180|69489323|FG003|Overall Study|Withdrawal by Subject|2|||
37811914|NCT01272180|69489320|FG000|Overall Study|Lost to Follow-up|15|||
37811915|NCT01272180|69489321|FG001|Overall Study|Lost to Follow-up|14|||
37811916|NCT01272180|69489322|FG002|Overall Study|Lost to Follow-up|8|||
37811917|NCT01272180|69489323|FG003|Overall Study|Lost to Follow-up|10|||
37811918|NCT01272180|69489320|FG000|Overall Study|Inappropriate enrollment|0|||
37811919|NCT01272180|69489321|FG001|Overall Study|Inappropriate enrollment|0|||
37811920|NCT01272180|69489322|FG002|Overall Study|Inappropriate enrollment|1|||
37811921|NCT01272180|69489323|FG003|Overall Study|Inappropriate enrollment|1|||
37811922|NCT01272180|69489320|FG000|Overall Study|Protocol Violation|0|||
37811923|NCT01272180|69489321|FG001|Overall Study|Protocol Violation|1|||
37811924|NCT01272180|69489322|FG002|Overall Study|Protocol Violation|0|||
37811925|NCT01272180|69489323|FG003|Overall Study|Protocol Violation|1|||
37811926|NCT01271712|69489339|FG000|Double Blind Treatment|Death|2|||
37811927|NCT01271712|69489340|FG001|Double Blind Treatment|Death|0|||
37811928|NCT01271712|69489339|FG000|Double Blind Treatment|Lack of Efficacy|1|||
37811929|NCT01271712|69489340|FG001|Double Blind Treatment|Lack of Efficacy|0|||
37811930|NCT01271712|69489339|FG000|Double Blind Treatment|Adverse Event|9|||
37811931|NCT01271712|69489340|FG001|Double Blind Treatment|Adverse Event|4|||
37811932|NCT01271712|69489339|FG000|Double Blind Treatment|Progressive disease|23|||
37811933|NCT01271712|69489340|FG001|Double Blind Treatment|Progressive disease|3|||
37811934|NCT01271712|69489339|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
37811935|NCT01271712|69489340|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
37811936|NCT01271712|69489339|FG000|Double Blind Treatment|Non compliance with study drug|2|||
37811937|NCT01271712|69489340|FG001|Double Blind Treatment|Non compliance with study drug|0|||
37811938|NCT01271712|69489339|FG000|Double Blind Treatment|receive no study drug|1|||
37811939|NCT01271712|69489340|FG001|Double Blind Treatment|receive no study drug|0|||
37811940|NCT01271712|69489339|FG000|Open Label Treatment|Death|6|||
37811941|NCT01271712|69489340|FG001|Open Label Treatment|Death|5|||
37811942|NCT01271712|69489339|FG000|Open Label Treatment|Withdrawal by Subject|6|||
37811943|NCT01271712|69489340|FG001|Open Label Treatment|Withdrawal by Subject|11|||
37811944|NCT01271712|69489339|FG000|Open Label Treatment|Physician Decision|2|||
37811945|NCT01271712|69489340|FG001|Open Label Treatment|Physician Decision|0|||
37811946|NCT01271712|69489339|FG000|Open Label Treatment|Adverse Event|14|||
37811947|NCT01271712|69489340|FG001|Open Label Treatment|Adverse Event|8|||
37811948|NCT01271712|69489339|FG000|Open Label Treatment|Progressive disease|59|||
37811949|NCT01271712|69489340|FG001|Open Label Treatment|Progressive disease|32|||
37811950|NCT01271712|69489339|FG000|Open Label Treatment|transferred to rollover study|1|||
37811951|NCT01271712|69489340|FG001|Open Label Treatment|transferred to rollover study|0|||
37811952|NCT01271712|69489339|FG000|Open Label Treatment|Non-compliance with study drug|1|||
37811953|NCT01271712|69489340|FG001|Open Label Treatment|Non-compliance with study drug|0|||
37811954|NCT01271712|69489339|FG000|Open Label Treatment|Protocol Violation|0|||
37811955|NCT01271712|69489340|FG001|Open Label Treatment|Protocol Violation|1|||
37811956|NCT01271712|69489339|FG000|Open Label Treatment|Switching to other therapy|2|||
37811957|NCT01271712|69489340|FG001|Open Label Treatment|Switching to other therapy|1|||
37811958|NCT01271712|69489339|FG000|Safety Follow-up|Death|11|||
37811959|NCT01271712|69489340|FG001|Safety Follow-up|Death|7|||
37811960|NCT01271712|69489339|FG000|Safety Follow-up|Withdrawal by Subject|4|||
37811961|NCT01271712|69489340|FG001|Safety Follow-up|Withdrawal by Subject|2|||
37811962|NCT01271712|69489339|FG000|Safety Follow-up|Protocol Violation|1|||
37811963|NCT01271712|69489340|FG001|Safety Follow-up|Protocol Violation|1|||
37811964|NCT01271712|69489339|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
37811965|NCT01271712|69489340|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
37811966|NCT01271712|69489339|FG000|Safety Follow-up|No follow-up|1|||
37811967|NCT01271712|69489340|FG001|Safety Follow-up|No follow-up|1|||
37811968|NCT01271712|69489339|FG000|Safety Follow-up|Progressive disease|1|||
37811969|NCT01271712|69489340|FG001|Safety Follow-up|Progressive disease|0|||
37811970|NCT01271712|69489339|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
37811971|NCT01271712|69489340|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
37811972|NCT01271010|69489349|FG000|Overall Study|Reason not specified|11|||
37811973|NCT01271010|69489349|FG000|Overall Study|Start of new CLL therapy|1|||
37811974|NCT01271010|69489349|FG000|Overall Study|Protocol Violation|1|||
37811975|NCT01271010|69489349|FG000|Overall Study|Death|2|||
37811976|NCT01271010|69489349|FG000|Overall Study|Progression and relapse of disease|1|||
37811977|NCT01271010|69489349|FG000|Overall Study|Withdrawal by Subject|18|||
37811978|NCT01271010|69489349|FG000|Overall Study|Disease progression|27|||
37811979|NCT01270620|69489355|FG000|Overall Study|Withdrawal by Subject|1|||
37811980|NCT01270620|69489356|FG001|Overall Study|Withdrawal by Subject|3|||
37811981|NCT01270464|69489371|FG000|Overall Study|Protocol Violation|4|||
37811982|NCT01270464|69489372|FG001|Overall Study|Protocol Violation|3|||
37811983|NCT01270464|69489373|FG002|Overall Study|Protocol Violation|2|||
37977393|NCT00406419|69664477|FG002|Overall Study|Lost to Follow-up|5|||
37977394|NCT00325468|69664490|FG000|Overall Study|Adverse Event|1|||
37977395|NCT00325468|69664491|FG001|Overall Study|Adverse Event|1|||
37977396|NCT00325468|69664492|FG002|Overall Study|Adverse Event|0|||
37811984|NCT01270464|69489371|FG000|Overall Study|Lack of Efficacy|2|||
37811985|NCT01270464|69489372|FG001|Overall Study|Lack of Efficacy|3|||
37811986|NCT01270464|69489373|FG002|Overall Study|Lack of Efficacy|1|||
37811987|NCT01270464|69489371|FG000|Overall Study|Adverse Event|9|||
37811988|NCT01270464|69489372|FG001|Overall Study|Adverse Event|1|||
37811989|NCT01270464|69489373|FG002|Overall Study|Adverse Event|7|||
37811990|NCT01270464|69489371|FG000|Overall Study|Withdrawal by Subject|2|||
37811991|NCT01270464|69489372|FG001|Overall Study|Withdrawal by Subject|1|||
37811992|NCT01270464|69489373|FG002|Overall Study|Withdrawal by Subject|4|||
37811993|NCT01270464|69489371|FG000|Overall Study|Lost to Follow-up|2|||
37811994|NCT01270464|69489372|FG001|Overall Study|Lost to Follow-up|3|||
37811995|NCT01270464|69489373|FG002|Overall Study|Lost to Follow-up|1|||
37811996|NCT01270464|69489371|FG000|Overall Study|Other|1|||
37811997|NCT01270464|69489372|FG001|Overall Study|Other|1|||
37811998|NCT01270464|69489373|FG002|Overall Study|Other|3|||
37811999|NCT00249834|69489389|FG000|Overall Study|Ovarian stimulation failed|1|||
37812000|NCT00249834|69489390|FG001|Overall Study|Ovarian stimulation failed|0|||
37812001|NCT00249834|69489391|FG002|Overall Study|Ovarian stimulation failed|0|||
37812002|NCT00249834|69489392|FG003|Overall Study|Ovarian stimulation failed|0|||
37812003|NCT00249834|69489393|FG004|Overall Study|Ovarian stimulation failed|0|||
37812004|NCT00249834|69489394|FG005|Overall Study|Ovarian stimulation failed|0|||
37812005|NCT00249834|69489395|FG006|Overall Study|Ovarian stimulation failed|0|||
37812006|NCT00249834|69489396|FG007|Overall Study|Ovarian stimulation failed|0|||
37812007|NCT00249834|69489389|FG000|Overall Study|Failure of down-regulation|0|||
37812008|NCT00249834|69489390|FG001|Overall Study|Failure of down-regulation|0|||
37812009|NCT00249834|69489391|FG002|Overall Study|Failure of down-regulation|0|||
37812010|NCT00249834|69489392|FG003|Overall Study|Failure of down-regulation|0|||
37812011|NCT00249834|69489393|FG004|Overall Study|Failure of down-regulation|0|||
37812012|NCT00249834|69489394|FG005|Overall Study|Failure of down-regulation|0|||
37812013|NCT00249834|69489395|FG006|Overall Study|Failure of down-regulation|1|||
37812014|NCT00249834|69489396|FG007|Overall Study|Failure of down-regulation|0|||
37812015|NCT00249834|69489389|FG000|Overall Study|Protocol Violation|0|||
37864384|NCT01259492|69548037|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
37977397|NCT00325468|69664493|FG003|Overall Study|Adverse Event|5|||
37977398|NCT00325468|69664494|FG004|Overall Study|Adverse Event|1|||
37977399|NCT00325468|69664490|FG000|Overall Study|Death|2|||
37977400|NCT00325468|69664491|FG001|Overall Study|Death|0|||
37977401|NCT00325468|69664492|FG002|Overall Study|Death|2|||
37977402|NCT00325468|69664493|FG003|Overall Study|Death|4|||
37812016|NCT00249834|69489390|FG001|Overall Study|Protocol Violation|19|||
37812017|NCT00249834|69489391|FG002|Overall Study|Protocol Violation|14|||
37812018|NCT00249834|69489392|FG003|Overall Study|Protocol Violation|8|||
37812019|NCT00249834|69489393|FG004|Overall Study|Protocol Violation|5|||
37812020|NCT00249834|69489394|FG005|Overall Study|Protocol Violation|2|||
37812021|NCT00249834|69489395|FG006|Overall Study|Protocol Violation|0|||
37812022|NCT00249834|69489396|FG007|Overall Study|Protocol Violation|0|||
37812023|NCT00249444|69489410|FG000|Overall Study|Lost to Follow-up|2|||
37812024|NCT00249444|69489411|FG001|Overall Study|Lost to Follow-up|2|||
37812025|NCT00249444|69489410|FG000|Overall Study|non-compliant|9|||
37977403|NCT00325468|69664494|FG004|Overall Study|Death|0|||
37977404|NCT00325468|69664490|FG000|Overall Study|Lost to Follow-up|0|||
37977405|NCT00325468|69664491|FG001|Overall Study|Lost to Follow-up|0|||
37812026|NCT00249444|69489411|FG001|Overall Study|non-compliant|11|||
37812027|NCT00249444|69489410|FG000|Overall Study|Adverse Event|1|||
37812028|NCT00249444|69489411|FG001|Overall Study|Adverse Event|1|||
37812029|NCT00249444|69489410|FG000|Overall Study|life event|0|||
37812030|NCT00249444|69489411|FG001|Overall Study|life event|1|||
37812031|NCT00249288|69489419|FG000|Overall Study|Lost to Follow-up|3|||
37812032|NCT00249288|69489420|FG001|Overall Study|Lost to Follow-up|3|||
37812033|NCT00249288|69489419|FG000|Overall Study|Withdrawal by Subject|2|||
37812034|NCT00249288|69489420|FG001|Overall Study|Withdrawal by Subject|2|||
37977406|NCT00325468|69664492|FG002|Overall Study|Lost to Follow-up|1|||
37977407|NCT00325468|69664493|FG003|Overall Study|Lost to Follow-up|2|||
37977408|NCT00325468|69664494|FG004|Overall Study|Lost to Follow-up|2|||
37977409|NCT00325468|69664490|FG000|Overall Study|Physician Decision|1|||
37977410|NCT00325468|69664491|FG001|Overall Study|Physician Decision|1|||
37977411|NCT00325468|69664492|FG002|Overall Study|Physician Decision|0|||
37812035|NCT00248040|69489437|FG000|Overall Study|transplantectomy|2|||
37812036|NCT00248040|69489438|FG001|Overall Study|transplantectomy|1|||
37812037|NCT00248040|69489439|FG002|Overall Study|transplantectomy|3|||
37812038|NCT00248040|69489437|FG000|Overall Study|transplant cancelled post treat start|1|||
37812039|NCT00248040|69489438|FG001|Overall Study|transplant cancelled post treat start|0|||
37812040|NCT00248040|69489439|FG002|Overall Study|transplant cancelled post treat start|0|||
37812041|NCT00248040|69489437|FG000|Overall Study|Death|0|||
37812042|NCT00248040|69489438|FG001|Overall Study|Death|0|||
37812043|NCT00248040|69489439|FG002|Overall Study|Death|1|||
37812044|NCT00247962|69489450|FG000|Overall Study|Adverse Event|15|||
37977412|NCT00325468|69664493|FG003|Overall Study|Physician Decision|1|||
37977413|NCT00325468|69664494|FG004|Overall Study|Physician Decision|0|||
37977414|NCT00325468|69664490|FG000|Overall Study|Withdrawal by Subject|3|||
37977415|NCT00325468|69664491|FG001|Overall Study|Withdrawal by Subject|1|||
37977416|NCT00325468|69664492|FG002|Overall Study|Withdrawal by Subject|0|||
37812045|NCT00247962|69489451|FG001|Overall Study|Adverse Event|12|||
37812046|NCT00247962|69489450|FG000|Overall Study|Lost to Follow-up|3|||
37812047|NCT00247962|69489451|FG001|Overall Study|Lost to Follow-up|1|||
37812048|NCT00247962|69489450|FG000|Overall Study|Physician Decision|0|||
37812049|NCT00247962|69489451|FG001|Overall Study|Physician Decision|1|||
37812050|NCT00247962|69489450|FG000|Overall Study|Protocol Violation|1|||
37812051|NCT00247962|69489451|FG001|Overall Study|Protocol Violation|1|||
37812052|NCT00247962|69489450|FG000|Overall Study|Withdrawal by Subject|3|||
37812053|NCT00247962|69489451|FG001|Overall Study|Withdrawal by Subject|2|||
37812054|NCT00247962|69489450|FG000|Overall Study|Lack of Efficacy|4|||
37812055|NCT00247962|69489451|FG001|Overall Study|Lack of Efficacy|2|||
37812056|NCT00247416|69489459|FG000|Overall Study|3 patients were found to be ineligible|1|||
37812057|NCT00247416|69489460|FG001|Overall Study|3 patients were found to be ineligible|2|||
37812058|NCT00246090|69489468|FG000|Overall Study|Adverse Event|25|||
37812059|NCT00246090|69489468|FG000|Overall Study|Withdrawal by Subject|7|||
37812060|NCT00246090|69489468|FG000|Overall Study|Progressive Disease|212|||
37812061|NCT00246090|69489468|FG000|Overall Study|Clinical Progression|30|||
37812062|NCT00246090|69489468|FG000|Overall Study|Physician Decision|11|||
37812063|NCT00246090|69489468|FG000|Overall Study|Not Otherwise Specified|10|||
37812064|NCT00246012|69489481|FG000|Overall Study|Adverse Event|0|||
37812065|NCT00246012|69489482|FG001|Overall Study|Adverse Event|0|||
37812066|NCT00246012|69489483|FG002|Overall Study|Adverse Event|0|||
37812067|NCT00246012|69489484|FG003|Overall Study|Adverse Event|0|||
37812068|NCT00246012|69489485|FG004|Overall Study|Adverse Event|0|||
37812069|NCT00246012|69489486|FG005|Overall Study|Adverse Event|1|||
37977417|NCT00325468|69664493|FG003|Overall Study|Withdrawal by Subject|14|||
37977418|NCT00325468|69664494|FG004|Overall Study|Withdrawal by Subject|4|||
37977419|NCT00325468|69664490|FG000|Overall Study|site closure etc|4|||
37977420|NCT00325468|69664491|FG001|Overall Study|site closure etc|2|||
37977421|NCT00325468|69664492|FG002|Overall Study|site closure etc|1|||
37977422|NCT00325468|69664493|FG003|Overall Study|site closure etc|8|||
37977423|NCT00325468|69664494|FG004|Overall Study|site closure etc|1|||
37977424|NCT00311584|69664509|FG000|Overall Study|Death|1|||
37977425|NCT00311584|69664510|FG001|Overall Study|Death|0|||
37812070|NCT00246012|69489487|FG006|Overall Study|Adverse Event|0|||
37812071|NCT00246012|69489488|FG007|Overall Study|Adverse Event|0|||
37812072|NCT00246012|69489489|FG008|Overall Study|Adverse Event|2|||
37812073|NCT00246012|69489481|FG000|Overall Study|Withdrawal by Subject|0|||
37812074|NCT00246012|69489482|FG001|Overall Study|Withdrawal by Subject|0|||
37812075|NCT00246012|69489483|FG002|Overall Study|Withdrawal by Subject|0|||
37812076|NCT00246012|69489484|FG003|Overall Study|Withdrawal by Subject|0|||
37812077|NCT00246012|69489485|FG004|Overall Study|Withdrawal by Subject|0|||
37812078|NCT00246012|69489486|FG005|Overall Study|Withdrawal by Subject|1|||
37812079|NCT00246012|69489487|FG006|Overall Study|Withdrawal by Subject|0|||
37977426|NCT00311584|69664509|FG000|Overall Study|Lack of Efficacy|12|||
37977427|NCT00311584|69664510|FG001|Overall Study|Lack of Efficacy|15|||
37977428|NCT00311584|69664509|FG000|Overall Study|Physician Decision|4|||
37977429|NCT00311584|69664510|FG001|Overall Study|Physician Decision|5|||
37977430|NCT00311584|69664509|FG000|Overall Study|Withdrawal by Subject|1|||
37977431|NCT00311584|69664510|FG001|Overall Study|Withdrawal by Subject|1|||
37977432|NCT00311584|69664509|FG000|Overall Study|ineligible|2|||
37977433|NCT00311584|69664510|FG001|Overall Study|ineligible|2|||
37977434|NCT00383331|69664518|FG000|Overall Study|Protocol Violation|0|||
37977435|NCT00383331|69664519|FG001|Overall Study|Protocol Violation|1|||
37977436|NCT03934541|69664529|FG000|Overall Study|Study Terminated by Sponsor|0|||
37977437|NCT03934541|69664530|FG001|Overall Study|Study Terminated by Sponsor|1|||
37977438|NCT03934541|69664531|FG002|Overall Study|Study Terminated by Sponsor|0|||
37977439|NCT03934541|69664532|FG003|Overall Study|Study Terminated by Sponsor|0|||
37812080|NCT00246012|69489488|FG007|Overall Study|Withdrawal by Subject|0|||
37812081|NCT00246012|69489489|FG008|Overall Study|Withdrawal by Subject|0|||
37812082|NCT00246012|69489481|FG000|Overall Study|Disease progression|3|||
37812083|NCT00246012|69489482|FG001|Overall Study|Disease progression|1|||
37812084|NCT00246012|69489483|FG002|Overall Study|Disease progression|2|||
37812085|NCT00246012|69489484|FG003|Overall Study|Disease progression|3|||
37812086|NCT00246012|69489485|FG004|Overall Study|Disease progression|3|||
37812087|NCT00246012|69489486|FG005|Overall Study|Disease progression|25|||
37812088|NCT00246012|69489487|FG006|Overall Study|Disease progression|30|||
37812089|NCT00246012|69489488|FG007|Overall Study|Disease progression|27|||
37812090|NCT00246012|69489489|FG008|Overall Study|Disease progression|26|||
37812091|NCT00246012|69489481|FG000|Overall Study|Other|0|||
37812092|NCT00246012|69489482|FG001|Overall Study|Other|0|||
37812093|NCT00246012|69489483|FG002|Overall Study|Other|0|||
37812094|NCT00246012|69489484|FG003|Overall Study|Other|0|||
37812095|NCT00246012|69489485|FG004|Overall Study|Other|0|||
37812096|NCT00246012|69489486|FG005|Overall Study|Other|0|||
37812097|NCT00246012|69489487|FG006|Overall Study|Other|0|||
37812098|NCT00246012|69489488|FG007|Overall Study|Other|1|||
37812099|NCT00246012|69489489|FG008|Overall Study|Other|0|||
37812100|NCT00246012|69489481|FG000|Overall Study|Randomly assigned but not treated|0|||
37812101|NCT00246012|69489482|FG001|Overall Study|Randomly assigned but not treated|0|||
37812102|NCT00246012|69489483|FG002|Overall Study|Randomly assigned but not treated|0|||
37812103|NCT00246012|69489484|FG003|Overall Study|Randomly assigned but not treated|0|||
37812104|NCT00246012|69489485|FG004|Overall Study|Randomly assigned but not treated|0|||
37812105|NCT00246012|69489486|FG005|Overall Study|Randomly assigned but not treated|1|||
37812106|NCT00246012|69489487|FG006|Overall Study|Randomly assigned but not treated|1|||
37812107|NCT00246012|69489488|FG007|Overall Study|Randomly assigned but not treated|0|||
37812108|NCT00246012|69489489|FG008|Overall Study|Randomly assigned but not treated|0|||
37812109|NCT00245856|69489511|FG000|Period Two|Withdrawal by Subject|0|||
37812110|NCT00245856|69489512|FG001|Period Two|Withdrawal by Subject|1|||
37812111|NCT00245466|69489522|FG000|Overall Study|Adverse Event|2|||
37812112|NCT00245466|69489523|FG001|Overall Study|Adverse Event|8|||
37812113|NCT00245466|69489524|FG002|Overall Study|Adverse Event|4|||
37812114|NCT00245466|69489522|FG000|Overall Study|Low prostate specific antigen suppr|16|||
37812115|NCT00245466|69489523|FG001|Overall Study|Low prostate specific antigen suppr|14|||
37812116|NCT00245466|69489524|FG002|Overall Study|Low prostate specific antigen suppr|5|||
37812117|NCT00245466|69489522|FG000|Overall Study|Insufficient testosterone suppr|12|||
37812118|NCT00245466|69489523|FG001|Overall Study|Insufficient testosterone suppr|12|||
37812119|NCT00245466|69489524|FG002|Overall Study|Insufficient testosterone suppr|21|||
37812120|NCT00245466|69489522|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
37812121|NCT00245466|69489523|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
37812122|NCT00245466|69489524|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
37812123|NCT00245466|69489522|FG000|Overall Study|Withdrawal by Subject|2|||
37812124|NCT00245466|69489523|FG001|Overall Study|Withdrawal by Subject|2|||
37812125|NCT00245466|69489524|FG002|Overall Study|Withdrawal by Subject|1|||
37812126|NCT00245466|69489522|FG000|Overall Study|Lost to Follow-up|3|||
37812127|NCT00245466|69489523|FG001|Overall Study|Lost to Follow-up|0|||
37977440|NCT00325234|69664544|FG000|Overall Study|Adverse Event|10|||
37977441|NCT00325234|69664545|FG001|Overall Study|Adverse Event|7|||
37864385|NCT01259492|69548038|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
37812128|NCT00245466|69489524|FG002|Overall Study|Lost to Follow-up|0|||
37812129|NCT00245466|69489522|FG000|Overall Study|Disease progression|0|||
37812130|NCT00245466|69489523|FG001|Overall Study|Disease progression|3|||
37812131|NCT00245466|69489524|FG002|Overall Study|Disease progression|1|||
37977442|NCT00325234|69664544|FG000|Overall Study|Death due to Study Disease|1|||
37812132|NCT00245466|69489522|FG000|Overall Study|Protocol Violation|1|||
37812133|NCT00245466|69489523|FG001|Overall Study|Protocol Violation|2|||
37812134|NCT00245466|69489524|FG002|Overall Study|Protocol Violation|2|||
37812135|NCT00245466|69489522|FG000|Overall Study|Death|0|||
37812136|NCT00245466|69489523|FG001|Overall Study|Death|2|||
37812137|NCT00245466|69489524|FG002|Overall Study|Death|0|||
37812138|NCT00245466|69489522|FG000|Overall Study|Administrative reasons|0|||
37864386|NCT01259492|69548039|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
37864387|NCT01259492|69548040|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
37812139|NCT00245466|69489523|FG001|Overall Study|Administrative reasons|1|||
37812140|NCT00245466|69489524|FG002|Overall Study|Administrative reasons|0|||
37812141|NCT00244764|69489532|FG000|Overall Study|Adverse Event|37|||
37812142|NCT00244764|69489532|FG000|Overall Study|Lost to Follow-up|23|||
37812143|NCT00244764|69489532|FG000|Overall Study|Withdrawal by Subject|12|||
37812144|NCT00244764|69489532|FG000|Overall Study|Disease Progression|13|||
37812145|NCT00244764|69489532|FG000|Overall Study|Protocol Violation|2|||
37812146|NCT00244764|69489532|FG000|Overall Study|Death|1|||
37812147|NCT00244764|69489532|FG000|Overall Study|Off Study Medication for >21 Days|1|||
37812148|NCT00244764|69489532|FG000|Overall Study|Declining Performance Status|1|||
37812149|NCT00244764|69489532|FG000|Overall Study|Participant was Hospitalized until Death|1|||
37812150|NCT00244764|69489532|FG000|Overall Study|Primary Investigator Discretion|2|||
37812151|NCT00244764|69489532|FG000|Overall Study|Sponsor Terminated Study|2|||
37812152|NCT00244764|69489532|FG000|Overall Study|Developed Secondary Malignancy|1|||
37812153|NCT00244374|69489537|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
37812154|NCT00244374|69489538|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
37812155|NCT00244374|69489539|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
37812156|NCT00244374|69489540|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
37812157|NCT00244374|69489541|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
37812158|NCT00244374|69489537|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
37812159|NCT00244374|69489538|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
37812160|NCT00244374|69489539|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
37812161|NCT00244374|69489540|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
37812162|NCT00244374|69489541|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
37812163|NCT00244374|69489537|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
37812164|NCT00244374|69489538|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
37812165|NCT00244374|69489539|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
37812166|NCT00244374|69489540|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
37812167|NCT00244374|69489541|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
37812168|NCT00244374|69489537|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
37812169|NCT00244374|69489538|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
37812170|NCT00244374|69489539|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
37812171|NCT00244374|69489540|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
37977443|NCT00325234|69664545|FG001|Overall Study|Death due to Study Disease|0|||
37977444|NCT00325234|69664544|FG000|Overall Study|Entry Criteria Not Met|1|||
37812172|NCT00244374|69489541|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
37812173|NCT00244374|69489537|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
37812174|NCT00244374|69489538|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
37812175|NCT00244374|69489539|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
37812176|NCT00244374|69489540|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
37812177|NCT00244374|69489541|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
37864388|NCT01259492|69548037|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
37864389|NCT01259492|69548038|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
37864390|NCT01259492|69548039|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
37977445|NCT00325234|69664545|FG001|Overall Study|Entry Criteria Not Met|2|||
37977446|NCT00325234|69664544|FG000|Overall Study|Subject Decision|6|||
37864391|NCT01259492|69548040|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
37864392|NCT01259492|69548037|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
37864393|NCT01259492|69548038|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
37694304|NCT01894516|69170603|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
37694305|NCT01894516|69170604|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
37694306|NCT01894516|69170605|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
37694307|NCT01894516|69170606|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
37864394|NCT01259492|69548039|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
37977447|NCT00325234|69664545|FG001|Overall Study|Subject Decision|8|||
37694308|NCT01894516|69170603|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
37812178|NCT00244374|69489537|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
37812179|NCT00244374|69489538|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
37812180|NCT00244374|69489539|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
37812181|NCT00244374|69489540|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
37812182|NCT00244374|69489541|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
37812183|NCT00244374|69489537|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
37812184|NCT00244374|69489538|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
37812185|NCT00244374|69489539|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
37812186|NCT00244374|69489540|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
37812187|NCT00244374|69489541|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
37812188|NCT00244374|69489537|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
37812189|NCT00244374|69489538|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
37812190|NCT00244374|69489539|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
37812191|NCT00244374|69489540|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
37812192|NCT00244374|69489541|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
37812193|NCT00244374|69489537|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
37812194|NCT00244374|69489538|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
37812195|NCT00244374|69489539|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
37812196|NCT00244374|69489540|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
37812197|NCT00244374|69489541|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
37812198|NCT00242658|69489559|FG000|Overall Study|Lost to Follow-up|22|||
37812199|NCT00242658|69489560|FG001|Overall Study|Lost to Follow-up|19|||
37812200|NCT00242580|69489569|FG000|Overall Study|Adverse Event|3|||
37812201|NCT00242580|69489570|FG001|Overall Study|Adverse Event|0|||
37812202|NCT00242580|69489571|FG002|Overall Study|Adverse Event|2|||
37812203|NCT00242580|69489569|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
37812204|NCT00242580|69489570|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
37812205|NCT00242580|69489571|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
37812206|NCT00242580|69489569|FG000|Overall Study|Protocol Violation|0|||
37812207|NCT00242580|69489570|FG001|Overall Study|Protocol Violation|0|||
37812208|NCT00242580|69489571|FG002|Overall Study|Protocol Violation|1|||
37977448|NCT00325234|69664544|FG000|Overall Study|Physician Decision|17|||
37977449|NCT00325234|69664545|FG001|Overall Study|Physician Decision|12|||
37977450|NCT00325234|69664544|FG000|Overall Study|Progressive Disease|34|||
37977451|NCT00325234|69664545|FG001|Overall Study|Progressive Disease|37|||
37977452|NCT00366249|69664555|FG000|Overall Study|Adverse Event|53|||
37977453|NCT00366249|69664556|FG001|Overall Study|Adverse Event|28|||
37977454|NCT00366249|69664555|FG000|Overall Study|Death|0|||
37977455|NCT00366249|69664556|FG001|Overall Study|Death|1|||
37977456|NCT00366249|69664555|FG000|Overall Study|Physician Decision|5|||
37977457|NCT00366249|69664556|FG001|Overall Study|Physician Decision|2|||
37977458|NCT00366249|69664555|FG000|Overall Study|Lost to Follow-up|2|||
37977459|NCT00366249|69664556|FG001|Overall Study|Lost to Follow-up|0|||
37977460|NCT00366249|69664555|FG000|Overall Study|Protocol Violation|1|||
37977461|NCT00366249|69664556|FG001|Overall Study|Protocol Violation|2|||
37977462|NCT00366249|69664555|FG000|Overall Study|Withdrawal by Subject|18|||
37977463|NCT00366249|69664556|FG001|Overall Study|Withdrawal by Subject|4|||
37977464|NCT00366249|69664555|FG000|Overall Study|Lack of Efficacy|21|||
37977465|NCT00366249|69664556|FG001|Overall Study|Lack of Efficacy|21|||
37977466|NCT00366249|69664555|FG000|Overall Study|Most due to osteomylitis status|31|||
37977467|NCT00366249|69664556|FG001|Overall Study|Most due to osteomylitis status|20|||
37977468|NCT00325156|69664562|FG000|Overall Study|Protocol Violation|8|||
37977469|NCT00325156|69664562|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
37977470|NCT00325156|69664562|FG000|Overall Study|Migrated/moved from study area|12|||
37977471|NCT00325156|69664562|FG000|Overall Study|Adverse event, non-fatal|3|||
37977472|NCT00325156|69664562|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
37977473|NCT00325156|69664562|FG000|Overall Study|Other|1|||
37812209|NCT00242580|69489569|FG000|Overall Study|Subject withdrew consent|2|||
37977474|NCT00325156|69664562|FG000|Overall Study|Withdrawal by Subject|31|||
37977475|NCT03927911|69664572|FG000|Overall Study|problems with eDiary|0|||
37977476|NCT03927911|69664573|FG001|Overall Study|problems with eDiary|1|||
37977477|NCT03927911|69664574|FG002|Overall Study|problems with eDiary|0|||
37977478|NCT03927911|69664575|FG003|Overall Study|problems with eDiary|1|||
37977479|NCT03927911|69664576|FG004|Overall Study|problems with eDiary|0|||
37977480|NCT03927911|69664577|FG005|Overall Study|problems with eDiary|4|||
37977481|NCT03927911|69664572|FG000|Overall Study|Adverse Event|0|||
37977482|NCT03927911|69664573|FG001|Overall Study|Adverse Event|0|||
37977483|NCT03927911|69664574|FG002|Overall Study|Adverse Event|0|||
37977484|NCT03927911|69664575|FG003|Overall Study|Adverse Event|0|||
37977485|NCT03927911|69664576|FG004|Overall Study|Adverse Event|0|||
37812210|NCT00242580|69489570|FG001|Overall Study|Subject withdrew consent|2|||
37812211|NCT00242580|69489571|FG002|Overall Study|Subject withdrew consent|5|||
37812212|NCT00242580|69489569|FG000|Overall Study|Lost to Follow-up|0|||
37812213|NCT00242580|69489570|FG001|Overall Study|Lost to Follow-up|3|||
37812214|NCT00242580|69489571|FG002|Overall Study|Lost to Follow-up|0|||
37812215|NCT00242580|69489569|FG000|Overall Study|Death|1|||
37812216|NCT00242580|69489570|FG001|Overall Study|Death|2|||
37812217|NCT00242580|69489571|FG002|Overall Study|Death|1|||
37812218|NCT00241644|69489583|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
37812219|NCT00241644|69489584|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
37812220|NCT00241644|69489585|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
37812221|NCT00241644|69489586|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
37812222|NCT00241644|69489583|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
37812223|NCT00241644|69489584|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
37812224|NCT00241644|69489585|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
37812225|NCT00241644|69489586|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
37812226|NCT00241644|69489583|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
37812227|NCT00241644|69489584|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
37812228|NCT00241644|69489585|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
37812229|NCT00241644|69489586|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
37977486|NCT03927911|69664577|FG005|Overall Study|Adverse Event|1|||
37977487|NCT03927911|69664572|FG000|Overall Study|not treated -study terminated by sponsor|0|||
37812230|NCT00241644|69489583|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
37812231|NCT00241644|69489584|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
37812232|NCT00241644|69489585|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
37812233|NCT00241644|69489586|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
37812234|NCT00241644|69489583|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
37812235|NCT00241644|69489584|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
37812236|NCT00241644|69489585|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
37812237|NCT00241644|69489586|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
37812238|NCT00241644|69489583|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
37812239|NCT00241644|69489584|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
37812240|NCT00241644|69489585|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
37812241|NCT00241644|69489586|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
37812242|NCT00241644|69489583|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
37812243|NCT00241644|69489584|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
37812244|NCT00241644|69489585|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
37812245|NCT00241644|69489586|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
37812246|NCT00241644|69489583|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
37812247|NCT00241644|69489584|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
37812248|NCT00241644|69489585|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
37812249|NCT00241644|69489586|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
37812250|NCT00241644|69489583|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
37812251|NCT00241644|69489584|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
37812252|NCT00241644|69489585|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
37812253|NCT00241644|69489586|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
37812254|NCT00241644|69489583|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
37812255|NCT00241644|69489584|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
37812256|NCT00241644|69489585|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
37812257|NCT00241644|69489586|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
37812258|NCT00241644|69489583|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
37812259|NCT00241644|69489584|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
37812260|NCT00241644|69489585|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
37812261|NCT00241644|69489586|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
37812262|NCT00241644|69489583|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
37812263|NCT00241644|69489584|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
37812264|NCT00241644|69489585|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
37812265|NCT00241644|69489586|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
37977488|NCT03927911|69664573|FG001|Overall Study|not treated -study terminated by sponsor|1|||
37812266|NCT00241644|69489583|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
37977489|NCT03927911|69664574|FG002|Overall Study|not treated -study terminated by sponsor|0|||
37812267|NCT00241644|69489584|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
37812268|NCT00241644|69489585|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
37812269|NCT00241644|69489586|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
37812270|NCT03804684|69489607|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
37812271|NCT03804684|69489608|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
37812272|NCT04295772|69489623|FG000|Overall Study|Protocol Violation|1|||
37812273|NCT04295772|69489624|FG001|Overall Study|Protocol Violation|0|||
37812274|NCT04295772|69489623|FG000|Overall Study|Ongoing for safety monitoring|14|||
37812275|NCT04295772|69489624|FG001|Overall Study|Ongoing for safety monitoring|1|||
37812276|NCT04295772|69489623|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
37812277|NCT04295772|69489624|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
37812278|NCT03888066|69489633|FG000|Run-in Phase|Randomization Criterion #1|24|||
37812279|NCT03888066|69489634|FG001|Run-in Phase|Randomization Criterion #1|0|||
37812280|NCT03888066|69489633|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
37812281|NCT03888066|69489634|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
37812282|NCT03888066|69489633|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
37812283|NCT03888066|69489634|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
37812284|NCT03888066|69489633|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
37812285|NCT03888066|69489634|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
37812286|NCT03888066|69489633|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
37812287|NCT03888066|69489634|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
37812288|NCT03888066|69489633|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
37812289|NCT03888066|69489634|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
37812290|NCT03888066|69489633|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
37812291|NCT03888066|69489634|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
37812292|NCT03888066|69489633|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
37812293|NCT03888066|69489634|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
37812294|NCT03888066|69489633|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
37812295|NCT03888066|69489634|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
37812296|NCT03888066|69489633|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
37812297|NCT03888066|69489634|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
37812298|NCT03888066|69489633|FG000|Run-in Phase|Randomization Criterion #2|5|||
37812299|NCT03888066|69489634|FG001|Run-in Phase|Randomization Criterion #2|0|||
37812300|NCT03888066|69489633|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
37812301|NCT03888066|69489634|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
37812302|NCT03888066|69489633|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
37812303|NCT03888066|69489634|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
37812304|NCT03888066|69489633|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
37812305|NCT03888066|69489634|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
37812306|NCT03888066|69489633|FG000|Run-in Phase|Randomization Criterion #3|11|||
37812307|NCT03888066|69489634|FG001|Run-in Phase|Randomization Criterion #3|0|||
37812308|NCT03888066|69489633|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
37812309|NCT03888066|69489634|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
37812310|NCT03888066|69489633|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
37812311|NCT03888066|69489634|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
37812312|NCT03888066|69489633|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
37812313|NCT03888066|69489634|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
37812314|NCT03888066|69489633|FG000|Run-in Phase|Randomization Criterion #4|3|||
37812315|NCT03888066|69489634|FG001|Run-in Phase|Randomization Criterion #4|0|||
37812316|NCT03888066|69489633|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
37812317|NCT03888066|69489634|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
37812318|NCT03888066|69489633|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
37812319|NCT03888066|69489634|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
37812320|NCT03888066|69489633|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
37812321|NCT03888066|69489634|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
37812322|NCT03888066|69489633|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
37694309|NCT01894516|69170604|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
37694310|NCT01894516|69170605|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
37812323|NCT03888066|69489634|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
37812324|NCT03888066|69489633|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
37812325|NCT03888066|69489634|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
37812326|NCT03888066|69489633|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
37812327|NCT03888066|69489634|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
37812328|NCT03888066|69489633|FG000|Run-in Phase|AE (Adverse Event)|17|||
37812329|NCT03888066|69489634|FG001|Run-in Phase|AE (Adverse Event)|0|||
37812330|NCT03888066|69489633|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
37812331|NCT03888066|69489634|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
37812332|NCT03888066|69489633|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
37812333|NCT03888066|69489634|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
37812334|NCT03888066|69489633|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
37812335|NCT03888066|69489634|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
37812336|NCT03888066|69489633|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
37812337|NCT03888066|69489634|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
37812338|NCT03888066|69489633|FG000|Run-in Phase|Withdrawal by Subject|43|||
37812339|NCT03888066|69489634|FG001|Run-in Phase|Withdrawal by Subject|0|||
37812340|NCT03888066|69489633|FG000|Run-in Phase|AE; Physician Decision|1|||
37812341|NCT03888066|69489634|FG001|Run-in Phase|AE; Physician Decision|0|||
37812342|NCT03888066|69489633|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
37812343|NCT03888066|69489634|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
37812344|NCT03888066|69489633|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
37812345|NCT03888066|69489634|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
37812346|NCT03888066|69489633|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
37812347|NCT03888066|69489634|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
37812348|NCT03888066|69489633|FG000|Run-in Phase|Death|1|||
37812349|NCT03888066|69489634|FG001|Run-in Phase|Death|0|||
37812350|NCT03888066|69489633|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
37812351|NCT03888066|69489634|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
37812352|NCT03888066|69489633|FG000|Run-in Phase|Physician Decision|1|||
37812353|NCT03888066|69489634|FG001|Run-in Phase|Physician Decision|0|||
37812354|NCT03888066|69489633|FG000|Run-in Phase|Protocol Violation|13|||
37812355|NCT03888066|69489634|FG001|Run-in Phase|Protocol Violation|0|||
37812356|NCT03888066|69489633|FG000|Run-in Phase|Sponsor Request|34|||
37812357|NCT03888066|69489634|FG001|Run-in Phase|Sponsor Request|0|||
37812358|NCT03888066|69489633|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
37812359|NCT03888066|69489634|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
37812360|NCT03888066|69489633|FG000|Run-in Phase|Withdrawal Of Consent|1|||
37812361|NCT03888066|69489634|FG001|Run-in Phase|Withdrawal Of Consent|0|||
37812362|NCT03888066|69489633|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
37812363|NCT03888066|69489634|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
37812364|NCT03888066|69489633|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
37812365|NCT03888066|69489634|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
37812366|NCT03888066|69489633|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
37812367|NCT03888066|69489634|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
37812368|NCT03888066|69489633|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
37812369|NCT03888066|69489634|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
37812370|NCT03888066|69489633|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
37812371|NCT03888066|69489634|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
37812372|NCT03888066|69489633|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
37812373|NCT03888066|69489634|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
37812374|NCT03888066|69489633|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
37812375|NCT03888066|69489634|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
37812376|NCT03888066|69489633|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
37812377|NCT03888066|69489634|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
37812378|NCT03888066|69489633|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
37812379|NCT03888066|69489634|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
37812380|NCT03888066|69489633|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
37812381|NCT03888066|69489634|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
37812382|NCT03888066|69489633|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
37812383|NCT03888066|69489634|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
37812384|NCT03888066|69489633|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
37812385|NCT03888066|69489634|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
37812386|NCT01049334|69489643|FG000|Overall Study|Withdrawal by Subject|5|||
37812387|NCT01049334|69489644|FG001|Overall Study|Withdrawal by Subject|3|||
37812388|NCT01049334|69489643|FG000|Overall Study|Adverse Event|2|||
37812389|NCT01049334|69489644|FG001|Overall Study|Adverse Event|3|||
37812390|NCT01049334|69489643|FG000|Overall Study|Physician Decision|2|||
37812391|NCT01049334|69489644|FG001|Overall Study|Physician Decision|0|||
37812392|NCT01049334|69489643|FG000|Overall Study|Protocol Violation|0|||
37812393|NCT01049334|69489644|FG001|Overall Study|Protocol Violation|1|||
37812394|NCT01048944|69489654|FG000|Overall Study|Protocol Violation|8|||
37812395|NCT01048944|69489655|FG001|Overall Study|Protocol Violation|10|||
37812396|NCT01048944|69489656|FG002|Overall Study|Protocol Violation|10|||
37812397|NCT01048944|69489657|FG003|Overall Study|Protocol Violation|2|||
37812398|NCT01048866|69489669|FG000|Overall Study|Adverse Event|1|||
37812399|NCT01048866|69489670|FG001|Overall Study|Adverse Event|0|||
37812400|NCT01048866|69489669|FG000|Overall Study|Protocol Violation|1|||
37977490|NCT03927911|69664575|FG003|Overall Study|not treated -study terminated by sponsor|0|||
37977491|NCT03927911|69664576|FG004|Overall Study|not treated -study terminated by sponsor|0|||
37977492|NCT03927911|69664577|FG005|Overall Study|not treated -study terminated by sponsor|0|||
37977493|NCT03927911|69664572|FG000|Overall Study|Surgery cancelled|0|||
37977494|NCT03927911|69664573|FG001|Overall Study|Surgery cancelled|0|||
37977495|NCT03927911|69664574|FG002|Overall Study|Surgery cancelled|0|||
37977496|NCT03927911|69664575|FG003|Overall Study|Surgery cancelled|1|||
37977497|NCT03927911|69664576|FG004|Overall Study|Surgery cancelled|0|||
37977498|NCT03927911|69664577|FG005|Overall Study|Surgery cancelled|1|||
37977499|NCT03927911|69664572|FG000|Overall Study|Protocol Violation|0|||
37977500|NCT03927911|69664573|FG001|Overall Study|Protocol Violation|0|||
37977501|NCT03927911|69664574|FG002|Overall Study|Protocol Violation|0|||
37977502|NCT03927911|69664575|FG003|Overall Study|Protocol Violation|0|||
37977503|NCT03927911|69664576|FG004|Overall Study|Protocol Violation|0|||
37977504|NCT03927911|69664577|FG005|Overall Study|Protocol Violation|1|||
37977505|NCT00383019|69664593|FG000|Overall Study|Adverse Event|5|||
37694311|NCT01894516|69170606|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
37694312|NCT01894516|69170603|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
37694313|NCT01894516|69170604|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
37694314|NCT01894516|69170605|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
37694315|NCT01894516|69170606|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
37694316|NCT01894516|69170603|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
37694317|NCT01894516|69170604|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
37694318|NCT01894516|69170605|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
37694319|NCT01894516|69170606|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
37694320|NCT01894516|69170603|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
37694321|NCT01894516|69170604|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
37694322|NCT01894516|69170605|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
37694323|NCT01894516|69170606|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
37694324|NCT01894516|69170603|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
37694325|NCT01894516|69170604|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
37694326|NCT01894516|69170605|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
37694327|NCT01894516|69170606|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
37694328|NCT01894516|69170603|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
37694329|NCT01894516|69170604|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
37694330|NCT01894516|69170605|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
37694331|NCT01894516|69170606|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
37694332|NCT02491463|69170624|FG000|Overall Study|Withdrawal by Subject|1|||
37694333|NCT02491463|69170625|FG001|Overall Study|Withdrawal by Subject|2|||
37812401|NCT01048866|69489670|FG001|Overall Study|Protocol Violation|0|||
37812402|NCT01048866|69489669|FG000|Overall Study|Physician Decision|1|||
37694334|NCT02491463|69170626|FG002|Overall Study|Withdrawal by Subject|0|||
37694335|NCT02491463|69170627|FG003|Overall Study|Withdrawal by Subject|0|||
37812403|NCT01048866|69489670|FG001|Overall Study|Physician Decision|0|||
37977506|NCT00383019|69664594|FG001|Overall Study|Adverse Event|1|||
37977507|NCT00383019|69664593|FG000|Overall Study|Withdrawal by Subject|0|||
37694336|NCT02491463|69170624|FG000|Overall Study|Migrated/moved from study area|1|||
37812404|NCT01048866|69489669|FG000|Overall Study|Withdrawal by Subject|0|||
37812405|NCT01048866|69489670|FG001|Overall Study|Withdrawal by Subject|2|||
37812406|NCT01048866|69489669|FG000|Overall Study|Lost to Follow-up|0|||
37977508|NCT00383019|69664594|FG001|Overall Study|Withdrawal by Subject|1|||
37977509|NCT00310804|69664602|FG000|Overall Study|Lost to Follow-up|2|||
37977510|NCT00310804|69664603|FG001|Overall Study|Lost to Follow-up|0|||
37977511|NCT00310804|69664602|FG000|Overall Study|Withdrawal by Subject|3|||
37812407|NCT01048866|69489670|FG001|Overall Study|Lost to Follow-up|2|||
37694337|NCT02491463|69170625|FG001|Overall Study|Migrated/moved from study area|5|||
37694338|NCT02491463|69170626|FG002|Overall Study|Migrated/moved from study area|1|||
37694339|NCT02491463|69170627|FG003|Overall Study|Migrated/moved from study area|1|||
37694340|NCT02491463|69170624|FG000|Overall Study|Lost to Follow-up|0|||
37694341|NCT02491463|69170625|FG001|Overall Study|Lost to Follow-up|3|||
37694342|NCT02491463|69170626|FG002|Overall Study|Lost to Follow-up|3|||
37694343|NCT02491463|69170627|FG003|Overall Study|Lost to Follow-up|0|||
37977512|NCT00310804|69664603|FG001|Overall Study|Withdrawal by Subject|0|||
37812408|NCT01048866|69489669|FG000|Overall Study|Other|1|||
37977513|NCT03826186|69664625|FG000|Overall Study|Protocol Violation|2|||
37977514|NCT03826186|69664626|FG001|Overall Study|Protocol Violation|0|||
37977515|NCT03826186|69664625|FG000|Overall Study|Withdrawal by Subject|1|||
37977516|NCT03826186|69664626|FG001|Overall Study|Withdrawal by Subject|0|||
37977517|NCT00382863|69664634|FG000|Overall Study|Death|9|||
37977518|NCT00382863|69664635|FG001|Overall Study|Death|9|||
37977519|NCT00382863|69664634|FG000|Overall Study|Lost to Follow-up|1|||
37812409|NCT01048866|69489670|FG001|Overall Study|Other|1|||
37812410|NCT01048788|69489679|FG000|Overall Study|Adverse Event|5|||
37812411|NCT01048788|69489680|FG001|Overall Study|Adverse Event|1|||
37812412|NCT01048788|69489681|FG002|Overall Study|Adverse Event|1|||
37812413|NCT01048788|69489679|FG000|Overall Study|Lack of Efficacy|0|||
37812414|NCT01048788|69489680|FG001|Overall Study|Lack of Efficacy|0|||
37812415|NCT01048788|69489681|FG002|Overall Study|Lack of Efficacy|1|||
37812416|NCT01048788|69489679|FG000|Overall Study|Withdrawal by Subject|0|||
37812417|NCT01048788|69489680|FG001|Overall Study|Withdrawal by Subject|1|||
37812418|NCT01048788|69489681|FG002|Overall Study|Withdrawal by Subject|0|||
37812419|NCT01048242|69489691|FG000|Overall Study|See study flow chart|4|||
37812420|NCT01048242|69489692|FG001|Overall Study|See study flow chart|2|||
37812421|NCT01047306|69489700|FG000|Overall Study|Withdrawal by Subject|2|||
37812422|NCT01047306|69489701|FG001|Overall Study|Withdrawal by Subject|0|||
37812423|NCT01047306|69489700|FG000|Overall Study|Lost to Follow-up|1|||
37812424|NCT01047306|69489701|FG001|Overall Study|Lost to Follow-up|0|||
37812425|NCT01046682|69489711|FG000|Overall Study|Adverse Event|2|||
37812426|NCT01046682|69489712|FG001|Overall Study|Adverse Event|0|||
37812427|NCT01044732|69489720|FG000|Overall Study|Lost to Follow-up|2|||
37812428|NCT01044732|69489721|FG001|Overall Study|Lost to Follow-up|1|||
37812429|NCT01044732|69489720|FG000|Overall Study|Physician Decision|5|||
37812430|NCT01044732|69489721|FG001|Overall Study|Physician Decision|3|||
37812431|NCT01044732|69489720|FG000|Overall Study|Protocol Violation|11|||
37812432|NCT01044732|69489721|FG001|Overall Study|Protocol Violation|12|||
37812433|NCT01044732|69489720|FG000|Overall Study|Withdrawal by Subject|0|||
37812434|NCT01044732|69489721|FG001|Overall Study|Withdrawal by Subject|1|||
37812435|NCT01044732|69489720|FG000|Overall Study|Inadequate bowel preparation|11|||
37812436|NCT01044732|69489721|FG001|Overall Study|Inadequate bowel preparation|17|||
37812437|NCT01044732|69489720|FG000|Overall Study|Inability to reach cecum|5|||
37812438|NCT01044732|69489721|FG001|Overall Study|Inability to reach cecum|2|||
37812439|NCT01044732|69489720|FG000|Overall Study|Technical error or malfunction|15|||
37812440|NCT01044732|69489721|FG001|Overall Study|Technical error or malfunction|14|||
37812441|NCT01044498|69489731|FG000|Overall Study|Withdrew consent|1|||
37812442|NCT01044498|69489732|FG001|Overall Study|Withdrew consent|1|||
37812443|NCT01044498|69489731|FG000|Overall Study|Adverse Event|1|||
37812444|NCT01044498|69489732|FG001|Overall Study|Adverse Event|1|||
37812445|NCT01044498|69489731|FG000|Overall Study|Other|1|||
37812446|NCT01044498|69489732|FG001|Overall Study|Other|0|||
37812447|NCT01043874|69489738|FG000|Overall Study|Adverse Event|3|||
37812448|NCT01043874|69489738|FG000|Overall Study|Withdrawal by Subject|1|||
37812449|NCT01043874|69489738|FG000|Overall Study|Lack of Efficacy|1|||
37977520|NCT00382863|69664635|FG001|Overall Study|Lost to Follow-up|2|||
37694344|NCT02038881|69170640|FG000|Overall Study|Withdrawal by Subject|0|||
37694345|NCT02038881|69170641|FG001|Overall Study|Withdrawal by Subject|0|||
37812450|NCT01043874|69489738|FG000|Overall Study|Administrative Problems|1|||
37812451|NCT01042938|69489744|FG000|Overall Study|Withdrawal by Subject|1|||
37812452|NCT01042938|69489745|FG001|Overall Study|Withdrawal by Subject|1|||
37812453|NCT01042938|69489744|FG000|Overall Study|Protocol Violation|1|||
37812454|NCT01042938|69489745|FG001|Overall Study|Protocol Violation|1|||
37812455|NCT01042938|69489744|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
37812456|NCT01042938|69489745|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
37812457|NCT01042158|69489753|FG000|Overall Study|Physician Decision|1|||
37812458|NCT03408444|69489761|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
37812459|NCT03408444|69489762|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
37977521|NCT00382863|69664634|FG000|Overall Study|Withdrawal by Subject|5|||
37977522|NCT00382863|69664635|FG001|Overall Study|Withdrawal by Subject|25|||
37977523|NCT03933449|69664643|FG000|Overall Study|Adverse Event|6|||
37812460|NCT03408444|69489763|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
37812461|NCT03408444|69489764|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
37812462|NCT03408444|69489761|FG000|Overall Study|Lens Discomfort|0|||
37812463|NCT03408444|69489762|FG001|Overall Study|Lens Discomfort|1|||
37812464|NCT03408444|69489763|FG002|Overall Study|Lens Discomfort|0|||
37812465|NCT03408444|69489764|FG003|Overall Study|Lens Discomfort|0|||
37812466|NCT03408444|69489761|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
37812467|NCT03408444|69489762|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
37812468|NCT03408444|69489763|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
37812469|NCT03408444|69489764|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
37812470|NCT03408444|69489761|FG000|Overall Study|Withdrawal by Subject|0|||
37812471|NCT03408444|69489762|FG001|Overall Study|Withdrawal by Subject|2|||
37812472|NCT03408444|69489763|FG002|Overall Study|Withdrawal by Subject|3|||
37812473|NCT03408444|69489764|FG003|Overall Study|Withdrawal by Subject|0|||
37812474|NCT03408444|69489761|FG000|Overall Study|Lost to Follow-up|0|||
37812475|NCT03408444|69489762|FG001|Overall Study|Lost to Follow-up|0|||
37812476|NCT03408444|69489763|FG002|Overall Study|Lost to Follow-up|1|||
37812477|NCT03408444|69489764|FG003|Overall Study|Lost to Follow-up|0|||
37812478|NCT03408444|69489761|FG000|Overall Study|Adverse Event|0|||
37812479|NCT03408444|69489762|FG001|Overall Study|Adverse Event|0|||
37812480|NCT03408444|69489763|FG002|Overall Study|Adverse Event|0|||
37812481|NCT03408444|69489764|FG003|Overall Study|Adverse Event|1|||
37812482|NCT03408444|69489761|FG000|Overall Study|Lens Handling Difficulties|0|||
37812483|NCT03408444|69489762|FG001|Overall Study|Lens Handling Difficulties|0|||
37812484|NCT03408444|69489763|FG002|Overall Study|Lens Handling Difficulties|1|||
37812485|NCT03408444|69489764|FG003|Overall Study|Lens Handling Difficulties|0|||
37812486|NCT03408444|69489761|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
37812487|NCT03408444|69489762|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
37812488|NCT03408444|69489763|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
37812489|NCT03408444|69489764|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
37812490|NCT03400956|69489794|FG000|Treatment Period 1|Adverse Event|0|||
37812491|NCT03400956|69489795|FG001|Treatment Period 1|Adverse Event|1|||
37812492|NCT03400956|69489796|FG002|Treatment Period 1|Adverse Event|0|||
37812493|NCT03400956|69489794|FG000|Treatment Period 1|Lost to Follow-up|0|||
37812494|NCT03400956|69489795|FG001|Treatment Period 1|Lost to Follow-up|0|||
37812495|NCT03400956|69489796|FG002|Treatment Period 1|Lost to Follow-up|1|||
37812496|NCT03400956|69489794|FG000|Treatment Period 1|Protocol Violation|0|||
37812497|NCT03400956|69489795|FG001|Treatment Period 1|Protocol Violation|2|||
37812498|NCT03400956|69489796|FG002|Treatment Period 1|Protocol Violation|0|||
37812499|NCT03400956|69489794|FG000|Treatment Period 1|Study terminated by sponsor|3|||
37812500|NCT03400956|69489795|FG001|Treatment Period 1|Study terminated by sponsor|1|||
37812501|NCT03400956|69489796|FG002|Treatment Period 1|Study terminated by sponsor|1|||
37812502|NCT03400956|69489794|FG000|Treatment Period 1|Withdrawal by Subject|0|||
37812503|NCT03400956|69489795|FG001|Treatment Period 1|Withdrawal by Subject|2|||
37812504|NCT03400956|69489796|FG002|Treatment Period 1|Withdrawal by Subject|4|||
37812505|NCT03400956|69489794|FG000|Treatment Period 1|Other|1|||
37812506|NCT03400956|69489795|FG001|Treatment Period 1|Other|2|||
37812507|NCT03400956|69489796|FG002|Treatment Period 1|Other|3|||
37812508|NCT03400956|69489794|FG000|Post-treatment Period 1|Adverse Event|0|||
37812509|NCT03400956|69489795|FG001|Post-treatment Period 1|Adverse Event|0|||
37812510|NCT03400956|69489796|FG002|Post-treatment Period 1|Adverse Event|1|||
37812511|NCT03400956|69489794|FG000|Post-treatment Period 1|Physician Decision|2|||
37812512|NCT03400956|69489795|FG001|Post-treatment Period 1|Physician Decision|3|||
37812513|NCT03400956|69489796|FG002|Post-treatment Period 1|Physician Decision|0|||
37812514|NCT03400956|69489794|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
37812515|NCT03400956|69489795|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
37977524|NCT03933449|69664644|FG001|Overall Study|Adverse Event|4|||
37812516|NCT03400956|69489796|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
37812517|NCT03400956|69489794|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
37812518|NCT03400956|69489795|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
37812519|NCT03400956|69489796|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
37812520|NCT03400956|69489794|FG000|Post-treatment Period 1|Other|4|||
37812521|NCT03400956|69489795|FG001|Post-treatment Period 1|Other|3|||
37812522|NCT03400956|69489796|FG002|Post-treatment Period 1|Other|4|||
37812523|NCT03400956|69489794|FG000|Treatment Period 2|Adverse Event|2|||
37812524|NCT03400956|69489795|FG001|Treatment Period 2|Adverse Event|1|||
37812525|NCT03400956|69489796|FG002|Treatment Period 2|Adverse Event|1|||
37812526|NCT03400956|69489794|FG000|Treatment Period 2|Lost to Follow-up|1|||
37812527|NCT03400956|69489795|FG001|Treatment Period 2|Lost to Follow-up|1|||
37812528|NCT03400956|69489796|FG002|Treatment Period 2|Lost to Follow-up|0|||
37812529|NCT03400956|69489794|FG000|Treatment Period 2|Withdrawal by Subject|0|||
37812530|NCT03400956|69489795|FG001|Treatment Period 2|Withdrawal by Subject|0|||
37812531|NCT03400956|69489796|FG002|Treatment Period 2|Withdrawal by Subject|3|||
37812532|NCT03400956|69489794|FG000|Treatment Period 2|Other|1|||
37812533|NCT03400956|69489795|FG001|Treatment Period 2|Other|1|||
37812534|NCT03400956|69489796|FG002|Treatment Period 2|Other|0|||
37812535|NCT03400956|69489794|FG000|Follow-up Period|Withdrawal by Subject|0|||
37812536|NCT03400956|69489795|FG001|Follow-up Period|Withdrawal by Subject|0|||
37812537|NCT03400956|69489796|FG002|Follow-up Period|Withdrawal by Subject|1|||
37812538|NCT03400956|69489794|FG000|Follow-up Period|Other|0|||
37812539|NCT03400956|69489795|FG001|Follow-up Period|Other|0|||
37812540|NCT03400956|69489796|FG002|Follow-up Period|Other|1|||
37812541|NCT00012012|69489809|FG000|Overall Study|Protocol Violation|1|||
37812542|NCT00012012|69489810|FG001|Overall Study|Protocol Violation|1|||
37812543|NCT00012012|69489809|FG000|Overall Study|Withdrawal by Subject|0|||
37812544|NCT00012012|69489810|FG001|Overall Study|Withdrawal by Subject|2|||
37812545|NCT00010374|69489816|FG000|Overall Study|False positive phrenic nerve test|1|||
37812546|NCT00559962|69489842|FG000|Overall Study|Adverse Event|1|||
37812547|NCT00559962|69489843|FG001|Overall Study|Adverse Event|7|||
37812548|NCT00559962|69489844|FG002|Overall Study|Adverse Event|8|||
37694346|NCT02038881|69170642|FG002|Overall Study|Withdrawal by Subject|1|||
37812549|NCT00559962|69489845|FG003|Overall Study|Adverse Event|5|||
37812550|NCT00559962|69489846|FG004|Overall Study|Adverse Event|11|||
37812551|NCT00559962|69489847|FG005|Overall Study|Adverse Event|4|||
37812552|NCT00559962|69489848|FG006|Overall Study|Adverse Event|4|||
37812553|NCT00559962|69489849|FG007|Overall Study|Adverse Event|2|||
37812554|NCT00559962|69489842|FG000|Overall Study|Lost to Follow-up|0|||
37812555|NCT00559962|69489843|FG001|Overall Study|Lost to Follow-up|1|||
37812556|NCT00559962|69489844|FG002|Overall Study|Lost to Follow-up|0|||
37812557|NCT00559962|69489845|FG003|Overall Study|Lost to Follow-up|0|||
37812558|NCT00559962|69489846|FG004|Overall Study|Lost to Follow-up|0|||
37812559|NCT00559962|69489847|FG005|Overall Study|Lost to Follow-up|0|||
37812560|NCT00559962|69489848|FG006|Overall Study|Lost to Follow-up|0|||
37812561|NCT00559962|69489849|FG007|Overall Study|Lost to Follow-up|0|||
37812562|NCT00559962|69489842|FG000|Overall Study|Withdrawal by Subject|1|||
37812563|NCT00559962|69489843|FG001|Overall Study|Withdrawal by Subject|1|||
37812564|NCT00559962|69489844|FG002|Overall Study|Withdrawal by Subject|2|||
37812565|NCT00559962|69489845|FG003|Overall Study|Withdrawal by Subject|0|||
37812566|NCT00559962|69489846|FG004|Overall Study|Withdrawal by Subject|3|||
37812567|NCT00559962|69489847|FG005|Overall Study|Withdrawal by Subject|1|||
37812568|NCT00559962|69489848|FG006|Overall Study|Withdrawal by Subject|0|||
37812569|NCT00559962|69489849|FG007|Overall Study|Withdrawal by Subject|2|||
37812570|NCT00559962|69489842|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
37812571|NCT00559962|69489843|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
37812572|NCT00559962|69489844|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
37812573|NCT00559962|69489845|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
37812574|NCT00559962|69489846|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
37812575|NCT00559962|69489847|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
37812576|NCT00559962|69489848|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
37812577|NCT00559962|69489849|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
37812578|NCT00559104|69489870|FG000|Overall Study|Lack of Efficacy|9|||
37812579|NCT00559104|69489871|FG001|Overall Study|Lack of Efficacy|0|||
37812580|NCT00558636|69489879|FG000|Treatment|Adverse Event|9|||
37812581|NCT00558636|69489880|FG001|Treatment|Adverse Event|2|||
37812582|NCT00558636|69489879|FG000|Treatment|Withdrawal by Subject|2|||
37812583|NCT00558636|69489880|FG001|Treatment|Withdrawal by Subject|0|||
37812584|NCT00558636|69489879|FG000|Treatment|Premature termination of the study|35|||
37812585|NCT00558636|69489880|FG001|Treatment|Premature termination of the study|37|||
37812586|NCT00558636|69489879|FG000|Treatment|Disease progression|1|||
37812587|NCT00558636|69489880|FG001|Treatment|Disease progression|5|||
37812588|NCT00558636|69489879|FG000|Follow-up|Premature termination of the study|12|||
37812589|NCT00558636|69489880|FG001|Follow-up|Premature termination of the study|7|||
37812590|NCT00558558|69489886|FG000|Overall Study|Unable to swallow|1|||
37812591|NCT00558558|69489886|FG000|Overall Study|Withdrawal by Subject|1|||
37812592|NCT00558558|69489886|FG000|Overall Study|Lack of Efficacy|4|||
37977525|NCT03933449|69664643|FG000|Overall Study|Death|55|||
37977526|NCT03933449|69664644|FG001|Overall Study|Death|57|||
37977527|NCT03933449|69664643|FG000|Overall Study|Sponsor Decision|1|||
37977528|NCT03933449|69664644|FG001|Overall Study|Sponsor Decision|0|||
37977529|NCT00290758|69664667|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
37977530|NCT00290758|69664668|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
37977531|NCT00290758|69664667|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
37977532|NCT00290758|69664668|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
37977533|NCT00290758|69664667|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
37977534|NCT00290758|69664668|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
37977535|NCT00290758|69664667|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
37977536|NCT00290758|69664668|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
37812593|NCT00557622|69489892|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
37812594|NCT00557622|69489893|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
37812595|NCT00557622|69489892|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
37812596|NCT00557622|69489893|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
37812597|NCT00557622|69489892|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
37812598|NCT00557622|69489893|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
37812599|NCT00557466|69489905|FG000|Overall Study|Adverse Event|3|||
37812600|NCT00557466|69489906|FG001|Overall Study|Adverse Event|1|||
37812601|NCT00557466|69489907|FG002|Overall Study|Adverse Event|4|||
37812602|NCT00557466|69489908|FG003|Overall Study|Adverse Event|1|||
37977537|NCT00290758|69664667|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
37977538|NCT00290758|69664668|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
37977539|NCT00290758|69664667|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
37977540|NCT00290758|69664668|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
37977541|NCT00290758|69664667|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
37977542|NCT00290758|69664668|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
37977543|NCT00290758|69664667|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
37977544|NCT00290758|69664668|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
37977545|NCT00372567|69664681|FG000|Phase 3 Study|Adverse Event|5|||
37977546|NCT00372567|69664682|FG001|Phase 3 Study|Adverse Event|1|||
37977547|NCT00372567|69664683|FG002|Phase 3 Study|Adverse Event|1|||
37977548|NCT00372567|69664681|FG000|Phase 3 Study|Death|1|||
37977549|NCT00372567|69664682|FG001|Phase 3 Study|Death|1|||
37977550|NCT00372567|69664683|FG002|Phase 3 Study|Death|0|||
37977551|NCT00372567|69664681|FG000|Phase 3 Study|Protocol Violation|0|||
37977552|NCT00372567|69664682|FG001|Phase 3 Study|Protocol Violation|0|||
37977553|NCT00372567|69664683|FG002|Phase 3 Study|Protocol Violation|1|||
37977554|NCT00372567|69664681|FG000|Phase 3 Study|Objective progression or relapse|10|||
37977555|NCT00372567|69664682|FG001|Phase 3 Study|Objective progression or relapse|13|||
37977556|NCT00372567|69664683|FG002|Phase 3 Study|Objective progression or relapse|4|||
37977557|NCT00372567|69664681|FG000|Phase 3 Study|Global deterioration of health status|0|||
37977558|NCT00372567|69664682|FG001|Phase 3 Study|Global deterioration of health status|1|||
37977559|NCT00372567|69664683|FG002|Phase 3 Study|Global deterioration of health status|0|||
37977560|NCT00372567|69664681|FG000|Phase 3 Study|Other|2|||
37977561|NCT00372567|69664682|FG001|Phase 3 Study|Other|2|||
37977562|NCT00372567|69664683|FG002|Phase 3 Study|Other|1|||
37977563|NCT00372567|69664681|FG000|Phase 3 Study|study terminated by sponsor|13|||
37977564|NCT00372567|69664682|FG001|Phase 3 Study|study terminated by sponsor|8|||
37977565|NCT00372567|69664683|FG002|Phase 3 Study|study terminated by sponsor|5|||
37977566|NCT00365547|69664691|FG000|Overall Study|Insurance did not cover Avastin|1|||
37977567|NCT00365547|69664691|FG000|Overall Study|Screen failure|1|||
37977568|NCT00365547|69664691|FG000|Overall Study|Withdrawal by Subject|1|||
37977569|NCT00545441|69664700|FG000|Overall Study|Fistula draining at 6 months|2|||
37977570|NCT00545441|69664701|FG001|Overall Study|Fistula draining at 6 months|4|||
37977571|NCT00545441|69664700|FG000|Overall Study|Lost to Follow-up|9|||
37977572|NCT00545441|69664701|FG001|Overall Study|Lost to Follow-up|5|||
37977573|NCT00545441|69664700|FG000|Overall Study|Technical failure|0|||
37977574|NCT00545441|69664701|FG001|Overall Study|Technical failure|1|||
37977575|NCT00545441|69664700|FG000|Overall Study|Withdrawal by Subject|1|||
37977576|NCT00545441|69664701|FG001|Overall Study|Withdrawal by Subject|1|||
37977577|NCT00545441|69664700|FG000|Overall Study|Persistence or recurrence of fistula|5|||
37977578|NCT00545441|69664701|FG001|Overall Study|Persistence or recurrence of fistula|2|||
37977579|NCT00545441|69664700|FG000|Overall Study|Patients were not treated|1|||
37977580|NCT00545441|69664701|FG001|Overall Study|Patients were not treated|3|||
37977581|NCT00294658|69664709|FG000|Overall Study|Death|0|||
37977582|NCT00294658|69664710|FG001|Overall Study|Death|1|||
37977583|NCT00294658|69664709|FG000|Overall Study|Lost to Follow-up|4|||
37977584|NCT00294658|69664710|FG001|Overall Study|Lost to Follow-up|0|||
37977585|NCT00294658|69664709|FG000|Overall Study|Physician Decision|1|||
37977586|NCT00294658|69664710|FG001|Overall Study|Physician Decision|2|||
37977587|NCT00294658|69664709|FG000|Overall Study|Pregnancy|0|||
37977588|NCT00294658|69664710|FG001|Overall Study|Pregnancy|1|||
37977589|NCT00294658|69664709|FG000|Overall Study|Withdrawal by Subject|0|||
37977590|NCT00294658|69664710|FG001|Overall Study|Withdrawal by Subject|4|||
37977591|NCT00294658|69664709|FG000|Overall Study|Found to have invasive thymoma|1|||
37977592|NCT00294658|69664710|FG001|Overall Study|Found to have invasive thymoma|0|||
37977593|NCT00294658|69664709|FG000|Overall Study|Patient and family were not satisfied|0|||
37977594|NCT00294658|69664710|FG001|Overall Study|Patient and family were not satisfied|1|||
37977595|NCT03923933|69664718|FG000|Overall Study|Lost to Follow-up|1|||
37977596|NCT03923933|69664719|FG001|Overall Study|Lost to Follow-up|0|||
37977597|NCT03923933|69664718|FG000|Overall Study|Withdrawal by Subject|0|||
37977598|NCT03923933|69664719|FG001|Overall Study|Withdrawal by Subject|1|||
37977599|NCT00372489|69664725|FG000|Overall Study|Adverse Event|18|||
37977600|NCT00372489|69664725|FG000|Overall Study|Lack of Efficacy|1|||
37977601|NCT00372489|69664725|FG000|Overall Study|Lost to Follow-up|3|||
37977602|NCT00372489|69664725|FG000|Overall Study|Physician Decision|3|||
37977603|NCT00372489|69664725|FG000|Overall Study|Withdrawal by Subject|5|||
37977604|NCT00372489|69664725|FG000|Overall Study|Patient Relocation|2|||
37977605|NCT00372489|69664725|FG000|Overall Study|Renal transplant|6|||
37977606|NCT00372489|69664725|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
37977607|NCT00372411|69664732|FG000|Overall Study|Withdrawal by Subject|3|||
37977608|NCT00372411|69664733|FG001|Overall Study|Withdrawal by Subject|4|||
37977609|NCT00372411|69664734|FG002|Overall Study|Withdrawal by Subject|1|||
37977610|NCT00372411|69664732|FG000|Overall Study|Death|0|||
37977611|NCT00372411|69664733|FG001|Overall Study|Death|2|||
37977612|NCT00372411|69664734|FG002|Overall Study|Death|1|||
37977613|NCT00372411|69664732|FG000|Overall Study|Lost to Follow-up|1|||
37977614|NCT00372411|69664733|FG001|Overall Study|Lost to Follow-up|1|||
37977615|NCT00372411|69664734|FG002|Overall Study|Lost to Follow-up|1|||
37977616|NCT00372411|69664732|FG000|Overall Study|Adverse Event|1|||
37977617|NCT00372411|69664733|FG001|Overall Study|Adverse Event|1|||
37977618|NCT00372411|69664734|FG002|Overall Study|Adverse Event|0|||
37977619|NCT00372255|69664744|FG000|Overall Study|Withdrawn for other reasons|2|||
37977620|NCT00372255|69664745|FG001|Overall Study|Withdrawn for other reasons|1|||
37977621|NCT00274456|69664756|FG000|Overall Study|Still on treatment|2|||
37977622|NCT00274456|69664757|FG001|Overall Study|Still on treatment|3|||
37977623|NCT00274456|69664758|FG002|Overall Study|Still on treatment|5|||
37977624|NCT00274456|69664759|FG003|Overall Study|Still on treatment|1|||
37977625|NCT00274456|69664756|FG000|Overall Study|Unacceptable toxicity|10|||
37977626|NCT00274456|69664757|FG001|Overall Study|Unacceptable toxicity|5|||
37977627|NCT00274456|69664758|FG002|Overall Study|Unacceptable toxicity|12|||
37977628|NCT00274456|69664759|FG003|Overall Study|Unacceptable toxicity|16|||
37977629|NCT00274456|69664756|FG000|Overall Study|Adverse Event|0|||
37977630|NCT00274456|69664757|FG001|Overall Study|Adverse Event|1|||
37977631|NCT00274456|69664758|FG002|Overall Study|Adverse Event|2|||
37977632|NCT00274456|69664759|FG003|Overall Study|Adverse Event|2|||
37977633|NCT00274456|69664756|FG000|Overall Study|Physician Decision|7|||
37977634|NCT00274456|69664757|FG001|Overall Study|Physician Decision|5|||
37977635|NCT00274456|69664758|FG002|Overall Study|Physician Decision|6|||
37977636|NCT00274456|69664759|FG003|Overall Study|Physician Decision|13|||
37977637|NCT00274456|69664756|FG000|Overall Study|Lost to Follow-up|0|||
37977638|NCT00274456|69664757|FG001|Overall Study|Lost to Follow-up|0|||
37977639|NCT00274456|69664758|FG002|Overall Study|Lost to Follow-up|1|||
37977640|NCT00274456|69664759|FG003|Overall Study|Lost to Follow-up|0|||
37977641|NCT00274456|69664756|FG000|Overall Study|Withdrawal by Subject|18|||
37694347|NCT02038881|69170640|FG000|Overall Study|Lost to Follow-up|2|||
37694348|NCT02038881|69170641|FG001|Overall Study|Lost to Follow-up|0|||
37694349|NCT02038881|69170642|FG002|Overall Study|Lost to Follow-up|0|||
37694350|NCT02038881|69170640|FG000|Overall Study|incarcerated|1|||
37694351|NCT02038881|69170641|FG001|Overall Study|incarcerated|0|||
37694352|NCT02038881|69170642|FG002|Overall Study|incarcerated|0|||
37694353|NCT01857622|69170655|FG000|Overall Study|Adverse Event|5|||
37694354|NCT01857622|69170656|FG001|Overall Study|Adverse Event|0|||
37694355|NCT01857622|69170657|FG002|Overall Study|Adverse Event|2|||
37694356|NCT01857622|69170655|FG000|Overall Study|Physician Decision|1|||
37694357|NCT01857622|69170656|FG001|Overall Study|Physician Decision|0|||
37694358|NCT01857622|69170657|FG002|Overall Study|Physician Decision|0|||
37694359|NCT01857622|69170655|FG000|Overall Study|Protocol Violation|4|||
37694360|NCT01857622|69170656|FG001|Overall Study|Protocol Violation|1|||
37694361|NCT01857622|69170657|FG002|Overall Study|Protocol Violation|0|||
37694362|NCT01857622|69170655|FG000|Overall Study|Withdrawal by Subject|1|||
37694363|NCT01857622|69170656|FG001|Overall Study|Withdrawal by Subject|0|||
37694364|NCT01857622|69170657|FG002|Overall Study|Withdrawal by Subject|0|||
37694365|NCT01857310|69170667|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
37694366|NCT01857310|69170668|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
37694367|NCT02472353|69170676|FG000|Overall Study|Lost to Follow-up|1|||
37694368|NCT02472353|69170677|FG001|Overall Study|Lost to Follow-up|1|||
37694369|NCT02472353|69170676|FG000|Overall Study|Withdrawal by Subject|2|||
37694370|NCT02472353|69170677|FG001|Overall Study|Withdrawal by Subject|1|||
37694371|NCT02472353|69170676|FG000|Overall Study|Study Termination|1|||
37694372|NCT02472353|69170677|FG001|Overall Study|Study Termination|4|||
37694373|NCT02491073|69170685|FG000|Overall Study|screen failure|1|||
37694374|NCT02491073|69170686|FG001|Overall Study|screen failure|0|||
37694375|NCT02314117|69170710|FG000|Overall Study|Lost to Follow-up|9|||
37694376|NCT02314117|69170711|FG001|Overall Study|Lost to Follow-up|14|||
37694377|NCT02314117|69170710|FG000|Overall Study|Withdrawal by Subject|3|||
37694378|NCT02314117|69170711|FG001|Overall Study|Withdrawal by Subject|2|||
37694379|NCT01893346|69170722|FG000|Overall Study|Lost to Follow-up|0|||
37694380|NCT01893346|69170723|FG001|Overall Study|Lost to Follow-up|1|||
37694381|NCT01893346|69170724|FG002|Overall Study|Lost to Follow-up|0|||
37694382|NCT01893346|69170725|FG003|Overall Study|Lost to Follow-up|0|||
37694383|NCT01893346|69170722|FG000|Overall Study|Protocol Violation|1|||
37694384|NCT01893346|69170723|FG001|Overall Study|Protocol Violation|0|||
37694385|NCT01893346|69170724|FG002|Overall Study|Protocol Violation|0|||
37977642|NCT00274456|69664757|FG001|Overall Study|Withdrawal by Subject|13|||
37977643|NCT00274456|69664758|FG002|Overall Study|Withdrawal by Subject|9|||
37977644|NCT00274456|69664759|FG003|Overall Study|Withdrawal by Subject|13|||
37977645|NCT00364923|69664769|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
37977646|NCT00364923|69664769|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
37977647|NCT00381849|69664775|FG000|Wash Out|Withdrawal by Subject|0|||
37977648|NCT00381849|69664776|FG001|Wash Out|Withdrawal by Subject|1|||
37977649|NCT00273052|69664784|FG000|Overall Study|Withdrawal by Subject|16|||
37694386|NCT01893346|69170725|FG003|Overall Study|Protocol Violation|0|||
37694387|NCT01893346|69170722|FG000|Overall Study|Withdrawal by Subject|2|||
37694388|NCT01893346|69170723|FG001|Overall Study|Withdrawal by Subject|0|||
37694389|NCT01893346|69170724|FG002|Overall Study|Withdrawal by Subject|0|||
37694390|NCT01893346|69170725|FG003|Overall Study|Withdrawal by Subject|0|||
37694391|NCT02490371|69170737|FG000|Overall Study|Lost to Follow-up|1|||
37694392|NCT02490371|69170738|FG001|Overall Study|Lost to Follow-up|1|||
37694393|NCT02058147|69170747|FG000|Overall Study|Randomized but not treated|0|||
37694394|NCT02058147|69170748|FG001|Overall Study|Randomized but not treated|0|||
37694395|NCT02058147|69170749|FG002|Overall Study|Randomized but not treated|1|||
37694396|NCT02058147|69170747|FG000|Overall Study|Adverse Event|12|||
37694397|NCT02058147|69170748|FG001|Overall Study|Adverse Event|9|||
37694398|NCT02058147|69170749|FG002|Overall Study|Adverse Event|21|||
37694399|NCT02058147|69170747|FG000|Overall Study|Lack of Efficacy|1|||
37694400|NCT02058147|69170748|FG001|Overall Study|Lack of Efficacy|0|||
37694401|NCT02058147|69170749|FG002|Overall Study|Lack of Efficacy|3|||
37694402|NCT02058147|69170747|FG000|Overall Study|Poor compliance to protocol|8|||
37694403|NCT02058147|69170748|FG001|Overall Study|Poor compliance to protocol|9|||
37694404|NCT02058147|69170749|FG002|Overall Study|Poor compliance to protocol|4|||
37694405|NCT02058147|69170747|FG000|Overall Study|Other than specified|8|||
37694406|NCT02058147|69170748|FG001|Overall Study|Other than specified|9|||
37694407|NCT02058147|69170749|FG002|Overall Study|Other than specified|0|||
37694408|NCT02489981|69170757|FG000|Overall Study|Adverse Event|21|||
37694409|NCT02489981|69170757|FG000|Overall Study|Insufficient effectiveness|16|||
37694410|NCT02489981|69170757|FG000|Overall Study|Improved|31|||
37812603|NCT00557466|69489909|FG004|Overall Study|Adverse Event|2|||
37812604|NCT00557466|69489910|FG005|Overall Study|Adverse Event|4|||
37812605|NCT00557466|69489905|FG000|Overall Study|Abnormal laboratory value(s)|1|||
37812606|NCT00557466|69489906|FG001|Overall Study|Abnormal laboratory value(s)|2|||
37812607|NCT00557466|69489907|FG002|Overall Study|Abnormal laboratory value(s)|0|||
37812608|NCT00557466|69489908|FG003|Overall Study|Abnormal laboratory value(s)|0|||
37812609|NCT00557466|69489909|FG004|Overall Study|Abnormal laboratory value(s)|0|||
37812610|NCT00557466|69489910|FG005|Overall Study|Abnormal laboratory value(s)|0|||
37812611|NCT00557466|69489905|FG000|Overall Study|Protocol deviation|0|||
37812612|NCT00557466|69489906|FG001|Overall Study|Protocol deviation|1|||
37812613|NCT00557466|69489907|FG002|Overall Study|Protocol deviation|0|||
37812614|NCT00557466|69489908|FG003|Overall Study|Protocol deviation|2|||
37812615|NCT00557466|69489909|FG004|Overall Study|Protocol deviation|0|||
37812616|NCT00557466|69489910|FG005|Overall Study|Protocol deviation|0|||
37812617|NCT00557466|69489905|FG000|Overall Study|Subject withdrew consent|0|||
37812618|NCT00557466|69489906|FG001|Overall Study|Subject withdrew consent|0|||
37812619|NCT00557466|69489907|FG002|Overall Study|Subject withdrew consent|0|||
37812620|NCT00557466|69489908|FG003|Overall Study|Subject withdrew consent|0|||
37812621|NCT00557466|69489909|FG004|Overall Study|Subject withdrew consent|1|||
37812622|NCT00557466|69489910|FG005|Overall Study|Subject withdrew consent|2|||
37812623|NCT00557466|69489905|FG000|Overall Study|Administrative problems|0|||
37812624|NCT00557466|69489906|FG001|Overall Study|Administrative problems|1|||
37812625|NCT00557466|69489907|FG002|Overall Study|Administrative problems|1|||
37812626|NCT00557466|69489908|FG003|Overall Study|Administrative problems|0|||
37812627|NCT00557466|69489909|FG004|Overall Study|Administrative problems|0|||
37812628|NCT00557466|69489910|FG005|Overall Study|Administrative problems|0|||
37812629|NCT00557466|69489905|FG000|Overall Study|Abnormal test procedure results|0|||
37812630|NCT00557466|69489906|FG001|Overall Study|Abnormal test procedure results|0|||
37812631|NCT00557466|69489907|FG002|Overall Study|Abnormal test procedure results|1|||
37812632|NCT00557466|69489908|FG003|Overall Study|Abnormal test procedure results|0|||
37812633|NCT00557466|69489909|FG004|Overall Study|Abnormal test procedure results|0|||
37812634|NCT00557466|69489910|FG005|Overall Study|Abnormal test procedure results|0|||
37812635|NCT00557466|69489905|FG000|Overall Study|Lost to Follow-up|0|||
37812636|NCT00557466|69489906|FG001|Overall Study|Lost to Follow-up|0|||
37812637|NCT00557466|69489907|FG002|Overall Study|Lost to Follow-up|0|||
37812638|NCT00557466|69489908|FG003|Overall Study|Lost to Follow-up|1|||
37812639|NCT00557466|69489909|FG004|Overall Study|Lost to Follow-up|0|||
37812640|NCT00557466|69489910|FG005|Overall Study|Lost to Follow-up|0|||
37812641|NCT00557310|69489924|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
37812642|NCT00557310|69489924|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
37812643|NCT00557310|69489924|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
37694411|NCT02489981|69170757|FG000|Overall Study|Lost to Follow-up|31|||
37694412|NCT02489981|69170757|FG000|Overall Study|Other than listed|28|||
37694413|NCT02471183|69170761|FG000|Main Treatment Period|Adverse Event|1|||
37812644|NCT00557310|69489924|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
37812645|NCT00557310|69489924|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
37694414|NCT02471183|69170761|FG000|Main Treatment Period|Withdrawal by Subject|1|||
37694415|NCT02471183|69170761|FG000|Extended Treatment Period|Lack of Efficacy|1|||
37812646|NCT00557310|69489924|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
37694416|NCT01855828|69170765|FG000|Overall Study|Adverse Event|1|||
37694417|NCT01855828|69170765|FG000|Overall Study|Withdrawal by Subject|1|||
37812647|NCT00555438|69489928|FG000|10 Days Post-operative|Death|4|||
37812648|NCT00555438|69489928|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
37812649|NCT00553644|69489932|FG000|Overall Study|Adverse Event|17|||
37812650|NCT00553644|69489932|FG000|Overall Study|Withdrawal by Subject|4|||
37812651|NCT00553644|69489932|FG000|Overall Study|Physician Decision|1|||
37812652|NCT00553644|69489932|FG000|Overall Study|Alternative therapy|6|||
37812653|NCT00553332|69489936|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
37812654|NCT00552396|69489947|FG000|Overall Study|protocol withdrawal criteria|3|||
37812655|NCT00552396|69489948|FG001|Overall Study|protocol withdrawal criteria|3|||
37812656|NCT00552396|69489949|FG002|Overall Study|protocol withdrawal criteria|3|||
37812657|NCT00552396|69489950|FG003|Overall Study|protocol withdrawal criteria|6|||
37812658|NCT00552396|69489951|FG004|Overall Study|protocol withdrawal criteria|3|||
37812659|NCT00552396|69489952|FG005|Overall Study|protocol withdrawal criteria|3|||
37812660|NCT00552396|69489953|FG006|Overall Study|protocol withdrawal criteria|9|||
37812661|NCT00552240|69489989|FG000|Overall Study|Adverse Event|9|||
37812662|NCT00552240|69489990|FG001|Overall Study|Adverse Event|9|||
37812663|NCT00552240|69489989|FG000|Overall Study|Protocol Violation|1|||
37812664|NCT00552240|69489990|FG001|Overall Study|Protocol Violation|1|||
37812665|NCT00552240|69489989|FG000|Overall Study|Lost to Follow-up|5|||
37812666|NCT00552240|69489990|FG001|Overall Study|Lost to Follow-up|6|||
37812667|NCT00552240|69489989|FG000|Overall Study|Withdrawal by Subject|2|||
37812668|NCT00552240|69489990|FG001|Overall Study|Withdrawal by Subject|2|||
37812669|NCT00552240|69489989|FG000|Overall Study|Lack of Efficacy|6|||
37812670|NCT00552240|69489990|FG001|Overall Study|Lack of Efficacy|0|||
37812671|NCT00552240|69489989|FG000|Overall Study|Other|1|||
37812672|NCT00552240|69489990|FG001|Overall Study|Other|0|||
37812673|NCT00552084|69489998|FG000|Overall Study|Adverse Event|2|||
37812674|NCT00552084|69489999|FG001|Overall Study|Adverse Event|3|||
37812675|NCT00552084|69489998|FG000|Overall Study|Withdrawal by Subject|4|||
37812676|NCT00552084|69489999|FG001|Overall Study|Withdrawal by Subject|5|||
37812677|NCT00552084|69489998|FG000|Overall Study|Protocol Violation|1|||
37812678|NCT00552084|69489999|FG001|Overall Study|Protocol Violation|0|||
37812679|NCT00552084|69489998|FG000|Overall Study|change in anti-arrythmic drug|1|||
37812680|NCT00552084|69489999|FG001|Overall Study|change in anti-arrythmic drug|1|||
37812681|NCT00550836|69490007|FG000|Overall Study|Withdrawal by Subject|3|||
37812682|NCT00550836|69490008|FG001|Overall Study|Withdrawal by Subject|9|||
37812683|NCT00550680|69490014|FG000|Overall Study|Administrative Reasons|1|||
37812684|NCT00550680|69490014|FG000|Overall Study|Adverse Event|5|||
37812685|NCT00550680|69490014|FG000|Overall Study|Death|3|||
37812686|NCT00550680|69490014|FG000|Overall Study|Early Improvement|1|||
37812687|NCT00550680|69490014|FG000|Overall Study|Lost to Follow-up|3|||
37812688|NCT00550680|69490014|FG000|Overall Study|Lack of Efficacy|1|||
37812689|NCT00550680|69490014|FG000|Overall Study|Other|10|||
37812690|NCT00550680|69490014|FG000|Overall Study|Protocol Violation|7|||
37812691|NCT00550680|69490014|FG000|Overall Study|Refused Treatment|19|||
37812692|NCT00550680|69490014|FG000|Overall Study|Screen Failure|6|||
37812693|NCT00554190|69490018|FG000|Overall Study|Termination forms not completed|10|||
37812694|NCT00556374|69490024|FG000|Overall Study|Withdrawal by Subject|235|||
37812695|NCT00556374|69490025|FG001|Overall Study|Withdrawal by Subject|205|||
37812696|NCT00556374|69490024|FG000|Overall Study|Death|158|||
37812697|NCT00556374|69490025|FG001|Overall Study|Death|127|||
37812698|NCT00556374|69490024|FG000|Overall Study|Lost to Follow-up|24|||
37812699|NCT00556374|69490025|FG001|Overall Study|Lost to Follow-up|17|||
37812700|NCT00556374|69490024|FG000|Overall Study|Continuing into Zoledronic Acid Substudy|50|||
37812701|NCT00556374|69490025|FG001|Overall Study|Continuing into Zoledronic Acid Substudy|0|||
37812702|NCT04677959|69490056|FG000|Overall Study|Adverse Event|1|||
37812703|NCT04677959|69490057|FG001|Overall Study|Adverse Event|9|||
37812704|NCT04677959|69490056|FG000|Overall Study|Withdrawal by Subject|2|||
37812705|NCT04677959|69490057|FG001|Overall Study|Withdrawal by Subject|15|||
37812706|NCT04677959|69490056|FG000|Overall Study|Withdrawal by parent/guardian|0|||
37694418|NCT02489279|69170776|FG000|Overall Study|Lost to Follow-up|12|||
37812707|NCT04677959|69490057|FG001|Overall Study|Withdrawal by parent/guardian|1|||
37812708|NCT04677959|69490056|FG000|Overall Study|Non-compliance with study drug|0|||
37812709|NCT04677959|69490057|FG001|Overall Study|Non-compliance with study drug|2|||
37812710|NCT04677959|69490056|FG000|Overall Study|Protocol deviation|0|||
37812711|NCT04677959|69490057|FG001|Overall Study|Protocol deviation|11|||
37812712|NCT04677959|69490056|FG000|Overall Study|Lost to Follow-up|9|||
37812713|NCT04677959|69490057|FG001|Overall Study|Lost to Follow-up|13|||
37812714|NCT04677959|69490056|FG000|Overall Study|Other than specified|0|||
37812715|NCT04677959|69490057|FG001|Overall Study|Other than specified|8|||
37812716|NCT04330638|69490084|FG000|Overall Study|Adverse Event|9|||
37812717|NCT04330638|69490085|FG001|Overall Study|Adverse Event|10|||
37812718|NCT04330638|69490086|FG002|Overall Study|Adverse Event|15|||
37812719|NCT04330638|69490087|FG003|Overall Study|Adverse Event|6|||
37812720|NCT04330638|69490088|FG004|Overall Study|Adverse Event|10|||
37812721|NCT04330638|69490089|FG005|Overall Study|Adverse Event|5|||
37812722|NCT04330638|69490084|FG000|Overall Study|Other|2|||
37694419|NCT02489279|69170777|FG001|Overall Study|Lost to Follow-up|10|||
37694420|NCT02489045|69170783|FG000|Overall Study|unable to collect usable data|53|||
37694421|NCT02489045|69170783|FG000|Follow-up|Lost to Follow-up|10|||
37694422|NCT02488109|69170789|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
37694423|NCT02488109|69170790|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
37812723|NCT04330638|69490085|FG001|Overall Study|Other|2|||
37812724|NCT04330638|69490086|FG002|Overall Study|Other|5|||
37812725|NCT04330638|69490087|FG003|Overall Study|Other|1|||
37812726|NCT04330638|69490088|FG004|Overall Study|Other|3|||
37812727|NCT04330638|69490089|FG005|Overall Study|Other|2|||
37812728|NCT04330638|69490084|FG000|Overall Study|Withdrawal by Subject|4|||
37812729|NCT04330638|69490085|FG001|Overall Study|Withdrawal by Subject|0|||
37812730|NCT04330638|69490086|FG002|Overall Study|Withdrawal by Subject|0|||
37812731|NCT04330638|69490087|FG003|Overall Study|Withdrawal by Subject|0|||
37812732|NCT04330638|69490088|FG004|Overall Study|Withdrawal by Subject|0|||
37812733|NCT04330638|69490089|FG005|Overall Study|Withdrawal by Subject|0|||
37812734|NCT04330638|69490084|FG000|Overall Study|Lost to Follow-up|3|||
37812735|NCT04330638|69490085|FG001|Overall Study|Lost to Follow-up|2|||
37812736|NCT04330638|69490086|FG002|Overall Study|Lost to Follow-up|3|||
37812737|NCT04330638|69490087|FG003|Overall Study|Lost to Follow-up|2|||
37812738|NCT04330638|69490088|FG004|Overall Study|Lost to Follow-up|3|||
37812739|NCT04330638|69490089|FG005|Overall Study|Lost to Follow-up|0|||
37812740|NCT04194541|69490110|FG000|Day 1 Through 13|Lost to Follow-up|3|||
37812741|NCT04194541|69490110|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
37812742|NCT04194541|69490110|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
37812743|NCT04006392|69490128|FG000|Overall Study|Lost to Follow-up|0|||
37812744|NCT04006392|69490129|FG001|Overall Study|Lost to Follow-up|1|||
37812745|NCT03959423|69490137|FG000|Overall Study|Withdrawal by Subject|2|||
37812746|NCT03959423|69490138|FG001|Overall Study|Withdrawal by Subject|3|||
37812747|NCT03959423|69490137|FG000|Overall Study|Physician Decision|0|||
37812748|NCT03959423|69490138|FG001|Overall Study|Physician Decision|1|||
37812749|NCT03959423|69490137|FG000|Overall Study|Lost to Follow-up|1|||
37812750|NCT03959423|69490138|FG001|Overall Study|Lost to Follow-up|0|||
37812751|NCT03959423|69490137|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
37812752|NCT03959423|69490138|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
37812753|NCT03786783|69490144|FG000|Overall Study|Death|1|||
37812754|NCT03786783|69490144|FG000|Overall Study|Physician Decision|6|||
37812755|NCT03786783|69490144|FG000|Overall Study|Withdrawal by Subject|2|||
37812756|NCT03786783|69490144|FG000|Overall Study|Disease Progression|7|||
37812757|NCT03786783|69490144|FG000|Overall Study|Patient/Parent Refusal|4|||
37812758|NCT03432494|69490158|FG000|Overall Study|Death|1|||
37812759|NCT03432494|69490158|FG000|Overall Study|Noncompliance|1|||
37694424|NCT02488109|69170789|FG000|12-month Follow-Up|Lost to Follow-up|4|||
37694425|NCT02488109|69170790|FG001|12-month Follow-Up|Lost to Follow-up|7|||
37812784|NCT03287830|69490176|FG000|Overall Study|Withdrawal by Subject|1|||
37812785|NCT03287830|69490177|FG001|Overall Study|Withdrawal by Subject|1|||
37812786|NCT03287830|69490176|FG000|Overall Study|not meeting inclusion criteria|5|||
37812787|NCT03287830|69490177|FG001|Overall Study|not meeting inclusion criteria|12|||
37812788|NCT03181633|69490187|FG000|Overall Study|Withdrawal by Subject|1|||
37812789|NCT03181633|69490187|FG000|Overall Study|Missing follow-up visit|1|||
37812790|NCT03122223|69490204|FG000|Overall Study|Withdrawal by Subject|2|||
37812791|NCT03122223|69490205|FG001|Overall Study|Withdrawal by Subject|2|||
37812792|NCT03122223|69490206|FG002|Overall Study|Withdrawal by Subject|1|||
37812793|NCT03122223|69490207|FG003|Overall Study|Withdrawal by Subject|0|||
37812794|NCT03122223|69490204|FG000|Overall Study|Lost to Follow-up|0|||
37812795|NCT03122223|69490205|FG001|Overall Study|Lost to Follow-up|2|||
37812796|NCT03122223|69490206|FG002|Overall Study|Lost to Follow-up|2|||
37812797|NCT03122223|69490207|FG003|Overall Study|Lost to Follow-up|0|||
37812798|NCT03122223|69490204|FG000|Overall Study|Participant unable to adhere|1|||
37812799|NCT03122223|69490205|FG001|Overall Study|Participant unable to adhere|1|||
37812800|NCT03122223|69490206|FG002|Overall Study|Participant unable to adhere|1|||
37812801|NCT03122223|69490207|FG003|Overall Study|Participant unable to adhere|0|||
37812802|NCT03077087|69490217|FG000|Overall Study|Physician Decision|2|||
37812803|NCT02853604|69490223|FG000|Overall Study|Withdrawal by Subject|12|||
37812804|NCT02853604|69490224|FG001|Overall Study|Withdrawal by Subject|35|||
37812805|NCT02853604|69490223|FG000|Overall Study|Lost to Follow-up|4|||
37812806|NCT02853604|69490224|FG001|Overall Study|Lost to Follow-up|8|||
37812807|NCT02853604|69490223|FG000|Overall Study|Death|1|||
37812808|NCT02853604|69490224|FG001|Overall Study|Death|5|||
37812809|NCT02853604|69490223|FG000|Overall Study|Miscellaneous|11|||
37812810|NCT02853604|69490224|FG001|Overall Study|Miscellaneous|2|||
37812811|NCT02853604|69490223|FG000|Overall Study|Progressive Disease|0|||
37812812|NCT02853604|69490224|FG001|Overall Study|Progressive Disease|2|||
37812813|NCT02632552|69490250|FG000|Overall Study|Lost to Follow-up|14|||
37812814|NCT02632552|69490251|FG001|Overall Study|Lost to Follow-up|8|||
37812815|NCT02632552|69490250|FG000|Overall Study|Withdrawal by Subject|2|||
37812816|NCT02632552|69490251|FG001|Overall Study|Withdrawal by Subject|0|||
37812817|NCT02632552|69490250|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
37812818|NCT02632552|69490251|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
37812819|NCT02525562|69490276|FG000|Overall Study|Death|9|||
37812820|NCT02525562|69490277|FG001|Overall Study|Death|0|||
37812821|NCT02525562|69490278|FG002|Overall Study|Death|0|||
37812822|NCT02525562|69490276|FG000|Overall Study|Lost to Follow-up|19|||
37812823|NCT02525562|69490277|FG001|Overall Study|Lost to Follow-up|0|||
37812824|NCT02525562|69490278|FG002|Overall Study|Lost to Follow-up|0|||
37812825|NCT02525562|69490276|FG000|Overall Study|Withdrawal by Subject|37|||
37812826|NCT02525562|69490277|FG001|Overall Study|Withdrawal by Subject|0|||
37812827|NCT02525562|69490278|FG002|Overall Study|Withdrawal by Subject|0|||
37812828|NCT02525562|69490276|FG000|Overall Study|Revision/Removal of Study Device|4|||
37812829|NCT02525562|69490277|FG001|Overall Study|Revision/Removal of Study Device|0|||
37812830|NCT02525562|69490278|FG002|Overall Study|Revision/Removal of Study Device|0|||
37812831|NCT02525562|69490276|FG000|Overall Study|Study Closed by Sponsor|154|||
37812832|NCT02525562|69490277|FG001|Overall Study|Study Closed by Sponsor|0|||
37812833|NCT02525562|69490278|FG002|Overall Study|Study Closed by Sponsor|0|||
37812834|NCT01992653|69490291|FG000|Overall Study|Death|0|||
37812835|NCT01992653|69490292|FG001|Overall Study|Death|0|||
37812836|NCT01992653|69490293|FG002|Overall Study|Death|1|||
37812837|NCT01992653|69490294|FG003|Overall Study|Death|0|||
37812838|NCT01992653|69490295|FG004|Overall Study|Death|1|||
37812839|NCT01992653|69490296|FG005|Overall Study|Death|0|||
37812840|NCT01992653|69490297|FG006|Overall Study|Death|4|||
37812841|NCT01992653|69490298|FG007|Overall Study|Death|2|||
37812842|NCT01992653|69490291|FG000|Overall Study|Lost to Follow-up|0|||
37812843|NCT01992653|69490292|FG001|Overall Study|Lost to Follow-up|0|||
37812844|NCT01992653|69490293|FG002|Overall Study|Lost to Follow-up|0|||
37812845|NCT01992653|69490294|FG003|Overall Study|Lost to Follow-up|0|||
37812846|NCT01992653|69490295|FG004|Overall Study|Lost to Follow-up|0|||
37812847|NCT01992653|69490296|FG005|Overall Study|Lost to Follow-up|0|||
37812848|NCT01992653|69490297|FG006|Overall Study|Lost to Follow-up|0|||
37812849|NCT01992653|69490298|FG007|Overall Study|Lost to Follow-up|1|||
37812850|NCT01992653|69490291|FG000|Overall Study|Study Completed|0|||
37812851|NCT01992653|69490292|FG001|Overall Study|Study Completed|0|||
37812852|NCT01992653|69490293|FG002|Overall Study|Study Completed|0|||
37812853|NCT01992653|69490294|FG003|Overall Study|Study Completed|0|||
37812854|NCT01992653|69490295|FG004|Overall Study|Study Completed|0|||
37812855|NCT01992653|69490296|FG005|Overall Study|Study Completed|0|||
37812856|NCT01992653|69490297|FG006|Overall Study|Study Completed|0|||
37812857|NCT01992653|69490298|FG007|Overall Study|Study Completed|1|||
37812858|NCT01992653|69490291|FG000|Overall Study|Disease Progression|0|||
37812859|NCT01992653|69490292|FG001|Overall Study|Disease Progression|0|||
37812860|NCT01992653|69490293|FG002|Overall Study|Disease Progression|0|||
37812861|NCT01992653|69490294|FG003|Overall Study|Disease Progression|0|||
37812862|NCT01992653|69490295|FG004|Overall Study|Disease Progression|0|||
37812863|NCT01992653|69490296|FG005|Overall Study|Disease Progression|0|||
37812864|NCT01992653|69490297|FG006|Overall Study|Disease Progression|4|||
37812865|NCT01992653|69490298|FG007|Overall Study|Disease Progression|0|||
37812866|NCT01654276|69490333|FG000|Overall Study|Lack of Efficacy|1|||
37812867|NCT01654276|69490333|FG000|Overall Study|Lost to Follow-up|4|||
37812868|NCT01654276|69490333|FG000|Overall Study|Withdrawal by Subject|1|||
37812869|NCT01399658|69490337|FG000|Overall Study|Ineligible|1|||
37812870|NCT01399658|69490337|FG000|Overall Study|Machine Technical Issue|3|||
37812871|NCT01399658|69490337|FG000|Overall Study|Alternative therapy|1|||
37812872|NCT01399658|69490337|FG000|Overall Study|No reason given|1|||
37812873|NCT00590122|69490343|FG000|Overall Study|swallowed oral dissolving dose|1|||
37812874|NCT00590122|69490344|FG001|Overall Study|swallowed oral dissolving dose|0|||
37812875|NCT01386658|69490373|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
37812876|NCT01386658|69490374|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
37812877|NCT01386658|69490373|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
37812878|NCT01386658|69490374|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
37812879|NCT01386684|69490384|FG000|Overall Study|Lost to Follow-up|51|||
37812880|NCT01386684|69490384|FG000|Overall Study|Other|51|||
37812881|NCT01386684|69490384|FG000|Overall Study|Death|47|||
37812882|NCT01386684|69490384|FG000|Overall Study|Withdrawal of Consent|44|||
37812883|NCT01386684|69490384|FG000|Overall Study|Alternative Therapy Required|37|||
37812884|NCT01386684|69490384|FG000|Overall Study|Disease Progression|28|||
37812885|NCT01386684|69490384|FG000|Overall Study|Adverse Event|20|||
37812886|NCT01386684|69490384|FG000|Overall Study|Noncompliance|8|||
37812887|NCT01386684|69490384|FG000|Overall Study|Protocol Violation|4|||
37812888|NCT01386684|69490384|FG000|Overall Study|Missing|3|||
37812889|NCT04980014|69490401|FG000|Overall Study|Participants who are Duplicated|1|||
37812890|NCT04980014|69490401|FG000|Overall Study|Follow-up Failure|13|||
37812891|NCT04980014|69490401|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
37812892|NCT04980014|69490401|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
37812893|NCT04980014|69490401|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
37812894|NCT05301322|69490424|FG000|Overall Study|Adverse Event|7|||
37812895|NCT05301322|69490425|FG001|Overall Study|Adverse Event|3|||
37694426|NCT02351167|69170801|FG000|Overall Study|Withdrawal by Subject|19|||
37694427|NCT02351167|69170802|FG001|Overall Study|Withdrawal by Subject|18|||
37694428|NCT02351167|69170803|FG002|Overall Study|Withdrawal by Subject|21|||
37694429|NCT02350309|69170818|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
37694430|NCT02350309|69170819|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
37694431|NCT02350309|69170820|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
37694432|NCT02350309|69170821|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
37694433|NCT02350309|69170822|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
37694434|NCT02350309|69170823|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
37694435|NCT02350309|69170818|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
37694436|NCT02350309|69170819|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
37694437|NCT02350309|69170820|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
37694438|NCT02350309|69170821|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
37694439|NCT02350309|69170822|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
37694440|NCT02350309|69170823|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
37694441|NCT02038647|69170840|FG000|Overall Study|Progressive Disease|50|||
37694442|NCT02038647|69170841|FG001|Overall Study|Progressive Disease|59|||
37694443|NCT02038647|69170840|FG000|Overall Study|Adverse Event|18|||
37694444|NCT02038647|69170841|FG001|Overall Study|Adverse Event|10|||
37694445|NCT02038647|69170840|FG000|Overall Study|Symptomatic Deterioration|7|||
37694446|NCT02038647|69170841|FG001|Overall Study|Symptomatic Deterioration|7|||
37694447|NCT02038647|69170840|FG000|Overall Study|Withdrawal by Subject|5|||
37694448|NCT02038647|69170841|FG001|Overall Study|Withdrawal by Subject|2|||
37694449|NCT02038647|69170840|FG000|Overall Study|Not Reported|0|||
37694450|NCT02038647|69170841|FG001|Overall Study|Not Reported|1|||
37694451|NCT02038647|69170840|FG000|Overall Study|Ongoing at Datacut|9|||
37694452|NCT02038647|69170841|FG001|Overall Study|Ongoing at Datacut|10|||
37812896|NCT05301322|69490424|FG000|Overall Study|Death|0|||
37812897|NCT05301322|69490425|FG001|Overall Study|Death|1|||
37812898|NCT05301322|69490424|FG000|Overall Study|Lost to Follow-up|2|||
37812899|NCT05301322|69490425|FG001|Overall Study|Lost to Follow-up|1|||
37812900|NCT05301322|69490424|FG000|Overall Study|Protocol Violation|3|||
37812901|NCT05301322|69490425|FG001|Overall Study|Protocol Violation|1|||
37694453|NCT02058069|69170847|FG000|Overall Study|Exclusion due to implant size|5|||
37812902|NCT05301322|69490424|FG000|Overall Study|Withdrawal by Subject|3|||
37694454|NCT02058069|69170847|FG000|Overall Study|Withdrawal by Subject|6|||
37694455|NCT02057835|69170861|FG000|Overall Study|Withdrawal by Subject|0|||
37694456|NCT02057835|69170862|FG001|Overall Study|Withdrawal by Subject|2|||
37694457|NCT02057835|69170863|FG002|Overall Study|Withdrawal by Subject|0|||
37812903|NCT05301322|69490425|FG001|Overall Study|Withdrawal by Subject|0|||
37812904|NCT05301322|69490424|FG000|Overall Study|Other|4|||
37694458|NCT02057835|69170864|FG003|Overall Study|Withdrawal by Subject|0|||
37694459|NCT02057835|69170865|FG004|Overall Study|Withdrawal by Subject|0|||
37694460|NCT02057835|69170866|FG005|Overall Study|Withdrawal by Subject|0|||
37694461|NCT02057835|69170867|FG006|Overall Study|Withdrawal by Subject|0|||
37694462|NCT02057835|69170868|FG007|Overall Study|Withdrawal by Subject|0|||
37694463|NCT02057835|69170869|FG008|Overall Study|Withdrawal by Subject|0|||
37694464|NCT02057835|69170870|FG009|Overall Study|Withdrawal by Subject|0|||
37694465|NCT02057757|69170901|FG000|Overall Study|Withdrawal by Subject|3|||
37694466|NCT02057757|69170902|FG001|Overall Study|Withdrawal by Subject|5|||
37694467|NCT02057757|69170901|FG000|Overall Study|Death|2|||
37694468|NCT02057757|69170902|FG001|Overall Study|Death|0|||
37694469|NCT02057757|69170901|FG000|Overall Study|Lost to Follow-up|8|||
37694470|NCT02057757|69170902|FG001|Overall Study|Lost to Follow-up|3|||
37694471|NCT02057757|69170901|FG000|Overall Study|Non-compliance|1|||
37694472|NCT02057757|69170902|FG001|Overall Study|Non-compliance|0|||
37694473|NCT02037477|69170916|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
37694474|NCT02037477|69170917|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
37812905|NCT05301322|69490425|FG001|Overall Study|Other|0|||
37812906|NCT04956575|69490463|FG000|Overall Study|Death|1|||
37694475|NCT02037477|69170918|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
37694476|NCT02037477|69170919|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
37694477|NCT02057523|69170929|FG000|Overall Study|Withdrawal by Subject|1|||
37694478|NCT02057523|69170929|FG000|Overall Study|Lack of Efficacy|1|||
37694479|NCT02037165|69170938|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
37694480|NCT02037165|69170939|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
37694481|NCT02037165|69170940|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
37694482|NCT02037165|69170941|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
37694483|NCT02037165|69170942|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
37694484|NCT02470403|69170963|FG000|Overall Study|Adverse Event|1|||
37694485|NCT02470403|69170964|FG001|Overall Study|Adverse Event|0|||
37694486|NCT02470403|69170965|FG002|Overall Study|Adverse Event|0|||
37694487|NCT02470403|69170966|FG003|Overall Study|Adverse Event|0|||
37812907|NCT04956575|69490464|FG001|Overall Study|Death|0|||
37812908|NCT04956575|69490465|FG002|Overall Study|Death|0|||
37812909|NCT04956575|69490466|FG003|Overall Study|Death|0|||
37812910|NCT04956575|69490467|FG004|Overall Study|Death|0|||
37812911|NCT04956575|69490468|FG005|Overall Study|Death|0|||
37812912|NCT04956575|69490469|FG006|Overall Study|Death|0|||
37812913|NCT04956575|69490470|FG007|Overall Study|Death|1|||
37812914|NCT04956575|69490471|FG008|Overall Study|Death|0|||
37812915|NCT04956575|69490472|FG009|Overall Study|Death|1|||
37812916|NCT04956575|69490473|FG010|Overall Study|Death|0|||
37812917|NCT04956575|69490474|FG011|Overall Study|Death|0|||
37812918|NCT04956575|69490463|FG000|Overall Study|Lost to Follow-up|3|||
37812919|NCT04956575|69490464|FG001|Overall Study|Lost to Follow-up|4|||
37812920|NCT04956575|69490465|FG002|Overall Study|Lost to Follow-up|2|||
37812921|NCT04956575|69490466|FG003|Overall Study|Lost to Follow-up|3|||
37812922|NCT04956575|69490467|FG004|Overall Study|Lost to Follow-up|1|||
37812923|NCT04956575|69490468|FG005|Overall Study|Lost to Follow-up|10|||
37812924|NCT04956575|69490469|FG006|Overall Study|Lost to Follow-up|11|||
37812925|NCT04956575|69490470|FG007|Overall Study|Lost to Follow-up|7|||
37812926|NCT04956575|69490471|FG008|Overall Study|Lost to Follow-up|4|||
37812927|NCT04956575|69490472|FG009|Overall Study|Lost to Follow-up|2|||
37812928|NCT04956575|69490473|FG010|Overall Study|Lost to Follow-up|3|||
37812929|NCT04956575|69490474|FG011|Overall Study|Lost to Follow-up|8|||
37812930|NCT04956575|69490463|FG000|Overall Study|Withdrawal by Subject|1|||
37812931|NCT04956575|69490464|FG001|Overall Study|Withdrawal by Subject|2|||
37812932|NCT04956575|69490465|FG002|Overall Study|Withdrawal by Subject|1|||
37812933|NCT04956575|69490466|FG003|Overall Study|Withdrawal by Subject|4|||
37812934|NCT04956575|69490467|FG004|Overall Study|Withdrawal by Subject|2|||
37812935|NCT04956575|69490468|FG005|Overall Study|Withdrawal by Subject|8|||
37812936|NCT04956575|69490469|FG006|Overall Study|Withdrawal by Subject|5|||
37812937|NCT04956575|69490470|FG007|Overall Study|Withdrawal by Subject|1|||
37812938|NCT04956575|69490471|FG008|Overall Study|Withdrawal by Subject|1|||
37812939|NCT04956575|69490472|FG009|Overall Study|Withdrawal by Subject|0|||
37812940|NCT04956575|69490473|FG010|Overall Study|Withdrawal by Subject|3|||
37812941|NCT04956575|69490474|FG011|Overall Study|Withdrawal by Subject|1|||
37977650|NCT00273052|69664785|FG001|Overall Study|Withdrawal by Subject|19|||
37694488|NCT02470403|69170967|FG004|Overall Study|Adverse Event|0|||
37694489|NCT02470403|69170963|FG000|Overall Study|Lost to Follow-up|0|||
37694490|NCT02470403|69170964|FG001|Overall Study|Lost to Follow-up|1|||
37694491|NCT02470403|69170965|FG002|Overall Study|Lost to Follow-up|0|||
37812942|NCT04720105|69490525|FG000|Overall Study|Lack of Efficacy|1|||
37812943|NCT04720105|69490525|FG000|Overall Study|Lost to Follow-up|1|||
37694492|NCT02470403|69170966|FG003|Overall Study|Lost to Follow-up|0|||
37694493|NCT02470403|69170967|FG004|Overall Study|Lost to Follow-up|0|||
37812944|NCT04720105|69490525|FG000|Overall Study|Withdrawal by Subject|3|||
37977651|NCT00273052|69664784|FG000|Overall Study|Adverse Event|21|||
37812945|NCT04585815|69490535|FG000|Sub-study A- Treatment Phase|Adverse Event|0|||
37812946|NCT04585815|69490536|FG001|Sub-study A- Treatment Phase|Adverse Event|1|||
37812947|NCT04585815|69490535|FG000|Sub-study A- Treatment Phase|Death|0|||
37812948|NCT04585815|69490536|FG001|Sub-study A- Treatment Phase|Death|1|||
37812949|NCT04585815|69490535|FG000|Sub-study A- Treatment Phase|Withdrawal by Subject|1|||
37812950|NCT04585815|69490536|FG001|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
37812951|NCT04585815|69490535|FG000|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
37812952|NCT04585815|69490536|FG001|Sub-study A- Treatment Phase|Global deterioration of health status|1|||
37812953|NCT04585815|69490535|FG000|Sub-study A- Treatment Phase|Other|1|||
37812954|NCT04585815|69490536|FG001|Sub-study A- Treatment Phase|Other|0|||
37812955|NCT04585815|69490535|FG000|Sub-study A- Treatment Phase|Ongoing treatment|2|||
37812956|NCT04585815|69490536|FG001|Sub-study A- Treatment Phase|Ongoing treatment|6|||
37812957|NCT04585815|69490535|FG000|Sub-study A- Follow-up Phase|Ongoing in study|0|||
37812958|NCT04585815|69490536|FG001|Sub-study A- Follow-up Phase|Ongoing in study|1|||
37812959|NCT04573309|69490546|FG000|Overall Study|Protocol Violation|1|||
37812960|NCT04573309|69490547|FG001|Overall Study|Protocol Violation|0|||
37812961|NCT04525885|69490556|FG000|Overall Study|Screen Failure|1|||
37812962|NCT04525885|69490557|FG001|Overall Study|Screen Failure|0|||
37812963|NCT04525885|69490558|FG002|Overall Study|Screen Failure|0|||
37812964|NCT04525885|69490556|FG000|Overall Study|Withdrawal by Subject|14|||
37812965|NCT04525885|69490557|FG001|Overall Study|Withdrawal by Subject|6|||
37812966|NCT04525885|69490558|FG002|Overall Study|Withdrawal by Subject|20|||
37812967|NCT04525885|69490556|FG000|Overall Study|Physician Decision|1|||
37812968|NCT04525885|69490557|FG001|Overall Study|Physician Decision|0|||
37812969|NCT04525885|69490558|FG002|Overall Study|Physician Decision|1|||
37812970|NCT04220866|69490582|FG000|Overall Study|Death|4|||
37812971|NCT04220866|69490583|FG001|Overall Study|Death|5|||
37812972|NCT04220866|69490582|FG000|Overall Study|Participation at the site terminated By Sponsor|2|||
37812973|NCT04220866|69490583|FG001|Overall Study|Participation at the site terminated By Sponsor|0|||
37812974|NCT04220866|69490582|FG000|Overall Study|Participation in the study terminated By Sponsor|2|||
37812975|NCT04220866|69490583|FG001|Overall Study|Participation in the study terminated By Sponsor|4|||
37812976|NCT04220866|69490582|FG000|Overall Study|Withdrawal by Subject|0|||
37812977|NCT04220866|69490583|FG001|Overall Study|Withdrawal by Subject|1|||
37812978|NCT04060680|69490593|FG000|Overall Study|Unsuccessful implant|17|||
37812979|NCT04060680|69490593|FG000|Overall Study|Adverse Event|3|||
37812980|NCT04060680|69490593|FG000|Overall Study|Death|2|||
37812981|NCT04060680|69490593|FG000|Overall Study|Study product no longer in use|1|||
37812982|NCT04060680|69490593|FG000|Overall Study|Withdrawal by Subject|1|||
37812983|NCT04004611|69490601|FG000|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
37812984|NCT04004611|69490602|FG001|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
37812985|NCT04004611|69490603|FG002|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
37812986|NCT04004611|69490604|FG003|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
37812987|NCT04004611|69490605|FG004|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
37812988|NCT04004611|69490606|FG005|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
37812989|NCT04004611|69490607|FG006|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
37812990|NCT04004611|69490608|FG007|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
37812991|NCT04004611|69490609|FG008|OL Maintenance Period (Wk 12-52)|Adverse Event|1|||
37812992|NCT04004611|69490601|FG000|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
37812993|NCT04004611|69490602|FG001|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
37812994|NCT04004611|69490603|FG002|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
37812995|NCT04004611|69490604|FG003|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
37812996|NCT04004611|69490605|FG004|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
37812997|NCT04004611|69490606|FG005|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
37812998|NCT04004611|69490607|FG006|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
37812999|NCT04004611|69490608|FG007|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
37813000|NCT04004611|69490609|FG008|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|3|||
37813001|NCT04004611|69490601|FG000|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
37813002|NCT04004611|69490602|FG001|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
37813003|NCT04004611|69490603|FG002|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
37813004|NCT04004611|69490604|FG003|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
37813005|NCT04004611|69490605|FG004|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|1|||
37813006|NCT04004611|69490606|FG005|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
37813007|NCT04004611|69490607|FG006|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
37813008|NCT04004611|69490608|FG007|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
37813009|NCT04004611|69490609|FG008|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
37813010|NCT04004611|69490601|FG000|OL Induction and Maintenance Period|Adverse Event|0|||
37813011|NCT04004611|69490602|FG001|OL Induction and Maintenance Period|Adverse Event|0|||
37813012|NCT04004611|69490603|FG002|OL Induction and Maintenance Period|Adverse Event|1|||
37813013|NCT04004611|69490604|FG003|OL Induction and Maintenance Period|Adverse Event|0|||
37813014|NCT04004611|69490605|FG004|OL Induction and Maintenance Period|Adverse Event|0|||
37977652|NCT00273052|69664785|FG001|Overall Study|Adverse Event|19|||
37813015|NCT04004611|69490606|FG005|OL Induction and Maintenance Period|Adverse Event|0|||
37813016|NCT04004611|69490607|FG006|OL Induction and Maintenance Period|Adverse Event|0|||
37813017|NCT04004611|69490608|FG007|OL Induction and Maintenance Period|Adverse Event|0|||
37813018|NCT04004611|69490609|FG008|OL Induction and Maintenance Period|Adverse Event|0|||
37813019|NCT04004611|69490601|FG000|OL Induction and Maintenance Period|Lack of Efficacy|1|||
37813020|NCT04004611|69490602|FG001|OL Induction and Maintenance Period|Lack of Efficacy|0|||
37813021|NCT04004611|69490603|FG002|OL Induction and Maintenance Period|Lack of Efficacy|4|||
37813022|NCT04004611|69490604|FG003|OL Induction and Maintenance Period|Lack of Efficacy|0|||
37813023|NCT04004611|69490605|FG004|OL Induction and Maintenance Period|Lack of Efficacy|0|||
37813024|NCT04004611|69490606|FG005|OL Induction and Maintenance Period|Lack of Efficacy|0|||
37813025|NCT04004611|69490607|FG006|OL Induction and Maintenance Period|Lack of Efficacy|0|||
37813026|NCT04004611|69490608|FG007|OL Induction and Maintenance Period|Lack of Efficacy|0|||
37813027|NCT04004611|69490609|FG008|OL Induction and Maintenance Period|Lack of Efficacy|0|||
37813028|NCT04004611|69490601|FG000|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
37813029|NCT04004611|69490602|FG001|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|1|||
37813030|NCT04004611|69490603|FG002|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
37813031|NCT04004611|69490604|FG003|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
37813032|NCT04004611|69490605|FG004|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
37813033|NCT04004611|69490606|FG005|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
37813034|NCT04004611|69490607|FG006|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
37813035|NCT04004611|69490608|FG007|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
37813036|NCT04004611|69490609|FG008|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
37813037|NCT03824938|69490639|FG000|Overall Study|Withdrawal by Subject|2|||
37813038|NCT03824938|69490640|FG001|Overall Study|Withdrawal by Subject|1|||
37813039|NCT03824938|69490641|FG002|Overall Study|Withdrawal by Subject|0|||
37813040|NCT03824938|69490642|FG003|Overall Study|Withdrawal by Subject|2|||
37813041|NCT03824938|69490643|FG004|Overall Study|Withdrawal by Subject|0|||
37813042|NCT03824938|69490644|FG005|Overall Study|Withdrawal by Subject|1|||
37813043|NCT03824938|69490639|FG000|Overall Study|Lost to Follow-up|0|||
37813044|NCT03824938|69490640|FG001|Overall Study|Lost to Follow-up|1|||
37813045|NCT03824938|69490641|FG002|Overall Study|Lost to Follow-up|0|||
37813046|NCT03824938|69490642|FG003|Overall Study|Lost to Follow-up|0|||
37813047|NCT03824938|69490643|FG004|Overall Study|Lost to Follow-up|1|||
37813048|NCT03824938|69490644|FG005|Overall Study|Lost to Follow-up|0|||
37813049|NCT03636373|69490654|FG000|Overall Study|Study closure due to Covid-19|1|||
37813050|NCT03636373|69490655|FG001|Overall Study|Study closure due to Covid-19|0|||
37813051|NCT03631706|69490669|FG000|Overall Study|Randomized, not treated|1|||
37813052|NCT03631706|69490670|FG001|Overall Study|Randomized, not treated|0|||
37813053|NCT03631706|69490669|FG000|Overall Study|Treatment ongoing|26|||
37813054|NCT03631706|69490670|FG001|Overall Study|Treatment ongoing|57|||
37813055|NCT03631706|69490669|FG000|Overall Study|Off treatment (Treatment completed and discontinued) and in follow up)|65|||
37813056|NCT03631706|69490670|FG001|Overall Study|Off treatment (Treatment completed and discontinued) and in follow up)|41|||
37977653|NCT00273052|69664784|FG000|Overall Study|Protocol Violation|14|||
37977654|NCT00273052|69664785|FG001|Overall Study|Protocol Violation|18|||
37977655|NCT00273052|69664784|FG000|Overall Study|Lost to Follow-up|7|||
37977656|NCT00273052|69664785|FG001|Overall Study|Lost to Follow-up|25|||
37977657|NCT00273052|69664784|FG000|Overall Study|Lack of Efficacy|6|||
37977658|NCT00273052|69664785|FG001|Overall Study|Lack of Efficacy|4|||
37977659|NCT00273052|69664784|FG000|Overall Study|Non-Compliance|3|||
37977660|NCT00273052|69664785|FG001|Overall Study|Non-Compliance|1|||
37977661|NCT00273052|69664784|FG000|Overall Study|Other|2|||
37977662|NCT00273052|69664785|FG001|Overall Study|Other|0|||
37977663|NCT00273052|69664784|FG000|Overall Study|Worsening serum lipid levels|0|||
37977664|NCT00273052|69664785|FG001|Overall Study|Worsening serum lipid levels|2|||
37977665|NCT00290290|69664793|FG000|Overall Study|Death|3|||
37977666|NCT00290290|69664794|FG001|Overall Study|Death|4|||
37977667|NCT00290290|69664793|FG000|Overall Study|Withdrawal by Subject|2|||
37977668|NCT00290290|69664794|FG001|Overall Study|Withdrawal by Subject|2|||
37977669|NCT00290290|69664793|FG000|Overall Study|Underwent clean surgical procedure|13|||
37977670|NCT00290290|69664794|FG001|Overall Study|Underwent clean surgical procedure|12|||
37977671|NCT00272038|69664800|FG000|Overall Study|withdrew before they received 2 cycles|7|||
37977672|NCT00271024|69664809|FG000|Overall Study|Lost Interest|3|||
37977673|NCT00271024|69664810|FG001|Overall Study|Lost Interest|4|||
37977674|NCT00271024|69664811|FG002|Overall Study|Lost Interest|2|||
37977675|NCT00271024|69664812|FG003|Overall Study|Lost Interest|3|||
37977676|NCT00271024|69664809|FG000|Overall Study|Unknown/Unspecified|11|||
37977677|NCT00271024|69664810|FG001|Overall Study|Unknown/Unspecified|11|||
37977678|NCT00271024|69664811|FG002|Overall Study|Unknown/Unspecified|8|||
37977679|NCT00271024|69664812|FG003|Overall Study|Unknown/Unspecified|4|||
37977680|NCT00271024|69664809|FG000|Overall Study|Protocol Violation|1|||
37977681|NCT00271024|69664810|FG001|Overall Study|Protocol Violation|6|||
37977682|NCT00271024|69664811|FG002|Overall Study|Protocol Violation|5|||
37977683|NCT00271024|69664812|FG003|Overall Study|Protocol Violation|11|||
37977684|NCT00271024|69664809|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
37977685|NCT00271024|69664810|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
37977686|NCT00271024|69664811|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
37977687|NCT00271024|69664812|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
37977688|NCT00271024|69664809|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
37977689|NCT00271024|69664810|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
37977690|NCT00271024|69664811|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
37977691|NCT00271024|69664812|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
37977692|NCT00381693|69664822|FG000|Overall Study|Death|1|||
37977693|NCT00381693|69664822|FG000|Overall Study|Adverse Event|4|||
37977694|NCT00381693|69664822|FG000|Overall Study|Patient Choice|1|||
37977695|NCT00381693|69664822|FG000|Overall Study|Progression|2|||
37977696|NCT00545363|69664828|FG000|Overall Study|Adverse Event|6|||
37977697|NCT00545363|69664829|FG001|Overall Study|Adverse Event|7|||
37977698|NCT00545363|69664828|FG000|Overall Study|Withdrawal by Subject|6|||
37813106|NCT03064126|69490710|FG000|Overall Study|Death|6|||
37813107|NCT03064126|69490711|FG001|Overall Study|Death|2|||
37813108|NCT03064126|69490712|FG002|Overall Study|Death|2|||
37813109|NCT03064126|69490713|FG003|Overall Study|Death|1|||
37813110|NCT03064126|69490710|FG000|Overall Study|Investigator Discretion|1|||
37813111|NCT03064126|69490711|FG001|Overall Study|Investigator Discretion|0|||
37813112|NCT03064126|69490712|FG002|Overall Study|Investigator Discretion|0|||
37813113|NCT03064126|69490713|FG003|Overall Study|Investigator Discretion|0|||
37813114|NCT03064126|69490710|FG000|Overall Study|Withdrawal by Subject|7|||
37813115|NCT03064126|69490711|FG001|Overall Study|Withdrawal by Subject|4|||
37813116|NCT03064126|69490712|FG002|Overall Study|Withdrawal by Subject|0|||
37694494|NCT02470403|69170963|FG000|Overall Study|Subject/guardian decision|1|||
37813117|NCT03064126|69490713|FG003|Overall Study|Withdrawal by Subject|0|||
37813118|NCT03064126|69490710|FG000|Overall Study|Subject moved|1|||
37813119|NCT03064126|69490711|FG001|Overall Study|Subject moved|0|||
37813120|NCT03064126|69490712|FG002|Overall Study|Subject moved|0|||
37813121|NCT03064126|69490713|FG003|Overall Study|Subject moved|0|||
37813122|NCT03064126|69490710|FG000|Overall Study|Protocol Violation|11|||
37813123|NCT03064126|69490711|FG001|Overall Study|Protocol Violation|1|||
37813124|NCT03064126|69490712|FG002|Overall Study|Protocol Violation|1|||
37813125|NCT03064126|69490713|FG003|Overall Study|Protocol Violation|0|||
37813126|NCT03004443|69490726|FG000|Overall Study|Pregnancy|0|||
37813127|NCT03004443|69490727|FG001|Overall Study|Pregnancy|1|||
37813128|NCT02277028|69490735|FG000|Overall Study|Lost to Follow-up|1|||
37813129|NCT02277028|69490736|FG001|Overall Study|Lost to Follow-up|0|||
37813130|NCT02277028|69490735|FG000|Overall Study|Withdrawal by Subject|0|||
37813131|NCT02277028|69490736|FG001|Overall Study|Withdrawal by Subject|1|||
37813132|NCT03735849|69490788|FG000|Overall Study|Lost to Follow-up|1|||
37813133|NCT03735849|69490789|FG001|Overall Study|Lost to Follow-up|0|||
37813134|NCT03735849|69490790|FG002|Overall Study|Lost to Follow-up|0|||
37813135|NCT03735849|69490788|FG000|Overall Study|Participant unable to adhere to visit|1|||
37813136|NCT03735849|69490789|FG001|Overall Study|Participant unable to adhere to visit|0|||
37813137|NCT03735849|69490790|FG002|Overall Study|Participant unable to adhere to visit|0|||
37813138|NCT03735849|69490788|FG000|Overall Study|Not Randomized|0|||
37813139|NCT03735849|69490789|FG001|Overall Study|Not Randomized|0|||
37813140|NCT03735849|69490790|FG002|Overall Study|Not Randomized|4|||
37813141|NCT03552393|69490797|FG000|Core Period|Kidney Transplant|1|||
37694495|NCT02470403|69170964|FG001|Overall Study|Subject/guardian decision|0|||
37813142|NCT03552393|69490797|FG000|Core Period|Prohibited Medication|1|||
37864395|NCT01259492|69548040|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
37813143|NCT03552393|69490797|FG000|Safety Extension Period|Kidney Transplant|4|||
37694496|NCT02470403|69170965|FG002|Overall Study|Subject/guardian decision|0|||
37694497|NCT02470403|69170966|FG003|Overall Study|Subject/guardian decision|4|||
37694498|NCT02470403|69170967|FG004|Overall Study|Subject/guardian decision|0|||
37813144|NCT03333382|69490803|FG000|Overall Study|Lost to Follow-up|1|||
37813145|NCT03333382|69490804|FG001|Overall Study|Lost to Follow-up|0|||
37813146|NCT03107611|69490843|FG000|Overall Study|Adverse Event|1|||
37813147|NCT03107611|69490844|FG001|Overall Study|Adverse Event|0|||
37813148|NCT03107611|69490845|FG002|Overall Study|Adverse Event|2|||
37813149|NCT03107611|69490843|FG000|Overall Study|Lost to Follow-up|3|||
37813150|NCT03107611|69490844|FG001|Overall Study|Lost to Follow-up|3|||
37813151|NCT03107611|69490845|FG002|Overall Study|Lost to Follow-up|3|||
37813152|NCT03107611|69490843|FG000|Overall Study|Protocol Violation|0|||
37813153|NCT03107611|69490844|FG001|Overall Study|Protocol Violation|0|||
37813154|NCT03107611|69490845|FG002|Overall Study|Protocol Violation|1|||
37813155|NCT03107611|69490843|FG000|Overall Study|Withdrawal by Subject|1|||
37813156|NCT03107611|69490844|FG001|Overall Study|Withdrawal by Subject|0|||
37813157|NCT03107611|69490845|FG002|Overall Study|Withdrawal by Subject|1|||
37813158|NCT03107611|69490843|FG000|Overall Study|Worsening signs/symptoms|2|||
37813159|NCT03107611|69490844|FG001|Overall Study|Worsening signs/symptoms|1|||
37813160|NCT03107611|69490845|FG002|Overall Study|Worsening signs/symptoms|2|||
37813161|NCT02720016|69490856|FG000|Overall Study|Separation of couple|6|||
37813162|NCT02720016|69490857|FG001|Overall Study|Separation of couple|8|||
37813163|NCT02720016|69490858|FG002|Overall Study|Separation of couple|2|||
37813164|NCT02720016|69490856|FG000|Overall Study|Withdrawal by Subject|6|||
37813165|NCT02720016|69490857|FG001|Overall Study|Withdrawal by Subject|6|||
37813166|NCT02720016|69490858|FG002|Overall Study|Withdrawal by Subject|4|||
37813167|NCT02720016|69490856|FG000|Overall Study|Scheduling issues|2|||
37694499|NCT01855750|69170984|FG000|Overall Study|Death|78|||
37694500|NCT01855750|69170985|FG001|Overall Study|Death|78|||
37694501|NCT01855750|69170984|FG000|Overall Study|Lost to Follow-up|9|||
37694502|NCT01855750|69170985|FG001|Overall Study|Lost to Follow-up|23|||
37694503|NCT01855750|69170984|FG000|Overall Study|Withdrawal by Subject|35|||
37694504|NCT01855750|69170985|FG001|Overall Study|Withdrawal by Subject|28|||
37694505|NCT01855750|69170984|FG000|Overall Study|Sponsor ends the study|297|||
37694506|NCT01855750|69170985|FG001|Overall Study|Sponsor ends the study|290|||
37694507|NCT01855126|69170993|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
37694508|NCT01855126|69170994|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
37813168|NCT02720016|69490857|FG001|Overall Study|Scheduling issues|4|||
37813169|NCT02720016|69490858|FG002|Overall Study|Scheduling issues|7|||
37813170|NCT02720016|69490856|FG000|Overall Study|Childcare|2|||
37813171|NCT02720016|69490857|FG001|Overall Study|Childcare|0|||
37813172|NCT02720016|69490858|FG002|Overall Study|Childcare|2|||
37813173|NCT02720016|69490856|FG000|Overall Study|Withdrawal by PI|2|||
37813174|NCT02720016|69490857|FG001|Overall Study|Withdrawal by PI|2|||
37813175|NCT02720016|69490858|FG002|Overall Study|Withdrawal by PI|0|||
37813176|NCT02720016|69490856|FG000|Overall Study|Moved away|2|||
37813177|NCT02720016|69490857|FG001|Overall Study|Moved away|0|||
37813178|NCT02720016|69490858|FG002|Overall Study|Moved away|0|||
37813179|NCT02720016|69490856|FG000|Overall Study|Not Primary Health Concern|0|||
37813180|NCT02720016|69490857|FG001|Overall Study|Not Primary Health Concern|0|||
37813181|NCT02720016|69490858|FG002|Overall Study|Not Primary Health Concern|2|||
37813182|NCT02720016|69490856|FG000|Overall Study|Transportation issues|0|||
37813183|NCT02720016|69490857|FG001|Overall Study|Transportation issues|0|||
37813184|NCT02720016|69490858|FG002|Overall Study|Transportation issues|1|||
37813185|NCT02720016|69490856|FG000|Overall Study|Other|0|||
37813186|NCT02720016|69490857|FG001|Overall Study|Other|0|||
37813187|NCT02720016|69490858|FG002|Overall Study|Other|2|||
37813188|NCT02607956|69490869|FG000|Double-Blinded Phase|Withdrew Consent|17|||
37694509|NCT01855126|69170993|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
37694510|NCT01855126|69170994|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
37694511|NCT01622673|69171010|FG000|Treatment Period 1|Withdrawal by Subject|0|||
37694512|NCT01622673|69171011|FG001|Treatment Period 1|Withdrawal by Subject|0|||
37694513|NCT01622673|69171012|FG002|Treatment Period 1|Withdrawal by Subject|0|||
37694514|NCT01622673|69171013|FG003|Treatment Period 1|Withdrawal by Subject|1|||
37694515|NCT01622673|69171014|FG004|Treatment Period 1|Withdrawal by Subject|0|||
37694516|NCT01622673|69171015|FG005|Treatment Period 1|Withdrawal by Subject|0|||
37694517|NCT01622673|69171010|FG000|Treatment Period 1|Protocol Violation|0|||
37694518|NCT01622673|69171011|FG001|Treatment Period 1|Protocol Violation|1|||
37694519|NCT01622673|69171012|FG002|Treatment Period 1|Protocol Violation|0|||
37694520|NCT01622673|69171013|FG003|Treatment Period 1|Protocol Violation|0|||
37694521|NCT01622673|69171014|FG004|Treatment Period 1|Protocol Violation|0|||
37694522|NCT01622673|69171015|FG005|Treatment Period 1|Protocol Violation|0|||
37694523|NCT01622673|69171010|FG000|Treatment Period 2|Withdrawal by Subject|0|||
37694524|NCT01622673|69171011|FG001|Treatment Period 2|Withdrawal by Subject|0|||
37694525|NCT01622673|69171012|FG002|Treatment Period 2|Withdrawal by Subject|0|||
37694526|NCT01622673|69171013|FG003|Treatment Period 2|Withdrawal by Subject|1|||
37813189|NCT02607956|69490870|FG001|Double-Blinded Phase|Withdrew Consent|19|||
37813190|NCT02607956|69490871|FG002|Double-Blinded Phase|Withdrew Consent|0|||
37813191|NCT02607956|69490872|FG003|Double-Blinded Phase|Withdrew Consent|0|||
37813192|NCT02607956|69490869|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
37813193|NCT02607956|69490870|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
37813194|NCT02607956|69490871|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
37813195|NCT02607956|69490872|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
37813196|NCT02607956|69490869|FG000|Double-Blinded Phase|Randomized but never treated|7|||
37813197|NCT02607956|69490870|FG001|Double-Blinded Phase|Randomized but never treated|5|||
37694527|NCT01622673|69171014|FG004|Treatment Period 2|Withdrawal by Subject|0|||
37694528|NCT01622673|69171015|FG005|Treatment Period 2|Withdrawal by Subject|0|||
37694529|NCT01622673|69171010|FG000|Treatment Period 3|Protocol Violation|0|||
37694530|NCT01622673|69171011|FG001|Treatment Period 3|Protocol Violation|1|||
37694531|NCT01622673|69171012|FG002|Treatment Period 3|Protocol Violation|0|||
37694532|NCT01622673|69171013|FG003|Treatment Period 3|Protocol Violation|0|||
37694533|NCT01622673|69171014|FG004|Treatment Period 3|Protocol Violation|0|||
37813198|NCT02607956|69490871|FG002|Double-Blinded Phase|Randomized but never treated|0|||
37813199|NCT02607956|69490872|FG003|Double-Blinded Phase|Randomized but never treated|0|||
37813200|NCT02607956|69490869|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
37813201|NCT02607956|69490870|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
37813202|NCT02607956|69490871|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
37813203|NCT02607956|69490872|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
37813204|NCT02607956|69490869|FG000|Double-Blinded Phase|Death|4|||
37813205|NCT02607956|69490870|FG001|Double-Blinded Phase|Death|4|||
37813206|NCT02607956|69490871|FG002|Double-Blinded Phase|Death|0|||
37813207|NCT02607956|69490872|FG003|Double-Blinded Phase|Death|0|||
37813208|NCT02607956|69490869|FG000|Double-Blinded Phase|Adverse Event|4|||
37813209|NCT02607956|69490870|FG001|Double-Blinded Phase|Adverse Event|3|||
37813210|NCT02607956|69490871|FG002|Double-Blinded Phase|Adverse Event|0|||
37813211|NCT02607956|69490872|FG003|Double-Blinded Phase|Adverse Event|0|||
37813212|NCT02607956|69490869|FG000|Double-Blinded Phase|Protocol Violation|3|||
37813213|NCT02607956|69490870|FG001|Double-Blinded Phase|Protocol Violation|1|||
37813214|NCT02607956|69490871|FG002|Double-Blinded Phase|Protocol Violation|0|||
37813215|NCT02607956|69490872|FG003|Double-Blinded Phase|Protocol Violation|0|||
37813216|NCT02607956|69490869|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
37813217|NCT02607956|69490870|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
37813218|NCT02607956|69490871|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
37813219|NCT02607956|69490872|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
37813220|NCT02607956|69490869|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
37813221|NCT02607956|69490870|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
37813222|NCT02607956|69490871|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
37813223|NCT02607956|69490872|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
37813224|NCT02607956|69490869|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
37813225|NCT02607956|69490870|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
37813226|NCT02607956|69490871|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
37813227|NCT02607956|69490872|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
37813228|NCT02607956|69490869|FG000|Open-Label Extension Phase|Death|0|||
37813229|NCT02607956|69490870|FG001|Open-Label Extension Phase|Death|0|||
37813230|NCT02607956|69490871|FG002|Open-Label Extension Phase|Death|1|||
37813231|NCT02607956|69490872|FG003|Open-Label Extension Phase|Death|3|||
37813232|NCT02607956|69490869|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
37813233|NCT02607956|69490870|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
37813234|NCT02607956|69490871|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
37813235|NCT02607956|69490872|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
37813236|NCT02607956|69490869|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
37813237|NCT02607956|69490870|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
37813238|NCT02607956|69490871|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
37813239|NCT02607956|69490872|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
37813240|NCT02607956|69490869|FG000|Open-Label Extension Phase|Protocol Violation|0|||
37813241|NCT02607956|69490870|FG001|Open-Label Extension Phase|Protocol Violation|0|||
37813242|NCT02607956|69490871|FG002|Open-Label Extension Phase|Protocol Violation|0|||
37813243|NCT02607956|69490872|FG003|Open-Label Extension Phase|Protocol Violation|2|||
37813244|NCT02607956|69490869|FG000|Open-Label Extension Phase|Pregnancy|0|||
37813245|NCT02607956|69490870|FG001|Open-Label Extension Phase|Pregnancy|0|||
37813246|NCT02607956|69490871|FG002|Open-Label Extension Phase|Pregnancy|0|||
37813247|NCT02607956|69490872|FG003|Open-Label Extension Phase|Pregnancy|1|||
37813248|NCT02564523|69490902|FG000|Overall Study|Withdrawal by Subject|3|||
37813249|NCT02564523|69490903|FG001|Overall Study|Withdrawal by Subject|0|||
37813250|NCT02564523|69490904|FG002|Overall Study|Withdrawal by Subject|1|||
37813251|NCT02564523|69490905|FG003|Overall Study|Withdrawal by Subject|0|||
37813252|NCT02564523|69490906|FG004|Overall Study|Withdrawal by Subject|1|||
37813253|NCT02564523|69490907|FG005|Overall Study|Withdrawal by Subject|0|||
37813254|NCT02564523|69490908|FG006|Overall Study|Withdrawal by Subject|1|||
37813255|NCT02564523|69490909|FG007|Overall Study|Withdrawal by Subject|0|||
37813256|NCT02564523|69490910|FG008|Overall Study|Withdrawal by Subject|0|||
37813257|NCT02564523|69490911|FG009|Overall Study|Withdrawal by Subject|0|||
37813258|NCT02564523|69490912|FG010|Overall Study|Withdrawal by Subject|1|||
37813259|NCT02564523|69490913|FG011|Overall Study|Withdrawal by Subject|0|||
37813260|NCT02564523|69490914|FG012|Overall Study|Withdrawal by Subject|1|||
37813261|NCT02564523|69490915|FG013|Overall Study|Withdrawal by Subject|0|||
37813262|NCT02564523|69490916|FG014|Overall Study|Withdrawal by Subject|0|||
37813263|NCT02564523|69490917|FG015|Overall Study|Withdrawal by Subject|0|||
37813264|NCT02564523|69490918|FG016|Overall Study|Withdrawal by Subject|0|||
37813265|NCT02564523|69490919|FG017|Overall Study|Withdrawal by Subject|0|||
37813266|NCT02564523|69490902|FG000|Overall Study|Adverse Event|0|||
37813267|NCT02564523|69490903|FG001|Overall Study|Adverse Event|0|||
37813268|NCT02564523|69490904|FG002|Overall Study|Adverse Event|0|||
37813269|NCT02564523|69490905|FG003|Overall Study|Adverse Event|0|||
37813270|NCT02564523|69490906|FG004|Overall Study|Adverse Event|0|||
37813271|NCT02564523|69490907|FG005|Overall Study|Adverse Event|0|||
37813272|NCT02564523|69490908|FG006|Overall Study|Adverse Event|0|||
37864396|NCT01259492|69548037|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
37813273|NCT02564523|69490909|FG007|Overall Study|Adverse Event|0|||
37813274|NCT02564523|69490910|FG008|Overall Study|Adverse Event|0|||
37813275|NCT02564523|69490911|FG009|Overall Study|Adverse Event|0|||
37813276|NCT02564523|69490912|FG010|Overall Study|Adverse Event|0|||
37813277|NCT02564523|69490913|FG011|Overall Study|Adverse Event|0|||
37813278|NCT02564523|69490914|FG012|Overall Study|Adverse Event|0|||
37813279|NCT02564523|69490915|FG013|Overall Study|Adverse Event|0|||
37813280|NCT02564523|69490916|FG014|Overall Study|Adverse Event|0|||
37813281|NCT02564523|69490917|FG015|Overall Study|Adverse Event|0|||
37813282|NCT02564523|69490918|FG016|Overall Study|Adverse Event|0|||
37813283|NCT02564523|69490919|FG017|Overall Study|Adverse Event|1|||
37813284|NCT02564523|69490902|FG000|Overall Study|Death|0|||
37813285|NCT02564523|69490903|FG001|Overall Study|Death|0|||
37813286|NCT02564523|69490904|FG002|Overall Study|Death|0|||
37813287|NCT02564523|69490905|FG003|Overall Study|Death|0|||
37813288|NCT02564523|69490906|FG004|Overall Study|Death|0|||
37813289|NCT02564523|69490907|FG005|Overall Study|Death|0|||
37813290|NCT02564523|69490908|FG006|Overall Study|Death|1|||
37813291|NCT02564523|69490909|FG007|Overall Study|Death|0|||
37813292|NCT02564523|69490910|FG008|Overall Study|Death|0|||
37813293|NCT02564523|69490911|FG009|Overall Study|Death|0|||
37813294|NCT02564523|69490912|FG010|Overall Study|Death|1|||
37813295|NCT02564523|69490913|FG011|Overall Study|Death|0|||
37813296|NCT02564523|69490914|FG012|Overall Study|Death|0|||
37694534|NCT01622673|69171015|FG005|Treatment Period 3|Protocol Violation|0|||
37813297|NCT02564523|69490915|FG013|Overall Study|Death|0|||
37813298|NCT02564523|69490916|FG014|Overall Study|Death|0|||
37813299|NCT02564523|69490917|FG015|Overall Study|Death|0|||
37813300|NCT02564523|69490918|FG016|Overall Study|Death|0|||
37813301|NCT02564523|69490919|FG017|Overall Study|Death|0|||
37813302|NCT02564523|69490902|FG000|Overall Study|Lost to Follow-up|2|||
37813303|NCT02564523|69490903|FG001|Overall Study|Lost to Follow-up|1|||
37813304|NCT02564523|69490904|FG002|Overall Study|Lost to Follow-up|4|||
37813305|NCT02564523|69490905|FG003|Overall Study|Lost to Follow-up|0|||
37813306|NCT02564523|69490906|FG004|Overall Study|Lost to Follow-up|1|||
37813307|NCT02564523|69490907|FG005|Overall Study|Lost to Follow-up|0|||
37813308|NCT02564523|69490908|FG006|Overall Study|Lost to Follow-up|1|||
37694535|NCT01855048|69171040|FG000|Overall Study|Withdrawal by Subject|0|||
37694536|NCT01855048|69171041|FG001|Overall Study|Withdrawal by Subject|1|||
37694537|NCT01855048|69171042|FG002|Overall Study|Withdrawal by Subject|0|||
37694538|NCT01855048|69171043|FG003|Overall Study|Withdrawal by Subject|0|||
37694539|NCT01855048|69171044|FG004|Overall Study|Withdrawal by Subject|1|||
37694540|NCT01855048|69171045|FG005|Overall Study|Withdrawal by Subject|0|||
37694541|NCT02469857|69171071|FG000|Overall Study|Death|24|||
37694542|NCT02469857|69171072|FG001|Overall Study|Death|29|||
37694543|NCT02469857|69171071|FG000|Overall Study|Discontinuation|1|||
37694544|NCT02469857|69171072|FG001|Overall Study|Discontinuation|3|||
37694545|NCT02036853|69171082|FG000|Overall Study|Adverse Event|0|||
37694546|NCT02036853|69171083|FG001|Overall Study|Adverse Event|2|||
37694547|NCT02036853|69171082|FG000|Overall Study|Lack of Efficacy|0|||
37694548|NCT02036853|69171083|FG001|Overall Study|Lack of Efficacy|2|||
37694549|NCT02036853|69171082|FG000|Overall Study|Physician Decision|0|||
37694550|NCT02036853|69171083|FG001|Overall Study|Physician Decision|1|||
37694551|NCT02036853|69171082|FG000|Overall Study|Withdrawal by Subject|0|||
37694552|NCT02036853|69171083|FG001|Overall Study|Withdrawal by Subject|1|||
37694553|NCT02469623|69171089|FG000|Overall Study|Not consented for long-term follow-up|4|||
37694554|NCT02469623|69171089|FG000|Overall Study|Lost to Follow-up|4|||
37694555|NCT02469623|69171089|FG000|Overall Study|Withdrawal by Subject|2|||
37694556|NCT02469623|69171089|FG000|Overall Study|Death|3|||
37694557|NCT02469077|69171096|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
37694558|NCT02469077|69171097|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
37694559|NCT02469077|69171096|FG000|Post Randomization/Intervention Period|Relocated|1|||
37694560|NCT02469077|69171097|FG001|Post Randomization/Intervention Period|Relocated|1|||
37694561|NCT02469077|69171096|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
37694562|NCT02469077|69171097|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
37694563|NCT02469077|69171096|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
37813309|NCT02564523|69490909|FG007|Overall Study|Lost to Follow-up|0|||
37813310|NCT02564523|69490910|FG008|Overall Study|Lost to Follow-up|0|||
37813311|NCT02564523|69490911|FG009|Overall Study|Lost to Follow-up|0|||
37813312|NCT02564523|69490912|FG010|Overall Study|Lost to Follow-up|0|||
37694564|NCT02469077|69171097|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
37694565|NCT02486627|69171109|FG000|Overall Study|Death|1|||
37694566|NCT02486627|69171110|FG001|Overall Study|Death|0|||
37813313|NCT02564523|69490913|FG011|Overall Study|Lost to Follow-up|1|||
37813314|NCT02564523|69490914|FG012|Overall Study|Lost to Follow-up|1|||
37813315|NCT02564523|69490915|FG013|Overall Study|Lost to Follow-up|0|||
37813316|NCT02564523|69490916|FG014|Overall Study|Lost to Follow-up|0|||
37813317|NCT02564523|69490917|FG015|Overall Study|Lost to Follow-up|0|||
37813318|NCT02564523|69490918|FG016|Overall Study|Lost to Follow-up|0|||
37813319|NCT02564523|69490919|FG017|Overall Study|Lost to Follow-up|0|||
37694567|NCT02486627|69171109|FG000|Overall Study|Other Unspecified|0|||
37694568|NCT02486627|69171110|FG001|Overall Study|Other Unspecified|2|||
37694569|NCT02486627|69171109|FG000|Overall Study|Consent Withdrawn by Participant|4|||
37694570|NCT02486627|69171110|FG001|Overall Study|Consent Withdrawn by Participant|3|||
37694571|NCT02486627|69171109|FG000|Overall Study|Significant Participant Noncompliance|1|||
37694572|NCT02486627|69171110|FG001|Overall Study|Significant Participant Noncompliance|1|||
37694573|NCT02486627|69171109|FG000|Overall Study|Lost to Follow-up|1|||
37694574|NCT02486627|69171110|FG001|Overall Study|Lost to Follow-up|3|||
37694575|NCT01644565|69171116|FG000|Overall Study|Undisclosed Medical History|1|||
37694576|NCT01644565|69171117|FG001|Overall Study|Undisclosed Medical History|0|||
37694577|NCT01644565|69171118|FG002|Overall Study|Undisclosed Medical History|0|||
37694578|NCT01644565|69171119|FG003|Overall Study|Undisclosed Medical History|0|||
37694579|NCT01644565|69171120|FG004|Overall Study|Undisclosed Medical History|0|||
37694580|NCT01644565|69171121|FG005|Overall Study|Undisclosed Medical History|0|||
37694581|NCT01644565|69171122|FG006|Overall Study|Undisclosed Medical History|0|||
37694582|NCT01644565|69171123|FG007|Overall Study|Undisclosed Medical History|0|||
37694583|NCT01644565|69171124|FG008|Overall Study|Undisclosed Medical History|0|||
37694584|NCT01644565|69171116|FG000|Overall Study|Lost to Follow-up|0|||
37694585|NCT01644565|69171117|FG001|Overall Study|Lost to Follow-up|0|||
37694586|NCT01644565|69171118|FG002|Overall Study|Lost to Follow-up|0|||
37694587|NCT01644565|69171119|FG003|Overall Study|Lost to Follow-up|1|||
37694588|NCT01644565|69171120|FG004|Overall Study|Lost to Follow-up|0|||
37694589|NCT01644565|69171121|FG005|Overall Study|Lost to Follow-up|0|||
37694590|NCT01644565|69171122|FG006|Overall Study|Lost to Follow-up|0|||
37694591|NCT01644565|69171123|FG007|Overall Study|Lost to Follow-up|2|||
37694592|NCT01644565|69171124|FG008|Overall Study|Lost to Follow-up|0|||
37694593|NCT01644565|69171116|FG000|Overall Study|Family emergency|0|||
37694594|NCT01644565|69171117|FG001|Overall Study|Family emergency|0|||
37694595|NCT01644565|69171118|FG002|Overall Study|Family emergency|0|||
37694596|NCT01644565|69171119|FG003|Overall Study|Family emergency|0|||
37694597|NCT01644565|69171120|FG004|Overall Study|Family emergency|1|||
37694598|NCT01644565|69171121|FG005|Overall Study|Family emergency|0|||
37694599|NCT01644565|69171122|FG006|Overall Study|Family emergency|0|||
37694600|NCT01644565|69171123|FG007|Overall Study|Family emergency|0|||
37694601|NCT01644565|69171124|FG008|Overall Study|Family emergency|0|||
37694602|NCT01644565|69171116|FG000|Overall Study|Relocation|0|||
37694603|NCT01644565|69171117|FG001|Overall Study|Relocation|0|||
37694604|NCT01644565|69171118|FG002|Overall Study|Relocation|0|||
37694605|NCT01644565|69171119|FG003|Overall Study|Relocation|0|||
37694606|NCT01644565|69171120|FG004|Overall Study|Relocation|0|||
37694607|NCT01644565|69171121|FG005|Overall Study|Relocation|0|||
37694608|NCT01644565|69171122|FG006|Overall Study|Relocation|0|||
37694609|NCT01644565|69171123|FG007|Overall Study|Relocation|0|||
37694610|NCT01644565|69171124|FG008|Overall Study|Relocation|1|||
37694611|NCT02485925|69171144|FG000|Overall Study|Withdrawal by Subject|3|||
37694612|NCT02485925|69171144|FG000|Overall Study|Death|1|||
37694613|NCT02485925|69171144|FG000|Overall Study|Lost to Follow-up|11|||
37694614|NCT02282293|69171150|FG000|Overall Study|Lost to Follow-up|2|||
37694615|NCT02282293|69171151|FG001|Overall Study|Lost to Follow-up|2|||
37694616|NCT02282293|69171150|FG000|Overall Study|Unable to comply with study procedures|1|||
37694617|NCT02282293|69171151|FG001|Overall Study|Unable to comply with study procedures|0|||
37694618|NCT02282293|69171150|FG000|Overall Study|Moved out of study area|0|||
37694619|NCT02282293|69171151|FG001|Overall Study|Moved out of study area|1|||
37694620|NCT01854658|69171161|FG000|Overall Study|Protocol Violation|6|||
37694621|NCT01854658|69171162|FG001|Overall Study|Protocol Violation|2|||
37694622|NCT01854658|69171163|FG002|Overall Study|Protocol Violation|2|||
37694623|NCT01854658|69171164|FG003|Overall Study|Protocol Violation|1|||
37694624|NCT01854658|69171161|FG000|Overall Study|Physician Decision|7|||
37694625|NCT01854658|69171162|FG001|Overall Study|Physician Decision|5|||
37694626|NCT01854658|69171163|FG002|Overall Study|Physician Decision|2|||
37813320|NCT02564523|69490902|FG000|Overall Study|Physician Decision|0|||
37813321|NCT02564523|69490903|FG001|Overall Study|Physician Decision|0|||
37813322|NCT02564523|69490904|FG002|Overall Study|Physician Decision|0|||
37813323|NCT02564523|69490905|FG003|Overall Study|Physician Decision|0|||
37813324|NCT02564523|69490906|FG004|Overall Study|Physician Decision|1|||
37694627|NCT01854658|69171164|FG003|Overall Study|Physician Decision|4|||
37694628|NCT01854658|69171161|FG000|Overall Study|Lost to Follow-up|8|||
37694629|NCT01854658|69171162|FG001|Overall Study|Lost to Follow-up|9|||
37694630|NCT01854658|69171163|FG002|Overall Study|Lost to Follow-up|8|||
37694631|NCT01854658|69171164|FG003|Overall Study|Lost to Follow-up|4|||
37694632|NCT01854658|69171161|FG000|Overall Study|Withdrawal by Subject|28|||
37694633|NCT01854658|69171162|FG001|Overall Study|Withdrawal by Subject|21|||
37694634|NCT01854658|69171163|FG002|Overall Study|Withdrawal by Subject|29|||
37694635|NCT01854658|69171164|FG003|Overall Study|Withdrawal by Subject|15|||
37694636|NCT01854658|69171161|FG000|Overall Study|Protocol-specified criteria|15|||
37694637|NCT01854658|69171162|FG001|Overall Study|Protocol-specified criteria|15|||
37694638|NCT01854658|69171163|FG002|Overall Study|Protocol-specified criteria|10|||
37813325|NCT02564523|69490907|FG005|Overall Study|Physician Decision|0|||
37694639|NCT01854658|69171164|FG003|Overall Study|Protocol-specified criteria|7|||
37694640|NCT01854658|69171161|FG000|Overall Study|Lack of Efficacy|3|||
37694641|NCT01854658|69171162|FG001|Overall Study|Lack of Efficacy|8|||
37694642|NCT01854658|69171163|FG002|Overall Study|Lack of Efficacy|4|||
37813326|NCT02564523|69490908|FG006|Overall Study|Physician Decision|0|||
37813327|NCT02564523|69490909|FG007|Overall Study|Physician Decision|0|||
37813328|NCT02564523|69490910|FG008|Overall Study|Physician Decision|0|||
37813329|NCT02564523|69490911|FG009|Overall Study|Physician Decision|0|||
37813330|NCT02564523|69490912|FG010|Overall Study|Physician Decision|1|||
37813331|NCT02564523|69490913|FG011|Overall Study|Physician Decision|0|||
37813332|NCT02564523|69490914|FG012|Overall Study|Physician Decision|0|||
37694643|NCT01854658|69171164|FG003|Overall Study|Lack of Efficacy|7|||
37813333|NCT02564523|69490915|FG013|Overall Study|Physician Decision|0|||
37813334|NCT02564523|69490916|FG014|Overall Study|Physician Decision|0|||
37813335|NCT02564523|69490917|FG015|Overall Study|Physician Decision|0|||
37813336|NCT02564523|69490918|FG016|Overall Study|Physician Decision|0|||
37813337|NCT02564523|69490919|FG017|Overall Study|Physician Decision|0|||
37813338|NCT02564523|69490902|FG000|Overall Study|Protocol Violation|2|||
37813339|NCT02564523|69490903|FG001|Overall Study|Protocol Violation|2|||
37813340|NCT02564523|69490904|FG002|Overall Study|Protocol Violation|5|||
37813341|NCT02564523|69490905|FG003|Overall Study|Protocol Violation|0|||
37813342|NCT02564523|69490906|FG004|Overall Study|Protocol Violation|1|||
37813343|NCT02564523|69490907|FG005|Overall Study|Protocol Violation|0|||
37813344|NCT02564523|69490908|FG006|Overall Study|Protocol Violation|0|||
37813345|NCT02564523|69490909|FG007|Overall Study|Protocol Violation|0|||
37813346|NCT02564523|69490910|FG008|Overall Study|Protocol Violation|0|||
37813347|NCT02564523|69490911|FG009|Overall Study|Protocol Violation|0|||
37813348|NCT02564523|69490912|FG010|Overall Study|Protocol Violation|0|||
37813349|NCT02564523|69490913|FG011|Overall Study|Protocol Violation|0|||
37813350|NCT02564523|69490914|FG012|Overall Study|Protocol Violation|0|||
37813351|NCT02564523|69490915|FG013|Overall Study|Protocol Violation|0|||
37813352|NCT02564523|69490916|FG014|Overall Study|Protocol Violation|0|||
37813353|NCT02564523|69490917|FG015|Overall Study|Protocol Violation|0|||
37813354|NCT02564523|69490918|FG016|Overall Study|Protocol Violation|0|||
37813355|NCT02564523|69490919|FG017|Overall Study|Protocol Violation|0|||
37813356|NCT02564523|69490902|FG000|Overall Study|Other|3|||
37813357|NCT02564523|69490903|FG001|Overall Study|Other|0|||
37813358|NCT02564523|69490904|FG002|Overall Study|Other|0|||
37813359|NCT02564523|69490905|FG003|Overall Study|Other|1|||
37813360|NCT02564523|69490906|FG004|Overall Study|Other|0|||
37813361|NCT02564523|69490907|FG005|Overall Study|Other|0|||
37813362|NCT02564523|69490908|FG006|Overall Study|Other|0|||
37813363|NCT02564523|69490909|FG007|Overall Study|Other|0|||
37813364|NCT02564523|69490910|FG008|Overall Study|Other|0|||
37813365|NCT02564523|69490911|FG009|Overall Study|Other|0|||
37813366|NCT02564523|69490912|FG010|Overall Study|Other|0|||
37813367|NCT02564523|69490913|FG011|Overall Study|Other|0|||
37813368|NCT02564523|69490914|FG012|Overall Study|Other|0|||
37813369|NCT02564523|69490915|FG013|Overall Study|Other|0|||
37813370|NCT02564523|69490916|FG014|Overall Study|Other|0|||
37813371|NCT02564523|69490917|FG015|Overall Study|Other|0|||
37813372|NCT02564523|69490918|FG016|Overall Study|Other|0|||
37813373|NCT02564523|69490919|FG017|Overall Study|Other|0|||
37813374|NCT01447628|69491026|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
37813375|NCT01447628|69491027|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
37813376|NCT01447628|69491028|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
37813377|NCT01447628|69491029|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
37813378|NCT00515853|69491051|FG000|Overall Study|Lost to Follow-up|9|||
37813379|NCT00515853|69491052|FG001|Overall Study|Lost to Follow-up|13|||
37813380|NCT00515853|69491051|FG000|Overall Study|Withdrawal by Subject|6|||
37813381|NCT00515853|69491052|FG001|Overall Study|Withdrawal by Subject|4|||
37694644|NCT01854658|69171161|FG000|Overall Study|Adverse Event|21|||
37694645|NCT01854658|69171162|FG001|Overall Study|Adverse Event|14|||
37694646|NCT01854658|69171163|FG002|Overall Study|Adverse Event|23|||
37694647|NCT01854658|69171164|FG003|Overall Study|Adverse Event|19|||
37813382|NCT00003458|69491058|FG000|Overall Study|Not evaluable|4|||
37813383|NCT05032872|69491065|FG000|Overall Study|Adverse Event|1|||
37813384|NCT05032872|69491066|FG001|Overall Study|Adverse Event|0|||
37813385|NCT05032872|69491065|FG000|Overall Study|Lost to Follow-up|2|||
37813386|NCT05032872|69491066|FG001|Overall Study|Lost to Follow-up|4|||
37813387|NCT05032872|69491065|FG000|Overall Study|Withdrawal by Subject|4|||
37813388|NCT05032872|69491066|FG001|Overall Study|Withdrawal by Subject|3|||
37813389|NCT04613739|69491092|FG000|Overall Study|Lost to Follow-up|6|||
37813390|NCT04613739|69491093|FG001|Overall Study|Lost to Follow-up|9|||
37813391|NCT04613739|69491092|FG000|Overall Study|potentially duplicative/fraudulent|1|||
37813392|NCT04613739|69491093|FG001|Overall Study|potentially duplicative/fraudulent|3|||
37813393|NCT04407806|69491120|FG000|Overall Study|Withdrawal by Subject|1|||
37813394|NCT04407806|69491121|FG001|Overall Study|Withdrawal by Subject|2|||
37813395|NCT04324021|69491130|FG000|Overall Study|Adverse Event|1|||
37813396|NCT04324021|69491131|FG001|Overall Study|Adverse Event|0|||
37813397|NCT04324021|69491132|FG002|Overall Study|Adverse Event|0|||
37813398|NCT04324021|69491130|FG000|Overall Study|Lack of Efficacy|0|||
37813399|NCT04324021|69491131|FG001|Overall Study|Lack of Efficacy|0|||
37813400|NCT04324021|69491132|FG002|Overall Study|Lack of Efficacy|1|||
37813401|NCT04324021|69491130|FG000|Overall Study|Death|1|||
37813402|NCT04324021|69491131|FG001|Overall Study|Death|1|||
37813403|NCT04324021|69491132|FG002|Overall Study|Death|0|||
37813404|NCT04209621|69491143|FG000|Overall Study|Death|1|||
37813405|NCT04209621|69491143|FG000|Overall Study|Study Terminated Early|2|||
37813406|NCT04186663|69491148|FG000|Overall Study|Lost to Follow-up|1|||
37813407|NCT04186663|69491148|FG000|Overall Study|Unable to complete blood draw|3|||
37813408|NCT04158219|69491152|FG000|Overall Study|Lost to Follow-up|1|||
37813409|NCT03954743|69491185|FG000|Overall Study|Adverse Event|1|||
37813410|NCT03954743|69491186|FG001|Overall Study|Adverse Event|0|||
37813411|NCT03954743|69491185|FG000|Overall Study|Lost to Follow-up|6|||
37813412|NCT03954743|69491186|FG001|Overall Study|Lost to Follow-up|4|||
37813413|NCT03954743|69491185|FG000|Overall Study|Protocol Violation|1|||
37813414|NCT03954743|69491186|FG001|Overall Study|Protocol Violation|0|||
37813415|NCT03954743|69491185|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
37813416|NCT03954743|69491186|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
37813417|NCT03954743|69491185|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
37813418|NCT03954743|69491186|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
37813419|NCT03880565|69491207|FG000|Overall Study|Withdrawal by Subject|1|||
37813420|NCT03880565|69491208|FG001|Overall Study|Withdrawal by Subject|0|||
37813421|NCT03782792|69491216|FG000|Overall Study|Patient left the country|0|||
37813422|NCT03782792|69491217|FG001|Overall Study|Patient left the country|1|||
37694648|NCT01854658|69171161|FG000|Overall Study|Administrative reasons|5|||
37694649|NCT01854658|69171162|FG001|Overall Study|Administrative reasons|1|||
37694650|NCT01854658|69171163|FG002|Overall Study|Administrative reasons|2|||
37694651|NCT01854658|69171164|FG003|Overall Study|Administrative reasons|2|||
37694652|NCT01892020|69171174|FG000|Period 1|Adverse Event|1|||
37813423|NCT03782792|69491216|FG000|Overall Study|Withdrawal by Subject|1|||
37813424|NCT03782792|69491217|FG001|Overall Study|Withdrawal by Subject|2|||
37813425|NCT03733119|69491227|FG000|Overall Study|Physician Decision|2|||
37813426|NCT03733119|69491228|FG001|Overall Study|Physician Decision|1|||
37813427|NCT03733119|69491227|FG000|Overall Study|ineligible to treat per protocol|0|||
37813428|NCT03733119|69491228|FG001|Overall Study|ineligible to treat per protocol|1|||
37813429|NCT03661996|69491239|FG000|Overall Study|Adverse Event|0|||
37813430|NCT03661996|69491240|FG001|Overall Study|Adverse Event|0|||
37813431|NCT03661996|69491241|FG002|Overall Study|Adverse Event|1|||
37813432|NCT03661996|69491242|FG003|Overall Study|Adverse Event|1|||
37813433|NCT03661996|69491243|FG004|Overall Study|Adverse Event|0|||
37813434|NCT03661996|69491239|FG000|Overall Study|Lost to Follow-up|5|||
37813435|NCT03661996|69491240|FG001|Overall Study|Lost to Follow-up|1|||
37813436|NCT03661996|69491241|FG002|Overall Study|Lost to Follow-up|2|||
37813437|NCT03661996|69491242|FG003|Overall Study|Lost to Follow-up|2|||
37813438|NCT03661996|69491243|FG004|Overall Study|Lost to Follow-up|6|||
37813439|NCT03661996|69491239|FG000|Overall Study|Physician Decision|1|||
37864397|NCT01259492|69548038|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
37864398|NCT01259492|69548039|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
37864399|NCT01259492|69548040|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
37864400|NCT01259492|69548037|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
37864401|NCT01259492|69548038|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
37864402|NCT01259492|69548039|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
37864403|NCT01259492|69548040|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
37864404|NCT01259492|69548037|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
37864405|NCT01259492|69548038|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
37864406|NCT01259492|69548039|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
37694653|NCT01892020|69171175|FG001|Period 1|Adverse Event|1|||
37694654|NCT01892020|69171174|FG000|Period 1|Protocol Violation|2|||
37694655|NCT01892020|69171175|FG001|Period 1|Protocol Violation|4|||
37813440|NCT03661996|69491240|FG001|Overall Study|Physician Decision|1|||
37813441|NCT03661996|69491241|FG002|Overall Study|Physician Decision|1|||
37813442|NCT03661996|69491242|FG003|Overall Study|Physician Decision|2|||
37864407|NCT01259492|69548040|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
37694656|NCT01892020|69171174|FG000|Period 1|Unclassified|0|||
37694657|NCT01892020|69171175|FG001|Period 1|Unclassified|1|||
37694658|NCT01892020|69171174|FG000|Period 2|Protocol Violation|1|||
37813443|NCT03661996|69491243|FG004|Overall Study|Physician Decision|0|||
37813444|NCT03661996|69491239|FG000|Overall Study|Protocol Violation|0|||
37813445|NCT03661996|69491240|FG001|Overall Study|Protocol Violation|0|||
37813446|NCT03661996|69491241|FG002|Overall Study|Protocol Violation|0|||
37813447|NCT03661996|69491242|FG003|Overall Study|Protocol Violation|0|||
37813448|NCT03661996|69491243|FG004|Overall Study|Protocol Violation|1|||
37694659|NCT01892020|69171175|FG001|Period 2|Protocol Violation|0|||
37864408|NCT01259492|69548037|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
37864409|NCT01259492|69548038|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
37864410|NCT01259492|69548039|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
37864411|NCT01259492|69548040|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
37864412|NCT01259492|69548037|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
37864413|NCT01259492|69548038|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
37864414|NCT01259492|69548039|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
37864415|NCT01259492|69548040|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
37864416|NCT01259492|69548037|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
37864417|NCT01259492|69548038|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
37864418|NCT01259492|69548039|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
37864419|NCT01259492|69548040|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
37864420|NCT01259492|69548037|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
37864421|NCT01259492|69548038|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
37864422|NCT01259492|69548039|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
37864423|NCT01259492|69548040|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
37864424|NCT01259492|69548037|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
37864425|NCT01259492|69548038|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
37864426|NCT01259492|69548039|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
37864427|NCT01259492|69548040|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
37864428|NCT01259492|69548037|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
37864429|NCT01259492|69548038|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
37864430|NCT01259492|69548039|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
37864431|NCT01259492|69548040|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
37864432|NCT01259492|69548037|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
37864433|NCT01259492|69548038|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
37864434|NCT01259492|69548039|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
37864435|NCT01259492|69548040|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
37864436|NCT01259492|69548037|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
37864437|NCT01259492|69548038|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
37864438|NCT01259492|69548039|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
37864439|NCT01259492|69548040|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
37864440|NCT01117623|69548057|FG000|Overall Study|Adverse Event|0|||
37864441|NCT01117623|69548058|FG001|Overall Study|Adverse Event|2|||
37864442|NCT01117623|69548059|FG002|Overall Study|Adverse Event|4|||
37864443|NCT01117623|69548060|FG003|Overall Study|Adverse Event|0|||
37864444|NCT01117623|69548061|FG004|Overall Study|Adverse Event|2|||
37864445|NCT01117623|69548062|FG005|Overall Study|Adverse Event|0|||
37864446|NCT01117623|69548063|FG006|Overall Study|Adverse Event|0|||
37864447|NCT01117623|69548064|FG007|Overall Study|Adverse Event|2|||
37864448|NCT01117623|69548057|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
37864449|NCT01117623|69548058|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
37864450|NCT01117623|69548059|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
37864451|NCT01117623|69548060|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
37864452|NCT01117623|69548061|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
37864453|NCT01117623|69548062|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
37813449|NCT03661996|69491239|FG000|Overall Study|Withdrawal by Subject|3|||
37813450|NCT03661996|69491240|FG001|Overall Study|Withdrawal by Subject|5|||
37813451|NCT03661996|69491241|FG002|Overall Study|Withdrawal by Subject|1|||
37813452|NCT03661996|69491242|FG003|Overall Study|Withdrawal by Subject|7|||
37813453|NCT03661996|69491243|FG004|Overall Study|Withdrawal by Subject|7|||
37813454|NCT03661996|69491239|FG000|Overall Study|Sponsors Decision|2|||
37813455|NCT03661996|69491240|FG001|Overall Study|Sponsors Decision|0|||
37813456|NCT03661996|69491241|FG002|Overall Study|Sponsors Decision|0|||
37813457|NCT03661996|69491242|FG003|Overall Study|Sponsors Decision|0|||
37813458|NCT03661996|69491243|FG004|Overall Study|Sponsors Decision|0|||
37813459|NCT03661996|69491239|FG000|Overall Study|Other|1|||
37813460|NCT03661996|69491240|FG001|Overall Study|Other|1|||
37813461|NCT03661996|69491241|FG002|Overall Study|Other|1|||
37813462|NCT03661996|69491242|FG003|Overall Study|Other|1|||
37813463|NCT03661996|69491243|FG004|Overall Study|Other|0|||
37813464|NCT03633461|69491260|FG000|Overall Study|Lost to Follow-up|0|||
37813465|NCT03633461|69491261|FG001|Overall Study|Lost to Follow-up|1|||
37813466|NCT03499314|69491289|FG000|Overall Study|Time Commitment|1|||
37813467|NCT03499314|69491290|FG001|Overall Study|Time Commitment|2|||
37813468|NCT03499314|69491289|FG000|Overall Study|Medical issue unrelated to research study|1|||
37813469|NCT03499314|69491290|FG001|Overall Study|Medical issue unrelated to research study|1|||
37813470|NCT03369431|69491298|FG000|Overall Study|Lost to Follow-up|1|||
37813471|NCT03369431|69491299|FG001|Overall Study|Lost to Follow-up|3|||
37864454|NCT01117623|69548063|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
37864455|NCT01117623|69548064|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
37864456|NCT01117623|69548057|FG000|Overall Study|Withdrawal by Subject|0|||
37864457|NCT01117623|69548058|FG001|Overall Study|Withdrawal by Subject|0|||
37864458|NCT01117623|69548059|FG002|Overall Study|Withdrawal by Subject|2|||
37864459|NCT01117623|69548060|FG003|Overall Study|Withdrawal by Subject|0|||
37864460|NCT01117623|69548061|FG004|Overall Study|Withdrawal by Subject|0|||
37864461|NCT01117623|69548062|FG005|Overall Study|Withdrawal by Subject|1|||
37864462|NCT01117623|69548063|FG006|Overall Study|Withdrawal by Subject|1|||
37864463|NCT01117623|69548064|FG007|Overall Study|Withdrawal by Subject|1|||
37864464|NCT01117623|69548057|FG000|Overall Study|Non-compliance with study medication|0|||
37864465|NCT01117623|69548058|FG001|Overall Study|Non-compliance with study medication|0|||
37864466|NCT01117623|69548059|FG002|Overall Study|Non-compliance with study medication|0|||
37864467|NCT01117623|69548060|FG003|Overall Study|Non-compliance with study medication|0|||
37864468|NCT01117623|69548061|FG004|Overall Study|Non-compliance with study medication|0|||
37864469|NCT01117623|69548062|FG005|Overall Study|Non-compliance with study medication|0|||
37864470|NCT01117623|69548063|FG006|Overall Study|Non-compliance with study medication|0|||
37864471|NCT01117623|69548064|FG007|Overall Study|Non-compliance with study medication|1|||
37864472|NCT01117623|69548057|FG000|Overall Study|Invest. text: completed all planned txs|0|||
37864473|NCT01117623|69548058|FG001|Overall Study|Invest. text: completed all planned txs|0|||
37864474|NCT01117623|69548059|FG002|Overall Study|Invest. text: completed all planned txs|0|||
37864475|NCT01117623|69548060|FG003|Overall Study|Invest. text: completed all planned txs|0|||
37864476|NCT01117623|69548061|FG004|Overall Study|Invest. text: completed all planned txs|0|||
37864477|NCT01117623|69548062|FG005|Overall Study|Invest. text: completed all planned txs|1|||
37864478|NCT01117623|69548063|FG006|Overall Study|Invest. text: completed all planned txs|0|||
37864479|NCT01117623|69548064|FG007|Overall Study|Invest. text: completed all planned txs|0|||
37864480|NCT01116687|69548084|FG000|Overall Study|Withdrawal by Subject|4|||
37864481|NCT01114737|69548090|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
37864482|NCT01114737|69548091|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
37864483|NCT01114737|69548090|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
37864484|NCT01114737|69548091|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
37864485|NCT01114737|69548090|FG000|Randomized Treatment Period|Pregnancy|1|||
37864486|NCT01114737|69548091|FG001|Randomized Treatment Period|Pregnancy|0|||
37813472|NCT03369431|69491298|FG000|Overall Study|Withdrawal by Subject|2|||
37813473|NCT03369431|69491299|FG001|Overall Study|Withdrawal by Subject|3|||
37813474|NCT03369431|69491298|FG000|Overall Study|Protocol Violation|1|||
37813475|NCT03369431|69491299|FG001|Overall Study|Protocol Violation|1|||
37813476|NCT03336866|69491308|FG000|Overall Study|Lost to Follow-up|2|||
37813477|NCT03336866|69491309|FG001|Overall Study|Lost to Follow-up|0|||
37813478|NCT03336866|69491310|FG002|Overall Study|Lost to Follow-up|3|||
37813479|NCT03336866|69491308|FG000|Overall Study|Withdrawal by Subject|1|||
37813480|NCT03336866|69491309|FG001|Overall Study|Withdrawal by Subject|1|||
37864487|NCT01114737|69548090|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
37864488|NCT01114737|69548091|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
37864489|NCT01114737|69548090|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
37864490|NCT01114737|69548091|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
37864491|NCT01114737|69548090|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
37864492|NCT01114737|69548091|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
37864493|NCT01113879|69548114|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
37864494|NCT01113879|69548115|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
37864495|NCT00979576|69548126|FG000|Combination Treatment Phase|Progressive disease|3|||
37864496|NCT00979576|69548127|FG001|Combination Treatment Phase|Progressive disease|1|||
37864497|NCT00979576|69548128|FG002|Combination Treatment Phase|Progressive disease|5|||
37864498|NCT00979576|69548126|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
37864499|NCT00979576|69548127|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
37864500|NCT00979576|69548128|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
37864501|NCT00979576|69548126|FG000|Combination Treatment Phase|Adverse Event|0|||
37864502|NCT00979576|69548127|FG001|Combination Treatment Phase|Adverse Event|2|||
37864503|NCT00979576|69548128|FG002|Combination Treatment Phase|Adverse Event|2|||
37864504|NCT00979576|69548126|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
37864505|NCT00979576|69548127|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
37864506|NCT00979576|69548128|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
37864507|NCT00979420|69548141|FG000|Overall Study|Adverse Event|1|||
37864508|NCT00979420|69548142|FG001|Overall Study|Adverse Event|0|||
37864509|NCT00979420|69548143|FG002|Overall Study|Adverse Event|0|||
37864510|NCT00979420|69548144|FG003|Overall Study|Adverse Event|0|||
37864511|NCT00979420|69548141|FG000|Overall Study|Lack of Efficacy|3|||
37864512|NCT00979420|69548142|FG001|Overall Study|Lack of Efficacy|0|||
37864513|NCT00979420|69548143|FG002|Overall Study|Lack of Efficacy|1|||
37864514|NCT00979420|69548144|FG003|Overall Study|Lack of Efficacy|1|||
37864515|NCT00979420|69548141|FG000|Overall Study|Other reasons not related to Viramune|3|||
37864516|NCT00979420|69548142|FG001|Overall Study|Other reasons not related to Viramune|0|||
37864517|NCT00979420|69548143|FG002|Overall Study|Other reasons not related to Viramune|0|||
37864518|NCT00979420|69548144|FG003|Overall Study|Other reasons not related to Viramune|1|||
37864519|NCT02702180|69548155|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
37864520|NCT02702180|69548156|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
37864521|NCT02702180|69548157|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
37864522|NCT02702180|69548155|FG000|Double-blind Treatment Period|Adverse Event|0|||
37864523|NCT02702180|69548156|FG001|Double-blind Treatment Period|Adverse Event|0|||
37864524|NCT02702180|69548157|FG002|Double-blind Treatment Period|Adverse Event|1|||
37864525|NCT02702180|69548155|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
37864526|NCT02702180|69548156|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
37864527|NCT02702180|69548157|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
37864528|NCT02702180|69548155|FG000|Double-blind Treatment Period|Protocol Violation|0|||
37864529|NCT02702180|69548156|FG001|Double-blind Treatment Period|Protocol Violation|0|||
37864530|NCT02702180|69548157|FG002|Double-blind Treatment Period|Protocol Violation|2|||
37864531|NCT02702180|69548155|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
37864532|NCT02702180|69548156|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
37864533|NCT02702180|69548157|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
37864534|NCT02702180|69548155|FG000|Open-label Treatment Period|Withdrawn in error|0|||
37864535|NCT02702180|69548156|FG001|Open-label Treatment Period|Withdrawn in error|0|||
37864536|NCT02702180|69548157|FG002|Open-label Treatment Period|Withdrawn in error|1|||
37864537|NCT00980980|69548169|FG000|Overall Study|Withdrawal by Hospital|0|||
37864538|NCT00980980|69548170|FG001|Overall Study|Withdrawal by Hospital|1|||
37864539|NCT00980980|69548171|FG002|Overall Study|Withdrawal by Hospital|0|||
37864540|NCT00980200|69548182|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
37864541|NCT00980200|69548183|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
37864542|NCT00980200|69548184|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
37864543|NCT00980200|69548185|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
37864544|NCT00980200|69548186|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
37864545|NCT00980200|69548182|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
37864546|NCT00980200|69548183|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
37864547|NCT00980200|69548184|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
37864548|NCT00980200|69548185|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
37864549|NCT00980200|69548186|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
37864550|NCT00979654|69548198|FG000|Overall Study|Lost to Follow-up|1|||
37864551|NCT00979654|69548198|FG000|Overall Study|Withdrawal by Subject|22|||
37864552|NCT00979654|69548198|FG000|Overall Study|Death|1|||
37864553|NCT00979654|69548198|FG000|Overall Study|Lack of Efficacy|6|||
37864554|NCT00979654|69548198|FG000|Overall Study|Adverse Event|1|||
37864555|NCT00979654|69548198|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
37864556|NCT00979654|69548198|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
37864557|NCT00979654|69548198|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
37864558|NCT00979654|69548198|FG000|Overall Study|Serious Adverse Event|1|||
37864559|NCT00979654|69548198|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
37864560|NCT00978562|69548202|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
37864561|NCT02865460|69548210|FG000|Overall Study|Adverse Event|1|||
37864562|NCT02865460|69548211|FG001|Overall Study|Adverse Event|0|||
37864563|NCT02865460|69548210|FG000|Overall Study|Withdrawal by Subject|1|||
37864564|NCT02865460|69548211|FG001|Overall Study|Withdrawal by Subject|1|||
37864565|NCT02865460|69548210|FG000|Overall Study|Lost to Follow-up|7|||
37864566|NCT02865460|69548211|FG001|Overall Study|Lost to Follow-up|4|||
37864567|NCT02865460|69548210|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
37864568|NCT02865460|69548211|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
37864569|NCT01206816|69548224|FG000|Overall Study|Protocol Violation|0|||
37864570|NCT01206816|69548225|FG001|Overall Study|Protocol Violation|0|||
37864571|NCT01206816|69548226|FG002|Overall Study|Protocol Violation|1|||
37864572|NCT01206816|69548227|FG003|Overall Study|Protocol Violation|0|||
37864573|NCT01206816|69548228|FG004|Overall Study|Protocol Violation|0|||
37864574|NCT01206816|69548229|FG005|Overall Study|Protocol Violation|0|||
37864575|NCT01206816|69548230|FG006|Overall Study|Protocol Violation|0|||
37864576|NCT01206816|69548224|FG000|Overall Study|Withdrawal by Subject|0|||
37864577|NCT01206816|69548225|FG001|Overall Study|Withdrawal by Subject|0|||
37864578|NCT01206816|69548226|FG002|Overall Study|Withdrawal by Subject|1|||
37864579|NCT01206816|69548227|FG003|Overall Study|Withdrawal by Subject|0|||
37864580|NCT01206816|69548228|FG004|Overall Study|Withdrawal by Subject|0|||
37864581|NCT01206816|69548229|FG005|Overall Study|Withdrawal by Subject|0|||
37864582|NCT01206816|69548230|FG006|Overall Study|Withdrawal by Subject|0|||
37864583|NCT01206816|69548224|FG000|Overall Study|Progressive disease|3|||
37864584|NCT01206816|69548225|FG001|Overall Study|Progressive disease|3|||
37864585|NCT01206816|69548226|FG002|Overall Study|Progressive disease|13|||
37864586|NCT01206816|69548227|FG003|Overall Study|Progressive disease|3|||
37864587|NCT01206816|69548228|FG004|Overall Study|Progressive disease|3|||
37864588|NCT01206816|69548229|FG005|Overall Study|Progressive disease|16|||
37864589|NCT01206816|69548230|FG006|Overall Study|Progressive disease|3|||
37864590|NCT01206816|69548224|FG000|Overall Study|Other AE|0|||
37864591|NCT01206816|69548225|FG001|Overall Study|Other AE|0|||
37864592|NCT01206816|69548226|FG002|Overall Study|Other AE|4|||
37813481|NCT03336866|69491310|FG002|Overall Study|Withdrawal by Subject|0|||
37813482|NCT03336866|69491308|FG000|Overall Study|Noncompliance with clinic house rules|0|||
37813483|NCT03336866|69491309|FG001|Overall Study|Noncompliance with clinic house rules|0|||
37813484|NCT03336866|69491310|FG002|Overall Study|Noncompliance with clinic house rules|1|||
37813485|NCT03332173|69491323|FG000|Overall Study|Death|7|||
37813486|NCT03332173|69491323|FG000|Overall Study|Withdrawal by Subject|6|||
37813487|NCT03332173|69491323|FG000|Overall Study|Lost to Follow-up|2|||
37813488|NCT03332173|69491323|FG000|Overall Study|Transferred to long-term extension study|29|||
37813489|NCT03322293|69491330|FG000|Overall Study|Lost to Follow-up|0|||
37813490|NCT03322293|69491331|FG001|Overall Study|Lost to Follow-up|0|||
37813491|NCT03322293|69491332|FG002|Overall Study|Lost to Follow-up|1|||
37694660|NCT02485691|69171183|FG000|Overall Study|Adverse Event|25|||
37813492|NCT03254394|69491354|FG000|Overall Study|Withdrawal by Subject|0|||
37813493|NCT03254394|69491355|FG001|Overall Study|Withdrawal by Subject|2|||
37864593|NCT01206816|69548227|FG003|Overall Study|Other AE|0|||
37864594|NCT01206816|69548228|FG004|Overall Study|Other AE|0|||
37864595|NCT01206816|69548229|FG005|Overall Study|Other AE|3|||
37864596|NCT01206816|69548230|FG006|Overall Study|Other AE|2|||
37864597|NCT01206816|69548224|FG000|Overall Study|other than stated above|0|||
37864598|NCT01206816|69548225|FG001|Overall Study|other than stated above|0|||
37813494|NCT03253809|69491361|FG000|Overall Study|Unable to obtain study related data|14|||
37864599|NCT01206816|69548226|FG002|Overall Study|other than stated above|1|||
37864600|NCT01206816|69548227|FG003|Overall Study|other than stated above|0|||
37864601|NCT01206816|69548228|FG004|Overall Study|other than stated above|0|||
37864602|NCT01206816|69548229|FG005|Overall Study|other than stated above|0|||
37864603|NCT01206816|69548230|FG006|Overall Study|other than stated above|1|||
37864604|NCT01206582|69548252|FG000|Overall Study|Withdrew prior to study|1|||
37864605|NCT01206582|69548253|FG001|Overall Study|Withdrew prior to study|0|||
37864606|NCT01206582|69548252|FG000|Overall Study|Discontinued intervention before week 8|1|||
37864607|NCT01206582|69548253|FG001|Overall Study|Discontinued intervention before week 8|2|||
37864608|NCT01259102|69548264|FG000|Overall Study|Adverse Event|1|||
37864609|NCT01259102|69548265|FG001|Overall Study|Adverse Event|0|||
37864610|NCT01259102|69548266|FG002|Overall Study|Adverse Event|1|||
37864611|NCT01259102|69548267|FG003|Overall Study|Adverse Event|1|||
37864612|NCT01259102|69548268|FG004|Overall Study|Adverse Event|0|||
37864613|NCT01259102|69548264|FG000|Overall Study|Other|0|||
37864614|NCT01259102|69548265|FG001|Overall Study|Other|0|||
37864615|NCT01259102|69548266|FG002|Overall Study|Other|1|||
37813495|NCT02998476|69491440|FG000|Overall Study|Lost to Follow-up|1|||
37813496|NCT02998476|69491441|FG001|Overall Study|Lost to Follow-up|0|||
37813497|NCT02998476|69491440|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
37813498|NCT02998476|69491441|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
37813499|NCT02998476|69491440|FG000|Overall Study|Withdrawal by Subject|1|||
37813500|NCT02998476|69491441|FG001|Overall Study|Withdrawal by Subject|2|||
37813501|NCT02998476|69491440|FG000|Overall Study|Death|45|||
37864616|NCT01259102|69548267|FG003|Overall Study|Other|1|||
37864617|NCT01259102|69548268|FG004|Overall Study|Other|1|||
37864618|NCT00978250|69548284|FG000|Overall Study|Late determination of ineligibility|0|||
37813502|NCT02998476|69491441|FG001|Overall Study|Death|2|||
37813503|NCT02998476|69491440|FG000|Overall Study|Other|6|||
37813504|NCT02998476|69491441|FG001|Overall Study|Other|1|||
37813505|NCT02924064|69491459|FG000|Overall Study|Adverse Event|2|||
37813506|NCT02924064|69491460|FG001|Overall Study|Adverse Event|2|||
37813507|NCT02924064|69491459|FG000|Overall Study|Lost to Follow-up|0|||
37813508|NCT02924064|69491460|FG001|Overall Study|Lost to Follow-up|2|||
37813509|NCT02924064|69491459|FG000|Overall Study|Physician Decision|0|||
37813510|NCT02924064|69491460|FG001|Overall Study|Physician Decision|2|||
37813511|NCT02924064|69491459|FG000|Overall Study|Protocol Violation|1|||
37813512|NCT02924064|69491460|FG001|Overall Study|Protocol Violation|3|||
37813513|NCT02924064|69491459|FG000|Overall Study|Withdrawal by Subject|4|||
37813514|NCT02924064|69491460|FG001|Overall Study|Withdrawal by Subject|5|||
37813515|NCT02924064|69491459|FG000|Overall Study|Other|17|||
37813516|NCT02924064|69491460|FG001|Overall Study|Other|29|||
37813517|NCT02916706|69491468|FG000|Overall Study|Adverse Event|0|||
37813518|NCT02916706|69491469|FG001|Overall Study|Adverse Event|1|||
37813519|NCT02916706|69491468|FG000|Overall Study|Lost to Follow-up|0|||
37813520|NCT02916706|69491469|FG001|Overall Study|Lost to Follow-up|1|||
37813521|NCT02916706|69491468|FG000|Overall Study|Physician Decision|1|||
37813522|NCT02916706|69491469|FG001|Overall Study|Physician Decision|0|||
37813523|NCT02916706|69491468|FG000|Overall Study|Protocol Violation|3|||
37813524|NCT02916706|69491469|FG001|Overall Study|Protocol Violation|1|||
37813525|NCT02916706|69491468|FG000|Overall Study|Withdrawal by Subject|6|||
37813526|NCT02916706|69491469|FG001|Overall Study|Withdrawal by Subject|9|||
37813527|NCT02916706|69491468|FG000|Overall Study|Other|5|||
37813528|NCT02916706|69491469|FG001|Overall Study|Other|19|||
37813529|NCT02889900|69491475|FG000|Overall Study|Adverse Event|11|||
37813530|NCT02889900|69491475|FG000|Overall Study|Condition under investigation worsened|32|||
37813531|NCT02889900|69491475|FG000|Overall Study|Other|5|||
37813532|NCT02889900|69491475|FG000|Overall Study|Withdrawal by Subject|7|||
37813533|NCT02889900|69491475|FG000|Overall Study|Not treated|2|||
37813534|NCT02866695|69491479|FG000|Overall Study|Adverse Event|1|||
37813535|NCT02866695|69491479|FG000|Overall Study|Lost to Follow-up|1|||
37813536|NCT02834793|69491485|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
37813537|NCT02834793|69491486|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
37813538|NCT02834793|69491487|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
37813539|NCT02834793|69491488|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
37813540|NCT02834793|69491485|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
37813541|NCT02834793|69491486|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
37813542|NCT02834793|69491487|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
37813543|NCT02834793|69491488|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
37813544|NCT02834793|69491485|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
37813545|NCT02834793|69491486|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
37813546|NCT02834793|69491487|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
37864619|NCT00978250|69548285|FG001|Overall Study|Late determination of ineligibility|1|||
37864620|NCT00978250|69548286|FG002|Overall Study|Late determination of ineligibility|0|||
37864621|NCT00978250|69548287|FG003|Overall Study|Late determination of ineligibility|1|||
37864622|NCT01259024|69548299|FG000|Overall Study|Physician Decision|1|||
37864623|NCT01257698|69548305|FG000|Overall Study|Protocol Violation|4|||
37864624|NCT01257698|69548306|FG001|Overall Study|Protocol Violation|0|||
37864625|NCT01257542|69548314|FG000|Overall Study|Protocol Violation|3|||
37864626|NCT01257542|69548315|FG001|Overall Study|Protocol Violation|5|||
37864627|NCT01257542|69548314|FG000|Overall Study|Withdrawal by Subject|0|||
37864628|NCT01257542|69548315|FG001|Overall Study|Withdrawal by Subject|2|||
37864629|NCT01257230|69548324|FG000|Overall Study|Not Treated|0|||
37864630|NCT01257230|69548325|FG001|Overall Study|Not Treated|0|||
37864631|NCT01257230|69548326|FG002|Overall Study|Not Treated|1|||
37864632|NCT01257230|69548324|FG000|Overall Study|Adverse Event|2|||
37864633|NCT01257230|69548325|FG001|Overall Study|Adverse Event|0|||
37864634|NCT01257230|69548326|FG002|Overall Study|Adverse Event|0|||
37864635|NCT01257230|69548324|FG000|Overall Study|Lack of Efficacy|0|||
37813547|NCT02834793|69491488|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
37813548|NCT02834793|69491485|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
37813549|NCT02834793|69491486|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
37813550|NCT02834793|69491487|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
37813551|NCT02834793|69491488|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
37813552|NCT02834793|69491485|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
37813553|NCT02834793|69491486|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
37813554|NCT02834793|69491487|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
37813555|NCT02834793|69491488|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
37813556|NCT02834793|69491485|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
37813557|NCT02834793|69491486|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
37813558|NCT02834793|69491487|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
37694661|NCT02485691|69171184|FG001|Overall Study|Adverse Event|11|||
37694662|NCT02485691|69171183|FG000|Overall Study|Poor compliance to protocol|0|||
37694663|NCT02485691|69171184|FG001|Overall Study|Poor compliance to protocol|1|||
37694664|NCT02485691|69171183|FG000|Overall Study|Disease progression|57|||
37694665|NCT02485691|69171184|FG001|Overall Study|Disease progression|92|||
37694666|NCT02485691|69171183|FG000|Overall Study|Investigator's decision|23|||
37694667|NCT02485691|69171184|FG001|Overall Study|Investigator's decision|5|||
37694668|NCT02485691|69171183|FG000|Overall Study|Participant's request|13|||
37694669|NCT02485691|69171184|FG001|Overall Study|Participant's request|6|||
37694670|NCT02485691|69171183|FG000|Overall Study|Other reason|8|||
37694671|NCT02485691|69171184|FG001|Overall Study|Other reason|9|||
37694672|NCT02485691|69171183|FG000|Overall Study|Randomized and not treated|3|||
37694673|NCT02485691|69171184|FG001|Overall Study|Randomized and not treated|2|||
37694674|NCT02517515|69171193|FG000|Overall Study|Adverse Event|0|||
37694675|NCT02517515|69171194|FG001|Overall Study|Adverse Event|1|||
37813559|NCT02834793|69491488|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
37813560|NCT02834793|69491485|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
37813561|NCT02834793|69491486|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
37813562|NCT02834793|69491487|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
37864636|NCT01257230|69548325|FG001|Overall Study|Lack of Efficacy|1|||
37977699|NCT00545363|69664829|FG001|Overall Study|Withdrawal by Subject|5|||
37977700|NCT00545363|69664828|FG000|Overall Study|Non-compliance|3|||
37977701|NCT00545363|69664829|FG001|Overall Study|Non-compliance|1|||
37977702|NCT00545363|69664828|FG000|Overall Study|Did not meet entry criteria|1|||
37977703|NCT00545363|69664829|FG001|Overall Study|Did not meet entry criteria|1|||
37864637|NCT01257230|69548326|FG002|Overall Study|Lack of Efficacy|0|||
37864638|NCT01257230|69548324|FG000|Overall Study|Protocol Violation|3|||
37977704|NCT00545363|69664828|FG000|Overall Study|Lost to Follow-up|2|||
37977705|NCT00545363|69664829|FG001|Overall Study|Lost to Follow-up|0|||
37977706|NCT00545363|69664828|FG000|Overall Study|Other|1|||
37977707|NCT00545363|69664829|FG001|Overall Study|Other|1|||
37864639|NCT01257230|69548325|FG001|Overall Study|Protocol Violation|0|||
37864640|NCT01257230|69548326|FG002|Overall Study|Protocol Violation|1|||
37864641|NCT01257230|69548324|FG000|Overall Study|Withdrawal by Subject|0|||
37864642|NCT01257230|69548325|FG001|Overall Study|Withdrawal by Subject|4|||
37864643|NCT01257230|69548326|FG002|Overall Study|Withdrawal by Subject|1|||
37977708|NCT00457392|69664837|FG000|Overall Study|Objective Progression or Relapse|229|||
37977709|NCT00457392|69664838|FG001|Overall Study|Objective Progression or Relapse|296|||
37864644|NCT01257230|69548324|FG000|Overall Study|Other reason not defined above|1|||
37864645|NCT01257230|69548325|FG001|Overall Study|Other reason not defined above|5|||
37864646|NCT01257230|69548326|FG002|Overall Study|Other reason not defined above|3|||
37864647|NCT01113801|69548339|FG000|Overall Study|Adverse Event|4|||
37864648|NCT01113801|69548340|FG001|Overall Study|Adverse Event|0|||
37864649|NCT01113801|69548341|FG002|Overall Study|Adverse Event|2|||
37864650|NCT01113801|69548342|FG003|Overall Study|Adverse Event|6|||
37977710|NCT00457392|69664837|FG000|Overall Study|Death|106|||
37694676|NCT02517515|69171193|FG000|Overall Study|Withdrew Consent|0|||
37694677|NCT02517515|69171194|FG001|Overall Study|Withdrew Consent|1|||
37694678|NCT02517515|69171193|FG000|Overall Study|Lost to Follow-up|1|||
37864651|NCT01113801|69548339|FG000|Overall Study|Death|4|||
37864652|NCT01113801|69548340|FG001|Overall Study|Death|5|||
37864653|NCT01113801|69548341|FG002|Overall Study|Death|3|||
37864654|NCT01113801|69548342|FG003|Overall Study|Death|4|||
37864655|NCT01113801|69548339|FG000|Overall Study|Protocol Violation|0|||
37864656|NCT01113801|69548340|FG001|Overall Study|Protocol Violation|1|||
37864657|NCT01113801|69548341|FG002|Overall Study|Protocol Violation|0|||
37864658|NCT01113801|69548342|FG003|Overall Study|Protocol Violation|0|||
37864659|NCT01113801|69548339|FG000|Overall Study|Withdrawal by Subject|9|||
37864660|NCT01113801|69548340|FG001|Overall Study|Withdrawal by Subject|7|||
37864661|NCT01113801|69548341|FG002|Overall Study|Withdrawal by Subject|7|||
37864662|NCT01113801|69548342|FG003|Overall Study|Withdrawal by Subject|8|||
37864663|NCT01113801|69548339|FG000|Overall Study|Physician Decision|2|||
37864664|NCT01113801|69548340|FG001|Overall Study|Physician Decision|2|||
37864665|NCT01113801|69548341|FG002|Overall Study|Physician Decision|3|||
37864666|NCT01113801|69548342|FG003|Overall Study|Physician Decision|3|||
37864667|NCT01113801|69548339|FG000|Overall Study|Sponsor Decision|15|||
37864668|NCT01113801|69548340|FG001|Overall Study|Sponsor Decision|21|||
37864669|NCT01113801|69548341|FG002|Overall Study|Sponsor Decision|20|||
37864670|NCT01113801|69548342|FG003|Overall Study|Sponsor Decision|15|||
37864671|NCT01113801|69548339|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
37864672|NCT01113801|69548340|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
37864673|NCT01113801|69548341|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
37864674|NCT01113801|69548342|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
37864675|NCT01256684|69548355|FG000|Overall Study|Adverse Event|1|||
37864676|NCT01256684|69548356|FG001|Overall Study|Adverse Event|4|||
37864677|NCT01256684|69548357|FG002|Overall Study|Adverse Event|2|||
37864678|NCT01256684|69548355|FG000|Overall Study|Withdrawal by Subject|4|||
37864679|NCT01256684|69548356|FG001|Overall Study|Withdrawal by Subject|0|||
37864680|NCT01256684|69548357|FG002|Overall Study|Withdrawal by Subject|2|||
37864681|NCT01256684|69548355|FG000|Overall Study|Physician Decision|0|||
37977711|NCT00457392|69664838|FG001|Overall Study|Death|106|||
37977712|NCT00457392|69664837|FG000|Overall Study|Adverse Event|84|||
37977713|NCT00457392|69664838|FG001|Overall Study|Adverse Event|41|||
37977714|NCT00457392|69664837|FG000|Overall Study|Global Deterioration of Health Status|22|||
37977715|NCT00457392|69664838|FG001|Overall Study|Global Deterioration of Health Status|8|||
37977716|NCT00457392|69664837|FG000|Overall Study|Withdrawal by Subject|14|||
37977717|NCT00457392|69664838|FG001|Overall Study|Withdrawal by Subject|8|||
37977718|NCT00457392|69664837|FG000|Overall Study|Lost to Follow-up|6|||
37977719|NCT00457392|69664838|FG001|Overall Study|Lost to Follow-up|7|||
37977720|NCT00457392|69664837|FG000|Overall Study|Protocol Violation|4|||
37977721|NCT00457392|69664838|FG001|Overall Study|Protocol Violation|3|||
37977722|NCT00457392|69664837|FG000|Overall Study|Other|7|||
37977723|NCT00457392|69664838|FG001|Overall Study|Other|4|||
37977724|NCT00457392|69664837|FG000|Overall Study|Study Terminated by Sponsor|1|||
37977725|NCT00457392|69664838|FG001|Overall Study|Study Terminated by Sponsor|4|||
37977726|NCT00457392|69664837|FG000|Overall Study|Randomized, Not Treated|7|||
37977727|NCT00457392|69664838|FG001|Overall Study|Randomized, Not Treated|3|||
37977728|NCT00545051|69664846|FG000|Overall Study|Adverse Event|7|||
37977729|NCT00545051|69664847|FG001|Overall Study|Adverse Event|3|||
37977730|NCT00545051|69664846|FG000|Overall Study|Death|1|||
37864682|NCT01256684|69548356|FG001|Overall Study|Physician Decision|1|||
37864683|NCT01256684|69548357|FG002|Overall Study|Physician Decision|0|||
37864684|NCT01256684|69548355|FG000|Overall Study|Lack of Efficacy|0|||
37864685|NCT01256684|69548356|FG001|Overall Study|Lack of Efficacy|1|||
37864686|NCT01256684|69548357|FG002|Overall Study|Lack of Efficacy|1|||
37864687|NCT01256684|69548355|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
37864688|NCT01256684|69548356|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
37864689|NCT01256684|69548357|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
37864690|NCT01204710|69548367|FG000|Randomization Treatment|Lost to Follow-up|1|||
37864691|NCT01204710|69548368|FG001|Randomization Treatment|Lost to Follow-up|0|||
37864692|NCT01204710|69548367|FG000|Randomization Treatment|Withdrawal by Subject|6|||
37864693|NCT01204710|69548368|FG001|Randomization Treatment|Withdrawal by Subject|5|||
37864694|NCT01204710|69548367|FG000|Randomization Treatment|Physician Decision|3|||
37864695|NCT01204710|69548368|FG001|Randomization Treatment|Physician Decision|2|||
37977731|NCT00545051|69664847|FG001|Overall Study|Death|0|||
37977732|NCT00545051|69664846|FG000|Overall Study|Violation of inclusion/exclusion|0|||
37977733|NCT00545051|69664847|FG001|Overall Study|Violation of inclusion/exclusion|2|||
37864696|NCT01204710|69548367|FG000|Randomization Treatment|Entry criteria not met|0|||
37977734|NCT00545051|69664846|FG000|Overall Study|Protocol Violation|1|||
37977735|NCT00545051|69664847|FG001|Overall Study|Protocol Violation|0|||
37694679|NCT02517515|69171194|FG001|Overall Study|Lost to Follow-up|0|||
37813563|NCT02834793|69491488|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
37813564|NCT02834793|69491485|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
37813565|NCT02834793|69491486|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
37813566|NCT02834793|69491487|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
37813567|NCT02834793|69491488|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
37813568|NCT02834793|69491485|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
37813569|NCT02834793|69491486|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
37813570|NCT02834793|69491487|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
37813571|NCT02834793|69491488|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
37813572|NCT02834793|69491485|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
37813573|NCT02834793|69491486|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
37813574|NCT02834793|69491487|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
37813575|NCT02834793|69491488|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
37813576|NCT02834793|69491485|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
37813577|NCT02834793|69491486|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
37813578|NCT02834793|69491487|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
37813579|NCT02834793|69491488|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
37813580|NCT02834793|69491485|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
37813581|NCT02834793|69491486|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
37813582|NCT02834793|69491487|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
37813583|NCT02834793|69491488|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
37813584|NCT02834793|69491485|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
37813585|NCT02834793|69491486|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
37813586|NCT02834793|69491487|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
37813587|NCT02834793|69491488|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
37813588|NCT02834793|69491485|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
37813589|NCT02834793|69491486|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
37813590|NCT02834793|69491487|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
37813591|NCT02834793|69491488|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
37813592|NCT02834793|69491485|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
37813593|NCT02834793|69491486|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
37813594|NCT02834793|69491487|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
37813595|NCT02834793|69491488|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
37864697|NCT01204710|69548368|FG001|Randomization Treatment|Entry criteria not met|1|||
37864698|NCT01204710|69548367|FG000|Randomization Treatment|Adverse Event|4|||
37864699|NCT01204710|69548368|FG001|Randomization Treatment|Adverse Event|2|||
37864700|NCT01204710|69548367|FG000|Randomization Treatment|Sponsor Decision|0|||
37864701|NCT01204710|69548368|FG001|Randomization Treatment|Sponsor Decision|1|||
37864702|NCT01204710|69548367|FG000|Randomization Treatment|Worsening of General condition|0|||
37864703|NCT01204710|69548368|FG001|Randomization Treatment|Worsening of General condition|1|||
37864704|NCT01204710|69548367|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
37864705|NCT01204710|69548368|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
37864706|NCT01204710|69548367|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
37813596|NCT02810457|69491498|FG000|Overall Study|Randomised but no treatment received|2|||
37813597|NCT02810457|69491499|FG001|Overall Study|Randomised but no treatment received|1|||
37864707|NCT01204710|69548368|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
37864708|NCT01204710|69548367|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
37864709|NCT01204710|69548368|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
37864710|NCT01204710|69548367|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
37813598|NCT02810457|69491498|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
37813599|NCT02810457|69491499|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
37813600|NCT02810457|69491498|FG000|Overall Study|Adverse Event|37|||
37813601|NCT02810457|69491499|FG001|Overall Study|Adverse Event|43|||
37813602|NCT02810457|69491498|FG000|Overall Study|Patient decision|31|||
37813603|NCT02810457|69491499|FG001|Overall Study|Patient decision|35|||
37813604|NCT02810457|69491498|FG000|Overall Study|Patient lost to follow-up|2|||
37864711|NCT01204710|69548368|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
37864712|NCT01256450|69548383|FG000|Open-label Titration|Adverse Event|39|||
37864713|NCT01256450|69548384|FG001|Open-label Titration|Adverse Event|0|||
37864714|NCT01256450|69548385|FG002|Open-label Titration|Adverse Event|0|||
37864715|NCT01256450|69548383|FG000|Open-label Titration|Lost to Follow-up|7|||
37864716|NCT01256450|69548384|FG001|Open-label Titration|Lost to Follow-up|0|||
37864717|NCT01256450|69548385|FG002|Open-label Titration|Lost to Follow-up|0|||
37977736|NCT00545051|69664846|FG000|Overall Study|Withdrawal by Subject|0|||
37977737|NCT00545051|69664847|FG001|Overall Study|Withdrawal by Subject|1|||
37977738|NCT00545051|69664846|FG000|Overall Study|Administrative reasons|0|||
37977739|NCT00545051|69664847|FG001|Overall Study|Administrative reasons|1|||
37864718|NCT01256450|69548383|FG000|Open-label Titration|Lack of analgesic effect|30|||
37864719|NCT01256450|69548384|FG001|Open-label Titration|Lack of analgesic effect|0|||
37864720|NCT01256450|69548385|FG002|Open-label Titration|Lack of analgesic effect|0|||
37864721|NCT01256450|69548383|FG000|Open-label Titration|Non-compliance|9|||
37864722|NCT01256450|69548384|FG001|Open-label Titration|Non-compliance|0|||
37864723|NCT01256450|69548385|FG002|Open-label Titration|Non-compliance|0|||
37864724|NCT01256450|69548383|FG000|Open-label Titration|Screen failure|1|||
37864725|NCT01256450|69548384|FG001|Open-label Titration|Screen failure|0|||
37864726|NCT01256450|69548385|FG002|Open-label Titration|Screen failure|0|||
37864727|NCT01256450|69548383|FG000|Open-label Titration|Other|13|||
37864728|NCT01256450|69548384|FG001|Open-label Titration|Other|0|||
37864729|NCT01256450|69548385|FG002|Open-label Titration|Other|0|||
37864730|NCT01256450|69548383|FG000|Double-blind Treatment|Adverse Event|0|||
37864731|NCT01256450|69548384|FG001|Double-blind Treatment|Adverse Event|8|||
37864732|NCT01256450|69548385|FG002|Double-blind Treatment|Adverse Event|6|||
37864733|NCT01256450|69548383|FG000|Double-blind Treatment|Lost to Follow-up|0|||
37864734|NCT01256450|69548384|FG001|Double-blind Treatment|Lost to Follow-up|1|||
37864735|NCT01256450|69548385|FG002|Double-blind Treatment|Lost to Follow-up|7|||
37864736|NCT01256450|69548383|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
37864737|NCT01256450|69548384|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
37864738|NCT01256450|69548385|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
37864739|NCT01256450|69548383|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
37864740|NCT01256450|69548384|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
37864741|NCT01256450|69548385|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
37864742|NCT01256450|69548383|FG000|Double-blind Treatment|Non-compliance|0|||
37864743|NCT01256450|69548384|FG001|Double-blind Treatment|Non-compliance|5|||
37864744|NCT01256450|69548385|FG002|Double-blind Treatment|Non-compliance|4|||
37977740|NCT00381615|69664857|FG000|Overall Study|Withdrawal by Subject|1|||
37977741|NCT00381615|69664858|FG001|Overall Study|Withdrawal by Subject|3|||
37977742|NCT00381615|69664859|FG002|Overall Study|Withdrawal by Subject|0|||
37813605|NCT02810457|69491499|FG001|Overall Study|Patient lost to follow-up|2|||
37864745|NCT01256450|69548383|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
37813606|NCT02810457|69491498|FG000|Overall Study|Death|39|||
37813607|NCT02810457|69491499|FG001|Overall Study|Death|28|||
37813608|NCT02810457|69491498|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
37813609|NCT02810457|69491499|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
37813610|NCT02810457|69491498|FG000|Overall Study|Clinical progression|15|||
37813611|NCT02810457|69491499|FG001|Overall Study|Clinical progression|16|||
37813612|NCT02810457|69491498|FG000|Overall Study|Investigator decision|3|||
37813613|NCT02810457|69491499|FG001|Overall Study|Investigator decision|2|||
37813614|NCT02810457|69491498|FG000|Overall Study|Patient ineligibility|3|||
37813615|NCT02810457|69491499|FG001|Overall Study|Patient ineligibility|0|||
37813616|NCT02810457|69491498|FG000|Overall Study|Miscalculated PD|1|||
37813617|NCT02810457|69491499|FG001|Overall Study|Miscalculated PD|0|||
37813618|NCT02810457|69491498|FG000|Overall Study|Physician Decision|0|||
37813619|NCT02810457|69491499|FG001|Overall Study|Physician Decision|1|||
37813620|NCT02745535|69491505|FG000|Overall Study|Death|1|||
37813621|NCT02745535|69491505|FG000|Overall Study|Adverse Event|3|||
37813622|NCT02745535|69491505|FG000|Overall Study|Lost to Follow-up|2|||
37813623|NCT02625090|69491539|FG000|Overall Study|Participant wants to be pregnant|2|||
37813624|NCT02625090|69491539|FG000|Overall Study|For the Promoter|1|||
37813625|NCT02625090|69491539|FG000|Overall Study|Sponsor's Decision|9|||
37864746|NCT01256450|69548384|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
37864747|NCT01256450|69548385|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
37864748|NCT01256450|69548383|FG000|Double-blind Treatment|Other|0|||
37864749|NCT01256450|69548384|FG001|Double-blind Treatment|Other|9|||
37864750|NCT01256450|69548385|FG002|Double-blind Treatment|Other|12|||
37864751|NCT01204398|69548392|FG000|Overall Study|Adverse Event|1|||
37864752|NCT01111851|69548398|FG000|Overall Study|All planned PET scans were not obtained.|2|||
37864753|NCT01111851|69548399|FG001|Overall Study|All planned PET scans were not obtained.|0|||
37864754|NCT01256294|69548405|FG000|Overall Study|Adverse Event|1|||
37813626|NCT02625090|69491539|FG000|Overall Study|Somnolence|1|||
37864755|NCT01256294|69548406|FG001|Overall Study|Adverse Event|0|||
37864756|NCT01256294|69548405|FG000|Overall Study|Withdrawal by Subject|1|||
37864757|NCT01256294|69548406|FG001|Overall Study|Withdrawal by Subject|1|||
37864758|NCT01256294|69548405|FG000|Overall Study|Protocol deviation|2|||
37864759|NCT01256294|69548406|FG001|Overall Study|Protocol deviation|1|||
37977743|NCT00381615|69664860|FG003|Overall Study|Withdrawal by Subject|1|||
37813627|NCT02625090|69491539|FG000|Overall Study|Study terminated by Sponsor|7|||
37813628|NCT02625090|69491539|FG000|Overall Study|Negative Benefit/Risk|1|||
37864760|NCT01256060|69548412|FG000|Overall Study|Lost to Follow-up|0|||
37864761|NCT01256060|69548413|FG001|Overall Study|Lost to Follow-up|1|||
37864762|NCT01256060|69548414|FG002|Overall Study|Lost to Follow-up|0|||
37864763|NCT01256060|69548415|FG003|Overall Study|Lost to Follow-up|0|||
37864764|NCT01255904|69548423|FG000|Overall Study|Physician Decision|1|||
37864765|NCT01255904|69548424|FG001|Overall Study|Physician Decision|4|||
37864766|NCT01255670|69548432|FG000|Overall Study|Adverse Event|10|||
37864767|NCT01255670|69548433|FG001|Overall Study|Adverse Event|10|||
37864768|NCT01255670|69548432|FG000|Overall Study|Lost to Follow-up|16|||
37864769|NCT01255670|69548433|FG001|Overall Study|Lost to Follow-up|10|||
37864770|NCT01255592|69548441|FG000|Overall Study|Adverse Event|5|||
37864771|NCT01255592|69548442|FG001|Overall Study|Adverse Event|0|||
37864772|NCT01255592|69548441|FG000|Overall Study|Withdrawal by Subject|1|||
37864773|NCT01255592|69548442|FG001|Overall Study|Withdrawal by Subject|0|||
37864774|NCT01255592|69548441|FG000|Overall Study|Other|0|||
37864775|NCT01255592|69548442|FG001|Overall Study|Other|1|||
37864776|NCT01255436|69548451|FG000|Overall Study|Lost to Follow-up|178|||
37864777|NCT01255436|69548452|FG001|Overall Study|Lost to Follow-up|191|||
37864778|NCT01255436|69548451|FG000|Overall Study|Death, stroke, or MI|4|||
37864779|NCT01255436|69548452|FG001|Overall Study|Death, stroke, or MI|3|||
37864780|NCT01203930|69548460|FG000|Overall Study|Disease Progression|0|||
37864781|NCT01203930|69548461|FG001|Overall Study|Disease Progression|4|||
37864782|NCT01203930|69548460|FG000|Overall Study|Death|3|||
37864783|NCT01203930|69548461|FG001|Overall Study|Death|1|||
37864784|NCT01203930|69548460|FG000|Overall Study|Withdrew Consent|1|||
37864785|NCT01203930|69548461|FG001|Overall Study|Withdrew Consent|10|||
37864786|NCT01203930|69548460|FG000|Overall Study|Investigator Request|0|||
37864787|NCT01203930|69548461|FG001|Overall Study|Investigator Request|8|||
37864788|NCT01203930|69548460|FG000|Overall Study|Study Terminated by Sponsor|0|||
37864789|NCT01203930|69548461|FG001|Overall Study|Study Terminated by Sponsor|12|||
37864790|NCT01203930|69548460|FG000|Overall Study|Poor tolerance of study drug|0|||
37864791|NCT01203930|69548461|FG001|Overall Study|Poor tolerance of study drug|1|||
37864792|NCT01203930|69548460|FG000|Overall Study|Adverse Event|17|||
37864793|NCT01203930|69548461|FG001|Overall Study|Adverse Event|5|||
37864794|NCT01254890|69548471|FG000|Overall Study|Ineligible|0|||
37864795|NCT01254890|69548472|FG001|Overall Study|Ineligible|3|||
37864796|NCT01254890|69548471|FG000|Overall Study|Withdrawal by Subject|1|||
37864797|NCT01254890|69548472|FG001|Overall Study|Withdrawal by Subject|2|||
37864798|NCT01254890|69548471|FG000|Overall Study|Disease Progression|0|||
37864799|NCT01254890|69548472|FG001|Overall Study|Disease Progression|5|||
37864800|NCT01203852|69548477|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
37864801|NCT01203852|69548477|FG000|Washout 2 Weeks|Physician Decision|46|||
37864802|NCT01105533|69548484|FG000|Overall Study|Death|0|||
37864803|NCT01105533|69548485|FG001|Overall Study|Death|0|||
37864804|NCT01105533|69548486|FG002|Overall Study|Death|0|||
37864805|NCT01105533|69548487|FG003|Overall Study|Death|0|||
37864806|NCT01105533|69548488|FG004|Overall Study|Death|1|||
37864807|NCT01105533|69548489|FG005|Overall Study|Death|0|||
37864808|NCT01105533|69548490|FG006|Overall Study|Death|0|||
37864809|NCT01105533|69548491|FG007|Overall Study|Death|0|||
37813629|NCT02625090|69491539|FG000|Overall Study|Protocol Deviation|2|||
37813630|NCT02625090|69491539|FG000|Overall Study|Lack of Efficacy|16|||
37813631|NCT02625090|69491539|FG000|Overall Study|Adverse Event|3|||
37813632|NCT02539225|69491546|FG000|Part A|Adverse Event|13|||
37813633|NCT02539225|69491547|FG001|Part A|Adverse Event|4|||
37813634|NCT02539225|69491546|FG000|Part A|Withdrawal by Subject|2|||
37813635|NCT02539225|69491547|FG001|Part A|Withdrawal by Subject|4|||
37813636|NCT02539225|69491546|FG000|Part A|Physician Decision|4|||
37813637|NCT02539225|69491547|FG001|Part A|Physician Decision|7|||
37813638|NCT02539225|69491546|FG000|Part A|Did Not Receive study Drug|1|||
37813639|NCT02539225|69491547|FG001|Part A|Did Not Receive study Drug|1|||
37813640|NCT02539225|69491546|FG000|Pre Treatment for Part B|Progressive disease|1|||
37813641|NCT02539225|69491547|FG001|Pre Treatment for Part B|Progressive disease|1|||
37864810|NCT01105533|69548492|FG008|Overall Study|Death|0|||
37864811|NCT01105533|69548484|FG000|Overall Study|Lack of Efficacy|1|||
37813642|NCT02539225|69491546|FG000|Pre Treatment for Part B|Adverse Event|1|||
37813643|NCT02539225|69491547|FG001|Pre Treatment for Part B|Adverse Event|1|||
37864812|NCT01105533|69548485|FG001|Overall Study|Lack of Efficacy|1|||
37864813|NCT01105533|69548486|FG002|Overall Study|Lack of Efficacy|3|||
37864814|NCT01105533|69548487|FG003|Overall Study|Lack of Efficacy|3|||
37864815|NCT01105533|69548488|FG004|Overall Study|Lack of Efficacy|4|||
37864816|NCT01105533|69548489|FG005|Overall Study|Lack of Efficacy|5|||
37864817|NCT01105533|69548490|FG006|Overall Study|Lack of Efficacy|3|||
37864818|NCT01105533|69548491|FG007|Overall Study|Lack of Efficacy|2|||
37864819|NCT01105533|69548492|FG008|Overall Study|Lack of Efficacy|9|||
37813644|NCT02539225|69491546|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
37813645|NCT02539225|69491547|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
37813646|NCT02539225|69491546|FG000|Pre Treatment for Part B|Physician Decision|2|||
37813647|NCT02539225|69491547|FG001|Pre Treatment for Part B|Physician Decision|0|||
37813648|NCT02539225|69491546|FG000|Part B|Adverse Event|4|||
37813649|NCT02539225|69491547|FG001|Part B|Adverse Event|4|||
37813650|NCT02539225|69491546|FG000|Part B|Withdrawal by Subject|0|||
37813651|NCT02539225|69491547|FG001|Part B|Withdrawal by Subject|3|||
37813652|NCT02539225|69491546|FG000|Part B|Physician Decision|0|||
37813653|NCT02539225|69491547|FG001|Part B|Physician Decision|9|||
37813654|NCT02526017|69491567|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
37813655|NCT02526017|69491568|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
37813656|NCT02526017|69491569|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
37813657|NCT02526017|69491570|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
37813658|NCT02526017|69491571|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
37813659|NCT02526017|69491572|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
37813660|NCT02526017|69491573|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
37813661|NCT02526017|69491574|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
37813662|NCT02526017|69491575|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
37813663|NCT02369653|69491644|FG000|Overall Study|Lost to Follow-up|0|||
37813664|NCT02369653|69491645|FG001|Overall Study|Lost to Follow-up|1|||
37813665|NCT02369653|69491644|FG000|Overall Study|Administrative reason by sponsor|0|||
37813666|NCT02369653|69491645|FG001|Overall Study|Administrative reason by sponsor|1|||
37813667|NCT02369653|69491644|FG000|Overall Study|Death|1|||
37813668|NCT02369653|69491645|FG001|Overall Study|Death|2|||
37813669|NCT02369653|69491644|FG000|Overall Study|Participant withdrew consent|13|||
37813670|NCT02369653|69491645|FG001|Overall Study|Participant withdrew consent|3|||
37813671|NCT02284568|69491658|FG000|Overall Study|Adverse Event|2|||
37813672|NCT02284568|69491659|FG001|Overall Study|Adverse Event|9|||
37813673|NCT02284568|69491660|FG002|Overall Study|Adverse Event|4|||
37813674|NCT02284568|69491658|FG000|Overall Study|Withdrawal by Subject|22|||
37813675|NCT02284568|69491659|FG001|Overall Study|Withdrawal by Subject|21|||
37813676|NCT02284568|69491660|FG002|Overall Study|Withdrawal by Subject|1|||
37813677|NCT02284568|69491658|FG000|Overall Study|Noncompliance with study drug admin|1|||
37813678|NCT02284568|69491659|FG001|Overall Study|Noncompliance with study drug admin|2|||
37813679|NCT02284568|69491660|FG002|Overall Study|Noncompliance with study drug admin|0|||
37813680|NCT02284568|69491658|FG000|Overall Study|Noncompliance|1|||
37813681|NCT02284568|69491659|FG001|Overall Study|Noncompliance|0|||
37813682|NCT02284568|69491660|FG002|Overall Study|Noncompliance|0|||
37813683|NCT02284568|69491658|FG000|Overall Study|Protocol Violation|0|||
37813684|NCT02284568|69491659|FG001|Overall Study|Protocol Violation|1|||
37813685|NCT02284568|69491660|FG002|Overall Study|Protocol Violation|0|||
37813686|NCT02284568|69491658|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
37813687|NCT02284568|69491659|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
37813688|NCT02284568|69491660|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
37813689|NCT02284568|69491658|FG000|Overall Study|Lost to Follow-up|0|||
37813690|NCT02284568|69491659|FG001|Overall Study|Lost to Follow-up|3|||
37813691|NCT02284568|69491660|FG002|Overall Study|Lost to Follow-up|0|||
37813692|NCT02284568|69491658|FG000|Overall Study|Lack of Efficacy|4|||
37813693|NCT02284568|69491659|FG001|Overall Study|Lack of Efficacy|7|||
37813694|NCT02284568|69491660|FG002|Overall Study|Lack of Efficacy|0|||
37813695|NCT02284568|69491658|FG000|Overall Study|Other|1|||
37813696|NCT02284568|69491659|FG001|Overall Study|Other|2|||
37813697|NCT02284568|69491660|FG002|Overall Study|Other|0|||
37813698|NCT02284568|69491658|FG000|Overall Study|Withdrew before taking study drug|0|||
37813699|NCT02284568|69491659|FG001|Overall Study|Withdrew before taking study drug|1|||
37813700|NCT02284568|69491660|FG002|Overall Study|Withdrew before taking study drug|0|||
37813701|NCT02195986|69491675|FG000|Overall Study|Adverse Event|3|||
37813702|NCT02195986|69491676|FG001|Overall Study|Adverse Event|0|||
37813703|NCT02195986|69491677|FG002|Overall Study|Adverse Event|0|||
37864820|NCT01105533|69548484|FG000|Overall Study|Adverse Event|0|||
37977744|NCT00381615|69664857|FG000|Overall Study|Lost to Follow-up|3|||
37977745|NCT00381615|69664858|FG001|Overall Study|Lost to Follow-up|2|||
37813704|NCT02195986|69491675|FG000|Overall Study|Withdrawal by Subject|0|||
37813705|NCT02195986|69491676|FG001|Overall Study|Withdrawal by Subject|3|||
37813706|NCT02195986|69491677|FG002|Overall Study|Withdrawal by Subject|0|||
37813707|NCT02195986|69491675|FG000|Overall Study|Family Emergency|0|||
37813708|NCT02195986|69491676|FG001|Overall Study|Family Emergency|0|||
37813709|NCT02195986|69491677|FG002|Overall Study|Family Emergency|1|||
37864821|NCT01105533|69548485|FG001|Overall Study|Adverse Event|0|||
37813710|NCT02195986|69491675|FG000|Overall Study|Protocol Violation|0|||
37813711|NCT02195986|69491676|FG001|Overall Study|Protocol Violation|1|||
37813712|NCT02195986|69491677|FG002|Overall Study|Protocol Violation|1|||
37813713|NCT02195986|69491675|FG000|Overall Study|Non-compliance|0|||
37864822|NCT01105533|69548486|FG002|Overall Study|Adverse Event|0|||
37813714|NCT02195986|69491676|FG001|Overall Study|Non-compliance|1|||
37813715|NCT02195986|69491677|FG002|Overall Study|Non-compliance|0|||
37813716|NCT01982630|69491693|FG000|Overall Study|Adverse Event|2|||
37864823|NCT01105533|69548487|FG003|Overall Study|Adverse Event|0|||
37864824|NCT01105533|69548488|FG004|Overall Study|Adverse Event|1|||
37864825|NCT01105533|69548489|FG005|Overall Study|Adverse Event|2|||
37864826|NCT01105533|69548490|FG006|Overall Study|Adverse Event|2|||
37864827|NCT01105533|69548491|FG007|Overall Study|Adverse Event|0|||
37864828|NCT01105533|69548492|FG008|Overall Study|Adverse Event|1|||
37977746|NCT00381615|69664859|FG002|Overall Study|Lost to Follow-up|0|||
37977747|NCT00381615|69664860|FG003|Overall Study|Lost to Follow-up|1|||
37977748|NCT00381615|69664857|FG000|Overall Study|Protocol Violation|0|||
37977749|NCT00381615|69664858|FG001|Overall Study|Protocol Violation|0|||
37977750|NCT00381615|69664859|FG002|Overall Study|Protocol Violation|1|||
37977751|NCT00381615|69664860|FG003|Overall Study|Protocol Violation|0|||
37977752|NCT00371865|69664874|FG000|Overall Study|Lack of Efficacy|0|||
37977753|NCT00371865|69664875|FG001|Overall Study|Lack of Efficacy|2|||
37977754|NCT00371865|69664874|FG000|Overall Study|Protocol Violation|3|||
37977755|NCT00371865|69664875|FG001|Overall Study|Protocol Violation|2|||
37977756|NCT00371865|69664874|FG000|Overall Study|Withdrawal by Subject|12|||
37977757|NCT00371865|69664875|FG001|Overall Study|Withdrawal by Subject|10|||
37977758|NCT00364845|69664883|FG000|Overall Study|Adverse Event|1|||
37813717|NCT01982630|69491694|FG001|Overall Study|Adverse Event|0|||
37813718|NCT01982630|69491695|FG002|Overall Study|Adverse Event|1|||
37813719|NCT01982630|69491696|FG003|Overall Study|Adverse Event|0|||
37813720|NCT01982630|69491697|FG004|Overall Study|Adverse Event|1|||
37813721|NCT01982630|69491698|FG005|Overall Study|Adverse Event|2|||
37813722|NCT01982630|69491699|FG006|Overall Study|Adverse Event|1|||
37813723|NCT01982630|69491700|FG007|Overall Study|Adverse Event|0|||
37813724|NCT01982630|69491693|FG000|Overall Study|Physician Decision|1|||
37813725|NCT01982630|69491694|FG001|Overall Study|Physician Decision|0|||
37813726|NCT01982630|69491695|FG002|Overall Study|Physician Decision|2|||
37813727|NCT01982630|69491696|FG003|Overall Study|Physician Decision|1|||
37813728|NCT01982630|69491697|FG004|Overall Study|Physician Decision|2|||
37813729|NCT01982630|69491698|FG005|Overall Study|Physician Decision|0|||
37813730|NCT01982630|69491699|FG006|Overall Study|Physician Decision|0|||
37813731|NCT01982630|69491700|FG007|Overall Study|Physician Decision|0|||
37813732|NCT01982630|69491693|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
37813733|NCT01982630|69491694|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
37813734|NCT01982630|69491695|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
37813735|NCT01982630|69491696|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
37813736|NCT01982630|69491697|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
37813737|NCT01982630|69491698|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
37813738|NCT01982630|69491699|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
37813739|NCT01982630|69491700|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
37813740|NCT01982630|69491693|FG000|Overall Study|Withdrawal by Subject|0|||
37813741|NCT01982630|69491694|FG001|Overall Study|Withdrawal by Subject|0|||
37813742|NCT01982630|69491695|FG002|Overall Study|Withdrawal by Subject|0|||
37813743|NCT01982630|69491696|FG003|Overall Study|Withdrawal by Subject|0|||
37813744|NCT01982630|69491697|FG004|Overall Study|Withdrawal by Subject|0|||
37813745|NCT01982630|69491698|FG005|Overall Study|Withdrawal by Subject|1|||
37813746|NCT01982630|69491699|FG006|Overall Study|Withdrawal by Subject|0|||
37813747|NCT01982630|69491700|FG007|Overall Study|Withdrawal by Subject|0|||
37813748|NCT01740297|69491765|FG000|Overall Study|Withdrawal by Subject|4|||
37813749|NCT01740297|69491766|FG001|Overall Study|Withdrawal by Subject|16|||
37977759|NCT00364845|69664884|FG001|Overall Study|Adverse Event|0|||
37813750|NCT01740297|69491767|FG002|Overall Study|Withdrawal by Subject|17|||
37977760|NCT00364845|69664883|FG000|Overall Study|Withdrawal by Subject|2|||
37977761|NCT00364845|69664884|FG001|Overall Study|Withdrawal by Subject|1|||
37977762|NCT00364845|69664883|FG000|Overall Study|Physician Decision|8|||
37864829|NCT01105533|69548484|FG000|Overall Study|Other|0|||
37864830|NCT01105533|69548485|FG001|Overall Study|Other|0|||
37977763|NCT00364845|69664884|FG001|Overall Study|Physician Decision|8|||
37977764|NCT00364845|69664883|FG000|Overall Study|Lost to Follow-up|0|||
37977765|NCT00364845|69664884|FG001|Overall Study|Lost to Follow-up|1|||
37977766|NCT00364845|69664883|FG000|Overall Study|Death|0|||
37977767|NCT00364845|69664884|FG001|Overall Study|Death|1|||
37977768|NCT00293722|69664890|FG000|Overall Study|Other|427|||
37977769|NCT00381303|69664896|FG000|Overall Study|Lost to Follow-up|25|||
37813751|NCT01740297|69491765|FG000|Overall Study|Death|8|||
37813752|NCT01740297|69491766|FG001|Overall Study|Death|46|||
37813753|NCT01740297|69491767|FG002|Overall Study|Death|40|||
37864831|NCT01105533|69548486|FG002|Overall Study|Other|0|||
37864832|NCT01105533|69548487|FG003|Overall Study|Other|0|||
37864833|NCT01105533|69548488|FG004|Overall Study|Other|1|||
37864834|NCT01105533|69548489|FG005|Overall Study|Other|0|||
37864835|NCT01105533|69548490|FG006|Overall Study|Other|3|||
37864836|NCT01105533|69548491|FG007|Overall Study|Other|1|||
37864837|NCT01105533|69548492|FG008|Overall Study|Other|2|||
37864838|NCT01105533|69548484|FG000|Overall Study|Physician Decision|0|||
37864839|NCT01105533|69548485|FG001|Overall Study|Physician Decision|0|||
37864840|NCT01105533|69548486|FG002|Overall Study|Physician Decision|0|||
37864841|NCT01105533|69548487|FG003|Overall Study|Physician Decision|0|||
37864842|NCT01105533|69548488|FG004|Overall Study|Physician Decision|0|||
37864843|NCT01105533|69548489|FG005|Overall Study|Physician Decision|0|||
37864844|NCT01105533|69548490|FG006|Overall Study|Physician Decision|0|||
37864845|NCT01105533|69548491|FG007|Overall Study|Physician Decision|1|||
37864846|NCT01105533|69548492|FG008|Overall Study|Physician Decision|0|||
37864847|NCT01203072|69548510|FG000|Overall Study|Adverse Event|5|||
37864848|NCT01203072|69548511|FG001|Overall Study|Adverse Event|3|||
37864849|NCT01203072|69548512|FG002|Overall Study|Adverse Event|2|||
37864850|NCT01203072|69548513|FG003|Overall Study|Adverse Event|4|||
37864851|NCT01203072|69548514|FG004|Overall Study|Adverse Event|2|||
37864852|NCT01203072|69548510|FG000|Overall Study|Lack of Efficacy|1|||
37864853|NCT01203072|69548511|FG001|Overall Study|Lack of Efficacy|0|||
37864854|NCT01203072|69548512|FG002|Overall Study|Lack of Efficacy|0|||
37864855|NCT01203072|69548513|FG003|Overall Study|Lack of Efficacy|0|||
37813754|NCT01740297|69491765|FG000|Overall Study|Lost to Follow-up|1|||
37813755|NCT01740297|69491766|FG001|Overall Study|Lost to Follow-up|2|||
37813756|NCT01740297|69491767|FG002|Overall Study|Lost to Follow-up|4|||
37813757|NCT01729754|69491781|FG000|Part 1|Adverse Event|2|||
37813758|NCT01729754|69491782|FG001|Part 1|Adverse Event|0|||
37813759|NCT01729754|69491783|FG002|Part 1|Adverse Event|0|||
37813760|NCT01729754|69491784|FG003|Part 1|Adverse Event|1|||
37813761|NCT01729754|69491785|FG004|Part 1|Adverse Event|0|||
37813762|NCT01729754|69491786|FG005|Part 1|Adverse Event|0|||
37813763|NCT01729754|69491787|FG006|Part 1|Adverse Event|2|||
37813764|NCT01729754|69491788|FG007|Part 1|Adverse Event|0|||
37813765|NCT01729754|69491789|FG008|Part 1|Adverse Event|0|||
37813766|NCT01729754|69491790|FG009|Part 1|Adverse Event|5|||
37813767|NCT01729754|69491781|FG000|Part 1|Lack of Efficacy|1|||
37813768|NCT01729754|69491782|FG001|Part 1|Lack of Efficacy|0|||
37813769|NCT01729754|69491783|FG002|Part 1|Lack of Efficacy|0|||
37813770|NCT01729754|69491784|FG003|Part 1|Lack of Efficacy|0|||
37813771|NCT01729754|69491785|FG004|Part 1|Lack of Efficacy|0|||
37813772|NCT01729754|69491786|FG005|Part 1|Lack of Efficacy|0|||
37813773|NCT01729754|69491787|FG006|Part 1|Lack of Efficacy|2|||
37813774|NCT01729754|69491788|FG007|Part 1|Lack of Efficacy|0|||
37813775|NCT01729754|69491789|FG008|Part 1|Lack of Efficacy|0|||
37813776|NCT01729754|69491790|FG009|Part 1|Lack of Efficacy|0|||
37864856|NCT01203072|69548514|FG004|Overall Study|Lack of Efficacy|0|||
37864857|NCT01203072|69548510|FG000|Overall Study|Lost to Follow-up|0|||
37977770|NCT00381303|69664897|FG001|Overall Study|Lost to Follow-up|9|||
37864858|NCT01203072|69548511|FG001|Overall Study|Lost to Follow-up|1|||
37864859|NCT01203072|69548512|FG002|Overall Study|Lost to Follow-up|0|||
37864860|NCT01203072|69548513|FG003|Overall Study|Lost to Follow-up|0|||
37864861|NCT01203072|69548514|FG004|Overall Study|Lost to Follow-up|0|||
37864862|NCT01203072|69548510|FG000|Overall Study|Protocol Violation|2|||
37864863|NCT01203072|69548511|FG001|Overall Study|Protocol Violation|0|||
37977771|NCT00381303|69664896|FG000|Overall Study|AE/HIV-related event|22|||
37977772|NCT00381303|69664897|FG001|Overall Study|AE/HIV-related event|6|||
37977773|NCT00381303|69664896|FG000|Overall Study|Non-Adherence|13|||
37813777|NCT01729754|69491781|FG000|Part 1|Lost to Follow-up|1|||
37813778|NCT01729754|69491782|FG001|Part 1|Lost to Follow-up|0|||
37813779|NCT01729754|69491783|FG002|Part 1|Lost to Follow-up|0|||
37813780|NCT01729754|69491784|FG003|Part 1|Lost to Follow-up|2|||
37813781|NCT01729754|69491785|FG004|Part 1|Lost to Follow-up|0|||
37813782|NCT01729754|69491786|FG005|Part 1|Lost to Follow-up|0|||
37813783|NCT01729754|69491787|FG006|Part 1|Lost to Follow-up|3|||
37813784|NCT01729754|69491788|FG007|Part 1|Lost to Follow-up|0|||
37813785|NCT01729754|69491789|FG008|Part 1|Lost to Follow-up|0|||
37813786|NCT01729754|69491790|FG009|Part 1|Lost to Follow-up|3|||
37813787|NCT01729754|69491781|FG000|Part 1|Non-compliance with Study Drug|1|||
37864864|NCT01203072|69548512|FG002|Overall Study|Protocol Violation|0|||
37864865|NCT01203072|69548513|FG003|Overall Study|Protocol Violation|0|||
37864866|NCT01203072|69548514|FG004|Overall Study|Protocol Violation|1|||
37813788|NCT01729754|69491782|FG001|Part 1|Non-compliance with Study Drug|0|||
37813789|NCT01729754|69491783|FG002|Part 1|Non-compliance with Study Drug|0|||
37813790|NCT01729754|69491784|FG003|Part 1|Non-compliance with Study Drug|0|||
37813791|NCT01729754|69491785|FG004|Part 1|Non-compliance with Study Drug|0|||
37813792|NCT01729754|69491786|FG005|Part 1|Non-compliance with Study Drug|0|||
37813793|NCT01729754|69491787|FG006|Part 1|Non-compliance with Study Drug|0|||
37813794|NCT01729754|69491788|FG007|Part 1|Non-compliance with Study Drug|0|||
37813795|NCT01729754|69491789|FG008|Part 1|Non-compliance with Study Drug|0|||
37813796|NCT01729754|69491790|FG009|Part 1|Non-compliance with Study Drug|0|||
37813797|NCT01729754|69491781|FG000|Part 1|Physician Decision|0|||
37864867|NCT01203072|69548510|FG000|Overall Study|Withdrawal by Subject|2|||
37864868|NCT01203072|69548511|FG001|Overall Study|Withdrawal by Subject|2|||
37864869|NCT01203072|69548512|FG002|Overall Study|Withdrawal by Subject|1|||
37864870|NCT01203072|69548513|FG003|Overall Study|Withdrawal by Subject|2|||
37864871|NCT01203072|69548514|FG004|Overall Study|Withdrawal by Subject|3|||
37864872|NCT01105377|69548528|FG000|Overall Study|Withdrawal by Subject|0|||
37864873|NCT01105377|69548529|FG001|Overall Study|Withdrawal by Subject|1|||
37864874|NCT01105065|69548535|FG000|Overall Study|Adverse Event|5|||
37864875|NCT01105065|69548535|FG000|Overall Study|Technical Problems|1|||
37864876|NCT01111539|69548541|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
37864877|NCT01111539|69548542|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
37864878|NCT01111539|69548543|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
37864879|NCT01111539|69548544|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
37864880|NCT01111539|69548545|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
37864881|NCT01111539|69548541|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
37864882|NCT01111539|69548542|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
37864883|NCT01111539|69548543|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
37864884|NCT01111539|69548544|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
37864885|NCT01111539|69548545|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
37864886|NCT01111539|69548541|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
37864887|NCT01111539|69548542|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
37864888|NCT01111539|69548543|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
37864889|NCT01111539|69548544|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
37864890|NCT01111539|69548545|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
37864891|NCT01111539|69548541|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
37864892|NCT01111539|69548542|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
37864893|NCT01111539|69548543|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
37864894|NCT01111539|69548544|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
37864895|NCT01111539|69548545|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
37864896|NCT01111539|69548541|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
37864897|NCT01111539|69548542|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
37864898|NCT01111539|69548543|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
37864899|NCT01111539|69548544|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
37864900|NCT01111539|69548545|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
37864901|NCT01111539|69548541|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
37864902|NCT01111539|69548542|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
37864903|NCT01111539|69548543|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
37813798|NCT01729754|69491782|FG001|Part 1|Physician Decision|0|||
37813799|NCT01729754|69491783|FG002|Part 1|Physician Decision|0|||
37813800|NCT01729754|69491784|FG003|Part 1|Physician Decision|0|||
37813801|NCT01729754|69491785|FG004|Part 1|Physician Decision|0|||
37813802|NCT01729754|69491786|FG005|Part 1|Physician Decision|0|||
37813803|NCT01729754|69491787|FG006|Part 1|Physician Decision|0|||
37864904|NCT01111539|69548544|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
37864905|NCT01111539|69548545|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
37864906|NCT01111539|69548541|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
37864907|NCT01111539|69548542|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
37864908|NCT01111539|69548543|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
37864909|NCT01111539|69548544|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
37864910|NCT01111539|69548545|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
37864911|NCT01111539|69548541|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
37864912|NCT01111539|69548542|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
37813804|NCT01729754|69491788|FG007|Part 1|Physician Decision|0|||
37813805|NCT01729754|69491789|FG008|Part 1|Physician Decision|0|||
37813806|NCT01729754|69491790|FG009|Part 1|Physician Decision|4|||
37813807|NCT01729754|69491781|FG000|Part 1|Pregnancy|0|||
37813808|NCT01729754|69491782|FG001|Part 1|Pregnancy|0|||
37813809|NCT01729754|69491783|FG002|Part 1|Pregnancy|0|||
37813810|NCT01729754|69491784|FG003|Part 1|Pregnancy|1|||
37813811|NCT01729754|69491785|FG004|Part 1|Pregnancy|0|||
37813812|NCT01729754|69491786|FG005|Part 1|Pregnancy|0|||
37813813|NCT01729754|69491787|FG006|Part 1|Pregnancy|0|||
37813814|NCT01729754|69491788|FG007|Part 1|Pregnancy|0|||
37813815|NCT01729754|69491789|FG008|Part 1|Pregnancy|0|||
37813816|NCT01729754|69491790|FG009|Part 1|Pregnancy|1|||
37813817|NCT01729754|69491781|FG000|Part 1|Progressive Disease|0|||
37813818|NCT01729754|69491782|FG001|Part 1|Progressive Disease|0|||
37813819|NCT01729754|69491783|FG002|Part 1|Progressive Disease|0|||
37813820|NCT01729754|69491784|FG003|Part 1|Progressive Disease|0|||
37813821|NCT01729754|69491785|FG004|Part 1|Progressive Disease|0|||
37813822|NCT01729754|69491786|FG005|Part 1|Progressive Disease|0|||
37864913|NCT01111539|69548543|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
37864914|NCT01111539|69548544|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
37813823|NCT01729754|69491787|FG006|Part 1|Progressive Disease|0|||
37864915|NCT01111539|69548545|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
37864916|NCT01111539|69548541|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
37864917|NCT01111539|69548542|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
37864918|NCT01111539|69548543|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
37864919|NCT01111539|69548544|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
37864920|NCT01111539|69548545|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
37864921|NCT01111539|69548541|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
37864922|NCT01111539|69548542|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
37864923|NCT01111539|69548543|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
37864924|NCT01111539|69548544|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
37864925|NCT01111539|69548545|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
37864926|NCT01111539|69548541|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
37864927|NCT01111539|69548542|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
37864928|NCT01111539|69548543|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
37864929|NCT01111539|69548544|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
37864930|NCT01111539|69548545|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
37864931|NCT01111539|69548541|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
37864932|NCT01111539|69548542|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
37864933|NCT01111539|69548543|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
37864934|NCT01111539|69548544|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
37864935|NCT01111539|69548545|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
37864936|NCT01111539|69548541|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
37864937|NCT01111539|69548542|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
37864938|NCT01111539|69548543|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
37864939|NCT01111539|69548544|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
37864940|NCT01111539|69548545|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
37864941|NCT01111539|69548541|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
37864942|NCT01111539|69548542|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
37864943|NCT01111539|69548543|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
37864944|NCT01111539|69548544|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
37864945|NCT01111539|69548545|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
37864946|NCT01111149|69548558|FG000|Overall Study|Protocol Violation|1|||
37864947|NCT01111149|69548559|FG001|Overall Study|Protocol Violation|1|||
37864948|NCT01111149|69548560|FG002|Overall Study|Protocol Violation|2|||
37864949|NCT01111149|69548558|FG000|Overall Study|Withdrawal by Subject|1|||
37864950|NCT01111149|69548559|FG001|Overall Study|Withdrawal by Subject|0|||
37864951|NCT01111149|69548560|FG002|Overall Study|Withdrawal by Subject|2|||
37813824|NCT01729754|69491788|FG007|Part 1|Progressive Disease|0|||
37864952|NCT01254656|69548571|FG000|Overall Study|Discontinued due to termination of study|40|||
37864953|NCT01254656|69548572|FG001|Overall Study|Discontinued due to termination of study|39|||
37864954|NCT01254656|69548573|FG002|Overall Study|Discontinued due to termination of study|13|||
37864955|NCT01254656|69548571|FG000|Overall Study|Lack of Efficacy|3|||
37813825|NCT01729754|69491789|FG008|Part 1|Progressive Disease|0|||
37813826|NCT01729754|69491790|FG009|Part 1|Progressive Disease|1|||
37813827|NCT01729754|69491781|FG000|Part 1|Protocol Violation|2|||
37813828|NCT01729754|69491782|FG001|Part 1|Protocol Violation|0|||
37813829|NCT01729754|69491783|FG002|Part 1|Protocol Violation|0|||
37813830|NCT01729754|69491784|FG003|Part 1|Protocol Violation|1|||
37813831|NCT01729754|69491785|FG004|Part 1|Protocol Violation|0|||
37864956|NCT01254656|69548572|FG001|Overall Study|Lack of Efficacy|0|||
37864957|NCT01254656|69548573|FG002|Overall Study|Lack of Efficacy|0|||
37864958|NCT01254656|69548571|FG000|Overall Study|Lost to Follow-up|1|||
37864959|NCT01254656|69548572|FG001|Overall Study|Lost to Follow-up|0|||
37864960|NCT01254656|69548573|FG002|Overall Study|Lost to Follow-up|2|||
37864961|NCT01254656|69548571|FG000|Overall Study|Withdrawal by Subject|2|||
37864962|NCT01254656|69548572|FG001|Overall Study|Withdrawal by Subject|2|||
37864963|NCT01254656|69548573|FG002|Overall Study|Withdrawal by Subject|1|||
37864964|NCT01254656|69548571|FG000|Overall Study|Pregnancy|0|||
37864965|NCT01254656|69548572|FG001|Overall Study|Pregnancy|0|||
37864966|NCT01254656|69548573|FG002|Overall Study|Pregnancy|2|||
37864967|NCT01254656|69548571|FG000|Overall Study|Adverse Event|1|||
37864968|NCT01254656|69548572|FG001|Overall Study|Adverse Event|1|||
37864969|NCT01254656|69548573|FG002|Overall Study|Adverse Event|0|||
37864970|NCT01254656|69548571|FG000|Overall Study|Death|0|||
37864971|NCT01254656|69548572|FG001|Overall Study|Death|1|||
37864972|NCT01254656|69548573|FG002|Overall Study|Death|0|||
37864973|NCT01110915|69548583|FG000|Overall Study|Death|2|||
37864974|NCT01110915|69548584|FG001|Overall Study|Death|1|||
37864975|NCT01110915|69548583|FG000|Overall Study|Lost to Follow-up|1|||
37864976|NCT01110915|69548584|FG001|Overall Study|Lost to Follow-up|0|||
37864977|NCT01110915|69548583|FG000|Overall Study|Withdrawal by Subject|7|||
37864978|NCT01110915|69548584|FG001|Overall Study|Withdrawal by Subject|1|||
37864979|NCT01254344|69548593|FG000|Overall Study|Adverse Event|2|||
37864980|NCT01254344|69548594|FG001|Overall Study|Adverse Event|5|||
37864981|NCT01254344|69548593|FG000|Overall Study|Physician Decision|7|||
37864982|NCT01254344|69548594|FG001|Overall Study|Physician Decision|4|||
37864983|NCT01254344|69548593|FG000|Overall Study|Protocol Violation|1|||
37864984|NCT01254344|69548594|FG001|Overall Study|Protocol Violation|4|||
37864985|NCT01254344|69548593|FG000|Overall Study|Withdrawal by Subject|3|||
37864986|NCT01254344|69548594|FG001|Overall Study|Withdrawal by Subject|6|||
37864987|NCT01102803|69548602|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
37864988|NCT01102803|69548603|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
37864989|NCT01102803|69548602|FG000|Post to Follow-Up|Lost to Follow-up|1|||
37977774|NCT00381303|69664897|FG001|Overall Study|Non-Adherence|6|||
37977775|NCT00381303|69664896|FG000|Overall Study|Withdrawal by Subject|13|||
37977776|NCT00381303|69664897|FG001|Overall Study|Withdrawal by Subject|6|||
37977777|NCT00381303|69664896|FG000|Overall Study|Virologic failure|6|||
37977778|NCT00381303|69664897|FG001|Overall Study|Virologic failure|4|||
37977779|NCT00381303|69664896|FG000|Overall Study|Ineligible to continue the trial|2|||
37977780|NCT00381303|69664897|FG001|Overall Study|Ineligible to continue the trial|1|||
37977781|NCT00381303|69664896|FG000|Overall Study|Pregnancy|2|||
37977782|NCT00381303|69664897|FG001|Overall Study|Pregnancy|0|||
37977783|NCT00381303|69664896|FG000|Overall Study|Physician Decision|1|||
37977784|NCT00381303|69664897|FG001|Overall Study|Physician Decision|0|||
37977785|NCT00381303|69664896|FG000|Overall Study|Physician's decision to close the site|3|||
37977786|NCT00381303|69664897|FG001|Overall Study|Physician's decision to close the site|1|||
37813832|NCT01729754|69491786|FG005|Part 1|Protocol Violation|0|||
37813833|NCT01729754|69491787|FG006|Part 1|Protocol Violation|1|||
37813834|NCT01729754|69491788|FG007|Part 1|Protocol Violation|0|||
37813835|NCT01729754|69491789|FG008|Part 1|Protocol Violation|0|||
37813836|NCT01729754|69491790|FG009|Part 1|Protocol Violation|0|||
37813837|NCT01729754|69491781|FG000|Part 1|Withdrawal by Subject|5|||
37813838|NCT01729754|69491782|FG001|Part 1|Withdrawal by Subject|0|||
37813839|NCT01729754|69491783|FG002|Part 1|Withdrawal by Subject|0|||
37813840|NCT01729754|69491784|FG003|Part 1|Withdrawal by Subject|7|||
37813841|NCT01729754|69491785|FG004|Part 1|Withdrawal by Subject|0|||
37813842|NCT01729754|69491786|FG005|Part 1|Withdrawal by Subject|0|||
37813843|NCT01729754|69491787|FG006|Part 1|Withdrawal by Subject|5|||
37813844|NCT01729754|69491788|FG007|Part 1|Withdrawal by Subject|0|||
37813845|NCT01729754|69491789|FG008|Part 1|Withdrawal by Subject|0|||
37813846|NCT01729754|69491790|FG009|Part 1|Withdrawal by Subject|6|||
37813847|NCT01729754|69491781|FG000|Part 1|Other Protocol Specified Criteria|2|||
37813848|NCT01729754|69491782|FG001|Part 1|Other Protocol Specified Criteria|0|||
37864990|NCT01102803|69548603|FG001|Post to Follow-Up|Lost to Follow-up|3|||
37977787|NCT00381303|69664896|FG000|Overall Study|Subject moved out of state|2|||
37694680|NCT02517515|69171193|FG000|Overall Study|Other|1|||
37864991|NCT01254188|69548611|FG000|Overall Study|Disease Progression|6|||
37864992|NCT01254188|69548611|FG000|Overall Study|Protocol Violation|6|||
37864993|NCT01254188|69548611|FG000|Overall Study|Pregnancy|2|||
37864994|NCT01254188|69548611|FG000|Overall Study|Death|4|||
37864995|NCT01254188|69548611|FG000|Overall Study|Lost to Follow-up|5|||
37813849|NCT01729754|69491783|FG002|Part 1|Other Protocol Specified Criteria|0|||
37864996|NCT01254188|69548611|FG000|Overall Study|Withdrawal by Subject|7|||
37864997|NCT01254188|69548611|FG000|Overall Study|Adverse Event|43|||
37864998|NCT01254188|69548611|FG000|Overall Study|per investigator discretion|20|||
37864999|NCT01109979|69548617|FG000|Overall Study|Physician Decision|2|||
37865000|NCT01109979|69548618|FG001|Overall Study|Physician Decision|0|||
37865001|NCT01109979|69548617|FG000|Overall Study|Withdrawal by Subject|0|||
37865002|NCT01109979|69548618|FG001|Overall Study|Withdrawal by Subject|1|||
37865003|NCT01102491|69548626|FG000|Overall Study|Protocol Violation|11|||
37865004|NCT01102491|69548627|FG001|Overall Study|Protocol Violation|12|||
37865005|NCT01102257|69548635|FG000|Overall Study|Adverse Event|1|||
37865006|NCT01102257|69548636|FG001|Overall Study|Adverse Event|0|||
37865007|NCT01102257|69548635|FG000|Overall Study|Adverse Event|1|||
37865008|NCT01102257|69548636|FG001|Overall Study|Adverse Event|0|||
37865009|NCT01253564|69548642|FG000|Overall Study|Disease Progression|22|||
37865010|NCT01253564|69548642|FG000|Overall Study|Withdrawal by Subject|1|||
37865011|NCT01253564|69548642|FG000|Overall Study|Serious Adverse Event|1|||
37865012|NCT01108809|69548646|FG000|Overall Study|Adverse Event|3|||
37865013|NCT01108809|69548646|FG000|Overall Study|Lost to Follow-up|1|||
37865014|NCT01253408|69548654|FG000|Overall Study|Adverse Event|0|||
37865015|NCT01253408|69548655|FG001|Overall Study|Adverse Event|1|||
37865016|NCT01253408|69548656|FG002|Overall Study|Adverse Event|0|||
37865017|NCT01253174|69548664|FG000|Period 1|Randomized but not treated|0|||
37865018|NCT01253174|69548665|FG001|Period 1|Randomized but not treated|1|||
37865019|NCT01253174|69548666|FG002|Period 1|Randomized but not treated|1|||
37865020|NCT01253174|69548667|FG003|Period 1|Randomized but not treated|0|||
37865021|NCT01253174|69548668|FG004|Period 1|Randomized but not treated|1|||
37865022|NCT01253174|69548669|FG005|Period 1|Randomized but not treated|0|||
37865023|NCT01253174|69548664|FG000|Period 2|Adverse Event|0|||
37865024|NCT01253174|69548665|FG001|Period 2|Adverse Event|0|||
37865025|NCT01253174|69548666|FG002|Period 2|Adverse Event|1|||
37865026|NCT01253174|69548667|FG003|Period 2|Adverse Event|0|||
37865027|NCT01253174|69548668|FG004|Period 2|Adverse Event|0|||
37865028|NCT01253174|69548669|FG005|Period 2|Adverse Event|0|||
37865029|NCT01253174|69548664|FG000|Period 3|Withdrawal by Subject|0|||
37865030|NCT01253174|69548665|FG001|Period 3|Withdrawal by Subject|1|||
37865031|NCT01253174|69548666|FG002|Period 3|Withdrawal by Subject|0|||
37865032|NCT01253174|69548667|FG003|Period 3|Withdrawal by Subject|0|||
37865033|NCT01253174|69548668|FG004|Period 3|Withdrawal by Subject|1|||
37865034|NCT01253174|69548669|FG005|Period 3|Withdrawal by Subject|0|||
37865035|NCT01253174|69548664|FG000|Period 3|Pregnancy|0|||
37865036|NCT01253174|69548665|FG001|Period 3|Pregnancy|0|||
37865037|NCT01253174|69548666|FG002|Period 3|Pregnancy|1|||
37865038|NCT01253174|69548667|FG003|Period 3|Pregnancy|0|||
37977788|NCT00381303|69664897|FG001|Overall Study|Subject moved out of state|0|||
37977789|NCT00381303|69664896|FG000|Overall Study|Subject taking too many different meds|1|||
37865039|NCT01253174|69548668|FG004|Period 3|Pregnancy|0|||
37865040|NCT01253174|69548669|FG005|Period 3|Pregnancy|0|||
37865041|NCT01108731|69548680|FG000|Overall Study|Withdrawal by Subject|1|||
37865042|NCT01108731|69548681|FG001|Overall Study|Withdrawal by Subject|1|||
37865043|NCT01108731|69548680|FG000|Overall Study|Adverse Event|3|||
37865044|NCT01108731|69548681|FG001|Overall Study|Adverse Event|3|||
37865045|NCT01253018|69548689|FG000|Overall Study|Lost to Follow-up|1|||
37865046|NCT01253018|69548690|FG001|Overall Study|Lost to Follow-up|1|||
37977790|NCT00381303|69664897|FG001|Overall Study|Subject taking too many different meds|0|||
37977791|NCT00381303|69664896|FG000|Overall Study|No virologic response by week 12|1|||
37977792|NCT00381303|69664897|FG001|Overall Study|No virologic response by week 12|0|||
37977793|NCT00381303|69664896|FG000|Overall Study|Subject was too busy for appointments|1|||
37865047|NCT01253018|69548689|FG000|Overall Study|Robot Repair Issues|2|||
37865048|NCT01253018|69548690|FG001|Overall Study|Robot Repair Issues|0|||
37865049|NCT01253018|69548689|FG000|Overall Study|Withdrawal by Subject|1|||
37865050|NCT01253018|69548690|FG001|Overall Study|Withdrawal by Subject|1|||
37865051|NCT01108341|69548697|FG000|Overall Study|Death|2|||
37865052|NCT01108341|69548697|FG000|Overall Study|Withdrawal by Subject|1|||
37865053|NCT01108341|69548697|FG000|Overall Study|Lost to Follow-up|1|||
37865054|NCT01108341|69548697|FG000|Overall Study|Other|1|||
37865055|NCT01108263|69548703|FG000|Overall Study|Adverse Event|0|||
37865056|NCT01108263|69548704|FG001|Overall Study|Adverse Event|1|||
37865057|NCT01108185|69548710|FG000|Overall Study|Non-compliance|15|||
37865058|NCT01108185|69548710|FG000|Overall Study|Lost to Follow-up|12|||
37865059|NCT01252940|69548716|FG000|Main Study Phase|Randomized but not treated|4|||
37865060|NCT01252940|69548717|FG001|Main Study Phase|Randomized but not treated|2|||
37865061|NCT01252940|69548716|FG000|Main Study Phase|Adverse Event|3|||
37813850|NCT01729754|69491784|FG003|Part 1|Other Protocol Specified Criteria|0|||
37813851|NCT01729754|69491785|FG004|Part 1|Other Protocol Specified Criteria|0|||
37813852|NCT01729754|69491786|FG005|Part 1|Other Protocol Specified Criteria|0|||
37813853|NCT01729754|69491787|FG006|Part 1|Other Protocol Specified Criteria|1|||
37813854|NCT01729754|69491788|FG007|Part 1|Other Protocol Specified Criteria|0|||
37813855|NCT01729754|69491789|FG008|Part 1|Other Protocol Specified Criteria|0|||
37813856|NCT01729754|69491790|FG009|Part 1|Other Protocol Specified Criteria|4|||
37813857|NCT01729754|69491781|FG000|Part 2|Adverse Event|2|||
37813858|NCT01729754|69491782|FG001|Part 2|Adverse Event|0|||
37813859|NCT01729754|69491783|FG002|Part 2|Adverse Event|0|||
37813860|NCT01729754|69491784|FG003|Part 2|Adverse Event|0|||
37813861|NCT01729754|69491785|FG004|Part 2|Adverse Event|0|||
37865062|NCT01252940|69548717|FG001|Main Study Phase|Adverse Event|1|||
37865063|NCT01252940|69548716|FG000|Main Study Phase|Lack of Efficacy|1|||
37865064|NCT01252940|69548717|FG001|Main Study Phase|Lack of Efficacy|0|||
37865065|NCT01252940|69548716|FG000|Main Study Phase|Lost to Follow-up|6|||
37865066|NCT01252940|69548717|FG001|Main Study Phase|Lost to Follow-up|1|||
37865067|NCT01252940|69548716|FG000|Main Study Phase|Physician Decision|1|||
37865068|NCT01252940|69548717|FG001|Main Study Phase|Physician Decision|0|||
37865069|NCT01252940|69548716|FG000|Main Study Phase|Protocol Violation|4|||
37865070|NCT01252940|69548717|FG001|Main Study Phase|Protocol Violation|2|||
37865071|NCT01252940|69548716|FG000|Main Study Phase|Withdrawal by Subject|6|||
37865072|NCT01252940|69548717|FG001|Main Study Phase|Withdrawal by Subject|5|||
37865073|NCT01252940|69548716|FG000|Main Study Phase|Subject Non-compliance|1|||
37865074|NCT01252940|69548717|FG001|Main Study Phase|Subject Non-compliance|1|||
37865075|NCT01252940|69548716|FG000|Extension Phase|Adverse Event|2|||
37865076|NCT01252940|69548717|FG001|Extension Phase|Adverse Event|1|||
37865077|NCT01252940|69548716|FG000|Extension Phase|Lack of Efficacy|1|||
37865078|NCT01252940|69548717|FG001|Extension Phase|Lack of Efficacy|0|||
37865079|NCT01252940|69548716|FG000|Extension Phase|Lost to Follow-up|5|||
37865080|NCT01252940|69548717|FG001|Extension Phase|Lost to Follow-up|0|||
37865081|NCT01252940|69548716|FG000|Extension Phase|Physician Decision|0|||
37865082|NCT01252940|69548717|FG001|Extension Phase|Physician Decision|1|||
37865083|NCT01252940|69548716|FG000|Extension Phase|Subject Non-compliance|1|||
37865084|NCT01252940|69548717|FG001|Extension Phase|Subject Non-compliance|0|||
37865085|NCT01252940|69548716|FG000|Extension Phase|Withdrawal by Subject|1|||
37865086|NCT01252940|69548717|FG001|Extension Phase|Withdrawal by Subject|1|||
37865087|NCT01252238|69548727|FG000|Overall Study|Sponsor terminated study|4|||
37865088|NCT01252238|69548728|FG001|Overall Study|Sponsor terminated study|4|||
37865089|NCT01252238|69548729|FG002|Overall Study|Sponsor terminated study|4|||
37865090|NCT01101477|69548743|FG000|Overall Study|Protocol Violation|5|||
37865091|NCT01101477|69548744|FG001|Overall Study|Protocol Violation|3|||
37865092|NCT01101477|69548745|FG002|Overall Study|Protocol Violation|1|||
37865093|NCT01251770|69548755|FG000|Overall Study|Protocol Violation|13|||
37865094|NCT01251770|69548756|FG001|Overall Study|Protocol Violation|7|||
37865095|NCT01101321|69548762|FG000|Period 1|Withdrawal by Subject|1|||
37865096|NCT01101321|69548763|FG001|Period 1|Withdrawal by Subject|1|||
37865097|NCT01101321|69548762|FG000|Period 1|Adverse Event|3|||
37865098|NCT01101321|69548763|FG001|Period 1|Adverse Event|3|||
37865099|NCT01101165|69548769|FG000|Period 1|Adverse Event|1|||
37865100|NCT01101165|69548770|FG001|Period 1|Adverse Event|2|||
37865101|NCT01101165|69548769|FG000|Period 1|Withdrawal by Subject|0|||
37865102|NCT01101165|69548770|FG001|Period 1|Withdrawal by Subject|2|||
37865103|NCT01101165|69548769|FG000|Period 1|Positive Drug Screen|0|||
37865104|NCT01101165|69548770|FG001|Period 1|Positive Drug Screen|1|||
37865105|NCT01101165|69548769|FG000|Period 1|Lost to Follow-up|1|||
37865106|NCT01101165|69548770|FG001|Period 1|Lost to Follow-up|0|||
37865107|NCT01101165|69548769|FG000|Period 2|Withdrawal by Subject|3|||
37865108|NCT01101165|69548770|FG001|Period 2|Withdrawal by Subject|1|||
37865109|NCT01101165|69548769|FG000|Period 2|Adverse Event|1|||
37865110|NCT01101165|69548770|FG001|Period 2|Adverse Event|0|||
37865111|NCT01100853|69548778|FG000|Overall Study|Lost to Follow-up|11|||
37865112|NCT01100853|69548779|FG001|Overall Study|Lost to Follow-up|6|||
37865113|NCT01100853|69548778|FG000|Overall Study|Received <4 study injections|10|||
37865114|NCT01100853|69548779|FG001|Overall Study|Received <4 study injections|13|||
37865115|NCT01100853|69548778|FG000|Overall Study|Withdrawal by Subject|6|||
37865116|NCT01100853|69548779|FG001|Overall Study|Withdrawal by Subject|4|||
37865117|NCT01100307|69548787|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
37865118|NCT01100307|69548788|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
37865119|NCT01100307|69548787|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
37865120|NCT01100307|69548788|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
37865121|NCT01100307|69548787|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
37865122|NCT01100307|69548788|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
37865123|NCT01100307|69548787|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
37865124|NCT01100307|69548788|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
37865125|NCT01100307|69548787|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
37865126|NCT01100307|69548788|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
37865127|NCT01100307|69548787|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
37865128|NCT01100307|69548788|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
37865129|NCT01100073|69548796|FG000|Overall Study|Lack of Efficacy|4|||
37865130|NCT01100073|69548796|FG000|Overall Study|Insufficient Tolerability|21|||
37865131|NCT01100073|69548796|FG000|Overall Study|Withdrawal by Subject|13|||
37865132|NCT01100073|69548796|FG000|Overall Study|Lost to Follow-up|39|||
37865133|NCT01100073|69548796|FG000|Overall Study|Lack of effect + patient's wish|2|||
37865134|NCT01100073|69548796|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
37865135|NCT01100073|69548796|FG000|Overall Study|Other|8|||
37865136|NCT01100073|69548796|FG000|Overall Study|Missing|5|||
37865137|NCT01099917|69548800|FG000|Overall Study|Adverse Event|3|||
37865138|NCT01099917|69548800|FG000|Overall Study|Not Treated|24|||
37865139|NCT01099215|69548806|FG000|Overall Study|Withdrawal by Subject|1|||
37865140|NCT01099215|69548807|FG001|Overall Study|Withdrawal by Subject|0|||
37865141|NCT01099215|69548806|FG000|Overall Study|Adverse Event|0|||
37865142|NCT01099215|69548807|FG001|Overall Study|Adverse Event|1|||
37865143|NCT01097655|69548813|FG000|Overall Study|Withdrawal by Subject|1|||
37865144|NCT01097655|69548813|FG000|Overall Study|Subject Documented Twice|1|||
37865145|NCT01097655|69548813|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
37865146|NCT01107405|69548822|FG000|Overall Study|Adverse Event|1|||
37865147|NCT01107405|69548823|FG001|Overall Study|Adverse Event|1|||
37865148|NCT01107405|69548824|FG002|Overall Study|Adverse Event|0|||
37865149|NCT01107405|69548825|FG003|Overall Study|Adverse Event|0|||
37865150|NCT01107405|69548826|FG004|Overall Study|Adverse Event|2|||
37865151|NCT01107405|69548822|FG000|Overall Study|Withdrawal by Subject|1|||
37865152|NCT01107405|69548823|FG001|Overall Study|Withdrawal by Subject|0|||
37865153|NCT01107405|69548824|FG002|Overall Study|Withdrawal by Subject|1|||
37865154|NCT01107405|69548825|FG003|Overall Study|Withdrawal by Subject|2|||
37865155|NCT01107405|69548826|FG004|Overall Study|Withdrawal by Subject|1|||
37865156|NCT01107405|69548822|FG000|Overall Study|Protocol Violation|0|||
37865157|NCT01107405|69548823|FG001|Overall Study|Protocol Violation|0|||
37865158|NCT01107405|69548824|FG002|Overall Study|Protocol Violation|1|||
37865159|NCT01107405|69548825|FG003|Overall Study|Protocol Violation|1|||
37865160|NCT01107405|69548826|FG004|Overall Study|Protocol Violation|0|||
37865161|NCT01097577|69548840|FG000|Overall Study|Adverse Event|0|||
37865162|NCT01097577|69548841|FG001|Overall Study|Adverse Event|1|||
37865163|NCT01097421|69548847|FG000|Overall Study|Adverse Event|8|||
37865164|NCT01097421|69548847|FG000|Overall Study|Protocol Violation|2|||
37865165|NCT01097421|69548847|FG000|Overall Study|Lost to Follow-up|1|||
37865166|NCT01097421|69548847|FG000|Overall Study|Withdrawal by Subject|3|||
37865167|NCT01251614|69548854|FG000|Overall Study|Adverse Event|1|||
37865168|NCT01251614|69548855|FG001|Overall Study|Adverse Event|0|||
37865169|NCT01251614|69548856|FG002|Overall Study|Adverse Event|1|||
37865170|NCT01251614|69548854|FG000|Overall Study|Lack of Efficacy|1|||
37865171|NCT01251614|69548855|FG001|Overall Study|Lack of Efficacy|9|||
37865172|NCT01251614|69548856|FG002|Overall Study|Lack of Efficacy|4|||
37865173|NCT01251614|69548854|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
37865174|NCT01251614|69548855|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
37865175|NCT01251614|69548856|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
37865176|NCT01251614|69548854|FG000|Overall Study|Pregnancy|0|||
37865177|NCT01251614|69548855|FG001|Overall Study|Pregnancy|0|||
37865178|NCT01251614|69548856|FG002|Overall Study|Pregnancy|2|||
37865179|NCT01251614|69548854|FG000|Overall Study|Loss of Disease Control|0|||
37865180|NCT01251614|69548855|FG001|Overall Study|Loss of Disease Control|1|||
37865181|NCT01251614|69548856|FG002|Overall Study|Loss of Disease Control|0|||
37865182|NCT01251614|69548854|FG000|Overall Study|Withdrawal by Subject|0|||
37865183|NCT01251614|69548855|FG001|Overall Study|Withdrawal by Subject|2|||
37865184|NCT01251614|69548856|FG002|Overall Study|Withdrawal by Subject|1|||
37865185|NCT01251614|69548854|FG000|Overall Study|Lost to Follow-up|0|||
37865186|NCT01251614|69548855|FG001|Overall Study|Lost to Follow-up|1|||
37865187|NCT01251614|69548856|FG002|Overall Study|Lost to Follow-up|0|||
37865188|NCT01106625|69548877|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
37865189|NCT01106625|69548878|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
37865190|NCT01106625|69548879|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
37865191|NCT01106625|69548877|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
37865192|NCT01106625|69548878|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
37865193|NCT01106625|69548879|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
37865194|NCT01106625|69548877|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
37865195|NCT01106625|69548878|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
37865196|NCT01106625|69548879|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
37865197|NCT01106625|69548877|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
37865198|NCT01106625|69548878|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
37865199|NCT01106625|69548879|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
37865200|NCT01106625|69548877|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
37977794|NCT00381303|69664897|FG001|Overall Study|Subject was too busy for appointments|0|||
37977795|NCT00381303|69664896|FG000|Overall Study|Subject did not continue visits|1|||
37977796|NCT00381303|69664897|FG001|Overall Study|Subject did not continue visits|0|||
37977797|NCT00381303|69664896|FG000|Overall Study|Subject primary physician's decision|1|||
37977798|NCT00381303|69664897|FG001|Overall Study|Subject primary physician's decision|0|||
37977799|NCT00448812|69664917|FG000|Year 2|Missed visit but remained in study|4|||
37977800|NCT00448812|69664918|FG001|Year 2|Missed visit but remained in study|1|||
37977801|NCT00448812|69664917|FG000|Year 3|Withdrawal by Subject|1|||
37977802|NCT00448812|69664918|FG001|Year 3|Withdrawal by Subject|3|||
37977803|NCT00448812|69664917|FG000|Year 3|Lost to Follow-up|1|||
37977804|NCT00448812|69664918|FG001|Year 3|Lost to Follow-up|0|||
37977805|NCT00448812|69664917|FG000|Year 3|Missed visit but remained in study|2|||
37977806|NCT00448812|69664918|FG001|Year 3|Missed visit but remained in study|0|||
37977807|NCT00448812|69664917|FG000|Year 5|Missed visit but remained in study|1|||
37977808|NCT00448812|69664918|FG001|Year 5|Missed visit but remained in study|0|||
37977809|NCT00364689|69664939|FG000|Overall Study|Lost to Follow-up|1|||
37977810|NCT00545129|69664947|FG000|Overall Study|Lack of Efficacy|2|||
37977811|NCT00545129|69664948|FG001|Overall Study|Lack of Efficacy|5|||
37977812|NCT00545129|69664947|FG000|Overall Study|Death|2|||
37977813|NCT00545129|69664948|FG001|Overall Study|Death|1|||
37977814|NCT00545129|69664947|FG000|Overall Study|Adverse Event|1|||
37977815|NCT00545129|69664948|FG001|Overall Study|Adverse Event|1|||
37977816|NCT00545129|69664947|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
37977817|NCT00545129|69664948|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
37977818|NCT00545129|69664947|FG000|Overall Study|Other|3|||
37977819|NCT00545129|69664948|FG001|Overall Study|Other|3|||
37977820|NCT00364611|69664956|FG000|Overall Study|Did not receive study medication|0|||
37977821|NCT00364611|69664957|FG001|Overall Study|Did not receive study medication|1|||
37977822|NCT00364611|69664956|FG000|Overall Study|Adverse Event|7|||
37977823|NCT00364611|69664957|FG001|Overall Study|Adverse Event|4|||
37977824|NCT00364611|69664956|FG000|Overall Study|Participant's Request|3|||
37977825|NCT00364611|69664957|FG001|Overall Study|Participant's Request|4|||
37977826|NCT00364611|69664956|FG000|Overall Study|Disease Progression|38|||
37977827|NCT00364611|69664957|FG001|Overall Study|Disease Progression|8|||
37977828|NCT00364611|69664956|FG000|Overall Study|Investigator decision|2|||
37977829|NCT00364611|69664957|FG001|Overall Study|Investigator decision|2|||
37977830|NCT00364611|69664956|FG000|Overall Study|Found Ineligible|1|||
37977831|NCT00364611|69664957|FG001|Overall Study|Found Ineligible|0|||
37977832|NCT00364611|69664956|FG000|Overall Study|Presumed CR on Study|0|||
37977833|NCT00364611|69664957|FG001|Overall Study|Presumed CR on Study|1|||
37977834|NCT00364611|69664956|FG000|Overall Study|Receiving Liver Ablation|0|||
37977835|NCT00364611|69664957|FG001|Overall Study|Receiving Liver Ablation|1|||
37977836|NCT00364533|69664968|FG000|Overall Study|Adverse Event|8|||
37977837|NCT00364533|69664969|FG001|Overall Study|Adverse Event|7|||
37977838|NCT00364533|69664970|FG002|Overall Study|Adverse Event|15|||
37977839|NCT00364533|69664971|FG003|Overall Study|Adverse Event|5|||
37977840|NCT00364533|69664972|FG004|Overall Study|Adverse Event|2|||
37977841|NCT00364533|69664968|FG000|Overall Study|Withdrawal by Subject|4|||
37977842|NCT00364533|69664969|FG001|Overall Study|Withdrawal by Subject|8|||
37977843|NCT00364533|69664970|FG002|Overall Study|Withdrawal by Subject|6|||
37977844|NCT00364533|69664971|FG003|Overall Study|Withdrawal by Subject|6|||
37977845|NCT00364533|69664972|FG004|Overall Study|Withdrawal by Subject|6|||
37977846|NCT00364533|69664968|FG000|Overall Study|Lack of Efficacy|22|||
37977847|NCT00364533|69664969|FG001|Overall Study|Lack of Efficacy|22|||
37865201|NCT01106625|69548878|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
37865202|NCT01106625|69548879|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
37865203|NCT01106625|69548877|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
37865204|NCT01106625|69548878|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
37865205|NCT01106625|69548879|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
37865206|NCT01106625|69548877|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
37865207|NCT01106625|69548878|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
37865208|NCT01106625|69548879|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
37865209|NCT01106625|69548877|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
37865210|NCT01106625|69548878|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
37865211|NCT01106625|69548879|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
37865212|NCT01106625|69548877|FG000|Core Period: Baseline to Week 26|Other|8|||
37865213|NCT01106625|69548878|FG001|Core Period: Baseline to Week 26|Other|7|||
37865214|NCT01106625|69548879|FG002|Core Period: Baseline to Week 26|Other|4|||
37977848|NCT00364533|69664970|FG002|Overall Study|Lack of Efficacy|21|||
37977849|NCT00364533|69664971|FG003|Overall Study|Lack of Efficacy|17|||
37977850|NCT00364533|69664972|FG004|Overall Study|Lack of Efficacy|42|||
37977851|NCT00364533|69664968|FG000|Overall Study|Subject discharged from hospital|4|||
37977852|NCT00364533|69664969|FG001|Overall Study|Subject discharged from hospital|1|||
37977853|NCT00364533|69664970|FG002|Overall Study|Subject discharged from hospital|2|||
37977854|NCT00364533|69664971|FG003|Overall Study|Subject discharged from hospital|3|||
37977855|NCT00364533|69664972|FG004|Overall Study|Subject discharged from hospital|1|||
37977856|NCT00364533|69664968|FG000|Overall Study|Variations in drug compliance|2|||
37977857|NCT00364533|69664969|FG001|Overall Study|Variations in drug compliance|1|||
37977858|NCT00364533|69664970|FG002|Overall Study|Variations in drug compliance|1|||
37977859|NCT00364533|69664971|FG003|Overall Study|Variations in drug compliance|0|||
37977860|NCT00364533|69664972|FG004|Overall Study|Variations in drug compliance|0|||
37977861|NCT00364533|69664968|FG000|Overall Study|Non-compliance|1|||
37977862|NCT00364533|69664969|FG001|Overall Study|Non-compliance|0|||
37865215|NCT01106625|69548877|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
37865216|NCT01106625|69548878|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
37865217|NCT01106625|69548879|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
37865218|NCT01106625|69548877|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
37977863|NCT00364533|69664970|FG002|Overall Study|Non-compliance|0|||
37977864|NCT00364533|69664971|FG003|Overall Study|Non-compliance|0|||
37977865|NCT00364533|69664972|FG004|Overall Study|Non-compliance|0|||
37977866|NCT00364533|69664968|FG000|Overall Study|Protocol Violation|1|||
37977867|NCT00364533|69664969|FG001|Overall Study|Protocol Violation|1|||
37977868|NCT00364533|69664970|FG002|Overall Study|Protocol Violation|0|||
37977869|NCT00364533|69664971|FG003|Overall Study|Protocol Violation|0|||
37977870|NCT00364533|69664972|FG004|Overall Study|Protocol Violation|0|||
37977871|NCT04006847|69664984|FG000|Overall Study|Product issue|1|||
37977872|NCT00544817|69664988|FG000|Combined Modality|Lack of Efficacy|2|||
37977873|NCT00544817|69664988|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
37977874|NCT00544817|69664988|FG000|Combined Modality|Adverse Event|2|||
37977875|NCT00544817|69664988|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
37977876|NCT00544817|69664988|FG000|No Treatment Interval|Lack of Efficacy|8|||
37977877|NCT00544817|69664988|FG000|No Treatment Interval|Physician Decision|3|||
37977878|NCT00544817|69664988|FG000|No Treatment Interval|Adverse Event|1|||
37977879|NCT00544817|69664988|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
37977880|NCT00544817|69664988|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
37865219|NCT01106625|69548878|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
37865220|NCT01106625|69548879|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
37865221|NCT01106625|69548877|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
37865222|NCT01106625|69548878|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
37865223|NCT01106625|69548879|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
37865224|NCT01106625|69548877|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
37865225|NCT01106625|69548878|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
37865226|NCT01106625|69548879|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
37865227|NCT01106625|69548877|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
37865228|NCT01106625|69548878|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
37865229|NCT01106625|69548879|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
37977881|NCT00544817|69664988|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
37977882|NCT00289978|69664995|FG000|Overall Study|Withdrawal by Subject|31|||
37977883|NCT00289978|69664996|FG001|Overall Study|Withdrawal by Subject|17|||
37977884|NCT00289978|69664997|FG002|Overall Study|Withdrawal by Subject|28|||
37977885|NCT00289978|69664995|FG000|Overall Study|Adverse Event|22|||
37977886|NCT00289978|69664996|FG001|Overall Study|Adverse Event|13|||
37977887|NCT00289978|69664997|FG002|Overall Study|Adverse Event|18|||
37977888|NCT00289978|69664995|FG000|Overall Study|Lack of Efficacy|13|||
37813862|NCT01729754|69491786|FG005|Part 2|Adverse Event|0|||
37813863|NCT01729754|69491787|FG006|Part 2|Adverse Event|0|||
37865230|NCT01106625|69548877|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
37865231|NCT01106625|69548878|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
37865232|NCT01106625|69548879|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
37865233|NCT01106625|69548877|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
37865234|NCT01106625|69548878|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
37865235|NCT01106625|69548879|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
37865236|NCT01106625|69548877|FG000|Extension Period: Week 26 to Week 52|Other|5|||
37865237|NCT01106625|69548878|FG001|Extension Period: Week 26 to Week 52|Other|5|||
37865238|NCT01106625|69548879|FG002|Extension Period: Week 26 to Week 52|Other|4|||
37865239|NCT01251380|69548890|FG000|Overall Study|Other (Not otherwise specified)|12|||
37865240|NCT01251380|69548890|FG000|Overall Study|Withdrawal by Subject|6|||
37977889|NCT00289978|69664996|FG001|Overall Study|Lack of Efficacy|6|||
37977890|NCT00289978|69664997|FG002|Overall Study|Lack of Efficacy|25|||
37977891|NCT00289978|69664995|FG000|Overall Study|Abnormal laboratory value(s)|20|||
37977892|NCT00289978|69664996|FG001|Overall Study|Abnormal laboratory value(s)|9|||
37977893|NCT00289978|69664997|FG002|Overall Study|Abnormal laboratory value(s)|1|||
37977894|NCT00289978|69664995|FG000|Overall Study|Lost to Follow-up|3|||
37977895|NCT00289978|69664996|FG001|Overall Study|Lost to Follow-up|5|||
37977896|NCT00289978|69664997|FG002|Overall Study|Lost to Follow-up|7|||
37977897|NCT00289978|69664995|FG000|Overall Study|Protocol Violation|5|||
37813864|NCT01729754|69491788|FG007|Part 2|Adverse Event|0|||
37813865|NCT01729754|69491789|FG008|Part 2|Adverse Event|1|||
37813866|NCT01729754|69491790|FG009|Part 2|Adverse Event|2|||
37813867|NCT01729754|69491781|FG000|Part 2|Lack of Efficacy|0|||
37813868|NCT01729754|69491782|FG001|Part 2|Lack of Efficacy|0|||
37813869|NCT01729754|69491783|FG002|Part 2|Lack of Efficacy|0|||
37813870|NCT01729754|69491784|FG003|Part 2|Lack of Efficacy|0|||
37813871|NCT01729754|69491785|FG004|Part 2|Lack of Efficacy|0|||
37813872|NCT01729754|69491786|FG005|Part 2|Lack of Efficacy|0|||
37813873|NCT01729754|69491787|FG006|Part 2|Lack of Efficacy|0|||
37813874|NCT01729754|69491788|FG007|Part 2|Lack of Efficacy|0|||
37813875|NCT01729754|69491789|FG008|Part 2|Lack of Efficacy|2|||
37813876|NCT01729754|69491790|FG009|Part 2|Lack of Efficacy|2|||
37813877|NCT01729754|69491781|FG000|Part 2|Lost to Follow-up|0|||
37813878|NCT01729754|69491782|FG001|Part 2|Lost to Follow-up|0|||
37813879|NCT01729754|69491783|FG002|Part 2|Lost to Follow-up|0|||
37813880|NCT01729754|69491784|FG003|Part 2|Lost to Follow-up|2|||
37813881|NCT01729754|69491785|FG004|Part 2|Lost to Follow-up|0|||
37813882|NCT01729754|69491786|FG005|Part 2|Lost to Follow-up|0|||
37865241|NCT01251380|69548890|FG000|Overall Study|Lack of Efficacy|1|||
37977898|NCT00289978|69664996|FG001|Overall Study|Protocol Violation|5|||
37977899|NCT00289978|69664997|FG002|Overall Study|Protocol Violation|4|||
37977900|NCT00289978|69664995|FG000|Overall Study|Abnormal test procedure result(s)|2|||
37813883|NCT01729754|69491787|FG006|Part 2|Lost to Follow-up|0|||
37813884|NCT01729754|69491788|FG007|Part 2|Lost to Follow-up|1|||
37813885|NCT01729754|69491789|FG008|Part 2|Lost to Follow-up|0|||
37865242|NCT01251380|69548890|FG000|Overall Study|Adverse Event|1|||
37865243|NCT01251380|69548890|FG000|Overall Study|Lost to Follow-up|2|||
37865244|NCT01251146|69548901|FG000|Overall Study|Lost to Follow-up|3|||
37865245|NCT01251146|69548902|FG001|Overall Study|Lost to Follow-up|10|||
37865246|NCT01096017|69548908|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
37865247|NCT01096017|69548909|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
37865248|NCT01106157|69548917|FG000|Overall Study|Withdrawal by Subject|1|||
37865249|NCT01106157|69548918|FG001|Overall Study|Withdrawal by Subject|0|||
37865250|NCT01094301|69548924|FG000|Trial Stage|Withdrawal by Subject|1|||
37865251|NCT01094301|69548924|FG000|Implant Stage|Adverse Event|1|||
37865252|NCT01094301|69548924|FG000|Implant Stage|Protocol Violation|1|||
37865253|NCT01094301|69548924|FG000|Implant Stage|Withdrawal by Subject|2|||
37865254|NCT01094301|69548924|FG000|Implant Stage|No return of pain|4|||
37865255|NCT01093755|69548932|FG000|Overall Study|Withdrawal by Subject|3|||
37865256|NCT01093755|69548933|FG001|Overall Study|Withdrawal by Subject|4|||
37865257|NCT01093599|69548941|FG000|Overall Study|Lost to Follow-up|32|||
37865258|NCT01093599|69548942|FG001|Overall Study|Lost to Follow-up|46|||
37865259|NCT01092663|69548950|FG000|Overall Study|Withdrawal by Subject|3|||
37865260|NCT01092663|69548951|FG001|Overall Study|Withdrawal by Subject|2|||
37865261|NCT01092663|69548950|FG000|Overall Study|Glucose >300mg/dL|1|||
37865262|NCT01092663|69548951|FG001|Overall Study|Glucose >300mg/dL|0|||
37865263|NCT01092663|69548950|FG000|Overall Study|High fasting triglyceride|2|||
37865264|NCT01092663|69548951|FG001|Overall Study|High fasting triglyceride|0|||
37865265|NCT01092663|69548950|FG000|Overall Study|Adverse Event|1|||
37865266|NCT01092663|69548951|FG001|Overall Study|Adverse Event|1|||
37977901|NCT00289978|69664996|FG001|Overall Study|Abnormal test procedure result(s)|1|||
37977902|NCT00289978|69664997|FG002|Overall Study|Abnormal test procedure result(s)|1|||
37977903|NCT00289978|69664995|FG000|Overall Study|Death|1|||
37865267|NCT01092663|69548950|FG000|Overall Study|Protocol Violation|0|||
37865268|NCT01092663|69548951|FG001|Overall Study|Protocol Violation|1|||
37865269|NCT01078623|69548962|FG000|Treatment Period 1|Adverse Event|1|||
37865270|NCT01078623|69548963|FG001|Treatment Period 1|Adverse Event|1|||
37865271|NCT01078623|69548964|FG002|Treatment Period 1|Adverse Event|1|||
37865272|NCT01078623|69548965|FG003|Treatment Period 1|Adverse Event|0|||
37977904|NCT00289978|69664996|FG001|Overall Study|Death|0|||
37694681|NCT02517515|69171194|FG001|Overall Study|Other|0|||
37865273|NCT01078623|69548966|FG004|Treatment Period 1|Adverse Event|0|||
37865274|NCT01078623|69548967|FG005|Treatment Period 1|Adverse Event|0|||
37865275|NCT01078623|69548968|FG006|Treatment Period 1|Adverse Event|1|||
37865276|NCT01078623|69548969|FG007|Treatment Period 1|Adverse Event|0|||
37865277|NCT01078623|69548970|FG008|Treatment Period 1|Adverse Event|1|||
37865278|NCT01078623|69548971|FG009|Treatment Period 1|Adverse Event|1|||
37865279|NCT01078623|69548972|FG010|Treatment Period 1|Adverse Event|0|||
37865280|NCT01078623|69548973|FG011|Treatment Period 1|Adverse Event|0|||
37865281|NCT01078623|69548974|FG012|Treatment Period 1|Adverse Event|0|||
37865282|NCT01078623|69548975|FG013|Treatment Period 1|Adverse Event|0|||
37865283|NCT01078623|69548976|FG014|Treatment Period 1|Adverse Event|0|||
37865284|NCT01078623|69548977|FG015|Treatment Period 1|Adverse Event|0|||
37865285|NCT01078623|69548978|FG016|Treatment Period 1|Adverse Event|0|||
37865286|NCT01078623|69548979|FG017|Treatment Period 1|Adverse Event|0|||
37865287|NCT01078623|69548980|FG018|Treatment Period 1|Adverse Event|0|||
37865288|NCT01078623|69548981|FG019|Treatment Period 1|Adverse Event|0|||
37865289|NCT01078623|69548962|FG000|Treatment Period 1|Withdrawal by Subject|0|||
37865290|NCT01078623|69548963|FG001|Treatment Period 1|Withdrawal by Subject|0|||
37865291|NCT01078623|69548964|FG002|Treatment Period 1|Withdrawal by Subject|0|||
37865292|NCT01078623|69548965|FG003|Treatment Period 1|Withdrawal by Subject|0|||
37865293|NCT01078623|69548966|FG004|Treatment Period 1|Withdrawal by Subject|0|||
37865294|NCT01078623|69548967|FG005|Treatment Period 1|Withdrawal by Subject|0|||
37865295|NCT01078623|69548968|FG006|Treatment Period 1|Withdrawal by Subject|0|||
37865296|NCT01078623|69548969|FG007|Treatment Period 1|Withdrawal by Subject|1|||
37865297|NCT01078623|69548970|FG008|Treatment Period 1|Withdrawal by Subject|0|||
37865298|NCT01078623|69548971|FG009|Treatment Period 1|Withdrawal by Subject|0|||
37865299|NCT01078623|69548972|FG010|Treatment Period 1|Withdrawal by Subject|1|||
37865300|NCT01078623|69548973|FG011|Treatment Period 1|Withdrawal by Subject|0|||
37865301|NCT01078623|69548974|FG012|Treatment Period 1|Withdrawal by Subject|0|||
37865302|NCT01078623|69548975|FG013|Treatment Period 1|Withdrawal by Subject|0|||
37865303|NCT01078623|69548976|FG014|Treatment Period 1|Withdrawal by Subject|0|||
37865304|NCT01078623|69548977|FG015|Treatment Period 1|Withdrawal by Subject|0|||
37865305|NCT01078623|69548978|FG016|Treatment Period 1|Withdrawal by Subject|0|||
37865306|NCT01078623|69548979|FG017|Treatment Period 1|Withdrawal by Subject|0|||
37865307|NCT01078623|69548980|FG018|Treatment Period 1|Withdrawal by Subject|0|||
37865308|NCT01078623|69548981|FG019|Treatment Period 1|Withdrawal by Subject|0|||
37865309|NCT01078623|69548962|FG000|Treatment Period 1|Protocol Violation|0|||
37865310|NCT01078623|69548963|FG001|Treatment Period 1|Protocol Violation|0|||
37865311|NCT01078623|69548964|FG002|Treatment Period 1|Protocol Violation|0|||
37865312|NCT01078623|69548965|FG003|Treatment Period 1|Protocol Violation|0|||
37865313|NCT01078623|69548966|FG004|Treatment Period 1|Protocol Violation|0|||
37865314|NCT01078623|69548967|FG005|Treatment Period 1|Protocol Violation|1|||
37865315|NCT01078623|69548968|FG006|Treatment Period 1|Protocol Violation|0|||
37865316|NCT01078623|69548969|FG007|Treatment Period 1|Protocol Violation|0|||
37865317|NCT01078623|69548970|FG008|Treatment Period 1|Protocol Violation|0|||
37865318|NCT01078623|69548971|FG009|Treatment Period 1|Protocol Violation|0|||
37865319|NCT01078623|69548972|FG010|Treatment Period 1|Protocol Violation|0|||
37865320|NCT01078623|69548973|FG011|Treatment Period 1|Protocol Violation|0|||
37865321|NCT01078623|69548974|FG012|Treatment Period 1|Protocol Violation|0|||
37865322|NCT01078623|69548975|FG013|Treatment Period 1|Protocol Violation|0|||
37865323|NCT01078623|69548976|FG014|Treatment Period 1|Protocol Violation|0|||
37865324|NCT01078623|69548977|FG015|Treatment Period 1|Protocol Violation|0|||
37865325|NCT01078623|69548978|FG016|Treatment Period 1|Protocol Violation|0|||
37865326|NCT01078623|69548979|FG017|Treatment Period 1|Protocol Violation|0|||
37865327|NCT01078623|69548980|FG018|Treatment Period 1|Protocol Violation|0|||
37865328|NCT01078623|69548981|FG019|Treatment Period 1|Protocol Violation|0|||
37865329|NCT01078623|69548962|FG000|Treatment Period 2|Adverse Event|0|||
37865330|NCT01078623|69548963|FG001|Treatment Period 2|Adverse Event|0|||
37865331|NCT01078623|69548964|FG002|Treatment Period 2|Adverse Event|0|||
37865332|NCT01078623|69548965|FG003|Treatment Period 2|Adverse Event|0|||
37865333|NCT01078623|69548966|FG004|Treatment Period 2|Adverse Event|0|||
37865334|NCT01078623|69548967|FG005|Treatment Period 2|Adverse Event|0|||
37977905|NCT00289978|69664997|FG002|Overall Study|Death|2|||
37977906|NCT00543803|69665005|FG000|Overall Study|Adverse Event|14|||
37977907|NCT00543803|69665005|FG000|Overall Study|Lack of Efficacy|22|||
37977908|NCT00543803|69665005|FG000|Overall Study|Lost to Follow-up|20|||
37977909|NCT00543803|69665005|FG000|Overall Study|Other|86|||
37977910|NCT00542321|69665013|FG000|Overall Study|Death|0|||
37977911|NCT00542321|69665014|FG001|Overall Study|Death|1|||
37977912|NCT00289900|69665026|FG000|Overall Study|Adverse Event|28|||
37977913|NCT00289900|69665027|FG001|Overall Study|Adverse Event|40|||
37977914|NCT00289900|69665028|FG002|Overall Study|Adverse Event|13|||
37977915|NCT00289900|69665029|FG003|Overall Study|Adverse Event|19|||
37977916|NCT00289900|69665030|FG004|Overall Study|Adverse Event|20|||
37977917|NCT00289900|69665031|FG005|Overall Study|Adverse Event|33|||
37977918|NCT00289900|69665026|FG000|Overall Study|Lost to Follow-up|7|||
37977919|NCT00289900|69665027|FG001|Overall Study|Lost to Follow-up|7|||
37977920|NCT00289900|69665028|FG002|Overall Study|Lost to Follow-up|8|||
37977921|NCT00289900|69665029|FG003|Overall Study|Lost to Follow-up|8|||
37977922|NCT00289900|69665030|FG004|Overall Study|Lost to Follow-up|4|||
37977923|NCT00289900|69665031|FG005|Overall Study|Lost to Follow-up|8|||
37977924|NCT00289900|69665026|FG000|Overall Study|Participant had flushing|18|||
37977925|NCT00289900|69665027|FG001|Overall Study|Participant had flushing|42|||
37977926|NCT00289900|69665028|FG002|Overall Study|Participant had flushing|1|||
37977927|NCT00289900|69665029|FG003|Overall Study|Participant had flushing|2|||
37694682|NCT02466659|69171203|FG000|Overall Study|Lost to Follow-up|5|||
37813886|NCT01729754|69491790|FG009|Part 2|Lost to Follow-up|2|||
37813887|NCT01729754|69491781|FG000|Part 2|Non-Compliance with Study Drug|0|||
37813888|NCT01729754|69491782|FG001|Part 2|Non-Compliance with Study Drug|0|||
37977928|NCT00289900|69665030|FG004|Overall Study|Participant had flushing|0|||
37977929|NCT00289900|69665031|FG005|Overall Study|Participant had flushing|4|||
37977930|NCT00289900|69665026|FG000|Overall Study|Other|0|||
37977931|NCT00289900|69665027|FG001|Overall Study|Other|0|||
37977932|NCT00289900|69665028|FG002|Overall Study|Other|0|||
37977933|NCT00289900|69665029|FG003|Overall Study|Other|5|||
37813889|NCT01729754|69491783|FG002|Part 2|Non-Compliance with Study Drug|0|||
37813890|NCT01729754|69491784|FG003|Part 2|Non-Compliance with Study Drug|0|||
37813891|NCT01729754|69491785|FG004|Part 2|Non-Compliance with Study Drug|0|||
37813892|NCT01729754|69491786|FG005|Part 2|Non-Compliance with Study Drug|0|||
37813893|NCT01729754|69491787|FG006|Part 2|Non-Compliance with Study Drug|0|||
37813894|NCT01729754|69491788|FG007|Part 2|Non-Compliance with Study Drug|0|||
37813895|NCT01729754|69491789|FG008|Part 2|Non-Compliance with Study Drug|0|||
37813896|NCT01729754|69491790|FG009|Part 2|Non-Compliance with Study Drug|1|||
37813897|NCT01729754|69491781|FG000|Part 2|Pregnancy|0|||
37813898|NCT01729754|69491782|FG001|Part 2|Pregnancy|0|||
37813899|NCT01729754|69491783|FG002|Part 2|Pregnancy|0|||
37813900|NCT01729754|69491784|FG003|Part 2|Pregnancy|1|||
37813901|NCT01729754|69491785|FG004|Part 2|Pregnancy|0|||
37813902|NCT01729754|69491786|FG005|Part 2|Pregnancy|0|||
37813903|NCT01729754|69491787|FG006|Part 2|Pregnancy|0|||
37813904|NCT01729754|69491788|FG007|Part 2|Pregnancy|0|||
37813905|NCT01729754|69491789|FG008|Part 2|Pregnancy|0|||
37977934|NCT00289900|69665030|FG004|Overall Study|Other|1|||
37977935|NCT00289900|69665031|FG005|Overall Study|Other|0|||
37977936|NCT00289900|69665026|FG000|Overall Study|Participant moved|1|||
37977937|NCT00289900|69665027|FG001|Overall Study|Participant moved|0|||
37977938|NCT00289900|69665028|FG002|Overall Study|Participant moved|0|||
37813906|NCT01729754|69491790|FG009|Part 2|Pregnancy|1|||
37977939|NCT00289900|69665029|FG003|Overall Study|Participant moved|1|||
37977940|NCT00289900|69665030|FG004|Overall Study|Participant moved|1|||
37977941|NCT00289900|69665031|FG005|Overall Study|Participant moved|1|||
37977942|NCT00289900|69665026|FG000|Overall Study|Withdrawal by Subject|10|||
37977943|NCT00289900|69665027|FG001|Overall Study|Withdrawal by Subject|21|||
37865335|NCT01078623|69548968|FG006|Treatment Period 2|Adverse Event|1|||
37865336|NCT01078623|69548969|FG007|Treatment Period 2|Adverse Event|0|||
37865337|NCT01078623|69548970|FG008|Treatment Period 2|Adverse Event|0|||
37865338|NCT01078623|69548971|FG009|Treatment Period 2|Adverse Event|0|||
37865339|NCT01078623|69548972|FG010|Treatment Period 2|Adverse Event|0|||
37865340|NCT01078623|69548973|FG011|Treatment Period 2|Adverse Event|0|||
37865341|NCT01078623|69548974|FG012|Treatment Period 2|Adverse Event|0|||
37865342|NCT01078623|69548975|FG013|Treatment Period 2|Adverse Event|0|||
37865343|NCT01078623|69548976|FG014|Treatment Period 2|Adverse Event|0|||
37865344|NCT01078623|69548977|FG015|Treatment Period 2|Adverse Event|0|||
37865345|NCT01078623|69548978|FG016|Treatment Period 2|Adverse Event|0|||
37865346|NCT01078623|69548979|FG017|Treatment Period 2|Adverse Event|0|||
37865347|NCT01078623|69548980|FG018|Treatment Period 2|Adverse Event|1|||
37865348|NCT01078623|69548981|FG019|Treatment Period 2|Adverse Event|0|||
37865349|NCT01078623|69548962|FG000|Treatment Period 2|Withdrawal by Subject|0|||
37865350|NCT01078623|69548963|FG001|Treatment Period 2|Withdrawal by Subject|0|||
37865351|NCT01078623|69548964|FG002|Treatment Period 2|Withdrawal by Subject|0|||
37865352|NCT01078623|69548965|FG003|Treatment Period 2|Withdrawal by Subject|0|||
37865353|NCT01078623|69548966|FG004|Treatment Period 2|Withdrawal by Subject|0|||
37865354|NCT01078623|69548967|FG005|Treatment Period 2|Withdrawal by Subject|1|||
37865355|NCT01078623|69548968|FG006|Treatment Period 2|Withdrawal by Subject|0|||
37865356|NCT01078623|69548969|FG007|Treatment Period 2|Withdrawal by Subject|0|||
37865357|NCT01078623|69548970|FG008|Treatment Period 2|Withdrawal by Subject|0|||
37865358|NCT01078623|69548971|FG009|Treatment Period 2|Withdrawal by Subject|0|||
37865359|NCT01078623|69548972|FG010|Treatment Period 2|Withdrawal by Subject|0|||
37865360|NCT01078623|69548973|FG011|Treatment Period 2|Withdrawal by Subject|0|||
37865361|NCT01078623|69548974|FG012|Treatment Period 2|Withdrawal by Subject|0|||
37865362|NCT01078623|69548975|FG013|Treatment Period 2|Withdrawal by Subject|0|||
37977944|NCT00289900|69665028|FG002|Overall Study|Withdrawal by Subject|8|||
37977945|NCT00289900|69665029|FG003|Overall Study|Withdrawal by Subject|18|||
37865363|NCT01078623|69548976|FG014|Treatment Period 2|Withdrawal by Subject|0|||
37865364|NCT01078623|69548977|FG015|Treatment Period 2|Withdrawal by Subject|0|||
37865365|NCT01078623|69548978|FG016|Treatment Period 2|Withdrawal by Subject|0|||
37865366|NCT01078623|69548979|FG017|Treatment Period 2|Withdrawal by Subject|0|||
37865367|NCT01078623|69548980|FG018|Treatment Period 2|Withdrawal by Subject|0|||
37865368|NCT01078623|69548981|FG019|Treatment Period 2|Withdrawal by Subject|0|||
37865369|NCT01078623|69548962|FG000|Treatment Period 3|Adverse Event|0|||
37865370|NCT01078623|69548963|FG001|Treatment Period 3|Adverse Event|0|||
37865371|NCT01078623|69548964|FG002|Treatment Period 3|Adverse Event|0|||
37865372|NCT01078623|69548965|FG003|Treatment Period 3|Adverse Event|0|||
37865373|NCT01078623|69548966|FG004|Treatment Period 3|Adverse Event|1|||
37865374|NCT01078623|69548967|FG005|Treatment Period 3|Adverse Event|0|||
37865375|NCT01078623|69548968|FG006|Treatment Period 3|Adverse Event|0|||
37865376|NCT01078623|69548969|FG007|Treatment Period 3|Adverse Event|0|||
37865377|NCT01078623|69548970|FG008|Treatment Period 3|Adverse Event|0|||
37865378|NCT01078623|69548971|FG009|Treatment Period 3|Adverse Event|0|||
37977946|NCT00289900|69665030|FG004|Overall Study|Withdrawal by Subject|12|||
37865379|NCT01078623|69548972|FG010|Treatment Period 3|Adverse Event|0|||
37865380|NCT01078623|69548973|FG011|Treatment Period 3|Adverse Event|0|||
37865381|NCT01078623|69548974|FG012|Treatment Period 3|Adverse Event|0|||
37865382|NCT01078623|69548975|FG013|Treatment Period 3|Adverse Event|1|||
37977947|NCT00289900|69665031|FG005|Overall Study|Withdrawal by Subject|11|||
37865383|NCT01078623|69548976|FG014|Treatment Period 3|Adverse Event|0|||
37865384|NCT01078623|69548977|FG015|Treatment Period 3|Adverse Event|0|||
37865385|NCT01078623|69548978|FG016|Treatment Period 3|Adverse Event|0|||
37865386|NCT01078623|69548979|FG017|Treatment Period 3|Adverse Event|0|||
37865387|NCT01078623|69548980|FG018|Treatment Period 3|Adverse Event|0|||
37865388|NCT01078623|69548981|FG019|Treatment Period 3|Adverse Event|0|||
37977948|NCT00289900|69665026|FG000|Overall Study|Protocol Violation|3|||
37977949|NCT00289900|69665027|FG001|Overall Study|Protocol Violation|9|||
37865389|NCT01078623|69548962|FG000|Treatment Period 4|Adverse Event|0|||
37865390|NCT01078623|69548963|FG001|Treatment Period 4|Adverse Event|0|||
37865391|NCT01078623|69548964|FG002|Treatment Period 4|Adverse Event|1|||
37865392|NCT01078623|69548965|FG003|Treatment Period 4|Adverse Event|0|||
37865393|NCT01078623|69548966|FG004|Treatment Period 4|Adverse Event|0|||
37865394|NCT01078623|69548967|FG005|Treatment Period 4|Adverse Event|0|||
37977950|NCT00289900|69665028|FG002|Overall Study|Protocol Violation|2|||
37977951|NCT00289900|69665029|FG003|Overall Study|Protocol Violation|6|||
37977952|NCT00289900|69665030|FG004|Overall Study|Protocol Violation|7|||
37977953|NCT00289900|69665031|FG005|Overall Study|Protocol Violation|4|||
37977954|NCT00289900|69665026|FG000|Overall Study|site terminated|1|||
37813907|NCT01729754|69491781|FG000|Part 2|Withdrawal by Subject|3|||
37813908|NCT01729754|69491782|FG001|Part 2|Withdrawal by Subject|0|||
37813909|NCT01729754|69491783|FG002|Part 2|Withdrawal by Subject|0|||
37813910|NCT01729754|69491784|FG003|Part 2|Withdrawal by Subject|2|||
37813911|NCT01729754|69491785|FG004|Part 2|Withdrawal by Subject|0|||
37813912|NCT01729754|69491786|FG005|Part 2|Withdrawal by Subject|0|||
37977955|NCT00289900|69665027|FG001|Overall Study|site terminated|0|||
37977956|NCT00289900|69665028|FG002|Overall Study|site terminated|1|||
37977957|NCT00289900|69665029|FG003|Overall Study|site terminated|0|||
37977958|NCT00289900|69665030|FG004|Overall Study|site terminated|0|||
37977959|NCT00289900|69665031|FG005|Overall Study|site terminated|0|||
37977960|NCT00289900|69665026|FG000|Overall Study|Not treated|0|||
37977961|NCT00289900|69665027|FG001|Overall Study|Not treated|1|||
37813913|NCT01729754|69491787|FG006|Part 2|Withdrawal by Subject|0|||
37813914|NCT01729754|69491788|FG007|Part 2|Withdrawal by Subject|1|||
37813915|NCT01729754|69491789|FG008|Part 2|Withdrawal by Subject|1|||
37813916|NCT01729754|69491790|FG009|Part 2|Withdrawal by Subject|4|||
37813917|NCT01729754|69491781|FG000|Part 2|Other Protocol Specified Criteria|1|||
37813918|NCT01729754|69491782|FG001|Part 2|Other Protocol Specified Criteria|0|||
37813919|NCT01729754|69491783|FG002|Part 2|Other Protocol Specified Criteria|0|||
37813920|NCT01729754|69491784|FG003|Part 2|Other Protocol Specified Criteria|0|||
37813921|NCT01729754|69491785|FG004|Part 2|Other Protocol Specified Criteria|0|||
37813922|NCT01729754|69491786|FG005|Part 2|Other Protocol Specified Criteria|0|||
37813923|NCT01729754|69491787|FG006|Part 2|Other Protocol Specified Criteria|0|||
37813924|NCT01729754|69491788|FG007|Part 2|Other Protocol Specified Criteria|1|||
37813925|NCT01729754|69491789|FG008|Part 2|Other Protocol Specified Criteria|0|||
37813926|NCT01729754|69491790|FG009|Part 2|Other Protocol Specified Criteria|0|||
37813927|NCT01729754|69491781|FG000|Part 3|Adverse Event|0|||
37813928|NCT01729754|69491782|FG001|Part 3|Adverse Event|0|||
37813929|NCT01729754|69491783|FG002|Part 3|Adverse Event|1|||
37813930|NCT01729754|69491784|FG003|Part 3|Adverse Event|0|||
37813931|NCT01729754|69491785|FG004|Part 3|Adverse Event|0|||
37813932|NCT01729754|69491786|FG005|Part 3|Adverse Event|5|||
37813933|NCT01729754|69491787|FG006|Part 3|Adverse Event|0|||
37813934|NCT01729754|69491788|FG007|Part 3|Adverse Event|0|||
37813935|NCT01729754|69491789|FG008|Part 3|Adverse Event|0|||
37813936|NCT01729754|69491790|FG009|Part 3|Adverse Event|3|||
37813937|NCT01729754|69491781|FG000|Part 3|Death|0|||
37813938|NCT01729754|69491782|FG001|Part 3|Death|0|||
37813939|NCT01729754|69491783|FG002|Part 3|Death|0|||
37813940|NCT01729754|69491784|FG003|Part 3|Death|0|||
37813941|NCT01729754|69491785|FG004|Part 3|Death|0|||
37813942|NCT01729754|69491786|FG005|Part 3|Death|2|||
37813943|NCT01729754|69491787|FG006|Part 3|Death|0|||
37813944|NCT01729754|69491788|FG007|Part 3|Death|0|||
37977962|NCT00289900|69665028|FG002|Overall Study|Not treated|0|||
37813945|NCT01729754|69491789|FG008|Part 3|Death|0|||
37813946|NCT01729754|69491790|FG009|Part 3|Death|0|||
37813947|NCT01729754|69491781|FG000|Part 3|Lack of Efficacy|0|||
37813948|NCT01729754|69491782|FG001|Part 3|Lack of Efficacy|0|||
37813949|NCT01729754|69491783|FG002|Part 3|Lack of Efficacy|0|||
37813950|NCT01729754|69491784|FG003|Part 3|Lack of Efficacy|0|||
37813951|NCT01729754|69491785|FG004|Part 3|Lack of Efficacy|2|||
37813952|NCT01729754|69491786|FG005|Part 3|Lack of Efficacy|0|||
37813953|NCT01729754|69491787|FG006|Part 3|Lack of Efficacy|0|||
37813954|NCT01729754|69491788|FG007|Part 3|Lack of Efficacy|0|||
37813955|NCT01729754|69491789|FG008|Part 3|Lack of Efficacy|0|||
37977963|NCT00289900|69665029|FG003|Overall Study|Not treated|0|||
37977964|NCT00289900|69665030|FG004|Overall Study|Not treated|0|||
37813956|NCT01729754|69491790|FG009|Part 3|Lack of Efficacy|4|||
37813957|NCT01729754|69491781|FG000|Part 3|Lost to Follow-up|0|||
37813958|NCT01729754|69491782|FG001|Part 3|Lost to Follow-up|1|||
37813959|NCT01729754|69491783|FG002|Part 3|Lost to Follow-up|2|||
37977965|NCT00289900|69665031|FG005|Overall Study|Not treated|0|||
37977966|NCT00543725|69665050|FG000|Overall Study|Adverse Event|18|||
37977967|NCT00543725|69665051|FG001|Overall Study|Adverse Event|27|||
37865395|NCT01078623|69548968|FG006|Treatment Period 4|Adverse Event|0|||
37865396|NCT01078623|69548969|FG007|Treatment Period 4|Adverse Event|0|||
37865397|NCT01078623|69548970|FG008|Treatment Period 4|Adverse Event|0|||
37865398|NCT01078623|69548971|FG009|Treatment Period 4|Adverse Event|0|||
37865399|NCT01078623|69548972|FG010|Treatment Period 4|Adverse Event|0|||
37977968|NCT00543725|69665050|FG000|Overall Study|Sponsor's Decision|0|||
37813960|NCT01729754|69491784|FG003|Part 3|Lost to Follow-up|0|||
37813961|NCT01729754|69491785|FG004|Part 3|Lost to Follow-up|0|||
37813962|NCT01729754|69491786|FG005|Part 3|Lost to Follow-up|3|||
37813963|NCT01729754|69491787|FG006|Part 3|Lost to Follow-up|0|||
37813964|NCT01729754|69491788|FG007|Part 3|Lost to Follow-up|0|||
37813965|NCT01729754|69491789|FG008|Part 3|Lost to Follow-up|1|||
37813966|NCT01729754|69491790|FG009|Part 3|Lost to Follow-up|0|||
37813967|NCT01729754|69491781|FG000|Part 3|Physician Decision|0|||
37813968|NCT01729754|69491782|FG001|Part 3|Physician Decision|0|||
37813969|NCT01729754|69491783|FG002|Part 3|Physician Decision|1|||
37813970|NCT01729754|69491784|FG003|Part 3|Physician Decision|0|||
37813971|NCT01729754|69491785|FG004|Part 3|Physician Decision|0|||
37813972|NCT01729754|69491786|FG005|Part 3|Physician Decision|0|||
37865400|NCT01078623|69548973|FG011|Treatment Period 4|Adverse Event|0|||
37865401|NCT01078623|69548974|FG012|Treatment Period 4|Adverse Event|0|||
37977969|NCT00543725|69665051|FG001|Overall Study|Sponsor's Decision|1|||
37813973|NCT01729754|69491787|FG006|Part 3|Physician Decision|0|||
37813974|NCT01729754|69491788|FG007|Part 3|Physician Decision|0|||
37865402|NCT01078623|69548975|FG013|Treatment Period 4|Adverse Event|0|||
37813975|NCT01729754|69491789|FG008|Part 3|Physician Decision|0|||
37813976|NCT01729754|69491790|FG009|Part 3|Physician Decision|0|||
37813977|NCT01729754|69491781|FG000|Part 3|Withdrawal by Subject|0|||
37813978|NCT01729754|69491782|FG001|Part 3|Withdrawal by Subject|4|||
37813979|NCT01729754|69491783|FG002|Part 3|Withdrawal by Subject|1|||
37813980|NCT01729754|69491784|FG003|Part 3|Withdrawal by Subject|0|||
37813981|NCT01729754|69491785|FG004|Part 3|Withdrawal by Subject|2|||
37813982|NCT01729754|69491786|FG005|Part 3|Withdrawal by Subject|1|||
37813983|NCT01729754|69491787|FG006|Part 3|Withdrawal by Subject|0|||
37813984|NCT01729754|69491788|FG007|Part 3|Withdrawal by Subject|2|||
37865403|NCT01078623|69548976|FG014|Treatment Period 4|Adverse Event|0|||
37865404|NCT01078623|69548977|FG015|Treatment Period 4|Adverse Event|0|||
37865405|NCT01078623|69548978|FG016|Treatment Period 4|Adverse Event|0|||
37865406|NCT01078623|69548979|FG017|Treatment Period 4|Adverse Event|0|||
37865407|NCT01078623|69548980|FG018|Treatment Period 4|Adverse Event|0|||
37865408|NCT01078623|69548981|FG019|Treatment Period 4|Adverse Event|0|||
37865409|NCT01078623|69548962|FG000|Treatment Period 4|Withdrawal by Subject|0|||
37865410|NCT01078623|69548963|FG001|Treatment Period 4|Withdrawal by Subject|0|||
37813985|NCT01729754|69491789|FG008|Part 3|Withdrawal by Subject|0|||
37865411|NCT01078623|69548964|FG002|Treatment Period 4|Withdrawal by Subject|0|||
37865412|NCT01078623|69548965|FG003|Treatment Period 4|Withdrawal by Subject|0|||
37865413|NCT01078623|69548966|FG004|Treatment Period 4|Withdrawal by Subject|0|||
37813986|NCT01729754|69491790|FG009|Part 3|Withdrawal by Subject|0|||
37813987|NCT01729754|69491781|FG000|Part 3|Other Protocol Specified Criteria|0|||
37813988|NCT01729754|69491782|FG001|Part 3|Other Protocol Specified Criteria|0|||
37813989|NCT01729754|69491783|FG002|Part 3|Other Protocol Specified Criteria|0|||
37813990|NCT01729754|69491784|FG003|Part 3|Other Protocol Specified Criteria|0|||
37813991|NCT01729754|69491785|FG004|Part 3|Other Protocol Specified Criteria|0|||
37813992|NCT01729754|69491786|FG005|Part 3|Other Protocol Specified Criteria|2|||
37813993|NCT01729754|69491787|FG006|Part 3|Other Protocol Specified Criteria|0|||
37813994|NCT01729754|69491788|FG007|Part 3|Other Protocol Specified Criteria|1|||
37865414|NCT01078623|69548967|FG005|Treatment Period 4|Withdrawal by Subject|0|||
37865415|NCT01078623|69548968|FG006|Treatment Period 4|Withdrawal by Subject|0|||
37865416|NCT01078623|69548969|FG007|Treatment Period 4|Withdrawal by Subject|0|||
37977970|NCT00543725|69665050|FG000|Overall Study|Subject Non-Compliant|4|||
37977971|NCT00543725|69665051|FG001|Overall Study|Subject Non-Compliant|4|||
37977972|NCT00543725|69665050|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
37977973|NCT00543725|69665051|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
37977974|NCT00543725|69665050|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
37977975|NCT00543725|69665051|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
37977976|NCT00543725|69665050|FG000|Overall Study|Protocol Violation|0|||
37977977|NCT00543725|69665051|FG001|Overall Study|Protocol Violation|1|||
37977978|NCT00543725|69665050|FG000|Overall Study|Withdrawal by Subject|4|||
37977979|NCT00543725|69665051|FG001|Overall Study|Withdrawal by Subject|13|||
37977980|NCT00543725|69665050|FG000|Overall Study|Lost to Follow-up|15|||
37977981|NCT00543725|69665051|FG001|Overall Study|Lost to Follow-up|11|||
37977982|NCT00543725|69665050|FG000|Overall Study|Other|3|||
37977983|NCT00543725|69665051|FG001|Overall Study|Other|3|||
37977984|NCT00269152|69665059|FG000|Overall Study|Adverse Event|9|||
37977985|NCT00269152|69665060|FG001|Overall Study|Adverse Event|3|||
37977986|NCT00269152|69665059|FG000|Overall Study|Withdrawal by Subject|7|||
37977987|NCT00269152|69665060|FG001|Overall Study|Withdrawal by Subject|3|||
37977988|NCT00269152|69665059|FG000|Overall Study|Physician Decision|2|||
37977989|NCT00269152|69665060|FG001|Overall Study|Physician Decision|3|||
37977990|NCT00269152|69665059|FG000|Overall Study|Protocol Violation|0|||
37977991|NCT00269152|69665060|FG001|Overall Study|Protocol Violation|1|||
37813995|NCT01729754|69491789|FG008|Part 3|Other Protocol Specified Criteria|0|||
37813996|NCT01729754|69491790|FG009|Part 3|Other Protocol Specified Criteria|0|||
37813997|NCT01515306|69491835|FG000|Overall Study|Adverse Event|3|||
37813998|NCT01515306|69491836|FG001|Overall Study|Adverse Event|2|||
37813999|NCT01515306|69491835|FG000|Overall Study|Progressive Disease|19|||
37814000|NCT01515306|69491836|FG001|Overall Study|Progressive Disease|9|||
37814001|NCT01515306|69491835|FG000|Overall Study|Withdrawal by Subject|1|||
37814002|NCT01515306|69491836|FG001|Overall Study|Withdrawal by Subject|2|||
37814003|NCT01515306|69491835|FG000|Overall Study|Physician Decision|1|||
37814004|NCT01515306|69491836|FG001|Overall Study|Physician Decision|1|||
37814005|NCT01423851|69491857|FG000|Whole Study|Disease progression|2|||
37814006|NCT01423851|69491858|FG001|Whole Study|Disease progression|1|||
37814007|NCT01423851|69491859|FG002|Whole Study|Disease progression|1|||
37814008|NCT01423851|69491860|FG003|Whole Study|Disease progression|4|||
37814009|NCT01423851|69491861|FG004|Whole Study|Disease progression|1|||
37814010|NCT01423851|69491862|FG005|Whole Study|Disease progression|3|||
37814011|NCT01423851|69491863|FG006|Whole Study|Disease progression|1|||
37814012|NCT01423851|69491864|FG007|Whole Study|Disease progression|4|||
37865417|NCT01078623|69548970|FG008|Treatment Period 4|Withdrawal by Subject|0|||
37865418|NCT01078623|69548971|FG009|Treatment Period 4|Withdrawal by Subject|0|||
37865419|NCT01078623|69548972|FG010|Treatment Period 4|Withdrawal by Subject|0|||
37865420|NCT01078623|69548973|FG011|Treatment Period 4|Withdrawal by Subject|0|||
37865421|NCT01078623|69548974|FG012|Treatment Period 4|Withdrawal by Subject|0|||
37865422|NCT01078623|69548975|FG013|Treatment Period 4|Withdrawal by Subject|0|||
37865423|NCT01078623|69548976|FG014|Treatment Period 4|Withdrawal by Subject|0|||
37865424|NCT01078623|69548977|FG015|Treatment Period 4|Withdrawal by Subject|1|||
37865425|NCT01078623|69548978|FG016|Treatment Period 4|Withdrawal by Subject|0|||
37865426|NCT01078623|69548979|FG017|Treatment Period 4|Withdrawal by Subject|0|||
37865427|NCT01078623|69548980|FG018|Treatment Period 4|Withdrawal by Subject|0|||
37865428|NCT01078623|69548981|FG019|Treatment Period 4|Withdrawal by Subject|0|||
37977992|NCT00379899|69665068|FG000|Overall Study|Adverse Event|7|||
37814013|NCT01423851|69491865|FG008|Whole Study|Disease progression|0|||
37814014|NCT01423851|69491866|FG009|Whole Study|Disease progression|2|||
37814015|NCT01423851|69491867|FG010|Whole Study|Disease progression|10|||
37814016|NCT01423851|69491857|FG000|Whole Study|Physician Decision|0|||
37814017|NCT01423851|69491858|FG001|Whole Study|Physician Decision|1|||
37814018|NCT01423851|69491859|FG002|Whole Study|Physician Decision|2|||
37814019|NCT01423851|69491860|FG003|Whole Study|Physician Decision|0|||
37814020|NCT01423851|69491861|FG004|Whole Study|Physician Decision|2|||
37865429|NCT01092507|69548995|FG000|Overall Study|Withdrawal by Subject|2|||
37865430|NCT01092507|69548996|FG001|Overall Study|Withdrawal by Subject|0|||
37865431|NCT01078545|69549002|FG000|Overall Study|Lost to Follow-up|13|||
37977993|NCT00379899|69665069|FG001|Overall Study|Adverse Event|3|||
37977994|NCT00379899|69665068|FG000|Overall Study|Death|10|||
37814021|NCT01423851|69491862|FG005|Whole Study|Physician Decision|0|||
37865432|NCT01078545|69549002|FG000|Overall Study|Physician Decision|6|||
37865433|NCT01078545|69549002|FG000|Overall Study|Withdrawal by Subject|3|||
37865434|NCT01078545|69549002|FG000|Overall Study|Death|3|||
37865435|NCT01078545|69549002|FG000|Overall Study|Participant moved to another physician|1|||
37865436|NCT01202760|69549009|FG000|Overall Study|Entry Criteria Not Met|0|||
37865437|NCT01202760|69549010|FG001|Overall Study|Entry Criteria Not Met|3|||
37865438|NCT01202760|69549011|FG002|Overall Study|Entry Criteria Not Met|1|||
37865439|NCT01202760|69549009|FG000|Overall Study|Adverse Event|11|||
37865440|NCT01202760|69549010|FG001|Overall Study|Adverse Event|9|||
37865441|NCT01202760|69549011|FG002|Overall Study|Adverse Event|10|||
37865442|NCT01202760|69549009|FG000|Overall Study|Death|2|||
37865443|NCT01202760|69549010|FG001|Overall Study|Death|1|||
37865444|NCT01202760|69549011|FG002|Overall Study|Death|0|||
37865445|NCT01202760|69549009|FG000|Overall Study|Lack of Efficacy|6|||
37865446|NCT01202760|69549010|FG001|Overall Study|Lack of Efficacy|8|||
37865447|NCT01202760|69549011|FG002|Overall Study|Lack of Efficacy|7|||
37865448|NCT01202760|69549009|FG000|Overall Study|Lost to Follow-up|0|||
37865449|NCT01202760|69549010|FG001|Overall Study|Lost to Follow-up|2|||
37977995|NCT00379899|69665069|FG001|Overall Study|Death|10|||
37977996|NCT00379899|69665068|FG000|Overall Study|Lost to Follow-up|2|||
37977997|NCT00379899|69665069|FG001|Overall Study|Lost to Follow-up|4|||
37977998|NCT00379899|69665068|FG000|Overall Study|Physician Decision|3|||
37977999|NCT00379899|69665069|FG001|Overall Study|Physician Decision|4|||
37978000|NCT00379899|69665068|FG000|Overall Study|Withdrawal by Subject|5|||
37978001|NCT00379899|69665069|FG001|Overall Study|Withdrawal by Subject|5|||
37978002|NCT00379899|69665068|FG000|Overall Study|Ineligibility determined|0|||
37865450|NCT01202760|69549011|FG002|Overall Study|Lost to Follow-up|1|||
37865451|NCT01202760|69549009|FG000|Overall Study|Parent / Caregiver Decision|0|||
37865452|NCT01202760|69549010|FG001|Overall Study|Parent / Caregiver Decision|1|||
37865453|NCT01202760|69549011|FG002|Overall Study|Parent / Caregiver Decision|0|||
37865454|NCT01202760|69549009|FG000|Overall Study|Withdrawal by Subject|17|||
37865455|NCT01202760|69549010|FG001|Overall Study|Withdrawal by Subject|18|||
37865456|NCT01202760|69549011|FG002|Overall Study|Withdrawal by Subject|14|||
37865457|NCT01202760|69549009|FG000|Overall Study|Physician Decision|0|||
37865458|NCT01202760|69549010|FG001|Overall Study|Physician Decision|1|||
37865459|NCT01202760|69549011|FG002|Overall Study|Physician Decision|0|||
37865460|NCT01202760|69549009|FG000|Overall Study|Protocol Violation|7|||
37865461|NCT01202760|69549010|FG001|Overall Study|Protocol Violation|5|||
37865462|NCT01202760|69549011|FG002|Overall Study|Protocol Violation|2|||
37865463|NCT01202760|69549009|FG000|Overall Study|Sponsor Decision|4|||
37865464|NCT01202760|69549010|FG001|Overall Study|Sponsor Decision|4|||
37865465|NCT01202760|69549011|FG002|Overall Study|Sponsor Decision|0|||
37865466|NCT01091259|69549031|FG000|Overall Study|Adverse Event|3|||
37865467|NCT01091259|69549031|FG000|Overall Study|Lack of Efficacy|2|||
37865468|NCT01091103|69549035|FG000|Overall Study|Adverse Event|1|||
37865469|NCT01091103|69549035|FG000|Overall Study|Progressive Disease|3|||
37865470|NCT01078389|69549043|FG000|Overall Study|Adverse Event|10|||
37865471|NCT01078389|69549044|FG001|Overall Study|Adverse Event|6|||
37865472|NCT01078389|69549043|FG000|Overall Study|Major Protocol Deviation|2|||
37865473|NCT01078389|69549044|FG001|Overall Study|Major Protocol Deviation|0|||
37865474|NCT01078389|69549043|FG000|Overall Study|Lost to Follow-up|23|||
37865475|NCT01078389|69549044|FG001|Overall Study|Lost to Follow-up|23|||
37865476|NCT01078389|69549043|FG000|Overall Study|Voluntary Withdrawal|20|||
37865477|NCT01078389|69549044|FG001|Overall Study|Voluntary Withdrawal|36|||
37865478|NCT01078389|69549043|FG000|Overall Study|Other|9|||
37865479|NCT01078389|69549044|FG001|Overall Study|Other|2|||
37865480|NCT01090323|69549052|FG000|Overall Study|Adverse Event|12|||
37865481|NCT01090323|69549053|FG001|Overall Study|Adverse Event|2|||
37865482|NCT01090323|69549052|FG000|Overall Study|Abnormal Lab Values|3|||
37865483|NCT01090323|69549053|FG001|Overall Study|Abnormal Lab Values|1|||
37865484|NCT01090323|69549052|FG000|Overall Study|Abnormal Test Procedure Results|2|||
37865485|NCT01090323|69549053|FG001|Overall Study|Abnormal Test Procedure Results|0|||
37865486|NCT01090323|69549052|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
37978003|NCT00379899|69665069|FG001|Overall Study|Ineligibility determined|1|||
37978004|NCT00379899|69665068|FG000|Overall Study|Noncompliance|1|||
37865487|NCT01090323|69549053|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
37865488|NCT01090323|69549052|FG000|Overall Study|Condition no longer requires drug|5|||
37865489|NCT01090323|69549053|FG001|Overall Study|Condition no longer requires drug|4|||
37978005|NCT00379899|69665069|FG001|Overall Study|Noncompliance|1|||
37978006|NCT00379899|69665068|FG000|Overall Study|Parathyroidectomy|0|||
37978007|NCT00379899|69665069|FG001|Overall Study|Parathyroidectomy|2|||
37865490|NCT01090323|69549052|FG000|Overall Study|Protocol Violation|2|||
37865491|NCT01090323|69549053|FG001|Overall Study|Protocol Violation|1|||
37978008|NCT00379899|69665068|FG000|Overall Study|Renal transplantation|5|||
37865492|NCT01090323|69549052|FG000|Overall Study|Withdrew consent|33|||
37865493|NCT01090323|69549053|FG001|Overall Study|Withdrew consent|11|||
37865494|NCT01090323|69549052|FG000|Overall Study|Lost to Follow-up|11|||
37865495|NCT01090323|69549053|FG001|Overall Study|Lost to Follow-up|6|||
37978009|NCT00379899|69665069|FG001|Overall Study|Renal transplantation|4|||
37865496|NCT01090323|69549052|FG000|Overall Study|Administrative problems|6|||
37865497|NCT01090323|69549053|FG001|Overall Study|Administrative problems|4|||
37865498|NCT01090323|69549052|FG000|Overall Study|Death|1|||
37865499|NCT01090323|69549053|FG001|Overall Study|Death|2|||
37865500|NCT01090323|69549052|FG000|Overall Study|Stopped end of core|7|||
37865501|NCT01090323|69549053|FG001|Overall Study|Stopped end of core|0|||
37865502|NCT01090323|69549052|FG000|Overall Study|Stopped end of extension 1#|3|||
37865503|NCT01090323|69549053|FG001|Overall Study|Stopped end of extension 1#|1|||
37865504|NCT01078155|69549059|FG000|Overall Study|Adverse Event|7|||
37814022|NCT01423851|69491863|FG006|Whole Study|Physician Decision|2|||
37814023|NCT01423851|69491864|FG007|Whole Study|Physician Decision|1|||
37814024|NCT01423851|69491865|FG008|Whole Study|Physician Decision|3|||
37814025|NCT01423851|69491866|FG009|Whole Study|Physician Decision|4|||
37814026|NCT01423851|69491867|FG010|Whole Study|Physician Decision|12|||
37814027|NCT01423851|69491857|FG000|Whole Study|Withdrawal by Subject|1|||
37814028|NCT01423851|69491858|FG001|Whole Study|Withdrawal by Subject|1|||
37814029|NCT01423851|69491859|FG002|Whole Study|Withdrawal by Subject|0|||
37814030|NCT01423851|69491860|FG003|Whole Study|Withdrawal by Subject|0|||
37814031|NCT01423851|69491861|FG004|Whole Study|Withdrawal by Subject|0|||
37814032|NCT01423851|69491862|FG005|Whole Study|Withdrawal by Subject|0|||
37814033|NCT01423851|69491863|FG006|Whole Study|Withdrawal by Subject|0|||
37865505|NCT01078155|69549059|FG000|Overall Study|Lack of Efficacy|16|||
37814034|NCT01423851|69491864|FG007|Whole Study|Withdrawal by Subject|0|||
37814035|NCT01423851|69491865|FG008|Whole Study|Withdrawal by Subject|2|||
37814036|NCT01423851|69491866|FG009|Whole Study|Withdrawal by Subject|0|||
37814037|NCT01423851|69491867|FG010|Whole Study|Withdrawal by Subject|4|||
37814038|NCT01423851|69491857|FG000|Whole Study|Adverse Event|0|||
37814039|NCT01423851|69491858|FG001|Whole Study|Adverse Event|0|||
37814040|NCT01423851|69491859|FG002|Whole Study|Adverse Event|0|||
37814041|NCT01423851|69491860|FG003|Whole Study|Adverse Event|2|||
37814042|NCT01423851|69491861|FG004|Whole Study|Adverse Event|0|||
37814043|NCT01423851|69491862|FG005|Whole Study|Adverse Event|0|||
37814044|NCT01423851|69491863|FG006|Whole Study|Adverse Event|0|||
37814045|NCT01423851|69491864|FG007|Whole Study|Adverse Event|3|||
37814046|NCT01423851|69491865|FG008|Whole Study|Adverse Event|3|||
37814047|NCT01423851|69491866|FG009|Whole Study|Adverse Event|2|||
37814048|NCT01423851|69491867|FG010|Whole Study|Adverse Event|3|||
37814049|NCT01334606|69491909|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
37814050|NCT01317875|69491925|FG000|Overall Study|Other|0|||
37814051|NCT01317875|69491926|FG001|Overall Study|Other|0|||
37814052|NCT01317875|69491927|FG002|Overall Study|Other|1|||
37814053|NCT01317875|69491928|FG003|Overall Study|Other|0|||
37814054|NCT01317875|69491929|FG004|Overall Study|Other|0|||
37814055|NCT01317875|69491930|FG005|Overall Study|Other|0|||
37814056|NCT01317875|69491931|FG006|Overall Study|Other|0|||
37814057|NCT01317875|69491932|FG007|Overall Study|Other|0|||
37814058|NCT01317875|69491933|FG008|Overall Study|Other|0|||
37814059|NCT01317875|69491934|FG009|Overall Study|Other|0|||
37814060|NCT01317875|69491925|FG000|Overall Study|Noncompliance with study drug|0|||
37814061|NCT01317875|69491926|FG001|Overall Study|Noncompliance with study drug|0|||
37814062|NCT01317875|69491927|FG002|Overall Study|Noncompliance with study drug|1|||
37814063|NCT01317875|69491928|FG003|Overall Study|Noncompliance with study drug|0|||
37814064|NCT01317875|69491929|FG004|Overall Study|Noncompliance with study drug|0|||
37814065|NCT01317875|69491930|FG005|Overall Study|Noncompliance with study drug|0|||
37814066|NCT01317875|69491931|FG006|Overall Study|Noncompliance with study drug|0|||
37814067|NCT01317875|69491932|FG007|Overall Study|Noncompliance with study drug|0|||
37814068|NCT01317875|69491933|FG008|Overall Study|Noncompliance with study drug|0|||
37814069|NCT01317875|69491934|FG009|Overall Study|Noncompliance with study drug|0|||
37814070|NCT01317875|69491925|FG000|Overall Study|Progressive Disease|1|||
37814071|NCT01317875|69491926|FG001|Overall Study|Progressive Disease|0|||
37814072|NCT01317875|69491927|FG002|Overall Study|Progressive Disease|2|||
37814073|NCT01317875|69491928|FG003|Overall Study|Progressive Disease|0|||
37865506|NCT01078155|69549059|FG000|Overall Study|Participant's Decision|6|||
37865507|NCT01078155|69549059|FG000|Overall Study|Lost to Follow-up|15|||
37814074|NCT01317875|69491929|FG004|Overall Study|Progressive Disease|1|||
37814075|NCT01317875|69491930|FG005|Overall Study|Progressive Disease|0|||
37814076|NCT01317875|69491931|FG006|Overall Study|Progressive Disease|0|||
37814077|NCT01317875|69491932|FG007|Overall Study|Progressive Disease|1|||
37814078|NCT01317875|69491933|FG008|Overall Study|Progressive Disease|0|||
37814079|NCT01317875|69491934|FG009|Overall Study|Progressive Disease|0|||
37814080|NCT01317875|69491925|FG000|Overall Study|Withdrawal by Subject|0|||
37814081|NCT01317875|69491926|FG001|Overall Study|Withdrawal by Subject|0|||
37814082|NCT01317875|69491927|FG002|Overall Study|Withdrawal by Subject|0|||
37814083|NCT01317875|69491928|FG003|Overall Study|Withdrawal by Subject|0|||
37814084|NCT01317875|69491929|FG004|Overall Study|Withdrawal by Subject|1|||
37814085|NCT01317875|69491930|FG005|Overall Study|Withdrawal by Subject|0|||
37814086|NCT01317875|69491931|FG006|Overall Study|Withdrawal by Subject|0|||
37814087|NCT01317875|69491932|FG007|Overall Study|Withdrawal by Subject|3|||
37814088|NCT01317875|69491933|FG008|Overall Study|Withdrawal by Subject|0|||
37865508|NCT01201356|69549063|FG000|Overall Study|Adverse Event|170|||
37865509|NCT01201356|69549063|FG000|Overall Study|Abnormal laboratory value(s)|51|||
37865510|NCT01201356|69549063|FG000|Overall Study|Abnormal test procedure result(s)|3|||
37865511|NCT01201356|69549063|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
37865512|NCT01201356|69549063|FG000|Overall Study|Condition no longer requires study drug|12|||
37865513|NCT01201356|69549063|FG000|Overall Study|Withdrawal by Subject|144|||
37865514|NCT01201356|69549063|FG000|Overall Study|Lost to Follow-up|50|||
37865515|NCT01201356|69549063|FG000|Overall Study|administrative problems|74|||
37865516|NCT01201356|69549063|FG000|Overall Study|Death|16|||
37865517|NCT01201356|69549063|FG000|Overall Study|Protocol Violation|12|||
37865518|NCT01200810|69549069|FG000|Overall Study|Physician Decision|1|||
37865519|NCT01200810|69549070|FG001|Overall Study|Physician Decision|0|||
37865520|NCT01200810|69549069|FG000|Overall Study|Withdrawal by Subject|1|||
37865521|NCT01200810|69549070|FG001|Overall Study|Withdrawal by Subject|2|||
37865522|NCT01200810|69549069|FG000|Overall Study|Sponsor stopped making study drug|3|||
37865523|NCT01200810|69549070|FG001|Overall Study|Sponsor stopped making study drug|3|||
37978010|NCT00379899|69665068|FG000|Overall Study|Coronary artery bypass graft|1|||
37978011|NCT00379899|69665069|FG001|Overall Study|Coronary artery bypass graft|1|||
37978012|NCT00379899|69665068|FG000|Overall Study|Other protocol-specified criteria|3|||
37814089|NCT01317875|69491934|FG009|Overall Study|Withdrawal by Subject|0|||
37865524|NCT01200342|69549076|FG000|Overall Study|Disease Progression|1|||
37978013|NCT00379899|69665069|FG001|Overall Study|Other protocol-specified criteria|4|||
37978014|NCT00379899|69665068|FG000|Overall Study|Other|3|||
37978015|NCT00379899|69665069|FG001|Overall Study|Other|1|||
37865525|NCT01199016|69549080|FG000|Overall Study|No longer meets eligibility criteria|4|||
37865526|NCT01199016|69549080|FG000|Overall Study|Entrance criteria|5|||
37865527|NCT01199016|69549080|FG000|Overall Study|Protocol Violation|9|||
37865528|NCT01199016|69549080|FG000|Overall Study|Other|13|||
37865529|NCT01199016|69549080|FG000|Overall Study|Withdrawal by Subject|21|||
37865530|NCT01199016|69549080|FG000|Overall Study|Lost to Follow-up|25|||
37865531|NCT01198548|69549084|FG000|Overall Study|Disease Progression|9|||
37865532|NCT01198548|69549084|FG000|Overall Study|Administrative Decision|1|||
37865533|NCT01198470|69549088|FG000|Overall Study|Adverse Event|2|||
37865534|NCT00977938|69549096|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
37865535|NCT00977938|69549097|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
37865536|NCT00977938|69549098|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
37865537|NCT00977938|69549099|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
37865538|NCT00977938|69549096|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
37865539|NCT00977938|69549097|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
37865540|NCT00977938|69549098|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
37865541|NCT00977938|69549099|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
37865542|NCT00977938|69549096|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
37865543|NCT00977938|69549097|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
37865544|NCT00977938|69549098|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
37865545|NCT00977938|69549099|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
37978016|NCT00371787|69665077|FG000|Overall Study|Withdrawal by Subject|3|||
37978017|NCT00371787|69665078|FG001|Overall Study|Withdrawal by Subject|1|||
37978018|NCT00363129|69665086|FG000|Overall Study|Withdrawal by Subject|11|||
37814090|NCT01317875|69491925|FG000|Overall Study|Physician Decision|0|||
37814091|NCT01317875|69491926|FG001|Overall Study|Physician Decision|1|||
37978019|NCT00363129|69665087|FG001|Overall Study|Withdrawal by Subject|18|||
37978020|NCT00363129|69665086|FG000|Overall Study|Adverse Event|8|||
37978021|NCT00363129|69665087|FG001|Overall Study|Adverse Event|3|||
37978022|NCT00363129|69665086|FG000|Overall Study|Alternate Treatment|2|||
37978023|NCT00363129|69665087|FG001|Overall Study|Alternate Treatment|4|||
37978024|NCT00363129|69665086|FG000|Overall Study|Other Medical Problems|2|||
37978025|NCT00363129|69665087|FG001|Overall Study|Other Medical Problems|4|||
37978026|NCT00363129|69665086|FG000|Overall Study|Death|0|||
37978027|NCT00363129|69665087|FG001|Overall Study|Death|1|||
37978028|NCT00363129|69665086|FG000|Overall Study|Other Reasons|6|||
37978029|NCT00363129|69665087|FG001|Overall Study|Other Reasons|3|||
37978030|NCT00268996|69665095|FG000|Overall Study|Adverse Event|11|||
37978031|NCT00268996|69665096|FG001|Overall Study|Adverse Event|7|||
37978032|NCT00268996|69665095|FG000|Overall Study|Lost to Follow-up|3|||
37978033|NCT00268996|69665096|FG001|Overall Study|Lost to Follow-up|1|||
37978034|NCT00268996|69665095|FG000|Overall Study|Withdrawal by Subject|5|||
37978035|NCT00268996|69665096|FG001|Overall Study|Withdrawal by Subject|11|||
37978036|NCT00268996|69665095|FG000|Overall Study|Non-compliance|1|||
37978037|NCT00268996|69665096|FG001|Overall Study|Non-compliance|0|||
37978038|NCT00268996|69665095|FG000|Overall Study|Other|1|||
37978039|NCT00268996|69665096|FG001|Overall Study|Other|1|||
37978040|NCT00371397|69665104|FG000|Session 1|Withdrawal by Subject|1|||
37978041|NCT00371397|69665105|FG001|Session 1|Withdrawal by Subject|0|||
37978042|NCT00371397|69665106|FG002|Session 1|Withdrawal by Subject|0|||
37694683|NCT02466659|69171204|FG001|Overall Study|Lost to Follow-up|2|||
37694684|NCT01891864|69171212|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
37694685|NCT01891864|69171213|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
37694686|NCT01891864|69171214|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
37694687|NCT01891864|69171215|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
37694688|NCT01891864|69171216|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
37694689|NCT01891864|69171217|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
37694690|NCT01891864|69171212|FG000|Treatment Period 1|Physician Decision|0|||
37694691|NCT01891864|69171213|FG001|Treatment Period 1|Physician Decision|1|||
37694692|NCT01891864|69171214|FG002|Treatment Period 1|Physician Decision|0|||
37694693|NCT01891864|69171215|FG003|Treatment Period 1|Physician Decision|0|||
37694694|NCT01891864|69171216|FG004|Treatment Period 1|Physician Decision|0|||
37694695|NCT01891864|69171217|FG005|Treatment Period 1|Physician Decision|0|||
37814092|NCT01317875|69491927|FG002|Overall Study|Physician Decision|1|||
37814093|NCT01317875|69491928|FG003|Overall Study|Physician Decision|0|||
37814094|NCT01317875|69491929|FG004|Overall Study|Physician Decision|2|||
37814095|NCT01317875|69491930|FG005|Overall Study|Physician Decision|0|||
37814096|NCT01317875|69491931|FG006|Overall Study|Physician Decision|0|||
37814097|NCT01317875|69491932|FG007|Overall Study|Physician Decision|2|||
37865546|NCT00977938|69549096|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
37865547|NCT00977938|69549097|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
37865548|NCT00977938|69549098|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
37865549|NCT00977938|69549099|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
37865550|NCT00977938|69549096|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
37865551|NCT00977938|69549097|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
37814098|NCT01317875|69491933|FG008|Overall Study|Physician Decision|0|||
37814099|NCT01317875|69491934|FG009|Overall Study|Physician Decision|0|||
37865552|NCT00977938|69549098|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
37865553|NCT00977938|69549099|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
37865554|NCT00977938|69549096|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
37865555|NCT00977938|69549097|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
37865556|NCT00977938|69549098|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
37865557|NCT00977938|69549099|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
37865558|NCT02716675|69549114|FG000|Overall Study|Death|2|||
37865559|NCT02716675|69549115|FG001|Overall Study|Death|3|||
37694696|NCT01891864|69171212|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
37694697|NCT01891864|69171213|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
37694698|NCT01891864|69171214|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
37694699|NCT01891864|69171215|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
37814100|NCT01317875|69491925|FG000|Overall Study|Death|0|||
37865560|NCT02716675|69549116|FG002|Overall Study|Death|0|||
37978043|NCT00371397|69665107|FG003|Session 1|Withdrawal by Subject|0|||
37978044|NCT00371397|69665108|FG004|Session 1|Withdrawal by Subject|0|||
37978045|NCT00371397|69665109|FG005|Session 1|Withdrawal by Subject|0|||
37978046|NCT00371397|69665110|FG006|Session 1|Withdrawal by Subject|0|||
37978047|NCT00371397|69665111|FG007|Session 1|Withdrawal by Subject|1|||
37978048|NCT00371397|69665112|FG008|Session 1|Withdrawal by Subject|0|||
37814101|NCT01317875|69491926|FG001|Overall Study|Death|0|||
37814102|NCT01317875|69491927|FG002|Overall Study|Death|2|||
37814103|NCT01317875|69491928|FG003|Overall Study|Death|1|||
37814104|NCT01317875|69491929|FG004|Overall Study|Death|0|||
37865561|NCT02716675|69549114|FG000|Overall Study|Physician Decision|2|||
37865562|NCT02716675|69549115|FG001|Overall Study|Physician Decision|1|||
37865563|NCT02716675|69549116|FG002|Overall Study|Physician Decision|1|||
37978049|NCT00371397|69665113|FG009|Session 1|Withdrawal by Subject|0|||
37978050|NCT00371397|69665114|FG010|Session 1|Withdrawal by Subject|0|||
37978051|NCT00371397|69665115|FG011|Session 1|Withdrawal by Subject|0|||
37978052|NCT00379587|69665121|FG000|Overall Study|Lost to Follow-up|2|||
37978053|NCT00289276|69665127|FG000|Second Part of FAST Study (Expansion)|Death|0|||
37978054|NCT00289276|69665128|FG001|Second Part of FAST Study (Expansion)|Death|2|||
37978055|NCT00289276|69665127|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
37978056|NCT00289276|69665128|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
37978057|NCT00289198|69665136|FG000|Overall Study|Adverse Event|0|||
37978058|NCT00289198|69665137|FG001|Overall Study|Adverse Event|2|||
37865564|NCT02716675|69549114|FG000|Overall Study|Lost to Follow-up|100|||
37865565|NCT02716675|69549115|FG001|Overall Study|Lost to Follow-up|87|||
37865566|NCT02716675|69549116|FG002|Overall Study|Lost to Follow-up|99|||
37865567|NCT02716675|69549114|FG000|Overall Study|Withdrawal by Subject|22|||
37865568|NCT02716675|69549115|FG001|Overall Study|Withdrawal by Subject|25|||
37978059|NCT00289198|69665136|FG000|Overall Study|Protocol Violation|2|||
37978060|NCT00289198|69665137|FG001|Overall Study|Protocol Violation|1|||
37814105|NCT01317875|69491930|FG005|Overall Study|Death|1|||
37814106|NCT01317875|69491931|FG006|Overall Study|Death|0|||
37978061|NCT00289198|69665136|FG000|Overall Study|Withdrawal by Subject|4|||
37978062|NCT00289198|69665137|FG001|Overall Study|Withdrawal by Subject|1|||
37978063|NCT00289198|69665136|FG000|Overall Study|Lack of Efficacy|2|||
37978064|NCT00289198|69665137|FG001|Overall Study|Lack of Efficacy|0|||
37978065|NCT00289198|69665136|FG000|Overall Study|Other: Low compliance|0|||
37978066|NCT00289198|69665137|FG001|Overall Study|Other: Low compliance|1|||
37978067|NCT00289198|69665136|FG000|Overall Study|Other: Physician's decision|0|||
37978068|NCT00289198|69665137|FG001|Overall Study|Other: Physician's decision|1|||
37978069|NCT00289198|69665136|FG000|Overall Study|Other: Unable to attend on schedule|2|||
37978070|NCT00289198|69665137|FG001|Overall Study|Other: Unable to attend on schedule|1|||
37978071|NCT00289198|69665136|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
37978072|NCT00289198|69665137|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
37978073|NCT00289198|69665136|FG000|Overall Study|Other: Impossible to come on visit|0|||
37978074|NCT00289198|69665137|FG001|Overall Study|Other: Impossible to come on visit|1|||
37978075|NCT00363051|69665146|FG000|Overall Study|Adminstrative problems|1|||
37978076|NCT00363051|69665147|FG001|Overall Study|Adminstrative problems|1|||
37978077|NCT00363051|69665146|FG000|Overall Study|Adverse Event|21|||
37978078|NCT00363051|69665147|FG001|Overall Study|Adverse Event|12|||
37978079|NCT00363051|69665146|FG000|Overall Study|New Cancer Therapy|2|||
37978080|NCT00363051|69665147|FG001|Overall Study|New Cancer Therapy|1|||
37978081|NCT00363051|69665146|FG000|Overall Study|Withdrawal by Subject|11|||
37978082|NCT00363051|69665147|FG001|Overall Study|Withdrawal by Subject|3|||
37978083|NCT00363051|69665146|FG000|Overall Study|Lost to Follow-up|0|||
37978084|NCT00363051|69665147|FG001|Overall Study|Lost to Follow-up|1|||
37978085|NCT00363051|69665146|FG000|Overall Study|Protocol Violation|0|||
37978086|NCT00363051|69665147|FG001|Overall Study|Protocol Violation|2|||
37978087|NCT00363051|69665146|FG000|Overall Study|Death|3|||
37814107|NCT01317875|69491932|FG007|Overall Study|Death|4|||
37814108|NCT01317875|69491933|FG008|Overall Study|Death|0|||
37814109|NCT01317875|69491934|FG009|Overall Study|Death|0|||
37814110|NCT01317875|69491925|FG000|Overall Study|Adverse Event|2|||
37814111|NCT01317875|69491926|FG001|Overall Study|Adverse Event|1|||
37814112|NCT01317875|69491927|FG002|Overall Study|Adverse Event|2|||
37814113|NCT01317875|69491928|FG003|Overall Study|Adverse Event|1|||
37814114|NCT01317875|69491929|FG004|Overall Study|Adverse Event|5|||
37814115|NCT01317875|69491930|FG005|Overall Study|Adverse Event|1|||
37814116|NCT01317875|69491931|FG006|Overall Study|Adverse Event|2|||
37814117|NCT01317875|69491932|FG007|Overall Study|Adverse Event|5|||
37978088|NCT00363051|69665147|FG001|Overall Study|Death|2|||
37978089|NCT00379353|69665157|FG000|Overall Study|Hospitalization|3|||
37978090|NCT00379353|69665158|FG001|Overall Study|Hospitalization|3|||
37865569|NCT02716675|69549116|FG002|Overall Study|Withdrawal by Subject|20|||
37978091|NCT00379353|69665157|FG000|Overall Study|Withdrawal by Subject|5|||
37814118|NCT01317875|69491933|FG008|Overall Study|Adverse Event|0|||
37814119|NCT01317875|69491934|FG009|Overall Study|Adverse Event|0|||
37814120|NCT00500071|69492010|FG000|Screening and Washout Phase|Protocol Violation|1|||
37865570|NCT02716675|69549114|FG000|Overall Study|Protocol Violation|0|||
37814121|NCT00500071|69492010|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
37978092|NCT00379353|69665158|FG001|Overall Study|Withdrawal by Subject|2|||
37978093|NCT00379353|69665157|FG000|Overall Study|Death|1|||
37978094|NCT00379353|69665158|FG001|Overall Study|Death|0|||
37978095|NCT00379353|69665157|FG000|Overall Study|Cardiac Tamponade|1|||
37978096|NCT00379353|69665158|FG001|Overall Study|Cardiac Tamponade|0|||
37978097|NCT00379353|69665157|FG000|Overall Study|Non-compliance|1|||
37978098|NCT00379353|69665158|FG001|Overall Study|Non-compliance|0|||
37978099|NCT00379353|69665157|FG000|Overall Study|Conflicting drug treatment|0|||
37978100|NCT00379353|69665158|FG001|Overall Study|Conflicting drug treatment|1|||
37978101|NCT00378573|69665174|FG000|Treatment Period|Adverse Event|9|||
37978102|NCT00378573|69665174|FG000|Treatment Period|Physician Decision|1|||
37978103|NCT00378573|69665174|FG000|Treatment Period|Withdrawal by Subject|2|||
37978104|NCT00378573|69665174|FG000|Treatment Period|Disease Progression|4|||
37978105|NCT00378573|69665174|FG000|Treatment Period|Sponsor decision to close study|1|||
37978106|NCT00378573|69665174|FG000|Follow-up|Death|12|||
37978107|NCT00378573|69665174|FG000|Follow-up|Lost to Follow-up|1|||
37978108|NCT00378573|69665174|FG000|Follow-up|Withdrawal by Subject|1|||
37978109|NCT03831945|69665180|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
37978110|NCT03831945|69665181|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
37978111|NCT03831945|69665180|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
37978112|NCT03831945|69665181|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
37978113|NCT03831945|69665180|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
37978114|NCT03831945|69665181|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
37978115|NCT00457002|69665189|FG000|Overall Study|Death|40|||
37978116|NCT00457002|69665190|FG001|Overall Study|Death|47|||
37978117|NCT00457002|69665189|FG000|Overall Study|Adverse Event|284|||
37978118|NCT00457002|69665190|FG001|Overall Study|Adverse Event|260|||
37978119|NCT00457002|69665189|FG000|Overall Study|Withdrawal by Subject|299|||
37978120|NCT00457002|69665190|FG001|Overall Study|Withdrawal by Subject|271|||
37978121|NCT00457002|69665189|FG000|Overall Study|Lost to Follow-up|72|||
37978122|NCT00457002|69665190|FG001|Overall Study|Lost to Follow-up|71|||
37978123|NCT00457002|69665189|FG000|Overall Study|Poor/Non-compliance|46|||
37978124|NCT00457002|69665190|FG001|Overall Study|Poor/Non-compliance|33|||
37978125|NCT00457002|69665189|FG000|Overall Study|No longer met criteria|41|||
37978126|NCT00457002|69665190|FG001|Overall Study|No longer met criteria|37|||
37978127|NCT00457002|69665189|FG000|Overall Study|Administrative reason by Sponsor|1|||
37978128|NCT00457002|69665190|FG001|Overall Study|Administrative reason by Sponsor|0|||
37978129|NCT00457002|69665189|FG000|Overall Study|non-specified|29|||
37814122|NCT00500071|69492010|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
37814123|NCT00500071|69492010|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
37814124|NCT00500071|69492010|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
37814125|NCT00500071|69492010|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
37814126|NCT00500071|69492010|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
37814127|NCT00447122|69492018|FG000|Overall Study|worsening medical condition -came off|0|||
37814128|NCT00447122|69492019|FG001|Overall Study|worsening medical condition -came off|1|||
37814129|NCT00447122|69492020|FG002|Overall Study|worsening medical condition -came off|0|||
37814130|NCT00447122|69492021|FG003|Overall Study|worsening medical condition -came off|0|||
37814131|NCT00382252|69492031|FG000|Overall Study|Death|4|||
37814132|NCT00382252|69492031|FG000|Overall Study|Protocol Violation|8|||
37814133|NCT00382252|69492031|FG000|Overall Study|Not treated by RFA|1|||
37814134|NCT00290251|69492038|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
37814135|NCT00290251|69492039|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
37814136|NCT00290251|69492040|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
37814137|NCT00290251|69492041|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
37814138|NCT00290251|69492042|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
37814139|NCT00290251|69492043|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
37814140|NCT00290251|69492038|FG000|Treatment 1 (Months 2-4)|headache|0|||
37814141|NCT00290251|69492039|FG001|Treatment 1 (Months 2-4)|headache|0|||
37814142|NCT00290251|69492040|FG002|Treatment 1 (Months 2-4)|headache|0|||
37814143|NCT00290251|69492041|FG003|Treatment 1 (Months 2-4)|headache|0|||
37814144|NCT00290251|69492042|FG004|Treatment 1 (Months 2-4)|headache|1|||
37814145|NCT00290251|69492043|FG005|Treatment 1 (Months 2-4)|headache|0|||
37814146|NCT00290251|69492038|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
37814147|NCT00290251|69492039|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
37814148|NCT00290251|69492040|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
37814149|NCT00290251|69492041|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
37814150|NCT00290251|69492042|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
37814151|NCT00290251|69492043|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
37814152|NCT01403948|69492079|FG000|Overall Study|Progressive disease|0|||
37814153|NCT01403948|69492080|FG001|Overall Study|Progressive disease|2|||
37814154|NCT01403948|69492081|FG002|Overall Study|Progressive disease|2|||
37814155|NCT01403948|69492082|FG003|Overall Study|Progressive disease|4|||
37814156|NCT01403948|69492083|FG004|Overall Study|Progressive disease|2|||
37814157|NCT01403948|69492084|FG005|Overall Study|Progressive disease|6|||
37814158|NCT01403948|69492085|FG006|Overall Study|Progressive disease|2|||
37814159|NCT01403948|69492086|FG007|Overall Study|Progressive disease|4|||
37814160|NCT01403948|69492087|FG008|Overall Study|Progressive disease|5|||
37814161|NCT01403948|69492088|FG009|Overall Study|Progressive disease|5|||
37814162|NCT01403948|69492079|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
37814163|NCT01403948|69492080|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
37814164|NCT01403948|69492081|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
37814165|NCT01403948|69492082|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
37814166|NCT01403948|69492083|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
37814167|NCT01403948|69492084|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
37814168|NCT01403948|69492085|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
37814169|NCT01403948|69492086|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
37814170|NCT01403948|69492087|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
37814171|NCT01403948|69492088|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
37814172|NCT01403948|69492079|FG000|Overall Study|Lost to Follow-up|0|||
37814173|NCT01403948|69492080|FG001|Overall Study|Lost to Follow-up|0|||
37814174|NCT01403948|69492081|FG002|Overall Study|Lost to Follow-up|0|||
37814175|NCT01403948|69492082|FG003|Overall Study|Lost to Follow-up|0|||
37814176|NCT01403948|69492083|FG004|Overall Study|Lost to Follow-up|0|||
37814177|NCT01403948|69492084|FG005|Overall Study|Lost to Follow-up|0|||
37814178|NCT01403948|69492085|FG006|Overall Study|Lost to Follow-up|0|||
37814179|NCT01403948|69492086|FG007|Overall Study|Lost to Follow-up|0|||
37814180|NCT01403948|69492087|FG008|Overall Study|Lost to Follow-up|0|||
37814181|NCT01403948|69492088|FG009|Overall Study|Lost to Follow-up|1|||
37814182|NCT01403948|69492079|FG000|Overall Study|Refused cont. medication|0|||
37814183|NCT01403948|69492080|FG001|Overall Study|Refused cont. medication|0|||
37814184|NCT01403948|69492081|FG002|Overall Study|Refused cont. medication|0|||
37814185|NCT01403948|69492082|FG003|Overall Study|Refused cont. medication|0|||
37814186|NCT01403948|69492083|FG004|Overall Study|Refused cont. medication|1|||
37814187|NCT01403948|69492084|FG005|Overall Study|Refused cont. medication|0|||
37978130|NCT00457002|69665190|FG001|Overall Study|non-specified|38|||
37978131|NCT00457002|69665189|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
37978132|NCT00457002|69665190|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
37978133|NCT00362115|69665203|FG000|Overall Study|Adverse Event|0|||
37978134|NCT00362115|69665204|FG001|Overall Study|Adverse Event|1|||
37978135|NCT00362115|69665205|FG002|Overall Study|Adverse Event|1|||
37978136|NCT00362115|69665206|FG003|Overall Study|Adverse Event|1|||
37978137|NCT00362115|69665207|FG004|Overall Study|Adverse Event|2|||
37978138|NCT00362115|69665208|FG005|Overall Study|Adverse Event|2|||
37978139|NCT00362115|69665209|FG006|Overall Study|Adverse Event|1|||
37978140|NCT00362115|69665203|FG000|Overall Study|Protocol Violation|0|||
37978141|NCT00362115|69665204|FG001|Overall Study|Protocol Violation|0|||
37978142|NCT00362115|69665205|FG002|Overall Study|Protocol Violation|0|||
37978143|NCT00362115|69665206|FG003|Overall Study|Protocol Violation|0|||
37978144|NCT00362115|69665207|FG004|Overall Study|Protocol Violation|0|||
37978145|NCT00362115|69665208|FG005|Overall Study|Protocol Violation|1|||
37978146|NCT00362115|69665209|FG006|Overall Study|Protocol Violation|0|||
37978147|NCT00362115|69665203|FG000|Overall Study|Lost to Follow-up|0|||
37978148|NCT00362115|69665204|FG001|Overall Study|Lost to Follow-up|1|||
37978149|NCT00362115|69665205|FG002|Overall Study|Lost to Follow-up|0|||
37978150|NCT00362115|69665206|FG003|Overall Study|Lost to Follow-up|0|||
37814188|NCT01403948|69492085|FG006|Overall Study|Refused cont. medication|0|||
37978151|NCT00362115|69665207|FG004|Overall Study|Lost to Follow-up|2|||
37978152|NCT00362115|69665208|FG005|Overall Study|Lost to Follow-up|0|||
37978153|NCT00362115|69665209|FG006|Overall Study|Lost to Follow-up|1|||
37978154|NCT00362115|69665203|FG000|Overall Study|Withdrawal by Subject|1|||
37978155|NCT00362115|69665204|FG001|Overall Study|Withdrawal by Subject|3|||
37814189|NCT01403948|69492086|FG007|Overall Study|Refused cont. medication|0|||
37814190|NCT01403948|69492087|FG008|Overall Study|Refused cont. medication|0|||
37978156|NCT00362115|69665205|FG002|Overall Study|Withdrawal by Subject|1|||
37978157|NCT00362115|69665206|FG003|Overall Study|Withdrawal by Subject|0|||
37978158|NCT00362115|69665207|FG004|Overall Study|Withdrawal by Subject|1|||
37978159|NCT00362115|69665208|FG005|Overall Study|Withdrawal by Subject|3|||
37978160|NCT00362115|69665209|FG006|Overall Study|Withdrawal by Subject|4|||
37978161|NCT00362115|69665203|FG000|Overall Study|Lack of Efficacy|1|||
37978162|NCT00362115|69665204|FG001|Overall Study|Lack of Efficacy|0|||
37978163|NCT00362115|69665205|FG002|Overall Study|Lack of Efficacy|5|||
37978164|NCT00362115|69665206|FG003|Overall Study|Lack of Efficacy|2|||
37978165|NCT00362115|69665207|FG004|Overall Study|Lack of Efficacy|2|||
37978166|NCT00362115|69665208|FG005|Overall Study|Lack of Efficacy|0|||
37978167|NCT00362115|69665209|FG006|Overall Study|Lack of Efficacy|3|||
37978168|NCT00362115|69665203|FG000|Overall Study|Physician Decision|0|||
37978169|NCT00362115|69665204|FG001|Overall Study|Physician Decision|0|||
37978170|NCT00362115|69665205|FG002|Overall Study|Physician Decision|0|||
37978171|NCT00362115|69665206|FG003|Overall Study|Physician Decision|0|||
37978172|NCT00362115|69665207|FG004|Overall Study|Physician Decision|0|||
37978173|NCT00362115|69665208|FG005|Overall Study|Physician Decision|0|||
37978174|NCT00362115|69665209|FG006|Overall Study|Physician Decision|3|||
37978175|NCT00362115|69665203|FG000|Overall Study|Other|0|||
37978176|NCT00362115|69665204|FG001|Overall Study|Other|1|||
37978177|NCT00362115|69665205|FG002|Overall Study|Other|0|||
37978178|NCT00362115|69665206|FG003|Overall Study|Other|1|||
37978179|NCT00362115|69665207|FG004|Overall Study|Other|0|||
37978180|NCT00362115|69665208|FG005|Overall Study|Other|1|||
37978181|NCT00362115|69665209|FG006|Overall Study|Other|0|||
37978182|NCT00485264|69665231|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
37978183|NCT00485264|69665232|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
37978184|NCT00485264|69665233|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
37978185|NCT00485264|69665234|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
37814191|NCT01403948|69492088|FG009|Overall Study|Refused cont. medication|1|||
37814192|NCT01403948|69492079|FG000|Overall Study|other than above|1|||
37814193|NCT01403948|69492080|FG001|Overall Study|other than above|2|||
37814194|NCT01403948|69492081|FG002|Overall Study|other than above|1|||
37814195|NCT01403948|69492082|FG003|Overall Study|other than above|0|||
37978186|NCT00485264|69665235|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
37978187|NCT00485264|69665236|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
37978188|NCT00485264|69665231|FG000|Overall Study|Death|1|||
37978189|NCT00485264|69665232|FG001|Overall Study|Death|0|||
37978190|NCT00485264|69665233|FG002|Overall Study|Death|0|||
37978191|NCT00485264|69665234|FG003|Overall Study|Death|0|||
37978192|NCT00485264|69665235|FG004|Overall Study|Death|1|||
37978193|NCT00485264|69665236|FG005|Overall Study|Death|0|||
37978194|NCT00485264|69665231|FG000|Overall Study|Adverse Event|1|||
37978195|NCT00485264|69665232|FG001|Overall Study|Adverse Event|0|||
37978196|NCT00485264|69665233|FG002|Overall Study|Adverse Event|2|||
37978197|NCT00485264|69665234|FG003|Overall Study|Adverse Event|3|||
37978198|NCT00485264|69665235|FG004|Overall Study|Adverse Event|1|||
37978199|NCT00485264|69665236|FG005|Overall Study|Adverse Event|3|||
37978200|NCT00485264|69665231|FG000|Overall Study|Pregnancy|4|||
37978201|NCT00485264|69665232|FG001|Overall Study|Pregnancy|0|||
37814196|NCT01403948|69492083|FG004|Overall Study|other than above|1|||
37978202|NCT00485264|69665233|FG002|Overall Study|Pregnancy|0|||
37978203|NCT00485264|69665234|FG003|Overall Study|Pregnancy|0|||
37978204|NCT00485264|69665235|FG004|Overall Study|Pregnancy|0|||
37978205|NCT00485264|69665236|FG005|Overall Study|Pregnancy|0|||
37978206|NCT00485264|69665231|FG000|Overall Study|Disallowed Medication|0|||
37978207|NCT00485264|69665232|FG001|Overall Study|Disallowed Medication|0|||
37978208|NCT00485264|69665233|FG002|Overall Study|Disallowed Medication|0|||
37978209|NCT00485264|69665234|FG003|Overall Study|Disallowed Medication|0|||
37978210|NCT00485264|69665235|FG004|Overall Study|Disallowed Medication|0|||
37978211|NCT00485264|69665236|FG005|Overall Study|Disallowed Medication|1|||
37978212|NCT00485264|69665231|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
37978213|NCT00485264|69665232|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
37978214|NCT00485264|69665233|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
37978215|NCT00485264|69665234|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
37978216|NCT00485264|69665235|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
37978217|NCT00485264|69665236|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
37978218|NCT00485264|69665231|FG000|Overall Study|Lack of Efficacy|0|||
37978219|NCT00485264|69665232|FG001|Overall Study|Lack of Efficacy|1|||
37978220|NCT00485264|69665233|FG002|Overall Study|Lack of Efficacy|0|||
37978221|NCT00485264|69665234|FG003|Overall Study|Lack of Efficacy|0|||
37978222|NCT00485264|69665235|FG004|Overall Study|Lack of Efficacy|0|||
37978223|NCT00485264|69665236|FG005|Overall Study|Lack of Efficacy|0|||
37978224|NCT00485264|69665231|FG000|Overall Study|Guardian Consent Withdrawn|1|||
37978225|NCT00485264|69665232|FG001|Overall Study|Guardian Consent Withdrawn|0|||
37978226|NCT00485264|69665233|FG002|Overall Study|Guardian Consent Withdrawn|0|||
37978227|NCT00485264|69665234|FG003|Overall Study|Guardian Consent Withdrawn|0|||
37978228|NCT00485264|69665235|FG004|Overall Study|Guardian Consent Withdrawn|1|||
37978229|NCT00485264|69665236|FG005|Overall Study|Guardian Consent Withdrawn|0|||
37978230|NCT00485264|69665231|FG000|Overall Study|Physician Decision|0|||
37978231|NCT00485264|69665232|FG001|Overall Study|Physician Decision|2|||
37978232|NCT00485264|69665233|FG002|Overall Study|Physician Decision|0|||
37978233|NCT00485264|69665234|FG003|Overall Study|Physician Decision|0|||
37978234|NCT00485264|69665235|FG004|Overall Study|Physician Decision|0|||
37978235|NCT00485264|69665236|FG005|Overall Study|Physician Decision|0|||
37978236|NCT00485264|69665231|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
37978237|NCT00485264|69665232|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
37978238|NCT00485264|69665233|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
37978239|NCT00485264|69665234|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
37978240|NCT00485264|69665235|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
37978241|NCT00485264|69665236|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
37978242|NCT00485264|69665231|FG000|Overall Study|Not Able to Attend Clinic|5|||
37978243|NCT00485264|69665232|FG001|Overall Study|Not Able to Attend Clinic|0|||
37978244|NCT00485264|69665233|FG002|Overall Study|Not Able to Attend Clinic|0|||
37978245|NCT00485264|69665234|FG003|Overall Study|Not Able to Attend Clinic|1|||
37978246|NCT00485264|69665235|FG004|Overall Study|Not Able to Attend Clinic|1|||
37978247|NCT00485264|69665236|FG005|Overall Study|Not Able to Attend Clinic|2|||
37978248|NCT00485264|69665231|FG000|Overall Study|Non-Compliant|17|||
37978249|NCT00485264|69665232|FG001|Overall Study|Non-Compliant|2|||
37978250|NCT00485264|69665233|FG002|Overall Study|Non-Compliant|1|||
37978251|NCT00485264|69665234|FG003|Overall Study|Non-Compliant|0|||
37978252|NCT00485264|69665235|FG004|Overall Study|Non-Compliant|1|||
37978253|NCT00485264|69665236|FG005|Overall Study|Non-Compliant|0|||
37978254|NCT00485264|69665231|FG000|Overall Study|Lost to Follow-up|2|||
37978255|NCT00485264|69665232|FG001|Overall Study|Lost to Follow-up|1|||
37978256|NCT00485264|69665233|FG002|Overall Study|Lost to Follow-up|1|||
37978257|NCT00485264|69665234|FG003|Overall Study|Lost to Follow-up|0|||
37978258|NCT00485264|69665235|FG004|Overall Study|Lost to Follow-up|0|||
37978259|NCT00485264|69665236|FG005|Overall Study|Lost to Follow-up|1|||
37978260|NCT00485264|69665231|FG000|Overall Study|Other Reason|3|||
37978261|NCT00485264|69665232|FG001|Overall Study|Other Reason|0|||
37978262|NCT00485264|69665233|FG002|Overall Study|Other Reason|0|||
37978263|NCT00485264|69665234|FG003|Overall Study|Other Reason|0|||
37978264|NCT00485264|69665235|FG004|Overall Study|Other Reason|0|||
37978265|NCT00485264|69665236|FG005|Overall Study|Other Reason|0|||
37978266|NCT00293254|69665257|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
37978267|NCT00293254|69665258|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
37978268|NCT00293254|69665257|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
37978269|NCT00293254|69665258|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
37978270|NCT00293254|69665257|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
37978271|NCT00293254|69665258|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
37978272|NCT00293254|69665257|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
37978273|NCT00293254|69665258|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
37978274|NCT00293254|69665257|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
37978275|NCT00293254|69665258|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
37978276|NCT00293254|69665257|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
37978277|NCT00293254|69665258|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
37978278|NCT00293254|69665257|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
37978279|NCT00293254|69665258|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
37978280|NCT00293254|69665257|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
37978281|NCT00293254|69665258|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
37978282|NCT00293254|69665257|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
37978283|NCT00293254|69665258|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
37978284|NCT00293254|69665257|FG000|Extension - Double-Blind Week 49-156|Death|4|||
37978285|NCT00293254|69665258|FG001|Extension - Double-Blind Week 49-156|Death|1|||
37978286|NCT00293254|69665257|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
37978287|NCT00293254|69665258|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
37978288|NCT00293254|69665257|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
37978289|NCT00293254|69665258|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
37978290|NCT00293254|69665257|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
37978291|NCT00293254|69665258|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
37978292|NCT00293254|69665257|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
37978293|NCT00293254|69665258|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
37978294|NCT00293254|69665257|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
37978295|NCT00293254|69665258|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
37978296|NCT00293254|69665257|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
37978297|NCT00293254|69665258|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
37978298|NCT00293254|69665257|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
37978299|NCT00293254|69665258|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
37978300|NCT00293254|69665257|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
37978301|NCT00293254|69665258|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
37978302|NCT00293254|69665257|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
37978303|NCT00293254|69665258|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
37978304|NCT00293254|69665257|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
37978305|NCT00293254|69665258|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
37694700|NCT01891864|69171216|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
37694701|NCT01891864|69171217|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
37694702|NCT01891864|69171212|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
37694703|NCT01891864|69171213|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
37694704|NCT01891864|69171214|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
37694705|NCT01891864|69171215|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
37694706|NCT01891864|69171216|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
37694707|NCT01891864|69171217|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
37694708|NCT01891864|69171212|FG000|Treatment Period 1|Withdrawal by Subject|2|||
37694709|NCT01891864|69171213|FG001|Treatment Period 1|Withdrawal by Subject|5|||
37694710|NCT01891864|69171214|FG002|Treatment Period 1|Withdrawal by Subject|0|||
37694711|NCT01891864|69171215|FG003|Treatment Period 1|Withdrawal by Subject|0|||
37694712|NCT01891864|69171216|FG004|Treatment Period 1|Withdrawal by Subject|0|||
37694713|NCT01891864|69171217|FG005|Treatment Period 1|Withdrawal by Subject|0|||
37694714|NCT01891864|69171212|FG000|Treatment Period 1|Lost to Follow-up|1|||
37694715|NCT01891864|69171213|FG001|Treatment Period 1|Lost to Follow-up|0|||
37694716|NCT01891864|69171214|FG002|Treatment Period 1|Lost to Follow-up|0|||
37694717|NCT01891864|69171215|FG003|Treatment Period 1|Lost to Follow-up|0|||
37694718|NCT01891864|69171216|FG004|Treatment Period 1|Lost to Follow-up|0|||
37694719|NCT01891864|69171217|FG005|Treatment Period 1|Lost to Follow-up|0|||
37694720|NCT01891864|69171212|FG000|Treatment Period 2|Protocol Violation|0|||
37694721|NCT01891864|69171213|FG001|Treatment Period 2|Protocol Violation|0|||
37694722|NCT01891864|69171214|FG002|Treatment Period 2|Protocol Violation|0|||
37694723|NCT01891864|69171215|FG003|Treatment Period 2|Protocol Violation|1|||
37694724|NCT01891864|69171216|FG004|Treatment Period 2|Protocol Violation|0|||
37694725|NCT01891864|69171217|FG005|Treatment Period 2|Protocol Violation|0|||
37694726|NCT01891864|69171212|FG000|Treatment Period 2|Physician Decision|0|||
37694727|NCT01891864|69171213|FG001|Treatment Period 2|Physician Decision|0|||
37694728|NCT01891864|69171214|FG002|Treatment Period 2|Physician Decision|1|||
37694729|NCT01891864|69171215|FG003|Treatment Period 2|Physician Decision|0|||
37694730|NCT01891864|69171216|FG004|Treatment Period 2|Physician Decision|0|||
37978306|NCT00293254|69665257|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
37978307|NCT00293254|69665258|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
37978308|NCT00293254|69665257|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
37978309|NCT00293254|69665258|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
37978310|NCT00293254|69665257|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
37694731|NCT01891864|69171217|FG005|Treatment Period 2|Physician Decision|0|||
37814197|NCT01403948|69492084|FG005|Overall Study|other than above|1|||
37814198|NCT01403948|69492085|FG006|Overall Study|other than above|2|||
37814199|NCT01403948|69492086|FG007|Overall Study|other than above|0|||
37814200|NCT01403948|69492087|FG008|Overall Study|other than above|0|||
37814201|NCT01403948|69492088|FG009|Overall Study|other than above|0|||
37814202|NCT01404312|69492116|FG000|Overall Study|Death|21|||
37814203|NCT01404312|69492117|FG001|Overall Study|Death|27|||
37978311|NCT00293254|69665258|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
37978312|NCT00293254|69665257|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
37978313|NCT00293254|69665258|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
37978314|NCT00293254|69665257|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
37814204|NCT01404312|69492116|FG000|Overall Study|Withdrawal by Subject|15|||
37814205|NCT01404312|69492117|FG001|Overall Study|Withdrawal by Subject|18|||
37814206|NCT01404312|69492116|FG000|Overall Study|Participant Unable to get to clinic|93|||
37814207|NCT01404312|69492117|FG001|Overall Study|Participant Unable to get to clinic|103|||
37814208|NCT01404312|69492116|FG000|Overall Study|Lost to Follow-up|115|||
37814209|NCT01404312|69492117|FG001|Overall Study|Lost to Follow-up|111|||
37814210|NCT01404312|69492116|FG000|Overall Study|Site closed|22|||
37814211|NCT01404312|69492117|FG001|Overall Study|Site closed|21|||
37694732|NCT01891864|69171212|FG000|Treatment Period 2|Site Termination|0|||
37814212|NCT01404312|69492116|FG000|Overall Study|Participant not willing to adhere to req|31|||
37814213|NCT01404312|69492117|FG001|Overall Study|Participant not willing to adhere to req|29|||
37865571|NCT02716675|69549115|FG001|Overall Study|Protocol Violation|3|||
37978315|NCT00293254|69665258|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
37978316|NCT00293254|69665257|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
37978317|NCT00293254|69665258|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
37978318|NCT00293254|69665257|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
37978319|NCT00293254|69665258|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
37978320|NCT00456846|69665272|FG000|Overall Study|Adverse Event|2|||
37978321|NCT00456846|69665273|FG001|Overall Study|Adverse Event|15|||
37978322|NCT00456846|69665272|FG000|Overall Study|Physician Decision|11|||
37978323|NCT00456846|69665273|FG001|Overall Study|Physician Decision|6|||
37978324|NCT00456846|69665272|FG000|Overall Study|Protocol Deviation|2|||
37978325|NCT00456846|69665273|FG001|Overall Study|Protocol Deviation|0|||
37978326|NCT00456846|69665272|FG000|Overall Study|Participant Discretion|1|||
37978327|NCT00456846|69665273|FG001|Overall Study|Participant Discretion|5|||
37978328|NCT00456846|69665272|FG000|Overall Study|Other|0|||
37978329|NCT00456846|69665273|FG001|Overall Study|Other|2|||
37978330|NCT00448344|69665281|FG000|Overall Study|Lost to Follow-up|20|||
37978331|NCT00448344|69665282|FG001|Overall Study|Lost to Follow-up|22|||
37978332|NCT00448344|69665281|FG000|Overall Study|Withdrawal by Subject|6|||
37978333|NCT00448344|69665282|FG001|Overall Study|Withdrawal by Subject|8|||
37978334|NCT00448344|69665281|FG000|Overall Study|Death|3|||
37978335|NCT00448344|69665282|FG001|Overall Study|Death|4|||
37978336|NCT00448344|69665281|FG000|Overall Study|Physician Decision|1|||
37978337|NCT00448344|69665282|FG001|Overall Study|Physician Decision|2|||
37978338|NCT00484094|69665288|FG000|Overall Study|Discontinued|39|||
37978339|NCT00484094|69665288|FG000|Overall Study|Other|3|||
37978340|NCT00447876|69665294|FG000|Overall Study|Withdrawal by Subject|1|||
37978341|NCT00447876|69665295|FG001|Overall Study|Withdrawal by Subject|4|||
37978342|NCT00447876|69665294|FG000|Overall Study|Lost to Follow-up|1|||
37978343|NCT00447876|69665295|FG001|Overall Study|Lost to Follow-up|0|||
37978344|NCT00447876|69665294|FG000|Overall Study|Deterioration of symptomology|1|||
37978345|NCT00447876|69665295|FG001|Overall Study|Deterioration of symptomology|0|||
37978346|NCT00456612|69665301|FG000|Overall Study|Withdrawal by Subject|3|||
37978347|NCT00456300|69665306|FG000|Overall Study|Adverse Event|1|||
37978348|NCT00456300|69665307|FG001|Overall Study|Adverse Event|0|||
37978349|NCT00267748|69665318|FG000|Non-randomized Period|Progressive disease|10|||
37978350|NCT00267748|69665319|FG001|Non-randomized Period|Progressive disease|0|||
37978351|NCT00267748|69665320|FG002|Non-randomized Period|Progressive disease|0|||
37978352|NCT00267748|69665318|FG000|Non-randomized Period|Adverse Event|8|||
37978353|NCT00267748|69665319|FG001|Non-randomized Period|Adverse Event|0|||
37978354|NCT00267748|69665320|FG002|Non-randomized Period|Adverse Event|0|||
37978355|NCT00267748|69665318|FG000|Non-randomized Period|Death|1|||
37978356|NCT00267748|69665319|FG001|Non-randomized Period|Death|0|||
37978357|NCT00267748|69665320|FG002|Non-randomized Period|Death|0|||
37978358|NCT00267748|69665318|FG000|Non-randomized Period|Participant not willing to participate|1|||
37978359|NCT00267748|69665319|FG001|Non-randomized Period|Participant not willing to participate|0|||
37978360|NCT00267748|69665320|FG002|Non-randomized Period|Participant not willing to participate|0|||
37978361|NCT00267748|69665318|FG000|Non-randomized Period|Other|3|||
37978362|NCT00267748|69665319|FG001|Non-randomized Period|Other|0|||
37978363|NCT00267748|69665320|FG002|Non-randomized Period|Other|0|||
37978364|NCT00267748|69665318|FG000|Randomized Period|Death|0|||
37978365|NCT00267748|69665319|FG001|Randomized Period|Death|2|||
37978366|NCT00267748|69665320|FG002|Randomized Period|Death|3|||
37978367|NCT00267748|69665318|FG000|Randomized Period|Adverse Event|0|||
37978368|NCT00267748|69665319|FG001|Randomized Period|Adverse Event|23|||
37978369|NCT00267748|69665320|FG002|Randomized Period|Adverse Event|25|||
37978370|NCT00267748|69665318|FG000|Randomized Period|Global deterioration of health status|0|||
37814214|NCT01404312|69492116|FG000|Overall Study|Severe debilitation, unable to continue|1|||
37814215|NCT01404312|69492117|FG001|Overall Study|Severe debilitation, unable to continue|2|||
37814216|NCT01414608|69492126|FG000|Overall Study|Ineligible|5|||
37814217|NCT01414608|69492127|FG001|Overall Study|Ineligible|2|||
37978371|NCT00267748|69665319|FG001|Randomized Period|Global deterioration of health status|6|||
37978372|NCT00267748|69665320|FG002|Randomized Period|Global deterioration of health status|7|||
37978373|NCT00267748|69665318|FG000|Randomized Period|Lost to Follow-up|0|||
37978374|NCT00267748|69665319|FG001|Randomized Period|Lost to Follow-up|1|||
37978375|NCT00267748|69665320|FG002|Randomized Period|Lost to Follow-up|0|||
37978376|NCT00267748|69665318|FG000|Randomized Period|Objective progression or relapse|0|||
37814218|NCT01420861|69492137|FG000|Overall Study|Adverse Event|2|||
37814219|NCT01420861|69492137|FG000|Overall Study|Study terminated by Sponsor|7|||
37978377|NCT00267748|69665319|FG001|Randomized Period|Objective progression or relapse|77|||
37978378|NCT00267748|69665320|FG002|Randomized Period|Objective progression or relapse|86|||
37978379|NCT00267748|69665318|FG000|Randomized Period|Withdrawal by Subject|0|||
37978380|NCT00267748|69665319|FG001|Randomized Period|Withdrawal by Subject|9|||
37978381|NCT00267748|69665320|FG002|Randomized Period|Withdrawal by Subject|2|||
37978382|NCT00267748|69665318|FG000|Randomized Period|Other|0|||
37978383|NCT00267748|69665319|FG001|Randomized Period|Other|9|||
37978384|NCT00267748|69665320|FG002|Randomized Period|Other|6|||
37814220|NCT01420861|69492137|FG000|Overall Study|Screen failure|7|||
37814221|NCT01420861|69492137|FG000|Overall Study|Randomized not Treated|2|||
37814222|NCT01425008|69492160|FG000|Dose Escalation Phase|Progressive Disease|2|||
37814223|NCT01425008|69492161|FG001|Dose Escalation Phase|Progressive Disease|3|||
37814224|NCT01425008|69492162|FG002|Dose Escalation Phase|Progressive Disease|2|||
37814225|NCT01425008|69492163|FG003|Dose Escalation Phase|Progressive Disease|3|||
37814226|NCT01425008|69492164|FG004|Dose Escalation Phase|Progressive Disease|5|||
37978385|NCT00267748|69665318|FG000|Randomized Period|randomized but not treated|0|||
37978386|NCT00267748|69665319|FG001|Randomized Period|randomized but not treated|0|||
37814227|NCT01425008|69492165|FG005|Dose Escalation Phase|Progressive Disease|4|||
37814228|NCT01425008|69492166|FG006|Dose Escalation Phase|Progressive Disease|0|||
37814229|NCT01425008|69492167|FG007|Dose Escalation Phase|Progressive Disease|2|||
37814230|NCT01425008|69492168|FG008|Dose Escalation Phase|Progressive Disease|6|||
37814231|NCT01425008|69492169|FG009|Dose Escalation Phase|Progressive Disease|2|||
37814232|NCT01425008|69492170|FG010|Dose Escalation Phase|Progressive Disease|0|||
37814233|NCT01425008|69492171|FG011|Dose Escalation Phase|Progressive Disease|0|||
37814234|NCT01425008|69492172|FG012|Dose Escalation Phase|Progressive Disease|0|||
37814235|NCT01425008|69492173|FG013|Dose Escalation Phase|Progressive Disease|0|||
37814236|NCT01425008|69492174|FG014|Dose Escalation Phase|Progressive Disease|0|||
37814237|NCT01425008|69492175|FG015|Dose Escalation Phase|Progressive Disease|0|||
37814238|NCT01425008|69492176|FG016|Dose Escalation Phase|Progressive Disease|0|||
37814239|NCT01425008|69492177|FG017|Dose Escalation Phase|Progressive Disease|0|||
37814240|NCT01425008|69492178|FG018|Dose Escalation Phase|Progressive Disease|0|||
37814241|NCT01425008|69492160|FG000|Dose Escalation Phase|Adverse Event|2|||
37814242|NCT01425008|69492161|FG001|Dose Escalation Phase|Adverse Event|0|||
37814243|NCT01425008|69492162|FG002|Dose Escalation Phase|Adverse Event|0|||
37814244|NCT01425008|69492163|FG003|Dose Escalation Phase|Adverse Event|0|||
37814245|NCT01425008|69492164|FG004|Dose Escalation Phase|Adverse Event|0|||
37814246|NCT01425008|69492165|FG005|Dose Escalation Phase|Adverse Event|2|||
37814247|NCT01425008|69492166|FG006|Dose Escalation Phase|Adverse Event|0|||
37814248|NCT01425008|69492167|FG007|Dose Escalation Phase|Adverse Event|0|||
37814249|NCT01425008|69492168|FG008|Dose Escalation Phase|Adverse Event|2|||
37814250|NCT01425008|69492169|FG009|Dose Escalation Phase|Adverse Event|0|||
37814251|NCT01425008|69492170|FG010|Dose Escalation Phase|Adverse Event|0|||
37814252|NCT01425008|69492171|FG011|Dose Escalation Phase|Adverse Event|0|||
37814253|NCT01425008|69492172|FG012|Dose Escalation Phase|Adverse Event|0|||
37814254|NCT01425008|69492173|FG013|Dose Escalation Phase|Adverse Event|0|||
37814255|NCT01425008|69492174|FG014|Dose Escalation Phase|Adverse Event|0|||
37814256|NCT01425008|69492175|FG015|Dose Escalation Phase|Adverse Event|0|||
37814257|NCT01425008|69492176|FG016|Dose Escalation Phase|Adverse Event|0|||
37814258|NCT01425008|69492177|FG017|Dose Escalation Phase|Adverse Event|0|||
37814259|NCT01425008|69492178|FG018|Dose Escalation Phase|Adverse Event|0|||
37814260|NCT01425008|69492160|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
37814261|NCT01425008|69492161|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
37814262|NCT01425008|69492162|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
37814263|NCT01425008|69492163|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
37814264|NCT01425008|69492164|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
37814265|NCT01425008|69492165|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
37814266|NCT01425008|69492166|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
37814267|NCT01425008|69492167|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
37814268|NCT01425008|69492168|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
37814269|NCT01425008|69492169|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
37978387|NCT00267748|69665320|FG002|Randomized Period|randomized but not treated|3|||
37978388|NCT00267202|69665329|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
37978389|NCT00267202|69665330|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
37978390|NCT00267202|69665329|FG000|Overall Study|Withdrawal by Subject|12|||
37814270|NCT01425008|69492170|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
37814271|NCT01425008|69492171|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
37814272|NCT01425008|69492172|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
37814273|NCT01425008|69492173|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
37814274|NCT01425008|69492174|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
37814275|NCT01425008|69492175|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
37865572|NCT02716675|69549116|FG002|Overall Study|Protocol Violation|1|||
37978391|NCT00267202|69665330|FG001|Overall Study|Withdrawal by Subject|15|||
37694733|NCT01891864|69171213|FG001|Treatment Period 2|Site Termination|0|||
37694734|NCT01891864|69171214|FG002|Treatment Period 2|Site Termination|1|||
37865573|NCT02716675|69549114|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
37865574|NCT02716675|69549115|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
37865575|NCT02716675|69549116|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
37865576|NCT02716675|69549114|FG000|Overall Study|Other|38|||
37865577|NCT02716675|69549115|FG001|Overall Study|Other|47|||
37865578|NCT02716675|69549116|FG002|Overall Study|Other|48|||
37865579|NCT00977548|69549129|FG000|Overall Study|Ineligible|4|||
37865580|NCT00977548|69549129|FG000|Overall Study|Adverse Event|8|||
37865581|NCT00977548|69549129|FG000|Overall Study|Withdrawal by Subject|1|||
37865582|NCT01090011|69549133|FG000|Overall Study|Progressive disease|128|||
37865583|NCT01090011|69549133|FG000|Overall Study|Adverse Event|32|||
37865584|NCT01090011|69549133|FG000|Overall Study|Protocol Violation|1|||
37865585|NCT01090011|69549133|FG000|Overall Study|Refusal to start/continue medication|5|||
37865586|NCT01090011|69549133|FG000|Overall Study|Other reason not defined above|5|||
37865587|NCT01251653|69549154|FG000|Overall Study|Progressive Disease|1|||
37865588|NCT01251653|69549155|FG001|Overall Study|Progressive Disease|7|||
37865589|NCT01251653|69549156|FG002|Overall Study|Progressive Disease|16|||
37865590|NCT01251653|69549157|FG003|Overall Study|Progressive Disease|4|||
37978392|NCT00267202|69665329|FG000|Overall Study|Adverse Event|13|||
37694735|NCT01891864|69171215|FG003|Treatment Period 2|Site Termination|2|||
37694736|NCT01891864|69171216|FG004|Treatment Period 2|Site Termination|0|||
37694737|NCT01891864|69171217|FG005|Treatment Period 2|Site Termination|0|||
37694738|NCT01891864|69171212|FG000|Treatment Period 2|Lack of Efficacy|0|||
37694739|NCT01891864|69171213|FG001|Treatment Period 2|Lack of Efficacy|0|||
37978393|NCT00267202|69665330|FG001|Overall Study|Adverse Event|7|||
37978394|NCT00267202|69665329|FG000|Overall Study|Protocol Violation|2|||
37978395|NCT00267202|69665330|FG001|Overall Study|Protocol Violation|3|||
37978396|NCT00267202|69665329|FG000|Overall Study|Administrative problems|2|||
37978397|NCT00267202|69665330|FG001|Overall Study|Administrative problems|1|||
37978398|NCT00267202|69665329|FG000|Overall Study|Lost to Follow-up|3|||
37694740|NCT01891864|69171214|FG002|Treatment Period 2|Lack of Efficacy|1|||
37694741|NCT01891864|69171215|FG003|Treatment Period 2|Lack of Efficacy|0|||
37694742|NCT01891864|69171216|FG004|Treatment Period 2|Lack of Efficacy|1|||
37814276|NCT01425008|69492176|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
37814277|NCT01425008|69492177|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
37814278|NCT01425008|69492178|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
37814279|NCT01425008|69492160|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
37814280|NCT01425008|69492161|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
37814281|NCT01425008|69492162|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
37814282|NCT01425008|69492163|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
37814283|NCT01425008|69492164|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
37814284|NCT01425008|69492165|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
37814285|NCT01425008|69492166|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
37694743|NCT01891864|69171217|FG005|Treatment Period 2|Lack of Efficacy|0|||
37694744|NCT01891864|69171212|FG000|Treatment Period 2|Adverse Event|0|||
37865591|NCT01251653|69549158|FG004|Overall Study|Progressive Disease|0|||
37865592|NCT01251653|69549159|FG005|Overall Study|Progressive Disease|17|||
37865593|NCT01251653|69549160|FG006|Overall Study|Progressive Disease|14|||
37865594|NCT01251653|69549161|FG007|Overall Study|Progressive Disease|7|||
37865595|NCT01251653|69549162|FG008|Overall Study|Progressive Disease|5|||
37865596|NCT01251653|69549154|FG000|Overall Study|Dose-limiting toxicity|0|||
37978399|NCT00267202|69665330|FG001|Overall Study|Lost to Follow-up|0|||
37694745|NCT01891864|69171213|FG001|Treatment Period 2|Adverse Event|0|||
37978400|NCT00267046|69665339|FG000|Overall Study|Disease progression|4|||
37978401|NCT00267046|69665340|FG001|Overall Study|Disease progression|2|||
37978402|NCT00267046|69665339|FG000|Overall Study|Chemotoxicity|2|||
37978403|NCT00267046|69665340|FG001|Overall Study|Chemotoxicity|0|||
37978404|NCT00267046|69665339|FG000|Overall Study|Open-label palifermin|2|||
37978405|NCT00267046|69665340|FG001|Overall Study|Open-label palifermin|7|||
37978406|NCT00267046|69665339|FG000|Overall Study|Surgery|3|||
37978407|NCT00267046|69665340|FG001|Overall Study|Surgery|1|||
37978408|NCT00267046|69665339|FG000|Overall Study|Withdrawal by Subject|1|||
37978409|NCT00267046|69665340|FG001|Overall Study|Withdrawal by Subject|0|||
37978410|NCT00267046|69665339|FG000|Overall Study|Radiation|0|||
37978411|NCT00267046|69665340|FG001|Overall Study|Radiation|1|||
37978412|NCT00441090|69665351|FG000|Overall Study|Adverse Event|0|||
37978413|NCT00441090|69665352|FG001|Overall Study|Adverse Event|1|||
37978414|NCT00441090|69665353|FG002|Overall Study|Adverse Event|1|||
37978415|NCT00441090|69665354|FG003|Overall Study|Adverse Event|0|||
37978416|NCT00441090|69665355|FG004|Overall Study|Adverse Event|0|||
37978417|NCT00441090|69665351|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
37978418|NCT00441090|69665352|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
37978419|NCT00441090|69665353|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
37978420|NCT00441090|69665354|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
37978421|NCT00441090|69665355|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
37978422|NCT00441090|69665351|FG000|Overall Study|Withdrawal by Subject|1|||
37978423|NCT00441090|69665352|FG001|Overall Study|Withdrawal by Subject|0|||
37978424|NCT00441090|69665353|FG002|Overall Study|Withdrawal by Subject|1|||
37978425|NCT00441090|69665354|FG003|Overall Study|Withdrawal by Subject|0|||
37978426|NCT00441090|69665355|FG004|Overall Study|Withdrawal by Subject|0|||
37865597|NCT01251653|69549155|FG001|Overall Study|Dose-limiting toxicity|1|||
37865598|NCT01251653|69549156|FG002|Overall Study|Dose-limiting toxicity|1|||
37865599|NCT01251653|69549157|FG003|Overall Study|Dose-limiting toxicity|1|||
37865600|NCT01251653|69549158|FG004|Overall Study|Dose-limiting toxicity|0|||
37865601|NCT01251653|69549159|FG005|Overall Study|Dose-limiting toxicity|0|||
37865602|NCT01251653|69549160|FG006|Overall Study|Dose-limiting toxicity|2|||
37865603|NCT01251653|69549161|FG007|Overall Study|Dose-limiting toxicity|0|||
37865604|NCT01251653|69549162|FG008|Overall Study|Dose-limiting toxicity|0|||
37865605|NCT01251653|69549154|FG000|Overall Study|Adverse Event|1|||
37865606|NCT01251653|69549155|FG001|Overall Study|Adverse Event|0|||
37865607|NCT01251653|69549156|FG002|Overall Study|Adverse Event|2|||
37865608|NCT01251653|69549157|FG003|Overall Study|Adverse Event|1|||
37865609|NCT01251653|69549158|FG004|Overall Study|Adverse Event|1|||
37865610|NCT01251653|69549159|FG005|Overall Study|Adverse Event|0|||
37865611|NCT01251653|69549160|FG006|Overall Study|Adverse Event|2|||
37865612|NCT01251653|69549161|FG007|Overall Study|Adverse Event|2|||
37865613|NCT01251653|69549162|FG008|Overall Study|Adverse Event|1|||
37865614|NCT01251653|69549154|FG000|Overall Study|Withdrawal by Subject|1|||
37865615|NCT01251653|69549155|FG001|Overall Study|Withdrawal by Subject|0|||
37865616|NCT01251653|69549156|FG002|Overall Study|Withdrawal by Subject|1|||
37865617|NCT01251653|69549157|FG003|Overall Study|Withdrawal by Subject|0|||
37865618|NCT01251653|69549158|FG004|Overall Study|Withdrawal by Subject|1|||
37865619|NCT01251653|69549159|FG005|Overall Study|Withdrawal by Subject|1|||
37865620|NCT01251653|69549160|FG006|Overall Study|Withdrawal by Subject|0|||
37865621|NCT01251653|69549161|FG007|Overall Study|Withdrawal by Subject|1|||
37865622|NCT01251653|69549162|FG008|Overall Study|Withdrawal by Subject|0|||
37865623|NCT01251653|69549154|FG000|Overall Study|Other reason not mentioned above|0|||
37978427|NCT00441090|69665351|FG000|Overall Study|Lack of Efficacy|1|||
37978428|NCT00441090|69665352|FG001|Overall Study|Lack of Efficacy|0|||
37978429|NCT00441090|69665353|FG002|Overall Study|Lack of Efficacy|0|||
37978430|NCT00441090|69665354|FG003|Overall Study|Lack of Efficacy|0|||
37978431|NCT00441090|69665355|FG004|Overall Study|Lack of Efficacy|0|||
37814286|NCT01425008|69492167|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
37814287|NCT01425008|69492168|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
37814288|NCT01425008|69492169|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
37814289|NCT01425008|69492170|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
37814290|NCT01425008|69492171|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
37814291|NCT01425008|69492172|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
37814292|NCT01425008|69492173|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
37814293|NCT01425008|69492174|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
37814294|NCT01425008|69492175|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
37865624|NCT01251653|69549155|FG001|Overall Study|Other reason not mentioned above|0|||
37865625|NCT01251653|69549156|FG002|Overall Study|Other reason not mentioned above|0|||
37865626|NCT01251653|69549157|FG003|Overall Study|Other reason not mentioned above|0|||
37865627|NCT01251653|69549158|FG004|Overall Study|Other reason not mentioned above|0|||
37865628|NCT01251653|69549159|FG005|Overall Study|Other reason not mentioned above|0|||
37978432|NCT00441012|69665369|FG000|Overall Study|Adverse Event|0|||
37978433|NCT00441012|69665370|FG001|Overall Study|Adverse Event|1|||
37978434|NCT00441012|69665369|FG000|Overall Study|Lost to Follow-up|3|||
37978435|NCT00441012|69665370|FG001|Overall Study|Lost to Follow-up|3|||
37865629|NCT01251653|69549160|FG006|Overall Study|Other reason not mentioned above|0|||
37865630|NCT01251653|69549161|FG007|Overall Study|Other reason not mentioned above|2|||
37865631|NCT01251653|69549162|FG008|Overall Study|Other reason not mentioned above|0|||
37865632|NCT00910663|69549200|FG000|Period 1|Withdrawal by Subject|0|||
37865633|NCT00910663|69549201|FG001|Period 1|Withdrawal by Subject|1|||
37865634|NCT01077375|69549209|FG000|Overall Study|Adverse Event|2|||
37865635|NCT01077375|69549210|FG001|Overall Study|Adverse Event|15|||
37865636|NCT01077375|69549209|FG000|Overall Study|Lack of Efficacy|6|||
37865637|NCT01077375|69549210|FG001|Overall Study|Lack of Efficacy|8|||
37865638|NCT01077375|69549209|FG000|Overall Study|Withdrawal by Subject|0|||
37865639|NCT01077375|69549210|FG001|Overall Study|Withdrawal by Subject|6|||
37865640|NCT01077375|69549209|FG000|Overall Study|Lost to Follow-up|2|||
37865641|NCT01077375|69549210|FG001|Overall Study|Lost to Follow-up|5|||
37865642|NCT01077375|69549209|FG000|Overall Study|Other Reason|0|||
37865643|NCT01077375|69549210|FG001|Overall Study|Other Reason|1|||
37865644|NCT01250873|69549218|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
37865645|NCT01250873|69549218|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
37865646|NCT01250171|69549227|FG000|Overall Study|Administrative reasons|1|||
37865647|NCT01250171|69549228|FG001|Overall Study|Administrative reasons|0|||
37865648|NCT01250171|69549229|FG002|Overall Study|Administrative reasons|0|||
37865649|NCT01077063|69549239|FG000|Overall Study|Adverse Event|3|||
37865650|NCT01077063|69549240|FG001|Overall Study|Adverse Event|0|||
37865651|NCT01077063|69549239|FG000|Overall Study|Death|1|||
37865652|NCT01077063|69549240|FG001|Overall Study|Death|1|||
37865653|NCT01077063|69549239|FG000|Overall Study|Withdrawal by Subject|0|||
37865654|NCT01077063|69549240|FG001|Overall Study|Withdrawal by Subject|2|||
37865655|NCT01248065|69549248|FG000|Overall Study|Lost to Follow-up|3|||
37865656|NCT01248065|69549249|FG001|Overall Study|Lost to Follow-up|5|||
37865657|NCT01248065|69549248|FG000|Overall Study|Withdrawal by Subject|14|||
37865658|NCT01248065|69549249|FG001|Overall Study|Withdrawal by Subject|11|||
37865659|NCT01248065|69549248|FG000|Overall Study|Adverse Event|3|||
37865660|NCT01248065|69549249|FG001|Overall Study|Adverse Event|0|||
37865661|NCT01248065|69549248|FG000|Overall Study|Third treatment failure event|3|||
37865662|NCT01248065|69549249|FG001|Overall Study|Third treatment failure event|1|||
37865663|NCT01248065|69549248|FG000|Overall Study|Other|3|||
37865664|NCT01248065|69549249|FG001|Overall Study|Other|5|||
37865665|NCT01250756|69549257|FG000|Infant Series|Withdrawal by Subject|4|||
37865666|NCT01250756|69549258|FG001|Infant Series|Withdrawal by Subject|5|||
37865667|NCT01250756|69549257|FG000|Infant Series|Randomized, Not Vaccinated|2|||
37865668|NCT01250756|69549258|FG001|Infant Series|Randomized, Not Vaccinated|2|||
37865669|NCT01250756|69549257|FG000|Infant Series|Other|22|||
37865670|NCT01250756|69549258|FG001|Infant Series|Other|0|||
37865671|NCT01250756|69549257|FG000|After Infant Series|Adverse Event|5|||
37865672|NCT01250756|69549258|FG001|After Infant Series|Adverse Event|2|||
37865673|NCT01250756|69549257|FG000|After Infant Series|Withdrawal by Subject|4|||
37865674|NCT01250756|69549258|FG001|After Infant Series|Withdrawal by Subject|1|||
37865675|NCT01250756|69549257|FG000|After Infant Series|Other|2|||
37865676|NCT01250756|69549258|FG001|After Infant Series|Other|1|||
37865677|NCT01250756|69549257|FG000|Toddler Dose|Adverse Event|0|||
37865678|NCT01250756|69549258|FG001|Toddler Dose|Adverse Event|1|||
37865679|NCT01250756|69549257|FG000|After Toddler Dose|Adverse Event|0|||
37978436|NCT00441012|69665369|FG000|Overall Study|Protocol Violation|10|||
37814295|NCT01425008|69492176|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
37814296|NCT01425008|69492177|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
37814297|NCT01425008|69492178|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
37814298|NCT01425008|69492160|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
37814299|NCT01425008|69492161|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
37814300|NCT01425008|69492162|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
37814301|NCT01425008|69492163|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
37814302|NCT01425008|69492164|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
37814303|NCT01425008|69492165|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
37814304|NCT01425008|69492166|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
37814305|NCT01425008|69492167|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
37865680|NCT01250756|69549258|FG001|After Toddler Dose|Adverse Event|1|||
37865681|NCT01250054|69549270|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
37865682|NCT01250054|69549271|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
37865683|NCT00977470|69549279|FG000|Overall Study|Lack of Efficacy|32|||
37865684|NCT00977470|69549280|FG001|Overall Study|Lack of Efficacy|30|||
37865685|NCT00977470|69549279|FG000|Overall Study|Physician Decision|2|||
37865686|NCT00977470|69549280|FG001|Overall Study|Physician Decision|0|||
37865687|NCT00977470|69549279|FG000|Overall Study|Adverse Event|1|||
37865688|NCT00977470|69549280|FG001|Overall Study|Adverse Event|2|||
37865689|NCT00977470|69549279|FG000|Overall Study|Protocol Violation|1|||
37865690|NCT00977470|69549280|FG001|Overall Study|Protocol Violation|0|||
37865691|NCT00977470|69549279|FG000|Overall Study|Withdrawal by Subject|0|||
37865692|NCT00977470|69549280|FG001|Overall Study|Withdrawal by Subject|2|||
37865693|NCT00977470|69549279|FG000|Overall Study|Death|0|||
37865694|NCT00977470|69549280|FG001|Overall Study|Death|2|||
37865695|NCT00977470|69549279|FG000|Overall Study|clinical decline|0|||
37865696|NCT00977470|69549280|FG001|Overall Study|clinical decline|1|||
37865697|NCT00977470|69549279|FG000|Overall Study|prolonged recovery post-surgery|0|||
37865698|NCT00977470|69549280|FG001|Overall Study|prolonged recovery post-surgery|1|||
37865699|NCT00977470|69549279|FG000|Overall Study|Still on-study|2|||
37865700|NCT00977470|69549280|FG001|Overall Study|Still on-study|0|||
37865701|NCT01245374|69549286|FG000|Overall Study|Protocol Violation|1|||
37865702|NCT01245374|69549286|FG000|Overall Study|Withdrawal by Subject|3|||
37865703|NCT00977314|69549293|FG000|Overall Study|Withdrawal by Subject|1|||
37865704|NCT00977314|69549294|FG001|Overall Study|Withdrawal by Subject|0|||
37865705|NCT00977314|69549293|FG000|Overall Study|Physician Decision|1|||
37865706|NCT00977314|69549294|FG001|Overall Study|Physician Decision|0|||
37865707|NCT01087203|69549302|FG000|Overall Study|Lost to Follow-up|2|||
37865708|NCT01087203|69549303|FG001|Overall Study|Lost to Follow-up|0|||
37865709|NCT01087203|69549302|FG000|Overall Study|Withdrawal by Subject|2|||
37865710|NCT01087203|69549303|FG001|Overall Study|Withdrawal by Subject|6|||
37865711|NCT01087203|69549302|FG000|Overall Study|Lack of Efficacy|1|||
37865712|NCT01087203|69549303|FG001|Overall Study|Lack of Efficacy|2|||
37865713|NCT01087203|69549302|FG000|Overall Study|Study terminated by sponsor|27|||
37865714|NCT01087203|69549303|FG001|Overall Study|Study terminated by sponsor|27|||
37865715|NCT01246583|69549314|FG000|Overall Study|Lost to Follow-up|0|||
37865716|NCT01246583|69549315|FG001|Overall Study|Lost to Follow-up|0|||
37865717|NCT01246583|69549316|FG002|Overall Study|Lost to Follow-up|0|||
37865718|NCT01246583|69549317|FG003|Overall Study|Lost to Follow-up|1|||
37865719|NCT01246583|69549314|FG000|Overall Study|Protocol Violation|0|||
37865720|NCT01246583|69549315|FG001|Overall Study|Protocol Violation|0|||
37865721|NCT01246583|69549316|FG002|Overall Study|Protocol Violation|1|||
37865722|NCT01246583|69549317|FG003|Overall Study|Protocol Violation|0|||
37865723|NCT01246583|69549314|FG000|Overall Study|Withdrawal by Subject|1|||
37865724|NCT01246583|69549315|FG001|Overall Study|Withdrawal by Subject|0|||
37865725|NCT01246583|69549316|FG002|Overall Study|Withdrawal by Subject|0|||
37865726|NCT01246583|69549317|FG003|Overall Study|Withdrawal by Subject|0|||
37865727|NCT01084239|69549330|FG000|28-Day Follow-up|Lost to Follow-up|4|||
37865728|NCT01084239|69549331|FG001|28-Day Follow-up|Lost to Follow-up|9|||
37865729|NCT01244906|69549339|FG000|Overall Study|Death|2|||
37865730|NCT01244906|69549339|FG000|Overall Study|Progression of disease post treatment|6|||
37865731|NCT01080807|69549345|FG000|Overall Study|Adverse Event|9|||
37865732|NCT01080807|69549346|FG001|Overall Study|Adverse Event|1|||
37865733|NCT01080807|69549345|FG000|Overall Study|Lack of Efficacy|0|||
37865734|NCT01080807|69549346|FG001|Overall Study|Lack of Efficacy|1|||
37865735|NCT01080807|69549345|FG000|Overall Study|Withdrawal by Subject|7|||
37865736|NCT01080807|69549346|FG001|Overall Study|Withdrawal by Subject|2|||
37865737|NCT01080807|69549345|FG000|Overall Study|Protocol Violation|7|||
37865738|NCT01080807|69549346|FG001|Overall Study|Protocol Violation|6|||
37865739|NCT01080807|69549345|FG000|Overall Study|Lost to Follow-up|6|||
37865740|NCT01080807|69549346|FG001|Overall Study|Lost to Follow-up|4|||
37865741|NCT01080807|69549345|FG000|Overall Study|Noncompliance with drug administration|1|||
37865742|NCT01080807|69549346|FG001|Overall Study|Noncompliance with drug administration|1|||
37865743|NCT01080807|69549345|FG000|Overall Study|Noncompliance to study procedures|1|||
37865744|NCT01080807|69549346|FG001|Overall Study|Noncompliance to study procedures|1|||
37814306|NCT01425008|69492168|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
37814307|NCT01425008|69492169|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
37814308|NCT01425008|69492170|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
37814309|NCT01425008|69492171|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
37814310|NCT01425008|69492172|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
37814311|NCT01425008|69492173|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
37814312|NCT01425008|69492174|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
37814313|NCT01425008|69492175|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
37814314|NCT01425008|69492176|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
37814315|NCT01425008|69492177|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
37814316|NCT01425008|69492178|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
37814317|NCT01425008|69492160|FG000|Dose Escalation Phase|Other|0|||
37814318|NCT01425008|69492161|FG001|Dose Escalation Phase|Other|0|||
37814319|NCT01425008|69492162|FG002|Dose Escalation Phase|Other|0|||
37814320|NCT01425008|69492163|FG003|Dose Escalation Phase|Other|0|||
37814321|NCT01425008|69492164|FG004|Dose Escalation Phase|Other|0|||
37814322|NCT01425008|69492165|FG005|Dose Escalation Phase|Other|0|||
37814323|NCT01425008|69492166|FG006|Dose Escalation Phase|Other|0|||
37814324|NCT01425008|69492167|FG007|Dose Escalation Phase|Other|0|||
37865745|NCT01080807|69549345|FG000|Overall Study|Began working day shift|0|||
37865746|NCT01080807|69549346|FG001|Overall Study|Began working day shift|2|||
37865747|NCT01080807|69549345|FG000|Overall Study|Laid off or terminated from job|1|||
37865748|NCT01080807|69549346|FG001|Overall Study|Laid off or terminated from job|2|||
37865749|NCT01080807|69549345|FG000|Overall Study|Stopped working consistent night shifts|0|||
37865750|NCT01080807|69549346|FG001|Overall Study|Stopped working consistent night shifts|1|||
37865751|NCT01080807|69549345|FG000|Overall Study|Work schedule changing|1|||
37865752|NCT01080807|69549346|FG001|Overall Study|Work schedule changing|1|||
37865753|NCT01080807|69549345|FG000|Overall Study|Work schedule and travel|0|||
37865754|NCT01080807|69549346|FG001|Overall Study|Work schedule and travel|1|||
37865755|NCT01080807|69549345|FG000|Overall Study|Switched to first shift|1|||
37865756|NCT01080807|69549346|FG001|Overall Study|Switched to first shift|0|||
37865757|NCT01080807|69549345|FG000|Overall Study|Moved away without notifying center|1|||
37865758|NCT01080807|69549346|FG001|Overall Study|Moved away without notifying center|0|||
37865759|NCT01076361|69549352|FG000|Overall Study|22 leads were excluded from analysis|21|||
37865760|NCT01079949|69549358|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
37865761|NCT01079949|69549359|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
37865762|NCT01079949|69549358|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
37865763|NCT01079949|69549359|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
37865764|NCT01079949|69549358|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
37865765|NCT01079949|69549359|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
37865766|NCT01079949|69549358|FG000|Overall Study|Randomized but not treated|1|||
37865767|NCT01079949|69549359|FG001|Overall Study|Randomized but not treated|0|||
37865768|NCT00909727|69549367|FG000|Overall Study|Adverse Event|1|||
37865769|NCT00909727|69549368|FG001|Overall Study|Adverse Event|0|||
37865770|NCT00909727|69549367|FG000|Overall Study|Wrong Genotype|1|||
37865771|NCT00909727|69549368|FG001|Overall Study|Wrong Genotype|0|||
37865772|NCT00909727|69549367|FG000|Overall Study|Withdrawal of Consent|1|||
37865773|NCT00909727|69549368|FG001|Overall Study|Withdrawal of Consent|0|||
37865774|NCT00909727|69549367|FG000|Overall Study|Prohibited Medication|1|||
37865775|NCT00909727|69549368|FG001|Overall Study|Prohibited Medication|0|||
37865776|NCT00977080|69549378|FG000|Overall Study|Adverse Event|2|||
37865777|NCT00977080|69549379|FG001|Overall Study|Adverse Event|7|||
37865778|NCT00977080|69549380|FG002|Overall Study|Adverse Event|7|||
37865779|NCT00977080|69549381|FG003|Overall Study|Adverse Event|7|||
37865780|NCT00977080|69549378|FG000|Overall Study|Withdrawal by Subject|1|||
37865781|NCT00977080|69549379|FG001|Overall Study|Withdrawal by Subject|5|||
37865782|NCT00977080|69549380|FG002|Overall Study|Withdrawal by Subject|1|||
37865783|NCT00977080|69549381|FG003|Overall Study|Withdrawal by Subject|5|||
37865784|NCT00977080|69549378|FG000|Overall Study|Protocol Violation|7|||
37865785|NCT00977080|69549379|FG001|Overall Study|Protocol Violation|3|||
37865786|NCT00977080|69549380|FG002|Overall Study|Protocol Violation|4|||
37865787|NCT00977080|69549381|FG003|Overall Study|Protocol Violation|3|||
37865788|NCT00977080|69549378|FG000|Overall Study|Noncompliance|0|||
37865789|NCT00977080|69549379|FG001|Overall Study|Noncompliance|2|||
37865790|NCT00977080|69549380|FG002|Overall Study|Noncompliance|1|||
37865791|NCT00977080|69549381|FG003|Overall Study|Noncompliance|0|||
37865792|NCT00977080|69549378|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
37865793|NCT00977080|69549379|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
37865794|NCT00977080|69549380|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
37865795|NCT00977080|69549381|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
37865796|NCT00977080|69549378|FG000|Overall Study|Required kidney transplantation|1|||
37865797|NCT00977080|69549379|FG001|Overall Study|Required kidney transplantation|3|||
37865798|NCT00977080|69549380|FG002|Overall Study|Required kidney transplantation|3|||
37865799|NCT00977080|69549381|FG003|Overall Study|Required kidney transplantation|1|||
37865800|NCT00977080|69549378|FG000|Overall Study|Travel for family reasons|1|||
37865801|NCT00977080|69549379|FG001|Overall Study|Travel for family reasons|0|||
37865802|NCT00977080|69549380|FG002|Overall Study|Travel for family reasons|0|||
37865803|NCT00977080|69549381|FG003|Overall Study|Travel for family reasons|0|||
37978437|NCT00441012|69665370|FG001|Overall Study|Protocol Violation|9|||
37814325|NCT01425008|69492168|FG008|Dose Escalation Phase|Other|1|||
37814326|NCT01425008|69492169|FG009|Dose Escalation Phase|Other|0|||
37814327|NCT01425008|69492170|FG010|Dose Escalation Phase|Other|0|||
37814328|NCT01425008|69492171|FG011|Dose Escalation Phase|Other|0|||
37814329|NCT01425008|69492172|FG012|Dose Escalation Phase|Other|0|||
37814330|NCT01425008|69492173|FG013|Dose Escalation Phase|Other|0|||
37814331|NCT01425008|69492174|FG014|Dose Escalation Phase|Other|0|||
37814332|NCT01425008|69492175|FG015|Dose Escalation Phase|Other|0|||
37814333|NCT01425008|69492176|FG016|Dose Escalation Phase|Other|0|||
37814334|NCT01425008|69492177|FG017|Dose Escalation Phase|Other|0|||
37814335|NCT01425008|69492178|FG018|Dose Escalation Phase|Other|0|||
37814336|NCT01425008|69492160|FG000|Dose Expansion Phase|Progressive Disease|0|||
37814337|NCT01425008|69492161|FG001|Dose Expansion Phase|Progressive Disease|0|||
37814338|NCT01425008|69492162|FG002|Dose Expansion Phase|Progressive Disease|0|||
37814339|NCT01425008|69492163|FG003|Dose Expansion Phase|Progressive Disease|0|||
37814340|NCT01425008|69492164|FG004|Dose Expansion Phase|Progressive Disease|0|||
37814341|NCT01425008|69492165|FG005|Dose Expansion Phase|Progressive Disease|0|||
37814342|NCT01425008|69492166|FG006|Dose Expansion Phase|Progressive Disease|0|||
37814343|NCT01425008|69492167|FG007|Dose Expansion Phase|Progressive Disease|0|||
37814344|NCT01425008|69492168|FG008|Dose Expansion Phase|Progressive Disease|0|||
37814345|NCT01425008|69492169|FG009|Dose Expansion Phase|Progressive Disease|0|||
37865804|NCT00975676|69549393|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
37865805|NCT00975676|69549394|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
37865806|NCT00975286|69549407|FG000|Overall Study|Adverse Event|9|||
37865807|NCT00975286|69549408|FG001|Overall Study|Adverse Event|19|||
37865808|NCT00975286|69549407|FG000|Overall Study|Protocol Violation|1|||
37865809|NCT00975286|69549408|FG001|Overall Study|Protocol Violation|2|||
37865810|NCT00975286|69549407|FG000|Overall Study|Withdrawal by Subject|0|||
37865811|NCT00975286|69549408|FG001|Overall Study|Withdrawal by Subject|2|||
37865812|NCT00975286|69549407|FG000|Overall Study|Familial and Personal Reasons|2|||
37865813|NCT00975286|69549408|FG001|Overall Study|Familial and Personal Reasons|2|||
37865814|NCT00975286|69549407|FG000|Overall Study|Poor Compliance to Protocol|0|||
37865815|NCT00975286|69549408|FG001|Overall Study|Poor Compliance to Protocol|2|||
37865816|NCT00975286|69549407|FG000|Overall Study|Sponsor Decision|0|||
37865817|NCT00975286|69549408|FG001|Overall Study|Sponsor Decision|2|||
37865818|NCT00907777|69549416|FG000|Overall Study|Withdrawal by Subject|0|||
37865819|NCT00907777|69549417|FG001|Overall Study|Withdrawal by Subject|1|||
37865820|NCT00908011|69549425|FG000|Overall Study|Withdrawal by Subject|2|||
37865821|NCT00908011|69549426|FG001|Overall Study|Withdrawal by Subject|2|||
37865822|NCT00976456|69549434|FG000|Overall Study|Adverse Event|17|||
37865823|NCT00976456|69549435|FG001|Overall Study|Adverse Event|22|||
37865824|NCT00976456|69549434|FG000|Overall Study|Death|7|||
37865825|NCT00976456|69549435|FG001|Overall Study|Death|9|||
37865826|NCT00976456|69549434|FG000|Overall Study|Lack of Efficacy|5|||
37865827|NCT00976456|69549435|FG001|Overall Study|Lack of Efficacy|2|||
37865828|NCT00976456|69549434|FG000|Overall Study|Withdrawal by Subject|3|||
37865829|NCT00976456|69549435|FG001|Overall Study|Withdrawal by Subject|1|||
37865830|NCT00976456|69549434|FG000|Overall Study|screening failure, unknown|11|||
37865831|NCT00976456|69549435|FG001|Overall Study|screening failure, unknown|4|||
37865832|NCT01243151|69549446|FG000|Overall Study|Adverse Event|0|||
37865833|NCT01243151|69549447|FG001|Overall Study|Adverse Event|1|||
37865834|NCT01243151|69549448|FG002|Overall Study|Adverse Event|0|||
37865835|NCT01243151|69549449|FG003|Overall Study|Adverse Event|0|||
37865836|NCT01243151|69549450|FG004|Overall Study|Adverse Event|0|||
37865837|NCT01243151|69549446|FG000|Overall Study|Protocol Violation|0|||
37865838|NCT01243151|69549447|FG001|Overall Study|Protocol Violation|0|||
37865839|NCT01243151|69549448|FG002|Overall Study|Protocol Violation|1|||
37865840|NCT01243151|69549449|FG003|Overall Study|Protocol Violation|0|||
37865841|NCT01243151|69549450|FG004|Overall Study|Protocol Violation|0|||
37865842|NCT01243151|69549446|FG000|Overall Study|Other|0|||
37865843|NCT01243151|69549447|FG001|Overall Study|Other|0|||
37865844|NCT01243151|69549448|FG002|Overall Study|Other|0|||
37865845|NCT01243151|69549449|FG003|Overall Study|Other|1|||
37865846|NCT01243151|69549450|FG004|Overall Study|Other|0|||
37865847|NCT01243151|69549446|FG000|Overall Study|Randomized but not treated|0|||
37865848|NCT01243151|69549447|FG001|Overall Study|Randomized but not treated|0|||
37865849|NCT01243151|69549448|FG002|Overall Study|Randomized but not treated|0|||
37865850|NCT01243151|69549449|FG003|Overall Study|Randomized but not treated|1|||
37865851|NCT01243151|69549450|FG004|Overall Study|Randomized but not treated|0|||
37865852|NCT00993148|69549466|FG000|Overall Study|Lost to Follow-up|2|||
37865853|NCT00993148|69549466|FG000|Overall Study|never initiated treatment|1|||
37865854|NCT00907621|69549472|FG000|Overall Study|Lost to Follow-up|6|||
37865855|NCT00907621|69549473|FG001|Overall Study|Lost to Follow-up|3|||
37865856|NCT00907621|69549472|FG000|Overall Study|intercurrent febrile illness|1|||
37865857|NCT00907621|69549473|FG001|Overall Study|intercurrent febrile illness|1|||
37865858|NCT00907153|69549492|FG000|Overall Study|Lost to Follow-up|1|||
37865859|NCT00907153|69549493|FG001|Overall Study|Lost to Follow-up|1|||
37865860|NCT00907153|69549492|FG000|Overall Study|Withdrawal by Subject|1|||
37865861|NCT00907153|69549493|FG001|Overall Study|Withdrawal by Subject|3|||
37865862|NCT00904033|69549503|FG000|Overall Study|Withdrawal by Subject|1|||
37865863|NCT00904033|69549504|FG001|Overall Study|Withdrawal by Subject|1|||
37865864|NCT00904033|69549505|FG002|Overall Study|Withdrawal by Subject|0|||
37865865|NCT00904033|69549506|FG003|Overall Study|Withdrawal by Subject|0|||
37978438|NCT00441012|69665369|FG000|Overall Study|Withdrawal by Subject|4|||
37865866|NCT00904033|69549503|FG000|Overall Study|Physician Decision|0|||
37865867|NCT00904033|69549504|FG001|Overall Study|Physician Decision|0|||
37865868|NCT00904033|69549505|FG002|Overall Study|Physician Decision|1|||
37865869|NCT00904033|69549506|FG003|Overall Study|Physician Decision|0|||
37865870|NCT00904033|69549503|FG000|Overall Study|Unable to obtain final blood draw|0|||
37865871|NCT00904033|69549504|FG001|Overall Study|Unable to obtain final blood draw|0|||
37978439|NCT00441012|69665370|FG001|Overall Study|Withdrawal by Subject|0|||
37978440|NCT00441012|69665369|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
37865872|NCT00904033|69549505|FG002|Overall Study|Unable to obtain final blood draw|0|||
37865873|NCT00904033|69549506|FG003|Overall Study|Unable to obtain final blood draw|2|||
37865874|NCT00903877|69549517|FG000|Overall Study|Did not meet study criteria|33|||
37865875|NCT00903877|69549517|FG000|Overall Study|Withdrawal by Subject|3|||
37865876|NCT00903877|69549517|FG000|Overall Study|Adverse Event|2|||
37865877|NCT00903877|69549517|FG000|Overall Study|Lost to Follow-up|1|||
37865878|NCT00903877|69549517|FG000|Overall Study|Participation put on hold|4|||
37865879|NCT01241591|69549525|FG000|Overall Study|Lack of Efficacy|5|||
37865880|NCT01241591|69549526|FG001|Overall Study|Lack of Efficacy|2|||
37865881|NCT01241591|69549527|FG002|Overall Study|Lack of Efficacy|2|||
37865882|NCT01241591|69549528|FG003|Overall Study|Lack of Efficacy|3|||
37865883|NCT01241591|69549525|FG000|Overall Study|Protocol Violation|5|||
37865884|NCT01241591|69549526|FG001|Overall Study|Protocol Violation|2|||
37865885|NCT01241591|69549527|FG002|Overall Study|Protocol Violation|3|||
37865886|NCT01241591|69549528|FG003|Overall Study|Protocol Violation|0|||
37865887|NCT01241591|69549525|FG000|Overall Study|Lost to Follow-up|1|||
37865888|NCT01241591|69549526|FG001|Overall Study|Lost to Follow-up|2|||
37865889|NCT01241591|69549527|FG002|Overall Study|Lost to Follow-up|2|||
37865890|NCT01241591|69549528|FG003|Overall Study|Lost to Follow-up|2|||
37865891|NCT01241591|69549525|FG000|Overall Study|Screen Failure|3|||
37865892|NCT01241591|69549526|FG001|Overall Study|Screen Failure|2|||
37865893|NCT01241591|69549527|FG002|Overall Study|Screen Failure|1|||
37865894|NCT01241591|69549528|FG003|Overall Study|Screen Failure|0|||
37865895|NCT01241591|69549525|FG000|Overall Study|Withdrawal by Subject|6|||
37865896|NCT01241591|69549526|FG001|Overall Study|Withdrawal by Subject|4|||
37865897|NCT01241591|69549527|FG002|Overall Study|Withdrawal by Subject|2|||
37865898|NCT01241591|69549528|FG003|Overall Study|Withdrawal by Subject|2|||
37865899|NCT01241591|69549525|FG000|Overall Study|Other|0|||
37865900|NCT01241591|69549526|FG001|Overall Study|Other|1|||
37865901|NCT01241591|69549527|FG002|Overall Study|Other|0|||
37865902|NCT01241591|69549528|FG003|Overall Study|Other|1|||
37865903|NCT01241591|69549525|FG000|Overall Study|Adverse Event|3|||
37865904|NCT01241591|69549526|FG001|Overall Study|Adverse Event|11|||
37865905|NCT01241591|69549527|FG002|Overall Study|Adverse Event|12|||
37978441|NCT00441012|69665370|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
37978442|NCT00286468|69665379|FG000|Overall Study|Hyperglycemic Rescue|28|||
37978443|NCT00286468|69665380|FG001|Overall Study|Hyperglycemic Rescue|30|||
37978444|NCT00286468|69665381|FG002|Overall Study|Hyperglycemic Rescue|31|||
37978445|NCT00286468|69665379|FG000|Overall Study|Adverse Event|2|||
37694746|NCT01891864|69171214|FG002|Treatment Period 2|Adverse Event|1|||
37694747|NCT01891864|69171215|FG003|Treatment Period 2|Adverse Event|2|||
37694748|NCT01891864|69171216|FG004|Treatment Period 2|Adverse Event|0|||
37694749|NCT01891864|69171217|FG005|Treatment Period 2|Adverse Event|4|||
37814346|NCT01425008|69492170|FG010|Dose Expansion Phase|Progressive Disease|10|||
37814347|NCT01425008|69492171|FG011|Dose Expansion Phase|Progressive Disease|4|||
37814348|NCT01425008|69492172|FG012|Dose Expansion Phase|Progressive Disease|12|||
37814349|NCT01425008|69492173|FG013|Dose Expansion Phase|Progressive Disease|1|||
37814350|NCT01425008|69492174|FG014|Dose Expansion Phase|Progressive Disease|5|||
37814351|NCT01425008|69492175|FG015|Dose Expansion Phase|Progressive Disease|8|||
37814352|NCT01425008|69492176|FG016|Dose Expansion Phase|Progressive Disease|9|||
37814353|NCT01425008|69492177|FG017|Dose Expansion Phase|Progressive Disease|2|||
37814354|NCT01425008|69492178|FG018|Dose Expansion Phase|Progressive Disease|10|||
37814355|NCT01425008|69492160|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
37814356|NCT01425008|69492161|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
37814357|NCT01425008|69492162|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
37814358|NCT01425008|69492163|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
37814359|NCT01425008|69492164|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
37814360|NCT01425008|69492165|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
37814361|NCT01425008|69492166|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
37814362|NCT01425008|69492167|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
37694750|NCT01891864|69171212|FG000|Treatment Period 2|Termination of Site|0|||
37694751|NCT01891864|69171213|FG001|Treatment Period 2|Termination of Site|0|||
37694752|NCT01891864|69171214|FG002|Treatment Period 2|Termination of Site|0|||
37694753|NCT01891864|69171215|FG003|Treatment Period 2|Termination of Site|0|||
37865906|NCT01241591|69549528|FG003|Overall Study|Adverse Event|4|||
37865907|NCT00906373|69549540|FG000|Overall Study|Withdrawal by Subject|0|||
37865908|NCT00906373|69549541|FG001|Overall Study|Withdrawal by Subject|5|||
37865909|NCT00906373|69549540|FG000|Overall Study|Other|0|||
37865910|NCT00906373|69549541|FG001|Overall Study|Other|1|||
37865911|NCT00906373|69549540|FG000|Overall Study|Still on treatment at cutoff date|0|||
37694754|NCT01891864|69171216|FG004|Treatment Period 2|Termination of Site|2|||
37694755|NCT01891864|69171217|FG005|Treatment Period 2|Termination of Site|0|||
37694756|NCT01891864|69171212|FG000|Treatment Period 2|Withdrawal by Subject|0|||
37814363|NCT01425008|69492168|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
37814364|NCT01425008|69492169|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
37865912|NCT00906373|69549541|FG001|Overall Study|Still on treatment at cutoff date|2|||
37865913|NCT00905437|69549554|FG000|Overall Study|Adverse Event|3|||
37694757|NCT01891864|69171213|FG001|Treatment Period 2|Withdrawal by Subject|0|||
37814365|NCT01425008|69492170|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
37865914|NCT00905437|69549555|FG001|Overall Study|Adverse Event|2|||
37978446|NCT00286468|69665380|FG001|Overall Study|Adverse Event|6|||
37694758|NCT01891864|69171214|FG002|Treatment Period 2|Withdrawal by Subject|3|||
37694759|NCT01891864|69171215|FG003|Treatment Period 2|Withdrawal by Subject|4|||
37694760|NCT01891864|69171216|FG004|Treatment Period 2|Withdrawal by Subject|1|||
37694761|NCT01891864|69171217|FG005|Treatment Period 2|Withdrawal by Subject|1|||
37694762|NCT01891864|69171212|FG000|Extension Period|Lack of Efficacy|0|||
37694763|NCT01891864|69171213|FG001|Extension Period|Lack of Efficacy|0|||
37694764|NCT01891864|69171214|FG002|Extension Period|Lack of Efficacy|0|||
37694765|NCT01891864|69171215|FG003|Extension Period|Lack of Efficacy|1|||
37694766|NCT01891864|69171216|FG004|Extension Period|Lack of Efficacy|1|||
37694767|NCT01891864|69171217|FG005|Extension Period|Lack of Efficacy|0|||
37694768|NCT01891864|69171212|FG000|Extension Period|Pregnancy|0|||
37814366|NCT01425008|69492171|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
37814367|NCT01425008|69492172|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
37814368|NCT01425008|69492173|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
37865915|NCT00905437|69549554|FG000|Overall Study|Lost to Follow-up|0|||
37865916|NCT00905437|69549555|FG001|Overall Study|Lost to Follow-up|1|||
37865917|NCT00905437|69549554|FG000|Overall Study|Withdrawal by Subject|0|||
37865918|NCT00905437|69549555|FG001|Overall Study|Withdrawal by Subject|1|||
37865919|NCT00905437|69549554|FG000|Overall Study|Other|5|||
37865920|NCT00905437|69549555|FG001|Overall Study|Other|6|||
37865921|NCT01238861|69549567|FG000|Overall Study|Lost to Follow-up|4|||
37865922|NCT01238861|69549568|FG001|Overall Study|Lost to Follow-up|2|||
37865923|NCT01238861|69549569|FG002|Overall Study|Lost to Follow-up|3|||
37865924|NCT01238861|69549570|FG003|Overall Study|Lost to Follow-up|1|||
37865925|NCT01238861|69549571|FG004|Overall Study|Lost to Follow-up|1|||
37865926|NCT01238861|69549572|FG005|Overall Study|Lost to Follow-up|2|||
37865927|NCT01238861|69549567|FG000|Overall Study|Unplanned surgery|1|||
37865928|NCT01238861|69549568|FG001|Overall Study|Unplanned surgery|0|||
37865929|NCT01238861|69549569|FG002|Overall Study|Unplanned surgery|0|||
37978447|NCT00286468|69665381|FG002|Overall Study|Adverse Event|4|||
37978448|NCT00286468|69665379|FG000|Overall Study|Protocol Violation|0|||
37978449|NCT00286468|69665380|FG001|Overall Study|Protocol Violation|3|||
37978450|NCT00286468|69665381|FG002|Overall Study|Protocol Violation|1|||
37978451|NCT00286468|69665379|FG000|Overall Study|Lost to Follow-up|1|||
37978452|NCT00286468|69665380|FG001|Overall Study|Lost to Follow-up|1|||
37978453|NCT00286468|69665381|FG002|Overall Study|Lost to Follow-up|2|||
37694769|NCT01891864|69171213|FG001|Extension Period|Pregnancy|0|||
37694770|NCT01891864|69171214|FG002|Extension Period|Pregnancy|1|||
37694771|NCT01891864|69171215|FG003|Extension Period|Pregnancy|0|||
37694772|NCT01891864|69171216|FG004|Extension Period|Pregnancy|0|||
37814369|NCT01425008|69492174|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
37814370|NCT01425008|69492175|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
37814371|NCT01425008|69492176|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
37814372|NCT01425008|69492177|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
37814373|NCT01425008|69492178|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
37814374|NCT01425008|69492160|FG000|Dose Expansion Phase|Other|0|||
37814375|NCT01425008|69492161|FG001|Dose Expansion Phase|Other|0|||
37814376|NCT01425008|69492162|FG002|Dose Expansion Phase|Other|0|||
37814377|NCT01425008|69492163|FG003|Dose Expansion Phase|Other|0|||
37814378|NCT01425008|69492164|FG004|Dose Expansion Phase|Other|0|||
37814379|NCT01425008|69492165|FG005|Dose Expansion Phase|Other|0|||
37814380|NCT01425008|69492166|FG006|Dose Expansion Phase|Other|0|||
37814381|NCT01425008|69492167|FG007|Dose Expansion Phase|Other|0|||
37814382|NCT01425008|69492168|FG008|Dose Expansion Phase|Other|0|||
37814383|NCT01425008|69492169|FG009|Dose Expansion Phase|Other|0|||
37814384|NCT01425008|69492170|FG010|Dose Expansion Phase|Other|0|||
37814385|NCT01425008|69492171|FG011|Dose Expansion Phase|Other|0|||
37814386|NCT01425008|69492172|FG012|Dose Expansion Phase|Other|1|||
37814387|NCT01425008|69492173|FG013|Dose Expansion Phase|Other|0|||
37814388|NCT01425008|69492174|FG014|Dose Expansion Phase|Other|0|||
37814389|NCT01425008|69492175|FG015|Dose Expansion Phase|Other|0|||
37814390|NCT01425008|69492176|FG016|Dose Expansion Phase|Other|2|||
37814391|NCT01425008|69492177|FG017|Dose Expansion Phase|Other|0|||
37814392|NCT01425008|69492178|FG018|Dose Expansion Phase|Other|4|||
37814393|NCT01425008|69492160|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
37865930|NCT01238861|69549570|FG003|Overall Study|Unplanned surgery|0|||
37814394|NCT01425008|69492161|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
37814395|NCT01425008|69492162|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
37978454|NCT00286468|69665379|FG000|Overall Study|Withdrawal by Subject|3|||
37978455|NCT00286468|69665380|FG001|Overall Study|Withdrawal by Subject|8|||
37814396|NCT01425008|69492163|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
37865931|NCT01238861|69549571|FG004|Overall Study|Unplanned surgery|0|||
37865932|NCT01238861|69549572|FG005|Overall Study|Unplanned surgery|0|||
37978456|NCT00286468|69665381|FG002|Overall Study|Withdrawal by Subject|11|||
37694773|NCT01891864|69171217|FG005|Extension Period|Pregnancy|0|||
37694774|NCT01891864|69171212|FG000|Extension Period|Adverse Event|0|||
37865933|NCT01238861|69549567|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
37978457|NCT00286468|69665379|FG000|Overall Study|Physician Decision|3|||
37978458|NCT00286468|69665380|FG001|Overall Study|Physician Decision|2|||
37865934|NCT01238861|69549568|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
37865935|NCT01238861|69549569|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
37865936|NCT01238861|69549570|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
37865937|NCT01238861|69549571|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
37865938|NCT01238861|69549572|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
37865939|NCT01238861|69549567|FG000|Overall Study|Incorrect enrollment/randomization|0|||
37865940|NCT01238861|69549568|FG001|Overall Study|Incorrect enrollment/randomization|0|||
37865941|NCT01238861|69549569|FG002|Overall Study|Incorrect enrollment/randomization|1|||
37865942|NCT01238861|69549570|FG003|Overall Study|Incorrect enrollment/randomization|0|||
37865943|NCT01238861|69549571|FG004|Overall Study|Incorrect enrollment/randomization|1|||
37865944|NCT01238861|69549572|FG005|Overall Study|Incorrect enrollment/randomization|0|||
37865945|NCT01238861|69549567|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
37865946|NCT01238861|69549568|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
37865947|NCT01238861|69549569|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
37865948|NCT01238861|69549570|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
37865949|NCT01238861|69549571|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
37865950|NCT01238861|69549572|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
37865951|NCT01238861|69549567|FG000|Overall Study|Subject moved out of state/area|0|||
37865952|NCT01238861|69549568|FG001|Overall Study|Subject moved out of state/area|0|||
37865953|NCT01238861|69549569|FG002|Overall Study|Subject moved out of state/area|1|||
37865954|NCT01238861|69549570|FG003|Overall Study|Subject moved out of state/area|1|||
37865955|NCT01238861|69549571|FG004|Overall Study|Subject moved out of state/area|0|||
37865956|NCT01238861|69549572|FG005|Overall Study|Subject moved out of state/area|0|||
37865957|NCT01238861|69549567|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
37865958|NCT01238861|69549568|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
37865959|NCT01238861|69549569|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
37865960|NCT01238861|69549570|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
37865961|NCT01238861|69549571|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
37865962|NCT01238861|69549572|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
37865963|NCT01238861|69549567|FG000|Overall Study|Personal problems|0|||
37865964|NCT01238861|69549568|FG001|Overall Study|Personal problems|0|||
37865965|NCT01238861|69549569|FG002|Overall Study|Personal problems|0|||
37865966|NCT01238861|69549570|FG003|Overall Study|Personal problems|1|||
37865967|NCT01238861|69549571|FG004|Overall Study|Personal problems|0|||
37865968|NCT01238861|69549572|FG005|Overall Study|Personal problems|0|||
37865969|NCT01238861|69549567|FG000|Overall Study|Unable to continue visits|0|||
37865970|NCT01238861|69549568|FG001|Overall Study|Unable to continue visits|0|||
37865971|NCT01238861|69549569|FG002|Overall Study|Unable to continue visits|0|||
37865972|NCT01238861|69549570|FG003|Overall Study|Unable to continue visits|1|||
37865973|NCT01238861|69549571|FG004|Overall Study|Unable to continue visits|0|||
37865974|NCT01238861|69549572|FG005|Overall Study|Unable to continue visits|1|||
37865975|NCT01238861|69549567|FG000|Overall Study|Serious adverse event|0|||
37865976|NCT01238861|69549568|FG001|Overall Study|Serious adverse event|0|||
37865977|NCT01238861|69549569|FG002|Overall Study|Serious adverse event|0|||
37865978|NCT01238861|69549570|FG003|Overall Study|Serious adverse event|0|||
37865979|NCT01238861|69549571|FG004|Overall Study|Serious adverse event|0|||
37865980|NCT01238861|69549572|FG005|Overall Study|Serious adverse event|1|||
37865981|NCT01238861|69549567|FG000|Overall Study|Lack of compliance|0|||
37865982|NCT01238861|69549568|FG001|Overall Study|Lack of compliance|0|||
37865983|NCT01238861|69549569|FG002|Overall Study|Lack of compliance|0|||
37865984|NCT01238861|69549570|FG003|Overall Study|Lack of compliance|0|||
37865985|NCT01238861|69549571|FG004|Overall Study|Lack of compliance|0|||
37865986|NCT01238861|69549572|FG005|Overall Study|Lack of compliance|1|||
37865987|NCT01238861|69549567|FG000|Overall Study|Adverse Event|0|||
37865988|NCT01238861|69549568|FG001|Overall Study|Adverse Event|1|||
37865989|NCT01238861|69549569|FG002|Overall Study|Adverse Event|0|||
37865990|NCT01238861|69549570|FG003|Overall Study|Adverse Event|0|||
37865991|NCT01238861|69549571|FG004|Overall Study|Adverse Event|0|||
37865992|NCT01238861|69549572|FG005|Overall Study|Adverse Event|0|||
37865993|NCT01238861|69549567|FG000|Overall Study|Withdrawal by Subject|6|||
37865994|NCT01238861|69549568|FG001|Overall Study|Withdrawal by Subject|5|||
37865995|NCT01238861|69549569|FG002|Overall Study|Withdrawal by Subject|4|||
37865996|NCT01238861|69549570|FG003|Overall Study|Withdrawal by Subject|8|||
37865997|NCT01238861|69549571|FG004|Overall Study|Withdrawal by Subject|10|||
37865998|NCT01238861|69549572|FG005|Overall Study|Withdrawal by Subject|9|||
37865999|NCT00903409|69549595|FG000|Overall Study|Adverse Event|11|||
37866000|NCT00903409|69549596|FG001|Overall Study|Adverse Event|9|||
37866001|NCT00903409|69549595|FG000|Overall Study|Non-compliance with Protocol|1|||
37866002|NCT00903409|69549596|FG001|Overall Study|Non-compliance with Protocol|1|||
37978459|NCT00286468|69665381|FG002|Overall Study|Physician Decision|1|||
37814397|NCT01425008|69492164|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
37814398|NCT01425008|69492165|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
37814399|NCT01425008|69492166|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
37814400|NCT01425008|69492167|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
37814401|NCT01425008|69492168|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
37814402|NCT01425008|69492169|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
37814403|NCT01425008|69492170|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
37866003|NCT00903409|69549595|FG000|Overall Study|Laboratory Abnormality|2|||
37978460|NCT00507026|69665392|FG000|Overall Study|Lack of Efficacy|6|||
37978461|NCT00507026|69665393|FG001|Overall Study|Lack of Efficacy|4|||
37978462|NCT00507026|69665394|FG002|Overall Study|Lack of Efficacy|21|||
37978463|NCT00507026|69665392|FG000|Overall Study|Withdrawal by Subject|2|||
37978464|NCT00507026|69665393|FG001|Overall Study|Withdrawal by Subject|0|||
37814404|NCT01425008|69492171|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
37866004|NCT00903409|69549596|FG001|Overall Study|Laboratory Abnormality|0|||
37978465|NCT00507026|69665394|FG002|Overall Study|Withdrawal by Subject|0|||
37978466|NCT00507026|69665392|FG000|Overall Study|Investigator Decision|1|||
37978467|NCT00507026|69665393|FG001|Overall Study|Investigator Decision|0|||
37978468|NCT00507026|69665394|FG002|Overall Study|Investigator Decision|0|||
37814405|NCT01425008|69492172|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
37814406|NCT01425008|69492173|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
37814407|NCT01425008|69492174|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
37814408|NCT01425008|69492175|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
37814409|NCT01425008|69492176|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
37814410|NCT01425008|69492177|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
37814411|NCT01425008|69492178|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
37814412|NCT01425008|69492160|FG000|Dose Expansion Phase|Adverse Event|0|||
37866005|NCT00903409|69549595|FG000|Overall Study|Withdrawal by Subject|8|||
37866006|NCT00903409|69549596|FG001|Overall Study|Withdrawal by Subject|8|||
37978469|NCT00507026|69665392|FG000|Overall Study|Adverse Event|2|||
37978470|NCT00507026|69665393|FG001|Overall Study|Adverse Event|0|||
37978471|NCT00507026|69665394|FG002|Overall Study|Adverse Event|0|||
37978472|NCT00507026|69665392|FG000|Overall Study|Protocol Violation|1|||
37978473|NCT00507026|69665393|FG001|Overall Study|Protocol Violation|0|||
37978474|NCT00507026|69665394|FG002|Overall Study|Protocol Violation|0|||
37978475|NCT00507026|69665392|FG000|Overall Study|Other|1|||
37978476|NCT00507026|69665393|FG001|Overall Study|Other|0|||
37978477|NCT00507026|69665394|FG002|Overall Study|Other|0|||
37978478|NCT00446550|69665404|FG000|Overall Study|Adverse Event|1|||
37866007|NCT00903409|69549595|FG000|Overall Study|Other|2|||
37866008|NCT00903409|69549596|FG001|Overall Study|Other|3|||
37866009|NCT00903409|69549595|FG000|Overall Study|Lost to Follow-up|2|||
37866010|NCT00903409|69549596|FG001|Overall Study|Lost to Follow-up|6|||
37866011|NCT01237223|69549610|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
37866012|NCT01237223|69549611|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
37866013|NCT01237223|69549612|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
37866014|NCT01237223|69549613|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
37866015|NCT01237223|69549614|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
37866016|NCT01237223|69549615|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
37866017|NCT01237223|69549610|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
37866018|NCT01237223|69549611|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
37866019|NCT01237223|69549612|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
37866020|NCT01237223|69549613|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
37866021|NCT01237223|69549614|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
37866022|NCT01237223|69549615|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
37866023|NCT01237223|69549610|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
37866024|NCT01237223|69549611|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
37866025|NCT01237223|69549612|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
37866026|NCT01237223|69549613|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
37866027|NCT01237223|69549614|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
37866028|NCT01237223|69549615|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
37866029|NCT01237223|69549610|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
37866030|NCT01237223|69549611|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
37866031|NCT01237223|69549612|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
37866032|NCT01237223|69549613|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
37866033|NCT01237223|69549614|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
37866034|NCT01237223|69549615|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
37866035|NCT01237223|69549610|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
37866036|NCT01237223|69549611|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
37866037|NCT01237223|69549612|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
37866038|NCT01237223|69549613|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
37866039|NCT01237223|69549614|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
37866040|NCT01237223|69549615|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
37866041|NCT01237223|69549610|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
37866042|NCT01237223|69549611|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
37866043|NCT01237223|69549612|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
37978479|NCT00446550|69665405|FG001|Overall Study|Adverse Event|0|||
37978480|NCT03847974|69665412|FG000|Overall Study|relocated out of region|3|||
37978481|NCT03847974|69665412|FG000|Overall Study|Withdrawal by Subject|2|||
37978482|NCT03847974|69665412|FG000|Overall Study|Adverse Event|1|||
37694775|NCT01891864|69171213|FG001|Extension Period|Adverse Event|0|||
37694776|NCT01891864|69171214|FG002|Extension Period|Adverse Event|4|||
37694777|NCT01891864|69171215|FG003|Extension Period|Adverse Event|2|||
37866044|NCT01237223|69549613|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
37978483|NCT00506948|69665416|FG000|Overall Study|Death|4|||
37978484|NCT00506948|69665416|FG000|Overall Study|Adverse Event|5|||
37978485|NCT00506948|69665416|FG000|Overall Study|Physician Decision|1|||
37978486|NCT00286234|69665424|FG000|Overall Study|Protocol Violation|1|||
37978487|NCT00286234|69665425|FG001|Overall Study|Protocol Violation|2|||
37978488|NCT00286234|69665426|FG002|Overall Study|Protocol Violation|0|||
37978489|NCT00286234|69665427|FG003|Overall Study|Protocol Violation|1|||
37978490|NCT00286234|69665424|FG000|Overall Study|Physician Decision|1|||
37978491|NCT00286234|69665425|FG001|Overall Study|Physician Decision|0|||
37978492|NCT00286234|69665426|FG002|Overall Study|Physician Decision|0|||
37694778|NCT01891864|69171216|FG004|Extension Period|Adverse Event|2|||
37814413|NCT01425008|69492161|FG001|Dose Expansion Phase|Adverse Event|0|||
37814414|NCT01425008|69492162|FG002|Dose Expansion Phase|Adverse Event|0|||
37814415|NCT01425008|69492163|FG003|Dose Expansion Phase|Adverse Event|0|||
37814416|NCT01425008|69492164|FG004|Dose Expansion Phase|Adverse Event|0|||
37814417|NCT01425008|69492165|FG005|Dose Expansion Phase|Adverse Event|0|||
37814418|NCT01425008|69492166|FG006|Dose Expansion Phase|Adverse Event|0|||
37814419|NCT01425008|69492167|FG007|Dose Expansion Phase|Adverse Event|0|||
37814420|NCT01425008|69492168|FG008|Dose Expansion Phase|Adverse Event|0|||
37814421|NCT01425008|69492169|FG009|Dose Expansion Phase|Adverse Event|0|||
37814422|NCT01425008|69492170|FG010|Dose Expansion Phase|Adverse Event|2|||
37814423|NCT01425008|69492171|FG011|Dose Expansion Phase|Adverse Event|3|||
37814424|NCT01425008|69492172|FG012|Dose Expansion Phase|Adverse Event|3|||
37814425|NCT01425008|69492173|FG013|Dose Expansion Phase|Adverse Event|0|||
37814426|NCT01425008|69492174|FG014|Dose Expansion Phase|Adverse Event|1|||
37814427|NCT01425008|69492175|FG015|Dose Expansion Phase|Adverse Event|1|||
37814428|NCT01425008|69492176|FG016|Dose Expansion Phase|Adverse Event|5|||
37814429|NCT01425008|69492177|FG017|Dose Expansion Phase|Adverse Event|0|||
37814430|NCT01425008|69492178|FG018|Dose Expansion Phase|Adverse Event|3|||
37814431|NCT01425008|69492160|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
37814432|NCT01425008|69492161|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
37814433|NCT01425008|69492162|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
37814434|NCT01425008|69492163|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
37814435|NCT01425008|69492164|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
37814436|NCT01425008|69492165|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
37814437|NCT01425008|69492166|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
37814438|NCT01425008|69492167|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
37814439|NCT01425008|69492168|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
37814440|NCT01425008|69492169|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
37814441|NCT01425008|69492170|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
37814442|NCT01425008|69492171|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
37814443|NCT01425008|69492172|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
37814444|NCT01425008|69492173|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
37814445|NCT01425008|69492174|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
37814446|NCT01425008|69492175|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
37814447|NCT01425008|69492176|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
37814448|NCT01425008|69492177|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
37814449|NCT01425008|69492178|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
37814450|NCT01425008|69492160|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
37814451|NCT01425008|69492161|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
37814452|NCT01425008|69492162|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
37814453|NCT01425008|69492163|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
37814454|NCT01425008|69492164|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
37814455|NCT01425008|69492165|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
37814456|NCT01425008|69492166|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
37814457|NCT01425008|69492167|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
37814458|NCT01425008|69492168|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
37814459|NCT01425008|69492169|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
37814460|NCT01425008|69492170|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
37814461|NCT01425008|69492171|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
37814462|NCT01425008|69492172|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
37814463|NCT01425008|69492173|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
37814464|NCT01425008|69492174|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
37814465|NCT01425008|69492175|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
37814466|NCT01425008|69492176|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
37814467|NCT01425008|69492177|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
37814468|NCT01425008|69492178|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
37814469|NCT04425902|69492231|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
37814470|NCT04072146|69492244|FG000|Overall Study|Adverse Event|0|||
37814471|NCT04072146|69492245|FG001|Overall Study|Adverse Event|1|||
37814472|NCT03861481|69492259|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
37978493|NCT00286234|69665427|FG003|Overall Study|Physician Decision|1|||
37866045|NCT01237223|69549614|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
37866046|NCT01237223|69549615|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
37866047|NCT01237223|69549610|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
37866048|NCT01237223|69549611|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
37866049|NCT01237223|69549612|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
37866050|NCT01237223|69549613|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
37866051|NCT01237223|69549614|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
37866052|NCT01237223|69549615|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
37866053|NCT01237223|69549610|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
37866054|NCT01237223|69549611|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
37866055|NCT01237223|69549612|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
37866056|NCT01237223|69549613|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
37866057|NCT01237223|69549614|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
37866058|NCT01237223|69549615|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
37866059|NCT01237223|69549610|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
37866060|NCT01237223|69549611|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
37866061|NCT01237223|69549612|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
37866062|NCT01237223|69549613|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
37866063|NCT01237223|69549614|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
37866064|NCT01237223|69549615|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
37866065|NCT01237223|69549610|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
37866066|NCT01237223|69549611|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
37866067|NCT01237223|69549612|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
37866068|NCT01237223|69549613|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
37866069|NCT01237223|69549614|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
37866070|NCT01237223|69549615|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
37866071|NCT01236755|69549631|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
37866072|NCT01236755|69549631|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
37866073|NCT01236755|69549631|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
37866074|NCT01236755|69549631|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
37814473|NCT03861481|69492260|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
37814474|NCT03861481|69492259|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
37814475|NCT03861481|69492260|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
37814476|NCT03861481|69492259|FG000|Overall Study|Relapse|1|||
37814477|NCT03861481|69492260|FG001|Overall Study|Relapse|0|||
37814478|NCT03861481|69492259|FG000|Overall Study|Withdrawal by Subject|0|||
37814479|NCT03861481|69492260|FG001|Overall Study|Withdrawal by Subject|1|||
37814480|NCT03861481|69492259|FG000|Overall Study|Lack of Efficacy|4|||
37866075|NCT01236365|69549638|FG000|Overall Study|Lost to Follow-up|0|||
37814481|NCT03861481|69492260|FG001|Overall Study|Lack of Efficacy|5|||
37866076|NCT01236365|69549639|FG001|Overall Study|Lost to Follow-up|2|||
37814482|NCT03648476|69492272|FG000|Overall Study|Withdrawal by Subject|2|||
37814483|NCT03648476|69492273|FG001|Overall Study|Withdrawal by Subject|1|||
37814484|NCT04545060|69492304|FG000|Overall Study|Adverse Event|0|||
37814485|NCT04545060|69492305|FG001|Overall Study|Adverse Event|1|||
37814486|NCT04545060|69492304|FG000|Overall Study|Death|0|||
37814487|NCT04545060|69492305|FG001|Overall Study|Death|5|||
37814488|NCT04545060|69492304|FG000|Overall Study|Lost to Follow-up|10|||
37814489|NCT04545060|69492305|FG001|Overall Study|Lost to Follow-up|13|||
37814490|NCT04545060|69492304|FG000|Overall Study|Physician Decision|3|||
37814491|NCT04545060|69492305|FG001|Overall Study|Physician Decision|0|||
37866077|NCT01236365|69549638|FG000|Overall Study|Moved Out of State|1|||
37866078|NCT01236365|69549639|FG001|Overall Study|Moved Out of State|0|||
37866079|NCT01236365|69549638|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
37978494|NCT00286234|69665424|FG000|Overall Study|Adverse Event|0|||
37978495|NCT00286234|69665425|FG001|Overall Study|Adverse Event|0|||
37814492|NCT04545060|69492304|FG000|Overall Study|Withdrawal by Subject|17|||
37978496|NCT00286234|69665426|FG002|Overall Study|Adverse Event|0|||
37978497|NCT00286234|69665427|FG003|Overall Study|Adverse Event|1|||
37978498|NCT00286234|69665424|FG000|Overall Study|Adverse Event|0|||
37978499|NCT00286234|69665425|FG001|Overall Study|Adverse Event|0|||
37978500|NCT00286234|69665426|FG002|Overall Study|Adverse Event|0|||
37694779|NCT01891864|69171217|FG005|Extension Period|Adverse Event|0|||
37814493|NCT04545060|69492305|FG001|Overall Study|Withdrawal by Subject|22|||
37814494|NCT03533660|69492361|FG000|Overall Study|Withdrawal by Subject|2|||
37814495|NCT03533660|69492362|FG001|Overall Study|Withdrawal by Subject|2|||
37814496|NCT03533660|69492361|FG000|Overall Study|Death|2|||
37814497|NCT03533660|69492362|FG001|Overall Study|Death|4|||
37814498|NCT03533660|69492361|FG000|Overall Study|Adverse Event|0|||
37814499|NCT03533660|69492362|FG001|Overall Study|Adverse Event|2|||
37814500|NCT03416127|69492376|FG000|Overall Study|Withdrawal by Subject|0|||
37814501|NCT03416127|69492377|FG001|Overall Study|Withdrawal by Subject|1|||
37814502|NCT03416127|69492378|FG002|Overall Study|Withdrawal by Subject|1|||
37814503|NCT02986334|69492412|FG000|Overall Study|Withdrawal by Subject|0|||
37814504|NCT02986334|69492413|FG001|Overall Study|Withdrawal by Subject|1|||
37814505|NCT02986334|69492414|FG002|Overall Study|Withdrawal by Subject|2|||
37814506|NCT02986334|69492412|FG000|Overall Study|Lost to Follow-up|1|||
37814507|NCT02986334|69492413|FG001|Overall Study|Lost to Follow-up|2|||
37814508|NCT02986334|69492414|FG002|Overall Study|Lost to Follow-up|1|||
37814509|NCT02986334|69492412|FG000|Overall Study|Adverse Event|0|||
37814510|NCT02986334|69492413|FG001|Overall Study|Adverse Event|2|||
37814511|NCT02986334|69492414|FG002|Overall Study|Adverse Event|1|||
37814512|NCT02986334|69492412|FG000|Overall Study|non compliance in phone ratings|2|||
37814513|NCT02986334|69492413|FG001|Overall Study|non compliance in phone ratings|1|||
37814514|NCT02986334|69492414|FG002|Overall Study|non compliance in phone ratings|2|||
37814515|NCT02986334|69492412|FG000|Overall Study|undisclosed comorbidities|0|||
37814516|NCT02986334|69492413|FG001|Overall Study|undisclosed comorbidities|1|||
37814517|NCT02986334|69492414|FG002|Overall Study|undisclosed comorbidities|1|||
37814518|NCT02210221|69492436|FG000|Overall Study|Lack of Efficacy|7|||
37814519|NCT02210221|69492436|FG000|Overall Study|Withdrawal by Subject|43|||
37814520|NCT02124902|69492449|FG000|Overall Study|Adverse Event|7|||
37814521|NCT02124902|69492450|FG001|Overall Study|Adverse Event|2|||
37814522|NCT02124902|69492449|FG000|Overall Study|Went to alternative treatment|4|||
37814523|NCT02124902|69492450|FG001|Overall Study|Went to alternative treatment|0|||
37814524|NCT02124902|69492449|FG000|Overall Study|Withdrawal by Subject|2|||
37814525|NCT02124902|69492450|FG001|Overall Study|Withdrawal by Subject|1|||
37814526|NCT02124902|69492449|FG000|Overall Study|Physician Decision|2|||
37814527|NCT02124902|69492450|FG001|Overall Study|Physician Decision|0|||
37814528|NCT02124902|69492449|FG000|Overall Study|Not eligible|1|||
37814529|NCT02124902|69492450|FG001|Overall Study|Not eligible|0|||
37814530|NCT02124902|69492449|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
37814531|NCT02124902|69492450|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
37814532|NCT01940341|69492458|FG000|Period 1: Double-blind Phase|Withdrew Consent|7|||
37814533|NCT01940341|69492459|FG001|Period 1: Double-blind Phase|Withdrew Consent|4|||
37814534|NCT01940341|69492460|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
37814535|NCT01940341|69492461|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
37814536|NCT01940341|69492458|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
37814537|NCT01940341|69492459|FG001|Period 1: Double-blind Phase|Lost to Follow-up|1|||
37814538|NCT01940341|69492460|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
37814539|NCT01940341|69492461|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
37814540|NCT01940341|69492458|FG000|Period 1: Double-blind Phase|Adverse Event|4|||
37814541|NCT01940341|69492459|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
37814542|NCT01940341|69492460|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
37814543|NCT01940341|69492461|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
37814544|NCT01940341|69492458|FG000|Period 1: Double-blind Phase|Investigator's Discretion|3|||
37814545|NCT01940341|69492459|FG001|Period 1: Double-blind Phase|Investigator's Discretion|1|||
37814546|NCT01940341|69492460|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
37814547|NCT01940341|69492461|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
37814548|NCT01940341|69492458|FG000|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
37814549|NCT01940341|69492459|FG001|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
37814550|NCT01940341|69492460|FG002|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
37814551|NCT01940341|69492461|FG003|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
37814552|NCT01940341|69492458|FG000|Period 1: Double-blind Phase|Death|0|||
37814553|NCT01940341|69492459|FG001|Period 1: Double-blind Phase|Death|1|||
37814554|NCT01940341|69492460|FG002|Period 1: Double-blind Phase|Death|0|||
37814555|NCT01940341|69492461|FG003|Period 1: Double-blind Phase|Death|0|||
37814556|NCT01940341|69492458|FG000|Period 1: Double-blind Phase|Pregnancy|0|||
37814557|NCT01940341|69492459|FG001|Period 1: Double-blind Phase|Pregnancy|1|||
37814558|NCT01940341|69492460|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
37814559|NCT01940341|69492461|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
37814560|NCT01940341|69492458|FG000|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|1|||
37814561|NCT01940341|69492459|FG001|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
37814562|NCT01940341|69492460|FG002|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
37814563|NCT01940341|69492461|FG003|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
37814564|NCT01940341|69492458|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
37814565|NCT01940341|69492459|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
37814566|NCT01940341|69492460|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
37814567|NCT01940341|69492461|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
37814568|NCT01940341|69492458|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
37814569|NCT01940341|69492459|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
37814570|NCT01940341|69492460|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|17|||
37814571|NCT01940341|69492461|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|4|||
37814572|NCT01940341|69492458|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
37814573|NCT01940341|69492459|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
37814574|NCT01940341|69492460|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|3|||
37814575|NCT01940341|69492461|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
37814576|NCT01940341|69492458|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
37814577|NCT01940341|69492459|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
37814578|NCT01940341|69492460|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|6|||
37814579|NCT01940341|69492461|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
37814580|NCT01940341|69492458|FG000|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
37814581|NCT01940341|69492459|FG001|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
37814582|NCT01940341|69492460|FG002|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|3|||
37814583|NCT01940341|69492461|FG003|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|1|||
37814584|NCT01940341|69492458|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
37814585|NCT01940341|69492459|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
37814586|NCT01940341|69492460|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|2|||
37814587|NCT01940341|69492461|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
37814588|NCT01940341|69492458|FG000|Period 2: Open-Label TAF Extension Phase|Death|0|||
37814589|NCT01940341|69492459|FG001|Period 2: Open-Label TAF Extension Phase|Death|0|||
37814590|NCT01940341|69492460|FG002|Period 2: Open-Label TAF Extension Phase|Death|1|||
37814591|NCT01940341|69492461|FG003|Period 2: Open-Label TAF Extension Phase|Death|0|||
37814592|NCT01940341|69492458|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
37814593|NCT01940341|69492459|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
37814594|NCT01940341|69492460|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
37814595|NCT01940341|69492461|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
37814596|NCT01940341|69492458|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
37814597|NCT01940341|69492459|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
37814598|NCT01940341|69492460|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
37814599|NCT01940341|69492461|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
37814600|NCT01940341|69492458|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
37814601|NCT01940341|69492459|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
37814602|NCT01940341|69492460|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
37814603|NCT01940341|69492461|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|1|||
37814604|NCT01940341|69492458|FG000|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
37814605|NCT01940341|69492459|FG001|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
37814606|NCT01940341|69492460|FG002|Period 2: Open-Label TAF Extension Phase|Progressive Disease|1|||
37814607|NCT01940341|69492461|FG003|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
37814608|NCT01877837|69492469|FG000|Overall Study|Lost to Follow-up|1|||
37814609|NCT01877837|69492469|FG000|Overall Study|Ineligible|4|||
37814610|NCT01624142|69492475|FG000|Overall Study|Withdrawal by Subject|14|||
37814611|NCT01624142|69492476|FG001|Overall Study|Withdrawal by Subject|4|||
37814612|NCT01624142|69492475|FG000|Overall Study|Death|3|||
37814613|NCT01624142|69492476|FG001|Overall Study|Death|6|||
37814614|NCT01624142|69492475|FG000|Overall Study|Study Closure|12|||
37814615|NCT01624142|69492476|FG001|Overall Study|Study Closure|6|||
37814616|NCT01624142|69492475|FG000|Overall Study|Lost to Follow-up|2|||
37866080|NCT01236365|69549639|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
37866081|NCT01235975|69549659|FG000|Overall Study|Serious Adverse Event|0|||
37866082|NCT01235975|69549660|FG001|Overall Study|Serious Adverse Event|1|||
37866083|NCT01235975|69549659|FG000|Overall Study|Withdrawal by Subject|8|||
37866084|NCT01235975|69549660|FG001|Overall Study|Withdrawal by Subject|2|||
37866085|NCT01235975|69549659|FG000|Overall Study|Migrated/moved from study area|2|||
37866086|NCT01235975|69549660|FG001|Overall Study|Migrated/moved from study area|1|||
37866087|NCT01235975|69549659|FG000|Overall Study|Lost to Follow-up|7|||
37866088|NCT01235975|69549660|FG001|Overall Study|Lost to Follow-up|3|||
37866089|NCT00903331|69549668|FG000|Overall Study|Death|4|||
37866090|NCT00903331|69549669|FG001|Overall Study|Death|8|||
37866091|NCT00903331|69549668|FG000|Overall Study|Withdrawal of consent|1|||
37866092|NCT00903331|69549669|FG001|Overall Study|Withdrawal of consent|8|||
37866093|NCT00903331|69549668|FG000|Overall Study|Lung transplant|0|||
37866094|NCT00903331|69549669|FG001|Overall Study|Lung transplant|2|||
37866095|NCT01235741|69549678|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
37866096|NCT01235741|69549679|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
37866097|NCT01235741|69549680|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
37866098|NCT01235741|69549678|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
37866099|NCT01235741|69549679|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
37866100|NCT01235741|69549680|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
37866101|NCT01235741|69549678|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
37866102|NCT01235741|69549679|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
37866103|NCT01235741|69549680|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
37866104|NCT01235741|69549678|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
37866105|NCT01235741|69549679|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
37866106|NCT01235741|69549680|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
37866107|NCT01235741|69549678|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
37866108|NCT01235741|69549679|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
37866109|NCT01235741|69549680|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
37814617|NCT01624142|69492476|FG001|Overall Study|Lost to Follow-up|0|||
37814618|NCT01624142|69492475|FG000|Overall Study|Other|1|||
37814619|NCT01624142|69492476|FG001|Overall Study|Other|0|||
37814620|NCT01535807|69492485|FG000|Overall Study|Withdrawal by Subject|1|||
37814621|NCT01535807|69492486|FG001|Overall Study|Withdrawal by Subject|1|||
37814622|NCT01535807|69492485|FG000|Overall Study|Data collection error|1|||
37814623|NCT01535807|69492486|FG001|Overall Study|Data collection error|1|||
37814624|NCT01375764|69492498|FG000|Overall Study|Lost to Follow-up|0|||
37814625|NCT01375764|69492499|FG001|Overall Study|Lost to Follow-up|1|||
37866110|NCT01235741|69549678|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
37866111|NCT01235741|69549679|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
37866112|NCT01235741|69549680|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
37866113|NCT01235741|69549678|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
37866114|NCT01235741|69549679|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
37866115|NCT01235741|69549680|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
37866116|NCT01235741|69549678|FG000|Randomized to Treatment|Adverse Event|0|||
37866117|NCT01235741|69549679|FG001|Randomized to Treatment|Adverse Event|1|||
37866118|NCT01235741|69549680|FG002|Randomized to Treatment|Adverse Event|1|||
37866119|NCT01235741|69549678|FG000|Randomized to Treatment|Sponsor terminated study|0|||
37866120|NCT01235741|69549679|FG001|Randomized to Treatment|Sponsor terminated study|35|||
37866121|NCT01235741|69549680|FG002|Randomized to Treatment|Sponsor terminated study|34|||
37866122|NCT01235741|69549678|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
37866123|NCT01235741|69549679|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
37866124|NCT01235741|69549680|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
37866125|NCT01235741|69549678|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
37866126|NCT01235741|69549679|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
37866127|NCT01235741|69549680|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
37866128|NCT01235741|69549678|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
37866129|NCT01235741|69549679|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
37866130|NCT01235741|69549680|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
37866131|NCT01235507|69549692|FG000|Overall Study|Adverse Event|1|||
37866132|NCT01235507|69549692|FG000|Overall Study|Withdrawal by Subject|1|||
37866133|NCT01235351|69549698|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
37866134|NCT01235351|69549699|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
37866135|NCT01076205|69549709|FG000|Overall Study|Adverse Drug Reaction|299|||
37866136|NCT01076205|69549709|FG000|Overall Study|Lack of Effectiveness|1423|||
37866137|NCT01076205|69549709|FG000|Overall Study|Other Reason|1075|||
37866138|NCT01076205|69549709|FG000|Overall Study|Unknown Reason|71|||
37866139|NCT01076205|69549709|FG000|Overall Study|Lost to Follow-up|3151|||
37866140|NCT01234883|69549731|FG000|Overall Study|Early treatment release|8|||
37866141|NCT01234883|69549732|FG001|Overall Study|Early treatment release|10|||
37866142|NCT01234883|69549731|FG000|Overall Study|Parent/guardian withdrew consent|1|||
37866143|NCT01234883|69549732|FG001|Overall Study|Parent/guardian withdrew consent|2|||
37866144|NCT01234883|69549731|FG000|Overall Study|Technical difficulties with IV infusion|0|||
37866145|NCT01234883|69549732|FG001|Overall Study|Technical difficulties with IV infusion|1|||
37866146|NCT01234883|69549731|FG000|Overall Study|Inclusion/exclusion failure|1|||
37866147|NCT01234883|69549732|FG001|Overall Study|Inclusion/exclusion failure|0|||
37866148|NCT01234649|69549740|FG000|Overall Study|Withdrawal by Subject|32|||
37866149|NCT01234649|69549741|FG001|Overall Study|Withdrawal by Subject|26|||
37866150|NCT01234649|69549740|FG000|Overall Study|Pregnancy|6|||
37866151|NCT01234649|69549741|FG001|Overall Study|Pregnancy|6|||
37814626|NCT01375764|69492500|FG002|Overall Study|Lost to Follow-up|0|||
37866152|NCT01234649|69549740|FG000|Overall Study|intolerant to side effects|4|||
37866153|NCT01234649|69549741|FG001|Overall Study|intolerant to side effects|3|||
37866154|NCT01234649|69549740|FG000|Overall Study|Allergic reaction|1|||
37866155|NCT01234649|69549741|FG001|Overall Study|Allergic reaction|0|||
37814627|NCT01375764|69492501|FG003|Overall Study|Lost to Follow-up|0|||
37866156|NCT01234649|69549740|FG000|Overall Study|Lack of Efficacy|0|||
37866157|NCT01234649|69549741|FG001|Overall Study|Lack of Efficacy|3|||
37866158|NCT01075815|69549749|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
37866159|NCT01075815|69549750|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
37866160|NCT01075815|69549749|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
37866161|NCT01075815|69549750|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
37866162|NCT01075815|69549749|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
37866163|NCT01075815|69549750|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
37866164|NCT01075191|69549756|FG000|Overall Study|Death|1|||
37866165|NCT01075191|69549756|FG000|Overall Study|Intensification|3|||
37866166|NCT01075191|69549756|FG000|Overall Study|Co-morbidities|1|||
37866167|NCT01075191|69549756|FG000|Overall Study|Adverse Event|4|||
37866168|NCT01075191|69549756|FG000|Overall Study|Noncompliance|3|||
37866169|NCT01075191|69549756|FG000|Overall Study|Therapy Break|3|||
37866170|NCT01075191|69549756|FG000|Overall Study|Patient's Wish|2|||
37866171|NCT01075191|69549756|FG000|Overall Study|Unknown Reasons|1|||
37866172|NCT00905359|69549762|FG000|Overall Study|Lost to Follow-up|17|||
37866173|NCT00905359|69549763|FG001|Overall Study|Lost to Follow-up|10|||
37866174|NCT00905359|69549762|FG000|Overall Study|Death|2|||
37866175|NCT00905359|69549763|FG001|Overall Study|Death|0|||
37866176|NCT00905359|69549762|FG000|Overall Study|Withdrawal consent|5|||
37866177|NCT00905359|69549763|FG001|Overall Study|Withdrawal consent|6|||
37866178|NCT01072149|69549769|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
37866179|NCT01072149|69549770|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
37866180|NCT01072149|69549771|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
37866181|NCT01072149|69549772|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
37866182|NCT01072149|69549773|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
37866183|NCT01072149|69549774|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
37866184|NCT01072149|69549775|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
37866185|NCT01072149|69549776|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
37866186|NCT01072149|69549777|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
37866187|NCT01072149|69549778|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
37866188|NCT01072149|69549779|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
37866189|NCT01072149|69549780|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
37866190|NCT01072149|69549781|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
37866191|NCT01072149|69549782|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
37866192|NCT01072149|69549783|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
37866193|NCT01072149|69549784|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
37866194|NCT01072149|69549785|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
37866195|NCT01072149|69549786|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
37866196|NCT01072149|69549769|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
37866197|NCT01072149|69549770|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
37866198|NCT01072149|69549771|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
37866199|NCT01072149|69549772|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
37866200|NCT01072149|69549773|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
37866201|NCT01072149|69549774|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
37866202|NCT01072149|69549775|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
37866203|NCT01072149|69549776|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
37866204|NCT01072149|69549777|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
37866205|NCT01072149|69549778|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
37866206|NCT01072149|69549779|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
37866207|NCT01072149|69549780|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
37866208|NCT01072149|69549781|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
37866209|NCT01072149|69549782|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
37866210|NCT01072149|69549783|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
37866211|NCT01072149|69549784|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
37866212|NCT01072149|69549785|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
37866213|NCT01072149|69549786|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
37866214|NCT01072149|69549769|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
37866215|NCT01072149|69549770|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
37866216|NCT01072149|69549771|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
37866217|NCT01072149|69549772|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
37866218|NCT01072149|69549773|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
37866219|NCT01072149|69549774|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
37866220|NCT01072149|69549775|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
37978501|NCT00286234|69665427|FG003|Overall Study|Adverse Event|1|||
37866221|NCT01072149|69549776|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
37866222|NCT01072149|69549777|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
37978502|NCT00445848|69665437|FG000|Overall Study|Adverse Event|14|||
37866223|NCT01072149|69549778|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
37978503|NCT00445848|69665437|FG000|Overall Study|Withdrawal by Subject|4|||
37866224|NCT01072149|69549779|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
37866225|NCT01072149|69549780|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
37978504|NCT00445848|69665437|FG000|Overall Study|Progression|62|||
37978505|NCT00445848|69665437|FG000|Overall Study|Other-Not protocol specified|5|||
37978506|NCT00286156|69665444|FG000|Overall Study|Missed 12 month visit|0|||
37866226|NCT01072149|69549781|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
37866227|NCT01072149|69549782|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
37866228|NCT01072149|69549783|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
37866229|NCT01072149|69549784|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
37866230|NCT01072149|69549785|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
37866231|NCT01072149|69549786|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
37866232|NCT01072149|69549769|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
37866233|NCT01072149|69549770|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
37866234|NCT01072149|69549771|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
37866235|NCT01072149|69549772|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
37866236|NCT01072149|69549773|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
37866237|NCT01072149|69549774|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
37866238|NCT01072149|69549775|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
37866239|NCT01072149|69549776|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
37866240|NCT01072149|69549777|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
37866241|NCT01072149|69549778|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
37866242|NCT01072149|69549779|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
37866243|NCT01072149|69549780|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
37866244|NCT01072149|69549781|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
37866245|NCT01072149|69549782|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
37866246|NCT01072149|69549783|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
37866247|NCT01072149|69549784|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
37866248|NCT01072149|69549785|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
37866249|NCT01072149|69549786|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
37866250|NCT01072149|69549769|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
37866251|NCT01072149|69549770|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
37978507|NCT00286156|69665445|FG001|Overall Study|Missed 12 month visit|0|||
37978508|NCT00286156|69665446|FG002|Overall Study|Missed 12 month visit|1|||
37978509|NCT00286156|69665444|FG000|Overall Study|AE: pulmonary embolus|0|||
37978510|NCT00286156|69665445|FG001|Overall Study|AE: pulmonary embolus|1|||
37978511|NCT00286156|69665446|FG002|Overall Study|AE: pulmonary embolus|0|||
37978512|NCT00286156|69665444|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
37978513|NCT00286156|69665445|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
37978514|NCT00286156|69665446|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
37978515|NCT00286156|69665444|FG000|Overall Study|AE: pneumonia|1|||
37978516|NCT00286156|69665445|FG001|Overall Study|AE: pneumonia|0|||
37978517|NCT00286156|69665446|FG002|Overall Study|AE: pneumonia|0|||
37978518|NCT00455520|69665456|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
37978519|NCT00455520|69665457|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
37978520|NCT00455520|69665456|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
37978521|NCT00455520|69665457|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
37978522|NCT00455520|69665456|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
37978523|NCT00455520|69665457|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
37978524|NCT00455520|69665456|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
37978525|NCT00455520|69665457|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
37978526|NCT00455520|69665456|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
37694780|NCT01891864|69171212|FG000|Extension Period|Withdrawal by Subject|0|||
37694781|NCT01891864|69171213|FG001|Extension Period|Withdrawal by Subject|0|||
37814628|NCT01375764|69492502|FG004|Overall Study|Lost to Follow-up|0|||
37814629|NCT01375764|69492498|FG000|Overall Study|Withdrawal by Subject|2|||
37814630|NCT01375764|69492499|FG001|Overall Study|Withdrawal by Subject|0|||
37814631|NCT01375764|69492500|FG002|Overall Study|Withdrawal by Subject|0|||
37814632|NCT01375764|69492501|FG003|Overall Study|Withdrawal by Subject|0|||
37814633|NCT01375764|69492502|FG004|Overall Study|Withdrawal by Subject|1|||
37814634|NCT01375764|69492498|FG000|Overall Study|Other|0|||
37814635|NCT01375764|69492499|FG001|Overall Study|Other|0|||
37814636|NCT01375764|69492500|FG002|Overall Study|Other|0|||
37814637|NCT01375764|69492501|FG003|Overall Study|Other|1|||
37814638|NCT01375764|69492502|FG004|Overall Study|Other|0|||
37814639|NCT00722046|69492521|FG000|Overall Study|Adverse Event|0|||
37814640|NCT00722046|69492522|FG001|Overall Study|Adverse Event|1|||
37814641|NCT00722046|69492523|FG002|Overall Study|Adverse Event|2|||
37814642|NCT00722046|69492524|FG003|Overall Study|Adverse Event|1|||
37814643|NCT00722046|69492525|FG004|Overall Study|Adverse Event|2|||
37814644|NCT00722046|69492526|FG005|Overall Study|Adverse Event|1|||
37814645|NCT00722046|69492527|FG006|Overall Study|Adverse Event|0|||
37814646|NCT00722046|69492521|FG000|Overall Study|Death|0|||
37866252|NCT01072149|69549771|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
37866253|NCT01072149|69549772|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
37866254|NCT01072149|69549773|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
37866255|NCT01072149|69549774|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
37866256|NCT01072149|69549775|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
37866257|NCT01072149|69549776|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
37866258|NCT01072149|69549777|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
37866259|NCT01072149|69549778|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
37866260|NCT01072149|69549779|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
37866261|NCT01072149|69549780|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
37866262|NCT01072149|69549781|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
37866263|NCT01072149|69549782|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
37866264|NCT01072149|69549783|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
37866265|NCT01072149|69549784|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
37866266|NCT01072149|69549785|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
37866267|NCT01072149|69549786|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
37866268|NCT01072149|69549769|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
37866269|NCT01072149|69549770|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
37866270|NCT01072149|69549771|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
37866271|NCT01072149|69549772|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
37866272|NCT01072149|69549773|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
37866273|NCT01072149|69549774|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
37866274|NCT01072149|69549775|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
37866275|NCT01072149|69549776|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
37866276|NCT01072149|69549777|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
37866277|NCT01072149|69549778|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
37866278|NCT01072149|69549779|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
37866279|NCT01072149|69549780|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
37866280|NCT01072149|69549781|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
37866281|NCT01072149|69549782|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
37866282|NCT01072149|69549783|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
37866283|NCT01072149|69549784|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
37866284|NCT01072149|69549785|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
37866285|NCT01072149|69549786|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
37866286|NCT01072149|69549769|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
37866287|NCT01072149|69549770|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
37866288|NCT01072149|69549771|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
37866289|NCT01072149|69549772|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
37866290|NCT01072149|69549773|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
37866291|NCT01072149|69549774|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
37866292|NCT01072149|69549775|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
37978527|NCT00455520|69665457|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
37866293|NCT01072149|69549776|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
37866294|NCT01072149|69549777|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
37866295|NCT01072149|69549778|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
37866296|NCT01072149|69549779|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
37866297|NCT01072149|69549780|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
37866298|NCT01072149|69549781|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
37978528|NCT00455520|69665456|FG000|Open Label Tapentadol Extended Release|All other|33|||
37978529|NCT00455520|69665457|FG001|Open Label Tapentadol Extended Release|All other|0|||
37978530|NCT00455520|69665456|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
37978531|NCT00455520|69665457|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
37978532|NCT00455520|69665456|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
37978533|NCT00455520|69665457|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
37978534|NCT00455520|69665456|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
37978535|NCT00455520|69665457|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
37978536|NCT00455520|69665456|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
37978537|NCT00455520|69665457|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
37978538|NCT00455520|69665456|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
37978539|NCT00455520|69665457|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
37978540|NCT00455520|69665456|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
37978541|NCT00455520|69665457|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
37866299|NCT01072149|69549782|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
37866300|NCT01072149|69549783|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
37866301|NCT01072149|69549784|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
37866302|NCT01072149|69549785|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
37866303|NCT01072149|69549786|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
37978542|NCT00440700|69665466|FG000|Overall Study|Withdrawal by Subject|8|||
37978543|NCT00440700|69665467|FG001|Overall Study|Withdrawal by Subject|8|||
37866304|NCT01072149|69549769|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
37866305|NCT01072149|69549770|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
37866306|NCT01072149|69549771|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
37978544|NCT00440700|69665468|FG002|Overall Study|Withdrawal by Subject|4|||
37978545|NCT00284050|69665479|FG000|Overall Study|Adverse Event|1|||
37978546|NCT00284050|69665480|FG001|Overall Study|Adverse Event|1|||
37978547|NCT00284050|69665481|FG002|Overall Study|Adverse Event|1|||
37978548|NCT00284050|69665479|FG000|Overall Study|Lack of Efficacy|0|||
37978549|NCT00284050|69665480|FG001|Overall Study|Lack of Efficacy|1|||
37978550|NCT00284050|69665481|FG002|Overall Study|Lack of Efficacy|3|||
37978551|NCT00284050|69665479|FG000|Overall Study|Protocol Violation|0|||
37978552|NCT00284050|69665480|FG001|Overall Study|Protocol Violation|1|||
37978553|NCT00284050|69665481|FG002|Overall Study|Protocol Violation|2|||
37978554|NCT00284050|69665479|FG000|Overall Study|Withdrawal by Subject|2|||
37978555|NCT00284050|69665480|FG001|Overall Study|Withdrawal by Subject|2|||
37978556|NCT00284050|69665481|FG002|Overall Study|Withdrawal by Subject|2|||
37978557|NCT00284050|69665479|FG000|Overall Study|Lost to Follow-up|1|||
37866307|NCT01072149|69549772|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
37866308|NCT01072149|69549773|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
37866309|NCT01072149|69549774|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
37866310|NCT01072149|69549775|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
37866311|NCT01072149|69549776|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
37866312|NCT01072149|69549777|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
37866313|NCT01072149|69549778|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
37866314|NCT01072149|69549779|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
37866315|NCT01072149|69549780|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
37866316|NCT01072149|69549781|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
37866317|NCT01072149|69549782|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
37866318|NCT01072149|69549783|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
37814647|NCT00722046|69492522|FG001|Overall Study|Death|1|||
37814648|NCT00722046|69492523|FG002|Overall Study|Death|0|||
37814649|NCT00722046|69492524|FG003|Overall Study|Death|0|||
37814650|NCT00722046|69492525|FG004|Overall Study|Death|0|||
37814651|NCT00722046|69492526|FG005|Overall Study|Death|0|||
37814652|NCT00722046|69492527|FG006|Overall Study|Death|2|||
37866319|NCT01072149|69549784|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
37866320|NCT01072149|69549785|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
37866321|NCT01072149|69549786|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
37866322|NCT01072149|69549769|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
37866323|NCT01072149|69549770|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
37866324|NCT01072149|69549771|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
37814653|NCT00722046|69492521|FG000|Overall Study|Protocol Violation|1|||
37814654|NCT00722046|69492522|FG001|Overall Study|Protocol Violation|0|||
37814655|NCT00722046|69492523|FG002|Overall Study|Protocol Violation|0|||
37814656|NCT00722046|69492524|FG003|Overall Study|Protocol Violation|0|||
37814657|NCT00722046|69492525|FG004|Overall Study|Protocol Violation|0|||
37814658|NCT00722046|69492526|FG005|Overall Study|Protocol Violation|1|||
37866325|NCT01072149|69549772|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
37866326|NCT01072149|69549773|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
37814659|NCT00722046|69492527|FG006|Overall Study|Protocol Violation|0|||
37814660|NCT00722046|69492521|FG000|Overall Study|Withdrawal by Subject|3|||
37814661|NCT00722046|69492522|FG001|Overall Study|Withdrawal by Subject|3|||
37814662|NCT00722046|69492523|FG002|Overall Study|Withdrawal by Subject|4|||
37866327|NCT01072149|69549774|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
37978558|NCT00284050|69665480|FG001|Overall Study|Lost to Follow-up|0|||
37978559|NCT00284050|69665481|FG002|Overall Study|Lost to Follow-up|1|||
37978560|NCT00284050|69665479|FG000|Overall Study|Death|1|||
37814663|NCT00722046|69492524|FG003|Overall Study|Withdrawal by Subject|4|||
37814664|NCT00722046|69492525|FG004|Overall Study|Withdrawal by Subject|4|||
37814665|NCT00722046|69492526|FG005|Overall Study|Withdrawal by Subject|7|||
37814666|NCT00722046|69492527|FG006|Overall Study|Withdrawal by Subject|3|||
37814667|NCT00722046|69492521|FG000|Overall Study|Randomized, but not treated|1|||
37814668|NCT00722046|69492522|FG001|Overall Study|Randomized, but not treated|1|||
37814669|NCT00722046|69492523|FG002|Overall Study|Randomized, but not treated|0|||
37814670|NCT00722046|69492524|FG003|Overall Study|Randomized, but not treated|2|||
37814671|NCT00722046|69492525|FG004|Overall Study|Randomized, but not treated|0|||
37814672|NCT00722046|69492526|FG005|Overall Study|Randomized, but not treated|0|||
37814673|NCT00722046|69492527|FG006|Overall Study|Randomized, but not treated|0|||
37814674|NCT00722046|69492521|FG000|Overall Study|Other|0|||
37978561|NCT00284050|69665480|FG001|Overall Study|Death|0|||
37866328|NCT01072149|69549775|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
37866329|NCT01072149|69549776|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
37866330|NCT01072149|69549777|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
37814675|NCT00722046|69492522|FG001|Overall Study|Other|0|||
37814676|NCT00722046|69492523|FG002|Overall Study|Other|1|||
37814677|NCT00722046|69492524|FG003|Overall Study|Other|1|||
37814678|NCT00722046|69492525|FG004|Overall Study|Other|3|||
37814679|NCT00722046|69492526|FG005|Overall Study|Other|2|||
37814680|NCT00722046|69492527|FG006|Overall Study|Other|1|||
37814681|NCT00614523|69492547|FG000|Overall Study|Adverse Event|4|||
37814682|NCT00614523|69492548|FG001|Overall Study|Adverse Event|20|||
37814683|NCT00614523|69492547|FG000|Overall Study|Death|5|||
37814684|NCT00614523|69492548|FG001|Overall Study|Death|8|||
37814685|NCT00614523|69492547|FG000|Overall Study|Lack of Efficacy|9|||
37814686|NCT00614523|69492548|FG001|Overall Study|Lack of Efficacy|11|||
37814687|NCT00614523|69492547|FG000|Overall Study|Lost to Follow-up|0|||
37866331|NCT01072149|69549778|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
37866332|NCT01072149|69549779|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
37866333|NCT01072149|69549780|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
37866334|NCT01072149|69549781|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
37866335|NCT01072149|69549782|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
37866336|NCT01072149|69549783|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
37866337|NCT01072149|69549784|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
37866338|NCT01072149|69549785|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
37866339|NCT01072149|69549786|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
37866340|NCT01072149|69549769|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
37866341|NCT01072149|69549770|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
37866342|NCT01072149|69549771|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
37866343|NCT01072149|69549772|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
37866344|NCT01072149|69549773|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
37866345|NCT01072149|69549774|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
37866346|NCT01072149|69549775|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
37866347|NCT01072149|69549776|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
37866348|NCT01072149|69549777|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
37866349|NCT01072149|69549778|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
37866350|NCT01072149|69549779|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
37866351|NCT01072149|69549780|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
37866352|NCT01072149|69549781|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
37866353|NCT01072149|69549782|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
37866354|NCT01072149|69549783|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
37866355|NCT01072149|69549784|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
37866356|NCT01072149|69549785|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
37866357|NCT01072149|69549786|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
37866358|NCT01072149|69549769|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
37814688|NCT00614523|69492548|FG001|Overall Study|Lost to Follow-up|1|||
37866359|NCT01072149|69549770|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
37866360|NCT01072149|69549771|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
37866361|NCT01072149|69549772|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
37866362|NCT01072149|69549773|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
37866363|NCT01072149|69549774|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
37866364|NCT01072149|69549775|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
37866365|NCT01072149|69549776|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
37866366|NCT01072149|69549777|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
37866367|NCT01072149|69549778|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
37866368|NCT01072149|69549779|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
37866369|NCT01072149|69549780|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
37866370|NCT01072149|69549781|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
37866371|NCT01072149|69549782|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
37814689|NCT00614523|69492547|FG000|Overall Study|Protocol Violation|3|||
37814690|NCT00614523|69492548|FG001|Overall Study|Protocol Violation|2|||
37814691|NCT00614523|69492547|FG000|Overall Study|Withdrawal by Subject|12|||
37814692|NCT00614523|69492548|FG001|Overall Study|Withdrawal by Subject|22|||
37866372|NCT01072149|69549783|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
37866373|NCT01072149|69549784|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
37866374|NCT01072149|69549785|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
37866375|NCT01072149|69549786|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
37866376|NCT01071915|69549796|FG000|Overall Study|Adverse Event|3|||
37866377|NCT01071915|69549796|FG000|Overall Study|Physician Decision|2|||
37866378|NCT01071915|69549796|FG000|Overall Study|Withdrawal by Subject|2|||
37866379|NCT01071915|69549796|FG000|Overall Study|Miscellaneous Reasons|2|||
37866380|NCT00904969|69549800|FG000|Overall Study|Lost to Follow-up|4|||
37866381|NCT00904969|69549800|FG000|Overall Study|Withdrawal by Subject|3|||
37866382|NCT00904969|69549800|FG000|Overall Study|Additional Treatments|11|||
37866383|NCT00904969|69549800|FG000|Overall Study|Case Aborted; Subject Exited|1|||
37814693|NCT00614523|69492547|FG000|Overall Study|Other|6|||
37814694|NCT00614523|69492548|FG001|Overall Study|Other|11|||
37814695|NCT00614523|69492547|FG000|Overall Study|Ineligibility Determined|1|||
37814696|NCT00614523|69492548|FG001|Overall Study|Ineligibility Determined|2|||
37814697|NCT00614523|69492547|FG000|Overall Study|Disease Progression|0|||
37814698|NCT00614523|69492548|FG001|Overall Study|Disease Progression|8|||
37866384|NCT01070979|69549822|FG000|Overall Study|Adverse Event|2|||
37866385|NCT01070979|69549823|FG001|Overall Study|Adverse Event|3|||
37866386|NCT01070979|69549824|FG002|Overall Study|Adverse Event|3|||
37866387|NCT01070979|69549822|FG000|Overall Study|Lost to Follow-up|2|||
37866388|NCT01070979|69549823|FG001|Overall Study|Lost to Follow-up|1|||
37866389|NCT01070979|69549824|FG002|Overall Study|Lost to Follow-up|1|||
37866390|NCT01070979|69549822|FG000|Overall Study|Protocol Violation|0|||
37866391|NCT01070979|69549823|FG001|Overall Study|Protocol Violation|2|||
37866392|NCT01070979|69549824|FG002|Overall Study|Protocol Violation|6|||
37866393|NCT01070979|69549822|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
37866394|NCT01070979|69549823|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
37866395|NCT01070979|69549824|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
37866396|NCT01070979|69549822|FG000|Overall Study|Withdrawal by Subject|3|||
37866397|NCT01070979|69549823|FG001|Overall Study|Withdrawal by Subject|1|||
37866398|NCT01070979|69549824|FG002|Overall Study|Withdrawal by Subject|1|||
37866399|NCT01070979|69549822|FG000|Overall Study|No study drug taken|0|||
37866400|NCT01070979|69549823|FG001|Overall Study|No study drug taken|1|||
37866401|NCT01070979|69549824|FG002|Overall Study|No study drug taken|0|||
37866402|NCT01234337|69549834|FG000|Overall Study|Adverse Event|58|||
37978562|NCT00284050|69665481|FG002|Overall Study|Death|0|||
37978563|NCT00293020|69665489|FG000|Overall Study|Withdrawal by Subject|34|||
37978564|NCT00293020|69665489|FG000|Overall Study|Adverse Event|30|||
37978565|NCT00293020|69665489|FG000|Overall Study|Death|32|||
37978566|NCT00293020|69665489|FG000|Overall Study|Lack of Efficacy|12|||
37978567|NCT00293020|69665489|FG000|Overall Study|Lost to Follow-up|4|||
37978568|NCT00293020|69665489|FG000|Overall Study|Protocol Violation|6|||
37978569|NCT00293020|69665489|FG000|Overall Study|Physician Decision|21|||
37978570|NCT00293020|69665489|FG000|Overall Study|Other Reason|22|||
37978571|NCT00293020|69665489|FG000|Overall Study|No dose taken|1|||
37978572|NCT00377637|69665497|FG000|Induction Phase|Adverse Event|12|||
37978573|NCT00377637|69665498|FG001|Induction Phase|Adverse Event|21|||
37978574|NCT00377637|69665499|FG002|Induction Phase|Adverse Event|0|||
37978575|NCT00377637|69665500|FG003|Induction Phase|Adverse Event|0|||
37978576|NCT00377637|69665497|FG000|Induction Phase|Deterioration/serum creatinine|2|||
37978577|NCT00377637|69665498|FG001|Induction Phase|Deterioration/serum creatinine|0|||
37978578|NCT00377637|69665499|FG002|Induction Phase|Deterioration/serum creatinine|0|||
37814699|NCT00614523|69492547|FG000|Overall Study|Administrative Decision|23|||
37814700|NCT00614523|69492548|FG001|Overall Study|Administrative Decision|46|||
37814701|NCT00523341|69492556|FG000|Overall Study|Withdrawal by Subject|399|||
37814702|NCT00523341|69492557|FG001|Overall Study|Withdrawal by Subject|427|||
37814703|NCT00523341|69492556|FG000|Overall Study|Other|181|||
37814704|NCT00523341|69492557|FG001|Overall Study|Other|198|||
37814705|NCT00523341|69492556|FG000|Overall Study|Adverse Event|122|||
37814706|NCT00523341|69492557|FG001|Overall Study|Adverse Event|155|||
37866403|NCT01234337|69549835|FG001|Overall Study|Adverse Event|21|||
37866404|NCT01234337|69549834|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
37978579|NCT00377637|69665500|FG003|Induction Phase|Deterioration/serum creatinine|0|||
37978580|NCT00377637|69665497|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
37814707|NCT00523341|69492556|FG000|Overall Study|Death|101|||
37866405|NCT01234337|69549835|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
37866406|NCT01234337|69549834|FG000|Overall Study|Investi. decision not protocol driven|5|||
37866407|NCT01234337|69549835|FG001|Overall Study|Investi. decision not protocol driven|6|||
37814708|NCT00523341|69492557|FG001|Overall Study|Death|110|||
37814709|NCT00523341|69492556|FG000|Overall Study|Lost to Follow-up|73|||
37866408|NCT01234337|69549834|FG000|Overall Study|Non-compliant with study medication|3|||
37978581|NCT00377637|69665498|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
37978582|NCT00377637|69665499|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
37978583|NCT00377637|69665500|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
37978584|NCT00377637|69665497|FG000|Induction Phase|Lost to Follow-up|2|||
37978585|NCT00377637|69665498|FG001|Induction Phase|Lost to Follow-up|1|||
37978586|NCT00377637|69665499|FG002|Induction Phase|Lost to Follow-up|0|||
37978587|NCT00377637|69665500|FG003|Induction Phase|Lost to Follow-up|0|||
37978588|NCT00377637|69665497|FG000|Induction Phase|Death|1|||
37978589|NCT00377637|69665498|FG001|Induction Phase|Death|3|||
37978590|NCT00377637|69665499|FG002|Induction Phase|Death|0|||
37978591|NCT00377637|69665500|FG003|Induction Phase|Death|0|||
37978592|NCT00377637|69665497|FG000|Induction Phase|Withdrawal by Subject|5|||
37866409|NCT01234337|69549835|FG001|Overall Study|Non-compliant with study medication|2|||
37866410|NCT01234337|69549834|FG000|Overall Study|Randomized but not treated|6|||
37866411|NCT01234337|69549835|FG001|Overall Study|Randomized but not treated|4|||
37866412|NCT01234337|69549834|FG000|Overall Study|Lost to Follow-up|0|||
37866413|NCT01234337|69549835|FG001|Overall Study|Lost to Follow-up|1|||
37866414|NCT01234337|69549834|FG000|Overall Study|Protocol Violation|2|||
37866415|NCT01234337|69549835|FG001|Overall Study|Protocol Violation|3|||
37866416|NCT01234337|69549834|FG000|Overall Study|Withdrawal by Subject|11|||
37866417|NCT01234337|69549835|FG001|Overall Study|Withdrawal by Subject|9|||
37866418|NCT01234337|69549834|FG000|Overall Study|Death|0|||
37866419|NCT01234337|69549835|FG001|Overall Study|Death|1|||
37866420|NCT01234337|69549834|FG000|Overall Study|Switch to commercial drug|0|||
37866421|NCT01234337|69549835|FG001|Overall Study|Switch to commercial drug|1|||
37866422|NCT01070043|69549843|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
37866423|NCT01070043|69549844|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
37866424|NCT01070043|69549845|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
37866425|NCT01070043|69549843|FG000|Double-Blind Treatment|Adverse Event|0|||
37866426|NCT01070043|69549844|FG001|Double-Blind Treatment|Adverse Event|0|||
37866427|NCT01070043|69549845|FG002|Double-Blind Treatment|Adverse Event|2|||
37866428|NCT01074255|69549851|FG000|Overall Study|Did not receive EMEND|2|||
37866429|NCT01073943|69549857|FG000|Overall Study|Withdrawal by Subject|8|||
37866430|NCT01073943|69549858|FG001|Overall Study|Withdrawal by Subject|2|||
37866431|NCT01073943|69549857|FG000|Overall Study|Protocol Violation|2|||
37866432|NCT01073943|69549858|FG001|Overall Study|Protocol Violation|1|||
37866433|NCT01073943|69549857|FG000|Overall Study|Adverse Event|1|||
37866434|NCT01073943|69549858|FG001|Overall Study|Adverse Event|1|||
37866435|NCT01073943|69549857|FG000|Overall Study|Lost to Follow-up|0|||
37866436|NCT01073943|69549858|FG001|Overall Study|Lost to Follow-up|2|||
37866437|NCT01073943|69549857|FG000|Overall Study|Power outage; colonoscopy not done|1|||
37866438|NCT01073943|69549858|FG001|Overall Study|Power outage; colonoscopy not done|0|||
37866439|NCT01073943|69549857|FG000|Overall Study|Subject forgot|0|||
37866440|NCT01073943|69549858|FG001|Overall Study|Subject forgot|1|||
37866441|NCT01073943|69549857|FG000|Overall Study|Unable to return for follow-up|0|||
37866442|NCT01073943|69549858|FG001|Overall Study|Unable to return for follow-up|1|||
37866443|NCT01073943|69549857|FG000|Overall Study|Could not tolerate prep|1|||
37866444|NCT01073943|69549858|FG001|Overall Study|Could not tolerate prep|0|||
37866445|NCT01073865|69549866|FG000|Overall Study|Reasons other than below|19|||
37866446|NCT01073865|69549867|FG001|Overall Study|Reasons other than below|31|||
37866447|NCT01073865|69549866|FG000|Overall Study|Lost to Follow-up|1|||
37866448|NCT01073865|69549867|FG001|Overall Study|Lost to Follow-up|1|||
37866449|NCT01073865|69549866|FG000|Overall Study|Death|3|||
37866450|NCT01073865|69549867|FG001|Overall Study|Death|2|||
37866451|NCT01073865|69549866|FG000|Overall Study|Withdrawal by Subject|5|||
37866452|NCT01073865|69549867|FG001|Overall Study|Withdrawal by Subject|5|||
37978593|NCT00377637|69665498|FG001|Induction Phase|Withdrawal by Subject|6|||
37978594|NCT00377637|69665499|FG002|Induction Phase|Withdrawal by Subject|0|||
37978595|NCT00377637|69665500|FG003|Induction Phase|Withdrawal by Subject|0|||
37978596|NCT00377637|69665497|FG000|Induction Phase|Physician Decision|3|||
37866453|NCT04862065|69549876|FG000|Screening|Protocol Violation|54|||
37866454|NCT04862065|69549877|FG001|Screening|Protocol Violation|0|||
37866455|NCT04862065|69549878|FG002|Screening|Protocol Violation|0|||
37866456|NCT04862065|69549876|FG000|Screening|Insufficient Sample|1|||
37866457|NCT04862065|69549877|FG001|Screening|Insufficient Sample|0|||
37866458|NCT04862065|69549878|FG002|Screening|Insufficient Sample|0|||
37978597|NCT00377637|69665498|FG001|Induction Phase|Physician Decision|1|||
37978598|NCT00377637|69665499|FG002|Induction Phase|Physician Decision|0|||
37978599|NCT00377637|69665500|FG003|Induction Phase|Physician Decision|0|||
37978600|NCT00377637|69665497|FG000|Induction Phase|Sponsor decision|1|||
37978601|NCT00377637|69665498|FG001|Induction Phase|Sponsor decision|2|||
37978602|NCT00377637|69665499|FG002|Induction Phase|Sponsor decision|0|||
37978603|NCT00377637|69665500|FG003|Induction Phase|Sponsor decision|0|||
37978604|NCT00377637|69665497|FG000|Induction Phase|Non-Compliance|1|||
37978605|NCT00377637|69665498|FG001|Induction Phase|Non-Compliance|0|||
37978606|NCT00377637|69665499|FG002|Induction Phase|Non-Compliance|0|||
37978607|NCT00377637|69665500|FG003|Induction Phase|Non-Compliance|0|||
37978608|NCT00377637|69665497|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
37978609|NCT00377637|69665498|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
37978610|NCT00377637|69665499|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
37978611|NCT00377637|69665500|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
37978612|NCT00377637|69665497|FG000|Maintenance Phase|Adverse Event|0|||
37978613|NCT00377637|69665498|FG001|Maintenance Phase|Adverse Event|0|||
37978614|NCT00377637|69665499|FG002|Maintenance Phase|Adverse Event|29|||
37978615|NCT00377637|69665500|FG003|Maintenance Phase|Adverse Event|43|||
37978616|NCT00377637|69665497|FG000|Maintenance Phase|Physician Decision|0|||
37978617|NCT00377637|69665498|FG001|Maintenance Phase|Physician Decision|0|||
37978618|NCT00377637|69665499|FG002|Maintenance Phase|Physician Decision|5|||
37978619|NCT00377637|69665500|FG003|Maintenance Phase|Physician Decision|4|||
37978620|NCT00377637|69665497|FG000|Maintenance Phase|Lost to Follow-up|0|||
37978621|NCT00377637|69665498|FG001|Maintenance Phase|Lost to Follow-up|0|||
37978622|NCT00377637|69665499|FG002|Maintenance Phase|Lost to Follow-up|3|||
37978623|NCT00377637|69665500|FG003|Maintenance Phase|Lost to Follow-up|1|||
37978624|NCT00377637|69665497|FG000|Maintenance Phase|Withdrawal by Subject|0|||
37978625|NCT00377637|69665498|FG001|Maintenance Phase|Withdrawal by Subject|0|||
37978626|NCT00377637|69665499|FG002|Maintenance Phase|Withdrawal by Subject|3|||
37978627|NCT00377637|69665500|FG003|Maintenance Phase|Withdrawal by Subject|3|||
37978628|NCT00377637|69665497|FG000|Maintenance Phase|Sponsor decision|0|||
37978629|NCT00377637|69665498|FG001|Maintenance Phase|Sponsor decision|0|||
37978630|NCT00377637|69665499|FG002|Maintenance Phase|Sponsor decision|2|||
37978631|NCT00377637|69665500|FG003|Maintenance Phase|Sponsor decision|3|||
37978632|NCT00377637|69665497|FG000|Maintenance Phase|Non-compliance|0|||
37978633|NCT00377637|69665498|FG001|Maintenance Phase|Non-compliance|0|||
37978634|NCT00377637|69665499|FG002|Maintenance Phase|Non-compliance|1|||
37978635|NCT00377637|69665500|FG003|Maintenance Phase|Non-compliance|1|||
37978636|NCT00377637|69665497|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
37978637|NCT00377637|69665498|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
37978638|NCT00377637|69665499|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
37978639|NCT00377637|69665500|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
37978640|NCT00377637|69665497|FG000|Maintenance Phase|Death|0|||
37978641|NCT00377637|69665498|FG001|Maintenance Phase|Death|0|||
37978642|NCT00377637|69665499|FG002|Maintenance Phase|Death|0|||
37978643|NCT00377637|69665500|FG003|Maintenance Phase|Death|1|||
37978644|NCT00377403|69665516|FG000|Overall Study|Unable to contact for telephone intervie|4|||
37978645|NCT00377403|69665517|FG001|Overall Study|Unable to contact for telephone intervie|7|||
37978646|NCT00370149|69665525|FG000|Overall Study|Physician Decision|16|||
37978647|NCT00370149|69665526|FG001|Overall Study|Physician Decision|16|||
37978648|NCT00370149|69665525|FG000|Overall Study|Protocol Violation|1|||
37978649|NCT00370149|69665526|FG001|Overall Study|Protocol Violation|0|||
37978650|NCT00370149|69665525|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
37978651|NCT00370149|69665526|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
37978652|NCT00370149|69665525|FG000|Overall Study|Pre-existing infection|0|||
37978653|NCT00370149|69665526|FG001|Overall Study|Pre-existing infection|1|||
37978654|NCT00370149|69665525|FG000|Overall Study|Antibiotic coated dressing placed|0|||
37978655|NCT00370149|69665526|FG001|Overall Study|Antibiotic coated dressing placed|1|||
37978656|NCT00292942|69665539|FG000|Overall Study|Withdrawal by Subject|0|||
37694782|NCT01891864|69171214|FG002|Extension Period|Withdrawal by Subject|1|||
37978657|NCT00292942|69665540|FG001|Overall Study|Withdrawal by Subject|0|||
37694783|NCT01891864|69171215|FG003|Extension Period|Withdrawal by Subject|2|||
37814710|NCT00523341|69492557|FG001|Overall Study|Lost to Follow-up|61|||
37814711|NCT00523341|69492556|FG000|Overall Study|Non-compliance|20|||
37814712|NCT00523341|69492557|FG001|Overall Study|Non-compliance|13|||
37814713|NCT00523341|69492556|FG000|Overall Study|Physician Decision|14|||
37814714|NCT00523341|69492557|FG001|Overall Study|Physician Decision|13|||
37814715|NCT00523341|69492556|FG000|Overall Study|Requirement for Alternative Therapy|4|||
37814716|NCT00523341|69492557|FG001|Overall Study|Requirement for Alternative Therapy|14|||
37814717|NCT00523341|69492556|FG000|Overall Study|Protocol Deviation|6|||
37814718|NCT00523341|69492557|FG001|Overall Study|Protocol Deviation|5|||
37978658|NCT00292942|69665541|FG002|Overall Study|Withdrawal by Subject|1|||
37978659|NCT00292942|69665542|FG003|Overall Study|Withdrawal by Subject|0|||
37978660|NCT00292942|69665539|FG000|Overall Study|Adverse Event|0|||
37978661|NCT00292942|69665540|FG001|Overall Study|Adverse Event|0|||
37814719|NCT00523341|69492556|FG000|Overall Study|Ineligibility Determined|3|||
37978662|NCT00292942|69665541|FG002|Overall Study|Adverse Event|0|||
37978663|NCT00292942|69665542|FG003|Overall Study|Adverse Event|1|||
37978664|NCT00483938|69665562|FG000|Overall Study|Protocol Violation|0|||
37978665|NCT00483938|69665563|FG001|Overall Study|Protocol Violation|0|||
37978666|NCT00483938|69665564|FG002|Overall Study|Protocol Violation|0|||
37978667|NCT00483938|69665565|FG003|Overall Study|Protocol Violation|0|||
37978668|NCT00483938|69665566|FG004|Overall Study|Protocol Violation|0|||
37978669|NCT00483938|69665567|FG005|Overall Study|Protocol Violation|0|||
37978670|NCT00483938|69665568|FG006|Overall Study|Protocol Violation|3|||
37978671|NCT00483938|69665562|FG000|Overall Study|Withdrawal by Subject|1|||
37978672|NCT00483938|69665563|FG001|Overall Study|Withdrawal by Subject|6|||
37978673|NCT00483938|69665564|FG002|Overall Study|Withdrawal by Subject|0|||
37978674|NCT00483938|69665565|FG003|Overall Study|Withdrawal by Subject|0|||
37978675|NCT00483938|69665566|FG004|Overall Study|Withdrawal by Subject|1|||
37978676|NCT00483938|69665567|FG005|Overall Study|Withdrawal by Subject|3|||
37978677|NCT00483938|69665568|FG006|Overall Study|Withdrawal by Subject|2|||
37978678|NCT00483938|69665562|FG000|Overall Study|Lost to Follow-up|1|||
37978679|NCT00483938|69665563|FG001|Overall Study|Lost to Follow-up|2|||
37978680|NCT00483938|69665564|FG002|Overall Study|Lost to Follow-up|0|||
37866459|NCT04862065|69549876|FG000|Follow-Up|Lost to Follow-up|3|||
37866460|NCT04862065|69549877|FG001|Follow-Up|Lost to Follow-up|0|||
37866461|NCT04862065|69549878|FG002|Follow-Up|Lost to Follow-up|0|||
37978681|NCT00483938|69665565|FG003|Overall Study|Lost to Follow-up|2|||
37978682|NCT00483938|69665566|FG004|Overall Study|Lost to Follow-up|1|||
37978683|NCT00483938|69665567|FG005|Overall Study|Lost to Follow-up|1|||
37978684|NCT00483938|69665568|FG006|Overall Study|Lost to Follow-up|3|||
37978685|NCT00483938|69665562|FG000|Overall Study|Death|0|||
37978686|NCT00483938|69665563|FG001|Overall Study|Death|2|||
37978687|NCT00483938|69665564|FG002|Overall Study|Death|0|||
37978688|NCT00483938|69665565|FG003|Overall Study|Death|0|||
37978689|NCT00483938|69665566|FG004|Overall Study|Death|0|||
37978690|NCT00483938|69665567|FG005|Overall Study|Death|0|||
37978691|NCT00483938|69665568|FG006|Overall Study|Death|0|||
37978692|NCT00483938|69665562|FG000|Overall Study|Other|3|||
37978693|NCT00483938|69665563|FG001|Overall Study|Other|9|||
37978694|NCT00483938|69665564|FG002|Overall Study|Other|0|||
37978695|NCT00483938|69665565|FG003|Overall Study|Other|4|||
37978696|NCT00483938|69665566|FG004|Overall Study|Other|0|||
37978697|NCT00483938|69665567|FG005|Overall Study|Other|4|||
37978698|NCT00483938|69665568|FG006|Overall Study|Other|32|||
37866462|NCT01073631|69549884|FG000|Overall Study|Death|82|||
37866463|NCT01073631|69549884|FG000|Overall Study|Adverse Event|24|||
37866464|NCT01073631|69549884|FG000|Overall Study|Other|63|||
37866465|NCT01073163|69549888|FG000|Overall Study|Adverse Event|1|||
37866466|NCT01073163|69549888|FG000|Overall Study|Disease Progression|1|||
37866467|NCT01073163|69549888|FG000|Overall Study|Early termination|1|||
37866468|NCT01072929|69549899|FG000|Overall Study|Adverse Event|8|||
37866469|NCT01072929|69549900|FG001|Overall Study|Adverse Event|11|||
37866470|NCT01072929|69549901|FG002|Overall Study|Adverse Event|2|||
37866471|NCT01072929|69549899|FG000|Overall Study|Lack of Efficacy|7|||
37866472|NCT01072929|69549900|FG001|Overall Study|Lack of Efficacy|4|||
37866473|NCT01072929|69549901|FG002|Overall Study|Lack of Efficacy|0|||
37866474|NCT01072929|69549899|FG000|Overall Study|Withdrawal by Subject|7|||
37866475|NCT01072929|69549900|FG001|Overall Study|Withdrawal by Subject|15|||
37866476|NCT01072929|69549901|FG002|Overall Study|Withdrawal by Subject|3|||
37866477|NCT01072929|69549899|FG000|Overall Study|Protocol Violation|13|||
37978699|NCT00370071|69665587|FG000|Overall Study|Withdrawal by Subject|2|||
37978700|NCT00369915|69665593|FG000|Overall Study|expected side effects|2|||
37978701|NCT00369915|69665594|FG001|Overall Study|expected side effects|1|||
37978702|NCT00369915|69665593|FG000|Overall Study|Withdrawal by Subject|4|||
37978703|NCT00369915|69665594|FG001|Overall Study|Withdrawal by Subject|1|||
37978704|NCT00369915|69665593|FG000|Overall Study|W/drawl by investigators|0|||
37978705|NCT00369915|69665594|FG001|Overall Study|W/drawl by investigators|1|||
37866478|NCT01072929|69549900|FG001|Overall Study|Protocol Violation|11|||
37866479|NCT01072929|69549901|FG002|Overall Study|Protocol Violation|2|||
37866480|NCT01072929|69549899|FG000|Overall Study|Lost to Follow-up|8|||
37866481|NCT01072929|69549900|FG001|Overall Study|Lost to Follow-up|4|||
37866482|NCT01072929|69549901|FG002|Overall Study|Lost to Follow-up|1|||
37866483|NCT01072929|69549899|FG000|Overall Study|Noncompliance with study medication|0|||
37866484|NCT01072929|69549900|FG001|Overall Study|Noncompliance with study medication|3|||
37978706|NCT00369681|69665600|FG000|Overall Study|Death|1|||
37978707|NCT00266812|69665606|FG000|Overall Study|Disease Progression|9|||
37978708|NCT00266812|69665607|FG001|Overall Study|Disease Progression|3|||
37978709|NCT00266812|69665606|FG000|Overall Study|Death|5|||
37978710|NCT00266812|69665607|FG001|Overall Study|Death|4|||
37978711|NCT00266812|69665606|FG000|Overall Study|Adverse Event|3|||
37978712|NCT00266812|69665607|FG001|Overall Study|Adverse Event|1|||
37978713|NCT00266812|69665606|FG000|Overall Study|Protocol Violation|0|||
37978714|NCT00266812|69665607|FG001|Overall Study|Protocol Violation|1|||
37978715|NCT00266812|69665606|FG000|Overall Study|Withdrawal by Subject|0|||
37978716|NCT00266812|69665607|FG001|Overall Study|Withdrawal by Subject|2|||
37978717|NCT00266812|69665606|FG000|Overall Study|Discontinued before starting study drug|4|||
37978718|NCT00266812|69665607|FG001|Overall Study|Discontinued before starting study drug|0|||
37978719|NCT00488774|69665617|FG000|Overall Study|Withdrawal of consent|2|||
37978720|NCT00488774|69665618|FG001|Overall Study|Withdrawal of consent|2|||
37978721|NCT00488774|69665619|FG002|Overall Study|Withdrawal of consent|2|||
37978722|NCT00488774|69665620|FG003|Overall Study|Withdrawal of consent|0|||
37978723|NCT00488774|69665617|FG000|Overall Study|Other|6|||
37978724|NCT00488774|69665618|FG001|Overall Study|Other|3|||
37978725|NCT00488774|69665619|FG002|Overall Study|Other|2|||
37978726|NCT00488774|69665620|FG003|Overall Study|Other|2|||
37978727|NCT00488774|69665617|FG000|Overall Study|Lost to Follow-up|0|||
37978728|NCT00488774|69665618|FG001|Overall Study|Lost to Follow-up|0|||
37978729|NCT00488774|69665619|FG002|Overall Study|Lost to Follow-up|1|||
37978730|NCT00488774|69665620|FG003|Overall Study|Lost to Follow-up|1|||
38021506|NCT03526861|69704650|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
38021507|NCT03526861|69704651|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
38021508|NCT03526861|69704652|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
38021509|NCT03526861|69704653|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
38021510|NCT03526861|69704654|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
38021511|NCT03526861|69704655|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
38021512|NCT03526861|69704656|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
38021513|NCT03526861|69704657|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
38021514|NCT03526861|69704649|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
38021515|NCT03526861|69704650|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
38021516|NCT03526861|69704651|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
38021517|NCT03526861|69704652|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
38021518|NCT03526861|69704653|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
38021519|NCT03526861|69704654|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
38021520|NCT03526861|69704655|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
37814720|NCT00523341|69492557|FG001|Overall Study|Ineligibility Determined|4|||
37814721|NCT00523341|69492556|FG000|Overall Study|Disease Progression|1|||
37814722|NCT00523341|69492557|FG001|Overall Study|Disease Progression|0|||
37814723|NCT00364013|69492565|FG000|Overall Study|Ineligibility determined|4|||
38021521|NCT03526861|69704656|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
38021522|NCT03526861|69704657|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
38021523|NCT03526861|69704649|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
38021524|NCT03526861|69704650|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
38021525|NCT03526861|69704651|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
38021526|NCT03526861|69704652|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
37866485|NCT01072929|69549901|FG002|Overall Study|Noncompliance with study medication|0|||
38021527|NCT03526861|69704653|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
38021528|NCT03526861|69704654|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
38021529|NCT03526861|69704655|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
38021530|NCT03526861|69704656|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
38021531|NCT03526861|69704657|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
37814724|NCT00364013|69492566|FG001|Overall Study|Ineligibility determined|2|||
37814725|NCT00364013|69492565|FG000|Overall Study|Adverse Event|4|||
37814726|NCT00364013|69492566|FG001|Overall Study|Adverse Event|3|||
37814727|NCT00364013|69492565|FG000|Overall Study|Withdrawal by Subject|13|||
37814728|NCT00364013|69492566|FG001|Overall Study|Withdrawal by Subject|18|||
37814729|NCT00364013|69492565|FG000|Overall Study|Physician Decision|3|||
37814730|NCT00364013|69492566|FG001|Overall Study|Physician Decision|3|||
37814731|NCT00364013|69492565|FG000|Overall Study|Lost to Follow-up|10|||
37866486|NCT01072929|69549899|FG000|Overall Study|Noncompliance with study procedures|1|||
37978731|NCT00361569|69665635|FG000|Overall Study|Protocol Violation|3|||
37978732|NCT00361569|69665636|FG001|Overall Study|Protocol Violation|2|||
37814732|NCT00364013|69492566|FG001|Overall Study|Lost to Follow-up|3|||
37814733|NCT00364013|69492565|FG000|Overall Study|Protocol-specified criteria|6|||
37814734|NCT00364013|69492566|FG001|Overall Study|Protocol-specified criteria|6|||
37814735|NCT00364013|69492565|FG000|Overall Study|Other|41|||
37814736|NCT00364013|69492566|FG001|Overall Study|Other|47|||
37814737|NCT00364013|69492565|FG000|Overall Study|Ongoing|20|||
37814738|NCT00364013|69492566|FG001|Overall Study|Ongoing|13|||
37814739|NCT00345839|69492578|FG000|Overall Study|Withdrawal by Subject|91|||
37814740|NCT00345839|69492579|FG001|Overall Study|Withdrawal by Subject|98|||
37814741|NCT00345839|69492578|FG000|Overall Study|Lost to Follow-up|58|||
37814742|NCT00345839|69492579|FG001|Overall Study|Lost to Follow-up|61|||
37814743|NCT00330759|69492587|FG000|Overall Study|Death|316|||
37814744|NCT00330759|69492588|FG001|Overall Study|Death|310|||
37814745|NCT00330759|69492587|FG000|Overall Study|Disease progression|104|||
37814746|NCT00330759|69492588|FG001|Overall Study|Disease progression|126|||
37814747|NCT00330759|69492587|FG000|Overall Study|Withdrawal by Subject|143|||
37814748|NCT00330759|69492588|FG001|Overall Study|Withdrawal by Subject|124|||
37814749|NCT00330759|69492587|FG000|Overall Study|Adverse Event|48|||
37814750|NCT00330759|69492588|FG001|Overall Study|Adverse Event|36|||
37866487|NCT01072929|69549900|FG001|Overall Study|Noncompliance with study procedures|0|||
37866488|NCT01072929|69549901|FG002|Overall Study|Noncompliance with study procedures|1|||
37866489|NCT01072929|69549899|FG000|Overall Study|Other|0|||
37866490|NCT01072929|69549900|FG001|Overall Study|Other|3|||
37694784|NCT01891864|69171216|FG004|Extension Period|Withdrawal by Subject|4|||
37694785|NCT01891864|69171217|FG005|Extension Period|Withdrawal by Subject|0|||
37978733|NCT00361569|69665637|FG002|Overall Study|Protocol Violation|4|||
37978734|NCT00361569|69665638|FG003|Overall Study|Protocol Violation|2|||
37814751|NCT00330759|69492587|FG000|Overall Study|Participant request|31|||
37814752|NCT00330759|69492588|FG001|Overall Study|Participant request|22|||
37866491|NCT01072929|69549901|FG002|Overall Study|Other|0|||
37694786|NCT01891864|69171212|FG000|Extension Period|Lost to Follow-up|0|||
37866492|NCT01231607|69549915|FG000|Overall Study|Adverse Event|0|||
37866493|NCT01231607|69549916|FG001|Overall Study|Adverse Event|8|||
37866494|NCT01231607|69549917|FG002|Overall Study|Adverse Event|4|||
37866495|NCT01231607|69549918|FG003|Overall Study|Adverse Event|4|||
37866496|NCT01231607|69549919|FG004|Overall Study|Adverse Event|5|||
37866497|NCT01231607|69549915|FG000|Overall Study|Lost to Follow-up|13|||
37866498|NCT01231607|69549916|FG001|Overall Study|Lost to Follow-up|11|||
37866499|NCT01231607|69549917|FG002|Overall Study|Lost to Follow-up|10|||
37866500|NCT01231607|69549918|FG003|Overall Study|Lost to Follow-up|10|||
37866501|NCT01231607|69549919|FG004|Overall Study|Lost to Follow-up|4|||
37866502|NCT01231607|69549915|FG000|Overall Study|Physician Decision|4|||
37866503|NCT01231607|69549916|FG001|Overall Study|Physician Decision|4|||
37866504|NCT01231607|69549917|FG002|Overall Study|Physician Decision|3|||
37866505|NCT01231607|69549918|FG003|Overall Study|Physician Decision|5|||
37866506|NCT01231607|69549919|FG004|Overall Study|Physician Decision|4|||
37866507|NCT01231607|69549915|FG000|Overall Study|Protocol Violation|3|||
37866508|NCT01231607|69549916|FG001|Overall Study|Protocol Violation|2|||
37866509|NCT01231607|69549917|FG002|Overall Study|Protocol Violation|0|||
37866510|NCT01231607|69549918|FG003|Overall Study|Protocol Violation|2|||
37866511|NCT01231607|69549919|FG004|Overall Study|Protocol Violation|2|||
37866512|NCT01231607|69549915|FG000|Overall Study|Withdrawal by Subject|9|||
37866513|NCT01231607|69549916|FG001|Overall Study|Withdrawal by Subject|9|||
37866514|NCT01231607|69549917|FG002|Overall Study|Withdrawal by Subject|14|||
37866515|NCT01231607|69549918|FG003|Overall Study|Withdrawal by Subject|17|||
37866516|NCT01231607|69549919|FG004|Overall Study|Withdrawal by Subject|9|||
37866517|NCT01231373|69549938|FG000|Overall Study|Withdrew consent prior to randomization|2|||
37866518|NCT01231373|69549939|FG001|Overall Study|Withdrew consent prior to randomization|1|||
37866519|NCT01231373|69549940|FG002|Overall Study|Withdrew consent prior to randomization|0|||
37866520|NCT01231373|69549941|FG003|Overall Study|Withdrew consent prior to randomization|0|||
37978735|NCT00361569|69665635|FG000|Overall Study|Withdrawal by Subject|2|||
37978736|NCT00361569|69665636|FG001|Overall Study|Withdrawal by Subject|1|||
37814753|NCT00330759|69492587|FG000|Overall Study|Lost to Follow-up|16|||
37814754|NCT00330759|69492588|FG001|Overall Study|Lost to Follow-up|22|||
37814755|NCT00330759|69492587|FG000|Overall Study|Noncompliance|15|||
37866521|NCT01231373|69549938|FG000|Overall Study|Lost to Follow-up|0|||
37866522|NCT01231373|69549939|FG001|Overall Study|Lost to Follow-up|0|||
37814756|NCT00330759|69492588|FG001|Overall Study|Noncompliance|17|||
37814757|NCT00330759|69492587|FG000|Overall Study|Physician Decision|1|||
37866523|NCT01231373|69549940|FG002|Overall Study|Lost to Follow-up|0|||
37866524|NCT01231373|69549941|FG003|Overall Study|Lost to Follow-up|1|||
37814758|NCT00330759|69492588|FG001|Overall Study|Physician Decision|2|||
37866525|NCT01231373|69549938|FG000|Overall Study|Withdrew Consent|1|||
37866526|NCT01231373|69549939|FG001|Overall Study|Withdrew Consent|0|||
37866527|NCT01231373|69549940|FG002|Overall Study|Withdrew Consent|0|||
37866528|NCT01231373|69549941|FG003|Overall Study|Withdrew Consent|0|||
37866529|NCT00975130|69549953|FG000|Study Part 1|Adverse Event|150|||
37866530|NCT00975130|69549954|FG001|Study Part 1|Adverse Event|0|||
37866531|NCT00975130|69549955|FG002|Study Part 1|Adverse Event|0|||
37866532|NCT00975130|69549953|FG000|Study Part 1|Lost to Follow-up|19|||
37978737|NCT00361569|69665637|FG002|Overall Study|Withdrawal by Subject|9|||
37978738|NCT00361569|69665638|FG003|Overall Study|Withdrawal by Subject|14|||
37866533|NCT00975130|69549954|FG001|Study Part 1|Lost to Follow-up|0|||
37866534|NCT00975130|69549955|FG002|Study Part 1|Lost to Follow-up|0|||
37866535|NCT00975130|69549953|FG000|Study Part 1|Withdrawal by Subject|61|||
37866536|NCT00975130|69549954|FG001|Study Part 1|Withdrawal by Subject|0|||
37866537|NCT00975130|69549955|FG002|Study Part 1|Withdrawal by Subject|0|||
37866538|NCT00975130|69549953|FG000|Study Part 1|Protocol Violation|13|||
37866539|NCT00975130|69549954|FG001|Study Part 1|Protocol Violation|0|||
37866540|NCT00975130|69549955|FG002|Study Part 1|Protocol Violation|0|||
37866541|NCT00975130|69549953|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
37866542|NCT00975130|69549954|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
37866543|NCT00975130|69549955|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
37866544|NCT00975130|69549953|FG000|Study Part 1|Administrative|4|||
37866545|NCT00975130|69549954|FG001|Study Part 1|Administrative|0|||
37866546|NCT00975130|69549955|FG002|Study Part 1|Administrative|0|||
37866547|NCT00975130|69549953|FG000|Study Part 1|Withdrew Consent|24|||
37866548|NCT00975130|69549954|FG001|Study Part 1|Withdrew Consent|0|||
37866549|NCT00975130|69549955|FG002|Study Part 1|Withdrew Consent|0|||
37866550|NCT00975130|69549953|FG000|Study Part 2|Adverse Event|0|||
37866551|NCT00975130|69549954|FG001|Study Part 2|Adverse Event|14|||
37866552|NCT00975130|69549955|FG002|Study Part 2|Adverse Event|7|||
37866553|NCT00975130|69549953|FG000|Study Part 2|Lost to Follow-up|0|||
37866554|NCT00975130|69549954|FG001|Study Part 2|Lost to Follow-up|0|||
37866555|NCT00975130|69549955|FG002|Study Part 2|Lost to Follow-up|1|||
37866556|NCT00975130|69549953|FG000|Study Part 2|Withdrawal by Subject|0|||
37866557|NCT00975130|69549954|FG001|Study Part 2|Withdrawal by Subject|13|||
37866558|NCT00975130|69549955|FG002|Study Part 2|Withdrawal by Subject|5|||
37866559|NCT00975130|69549953|FG000|Study Part 2|Withdrew Consent|0|||
37978739|NCT00361569|69665635|FG000|Overall Study|Adverse Event|3|||
37978740|NCT00361569|69665636|FG001|Overall Study|Adverse Event|5|||
37814759|NCT00330759|69492587|FG000|Overall Study|Protocol deviation|0|||
37814760|NCT00330759|69492588|FG001|Overall Study|Protocol deviation|2|||
37814761|NCT00330759|69492587|FG000|Overall Study|Ineligibility determined|2|||
37814762|NCT00330759|69492588|FG001|Overall Study|Ineligibility determined|1|||
37814763|NCT00330759|69492587|FG000|Overall Study|Other|36|||
37814764|NCT00330759|69492588|FG001|Overall Study|Other|44|||
37814765|NCT00113763|69492596|FG000|Overall Study|Adverse Event|5|||
37814766|NCT00113763|69492597|FG001|Overall Study|Adverse Event|2|||
37814767|NCT00113763|69492596|FG000|Overall Study|Disease Progression|28|||
37814768|NCT00113763|69492597|FG001|Overall Study|Disease Progression|14|||
37814769|NCT00113763|69492596|FG000|Overall Study|Lost to Follow-up|10|||
37814770|NCT00113763|69492597|FG001|Overall Study|Lost to Follow-up|0|||
37814771|NCT00113763|69492596|FG000|Overall Study|Withdrawal by Subject|1|||
37814772|NCT00113763|69492597|FG001|Overall Study|Withdrawal by Subject|4|||
37814773|NCT00113763|69492596|FG000|Overall Study|Other|27|||
37814774|NCT00113763|69492597|FG001|Overall Study|Other|6|||
37814775|NCT00113763|69492596|FG000|Overall Study|Non-compliance|1|||
37814776|NCT00113763|69492597|FG001|Overall Study|Non-compliance|0|||
37814777|NCT00113763|69492596|FG000|Overall Study|Ongoing|1|||
37814778|NCT00113763|69492597|FG001|Overall Study|Ongoing|0|||
37814779|NCT05166902|69492611|FG000|First Intervention|Lost to Follow-up|0|||
37814780|NCT05166902|69492612|FG001|First Intervention|Lost to Follow-up|1|||
37814781|NCT05142566|69492618|FG000|Overall Study|Protocol Violation|1|||
37814782|NCT05083949|69492624|FG000|Period 1|Positive doping for Tetrahydrocannabinol (THC)|2|||
37814783|NCT05083949|69492625|FG001|Period 1|Positive doping for Tetrahydrocannabinol (THC)|1|||
37814784|NCT05083949|69492624|FG000|Period 1|Adverse Event|1|||
37814785|NCT05083949|69492625|FG001|Period 1|Adverse Event|1|||
37814786|NCT05083949|69492624|FG000|Period 2|The patient was not able to eat the full content of the breakfast|1|||
37814787|NCT05083949|69492625|FG001|Period 2|The patient was not able to eat the full content of the breakfast|0|||
37814788|NCT05083949|69492624|FG000|Period 2|Adverse Event|0|||
37814789|NCT05083949|69492625|FG001|Period 2|Adverse Event|2|||
37866560|NCT00975130|69549954|FG001|Study Part 2|Withdrew Consent|6|||
37866561|NCT00975130|69549955|FG002|Study Part 2|Withdrew Consent|2|||
37866562|NCT00975130|69549953|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
37866563|NCT00975130|69549954|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
37866564|NCT00975130|69549955|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
37866565|NCT00975130|69549953|FG000|Study Part 2|Administrative|0|||
37866566|NCT00975130|69549954|FG001|Study Part 2|Administrative|1|||
37866567|NCT00975130|69549955|FG002|Study Part 2|Administrative|0|||
37866568|NCT00975130|69549953|FG000|Study Part 2|Protocol Violation|0|||
37814790|NCT04982575|69492637|FG000|Overall Study|Withdrawal by Subject|2|||
37814791|NCT04982575|69492638|FG001|Overall Study|Withdrawal by Subject|0|||
37866569|NCT00975130|69549954|FG001|Study Part 2|Protocol Violation|0|||
37866570|NCT00975130|69549955|FG002|Study Part 2|Protocol Violation|1|||
37866571|NCT01230827|69549972|FG000|Overall Study|Lost to Follow-up|0|||
37866572|NCT01230827|69549973|FG001|Overall Study|Lost to Follow-up|0|||
37866573|NCT01230827|69549974|FG002|Overall Study|Lost to Follow-up|1|||
37866574|NCT01230827|69549975|FG003|Overall Study|Lost to Follow-up|3|||
37978741|NCT00361569|69665637|FG002|Overall Study|Adverse Event|2|||
37978742|NCT00361569|69665638|FG003|Overall Study|Adverse Event|2|||
37866575|NCT01230827|69549972|FG000|Overall Study|Withdrawal by Subject|1|||
37866576|NCT01230827|69549973|FG001|Overall Study|Withdrawal by Subject|0|||
37866577|NCT01230827|69549974|FG002|Overall Study|Withdrawal by Subject|3|||
37866578|NCT01230827|69549975|FG003|Overall Study|Withdrawal by Subject|2|||
37866579|NCT01230827|69549972|FG000|Overall Study|Lack of Efficacy|14|||
37866580|NCT01230827|69549973|FG001|Overall Study|Lack of Efficacy|1|||
37978743|NCT00361569|69665635|FG000|Overall Study|Lost to Follow-up|2|||
37978744|NCT00361569|69665636|FG001|Overall Study|Lost to Follow-up|3|||
37978745|NCT00361569|69665637|FG002|Overall Study|Lost to Follow-up|3|||
37978746|NCT00361569|69665638|FG003|Overall Study|Lost to Follow-up|2|||
37978747|NCT00361569|69665635|FG000|Overall Study|Not specified by investigator|2|||
37978748|NCT00361569|69665636|FG001|Overall Study|Not specified by investigator|0|||
37978749|NCT00361569|69665637|FG002|Overall Study|Not specified by investigator|0|||
37978750|NCT00361569|69665638|FG003|Overall Study|Not specified by investigator|1|||
37978751|NCT00488618|69665650|FG000|Overall Study|Adverse Event|13|||
37978752|NCT00488618|69665651|FG001|Overall Study|Adverse Event|17|||
37978753|NCT00488618|69665650|FG000|Overall Study|Insufficient Therapeutic Response|18|||
37978754|NCT00488618|69665651|FG001|Overall Study|Insufficient Therapeutic Response|11|||
37978755|NCT00488618|69665650|FG000|Overall Study|Protocol Violation|0|||
37978756|NCT00488618|69665651|FG001|Overall Study|Protocol Violation|2|||
37978757|NCT00488618|69665650|FG000|Overall Study|Withdrawal of Consent|15|||
37978758|NCT00488618|69665651|FG001|Overall Study|Withdrawal of Consent|13|||
37978759|NCT00488618|69665650|FG000|Overall Study|Lost to Follow-up|1|||
37978760|NCT00488618|69665651|FG001|Overall Study|Lost to Follow-up|0|||
37978761|NCT00266656|69665659|FG000|Overall Study|Death|1|||
37978762|NCT00266656|69665660|FG001|Overall Study|Death|0|||
37978763|NCT00266656|69665659|FG000|Overall Study|Lost to Follow-up|4|||
37978764|NCT00266656|69665660|FG001|Overall Study|Lost to Follow-up|1|||
37978765|NCT00266656|69665659|FG000|Overall Study|Withdrawal by Subject|4|||
37978766|NCT00266656|69665660|FG001|Overall Study|Withdrawal by Subject|2|||
37814792|NCT04982575|69492639|FG002|Overall Study|Withdrawal by Subject|2|||
37814793|NCT05776901|69492670|FG000|Overall Study|Covid delays and grant termination without continuation.|3|||
37814794|NCT05513625|69492674|FG000|Overall Study|Withdrawal by Subject|1|||
37814795|NCT05344560|69492680|FG000|Period 1|Subject out of visit window|1|||
37814796|NCT05344560|69492681|FG001|Period 1|Subject out of visit window|1|||
37814797|NCT05344560|69492680|FG000|Period 2|Covid-19 Related|1|||
37814798|NCT05344560|69492681|FG001|Period 2|Covid-19 Related|0|||
37814799|NCT05344560|69492680|FG000|Period 2|Adverse Event|1|||
37814800|NCT05344560|69492681|FG001|Period 2|Adverse Event|0|||
37866581|NCT01230827|69549974|FG002|Overall Study|Lack of Efficacy|2|||
37866582|NCT01230827|69549975|FG003|Overall Study|Lack of Efficacy|3|||
37866583|NCT01230827|69549972|FG000|Overall Study|Adverse Event|4|||
37978767|NCT00266656|69665659|FG000|Overall Study|Did Not Reach Final Height|4|||
37866584|NCT01230827|69549973|FG001|Overall Study|Adverse Event|2|||
37866585|NCT01230827|69549974|FG002|Overall Study|Adverse Event|3|||
37866586|NCT01230827|69549975|FG003|Overall Study|Adverse Event|7|||
37978768|NCT00266656|69665660|FG001|Overall Study|Did Not Reach Final Height|8|||
37978769|NCT00266656|69665659|FG000|Overall Study|Parent/Caregiver Decision|1|||
37978770|NCT00266656|69665660|FG001|Overall Study|Parent/Caregiver Decision|2|||
37978771|NCT00483704|69665669|FG000|Randomization|Withdrawal by Subject|19|||
37978772|NCT00483704|69665670|FG001|Randomization|Withdrawal by Subject|28|||
37978773|NCT00483704|69665671|FG002|Randomization|Withdrawal by Subject|18|||
37978774|NCT00483704|69665669|FG000|Randomization|Protocol Violation|14|||
37978775|NCT00483704|69665670|FG001|Randomization|Protocol Violation|25|||
37978776|NCT00483704|69665671|FG002|Randomization|Protocol Violation|22|||
37978777|NCT00483704|69665669|FG000|Randomization|Lost to Follow-up|14|||
37978778|NCT00483704|69665670|FG001|Randomization|Lost to Follow-up|14|||
37978779|NCT00483704|69665671|FG002|Randomization|Lost to Follow-up|19|||
37866587|NCT01230827|69549972|FG000|Overall Study|Recovery|0|||
37866588|NCT01230827|69549973|FG001|Overall Study|Recovery|6|||
37866589|NCT01230827|69549974|FG002|Overall Study|Recovery|0|||
37866590|NCT01230827|69549975|FG003|Overall Study|Recovery|0|||
37866591|NCT01230827|69549972|FG000|Overall Study|Study terminated by Sponsor|0|||
37866592|NCT01230827|69549973|FG001|Overall Study|Study terminated by Sponsor|2|||
37866593|NCT01230827|69549974|FG002|Overall Study|Study terminated by Sponsor|56|||
37866594|NCT01230827|69549975|FG003|Overall Study|Study terminated by Sponsor|63|||
37866595|NCT01230749|69549987|FG000|Overall Study|Adverse Event|0|||
37866596|NCT01230749|69549988|FG001|Overall Study|Adverse Event|0|||
37866597|NCT01230749|69549989|FG002|Overall Study|Adverse Event|0|||
37866598|NCT01230749|69549990|FG003|Overall Study|Adverse Event|1|||
37866599|NCT01230749|69549987|FG000|Overall Study|Physician Decision|0|||
37866600|NCT01230749|69549988|FG001|Overall Study|Physician Decision|0|||
37866601|NCT01230749|69549989|FG002|Overall Study|Physician Decision|1|||
37866602|NCT01230749|69549990|FG003|Overall Study|Physician Decision|0|||
37866603|NCT01230749|69549987|FG000|Overall Study|Withdrawal by Subject|0|||
37866604|NCT01230749|69549988|FG001|Overall Study|Withdrawal by Subject|1|||
37866605|NCT01230749|69549989|FG002|Overall Study|Withdrawal by Subject|0|||
37866606|NCT01230749|69549990|FG003|Overall Study|Withdrawal by Subject|0|||
37866607|NCT01230749|69549987|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
37866608|NCT01230749|69549988|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
37866609|NCT01230749|69549989|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
37866610|NCT01230749|69549990|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
37866611|NCT00903175|69550005|FG000|Period 1 - First Line|Adverse Event|36|||
37866612|NCT00903175|69550006|FG001|Period 1 - First Line|Adverse Event|50|||
37866613|NCT00903175|69550005|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
37866614|NCT00903175|69550006|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
37866615|NCT00903175|69550005|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
37866616|NCT00903175|69550006|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
37866617|NCT00903175|69550005|FG000|Period 1 - First Line|Protocol Violation|3|||
37866618|NCT00903175|69550006|FG001|Period 1 - First Line|Protocol Violation|3|||
37866619|NCT00903175|69550005|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
37866620|NCT00903175|69550006|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
37866621|NCT00903175|69550005|FG000|Period 1 - First Line|Administrative problems|12|||
37866622|NCT00903175|69550006|FG001|Period 1 - First Line|Administrative problems|13|||
37866623|NCT00903175|69550005|FG000|Period 1 - First Line|Death|17|||
37866624|NCT00903175|69550006|FG001|Period 1 - First Line|Death|10|||
37866625|NCT00903175|69550005|FG000|Period 2 - Second Line|Missing|1|||
37866626|NCT00903175|69550006|FG001|Period 2 - Second Line|Missing|0|||
37866627|NCT00903175|69550005|FG000|Period 2 - Second Line|Adverse Event|16|||
37866628|NCT00903175|69550006|FG001|Period 2 - Second Line|Adverse Event|20|||
37866629|NCT00903175|69550005|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
37866630|NCT00903175|69550006|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
37866631|NCT00903175|69550005|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
37866632|NCT00903175|69550006|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
37866633|NCT00903175|69550005|FG000|Period 2 - Second Line|Administrative problems|19|||
37866634|NCT00903175|69550006|FG001|Period 2 - Second Line|Administrative problems|9|||
37866635|NCT00903175|69550005|FG000|Period 2 - Second Line|Death|5|||
37978780|NCT00483704|69665669|FG000|Randomization|Pregnancy|1|||
37866636|NCT00903175|69550006|FG001|Period 2 - Second Line|Death|2|||
37866637|NCT01229735|69550014|FG000|Overall Study|Lack of Efficacy|8|||
37978781|NCT00483704|69665670|FG001|Randomization|Pregnancy|0|||
37866638|NCT01229735|69550015|FG001|Overall Study|Lack of Efficacy|8|||
37866639|NCT01229735|69550014|FG000|Overall Study|Protocol Violation|13|||
37866640|NCT01229735|69550015|FG001|Overall Study|Protocol Violation|8|||
37866641|NCT01229735|69550014|FG000|Overall Study|Lost to Follow-up|0|||
37978782|NCT00483704|69665671|FG002|Randomization|Pregnancy|0|||
37866642|NCT01229735|69550015|FG001|Overall Study|Lost to Follow-up|2|||
37866643|NCT01229735|69550014|FG000|Overall Study|Withdrawal by Subject|18|||
37866644|NCT01229735|69550015|FG001|Overall Study|Withdrawal by Subject|17|||
37866645|NCT01229735|69550014|FG000|Overall Study|Other Reason|13|||
37978783|NCT00483704|69665669|FG000|Randomization|Physician Decision|2|||
37866646|NCT01229735|69550015|FG001|Overall Study|Other Reason|10|||
37866647|NCT01229735|69550014|FG000|Overall Study|SAE, non-fatal|0|||
37866648|NCT01229735|69550015|FG001|Overall Study|SAE, non-fatal|4|||
37866649|NCT01229735|69550014|FG000|Overall Study|AE, non-serious non-fatal|13|||
37866650|NCT01229735|69550015|FG001|Overall Study|AE, non-serious non-fatal|17|||
37866651|NCT01229735|69550014|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
37866652|NCT01229735|69550015|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
37866653|NCT00974974|69550034|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
37866654|NCT00974974|69550035|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
37866655|NCT00974974|69550034|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
37866656|NCT00974974|69550035|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
37866657|NCT00974974|69550034|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
37866658|NCT00974974|69550035|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
37866659|NCT00974974|69550034|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
37866660|NCT00974974|69550035|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
37866661|NCT00974974|69550034|FG000|IR CD-LD Dose Adjustment|Various|0|||
37866662|NCT00974974|69550035|FG001|IR CD-LD Dose Adjustment|Various|9|||
37866663|NCT00974974|69550034|FG000|IPX066 Dose Conversion|Adverse Event|23|||
37866664|NCT00974974|69550035|FG001|IPX066 Dose Conversion|Adverse Event|0|||
37866665|NCT00974974|69550034|FG000|IPX066 Dose Conversion|Death|2|||
37866666|NCT00974974|69550035|FG001|IPX066 Dose Conversion|Death|0|||
37866667|NCT00974974|69550034|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
37866668|NCT00974974|69550035|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
37866669|NCT00974974|69550034|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
37866670|NCT00974974|69550035|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
37866671|NCT00974974|69550034|FG000|IPX066 Dose Conversion|Various|3|||
37866672|NCT00974974|69550035|FG001|IPX066 Dose Conversion|Various|0|||
37866673|NCT00974974|69550034|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
37866674|NCT00974974|69550035|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
37866675|NCT00974974|69550034|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
37866676|NCT00974974|69550035|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
37866677|NCT00974974|69550034|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
37866678|NCT00974974|69550035|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
37866679|NCT00974974|69550034|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
37866680|NCT00974974|69550035|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
37866681|NCT00974974|69550034|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
37866682|NCT00974974|69550035|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
37866683|NCT00974974|69550034|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
37866684|NCT00974974|69550035|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
37866685|NCT00974974|69550034|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
37866686|NCT00974974|69550035|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
37866687|NCT00974974|69550034|FG000|Maintenance - Double Blind Treatment|Various|4|||
37866688|NCT00974974|69550035|FG001|Maintenance - Double Blind Treatment|Various|0|||
37866689|NCT01233869|69550045|FG000|Initial Treatment Period (24 Months)|Death|1|||
37866690|NCT01233869|69550046|FG001|Initial Treatment Period (24 Months)|Death|0|||
37978784|NCT00483704|69665670|FG001|Randomization|Physician Decision|4|||
37978785|NCT00483704|69665671|FG002|Randomization|Physician Decision|0|||
37978786|NCT00483704|69665669|FG000|Randomization|Progressive disease|0|||
37978787|NCT00483704|69665670|FG001|Randomization|Progressive disease|0|||
37978788|NCT00483704|69665671|FG002|Randomization|Progressive disease|1|||
37978789|NCT00483704|69665669|FG000|Randomization|Lack of qualifying migraines|21|||
37814801|NCT05344560|69492680|FG000|Period 2|Subject out of visit window|1|||
37814802|NCT05344560|69492681|FG001|Period 2|Subject out of visit window|1|||
37814803|NCT05344560|69492680|FG000|Period 3|Subject out of visit window|1|||
37814804|NCT05344560|69492681|FG001|Period 3|Subject out of visit window|0|||
37814805|NCT05024058|69492701|FG000|Treatment|Study terminated by sponsor|5|||
37814806|NCT05024058|69492702|FG001|Treatment|Study terminated by sponsor|6|||
37814807|NCT05024058|69492703|FG002|Treatment|Study terminated by sponsor|4|||
37814808|NCT05024058|69492704|FG003|Treatment|Study terminated by sponsor|2|||
37814809|NCT05024058|69492705|FG004|Treatment|Study terminated by sponsor|3|||
37814810|NCT05024058|69492706|FG005|Treatment|Study terminated by sponsor|3|||
37814811|NCT05024058|69492707|FG006|Treatment|Study terminated by sponsor|1|||
37814812|NCT05024058|69492708|FG007|Treatment|Study terminated by sponsor|3|||
37814813|NCT05024058|69492709|FG008|Treatment|Study terminated by sponsor|6|||
37814814|NCT05024058|69492710|FG009|Treatment|Study terminated by sponsor|6|||
37866691|NCT01233869|69550047|FG002|Initial Treatment Period (24 Months)|Death|0|||
37866692|NCT01233869|69550048|FG003|Initial Treatment Period (24 Months)|Death|0|||
37866693|NCT01233869|69550045|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
37978790|NCT00483704|69665670|FG001|Randomization|Lack of qualifying migraines|25|||
37978791|NCT00483704|69665671|FG002|Randomization|Lack of qualifying migraines|31|||
37866694|NCT01233869|69550046|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
37866695|NCT01233869|69550047|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
37866696|NCT01233869|69550048|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
37866697|NCT01233869|69550045|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
37866698|NCT01233869|69550046|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
37866699|NCT01233869|69550047|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
37866700|NCT01233869|69550048|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
37866701|NCT01233869|69550045|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
37866702|NCT01233869|69550046|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
37866703|NCT01233869|69550047|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
37866704|NCT01233869|69550048|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
37866705|NCT01233869|69550045|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
37866706|NCT01233869|69550046|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
37866707|NCT01233869|69550047|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
37866708|NCT01233869|69550048|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
37866709|NCT01233869|69550045|FG000|Extended Treatment Period (46 Months)|Other|3|||
37866710|NCT01233869|69550046|FG001|Extended Treatment Period (46 Months)|Other|0|||
37866711|NCT01233869|69550047|FG002|Extended Treatment Period (46 Months)|Other|0|||
37866712|NCT01233869|69550048|FG003|Extended Treatment Period (46 Months)|Other|3|||
37866713|NCT01233869|69550045|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
37866714|NCT01233869|69550046|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
37866715|NCT01233869|69550047|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
37866716|NCT01233869|69550048|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
37866717|NCT00992992|69550058|FG000|Overall Study|Lost to Follow-up|3|||
37866718|NCT00992992|69550058|FG000|Overall Study|Death|16|||
37978792|NCT00483704|69665669|FG000|Treatment|Lack of qualifying migraines|101|||
37978793|NCT00483704|69665670|FG001|Treatment|Lack of qualifying migraines|99|||
37978794|NCT00483704|69665671|FG002|Treatment|Lack of qualifying migraines|116|||
37978795|NCT00483704|69665669|FG000|Treatment|Adverse Event|3|||
37978796|NCT00483704|69665670|FG001|Treatment|Adverse Event|5|||
37978797|NCT00483704|69665671|FG002|Treatment|Adverse Event|4|||
37978798|NCT00483704|69665669|FG000|Treatment|Withdrawal by Subject|16|||
37978799|NCT00483704|69665670|FG001|Treatment|Withdrawal by Subject|12|||
37978800|NCT00483704|69665671|FG002|Treatment|Withdrawal by Subject|21|||
37978801|NCT00483704|69665669|FG000|Treatment|Protocol Violation|6|||
37866719|NCT00992992|69550058|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
37866720|NCT00992992|69550058|FG000|Overall Study|Sponsor Closed the Study|4|||
37866721|NCT00992836|69550062|FG000|Overall Study|Lost to Follow-up|1|||
37866722|NCT00992836|69550062|FG000|Overall Study|Withdrawal by Subject|2|||
37866723|NCT00992836|69550062|FG000|Overall Study|Protocol Violation|2|||
37866724|NCT00992446|69550072|FG000|Overall Study|Disease Progression|1|||
37866725|NCT00992446|69550072|FG000|Overall Study|Withdrawal by Subject|2|||
37866726|NCT00992446|69550072|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
37866727|NCT04344301|69550078|FG000|Overall Study|Withdrawal by Subject|1|||
37866728|NCT04344301|69550079|FG001|Overall Study|Withdrawal by Subject|0|||
37866729|NCT04344301|69550078|FG000|Overall Study|Death|0|||
37866730|NCT04344301|69550079|FG001|Overall Study|Death|1|||
37866731|NCT00970294|69550086|FG000|Overall Study|Physician Decision|4|||
37866732|NCT00970294|69550086|FG000|Overall Study|Withdrawal by Subject|1|||
37866733|NCT00969436|69550093|FG000|Overall Study|Protocol Violation|1|||
37978802|NCT00483704|69665670|FG001|Treatment|Protocol Violation|3|||
37978803|NCT00483704|69665671|FG002|Treatment|Protocol Violation|5|||
37814815|NCT05024058|69492701|FG000|Follow-up|Withdrawal by Subject|1|||
37814816|NCT05024058|69492702|FG001|Follow-up|Withdrawal by Subject|0|||
37814817|NCT05024058|69492703|FG002|Follow-up|Withdrawal by Subject|1|||
37814818|NCT05024058|69492704|FG003|Follow-up|Withdrawal by Subject|0|||
37814819|NCT05024058|69492705|FG004|Follow-up|Withdrawal by Subject|0|||
37814820|NCT05024058|69492706|FG005|Follow-up|Withdrawal by Subject|0|||
37814821|NCT05024058|69492707|FG006|Follow-up|Withdrawal by Subject|0|||
37814822|NCT05024058|69492708|FG007|Follow-up|Withdrawal by Subject|1|||
37814823|NCT05024058|69492709|FG008|Follow-up|Withdrawal by Subject|0|||
37814824|NCT05024058|69492710|FG009|Follow-up|Withdrawal by Subject|1|||
37814825|NCT05013008|69492733|FG000|Overall Study|Exclusion from mBFAS|5|||
37814826|NCT05013008|69492734|FG001|Overall Study|Exclusion from mBFAS|25|||
37814827|NCT04826900|69492742|FG000|Overall Study|Family factor|1|||
37814828|NCT04826900|69492743|FG001|Overall Study|Family factor|1|||
37866734|NCT00969436|69550094|FG001|Overall Study|Protocol Violation|3|||
37866735|NCT00969436|69550095|FG002|Overall Study|Protocol Violation|0|||
37866736|NCT00969436|69550093|FG000|Overall Study|Migrated/moved from study area|12|||
37866737|NCT00969436|69550094|FG001|Overall Study|Migrated/moved from study area|10|||
37866738|NCT00969436|69550095|FG002|Overall Study|Migrated/moved from study area|2|||
37978804|NCT00483704|69665669|FG000|Treatment|Lost to Follow-up|2|||
37866739|NCT00969436|69550093|FG000|Overall Study|Father - serious health problem|0|||
37866740|NCT00969436|69550094|FG001|Overall Study|Father - serious health problem|0|||
37866741|NCT00969436|69550095|FG002|Overall Study|Father - serious health problem|1|||
37866742|NCT00969436|69550093|FG000|Overall Study|Parents personal problem|0|||
37866743|NCT00969436|69550094|FG001|Overall Study|Parents personal problem|0|||
37866744|NCT00969436|69550095|FG002|Overall Study|Parents personal problem|1|||
37866745|NCT00969436|69550093|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
37866746|NCT00969436|69550094|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
37866747|NCT00969436|69550095|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
37866748|NCT00969436|69550093|FG000|Overall Study|Withdrawal by Subject|3|||
37866749|NCT00969436|69550094|FG001|Overall Study|Withdrawal by Subject|0|||
37866750|NCT00969436|69550095|FG002|Overall Study|Withdrawal by Subject|2|||
37866751|NCT00969436|69550093|FG000|Overall Study|Lost to Follow-up|8|||
37866752|NCT00969436|69550094|FG001|Overall Study|Lost to Follow-up|8|||
37866753|NCT00969436|69550095|FG002|Overall Study|Lost to Follow-up|5|||
37866754|NCT00900757|69550103|FG000|Overall Study|screen failure|19|||
37866755|NCT00969280|69550109|FG000|Overall Study|Protocol Violation|2|||
37866756|NCT00969280|69550110|FG001|Overall Study|Protocol Violation|1|||
37866757|NCT00969280|69550109|FG000|Overall Study|Withdrawal by Subject|0|||
37866758|NCT00969280|69550110|FG001|Overall Study|Withdrawal by Subject|1|||
37866759|NCT00969280|69550109|FG000|Overall Study|infection of influenza A(H1N1)|0|||
37866760|NCT00969280|69550110|FG001|Overall Study|infection of influenza A(H1N1)|1|||
37866761|NCT00969124|69550116|FG000|Overall Study|Protocol Violation|2|||
37866762|NCT00969124|69550116|FG000|Overall Study|Inadequate bowel preparation|15|||
37866763|NCT00969124|69550116|FG000|Overall Study|Inability to reach cecum|9|||
37866764|NCT00969124|69550116|FG000|Overall Study|Previously unrecognized disease|3|||
37866765|NCT00969124|69550116|FG000|Overall Study|Technical error|1|||
37866766|NCT00900601|69550121|FG000|Overall Study|Physician Decision|1|||
37866767|NCT00901927|69550148|FG000|Overall Study|Lack of Efficacy|1|||
37866768|NCT00901927|69550148|FG000|Overall Study|Protocol Violation|3|||
37866769|NCT00901927|69550148|FG000|Overall Study|Withdrawal by Subject|2|||
37866770|NCT00968968|69550154|FG000|Overall Study|Study closed/terminated|10|||
37866771|NCT00968968|69550155|FG001|Overall Study|Study closed/terminated|10|||
37866772|NCT00968968|69550154|FG000|Overall Study|Protocol defined stopping criteria|3|||
37866773|NCT00968968|69550155|FG001|Overall Study|Protocol defined stopping criteria|1|||
37866774|NCT00968968|69550154|FG000|Overall Study|Withdrawal by Subject|2|||
37866775|NCT00968968|69550155|FG001|Overall Study|Withdrawal by Subject|0|||
37866776|NCT00968968|69550154|FG000|Overall Study|Physician Decision|1|||
37866777|NCT00968968|69550155|FG001|Overall Study|Physician Decision|2|||
37866778|NCT00968968|69550154|FG000|Overall Study|Lost to Follow-up|0|||
37866779|NCT00968968|69550155|FG001|Overall Study|Lost to Follow-up|1|||
37866780|NCT00973102|69550164|FG000|Overall Study|Protocol Violation|1|||
37866781|NCT00973102|69550165|FG001|Overall Study|Protocol Violation|0|||
37866782|NCT00973102|69550164|FG000|Overall Study|Prisoner|0|||
37866783|NCT00973102|69550165|FG001|Overall Study|Prisoner|1|||
37866784|NCT00901459|69550171|FG000|Overall Study|Withdrawal by Subject|6|||
37866785|NCT00896233|69550182|FG000|Overall Study|Claustrophobia during MRI|1|||
37866786|NCT00899431|69550207|FG000|Overall Study|Physician Decision|1|||
37866787|NCT00899431|69550208|FG001|Overall Study|Physician Decision|0|||
37866788|NCT00899431|69550209|FG002|Overall Study|Physician Decision|0|||
37866789|NCT00899353|69550220|FG000|Overall Study|Adverse Event|2|||
37866790|NCT00899353|69550220|FG000|Overall Study|Lost to Follow-up|1|||
37866791|NCT00899353|69550220|FG000|Overall Study|Withdrawal by Subject|2|||
37866792|NCT00898807|69550243|FG000|Overall Study|Withdrawal by Subject|5|||
37866793|NCT00898807|69550244|FG001|Overall Study|Withdrawal by Subject|3|||
37866794|NCT00898807|69550243|FG000|Overall Study|Family pressure to discontinue|2|||
37866795|NCT00898807|69550244|FG001|Overall Study|Family pressure to discontinue|2|||
37866796|NCT00898807|69550243|FG000|Overall Study|Lost to Follow-up|1|||
37866797|NCT00898807|69550244|FG001|Overall Study|Lost to Follow-up|3|||
37866798|NCT00898807|69550243|FG000|Overall Study|Death|0|||
37866799|NCT00898807|69550244|FG001|Overall Study|Death|1|||
37866800|NCT01229267|69550255|FG000|Overall Study|Adverse Event|4|||
37866801|NCT01229267|69550256|FG001|Overall Study|Adverse Event|6|||
37866802|NCT01229267|69550257|FG002|Overall Study|Adverse Event|3|||
37866803|NCT01229267|69550258|FG003|Overall Study|Adverse Event|2|||
37866804|NCT01229267|69550259|FG004|Overall Study|Adverse Event|10|||
37866805|NCT01229267|69550255|FG000|Overall Study|Death|40|||
37866806|NCT01229267|69550256|FG001|Overall Study|Death|37|||
37866807|NCT01229267|69550257|FG002|Overall Study|Death|35|||
37866808|NCT01229267|69550258|FG003|Overall Study|Death|13|||
37866809|NCT01229267|69550259|FG004|Overall Study|Death|103|||
37866810|NCT01229267|69550255|FG000|Overall Study|Withdrawal by Subject|23|||
37866811|NCT01229267|69550256|FG001|Overall Study|Withdrawal by Subject|22|||
37866812|NCT01229267|69550257|FG002|Overall Study|Withdrawal by Subject|32|||
37866813|NCT01229267|69550258|FG003|Overall Study|Withdrawal by Subject|14|||
37866814|NCT01229267|69550259|FG004|Overall Study|Withdrawal by Subject|59|||
37866815|NCT01229267|69550255|FG000|Overall Study|Protocol Violation|0|||
37866816|NCT01229267|69550256|FG001|Overall Study|Protocol Violation|1|||
37866817|NCT01229267|69550257|FG002|Overall Study|Protocol Violation|0|||
37866818|NCT01229267|69550258|FG003|Overall Study|Protocol Violation|0|||
37866819|NCT01229267|69550259|FG004|Overall Study|Protocol Violation|0|||
37866820|NCT01229267|69550255|FG000|Overall Study|Progressive disease|0|||
37866821|NCT01229267|69550256|FG001|Overall Study|Progressive disease|0|||
37866822|NCT01229267|69550257|FG002|Overall Study|Progressive disease|0|||
37866823|NCT01229267|69550258|FG003|Overall Study|Progressive disease|0|||
37866824|NCT01229267|69550259|FG004|Overall Study|Progressive disease|1|||
37866825|NCT01229267|69550255|FG000|Overall Study|Physician Decision|8|||
37866826|NCT01229267|69550256|FG001|Overall Study|Physician Decision|11|||
37866827|NCT01229267|69550257|FG002|Overall Study|Physician Decision|8|||
37866828|NCT01229267|69550258|FG003|Overall Study|Physician Decision|3|||
37866829|NCT01229267|69550259|FG004|Overall Study|Physician Decision|25|||
37866830|NCT01229267|69550255|FG000|Overall Study|Lost to Follow-up|6|||
37866831|NCT01229267|69550256|FG001|Overall Study|Lost to Follow-up|5|||
37866832|NCT01229267|69550257|FG002|Overall Study|Lost to Follow-up|8|||
37866833|NCT01229267|69550258|FG003|Overall Study|Lost to Follow-up|3|||
37866834|NCT01229267|69550259|FG004|Overall Study|Lost to Follow-up|22|||
37866835|NCT00897715|69550268|FG000|Overall Study|Lost to Follow-up|0|||
37866836|NCT00897715|69550269|FG001|Overall Study|Lost to Follow-up|1|||
37866837|NCT00897715|69550268|FG000|Overall Study|Physician Decision|1|||
37866838|NCT00897715|69550269|FG001|Overall Study|Physician Decision|0|||
37866839|NCT00897715|69550268|FG000|Overall Study|increased risk of infection|1|||
37866840|NCT00897715|69550269|FG001|Overall Study|increased risk of infection|0|||
37866841|NCT01229111|69550275|FG000|Overall Study|Death|1|||
37866842|NCT00894361|69550281|FG000|Overall Study|deaths and less than 2 years followup|24|||
37866843|NCT00894361|69550282|FG001|Overall Study|deaths and less than 2 years followup|64|||
37866844|NCT01228175|69550292|FG000|Overall Study|Lost to Follow-up|64|||
37866845|NCT01228175|69550293|FG001|Overall Study|Lost to Follow-up|50|||
37866846|NCT01228175|69550292|FG000|Overall Study|Withdrawal by Subject|1|||
37866847|NCT01228175|69550293|FG001|Overall Study|Withdrawal by Subject|2|||
37866848|NCT01228175|69550292|FG000|Overall Study|Physician Decision|1|||
37866849|NCT01228175|69550293|FG001|Overall Study|Physician Decision|1|||
37866850|NCT01228019|69550299|FG000|Overall Study|Dose Violation|70|||
37866851|NCT01228019|69550299|FG000|Overall Study|Duplicate enrollment|1|||
37866852|NCT01228019|69550299|FG000|Overall Study|Missing pre-treatment data|72|||
37866853|NCT01228019|69550299|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
37866854|NCT01228019|69550299|FG000|Overall Study|Violation of Entry Criterion|9|||
37866855|NCT02987959|69550303|FG000|Overall Study|Grantor stopped supply of drugs|6|||
37866856|NCT01227707|69550307|FG000|Overall Study|Adverse Event|10|||
37866857|NCT01227707|69550307|FG000|Overall Study|Progression of disease|3|||
37866858|NCT01227707|69550307|FG000|Overall Study|Withdrawal by Subject|1|||
37866859|NCT01227707|69550307|FG000|Overall Study|Patient non-compliance|3|||
37866860|NCT01227707|69550307|FG000|Overall Study|Medical decision|6|||
37866861|NCT01227707|69550307|FG000|Overall Study|Death|1|||
37866862|NCT00895843|69550313|FG000|Overall Study|Protocol Violation|12|||
37866863|NCT00895843|69550314|FG001|Overall Study|Protocol Violation|12|||
37866864|NCT00895453|69550323|FG000|Overall Study|Lost to Follow-up|25|||
37866865|NCT00895453|69550324|FG001|Overall Study|Lost to Follow-up|25|||
37866866|NCT00895453|69550325|FG002|Overall Study|Lost to Follow-up|23|||
37866867|NCT00893971|69550333|FG000|Overall Study|Physician Decision|3|||
37866868|NCT00893737|69550346|FG000|Overall Study|Adverse Event|4|||
37866869|NCT00893737|69550346|FG000|Overall Study|Withdrawal by Subject|2|||
37866870|NCT00893737|69550346|FG000|Overall Study|Lost to Follow-up|6|||
37866871|NCT00893113|69550352|FG000|Overall Study|Lost to Follow-up|4|||
37866872|NCT00893113|69550353|FG001|Overall Study|Lost to Follow-up|8|||
37866873|NCT00893113|69550352|FG000|Overall Study|Early Termination|1|||
37866874|NCT00893113|69550353|FG001|Overall Study|Early Termination|1|||
37866875|NCT00893113|69550352|FG000|Overall Study|Withdrew Consent|8|||
37866876|NCT00893113|69550353|FG001|Overall Study|Withdrew Consent|7|||
37866877|NCT00892957|69550361|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
37866878|NCT00892957|69550362|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
37866879|NCT00892957|69550361|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
37866880|NCT00892957|69550362|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
37866881|NCT00968812|69550385|FG000|Overall Study|Adverse Event|30|||
37866882|NCT00968812|69550386|FG001|Overall Study|Adverse Event|46|||
37866883|NCT00968812|69550387|FG002|Overall Study|Adverse Event|33|||
37866884|NCT00968812|69550385|FG000|Overall Study|Death|2|||
37866885|NCT00968812|69550386|FG001|Overall Study|Death|2|||
37866886|NCT00968812|69550387|FG002|Overall Study|Death|1|||
37866887|NCT00968812|69550385|FG000|Overall Study|Lack of Efficacy|9|||
37978805|NCT00483704|69665670|FG001|Treatment|Lost to Follow-up|7|||
37978806|NCT00483704|69665671|FG002|Treatment|Lost to Follow-up|5|||
37866888|NCT00968812|69550386|FG001|Overall Study|Lack of Efficacy|7|||
37866889|NCT00968812|69550387|FG002|Overall Study|Lack of Efficacy|16|||
37866890|NCT00968812|69550385|FG000|Overall Study|Lost to Follow-up|17|||
37866891|NCT00968812|69550386|FG001|Overall Study|Lost to Follow-up|12|||
37866892|NCT00968812|69550387|FG002|Overall Study|Lost to Follow-up|11|||
37866893|NCT00968812|69550385|FG000|Overall Study|Physician Decision|8|||
37866894|NCT00968812|69550386|FG001|Overall Study|Physician Decision|5|||
37866895|NCT00968812|69550387|FG002|Overall Study|Physician Decision|9|||
37866896|NCT00968812|69550385|FG000|Overall Study|Protocol Violation|7|||
37866897|NCT00968812|69550386|FG001|Overall Study|Protocol Violation|4|||
37694787|NCT01891864|69171213|FG001|Extension Period|Lost to Follow-up|0|||
37694788|NCT01891864|69171214|FG002|Extension Period|Lost to Follow-up|2|||
37694789|NCT01891864|69171215|FG003|Extension Period|Lost to Follow-up|0|||
37814829|NCT04721158|69492749|FG000|Overall Study|Lost to Follow-up|4|||
37814830|NCT04721158|69492749|FG000|Overall Study|Device did not connect|1|||
37814831|NCT04263766|69492756|FG000|Overall Study|Withdrawal by Subject|6|||
37814832|NCT04263766|69492757|FG001|Overall Study|Withdrawal by Subject|4|||
37814833|NCT04263766|69492756|FG000|Overall Study|Lack of Efficacy|1|||
37814834|NCT04263766|69492757|FG001|Overall Study|Lack of Efficacy|3|||
37814835|NCT04225039|69492781|FG000|Overall Study|Withdrawal by Subject|1|||
37814836|NCT04225039|69492782|FG001|Overall Study|Withdrawal by Subject|0|||
37814837|NCT04225039|69492783|FG002|Overall Study|Withdrawal by Subject|0|||
37814838|NCT04225039|69492784|FG003|Overall Study|Withdrawal by Subject|1|||
37814839|NCT04225039|69492781|FG000|Overall Study|Currently active on study treatment|0|||
37814840|NCT04225039|69492782|FG001|Overall Study|Currently active on study treatment|1|||
37814841|NCT04225039|69492783|FG002|Overall Study|Currently active on study treatment|0|||
37814842|NCT04225039|69492784|FG003|Overall Study|Currently active on study treatment|0|||
37814843|NCT04225039|69492781|FG000|Overall Study|Protocol deviation; data not analyzed for efficacy|2|||
37814844|NCT04225039|69492782|FG001|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
37814845|NCT04225039|69492783|FG002|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
37814846|NCT04225039|69492784|FG003|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
37814847|NCT04225039|69492781|FG000|Overall Study|Ineligible for treatment|0|||
37814848|NCT04225039|69492782|FG001|Overall Study|Ineligible for treatment|0|||
37814849|NCT04225039|69492783|FG002|Overall Study|Ineligible for treatment|0|||
37814850|NCT04225039|69492784|FG003|Overall Study|Ineligible for treatment|4|||
37814851|NCT04203199|69492793|FG000|First Intervention Period|Lost to Follow-up|0|||
37814852|NCT04203199|69492794|FG001|First Intervention Period|Lost to Follow-up|1|||
37814853|NCT04203199|69492793|FG000|Second Intervention Period|Medication change|1|||
37814854|NCT04203199|69492794|FG001|Second Intervention Period|Medication change|0|||
37814855|NCT04191733|69492802|FG000|Overall Study|Withdrawn due to study closure|13|||
37814856|NCT04191733|69492803|FG001|Overall Study|Withdrawn due to study closure|14|||
37814857|NCT04191733|69492802|FG000|Overall Study|Withdrawal by Subject|2|||
37814858|NCT04191733|69492803|FG001|Overall Study|Withdrawal by Subject|4|||
37814859|NCT04191733|69492802|FG000|Overall Study|Physician Decision|1|||
37978807|NCT00483704|69665669|FG000|Treatment|Lack of Efficacy|1|||
37694790|NCT01891864|69171216|FG004|Extension Period|Lost to Follow-up|0|||
37814860|NCT04191733|69492803|FG001|Overall Study|Physician Decision|1|||
37814861|NCT04191733|69492802|FG000|Overall Study|Lost to Follow-up|5|||
37978808|NCT00483704|69665670|FG001|Treatment|Lack of Efficacy|1|||
37978809|NCT00483704|69665671|FG002|Treatment|Lack of Efficacy|1|||
37978810|NCT00483704|69665669|FG000|Treatment|Pregnancy|0|||
37978811|NCT00483704|69665670|FG001|Treatment|Pregnancy|1|||
37978812|NCT00483704|69665671|FG002|Treatment|Pregnancy|0|||
37978813|NCT00483704|69665669|FG000|Treatment|Physician Decision|0|||
37978814|NCT00483704|69665670|FG001|Treatment|Physician Decision|1|||
37814862|NCT04191733|69492803|FG001|Overall Study|Lost to Follow-up|6|||
37814863|NCT04191733|69492802|FG000|Overall Study|Death|0|||
37814864|NCT04191733|69492803|FG001|Overall Study|Death|1|||
37814865|NCT04049097|69492809|FG000|Overall Study|Adverse Event|18|||
37814866|NCT04049097|69492809|FG000|Overall Study|Death|2|||
37814867|NCT04049097|69492809|FG000|Overall Study|Lost to Follow-up|1|||
37814868|NCT04049097|69492809|FG000|Overall Study|Physician Decision|2|||
37814869|NCT04049097|69492809|FG000|Overall Study|Withdrawal by Subject|9|||
37814870|NCT04049097|69492809|FG000|Overall Study|Protocol Violation|2|||
37814871|NCT04049097|69492809|FG000|Overall Study|Other|1|||
37814872|NCT04049097|69492809|FG000|Overall Study|The trial was terminated early by the sponsor|86|||
37814873|NCT04002310|69492818|FG000|Overall Study|Sponsor put on hold on treatment plan.|0|||
37814874|NCT04002310|69492819|FG001|Overall Study|Sponsor put on hold on treatment plan.|0|||
37814875|NCT04002310|69492820|FG002|Overall Study|Sponsor put on hold on treatment plan.|0|||
37814876|NCT04002310|69492821|FG003|Overall Study|Sponsor put on hold on treatment plan.|0|||
37814877|NCT04002310|69492822|FG004|Overall Study|Sponsor put on hold on treatment plan.|1|||
37814878|NCT03887650|69492845|FG000|Preoperative-48 Hours Postoperative|Withdrawal by Subject|0|||
37814879|NCT03887650|69492846|FG001|Preoperative-48 Hours Postoperative|Withdrawal by Subject|1|||
37814880|NCT03887650|69492845|FG000|48-96 Hours Postoperative|Withdrawal by Subject|0|||
37814881|NCT03887650|69492846|FG001|48-96 Hours Postoperative|Withdrawal by Subject|2|||
37814882|NCT03887650|69492845|FG000|60 Postoperative Days|Withdrawal by Subject|1|||
37814883|NCT03887650|69492846|FG001|60 Postoperative Days|Withdrawal by Subject|0|||
37814884|NCT03345342|69492884|FG000|Open-Label Phase|Adverse Event|30|||
37814885|NCT03345342|69492885|FG001|Open-Label Phase|Adverse Event|0|||
37814886|NCT03345342|69492886|FG002|Open-Label Phase|Adverse Event|0|||
37814887|NCT03345342|69492887|FG003|Open-Label Phase|Adverse Event|0|||
37814888|NCT03345342|69492888|FG004|Open-Label Phase|Adverse Event|0|||
37814889|NCT03345342|69492884|FG000|Open-Label Phase|Death|1|||
37814890|NCT03345342|69492885|FG001|Open-Label Phase|Death|0|||
37814891|NCT03345342|69492886|FG002|Open-Label Phase|Death|0|||
37814892|NCT03345342|69492887|FG003|Open-Label Phase|Death|0|||
37814893|NCT03345342|69492888|FG004|Open-Label Phase|Death|0|||
37814894|NCT03345342|69492884|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
37814895|NCT03345342|69492885|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
37814896|NCT03345342|69492886|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
37814897|NCT03345342|69492887|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
37814898|NCT03345342|69492888|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
37814899|NCT03345342|69492884|FG000|Open-Label Phase|Lack of Efficacy|6|||
37814900|NCT03345342|69492885|FG001|Open-Label Phase|Lack of Efficacy|0|||
37814901|NCT03345342|69492886|FG002|Open-Label Phase|Lack of Efficacy|0|||
37814902|NCT03345342|69492887|FG003|Open-Label Phase|Lack of Efficacy|0|||
37814903|NCT03345342|69492888|FG004|Open-Label Phase|Lack of Efficacy|0|||
37814904|NCT03345342|69492884|FG000|Open-Label Phase|Lost to Follow-up|9|||
37814905|NCT03345342|69492885|FG001|Open-Label Phase|Lost to Follow-up|0|||
37814906|NCT03345342|69492886|FG002|Open-Label Phase|Lost to Follow-up|0|||
37814907|NCT03345342|69492887|FG003|Open-Label Phase|Lost to Follow-up|0|||
37814908|NCT03345342|69492888|FG004|Open-Label Phase|Lost to Follow-up|0|||
37814909|NCT03345342|69492884|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
37814910|NCT03345342|69492885|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
37814911|NCT03345342|69492886|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
37814912|NCT03345342|69492887|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
37814913|NCT03345342|69492888|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
37814914|NCT03345342|69492884|FG000|Open-Label Phase|Physician Decision|4|||
37814915|NCT03345342|69492885|FG001|Open-Label Phase|Physician Decision|0|||
37814916|NCT03345342|69492886|FG002|Open-Label Phase|Physician Decision|0|||
37814917|NCT03345342|69492887|FG003|Open-Label Phase|Physician Decision|0|||
37814918|NCT03345342|69492888|FG004|Open-Label Phase|Physician Decision|0|||
37814919|NCT03345342|69492884|FG000|Open-Label Phase|Protocol Violation|8|||
37814920|NCT03345342|69492885|FG001|Open-Label Phase|Protocol Violation|0|||
37814921|NCT03345342|69492886|FG002|Open-Label Phase|Protocol Violation|0|||
37814922|NCT03345342|69492887|FG003|Open-Label Phase|Protocol Violation|0|||
37814923|NCT03345342|69492888|FG004|Open-Label Phase|Protocol Violation|0|||
37814924|NCT03345342|69492884|FG000|Open-Label Phase|Withdrawal by Subject|57|||
37814925|NCT03345342|69492885|FG001|Open-Label Phase|Withdrawal by Subject|0|||
37814926|NCT03345342|69492886|FG002|Open-Label Phase|Withdrawal by Subject|0|||
37814927|NCT03345342|69492887|FG003|Open-Label Phase|Withdrawal by Subject|0|||
37814928|NCT03345342|69492888|FG004|Open-Label Phase|Withdrawal by Subject|0|||
37814929|NCT03345342|69492884|FG000|Open-Label Phase|Other|15|||
37978815|NCT00483704|69665671|FG002|Treatment|Physician Decision|4|||
37866898|NCT00968812|69550387|FG002|Overall Study|Protocol Violation|3|||
37866899|NCT00968812|69550385|FG000|Overall Study|Withdrawal by Subject|17|||
37866900|NCT00968812|69550386|FG001|Overall Study|Withdrawal by Subject|23|||
37866901|NCT00968812|69550387|FG002|Overall Study|Withdrawal by Subject|25|||
37866902|NCT00968812|69550385|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
37866903|NCT00968812|69550386|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
37866904|NCT00968812|69550387|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
37866905|NCT00968812|69550385|FG000|Overall Study|Noncompliance with study drug|4|||
37866906|NCT00968812|69550386|FG001|Overall Study|Noncompliance with study drug|1|||
37866907|NCT00968812|69550387|FG002|Overall Study|Noncompliance with study drug|6|||
37866908|NCT00968812|69550385|FG000|Overall Study|Unable to take rescue therapy|12|||
37866909|NCT00968812|69550386|FG001|Overall Study|Unable to take rescue therapy|12|||
37866910|NCT00968812|69550387|FG002|Overall Study|Unable to take rescue therapy|17|||
37866911|NCT00968812|69550385|FG000|Overall Study|Other|25|||
37866912|NCT00968812|69550386|FG001|Overall Study|Other|37|||
37866913|NCT00968812|69550387|FG002|Overall Study|Other|40|||
37978816|NCT00483548|69665684|FG000|Overall Study|Randomized; not treated with study drug|1|||
37978817|NCT00483548|69665685|FG001|Overall Study|Randomized; not treated with study drug|3|||
37978818|NCT00483548|69665684|FG000|Overall Study|Adverse Event|25|||
37978819|NCT00483548|69665685|FG001|Overall Study|Adverse Event|14|||
37978820|NCT00483548|69665684|FG000|Overall Study|Laboratory abnormality|1|||
37978821|NCT00483548|69665685|FG001|Overall Study|Laboratory abnormality|2|||
37978822|NCT00483548|69665684|FG000|Overall Study|Lack of Efficacy|4|||
37978823|NCT00483548|69665685|FG001|Overall Study|Lack of Efficacy|8|||
37978824|NCT00483548|69665684|FG000|Overall Study|Protocol Violation|11|||
37978825|NCT00483548|69665685|FG001|Overall Study|Protocol Violation|7|||
37978826|NCT00483548|69665684|FG000|Overall Study|Pregnancy|1|||
37978827|NCT00483548|69665685|FG001|Overall Study|Pregnancy|0|||
37978828|NCT00483548|69665684|FG000|Overall Study|Protocol required discontinuation|6|||
37978829|NCT00483548|69665685|FG001|Overall Study|Protocol required discontinuation|6|||
37978830|NCT00483548|69665684|FG000|Overall Study|Unable to comply with protocol schedule|1|||
37978831|NCT00483548|69665685|FG001|Overall Study|Unable to comply with protocol schedule|0|||
37978832|NCT00483548|69665684|FG000|Overall Study|Non-compliance with medication|2|||
37978833|NCT00483548|69665685|FG001|Overall Study|Non-compliance with medication|0|||
37978834|NCT00483548|69665684|FG000|Overall Study|Lost to Follow-up|3|||
37978835|NCT00483548|69665685|FG001|Overall Study|Lost to Follow-up|4|||
37978836|NCT00483548|69665684|FG000|Overall Study|Withdrawal by Subject|5|||
37978837|NCT00483548|69665685|FG001|Overall Study|Withdrawal by Subject|2|||
37978838|NCT00445770|69665694|FG000|Overall Study|Adverse Event|9|||
37978839|NCT00445770|69665695|FG001|Overall Study|Adverse Event|15|||
37978840|NCT00445770|69665696|FG002|Overall Study|Adverse Event|19|||
37978841|NCT00445770|69665694|FG000|Overall Study|Lack of Efficacy|38|||
37978842|NCT00445770|69665695|FG001|Overall Study|Lack of Efficacy|13|||
37978843|NCT00445770|69665696|FG002|Overall Study|Lack of Efficacy|6|||
37978844|NCT00445770|69665694|FG000|Overall Study|Lost to Follow-up|0|||
37978845|NCT00445770|69665695|FG001|Overall Study|Lost to Follow-up|2|||
37978846|NCT00445770|69665696|FG002|Overall Study|Lost to Follow-up|0|||
37978847|NCT00445770|69665694|FG000|Overall Study|Other|6|||
37978848|NCT00445770|69665695|FG001|Overall Study|Other|5|||
37978849|NCT00445770|69665696|FG002|Overall Study|Other|6|||
37978850|NCT00266032|69665709|FG000|Treatment|Adverse Event|42|||
37978851|NCT00266032|69665710|FG001|Treatment|Adverse Event|26|||
37978852|NCT00266032|69665711|FG002|Treatment|Adverse Event|10|||
37978853|NCT00266032|69665709|FG000|Treatment|Lost to Follow-up|19|||
37978854|NCT00266032|69665710|FG001|Treatment|Lost to Follow-up|4|||
37978855|NCT00266032|69665711|FG002|Treatment|Lost to Follow-up|2|||
37978856|NCT00266032|69665709|FG000|Treatment|Pregnancy|3|||
37978857|NCT00266032|69665710|FG001|Treatment|Pregnancy|2|||
37978858|NCT00266032|69665711|FG002|Treatment|Pregnancy|2|||
37978859|NCT00266032|69665709|FG000|Treatment|Protocol Violation|6|||
37978860|NCT00266032|69665710|FG001|Treatment|Protocol Violation|14|||
37978861|NCT00266032|69665711|FG002|Treatment|Protocol Violation|13|||
37978862|NCT00266032|69665709|FG000|Treatment|Withdrawal by Subject|28|||
37978863|NCT00266032|69665710|FG001|Treatment|Withdrawal by Subject|13|||
37978864|NCT00266032|69665711|FG002|Treatment|Withdrawal by Subject|12|||
37866914|NCT00992056|69550400|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
37866915|NCT00992056|69550401|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
37866916|NCT00992056|69550400|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
37978865|NCT00266032|69665709|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
37978866|NCT00266032|69665710|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
37978867|NCT00266032|69665711|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
37978868|NCT00266032|69665709|FG000|Open-label Safety Extension|Adverse Event|5|||
37978869|NCT00266032|69665710|FG001|Open-label Safety Extension|Adverse Event|0|||
37978870|NCT00266032|69665711|FG002|Open-label Safety Extension|Adverse Event|4|||
37978871|NCT00266032|69665709|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
37978872|NCT00266032|69665710|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
37978873|NCT00266032|69665711|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
37978874|NCT00266032|69665709|FG000|Open-label Safety Extension|Pregnancy|4|||
37978875|NCT00266032|69665710|FG001|Open-label Safety Extension|Pregnancy|1|||
37978876|NCT00266032|69665711|FG002|Open-label Safety Extension|Pregnancy|2|||
37978877|NCT00266032|69665709|FG000|Open-label Safety Extension|Protocol Violation|1|||
37978878|NCT00266032|69665710|FG001|Open-label Safety Extension|Protocol Violation|3|||
37978879|NCT00266032|69665711|FG002|Open-label Safety Extension|Protocol Violation|2|||
37978880|NCT00266032|69665709|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
37978881|NCT00266032|69665710|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
37978882|NCT00266032|69665711|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
37978883|NCT00266032|69665709|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
37978884|NCT00266032|69665710|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
37978885|NCT00266032|69665711|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
37978886|NCT00483002|69665719|FG000|Overall Study|Adverse Event|68|||
37978887|NCT00483002|69665719|FG000|Overall Study|Lack of Efficacy|555|||
37978888|NCT00483002|69665719|FG000|Overall Study|Lost to Follow-up|962|||
37978889|NCT00483002|69665719|FG000|Overall Study|Other|2|||
37978890|NCT00483002|69665719|FG000|Overall Study|Other|967|||
37978891|NCT00482612|69665727|FG000|In-treatment Period|No study medication administered|0|||
37978892|NCT00482612|69665728|FG001|In-treatment Period|No study medication administered|0|||
37866917|NCT00992056|69550401|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
37866918|NCT00972322|69550409|FG000|Overall Study|Adverse Event|2|||
37866919|NCT00972322|69550410|FG001|Overall Study|Adverse Event|1|||
37866920|NCT00972322|69550409|FG000|Overall Study|Positive drug screen|0|||
37866921|NCT00972322|69550410|FG001|Overall Study|Positive drug screen|1|||
37866922|NCT00972322|69550409|FG000|Overall Study|Lost to Follow-up|0|||
37866923|NCT00972322|69550410|FG001|Overall Study|Lost to Follow-up|1|||
37866924|NCT00972322|69550409|FG000|Overall Study|Consistently high glucose values|1|||
37866925|NCT00972322|69550410|FG001|Overall Study|Consistently high glucose values|0|||
37866926|NCT00967798|69550418|FG000|Overall Study|Withdrawal by Subject|5|||
37978893|NCT00482612|69665729|FG002|In-treatment Period|No study medication administered|1|||
37978894|NCT00482612|69665730|FG003|In-treatment Period|No study medication administered|0|||
37978895|NCT00482612|69665727|FG000|Follow-up Period|Other|4|||
37978896|NCT00482612|69665728|FG001|Follow-up Period|Other|2|||
37978897|NCT00482612|69665729|FG002|Follow-up Period|Other|1|||
37978898|NCT00482612|69665730|FG003|Follow-up Period|Other|2|||
37814930|NCT03345342|69492885|FG001|Open-Label Phase|Other|0|||
37814931|NCT03345342|69492886|FG002|Open-Label Phase|Other|0|||
37814932|NCT03345342|69492887|FG003|Open-Label Phase|Other|0|||
37814933|NCT03345342|69492888|FG004|Open-Label Phase|Other|0|||
37814934|NCT03345342|69492884|FG000|Double-Blind Phase|Adverse Event|0|||
37814935|NCT03345342|69492885|FG001|Double-Blind Phase|Adverse Event|1|||
37814936|NCT03345342|69492886|FG002|Double-Blind Phase|Adverse Event|6|||
37814937|NCT03345342|69492887|FG003|Double-Blind Phase|Adverse Event|0|||
37814938|NCT03345342|69492888|FG004|Double-Blind Phase|Adverse Event|0|||
37814939|NCT03345342|69492884|FG000|Double-Blind Phase|Death|0|||
37814940|NCT03345342|69492885|FG001|Double-Blind Phase|Death|2|||
37814941|NCT03345342|69492886|FG002|Double-Blind Phase|Death|1|||
37814942|NCT03345342|69492887|FG003|Double-Blind Phase|Death|0|||
37814943|NCT03345342|69492888|FG004|Double-Blind Phase|Death|0|||
37814944|NCT03345342|69492884|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
37814945|NCT03345342|69492885|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
37814946|NCT03345342|69492886|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
37814947|NCT03345342|69492887|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
37814948|NCT03345342|69492888|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
37814949|NCT03345342|69492884|FG000|Double-Blind Phase|Lost to Follow-up|0|||
37814950|NCT03345342|69492885|FG001|Double-Blind Phase|Lost to Follow-up|1|||
37814951|NCT03345342|69492886|FG002|Double-Blind Phase|Lost to Follow-up|7|||
37814952|NCT03345342|69492887|FG003|Double-Blind Phase|Lost to Follow-up|0|||
37814953|NCT03345342|69492888|FG004|Double-Blind Phase|Lost to Follow-up|0|||
37814954|NCT03345342|69492884|FG000|Double-Blind Phase|Physician Decision|0|||
37814955|NCT03345342|69492885|FG001|Double-Blind Phase|Physician Decision|1|||
37866927|NCT00967798|69550419|FG001|Overall Study|Withdrawal by Subject|2|||
37866928|NCT00967798|69550418|FG000|Overall Study|Lost to Follow-up|4|||
37866929|NCT00967798|69550419|FG001|Overall Study|Lost to Follow-up|1|||
37978899|NCT00482612|69665727|FG000|Follow-up Period|Lack of compliance|0|||
37978900|NCT00482612|69665728|FG001|Follow-up Period|Lack of compliance|0|||
37978901|NCT00482612|69665729|FG002|Follow-up Period|Lack of compliance|1|||
37978902|NCT00482612|69665730|FG003|Follow-up Period|Lack of compliance|0|||
37978903|NCT00482612|69665727|FG000|Follow-up Period|Lost to Follow-up|0|||
37978904|NCT00482612|69665728|FG001|Follow-up Period|Lost to Follow-up|4|||
37978905|NCT00482612|69665729|FG002|Follow-up Period|Lost to Follow-up|2|||
37978906|NCT00482612|69665730|FG003|Follow-up Period|Lost to Follow-up|1|||
37978907|NCT00482612|69665727|FG000|Follow-up Period|Adverse Event|4|||
37978908|NCT00482612|69665728|FG001|Follow-up Period|Adverse Event|7|||
37978909|NCT00482612|69665729|FG002|Follow-up Period|Adverse Event|9|||
37978910|NCT00482612|69665730|FG003|Follow-up Period|Adverse Event|0|||
37978911|NCT00482612|69665727|FG000|Follow-up Period|Lack of Efficacy|2|||
37978912|NCT00482612|69665728|FG001|Follow-up Period|Lack of Efficacy|0|||
37978913|NCT00482612|69665729|FG002|Follow-up Period|Lack of Efficacy|1|||
37978914|NCT00482612|69665730|FG003|Follow-up Period|Lack of Efficacy|0|||
37978915|NCT00482612|69665727|FG000|Follow-up Period|Withdrawal by Subject|3|||
37978916|NCT00482612|69665728|FG001|Follow-up Period|Withdrawal by Subject|5|||
37978917|NCT00482612|69665729|FG002|Follow-up Period|Withdrawal by Subject|7|||
37978918|NCT00482612|69665730|FG003|Follow-up Period|Withdrawal by Subject|2|||
37978919|NCT00482612|69665727|FG000|Follow-up Period|Reasons not related to trial|1|||
37978920|NCT00482612|69665728|FG001|Follow-up Period|Reasons not related to trial|0|||
37978921|NCT00482612|69665729|FG002|Follow-up Period|Reasons not related to trial|1|||
37866930|NCT00965458|69550427|FG000|Overall Study|Adverse Event|1|||
37694791|NCT01891864|69171217|FG005|Extension Period|Lost to Follow-up|0|||
37694792|NCT02485301|69171231|FG000|Overall Study|Serious Adverse Events|2|||
37694793|NCT02485301|69171232|FG001|Overall Study|Serious Adverse Events|1|||
37866931|NCT00965458|69550428|FG001|Overall Study|Adverse Event|0|||
37866932|NCT00965458|69550427|FG000|Overall Study|Lost to Follow-up|1|||
37866933|NCT00965458|69550428|FG001|Overall Study|Lost to Follow-up|3|||
37866934|NCT00965458|69550427|FG000|Overall Study|Withdrawal by Subject|0|||
37866935|NCT00965458|69550428|FG001|Overall Study|Withdrawal by Subject|1|||
37694794|NCT02485301|69171231|FG000|Overall Study|Protocol Violation|0|||
37694795|NCT02485301|69171232|FG001|Overall Study|Protocol Violation|1|||
37866936|NCT00972244|69550441|FG000|Overall Study|Incorrect Enrolment|1|||
37866937|NCT00972244|69550442|FG001|Overall Study|Incorrect Enrolment|0|||
37978922|NCT00482612|69665730|FG003|Follow-up Period|Reasons not related to trial|3|||
37978923|NCT00282568|69665744|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
37866938|NCT00972244|69550443|FG002|Overall Study|Incorrect Enrolment|0|||
37866939|NCT00972244|69550444|FG003|Overall Study|Incorrect Enrolment|0|||
37866940|NCT00972244|69550445|FG004|Overall Study|Incorrect Enrolment|0|||
37866941|NCT00972244|69550441|FG000|Overall Study|Adverse Event|0|||
37866942|NCT00972244|69550442|FG001|Overall Study|Adverse Event|1|||
37866943|NCT00972244|69550443|FG002|Overall Study|Adverse Event|1|||
37866944|NCT00972244|69550444|FG003|Overall Study|Adverse Event|0|||
37866945|NCT00972244|69550445|FG004|Overall Study|Adverse Event|0|||
37866946|NCT00972244|69550441|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
37866947|NCT00972244|69550442|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
37866948|NCT00972244|69550443|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
37866949|NCT00972244|69550444|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
37866950|NCT00972244|69550445|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
37866951|NCT00972244|69550441|FG000|Overall Study|Withdrawal by Subject|1|||
37866952|NCT00972244|69550442|FG001|Overall Study|Withdrawal by Subject|2|||
37866953|NCT00972244|69550443|FG002|Overall Study|Withdrawal by Subject|1|||
37866954|NCT00972244|69550444|FG003|Overall Study|Withdrawal by Subject|0|||
37978924|NCT00282568|69665744|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
37866955|NCT00972244|69550445|FG004|Overall Study|Withdrawal by Subject|1|||
37866956|NCT00972244|69550441|FG000|Overall Study|Safety|0|||
37866957|NCT00972244|69550442|FG001|Overall Study|Safety|0|||
37866958|NCT00972244|69550443|FG002|Overall Study|Safety|0|||
37866959|NCT00972244|69550444|FG003|Overall Study|Safety|0|||
37866960|NCT00972244|69550445|FG004|Overall Study|Safety|1|||
37866961|NCT00972244|69550441|FG000|Overall Study|Death|1|||
37866962|NCT00972244|69550442|FG001|Overall Study|Death|0|||
37978925|NCT00282568|69665744|FG000|Extended Treatment Period|Adverse Event|17|||
37978926|NCT00282568|69665744|FG000|Extended Treatment Period|Non-compliance|4|||
37978927|NCT00282568|69665744|FG000|Extended Treatment Period|Physician Decision|1|||
37978928|NCT00282568|69665744|FG000|Extended Treatment Period|Lost to Follow-up|2|||
37978929|NCT00265564|69665750|FG000|Overall Study|Lost to Follow-up|5|||
37978930|NCT00265564|69665751|FG001|Overall Study|Lost to Follow-up|7|||
37978931|NCT00265564|69665750|FG000|Overall Study|met exclusion criteria|5|||
37866963|NCT00972244|69550443|FG002|Overall Study|Death|0|||
37866964|NCT00972244|69550444|FG003|Overall Study|Death|0|||
37866965|NCT00972244|69550445|FG004|Overall Study|Death|0|||
37866966|NCT00972244|69550441|FG000|Overall Study|Various|0|||
37866967|NCT00972244|69550442|FG001|Overall Study|Various|0|||
37866968|NCT00972244|69550443|FG002|Overall Study|Various|0|||
37866969|NCT00972244|69550444|FG003|Overall Study|Various|0|||
37866970|NCT00972244|69550445|FG004|Overall Study|Various|2|||
37866971|NCT00892723|69550460|FG000|Overall Study|Lost to Follow-up|1|||
37866972|NCT00892723|69550461|FG001|Overall Study|Lost to Follow-up|3|||
37866973|NCT00892723|69550462|FG002|Overall Study|Lost to Follow-up|1|||
37866974|NCT00892723|69550460|FG000|Overall Study|Withdrawal by Subject|1|||
37866975|NCT00892723|69550461|FG001|Overall Study|Withdrawal by Subject|1|||
37866976|NCT00892723|69550462|FG002|Overall Study|Withdrawal by Subject|1|||
37866977|NCT03811912|69550505|FG000|Overall Study|Withdrew Consent|4|||
37866978|NCT03811912|69550506|FG001|Overall Study|Withdrew Consent|2|||
37866979|NCT00971932|69550512|FG000|Overall Study|Withdrawal by Subject|1|||
37866980|NCT00971932|69550512|FG000|Overall Study|Investigator's decision|2|||
37866981|NCT00971932|69550512|FG000|Overall Study|Ongoing|4|||
37866982|NCT00970684|69550516|FG000|Overall Study|Lack of Efficacy|5|||
37866983|NCT00970684|69550516|FG000|Overall Study|Adverse Event|4|||
37866984|NCT00970684|69550516|FG000|Overall Study|Withdrawal by Subject|1|||
37866985|NCT00967330|69550522|FG000|Overall Study|Protocol Violation|3|||
37866986|NCT00967330|69550523|FG001|Overall Study|Protocol Violation|4|||
37866987|NCT00967330|69550522|FG000|Overall Study|Regular|10|||
37866988|NCT00967330|69550523|FG001|Overall Study|Regular|3|||
37866989|NCT00967330|69550522|FG000|Overall Study|Withdrawal by Subject|6|||
37866990|NCT00967330|69550523|FG001|Overall Study|Withdrawal by Subject|0|||
37866991|NCT00967330|69550522|FG000|Overall Study|Lost to Follow-up|1|||
37866992|NCT00967330|69550523|FG001|Overall Study|Lost to Follow-up|1|||
37866993|NCT00967330|69550522|FG000|Overall Study|Death|102|||
37866994|NCT00967330|69550523|FG001|Overall Study|Death|51|||
37866995|NCT00967330|69550522|FG000|Overall Study|Severe protocol deviation|0|||
37866996|NCT00967330|69550523|FG001|Overall Study|Severe protocol deviation|1|||
37866997|NCT00967018|69550529|FG000|Overall Study|Adverse Event|2|||
37866998|NCT00967018|69550529|FG000|Overall Study|Physician Decision|7|||
37866999|NCT00967018|69550529|FG000|Overall Study|Lost to Follow-up|2|||
37867000|NCT00967018|69550529|FG000|Overall Study|Withdrawal by Subject|1|||
37867001|NCT00967018|69550529|FG000|Overall Study|Miscellaneous Reasons|9|||
37867002|NCT00965146|69550533|FG000|Overall Study|Death|7|||
37867003|NCT00965146|69550533|FG000|Overall Study|Lost to Follow-up|22|||
37867004|NCT00965146|69550533|FG000|Overall Study|Withdrawal by Subject|17|||
37978932|NCT00265564|69665751|FG001|Overall Study|met exclusion criteria|2|||
37814956|NCT03345342|69492886|FG002|Double-Blind Phase|Physician Decision|4|||
37814957|NCT03345342|69492887|FG003|Double-Blind Phase|Physician Decision|0|||
37814958|NCT03345342|69492888|FG004|Double-Blind Phase|Physician Decision|0|||
37814959|NCT03345342|69492884|FG000|Double-Blind Phase|Protocol Violation|0|||
37814960|NCT03345342|69492885|FG001|Double-Blind Phase|Protocol Violation|0|||
37814961|NCT03345342|69492886|FG002|Double-Blind Phase|Protocol Violation|1|||
37814962|NCT03345342|69492887|FG003|Double-Blind Phase|Protocol Violation|0|||
37814963|NCT03345342|69492888|FG004|Double-Blind Phase|Protocol Violation|0|||
37814964|NCT03345342|69492884|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
37814965|NCT03345342|69492885|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
37814966|NCT03345342|69492886|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
37814967|NCT03345342|69492887|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
37814968|NCT03345342|69492888|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
37814969|NCT03345342|69492884|FG000|Double-Blind Phase|Other|0|||
37814970|NCT03345342|69492885|FG001|Double-Blind Phase|Other|1|||
37814971|NCT03345342|69492886|FG002|Double-Blind Phase|Other|3|||
37814972|NCT03345342|69492887|FG003|Double-Blind Phase|Other|0|||
37814973|NCT03345342|69492888|FG004|Double-Blind Phase|Other|0|||
37814974|NCT03345342|69492884|FG000|Follow-Up Phase|Adverse Event|0|||
37814975|NCT03345342|69492885|FG001|Follow-Up Phase|Adverse Event|0|||
37814976|NCT03345342|69492886|FG002|Follow-Up Phase|Adverse Event|0|||
37814977|NCT03345342|69492887|FG003|Follow-Up Phase|Adverse Event|0|||
37814978|NCT03345342|69492888|FG004|Follow-Up Phase|Adverse Event|4|||
37814979|NCT03345342|69492884|FG000|Follow-Up Phase|Lost to Follow-up|0|||
37814980|NCT03345342|69492885|FG001|Follow-Up Phase|Lost to Follow-up|0|||
37814981|NCT03345342|69492886|FG002|Follow-Up Phase|Lost to Follow-up|0|||
37814982|NCT03345342|69492887|FG003|Follow-Up Phase|Lost to Follow-up|0|||
37814983|NCT03345342|69492888|FG004|Follow-Up Phase|Lost to Follow-up|6|||
37867005|NCT00965146|69550533|FG000|Overall Study|Unable to return|1|||
37867006|NCT00965146|69550533|FG000|Overall Study|Unwilling to return|11|||
37867007|NCT00965146|69550533|FG000|Overall Study|Intercurrent illness|1|||
37814984|NCT03345342|69492884|FG000|Follow-Up Phase|Physician Decision|0|||
37867008|NCT00965146|69550533|FG000|Overall Study|Revision / Removal of Study Implant|6|||
37867009|NCT00965146|69550533|FG000|Overall Study|Overall Study Termination|145|||
37867010|NCT00966940|69550539|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
37867011|NCT00966940|69550540|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
37867012|NCT00966940|69550539|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
37867013|NCT00966940|69550540|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
37867014|NCT00965848|69550546|FG000|Overall Study|Protocol Violation|3|||
37867015|NCT00965848|69550547|FG001|Overall Study|Protocol Violation|0|||
37867016|NCT00965848|69550548|FG002|Overall Study|Protocol Violation|1|||
37867017|NCT00965848|69550546|FG000|Overall Study|Death|11|||
37867018|NCT00965848|69550547|FG001|Overall Study|Death|1|||
37867019|NCT00965848|69550548|FG002|Overall Study|Death|5|||
37867020|NCT00965848|69550546|FG000|Overall Study|Lost to Follow-up|0|||
37867021|NCT00965848|69550547|FG001|Overall Study|Lost to Follow-up|0|||
37867022|NCT00965848|69550548|FG002|Overall Study|Lost to Follow-up|1|||
37814985|NCT03345342|69492885|FG001|Follow-Up Phase|Physician Decision|0|||
37867023|NCT00965848|69550546|FG000|Overall Study|Withdrawal by Subject|1|||
37867024|NCT00965848|69550547|FG001|Overall Study|Withdrawal by Subject|0|||
37867025|NCT00965848|69550548|FG002|Overall Study|Withdrawal by Subject|0|||
37867026|NCT00965848|69550546|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
37867027|NCT00965848|69550547|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
37978933|NCT00376623|69665760|FG000|Overall Study|Progressive disease|35|||
37978934|NCT00376623|69665761|FG001|Overall Study|Progressive disease|22|||
37978935|NCT00376623|69665762|FG002|Overall Study|Progressive disease|17|||
37978936|NCT00376623|69665760|FG000|Overall Study|Lost to Follow-up|0|||
37978937|NCT00376623|69665761|FG001|Overall Study|Lost to Follow-up|1|||
37978938|NCT00376623|69665762|FG002|Overall Study|Lost to Follow-up|0|||
37978939|NCT00376623|69665760|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
37867028|NCT00965848|69550548|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
37867029|NCT00965848|69550546|FG000|Overall Study|Not Clinically Evaluable|7|||
37867030|NCT00965848|69550547|FG001|Overall Study|Not Clinically Evaluable|1|||
37867031|NCT00965848|69550548|FG002|Overall Study|Not Clinically Evaluable|1|||
37867032|NCT00965848|69550546|FG000|Overall Study|Other|5|||
37867033|NCT00965848|69550547|FG001|Overall Study|Other|0|||
37867034|NCT00965848|69550548|FG002|Overall Study|Other|1|||
37867035|NCT00961636|69550559|FG000|Overall Study|Adverse Event|35|||
37867036|NCT00961636|69550560|FG001|Overall Study|Adverse Event|54|||
37867037|NCT00961636|69550561|FG002|Overall Study|Adverse Event|13|||
37867038|NCT00961636|69550559|FG000|Overall Study|Flushing Symptoms|29|||
37867039|NCT00961636|69550560|FG001|Overall Study|Flushing Symptoms|46|||
37867040|NCT00961636|69550561|FG002|Overall Study|Flushing Symptoms|3|||
37867041|NCT00961636|69550559|FG000|Overall Study|Lost to Follow-up|2|||
37867042|NCT00961636|69550560|FG001|Overall Study|Lost to Follow-up|3|||
37867043|NCT00961636|69550561|FG002|Overall Study|Lost to Follow-up|1|||
37867044|NCT00961636|69550559|FG000|Overall Study|Physician Decision|3|||
37867045|NCT00961636|69550560|FG001|Overall Study|Physician Decision|1|||
37867046|NCT00961636|69550561|FG002|Overall Study|Physician Decision|1|||
37978940|NCT00376623|69665761|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
37978941|NCT00376623|69665762|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
37814986|NCT03345342|69492886|FG002|Follow-Up Phase|Physician Decision|0|||
37814987|NCT03345342|69492887|FG003|Follow-Up Phase|Physician Decision|0|||
37814988|NCT03345342|69492888|FG004|Follow-Up Phase|Physician Decision|5|||
37814989|NCT03345342|69492884|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
37814990|NCT03345342|69492885|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
37814991|NCT03345342|69492886|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
37814992|NCT03345342|69492887|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
37814993|NCT03345342|69492888|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
37814994|NCT03345342|69492884|FG000|Follow-Up Phase|Other|0|||
37814995|NCT03345342|69492885|FG001|Follow-Up Phase|Other|0|||
37814996|NCT03345342|69492886|FG002|Follow-Up Phase|Other|0|||
37814997|NCT03345342|69492887|FG003|Follow-Up Phase|Other|3|||
37814998|NCT03345342|69492888|FG004|Follow-Up Phase|Other|1|||
37814999|NCT03192176|69492912|FG000|Overall Study|Adverse Event|1|||
37815000|NCT03192176|69492913|FG001|Overall Study|Adverse Event|0|||
37815001|NCT03192176|69492914|FG002|Overall Study|Adverse Event|4|||
37815002|NCT03192176|69492915|FG003|Overall Study|Adverse Event|5|||
37815003|NCT03192176|69492916|FG004|Overall Study|Adverse Event|3|||
37815004|NCT03192176|69492917|FG005|Overall Study|Adverse Event|2|||
37815005|NCT03192176|69492918|FG006|Overall Study|Adverse Event|3|||
37815006|NCT03192176|69492919|FG007|Overall Study|Adverse Event|3|||
37815007|NCT03192176|69492912|FG000|Overall Study|Lost to Follow-up|0|||
37867047|NCT00961636|69550559|FG000|Overall Study|Protocol Violation|9|||
37867048|NCT00961636|69550560|FG001|Overall Study|Protocol Violation|5|||
37867049|NCT00961636|69550561|FG002|Overall Study|Protocol Violation|1|||
37867050|NCT00961636|69550559|FG000|Overall Study|Withdrawal by Subject|29|||
37867051|NCT00961636|69550560|FG001|Overall Study|Withdrawal by Subject|22|||
37867052|NCT00961636|69550561|FG002|Overall Study|Withdrawal by Subject|13|||
37867053|NCT00964678|69550569|FG000|Overall Study|Physician Decision|4|||
37867054|NCT00964366|69550576|FG000|Overall Study|Did not qualify at Day 1|1|||
37867055|NCT00964366|69550577|FG001|Overall Study|Did not qualify at Day 1|0|||
37694796|NCT02485301|69171231|FG000|Overall Study|Withdrawal by Subject|6|||
37815008|NCT03192176|69492913|FG001|Overall Study|Lost to Follow-up|0|||
37815009|NCT03192176|69492914|FG002|Overall Study|Lost to Follow-up|1|||
37815010|NCT03192176|69492915|FG003|Overall Study|Lost to Follow-up|2|||
37815011|NCT03192176|69492916|FG004|Overall Study|Lost to Follow-up|3|||
37815012|NCT03192176|69492917|FG005|Overall Study|Lost to Follow-up|1|||
37815013|NCT03192176|69492918|FG006|Overall Study|Lost to Follow-up|1|||
37815014|NCT03192176|69492919|FG007|Overall Study|Lost to Follow-up|1|||
37815015|NCT03192176|69492912|FG000|Overall Study|Physician Decision|1|||
37815016|NCT03192176|69492913|FG001|Overall Study|Physician Decision|0|||
37815017|NCT03192176|69492914|FG002|Overall Study|Physician Decision|0|||
37978942|NCT00376623|69665760|FG000|Overall Study|Not treated with BI 2536|1|||
37978943|NCT00376623|69665761|FG001|Overall Study|Not treated with BI 2536|0|||
37978944|NCT00376623|69665762|FG002|Overall Study|Not treated with BI 2536|0|||
37978945|NCT00376623|69665760|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
37815018|NCT03192176|69492915|FG003|Overall Study|Physician Decision|0|||
37815019|NCT03192176|69492916|FG004|Overall Study|Physician Decision|0|||
37815020|NCT03192176|69492917|FG005|Overall Study|Physician Decision|2|||
37867056|NCT00964366|69550576|FG000|Overall Study|Withdrawal by Subject|0|||
37867057|NCT00964366|69550577|FG001|Overall Study|Withdrawal by Subject|1|||
37867058|NCT00960154|69550585|FG000|Overall Study|Study termination|25|||
37867059|NCT00960154|69550586|FG001|Overall Study|Study termination|25|||
37867060|NCT00960076|69550594|FG000|Overall Study|Adverse Event|1|||
37815021|NCT03192176|69492918|FG006|Overall Study|Physician Decision|1|||
37815022|NCT03192176|69492919|FG007|Overall Study|Physician Decision|0|||
37867061|NCT00960076|69550595|FG001|Overall Study|Adverse Event|7|||
37867062|NCT00960076|69550594|FG000|Overall Study|No longer met study criteria|1|||
37867063|NCT00960076|69550595|FG001|Overall Study|No longer met study criteria|5|||
37867064|NCT00960076|69550594|FG000|Overall Study|Withdrawal by Subject|1|||
37867065|NCT00960076|69550595|FG001|Overall Study|Withdrawal by Subject|2|||
37867066|NCT00960076|69550594|FG000|Overall Study|Lost to Follow-up|3|||
37867067|NCT00960076|69550595|FG001|Overall Study|Lost to Follow-up|3|||
37867068|NCT00960076|69550594|FG000|Overall Study|Severe non-compliance to protocol|1|||
37867069|NCT00960076|69550595|FG001|Overall Study|Severe non-compliance to protocol|2|||
37867070|NCT00960076|69550594|FG000|Overall Study|Hyperglycemia|1|||
37867071|NCT00960076|69550595|FG001|Overall Study|Hyperglycemia|5|||
37867072|NCT00960076|69550594|FG000|Overall Study|Did not attend the termination visit|0|||
37867073|NCT00960076|69550595|FG001|Overall Study|Did not attend the termination visit|1|||
37867074|NCT01227629|69550611|FG000|Overall Study|Adverse Event|2|||
37867075|NCT01227629|69550612|FG001|Overall Study|Adverse Event|2|||
37867076|NCT01227629|69550613|FG002|Overall Study|Adverse Event|1|||
37867077|NCT01227629|69550614|FG003|Overall Study|Adverse Event|6|||
37867078|NCT01227629|69550615|FG004|Overall Study|Adverse Event|1|||
37867079|NCT01227629|69550616|FG005|Overall Study|Adverse Event|1|||
37867080|NCT01227629|69550617|FG006|Overall Study|Adverse Event|6|||
37867081|NCT01227629|69550618|FG007|Overall Study|Adverse Event|6|||
37978946|NCT00376623|69665761|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
37978947|NCT00376623|69665762|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
38043778|NCT02101853|69731873|FG001|Post Induction Randomization|Protocol Violation|3|||
37815023|NCT03192176|69492912|FG000|Overall Study|Protocol Deviation|1|||
37815024|NCT03192176|69492913|FG001|Overall Study|Protocol Deviation|1|||
37815025|NCT03192176|69492914|FG002|Overall Study|Protocol Deviation|0|||
37867082|NCT01227629|69550619|FG008|Overall Study|Adverse Event|4|||
38043779|NCT02101853|69731874|FG002|Post Induction Randomization|Protocol Violation|0|||
37815026|NCT03192176|69492915|FG003|Overall Study|Protocol Deviation|0|||
37867083|NCT01227629|69550620|FG009|Overall Study|Adverse Event|0|||
37867084|NCT01227629|69550611|FG000|Overall Study|Protocol Violation|0|||
37867085|NCT01227629|69550612|FG001|Overall Study|Protocol Violation|0|||
38043780|NCT02101853|69731875|FG003|Post Induction Randomization|Protocol Violation|0|||
38043781|NCT02101853|69731876|FG004|Post Induction Randomization|Protocol Violation|0|||
38043782|NCT02101853|69731877|FG005|Post Induction Randomization|Protocol Violation|0|||
38043783|NCT02101853|69731872|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
38043784|NCT02101853|69731873|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
38043785|NCT02101853|69731874|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
38043786|NCT02101853|69731875|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
38043787|NCT02101853|69731876|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
38043788|NCT02101853|69731877|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
37867086|NCT01227629|69550613|FG002|Overall Study|Protocol Violation|0|||
37867087|NCT01227629|69550614|FG003|Overall Study|Protocol Violation|1|||
37867088|NCT01227629|69550615|FG004|Overall Study|Protocol Violation|0|||
37867089|NCT01227629|69550616|FG005|Overall Study|Protocol Violation|0|||
37867090|NCT01227629|69550617|FG006|Overall Study|Protocol Violation|0|||
37867091|NCT01227629|69550618|FG007|Overall Study|Protocol Violation|0|||
37867092|NCT01227629|69550619|FG008|Overall Study|Protocol Violation|0|||
37867093|NCT01227629|69550620|FG009|Overall Study|Protocol Violation|0|||
37867094|NCT01227629|69550611|FG000|Overall Study|Lost to Follow-up|0|||
37867095|NCT01227629|69550612|FG001|Overall Study|Lost to Follow-up|0|||
37867096|NCT01227629|69550613|FG002|Overall Study|Lost to Follow-up|0|||
37867097|NCT01227629|69550614|FG003|Overall Study|Lost to Follow-up|0|||
37867098|NCT01227629|69550615|FG004|Overall Study|Lost to Follow-up|1|||
37867099|NCT01227629|69550616|FG005|Overall Study|Lost to Follow-up|0|||
37867100|NCT01227629|69550617|FG006|Overall Study|Lost to Follow-up|0|||
37867101|NCT01227629|69550618|FG007|Overall Study|Lost to Follow-up|0|||
37867102|NCT01227629|69550619|FG008|Overall Study|Lost to Follow-up|0|||
37867103|NCT01227629|69550620|FG009|Overall Study|Lost to Follow-up|0|||
37867104|NCT01227629|69550611|FG000|Overall Study|Withdrawal by Subject|0|||
37867105|NCT01227629|69550612|FG001|Overall Study|Withdrawal by Subject|0|||
37867106|NCT01227629|69550613|FG002|Overall Study|Withdrawal by Subject|0|||
37867107|NCT01227629|69550614|FG003|Overall Study|Withdrawal by Subject|0|||
37867108|NCT01227629|69550615|FG004|Overall Study|Withdrawal by Subject|0|||
37867109|NCT01227629|69550616|FG005|Overall Study|Withdrawal by Subject|0|||
37867110|NCT01227629|69550617|FG006|Overall Study|Withdrawal by Subject|2|||
37867111|NCT01227629|69550618|FG007|Overall Study|Withdrawal by Subject|0|||
37867112|NCT01227629|69550619|FG008|Overall Study|Withdrawal by Subject|0|||
37867113|NCT01227629|69550620|FG009|Overall Study|Withdrawal by Subject|1|||
37867114|NCT01227629|69550611|FG000|Overall Study|Other|0|||
37867115|NCT01227629|69550612|FG001|Overall Study|Other|0|||
37867116|NCT01227629|69550613|FG002|Overall Study|Other|0|||
37867117|NCT01227629|69550614|FG003|Overall Study|Other|1|||
37867118|NCT01227629|69550615|FG004|Overall Study|Other|0|||
37867119|NCT01227629|69550616|FG005|Overall Study|Other|0|||
37867120|NCT01227629|69550617|FG006|Overall Study|Other|0|||
37867121|NCT01227629|69550618|FG007|Overall Study|Other|0|||
37867122|NCT01227629|69550619|FG008|Overall Study|Other|2|||
37867123|NCT01227629|69550620|FG009|Overall Study|Other|1|||
37867124|NCT00963820|69550666|FG000|Dose Escalation Phase|Progressive Disease|3|||
37867125|NCT00963820|69550667|FG001|Dose Escalation Phase|Progressive Disease|3|||
37867126|NCT00963820|69550668|FG002|Dose Escalation Phase|Progressive Disease|3|||
37867127|NCT00963820|69550669|FG003|Dose Escalation Phase|Progressive Disease|3|||
37867128|NCT00963820|69550670|FG004|Dose Escalation Phase|Progressive Disease|4|||
37978948|NCT00376623|69665760|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
37867129|NCT00963820|69550671|FG005|Dose Escalation Phase|Progressive Disease|3|||
37867130|NCT00963820|69550672|FG006|Dose Escalation Phase|Progressive Disease|3|||
37867131|NCT00963820|69550673|FG007|Dose Escalation Phase|Progressive Disease|2|||
37978949|NCT00376623|69665761|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
37867132|NCT00963820|69550674|FG008|Dose Escalation Phase|Progressive Disease|0|||
37867133|NCT00963820|69550675|FG009|Dose Escalation Phase|Progressive Disease|0|||
37867134|NCT00963820|69550676|FG010|Dose Escalation Phase|Progressive Disease|0|||
37867135|NCT00963820|69550677|FG011|Dose Escalation Phase|Progressive Disease|0|||
37867136|NCT00963820|69550666|FG000|Dose Escalation Phase|Adverse Event|0|||
37978950|NCT00376623|69665762|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
37867137|NCT00963820|69550667|FG001|Dose Escalation Phase|Adverse Event|0|||
37867138|NCT00963820|69550668|FG002|Dose Escalation Phase|Adverse Event|0|||
37867139|NCT00963820|69550669|FG003|Dose Escalation Phase|Adverse Event|0|||
37978951|NCT00376623|69665760|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
37978952|NCT00376623|69665761|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
37867140|NCT00963820|69550670|FG004|Dose Escalation Phase|Adverse Event|0|||
37867141|NCT00963820|69550671|FG005|Dose Escalation Phase|Adverse Event|0|||
37867142|NCT00963820|69550672|FG006|Dose Escalation Phase|Adverse Event|3|||
37867143|NCT00963820|69550673|FG007|Dose Escalation Phase|Adverse Event|1|||
37978953|NCT00376623|69665762|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
37978954|NCT00376623|69665760|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
37978955|NCT00376623|69665761|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
37978956|NCT00376623|69665762|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
37978957|NCT00376623|69665760|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
37867144|NCT00963820|69550674|FG008|Dose Escalation Phase|Adverse Event|0|||
37978958|NCT00376623|69665761|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
37978959|NCT00376623|69665762|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
37978960|NCT00376623|69665760|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
37978961|NCT00376623|69665761|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
37867145|NCT00963820|69550675|FG009|Dose Escalation Phase|Adverse Event|0|||
37867146|NCT00963820|69550676|FG010|Dose Escalation Phase|Adverse Event|0|||
37867147|NCT00963820|69550677|FG011|Dose Escalation Phase|Adverse Event|0|||
37867148|NCT00963820|69550666|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
37867149|NCT00963820|69550667|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
37867150|NCT00963820|69550668|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
37867151|NCT00963820|69550669|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
37867152|NCT00963820|69550670|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
37867153|NCT00963820|69550671|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
37867154|NCT00963820|69550672|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
37867155|NCT00963820|69550673|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
37867156|NCT00963820|69550674|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
37867157|NCT00963820|69550675|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
37867158|NCT00963820|69550676|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
37867159|NCT00963820|69550677|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
37867160|NCT00963820|69550666|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
37867161|NCT00963820|69550667|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
37867162|NCT00963820|69550668|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
37867163|NCT00963820|69550669|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
37867164|NCT00963820|69550670|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
37867165|NCT00963820|69550671|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
37867166|NCT00963820|69550672|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
37867167|NCT00963820|69550673|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
37867168|NCT00963820|69550674|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
37867169|NCT00963820|69550675|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
37867170|NCT00963820|69550676|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
37867171|NCT00963820|69550677|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
37867172|NCT00963820|69550666|FG000|Expansion Phase|Progressive Disease|0|||
37867173|NCT00963820|69550667|FG001|Expansion Phase|Progressive Disease|0|||
37867174|NCT00963820|69550668|FG002|Expansion Phase|Progressive Disease|0|||
37867175|NCT00963820|69550669|FG003|Expansion Phase|Progressive Disease|0|||
37867176|NCT00963820|69550670|FG004|Expansion Phase|Progressive Disease|0|||
37867177|NCT00963820|69550671|FG005|Expansion Phase|Progressive Disease|0|||
37867178|NCT00963820|69550672|FG006|Expansion Phase|Progressive Disease|0|||
37867179|NCT00963820|69550673|FG007|Expansion Phase|Progressive Disease|0|||
37867180|NCT00963820|69550674|FG008|Expansion Phase|Progressive Disease|8|||
37867181|NCT00963820|69550675|FG009|Expansion Phase|Progressive Disease|6|||
37867182|NCT00963820|69550676|FG010|Expansion Phase|Progressive Disease|4|||
37867183|NCT00963820|69550677|FG011|Expansion Phase|Progressive Disease|2|||
37867184|NCT00963820|69550666|FG000|Expansion Phase|Adverse Event|0|||
37867185|NCT00963820|69550667|FG001|Expansion Phase|Adverse Event|0|||
37867186|NCT00963820|69550668|FG002|Expansion Phase|Adverse Event|0|||
37867187|NCT00963820|69550669|FG003|Expansion Phase|Adverse Event|0|||
37867188|NCT00963820|69550670|FG004|Expansion Phase|Adverse Event|0|||
37867189|NCT00963820|69550671|FG005|Expansion Phase|Adverse Event|0|||
37867190|NCT00963820|69550672|FG006|Expansion Phase|Adverse Event|0|||
37867191|NCT00963820|69550673|FG007|Expansion Phase|Adverse Event|0|||
37867192|NCT00963820|69550674|FG008|Expansion Phase|Adverse Event|1|||
37867193|NCT00963820|69550675|FG009|Expansion Phase|Adverse Event|3|||
37867194|NCT00963820|69550676|FG010|Expansion Phase|Adverse Event|0|||
37867195|NCT00963820|69550677|FG011|Expansion Phase|Adverse Event|0|||
37694797|NCT02485301|69171232|FG001|Overall Study|Withdrawal by Subject|7|||
37815027|NCT03192176|69492916|FG004|Overall Study|Protocol Deviation|2|||
37867196|NCT00963820|69550666|FG000|Expansion Phase|Withdrawal by Subject|0|||
37867197|NCT00963820|69550667|FG001|Expansion Phase|Withdrawal by Subject|0|||
37867198|NCT00963820|69550668|FG002|Expansion Phase|Withdrawal by Subject|0|||
37867199|NCT00963820|69550669|FG003|Expansion Phase|Withdrawal by Subject|0|||
37978962|NCT00376623|69665762|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
37978963|NCT00376623|69665760|FG000|Overall Study|Increase of tumour markers|0|||
37978964|NCT00376623|69665761|FG001|Overall Study|Increase of tumour markers|1|||
37815028|NCT03192176|69492917|FG005|Overall Study|Protocol Deviation|0|||
37815029|NCT03192176|69492918|FG006|Overall Study|Protocol Deviation|0|||
37815030|NCT03192176|69492919|FG007|Overall Study|Protocol Deviation|0|||
37815031|NCT03192176|69492912|FG000|Overall Study|Withdrawal by Subject|3|||
37815032|NCT03192176|69492913|FG001|Overall Study|Withdrawal by Subject|4|||
37815033|NCT03192176|69492914|FG002|Overall Study|Withdrawal by Subject|0|||
37815034|NCT03192176|69492915|FG003|Overall Study|Withdrawal by Subject|4|||
37815035|NCT03192176|69492916|FG004|Overall Study|Withdrawal by Subject|3|||
37815036|NCT03192176|69492917|FG005|Overall Study|Withdrawal by Subject|4|||
37815037|NCT03192176|69492918|FG006|Overall Study|Withdrawal by Subject|4|||
37815038|NCT03192176|69492919|FG007|Overall Study|Withdrawal by Subject|2|||
37815039|NCT03192176|69492912|FG000|Overall Study|Miscellaneous|1|||
37815040|NCT03192176|69492913|FG001|Overall Study|Miscellaneous|0|||
37815041|NCT03192176|69492914|FG002|Overall Study|Miscellaneous|1|||
37815042|NCT03192176|69492915|FG003|Overall Study|Miscellaneous|1|||
37815043|NCT03192176|69492916|FG004|Overall Study|Miscellaneous|1|||
37815044|NCT03192176|69492917|FG005|Overall Study|Miscellaneous|2|||
37815045|NCT03192176|69492918|FG006|Overall Study|Miscellaneous|0|||
37815046|NCT03192176|69492919|FG007|Overall Study|Miscellaneous|1|||
37815047|NCT02795156|69492946|FG000|Overall Study|Progressive Disease|22|||
37815048|NCT02795156|69492947|FG001|Overall Study|Progressive Disease|7|||
37815049|NCT02795156|69492948|FG002|Overall Study|Progressive Disease|34|||
37815050|NCT02795156|69492949|FG003|Overall Study|Progressive Disease|7|||
37815051|NCT02795156|69492946|FG000|Overall Study|Adverse Event|13|||
37867200|NCT00963820|69550670|FG004|Expansion Phase|Withdrawal by Subject|0|||
37694798|NCT02485301|69171231|FG000|Overall Study|Migrated/moved from study area|10|||
37815052|NCT02795156|69492947|FG001|Overall Study|Adverse Event|2|||
37815053|NCT02795156|69492948|FG002|Overall Study|Adverse Event|3|||
37815054|NCT02795156|69492949|FG003|Overall Study|Adverse Event|2|||
37867201|NCT00963820|69550671|FG005|Expansion Phase|Withdrawal by Subject|0|||
37867202|NCT00963820|69550672|FG006|Expansion Phase|Withdrawal by Subject|0|||
37867203|NCT00963820|69550673|FG007|Expansion Phase|Withdrawal by Subject|0|||
37867204|NCT00963820|69550674|FG008|Expansion Phase|Withdrawal by Subject|1|||
37867205|NCT00963820|69550675|FG009|Expansion Phase|Withdrawal by Subject|0|||
37867206|NCT00963820|69550676|FG010|Expansion Phase|Withdrawal by Subject|1|||
37978965|NCT00376623|69665762|FG002|Overall Study|Increase of tumour markers|0|||
37978966|NCT00376623|69665760|FG000|Overall Study|Bone metastasis|1|||
37978967|NCT00376623|69665761|FG001|Overall Study|Bone metastasis|0|||
37978968|NCT00376623|69665762|FG002|Overall Study|Bone metastasis|0|||
37815055|NCT02795156|69492946|FG000|Overall Study|Death|1|||
37815056|NCT02795156|69492947|FG001|Overall Study|Death|1|||
37815057|NCT02795156|69492948|FG002|Overall Study|Death|1|||
37815058|NCT02795156|69492949|FG003|Overall Study|Death|0|||
37815059|NCT02795156|69492946|FG000|Overall Study|Physician Decision|1|||
37815060|NCT02795156|69492947|FG001|Overall Study|Physician Decision|0|||
37815061|NCT02795156|69492948|FG002|Overall Study|Physician Decision|1|||
37815062|NCT02795156|69492949|FG003|Overall Study|Physician Decision|0|||
37815063|NCT02795156|69492946|FG000|Overall Study|Withdrawal by Subject|2|||
37815064|NCT02795156|69492947|FG001|Overall Study|Withdrawal by Subject|0|||
37815065|NCT02795156|69492948|FG002|Overall Study|Withdrawal by Subject|3|||
37815066|NCT02795156|69492949|FG003|Overall Study|Withdrawal by Subject|0|||
37815067|NCT02531594|69492980|FG000|Overall Study|Withdrawal by Subject|7|||
37815068|NCT02531594|69492981|FG001|Overall Study|Withdrawal by Subject|8|||
37815069|NCT02365467|69492996|FG000|Overall Study|Death|3|||
37815070|NCT01256593|69493009|FG000|Overall Study|Protocol Violation|26|||
37815071|NCT01256593|69493009|FG000|Overall Study|No Drug Administration Information|2|||
37815072|NCT01256593|69493009|FG000|Overall Study|No Visit After Treatment|186|||
37815073|NCT00562640|69493027|FG000|Overall Study|Death|0|||
37815074|NCT00562640|69493028|FG001|Overall Study|Death|1|||
37815075|NCT00562640|69493029|FG002|Overall Study|Death|1|||
37815076|NCT00562640|69493030|FG003|Overall Study|Death|0|||
37815077|NCT04554394|69493055|FG000|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
37815078|NCT04554394|69493056|FG001|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
37815079|NCT04554394|69493055|FG000|Overall Study|Withdrawal by Subject|2|||
37815080|NCT04554394|69493056|FG001|Overall Study|Withdrawal by Subject|2|||
37815081|NCT04554394|69493055|FG000|Overall Study|Lost to Follow-up|2|||
37815082|NCT04554394|69493056|FG001|Overall Study|Lost to Follow-up|2|||
37815083|NCT04554394|69493055|FG000|Overall Study|Physician Decision|1|||
37815084|NCT04554394|69493056|FG001|Overall Study|Physician Decision|1|||
37815085|NCT04518410|69493086|FG000|Overall Study|Lost to Follow-up|1|||
37815086|NCT04518410|69493087|FG001|Overall Study|Lost to Follow-up|1|||
37815087|NCT04518410|69493088|FG002|Overall Study|Lost to Follow-up|8|||
37815088|NCT04518410|69493089|FG003|Overall Study|Lost to Follow-up|5|||
37815089|NCT04518410|69493090|FG004|Overall Study|Lost to Follow-up|92|||
37815090|NCT04518410|69493091|FG005|Overall Study|Lost to Follow-up|27|||
37815091|NCT04518410|69493092|FG006|Overall Study|Lost to Follow-up|26|||
37867207|NCT00963820|69550677|FG011|Expansion Phase|Withdrawal by Subject|1|||
37978969|NCT00445692|69665776|FG000|Overall Study|Adverse Event|11|||
37815092|NCT04518410|69493093|FG007|Overall Study|Lost to Follow-up|3|||
37815093|NCT04518410|69493094|FG008|Overall Study|Lost to Follow-up|2|||
37815094|NCT04518410|69493095|FG009|Overall Study|Lost to Follow-up|15|||
37815095|NCT04518410|69493096|FG010|Overall Study|Lost to Follow-up|9|||
37815096|NCT04518410|69493097|FG011|Overall Study|Lost to Follow-up|13|||
37815097|NCT04518410|69493098|FG012|Overall Study|Lost to Follow-up|9|||
37815098|NCT04518410|69493099|FG013|Overall Study|Lost to Follow-up|14|||
37815099|NCT04518410|69493100|FG014|Overall Study|Lost to Follow-up|8|||
37815100|NCT04518410|69493101|FG015|Overall Study|Lost to Follow-up|10|||
37815101|NCT04518410|69493102|FG016|Overall Study|Lost to Follow-up|6|||
37815102|NCT04518410|69493103|FG017|Overall Study|Lost to Follow-up|8|||
37815103|NCT04518410|69493104|FG018|Overall Study|Lost to Follow-up|20|||
37815104|NCT04518410|69493105|FG019|Overall Study|Lost to Follow-up|6|||
37815105|NCT04518410|69493106|FG020|Overall Study|Lost to Follow-up|4|||
37815106|NCT04518410|69493107|FG021|Overall Study|Lost to Follow-up|22|||
37815107|NCT04518410|69493108|FG022|Overall Study|Lost to Follow-up|1|||
37815108|NCT04518410|69493109|FG023|Overall Study|Lost to Follow-up|7|||
37815109|NCT04518410|69493110|FG024|Overall Study|Lost to Follow-up|6|||
37815110|NCT04518410|69493086|FG000|Overall Study|Withdrawal by Subject|1|||
37815111|NCT04518410|69493087|FG001|Overall Study|Withdrawal by Subject|2|||
37978970|NCT00445692|69665776|FG000|Overall Study|Lack of Efficacy|5|||
37978971|NCT03824236|69665785|FG000|Overall Study|Lost to Follow-up|0|||
37815112|NCT04518410|69493088|FG002|Overall Study|Withdrawal by Subject|2|||
37815113|NCT04518410|69493089|FG003|Overall Study|Withdrawal by Subject|3|||
37815114|NCT04518410|69493090|FG004|Overall Study|Withdrawal by Subject|20|||
37815115|NCT04518410|69493091|FG005|Overall Study|Withdrawal by Subject|21|||
37815116|NCT04518410|69493092|FG006|Overall Study|Withdrawal by Subject|27|||
37815117|NCT04518410|69493093|FG007|Overall Study|Withdrawal by Subject|6|||
37815118|NCT04518410|69493094|FG008|Overall Study|Withdrawal by Subject|2|||
37815119|NCT04518410|69493095|FG009|Overall Study|Withdrawal by Subject|12|||
37815120|NCT04518410|69493096|FG010|Overall Study|Withdrawal by Subject|6|||
37815121|NCT04518410|69493097|FG011|Overall Study|Withdrawal by Subject|7|||
37815122|NCT04518410|69493098|FG012|Overall Study|Withdrawal by Subject|2|||
37815123|NCT04518410|69493099|FG013|Overall Study|Withdrawal by Subject|13|||
37815124|NCT04518410|69493100|FG014|Overall Study|Withdrawal by Subject|4|||
37815125|NCT04518410|69493101|FG015|Overall Study|Withdrawal by Subject|9|||
37815126|NCT04518410|69493102|FG016|Overall Study|Withdrawal by Subject|0|||
37815127|NCT04518410|69493103|FG017|Overall Study|Withdrawal by Subject|14|||
37815128|NCT04518410|69493104|FG018|Overall Study|Withdrawal by Subject|13|||
37815129|NCT04518410|69493105|FG019|Overall Study|Withdrawal by Subject|9|||
37815130|NCT04518410|69493106|FG020|Overall Study|Withdrawal by Subject|13|||
37815131|NCT04518410|69493107|FG021|Overall Study|Withdrawal by Subject|3|||
37815132|NCT04518410|69493108|FG022|Overall Study|Withdrawal by Subject|2|||
37815133|NCT04518410|69493109|FG023|Overall Study|Withdrawal by Subject|9|||
37815134|NCT04518410|69493110|FG024|Overall Study|Withdrawal by Subject|8|||
37815135|NCT04518410|69493086|FG000|Overall Study|Other|1|||
37815136|NCT04518410|69493087|FG001|Overall Study|Other|0|||
37815137|NCT04518410|69493088|FG002|Overall Study|Other|0|||
37815138|NCT04518410|69493089|FG003|Overall Study|Other|1|||
37815139|NCT04518410|69493090|FG004|Overall Study|Other|6|||
37815140|NCT04518410|69493091|FG005|Overall Study|Other|6|||
37815141|NCT04518410|69493092|FG006|Overall Study|Other|5|||
37815142|NCT04518410|69493093|FG007|Overall Study|Other|2|||
37815143|NCT04518410|69493094|FG008|Overall Study|Other|0|||
37815144|NCT04518410|69493095|FG009|Overall Study|Other|1|||
37978972|NCT03824236|69665786|FG001|Overall Study|Lost to Follow-up|0|||
37978973|NCT03824236|69665787|FG002|Overall Study|Lost to Follow-up|1|||
37815145|NCT04518410|69493096|FG010|Overall Study|Other|0|||
37815146|NCT04518410|69493097|FG011|Overall Study|Other|2|||
37867208|NCT00963820|69550666|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
37867209|NCT00963820|69550667|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
37867210|NCT00963820|69550668|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
37815147|NCT04518410|69493098|FG012|Overall Study|Other|0|||
37867211|NCT00963820|69550669|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
37867212|NCT00963820|69550670|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
37867213|NCT00963820|69550671|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
37867214|NCT00963820|69550672|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
37867215|NCT00963820|69550673|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
37867216|NCT00963820|69550674|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
37867217|NCT00963820|69550675|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
37867218|NCT00963820|69550676|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
37867219|NCT00963820|69550677|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
37867220|NCT01227395|69550696|FG000|Overall Study|Protocol Violation|0|||
37867221|NCT01227395|69550697|FG001|Overall Study|Protocol Violation|1|||
37867222|NCT01226459|69550724|FG000|Overall Study|Adverse Event|2|||
37867223|NCT01226459|69550725|FG001|Overall Study|Adverse Event|8|||
37978974|NCT00282412|69665795|FG000|Overall Study|Death|2|||
37978975|NCT00282334|69665801|FG000|Overall Study|Withdrawal by Subject|8|||
37978976|NCT00282334|69665802|FG001|Overall Study|Withdrawal by Subject|5|||
37978977|NCT00282256|69665808|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
37978978|NCT00282256|69665808|FG000|Extension Treatment Period|Adverse Event|2|||
37815148|NCT04518410|69493099|FG013|Overall Study|Other|0|||
37815149|NCT04518410|69493100|FG014|Overall Study|Other|0|||
37815150|NCT04518410|69493101|FG015|Overall Study|Other|3|||
37815151|NCT04518410|69493102|FG016|Overall Study|Other|1|||
37815152|NCT04518410|69493103|FG017|Overall Study|Other|1|||
37815153|NCT04518410|69493104|FG018|Overall Study|Other|1|||
37815154|NCT04518410|69493105|FG019|Overall Study|Other|0|||
37815155|NCT04518410|69493106|FG020|Overall Study|Other|0|||
37815156|NCT04518410|69493107|FG021|Overall Study|Other|0|||
37815157|NCT04518410|69493108|FG022|Overall Study|Other|1|||
37867224|NCT01226459|69550724|FG000|Overall Study|Protocol Violation|4|||
37867225|NCT01226459|69550725|FG001|Overall Study|Protocol Violation|3|||
37867226|NCT01226459|69550724|FG000|Overall Study|Withdrawal by Subject|10|||
37867227|NCT01226459|69550725|FG001|Overall Study|Withdrawal by Subject|13|||
37867228|NCT01226459|69550724|FG000|Overall Study|Lost to Follow-up|4|||
37867229|NCT01226459|69550725|FG001|Overall Study|Lost to Follow-up|8|||
37867230|NCT01226459|69550724|FG000|Overall Study|Pregnancy|1|||
37867231|NCT01226459|69550725|FG001|Overall Study|Pregnancy|0|||
37867232|NCT01225991|69550731|FG000|Overall Study|Withdrawal by Subject|6|||
37978979|NCT00265330|69665812|FG000|Overall Study|Adverse Event|41|||
37978980|NCT00265330|69665812|FG000|Overall Study|Lost to Follow-up|8|||
37978981|NCT00265330|69665812|FG000|Overall Study|Withdrawal by Subject|34|||
37978982|NCT00265330|69665812|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
37978983|NCT00265330|69665812|FG000|Overall Study|Lack of Efficacy|4|||
37978984|NCT00265330|69665812|FG000|Overall Study|Family Scheduling Conflicts|1|||
37978985|NCT00265330|69665812|FG000|Overall Study|Began Taking Formulary Geodon|1|||
37978986|NCT00265330|69665812|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
37978987|NCT00265330|69665812|FG000|Overall Study|Site Closed by Sponsor|1|||
37978988|NCT00265330|69665812|FG000|Overall Study|Principal Investigators Request|1|||
37978989|NCT00265330|69665812|FG000|Overall Study|Withdrew Consent|1|||
37978990|NCT00265330|69665812|FG000|Overall Study|Protocol Violation|1|||
37978991|NCT00292318|69665818|FG000|Overall Study|Study terminated by officials|2|||
37978992|NCT00292318|69665819|FG001|Overall Study|Study terminated by officials|1|||
37978993|NCT00281632|69665825|FG000|Overall Study|Adverse Event|7|||
37978994|NCT00281632|69665825|FG000|Overall Study|Withdrawal by Subject|2|||
37978995|NCT00281632|69665825|FG000|Overall Study|Disease Progression|22|||
37978996|NCT00281632|69665825|FG000|Overall Study|Death|1|||
37978997|NCT00281632|69665825|FG000|Overall Study|Physician Decision|1|||
37978998|NCT00281632|69665825|FG000|Overall Study|Ongoing|3|||
37978999|NCT00543569|69665841|FG000|Overall Study|Death|2|||
37979000|NCT00543569|69665842|FG001|Overall Study|Death|2|||
37979001|NCT00543569|69665843|FG002|Overall Study|Death|3|||
37979002|NCT00543569|69665844|FG003|Overall Study|Death|1|||
37979003|NCT00543569|69665841|FG000|Overall Study|Lost to Follow-up|0|||
37979004|NCT00543569|69665842|FG001|Overall Study|Lost to Follow-up|0|||
37979005|NCT00543569|69665843|FG002|Overall Study|Lost to Follow-up|1|||
37979006|NCT00543569|69665844|FG003|Overall Study|Lost to Follow-up|1|||
37979007|NCT00543569|69665841|FG000|Overall Study|Miscellaneous Reasons|7|||
37979008|NCT00543569|69665842|FG001|Overall Study|Miscellaneous Reasons|3|||
37979009|NCT00543569|69665843|FG002|Overall Study|Miscellaneous Reasons|11|||
37979010|NCT00543569|69665844|FG003|Overall Study|Miscellaneous Reasons|4|||
37979011|NCT00543569|69665841|FG000|Overall Study|Randomized but never received study drug|3|||
37815158|NCT04518410|69493109|FG023|Overall Study|Other|2|||
37815159|NCT04518410|69493110|FG024|Overall Study|Other|2|||
37815160|NCT04518410|69493086|FG000|Overall Study|Protocol Violation|0|||
37815161|NCT04518410|69493087|FG001|Overall Study|Protocol Violation|0|||
37815162|NCT04518410|69493088|FG002|Overall Study|Protocol Violation|0|||
37815163|NCT04518410|69493089|FG003|Overall Study|Protocol Violation|2|||
37815164|NCT04518410|69493090|FG004|Overall Study|Protocol Violation|17|||
37867233|NCT00959374|69550735|FG000|Overall Study|Withdrawal by Subject|2|||
37867234|NCT00959374|69550735|FG000|Overall Study|Lost to Follow-up|14|||
37867235|NCT00959374|69550735|FG000|Overall Study|Death|1|||
37867236|NCT00959374|69550735|FG000|Overall Study|Protocol Violation|1|||
37867237|NCT00959374|69550735|FG000|Overall Study|Implant Removed/Not Replaced|4|||
37867238|NCT00959374|69550735|FG000|Overall Study|Physician Decision|1|||
37867239|NCT01225835|69550745|FG000|Overall Study|Completed protocol|2|||
37867240|NCT01225835|69550746|FG001|Overall Study|Completed protocol|1|||
37867241|NCT01225835|69550745|FG000|Overall Study|Did not meet hCG criterion|2|||
37867242|NCT01225835|69550746|FG001|Overall Study|Did not meet hCG criterion|0|||
37867243|NCT01225835|69550745|FG000|Overall Study|Adverse Event|2|||
37815165|NCT04518410|69493091|FG005|Overall Study|Protocol Violation|1|||
37815166|NCT04518410|69493092|FG006|Overall Study|Protocol Violation|2|||
37815167|NCT04518410|69493093|FG007|Overall Study|Protocol Violation|1|||
37815168|NCT04518410|69493094|FG008|Overall Study|Protocol Violation|0|||
37815169|NCT04518410|69493095|FG009|Overall Study|Protocol Violation|0|||
37867244|NCT01225835|69550746|FG001|Overall Study|Adverse Event|1|||
37979012|NCT00543569|69665842|FG001|Overall Study|Randomized but never received study drug|3|||
37979013|NCT00543569|69665843|FG002|Overall Study|Randomized but never received study drug|5|||
37979014|NCT00543569|69665844|FG003|Overall Study|Randomized but never received study drug|3|||
37979015|NCT00445458|69665858|FG000|Overall Study|Disease Progression|3|||
37979016|NCT00445458|69665859|FG001|Overall Study|Disease Progression|4|||
37979017|NCT00445458|69665860|FG002|Overall Study|Disease Progression|54|||
37815170|NCT04518410|69493096|FG010|Overall Study|Protocol Violation|0|||
37815171|NCT04518410|69493097|FG011|Overall Study|Protocol Violation|0|||
37815172|NCT04518410|69493098|FG012|Overall Study|Protocol Violation|0|||
37815173|NCT04518410|69493099|FG013|Overall Study|Protocol Violation|0|||
37867245|NCT01225835|69550745|FG000|Overall Study|Other|1|||
37867246|NCT01225835|69550746|FG001|Overall Study|Other|1|||
37867247|NCT00962650|69550758|FG000|Overall Study|Transgastric DP was not completed|2|||
37867248|NCT00958828|69550766|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
37867249|NCT00958828|69550767|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
37867250|NCT00958828|69550766|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
37979018|NCT00445458|69665861|FG003|Overall Study|Disease Progression|27|||
37979019|NCT00445458|69665858|FG000|Overall Study|Withdrawal by Subject|0|||
37979020|NCT00445458|69665859|FG001|Overall Study|Withdrawal by Subject|0|||
37979021|NCT00445458|69665860|FG002|Overall Study|Withdrawal by Subject|7|||
37979022|NCT00445458|69665861|FG003|Overall Study|Withdrawal by Subject|0|||
37979023|NCT00445458|69665858|FG000|Overall Study|Adverse Event|0|||
37979024|NCT00445458|69665859|FG001|Overall Study|Adverse Event|0|||
37979025|NCT00445458|69665860|FG002|Overall Study|Adverse Event|3|||
37979026|NCT00445458|69665861|FG003|Overall Study|Adverse Event|0|||
37979027|NCT00445458|69665858|FG000|Overall Study|Death|0|||
37979028|NCT00445458|69665859|FG001|Overall Study|Death|1|||
37979029|NCT00445458|69665860|FG002|Overall Study|Death|2|||
37979030|NCT00445458|69665861|FG003|Overall Study|Death|0|||
37979031|NCT00445458|69665858|FG000|Overall Study|Physician Decision|0|||
37979032|NCT00445458|69665859|FG001|Overall Study|Physician Decision|0|||
37867251|NCT00958828|69550767|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
37867252|NCT00960934|69550779|FG000|Overall Study|Adverse Event|2|||
37867253|NCT00960934|69550780|FG001|Overall Study|Adverse Event|3|||
37867254|NCT00960934|69550781|FG002|Overall Study|Adverse Event|3|||
37867255|NCT00960934|69550782|FG003|Overall Study|Adverse Event|2|||
37867256|NCT00960934|69550783|FG004|Overall Study|Adverse Event|4|||
37867257|NCT00960934|69550784|FG005|Overall Study|Adverse Event|3|||
37867258|NCT00960934|69550779|FG000|Overall Study|Lack of Efficacy|1|||
37867259|NCT00960934|69550780|FG001|Overall Study|Lack of Efficacy|0|||
37867260|NCT00960934|69550781|FG002|Overall Study|Lack of Efficacy|0|||
37867261|NCT00960934|69550782|FG003|Overall Study|Lack of Efficacy|0|||
37867262|NCT00960934|69550783|FG004|Overall Study|Lack of Efficacy|0|||
37867263|NCT00960934|69550784|FG005|Overall Study|Lack of Efficacy|0|||
37867264|NCT00960934|69550779|FG000|Overall Study|Lost to Follow-up|0|||
37867265|NCT00960934|69550780|FG001|Overall Study|Lost to Follow-up|1|||
37867266|NCT00960934|69550781|FG002|Overall Study|Lost to Follow-up|0|||
37867267|NCT00960934|69550782|FG003|Overall Study|Lost to Follow-up|0|||
37867268|NCT00960934|69550783|FG004|Overall Study|Lost to Follow-up|0|||
37867269|NCT00960934|69550784|FG005|Overall Study|Lost to Follow-up|0|||
37867270|NCT00960934|69550779|FG000|Overall Study|Other|2|||
37867271|NCT00960934|69550780|FG001|Overall Study|Other|1|||
37867272|NCT00960934|69550781|FG002|Overall Study|Other|5|||
37867273|NCT00960934|69550782|FG003|Overall Study|Other|4|||
37867274|NCT00960934|69550783|FG004|Overall Study|Other|2|||
37815174|NCT04518410|69493100|FG014|Overall Study|Protocol Violation|0|||
37815175|NCT04518410|69493101|FG015|Overall Study|Protocol Violation|0|||
37815176|NCT04518410|69493102|FG016|Overall Study|Protocol Violation|1|||
37867275|NCT00960934|69550784|FG005|Overall Study|Other|2|||
37867276|NCT00960934|69550779|FG000|Overall Study|Physician Decision|0|||
37867277|NCT00960934|69550780|FG001|Overall Study|Physician Decision|1|||
37867278|NCT00960934|69550781|FG002|Overall Study|Physician Decision|0|||
37867279|NCT00960934|69550782|FG003|Overall Study|Physician Decision|0|||
37867280|NCT00960934|69550783|FG004|Overall Study|Physician Decision|0|||
37867281|NCT00960934|69550784|FG005|Overall Study|Physician Decision|0|||
37867282|NCT00960934|69550779|FG000|Overall Study|Progressive Disease|1|||
37867283|NCT00960934|69550780|FG001|Overall Study|Progressive Disease|1|||
37979033|NCT00445458|69665860|FG002|Overall Study|Physician Decision|1|||
37979034|NCT00445458|69665861|FG003|Overall Study|Physician Decision|1|||
37815177|NCT04518410|69493103|FG017|Overall Study|Protocol Violation|1|||
37867284|NCT00960934|69550781|FG002|Overall Study|Progressive Disease|0|||
37867285|NCT00960934|69550782|FG003|Overall Study|Progressive Disease|0|||
37867286|NCT00960934|69550783|FG004|Overall Study|Progressive Disease|1|||
37867287|NCT00960934|69550784|FG005|Overall Study|Progressive Disease|1|||
37979035|NCT00445458|69665858|FG000|Overall Study|Surgery|0|||
37979036|NCT00445458|69665859|FG001|Overall Study|Surgery|0|||
37815178|NCT04518410|69493104|FG018|Overall Study|Protocol Violation|0|||
37815179|NCT04518410|69493105|FG019|Overall Study|Protocol Violation|0|||
37815180|NCT04518410|69493106|FG020|Overall Study|Protocol Violation|1|||
37815181|NCT04518410|69493107|FG021|Overall Study|Protocol Violation|2|||
37815182|NCT04518410|69493108|FG022|Overall Study|Protocol Violation|0|||
37867288|NCT00960934|69550779|FG000|Overall Study|Protocol Violation|3|||
37867289|NCT00960934|69550780|FG001|Overall Study|Protocol Violation|4|||
37815183|NCT04518410|69493109|FG023|Overall Study|Protocol Violation|3|||
37815184|NCT04518410|69493110|FG024|Overall Study|Protocol Violation|0|||
37867290|NCT00960934|69550781|FG002|Overall Study|Protocol Violation|0|||
37815185|NCT04518410|69493086|FG000|Overall Study|Death|0|||
37979037|NCT00445458|69665860|FG002|Overall Study|Surgery|1|||
37979038|NCT00445458|69665861|FG003|Overall Study|Surgery|0|||
37979039|NCT03914417|69665874|FG000|Overall Study|Withdrawal by Subject|2|||
37867291|NCT00960934|69550782|FG003|Overall Study|Protocol Violation|3|||
37867292|NCT00960934|69550783|FG004|Overall Study|Protocol Violation|3|||
37867293|NCT00960934|69550784|FG005|Overall Study|Protocol Violation|2|||
37867294|NCT00960934|69550779|FG000|Overall Study|Withdrawal by Subject|5|||
37867295|NCT00960934|69550780|FG001|Overall Study|Withdrawal by Subject|6|||
37867296|NCT00960934|69550781|FG002|Overall Study|Withdrawal by Subject|4|||
37867297|NCT00960934|69550782|FG003|Overall Study|Withdrawal by Subject|5|||
37867298|NCT00960934|69550783|FG004|Overall Study|Withdrawal by Subject|5|||
37867299|NCT00960934|69550784|FG005|Overall Study|Withdrawal by Subject|7|||
37867300|NCT00960934|69550779|FG000|Overall Study|Study Terminated by Sponsor|50|||
37867301|NCT00960934|69550780|FG001|Overall Study|Study Terminated by Sponsor|46|||
37867302|NCT00960934|69550781|FG002|Overall Study|Study Terminated by Sponsor|52|||
37867303|NCT00960934|69550782|FG003|Overall Study|Study Terminated by Sponsor|50|||
37867304|NCT00960934|69550783|FG004|Overall Study|Study Terminated by Sponsor|49|||
37867305|NCT00960934|69550784|FG005|Overall Study|Study Terminated by Sponsor|49|||
37867306|NCT00892177|69550801|FG000|Phase II|Ineligible|0|||
37867307|NCT00892177|69550802|FG001|Phase II|Ineligible|0|||
37867308|NCT00892177|69550803|FG002|Phase II|Ineligible|0|||
37867309|NCT00892177|69550804|FG003|Phase II|Ineligible|0|||
37867310|NCT00892177|69550805|FG004|Phase II|Ineligible|1|||
37867311|NCT00892177|69550806|FG005|Phase II|Ineligible|1|||
37867312|NCT00892177|69550801|FG000|Phase II|Withdrawal by Subject|0|||
37867313|NCT00892177|69550802|FG001|Phase II|Withdrawal by Subject|0|||
37867314|NCT00892177|69550803|FG002|Phase II|Withdrawal by Subject|0|||
37867315|NCT00892177|69550804|FG003|Phase II|Withdrawal by Subject|0|||
37867316|NCT00892177|69550805|FG004|Phase II|Withdrawal by Subject|4|||
37867317|NCT00892177|69550806|FG005|Phase II|Withdrawal by Subject|1|||
37867318|NCT00962104|69550823|FG000|Overall Study|Adverse Event|10|||
37867319|NCT00962104|69550824|FG001|Overall Study|Adverse Event|3|||
37867320|NCT00962104|69550823|FG000|Overall Study|Entry Criteria Not Met|1|||
37867321|NCT00962104|69550824|FG001|Overall Study|Entry Criteria Not Met|2|||
37867322|NCT00962104|69550823|FG000|Overall Study|Lack of Efficacy|0|||
37867323|NCT00962104|69550824|FG001|Overall Study|Lack of Efficacy|1|||
37867324|NCT00962104|69550823|FG000|Overall Study|Lost to Follow-up|10|||
37867325|NCT00962104|69550824|FG001|Overall Study|Lost to Follow-up|4|||
37867326|NCT00962104|69550823|FG000|Overall Study|Physician Decision|1|||
37867327|NCT00962104|69550824|FG001|Overall Study|Physician Decision|0|||
37867328|NCT00962104|69550823|FG000|Overall Study|Protocol Violation|6|||
37867329|NCT00962104|69550824|FG001|Overall Study|Protocol Violation|8|||
37867330|NCT00962104|69550823|FG000|Overall Study|Sponsor Decision|0|||
37867331|NCT00962104|69550824|FG001|Overall Study|Sponsor Decision|1|||
37867332|NCT00962104|69550823|FG000|Overall Study|Withdrawal by Subject|10|||
37867333|NCT00962104|69550824|FG001|Overall Study|Withdrawal by Subject|6|||
37867334|NCT00962104|69550823|FG000|Overall Study|Other|2|||
37867335|NCT00962104|69550824|FG001|Overall Study|Other|0|||
37867336|NCT02821000|69550830|FG000|Overall Study|Death|44|||
37867337|NCT02821000|69550830|FG000|Overall Study|Withdrawal by Subject|1|||
37979040|NCT00541385|69665880|FG000|Overall Study|Adverse Event|6|||
37979041|NCT00541385|69665881|FG001|Overall Study|Adverse Event|3|||
37979042|NCT00541385|69665880|FG000|Overall Study|Withdrawal by Subject|2|||
37979043|NCT00541385|69665881|FG001|Overall Study|Withdrawal by Subject|2|||
37979044|NCT00541385|69665880|FG000|Overall Study|Lost to Follow-up|6|||
37979045|NCT00541385|69665881|FG001|Overall Study|Lost to Follow-up|1|||
37979046|NCT00541385|69665880|FG000|Overall Study|Parasite reappearance/malaria|67|||
37815186|NCT04518410|69493087|FG001|Overall Study|Death|0|||
37815187|NCT04518410|69493088|FG002|Overall Study|Death|0|||
37815188|NCT04518410|69493089|FG003|Overall Study|Death|0|||
37815189|NCT04518410|69493090|FG004|Overall Study|Death|12|||
37815190|NCT04518410|69493091|FG005|Overall Study|Death|2|||
37815191|NCT04518410|69493092|FG006|Overall Study|Death|11|||
37815192|NCT04518410|69493093|FG007|Overall Study|Death|0|||
37815193|NCT04518410|69493094|FG008|Overall Study|Death|1|||
37815194|NCT04518410|69493095|FG009|Overall Study|Death|0|||
37815195|NCT04518410|69493096|FG010|Overall Study|Death|0|||
37867338|NCT02821000|69550830|FG000|Overall Study|Ongoing in Study|58|||
37867339|NCT00892099|69550837|FG000|Overall Study|Death|1|||
37867340|NCT00892099|69550838|FG001|Overall Study|Death|0|||
37867341|NCT00892099|69550839|FG002|Overall Study|Death|1|||
37867342|NCT00892099|69550837|FG000|Overall Study|Adverse Event|1|||
37867343|NCT00892099|69550838|FG001|Overall Study|Adverse Event|0|||
37867344|NCT00892099|69550839|FG002|Overall Study|Adverse Event|0|||
37867345|NCT00892099|69550837|FG000|Overall Study|replocated|1|||
37867346|NCT00892099|69550838|FG001|Overall Study|replocated|0|||
37979047|NCT00541385|69665881|FG001|Overall Study|Parasite reappearance/malaria|32|||
37815196|NCT04518410|69493097|FG011|Overall Study|Death|0|||
37815197|NCT04518410|69493098|FG012|Overall Study|Death|0|||
37815198|NCT04518410|69493099|FG013|Overall Study|Death|1|||
37815199|NCT04518410|69493100|FG014|Overall Study|Death|1|||
37867347|NCT00892099|69550839|FG002|Overall Study|replocated|2|||
37979048|NCT00265096|69665890|FG000|Overall Study|Adverse Event|14|||
37979049|NCT00265096|69665891|FG001|Overall Study|Adverse Event|18|||
37979050|NCT00265096|69665892|FG002|Overall Study|Adverse Event|18|||
37694799|NCT02485301|69171232|FG001|Overall Study|Migrated/moved from study area|19|||
37815200|NCT04518410|69493101|FG015|Overall Study|Death|0|||
37867348|NCT00892099|69550837|FG000|Overall Study|Prolonged hospitalization|1|||
37867349|NCT00892099|69550838|FG001|Overall Study|Prolonged hospitalization|0|||
37867350|NCT00892099|69550839|FG002|Overall Study|Prolonged hospitalization|1|||
37867351|NCT00892099|69550837|FG000|Overall Study|no further details|1|||
37867352|NCT00892099|69550838|FG001|Overall Study|no further details|0|||
37867353|NCT00892099|69550839|FG002|Overall Study|no further details|1|||
37867354|NCT00892099|69550837|FG000|Overall Study|kidney function recovered|0|||
37867355|NCT00892099|69550838|FG001|Overall Study|kidney function recovered|1|||
37867356|NCT00892099|69550839|FG002|Overall Study|kidney function recovered|0|||
37867357|NCT00892099|69550837|FG000|Overall Study|investigator decision|0|||
37867358|NCT00892099|69550838|FG001|Overall Study|investigator decision|0|||
37867359|NCT00892099|69550839|FG002|Overall Study|investigator decision|1|||
37867360|NCT00892099|69550837|FG000|Overall Study|Lost to Follow-up|0|||
37867361|NCT00892099|69550838|FG001|Overall Study|Lost to Follow-up|0|||
37867362|NCT00892099|69550839|FG002|Overall Study|Lost to Follow-up|1|||
37867363|NCT00960856|69550847|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
37867364|NCT00960856|69550848|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
37867365|NCT00960856|69550849|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
37867366|NCT00960856|69550850|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
37867367|NCT00960856|69550847|FG000|Washout Period of 7 Days|Adverse Event|0|||
37867368|NCT00960856|69550848|FG001|Washout Period of 7 Days|Adverse Event|0|||
37867369|NCT00960856|69550849|FG002|Washout Period of 7 Days|Adverse Event|1|||
37867370|NCT00960856|69550850|FG003|Washout Period of 7 Days|Adverse Event|0|||
37867371|NCT00958438|69550863|FG000|Overall Study|Protocol Violation|3|||
37867372|NCT00958438|69550864|FG001|Overall Study|Protocol Violation|2|||
37867373|NCT00958438|69550865|FG002|Overall Study|Protocol Violation|2|||
37867374|NCT00958438|69550863|FG000|Overall Study|Withdrawal by Subject|4|||
37867375|NCT00958438|69550864|FG001|Overall Study|Withdrawal by Subject|2|||
37867376|NCT00958438|69550865|FG002|Overall Study|Withdrawal by Subject|1|||
37867377|NCT00958438|69550863|FG000|Overall Study|Adverse Event|0|||
37867378|NCT00958438|69550864|FG001|Overall Study|Adverse Event|3|||
37867379|NCT00958438|69550865|FG002|Overall Study|Adverse Event|0|||
37867380|NCT00958438|69550863|FG000|Overall Study|Physician Decision|1|||
37867381|NCT00958438|69550864|FG001|Overall Study|Physician Decision|0|||
37867382|NCT00958438|69550865|FG002|Overall Study|Physician Decision|1|||
37867383|NCT00958438|69550863|FG000|Overall Study|Other than specified above|2|||
37867384|NCT00958438|69550864|FG001|Overall Study|Other than specified above|3|||
37867385|NCT00958438|69550865|FG002|Overall Study|Other than specified above|2|||
37867386|NCT00958360|69550875|FG000|Overall Study|Withdrawal by Subject|3|||
37867387|NCT00958360|69550876|FG001|Overall Study|Withdrawal by Subject|1|||
37867388|NCT00958360|69550875|FG000|Overall Study|Death|6|||
37867389|NCT00958360|69550876|FG001|Overall Study|Death|7|||
37867390|NCT00958360|69550875|FG000|Overall Study|Physician Decision|2|||
37867391|NCT00958360|69550876|FG001|Overall Study|Physician Decision|1|||
37815201|NCT04518410|69493102|FG016|Overall Study|Death|0|||
37815202|NCT04518410|69493103|FG017|Overall Study|Death|1|||
37815203|NCT04518410|69493104|FG018|Overall Study|Death|3|||
37815204|NCT04518410|69493105|FG019|Overall Study|Death|4|||
37815205|NCT04518410|69493106|FG020|Overall Study|Death|1|||
37815206|NCT04518410|69493107|FG021|Overall Study|Death|0|||
37815207|NCT04518410|69493108|FG022|Overall Study|Death|0|||
37815208|NCT04518410|69493109|FG023|Overall Study|Death|0|||
37815209|NCT04518410|69493110|FG024|Overall Study|Death|0|||
37815210|NCT04518410|69493086|FG000|Overall Study|Requirement to start alternative therapy|0|||
37815211|NCT04518410|69493087|FG001|Overall Study|Requirement to start alternative therapy|0|||
37867392|NCT00958360|69550875|FG000|Overall Study|Lost to Follow-up|0|||
37867393|NCT00958360|69550876|FG001|Overall Study|Lost to Follow-up|1|||
37867394|NCT00888433|69550884|FG000|Overall Study|Withdrawal by Subject|1|||
37867395|NCT00888433|69550885|FG001|Overall Study|Withdrawal by Subject|2|||
37867396|NCT00888433|69550884|FG000|Overall Study|Missed Visit|2|||
37867397|NCT00888433|69550885|FG001|Overall Study|Missed Visit|1|||
37867398|NCT01243424|69550893|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
37867399|NCT01243424|69550894|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
37979051|NCT00265096|69665890|FG000|Overall Study|Lost to Follow-up|2|||
37867400|NCT01243424|69550893|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
37867401|NCT01243424|69550894|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
37867402|NCT01243424|69550893|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
37979052|NCT00265096|69665891|FG001|Overall Study|Lost to Follow-up|5|||
37815212|NCT04518410|69493088|FG002|Overall Study|Requirement to start alternative therapy|1|||
37815213|NCT04518410|69493089|FG003|Overall Study|Requirement to start alternative therapy|0|||
37815214|NCT04518410|69493090|FG004|Overall Study|Requirement to start alternative therapy|0|||
37867403|NCT01243424|69550894|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
37867404|NCT01243424|69550893|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
37867405|NCT01243424|69550894|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
37867406|NCT01243424|69550893|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
37867407|NCT01243424|69550894|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
37867408|NCT01243424|69550893|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
37867409|NCT01243424|69550894|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
37867410|NCT01243424|69550893|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
37867411|NCT01243424|69550894|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
37867412|NCT01243424|69550893|FG000|Discontinuation From Treatment|Not treated|5|||
37867413|NCT01243424|69550894|FG001|Discontinuation From Treatment|Not treated|4|||
37867414|NCT01243424|69550893|FG000|Discontinuation From Treatment|Adverse Event|457|||
37867415|NCT01243424|69550894|FG001|Discontinuation From Treatment|Adverse Event|523|||
37867416|NCT01243424|69550893|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
37867417|NCT01243424|69550894|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
37867418|NCT01243424|69550893|FG000|Discontinuation From Treatment|Protocol Violation|46|||
37867419|NCT01243424|69550894|FG001|Discontinuation From Treatment|Protocol Violation|47|||
37867420|NCT01243424|69550893|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
37867421|NCT01243424|69550894|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
37867422|NCT01243424|69550893|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
37867423|NCT01243424|69550894|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
37867424|NCT01243424|69550893|FG000|Discontinuation From Treatment|Other than listed above|230|||
37867425|NCT01243424|69550894|FG001|Discontinuation From Treatment|Other than listed above|211|||
37867426|NCT00887809|69550903|FG000|Overall Study|Patient Not Treated|3|||
37867427|NCT00887809|69550904|FG001|Overall Study|Patient Not Treated|0|||
37867428|NCT00887809|69550903|FG000|Overall Study|Death|1|||
37867429|NCT00887809|69550904|FG001|Overall Study|Death|0|||
37867430|NCT00958126|69550918|FG000|Overall Study|Serious Adverse Event|0|||
37867431|NCT00958126|69550919|FG001|Overall Study|Serious Adverse Event|2|||
37867432|NCT00958126|69550920|FG002|Overall Study|Serious Adverse Event|0|||
37867433|NCT00958126|69550921|FG003|Overall Study|Serious Adverse Event|0|||
37867434|NCT00958126|69550922|FG004|Overall Study|Serious Adverse Event|0|||
37867435|NCT00958126|69550923|FG005|Overall Study|Serious Adverse Event|0|||
37867436|NCT00958126|69550924|FG006|Overall Study|Serious Adverse Event|1|||
37867437|NCT00958126|69550925|FG007|Overall Study|Serious Adverse Event|0|||
37867438|NCT00958126|69550918|FG000|Overall Study|Withdrawal by Subject|0|||
37867439|NCT00958126|69550919|FG001|Overall Study|Withdrawal by Subject|2|||
37867440|NCT00958126|69550920|FG002|Overall Study|Withdrawal by Subject|0|||
37867441|NCT00958126|69550921|FG003|Overall Study|Withdrawal by Subject|0|||
37867442|NCT00958126|69550922|FG004|Overall Study|Withdrawal by Subject|0|||
37867443|NCT00958126|69550923|FG005|Overall Study|Withdrawal by Subject|0|||
37867444|NCT00958126|69550924|FG006|Overall Study|Withdrawal by Subject|0|||
37867445|NCT00958126|69550925|FG007|Overall Study|Withdrawal by Subject|0|||
37867446|NCT00958126|69550918|FG000|Overall Study|Moved away from study area|0|||
37867447|NCT00958126|69550919|FG001|Overall Study|Moved away from study area|0|||
37867448|NCT00958126|69550920|FG002|Overall Study|Moved away from study area|1|||
37867449|NCT00958126|69550921|FG003|Overall Study|Moved away from study area|1|||
37867450|NCT00958126|69550922|FG004|Overall Study|Moved away from study area|0|||
37815215|NCT04518410|69493091|FG005|Overall Study|Requirement to start alternative therapy|0|||
37815216|NCT04518410|69493092|FG006|Overall Study|Requirement to start alternative therapy|0|||
37815217|NCT04518410|69493093|FG007|Overall Study|Requirement to start alternative therapy|0|||
37815218|NCT04518410|69493094|FG008|Overall Study|Requirement to start alternative therapy|0|||
37815219|NCT04518410|69493095|FG009|Overall Study|Requirement to start alternative therapy|0|||
37815220|NCT04518410|69493096|FG010|Overall Study|Requirement to start alternative therapy|0|||
37815221|NCT04518410|69493097|FG011|Overall Study|Requirement to start alternative therapy|0|||
37815222|NCT04518410|69493098|FG012|Overall Study|Requirement to start alternative therapy|0|||
37815223|NCT04518410|69493099|FG013|Overall Study|Requirement to start alternative therapy|0|||
37815224|NCT04518410|69493100|FG014|Overall Study|Requirement to start alternative therapy|0|||
37815225|NCT04518410|69493101|FG015|Overall Study|Requirement to start alternative therapy|0|||
37815226|NCT04518410|69493102|FG016|Overall Study|Requirement to start alternative therapy|0|||
37815227|NCT04518410|69493103|FG017|Overall Study|Requirement to start alternative therapy|0|||
37815228|NCT04518410|69493104|FG018|Overall Study|Requirement to start alternative therapy|0|||
37815229|NCT04518410|69493105|FG019|Overall Study|Requirement to start alternative therapy|0|||
37815230|NCT04518410|69493106|FG020|Overall Study|Requirement to start alternative therapy|0|||
37867451|NCT00958126|69550923|FG005|Overall Study|Moved away from study area|0|||
37867452|NCT00958126|69550924|FG006|Overall Study|Moved away from study area|0|||
37867453|NCT00958126|69550925|FG007|Overall Study|Moved away from study area|0|||
37867454|NCT00958126|69550918|FG000|Overall Study|Lost to Follow-up|1|||
37867455|NCT00958126|69550919|FG001|Overall Study|Lost to Follow-up|5|||
37979053|NCT00265096|69665892|FG002|Overall Study|Lost to Follow-up|3|||
37979054|NCT00265096|69665890|FG000|Overall Study|Death|0|||
37979055|NCT00265096|69665891|FG001|Overall Study|Death|1|||
37979056|NCT00265096|69665892|FG002|Overall Study|Death|2|||
37867456|NCT00958126|69550920|FG002|Overall Study|Lost to Follow-up|9|||
37815231|NCT04518410|69493107|FG021|Overall Study|Requirement to start alternative therapy|0|||
37815232|NCT04518410|69493108|FG022|Overall Study|Requirement to start alternative therapy|1|||
37815233|NCT04518410|69493109|FG023|Overall Study|Requirement to start alternative therapy|0|||
37815234|NCT04518410|69493110|FG024|Overall Study|Requirement to start alternative therapy|0|||
37815235|NCT04518410|69493086|FG000|Overall Study|Ongoing in study|0|||
37815236|NCT04518410|69493087|FG001|Overall Study|Ongoing in study|0|||
37815237|NCT04518410|69493088|FG002|Overall Study|Ongoing in study|0|||
37815238|NCT04518410|69493089|FG003|Overall Study|Ongoing in study|0|||
37815239|NCT04518410|69493090|FG004|Overall Study|Ongoing in study|0|||
37815240|NCT04518410|69493091|FG005|Overall Study|Ongoing in study|0|||
37815241|NCT04518410|69493092|FG006|Overall Study|Ongoing in study|0|||
37815242|NCT04518410|69493093|FG007|Overall Study|Ongoing in study|0|||
37815243|NCT04518410|69493094|FG008|Overall Study|Ongoing in study|0|||
37815244|NCT04518410|69493095|FG009|Overall Study|Ongoing in study|0|||
37815245|NCT04518410|69493096|FG010|Overall Study|Ongoing in study|0|||
37815246|NCT04518410|69493097|FG011|Overall Study|Ongoing in study|0|||
37815247|NCT04518410|69493098|FG012|Overall Study|Ongoing in study|0|||
37815248|NCT04518410|69493099|FG013|Overall Study|Ongoing in study|0|||
37815249|NCT04518410|69493100|FG014|Overall Study|Ongoing in study|0|||
37815250|NCT04518410|69493101|FG015|Overall Study|Ongoing in study|0|||
37815251|NCT04518410|69493102|FG016|Overall Study|Ongoing in study|0|||
37815252|NCT04518410|69493103|FG017|Overall Study|Ongoing in study|193|||
37815253|NCT04518410|69493104|FG018|Overall Study|Ongoing in study|173|||
37815254|NCT04518410|69493105|FG019|Overall Study|Ongoing in study|50|||
37815255|NCT04518410|69493106|FG020|Overall Study|Ongoing in study|65|||
37815256|NCT04518410|69493107|FG021|Overall Study|Ongoing in study|0|||
37867457|NCT00958126|69550921|FG003|Overall Study|Lost to Follow-up|8|||
37867458|NCT00958126|69550922|FG004|Overall Study|Lost to Follow-up|0|||
37979057|NCT00265096|69665890|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
37815257|NCT04518410|69493108|FG022|Overall Study|Ongoing in study|0|||
37979058|NCT00265096|69665891|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
37867459|NCT00958126|69550923|FG005|Overall Study|Lost to Follow-up|0|||
37815258|NCT04518410|69493109|FG023|Overall Study|Ongoing in study|0|||
37815259|NCT04518410|69493110|FG024|Overall Study|Ongoing in study|0|||
37867460|NCT00958126|69550924|FG006|Overall Study|Lost to Follow-up|0|||
37867461|NCT00958126|69550925|FG007|Overall Study|Lost to Follow-up|0|||
37867462|NCT00958126|69550918|FG000|Overall Study|Sponsor/Investigator decision|0|||
37867463|NCT00958126|69550919|FG001|Overall Study|Sponsor/Investigator decision|0|||
37867464|NCT00958126|69550920|FG002|Overall Study|Sponsor/Investigator decision|0|||
37867465|NCT00958126|69550921|FG003|Overall Study|Sponsor/Investigator decision|1|||
37867466|NCT00958126|69550922|FG004|Overall Study|Sponsor/Investigator decision|0|||
37867467|NCT00958126|69550923|FG005|Overall Study|Sponsor/Investigator decision|0|||
37867468|NCT00958126|69550924|FG006|Overall Study|Sponsor/Investigator decision|0|||
37867469|NCT00958126|69550925|FG007|Overall Study|Sponsor/Investigator decision|0|||
37867470|NCT00958126|69550918|FG000|Overall Study|Other Reason|0|||
37867471|NCT00958126|69550919|FG001|Overall Study|Other Reason|0|||
37867472|NCT00958126|69550920|FG002|Overall Study|Other Reason|0|||
37867473|NCT00958126|69550921|FG003|Overall Study|Other Reason|1|||
37867474|NCT00958126|69550922|FG004|Overall Study|Other Reason|0|||
37867475|NCT00958126|69550923|FG005|Overall Study|Other Reason|1|||
37867476|NCT00958126|69550924|FG006|Overall Study|Other Reason|0|||
37867477|NCT00958126|69550925|FG007|Overall Study|Other Reason|0|||
37867478|NCT00887341|69550949|FG000|Overall Study|Refused treatment|1|||
37815260|NCT04518410|69493086|FG000|Overall Study|Randomized but not treated|0|||
37815261|NCT04518410|69493087|FG001|Overall Study|Randomized but not treated|0|||
37815262|NCT04518410|69493088|FG002|Overall Study|Randomized but not treated|0|||
37867479|NCT00887341|69550950|FG001|Overall Study|Refused treatment|0|||
37867480|NCT00887341|69550949|FG000|Overall Study|Withdrawal by Subject|1|||
37867481|NCT00887341|69550950|FG001|Overall Study|Withdrawal by Subject|1|||
37867482|NCT00887341|69550949|FG000|Overall Study|Adverse Event|0|||
37867483|NCT00887341|69550950|FG001|Overall Study|Adverse Event|1|||
37867484|NCT00887341|69550949|FG000|Overall Study|Lost to Follow-up|0|||
37867485|NCT00887341|69550950|FG001|Overall Study|Lost to Follow-up|1|||
37867486|NCT00886795|69550956|FG000|Overall Study|Lack of Efficacy|1|||
37867487|NCT00889681|69550973|FG000|Overall Study|Not meeting qualification Criteria|2|||
37867488|NCT00889681|69550973|FG000|Overall Study|Insurance disapproval|1|||
37867489|NCT00957658|69550977|FG000|Overall Study|Death|1|||
37867490|NCT00957658|69550977|FG000|Overall Study|Lost to Follow-up|4|||
37867491|NCT00957658|69550977|FG000|Overall Study|Withdrawal by Subject|12|||
37867492|NCT00957658|69550977|FG000|Overall Study|Revision|1|||
37867493|NCT00957658|69550977|FG000|Overall Study|Incomplete 2 yr data|28|||
37867494|NCT00957658|69550977|FG000|Overall Study|Site termination|10|||
37867495|NCT00957658|69550977|FG000|Overall Study|unwilling/unable to return|2|||
37867496|NCT00957658|69550977|FG000|Overall Study|surgery cancelled|2|||
37867497|NCT00957658|69550977|FG000|Overall Study|Protocol Violation|5|||
37867498|NCT00953680|69550983|FG000|Period 1|Withdrawal by Subject|0|||
37867499|NCT00953680|69550984|FG001|Period 1|Withdrawal by Subject|1|||
37867500|NCT00890929|69550990|FG000|Overall Study|Death before treatment|2|||
37867501|NCT00890929|69550990|FG000|Overall Study|Withdrawal by Subject|3|||
37867502|NCT00890929|69550990|FG000|Overall Study|Physician Decision|1|||
37867503|NCT00886639|69550994|FG000|Overall Study|acute exacerbation|14|||
37867504|NCT00886639|69550994|FG000|Overall Study|non-compliance|2|||
37867505|NCT00889603|69550998|FG000|Overall Study|Adverse Event|7|||
37867506|NCT00889603|69550998|FG000|Overall Study|Death|3|||
37867507|NCT00889603|69550998|FG000|Overall Study|Lost to Follow-up|19|||
37867508|NCT00889603|69550998|FG000|Overall Study|No longer willing to participant in stud|4|||
37815263|NCT04518410|69493089|FG003|Overall Study|Randomized but not treated|2|||
37815264|NCT04518410|69493090|FG004|Overall Study|Randomized but not treated|6|||
37815265|NCT04518410|69493091|FG005|Overall Study|Randomized but not treated|6|||
37815266|NCT04518410|69493092|FG006|Overall Study|Randomized but not treated|3|||
37867509|NCT00889603|69550998|FG000|Overall Study|Other|4|||
37867510|NCT00886483|69551004|FG000|Overall Study|Lost to Follow-up|0|||
37867511|NCT00886483|69551005|FG001|Overall Study|Lost to Follow-up|1|||
37867512|NCT00886483|69551004|FG000|Overall Study|Pursue medications|1|||
37867513|NCT00886483|69551005|FG001|Overall Study|Pursue medications|2|||
37867514|NCT00886483|69551004|FG000|Overall Study|Distance to center, poor grades|1|||
37867515|NCT00886483|69551005|FG001|Overall Study|Distance to center, poor grades|0|||
37815267|NCT04518410|69493093|FG007|Overall Study|Randomized but not treated|3|||
37867516|NCT00886015|69551021|FG000|Overall Study|Death|0|||
37867517|NCT00886015|69551022|FG001|Overall Study|Death|2|||
37867518|NCT00890695|69551030|FG000|Overall Study|Protocol Violation|1|||
37867519|NCT00890695|69551031|FG001|Overall Study|Protocol Violation|0|||
37867520|NCT00957580|69551040|FG000|Overall Study|Ongoing at data cut-off|0|||
37867521|NCT00957580|69551041|FG001|Overall Study|Ongoing at data cut-off|1|||
37867522|NCT00957580|69551042|FG002|Overall Study|Ongoing at data cut-off|0|||
37867523|NCT00957580|69551040|FG000|Overall Study|Enrolled but not treated|0|||
37867524|NCT00957580|69551041|FG001|Overall Study|Enrolled but not treated|1|||
37867525|NCT00957580|69551042|FG002|Overall Study|Enrolled but not treated|0|||
37867526|NCT00957424|69551063|FG000|Overall Study|Lost to Follow-up|19|||
37867527|NCT00957424|69551063|FG000|Overall Study|Protocol Violation|3|||
37867528|NCT00957424|69551063|FG000|Overall Study|Withdrawal by Subject|1|||
37867529|NCT01061151|69551071|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
37867530|NCT01061151|69551072|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
37867531|NCT01061151|69551073|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
37867532|NCT01061151|69551074|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
37867533|NCT01061151|69551071|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
37867534|NCT01061151|69551072|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
37867535|NCT01061151|69551073|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
37867536|NCT01061151|69551074|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
37867537|NCT01061151|69551071|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
37867538|NCT01061151|69551072|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
37867539|NCT01061151|69551073|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
37867540|NCT01061151|69551074|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
37867541|NCT01061151|69551071|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
37867542|NCT01061151|69551072|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
37867543|NCT01061151|69551073|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
37867544|NCT01061151|69551074|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
37867545|NCT01061151|69551071|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
37867546|NCT01061151|69551072|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
37867547|NCT01061151|69551073|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
37867548|NCT01061151|69551074|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
37867549|NCT01061151|69551071|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
37867550|NCT01061151|69551072|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
37867551|NCT01061151|69551073|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
37867552|NCT01061151|69551074|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
37867553|NCT01061151|69551071|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
37867554|NCT01061151|69551072|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
37867555|NCT01061151|69551073|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
37867556|NCT01061151|69551074|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
37867557|NCT01061151|69551071|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
37867558|NCT01061151|69551072|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
37867559|NCT01061151|69551073|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
37867560|NCT01061151|69551074|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
37867561|NCT01061151|69551071|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
37867562|NCT01061151|69551072|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
37867563|NCT01061151|69551073|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
37867564|NCT01061151|69551074|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
37867565|NCT01061151|69551071|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
37867566|NCT01061151|69551072|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
37867567|NCT01061151|69551073|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
37867568|NCT01061151|69551074|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
37867569|NCT01061151|69551071|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
37867570|NCT01061151|69551072|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
37867571|NCT01061151|69551073|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
37867572|NCT01061151|69551074|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
37867573|NCT01061151|69551071|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
37867574|NCT01061151|69551072|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
37867575|NCT01061151|69551073|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
37867576|NCT01061151|69551074|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
37867577|NCT01061151|69551071|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
37867578|NCT01061151|69551072|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
37867579|NCT01061151|69551073|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
37867580|NCT01061151|69551074|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
37867581|NCT01061151|69551071|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
37867582|NCT01061151|69551072|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
37867583|NCT01061151|69551073|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
37867584|NCT01061151|69551074|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
37867585|NCT01061151|69551071|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
37867586|NCT01061151|69551072|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
37867587|NCT01061151|69551073|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
37867588|NCT01061151|69551074|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
37867589|NCT01241552|69551098|FG000|Overall Study|Lack of Efficacy|1|||
37867590|NCT01241552|69551099|FG001|Overall Study|Lack of Efficacy|0|||
37867591|NCT01241552|69551100|FG002|Overall Study|Lack of Efficacy|0|||
37867592|NCT01241552|69551101|FG003|Overall Study|Lack of Efficacy|0|||
37867593|NCT01241552|69551098|FG000|Overall Study|Death|26|||
37867594|NCT01241552|69551099|FG001|Overall Study|Death|30|||
37867595|NCT01241552|69551100|FG002|Overall Study|Death|20|||
37867596|NCT01241552|69551101|FG003|Overall Study|Death|25|||
37867597|NCT01241552|69551098|FG000|Overall Study|Adverse Event|1|||
37867598|NCT01241552|69551099|FG001|Overall Study|Adverse Event|1|||
37867599|NCT01241552|69551100|FG002|Overall Study|Adverse Event|0|||
37867600|NCT01241552|69551101|FG003|Overall Study|Adverse Event|0|||
37867601|NCT01241552|69551098|FG000|Overall Study|Technical Problems|2|||
37867602|NCT01241552|69551099|FG001|Overall Study|Technical Problems|0|||
37867603|NCT01241552|69551100|FG002|Overall Study|Technical Problems|2|||
37867604|NCT01241552|69551101|FG003|Overall Study|Technical Problems|2|||
37867605|NCT01241552|69551098|FG000|Overall Study|Progressive Disease|0|||
37867606|NCT01241552|69551099|FG001|Overall Study|Progressive Disease|0|||
37867607|NCT01241552|69551100|FG002|Overall Study|Progressive Disease|1|||
37867608|NCT01241552|69551101|FG003|Overall Study|Progressive Disease|2|||
37867609|NCT01241552|69551098|FG000|Overall Study|Protocol Violation|0|||
37867610|NCT01241552|69551099|FG001|Overall Study|Protocol Violation|2|||
37867611|NCT01241552|69551100|FG002|Overall Study|Protocol Violation|6|||
37867612|NCT01241552|69551101|FG003|Overall Study|Protocol Violation|1|||
37867613|NCT01241552|69551098|FG000|Overall Study|Withdrawal by Subject|7|||
37867614|NCT01241552|69551099|FG001|Overall Study|Withdrawal by Subject|15|||
37867615|NCT01241552|69551100|FG002|Overall Study|Withdrawal by Subject|14|||
37867616|NCT01241552|69551101|FG003|Overall Study|Withdrawal by Subject|15|||
37867617|NCT01241552|69551098|FG000|Overall Study|Physician Decision|2|||
37867618|NCT01241552|69551099|FG001|Overall Study|Physician Decision|4|||
37867619|NCT01241552|69551100|FG002|Overall Study|Physician Decision|2|||
37867620|NCT01241552|69551101|FG003|Overall Study|Physician Decision|3|||
37867621|NCT01241552|69551098|FG000|Overall Study|Lost to Follow-up|2|||
37867622|NCT01241552|69551099|FG001|Overall Study|Lost to Follow-up|11|||
37867623|NCT01241552|69551100|FG002|Overall Study|Lost to Follow-up|15|||
37867624|NCT01241552|69551101|FG003|Overall Study|Lost to Follow-up|16|||
37867625|NCT00948922|69551114|FG000|Overall Study|Did not start study treatment|2|||
37867626|NCT00948922|69551115|FG001|Overall Study|Did not start study treatment|5|||
37867627|NCT00948922|69551116|FG002|Overall Study|Did not start study treatment|0|||
37867628|NCT00948922|69551114|FG000|Overall Study|Withdrawal by Subject|0|||
37867629|NCT00948922|69551115|FG001|Overall Study|Withdrawal by Subject|2|||
37867630|NCT00948922|69551116|FG002|Overall Study|Withdrawal by Subject|1|||
37867631|NCT00948922|69551114|FG000|Overall Study|Death|3|||
37867632|NCT00948922|69551115|FG001|Overall Study|Death|0|||
37867633|NCT00948922|69551116|FG002|Overall Study|Death|0|||
37867634|NCT00948922|69551114|FG000|Overall Study|Disease progression|0|||
37867635|NCT00948922|69551115|FG001|Overall Study|Disease progression|1|||
37867636|NCT00948922|69551116|FG002|Overall Study|Disease progression|0|||
37867637|NCT00948922|69551114|FG000|Overall Study|Insurance issues|1|||
37867638|NCT00948922|69551115|FG001|Overall Study|Insurance issues|0|||
37867639|NCT00948922|69551116|FG002|Overall Study|Insurance issues|0|||
37867640|NCT00948922|69551114|FG000|Overall Study|Transplant eligibility issues|2|||
37867641|NCT00948922|69551115|FG001|Overall Study|Transplant eligibility issues|3|||
37867642|NCT00948922|69551116|FG002|Overall Study|Transplant eligibility issues|0|||
37979059|NCT00265096|69665892|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
37979060|NCT00265096|69665890|FG000|Overall Study|Other|11|||
37979061|NCT00265096|69665891|FG001|Overall Study|Other|19|||
37867643|NCT00948922|69551114|FG000|Overall Study|Not evaluable at time of analysis|0|||
37867644|NCT00948922|69551115|FG001|Overall Study|Not evaluable at time of analysis|3|||
37867645|NCT00948922|69551116|FG002|Overall Study|Not evaluable at time of analysis|0|||
37867646|NCT01239992|69551128|FG000|Overall Study|Withdrawal by Subject|2|||
37867647|NCT01072539|69551132|FG000|Overall Study|Treated prior to the Site Initiation|1|||
37867648|NCT01072539|69551132|FG000|Overall Study|Protocol Violation|2|||
37979062|NCT00265096|69665892|FG002|Overall Study|Other|10|||
37979063|NCT00281320|69665904|FG000|Overall Study|Adverse Event|12|||
37979064|NCT00281320|69665905|FG001|Overall Study|Adverse Event|9|||
37867649|NCT01239680|69551138|FG000|Overall Study|Withdrawal by Subject|2|||
37867650|NCT01239680|69551139|FG001|Overall Study|Withdrawal by Subject|0|||
37867651|NCT01238900|69551145|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
37867652|NCT01238900|69551145|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
37979065|NCT00281320|69665904|FG000|Overall Study|Lack of Efficacy|4|||
37867653|NCT01238822|69551150|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
37867654|NCT01238588|69551160|FG000|Overall Study|Withdrawal by Subject|1|||
37867655|NCT01238588|69551160|FG000|Overall Study|Physician Decision|2|||
37867656|NCT01047501|69551167|FG000|Overall Study|Adverse Event|7|||
37867657|NCT01047501|69551168|FG001|Overall Study|Adverse Event|8|||
37867658|NCT01047501|69551169|FG002|Overall Study|Adverse Event|5|||
37867659|NCT01047501|69551167|FG000|Overall Study|Withdrew Consent|6|||
37867660|NCT01047501|69551168|FG001|Overall Study|Withdrew Consent|2|||
37867661|NCT01047501|69551169|FG002|Overall Study|Withdrew Consent|4|||
37867662|NCT01047501|69551167|FG000|Overall Study|Lost to Follow-up|0|||
37867663|NCT01047501|69551168|FG001|Overall Study|Lost to Follow-up|1|||
37867664|NCT01047501|69551169|FG002|Overall Study|Lost to Follow-up|1|||
37867665|NCT01047501|69551167|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
37867666|NCT01047501|69551168|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
37867667|NCT01047501|69551169|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
37867668|NCT01047501|69551167|FG000|Overall Study|Death|1|||
37867669|NCT01047501|69551168|FG001|Overall Study|Death|0|||
37867670|NCT01047501|69551169|FG002|Overall Study|Death|0|||
37867671|NCT01047501|69551167|FG000|Overall Study|Other discontinuation|1|||
37867672|NCT01047501|69551168|FG001|Overall Study|Other discontinuation|0|||
37867673|NCT01047501|69551169|FG002|Overall Study|Other discontinuation|1|||
37867674|NCT01047501|69551167|FG000|Overall Study|Investigator judgement|0|||
37867675|NCT01047501|69551168|FG001|Overall Study|Investigator judgement|0|||
37979066|NCT00281320|69665905|FG001|Overall Study|Lack of Efficacy|3|||
37979067|NCT00281320|69665904|FG000|Overall Study|Withdrawal by Subject|5|||
37979068|NCT00281320|69665905|FG001|Overall Study|Withdrawal by Subject|6|||
37979069|NCT00281320|69665904|FG000|Overall Study|Lost to Follow-up|1|||
37979070|NCT00281320|69665905|FG001|Overall Study|Lost to Follow-up|2|||
37979071|NCT00281320|69665904|FG000|Overall Study|Other|3|||
37979072|NCT00281320|69665905|FG001|Overall Study|Other|1|||
37979073|NCT00541307|69665917|FG000|Overall Study|Death|5|||
37979074|NCT00541307|69665917|FG000|Overall Study|Physician Decision|3|||
37979075|NCT00541307|69665917|FG000|Overall Study|Withdrawal by Subject|6|||
37979076|NCT00541307|69665917|FG000|Overall Study|Lost to Follow-up|4|||
37979077|NCT00541307|69665917|FG000|Overall Study|Subject returned early (outside window)|1|||
37979078|NCT00541307|69665917|FG000|Overall Study|Surgical Bypass|5|||
37979079|NCT00541229|69665927|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
37979080|NCT00541229|69665928|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
37694800|NCT02485301|69171231|FG000|Overall Study|Lost to Follow-up|17|||
37694801|NCT02485301|69171232|FG001|Overall Study|Lost to Follow-up|17|||
37979081|NCT00541229|69665929|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
37979082|NCT00541229|69665930|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
37979083|NCT00541229|69665931|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
37979084|NCT00541229|69665932|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
37979085|NCT00541229|69665927|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
37979086|NCT00541229|69665928|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
37979087|NCT00541229|69665929|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
37979088|NCT00541229|69665930|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
37979089|NCT00541229|69665931|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
37979090|NCT00541229|69665932|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
37694802|NCT02485301|69171231|FG000|Overall Study|Other|3|||
37815268|NCT04518410|69493094|FG008|Overall Study|Randomized but not treated|0|||
37815269|NCT04518410|69493095|FG009|Overall Study|Randomized but not treated|4|||
37815270|NCT04518410|69493096|FG010|Overall Study|Randomized but not treated|0|||
37815271|NCT04518410|69493097|FG011|Overall Study|Randomized but not treated|0|||
37815272|NCT04518410|69493098|FG012|Overall Study|Randomized but not treated|1|||
37815273|NCT04518410|69493099|FG013|Overall Study|Randomized but not treated|4|||
37815274|NCT04518410|69493100|FG014|Overall Study|Randomized but not treated|3|||
37815275|NCT04518410|69493101|FG015|Overall Study|Randomized but not treated|3|||
37867676|NCT01047501|69551169|FG002|Overall Study|Investigator judgement|1|||
37979091|NCT00541229|69665927|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
37979092|NCT00541229|69665928|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
37979093|NCT00541229|69665929|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
37979094|NCT00541229|69665930|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
37979095|NCT00541229|69665931|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
37815276|NCT04518410|69493102|FG016|Overall Study|Randomized but not treated|4|||
37815277|NCT04518410|69493103|FG017|Overall Study|Randomized but not treated|6|||
37815278|NCT04518410|69493104|FG018|Overall Study|Randomized but not treated|4|||
37867677|NCT01238120|69551181|FG000|Overall Study|Withdrawal by Subject|4|||
37867678|NCT01238120|69551182|FG001|Overall Study|Withdrawal by Subject|1|||
37694803|NCT02485301|69171232|FG001|Overall Study|Other|4|||
37867679|NCT01238120|69551183|FG002|Overall Study|Withdrawal by Subject|2|||
37979096|NCT00541229|69665932|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
37979097|NCT00541229|69665927|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
37979098|NCT00541229|69665928|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
37979099|NCT00541229|69665929|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
37979100|NCT00541229|69665930|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
37979101|NCT00541229|69665931|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
37979102|NCT00541229|69665932|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
37979103|NCT00541229|69665927|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
37979104|NCT00541229|69665928|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
37979105|NCT00541229|69665929|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
37979106|NCT00541229|69665930|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
37815279|NCT04518410|69493105|FG019|Overall Study|Randomized but not treated|0|||
37979107|NCT00541229|69665931|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
37979108|NCT00541229|69665932|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
37979109|NCT00541229|69665927|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
37979110|NCT00541229|69665928|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
37979111|NCT00541229|69665929|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
37815280|NCT04518410|69493106|FG020|Overall Study|Randomized but not treated|0|||
37979112|NCT00541229|69665930|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
37979113|NCT00541229|69665931|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
37979114|NCT00541229|69665932|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
37979115|NCT00541229|69665927|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
37979116|NCT00541229|69665928|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
37979117|NCT00541229|69665929|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
37979118|NCT00541229|69665930|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
37979119|NCT00541229|69665931|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
37979120|NCT00541229|69665932|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
37979121|NCT00541229|69665927|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
37979122|NCT00541229|69665928|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
37979123|NCT00541229|69665929|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
37979124|NCT00541229|69665930|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
37979125|NCT00541229|69665931|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
37979126|NCT00541229|69665932|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
37979127|NCT00541229|69665927|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
37979128|NCT00541229|69665928|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
37979129|NCT00541229|69665929|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
37979130|NCT00541229|69665930|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
37979131|NCT00541229|69665931|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
37979132|NCT00541229|69665932|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
37979133|NCT00541229|69665927|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
37979134|NCT00541229|69665928|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
37979135|NCT00541229|69665929|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
37979136|NCT00541229|69665930|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
37979137|NCT00541229|69665931|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
37979138|NCT00541229|69665932|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
37979139|NCT00541229|69665927|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
37979140|NCT00541229|69665928|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
37979141|NCT00541229|69665929|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
37979142|NCT00541229|69665930|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
37979143|NCT00541229|69665931|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
37979144|NCT00541229|69665932|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
37979145|NCT00541229|69665927|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
37815281|NCT04518410|69493107|FG021|Overall Study|Randomized but not treated|5|||
37815282|NCT04518410|69493108|FG022|Overall Study|Randomized but not treated|0|||
37815283|NCT04518410|69493109|FG023|Overall Study|Randomized but not treated|3|||
37815284|NCT04518410|69493110|FG024|Overall Study|Randomized but not treated|1|||
37815285|NCT04518410|69493086|FG000|Overall Study|Screen Fail but Randomized|0|||
37815286|NCT04518410|69493087|FG001|Overall Study|Screen Fail but Randomized|0|||
37815287|NCT04518410|69493088|FG002|Overall Study|Screen Fail but Randomized|0|||
37815288|NCT04518410|69493089|FG003|Overall Study|Screen Fail but Randomized|0|||
37815289|NCT04518410|69493090|FG004|Overall Study|Screen Fail but Randomized|2|||
37815290|NCT04518410|69493091|FG005|Overall Study|Screen Fail but Randomized|0|||
37815291|NCT04518410|69493092|FG006|Overall Study|Screen Fail but Randomized|0|||
37979146|NCT00541229|69665928|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
37979147|NCT00541229|69665929|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
37979148|NCT00541229|69665930|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
37979149|NCT00541229|69665931|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
37979150|NCT00541229|69665932|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
37979151|NCT00541229|69665927|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
37867680|NCT01238120|69551184|FG003|Overall Study|Withdrawal by Subject|5|||
37867681|NCT01238120|69551181|FG000|Overall Study|Lost to Follow-up|2|||
37867682|NCT01238120|69551182|FG001|Overall Study|Lost to Follow-up|0|||
37867683|NCT01238120|69551183|FG002|Overall Study|Lost to Follow-up|1|||
37867684|NCT01238120|69551184|FG003|Overall Study|Lost to Follow-up|1|||
37867685|NCT01238120|69551181|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
37867686|NCT01238120|69551182|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
37867687|NCT01238120|69551183|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
37867688|NCT01238120|69551184|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
37867689|NCT01237340|69551194|FG000|Overall Study|Adverse Event|3|||
37867690|NCT01237340|69551194|FG000|Overall Study|Withdrawal by Subject|1|||
37867691|NCT01237340|69551194|FG000|Overall Study|Early termination of the trial|36|||
37867692|NCT01045707|69551203|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
37867693|NCT01045707|69551204|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
37867694|NCT01045707|69551203|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
37867695|NCT01045707|69551204|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
37867696|NCT01045707|69551203|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
37867697|NCT01045707|69551204|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
37867698|NCT01045707|69551203|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
37867699|NCT01045707|69551204|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
37867700|NCT01045707|69551203|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
37867701|NCT01045707|69551204|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
37867702|NCT01045707|69551203|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
37867703|NCT01045707|69551204|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
37867704|NCT01045707|69551203|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
37867705|NCT01045707|69551204|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
37867706|NCT01045707|69551203|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
37979152|NCT00541229|69665928|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
37979153|NCT00541229|69665929|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
37979154|NCT00541229|69665930|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
37867707|NCT01045707|69551204|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
37867708|NCT01045707|69551203|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
37867709|NCT01045707|69551204|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
37867710|NCT01054599|69551212|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
37867711|NCT01054599|69551213|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
37867712|NCT01054599|69551212|FG000|Overall Study|Protocol Violation|1|||
37867713|NCT01054599|69551213|FG001|Overall Study|Protocol Violation|0|||
37867714|NCT01054599|69551212|FG000|Overall Study|Spells/seizure-like episodes|1|||
37867715|NCT01054599|69551213|FG001|Overall Study|Spells/seizure-like episodes|1|||
37867716|NCT01054599|69551212|FG000|Overall Study|Timing/scheduling difficulties|1|||
37867717|NCT01054599|69551213|FG001|Overall Study|Timing/scheduling difficulties|1|||
37867718|NCT01054599|69551212|FG000|Overall Study|Visual impairment, WTAR <80|0|||
37867719|NCT01054599|69551213|FG001|Overall Study|Visual impairment, WTAR <80|1|||
37867720|NCT01054599|69551212|FG000|Overall Study|Lost to Follow-up|0|||
37867721|NCT01054599|69551213|FG001|Overall Study|Lost to Follow-up|2|||
37867722|NCT01054599|69551212|FG000|Overall Study|Adverse Event|0|||
37867723|NCT01054599|69551213|FG001|Overall Study|Adverse Event|1|||
37867724|NCT01054599|69551212|FG000|Overall Study|Withdrawal by Subject|0|||
37867725|NCT01054599|69551213|FG001|Overall Study|Withdrawal by Subject|1|||
37867726|NCT00948766|69551221|FG000|Core Study|Adverse Event|73|||
37867727|NCT00948766|69551222|FG001|Core Study|Adverse Event|51|||
37867728|NCT00948766|69551221|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
37867729|NCT00948766|69551222|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
37867730|NCT00948766|69551221|FG000|Core Study|Patient Withdrew Consent|27|||
37867731|NCT00948766|69551222|FG001|Core Study|Patient Withdrew Consent|46|||
37867732|NCT00948766|69551221|FG000|Core Study|Lost to Follow-up|3|||
37867733|NCT00948766|69551222|FG001|Core Study|Lost to Follow-up|2|||
37867734|NCT00948766|69551221|FG000|Core Study|Administrative Problems|2|||
37867735|NCT00948766|69551222|FG001|Core Study|Administrative Problems|2|||
37867736|NCT00948766|69551221|FG000|Core Study|Death|1|||
37867737|NCT00948766|69551222|FG001|Core Study|Death|1|||
37867738|NCT00948766|69551221|FG000|Core Study|Protocol Deviation|8|||
37867739|NCT00948766|69551222|FG001|Core Study|Protocol Deviation|10|||
37867740|NCT00948766|69551221|FG000|Extension Study|Adverse Event|43|||
37867741|NCT00948766|69551222|FG001|Extension Study|Adverse Event|0|||
37867742|NCT00948766|69551221|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
37867743|NCT00948766|69551222|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
37867744|NCT00948766|69551221|FG000|Extension Study|Study Drug No Longer Required|1|||
37867745|NCT00948766|69551222|FG001|Extension Study|Study Drug No Longer Required|0|||
37867746|NCT00948766|69551221|FG000|Extension Study|Patient Withdrew Consent|32|||
37867747|NCT00948766|69551222|FG001|Extension Study|Patient Withdrew Consent|0|||
37867748|NCT00948766|69551221|FG000|Extension Study|Lost to Follow-up|8|||
37867749|NCT00948766|69551222|FG001|Extension Study|Lost to Follow-up|0|||
37867750|NCT00948766|69551221|FG000|Extension Study|Administrative Problems|1|||
37867751|NCT00948766|69551222|FG001|Extension Study|Administrative Problems|0|||
37867752|NCT00948766|69551221|FG000|Extension Study|Death|4|||
37867753|NCT00948766|69551222|FG001|Extension Study|Death|0|||
37867754|NCT01053663|69551232|FG000|Overall Study|Death|2|||
37867755|NCT01053663|69551232|FG000|Overall Study|Lost to Follow-up|1|||
37867756|NCT01053663|69551232|FG000|Overall Study|Poor IV Access|1|||
37867757|NCT01053663|69551232|FG000|Overall Study|Transferred to Another Hospital|1|||
37867758|NCT01053663|69551232|FG000|Overall Study|Negative Influenza Diagnosis|1|||
37867759|NCT01235546|69551244|FG000|Overall Study|Staff error, medication not administered|1|||
37867760|NCT01235546|69551245|FG001|Overall Study|Staff error, medication not administered|0|||
37867761|NCT01235546|69551244|FG000|Overall Study|Protocol Violation|1|||
37867762|NCT01235546|69551245|FG001|Overall Study|Protocol Violation|1|||
37867763|NCT01053429|69551260|FG000|Overall Study|Adverse Event|64|||
37867764|NCT01053429|69551260|FG000|Overall Study|Other|309|||
37867765|NCT01233284|69551264|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
37867766|NCT01233284|69551265|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
37867767|NCT01233284|69551266|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
37867768|NCT01233284|69551267|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
37815292|NCT04518410|69493093|FG007|Overall Study|Screen Fail but Randomized|0|||
37815293|NCT04518410|69493094|FG008|Overall Study|Screen Fail but Randomized|0|||
37867769|NCT01233284|69551268|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
37867770|NCT01233284|69551264|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
37867771|NCT01233284|69551265|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
37867772|NCT01233284|69551266|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
37867773|NCT01233284|69551267|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
37867774|NCT01233284|69551268|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
37867775|NCT01233284|69551264|FG000|Period 1 (4 Weeks)|Other|0|||
37867776|NCT01233284|69551265|FG001|Period 1 (4 Weeks)|Other|0|||
37867777|NCT01233284|69551266|FG002|Period 1 (4 Weeks)|Other|1|||
37867778|NCT01233284|69551267|FG003|Period 1 (4 Weeks)|Other|0|||
37867779|NCT01233284|69551268|FG004|Period 1 (4 Weeks)|Other|0|||
37867780|NCT01233284|69551264|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
37867781|NCT01233284|69551265|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
37867782|NCT01233284|69551266|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
37815294|NCT04518410|69493095|FG009|Overall Study|Screen Fail but Randomized|0|||
37815295|NCT04518410|69493096|FG010|Overall Study|Screen Fail but Randomized|0|||
37815296|NCT04518410|69493097|FG011|Overall Study|Screen Fail but Randomized|0|||
37867783|NCT01233284|69551267|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
37867784|NCT01233284|69551268|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
37867785|NCT01233284|69551264|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
37867786|NCT01233284|69551265|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
37867787|NCT01233284|69551266|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
37867788|NCT01233284|69551267|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
37867789|NCT01233284|69551268|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
37867790|NCT01233284|69551264|FG000|Period 3 (4 Weeks)|Other|0|||
37867791|NCT01233284|69551265|FG001|Period 3 (4 Weeks)|Other|0|||
37815297|NCT04518410|69493098|FG012|Overall Study|Screen Fail but Randomized|0|||
37815298|NCT04518410|69493099|FG013|Overall Study|Screen Fail but Randomized|0|||
37815299|NCT04518410|69493100|FG014|Overall Study|Screen Fail but Randomized|0|||
37815300|NCT04518410|69493101|FG015|Overall Study|Screen Fail but Randomized|0|||
37815301|NCT04518410|69493102|FG016|Overall Study|Screen Fail but Randomized|0|||
37815302|NCT04518410|69493103|FG017|Overall Study|Screen Fail but Randomized|0|||
37815303|NCT04518410|69493104|FG018|Overall Study|Screen Fail but Randomized|0|||
37815304|NCT04518410|69493105|FG019|Overall Study|Screen Fail but Randomized|0|||
37815305|NCT04518410|69493106|FG020|Overall Study|Screen Fail but Randomized|0|||
37815306|NCT04518410|69493107|FG021|Overall Study|Screen Fail but Randomized|0|||
37815307|NCT04518410|69493108|FG022|Overall Study|Screen Fail but Randomized|0|||
37815308|NCT04518410|69493109|FG023|Overall Study|Screen Fail but Randomized|0|||
37867792|NCT01233284|69551266|FG002|Period 3 (4 Weeks)|Other|0|||
37867793|NCT01233284|69551267|FG003|Period 3 (4 Weeks)|Other|1|||
37867794|NCT01233284|69551268|FG004|Period 3 (4 Weeks)|Other|0|||
37867795|NCT01233284|69551264|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
37867796|NCT01233284|69551265|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
37867797|NCT01233284|69551266|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
37867798|NCT01233284|69551267|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
37867799|NCT01233284|69551268|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
37867800|NCT01233284|69551264|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
37867801|NCT01233284|69551265|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
37867802|NCT01233284|69551266|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
37867803|NCT01233284|69551267|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
37867804|NCT01233284|69551268|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
37867805|NCT00948688|69551278|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
37867806|NCT00948688|69551279|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
37867807|NCT00948688|69551278|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
37867808|NCT00948688|69551279|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
37867809|NCT00948688|69551278|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
37867810|NCT00948688|69551279|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
37867811|NCT01233050|69551288|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
37867812|NCT01233050|69551289|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
37867813|NCT01232894|69551297|FG000|Overall Study|Lost to Follow-up|0|||
37867814|NCT01232894|69551298|FG001|Overall Study|Lost to Follow-up|1|||
37867815|NCT01232894|69551297|FG000|Overall Study|Death|1|||
37867816|NCT01232894|69551298|FG001|Overall Study|Death|0|||
37867817|NCT01232894|69551297|FG000|Overall Study|Protocol Violation|1|||
37867818|NCT01232894|69551298|FG001|Overall Study|Protocol Violation|1|||
37867819|NCT01232894|69551297|FG000|Overall Study|Withdrawal by Subject|8|||
37867820|NCT01232894|69551298|FG001|Overall Study|Withdrawal by Subject|5|||
37867821|NCT01232894|69551297|FG000|Overall Study|Physician Decision|2|||
37867822|NCT01232894|69551298|FG001|Overall Study|Physician Decision|1|||
37867823|NCT01049217|69551306|FG000|Overall Study|Adverse Event|2|||
37867824|NCT01049217|69551307|FG001|Overall Study|Adverse Event|1|||
37867825|NCT01049217|69551306|FG000|Overall Study|Lack of Efficacy|1|||
37867826|NCT01049217|69551307|FG001|Overall Study|Lack of Efficacy|1|||
37867827|NCT01049217|69551306|FG000|Overall Study|Lost to Follow-up|3|||
37867828|NCT01049217|69551307|FG001|Overall Study|Lost to Follow-up|8|||
37867829|NCT01049217|69551306|FG000|Overall Study|Withdrawal by Subject|4|||
37867830|NCT01049217|69551307|FG001|Overall Study|Withdrawal by Subject|3|||
37867831|NCT01049217|69551306|FG000|Overall Study|Protocol Violation|1|||
37867832|NCT01049217|69551307|FG001|Overall Study|Protocol Violation|3|||
37867833|NCT01049217|69551306|FG000|Overall Study|Pregnancy|1|||
37867834|NCT01049217|69551307|FG001|Overall Study|Pregnancy|0|||
37867835|NCT01049217|69551306|FG000|Overall Study|Study Terminated by Sponsor|43|||
37867836|NCT01049217|69551307|FG001|Overall Study|Study Terminated by Sponsor|43|||
37867837|NCT01049217|69551306|FG000|Overall Study|Other|1|||
37867838|NCT01049217|69551307|FG001|Overall Study|Other|2|||
37867839|NCT01049217|69551306|FG000|Overall Study|Randomized but not Treated|0|||
37867840|NCT01049217|69551307|FG001|Overall Study|Randomized but not Treated|2|||
37867841|NCT01232738|69551313|FG000|Overall Study|Death|3|||
37867842|NCT01232738|69551313|FG000|Overall Study|Physician Decision|2|||
37867843|NCT01232738|69551313|FG000|Overall Study|Lost to Follow-up|1|||
37867844|NCT01232738|69551313|FG000|Overall Study|Withdrawal by Subject|2|||
37867845|NCT01232738|69551313|FG000|Overall Study|Adverse Event|5|||
37867846|NCT00957268|69551326|FG000|Overall Study|Voluntary Withdrawal|0|||
37867847|NCT00957268|69551327|FG001|Overall Study|Voluntary Withdrawal|0|||
37867848|NCT00957268|69551328|FG002|Overall Study|Voluntary Withdrawal|1|||
37867849|NCT00957268|69551329|FG003|Overall Study|Voluntary Withdrawal|0|||
37867850|NCT00957268|69551330|FG004|Overall Study|Voluntary Withdrawal|0|||
37867851|NCT01230788|69551342|FG000|Overall Study|Prescribed exclusion drug|1|||
37867852|NCT01230710|69551346|FG000|Overall Study|Disease Progression|41|||
37867853|NCT01230710|69551346|FG000|Overall Study|Lost to Follow-up|3|||
37867854|NCT01230710|69551346|FG000|Overall Study|Death|4|||
37867855|NCT01230710|69551346|FG000|Overall Study|Withdrawal of Consent|1|||
37867856|NCT01230554|69551350|FG000|Overall Study|Lost to Follow-up|2|||
37867857|NCT01230554|69551350|FG000|Overall Study|Inability to maintain visit schedule|1|||
37867858|NCT01040793|69551354|FG000|Overall Study|Adverse Event|5|||
37867859|NCT01040793|69551355|FG001|Overall Study|Adverse Event|3|||
37867860|NCT01040793|69551356|FG002|Overall Study|Adverse Event|0|||
37867861|NCT01040793|69551357|FG003|Overall Study|Adverse Event|2|||
37867862|NCT01040793|69551358|FG004|Overall Study|Adverse Event|2|||
37867863|NCT01040793|69551359|FG005|Overall Study|Adverse Event|1|||
37867864|NCT01040793|69551354|FG000|Overall Study|Protocol Violation|1|||
37694804|NCT02484911|69171240|FG000|Overall Study|Withdrawal by Subject|2|||
37867865|NCT01040793|69551355|FG001|Overall Study|Protocol Violation|1|||
37867866|NCT01040793|69551356|FG002|Overall Study|Protocol Violation|1|||
37867867|NCT01040793|69551357|FG003|Overall Study|Protocol Violation|0|||
37867868|NCT01040793|69551358|FG004|Overall Study|Protocol Violation|1|||
37867869|NCT01040793|69551359|FG005|Overall Study|Protocol Violation|0|||
37867870|NCT01040793|69551354|FG000|Overall Study|Lost to Follow-up|0|||
37867871|NCT01040793|69551355|FG001|Overall Study|Lost to Follow-up|1|||
37867872|NCT01040793|69551356|FG002|Overall Study|Lost to Follow-up|1|||
37867873|NCT01040793|69551357|FG003|Overall Study|Lost to Follow-up|0|||
37867874|NCT01040793|69551358|FG004|Overall Study|Lost to Follow-up|0|||
37867875|NCT01040793|69551359|FG005|Overall Study|Lost to Follow-up|0|||
37867876|NCT01040793|69551354|FG000|Overall Study|Withdrawal by Subject|0|||
37867877|NCT01040793|69551355|FG001|Overall Study|Withdrawal by Subject|0|||
37867878|NCT01040793|69551356|FG002|Overall Study|Withdrawal by Subject|0|||
37867879|NCT01040793|69551357|FG003|Overall Study|Withdrawal by Subject|2|||
37867880|NCT01040793|69551358|FG004|Overall Study|Withdrawal by Subject|0|||
37867881|NCT01040793|69551359|FG005|Overall Study|Withdrawal by Subject|0|||
37867882|NCT01040793|69551354|FG000|Overall Study|Other reasons not listed above|0|||
37867883|NCT01040793|69551355|FG001|Overall Study|Other reasons not listed above|0|||
37867884|NCT01040793|69551356|FG002|Overall Study|Other reasons not listed above|1|||
37867885|NCT01040793|69551357|FG003|Overall Study|Other reasons not listed above|0|||
37867886|NCT01040793|69551358|FG004|Overall Study|Other reasons not listed above|1|||
37867887|NCT01040793|69551359|FG005|Overall Study|Other reasons not listed above|0|||
37867888|NCT00948064|69551372|FG000|Phase I|No treatment received|1|||
37867889|NCT00948064|69551373|FG001|Phase I|No treatment received|0|||
37867890|NCT00948064|69551374|FG002|Phase I|No treatment received|0|||
37867891|NCT00948064|69551372|FG000|Phase II|Physician Decision|0|||
37867892|NCT00948064|69551373|FG001|Phase II|Physician Decision|0|||
37867893|NCT00948064|69551374|FG002|Phase II|Physician Decision|1|||
37867894|NCT00948064|69551372|FG000|Phase II|Withdrawal by Subject|0|||
37867895|NCT00948064|69551373|FG001|Phase II|Withdrawal by Subject|1|||
37867896|NCT00948064|69551374|FG002|Phase II|Withdrawal by Subject|0|||
37867897|NCT00953524|69551388|FG000|Overall Study|Adverse Event|2|||
37867898|NCT00953524|69551389|FG001|Overall Study|Adverse Event|0|||
37867899|NCT00953524|69551390|FG002|Overall Study|Adverse Event|1|||
37867900|NCT00953524|69551391|FG003|Overall Study|Adverse Event|2|||
37867901|NCT00953524|69551388|FG000|Overall Study|Protocol Violation|18|||
37867902|NCT00953524|69551389|FG001|Overall Study|Protocol Violation|10|||
37867903|NCT00953524|69551390|FG002|Overall Study|Protocol Violation|11|||
37867904|NCT00953524|69551391|FG003|Overall Study|Protocol Violation|6|||
37867905|NCT00953524|69551388|FG000|Overall Study|Lost to Follow-up|0|||
37867906|NCT00953524|69551389|FG001|Overall Study|Lost to Follow-up|1|||
37867907|NCT00953524|69551390|FG002|Overall Study|Lost to Follow-up|1|||
37867908|NCT00953524|69551391|FG003|Overall Study|Lost to Follow-up|0|||
37867909|NCT00953524|69551388|FG000|Overall Study|Withdrawal by Subject|2|||
37867910|NCT00953524|69551389|FG001|Overall Study|Withdrawal by Subject|4|||
37867911|NCT00953524|69551390|FG002|Overall Study|Withdrawal by Subject|1|||
37867912|NCT00953524|69551391|FG003|Overall Study|Withdrawal by Subject|0|||
37867913|NCT01040403|69551410|FG000|Overall Study|Adverse Event|10|||
37867914|NCT01040403|69551410|FG000|Overall Study|Protocol Violation|2|||
37867915|NCT01040403|69551410|FG000|Overall Study|Lost to Follow-up|1|||
37867916|NCT01040403|69551410|FG000|Overall Study|Not treated|1|||
37867917|NCT01040403|69551410|FG000|Overall Study|Other reason not defined above|6|||
37867918|NCT00957034|69551432|FG000|Overall Study|Adverse Event|0|||
37867919|NCT00957034|69551433|FG001|Overall Study|Adverse Event|1|||
37867920|NCT00957034|69551434|FG002|Overall Study|Adverse Event|1|||
37867921|NCT00957034|69551432|FG000|Overall Study|Sponsor Terminated Study|6|||
37867922|NCT00957034|69551433|FG001|Overall Study|Sponsor Terminated Study|1|||
37867923|NCT00957034|69551434|FG002|Overall Study|Sponsor Terminated Study|5|||
37867924|NCT00957034|69551432|FG000|Overall Study|Withdrawal by Subject|0|||
37867925|NCT00957034|69551433|FG001|Overall Study|Withdrawal by Subject|2|||
37867926|NCT00957034|69551434|FG002|Overall Study|Withdrawal by Subject|0|||
37867927|NCT00953056|69551448|FG000|Overall Study|Withdrew Consent|0|||
37867928|NCT00953056|69551449|FG001|Overall Study|Withdrew Consent|0|||
37867929|NCT00953056|69551450|FG002|Overall Study|Withdrew Consent|0|||
37867930|NCT00953056|69551451|FG003|Overall Study|Withdrew Consent|0|||
37867931|NCT00953056|69551452|FG004|Overall Study|Withdrew Consent|2|||
37867932|NCT00953056|69551453|FG005|Overall Study|Withdrew Consent|3|||
37867933|NCT00953056|69551448|FG000|Overall Study|Serious Adverse Event|0|||
37867934|NCT00953056|69551449|FG001|Overall Study|Serious Adverse Event|0|||
37867935|NCT00953056|69551450|FG002|Overall Study|Serious Adverse Event|0|||
37867936|NCT00953056|69551451|FG003|Overall Study|Serious Adverse Event|0|||
37867937|NCT00953056|69551452|FG004|Overall Study|Serious Adverse Event|0|||
37867938|NCT00953056|69551453|FG005|Overall Study|Serious Adverse Event|1|||
37867939|NCT00952822|69551478|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
37867940|NCT00952822|69551479|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
37867941|NCT00952822|69551480|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
37867942|NCT00952822|69551481|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
37867943|NCT00952822|69551478|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
37867944|NCT00952822|69551479|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
37867945|NCT00952822|69551480|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
37867946|NCT00952822|69551481|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
37815309|NCT04518410|69493110|FG024|Overall Study|Screen Fail but Randomized|0|||
37815310|NCT04518410|69493086|FG000|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
37815311|NCT04518410|69493087|FG001|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
37815312|NCT04518410|69493088|FG002|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
37815313|NCT04518410|69493089|FG003|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
37815314|NCT04518410|69493090|FG004|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|81|||
37815315|NCT04518410|69493091|FG005|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
37815316|NCT04518410|69493092|FG006|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|9|||
37815317|NCT04518410|69493093|FG007|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
37815318|NCT04518410|69493094|FG008|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
37815319|NCT04518410|69493095|FG009|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
37815320|NCT04518410|69493096|FG010|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
37815321|NCT04518410|69493097|FG011|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
37815322|NCT04518410|69493098|FG012|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
37815323|NCT04518410|69493099|FG013|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
37815324|NCT04518410|69493100|FG014|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
37815325|NCT04518410|69493101|FG015|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
37815326|NCT04518410|69493102|FG016|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
37815327|NCT04518410|69493103|FG017|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
37815328|NCT04518410|69493104|FG018|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
37815329|NCT04518410|69493105|FG019|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
37815330|NCT04518410|69493106|FG020|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
37815331|NCT04518410|69493107|FG021|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
37815332|NCT04518410|69493108|FG022|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
37815333|NCT04518410|69493109|FG023|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
37815334|NCT04518410|69493110|FG024|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
37815335|NCT04518410|69493086|FG000|Overall Study|Dual Enrolled Subject|0|||
37815336|NCT04518410|69493087|FG001|Overall Study|Dual Enrolled Subject|0|||
37815337|NCT04518410|69493088|FG002|Overall Study|Dual Enrolled Subject|0|||
37815338|NCT04518410|69493089|FG003|Overall Study|Dual Enrolled Subject|0|||
37815339|NCT04518410|69493090|FG004|Overall Study|Dual Enrolled Subject|0|||
37815340|NCT04518410|69493091|FG005|Overall Study|Dual Enrolled Subject|0|||
37815341|NCT04518410|69493092|FG006|Overall Study|Dual Enrolled Subject|0|||
37815342|NCT04518410|69493093|FG007|Overall Study|Dual Enrolled Subject|0|||
37815343|NCT04518410|69493094|FG008|Overall Study|Dual Enrolled Subject|0|||
37815344|NCT04518410|69493095|FG009|Overall Study|Dual Enrolled Subject|0|||
37815345|NCT04518410|69493096|FG010|Overall Study|Dual Enrolled Subject|0|||
37815346|NCT04518410|69493097|FG011|Overall Study|Dual Enrolled Subject|0|||
37815347|NCT04518410|69493098|FG012|Overall Study|Dual Enrolled Subject|0|||
37815348|NCT04518410|69493099|FG013|Overall Study|Dual Enrolled Subject|0|||
37815349|NCT04518410|69493100|FG014|Overall Study|Dual Enrolled Subject|0|||
37815350|NCT04518410|69493101|FG015|Overall Study|Dual Enrolled Subject|0|||
37815351|NCT04518410|69493102|FG016|Overall Study|Dual Enrolled Subject|0|||
37815352|NCT04518410|69493103|FG017|Overall Study|Dual Enrolled Subject|1|||
37815353|NCT04518410|69493104|FG018|Overall Study|Dual Enrolled Subject|0|||
37815354|NCT04518410|69493105|FG019|Overall Study|Dual Enrolled Subject|0|||
37815355|NCT04518410|69493106|FG020|Overall Study|Dual Enrolled Subject|0|||
37815356|NCT04518410|69493107|FG021|Overall Study|Dual Enrolled Subject|0|||
37815357|NCT04518410|69493108|FG022|Overall Study|Dual Enrolled Subject|0|||
37815358|NCT04518410|69493109|FG023|Overall Study|Dual Enrolled Subject|0|||
37815359|NCT04518410|69493110|FG024|Overall Study|Dual Enrolled Subject|0|||
37815360|NCT04517864|69493170|FG000|Placebo-Controlled Phase|Adverse Event|1|||
37815361|NCT04517864|69493171|FG001|Placebo-Controlled Phase|Adverse Event|0|||
37815362|NCT04517864|69493170|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
37815363|NCT04517864|69493171|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
37815364|NCT04517864|69493170|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
37815365|NCT04517864|69493171|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
37815366|NCT04517864|69493170|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
37815367|NCT04517864|69493171|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
37815368|NCT04517864|69493170|FG000|Active Therapy Extension Phase|Adverse Event|1|||
37815369|NCT04517864|69493171|FG001|Active Therapy Extension Phase|Adverse Event|0|||
37815370|NCT04507204|69493192|FG000|Overall Study|Adverse Event|8|||
37815371|NCT04507204|69493193|FG001|Overall Study|Adverse Event|13|||
37815372|NCT04507204|69493192|FG000|Overall Study|Death|0|||
37815373|NCT04507204|69493193|FG001|Overall Study|Death|1|||
37815374|NCT04507204|69493192|FG000|Overall Study|Lost to Follow-up|15|||
37815375|NCT04507204|69493193|FG001|Overall Study|Lost to Follow-up|14|||
37815376|NCT04507204|69493192|FG000|Overall Study|Poor Compliance with Protocol|2|||
37815377|NCT04507204|69493193|FG001|Overall Study|Poor Compliance with Protocol|4|||
37815378|NCT04507204|69493192|FG000|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|4|||
37815379|NCT04507204|69493193|FG001|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|3|||
37815380|NCT04507204|69493192|FG000|Overall Study|Withdrawal of Patient Consent|21|||
37815381|NCT04507204|69493193|FG001|Overall Study|Withdrawal of Patient Consent|13|||
37815382|NCT04135937|69493217|FG000|Overall Study|Lost to Follow-up|2|||
37815383|NCT04135937|69493217|FG000|Overall Study|Withdrawal by Subject|1|||
37815384|NCT04060147|69493221|FG000|Overall Study|Withdrew consent|1|||
37815385|NCT04045132|69493227|FG000|Overall Study|Lost to Follow-up|3|||
37815386|NCT04045132|69493228|FG001|Overall Study|Lost to Follow-up|6|||
37815387|NCT04019041|69493266|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|3|||
37815388|NCT04019041|69493267|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|5|||
37979155|NCT00541229|69665931|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
37979156|NCT00541229|69665932|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
37979157|NCT00541229|69665927|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
37867947|NCT01038297|69551495|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
37867948|NCT01038297|69551496|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
37867949|NCT01038297|69551497|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
37867950|NCT00955708|69551514|FG000|Overall Study|Death|269|||
37867951|NCT00955708|69551514|FG000|Overall Study|Lost to Follow-up|72|||
37867952|NCT00955708|69551514|FG000|Overall Study|Physician Decision|36|||
37867953|NCT00955708|69551514|FG000|Overall Study|Protocol Violation|134|||
37867954|NCT00955708|69551514|FG000|Overall Study|Registry Conclusion|186|||
37867955|NCT00955708|69551514|FG000|Overall Study|Product removed from service|94|||
37867956|NCT00955708|69551514|FG000|Overall Study|Patient Refused to participate further|116|||
37867957|NCT00955708|69551514|FG000|Overall Study|Closure of study location|60|||
37867958|NCT00955708|69551514|FG000|Overall Study|Patient changed care provider/moved|91|||
37867959|NCT01037985|69551518|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
37867960|NCT01037985|69551519|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
37867961|NCT01037985|69551518|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
37867962|NCT01037985|69551519|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
37867963|NCT01037985|69551518|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
37867964|NCT01037985|69551519|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
37867965|NCT01037985|69551518|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
37867966|NCT01037985|69551519|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
37867967|NCT00955474|69551531|FG000|Overall Study|Physician Decision|7|||
37867968|NCT00955474|69551532|FG001|Overall Study|Physician Decision|5|||
37867969|NCT01229150|69551544|FG000|Overall Study|Toxicity|2|||
37867970|NCT01229150|69551545|FG001|Overall Study|Toxicity|2|||
37867971|NCT01229150|69551546|FG002|Overall Study|Toxicity|0|||
37867972|NCT01229150|69551547|FG003|Overall Study|Toxicity|0|||
37867973|NCT00952588|69551563|FG000|Overall Study|Death|28|||
37867974|NCT00952588|69551564|FG001|Overall Study|Death|13|||
37867975|NCT00952588|69551563|FG000|Overall Study|Withdrawal by Subject|2|||
37979158|NCT00541229|69665928|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
37979159|NCT00541229|69665929|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
37694805|NCT02484911|69171241|FG001|Overall Study|Withdrawal by Subject|1|||
37979160|NCT00541229|69665930|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
37979161|NCT00541229|69665931|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
37979162|NCT00541229|69665932|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
37979163|NCT00541229|69665927|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
37979164|NCT00541229|69665928|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
37979165|NCT00541229|69665929|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
37979166|NCT00541229|69665930|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
37979167|NCT00541229|69665931|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
37979168|NCT00541229|69665932|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
37979169|NCT00541229|69665927|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
37979170|NCT00541229|69665928|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
37979171|NCT00541229|69665929|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
37979172|NCT00541229|69665930|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
37979173|NCT00541229|69665931|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
37979174|NCT00541229|69665932|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
37694806|NCT02484911|69171240|FG000|Overall Study|Protocol Violation|2|||
37867976|NCT00952588|69551564|FG001|Overall Study|Withdrawal by Subject|5|||
37867977|NCT00952588|69551563|FG000|Overall Study|Adverse Event|2|||
37867978|NCT00952588|69551564|FG001|Overall Study|Adverse Event|3|||
37867979|NCT00952588|69551563|FG000|Overall Study|Lost to Follow-up|2|||
37694807|NCT02484911|69171241|FG001|Overall Study|Protocol Violation|1|||
37867980|NCT00952588|69551564|FG001|Overall Study|Lost to Follow-up|0|||
37867981|NCT00952588|69551563|FG000|Overall Study|Physician Decision|0|||
37867982|NCT00952588|69551564|FG001|Overall Study|Physician Decision|1|||
37867983|NCT00952588|69551563|FG000|Overall Study|Lack of Efficacy|2|||
37867984|NCT00952588|69551564|FG001|Overall Study|Lack of Efficacy|2|||
37867985|NCT01227902|69551574|FG000|Overall Study|Adverse Event|12|||
37867986|NCT01227902|69551575|FG001|Overall Study|Adverse Event|8|||
37867987|NCT01227902|69551576|FG002|Overall Study|Adverse Event|11|||
37867988|NCT01227902|69551577|FG003|Overall Study|Adverse Event|4|||
37867989|NCT01227902|69551574|FG000|Overall Study|Lack of Efficacy|1|||
37867990|NCT01227902|69551575|FG001|Overall Study|Lack of Efficacy|2|||
37867991|NCT01227902|69551576|FG002|Overall Study|Lack of Efficacy|2|||
37867992|NCT01227902|69551577|FG003|Overall Study|Lack of Efficacy|1|||
37979175|NCT00481988|69665942|FG000|Overall Study|Withdrawal by Subject|1|||
37867993|NCT01227902|69551574|FG000|Overall Study|Protocol Violation|1|||
37867994|NCT01227902|69551575|FG001|Overall Study|Protocol Violation|0|||
37867995|NCT01227902|69551576|FG002|Overall Study|Protocol Violation|0|||
37867996|NCT01227902|69551577|FG003|Overall Study|Protocol Violation|0|||
37867997|NCT01227902|69551574|FG000|Overall Study|Lost to Follow-up|0|||
37867998|NCT01227902|69551575|FG001|Overall Study|Lost to Follow-up|0|||
37867999|NCT01227902|69551576|FG002|Overall Study|Lost to Follow-up|1|||
37868000|NCT01227902|69551577|FG003|Overall Study|Lost to Follow-up|2|||
37868001|NCT01227902|69551574|FG000|Overall Study|Physician Decision|0|||
37868002|NCT01227902|69551575|FG001|Overall Study|Physician Decision|1|||
37868003|NCT01227902|69551576|FG002|Overall Study|Physician Decision|1|||
37868004|NCT01227902|69551577|FG003|Overall Study|Physician Decision|0|||
37868005|NCT01227902|69551574|FG000|Overall Study|Withdrawal by Subject|4|||
37868006|NCT01227902|69551575|FG001|Overall Study|Withdrawal by Subject|2|||
37868007|NCT01227902|69551576|FG002|Overall Study|Withdrawal by Subject|4|||
37868008|NCT01227902|69551577|FG003|Overall Study|Withdrawal by Subject|3|||
37868009|NCT00946192|69551591|FG000|Overall Study|Lost to Follow-up|6|||
37868010|NCT00946192|69551592|FG001|Overall Study|Lost to Follow-up|11|||
37868011|NCT00946192|69551593|FG002|Overall Study|Lost to Follow-up|9|||
37868012|NCT00946192|69551591|FG000|Overall Study|Withdrawal by Subject|10|||
37868013|NCT00946192|69551592|FG001|Overall Study|Withdrawal by Subject|7|||
37868014|NCT00946192|69551593|FG002|Overall Study|Withdrawal by Subject|3|||
37868015|NCT00946192|69551591|FG000|Overall Study|Did not start medication|2|||
37868016|NCT00946192|69551592|FG001|Overall Study|Did not start medication|0|||
37868017|NCT00946192|69551593|FG002|Overall Study|Did not start medication|0|||
37868018|NCT01037127|69551603|FG000|Overall Study|Lost to Follow-up|2|||
37868019|NCT01037127|69551604|FG001|Overall Study|Lost to Follow-up|4|||
37868020|NCT01037127|69551603|FG000|Overall Study|Physician Decision|1|||
37868021|NCT01037127|69551604|FG001|Overall Study|Physician Decision|0|||
37868022|NCT01037127|69551603|FG000|Overall Study|Study Closed Terminated|2|||
37868023|NCT01037127|69551604|FG001|Overall Study|Study Closed Terminated|17|||
37868024|NCT00946114|69551622|FG000|Overall Study|Death|5|||
37868025|NCT00946114|69551623|FG001|Overall Study|Death|2|||
37868026|NCT00946114|69551622|FG000|Overall Study|Other|1|||
37868027|NCT00946114|69551623|FG001|Overall Study|Other|0|||
37868028|NCT00946114|69551622|FG000|Overall Study|Withdrawal by Subject|2|||
37868029|NCT00946114|69551623|FG001|Overall Study|Withdrawal by Subject|0|||
37868030|NCT01038921|69551631|FG000|Overall Study|Withdrawal by Subject|1|||
37868031|NCT01038921|69551632|FG001|Overall Study|Withdrawal by Subject|0|||
37868032|NCT01038921|69551631|FG000|Overall Study|Physician Decision|1|||
37868033|NCT01038921|69551632|FG001|Overall Study|Physician Decision|0|||
37868034|NCT01038687|69551641|FG000|Overall Study|Adverse Event|0|||
37868035|NCT01038687|69551642|FG001|Overall Study|Adverse Event|2|||
37868036|NCT01038687|69551643|FG002|Overall Study|Adverse Event|1|||
37868037|NCT01081912|69551651|FG000|Conversion/Titration|Adverse Event|47|||
37979176|NCT00481988|69665943|FG001|Overall Study|Withdrawal by Subject|1|||
37979177|NCT00481832|69665960|FG000|Enrollment|Physician Decision|8|||
37868038|NCT01081912|69551652|FG001|Conversion/Titration|Adverse Event|0|||
37868039|NCT01081912|69551653|FG002|Conversion/Titration|Adverse Event|0|||
37868040|NCT01081912|69551651|FG000|Conversion/Titration|Lack of Efficacy|17|||
37868041|NCT01081912|69551652|FG001|Conversion/Titration|Lack of Efficacy|0|||
37868042|NCT01081912|69551653|FG002|Conversion/Titration|Lack of Efficacy|0|||
37868043|NCT01081912|69551651|FG000|Conversion/Titration|Lost to Follow-up|5|||
37979178|NCT00481832|69665960|FG000|Enrollment|Unable to collect enough stem cells|2|||
37868044|NCT01081912|69551652|FG001|Conversion/Titration|Lost to Follow-up|0|||
37868045|NCT01081912|69551653|FG002|Conversion/Titration|Lost to Follow-up|0|||
37979179|NCT00481832|69665960|FG000|Inter-transplant Period|Adverse Event|4|||
37868046|NCT01081912|69551651|FG000|Conversion/Titration|Physician Decision|2|||
37868047|NCT01081912|69551652|FG001|Conversion/Titration|Physician Decision|0|||
37868048|NCT01081912|69551653|FG002|Conversion/Titration|Physician Decision|0|||
37868049|NCT01081912|69551651|FG000|Conversion/Titration|Protocol Violation|67|||
37868050|NCT01081912|69551652|FG001|Conversion/Titration|Protocol Violation|0|||
37868051|NCT01081912|69551653|FG002|Conversion/Titration|Protocol Violation|0|||
37979180|NCT00481832|69665960|FG000|Inter-transplant Period|Death|3|||
37868052|NCT01081912|69551651|FG000|Conversion/Titration|Withdrawal by Subject|23|||
37868053|NCT01081912|69551652|FG001|Conversion/Titration|Withdrawal by Subject|0|||
37868054|NCT01081912|69551653|FG002|Conversion/Titration|Withdrawal by Subject|0|||
37868055|NCT01081912|69551651|FG000|Conversion/Titration|Non-Compliance|47|||
37868056|NCT01081912|69551652|FG001|Conversion/Titration|Non-Compliance|0|||
37868057|NCT01081912|69551653|FG002|Conversion/Titration|Non-Compliance|0|||
37868058|NCT01081912|69551651|FG000|Maintenance Treatment|Adverse Event|0|||
37868059|NCT01081912|69551652|FG001|Maintenance Treatment|Adverse Event|2|||
37694808|NCT02466425|69171250|FG000|Overall Study|Adverse Event|3|||
37694809|NCT02466425|69171251|FG001|Overall Study|Adverse Event|11|||
37694810|NCT02466425|69171250|FG000|Overall Study|Lack of Efficacy|4|||
37694811|NCT02466425|69171251|FG001|Overall Study|Lack of Efficacy|1|||
37868060|NCT01081912|69551653|FG002|Maintenance Treatment|Adverse Event|12|||
37868061|NCT01081912|69551651|FG000|Maintenance Treatment|Lack of Efficacy|0|||
37868062|NCT01081912|69551652|FG001|Maintenance Treatment|Lack of Efficacy|14|||
37868063|NCT01081912|69551653|FG002|Maintenance Treatment|Lack of Efficacy|64|||
37868064|NCT01081912|69551651|FG000|Maintenance Treatment|Lost to Follow-up|0|||
37868065|NCT01081912|69551652|FG001|Maintenance Treatment|Lost to Follow-up|1|||
37868066|NCT01081912|69551653|FG002|Maintenance Treatment|Lost to Follow-up|0|||
37868067|NCT01081912|69551651|FG000|Maintenance Treatment|Physician Decision|0|||
37868068|NCT01081912|69551652|FG001|Maintenance Treatment|Physician Decision|0|||
37868069|NCT01081912|69551653|FG002|Maintenance Treatment|Physician Decision|1|||
37868070|NCT01081912|69551651|FG000|Maintenance Treatment|Protocol Violation|0|||
37868071|NCT01081912|69551652|FG001|Maintenance Treatment|Protocol Violation|1|||
37868072|NCT01081912|69551653|FG002|Maintenance Treatment|Protocol Violation|2|||
37868073|NCT01081912|69551651|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
37868074|NCT01081912|69551652|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
37868075|NCT01081912|69551653|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
37868076|NCT01081912|69551651|FG000|Maintenance Treatment|Non-Compliance|0|||
37868077|NCT01081912|69551652|FG001|Maintenance Treatment|Non-Compliance|4|||
37868078|NCT01081912|69551653|FG002|Maintenance Treatment|Non-Compliance|7|||
37868079|NCT01081912|69551651|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
37868080|NCT01081912|69551652|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
37868081|NCT01081912|69551653|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
37868082|NCT01038609|69551665|FG000|Overall Study|Adverse Event|0|||
37868083|NCT01038609|69551666|FG001|Overall Study|Adverse Event|0|||
37868084|NCT01038609|69551667|FG002|Overall Study|Adverse Event|1|||
37868085|NCT01038609|69551668|FG003|Overall Study|Adverse Event|0|||
37868086|NCT01038609|69551669|FG004|Overall Study|Adverse Event|0|||
37868087|NCT01038609|69551665|FG000|Overall Study|Dosing Error|0|||
37868088|NCT01038609|69551666|FG001|Overall Study|Dosing Error|0|||
37868089|NCT01038609|69551667|FG002|Overall Study|Dosing Error|0|||
37868090|NCT01038609|69551668|FG003|Overall Study|Dosing Error|1|||
37868091|NCT01038609|69551669|FG004|Overall Study|Dosing Error|1|||
37815389|NCT04019041|69493268|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
37815390|NCT04019041|69493269|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
37815391|NCT04019041|69493270|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
37815392|NCT04019041|69493271|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
37815393|NCT04019041|69493266|FG000|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
37815394|NCT04019041|69493267|FG001|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
37815395|NCT04019041|69493268|FG002|Placebo Controlled Period (Weeks 0-16)|Adverse Event|2|||
37815396|NCT04019041|69493269|FG003|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
37815397|NCT04019041|69493270|FG004|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
37815398|NCT04019041|69493271|FG005|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
37815399|NCT04019041|69493266|FG000|Placebo Controlled Period (Weeks 0-16)|Other|1|||
37815400|NCT04019041|69493267|FG001|Placebo Controlled Period (Weeks 0-16)|Other|2|||
37868092|NCT01038609|69551665|FG000|Overall Study|Death in the Family|1|||
37868093|NCT01038609|69551666|FG001|Overall Study|Death in the Family|0|||
37868094|NCT01038609|69551667|FG002|Overall Study|Death in the Family|0|||
37868095|NCT01038609|69551668|FG003|Overall Study|Death in the Family|0|||
37868096|NCT01038609|69551669|FG004|Overall Study|Death in the Family|0|||
37868097|NCT01038609|69551665|FG000|Overall Study|Refusal of Blood Draws|0|||
37868098|NCT01038609|69551666|FG001|Overall Study|Refusal of Blood Draws|1|||
37868099|NCT01038609|69551667|FG002|Overall Study|Refusal of Blood Draws|0|||
37868100|NCT01038609|69551668|FG003|Overall Study|Refusal of Blood Draws|0|||
37868101|NCT01038609|69551669|FG004|Overall Study|Refusal of Blood Draws|0|||
37868102|NCT02357134|69551685|FG000|Overall Study|Lost to Follow-up|1|||
37868103|NCT02357134|69551686|FG001|Overall Study|Lost to Follow-up|0|||
37868104|NCT02357134|69551687|FG002|Overall Study|Lost to Follow-up|0|||
37868105|NCT02357134|69551688|FG003|Overall Study|Lost to Follow-up|0|||
37868106|NCT00745420|69551698|FG000|Overall Study|Ineligible|1|||
37868107|NCT02853370|69551702|FG000|Overall Study|Physician Decision|1|||
37868108|NCT02853370|69551702|FG000|Overall Study|Lack of Efficacy|2|||
37868109|NCT02853370|69551702|FG000|Overall Study|Death|1|||
37868110|NCT02853370|69551702|FG000|Overall Study|Adverse Event|4|||
37868111|NCT02853370|69551702|FG000|Overall Study|Withdrawal by Subject|3|||
37868112|NCT01879072|69551707|FG000|Overall Study|Withdrawal by Subject|121|||
37868113|NCT01879072|69551707|FG000|Overall Study|Not Transplanted|30|||
37868114|NCT00954538|69551713|FG000|Part III|Withdrawal by Subject|0|||
37868115|NCT00954538|69551714|FG001|Part III|Withdrawal by Subject|0|||
37868116|NCT00954538|69551715|FG002|Part III|Withdrawal by Subject|0|||
37868117|NCT00954538|69551716|FG003|Part III|Withdrawal by Subject|0|||
37868118|NCT00954538|69551717|FG004|Part III|Withdrawal by Subject|1|||
37868119|NCT00954538|69551718|FG005|Part III|Withdrawal by Subject|0|||
37868120|NCT00943852|69551727|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
37868121|NCT00943852|69551728|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
37868122|NCT00943852|69551729|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
37868123|NCT00943852|69551730|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
37868124|NCT00943852|69551731|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
37868125|NCT00943852|69551732|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
37868126|NCT00943852|69551733|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
37868127|NCT00943852|69551734|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
37868128|NCT00943852|69551735|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
37868129|NCT00943852|69551736|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
37868130|NCT00943852|69551727|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
37868131|NCT00943852|69551728|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
37868132|NCT00943852|69551729|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
37868133|NCT00943852|69551730|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
37868134|NCT00943852|69551731|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
37868135|NCT00943852|69551732|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
37868136|NCT00943852|69551733|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
37868137|NCT00943852|69551734|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
37868138|NCT00943852|69551735|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
37979181|NCT00481832|69665960|FG000|Inter-transplant Period|Physician Decision|4|||
37979182|NCT00481832|69665960|FG000|Inter-transplant Period|Disease relapse|11|||
37979183|NCT00481832|69665960|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
37979184|NCT00481676|69665966|FG000|Overall Study|Adverse Event|0|||
37868139|NCT00943852|69551736|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
37868140|NCT00943852|69551727|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
37868141|NCT00943852|69551728|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
37868142|NCT00943852|69551729|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
37868143|NCT00943852|69551730|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
37868144|NCT00943852|69551731|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
37979185|NCT00481676|69665967|FG001|Overall Study|Adverse Event|1|||
37979186|NCT00481676|69665966|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
37979187|NCT00481676|69665967|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
37979188|NCT00481676|69665966|FG000|Overall Study|Administrative problem|1|||
37868145|NCT00943852|69551732|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
37979189|NCT00481676|69665967|FG001|Overall Study|Administrative problem|0|||
37868146|NCT00943852|69551733|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
37868147|NCT00943852|69551734|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
37868148|NCT00943852|69551735|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
37868149|NCT00943852|69551736|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
37868150|NCT00943852|69551727|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
37868151|NCT00943852|69551728|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
37868152|NCT00943852|69551729|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
37868153|NCT00943852|69551730|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
37868154|NCT00943852|69551731|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
37868155|NCT00943852|69551732|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
37868156|NCT00943852|69551733|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
37868157|NCT00943852|69551734|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
37868158|NCT00943852|69551735|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
37868159|NCT00943852|69551736|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
37868160|NCT00943852|69551727|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
37868161|NCT00943852|69551728|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
37868162|NCT00943852|69551729|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
37868163|NCT00943852|69551730|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
37868164|NCT00943852|69551731|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
37868165|NCT00943852|69551732|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
37868166|NCT00943852|69551733|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
37868167|NCT00943852|69551734|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
37868168|NCT00943852|69551735|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
37868169|NCT00943852|69551736|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
37868170|NCT00952276|69551751|FG000|Overall Study|Withdrawal by Subject|1|||
37868171|NCT00952276|69551752|FG001|Overall Study|Withdrawal by Subject|0|||
37868172|NCT00952276|69551753|FG002|Overall Study|Withdrawal by Subject|0|||
37868173|NCT00952276|69551754|FG003|Overall Study|Withdrawal by Subject|1|||
37868174|NCT00952276|69551755|FG004|Overall Study|Withdrawal by Subject|0|||
37868175|NCT00943384|69551767|FG000|Overall Study|Dispositioned prior to treatment|23|||
37868176|NCT00943384|69551767|FG000|Overall Study|Treated off protocol-protocol violation|5|||
37868177|NCT00943384|69551767|FG000|Overall Study|Lost to Follow-up|16|||
37868178|NCT00943384|69551767|FG000|Overall Study|Withdrawal by Subject|5|||
37868179|NCT00943306|69551771|FG000|Overall Study|Physician Decision|1|||
37868180|NCT00943306|69551771|FG000|Overall Study|Death|1|||
37868181|NCT00943306|69551771|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
37868182|NCT01198002|69551778|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
37868183|NCT01198002|69551779|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
37868184|NCT01198002|69551780|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
37868185|NCT01198002|69551778|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
37868186|NCT01198002|69551779|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
37868187|NCT01198002|69551780|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
37868188|NCT01198002|69551778|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
37868189|NCT01198002|69551779|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
37868190|NCT01198002|69551780|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
37868191|NCT01198002|69551778|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
37868192|NCT01198002|69551779|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
37868193|NCT01198002|69551780|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
37868194|NCT01198002|69551778|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
37868195|NCT01198002|69551779|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
37868196|NCT01198002|69551780|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
37868197|NCT01198002|69551778|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
37868198|NCT01198002|69551779|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
37868199|NCT01198002|69551780|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
37868200|NCT01198002|69551778|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
37868201|NCT01198002|69551779|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
37868202|NCT01198002|69551780|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
37868203|NCT01198002|69551778|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
37868204|NCT01198002|69551779|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
37868205|NCT01198002|69551780|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
37868206|NCT01198002|69551778|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
37868207|NCT01198002|69551779|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
37868208|NCT01198002|69551780|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
37868209|NCT01198002|69551778|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
37868210|NCT01198002|69551779|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
37868211|NCT01198002|69551780|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
37868212|NCT01198002|69551778|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
37868213|NCT01198002|69551779|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
37868214|NCT01198002|69551780|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
37868215|NCT01198002|69551778|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
37868216|NCT01198002|69551779|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
37868217|NCT01198002|69551780|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
37868218|NCT01198002|69551778|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
37868219|NCT01198002|69551779|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
37868220|NCT01198002|69551780|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
37868221|NCT01198002|69551778|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
37868222|NCT01198002|69551779|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
37868223|NCT01198002|69551780|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
37868224|NCT01198002|69551778|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
37868225|NCT01198002|69551779|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
37868226|NCT01198002|69551780|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
37868227|NCT01197534|69551813|FG000|Overall Study|Not reported|16|||
37868228|NCT01197534|69551814|FG001|Overall Study|Not reported|10|||
37868229|NCT01197534|69551815|FG002|Overall Study|Not reported|16|||
37868230|NCT01197534|69551813|FG000|Overall Study|Enrolment in long term extension|57|||
37868231|NCT01197534|69551814|FG001|Overall Study|Enrolment in long term extension|66|||
37868232|NCT01197534|69551815|FG002|Overall Study|Enrolment in long term extension|119|||
37868233|NCT01197534|69551813|FG000|Overall Study|Severe non-compliance to protocol|3|||
37868234|NCT01197534|69551814|FG001|Overall Study|Severe non-compliance to protocol|4|||
37868235|NCT01197534|69551815|FG002|Overall Study|Severe non-compliance to protocol|1|||
37868236|NCT01197534|69551813|FG000|Overall Study|Lack of therapeutic response|9|||
37868237|NCT01197534|69551814|FG001|Overall Study|Lack of therapeutic response|4|||
37868238|NCT01197534|69551815|FG002|Overall Study|Lack of therapeutic response|9|||
37868239|NCT01197534|69551813|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
37868240|NCT01197534|69551814|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
37868241|NCT01197534|69551815|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
37868242|NCT01197534|69551813|FG000|Overall Study|Lost to Follow-up|1|||
37868243|NCT01197534|69551814|FG001|Overall Study|Lost to Follow-up|4|||
37868244|NCT01197534|69551815|FG002|Overall Study|Lost to Follow-up|2|||
37868245|NCT01197534|69551813|FG000|Overall Study|Adverse Event|35|||
37868246|NCT01197534|69551814|FG001|Overall Study|Adverse Event|36|||
37868247|NCT01197534|69551815|FG002|Overall Study|Adverse Event|24|||
37868248|NCT01197378|69551826|FG000|Overall Study|Adverse Event|3|||
37868249|NCT01197378|69551826|FG000|Overall Study|Withdrawal by Subject|1|||
37868250|NCT01197378|69551826|FG000|Overall Study|Physician Decision|1|||
37868251|NCT01197378|69551826|FG000|Overall Study|Other|2|||
37868252|NCT01197300|69551832|FG000|Overall Study|Lost to Follow-up|0|||
37868253|NCT01197300|69551833|FG001|Overall Study|Lost to Follow-up|1|||
37868254|NCT01197300|69551832|FG000|Overall Study|Protocol Violation|0|||
37868255|NCT01197300|69551833|FG001|Overall Study|Protocol Violation|1|||
37868256|NCT01196988|69551848|FG000|Overall Study|Adverse Event|1|||
37868257|NCT01196988|69551849|FG001|Overall Study|Adverse Event|2|||
37868258|NCT01196988|69551850|FG002|Overall Study|Adverse Event|0|||
37868259|NCT01196988|69551851|FG003|Overall Study|Adverse Event|0|||
37868260|NCT01196988|69551848|FG000|Overall Study|Withdrawal by Subject|5|||
37868261|NCT01196988|69551849|FG001|Overall Study|Withdrawal by Subject|1|||
37868262|NCT01196988|69551850|FG002|Overall Study|Withdrawal by Subject|4|||
37868263|NCT01196988|69551851|FG003|Overall Study|Withdrawal by Subject|0|||
37868264|NCT01196988|69551848|FG000|Overall Study|Lost to Follow-up|16|||
37868265|NCT01196988|69551849|FG001|Overall Study|Lost to Follow-up|29|||
37868266|NCT01196988|69551850|FG002|Overall Study|Lost to Follow-up|21|||
37868267|NCT01196988|69551851|FG003|Overall Study|Lost to Follow-up|1|||
37868268|NCT01196988|69551848|FG000|Overall Study|Other|2|||
37868269|NCT01196988|69551849|FG001|Overall Study|Other|0|||
37868270|NCT01196988|69551850|FG002|Overall Study|Other|0|||
37868271|NCT01196988|69551851|FG003|Overall Study|Other|0|||
37868272|NCT01196052|69551862|FG000|Overall Study|Adverse Event|9|||
37868273|NCT01196052|69551862|FG000|Overall Study|Lost to Follow-up|1|||
37868274|NCT01196052|69551862|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
37868275|NCT01196052|69551862|FG000|Overall Study|Reason not Specified|5|||
37868276|NCT01196052|69551862|FG000|Overall Study|Withdrawal by Subject|6|||
37868277|NCT01195662|69551869|FG000|Double Blind Treatment Period|Adverse Event|4|||
37979190|NCT00542789|69665975|FG000|Overall Study|Adverse Event|18|||
37868278|NCT01195662|69551870|FG001|Double Blind Treatment Period|Adverse Event|1|||
37868279|NCT01195662|69551871|FG002|Double Blind Treatment Period|Adverse Event|2|||
37868280|NCT01195662|69551869|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
37868281|NCT01195662|69551870|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
37868282|NCT01195662|69551871|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
37979191|NCT00542789|69665976|FG001|Overall Study|Adverse Event|17|||
37868283|NCT01195662|69551869|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
37868284|NCT01195662|69551870|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
37868285|NCT01195662|69551871|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
37868286|NCT01195662|69551869|FG000|Double Blind Treatment Period|Administrative reason|2|||
37868287|NCT01195662|69551870|FG001|Double Blind Treatment Period|Administrative reason|1|||
37868288|NCT01195662|69551871|FG002|Double Blind Treatment Period|Administrative reason|1|||
37868289|NCT01195662|69551869|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
37868290|NCT01195662|69551870|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
37868291|NCT01195662|69551871|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
37868292|NCT01195662|69551869|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
37868293|NCT01195662|69551870|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
37868294|NCT01195662|69551871|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
37868295|NCT01195662|69551869|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
37868296|NCT01195662|69551870|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
37868297|NCT01195662|69551871|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
37868298|NCT01195662|69551869|FG000|Double Blind Treatment Period|Non-specified|3|||
37868299|NCT01195662|69551870|FG001|Double Blind Treatment Period|Non-specified|0|||
37868300|NCT01195662|69551871|FG002|Double Blind Treatment Period|Non-specified|0|||
37868301|NCT01195662|69551869|FG000|Double Blind Treatment Period|Missing disposition information|0|||
37868302|NCT01195662|69551870|FG001|Double Blind Treatment Period|Missing disposition information|1|||
37868303|NCT01195662|69551871|FG002|Double Blind Treatment Period|Missing disposition information|1|||
37868304|NCT01195662|69551869|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
37868305|NCT01195662|69551870|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
37868306|NCT01195662|69551871|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
37868307|NCT01195662|69551869|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
37868308|NCT01195662|69551870|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
37868309|NCT01195662|69551871|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
37979192|NCT00542789|69665975|FG000|Overall Study|Withdrawal by Subject|7|||
37979193|NCT00542789|69665976|FG001|Overall Study|Withdrawal by Subject|3|||
37979194|NCT00542789|69665975|FG000|Overall Study|Protocol Violation|8|||
37979195|NCT00542789|69665976|FG001|Overall Study|Protocol Violation|1|||
37979196|NCT00542789|69665975|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
37979197|NCT00542789|69665976|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
37979198|NCT00464672|69665984|FG000|Overall Study|withdrawal of consent|0|||
37979199|NCT00464672|69665985|FG001|Overall Study|withdrawal of consent|0|||
37979200|NCT00464672|69665986|FG002|Overall Study|withdrawal of consent|0|||
37979201|NCT00464672|69665987|FG003|Overall Study|withdrawal of consent|1|||
37979202|NCT00464672|69665988|FG004|Overall Study|withdrawal of consent|9|||
37979203|NCT00464672|69665989|FG005|Overall Study|withdrawal of consent|4|||
37979204|NCT00464672|69665984|FG000|Overall Study|Lost to Follow-up|25|||
37979205|NCT00464672|69665985|FG001|Overall Study|Lost to Follow-up|10|||
37979206|NCT00464672|69665986|FG002|Overall Study|Lost to Follow-up|0|||
37979207|NCT00464672|69665987|FG003|Overall Study|Lost to Follow-up|0|||
37979208|NCT00464672|69665988|FG004|Overall Study|Lost to Follow-up|1|||
37979209|NCT00464672|69665989|FG005|Overall Study|Lost to Follow-up|0|||
37979210|NCT00473876|69666019|FG000|Overall Study|Lost to Follow-up|3|||
37979211|NCT00473876|69666020|FG001|Overall Study|Lost to Follow-up|1|||
37979212|NCT00463580|69666030|FG000|Overall Study|Lost to Follow-up|1|||
37868310|NCT01195272|69551880|FG000|Overall Study|Adverse Event|1|||
37868311|NCT01195272|69551880|FG000|Overall Study|Lack of Efficacy|3|||
37868312|NCT01194804|69551884|FG000|Overall Study|Withdrawal by Subject|1|||
37868313|NCT01194414|69551908|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
37868314|NCT01194414|69551909|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
37868315|NCT01194414|69551910|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
37868316|NCT01194414|69551911|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
37868317|NCT01194414|69551908|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
37868318|NCT01194414|69551909|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
37868319|NCT01194414|69551910|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
37868320|NCT01194414|69551911|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
37868321|NCT01194414|69551908|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
37868322|NCT01194414|69551909|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
37868323|NCT01194414|69551910|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
37979213|NCT00463580|69666031|FG001|Overall Study|Lost to Follow-up|0|||
37868324|NCT01194414|69551911|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
37979214|NCT00463580|69666030|FG000|Overall Study|Schedule conflict|2|||
37979215|NCT00463580|69666031|FG001|Overall Study|Schedule conflict|0|||
37868325|NCT01194414|69551908|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
37979216|NCT00463580|69666030|FG000|Overall Study|Medical/psychiatric complications|0|||
37979217|NCT00463580|69666031|FG001|Overall Study|Medical/psychiatric complications|2|||
37979218|NCT00540449|69666045|FG000|Overall Study|Adverse Event|12|||
37868326|NCT01194414|69551909|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
37868327|NCT01194414|69551910|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
37868328|NCT01194414|69551911|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
37868329|NCT01194414|69551908|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
37868330|NCT01194414|69551909|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
37868331|NCT01194414|69551910|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
37868332|NCT01194414|69551911|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
37868333|NCT01194414|69551908|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
37868334|NCT01194414|69551909|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
37868335|NCT01194414|69551910|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
37868336|NCT01194414|69551911|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
37868337|NCT01194414|69551908|FG000|24 Weeks Double Blind Period|Other|0|||
37868338|NCT01194414|69551909|FG001|24 Weeks Double Blind Period|Other|1|||
37868339|NCT01194414|69551910|FG002|24 Weeks Double Blind Period|Other|0|||
37868340|NCT01194414|69551911|FG003|24 Weeks Double Blind Period|Other|0|||
37868341|NCT01194414|69551908|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
37868342|NCT01194414|69551909|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
37868343|NCT01194414|69551910|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
37868344|NCT01194414|69551911|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
37868345|NCT01194414|69551908|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
37868346|NCT01194414|69551909|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
37868347|NCT01194414|69551910|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
37868348|NCT01194414|69551911|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
37868349|NCT01194414|69551908|FG000|24 Weeks Double Blind Period|Death|0|||
37868350|NCT01194414|69551909|FG001|24 Weeks Double Blind Period|Death|1|||
37868351|NCT01194414|69551910|FG002|24 Weeks Double Blind Period|Death|0|||
37868352|NCT01194414|69551911|FG003|24 Weeks Double Blind Period|Death|0|||
37868353|NCT01194414|69551908|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
37868354|NCT01194414|69551909|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
37868355|NCT01194414|69551910|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
37868356|NCT01194414|69551911|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
37868357|NCT01194414|69551908|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
37868358|NCT01194414|69551909|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
37868359|NCT01194414|69551910|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
37868360|NCT01194414|69551911|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
37868361|NCT01194414|69551908|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
37868362|NCT01194414|69551909|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
37868363|NCT01194414|69551910|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
37868364|NCT01194414|69551911|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
37868365|NCT01194414|69551908|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
37868366|NCT01194414|69551909|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
37868367|NCT01194414|69551910|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
37868368|NCT01194414|69551911|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
37868369|NCT01194414|69551908|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
37868370|NCT01194414|69551909|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
37868371|NCT01194414|69551910|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
37868372|NCT01194414|69551911|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
37868373|NCT01194414|69551908|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
37868374|NCT01194414|69551909|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
37868375|NCT01194414|69551910|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
37868376|NCT01194414|69551911|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
37868377|NCT01194414|69551908|FG000|72 Weeks Open Label Extension|Other|2|||
37868378|NCT01194414|69551909|FG001|72 Weeks Open Label Extension|Other|1|||
37868379|NCT01194414|69551910|FG002|72 Weeks Open Label Extension|Other|0|||
37868380|NCT01194414|69551911|FG003|72 Weeks Open Label Extension|Other|0|||
37868381|NCT01194414|69551908|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
37868382|NCT01194414|69551909|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
37868383|NCT01194414|69551910|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
37868384|NCT01194414|69551911|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
37868385|NCT01194414|69551908|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
37868386|NCT01194414|69551909|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
37868387|NCT01194414|69551910|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
37868388|NCT01194414|69551911|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
37868389|NCT01194414|69551908|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
37868390|NCT01194414|69551909|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
37868391|NCT01194414|69551910|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
37868392|NCT01194414|69551911|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
37868393|NCT01194414|69551908|FG000|72 Weeks Open Label Extension|Death|1|||
37868394|NCT01194414|69551909|FG001|72 Weeks Open Label Extension|Death|2|||
37868395|NCT01194414|69551910|FG002|72 Weeks Open Label Extension|Death|0|||
37868396|NCT01194414|69551911|FG003|72 Weeks Open Label Extension|Death|2|||
37868397|NCT01194258|69551923|FG000|Titration Period|Withdrawal by Subject|6|||
37868398|NCT01194258|69551924|FG001|Titration Period|Withdrawal by Subject|0|||
37868399|NCT01194258|69551925|FG002|Titration Period|Withdrawal by Subject|0|||
37868400|NCT01194258|69551926|FG003|Titration Period|Withdrawal by Subject|0|||
37868401|NCT01194258|69551927|FG004|Titration Period|Withdrawal by Subject|0|||
37868402|NCT01194258|69551923|FG000|Titration Period|Lost to Follow-up|2|||
37868403|NCT01194258|69551924|FG001|Titration Period|Lost to Follow-up|0|||
37868404|NCT01194258|69551925|FG002|Titration Period|Lost to Follow-up|0|||
37868405|NCT01194258|69551926|FG003|Titration Period|Lost to Follow-up|0|||
37868406|NCT01194258|69551927|FG004|Titration Period|Lost to Follow-up|0|||
37868407|NCT01194258|69551923|FG000|Titration Period|Titration failure|3|||
37868408|NCT01194258|69551924|FG001|Titration Period|Titration failure|0|||
37868409|NCT01194258|69551925|FG002|Titration Period|Titration failure|0|||
37868410|NCT01194258|69551926|FG003|Titration Period|Titration failure|0|||
37868411|NCT01194258|69551927|FG004|Titration Period|Titration failure|0|||
37868412|NCT01194258|69551923|FG000|Period 1 (12 Weeks)|Death|0|||
37979219|NCT00540449|69666046|FG001|Overall Study|Adverse Event|32|||
37979220|NCT00540449|69666045|FG000|Overall Study|Sponsor's Decision|1|||
37979221|NCT00540449|69666046|FG001|Overall Study|Sponsor's Decision|1|||
37979222|NCT00540449|69666045|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
37979223|NCT00540449|69666046|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
37979224|NCT00540449|69666045|FG000|Overall Study|Lost to Follow-up|19|||
37979225|NCT00540449|69666046|FG001|Overall Study|Lost to Follow-up|17|||
37979226|NCT00540449|69666045|FG000|Overall Study|Subject Non-Compliant|7|||
37979227|NCT00540449|69666046|FG001|Overall Study|Subject Non-Compliant|5|||
37979228|NCT00540449|69666045|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
37979229|NCT00540449|69666046|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
37979230|NCT00540449|69666045|FG000|Overall Study|Withdrawal by Subject|10|||
37979231|NCT00540449|69666046|FG001|Overall Study|Withdrawal by Subject|10|||
37979232|NCT00540449|69666045|FG000|Overall Study|Other|1|||
37979233|NCT00540449|69666046|FG001|Overall Study|Other|4|||
37868413|NCT01194258|69551924|FG001|Period 1 (12 Weeks)|Death|0|||
37868414|NCT01194258|69551925|FG002|Period 1 (12 Weeks)|Death|0|||
37868415|NCT01194258|69551926|FG003|Period 1 (12 Weeks)|Death|0|||
37868416|NCT01194258|69551927|FG004|Period 1 (12 Weeks)|Death|1|||
37868417|NCT01194258|69551923|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
37868418|NCT01194258|69551924|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
37868419|NCT01194258|69551925|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
37868420|NCT01194258|69551926|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
37868421|NCT01194258|69551927|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
37868422|NCT01194258|69551923|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
37868423|NCT01194258|69551924|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
37868424|NCT01194258|69551925|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
37979234|NCT03911843|69666054|FG000|Overall Study|Adverse Event|2|||
37979235|NCT03911843|69666055|FG001|Overall Study|Adverse Event|0|||
37979236|NCT03911843|69666054|FG000|Overall Study|Protocol Violation|2|||
37979237|NCT03911843|69666055|FG001|Overall Study|Protocol Violation|0|||
37979238|NCT03911843|69666054|FG000|Overall Study|Lost to Follow-up|0|||
37979239|NCT03911843|69666055|FG001|Overall Study|Lost to Follow-up|1|||
37868425|NCT01194258|69551926|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
37868426|NCT01194258|69551927|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
37868427|NCT01194258|69551923|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
37868428|NCT01194258|69551924|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
37868429|NCT01194258|69551925|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
37868430|NCT01194258|69551926|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
37868431|NCT01194258|69551927|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
37868432|NCT01193556|69551940|FG000|Overall Study|Study termination|26|||
37868433|NCT01193556|69551941|FG001|Overall Study|Study termination|25|||
37979240|NCT00361335|69666066|FG000|IV Period: Baseline to E0|Adverse Event|9|||
37979241|NCT00361335|69666067|FG001|IV Period: Baseline to E0|Adverse Event|4|||
37979242|NCT00361335|69666068|FG002|IV Period: Baseline to E0|Adverse Event|5|||
37979243|NCT00361335|69666069|FG003|IV Period: Baseline to E0|Adverse Event|9|||
37979244|NCT00361335|69666070|FG004|IV Period: Baseline to E0|Adverse Event|8|||
37979245|NCT00361335|69666071|FG005|IV Period: Baseline to E0|Adverse Event|0|||
37979246|NCT00361335|69666072|FG006|IV Period: Baseline to E0|Adverse Event|0|||
37979247|NCT00361335|69666066|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
37868434|NCT00951496|69551954|FG000|Overall Study|Did not initiate study treatment|10|||
37868435|NCT00951496|69551955|FG001|Overall Study|Did not initiate study treatment|8|||
37868436|NCT00951496|69551956|FG002|Overall Study|Did not initiate study treatment|13|||
37868437|NCT01193244|69551969|FG000|Overall Study|Withdrawal by Subject|79|||
37868438|NCT01193244|69551970|FG001|Overall Study|Withdrawal by Subject|97|||
37868439|NCT01193244|69551969|FG000|Overall Study|Other|303|||
37868440|NCT01193244|69551970|FG001|Overall Study|Other|278|||
37868441|NCT01193244|69551969|FG000|Overall Study|Lost to Follow-up|6|||
37868442|NCT01193244|69551970|FG001|Overall Study|Lost to Follow-up|15|||
37868443|NCT01192152|69551976|FG000|Period 1|left prematurely (while on treatment B)|0|||
37868444|NCT01192152|69551977|FG001|Period 1|left prematurely (while on treatment B)|1|||
37868445|NCT01192152|69551976|FG000|Period 3|family emergency|1|||
37868446|NCT01192152|69551977|FG001|Period 3|family emergency|0|||
37868447|NCT01191840|69551987|FG000|Overall Study|withdrew consent|2|||
37868448|NCT01191840|69551988|FG001|Overall Study|withdrew consent|1|||
37868449|NCT01191840|69551987|FG000|Overall Study|Subject discontinued treatment|1|||
37868450|NCT01191840|69551988|FG001|Overall Study|Subject discontinued treatment|2|||
37868451|NCT01191840|69551987|FG000|Overall Study|Lost to Follow-up|4|||
37868452|NCT01191840|69551988|FG001|Overall Study|Lost to Follow-up|6|||
37868453|NCT01191840|69551987|FG000|Overall Study|Non Staph Infection|4|||
37868454|NCT01191840|69551988|FG001|Overall Study|Non Staph Infection|3|||
37868455|NCT01191840|69551987|FG000|Overall Study|ineligible at enrollment|1|||
37868456|NCT01191840|69551988|FG001|Overall Study|ineligible at enrollment|0|||
37979248|NCT00361335|69666067|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
37979249|NCT00361335|69666068|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
37979250|NCT00361335|69666069|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
37979251|NCT00361335|69666070|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
37979252|NCT00361335|69666071|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
37979253|NCT00361335|69666072|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
37868457|NCT01191840|69551987|FG000|Overall Study|IRB approval lapse|0|||
37868458|NCT01191840|69551988|FG001|Overall Study|IRB approval lapse|2|||
37868459|NCT01191840|69551987|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
37868460|NCT01191840|69551988|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
37868461|NCT01191840|69551987|FG000|Overall Study|Withdrawal by Subject|2|||
37868462|NCT01191840|69551988|FG001|Overall Study|Withdrawal by Subject|0|||
37868463|NCT00943072|69552000|FG000|Overall Study|Adverse Event|0|||
37868464|NCT00943072|69552001|FG001|Overall Study|Adverse Event|3|||
37868465|NCT00943072|69552000|FG000|Overall Study|Death|0|||
37868466|NCT00943072|69552001|FG001|Overall Study|Death|2|||
37868467|NCT00943072|69552000|FG000|Overall Study|Withdrawal by Subject|3|||
37868468|NCT00943072|69552001|FG001|Overall Study|Withdrawal by Subject|1|||
37868469|NCT00943072|69552000|FG000|Overall Study|Protocol Violation|0|||
37868470|NCT00943072|69552001|FG001|Overall Study|Protocol Violation|1|||
37868471|NCT00943072|69552000|FG000|Overall Study|Lost to Follow-up|1|||
37868472|NCT00943072|69552001|FG001|Overall Study|Lost to Follow-up|2|||
37868473|NCT00943072|69552000|FG000|Overall Study|Lack of Efficacy|0|||
37868474|NCT00943072|69552001|FG001|Overall Study|Lack of Efficacy|4|||
37868475|NCT00943072|69552000|FG000|Overall Study|Other|1|||
37868476|NCT00943072|69552001|FG001|Overall Study|Other|1|||
37868477|NCT00942994|69552011|FG000|Overall Study|Adverse Event|7|||
37868478|NCT00942994|69552012|FG001|Overall Study|Adverse Event|4|||
37868479|NCT00942994|69552011|FG000|Overall Study|Abnormal laboratory value(s)|1|||
37868480|NCT00942994|69552012|FG001|Overall Study|Abnormal laboratory value(s)|0|||
37868481|NCT00942994|69552011|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
37868482|NCT00942994|69552012|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
37979254|NCT00361335|69666066|FG000|IV Period: Baseline to E0|Death|1|||
37979255|NCT00361335|69666067|FG001|IV Period: Baseline to E0|Death|1|||
37979256|NCT00361335|69666068|FG002|IV Period: Baseline to E0|Death|1|||
37979257|NCT00361335|69666069|FG003|IV Period: Baseline to E0|Death|1|||
37979258|NCT00361335|69666070|FG004|IV Period: Baseline to E0|Death|0|||
37979259|NCT00361335|69666071|FG005|IV Period: Baseline to E0|Death|0|||
37979260|NCT00361335|69666072|FG006|IV Period: Baseline to E0|Death|0|||
37979261|NCT00361335|69666066|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
37979262|NCT00361335|69666067|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
37979263|NCT00361335|69666068|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
37979264|NCT00361335|69666069|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
37979265|NCT00361335|69666070|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
37694812|NCT02466425|69171250|FG000|Overall Study|Lost to Follow-up|3|||
37868483|NCT00942994|69552011|FG000|Overall Study|Patient withdrew consent|5|||
37868484|NCT00942994|69552012|FG001|Overall Study|Patient withdrew consent|8|||
37868485|NCT00942994|69552011|FG000|Overall Study|Lost to Follow-up|1|||
37868486|NCT00942994|69552012|FG001|Overall Study|Lost to Follow-up|4|||
37868487|NCT00942994|69552011|FG000|Overall Study|Protocol deviation|1|||
37868488|NCT00942994|69552012|FG001|Overall Study|Protocol deviation|2|||
37868489|NCT00942604|69552020|FG000|Overall Study|Protocol Violation|1|||
37868490|NCT00942604|69552021|FG001|Overall Study|Protocol Violation|1|||
37868491|NCT00942604|69552020|FG000|Overall Study|Adverse Event|0|||
37868492|NCT00942604|69552021|FG001|Overall Study|Adverse Event|1|||
37868493|NCT00942604|69552020|FG000|Overall Study|Withdrawal by Subject|0|||
37868494|NCT00942604|69552021|FG001|Overall Study|Withdrawal by Subject|1|||
37868495|NCT00942604|69552020|FG000|Overall Study|Patient relocation|1|||
37868496|NCT00942604|69552021|FG001|Overall Study|Patient relocation|1|||
37694813|NCT02466425|69171251|FG001|Overall Study|Lost to Follow-up|0|||
37868497|NCT01188564|69552029|FG000|Double-blind Phase|randomized not treated|1|||
37868498|NCT01188564|69552030|FG001|Double-blind Phase|randomized not treated|0|||
37868499|NCT01187550|69552038|FG000|Overall Study|Protocol Violation|3|||
37868500|NCT01187550|69552039|FG001|Overall Study|Protocol Violation|1|||
37868501|NCT01187550|69552038|FG000|Overall Study|Other|3|||
37868502|NCT01187550|69552039|FG001|Overall Study|Other|0|||
37868503|NCT01187550|69552038|FG000|Overall Study|Randomized but not treated|8|||
37868504|NCT01187550|69552039|FG001|Overall Study|Randomized but not treated|0|||
37868505|NCT01186770|69552049|FG000|Overall Study|Ineligibility|0|||
37868506|NCT01186770|69552050|FG001|Overall Study|Ineligibility|0|||
37868507|NCT01186770|69552051|FG002|Overall Study|Ineligibility|2|||
37868508|NCT01186770|69552052|FG003|Overall Study|Ineligibility|0|||
37868509|NCT01186770|69552049|FG000|Overall Study|Protocol Violation|7|||
37868510|NCT01186770|69552050|FG001|Overall Study|Protocol Violation|9|||
37815401|NCT04019041|69493268|FG002|Placebo Controlled Period (Weeks 0-16)|Other|1|||
37815402|NCT04019041|69493269|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
37694814|NCT02466425|69171250|FG000|Overall Study|Protocol Violation|1|||
37694815|NCT02466425|69171251|FG001|Overall Study|Protocol Violation|0|||
37868511|NCT01186770|69552051|FG002|Overall Study|Protocol Violation|12|||
37868512|NCT01186770|69552052|FG003|Overall Study|Protocol Violation|14|||
37868513|NCT01186770|69552049|FG000|Overall Study|Adverse Event|2|||
37868514|NCT01186770|69552050|FG001|Overall Study|Adverse Event|9|||
37868515|NCT01186770|69552051|FG002|Overall Study|Adverse Event|7|||
37868516|NCT01186770|69552052|FG003|Overall Study|Adverse Event|9|||
37868517|NCT01186770|69552049|FG000|Overall Study|Withdrawal by Subject|15|||
37868518|NCT01186770|69552050|FG001|Overall Study|Withdrawal by Subject|13|||
37868519|NCT01186770|69552051|FG002|Overall Study|Withdrawal by Subject|11|||
37868520|NCT01186770|69552052|FG003|Overall Study|Withdrawal by Subject|17|||
37868521|NCT01186770|69552049|FG000|Overall Study|Lost to Follow-up|10|||
37868522|NCT01186770|69552050|FG001|Overall Study|Lost to Follow-up|6|||
37868523|NCT01186770|69552051|FG002|Overall Study|Lost to Follow-up|14|||
37868524|NCT01186770|69552052|FG003|Overall Study|Lost to Follow-up|9|||
37868525|NCT01186770|69552049|FG000|Overall Study|Insufficient response to treatment|7|||
37868526|NCT01186770|69552050|FG001|Overall Study|Insufficient response to treatment|8|||
37868527|NCT01186770|69552051|FG002|Overall Study|Insufficient response to treatment|5|||
37868528|NCT01186770|69552052|FG003|Overall Study|Insufficient response to treatment|7|||
37868529|NCT01186770|69552049|FG000|Overall Study|Other than specified|0|||
37868530|NCT01186770|69552050|FG001|Overall Study|Other than specified|1|||
37979266|NCT00361335|69666071|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
37979267|NCT00361335|69666072|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
37979268|NCT00361335|69666066|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
37815403|NCT04019041|69493270|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
37815404|NCT04019041|69493271|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
37815405|NCT04019041|69493266|FG000|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
37815406|NCT04019041|69493267|FG001|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
37815407|NCT04019041|69493268|FG002|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|1|||
37815408|NCT04019041|69493269|FG003|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
37815409|NCT04019041|69493270|FG004|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
37815410|NCT04019041|69493271|FG005|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
37815411|NCT04019041|69493266|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
37815412|NCT04019041|69493267|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
37815413|NCT04019041|69493268|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
37815414|NCT04019041|69493269|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|4|||
37815415|NCT04019041|69493270|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
37815416|NCT04019041|69493271|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
37815417|NCT04019041|69493266|FG000|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
37815418|NCT04019041|69493267|FG001|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
37815419|NCT04019041|69493268|FG002|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
37815420|NCT04019041|69493269|FG003|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|1|||
37868531|NCT01186770|69552051|FG002|Overall Study|Other than specified|1|||
37868532|NCT01186770|69552052|FG003|Overall Study|Other than specified|2|||
37868533|NCT01186692|69552062|FG000|Overall Study|Not Catheterized|11|||
37868534|NCT01186692|69552062|FG000|Overall Study|Futher testing contraindicated implant|19|||
37868535|NCT01186692|69552062|FG000|Overall Study|Adverse Event|2|||
37868536|NCT01186458|69552070|FG000|Overall Study|Adverse Event|1|||
37868537|NCT01185834|69552074|FG000|Overall Study|Lost to Follow-up|2|||
37868538|NCT01185834|69552074|FG000|Overall Study|Discomfort|4|||
37868539|NCT01185834|69552074|FG000|Overall Study|Biomicroscopy|4|||
37868540|NCT01185834|69552074|FG000|Overall Study|Time/Job Conflict|2|||
37868541|NCT01185834|69552074|FG000|Overall Study|Early exit - Site error|2|||
37868542|NCT01185600|69552080|FG000|Overall Study|Adverse Event|1|||
37868543|NCT01185600|69552081|FG001|Overall Study|Adverse Event|1|||
37979269|NCT00361335|69666067|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
37979270|NCT00361335|69666068|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
37979271|NCT00361335|69666069|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
37979272|NCT00361335|69666070|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
37979273|NCT00361335|69666071|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
37979274|NCT00361335|69666072|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
37979275|NCT00361335|69666066|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
37979276|NCT00361335|69666067|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
37979277|NCT00361335|69666068|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
37979278|NCT00361335|69666069|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
37979279|NCT00361335|69666070|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
37979280|NCT00361335|69666071|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
37979281|NCT00361335|69666072|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
37979282|NCT00361335|69666066|FG000|IV Period: Baseline to E0|Other|2|||
37979283|NCT00361335|69666067|FG001|IV Period: Baseline to E0|Other|9|||
37979284|NCT00361335|69666068|FG002|IV Period: Baseline to E0|Other|9|||
37979285|NCT00361335|69666069|FG003|IV Period: Baseline to E0|Other|3|||
37979286|NCT00361335|69666070|FG004|IV Period: Baseline to E0|Other|2|||
37979287|NCT00361335|69666071|FG005|IV Period: Baseline to E0|Other|0|||
37979288|NCT00361335|69666072|FG006|IV Period: Baseline to E0|Other|0|||
37979289|NCT00361335|69666066|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
37979290|NCT00361335|69666067|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
37979291|NCT00361335|69666068|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
37979292|NCT00361335|69666069|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
37979293|NCT00361335|69666070|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
37979294|NCT00361335|69666071|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
37979295|NCT00361335|69666072|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
37979296|NCT00361335|69666066|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
37979297|NCT00361335|69666067|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
37979298|NCT00361335|69666068|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
37979299|NCT00361335|69666069|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
37979300|NCT00361335|69666070|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
37979301|NCT00361335|69666071|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
37868544|NCT01185600|69552080|FG000|Overall Study|Death|0|||
37868545|NCT01185600|69552081|FG001|Overall Study|Death|1|||
37868546|NCT01185600|69552080|FG000|Overall Study|Lost to Follow-up|0|||
37868547|NCT01185600|69552081|FG001|Overall Study|Lost to Follow-up|5|||
37868548|NCT01185600|69552080|FG000|Overall Study|Physician Decision|29|||
37868549|NCT01185600|69552081|FG001|Overall Study|Physician Decision|35|||
37868550|NCT01185600|69552080|FG000|Overall Study|Withdrawal by Subject|1|||
37868551|NCT01185600|69552081|FG001|Overall Study|Withdrawal by Subject|1|||
37868552|NCT01185600|69552080|FG000|Overall Study|Hold by DSMB|1|||
37868553|NCT01185600|69552081|FG001|Overall Study|Hold by DSMB|2|||
37868554|NCT01185522|69552090|FG000|Overall Study|Lack of Efficacy|28|||
37868555|NCT01185522|69552090|FG000|Overall Study|Lost to Follow-up|19|||
37868556|NCT01185522|69552090|FG000|Overall Study|Withdrawal by Subject|10|||
37868557|NCT01185522|69552090|FG000|Overall Study|Poor tolerance|39|||
37868558|NCT01185522|69552090|FG000|Overall Study|Other reasons|12|||
37868559|NCT01185366|69552097|FG000|First Line Therapy|Insurance Coverage Denied|1|||
37868560|NCT01185366|69552098|FG001|First Line Therapy|Insurance Coverage Denied|1|||
37868561|NCT01185366|69552097|FG000|First Line Therapy|Withdrawal by Subject|1|||
37868562|NCT01185366|69552098|FG001|First Line Therapy|Withdrawal by Subject|0|||
37868563|NCT01185366|69552097|FG000|First Line Therapy|Lack of Metastatic Site|1|||
37868564|NCT01185366|69552098|FG001|First Line Therapy|Lack of Metastatic Site|0|||
37868565|NCT01185366|69552097|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
37868566|NCT01185366|69552098|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
37868567|NCT01185366|69552097|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
37868568|NCT01185366|69552098|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
37868569|NCT01185366|69552097|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
37868570|NCT01185366|69552098|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
37868571|NCT01185366|69552097|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
37868572|NCT01185366|69552098|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
37868573|NCT01185288|69552108|FG000|Overall Study|Adverse Event|7|||
37868574|NCT01185288|69552109|FG001|Overall Study|Adverse Event|6|||
37868575|NCT01185288|69552108|FG000|Overall Study|Withdrawal by Subject|6|||
37868576|NCT01185288|69552109|FG001|Overall Study|Withdrawal by Subject|4|||
37868577|NCT01185288|69552108|FG000|Overall Study|Lost to Follow-up|2|||
37868578|NCT01185288|69552109|FG001|Overall Study|Lost to Follow-up|5|||
37868579|NCT01185288|69552108|FG000|Overall Study|Lack of Efficacy|2|||
37868580|NCT01185288|69552109|FG001|Overall Study|Lack of Efficacy|0|||
37868581|NCT01185288|69552108|FG000|Overall Study|Investigator discretion|1|||
37868582|NCT01185288|69552109|FG001|Overall Study|Investigator discretion|0|||
37868583|NCT01185288|69552108|FG000|Overall Study|Did not meet inclusion criteria|1|||
37868584|NCT01185288|69552109|FG001|Overall Study|Did not meet inclusion criteria|0|||
37868585|NCT01185288|69552108|FG000|Overall Study|Noncompliance|0|||
37868586|NCT01185288|69552109|FG001|Overall Study|Noncompliance|1|||
37868587|NCT01184508|69552117|FG000|Overall Study|Adverse Event|4|||
37868588|NCT01184508|69552118|FG001|Overall Study|Adverse Event|6|||
37868589|NCT01184508|69552117|FG000|Overall Study|Lack of Efficacy|1|||
37868590|NCT01184508|69552118|FG001|Overall Study|Lack of Efficacy|1|||
37868591|NCT01184508|69552117|FG000|Overall Study|Lost to Follow-up|1|||
37979302|NCT00361335|69666072|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
37694816|NCT02466425|69171250|FG000|Overall Study|Withdrawal by Subject|0|||
37868592|NCT01184508|69552118|FG001|Overall Study|Lost to Follow-up|1|||
37868593|NCT01184508|69552117|FG000|Overall Study|Physician Decision|1|||
37868594|NCT01184508|69552118|FG001|Overall Study|Physician Decision|0|||
37868595|NCT01184508|69552117|FG000|Overall Study|Protocol Violation|3|||
37868596|NCT01184508|69552118|FG001|Overall Study|Protocol Violation|1|||
37868597|NCT01184508|69552117|FG000|Overall Study|Sponsor Decision|5|||
37868598|NCT01184508|69552118|FG001|Overall Study|Sponsor Decision|2|||
37868599|NCT01184508|69552117|FG000|Overall Study|Withdrawal by Subject|1|||
37868600|NCT01184508|69552118|FG001|Overall Study|Withdrawal by Subject|3|||
37868601|NCT01184508|69552117|FG000|Overall Study|Randomized, Not Treated|0|||
37868602|NCT01184508|69552118|FG001|Overall Study|Randomized, Not Treated|1|||
37868603|NCT01184118|69552125|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
37868604|NCT01184118|69552125|FG000|Overall Study|No physiologic confirmation of asthma|8|||
37868605|NCT01184118|69552125|FG000|Overall Study|FEV1 <60% predicted|2|||
37868606|NCT01184118|69552125|FG000|Overall Study|Exclusionary medical condition|2|||
37868607|NCT01184118|69552125|FG000|Overall Study|Withdrawal by Subject|5|||
37979303|NCT00361335|69666066|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
37979304|NCT00361335|69666067|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
37979305|NCT00361335|69666068|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
37979306|NCT00361335|69666069|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
37979307|NCT00361335|69666070|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
37979308|NCT00361335|69666071|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
37979309|NCT00361335|69666072|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
37979310|NCT00361335|69666066|FG000|SC Period: Week E0 to Week E24|Death|0|||
37979311|NCT00361335|69666067|FG001|SC Period: Week E0 to Week E24|Death|0|||
37979312|NCT00361335|69666068|FG002|SC Period: Week E0 to Week E24|Death|0|||
37979313|NCT00361335|69666069|FG003|SC Period: Week E0 to Week E24|Death|0|||
37979314|NCT00361335|69666070|FG004|SC Period: Week E0 to Week E24|Death|0|||
37979315|NCT00361335|69666071|FG005|SC Period: Week E0 to Week E24|Death|0|||
37979316|NCT00361335|69666072|FG006|SC Period: Week E0 to Week E24|Death|1|||
37979317|NCT00361335|69666066|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
37979318|NCT00361335|69666067|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
37979319|NCT00361335|69666068|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
37979320|NCT00361335|69666069|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
37979321|NCT00361335|69666070|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
37979322|NCT00361335|69666071|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
37979323|NCT00361335|69666072|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
37979324|NCT00361335|69666066|FG000|SC Period: Week E0 to Week E24|Other|1|||
37979325|NCT00361335|69666067|FG001|SC Period: Week E0 to Week E24|Other|0|||
37979326|NCT00361335|69666068|FG002|SC Period: Week E0 to Week E24|Other|0|||
37979327|NCT00361335|69666069|FG003|SC Period: Week E0 to Week E24|Other|1|||
37979328|NCT00361335|69666070|FG004|SC Period: Week E0 to Week E24|Other|0|||
37979329|NCT00361335|69666071|FG005|SC Period: Week E0 to Week E24|Other|1|||
37815421|NCT04019041|69493270|FG004|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
37815422|NCT04019041|69493271|FG005|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
37815423|NCT04019041|69493266|FG000|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
37815424|NCT04019041|69493267|FG001|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
37815425|NCT04019041|69493268|FG002|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
37815426|NCT04019041|69493269|FG003|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
37815427|NCT04019041|69493270|FG004|Active Treatment+Safety F-U (Week 17-36)|Death|1|||
37815428|NCT04019041|69493271|FG005|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
37815429|NCT04019041|69493266|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
37815430|NCT04019041|69493267|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
37815431|NCT04019041|69493268|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
37815432|NCT04019041|69493269|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
37815433|NCT04019041|69493270|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|2|||
37815434|NCT04019041|69493271|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
37815435|NCT04019041|69493266|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
37815436|NCT04019041|69493267|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
37815437|NCT04019041|69493268|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
37815438|NCT04019041|69493269|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
37815439|NCT04019041|69493270|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|3|||
37815440|NCT04019041|69493271|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|1|||
37815441|NCT03919448|69493300|FG000|Overall Study|Withdrawal by Subject|1|||
37815442|NCT03919448|69493301|FG001|Overall Study|Withdrawal by Subject|0|||
37815443|NCT03919448|69493302|FG002|Overall Study|Withdrawal by Subject|0|||
37815444|NCT03795922|69493329|FG000|Overall Study|Adverse Event|2|||
37815445|NCT03795922|69493330|FG001|Overall Study|Adverse Event|1|||
37815446|NCT03795922|69493329|FG000|Overall Study|Withdrawal by Subject|5|||
37815447|NCT03795922|69493330|FG001|Overall Study|Withdrawal by Subject|13|||
37815448|NCT03795922|69493329|FG000|Overall Study|Lost to Follow-up|2|||
37815449|NCT03795922|69493330|FG001|Overall Study|Lost to Follow-up|3|||
37815450|NCT03795922|69493329|FG000|Overall Study|Pregnancy|0|||
37815451|NCT03795922|69493330|FG001|Overall Study|Pregnancy|1|||
37815452|NCT03795922|69493329|FG000|Overall Study|Physician Decision|1|||
37868608|NCT01183884|69552129|FG000|Overall Study|Progressive Disease|26|||
37979330|NCT00361335|69666072|FG006|SC Period: Week E0 to Week E24|Other|2|||
37815453|NCT03795922|69493330|FG001|Overall Study|Physician Decision|2|||
37979331|NCT00361335|69666066|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
37979332|NCT00361335|69666067|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
37979333|NCT00361335|69666068|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
37868609|NCT01183884|69552129|FG000|Overall Study|Adverse Event|3|||
37868610|NCT01183884|69552129|FG000|Overall Study|Withdrawal by Subject|1|||
37868611|NCT01183884|69552129|FG000|Overall Study|Other Complicating Disease|3|||
37868612|NCT01183884|69552129|FG000|Overall Study|Not Treated|1|||
37868613|NCT01183884|69552129|FG000|Overall Study|Other|4|||
37868614|NCT01183260|69552135|FG000|Overall Study|Intraop screen failure|2|||
37868615|NCT01183260|69552136|FG001|Overall Study|Intraop screen failure|0|||
37868616|NCT01183260|69552135|FG000|Overall Study|Withdrawal by Subject|1|||
37868617|NCT01183260|69552136|FG001|Overall Study|Withdrawal by Subject|1|||
37868618|NCT01183260|69552135|FG000|Overall Study|Revised within 30 days|0|||
37868619|NCT01183260|69552136|FG001|Overall Study|Revised within 30 days|1|||
37868620|NCT01183260|69552135|FG000|Overall Study|Death|1|||
37868621|NCT01183260|69552136|FG001|Overall Study|Death|0|||
37868622|NCT01191762|69552144|FG000|Overall Study|Adverse Event|1|||
37868623|NCT01191762|69552145|FG001|Overall Study|Adverse Event|0|||
37868624|NCT01723774|69552154|FG000|Neoadjuvant|Ki67 > 10%|4|||
37868625|NCT01723774|69552155|FG001|Neoadjuvant|Ki67 > 10%|0|||
37868626|NCT01723774|69552156|FG002|Neoadjuvant|Ki67 > 10%|10|||
37868627|NCT01723774|69552157|FG003|Neoadjuvant|Ki67 > 10%|0|||
37868628|NCT01723774|69552154|FG000|Neoadjuvant|Withdrawal by Subject|3|||
37868629|NCT01723774|69552155|FG001|Neoadjuvant|Withdrawal by Subject|1|||
37868630|NCT01723774|69552156|FG002|Neoadjuvant|Withdrawal by Subject|0|||
37868631|NCT01723774|69552157|FG003|Neoadjuvant|Withdrawal by Subject|0|||
37868632|NCT01723774|69552154|FG000|Neoadjuvant|Disease progression|0|||
37868633|NCT01723774|69552155|FG001|Neoadjuvant|Disease progression|1|||
37868634|NCT01723774|69552156|FG002|Neoadjuvant|Disease progression|1|||
37868635|NCT01723774|69552157|FG003|Neoadjuvant|Disease progression|0|||
37868636|NCT01723774|69552154|FG000|Neoadjuvant|Adverse Event|0|||
37868637|NCT01723774|69552155|FG001|Neoadjuvant|Adverse Event|1|||
37868638|NCT01723774|69552156|FG002|Neoadjuvant|Adverse Event|2|||
37868639|NCT01723774|69552157|FG003|Neoadjuvant|Adverse Event|0|||
37868640|NCT01723774|69552154|FG000|Neoadjuvant|High estradiol|0|||
37868641|NCT01723774|69552155|FG001|Neoadjuvant|High estradiol|1|||
37979334|NCT00361335|69666069|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
37979335|NCT00361335|69666070|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
37979336|NCT00361335|69666071|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
37979337|NCT00361335|69666072|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
37979338|NCT00264550|69666092|FG000|Overall Study|Death|0|||
37979339|NCT00264550|69666093|FG001|Overall Study|Death|3|||
37979340|NCT00264550|69666094|FG002|Overall Study|Death|0|||
37979341|NCT00264550|69666095|FG003|Overall Study|Death|0|||
37979342|NCT00264550|69666092|FG000|Overall Study|Lost to Follow-up|3|||
37979343|NCT00264550|69666093|FG001|Overall Study|Lost to Follow-up|1|||
37979344|NCT00264550|69666094|FG002|Overall Study|Lost to Follow-up|1|||
37979345|NCT00264550|69666095|FG003|Overall Study|Lost to Follow-up|1|||
37979346|NCT00264550|69666092|FG000|Overall Study|Adverse Event|23|||
37979347|NCT00264550|69666093|FG001|Overall Study|Adverse Event|18|||
37979348|NCT00264550|69666094|FG002|Overall Study|Adverse Event|9|||
37979349|NCT00264550|69666095|FG003|Overall Study|Adverse Event|14|||
37979350|NCT00264550|69666092|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
37979351|NCT00264550|69666093|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
37979352|NCT00264550|69666094|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
37979353|NCT00264550|69666095|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
37979354|NCT00264550|69666092|FG000|Overall Study|Discontinued oral study agent|0|||
37979355|NCT00264550|69666093|FG001|Overall Study|Discontinued oral study agent|1|||
37979356|NCT00264550|69666094|FG002|Overall Study|Discontinued oral study agent|0|||
37868642|NCT01723774|69552156|FG002|Neoadjuvant|High estradiol|0|||
37868643|NCT01723774|69552157|FG003|Neoadjuvant|High estradiol|0|||
37868644|NCT01723774|69552154|FG000|Adjuvant|Still on active treatment|0|||
37868645|NCT01723774|69552155|FG001|Adjuvant|Still on active treatment|0|||
37979357|NCT00264550|69666095|FG003|Overall Study|Discontinued oral study agent|0|||
37868646|NCT01723774|69552156|FG002|Adjuvant|Still on active treatment|0|||
37868647|NCT01723774|69552157|FG003|Adjuvant|Still on active treatment|1|||
37868648|NCT01190514|69552166|FG000|First Intervention (Period 1)|Adverse Event|1|||
37868649|NCT01190514|69552167|FG001|First Intervention (Period 1)|Adverse Event|0|||
37868650|NCT01190514|69552168|FG002|First Intervention (Period 1)|Adverse Event|0|||
37868651|NCT01190514|69552169|FG003|First Intervention (Period 1)|Adverse Event|0|||
37868652|NCT01190514|69552166|FG000|Third Intervention (Period 3)|Adverse Event|1|||
37868653|NCT01190514|69552167|FG001|Third Intervention (Period 3)|Adverse Event|0|||
37868654|NCT01190514|69552168|FG002|Third Intervention (Period 3)|Adverse Event|0|||
37868655|NCT01190514|69552169|FG003|Third Intervention (Period 3)|Adverse Event|0|||
37868656|NCT01190436|69552179|FG000|Overall Study|Lost to Follow-up|35|||
37868657|NCT01190436|69552179|FG000|Overall Study|Other|4|||
37868658|NCT01035255|69552186|FG000|Overall Study|Death|724|||
37868659|NCT01035255|69552187|FG001|Overall Study|Death|844|||
37868660|NCT01035255|69552186|FG000|Overall Study|Lost to Follow-up|2|||
37868661|NCT01035255|69552187|FG001|Overall Study|Lost to Follow-up|5|||
37979358|NCT00264550|69666092|FG000|Overall Study|Other|13|||
37979359|NCT00264550|69666093|FG001|Overall Study|Other|7|||
37979360|NCT00264550|69666094|FG002|Overall Study|Other|3|||
37979361|NCT00264550|69666095|FG003|Overall Study|Other|9|||
37979362|NCT00541931|69666107|FG000|Overall Study|Adverse Event|1|||
37979363|NCT00541931|69666108|FG001|Overall Study|Adverse Event|0|||
37979364|NCT00541931|69666107|FG000|Overall Study|Lost to Follow-up|3|||
37868662|NCT01035255|69552186|FG000|Overall Study|patient's request|15|||
37868663|NCT01035255|69552187|FG001|Overall Study|patient's request|13|||
37868664|NCT01190124|69552196|FG000|Overall Study|Death|3|||
37868665|NCT01190124|69552197|FG001|Overall Study|Death|0|||
37868666|NCT01190124|69552198|FG002|Overall Study|Death|0|||
37868667|NCT01190124|69552196|FG000|Overall Study|Therapeutic Failure|12|||
37868668|NCT01190124|69552197|FG001|Overall Study|Therapeutic Failure|0|||
37868669|NCT01190124|69552198|FG002|Overall Study|Therapeutic Failure|1|||
37868670|NCT01190124|69552196|FG000|Overall Study|Lost to Follow-up|2|||
37868671|NCT01190124|69552197|FG001|Overall Study|Lost to Follow-up|0|||
37979365|NCT00541931|69666108|FG001|Overall Study|Lost to Follow-up|3|||
37979366|NCT00541931|69666107|FG000|Overall Study|Withdrawal by Subject|1|||
37979367|NCT00541931|69666108|FG001|Overall Study|Withdrawal by Subject|0|||
37979368|NCT00541931|69666107|FG000|Overall Study|Transportation Issue|0|||
37979369|NCT00541931|69666108|FG001|Overall Study|Transportation Issue|1|||
37979370|NCT00368979|69666118|FG000|Overall Study|Adverse Event|9|||
37979371|NCT00368979|69666119|FG001|Overall Study|Adverse Event|16|||
37979372|NCT00368979|69666118|FG000|Overall Study|Lack of Efficacy|5|||
37868672|NCT01190124|69552198|FG002|Overall Study|Lost to Follow-up|0|||
37868673|NCT01189890|69552211|FG000|Overall Study|Adverse Event|3|||
37868674|NCT01189890|69552212|FG001|Overall Study|Adverse Event|4|||
37868675|NCT01189890|69552211|FG000|Overall Study|Lack of Efficacy|7|||
37868676|NCT01189890|69552212|FG001|Overall Study|Lack of Efficacy|2|||
37868677|NCT01189890|69552211|FG000|Overall Study|Lost to Follow-up|1|||
37868678|NCT01189890|69552212|FG001|Overall Study|Lost to Follow-up|7|||
37868679|NCT01189890|69552211|FG000|Overall Study|Protocol Violation|1|||
37868680|NCT01189890|69552212|FG001|Overall Study|Protocol Violation|5|||
37815454|NCT03795922|69493329|FG000|Overall Study|Protocol Violation|0|||
37815455|NCT03795922|69493330|FG001|Overall Study|Protocol Violation|1|||
37815456|NCT03795922|69493329|FG000|Overall Study|Other (Early termination, COVID, Family issue)|3|||
37815457|NCT03795922|69493330|FG001|Overall Study|Other (Early termination, COVID, Family issue)|4|||
37815458|NCT03794089|69493340|FG000|Overall Study|Lost to Follow-up|4|||
37815459|NCT03794089|69493341|FG001|Overall Study|Lost to Follow-up|1|||
37815460|NCT03794089|69493340|FG000|Overall Study|Withdrawal by Subject|2|||
37815461|NCT03794089|69493341|FG001|Overall Study|Withdrawal by Subject|0|||
37815462|NCT03769025|69493349|FG000|Overall Study|Withdrawal by Subject|1|||
37815463|NCT03769025|69493350|FG001|Overall Study|Withdrawal by Subject|1|||
37815464|NCT03769025|69493349|FG000|Overall Study|Lost to Follow-up|4|||
37815465|NCT03769025|69493350|FG001|Overall Study|Lost to Follow-up|3|||
37815466|NCT03762473|69493358|FG000|Overall Study|Death|1|||
37815467|NCT03762473|69493359|FG001|Overall Study|Death|0|||
37815468|NCT03759366|69493365|FG000|Primary Evaluation Period (26 Weeks)|Ongoing during the Primary Evaluation Period|1|||
37815469|NCT03759366|69493365|FG000|Extension Period (Up to 208 Weeks)|Ongoing during the Extension Period|10|||
37815470|NCT03745989|69493372|FG000|Overall Study|Death|3|||
37815471|NCT03745989|69493373|FG001|Overall Study|Death|7|||
37815472|NCT03745989|69493374|FG002|Overall Study|Death|4|||
37815473|NCT03745989|69493372|FG000|Overall Study|Lost to Follow-up|0|||
37815474|NCT03745989|69493373|FG001|Overall Study|Lost to Follow-up|2|||
37815475|NCT03745989|69493374|FG002|Overall Study|Lost to Follow-up|0|||
37815476|NCT03745989|69493372|FG000|Overall Study|Sponsor Decision|0|||
37815477|NCT03745989|69493373|FG001|Overall Study|Sponsor Decision|2|||
37815478|NCT03745989|69493374|FG002|Overall Study|Sponsor Decision|8|||
37815479|NCT03745989|69493372|FG000|Overall Study|Withdrawal by Subject|0|||
37815480|NCT03745989|69493373|FG001|Overall Study|Withdrawal by Subject|1|||
37815481|NCT03745989|69493374|FG002|Overall Study|Withdrawal by Subject|3|||
37815482|NCT03646656|69493404|FG000|Overall Study|Lost to Follow-up|1|||
37815483|NCT03646656|69493405|FG001|Overall Study|Lost to Follow-up|0|||
37815484|NCT03646656|69493404|FG000|Overall Study|Withdrawal by Subject|2|||
37815485|NCT03646656|69493405|FG001|Overall Study|Withdrawal by Subject|0|||
37815486|NCT03555435|69493418|FG000|Overall Study|Lost to Follow-up|17|||
37815487|NCT03555435|69493419|FG001|Overall Study|Lost to Follow-up|19|||
37868681|NCT01189890|69552211|FG000|Overall Study|Withdrawal by Subject|15|||
37868682|NCT01189890|69552212|FG001|Overall Study|Withdrawal by Subject|11|||
37868683|NCT01189890|69552211|FG000|Overall Study|Non Compliance|0|||
37868684|NCT01189890|69552212|FG001|Overall Study|Non Compliance|1|||
37868685|NCT01189890|69552211|FG000|Overall Study|Physician Decision|5|||
37868686|NCT01189890|69552212|FG001|Overall Study|Physician Decision|4|||
37868687|NCT01189890|69552211|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
37979373|NCT00368979|69666119|FG001|Overall Study|Lack of Efficacy|3|||
37979374|NCT00368979|69666118|FG000|Overall Study|Other|3|||
37979375|NCT00368979|69666119|FG001|Overall Study|Other|1|||
37979376|NCT00368979|69666118|FG000|Overall Study|Lost to Follow-up|1|||
37979377|NCT00368979|69666119|FG001|Overall Study|Lost to Follow-up|0|||
37979378|NCT00368979|69666118|FG000|Overall Study|Protocol Violation|2|||
37979379|NCT00368979|69666119|FG001|Overall Study|Protocol Violation|1|||
37979380|NCT00368979|69666118|FG000|Overall Study|Withdrawal by Subject|5|||
37979381|NCT00368979|69666119|FG001|Overall Study|Withdrawal by Subject|9|||
37979382|NCT00264238|69666125|FG000|Overall Study|Protocol Violation|1|||
37979383|NCT00540293|69666131|FG000|Overall Study|Adverse event related to study drug|10|||
37979384|NCT00540293|69666131|FG000|Overall Study|Adverse event not related to study drug|7|||
37979385|NCT00540293|69666131|FG000|Overall Study|Withdrawal by Subject|6|||
37979386|NCT00540293|69666131|FG000|Overall Study|Protocol violation, & subject schedule|12|||
37979387|NCT00359073|69666172|FG000|Overall Study|Withdrawal by Subject|1|||
37979388|NCT00359073|69666173|FG001|Overall Study|Withdrawal by Subject|1|||
37979389|NCT00359073|69666172|FG000|Overall Study|Eligibility criteria no longer met|3|||
37979390|NCT00359073|69666173|FG001|Overall Study|Eligibility criteria no longer met|0|||
37979391|NCT00359073|69666172|FG000|Overall Study|developed RV16 antibody|0|||
37979392|NCT00359073|69666173|FG001|Overall Study|developed RV16 antibody|1|||
37979393|NCT03918239|69666183|FG000|Overall Study|Lost to Follow-up|3|||
37979394|NCT03918239|69666184|FG001|Overall Study|Lost to Follow-up|1|||
37979395|NCT03918239|69666183|FG000|Overall Study|Pregnancy|0|||
37979396|NCT03918239|69666184|FG001|Overall Study|Pregnancy|2|||
37979397|NCT03918239|69666183|FG000|Overall Study|Withdrawal by Subject|3|||
37979398|NCT03918239|69666184|FG001|Overall Study|Withdrawal by Subject|3|||
37979399|NCT03918239|69666183|FG000|Overall Study|positive urine drug screening results|4|||
37979400|NCT03918239|69666184|FG001|Overall Study|positive urine drug screening results|1|||
37979401|NCT00368745|69666192|FG000|Double-blind Treatment Period|Adverse Event|6|||
37979402|NCT00368745|69666193|FG001|Double-blind Treatment Period|Adverse Event|6|||
37979403|NCT00368745|69666192|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
37979404|NCT00368745|69666193|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
37979405|NCT00368745|69666192|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
37979406|NCT00368745|69666193|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
37979407|NCT00368745|69666192|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
37979408|NCT00368745|69666193|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
37979409|NCT00368745|69666192|FG000|Double-blind Treatment Period|Other|7|||
37979410|NCT00368745|69666193|FG001|Double-blind Treatment Period|Other|6|||
37979411|NCT00454818|69666207|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
37979412|NCT00454818|69666208|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
37979413|NCT00454818|69666209|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
37979414|NCT00454818|69666210|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
37979415|NCT00454818|69666211|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
37979416|NCT00454818|69666207|FG000|Phase I: Open-label Dose-escalation|Death|0|||
37979417|NCT00454818|69666208|FG001|Phase I: Open-label Dose-escalation|Death|1|||
37979418|NCT00454818|69666209|FG002|Phase I: Open-label Dose-escalation|Death|0|||
37979419|NCT00454818|69666210|FG003|Phase I: Open-label Dose-escalation|Death|0|||
37979420|NCT00454818|69666211|FG004|Phase I: Open-label Dose-escalation|Death|0|||
37979421|NCT00454818|69666207|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
37979422|NCT00454818|69666208|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
37979423|NCT00454818|69666209|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
37979424|NCT00454818|69666210|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
37979425|NCT00454818|69666211|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
37979426|NCT00454818|69666207|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
37979427|NCT00454818|69666208|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
37979428|NCT00454818|69666209|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
37979429|NCT00454818|69666210|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
37815488|NCT03555435|69493420|FG002|Overall Study|Lost to Follow-up|8|||
37815489|NCT03521115|69493430|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
37815490|NCT03521115|69493431|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
37815491|NCT03521115|69493430|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
37815492|NCT03521115|69493431|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
37815493|NCT03520413|69493445|FG000|Overall Study|Lost to Follow-up|1|||
37815494|NCT03520413|69493446|FG001|Overall Study|Lost to Follow-up|1|||
37815495|NCT03520413|69493445|FG000|Overall Study|Withdrawal by Subject|1|||
37815496|NCT03520413|69493446|FG001|Overall Study|Withdrawal by Subject|2|||
37815497|NCT03520413|69493445|FG000|Overall Study|Death|0|||
37815498|NCT03520413|69493446|FG001|Overall Study|Death|1|||
37815499|NCT03520413|69493445|FG000|Overall Study|Physician Decision|3|||
37815500|NCT03520413|69493446|FG001|Overall Study|Physician Decision|3|||
37815501|NCT03520413|69493445|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
37815502|NCT03520413|69493446|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
37815503|NCT03419897|69493453|FG000|Overall Study|Death|180|||
37815504|NCT03419897|69493453|FG000|Overall Study|Lost to Follow-up|1|||
37979430|NCT00454818|69666211|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
37979431|NCT00454818|69666207|FG000|Phase 2: Randomized Double-blind|Death|0|||
37868688|NCT01189890|69552212|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
37868689|NCT01189812|69552220|FG000|Overall Study|Withdrawal by Subject|2|||
37868690|NCT01189812|69552221|FG001|Overall Study|Withdrawal by Subject|3|||
37868691|NCT01189812|69552220|FG000|Overall Study|Adverse Event|1|||
37868692|NCT01189812|69552221|FG001|Overall Study|Adverse Event|0|||
37868693|NCT01189812|69552220|FG000|Overall Study|Out of Window|4|||
37868694|NCT01189812|69552221|FG001|Overall Study|Out of Window|3|||
37868695|NCT01189812|69552220|FG000|Overall Study|Moved out of State|1|||
37868696|NCT01189812|69552221|FG001|Overall Study|Moved out of State|2|||
37868697|NCT00950950|69552229|FG000|Overall Study|Adverse Event|1|||
37868698|NCT00950950|69552230|FG001|Overall Study|Adverse Event|0|||
37868699|NCT00950950|69552229|FG000|Overall Study|Withdrawal by Subject|0|||
37868700|NCT00950950|69552230|FG001|Overall Study|Withdrawal by Subject|1|||
37868701|NCT00950872|69552237|FG000|Overall Study|Withdrawal by Subject|1|||
37868702|NCT00950872|69552237|FG000|Overall Study|Did not have surgery|2|||
37868703|NCT01189500|69552241|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
37868704|NCT01189500|69552241|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
37868705|NCT00938860|69552250|FG000|Overall Study|Adverse Event|2|||
37868706|NCT00938860|69552251|FG001|Overall Study|Adverse Event|1|||
37868707|NCT00938860|69552250|FG000|Overall Study|Abnormal laboratory values|2|||
37868708|NCT00938860|69552251|FG001|Overall Study|Abnormal laboratory values|2|||
37868709|NCT00938860|69552250|FG000|Overall Study|Withdrawal by Subject|11|||
37868710|NCT00938860|69552251|FG001|Overall Study|Withdrawal by Subject|8|||
37868711|NCT00938860|69552250|FG000|Overall Study|Lost to Follow-up|4|||
37868712|NCT00938860|69552251|FG001|Overall Study|Lost to Follow-up|4|||
37868713|NCT00938860|69552250|FG000|Overall Study|Administration problems|2|||
37868714|NCT00938860|69552251|FG001|Overall Study|Administration problems|0|||
37868715|NCT00938860|69552250|FG000|Overall Study|Death|1|||
37868716|NCT00938860|69552251|FG001|Overall Study|Death|1|||
37868717|NCT00938860|69552250|FG000|Overall Study|Protocol Violation|3|||
37868718|NCT00938860|69552251|FG001|Overall Study|Protocol Violation|1|||
37868719|NCT00938470|69552259|FG000|Overall Study|Disease Progression|3|||
37868720|NCT00938470|69552260|FG001|Overall Study|Disease Progression|0|||
37868721|NCT00938470|69552259|FG000|Overall Study|Alternate Treatment|1|||
37868722|NCT00938470|69552260|FG001|Overall Study|Alternate Treatment|0|||
37868723|NCT00938470|69552259|FG000|Overall Study|Death|3|||
37868724|NCT00938470|69552260|FG001|Overall Study|Death|2|||
37868725|NCT00938470|69552259|FG000|Overall Study|Other Reason|0|||
37868726|NCT00938470|69552260|FG001|Overall Study|Other Reason|1|||
37868727|NCT00938392|69552268|FG000|Overall Study|Adverse Event|0|||
37868728|NCT00938392|69552269|FG001|Overall Study|Adverse Event|1|||
37868729|NCT00938392|69552268|FG000|Overall Study|Withdrawal by Subject|0|||
37868730|NCT00938392|69552269|FG001|Overall Study|Withdrawal by Subject|1|||
37868731|NCT00938392|69552268|FG000|Overall Study|Lost to Follow-up|2|||
37868732|NCT00938392|69552269|FG001|Overall Study|Lost to Follow-up|2|||
37868733|NCT01022853|69552280|FG000|Overall Study|Progressive disease|2|||
37868734|NCT01022853|69552281|FG001|Overall Study|Progressive disease|3|||
37868735|NCT01022853|69552282|FG002|Overall Study|Progressive disease|11|||
37868736|NCT01022853|69552283|FG003|Overall Study|Progressive disease|7|||
37868737|NCT01022853|69552284|FG004|Overall Study|Progressive disease|1|||
37868738|NCT01022853|69552280|FG000|Overall Study|Dose-limiting toxicity|0|||
37868739|NCT01022853|69552281|FG001|Overall Study|Dose-limiting toxicity|0|||
37868740|NCT01022853|69552282|FG002|Overall Study|Dose-limiting toxicity|0|||
37868741|NCT01022853|69552283|FG003|Overall Study|Dose-limiting toxicity|0|||
37868742|NCT01022853|69552284|FG004|Overall Study|Dose-limiting toxicity|1|||
37868743|NCT01022853|69552280|FG000|Overall Study|Withdrawal by Subject|0|||
37868744|NCT01022853|69552281|FG001|Overall Study|Withdrawal by Subject|1|||
37868745|NCT01022853|69552282|FG002|Overall Study|Withdrawal by Subject|1|||
37868746|NCT01022853|69552283|FG003|Overall Study|Withdrawal by Subject|1|||
37868747|NCT01022853|69552284|FG004|Overall Study|Withdrawal by Subject|0|||
37868748|NCT01022853|69552280|FG000|Overall Study|Other not stated above|1|||
37868749|NCT01022853|69552281|FG001|Overall Study|Other not stated above|0|||
37979432|NCT00454818|69666208|FG001|Phase 2: Randomized Double-blind|Death|1|||
37868750|NCT01022853|69552282|FG002|Overall Study|Other not stated above|1|||
37868751|NCT01022853|69552283|FG003|Overall Study|Other not stated above|0|||
37868752|NCT01022853|69552284|FG004|Overall Study|Other not stated above|0|||
37868753|NCT01034709|69552301|FG000|Overall Study|Protocol Violation|9|||
37868754|NCT01034709|69552302|FG001|Overall Study|Protocol Violation|16|||
37868755|NCT00937768|69552310|FG000|Overall Study|Refused Further Treatment|3|||
37868756|NCT00937768|69552311|FG001|Overall Study|Refused Further Treatment|2|||
37868757|NCT00937768|69552310|FG000|Overall Study|Disease Progression|1|||
37868758|NCT00937768|69552311|FG001|Overall Study|Disease Progression|1|||
37868759|NCT00937768|69552310|FG000|Overall Study|Alternate Treatment|0|||
37979433|NCT00454818|69666209|FG002|Phase 2: Randomized Double-blind|Death|0|||
37868760|NCT00937768|69552311|FG001|Overall Study|Alternate Treatment|1|||
37868761|NCT00937768|69552310|FG000|Overall Study|No Further Funding|4|||
37868762|NCT00937768|69552311|FG001|Overall Study|No Further Funding|4|||
37868763|NCT00940888|69552317|FG000|Overall Study|Unsuccessful Implant|4|||
37868764|NCT00940888|69552317|FG000|Overall Study|Death|461|||
37868765|NCT00940888|69552317|FG000|Overall Study|Withdrawn - Non-Death|364|||
37868766|NCT00940888|69552317|FG000|Overall Study|Lost to Follow-up|6|||
37868767|NCT01189266|69552324|FG000|Overall Study|Adverse Event|1|||
37868768|NCT01189266|69552325|FG001|Overall Study|Adverse Event|0|||
37868769|NCT01189266|69552326|FG002|Overall Study|Adverse Event|5|||
37868770|NCT01189266|69552324|FG000|Overall Study|Death|0|||
37868771|NCT01189266|69552325|FG001|Overall Study|Death|0|||
37868772|NCT01189266|69552326|FG002|Overall Study|Death|5|||
37868773|NCT01189266|69552324|FG000|Overall Study|Lack of Efficacy|4|||
37868774|NCT01189266|69552325|FG001|Overall Study|Lack of Efficacy|5|||
37868775|NCT01189266|69552326|FG002|Overall Study|Lack of Efficacy|44|||
37868776|NCT01189266|69552324|FG000|Overall Study|Physician Decision|0|||
37868777|NCT01189266|69552325|FG001|Overall Study|Physician Decision|0|||
37868778|NCT01189266|69552326|FG002|Overall Study|Physician Decision|1|||
37868779|NCT01189266|69552324|FG000|Overall Study|Protocol Violation|0|||
37868780|NCT01189266|69552325|FG001|Overall Study|Protocol Violation|1|||
37868781|NCT01189266|69552326|FG002|Overall Study|Protocol Violation|1|||
37868782|NCT01189266|69552324|FG000|Overall Study|Withdrawal by Subject|0|||
37868783|NCT01189266|69552325|FG001|Overall Study|Withdrawal by Subject|0|||
37868784|NCT01189266|69552326|FG002|Overall Study|Withdrawal by Subject|1|||
37868785|NCT01189266|69552324|FG000|Overall Study|Patient refuses further therapy|1|||
37868786|NCT01189266|69552325|FG001|Overall Study|Patient refuses further therapy|0|||
37868787|NCT01189266|69552326|FG002|Overall Study|Patient refuses further therapy|7|||
37868788|NCT01189266|69552324|FG000|Overall Study|No treatment|0|||
37868789|NCT01189266|69552325|FG001|Overall Study|No treatment|0|||
37868790|NCT01189266|69552326|FG002|Overall Study|No treatment|1|||
37868791|NCT01189032|69552338|FG000|Overall Study|Adverse Event|1|||
37868792|NCT01189032|69552339|FG001|Overall Study|Adverse Event|3|||
37868793|NCT01189032|69552340|FG002|Overall Study|Adverse Event|4|||
37868794|NCT01189032|69552338|FG000|Overall Study|Lack of Efficacy|2|||
37868795|NCT01189032|69552339|FG001|Overall Study|Lack of Efficacy|3|||
37868796|NCT01189032|69552340|FG002|Overall Study|Lack of Efficacy|0|||
37868797|NCT01189032|69552338|FG000|Overall Study|Withdrawal by Subject|1|||
37868798|NCT01189032|69552339|FG001|Overall Study|Withdrawal by Subject|0|||
37868799|NCT01189032|69552340|FG002|Overall Study|Withdrawal by Subject|1|||
37868800|NCT01189032|69552338|FG000|Overall Study|Protocol Violation|1|||
37868801|NCT01189032|69552339|FG001|Overall Study|Protocol Violation|1|||
37868802|NCT01189032|69552340|FG002|Overall Study|Protocol Violation|1|||
37868803|NCT01188798|69552350|FG000|Overall Study|Death|0|||
37868804|NCT01188798|69552351|FG001|Overall Study|Death|1|||
37868805|NCT01188798|69552350|FG000|Overall Study|Required additional transplant|1|||
37979434|NCT00454818|69666210|FG003|Phase 2: Randomized Double-blind|Death|0|||
37979435|NCT00454818|69666211|FG004|Phase 2: Randomized Double-blind|Death|1|||
37979436|NCT00454818|69666207|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
37815505|NCT03419897|69493453|FG000|Overall Study|Withdrawal by Subject|6|||
37815506|NCT03419897|69493453|FG000|Overall Study|Sponsor Decision|61|||
37815507|NCT03419897|69493453|FG000|Overall Study|Physician Decision|1|||
37815508|NCT03418129|69493460|FG000|Overall Study|Lost to Follow-up|11|||
37815509|NCT03418129|69493461|FG001|Overall Study|Lost to Follow-up|20|||
37815510|NCT03418129|69493462|FG002|Overall Study|Lost to Follow-up|15|||
37815511|NCT03418129|69493460|FG000|Overall Study|Withdrawal by Subject|3|||
37815512|NCT03418129|69493461|FG001|Overall Study|Withdrawal by Subject|6|||
37815513|NCT03418129|69493462|FG002|Overall Study|Withdrawal by Subject|4|||
37815514|NCT03344796|69493480|FG000|Overall Study|Lost to Follow-up|0|||
37815515|NCT03344796|69493481|FG001|Overall Study|Lost to Follow-up|0|||
37815516|NCT03344796|69493482|FG002|Overall Study|Lost to Follow-up|0|||
37815517|NCT03344796|69493483|FG003|Overall Study|Lost to Follow-up|0|||
37815518|NCT03344796|69493484|FG004|Overall Study|Lost to Follow-up|0|||
37815519|NCT03344796|69493485|FG005|Overall Study|Lost to Follow-up|2|||
37815520|NCT03335488|69493508|FG000|Maintenance Period|Withdrawal by Parent/Guardian|1|||
37815521|NCT03335488|69493509|FG001|Maintenance Period|Withdrawal by Parent/Guardian|0|||
37815522|NCT03335488|69493508|FG000|Safety Extension Period|Adverse Event|1|||
37815523|NCT03335488|69493509|FG001|Safety Extension Period|Adverse Event|0|||
37815524|NCT03335488|69493508|FG000|Safety Extension Period|Did Not Return to Study Visit|1|||
37868806|NCT01188798|69552351|FG001|Overall Study|Required additional transplant|1|||
37868807|NCT01188798|69552350|FG000|Overall Study|Protocol closure|1|||
37979437|NCT00454818|69666208|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
37868808|NCT01188798|69552351|FG001|Overall Study|Protocol closure|1|||
37868809|NCT01183104|69552360|FG000|Overall Study|Adverse Event|8|||
37868810|NCT01183104|69552361|FG001|Overall Study|Adverse Event|6|||
37868811|NCT01183104|69552360|FG000|Overall Study|Death|0|||
37868812|NCT01183104|69552361|FG001|Overall Study|Death|1|||
37868813|NCT01183104|69552360|FG000|Overall Study|Lost to Follow-up|14|||
37868814|NCT01183104|69552361|FG001|Overall Study|Lost to Follow-up|7|||
37868815|NCT01183104|69552360|FG000|Overall Study|Physician Decision|5|||
37868816|NCT01183104|69552361|FG001|Overall Study|Physician Decision|8|||
37868817|NCT01183104|69552360|FG000|Overall Study|Withdrawal by Subject|6|||
37868818|NCT01183104|69552361|FG001|Overall Study|Withdrawal by Subject|11|||
37868819|NCT01183104|69552360|FG000|Overall Study|Nonparticipation in Extension Study|39|||
37868820|NCT01183104|69552361|FG001|Overall Study|Nonparticipation in Extension Study|50|||
37868821|NCT01183104|69552360|FG000|Overall Study|Did not receive study drug|5|||
37868822|NCT01183104|69552361|FG001|Overall Study|Did not receive study drug|9|||
37868823|NCT01163292|69552369|FG000|Overall Study|Lack of Efficacy|9|||
37868824|NCT01163292|69552370|FG001|Overall Study|Lack of Efficacy|0|||
37868825|NCT01163292|69552369|FG000|Overall Study|Adverse Event|6|||
37868826|NCT01163292|69552370|FG001|Overall Study|Adverse Event|0|||
37868827|NCT01163292|69552369|FG000|Overall Study|Initiation of biological therapy|0|||
37868828|NCT01163292|69552370|FG001|Overall Study|Initiation of biological therapy|15|||
37868829|NCT01163292|69552369|FG000|Overall Study|Sufficient response to adalimumab|8|||
37868830|NCT01163292|69552370|FG001|Overall Study|Sufficient response to adalimumab|0|||
37868831|NCT01163292|69552369|FG000|Overall Study|Refusal to receive adalimumab|7|||
37868832|NCT01163292|69552370|FG001|Overall Study|Refusal to receive adalimumab|0|||
37979438|NCT00454818|69666209|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
37979439|NCT00454818|69666210|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
37979440|NCT00454818|69666211|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
37979441|NCT00454818|69666207|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
37979442|NCT00454818|69666208|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
37979443|NCT00454818|69666209|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
37979444|NCT00454818|69666210|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
37979445|NCT00454818|69666211|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
37979446|NCT00445224|69666230|FG000|Specific Exercises|Withdrawal by Subject|3|||
37979447|NCT00445224|69666231|FG001|Specific Exercises|Withdrawal by Subject|3|||
37979448|NCT00445224|69666230|FG000|Specific Exercises|Withdrawal by Subject|1|||
37979449|NCT00445224|69666231|FG001|Specific Exercises|Withdrawal by Subject|0|||
37815525|NCT03335488|69493509|FG001|Safety Extension Period|Did Not Return to Study Visit|0|||
37815526|NCT03261700|69493528|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
37815527|NCT03261700|69493529|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
37815528|NCT03238417|69493540|FG000|Overall|non-response|955|||
37815529|NCT03238417|69493541|FG001|Overall|non-response|1920|||
37815530|NCT03238417|69493540|FG000|Overall|partial completion|48|||
37815531|NCT03238417|69493541|FG001|Overall|partial completion|68|||
37815532|NCT03238417|69493540|FG000|Baseline|Partial completion|17|||
37815533|NCT03238417|69493541|FG001|Baseline|Partial completion|48|||
37815534|NCT03238417|69493540|FG000|Baseline|non-response|372|||
37815535|NCT03238417|69493541|FG001|Baseline|non-response|669|||
37815536|NCT03238417|69493540|FG000|12-month|non-response|296|||
37815537|NCT03238417|69493541|FG001|12-month|non-response|669|||
37815538|NCT03238417|69493540|FG000|12-month|partial completion|23|||
37815539|NCT03238417|69493541|FG001|12-month|partial completion|37|||
37815540|NCT03238417|69493540|FG000|24-month|non-response|287|||
37815541|NCT03238417|69493541|FG001|24-month|non-response|594|||
37815542|NCT03238417|69493540|FG000|24-month|partial completion|8|||
37815543|NCT03238417|69493541|FG001|24-month|partial completion|31|||
37815544|NCT03215277|69493549|FG000|Overall Study|Adverse Event|2|||
37815545|NCT03215277|69493550|FG001|Overall Study|Adverse Event|3|||
37815546|NCT03215277|69493549|FG000|Overall Study|Death|1|||
37815547|NCT03215277|69493550|FG001|Overall Study|Death|0|||
37815548|NCT03215277|69493549|FG000|Overall Study|Lost to Follow-up|0|||
37815549|NCT03215277|69493550|FG001|Overall Study|Lost to Follow-up|1|||
37815550|NCT03215277|69493549|FG000|Overall Study|Participant was unable to attend clinic visit|0|||
37815551|NCT03215277|69493550|FG001|Overall Study|Participant was unable to attend clinic visit|1|||
37815552|NCT03185013|69493560|FG000|Overall Study|Withdrawal by Subject|5|||
37815553|NCT03185013|69493561|FG001|Overall Study|Withdrawal by Subject|3|||
37815554|NCT03185013|69493560|FG000|Overall Study|Adverse Event|1|||
37815555|NCT03185013|69493561|FG001|Overall Study|Adverse Event|0|||
37815556|NCT03185013|69493560|FG000|Overall Study|Progressive Disease|1|||
37815557|NCT03185013|69493561|FG001|Overall Study|Progressive Disease|0|||
37815558|NCT03185013|69493560|FG000|Overall Study|Lost to Follow-up|8|||
37815559|NCT03185013|69493561|FG001|Overall Study|Lost to Follow-up|2|||
37815560|NCT03185013|69493560|FG000|Overall Study|Physician Decision|1|||
37815561|NCT03185013|69493561|FG001|Overall Study|Physician Decision|0|||
37815562|NCT03185013|69493560|FG000|Overall Study|Protocol Deviation|2|||
37868833|NCT01163292|69552369|FG000|Overall Study|Economic reasons|6|||
37868834|NCT01163292|69552370|FG001|Overall Study|Economic reasons|0|||
37868835|NCT01163292|69552369|FG000|Overall Study|No further visits|5|||
37868836|NCT01163292|69552370|FG001|Overall Study|No further visits|7|||
37868837|NCT00950248|69552378|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
37868838|NCT00950248|69552379|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
37868839|NCT00950248|69552380|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
37868840|NCT00950248|69552378|FG000|Year 1: Baseline|worsening of symptoms|2|||
37868841|NCT00950248|69552379|FG001|Year 1: Baseline|worsening of symptoms|0|||
37815563|NCT03185013|69493561|FG001|Overall Study|Protocol Deviation|0|||
37815564|NCT03185013|69493560|FG000|Overall Study|Reason not Specified|3|||
37815565|NCT03185013|69493561|FG001|Overall Study|Reason not Specified|2|||
37815566|NCT03185013|69493560|FG000|Overall Study|Death|1|||
37815567|NCT03185013|69493561|FG001|Overall Study|Death|0|||
37868842|NCT00950248|69552380|FG002|Year 1: Baseline|worsening of symptoms|0|||
37868843|NCT00950248|69552378|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
37868844|NCT00950248|69552379|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
37868845|NCT00950248|69552380|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
37868846|NCT00950248|69552378|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
37868847|NCT00950248|69552379|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
37868848|NCT00950248|69552380|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
37868849|NCT00950248|69552378|FG000|Year 2&3 Treatment Randomization|Death|0|||
37868850|NCT00950248|69552379|FG001|Year 2&3 Treatment Randomization|Death|0|||
37868851|NCT00950248|69552380|FG002|Year 2&3 Treatment Randomization|Death|1|||
37868852|NCT00950248|69552378|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
37868853|NCT00950248|69552379|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
37868854|NCT00950248|69552380|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
37868855|NCT00950170|69552387|FG000|Overall Study|Parent/Legal Guardian Request|1|||
37694817|NCT02466425|69171251|FG001|Overall Study|Withdrawal by Subject|1|||
37694818|NCT02466425|69171250|FG000|Overall Study|Other|1|||
37694819|NCT02466425|69171251|FG001|Overall Study|Other|3|||
37694820|NCT02466425|69171250|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
37694821|NCT02466425|69171251|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
37694822|NCT02451917|69171259|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
37694823|NCT02451917|69171260|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
37694824|NCT02451917|69171259|FG000|First Intervention (24 Weeks)|Death|0|||
37694825|NCT02451917|69171260|FG001|First Intervention (24 Weeks)|Death|1|||
37694826|NCT02451917|69171259|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
37694827|NCT02451917|69171260|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
37815568|NCT03182907|69493569|FG000|Overall Study|Death|3|||
37815569|NCT03182907|69493570|FG001|Overall Study|Death|0|||
37815570|NCT03182907|69493569|FG000|Overall Study|Protocol Violation|4|||
37868856|NCT00950170|69552387|FG000|Overall Study|Adverse Event|2|||
37868857|NCT00950170|69552387|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
37868858|NCT01227824|69552411|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
37868859|NCT01227824|69552412|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
37868860|NCT01227824|69552413|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
37868861|NCT01227824|69552411|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
37868862|NCT01227824|69552412|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
37868863|NCT01227824|69552413|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
37868864|NCT01227824|69552411|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
37868865|NCT01227824|69552412|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
37868866|NCT01227824|69552413|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
37868867|NCT01227824|69552411|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
37868868|NCT01227824|69552412|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
37868869|NCT01227824|69552413|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
37868870|NCT01227824|69552411|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
37868871|NCT01227824|69552412|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
37868872|NCT01227824|69552413|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
37868873|NCT01227824|69552411|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
37868874|NCT01227824|69552412|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
37868875|NCT01227824|69552413|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
37868876|NCT01227824|69552411|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
37868877|NCT01227824|69552412|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
37868878|NCT01227824|69552413|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
37868879|NCT01227824|69552411|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
37815571|NCT03182907|69493570|FG001|Overall Study|Protocol Violation|0|||
37815572|NCT03182907|69493569|FG000|Overall Study|Lost to Follow-up|1|||
37815573|NCT03182907|69493570|FG001|Overall Study|Lost to Follow-up|0|||
37815574|NCT03182907|69493569|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
37815575|NCT03182907|69493570|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
37815576|NCT03126019|69493581|FG000|Overall Study|Participants Still Ongoing in the Study|17|||
37815577|NCT03126019|69493582|FG001|Overall Study|Participants Still Ongoing in the Study|87|||
37815578|NCT03126019|69493581|FG000|Overall Study|Death|2|||
37815579|NCT03126019|69493582|FG001|Overall Study|Death|7|||
37815580|NCT03126019|69493581|FG000|Overall Study|Lost to Follow-up|2|||
37815581|NCT03126019|69493582|FG001|Overall Study|Lost to Follow-up|3|||
37694828|NCT02349451|69171273|FG000|Overall Study|Withdrawal by Subject|0|||
37694829|NCT02349451|69171274|FG001|Overall Study|Withdrawal by Subject|1|||
37979450|NCT00358917|69666248|FG000|Overall Study|Adverse Event|14|||
37694830|NCT02349451|69171275|FG002|Overall Study|Withdrawal by Subject|2|||
37815582|NCT03126019|69493581|FG000|Overall Study|Withdrawal by Participant|1|||
37815583|NCT03126019|69493582|FG001|Overall Study|Withdrawal by Participant|3|||
37868880|NCT01227824|69552412|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
37868881|NCT01227824|69552413|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
37868882|NCT01227824|69552411|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
37868883|NCT01227824|69552412|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
37868884|NCT01227824|69552413|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
37868885|NCT01227824|69552411|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
37868886|NCT01227824|69552412|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
37868887|NCT01227824|69552413|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
37868888|NCT01227824|69552411|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
37868889|NCT01227824|69552412|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
37868890|NCT01227824|69552413|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
37868891|NCT01227824|69552411|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
37868892|NCT01227824|69552412|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
37868893|NCT01227824|69552413|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
37868894|NCT01227824|69552411|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
37868895|NCT01227824|69552412|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
37868896|NCT01227824|69552413|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
37868897|NCT01227824|69552411|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
37868898|NCT01227824|69552412|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
37868899|NCT01227824|69552413|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
37868900|NCT01227824|69552411|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
37868901|NCT01227824|69552412|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
37868902|NCT01227824|69552413|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
37868903|NCT00949702|69552420|FG000|Overall Study|Death|40|||
37868904|NCT00949702|69552420|FG000|Overall Study|Disease progression|7|||
37868905|NCT00949702|69552420|FG000|Overall Study|Withdrawal of consent|1|||
37868906|NCT01034631|69552427|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
37868907|NCT01034631|69552428|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
37868908|NCT01034631|69552429|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
37868909|NCT01034631|69552427|FG000|Phase II|Not Evaluable per protocol|0|||
37868910|NCT01034631|69552428|FG001|Phase II|Not Evaluable per protocol|0|||
37868911|NCT01034631|69552429|FG002|Phase II|Not Evaluable per protocol|2|||
37868912|NCT01034631|69552427|FG000|Phase II|Determined Ineligible per protocol|0|||
37868913|NCT01034631|69552428|FG001|Phase II|Determined Ineligible per protocol|1|||
37979451|NCT00358917|69666249|FG001|Overall Study|Adverse Event|21|||
37979452|NCT00358917|69666248|FG000|Overall Study|Withdrawal by Subject|5|||
37868914|NCT01034631|69552429|FG002|Phase II|Determined Ineligible per protocol|0|||
37868915|NCT01227668|69552441|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
37868916|NCT01227668|69552442|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
37868917|NCT01227668|69552441|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
37868918|NCT01227668|69552442|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
37868919|NCT01227668|69552441|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
37868920|NCT01227668|69552442|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
37868921|NCT01227668|69552441|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
37868922|NCT01227668|69552442|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
37868923|NCT01227668|69552441|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
37868924|NCT01227668|69552442|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
37868925|NCT01227668|69552441|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
37868926|NCT01227668|69552442|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
37979453|NCT00358917|69666249|FG001|Overall Study|Withdrawal by Subject|7|||
37868927|NCT01227668|69552441|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
37868928|NCT01227668|69552442|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
37979454|NCT00358917|69666248|FG000|Overall Study|Lost to Follow-up|20|||
37979455|NCT00358917|69666249|FG001|Overall Study|Lost to Follow-up|17|||
37979456|NCT00358917|69666248|FG000|Overall Study|Noncompliance|12|||
37979457|NCT00358917|69666249|FG001|Overall Study|Noncompliance|11|||
37979458|NCT00358917|69666248|FG000|Overall Study|Death|2|||
37979459|NCT00358917|69666249|FG001|Overall Study|Death|3|||
37868929|NCT01227668|69552441|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
37868930|NCT01227668|69552442|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
37868931|NCT01227668|69552441|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
37868932|NCT01227668|69552442|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
37868933|NCT01227668|69552441|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
37979460|NCT00358917|69666248|FG000|Overall Study|Virologic failure|11|||
37979461|NCT00358917|69666249|FG001|Overall Study|Virologic failure|8|||
37868934|NCT01227668|69552442|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
37979462|NCT00358917|69666248|FG000|Overall Study|Unable to Continue Participation|2|||
37868935|NCT01227668|69552441|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
37868936|NCT01227668|69552442|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
37868937|NCT01227668|69552441|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
37868938|NCT01227668|69552442|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
37979463|NCT00358917|69666249|FG001|Overall Study|Unable to Continue Participation|2|||
37979464|NCT00264004|69666261|FG000|Overall Study|Adverse Event|2|||
37979465|NCT00264004|69666262|FG001|Overall Study|Adverse Event|3|||
37979466|NCT00264004|69666263|FG002|Overall Study|Adverse Event|6|||
37979467|NCT00264004|69666264|FG003|Overall Study|Adverse Event|4|||
37979468|NCT00264004|69666261|FG000|Overall Study|Withdrawal by Subject|0|||
37979469|NCT00264004|69666262|FG001|Overall Study|Withdrawal by Subject|1|||
37979470|NCT00264004|69666263|FG002|Overall Study|Withdrawal by Subject|2|||
37979471|NCT00264004|69666264|FG003|Overall Study|Withdrawal by Subject|2|||
37979472|NCT00264004|69666261|FG000|Overall Study|Other|2|||
37979473|NCT00264004|69666262|FG001|Overall Study|Other|2|||
37694831|NCT02349451|69171276|FG003|Overall Study|Withdrawal by Subject|1|||
37815584|NCT03126019|69493581|FG000|Overall Study|Reason not Specified|1|||
37815585|NCT03126019|69493582|FG001|Overall Study|Reason not Specified|3|||
37868939|NCT01227512|69552454|FG000|Overall Study|Physician Decision|6|||
37868940|NCT01227512|69552455|FG001|Overall Study|Physician Decision|6|||
37868941|NCT01227512|69552454|FG000|Overall Study|Adverse Event|4|||
37868942|NCT01227512|69552455|FG001|Overall Study|Adverse Event|3|||
37815586|NCT03036813|69493592|FG000|Overall Study|Adverse Event|6|||
37815587|NCT03036813|69493593|FG001|Overall Study|Adverse Event|11|||
37815588|NCT03036813|69493594|FG002|Overall Study|Adverse Event|6|||
37815589|NCT03036813|69493592|FG000|Overall Study|Withdrawal by Subject|12|||
37815590|NCT03036813|69493593|FG001|Overall Study|Withdrawal by Subject|6|||
37815591|NCT03036813|69493594|FG002|Overall Study|Withdrawal by Subject|10|||
37868943|NCT01227512|69552454|FG000|Overall Study|Withdrawal by Subject|3|||
37868944|NCT01227512|69552455|FG001|Overall Study|Withdrawal by Subject|0|||
37868945|NCT01227512|69552454|FG000|Overall Study|Participant met withdrawal criteria|0|||
37868946|NCT01227512|69552455|FG001|Overall Study|Participant met withdrawal criteria|1|||
37868947|NCT01227278|69552465|FG000|Overall Study|Withdrawal by Subject|4|||
37868948|NCT01227278|69552466|FG001|Overall Study|Withdrawal by Subject|4|||
37868949|NCT01227278|69552465|FG000|Overall Study|Death|0|||
37868950|NCT01227278|69552466|FG001|Overall Study|Death|2|||
37868951|NCT01227278|69552465|FG000|Overall Study|Other|1|||
37868952|NCT01227278|69552466|FG001|Overall Study|Other|2|||
37868953|NCT01034397|69552474|FG000|Overall Study|Lack of compliance|0|||
37868954|NCT01034397|69552475|FG001|Overall Study|Lack of compliance|1|||
37868955|NCT01034397|69552474|FG000|Overall Study|Lack of Efficacy|3|||
37868956|NCT01034397|69552475|FG001|Overall Study|Lack of Efficacy|0|||
37868957|NCT01034397|69552474|FG000|Overall Study|Adverse Event|4|||
37868958|NCT01034397|69552475|FG001|Overall Study|Adverse Event|0|||
37868959|NCT01034397|69552474|FG000|Overall Study|Other|0|||
37868960|NCT01034397|69552475|FG001|Overall Study|Other|1|||
37815592|NCT03036813|69493592|FG000|Overall Study|Lost to Follow-up|1|||
37815593|NCT03036813|69493593|FG001|Overall Study|Lost to Follow-up|1|||
37815594|NCT03036813|69493594|FG002|Overall Study|Lost to Follow-up|0|||
37815595|NCT03036813|69493592|FG000|Overall Study|Physician Decision|2|||
37815596|NCT03036813|69493593|FG001|Overall Study|Physician Decision|1|||
37815597|NCT03036813|69493594|FG002|Overall Study|Physician Decision|1|||
37815598|NCT03036813|69493592|FG000|Overall Study|Non-Compliance|1|||
37815599|NCT03036813|69493593|FG001|Overall Study|Non-Compliance|5|||
37815600|NCT03036813|69493594|FG002|Overall Study|Non-Compliance|3|||
37815601|NCT03036813|69493592|FG000|Overall Study|Pregnancy|0|||
37815602|NCT03036813|69493593|FG001|Overall Study|Pregnancy|0|||
37815603|NCT03036813|69493594|FG002|Overall Study|Pregnancy|1|||
37815604|NCT03036813|69493592|FG000|Overall Study|Other|0|||
37815605|NCT03036813|69493593|FG001|Overall Study|Other|3|||
37815606|NCT03036813|69493594|FG002|Overall Study|Other|5|||
37815607|NCT03007953|69493607|FG000|Overall Study|Withdrawal by Subject|5|||
37815608|NCT03007953|69493608|FG001|Overall Study|Withdrawal by Subject|2|||
37815609|NCT03007953|69493607|FG000|Overall Study|Death|5|||
37815610|NCT03007953|69493608|FG001|Overall Study|Death|7|||
37815611|NCT03007953|69493607|FG000|Overall Study|Lost to Follow-up|3|||
37868961|NCT01227044|69552492|FG000|Overall Study|Lost to Follow-up|5|||
37868962|NCT01227044|69552493|FG001|Overall Study|Lost to Follow-up|7|||
37815612|NCT03007953|69493608|FG001|Overall Study|Lost to Follow-up|2|||
37868963|NCT01227044|69552492|FG000|Overall Study|Discontinued Intervention|1|||
37868964|NCT01227044|69552493|FG001|Overall Study|Discontinued Intervention|2|||
37979474|NCT00264004|69666263|FG002|Overall Study|Other|0|||
37979475|NCT00264004|69666264|FG003|Overall Study|Other|3|||
37979476|NCT00264004|69666261|FG000|Overall Study|Development study specific disc. crit.|1|||
37979477|NCT00264004|69666262|FG001|Overall Study|Development study specific disc. crit.|0|||
37979478|NCT00264004|69666263|FG002|Overall Study|Development study specific disc. crit.|1|||
37815613|NCT03007953|69493607|FG000|Overall Study|Enrolled in Hospice|3|||
37815614|NCT03007953|69493608|FG001|Overall Study|Enrolled in Hospice|2|||
37815615|NCT02919618|69493623|FG000|Overall Study|Death|1|||
37979479|NCT00264004|69666264|FG003|Overall Study|Development study specific disc. crit.|0|||
37979480|NCT00264004|69666261|FG000|Overall Study|Cond. under inv. worsened|9|||
37979481|NCT00264004|69666262|FG001|Overall Study|Cond. under inv. worsened|5|||
37815616|NCT02911701|69493640|FG000|Overall Study|Withdrawal by Subject|2|||
37815617|NCT02911701|69493641|FG001|Overall Study|Withdrawal by Subject|4|||
37868965|NCT01225952|69552502|FG000|Overall Study|Lost to Follow-up|1|||
37868966|NCT01225952|69552503|FG001|Overall Study|Lost to Follow-up|0|||
37868967|NCT01225952|69552504|FG002|Overall Study|Lost to Follow-up|0|||
37979482|NCT00264004|69666263|FG002|Overall Study|Cond. under inv. worsened|3|||
37979483|NCT00264004|69666264|FG003|Overall Study|Cond. under inv. worsened|4|||
37979484|NCT00264004|69666261|FG000|Overall Study|Not treated|3|||
37979485|NCT00264004|69666262|FG001|Overall Study|Not treated|0|||
37979486|NCT00264004|69666263|FG002|Overall Study|Not treated|2|||
37979487|NCT00264004|69666264|FG003|Overall Study|Not treated|2|||
37979488|NCT00368355|69666276|FG000|Overall Study|Adverse Event|1|||
37979489|NCT00368355|69666277|FG001|Overall Study|Adverse Event|0|||
37979490|NCT00368355|69666276|FG000|Overall Study|Death|2|||
37979491|NCT00368355|69666277|FG001|Overall Study|Death|4|||
37979492|NCT00368355|69666276|FG000|Overall Study|Relapse|6|||
37979493|NCT00368355|69666277|FG001|Overall Study|Relapse|10|||
37979494|NCT00368355|69666276|FG000|Overall Study|Subsequent transplant|0|||
37979495|NCT00368355|69666277|FG001|Overall Study|Subsequent transplant|3|||
37979496|NCT00368355|69666276|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
37979497|NCT00368355|69666277|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
37979498|NCT00445146|69666283|FG000|Overall Study|Withdrew Consent|29|||
37979499|NCT00445146|69666283|FG000|Overall Study|Lack of Efficacy|28|||
37979500|NCT00445146|69666283|FG000|Overall Study|Investigator's Discretion|22|||
37979501|NCT00445146|69666283|FG000|Overall Study|Adverse Event|13|||
37868968|NCT01225952|69552502|FG000|Overall Study|Study Eye Explanted|0|||
37868969|NCT01225952|69552503|FG001|Overall Study|Study Eye Explanted|0|||
37868970|NCT01225952|69552504|FG002|Overall Study|Study Eye Explanted|1|||
37868971|NCT01225952|69552502|FG000|Overall Study|Withdrawal by Subject|4|||
37979502|NCT00445146|69666283|FG000|Overall Study|Lost to Follow-up|13|||
37979503|NCT00445146|69666283|FG000|Overall Study|Death|9|||
37979504|NCT00445146|69666283|FG000|Overall Study|Protocol Violation|4|||
37815618|NCT02911701|69493640|FG000|Overall Study|Adverse Event|1|||
37868972|NCT01225952|69552503|FG001|Overall Study|Withdrawal by Subject|4|||
37868973|NCT01225952|69552504|FG002|Overall Study|Withdrawal by Subject|5|||
37868974|NCT01225952|69552502|FG000|Overall Study|Surgical complications|1|||
37868975|NCT01225952|69552503|FG001|Overall Study|Surgical complications|0|||
37868976|NCT01225952|69552504|FG002|Overall Study|Surgical complications|0|||
37868977|NCT01034163|69552514|FG000|Overall Study|Treatment completed as per protocol|8|||
37868978|NCT01034163|69552515|FG001|Overall Study|Treatment completed as per protocol|7|||
37868979|NCT01034163|69552514|FG000|Overall Study|Withdrawal by Subject|8|||
37868980|NCT01034163|69552515|FG001|Overall Study|Withdrawal by Subject|2|||
37868981|NCT01034163|69552514|FG000|Overall Study|Protocol deviation|1|||
37868982|NCT01034163|69552515|FG001|Overall Study|Protocol deviation|0|||
37868983|NCT01034163|69552514|FG000|Overall Study|Disease progression|3|||
37868984|NCT01034163|69552515|FG001|Overall Study|Disease progression|4|||
37868985|NCT01034163|69552514|FG000|Overall Study|Adverse Event|6|||
37868986|NCT01034163|69552515|FG001|Overall Study|Adverse Event|0|||
37868987|NCT01034163|69552514|FG000|Overall Study|Administrative problems|0|||
37868988|NCT01034163|69552515|FG001|Overall Study|Administrative problems|1|||
37868989|NCT01034163|69552514|FG000|Overall Study|Abnormal laboratory value|1|||
37868990|NCT01034163|69552515|FG001|Overall Study|Abnormal laboratory value|0|||
37868991|NCT01033851|69552523|FG000|Overall Study|Withdrawal by Subject|3|||
37815619|NCT02911701|69493641|FG001|Overall Study|Adverse Event|0|||
37815620|NCT02896257|69493651|FG000|Providers|Without eligible patients|21|||
37815621|NCT02896257|69493652|FG001|Providers|Without eligible patients|28|||
37815622|NCT02896257|69493651|FG000|Patients|PFT entry criteria not met|43|||
37815623|NCT02896257|69493652|FG001|Patients|PFT entry criteria not met|50|||
37815624|NCT02896257|69493651|FG000|Patients|No capacity to review|8|||
37815625|NCT02896257|69493652|FG001|Patients|No capacity to review|11|||
37815626|NCT02896257|69493651|FG000|Patients|Appointment rescheduled/cancelled|5|||
37868992|NCT01033851|69552524|FG001|Overall Study|Withdrawal by Subject|7|||
37868993|NCT01162122|69552532|FG000|Overall Study|Withdrawal by Subject|52|||
37868994|NCT01162122|69552533|FG001|Overall Study|Withdrawal by Subject|43|||
37868995|NCT01162122|69552532|FG000|Overall Study|Lost to Follow-up|73|||
37868996|NCT01162122|69552533|FG001|Overall Study|Lost to Follow-up|91|||
37815627|NCT02896257|69493652|FG001|Patients|Appointment rescheduled/cancelled|7|||
37868997|NCT01162122|69552532|FG000|Overall Study|Adverse Event|3|||
37979505|NCT00445146|69666283|FG000|Overall Study|Pregnancy|1|||
37979506|NCT00368277|69666289|FG000|Overall Study|Adverse Event|33|||
37815628|NCT02896257|69493651|FG000|Patients|PCP not assigned a clinic|4|||
37868998|NCT01162122|69552533|FG001|Overall Study|Adverse Event|2|||
37979507|NCT00368277|69666290|FG001|Overall Study|Adverse Event|49|||
37979508|NCT00368277|69666289|FG000|Overall Study|Death|2|||
37979509|NCT00368277|69666290|FG001|Overall Study|Death|1|||
37868999|NCT01162122|69552532|FG000|Overall Study|Death|51|||
37979510|NCT00368277|69666289|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
37979511|NCT00368277|69666290|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
37869000|NCT01162122|69552533|FG001|Overall Study|Death|46|||
37869001|NCT01162122|69552532|FG000|Overall Study|Protocol Violation|2|||
37869002|NCT01162122|69552533|FG001|Overall Study|Protocol Violation|2|||
37869003|NCT01162122|69552532|FG000|Overall Study|Inappropriate enrollment|5|||
37869004|NCT01162122|69552533|FG001|Overall Study|Inappropriate enrollment|4|||
37869005|NCT01162122|69552532|FG000|Overall Study|Administrative reason|1|||
37869006|NCT01162122|69552533|FG001|Overall Study|Administrative reason|1|||
37869007|NCT01162122|69552532|FG000|Overall Study|Unable to classify|3|||
37869008|NCT01162122|69552533|FG001|Overall Study|Unable to classify|7|||
37869009|NCT01162122|69552532|FG000|Overall Study|Missing primary reason|1|||
37869010|NCT01162122|69552533|FG001|Overall Study|Missing primary reason|0|||
37869011|NCT01033071|69552545|FG000|Overall Study|Adverse Event|28|||
37869012|NCT01033071|69552546|FG001|Overall Study|Adverse Event|51|||
37869013|NCT01033071|69552547|FG002|Overall Study|Adverse Event|26|||
37869014|NCT01033071|69552545|FG000|Overall Study|Protocol Violation|0|||
37869015|NCT01033071|69552546|FG001|Overall Study|Protocol Violation|2|||
37869016|NCT01033071|69552547|FG002|Overall Study|Protocol Violation|1|||
37869017|NCT01033071|69552545|FG000|Overall Study|Lost to Follow-up|4|||
37869018|NCT01033071|69552546|FG001|Overall Study|Lost to Follow-up|5|||
37869019|NCT01033071|69552547|FG002|Overall Study|Lost to Follow-up|5|||
37869020|NCT01033071|69552545|FG000|Overall Study|Withdrawal by Subject|17|||
37869021|NCT01033071|69552546|FG001|Overall Study|Withdrawal by Subject|14|||
37694832|NCT02409368|69171293|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
37694833|NCT02409368|69171294|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
37694834|NCT02409368|69171295|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
37694835|NCT02409368|69171296|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
37694836|NCT02409368|69171293|FG000|ECOG Reclassification|Death|1|||
37694837|NCT02409368|69171294|FG001|ECOG Reclassification|Death|5|||
37694838|NCT02409368|69171295|FG002|ECOG Reclassification|Death|0|||
37815629|NCT02896257|69493652|FG001|Patients|PCP not assigned a clinic|0|||
37815630|NCT02896257|69493651|FG000|Patients|No history of COPD|0|||
37869022|NCT01033071|69552547|FG002|Overall Study|Withdrawal by Subject|11|||
37869023|NCT01033071|69552545|FG000|Overall Study|Lack of Efficacy|0|||
37869024|NCT01033071|69552546|FG001|Overall Study|Lack of Efficacy|1|||
37869025|NCT01033071|69552547|FG002|Overall Study|Lack of Efficacy|1|||
37869026|NCT01033071|69552545|FG000|Overall Study|Other|6|||
37869027|NCT01033071|69552546|FG001|Overall Study|Other|4|||
37869028|NCT01033071|69552547|FG002|Overall Study|Other|3|||
37979512|NCT00368277|69666289|FG000|Overall Study|Protocol deviation|7|||
37979513|NCT00368277|69666290|FG001|Overall Study|Protocol deviation|0|||
37979514|NCT00368277|69666289|FG000|Overall Study|Patient withdrew consent|32|||
37979515|NCT00368277|69666290|FG001|Overall Study|Patient withdrew consent|28|||
37979516|NCT00368277|69666289|FG000|Overall Study|Lost to Follow-up|8|||
37694839|NCT02409368|69171296|FG003|ECOG Reclassification|Death|0|||
37694840|NCT02409368|69171293|FG000|ECOG Reclassification|Disease Progression|113|||
37815631|NCT02896257|69493652|FG001|Patients|No history of COPD|1|||
37815632|NCT02896257|69493651|FG000|Patients|Deceased between review and index date|0|||
37815633|NCT02896257|69493652|FG001|Patients|Deceased between review and index date|1|||
37815634|NCT02896257|69493651|FG000|Patients|No ICS Rx upon review|1|||
37815635|NCT02896257|69493652|FG001|Patients|No ICS Rx upon review|1|||
37815636|NCT02896257|69493651|FG000|Patients|Protocol Violation|2|||
37815637|NCT02896257|69493652|FG001|Patients|Protocol Violation|1|||
37815638|NCT02896257|69493651|FG000|Patients|Hospice care|0|||
37815639|NCT02896257|69493652|FG001|Patients|Hospice care|1|||
37815640|NCT02874742|69493662|FG000|Overall Study|Death|0|||
37815641|NCT02874742|69493663|FG001|Overall Study|Death|1|||
37815642|NCT02874742|69493664|FG002|Overall Study|Death|0|||
37815643|NCT02874742|69493662|FG000|Overall Study|Lost to Follow-up|5|||
37815644|NCT02874742|69493663|FG001|Overall Study|Lost to Follow-up|4|||
37815645|NCT02874742|69493664|FG002|Overall Study|Lost to Follow-up|1|||
37869029|NCT01032915|69552559|FG000|Overall Study|Adverse Event|2|||
37869030|NCT01032915|69552560|FG001|Overall Study|Adverse Event|2|||
37979517|NCT00368277|69666290|FG001|Overall Study|Lost to Follow-up|6|||
37869031|NCT01032915|69552561|FG002|Overall Study|Adverse Event|1|||
37869032|NCT01032915|69552562|FG003|Overall Study|Adverse Event|1|||
37869033|NCT01032915|69552559|FG000|Overall Study|Abnormal test procedure result|0|||
37694841|NCT02409368|69171294|FG001|ECOG Reclassification|Disease Progression|382|||
37815646|NCT02874742|69493662|FG000|Overall Study|Withdrawal by Subject|17|||
37815647|NCT02874742|69493663|FG001|Overall Study|Withdrawal by Subject|8|||
37815648|NCT02874742|69493664|FG002|Overall Study|Withdrawal by Subject|0|||
37815649|NCT02874742|69493662|FG000|Overall Study|Other|4|||
37815650|NCT02874742|69493663|FG001|Overall Study|Other|1|||
37869034|NCT01032915|69552560|FG001|Overall Study|Abnormal test procedure result|0|||
37869035|NCT01032915|69552561|FG002|Overall Study|Abnormal test procedure result|1|||
37869036|NCT01032915|69552562|FG003|Overall Study|Abnormal test procedure result|0|||
37869037|NCT01032915|69552559|FG000|Overall Study|Withdrawal by Subject|0|||
37869038|NCT01032915|69552560|FG001|Overall Study|Withdrawal by Subject|3|||
37869039|NCT01032915|69552561|FG002|Overall Study|Withdrawal by Subject|1|||
37869040|NCT01032915|69552562|FG003|Overall Study|Withdrawal by Subject|1|||
37869041|NCT01032915|69552559|FG000|Overall Study|Administrative reasons|5|||
37869042|NCT01032915|69552560|FG001|Overall Study|Administrative reasons|6|||
37869043|NCT01032915|69552561|FG002|Overall Study|Administrative reasons|4|||
37815651|NCT02874742|69493664|FG002|Overall Study|Other|0|||
37815652|NCT02874742|69493662|FG000|Overall Study|Progressive Disease|1|||
37815653|NCT02874742|69493663|FG001|Overall Study|Progressive Disease|0|||
37815654|NCT02874742|69493664|FG002|Overall Study|Progressive Disease|0|||
37869044|NCT01032915|69552562|FG003|Overall Study|Administrative reasons|4|||
37869045|NCT01032915|69552559|FG000|Overall Study|Protocol Violation|1|||
37869046|NCT01032915|69552560|FG001|Overall Study|Protocol Violation|0|||
37815655|NCT02874742|69493662|FG000|Overall Study|Screen Failure|0|||
37815656|NCT02874742|69493663|FG001|Overall Study|Screen Failure|2|||
37815657|NCT02874742|69493664|FG002|Overall Study|Screen Failure|0|||
37815658|NCT02749292|69493674|FG000|Overall Study|Physician Decision|1|||
37869047|NCT01032915|69552561|FG002|Overall Study|Protocol Violation|0|||
37869048|NCT01032915|69552562|FG003|Overall Study|Protocol Violation|1|||
37869049|NCT01161498|69552574|FG000|Overall Study|Disease Progression|0|||
37869050|NCT01161498|69552575|FG001|Overall Study|Disease Progression|1|||
37869051|NCT01180998|69552584|FG000|Overall Study|Poor Vision|0|||
37869052|NCT01180998|69552585|FG001|Overall Study|Poor Vision|2|||
37869053|NCT01180998|69552586|FG002|Overall Study|Poor Vision|2|||
37869054|NCT01180998|69552584|FG000|Overall Study|Lost to Follow-up|0|||
37869055|NCT01180998|69552585|FG001|Overall Study|Lost to Follow-up|0|||
37869056|NCT01180998|69552586|FG002|Overall Study|Lost to Follow-up|1|||
37869057|NCT01180998|69552584|FG000|Overall Study|Protocol Violation|1|||
37869058|NCT01180998|69552585|FG001|Overall Study|Protocol Violation|2|||
37869059|NCT01180998|69552586|FG002|Overall Study|Protocol Violation|0|||
37869060|NCT01180998|69552584|FG000|Overall Study|Withdrawal by Subject|0|||
37869061|NCT01180998|69552585|FG001|Overall Study|Withdrawal by Subject|0|||
37869062|NCT01180998|69552586|FG002|Overall Study|Withdrawal by Subject|1|||
37869063|NCT01180998|69552584|FG000|Overall Study|Poor comfort|3|||
37869064|NCT01180998|69552585|FG001|Overall Study|Poor comfort|0|||
37869065|NCT01180998|69552586|FG002|Overall Study|Poor comfort|4|||
37869066|NCT01180998|69552584|FG000|Overall Study|Poor lens handling|0|||
37869067|NCT01180998|69552585|FG001|Overall Study|Poor lens handling|0|||
37869068|NCT01180998|69552586|FG002|Overall Study|Poor lens handling|2|||
37869069|NCT01029795|69552597|FG000|Overall Study|Entry Criteria Not Met|2|||
37869070|NCT01029795|69552598|FG001|Overall Study|Entry Criteria Not Met|1|||
37869071|NCT01029795|69552597|FG000|Overall Study|Physician Decision|2|||
37869072|NCT01029795|69552598|FG001|Overall Study|Physician Decision|1|||
37869073|NCT01029795|69552597|FG000|Overall Study|Sponsor Decision|11|||
37869074|NCT01029795|69552598|FG001|Overall Study|Sponsor Decision|17|||
37869075|NCT01029795|69552597|FG000|Overall Study|Withdrawal by Subject|1|||
37869076|NCT01029795|69552598|FG001|Overall Study|Withdrawal by Subject|3|||
37869077|NCT01032837|69552608|FG000|Overall Study|Adverse event/internal illness|0|||
37869078|NCT01032837|69552609|FG001|Overall Study|Adverse event/internal illness|1|||
37815659|NCT02749292|69493675|FG001|Overall Study|Physician Decision|0|||
37815660|NCT02749292|69493674|FG000|Overall Study|Withdrawal by Subject|5|||
37815661|NCT02749292|69493675|FG001|Overall Study|Withdrawal by Subject|7|||
37815662|NCT02749292|69493674|FG000|Overall Study|Minor relapse, BVAS-WG = 2|1|||
37869079|NCT01032837|69552610|FG002|Overall Study|Adverse event/internal illness|0|||
37869080|NCT01032837|69552611|FG003|Overall Study|Adverse event/internal illness|1|||
37869081|NCT01032837|69552608|FG000|Overall Study|Withdrew consent|0|||
37869082|NCT01032837|69552609|FG001|Overall Study|Withdrew consent|2|||
37979518|NCT00280150|69666300|FG000|Overall Study|Adverse Event|0|||
37815663|NCT02749292|69493675|FG001|Overall Study|Minor relapse, BVAS-WG = 2|7|||
37815664|NCT02749292|69493674|FG000|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|2|||
37815665|NCT02749292|69493675|FG001|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|4|||
37869083|NCT01032837|69552610|FG002|Overall Study|Withdrew consent|0|||
37979519|NCT00280150|69666301|FG001|Overall Study|Adverse Event|1|||
37815666|NCT02749292|69493674|FG000|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|2|||
37869084|NCT01032837|69552611|FG003|Overall Study|Withdrew consent|1|||
37869085|NCT01032837|69552608|FG000|Overall Study|Failed to return|0|||
37869086|NCT01032837|69552609|FG001|Overall Study|Failed to return|0|||
37869087|NCT01032837|69552610|FG002|Overall Study|Failed to return|1|||
37869088|NCT01032837|69552611|FG003|Overall Study|Failed to return|0|||
37869089|NCT01032837|69552608|FG000|Overall Study|Refused treatment|0|||
37869090|NCT01032837|69552609|FG001|Overall Study|Refused treatment|0|||
37869091|NCT01032837|69552610|FG002|Overall Study|Refused treatment|0|||
37869092|NCT01032837|69552611|FG003|Overall Study|Refused treatment|1|||
37869093|NCT01180296|69552623|FG000|Overall Study|Protocol Violation|1|||
37869094|NCT01180296|69552624|FG001|Overall Study|Protocol Violation|2|||
37869095|NCT01160640|69552634|FG000|Overall Study|Physician Decision|3|||
37869096|NCT01160640|69552635|FG001|Overall Study|Physician Decision|3|||
37869097|NCT01160640|69552634|FG000|Overall Study|Incarceration|1|||
37869098|NCT01160640|69552635|FG001|Overall Study|Incarceration|0|||
37869099|NCT01160640|69552634|FG000|Overall Study|Withdrawal by Subject|0|||
37869100|NCT01160640|69552635|FG001|Overall Study|Withdrawal by Subject|3|||
37869101|NCT01160484|69552643|FG000|Overall Study|Lack of Efficacy|9|||
37869102|NCT01160484|69552643|FG000|Overall Study|Adverse Event|6|||
37869103|NCT01160484|69552643|FG000|Overall Study|Withdrawal by Subject|2|||
37869104|NCT01160484|69552643|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
37869105|NCT01032291|69552650|FG000|Safety Lead-in|Adverse Event|1|||
37869106|NCT01032291|69552651|FG001|Safety Lead-in|Adverse Event|0|||
37869107|NCT01032291|69552652|FG002|Safety Lead-in|Adverse Event|0|||
37869108|NCT01032291|69552650|FG000|Safety Lead-in|Death|1|||
37869109|NCT01032291|69552651|FG001|Safety Lead-in|Death|0|||
37869110|NCT01032291|69552652|FG002|Safety Lead-in|Death|0|||
37869111|NCT01032291|69552650|FG000|Proof of Concept|Adverse Event|0|||
37869112|NCT01032291|69552651|FG001|Proof of Concept|Adverse Event|5|||
37869113|NCT01032291|69552652|FG002|Proof of Concept|Adverse Event|1|||
37869114|NCT01032291|69552650|FG000|Proof of Concept|Death|0|||
37869115|NCT01032291|69552651|FG001|Proof of Concept|Death|1|||
37869116|NCT01032291|69552652|FG002|Proof of Concept|Death|2|||
37869117|NCT01032291|69552650|FG000|Proof of Concept|Lack of Efficacy|0|||
37869118|NCT01032291|69552651|FG001|Proof of Concept|Lack of Efficacy|1|||
37869119|NCT01032291|69552652|FG002|Proof of Concept|Lack of Efficacy|0|||
37869120|NCT01032291|69552650|FG000|Proof of Concept|Never Received Study Drug|0|||
37869121|NCT01032291|69552651|FG001|Proof of Concept|Never Received Study Drug|1|||
37869122|NCT01032291|69552652|FG002|Proof of Concept|Never Received Study Drug|0|||
37869123|NCT01159938|69552666|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
37815667|NCT02749292|69493675|FG001|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|3|||
37815668|NCT02749292|69493674|FG000|Overall Study|Adverse Event|4|||
37815669|NCT02749292|69493675|FG001|Overall Study|Adverse Event|1|||
37815670|NCT02749292|69493674|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|2|||
37815671|NCT02749292|69493675|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|0|||
37815672|NCT02749292|69493674|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|4|||
37815673|NCT02749292|69493675|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|1|||
37815674|NCT02749292|69493674|FG000|Overall Study|Requiring glucocorticoids|0|||
37815675|NCT02749292|69493675|FG001|Overall Study|Requiring glucocorticoids|3|||
37815676|NCT02749292|69493674|FG000|Overall Study|Cancer|1|||
37815677|NCT02749292|69493675|FG001|Overall Study|Cancer|0|||
37815678|NCT02689076|69493694|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
37815679|NCT02689076|69493695|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
37815680|NCT02689076|69493696|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
37815681|NCT02689076|69493694|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
37815682|NCT02689076|69493695|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
37815683|NCT02689076|69493696|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
37815684|NCT02689076|69493694|FG000|Overall Study|Did not have an HIE match|2|||
37815685|NCT02689076|69493695|FG001|Overall Study|Did not have an HIE match|0|||
37815686|NCT02689076|69493696|FG002|Overall Study|Did not have an HIE match|0|||
37815687|NCT02689076|69493694|FG000|Overall Study|Death during non-VA encounter|2|||
37815688|NCT02689076|69493695|FG001|Overall Study|Death during non-VA encounter|5|||
37869124|NCT01159938|69552667|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
37869125|NCT01159938|69552668|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
37869126|NCT01159938|69552669|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
37869127|NCT01159938|69552670|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
37869128|NCT01029405|69552695|FG000|Overall Study|Withdrawal by Subject|0|||
37869129|NCT01029405|69552696|FG001|Overall Study|Withdrawal by Subject|1|||
37869130|NCT01029405|69552697|FG002|Overall Study|Withdrawal by Subject|2|||
37869131|NCT01029405|69552698|FG003|Overall Study|Withdrawal by Subject|0|||
37869132|NCT01029405|69552695|FG000|Overall Study|Protocol Violation|0|||
37869133|NCT01029405|69552696|FG001|Overall Study|Protocol Violation|0|||
37869134|NCT01029405|69552697|FG002|Overall Study|Protocol Violation|0|||
37869135|NCT01029405|69552698|FG003|Overall Study|Protocol Violation|1|||
37979520|NCT00280150|69666302|FG002|Overall Study|Adverse Event|2|||
37979521|NCT00280150|69666303|FG003|Overall Study|Adverse Event|3|||
37979522|NCT00280150|69666300|FG000|Overall Study|Lack of Efficacy|0|||
37979523|NCT00280150|69666301|FG001|Overall Study|Lack of Efficacy|0|||
37979524|NCT00280150|69666302|FG002|Overall Study|Lack of Efficacy|0|||
37979525|NCT00280150|69666303|FG003|Overall Study|Lack of Efficacy|3|||
37979526|NCT00280150|69666300|FG000|Overall Study|Physician Decision|0|||
37979527|NCT00280150|69666301|FG001|Overall Study|Physician Decision|0|||
37979528|NCT00280150|69666302|FG002|Overall Study|Physician Decision|0|||
37979529|NCT00280150|69666303|FG003|Overall Study|Physician Decision|1|||
37979530|NCT00280150|69666300|FG000|Overall Study|Protocol Violation|0|||
37979531|NCT00280150|69666301|FG001|Overall Study|Protocol Violation|0|||
37979532|NCT00280150|69666302|FG002|Overall Study|Protocol Violation|0|||
37979533|NCT00280150|69666303|FG003|Overall Study|Protocol Violation|1|||
37979534|NCT00280150|69666300|FG000|Overall Study|Withdrawal by Subject|0|||
37979535|NCT00280150|69666301|FG001|Overall Study|Withdrawal by Subject|0|||
37979536|NCT00280150|69666302|FG002|Overall Study|Withdrawal by Subject|0|||
37979537|NCT00280150|69666303|FG003|Overall Study|Withdrawal by Subject|1|||
37979538|NCT00280150|69666300|FG000|Overall Study|Did not get consolidation therapy|3|||
37815689|NCT02689076|69493696|FG002|Overall Study|Death during non-VA encounter|0|||
37815690|NCT02689076|69493694|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
37815691|NCT02689076|69493695|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
37815692|NCT02689076|69493696|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
37815693|NCT02689076|69493694|FG000|Overall Study|Participant no longer active in VA system|1|||
37815694|NCT02689076|69493695|FG001|Overall Study|Participant no longer active in VA system|0|||
37815695|NCT02689076|69493696|FG002|Overall Study|Participant no longer active in VA system|0|||
37815696|NCT02689076|69493694|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
37815697|NCT02689076|69493695|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
37815698|NCT02689076|69493696|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
37815699|NCT02576990|69493706|FG000|Overall Study|Death|29|||
37815700|NCT02576990|69493707|FG001|Overall Study|Death|18|||
37815701|NCT02576990|69493706|FG000|Overall Study|Physician Decision|1|||
37815702|NCT02576990|69493707|FG001|Overall Study|Physician Decision|0|||
37815703|NCT02576990|69493706|FG000|Overall Study|Screen failure|2|||
37815704|NCT02576990|69493707|FG001|Overall Study|Screen failure|0|||
37815705|NCT02576990|69493706|FG000|Overall Study|Sponsor's decision|24|||
37815706|NCT02576990|69493707|FG001|Overall Study|Sponsor's decision|4|||
37815707|NCT02576990|69493706|FG000|Overall Study|Withdrawal by Subject|0|||
37815708|NCT02576990|69493707|FG001|Overall Study|Withdrawal by Subject|2|||
37815709|NCT02550561|69493713|FG000|Overall Study|Lost to Follow-up|5|||
37815710|NCT02550561|69493713|FG000|Overall Study|Withdrawal by Subject|1|||
37815711|NCT02524171|69493723|FG000|6-month Follow-up|Lost to Follow-up|53|||
37979539|NCT00280150|69666301|FG001|Overall Study|Did not get consolidation therapy|0|||
37979540|NCT00280150|69666302|FG002|Overall Study|Did not get consolidation therapy|3|||
37979541|NCT00280150|69666303|FG003|Overall Study|Did not get consolidation therapy|0|||
37979542|NCT00280150|69666300|FG000|Overall Study|Declining Performance Status|0|||
37979543|NCT00280150|69666301|FG001|Overall Study|Declining Performance Status|0|||
37815712|NCT02524171|69493724|FG001|6-month Follow-up|Lost to Follow-up|45|||
37815713|NCT02524171|69493723|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
37979544|NCT00280150|69666302|FG002|Overall Study|Declining Performance Status|0|||
37979545|NCT00280150|69666303|FG003|Overall Study|Declining Performance Status|1|||
37979546|NCT00279916|69666316|FG000|Overall Study|Withdrawal by Subject|4|||
37979547|NCT00279916|69666317|FG001|Overall Study|Withdrawal by Subject|3|||
37979548|NCT00279916|69666316|FG000|Overall Study|Lost to Follow-up|3|||
37979549|NCT00279916|69666317|FG001|Overall Study|Lost to Follow-up|2|||
37979550|NCT00358527|69666325|FG000|Overall Study|Adverse Event|4|||
37979551|NCT00358527|69666326|FG001|Overall Study|Adverse Event|0|||
37979552|NCT00358527|69666325|FG000|Overall Study|Withdrawal by Subject|1|||
37979553|NCT00358527|69666326|FG001|Overall Study|Withdrawal by Subject|1|||
37869136|NCT01029405|69552695|FG000|Overall Study|Adverse Event|0|||
37869137|NCT01029405|69552696|FG001|Overall Study|Adverse Event|0|||
37869138|NCT01029405|69552697|FG002|Overall Study|Adverse Event|1|||
37869139|NCT01029405|69552698|FG003|Overall Study|Adverse Event|1|||
37869140|NCT01029405|69552695|FG000|Overall Study|Lost to Follow-up|2|||
37869141|NCT01029405|69552696|FG001|Overall Study|Lost to Follow-up|1|||
37869142|NCT01029405|69552697|FG002|Overall Study|Lost to Follow-up|1|||
37869143|NCT01029405|69552698|FG003|Overall Study|Lost to Follow-up|2|||
37869144|NCT01029405|69552695|FG000|Overall Study|Other|0|||
37869145|NCT01029405|69552696|FG001|Overall Study|Other|1|||
37869146|NCT01029405|69552697|FG002|Overall Study|Other|0|||
37869147|NCT01029405|69552698|FG003|Overall Study|Other|1|||
37869148|NCT01021683|69552708|FG000|Overall Study|Lack of Efficacy|12|||
37869149|NCT01021683|69552708|FG000|Overall Study|Recovery of neutrophil count|51|||
37869150|NCT01021683|69552708|FG000|Overall Study|Other|8|||
37869151|NCT01021293|69552714|FG000|Overall Study|Serious Adverse Event|2|||
37869152|NCT01021293|69552715|FG001|Overall Study|Serious Adverse Event|1|||
37869153|NCT01021293|69552714|FG000|Overall Study|Adverse Event|2|||
37869154|NCT01021293|69552715|FG001|Overall Study|Adverse Event|1|||
37869155|NCT01021293|69552714|FG000|Overall Study|Withdrawal by Subject|1|||
37869156|NCT01021293|69552715|FG001|Overall Study|Withdrawal by Subject|3|||
37869157|NCT01021293|69552714|FG000|Overall Study|Migrated/moved from study area|6|||
37869158|NCT01021293|69552715|FG001|Overall Study|Migrated/moved from study area|18|||
37869159|NCT01021293|69552714|FG000|Overall Study|Lost to Follow-up|1|||
37869160|NCT01021293|69552715|FG001|Overall Study|Lost to Follow-up|1|||
37869161|NCT04625725|69552724|FG000|Overall Study|Death|4|||
37869162|NCT04625725|69552725|FG001|Overall Study|Death|4|||
37869163|NCT04625725|69552724|FG000|Overall Study|Lost to Follow-up|11|||
37869164|NCT04625725|69552725|FG001|Overall Study|Lost to Follow-up|8|||
37869165|NCT04625725|69552724|FG000|Overall Study|Physician Decision|1|||
37869166|NCT04625725|69552725|FG001|Overall Study|Physician Decision|0|||
37869167|NCT04625725|69552724|FG000|Overall Study|Withdrawal by Subject|56|||
37869168|NCT04625725|69552725|FG001|Overall Study|Withdrawal by Subject|32|||
37869169|NCT04625725|69552724|FG000|Overall Study|"Includes participants who discontinued early with reason other selected."|18|||
37869170|NCT04625725|69552725|FG001|Overall Study|"Includes participants who discontinued early with reason other selected."|10|||
37869171|NCT04625725|69552724|FG000|Overall Study|Ongoing in study|3409|||
37979554|NCT00358527|69666325|FG000|Overall Study|Non-compliance with protocol|6|||
37979555|NCT00358527|69666326|FG001|Overall Study|Non-compliance with protocol|1|||
37979556|NCT00358527|69666325|FG000|Overall Study|Administrative|2|||
37979557|NCT00358527|69666326|FG001|Overall Study|Administrative|1|||
37869172|NCT04625725|69552725|FG001|Overall Study|Ongoing in study|1700|||
37869173|NCT04625725|69552724|FG000|Overall Study|Protocol Deviation|1|||
37869174|NCT04625725|69552725|FG001|Overall Study|Protocol Deviation|0|||
37869175|NCT01021215|69552733|FG000|Overall Study|Lost to Follow-up|3|||
37869176|NCT01021215|69552734|FG001|Overall Study|Lost to Follow-up|0|||
37869177|NCT01021137|69552744|FG000|Overall Study|Lost to Follow-up|9|||
37869178|NCT01021137|69552745|FG001|Overall Study|Lost to Follow-up|4|||
37869179|NCT01021137|69552746|FG002|Overall Study|Lost to Follow-up|2|||
37869180|NCT01021137|69552747|FG003|Overall Study|Lost to Follow-up|6|||
37869181|NCT01021137|69552744|FG000|Overall Study|Withdrawal by Subject|1|||
37869182|NCT01021137|69552745|FG001|Overall Study|Withdrawal by Subject|0|||
37869183|NCT01021137|69552746|FG002|Overall Study|Withdrawal by Subject|0|||
37979558|NCT00251758|69666335|FG000|Overall Study|Adverse Event|7|||
37979559|NCT00251758|69666336|FG001|Overall Study|Adverse Event|9|||
37979560|NCT00251758|69666337|FG002|Overall Study|Adverse Event|11|||
37815714|NCT02524171|69493724|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
37815715|NCT02511106|69493732|FG000|Overall Study|Lost to Follow-up|1|||
37815716|NCT02511106|69493733|FG001|Overall Study|Lost to Follow-up|2|||
37815717|NCT02511106|69493732|FG000|Overall Study|Withdrawal by Subject|19|||
37815718|NCT02511106|69493733|FG001|Overall Study|Withdrawal by Subject|14|||
37815719|NCT02511106|69493732|FG000|Overall Study|Ongoing study at data cut-off|309|||
37815720|NCT02511106|69493733|FG001|Overall Study|Ongoing study at data cut-off|307|||
37815721|NCT02511106|69493732|FG000|Overall Study|Without specified reason|1|||
37869184|NCT01021137|69552747|FG003|Overall Study|Withdrawal by Subject|3|||
37869185|NCT01020981|69552760|FG000|Overall Study|Did not return mailed survey|74|||
37869186|NCT01020981|69552761|FG001|Overall Study|Did not return mailed survey|58|||
37979561|NCT00251758|69666335|FG000|Overall Study|Lost to Follow-up|4|||
37869187|NCT01020981|69552760|FG000|Overall Study|Survey returned undeliverable|8|||
37869188|NCT01020981|69552761|FG001|Overall Study|Survey returned undeliverable|32|||
37869189|NCT01020981|69552760|FG000|Overall Study|Participant declined to complete survey|2|||
37869190|NCT01020981|69552761|FG001|Overall Study|Participant declined to complete survey|0|||
37869191|NCT01020747|69552769|FG000|Overall Study|Withdrawal by Subject|1|||
37869192|NCT01020435|69552776|FG000|Overall Study|Lost to Follow-up|0|||
37869193|NCT01020435|69552777|FG001|Overall Study|Lost to Follow-up|1|||
37869194|NCT01031979|69552786|FG000|Overall Study|Lost to Follow-up|5|||
37869195|NCT01031979|69552787|FG001|Overall Study|Lost to Follow-up|4|||
37869196|NCT01020123|69552800|FG000|Main Period|Withdrawal by Subject|6|||
37869197|NCT01020123|69552801|FG001|Main Period|Withdrawal by Subject|5|||
37869198|NCT01020123|69552802|FG002|Main Period|Withdrawal by Subject|3|||
37869199|NCT01020123|69552803|FG003|Main Period|Withdrawal by Subject|1|||
37869200|NCT01020123|69552804|FG004|Main Period|Withdrawal by Subject|6|||
37869201|NCT01020123|69552805|FG005|Main Period|Withdrawal by Subject|3|||
37869202|NCT01020123|69552806|FG006|Main Period|Withdrawal by Subject|2|||
37869203|NCT01020123|69552800|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
37869204|NCT01020123|69552801|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
37869205|NCT01020123|69552802|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
37869206|NCT01020123|69552803|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
37869207|NCT01020123|69552804|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
37869208|NCT01020123|69552805|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
37869209|NCT01020123|69552806|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
37869210|NCT01020123|69552800|FG000|Main Period|Adverse Event|5|||
37869211|NCT01020123|69552801|FG001|Main Period|Adverse Event|2|||
37869212|NCT01020123|69552802|FG002|Main Period|Adverse Event|2|||
37869213|NCT01020123|69552803|FG003|Main Period|Adverse Event|1|||
37869214|NCT01020123|69552804|FG004|Main Period|Adverse Event|1|||
37869215|NCT01020123|69552805|FG005|Main Period|Adverse Event|2|||
37869216|NCT01020123|69552806|FG006|Main Period|Adverse Event|1|||
37869217|NCT01020123|69552800|FG000|Main Period|Protocol Violation|4|||
37869218|NCT01020123|69552801|FG001|Main Period|Protocol Violation|4|||
37869219|NCT01020123|69552802|FG002|Main Period|Protocol Violation|2|||
37869220|NCT01020123|69552803|FG003|Main Period|Protocol Violation|5|||
37869221|NCT01020123|69552804|FG004|Main Period|Protocol Violation|2|||
37869222|NCT01020123|69552805|FG005|Main Period|Protocol Violation|3|||
37869223|NCT01020123|69552806|FG006|Main Period|Protocol Violation|2|||
37869224|NCT01020123|69552800|FG000|Main Period|Lost to Follow-up|0|||
37869225|NCT01020123|69552801|FG001|Main Period|Lost to Follow-up|2|||
37869226|NCT01020123|69552802|FG002|Main Period|Lost to Follow-up|0|||
37869227|NCT01020123|69552803|FG003|Main Period|Lost to Follow-up|0|||
37869228|NCT01020123|69552804|FG004|Main Period|Lost to Follow-up|0|||
37869229|NCT01020123|69552805|FG005|Main Period|Lost to Follow-up|0|||
37869230|NCT01020123|69552806|FG006|Main Period|Lost to Follow-up|0|||
37869231|NCT01020123|69552800|FG000|Main Period|Unclasified|2|||
37869232|NCT01020123|69552801|FG001|Main Period|Unclasified|0|||
37869233|NCT01020123|69552802|FG002|Main Period|Unclasified|1|||
37869234|NCT01020123|69552803|FG003|Main Period|Unclasified|0|||
37869235|NCT01020123|69552804|FG004|Main Period|Unclasified|1|||
37869236|NCT01020123|69552805|FG005|Main Period|Unclasified|3|||
37869237|NCT01020123|69552806|FG006|Main Period|Unclasified|6|||
37869238|NCT01020123|69552800|FG000|Extention Period|Withdrawal by Subject|2|||
37869239|NCT01020123|69552801|FG001|Extention Period|Withdrawal by Subject|1|||
37869240|NCT01020123|69552802|FG002|Extention Period|Withdrawal by Subject|1|||
37869241|NCT01020123|69552803|FG003|Extention Period|Withdrawal by Subject|0|||
37869242|NCT01020123|69552804|FG004|Extention Period|Withdrawal by Subject|0|||
37869243|NCT01020123|69552805|FG005|Extention Period|Withdrawal by Subject|0|||
37869244|NCT01020123|69552806|FG006|Extention Period|Withdrawal by Subject|0|||
37869245|NCT01020123|69552800|FG000|Extention Period|Adverse Event|0|||
37869246|NCT01020123|69552801|FG001|Extention Period|Adverse Event|0|||
37869247|NCT01020123|69552802|FG002|Extention Period|Adverse Event|0|||
37869248|NCT01020123|69552803|FG003|Extention Period|Adverse Event|1|||
37869249|NCT01020123|69552804|FG004|Extention Period|Adverse Event|0|||
37869250|NCT01020123|69552805|FG005|Extention Period|Adverse Event|0|||
37869251|NCT01020123|69552806|FG006|Extention Period|Adverse Event|0|||
37869252|NCT01020123|69552800|FG000|Extention Period|Protocol Violation|1|||
37869253|NCT01020123|69552801|FG001|Extention Period|Protocol Violation|1|||
37869254|NCT01020123|69552802|FG002|Extention Period|Protocol Violation|1|||
37869255|NCT01020123|69552803|FG003|Extention Period|Protocol Violation|0|||
37869256|NCT01020123|69552804|FG004|Extention Period|Protocol Violation|0|||
37869257|NCT01020123|69552805|FG005|Extention Period|Protocol Violation|0|||
37869258|NCT01020123|69552806|FG006|Extention Period|Protocol Violation|1|||
37869259|NCT01020123|69552800|FG000|Extention Period|Lost to Follow-up|0|||
37869260|NCT01020123|69552801|FG001|Extention Period|Lost to Follow-up|0|||
37869261|NCT01020123|69552802|FG002|Extention Period|Lost to Follow-up|0|||
37869262|NCT01020123|69552803|FG003|Extention Period|Lost to Follow-up|0|||
37869263|NCT01020123|69552804|FG004|Extention Period|Lost to Follow-up|0|||
37869264|NCT01020123|69552805|FG005|Extention Period|Lost to Follow-up|2|||
37869265|NCT01020123|69552806|FG006|Extention Period|Lost to Follow-up|0|||
37869266|NCT01028391|69552847|FG000|Overall Study|Adverse Event|4|||
37869267|NCT01028391|69552848|FG001|Overall Study|Adverse Event|0|||
37869268|NCT01028391|69552847|FG000|Overall Study|Lack of Efficacy|0|||
37869269|NCT01028391|69552848|FG001|Overall Study|Lack of Efficacy|2|||
37869270|NCT01028391|69552847|FG000|Overall Study|Lost to Follow-up|3|||
37869271|NCT01028391|69552848|FG001|Overall Study|Lost to Follow-up|4|||
37869272|NCT01028391|69552847|FG000|Overall Study|Physician Decision|0|||
37869273|NCT01028391|69552848|FG001|Overall Study|Physician Decision|1|||
37869274|NCT01028391|69552847|FG000|Overall Study|Withdrawal by Subject|6|||
37869275|NCT01028391|69552848|FG001|Overall Study|Withdrawal by Subject|3|||
37869276|NCT01028391|69552847|FG000|Overall Study|Needed excluded medication|1|||
37869277|NCT01028391|69552848|FG001|Overall Study|Needed excluded medication|1|||
37869278|NCT01179672|69552856|FG000|Overall Study|Adverse Event|17|||
37869279|NCT01179672|69552857|FG001|Overall Study|Adverse Event|8|||
37869280|NCT01179672|69552856|FG000|Overall Study|Withdrawal by Subject|10|||
37869281|NCT01179672|69552857|FG001|Overall Study|Withdrawal by Subject|12|||
37869282|NCT01179672|69552856|FG000|Overall Study|Entry Criteria Not Met|0|||
37979562|NCT00251758|69666336|FG001|Overall Study|Lost to Follow-up|2|||
37979563|NCT00251758|69666337|FG002|Overall Study|Lost to Follow-up|5|||
37979564|NCT00251758|69666335|FG000|Overall Study|Withdrawal by Subject|13|||
37979565|NCT00251758|69666336|FG001|Overall Study|Withdrawal by Subject|7|||
37979566|NCT00251758|69666337|FG002|Overall Study|Withdrawal by Subject|3|||
37979567|NCT00251758|69666335|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
37979568|NCT00251758|69666336|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
37979569|NCT00251758|69666337|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
37979570|NCT00251758|69666335|FG000|Overall Study|Lack of Efficacy|3|||
37979571|NCT00251758|69666336|FG001|Overall Study|Lack of Efficacy|0|||
37979572|NCT00251758|69666337|FG002|Overall Study|Lack of Efficacy|0|||
37979573|NCT00251758|69666335|FG000|Overall Study|Noncompliant|0|||
37979574|NCT00251758|69666336|FG001|Overall Study|Noncompliant|2|||
37979575|NCT00251758|69666337|FG002|Overall Study|Noncompliant|2|||
37979576|NCT00251758|69666335|FG000|Overall Study|Pregnancy|0|||
37979577|NCT00251758|69666336|FG001|Overall Study|Pregnancy|1|||
37979578|NCT00251758|69666337|FG002|Overall Study|Pregnancy|0|||
37979579|NCT00251758|69666335|FG000|Overall Study|Per Subject Request|0|||
37979580|NCT00251758|69666336|FG001|Overall Study|Per Subject Request|0|||
37979581|NCT00251758|69666337|FG002|Overall Study|Per Subject Request|1|||
37979582|NCT00251758|69666335|FG000|Overall Study|Per Investigator Request|1|||
37979583|NCT00251758|69666336|FG001|Overall Study|Per Investigator Request|0|||
37979584|NCT00251758|69666337|FG002|Overall Study|Per Investigator Request|0|||
37815722|NCT02511106|69493733|FG001|Overall Study|Without specified reason|0|||
37815723|NCT02511106|69493732|FG000|Overall Study|Missing|1|||
37815724|NCT02511106|69493733|FG001|Overall Study|Missing|0|||
37815725|NCT02500589|69493743|FG000|Overall Study|Withdrawal by Subject|11|||
37815726|NCT02500589|69493744|FG001|Overall Study|Withdrawal by Subject|14|||
37815727|NCT02500589|69493743|FG000|Overall Study|Lost to Follow-up|10|||
37815728|NCT02500589|69493744|FG001|Overall Study|Lost to Follow-up|12|||
37815729|NCT02500589|69493743|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
37815730|NCT02500589|69493744|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
37815731|NCT02500589|69493743|FG000|Overall Study|Death|7|||
37815732|NCT02500589|69493744|FG001|Overall Study|Death|5|||
37815733|NCT02481830|69493756|FG000|Pre-treatment|Participant no longer meets Study Criteria|1|||
37815734|NCT02481830|69493757|FG001|Pre-treatment|Participant no longer meets Study Criteria|4|||
37815735|NCT02481830|69493756|FG000|Pre-treatment|Withdrawal by Subject|0|||
37815736|NCT02481830|69493757|FG001|Pre-treatment|Withdrawal by Subject|10|||
37815737|NCT02481830|69493756|FG000|Pre-treatment|Disease Progression|1|||
37815738|NCT02481830|69493757|FG001|Pre-treatment|Disease Progression|1|||
37815739|NCT02481830|69493756|FG000|Pre-treatment|Other reasons|0|||
37815740|NCT02481830|69493757|FG001|Pre-treatment|Other reasons|1|||
37815741|NCT02481830|69493756|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
37815742|NCT02481830|69493757|FG001|Pre-treatment|Participant request to discontinue study treatment|4|||
37815743|NCT02481830|69493756|FG000|Treatment|Disease Progression|233|||
37815744|NCT02481830|69493757|FG001|Treatment|Disease Progression|171|||
37815745|NCT02481830|69493756|FG000|Treatment|Study drug toxicity|18|||
37869283|NCT01179672|69552857|FG001|Overall Study|Entry Criteria Not Met|2|||
37869284|NCT01179672|69552856|FG000|Overall Study|Lost to Follow-up|0|||
37869285|NCT01179672|69552857|FG001|Overall Study|Lost to Follow-up|1|||
37869286|NCT01179672|69552856|FG000|Overall Study|Protocol Violation|2|||
37979585|NCT00279214|69666347|FG000|Overall Study|Physician Decision|3|||
37979586|NCT00279214|69666348|FG001|Overall Study|Physician Decision|2|||
37979587|NCT00262834|69666356|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
37979588|NCT00262834|69666357|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
37979589|NCT00541775|69666366|FG000|Overall Study|Adverse Event|3|||
37979590|NCT00541775|69666367|FG001|Overall Study|Adverse Event|2|||
37815746|NCT02481830|69493757|FG001|Treatment|Study drug toxicity|38|||
37869287|NCT01179672|69552857|FG001|Overall Study|Protocol Violation|2|||
37869288|NCT01179672|69552856|FG000|Overall Study|Physician Decision|1|||
37869289|NCT01179672|69552857|FG001|Overall Study|Physician Decision|1|||
37869290|NCT01030965|69552871|FG000|Overall Study|Lack of Efficacy|3|||
37869291|NCT01030965|69552872|FG001|Overall Study|Lack of Efficacy|2|||
37869292|NCT01030965|69552873|FG002|Overall Study|Lack of Efficacy|0|||
37869293|NCT01030965|69552874|FG003|Overall Study|Lack of Efficacy|3|||
37869294|NCT01030965|69552871|FG000|Overall Study|Protocol Violation|1|||
37869295|NCT01030965|69552872|FG001|Overall Study|Protocol Violation|1|||
37869296|NCT01030965|69552873|FG002|Overall Study|Protocol Violation|1|||
37869297|NCT01030965|69552874|FG003|Overall Study|Protocol Violation|1|||
37869298|NCT01030965|69552871|FG000|Overall Study|Adverse Event|0|||
37869299|NCT01030965|69552872|FG001|Overall Study|Adverse Event|1|||
37869300|NCT01030965|69552873|FG002|Overall Study|Adverse Event|2|||
37869301|NCT01030965|69552874|FG003|Overall Study|Adverse Event|1|||
37869302|NCT01030965|69552871|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
37869303|NCT01030965|69552872|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
37869304|NCT01030965|69552873|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
37869305|NCT01030965|69552874|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
37869306|NCT01030965|69552871|FG000|Overall Study|Withdrawal by Subject|0|||
37869307|NCT01030965|69552872|FG001|Overall Study|Withdrawal by Subject|1|||
37869308|NCT01030965|69552873|FG002|Overall Study|Withdrawal by Subject|0|||
37869309|NCT01030965|69552874|FG003|Overall Study|Withdrawal by Subject|2|||
37869310|NCT01179516|69552887|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
37869311|NCT01179516|69552888|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
37869312|NCT01179516|69552889|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
37869313|NCT01179516|69552887|FG000|Overall Study|Lack of Efficacy|4|||
37869314|NCT01179516|69552888|FG001|Overall Study|Lack of Efficacy|2|||
37869315|NCT01179516|69552889|FG002|Overall Study|Lack of Efficacy|0|||
37869316|NCT01179516|69552887|FG000|Overall Study|Noncompliance with Study Drug|2|||
37869317|NCT01179516|69552888|FG001|Overall Study|Noncompliance with Study Drug|0|||
37869318|NCT01179516|69552889|FG002|Overall Study|Noncompliance with Study Drug|1|||
37869319|NCT01179516|69552887|FG000|Overall Study|Protocol Deviations|4|||
37869320|NCT01179516|69552888|FG001|Overall Study|Protocol Deviations|3|||
37979591|NCT00541775|69666368|FG002|Overall Study|Adverse Event|1|||
37979592|NCT00541775|69666366|FG000|Overall Study|Lack of Efficacy|0|||
37979593|NCT00541775|69666367|FG001|Overall Study|Lack of Efficacy|0|||
37869321|NCT01179516|69552889|FG002|Overall Study|Protocol Deviations|3|||
37869322|NCT01179516|69552887|FG000|Overall Study|Withdrawal of Consent|2|||
37869323|NCT01179516|69552888|FG001|Overall Study|Withdrawal of Consent|6|||
37869324|NCT01179516|69552889|FG002|Overall Study|Withdrawal of Consent|10|||
37869325|NCT01179516|69552887|FG000|Overall Study|Lost to Follow-up|7|||
37869326|NCT01179516|69552888|FG001|Overall Study|Lost to Follow-up|7|||
37869327|NCT01179516|69552889|FG002|Overall Study|Lost to Follow-up|3|||
37869328|NCT01179516|69552887|FG000|Overall Study|Other|2|||
37869329|NCT01179516|69552888|FG001|Overall Study|Other|0|||
37869330|NCT01179516|69552889|FG002|Overall Study|Other|2|||
37869331|NCT01018953|69552897|FG000|Overall Study|Adverse Event|2|||
37869332|NCT01018953|69552897|FG000|Overall Study|Withdrawal by Subject|1|||
37869333|NCT01018953|69552897|FG000|Overall Study|Study termination by sponsor|5|||
37869334|NCT01158924|69552904|FG000|Overall Study|Withdrawal by Subject|1|||
37869335|NCT01158924|69552905|FG001|Overall Study|Withdrawal by Subject|2|||
37869336|NCT01158924|69552904|FG000|Overall Study|Lost to Follow-up|0|||
37869337|NCT01158924|69552905|FG001|Overall Study|Lost to Follow-up|1|||
37869338|NCT01027845|69552913|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
37869339|NCT01027845|69552914|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
37869340|NCT01027845|69552915|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
37869341|NCT01027845|69552916|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
37979594|NCT00541775|69666368|FG002|Overall Study|Lack of Efficacy|3|||
37815747|NCT02481830|69493756|FG000|Treatment|Death|1|||
37815748|NCT02481830|69493757|FG001|Treatment|Death|1|||
37815749|NCT02481830|69493756|FG000|Treatment|Adverse Event unrelated to Study drug|14|||
37815750|NCT02481830|69493757|FG001|Treatment|Adverse Event unrelated to Study drug|11|||
37815751|NCT02481830|69493756|FG000|Treatment|Participants request to discontinue Study treatment|6|||
37815752|NCT02481830|69493757|FG001|Treatment|Participants request to discontinue Study treatment|34|||
37815753|NCT02481830|69493756|FG000|Treatment|Withdrawal by Subject|2|||
37815754|NCT02481830|69493757|FG001|Treatment|Withdrawal by Subject|3|||
37815755|NCT02481830|69493756|FG000|Treatment|Lost to Follow-up|1|||
37815756|NCT02481830|69493757|FG001|Treatment|Lost to Follow-up|0|||
37815757|NCT02481830|69493756|FG000|Treatment|Maximum Clinical Benefit|0|||
37869342|NCT01027845|69552913|FG000|Primary Vaccination Phase|Adverse Event|1|||
37869343|NCT01027845|69552914|FG001|Primary Vaccination Phase|Adverse Event|0|||
37869344|NCT01027845|69552915|FG002|Primary Vaccination Phase|Adverse Event|0|||
37869345|NCT01027845|69552916|FG003|Primary Vaccination Phase|Adverse Event|0|||
37869346|NCT01027845|69552913|FG000|Primary Vaccination Phase|Protocol Violation|1|||
37869347|NCT01027845|69552914|FG001|Primary Vaccination Phase|Protocol Violation|0|||
37979595|NCT00541775|69666366|FG000|Overall Study|Lost to Follow-up|0|||
37869348|NCT01027845|69552915|FG002|Primary Vaccination Phase|Protocol Violation|0|||
37869349|NCT01027845|69552916|FG003|Primary Vaccination Phase|Protocol Violation|0|||
37869350|NCT01027845|69552913|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
37869351|NCT01027845|69552914|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
37869352|NCT01027845|69552915|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
37869353|NCT01027845|69552916|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
37869354|NCT01027845|69552913|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
37869355|NCT01027845|69552914|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
37869356|NCT01027845|69552915|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
37869357|NCT01027845|69552916|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
37869358|NCT01027845|69552913|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
37869359|NCT01027845|69552914|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
37869360|NCT01027845|69552915|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
37869361|NCT01027845|69552916|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
37869362|NCT01017549|69552925|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
37869363|NCT01017549|69552925|FG000|One-year Follow-up|Lost to Follow-up|2|||
37869364|NCT01017549|69552925|FG000|One-year Follow-up|Withdrawal by Subject|5|||
37869365|NCT01017549|69552925|FG000|5 Year Follow-up|Lost to Follow-up|9|||
37869366|NCT01017549|69552925|FG000|5 Year Follow-up|Mastectomy|3|||
37869367|NCT01030341|69552929|FG000|Overall Study|Withdrawal by Subject|1|||
37869368|NCT01030341|69552929|FG000|Overall Study|Lost to Follow-up|2|||
37869369|NCT01026831|69552935|FG000|Overall Study|Adverse Event|4|||
37869370|NCT01026831|69552936|FG001|Overall Study|Adverse Event|3|||
37869371|NCT01026831|69552935|FG000|Overall Study|Lost to Follow-up|2|||
37869372|NCT01026831|69552936|FG001|Overall Study|Lost to Follow-up|0|||
37869373|NCT01026831|69552935|FG000|Overall Study|Physician Decision|1|||
37869374|NCT01026831|69552936|FG001|Overall Study|Physician Decision|1|||
37869375|NCT01026831|69552935|FG000|Overall Study|Protocol Violation|0|||
37869376|NCT01026831|69552936|FG001|Overall Study|Protocol Violation|2|||
37869377|NCT01026831|69552935|FG000|Overall Study|Withdrawal by Subject|7|||
37869378|NCT01026831|69552936|FG001|Overall Study|Withdrawal by Subject|5|||
37869379|NCT01016067|69552944|FG000|Overall Study|Lost to Follow-up|1|||
37869380|NCT01016067|69552945|FG001|Overall Study|Lost to Follow-up|2|||
37869381|NCT01016067|69552944|FG000|Overall Study|Physician Decision|1|||
37869382|NCT01016067|69552945|FG001|Overall Study|Physician Decision|1|||
37869383|NCT01016067|69552944|FG000|Overall Study|Withdrew due to Relocation|0|||
37869384|NCT01016067|69552945|FG001|Overall Study|Withdrew due to Relocation|1|||
37869385|NCT01015833|69552953|FG000|Overall Study|Death|1|||
37869386|NCT01015833|69552954|FG001|Overall Study|Death|0|||
37979596|NCT00541775|69666367|FG001|Overall Study|Lost to Follow-up|0|||
37979597|NCT00541775|69666368|FG002|Overall Study|Lost to Follow-up|2|||
37694842|NCT02409368|69171295|FG002|ECOG Reclassification|Disease Progression|70|||
37815758|NCT02481830|69493757|FG001|Treatment|Maximum Clinical Benefit|5|||
37815759|NCT02481830|69493756|FG000|Treatment|Administrative reason by sponsor|1|||
37815760|NCT02481830|69493757|FG001|Treatment|Administrative reason by sponsor|1|||
37815761|NCT02481830|69493756|FG000|Treatment|Other reasons|6|||
37815762|NCT02481830|69493757|FG001|Treatment|Other reasons|1|||
37815763|NCT02477111|69493763|FG000|Overall Study|Death|5|||
37815764|NCT02477111|69493763|FG000|Overall Study|Withdrawal by Subject|2|||
37815765|NCT02477111|69493763|FG000|Overall Study|missed visit|4|||
37815766|NCT02425943|69493771|FG000|Overall Study|Adverse Event|3|||
37815767|NCT02425943|69493772|FG001|Overall Study|Adverse Event|1|||
37815768|NCT02425943|69493771|FG000|Overall Study|Lost to Follow-up|59|||
37815769|NCT02425943|69493772|FG001|Overall Study|Lost to Follow-up|37|||
37815770|NCT02425943|69493771|FG000|Overall Study|Protocol Violation|4|||
37815771|NCT02425943|69493772|FG001|Overall Study|Protocol Violation|1|||
37869387|NCT01015833|69552953|FG000|Overall Study|Withdrawal by Subject|3|||
37869388|NCT01015833|69552954|FG001|Overall Study|Withdrawal by Subject|2|||
37869389|NCT01015833|69552953|FG000|Overall Study|Adverse Event|0|||
37869390|NCT01015833|69552954|FG001|Overall Study|Adverse Event|1|||
37979598|NCT00541775|69666366|FG000|Overall Study|Protocol Violation|1|||
37815772|NCT02425943|69493771|FG000|Overall Study|Withdrawal by Subject|64|||
37815773|NCT02425943|69493772|FG001|Overall Study|Withdrawal by Subject|31|||
37815774|NCT02425943|69493771|FG000|Overall Study|Other|6|||
37815775|NCT02425943|69493772|FG001|Overall Study|Other|0|||
37869391|NCT01015833|69552953|FG000|Overall Study|Physician Decision|2|||
37869392|NCT01015833|69552954|FG001|Overall Study|Physician Decision|0|||
37979599|NCT00541775|69666367|FG001|Overall Study|Protocol Violation|0|||
37815776|NCT02383173|69493782|FG000|Overall Study|Palliative Care Team withdrew|0|||
37869393|NCT01015833|69552953|FG000|Overall Study|Symptomatic deterioration|0|||
37869394|NCT01015833|69552954|FG001|Overall Study|Symptomatic deterioration|1|||
37869395|NCT01015833|69552953|FG000|Overall Study|Other|5|||
37869396|NCT01015833|69552954|FG001|Overall Study|Other|1|||
37869397|NCT01015833|69552953|FG000|Overall Study|Motor Vehicle Accidents|1|||
37869398|NCT01015833|69552954|FG001|Overall Study|Motor Vehicle Accidents|0|||
37869399|NCT01015833|69552953|FG000|Overall Study|Did not start treatment|1|||
37869400|NCT01015833|69552954|FG001|Overall Study|Did not start treatment|0|||
37869401|NCT01015677|69552972|FG000|Overall Study|Adverse Event|0|||
37869402|NCT01015677|69552973|FG001|Overall Study|Adverse Event|1|||
37869403|NCT01015677|69552974|FG002|Overall Study|Adverse Event|0|||
37979600|NCT00541775|69666368|FG002|Overall Study|Protocol Violation|0|||
37979601|NCT00541775|69666366|FG000|Overall Study|Withdrawal by Subject and Other|5|||
37979602|NCT00541775|69666367|FG001|Overall Study|Withdrawal by Subject and Other|0|||
37979603|NCT00541775|69666368|FG002|Overall Study|Withdrawal by Subject and Other|2|||
37979604|NCT00539513|69666378|FG000|Overall Study|Withdrawal by Subject|2|||
37979605|NCT00539513|69666379|FG001|Overall Study|Withdrawal by Subject|1|||
37979606|NCT00539513|69666378|FG000|Overall Study|Lost to Follow-up|0|||
37979607|NCT00539513|69666379|FG001|Overall Study|Lost to Follow-up|1|||
37979608|NCT00454584|69666388|FG000|Controlled Period|Adverse Event|5|||
37979609|NCT00454584|69666389|FG001|Controlled Period|Adverse Event|2|||
37979610|NCT00454584|69666390|FG002|Controlled Period|Adverse Event|1|||
37979611|NCT00454584|69666391|FG003|Controlled Period|Adverse Event|0|||
37979612|NCT00454584|69666392|FG004|Controlled Period|Adverse Event|0|||
37979613|NCT00454584|69666393|FG005|Controlled Period|Adverse Event|0|||
37979614|NCT00454584|69666388|FG000|Controlled Period|Lost to Follow-up|1|||
37979615|NCT00454584|69666389|FG001|Controlled Period|Lost to Follow-up|2|||
37979616|NCT00454584|69666390|FG002|Controlled Period|Lost to Follow-up|2|||
37979617|NCT00454584|69666391|FG003|Controlled Period|Lost to Follow-up|0|||
37979618|NCT00454584|69666392|FG004|Controlled Period|Lost to Follow-up|0|||
37979619|NCT00454584|69666393|FG005|Controlled Period|Lost to Follow-up|0|||
37979620|NCT00454584|69666388|FG000|Controlled Period|Other|5|||
37979621|NCT00454584|69666389|FG001|Controlled Period|Other|4|||
37979622|NCT00454584|69666390|FG002|Controlled Period|Other|2|||
37979623|NCT00454584|69666391|FG003|Controlled Period|Other|0|||
37979624|NCT00454584|69666392|FG004|Controlled Period|Other|0|||
37979625|NCT00454584|69666393|FG005|Controlled Period|Other|0|||
37979626|NCT00454584|69666388|FG000|After Controlled Period|Adverse Event|0|||
37979627|NCT00454584|69666389|FG001|After Controlled Period|Adverse Event|0|||
37979628|NCT00454584|69666390|FG002|After Controlled Period|Adverse Event|0|||
37979629|NCT00454584|69666391|FG003|After Controlled Period|Adverse Event|9|||
37979630|NCT00454584|69666392|FG004|After Controlled Period|Adverse Event|3|||
37979631|NCT00454584|69666393|FG005|After Controlled Period|Adverse Event|9|||
37979632|NCT00454584|69666388|FG000|After Controlled Period|Lack of Efficacy|0|||
37979633|NCT00454584|69666389|FG001|After Controlled Period|Lack of Efficacy|0|||
37979634|NCT00454584|69666390|FG002|After Controlled Period|Lack of Efficacy|0|||
37979635|NCT00454584|69666391|FG003|After Controlled Period|Lack of Efficacy|1|||
37979636|NCT00454584|69666392|FG004|After Controlled Period|Lack of Efficacy|0|||
37979637|NCT00454584|69666393|FG005|After Controlled Period|Lack of Efficacy|0|||
37979638|NCT00454584|69666388|FG000|After Controlled Period|Lost to Follow-up|0|||
37979639|NCT00454584|69666389|FG001|After Controlled Period|Lost to Follow-up|0|||
37979640|NCT00454584|69666390|FG002|After Controlled Period|Lost to Follow-up|0|||
37979641|NCT00454584|69666391|FG003|After Controlled Period|Lost to Follow-up|2|||
37979642|NCT00454584|69666392|FG004|After Controlled Period|Lost to Follow-up|4|||
37979643|NCT00454584|69666393|FG005|After Controlled Period|Lost to Follow-up|6|||
37979644|NCT00454584|69666388|FG000|After Controlled Period|Other|0|||
37979645|NCT00454584|69666389|FG001|After Controlled Period|Other|0|||
37979646|NCT00454584|69666390|FG002|After Controlled Period|Other|0|||
37979647|NCT00454584|69666391|FG003|After Controlled Period|Other|1|||
37979648|NCT00454584|69666392|FG004|After Controlled Period|Other|0|||
37979649|NCT00454584|69666393|FG005|After Controlled Period|Other|0|||
37979650|NCT00454584|69666388|FG000|After Controlled Period|Other|0|||
37815777|NCT02383173|69493783|FG001|Overall Study|Palliative Care Team withdrew|2|||
37815778|NCT02380690|69493791|FG000|Overall Study|Lost to Follow-up|14|||
37815779|NCT02380690|69493792|FG001|Overall Study|Lost to Follow-up|4|||
37815780|NCT02380690|69493791|FG000|Overall Study|Withdrawal by Subject|20|||
37815781|NCT02380690|69493792|FG001|Overall Study|Withdrawal by Subject|8|||
37815782|NCT02311673|69493834|FG000|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
37815783|NCT02311673|69493835|FG001|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
37815784|NCT02311673|69493836|FG002|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|1|||
37979651|NCT00454584|69666389|FG001|After Controlled Period|Other|0|||
37979652|NCT00454584|69666390|FG002|After Controlled Period|Other|0|||
37979653|NCT00454584|69666391|FG003|After Controlled Period|Other|13|||
37979654|NCT00454584|69666392|FG004|After Controlled Period|Other|5|||
37979655|NCT00454584|69666393|FG005|After Controlled Period|Other|17|||
37979656|NCT00445068|69666407|FG000|Overall Study|Disease progression|26|||
37979657|NCT00445068|69666407|FG000|Overall Study|Adverse Event|5|||
37979658|NCT00445068|69666407|FG000|Overall Study|Abnormal laboratory value|2|||
37979659|NCT00445068|69666407|FG000|Overall Study|Withdrawal by Subject|2|||
37979660|NCT00445068|69666407|FG000|Overall Study|Death|1|||
37979661|NCT00539279|69666413|FG000|Treatment|Withdrawal by Subject|10|||
37979662|NCT00539279|69666414|FG001|Treatment|Withdrawal by Subject|8|||
37979663|NCT00539279|69666413|FG000|Treatment|Death|1|||
37979664|NCT00539279|69666414|FG001|Treatment|Death|0|||
37979665|NCT00539279|69666413|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
37979666|NCT00539279|69666414|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
37979667|NCT00539279|69666413|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
37979668|NCT00539279|69666414|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
37979669|NCT00444912|69666422|FG000|Overall Study|Death|1|||
37979670|NCT00444912|69666423|FG001|Overall Study|Death|2|||
37979671|NCT00444912|69666422|FG000|Overall Study|Lost to Follow-up|1|||
37979672|NCT00444912|69666423|FG001|Overall Study|Lost to Follow-up|0|||
37979673|NCT00444912|69666422|FG000|Overall Study|Participant Failed Mobilization|1|||
37979674|NCT00444912|69666423|FG001|Overall Study|Participant Failed Mobilization|0|||
37979675|NCT00538733|69666429|FG000|Overall Study|Adverse Event|8|||
37979676|NCT00538733|69666429|FG000|Overall Study|Death|1|||
37979677|NCT00538733|69666429|FG000|Overall Study|declined to participate|2|||
37979678|NCT00538733|69666429|FG000|Overall Study|still on therapy|1|||
37979679|NCT00444678|69666436|FG000|Overall Study|Toxicity|11|||
37979680|NCT00444678|69666436|FG000|Overall Study|Disease Progression|12|||
37979681|NCT00444678|69666436|FG000|Overall Study|Death|3|||
37979682|NCT00444678|69666436|FG000|Overall Study|Physician Decision|3|||
37979683|NCT00444678|69666436|FG000|Overall Study|Withdrawal by Subject|2|||
37979684|NCT00358449|69666443|FG000|Overall Study|Adverse Event|1|||
37979685|NCT00358449|69666444|FG001|Overall Study|Adverse Event|0|||
37979686|NCT00358449|69666445|FG002|Overall Study|Adverse Event|1|||
37979687|NCT00358449|69666443|FG000|Overall Study|Lost to Follow-up|1|||
37979688|NCT00358449|69666444|FG001|Overall Study|Lost to Follow-up|0|||
37979689|NCT00358449|69666445|FG002|Overall Study|Lost to Follow-up|0|||
37979690|NCT00358449|69666443|FG000|Overall Study|Withdrawal by Subject|2|||
37979691|NCT00358449|69666444|FG001|Overall Study|Withdrawal by Subject|0|||
37979692|NCT00358449|69666445|FG002|Overall Study|Withdrawal by Subject|0|||
37979693|NCT00358449|69666443|FG000|Overall Study|Lack of Efficacy|0|||
37979694|NCT00358449|69666444|FG001|Overall Study|Lack of Efficacy|1|||
37979695|NCT00358449|69666445|FG002|Overall Study|Lack of Efficacy|0|||
37979696|NCT00358449|69666443|FG000|Overall Study|Steriod Inhaler was Increased|0|||
37979697|NCT00358449|69666444|FG001|Overall Study|Steriod Inhaler was Increased|0|||
37979698|NCT00358449|69666445|FG002|Overall Study|Steriod Inhaler was Increased|1|||
37979699|NCT00539981|69666457|FG000|Overall Study|Adverse events (AE)|3|||
37979700|NCT00539981|69666458|FG001|Overall Study|Adverse events (AE)|3|||
37979701|NCT00539981|69666457|FG000|Overall Study|Lost to Follow-up|260|||
37979702|NCT00539981|69666458|FG001|Overall Study|Lost to Follow-up|251|||
37979703|NCT00539981|69666457|FG000|Overall Study|Withdrew consent|22|||
37979704|NCT00539981|69666458|FG001|Overall Study|Withdrew consent|14|||
37979705|NCT00539981|69666457|FG000|Overall Study|Death|1|||
37979706|NCT00539981|69666458|FG001|Overall Study|Death|1|||
37979707|NCT00539981|69666457|FG000|Overall Study|Other reason-unspecified|9|||
37979708|NCT00539981|69666458|FG001|Overall Study|Other reason-unspecified|13|||
37979709|NCT00367341|69666469|FG000|Overall Study|Physician Decision|1|||
37979710|NCT00367341|69666470|FG001|Overall Study|Physician Decision|0|||
37979711|NCT00367341|69666469|FG000|Overall Study|Protocol Violation|1|||
37979712|NCT00367341|69666470|FG001|Overall Study|Protocol Violation|0|||
37979713|NCT00440466|69666479|FG000|Overall Study|Death|3|||
37979714|NCT00440466|69666480|FG001|Overall Study|Death|2|||
37979715|NCT00440466|69666481|FG002|Overall Study|Death|9|||
37979716|NCT00440466|69666479|FG000|Overall Study|Adverse Event|3|||
37979717|NCT00440466|69666480|FG001|Overall Study|Adverse Event|4|||
37979718|NCT00440466|69666481|FG002|Overall Study|Adverse Event|11|||
37979719|NCT00440466|69666479|FG000|Overall Study|Lost to Follow-up|1|||
37979720|NCT00440466|69666480|FG001|Overall Study|Lost to Follow-up|0|||
37979721|NCT00440466|69666481|FG002|Overall Study|Lost to Follow-up|2|||
37979722|NCT00440466|69666479|FG000|Overall Study|Physician Decision|2|||
37979723|NCT00440466|69666480|FG001|Overall Study|Physician Decision|0|||
37979724|NCT00440466|69666481|FG002|Overall Study|Physician Decision|1|||
37979725|NCT00440466|69666479|FG000|Overall Study|Protocol Violation|2|||
37979726|NCT00440466|69666480|FG001|Overall Study|Protocol Violation|0|||
37979727|NCT00440466|69666481|FG002|Overall Study|Protocol Violation|4|||
37979728|NCT00440466|69666479|FG000|Overall Study|Withdrawal by Subject|2|||
37979729|NCT00440466|69666480|FG001|Overall Study|Withdrawal by Subject|5|||
37979730|NCT00440466|69666481|FG002|Overall Study|Withdrawal by Subject|9|||
37979731|NCT00440466|69666479|FG000|Overall Study|Began Dialysis|0|||
37979732|NCT00440466|69666480|FG001|Overall Study|Began Dialysis|0|||
37979733|NCT00440466|69666481|FG002|Overall Study|Began Dialysis|1|||
37979734|NCT00440466|69666479|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
37979735|NCT00440466|69666480|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
37979736|NCT00440466|69666481|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
37979737|NCT00537485|69666491|FG000|Overall Study|Adverse Event|10|||
37979738|NCT00537485|69666492|FG001|Overall Study|Adverse Event|5|||
37979739|NCT00537485|69666491|FG000|Overall Study|Withdrawal by Subject|3|||
37979740|NCT00537485|69666492|FG001|Overall Study|Withdrawal by Subject|2|||
37979741|NCT00537485|69666491|FG000|Overall Study|Withdrawal by Subject|1|||
37979742|NCT00537485|69666492|FG001|Overall Study|Withdrawal by Subject|3|||
37979743|NCT00537485|69666491|FG000|Overall Study|Physician Decision|1|||
37979744|NCT00537485|69666492|FG001|Overall Study|Physician Decision|0|||
37979745|NCT00616967|69666500|FG000|Overall Study|Withdrawal by Subject|0|||
37979746|NCT00616967|69666501|FG001|Overall Study|Withdrawal by Subject|0|||
37979747|NCT00616967|69666502|FG002|Overall Study|Withdrawal by Subject|1|||
37979748|NCT00537329|69666520|FG000|Overall Study|Death|10|||
37979749|NCT00537329|69666520|FG000|Overall Study|Adverse Event|3|||
37979750|NCT00537329|69666520|FG000|Overall Study|Lack of Efficacy|2|||
37979751|NCT00537329|69666520|FG000|Overall Study|Lost to Follow-up|6|||
37979752|NCT00537329|69666520|FG000|Overall Study|Withdrawal by Subject|4|||
37979753|NCT00537329|69666520|FG000|Overall Study|Other|1|||
37979754|NCT03897179|69666524|FG000|Overall Study|Withdrawal by Subject|1|||
37979755|NCT03905135|69666530|FG000|Dose Escalation|Adverse Event|1|||
37979756|NCT03905135|69666531|FG001|Dose Escalation|Adverse Event|1|||
37979757|NCT03905135|69666530|FG000|Dose Escalation|Progressive disease|3|||
37979758|NCT03905135|69666531|FG001|Dose Escalation|Progressive disease|1|||
37979759|NCT03905135|69666530|FG000|Dose Escalation|Intercurrent illness|1|||
37979760|NCT03905135|69666531|FG001|Dose Escalation|Intercurrent illness|0|||
37979761|NCT00357903|69666541|FG000|Overall Study|Adverse Event|87|||
37979762|NCT00357903|69666542|FG001|Overall Study|Adverse Event|4|||
37979763|NCT00357903|69666541|FG000|Overall Study|Death|33|||
37979764|NCT00357903|69666542|FG001|Overall Study|Death|0|||
37979765|NCT00357903|69666541|FG000|Overall Study|Lost to Follow-up|23|||
37979766|NCT00357903|69666542|FG001|Overall Study|Lost to Follow-up|4|||
37979767|NCT00357903|69666541|FG000|Overall Study|Physician Decision|39|||
37979768|NCT00357903|69666542|FG001|Overall Study|Physician Decision|5|||
37979769|NCT00357903|69666541|FG000|Overall Study|Withdrawal by Subject|57|||
37979770|NCT00357903|69666542|FG001|Overall Study|Withdrawal by Subject|7|||
37979771|NCT00357903|69666541|FG000|Overall Study|Completed month 12 only|0|||
37979772|NCT00357903|69666542|FG001|Overall Study|Completed month 12 only|1|||
37979773|NCT00357903|69666541|FG000|Overall Study|Protocol issues|14|||
37979774|NCT00357903|69666542|FG001|Overall Study|Protocol issues|3|||
37979775|NCT00357903|69666541|FG000|Overall Study|Response status|61|||
37979776|NCT00357903|69666542|FG001|Overall Study|Response status|9|||
37815785|NCT02311673|69493837|FG003|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
37815786|NCT02284113|69493871|FG000|Overall Study|Adverse Event|1|||
37815787|NCT02284113|69493872|FG001|Overall Study|Adverse Event|0|||
37815788|NCT02284113|69493871|FG000|Overall Study|non-compliance|0|||
37815789|NCT02284113|69493872|FG001|Overall Study|non-compliance|1|||
37815790|NCT02284113|69493871|FG000|Overall Study|Withdrawal by Subject|0|||
37815791|NCT02284113|69493872|FG001|Overall Study|Withdrawal by Subject|1|||
37815792|NCT02284113|69493871|FG000|Overall Study|not provided|0|||
37815793|NCT02284113|69493872|FG001|Overall Study|not provided|1|||
37815794|NCT02284113|69493871|FG000|Overall Study|surgery cancelled|2|||
37815795|NCT02284113|69493872|FG001|Overall Study|surgery cancelled|0|||
37815796|NCT02233738|69493880|FG000|Overall Study|Lost to Follow-up|5|||
37815797|NCT02233738|69493881|FG001|Overall Study|Lost to Follow-up|12|||
37815798|NCT02233738|69493880|FG000|Overall Study|Death|0|||
37815799|NCT02233738|69493881|FG001|Overall Study|Death|1|||
37815800|NCT02233738|69493880|FG000|Overall Study|Withdrawal by Subject|0|||
37815801|NCT02233738|69493881|FG001|Overall Study|Withdrawal by Subject|1|||
37979777|NCT00357903|69666541|FG000|Overall Study|Other|49|||
37979778|NCT00357903|69666542|FG001|Overall Study|Other|10|||
37979779|NCT00348933|69666549|FG000|Overall Study|Withdrawal by Subject|10|||
37979780|NCT00348933|69666549|FG000|Overall Study|Lost to Follow-up|6|||
37979781|NCT00348933|69666549|FG000|Overall Study|Protocol Violation|2|||
37979782|NCT00348933|69666549|FG000|Overall Study|Adverse Event|7|||
37979783|NCT03896477|69666557|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
37815802|NCT02233738|69493880|FG000|Overall Study|Did not return after Baseline|3|||
37815803|NCT02233738|69493881|FG001|Overall Study|Did not return after Baseline|2|||
37815804|NCT01959698|69494069|FG000|Overall Study|Adverse Event|0|||
37815805|NCT01959698|69494070|FG001|Overall Study|Adverse Event|0|||
37815806|NCT01959698|69494071|FG002|Overall Study|Adverse Event|0|||
37979784|NCT03896477|69666558|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
37979785|NCT03896477|69666559|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
37979786|NCT03896477|69666557|FG000|Overall Study|Parent Requested Withdrawal|8|||
37979787|NCT03896477|69666558|FG001|Overall Study|Parent Requested Withdrawal|12|||
37979788|NCT03896477|69666559|FG002|Overall Study|Parent Requested Withdrawal|9|||
37979789|NCT03896477|69666557|FG000|Overall Study|Adverse Event|0|||
37979790|NCT03896477|69666558|FG001|Overall Study|Adverse Event|0|||
37979791|NCT03896477|69666559|FG002|Overall Study|Adverse Event|1|||
37979792|NCT03896477|69666557|FG000|Overall Study|Death|1|||
37979793|NCT03896477|69666558|FG001|Overall Study|Death|0|||
37979794|NCT03896477|69666559|FG002|Overall Study|Death|0|||
37979795|NCT03896477|69666557|FG000|Overall Study|Other|5|||
37979796|NCT03896477|69666558|FG001|Overall Study|Other|6|||
37979797|NCT03896477|69666559|FG002|Overall Study|Other|7|||
37979798|NCT03896477|69666557|FG000|Overall Study|Lost to Follow-up|2|||
37979799|NCT03896477|69666558|FG001|Overall Study|Lost to Follow-up|1|||
37979800|NCT03896477|69666559|FG002|Overall Study|Lost to Follow-up|1|||
37979801|NCT00444600|69666574|FG000|Overall Study|Death|7|||
37979802|NCT00444600|69666575|FG001|Overall Study|Death|5|||
37979803|NCT00444600|69666576|FG002|Overall Study|Death|3|||
37979804|NCT00444600|69666577|FG003|Overall Study|Death|2|||
37979805|NCT00444600|69666574|FG000|Overall Study|Dropped|11|||
37979806|NCT00444600|69666575|FG001|Overall Study|Dropped|11|||
37979807|NCT00444600|69666576|FG002|Overall Study|Dropped|7|||
37979808|NCT00444600|69666577|FG003|Overall Study|Dropped|7|||
37979809|NCT00444600|69666574|FG000|Overall Study|Missed visit|1|||
37979810|NCT00444600|69666575|FG001|Overall Study|Missed visit|0|||
37979811|NCT00444600|69666576|FG002|Overall Study|Missed visit|0|||
37979812|NCT00444600|69666577|FG003|Overall Study|Missed visit|1|||
37979813|NCT00537095|69666595|FG000|Overall Study|surgery|1|||
37979814|NCT00537095|69666596|FG001|Overall Study|surgery|0|||
37979815|NCT00537095|69666595|FG000|Overall Study|Adverse Event|24|||
37979816|NCT00537095|69666596|FG001|Overall Study|Adverse Event|4|||
37979817|NCT00537095|69666595|FG000|Overall Study|disease progression|21|||
37979818|NCT00537095|69666596|FG001|Overall Study|disease progression|48|||
37979819|NCT00537095|69666595|FG000|Overall Study|Death|3|||
37979820|NCT00537095|69666596|FG001|Overall Study|Death|1|||
37815807|NCT01959698|69494072|FG003|Overall Study|Adverse Event|0|||
37815808|NCT01959698|69494073|FG004|Overall Study|Adverse Event|0|||
37979821|NCT00537095|69666595|FG000|Overall Study|Withdrawal by Subject|2|||
37979822|NCT00537095|69666596|FG001|Overall Study|Withdrawal by Subject|2|||
37979823|NCT00537095|69666595|FG000|Overall Study|subjective disease progression|0|||
37979824|NCT00537095|69666596|FG001|Overall Study|subjective disease progression|1|||
37979825|NCT00537095|69666595|FG000|Overall Study|Incorrect enrolment|0|||
37979826|NCT00537095|69666596|FG001|Overall Study|Incorrect enrolment|1|||
37979827|NCT00443898|69666606|FG000|Overall Study|Adverse Event|0|||
37979828|NCT00443898|69666607|FG001|Overall Study|Adverse Event|0|||
37979829|NCT00443898|69666608|FG002|Overall Study|Adverse Event|1|||
37979830|NCT00443898|69666609|FG003|Overall Study|Adverse Event|1|||
37979831|NCT00443898|69666606|FG000|Overall Study|Lack of Efficacy|2|||
37979832|NCT00443898|69666607|FG001|Overall Study|Lack of Efficacy|3|||
37979833|NCT00443898|69666608|FG002|Overall Study|Lack of Efficacy|3|||
37979834|NCT00443898|69666609|FG003|Overall Study|Lack of Efficacy|1|||
37979835|NCT00443898|69666606|FG000|Overall Study|Protocol Violation|1|||
37979836|NCT00443898|69666607|FG001|Overall Study|Protocol Violation|1|||
37979837|NCT00443898|69666608|FG002|Overall Study|Protocol Violation|1|||
37979838|NCT00443898|69666609|FG003|Overall Study|Protocol Violation|0|||
37979839|NCT00443898|69666606|FG000|Overall Study|Withdrawal by Subject|11|||
37979840|NCT00443898|69666607|FG001|Overall Study|Withdrawal by Subject|10|||
37979841|NCT00443898|69666608|FG002|Overall Study|Withdrawal by Subject|10|||
37979842|NCT00443898|69666609|FG003|Overall Study|Withdrawal by Subject|6|||
37979843|NCT00443898|69666606|FG000|Overall Study|Lost to Follow-up|10|||
37979844|NCT00443898|69666607|FG001|Overall Study|Lost to Follow-up|10|||
37979845|NCT00443898|69666608|FG002|Overall Study|Lost to Follow-up|14|||
37979846|NCT00443898|69666609|FG003|Overall Study|Lost to Follow-up|10|||
37979847|NCT00443898|69666606|FG000|Overall Study|Death|0|||
37815809|NCT01959698|69494074|FG005|Overall Study|Adverse Event|0|||
37815810|NCT01959698|69494075|FG006|Overall Study|Adverse Event|1|||
37815811|NCT01959698|69494069|FG000|Overall Study|Physician Decision|1|||
37815812|NCT01959698|69494070|FG001|Overall Study|Physician Decision|0|||
37815813|NCT01959698|69494071|FG002|Overall Study|Physician Decision|1|||
37815814|NCT01959698|69494072|FG003|Overall Study|Physician Decision|2|||
37979848|NCT00443898|69666607|FG001|Overall Study|Death|1|||
37979849|NCT00443898|69666608|FG002|Overall Study|Death|0|||
37979850|NCT00443898|69666609|FG003|Overall Study|Death|0|||
37979851|NCT00537017|69666619|FG000|Treatment Phase|Adverse Event|19|||
37979852|NCT00537017|69666619|FG000|Treatment Phase|Withdrawal by Subject|13|||
37979853|NCT00537017|69666619|FG000|Treatment Phase|Protocol Violation|2|||
37979854|NCT00537017|69666619|FG000|Follow-up Phase|Withdrawal by Subject|9|||
37979855|NCT00348309|69666626|FG000|Overall Study|Adverse Event|56|||
37979856|NCT00348309|69666627|FG001|Overall Study|Adverse Event|28|||
37979857|NCT00348309|69666628|FG002|Overall Study|Adverse Event|63|||
37815815|NCT01959698|69494073|FG004|Overall Study|Physician Decision|0|||
37979858|NCT00348309|69666626|FG000|Overall Study|Lost to Follow-up|6|||
37979859|NCT00348309|69666627|FG001|Overall Study|Lost to Follow-up|7|||
37979860|NCT00348309|69666628|FG002|Overall Study|Lost to Follow-up|4|||
37979861|NCT00348309|69666626|FG000|Overall Study|Protocol Violation|7|||
37979862|NCT00348309|69666627|FG001|Overall Study|Protocol Violation|12|||
37979863|NCT00348309|69666628|FG002|Overall Study|Protocol Violation|7|||
37979864|NCT00348309|69666626|FG000|Overall Study|Withdrawal by Subject|33|||
37979865|NCT00348309|69666627|FG001|Overall Study|Withdrawal by Subject|37|||
37979866|NCT00348309|69666628|FG002|Overall Study|Withdrawal by Subject|40|||
37979867|NCT00348309|69666626|FG000|Overall Study|Non-compliance|8|||
37979868|NCT00348309|69666627|FG001|Overall Study|Non-compliance|6|||
37979869|NCT00348309|69666628|FG002|Overall Study|Non-compliance|8|||
37979870|NCT00348309|69666626|FG000|Overall Study|Death of caregiver|1|||
37979871|NCT00348309|69666627|FG001|Overall Study|Death of caregiver|0|||
37979872|NCT00348309|69666628|FG002|Overall Study|Death of caregiver|1|||
37979873|NCT00348309|69666626|FG000|Overall Study|Lack of insight, dementia|1|||
37979874|NCT00348309|69666627|FG001|Overall Study|Lack of insight, dementia|0|||
37979875|NCT00348309|69666628|FG002|Overall Study|Lack of insight, dementia|0|||
37979876|NCT00348309|69666626|FG000|Overall Study|Wrong bottle allocated|1|||
37979877|NCT00348309|69666627|FG001|Overall Study|Wrong bottle allocated|0|||
37979878|NCT00348309|69666628|FG002|Overall Study|Wrong bottle allocated|0|||
37979879|NCT00348309|69666626|FG000|Overall Study|Caregiver sick|1|||
37979880|NCT00348309|69666627|FG001|Overall Study|Caregiver sick|0|||
37979881|NCT00348309|69666628|FG002|Overall Study|Caregiver sick|0|||
37979882|NCT00348309|69666626|FG000|Overall Study|Use of prohibited medication|5|||
37979883|NCT00348309|69666627|FG001|Overall Study|Use of prohibited medication|2|||
37979884|NCT00348309|69666628|FG002|Overall Study|Use of prohibited medication|2|||
37979885|NCT00348309|69666626|FG000|Overall Study|Caregiver withdrawal|3|||
37694843|NCT02409368|69171296|FG003|ECOG Reclassification|Disease Progression|1|||
37979886|NCT00348309|69666627|FG001|Overall Study|Caregiver withdrawal|0|||
37979887|NCT00348309|69666628|FG002|Overall Study|Caregiver withdrawal|7|||
37979888|NCT00348309|69666626|FG000|Overall Study|Unable to complete ET visit|1|||
37979889|NCT00348309|69666627|FG001|Overall Study|Unable to complete ET visit|0|||
37979890|NCT00348309|69666628|FG002|Overall Study|Unable to complete ET visit|0|||
37979891|NCT00348309|69666626|FG000|Overall Study|PI closing medical practice|1|||
37979892|NCT00348309|69666627|FG001|Overall Study|PI closing medical practice|0|||
37979893|NCT00348309|69666628|FG002|Overall Study|PI closing medical practice|0|||
37979894|NCT00348309|69666626|FG000|Overall Study|Principal investigator's decision|1|||
37979895|NCT00348309|69666627|FG001|Overall Study|Principal investigator's decision|0|||
37979896|NCT00348309|69666628|FG002|Overall Study|Principal investigator's decision|0|||
37979897|NCT00348309|69666626|FG000|Overall Study|No disponibility of medication|1|||
37694844|NCT02409368|69171293|FG000|ECOG Reclassification|Lost to Follow-up|1|||
37815816|NCT01959698|69494074|FG005|Overall Study|Physician Decision|3|||
37815817|NCT01959698|69494075|FG006|Overall Study|Physician Decision|3|||
37815818|NCT01910402|69494094|FG000|Randomized Phase (Up to 48 Weeks)|Adverse Event|10|||
37815819|NCT01910402|69494095|FG001|Randomized Phase (Up to 48 Weeks)|Adverse Event|18|||
37815820|NCT01910402|69494096|FG002|Randomized Phase (Up to 48 Weeks)|Adverse Event|0|||
37815821|NCT01910402|69494094|FG000|Randomized Phase (Up to 48 Weeks)|Physician Decision|1|||
37815822|NCT01910402|69494095|FG001|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
37815823|NCT01910402|69494096|FG002|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
37815824|NCT01910402|69494094|FG000|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|5|||
37815825|NCT01910402|69494095|FG001|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|4|||
37815826|NCT01910402|69494096|FG002|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|0|||
37979898|NCT00348309|69666627|FG001|Overall Study|No disponibility of medication|0|||
37694845|NCT02409368|69171294|FG001|ECOG Reclassification|Lost to Follow-up|5|||
37979899|NCT00348309|69666628|FG002|Overall Study|No disponibility of medication|0|||
37979900|NCT00348309|69666626|FG000|Overall Study|Worsened neurodegenerative disease|1|||
37979901|NCT00348309|69666627|FG001|Overall Study|Worsened neurodegenerative disease|0|||
37979902|NCT00348309|69666628|FG002|Overall Study|Worsened neurodegenerative disease|0|||
37979903|NCT00348309|69666626|FG000|Overall Study|Cognitive and behaviour worsening|2|||
37979904|NCT00348309|69666627|FG001|Overall Study|Cognitive and behaviour worsening|0|||
37979905|NCT00348309|69666628|FG002|Overall Study|Cognitive and behaviour worsening|0|||
37979906|NCT00348309|69666626|FG000|Overall Study|Worsening of alzheimer|1|||
37979907|NCT00348309|69666627|FG001|Overall Study|Worsening of alzheimer|0|||
37979908|NCT00348309|69666628|FG002|Overall Study|Worsening of alzheimer|1|||
37979909|NCT00348309|69666626|FG000|Overall Study|Did not appear in time for Visit 3|1|||
37979910|NCT00348309|69666627|FG001|Overall Study|Did not appear in time for Visit 3|0|||
37979911|NCT00348309|69666628|FG002|Overall Study|Did not appear in time for Visit 3|0|||
37979912|NCT00348309|69666626|FG000|Overall Study|Participant died|2|||
37979913|NCT00348309|69666627|FG001|Overall Study|Participant died|1|||
37979914|NCT00348309|69666628|FG002|Overall Study|Participant died|1|||
37979915|NCT00348309|69666626|FG000|Overall Study|Decision of sponsor|1|||
37979916|NCT00348309|69666627|FG001|Overall Study|Decision of sponsor|0|||
37979917|NCT00348309|69666628|FG002|Overall Study|Decision of sponsor|0|||
37979918|NCT00348309|69666626|FG000|Overall Study|Ineffectiveness of treatment|0|||
37979919|NCT00348309|69666627|FG001|Overall Study|Ineffectiveness of treatment|1|||
37979920|NCT00348309|69666628|FG002|Overall Study|Ineffectiveness of treatment|0|||
37979921|NCT00348309|69666626|FG000|Overall Study|A foul of exclusion criteria|0|||
37979922|NCT00348309|69666627|FG001|Overall Study|A foul of exclusion criteria|1|||
37979923|NCT00348309|69666628|FG002|Overall Study|A foul of exclusion criteria|0|||
37979924|NCT00348309|69666626|FG000|Overall Study|Participant was hospitalized|0|||
37979925|NCT00348309|69666627|FG001|Overall Study|Participant was hospitalized|1|||
37979926|NCT00348309|69666628|FG002|Overall Study|Participant was hospitalized|0|||
37979927|NCT00348309|69666626|FG000|Overall Study|Sponsor refuseal|0|||
37979928|NCT00348309|69666627|FG001|Overall Study|Sponsor refuseal|1|||
37979929|NCT00348309|69666628|FG002|Overall Study|Sponsor refuseal|1|||
37979930|NCT00348309|69666626|FG000|Overall Study|Forgot often medication|0|||
37815827|NCT01910402|69494094|FG000|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|11|||
37815828|NCT01910402|69494095|FG001|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|13|||
37815829|NCT01910402|69494096|FG002|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|0|||
37815830|NCT01910402|69494094|FG000|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|5|||
37815831|NCT01910402|69494095|FG001|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|7|||
37815832|NCT01910402|69494096|FG002|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|0|||
37815833|NCT01910402|69494094|FG000|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
37815834|NCT01910402|69494095|FG001|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
37815835|NCT01910402|69494096|FG002|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|0|||
37815836|NCT01910402|69494094|FG000|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|10|||
37815837|NCT01910402|69494095|FG001|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|13|||
37815838|NCT01910402|69494096|FG002|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|0|||
37815839|NCT01910402|69494094|FG000|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
37815840|NCT01910402|69494095|FG001|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
37815841|NCT01910402|69494096|FG002|Continuation Phase(From Weeks 48 to 432)|Physician Decision|1|||
37815842|NCT01910402|69494094|FG000|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
37815843|NCT01910402|69494095|FG001|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
37815844|NCT01910402|69494096|FG002|Continuation Phase(From Weeks 48 to 432)|Adverse Event|4|||
37815845|NCT01910402|69494094|FG000|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
37815846|NCT01910402|69494095|FG001|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
37815847|NCT01910402|69494096|FG002|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|7|||
37815848|NCT01910402|69494094|FG000|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
37815849|NCT01910402|69494095|FG001|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
37815850|NCT01910402|69494096|FG002|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|8|||
37815851|NCT01910402|69494094|FG000|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
37815852|NCT01910402|69494095|FG001|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
37815853|NCT01910402|69494096|FG002|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|1|||
37815854|NCT01910402|69494094|FG000|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
37815855|NCT01910402|69494095|FG001|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
37869404|NCT01015677|69552972|FG000|Overall Study|Lack of Efficacy|0|||
37869405|NCT01015677|69552973|FG001|Overall Study|Lack of Efficacy|1|||
37869406|NCT01015677|69552974|FG002|Overall Study|Lack of Efficacy|0|||
37869407|NCT01015677|69552972|FG000|Overall Study|Protocol Violation|0|||
37979931|NCT00348309|69666627|FG001|Overall Study|Forgot often medication|1|||
37979932|NCT00348309|69666628|FG002|Overall Study|Forgot often medication|0|||
37979933|NCT00348309|69666626|FG000|Overall Study|Medical Monitor decision|0|||
37979934|NCT00348309|69666627|FG001|Overall Study|Medical Monitor decision|0|||
37869408|NCT01015677|69552973|FG001|Overall Study|Protocol Violation|1|||
37869409|NCT01015677|69552974|FG002|Overall Study|Protocol Violation|0|||
37869410|NCT01015677|69552972|FG000|Overall Study|Withdrawal by Subject|1|||
37869411|NCT01015677|69552973|FG001|Overall Study|Withdrawal by Subject|1|||
37869412|NCT01015677|69552974|FG002|Overall Study|Withdrawal by Subject|0|||
37869413|NCT01225211|69553014|FG000|Overall Study|Adverse Event|0|||
37869414|NCT01225211|69553015|FG001|Overall Study|Adverse Event|0|||
37869415|NCT01225211|69553016|FG002|Overall Study|Adverse Event|1|||
37869416|NCT01225211|69553017|FG003|Overall Study|Adverse Event|0|||
37869417|NCT01225211|69553018|FG004|Overall Study|Adverse Event|0|||
37869418|NCT01225211|69553019|FG005|Overall Study|Adverse Event|0|||
37869419|NCT01225211|69553020|FG006|Overall Study|Adverse Event|0|||
37869420|NCT01225211|69553021|FG007|Overall Study|Adverse Event|0|||
37869421|NCT01225211|69553022|FG008|Overall Study|Adverse Event|0|||
37869422|NCT01225211|69553023|FG009|Overall Study|Adverse Event|1|||
37869423|NCT01225211|69553014|FG000|Overall Study|Withdrawal by Subject|0|||
37869424|NCT01225211|69553015|FG001|Overall Study|Withdrawal by Subject|0|||
37869425|NCT01225211|69553016|FG002|Overall Study|Withdrawal by Subject|0|||
37869426|NCT01225211|69553017|FG003|Overall Study|Withdrawal by Subject|0|||
37869427|NCT01225211|69553018|FG004|Overall Study|Withdrawal by Subject|0|||
37869428|NCT01225211|69553019|FG005|Overall Study|Withdrawal by Subject|0|||
37869429|NCT01225211|69553020|FG006|Overall Study|Withdrawal by Subject|1|||
37869430|NCT01225211|69553021|FG007|Overall Study|Withdrawal by Subject|0|||
37869431|NCT01225211|69553022|FG008|Overall Study|Withdrawal by Subject|1|||
37869432|NCT01225211|69553023|FG009|Overall Study|Withdrawal by Subject|3|||
37869433|NCT01225211|69553014|FG000|Overall Study|Other|0|||
37869434|NCT01225211|69553015|FG001|Overall Study|Other|0|||
37869435|NCT01225211|69553016|FG002|Overall Study|Other|0|||
37869436|NCT01225211|69553017|FG003|Overall Study|Other|0|||
37869437|NCT01225211|69553018|FG004|Overall Study|Other|0|||
37869438|NCT01225211|69553019|FG005|Overall Study|Other|0|||
37869439|NCT01225211|69553020|FG006|Overall Study|Other|0|||
37869440|NCT01225211|69553021|FG007|Overall Study|Other|0|||
37869441|NCT01225211|69553022|FG008|Overall Study|Other|0|||
37869442|NCT01225211|69553023|FG009|Overall Study|Other|1|||
37869443|NCT01224821|69553106|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
37869444|NCT01224821|69553106|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
37869445|NCT01224821|69553106|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
37869446|NCT01224821|69553106|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
37869447|NCT01224821|69553106|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
37869448|NCT01224821|69553106|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
37869449|NCT01224821|69553106|FG000|Long-Term Follow-Up|Death|2|||
37869450|NCT01224821|69553106|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
37869451|NCT01224431|69553123|FG000|Overall Study|not randomized|0|||
37869452|NCT01224431|69553124|FG001|Overall Study|not randomized|4|||
37869453|NCT01224431|69553123|FG000|Overall Study|no video record|0|||
37869454|NCT01224431|69553124|FG001|Overall Study|no video record|1|||
37869455|NCT01223183|69553134|FG000|Imaging Day 1|Physician Decision|0|||
37869456|NCT01223183|69553135|FG001|Imaging Day 1|Physician Decision|1|||
37869457|NCT01223183|69553134|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
37869458|NCT01223183|69553135|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
37869459|NCT01223183|69553134|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
37869460|NCT01223183|69553135|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
37869461|NCT01223027|69553144|FG000|Overall Study|Adverse Event|20|||
37869462|NCT01223027|69553145|FG001|Overall Study|Adverse Event|10|||
37869463|NCT01223027|69553144|FG000|Overall Study|Death|42|||
37869464|NCT01223027|69553145|FG001|Overall Study|Death|42|||
37869465|NCT01223027|69553144|FG000|Overall Study|Lost to Follow-up|2|||
37869466|NCT01223027|69553145|FG001|Overall Study|Lost to Follow-up|1|||
37869467|NCT01223027|69553144|FG000|Overall Study|Physician Decision|4|||
37869468|NCT01223027|69553145|FG001|Overall Study|Physician Decision|8|||
37869469|NCT01223027|69553144|FG000|Overall Study|Progressive Disease|167|||
37869470|NCT01223027|69553145|FG001|Overall Study|Progressive Disease|183|||
37869471|NCT01223027|69553144|FG000|Overall Study|Protocol Violation|2|||
37869472|NCT01223027|69553145|FG001|Overall Study|Protocol Violation|1|||
37869473|NCT01223027|69553144|FG000|Overall Study|Subject/guardian decicion|18|||
37869474|NCT01223027|69553145|FG001|Overall Study|Subject/guardian decicion|16|||
37869475|NCT01223027|69553144|FG000|Overall Study|New therapy for study indication|17|||
37869476|NCT01223027|69553145|FG001|Overall Study|New therapy for study indication|8|||
37869477|NCT01223027|69553144|FG000|Overall Study|Study terminated by sponsor|2|||
37869478|NCT01223027|69553145|FG001|Overall Study|Study terminated by sponsor|8|||
37869479|NCT01015287|69553153|FG000|Overall Study|Death|21|||
37869480|NCT01015287|69553154|FG001|Overall Study|Death|16|||
37869481|NCT01015287|69553153|FG000|Overall Study|Adverse Event|1|||
37869482|NCT01015287|69553154|FG001|Overall Study|Adverse Event|0|||
37869483|NCT01015287|69553153|FG000|Overall Study|Sponsor Decision|3|||
37869484|NCT01015287|69553154|FG001|Overall Study|Sponsor Decision|7|||
37869485|NCT01015287|69553153|FG000|Overall Study|Physician Decision|19|||
37869486|NCT01015287|69553154|FG001|Overall Study|Physician Decision|21|||
37869487|NCT01015287|69553153|FG000|Overall Study|Withdrawal by Subject|14|||
37869488|NCT01015287|69553154|FG001|Overall Study|Withdrawal by Subject|19|||
37869489|NCT01015287|69553153|FG000|Overall Study|Entry Criteria not Met|11|||
37869490|NCT01015287|69553154|FG001|Overall Study|Entry Criteria not Met|14|||
37869491|NCT01015287|69553153|FG000|Overall Study|Lost to Follow-up|2|||
37869492|NCT01015287|69553154|FG001|Overall Study|Lost to Follow-up|1|||
37869493|NCT01015287|69553153|FG000|Overall Study|Protocol Violation|1|||
37869494|NCT01015287|69553154|FG001|Overall Study|Protocol Violation|1|||
37869495|NCT01015131|69553162|FG000|Overall Study|Physician Decision|1|||
37869496|NCT01015131|69553162|FG000|Overall Study|Protocol Violation|1|||
37869497|NCT01015131|69553162|FG000|Overall Study|Withdrawal by Subject|2|||
37869498|NCT01015131|69553162|FG000|Overall Study|Other Protocol Specified Criteria|4|||
37869499|NCT01222715|69553168|FG000|Overall Study|Adverse Event|0|||
37869500|NCT01222715|69553169|FG001|Overall Study|Adverse Event|4|||
37869501|NCT01222715|69553168|FG000|Overall Study|Death|0|||
37869502|NCT01222715|69553169|FG001|Overall Study|Death|1|||
37869503|NCT01222715|69553168|FG000|Overall Study|Lack of Efficacy|22|||
37869504|NCT01222715|69553169|FG001|Overall Study|Lack of Efficacy|14|||
37869505|NCT01222715|69553168|FG000|Overall Study|Physician Decision|12|||
37869506|NCT01222715|69553169|FG001|Overall Study|Physician Decision|2|||
37869507|NCT01222715|69553168|FG000|Overall Study|Refusal of further protocol therapy|0|||
37869508|NCT01222715|69553169|FG001|Overall Study|Refusal of further protocol therapy|4|||
37869509|NCT01222715|69553168|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
37869510|NCT01222715|69553169|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
37869511|NCT01222715|69553168|FG000|Overall Study|Ineligible|0|||
37869512|NCT01222715|69553169|FG001|Overall Study|Ineligible|1|||
37869513|NCT01222715|69553168|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
37869514|NCT01222715|69553169|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
37869515|NCT01222403|69553177|FG000|Overall Study|Inappropriate enrollment|0|||
37869516|NCT01222403|69553178|FG001|Overall Study|Inappropriate enrollment|2|||
37869517|NCT01222247|69553186|FG000|Overall Study|Lost to Follow-up|2|||
37869518|NCT01222247|69553187|FG001|Overall Study|Lost to Follow-up|2|||
37869519|NCT01014975|69553193|FG000|Overall Study|Withdrawal by Subject|1|||
37869520|NCT01014975|69553194|FG001|Overall Study|Withdrawal by Subject|0|||
37869521|NCT01014975|69553195|FG002|Overall Study|Withdrawal by Subject|1|||
37869522|NCT01014975|69553193|FG000|Overall Study|Death|3|||
37869523|NCT01014975|69553194|FG001|Overall Study|Death|3|||
37869524|NCT01014975|69553195|FG002|Overall Study|Death|4|||
37869525|NCT01014975|69553193|FG000|Overall Study|Lost to Follow-up|0|||
37869526|NCT01014975|69553194|FG001|Overall Study|Lost to Follow-up|0|||
37869527|NCT01014975|69553195|FG002|Overall Study|Lost to Follow-up|1|||
37869528|NCT01221623|69553205|FG000|Overall Study|Withdrawal by Subject|19|||
37869529|NCT01221623|69553206|FG001|Overall Study|Withdrawal by Subject|8|||
37869530|NCT01221623|69553205|FG000|Overall Study|Lost to Follow-up|7|||
37869531|NCT01221623|69553206|FG001|Overall Study|Lost to Follow-up|1|||
37869532|NCT01221623|69553205|FG000|Overall Study|Adverse Event|6|||
37869533|NCT01221623|69553206|FG001|Overall Study|Adverse Event|3|||
37869534|NCT01221623|69553205|FG000|Overall Study|Death|1|||
37869535|NCT01221623|69553206|FG001|Overall Study|Death|0|||
37869536|NCT01221623|69553205|FG000|Overall Study|Other|5|||
37869537|NCT01221623|69553206|FG001|Overall Study|Other|2|||
37869538|NCT01014585|69553216|FG000|Overall Study|Adverse Event|0|||
37869539|NCT01014585|69553217|FG001|Overall Study|Adverse Event|2|||
37869540|NCT01014585|69553218|FG002|Overall Study|Adverse Event|0|||
37869541|NCT01014585|69553219|FG003|Overall Study|Adverse Event|3|||
37869542|NCT01014585|69553216|FG000|Overall Study|Withdrawal by Subject|2|||
37869543|NCT01014585|69553217|FG001|Overall Study|Withdrawal by Subject|0|||
37869544|NCT01014585|69553218|FG002|Overall Study|Withdrawal by Subject|1|||
37869545|NCT01014585|69553219|FG003|Overall Study|Withdrawal by Subject|3|||
37869546|NCT01014585|69553216|FG000|Overall Study|Lost to Follow-up|0|||
37869547|NCT01014585|69553217|FG001|Overall Study|Lost to Follow-up|0|||
37869548|NCT01014585|69553218|FG002|Overall Study|Lost to Follow-up|0|||
37869549|NCT01014585|69553219|FG003|Overall Study|Lost to Follow-up|2|||
37869550|NCT01014585|69553216|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
37869551|NCT01014585|69553217|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
37869552|NCT01014585|69553218|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
37869553|NCT01014585|69553219|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
37869554|NCT01221233|69553231|FG000|Overall Study|Withdrawal by Subject|3|||
37979935|NCT00348309|69666628|FG002|Overall Study|Medical Monitor decision|1|||
37979936|NCT00348309|69666626|FG000|Overall Study|Increased dose of Aricept|0|||
37979937|NCT00348309|69666627|FG001|Overall Study|Increased dose of Aricept|0|||
37979938|NCT00348309|69666628|FG002|Overall Study|Increased dose of Aricept|1|||
37979939|NCT00348309|69666626|FG000|Overall Study|Site closure|0|||
37979940|NCT00348309|69666627|FG001|Overall Study|Site closure|0|||
37979941|NCT00348309|69666628|FG002|Overall Study|Site closure|1|||
37979942|NCT00348309|69666626|FG000|Overall Study|Adverse event not attended|0|||
37979943|NCT00348309|69666627|FG001|Overall Study|Adverse event not attended|0|||
37979944|NCT00348309|69666628|FG002|Overall Study|Adverse event not attended|1|||
37979945|NCT00348309|69666626|FG000|Overall Study|ECG abnormal|0|||
37979946|NCT00348309|69666627|FG001|Overall Study|ECG abnormal|0|||
37979947|NCT00348309|69666628|FG002|Overall Study|ECG abnormal|2|||
37979948|NCT00348309|69666626|FG000|Overall Study|Cardiologist recommendations|0|||
37979949|NCT00348309|69666627|FG001|Overall Study|Cardiologist recommendations|0|||
37979950|NCT00348309|69666628|FG002|Overall Study|Cardiologist recommendations|1|||
37979951|NCT00348309|69666626|FG000|Overall Study|HCV career|0|||
37979952|NCT00348309|69666627|FG001|Overall Study|HCV career|0|||
37979953|NCT00348309|69666628|FG002|Overall Study|HCV career|1|||
37979954|NCT00440310|69666639|FG000|Overall Study|Lost to Follow-up|4|||
37979955|NCT00440310|69666640|FG001|Overall Study|Lost to Follow-up|5|||
37979956|NCT00440310|69666639|FG000|Overall Study|Protocol Violation|0|||
37979957|NCT00440310|69666640|FG001|Overall Study|Protocol Violation|1|||
37979958|NCT00440310|69666639|FG000|Overall Study|Withdrawal by Subject|15|||
37979959|NCT00440310|69666640|FG001|Overall Study|Withdrawal by Subject|14|||
37979960|NCT00440310|69666639|FG000|Overall Study|No Reply at EOS|7|||
37979961|NCT00440310|69666640|FG001|Overall Study|No Reply at EOS|7|||
37979962|NCT00440310|69666639|FG000|Overall Study|Other|1|||
37815856|NCT01910402|69494096|FG002|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|15|||
37815857|NCT01757535|69494123|FG000|Overall Study|Disease Relapse|143|||
37869555|NCT01221233|69553232|FG001|Overall Study|Withdrawal by Subject|1|||
37869556|NCT01220609|69553238|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
37869557|NCT01220609|69553238|FG000|Overall Study|Ineligible- Wrong cell type|1|||
37869558|NCT01220609|69553238|FG000|Overall Study|Ineligible-Never treated|1|||
37869559|NCT01220297|69553250|FG000|Overall Study|Death|2|||
37869560|NCT01220297|69553250|FG000|Overall Study|Lost to Follow-up|1|||
37869561|NCT01219985|69553256|FG000|Overall Study|Physician Decision|20|||
37869562|NCT01218659|69553264|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
37869563|NCT01218659|69553265|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
37869564|NCT01218659|69553266|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
37869565|NCT01218659|69553264|FG000|18-Month Randomized Period|Did not receive study drug|0|||
37869566|NCT01218659|69553265|FG001|18-Month Randomized Period|Did not receive study drug|3|||
37869567|NCT01218659|69553266|FG002|18-Month Randomized Period|Did not receive study drug|0|||
37869568|NCT01218659|69553264|FG000|12-Month OLE|Withdrawal by Subject|0|||
37869569|NCT01218659|69553265|FG001|12-Month OLE|Withdrawal by Subject|0|||
37869570|NCT01218659|69553266|FG002|12-Month OLE|Withdrawal by Subject|2|||
37869571|NCT01218659|69553264|FG000|12-Month OLE|Physician Decision|0|||
37869572|NCT01218659|69553265|FG001|12-Month OLE|Physician Decision|0|||
37869573|NCT01218659|69553266|FG002|12-Month OLE|Physician Decision|1|||
37815858|NCT01757535|69494124|FG001|Overall Study|Disease Relapse|180|||
37815859|NCT01757535|69494123|FG000|Overall Study|Adverse Event|29|||
37815860|NCT01757535|69494124|FG001|Overall Study|Adverse Event|11|||
37815861|NCT01757535|69494123|FG000|Overall Study|Withdrawal by Subject|9|||
37815862|NCT01757535|69494124|FG001|Overall Study|Withdrawal by Subject|13|||
37815863|NCT01757535|69494123|FG000|Overall Study|Miscellaneous|5|||
37815864|NCT01757535|69494124|FG001|Overall Study|Miscellaneous|2|||
37815865|NCT01757535|69494123|FG000|Overall Study|Physician Decision|6|||
37815866|NCT01757535|69494124|FG001|Overall Study|Physician Decision|0|||
37815867|NCT01757535|69494123|FG000|Overall Study|Death|1|||
37815868|NCT01757535|69494124|FG001|Overall Study|Death|2|||
37815869|NCT01614197|69494138|FG000|Overall Study|Withdrawal by Subject|0|||
37815870|NCT01614197|69494139|FG001|Overall Study|Withdrawal by Subject|1|||
37815871|NCT01614197|69494140|FG002|Overall Study|Withdrawal by Subject|0|||
37815872|NCT01614197|69494141|FG003|Overall Study|Withdrawal by Subject|0|||
37815873|NCT01236521|69494175|FG000|Overall Study|Withdrawal by Subject|12|||
37815874|NCT01236521|69494176|FG001|Overall Study|Withdrawal by Subject|17|||
37869574|NCT01218659|69553264|FG000|12-Month OLE|Lost to Follow-up|0|||
37869575|NCT01218659|69553265|FG001|12-Month OLE|Lost to Follow-up|0|||
37869576|NCT01218659|69553266|FG002|12-Month OLE|Lost to Follow-up|1|||
37869577|NCT01218659|69553264|FG000|12-Month OLE|Pregnancy|0|||
37979963|NCT00440310|69666640|FG001|Overall Study|Other|0|||
37979964|NCT00440310|69666639|FG000|Overall Study|Status Unknown|1|||
37979965|NCT00440310|69666640|FG001|Overall Study|Status Unknown|3|||
37979966|NCT00440232|69666648|FG000|Overall Study|Lost to Follow-up|1|||
37979967|NCT00440232|69666649|FG001|Overall Study|Lost to Follow-up|1|||
37979968|NCT00440232|69666648|FG000|Overall Study|Unable to treat within allowed time|0|||
37979969|NCT00440232|69666649|FG001|Overall Study|Unable to treat within allowed time|1|||
37869578|NCT01218659|69553265|FG001|12-Month OLE|Pregnancy|0|||
37869579|NCT01218659|69553266|FG002|12-Month OLE|Pregnancy|1|||
37869580|NCT01218659|69553264|FG000|12-Month OLE|Lack of Efficacy|0|||
37869581|NCT01218659|69553265|FG001|12-Month OLE|Lack of Efficacy|0|||
37869582|NCT01218659|69553266|FG002|12-Month OLE|Lack of Efficacy|1|||
37869583|NCT01218659|69553264|FG000|12-Month OLE|Declined to participate in the OLE|0|||
37869584|NCT01218659|69553265|FG001|12-Month OLE|Declined to participate in the OLE|0|||
37869585|NCT01218659|69553266|FG002|12-Month OLE|Declined to participate in the OLE|4|||
37869586|NCT00940498|69553281|FG000|Overall Study|Death|2|||
37869587|NCT00940498|69553282|FG001|Overall Study|Death|0|||
37869588|NCT00940498|69553283|FG002|Overall Study|Death|0|||
37869589|NCT00940498|69553284|FG003|Overall Study|Death|1|||
37869590|NCT00940498|69553285|FG004|Overall Study|Death|5|||
37869591|NCT00940498|69553286|FG005|Overall Study|Death|0|||
37869592|NCT00940498|69553287|FG006|Overall Study|Death|1|||
37869593|NCT00940498|69553288|FG007|Overall Study|Death|0|||
37869594|NCT00940498|69553281|FG000|Overall Study|Lost to Follow-up|1|||
37869595|NCT00940498|69553282|FG001|Overall Study|Lost to Follow-up|1|||
37869596|NCT00940498|69553283|FG002|Overall Study|Lost to Follow-up|2|||
37869597|NCT00940498|69553284|FG003|Overall Study|Lost to Follow-up|0|||
37869598|NCT00940498|69553285|FG004|Overall Study|Lost to Follow-up|1|||
37869599|NCT00940498|69553286|FG005|Overall Study|Lost to Follow-up|0|||
37869600|NCT00940498|69553287|FG006|Overall Study|Lost to Follow-up|0|||
37869601|NCT00940498|69553288|FG007|Overall Study|Lost to Follow-up|1|||
37869602|NCT00940498|69553281|FG000|Overall Study|Disease Progression|0|||
37869603|NCT00940498|69553282|FG001|Overall Study|Disease Progression|0|||
37979970|NCT00440232|69666648|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
37979971|NCT00440232|69666649|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
37979972|NCT00356889|69666655|FG000|Overall Study|Protocol Violation|2|||
37979973|NCT00356889|69666655|FG000|Overall Study|Adverse Event|1|||
37869604|NCT00940498|69553283|FG002|Overall Study|Disease Progression|1|||
37869605|NCT00940498|69553284|FG003|Overall Study|Disease Progression|1|||
37869606|NCT00940498|69553285|FG004|Overall Study|Disease Progression|0|||
37869607|NCT00940498|69553286|FG005|Overall Study|Disease Progression|1|||
37869608|NCT00940498|69553287|FG006|Overall Study|Disease Progression|0|||
37869609|NCT00940498|69553288|FG007|Overall Study|Disease Progression|0|||
37869610|NCT00940498|69553281|FG000|Overall Study|Physician Decision|0|||
37869611|NCT00940498|69553282|FG001|Overall Study|Physician Decision|0|||
37869612|NCT00940498|69553283|FG002|Overall Study|Physician Decision|0|||
37869613|NCT00940498|69553284|FG003|Overall Study|Physician Decision|0|||
37869614|NCT00940498|69553285|FG004|Overall Study|Physician Decision|2|||
37869615|NCT00940498|69553286|FG005|Overall Study|Physician Decision|0|||
37869616|NCT00940498|69553287|FG006|Overall Study|Physician Decision|0|||
37869617|NCT00940498|69553288|FG007|Overall Study|Physician Decision|0|||
37979974|NCT00356811|69666660|FG000|Overall Study|Death|35|||
37979975|NCT00356811|69666660|FG000|Overall Study|Lost to Follow-up|2|||
37979976|NCT00356811|69666660|FG000|Overall Study|Withdrawal by Subject|6|||
37979977|NCT00356811|69666660|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
37979978|NCT00356811|69666660|FG000|Overall Study|Study Is Terminating|3|||
37869618|NCT00940498|69553281|FG000|Overall Study|Not treated due to disease related pain|0|||
37979979|NCT00356811|69666660|FG000|Overall Study|Site Closed during Follow-up|2|||
37979980|NCT00439218|69666665|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
37979981|NCT00535223|69666684|FG000|Overall Study|Withdrawal by Subject|4|||
37869619|NCT00940498|69553282|FG001|Overall Study|Not treated due to disease related pain|0|||
37869620|NCT00940498|69553283|FG002|Overall Study|Not treated due to disease related pain|0|||
37869621|NCT00940498|69553284|FG003|Overall Study|Not treated due to disease related pain|0|||
37979982|NCT00535223|69666685|FG001|Overall Study|Withdrawal by Subject|1|||
37869622|NCT00940498|69553285|FG004|Overall Study|Not treated due to disease related pain|1|||
37869623|NCT00940498|69553286|FG005|Overall Study|Not treated due to disease related pain|0|||
37869624|NCT00940498|69553287|FG006|Overall Study|Not treated due to disease related pain|0|||
37869625|NCT00940498|69553288|FG007|Overall Study|Not treated due to disease related pain|0|||
37869626|NCT00940342|69553315|FG000|Overall Study|Adverse Event|0|||
37869627|NCT00940342|69553316|FG001|Overall Study|Adverse Event|2|||
37869628|NCT00940342|69553317|FG002|Overall Study|Adverse Event|1|||
37869629|NCT00936910|69553325|FG000|Overall Study|Lack of Efficacy|3|||
37979983|NCT00536939|69666691|FG000|Overall Study|Withdrawal by Subject|1|||
37979984|NCT00536939|69666692|FG001|Overall Study|Withdrawal by Subject|0|||
37979985|NCT00536939|69666691|FG000|Overall Study|Other Complicating Disease|1|||
37979986|NCT00536939|69666692|FG001|Overall Study|Other Complicating Disease|0|||
37979987|NCT00347919|69666700|FG000|Overall Study|Lost to Follow-up|11|||
37979988|NCT00347919|69666701|FG001|Overall Study|Lost to Follow-up|13|||
37979989|NCT00347919|69666702|FG002|Overall Study|Lost to Follow-up|0|||
37979990|NCT00347919|69666700|FG000|Overall Study|Withdrawal by Subject|6|||
37979991|NCT00347919|69666701|FG001|Overall Study|Withdrawal by Subject|8|||
37979992|NCT00347919|69666702|FG002|Overall Study|Withdrawal by Subject|0|||
37979993|NCT00347919|69666700|FG000|Overall Study|Physician Decision|1|||
37979994|NCT00347919|69666701|FG001|Overall Study|Physician Decision|1|||
37979995|NCT00347919|69666702|FG002|Overall Study|Physician Decision|0|||
37979996|NCT00347919|69666700|FG000|Overall Study|Sponsor terminated study|15|||
37979997|NCT00347919|69666701|FG001|Overall Study|Sponsor terminated study|10|||
37979998|NCT00347919|69666702|FG002|Overall Study|Sponsor terminated study|16|||
37979999|NCT00347919|69666700|FG000|Overall Study|Death|35|||
37980000|NCT00347919|69666701|FG001|Overall Study|Death|42|||
37980001|NCT00347919|69666702|FG002|Overall Study|Death|19|||
37980002|NCT00347919|69666700|FG000|Overall Study|Par. Started Other Treatment|1|||
37980003|NCT00347919|69666701|FG001|Overall Study|Par. Started Other Treatment|1|||
37980004|NCT00347919|69666702|FG002|Overall Study|Par. Started Other Treatment|1|||
37980005|NCT00347919|69666700|FG000|Overall Study|Missing|2|||
37980006|NCT00347919|69666701|FG001|Overall Study|Missing|1|||
37980007|NCT00347919|69666702|FG002|Overall Study|Missing|2|||
37980008|NCT00439140|69666715|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
37980009|NCT00439140|69666716|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
37980010|NCT00439140|69666717|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
37980011|NCT00439140|69666715|FG000|Treatment Cycle 1|Personal reasons|0|||
37980012|NCT00439140|69666716|FG001|Treatment Cycle 1|Personal reasons|2|||
37980013|NCT00439140|69666717|FG002|Treatment Cycle 1|Personal reasons|0|||
37980014|NCT00439140|69666715|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
37980015|NCT00439140|69666716|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
37869630|NCT00940108|69553334|FG000|Overall Study|Adverse Event|2|||
37869631|NCT00940108|69553335|FG001|Overall Study|Adverse Event|4|||
37869632|NCT00940108|69553336|FG002|Overall Study|Adverse Event|0|||
37869633|NCT00940108|69553337|FG003|Overall Study|Adverse Event|2|||
37869634|NCT00940108|69553334|FG000|Overall Study|Withdrew Consent|2|||
37869635|NCT00940108|69553335|FG001|Overall Study|Withdrew Consent|1|||
37869636|NCT00940108|69553336|FG002|Overall Study|Withdrew Consent|0|||
37869637|NCT00940108|69553337|FG003|Overall Study|Withdrew Consent|1|||
37869638|NCT00940108|69553334|FG000|Overall Study|Dose 2 contraindicated|1|||
37869639|NCT00940108|69553335|FG001|Overall Study|Dose 2 contraindicated|1|||
37869640|NCT00940108|69553336|FG002|Overall Study|Dose 2 contraindicated|0|||
37869641|NCT00940108|69553337|FG003|Overall Study|Dose 2 contraindicated|1|||
37869642|NCT00940108|69553334|FG000|Overall Study|Declined further vaccination|0|||
37869643|NCT00940108|69553335|FG001|Overall Study|Declined further vaccination|1|||
37869644|NCT00940108|69553336|FG002|Overall Study|Declined further vaccination|3|||
37869645|NCT00940108|69553337|FG003|Overall Study|Declined further vaccination|0|||
37869646|NCT00940108|69553334|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
37869647|NCT00940108|69553335|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
37869648|NCT00940108|69553336|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
37869649|NCT00940108|69553337|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
37980016|NCT00439140|69666717|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
37980017|NCT00439140|69666715|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
37980018|NCT00439140|69666716|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
37980019|NCT00439140|69666717|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
37869650|NCT00940108|69553334|FG000|Overall Study|Viral illness after Dose 1|0|||
37869651|NCT00940108|69553335|FG001|Overall Study|Viral illness after Dose 1|1|||
37869652|NCT00940108|69553336|FG002|Overall Study|Viral illness after Dose 1|0|||
37869653|NCT00940108|69553337|FG003|Overall Study|Viral illness after Dose 1|0|||
37869654|NCT00940108|69553334|FG000|Overall Study|Diagnosed with H1N1|0|||
37869655|NCT00940108|69553335|FG001|Overall Study|Diagnosed with H1N1|0|||
37980020|NCT00439140|69666715|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
37980021|NCT00439140|69666716|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
37980022|NCT00439140|69666717|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
37980023|NCT00356421|69666727|FG000|Overall Study|Lack of Efficacy|3|||
37869656|NCT00940108|69553336|FG002|Overall Study|Diagnosed with H1N1|0|||
37869657|NCT00940108|69553337|FG003|Overall Study|Diagnosed with H1N1|1|||
37869658|NCT00936598|69553349|FG000|Overall Study|Withdrawal by Subject|1|||
37869659|NCT00936598|69553350|FG001|Overall Study|Withdrawal by Subject|0|||
37869660|NCT00936598|69553349|FG000|Overall Study|Ineligible after consent|1|||
37869661|NCT00936598|69553350|FG001|Overall Study|Ineligible after consent|0|||
37869662|NCT01025817|69553358|FG000|Completed Study Medication|Adverse Event|66|||
37869663|NCT01025817|69553359|FG001|Completed Study Medication|Adverse Event|39|||
37869664|NCT01025817|69553358|FG000|Completed Study Medication|Protocol Deviation|9|||
37869665|NCT01025817|69553359|FG001|Completed Study Medication|Protocol Deviation|8|||
37869666|NCT01025817|69553358|FG000|Completed Study Medication|Withdrawal by Subject|8|||
37869667|NCT01025817|69553359|FG001|Completed Study Medication|Withdrawal by Subject|9|||
37869668|NCT01025817|69553358|FG000|Completed Study Medication|Administrative problems|7|||
37869669|NCT01025817|69553359|FG001|Completed Study Medication|Administrative problems|5|||
37869670|NCT01025817|69553358|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
37869671|NCT01025817|69553359|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
37869672|NCT01025817|69553358|FG000|Completed Study Medication|Abnormal test procedure|4|||
37869673|NCT01025817|69553359|FG001|Completed Study Medication|Abnormal test procedure|0|||
37869674|NCT01025817|69553358|FG000|Completed Study Medication|Graft loss|2|||
37869675|NCT01025817|69553359|FG001|Completed Study Medication|Graft loss|5|||
37869676|NCT01025817|69553358|FG000|Completed Study Medication|Death|2|||
37869677|NCT01025817|69553359|FG001|Completed Study Medication|Death|2|||
37869678|NCT01025817|69553358|FG000|Completed Study Medication|Abnormal lab values|0|||
37869679|NCT01025817|69553359|FG001|Completed Study Medication|Abnormal lab values|2|||
37869680|NCT01025817|69553358|FG000|Completed Study Medication|Subject no longer required study drug|0|||
37869681|NCT01025817|69553359|FG001|Completed Study Medication|Subject no longer required study drug|1|||
37869682|NCT01025817|69553358|FG000|Completed Study Medication|Lost to Follow-up|0|||
37869683|NCT01025817|69553359|FG001|Completed Study Medication|Lost to Follow-up|1|||
37869684|NCT01025817|69553358|FG000|Completed Study|Withdrawal by Subject|8|||
37869685|NCT01025817|69553359|FG001|Completed Study|Withdrawal by Subject|16|||
37869686|NCT01025817|69553358|FG000|Completed Study|Death|6|||
37869687|NCT01025817|69553359|FG001|Completed Study|Death|5|||
37869688|NCT01025817|69553358|FG000|Completed Study|Missing|2|||
37869689|NCT01025817|69553359|FG001|Completed Study|Missing|0|||
37869690|NCT01025817|69553358|FG000|Completed Study|Lost to Follow-up|0|||
37869691|NCT01025817|69553359|FG001|Completed Study|Lost to Follow-up|1|||
37869692|NCT00939640|69553365|FG000|Overall Study|Physician Decision|1|||
37869693|NCT01218113|69553377|FG000|Overall Study|Withdrawal by Subject|1|||
37869694|NCT01218113|69553378|FG001|Overall Study|Withdrawal by Subject|0|||
37869695|NCT01218113|69553379|FG002|Overall Study|Withdrawal by Subject|1|||
37869696|NCT01218113|69553377|FG000|Overall Study|Lost to Follow-up|4|||
37869697|NCT01218113|69553378|FG001|Overall Study|Lost to Follow-up|1|||
37869698|NCT01218113|69553379|FG002|Overall Study|Lost to Follow-up|4|||
37869699|NCT01218113|69553377|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
37869700|NCT01218113|69553378|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
37869701|NCT01218113|69553379|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
37869702|NCT03873493|69553394|FG000|Overall Study|Withdrawal by Subject|1|||
37869703|NCT03873493|69553394|FG000|Overall Study|Death|9|||
37869704|NCT03873493|69553394|FG000|Overall Study|Lost to Follow-up|1|||
37869705|NCT03873493|69553394|FG000|Overall Study|Study Terminated by Sponsor|1|||
37869706|NCT03873493|69553394|FG000|Overall Study|Other|2|||
37869707|NCT00939484|69553414|FG000|Overall Study|Progression/Relapse|8|||
37869708|NCT00939484|69553415|FG001|Overall Study|Progression/Relapse|20|||
37869709|NCT00939484|69553416|FG002|Overall Study|Progression/Relapse|3|||
37869710|NCT01010217|69553431|FG000|Overall Study|Lost to Follow-up|4|||
37869711|NCT01010217|69553432|FG001|Overall Study|Lost to Follow-up|5|||
37869712|NCT01010217|69553433|FG002|Overall Study|Lost to Follow-up|1|||
37869713|NCT01010217|69553434|FG003|Overall Study|Lost to Follow-up|0|||
37869714|NCT01010217|69553435|FG004|Overall Study|Lost to Follow-up|0|||
37869715|NCT01010217|69553431|FG000|Overall Study|Withdrawal by Subject|1|||
37869716|NCT01010217|69553432|FG001|Overall Study|Withdrawal by Subject|0|||
37869717|NCT01010217|69553433|FG002|Overall Study|Withdrawal by Subject|0|||
37869718|NCT01010217|69553434|FG003|Overall Study|Withdrawal by Subject|0|||
37869719|NCT01010217|69553435|FG004|Overall Study|Withdrawal by Subject|0|||
37869720|NCT01010217|69553431|FG000|Overall Study|Physician Decision|0|||
37869721|NCT01010217|69553432|FG001|Overall Study|Physician Decision|0|||
37869722|NCT01010217|69553433|FG002|Overall Study|Physician Decision|0|||
37980024|NCT00356421|69666728|FG001|Overall Study|Lack of Efficacy|0|||
37869723|NCT01010217|69553434|FG003|Overall Study|Physician Decision|6|||
37869724|NCT01010217|69553435|FG004|Overall Study|Physician Decision|3|||
37869725|NCT01217957|69553452|FG000|Phase 1|Withdrawal by Patient|1|||
37869726|NCT01217957|69553453|FG001|Phase 1|Withdrawal by Patient|0|||
37980025|NCT00356421|69666727|FG000|Overall Study|Withdrawal by Subject|9|||
37980026|NCT00356421|69666728|FG001|Overall Study|Withdrawal by Subject|2|||
37980027|NCT00356421|69666727|FG000|Overall Study|Related to study drug|15|||
37980028|NCT00356421|69666728|FG001|Overall Study|Related to study drug|12|||
37980029|NCT00356421|69666727|FG000|Overall Study|Not related to study drug|5|||
37980030|NCT00356421|69666728|FG001|Overall Study|Not related to study drug|3|||
37980031|NCT00443820|69666738|FG000|Overall Study|Adverse Event|1|||
37980032|NCT00443820|69666739|FG001|Overall Study|Adverse Event|1|||
37980033|NCT00443820|69666740|FG002|Overall Study|Adverse Event|0|||
37980034|NCT00443820|69666741|FG003|Overall Study|Adverse Event|0|||
37980035|NCT00443820|69666738|FG000|Overall Study|Lack of Efficacy|3|||
37980036|NCT00443820|69666739|FG001|Overall Study|Lack of Efficacy|2|||
37980037|NCT00443820|69666740|FG002|Overall Study|Lack of Efficacy|1|||
37980038|NCT00443820|69666741|FG003|Overall Study|Lack of Efficacy|1|||
37980039|NCT00443820|69666738|FG000|Overall Study|Protocol Violation|2|||
37980040|NCT00443820|69666739|FG001|Overall Study|Protocol Violation|1|||
37980041|NCT00443820|69666740|FG002|Overall Study|Protocol Violation|2|||
37980042|NCT00443820|69666741|FG003|Overall Study|Protocol Violation|1|||
37980043|NCT00443820|69666738|FG000|Overall Study|Withdrawal by Subject|6|||
37980044|NCT00443820|69666739|FG001|Overall Study|Withdrawal by Subject|7|||
37980045|NCT00443820|69666740|FG002|Overall Study|Withdrawal by Subject|8|||
37980046|NCT00443820|69666741|FG003|Overall Study|Withdrawal by Subject|9|||
37980047|NCT00443820|69666738|FG000|Overall Study|Lost to Follow-up|9|||
37980048|NCT00443820|69666739|FG001|Overall Study|Lost to Follow-up|8|||
37980049|NCT00443820|69666740|FG002|Overall Study|Lost to Follow-up|6|||
37980050|NCT00443820|69666741|FG003|Overall Study|Lost to Follow-up|5|||
37980051|NCT00443820|69666738|FG000|Overall Study|Administrative problems|0|||
37980052|NCT00443820|69666739|FG001|Overall Study|Administrative problems|0|||
37980053|NCT00443820|69666740|FG002|Overall Study|Administrative problems|0|||
37980054|NCT00443820|69666741|FG003|Overall Study|Administrative problems|1|||
37980055|NCT00443820|69666738|FG000|Overall Study|Death|0|||
37980056|NCT00443820|69666739|FG001|Overall Study|Death|0|||
37980057|NCT00443820|69666740|FG002|Overall Study|Death|1|||
37980058|NCT00443820|69666741|FG003|Overall Study|Death|0|||
37980059|NCT00438672|69666753|FG000|Overall Study|Lost to Follow-up|7|||
37980060|NCT00438672|69666754|FG001|Overall Study|Lost to Follow-up|9|||
37980061|NCT00438360|69666762|FG000|Overall Study|Adverse Event|6|||
37980062|NCT00438360|69666763|FG001|Overall Study|Adverse Event|1|||
37980063|NCT00438360|69666762|FG000|Overall Study|Lack of Efficacy|42|||
37980064|NCT00438360|69666763|FG001|Overall Study|Lack of Efficacy|27|||
37980065|NCT00438360|69666762|FG000|Overall Study|Other|24|||
37980066|NCT00438360|69666763|FG001|Overall Study|Other|15|||
37980067|NCT00536471|69666773|FG000|Overall Study|Lost to Follow-up|48|||
37980068|NCT00536471|69666774|FG001|Overall Study|Lost to Follow-up|23|||
37980069|NCT00536471|69666775|FG002|Overall Study|Lost to Follow-up|48|||
37980070|NCT00536471|69666776|FG003|Overall Study|Lost to Follow-up|22|||
37980071|NCT00536471|69666773|FG000|Overall Study|Adverse Event|32|||
37980072|NCT00536471|69666774|FG001|Overall Study|Adverse Event|16|||
37980073|NCT00536471|69666775|FG002|Overall Study|Adverse Event|28|||
37980074|NCT00536471|69666776|FG003|Overall Study|Adverse Event|13|||
37980075|NCT00536471|69666773|FG000|Overall Study|Withdrawal by Subject|40|||
37980076|NCT00536471|69666774|FG001|Overall Study|Withdrawal by Subject|24|||
37980077|NCT00536471|69666775|FG002|Overall Study|Withdrawal by Subject|43|||
37980078|NCT00536471|69666776|FG003|Overall Study|Withdrawal by Subject|21|||
37980079|NCT00536471|69666773|FG000|Overall Study|Lack of Efficacy|17|||
37980080|NCT00536471|69666774|FG001|Overall Study|Lack of Efficacy|18|||
37980081|NCT00536471|69666775|FG002|Overall Study|Lack of Efficacy|11|||
37980082|NCT00536471|69666776|FG003|Overall Study|Lack of Efficacy|9|||
37980083|NCT00536471|69666773|FG000|Overall Study|Protocol Violation|8|||
37980084|NCT00536471|69666774|FG001|Overall Study|Protocol Violation|1|||
37980085|NCT00536471|69666775|FG002|Overall Study|Protocol Violation|2|||
37980086|NCT00536471|69666776|FG003|Overall Study|Protocol Violation|3|||
37980087|NCT00536471|69666773|FG000|Overall Study|Physician Decision|11|||
37980088|NCT00536471|69666774|FG001|Overall Study|Physician Decision|1|||
37869727|NCT01217957|69553454|FG002|Phase 1|Withdrawal by Patient|1|||
37869728|NCT01217957|69553455|FG003|Phase 1|Withdrawal by Patient|1|||
37869729|NCT01217957|69553456|FG004|Phase 1|Withdrawal by Patient|0|||
37980089|NCT00536471|69666775|FG002|Overall Study|Physician Decision|3|||
37980090|NCT00536471|69666776|FG003|Overall Study|Physician Decision|2|||
37980091|NCT00536471|69666773|FG000|Overall Study|Death|0|||
37980092|NCT00536471|69666774|FG001|Overall Study|Death|0|||
37980093|NCT00536471|69666775|FG002|Overall Study|Death|1|||
37980094|NCT00536471|69666776|FG003|Overall Study|Death|2|||
37980095|NCT00536471|69666773|FG000|Overall Study|Sponsor Decision|0|||
37980096|NCT00536471|69666774|FG001|Overall Study|Sponsor Decision|1|||
37980097|NCT00536471|69666775|FG002|Overall Study|Sponsor Decision|3|||
37980098|NCT00536471|69666776|FG003|Overall Study|Sponsor Decision|2|||
37980099|NCT00359619|69666800|FG000|Overall Study|Adverse Event|0|||
37980100|NCT00359619|69666801|FG001|Overall Study|Adverse Event|0|||
37980101|NCT00359619|69666802|FG002|Overall Study|Adverse Event|1|||
37980102|NCT00359619|69666803|FG003|Overall Study|Adverse Event|0|||
37980103|NCT00359619|69666804|FG004|Overall Study|Adverse Event|0|||
37980104|NCT00359619|69666805|FG005|Overall Study|Adverse Event|0|||
37980105|NCT00359619|69666806|FG006|Overall Study|Adverse Event|1|||
37980106|NCT00359619|69666800|FG000|Overall Study|Withdrawal by Subject|3|||
37980107|NCT00359619|69666801|FG001|Overall Study|Withdrawal by Subject|1|||
37980108|NCT00359619|69666802|FG002|Overall Study|Withdrawal by Subject|4|||
37980109|NCT00359619|69666803|FG003|Overall Study|Withdrawal by Subject|2|||
37694846|NCT02409368|69171295|FG002|ECOG Reclassification|Lost to Follow-up|0|||
37980110|NCT00359619|69666804|FG004|Overall Study|Withdrawal by Subject|2|||
37980111|NCT00359619|69666805|FG005|Overall Study|Withdrawal by Subject|0|||
37980112|NCT00359619|69666806|FG006|Overall Study|Withdrawal by Subject|3|||
37980113|NCT00359619|69666800|FG000|Overall Study|Other|1|||
37980114|NCT00359619|69666801|FG001|Overall Study|Other|0|||
37980115|NCT00359619|69666802|FG002|Overall Study|Other|0|||
37980116|NCT00359619|69666803|FG003|Overall Study|Other|0|||
37980117|NCT00359619|69666804|FG004|Overall Study|Other|0|||
37980118|NCT00359619|69666805|FG005|Overall Study|Other|0|||
37980119|NCT00359619|69666806|FG006|Overall Study|Other|0|||
37980120|NCT00359619|69666800|FG000|Overall Study|Lost to Follow-up|4|||
37980121|NCT00359619|69666801|FG001|Overall Study|Lost to Follow-up|4|||
37980122|NCT00359619|69666802|FG002|Overall Study|Lost to Follow-up|2|||
37980123|NCT00359619|69666803|FG003|Overall Study|Lost to Follow-up|1|||
37980124|NCT00359619|69666804|FG004|Overall Study|Lost to Follow-up|1|||
37980125|NCT00359619|69666805|FG005|Overall Study|Lost to Follow-up|5|||
37980126|NCT00359619|69666806|FG006|Overall Study|Lost to Follow-up|0|||
37980127|NCT00437658|69666825|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
37980128|NCT00437658|69666826|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
37980129|NCT00437658|69666827|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
37980130|NCT00437658|69666825|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
37980131|NCT00437658|69666826|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
37869730|NCT01217957|69553452|FG000|Phase 2|Withdrawal by Patient|0|||
37869731|NCT01217957|69553453|FG001|Phase 2|Withdrawal by Patient|0|||
37869732|NCT01217957|69553454|FG002|Phase 2|Withdrawal by Patient|0|||
37869733|NCT01217957|69553455|FG003|Phase 2|Withdrawal by Patient|0|||
37869734|NCT01217957|69553456|FG004|Phase 2|Withdrawal by Patient|1|||
37869735|NCT00939094|69553479|FG000|Overall Study|Adverse Event|9|||
37869736|NCT00939094|69553480|FG001|Overall Study|Adverse Event|0|||
37869737|NCT00939094|69553479|FG000|Overall Study|Withdrawal by Subject|1|||
37869738|NCT00939094|69553480|FG001|Overall Study|Withdrawal by Subject|6|||
37869739|NCT00939094|69553479|FG000|Overall Study|Lost to Follow-up|1|||
37869740|NCT00939094|69553480|FG001|Overall Study|Lost to Follow-up|1|||
37869741|NCT00939094|69553479|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
37869742|NCT00939094|69553480|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
37869743|NCT00939094|69553479|FG000|Overall Study|Severe non-compliance to protocol|0|||
37869744|NCT00939094|69553480|FG001|Overall Study|Severe non-compliance to protocol|1|||
37869745|NCT00939094|69553479|FG000|Overall Study|Study stopped by sponsor|0|||
37869746|NCT00939094|69553480|FG001|Overall Study|Study stopped by sponsor|2|||
37869747|NCT00939094|69553479|FG000|Overall Study|Abnormal ECG findings|1|||
37869748|NCT00939094|69553480|FG001|Overall Study|Abnormal ECG findings|0|||
37869749|NCT01217801|69553488|FG000|Period 1|Protocol Violation|1|||
37869750|NCT01217801|69553489|FG001|Period 1|Protocol Violation|1|||
37869751|NCT01217801|69553488|FG000|Period 1|Withdrawal by Subject|0|||
37869752|NCT01217801|69553489|FG001|Period 1|Withdrawal by Subject|1|||
37869753|NCT00935818|69553497|FG000|Overall Study|Withdrawal by Subject|45|||
37869754|NCT00935818|69553498|FG001|Overall Study|Withdrawal by Subject|50|||
37869755|NCT00935818|69553497|FG000|Overall Study|Lost to Follow-up|40|||
37869756|NCT00935818|69553498|FG001|Overall Study|Lost to Follow-up|42|||
37869757|NCT00935818|69553497|FG000|Overall Study|Adverse Event|6|||
37869758|NCT00935818|69553498|FG001|Overall Study|Adverse Event|7|||
37869759|NCT00935818|69553497|FG000|Overall Study|Physician Decision|0|||
37869760|NCT00935818|69553498|FG001|Overall Study|Physician Decision|1|||
37869761|NCT01216319|69553504|FG000|Overall Study|Lost to Follow-up|2|||
37869762|NCT01216319|69553504|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
37869763|NCT00936208|69553510|FG000|Overall Study|Protocol Violation|37|||
37869764|NCT00936208|69553511|FG001|Overall Study|Protocol Violation|22|||
37869765|NCT01216163|69553520|FG000|Overall Study|Withdrawal by Subject|1|||
37869766|NCT01216163|69553521|FG001|Overall Study|Withdrawal by Subject|1|||
37980132|NCT00437658|69666827|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
37980133|NCT00437658|69666825|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
37980134|NCT00437658|69666826|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
37980135|NCT00437658|69666827|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
37869767|NCT01216163|69553522|FG002|Overall Study|Withdrawal by Subject|0|||
37869768|NCT00933244|69553533|FG000|Overall Study|Withdrawal by Subject|5|||
37980136|NCT00437658|69666825|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
37980137|NCT00437658|69666826|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
37980138|NCT00437658|69666827|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
37869769|NCT00933244|69553534|FG001|Overall Study|Withdrawal by Subject|1|||
37869770|NCT00933244|69553535|FG002|Overall Study|Withdrawal by Subject|3|||
37869771|NCT00930046|69553545|FG000|Overall Study|Wound catheter malfunctioned|1|||
37869772|NCT00930046|69553546|FG001|Overall Study|Wound catheter malfunctioned|2|||
37869773|NCT00935584|69553554|FG000|Overall Study|Withdrawal by Subject|9|||
37869774|NCT00935584|69553555|FG001|Overall Study|Withdrawal by Subject|0|||
37869775|NCT00935584|69553554|FG000|Overall Study|Death|3|||
37869776|NCT00935584|69553555|FG001|Overall Study|Death|0|||
37980139|NCT00437658|69666825|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
37980140|NCT00437658|69666826|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
37980141|NCT00437658|69666827|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
37980142|NCT00437658|69666825|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
37980143|NCT00437658|69666826|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
37980144|NCT00437658|69666827|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
37980145|NCT00437658|69666825|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
37980146|NCT00437658|69666826|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
37980147|NCT00437658|69666827|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
37980148|NCT00437658|69666825|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
37980149|NCT00437658|69666826|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
37980150|NCT00437658|69666827|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
37980151|NCT00437658|69666825|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
37980152|NCT00437658|69666826|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
37980153|NCT00437658|69666827|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
37980154|NCT00437658|69666825|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
37980155|NCT00437658|69666826|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
37980156|NCT00437658|69666827|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
37980157|NCT00437658|69666825|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
37980158|NCT00437658|69666826|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
37980159|NCT00437658|69666827|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
37980160|NCT00437658|69666825|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
37980161|NCT00437658|69666826|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
37980162|NCT00437658|69666827|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
37980163|NCT00356265|69666838|FG000|Overall Study|Withdrawal by Subject|0|||
37980164|NCT00356265|69666839|FG001|Overall Study|Withdrawal by Subject|0|||
37980165|NCT00356265|69666840|FG002|Overall Study|Withdrawal by Subject|1|||
37980166|NCT00535145|69666849|FG000|Phase I|Adverse Event|3|||
37980167|NCT00535145|69666849|FG000|Phase I|Lost to Follow-up|7|||
37980168|NCT00535145|69666849|FG000|Phase I|Withdrawal by Subject|6|||
37980169|NCT00535145|69666849|FG000|Phase I|(eligibility)|8|||
37869777|NCT00935584|69553554|FG000|Overall Study|Lost to Follow-up|8|||
37869778|NCT00935584|69553555|FG001|Overall Study|Lost to Follow-up|0|||
37869779|NCT00935584|69553554|FG000|Overall Study|No show|9|||
37869780|NCT00935584|69553555|FG001|Overall Study|No show|0|||
37869781|NCT00935584|69553554|FG000|Overall Study|Relocated|3|||
37869782|NCT00935584|69553555|FG001|Overall Study|Relocated|0|||
37869783|NCT00935584|69553554|FG000|Overall Study|Patient changed provider|3|||
37980170|NCT00535145|69666849|FG000|Phase I|(protocol violation)|1|||
37980171|NCT00535145|69666849|FG000|Phase I|(PI decision)|1|||
37980172|NCT00535145|69666849|FG000|Phase I|(diagnosis)|3|||
37815875|NCT01236521|69494175|FG000|Overall Study|Death|2|||
37815876|NCT01236521|69494176|FG001|Overall Study|Death|1|||
37815877|NCT01236521|69494175|FG000|Overall Study|Lost to Follow-up|9|||
37815878|NCT01236521|69494176|FG001|Overall Study|Lost to Follow-up|7|||
37815879|NCT01226797|69494184|FG000|Overall Study|Adverse Event|1|||
37815880|NCT01226797|69494185|FG001|Overall Study|Adverse Event|0|||
37815881|NCT01226797|69494184|FG000|Overall Study|No longer willing to participate|1|||
37815882|NCT01226797|69494185|FG001|Overall Study|No longer willing to participate|0|||
37815883|NCT01226797|69494184|FG000|Overall Study|Protocol Violation|0|||
37815884|NCT01226797|69494185|FG001|Overall Study|Protocol Violation|1|||
37815885|NCT01142908|69494193|FG000|Overall Study|Lost to Follow-up|19|||
37815886|NCT01142908|69494194|FG001|Overall Study|Lost to Follow-up|13|||
37815887|NCT01142908|69494193|FG000|Overall Study|Death|1|||
37815888|NCT01142908|69494194|FG001|Overall Study|Death|4|||
37815889|NCT01142908|69494193|FG000|Overall Study|Excluded - did not meet criteria|9|||
37815890|NCT01142908|69494194|FG001|Overall Study|Excluded - did not meet criteria|5|||
37815891|NCT01142908|69494193|FG000|Overall Study|Withdrawal by Subject|3|||
37815892|NCT01142908|69494194|FG001|Overall Study|Withdrawal by Subject|0|||
37815893|NCT04962230|69494252|FG000|Carbamazepine+PF-07321332/Ritonavir|Withdrawal by Subject|1|||
37815894|NCT04962230|69494252|FG000|Carbamazepine+PF-07321332/Ritonavir|Adverse Event|1|||
37815895|NCT04919317|69494333|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
37815896|NCT04919317|69494334|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
37815897|NCT04919317|69494333|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
37815898|NCT04919317|69494334|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
37869784|NCT00935584|69553555|FG001|Overall Study|Patient changed provider|0|||
37869785|NCT00935584|69553554|FG000|Overall Study|Provider dropped out of study|14|||
37869786|NCT00935584|69553555|FG001|Overall Study|Provider dropped out of study|4|||
37869787|NCT01215851|69553565|FG000|Treatment Period|Adverse Event|1|||
37869788|NCT01215851|69553566|FG001|Treatment Period|Adverse Event|1|||
37869789|NCT01215851|69553567|FG002|Treatment Period|Adverse Event|1|||
37869790|NCT01215851|69553568|FG003|Treatment Period|Adverse Event|3|||
37869791|NCT01215851|69553569|FG004|Treatment Period|Adverse Event|0|||
37869792|NCT01215851|69553570|FG005|Treatment Period|Adverse Event|1|||
37869793|NCT01215851|69553565|FG000|Follow up Period|Lost to Follow-up|0|||
37869794|NCT01215851|69553566|FG001|Follow up Period|Lost to Follow-up|0|||
37869795|NCT01215851|69553567|FG002|Follow up Period|Lost to Follow-up|0|||
37869796|NCT01215851|69553568|FG003|Follow up Period|Lost to Follow-up|0|||
37869797|NCT01215851|69553569|FG004|Follow up Period|Lost to Follow-up|0|||
37869798|NCT01215851|69553570|FG005|Follow up Period|Lost to Follow-up|1|||
37869799|NCT00933166|69553585|FG000|Overall Study|Lost to Follow-up|4|||
37869800|NCT00933166|69553585|FG000|Overall Study|Lack of Efficacy|9|||
37869801|NCT00933166|69553585|FG000|Overall Study|Unavailable|4|||
37869802|NCT00933166|69553585|FG000|Overall Study|Withdrawal by Subject|1|||
37869803|NCT00935272|69553591|FG000|Overall Study|Lost to Follow-up|10|||
37869804|NCT00935272|69553592|FG001|Overall Study|Lost to Follow-up|3|||
37869805|NCT00935272|69553591|FG000|Overall Study|Withdrawal by Subject|8|||
37980173|NCT00535145|69666849|FG000|Phase II|Adverse Event|2|||
37980174|NCT00535145|69666849|FG000|Phase II|Lack of Efficacy|1|||
37980175|NCT00535145|69666849|FG000|Phase II|Lost to Follow-up|5|||
37980176|NCT00535145|69666849|FG000|Phase II|Withdrawal by Subject|5|||
37980177|NCT00535145|69666849|FG000|Phase II|Subject non-compliance|2|||
37980178|NCT00437268|69666859|FG000|Overall Study|Adverse Event|1|||
37980179|NCT00437268|69666860|FG001|Overall Study|Adverse Event|1|||
37980180|NCT00437268|69666859|FG000|Overall Study|Withdrawal by Subject|2|||
37980181|NCT00437268|69666860|FG001|Overall Study|Withdrawal by Subject|2|||
37980182|NCT00437268|69666859|FG000|Overall Study|Progressive disease|9|||
37980183|NCT00437268|69666860|FG001|Overall Study|Progressive disease|9|||
37815899|NCT04789577|69494404|FG000|Overall Study|Withdrawal by Subject|1|||
37815900|NCT04789577|69494405|FG001|Overall Study|Withdrawal by Subject|1|||
37815901|NCT04789577|69494406|FG002|Overall Study|Withdrawal by Subject|1|||
37815902|NCT04789577|69494407|FG003|Overall Study|Withdrawal by Subject|3|||
37815903|NCT04789577|69494408|FG004|Overall Study|Withdrawal by Subject|1|||
37815904|NCT04789577|69494409|FG005|Overall Study|Withdrawal by Subject|7|||
37815905|NCT04789577|69494410|FG006|Overall Study|Withdrawal by Subject|1|||
37815906|NCT04789577|69494404|FG000|Overall Study|Lost to Follow-up|7|||
37815907|NCT04789577|69494405|FG001|Overall Study|Lost to Follow-up|12|||
37869806|NCT00935272|69553592|FG001|Overall Study|Withdrawal by Subject|2|||
37980184|NCT00437268|69666859|FG000|Overall Study|Physician Decision|1|||
37980185|NCT00437268|69666860|FG001|Overall Study|Physician Decision|0|||
37980186|NCT00437268|69666859|FG000|Overall Study|Death|0|||
37980187|NCT00437268|69666860|FG001|Overall Study|Death|1|||
37980188|NCT00437034|69666868|FG000|Overall Study|Adverse Event|1|||
37980189|NCT00437034|69666868|FG000|Overall Study|Disease progression during treatment|5|||
37980190|NCT00337467|69666872|FG000|Overall Study|Adverse Event|3|||
37980191|NCT00337467|69666872|FG000|Overall Study|Subject Withdrew Consent|2|||
37815908|NCT04789577|69494406|FG002|Overall Study|Lost to Follow-up|7|||
37869807|NCT00935272|69553591|FG000|Overall Study|Physician Decision|1|||
37869808|NCT00935272|69553592|FG001|Overall Study|Physician Decision|0|||
37869809|NCT00935272|69553591|FG000|Overall Study|Protocol Violation|0|||
37815909|NCT04789577|69494407|FG003|Overall Study|Lost to Follow-up|10|||
37815910|NCT04789577|69494408|FG004|Overall Study|Lost to Follow-up|8|||
37869810|NCT00935272|69553592|FG001|Overall Study|Protocol Violation|1|||
37980192|NCT00337467|69666872|FG000|Overall Study|Pregnancy|1|||
37980193|NCT00337467|69666872|FG000|Overall Study|Lost to Follow-up|2|||
37980194|NCT00337467|69666872|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
37980195|NCT00337077|69666882|FG000|Overall Study|Progressive disease|25|||
37980196|NCT00337077|69666883|FG001|Overall Study|Progressive disease|37|||
37980197|NCT00337077|69666884|FG002|Overall Study|Progressive disease|19|||
37869811|NCT01010061|69553601|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
37869812|NCT01010061|69553602|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
37869813|NCT01010061|69553601|FG000|Overall Study|Disease Progression|2|||
37869814|NCT01010061|69553602|FG001|Overall Study|Disease Progression|8|||
37869815|NCT01010061|69553601|FG000|Overall Study|Withdrew Consent|5|||
37869816|NCT01010061|69553602|FG001|Overall Study|Withdrew Consent|1|||
37869817|NCT01010061|69553601|FG000|Overall Study|Death|3|||
37869818|NCT01010061|69553602|FG001|Overall Study|Death|6|||
37980198|NCT00337077|69666882|FG000|Overall Study|Adverse Event|7|||
37980199|NCT00337077|69666883|FG001|Overall Study|Adverse Event|7|||
37980200|NCT00337077|69666884|FG002|Overall Study|Adverse Event|1|||
37980201|NCT00337077|69666882|FG000|Overall Study|Death|0|||
37980202|NCT00337077|69666883|FG001|Overall Study|Death|1|||
37980203|NCT00337077|69666884|FG002|Overall Study|Death|0|||
37980204|NCT00337077|69666882|FG000|Overall Study|Withdrawal by Subject|7|||
37980205|NCT00337077|69666883|FG001|Overall Study|Withdrawal by Subject|2|||
37980206|NCT00337077|69666884|FG002|Overall Study|Withdrawal by Subject|2|||
37980207|NCT00337077|69666882|FG000|Overall Study|Alternative therapy|1|||
37980208|NCT00337077|69666883|FG001|Overall Study|Alternative therapy|0|||
37980209|NCT00337077|69666884|FG002|Overall Study|Alternative therapy|0|||
37980210|NCT00337077|69666882|FG000|Overall Study|Physician Decision|1|||
37980211|NCT00337077|69666883|FG001|Overall Study|Physician Decision|4|||
37980212|NCT00337077|69666884|FG002|Overall Study|Physician Decision|2|||
37980213|NCT00337077|69666882|FG000|Overall Study|Never started treatment|1|||
37980214|NCT00337077|69666883|FG001|Overall Study|Never started treatment|1|||
37980215|NCT00337077|69666884|FG002|Overall Study|Never started treatment|0|||
37980216|NCT00337077|69666882|FG000|Overall Study|Ineligible|1|||
37815911|NCT04789577|69494409|FG005|Overall Study|Lost to Follow-up|6|||
37815912|NCT04789577|69494410|FG006|Overall Study|Lost to Follow-up|10|||
37815913|NCT04789577|69494404|FG000|Overall Study|Migrated Or Moved From The Study Area|0|||
37815914|NCT04789577|69494405|FG001|Overall Study|Migrated Or Moved From The Study Area|0|||
37815915|NCT04789577|69494406|FG002|Overall Study|Migrated Or Moved From The Study Area|0|||
37815916|NCT04789577|69494407|FG003|Overall Study|Migrated Or Moved From The Study Area|1|||
37815917|NCT04789577|69494408|FG004|Overall Study|Migrated Or Moved From The Study Area|0|||
37815918|NCT04789577|69494409|FG005|Overall Study|Migrated Or Moved From The Study Area|0|||
37815919|NCT04789577|69494410|FG006|Overall Study|Migrated Or Moved From The Study Area|0|||
37815920|NCT04789577|69494404|FG000|Overall Study|AE Requiring Expedited Reporting|0|||
37815921|NCT04789577|69494405|FG001|Overall Study|AE Requiring Expedited Reporting|0|||
37815922|NCT04789577|69494406|FG002|Overall Study|AE Requiring Expedited Reporting|0|||
37815923|NCT04789577|69494407|FG003|Overall Study|AE Requiring Expedited Reporting|0|||
37815924|NCT04789577|69494408|FG004|Overall Study|AE Requiring Expedited Reporting|0|||
37815925|NCT04789577|69494409|FG005|Overall Study|AE Requiring Expedited Reporting|1|||
37815926|NCT04789577|69494410|FG006|Overall Study|AE Requiring Expedited Reporting|0|||
37815927|NCT04480463|69494471|FG000|Overall Study|Death|0|||
37815928|NCT04480463|69494472|FG001|Overall Study|Death|1|||
37869819|NCT01010061|69553601|FG000|Overall Study|Administrative/Other|0|||
37980217|NCT00337077|69666883|FG001|Overall Study|Ineligible|1|||
37980218|NCT00337077|69666884|FG002|Overall Study|Ineligible|1|||
37980219|NCT00428220|69666890|FG000|Overall Study|Participant died|8|||
37980220|NCT00428220|69666890|FG000|Overall Study|Global deterioration of health status|7|||
37980221|NCT00428220|69666890|FG000|Overall Study|Lost to Follow-up|4|||
37815929|NCT04480463|69494471|FG000|Overall Study|Adverse Event|6|||
37869820|NCT01010061|69553602|FG001|Overall Study|Administrative/Other|1|||
37869821|NCT01010061|69553601|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
37869822|NCT01010061|69553602|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
37869823|NCT01010061|69553601|FG000|Overall Study|Insufficient Therapeutic Response|1|||
37869824|NCT01010061|69553602|FG001|Overall Study|Insufficient Therapeutic Response|5|||
37869825|NCT01010061|69553601|FG000|Overall Study|Violation of Selection Criteria|0|||
37869826|NCT01010061|69553602|FG001|Overall Study|Violation of Selection Criteria|1|||
37869827|NCT01010061|69553601|FG000|Overall Study|Did Not Receive Treatment|2|||
37869828|NCT01010061|69553602|FG001|Overall Study|Did Not Receive Treatment|2|||
37869829|NCT00929734|69553622|FG000|Overall Study|Lost to Follow-up|2|||
37869830|NCT00929734|69553623|FG001|Overall Study|Lost to Follow-up|1|||
37869831|NCT00929734|69553622|FG000|Overall Study|Withdrawal by Subject|0|||
37869832|NCT00929734|69553623|FG001|Overall Study|Withdrawal by Subject|2|||
37869833|NCT01013883|69553631|FG000|Overall Study|Lost to Follow-up|2|||
37869834|NCT01013883|69553632|FG001|Overall Study|Lost to Follow-up|2|||
37869835|NCT01009983|69553638|FG000|Overall Study|necessary scans not completed|1|||
37869836|NCT01215227|69553652|FG000|Overall Study|Adverse Event|11|||
37869837|NCT01215227|69553653|FG001|Overall Study|Adverse Event|11|||
37869838|NCT01215227|69553654|FG002|Overall Study|Adverse Event|4|||
37869839|NCT01215227|69553655|FG003|Overall Study|Adverse Event|8|||
37869840|NCT01215227|69553656|FG004|Overall Study|Adverse Event|7|||
37869841|NCT01215227|69553657|FG005|Overall Study|Adverse Event|6|||
37869842|NCT01215227|69553652|FG000|Overall Study|Treatment Failure|8|||
37869843|NCT01215227|69553653|FG001|Overall Study|Treatment Failure|4|||
37869844|NCT01215227|69553654|FG002|Overall Study|Treatment Failure|1|||
37869845|NCT01215227|69553655|FG003|Overall Study|Treatment Failure|5|||
37869846|NCT01215227|69553656|FG004|Overall Study|Treatment Failure|1|||
37869847|NCT01215227|69553657|FG005|Overall Study|Treatment Failure|1|||
37869848|NCT01215227|69553652|FG000|Overall Study|Lost to Follow-up|1|||
37869849|NCT01215227|69553653|FG001|Overall Study|Lost to Follow-up|4|||
37869850|NCT01215227|69553654|FG002|Overall Study|Lost to Follow-up|1|||
37869851|NCT01215227|69553655|FG003|Overall Study|Lost to Follow-up|1|||
37869852|NCT01215227|69553656|FG004|Overall Study|Lost to Follow-up|1|||
37869853|NCT01215227|69553657|FG005|Overall Study|Lost to Follow-up|2|||
37869854|NCT01215227|69553652|FG000|Overall Study|Subject Withdrew Consent|16|||
37869855|NCT01215227|69553653|FG001|Overall Study|Subject Withdrew Consent|20|||
37869856|NCT01215227|69553654|FG002|Overall Study|Subject Withdrew Consent|7|||
37869857|NCT01215227|69553655|FG003|Overall Study|Subject Withdrew Consent|10|||
37869858|NCT01215227|69553656|FG004|Overall Study|Subject Withdrew Consent|11|||
37869859|NCT01215227|69553657|FG005|Overall Study|Subject Withdrew Consent|8|||
37869860|NCT01215227|69553652|FG000|Overall Study|Non-Compliance With Protocol|2|||
37869861|NCT01215227|69553653|FG001|Overall Study|Non-Compliance With Protocol|6|||
37869862|NCT01215227|69553654|FG002|Overall Study|Non-Compliance With Protocol|1|||
37869863|NCT01215227|69553655|FG003|Overall Study|Non-Compliance With Protocol|0|||
37869864|NCT01215227|69553656|FG004|Overall Study|Non-Compliance With Protocol|0|||
37869865|NCT01215227|69553657|FG005|Overall Study|Non-Compliance With Protocol|0|||
37869866|NCT01215227|69553652|FG000|Overall Study|Administrative|83|||
37869867|NCT01215227|69553653|FG001|Overall Study|Administrative|73|||
37869868|NCT01215227|69553654|FG002|Overall Study|Administrative|42|||
37869869|NCT01215227|69553655|FG003|Overall Study|Administrative|24|||
37869870|NCT01215227|69553656|FG004|Overall Study|Administrative|28|||
37869871|NCT01215227|69553657|FG005|Overall Study|Administrative|40|||
37869872|NCT01215227|69553652|FG000|Overall Study|Missing Status|0|||
37869873|NCT01215227|69553653|FG001|Overall Study|Missing Status|1|||
37869874|NCT01215227|69553654|FG002|Overall Study|Missing Status|0|||
37869875|NCT01215227|69553655|FG003|Overall Study|Missing Status|0|||
37869876|NCT01215227|69553656|FG004|Overall Study|Missing Status|0|||
37869877|NCT01215227|69553657|FG005|Overall Study|Missing Status|0|||
37869878|NCT01215227|69553652|FG000|Overall Study|Randomized but not treated|0|||
37869879|NCT01215227|69553653|FG001|Overall Study|Randomized but not treated|0|||
37815930|NCT04480463|69494472|FG001|Overall Study|Adverse Event|8|||
37815931|NCT04480463|69494471|FG000|Overall Study|Lost to Follow-up|3|||
37815932|NCT04480463|69494472|FG001|Overall Study|Lost to Follow-up|2|||
37815933|NCT04480463|69494471|FG000|Overall Study|Physician Decision|2|||
37815934|NCT04480463|69494472|FG001|Overall Study|Physician Decision|5|||
37815935|NCT04480463|69494471|FG000|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|2|||
37815936|NCT04480463|69494472|FG001|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|3|||
37815937|NCT04480463|69494471|FG000|Overall Study|Protocol Violation|2|||
37815938|NCT04480463|69494472|FG001|Overall Study|Protocol Violation|1|||
37815939|NCT04480463|69494471|FG000|Overall Study|Withdrawal by Subject|6|||
37815940|NCT04480463|69494472|FG001|Overall Study|Withdrawal by Subject|7|||
37869880|NCT01215227|69553654|FG002|Overall Study|Randomized but not treated|1|||
37869881|NCT01215227|69553655|FG003|Overall Study|Randomized but not treated|1|||
37869882|NCT01215227|69553656|FG004|Overall Study|Randomized but not treated|0|||
37869883|NCT01215227|69553657|FG005|Overall Study|Randomized but not treated|1|||
37869884|NCT01009515|69553671|FG000|Overall Study|Withdrawal by Subject|3|||
37869885|NCT01214915|69553675|FG000|Overall Study|Adverse Event|8|||
37869886|NCT01214915|69553675|FG000|Overall Study|Lack of Efficacy|3|||
37869887|NCT01009281|69553679|FG000|Overall Study|Administrative problems|7|||
37869888|NCT01009203|69553683|FG000|Overall Study|Withdrawal by Subject|1|||
37869889|NCT01009203|69553683|FG000|Overall Study|Adverse Event|5|||
37869890|NCT01009203|69553683|FG000|Overall Study|Treatment-unrelated death|1|||
37869891|NCT01009047|69553689|FG000|Overall Study|Adverse Event|5|||
37869892|NCT01009047|69553690|FG001|Overall Study|Adverse Event|0|||
37869893|NCT01009047|69553689|FG000|Overall Study|Lost to Follow-up|0|||
37869894|NCT01009047|69553690|FG001|Overall Study|Lost to Follow-up|2|||
37869895|NCT01009047|69553689|FG000|Overall Study|Lack of Efficacy|4|||
37869896|NCT01009047|69553690|FG001|Overall Study|Lack of Efficacy|11|||
37869897|NCT01009047|69553689|FG000|Overall Study|Withdrawal by consent|16|||
37869898|NCT01009047|69553690|FG001|Overall Study|Withdrawal by consent|11|||
37869899|NCT01009047|69553689|FG000|Overall Study|Other|3|||
37869900|NCT01009047|69553690|FG001|Overall Study|Other|2|||
37869901|NCT01025193|69553696|FG000|Overall Study|Protocol Violation|1|||
37869902|NCT01025193|69553696|FG000|Overall Study|Adverse Event|3|||
37869903|NCT01025037|69553704|FG000|Overall Study|Adverse Event|3|||
37869904|NCT01025037|69553704|FG000|Overall Study|Lost to Follow-up|7|||
37869905|NCT01025037|69553704|FG000|Overall Study|Withdrawal by Subject|1|||
37869906|NCT01214837|69553711|FG000|Overall Study|Death|0|||
37869907|NCT01214837|69553712|FG001|Overall Study|Death|0|||
37869908|NCT01214837|69553713|FG002|Overall Study|Death|1|||
37869909|NCT01214837|69553711|FG000|Overall Study|Adverse Event|1|||
37869910|NCT01214837|69553712|FG001|Overall Study|Adverse Event|2|||
37869911|NCT01214837|69553713|FG002|Overall Study|Adverse Event|1|||
37869912|NCT01214837|69553711|FG000|Overall Study|Withdrawal by Subject|27|||
37869913|NCT01214837|69553712|FG001|Overall Study|Withdrawal by Subject|36|||
37869914|NCT01214837|69553713|FG002|Overall Study|Withdrawal by Subject|28|||
37869915|NCT01214837|69553711|FG000|Overall Study|Lost to Follow-up|20|||
37869916|NCT01214837|69553712|FG001|Overall Study|Lost to Follow-up|15|||
37869917|NCT01214837|69553713|FG002|Overall Study|Lost to Follow-up|21|||
37869918|NCT01214837|69553711|FG000|Overall Study|Inappropriate Enrolment|0|||
37869919|NCT01214837|69553712|FG001|Overall Study|Inappropriate Enrolment|1|||
37869920|NCT01214837|69553713|FG002|Overall Study|Inappropriate Enrolment|2|||
37869921|NCT01214837|69553711|FG000|Overall Study|Administrative Reason|2|||
37869922|NCT01214837|69553712|FG001|Overall Study|Administrative Reason|6|||
37869923|NCT01214837|69553713|FG002|Overall Study|Administrative Reason|4|||
37869924|NCT01214837|69553711|FG000|Overall Study|Protocol Violation|3|||
37869925|NCT01214837|69553712|FG001|Overall Study|Protocol Violation|1|||
37869926|NCT01214837|69553713|FG002|Overall Study|Protocol Violation|5|||
37869927|NCT01214837|69553711|FG000|Overall Study|Unable to Classify|1|||
37869928|NCT01214837|69553712|FG001|Overall Study|Unable to Classify|3|||
37980222|NCT00428220|69666890|FG000|Overall Study|Objective progression or relapse|123|||
37980223|NCT00428220|69666890|FG000|Overall Study|Participant refused continued treatment|7|||
37980224|NCT00428220|69666890|FG000|Overall Study|Adverse Event|51|||
37980225|NCT00428220|69666890|FG000|Overall Study|Other|23|||
37869929|NCT01214837|69553713|FG002|Overall Study|Unable to Classify|0|||
37980226|NCT00345579|69666920|FG000|Overall Study|Adverse Event|9|||
37869930|NCT01024959|69553722|FG000|Overall Study|ineligible|12|||
37980227|NCT00345579|69666921|FG001|Overall Study|Adverse Event|6|||
37980228|NCT00345579|69666920|FG000|Overall Study|Protocol Violation|14|||
37980229|NCT00345579|69666921|FG001|Overall Study|Protocol Violation|5|||
37869931|NCT01024959|69553722|FG000|Overall Study|results not evaluable|12|||
37869932|NCT01024959|69553722|FG000|Overall Study|missing results required for analysis|17|||
37980230|NCT00345579|69666920|FG000|Overall Study|Withdrawal by Subject|50|||
37980231|NCT00345579|69666921|FG001|Overall Study|Withdrawal by Subject|17|||
37980232|NCT00345579|69666920|FG000|Overall Study|Lost to Follow-up|82|||
37980233|NCT00345579|69666921|FG001|Overall Study|Lost to Follow-up|36|||
37980234|NCT00345579|69666920|FG000|Overall Study|Other|9|||
37980235|NCT00345579|69666921|FG001|Overall Study|Other|1|||
37980236|NCT00335829|69666928|FG000|Overall Study|Withdrawal by Subject|1|||
37980237|NCT00335829|69666928|FG000|Overall Study|Lost to Follow-up|1|||
37980238|NCT00335829|69666928|FG000|Overall Study|Adverse Event|1|||
37869969|NCT01008423|69553764|FG000|Overall Study|Adverse Event|13|||
37869970|NCT01008423|69553765|FG001|Overall Study|Adverse Event|6|||
37869971|NCT01008423|69553764|FG000|Overall Study|Withdrawal by Subject|4|||
37869972|NCT01008423|69553765|FG001|Overall Study|Withdrawal by Subject|7|||
37869973|NCT01008423|69553764|FG000|Overall Study|Lost to Follow-up|0|||
37869974|NCT01008423|69553765|FG001|Overall Study|Lost to Follow-up|2|||
37869975|NCT01008423|69553764|FG000|Overall Study|Low Cortisol|0|||
37869976|NCT01008423|69553765|FG001|Overall Study|Low Cortisol|1|||
37869977|NCT01008423|69553764|FG000|Overall Study|Lack of Efficacy|0|||
37869978|NCT01008423|69553765|FG001|Overall Study|Lack of Efficacy|5|||
37869979|NCT01008423|69553764|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
37869980|NCT01008423|69553765|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
37869981|NCT01008423|69553764|FG000|Overall Study|Personal Conflict|1|||
37869982|NCT01008423|69553765|FG001|Overall Study|Personal Conflict|0|||
37869983|NCT01008423|69553764|FG000|Overall Study|Other|0|||
37869984|NCT01008423|69553765|FG001|Overall Study|Other|1|||
37869985|NCT01012947|69553776|FG000|Overall Study|Lost to Follow-up|131|||
37869986|NCT01012947|69553777|FG001|Overall Study|Lost to Follow-up|135|||
37869987|NCT01012947|69553778|FG002|Overall Study|Lost to Follow-up|130|||
37869988|NCT01012947|69553779|FG003|Overall Study|Lost to Follow-up|118|||
37869989|NCT01012947|69553780|FG004|Overall Study|Lost to Follow-up|142|||
37869990|NCT01214603|69553812|FG000|Overall Study|Adverse Event|0|||
37869991|NCT01214603|69553813|FG001|Overall Study|Adverse Event|0|||
37869992|NCT01214603|69553814|FG002|Overall Study|Adverse Event|1|||
37869993|NCT01214603|69553812|FG000|Overall Study|Death|1|||
37869994|NCT01214603|69553813|FG001|Overall Study|Death|0|||
37869995|NCT01214603|69553814|FG002|Overall Study|Death|0|||
37869996|NCT01214603|69553812|FG000|Overall Study|Progressive Disease|4|||
37869997|NCT01214603|69553813|FG001|Overall Study|Progressive Disease|1|||
37869998|NCT01214603|69553814|FG002|Overall Study|Progressive Disease|3|||
37869999|NCT01212185|69553825|FG000|Overall Study|Protocol Violation|2|||
37870000|NCT01212185|69553826|FG001|Overall Study|Protocol Violation|1|||
37870001|NCT01995175|69553832|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
37980239|NCT00344019|69666935|FG000|Overall Study|did not meet final inclusion criteria|0|||
37980240|NCT00344019|69666936|FG001|Overall Study|did not meet final inclusion criteria|0|||
37980241|NCT00344019|69666937|FG002|Overall Study|did not meet final inclusion criteria|74|||
37980242|NCT00535847|69666951|FG000|Overall Study|Adverse Event|5|||
37980243|NCT00535847|69666952|FG001|Overall Study|Adverse Event|3|||
37980244|NCT00535847|69666953|FG002|Overall Study|Adverse Event|2|||
37980245|NCT00535847|69666951|FG000|Overall Study|Non compliance|1|||
37980246|NCT00535847|69666952|FG001|Overall Study|Non compliance|1|||
37980247|NCT00535847|69666953|FG002|Overall Study|Non compliance|0|||
37870002|NCT01995175|69553832|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
37870003|NCT01995175|69553832|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
37870004|NCT01995175|69553832|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
37870005|NCT01995175|69553832|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
37870006|NCT01995175|69553832|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
37870007|NCT01995175|69553832|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
37870008|NCT01995175|69553832|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
37870009|NCT01995175|69553832|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
37870010|NCT01752907|69553921|FG000|Overall Study|Withdrawal by Subject|4|||
37870011|NCT01752907|69553922|FG001|Overall Study|Withdrawal by Subject|10|||
37870012|NCT01752907|69553921|FG000|Overall Study|Lost to Follow-up|2|||
37870013|NCT01752907|69553922|FG001|Overall Study|Lost to Follow-up|1|||
37870014|NCT01752907|69553921|FG000|Overall Study|Decision by Sponsor|6|||
37870015|NCT01752907|69553922|FG001|Overall Study|Decision by Sponsor|9|||
37870016|NCT03439189|69553928|FG000|Overall Study|Protocol Violation|19|||
37980248|NCT00535847|69666951|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
37980249|NCT00535847|69666952|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
37980250|NCT00535847|69666953|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
37980251|NCT00334893|69666967|FG000|Overall Study|Not Treated|1|||
37980252|NCT00334893|69666968|FG001|Overall Study|Not Treated|0|||
37980253|NCT00334737|69666979|FG000|Hospital Phase|Death|1|||
37980254|NCT00334737|69666980|FG001|Hospital Phase|Death|2|||
37980255|NCT00334737|69666981|FG002|Hospital Phase|Death|3|||
37815941|NCT04480463|69494471|FG000|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|0|||
37815942|NCT04480463|69494472|FG001|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|1|||
37815943|NCT04480463|69494471|FG000|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|1|||
37815944|NCT04480463|69494472|FG001|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|0|||
37815945|NCT04480463|69494471|FG000|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|1|||
37815946|NCT04480463|69494472|FG001|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|0|||
37815947|NCT04480463|69494471|FG000|Overall Study|Other|6|||
37815948|NCT04480463|69494472|FG001|Overall Study|Other|4|||
37815949|NCT04285853|69494480|FG000|Overall Study|Withdrawal by Subject|1|||
37870017|NCT03439189|69553928|FG000|Overall Study|Lack of Efficacy|63|||
37870018|NCT01211483|69553937|FG000|Phase 1b|Death|6|||
37870019|NCT01211483|69553938|FG001|Phase 1b|Death|0|||
37980256|NCT00334737|69666979|FG000|Hospital Phase|Withdrawal by Subject|0|||
37980257|NCT00334737|69666980|FG001|Hospital Phase|Withdrawal by Subject|0|||
37980258|NCT00334737|69666981|FG002|Hospital Phase|Withdrawal by Subject|1|||
37980259|NCT00334737|69666979|FG000|Hospital Phase|Did not receive study drug|1|||
37980260|NCT00334737|69666980|FG001|Hospital Phase|Did not receive study drug|0|||
37870020|NCT01211483|69553939|FG002|Phase 1b|Death|0|||
37870021|NCT01211483|69553940|FG003|Phase 1b|Death|0|||
37870022|NCT01211483|69553937|FG000|Phase 1b|Withdrawal by Subject|1|||
37870023|NCT01211483|69553938|FG001|Phase 1b|Withdrawal by Subject|0|||
37870024|NCT01211483|69553939|FG002|Phase 1b|Withdrawal by Subject|0|||
37870025|NCT01211483|69553940|FG003|Phase 1b|Withdrawal by Subject|0|||
37870026|NCT01211483|69553937|FG000|Phase 2|Lost to Follow-up|0|||
37870027|NCT01211483|69553938|FG001|Phase 2|Lost to Follow-up|1|||
37870028|NCT01211483|69553939|FG002|Phase 2|Lost to Follow-up|1|||
37870029|NCT01211483|69553940|FG003|Phase 2|Lost to Follow-up|2|||
37870030|NCT01211483|69553937|FG000|Phase 2|Death|0|||
37870031|NCT01211483|69553938|FG001|Phase 2|Death|64|||
37870032|NCT01211483|69553939|FG002|Phase 2|Death|53|||
37870033|NCT01211483|69553940|FG003|Phase 2|Death|53|||
37870034|NCT01211483|69553937|FG000|Phase 2|Withdrawal by Subject|0|||
37870035|NCT01211483|69553938|FG001|Phase 2|Withdrawal by Subject|1|||
37870036|NCT01211483|69553939|FG002|Phase 2|Withdrawal by Subject|10|||
37870037|NCT01211483|69553940|FG003|Phase 2|Withdrawal by Subject|5|||
37870038|NCT01211483|69553937|FG000|Phase 2|Study terminated by Sponsor|0|||
37870039|NCT01211483|69553938|FG001|Phase 2|Study terminated by Sponsor|6|||
37870040|NCT01211483|69553939|FG002|Phase 2|Study terminated by Sponsor|8|||
37870041|NCT01211483|69553940|FG003|Phase 2|Study terminated by Sponsor|11|||
37870042|NCT01210001|69553957|FG000|Overall Study|Not treated|1|||
37870043|NCT01210001|69553958|FG001|Overall Study|Not treated|0|||
37870044|NCT01210001|69553959|FG002|Overall Study|Not treated|0|||
37870045|NCT01210001|69553957|FG000|Overall Study|Adverse Event|4|||
37870046|NCT01210001|69553958|FG001|Overall Study|Adverse Event|2|||
37870047|NCT01210001|69553959|FG002|Overall Study|Adverse Event|5|||
37870048|NCT01210001|69553957|FG000|Overall Study|Non compliant with protocol|2|||
37870049|NCT01210001|69553958|FG001|Overall Study|Non compliant with protocol|2|||
37870050|NCT01210001|69553959|FG002|Overall Study|Non compliant with protocol|3|||
37870051|NCT01210001|69553957|FG000|Overall Study|Lost to Follow-up|4|||
37870052|NCT01210001|69553958|FG001|Overall Study|Lost to Follow-up|3|||
37870053|NCT01210001|69553959|FG002|Overall Study|Lost to Follow-up|2|||
37870054|NCT01210001|69553957|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
37870055|NCT01210001|69553958|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
37870056|NCT01210001|69553959|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
37870057|NCT01210001|69553957|FG000|Overall Study|Other reason not defined above|2|||
37870058|NCT01210001|69553958|FG001|Overall Study|Other reason not defined above|2|||
37870059|NCT01210001|69553959|FG002|Overall Study|Other reason not defined above|1|||
37870060|NCT01209689|69554000|FG000|Overall Study|Insufficient Therapeutic Response|7|||
37870061|NCT01209689|69554001|FG001|Overall Study|Insufficient Therapeutic Response|2|||
37870062|NCT01209689|69554000|FG000|Overall Study|Refused Treatment|8|||
37870063|NCT01209689|69554001|FG001|Overall Study|Refused Treatment|3|||
37870064|NCT01209689|69554000|FG000|Overall Study|Adverse Event|4|||
37870065|NCT01209689|69554001|FG001|Overall Study|Adverse Event|0|||
37870066|NCT01209689|69554000|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
37870067|NCT01209689|69554001|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
37870068|NCT01209689|69554000|FG000|Overall Study|Failure to Return|3|||
37870069|NCT01209689|69554001|FG001|Overall Study|Failure to Return|0|||
37870070|NCT01209689|69554000|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
37870071|NCT01209689|69554001|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
37870072|NCT01209143|69554009|FG000|Overall Study|Adverse Event|2|||
37870073|NCT01209143|69554010|FG001|Overall Study|Adverse Event|1|||
37870074|NCT01209143|69554009|FG000|Overall Study|Death|0|||
37870075|NCT01209143|69554010|FG001|Overall Study|Death|1|||
37870076|NCT01209143|69554009|FG000|Overall Study|Physician Decision|3|||
37980261|NCT00334737|69666981|FG002|Hospital Phase|Did not receive study drug|0|||
37870077|NCT01209143|69554010|FG001|Overall Study|Physician Decision|1|||
37870078|NCT01209143|69554009|FG000|Overall Study|Lost to Follow-up|1|||
37870079|NCT01209143|69554010|FG001|Overall Study|Lost to Follow-up|0|||
37870080|NCT01209143|69554009|FG000|Overall Study|Withdrawal by Subject|2|||
37870081|NCT01209143|69554010|FG001|Overall Study|Withdrawal by Subject|1|||
37870082|NCT01209143|69554009|FG000|Overall Study|Disease progression|11|||
37870083|NCT01209143|69554010|FG001|Overall Study|Disease progression|16|||
37870084|NCT01023789|69554016|FG000|3 - Year Visit|Death|29|||
37870085|NCT01023789|69554016|FG000|3 - Year Visit|Withdrawal of consent|1|||
37870086|NCT01023789|69554016|FG000|3 - Year Visit|Lost to Follow-up|13|||
37980262|NCT00334737|69666979|FG000|Follow up Phase|Lost to Follow-up|5|||
37980263|NCT00334737|69666980|FG001|Follow up Phase|Lost to Follow-up|3|||
37870087|NCT01208207|69554023|FG000|Part I|Adverse Event|19|||
37870088|NCT01208207|69554024|FG001|Part I|Adverse Event|2|||
37870089|NCT01208207|69554025|FG002|Part I|Adverse Event|6|||
37870090|NCT01208207|69554026|FG003|Part I|Adverse Event|0|||
37870091|NCT01208207|69554027|FG004|Part I|Adverse Event|0|||
37870092|NCT01208207|69554028|FG005|Part I|Adverse Event|0|||
37870093|NCT01208207|69554029|FG006|Part I|Adverse Event|0|||
37870094|NCT01208207|69554023|FG000|Part I|Lack of Efficacy|21|||
37870095|NCT01208207|69554024|FG001|Part I|Lack of Efficacy|3|||
37870096|NCT01208207|69554025|FG002|Part I|Lack of Efficacy|2|||
37870097|NCT01208207|69554026|FG003|Part I|Lack of Efficacy|0|||
37870098|NCT01208207|69554027|FG004|Part I|Lack of Efficacy|0|||
37870099|NCT01208207|69554028|FG005|Part I|Lack of Efficacy|0|||
37870100|NCT01208207|69554029|FG006|Part I|Lack of Efficacy|0|||
37870101|NCT01208207|69554023|FG000|Part I|Lost to Follow-up|6|||
37870102|NCT01208207|69554024|FG001|Part I|Lost to Follow-up|1|||
37870103|NCT01208207|69554025|FG002|Part I|Lost to Follow-up|0|||
37870104|NCT01208207|69554026|FG003|Part I|Lost to Follow-up|0|||
37870105|NCT01208207|69554027|FG004|Part I|Lost to Follow-up|0|||
37870106|NCT01208207|69554028|FG005|Part I|Lost to Follow-up|0|||
37870107|NCT01208207|69554029|FG006|Part I|Lost to Follow-up|0|||
37870108|NCT01208207|69554023|FG000|Part I|Non-Compliance With Study Drug|1|||
37870109|NCT01208207|69554024|FG001|Part I|Non-Compliance With Study Drug|0|||
37870110|NCT01208207|69554025|FG002|Part I|Non-Compliance With Study Drug|1|||
37870111|NCT01208207|69554026|FG003|Part I|Non-Compliance With Study Drug|0|||
37870112|NCT01208207|69554027|FG004|Part I|Non-Compliance With Study Drug|0|||
37870113|NCT01208207|69554028|FG005|Part I|Non-Compliance With Study Drug|0|||
37870114|NCT01208207|69554029|FG006|Part I|Non-Compliance With Study Drug|0|||
37870115|NCT01208207|69554023|FG000|Part I|Physician Decision|0|||
37870116|NCT01208207|69554024|FG001|Part I|Physician Decision|1|||
37870117|NCT01208207|69554025|FG002|Part I|Physician Decision|0|||
37870118|NCT01208207|69554026|FG003|Part I|Physician Decision|0|||
37870119|NCT01208207|69554027|FG004|Part I|Physician Decision|0|||
37870120|NCT01208207|69554028|FG005|Part I|Physician Decision|0|||
37870121|NCT01208207|69554029|FG006|Part I|Physician Decision|0|||
37870122|NCT01208207|69554023|FG000|Part I|Progressive Disease|1|||
37870123|NCT01208207|69554024|FG001|Part I|Progressive Disease|0|||
37870124|NCT01208207|69554025|FG002|Part I|Progressive Disease|0|||
37870125|NCT01208207|69554026|FG003|Part I|Progressive Disease|0|||
37870126|NCT01208207|69554027|FG004|Part I|Progressive Disease|0|||
37870127|NCT01208207|69554028|FG005|Part I|Progressive Disease|0|||
37815950|NCT04285853|69494481|FG001|Overall Study|Withdrawal by Subject|0|||
37815951|NCT04285853|69494480|FG000|Overall Study|Lost to Follow-up|9|||
37815952|NCT04285853|69494481|FG001|Overall Study|Lost to Follow-up|5|||
37815953|NCT04128696|69494489|FG000|Overall Study|Lost to Follow-up|0|||
37815954|NCT04128696|69494490|FG001|Overall Study|Lost to Follow-up|1|||
37815955|NCT04128696|69494489|FG000|Overall Study|Withdrawal by Subject|8|||
37815956|NCT04128696|69494490|FG001|Overall Study|Withdrawal by Subject|5|||
37815957|NCT04128696|69494489|FG000|Overall Study|In Follow-up|47|||
37815958|NCT04128696|69494490|FG001|Overall Study|In Follow-up|51|||
37815959|NCT04128696|69494489|FG000|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|52|||
37815960|NCT04128696|69494490|FG001|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|62|||
37815961|NCT04102579|69494498|FG000|Overall Study|Withdrawal by Subject|3|||
37815962|NCT04102579|69494499|FG001|Overall Study|Withdrawal by Subject|4|||
37815963|NCT04102579|69494498|FG000|Overall Study|Lost to Follow-up|0|||
37815964|NCT04102579|69494499|FG001|Overall Study|Lost to Follow-up|1|||
37815965|NCT04102579|69494498|FG000|Overall Study|Discontinued Due to COVID-19-related Study Pause|3|||
37815966|NCT04102579|69494499|FG001|Overall Study|Discontinued Due to COVID-19-related Study Pause|4|||
37815967|NCT04102579|69494498|FG000|Overall Study|Other than Specified|1|||
37815968|NCT04102579|69494499|FG001|Overall Study|Other than Specified|0|||
37815969|NCT04102579|69494498|FG000|Overall Study|Not Dosed with Study Drug|0|||
37815970|NCT04102579|69494499|FG001|Overall Study|Not Dosed with Study Drug|1|||
37815971|NCT04034004|69494619|FG000|Overall Study|Withdrawal by Subject|1|||
37815972|NCT04034004|69494620|FG001|Overall Study|Withdrawal by Subject|2|||
37815973|NCT04034004|69494621|FG002|Overall Study|Withdrawal by Subject|2|||
37815974|NCT04034004|69494622|FG003|Overall Study|Withdrawal by Subject|3|||
37815975|NCT04034004|69494619|FG000|Overall Study|could not find vein to administer IV|2|||
37815976|NCT04034004|69494620|FG001|Overall Study|could not find vein to administer IV|1|||
37815977|NCT04034004|69494621|FG002|Overall Study|could not find vein to administer IV|0|||
37815978|NCT04034004|69494622|FG003|Overall Study|could not find vein to administer IV|0|||
37815979|NCT04034004|69494619|FG000|Overall Study|nurse accidentally unblinded subject|0|||
37870128|NCT01208207|69554029|FG006|Part I|Progressive Disease|0|||
37870129|NCT01208207|69554023|FG000|Part I|Protocol Violation|8|||
37870130|NCT01208207|69554024|FG001|Part I|Protocol Violation|0|||
37870131|NCT01208207|69554025|FG002|Part I|Protocol Violation|2|||
37870132|NCT01208207|69554026|FG003|Part I|Protocol Violation|0|||
37870133|NCT01208207|69554027|FG004|Part I|Protocol Violation|0|||
37870134|NCT01208207|69554028|FG005|Part I|Protocol Violation|0|||
37870135|NCT01208207|69554029|FG006|Part I|Protocol Violation|0|||
37870136|NCT01208207|69554023|FG000|Part I|Withdrawal by Subject|14|||
37870137|NCT01208207|69554024|FG001|Part I|Withdrawal by Subject|4|||
37870138|NCT01208207|69554025|FG002|Part I|Withdrawal by Subject|4|||
37815980|NCT04034004|69494620|FG001|Overall Study|nurse accidentally unblinded subject|0|||
37870139|NCT01208207|69554026|FG003|Part I|Withdrawal by Subject|0|||
37870140|NCT01208207|69554027|FG004|Part I|Withdrawal by Subject|0|||
37870141|NCT01208207|69554028|FG005|Part I|Withdrawal by Subject|0|||
37870142|NCT01208207|69554029|FG006|Part I|Withdrawal by Subject|0|||
37870143|NCT01208207|69554023|FG000|Part II|Withdrawal by Subject|0|||
37870144|NCT01208207|69554024|FG001|Part II|Withdrawal by Subject|0|||
37870145|NCT01208207|69554025|FG002|Part II|Withdrawal by Subject|0|||
37870146|NCT01208207|69554026|FG003|Part II|Withdrawal by Subject|10|||
37870147|NCT01208207|69554027|FG004|Part II|Withdrawal by Subject|9|||
37870148|NCT01208207|69554028|FG005|Part II|Withdrawal by Subject|3|||
37870149|NCT01208207|69554029|FG006|Part II|Withdrawal by Subject|5|||
37870150|NCT01208207|69554023|FG000|Part II|Adverse Event|0|||
37870151|NCT01208207|69554024|FG001|Part II|Adverse Event|0|||
37870152|NCT01208207|69554025|FG002|Part II|Adverse Event|0|||
37870153|NCT01208207|69554026|FG003|Part II|Adverse Event|5|||
37870154|NCT01208207|69554027|FG004|Part II|Adverse Event|9|||
37870155|NCT01208207|69554028|FG005|Part II|Adverse Event|4|||
37870156|NCT01208207|69554029|FG006|Part II|Adverse Event|2|||
37870157|NCT01208207|69554023|FG000|Part II|Lack of Efficacy|0|||
37870158|NCT01208207|69554024|FG001|Part II|Lack of Efficacy|0|||
37870159|NCT01208207|69554025|FG002|Part II|Lack of Efficacy|0|||
37870160|NCT01208207|69554026|FG003|Part II|Lack of Efficacy|6|||
37870161|NCT01208207|69554027|FG004|Part II|Lack of Efficacy|4|||
37870162|NCT01208207|69554028|FG005|Part II|Lack of Efficacy|3|||
37870163|NCT01208207|69554029|FG006|Part II|Lack of Efficacy|3|||
37870164|NCT01208207|69554023|FG000|Part II|Lost to Follow-up|0|||
37870165|NCT01208207|69554024|FG001|Part II|Lost to Follow-up|0|||
37870166|NCT01208207|69554025|FG002|Part II|Lost to Follow-up|0|||
37870167|NCT01208207|69554026|FG003|Part II|Lost to Follow-up|4|||
37870168|NCT01208207|69554027|FG004|Part II|Lost to Follow-up|0|||
37870169|NCT01208207|69554028|FG005|Part II|Lost to Follow-up|2|||
37870170|NCT01208207|69554029|FG006|Part II|Lost to Follow-up|1|||
37870171|NCT01208207|69554023|FG000|Part II|Non-Compliance With Study Drug|0|||
37870172|NCT01208207|69554024|FG001|Part II|Non-Compliance With Study Drug|0|||
37870173|NCT01208207|69554025|FG002|Part II|Non-Compliance With Study Drug|0|||
37870174|NCT01208207|69554026|FG003|Part II|Non-Compliance With Study Drug|4|||
37870175|NCT01208207|69554027|FG004|Part II|Non-Compliance With Study Drug|1|||
37870176|NCT01208207|69554028|FG005|Part II|Non-Compliance With Study Drug|1|||
37870177|NCT01208207|69554029|FG006|Part II|Non-Compliance With Study Drug|0|||
37870178|NCT01208207|69554023|FG000|Part II|Physician Decision|0|||
37870179|NCT01208207|69554024|FG001|Part II|Physician Decision|0|||
37870180|NCT01208207|69554025|FG002|Part II|Physician Decision|0|||
37870181|NCT01208207|69554026|FG003|Part II|Physician Decision|1|||
37980264|NCT00334737|69666981|FG002|Follow up Phase|Lost to Follow-up|6|||
37980265|NCT00427908|69666993|FG000|Primary Phase|Lost to Follow-up|4|||
37980266|NCT00427908|69666994|FG001|Primary Phase|Lost to Follow-up|0|||
37980267|NCT00427908|69666995|FG002|Primary Phase|Lost to Follow-up|2|||
37980268|NCT00427908|69666996|FG003|Primary Phase|Lost to Follow-up|0|||
37980269|NCT00427908|69666993|FG000|Primary Phase|Withdrawal by Subject|1|||
37980270|NCT00427908|69666994|FG001|Primary Phase|Withdrawal by Subject|2|||
37980271|NCT00427908|69666995|FG002|Primary Phase|Withdrawal by Subject|1|||
37980272|NCT00427908|69666996|FG003|Primary Phase|Withdrawal by Subject|0|||
37815981|NCT04034004|69494621|FG002|Overall Study|nurse accidentally unblinded subject|0|||
37815982|NCT04034004|69494622|FG003|Overall Study|nurse accidentally unblinded subject|1|||
37815983|NCT03848065|69494637|FG000|Overall Study|Death|0|||
37815984|NCT03848065|69494638|FG001|Overall Study|Death|1|||
37815985|NCT03848065|69494639|FG002|Overall Study|Death|0|||
37815986|NCT03848065|69494637|FG000|Overall Study|Lost to Follow-up|0|||
37815987|NCT03848065|69494638|FG001|Overall Study|Lost to Follow-up|0|||
37815988|NCT03848065|69494639|FG002|Overall Study|Lost to Follow-up|1|||
37980273|NCT00427908|69666993|FG000|Primary Phase|Adverse Event|0|||
37980274|NCT00427908|69666994|FG001|Primary Phase|Adverse Event|1|||
37980275|NCT00427908|69666995|FG002|Primary Phase|Adverse Event|0|||
37980276|NCT00427908|69666996|FG003|Primary Phase|Adverse Event|0|||
37980277|NCT00334113|69667033|FG000|Overall Study|Lost to Follow-up|2|||
37694847|NCT02409368|69171296|FG003|ECOG Reclassification|Lost to Follow-up|0|||
37694848|NCT02409368|69171293|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
37694849|NCT02409368|69171294|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
37694850|NCT02409368|69171295|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
37694851|NCT02409368|69171296|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
37815989|NCT03848065|69494637|FG000|Overall Study|Physician Decision|0|||
37870182|NCT01208207|69554027|FG004|Part II|Physician Decision|0|||
37870183|NCT01208207|69554028|FG005|Part II|Physician Decision|2|||
37870184|NCT01208207|69554029|FG006|Part II|Physician Decision|0|||
37980278|NCT00334113|69667034|FG001|Overall Study|Lost to Follow-up|2|||
37980279|NCT00334113|69667033|FG000|Overall Study|Withdrawal by Subject|0|||
37980280|NCT00334113|69667034|FG001|Overall Study|Withdrawal by Subject|1|||
37815990|NCT03848065|69494638|FG001|Overall Study|Physician Decision|0|||
37815991|NCT03848065|69494639|FG002|Overall Study|Physician Decision|1|||
37870185|NCT01208207|69554023|FG000|Part II|Protocol Violation|0|||
37870186|NCT01208207|69554024|FG001|Part II|Protocol Violation|0|||
37870187|NCT01208207|69554025|FG002|Part II|Protocol Violation|0|||
37870188|NCT01208207|69554026|FG003|Part II|Protocol Violation|1|||
37870189|NCT01208207|69554027|FG004|Part II|Protocol Violation|0|||
37870190|NCT01208207|69554028|FG005|Part II|Protocol Violation|0|||
37870191|NCT01208207|69554029|FG006|Part II|Protocol Violation|0|||
37980281|NCT00416598|69667040|FG000|Induction & Intensification|Adverse Event|38|||
37980282|NCT00416598|69667040|FG000|Induction & Intensification|Death|32|||
37980283|NCT00416598|69667040|FG000|Induction & Intensification|Withdrawal by Subject|46|||
37980284|NCT00416598|69667040|FG000|Induction & Intensification|Alternative Treatment|135|||
37980285|NCT00416598|69667040|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
37980286|NCT00416598|69667040|FG000|Induction & Intensification|Relapse/progression|29|||
37980287|NCT00416598|69667040|FG000|Induction & Intensification|Failed induction|87|||
37980288|NCT00416598|69667040|FG000|Decitabine Maintenance|Adverse Event|5|||
37980289|NCT00416598|69667040|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
37980290|NCT00416598|69667040|FG000|Decitabine Maintenance|Progression/relapse|38|||
37980291|NCT00416598|69667040|FG000|Decitabine Maintenance|Alternative treatment|2|||
37980292|NCT00416598|69667040|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
37980293|NCT00534599|69667046|FG000|Overall Study|Adverse Event|25|||
37980294|NCT00534599|69667047|FG001|Overall Study|Adverse Event|4|||
37980295|NCT00534599|69667046|FG000|Overall Study|Incorrect enrollment|2|||
37980296|NCT00534599|69667047|FG001|Overall Study|Incorrect enrollment|1|||
37870192|NCT01208207|69554023|FG000|Part II|Technical Problems|0|||
37870193|NCT01208207|69554024|FG001|Part II|Technical Problems|0|||
37870194|NCT01208207|69554025|FG002|Part II|Technical Problems|0|||
37870195|NCT01208207|69554026|FG003|Part II|Technical Problems|1|||
37870196|NCT01208207|69554027|FG004|Part II|Technical Problems|0|||
37870197|NCT01208207|69554028|FG005|Part II|Technical Problems|1|||
37870198|NCT01208207|69554029|FG006|Part II|Technical Problems|0|||
37870199|NCT01012713|69554060|FG000|Overall Study|Lack of Efficacy|3|||
37870200|NCT01007253|69554065|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
37870201|NCT01007253|69554066|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
37870202|NCT01007253|69554067|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
37870203|NCT01007253|69554068|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
37870204|NCT01006707|69554078|FG000|Study Session 1|Lost to Follow-up|2|||
37870205|NCT01006707|69554079|FG001|Study Session 1|Lost to Follow-up|0|||
37870206|NCT01006707|69554080|FG002|Study Session 1|Lost to Follow-up|0|||
37870207|NCT01006707|69554078|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
37870208|NCT01006707|69554079|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
37870209|NCT01006707|69554080|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
37870210|NCT01006629|69554088|FG000|Overall Study|Adverse Event|1|||
37870211|NCT01006629|69554088|FG000|Overall Study|Parent refused to continue participation|1|||
37870212|NCT01006629|69554088|FG000|Overall Study|Parent unable to perform site visit|4|||
37870213|NCT01012323|69554092|FG000|Overall Study|Investigator Judgment|1|||
37870214|NCT01011933|69554096|FG000|Overall Study|Wrong cell type|1|||
37870215|NCT01011933|69554096|FG000|Overall Study|Improper pre-protocol Rx|1|||
37870216|NCT01011933|69554096|FG000|Overall Study|Inadequate pathology|1|||
37870217|NCT01011933|69554096|FG000|Overall Study|Never treated|1|||
37870218|NCT01011465|69554118|FG000|Overall Study|Withdrawal by Subject|2|||
37870219|NCT01011465|69554119|FG001|Overall Study|Withdrawal by Subject|1|||
37870220|NCT01011465|69554120|FG002|Overall Study|Withdrawal by Subject|0|||
37870221|NCT01011465|69554121|FG003|Overall Study|Withdrawal by Subject|0|||
37870222|NCT01011465|69554122|FG004|Overall Study|Withdrawal by Subject|1|||
37870223|NCT01011465|69554123|FG005|Overall Study|Withdrawal by Subject|0|||
37870224|NCT01011465|69554124|FG006|Overall Study|Withdrawal by Subject|1|||
37870225|NCT01011465|69554125|FG007|Overall Study|Withdrawal by Subject|0|||
37870226|NCT01011387|69554150|FG000|Overall Study|Withdrawal by Subject|3|||
37870227|NCT01011387|69554150|FG000|Overall Study|Adverse Event|2|||
37870228|NCT01011387|69554150|FG000|Overall Study|Protocol Violation|1|||
37870229|NCT01011309|69554157|FG000|Overall Study|Adverse Event|2|||
37870230|NCT01011309|69554158|FG001|Overall Study|Adverse Event|1|||
37870231|NCT01011309|69554159|FG002|Overall Study|Adverse Event|2|||
37870232|NCT01011309|69554157|FG000|Overall Study|Lack of Efficacy|0|||
37870233|NCT01011309|69554158|FG001|Overall Study|Lack of Efficacy|1|||
37980297|NCT00534599|69667046|FG000|Overall Study|Mis-randomization|2|||
37980298|NCT00534599|69667047|FG001|Overall Study|Mis-randomization|2|||
37980299|NCT00534599|69667046|FG000|Overall Study|Developed study-specific d/c criteria|5|||
37980300|NCT00534599|69667047|FG001|Overall Study|Developed study-specific d/c criteria|0|||
37980301|NCT00534599|69667046|FG000|Overall Study|Lack of Efficacy|0|||
37980302|NCT00534599|69667047|FG001|Overall Study|Lack of Efficacy|1|||
37870234|NCT01011309|69554159|FG002|Overall Study|Lack of Efficacy|0|||
37980303|NCT00534599|69667046|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
37980304|NCT00534599|69667047|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
37980305|NCT00534599|69667046|FG000|Overall Study|Protocol Violation|1|||
37980306|NCT00534599|69667047|FG001|Overall Study|Protocol Violation|3|||
37980307|NCT00534599|69667046|FG000|Overall Study|Lost to Follow-up|11|||
37980308|NCT00534599|69667047|FG001|Overall Study|Lost to Follow-up|14|||
37980309|NCT00534599|69667046|FG000|Overall Study|Withdrawal by Subject|4|||
37980310|NCT00534599|69667047|FG001|Overall Study|Withdrawal by Subject|6|||
37870235|NCT01011309|69554157|FG000|Overall Study|Protocol Violation|0|||
37980311|NCT00534599|69667046|FG000|Overall Study|Other|7|||
37980312|NCT00534599|69667047|FG001|Overall Study|Other|0|||
37980313|NCT03892889|69667070|FG000|Overall Study|Adverse Event|17|||
37980314|NCT03892889|69667070|FG000|Overall Study|Lack of Efficacy|1|||
37980315|NCT03892889|69667070|FG000|Overall Study|Lost to Follow-up|46|||
37980316|NCT03892889|69667070|FG000|Overall Study|Non-compliance with study drug|22|||
37980317|NCT03892889|69667070|FG000|Overall Study|Pregnancy|1|||
37980318|NCT03892889|69667070|FG000|Overall Study|Protocol Deviation|3|||
37980319|NCT03892889|69667070|FG000|Overall Study|Withdrawal by Subject|50|||
37980320|NCT03892889|69667070|FG000|Overall Study|Withdrawal by Caregiver|1|||
37980321|NCT03892889|69667070|FG000|Overall Study|Study Terminated by Sponsor|50|||
37980322|NCT03892889|69667070|FG000|Overall Study|Physician Decision|8|||
37980323|NCT03892889|69667070|FG000|Overall Study|Reason not Specified|5|||
37980324|NCT00473330|69667077|FG000|Core Study|Adverse Event|4|||
37980325|NCT00473330|69667078|FG001|Core Study|Adverse Event|4|||
37980326|NCT00473330|69667079|FG002|Core Study|Adverse Event|1|||
37980327|NCT00473330|69667077|FG000|Core Study|Death|6|||
37980328|NCT00473330|69667078|FG001|Core Study|Death|4|||
37980329|NCT00473330|69667079|FG002|Core Study|Death|4|||
37980330|NCT00473330|69667077|FG000|Core Study|Lost to Follow-up|5|||
37980331|NCT00473330|69667078|FG001|Core Study|Lost to Follow-up|5|||
37980332|NCT00473330|69667079|FG002|Core Study|Lost to Follow-up|10|||
37980333|NCT00473330|69667077|FG000|Core Study|Physician Decision|2|||
37980334|NCT00473330|69667078|FG001|Core Study|Physician Decision|1|||
37980335|NCT00473330|69667079|FG002|Core Study|Physician Decision|3|||
37980336|NCT00473330|69667077|FG000|Core Study|Subject Non-compliance|1|||
37980337|NCT00473330|69667078|FG001|Core Study|Subject Non-compliance|2|||
37980338|NCT00473330|69667079|FG002|Core Study|Subject Non-compliance|1|||
37980339|NCT00473330|69667077|FG000|Core Study|Subject Required Other Therapy|0|||
37980340|NCT00473330|69667078|FG001|Core Study|Subject Required Other Therapy|1|||
37980341|NCT00473330|69667079|FG002|Core Study|Subject Required Other Therapy|3|||
37980342|NCT00473330|69667077|FG000|Core Study|Subject's Decision|9|||
37980343|NCT00473330|69667078|FG001|Core Study|Subject's Decision|8|||
37694852|NCT02409368|69171293|FG000|ECOG Reclassification|Poor/non-compliance|0|||
37694853|NCT02409368|69171294|FG001|ECOG Reclassification|Poor/non-compliance|3|||
37694854|NCT02409368|69171295|FG002|ECOG Reclassification|Poor/non-compliance|2|||
37694855|NCT02409368|69171296|FG003|ECOG Reclassification|Poor/non-compliance|0|||
37694856|NCT02409368|69171293|FG000|ECOG Reclassification|Study drug toxicity|17|||
37694857|NCT02409368|69171294|FG001|ECOG Reclassification|Study drug toxicity|42|||
37694858|NCT02409368|69171295|FG002|ECOG Reclassification|Study drug toxicity|7|||
37694859|NCT02409368|69171296|FG003|ECOG Reclassification|Study drug toxicity|0|||
37815992|NCT03629223|69494650|FG000|Treatment Period 1 (21 Days)|Adverse Event|0|||
37980344|NCT00473330|69667079|FG002|Core Study|Subject's Decision|19|||
37980345|NCT00473330|69667077|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
37980346|NCT00473330|69667078|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
37980347|NCT00473330|69667079|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
37980348|NCT00473330|69667077|FG000|Open-label Extension Through Month 48|Death|2|||
37980349|NCT00473330|69667078|FG001|Open-label Extension Through Month 48|Death|0|||
37980350|NCT00473330|69667079|FG002|Open-label Extension Through Month 48|Death|0|||
37980351|NCT00473330|69667077|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
37980352|NCT00473330|69667078|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
37980353|NCT00473330|69667079|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
37980354|NCT00473330|69667077|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
37980355|NCT00473330|69667078|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
37980356|NCT00473330|69667079|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
37980357|NCT00473330|69667077|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
37980358|NCT00473330|69667078|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
37980359|NCT00473330|69667079|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
37980360|NCT00473330|69667077|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
37980361|NCT00473330|69667078|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
37980362|NCT00473330|69667079|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
37980363|NCT00473330|69667077|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
37980364|NCT00473330|69667078|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
37980365|NCT00473330|69667079|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
37980366|NCT00473330|69667077|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
37980367|NCT00473330|69667078|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
37980368|NCT00473330|69667079|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
37980369|NCT00473330|69667077|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
37980370|NCT00473330|69667078|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
37870236|NCT01011309|69554158|FG001|Overall Study|Protocol Violation|1|||
37980371|NCT00473330|69667079|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
37980372|NCT00473330|69667077|FG000|Open-label Extension Through Month 60|Death|2|||
37980373|NCT00473330|69667078|FG001|Open-label Extension Through Month 60|Death|2|||
37980374|NCT00473330|69667079|FG002|Open-label Extension Through Month 60|Death|1|||
37980375|NCT00473330|69667077|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
37980376|NCT00473330|69667078|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
37870237|NCT01011309|69554159|FG002|Overall Study|Protocol Violation|3|||
37870238|NCT01011153|69554170|FG000|Overall Study|Less than 78 cases completed|8|||
37870239|NCT01011153|69554171|FG001|Overall Study|Less than 78 cases completed|11|||
37870240|NCT01011153|69554172|FG002|Overall Study|Less than 78 cases completed|9|||
37980377|NCT00473330|69667079|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
37980378|NCT00473330|69667077|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
37980379|NCT00473330|69667078|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
37980380|NCT00473330|69667079|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
37980381|NCT00473330|69667077|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
37980382|NCT00473330|69667078|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
37980383|NCT00473330|69667079|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
37980384|NCT00473330|69667077|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
37980385|NCT00473330|69667078|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
37980386|NCT00473330|69667079|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
37980387|NCT00473330|69667077|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
37980388|NCT00473330|69667078|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
37980389|NCT00473330|69667079|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
37980390|NCT00473330|69667077|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
37980391|NCT00473330|69667078|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
37980392|NCT00473330|69667079|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
37980393|NCT00416520|69667109|FG000|Open-label Period|Adverse Event|28|||
37980394|NCT00416520|69667110|FG001|Open-label Period|Adverse Event|10|||
37980395|NCT00416520|69667111|FG002|Open-label Period|Adverse Event|0|||
37980396|NCT00416520|69667112|FG003|Open-label Period|Adverse Event|0|||
37980397|NCT00416520|69667109|FG000|Open-label Period|Death|2|||
37980398|NCT00416520|69667110|FG001|Open-label Period|Death|1|||
37980399|NCT00416520|69667111|FG002|Open-label Period|Death|0|||
37980400|NCT00416520|69667112|FG003|Open-label Period|Death|0|||
37980401|NCT00416520|69667109|FG000|Open-label Period|Lack of Efficacy|8|||
37980402|NCT00416520|69667110|FG001|Open-label Period|Lack of Efficacy|1|||
37980403|NCT00416520|69667111|FG002|Open-label Period|Lack of Efficacy|0|||
37980404|NCT00416520|69667112|FG003|Open-label Period|Lack of Efficacy|0|||
37980405|NCT00416520|69667109|FG000|Open-label Period|Protocol Violation|3|||
37980406|NCT00416520|69667110|FG001|Open-label Period|Protocol Violation|3|||
37980407|NCT00416520|69667111|FG002|Open-label Period|Protocol Violation|0|||
37980408|NCT00416520|69667112|FG003|Open-label Period|Protocol Violation|0|||
37980409|NCT00416520|69667109|FG000|Open-label Period|Withdrawal by Subject|16|||
37980410|NCT00416520|69667110|FG001|Open-label Period|Withdrawal by Subject|5|||
37980411|NCT00416520|69667111|FG002|Open-label Period|Withdrawal by Subject|0|||
37980412|NCT00416520|69667112|FG003|Open-label Period|Withdrawal by Subject|0|||
37980413|NCT00416520|69667109|FG000|Open-label Period|Other Reasons|3|||
37980414|NCT00416520|69667110|FG001|Open-label Period|Other Reasons|12|||
37980415|NCT00416520|69667111|FG002|Open-label Period|Other Reasons|0|||
37980416|NCT00416520|69667112|FG003|Open-label Period|Other Reasons|0|||
37980417|NCT00416520|69667109|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
37980418|NCT00416520|69667110|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
37980419|NCT00416520|69667111|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
37980420|NCT00416520|69667112|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
37980421|NCT00416520|69667109|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
37980422|NCT00416520|69667110|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
37980423|NCT00416520|69667111|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
37980424|NCT00416520|69667112|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
37694860|NCT02409368|69171293|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
37694861|NCT02409368|69171294|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
37694862|NCT02409368|69171295|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
37694863|NCT02409368|69171296|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
37815993|NCT03629223|69494651|FG001|Treatment Period 1 (21 Days)|Adverse Event|0|||
37815994|NCT03629223|69494652|FG002|Treatment Period 1 (21 Days)|Adverse Event|0|||
37815995|NCT03629223|69494653|FG003|Treatment Period 1 (21 Days)|Adverse Event|1|||
37815996|NCT03629223|69494654|FG004|Treatment Period 1 (21 Days)|Adverse Event|0|||
37815997|NCT03629223|69494655|FG005|Treatment Period 1 (21 Days)|Adverse Event|0|||
37815998|NCT03629223|69494650|FG000|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
37815999|NCT03629223|69494651|FG001|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
37816000|NCT03629223|69494652|FG002|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
37816001|NCT03629223|69494653|FG003|Treatment Period 1 (21 Days)|Lost to Follow-up|1|||
37870241|NCT00997893|69554204|FG000|Overall Study|Adverse Event|1|||
37870242|NCT00997893|69554205|FG001|Overall Study|Adverse Event|0|||
37694864|NCT02409368|69171293|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
37694865|NCT02409368|69171294|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
37870243|NCT00997893|69554206|FG002|Overall Study|Adverse Event|0|||
37870244|NCT00997893|69554204|FG000|Overall Study|Unable to meet study timelines|1|||
37816002|NCT03629223|69494654|FG004|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
37816003|NCT03629223|69494655|FG005|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
37870245|NCT00997893|69554205|FG001|Overall Study|Unable to meet study timelines|0|||
37870246|NCT00997893|69554206|FG002|Overall Study|Unable to meet study timelines|0|||
37870247|NCT00997893|69554204|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
37870248|NCT00997893|69554205|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
37870249|NCT00997893|69554206|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
37870250|NCT02905825|69554223|FG000|Overall Study|Protocol Violation|11|||
37870251|NCT02905825|69554223|FG000|Overall Study|Device Malfunction|1|||
37870252|NCT01208051|69554232|FG000|Total Enrollment|Withdrawal by Subject|0|||
37870253|NCT01208051|69554233|FG001|Total Enrollment|Withdrawal by Subject|1|||
37870254|NCT01208051|69554234|FG002|Total Enrollment|Withdrawal by Subject|0|||
37980425|NCT00416520|69667109|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
37980426|NCT00416520|69667110|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
37980427|NCT00416520|69667111|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
37980428|NCT00416520|69667112|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
37980429|NCT00533429|69667124|FG000|Overall Study|Adverse Event|3|||
37980430|NCT00533429|69667125|FG001|Overall Study|Adverse Event|1|||
37980431|NCT00533429|69667124|FG000|Overall Study|Death|1|||
37980432|NCT00533429|69667125|FG001|Overall Study|Death|0|||
37980433|NCT00533429|69667124|FG000|Overall Study|Withdrawal by Subject|2|||
37980434|NCT00533429|69667125|FG001|Overall Study|Withdrawal by Subject|0|||
37980435|NCT00533429|69667124|FG000|Overall Study|Progressive Disease|12|||
37980436|NCT00533429|69667125|FG001|Overall Study|Progressive Disease|13|||
37980437|NCT00533429|69667124|FG000|Overall Study|Symptomatic deterioration|1|||
37980438|NCT00533429|69667125|FG001|Overall Study|Symptomatic deterioration|2|||
37870255|NCT01208051|69554235|FG003|Total Enrollment|Withdrawal by Subject|0|||
37980439|NCT00533273|69667135|FG000|Double-blind|Withdrew consent|0|||
37980440|NCT00533273|69667136|FG001|Double-blind|Withdrew consent|2|||
37816004|NCT03629223|69494650|FG000|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
37816005|NCT03629223|69494651|FG001|Treatment Period 1 (21 Days)|Benzodiazepines positive|1|||
37816006|NCT03629223|69494652|FG002|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
37816007|NCT03629223|69494653|FG003|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
37816008|NCT03629223|69494654|FG004|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
37816009|NCT03629223|69494655|FG005|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
37816010|NCT03629223|69494650|FG000|Treatment Period 1 (21 Days)|Toothache treatment|0|||
37816011|NCT03629223|69494651|FG001|Treatment Period 1 (21 Days)|Toothache treatment|1|||
37816012|NCT03629223|69494652|FG002|Treatment Period 1 (21 Days)|Toothache treatment|0|||
37816013|NCT03629223|69494653|FG003|Treatment Period 1 (21 Days)|Toothache treatment|0|||
37870256|NCT01208051|69554236|FG004|Total Enrollment|Withdrawal by Subject|2|||
37980441|NCT00533273|69667135|FG000|Open-label|Withdrawal by Subject|6|||
37980442|NCT00533273|69667136|FG001|Open-label|Withdrawal by Subject|0|||
37980443|NCT03891641|69667144|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
37980444|NCT03891641|69667145|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
37980445|NCT00339183|69667153|FG000|Overall Study|Adverse Event|5|||
37980446|NCT00339183|69667154|FG001|Overall Study|Adverse Event|3|||
37980447|NCT00339183|69667153|FG000|Overall Study|Withdrawal by Subject|16|||
37870257|NCT01208051|69554232|FG000|Total Enrollment|Brain metastases|0|||
37870258|NCT01208051|69554233|FG001|Total Enrollment|Brain metastases|0|||
37870259|NCT01208051|69554234|FG002|Total Enrollment|Brain metastases|1|||
37870260|NCT01208051|69554235|FG003|Total Enrollment|Brain metastases|0|||
37870261|NCT01208051|69554236|FG004|Total Enrollment|Brain metastases|0|||
37870262|NCT01207583|69554255|FG000|Overall Study|Withdrawal by Subject|0|||
37870263|NCT01207583|69554256|FG001|Overall Study|Withdrawal by Subject|3|||
37870264|NCT01207583|69554257|FG002|Overall Study|Withdrawal by Subject|1|||
37870265|NCT01207583|69554255|FG000|Overall Study|Participant failed to return|1|||
37870266|NCT01207583|69554256|FG001|Overall Study|Participant failed to return|0|||
37870267|NCT01207583|69554257|FG002|Overall Study|Participant failed to return|0|||
37870268|NCT01207583|69554255|FG000|Overall Study|Lost to Follow-up|0|||
37870269|NCT01207583|69554256|FG001|Overall Study|Lost to Follow-up|2|||
37870270|NCT01207583|69554257|FG002|Overall Study|Lost to Follow-up|0|||
37870271|NCT01207427|69554281|FG000|Double-blind Treatment Period|Adverse Event|0|||
37870272|NCT01207427|69554282|FG001|Double-blind Treatment Period|Adverse Event|1|||
37870273|NCT01207427|69554283|FG002|Double-blind Treatment Period|Adverse Event|0|||
37870274|NCT01207427|69554281|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
37870275|NCT01207427|69554282|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
37870276|NCT01207427|69554283|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
37870277|NCT01207427|69554281|FG000|Double-blind Treatment Period|Protocol Violation|2|||
37870278|NCT01207427|69554282|FG001|Double-blind Treatment Period|Protocol Violation|1|||
37870279|NCT01207427|69554283|FG002|Double-blind Treatment Period|Protocol Violation|1|||
37870280|NCT01207427|69554281|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
37870281|NCT01207427|69554282|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
37870282|NCT01207427|69554283|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
37870283|NCT04713553|69554296|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
37870284|NCT04713553|69554297|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
37870285|NCT04713553|69554298|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
37870286|NCT04713553|69554299|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
37870287|NCT04713553|69554300|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
37870288|NCT04713553|69554301|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
37870289|NCT04713553|69554302|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
37870290|NCT04713553|69554296|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
37870291|NCT04713553|69554297|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
37870292|NCT04713553|69554298|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
37870293|NCT04713553|69554299|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
37870294|NCT04713553|69554300|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
37870295|NCT04713553|69554301|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
37870296|NCT04713553|69554302|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
37870297|NCT04713553|69554296|FG000|Primary Study (2 Months)|Other|1|||
37870298|NCT04713553|69554297|FG001|Primary Study (2 Months)|Other|2|||
37870299|NCT04713553|69554298|FG002|Primary Study (2 Months)|Other|0|||
37870300|NCT04713553|69554299|FG003|Primary Study (2 Months)|Other|0|||
37870301|NCT04713553|69554300|FG004|Primary Study (2 Months)|Other|1|||
37870302|NCT04713553|69554301|FG005|Primary Study (2 Months)|Other|0|||
37870303|NCT04713553|69554302|FG006|Primary Study (2 Months)|Other|0|||
37870304|NCT04713553|69554296|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
37870305|NCT04713553|69554297|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
37870306|NCT04713553|69554298|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
37870307|NCT04713553|69554299|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
37870308|NCT04713553|69554300|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
37870309|NCT04713553|69554301|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
37870310|NCT04713553|69554302|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
37870311|NCT04713553|69554296|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
37870312|NCT04713553|69554297|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
37870313|NCT04713553|69554298|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
37870314|NCT04713553|69554299|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
37870315|NCT04713553|69554300|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
37870316|NCT04713553|69554301|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
37870317|NCT04713553|69554302|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
37870318|NCT01206101|69554325|FG000|Overall Study|Adverse Event|1|||
37870319|NCT01206101|69554326|FG001|Overall Study|Adverse Event|0|||
37870320|NCT01206101|69554325|FG000|Overall Study|Physician Decision|0|||
37870321|NCT01206101|69554326|FG001|Overall Study|Physician Decision|1|||
37870322|NCT01206101|69554325|FG000|Overall Study|Unclassified|1|||
37870323|NCT01206101|69554326|FG001|Overall Study|Unclassified|0|||
37870324|NCT01205165|69554332|FG000|Overall Study|Lost to Follow-up|2|||
37870325|NCT00997503|69554337|FG000|Overall Study|Death|53|||
37870326|NCT00997503|69554337|FG000|Overall Study|Withdrawal by Subject|76|||
37870327|NCT00997503|69554337|FG000|Overall Study|Lost to Follow-up|33|||
37870328|NCT00997503|69554337|FG000|Overall Study|Adverse Event|3|||
37870329|NCT00997503|69554337|FG000|Overall Study|Physician Decision|10|||
37870330|NCT00997503|69554337|FG000|Overall Study|Missed 12-month follow-up|85|||
37870331|NCT00997503|69554337|FG000|Overall Study|Other reason|13|||
37870332|NCT01204775|69554346|FG000|Overall Study|Poor/non-compliance|0|||
37870333|NCT01204775|69554347|FG001|Overall Study|Poor/non-compliance|1|||
37870334|NCT01204775|69554346|FG000|Overall Study|Withdrawal by Subject|1|||
37870335|NCT01204775|69554347|FG001|Overall Study|Withdrawal by Subject|0|||
37870336|NCT00997035|69554355|FG000|3-week Followup Visit|Lost to Follow-up|9|||
37870337|NCT00997035|69554356|FG001|3-week Followup Visit|Lost to Follow-up|6|||
37870338|NCT00997035|69554355|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
37870339|NCT00997035|69554356|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
37870340|NCT01204697|69554374|FG000|Overall Study|Death|26|||
37870341|NCT01204697|69554375|FG001|Overall Study|Death|27|||
37870342|NCT01204697|69554374|FG000|Overall Study|Lost to Follow-up|3|||
37870343|NCT01204697|69554375|FG001|Overall Study|Lost to Follow-up|4|||
37870344|NCT01204697|69554374|FG000|Overall Study|Withdrawal by Subject|2|||
37870345|NCT01204697|69554375|FG001|Overall Study|Withdrawal by Subject|4|||
37870346|NCT01204697|69554374|FG000|Overall Study|Randomized, but not treated|0|||
37980448|NCT00339183|69667154|FG001|Overall Study|Withdrawal by Subject|19|||
37980449|NCT00339183|69667153|FG000|Overall Study|Physician Decision|2|||
37980450|NCT00339183|69667154|FG001|Overall Study|Physician Decision|4|||
37980451|NCT00339183|69667153|FG000|Overall Study|Lost to Follow-up|17|||
37980452|NCT00339183|69667154|FG001|Overall Study|Lost to Follow-up|17|||
37980453|NCT00339183|69667153|FG000|Overall Study|Protocol-specified criteria|12|||
37980454|NCT00339183|69667154|FG001|Overall Study|Protocol-specified criteria|8|||
37980455|NCT00339183|69667153|FG000|Overall Study|Missing reason|3|||
37980456|NCT00339183|69667154|FG001|Overall Study|Missing reason|1|||
37870347|NCT01204697|69554375|FG001|Overall Study|Randomized, but not treated|1|||
37870348|NCT01001325|69554383|FG000|Overall Study|Lost to Follow-up|16|||
37870349|NCT01001325|69554384|FG001|Overall Study|Lost to Follow-up|10|||
37870350|NCT01001325|69554383|FG000|Overall Study|Protocol Violation|2|||
37870351|NCT01001325|69554384|FG001|Overall Study|Protocol Violation|0|||
37870352|NCT01203917|69554390|FG000|Overall Study|Death|29|||
37870353|NCT01203917|69554390|FG000|Overall Study|Lost to Follow-up|2|||
37870354|NCT01203917|69554390|FG000|Overall Study|Withdrawal by Subject|3|||
37870355|NCT01203917|69554390|FG000|Overall Study|Due to objective disease progression|1|||
37870356|NCT01203917|69554390|FG000|Overall Study|Due to EGFR M+I patient|1|||
37870357|NCT01202903|69554396|FG000|Overall Study|Administrative Probelms|1|||
37870358|NCT01202903|69554397|FG001|Overall Study|Administrative Probelms|4|||
37870359|NCT01202903|69554396|FG000|Overall Study|Protocol Violation|0|||
37870360|NCT01202903|69554397|FG001|Overall Study|Protocol Violation|1|||
37870361|NCT01202903|69554396|FG000|Overall Study|Death|1|||
37870362|NCT01202903|69554397|FG001|Overall Study|Death|0|||
37870363|NCT01202903|69554396|FG000|Overall Study|Lost to Follow-up|1|||
37870364|NCT01202903|69554397|FG001|Overall Study|Lost to Follow-up|1|||
37870365|NCT01202903|69554396|FG000|Overall Study|Lack of Efficacy|1|||
37870366|NCT01202903|69554397|FG001|Overall Study|Lack of Efficacy|3|||
37870367|NCT01202903|69554396|FG000|Overall Study|Adverse Event|3|||
37870368|NCT01202903|69554397|FG001|Overall Study|Adverse Event|3|||
37870369|NCT01202903|69554396|FG000|Overall Study|Withdrawal by Subject|4|||
37870370|NCT01202903|69554397|FG001|Overall Study|Withdrawal by Subject|4|||
37870371|NCT01001169|69554405|FG000|Overall Study|Withdrawal by Subject|2|||
37870372|NCT01001169|69554406|FG001|Overall Study|Withdrawal by Subject|1|||
37870373|NCT01202747|69554420|FG000|Overall Study|Withdrawal by Subject|1|||
37870374|NCT00996801|69554430|FG000|Overall Study|Adverse Event|6|||
37870375|NCT00996801|69554431|FG001|Overall Study|Adverse Event|4|||
37870376|NCT00996801|69554432|FG002|Overall Study|Adverse Event|12|||
37870377|NCT00996801|69554433|FG003|Overall Study|Adverse Event|17|||
37870378|NCT00996801|69554434|FG004|Overall Study|Adverse Event|31|||
37870379|NCT00996801|69554435|FG005|Overall Study|Adverse Event|3|||
37980457|NCT00339183|69667153|FG000|Overall Study|Other|46|||
37980458|NCT00339183|69667154|FG001|Overall Study|Other|40|||
37980459|NCT00339183|69667153|FG000|Overall Study|Ongoing|20|||
37870380|NCT00996801|69554430|FG000|Overall Study|Lack of Efficacy|3|||
37870381|NCT00996801|69554431|FG001|Overall Study|Lack of Efficacy|0|||
37870382|NCT00996801|69554432|FG002|Overall Study|Lack of Efficacy|1|||
37870383|NCT00996801|69554433|FG003|Overall Study|Lack of Efficacy|3|||
37870384|NCT00996801|69554434|FG004|Overall Study|Lack of Efficacy|0|||
37870385|NCT00996801|69554435|FG005|Overall Study|Lack of Efficacy|1|||
37870386|NCT00996801|69554430|FG000|Overall Study|Lost to Follow-up|0|||
37870387|NCT00996801|69554431|FG001|Overall Study|Lost to Follow-up|0|||
37870388|NCT00996801|69554432|FG002|Overall Study|Lost to Follow-up|0|||
37870389|NCT00996801|69554433|FG003|Overall Study|Lost to Follow-up|3|||
37870390|NCT00996801|69554434|FG004|Overall Study|Lost to Follow-up|3|||
37870391|NCT00996801|69554435|FG005|Overall Study|Lost to Follow-up|2|||
37870392|NCT00996801|69554430|FG000|Overall Study|Physician Decision|0|||
37980460|NCT00339183|69667154|FG001|Overall Study|Ongoing|13|||
37870393|NCT00996801|69554431|FG001|Overall Study|Physician Decision|0|||
37870394|NCT00996801|69554432|FG002|Overall Study|Physician Decision|0|||
37870395|NCT00996801|69554433|FG003|Overall Study|Physician Decision|1|||
37870396|NCT00996801|69554434|FG004|Overall Study|Physician Decision|0|||
37870397|NCT00996801|69554435|FG005|Overall Study|Physician Decision|0|||
37870398|NCT00996801|69554430|FG000|Overall Study|Progressive Disease|0|||
37870399|NCT00996801|69554431|FG001|Overall Study|Progressive Disease|1|||
37870400|NCT00996801|69554432|FG002|Overall Study|Progressive Disease|0|||
37870401|NCT00996801|69554433|FG003|Overall Study|Progressive Disease|0|||
37870402|NCT00996801|69554434|FG004|Overall Study|Progressive Disease|0|||
37870403|NCT00996801|69554435|FG005|Overall Study|Progressive Disease|0|||
37870404|NCT00996801|69554430|FG000|Overall Study|Protocol Violation|3|||
37870405|NCT00996801|69554431|FG001|Overall Study|Protocol Violation|4|||
37870406|NCT00996801|69554432|FG002|Overall Study|Protocol Violation|1|||
37980461|NCT00333801|69667166|FG000|Overall Study|Moved to another state|5|||
37980462|NCT00333801|69667167|FG001|Overall Study|Moved to another state|3|||
37980463|NCT00333801|69667166|FG000|Overall Study|Lost to Follow-up|2|||
37980464|NCT00333801|69667167|FG001|Overall Study|Lost to Follow-up|0|||
37980465|NCT00333801|69667166|FG000|Overall Study|Incarcerated|1|||
37980466|NCT00333801|69667167|FG001|Overall Study|Incarcerated|2|||
37980467|NCT00333801|69667166|FG000|Overall Study|Withdrawal by Subject|0|||
37980468|NCT00333801|69667167|FG001|Overall Study|Withdrawal by Subject|1|||
37870407|NCT00996801|69554433|FG003|Overall Study|Protocol Violation|2|||
37870408|NCT00996801|69554434|FG004|Overall Study|Protocol Violation|3|||
37870409|NCT00996801|69554435|FG005|Overall Study|Protocol Violation|4|||
37870410|NCT00996801|69554430|FG000|Overall Study|Study Terminated by Sponsor|0|||
37870411|NCT00996801|69554431|FG001|Overall Study|Study Terminated by Sponsor|1|||
37870412|NCT00996801|69554432|FG002|Overall Study|Study Terminated by Sponsor|0|||
37870413|NCT00996801|69554433|FG003|Overall Study|Study Terminated by Sponsor|0|||
37870414|NCT00996801|69554434|FG004|Overall Study|Study Terminated by Sponsor|46|||
37870415|NCT00996801|69554435|FG005|Overall Study|Study Terminated by Sponsor|0|||
37870416|NCT00996801|69554430|FG000|Overall Study|Withdrawal by Subject|8|||
37870417|NCT00996801|69554431|FG001|Overall Study|Withdrawal by Subject|6|||
37870418|NCT00996801|69554432|FG002|Overall Study|Withdrawal by Subject|9|||
37870419|NCT00996801|69554433|FG003|Overall Study|Withdrawal by Subject|5|||
37870420|NCT00996801|69554434|FG004|Overall Study|Withdrawal by Subject|5|||
37870421|NCT00996801|69554435|FG005|Overall Study|Withdrawal by Subject|9|||
37870422|NCT00996489|69554451|FG000|Overall Study|Device failure|45|||
37980469|NCT00532883|69667177|FG000|Overall Study|Adverse Event|1|||
37816014|NCT03629223|69494654|FG004|Treatment Period 1 (21 Days)|Toothache treatment|0|||
37816015|NCT03629223|69494655|FG005|Treatment Period 1 (21 Days)|Toothache treatment|0|||
37816016|NCT03629223|69494650|FG000|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|1|||
37816017|NCT03629223|69494651|FG001|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
37816018|NCT03629223|69494652|FG002|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
37816019|NCT03629223|69494653|FG003|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
37816020|NCT03629223|69494654|FG004|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
37816021|NCT03629223|69494655|FG005|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
37816022|NCT03547908|69494671|FG000|Overall Study|Still On Study|115|||
37816023|NCT03547908|69494672|FG001|Overall Study|Still On Study|118|||
37816024|NCT03547908|69494671|FG000|Overall Study|Lost to Follow-up|2|||
37816025|NCT03547908|69494672|FG001|Overall Study|Lost to Follow-up|2|||
37816026|NCT03547908|69494671|FG000|Overall Study|Withdrew Consent|2|||
37816027|NCT03547908|69494672|FG001|Overall Study|Withdrew Consent|1|||
37816028|NCT03547908|69494671|FG000|Overall Study|Adverse Event|1|||
37816029|NCT03547908|69494672|FG001|Overall Study|Adverse Event|0|||
37870423|NCT00996489|69554451|FG000|Overall Study|Discontinued|116|||
37980470|NCT00532883|69667178|FG001|Overall Study|Adverse Event|0|||
37816030|NCT03547908|69494671|FG000|Overall Study|Death|1|||
37816031|NCT03547908|69494672|FG001|Overall Study|Death|0|||
37870424|NCT01000311|69554457|FG000|Overall Study|Adverse Event|2|||
37870425|NCT01000311|69554458|FG001|Overall Study|Adverse Event|5|||
37870426|NCT01000311|69554457|FG000|Overall Study|Withdrawal by Subject|16|||
37980471|NCT00532883|69667179|FG002|Overall Study|Adverse Event|0|||
37816032|NCT03547908|69494671|FG000|Overall Study|Investigator's Discretion|0|||
37870427|NCT01000311|69554458|FG001|Overall Study|Withdrawal by Subject|24|||
37980472|NCT00532883|69667180|FG003|Overall Study|Adverse Event|1|||
37870428|NCT01000311|69554457|FG000|Overall Study|Lost to Follow-up|15|||
37870429|NCT01000311|69554458|FG001|Overall Study|Lost to Follow-up|24|||
37870430|NCT01000311|69554457|FG000|Overall Study|Protocol Violation|1|||
37870431|NCT01000311|69554458|FG001|Overall Study|Protocol Violation|2|||
37870432|NCT01000311|69554457|FG000|Overall Study|Inappropriate enrollment|2|||
37870433|NCT01000311|69554458|FG001|Overall Study|Inappropriate enrollment|0|||
37870434|NCT01000311|69554457|FG000|Overall Study|Administrative reason|9|||
37870435|NCT01000311|69554458|FG001|Overall Study|Administrative reason|15|||
37870436|NCT01003899|69554464|FG000|Overall Study|Other Adverse Event|8|||
37870437|NCT01003899|69554464|FG000|Overall Study|Not entered|4|||
37870438|NCT01003899|69554464|FG000|Overall Study|Not treated|1|||
37870439|NCT01003899|69554464|FG000|Overall Study|Progressive disease|34|||
37870440|NCT01000155|69554468|FG000|Overall Study|Withdrawal by Subject|1|||
37870441|NCT01000155|69554468|FG000|Overall Study|Adverse Event|1|||
37870442|NCT00999921|69554474|FG000|Overall Study|Lost to Follow-up|10|||
37870443|NCT00999921|69554475|FG001|Overall Study|Lost to Follow-up|19|||
37870444|NCT01002573|69554486|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
37870445|NCT01002573|69554487|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
37870446|NCT00999687|69554493|FG000|First Intervention|Withdrawal by Subject|1|||
37870447|NCT00999687|69554493|FG000|Second Intervention|Withdrawal by Subject|2|||
37870448|NCT00999687|69554493|FG000|Second Intervention|Lack of Efficacy|1|||
37870449|NCT00996333|69554499|FG000|Overall Study|Screen failure|1|||
37870450|NCT00996333|69554499|FG000|Overall Study|Withdrawal by Subject|1|||
37870451|NCT00996333|69554499|FG000|Overall Study|Death|4|||
37870452|NCT00996333|69554499|FG000|Overall Study|Adverse Event|1|||
37870453|NCT00996333|69554499|FG000|Overall Study|Physician Decision|1|||
37870454|NCT00996333|69554499|FG000|Overall Study|Other|5|||
37870455|NCT00995865|69554506|FG000|Overall Study|Protocol Violation|2|||
37870456|NCT00995865|69554507|FG001|Overall Study|Protocol Violation|0|||
37870457|NCT00995865|69554508|FG002|Overall Study|Protocol Violation|0|||
37816033|NCT03547908|69494672|FG001|Overall Study|Investigator's Discretion|1|||
37816034|NCT03547908|69494671|FG000|Overall Study|Randomized But Never Treated|1|||
37816035|NCT03547908|69494672|FG001|Overall Study|Randomized But Never Treated|0|||
37816036|NCT03395405|69494680|FG000|Overall Study|Death|0|||
37816037|NCT03395405|69494681|FG001|Overall Study|Death|2|||
37816038|NCT03395405|69494680|FG000|Overall Study|Lost to Follow-up|0|||
37816039|NCT03395405|69494681|FG001|Overall Study|Lost to Follow-up|1|||
37816040|NCT03395405|69494680|FG000|Overall Study|Protocol Violation|0|||
37816041|NCT03395405|69494681|FG001|Overall Study|Protocol Violation|1|||
37816042|NCT03395405|69494680|FG000|Overall Study|Withdrawal by Subject|3|||
37816043|NCT03395405|69494681|FG001|Overall Study|Withdrawal by Subject|1|||
37816044|NCT03395405|69494680|FG000|Overall Study|COVID-19 Pandemic|1|||
37816045|NCT03395405|69494681|FG001|Overall Study|COVID-19 Pandemic|0|||
37816046|NCT03381248|69494689|FG000|0-6 Months|Withdrawal by Subject|4|||
37816047|NCT03381248|69494690|FG001|0-6 Months|Withdrawal by Subject|1|||
37816048|NCT03381248|69494689|FG000|0-6 Months|Lost to Follow-up|3|||
37816049|NCT03381248|69494690|FG001|0-6 Months|Lost to Follow-up|2|||
37816050|NCT03381248|69494689|FG000|0-6 Months|Lack of Efficacy|1|||
37816051|NCT03381248|69494690|FG001|0-6 Months|Lack of Efficacy|0|||
37816052|NCT03381248|69494689|FG000|0-6 Months|Adverse Event|1|||
37816053|NCT03381248|69494690|FG001|0-6 Months|Adverse Event|0|||
37816054|NCT03381248|69494689|FG000|0-6 Months|Protocol Violation|2|||
37816055|NCT03381248|69494690|FG001|0-6 Months|Protocol Violation|1|||
37816056|NCT03381248|69494689|FG000|0-6 Months|Physician Decision|1|||
37816057|NCT03381248|69494690|FG001|0-6 Months|Physician Decision|0|||
37816058|NCT03381248|69494689|FG000|0-6 Months|Planning another procedure|1|||
37816059|NCT03381248|69494690|FG001|0-6 Months|Planning another procedure|2|||
37816060|NCT03381248|69494689|FG000|6-12 Months|Withdrawal by Subject|1|||
37816061|NCT03381248|69494690|FG001|6-12 Months|Withdrawal by Subject|3|||
37816062|NCT03381248|69494689|FG000|6-12 Months|Lost to Follow-up|0|||
37816063|NCT03381248|69494690|FG001|6-12 Months|Lost to Follow-up|2|||
37816064|NCT03381248|69494689|FG000|6-12 Months|Protocol Violation|3|||
37816065|NCT03381248|69494690|FG001|6-12 Months|Protocol Violation|2|||
37816066|NCT03381248|69494689|FG000|6-12 Months|Planning another procedure|6|||
37816067|NCT03381248|69494690|FG001|6-12 Months|Planning another procedure|2|||
37816068|NCT03381248|69494689|FG000|12 - 24 Months (Extension Study)|Withdrawal by Subject|3|||
37816069|NCT03381248|69494690|FG001|12 - 24 Months (Extension Study)|Withdrawal by Subject|0|||
37816070|NCT03381248|69494689|FG000|12 - 24 Months (Extension Study)|Lost to Follow-up|1|||
37816071|NCT03381248|69494690|FG001|12 - 24 Months (Extension Study)|Lost to Follow-up|0|||
37816072|NCT03381248|69494689|FG000|12 - 24 Months (Extension Study)|Received another procedure|5|||
37816073|NCT03381248|69494690|FG001|12 - 24 Months (Extension Study)|Received another procedure|0|||
37870458|NCT00995865|69554506|FG000|Overall Study|Lost to Follow-up|0|||
37870459|NCT00995865|69554507|FG001|Overall Study|Lost to Follow-up|0|||
37870460|NCT00995865|69554508|FG002|Overall Study|Lost to Follow-up|1|||
37870461|NCT00995709|69554524|FG000|Overall Study|Adverse Event|4|||
37816074|NCT03354663|69494701|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
37816075|NCT03354663|69494701|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
37870462|NCT00995709|69554525|FG001|Overall Study|Adverse Event|2|||
37870463|NCT00995709|69554526|FG002|Overall Study|Adverse Event|0|||
37870464|NCT00995709|69554524|FG000|Overall Study|Lack of Efficacy|0|||
37870465|NCT00995709|69554525|FG001|Overall Study|Lack of Efficacy|1|||
37870466|NCT00995709|69554526|FG002|Overall Study|Lack of Efficacy|4|||
37870467|NCT00995709|69554524|FG000|Overall Study|Withdrawal by Subject|0|||
37870468|NCT00995709|69554525|FG001|Overall Study|Withdrawal by Subject|4|||
37980473|NCT00532883|69667177|FG000|Overall Study|Lost to Follow-up|1|||
37980474|NCT00532883|69667178|FG001|Overall Study|Lost to Follow-up|1|||
37980475|NCT00532883|69667179|FG002|Overall Study|Lost to Follow-up|1|||
37980476|NCT00532883|69667180|FG003|Overall Study|Lost to Follow-up|0|||
37980477|NCT00532883|69667177|FG000|Overall Study|Withdrawal by Subject|0|||
37980478|NCT00532883|69667178|FG001|Overall Study|Withdrawal by Subject|1|||
37980479|NCT00532883|69667179|FG002|Overall Study|Withdrawal by Subject|1|||
37980480|NCT00532883|69667180|FG003|Overall Study|Withdrawal by Subject|0|||
37870469|NCT00995709|69554526|FG002|Overall Study|Withdrawal by Subject|1|||
37870470|NCT00995709|69554524|FG000|Overall Study|Lost to Follow-up|1|||
37870471|NCT00995709|69554525|FG001|Overall Study|Lost to Follow-up|0|||
37870472|NCT00995709|69554526|FG002|Overall Study|Lost to Follow-up|0|||
37870473|NCT00995709|69554524|FG000|Overall Study|Death|0|||
37980481|NCT00532883|69667177|FG000|Overall Study|Subject was Nonadherent|0|||
37980482|NCT00532883|69667178|FG001|Overall Study|Subject was Nonadherent|1|||
37980483|NCT00532883|69667179|FG002|Overall Study|Subject was Nonadherent|1|||
37980484|NCT00532883|69667180|FG003|Overall Study|Subject was Nonadherent|0|||
37980485|NCT00532883|69667177|FG000|Overall Study|Early Study Termination|4|||
37980486|NCT00532883|69667178|FG001|Overall Study|Early Study Termination|4|||
37980487|NCT00532883|69667179|FG002|Overall Study|Early Study Termination|1|||
37980488|NCT00532883|69667180|FG003|Overall Study|Early Study Termination|4|||
37980489|NCT00354159|69667192|FG000|Randomized Study Period|Withdrawal by Subject|5|||
37980490|NCT00354159|69667193|FG001|Randomized Study Period|Withdrawal by Subject|3|||
37980491|NCT00354159|69667192|FG000|Randomized Study Period|Physician Decision|6|||
37980492|NCT00354159|69667193|FG001|Randomized Study Period|Physician Decision|10|||
37980493|NCT00354159|69667192|FG000|Randomized Study Period|Lost to Follow-up|4|||
37980494|NCT00354159|69667193|FG001|Randomized Study Period|Lost to Follow-up|0|||
37980495|NCT00354159|69667192|FG000|Randomized Study Period|Death|7|||
37980496|NCT00354159|69667193|FG001|Randomized Study Period|Death|9|||
37980497|NCT00354159|69667192|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
37980498|NCT00354159|69667193|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
37980499|NCT00354159|69667192|FG000|Long-term Follow-up|Physician Decision|127|||
37980500|NCT00354159|69667193|FG001|Long-term Follow-up|Physician Decision|122|||
37980501|NCT00354159|69667192|FG000|Long-term Follow-up|Lost to Follow-up|1|||
37980502|NCT00354159|69667193|FG001|Long-term Follow-up|Lost to Follow-up|0|||
37980503|NCT00354159|69667192|FG000|Long-term Follow-up|Death|14|||
37980504|NCT00354159|69667193|FG001|Long-term Follow-up|Death|11|||
37980505|NCT00354159|69667192|FG000|Long-term Follow-up|Study Closed|29|||
37980506|NCT00354159|69667193|FG001|Long-term Follow-up|Study Closed|34|||
37980507|NCT00338949|69667208|FG000|Subject Screening|Screen failures|11|||
37980508|NCT00338949|69667209|FG001|Subject Screening|Screen failures|11|||
37980509|NCT00338949|69667208|FG000|Randomization|Withdrawal by Subject|1|||
37980510|NCT00338949|69667209|FG001|Randomization|Withdrawal by Subject|0|||
37870474|NCT00995709|69554525|FG001|Overall Study|Death|1|||
37870475|NCT00995709|69554526|FG002|Overall Study|Death|0|||
37870476|NCT00995709|69554524|FG000|Overall Study|Protocol Violation|2|||
37870477|NCT00995709|69554525|FG001|Overall Study|Protocol Violation|1|||
37870478|NCT00995709|69554526|FG002|Overall Study|Protocol Violation|0|||
37870479|NCT00998985|69554548|FG000|Overall Study|Withdrawal by Subject|0|||
37870480|NCT00998985|69554549|FG001|Overall Study|Withdrawal by Subject|0|||
37870481|NCT00998985|69554550|FG002|Overall Study|Withdrawal by Subject|0|||
37870482|NCT00998985|69554551|FG003|Overall Study|Withdrawal by Subject|0|||
37870483|NCT00998985|69554552|FG004|Overall Study|Withdrawal by Subject|0|||
37870484|NCT00998985|69554553|FG005|Overall Study|Withdrawal by Subject|0|||
37870485|NCT00998985|69554554|FG006|Overall Study|Withdrawal by Subject|0|||
37870486|NCT00998985|69554555|FG007|Overall Study|Withdrawal by Subject|0|||
37980511|NCT00338949|69667208|FG000|Randomization|Adverse Event|0|||
37980512|NCT00338949|69667209|FG001|Randomization|Adverse Event|5|||
37980513|NCT00332709|69667217|FG000|Overall Study|Adverse Event|11|||
37980514|NCT00332709|69667218|FG001|Overall Study|Adverse Event|14|||
37980515|NCT00332709|69667217|FG000|Overall Study|Withdrawal by Subject|2|||
37980516|NCT00332709|69667218|FG001|Overall Study|Withdrawal by Subject|3|||
37870487|NCT00998985|69554556|FG008|Overall Study|Withdrawal by Subject|1|||
37870488|NCT00998985|69554557|FG009|Overall Study|Withdrawal by Subject|0|||
37870489|NCT00998985|69554558|FG010|Overall Study|Withdrawal by Subject|0|||
37870490|NCT00998985|69554559|FG011|Overall Study|Withdrawal by Subject|0|||
37870491|NCT00998985|69554560|FG012|Overall Study|Withdrawal by Subject|0|||
37870492|NCT00998985|69554561|FG013|Overall Study|Withdrawal by Subject|0|||
37870493|NCT00998985|69554548|FG000|Overall Study|Protocol Violation|0|||
37870494|NCT00998985|69554549|FG001|Overall Study|Protocol Violation|0|||
37870495|NCT00998985|69554550|FG002|Overall Study|Protocol Violation|0|||
37870496|NCT00998985|69554551|FG003|Overall Study|Protocol Violation|0|||
37870497|NCT00998985|69554552|FG004|Overall Study|Protocol Violation|0|||
37870498|NCT00998985|69554553|FG005|Overall Study|Protocol Violation|1|||
37870499|NCT00998985|69554554|FG006|Overall Study|Protocol Violation|0|||
37870500|NCT00998985|69554555|FG007|Overall Study|Protocol Violation|0|||
37870501|NCT00998985|69554556|FG008|Overall Study|Protocol Violation|0|||
37870502|NCT00998985|69554557|FG009|Overall Study|Protocol Violation|0|||
37870503|NCT00998985|69554558|FG010|Overall Study|Protocol Violation|0|||
37870504|NCT00998985|69554559|FG011|Overall Study|Protocol Violation|0|||
37870505|NCT00998985|69554560|FG012|Overall Study|Protocol Violation|0|||
37870506|NCT00998985|69554561|FG013|Overall Study|Protocol Violation|0|||
37870507|NCT00995553|69554608|FG000|Overall Study|Withdrawal by Subject|2|||
37870508|NCT00995553|69554609|FG001|Overall Study|Withdrawal by Subject|6|||
37870509|NCT00991887|69554617|FG000|Overall Study|Lost to Follow-up|2|||
37980517|NCT00332709|69667217|FG000|Overall Study|Lost to Follow-up|2|||
37870510|NCT00991887|69554618|FG001|Overall Study|Lost to Follow-up|1|||
37870511|NCT01002339|69554627|FG000|Overall Study|Withdrawal by Subject|0|||
37870512|NCT01002339|69554628|FG001|Overall Study|Withdrawal by Subject|1|||
37870513|NCT01002339|69554629|FG002|Overall Study|Withdrawal by Subject|0|||
37870514|NCT01002339|69554627|FG000|Overall Study|Incorrect treatment assignment|0|||
37870515|NCT01002339|69554628|FG001|Overall Study|Incorrect treatment assignment|0|||
37870516|NCT01002339|69554629|FG002|Overall Study|Incorrect treatment assignment|1|||
37870517|NCT01002339|69554627|FG000|Overall Study|Protocol Violation|0|||
37870518|NCT01002339|69554628|FG001|Overall Study|Protocol Violation|0|||
37870519|NCT01002339|69554629|FG002|Overall Study|Protocol Violation|2|||
37870520|NCT01002339|69554627|FG000|Overall Study|Lung cancer detected before transplant|0|||
37870521|NCT01002339|69554628|FG001|Overall Study|Lung cancer detected before transplant|0|||
37870522|NCT01002339|69554629|FG002|Overall Study|Lung cancer detected before transplant|1|||
37870523|NCT01002339|69554627|FG000|Overall Study|Randomized. Not transplanted|0|||
37870524|NCT01002339|69554628|FG001|Overall Study|Randomized. Not transplanted|0|||
37870525|NCT01002339|69554629|FG002|Overall Study|Randomized. Not transplanted|1|||
37870526|NCT01002105|69554639|FG000|Overall Study|Lost to Follow-up|10|||
37870527|NCT01002105|69554640|FG001|Overall Study|Lost to Follow-up|16|||
37980518|NCT00332709|69667218|FG001|Overall Study|Lost to Follow-up|0|||
37870528|NCT01002105|69554639|FG000|Overall Study|non compliance|5|||
37870529|NCT01002105|69554640|FG001|Overall Study|non compliance|3|||
37870530|NCT01002105|69554639|FG000|Overall Study|condition worsened|4|||
37870531|NCT01002105|69554640|FG001|Overall Study|condition worsened|2|||
37870532|NCT02605993|69554653|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
37870533|NCT02605993|69554654|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
37870534|NCT02605993|69554655|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
37870535|NCT02605993|69554656|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
37870536|NCT00995085|69554666|FG000|Overall Study|Withdrawal by Subject|5|||
37870537|NCT00603733|69554672|FG000|Active Phase ITT|Adverse Event|8|||
37870538|NCT00603733|69554673|FG001|Active Phase ITT|Adverse Event|7|||
37870539|NCT00603733|69554672|FG000|Active Phase ITT|Withdrawal by Subject|0|||
37870540|NCT00603733|69554673|FG001|Active Phase ITT|Withdrawal by Subject|3|||
37870541|NCT00603733|69554672|FG000|Active Phase ITT|Lost to Follow-up|0|||
37870542|NCT00603733|69554673|FG001|Active Phase ITT|Lost to Follow-up|1|||
37870543|NCT00603733|69554672|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
37870544|NCT00603733|69554673|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
37870545|NCT00603733|69554672|FG000|Active Phase ITT|Lack of Efficacy|1|||
37870546|NCT00603733|69554673|FG001|Active Phase ITT|Lack of Efficacy|2|||
37870547|NCT00603733|69554672|FG000|Active Phase ITT|Subject moved, site closed|1|||
37870548|NCT00603733|69554673|FG001|Active Phase ITT|Subject moved, site closed|1|||
37870549|NCT00603733|69554672|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
37870550|NCT00603733|69554673|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
37870551|NCT00603733|69554672|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
37870552|NCT00603733|69554673|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
37870553|NCT00603733|69554672|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
37870554|NCT00603733|69554673|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
37980519|NCT00332709|69667217|FG000|Overall Study|Administrative Problems|0|||
37870555|NCT00603733|69554672|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
37870556|NCT00603733|69554673|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
37870557|NCT00603733|69554672|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
37870558|NCT00603733|69554673|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
37980520|NCT00332709|69667218|FG001|Overall Study|Administrative Problems|3|||
37980521|NCT00332709|69667217|FG000|Overall Study|Abnormal test procedure result|1|||
37980522|NCT00332709|69667218|FG001|Overall Study|Abnormal test procedure result|0|||
37870559|NCT00603733|69554672|FG000|Maintenance Phase ITT|Adverse Event|3|||
37870560|NCT00603733|69554673|FG001|Maintenance Phase ITT|Adverse Event|6|||
37870561|NCT00603733|69554672|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
37870562|NCT00603733|69554673|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
37870563|NCT00603733|69554672|FG000|Maintenance Phase ITT|Protocol Violation|1|||
37870564|NCT00603733|69554673|FG001|Maintenance Phase ITT|Protocol Violation|1|||
37870565|NCT00603733|69554672|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
37870566|NCT00603733|69554673|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
37870567|NCT00603733|69554672|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
37870568|NCT00603733|69554673|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
37870569|NCT00603733|69554672|FG000|Maintenance Phase ITT|Physician Decision|0|||
37870570|NCT00603733|69554673|FG001|Maintenance Phase ITT|Physician Decision|1|||
37870571|NCT00603733|69554672|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
37870572|NCT00603733|69554673|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
37870573|NCT04631107|69554679|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
37870574|NCT04631107|69554679|FG000|Second Intervention (1 Night)|Adverse Event|1|||
37870575|NCT04631107|69554679|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
37870576|NCT04631107|69554679|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
37870577|NCT00995007|69554689|FG000|Overall Study|Withdrew consent|1|||
37870578|NCT00995007|69554690|FG001|Overall Study|Withdrew consent|0|||
37870579|NCT00995007|69554689|FG000|Overall Study|Refused further treatment|8|||
37870580|NCT00995007|69554690|FG001|Overall Study|Refused further treatment|2|||
37870581|NCT00995007|69554689|FG000|Overall Study|Toxicity|8|||
37870582|NCT00995007|69554690|FG001|Overall Study|Toxicity|0|||
37870583|NCT00994461|69554708|FG000|Overall Study|Adverse Event|2|||
37694866|NCT02409368|69171295|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
37694867|NCT02409368|69171296|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
37694868|NCT02409368|69171293|FG000|ECOG Reclassification|Participant withdrew consent|2|||
37694869|NCT02409368|69171294|FG001|ECOG Reclassification|Participant withdrew consent|3|||
37694870|NCT02409368|69171295|FG002|ECOG Reclassification|Participant withdrew consent|4|||
37694871|NCT02409368|69171296|FG003|ECOG Reclassification|Participant withdrew consent|0|||
37694872|NCT02409368|69171293|FG000|ECOG Reclassification|Other Reasons|5|||
37694873|NCT02409368|69171294|FG001|ECOG Reclassification|Other Reasons|26|||
37694874|NCT02409368|69171295|FG002|ECOG Reclassification|Other Reasons|2|||
37870584|NCT00994461|69554709|FG001|Overall Study|Adverse Event|1|||
37870585|NCT00994461|69554710|FG002|Overall Study|Adverse Event|0|||
37870586|NCT00993915|69554718|FG000|Overall Study|Insufficient clinical response|3|||
37870587|NCT00993915|69554718|FG000|Overall Study|Withdrawal by Subject|2|||
37870588|NCT00993915|69554718|FG000|Overall Study|Other|1|||
37694875|NCT02409368|69171296|FG003|ECOG Reclassification|Other Reasons|0|||
37870589|NCT00993915|69554718|FG000|Overall Study|Ongoing|3|||
37870590|NCT01202591|69554728|FG000|Overall Study|Adverse Event|2|||
37870591|NCT01202591|69554729|FG001|Overall Study|Adverse Event|1|||
37870592|NCT01202591|69554730|FG002|Overall Study|Adverse Event|4|||
37870593|NCT01202591|69554731|FG003|Overall Study|Adverse Event|4|||
37870594|NCT01202591|69554732|FG004|Overall Study|Adverse Event|0|||
37870595|NCT01202591|69554733|FG005|Overall Study|Adverse Event|0|||
37870596|NCT01202591|69554728|FG000|Overall Study|Other reason as per investigator|3|||
37870597|NCT01202591|69554729|FG001|Overall Study|Other reason as per investigator|4|||
37870598|NCT01202591|69554730|FG002|Overall Study|Other reason as per investigator|7|||
37980523|NCT00332241|69667226|FG000|Overall Study|Lack of Efficacy|6|||
37980524|NCT00332241|69667227|FG001|Overall Study|Lack of Efficacy|1|||
37870599|NCT01202591|69554731|FG003|Overall Study|Other reason as per investigator|3|||
37870600|NCT01202591|69554732|FG004|Overall Study|Other reason as per investigator|1|||
37870601|NCT01202591|69554733|FG005|Overall Study|Other reason as per investigator|3|||
37870602|NCT01202591|69554728|FG000|Overall Study|Withdrawal by Subject|0|||
37870603|NCT01202591|69554729|FG001|Overall Study|Withdrawal by Subject|0|||
37870604|NCT01202591|69554730|FG002|Overall Study|Withdrawal by Subject|0|||
37870605|NCT01202591|69554731|FG003|Overall Study|Withdrawal by Subject|0|||
37980525|NCT00332241|69667226|FG000|Overall Study|Adverse Event|3|||
37870606|NCT01202591|69554732|FG004|Overall Study|Withdrawal by Subject|2|||
37980526|NCT00332241|69667227|FG001|Overall Study|Adverse Event|5|||
37870607|NCT01202591|69554733|FG005|Overall Study|Withdrawal by Subject|1|||
37870608|NCT01202591|69554728|FG000|Overall Study|Objective Disease Progression|0|||
37870609|NCT01202591|69554729|FG001|Overall Study|Objective Disease Progression|0|||
37870610|NCT01202591|69554730|FG002|Overall Study|Objective Disease Progression|0|||
37870611|NCT01202591|69554731|FG003|Overall Study|Objective Disease Progression|0|||
37870612|NCT01202591|69554732|FG004|Overall Study|Objective Disease Progression|2|||
37870613|NCT01202591|69554733|FG005|Overall Study|Objective Disease Progression|0|||
37870614|NCT01202279|69554749|FG000|Overall Study|Adverse Event|8|||
37870615|NCT01202279|69554750|FG001|Overall Study|Adverse Event|6|||
37870616|NCT01202279|69554749|FG000|Overall Study|Withdrawal by Subject|13|||
37870617|NCT01202279|69554750|FG001|Overall Study|Withdrawal by Subject|10|||
37870618|NCT01202279|69554749|FG000|Overall Study|Physician Decision|0|||
37870619|NCT01202279|69554750|FG001|Overall Study|Physician Decision|1|||
37870620|NCT01202279|69554749|FG000|Overall Study|Lost to Follow-up|10|||
37870621|NCT01202279|69554750|FG001|Overall Study|Lost to Follow-up|7|||
37870622|NCT01202279|69554749|FG000|Overall Study|Protocol Violation|1|||
37870623|NCT01202279|69554750|FG001|Overall Study|Protocol Violation|1|||
37870624|NCT01202279|69554749|FG000|Overall Study|study compliance|5|||
37870625|NCT01202279|69554750|FG001|Overall Study|study compliance|2|||
37870626|NCT01201967|69554758|FG000|Overall Study|Lost to Follow-up|6|||
37870627|NCT01201967|69554759|FG001|Overall Study|Lost to Follow-up|5|||
37870628|NCT01201811|69554775|FG000|Overall Study|Adverse Event|6|||
37870629|NCT01201811|69554775|FG000|Overall Study|Disease progression|3|||
37870630|NCT01201811|69554775|FG000|Overall Study|Withdrawal by Subject|3|||
37870631|NCT01201811|69554775|FG000|Overall Study|Death|4|||
37870632|NCT01201811|69554775|FG000|Overall Study|Treatment Failure|2|||
37870633|NCT01201811|69554775|FG000|Overall Study|Physician Decision|1|||
37870634|NCT01201343|69554779|FG000|Overall Study|Adverse Event|6|||
37870635|NCT01201343|69554779|FG000|Overall Study|Withdrawal by Subject|5|||
37870636|NCT01201343|69554779|FG000|Overall Study|Lost to Follow-up|2|||
37870637|NCT01201343|69554779|FG000|Overall Study|Lack of Efficacy|2|||
37870638|NCT01201343|69554779|FG000|Overall Study|Participant wrongly included in trial|1|||
37870639|NCT01201343|69554779|FG000|Overall Study|Randomized, not treated|3|||
37980527|NCT00332241|69667226|FG000|Overall Study|Withdrawal by Subject|2|||
37980528|NCT00332241|69667227|FG001|Overall Study|Withdrawal by Subject|1|||
37980529|NCT00332241|69667226|FG000|Overall Study|Lost to Follow-up|4|||
37816076|NCT03354663|69494701|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
37816077|NCT03354663|69494701|FG000|Completed 30-day Visit|Missed Visit|1|||
37816078|NCT03305419|69494717|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
37816079|NCT03305419|69494718|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
37816080|NCT03305419|69494719|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
37816081|NCT03305419|69494720|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
37816082|NCT03305419|69494721|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
37816083|NCT03305419|69494722|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
37816084|NCT03305419|69494723|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
37816085|NCT03305419|69494724|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
37816086|NCT03305419|69494717|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
37816087|NCT03305419|69494718|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
37870640|NCT01201265|69554783|FG000|Overall Study|Death|14|||
37816088|NCT03305419|69494719|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
37816089|NCT03305419|69494720|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
37870641|NCT01201265|69554783|FG000|Overall Study|Insufficient Therapeutic Response|3|||
37870642|NCT01201265|69554783|FG000|Overall Study|Lost to Follow-up|10|||
37870643|NCT01201265|69554783|FG000|Overall Study|Withdrawal by Subject|7|||
37870644|NCT01201265|69554783|FG000|Overall Study|Disease Progression|4|||
37870645|NCT04246801|69554789|FG000|Overall Study|Adverse Event|1|||
37870646|NCT04246801|69554790|FG001|Overall Study|Adverse Event|1|||
37870647|NCT04246801|69554789|FG000|Overall Study|Protocol Violation|1|||
37980530|NCT00332241|69667227|FG001|Overall Study|Lost to Follow-up|1|||
37870648|NCT04246801|69554790|FG001|Overall Study|Protocol Violation|1|||
37870649|NCT04246801|69554789|FG000|Overall Study|Lack of Efficacy|0|||
37870650|NCT04246801|69554790|FG001|Overall Study|Lack of Efficacy|2|||
37870651|NCT04246801|69554789|FG000|Overall Study|Lost to Follow-up|1|||
37870652|NCT04246801|69554790|FG001|Overall Study|Lost to Follow-up|1|||
37870653|NCT04246801|69554789|FG000|Overall Study|Withdrawal by Subject|2|||
37870654|NCT04246801|69554790|FG001|Overall Study|Withdrawal by Subject|1|||
37870655|NCT01200797|69554796|FG000|Overall Study|symptomatic deterioration|2|||
37870656|NCT01200797|69554796|FG000|Overall Study|Adverse Event|4|||
37870657|NCT01200797|69554796|FG000|Overall Study|Disease Progression|13|||
37870658|NCT01200485|69554801|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
37870659|NCT01200485|69554802|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
37870660|NCT01200485|69554803|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
37870661|NCT01200485|69554801|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
37870662|NCT01200485|69554802|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
37870663|NCT01200485|69554803|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
37870664|NCT01200407|69554810|FG000|Overall Study|Lost to Follow-up|56|||
37870665|NCT01200407|69554810|FG000|Overall Study|Adverse Event|3|||
37870666|NCT01200407|69554810|FG000|Overall Study|Withdrawal by Subject|4|||
37870667|NCT01200407|69554810|FG000|Overall Study|Other|19|||
37870668|NCT01200329|69554814|FG000|Overall Study|Lack of financial coverage|2|||
37870669|NCT01200329|69554814|FG000|Overall Study|Progressive disease|1|||
37870670|NCT01199939|69554818|FG000|Overall Study|Adverse Event|4|||
37870671|NCT01199939|69554818|FG000|Overall Study|Protocol Violation|3|||
37870672|NCT01199939|69554818|FG000|Overall Study|Lost to Follow-up|2|||
37980531|NCT00337935|69667235|FG000|Overall Study|Adverse Event|2|||
37980532|NCT00337935|69667236|FG001|Overall Study|Adverse Event|5|||
37980533|NCT00337935|69667235|FG000|Overall Study|Death|2|||
37980534|NCT00337935|69667236|FG001|Overall Study|Death|8|||
37980535|NCT00337935|69667235|FG000|Overall Study|Physician Decision|1|||
37980536|NCT00337935|69667236|FG001|Overall Study|Physician Decision|1|||
37980537|NCT00337935|69667235|FG000|Overall Study|Lost to Follow-up|0|||
37980538|NCT00337935|69667236|FG001|Overall Study|Lost to Follow-up|1|||
37980539|NCT00337935|69667235|FG000|Overall Study|Protocol Violation|4|||
37980540|NCT00337935|69667236|FG001|Overall Study|Protocol Violation|3|||
37980541|NCT00337935|69667235|FG000|Overall Study|Withdrawal by Subject|1|||
37980542|NCT00337935|69667236|FG001|Overall Study|Withdrawal by Subject|7|||
37980543|NCT00337935|69667235|FG000|Overall Study|Other|0|||
37980544|NCT00337935|69667236|FG001|Overall Study|Other|1|||
37980545|NCT00337935|69667235|FG000|Overall Study|Lack of Efficacy|0|||
37980546|NCT00337935|69667236|FG001|Overall Study|Lack of Efficacy|1|||
37980547|NCT00337779|69667245|FG000|Overall Study|Withdrawal by Subject|10|||
37980548|NCT00337779|69667246|FG001|Overall Study|Withdrawal by Subject|12|||
37980549|NCT00337779|69667245|FG000|Overall Study|Sponsor decision|1|||
37980550|NCT00337779|69667246|FG001|Overall Study|Sponsor decision|1|||
37980551|NCT00337779|69667245|FG000|Overall Study|Physician Decision|3|||
37816090|NCT03305419|69494721|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
37980552|NCT00337779|69667246|FG001|Overall Study|Physician Decision|6|||
37980553|NCT00337779|69667245|FG000|Overall Study|Protocol Violation|1|||
37980554|NCT00337779|69667246|FG001|Overall Study|Protocol Violation|1|||
37980555|NCT00337779|69667245|FG000|Overall Study|Lost to Follow-up|6|||
37980556|NCT00337779|69667246|FG001|Overall Study|Lost to Follow-up|5|||
37980557|NCT00337779|69667245|FG000|Overall Study|Adverse Event|28|||
37816091|NCT03305419|69494722|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
37816092|NCT03305419|69494723|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
37816093|NCT03305419|69494724|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
37816094|NCT03305419|69494717|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
37816095|NCT03305419|69494718|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
37816096|NCT03305419|69494719|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
37816097|NCT03305419|69494720|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
37816098|NCT03305419|69494721|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
37816099|NCT03305419|69494722|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
37816100|NCT03305419|69494723|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
37870673|NCT01199939|69554818|FG000|Overall Study|Reached a virologic endpoint|4|||
37870674|NCT01199861|69554824|FG000|Overall Study|Administrative problems|1|||
37870675|NCT01199861|69554825|FG001|Overall Study|Administrative problems|0|||
37980558|NCT00337779|69667246|FG001|Overall Study|Adverse Event|51|||
37980559|NCT00337779|69667245|FG000|Overall Study|Pregnancy|3|||
37980560|NCT00337779|69667246|FG001|Overall Study|Pregnancy|2|||
37980561|NCT00337779|69667245|FG000|Overall Study|Death|0|||
37980562|NCT00337779|69667246|FG001|Overall Study|Death|1|||
37870676|NCT01199861|69554824|FG000|Overall Study|Adverse Event|1|||
37980563|NCT00352755|69667252|FG000|Overall Study|Physician Decision|1|||
37980564|NCT00352755|69667252|FG000|Overall Study|Adverse Event|1|||
37980565|NCT00533897|69667259|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
37980566|NCT00533897|69667260|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
37980567|NCT00533897|69667261|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
37980568|NCT00533897|69667262|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
37980569|NCT00533897|69667263|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
37980570|NCT00533897|69667264|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
37980571|NCT00533897|69667265|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
37980572|NCT00533897|69667266|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
37980573|NCT00533897|69667259|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
37980574|NCT00533897|69667260|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
37980575|NCT00533897|69667261|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
37980576|NCT00533897|69667262|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
37980577|NCT00533897|69667263|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
37980578|NCT00533897|69667264|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
37980579|NCT00533897|69667265|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
37980580|NCT00533897|69667266|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
37980581|NCT00533897|69667259|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
37980582|NCT00533897|69667260|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
37980583|NCT00533897|69667261|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
37980584|NCT00533897|69667262|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
37980585|NCT00533897|69667263|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
37980586|NCT00533897|69667264|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
37980587|NCT00533897|69667265|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
37980588|NCT00533897|69667266|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
37980589|NCT00533897|69667259|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
37980590|NCT00533897|69667260|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
37980591|NCT00533897|69667261|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
37980592|NCT00533897|69667262|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
37980593|NCT00533897|69667263|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
37980594|NCT00533897|69667264|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
37980595|NCT00533897|69667265|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
37980596|NCT00533897|69667266|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
37980597|NCT00533897|69667259|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
37980598|NCT00533897|69667260|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
37980599|NCT00533897|69667261|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
37694876|NCT02409368|69171293|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
37694877|NCT02409368|69171294|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
37694878|NCT02409368|69171295|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
37694879|NCT02409368|69171296|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
37694880|NCT01853878|69171309|FG000|Overall Study|Recurrence|2|||
37694881|NCT01853878|69171310|FG001|Overall Study|Recurrence|0|||
37694882|NCT01853878|69171309|FG000|Overall Study|Adverse Event|2|||
37694883|NCT01853878|69171310|FG001|Overall Study|Adverse Event|0|||
37694884|NCT01853878|69171309|FG000|Overall Study|Withdrawal by Subject|3|||
37694885|NCT01853878|69171310|FG001|Overall Study|Withdrawal by Subject|1|||
37694886|NCT01853878|69171309|FG000|Overall Study|Migrated/moved from the study area|1|||
37980600|NCT00533897|69667262|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
37980601|NCT00533897|69667263|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
37694887|NCT01853878|69171310|FG001|Overall Study|Migrated/moved from the study area|0|||
37694888|NCT01853878|69171309|FG000|Overall Study|Other|55|||
37694889|NCT01853878|69171310|FG001|Overall Study|Other|43|||
37694890|NCT02342678|69171318|FG000|Overall Study|Lost to Follow-up|0|||
37694891|NCT02342678|69171319|FG001|Overall Study|Lost to Follow-up|1|||
37694892|NCT02342678|69171318|FG000|Overall Study|Too busy to complete study|0|||
37694893|NCT02342678|69171319|FG001|Overall Study|Too busy to complete study|2|||
37816101|NCT03305419|69494724|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
37816102|NCT03305419|69494717|FG000|Part B (14 Days)|Adverse Event|0|||
37816103|NCT03305419|69494718|FG001|Part B (14 Days)|Adverse Event|0|||
37816104|NCT03305419|69494719|FG002|Part B (14 Days)|Adverse Event|0|||
37816105|NCT03305419|69494720|FG003|Part B (14 Days)|Adverse Event|0|||
37980602|NCT00533897|69667264|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
37694894|NCT02342678|69171318|FG000|Overall Study|Family illness/emergency|0|||
37694895|NCT02342678|69171319|FG001|Overall Study|Family illness/emergency|1|||
37694896|NCT02342678|69171318|FG000|Overall Study|Illness/medical reason|1|||
37870677|NCT01199861|69554825|FG001|Overall Study|Adverse Event|0|||
37870678|NCT01199705|69554845|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
37870679|NCT01199471|69554860|FG000|Overall Study|Protocol Violation|4|||
37870680|NCT01199471|69554860|FG000|Overall Study|Withdrawal by Subject|1|||
37870681|NCT01199471|69554860|FG000|Overall Study|Physician Decision|1|||
37870682|NCT01198145|69554867|FG000|Overall Study|Withdrawal by Subject|1|||
37870683|NCT01198145|69554868|FG001|Overall Study|Withdrawal by Subject|1|||
37870684|NCT01197911|69554878|FG000|Overall Study|Adverse Event|0|||
37870685|NCT01197911|69554879|FG001|Overall Study|Adverse Event|0|||
37870686|NCT01197911|69554880|FG002|Overall Study|Adverse Event|1|||
37870687|NCT01197755|69554892|FG000|Overall Study|Adverse Event|8|||
37870688|NCT01197755|69554893|FG001|Overall Study|Adverse Event|10|||
37870689|NCT01197755|69554894|FG002|Overall Study|Adverse Event|10|||
37870690|NCT01197755|69554892|FG000|Overall Study|Study-specific discontinuation criteria|2|||
37870691|NCT01197755|69554893|FG001|Overall Study|Study-specific discontinuation criteria|1|||
37694897|NCT02342678|69171319|FG001|Overall Study|Illness/medical reason|1|||
37816106|NCT03305419|69494721|FG004|Part B (14 Days)|Adverse Event|1|||
37816107|NCT03305419|69494722|FG005|Part B (14 Days)|Adverse Event|2|||
37816108|NCT03305419|69494723|FG006|Part B (14 Days)|Adverse Event|4|||
37816109|NCT03305419|69494724|FG007|Part B (14 Days)|Adverse Event|0|||
37816110|NCT03305419|69494717|FG000|Part B (14 Days)|Physician Decision|0|||
37816111|NCT03305419|69494718|FG001|Part B (14 Days)|Physician Decision|0|||
37816112|NCT03305419|69494719|FG002|Part B (14 Days)|Physician Decision|0|||
37816113|NCT03305419|69494720|FG003|Part B (14 Days)|Physician Decision|0|||
37816114|NCT03305419|69494721|FG004|Part B (14 Days)|Physician Decision|2|||
37816115|NCT03305419|69494722|FG005|Part B (14 Days)|Physician Decision|8|||
37816116|NCT03305419|69494723|FG006|Part B (14 Days)|Physician Decision|1|||
37816117|NCT03305419|69494724|FG007|Part B (14 Days)|Physician Decision|0|||
37816118|NCT03277105|69494749|FG000|Overall Study|Death|77|||
37816119|NCT03277105|69494750|FG001|Overall Study|Death|73|||
37816120|NCT03277105|69494749|FG000|Overall Study|Lost to Follow-up|0|||
37816121|NCT03277105|69494750|FG001|Overall Study|Lost to Follow-up|3|||
37816122|NCT03277105|69494749|FG000|Overall Study|Withdrawal by Subject|10|||
37816123|NCT03277105|69494750|FG001|Overall Study|Withdrawal by Subject|9|||
37816124|NCT03277105|69494749|FG000|Overall Study|Other|1|||
37816125|NCT03277105|69494750|FG001|Overall Study|Other|3|||
37816126|NCT03277105|69494749|FG000|Overall Study|Ongoing|171|||
37816127|NCT03277105|69494750|FG001|Overall Study|Ongoing|175|||
37816128|NCT03096782|69494776|FG000|Overall Study|Death|1|||
37816129|NCT03096782|69494776|FG000|Overall Study|Participant Relapsed|1|||
37816130|NCT03052049|69494787|FG000|Overall Study|Withdrawal by Subject|2|||
37816131|NCT03019536|69494807|FG000|Overall Study|Withdrawal by Subject|1|||
37816132|NCT03019536|69494808|FG001|Overall Study|Withdrawal by Subject|1|||
37816133|NCT03019536|69494809|FG002|Overall Study|Withdrawal by Subject|0|||
37816134|NCT03019536|69494807|FG000|Overall Study|Adverse Event|0|||
37816135|NCT03019536|69494808|FG001|Overall Study|Adverse Event|0|||
37816136|NCT03019536|69494809|FG002|Overall Study|Adverse Event|2|||
37816137|NCT02838420|69494821|FG000|Overall Study|Ongoing in Study|113|||
37816138|NCT02838420|69494822|FG001|Overall Study|Ongoing in Study|45|||
37816139|NCT02838420|69494821|FG000|Overall Study|Lost to Follow-up|1|||
37816140|NCT02838420|69494822|FG001|Overall Study|Lost to Follow-up|0|||
37816141|NCT02838420|69494821|FG000|Overall Study|Withdrawal by Subject|3|||
37816142|NCT02838420|69494822|FG001|Overall Study|Withdrawal by Subject|4|||
37816143|NCT02838420|69494821|FG000|Overall Study|Death|8|||
37816144|NCT02838420|69494822|FG001|Overall Study|Death|13|||
37816145|NCT02673775|69494828|FG000|Washout (at Least 2 Weeks)|Lost to Follow-up|1|||
37816146|NCT02673775|69494829|FG001|Washout (at Least 2 Weeks)|Lost to Follow-up|0|||
37816147|NCT02673775|69494828|FG000|Washout (at Least 2 Weeks)|Physician Decision|1|||
37816148|NCT02673775|69494829|FG001|Washout (at Least 2 Weeks)|Physician Decision|0|||
37816149|NCT02673775|69494828|FG000|Washout (at Least 2 Weeks)|Withdrawal by Subject|0|||
37816150|NCT02673775|69494829|FG001|Washout (at Least 2 Weeks)|Withdrawal by Subject|2|||
37870692|NCT01197755|69554894|FG002|Overall Study|Study-specific discontinuation criteria|0|||
37980603|NCT00533897|69667265|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
37980604|NCT00533897|69667266|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
37870693|NCT01197755|69554892|FG000|Overall Study|Entered the long-term extension study|18|||
37870694|NCT01197755|69554893|FG001|Overall Study|Entered the long-term extension study|21|||
37870695|NCT01197755|69554894|FG002|Overall Study|Entered the long-term extension study|35|||
37870696|NCT01197755|69554892|FG000|Overall Study|Lack of therapeutic response|0|||
37870697|NCT01197755|69554893|FG001|Overall Study|Lack of therapeutic response|7|||
37870698|NCT01197755|69554894|FG002|Overall Study|Lack of therapeutic response|4|||
37870699|NCT01197755|69554892|FG000|Overall Study|Severe non-compliance to the protocol|2|||
37870700|NCT01197755|69554893|FG001|Overall Study|Severe non-compliance to the protocol|1|||
37870701|NCT01197755|69554894|FG002|Overall Study|Severe non-compliance to the protocol|2|||
37870702|NCT01197755|69554892|FG000|Overall Study|Withdrawal by Subject|1|||
37870703|NCT01197755|69554893|FG001|Overall Study|Withdrawal by Subject|0|||
37870704|NCT01197755|69554894|FG002|Overall Study|Withdrawal by Subject|0|||
37870705|NCT01197755|69554892|FG000|Overall Study|Lost to Follow-up|0|||
37870706|NCT01197755|69554893|FG001|Overall Study|Lost to Follow-up|0|||
37870707|NCT01197755|69554894|FG002|Overall Study|Lost to Follow-up|1|||
37870708|NCT01197755|69554892|FG000|Overall Study|eg, change in circumstances|7|||
37870709|NCT01197755|69554893|FG001|Overall Study|eg, change in circumstances|3|||
37870710|NCT01197755|69554894|FG002|Overall Study|eg, change in circumstances|2|||
37870711|NCT01179048|69554906|FG000|Overall Study|Withdrawn - does not allow contact|4|||
37870712|NCT01179048|69554907|FG001|Overall Study|Withdrawn - does not allow contact|8|||
37870713|NCT01179048|69554906|FG000|Overall Study|Lost to Follow-up|8|||
37870714|NCT01179048|69554907|FG001|Overall Study|Lost to Follow-up|9|||
37870715|NCT01179048|69554906|FG000|Overall Study|Alive|127|||
37870716|NCT01179048|69554907|FG001|Overall Study|Alive|142|||
37870717|NCT00603265|69554916|FG000|Overall Study|Adverse Event|2|||
37870718|NCT00603265|69554917|FG001|Overall Study|Adverse Event|11|||
37870719|NCT00603265|69554918|FG002|Overall Study|Adverse Event|1|||
37870720|NCT00603265|69554916|FG000|Overall Study|Withdrawal by Subject|1|||
37870721|NCT00603265|69554917|FG001|Overall Study|Withdrawal by Subject|2|||
37870722|NCT00603265|69554918|FG002|Overall Study|Withdrawal by Subject|1|||
37870723|NCT00603265|69554916|FG000|Overall Study|Lack of Efficacy|3|||
37870724|NCT00603265|69554917|FG001|Overall Study|Lack of Efficacy|0|||
37870725|NCT00603265|69554918|FG002|Overall Study|Lack of Efficacy|3|||
37870726|NCT00603265|69554916|FG000|Overall Study|Lost to Follow-up|0|||
37870727|NCT00603265|69554917|FG001|Overall Study|Lost to Follow-up|1|||
37870728|NCT00603265|69554918|FG002|Overall Study|Lost to Follow-up|0|||
37870729|NCT00603265|69554916|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
37870730|NCT00603265|69554917|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
37870731|NCT00603265|69554918|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
37870732|NCT00603265|69554916|FG000|Overall Study|Participant Left Country, No Responses|0|||
37870733|NCT00603265|69554917|FG001|Overall Study|Participant Left Country, No Responses|1|||
37870734|NCT00603265|69554918|FG002|Overall Study|Participant Left Country, No Responses|0|||
37870735|NCT00603265|69554916|FG000|Overall Study|Protocol Violation|1|||
37870736|NCT00603265|69554917|FG001|Overall Study|Protocol Violation|0|||
37870737|NCT00603265|69554918|FG002|Overall Study|Protocol Violation|0|||
37870738|NCT04010227|69554928|FG000|Overall Study|Death|1|||
37870739|NCT04010227|69554929|FG001|Overall Study|Death|2|||
37870740|NCT04010227|69554928|FG000|Overall Study|Medical Reasons|4|||
37870741|NCT04010227|69554929|FG001|Overall Study|Medical Reasons|3|||
37980605|NCT00533897|69667259|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
37870742|NCT04010227|69554928|FG000|Overall Study|Withdrawal by Subject|2|||
37870743|NCT04010227|69554929|FG001|Overall Study|Withdrawal by Subject|0|||
37870744|NCT04010227|69554928|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
37870745|NCT04010227|69554929|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
37870746|NCT01158534|69554936|FG000|Overall Study|Withdrawal by Subject|1|||
37870747|NCT01158534|69554936|FG000|Overall Study|Death|1|||
37870748|NCT01158534|69554936|FG000|Overall Study|Other|1|||
37870749|NCT01158378|69554942|FG000|Overall Study|Death|4|||
37870750|NCT01158378|69554943|FG001|Overall Study|Death|5|||
37816151|NCT02673775|69494828|FG000|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
37870751|NCT01158378|69554942|FG000|Overall Study|Lost to Follow-up|2|||
37870752|NCT01158378|69554943|FG001|Overall Study|Lost to Follow-up|4|||
37870753|NCT01158378|69554942|FG000|Overall Study|Withdrawal by Subject|4|||
37870754|NCT01158378|69554943|FG001|Overall Study|Withdrawal by Subject|0|||
37870755|NCT01158222|69554950|FG000|Overall Study|Not eligible for intermediate phase|17|||
37870756|NCT01197521|69554957|FG000|Overall Study|Not reported|24|||
37870757|NCT01197521|69554958|FG001|Overall Study|Not reported|25|||
37870758|NCT01197521|69554959|FG002|Overall Study|Not reported|21|||
37816152|NCT02673775|69494829|FG001|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
37816153|NCT02666768|69494835|FG000|Overall Study|Withdrawal by Subject|4|||
37816154|NCT02618408|69494865|FG000|Overall Study|Withdrawal by Subject|1|||
37870759|NCT01197521|69554957|FG000|Overall Study|Enrolment in long term extension|42|||
37870760|NCT01197521|69554958|FG001|Overall Study|Enrolment in long term extension|36|||
37870761|NCT01197521|69554959|FG002|Overall Study|Enrolment in long term extension|87|||
37870762|NCT01197521|69554957|FG000|Overall Study|Severe non-compliance to protocol|1|||
37870763|NCT01197521|69554958|FG001|Overall Study|Severe non-compliance to protocol|3|||
37870764|NCT01197521|69554959|FG002|Overall Study|Severe non-compliance to protocol|3|||
37870765|NCT01197521|69554957|FG000|Overall Study|Lack of therapeutic response|2|||
37870766|NCT01197521|69554958|FG001|Overall Study|Lack of therapeutic response|3|||
37870767|NCT01197521|69554959|FG002|Overall Study|Lack of therapeutic response|4|||
37870768|NCT01197521|69554957|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
37870769|NCT01197521|69554958|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
37870770|NCT01197521|69554959|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
37870771|NCT01197521|69554957|FG000|Overall Study|Lost to Follow-up|3|||
37816155|NCT02618408|69494866|FG001|Overall Study|Withdrawal by Subject|0|||
37816156|NCT02618408|69494867|FG002|Overall Study|Withdrawal by Subject|4|||
37816157|NCT02618408|69494865|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
37816158|NCT02618408|69494866|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
37816159|NCT02618408|69494867|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
37816160|NCT02618408|69494865|FG000|Overall Study|Lost to Follow-up|4|||
37870772|NCT01197521|69554958|FG001|Overall Study|Lost to Follow-up|2|||
37870773|NCT01197521|69554959|FG002|Overall Study|Lost to Follow-up|2|||
37870774|NCT01197521|69554957|FG000|Overall Study|Adverse Event|25|||
37870775|NCT01197521|69554958|FG001|Overall Study|Adverse Event|28|||
37870776|NCT01197521|69554959|FG002|Overall Study|Adverse Event|24|||
37870777|NCT01157676|69554972|FG000|Randomization|Death|1|||
37870778|NCT01157676|69554973|FG001|Randomization|Death|1|||
37870779|NCT01157676|69554972|FG000|Randomization|unresectable|2|||
37870780|NCT01157676|69554973|FG001|Randomization|unresectable|3|||
37870781|NCT01157676|69554972|FG000|Randomization|Withdrawal by Subject|17|||
37870782|NCT01157676|69554973|FG001|Randomization|Withdrawal by Subject|13|||
37870783|NCT01157676|69554972|FG000|Randomization|Physician Decision|1|||
37870784|NCT01157676|69554973|FG001|Randomization|Physician Decision|0|||
37870785|NCT01157676|69554972|FG000|Surgery|underwent open cystectomy|0|||
37870786|NCT01157676|69554973|FG001|Surgery|underwent open cystectomy|4|||
37870787|NCT01157676|69554972|FG000|Surgery|converted to open procedure|0|||
37870788|NCT01157676|69554973|FG001|Surgery|converted to open procedure|5|||
37870789|NCT01157676|69554972|FG000|Surgery|underwent robotic cystectomy|1|||
37870790|NCT01157676|69554973|FG001|Surgery|underwent robotic cystectomy|0|||
37870791|NCT00991341|69554987|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
37870792|NCT00991341|69554988|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
37870793|NCT00991341|69554987|FG000|Overall Study|Death|3|||
37870794|NCT00991341|69554988|FG001|Overall Study|Death|0|||
37870795|NCT00991341|69554987|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
37870796|NCT00991341|69554988|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
37870797|NCT00991341|69554987|FG000|Overall Study|Physician Decision|1|||
37870798|NCT00991341|69554988|FG001|Overall Study|Physician Decision|2|||
37870799|NCT00991341|69554987|FG000|Overall Study|Withdrawal by Subject|3|||
37870800|NCT00991341|69554988|FG001|Overall Study|Withdrawal by Subject|4|||
37870801|NCT00990249|69554994|FG000|Overall Study|Disease Progression|8|||
37870802|NCT00990249|69554994|FG000|Overall Study|Non-Compliance|1|||
37870803|NCT00990249|69554994|FG000|Overall Study|Death|2|||
37870804|NCT00990249|69554994|FG000|Overall Study|Not treated|2|||
37870805|NCT02846545|69555000|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
37870806|NCT02846545|69555001|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
37870807|NCT02846545|69555000|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
37870808|NCT02846545|69555001|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
37870809|NCT02846545|69555000|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
37870810|NCT02846545|69555001|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
37870811|NCT02846545|69555000|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
37870812|NCT02846545|69555001|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
37870813|NCT02846545|69555000|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
37870814|NCT02846545|69555001|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
37870815|NCT00990093|69555011|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
37870816|NCT00990093|69555012|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
37870817|NCT00990093|69555011|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
37870818|NCT00990093|69555012|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
37870819|NCT00990093|69555011|FG000|Test Period 1 (1-14 Days)|Other|1|||
37870820|NCT00990093|69555012|FG001|Test Period 1 (1-14 Days)|Other|0|||
37870821|NCT00990093|69555011|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
37870822|NCT00990093|69555012|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
37816161|NCT02618408|69494866|FG001|Overall Study|Lost to Follow-up|2|||
37816162|NCT02618408|69494867|FG002|Overall Study|Lost to Follow-up|6|||
37816163|NCT02618408|69494865|FG000|Overall Study|Adverse Event|4|||
37816164|NCT02618408|69494866|FG001|Overall Study|Adverse Event|0|||
37816165|NCT02618408|69494867|FG002|Overall Study|Adverse Event|10|||
37816166|NCT02618408|69494865|FG000|Overall Study|Physician Decision|1|||
37816167|NCT02618408|69494866|FG001|Overall Study|Physician Decision|1|||
37870823|NCT00990093|69555011|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
37870824|NCT00990093|69555012|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
37870825|NCT00990093|69555011|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
37870826|NCT00990093|69555012|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
37870827|NCT00990093|69555011|FG000|Test Period 2 (15-28 Days)|Other|0|||
37816168|NCT02618408|69494867|FG002|Overall Study|Physician Decision|2|||
37870828|NCT00990093|69555012|FG001|Test Period 2 (15-28 Days)|Other|1|||
37816169|NCT02618408|69494865|FG000|Overall Study|Protocol Violation|1|||
37816170|NCT02618408|69494866|FG001|Overall Study|Protocol Violation|1|||
37870829|NCT00984165|69555022|FG000|Overall Study|Death on study|2|||
37870830|NCT00984165|69555023|FG001|Overall Study|Death on study|0|||
37870831|NCT00984165|69555024|FG002|Overall Study|Death on study|0|||
37870832|NCT00984165|69555025|FG003|Overall Study|Death on study|0|||
37870833|NCT00984165|69555022|FG000|Overall Study|Disease progression on study|5|||
37870834|NCT00984165|69555023|FG001|Overall Study|Disease progression on study|1|||
37870835|NCT00984165|69555024|FG002|Overall Study|Disease progression on study|0|||
37870836|NCT00984165|69555025|FG003|Overall Study|Disease progression on study|0|||
37870837|NCT00984165|69555022|FG000|Overall Study|Death of recipient|0|||
37870838|NCT00984165|69555023|FG001|Overall Study|Death of recipient|0|||
37870839|NCT00984165|69555024|FG002|Overall Study|Death of recipient|0|||
37870840|NCT00984165|69555025|FG003|Overall Study|Death of recipient|1|||
37870841|NCT00984165|69555022|FG000|Overall Study|New protocol|0|||
37870842|NCT00984165|69555023|FG001|Overall Study|New protocol|0|||
37870843|NCT00984165|69555024|FG002|Overall Study|New protocol|0|||
37870844|NCT00984165|69555025|FG003|Overall Study|New protocol|1|||
37870845|NCT00984165|69555022|FG000|Overall Study|P+/donor pair removed from protocol|0|||
37816171|NCT02618408|69494867|FG002|Overall Study|Protocol Violation|2|||
37816172|NCT02618408|69494865|FG000|Overall Study|Other, Multiple Categories|0|||
37816173|NCT02618408|69494866|FG001|Overall Study|Other, Multiple Categories|0|||
37816174|NCT02618408|69494867|FG002|Overall Study|Other, Multiple Categories|4|||
37816175|NCT02471144|69494891|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
37816176|NCT02471144|69494892|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
37816177|NCT02471144|69494893|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
37816178|NCT02471144|69494894|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
37816179|NCT02471144|69494895|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
37816180|NCT02471144|69494896|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
37816181|NCT02471144|69494897|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
37816182|NCT02471144|69494898|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
37816183|NCT02471144|69494899|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
37816184|NCT02471144|69494900|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
37816185|NCT02471144|69494901|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
37816186|NCT02471144|69494891|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
37816187|NCT02471144|69494892|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
37816188|NCT02471144|69494893|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
37816189|NCT02471144|69494894|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
37816190|NCT02471144|69494895|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
37816191|NCT02471144|69494896|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
37816192|NCT02471144|69494897|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
37816193|NCT02471144|69494898|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
37816194|NCT02471144|69494899|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
37816195|NCT02471144|69494900|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
37816196|NCT02471144|69494901|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
37870846|NCT00984165|69555023|FG001|Overall Study|P+/donor pair removed from protocol|0|||
37870847|NCT00984165|69555024|FG002|Overall Study|P+/donor pair removed from protocol|0|||
37816197|NCT02471144|69494891|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
37816198|NCT02471144|69494892|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
37816199|NCT02471144|69494893|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
37870848|NCT00984165|69555025|FG003|Overall Study|P+/donor pair removed from protocol|1|||
37870849|NCT00984165|69555022|FG000|Overall Study|removed with a pair recipient|0|||
37870850|NCT00984165|69555023|FG001|Overall Study|removed with a pair recipient|0|||
37870851|NCT00984165|69555024|FG002|Overall Study|removed with a pair recipient|0|||
37870852|NCT00984165|69555025|FG003|Overall Study|removed with a pair recipient|1|||
37870853|NCT00993291|69555036|FG000|Overall Study|Withdrawal by Subject|1|||
37870854|NCT01196975|69555045|FG000|Overall Study|Adverse Event|2|||
37870855|NCT01196975|69555046|FG001|Overall Study|Adverse Event|2|||
37870856|NCT01196975|69555047|FG002|Overall Study|Adverse Event|0|||
37870857|NCT01196975|69555048|FG003|Overall Study|Adverse Event|0|||
37870858|NCT01196975|69555049|FG004|Overall Study|Adverse Event|2|||
37870859|NCT01196975|69555045|FG000|Overall Study|Withdrawal by Subject|2|||
37870860|NCT01196975|69555046|FG001|Overall Study|Withdrawal by Subject|1|||
37870861|NCT01196975|69555047|FG002|Overall Study|Withdrawal by Subject|0|||
37870862|NCT01196975|69555048|FG003|Overall Study|Withdrawal by Subject|1|||
37870863|NCT01196975|69555049|FG004|Overall Study|Withdrawal by Subject|0|||
37816200|NCT02471144|69494894|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
37816201|NCT02471144|69494895|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
37816202|NCT02471144|69494896|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
37870864|NCT01196975|69555045|FG000|Overall Study|Lost to Follow-up|11|||
37870865|NCT01196975|69555046|FG001|Overall Study|Lost to Follow-up|6|||
37870866|NCT01196975|69555047|FG002|Overall Study|Lost to Follow-up|5|||
37980606|NCT00533897|69667260|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
37980607|NCT00533897|69667261|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
37980608|NCT00533897|69667262|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
37980609|NCT00533897|69667263|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
37980610|NCT00533897|69667264|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
37980611|NCT00533897|69667265|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
37980612|NCT00533897|69667266|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
37980613|NCT00533897|69667259|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
37980614|NCT00533897|69667260|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
37980615|NCT00533897|69667261|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
37816203|NCT02471144|69494897|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
37816204|NCT02471144|69494898|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
37816205|NCT02471144|69494899|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
37816206|NCT02471144|69494900|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
37870867|NCT01196975|69555048|FG003|Overall Study|Lost to Follow-up|5|||
37870868|NCT01196975|69555049|FG004|Overall Study|Lost to Follow-up|11|||
37870869|NCT00992589|69555084|FG000|Open-Label Phase|Adverse Event|4|||
37870870|NCT00992589|69555085|FG001|Open-Label Phase|Adverse Event|0|||
37870871|NCT00992589|69555086|FG002|Open-Label Phase|Adverse Event|0|||
37870872|NCT00992589|69555087|FG003|Open-Label Phase|Adverse Event|0|||
37870873|NCT00992589|69555084|FG000|Open-Label Phase|Withdrawal by Subject|20|||
37870874|NCT00992589|69555085|FG001|Open-Label Phase|Withdrawal by Subject|0|||
37694898|NCT02342288|69171327|FG000|Overall Study|no protocol anesthesiologist available|3|||
37694899|NCT02342288|69171328|FG001|Overall Study|no protocol anesthesiologist available|2|||
37816207|NCT02471144|69494901|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
37816208|NCT02471144|69494891|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
37816209|NCT02471144|69494892|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
37816210|NCT02471144|69494893|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
37816211|NCT02471144|69494894|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
37816212|NCT02471144|69494895|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
37816213|NCT02471144|69494896|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
37816214|NCT02471144|69494897|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
37816215|NCT02471144|69494898|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
37816216|NCT02471144|69494899|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
37816217|NCT02471144|69494900|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
37816218|NCT02471144|69494901|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
37816219|NCT02471144|69494891|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
37816220|NCT02471144|69494892|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
37694900|NCT02342288|69171327|FG000|Overall Study|anesthesia leak in system|1|||
37694901|NCT02342288|69171328|FG001|Overall Study|anesthesia leak in system|0|||
37694902|NCT02342288|69171327|FG000|Overall Study|Withdrawal by Subject|1|||
37694903|NCT02342288|69171328|FG001|Overall Study|Withdrawal by Subject|0|||
37694904|NCT02342288|69171327|FG000|Overall Study|coordinator contaminated with blood|0|||
37694905|NCT02342288|69171328|FG001|Overall Study|coordinator contaminated with blood|1|||
37694906|NCT02342288|69171327|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
37694907|NCT02342288|69171328|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
37694908|NCT02342288|69171327|FG000|Overall Study|coordinator not available|0|||
37694909|NCT02342288|69171328|FG001|Overall Study|coordinator not available|2|||
37694910|NCT01853644|69171334|FG000|Registration and Treatment Start|Did not start treatment|1|||
37694911|NCT01853644|69171334|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
37816221|NCT02471144|69494893|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
37816222|NCT02471144|69494894|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
37816223|NCT02471144|69494895|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
37816224|NCT02471144|69494896|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
37816225|NCT02471144|69494897|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
37816226|NCT02471144|69494898|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
37816227|NCT02471144|69494899|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
37816228|NCT02471144|69494900|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
37816229|NCT02471144|69494901|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
37870875|NCT00992589|69555086|FG002|Open-Label Phase|Withdrawal by Subject|0|||
37870876|NCT00992589|69555087|FG003|Open-Label Phase|Withdrawal by Subject|0|||
37870877|NCT00992589|69555084|FG000|Open-Label Phase|Lost to Follow-up|1|||
37870878|NCT00992589|69555085|FG001|Open-Label Phase|Lost to Follow-up|0|||
37816230|NCT02471144|69494891|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
37870879|NCT00992589|69555086|FG002|Open-Label Phase|Lost to Follow-up|0|||
37816231|NCT02471144|69494892|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
37816232|NCT02471144|69494893|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
37816233|NCT02471144|69494894|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
37816234|NCT02471144|69494895|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
37816235|NCT02471144|69494896|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
37816236|NCT02471144|69494897|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
37816237|NCT02471144|69494898|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
37816238|NCT02471144|69494899|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
37816239|NCT02471144|69494900|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
37816240|NCT02471144|69494901|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
37980616|NCT00533897|69667262|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
37980617|NCT00533897|69667263|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
37980618|NCT00533897|69667264|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
37980619|NCT00533897|69667265|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
37816241|NCT02471144|69494891|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
37816242|NCT02471144|69494892|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
37816243|NCT02471144|69494893|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
37816244|NCT02471144|69494894|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
37816245|NCT02471144|69494895|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
37816246|NCT02471144|69494896|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
37816247|NCT02471144|69494897|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
37816248|NCT02471144|69494898|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
37816249|NCT02471144|69494899|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
37816250|NCT02471144|69494900|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
37816251|NCT02471144|69494901|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
37816252|NCT02471144|69494891|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
37816253|NCT02471144|69494892|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
37980620|NCT00533897|69667266|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
37980621|NCT00533897|69667259|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
37980622|NCT00533897|69667260|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
37980623|NCT00533897|69667261|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
37980624|NCT00533897|69667262|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
37980625|NCT00533897|69667263|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
37980626|NCT00533897|69667264|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
37980627|NCT00533897|69667265|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
37980628|NCT00533897|69667266|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
37980629|NCT00533897|69667259|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
37980630|NCT00533897|69667260|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
37980631|NCT00533897|69667261|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
37980632|NCT00533897|69667262|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
37980633|NCT00533897|69667263|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
37980634|NCT00533897|69667264|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
37980635|NCT00533897|69667265|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
37816254|NCT02471144|69494893|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
37816255|NCT02471144|69494894|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
37816256|NCT02471144|69494895|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
37816257|NCT02471144|69494896|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
37816258|NCT02471144|69494897|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
37980636|NCT00533897|69667266|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
37980637|NCT00533897|69667259|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
37980638|NCT00533897|69667260|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
37870880|NCT00992589|69555087|FG003|Open-Label Phase|Lost to Follow-up|0|||
37870881|NCT00992589|69555084|FG000|Open-Label Phase|Protocol Violation|3|||
37870882|NCT00992589|69555085|FG001|Open-Label Phase|Protocol Violation|0|||
37870883|NCT00992589|69555086|FG002|Open-Label Phase|Protocol Violation|0|||
37870884|NCT00992589|69555087|FG003|Open-Label Phase|Protocol Violation|0|||
37870885|NCT00992589|69555084|FG000|Open-Label Phase|Physician Decision|4|||
37870886|NCT00992589|69555085|FG001|Open-Label Phase|Physician Decision|0|||
37870887|NCT00992589|69555086|FG002|Open-Label Phase|Physician Decision|0|||
37870888|NCT00992589|69555087|FG003|Open-Label Phase|Physician Decision|0|||
37870889|NCT00992589|69555084|FG000|Open-Label Phase|Other|45|||
37870890|NCT00992589|69555085|FG001|Open-Label Phase|Other|0|||
37870891|NCT00992589|69555086|FG002|Open-Label Phase|Other|0|||
37870892|NCT00992589|69555087|FG003|Open-Label Phase|Other|0|||
37870893|NCT00992589|69555084|FG000|Double-Blind Phase|Adverse Event|0|||
37870894|NCT00992589|69555085|FG001|Double-Blind Phase|Adverse Event|6|||
37870895|NCT00992589|69555086|FG002|Double-Blind Phase|Adverse Event|2|||
37870896|NCT00992589|69555087|FG003|Double-Blind Phase|Adverse Event|3|||
37870897|NCT00992589|69555084|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
37870898|NCT00992589|69555085|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
37870899|NCT00992589|69555086|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
37870900|NCT00992589|69555087|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
37870901|NCT00992589|69555084|FG000|Double-Blind Phase|Lost to Follow-up|0|||
37870902|NCT00992589|69555085|FG001|Double-Blind Phase|Lost to Follow-up|0|||
37870903|NCT00992589|69555086|FG002|Double-Blind Phase|Lost to Follow-up|0|||
37870904|NCT00992589|69555087|FG003|Double-Blind Phase|Lost to Follow-up|2|||
37870905|NCT00992589|69555084|FG000|Double-Blind Phase|Other|0|||
37870906|NCT00992589|69555085|FG001|Double-Blind Phase|Other|1|||
37870907|NCT00992589|69555086|FG002|Double-Blind Phase|Other|6|||
37870908|NCT00992589|69555087|FG003|Double-Blind Phase|Other|3|||
37870909|NCT01196741|69555107|FG000|Overall Study|Disease progression|34|||
37870910|NCT01196741|69555108|FG001|Overall Study|Disease progression|14|||
37870911|NCT01196741|69555107|FG000|Overall Study|Adverse Event|10|||
37870912|NCT01196741|69555108|FG001|Overall Study|Adverse Event|6|||
37870913|NCT01196741|69555107|FG000|Overall Study|Serious Adverse Event|3|||
37870914|NCT01196741|69555108|FG001|Overall Study|Serious Adverse Event|1|||
37870915|NCT01196741|69555107|FG000|Overall Study|Dose limiting Adverse Event|2|||
37870916|NCT01196741|69555108|FG001|Overall Study|Dose limiting Adverse Event|1|||
37870917|NCT01196741|69555107|FG000|Overall Study|Withdrawal by Subject|3|||
37870918|NCT01196741|69555108|FG001|Overall Study|Withdrawal by Subject|0|||
37870919|NCT01196741|69555107|FG000|Overall Study|Other reason|3|||
37870920|NCT01196741|69555108|FG001|Overall Study|Other reason|3|||
37870921|NCT01196741|69555107|FG000|Overall Study|Other|3|||
37694912|NCT01853644|69171334|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
37694913|NCT01853644|69171334|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
37694914|NCT01853644|69171334|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
37694915|NCT01853644|69171334|FG000|Continued Treatment After First Response|Adverse Event|2|||
37694916|NCT01853644|69171334|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
37694917|NCT02374346|69171338|FG000|Overall Study|operated or discharged during weekend|48|||
37694918|NCT01853254|69171344|FG000|Overall Study|Abnormal Laboratory Test|1|||
37694919|NCT01853254|69171344|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
37694920|NCT01853254|69171344|FG000|Overall Study|Death|1|||
37694921|NCT01853254|69171344|FG000|Overall Study|Failure to Return|43|||
37816259|NCT02471144|69494898|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
37816260|NCT02471144|69494899|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
37816261|NCT02471144|69494900|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
37816262|NCT02471144|69494901|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
37816263|NCT02471144|69494891|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
37816264|NCT02471144|69494892|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
37816265|NCT02471144|69494893|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
37816266|NCT02471144|69494894|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
37816267|NCT02471144|69494895|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
37816268|NCT02471144|69494896|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
37870922|NCT01196741|69555108|FG001|Overall Study|Other|2|||
37870923|NCT01196741|69555107|FG000|Overall Study|Protocol Violation|2|||
37870924|NCT01196741|69555108|FG001|Overall Study|Protocol Violation|1|||
37870925|NCT00983385|69555114|FG000|Observation Period|Not eligible to be dosed|20|||
37870926|NCT00983385|69555114|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
37870927|NCT00992511|69555137|FG000|Overall Study|Migrated/moved from study area|1|||
37870928|NCT00992511|69555138|FG001|Overall Study|Migrated/moved from study area|0|||
37870929|NCT00992511|69555139|FG002|Overall Study|Migrated/moved from study area|1|||
37980639|NCT00533897|69667261|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
37980640|NCT00533897|69667262|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
37980641|NCT00533897|69667263|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
37980642|NCT00533897|69667264|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
37980643|NCT00533897|69667265|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
37980644|NCT00533897|69667266|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
37980645|NCT00533897|69667259|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
37694922|NCT01853254|69171344|FG000|Overall Study|Insufficient Therapeutic Response|22|||
37694923|NCT01853254|69171344|FG000|Overall Study|Refusal of Treatment|1|||
37694924|NCT01853254|69171344|FG000|Overall Study|Other Protocol Violation|1|||
37694925|NCT01853254|69171344|FG000|Overall Study|Withdrawal of Consent|16|||
37694926|NCT01853254|69171344|FG000|Overall Study|Administrative/Other|16|||
37694927|NCT02373098|69171350|FG000|Overall Study|Lost to Follow-up|1|||
37694928|NCT02373098|69171351|FG001|Overall Study|Lost to Follow-up|0|||
37694929|NCT02373098|69171350|FG000|Overall Study|Protocol Violation|3|||
37694930|NCT02373098|69171351|FG001|Overall Study|Protocol Violation|0|||
37694931|NCT02373098|69171350|FG000|Overall Study|Withdrawal by Subject|5|||
37694932|NCT02373098|69171351|FG001|Overall Study|Withdrawal by Subject|0|||
37694933|NCT02373098|69171350|FG000|Overall Study|Adverse Event|3|||
37980646|NCT00533897|69667260|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
37980647|NCT00533897|69667261|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
37694934|NCT02373098|69171351|FG001|Overall Study|Adverse Event|0|||
37694935|NCT01853176|69171365|FG000|Overall Study|Study terminated|4|||
37694936|NCT01853176|69171366|FG001|Overall Study|Study terminated|0|||
37816269|NCT02471144|69494897|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
37816270|NCT02471144|69494898|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
37816271|NCT02471144|69494899|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
37870930|NCT00992511|69555140|FG003|Overall Study|Migrated/moved from study area|2|||
37870931|NCT00992511|69555137|FG000|Overall Study|Lost to Follow-up|1|||
37870932|NCT00992511|69555138|FG001|Overall Study|Lost to Follow-up|0|||
37870933|NCT00992511|69555139|FG002|Overall Study|Lost to Follow-up|0|||
37870934|NCT00992511|69555140|FG003|Overall Study|Lost to Follow-up|2|||
37870935|NCT00992511|69555137|FG000|Overall Study|Withdrawal by Subject|0|||
37870936|NCT00992511|69555138|FG001|Overall Study|Withdrawal by Subject|0|||
37870937|NCT00992511|69555139|FG002|Overall Study|Withdrawal by Subject|1|||
37816272|NCT02471144|69494900|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|6|||
37816273|NCT02471144|69494901|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|3|||
37816274|NCT02471144|69494891|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
37816275|NCT02471144|69494892|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
37816276|NCT02471144|69494893|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
37816277|NCT02471144|69494894|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
37694937|NCT02372396|69171374|FG000|Overall Study|Lost to Follow-up|7|||
37694938|NCT02372396|69171375|FG001|Overall Study|Lost to Follow-up|9|||
37694939|NCT01835548|69171383|FG000|Dose Optimization Period|Adverse Event|0|||
37816278|NCT02471144|69494895|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
37816279|NCT02471144|69494896|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
37816280|NCT02471144|69494897|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
37816281|NCT02471144|69494898|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
37816282|NCT02471144|69494899|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
37816283|NCT02471144|69494900|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
37816284|NCT02471144|69494901|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
37816285|NCT02471144|69494891|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
37816286|NCT02471144|69494892|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
37816287|NCT02471144|69494893|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
37816288|NCT02471144|69494894|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
37816289|NCT02471144|69494895|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
37870938|NCT00992511|69555140|FG003|Overall Study|Withdrawal by Subject|1|||
37870939|NCT01196429|69555152|FG000|Overall Study|Ineligible - inadequate pathology|1|||
37816290|NCT02471144|69494896|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
37980648|NCT00533897|69667262|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
37980649|NCT00533897|69667263|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
37694940|NCT01835548|69171384|FG001|Dose Optimization Period|Adverse Event|0|||
37870940|NCT01196429|69555153|FG001|Overall Study|Ineligible - inadequate pathology|0|||
37870941|NCT01196429|69555152|FG000|Overall Study|Ineligible - wrong cell type|1|||
37870942|NCT01196429|69555153|FG001|Overall Study|Ineligible - wrong cell type|0|||
37870943|NCT01196429|69555152|FG000|Overall Study|Refused - Never Treated|1|||
37870944|NCT01196429|69555153|FG001|Overall Study|Refused - Never Treated|0|||
37870945|NCT01157364|69555167|FG000|Overall Study|Other Reasons|1|||
37870946|NCT01157364|69555168|FG001|Overall Study|Other Reasons|1|||
37870947|NCT01157364|69555169|FG002|Overall Study|Other Reasons|2|||
37870948|NCT01157364|69555170|FG003|Overall Study|Other Reasons|1|||
37870949|NCT01157364|69555171|FG004|Overall Study|Other Reasons|0|||
37870950|NCT01157364|69555172|FG005|Overall Study|Other Reasons|0|||
37870951|NCT01157364|69555167|FG000|Overall Study|Personal Reasons|0|||
37870952|NCT01157364|69555168|FG001|Overall Study|Personal Reasons|2|||
37870953|NCT01157364|69555169|FG002|Overall Study|Personal Reasons|0|||
37870954|NCT01157364|69555170|FG003|Overall Study|Personal Reasons|0|||
37870955|NCT01157364|69555171|FG004|Overall Study|Personal Reasons|1|||
37870956|NCT01157364|69555172|FG005|Overall Study|Personal Reasons|1|||
37870957|NCT01157364|69555167|FG000|Overall Study|Lost to Follow-up|1|||
37870958|NCT01157364|69555168|FG001|Overall Study|Lost to Follow-up|0|||
37870959|NCT01157364|69555169|FG002|Overall Study|Lost to Follow-up|1|||
37870960|NCT01157364|69555170|FG003|Overall Study|Lost to Follow-up|0|||
37870961|NCT01157364|69555171|FG004|Overall Study|Lost to Follow-up|0|||
37980650|NCT00533897|69667264|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
37980651|NCT00533897|69667265|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
37980652|NCT00533897|69667266|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
37980653|NCT00533897|69667259|FG000|Long Term Extension (LTE)|Death|0|||
37980654|NCT00533897|69667260|FG001|Long Term Extension (LTE)|Death|0|||
37980655|NCT00533897|69667261|FG002|Long Term Extension (LTE)|Death|0|||
37980656|NCT00533897|69667262|FG003|Long Term Extension (LTE)|Death|0|||
37980657|NCT00533897|69667263|FG004|Long Term Extension (LTE)|Death|0|||
37980658|NCT00533897|69667264|FG005|Long Term Extension (LTE)|Death|0|||
37980659|NCT00533897|69667265|FG006|Long Term Extension (LTE)|Death|1|||
37980660|NCT00533897|69667266|FG007|Long Term Extension (LTE)|Death|3|||
37980661|NCT00533897|69667259|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
37870962|NCT01157364|69555172|FG005|Overall Study|Lost to Follow-up|0|||
37870963|NCT01157364|69555167|FG000|Overall Study|Lack of Efficacy|0|||
37980662|NCT00533897|69667260|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
37816291|NCT02471144|69494897|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
37870964|NCT01157364|69555168|FG001|Overall Study|Lack of Efficacy|0|||
37870965|NCT01157364|69555169|FG002|Overall Study|Lack of Efficacy|0|||
37870966|NCT01157364|69555170|FG003|Overall Study|Lack of Efficacy|1|||
37870967|NCT01157364|69555171|FG004|Overall Study|Lack of Efficacy|0|||
37870968|NCT01157364|69555172|FG005|Overall Study|Lack of Efficacy|0|||
37870969|NCT01157364|69555167|FG000|Overall Study|Adverse Event|0|||
37870970|NCT01157364|69555168|FG001|Overall Study|Adverse Event|1|||
37870971|NCT01157364|69555169|FG002|Overall Study|Adverse Event|1|||
37870972|NCT01157364|69555170|FG003|Overall Study|Adverse Event|0|||
37870973|NCT01157364|69555171|FG004|Overall Study|Adverse Event|1|||
37870974|NCT01157364|69555172|FG005|Overall Study|Adverse Event|0|||
37870975|NCT01195415|69555186|FG000|Overall Study|No repeat biopsy due to progression|2|||
37870976|NCT01195103|69555193|FG000|Overall Study|Withdrawal by Subject|1|||
37870977|NCT01195103|69555194|FG001|Overall Study|Withdrawal by Subject|0|||
37870978|NCT01195103|69555195|FG002|Overall Study|Withdrawal by Subject|0|||
37870979|NCT01194869|69555203|FG000|Overall Study|Disease Progression|2|||
37870980|NCT01194869|69555203|FG000|Overall Study|Toxicity|2|||
37870981|NCT01177800|69555209|FG000|Overall Study|Adverse Event|9|||
37870982|NCT01177800|69555210|FG001|Overall Study|Adverse Event|3|||
37870983|NCT01177800|69555209|FG000|Overall Study|Protocol Violation|0|||
37870984|NCT01177800|69555210|FG001|Overall Study|Protocol Violation|1|||
37980663|NCT00533897|69667261|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
37980664|NCT00533897|69667262|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
37980665|NCT00533897|69667263|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
37816292|NCT02471144|69494898|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
37816293|NCT02471144|69494899|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
37816294|NCT02471144|69494900|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
37816295|NCT02471144|69494901|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
37816296|NCT02471144|69494891|FG000|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
37816297|NCT02471144|69494892|FG001|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
37816298|NCT02471144|69494893|FG002|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
37816299|NCT02471144|69494894|FG003|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
37816300|NCT02471144|69494895|FG004|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
37870985|NCT01177800|69555209|FG000|Overall Study|Physician Decision|1|||
37870986|NCT01177800|69555210|FG001|Overall Study|Physician Decision|0|||
37870987|NCT01177800|69555209|FG000|Overall Study|Withdrawal of informed consent|0|||
37870988|NCT01177800|69555210|FG001|Overall Study|Withdrawal of informed consent|1|||
37870989|NCT01177722|69555220|FG000|Overall Study|Serious Adverse Event|0|||
37870990|NCT01177722|69555221|FG001|Overall Study|Serious Adverse Event|0|||
37870991|NCT01177722|69555222|FG002|Overall Study|Serious Adverse Event|1|||
37870992|NCT01177722|69555223|FG003|Overall Study|Serious Adverse Event|0|||
37870993|NCT01177722|69555220|FG000|Overall Study|Protocol Violation|0|||
37870994|NCT01177722|69555221|FG001|Overall Study|Protocol Violation|0|||
37870995|NCT01177722|69555222|FG002|Overall Study|Protocol Violation|1|||
37870996|NCT01177722|69555223|FG003|Overall Study|Protocol Violation|0|||
37870997|NCT01177722|69555220|FG000|Overall Study|Lost to Follow-up|3|||
37870998|NCT01177722|69555221|FG001|Overall Study|Lost to Follow-up|4|||
37870999|NCT01177722|69555222|FG002|Overall Study|Lost to Follow-up|3|||
37871000|NCT01177722|69555223|FG003|Overall Study|Lost to Follow-up|1|||
37871001|NCT01177722|69555220|FG000|Overall Study|Withdrawal by Subject|10|||
37871002|NCT01177722|69555221|FG001|Overall Study|Withdrawal by Subject|6|||
37871003|NCT01177722|69555222|FG002|Overall Study|Withdrawal by Subject|4|||
37871004|NCT01177722|69555223|FG003|Overall Study|Withdrawal by Subject|6|||
37871005|NCT01177410|69555237|FG000|Overall Study|Adverse Event|0|||
37871006|NCT01177410|69555238|FG001|Overall Study|Adverse Event|2|||
37871007|NCT01177410|69555239|FG002|Overall Study|Adverse Event|2|||
37871008|NCT01177410|69555237|FG000|Overall Study|Withdrawal by Subject|1|||
37871009|NCT01177410|69555238|FG001|Overall Study|Withdrawal by Subject|4|||
37871010|NCT01177410|69555239|FG002|Overall Study|Withdrawal by Subject|3|||
37871011|NCT01177410|69555237|FG000|Overall Study|Lost to Follow-up|0|||
37871012|NCT01177410|69555238|FG001|Overall Study|Lost to Follow-up|1|||
37871013|NCT01177410|69555239|FG002|Overall Study|Lost to Follow-up|0|||
37871014|NCT01156116|69555249|FG000|Overall Study|Withdrawal by Subject|3|||
37871015|NCT01156116|69555250|FG001|Overall Study|Withdrawal by Subject|1|||
37871016|NCT01156116|69555249|FG000|Overall Study|CPAP intolerance|2|||
37871017|NCT01156116|69555250|FG001|Overall Study|CPAP intolerance|0|||
37871018|NCT01155726|69555256|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
37871019|NCT01155726|69555257|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
37871020|NCT01155726|69555258|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
37871021|NCT01155726|69555259|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
37871022|NCT01155570|69555281|FG000|Overall Study|Adverse Event|39|||
37871023|NCT01155570|69555281|FG000|Overall Study|Lack of Efficacy|46|||
37871024|NCT01155570|69555281|FG000|Overall Study|Participant's Economic Reasons|17|||
37871025|NCT01155570|69555281|FG000|Overall Study|No Hospital Visits|7|||
37871026|NCT01155570|69555281|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
37871027|NCT01155570|69555281|FG000|Overall Study|Adverse Event + Other Reasons|7|||
37871028|NCT01155570|69555281|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
37871029|NCT01155570|69555281|FG000|Overall Study|Other Reasons|23|||
37871030|NCT01155024|69555287|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
37871031|NCT01155024|69555288|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
37871032|NCT01155024|69555287|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
37871033|NCT01155024|69555288|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
37871034|NCT01155024|69555287|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
37871035|NCT01155024|69555288|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
37871036|NCT01176240|69555299|FG000|Study 306A|Lack of Efficacy|2|||
37871037|NCT01176240|69555300|FG001|Study 306A|Lack of Efficacy|1|||
37871038|NCT01176240|69555299|FG000|Study 306A|Protocol Violation|0|||
37816301|NCT02471144|69494896|FG005|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
37816302|NCT02471144|69494897|FG006|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
37816303|NCT02471144|69494898|FG007|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
37816304|NCT02471144|69494899|FG008|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
37816305|NCT02471144|69494900|FG009|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
37816306|NCT02471144|69494901|FG010|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
37816307|NCT02471144|69494891|FG000|Extension Period (Week 52 to Week 236)|Technical problems|0|||
37816308|NCT02471144|69494892|FG001|Extension Period (Week 52 to Week 236)|Technical problems|0|||
37816309|NCT02471144|69494893|FG002|Extension Period (Week 52 to Week 236)|Technical problems|0|||
37816310|NCT02471144|69494894|FG003|Extension Period (Week 52 to Week 236)|Technical problems|0|||
37816311|NCT02471144|69494895|FG004|Extension Period (Week 52 to Week 236)|Technical problems|0|||
37816312|NCT02471144|69494896|FG005|Extension Period (Week 52 to Week 236)|Technical problems|0|||
37816313|NCT02471144|69494897|FG006|Extension Period (Week 52 to Week 236)|Technical problems|0|||
37816314|NCT02471144|69494898|FG007|Extension Period (Week 52 to Week 236)|Technical problems|0|||
37816315|NCT02471144|69494899|FG008|Extension Period (Week 52 to Week 236)|Technical problems|0|||
37871039|NCT01176240|69555300|FG001|Study 306A|Protocol Violation|1|||
37871040|NCT01176240|69555299|FG000|Study 306A|Withdrawal by Subject|0|||
37871041|NCT01176240|69555300|FG001|Study 306A|Withdrawal by Subject|1|||
37871042|NCT01176240|69555299|FG000|Study 306A|Stop due to diverse problems|1|||
37871043|NCT01176240|69555300|FG001|Study 306A|Stop due to diverse problems|0|||
37871044|NCT01176240|69555299|FG000|Study 306B|Lack of Efficacy|5|||
37871045|NCT01176240|69555300|FG001|Study 306B|Lack of Efficacy|3|||
37871046|NCT01176240|69555299|FG000|Study 306B|Adverse Event|10|||
37871047|NCT01176240|69555300|FG001|Study 306B|Adverse Event|5|||
37871048|NCT01176240|69555299|FG000|Study 306B|Protocol Violation|2|||
37871049|NCT01176240|69555300|FG001|Study 306B|Protocol Violation|3|||
37871050|NCT01176240|69555299|FG000|Study 306B|Withdrawal by Subject|4|||
37871051|NCT01176240|69555300|FG001|Study 306B|Withdrawal by Subject|1|||
37871052|NCT01176240|69555299|FG000|Study 306B|Physician Decision|2|||
37871053|NCT01176240|69555300|FG001|Study 306B|Physician Decision|1|||
37871054|NCT01176240|69555299|FG000|Study 306B|Supine Hypertension|1|||
37871055|NCT01176240|69555300|FG001|Study 306B|Supine Hypertension|2|||
37871056|NCT01176240|69555299|FG000|Study 306B|Lost to Follow-up|0|||
37871057|NCT01176240|69555300|FG001|Study 306B|Lost to Follow-up|1|||
37871058|NCT01176240|69555299|FG000|Study 306B|withdrew prior to dosing|2|||
37871059|NCT01176240|69555300|FG001|Study 306B|withdrew prior to dosing|1|||
37871060|NCT00988221|69555309|FG000|Part I|Adverse Event|0|||
37871061|NCT00988221|69555310|FG001|Part I|Adverse Event|1|||
37871062|NCT00988221|69555311|FG002|Part I|Adverse Event|2|||
37871063|NCT00988221|69555312|FG003|Part I|Adverse Event|0|||
37871064|NCT00988221|69555309|FG000|Part I|Insufficient Therapeutic Response|4|||
37871065|NCT00988221|69555310|FG001|Part I|Insufficient Therapeutic Response|6|||
37871066|NCT00988221|69555311|FG002|Part I|Insufficient Therapeutic Response|5|||
37871067|NCT00988221|69555312|FG003|Part I|Insufficient Therapeutic Response|0|||
37871068|NCT00988221|69555309|FG000|Part I|Refused Treatment|0|||
37871069|NCT00988221|69555310|FG001|Part I|Refused Treatment|2|||
37871070|NCT00988221|69555311|FG002|Part I|Refused Treatment|1|||
37871071|NCT00988221|69555312|FG003|Part I|Refused Treatment|0|||
37871072|NCT00988221|69555309|FG000|Part I|Lost to Follow-up|0|||
37871073|NCT00988221|69555310|FG001|Part I|Lost to Follow-up|1|||
37871074|NCT00988221|69555311|FG002|Part I|Lost to Follow-up|0|||
37871075|NCT00988221|69555312|FG003|Part I|Lost to Follow-up|0|||
37871076|NCT00988221|69555309|FG000|Part II|Adverse Event|1|||
37871077|NCT00988221|69555310|FG001|Part II|Adverse Event|0|||
37871078|NCT00988221|69555311|FG002|Part II|Adverse Event|0|||
37871079|NCT00988221|69555312|FG003|Part II|Adverse Event|1|||
37871080|NCT00988221|69555309|FG000|Part II|Withdrawal by Subject|0|||
37871081|NCT00988221|69555310|FG001|Part II|Withdrawal by Subject|0|||
37871082|NCT00988221|69555311|FG002|Part II|Withdrawal by Subject|2|||
37871083|NCT00988221|69555312|FG003|Part II|Withdrawal by Subject|2|||
37871084|NCT00988221|69555309|FG000|Part II|Reason not Specified|0|||
37871085|NCT00988221|69555310|FG001|Part II|Reason not Specified|0|||
37871086|NCT00988221|69555311|FG002|Part II|Reason not Specified|1|||
37871087|NCT00988221|69555312|FG003|Part II|Reason not Specified|0|||
37871088|NCT00988221|69555309|FG000|Part III|Adverse Event|1|||
37871089|NCT00988221|69555310|FG001|Part III|Adverse Event|0|||
37871090|NCT00988221|69555311|FG002|Part III|Adverse Event|1|||
37871091|NCT00988221|69555312|FG003|Part III|Adverse Event|0|||
37694941|NCT01835548|69171385|FG002|Dose Optimization Period|Adverse Event|1|||
37694942|NCT01835548|69171383|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
37694943|NCT01835548|69171384|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
37694944|NCT01835548|69171385|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
37694945|NCT01835548|69171383|FG000|Double-Blind Treatment Period|Adverse Event|0|||
37816316|NCT02471144|69494900|FG009|Extension Period (Week 52 to Week 236)|Technical problems|1|||
37816317|NCT02471144|69494901|FG010|Extension Period (Week 52 to Week 236)|Technical problems|0|||
37816318|NCT02471144|69494891|FG000|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
37816319|NCT02471144|69494892|FG001|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
37816320|NCT02471144|69494893|FG002|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
37816321|NCT02471144|69494894|FG003|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
37816322|NCT02471144|69494895|FG004|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
37816323|NCT02471144|69494896|FG005|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
37816324|NCT02471144|69494897|FG006|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
37816325|NCT02471144|69494898|FG007|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
37816326|NCT02471144|69494899|FG008|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
37871092|NCT00988221|69555309|FG000|Part III|Insufficient Therapeutic Response|0|||
37871093|NCT00988221|69555310|FG001|Part III|Insufficient Therapeutic Response|1|||
37871094|NCT00988221|69555311|FG002|Part III|Insufficient Therapeutic Response|1|||
37871095|NCT00988221|69555312|FG003|Part III|Insufficient Therapeutic Response|0|||
37871096|NCT00988221|69555309|FG000|Part III|Refused Treatment|0|||
37871097|NCT00988221|69555310|FG001|Part III|Refused Treatment|0|||
37871098|NCT00988221|69555311|FG002|Part III|Refused Treatment|1|||
37871099|NCT00988221|69555312|FG003|Part III|Refused Treatment|0|||
37871100|NCT01149096|69555333|FG000|Overall Study|Lost to Follow-up|0|||
37694946|NCT01835548|69171384|FG001|Double-Blind Treatment Period|Adverse Event|1|||
37871101|NCT01149096|69555334|FG001|Overall Study|Lost to Follow-up|1|||
37871102|NCT01175382|69555344|FG000|Overall Study|Lost to Follow-up|4|||
37871103|NCT01175382|69555345|FG001|Overall Study|Lost to Follow-up|3|||
37871104|NCT01175382|69555346|FG002|Overall Study|Lost to Follow-up|1|||
37871105|NCT01175382|69555344|FG000|Overall Study|Physician Decision|0|||
37694947|NCT01835548|69171385|FG002|Double-Blind Treatment Period|Adverse Event|0|||
37871106|NCT01175382|69555345|FG001|Overall Study|Physician Decision|1|||
37871107|NCT01175382|69555346|FG002|Overall Study|Physician Decision|0|||
37871108|NCT01175382|69555344|FG000|Overall Study|Withdrawal by Subject|0|||
37871109|NCT01175382|69555345|FG001|Overall Study|Withdrawal by Subject|0|||
37871110|NCT01175382|69555346|FG002|Overall Study|Withdrawal by Subject|1|||
37871111|NCT01175382|69555344|FG000|Overall Study|No longer having problem|1|||
37871112|NCT01175382|69555345|FG001|Overall Study|No longer having problem|0|||
37871113|NCT01175382|69555346|FG002|Overall Study|No longer having problem|1|||
37871114|NCT01175382|69555344|FG000|Overall Study|Unable/unwilling to attend visits|3|||
37871115|NCT01175382|69555345|FG001|Overall Study|Unable/unwilling to attend visits|1|||
37871116|NCT01175382|69555346|FG002|Overall Study|Unable/unwilling to attend visits|2|||
37871117|NCT01175382|69555344|FG000|Overall Study|Unwilling to follow protocol|0|||
37871118|NCT01175382|69555345|FG001|Overall Study|Unwilling to follow protocol|1|||
37871119|NCT01175382|69555346|FG002|Overall Study|Unwilling to follow protocol|0|||
37871120|NCT01175382|69555344|FG000|Overall Study|Unable to tolerate study meds|0|||
37871121|NCT01175382|69555345|FG001|Overall Study|Unable to tolerate study meds|1|||
37871122|NCT01175382|69555346|FG002|Overall Study|Unable to tolerate study meds|1|||
37871123|NCT01194245|69555359|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
37871124|NCT01194245|69555360|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
37871125|NCT01194245|69555361|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
37871126|NCT01194245|69555362|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
37871127|NCT01194245|69555363|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
37871128|NCT01194245|69555359|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
37871129|NCT01194245|69555360|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
37871130|NCT01194245|69555361|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
37871131|NCT01194245|69555362|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
37871132|NCT01194245|69555363|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
37871133|NCT01194245|69555359|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
37871134|NCT01194245|69555360|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
37980666|NCT00533897|69667264|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
37980667|NCT00533897|69667265|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
37980668|NCT00533897|69667266|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
37980669|NCT00533897|69667259|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
37980670|NCT00533897|69667260|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
37980671|NCT00533897|69667261|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
37980672|NCT00533897|69667262|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
37980673|NCT00533897|69667263|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
37980674|NCT00533897|69667264|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
37980675|NCT00533897|69667265|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
37980676|NCT00533897|69667266|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
37980677|NCT00533897|69667259|FG000|Long Term Extension (LTE)|Adverse Event|0|||
37980678|NCT00533897|69667260|FG001|Long Term Extension (LTE)|Adverse Event|0|||
37980679|NCT00533897|69667261|FG002|Long Term Extension (LTE)|Adverse Event|0|||
37980680|NCT00533897|69667262|FG003|Long Term Extension (LTE)|Adverse Event|0|||
37980681|NCT00533897|69667263|FG004|Long Term Extension (LTE)|Adverse Event|0|||
37980682|NCT00533897|69667264|FG005|Long Term Extension (LTE)|Adverse Event|0|||
37980683|NCT00533897|69667265|FG006|Long Term Extension (LTE)|Adverse Event|2|||
37980684|NCT00533897|69667266|FG007|Long Term Extension (LTE)|Adverse Event|5|||
37980685|NCT00533897|69667259|FG000|Long Term Extension (LTE)|Pregnancy|0|||
37980686|NCT00533897|69667260|FG001|Long Term Extension (LTE)|Pregnancy|0|||
37980687|NCT00533897|69667261|FG002|Long Term Extension (LTE)|Pregnancy|0|||
37980688|NCT00533897|69667262|FG003|Long Term Extension (LTE)|Pregnancy|0|||
37980689|NCT00533897|69667263|FG004|Long Term Extension (LTE)|Pregnancy|0|||
37980690|NCT00533897|69667264|FG005|Long Term Extension (LTE)|Pregnancy|0|||
37694948|NCT01835548|69171383|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
37694949|NCT01835548|69171384|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
37816327|NCT02471144|69494900|FG009|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
37816328|NCT02471144|69494901|FG010|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
37816329|NCT02403674|69494923|FG000|Overall Study|Adverse Event|10|||
37816330|NCT02403674|69494924|FG001|Overall Study|Adverse Event|23|||
37816331|NCT02403674|69494923|FG000|Overall Study|Death|1|||
37816332|NCT02403674|69494924|FG001|Overall Study|Death|3|||
37816333|NCT02403674|69494923|FG000|Overall Study|Lack of Efficacy|18|||
37816334|NCT02403674|69494924|FG001|Overall Study|Lack of Efficacy|10|||
37816335|NCT02403674|69494923|FG000|Overall Study|Lost to Follow-up|6|||
37816336|NCT02403674|69494924|FG001|Overall Study|Lost to Follow-up|7|||
37980691|NCT00533897|69667265|FG006|Long Term Extension (LTE)|Pregnancy|0|||
37980692|NCT00533897|69667266|FG007|Long Term Extension (LTE)|Pregnancy|2|||
37980693|NCT00533897|69667259|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
37980694|NCT00533897|69667260|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
37816337|NCT02403674|69494923|FG000|Overall Study|Noncompliance with study drug|1|||
37980695|NCT00533897|69667261|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
37980696|NCT00533897|69667262|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
37871135|NCT01194245|69555361|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
37871136|NCT01194245|69555362|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
37871137|NCT01194245|69555363|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
37871138|NCT01194245|69555359|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
37871139|NCT01194245|69555360|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
37871140|NCT01194245|69555361|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
37871141|NCT01194245|69555362|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
37871142|NCT01194245|69555363|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
37871143|NCT01194245|69555359|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
37871144|NCT01194245|69555360|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
37871145|NCT01194245|69555361|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
37871146|NCT01194245|69555362|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
37871147|NCT01194245|69555363|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
37871148|NCT01194245|69555359|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
37871149|NCT01194245|69555360|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
37871150|NCT01194245|69555361|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
37871151|NCT01194245|69555362|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
37871152|NCT01194245|69555363|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
37871153|NCT00979407|69555374|FG000|Overall Study|Withdrawal by Subject|3|||
37871154|NCT00979407|69555375|FG001|Overall Study|Withdrawal by Subject|4|||
37871155|NCT00979407|69555374|FG000|Overall Study|Lost to Follow-up|3|||
37871156|NCT00979407|69555375|FG001|Overall Study|Lost to Follow-up|3|||
37871157|NCT01148862|69555383|FG000|Second Intervention|Withdrawal by Subject|0|||
37871158|NCT01148862|69555384|FG001|Second Intervention|Withdrawal by Subject|2|||
37871159|NCT00975975|69555390|FG000|Overall Study|Death|6|||
37871160|NCT01193153|69555394|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
37871161|NCT01193153|69555395|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
37871162|NCT01193153|69555394|FG000|Open-label Lead in Period|Pregnancy|1|||
37871163|NCT01193153|69555395|FG001|Open-label Lead in Period|Pregnancy|0|||
37871164|NCT01193153|69555394|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
37871165|NCT01193153|69555395|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
37871166|NCT01193153|69555394|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
37871167|NCT01193153|69555395|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
37871168|NCT01193153|69555394|FG000|Open-label Lead in Period|Other|14|||
37871169|NCT01193153|69555395|FG001|Open-label Lead in Period|Other|0|||
37871170|NCT01193153|69555394|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
37871171|NCT01193153|69555395|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
37871172|NCT01193153|69555394|FG000|Open-label Lead in Period|Adverse Event|41|||
37871173|NCT01193153|69555395|FG001|Open-label Lead in Period|Adverse Event|0|||
37871174|NCT01193153|69555394|FG000|Open-label Lead in Period|Death|1|||
37871175|NCT01193153|69555395|FG001|Open-label Lead in Period|Death|0|||
37871176|NCT01193153|69555394|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
37871177|NCT01193153|69555395|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
37871178|NCT01193153|69555394|FG000|Open-label Stabilization Period|Adverse Event|9|||
37871179|NCT01193153|69555395|FG001|Open-label Stabilization Period|Adverse Event|0|||
37871180|NCT01193153|69555394|FG000|Open-label Stabilization Period|Death|2|||
37871181|NCT01193153|69555395|FG001|Open-label Stabilization Period|Death|0|||
37871182|NCT01193153|69555394|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
37871183|NCT01193153|69555395|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
37871184|NCT01193153|69555394|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
37871185|NCT01193153|69555395|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
37871186|NCT01193153|69555394|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
37871187|NCT01193153|69555395|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
37694950|NCT01835548|69171385|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
37694951|NCT01852942|69171399|FG000|Overall Study|Physician Decision|1|||
37871188|NCT01193153|69555394|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
37871189|NCT01193153|69555395|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
37871190|NCT01193153|69555394|FG000|Open-label Stabilization Period|Other|8|||
37871191|NCT01193153|69555395|FG001|Open-label Stabilization Period|Other|0|||
37871192|NCT01193153|69555394|FG000|Double Blind Relapse Prevention Period|Other|2|||
37871193|NCT01193153|69555395|FG001|Double Blind Relapse Prevention Period|Other|3|||
37871194|NCT01193153|69555394|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
37871195|NCT01193153|69555395|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
37871196|NCT01193153|69555394|FG000|Double Blind Relapse Prevention Period|Death|2|||
37871197|NCT01193153|69555395|FG001|Double Blind Relapse Prevention Period|Death|0|||
37871198|NCT01193153|69555394|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
37980697|NCT00533897|69667263|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
37871199|NCT01193153|69555395|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
37871200|NCT01193153|69555394|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
37871201|NCT01193153|69555395|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
37871202|NCT01193153|69555394|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
37871203|NCT01193153|69555395|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
37871204|NCT01193153|69555394|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
37871205|NCT01193153|69555395|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
37871206|NCT01193153|69555394|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
37871207|NCT01193153|69555395|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
37871208|NCT01192295|69555406|FG000|Overall Study|Adverse Event|3|||
37871209|NCT01192295|69555407|FG001|Overall Study|Adverse Event|7|||
37871210|NCT01192295|69555406|FG000|Overall Study|Withdrawal by Subject|3|||
37871211|NCT01192295|69555407|FG001|Overall Study|Withdrawal by Subject|4|||
37871212|NCT01192295|69555406|FG000|Overall Study|Lost to Follow-up|0|||
37871213|NCT01192295|69555407|FG001|Overall Study|Lost to Follow-up|1|||
37871214|NCT01192295|69555406|FG000|Overall Study|Lack of Efficacy|0|||
37871215|NCT01192295|69555407|FG001|Overall Study|Lack of Efficacy|5|||
37871216|NCT01192295|69555406|FG000|Overall Study|Administrative|4|||
37871217|NCT01192295|69555407|FG001|Overall Study|Administrative|6|||
37871218|NCT01154166|69555417|FG000|Overall Study|Adverse Event|14|||
37871219|NCT01154166|69555418|FG001|Overall Study|Adverse Event|9|||
37871220|NCT01154166|69555417|FG000|Overall Study|Lost to Follow-up|1|||
37871221|NCT01154166|69555418|FG001|Overall Study|Lost to Follow-up|1|||
37871222|NCT01154166|69555417|FG000|Overall Study|Protocol Violation|4|||
37871223|NCT01154166|69555418|FG001|Overall Study|Protocol Violation|1|||
37871224|NCT01154166|69555417|FG000|Overall Study|Withdrawal by Subject|10|||
37871225|NCT01154166|69555418|FG001|Overall Study|Withdrawal by Subject|1|||
37871226|NCT01154166|69555417|FG000|Overall Study|Lack of Efficacy|3|||
37871227|NCT01154166|69555418|FG001|Overall Study|Lack of Efficacy|0|||
37871228|NCT01154166|69555417|FG000|Overall Study|Disease Progression|1|||
37871229|NCT01154166|69555418|FG001|Overall Study|Disease Progression|0|||
37871230|NCT01154166|69555417|FG000|Overall Study|Poor Compliance|1|||
37871231|NCT01154166|69555418|FG001|Overall Study|Poor Compliance|0|||
37871232|NCT00975585|69555426|FG000|Overall Study|Adverse Event|0|||
37871233|NCT00975585|69555427|FG001|Overall Study|Adverse Event|4|||
37871234|NCT00975585|69555426|FG000|Overall Study|Lost to Follow-up|3|||
37871235|NCT00975585|69555427|FG001|Overall Study|Lost to Follow-up|5|||
37871236|NCT00975585|69555426|FG000|Overall Study|Withdrawal by Subject|2|||
37871237|NCT00975585|69555427|FG001|Overall Study|Withdrawal by Subject|1|||
37871238|NCT00975585|69555426|FG000|Overall Study|Lens issue|2|||
37871239|NCT00975585|69555427|FG001|Overall Study|Lens issue|2|||
37871240|NCT01181921|69555435|FG000|Overall Study|Lost to Follow-up|1|||
37871241|NCT01174446|69555439|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
37871242|NCT01174446|69555440|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
37871243|NCT01174446|69555441|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
37871244|NCT01174446|69555442|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
37871245|NCT01174446|69555439|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
37871246|NCT01174446|69555440|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
37871247|NCT01174446|69555441|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
37871248|NCT01174446|69555442|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
37871249|NCT01174446|69555439|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
37871250|NCT01174446|69555440|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
37871251|NCT01174446|69555441|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
37871252|NCT01174446|69555442|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
37871253|NCT01174446|69555439|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
37871254|NCT01174446|69555440|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
37871255|NCT01174446|69555441|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
37871256|NCT01174446|69555442|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
37871257|NCT00932698|69555500|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
37871258|NCT00932698|69555501|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
37871259|NCT00932698|69555502|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
37694952|NCT01852942|69171400|FG001|Overall Study|Physician Decision|0|||
37871260|NCT00932698|69555503|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
37871261|NCT00932698|69555504|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
37871262|NCT00932698|69555505|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
37871263|NCT00932698|69555506|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
37871264|NCT00932698|69555507|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
37871265|NCT00932698|69555508|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
37871266|NCT00932698|69555509|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
37871267|NCT00932698|69555510|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
37871268|NCT00932698|69555500|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
37871269|NCT00932698|69555501|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
37871270|NCT00932698|69555502|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
37871271|NCT00932698|69555503|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
37871272|NCT00932698|69555504|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
37871273|NCT00932698|69555505|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
37871274|NCT00932698|69555506|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
37871275|NCT00932698|69555507|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
37871276|NCT00932698|69555508|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
37871277|NCT00932698|69555509|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
37871278|NCT00932698|69555510|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
37871279|NCT00932698|69555500|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
37871280|NCT00932698|69555501|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
37871281|NCT00932698|69555502|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
37871282|NCT00932698|69555503|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
37871283|NCT00932698|69555504|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
37871284|NCT00932698|69555505|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
37871285|NCT00932698|69555506|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
37871286|NCT00932698|69555507|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
37871287|NCT00932698|69555508|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
37871288|NCT00932698|69555509|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
37871289|NCT00932698|69555510|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
37980698|NCT00533897|69667264|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
37980699|NCT00533897|69667265|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
37871290|NCT00932698|69555500|FG000|Part 1 (Dose Escalation)|Other|0|||
37871291|NCT00932698|69555501|FG001|Part 1 (Dose Escalation)|Other|0|||
37871292|NCT00932698|69555502|FG002|Part 1 (Dose Escalation)|Other|1|||
37871293|NCT00932698|69555503|FG003|Part 1 (Dose Escalation)|Other|0|||
37871294|NCT00932698|69555504|FG004|Part 1 (Dose Escalation)|Other|0|||
37871295|NCT00932698|69555505|FG005|Part 1 (Dose Escalation)|Other|0|||
37871296|NCT00932698|69555506|FG006|Part 1 (Dose Escalation)|Other|1|||
37871297|NCT00932698|69555507|FG007|Part 1 (Dose Escalation)|Other|0|||
37871298|NCT00932698|69555508|FG008|Part 1 (Dose Escalation)|Other|0|||
37871299|NCT00932698|69555509|FG009|Part 1 (Dose Escalation)|Other|0|||
37871300|NCT00932698|69555510|FG010|Part 1 (Dose Escalation)|Other|0|||
37871301|NCT00932698|69555500|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
37871302|NCT00932698|69555501|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
37871303|NCT00932698|69555502|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
37871304|NCT00932698|69555503|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
37871305|NCT00932698|69555504|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
37980700|NCT00533897|69667266|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
37980701|NCT00533897|69667259|FG000|Long Term Extension (LTE)|Other|0|||
37980702|NCT00533897|69667260|FG001|Long Term Extension (LTE)|Other|0|||
37871306|NCT00932698|69555505|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
37871307|NCT00932698|69555506|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
37871308|NCT00932698|69555507|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
37871309|NCT00932698|69555508|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
37871310|NCT00932698|69555509|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
37871311|NCT00932698|69555510|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
37871312|NCT00932698|69555500|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
37871313|NCT00932698|69555501|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
37871314|NCT00932698|69555502|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
37871315|NCT00932698|69555503|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
37871316|NCT00932698|69555504|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
37871317|NCT00932698|69555505|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
37871318|NCT00932698|69555506|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
37871319|NCT00932698|69555507|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
37871320|NCT00932698|69555508|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
37871321|NCT00932698|69555509|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
37871322|NCT00932698|69555510|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
37871323|NCT00932698|69555500|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
37980703|NCT00533897|69667261|FG002|Long Term Extension (LTE)|Other|0|||
37980704|NCT00533897|69667262|FG003|Long Term Extension (LTE)|Other|0|||
37871324|NCT00932698|69555501|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
37871325|NCT00932698|69555502|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
37871326|NCT00932698|69555503|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
37871327|NCT00932698|69555504|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
37871328|NCT00932698|69555505|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
37871329|NCT00932698|69555506|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
37871330|NCT00932698|69555507|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
37871331|NCT00932698|69555508|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
37871332|NCT00932698|69555509|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
37871333|NCT00932698|69555510|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
37871334|NCT00978627|69555538|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
37871335|NCT00978627|69555539|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
37871336|NCT00978627|69555538|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
37871337|NCT00978627|69555539|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
37871338|NCT00978627|69555538|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
37871339|NCT00978627|69555539|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
37871340|NCT00978627|69555538|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
37871341|NCT00978627|69555539|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
37871342|NCT00978627|69555538|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
37871343|NCT00978627|69555539|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
37871344|NCT00978627|69555538|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
37871345|NCT00978627|69555539|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
37871346|NCT00978627|69555538|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
37871347|NCT00978627|69555539|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
37871348|NCT00978627|69555538|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
37871349|NCT00978627|69555539|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
37980705|NCT00533897|69667263|FG004|Long Term Extension (LTE)|Other|0|||
37980706|NCT00533897|69667264|FG005|Long Term Extension (LTE)|Other|0|||
37980707|NCT00533897|69667265|FG006|Long Term Extension (LTE)|Other|1|||
37980708|NCT00533897|69667266|FG007|Long Term Extension (LTE)|Other|6|||
37980709|NCT00426660|69667297|FG000|Overall Study|Death|14|||
37980710|NCT00426660|69667297|FG000|Overall Study|Adverse Event|23|||
37980711|NCT00426660|69667297|FG000|Overall Study|Insufficient Clinical Response|22|||
37980712|NCT00426660|69667297|FG000|Overall Study|Lost to Follow-up|15|||
37980713|NCT00426660|69667297|FG000|Overall Study|Other|23|||
37980714|NCT00426660|69667297|FG000|Overall Study|Withdrawal by Subject|18|||
37980715|NCT00426660|69667297|FG000|Overall Study|Protocol Violation|1|||
37980716|NCT00426660|69667297|FG000|Overall Study|Enrolled Not Treated|15|||
37871350|NCT00978627|69555538|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
37871351|NCT00978627|69555539|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
37871352|NCT01181609|69555545|FG000|Overall Study|Adverse Event|1|||
37871353|NCT01181609|69555545|FG000|Overall Study|Withdrawal by Subject|1|||
37871354|NCT01181609|69555545|FG000|Overall Study|Lost to Follow-up|1|||
37871355|NCT01181609|69555545|FG000|Overall Study|Death|50|||
37871356|NCT01154010|69555551|FG000|Overall Study|Lost to Follow-up|0|||
37871357|NCT01154010|69555552|FG001|Overall Study|Lost to Follow-up|1|||
37871358|NCT01174368|69555558|FG000|Overall Study|Withdrawal by Subject|1|||
37980717|NCT00426270|69667301|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
37980718|NCT00426270|69667301|FG000|Overall Study|Adverse Event|5|||
37871359|NCT01147926|69555564|FG000|Overall Study|Subject Withdrew Consent|9|||
37871360|NCT01147926|69555565|FG001|Overall Study|Subject Withdrew Consent|10|||
37871361|NCT01147926|69555564|FG000|Overall Study|Adverse Event|7|||
37816338|NCT02403674|69494924|FG001|Overall Study|Noncompliance with study drug|2|||
37816339|NCT02403674|69494923|FG000|Overall Study|Withdrawal by Subject|8|||
37816340|NCT02403674|69494924|FG001|Overall Study|Withdrawal by Subject|11|||
37816341|NCT02403674|69494923|FG000|Overall Study|Physician Decision|2|||
37816342|NCT02403674|69494924|FG001|Overall Study|Physician Decision|2|||
37816343|NCT02403674|69494923|FG000|Overall Study|Not treated with study drug|4|||
37816344|NCT02403674|69494924|FG001|Overall Study|Not treated with study drug|2|||
37816345|NCT02403674|69494923|FG000|Overall Study|Pregnancy|1|||
37816346|NCT02403674|69494924|FG001|Overall Study|Pregnancy|1|||
37816347|NCT02403674|69494923|FG000|Overall Study|Protocol Violation|4|||
37871362|NCT01147926|69555565|FG001|Overall Study|Adverse Event|6|||
37871363|NCT01147926|69555564|FG000|Overall Study|Subject Non-Compliant|5|||
37871364|NCT01147926|69555565|FG001|Overall Study|Subject Non-Compliant|4|||
37871365|NCT01147926|69555564|FG000|Overall Study|Principal investigator left hospital|1|||
37871366|NCT01147926|69555565|FG001|Overall Study|Principal investigator left hospital|3|||
37871367|NCT01147926|69555564|FG000|Overall Study|Selection criteria not met|3|||
37871368|NCT01147926|69555565|FG001|Overall Study|Selection criteria not met|1|||
37871369|NCT01147926|69555564|FG000|Overall Study|Lost to Follow-up|0|||
37871370|NCT01147926|69555565|FG001|Overall Study|Lost to Follow-up|2|||
37871371|NCT01147926|69555564|FG000|Overall Study|Sponsor's Decision|0|||
37871372|NCT01147926|69555565|FG001|Overall Study|Sponsor's Decision|1|||
37871373|NCT01147926|69555564|FG000|Overall Study|Lack of Efficacy|1|||
37694953|NCT01852942|69171399|FG000|Overall Study|Death|1|||
37694954|NCT01852942|69171400|FG001|Overall Study|Death|1|||
37694955|NCT01852942|69171399|FG000|Overall Study|Withdrawal by Subject|2|||
37694956|NCT01852942|69171400|FG001|Overall Study|Withdrawal by Subject|3|||
37694957|NCT01852942|69171399|FG000|Overall Study|Lost to Follow-up|1|||
37694958|NCT01852942|69171400|FG001|Overall Study|Lost to Follow-up|2|||
37694959|NCT01852162|69171409|FG000|Overall Study|Adverse Event|1|||
37694960|NCT01852162|69171410|FG001|Overall Study|Adverse Event|0|||
37694961|NCT01852162|69171409|FG000|Overall Study|Withdrawal by Subject|3|||
37816348|NCT02403674|69494924|FG001|Overall Study|Protocol Violation|2|||
37871374|NCT01147926|69555565|FG001|Overall Study|Lack of Efficacy|0|||
37871375|NCT01147926|69555564|FG000|Overall Study|Too busy, no time for study|1|||
37871376|NCT01147926|69555565|FG001|Overall Study|Too busy, no time for study|0|||
37871377|NCT01147926|69555564|FG000|Overall Study|Went on holiday|0|||
37871378|NCT01147926|69555565|FG001|Overall Study|Went on holiday|1|||
37871379|NCT01147926|69555564|FG000|Overall Study|Colonoscopy result|0|||
37871380|NCT01147926|69555565|FG001|Overall Study|Colonoscopy result|1|||
37871381|NCT00975507|69555573|FG000|Overall Study|Adverse Event|1|||
37871382|NCT00975507|69555574|FG001|Overall Study|Adverse Event|0|||
37871383|NCT00975507|69555573|FG000|Overall Study|Lost to Follow-up|7|||
37871384|NCT00975507|69555574|FG001|Overall Study|Lost to Follow-up|1|||
37871385|NCT00975507|69555573|FG000|Overall Study|Protocol Violation|2|||
37871386|NCT00975507|69555574|FG001|Overall Study|Protocol Violation|0|||
37871387|NCT00975507|69555573|FG000|Overall Study|Withdrawal by Subject|10|||
37871388|NCT00975507|69555574|FG001|Overall Study|Withdrawal by Subject|3|||
37871389|NCT01147848|69555584|FG000|Run-in Period|Screen Failure|623|||
37871390|NCT01147848|69555585|FG001|Run-in Period|Screen Failure|0|||
37980719|NCT00330681|69667307|FG000|Overall Study|Adverse Event|3|||
37980720|NCT00330681|69667308|FG001|Overall Study|Adverse Event|6|||
37694962|NCT01852162|69171410|FG001|Overall Study|Withdrawal by Subject|1|||
37816349|NCT02352948|69494941|FG000|Overall Study|Death|47|||
37816350|NCT02352948|69494942|FG001|Overall Study|Death|48|||
37871391|NCT01147848|69555586|FG002|Run-in Period|Screen Failure|0|||
37871392|NCT01147848|69555584|FG000|Run-in Period|Run-in Failure|135|||
37871393|NCT01147848|69555585|FG001|Run-in Period|Run-in Failure|0|||
37871394|NCT01147848|69555586|FG002|Run-in Period|Run-in Failure|0|||
37871395|NCT01147848|69555584|FG000|Randomized Phase|Adverse Event|0|||
37871396|NCT01147848|69555585|FG001|Randomized Phase|Adverse Event|6|||
37816351|NCT02352948|69494943|FG002|Overall Study|Death|114|||
37871397|NCT01147848|69555586|FG002|Randomized Phase|Adverse Event|8|||
37694963|NCT01835470|69171416|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
37871398|NCT01147848|69555584|FG000|Randomized Phase|Lack of Efficacy|0|||
37871399|NCT01147848|69555585|FG001|Randomized Phase|Lack of Efficacy|20|||
37871400|NCT01147848|69555586|FG002|Randomized Phase|Lack of Efficacy|11|||
37871401|NCT01147848|69555584|FG000|Randomized Phase|Protocol Violation|0|||
37871402|NCT01147848|69555585|FG001|Randomized Phase|Protocol Violation|7|||
37871403|NCT01147848|69555586|FG002|Randomized Phase|Protocol Violation|10|||
37871404|NCT01147848|69555584|FG000|Randomized Phase|Lost to Follow-up|0|||
37871405|NCT01147848|69555585|FG001|Randomized Phase|Lost to Follow-up|5|||
37871406|NCT01147848|69555586|FG002|Randomized Phase|Lost to Follow-up|7|||
37871407|NCT01147848|69555584|FG000|Randomized Phase|Physician Decision|0|||
37871408|NCT01147848|69555585|FG001|Randomized Phase|Physician Decision|0|||
37871409|NCT01147848|69555586|FG002|Randomized Phase|Physician Decision|1|||
37871410|NCT01147848|69555584|FG000|Randomized Phase|Withdrawal by Subject|0|||
37871411|NCT01147848|69555585|FG001|Randomized Phase|Withdrawal by Subject|7|||
37871412|NCT01147848|69555586|FG002|Randomized Phase|Withdrawal by Subject|9|||
37871413|NCT00929656|69555595|FG000|Overall Study|Lost to Follow-up|0|||
37871414|NCT00929656|69555596|FG001|Overall Study|Lost to Follow-up|1|||
37871415|NCT00977613|69555602|FG000|Overall Study|Lost to Follow-up|16|||
37871416|NCT01152996|69555606|FG000|Overall Study|Withdrawal by Subject|142|||
37871417|NCT01152996|69555606|FG000|Overall Study|Adverse Event|115|||
37871418|NCT01152996|69555606|FG000|Overall Study|Lost to Follow-up|112|||
37871419|NCT01152996|69555606|FG000|Overall Study|Lack of Efficacy|68|||
37871420|NCT01152996|69555606|FG000|Overall Study|Noncompliance|41|||
37871421|NCT01152996|69555606|FG000|Overall Study|Other|36|||
37871422|NCT01152996|69555606|FG000|Overall Study|Protocol Violation|22|||
37871423|NCT01152996|69555606|FG000|Overall Study|Elevated liver enzymes|1|||
37871424|NCT00979953|69555614|FG000|Overall Study|Adverse Event|5|||
37871425|NCT00979953|69555615|FG001|Overall Study|Adverse Event|2|||
37816352|NCT02352948|69494944|FG003|Overall Study|Death|74|||
37816353|NCT02352948|69494945|FG004|Overall Study|Death|77|||
37816354|NCT02352948|69494946|FG005|Overall Study|Death|44|||
37816355|NCT02352948|69494941|FG000|Overall Study|Lost to Follow-up|1|||
37816356|NCT02352948|69494942|FG001|Overall Study|Lost to Follow-up|0|||
37816357|NCT02352948|69494943|FG002|Overall Study|Lost to Follow-up|2|||
37816358|NCT02352948|69494944|FG003|Overall Study|Lost to Follow-up|1|||
37816359|NCT02352948|69494945|FG004|Overall Study|Lost to Follow-up|2|||
37816360|NCT02352948|69494946|FG005|Overall Study|Lost to Follow-up|1|||
37816361|NCT02352948|69494941|FG000|Overall Study|Withdrawal by Subject|1|||
37816362|NCT02352948|69494942|FG001|Overall Study|Withdrawal by Subject|10|||
37871426|NCT00979953|69555616|FG002|Overall Study|Adverse Event|17|||
37816363|NCT02352948|69494943|FG002|Overall Study|Withdrawal by Subject|11|||
37816364|NCT02352948|69494944|FG003|Overall Study|Withdrawal by Subject|23|||
37816365|NCT02352948|69494945|FG004|Overall Study|Withdrawal by Subject|9|||
37816366|NCT02352948|69494946|FG005|Overall Study|Withdrawal by Subject|4|||
37816367|NCT02352948|69494941|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
37871427|NCT00979953|69555617|FG003|Overall Study|Adverse Event|4|||
37871428|NCT00979953|69555614|FG000|Overall Study|Lack of Efficacy|1|||
37871429|NCT00979953|69555615|FG001|Overall Study|Lack of Efficacy|2|||
37871430|NCT00979953|69555616|FG002|Overall Study|Lack of Efficacy|0|||
37871431|NCT00979953|69555617|FG003|Overall Study|Lack of Efficacy|0|||
37871432|NCT00979953|69555614|FG000|Overall Study|Lost to Follow-up|1|||
37871433|NCT00979953|69555615|FG001|Overall Study|Lost to Follow-up|1|||
37871434|NCT00979953|69555616|FG002|Overall Study|Lost to Follow-up|1|||
37871435|NCT00979953|69555617|FG003|Overall Study|Lost to Follow-up|0|||
37871436|NCT00979953|69555614|FG000|Overall Study|Withdrawal by Subject|0|||
37871437|NCT00979953|69555615|FG001|Overall Study|Withdrawal by Subject|0|||
37871438|NCT00979953|69555616|FG002|Overall Study|Withdrawal by Subject|2|||
37871439|NCT00979953|69555617|FG003|Overall Study|Withdrawal by Subject|1|||
37871440|NCT00979953|69555614|FG000|Overall Study|Protocol Violation|1|||
37871441|NCT00979953|69555615|FG001|Overall Study|Protocol Violation|0|||
37871442|NCT00979953|69555616|FG002|Overall Study|Protocol Violation|2|||
37871443|NCT00979953|69555617|FG003|Overall Study|Protocol Violation|2|||
37871444|NCT01181531|69555629|FG000|Overall Study|Other|17|||
37871445|NCT01181531|69555630|FG001|Overall Study|Other|12|||
37871446|NCT01181531|69555629|FG000|Overall Study|Partial consent by subject withdrawn|0|||
37871447|NCT01181531|69555630|FG001|Overall Study|Partial consent by subject withdrawn|1|||
37871448|NCT01181531|69555629|FG000|Overall Study|Physician Decision|3|||
37871449|NCT01181531|69555630|FG001|Overall Study|Physician Decision|1|||
37871450|NCT01181531|69555629|FG000|Overall Study|Noncompliance|2|||
37871451|NCT01181531|69555630|FG001|Overall Study|Noncompliance|2|||
37871452|NCT01181531|69555629|FG000|Overall Study|Ineligibility determined|1|||
37871453|NCT01181531|69555630|FG001|Overall Study|Ineligibility determined|2|||
37871454|NCT01181531|69555629|FG000|Overall Study|Protocol Specified Criteria|15|||
37871455|NCT01181531|69555630|FG001|Overall Study|Protocol Specified Criteria|8|||
37871456|NCT01181531|69555629|FG000|Overall Study|Pregnancy|0|||
37871457|NCT01181531|69555630|FG001|Overall Study|Pregnancy|1|||
37871458|NCT01181531|69555629|FG000|Overall Study|Withdrawal by Subject|8|||
37871459|NCT01181531|69555630|FG001|Overall Study|Withdrawal by Subject|7|||
37871460|NCT01181531|69555629|FG000|Overall Study|Protocol Violation|6|||
37871461|NCT01181531|69555630|FG001|Overall Study|Protocol Violation|6|||
37871462|NCT01181531|69555629|FG000|Overall Study|Death|9|||
37871463|NCT01181531|69555630|FG001|Overall Study|Death|12|||
37871464|NCT01181531|69555629|FG000|Overall Study|Adverse Event|0|||
37871465|NCT01181531|69555630|FG001|Overall Study|Adverse Event|1|||
37871466|NCT01152450|69555636|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
37871467|NCT01152450|69555637|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
37871468|NCT01152450|69555638|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
37871469|NCT01152450|69555639|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
37871470|NCT01152450|69555640|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
37871471|NCT01152450|69555641|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
37871472|NCT01152450|69555636|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
37871473|NCT01152450|69555637|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
37871474|NCT01152450|69555638|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
37871475|NCT01152450|69555639|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
37871476|NCT01152450|69555640|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
37871477|NCT01152450|69555641|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
37871478|NCT01152450|69555636|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
37871479|NCT01152450|69555637|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
37871480|NCT01152450|69555638|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
37871481|NCT01152450|69555639|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
37871482|NCT01152450|69555640|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
37871483|NCT01152450|69555641|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
37871484|NCT01181141|69555651|FG000|Overall Study|Adverse Event|2|||
37871485|NCT01181141|69555652|FG001|Overall Study|Adverse Event|1|||
37871486|NCT01181141|69555651|FG000|Overall Study|Lack of Efficacy|1|||
37871487|NCT01181141|69555652|FG001|Overall Study|Lack of Efficacy|0|||
37871488|NCT01181141|69555651|FG000|Overall Study|Lost to Follow-up|1|||
37871489|NCT01181141|69555652|FG001|Overall Study|Lost to Follow-up|1|||
37871490|NCT01181141|69555651|FG000|Overall Study|Physician Decision|2|||
37871491|NCT01181141|69555652|FG001|Overall Study|Physician Decision|0|||
37871492|NCT01181141|69555651|FG000|Overall Study|Protocol Violation|3|||
37871493|NCT01181141|69555652|FG001|Overall Study|Protocol Violation|1|||
37871494|NCT01181141|69555651|FG000|Overall Study|Withdrawal by Subject|3|||
37871495|NCT01181141|69555652|FG001|Overall Study|Withdrawal by Subject|1|||
37871496|NCT01173120|69555658|FG000|Overall Study|Lack of Efficacy|2|||
37871497|NCT01173120|69555658|FG000|Overall Study|Lost to Follow-up|1|||
37871498|NCT01173120|69555658|FG000|Overall Study|Participant Decision|2|||
37871499|NCT01173120|69555658|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
37871500|NCT01173120|69555658|FG000|Overall Study|Switch-Participant Decision|12|||
37871501|NCT01173120|69555658|FG000|Overall Study|Switch-Difficulty With Device|12|||
37871502|NCT00977379|69555666|FG000|Overall Study|Withdrawal by Subject|1|||
37980721|NCT00330681|69667307|FG000|Overall Study|Protocol Violation|0|||
37980722|NCT00330681|69667308|FG001|Overall Study|Protocol Violation|1|||
37980723|NCT00330681|69667307|FG000|Overall Study|Withdrawal by Subject|5|||
37980724|NCT00330681|69667308|FG001|Overall Study|Withdrawal by Subject|5|||
37980725|NCT00330681|69667307|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
37980726|NCT00330681|69667308|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
37980727|NCT00329901|69667317|FG000|Overall Study|Withdrawal by Subject|4|||
37980728|NCT00329901|69667318|FG001|Overall Study|Withdrawal by Subject|3|||
37980729|NCT00329901|69667319|FG002|Overall Study|Withdrawal by Subject|2|||
37980730|NCT00329901|69667317|FG000|Overall Study|Lost to Follow-up|2|||
37980731|NCT00329901|69667318|FG001|Overall Study|Lost to Follow-up|0|||
37980732|NCT00329901|69667319|FG002|Overall Study|Lost to Follow-up|1|||
37980733|NCT00329901|69667317|FG000|Overall Study|Protocol Violation|1|||
37980734|NCT00329901|69667318|FG001|Overall Study|Protocol Violation|0|||
37980735|NCT00329901|69667319|FG002|Overall Study|Protocol Violation|1|||
37980736|NCT00329901|69667317|FG000|Overall Study|Unable to classify|2|||
37980737|NCT00329901|69667318|FG001|Overall Study|Unable to classify|2|||
37980738|NCT00329901|69667319|FG002|Overall Study|Unable to classify|0|||
37980739|NCT00436956|69667331|FG000|Overall Study|Not evaluable|1|||
37980740|NCT00436956|69667332|FG001|Overall Study|Not evaluable|0|||
37980741|NCT00329745|69667341|FG000|Overall Study|Protocol Violation|1|||
37980742|NCT00329745|69667342|FG001|Overall Study|Protocol Violation|0|||
37980743|NCT00329745|69667341|FG000|Overall Study|Withdrawal by Subject|0|||
37980744|NCT00329745|69667342|FG001|Overall Study|Withdrawal by Subject|1|||
37980745|NCT00329745|69667341|FG000|Overall Study|Lost to Follow-up|86|||
37980746|NCT00329745|69667342|FG001|Overall Study|Lost to Follow-up|101|||
37980747|NCT00436644|69667348|FG000|Overall Study|Adverse Event|2|||
37980748|NCT00436644|69667348|FG000|Overall Study|Death|1|||
37980749|NCT00324987|69667354|FG000|Overall Study|Adverse Event|2|||
37980750|NCT00324987|69667355|FG001|Overall Study|Adverse Event|1|||
37980751|NCT00324987|69667354|FG000|Overall Study|Withdrawal by Subject|1|||
37980752|NCT00324987|69667355|FG001|Overall Study|Withdrawal by Subject|1|||
37980753|NCT00324987|69667354|FG000|Overall Study|Progression|1|||
37980754|NCT00324987|69667355|FG001|Overall Study|Progression|1|||
37980755|NCT00324987|69667354|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
37980756|NCT00324987|69667355|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
37980757|NCT00324675|69667363|FG000|Overall Study|Adverse Event|1|||
37980758|NCT00324675|69667364|FG001|Overall Study|Adverse Event|0|||
37980759|NCT00436566|69667370|FG000|Overall Study|Withdrawal by Subject|2|||
37980760|NCT00436566|69667370|FG000|Overall Study|Protocol Violation|1|||
37980761|NCT00352365|69667374|FG000|Induction Therapy|Adverse Event|7|||
37980762|NCT00352365|69667374|FG000|Induction Therapy|Progression/Relapse|8|||
37980763|NCT00352365|69667374|FG000|Induction Therapy|Death|7|||
37980764|NCT00352365|69667374|FG000|Induction Therapy|Not protocol specified|1|||
37871503|NCT00977379|69555667|FG001|Overall Study|Withdrawal by Subject|1|||
37980765|NCT00352365|69667374|FG000|Induction Therapy|Not eligible|3|||
37871504|NCT00977379|69555666|FG000|Overall Study|Death|7|||
37871505|NCT00977379|69555667|FG001|Overall Study|Death|9|||
37871506|NCT00977379|69555666|FG000|Overall Study|Premature Study Termination|4|||
37871507|NCT00977379|69555667|FG001|Overall Study|Premature Study Termination|0|||
37871508|NCT00977379|69555666|FG000|Overall Study|Participant Moving House|0|||
37871509|NCT00977379|69555667|FG001|Overall Study|Participant Moving House|1|||
37871510|NCT00977379|69555666|FG000|Overall Study|Randomization Error|0|||
37871511|NCT00977379|69555667|FG001|Overall Study|Randomization Error|1|||
37871512|NCT01180985|69555673|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
37871513|NCT01180985|69555674|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
37871514|NCT01147536|69555681|FG000|Overall Study|Administrative study close|2|||
37980766|NCT00352365|69667374|FG000|Induction Therapy|Death before starting protocol therapy|1|||
37980767|NCT00352365|69667374|FG000|Maintenance Therapy|Progression/Relapse|3|||
37871515|NCT01147536|69555681|FG000|Overall Study|Death|1|||
37980768|NCT00352365|69667374|FG000|Maintenance Therapy|Death|2|||
37980769|NCT00352365|69667374|FG000|Maintenance Therapy|Not protocol specified|3|||
37980770|NCT00352365|69667374|FG000|Maintenance Therapy|Not eligible|4|||
37871516|NCT01154088|69555688|FG000|Overall Study|Lost to Follow-up|4|||
37871517|NCT01154088|69555689|FG001|Overall Study|Lost to Follow-up|6|||
37980771|NCT00532493|69667384|FG000|Overall Study|Death|1|||
37980772|NCT00532493|69667385|FG001|Overall Study|Death|1|||
37980773|NCT00532493|69667384|FG000|Overall Study|Lost to Follow-up|10|||
37871518|NCT01154088|69555690|FG002|Overall Study|Lost to Follow-up|7|||
37871519|NCT01180049|69555701|FG000|Overall Study|Other|9|||
37871520|NCT01180049|69555702|FG001|Overall Study|Other|7|||
37871521|NCT01180049|69555701|FG000|Overall Study|Lost to Follow-up|8|||
37871522|NCT01180049|69555702|FG001|Overall Study|Lost to Follow-up|6|||
37871523|NCT01180049|69555701|FG000|Overall Study|Death|36|||
37871524|NCT01180049|69555702|FG001|Overall Study|Death|35|||
37871525|NCT01147458|69555708|FG000|First Intervention|Study terminated by sponsor|8|||
37871526|NCT01147458|69555709|FG001|First Intervention|Study terminated by sponsor|8|||
37871527|NCT01147458|69555710|FG002|First Intervention|Study terminated by sponsor|7|||
37871528|NCT01147458|69555711|FG003|First Intervention|Study terminated by sponsor|8|||
37871529|NCT01147458|69555708|FG000|First Intervention|Protocol Violation|2|||
37871530|NCT01147458|69555709|FG001|First Intervention|Protocol Violation|3|||
37871531|NCT01147458|69555710|FG002|First Intervention|Protocol Violation|2|||
37871532|NCT01147458|69555711|FG003|First Intervention|Protocol Violation|3|||
37871533|NCT01147458|69555708|FG000|First Intervention|Withdrawal by Subject|3|||
37871534|NCT01147458|69555709|FG001|First Intervention|Withdrawal by Subject|0|||
37871535|NCT01147458|69555710|FG002|First Intervention|Withdrawal by Subject|1|||
37871536|NCT01147458|69555711|FG003|First Intervention|Withdrawal by Subject|0|||
37871537|NCT01147458|69555708|FG000|First Intervention|Adverse Event|0|||
37871538|NCT01147458|69555709|FG001|First Intervention|Adverse Event|3|||
37871539|NCT01147458|69555710|FG002|First Intervention|Adverse Event|2|||
37871540|NCT01147458|69555711|FG003|First Intervention|Adverse Event|3|||
37871541|NCT01147458|69555708|FG000|First Intervention|Other|1|||
37871542|NCT01147458|69555709|FG001|First Intervention|Other|2|||
37871543|NCT01147458|69555710|FG002|First Intervention|Other|0|||
37871544|NCT01147458|69555711|FG003|First Intervention|Other|0|||
37871545|NCT01147458|69555708|FG000|Second Intervention|Study terminated by sponsor|7|||
37871546|NCT01147458|69555709|FG001|Second Intervention|Study terminated by sponsor|5|||
37871547|NCT01147458|69555710|FG002|Second Intervention|Study terminated by sponsor|5|||
37871548|NCT01147458|69555711|FG003|Second Intervention|Study terminated by sponsor|3|||
37871549|NCT01147458|69555708|FG000|Second Intervention|Protocol Violation|0|||
37871550|NCT01147458|69555709|FG001|Second Intervention|Protocol Violation|1|||
37871551|NCT01147458|69555710|FG002|Second Intervention|Protocol Violation|1|||
37871552|NCT01147458|69555711|FG003|Second Intervention|Protocol Violation|0|||
37871553|NCT01147458|69555708|FG000|Second Intervention|Withdrawal by Subject|0|||
37871554|NCT01147458|69555709|FG001|Second Intervention|Withdrawal by Subject|1|||
37871555|NCT01147458|69555710|FG002|Second Intervention|Withdrawal by Subject|0|||
37871556|NCT01147458|69555711|FG003|Second Intervention|Withdrawal by Subject|0|||
37871557|NCT01147458|69555708|FG000|Second Intervention|Adverse Event|2|||
37871558|NCT01147458|69555709|FG001|Second Intervention|Adverse Event|0|||
37871559|NCT01147458|69555710|FG002|Second Intervention|Adverse Event|1|||
37871560|NCT01147458|69555711|FG003|Second Intervention|Adverse Event|1|||
37871561|NCT01147458|69555708|FG000|Second Intervention|Other|0|||
37871562|NCT01147458|69555709|FG001|Second Intervention|Other|0|||
37871563|NCT01147458|69555710|FG002|Second Intervention|Other|1|||
37816368|NCT02352948|69494942|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
37816369|NCT02352948|69494943|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
37816370|NCT02352948|69494944|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
37816371|NCT02352948|69494945|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
37816372|NCT02352948|69494946|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
37816373|NCT02352948|69494941|FG000|Overall Study|Other|0|||
37816374|NCT02352948|69494942|FG001|Overall Study|Other|0|||
37816375|NCT02352948|69494943|FG002|Overall Study|Other|2|||
37816376|NCT02352948|69494944|FG003|Overall Study|Other|0|||
37816377|NCT02352948|69494945|FG004|Overall Study|Other|0|||
37816378|NCT02352948|69494946|FG005|Overall Study|Other|0|||
37816379|NCT02246621|69495022|FG000|Overall Study|Withdrawal by Subject|28|||
37816380|NCT02246621|69495023|FG001|Overall Study|Withdrawal by Subject|16|||
37816381|NCT02246621|69495022|FG000|Overall Study|Lost to Follow-up|1|||
37816382|NCT02246621|69495023|FG001|Overall Study|Lost to Follow-up|0|||
37816383|NCT02246621|69495022|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
37871564|NCT01147458|69555711|FG003|Second Intervention|Other|0|||
37871565|NCT01172808|69555727|FG000|Overall Study|Adverse Event|8|||
37871566|NCT01172808|69555728|FG001|Overall Study|Adverse Event|4|||
37871567|NCT01172808|69555729|FG002|Overall Study|Adverse Event|8|||
37871568|NCT01172808|69555730|FG003|Overall Study|Adverse Event|3|||
37871569|NCT01172808|69555727|FG000|Overall Study|Lack of Efficacy|1|||
37871570|NCT01172808|69555728|FG001|Overall Study|Lack of Efficacy|0|||
37871571|NCT01172808|69555729|FG002|Overall Study|Lack of Efficacy|0|||
37871572|NCT01172808|69555730|FG003|Overall Study|Lack of Efficacy|0|||
37871573|NCT01172808|69555727|FG000|Overall Study|Protocol Violation|2|||
37816384|NCT02246621|69495023|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
37816385|NCT02197234|69495029|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
37871574|NCT01172808|69555728|FG001|Overall Study|Protocol Violation|2|||
37871575|NCT01172808|69555729|FG002|Overall Study|Protocol Violation|2|||
37816386|NCT02197234|69495029|FG000|Part A: Day 3-30 (AZD9291 Alone)|Adverse Event|1|||
37871576|NCT01172808|69555730|FG003|Overall Study|Protocol Violation|0|||
37871577|NCT01172808|69555727|FG000|Overall Study|Lost to Follow-up|0|||
37871578|NCT01172808|69555728|FG001|Overall Study|Lost to Follow-up|1|||
37871579|NCT01172808|69555729|FG002|Overall Study|Lost to Follow-up|1|||
37871580|NCT01172808|69555730|FG003|Overall Study|Lost to Follow-up|3|||
37871581|NCT01172808|69555727|FG000|Overall Study|Withdrawal by Subject|4|||
37871582|NCT01172808|69555728|FG001|Overall Study|Withdrawal by Subject|1|||
37871583|NCT01172808|69555729|FG002|Overall Study|Withdrawal by Subject|3|||
37871584|NCT01172808|69555730|FG003|Overall Study|Withdrawal by Subject|2|||
37871585|NCT01172808|69555727|FG000|Overall Study|Other|6|||
37871586|NCT01172808|69555728|FG001|Overall Study|Other|5|||
37871587|NCT01172808|69555729|FG002|Overall Study|Other|9|||
37871588|NCT01172808|69555730|FG003|Overall Study|Other|7|||
37871589|NCT01151280|69555740|FG000|Overall Study|Adverse Event|1|||
37871590|NCT01151280|69555740|FG000|Overall Study|Lack of Efficacy|3|||
37871591|NCT01149486|69555746|FG000|First Intervention|Adverse Event|0|||
37871592|NCT01149486|69555747|FG001|First Intervention|Adverse Event|1|||
37871593|NCT00601705|69555753|FG000|Overall Study|Withdrawal by Subject|1|||
37871594|NCT01179737|69555762|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
37871595|NCT01179737|69555763|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
37871596|NCT01179737|69555764|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
37871597|NCT01179737|69555765|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
37871598|NCT01179737|69555762|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
37871599|NCT01179737|69555763|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
37871600|NCT01179737|69555764|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
37871601|NCT01179737|69555765|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
37871602|NCT01179737|69555762|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
37871603|NCT01179737|69555763|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
37871604|NCT01179737|69555764|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
37871605|NCT01179737|69555765|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
37871606|NCT01179737|69555762|FG000|Cohort 1 & Cohort 2|Death|0|||
37871607|NCT01179737|69555763|FG001|Cohort 1 & Cohort 2|Death|0|||
37871608|NCT01179737|69555764|FG002|Cohort 1 & Cohort 2|Death|1|||
37871609|NCT01179737|69555765|FG003|Cohort 1 & Cohort 2|Death|0|||
37871610|NCT01179737|69555762|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
37871611|NCT01179737|69555763|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
37871612|NCT01179737|69555764|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
37871613|NCT01179737|69555765|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
37871614|NCT01179737|69555762|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
37980774|NCT00532493|69667385|FG001|Overall Study|Lost to Follow-up|7|||
37980775|NCT00532493|69667384|FG000|Overall Study|Withdrawal by Subject|7|||
37980776|NCT00532493|69667385|FG001|Overall Study|Withdrawal by Subject|9|||
37980777|NCT00532493|69667384|FG000|Overall Study|Physician Decision|1|||
37980778|NCT00532493|69667385|FG001|Overall Study|Physician Decision|6|||
37980779|NCT00532493|69667384|FG000|Overall Study|Adverse Event|6|||
37980780|NCT00532493|69667385|FG001|Overall Study|Adverse Event|5|||
37980781|NCT00532493|69667384|FG000|Overall Study|Protocol Deviation|1|||
37980782|NCT00532493|69667385|FG001|Overall Study|Protocol Deviation|0|||
37980783|NCT00532493|69667384|FG000|Overall Study|Subject Moved Away|3|||
37980784|NCT00532493|69667385|FG001|Overall Study|Subject Moved Away|1|||
37980785|NCT00532493|69667384|FG000|Overall Study|Contraindicative Medication|1|||
37980786|NCT00532493|69667385|FG001|Overall Study|Contraindicative Medication|0|||
37980787|NCT00533507|69667393|FG000|Overall Study|Withdrawal by Subject|1|||
37980788|NCT03886493|69667397|FG000|Overall Study|Adverse Event|1|||
37871615|NCT01179737|69555763|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
37871616|NCT01179737|69555764|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
37980789|NCT00352053|69667403|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
37980790|NCT00352053|69667404|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
37980791|NCT00352053|69667403|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
37871617|NCT01179737|69555765|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
37871618|NCT01179737|69555762|FG000|Extension|The study was terminated|3|||
37980792|NCT00352053|69667404|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
37980793|NCT00352053|69667403|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
37980794|NCT00352053|69667404|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
37980795|NCT00352053|69667403|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
37871619|NCT01179737|69555763|FG001|Extension|The study was terminated|0|||
37871620|NCT01179737|69555764|FG002|Extension|The study was terminated|0|||
37871621|NCT01179737|69555765|FG003|Extension|The study was terminated|0|||
37871622|NCT00929110|69555777|FG000|Overall Study|Adverse Event|40|||
37871623|NCT00929110|69555778|FG001|Overall Study|Adverse Event|29|||
37980796|NCT00352053|69667404|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
37980797|NCT00352053|69667403|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
37980798|NCT00352053|69667404|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
37980799|NCT00352053|69667403|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
37980800|NCT00352053|69667404|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
37871624|NCT00929110|69555779|FG002|Overall Study|Adverse Event|18|||
37871625|NCT00929110|69555777|FG000|Overall Study|Subject withdrew consent|40|||
37871626|NCT00929110|69555778|FG001|Overall Study|Subject withdrew consent|23|||
37871627|NCT00929110|69555779|FG002|Overall Study|Subject withdrew consent|26|||
37871628|NCT00929110|69555777|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
37871629|NCT00929110|69555778|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
37871630|NCT00929110|69555779|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
37871631|NCT00929110|69555777|FG000|Overall Study|Lost to Follow-up|7|||
37871632|NCT00929110|69555778|FG001|Overall Study|Lost to Follow-up|7|||
37871633|NCT00929110|69555779|FG002|Overall Study|Lost to Follow-up|3|||
37871634|NCT00929110|69555777|FG000|Overall Study|Protocol deviation|5|||
37980801|NCT00352053|69667403|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
37980802|NCT00352053|69667404|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
37816387|NCT02197234|69495029|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
37816388|NCT02197234|69495029|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
37816389|NCT02197234|69495029|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
37816390|NCT02197234|69495029|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
37816391|NCT02197234|69495029|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
37816392|NCT02125461|69495038|FG000|Overall Study|Withdrawal by Subject|30|||
37816393|NCT02125461|69495039|FG001|Overall Study|Withdrawal by Subject|16|||
37816394|NCT02125461|69495038|FG000|Overall Study|Lost to Follow-up|8|||
37816395|NCT02125461|69495039|FG001|Overall Study|Lost to Follow-up|3|||
37816396|NCT02125461|69495038|FG000|Overall Study|Death|260|||
37816397|NCT02125461|69495039|FG001|Overall Study|Death|149|||
37816398|NCT02125461|69495038|FG000|Overall Study|Missing Termination Reason|0|||
37816399|NCT02125461|69495039|FG001|Overall Study|Missing Termination Reason|1|||
37816400|NCT02096042|69495045|FG000|Overall Study|Disease Progression|1|||
37816401|NCT02096042|69495046|FG001|Overall Study|Disease Progression|0|||
37816402|NCT02096042|69495047|FG002|Overall Study|Disease Progression|0|||
37816403|NCT02003924|69495056|FG000|Double-blind Phase|Lost to Follow-up|2|||
37816404|NCT02003924|69495057|FG001|Double-blind Phase|Lost to Follow-up|1|||
37816405|NCT02003924|69495058|FG002|Double-blind Phase|Lost to Follow-up|0|||
37816406|NCT02003924|69495056|FG000|Double-blind Phase|Protocol Violation|1|||
37816407|NCT02003924|69495057|FG001|Double-blind Phase|Protocol Violation|2|||
37816408|NCT02003924|69495058|FG002|Double-blind Phase|Protocol Violation|0|||
37816409|NCT02003924|69495056|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
37816410|NCT02003924|69495057|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
37816411|NCT02003924|69495058|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
37816412|NCT02003924|69495056|FG000|Double-blind Phase|Disease Progression|229|||
37816413|NCT02003924|69495057|FG001|Double-blind Phase|Disease Progression|247|||
37816414|NCT02003924|69495058|FG002|Double-blind Phase|Disease Progression|0|||
37816415|NCT02003924|69495056|FG000|Double-blind Phase|Adverse Event|120|||
37816416|NCT02003924|69495057|FG001|Double-blind Phase|Adverse Event|31|||
37816417|NCT02003924|69495058|FG002|Double-blind Phase|Adverse Event|0|||
37816418|NCT02003924|69495056|FG000|Double-blind Phase|Randomized But not Treated|3|||
37816419|NCT02003924|69495057|FG001|Double-blind Phase|Randomized But not Treated|3|||
37816420|NCT02003924|69495058|FG002|Double-blind Phase|Randomized But not Treated|0|||
37694964|NCT01835470|69171416|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
37694965|NCT02451137|69171423|FG000|Overall Study|Randomized but not treated|19|||
37816421|NCT02003924|69495056|FG000|Double-blind Phase|Other|29|||
37871635|NCT00929110|69555778|FG001|Overall Study|Protocol deviation|2|||
37871636|NCT00929110|69555779|FG002|Overall Study|Protocol deviation|4|||
37871637|NCT00929110|69555777|FG000|Overall Study|Administrative problems|4|||
37871638|NCT00929110|69555778|FG001|Overall Study|Administrative problems|1|||
37871639|NCT00929110|69555779|FG002|Overall Study|Administrative problems|2|||
37871640|NCT00929110|69555777|FG000|Overall Study|Death|2|||
37816422|NCT02003924|69495057|FG001|Double-blind Phase|Other|50|||
37816423|NCT02003924|69495058|FG002|Double-blind Phase|Other|0|||
37816424|NCT02003924|69495056|FG000|Open-label Phase|Lost to Follow-up|0|||
37816425|NCT02003924|69495057|FG001|Open-label Phase|Lost to Follow-up|0|||
37816426|NCT02003924|69495058|FG002|Open-label Phase|Lost to Follow-up|1|||
37816427|NCT02003924|69495056|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
37816428|NCT02003924|69495057|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
37816429|NCT02003924|69495058|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
37816430|NCT02003924|69495056|FG000|Open-label Phase|Disease Progression|59|||
37816431|NCT02003924|69495057|FG001|Open-label Phase|Disease Progression|0|||
37816432|NCT02003924|69495058|FG002|Open-label Phase|Disease Progression|5|||
37816433|NCT02003924|69495056|FG000|Open-label Phase|Adverse Event|25|||
37816434|NCT02003924|69495057|FG001|Open-label Phase|Adverse Event|0|||
37816435|NCT02003924|69495058|FG002|Open-label Phase|Adverse Event|10|||
37871641|NCT00929110|69555778|FG001|Overall Study|Death|2|||
37871642|NCT00929110|69555779|FG002|Overall Study|Death|2|||
37694966|NCT02451137|69171424|FG001|Overall Study|Randomized but not treated|27|||
37816436|NCT02003924|69495056|FG000|Open-label Phase|Other|7|||
37816437|NCT02003924|69495057|FG001|Open-label Phase|Other|0|||
37871643|NCT00929110|69555777|FG000|Overall Study|Abnormal laboratory value(s)|0|||
37871644|NCT00929110|69555778|FG001|Overall Study|Abnormal laboratory value(s)|1|||
37871645|NCT00929110|69555779|FG002|Overall Study|Abnormal laboratory value(s)|0|||
37871646|NCT00929110|69555777|FG000|Overall Study|Abnormal test procedure result(s)|0|||
37871647|NCT00929110|69555778|FG001|Overall Study|Abnormal test procedure result(s)|1|||
37871648|NCT00929110|69555779|FG002|Overall Study|Abnormal test procedure result(s)|1|||
37871649|NCT00929110|69555777|FG000|Overall Study|Patient inability to use the device|0|||
37871650|NCT00929110|69555778|FG001|Overall Study|Patient inability to use the device|1|||
37871651|NCT00929110|69555779|FG002|Overall Study|Patient inability to use the device|0|||
37871652|NCT01147068|69555794|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
37871653|NCT01147068|69555795|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
37871654|NCT01147068|69555796|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
37871655|NCT01147068|69555797|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
37871656|NCT01147068|69555798|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
37871657|NCT01147068|69555799|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
37871658|NCT01147068|69555800|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
37871659|NCT01147068|69555794|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
37871660|NCT01147068|69555795|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
37871661|NCT01147068|69555796|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
37871662|NCT01147068|69555797|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
37871663|NCT01147068|69555798|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
37980803|NCT00352053|69667403|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
37980804|NCT00352053|69667404|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
37980805|NCT00352053|69667403|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
37980806|NCT00352053|69667404|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
37980807|NCT00352053|69667403|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
37980808|NCT00352053|69667404|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
37980809|NCT00352053|69667403|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
37980810|NCT00352053|69667404|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
37980811|NCT00352053|69667403|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
37980812|NCT00352053|69667404|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
37980813|NCT00352053|69667403|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
37816438|NCT02003924|69495058|FG002|Open-label Phase|Other|0|||
37816439|NCT02003924|69495056|FG000|Long-term Follow-up Phase|Death|288|||
37816440|NCT02003924|69495057|FG001|Long-term Follow-up Phase|Death|174|||
37980814|NCT00352053|69667404|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
37980815|NCT00351819|69667420|FG000|Overall Study|Lost to Follow-up|4|||
37980816|NCT00351819|69667421|FG001|Overall Study|Lost to Follow-up|4|||
37980817|NCT00351819|69667420|FG000|Overall Study|Withdrawal by Subject|0|||
37980818|NCT00351819|69667421|FG001|Overall Study|Withdrawal by Subject|4|||
37980819|NCT00351819|69667420|FG000|Overall Study|Elevated PSA|1|||
37980820|NCT00351819|69667421|FG001|Overall Study|Elevated PSA|1|||
37980821|NCT00351819|69667420|FG000|Overall Study|Traumatic ankle fracture|1|||
37816441|NCT02003924|69495058|FG002|Long-term Follow-up Phase|Death|4|||
37816442|NCT02003924|69495056|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
37816443|NCT02003924|69495057|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
37816444|NCT02003924|69495058|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
37816445|NCT02003924|69495056|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
37816446|NCT02003924|69495057|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
37816447|NCT02003924|69495058|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
37816448|NCT02003924|69495056|FG000|Long-term Follow-up Phase|Other|5|||
37816449|NCT02003924|69495057|FG001|Long-term Follow-up Phase|Other|2|||
37816450|NCT02003924|69495058|FG002|Long-term Follow-up Phase|Other|1|||
37816451|NCT01940471|69495067|FG000|Period 1: Double-blind Phase|Withdrew Consent|31|||
37816452|NCT01940471|69495068|FG001|Period 1: Double-blind Phase|Withdrew Consent|18|||
37816453|NCT01940471|69495069|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
37816454|NCT01940471|69495070|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
37816455|NCT01940471|69495067|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
37816456|NCT01940471|69495068|FG001|Period 1: Double-blind Phase|Lost to Follow-up|6|||
37871664|NCT01147068|69555799|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
37816457|NCT01940471|69495069|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
37816458|NCT01940471|69495070|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
37871665|NCT01147068|69555800|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
37871666|NCT01147068|69555794|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
37871667|NCT01147068|69555795|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
37871668|NCT01147068|69555796|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
37871669|NCT01147068|69555797|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
37871670|NCT01147068|69555798|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
37871671|NCT01147068|69555799|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
37980822|NCT00351819|69667421|FG001|Overall Study|Traumatic ankle fracture|0|||
37980823|NCT00351819|69667420|FG000|Overall Study|Unprofessional behavior|1|||
37980824|NCT00351819|69667421|FG001|Overall Study|Unprofessional behavior|0|||
37871672|NCT01147068|69555800|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
37871673|NCT01147068|69555794|FG000|Subjects That Received 2nd Dose|Other|0|||
37871674|NCT01147068|69555795|FG001|Subjects That Received 2nd Dose|Other|3|||
37871675|NCT01147068|69555796|FG002|Subjects That Received 2nd Dose|Other|3|||
37871676|NCT01147068|69555797|FG003|Subjects That Received 2nd Dose|Other|0|||
37871677|NCT01147068|69555798|FG004|Subjects That Received 2nd Dose|Other|1|||
37871678|NCT01147068|69555799|FG005|Subjects That Received 2nd Dose|Other|0|||
37871679|NCT01147068|69555800|FG006|Subjects That Received 2nd Dose|Other|0|||
37694967|NCT02451137|69171423|FG000|Overall Study|Adverse Event|43|||
37871680|NCT01147068|69555794|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
37871681|NCT01147068|69555795|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
37871682|NCT01147068|69555796|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
37871683|NCT01147068|69555797|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
37871684|NCT01147068|69555798|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
37871685|NCT01147068|69555799|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
37871686|NCT01147068|69555800|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
37871687|NCT01147068|69555794|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
37871688|NCT01147068|69555795|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
37871689|NCT01147068|69555796|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
37871690|NCT01147068|69555797|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
37871691|NCT01147068|69555798|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
37871692|NCT01147068|69555799|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
37871693|NCT01147068|69555800|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
37871694|NCT01147068|69555794|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
37871695|NCT01147068|69555795|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
37871696|NCT01147068|69555796|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
37871697|NCT01147068|69555797|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
37871698|NCT01147068|69555798|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
37871699|NCT01147068|69555799|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
37871700|NCT01147068|69555800|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
37871701|NCT01146912|69555823|FG000|Overall Study|Already received influenza vaccination|817|||
37871702|NCT01146912|69555824|FG001|Overall Study|Already received influenza vaccination|822|||
37871703|NCT01146912|69555825|FG002|Overall Study|Already received influenza vaccination|13|||
37871704|NCT01146912|69555826|FG003|Overall Study|Already received influenza vaccination|15|||
37871705|NCT01146912|69555827|FG004|Overall Study|Already received influenza vaccination|41|||
37871706|NCT01146912|69555828|FG005|Overall Study|Already received influenza vaccination|61|||
37871707|NCT01146912|69555829|FG006|Overall Study|Already received influenza vaccination|56|||
37871708|NCT01146912|69555830|FG007|Overall Study|Already received influenza vaccination|0|||
37871709|NCT01146912|69555823|FG000|Overall Study|< 14 weeks gestational age|0|||
37871710|NCT01146912|69555824|FG001|Overall Study|< 14 weeks gestational age|0|||
37980825|NCT00351819|69667420|FG000|Overall Study|Non-compliance|0|||
37980826|NCT00351819|69667421|FG001|Overall Study|Non-compliance|1|||
37980827|NCT00351819|69667420|FG000|Overall Study|Incarcerated|0|||
37980828|NCT00351819|69667421|FG001|Overall Study|Incarcerated|1|||
37980829|NCT00351819|69667420|FG000|Overall Study|Enrolled in another trial|0|||
37980830|NCT00351819|69667421|FG001|Overall Study|Enrolled in another trial|1|||
37694968|NCT02451137|69171424|FG001|Overall Study|Adverse Event|42|||
37980831|NCT00351351|69667429|FG000|Overall Study|surgical access pbs; device issues|9|||
37980832|NCT00351351|69667430|FG001|Overall Study|surgical access pbs; device issues|4|||
37871711|NCT01146912|69555825|FG002|Overall Study|< 14 weeks gestational age|3|||
37871712|NCT01146912|69555826|FG003|Overall Study|< 14 weeks gestational age|2|||
37980833|NCT00323115|69667436|FG000|Vaccine Administration|Adverse Event|1|||
37980834|NCT00323115|69667436|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
37980835|NCT00322881|69667445|FG000|Overall Study|Death|2|||
37980836|NCT00322881|69667445|FG000|Overall Study|Adverse Event|1|||
37980837|NCT00322881|69667445|FG000|Overall Study|Disease Progression|2|||
37980838|NCT00415194|69667451|FG000|Overall Study|Adverse Event|37|||
37980839|NCT00415194|69667452|FG001|Overall Study|Adverse Event|32|||
37980840|NCT00415194|69667451|FG000|Overall Study|Entry Criteria Not Met|4|||
37980841|NCT00415194|69667452|FG001|Overall Study|Entry Criteria Not Met|8|||
37871713|NCT01146912|69555827|FG004|Overall Study|< 14 weeks gestational age|0|||
37871714|NCT01146912|69555828|FG005|Overall Study|< 14 weeks gestational age|0|||
37871715|NCT01146912|69555829|FG006|Overall Study|< 14 weeks gestational age|0|||
37871716|NCT01146912|69555830|FG007|Overall Study|< 14 weeks gestational age|0|||
37871717|NCT01146912|69555823|FG000|Overall Study|Duplicate patient|0|||
37871718|NCT01146912|69555824|FG001|Overall Study|Duplicate patient|0|||
37871719|NCT01146912|69555825|FG002|Overall Study|Duplicate patient|1|||
37871720|NCT01146912|69555826|FG003|Overall Study|Duplicate patient|0|||
37871721|NCT01146912|69555827|FG004|Overall Study|Duplicate patient|0|||
37871722|NCT01146912|69555828|FG005|Overall Study|Duplicate patient|0|||
37871723|NCT01146912|69555829|FG006|Overall Study|Duplicate patient|0|||
37871724|NCT01146912|69555830|FG007|Overall Study|Duplicate patient|0|||
37871725|NCT01134042|69555852|FG000|Overall Study|Adverse Event|3|||
37871726|NCT01134042|69555853|FG001|Overall Study|Adverse Event|7|||
37871727|NCT01134042|69555854|FG002|Overall Study|Adverse Event|2|||
37871728|NCT01134042|69555852|FG000|Overall Study|Lack of Efficacy|21|||
37871729|NCT01134042|69555853|FG001|Overall Study|Lack of Efficacy|6|||
37871730|NCT01134042|69555854|FG002|Overall Study|Lack of Efficacy|18|||
37871731|NCT01134042|69555852|FG000|Overall Study|Protocol Violation|5|||
37871732|NCT01134042|69555853|FG001|Overall Study|Protocol Violation|3|||
37871733|NCT01134042|69555854|FG002|Overall Study|Protocol Violation|5|||
37871734|NCT01134042|69555852|FG000|Overall Study|Lost to Follow-up|2|||
37871735|NCT01134042|69555853|FG001|Overall Study|Lost to Follow-up|0|||
37871736|NCT01134042|69555854|FG002|Overall Study|Lost to Follow-up|1|||
37980842|NCT00415194|69667451|FG000|Overall Study|Lost to Follow-up|1|||
37980843|NCT00415194|69667452|FG001|Overall Study|Lost to Follow-up|0|||
37980844|NCT00415194|69667451|FG000|Overall Study|Physician Decision|10|||
37980845|NCT00415194|69667452|FG001|Overall Study|Physician Decision|16|||
37980846|NCT00415194|69667451|FG000|Overall Study|Progressive Disease|180|||
37980847|NCT00415194|69667452|FG001|Overall Study|Progressive Disease|217|||
37980848|NCT00415194|69667451|FG000|Overall Study|Protocol Violation|4|||
37980849|NCT00415194|69667452|FG001|Overall Study|Protocol Violation|2|||
37980850|NCT00415194|69667451|FG000|Overall Study|Withdrawal by Subject|28|||
37980851|NCT00415194|69667452|FG001|Overall Study|Withdrawal by Subject|21|||
37980852|NCT00415194|69667451|FG000|Overall Study|Death Due to Study Disease|26|||
37980853|NCT00415194|69667452|FG001|Overall Study|Death Due to Study Disease|29|||
37816459|NCT01940471|69495067|FG000|Period 1: Double-blind Phase|Investigator's Discretion|8|||
37816460|NCT01940471|69495068|FG001|Period 1: Double-blind Phase|Investigator's Discretion|5|||
37816461|NCT01940471|69495069|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
37816462|NCT01940471|69495070|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
37816463|NCT01940471|69495067|FG000|Period 1: Double-blind Phase|Pregnancy|9|||
37816464|NCT01940471|69495068|FG001|Period 1: Double-blind Phase|Pregnancy|2|||
37816465|NCT01940471|69495069|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
37816466|NCT01940471|69495070|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
37816467|NCT01940471|69495067|FG000|Period 1: Double-blind Phase|Non-Compliance with Study Drug|3|||
37816468|NCT01940471|69495068|FG001|Period 1: Double-blind Phase|Non-Compliance with Study Drug|2|||
37816469|NCT01940471|69495069|FG002|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
37871737|NCT01134042|69555852|FG000|Overall Study|Physician Decision|4|||
37871738|NCT01134042|69555853|FG001|Overall Study|Physician Decision|8|||
37980854|NCT00415194|69667451|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
37980855|NCT00415194|69667452|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
37980856|NCT00415194|69667451|FG000|Overall Study|Death Due to Procedural Related AE|0|||
37980857|NCT00415194|69667452|FG001|Overall Study|Death Due to Procedural Related AE|1|||
37980858|NCT00415194|69667451|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
37980859|NCT00415194|69667452|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
37980860|NCT00436332|69667458|FG000|Overall Study|Adverse Event|9|||
37980861|NCT00436332|69667458|FG000|Overall Study|Withdrawal by Subject|2|||
37980862|NCT00436332|69667458|FG000|Overall Study|Progression|59|||
37871739|NCT01134042|69555854|FG002|Overall Study|Physician Decision|1|||
37980863|NCT00436332|69667458|FG000|Overall Study|Death|2|||
37871740|NCT01134042|69555852|FG000|Overall Study|Withdrawal by Subject|13|||
37871741|NCT01134042|69555853|FG001|Overall Study|Withdrawal by Subject|4|||
37871742|NCT01134042|69555854|FG002|Overall Study|Withdrawal by Subject|7|||
37871743|NCT01179347|69555865|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
37871744|NCT01179347|69555866|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
37871745|NCT01179347|69555865|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
37871746|NCT01179347|69555866|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
37871747|NCT01179347|69555865|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
37871748|NCT01179347|69555866|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
37871749|NCT01179347|69555865|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
37871750|NCT01179347|69555866|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
37871751|NCT01179347|69555865|FG000|Double-blind Period (12 Weeks)|Other|2|||
37871752|NCT01179347|69555866|FG001|Double-blind Period (12 Weeks)|Other|4|||
37871753|NCT01179347|69555865|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
37871754|NCT01179347|69555866|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
37871755|NCT01179347|69555865|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
37871756|NCT01179347|69555866|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
37871757|NCT01179347|69555865|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
37871758|NCT01179347|69555866|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
37871759|NCT01179347|69555865|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
37871760|NCT01179347|69555866|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
37871761|NCT01179347|69555865|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
37871762|NCT01179347|69555866|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
37871763|NCT01179347|69555865|FG000|Open-label Period (12 Weeks)|Other|7|||
37871764|NCT01179347|69555866|FG001|Open-label Period (12 Weeks)|Other|4|||
37871765|NCT01146288|69555876|FG000|First Intervention(1 Day)|Adverse Event|0|||
37871766|NCT01146288|69555877|FG001|First Intervention(1 Day)|Adverse Event|1|||
37871767|NCT01146054|69555884|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
37871768|NCT01146054|69555884|FG000|Overall Study|Rapid tumor progression|2|||
37871769|NCT01146054|69555884|FG000|Overall Study|Other illness precluded treatment|2|||
37871770|NCT01146054|69555884|FG000|Overall Study|Lost to Follow-up|1|||
37871771|NCT01145898|69555890|FG000|3-year Treatment|medication change by treating physician|3|||
37871772|NCT01145898|69555891|FG001|3-year Treatment|medication change by treating physician|16|||
37871773|NCT01133418|69555898|FG000|Overall Study|Lost to Follow-up|5|||
37871774|NCT01133418|69555899|FG001|Overall Study|Lost to Follow-up|6|||
37871775|NCT00931918|69555907|FG000|Overall Study|Adverse Event|4|||
37871776|NCT00931918|69555908|FG001|Overall Study|Adverse Event|6|||
37871777|NCT00931918|69555907|FG000|Overall Study|Progressive Disease|2|||
37871778|NCT00931918|69555908|FG001|Overall Study|Progressive Disease|1|||
37871779|NCT00931918|69555907|FG000|Overall Study|Symptomatic Deterioration|1|||
37871780|NCT00931918|69555908|FG001|Overall Study|Symptomatic Deterioration|0|||
37871781|NCT00931918|69555907|FG000|Overall Study|Withdrawal by Patient|3|||
37871782|NCT00931918|69555908|FG001|Overall Study|Withdrawal by Patient|4|||
37871783|NCT00931918|69555907|FG000|Overall Study|Other Reason not Specified|4|||
37871784|NCT00931918|69555908|FG001|Overall Study|Other Reason not Specified|4|||
37871785|NCT00931918|69555907|FG000|Overall Study|Did not receive study drug|3|||
37871786|NCT00931918|69555908|FG001|Overall Study|Did not receive study drug|2|||
37980864|NCT00436332|69667458|FG000|Overall Study|Not Protocol Specified|6|||
37980865|NCT00436332|69667458|FG000|Overall Study|Ineligible|2|||
37980866|NCT00436332|69667458|FG000|Overall Study|Never Received Treatment|3|||
37980867|NCT00532259|69667462|FG000|Overall Study|Withdrawal by Subject|2|||
37980868|NCT00532259|69667462|FG000|Overall Study|Adverse Event|1|||
37980869|NCT00532259|69667462|FG000|Overall Study|Death|1|||
37980870|NCT00532259|69667462|FG000|Overall Study|Lack of Efficacy|21|||
37871787|NCT01179191|69555914|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
37871788|NCT01179191|69555914|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
37980871|NCT00532259|69667462|FG000|Overall Study|Lost to Follow-up|3|||
37980872|NCT00532259|69667462|FG000|Overall Study|Physician Decision|3|||
37980873|NCT00532259|69667462|FG000|Overall Study|Protocol Violation|1|||
37980874|NCT00322491|69667469|FG000|Overall Study|Adverse Event|1|||
37980875|NCT00322491|69667470|FG001|Overall Study|Adverse Event|0|||
37871789|NCT01179191|69555914|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
37871790|NCT01179191|69555914|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
37980876|NCT00322491|69667469|FG000|Overall Study|Death|1|||
37871791|NCT01179191|69555914|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
37871792|NCT01179191|69555914|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
37871793|NCT01179191|69555914|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
37871794|NCT01179191|69555914|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
37871795|NCT01179191|69555914|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
37871796|NCT01179191|69555914|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
37871797|NCT01179191|69555914|FG000|Maintenance Phase (8 Weeks)|Other|66|||
37871798|NCT01169844|69555920|FG000|Overall Study|Adverse Event|0|||
37871799|NCT01169844|69555921|FG001|Overall Study|Adverse Event|1|||
37871800|NCT01169844|69555920|FG000|Overall Study|Patient withdrew consent|4|||
37871801|NCT01169844|69555921|FG001|Overall Study|Patient withdrew consent|0|||
37871802|NCT01169844|69555920|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
37871803|NCT01169844|69555921|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
37871804|NCT01132482|69555929|FG000|Overall Study|Adverse Event|1|||
37871805|NCT01132482|69555930|FG001|Overall Study|Adverse Event|0|||
37871806|NCT00931762|69555936|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
37871807|NCT00931762|69555936|FG000|Overall Study|Administrative Problems|5|||
37871808|NCT00931762|69555936|FG000|Overall Study|Death|1|||
37871809|NCT00931762|69555936|FG000|Overall Study|Disease Progression|3|||
37871810|NCT00931762|69555936|FG000|Overall Study|Adverse Event (s)|11|||
37871811|NCT00931762|69555936|FG000|Overall Study|Subject withdrew consent|13|||
37871812|NCT01132326|69555940|FG000|Overall Study|Lack of Efficacy|25|||
37871813|NCT01132326|69555940|FG000|Overall Study|Adverse Event|37|||
37871814|NCT01132326|69555940|FG000|Overall Study|Protocol Violation|1|||
37871815|NCT01132326|69555940|FG000|Overall Study|Lost to Follow-up|16|||
37871816|NCT01132326|69555940|FG000|Overall Study|Withdrawal by Subject|40|||
37871817|NCT01132326|69555940|FG000|Overall Study|Physician Decision|10|||
37871818|NCT01132326|69555940|FG000|Overall Study|Study Termination|80|||
37871819|NCT01132326|69555940|FG000|Overall Study|Declining Health|1|||
37871820|NCT01132326|69555940|FG000|Overall Study|Pregnancy|1|||
37871821|NCT01132326|69555940|FG000|Overall Study|Caregiver Withdrew Consent|1|||
37871822|NCT01132326|69555940|FG000|Overall Study|Death|5|||
37871823|NCT01132326|69555940|FG000|Overall Study|Subject Unable to Come To Visits|1|||
37871824|NCT01178411|69555944|FG000|Overall Study|Adverse Event|5|||
37871825|NCT01178411|69555944|FG000|Overall Study|Withdrawal by Subject|4|||
37871826|NCT01178411|69555944|FG000|Overall Study|Protocol Violation|1|||
37871827|NCT01178411|69555944|FG000|Overall Study|Progressive disease per RECIST|32|||
37871828|NCT01178411|69555944|FG000|Overall Study|Progressive disease per clinician|9|||
37980877|NCT00322491|69667470|FG001|Overall Study|Death|2|||
37980878|NCT00322023|69667480|FG000|Overall Study|various|0|||
37980879|NCT00322023|69667481|FG001|Overall Study|various|2|||
37694969|NCT02451137|69171423|FG000|Overall Study|Lack of Efficacy|4|||
37980880|NCT00322023|69667482|FG002|Overall Study|various|6|||
37871829|NCT01178411|69555944|FG000|Overall Study|Physician Decision|6|||
37871830|NCT01178411|69555944|FG000|Overall Study|Death|1|||
37871831|NCT01178411|69555944|FG000|Overall Study|No reason provided|1|||
37871832|NCT01178411|69555944|FG000|Overall Study|Drug manufacturing ended|1|||
37871833|NCT01145508|69555950|FG000|Overall Study|Adverse Event|1|||
37871834|NCT01145508|69555951|FG001|Overall Study|Adverse Event|0|||
37871835|NCT01145508|69555950|FG000|Overall Study|Death|1|||
37871836|NCT01145508|69555951|FG001|Overall Study|Death|0|||
37871837|NCT01145508|69555950|FG000|Overall Study|Physician Decision|2|||
37871838|NCT01145508|69555951|FG001|Overall Study|Physician Decision|1|||
37871839|NCT01145508|69555950|FG000|Overall Study|Never started treatment|1|||
37871840|NCT01145508|69555951|FG001|Overall Study|Never started treatment|1|||
37871841|NCT00931528|69555959|FG000|Overall Study|Protocol Violation|9|||
37871842|NCT00931528|69555960|FG001|Overall Study|Protocol Violation|12|||
37871843|NCT00931528|69555959|FG000|Overall Study|Withdrawal by Subject|4|||
37871844|NCT00931528|69555960|FG001|Overall Study|Withdrawal by Subject|12|||
37871845|NCT00931528|69555959|FG000|Overall Study|Lost to Follow-up|6|||
37871846|NCT00931528|69555960|FG001|Overall Study|Lost to Follow-up|13|||
37871847|NCT00931528|69555959|FG000|Overall Study|Assessment outside of Time Frame|22|||
37871848|NCT00931528|69555960|FG001|Overall Study|Assessment outside of Time Frame|23|||
37871849|NCT00975195|69555969|FG000|Overall Study|Adverse Event|108|||
37871850|NCT00975195|69555970|FG001|Overall Study|Adverse Event|101|||
37871851|NCT00975195|69555969|FG000|Overall Study|Lack of Efficacy|6|||
37871852|NCT00975195|69555970|FG001|Overall Study|Lack of Efficacy|6|||
37871853|NCT00975195|69555969|FG000|Overall Study|Protocol Violation|27|||
37871854|NCT00975195|69555970|FG001|Overall Study|Protocol Violation|23|||
37871855|NCT00975195|69555969|FG000|Overall Study|Lost to Follow-up|9|||
37871856|NCT00975195|69555970|FG001|Overall Study|Lost to Follow-up|7|||
37871857|NCT00975195|69555969|FG000|Overall Study|Withdrawal by Subject|48|||
37871858|NCT00975195|69555970|FG001|Overall Study|Withdrawal by Subject|61|||
37871859|NCT00975195|69555969|FG000|Overall Study|Other reason not defined above|29|||
37871860|NCT00975195|69555970|FG001|Overall Study|Other reason not defined above|33|||
37980881|NCT00414960|69667492|FG000|Overall Study|Adverse Event|4|||
37980882|NCT00414960|69667493|FG001|Overall Study|Adverse Event|0|||
37871861|NCT00975195|69555969|FG000|Overall Study|Not treated|1|||
37871862|NCT00975195|69555970|FG001|Overall Study|Not treated|2|||
37871863|NCT01145352|69555976|FG000|Overall Study|Found to have been registered twice|6|||
37871864|NCT01145352|69555976|FG000|Overall Study|Treated before marketing approval|4|||
37980883|NCT00414960|69667492|FG000|Overall Study|Withdrawal by Subject|3|||
37980884|NCT00414960|69667493|FG001|Overall Study|Withdrawal by Subject|0|||
37980885|NCT00414960|69667492|FG000|Overall Study|Physician Decision|0|||
37980886|NCT00414960|69667493|FG001|Overall Study|Physician Decision|1|||
37980887|NCT00321789|69667501|FG000|Overall Study|Lost to Follow-up|4|||
37980888|NCT00321789|69667502|FG001|Overall Study|Lost to Follow-up|7|||
37980889|NCT00321789|69667501|FG000|Overall Study|Withdrawal by Subject|6|||
37980890|NCT00321789|69667502|FG001|Overall Study|Withdrawal by Subject|6|||
37980891|NCT00321789|69667501|FG000|Overall Study|Protocol Violation|5|||
37980892|NCT00321789|69667502|FG001|Overall Study|Protocol Violation|3|||
37980893|NCT00414726|69667510|FG000|Overall Study|Withdrawal by Subject|0|||
37980894|NCT00414726|69667511|FG001|Overall Study|Withdrawal by Subject|1|||
37980895|NCT00531947|69667519|FG000|Overall Study|Adverse Event|5|||
37980896|NCT00531947|69667520|FG001|Overall Study|Adverse Event|10|||
37980897|NCT00531947|69667519|FG000|Overall Study|Lost to Follow-up|12|||
37980898|NCT00531947|69667520|FG001|Overall Study|Lost to Follow-up|9|||
37980899|NCT00531947|69667519|FG000|Overall Study|Withdrawal by Subject|14|||
37980900|NCT00531947|69667520|FG001|Overall Study|Withdrawal by Subject|19|||
37980901|NCT00531947|69667519|FG000|Overall Study|Protocol Violation|2|||
37980902|NCT00531947|69667520|FG001|Overall Study|Protocol Violation|1|||
37980903|NCT00531947|69667519|FG000|Overall Study|Non-Compliance|4|||
37980904|NCT00531947|69667520|FG001|Overall Study|Non-Compliance|7|||
37871865|NCT01145352|69555976|FG000|Overall Study|Syringe formulation was used|1|||
37871866|NCT01178099|69555984|FG000|Overall Study|Physician Decision|0|||
37871867|NCT01178099|69555985|FG001|Overall Study|Physician Decision|1|||
37871868|NCT01169532|69555995|FG000|Overall Study|Withdrawal by Subject|1|||
37871869|NCT00928564|69556001|FG000|Overall Study|Lost to Follow-up|6|||
37871870|NCT00928564|69556002|FG001|Overall Study|Lost to Follow-up|0|||
37871871|NCT01177943|69556010|FG000|First Intervention|Withdrawal by Subject|2|||
37980905|NCT00531947|69667519|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
37871872|NCT01177943|69556011|FG001|First Intervention|Withdrawal by Subject|0|||
37980906|NCT00531947|69667520|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
37980907|NCT00530855|69667526|FG000|Overall Study|Lack of Efficacy|20|||
37980908|NCT00530855|69667526|FG000|Overall Study|Withdrawal by Subject|30|||
37980909|NCT00530855|69667526|FG000|Overall Study|Fatal Serious AE|3|||
37871873|NCT01131312|69556020|FG000|Overall Study|Lost to Follow-up|425|||
37871874|NCT01131312|69556021|FG001|Overall Study|Lost to Follow-up|229|||
37871875|NCT01131312|69556022|FG002|Overall Study|Lost to Follow-up|351|||
37871876|NCT01177787|69556030|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
37871877|NCT01177787|69556030|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
37871878|NCT01177787|69556030|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
37871879|NCT00928486|69556042|FG000|Overall Study|Adverse Event|2|||
37871880|NCT00928486|69556042|FG000|Overall Study|Disease Progression|7|||
37871881|NCT00928486|69556042|FG000|Overall Study|Withdrawal by Subject|1|||
37980910|NCT00530855|69667526|FG000|Overall Study|Non Fatal Serious AE|7|||
37980911|NCT00530855|69667526|FG000|Overall Study|Non Fatal Non Serious AE|12|||
37980912|NCT00530855|69667526|FG000|Overall Study|Protocol Violation|3|||
37980913|NCT00530855|69667526|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
37980914|NCT00530855|69667526|FG000|Overall Study|Lost to Follow-up|9|||
37980915|NCT00530855|69667526|FG000|Overall Study|Other reason for premature termination|17|||
37980916|NCT00530777|69667532|FG000|Overall Study|Lost to Follow-up|0|||
37980917|NCT00530777|69667533|FG001|Overall Study|Lost to Follow-up|1|||
37980918|NCT00530777|69667532|FG000|Overall Study|Death|1|||
37980919|NCT00530777|69667533|FG001|Overall Study|Death|2|||
37980920|NCT00530777|69667532|FG000|Overall Study|Physician Decision|1|||
37980921|NCT00530777|69667533|FG001|Overall Study|Physician Decision|0|||
37980922|NCT00530777|69667532|FG000|Overall Study|Withdrawal by Subject|0|||
37980923|NCT00530777|69667533|FG001|Overall Study|Withdrawal by Subject|1|||
37980924|NCT00530777|69667532|FG000|Overall Study|Unable to adhere to visit schedule|5|||
37816470|NCT01940471|69495070|FG003|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
37816471|NCT01940471|69495067|FG000|Period 1: Double-blind Phase|Adverse Event|2|||
37816472|NCT01940471|69495068|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
37816473|NCT01940471|69495069|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
37816474|NCT01940471|69495070|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
37816475|NCT01940471|69495067|FG000|Period 1: Double-blind Phase|Death|2|||
37816476|NCT01940471|69495068|FG001|Period 1: Double-blind Phase|Death|1|||
37816477|NCT01940471|69495069|FG002|Period 1: Double-blind Phase|Death|0|||
37816478|NCT01940471|69495070|FG003|Period 1: Double-blind Phase|Death|0|||
37816479|NCT01940471|69495067|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
37816480|NCT01940471|69495068|FG001|Period 1: Double-blind Phase|Lack of Efficacy|1|||
37816481|NCT01940471|69495069|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
37816482|NCT01940471|69495070|FG003|Period 1: Double-blind Phase|Lack of Efficacy|0|||
37816483|NCT01940471|69495067|FG000|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
37816484|NCT01940471|69495068|FG001|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
37816485|NCT01940471|69495069|FG002|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
37816486|NCT01940471|69495070|FG003|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
37816487|NCT01940471|69495067|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
37816488|NCT01940471|69495068|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
37816489|NCT01940471|69495069|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
37816490|NCT01940471|69495070|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
37816491|NCT01940471|69495067|FG000|Period 1: Double-blind Phase|HbsAg Seroconversion|1|||
37816492|NCT01940471|69495068|FG001|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
37816493|NCT01940471|69495069|FG002|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
37816494|NCT01940471|69495070|FG003|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
37816495|NCT01940471|69495067|FG000|Period 1: Double-blind Phase|Protocol Violation|0|||
37816496|NCT01940471|69495068|FG001|Period 1: Double-blind Phase|Protocol Violation|1|||
37816497|NCT01940471|69495069|FG002|Period 1: Double-blind Phase|Protocol Violation|0|||
37816498|NCT01940471|69495070|FG003|Period 1: Double-blind Phase|Protocol Violation|0|||
37816499|NCT01940471|69495067|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
37816500|NCT01940471|69495068|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
37816501|NCT01940471|69495069|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|48|||
37816502|NCT01940471|69495070|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|22|||
37816503|NCT01940471|69495067|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
37816504|NCT01940471|69495068|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
37816505|NCT01940471|69495069|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|13|||
37816506|NCT01940471|69495070|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|8|||
37816507|NCT01940471|69495067|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
37816508|NCT01940471|69495068|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
37816509|NCT01940471|69495069|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|9|||
37816510|NCT01940471|69495070|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
37980925|NCT00530777|69667533|FG001|Overall Study|Unable to adhere to visit schedule|1|||
37980926|NCT03882047|69667542|FG000|Overall Study|Adverse Event|0|||
37980927|NCT03882047|69667543|FG001|Overall Study|Adverse Event|2|||
37980928|NCT03882047|69667544|FG002|Overall Study|Adverse Event|2|||
37980929|NCT03882047|69667542|FG000|Overall Study|Treatment Failure|3|||
37980930|NCT03882047|69667543|FG001|Overall Study|Treatment Failure|3|||
37980931|NCT03882047|69667544|FG002|Overall Study|Treatment Failure|12|||
37871882|NCT01168596|69556048|FG000|Overall Study|Withdrawal by Subject|3|||
37871883|NCT01168596|69556049|FG001|Overall Study|Withdrawal by Subject|1|||
37871884|NCT01177553|69556057|FG000|Overall Study|babies not yet 6 months of age|1|||
37871885|NCT01177553|69556058|FG001|Overall Study|babies not yet 6 months of age|0|||
37871886|NCT00928408|69556064|FG000|Overall Study|Other|2|||
37871887|NCT00928408|69556064|FG000|Overall Study|Withdrawal by Subject|4|||
37871888|NCT00928408|69556064|FG000|Overall Study|Death|5|||
37871889|NCT00928408|69556064|FG000|Overall Study|Lost to Follow-up|12|||
37871890|NCT00928252|69556068|FG000|Overall Study|Physician Decision|3|||
37871891|NCT01177007|69556074|FG000|Overall Study|Lost to Follow-up|2|||
37871892|NCT01177007|69556074|FG000|Overall Study|Death|4|||
37871893|NCT01177007|69556074|FG000|Overall Study|Entered hospice care|5|||
37871894|NCT01177007|69556074|FG000|Overall Study|Required additional Y90 treatment|6|||
37871895|NCT01177007|69556074|FG000|Overall Study|Change in treatment modality|21|||
37871896|NCT00930982|69556082|FG000|Overall Study|Adverse Event|19|||
37871897|NCT00930982|69556083|FG001|Overall Study|Adverse Event|23|||
37871898|NCT00930982|69556082|FG000|Overall Study|Protocol Violation|1|||
37871899|NCT00930982|69556083|FG001|Overall Study|Protocol Violation|5|||
37871900|NCT00930982|69556082|FG000|Overall Study|Withdrawal by Subject|1|||
37871901|NCT00930982|69556083|FG001|Overall Study|Withdrawal by Subject|1|||
37871902|NCT01176773|69556089|FG000|Overall Study|Screen Failure|2|||
37871903|NCT01176773|69556089|FG000|Overall Study|Withdrew consent|1|||
37871904|NCT00928018|69556096|FG000|Overall Study|Withdrawal by Subject|1|||
37871905|NCT00928018|69556097|FG001|Overall Study|Withdrawal by Subject|0|||
37871906|NCT00927940|69556107|FG000|Overall Study|Death|1|||
37871907|NCT00927862|69556114|FG000|Overall Study|Missing data needed for endpt analyses|27|||
37871908|NCT00927862|69556115|FG001|Overall Study|Missing data needed for endpt analyses|45|||
37871909|NCT00976989|69556126|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
37871910|NCT00976989|69556127|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
37871911|NCT00976989|69556128|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
37871912|NCT00976989|69556126|FG000|Overall Study|Death|5|||
37871913|NCT00976989|69556127|FG001|Overall Study|Death|7|||
37871914|NCT00976989|69556128|FG002|Overall Study|Death|10|||
37871915|NCT00976989|69556126|FG000|Overall Study|Refused Treatment|4|||
37871916|NCT00976989|69556127|FG001|Overall Study|Refused Treatment|3|||
37871917|NCT00976989|69556128|FG002|Overall Study|Refused Treatment|5|||
37871918|NCT00976989|69556126|FG000|Overall Study|Failure to Return|2|||
37871919|NCT00976989|69556127|FG001|Overall Study|Failure to Return|1|||
37871920|NCT00976989|69556128|FG002|Overall Study|Failure to Return|0|||
37871921|NCT00976989|69556126|FG000|Overall Study|Recurrence of Disease|0|||
37871922|NCT00976989|69556127|FG001|Overall Study|Recurrence of Disease|1|||
37871923|NCT00976989|69556128|FG002|Overall Study|Recurrence of Disease|0|||
37871924|NCT00976989|69556126|FG000|Overall Study|Other|1|||
37816511|NCT01940471|69495067|FG000|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
37816512|NCT01940471|69495068|FG001|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
37816513|NCT01940471|69495069|FG002|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|5|||
37816514|NCT01940471|69495070|FG003|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|4|||
37816515|NCT01940471|69495067|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
37816516|NCT01940471|69495068|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
37816517|NCT01940471|69495069|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|5|||
37816518|NCT01940471|69495070|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|1|||
37816519|NCT01940471|69495067|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
37816520|NCT01940471|69495068|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
37816521|NCT01940471|69495069|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|4|||
37816522|NCT01940471|69495070|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
37816523|NCT01940471|69495067|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
37816524|NCT01940471|69495068|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
37816525|NCT01940471|69495069|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|5|||
37816526|NCT01940471|69495070|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
37816527|NCT01940471|69495067|FG000|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
37871925|NCT00976989|69556127|FG001|Overall Study|Other|0|||
37871926|NCT00976989|69556128|FG002|Overall Study|Other|1|||
37871927|NCT00927784|69556138|FG000|Overall Study|Death|1|||
37871928|NCT00927784|69556139|FG001|Overall Study|Death|0|||
37871929|NCT00927784|69556138|FG000|Overall Study|Withdrawal by Subject|1|||
37871930|NCT00927784|69556139|FG001|Overall Study|Withdrawal by Subject|0|||
37871931|NCT05056987|69556156|FG000|First Wear Period, Day 14 or Day 28|Adverse Event|1|||
37871932|NCT05056987|69556157|FG001|First Wear Period, Day 14 or Day 28|Adverse Event|0|||
37871933|NCT05056987|69556156|FG000|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|0|||
37871934|NCT05056987|69556157|FG001|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|2|||
37871935|NCT03439852|69556190|FG000|Baseline to 12 Weeks|Failed complete 12 wk survey|4|||
37871936|NCT03439852|69556191|FG001|Baseline to 12 Weeks|Failed complete 12 wk survey|7|||
37871937|NCT03439852|69556190|FG000|12weeks to 24weeks|failed complete 12 or 24 wk surveys|2|||
37871938|NCT03439852|69556191|FG001|12weeks to 24weeks|failed complete 12 or 24 wk surveys|0|||
37980932|NCT03882047|69667542|FG000|Overall Study|Lost to Follow-up|0|||
37980933|NCT03882047|69667543|FG001|Overall Study|Lost to Follow-up|1|||
37980934|NCT03882047|69667544|FG002|Overall Study|Lost to Follow-up|0|||
37980935|NCT03882047|69667542|FG000|Overall Study|Did Not Wish to Continue|1|||
37980936|NCT03882047|69667543|FG001|Overall Study|Did Not Wish to Continue|4|||
37980937|NCT03882047|69667544|FG002|Overall Study|Did Not Wish to Continue|1|||
37980938|NCT03882047|69667542|FG000|Overall Study|Noncompliance With Protocol|2|||
37980939|NCT03882047|69667543|FG001|Overall Study|Noncompliance With Protocol|0|||
37980940|NCT03882047|69667544|FG002|Overall Study|Noncompliance With Protocol|0|||
37980941|NCT03882047|69667542|FG000|Overall Study|Did Not Meet Eligibility|0|||
37980942|NCT03882047|69667543|FG001|Overall Study|Did Not Meet Eligibility|0|||
37980943|NCT03882047|69667544|FG002|Overall Study|Did Not Meet Eligibility|1|||
37980944|NCT00530621|69667554|FG000|Overall Study|Adverse Event|11|||
37980945|NCT00530621|69667555|FG001|Overall Study|Adverse Event|8|||
37980946|NCT00530621|69667554|FG000|Overall Study|Physician Decision|2|||
37980947|NCT00530621|69667555|FG001|Overall Study|Physician Decision|4|||
37980948|NCT00530621|69667554|FG000|Overall Study|Progressive Disease (PD)|47|||
37871939|NCT03439852|69556190|FG000|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|1|||
37871940|NCT03439852|69556191|FG001|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|0|||
37871941|NCT03355300|69556202|FG000|Overall Study|Physician Decision|0|||
37871942|NCT03355300|69556203|FG001|Overall Study|Physician Decision|1|||
37871943|NCT03355300|69556202|FG000|Overall Study|Lack of Efficacy|2|||
37871944|NCT03355300|69556203|FG001|Overall Study|Lack of Efficacy|1|||
37871945|NCT03355300|69556202|FG000|Overall Study|Other reason|1|||
37871946|NCT03355300|69556203|FG001|Overall Study|Other reason|0|||
37871947|NCT03332056|69556211|FG000|Overall Study|Incomplete questionnaires|8|||
37871948|NCT03332056|69556212|FG001|Overall Study|Incomplete questionnaires|9|||
37871949|NCT03332056|69556211|FG000|Overall Study|Passed stone prior to surgery date|1|||
37871950|NCT03332056|69556212|FG001|Overall Study|Passed stone prior to surgery date|0|||
37871951|NCT03332056|69556211|FG000|Overall Study|Did not require a ureteral stent|0|||
37871952|NCT03332056|69556212|FG001|Overall Study|Did not require a ureteral stent|1|||
37871953|NCT03093350|69556218|FG000|Overall Study|Death|1|||
37871954|NCT03093350|69556218|FG000|Overall Study|Signed consent, never began treartment|1|||
37871955|NCT02901041|69556224|FG000|Overall Study|Withdrawal by PI|4|||
37871956|NCT02901041|69556225|FG001|Overall Study|Withdrawal by PI|8|||
37871957|NCT02901041|69556224|FG000|Overall Study|Withdrawal by Subject|7|||
37871958|NCT02901041|69556225|FG001|Overall Study|Withdrawal by Subject|3|||
37871959|NCT02547987|69556259|FG000|Overall Study|Withdrawal by Subject|1|||
37871960|NCT02547987|69556259|FG000|Overall Study|Adverse Event|2|||
37871961|NCT02513199|69556263|FG000|Treatment|Death|1|||
37871962|NCT02513199|69556263|FG000|Treatment|Lost to Follow-up|1|||
37871963|NCT02513199|69556263|FG000|Follow-Up|Death|11|||
37871964|NCT00999804|69556285|FG000|Overall Study|Lack of Efficacy|9|||
37871965|NCT00999804|69556286|FG001|Overall Study|Lack of Efficacy|2|||
37871966|NCT00999804|69556285|FG000|Overall Study|Adverse Event|4|||
37871967|NCT00999804|69556286|FG001|Overall Study|Adverse Event|3|||
37871968|NCT00999804|69556285|FG000|Overall Study|Withdrawal by Subject|4|||
37871969|NCT00999804|69556286|FG001|Overall Study|Withdrawal by Subject|0|||
37871970|NCT00999804|69556285|FG000|Overall Study|Death|1|||
37871971|NCT00999804|69556286|FG001|Overall Study|Death|0|||
37871972|NCT00999804|69556285|FG000|Overall Study|Ineligible|3|||
37871973|NCT00999804|69556286|FG001|Overall Study|Ineligible|0|||
37871974|NCT00927472|69556298|FG000|Overall Study|Withdrawal by Subject|10|||
37871975|NCT00927472|69556299|FG001|Overall Study|Withdrawal by Subject|11|||
37871976|NCT00927472|69556298|FG000|Overall Study|Lost to Follow-up|1|||
37871977|NCT00927472|69556299|FG001|Overall Study|Lost to Follow-up|6|||
37871978|NCT00927472|69556298|FG000|Overall Study|Protocol Violation|0|||
37871979|NCT00927472|69556299|FG001|Overall Study|Protocol Violation|1|||
37871980|NCT00927472|69556298|FG000|Overall Study|Post treatment Assessment out of window|0|||
37694970|NCT02451137|69171424|FG001|Overall Study|Lack of Efficacy|9|||
37871981|NCT00927472|69556299|FG001|Overall Study|Post treatment Assessment out of window|4|||
37871982|NCT00927394|69556307|FG000|Overall Study|Adverse Event|14|||
37871983|NCT00927394|69556308|FG001|Overall Study|Adverse Event|9|||
37871984|NCT00927394|69556307|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
37980949|NCT00530621|69667555|FG001|Overall Study|Progressive Disease (PD)|40|||
37980950|NCT00530621|69667554|FG000|Overall Study|Sponsor Decision|12|||
37980951|NCT00530621|69667555|FG001|Overall Study|Sponsor Decision|15|||
37871985|NCT00927394|69556308|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
37871986|NCT00927394|69556307|FG000|Overall Study|Withdrawal by Subject|20|||
37871987|NCT00927394|69556308|FG001|Overall Study|Withdrawal by Subject|24|||
37871988|NCT00927394|69556307|FG000|Overall Study|Lost to Follow-up|8|||
37871989|NCT00927394|69556308|FG001|Overall Study|Lost to Follow-up|14|||
37871990|NCT00927394|69556307|FG000|Overall Study|Administrative Problem|1|||
37871991|NCT00927394|69556308|FG001|Overall Study|Administrative Problem|0|||
37871992|NCT00927394|69556307|FG000|Overall Study|Death|1|||
37871993|NCT00927394|69556308|FG001|Overall Study|Death|1|||
37871994|NCT00927394|69556307|FG000|Overall Study|Protocol deviation|16|||
37871995|NCT00927394|69556308|FG001|Overall Study|Protocol deviation|13|||
37871996|NCT00927394|69556307|FG000|Overall Study|Randomized in error|0|||
37871997|NCT00927394|69556308|FG001|Overall Study|Randomized in error|1|||
37871998|NCT00976911|69556317|FG000|Overall Study|Withdrawal by Subject|4|||
37871999|NCT00976911|69556318|FG001|Overall Study|Withdrawal by Subject|6|||
37872000|NCT00976911|69556317|FG000|Overall Study|Death|138|||
37872001|NCT00976911|69556318|FG001|Overall Study|Death|126|||
37872002|NCT00976911|69556317|FG000|Overall Study|Adverse Event|0|||
37872003|NCT00976911|69556318|FG001|Overall Study|Adverse Event|1|||
37872004|NCT00976911|69556317|FG000|Overall Study|Protocol Violation|2|||
37872005|NCT00976911|69556318|FG001|Overall Study|Protocol Violation|0|||
37872006|NCT00976911|69556317|FG000|Overall Study|Other|8|||
37872007|NCT00976911|69556318|FG001|Overall Study|Other|9|||
37872008|NCT00976911|69556317|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
37872009|NCT00976911|69556318|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
37872010|NCT00934648|69556324|FG000|Overall Study|Failure to return|8|||
37872011|NCT00934648|69556324|FG000|Overall Study|Withdrawal by Subject|1|||
37872012|NCT01175213|69556332|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
37872013|NCT01175213|69556333|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
37872014|NCT01175213|69556332|FG000|IGSC, 10%/rHuPH20|Death|1|||
37872015|NCT01175213|69556333|FG001|IGSC, 10%/rHuPH20|Death|0|||
37872016|NCT01175213|69556332|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
37872017|NCT01175213|69556333|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
37872018|NCT01175213|69556332|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
37872019|NCT01175213|69556333|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
37872020|NCT01175213|69556332|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
37872021|NCT01175213|69556333|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
37872022|NCT01175213|69556332|FG000|Safety Follow-up|Adverse Event|1|||
37872023|NCT01175213|69556333|FG001|Safety Follow-up|Adverse Event|0|||
37872024|NCT00974259|69556344|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
37872025|NCT00974259|69556345|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
37872026|NCT00927082|69556355|FG000|Overall Study|Lost to Follow-up|9|||
37872027|NCT00927082|69556356|FG001|Overall Study|Lost to Follow-up|8|||
37872028|NCT00927082|69556357|FG002|Overall Study|Lost to Follow-up|12|||
37872029|NCT00927082|69556358|FG003|Overall Study|Lost to Follow-up|16|||
37872030|NCT00927082|69556355|FG000|Overall Study|Withdrawal by Subject|3|||
37872031|NCT00927082|69556356|FG001|Overall Study|Withdrawal by Subject|2|||
37872032|NCT00927082|69556357|FG002|Overall Study|Withdrawal by Subject|7|||
37872033|NCT00927082|69556358|FG003|Overall Study|Withdrawal by Subject|2|||
37872034|NCT00927082|69556355|FG000|Overall Study|Death|0|||
37872035|NCT00927082|69556356|FG001|Overall Study|Death|0|||
37872036|NCT00927082|69556357|FG002|Overall Study|Death|1|||
37872037|NCT00927082|69556358|FG003|Overall Study|Death|0|||
37872038|NCT00927082|69556355|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
37872039|NCT00927082|69556356|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
37872040|NCT00927082|69556357|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
37872041|NCT00927082|69556358|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
37872042|NCT00976677|69556374|FG000|Overall Study|Adverse Event|1|||
37872043|NCT00976677|69556375|FG001|Overall Study|Adverse Event|0|||
37872044|NCT00976677|69556374|FG000|Overall Study|Withdrawal by Subject|0|||
37872045|NCT00976677|69556375|FG001|Overall Study|Withdrawal by Subject|2|||
37872046|NCT00976677|69556374|FG000|Overall Study|Disease progression|1|||
37872047|NCT00976677|69556375|FG001|Overall Study|Disease progression|1|||
37872048|NCT00976677|69556374|FG000|Overall Study|Trial unblinded|2|||
37872049|NCT00976677|69556375|FG001|Overall Study|Trial unblinded|2|||
37872050|NCT00976677|69556374|FG000|Overall Study|Unknown/Missing|1|||
37872051|NCT00976677|69556375|FG001|Overall Study|Unknown/Missing|0|||
37872052|NCT00926536|69556383|FG000|Overall Study|Physician Decision|1|||
37872053|NCT00926536|69556384|FG001|Overall Study|Physician Decision|2|||
37872054|NCT00923260|69556392|FG000|Overall Study|Lost to Follow-up|1|||
37872055|NCT00923260|69556393|FG001|Overall Study|Lost to Follow-up|1|||
37872056|NCT00934102|69556399|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
37872057|NCT00934102|69556400|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
37872058|NCT00934102|69556401|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
37872059|NCT00970281|69556420|FG000|Overall Study|Lack of Efficacy|1|||
37872060|NCT00970281|69556421|FG001|Overall Study|Lack of Efficacy|14|||
37872061|NCT00970281|69556420|FG000|Overall Study|Withdrawal by Subject|0|||
37872062|NCT00970281|69556421|FG001|Overall Study|Withdrawal by Subject|1|||
37872063|NCT00970281|69556420|FG000|Overall Study|Physician Decision|1|||
37872064|NCT00970281|69556421|FG001|Overall Study|Physician Decision|1|||
37872065|NCT00976209|69556429|FG000|Treatment Period 1|Protocol Violation|1|||
37872066|NCT00976209|69556430|FG001|Treatment Period 1|Protocol Violation|0|||
37872067|NCT00976209|69556429|FG000|Treatment Period 1|Lost to Follow-up|2|||
37694971|NCT02451137|69171423|FG000|Overall Study|Participant decision:discontinue insulin|41|||
37872068|NCT00976209|69556430|FG001|Treatment Period 1|Lost to Follow-up|0|||
37872069|NCT00976209|69556429|FG000|Treatment Period 1|Other|0|||
37872070|NCT00976209|69556430|FG001|Treatment Period 1|Other|1|||
37872071|NCT00976209|69556429|FG000|Wash-out Period|Adverse Event|1|||
37872072|NCT00976209|69556430|FG001|Wash-out Period|Adverse Event|2|||
37872073|NCT00976209|69556429|FG000|Wash-out Period|Lost to Follow-up|1|||
37872074|NCT00976209|69556430|FG001|Wash-out Period|Lost to Follow-up|0|||
37872075|NCT00976209|69556429|FG000|Wash-out Period|Protocol Violation|1|||
37872076|NCT00976209|69556430|FG001|Wash-out Period|Protocol Violation|0|||
37872077|NCT00976209|69556429|FG000|Wash-out Period|Other|1|||
37872078|NCT00976209|69556430|FG001|Wash-out Period|Other|0|||
37872079|NCT00976209|69556429|FG000|Treatment Period 2|Withdrawal by Subject|0|||
37872080|NCT00976209|69556430|FG001|Treatment Period 2|Withdrawal by Subject|1|||
37872081|NCT00976209|69556429|FG000|Treatment Period 2|Lost to Follow-up|0|||
37872082|NCT00976209|69556430|FG001|Treatment Period 2|Lost to Follow-up|1|||
37872083|NCT00925990|69556437|FG000|Overall Study|Adverse Event|1|||
37872084|NCT00925990|69556438|FG001|Overall Study|Adverse Event|3|||
37872085|NCT00925990|69556437|FG000|Overall Study|Withdrawal by Subject|2|||
37872086|NCT00925990|69556438|FG001|Overall Study|Withdrawal by Subject|2|||
37872087|NCT00925990|69556437|FG000|Overall Study|Lost to Follow-up|1|||
37872088|NCT00925990|69556438|FG001|Overall Study|Lost to Follow-up|3|||
37872089|NCT00925990|69556437|FG000|Overall Study|Physician Decision|1|||
37872090|NCT00925990|69556438|FG001|Overall Study|Physician Decision|1|||
37872091|NCT00925990|69556437|FG000|Overall Study|moved out of state, missed medication|0|||
37872092|NCT00925990|69556438|FG001|Overall Study|moved out of state, missed medication|2|||
37872093|NCT01131078|69556447|FG000|Overall Study|Adverse Event|22|||
37872094|NCT01131078|69556448|FG001|Overall Study|Adverse Event|12|||
37872095|NCT01131078|69556449|FG002|Overall Study|Adverse Event|17|||
37872096|NCT01131078|69556447|FG000|Overall Study|Progressive Disease|58|||
37872097|NCT01131078|69556448|FG001|Overall Study|Progressive Disease|77|||
37872098|NCT01131078|69556449|FG002|Overall Study|Progressive Disease|71|||
37872099|NCT01131078|69556447|FG000|Overall Study|Protocol Violation|1|||
37872100|NCT01131078|69556448|FG001|Overall Study|Protocol Violation|0|||
37872101|NCT01131078|69556449|FG002|Overall Study|Protocol Violation|0|||
37872102|NCT01131078|69556447|FG000|Overall Study|Lost to Follow-up|1|||
37872103|NCT01131078|69556448|FG001|Overall Study|Lost to Follow-up|1|||
37872104|NCT01131078|69556449|FG002|Overall Study|Lost to Follow-up|1|||
37872105|NCT01131078|69556447|FG000|Overall Study|Withdrawal by Subject|2|||
37872106|NCT01131078|69556448|FG001|Overall Study|Withdrawal by Subject|4|||
37872107|NCT01131078|69556449|FG002|Overall Study|Withdrawal by Subject|3|||
37872108|NCT01131078|69556447|FG000|Overall Study|Non-compliance|3|||
37872109|NCT01131078|69556448|FG001|Overall Study|Non-compliance|0|||
37872110|NCT01131078|69556449|FG002|Overall Study|Non-compliance|0|||
37872111|NCT01131078|69556447|FG000|Overall Study|Physician Decision|10|||
37872112|NCT01131078|69556448|FG001|Overall Study|Physician Decision|6|||
37872113|NCT01131078|69556449|FG002|Overall Study|Physician Decision|8|||
37872114|NCT01131078|69556447|FG000|Overall Study|Death|4|||
37872115|NCT01131078|69556448|FG001|Overall Study|Death|0|||
37872116|NCT01131078|69556449|FG002|Overall Study|Death|2|||
37872117|NCT01131078|69556447|FG000|Overall Study|Other|0|||
37872118|NCT01131078|69556448|FG001|Overall Study|Other|1|||
37872119|NCT01131078|69556449|FG002|Overall Study|Other|0|||
37872120|NCT01167582|69556461|FG000|Overall Study|Lost to Follow-up|0|||
37872121|NCT01167582|69556462|FG001|Overall Study|Lost to Follow-up|1|||
37872122|NCT01167426|69556468|FG000|Overall Study|Lost to Follow-up|6|||
37872123|NCT01167426|69556468|FG000|Overall Study|Protocol Violation|1|||
37872124|NCT01167426|69556468|FG000|Overall Study|Withdrawal by Subject|2|||
37872125|NCT01167426|69556468|FG000|Overall Study|Sponsor Decision|1|||
37872126|NCT00922636|69556478|FG000|Overall Study|Adverse Event|3|||
37872127|NCT00922636|69556479|FG001|Overall Study|Adverse Event|3|||
37872128|NCT00922636|69556480|FG002|Overall Study|Adverse Event|2|||
37872129|NCT00922636|69556481|FG003|Overall Study|Adverse Event|3|||
37872130|NCT00922636|69556482|FG004|Overall Study|Adverse Event|2|||
37872131|NCT00922636|69556478|FG000|Overall Study|Lack of Efficacy|1|||
37872132|NCT00922636|69556479|FG001|Overall Study|Lack of Efficacy|7|||
37872133|NCT00922636|69556480|FG002|Overall Study|Lack of Efficacy|3|||
37872134|NCT00922636|69556481|FG003|Overall Study|Lack of Efficacy|2|||
37872135|NCT00922636|69556482|FG004|Overall Study|Lack of Efficacy|4|||
37872136|NCT00922636|69556478|FG000|Overall Study|Sponsor Decision|0|||
37872137|NCT00922636|69556479|FG001|Overall Study|Sponsor Decision|0|||
37872138|NCT00922636|69556480|FG002|Overall Study|Sponsor Decision|2|||
37872139|NCT00922636|69556481|FG003|Overall Study|Sponsor Decision|0|||
37872140|NCT00922636|69556482|FG004|Overall Study|Sponsor Decision|0|||
37872141|NCT00922636|69556478|FG000|Overall Study|Withdrawal by Subject|0|||
37872142|NCT00922636|69556479|FG001|Overall Study|Withdrawal by Subject|0|||
37872143|NCT00922636|69556480|FG002|Overall Study|Withdrawal by Subject|5|||
37872144|NCT00922636|69556481|FG003|Overall Study|Withdrawal by Subject|2|||
37872145|NCT00922636|69556482|FG004|Overall Study|Withdrawal by Subject|4|||
37872146|NCT00922636|69556478|FG000|Overall Study|Protocol Violation|0|||
37872147|NCT00922636|69556479|FG001|Overall Study|Protocol Violation|0|||
37872148|NCT00922636|69556480|FG002|Overall Study|Protocol Violation|2|||
37872149|NCT00922636|69556481|FG003|Overall Study|Protocol Violation|2|||
37872150|NCT00922636|69556482|FG004|Overall Study|Protocol Violation|0|||
37872151|NCT00922636|69556478|FG000|Overall Study|Entry Criteria Not Met|0|||
37872152|NCT00922636|69556479|FG001|Overall Study|Entry Criteria Not Met|0|||
37872153|NCT00922636|69556480|FG002|Overall Study|Entry Criteria Not Met|1|||
37816528|NCT01940471|69495068|FG001|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
37816529|NCT01940471|69495069|FG002|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|2|||
37816530|NCT01940471|69495070|FG003|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
37816531|NCT01940471|69495067|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
37816532|NCT01940471|69495068|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
37816533|NCT01940471|69495069|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
37816534|NCT01940471|69495070|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
37816535|NCT01751906|69495090|FG000|Overall Study|Lost to Follow-up|151|||
37816536|NCT01751906|69495091|FG001|Overall Study|Lost to Follow-up|68|||
37816537|NCT01751906|69495090|FG000|Overall Study|Withdrawal by Subject|22|||
37816538|NCT01751906|69495091|FG001|Overall Study|Withdrawal by Subject|18|||
37816539|NCT01751906|69495090|FG000|Overall Study|Physician Decision|5|||
37816540|NCT01751906|69495091|FG001|Overall Study|Physician Decision|2|||
37816541|NCT01751906|69495090|FG000|Overall Study|Death|84|||
37816542|NCT01751906|69495091|FG001|Overall Study|Death|43|||
37816543|NCT01751906|69495090|FG000|Overall Study|Denied on premises for follow-up by law|1|||
37816544|NCT01751906|69495091|FG001|Overall Study|Denied on premises for follow-up by law|0|||
37816545|NCT01730937|69495099|FG000|Overall Study|Protocol Violation|5|||
37816546|NCT01730937|69495100|FG001|Overall Study|Protocol Violation|11|||
37816547|NCT01560416|69495108|FG000|Randomized Phase|Crossover Participants|7|||
37816548|NCT01560416|69495109|FG001|Randomized Phase|Crossover Participants|0|||
37816549|NCT01279850|69495121|FG000|Overall Study|Protocol Violation|50|||
37816550|NCT01279850|69495121|FG000|Overall Study|No Drug Administration Information|7|||
37816551|NCT01279850|69495121|FG000|Overall Study|No Visit After Treatment|34|||
37816552|NCT01035463|69495127|FG000|Overall Study|Adverse Event|0|||
37816553|NCT01035463|69495128|FG001|Overall Study|Adverse Event|0|||
37816554|NCT01035463|69495129|FG002|Overall Study|Adverse Event|4|||
37816555|NCT01035463|69495130|FG003|Overall Study|Adverse Event|1|||
37816556|NCT01035463|69495131|FG004|Overall Study|Adverse Event|5|||
37816557|NCT01035463|69495132|FG005|Overall Study|Adverse Event|7|||
37872154|NCT00922636|69556481|FG003|Overall Study|Entry Criteria Not Met|1|||
37872155|NCT00922636|69556482|FG004|Overall Study|Entry Criteria Not Met|0|||
37872156|NCT00922636|69556478|FG000|Overall Study|Parent/Caregiver Decision|2|||
37816558|NCT01035463|69495127|FG000|Overall Study|Withdrawal by Subject|0|||
37816559|NCT01035463|69495128|FG001|Overall Study|Withdrawal by Subject|2|||
37816560|NCT01035463|69495129|FG002|Overall Study|Withdrawal by Subject|1|||
37872157|NCT00922636|69556479|FG001|Overall Study|Parent/Caregiver Decision|4|||
37872158|NCT00922636|69556480|FG002|Overall Study|Parent/Caregiver Decision|3|||
37872159|NCT00922636|69556481|FG003|Overall Study|Parent/Caregiver Decision|5|||
37872160|NCT00922636|69556482|FG004|Overall Study|Parent/Caregiver Decision|2|||
37872161|NCT00922636|69556478|FG000|Overall Study|Lost to Follow-up|1|||
37872162|NCT00922636|69556479|FG001|Overall Study|Lost to Follow-up|2|||
37872163|NCT00922636|69556480|FG002|Overall Study|Lost to Follow-up|2|||
37872164|NCT00922636|69556481|FG003|Overall Study|Lost to Follow-up|2|||
37872165|NCT00922636|69556482|FG004|Overall Study|Lost to Follow-up|4|||
37872166|NCT01175135|69556503|FG000|Overall Study|Adverse Event|2|||
37872167|NCT01175135|69556504|FG001|Overall Study|Adverse Event|5|||
37872168|NCT01175135|69556505|FG002|Overall Study|Adverse Event|3|||
37872169|NCT01175135|69556506|FG003|Overall Study|Adverse Event|4|||
37872170|NCT01175135|69556503|FG000|Overall Study|Death|1|||
37872171|NCT01175135|69556504|FG001|Overall Study|Death|0|||
37872172|NCT01175135|69556505|FG002|Overall Study|Death|0|||
37872173|NCT01175135|69556506|FG003|Overall Study|Death|0|||
37872174|NCT01175135|69556503|FG000|Overall Study|Lack of Efficacy|4|||
37872175|NCT01175135|69556504|FG001|Overall Study|Lack of Efficacy|5|||
37872176|NCT01175135|69556505|FG002|Overall Study|Lack of Efficacy|0|||
37872177|NCT01175135|69556506|FG003|Overall Study|Lack of Efficacy|5|||
37872178|NCT01175135|69556503|FG000|Overall Study|Lost to Follow-up|1|||
37872179|NCT01175135|69556504|FG001|Overall Study|Lost to Follow-up|2|||
37872180|NCT01175135|69556505|FG002|Overall Study|Lost to Follow-up|0|||
37872181|NCT01175135|69556506|FG003|Overall Study|Lost to Follow-up|0|||
37872182|NCT01175135|69556503|FG000|Overall Study|Protocol Violation|1|||
37872183|NCT01175135|69556504|FG001|Overall Study|Protocol Violation|1|||
37872184|NCT01175135|69556505|FG002|Overall Study|Protocol Violation|0|||
37872185|NCT01175135|69556506|FG003|Overall Study|Protocol Violation|0|||
37872186|NCT01175135|69556503|FG000|Overall Study|Withdrawal by Subject|4|||
37872187|NCT01175135|69556504|FG001|Overall Study|Withdrawal by Subject|8|||
37872188|NCT01175135|69556505|FG002|Overall Study|Withdrawal by Subject|5|||
37816561|NCT01035463|69495130|FG003|Overall Study|Withdrawal by Subject|0|||
37816562|NCT01035463|69495131|FG004|Overall Study|Withdrawal by Subject|1|||
37816563|NCT01035463|69495132|FG005|Overall Study|Withdrawal by Subject|4|||
37816564|NCT01035463|69495127|FG000|Overall Study|Disease progression|0|||
37816565|NCT01035463|69495128|FG001|Overall Study|Disease progression|0|||
37872189|NCT01175135|69556506|FG003|Overall Study|Withdrawal by Subject|5|||
37872190|NCT01175135|69556503|FG000|Overall Study|Other|3|||
37872191|NCT01175135|69556504|FG001|Overall Study|Other|1|||
37872192|NCT01175135|69556505|FG002|Overall Study|Other|3|||
37872193|NCT01175135|69556506|FG003|Overall Study|Other|0|||
37872194|NCT01175135|69556503|FG000|Overall Study|Randomized But Not Treated|0|||
37872195|NCT01175135|69556504|FG001|Overall Study|Randomized But Not Treated|0|||
37872196|NCT01175135|69556505|FG002|Overall Study|Randomized But Not Treated|1|||
37872197|NCT01175135|69556506|FG003|Overall Study|Randomized But Not Treated|0|||
37872198|NCT00922480|69556518|FG000|Main Study|Protocol Violation|3|||
37872199|NCT00922480|69556519|FG001|Main Study|Protocol Violation|6|||
37816566|NCT01035463|69495129|FG002|Overall Study|Disease progression|0|||
37816567|NCT01035463|69495130|FG003|Overall Study|Disease progression|0|||
37816568|NCT01035463|69495131|FG004|Overall Study|Disease progression|0|||
37816569|NCT01035463|69495132|FG005|Overall Study|Disease progression|3|||
37816570|NCT01035463|69495127|FG000|Overall Study|Other Malignancy|0|||
37816571|NCT01035463|69495128|FG001|Overall Study|Other Malignancy|0|||
37816572|NCT01035463|69495129|FG002|Overall Study|Other Malignancy|0|||
37816573|NCT01035463|69495130|FG003|Overall Study|Other Malignancy|0|||
37816574|NCT01035463|69495131|FG004|Overall Study|Other Malignancy|0|||
37816575|NCT01035463|69495132|FG005|Overall Study|Other Malignancy|2|||
37816576|NCT01035463|69495127|FG000|Overall Study|Other|0|||
37816577|NCT01035463|69495128|FG001|Overall Study|Other|0|||
37816578|NCT01035463|69495129|FG002|Overall Study|Other|0|||
37816579|NCT01035463|69495130|FG003|Overall Study|Other|1|||
37816580|NCT01035463|69495131|FG004|Overall Study|Other|0|||
37872200|NCT00922480|69556518|FG000|Main Study|Adverse Event|6|||
37872201|NCT00922480|69556519|FG001|Main Study|Adverse Event|7|||
37872202|NCT00922480|69556518|FG000|Main Study|Lack of Efficacy|3|||
37980952|NCT00530621|69667554|FG000|Overall Study|Subject Decision|4|||
37816581|NCT01035463|69495132|FG005|Overall Study|Other|2|||
37872203|NCT00922480|69556519|FG001|Main Study|Lack of Efficacy|0|||
37816582|NCT00936390|69495141|FG000|Overall Study|Protocol Violation|21|||
37816583|NCT00936390|69495142|FG001|Overall Study|Protocol Violation|25|||
37816584|NCT00085202|69495186|FG000|Overall Study|Still on therapy|2|||
37872204|NCT00922480|69556518|FG000|Main Study|Withdrawal by Subject|20|||
37872205|NCT00922480|69556519|FG001|Main Study|Withdrawal by Subject|15|||
37872206|NCT00922480|69556518|FG000|Main Study|Lost to Follow-up|5|||
37816585|NCT00085202|69495187|FG001|Overall Study|Still on therapy|0|||
37816586|NCT00085202|69495186|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
37816587|NCT00085202|69495187|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
37816588|NCT00085202|69495186|FG000|Overall Study|Excessive toxicity|6|||
37816589|NCT00085202|69495187|FG001|Overall Study|Excessive toxicity|5|||
37816590|NCT00085202|69495186|FG000|Overall Study|Non-specified|3|||
37816591|NCT00085202|69495187|FG001|Overall Study|Non-specified|5|||
37816592|NCT00085202|69495186|FG000|Overall Study|Withdrawal by Subject|2|||
37816593|NCT00085202|69495187|FG001|Overall Study|Withdrawal by Subject|1|||
37816594|NCT00085202|69495186|FG000|Overall Study|Physician Decision|4|||
37816595|NCT00085202|69495187|FG001|Overall Study|Physician Decision|1|||
37816596|NCT00085202|69495186|FG000|Overall Study|Progressive disease|1|||
37816597|NCT00085202|69495187|FG001|Overall Study|Progressive disease|11|||
37816598|NCT01470326|69495211|FG000|Overall Study|Protocol Violation|32|||
37816599|NCT01470326|69495211|FG000|Overall Study|No Drug Administration Information|2|||
37816600|NCT01470326|69495211|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
37816601|NCT01480180|69495226|FG000|Main Phase|Withdrawal criteria|12|||
37816602|NCT01480180|69495227|FG001|Main Phase|Withdrawal criteria|1|||
37816603|NCT01480180|69495228|FG002|Main Phase|Withdrawal criteria|0|||
37816604|NCT01480180|69495229|FG003|Main Phase|Withdrawal criteria|0|||
37872207|NCT00922480|69556519|FG001|Main Study|Lost to Follow-up|0|||
37872208|NCT00922480|69556518|FG000|Main Study|Physician Decision|0|||
37872209|NCT00922480|69556519|FG001|Main Study|Physician Decision|1|||
37872210|NCT00922480|69556518|FG000|Extension Study|Protocol Violation|3|||
37872211|NCT00922480|69556519|FG001|Extension Study|Protocol Violation|0|||
37694972|NCT02451137|69171424|FG001|Overall Study|Participant decision:discontinue insulin|43|||
37694973|NCT02451137|69171423|FG000|Overall Study|Hypoglycemia|2|||
37872212|NCT00922480|69556518|FG000|Extension Study|Adverse Event|1|||
37872213|NCT00922480|69556519|FG001|Extension Study|Adverse Event|1|||
37872214|NCT00922480|69556518|FG000|Extension Study|Withdrawal by Subject|1|||
37872215|NCT00922480|69556519|FG001|Extension Study|Withdrawal by Subject|1|||
37872216|NCT00922480|69556518|FG000|Extension Study|Others|0|||
37872217|NCT00922480|69556519|FG001|Extension Study|Others|1|||
37872218|NCT00973479|69556529|FG000|Overall Study|Lost to Follow-up|0|||
37872219|NCT00973479|69556530|FG001|Overall Study|Lost to Follow-up|3|||
37872220|NCT00973479|69556529|FG000|Overall Study|Death|2|||
37872221|NCT00973479|69556530|FG001|Overall Study|Death|2|||
37872222|NCT00973479|69556529|FG000|Overall Study|Withdrawal by Subject|15|||
37872223|NCT00973479|69556530|FG001|Overall Study|Withdrawal by Subject|16|||
37872224|NCT00973479|69556529|FG000|Overall Study|Lack of Efficacy|5|||
37872225|NCT00973479|69556530|FG001|Overall Study|Lack of Efficacy|7|||
37872226|NCT00973479|69556529|FG000|Overall Study|Adverse Event|12|||
37872227|NCT00973479|69556530|FG001|Overall Study|Adverse Event|32|||
37872228|NCT00973479|69556529|FG000|Overall Study|Protocol Violation|2|||
37872229|NCT00973479|69556530|FG001|Overall Study|Protocol Violation|2|||
37872230|NCT00973479|69556529|FG000|Overall Study|Other|1|||
37872231|NCT00973479|69556530|FG001|Overall Study|Other|7|||
37872232|NCT01173653|69556540|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
37872233|NCT01173653|69556541|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
37872234|NCT01172873|69556549|FG000|Overall Study|Withdrawal by Subject|3|||
37872235|NCT01172873|69556550|FG001|Overall Study|Withdrawal by Subject|2|||
37872236|NCT00925600|69556562|FG000|Overall Study|Withdrawal by Subject|16|||
37816605|NCT01480180|69495230|FG004|Main Phase|Withdrawal criteria|0|||
37872237|NCT00925600|69556563|FG001|Overall Study|Withdrawal by Subject|14|||
37872238|NCT00925600|69556562|FG000|Overall Study|Death|4|||
37872239|NCT00925600|69556563|FG001|Overall Study|Death|3|||
37872240|NCT00925600|69556562|FG000|Overall Study|Lost to Follow-up|2|||
37872241|NCT00925600|69556563|FG001|Overall Study|Lost to Follow-up|2|||
37872242|NCT00925600|69556562|FG000|Overall Study|Disease Progression|1|||
37872243|NCT00925600|69556563|FG001|Overall Study|Disease Progression|3|||
37872244|NCT00925600|69556562|FG000|Overall Study|Administrative Decision|1|||
37872245|NCT00925600|69556563|FG001|Overall Study|Administrative Decision|1|||
37872246|NCT00925600|69556562|FG000|Overall Study|Noncompliance|2|||
37872247|NCT00925600|69556563|FG001|Overall Study|Noncompliance|0|||
37872248|NCT00925600|69556562|FG000|Overall Study|Ineligibility Determined|2|||
37872249|NCT00925600|69556563|FG001|Overall Study|Ineligibility Determined|0|||
37816606|NCT01480180|69495231|FG005|Main Phase|Withdrawal criteria|0|||
37816607|NCT01480180|69495226|FG000|Main Phase|Lack of Efficacy|1|||
37816608|NCT01480180|69495227|FG001|Main Phase|Lack of Efficacy|0|||
37816609|NCT01480180|69495228|FG002|Main Phase|Lack of Efficacy|0|||
37816610|NCT01480180|69495229|FG003|Main Phase|Lack of Efficacy|0|||
37872250|NCT00925600|69556562|FG000|Overall Study|Protocol Deviation|0|||
37872251|NCT00925600|69556563|FG001|Overall Study|Protocol Deviation|1|||
37872252|NCT00925600|69556562|FG000|Overall Study|Requirement for Alternative Therapy|0|||
37872253|NCT00925600|69556563|FG001|Overall Study|Requirement for Alternative Therapy|1|||
37872254|NCT00925600|69556562|FG000|Overall Study|Other|3|||
37872255|NCT00925600|69556563|FG001|Overall Study|Other|1|||
37872256|NCT00925600|69556562|FG000|Overall Study|Adverse Event|1|||
37872257|NCT00925600|69556563|FG001|Overall Study|Adverse Event|2|||
37872258|NCT00968253|69556576|FG000|Overall Study|Death|0|||
37872259|NCT00968253|69556577|FG001|Overall Study|Death|0|||
37872260|NCT00968253|69556578|FG002|Overall Study|Death|2|||
37872261|NCT00968253|69556576|FG000|Overall Study|Withdrawal by Subject|0|||
37872262|NCT00968253|69556577|FG001|Overall Study|Withdrawal by Subject|0|||
37872263|NCT00968253|69556578|FG002|Overall Study|Withdrawal by Subject|1|||
37872264|NCT00968253|69556576|FG000|Overall Study|Disease Progression|0|||
37872265|NCT00968253|69556577|FG001|Overall Study|Disease Progression|3|||
37872266|NCT00968253|69556578|FG002|Overall Study|Disease Progression|3|||
37872267|NCT00968253|69556576|FG000|Overall Study|Adverse Event|0|||
37872268|NCT00968253|69556577|FG001|Overall Study|Adverse Event|0|||
37872269|NCT00968253|69556578|FG002|Overall Study|Adverse Event|1|||
37872270|NCT00964743|69556587|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
37872271|NCT00925522|69556591|FG000|Overall Study|study closed -- business decision|20|||
37872272|NCT01130532|69556598|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
37872273|NCT01130532|69556599|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
37872274|NCT01130532|69556600|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
37872275|NCT01130532|69556601|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
37872276|NCT01130532|69556598|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
37872277|NCT01130532|69556599|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
37872278|NCT01130532|69556600|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
37872279|NCT01130532|69556601|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
37872280|NCT01130532|69556598|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
37872281|NCT01130532|69556599|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
37872282|NCT01130532|69556600|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
37872283|NCT01130532|69556601|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
37872284|NCT01130532|69556598|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
37872285|NCT01130532|69556599|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
37980953|NCT00530621|69667555|FG001|Overall Study|Subject Decision|7|||
37980954|NCT00530621|69667554|FG000|Overall Study|Death|3|||
37980955|NCT00530621|69667555|FG001|Overall Study|Death|6|||
37980956|NCT00530621|69667554|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
37980957|NCT00530621|69667555|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
37980958|NCT00531479|69667567|FG000|Overall Study|Death|68|||
37872286|NCT01130532|69556600|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
37980959|NCT00531479|69667568|FG001|Overall Study|Death|71|||
37980960|NCT00531479|69667567|FG000|Overall Study|Lost to Follow-up|0|||
37980961|NCT00531479|69667568|FG001|Overall Study|Lost to Follow-up|2|||
37980962|NCT00531479|69667567|FG000|Overall Study|Other|0|||
37816611|NCT01480180|69495230|FG004|Main Phase|Lack of Efficacy|0|||
37816612|NCT01480180|69495231|FG005|Main Phase|Lack of Efficacy|0|||
37816613|NCT01480180|69495226|FG000|Main Phase|Non-compliance|3|||
37816614|NCT01480180|69495227|FG001|Main Phase|Non-compliance|0|||
37816615|NCT01480180|69495228|FG002|Main Phase|Non-compliance|0|||
37816616|NCT01480180|69495229|FG003|Main Phase|Non-compliance|0|||
37816617|NCT01480180|69495230|FG004|Main Phase|Non-compliance|0|||
37816618|NCT01480180|69495231|FG005|Main Phase|Non-compliance|0|||
37816619|NCT01480180|69495226|FG000|Main Phase|Unclassified|3|||
37816620|NCT01480180|69495227|FG001|Main Phase|Unclassified|0|||
37816621|NCT01480180|69495228|FG002|Main Phase|Unclassified|0|||
37816622|NCT01480180|69495229|FG003|Main Phase|Unclassified|0|||
37816623|NCT01480180|69495230|FG004|Main Phase|Unclassified|0|||
37816624|NCT01480180|69495231|FG005|Main Phase|Unclassified|0|||
37816625|NCT01480180|69495226|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
37816626|NCT01480180|69495227|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
37816627|NCT01480180|69495228|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
37816628|NCT01480180|69495229|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
37816629|NCT01480180|69495230|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
37816630|NCT01480180|69495231|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
37816631|NCT01480180|69495226|FG000|Extension Phase, Part 1|Unclassified|0|||
37872287|NCT01130532|69556601|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
37980963|NCT00531479|69667568|FG001|Overall Study|Other|1|||
37816632|NCT01480180|69495227|FG001|Extension Phase, Part 1|Unclassified|0|||
37872288|NCT01130532|69556598|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
37872289|NCT01130532|69556599|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
37872290|NCT01130532|69556600|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
37872291|NCT01130532|69556601|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
37872292|NCT01130532|69556598|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
37980964|NCT00531479|69667567|FG000|Overall Study|Withdrawal by Subject|6|||
37980965|NCT00531479|69667568|FG001|Overall Study|Withdrawal by Subject|6|||
37816633|NCT01480180|69495228|FG002|Extension Phase, Part 1|Unclassified|1|||
37816634|NCT01480180|69495229|FG003|Extension Phase, Part 1|Unclassified|0|||
37980966|NCT00531479|69667567|FG000|Overall Study|Did not receive treatment|2|||
37980967|NCT00531479|69667568|FG001|Overall Study|Did not receive treatment|3|||
37980968|NCT00530075|69667574|FG000|Overall Study|Adverse Event|1|||
37980969|NCT00530075|69667574|FG000|Overall Study|Death|1|||
37980970|NCT00530075|69667574|FG000|Overall Study|Lack of Efficacy|3|||
37980971|NCT00530075|69667574|FG000|Overall Study|Protocol Violation|1|||
37980972|NCT00530075|69667574|FG000|Overall Study|Withdrawal by Subject|1|||
37980973|NCT00531011|69667580|FG000|Overall Study|Withdrawal by Subject|2|||
37980974|NCT00531011|69667581|FG001|Overall Study|Withdrawal by Subject|4|||
37980975|NCT00531011|69667580|FG000|Overall Study|Death|1|||
37980976|NCT00531011|69667581|FG001|Overall Study|Death|0|||
37980977|NCT00531011|69667580|FG000|Overall Study|Lost to Follow-up|1|||
37980978|NCT00531011|69667581|FG001|Overall Study|Lost to Follow-up|0|||
37980979|NCT00531011|69667580|FG000|Overall Study|Physician Decision|0|||
37980980|NCT00531011|69667581|FG001|Overall Study|Physician Decision|3|||
37980981|NCT00529217|69667587|FG000|Overall Study|Lack of Efficacy|2|||
37980982|NCT00529217|69667587|FG000|Overall Study|Unable to adhere to study schedule|2|||
37980983|NCT00471146|69667594|FG000|Overall Study|Adverse Event|32|||
37980984|NCT00471146|69667595|FG001|Overall Study|Adverse Event|33|||
37980985|NCT00471146|69667594|FG000|Overall Study|Withdrawal by Subject|14|||
37980986|NCT00471146|69667595|FG001|Overall Study|Withdrawal by Subject|11|||
37980987|NCT00471146|69667594|FG000|Overall Study|Death|11|||
37980988|NCT00471146|69667595|FG001|Overall Study|Death|12|||
37980989|NCT00471146|69667594|FG000|Overall Study|Lost to Follow-up|4|||
37980990|NCT00471146|69667595|FG001|Overall Study|Lost to Follow-up|2|||
37980991|NCT00471146|69667594|FG000|Overall Study|Protocol Violation|2|||
37980992|NCT00471146|69667595|FG001|Overall Study|Protocol Violation|2|||
37980993|NCT00471146|69667594|FG000|Overall Study|Objective progression or relapse|84|||
37980994|NCT00471146|69667595|FG001|Overall Study|Objective progression or relapse|87|||
37980995|NCT00471146|69667594|FG000|Overall Study|Global deterioration of health status|12|||
37980996|NCT00471146|69667595|FG001|Overall Study|Global deterioration of health status|14|||
37980997|NCT00471146|69667594|FG000|Overall Study|Randomized but not treated|9|||
37980998|NCT00471146|69667595|FG001|Overall Study|Randomized but not treated|8|||
37980999|NCT00471146|69667594|FG000|Overall Study|Other|4|||
37981000|NCT00471146|69667595|FG001|Overall Study|Other|5|||
37981001|NCT00469898|69667601|FG000|Overall Study|Adverse Event|7|||
37981002|NCT00469898|69667601|FG000|Overall Study|Withdrawal by Subject|4|||
37981003|NCT00469898|69667601|FG000|Overall Study|Death|4|||
37981004|NCT00469898|69667601|FG000|Overall Study|Disease progression|9|||
37981005|NCT00469898|69667601|FG000|Overall Study|Decreased performance status|1|||
37981006|NCT00529763|69667608|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
37981007|NCT00529763|69667609|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5|||
37981008|NCT00529763|69667610|FG002|Overall Study|Adverse Event Unrelated to Study Drug|3|||
37981009|NCT00529763|69667608|FG000|Overall Study|Death|1|||
37981010|NCT00529763|69667609|FG001|Overall Study|Death|1|||
37981011|NCT00529763|69667610|FG002|Overall Study|Death|1|||
37981012|NCT00529763|69667608|FG000|Overall Study|Disease Progression|10|||
37981013|NCT00529763|69667609|FG001|Overall Study|Disease Progression|16|||
37981014|NCT00529763|69667610|FG002|Overall Study|Disease Progression|11|||
37981015|NCT00529763|69667608|FG000|Overall Study|Lost to Follow-up|1|||
37981016|NCT00529763|69667609|FG001|Overall Study|Lost to Follow-up|2|||
37981017|NCT00529763|69667610|FG002|Overall Study|Lost to Follow-up|3|||
37981018|NCT00529763|69667608|FG000|Overall Study|Stem Cell Transplant|0|||
37981019|NCT00529763|69667609|FG001|Overall Study|Stem Cell Transplant|3|||
37981020|NCT00529763|69667610|FG002|Overall Study|Stem Cell Transplant|1|||
37981021|NCT00529763|69667608|FG000|Overall Study|Study Drug Toxicity|3|||
37981022|NCT00529763|69667609|FG001|Overall Study|Study Drug Toxicity|6|||
37981023|NCT00529763|69667610|FG002|Overall Study|Study Drug Toxicity|4|||
37981024|NCT00529763|69667608|FG000|Overall Study|Participant Withdrew Consent|2|||
37981025|NCT00529763|69667609|FG001|Overall Study|Participant Withdrew Consent|3|||
37981026|NCT00529763|69667610|FG002|Overall Study|Participant Withdrew Consent|4|||
37981027|NCT00529763|69667608|FG000|Overall Study|Other reasons|2|||
37981028|NCT00529763|69667609|FG001|Overall Study|Other reasons|0|||
37981029|NCT00529763|69667610|FG002|Overall Study|Other reasons|2|||
37981030|NCT00529763|69667608|FG000|Overall Study|Participant request to discontinue treatment|1|||
37981031|NCT00529763|69667609|FG001|Overall Study|Participant request to discontinue treatment|1|||
37981032|NCT00529763|69667610|FG002|Overall Study|Participant request to discontinue treatment|3|||
37694974|NCT02451137|69171424|FG001|Overall Study|Hypoglycemia|1|||
37694975|NCT02451137|69171423|FG000|Overall Study|Investigator's decision|23|||
37981033|NCT00486902|69667625|FG000|Overall Study|Withdrawal by Subject|1|||
37981034|NCT00486902|69667626|FG001|Overall Study|Withdrawal by Subject|2|||
37981035|NCT00486902|69667625|FG000|Overall Study|decision for postpartum tubal ligation|3|||
37981036|NCT00486902|69667626|FG001|Overall Study|decision for postpartum tubal ligation|1|||
37981037|NCT00486902|69667625|FG000|Overall Study|spinal anesthetic protocal violation|1|||
37981038|NCT00486902|69667626|FG001|Overall Study|spinal anesthetic protocal violation|1|||
37981039|NCT00486902|69667625|FG000|Overall Study|Did not meet inclusion criteria|1|||
37981040|NCT00486902|69667626|FG001|Overall Study|Did not meet inclusion criteria|0|||
37981041|NCT00486902|69667625|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
37981042|NCT00486902|69667626|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
37981043|NCT03687827|69667632|FG000|Treatment Period 1|Death|0|||
37981044|NCT03687827|69667633|FG001|Treatment Period 1|Death|1|||
37872293|NCT01130532|69556599|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
37872294|NCT01130532|69556600|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
37872295|NCT01130532|69556601|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
37872296|NCT01130532|69556598|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
37872297|NCT01130532|69556599|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
37872298|NCT01130532|69556600|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
37872299|NCT01130532|69556601|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
37872300|NCT01130532|69556598|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
37872301|NCT01130532|69556599|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
37872302|NCT01130532|69556600|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
37816635|NCT01480180|69495230|FG004|Extension Phase, Part 1|Unclassified|0|||
37816636|NCT01480180|69495231|FG005|Extension Phase, Part 1|Unclassified|0|||
37816637|NCT01480180|69495226|FG000|Extension Phase, Part 1|Adverse Event|0|||
37816638|NCT01480180|69495227|FG001|Extension Phase, Part 1|Adverse Event|0|||
37816639|NCT01480180|69495228|FG002|Extension Phase, Part 1|Adverse Event|4|||
37816640|NCT01480180|69495229|FG003|Extension Phase, Part 1|Adverse Event|1|||
37816641|NCT01480180|69495230|FG004|Extension Phase, Part 1|Adverse Event|0|||
37816642|NCT01480180|69495231|FG005|Extension Phase, Part 1|Adverse Event|0|||
37816643|NCT01480180|69495226|FG000|Extension Phase, Part 1|Change of treatment|0|||
37816644|NCT01480180|69495227|FG001|Extension Phase, Part 1|Change of treatment|0|||
37816645|NCT01480180|69495228|FG002|Extension Phase, Part 1|Change of treatment|0|||
37816646|NCT01480180|69495229|FG003|Extension Phase, Part 1|Change of treatment|9|||
37816647|NCT01480180|69495230|FG004|Extension Phase, Part 1|Change of treatment|0|||
37872303|NCT01130532|69556601|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
37872304|NCT01130532|69556598|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
37872305|NCT01130532|69556599|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
37872306|NCT01130532|69556600|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
37872307|NCT01130532|69556601|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
37872308|NCT01130532|69556598|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
37872309|NCT01130532|69556599|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
37872310|NCT01130532|69556600|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
37872311|NCT01130532|69556601|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
37872312|NCT01130532|69556598|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
37872313|NCT01130532|69556599|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
37872314|NCT01130532|69556600|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
37872315|NCT01130532|69556601|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
37872316|NCT00972777|69556615|FG000|Overall Study|Adverse Event|3|||
37872317|NCT00972777|69556616|FG001|Overall Study|Adverse Event|2|||
37872318|NCT00972777|69556615|FG000|Overall Study|Lost to Follow-up|0|||
37872319|NCT00972777|69556616|FG001|Overall Study|Lost to Follow-up|4|||
37872320|NCT00972777|69556615|FG000|Overall Study|Withdrawal by Subject|4|||
37872321|NCT00972777|69556616|FG001|Overall Study|Withdrawal by Subject|5|||
37872322|NCT00972777|69556615|FG000|Overall Study|Physician Decision|4|||
37872323|NCT00972777|69556616|FG001|Overall Study|Physician Decision|0|||
37872324|NCT00972777|69556615|FG000|Overall Study|Protocol Violation|0|||
37872325|NCT00972777|69556616|FG001|Overall Study|Protocol Violation|2|||
37872326|NCT00972777|69556615|FG000|Overall Study|Screening Failure|2|||
37872327|NCT00972777|69556616|FG001|Overall Study|Screening Failure|1|||
37872328|NCT00972777|69556615|FG000|Overall Study|Missed visit|1|||
37872329|NCT00972777|69556616|FG001|Overall Study|Missed visit|0|||
37872330|NCT00918736|69556622|FG000|Overall Study|Withdrawal by Subject|4|||
37872331|NCT01172639|69556631|FG000|Overall Study|Death|1|||
37872332|NCT01172639|69556632|FG001|Overall Study|Death|1|||
37872333|NCT01172639|69556633|FG002|Overall Study|Death|0|||
37872334|NCT01172639|69556634|FG003|Overall Study|Death|0|||
37872335|NCT01172639|69556635|FG004|Overall Study|Death|0|||
37981045|NCT03687827|69667632|FG000|Treatment Period 1|Lost to Follow-up|2|||
37981046|NCT03687827|69667633|FG001|Treatment Period 1|Lost to Follow-up|2|||
37981047|NCT03687827|69667632|FG000|Treatment Period 1|Physician Decision|5|||
37981048|NCT03687827|69667633|FG001|Treatment Period 1|Physician Decision|2|||
37981049|NCT03687827|69667632|FG000|Treatment Period 1|Withdrawal by Subject|7|||
37981050|NCT03687827|69667633|FG001|Treatment Period 1|Withdrawal by Subject|3|||
37872336|NCT01172639|69556631|FG000|Overall Study|Lost to Follow-up|9|||
37872337|NCT01172639|69556632|FG001|Overall Study|Lost to Follow-up|7|||
37872338|NCT01172639|69556633|FG002|Overall Study|Lost to Follow-up|11|||
37872339|NCT01172639|69556634|FG003|Overall Study|Lost to Follow-up|6|||
37872340|NCT01172639|69556635|FG004|Overall Study|Lost to Follow-up|6|||
37981051|NCT03687827|69667632|FG000|Treatment Period 2|Physician Decision|4|||
37872341|NCT01172639|69556631|FG000|Overall Study|Withdrawal by Subject|3|||
37872342|NCT01172639|69556632|FG001|Overall Study|Withdrawal by Subject|3|||
37872343|NCT01172639|69556633|FG002|Overall Study|Withdrawal by Subject|5|||
37872344|NCT01172639|69556634|FG003|Overall Study|Withdrawal by Subject|5|||
37694976|NCT02451137|69171424|FG001|Overall Study|Investigator's decision|19|||
37816648|NCT01480180|69495231|FG005|Extension Phase, Part 1|Change of treatment|0|||
37816649|NCT01480180|69495226|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
37816650|NCT01480180|69495227|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
37816651|NCT01480180|69495228|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
37816652|NCT01480180|69495229|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
37816653|NCT01480180|69495230|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
37816654|NCT01480180|69495231|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
37816655|NCT01480180|69495226|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
37816656|NCT01480180|69495227|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
37816657|NCT01480180|69495228|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
37816658|NCT01480180|69495229|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
37816659|NCT01480180|69495230|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
37816660|NCT01480180|69495231|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
37816661|NCT01480180|69495226|FG000|Extension Phase, Part 2|Unclassified|0|||
37816662|NCT01480180|69495227|FG001|Extension Phase, Part 2|Unclassified|0|||
37816663|NCT01480180|69495228|FG002|Extension Phase, Part 2|Unclassified|3|||
37816664|NCT01480180|69495229|FG003|Extension Phase, Part 2|Unclassified|1|||
37816665|NCT01480180|69495230|FG004|Extension Phase, Part 2|Unclassified|1|||
37816666|NCT01480180|69495231|FG005|Extension Phase, Part 2|Unclassified|0|||
37816667|NCT05300087|69495262|FG000|Overall Study|Withdrawal by Subject|0|||
37816668|NCT05300087|69495263|FG001|Overall Study|Withdrawal by Subject|1|||
37816669|NCT04803734|69495276|FG000|Overall Study|Withdrawal by Subject|0|||
37816670|NCT04803734|69495277|FG001|Overall Study|Withdrawal by Subject|1|||
37816671|NCT04803734|69495276|FG000|Overall Study|Protocol Violation|0|||
37816672|NCT04803734|69495277|FG001|Overall Study|Protocol Violation|1|||
37816673|NCT04112173|69495313|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
37816674|NCT03872453|69495321|FG000|Overall Study|Adverse Event|1|||
37816675|NCT03872453|69495322|FG001|Overall Study|Adverse Event|1|||
37816676|NCT03872453|69495323|FG002|Overall Study|Adverse Event|0|||
37816677|NCT03872453|69495324|FG003|Overall Study|Adverse Event|0|||
37816678|NCT03872453|69495321|FG000|Overall Study|Lost to Follow-up|8|||
37816679|NCT03872453|69495322|FG001|Overall Study|Lost to Follow-up|7|||
37816680|NCT03872453|69495323|FG002|Overall Study|Lost to Follow-up|4|||
37816681|NCT03872453|69495324|FG003|Overall Study|Lost to Follow-up|4|||
37816682|NCT03872453|69495321|FG000|Overall Study|Never Treated Migraine|19|||
37816683|NCT03872453|69495322|FG001|Overall Study|Never Treated Migraine|17|||
37816684|NCT03872453|69495323|FG002|Overall Study|Never Treated Migraine|13|||
37816685|NCT03872453|69495324|FG003|Overall Study|Never Treated Migraine|12|||
37816686|NCT03872453|69495321|FG000|Overall Study|Pregnancy|1|||
37816687|NCT03872453|69495322|FG001|Overall Study|Pregnancy|0|||
37816688|NCT03872453|69495323|FG002|Overall Study|Pregnancy|0|||
37816689|NCT03872453|69495324|FG003|Overall Study|Pregnancy|0|||
37816690|NCT03872453|69495321|FG000|Overall Study|Protocol Deviation|2|||
37816691|NCT03872453|69495322|FG001|Overall Study|Protocol Deviation|0|||
37816692|NCT03872453|69495323|FG002|Overall Study|Protocol Deviation|0|||
37816693|NCT03872453|69495324|FG003|Overall Study|Protocol Deviation|2|||
37816694|NCT03872453|69495321|FG000|Overall Study|Withdrawal by Subject|0|||
37816695|NCT03872453|69495322|FG001|Overall Study|Withdrawal by Subject|1|||
37816696|NCT03872453|69495323|FG002|Overall Study|Withdrawal by Subject|2|||
37816697|NCT03872453|69495324|FG003|Overall Study|Withdrawal by Subject|0|||
37872345|NCT01172639|69556635|FG004|Overall Study|Withdrawal by Subject|0|||
37872346|NCT01144182|69556649|FG000|Overall Study|Death|5|||
37872347|NCT01144182|69556650|FG001|Overall Study|Death|6|||
37872348|NCT01144182|69556649|FG000|Overall Study|Withdrawal by Subject|3|||
37694977|NCT02451137|69171423|FG000|Overall Study|Lost to Follow-up|53|||
37694978|NCT02451137|69171424|FG001|Overall Study|Lost to Follow-up|61|||
37694979|NCT02451137|69171423|FG000|Overall Study|Physician Decision|6|||
37694980|NCT02451137|69171424|FG001|Overall Study|Physician Decision|5|||
37694981|NCT02451137|69171423|FG000|Overall Study|Sponsor decision|13|||
37694982|NCT02451137|69171424|FG001|Overall Study|Sponsor decision|25|||
37694983|NCT02451137|69171423|FG000|Overall Study|Withdrawal by Subject|40|||
37694984|NCT02451137|69171424|FG001|Overall Study|Withdrawal by Subject|63|||
37694985|NCT02451137|69171423|FG000|Overall Study|Other than specified above|2|||
37694986|NCT02451137|69171424|FG001|Overall Study|Other than specified above|3|||
37694987|NCT02372006|69171433|FG000|Overall Study|Progressive disease|8|||
37872349|NCT01144182|69556650|FG001|Overall Study|Withdrawal by Subject|6|||
37694988|NCT02372006|69171434|FG001|Overall Study|Progressive disease|7|||
37694989|NCT02372006|69171435|FG002|Overall Study|Progressive disease|34|||
37694990|NCT02372006|69171433|FG000|Overall Study|Dose limiting toxicity|0|||
37816698|NCT03872453|69495321|FG000|Overall Study|Other Than Specified|1|||
37816699|NCT03872453|69495322|FG001|Overall Study|Other Than Specified|0|||
37816700|NCT03872453|69495323|FG002|Overall Study|Other Than Specified|0|||
37816701|NCT03872453|69495324|FG003|Overall Study|Other Than Specified|0|||
37872350|NCT01144182|69556649|FG000|Overall Study|Lost to Follow-up|9|||
37872351|NCT01144182|69556650|FG001|Overall Study|Lost to Follow-up|9|||
37872352|NCT01225562|69556660|FG000|Overall Study|Withdrawal by Subject|52|||
37872353|NCT01225562|69556661|FG001|Overall Study|Withdrawal by Subject|50|||
37981052|NCT03687827|69667633|FG001|Treatment Period 2|Physician Decision|1|||
37981053|NCT03687827|69667632|FG000|Treatment Period 2|Withdrawal by Subject|1|||
37872354|NCT01225562|69556662|FG002|Overall Study|Withdrawal by Subject|52|||
37872355|NCT01225562|69556660|FG000|Overall Study|Lost to Follow-up|3|||
37872356|NCT01225562|69556661|FG001|Overall Study|Lost to Follow-up|6|||
37872357|NCT01225562|69556662|FG002|Overall Study|Lost to Follow-up|1|||
37872358|NCT00925288|69556672|FG000|Overall Study|Lost to Follow-up|9|||
37872359|NCT00925288|69556673|FG001|Overall Study|Lost to Follow-up|7|||
37872360|NCT01143714|69556683|FG000|Overall Study|Adverse Event|4|||
37872361|NCT01143714|69556684|FG001|Overall Study|Adverse Event|2|||
37872362|NCT01143714|69556683|FG000|Overall Study|Withdrawal by Subject|1|||
37872363|NCT01143714|69556684|FG001|Overall Study|Withdrawal by Subject|0|||
37872364|NCT01143714|69556683|FG000|Overall Study|Subject non-compliance|0|||
37872365|NCT01143714|69556684|FG001|Overall Study|Subject non-compliance|1|||
37872366|NCT01143714|69556683|FG000|Overall Study|wound closed = deemed healed|1|||
37872367|NCT01143714|69556684|FG001|Overall Study|wound closed = deemed healed|0|||
37872368|NCT01143714|69556683|FG000|Overall Study|wound size increased|1|||
37872369|NCT01143714|69556684|FG001|Overall Study|wound size increased|0|||
37872370|NCT00972543|69556705|FG000|Overall Study|Adverse Event|1|||
37981054|NCT03687827|69667633|FG001|Treatment Period 2|Withdrawal by Subject|2|||
37981055|NCT00529529|69667642|FG000|Overall Study|Adverse Event|12|||
37981056|NCT00529529|69667643|FG001|Overall Study|Adverse Event|17|||
37981057|NCT00529529|69667644|FG002|Overall Study|Adverse Event|8|||
37981058|NCT00529529|69667642|FG000|Overall Study|Subject withdrew consent|12|||
37981059|NCT00529529|69667643|FG001|Overall Study|Subject withdrew consent|9|||
37872371|NCT00972543|69556706|FG001|Overall Study|Adverse Event|0|||
37872372|NCT00972543|69556705|FG000|Overall Study|Early study termination by sponsor|4|||
37872373|NCT00972543|69556706|FG001|Overall Study|Early study termination by sponsor|1|||
37872374|NCT00925132|69556712|FG000|Overall Study|Withdrawal by Subject|2|||
37872375|NCT00925132|69556713|FG001|Overall Study|Withdrawal by Subject|0|||
37981060|NCT00529529|69667644|FG002|Overall Study|Subject withdrew consent|12|||
37981061|NCT00529529|69667642|FG000|Overall Study|Protocol deviation|8|||
37981062|NCT00529529|69667643|FG001|Overall Study|Protocol deviation|12|||
37981063|NCT00529529|69667644|FG002|Overall Study|Protocol deviation|5|||
37694991|NCT02372006|69171434|FG001|Overall Study|Dose limiting toxicity|1|||
37694992|NCT02372006|69171435|FG002|Overall Study|Dose limiting toxicity|0|||
37694993|NCT02372006|69171433|FG000|Overall Study|Adverse Event|0|||
37694994|NCT02372006|69171434|FG001|Overall Study|Adverse Event|0|||
37694995|NCT02372006|69171435|FG002|Overall Study|Adverse Event|3|||
37694996|NCT02372006|69171433|FG000|Overall Study|Withdrawal by Subject|0|||
37981064|NCT00529529|69667642|FG000|Overall Study|Lost to Follow-up|5|||
37981065|NCT00529529|69667643|FG001|Overall Study|Lost to Follow-up|3|||
37981066|NCT00529529|69667644|FG002|Overall Study|Lost to Follow-up|1|||
37981067|NCT00529529|69667642|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
37694997|NCT02372006|69171434|FG001|Overall Study|Withdrawal by Subject|1|||
37816702|NCT03726879|69495336|FG000|Overall Study|Death|6|||
37816703|NCT03726879|69495337|FG001|Overall Study|Death|4|||
37816704|NCT03726879|69495336|FG000|Overall Study|Physician Decision|0|||
37816705|NCT03726879|69495337|FG001|Overall Study|Physician Decision|2|||
37816706|NCT03726879|69495336|FG000|Overall Study|Protocol Violation|0|||
37816707|NCT03726879|69495337|FG001|Overall Study|Protocol Violation|1|||
37816708|NCT03726879|69495336|FG000|Overall Study|Withdrawal by Subject|5|||
37816709|NCT03726879|69495337|FG001|Overall Study|Withdrawal by Subject|5|||
37816710|NCT03726879|69495336|FG000|Overall Study|TSH result is unstable|0|||
37816711|NCT03726879|69495337|FG001|Overall Study|TSH result is unstable|1|||
37816712|NCT03726879|69495336|FG000|Overall Study|Continuing on Study|215|||
37816713|NCT03726879|69495337|FG001|Overall Study|Continuing on Study|215|||
37816714|NCT03721835|69495343|FG000|Overall Study|Participant not able to return|1|||
37816715|NCT03721835|69495343|FG000|Overall Study|Lost to Follow-up|1|||
37816716|NCT03721835|69495343|FG000|Overall Study|Revision of the components of the study device|2|||
37872376|NCT00925132|69556714|FG002|Overall Study|Withdrawal by Subject|0|||
37981068|NCT00529529|69667643|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
37981069|NCT00529529|69667644|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
37981070|NCT00529529|69667642|FG000|Overall Study|Death|2|||
37694998|NCT02372006|69171435|FG002|Overall Study|Withdrawal by Subject|1|||
37816717|NCT03721835|69495343|FG000|Overall Study|Sponsor terminated study|6|||
37816718|NCT03721835|69495343|FG000|Overall Study|Death|1|||
37816719|NCT03721835|69495343|FG000|Overall Study|Sponsor decision|1|||
37816720|NCT03565991|69495349|FG000|Overall Study|Other|11|||
37816721|NCT03565991|69495350|FG001|Overall Study|Other|0|||
37872377|NCT00925132|69556715|FG003|Overall Study|Withdrawal by Subject|0|||
37872378|NCT00925132|69556716|FG004|Overall Study|Withdrawal by Subject|1|||
37872379|NCT00925132|69556712|FG000|Overall Study|Removed due to disease progression|0|||
37872380|NCT00925132|69556713|FG001|Overall Study|Removed due to disease progression|0|||
37816722|NCT03565991|69495349|FG000|Overall Study|Global deterioration of health status|14|||
37816723|NCT03565991|69495350|FG001|Overall Study|Global deterioration of health status|4|||
37816724|NCT03565991|69495349|FG000|Overall Study|Withdrawal by Subject|2|||
37816725|NCT03565991|69495350|FG001|Overall Study|Withdrawal by Subject|6|||
37816726|NCT03565991|69495349|FG000|Overall Study|Progressive disease|121|||
37816727|NCT03565991|69495350|FG001|Overall Study|Progressive disease|29|||
37872381|NCT00925132|69556714|FG002|Overall Study|Removed due to disease progression|0|||
37872382|NCT00925132|69556715|FG003|Overall Study|Removed due to disease progression|0|||
37872383|NCT00925132|69556716|FG004|Overall Study|Removed due to disease progression|4|||
37872384|NCT01143402|69556725|FG000|Overall Study|Rapid clinical decline|1|||
37816728|NCT03565991|69495349|FG000|Overall Study|Death|3|||
37816729|NCT03565991|69495350|FG001|Overall Study|Death|0|||
37816730|NCT03565991|69495349|FG000|Overall Study|Adverse Event|7|||
37816731|NCT03565991|69495350|FG001|Overall Study|Adverse Event|2|||
37816732|NCT03186638|69495360|FG000|Overall Study|Withdrawal by Subject|4|||
37816733|NCT03186638|69495361|FG001|Overall Study|Withdrawal by Subject|4|||
37816734|NCT03186638|69495360|FG000|Overall Study|Withdrawn due to medical problem|3|||
37816735|NCT03186638|69495361|FG001|Overall Study|Withdrawn due to medical problem|2|||
37816736|NCT03186638|69495360|FG000|Overall Study|Lost to Follow-up|1|||
37816737|NCT03186638|69495361|FG001|Overall Study|Lost to Follow-up|0|||
37816738|NCT02927301|69495376|FG000|Overall Study|Adverse Event|7|||
37872385|NCT01143402|69556726|FG001|Overall Study|Rapid clinical decline|1|||
37872386|NCT01143402|69556727|FG002|Overall Study|Rapid clinical decline|0|||
37872387|NCT01143402|69556725|FG000|Overall Study|Not Treated|0|||
37872388|NCT01143402|69556726|FG001|Overall Study|Not Treated|0|||
37872389|NCT01143402|69556727|FG002|Overall Study|Not Treated|1|||
37872390|NCT01171625|69556734|FG000|Overall Study|On-Protocol|67|||
37872391|NCT01171625|69556734|FG000|Overall Study|Death|38|||
37872392|NCT01171625|69556734|FG000|Overall Study|Withdrawal by Subject|31|||
37872393|NCT01171625|69556734|FG000|Overall Study|Explanted|10|||
37872394|NCT01171625|69556734|FG000|Overall Study|Lost to Follow-up|5|||
37872395|NCT01171625|69556734|FG000|Overall Study|Patient received valve-in-valve|3|||
37872396|NCT01171625|69556734|FG000|Overall Study|Other|1|||
37872397|NCT01171625|69556734|FG000|Overall Study|Consented but did not receive device|25|||
37872398|NCT00924898|69556746|FG000|Overall Study|Withdrawal by Subject|2|||
37872399|NCT01167192|69556755|FG000|Overall Study|Adverse Event|1|||
37872400|NCT01167192|69556755|FG000|Overall Study|Death|1|||
37872401|NCT01167192|69556755|FG000|Overall Study|Withdrawal by Subject|1|||
37872402|NCT01167192|69556755|FG000|Overall Study|Insurance denial|1|||
37816739|NCT02927301|69495376|FG000|Overall Study|Withdrawal by Subject|1|||
37816740|NCT02927301|69495376|FG000|Overall Study|Physician Decision|2|||
37816741|NCT02691663|69495382|FG000|Overall Study|Screen failure after baseline|2|||
37872403|NCT01166958|69556761|FG000|Overall Study|Withdrawal by Subject|1|||
37872404|NCT01166958|69556762|FG001|Overall Study|Withdrawal by Subject|0|||
37872405|NCT01170221|69556770|FG000|Overall Study|Lost to Follow-up|22|||
37872406|NCT01170221|69556771|FG001|Overall Study|Lost to Follow-up|21|||
37816742|NCT02691663|69495383|FG001|Overall Study|Screen failure after baseline|2|||
37872407|NCT01170221|69556770|FG000|Overall Study|Withdrawal by Subject|9|||
37816743|NCT02691663|69495382|FG000|Overall Study|withdrawn after Follow up 1 visit|2|||
37816744|NCT02691663|69495383|FG001|Overall Study|withdrawn after Follow up 1 visit|2|||
37816745|NCT02691663|69495382|FG000|Overall Study|Withdrawn after Follow up 2|1|||
37816746|NCT02691663|69495383|FG001|Overall Study|Withdrawn after Follow up 2|1|||
37816747|NCT02691663|69495382|FG000|Overall Study|Lost to Follow-up|3|||
37872408|NCT01170221|69556771|FG001|Overall Study|Withdrawal by Subject|7|||
37872409|NCT01170221|69556770|FG000|Overall Study|Subject completed only screening and LFU|1|||
37872410|NCT01170221|69556771|FG001|Overall Study|Subject completed only screening and LFU|0|||
37872411|NCT01170221|69556770|FG000|Overall Study|Randomized but not treated|1|||
37872412|NCT01170221|69556771|FG001|Overall Study|Randomized but not treated|0|||
37872413|NCT01166646|69556779|FG000|Overall Study|Protocol Violation|0|||
37872414|NCT01166646|69556780|FG001|Overall Study|Protocol Violation|1|||
37872415|NCT01166646|69556779|FG000|Overall Study|Adverse Event|1|||
37872416|NCT01166646|69556780|FG001|Overall Study|Adverse Event|0|||
37872417|NCT01129284|69556789|FG000|Overall Study|Adverse Event|2|||
37872418|NCT01129284|69556790|FG001|Overall Study|Adverse Event|0|||
37872419|NCT01129284|69556791|FG002|Overall Study|Adverse Event|1|||
37872420|NCT01166568|69556802|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
37872421|NCT01166568|69556803|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
37872422|NCT01166568|69556804|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
37872423|NCT01166568|69556802|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
37872424|NCT01166568|69556803|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
37872425|NCT01166568|69556804|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
37872426|NCT01166568|69556802|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
37872427|NCT01166568|69556803|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
37872428|NCT01166568|69556804|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
37872429|NCT01166178|69556812|FG000|Overall Study|Withdrawal by Subject|1|||
37872430|NCT01166178|69556813|FG001|Overall Study|Withdrawal by Subject|0|||
37872431|NCT01166178|69556812|FG000|Overall Study|Study was terminated|20|||
37872432|NCT01166178|69556813|FG001|Overall Study|Study was terminated|8|||
37872433|NCT00924820|69556819|FG000|Overall Study|Death|2|||
37872434|NCT00924820|69556819|FG000|Overall Study|Ineligible, Screen Failure|5|||
37872435|NCT01225172|69556825|FG000|Overall Study|Subject decision to stop|1|||
37872436|NCT01225172|69556826|FG001|Overall Study|Subject decision to stop|0|||
37872437|NCT01225172|69556825|FG000|Overall Study|Subject request to discontinue treatment|3|||
37872438|NCT01225172|69556826|FG001|Overall Study|Subject request to discontinue treatment|1|||
37872439|NCT01225172|69556825|FG000|Overall Study|Subject no longer meets study criteria|1|||
37872440|NCT01225172|69556826|FG001|Overall Study|Subject no longer meets study criteria|0|||
37872441|NCT01225172|69556825|FG000|Overall Study|Withdrawal by Subject|1|||
37872442|NCT01225172|69556826|FG001|Overall Study|Withdrawal by Subject|0|||
37816748|NCT02691663|69495383|FG001|Overall Study|Lost to Follow-up|2|||
37816749|NCT02639065|69495390|FG000|Study Treatment|Disease Progression|13|||
37816750|NCT02639065|69495390|FG000|Study Treatment|Adverse Event|9|||
37872443|NCT01143324|69556832|FG000|Overall Study|Lost to Follow-up|11|||
37872444|NCT01143324|69556832|FG000|Overall Study|Withdrawal by Subject|4|||
37872445|NCT01143324|69556832|FG000|Overall Study|Explant of the device|4|||
37872446|NCT01224782|69556836|FG000|Overall Study|Lost to Follow-up|177|||
37872447|NCT01224782|69556836|FG000|Overall Study|Withdrawal by Subject|16|||
37872448|NCT01224782|69556836|FG000|Overall Study|Death|14|||
37872449|NCT01224782|69556836|FG000|Overall Study|Improvement|13|||
37872450|NCT01224782|69556836|FG000|Overall Study|Adverse Event|12|||
37872451|NCT01224782|69556836|FG000|Overall Study|Adverse Reaction|11|||
37872452|NCT01224782|69556836|FG000|Overall Study|Noncompliance|10|||
37872453|NCT01224782|69556836|FG000|Overall Study|Other|4|||
37872454|NCT01224782|69556836|FG000|Overall Study|Start of Dialysis|3|||
37872455|NCT01224782|69556836|FG000|Overall Study|Change of Treatment|1|||
37872456|NCT01224782|69556836|FG000|Overall Study|Financial Reasons|1|||
37872457|NCT01224782|69556836|FG000|Overall Study|Deterioration|1|||
37872458|NCT01224782|69556836|FG000|Overall Study|Transplantation|1|||
37872459|NCT01224158|69556842|FG000|Overall Study|Withdrawal by Subject|1|||
37872460|NCT01224158|69556843|FG001|Overall Study|Withdrawal by Subject|0|||
37872461|NCT01129128|69556852|FG000|Overall Study|Lost to Follow-up|2|||
37872462|NCT01129128|69556853|FG001|Overall Study|Lost to Follow-up|2|||
37872463|NCT01129128|69556854|FG002|Overall Study|Lost to Follow-up|1|||
37872464|NCT01129128|69556852|FG000|Overall Study|Protocol Violation|0|||
37872465|NCT01129128|69556853|FG001|Overall Study|Protocol Violation|1|||
37872466|NCT01129128|69556854|FG002|Overall Study|Protocol Violation|0|||
37872467|NCT01129128|69556852|FG000|Overall Study|Withdrawal by Subject|0|||
37872468|NCT01129128|69556853|FG001|Overall Study|Withdrawal by Subject|1|||
37872469|NCT01129128|69556854|FG002|Overall Study|Withdrawal by Subject|3|||
37872470|NCT01129128|69556852|FG000|Overall Study|Physician Decision|1|||
37872471|NCT01129128|69556853|FG001|Overall Study|Physician Decision|0|||
37872472|NCT01129128|69556854|FG002|Overall Study|Physician Decision|0|||
37872473|NCT01222520|69556864|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
37872474|NCT01222520|69556865|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
37872475|NCT01222520|69556864|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
37872476|NCT01222520|69556865|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
37872477|NCT01222520|69556864|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
37872478|NCT01222520|69556865|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
37872479|NCT01222520|69556864|FG000|Double-blind Period|Adverse Event|0|||
37872480|NCT01222520|69556865|FG001|Double-blind Period|Adverse Event|1|||
37872481|NCT01222520|69556864|FG000|Double-blind Period|Lack of Efficacy|0|||
37872482|NCT01222520|69556865|FG001|Double-blind Period|Lack of Efficacy|1|||
37872483|NCT01222520|69556864|FG000|Double-blind Period|Study medication stolen|1|||
37872484|NCT01222520|69556865|FG001|Double-blind Period|Study medication stolen|0|||
37872485|NCT01221350|69556873|FG000|Overall Study|Discontinued intervention (GERD)|1|||
37872486|NCT01221350|69556874|FG001|Overall Study|Discontinued intervention (GERD)|0|||
37872487|NCT01221350|69556873|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
37872488|NCT01221350|69556874|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
37872489|NCT01221350|69556873|FG000|Overall Study|Withdrawal by Subject|4|||
37872490|NCT01221350|69556874|FG001|Overall Study|Withdrawal by Subject|2|||
37872491|NCT01221272|69556882|FG000|Period 1|Adverse Event|2|||
37872492|NCT01221272|69556883|FG001|Period 1|Adverse Event|0|||
37816751|NCT02639065|69495390|FG000|Study Treatment|Withdrawal by Subject|1|||
37816752|NCT02639065|69495390|FG000|Follow up|Subject refused to follow up|1|||
37816753|NCT02639065|69495390|FG000|Follow up|Symptomatic Deterioration|2|||
37816754|NCT02639065|69495390|FG000|Follow up|Death|2|||
37816755|NCT02639065|69495390|FG000|Follow up|Study Terminated|1|||
37816756|NCT02639065|69495390|FG000|Follow up|Disease Progression|3|||
37816757|NCT02566785|69495396|FG000|Overall Study|Lost to Follow-up|0|||
37816758|NCT02566785|69495397|FG001|Overall Study|Lost to Follow-up|2|||
37816759|NCT02566785|69495396|FG000|Overall Study|Worsening condition|1|||
37816760|NCT02566785|69495397|FG001|Overall Study|Worsening condition|1|||
37816761|NCT02451943|69495405|FG000|Overall Study|On Treatment|4|||
37816762|NCT02451943|69495406|FG001|Overall Study|On Treatment|4|||
37816763|NCT02451943|69495405|FG000|Overall Study|Withdrawal by Subject|13|||
37816764|NCT02451943|69495406|FG001|Overall Study|Withdrawal by Subject|16|||
37816765|NCT02451943|69495405|FG000|Overall Study|Lost to Follow-up|3|||
37816766|NCT02451943|69495406|FG001|Overall Study|Lost to Follow-up|4|||
37816767|NCT02344537|69495414|FG000|Overall Study|Protocol Violation|1|||
37816768|NCT02344537|69495415|FG001|Overall Study|Protocol Violation|1|||
37816769|NCT02344537|69495414|FG000|Overall Study|Subject started another treatment after wk 6|1|||
37816770|NCT02344537|69495415|FG001|Overall Study|Subject started another treatment after wk 6|0|||
37816771|NCT02344537|69495414|FG000|Overall Study|Participants completed the treatment but the week 8 data not available.|2|||
37872493|NCT01221272|69556882|FG000|Period 1|Consent Withdrawal|0|||
37872494|NCT01221272|69556883|FG001|Period 1|Consent Withdrawal|1|||
37816772|NCT02344537|69495415|FG001|Overall Study|Participants completed the treatment but the week 8 data not available.|1|||
37872495|NCT01221272|69556882|FG000|Period 1|Significant Dosing Noncompliance|0|||
37872496|NCT01221272|69556883|FG001|Period 1|Significant Dosing Noncompliance|1|||
37872497|NCT01221272|69556882|FG000|Period 2|Adverse Event|0|||
37872498|NCT01221272|69556883|FG001|Period 2|Adverse Event|2|||
37872499|NCT01220414|69556894|FG000|Overall Study|Withdrawal by Subject|1|||
37816773|NCT01092702|69495432|FG000|Overall Study|Withdrawal by Subject|7|||
37816774|NCT01092702|69495432|FG000|Overall Study|Lost to Follow-up|2|||
37816775|NCT00658879|69495461|FG000|Overall Study|Protocol Violation|1|||
37872500|NCT01220414|69556895|FG001|Overall Study|Withdrawal by Subject|0|||
37872501|NCT01220414|69556896|FG002|Overall Study|Withdrawal by Subject|0|||
37872502|NCT01220414|69556897|FG003|Overall Study|Withdrawal by Subject|1|||
37872503|NCT01128894|69556906|FG000|Overall Study|Adverse Event|31|||
37872504|NCT01128894|69556907|FG001|Overall Study|Adverse Event|41|||
37872505|NCT01128894|69556906|FG000|Overall Study|Protocol Violation|2|||
37872506|NCT01128894|69556907|FG001|Overall Study|Protocol Violation|1|||
37872507|NCT01128894|69556906|FG000|Overall Study|Noncompliance|4|||
37872508|NCT01128894|69556907|FG001|Overall Study|Noncompliance|5|||
37872509|NCT01128894|69556906|FG000|Overall Study|Lost to Follow-up|8|||
37872510|NCT01128894|69556907|FG001|Overall Study|Lost to Follow-up|8|||
37872511|NCT01128894|69556906|FG000|Overall Study|Withdrawal by Subject|10|||
37872512|NCT01128894|69556907|FG001|Overall Study|Withdrawal by Subject|12|||
37872513|NCT01128894|69556906|FG000|Overall Study|Physician Decision|2|||
37872514|NCT01128894|69556907|FG001|Overall Study|Physician Decision|1|||
37872515|NCT01128894|69556906|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
37872516|NCT01128894|69556907|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
37872517|NCT01220180|69556916|FG000|Overall Study|Lost to Follow-up|76|||
37872518|NCT01220180|69556916|FG000|Overall Study|Other|72|||
37872519|NCT01220180|69556916|FG000|Overall Study|Adverse Event|35|||
37872520|NCT01220180|69556916|FG000|Overall Study|Lack of Efficacy|22|||
37872521|NCT01220180|69556916|FG000|Overall Study|Death|1|||
37872522|NCT01220180|69556916|FG000|Overall Study|Randomized but not treated|1|||
37872523|NCT01220024|69556922|FG000|Overall Study|Lost to Follow-up|1|||
37872524|NCT01220024|69556923|FG001|Overall Study|Lost to Follow-up|1|||
37872525|NCT01128738|69556931|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
37872526|NCT01128738|69556932|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
37872527|NCT01128738|69556931|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
37872528|NCT01128738|69556932|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
37872529|NCT01128738|69556931|FG000|Second TP|Lost to Follow-up|0|||
37872530|NCT01128738|69556932|FG001|Second TP|Lost to Follow-up|1|||
37872531|NCT01128738|69556931|FG000|Second TP|Withdrawal by Subject|0|||
37872532|NCT01128738|69556932|FG001|Second TP|Withdrawal by Subject|2|||
37872533|NCT01143090|69556939|FG000|Overall Study|Lack of Efficacy|2|||
37872534|NCT01143090|69556939|FG000|Overall Study|Adverse Event|17|||
37872535|NCT01143090|69556939|FG000|Overall Study|Lost to Follow-up|9|||
37872536|NCT01143090|69556939|FG000|Overall Study|Protocol Violation|2|||
37872537|NCT01143090|69556939|FG000|Overall Study|Withdrawal by Subject|18|||
37872538|NCT01143090|69556939|FG000|Overall Study|Non-compliance with study drug|1|||
37872539|NCT01143090|69556939|FG000|Overall Study|Failure to meet eligibility criteria|1|||
37872540|NCT01143090|69556939|FG000|Overall Study|Administrative|1|||
37816776|NCT00591851|69495465|FG000|Overall Study|Withdrawal by Subject|3|||
37816777|NCT00591851|69495465|FG000|Overall Study|Adverse Event|2|||
37816778|NCT00591851|69495465|FG000|Overall Study|Progressive Disease|1|||
37816779|NCT00336024|69495471|FG000|Overall Study|Death|2|||
37816780|NCT00336024|69495472|FG001|Overall Study|Death|1|||
37816781|NCT00336024|69495471|FG000|Overall Study|Physician Decision|4|||
37872541|NCT01165554|69556943|FG000|Overall Study|Withdrawal by Subject|23|||
37872542|NCT01218308|69556952|FG000|Overall Study|Adverse Event|1|||
37872543|NCT01218308|69556953|FG001|Overall Study|Adverse Event|2|||
37872544|NCT01218308|69556952|FG000|Overall Study|Protocol Violation|0|||
37872545|NCT01218308|69556953|FG001|Overall Study|Protocol Violation|2|||
37872546|NCT01218308|69556952|FG000|Overall Study|Withdrawal by Subject|61|||
37816782|NCT00336024|69495472|FG001|Overall Study|Physician Decision|1|||
37816783|NCT00336024|69495471|FG000|Overall Study|Protocol Violation|1|||
37816784|NCT00336024|69495472|FG001|Overall Study|Protocol Violation|0|||
37816785|NCT00336024|69495471|FG000|Overall Study|Withdrawal by Subject|1|||
37816786|NCT00336024|69495472|FG001|Overall Study|Withdrawal by Subject|2|||
37816787|NCT00336024|69495471|FG000|Overall Study|Failure to fulfill consolidation|1|||
37816788|NCT00336024|69495472|FG001|Overall Study|Failure to fulfill consolidation|1|||
37872547|NCT01218308|69556953|FG001|Overall Study|Withdrawal by Subject|64|||
37872548|NCT01218308|69556952|FG000|Overall Study|Lost to Follow-up|27|||
37872549|NCT01218308|69556953|FG001|Overall Study|Lost to Follow-up|31|||
37872550|NCT01218308|69556952|FG000|Overall Study|Other|14|||
37872551|NCT01218308|69556953|FG001|Overall Study|Other|21|||
37872552|NCT01165320|69556961|FG000|Overall Study|Clinical adverse experience|2|||
37872553|NCT01165320|69556962|FG001|Overall Study|Clinical adverse experience|1|||
37872554|NCT01165320|69556963|FG002|Overall Study|Clinical adverse experience|0|||
37872555|NCT01165320|69556961|FG000|Overall Study|Laboratory adverse experience|1|||
37872556|NCT01165320|69556962|FG001|Overall Study|Laboratory adverse experience|0|||
37872557|NCT01165320|69556963|FG002|Overall Study|Laboratory adverse experience|0|||
37872558|NCT01165320|69556961|FG000|Overall Study|Lack of Efficacy|0|||
37872559|NCT01165320|69556962|FG001|Overall Study|Lack of Efficacy|2|||
37872560|NCT01165320|69556963|FG002|Overall Study|Lack of Efficacy|0|||
37872561|NCT01165320|69556961|FG000|Overall Study|Reason unknown|0|||
37872562|NCT01165320|69556962|FG001|Overall Study|Reason unknown|1|||
37872563|NCT01165320|69556963|FG002|Overall Study|Reason unknown|0|||
37872564|NCT01217606|69556971|FG000|Initial Treatment Phase|Other Reasons|0|||
37872565|NCT01217606|69556972|FG001|Initial Treatment Phase|Other Reasons|2|||
37872566|NCT01217606|69556971|FG000|Initial Treatment Phase|Protocol Violation|3|||
37872567|NCT01217606|69556972|FG001|Initial Treatment Phase|Protocol Violation|2|||
37872568|NCT01217606|69556971|FG000|Initial Treatment Phase|Personal Reasons|0|||
37816789|NCT00336024|69495471|FG000|Overall Study|Progressive Disease|4|||
37816790|NCT00336024|69495472|FG001|Overall Study|Progressive Disease|7|||
37816791|NCT00336024|69495471|FG000|Overall Study|Ineligible|7|||
37816792|NCT00336024|69495472|FG001|Overall Study|Ineligible|7|||
37816793|NCT00133705|69495480|FG000|Overall Study|Withdrawal by Subject|2|||
37816794|NCT00133705|69495481|FG001|Overall Study|Withdrawal by Subject|3|||
37816795|NCT01545050|69495492|FG000|Overall Study|Lack of Efficacy|0|||
37816796|NCT01545050|69495493|FG001|Overall Study|Lack of Efficacy|0|||
37816797|NCT01545050|69495494|FG002|Overall Study|Lack of Efficacy|0|||
37816798|NCT01545050|69495495|FG003|Overall Study|Lack of Efficacy|3|||
37816799|NCT01545050|69495496|FG004|Overall Study|Lack of Efficacy|2|||
37816800|NCT01545050|69495492|FG000|Overall Study|Adverse Event|1|||
37872569|NCT01217606|69556972|FG001|Initial Treatment Phase|Personal Reasons|2|||
37872570|NCT01217606|69556971|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
37872571|NCT01217606|69556972|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
37872572|NCT01217606|69556971|FG000|Initial Treatment Phase|Adverse Event|10|||
37981071|NCT00529529|69667643|FG001|Overall Study|Death|0|||
37981072|NCT00529529|69667644|FG002|Overall Study|Death|0|||
37981073|NCT00529529|69667642|FG000|Overall Study|Abnormal test procedure result(s)|1|||
37981074|NCT00529529|69667643|FG001|Overall Study|Abnormal test procedure result(s)|0|||
37872573|NCT01217606|69556972|FG001|Initial Treatment Phase|Adverse Event|6|||
37872574|NCT01217606|69556971|FG000|9-Month Masked Extension|Adverse Event|3|||
37872575|NCT01217606|69556972|FG001|9-Month Masked Extension|Adverse Event|6|||
37872576|NCT01217606|69556971|FG000|9-Month Masked Extension|Other Reasons|4|||
37872577|NCT01217606|69556972|FG001|9-Month Masked Extension|Other Reasons|4|||
37872578|NCT01217606|69556971|FG000|9-Month Masked Extension|Personal Reasons|2|||
37872579|NCT01217606|69556972|FG001|9-Month Masked Extension|Personal Reasons|1|||
37872580|NCT01217606|69556971|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
37872581|NCT01217606|69556972|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
37872582|NCT01217606|69556971|FG000|9-Month Masked Extension|Pregnancy|1|||
37872583|NCT01217606|69556972|FG001|9-Month Masked Extension|Pregnancy|0|||
37872584|NCT01217606|69556971|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
37872585|NCT01217606|69556972|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
37872586|NCT01128114|69556978|FG000|Overall Study|Treatment Withdrawn|6|||
37872587|NCT01128114|69556978|FG000|Overall Study|Screening Failed|2|||
37872588|NCT01217060|69556982|FG000|Overall Study|Withdrawal by Subject|1|||
37872589|NCT04816669|69556990|FG000|Part 1|Adverse Event|1|||
37872590|NCT04816669|69556991|FG001|Part 1|Adverse Event|1|||
37872591|NCT04816669|69556992|FG002|Part 1|Adverse Event|0|||
37872592|NCT04816669|69556993|FG003|Part 1|Adverse Event|0|||
37872593|NCT04816669|69556990|FG000|Part 1|Lost to Follow-up|2|||
37872594|NCT04816669|69556991|FG001|Part 1|Lost to Follow-up|2|||
37872595|NCT04816669|69556992|FG002|Part 1|Lost to Follow-up|0|||
37872596|NCT04816669|69556993|FG003|Part 1|Lost to Follow-up|0|||
37872597|NCT04816669|69556990|FG000|Part 1|Protocol Violation|0|||
37872598|NCT04816669|69556991|FG001|Part 1|Protocol Violation|1|||
37872599|NCT04816669|69556992|FG002|Part 1|Protocol Violation|0|||
37872600|NCT04816669|69556993|FG003|Part 1|Protocol Violation|0|||
37872601|NCT04816669|69556990|FG000|Part 1|Withdrawal by Subject|1|||
37872602|NCT04816669|69556991|FG001|Part 1|Withdrawal by Subject|2|||
37872603|NCT04816669|69556992|FG002|Part 1|Withdrawal by Subject|0|||
37872604|NCT04816669|69556993|FG003|Part 1|Withdrawal by Subject|0|||
37981075|NCT00529529|69667644|FG002|Overall Study|Abnormal test procedure result(s)|0|||
37981076|NCT00529529|69667642|FG000|Overall Study|Administrative problems|1|||
37981077|NCT00529529|69667643|FG001|Overall Study|Administrative problems|0|||
37816801|NCT01545050|69495493|FG001|Overall Study|Adverse Event|1|||
37816802|NCT01545050|69495494|FG002|Overall Study|Adverse Event|2|||
37816803|NCT01545050|69495495|FG003|Overall Study|Adverse Event|2|||
37872605|NCT04816669|69556990|FG000|Part 2|Other|0|||
37872606|NCT04816669|69556991|FG001|Part 2|Other|0|||
37872607|NCT04816669|69556992|FG002|Part 2|Other|1|||
37872608|NCT04816669|69556993|FG003|Part 2|Other|0|||
37872609|NCT04816669|69556990|FG000|Part 2|Withdrawal by Subject|0|||
37872610|NCT04816669|69556991|FG001|Part 2|Withdrawal by Subject|0|||
37872611|NCT04816669|69556992|FG002|Part 2|Withdrawal by Subject|0|||
37872612|NCT04816669|69556993|FG003|Part 2|Withdrawal by Subject|1|||
37872613|NCT04816669|69556990|FG000|Part 2|Lost to Follow-up|0|||
37816804|NCT01545050|69495496|FG004|Overall Study|Adverse Event|0|||
37872614|NCT04816669|69556991|FG001|Part 2|Lost to Follow-up|0|||
37872615|NCT04816669|69556992|FG002|Part 2|Lost to Follow-up|1|||
37872616|NCT04816669|69556993|FG003|Part 2|Lost to Follow-up|0|||
37872617|NCT01165242|69557010|FG000|Overall Study|Unreachable Subjects|1|||
37981078|NCT00529529|69667644|FG002|Overall Study|Administrative problems|3|||
37872618|NCT01165242|69557011|FG001|Overall Study|Unreachable Subjects|0|||
37872619|NCT01165242|69557012|FG002|Overall Study|Unreachable Subjects|0|||
37872620|NCT01165242|69557010|FG000|Overall Study|Incarcerated Subjects|0|||
37872621|NCT01165242|69557011|FG001|Overall Study|Incarcerated Subjects|1|||
37872622|NCT01165242|69557012|FG002|Overall Study|Incarcerated Subjects|0|||
37872623|NCT01165242|69557010|FG000|Overall Study|Visit 2 Declined by Subject|0|||
37872624|NCT01165242|69557011|FG001|Overall Study|Visit 2 Declined by Subject|0|||
37872625|NCT01165242|69557012|FG002|Overall Study|Visit 2 Declined by Subject|1|||
37872626|NCT01165242|69557010|FG000|Overall Study|Withdrawal by Subject|0|||
37872627|NCT01165242|69557011|FG001|Overall Study|Withdrawal by Subject|2|||
37872628|NCT01165242|69557012|FG002|Overall Study|Withdrawal by Subject|2|||
37872629|NCT01165242|69557010|FG000|Overall Study|Extended Holiday|0|||
37872630|NCT01165242|69557011|FG001|Overall Study|Extended Holiday|0|||
37872631|NCT01165242|69557012|FG002|Overall Study|Extended Holiday|1|||
37872632|NCT01165242|69557010|FG000|Overall Study|Lost to Follow-up|9|||
37872633|NCT01165242|69557011|FG001|Overall Study|Lost to Follow-up|7|||
37872634|NCT01165242|69557012|FG002|Overall Study|Lost to Follow-up|10|||
37981079|NCT05655377|69667652|FG000|Overall Study|Withdrawal by Subject|2|||
37981080|NCT00486434|69667658|FG000|Overall Study|Withdrawal by Subject|34|||
37981081|NCT00486434|69667659|FG001|Overall Study|Withdrawal by Subject|39|||
37981082|NCT00486434|69667658|FG000|Overall Study|Adverse Event|118|||
37981083|NCT00486434|69667659|FG001|Overall Study|Adverse Event|44|||
37981084|NCT00486434|69667658|FG000|Overall Study|Protocol Violation|22|||
37981085|NCT00486434|69667659|FG001|Overall Study|Protocol Violation|21|||
37981086|NCT00486434|69667658|FG000|Overall Study|Lack of Efficacy|12|||
37981087|NCT00486434|69667659|FG001|Overall Study|Lack of Efficacy|19|||
37981088|NCT00486434|69667658|FG000|Overall Study|Lost to Follow-up|2|||
37981089|NCT00486434|69667659|FG001|Overall Study|Lost to Follow-up|3|||
37981090|NCT00486434|69667658|FG000|Overall Study|Death|1|||
37981091|NCT00486434|69667659|FG001|Overall Study|Death|2|||
37981092|NCT00486434|69667658|FG000|Overall Study|Personal reasons|5|||
37981093|NCT00486434|69667659|FG001|Overall Study|Personal reasons|6|||
37981094|NCT00424632|69667668|FG000|Overall Study|Death|0|||
37981095|NCT00424632|69667669|FG001|Overall Study|Death|0|||
37981096|NCT00424632|69667670|FG002|Overall Study|Death|0|||
37981097|NCT00424632|69667671|FG003|Overall Study|Death|0|||
37816805|NCT01545050|69495492|FG000|Overall Study|Discontinued study treatment|1|||
37816806|NCT01545050|69495493|FG001|Overall Study|Discontinued study treatment|0|||
37816807|NCT01545050|69495494|FG002|Overall Study|Discontinued study treatment|0|||
37816808|NCT01545050|69495495|FG003|Overall Study|Discontinued study treatment|0|||
37816809|NCT01545050|69495496|FG004|Overall Study|Discontinued study treatment|0|||
37816810|NCT01545050|69495492|FG000|Overall Study|Withdrawal by Subject|1|||
37816811|NCT01545050|69495493|FG001|Overall Study|Withdrawal by Subject|0|||
37816812|NCT01545050|69495494|FG002|Overall Study|Withdrawal by Subject|0|||
37816813|NCT01545050|69495495|FG003|Overall Study|Withdrawal by Subject|2|||
37816814|NCT01545050|69495496|FG004|Overall Study|Withdrawal by Subject|1|||
37872635|NCT01170065|69557025|FG000|Overall Study|Adverse Event|17|||
37981098|NCT00424632|69667672|FG004|Overall Study|Death|0|||
37981099|NCT00424632|69667673|FG005|Overall Study|Death|2|||
37816815|NCT01545050|69495492|FG000|Overall Study|Participant no longer meets study criteria|0|||
37872636|NCT01170065|69557026|FG001|Overall Study|Adverse Event|50|||
37981100|NCT00424632|69667674|FG006|Overall Study|Death|0|||
37981101|NCT00424632|69667675|FG007|Overall Study|Death|0|||
37981102|NCT00424632|69667676|FG008|Overall Study|Death|0|||
37981103|NCT00424632|69667677|FG009|Overall Study|Death|0|||
37981104|NCT00424632|69667668|FG000|Overall Study|Adverse Event|0|||
37872637|NCT01170065|69557027|FG002|Overall Study|Adverse Event|10|||
37872638|NCT01170065|69557025|FG000|Overall Study|Lost to Follow-up|1|||
37872639|NCT01170065|69557026|FG001|Overall Study|Lost to Follow-up|4|||
37981105|NCT00424632|69667669|FG001|Overall Study|Adverse Event|0|||
37872640|NCT01170065|69557027|FG002|Overall Study|Lost to Follow-up|1|||
37981106|NCT00424632|69667670|FG002|Overall Study|Adverse Event|0|||
37981107|NCT00424632|69667671|FG003|Overall Study|Adverse Event|0|||
37981108|NCT00424632|69667672|FG004|Overall Study|Adverse Event|0|||
37981109|NCT00424632|69667673|FG005|Overall Study|Adverse Event|0|||
37872641|NCT01170065|69557025|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
37872642|NCT01170065|69557026|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
37872643|NCT01170065|69557027|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
37872644|NCT01170065|69557025|FG000|Overall Study|Reason other than specified|3|||
37872645|NCT01170065|69557026|FG001|Overall Study|Reason other than specified|8|||
37872646|NCT01170065|69557027|FG002|Overall Study|Reason other than specified|3|||
37872647|NCT01170065|69557025|FG000|Overall Study|Ongoing after planned observation time|5|||
37872648|NCT01170065|69557026|FG001|Overall Study|Ongoing after planned observation time|26|||
37816816|NCT01545050|69495493|FG001|Overall Study|Participant no longer meets study criteria|2|||
37816817|NCT01545050|69495494|FG002|Overall Study|Participant no longer meets study criteria|0|||
37872649|NCT01170065|69557027|FG002|Overall Study|Ongoing after planned observation time|10|||
37872650|NCT00966693|69557039|FG000|Overall Study|Adverse Event|0|||
37872651|NCT00966693|69557040|FG001|Overall Study|Adverse Event|0|||
37872652|NCT00966693|69557041|FG002|Overall Study|Adverse Event|1|||
37872653|NCT00966693|69557042|FG003|Overall Study|Adverse Event|2|||
37872654|NCT00966693|69557039|FG000|Overall Study|Death|0|||
37872655|NCT00966693|69557040|FG001|Overall Study|Death|0|||
37872656|NCT00966693|69557041|FG002|Overall Study|Death|1|||
37872657|NCT00966693|69557042|FG003|Overall Study|Death|0|||
37872658|NCT00966693|69557039|FG000|Overall Study|Withdrawal by Subject|1|||
37981110|NCT00424632|69667674|FG006|Overall Study|Adverse Event|0|||
37816818|NCT01545050|69495495|FG003|Overall Study|Participant no longer meets study criteria|0|||
37872659|NCT00966693|69557040|FG001|Overall Study|Withdrawal by Subject|0|||
37872660|NCT00966693|69557041|FG002|Overall Study|Withdrawal by Subject|0|||
37872661|NCT00966693|69557042|FG003|Overall Study|Withdrawal by Subject|5|||
37872662|NCT00966693|69557039|FG000|Overall Study|Disease Progression|0|||
37872663|NCT00966693|69557040|FG001|Overall Study|Disease Progression|0|||
37872664|NCT00966693|69557041|FG002|Overall Study|Disease Progression|1|||
37872665|NCT00966693|69557042|FG003|Overall Study|Disease Progression|16|||
37872666|NCT01215968|69557054|FG000|Overall Study|Adverse Event|0|||
37872667|NCT01215968|69557055|FG001|Overall Study|Adverse Event|2|||
37872668|NCT01215968|69557054|FG000|Overall Study|Protocol Violation|2|||
37872669|NCT01215968|69557055|FG001|Overall Study|Protocol Violation|4|||
37872670|NCT01215968|69557054|FG000|Overall Study|Not received study drug|0|||
37872671|NCT01215968|69557055|FG001|Overall Study|Not received study drug|1|||
37981111|NCT00424632|69667675|FG007|Overall Study|Adverse Event|0|||
37816819|NCT01545050|69495496|FG004|Overall Study|Participant no longer meets study criteria|1|||
37816820|NCT01545050|69495492|FG000|Overall Study|Administrative reason by sponsor|4|||
37816821|NCT01545050|69495493|FG001|Overall Study|Administrative reason by sponsor|2|||
37816822|NCT01545050|69495494|FG002|Overall Study|Administrative reason by sponsor|3|||
37816823|NCT01545050|69495495|FG003|Overall Study|Administrative reason by sponsor|5|||
37816824|NCT01545050|69495496|FG004|Overall Study|Administrative reason by sponsor|5|||
37816825|NCT01555021|69495523|FG000|Overall Study|Lost to Follow-up|1|||
37816826|NCT01555021|69495524|FG001|Overall Study|Lost to Follow-up|2|||
37816827|NCT04721925|69495538|FG000|2-Month Assessment|Lost to Follow-up|5|||
37816828|NCT04721925|69495539|FG001|2-Month Assessment|Lost to Follow-up|3|||
37816829|NCT04721925|69495538|FG000|4-Month Assessment|Lost to Follow-up|3|||
37816830|NCT04721925|69495539|FG001|4-Month Assessment|Lost to Follow-up|6|||
37816831|NCT04677660|69495546|FG000|Overall Study|Lost to Follow-up|0|||
37816832|NCT04677660|69495547|FG001|Overall Study|Lost to Follow-up|2|||
37816833|NCT04677660|69495546|FG000|Overall Study|Withdrawal by Subject|0|||
37816834|NCT04677660|69495547|FG001|Overall Study|Withdrawal by Subject|1|||
37816835|NCT04677660|69495546|FG000|Overall Study|Chose Publicly Available Vaccine|43|||
37816836|NCT04677660|69495547|FG001|Overall Study|Chose Publicly Available Vaccine|10|||
37981112|NCT00424632|69667676|FG008|Overall Study|Adverse Event|3|||
37981113|NCT00424632|69667677|FG009|Overall Study|Adverse Event|2|||
37816837|NCT04518995|69495556|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|2|||
37872672|NCT00963807|69557064|FG000|Overall Study|Physician Decision|2|||
37872673|NCT00963807|69557064|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
37872674|NCT00963807|69557064|FG000|Overall Study|Disease progression|15|||
37872675|NCT01142466|69557072|FG000|Overall Study|Adverse Event|2|||
37872676|NCT01142466|69557073|FG001|Overall Study|Adverse Event|1|||
37872677|NCT01142466|69557072|FG000|Overall Study|Withdrawal by Subject|1|||
37872678|NCT01142466|69557073|FG001|Overall Study|Withdrawal by Subject|1|||
37981114|NCT00424632|69667668|FG000|Overall Study|Global deterioration of health status|0|||
37694999|NCT02372006|69171433|FG000|Overall Study|Other reason for not completing|0|||
37695000|NCT02372006|69171434|FG001|Overall Study|Other reason for not completing|0|||
37695001|NCT02372006|69171435|FG002|Overall Study|Other reason for not completing|1|||
37695002|NCT02406248|69171444|FG000|Overall Study|Death|7|||
37695003|NCT02406248|69171444|FG000|Overall Study|Withdrawal by Subject|2|||
37695004|NCT02450903|69171448|FG000|Overall Study|Adverse Event|3|||
37816838|NCT04518995|69495557|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|8|||
37816839|NCT04518995|69495558|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|4|||
37872679|NCT01215734|69557081|FG000|Overall Study|Death|0|||
37872680|NCT01215734|69557082|FG001|Overall Study|Death|1|||
37872681|NCT01169987|69557088|FG000|Overall Study|Withdrawal by Subject|3|||
37872682|NCT01169987|69557088|FG000|Overall Study|Lost to Follow-up|24|||
37872683|NCT01169987|69557088|FG000|Overall Study|Other|4|||
37872684|NCT01215422|69557102|FG000|Overall Study|Relocation|1|||
37981115|NCT00424632|69667669|FG001|Overall Study|Global deterioration of health status|0|||
37981116|NCT00424632|69667670|FG002|Overall Study|Global deterioration of health status|0|||
37981117|NCT00424632|69667671|FG003|Overall Study|Global deterioration of health status|1|||
37981118|NCT00424632|69667672|FG004|Overall Study|Global deterioration of health status|1|||
37981119|NCT00424632|69667673|FG005|Overall Study|Global deterioration of health status|0|||
37981120|NCT00424632|69667674|FG006|Overall Study|Global deterioration of health status|0|||
37816840|NCT04518995|69495556|FG000|Overall Study|Lack of Efficacy|2|||
37816841|NCT04518995|69495557|FG001|Overall Study|Lack of Efficacy|1|||
37872685|NCT01215422|69557103|FG001|Overall Study|Relocation|0|||
37872686|NCT01215422|69557104|FG002|Overall Study|Relocation|0|||
37872687|NCT01215422|69557105|FG003|Overall Study|Relocation|0|||
37872688|NCT01215422|69557102|FG000|Overall Study|Failed intubations|0|||
37872689|NCT01215422|69557103|FG001|Overall Study|Failed intubations|0|||
37872690|NCT01215422|69557104|FG002|Overall Study|Failed intubations|3|||
37872691|NCT01215422|69557105|FG003|Overall Study|Failed intubations|8|||
37872692|NCT01215422|69557102|FG000|Overall Study|Did not complete all intubations|7|||
37872693|NCT01215422|69557103|FG001|Overall Study|Did not complete all intubations|0|||
37872694|NCT01215422|69557104|FG002|Overall Study|Did not complete all intubations|0|||
37872695|NCT01215422|69557105|FG003|Overall Study|Did not complete all intubations|0|||
37872696|NCT00972153|69557130|FG000|Overall Study|Equipment malfunction during case|0|||
37872697|NCT00972153|69557131|FG001|Overall Study|Equipment malfunction during case|1|||
37872698|NCT00972153|69557132|FG002|Overall Study|Equipment malfunction during case|0|||
37872699|NCT00971997|69557140|FG000|Overall Study|Adverse Event|2|||
37872700|NCT00971997|69557140|FG000|Overall Study|Death|1|||
37816842|NCT04518995|69495558|FG002|Overall Study|Lack of Efficacy|0|||
37816843|NCT04518995|69495556|FG000|Overall Study|Non-compliance With Study Drug|0|||
37816844|NCT04518995|69495557|FG001|Overall Study|Non-compliance With Study Drug|3|||
37816845|NCT04518995|69495558|FG002|Overall Study|Non-compliance With Study Drug|2|||
37816846|NCT04518995|69495556|FG000|Overall Study|Pregnancy|0|||
37816847|NCT04518995|69495557|FG001|Overall Study|Pregnancy|0|||
37816848|NCT04518995|69495558|FG002|Overall Study|Pregnancy|1|||
37816849|NCT04518995|69495556|FG000|Overall Study|Protocol Violation|2|||
37816850|NCT04518995|69495557|FG001|Overall Study|Protocol Violation|0|||
37816851|NCT04518995|69495558|FG002|Overall Study|Protocol Violation|1|||
37816852|NCT04518995|69495556|FG000|Overall Study|Reason not Specified|4|||
37816853|NCT04518995|69495557|FG001|Overall Study|Reason not Specified|11|||
37816854|NCT04518995|69495558|FG002|Overall Study|Reason not Specified|2|||
37816855|NCT04518995|69495556|FG000|Overall Study|Lost to Follow-up|1|||
37816856|NCT04518995|69495557|FG001|Overall Study|Lost to Follow-up|10|||
37872701|NCT00971997|69557140|FG000|Overall Study|Protocol Violation|4|||
37872702|NCT00971997|69557140|FG000|Overall Study|Withdrawal by Subject|5|||
37872703|NCT00971997|69557140|FG000|Overall Study|Physician Decision|7|||
37872704|NCT01127646|69557149|FG000|Overall Study|Entry Criteria Not Met|1|||
37872705|NCT01127646|69557150|FG001|Overall Study|Entry Criteria Not Met|0|||
37981121|NCT00424632|69667675|FG007|Overall Study|Global deterioration of health status|0|||
37981122|NCT00424632|69667676|FG008|Overall Study|Global deterioration of health status|0|||
37816857|NCT04518995|69495558|FG002|Overall Study|Lost to Follow-up|6|||
37816858|NCT04505722|69495568|FG000|Overall Study|Adverse Event|1|||
37816859|NCT04505722|69495569|FG001|Overall Study|Adverse Event|2|||
37872706|NCT01127646|69557149|FG000|Overall Study|Protocol Violation|0|||
37872707|NCT01127646|69557150|FG001|Overall Study|Protocol Violation|1|||
37872708|NCT01215188|69557161|FG000|Overall Study|Lost to Follow-up|22|||
37872709|NCT01215188|69557162|FG001|Overall Study|Lost to Follow-up|22|||
37872710|NCT01215188|69557163|FG002|Overall Study|Lost to Follow-up|16|||
37872711|NCT01215188|69557161|FG000|Overall Study|Adverse Event|1|||
37872712|NCT01215188|69557162|FG001|Overall Study|Adverse Event|1|||
37872713|NCT01215188|69557163|FG002|Overall Study|Adverse Event|3|||
37872714|NCT01215188|69557161|FG000|Overall Study|Physician Decision|2|||
37872715|NCT01215188|69557162|FG001|Overall Study|Physician Decision|1|||
37872716|NCT01215188|69557163|FG002|Overall Study|Physician Decision|0|||
37872717|NCT01215188|69557161|FG000|Overall Study|Lack of Efficacy|0|||
37872718|NCT01215188|69557162|FG001|Overall Study|Lack of Efficacy|0|||
37872719|NCT01215188|69557163|FG002|Overall Study|Lack of Efficacy|1|||
37872720|NCT01215188|69557161|FG000|Overall Study|Protocol Violation|1|||
37872721|NCT01215188|69557162|FG001|Overall Study|Protocol Violation|1|||
37872722|NCT01215188|69557163|FG002|Overall Study|Protocol Violation|1|||
37872723|NCT01215188|69557161|FG000|Overall Study|Withdrawal by Subject|32|||
37872724|NCT01215188|69557162|FG001|Overall Study|Withdrawal by Subject|34|||
37872725|NCT01215188|69557163|FG002|Overall Study|Withdrawal by Subject|31|||
37872726|NCT01215032|69557171|FG000|Overall Study|Adverse Event|3|||
37872727|NCT01215032|69557171|FG000|Overall Study|Lack of Efficacy|17|||
37872728|NCT00962247|69557177|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
37872729|NCT00962247|69557177|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
37872730|NCT00918580|69557183|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
37872731|NCT00918580|69557183|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
37872732|NCT00918580|69557183|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
37872733|NCT00918580|69557183|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
37872734|NCT00918580|69557183|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
37872735|NCT00918580|69557183|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
37872736|NCT00918580|69557183|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
37872737|NCT00920686|69557193|FG000|Overall Study|Lost to Follow-up|2|||
37872738|NCT00920686|69557194|FG001|Overall Study|Lost to Follow-up|3|||
37872739|NCT00920686|69557195|FG002|Overall Study|Lost to Follow-up|1|||
37872740|NCT00920686|69557193|FG000|Overall Study|Study drug dosing criteria not met|17|||
37872741|NCT00920686|69557194|FG001|Overall Study|Study drug dosing criteria not met|19|||
37872742|NCT00920686|69557195|FG002|Overall Study|Study drug dosing criteria not met|12|||
37872743|NCT01214720|69557209|FG000|Overall Study|Alive and still on treatment|34|||
37872744|NCT01214720|69557210|FG001|Overall Study|Alive and still on treatment|18|||
37872745|NCT01214720|69557209|FG000|Overall Study|Alive and in follow-up|45|||
37872746|NCT01214720|69557210|FG001|Overall Study|Alive and in follow-up|48|||
37872747|NCT01214720|69557209|FG000|Overall Study|Lost to Follow-up|6|||
37872748|NCT01214720|69557210|FG001|Overall Study|Lost to Follow-up|2|||
37872749|NCT01142232|69557221|FG000|Overall Study|Adverse Event|1|||
37872750|NCT01142232|69557222|FG001|Overall Study|Adverse Event|2|||
37872751|NCT01142232|69557223|FG002|Overall Study|Adverse Event|1|||
37872752|NCT01142232|69557224|FG003|Overall Study|Adverse Event|0|||
37872753|NCT01142232|69557225|FG004|Overall Study|Adverse Event|4|||
37872754|NCT01142232|69557221|FG000|Overall Study|Death|0|||
37872755|NCT01142232|69557222|FG001|Overall Study|Death|0|||
37872756|NCT01142232|69557223|FG002|Overall Study|Death|0|||
37872757|NCT01142232|69557224|FG003|Overall Study|Death|0|||
37872758|NCT01142232|69557225|FG004|Overall Study|Death|1|||
37872759|NCT01142232|69557221|FG000|Overall Study|Disease Progression|2|||
37872760|NCT01142232|69557222|FG001|Overall Study|Disease Progression|0|||
37872761|NCT01142232|69557223|FG002|Overall Study|Disease Progression|1|||
37872762|NCT01142232|69557224|FG003|Overall Study|Disease Progression|2|||
37872763|NCT01142232|69557225|FG004|Overall Study|Disease Progression|12|||
37872764|NCT01142232|69557221|FG000|Overall Study|Withdrawal by Subject|0|||
37872765|NCT01142232|69557222|FG001|Overall Study|Withdrawal by Subject|0|||
37872766|NCT01142232|69557223|FG002|Overall Study|Withdrawal by Subject|0|||
37872767|NCT01142232|69557224|FG003|Overall Study|Withdrawal by Subject|1|||
37872768|NCT01142232|69557225|FG004|Overall Study|Withdrawal by Subject|3|||
37872769|NCT01142232|69557221|FG000|Overall Study|Physician Decision|0|||
37872770|NCT01142232|69557222|FG001|Overall Study|Physician Decision|1|||
37981123|NCT00424632|69667677|FG009|Overall Study|Global deterioration of health status|0|||
37981124|NCT00424632|69667668|FG000|Overall Study|Objective progression or relapse|1|||
37872771|NCT01142232|69557223|FG002|Overall Study|Physician Decision|0|||
37872772|NCT01142232|69557224|FG003|Overall Study|Physician Decision|2|||
37872773|NCT01142232|69557225|FG004|Overall Study|Physician Decision|10|||
37872774|NCT01142232|69557221|FG000|Overall Study|Alternative Therapy|0|||
37872775|NCT01142232|69557222|FG001|Overall Study|Alternative Therapy|1|||
37872776|NCT01142232|69557223|FG002|Overall Study|Alternative Therapy|1|||
37872777|NCT01142232|69557224|FG003|Overall Study|Alternative Therapy|0|||
37872778|NCT01142232|69557225|FG004|Overall Study|Alternative Therapy|1|||
37872779|NCT01142232|69557221|FG000|Overall Study|Off Trt for other complicating disease|0|||
37872780|NCT01142232|69557222|FG001|Overall Study|Off Trt for other complicating disease|0|||
37872781|NCT01142232|69557223|FG002|Overall Study|Off Trt for other complicating disease|0|||
37872782|NCT01142232|69557224|FG003|Overall Study|Off Trt for other complicating disease|0|||
37872783|NCT01142232|69557225|FG004|Overall Study|Off Trt for other complicating disease|1|||
37872784|NCT01142232|69557221|FG000|Overall Study|Noncompliance|0|||
37872785|NCT01142232|69557222|FG001|Overall Study|Noncompliance|0|||
37872786|NCT01142232|69557223|FG002|Overall Study|Noncompliance|0|||
37872787|NCT01142232|69557224|FG003|Overall Study|Noncompliance|0|||
37872788|NCT01142232|69557225|FG004|Overall Study|Noncompliance|2|||
37872789|NCT01140906|69557241|FG000|Overall Study|Adverse Event|7|||
37981125|NCT00424632|69667669|FG001|Overall Study|Objective progression or relapse|1|||
37981126|NCT00424632|69667670|FG002|Overall Study|Objective progression or relapse|1|||
37981127|NCT00424632|69667671|FG003|Overall Study|Objective progression or relapse|2|||
37981128|NCT00424632|69667672|FG004|Overall Study|Objective progression or relapse|2|||
37981129|NCT00424632|69667673|FG005|Overall Study|Objective progression or relapse|13|||
37981130|NCT00424632|69667674|FG006|Overall Study|Objective progression or relapse|7|||
37872790|NCT01140906|69557242|FG001|Overall Study|Adverse Event|10|||
37872791|NCT01140906|69557243|FG002|Overall Study|Adverse Event|17|||
37872792|NCT01140906|69557244|FG003|Overall Study|Adverse Event|7|||
37872793|NCT01140906|69557241|FG000|Overall Study|Lack of Efficacy|6|||
37872794|NCT01140906|69557242|FG001|Overall Study|Lack of Efficacy|8|||
37872795|NCT01140906|69557243|FG002|Overall Study|Lack of Efficacy|2|||
37872796|NCT01140906|69557244|FG003|Overall Study|Lack of Efficacy|1|||
37872797|NCT01140906|69557241|FG000|Overall Study|Non-compliance|0|||
37872798|NCT01140906|69557242|FG001|Overall Study|Non-compliance|1|||
37872799|NCT01140906|69557243|FG002|Overall Study|Non-compliance|0|||
37872800|NCT01140906|69557244|FG003|Overall Study|Non-compliance|1|||
37872801|NCT01140906|69557241|FG000|Overall Study|Protocol Violation|5|||
37872802|NCT01140906|69557242|FG001|Overall Study|Protocol Violation|3|||
37872803|NCT01140906|69557243|FG002|Overall Study|Protocol Violation|2|||
37872804|NCT01140906|69557244|FG003|Overall Study|Protocol Violation|1|||
37872805|NCT01140906|69557241|FG000|Overall Study|Withdrawal of consent|6|||
37872806|NCT01140906|69557242|FG001|Overall Study|Withdrawal of consent|6|||
37872807|NCT01140906|69557243|FG002|Overall Study|Withdrawal of consent|2|||
37872808|NCT01140906|69557244|FG003|Overall Study|Withdrawal of consent|2|||
37872809|NCT01140906|69557241|FG000|Overall Study|Lost to Follow-up|1|||
37872810|NCT01140906|69557242|FG001|Overall Study|Lost to Follow-up|1|||
37872811|NCT01140906|69557243|FG002|Overall Study|Lost to Follow-up|0|||
37872812|NCT01140906|69557244|FG003|Overall Study|Lost to Follow-up|2|||
37872813|NCT01140906|69557241|FG000|Overall Study|Administrative or other reason|0|||
37872814|NCT01140906|69557242|FG001|Overall Study|Administrative or other reason|5|||
37981131|NCT00424632|69667675|FG007|Overall Study|Objective progression or relapse|3|||
37981132|NCT00424632|69667676|FG008|Overall Study|Objective progression or relapse|12|||
37872815|NCT01140906|69557243|FG002|Overall Study|Administrative or other reason|3|||
37872816|NCT01140906|69557244|FG003|Overall Study|Administrative or other reason|2|||
37872817|NCT00962091|69557261|FG000|Overall Study|Withdrawal by Subject|1|||
37872818|NCT00962091|69557262|FG001|Overall Study|Withdrawal by Subject|2|||
37872819|NCT00962091|69557263|FG002|Overall Study|Withdrawal by Subject|1|||
37872820|NCT00962091|69557264|FG003|Overall Study|Withdrawal by Subject|1|||
37872821|NCT00962091|69557265|FG004|Overall Study|Withdrawal by Subject|0|||
37872822|NCT00962091|69557266|FG005|Overall Study|Withdrawal by Subject|1|||
37872823|NCT00962091|69557267|FG006|Overall Study|Withdrawal by Subject|0|||
37872824|NCT00962091|69557261|FG000|Overall Study|Adverse Event|0|||
37872825|NCT00962091|69557262|FG001|Overall Study|Adverse Event|0|||
37872826|NCT00962091|69557263|FG002|Overall Study|Adverse Event|0|||
37872827|NCT00962091|69557264|FG003|Overall Study|Adverse Event|0|||
37872828|NCT00962091|69557265|FG004|Overall Study|Adverse Event|0|||
37872829|NCT00962091|69557266|FG005|Overall Study|Adverse Event|0|||
37872830|NCT00962091|69557267|FG006|Overall Study|Adverse Event|1|||
37872831|NCT01163916|69557294|FG000|Overall Study|Withdrawal by Subject|2|||
37872832|NCT01163916|69557295|FG001|Overall Study|Withdrawal by Subject|0|||
37872833|NCT01163916|69557296|FG002|Overall Study|Withdrawal by Subject|2|||
37872834|NCT01163916|69557294|FG000|Overall Study|Adverse Event|2|||
37872835|NCT01163916|69557295|FG001|Overall Study|Adverse Event|0|||
37872836|NCT01163916|69557296|FG002|Overall Study|Adverse Event|1|||
37872837|NCT01163916|69557294|FG000|Overall Study|Lack of Efficacy|2|||
37872838|NCT01163916|69557295|FG001|Overall Study|Lack of Efficacy|0|||
37981133|NCT00424632|69667677|FG009|Overall Study|Objective progression or relapse|4|||
37981134|NCT00424632|69667668|FG000|Overall Study|Other|0|||
37872839|NCT01163916|69557296|FG002|Overall Study|Lack of Efficacy|1|||
37872840|NCT01163916|69557294|FG000|Overall Study|Other|24|||
37872841|NCT01163916|69557295|FG001|Overall Study|Other|4|||
37872842|NCT01163916|69557296|FG002|Overall Study|Other|16|||
37872843|NCT01122576|69557312|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
37872844|NCT01122576|69557313|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
37872845|NCT01122576|69557314|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
37872846|NCT01122576|69557312|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
37872847|NCT01122576|69557313|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
37872848|NCT01122576|69557314|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
37872849|NCT01122576|69557312|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
37872850|NCT01122576|69557313|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
37872851|NCT01122576|69557314|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
37872852|NCT00965523|69557325|FG000|Study 221|Progressive Disease|4|||
37872853|NCT00965523|69557325|FG000|Study 221|Physician Decision|3|||
37872854|NCT00965523|69557325|FG000|Study 224|Progressive Disease|5|||
37872855|NCT00965523|69557325|FG000|Study 224|Physician Decision|1|||
37872856|NCT01122264|69557332|FG000|Overall Study|Adverse Event|6|||
37872857|NCT01122264|69557333|FG001|Overall Study|Adverse Event|5|||
37872858|NCT01122264|69557334|FG002|Overall Study|Adverse Event|7|||
37872859|NCT01122264|69557332|FG000|Overall Study|Death|1|||
37872860|NCT01122264|69557333|FG001|Overall Study|Death|0|||
37872861|NCT01122264|69557334|FG002|Overall Study|Death|0|||
37872862|NCT01122264|69557332|FG000|Overall Study|Lost to Follow-up|5|||
37872863|NCT01122264|69557333|FG001|Overall Study|Lost to Follow-up|9|||
37872864|NCT01122264|69557334|FG002|Overall Study|Lost to Follow-up|13|||
37872865|NCT01122264|69557332|FG000|Overall Study|Entry Criteria Not Met|1|||
37872866|NCT01122264|69557333|FG001|Overall Study|Entry Criteria Not Met|0|||
37872867|NCT01122264|69557334|FG002|Overall Study|Entry Criteria Not Met|0|||
37872868|NCT01122264|69557332|FG000|Overall Study|Protocol Violation|7|||
37872869|NCT01122264|69557333|FG001|Overall Study|Protocol Violation|7|||
37872870|NCT01122264|69557334|FG002|Overall Study|Protocol Violation|9|||
37872871|NCT01122264|69557332|FG000|Overall Study|Withdrawal by Subject|6|||
37872872|NCT01122264|69557333|FG001|Overall Study|Withdrawal by Subject|6|||
37872873|NCT01122264|69557334|FG002|Overall Study|Withdrawal by Subject|16|||
37872874|NCT01122264|69557332|FG000|Overall Study|Physician Decision|3|||
37872875|NCT01122264|69557333|FG001|Overall Study|Physician Decision|1|||
37981135|NCT00424632|69667669|FG001|Overall Study|Other|0|||
37981136|NCT00424632|69667670|FG002|Overall Study|Other|0|||
37872876|NCT01122264|69557334|FG002|Overall Study|Physician Decision|1|||
37872877|NCT01122264|69557332|FG000|Overall Study|Lack of Efficacy|3|||
37872878|NCT01122264|69557333|FG001|Overall Study|Lack of Efficacy|1|||
37872879|NCT01122264|69557334|FG002|Overall Study|Lack of Efficacy|1|||
37872880|NCT00920218|69557350|FG000|Overall Study|Serious Adverse Event|2|||
37872881|NCT00920218|69557351|FG001|Overall Study|Serious Adverse Event|0|||
37872882|NCT00920218|69557352|FG002|Overall Study|Serious Adverse Event|2|||
37872883|NCT00920218|69557353|FG003|Overall Study|Serious Adverse Event|1|||
37872884|NCT00920218|69557350|FG000|Overall Study|Withdrawal by Subject|0|||
37872885|NCT00920218|69557351|FG001|Overall Study|Withdrawal by Subject|3|||
37872886|NCT00920218|69557352|FG002|Overall Study|Withdrawal by Subject|2|||
37872887|NCT00920218|69557353|FG003|Overall Study|Withdrawal by Subject|0|||
37872888|NCT00920218|69557350|FG000|Overall Study|Migrated/moved from study area|0|||
37872889|NCT00920218|69557351|FG001|Overall Study|Migrated/moved from study area|0|||
37872890|NCT00920218|69557352|FG002|Overall Study|Migrated/moved from study area|1|||
37872891|NCT00920218|69557353|FG003|Overall Study|Migrated/moved from study area|0|||
37872892|NCT00920218|69557350|FG000|Overall Study|Lost to Follow-up|0|||
37872893|NCT00920218|69557351|FG001|Overall Study|Lost to Follow-up|1|||
37872894|NCT00920218|69557352|FG002|Overall Study|Lost to Follow-up|0|||
37981137|NCT00424632|69667671|FG003|Overall Study|Other|1|||
37981138|NCT00424632|69667672|FG004|Overall Study|Other|0|||
37981139|NCT00424632|69667673|FG005|Overall Study|Other|0|||
37981140|NCT00424632|69667674|FG006|Overall Study|Other|0|||
37981141|NCT00424632|69667675|FG007|Overall Study|Other|0|||
37981142|NCT00424632|69667676|FG008|Overall Study|Other|1|||
37981143|NCT00424632|69667677|FG009|Overall Study|Other|0|||
37981144|NCT00529451|69667712|FG000|Overall Study|Subject withdrew consent|16|||
37872895|NCT00920218|69557353|FG003|Overall Study|Lost to Follow-up|3|||
37872896|NCT00920218|69557350|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
37872897|NCT00920218|69557351|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
37872898|NCT00920218|69557352|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
37872899|NCT00920218|69557353|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
37872900|NCT00920218|69557350|FG000|Overall Study|Other|0|||
37981145|NCT00529451|69667713|FG001|Overall Study|Subject withdrew consent|21|||
37872901|NCT00920218|69557351|FG001|Overall Study|Other|0|||
37872902|NCT00920218|69557352|FG002|Overall Study|Other|1|||
37872903|NCT00920218|69557353|FG003|Overall Study|Other|0|||
37872904|NCT01121562|69557367|FG000|Overall Study|Objective progression or relapse|8|||
37872905|NCT01121562|69557367|FG000|Overall Study|Withdrawal by Subject|1|||
37872906|NCT01121562|69557367|FG000|Overall Study|Adverse Event|1|||
37872907|NCT01121562|69557367|FG000|Overall Study|Sponsor Decision|1|||
37981146|NCT00529451|69667714|FG002|Overall Study|Subject withdrew consent|13|||
37981147|NCT00529451|69667715|FG003|Overall Study|Subject withdrew consent|12|||
37981148|NCT00529451|69667712|FG000|Overall Study|Adverse Event|9|||
37981149|NCT00529451|69667713|FG001|Overall Study|Adverse Event|16|||
37981150|NCT00529451|69667714|FG002|Overall Study|Adverse Event|14|||
37981151|NCT00529451|69667715|FG003|Overall Study|Adverse Event|8|||
37981152|NCT00529451|69667712|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
37981153|NCT00529451|69667713|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
37981154|NCT00529451|69667714|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
37981155|NCT00529451|69667715|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
37981156|NCT00529451|69667712|FG000|Overall Study|Lost to Follow-up|4|||
37981157|NCT00529451|69667713|FG001|Overall Study|Lost to Follow-up|7|||
37981158|NCT00529451|69667714|FG002|Overall Study|Lost to Follow-up|4|||
37981159|NCT00529451|69667715|FG003|Overall Study|Lost to Follow-up|4|||
37981160|NCT00529451|69667712|FG000|Overall Study|Protocol deviation|1|||
37981161|NCT00529451|69667713|FG001|Overall Study|Protocol deviation|1|||
37981162|NCT00529451|69667714|FG002|Overall Study|Protocol deviation|4|||
37981163|NCT00529451|69667715|FG003|Overall Study|Protocol deviation|1|||
37981164|NCT00529451|69667712|FG000|Overall Study|Administrative problems|1|||
37981165|NCT00529451|69667713|FG001|Overall Study|Administrative problems|1|||
37981166|NCT00529451|69667714|FG002|Overall Study|Administrative problems|0|||
37981167|NCT00529451|69667715|FG003|Overall Study|Administrative problems|2|||
37981168|NCT03876743|69667732|FG000|Overall Study|Lost to Follow-up|6|||
37981169|NCT03876743|69667733|FG001|Overall Study|Lost to Follow-up|4|||
37981170|NCT03876743|69667734|FG002|Overall Study|Lost to Follow-up|4|||
37981171|NCT03876743|69667735|FG003|Overall Study|Lost to Follow-up|7|||
37981172|NCT00486278|69667749|FG000|Overall Study|Adverse Event|5|||
37981173|NCT00486278|69667749|FG000|Overall Study|Withdrawal by Subject|2|||
37981174|NCT00486278|69667749|FG000|Overall Study|Physician Decision|2|||
37981175|NCT00321711|69667768|FG000|Part A|Adverse Event|3|||
37981176|NCT00321711|69667769|FG001|Part A|Adverse Event|3|||
37981177|NCT00321711|69667770|FG002|Part A|Adverse Event|2|||
37981178|NCT00321711|69667771|FG003|Part A|Adverse Event|0|||
37981179|NCT00321711|69667772|FG004|Part A|Adverse Event|0|||
37981180|NCT00321711|69667768|FG000|Part A|Withdrawal by Subject|1|||
37981181|NCT00321711|69667769|FG001|Part A|Withdrawal by Subject|1|||
37981182|NCT00321711|69667770|FG002|Part A|Withdrawal by Subject|1|||
37981183|NCT00321711|69667771|FG003|Part A|Withdrawal by Subject|0|||
37981184|NCT00321711|69667772|FG004|Part A|Withdrawal by Subject|0|||
37981185|NCT00321711|69667768|FG000|Part A|Disease progression|0|||
37981186|NCT00321711|69667769|FG001|Part A|Disease progression|1|||
37981187|NCT00321711|69667770|FG002|Part A|Disease progression|0|||
37981188|NCT00321711|69667771|FG003|Part A|Disease progression|0|||
37981189|NCT00321711|69667772|FG004|Part A|Disease progression|0|||
37981190|NCT00321711|69667768|FG000|Part A|Requirement for alternative therapy|0|||
37981191|NCT00321711|69667769|FG001|Part A|Requirement for alternative therapy|2|||
37816860|NCT04505722|69495568|FG000|Overall Study|Death|34|||
37816861|NCT04505722|69495569|FG001|Overall Study|Death|63|||
37816862|NCT04505722|69495568|FG000|Overall Study|Lost to Follow-up|271|||
37816863|NCT04505722|69495569|FG001|Overall Study|Lost to Follow-up|333|||
37816864|NCT04505722|69495568|FG000|Overall Study|Physician Decision|17|||
37816865|NCT04505722|69495569|FG001|Overall Study|Physician Decision|17|||
37981192|NCT00321711|69667770|FG002|Part A|Requirement for alternative therapy|1|||
37981193|NCT00321711|69667771|FG003|Part A|Requirement for alternative therapy|0|||
37981194|NCT00321711|69667772|FG004|Part A|Requirement for alternative therapy|0|||
37981195|NCT00321711|69667768|FG000|Part A|Physician Decision|0|||
37981196|NCT00321711|69667769|FG001|Part A|Physician Decision|1|||
37981197|NCT00321711|69667770|FG002|Part A|Physician Decision|3|||
37981198|NCT00321711|69667771|FG003|Part A|Physician Decision|0|||
37816866|NCT04505722|69495568|FG000|Overall Study|Protocol Violation|0|||
37816867|NCT04505722|69495569|FG001|Overall Study|Protocol Violation|1|||
37816868|NCT04505722|69495568|FG000|Overall Study|Withdrawal by Subject|376|||
37816869|NCT04505722|69495569|FG001|Overall Study|Withdrawal by Subject|714|||
37981199|NCT00321711|69667772|FG004|Part A|Physician Decision|0|||
37981200|NCT00321711|69667768|FG000|Part A|Other|1|||
37872908|NCT01121562|69557367|FG000|Overall Study|Met study discontinuation criteria|1|||
37872909|NCT01121484|69557373|FG000|Overall Study|Adverse Event|12|||
37872910|NCT01121484|69557374|FG001|Overall Study|Adverse Event|5|||
37872911|NCT01121484|69557373|FG000|Overall Study|Lack of Efficacy|3|||
37872912|NCT01121484|69557374|FG001|Overall Study|Lack of Efficacy|11|||
37872913|NCT01121484|69557373|FG000|Overall Study|Lost to Follow-up|5|||
37872914|NCT01121484|69557374|FG001|Overall Study|Lost to Follow-up|9|||
37872915|NCT01121484|69557373|FG000|Overall Study|Physician Decision|0|||
37981201|NCT00321711|69667769|FG001|Part A|Other|2|||
37981202|NCT00321711|69667770|FG002|Part A|Other|3|||
37981203|NCT00321711|69667771|FG003|Part A|Other|0|||
37981204|NCT00321711|69667772|FG004|Part A|Other|0|||
37981205|NCT00321711|69667768|FG000|Part A|Protocol deviation|0|||
37981206|NCT00321711|69667769|FG001|Part A|Protocol deviation|0|||
37981207|NCT00321711|69667770|FG002|Part A|Protocol deviation|1|||
37981208|NCT00321711|69667771|FG003|Part A|Protocol deviation|0|||
37981209|NCT00321711|69667772|FG004|Part A|Protocol deviation|0|||
37981210|NCT00321711|69667768|FG000|Part B|Noncompliance|0|||
37981211|NCT00321711|69667769|FG001|Part B|Noncompliance|0|||
37981212|NCT00321711|69667770|FG002|Part B|Noncompliance|0|||
37872916|NCT01121484|69557374|FG001|Overall Study|Physician Decision|3|||
37872917|NCT01121484|69557373|FG000|Overall Study|Protocol Violation|1|||
37872918|NCT01121484|69557374|FG001|Overall Study|Protocol Violation|0|||
37872919|NCT01121484|69557373|FG000|Overall Study|Withdrawal by Subject|8|||
37872920|NCT01121484|69557374|FG001|Overall Study|Withdrawal by Subject|7|||
37872921|NCT01121484|69557373|FG000|Overall Study|Discontinuation of study by sponsor|0|||
37872922|NCT01121484|69557374|FG001|Overall Study|Discontinuation of study by sponsor|1|||
37872923|NCT01121484|69557373|FG000|Overall Study|Other|3|||
37872924|NCT01121484|69557374|FG001|Overall Study|Other|3|||
37872925|NCT01121484|69557373|FG000|Overall Study|Randomized, not treated|1|||
37872926|NCT01121484|69557374|FG001|Overall Study|Randomized, not treated|4|||
37872927|NCT01169675|69557385|FG000|Overall Study|Progressive disease|13|||
37872928|NCT01169675|69557386|FG001|Overall Study|Progressive disease|2|||
37872929|NCT01169675|69557387|FG002|Overall Study|Progressive disease|5|||
37872930|NCT01169675|69557388|FG003|Overall Study|Progressive disease|15|||
37872931|NCT01169675|69557389|FG004|Overall Study|Progressive disease|1|||
37872932|NCT01169675|69557385|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
37872933|NCT01169675|69557386|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
37872934|NCT01169675|69557387|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
37872935|NCT01169675|69557388|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
37872936|NCT01169675|69557389|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
37872937|NCT01169675|69557385|FG000|Overall Study|Adverse Event|5|||
37872938|NCT01169675|69557386|FG001|Overall Study|Adverse Event|1|||
37872939|NCT01169675|69557387|FG002|Overall Study|Adverse Event|2|||
37872940|NCT01169675|69557388|FG003|Overall Study|Adverse Event|0|||
37872941|NCT01169675|69557389|FG004|Overall Study|Adverse Event|0|||
37872942|NCT01169675|69557385|FG000|Overall Study|Withdrawal by Subject|1|||
37981213|NCT00321711|69667771|FG003|Part B|Noncompliance|0|||
37981214|NCT00321711|69667772|FG004|Part B|Noncompliance|1|||
37872943|NCT01169675|69557386|FG001|Overall Study|Withdrawal by Subject|0|||
37872944|NCT01169675|69557387|FG002|Overall Study|Withdrawal by Subject|0|||
37981215|NCT00321711|69667768|FG000|Part B|Adverse Event|0|||
37981216|NCT00321711|69667769|FG001|Part B|Adverse Event|0|||
37872945|NCT01169675|69557388|FG003|Overall Study|Withdrawal by Subject|1|||
37872946|NCT01169675|69557389|FG004|Overall Study|Withdrawal by Subject|2|||
37872947|NCT01169675|69557385|FG000|Overall Study|Other Reason Not Defined Above|0|||
37981217|NCT00321711|69667770|FG002|Part B|Adverse Event|0|||
37981218|NCT00321711|69667771|FG003|Part B|Adverse Event|2|||
37981219|NCT00321711|69667772|FG004|Part B|Adverse Event|1|||
37981220|NCT00321711|69667768|FG000|Part B|Disease progression|0|||
37981221|NCT00321711|69667769|FG001|Part B|Disease progression|0|||
37981222|NCT00321711|69667770|FG002|Part B|Disease progression|0|||
37981223|NCT00321711|69667771|FG003|Part B|Disease progression|1|||
37872948|NCT01169675|69557386|FG001|Overall Study|Other Reason Not Defined Above|0|||
37872949|NCT01169675|69557387|FG002|Overall Study|Other Reason Not Defined Above|0|||
37872950|NCT01169675|69557388|FG003|Overall Study|Other Reason Not Defined Above|1|||
37872951|NCT01169675|69557389|FG004|Overall Study|Other Reason Not Defined Above|1|||
37872952|NCT00924664|69557403|FG000|Overall Study|Adverse Event|23|||
37872953|NCT00924664|69557404|FG001|Overall Study|Adverse Event|39|||
37872954|NCT00924664|69557403|FG000|Overall Study|Lack of Efficacy|10|||
37872955|NCT00924664|69557404|FG001|Overall Study|Lack of Efficacy|15|||
37872956|NCT00924664|69557403|FG000|Overall Study|Lost to Follow-up|10|||
37872957|NCT00924664|69557404|FG001|Overall Study|Lost to Follow-up|12|||
37872958|NCT00924664|69557403|FG000|Overall Study|Withdrawal by Subject|47|||
37872959|NCT00924664|69557404|FG001|Overall Study|Withdrawal by Subject|71|||
37872960|NCT00924664|69557403|FG000|Overall Study|Protocol Violation|2|||
37872961|NCT00924664|69557404|FG001|Overall Study|Protocol Violation|5|||
37872962|NCT00924664|69557403|FG000|Overall Study|Pregnancy|1|||
37872963|NCT00924664|69557404|FG001|Overall Study|Pregnancy|1|||
37872964|NCT00924664|69557403|FG000|Overall Study|Death|0|||
37872965|NCT00924664|69557404|FG001|Overall Study|Death|2|||
37872966|NCT00924664|69557403|FG000|Overall Study|Study terminated by sponsor|199|||
37872967|NCT00924664|69557404|FG001|Overall Study|Study terminated by sponsor|330|||
37872968|NCT00924664|69557403|FG000|Overall Study|Other|29|||
37872969|NCT00924664|69557404|FG001|Overall Study|Other|52|||
37872970|NCT00924664|69557403|FG000|Overall Study|Randomized but not Treated|1|||
37872971|NCT00924664|69557404|FG001|Overall Study|Randomized but not Treated|0|||
37872972|NCT00600067|69557412|FG000|Overall Study|Adverse Event|0|||
37872973|NCT00600067|69557413|FG001|Overall Study|Adverse Event|1|||
37981224|NCT00321711|69667772|FG004|Part B|Disease progression|0|||
37981225|NCT00321711|69667768|FG000|Part B|Physician Decision|0|||
37981226|NCT00321711|69667769|FG001|Part B|Physician Decision|0|||
37981227|NCT00321711|69667770|FG002|Part B|Physician Decision|0|||
37981228|NCT00321711|69667771|FG003|Part B|Physician Decision|1|||
37981229|NCT00321711|69667772|FG004|Part B|Physician Decision|2|||
37981230|NCT00321711|69667768|FG000|Part B|Death|0|||
37981231|NCT00321711|69667769|FG001|Part B|Death|0|||
37872974|NCT00600067|69557412|FG000|Overall Study|Lost to Follow-up|2|||
37872975|NCT00600067|69557413|FG001|Overall Study|Lost to Follow-up|3|||
37872976|NCT00600067|69557412|FG000|Overall Study|protocol non-compliance|0|||
37872977|NCT00600067|69557413|FG001|Overall Study|protocol non-compliance|3|||
37872978|NCT00600067|69557412|FG000|Overall Study|Lack of Efficacy|1|||
37872979|NCT00600067|69557413|FG001|Overall Study|Lack of Efficacy|0|||
37872980|NCT00970593|69557427|FG000|Overall Study|Adverse Event|1|||
37872981|NCT00970593|69557428|FG001|Overall Study|Adverse Event|1|||
37872982|NCT00970593|69557429|FG002|Overall Study|Adverse Event|0|||
37872983|NCT00970593|69557430|FG003|Overall Study|Adverse Event|0|||
37872984|NCT00970593|69557431|FG004|Overall Study|Adverse Event|0|||
37872985|NCT00970593|69557432|FG005|Overall Study|Adverse Event|0|||
37872986|NCT00970593|69557433|FG006|Overall Study|Adverse Event|0|||
37872987|NCT00970593|69557427|FG000|Overall Study|Discontinuation of study by sponsor|0|||
37872988|NCT00970593|69557428|FG001|Overall Study|Discontinuation of study by sponsor|0|||
37872989|NCT00970593|69557429|FG002|Overall Study|Discontinuation of study by sponsor|5|||
37872990|NCT00970593|69557430|FG003|Overall Study|Discontinuation of study by sponsor|0|||
37872991|NCT00970593|69557431|FG004|Overall Study|Discontinuation of study by sponsor|0|||
37872992|NCT00970593|69557432|FG005|Overall Study|Discontinuation of study by sponsor|0|||
37872993|NCT00970593|69557433|FG006|Overall Study|Discontinuation of study by sponsor|2|||
37872994|NCT00970593|69557427|FG000|Overall Study|Withdrawal by Subject|0|||
37872995|NCT00970593|69557428|FG001|Overall Study|Withdrawal by Subject|0|||
37872996|NCT00970593|69557429|FG002|Overall Study|Withdrawal by Subject|1|||
37872997|NCT00970593|69557430|FG003|Overall Study|Withdrawal by Subject|0|||
37872998|NCT00970593|69557431|FG004|Overall Study|Withdrawal by Subject|0|||
37872999|NCT00970593|69557432|FG005|Overall Study|Withdrawal by Subject|0|||
37873000|NCT00970593|69557433|FG006|Overall Study|Withdrawal by Subject|0|||
37873001|NCT00962013|69557453|FG000|Overall Study|Did not have surgery|1|||
37873002|NCT00962013|69557453|FG000|Overall Study|Death|8|||
37873003|NCT00962013|69557453|FG000|Overall Study|Lost to Follow-up|12|||
37873004|NCT00962013|69557453|FG000|Overall Study|Unable/Unwilling to return|6|||
37873005|NCT00962013|69557453|FG000|Overall Study|Withdrawal by Subject|8|||
37873006|NCT00962013|69557453|FG000|Overall Study|Removal of study device|3|||
37873007|NCT00962013|69557453|FG000|Overall Study|Site Termination|24|||
37873008|NCT00962013|69557453|FG000|Overall Study|No 5 year evaluation|6|||
37873009|NCT00970359|69557457|FG000|Overall Study|Not Treated|4|||
37873010|NCT01121406|69557463|FG000|Overall Study|Progressive disease RECIST|44|||
37873011|NCT01121406|69557464|FG001|Overall Study|Progressive disease RECIST|28|||
37981232|NCT00321711|69667770|FG002|Part B|Death|0|||
37981233|NCT00321711|69667771|FG003|Part B|Death|2|||
37981234|NCT00321711|69667772|FG004|Part B|Death|1|||
37873012|NCT01121406|69557463|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
37873013|NCT01121406|69557464|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
37873014|NCT01121406|69557463|FG000|Overall Study|Other AE|3|||
37873015|NCT01121406|69557464|FG001|Overall Study|Other AE|10|||
37873016|NCT01121406|69557463|FG000|Overall Study|Non-compliant with protocol|0|||
37873017|NCT01121406|69557464|FG001|Overall Study|Non-compliant with protocol|2|||
37873018|NCT01121406|69557463|FG000|Overall Study|Lost to Follow-up|0|||
37873019|NCT01121406|69557464|FG001|Overall Study|Lost to Follow-up|1|||
37873020|NCT01121406|69557463|FG000|Overall Study|Refused continuation of study med.|1|||
37873021|NCT01121406|69557464|FG001|Overall Study|Refused continuation of study med.|2|||
37873022|NCT01121406|69557463|FG000|Overall Study|Reason other than specified above|2|||
37873023|NCT01121406|69557464|FG001|Overall Study|Reason other than specified above|6|||
37873024|NCT01121406|69557463|FG000|Overall Study|Not treated|1|||
37873025|NCT01121406|69557464|FG001|Overall Study|Not treated|0|||
37873026|NCT00960687|69557473|FG000|Washout Period of 7 Days|Adverse Event|3|||
37873027|NCT00960687|69557474|FG001|Washout Period of 7 Days|Adverse Event|2|||
37873028|NCT00960687|69557473|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
37873029|NCT00960687|69557474|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
37873030|NCT00920140|69557485|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
37873031|NCT00920140|69557486|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
37873032|NCT00920140|69557487|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
37873033|NCT00920140|69557488|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
37873034|NCT00920140|69557489|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
37873035|NCT00920140|69557485|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
37873036|NCT00920140|69557486|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
37873037|NCT00920140|69557487|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
37873038|NCT00920140|69557488|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
37873039|NCT00920140|69557489|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
37873040|NCT00920140|69557485|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
37873041|NCT00920140|69557486|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
37873042|NCT00920140|69557487|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
37873043|NCT00920140|69557488|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
37873044|NCT00920140|69557489|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
37873045|NCT00920140|69557485|FG000|Phase 2|Adverse Event|0|||
37873046|NCT00920140|69557486|FG001|Phase 2|Adverse Event|0|||
37873047|NCT00920140|69557487|FG002|Phase 2|Adverse Event|14|||
37873048|NCT00920140|69557488|FG003|Phase 2|Adverse Event|2|||
37873049|NCT00920140|69557489|FG004|Phase 2|Adverse Event|3|||
37873050|NCT00920140|69557485|FG000|Phase 2|Lack of Efficacy|0|||
37873051|NCT00920140|69557486|FG001|Phase 2|Lack of Efficacy|0|||
37873052|NCT00920140|69557487|FG002|Phase 2|Lack of Efficacy|29|||
37873053|NCT00920140|69557488|FG003|Phase 2|Lack of Efficacy|14|||
37873054|NCT00920140|69557489|FG004|Phase 2|Lack of Efficacy|5|||
37873055|NCT00920140|69557485|FG000|Phase 2|Lost to Follow-up|0|||
37873056|NCT00920140|69557486|FG001|Phase 2|Lost to Follow-up|0|||
37873057|NCT00920140|69557487|FG002|Phase 2|Lost to Follow-up|0|||
37873058|NCT00920140|69557488|FG003|Phase 2|Lost to Follow-up|1|||
37873059|NCT00920140|69557489|FG004|Phase 2|Lost to Follow-up|0|||
37873060|NCT00920140|69557485|FG000|Phase 2|Physician Decision|0|||
37873061|NCT00920140|69557486|FG001|Phase 2|Physician Decision|0|||
37873062|NCT00920140|69557487|FG002|Phase 2|Physician Decision|3|||
37873063|NCT00920140|69557488|FG003|Phase 2|Physician Decision|3|||
37873064|NCT00920140|69557489|FG004|Phase 2|Physician Decision|2|||
37873065|NCT00920140|69557485|FG000|Phase 2|Withdrawal by Subject|0|||
37873066|NCT00920140|69557486|FG001|Phase 2|Withdrawal by Subject|0|||
37873067|NCT00920140|69557487|FG002|Phase 2|Withdrawal by Subject|4|||
37873068|NCT00920140|69557488|FG003|Phase 2|Withdrawal by Subject|2|||
37873069|NCT00920140|69557489|FG004|Phase 2|Withdrawal by Subject|1|||
37873070|NCT01120782|69557502|FG000|Overall Study|Test article shipping error|11|||
37873071|NCT01120626|69557508|FG000|Overall Study|Withdrawal by Subject|1|||
37873072|NCT01120626|69557509|FG001|Overall Study|Withdrawal by Subject|0|||
37873073|NCT00924508|69557515|FG000|Overall Study|Withdrawal by Subject|3|||
37873074|NCT01139658|69557524|FG000|Overall Study|Adverse Event|10|||
37873075|NCT01139658|69557525|FG001|Overall Study|Adverse Event|27|||
37873076|NCT01139658|69557524|FG000|Overall Study|Lack of Efficacy|15|||
37873077|NCT01139658|69557525|FG001|Overall Study|Lack of Efficacy|7|||
37873078|NCT01139658|69557524|FG000|Overall Study|Withdrawal by Subject|2|||
37873079|NCT01139658|69557525|FG001|Overall Study|Withdrawal by Subject|4|||
37873080|NCT01139658|69557524|FG000|Overall Study|No documentation of treatment|1|||
37873081|NCT01139658|69557525|FG001|Overall Study|No documentation of treatment|0|||
37981235|NCT00486044|69667786|FG000|Overall Study|Withdrawal by Subject|2|||
37873082|NCT01139658|69557524|FG000|Overall Study|Other|28|||
37873083|NCT01139658|69557525|FG001|Overall Study|Other|75|||
37873084|NCT01139580|69557533|FG000|Overall Study|Adverse Event|5|||
37873085|NCT01139580|69557534|FG001|Overall Study|Adverse Event|4|||
37873086|NCT01139580|69557533|FG000|Overall Study|Lost to Follow-up|9|||
37873087|NCT01139580|69557534|FG001|Overall Study|Lost to Follow-up|1|||
37873088|NCT01139580|69557533|FG000|Overall Study|Lack of Efficacy|0|||
37873089|NCT01139580|69557534|FG001|Overall Study|Lack of Efficacy|2|||
37873090|NCT01139580|69557533|FG000|Overall Study|Withdrawal by Subject|6|||
37873091|NCT01139580|69557534|FG001|Overall Study|Withdrawal by Subject|9|||
37873092|NCT01139580|69557533|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
37873093|NCT01139580|69557534|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
37873094|NCT01139580|69557533|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
37873095|NCT01139580|69557534|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
37873096|NCT01139580|69557533|FG000|Overall Study|Misrandomized|1|||
37873097|NCT01139580|69557534|FG001|Overall Study|Misrandomized|0|||
37873098|NCT01139580|69557533|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
37873099|NCT01139580|69557534|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
37873100|NCT01139580|69557533|FG000|Overall Study|Participant Randomization in Error|0|||
37873101|NCT01139580|69557534|FG001|Overall Study|Participant Randomization in Error|1|||
37873102|NCT00917644|69557540|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
37873103|NCT00917644|69557541|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
37873104|NCT00917644|69557540|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
37873105|NCT00917644|69557541|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
37873106|NCT00917644|69557540|FG000|Period 2: Second Intervention|family emergency|1|||
37873107|NCT00917644|69557541|FG001|Period 2: Second Intervention|family emergency|0|||
37873108|NCT01137786|69557549|FG000|Overall Study|Lost to Follow-up|0|||
37873109|NCT01137786|69557550|FG001|Overall Study|Lost to Follow-up|2|||
37873110|NCT01137786|69557549|FG000|Overall Study|Withdrawal by Subject|1|||
37873111|NCT01137786|69557550|FG001|Overall Study|Withdrawal by Subject|1|||
37873112|NCT00599755|69557558|FG000|Overall Study|Adverse Event|11|||
37981236|NCT00486044|69667787|FG001|Overall Study|Withdrawal by Subject|1|||
37981237|NCT00486044|69667786|FG000|Overall Study|Adverse Event|0|||
37981238|NCT00486044|69667787|FG001|Overall Study|Adverse Event|1|||
37981239|NCT00486044|69667786|FG000|Overall Study|Lost to Follow-up|0|||
37981240|NCT00486044|69667787|FG001|Overall Study|Lost to Follow-up|1|||
37981241|NCT00351273|69667796|FG000|Overall Study|Lost to Follow-up|1|||
37981242|NCT00351273|69667797|FG001|Overall Study|Lost to Follow-up|2|||
37981243|NCT00351273|69667798|FG002|Overall Study|Lost to Follow-up|5|||
37873113|NCT00599755|69557558|FG000|Overall Study|Withdrawal by Subject|2|||
37873114|NCT00599755|69557558|FG000|Overall Study|Progression of Disease|3|||
37873115|NCT00599755|69557558|FG000|Overall Study|Other Reason|2|||
37873116|NCT00599755|69557558|FG000|Overall Study|No data available|1|||
37981244|NCT00327717|69667813|FG000|Overall Study|Adverse Event|6|||
37873117|NCT00600613|69557562|FG000|Overall Study|Protocol Deviation|1|||
37873118|NCT01125930|69557568|FG000|Overall Study|Adverse Event|0|||
37873119|NCT01125930|69557569|FG001|Overall Study|Adverse Event|1|||
37873120|NCT01125930|69557568|FG000|Overall Study|Withdrawal by Subject|1|||
37873121|NCT01125930|69557569|FG001|Overall Study|Withdrawal by Subject|6|||
37873122|NCT01125930|69557568|FG000|Overall Study|Protocol Violation|0|||
37873123|NCT01125930|69557569|FG001|Overall Study|Protocol Violation|1|||
37873124|NCT01125930|69557568|FG000|Overall Study|Lost to Follow-up|0|||
37873125|NCT01125930|69557569|FG001|Overall Study|Lost to Follow-up|2|||
37873126|NCT00918346|69557600|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
37981245|NCT00327717|69667814|FG001|Overall Study|Adverse Event|6|||
37981246|NCT00327717|69667813|FG000|Overall Study|Lack of Efficacy|0|||
37981247|NCT00327717|69667814|FG001|Overall Study|Lack of Efficacy|1|||
37981248|NCT00327717|69667813|FG000|Overall Study|Withdrawal by Subject|3|||
37981249|NCT00327717|69667814|FG001|Overall Study|Withdrawal by Subject|7|||
37981250|NCT00463346|69667822|FG000|Overall Study|Withdrawal by Subject|3|||
37981251|NCT00463346|69667823|FG001|Overall Study|Withdrawal by Subject|3|||
37816870|NCT04505722|69495568|FG000|Overall Study|Other|61|||
37816871|NCT04505722|69495569|FG001|Overall Study|Other|98|||
37816872|NCT04505722|69495568|FG000|Overall Study|Still ongoing|21138|||
37816873|NCT04505722|69495569|FG001|Overall Study|Still ongoing|20662|||
37816874|NCT04505722|69495568|FG000|Overall Study|Randomized not vaccinated|276|||
37816875|NCT04505722|69495569|FG001|Overall Study|Randomized not vaccinated|260|||
37816876|NCT04474691|69495575|FG000|Overall Study|Withdrawal by Subject|9|||
37816877|NCT04014075|69495607|FG000|Overall Study|Progressive Disease|48|||
37873127|NCT00918346|69557601|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
37873128|NCT00913978|69557612|FG000|Overall Study|Surgeon choice|1|||
37816878|NCT04014075|69495607|FG000|Overall Study|Adverse Event|11|||
37816879|NCT04014075|69495607|FG000|Overall Study|Clinical Progression|4|||
37816880|NCT04014075|69495607|FG000|Overall Study|Death|2|||
37873129|NCT00913978|69557613|FG001|Overall Study|Surgeon choice|3|||
37873130|NCT01137474|69557623|FG000|Overall Study|Adverse Event|3|||
37873131|NCT01137474|69557624|FG001|Overall Study|Adverse Event|5|||
37873132|NCT01137474|69557625|FG002|Overall Study|Adverse Event|1|||
37981252|NCT00462488|69667833|FG000|Overall Study|Protocol Violation|1|||
37981253|NCT00462488|69667834|FG001|Overall Study|Protocol Violation|0|||
37981254|NCT00462488|69667833|FG000|Overall Study|Lack of Efficacy|19|||
37981255|NCT00462488|69667834|FG001|Overall Study|Lack of Efficacy|17|||
37981256|NCT00454142|69667840|FG000|Overall Study|Withdrawal by Subject|1|||
37981257|NCT00424476|69667849|FG000|Overall Study|Withdrawal by Subject|7|||
37981258|NCT00424476|69667850|FG001|Overall Study|Withdrawal by Subject|6|||
37873133|NCT01137474|69557626|FG003|Overall Study|Adverse Event|3|||
37873134|NCT01137474|69557623|FG000|Overall Study|Withdrawal by Subject|7|||
37873135|NCT01137474|69557624|FG001|Overall Study|Withdrawal by Subject|2|||
37873136|NCT01137474|69557625|FG002|Overall Study|Withdrawal by Subject|6|||
37873137|NCT01137474|69557626|FG003|Overall Study|Withdrawal by Subject|9|||
37873138|NCT01137474|69557623|FG000|Overall Study|No longer met study criteria|6|||
37873139|NCT01137474|69557624|FG001|Overall Study|No longer met study criteria|1|||
37873140|NCT01137474|69557625|FG002|Overall Study|No longer met study criteria|0|||
37873141|NCT01137474|69557626|FG003|Overall Study|No longer met study criteria|5|||
37873142|NCT01137474|69557623|FG000|Overall Study|Lost to Follow-up|5|||
37873143|NCT01137474|69557624|FG001|Overall Study|Lost to Follow-up|1|||
37981259|NCT00424476|69667851|FG002|Overall Study|Withdrawal by Subject|3|||
37981260|NCT00424476|69667849|FG000|Overall Study|Adverse Event|19|||
37981261|NCT00424476|69667850|FG001|Overall Study|Adverse Event|16|||
37981262|NCT00424476|69667851|FG002|Overall Study|Adverse Event|15|||
37981263|NCT00424476|69667849|FG000|Overall Study|Lack of Efficacy|16|||
37981264|NCT00424476|69667850|FG001|Overall Study|Lack of Efficacy|12|||
37981265|NCT00424476|69667851|FG002|Overall Study|Lack of Efficacy|12|||
37981266|NCT00424476|69667849|FG000|Overall Study|Lack of Compliance|1|||
37981267|NCT00424476|69667850|FG001|Overall Study|Lack of Compliance|1|||
37981268|NCT00424476|69667851|FG002|Overall Study|Lack of Compliance|1|||
37981269|NCT00424476|69667849|FG000|Overall Study|Lost to Follow-up|4|||
37981270|NCT00424476|69667850|FG001|Overall Study|Lost to Follow-up|6|||
37981271|NCT00424476|69667851|FG002|Overall Study|Lost to Follow-up|3|||
37816881|NCT04014075|69495607|FG000|Overall Study|Withdrawal by Subject|2|||
37816882|NCT04014075|69495607|FG000|Overall Study|Miscellaneous|1|||
37816883|NCT04014075|69495607|FG000|Overall Study|Physician Decision|1|||
37816884|NCT03840174|69495615|FG000|Overall Study|Withdrawal by Subject|1|||
37816885|NCT03840174|69495616|FG001|Overall Study|Withdrawal by Subject|0|||
37816886|NCT03840174|69495617|FG002|Overall Study|Withdrawal by Subject|0|||
37816887|NCT03840174|69495618|FG003|Overall Study|Withdrawal by Subject|0|||
37816888|NCT03786718|69495629|FG000|Overall Study|Lost to Follow-up|3|||
37816889|NCT03786718|69495629|FG000|Overall Study|Withdrawal by Subject|1|||
37873144|NCT01137474|69557625|FG002|Overall Study|Lost to Follow-up|0|||
37873145|NCT01137474|69557626|FG003|Overall Study|Lost to Follow-up|2|||
37873146|NCT01137474|69557623|FG000|Overall Study|Lack of Efficacy|0|||
37873147|NCT01137474|69557624|FG001|Overall Study|Lack of Efficacy|0|||
37873148|NCT01137474|69557625|FG002|Overall Study|Lack of Efficacy|0|||
37873149|NCT01137474|69557626|FG003|Overall Study|Lack of Efficacy|2|||
37873150|NCT01137474|69557623|FG000|Overall Study|Other|3|||
37873151|NCT01137474|69557624|FG001|Overall Study|Other|1|||
37873152|NCT01137474|69557625|FG002|Overall Study|Other|0|||
37873153|NCT01137474|69557626|FG003|Overall Study|Other|0|||
37873154|NCT01137474|69557623|FG000|Overall Study|Pregnancy|0|||
37873155|NCT01137474|69557624|FG001|Overall Study|Pregnancy|1|||
37873156|NCT01137474|69557625|FG002|Overall Study|Pregnancy|0|||
37873157|NCT01137474|69557626|FG003|Overall Study|Pregnancy|0|||
37873158|NCT01137474|69557623|FG000|Overall Study|Administrative reason by sponsor|0|||
37873159|NCT01137474|69557624|FG001|Overall Study|Administrative reason by sponsor|1|||
37873160|NCT01137474|69557625|FG002|Overall Study|Administrative reason by sponsor|0|||
37873161|NCT01137474|69557626|FG003|Overall Study|Administrative reason by sponsor|0|||
37873162|NCT01168973|69557638|FG000|Overall Study|Progressive Disease|341|||
37873163|NCT01168973|69557639|FG001|Overall Study|Progressive Disease|429|||
37873164|NCT01168973|69557638|FG000|Overall Study|Adverse Event|94|||
37873165|NCT01168973|69557639|FG001|Overall Study|Adverse Event|55|||
37873166|NCT01168973|69557638|FG000|Overall Study|Withdrawal by Subject|90|||
37981272|NCT00424476|69667849|FG000|Overall Study|Protocol Violation|7|||
37981273|NCT00424476|69667850|FG001|Overall Study|Protocol Violation|2|||
37873167|NCT01168973|69557639|FG001|Overall Study|Withdrawal by Subject|53|||
37873168|NCT01168973|69557638|FG000|Overall Study|Death|42|||
37873169|NCT01168973|69557639|FG001|Overall Study|Death|45|||
37873170|NCT01168973|69557638|FG000|Overall Study|Physician Decision|37|||
37873171|NCT01168973|69557639|FG001|Overall Study|Physician Decision|19|||
37873172|NCT01168973|69557638|FG000|Overall Study|Sponsor Decision|2|||
37873173|NCT01168973|69557639|FG001|Overall Study|Sponsor Decision|1|||
37873174|NCT01168973|69557638|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
37981274|NCT00424476|69667851|FG002|Overall Study|Protocol Violation|3|||
37981275|NCT00424476|69667849|FG000|Overall Study|Physician Decision|3|||
37981276|NCT00424476|69667850|FG001|Overall Study|Physician Decision|2|||
37981277|NCT00424476|69667851|FG002|Overall Study|Physician Decision|3|||
37981278|NCT00424476|69667849|FG000|Overall Study|Other|4|||
37981279|NCT00424476|69667850|FG001|Overall Study|Other|3|||
37981280|NCT00424476|69667851|FG002|Overall Study|Other|9|||
37981281|NCT00453986|69667864|FG000|Overall Study|Lost to Follow-up|6|||
37981282|NCT00453986|69667865|FG001|Overall Study|Lost to Follow-up|5|||
37981283|NCT00453986|69667866|FG002|Overall Study|Lost to Follow-up|6|||
37981284|NCT00453986|69667867|FG003|Overall Study|Lost to Follow-up|2|||
37981285|NCT00453986|69667868|FG004|Overall Study|Lost to Follow-up|0|||
37981286|NCT00435942|69667886|FG000|Overall Study|Death|17|||
37981287|NCT00435942|69667887|FG001|Overall Study|Death|10|||
37981288|NCT00435942|69667886|FG000|Overall Study|Withdrawal by Subject|2|||
37981289|NCT00435942|69667887|FG001|Overall Study|Withdrawal by Subject|0|||
37873175|NCT01168973|69557639|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
37981290|NCT00435942|69667886|FG000|Overall Study|Lost to Follow-up|0|||
37981291|NCT00435942|69667887|FG001|Overall Study|Lost to Follow-up|16|||
37981292|NCT00435942|69667886|FG000|Overall Study|Conversion to Open Repair|1|||
37981293|NCT00435942|69667887|FG001|Overall Study|Conversion to Open Repair|0|||
37981294|NCT00435942|69667886|FG000|Overall Study|Technical Failure|3|||
37981295|NCT00435942|69667887|FG001|Overall Study|Technical Failure|0|||
37981296|NCT00435942|69667886|FG000|Overall Study|Other|0|||
37981297|NCT00435942|69667887|FG001|Overall Study|Other|1|||
37981298|NCT00453362|69667893|FG000|Overall Study|Adverse Event|5|||
37981299|NCT00453362|69667893|FG000|Overall Study|Death|7|||
37981300|NCT00453362|69667893|FG000|Overall Study|Physician Decision|2|||
37981301|NCT00453362|69667893|FG000|Overall Study|Withdrawal by Subject|3|||
37981302|NCT00453362|69667893|FG000|Overall Study|Progression of disease|56|||
37981303|NCT00453362|69667893|FG000|Overall Study|Screening Failure|14|||
37981304|NCT00424398|69667912|FG000|Overall Study|Withdrawal by Subject|2|||
37981305|NCT00424398|69667913|FG001|Overall Study|Withdrawal by Subject|1|||
37981306|NCT00424398|69667914|FG002|Overall Study|Withdrawal by Subject|0|||
37981307|NCT00424398|69667912|FG000|Overall Study|Subject met exclusion criteria|1|||
37981308|NCT00424398|69667913|FG001|Overall Study|Subject met exclusion criteria|0|||
37981309|NCT00424398|69667914|FG002|Overall Study|Subject met exclusion criteria|0|||
37981310|NCT00461786|69667922|FG000|Overall Study|Entry Criteria Not Met|2|||
37981311|NCT00461786|69667922|FG000|Overall Study|Inevaluable (Never Treated)|1|||
37873176|NCT03918109|69557649|FG000|Overall Study|Withdrawal by Subject|0|||
37873177|NCT03918109|69557650|FG001|Overall Study|Withdrawal by Subject|0|||
37873178|NCT03918109|69557651|FG002|Overall Study|Withdrawal by Subject|2|||
37873179|NCT03918109|69557652|FG003|Overall Study|Withdrawal by Subject|1|||
37873180|NCT03918109|69557649|FG000|Overall Study|Lost to Follow-up|0|||
37873181|NCT03918109|69557650|FG001|Overall Study|Lost to Follow-up|0|||
37873182|NCT03918109|69557651|FG002|Overall Study|Lost to Follow-up|0|||
37873183|NCT03918109|69557652|FG003|Overall Study|Lost to Follow-up|1|||
37873184|NCT01168427|69557662|FG000|Overall Study|Patient exited prior to implant|1|||
37873185|NCT01124916|69557668|FG000|Overall Study|Lost to Follow-up|3|||
37873186|NCT01124916|69557669|FG001|Overall Study|Lost to Follow-up|2|||
37873187|NCT00916006|69557677|FG000|Overall Study|Adverse Event|1|||
37873188|NCT00916006|69557678|FG001|Overall Study|Adverse Event|1|||
37873189|NCT00916006|69557677|FG000|Overall Study|Withdrawal by Subject|2|||
37873190|NCT00916006|69557678|FG001|Overall Study|Withdrawal by Subject|5|||
37873191|NCT00916006|69557677|FG000|Overall Study|Protocol Violation|0|||
37873192|NCT00916006|69557678|FG001|Overall Study|Protocol Violation|1|||
37873193|NCT01168349|69557695|FG000|Overall Study|Death|157|||
37981312|NCT00435162|69667929|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
37695005|NCT02450903|69171448|FG000|Overall Study|Progressive disease|15|||
37981313|NCT00435162|69667930|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
37981314|NCT00435162|69667931|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
37981315|NCT00435162|69667932|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
37873194|NCT01168349|69557695|FG000|Overall Study|Lost to Follow-up|34|||
37981316|NCT00435162|69667933|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
37981317|NCT00435162|69667934|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
37981318|NCT03836664|69667949|FG000|Overall Study|Didn't complete forms and lost drug|3|||
37981319|NCT03836664|69667950|FG001|Overall Study|Didn't complete forms and lost drug|3|||
37981320|NCT00350727|69667963|FG000|Phase I: Dose Escalation|Adverse Event|4|||
37981321|NCT00350727|69667964|FG001|Phase I: Dose Escalation|Adverse Event|0|||
37981322|NCT00350727|69667965|FG002|Phase I: Dose Escalation|Adverse Event|0|||
37981323|NCT00350727|69667963|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
37981324|NCT00350727|69667964|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
37981325|NCT00350727|69667965|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
37981326|NCT00350727|69667963|FG000|Phase I: Dose Escalation|Death|1|||
37981327|NCT00350727|69667964|FG001|Phase I: Dose Escalation|Death|0|||
37981328|NCT00350727|69667965|FG002|Phase I: Dose Escalation|Death|0|||
37981329|NCT00350727|69667963|FG000|Phase I: Dose Escalation|Physician Decision|1|||
37981330|NCT00350727|69667964|FG001|Phase I: Dose Escalation|Physician Decision|0|||
37981331|NCT00350727|69667965|FG002|Phase I: Dose Escalation|Physician Decision|0|||
37981332|NCT00350727|69667963|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
37981333|NCT00350727|69667964|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
37981334|NCT00350727|69667965|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
37981335|NCT00350727|69667963|FG000|Phase II|Disease Progression|0|||
37981336|NCT00350727|69667964|FG001|Phase II|Disease Progression|15|||
37981337|NCT00350727|69667965|FG002|Phase II|Disease Progression|16|||
37981338|NCT00350727|69667963|FG000|Phase II|Clinical Deterioration|0|||
37981339|NCT00350727|69667964|FG001|Phase II|Clinical Deterioration|1|||
37981340|NCT00350727|69667965|FG002|Phase II|Clinical Deterioration|0|||
37981341|NCT00350727|69667963|FG000|Phase II|Withdrawal by Subject|0|||
37981342|NCT00350727|69667964|FG001|Phase II|Withdrawal by Subject|2|||
37981343|NCT00350727|69667965|FG002|Phase II|Withdrawal by Subject|1|||
37981344|NCT00350727|69667963|FG000|Phase II|Adverse Event|0|||
37981345|NCT00350727|69667964|FG001|Phase II|Adverse Event|1|||
37981346|NCT00350727|69667965|FG002|Phase II|Adverse Event|1|||
37981347|NCT00350727|69667963|FG000|Phase II|Death|0|||
37981348|NCT00350727|69667964|FG001|Phase II|Death|0|||
37981349|NCT00350727|69667965|FG002|Phase II|Death|2|||
37981350|NCT00350727|69667963|FG000|Phase II|Sponsor Terminated Study|0|||
37981351|NCT00350727|69667964|FG001|Phase II|Sponsor Terminated Study|0|||
37981352|NCT00350727|69667965|FG002|Phase II|Sponsor Terminated Study|1|||
37981353|NCT00350727|69667963|FG000|Phase II|Enrolled in Rollover Study|0|||
37981354|NCT00350727|69667964|FG001|Phase II|Enrolled in Rollover Study|0|||
37981355|NCT00350727|69667965|FG002|Phase II|Enrolled in Rollover Study|1|||
37981356|NCT00434304|69667984|FG000|Overall Study|Adverse Event|14|||
37695006|NCT02450903|69171448|FG000|Overall Study|Switched to commercial drug|1|||
37816890|NCT03786718|69495629|FG000|Overall Study|Did not use the intervention|2|||
37816891|NCT03786718|69495629|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
37816892|NCT03400943|69495662|FG000|Treatment Period 1|Adverse Event|0|||
37816893|NCT03400943|69495663|FG001|Treatment Period 1|Adverse Event|0|||
37816894|NCT03400943|69495664|FG002|Treatment Period 1|Adverse Event|0|||
37816895|NCT03400943|69495665|FG003|Treatment Period 1|Adverse Event|1|||
37981357|NCT00434304|69667984|FG000|Overall Study|Lack of Efficacy|2|||
37981358|NCT00434304|69667984|FG000|Overall Study|Withdrawal by Subject|4|||
37981359|NCT00424008|69667991|FG000|Overall Study|Adverse Event|8|||
37981360|NCT00424008|69667992|FG001|Overall Study|Adverse Event|6|||
37981361|NCT00424008|69667991|FG000|Overall Study|Lack of Efficacy|40|||
37981362|NCT00424008|69667992|FG001|Overall Study|Lack of Efficacy|34|||
37981363|NCT00424008|69667991|FG000|Overall Study|Lost to Follow-up|1|||
37981364|NCT00424008|69667992|FG001|Overall Study|Lost to Follow-up|2|||
37981365|NCT00424008|69667991|FG000|Overall Study|Withdrawal by Subject|5|||
37981366|NCT00424008|69667992|FG001|Overall Study|Withdrawal by Subject|8|||
37981367|NCT00424008|69667991|FG000|Overall Study|Noncompliance with protocol|13|||
37981368|NCT00424008|69667992|FG001|Overall Study|Noncompliance with protocol|7|||
37981369|NCT00424008|69667991|FG000|Overall Study|Did not meet protocol eligibility|16|||
37981370|NCT00424008|69667992|FG001|Overall Study|Did not meet protocol eligibility|21|||
37981371|NCT00424008|69667991|FG000|Overall Study|Administrative|266|||
37981372|NCT00424008|69667992|FG001|Overall Study|Administrative|257|||
37981373|NCT00423930|69667999|FG000|Overall Study|Withdrawal by Subject|2|||
37981374|NCT00423852|69668003|FG000|Overall Study|Removed pior to the high-dose portion|3|||
37981375|NCT00461708|69668009|FG000|Overall Study|Adverse Event|17|||
37981376|NCT00461708|69668010|FG001|Overall Study|Adverse Event|7|||
37981377|NCT00461708|69668009|FG000|Overall Study|Lack of Efficacy|68|||
37981378|NCT00461708|69668010|FG001|Overall Study|Lack of Efficacy|20|||
37981379|NCT00461708|69668009|FG000|Overall Study|Physician Decision|10|||
37981380|NCT00461708|69668010|FG001|Overall Study|Physician Decision|4|||
37981381|NCT00461708|69668009|FG000|Overall Study|Withdrawal by Subject|8|||
37981382|NCT00461708|69668010|FG001|Overall Study|Withdrawal by Subject|2|||
37981383|NCT00461708|69668009|FG000|Overall Study|Other|4|||
37981384|NCT00461708|69668010|FG001|Overall Study|Other|4|||
37981385|NCT00461708|69668009|FG000|Overall Study|Death|8|||
37981386|NCT00461708|69668010|FG001|Overall Study|Death|1|||
37981387|NCT00327171|69668021|FG000|Overall Study|Did not receive study medication|3|||
37981388|NCT00327171|69668022|FG001|Overall Study|Did not receive study medication|0|||
37981389|NCT00327171|69668021|FG000|Overall Study|Adverse Event|23|||
37981390|NCT00327171|69668022|FG001|Overall Study|Adverse Event|23|||
37981391|NCT00327171|69668021|FG000|Overall Study|Disease progression/lack of efficacy|68|||
37981392|NCT00327171|69668022|FG001|Overall Study|Disease progression/lack of efficacy|69|||
37981393|NCT00327171|69668021|FG000|Overall Study|Investigator/participant request|1|||
37981394|NCT00327171|69668022|FG001|Overall Study|Investigator/participant request|8|||
37981395|NCT00327171|69668021|FG000|Overall Study|Clinical progression|12|||
37981396|NCT00327171|69668022|FG001|Overall Study|Clinical progression|8|||
37981397|NCT00327171|69668021|FG000|Overall Study|Undisclosed history of ischemia|0|||
37981398|NCT00327171|69668022|FG001|Overall Study|Undisclosed history of ischemia|1|||
37981399|NCT00327171|69668021|FG000|Overall Study|Other|1|||
37816896|NCT03400943|69495662|FG000|Treatment Period 1|Lost to Follow-up|1|||
37816897|NCT03400943|69495663|FG001|Treatment Period 1|Lost to Follow-up|0|||
37816898|NCT03400943|69495664|FG002|Treatment Period 1|Lost to Follow-up|0|||
37816899|NCT03400943|69495665|FG003|Treatment Period 1|Lost to Follow-up|0|||
37816900|NCT03400943|69495662|FG000|Treatment Period 1|Protocol Violation|0|||
37816901|NCT03400943|69495663|FG001|Treatment Period 1|Protocol Violation|1|||
37816902|NCT03400943|69495664|FG002|Treatment Period 1|Protocol Violation|1|||
37816903|NCT03400943|69495665|FG003|Treatment Period 1|Protocol Violation|0|||
37816904|NCT03400943|69495662|FG000|Treatment Period 1|Study terminated by sponsor|2|||
37816905|NCT03400943|69495663|FG001|Treatment Period 1|Study terminated by sponsor|0|||
37816906|NCT03400943|69495664|FG002|Treatment Period 1|Study terminated by sponsor|0|||
37816907|NCT03400943|69495665|FG003|Treatment Period 1|Study terminated by sponsor|1|||
37816908|NCT03400943|69495662|FG000|Treatment Period 1|Withdrawal by Subject|0|||
37816909|NCT03400943|69495663|FG001|Treatment Period 1|Withdrawal by Subject|0|||
37981400|NCT00327171|69668022|FG001|Overall Study|Other|0|||
37981401|NCT00461630|69668030|FG000|Overall Study|Death|798|||
37981402|NCT00461630|69668031|FG001|Overall Study|Death|732|||
37981403|NCT00461630|69668030|FG000|Overall Study|Lost to Follow-up|108|||
37981404|NCT00461630|69668031|FG001|Overall Study|Lost to Follow-up|95|||
37981405|NCT00461552|69668039|FG000|Overall Study|Drug Dispensing error|0|||
37981406|NCT00461552|69668040|FG001|Overall Study|Drug Dispensing error|2|||
37981407|NCT00453206|69668046|FG000|Overall Study|Death|1|||
37981408|NCT03850496|69668053|FG000|Overall Study|Withdrawal by Subject|1|||
37981409|NCT03850496|69668054|FG001|Overall Study|Withdrawal by Subject|0|||
37981410|NCT03850496|69668055|FG002|Overall Study|Withdrawal by Subject|0|||
37816910|NCT03400943|69495664|FG002|Treatment Period 1|Withdrawal by Subject|3|||
37816911|NCT03400943|69495665|FG003|Treatment Period 1|Withdrawal by Subject|1|||
37981411|NCT03850496|69668053|FG000|Overall Study|Lost to Follow-up|0|||
37981412|NCT03850496|69668054|FG001|Overall Study|Lost to Follow-up|1|||
37981413|NCT03850496|69668055|FG002|Overall Study|Lost to Follow-up|4|||
37981414|NCT00327015|69668067|FG000|Overall Study|Lack of Efficacy|18|||
37816912|NCT03400943|69495662|FG000|Treatment Period 1|Other|2|||
37873195|NCT01168349|69557695|FG000|Overall Study|Withdrawal by Subject|9|||
37873196|NCT01168349|69557695|FG000|Overall Study|Kidney transplantation|3|||
37873197|NCT01168349|69557695|FG000|Overall Study|Other|22|||
37873198|NCT01168349|69557695|FG000|Overall Study|Protocol Violation|76|||
37873199|NCT00915772|69557718|FG000|Overall Study|Adverse Event|12|||
37873200|NCT00915772|69557719|FG001|Overall Study|Adverse Event|13|||
37873201|NCT00915772|69557720|FG002|Overall Study|Adverse Event|11|||
37873202|NCT00915772|69557718|FG000|Overall Study|Protocol Violation|4|||
37873203|NCT00915772|69557719|FG001|Overall Study|Protocol Violation|1|||
37873204|NCT00915772|69557720|FG002|Overall Study|Protocol Violation|2|||
37873205|NCT00915772|69557718|FG000|Overall Study|Lost to Follow-up|1|||
37873206|NCT00915772|69557719|FG001|Overall Study|Lost to Follow-up|2|||
37873207|NCT00915772|69557720|FG002|Overall Study|Lost to Follow-up|2|||
37873208|NCT00915772|69557718|FG000|Overall Study|Lack of Efficacy|9|||
37873209|NCT00915772|69557719|FG001|Overall Study|Lack of Efficacy|15|||
37873210|NCT00915772|69557720|FG002|Overall Study|Lack of Efficacy|3|||
37873211|NCT00915772|69557718|FG000|Overall Study|Refused to continue trial medication|6|||
37981415|NCT00327015|69668068|FG001|Overall Study|Lack of Efficacy|18|||
37981416|NCT00327015|69668069|FG002|Overall Study|Lack of Efficacy|35|||
37981417|NCT00327015|69668070|FG003|Overall Study|Lack of Efficacy|29|||
37981418|NCT00327015|69668067|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
37981419|NCT00327015|69668068|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
37816913|NCT03400943|69495663|FG001|Treatment Period 1|Other|1|||
37816914|NCT03400943|69495664|FG002|Treatment Period 1|Other|2|||
37816915|NCT03400943|69495665|FG003|Treatment Period 1|Other|2|||
37816916|NCT03400943|69495662|FG000|Post-treatment Period 1|Adverse Event|2|||
37816917|NCT03400943|69495663|FG001|Post-treatment Period 1|Adverse Event|0|||
37816918|NCT03400943|69495664|FG002|Post-treatment Period 1|Adverse Event|0|||
37816919|NCT03400943|69495665|FG003|Post-treatment Period 1|Adverse Event|0|||
37816920|NCT03400943|69495662|FG000|Post-treatment Period 1|Protocol Violation|1|||
37816921|NCT03400943|69495663|FG001|Post-treatment Period 1|Protocol Violation|0|||
37816922|NCT03400943|69495664|FG002|Post-treatment Period 1|Protocol Violation|0|||
37816923|NCT03400943|69495665|FG003|Post-treatment Period 1|Protocol Violation|0|||
37816924|NCT03400943|69495662|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
37816925|NCT03400943|69495663|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
37816926|NCT03400943|69495664|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
37816927|NCT03400943|69495665|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
37816928|NCT03400943|69495662|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
37816929|NCT03400943|69495663|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
37816930|NCT03400943|69495664|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
37816931|NCT03400943|69495665|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
37816932|NCT03400943|69495662|FG000|Post-treatment Period 1|Other|2|||
37816933|NCT03400943|69495663|FG001|Post-treatment Period 1|Other|0|||
37816934|NCT03400943|69495664|FG002|Post-treatment Period 1|Other|4|||
37816935|NCT03400943|69495665|FG003|Post-treatment Period 1|Other|5|||
37816936|NCT03400943|69495662|FG000|Treatment Period 2|Study terminated by sponsor|0|||
37816937|NCT03400943|69495663|FG001|Treatment Period 2|Study terminated by sponsor|1|||
37816938|NCT03400943|69495664|FG002|Treatment Period 2|Study terminated by sponsor|0|||
37816939|NCT03400943|69495665|FG003|Treatment Period 2|Study terminated by sponsor|0|||
37816940|NCT03400943|69495662|FG000|Treatment Period 2|Withdrawal by Subject|0|||
37816941|NCT03400943|69495663|FG001|Treatment Period 2|Withdrawal by Subject|1|||
37816942|NCT03400943|69495664|FG002|Treatment Period 2|Withdrawal by Subject|0|||
37816943|NCT03400943|69495665|FG003|Treatment Period 2|Withdrawal by Subject|0|||
37816944|NCT03400943|69495662|FG000|Treatment Period 2|Other|1|||
37816945|NCT03400943|69495663|FG001|Treatment Period 2|Other|6|||
37816946|NCT03400943|69495664|FG002|Treatment Period 2|Other|0|||
37816947|NCT03400943|69495665|FG003|Treatment Period 2|Other|0|||
37816948|NCT03400943|69495662|FG000|Follow-up Period|Withdrawal by Subject|1|||
37816949|NCT03400943|69495663|FG001|Follow-up Period|Withdrawal by Subject|0|||
37816950|NCT03400943|69495664|FG002|Follow-up Period|Withdrawal by Subject|0|||
37816951|NCT03400943|69495665|FG003|Follow-up Period|Withdrawal by Subject|0|||
37816952|NCT03321526|69495679|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
37816953|NCT03321526|69495680|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
37816954|NCT03321526|69495679|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
37816955|NCT03321526|69495680|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
37873212|NCT00915772|69557719|FG001|Overall Study|Refused to continue trial medication|8|||
37873213|NCT00915772|69557720|FG002|Overall Study|Refused to continue trial medication|4|||
37816956|NCT03321526|69495679|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
37816957|NCT03321526|69495680|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
37816958|NCT03321526|69495679|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
37816959|NCT03321526|69495680|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
37816960|NCT03321526|69495679|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
37873214|NCT00915772|69557718|FG000|Overall Study|Any other reason|4|||
37873215|NCT00915772|69557719|FG001|Overall Study|Any other reason|7|||
37873216|NCT00915772|69557720|FG002|Overall Study|Any other reason|7|||
37873217|NCT00912964|69557732|FG000|Overall Study|Eligibility criterion not met|1|||
37873218|NCT00912964|69557733|FG001|Overall Study|Eligibility criterion not met|1|||
37873219|NCT00912964|69557734|FG002|Overall Study|Eligibility criterion not met|0|||
37873220|NCT00912964|69557732|FG000|Overall Study|Adverse Event|15|||
37873221|NCT00912964|69557733|FG001|Overall Study|Adverse Event|18|||
37873222|NCT00912964|69557734|FG002|Overall Study|Adverse Event|12|||
37873223|NCT00912964|69557732|FG000|Overall Study|Lack of Efficacy|11|||
37873224|NCT00912964|69557733|FG001|Overall Study|Lack of Efficacy|4|||
37873225|NCT00912964|69557734|FG002|Overall Study|Lack of Efficacy|3|||
37873226|NCT00912964|69557732|FG000|Overall Study|Withdrawal by Subject|20|||
37873227|NCT00912964|69557733|FG001|Overall Study|Withdrawal by Subject|12|||
37873228|NCT00912964|69557734|FG002|Overall Study|Withdrawal by Subject|18|||
37873229|NCT00912964|69557732|FG000|Overall Study|Lost to Follow-up|4|||
37873230|NCT00912964|69557733|FG001|Overall Study|Lost to Follow-up|3|||
37873231|NCT00912964|69557734|FG002|Overall Study|Lost to Follow-up|3|||
37873232|NCT00912964|69557732|FG000|Overall Study|Protocol Violation|5|||
37873233|NCT00912964|69557733|FG001|Overall Study|Protocol Violation|3|||
37873234|NCT00912964|69557734|FG002|Overall Study|Protocol Violation|8|||
37873235|NCT00912964|69557732|FG000|Overall Study|Taking exclusionary medications|7|||
37873236|NCT00912964|69557733|FG001|Overall Study|Taking exclusionary medications|4|||
37873237|NCT00912964|69557734|FG002|Overall Study|Taking exclusionary medications|8|||
37981420|NCT00327015|69668069|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
37981421|NCT00327015|69668070|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
37873238|NCT00912964|69557732|FG000|Overall Study|Medical History|1|||
37873239|NCT00912964|69557733|FG001|Overall Study|Medical History|0|||
37873240|NCT00912964|69557734|FG002|Overall Study|Medical History|0|||
37873241|NCT00912964|69557732|FG000|Overall Study|Non-compliance with study procedures|2|||
37981422|NCT00327015|69668067|FG000|Overall Study|Lost to Follow-up|22|||
37981423|NCT00327015|69668068|FG001|Overall Study|Lost to Follow-up|23|||
37981424|NCT00327015|69668069|FG002|Overall Study|Lost to Follow-up|29|||
37981425|NCT00327015|69668070|FG003|Overall Study|Lost to Follow-up|22|||
37981426|NCT00327015|69668067|FG000|Overall Study|Adverse Event|14|||
37981427|NCT00327015|69668068|FG001|Overall Study|Adverse Event|10|||
37981428|NCT00327015|69668069|FG002|Overall Study|Adverse Event|14|||
37981429|NCT00327015|69668070|FG003|Overall Study|Adverse Event|14|||
37981430|NCT00327015|69668067|FG000|Overall Study|Subject no longer meets study criteria|4|||
37981431|NCT00327015|69668068|FG001|Overall Study|Subject no longer meets study criteria|2|||
37981432|NCT00327015|69668069|FG002|Overall Study|Subject no longer meets study criteria|8|||
37981433|NCT00327015|69668070|FG003|Overall Study|Subject no longer meets study criteria|7|||
37981434|NCT00327015|69668067|FG000|Overall Study|Poor/Noncompliance|11|||
37981435|NCT00327015|69668068|FG001|Overall Study|Poor/Noncompliance|8|||
37981436|NCT00327015|69668069|FG002|Overall Study|Poor/Noncompliance|4|||
37981437|NCT00327015|69668070|FG003|Overall Study|Poor/Noncompliance|5|||
37981438|NCT00327015|69668067|FG000|Overall Study|Physician Decision|0|||
37981439|NCT00327015|69668068|FG001|Overall Study|Physician Decision|1|||
37981440|NCT00327015|69668069|FG002|Overall Study|Physician Decision|3|||
37981441|NCT00327015|69668070|FG003|Overall Study|Physician Decision|2|||
37981442|NCT00327015|69668067|FG000|Overall Study|Death|1|||
37981443|NCT00327015|69668068|FG001|Overall Study|Death|2|||
37981444|NCT00327015|69668069|FG002|Overall Study|Death|2|||
37981445|NCT00327015|69668070|FG003|Overall Study|Death|3|||
37981446|NCT00327015|69668067|FG000|Overall Study|Pregnancy|0|||
37981447|NCT00327015|69668068|FG001|Overall Study|Pregnancy|2|||
37981448|NCT00327015|69668069|FG002|Overall Study|Pregnancy|1|||
37981449|NCT00327015|69668070|FG003|Overall Study|Pregnancy|1|||
37981450|NCT00327015|69668067|FG000|Overall Study|Administrative Reason by Sponsor|1|||
37981451|NCT00327015|69668068|FG001|Overall Study|Administrative Reason by Sponsor|2|||
37981452|NCT00327015|69668069|FG002|Overall Study|Administrative Reason by Sponsor|2|||
37981453|NCT00327015|69668070|FG003|Overall Study|Administrative Reason by Sponsor|1|||
37873242|NCT00912964|69557733|FG001|Overall Study|Non-compliance with study procedures|0|||
37873243|NCT00912964|69557734|FG002|Overall Study|Non-compliance with study procedures|0|||
37873244|NCT00912964|69557732|FG000|Overall Study|Violation of exclusion criterion|0|||
37981454|NCT00434148|69668082|FG000|Overall Study|Adverse Event|18|||
37981455|NCT00434148|69668083|FG001|Overall Study|Adverse Event|18|||
37981456|NCT00434148|69668082|FG000|Overall Study|Lack of Efficacy|25|||
37981457|NCT00434148|69668083|FG001|Overall Study|Lack of Efficacy|28|||
37981458|NCT00434148|69668082|FG000|Overall Study|Withdrawal by Subject|15|||
37981459|NCT00434148|69668083|FG001|Overall Study|Withdrawal by Subject|15|||
37981460|NCT00434148|69668082|FG000|Overall Study|Protocol Violation|4|||
37873245|NCT00912964|69557733|FG001|Overall Study|Violation of exclusion criterion|0|||
37873246|NCT00912964|69557734|FG002|Overall Study|Violation of exclusion criterion|2|||
37873247|NCT00912964|69557732|FG000|Overall Study|Randomized but never received study drug|0|||
37873248|NCT00912964|69557733|FG001|Overall Study|Randomized but never received study drug|1|||
37873249|NCT00912964|69557734|FG002|Overall Study|Randomized but never received study drug|0|||
37981461|NCT00434148|69668083|FG001|Overall Study|Protocol Violation|0|||
37981462|NCT00434148|69668082|FG000|Overall Study|Administrative problems|6|||
37981463|NCT00434148|69668083|FG001|Overall Study|Administrative problems|10|||
37981464|NCT00434148|69668082|FG000|Overall Study|Lost to Follow-up|0|||
37981465|NCT00434148|69668083|FG001|Overall Study|Lost to Follow-up|1|||
37981466|NCT00434148|69668082|FG000|Overall Study|Condition no longer requires study drug|1|||
37981467|NCT00434148|69668083|FG001|Overall Study|Condition no longer requires study drug|0|||
37981468|NCT00434148|69668082|FG000|Overall Study|Abnormal test procedure result|0|||
37981469|NCT00434148|69668083|FG001|Overall Study|Abnormal test procedure result|1|||
37981470|NCT00468728|69668091|FG000|Treatment|criteria for mITT population|4|||
37873250|NCT00913744|69557744|FG000|Overall Study|Adverse Event|2|||
37873251|NCT00913744|69557745|FG001|Overall Study|Adverse Event|0|||
37873252|NCT00913744|69557744|FG000|Overall Study|Withdrawal by Subject|2|||
37873253|NCT00913744|69557745|FG001|Overall Study|Withdrawal by Subject|1|||
37873254|NCT00913744|69557744|FG000|Overall Study|Death|1|||
37873255|NCT00913744|69557745|FG001|Overall Study|Death|0|||
37873256|NCT00912808|69557753|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
37873257|NCT00912808|69557754|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
37873258|NCT00912808|69557753|FG000|Washout|Withdrawal by Subject|0|||
37873259|NCT00912808|69557754|FG001|Washout|Withdrawal by Subject|1|||
37873260|NCT00912808|69557753|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
37873261|NCT00912808|69557754|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
37873262|NCT00912808|69557753|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
37873263|NCT00912808|69557754|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
37873264|NCT00960531|69557771|FG000|Overall Study|Lack of Efficacy|1|||
37873265|NCT00960531|69557772|FG001|Overall Study|Lack of Efficacy|0|||
37873266|NCT00960531|69557773|FG002|Overall Study|Lack of Efficacy|0|||
37873267|NCT00960531|69557774|FG003|Overall Study|Lack of Efficacy|0|||
37873268|NCT00960531|69557775|FG004|Overall Study|Lack of Efficacy|0|||
37873269|NCT00960531|69557776|FG005|Overall Study|Lack of Efficacy|0|||
37873270|NCT00960531|69557777|FG006|Overall Study|Lack of Efficacy|0|||
37873271|NCT00960531|69557778|FG007|Overall Study|Lack of Efficacy|0|||
37873272|NCT00960531|69557779|FG008|Overall Study|Lack of Efficacy|0|||
37873273|NCT00960531|69557780|FG009|Overall Study|Lack of Efficacy|0|||
37981471|NCT00468728|69668092|FG001|Treatment|criteria for mITT population|11|||
37981472|NCT00468728|69668091|FG000|Follow-up|mITT failure|34|||
37981473|NCT00468728|69668092|FG001|Follow-up|mITT failure|31|||
37981474|NCT00433914|69668102|FG000|Overall Study|Withdrawal by Subject|0|||
37695007|NCT02450903|69171448|FG000|Overall Study|Subject/guardian decision|1|||
37695008|NCT02371616|69171454|FG000|Overall Study|Protocol Violation|2|||
37695009|NCT02371616|69171455|FG001|Overall Study|Protocol Violation|1|||
37873274|NCT00960531|69557771|FG000|Overall Study|Withdrawal by Subject|1|||
37873275|NCT00960531|69557772|FG001|Overall Study|Withdrawal by Subject|0|||
37873276|NCT00960531|69557773|FG002|Overall Study|Withdrawal by Subject|5|||
37873277|NCT00960531|69557774|FG003|Overall Study|Withdrawal by Subject|2|||
37873278|NCT00960531|69557775|FG004|Overall Study|Withdrawal by Subject|0|||
37873279|NCT00960531|69557776|FG005|Overall Study|Withdrawal by Subject|0|||
37873280|NCT00960531|69557777|FG006|Overall Study|Withdrawal by Subject|2|||
37873281|NCT00960531|69557778|FG007|Overall Study|Withdrawal by Subject|0|||
37873282|NCT00960531|69557779|FG008|Overall Study|Withdrawal by Subject|1|||
37873283|NCT00960531|69557780|FG009|Overall Study|Withdrawal by Subject|0|||
37873284|NCT00960531|69557771|FG000|Overall Study|Caregiver Request|2|||
37873285|NCT00960531|69557772|FG001|Overall Study|Caregiver Request|0|||
37873286|NCT00960531|69557773|FG002|Overall Study|Caregiver Request|6|||
37873287|NCT00960531|69557774|FG003|Overall Study|Caregiver Request|5|||
37873288|NCT00960531|69557775|FG004|Overall Study|Caregiver Request|0|||
37873289|NCT00960531|69557776|FG005|Overall Study|Caregiver Request|2|||
37873290|NCT00960531|69557777|FG006|Overall Study|Caregiver Request|3|||
37873291|NCT00960531|69557778|FG007|Overall Study|Caregiver Request|1|||
37873292|NCT00960531|69557779|FG008|Overall Study|Caregiver Request|3|||
37873293|NCT00960531|69557780|FG009|Overall Study|Caregiver Request|0|||
37873294|NCT00960531|69557771|FG000|Overall Study|Investigator Request|0|||
37873295|NCT00960531|69557772|FG001|Overall Study|Investigator Request|0|||
37873296|NCT00960531|69557773|FG002|Overall Study|Investigator Request|1|||
37873297|NCT00960531|69557774|FG003|Overall Study|Investigator Request|0|||
37873298|NCT00960531|69557775|FG004|Overall Study|Investigator Request|0|||
37873299|NCT00960531|69557776|FG005|Overall Study|Investigator Request|0|||
37873300|NCT00960531|69557777|FG006|Overall Study|Investigator Request|0|||
37695010|NCT02371616|69171454|FG000|Overall Study|Adverse Event|0|||
37695011|NCT02371616|69171455|FG001|Overall Study|Adverse Event|1|||
37873301|NCT00960531|69557778|FG007|Overall Study|Investigator Request|0|||
37873302|NCT00960531|69557779|FG008|Overall Study|Investigator Request|0|||
37873303|NCT00960531|69557780|FG009|Overall Study|Investigator Request|0|||
37873304|NCT00960531|69557771|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
37873305|NCT00960531|69557772|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
37873306|NCT00960531|69557773|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
37873307|NCT00960531|69557774|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
37981475|NCT00433914|69668103|FG001|Overall Study|Withdrawal by Subject|2|||
37981476|NCT00433914|69668102|FG000|Overall Study|Lost to Follow-up|0|||
37873308|NCT00960531|69557775|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
37873309|NCT00960531|69557776|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
37873310|NCT00960531|69557777|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
37873311|NCT00960531|69557778|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
37873312|NCT00960531|69557779|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
37873313|NCT00960531|69557780|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
37873314|NCT00960531|69557771|FG000|Overall Study|Lost to Follow-up|0|||
37873315|NCT00960531|69557772|FG001|Overall Study|Lost to Follow-up|0|||
37873316|NCT00960531|69557773|FG002|Overall Study|Lost to Follow-up|1|||
37873317|NCT00960531|69557774|FG003|Overall Study|Lost to Follow-up|0|||
37873318|NCT00960531|69557775|FG004|Overall Study|Lost to Follow-up|0|||
37873319|NCT00960531|69557776|FG005|Overall Study|Lost to Follow-up|0|||
37873320|NCT00960531|69557777|FG006|Overall Study|Lost to Follow-up|1|||
37873321|NCT00960531|69557778|FG007|Overall Study|Lost to Follow-up|0|||
37873322|NCT00960531|69557779|FG008|Overall Study|Lost to Follow-up|0|||
37873323|NCT00960531|69557780|FG009|Overall Study|Lost to Follow-up|0|||
37873324|NCT00960531|69557771|FG000|Overall Study|Failed to Return|2|||
37873325|NCT00960531|69557772|FG001|Overall Study|Failed to Return|0|||
37873326|NCT00960531|69557773|FG002|Overall Study|Failed to Return|0|||
37873327|NCT00960531|69557774|FG003|Overall Study|Failed to Return|0|||
37873328|NCT00960531|69557775|FG004|Overall Study|Failed to Return|0|||
37873329|NCT00960531|69557776|FG005|Overall Study|Failed to Return|0|||
37873330|NCT00960531|69557777|FG006|Overall Study|Failed to Return|0|||
37873331|NCT00960531|69557778|FG007|Overall Study|Failed to Return|2|||
37873332|NCT00960531|69557779|FG008|Overall Study|Failed to Return|0|||
37873333|NCT00960531|69557780|FG009|Overall Study|Failed to Return|0|||
37873334|NCT00960531|69557771|FG000|Overall Study|Adverse Event (AE)|2|||
37816961|NCT03321526|69495680|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
37816962|NCT03321526|69495679|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
37816963|NCT03321526|69495680|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
37816964|NCT03321526|69495679|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
37816965|NCT03321526|69495680|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
37816966|NCT03321526|69495679|FG000|Follow-up Phase (2 Weeks)|Other|24|||
37816967|NCT03321526|69495680|FG001|Follow-up Phase (2 Weeks)|Other|24|||
37816968|NCT03153111|69495694|FG000|Overall Study|Death|2|||
37816969|NCT03153111|69495695|FG001|Overall Study|Death|5|||
37873335|NCT00960531|69557772|FG001|Overall Study|Adverse Event (AE)|0|||
37873336|NCT00960531|69557773|FG002|Overall Study|Adverse Event (AE)|0|||
37873337|NCT00960531|69557774|FG003|Overall Study|Adverse Event (AE)|0|||
37873338|NCT00960531|69557775|FG004|Overall Study|Adverse Event (AE)|0|||
37873339|NCT00960531|69557776|FG005|Overall Study|Adverse Event (AE)|1|||
37873340|NCT00960531|69557777|FG006|Overall Study|Adverse Event (AE)|2|||
37873341|NCT00960531|69557778|FG007|Overall Study|Adverse Event (AE)|0|||
37873342|NCT00960531|69557779|FG008|Overall Study|Adverse Event (AE)|2|||
37873343|NCT00960531|69557780|FG009|Overall Study|Adverse Event (AE)|0|||
37873344|NCT00960531|69557771|FG000|Overall Study|Reason not Specified|2|||
37873345|NCT00960531|69557772|FG001|Overall Study|Reason not Specified|1|||
37873346|NCT00960531|69557773|FG002|Overall Study|Reason not Specified|13|||
37873347|NCT00960531|69557774|FG003|Overall Study|Reason not Specified|1|||
37873348|NCT00960531|69557775|FG004|Overall Study|Reason not Specified|2|||
37873349|NCT00960531|69557776|FG005|Overall Study|Reason not Specified|0|||
37873350|NCT00960531|69557777|FG006|Overall Study|Reason not Specified|16|||
37873351|NCT00960531|69557778|FG007|Overall Study|Reason not Specified|0|||
37873352|NCT00960531|69557779|FG008|Overall Study|Reason not Specified|8|||
37873353|NCT00960531|69557780|FG009|Overall Study|Reason not Specified|1|||
37873354|NCT00960375|69557808|FG000|Overall Study|Lost to Follow-up|20|||
37873355|NCT00960375|69557809|FG001|Overall Study|Lost to Follow-up|22|||
37873356|NCT00957801|69557828|FG000|Overall Study|Withdrawal by Subject|0|||
37873357|NCT00957801|69557829|FG001|Overall Study|Withdrawal by Subject|0|||
37873358|NCT00957801|69557830|FG002|Overall Study|Withdrawal by Subject|0|||
37873359|NCT00957801|69557831|FG003|Overall Study|Withdrawal by Subject|1|||
37873360|NCT00957723|69557841|FG000|Overall Study|Death|3|||
37873361|NCT00957723|69557841|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
37873362|NCT00957723|69557841|FG000|Overall Study|Lost to Follow-up|8|||
37873363|NCT00957723|69557841|FG000|Overall Study|Withdrawal by Subject|24|||
37873364|NCT00957723|69557841|FG000|Overall Study|Investigative Site Terminated|61|||
37873365|NCT00957723|69557841|FG000|Overall Study|Intercurrent Illness|2|||
37873366|NCT00957723|69557841|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
37873367|NCT03778021|69557849|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
37873368|NCT03778021|69557850|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
37873369|NCT00911170|69557859|FG000|Treatment Period|Randomized in error|1|||
37816970|NCT03153111|69495694|FG000|Overall Study|Lost to Follow-up|1|||
37816971|NCT03153111|69495695|FG001|Overall Study|Lost to Follow-up|0|||
37873370|NCT00911170|69557860|FG001|Treatment Period|Randomized in error|1|||
37873371|NCT00911170|69557859|FG000|Treatment Period|Ineligibility determined|1|||
37873372|NCT00911170|69557860|FG001|Treatment Period|Ineligibility determined|3|||
37981477|NCT00433914|69668103|FG001|Overall Study|Lost to Follow-up|1|||
37981478|NCT00468650|69668109|FG000|Overall Study|Lost to Follow-up|4|||
37981479|NCT00468650|69668109|FG000|Overall Study|Withdrawal by Subject|2|||
37873373|NCT00911170|69557859|FG000|Treatment Period|Protocol deviation|1|||
37873374|NCT00911170|69557860|FG001|Treatment Period|Protocol deviation|2|||
37873375|NCT00911170|69557859|FG000|Treatment Period|Adverse Event|9|||
37873376|NCT00911170|69557860|FG001|Treatment Period|Adverse Event|10|||
37873377|NCT00911170|69557859|FG000|Treatment Period|Withdrawal by Subject|4|||
37873378|NCT00911170|69557860|FG001|Treatment Period|Withdrawal by Subject|4|||
37873379|NCT00911170|69557859|FG000|Treatment Period|Disease progression|0|||
37873380|NCT00911170|69557860|FG001|Treatment Period|Disease progression|2|||
37873381|NCT00911170|69557859|FG000|Treatment Period|Physician Decision|5|||
37873382|NCT00911170|69557860|FG001|Treatment Period|Physician Decision|5|||
37873383|NCT00911170|69557859|FG000|Treatment Period|Lost to Follow-up|0|||
37873384|NCT00911170|69557860|FG001|Treatment Period|Lost to Follow-up|1|||
37873385|NCT00911170|69557859|FG000|Treatment Period|Death|6|||
37873386|NCT00911170|69557860|FG001|Treatment Period|Death|9|||
37873387|NCT00911170|69557859|FG000|Long Term Follow-Up|Continuing in study|274|||
37873388|NCT00911170|69557860|FG001|Long Term Follow-Up|Continuing in study|269|||
37873389|NCT00911170|69557859|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
37873390|NCT00911170|69557860|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
37873391|NCT00911170|69557859|FG000|Long Term Follow-Up|Physician Decision|5|||
37873392|NCT00911170|69557860|FG001|Long Term Follow-Up|Physician Decision|4|||
37816972|NCT03153111|69495694|FG000|Overall Study|Physician Decision|5|||
37816973|NCT03153111|69495695|FG001|Overall Study|Physician Decision|1|||
37816974|NCT03153111|69495694|FG000|Overall Study|Withdrawal by Subject|3|||
37816975|NCT03153111|69495695|FG001|Overall Study|Withdrawal by Subject|3|||
37873393|NCT00911170|69557859|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
37873394|NCT00911170|69557860|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
37873395|NCT00911170|69557859|FG000|Long Term Follow-Up|Death|116|||
37873396|NCT00911170|69557860|FG001|Long Term Follow-Up|Death|121|||
37873397|NCT01167881|69557868|FG000|Overall Study|Adverse Event|47|||
37873398|NCT01167881|69557869|FG001|Overall Study|Adverse Event|51|||
37816976|NCT03126435|69495703|FG000|Overall Study|Death|90|||
37816977|NCT03126435|69495704|FG001|Overall Study|Death|84|||
37816978|NCT03126435|69495703|FG000|Overall Study|Lost to Follow-up|4|||
37816979|NCT03126435|69495704|FG001|Overall Study|Lost to Follow-up|3|||
37816980|NCT03126435|69495703|FG000|Overall Study|Physician Decision|0|||
37816981|NCT03126435|69495704|FG001|Overall Study|Physician Decision|1|||
37816982|NCT03126435|69495703|FG000|Overall Study|Withdrawal by Subject|6|||
37816983|NCT03126435|69495704|FG001|Overall Study|Withdrawal by Subject|12|||
37816984|NCT03126435|69495703|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
37816985|NCT03126435|69495704|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
37816986|NCT02823574|69495725|FG000|Randomization|Disease Progression|0|||
37816987|NCT02823574|69495726|FG001|Randomization|Disease Progression|0|||
37816988|NCT02823574|69495727|FG002|Randomization|Disease Progression|1|||
37816989|NCT02823574|69495728|FG003|Randomization|Disease Progression|0|||
37816990|NCT02823574|69495725|FG000|Randomization|AE unrelated to Study Drug|1|||
37816991|NCT02823574|69495726|FG001|Randomization|AE unrelated to Study Drug|0|||
37816992|NCT02823574|69495727|FG002|Randomization|AE unrelated to Study Drug|0|||
37816993|NCT02823574|69495728|FG003|Randomization|AE unrelated to Study Drug|0|||
37816994|NCT02823574|69495725|FG000|Treatment Period|Poor/Non Compliance|1|||
37873399|NCT01167881|69557868|FG000|Overall Study|Lack of Efficacy|4|||
37873400|NCT01167881|69557869|FG001|Overall Study|Lack of Efficacy|7|||
37873401|NCT01167881|69557868|FG000|Overall Study|Non compliant with protocol|9|||
37873402|NCT01167881|69557869|FG001|Overall Study|Non compliant with protocol|18|||
37873403|NCT01167881|69557868|FG000|Overall Study|Lost to Follow-up|19|||
37873404|NCT01167881|69557869|FG001|Overall Study|Lost to Follow-up|20|||
37873405|NCT01167881|69557868|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
37873406|NCT01167881|69557869|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
37873407|NCT01167881|69557868|FG000|Overall Study|Not treated|4|||
37816995|NCT02823574|69495726|FG001|Treatment Period|Poor/Non Compliance|0|||
37873408|NCT01167881|69557869|FG001|Overall Study|Not treated|0|||
37873409|NCT01167881|69557868|FG000|Overall Study|Other not defined above|31|||
37873410|NCT01167881|69557869|FG001|Overall Study|Other not defined above|55|||
37873411|NCT00960063|69557878|FG000|Overall Study|Adverse Event|1|||
37873412|NCT00960063|69557879|FG001|Overall Study|Adverse Event|0|||
37981480|NCT00468650|69668109|FG000|Overall Study|Protocol Violation|1|||
37981481|NCT00423150|69668114|FG000|Overall Study|Adverse Event|11|||
37816996|NCT02823574|69495727|FG002|Treatment Period|Poor/Non Compliance|0|||
37816997|NCT02823574|69495728|FG003|Treatment Period|Poor/Non Compliance|1|||
37816998|NCT02823574|69495725|FG000|Treatment Period|Maximum Clinical Benefit|8|||
37873413|NCT00960063|69557880|FG002|Overall Study|Adverse Event|0|||
37816999|NCT02823574|69495726|FG001|Treatment Period|Maximum Clinical Benefit|4|||
37817000|NCT02823574|69495727|FG002|Treatment Period|Maximum Clinical Benefit|7|||
37817001|NCT02823574|69495728|FG003|Treatment Period|Maximum Clinical Benefit|1|||
37817002|NCT02823574|69495725|FG000|Treatment Period|Lost to Follow-up|1|||
37817003|NCT02823574|69495726|FG001|Treatment Period|Lost to Follow-up|1|||
37817004|NCT02823574|69495727|FG002|Treatment Period|Lost to Follow-up|0|||
37817005|NCT02823574|69495728|FG003|Treatment Period|Lost to Follow-up|0|||
37817006|NCT02823574|69495725|FG000|Treatment Period|Participant withdrew consent|4|||
37817007|NCT02823574|69495726|FG001|Treatment Period|Participant withdrew consent|0|||
37817008|NCT02823574|69495727|FG002|Treatment Period|Participant withdrew consent|0|||
37817009|NCT02823574|69495728|FG003|Treatment Period|Participant withdrew consent|1|||
37817010|NCT02823574|69495725|FG000|Treatment Period|Participant request to discontinue|5|||
37817011|NCT02823574|69495726|FG001|Treatment Period|Participant request to discontinue|0|||
37817012|NCT02823574|69495727|FG002|Treatment Period|Participant request to discontinue|3|||
37817013|NCT02823574|69495728|FG003|Treatment Period|Participant request to discontinue|2|||
37817014|NCT02823574|69495725|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
37817015|NCT02823574|69495726|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
37817016|NCT02823574|69495727|FG002|Treatment Period|Adverse Event unrelated to to study Drug|9|||
37817017|NCT02823574|69495728|FG003|Treatment Period|Adverse Event unrelated to to study Drug|2|||
37817018|NCT02823574|69495725|FG000|Treatment Period|Study Drug Toxicity|11|||
37817019|NCT02823574|69495726|FG001|Treatment Period|Study Drug Toxicity|2|||
37873414|NCT00960063|69557878|FG000|Overall Study|Progression of Disease|0|||
37873415|NCT00960063|69557879|FG001|Overall Study|Progression of Disease|0|||
37873416|NCT00960063|69557880|FG002|Overall Study|Progression of Disease|3|||
37817020|NCT02823574|69495727|FG002|Treatment Period|Study Drug Toxicity|14|||
37817021|NCT02823574|69495728|FG003|Treatment Period|Study Drug Toxicity|4|||
37873417|NCT00959907|69557890|FG000|Overall Study|Protocol Violation|0|||
37873418|NCT00959907|69557891|FG001|Overall Study|Protocol Violation|1|||
37873419|NCT00959907|69557890|FG000|Overall Study|Adverse Event|1|||
37873420|NCT00959907|69557891|FG001|Overall Study|Adverse Event|0|||
37873421|NCT00959907|69557890|FG000|Overall Study|Withdrawal by Subject|2|||
37873422|NCT00959907|69557891|FG001|Overall Study|Withdrawal by Subject|0|||
37873423|NCT00912340|69557900|FG000|Overall Study|Adverse Event|2|||
37873424|NCT00912340|69557901|FG001|Overall Study|Adverse Event|4|||
37873425|NCT00912340|69557902|FG002|Overall Study|Adverse Event|0|||
37873426|NCT00912340|69557900|FG000|Overall Study|Protocol revised to remove arm|0|||
37873427|NCT00912340|69557901|FG001|Overall Study|Protocol revised to remove arm|0|||
37873428|NCT00912340|69557902|FG002|Overall Study|Protocol revised to remove arm|4|||
37873429|NCT01167257|69557912|FG000|Overall Study|Lost to Follow-up|2|||
37873430|NCT01167257|69557913|FG001|Overall Study|Lost to Follow-up|2|||
37873431|NCT01167257|69557912|FG000|Overall Study|Withdrew consent|1|||
37873432|NCT01167257|69557913|FG001|Overall Study|Withdrew consent|1|||
37873433|NCT01119846|69557926|FG000|Overall Study|Adverse Event|1|||
37873434|NCT01119846|69557927|FG001|Overall Study|Adverse Event|0|||
37873435|NCT01119846|69557928|FG002|Overall Study|Adverse Event|6|||
37873436|NCT01119846|69557926|FG000|Overall Study|Physician Decision|1|||
37873437|NCT01119846|69557927|FG001|Overall Study|Physician Decision|0|||
37873438|NCT01119846|69557928|FG002|Overall Study|Physician Decision|0|||
37873439|NCT01119846|69557926|FG000|Overall Study|Protocol Violation|0|||
37873440|NCT01119846|69557927|FG001|Overall Study|Protocol Violation|0|||
37873441|NCT01119846|69557928|FG002|Overall Study|Protocol Violation|1|||
37873442|NCT01119846|69557926|FG000|Overall Study|Withdrawal by Subject|0|||
37981482|NCT00423150|69668114|FG000|Overall Study|Progression of disease being studied|69|||
37695012|NCT02371616|69171454|FG000|Overall Study|Withdrawal of Consent|1|||
37695013|NCT02371616|69171455|FG001|Overall Study|Withdrawal of Consent|0|||
37695014|NCT02371616|69171454|FG000|Overall Study|Other (Not specified)|1|||
37695015|NCT02371616|69171455|FG001|Overall Study|Other (Not specified)|5|||
37695016|NCT02370914|69171461|FG000|Overall Study|Protocol Violation|2|||
37695017|NCT02370602|69171471|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
37695018|NCT02370602|69171472|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
37817022|NCT02823574|69495725|FG000|Treatment Period|Disease Progression|113|||
37817023|NCT02823574|69495726|FG001|Treatment Period|Disease Progression|64|||
37873443|NCT01119846|69557927|FG001|Overall Study|Withdrawal by Subject|0|||
37873444|NCT01119846|69557928|FG002|Overall Study|Withdrawal by Subject|4|||
37873445|NCT01167179|69557965|FG000|Overall Study|disease recurrence|4|||
37873446|NCT01167179|69557966|FG001|Overall Study|disease recurrence|4|||
37873447|NCT01167179|69557965|FG000|Overall Study|Death|4|||
37873448|NCT01167179|69557966|FG001|Overall Study|Death|10|||
37873449|NCT01167179|69557965|FG000|Overall Study|Withdrawal by Subject|1|||
37873450|NCT01167179|69557966|FG001|Overall Study|Withdrawal by Subject|2|||
37873451|NCT01167179|69557965|FG000|Overall Study|diverse|6|||
37873452|NCT01167179|69557966|FG001|Overall Study|diverse|5|||
37873453|NCT01167023|69558039|FG000|Overall Study|Lost to Follow-up|0|||
37873454|NCT01167023|69558040|FG001|Overall Study|Lost to Follow-up|1|||
37981483|NCT00423150|69668114|FG000|Overall Study|Withdrawal by Subject|1|||
37981484|NCT00423150|69668114|FG000|Overall Study|Non-compliance with protocol|1|||
37873455|NCT01167023|69558041|FG002|Overall Study|Lost to Follow-up|1|||
37873456|NCT01167023|69558039|FG000|Overall Study|Screen Failure|0|||
37873457|NCT01167023|69558040|FG001|Overall Study|Screen Failure|1|||
37873458|NCT01167023|69558041|FG002|Overall Study|Screen Failure|0|||
37873459|NCT01167023|69558039|FG000|Overall Study|Sponsor Decision|0|||
37873460|NCT01167023|69558040|FG001|Overall Study|Sponsor Decision|1|||
37873461|NCT01167023|69558041|FG002|Overall Study|Sponsor Decision|0|||
37873462|NCT01167023|69558039|FG000|Overall Study|Withdrawal by Subject|0|||
37873463|NCT01167023|69558040|FG001|Overall Study|Withdrawal by Subject|0|||
37873464|NCT01167023|69558041|FG002|Overall Study|Withdrawal by Subject|1|||
37873465|NCT03484117|69558049|FG000|Overall Study|Lost to Follow-up|1|||
37873466|NCT03484117|69558050|FG001|Overall Study|Lost to Follow-up|3|||
37873467|NCT03484117|69558049|FG000|Overall Study|Declined participation in exit assess|1|||
37873468|NCT03484117|69558050|FG001|Overall Study|Declined participation in exit assess|1|||
37873469|NCT01166945|69558058|FG000|Randomized|diagnosed with Group A strep|4|||
37873470|NCT01166945|69558059|FG001|Randomized|diagnosed with Group A strep|4|||
37873471|NCT01166945|69558058|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
37873472|NCT01166945|69558059|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
37873473|NCT01166945|69558058|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
37873474|NCT01166945|69558059|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
37873475|NCT01166945|69558058|FG000|Day 30|Lost to Follow-up|4|||
37873476|NCT01166945|69558059|FG001|Day 30|Lost to Follow-up|3|||
37873477|NCT00910000|69558073|FG000|Overall Study|Adverse Event|0|||
37873478|NCT00910000|69558074|FG001|Overall Study|Adverse Event|3|||
37873479|NCT00910000|69558075|FG002|Overall Study|Adverse Event|2|||
37873480|NCT00910000|69558076|FG003|Overall Study|Adverse Event|2|||
37873481|NCT00910000|69558077|FG004|Overall Study|Adverse Event|0|||
37873482|NCT00910000|69558078|FG005|Overall Study|Adverse Event|1|||
37873483|NCT00910000|69558073|FG000|Overall Study|Withdrawal by Subject|0|||
37873484|NCT00910000|69558074|FG001|Overall Study|Withdrawal by Subject|0|||
37873485|NCT00910000|69558075|FG002|Overall Study|Withdrawal by Subject|1|||
37873486|NCT00910000|69558076|FG003|Overall Study|Withdrawal by Subject|0|||
37873487|NCT00910000|69558077|FG004|Overall Study|Withdrawal by Subject|1|||
37873488|NCT00910000|69558078|FG005|Overall Study|Withdrawal by Subject|0|||
37873489|NCT01119768|69558099|FG000|Treatment Period|Lack of Efficacy|18|||
37873490|NCT01119768|69558100|FG001|Treatment Period|Lack of Efficacy|25|||
37873491|NCT01165307|69558108|FG000|Overall Study|Lost to Follow-up|11|||
37873492|NCT01165307|69558109|FG001|Overall Study|Lost to Follow-up|3|||
37873493|NCT01165307|69558108|FG000|Overall Study|Withdrawal by Subject|2|||
37873494|NCT01165307|69558109|FG001|Overall Study|Withdrawal by Subject|0|||
37873495|NCT01165307|69558108|FG000|Overall Study|Subject not available for contact|1|||
37873496|NCT01165307|69558109|FG001|Overall Study|Subject not available for contact|0|||
37873497|NCT00960999|69558117|FG000|Overall Study|Withdrawal by Subject|1|||
37873498|NCT00960999|69558118|FG001|Overall Study|Withdrawal by Subject|0|||
37873499|NCT00960999|69558117|FG000|Overall Study|Protocol Violation|5|||
37873500|NCT00960999|69558118|FG001|Overall Study|Protocol Violation|2|||
37873501|NCT00960999|69558117|FG000|Overall Study|RT dose constraints not met|2|||
37873502|NCT00960999|69558118|FG001|Overall Study|RT dose constraints not met|0|||
37873503|NCT01124838|69558126|FG000|Overall Study|Miscellaneous|4|||
37873504|NCT01124838|69558127|FG001|Overall Study|Miscellaneous|2|||
37873505|NCT01124838|69558126|FG000|Overall Study|Adverse Event|7|||
37873506|NCT01124838|69558127|FG001|Overall Study|Adverse Event|11|||
37873507|NCT01124838|69558126|FG000|Overall Study|Lack of Efficacy|2|||
37873508|NCT01124838|69558127|FG001|Overall Study|Lack of Efficacy|0|||
37873509|NCT01124838|69558126|FG000|Overall Study|Withdrawal by Subject|3|||
37873510|NCT01124838|69558127|FG001|Overall Study|Withdrawal by Subject|2|||
37873511|NCT01124838|69558126|FG000|Overall Study|Lost to Follow-up|2|||
37981485|NCT00423150|69668114|FG000|Overall Study|Administrative|4|||
37981486|NCT00433836|69668120|FG000|Overall Study|Adverse Event|7|||
37981487|NCT00433836|69668121|FG001|Overall Study|Adverse Event|0|||
37981488|NCT00433836|69668120|FG000|Overall Study|Lost to Follow-up|3|||
37873512|NCT01124838|69558127|FG001|Overall Study|Lost to Follow-up|0|||
37873513|NCT00959751|69558137|FG000|Overall Study|Lost to Follow-up|2|||
37873514|NCT00959751|69558138|FG001|Overall Study|Lost to Follow-up|3|||
37873515|NCT00959751|69558137|FG000|Overall Study|Consent Withdrawn|0|||
37873516|NCT00959751|69558138|FG001|Overall Study|Consent Withdrawn|1|||
37873517|NCT00959751|69558137|FG000|Overall Study|Non-compliance to Study Procedures|0|||
37873518|NCT00959751|69558138|FG001|Overall Study|Non-compliance to Study Procedures|1|||
37873519|NCT00959751|69558137|FG000|Overall Study|No migraine headache without aura|7|||
37873520|NCT00959751|69558138|FG001|Overall Study|No migraine headache without aura|7|||
37981489|NCT00433836|69668121|FG001|Overall Study|Lost to Follow-up|0|||
37873521|NCT00910858|69558147|FG000|Pharmacokinetic Phase|Adverse Event|1|||
37873522|NCT00910858|69558148|FG001|Pharmacokinetic Phase|Adverse Event|0|||
37873523|NCT00910858|69558149|FG002|Pharmacokinetic Phase|Adverse Event|0|||
37873524|NCT00910858|69558147|FG000|Monotherapy Phase|Adverse Event|3|||
37873525|NCT00910858|69558148|FG001|Monotherapy Phase|Adverse Event|2|||
37873526|NCT00910858|69558149|FG002|Monotherapy Phase|Adverse Event|0|||
37873527|NCT00910858|69558147|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
37873528|NCT00910858|69558148|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
37873529|NCT00910858|69558149|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
37873530|NCT00910858|69558147|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
37873531|NCT00910858|69558148|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
37873532|NCT00910858|69558149|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
37873533|NCT00910858|69558147|FG000|Monotherapy Phase|Protocol Violation|1|||
37873534|NCT00910858|69558148|FG001|Monotherapy Phase|Protocol Violation|0|||
37873535|NCT00910858|69558149|FG002|Monotherapy Phase|Protocol Violation|0|||
37873536|NCT00910858|69558147|FG000|Monotherapy Phase|Other|3|||
37873537|NCT00910858|69558148|FG001|Monotherapy Phase|Other|4|||
37873538|NCT00910858|69558149|FG002|Monotherapy Phase|Other|2|||
37873539|NCT00910858|69558147|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
37873540|NCT00910858|69558148|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
37873541|NCT00910858|69558149|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
37873542|NCT00910858|69558147|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
37873543|NCT00910858|69558148|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
37873544|NCT00910858|69558149|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
37873545|NCT00910858|69558147|FG000|Combined Treatment Phase|Protocol Violation|1|||
37873546|NCT00910858|69558148|FG001|Combined Treatment Phase|Protocol Violation|0|||
37873547|NCT00910858|69558149|FG002|Combined Treatment Phase|Protocol Violation|0|||
37873548|NCT00910858|69558147|FG000|Combined Treatment Phase|Other|0|||
37873549|NCT00910858|69558148|FG001|Combined Treatment Phase|Other|2|||
37873550|NCT00910858|69558149|FG002|Combined Treatment Phase|Other|1|||
37873551|NCT00598975|69558167|FG000|Overall Study|Adverse Event|1|||
37873552|NCT00598975|69558168|FG001|Overall Study|Adverse Event|1|||
37873553|NCT00598975|69558167|FG000|Overall Study|Brain metastases|1|||
37873554|NCT00598975|69558168|FG001|Overall Study|Brain metastases|0|||
37873555|NCT00598975|69558167|FG000|Overall Study|Withdrawal by Subject|1|||
37873556|NCT00598975|69558168|FG001|Overall Study|Withdrawal by Subject|1|||
37873557|NCT00598975|69558167|FG000|Overall Study|Withdrawal of consent|0|||
37981490|NCT00433836|69668120|FG000|Overall Study|Withdrawal by Subject|2|||
37873558|NCT00598975|69558168|FG001|Overall Study|Withdrawal of consent|1|||
37873559|NCT00598975|69558167|FG000|Overall Study|Disease progression|8|||
37873560|NCT00598975|69558168|FG001|Overall Study|Disease progression|3|||
37873561|NCT00598975|69558167|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
37873562|NCT00598975|69558168|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
37873563|NCT00957021|69558176|FG000|Overall Study|Death|5|||
37873564|NCT00957021|69558176|FG000|Overall Study|Lost to Follow-up|8|||
37695019|NCT02370602|69171473|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
37817024|NCT02823574|69495727|FG002|Treatment Period|Disease Progression|82|||
37981491|NCT00433836|69668121|FG001|Overall Study|Withdrawal by Subject|1|||
37817025|NCT02823574|69495728|FG003|Treatment Period|Disease Progression|43|||
37817026|NCT02823574|69495725|FG000|Treatment Period|Other reasons|5|||
37817027|NCT02823574|69495726|FG001|Treatment Period|Other reasons|9|||
37817028|NCT02823574|69495727|FG002|Treatment Period|Other reasons|3|||
37817029|NCT02823574|69495728|FG003|Treatment Period|Other reasons|6|||
37817030|NCT02823574|69495725|FG000|Treatment Period|Participant no longer meets study criteria|0|||
37817031|NCT02823574|69495726|FG001|Treatment Period|Participant no longer meets study criteria|0|||
37817032|NCT02823574|69495727|FG002|Treatment Period|Participant no longer meets study criteria|1|||
37817033|NCT02823574|69495728|FG003|Treatment Period|Participant no longer meets study criteria|0|||
37817034|NCT02823574|69495725|FG000|Treatment Period|Death|0|||
37817035|NCT02823574|69495726|FG001|Treatment Period|Death|0|||
37817036|NCT02823574|69495727|FG002|Treatment Period|Death|3|||
37817037|NCT02823574|69495728|FG003|Treatment Period|Death|1|||
37817038|NCT02746809|69495741|FG000|Enrollment|Inclusion Exclusion not met|9|||
37817039|NCT02746809|69495741|FG000|Enrollment|Withdrawal by Subject|1|||
37817040|NCT02746809|69495741|FG000|Enrollment|Expected Enrollment Met|2|||
37817041|NCT02746809|69495741|FG000|Procedure|Death|1|||
37817042|NCT02746809|69495741|FG000|1-Month|Death|5|||
37817043|NCT02746809|69495741|FG000|6-Month|Death|2|||
37817044|NCT02746809|69495741|FG000|6-Month|Withdrawal by Subject|1|||
37817045|NCT02746809|69495741|FG000|12-Month|Death|3|||
37817046|NCT02746809|69495741|FG000|12-Month|Withdrawal by Subject|2|||
37817047|NCT02746809|69495741|FG000|24-Month|Death|1|||
37817048|NCT02746809|69495741|FG000|24-Month|Withdrawal by Subject|1|||
37817049|NCT02746809|69495741|FG000|36-Month|Death|8|||
37695020|NCT02370602|69171474|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
37817050|NCT02746809|69495741|FG000|36-Month|Withdrawal by Subject|1|||
37817051|NCT02746809|69495741|FG000|48-Month|Death|7|||
37817052|NCT02746809|69495741|FG000|48-Month|Withdrawal by Subject|1|||
37873565|NCT00957021|69558176|FG000|Overall Study|Withdrawal by Subject|34|||
37981492|NCT00433836|69668120|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
37981493|NCT00433836|69668121|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
37981494|NCT00433836|69668120|FG000|Overall Study|Protocol Violation|0|||
37873566|NCT00957021|69558176|FG000|Overall Study|No 2 yr ROM data|35|||
37873567|NCT00957021|69558176|FG000|Overall Study|Revised study component by 2 yr visit|8|||
37873568|NCT00957021|69558176|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
37873569|NCT00957021|69558176|FG000|Overall Study|Surgery Cancelled|9|||
37873570|NCT00957021|69558176|FG000|Overall Study|Termination due to language issue|2|||
37873571|NCT01124604|69558183|FG000|Overall Study|Adverse Event|10|||
37873572|NCT01124604|69558184|FG001|Overall Study|Adverse Event|1|||
37873573|NCT01124604|69558183|FG000|Overall Study|Lack of Efficacy|1|||
37873574|NCT01124604|69558184|FG001|Overall Study|Lack of Efficacy|0|||
37873575|NCT01124604|69558183|FG000|Overall Study|Withdrawal by Subject|4|||
37873576|NCT01124604|69558184|FG001|Overall Study|Withdrawal by Subject|0|||
37873577|NCT01124604|69558183|FG000|Overall Study|Disease Progression|0|||
37873578|NCT01124604|69558184|FG001|Overall Study|Disease Progression|1|||
37873579|NCT00909844|69558190|FG000|Overall Study|Adverse Event|1|||
37873580|NCT00909844|69558190|FG000|Overall Study|Withdrawal by Subject|1|||
37873581|NCT00909844|69558190|FG000|Overall Study|Lost to Follow-up|2|||
37873582|NCT01124448|69558197|FG000|Overall Study|Lost to Follow-up|0|||
37873583|NCT01124448|69558198|FG001|Overall Study|Lost to Follow-up|3|||
37873584|NCT01124448|69558197|FG000|Overall Study|Protocol Violation|2|||
37873585|NCT01124448|69558198|FG001|Overall Study|Protocol Violation|0|||
37873586|NCT01124292|69558207|FG000|Overall Study|Lost to Follow-up|2|||
37981495|NCT00433836|69668121|FG001|Overall Study|Protocol Violation|2|||
37981496|NCT00433836|69668120|FG000|Overall Study|Condition no longer requires study drug|0|||
37981497|NCT00433836|69668121|FG001|Overall Study|Condition no longer requires study drug|1|||
37981498|NCT00433836|69668120|FG000|Overall Study|Abnormal laboratory values|0|||
37981499|NCT00433836|69668121|FG001|Overall Study|Abnormal laboratory values|1|||
37981500|NCT00433446|69668127|FG000|Overall Study|Adverse Event|4|||
37981501|NCT00433446|69668127|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
37981502|NCT00433446|69668127|FG000|Overall Study|Progression|44|||
37817053|NCT02746809|69495741|FG000|60-Month|Death|1|||
37817054|NCT02746809|69495741|FG000|60-Month|Lost to Follow-up|2|||
37817055|NCT02525796|69495750|FG000|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
37817056|NCT02525796|69495751|FG001|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
37817057|NCT02525796|69495752|FG002|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
37817058|NCT02525796|69495750|FG000|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|1|||
37817059|NCT02525796|69495751|FG001|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
37817060|NCT02525796|69495752|FG002|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
37817061|NCT02525796|69495750|FG000|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
37817062|NCT02525796|69495751|FG001|Randomization to Monotherapy for 4 Weeks|Physician Decision|1|||
37817063|NCT02525796|69495752|FG002|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
37817064|NCT02525796|69495750|FG000|Open-label Addition of Cinacalcet|Withdrawal by Subject|2|||
37817065|NCT02525796|69495751|FG001|Open-label Addition of Cinacalcet|Withdrawal by Subject|0|||
37817066|NCT02525796|69495752|FG002|Open-label Addition of Cinacalcet|Withdrawal by Subject|1|||
37817067|NCT02525796|69495750|FG000|Open-label Addition of Cinacalcet|Adverse Event|2|||
37817068|NCT02525796|69495751|FG001|Open-label Addition of Cinacalcet|Adverse Event|2|||
37817069|NCT02525796|69495752|FG002|Open-label Addition of Cinacalcet|Adverse Event|2|||
37817070|NCT02360280|69495768|FG000|Overall Study|Withdrawal by Subject|2|||
37817071|NCT02360280|69495769|FG001|Overall Study|Withdrawal by Subject|0|||
37817072|NCT02360280|69495768|FG000|Overall Study|Adverse Event|0|||
37817073|NCT02360280|69495769|FG001|Overall Study|Adverse Event|1|||
37817074|NCT02360280|69495768|FG000|Overall Study|Lost to Follow-up|1|||
37817075|NCT02360280|69495769|FG001|Overall Study|Lost to Follow-up|0|||
37817076|NCT02201251|69495777|FG000|Overall Study|Adverse Event|1|||
37817077|NCT02201251|69495778|FG001|Overall Study|Adverse Event|1|||
37817078|NCT02201251|69495777|FG000|Overall Study|Protocol Violation|1|||
37817079|NCT02201251|69495778|FG001|Overall Study|Protocol Violation|0|||
37817080|NCT02201251|69495777|FG000|Overall Study|Noncompliance with Study Drug|0|||
37817081|NCT02201251|69495778|FG001|Overall Study|Noncompliance with Study Drug|1|||
37817082|NCT02201251|69495777|FG000|Overall Study|Withdrawal by Subject|2|||
37817083|NCT02201251|69495778|FG001|Overall Study|Withdrawal by Subject|1|||
37817084|NCT02027545|69495786|FG000|Overall Study|Failed to sign HIPAA|0|||
37817085|NCT02027545|69495787|FG001|Overall Study|Failed to sign HIPAA|2|||
37817086|NCT02027545|69495786|FG000|Overall Study|Failed to attend study visit|2|||
37873587|NCT01124292|69558208|FG001|Overall Study|Lost to Follow-up|4|||
37873588|NCT01124292|69558209|FG002|Overall Study|Lost to Follow-up|3|||
37873589|NCT01124292|69558207|FG000|Overall Study|Physician Decision|0|||
37873590|NCT01124292|69558208|FG001|Overall Study|Physician Decision|3|||
37873591|NCT01124292|69558209|FG002|Overall Study|Physician Decision|2|||
37981503|NCT00433446|69668127|FG000|Overall Study|Other - Not Protocol specified|3|||
37981504|NCT00433446|69668127|FG000|Overall Study|Ineligible|9|||
37981505|NCT00468104|69668131|FG000|First Intervention|Protocol Violation|2|||
37981506|NCT00468104|69668132|FG001|First Intervention|Protocol Violation|1|||
37981507|NCT00468104|69668131|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
37981508|NCT00468104|69668132|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
37981509|NCT00468104|69668131|FG000|First Intervention|died within 3 weeks|1|||
37981510|NCT00468104|69668132|FG001|First Intervention|died within 3 weeks|0|||
37981511|NCT00468104|69668131|FG000|First Intervention|malposition/blocked chest tube tube|2|||
37873592|NCT01124292|69558207|FG000|Overall Study|Withdrawal by Subject|0|||
37873593|NCT01124292|69558208|FG001|Overall Study|Withdrawal by Subject|6|||
37873594|NCT01124292|69558209|FG002|Overall Study|Withdrawal by Subject|2|||
37873595|NCT01124292|69558207|FG000|Overall Study|medical issue unrelated to the study|0|||
37873596|NCT01124292|69558208|FG001|Overall Study|medical issue unrelated to the study|0|||
37873597|NCT01124292|69558209|FG002|Overall Study|medical issue unrelated to the study|2|||
37873598|NCT01124292|69558207|FG000|Overall Study|piercing track closed|0|||
37873599|NCT01124292|69558208|FG001|Overall Study|piercing track closed|2|||
37873600|NCT01124292|69558209|FG002|Overall Study|piercing track closed|1|||
37873601|NCT01136772|69558222|FG000|Overall Study|Adverse Event|15|||
37873602|NCT01136772|69558223|FG001|Overall Study|Adverse Event|14|||
37873603|NCT01136772|69558222|FG000|Overall Study|Lack of Efficacy|42|||
37873604|NCT01136772|69558223|FG001|Overall Study|Lack of Efficacy|39|||
37873605|NCT01136772|69558222|FG000|Overall Study|Administrative|14|||
37873606|NCT01136772|69558223|FG001|Overall Study|Administrative|12|||
37873607|NCT01136772|69558222|FG000|Overall Study|Withdrawal by Subject|33|||
37873608|NCT01136772|69558223|FG001|Overall Study|Withdrawal by Subject|36|||
37873609|NCT01136772|69558222|FG000|Overall Study|Did not receive injection|10|||
37873610|NCT01136772|69558223|FG001|Overall Study|Did not receive injection|7|||
37873611|NCT01136772|69558222|FG000|Overall Study|Did not follow up after first injection|2|||
37873612|NCT01136772|69558223|FG001|Overall Study|Did not follow up after first injection|2|||
37873613|NCT00909532|69558231|FG000|Overall Study|Adverse Event|4|||
37873614|NCT00909532|69558232|FG001|Overall Study|Adverse Event|1|||
37873615|NCT00909532|69558231|FG000|Overall Study|Pregnancy|0|||
37981512|NCT00468104|69668132|FG001|First Intervention|malposition/blocked chest tube tube|0|||
37981513|NCT00468104|69668131|FG000|First Intervention|large lung mass with minimal effusion|1|||
37873616|NCT00909532|69558232|FG001|Overall Study|Pregnancy|1|||
37873617|NCT00909532|69558231|FG000|Overall Study|Prohibited Medication|2|||
37873618|NCT00909532|69558232|FG001|Overall Study|Prohibited Medication|1|||
37981514|NCT00468104|69668132|FG001|First Intervention|large lung mass with minimal effusion|0|||
37981515|NCT00468104|69668131|FG000|First Intervention|associated prolonged pneumothorax|1|||
37981516|NCT00468104|69668132|FG001|First Intervention|associated prolonged pneumothorax|0|||
37981517|NCT00468104|69668131|FG000|First Intervention|trapped lung|1|||
37981518|NCT00468104|69668132|FG001|First Intervention|trapped lung|0|||
37981519|NCT00468104|69668131|FG000|Second Intervention|Withdrawal by Subject|5|||
37873619|NCT00909532|69558231|FG000|Overall Study|Withdrawal of Consent|1|||
37873620|NCT00909532|69558232|FG001|Overall Study|Withdrawal of Consent|1|||
37873621|NCT00909532|69558231|FG000|Overall Study|Noncompliance with Study Requirements|0|||
37873622|NCT00909532|69558232|FG001|Overall Study|Noncompliance with Study Requirements|2|||
37873623|NCT00909532|69558231|FG000|Overall Study|Physician Decision|1|||
37873624|NCT00909532|69558232|FG001|Overall Study|Physician Decision|0|||
37873625|NCT00909532|69558231|FG000|Overall Study|Wrong Genotype|1|||
37873626|NCT00909532|69558232|FG001|Overall Study|Wrong Genotype|0|||
37873627|NCT00909532|69558231|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
37873628|NCT00909532|69558232|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
37981520|NCT00468104|69668132|FG001|Second Intervention|Withdrawal by Subject|2|||
37981521|NCT00468104|69668131|FG000|Second Intervention|discarded for malposition of chest tube|0|||
37981522|NCT00468104|69668132|FG001|Second Intervention|discarded for malposition of chest tube|2|||
37981523|NCT00326625|69668143|FG000|Overall Study|Adverse Event|20|||
37981524|NCT00326625|69668144|FG001|Overall Study|Adverse Event|9|||
37981525|NCT00326625|69668143|FG000|Overall Study|Withdrawal by Subject|15|||
37981526|NCT00326625|69668144|FG001|Overall Study|Withdrawal by Subject|12|||
37981527|NCT00326625|69668143|FG000|Overall Study|Death|18|||
37981528|NCT00326625|69668144|FG001|Overall Study|Death|16|||
37981529|NCT00326625|69668143|FG000|Overall Study|Lost to Follow-up|1|||
37981530|NCT00326625|69668144|FG001|Overall Study|Lost to Follow-up|0|||
37981531|NCT00326625|69668143|FG000|Overall Study|prescheduled medical intervention|0|||
37873629|NCT01136382|69558241|FG000|Overall Study|Other|8|||
37981532|NCT00326625|69668144|FG001|Overall Study|prescheduled medical intervention|1|||
37981533|NCT00433290|69668152|FG000|Overall Study|Adverse Event|24|||
37873630|NCT01136382|69558242|FG001|Overall Study|Other|3|||
37873631|NCT01136382|69558241|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
37873632|NCT01136382|69558242|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
37873633|NCT01136382|69558241|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
37873634|NCT01136382|69558242|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
37873635|NCT01136382|69558241|FG000|Overall Study|Withdrawal by Subject|4|||
37873636|NCT01136382|69558242|FG001|Overall Study|Withdrawal by Subject|1|||
37873637|NCT00912028|69558251|FG000|Overall Study|Lost to Follow-up|2|||
37981534|NCT00433290|69668153|FG001|Overall Study|Adverse Event|7|||
37981535|NCT00433290|69668152|FG000|Overall Study|Lack of Efficacy|1|||
37873638|NCT00912028|69558252|FG001|Overall Study|Lost to Follow-up|3|||
37981536|NCT00433290|69668153|FG001|Overall Study|Lack of Efficacy|5|||
37873639|NCT00912028|69558253|FG002|Overall Study|Lost to Follow-up|0|||
37873640|NCT00912028|69558254|FG003|Overall Study|Lost to Follow-up|1|||
37873641|NCT00912028|69558255|FG004|Overall Study|Lost to Follow-up|3|||
37873642|NCT00912028|69558251|FG000|Overall Study|Withdrawal by Subject|3|||
37873643|NCT00912028|69558252|FG001|Overall Study|Withdrawal by Subject|0|||
37873644|NCT00912028|69558253|FG002|Overall Study|Withdrawal by Subject|0|||
37873645|NCT00912028|69558254|FG003|Overall Study|Withdrawal by Subject|0|||
37873646|NCT00912028|69558255|FG004|Overall Study|Withdrawal by Subject|0|||
37873647|NCT02731729|69558267|FG000|Overall Study|Death|2|||
37873648|NCT02731729|69558268|FG001|Overall Study|Death|2|||
37873649|NCT02731729|69558267|FG000|Overall Study|Study terminated by Sponsor|6|||
37873650|NCT02731729|69558268|FG001|Overall Study|Study terminated by Sponsor|6|||
37873651|NCT02731729|69558267|FG000|Overall Study|Withdrawal by Subject|1|||
37873652|NCT02731729|69558268|FG001|Overall Study|Withdrawal by Subject|0|||
37873653|NCT01119066|69558278|FG000|Overall Study|Withdrawal by Subject|4|||
37873654|NCT01119066|69558279|FG001|Overall Study|Withdrawal by Subject|6|||
37873655|NCT01119066|69558280|FG002|Overall Study|Withdrawal by Subject|0|||
37873656|NCT01119066|69558281|FG003|Overall Study|Withdrawal by Subject|0|||
37873657|NCT01119066|69558278|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
37873658|NCT01119066|69558279|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
37873659|NCT01119066|69558280|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
37873660|NCT01119066|69558281|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
37873661|NCT01119066|69558278|FG000|Overall Study|Relapse identified before transplant|1|||
37873662|NCT01119066|69558279|FG001|Overall Study|Relapse identified before transplant|0|||
37873663|NCT01119066|69558280|FG002|Overall Study|Relapse identified before transplant|0|||
37873664|NCT01119066|69558281|FG003|Overall Study|Relapse identified before transplant|0|||
37873665|NCT01119066|69558278|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
37873666|NCT01119066|69558279|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
37873667|NCT01119066|69558280|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
37873668|NCT01119066|69558281|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
37873669|NCT01119066|69558278|FG000|Overall Study|Relapse identified before transplant|0|||
37873670|NCT01119066|69558279|FG001|Overall Study|Relapse identified before transplant|4|||
37873671|NCT01119066|69558280|FG002|Overall Study|Relapse identified before transplant|0|||
37873672|NCT01119066|69558281|FG003|Overall Study|Relapse identified before transplant|0|||
37873673|NCT00910624|69558295|FG000|Treatment Phase|Adverse Event|2|||
37981537|NCT00433290|69668152|FG000|Overall Study|Withdrawal by Subject|4|||
37981538|NCT00433290|69668153|FG001|Overall Study|Withdrawal by Subject|2|||
37981539|NCT00433290|69668152|FG000|Overall Study|Protocol Violation|3|||
37817087|NCT02027545|69495787|FG001|Overall Study|Failed to attend study visit|0|||
37817088|NCT02027545|69495786|FG000|Overall Study|Protocol Violation|1|||
37817089|NCT02027545|69495787|FG001|Overall Study|Protocol Violation|0|||
37817090|NCT01867242|69495817|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
37817091|NCT01867242|69495818|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
37817092|NCT01867242|69495819|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
37817093|NCT01858688|69495827|FG000|Overall Study|Withdrawal by Subject|8|||
37817094|NCT01858688|69495827|FG000|Overall Study|Participant began another therapy|3|||
37817095|NCT01858688|69495827|FG000|Overall Study|Physician Decision|2|||
37817096|NCT01858688|69495827|FG000|Overall Study|Progressive Disease|2|||
37817097|NCT01858688|69495827|FG000|Overall Study|Reason not reproted|5|||
37817098|NCT01599234|69495846|FG000|Overall Study|Adverse Event|9|||
37817099|NCT01599234|69495847|FG001|Overall Study|Adverse Event|5|||
37981540|NCT00433290|69668153|FG001|Overall Study|Protocol Violation|2|||
37981541|NCT00433290|69668152|FG000|Overall Study|Physician Decision|2|||
37981542|NCT00433290|69668153|FG001|Overall Study|Physician Decision|0|||
37981543|NCT00433290|69668152|FG000|Overall Study|Entry Criteria Not Met|0|||
37981544|NCT00433290|69668153|FG001|Overall Study|Entry Criteria Not Met|1|||
37981545|NCT00433290|69668152|FG000|Overall Study|Lost to Follow-up|1|||
37817100|NCT01599234|69495846|FG000|Overall Study|Withdrawal by Subject|2|||
37873674|NCT00910624|69558296|FG001|Treatment Phase|Adverse Event|6|||
37873675|NCT00910624|69558297|FG002|Treatment Phase|Adverse Event|6|||
37873676|NCT00910624|69558298|FG003|Treatment Phase|Adverse Event|0|||
37873677|NCT00910624|69558295|FG000|Treatment Phase|Treatment Failure|23|||
37873678|NCT00910624|69558296|FG001|Treatment Phase|Treatment Failure|10|||
37873679|NCT00910624|69558297|FG002|Treatment Phase|Treatment Failure|0|||
37873680|NCT00910624|69558298|FG003|Treatment Phase|Treatment Failure|0|||
37873681|NCT00910624|69558295|FG000|Treatment Phase|Lost to Follow-up|0|||
37873682|NCT00910624|69558296|FG001|Treatment Phase|Lost to Follow-up|0|||
37873683|NCT00910624|69558297|FG002|Treatment Phase|Lost to Follow-up|1|||
37873684|NCT00910624|69558298|FG003|Treatment Phase|Lost to Follow-up|0|||
37873685|NCT00910624|69558295|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
37873686|NCT00910624|69558296|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
37873687|NCT00910624|69558297|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
37873688|NCT00910624|69558298|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
37873689|NCT00910624|69558295|FG000|Treatment Phase|Withdrawal by Subject|2|||
37873690|NCT00910624|69558296|FG001|Treatment Phase|Withdrawal by Subject|1|||
37873691|NCT00910624|69558297|FG002|Treatment Phase|Withdrawal by Subject|0|||
37873692|NCT00910624|69558298|FG003|Treatment Phase|Withdrawal by Subject|0|||
37873693|NCT00910624|69558295|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
37873694|NCT00910624|69558296|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
37873695|NCT00910624|69558297|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
37873696|NCT00910624|69558298|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
37873697|NCT00910624|69558295|FG000|Follow-Up Phase|Adverse Event|0|||
37873698|NCT00910624|69558296|FG001|Follow-Up Phase|Adverse Event|0|||
37873699|NCT00910624|69558297|FG002|Follow-Up Phase|Adverse Event|1|||
37873700|NCT00910624|69558298|FG003|Follow-Up Phase|Adverse Event|0|||
37873701|NCT00910624|69558295|FG000|Follow-Up Phase|Lost to Follow-up|3|||
37873702|NCT00910624|69558296|FG001|Follow-Up Phase|Lost to Follow-up|1|||
37873703|NCT00910624|69558297|FG002|Follow-Up Phase|Lost to Follow-up|2|||
37873704|NCT00910624|69558298|FG003|Follow-Up Phase|Lost to Follow-up|0|||
37873705|NCT00910624|69558295|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
37873706|NCT00910624|69558296|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
37873707|NCT00910624|69558297|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
37873708|NCT00910624|69558298|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
37873709|NCT00910624|69558295|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
37873710|NCT00910624|69558296|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
37873711|NCT00910624|69558297|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
37873712|NCT00910624|69558298|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
37873713|NCT00910624|69558295|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
37873714|NCT00910624|69558296|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
37873715|NCT00910624|69558297|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
37873716|NCT00910624|69558298|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
37873717|NCT00910624|69558295|FG000|Follow-Up Phase|Administrative|0|||
37817101|NCT01599234|69495847|FG001|Overall Study|Withdrawal by Subject|1|||
37817102|NCT01599234|69495846|FG000|Overall Study|Lost to Follow-up|1|||
37817103|NCT01599234|69495847|FG001|Overall Study|Lost to Follow-up|2|||
37817104|NCT01599234|69495846|FG000|Overall Study|Lack of Efficacy|2|||
37873718|NCT00910624|69558296|FG001|Follow-Up Phase|Administrative|1|||
37873719|NCT00910624|69558297|FG002|Follow-Up Phase|Administrative|1|||
37873720|NCT00910624|69558298|FG003|Follow-Up Phase|Administrative|0|||
37817105|NCT01599234|69495847|FG001|Overall Study|Lack of Efficacy|4|||
37817106|NCT01599234|69495846|FG000|Overall Study|Unable to operate spray|1|||
37817107|NCT01599234|69495847|FG001|Overall Study|Unable to operate spray|0|||
37817108|NCT01599234|69495846|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
37817109|NCT01599234|69495847|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
37817110|NCT01599234|69495846|FG000|Overall Study|Death|1|||
37817111|NCT01599234|69495847|FG001|Overall Study|Death|0|||
37817112|NCT01599234|69495846|FG000|Overall Study|Patient would not stop driving|1|||
37817113|NCT01599234|69495847|FG001|Overall Study|Patient would not stop driving|0|||
37817114|NCT01599234|69495846|FG000|Overall Study|Contra-indication discovered|0|||
37817115|NCT01599234|69495847|FG001|Overall Study|Contra-indication discovered|1|||
37873721|NCT01123980|69558312|FG000|Overall Study|Adverse Event|1|||
37817116|NCT01599234|69495846|FG000|Overall Study|Pregnancy|0|||
37873722|NCT01123980|69558313|FG001|Overall Study|Adverse Event|1|||
37817117|NCT01599234|69495847|FG001|Overall Study|Pregnancy|1|||
37817118|NCT01393301|69495855|FG000|Overall Study|Lost to Follow-up|5|||
37817119|NCT01393301|69495856|FG001|Overall Study|Lost to Follow-up|3|||
37873723|NCT01123980|69558312|FG000|Overall Study|Lack of Efficacy|1|||
37873724|NCT01123980|69558313|FG001|Overall Study|Lack of Efficacy|0|||
37873725|NCT01123980|69558312|FG000|Overall Study|Physician Decision|0|||
37873726|NCT01123980|69558313|FG001|Overall Study|Physician Decision|1|||
37981546|NCT00433290|69668153|FG001|Overall Study|Lost to Follow-up|0|||
37981547|NCT00467870|69668165|FG000|Overall Study|Adverse Event|13|||
37981548|NCT00467870|69668166|FG001|Overall Study|Adverse Event|9|||
37981549|NCT00467870|69668167|FG002|Overall Study|Adverse Event|1|||
37873727|NCT01123980|69558312|FG000|Overall Study|Lost to Follow-up|0|||
37873728|NCT01123980|69558313|FG001|Overall Study|Lost to Follow-up|6|||
37873729|NCT01123980|69558312|FG000|Overall Study|Protocol Violation|6|||
37873730|NCT01123980|69558313|FG001|Overall Study|Protocol Violation|6|||
37873731|NCT01123980|69558312|FG000|Overall Study|Withdrawal by Subject|5|||
37873732|NCT01123980|69558313|FG001|Overall Study|Withdrawal by Subject|3|||
37873733|NCT01123980|69558312|FG000|Overall Study|Unclassified|6|||
37873734|NCT01123980|69558313|FG001|Overall Study|Unclassified|7|||
37873735|NCT01118520|69558322|FG000|Overall Study|AAA repair|9|||
37873736|NCT01118520|69558323|FG001|Overall Study|AAA repair|7|||
37873737|NCT01118520|69558324|FG002|Overall Study|AAA repair|9|||
37873738|NCT01118520|69558322|FG000|Overall Study|Adverse Event|3|||
37873739|NCT01118520|69558323|FG001|Overall Study|Adverse Event|3|||
37873740|NCT01118520|69558324|FG002|Overall Study|Adverse Event|3|||
37873741|NCT01118520|69558322|FG000|Overall Study|Withdrawal by Subject|8|||
37873742|NCT01118520|69558323|FG001|Overall Study|Withdrawal by Subject|13|||
37873743|NCT01118520|69558324|FG002|Overall Study|Withdrawal by Subject|8|||
37873744|NCT01135992|69558332|FG000|Overall Study|Adverse Event|1|||
37873745|NCT01135992|69558332|FG000|Overall Study|Lack of Efficacy|1|||
37873746|NCT01135992|69558332|FG000|Overall Study|Protocol Violation|2|||
37873747|NCT01135992|69558332|FG000|Overall Study|Withdrawal criteria|10|||
37873748|NCT01135992|69558332|FG000|Overall Study|Unclassified|7|||
37873749|NCT00959049|69558342|FG000|Overall Study|Adverse Event|1|||
37873750|NCT00959049|69558343|FG001|Overall Study|Adverse Event|0|||
37873751|NCT00959049|69558344|FG002|Overall Study|Adverse Event|0|||
37873752|NCT00959049|69558345|FG003|Overall Study|Adverse Event|0|||
37873753|NCT00959049|69558346|FG004|Overall Study|Adverse Event|0|||
37873754|NCT00959049|69558347|FG005|Overall Study|Adverse Event|0|||
37873755|NCT00959049|69558342|FG000|Overall Study|Lost to Follow-up|17|||
37873756|NCT00959049|69558343|FG001|Overall Study|Lost to Follow-up|5|||
37873757|NCT00959049|69558344|FG002|Overall Study|Lost to Follow-up|1|||
37873758|NCT00959049|69558345|FG003|Overall Study|Lost to Follow-up|10|||
37873759|NCT00959049|69558346|FG004|Overall Study|Lost to Follow-up|9|||
37873760|NCT00959049|69558347|FG005|Overall Study|Lost to Follow-up|1|||
37873761|NCT00959049|69558342|FG000|Overall Study|Contraindicated medication|0|||
37873762|NCT00959049|69558343|FG001|Overall Study|Contraindicated medication|0|||
37873763|NCT00959049|69558344|FG002|Overall Study|Contraindicated medication|0|||
37873764|NCT00959049|69558345|FG003|Overall Study|Contraindicated medication|1|||
37873765|NCT00959049|69558346|FG004|Overall Study|Contraindicated medication|0|||
37873766|NCT00959049|69558347|FG005|Overall Study|Contraindicated medication|0|||
37873767|NCT00959049|69558342|FG000|Overall Study|Withdrawal by Subject|0|||
37873768|NCT00959049|69558343|FG001|Overall Study|Withdrawal by Subject|2|||
37981550|NCT00467870|69668168|FG003|Overall Study|Adverse Event|15|||
37981551|NCT00467870|69668169|FG004|Overall Study|Adverse Event|15|||
37981552|NCT00467870|69668170|FG005|Overall Study|Adverse Event|1|||
37981553|NCT00467870|69668165|FG000|Overall Study|Protocol Violation|2|||
37981554|NCT00467870|69668166|FG001|Overall Study|Protocol Violation|1|||
37981555|NCT00467870|69668167|FG002|Overall Study|Protocol Violation|1|||
37981556|NCT00467870|69668168|FG003|Overall Study|Protocol Violation|2|||
37981557|NCT00467870|69668169|FG004|Overall Study|Protocol Violation|0|||
37981558|NCT00467870|69668170|FG005|Overall Study|Protocol Violation|0|||
37981559|NCT00467870|69668165|FG000|Overall Study|Withdrawal by Subject|14|||
37981560|NCT00467870|69668166|FG001|Overall Study|Withdrawal by Subject|21|||
37981561|NCT00467870|69668167|FG002|Overall Study|Withdrawal by Subject|0|||
37817120|NCT01393301|69495855|FG000|Overall Study|Withdrawal by Subject|2|||
37817121|NCT01393301|69495856|FG001|Overall Study|Withdrawal by Subject|0|||
37817122|NCT01393301|69495855|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
37817123|NCT01393301|69495856|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
37817124|NCT01251861|69495864|FG000|Overall Study|Disease progression|6|||
37817125|NCT01251861|69495865|FG001|Overall Study|Disease progression|6|||
37817126|NCT01251861|69495864|FG000|Overall Study|Adverse Event|2|||
37817127|NCT01251861|69495865|FG001|Overall Study|Adverse Event|17|||
37817128|NCT01251861|69495864|FG000|Overall Study|Withdrawal by Subject|2|||
37817129|NCT01251861|69495865|FG001|Overall Study|Withdrawal by Subject|2|||
37817130|NCT01251861|69495864|FG000|Overall Study|Alternative therapy|1|||
37817131|NCT01251861|69495865|FG001|Overall Study|Alternative therapy|0|||
37873769|NCT00959049|69558344|FG002|Overall Study|Withdrawal by Subject|0|||
37873770|NCT00959049|69558345|FG003|Overall Study|Withdrawal by Subject|0|||
37873771|NCT00959049|69558346|FG004|Overall Study|Withdrawal by Subject|0|||
37873772|NCT00959049|69558347|FG005|Overall Study|Withdrawal by Subject|0|||
37873773|NCT00956943|69558374|FG000|Overall Study|Lost to Follow-up|9|||
37873774|NCT00956943|69558375|FG001|Overall Study|Lost to Follow-up|10|||
37981562|NCT00467870|69668168|FG003|Overall Study|Withdrawal by Subject|9|||
37981563|NCT00467870|69668169|FG004|Overall Study|Withdrawal by Subject|10|||
37981564|NCT00467870|69668170|FG005|Overall Study|Withdrawal by Subject|1|||
37981565|NCT00467870|69668165|FG000|Overall Study|Lost to Follow-up|5|||
37981566|NCT00467870|69668166|FG001|Overall Study|Lost to Follow-up|3|||
37981567|NCT00467870|69668167|FG002|Overall Study|Lost to Follow-up|1|||
37981568|NCT00467870|69668168|FG003|Overall Study|Lost to Follow-up|1|||
37981569|NCT00467870|69668169|FG004|Overall Study|Lost to Follow-up|3|||
37873775|NCT00958893|69558381|FG000|Overall Study|Study prematurely terminated|4|||
37873776|NCT01135914|69558388|FG000|Overall Study|Withdrawal by Subject|1|||
37873777|NCT01135914|69558389|FG001|Overall Study|Withdrawal by Subject|3|||
37873778|NCT01135914|69558390|FG002|Overall Study|Withdrawal by Subject|6|||
37873779|NCT01135914|69558388|FG000|Overall Study|Lost to Follow-up|1|||
37873780|NCT01135914|69558389|FG001|Overall Study|Lost to Follow-up|0|||
37873781|NCT01135914|69558390|FG002|Overall Study|Lost to Follow-up|1|||
37873782|NCT01135914|69558388|FG000|Overall Study|Protocol Violation|0|||
37873783|NCT01135914|69558389|FG001|Overall Study|Protocol Violation|0|||
37873784|NCT01135914|69558390|FG002|Overall Study|Protocol Violation|3|||
37873785|NCT01135914|69558388|FG000|Overall Study|Lack of Efficacy|2|||
37873786|NCT01135914|69558389|FG001|Overall Study|Lack of Efficacy|1|||
37873787|NCT01135914|69558390|FG002|Overall Study|Lack of Efficacy|10|||
37873788|NCT01135914|69558388|FG000|Overall Study|Adverse Event|0|||
37873789|NCT01135914|69558389|FG001|Overall Study|Adverse Event|1|||
37873790|NCT01135914|69558390|FG002|Overall Study|Adverse Event|2|||
37873791|NCT00907738|69558403|FG000|Overall Study|Adverse Event|2|||
37873792|NCT00907738|69558404|FG001|Overall Study|Adverse Event|0|||
37873793|NCT00907738|69558405|FG002|Overall Study|Adverse Event|1|||
37873794|NCT00907738|69558406|FG003|Overall Study|Adverse Event|0|||
37873795|NCT00907738|69558407|FG004|Overall Study|Adverse Event|0|||
37873796|NCT00907738|69558403|FG000|Overall Study|not specified or withdrew consent|3|||
37873797|NCT00907738|69558404|FG001|Overall Study|not specified or withdrew consent|0|||
37873798|NCT00907738|69558405|FG002|Overall Study|not specified or withdrew consent|0|||
37873799|NCT00907738|69558406|FG003|Overall Study|not specified or withdrew consent|0|||
37873800|NCT00907738|69558407|FG004|Overall Study|not specified or withdrew consent|0|||
37873801|NCT00907738|69558403|FG000|Overall Study|Disease progression|8|||
37873802|NCT00907738|69558404|FG001|Overall Study|Disease progression|1|||
37873803|NCT00907738|69558405|FG002|Overall Study|Disease progression|6|||
37873804|NCT00907738|69558406|FG003|Overall Study|Disease progression|4|||
37981570|NCT00467870|69668170|FG005|Overall Study|Lost to Follow-up|0|||
37817132|NCT01251861|69495864|FG000|Overall Study|Other complicating disease|0|||
37873805|NCT00907738|69558407|FG004|Overall Study|Disease progression|2|||
37873806|NCT01123356|69558423|FG000|Overall Study|Adverse Event|2|||
37873807|NCT01123356|69558423|FG000|Overall Study|Lack of Efficacy|4|||
37873808|NCT01123356|69558423|FG000|Overall Study|Withdrawal by Subject|1|||
37873809|NCT00908596|69558432|FG000|Overall Study|Other reasons|46|||
37873810|NCT00908596|69558433|FG001|Overall Study|Other reasons|6|||
37873811|NCT00908596|69558434|FG002|Overall Study|Other reasons|2|||
37873812|NCT00908596|69558435|FG003|Overall Study|Other reasons|0|||
37873813|NCT00908596|69558432|FG000|Overall Study|Lost to Follow-up|0|||
37873814|NCT00908596|69558433|FG001|Overall Study|Lost to Follow-up|1|||
37873815|NCT00908596|69558434|FG002|Overall Study|Lost to Follow-up|12|||
37873816|NCT00908596|69558435|FG003|Overall Study|Lost to Follow-up|4|||
37873817|NCT00908596|69558432|FG000|Overall Study|Death|0|||
37873818|NCT00908596|69558433|FG001|Overall Study|Death|5|||
37873819|NCT00908596|69558434|FG002|Overall Study|Death|57|||
37873820|NCT00908596|69558435|FG003|Overall Study|Death|32|||
37981571|NCT00467870|69668165|FG000|Overall Study|Subject Non-compliance|3|||
37981572|NCT00467870|69668166|FG001|Overall Study|Subject Non-compliance|4|||
37817133|NCT01251861|69495865|FG001|Overall Study|Other complicating disease|1|||
37817134|NCT01251861|69495864|FG000|Overall Study|Physician Decision|1|||
37817135|NCT01251861|69495865|FG001|Overall Study|Physician Decision|0|||
37817136|NCT01251861|69495864|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
37817137|NCT01251861|69495865|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
37817138|NCT01251861|69495864|FG000|Overall Study|Other|1|||
37817139|NCT01251861|69495865|FG001|Overall Study|Other|0|||
37817140|NCT01251861|69495864|FG000|Overall Study|Never started therapy|4|||
37817141|NCT01251861|69495865|FG001|Overall Study|Never started therapy|1|||
37817142|NCT01251861|69495864|FG000|Overall Study|Potential interaction of drugs|0|||
37817143|NCT01251861|69495865|FG001|Overall Study|Potential interaction of drugs|1|||
37981573|NCT00467870|69668167|FG002|Overall Study|Subject Non-compliance|0|||
37873821|NCT00908596|69558432|FG000|Overall Study|Protocol Violation|1|||
37873822|NCT00908596|69558433|FG001|Overall Study|Protocol Violation|0|||
37873823|NCT00908596|69558434|FG002|Overall Study|Protocol Violation|0|||
37873824|NCT00908596|69558435|FG003|Overall Study|Protocol Violation|0|||
37981574|NCT00467870|69668168|FG003|Overall Study|Subject Non-compliance|1|||
37873825|NCT00908596|69558432|FG000|Overall Study|Withdrawal by Subject|0|||
37873826|NCT00908596|69558433|FG001|Overall Study|Withdrawal by Subject|1|||
37981575|NCT00467870|69668169|FG004|Overall Study|Subject Non-compliance|5|||
37873827|NCT00908596|69558434|FG002|Overall Study|Withdrawal by Subject|3|||
37873828|NCT00908596|69558435|FG003|Overall Study|Withdrawal by Subject|1|||
37873829|NCT01118052|69558445|FG000|Overall Study|Never treated|2|||
37873830|NCT01123200|69558455|FG000|Overall Study|Withdrawal by Subject|1|||
37873831|NCT00955617|69558459|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
37873832|NCT00955617|69558460|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
37873833|NCT00955617|69558459|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
37873834|NCT00955617|69558460|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
37873835|NCT00955617|69558459|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
37873836|NCT00955617|69558460|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
37873837|NCT00955617|69558459|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
37873838|NCT00955617|69558460|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
37873839|NCT00958347|69558466|FG000|Overall Study|Death|43|||
37873840|NCT00958347|69558466|FG000|Overall Study|Withdrawal by Subject|23|||
37873841|NCT00958347|69558466|FG000|Overall Study|Lost to Follow-up|15|||
37873842|NCT00958347|69558466|FG000|Overall Study|revision/removal|10|||
37873843|NCT00958347|69558466|FG000|Overall Study|study termination|135|||
37873844|NCT00958191|69558470|FG000|Overall Study|Death|4|||
37873845|NCT00958191|69558470|FG000|Overall Study|Lost to Follow-up|5|||
37873846|NCT00958191|69558470|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
37873847|NCT00958191|69558470|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
37873848|NCT00958191|69558470|FG000|Overall Study|Revision of study device|4|||
37873849|NCT00958191|69558470|FG000|Overall Study|Site termination|11|||
37873850|NCT00958191|69558470|FG000|Overall Study|No 5 yr x-rays|56|||
37873851|NCT00960843|69558478|FG000|Overall Study|Lost to Follow-up|2|||
37873852|NCT00960843|69558479|FG001|Overall Study|Lost to Follow-up|0|||
37873853|NCT00960843|69558478|FG000|Overall Study|Protocol Violation|0|||
37873854|NCT00960843|69558479|FG001|Overall Study|Protocol Violation|4|||
37873855|NCT00960843|69558478|FG000|Overall Study|Repeated needle dislodgment|0|||
37873856|NCT00960843|69558479|FG001|Overall Study|Repeated needle dislodgment|1|||
37873857|NCT02396199|69558485|FG000|Overall Study|Lost to Follow-up|1|||
37873858|NCT02396199|69558485|FG000|Overall Study|Death|4|||
37873859|NCT01605253|69558491|FG000|Overall Study|Physician Decision|3|||
37873860|NCT01605253|69558492|FG001|Overall Study|Physician Decision|2|||
37873861|NCT01605253|69558491|FG000|Overall Study|Lost to Follow-up|3|||
37873862|NCT01605253|69558492|FG001|Overall Study|Lost to Follow-up|1|||
37873863|NCT00955305|69558502|FG000|Overall Study|Disease progression|39|||
37873864|NCT00955305|69558503|FG001|Overall Study|Disease progression|41|||
37873865|NCT00955305|69558502|FG000|Overall Study|Adverse Event|22|||
37873866|NCT00955305|69558503|FG001|Overall Study|Adverse Event|22|||
37873867|NCT00955305|69558502|FG000|Overall Study|Death|2|||
37873868|NCT00955305|69558503|FG001|Overall Study|Death|1|||
37873869|NCT00955305|69558502|FG000|Overall Study|Withdrawal by Subject|5|||
37873870|NCT00955305|69558503|FG001|Overall Study|Withdrawal by Subject|4|||
37873871|NCT00955305|69558502|FG000|Overall Study|Alternative therapy|4|||
37873872|NCT00955305|69558503|FG001|Overall Study|Alternative therapy|0|||
37873873|NCT00955305|69558502|FG000|Overall Study|Other complicating disease|2|||
37873874|NCT00955305|69558503|FG001|Overall Study|Other complicating disease|4|||
37873875|NCT00955305|69558502|FG000|Overall Study|Physician Decision|1|||
37873876|NCT00955305|69558503|FG001|Overall Study|Physician Decision|0|||
37873877|NCT00955305|69558502|FG000|Overall Study|Continued presence of residual disease|0|||
37873878|NCT00955305|69558503|FG001|Overall Study|Continued presence of residual disease|1|||
37873879|NCT00955305|69558502|FG000|Overall Study|Functional decline|2|||
37873880|NCT00955305|69558503|FG001|Overall Study|Functional decline|0|||
37873881|NCT00955305|69558502|FG000|Overall Study|Maximum response achieved|0|||
37873882|NCT00955305|69558503|FG001|Overall Study|Maximum response achieved|1|||
37873883|NCT00955305|69558502|FG000|Overall Study|Lost to Follow-up|0|||
37817144|NCT00716625|69495871|FG000|Overall Study|Safety was not Assessable|1|||
37817145|NCT00713323|69495898|FG000|Overall Study|Adverse Event|75|||
37817146|NCT00713323|69495898|FG000|Overall Study|Withdrawal by Subject|15|||
37817147|NCT00713323|69495898|FG000|Overall Study|Lost to Follow-up|11|||
37817148|NCT00713323|69495898|FG000|Overall Study|Lack of Efficacy|36|||
37817149|NCT00713323|69495898|FG000|Overall Study|Low creatine clearance at screening|1|||
37817150|NCT00713323|69495898|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
37873884|NCT00955305|69558503|FG001|Overall Study|Lost to Follow-up|1|||
37873885|NCT00955305|69558502|FG000|Overall Study|No off-treatment reason submitted|1|||
37873886|NCT00955305|69558503|FG001|Overall Study|No off-treatment reason submitted|0|||
37981576|NCT00467870|69668170|FG005|Overall Study|Subject Non-compliance|0|||
37981577|NCT00467870|69668165|FG000|Overall Study|Other/Unknown|8|||
37873887|NCT00955305|69558502|FG000|Overall Study|Never started protocol treatment|5|||
37981578|NCT00467870|69668166|FG001|Overall Study|Other/Unknown|5|||
37817151|NCT00713323|69495898|FG000|Overall Study|Surgery cured allodynic pain|1|||
37817152|NCT00713323|69495898|FG000|Overall Study|Pain free|1|||
37873888|NCT00955305|69558503|FG001|Overall Study|Never started protocol treatment|5|||
37817153|NCT00713323|69495898|FG000|Overall Study|Non-compliance|1|||
37873889|NCT00955305|69558502|FG000|Overall Study|Ineligible|5|||
37873890|NCT00955305|69558503|FG001|Overall Study|Ineligible|7|||
37873891|NCT00598585|69558511|FG000|Overall Study|Lost to Follow-up|1|||
37873892|NCT00598585|69558512|FG001|Overall Study|Lost to Follow-up|0|||
37873893|NCT00953667|69558518|FG000|Overall Study|Lost to Follow-up|11|||
37873894|NCT00953667|69558518|FG000|Overall Study|Physician Decision|35|||
37873895|NCT00953667|69558518|FG000|Overall Study|Withdrawal by Subject|63|||
37873896|NCT00953667|69558518|FG000|Overall Study|Adverse Event|10|||
37873897|NCT00953667|69558518|FG000|Overall Study|poor venous access,unable to draw blood|4|||
37873898|NCT00883129|69558524|FG000|Overall Study|Adverse Event|7|||
37873899|NCT00883129|69558525|FG001|Overall Study|Adverse Event|15|||
37873900|NCT00883129|69558524|FG000|Overall Study|Withdrawal by Subject|8|||
37873901|NCT00883129|69558525|FG001|Overall Study|Withdrawal by Subject|9|||
37873902|NCT00883129|69558524|FG000|Overall Study|Non-compliance|3|||
37873903|NCT00883129|69558525|FG001|Overall Study|Non-compliance|6|||
37873904|NCT00883129|69558524|FG000|Overall Study|Lost to Follow-up|1|||
37873905|NCT00883129|69558525|FG001|Overall Study|Lost to Follow-up|2|||
37873906|NCT00883129|69558524|FG000|Overall Study|Death|1|||
37873907|NCT00883129|69558525|FG001|Overall Study|Death|2|||
37873908|NCT00883129|69558524|FG000|Overall Study|Defined Treatment Failure|0|||
37873909|NCT00883129|69558525|FG001|Overall Study|Defined Treatment Failure|2|||
37873910|NCT00905632|69558556|FG000|Overall Study|Adverse Event|0|||
37873911|NCT00905632|69558557|FG001|Overall Study|Adverse Event|0|||
37873912|NCT00905632|69558558|FG002|Overall Study|Adverse Event|0|||
37873913|NCT00905632|69558559|FG003|Overall Study|Adverse Event|0|||
37873914|NCT00905632|69558560|FG004|Overall Study|Adverse Event|0|||
37873915|NCT00905632|69558561|FG005|Overall Study|Adverse Event|1|||
37873916|NCT00905632|69558562|FG006|Overall Study|Adverse Event|4|||
37873917|NCT00954447|69558587|FG000|Overall Study|Adverse Event|33|||
37873918|NCT00954447|69558588|FG001|Overall Study|Adverse Event|25|||
37873919|NCT00954447|69558587|FG000|Overall Study|Lack of Efficacy|17|||
37873920|NCT00954447|69558588|FG001|Overall Study|Lack of Efficacy|3|||
37873921|NCT00954447|69558587|FG000|Overall Study|Protocol Violation|5|||
37873922|NCT00954447|69558588|FG001|Overall Study|Protocol Violation|7|||
37873923|NCT00954447|69558587|FG000|Overall Study|Lost to Follow-up|8|||
37873924|NCT00954447|69558588|FG001|Overall Study|Lost to Follow-up|14|||
37873925|NCT00954447|69558587|FG000|Overall Study|Withdrawal by Subject|26|||
37873926|NCT00954447|69558588|FG001|Overall Study|Withdrawal by Subject|21|||
37873927|NCT00954447|69558587|FG000|Overall Study|Other|21|||
37873928|NCT00954447|69558588|FG001|Overall Study|Other|18|||
37873929|NCT00904150|69558596|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
37873930|NCT00904150|69558597|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
37873931|NCT00904150|69558596|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
37873932|NCT00904150|69558597|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
37873933|NCT00903760|69558605|FG000|Overall Study|Disease Progression/Death|8|||
37981579|NCT00467870|69668167|FG002|Overall Study|Other/Unknown|1|||
37981580|NCT00467870|69668168|FG003|Overall Study|Other/Unknown|5|||
37817154|NCT00713323|69495898|FG000|Overall Study|Pain resolved|1|||
37817155|NCT00713323|69495898|FG000|Overall Study|Subject travelling to USA|1|||
37873934|NCT00903760|69558606|FG001|Overall Study|Disease Progression/Death|6|||
37873935|NCT00903760|69558605|FG000|Overall Study|Stem Cell Transplant|8|||
37873936|NCT00903760|69558606|FG001|Overall Study|Stem Cell Transplant|4|||
37873937|NCT00903760|69558605|FG000|Overall Study|Physician Decision|1|||
37981581|NCT00467870|69668169|FG004|Overall Study|Other/Unknown|4|||
37817156|NCT00713323|69495898|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
37817157|NCT00713323|69495898|FG000|Overall Study|Treatment that may interact with Sativex|1|||
37817158|NCT00710554|69495915|FG000|Overall Study|Adverse Event|24|||
37817159|NCT00710554|69495916|FG001|Overall Study|Adverse Event|7|||
37817160|NCT00710554|69495915|FG000|Overall Study|Withdrawal by Subject|7|||
37817161|NCT00710554|69495916|FG001|Overall Study|Withdrawal by Subject|3|||
37817162|NCT00710554|69495915|FG000|Overall Study|Lost to Follow-up|7|||
37817163|NCT00710554|69495916|FG001|Overall Study|Lost to Follow-up|1|||
37817164|NCT00710554|69495915|FG000|Overall Study|Lack of Efficacy|11|||
37817165|NCT00710554|69495916|FG001|Overall Study|Lack of Efficacy|12|||
37873938|NCT00903760|69558606|FG001|Overall Study|Physician Decision|2|||
37873939|NCT00903760|69558605|FG000|Overall Study|Death|0|||
37873940|NCT00903760|69558606|FG001|Overall Study|Death|1|||
37873941|NCT00903760|69558605|FG000|Overall Study|Lost to Follow-up|1|||
37873942|NCT00903760|69558606|FG001|Overall Study|Lost to Follow-up|0|||
37817166|NCT00710554|69495915|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
37817167|NCT00710554|69495916|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
37817168|NCT00710424|69495924|FG000|Overall Study|Adverse Event|30|||
37873943|NCT00903760|69558605|FG000|Overall Study|Withdrawal by Subject|1|||
37873944|NCT00903760|69558606|FG001|Overall Study|Withdrawal by Subject|2|||
37873945|NCT00903760|69558605|FG000|Overall Study|Off treatment for long period|0|||
37873946|NCT00903760|69558606|FG001|Overall Study|Off treatment for long period|1|||
37873947|NCT00883051|69558617|FG000|Overall Study|Lost to Follow-up|0|||
37817169|NCT00710424|69495925|FG001|Overall Study|Adverse Event|12|||
37873948|NCT00883051|69558618|FG001|Overall Study|Lost to Follow-up|0|||
37873949|NCT00883051|69558619|FG002|Overall Study|Lost to Follow-up|0|||
37873950|NCT00883051|69558620|FG003|Overall Study|Lost to Follow-up|0|||
37873951|NCT00883051|69558621|FG004|Overall Study|Lost to Follow-up|1|||
37873952|NCT00883051|69558617|FG000|Overall Study|Did not use study medication|24|||
37873953|NCT00883051|69558618|FG001|Overall Study|Did not use study medication|22|||
37873954|NCT00883051|69558619|FG002|Overall Study|Did not use study medication|29|||
37873955|NCT00883051|69558620|FG003|Overall Study|Did not use study medication|29|||
37873956|NCT00883051|69558621|FG004|Overall Study|Did not use study medication|17|||
37873957|NCT00903682|69558635|FG000|Overall Study|Adverse Event|6|||
37873958|NCT00903682|69558636|FG001|Overall Study|Adverse Event|13|||
37873959|NCT00903682|69558635|FG000|Overall Study|Lost to Follow-up|1|||
37873960|NCT00903682|69558636|FG001|Overall Study|Lost to Follow-up|0|||
37873961|NCT00903682|69558635|FG000|Overall Study|Withdrawal by Subject|5|||
37873962|NCT00903682|69558636|FG001|Overall Study|Withdrawal by Subject|0|||
37873963|NCT00903682|69558635|FG000|Overall Study|Pregnancy|0|||
37873964|NCT00903682|69558636|FG001|Overall Study|Pregnancy|1|||
37873965|NCT00903682|69558635|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
37873966|NCT00903682|69558636|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
37873967|NCT00903682|69558635|FG000|Overall Study|Subject Non-Compliant|1|||
37873968|NCT00903682|69558636|FG001|Overall Study|Subject Non-Compliant|0|||
37873969|NCT00903682|69558635|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
37873970|NCT00903682|69558636|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
37873971|NCT00903682|69558635|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
37873972|NCT00903682|69558636|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
37873973|NCT01117428|69558648|FG000|Overall Study|Lack of Efficacy|1|||
37873974|NCT01117428|69558649|FG001|Overall Study|Lack of Efficacy|0|||
37873975|NCT01117428|69558650|FG002|Overall Study|Lack of Efficacy|0|||
37873976|NCT01117428|69558651|FG003|Overall Study|Lack of Efficacy|0|||
37873977|NCT01117428|69558652|FG004|Overall Study|Lack of Efficacy|0|||
37873978|NCT01117428|69558653|FG005|Overall Study|Lack of Efficacy|0|||
37873979|NCT01117428|69558648|FG000|Overall Study|Adverse Event|4|||
37873980|NCT01117428|69558649|FG001|Overall Study|Adverse Event|0|||
37873981|NCT01117428|69558650|FG002|Overall Study|Adverse Event|0|||
37873982|NCT01117428|69558651|FG003|Overall Study|Adverse Event|0|||
37695021|NCT02370602|69171475|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
37695022|NCT02370602|69171476|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
37695023|NCT02370368|69171495|FG000|Overall Study|Adverse Event|1|||
37695024|NCT02370368|69171496|FG001|Overall Study|Adverse Event|2|||
37695025|NCT02370368|69171495|FG000|Overall Study|Withdrawal by Subject|5|||
37695026|NCT02370368|69171496|FG001|Overall Study|Withdrawal by Subject|4|||
37695027|NCT02340806|69171504|FG000|Overall Study|Protocol Violation|2|||
37695028|NCT02340806|69171505|FG001|Overall Study|Protocol Violation|0|||
37695029|NCT02340806|69171504|FG000|Overall Study|epidural catheter replaced|2|||
37695030|NCT02340806|69171505|FG001|Overall Study|epidural catheter replaced|1|||
37695031|NCT02340806|69171504|FG000|Overall Study|history of chronic pain medication|1|||
37695032|NCT02340806|69171505|FG001|Overall Study|history of chronic pain medication|0|||
37695033|NCT02340806|69171504|FG000|Overall Study|re-dose < 90 min of CSE|1|||
37695034|NCT02340806|69171505|FG001|Overall Study|re-dose < 90 min of CSE|3|||
37695035|NCT02338154|69171511|FG000|Overall Study|Death|46|||
37695036|NCT02338154|69171511|FG000|Overall Study|Valve Implant Failure|17|||
37695037|NCT02338154|69171511|FG000|Overall Study|Valve Explant|11|||
37817170|NCT00710424|69495924|FG000|Overall Study|Lack of Efficacy|4|||
37817171|NCT00710424|69495925|FG001|Overall Study|Lack of Efficacy|5|||
37817172|NCT00710424|69495924|FG000|Overall Study|Withdrawal by Subject|5|||
37817173|NCT00710424|69495925|FG001|Overall Study|Withdrawal by Subject|3|||
37817174|NCT00710424|69495924|FG000|Overall Study|Lost to Follow-up|0|||
37817175|NCT00710424|69495925|FG001|Overall Study|Lost to Follow-up|1|||
37817176|NCT00710424|69495924|FG000|Overall Study|Refused medication, no side effects|1|||
37817177|NCT00710424|69495925|FG001|Overall Study|Refused medication, no side effects|0|||
37817178|NCT00710424|69495924|FG000|Overall Study|Non-compliance with stable analgesia|1|||
37695038|NCT02338154|69171511|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
37695039|NCT02338154|69171511|FG000|Overall Study|Lost to Follow-up|8|||
37695040|NCT02338154|69171511|FG000|Overall Study|Other Reason|3|||
37695041|NCT02338154|69171511|FG000|Overall Study|Patients Without Exit Form|47|||
37695042|NCT02338154|69171511|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
37817179|NCT00710424|69495925|FG001|Overall Study|Non-compliance with stable analgesia|0|||
37695043|NCT01835158|69171525|FG000|Overall Study|Withdrawal by Subject|1|||
37873983|NCT01117428|69558652|FG004|Overall Study|Adverse Event|1|||
37873984|NCT01117428|69558653|FG005|Overall Study|Adverse Event|2|||
37873985|NCT01117428|69558648|FG000|Overall Study|Death|0|||
37873986|NCT01117428|69558649|FG001|Overall Study|Death|1|||
37981582|NCT00467870|69668170|FG005|Overall Study|Other/Unknown|0|||
37695044|NCT01835158|69171526|FG001|Overall Study|Withdrawal by Subject|6|||
37695045|NCT02337764|69171532|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
37695046|NCT02337764|69171532|FG000|Overall Study|Voluntary Withdrawal|12|||
37695047|NCT02337764|69171532|FG000|Overall Study|Lack of Efficacy|2|||
37695048|NCT01834222|69171536|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
37695049|NCT01833832|69171540|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
37695050|NCT01833520|69171546|FG000|Overall Study|Lack of Efficacy|3|||
37695051|NCT01833520|69171547|FG001|Overall Study|Lack of Efficacy|3|||
37695052|NCT01833520|69171548|FG002|Overall Study|Lack of Efficacy|8|||
37817180|NCT00710424|69495924|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
37817181|NCT00710424|69495925|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
37817182|NCT00710424|69495924|FG000|Overall Study|Subject thought medication changed|1|||
37873987|NCT01117428|69558650|FG002|Overall Study|Death|2|||
37817183|NCT00710424|69495925|FG001|Overall Study|Subject thought medication changed|0|||
37817184|NCT00710424|69495924|FG000|Overall Study|Ceased treatment due to travel|1|||
37817185|NCT00710424|69495925|FG001|Overall Study|Ceased treatment due to travel|0|||
37817186|NCT00710424|69495924|FG000|Overall Study|Subject preferred paracetamol|0|||
37817187|NCT00710424|69495925|FG001|Overall Study|Subject preferred paracetamol|1|||
37817188|NCT00710424|69495924|FG000|Overall Study|Felt good so stopped treatment|0|||
37817189|NCT00710424|69495925|FG001|Overall Study|Felt good so stopped treatment|1|||
37817190|NCT00118846|69495955|FG000|Overall Study|Gastrointestinal (GI) intolerance|3|||
37817191|NCT00118846|69495956|FG001|Overall Study|Gastrointestinal (GI) intolerance|3|||
37817192|NCT00118846|69495955|FG000|Overall Study|Started menopausal hormone replacement therapy (HRT)|3|||
37817193|NCT00118846|69495956|FG001|Overall Study|Started menopausal hormone replacement therapy (HRT)|0|||
37817194|NCT00118846|69495955|FG000|Overall Study|Physician Decision|1|||
37817195|NCT00118846|69495956|FG001|Overall Study|Physician Decision|0|||
37817196|NCT00118846|69495955|FG000|Overall Study|Medical condition|2|||
37817197|NCT00118846|69495956|FG001|Overall Study|Medical condition|2|||
37817198|NCT00118846|69495955|FG000|Overall Study|Lost to Follow-up|0|||
37817199|NCT00118846|69495956|FG001|Overall Study|Lost to Follow-up|2|||
37817200|NCT00118846|69495955|FG000|Overall Study|Personal reason|4|||
37873988|NCT01117428|69558651|FG003|Overall Study|Death|0|||
37873989|NCT01117428|69558652|FG004|Overall Study|Death|0|||
37873990|NCT01117428|69558653|FG005|Overall Study|Death|1|||
37873991|NCT01117428|69558648|FG000|Overall Study|Physician Decision|0|||
37873992|NCT01117428|69558649|FG001|Overall Study|Physician Decision|1|||
37873993|NCT01117428|69558650|FG002|Overall Study|Physician Decision|0|||
37873994|NCT01117428|69558651|FG003|Overall Study|Physician Decision|0|||
37873995|NCT01117428|69558652|FG004|Overall Study|Physician Decision|0|||
37873996|NCT01117428|69558653|FG005|Overall Study|Physician Decision|0|||
37873997|NCT01117428|69558648|FG000|Overall Study|Withdrawal by Subject|0|||
37873998|NCT01117428|69558649|FG001|Overall Study|Withdrawal by Subject|0|||
37873999|NCT01117428|69558650|FG002|Overall Study|Withdrawal by Subject|1|||
37874000|NCT01117428|69558651|FG003|Overall Study|Withdrawal by Subject|0|||
37874001|NCT01117428|69558652|FG004|Overall Study|Withdrawal by Subject|0|||
37874002|NCT01117428|69558653|FG005|Overall Study|Withdrawal by Subject|0|||
37874003|NCT01117428|69558648|FG000|Overall Study|Progressive disease|15|||
37874004|NCT01117428|69558649|FG001|Overall Study|Progressive disease|27|||
37874005|NCT01117428|69558650|FG002|Overall Study|Progressive disease|10|||
37874006|NCT01117428|69558651|FG003|Overall Study|Progressive disease|12|||
37874007|NCT01117428|69558652|FG004|Overall Study|Progressive disease|16|||
37874008|NCT01117428|69558653|FG005|Overall Study|Progressive disease|17|||
37874009|NCT00655681|69558671|FG000|Overall Study|Lost to Follow-up|1|||
37874010|NCT00655681|69558672|FG001|Overall Study|Lost to Follow-up|1|||
37874011|NCT01135524|69558691|FG000|Overall Study|Withdrawal by Subject|14|||
37874012|NCT01135524|69558691|FG000|Overall Study|Adverse Event|20|||
37874013|NCT01135524|69558691|FG000|Overall Study|Lost to Follow-up|3|||
37817201|NCT00118846|69495956|FG001|Overall Study|Personal reason|5|||
37817202|NCT04705051|69495962|FG000|Overall Study|Enrolled but not treated|1|||
37874014|NCT01135524|69558691|FG000|Overall Study|Administrative|151|||
37874015|NCT01135524|69558691|FG000|Overall Study|Lack of Efficacy|8|||
37874016|NCT00948675|69558697|FG000|Overall Study|Lost to Follow-up|1|||
37874017|NCT00948675|69558698|FG001|Overall Study|Lost to Follow-up|0|||
37874018|NCT00903370|69558706|FG000|Overall Study|Death|13|||
37817203|NCT04705051|69495962|FG000|Overall Study|Study terminated by sponsor|23|||
37817204|NCT04464421|69495969|FG000|Overall Study|Lost to Follow-up|2|||
37817205|NCT04464421|69495970|FG001|Overall Study|Lost to Follow-up|2|||
37817206|NCT04112784|69495988|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
37874019|NCT00903370|69558707|FG001|Overall Study|Death|10|||
37874020|NCT00903370|69558706|FG000|Overall Study|Withdrawal by Subject|9|||
37874021|NCT00903370|69558707|FG001|Overall Study|Withdrawal by Subject|6|||
37874022|NCT00903370|69558706|FG000|Overall Study|Lost to Follow-up|6|||
37695053|NCT01833520|69171549|FG003|Overall Study|Lack of Efficacy|3|||
37695054|NCT01850602|69171563|FG000|Overall Study|Adverse Event|7|||
37874023|NCT00903370|69558707|FG001|Overall Study|Lost to Follow-up|8|||
37874024|NCT01110408|69558715|FG000|Overall Study|Protocol Violation|1|||
37874025|NCT01110408|69558716|FG001|Overall Study|Protocol Violation|0|||
37874026|NCT00953043|69558724|FG000|Overall Study|Withdrawal by Subject|4|||
37874027|NCT00953043|69558725|FG001|Overall Study|Withdrawal by Subject|0|||
37874028|NCT00953043|69558724|FG000|Overall Study|Physician Decision|0|||
37874029|NCT00953043|69558725|FG001|Overall Study|Physician Decision|2|||
37874030|NCT01135134|69558733|FG000|Overall Study|Adverse Event|1|||
37874031|NCT01135134|69558734|FG001|Overall Study|Adverse Event|1|||
37874032|NCT01135134|69558733|FG000|Overall Study|Did not meet protocol eligibility|1|||
37874033|NCT01135134|69558734|FG001|Overall Study|Did not meet protocol eligibility|0|||
37874034|NCT00948441|69558742|FG000|Overall Study|no longer meet inclusion criteria|1|||
37874035|NCT00948441|69558743|FG001|Overall Study|no longer meet inclusion criteria|4|||
37874036|NCT01117350|69558753|FG000|Comparative Period|Not Treated|5|||
37874037|NCT01117350|69558754|FG001|Comparative Period|Not Treated|8|||
37874038|NCT01117350|69558753|FG000|Comparative Period|Adverse Event|6|||
37874039|NCT01117350|69558754|FG001|Comparative Period|Adverse Event|33|||
37874040|NCT01117350|69558753|FG000|Comparative Period|Lost to Follow-up|11|||
37874041|NCT01117350|69558754|FG001|Comparative Period|Lost to Follow-up|7|||
37874042|NCT01117350|69558753|FG000|Comparative Period|Withdrawal by Subject|9|||
37874043|NCT01117350|69558754|FG001|Comparative Period|Withdrawal by Subject|13|||
37874044|NCT01117350|69558753|FG000|Comparative Period|Protocol Violation|8|||
37874045|NCT01117350|69558754|FG001|Comparative Period|Protocol Violation|12|||
37874046|NCT01117350|69558753|FG000|Comparative Period|Lack of Efficacy|1|||
37874047|NCT01117350|69558754|FG001|Comparative Period|Lack of Efficacy|0|||
37874048|NCT01117350|69558753|FG000|Comparative Period|Physician Decision|0|||
37874049|NCT01117350|69558754|FG001|Comparative Period|Physician Decision|1|||
37874050|NCT01117350|69558753|FG000|Comparative Period|Move to another city/country|2|||
37874051|NCT01117350|69558754|FG001|Comparative Period|Move to another city/country|1|||
37874052|NCT01117350|69558753|FG000|Extension Period|Not included in extension, not treated|0|||
37874053|NCT01117350|69558754|FG001|Extension Period|Not included in extension, not treated|50|||
37874054|NCT01117350|69558753|FG000|Extension Period|Adverse Event|0|||
37874055|NCT01117350|69558754|FG001|Extension Period|Adverse Event|2|||
37874056|NCT01117350|69558753|FG000|Extension Period|Protocol Violation|0|||
37874057|NCT01117350|69558754|FG001|Extension Period|Protocol Violation|2|||
37874058|NCT01117350|69558753|FG000|Extension Period|Lost to Follow-up|0|||
37874059|NCT01117350|69558754|FG001|Extension Period|Lost to Follow-up|2|||
37874060|NCT01117350|69558753|FG000|Extension Period|Withdrawal by Subject|0|||
37874061|NCT01117350|69558754|FG001|Extension Period|Withdrawal by Subject|3|||
37874062|NCT01117350|69558753|FG000|Extension Period|Lack of Efficacy|0|||
37874063|NCT01117350|69558754|FG001|Extension Period|Lack of Efficacy|2|||
37874064|NCT01117350|69558753|FG000|Extension Period|Inclusion criteria not respected|0|||
37874065|NCT01117350|69558754|FG001|Extension Period|Inclusion criteria not respected|1|||
37874066|NCT01117350|69558753|FG000|Extension Period|Prohibited medication|0|||
37874067|NCT01117350|69558754|FG001|Extension Period|Prohibited medication|1|||
37874068|NCT00952731|69558765|FG000|Overall Study|Drug supply expired|1|||
37874069|NCT00952731|69558766|FG001|Overall Study|Drug supply expired|0|||
37874070|NCT00947427|69558774|FG000|Overall Study|Withdrawal by Subject|1|||
37874071|NCT00947427|69558775|FG001|Overall Study|Withdrawal by Subject|3|||
37874072|NCT00947427|69558774|FG000|Overall Study|Protocol Violation|0|||
37874073|NCT00947427|69558775|FG001|Overall Study|Protocol Violation|1|||
37874074|NCT01116882|69558783|FG000|30-day|Lost to Follow-up|50|||
37874075|NCT01116882|69558784|FG001|30-day|Lost to Follow-up|21|||
37874076|NCT01116882|69558783|FG000|30-day|Withdrawal by Subject|2|||
37874077|NCT01116882|69558784|FG001|30-day|Withdrawal by Subject|4|||
37874078|NCT01116882|69558783|FG000|30-day|Other Reasons|16|||
37817207|NCT04112784|69495988|FG000|Overall Study|Screen Failures|4|||
37817208|NCT04049617|69495998|FG000|Overall Study|Adverse Event|0|||
37817209|NCT04049617|69495999|FG001|Overall Study|Adverse Event|0|||
37817210|NCT04049617|69496000|FG002|Overall Study|Adverse Event|0|||
37817211|NCT04049617|69496001|FG003|Overall Study|Adverse Event|1|||
37817212|NCT04049617|69496002|FG004|Overall Study|Adverse Event|0|||
37817213|NCT04049617|69496003|FG005|Overall Study|Adverse Event|0|||
37817214|NCT04049617|69495998|FG000|Overall Study|Death|0|||
37874079|NCT01116882|69558784|FG001|30-day|Other Reasons|6|||
37874080|NCT01116882|69558783|FG000|12-month|Lost to Follow-up|111|||
37874081|NCT01116882|69558784|FG001|12-month|Lost to Follow-up|42|||
37874082|NCT01116882|69558783|FG000|12-month|Other Reasons|151|||
37874083|NCT01116882|69558784|FG001|12-month|Other Reasons|49|||
37874084|NCT01116882|69558783|FG000|12-month|Withdrawal by Subject|5|||
37817215|NCT04049617|69495999|FG001|Overall Study|Death|0|||
37874085|NCT01116882|69558784|FG001|12-month|Withdrawal by Subject|8|||
37874086|NCT00953745|69558795|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
37874087|NCT00953745|69558796|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
37817216|NCT04049617|69496000|FG002|Overall Study|Death|0|||
37817217|NCT04049617|69496001|FG003|Overall Study|Death|0|||
37874088|NCT00953745|69558795|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
37817218|NCT04049617|69496002|FG004|Overall Study|Death|0|||
37817219|NCT04049617|69496003|FG005|Overall Study|Death|1|||
37874089|NCT00953745|69558796|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
37874090|NCT00953745|69558795|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
37874091|NCT00953745|69558796|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
37874092|NCT00953745|69558795|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
37874093|NCT00953745|69558796|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
37874094|NCT00953745|69558795|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
37874095|NCT00953745|69558796|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
37874096|NCT00953745|69558795|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
37874097|NCT00953745|69558796|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
37874098|NCT00902746|69558813|FG000|Overall Study|Protocol Violation|7|||
37874099|NCT00902746|69558813|FG000|Overall Study|Withdrawal by Subject|16|||
37874100|NCT00902746|69558813|FG000|Overall Study|Adverse Event|8|||
37981583|NCT00467558|69668182|FG000|Overall Study|Lost to Follow-up|2|||
37981584|NCT00467558|69668183|FG001|Overall Study|Lost to Follow-up|0|||
37981585|NCT00422292|69668193|FG000|Overall Study|Serious adverse events|1|||
37981586|NCT00422292|69668194|FG001|Overall Study|Serious adverse events|4|||
37981587|NCT00422292|69668195|FG002|Overall Study|Serious adverse events|0|||
37981588|NCT00422292|69668196|FG003|Overall Study|Serious adverse events|0|||
37981589|NCT00422292|69668193|FG000|Overall Study|Adverse Event|1|||
37981590|NCT00422292|69668194|FG001|Overall Study|Adverse Event|0|||
37981591|NCT00422292|69668195|FG002|Overall Study|Adverse Event|1|||
37981592|NCT00422292|69668196|FG003|Overall Study|Adverse Event|0|||
37981593|NCT00422292|69668193|FG000|Overall Study|Protocol Violation|4|||
37981594|NCT00422292|69668194|FG001|Overall Study|Protocol Violation|25|||
37981595|NCT00422292|69668195|FG002|Overall Study|Protocol Violation|8|||
37981596|NCT00422292|69668196|FG003|Overall Study|Protocol Violation|5|||
37981597|NCT00422292|69668193|FG000|Overall Study|Lost to Follow-up|6|||
37981598|NCT00422292|69668194|FG001|Overall Study|Lost to Follow-up|12|||
37981599|NCT00422292|69668195|FG002|Overall Study|Lost to Follow-up|6|||
37981600|NCT00422292|69668196|FG003|Overall Study|Lost to Follow-up|6|||
37981601|NCT00422292|69668193|FG000|Overall Study|Withdrawal by Subject|6|||
37981602|NCT00422292|69668194|FG001|Overall Study|Withdrawal by Subject|25|||
37981603|NCT00422292|69668195|FG002|Overall Study|Withdrawal by Subject|7|||
37981604|NCT00422292|69668196|FG003|Overall Study|Withdrawal by Subject|13|||
37981605|NCT00452348|69668208|FG000|Overall Study|Adverse Event|6|||
37981606|NCT00452348|69668209|FG001|Overall Study|Adverse Event|9|||
37981607|NCT00452348|69668208|FG000|Overall Study|Lack of Efficacy|10|||
37981608|NCT00452348|69668209|FG001|Overall Study|Lack of Efficacy|9|||
37981609|NCT00452348|69668208|FG000|Overall Study|Lost to Follow-up|14|||
37981610|NCT00452348|69668209|FG001|Overall Study|Lost to Follow-up|8|||
37981611|NCT00452348|69668208|FG000|Overall Study|Protocol Violation|22|||
37981612|NCT00452348|69668209|FG001|Overall Study|Protocol Violation|28|||
37817220|NCT04049617|69495998|FG000|Overall Study|Lost to Follow-up|0|||
37817221|NCT04049617|69495999|FG001|Overall Study|Lost to Follow-up|0|||
37817222|NCT04049617|69496000|FG002|Overall Study|Lost to Follow-up|0|||
37817223|NCT04049617|69496001|FG003|Overall Study|Lost to Follow-up|1|||
37817224|NCT04049617|69496002|FG004|Overall Study|Lost to Follow-up|0|||
37817225|NCT04049617|69496003|FG005|Overall Study|Lost to Follow-up|0|||
37817226|NCT04049617|69495998|FG000|Overall Study|Withdrew consent|0|||
37817227|NCT04049617|69495999|FG001|Overall Study|Withdrew consent|0|||
37817228|NCT04049617|69496000|FG002|Overall Study|Withdrew consent|1|||
37817229|NCT04049617|69496001|FG003|Overall Study|Withdrew consent|0|||
37817230|NCT04049617|69496002|FG004|Overall Study|Withdrew consent|0|||
37817231|NCT04049617|69496003|FG005|Overall Study|Withdrew consent|0|||
37817232|NCT03911154|69496019|FG000|Overall Study|Withdrawal by Subject|1|||
37874101|NCT00902746|69558813|FG000|Overall Study|Lost to Follow-up|3|||
37874102|NCT00902746|69558813|FG000|Overall Study|Physician Decision|2|||
37874103|NCT00902668|69558826|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
37874104|NCT00947349|69558834|FG000|Triple Treatment Combination Period|Adverse Event|0|||
37874105|NCT00947349|69558835|FG001|Triple Treatment Combination Period|Adverse Event|1|||
37874106|NCT00947349|69558836|FG002|Triple Treatment Combination Period|Adverse Event|0|||
37874107|NCT00947349|69558837|FG003|Triple Treatment Combination Period|Adverse Event|0|||
37874108|NCT00947349|69558834|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
37874109|NCT00947349|69558835|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
37874110|NCT00947349|69558836|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
37874111|NCT00947349|69558837|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
37874112|NCT00947349|69558834|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
37874113|NCT00947349|69558835|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
37981613|NCT00452348|69668208|FG000|Overall Study|Withdrawal by Subject|18|||
37981614|NCT00452348|69668209|FG001|Overall Study|Withdrawal by Subject|21|||
37981615|NCT00452348|69668208|FG000|Overall Study|Other|9|||
37981616|NCT00452348|69668209|FG001|Overall Study|Other|9|||
37981617|NCT00452114|69668217|FG000|Overall Study|Physician Decision|3|||
37981618|NCT00452114|69668218|FG001|Overall Study|Physician Decision|3|||
37981619|NCT00320541|69668226|FG000|Overall Study|Adverse Event|21|||
37874114|NCT00947349|69558836|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
37874115|NCT00947349|69558837|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
37874116|NCT00947349|69558834|FG000|Overall Study Standard of Care|Other|0|||
37874117|NCT00947349|69558835|FG001|Overall Study Standard of Care|Other|0|||
37874118|NCT00947349|69558836|FG002|Overall Study Standard of Care|Other|0|||
37874119|NCT00947349|69558837|FG003|Overall Study Standard of Care|Other|1|||
37874120|NCT00947193|69558865|FG000|Overall Study|Lost to Follow-up|1|||
37874121|NCT00947193|69558866|FG001|Overall Study|Lost to Follow-up|0|||
37874122|NCT00947193|69558865|FG000|Overall Study|Withdrawal by Subject|1|||
37874123|NCT00947193|69558866|FG001|Overall Study|Withdrawal by Subject|0|||
37874124|NCT00947193|69558865|FG000|Overall Study|Factor VIII >1%|1|||
37874125|NCT00947193|69558866|FG001|Overall Study|Factor VIII >1%|0|||
37874126|NCT00947115|69558874|FG000|Overall Study|Missed reporting interval|3|||
37874127|NCT00947115|69558875|FG001|Overall Study|Missed reporting interval|4|||
37874128|NCT00947115|69558876|FG002|Overall Study|Missed reporting interval|2|||
37874129|NCT00947115|69558874|FG000|Overall Study|Physician Decision|0|||
37874130|NCT00947115|69558875|FG001|Overall Study|Physician Decision|2|||
37874131|NCT00947115|69558876|FG002|Overall Study|Physician Decision|0|||
37874132|NCT00947115|69558874|FG000|Overall Study|Death|0|||
37874133|NCT00947115|69558875|FG001|Overall Study|Death|1|||
37874134|NCT00947115|69558876|FG002|Overall Study|Death|1|||
37874135|NCT00947115|69558874|FG000|Overall Study|Migrated from study area|2|||
37874136|NCT00947115|69558875|FG001|Overall Study|Migrated from study area|0|||
37874137|NCT00947115|69558876|FG002|Overall Study|Migrated from study area|0|||
37874138|NCT00947115|69558874|FG000|Overall Study|Withdrawal by Subject|1|||
37981620|NCT00320541|69668227|FG001|Overall Study|Adverse Event|19|||
37874139|NCT00947115|69558875|FG001|Overall Study|Withdrawal by Subject|3|||
37874140|NCT00947115|69558876|FG002|Overall Study|Withdrawal by Subject|4|||
37874141|NCT00947115|69558874|FG000|Overall Study|Lost to Follow-up|11|||
37874142|NCT00947115|69558875|FG001|Overall Study|Lost to Follow-up|12|||
37874143|NCT00947115|69558876|FG002|Overall Study|Lost to Follow-up|8|||
37874144|NCT00952419|69558887|FG000|Overall Study|Adverse Event|2|||
37874145|NCT00952419|69558888|FG001|Overall Study|Adverse Event|0|||
37874146|NCT00952419|69558889|FG002|Overall Study|Adverse Event|0|||
37874147|NCT00952419|69558887|FG000|Overall Study|Protocol Violation|3|||
37874148|NCT00952419|69558888|FG001|Overall Study|Protocol Violation|7|||
37874149|NCT00952419|69558889|FG002|Overall Study|Protocol Violation|0|||
37874150|NCT00952419|69558887|FG000|Overall Study|Withdrawal by Subject|1|||
37874151|NCT00952419|69558888|FG001|Overall Study|Withdrawal by Subject|3|||
37874152|NCT00952419|69558889|FG002|Overall Study|Withdrawal by Subject|0|||
37874153|NCT00902278|69558902|FG000|Overall Study|Physician Decision|1|||
37695055|NCT01850602|69171564|FG001|Overall Study|Adverse Event|10|||
37695056|NCT01850602|69171563|FG000|Overall Study|Physician Decision|2|||
37695057|NCT01850602|69171564|FG001|Overall Study|Physician Decision|1|||
37695058|NCT01850602|69171563|FG000|Overall Study|Withdrawal by Subject|2|||
37874154|NCT00902278|69558903|FG001|Overall Study|Physician Decision|0|||
37874155|NCT00902278|69558904|FG002|Overall Study|Physician Decision|2|||
37874156|NCT00902278|69558905|FG003|Overall Study|Physician Decision|0|||
37874157|NCT00902278|69558906|FG004|Overall Study|Physician Decision|1|||
37874158|NCT00902278|69558902|FG000|Overall Study|Lost to Follow-up|3|||
37874159|NCT00902278|69558903|FG001|Overall Study|Lost to Follow-up|2|||
37874160|NCT00902278|69558904|FG002|Overall Study|Lost to Follow-up|3|||
37874161|NCT00902278|69558905|FG003|Overall Study|Lost to Follow-up|0|||
37874162|NCT00902278|69558906|FG004|Overall Study|Lost to Follow-up|1|||
37874163|NCT01998633|69558920|FG000|Overall Study|Death|1|||
37874164|NCT00952341|69558930|FG000|Cycle 1|Adverse Event|4|||
37874165|NCT00952341|69558931|FG001|Cycle 1|Adverse Event|1|||
37874166|NCT00952341|69558930|FG000|Cycle 1|Withdrawal by Subject|3|||
37874167|NCT00952341|69558931|FG001|Cycle 1|Withdrawal by Subject|8|||
37874168|NCT00952341|69558930|FG000|Cycle 1|Protocol Violation|2|||
37874169|NCT00952341|69558931|FG001|Cycle 1|Protocol Violation|1|||
37874170|NCT00952341|69558930|FG000|Cycle 1|Lost to Follow-up|11|||
37981621|NCT00320541|69668226|FG000|Overall Study|Protocol Violation|0|||
37695059|NCT01850602|69171564|FG001|Overall Study|Withdrawal by Subject|4|||
37695060|NCT01850602|69171563|FG000|Overall Study|Decrease in serum calcium|2|||
37874171|NCT00952341|69558931|FG001|Cycle 1|Lost to Follow-up|2|||
37874172|NCT00952341|69558930|FG000|Cycle 1|Physician Decision|0|||
37874173|NCT00952341|69558931|FG001|Cycle 1|Physician Decision|1|||
37874174|NCT00952341|69558930|FG000|Cycle 2|Withdrawal by Subject|1|||
37874175|NCT00952341|69558931|FG001|Cycle 2|Withdrawal by Subject|1|||
37874176|NCT00952341|69558930|FG000|Cycle 2|Protocol Violation|1|||
37874177|NCT00952341|69558931|FG001|Cycle 2|Protocol Violation|0|||
37874178|NCT00952341|69558930|FG000|Cycle 2|Lost to Follow-up|6|||
37874179|NCT00952341|69558931|FG001|Cycle 2|Lost to Follow-up|9|||
37874180|NCT00952341|69558930|FG000|Cycle 2|Physician Decision|1|||
37981622|NCT00320541|69668227|FG001|Overall Study|Protocol Violation|1|||
37874181|NCT00952341|69558931|FG001|Cycle 2|Physician Decision|1|||
37874182|NCT00952341|69558930|FG000|Cycle 2|Progressive Disease|0|||
37874183|NCT00952341|69558931|FG001|Cycle 2|Progressive Disease|1|||
37874184|NCT00946881|69558937|FG000|First Treatment|Withdrawal by Subject|1|||
37874185|NCT00946881|69558937|FG000|First Treatment|Patient relocated to another state|1|||
37874186|NCT00946881|69558937|FG000|Retreatment|Withdrawal by Subject|1|||
37874187|NCT01214642|69558974|FG000|Overall Study|Progressive Disease|3|||
37874188|NCT01214642|69558975|FG001|Overall Study|Progressive Disease|2|||
37874189|NCT01214642|69558976|FG002|Overall Study|Progressive Disease|3|||
37874190|NCT01214642|69558977|FG003|Overall Study|Progressive Disease|5|||
37874191|NCT01214642|69558978|FG004|Overall Study|Progressive Disease|5|||
37874192|NCT01214642|69558979|FG005|Overall Study|Progressive Disease|3|||
37874193|NCT01214642|69558980|FG006|Overall Study|Progressive Disease|5|||
37874194|NCT01214642|69558981|FG007|Overall Study|Progressive Disease|3|||
37874195|NCT01214642|69558982|FG008|Overall Study|Progressive Disease|10|||
37874196|NCT01214642|69558983|FG009|Overall Study|Progressive Disease|2|||
37874197|NCT01214642|69558984|FG010|Overall Study|Progressive Disease|1|||
37874198|NCT01214642|69558985|FG011|Overall Study|Progressive Disease|4|||
37874199|NCT01214642|69558974|FG000|Overall Study|Adverse Event|0|||
37874200|NCT01214642|69558975|FG001|Overall Study|Adverse Event|1|||
37874201|NCT01214642|69558976|FG002|Overall Study|Adverse Event|0|||
37874202|NCT01214642|69558977|FG003|Overall Study|Adverse Event|0|||
37874203|NCT01214642|69558978|FG004|Overall Study|Adverse Event|0|||
37874204|NCT01214642|69558979|FG005|Overall Study|Adverse Event|0|||
37817233|NCT03781778|69496037|FG000|Overall Study|Withdrawal by Subject|2|||
37817234|NCT03781778|69496038|FG001|Overall Study|Withdrawal by Subject|2|||
37817235|NCT03710590|69496046|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
37817236|NCT03710590|69496047|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
37817237|NCT03465722|69496099|FG000|Overall Study|Withdrawal by Subject|21|||
37817238|NCT03465722|69496100|FG001|Overall Study|Withdrawal by Subject|14|||
37817239|NCT03465722|69496099|FG000|Overall Study|Death|89|||
37817240|NCT03465722|69496100|FG001|Overall Study|Death|87|||
37817241|NCT03465722|69496099|FG000|Overall Study|Lost to Follow-up|5|||
37817242|NCT03465722|69496100|FG001|Overall Study|Lost to Follow-up|3|||
37874205|NCT01214642|69558980|FG006|Overall Study|Adverse Event|1|||
37874206|NCT01214642|69558981|FG007|Overall Study|Adverse Event|0|||
37874207|NCT01214642|69558982|FG008|Overall Study|Adverse Event|0|||
37874208|NCT01214642|69558983|FG009|Overall Study|Adverse Event|1|||
37874209|NCT01214642|69558984|FG010|Overall Study|Adverse Event|1|||
37874210|NCT01214642|69558985|FG011|Overall Study|Adverse Event|0|||
37874211|NCT01214642|69558974|FG000|Overall Study|Death|0|||
37981623|NCT00320541|69668226|FG000|Overall Study|Withdrawal by Subject|12|||
37981624|NCT00320541|69668227|FG001|Overall Study|Withdrawal by Subject|16|||
37981625|NCT00320541|69668226|FG000|Overall Study|Physician Decision|9|||
37981626|NCT00320541|69668227|FG001|Overall Study|Physician Decision|13|||
37981627|NCT00320541|69668226|FG000|Overall Study|Other|3|||
37981628|NCT00320541|69668227|FG001|Overall Study|Other|4|||
37981629|NCT00320541|69668226|FG000|Overall Study|Sponsor Decision|2|||
37817243|NCT03465722|69496099|FG000|Overall Study|Administrative/Other|33|||
37817244|NCT03465722|69496100|FG001|Overall Study|Administrative/Other|32|||
37817245|NCT03465722|69496099|FG000|Overall Study|Not treated|1|||
37817246|NCT03465722|69496100|FG001|Overall Study|Not treated|2|||
37817247|NCT03465722|69496099|FG000|Overall Study|Sponsor decision|91|||
37817248|NCT03465722|69496100|FG001|Overall Study|Sponsor decision|98|||
37817249|NCT03205423|69496106|FG000|Overall Study|Personal|1|||
37981630|NCT00320541|69668227|FG001|Overall Study|Sponsor Decision|1|||
37981631|NCT00320541|69668226|FG000|Overall Study|Death due to Study Disease|1|||
37981632|NCT00320541|69668227|FG001|Overall Study|Death due to Study Disease|3|||
37981633|NCT00320541|69668226|FG000|Overall Study|Death due to Adverse Event(s)|1|||
37981634|NCT00320541|69668227|FG001|Overall Study|Death due to Adverse Event(s)|0|||
37981635|NCT00320541|69668226|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
37981636|NCT00320541|69668227|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
37981637|NCT00320385|69668235|FG000|Overall Study|Lost to Follow-up|7|||
37981638|NCT00320385|69668236|FG001|Overall Study|Lost to Follow-up|10|||
37981639|NCT00320385|69668235|FG000|Overall Study|Withdrawal by Subject|6|||
37817250|NCT03205423|69496107|FG001|Overall Study|Personal|1|||
37817251|NCT03205423|69496106|FG000|Overall Study|Physician Decision|0|||
37874212|NCT01214642|69558975|FG001|Overall Study|Death|0|||
37817252|NCT03205423|69496107|FG001|Overall Study|Physician Decision|2|||
37817253|NCT03073603|69496116|FG000|Overall Study|Noncompliance|3|||
37981640|NCT00320385|69668236|FG001|Overall Study|Withdrawal by Subject|7|||
37817254|NCT03073603|69496117|FG001|Overall Study|Noncompliance|1|||
37817255|NCT03073603|69496116|FG000|Overall Study|Adverse Event|5|||
37817256|NCT03073603|69496117|FG001|Overall Study|Adverse Event|3|||
37817257|NCT03073603|69496116|FG000|Overall Study|Physician Decision|1|||
37874213|NCT01214642|69558976|FG002|Overall Study|Death|1|||
37874214|NCT01214642|69558977|FG003|Overall Study|Death|0|||
37874215|NCT01214642|69558978|FG004|Overall Study|Death|0|||
37874216|NCT01214642|69558979|FG005|Overall Study|Death|0|||
37874217|NCT01214642|69558980|FG006|Overall Study|Death|0|||
37874218|NCT01214642|69558981|FG007|Overall Study|Death|0|||
37981641|NCT00320385|69668235|FG000|Overall Study|Sponsor Terminated Study|2|||
37981642|NCT00320385|69668236|FG001|Overall Study|Sponsor Terminated Study|1|||
37981643|NCT00320385|69668235|FG000|Overall Study|Investigator Decision|0|||
37981644|NCT00320385|69668236|FG001|Overall Study|Investigator Decision|1|||
37981645|NCT00320385|69668235|FG000|Overall Study|Death|1|||
37981646|NCT00320385|69668236|FG001|Overall Study|Death|2|||
37981647|NCT00320385|69668235|FG000|Overall Study|Serious Adverse Event|1|||
37817258|NCT03073603|69496117|FG001|Overall Study|Physician Decision|2|||
37817259|NCT03073603|69496116|FG000|Overall Study|Required treatment not allowed by protocol|1|||
37695061|NCT01850602|69171564|FG001|Overall Study|Decrease in serum calcium|3|||
37695062|NCT01850602|69171563|FG000|Overall Study|Increase in serum ferritin|1|||
37695063|NCT01850602|69171564|FG001|Overall Study|Increase in serum ferritin|0|||
37981648|NCT00320385|69668236|FG001|Overall Study|Serious Adverse Event|0|||
37981649|NCT00320385|69668235|FG000|Overall Study|Withdrew Consent|1|||
37695064|NCT01832818|69171570|FG000|Overall Study|Lost to Follow-up|6|||
37695065|NCT02405780|69171578|FG000|Period I|Adverse Event|8|||
37695066|NCT02405780|69171579|FG001|Period I|Adverse Event|0|||
37695067|NCT02405780|69171580|FG002|Period I|Adverse Event|3|||
37695068|NCT02405780|69171581|FG003|Period I|Adverse Event|7|||
37695069|NCT02405780|69171578|FG000|Period I|Medical reasons|1|||
37817260|NCT03073603|69496117|FG001|Overall Study|Required treatment not allowed by protocol|0|||
37817261|NCT03073603|69496116|FG000|Overall Study|Financial or insurance-related|8|||
37817262|NCT03073603|69496117|FG001|Overall Study|Financial or insurance-related|0|||
37817263|NCT03073603|69496116|FG000|Overall Study|Withdrawal by Subject|0|||
37817264|NCT03073603|69496117|FG001|Overall Study|Withdrawal by Subject|1|||
37817265|NCT03073603|69496116|FG000|Overall Study|Discontinued DMT|4|||
37817266|NCT03073603|69496117|FG001|Overall Study|Discontinued DMT|0|||
37817267|NCT03073603|69496116|FG000|Overall Study|Restarted DMT|0|||
37817268|NCT03073603|69496117|FG001|Overall Study|Restarted DMT|1|||
37817269|NCT03002155|69496129|FG000|Overall Study|Lost to Follow-up|1|||
37817270|NCT03002155|69496130|FG001|Overall Study|Lost to Follow-up|2|||
37817271|NCT03002155|69496129|FG000|Overall Study|Withdrawal by Subject|1|||
37817272|NCT03002155|69496130|FG001|Overall Study|Withdrawal by Subject|0|||
37817273|NCT03002155|69496129|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
37817274|NCT03002155|69496130|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
37817275|NCT02918006|69496140|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
37817276|NCT02918006|69496141|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
37817277|NCT02918006|69496142|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
37817278|NCT02918006|69496140|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
37817279|NCT02918006|69496141|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
37817280|NCT02918006|69496142|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
37817281|NCT02918006|69496140|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
37817282|NCT02918006|69496141|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
37817283|NCT02918006|69496142|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
37817284|NCT02918006|69496140|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
37817285|NCT02918006|69496141|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
37817286|NCT02918006|69496142|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
37817287|NCT02918006|69496140|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
37817288|NCT02918006|69496141|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
37817289|NCT02918006|69496142|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
37817290|NCT02918006|69496140|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
37817291|NCT02918006|69496141|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
37817292|NCT02918006|69496142|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
37817293|NCT02918006|69496140|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
37817294|NCT02918006|69496141|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
37817295|NCT02918006|69496142|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
37817296|NCT02918006|69496140|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
37817297|NCT02918006|69496141|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
37817298|NCT02918006|69496142|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
37817299|NCT02918006|69496140|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
37817300|NCT02918006|69496141|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
37817301|NCT02918006|69496142|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
37817302|NCT02179749|69496191|FG000|Overall Study|Adverse Event|0|||
37817303|NCT02179749|69496192|FG001|Overall Study|Adverse Event|0|||
37817304|NCT02179749|69496193|FG002|Overall Study|Adverse Event|1|||
37817305|NCT02179749|69496191|FG000|Overall Study|Withdrawal by Subject|0|||
37817306|NCT02179749|69496192|FG001|Overall Study|Withdrawal by Subject|0|||
37981650|NCT00320385|69668236|FG001|Overall Study|Withdrew Consent|0|||
37695070|NCT02405780|69171579|FG001|Period I|Medical reasons|1|||
37695071|NCT02405780|69171580|FG002|Period I|Medical reasons|0|||
37874219|NCT01214642|69558982|FG008|Overall Study|Death|0|||
37695072|NCT02405780|69171581|FG003|Period I|Medical reasons|1|||
37874220|NCT01214642|69558983|FG009|Overall Study|Death|0|||
37874221|NCT01214642|69558984|FG010|Overall Study|Death|1|||
37874222|NCT01214642|69558985|FG011|Overall Study|Death|0|||
37874223|NCT01214642|69558974|FG000|Overall Study|Withdrawal by Subject|0|||
37874224|NCT01214642|69558975|FG001|Overall Study|Withdrawal by Subject|0|||
37874225|NCT01214642|69558976|FG002|Overall Study|Withdrawal by Subject|1|||
37874226|NCT01214642|69558977|FG003|Overall Study|Withdrawal by Subject|0|||
37874227|NCT01214642|69558978|FG004|Overall Study|Withdrawal by Subject|0|||
37874228|NCT01214642|69558979|FG005|Overall Study|Withdrawal by Subject|0|||
37874229|NCT01214642|69558980|FG006|Overall Study|Withdrawal by Subject|0|||
37874230|NCT01214642|69558981|FG007|Overall Study|Withdrawal by Subject|0|||
37874231|NCT01214642|69558982|FG008|Overall Study|Withdrawal by Subject|3|||
37874232|NCT01214642|69558983|FG009|Overall Study|Withdrawal by Subject|1|||
37874233|NCT01214642|69558984|FG010|Overall Study|Withdrawal by Subject|1|||
37874234|NCT01214642|69558985|FG011|Overall Study|Withdrawal by Subject|0|||
37874235|NCT01214642|69558974|FG000|Overall Study|Physician Decision|0|||
37874236|NCT01214642|69558975|FG001|Overall Study|Physician Decision|0|||
37874237|NCT01214642|69558976|FG002|Overall Study|Physician Decision|1|||
37874238|NCT01214642|69558977|FG003|Overall Study|Physician Decision|1|||
37874239|NCT01214642|69558978|FG004|Overall Study|Physician Decision|1|||
37874240|NCT01214642|69558979|FG005|Overall Study|Physician Decision|0|||
37874241|NCT01214642|69558980|FG006|Overall Study|Physician Decision|0|||
37874242|NCT01214642|69558981|FG007|Overall Study|Physician Decision|0|||
37874243|NCT01214642|69558982|FG008|Overall Study|Physician Decision|0|||
37874244|NCT01214642|69558983|FG009|Overall Study|Physician Decision|0|||
37874245|NCT01214642|69558984|FG010|Overall Study|Physician Decision|0|||
37874246|NCT01214642|69558985|FG011|Overall Study|Physician Decision|2|||
37874247|NCT01214252|69559028|FG000|Overall Study|Not eligible per protocol|82|||
37874248|NCT01214174|69559036|FG000|Overall Study|Withdrawal by Subject|0|||
37874249|NCT01214174|69559037|FG001|Overall Study|Withdrawal by Subject|0|||
37874250|NCT01214174|69559038|FG002|Overall Study|Withdrawal by Subject|1|||
37874251|NCT00901342|69559046|FG000|Overall Study|Adverse Event|1|||
37874252|NCT00901342|69559046|FG000|Overall Study|Death|4|||
37874253|NCT00901342|69559046|FG000|Overall Study|Disease progression|1|||
37874254|NCT00901342|69559046|FG000|Overall Study|Withdrawal by Subject|9|||
37874255|NCT00901186|69559052|FG000|Overall Study|Lack of Efficacy|0|||
37874256|NCT00901186|69559053|FG001|Overall Study|Lack of Efficacy|1|||
37874257|NCT00901186|69559052|FG000|Overall Study|Abnormal laboratory values|0|||
37874258|NCT00901186|69559053|FG001|Overall Study|Abnormal laboratory values|1|||
37874259|NCT00901186|69559052|FG000|Overall Study|Lost to Follow-up|2|||
37874260|NCT00901186|69559053|FG001|Overall Study|Lost to Follow-up|0|||
37874261|NCT00901186|69559052|FG000|Overall Study|Adverse Event|2|||
37874262|NCT00901186|69559053|FG001|Overall Study|Adverse Event|4|||
37874263|NCT00901186|69559052|FG000|Overall Study|Administration problems|0|||
37874264|NCT00901186|69559053|FG001|Overall Study|Administration problems|1|||
37874265|NCT00901186|69559052|FG000|Overall Study|Protocol deviations|5|||
37874266|NCT00901186|69559053|FG001|Overall Study|Protocol deviations|4|||
37874267|NCT01213472|69559059|FG000|Overall Study|Recurrence/Progressive disease|25|||
37874268|NCT01213472|69559059|FG000|Overall Study|Withdrawal by Subject|1|||
37874269|NCT01213472|69559059|FG000|Overall Study|Physician Decision|1|||
37874270|NCT00900796|69559063|FG000|Phase 1|Lacked sufficient information|4|||
37981651|NCT00320385|69668235|FG000|Overall Study|Adverse Event|0|||
37817307|NCT02179749|69496193|FG002|Overall Study|Withdrawal by Subject|1|||
37817308|NCT02075593|69496204|FG000|Overall Study|Withdrawal by Subject|1|||
37817309|NCT00641186|69496237|FG000|Overall Study|Adverse Event|3|||
37817310|NCT01595009|69496243|FG000|Core|Patients completed per protocol|85|||
37817311|NCT01595009|69496244|FG001|Core|Patients completed per protocol|44|||
37817312|NCT01595009|69496245|FG002|Core|Patients completed per protocol|0|||
37817313|NCT01595009|69496246|FG003|Core|Patients completed per protocol|0|||
37817314|NCT01595009|69496243|FG000|Core|Adverse Event|19|||
37695073|NCT02405780|69171578|FG000|Period I|Screening Failure|1|||
37695074|NCT02405780|69171579|FG001|Period I|Screening Failure|0|||
37695075|NCT02405780|69171580|FG002|Period I|Screening Failure|1|||
37817315|NCT01595009|69496244|FG001|Core|Adverse Event|23|||
37874271|NCT00900796|69559063|FG000|Phase 1|Missing information at Week 16|7|||
37874272|NCT00900796|69559063|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
37874273|NCT00900796|69559063|FG000|Phase 2|Lost to Follow-up|5|||
37874274|NCT01213082|69559071|FG000|Overall Study|Lost to Follow-up|6|||
37874275|NCT01213082|69559072|FG001|Overall Study|Lost to Follow-up|7|||
37874276|NCT01213082|69559073|FG002|Overall Study|Lost to Follow-up|4|||
37874277|NCT01213082|69559071|FG000|Overall Study|Physician Decision|0|||
37874278|NCT01213082|69559072|FG001|Overall Study|Physician Decision|0|||
37874279|NCT01213082|69559073|FG002|Overall Study|Physician Decision|1|||
37981652|NCT00320385|69668236|FG001|Overall Study|Adverse Event|1|||
37874280|NCT00885703|69559088|FG000|Overall Study|Death|9|||
37874281|NCT00885703|69559089|FG001|Overall Study|Death|7|||
37695076|NCT02405780|69171581|FG003|Period I|Screening Failure|0|||
37817316|NCT01595009|69496245|FG002|Core|Adverse Event|0|||
37874282|NCT00885703|69559090|FG002|Overall Study|Death|8|||
37874283|NCT00885703|69559091|FG003|Overall Study|Death|7|||
37874284|NCT00885703|69559092|FG004|Overall Study|Death|7|||
37874285|NCT00885703|69559093|FG005|Overall Study|Death|8|||
37874286|NCT00885703|69559094|FG006|Overall Study|Death|4|||
37874287|NCT00885703|69559088|FG000|Overall Study|Lost to Follow-up|0|||
37874288|NCT00885703|69559089|FG001|Overall Study|Lost to Follow-up|0|||
37874289|NCT00885703|69559090|FG002|Overall Study|Lost to Follow-up|1|||
37874290|NCT00885703|69559091|FG003|Overall Study|Lost to Follow-up|0|||
37874291|NCT00885703|69559092|FG004|Overall Study|Lost to Follow-up|0|||
37874292|NCT00885703|69559093|FG005|Overall Study|Lost to Follow-up|1|||
37874293|NCT00885703|69559094|FG006|Overall Study|Lost to Follow-up|0|||
37874294|NCT00885703|69559088|FG000|Overall Study|Withdrawal by Subject|0|||
37874295|NCT00885703|69559089|FG001|Overall Study|Withdrawal by Subject|0|||
37874296|NCT00885703|69559090|FG002|Overall Study|Withdrawal by Subject|0|||
37874297|NCT00885703|69559091|FG003|Overall Study|Withdrawal by Subject|1|||
37874298|NCT00885703|69559092|FG004|Overall Study|Withdrawal by Subject|3|||
37874299|NCT00885703|69559093|FG005|Overall Study|Withdrawal by Subject|1|||
37874300|NCT00885703|69559094|FG006|Overall Study|Withdrawal by Subject|1|||
37874301|NCT00885703|69559088|FG000|Overall Study|Ineligible (no CM)|1|||
37874302|NCT00885703|69559089|FG001|Overall Study|Ineligible (no CM)|3|||
37874303|NCT00885703|69559090|FG002|Overall Study|Ineligible (no CM)|2|||
37874304|NCT00885703|69559091|FG003|Overall Study|Ineligible (no CM)|1|||
37874305|NCT00885703|69559092|FG004|Overall Study|Ineligible (no CM)|2|||
37874306|NCT00885703|69559093|FG005|Overall Study|Ineligible (no CM)|3|||
37874307|NCT00885703|69559094|FG006|Overall Study|Ineligible (no CM)|1|||
37874308|NCT00901576|69559120|FG000|Second Intervention|Withdrawal by Subject|0|||
37874309|NCT00901576|69559121|FG001|Second Intervention|Withdrawal by Subject|0|||
37874310|NCT00901576|69559122|FG002|Second Intervention|Withdrawal by Subject|0|||
37874311|NCT00901576|69559123|FG003|Second Intervention|Withdrawal by Subject|1|||
37874312|NCT00901576|69559124|FG004|Second Intervention|Withdrawal by Subject|0|||
37874313|NCT00901576|69559125|FG005|Second Intervention|Withdrawal by Subject|1|||
37874314|NCT00901576|69559120|FG000|Second Intervention|Physician Decision|1|||
37874315|NCT00901576|69559121|FG001|Second Intervention|Physician Decision|0|||
37874316|NCT00901576|69559122|FG002|Second Intervention|Physician Decision|0|||
37874317|NCT00901576|69559123|FG003|Second Intervention|Physician Decision|0|||
37874318|NCT00901576|69559124|FG004|Second Intervention|Physician Decision|0|||
37874319|NCT00901576|69559125|FG005|Second Intervention|Physician Decision|0|||
37874320|NCT00882583|69559135|FG000|Overall Study|Physician Decision|1|||
37874321|NCT00882583|69559136|FG001|Overall Study|Physician Decision|0|||
37874322|NCT00882583|69559135|FG000|Overall Study|Adverse Event|0|||
37874323|NCT00882583|69559136|FG001|Overall Study|Adverse Event|1|||
37874324|NCT00900562|69559144|FG000|Overall Study|Progressive disease|9|||
37874325|NCT00900562|69559145|FG001|Overall Study|Progressive disease|5|||
37874326|NCT00900562|69559144|FG000|Overall Study|Toxicity|1|||
37874327|NCT00900562|69559145|FG001|Overall Study|Toxicity|0|||
37874328|NCT00900562|69559144|FG000|Overall Study|Death|1|||
37874329|NCT00900562|69559145|FG001|Overall Study|Death|1|||
37874330|NCT00900562|69559144|FG000|Overall Study|Withdrawal by Subject|0|||
37874331|NCT00900562|69559145|FG001|Overall Study|Withdrawal by Subject|1|||
37874332|NCT00900562|69559144|FG000|Overall Study|Unrelated adverse event|1|||
37874333|NCT00900562|69559145|FG001|Overall Study|Unrelated adverse event|0|||
37874334|NCT00599521|69559154|FG000|Overall Study|Lack of Efficacy|4|||
37874335|NCT00599521|69559155|FG001|Overall Study|Lack of Efficacy|8|||
37874336|NCT00599521|69559154|FG000|Overall Study|Adverse Event|4|||
37874337|NCT00599521|69559155|FG001|Overall Study|Adverse Event|1|||
37874338|NCT00599521|69559154|FG000|Overall Study|Withdrawal by Subject|28|||
37874339|NCT00599521|69559155|FG001|Overall Study|Withdrawal by Subject|34|||
37874340|NCT00599521|69559154|FG000|Overall Study|Protocol Violation|1|||
37874341|NCT00599521|69559155|FG001|Overall Study|Protocol Violation|1|||
37874342|NCT00599521|69559154|FG000|Overall Study|Lost to Follow-up|23|||
37874343|NCT00599521|69559155|FG001|Overall Study|Lost to Follow-up|23|||
37874344|NCT00599521|69559154|FG000|Overall Study|Pregnancy|0|||
37874345|NCT00599521|69559155|FG001|Overall Study|Pregnancy|2|||
37874346|NCT00882115|69559161|FG000|Overall Study|Withdrawal by Subject|3|||
37874347|NCT00882115|69559161|FG000|Overall Study|did not respond to DEP challe|6|||
37874348|NCT00881959|69559167|FG000|Overall Study|Lost to Follow-up|2|||
37874349|NCT00881959|69559168|FG001|Overall Study|Lost to Follow-up|4|||
37874350|NCT00884377|69559176|FG000|Overall Study|Withdrawal by Subject|1|||
37874351|NCT00884377|69559177|FG001|Overall Study|Withdrawal by Subject|0|||
37874352|NCT00884377|69559176|FG000|Overall Study|Could not confirm diagnosis|1|||
37874353|NCT00884377|69559177|FG001|Overall Study|Could not confirm diagnosis|0|||
37874354|NCT00884377|69559176|FG000|Overall Study|Physician Decision|0|||
37874355|NCT00884377|69559177|FG001|Overall Study|Physician Decision|1|||
37874356|NCT00884221|69559191|FG000|Overall Study|Withdrawal by Subject|0|||
37874357|NCT00884221|69559192|FG001|Overall Study|Withdrawal by Subject|3|||
37874358|NCT00884221|69559191|FG000|Overall Study|Adverse Event|6|||
37874359|NCT00884221|69559192|FG001|Overall Study|Adverse Event|3|||
37874360|NCT00884221|69559191|FG000|Overall Study|Protocol Violation|16|||
37874361|NCT00884221|69559192|FG001|Overall Study|Protocol Violation|13|||
37874362|NCT00884221|69559191|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
37874363|NCT00884221|69559192|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
37874364|NCT00899548|69559213|FG000|Overall Study|Physician Decision|3|||
37874365|NCT00899392|69559223|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
37874366|NCT00899392|69559224|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
37874367|NCT00690898|69559230|FG000|SCREENING|Screen failure|18|||
37874368|NCT00690898|69559230|FG000|TREATMENT|Adverse Event|3|||
37874369|NCT00690898|69559230|FG000|TREATMENT|Lack of Efficacy|18|||
37874370|NCT00690898|69559230|FG000|TREATMENT|Withdrawal by Subject|4|||
37874371|NCT00690898|69559230|FG000|TREATMENT|Other (not otherwise specified)|1|||
37874372|NCT00895414|69559234|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
37874373|NCT00895414|69559235|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
37981653|NCT00326001|69668244|FG000|Overall Study|Adverse Event|4|||
37981654|NCT00326001|69668245|FG001|Overall Study|Adverse Event|5|||
37981655|NCT00326001|69668244|FG000|Overall Study|Physician Decision|3|||
37981656|NCT00326001|69668245|FG001|Overall Study|Physician Decision|3|||
37981657|NCT00309777|69668255|FG000|Overall Study|Adverse Event|13|||
37981658|NCT00309777|69668256|FG001|Overall Study|Adverse Event|2|||
37981659|NCT00309777|69668257|FG002|Overall Study|Adverse Event|8|||
37981660|NCT00309777|69668258|FG003|Overall Study|Adverse Event|1|||
37874374|NCT00895414|69559234|FG000|First Intervention (14 Days)|Physician Decision|0|||
37874375|NCT00895414|69559235|FG001|First Intervention (14 Days)|Physician Decision|1|||
37874376|NCT01212770|69559244|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
37874377|NCT01212770|69559245|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
37874378|NCT01212770|69559246|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
37874379|NCT01212770|69559247|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
37874380|NCT01212770|69559248|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
37874381|NCT01212770|69559249|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
37874382|NCT01212770|69559250|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
37981661|NCT00309777|69668255|FG000|Overall Study|Protocol Violation|4|||
37981662|NCT00309777|69668256|FG001|Overall Study|Protocol Violation|1|||
37981663|NCT00309777|69668257|FG002|Overall Study|Protocol Violation|3|||
37981664|NCT00309777|69668258|FG003|Overall Study|Protocol Violation|1|||
37981665|NCT00309777|69668255|FG000|Overall Study|Withdrawal by Subject|6|||
37981666|NCT00309777|69668256|FG001|Overall Study|Withdrawal by Subject|5|||
37981667|NCT00309777|69668257|FG002|Overall Study|Withdrawal by Subject|7|||
37981668|NCT00309777|69668258|FG003|Overall Study|Withdrawal by Subject|2|||
37981669|NCT00309777|69668255|FG000|Overall Study|Lost to Follow-up|0|||
37981670|NCT00309777|69668256|FG001|Overall Study|Lost to Follow-up|0|||
37981671|NCT00309777|69668257|FG002|Overall Study|Lost to Follow-up|1|||
37695077|NCT02405780|69171578|FG000|Period I|Withdrawal by Subject|9|||
37695078|NCT02405780|69171579|FG001|Period I|Withdrawal by Subject|1|||
37695079|NCT02405780|69171580|FG002|Period I|Withdrawal by Subject|3|||
37695080|NCT02405780|69171581|FG003|Period I|Withdrawal by Subject|4|||
37695081|NCT02405780|69171578|FG000|Period I|Non-compliance with study procedures|8|||
37817317|NCT01595009|69496246|FG003|Core|Adverse Event|0|||
37817318|NCT01595009|69496243|FG000|Core|Disease progression|14|||
37817319|NCT01595009|69496244|FG001|Core|Disease progression|26|||
37817320|NCT01595009|69496245|FG002|Core|Disease progression|0|||
37817321|NCT01595009|69496246|FG003|Core|Disease progression|0|||
37817322|NCT01595009|69496243|FG000|Core|Withdrawal by Subject|4|||
37817323|NCT01595009|69496244|FG001|Core|Withdrawal by Subject|17|||
37817324|NCT01595009|69496245|FG002|Core|Withdrawal by Subject|0|||
37817325|NCT01595009|69496246|FG003|Core|Withdrawal by Subject|0|||
37817326|NCT01595009|69496243|FG000|Core|Death|3|||
37817327|NCT01595009|69496244|FG001|Core|Death|6|||
37817328|NCT01595009|69496245|FG002|Core|Death|0|||
37817329|NCT01595009|69496246|FG003|Core|Death|0|||
37817330|NCT01595009|69496243|FG000|Core|Lost to Follow-up|1|||
37817331|NCT01595009|69496244|FG001|Core|Lost to Follow-up|2|||
37817332|NCT01595009|69496245|FG002|Core|Lost to Follow-up|0|||
37817333|NCT01595009|69496246|FG003|Core|Lost to Follow-up|0|||
37817334|NCT01595009|69496243|FG000|Core|Protocol deviation|0|||
37817335|NCT01595009|69496244|FG001|Core|Protocol deviation|1|||
37817336|NCT01595009|69496245|FG002|Core|Protocol deviation|0|||
37817337|NCT01595009|69496246|FG003|Core|Protocol deviation|0|||
37817338|NCT01595009|69496243|FG000|Core|Administrative problems|0|||
37817339|NCT01595009|69496244|FG001|Core|Administrative problems|1|||
37817340|NCT01595009|69496245|FG002|Core|Administrative problems|0|||
37817341|NCT01595009|69496246|FG003|Core|Administrative problems|0|||
37817342|NCT01595009|69496243|FG000|Extension|Administrative problems|0|||
37817343|NCT01595009|69496244|FG001|Extension|Administrative problems|0|||
37817344|NCT01595009|69496245|FG002|Extension|Administrative problems|0|||
37817345|NCT01595009|69496246|FG003|Extension|Administrative problems|1|||
37817346|NCT01595009|69496243|FG000|Extension|Patients completed per protocol|0|||
37817347|NCT01595009|69496244|FG001|Extension|Patients completed per protocol|0|||
37817348|NCT01595009|69496245|FG002|Extension|Patients completed per protocol|0|||
37981672|NCT00309777|69668258|FG003|Overall Study|Lost to Follow-up|0|||
37981673|NCT00309777|69668255|FG000|Overall Study|Death|0|||
37817349|NCT01595009|69496246|FG003|Extension|Patients completed per protocol|2|||
37817350|NCT01595009|69496243|FG000|Extension|Disease progression|0|||
37817351|NCT01595009|69496244|FG001|Extension|Disease progression|0|||
37817352|NCT01595009|69496245|FG002|Extension|Disease progression|4|||
37817353|NCT01595009|69496246|FG003|Extension|Disease progression|7|||
37817354|NCT01595009|69496243|FG000|Extension|Adverse Event|0|||
37817355|NCT01595009|69496244|FG001|Extension|Adverse Event|0|||
37981674|NCT00309777|69668256|FG001|Overall Study|Death|1|||
37874383|NCT01212770|69559251|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
37874384|NCT01212770|69559252|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
37874385|NCT01212770|69559244|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
37874386|NCT01212770|69559245|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
37874387|NCT01212770|69559246|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
37874388|NCT01212770|69559247|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
37874389|NCT01212770|69559248|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
37874390|NCT01212770|69559249|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
37874391|NCT01212770|69559250|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
37874392|NCT01212770|69559251|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
37874393|NCT01212770|69559252|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
37874394|NCT01212770|69559244|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
37874395|NCT01212770|69559245|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
37874396|NCT01212770|69559246|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
37874397|NCT01212770|69559247|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
37874398|NCT01212770|69559248|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
37874399|NCT01212770|69559249|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
37874400|NCT01212770|69559250|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
37874401|NCT01212770|69559251|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
37874402|NCT01212770|69559252|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
37874403|NCT01212770|69559244|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
37874404|NCT01212770|69559245|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
37874405|NCT01212770|69559246|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
37874406|NCT01212770|69559247|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
37874407|NCT01212770|69559248|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
37874408|NCT01212770|69559249|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
37874409|NCT01212770|69559250|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
37874410|NCT01212770|69559251|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
37874411|NCT01212770|69559252|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
37874412|NCT01212770|69559244|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
37874413|NCT01212770|69559245|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
37874414|NCT01212770|69559246|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
37874415|NCT01212770|69559247|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
37874416|NCT01212770|69559248|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
37874417|NCT01212770|69559249|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
37874418|NCT01212770|69559250|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
37874419|NCT01212770|69559251|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
37874420|NCT01212770|69559252|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
37874421|NCT01212770|69559244|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
37874422|NCT01212770|69559245|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
37874423|NCT01212770|69559246|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
37874424|NCT01212770|69559247|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
37874425|NCT01212770|69559248|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
37874426|NCT01212770|69559249|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
37874427|NCT01212770|69559250|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
37874428|NCT01212770|69559251|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
37874429|NCT01212770|69559252|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
37874430|NCT01212770|69559244|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
37981675|NCT00309777|69668257|FG002|Overall Study|Death|0|||
37981676|NCT00309777|69668258|FG003|Overall Study|Death|0|||
37981677|NCT00309387|69668270|FG000|Overall Study|Death|72|||
37981678|NCT00309387|69668271|FG001|Overall Study|Death|73|||
37981679|NCT00309387|69668270|FG000|Overall Study|Lost to Follow-up|70|||
37981680|NCT00309387|69668271|FG001|Overall Study|Lost to Follow-up|86|||
37981681|NCT00325143|69668278|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
37981682|NCT00325143|69668278|FG000|Overall Study|Migrated/moved from study area|1|||
37981683|NCT00325143|69668278|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
37981684|NCT00325143|69668278|FG000|Overall Study|Withdrawal by Subject|8|||
37981685|NCT00319839|69668282|FG000|Overall Study|Adverse Event|5|||
37981686|NCT00319839|69668282|FG000|Overall Study|Withdrawal by Subject|1|||
37981687|NCT00319449|69668288|FG000|Overall Study|Subject did not wish to continue|1|||
37981688|NCT00319449|69668289|FG001|Overall Study|Subject did not wish to continue|0|||
37981689|NCT00319449|69668288|FG000|Overall Study|Noncompliance with the protocol|1|||
37981690|NCT00319449|69668289|FG001|Overall Study|Noncompliance with the protocol|0|||
37981691|NCT00308997|69668297|FG000|Overall Study|Subject feigned clinical data|0|||
37981692|NCT00308997|69668298|FG001|Overall Study|Subject feigned clinical data|1|||
37981693|NCT00308997|69668297|FG000|Overall Study|Unable to tolerate intervention|1|||
37874431|NCT01212770|69559245|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
37874432|NCT01212770|69559246|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
37874433|NCT01212770|69559247|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
37874434|NCT01212770|69559248|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
37874435|NCT01212770|69559249|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
37874436|NCT01212770|69559250|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
37874437|NCT01212770|69559251|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
37874438|NCT01212770|69559252|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
37874439|NCT01212770|69559244|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
37874440|NCT01212770|69559245|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
37874441|NCT01212770|69559246|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
37874442|NCT01212770|69559247|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
37874443|NCT01212770|69559248|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
37874444|NCT01212770|69559249|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
37874445|NCT01212770|69559250|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
37874446|NCT01212770|69559251|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
37874447|NCT01212770|69559252|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
37874448|NCT01212770|69559244|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
37874449|NCT01212770|69559245|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
37874450|NCT01212770|69559246|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
37874451|NCT01212770|69559247|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
37874452|NCT01212770|69559248|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
37874453|NCT01212770|69559249|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
37874454|NCT01212770|69559250|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
37874455|NCT01212770|69559251|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
37874456|NCT01212770|69559252|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
37874457|NCT01212770|69559244|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
37874458|NCT01212770|69559245|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
37874459|NCT01212770|69559246|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
37874460|NCT01212770|69559247|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
37874461|NCT01212770|69559248|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
37874462|NCT01212770|69559249|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
37874463|NCT01212770|69559250|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
37874464|NCT01212770|69559251|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
37874465|NCT01212770|69559252|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
37874466|NCT01212770|69559244|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
37874467|NCT01212770|69559245|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
37874468|NCT01212770|69559246|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
37874469|NCT01212770|69559247|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
37874470|NCT01212770|69559248|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
37874471|NCT01212770|69559249|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
37874472|NCT01212770|69559250|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
37874473|NCT01212770|69559251|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
37874474|NCT01212770|69559252|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
37874475|NCT01212770|69559244|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
37874476|NCT01212770|69559245|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
37874477|NCT01212770|69559246|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
37874478|NCT01212770|69559247|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
37874479|NCT01212770|69559248|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
37874480|NCT01212770|69559249|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
37874481|NCT01212770|69559250|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
37874482|NCT01212770|69559251|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
37874483|NCT01212770|69559252|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
37874484|NCT01212770|69559244|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
37874485|NCT01212770|69559245|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
37874486|NCT01212770|69559246|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
37874487|NCT01212770|69559247|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
37874488|NCT01212770|69559248|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
37874489|NCT01212770|69559249|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
37874490|NCT01212770|69559250|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
37874491|NCT01212770|69559251|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
37874492|NCT01212770|69559252|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
37874493|NCT01212770|69559244|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
37874494|NCT01212770|69559245|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
37874495|NCT01212770|69559246|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
37874496|NCT01212770|69559247|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
37874497|NCT01212770|69559248|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
37874498|NCT01212770|69559249|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
37874499|NCT01212770|69559250|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
37874500|NCT01212770|69559251|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
37874501|NCT01212770|69559252|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
37874502|NCT01212770|69559244|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
37874503|NCT01212770|69559245|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
37874504|NCT01212770|69559246|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
37874505|NCT01212770|69559247|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
37874506|NCT01212770|69559248|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
37874507|NCT01212770|69559249|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
37874508|NCT01212770|69559250|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
37874509|NCT01212770|69559251|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
37874510|NCT01212770|69559252|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
37874511|NCT01212770|69559244|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
37874512|NCT01212770|69559245|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
37874513|NCT01212770|69559246|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
37874514|NCT01212770|69559247|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
37874515|NCT01212770|69559248|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
37874516|NCT01212770|69559249|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
37874517|NCT01212770|69559250|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
37874518|NCT01212770|69559251|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
37874519|NCT01212770|69559252|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
37874520|NCT01212770|69559244|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
37874521|NCT01212770|69559245|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
37874522|NCT01212770|69559246|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
37981694|NCT00308997|69668298|FG001|Overall Study|Unable to tolerate intervention|0|||
37981695|NCT00308685|69668306|FG000|Overall Study|Lost to Follow-up|1|||
37981696|NCT00308685|69668307|FG001|Overall Study|Lost to Follow-up|0|||
37817356|NCT01595009|69496245|FG002|Extension|Adverse Event|0|||
37817357|NCT01595009|69496246|FG003|Extension|Adverse Event|1|||
37817358|NCT05553808|69496263|FG000|Overall Study|Death|25|||
37817359|NCT05553808|69496264|FG001|Overall Study|Death|62|||
37817360|NCT05553808|69496263|FG000|Overall Study|Site Closed|6|||
37817361|NCT05553808|69496264|FG001|Overall Study|Site Closed|6|||
37817362|NCT05553808|69496263|FG000|Overall Study|Lost to Follow-up|1|||
37817363|NCT05553808|69496264|FG001|Overall Study|Lost to Follow-up|0|||
37817364|NCT05553808|69496263|FG000|Overall Study|Withdrawal by Subject|3|||
37817365|NCT05553808|69496264|FG001|Overall Study|Withdrawal by Subject|2|||
37817366|NCT04997161|69496280|FG000|Overall Study|Study terminated by sponsor|3|||
37817367|NCT04753216|69496284|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
37817368|NCT04753216|69496284|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
37817369|NCT04753216|69496284|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
37817370|NCT04530747|69496317|FG000|Overall Study|Withdrawal by Subject|1|||
37817371|NCT04530747|69496318|FG001|Overall Study|Withdrawal by Subject|0|||
37817372|NCT04493242|69496329|FG000|Overall Study|Death|10|||
37817373|NCT04493242|69496330|FG001|Overall Study|Death|14|||
37817374|NCT04493242|69496331|FG002|Overall Study|Death|16|||
37817375|NCT04493242|69496329|FG000|Overall Study|Lost to Follow-up|1|||
37817376|NCT04493242|69496330|FG001|Overall Study|Lost to Follow-up|1|||
37817377|NCT04493242|69496331|FG002|Overall Study|Lost to Follow-up|0|||
37817378|NCT04493242|69496329|FG000|Overall Study|Withdrawal by Subject|1|||
37817379|NCT04493242|69496330|FG001|Overall Study|Withdrawal by Subject|0|||
37817380|NCT04493242|69496331|FG002|Overall Study|Withdrawal by Subject|0|||
37817381|NCT04493242|69496329|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
37817382|NCT04493242|69496330|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
37817383|NCT04493242|69496331|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
37817384|NCT04493242|69496329|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
37817385|NCT04493242|69496330|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
37817386|NCT04493242|69496331|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
37817387|NCT04040751|69496352|FG000|Overall Study|Withdrawal by Subject|2|||
37817388|NCT04040751|69496353|FG001|Overall Study|Withdrawal by Subject|0|||
37817389|NCT04040751|69496354|FG002|Overall Study|Withdrawal by Subject|2|||
37817390|NCT04040751|69496355|FG003|Overall Study|Withdrawal by Subject|0|||
37817391|NCT03997916|69496365|FG000|Overall Study|Protocol Violation|35|||
37874523|NCT01212770|69559247|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
37874524|NCT01212770|69559248|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
37874525|NCT01212770|69559249|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
37874526|NCT01212770|69559250|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
37874527|NCT01212770|69559251|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
37874528|NCT01212770|69559252|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
37874529|NCT01212770|69559244|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
37874530|NCT01212770|69559245|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
37874531|NCT01212770|69559246|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
37874532|NCT01212770|69559247|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
37874533|NCT01212770|69559248|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
37874534|NCT01212770|69559249|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
37874535|NCT01212770|69559250|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
37874536|NCT01212770|69559251|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
37874537|NCT01212770|69559252|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
37874538|NCT01212770|69559244|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
37874539|NCT01212770|69559245|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
37874540|NCT01212770|69559246|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
37874541|NCT01212770|69559247|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
37874542|NCT01212770|69559248|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
37874543|NCT01212770|69559249|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
37874544|NCT01212770|69559250|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
37874545|NCT01212770|69559251|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
37874546|NCT01212770|69559252|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
37874547|NCT01212770|69559244|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
37874548|NCT01212770|69559245|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
37874549|NCT01212770|69559246|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
37874550|NCT01212770|69559247|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
37874551|NCT01212770|69559248|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
37874552|NCT01212770|69559249|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
37874553|NCT01212770|69559250|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
37874554|NCT01212770|69559251|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
37874555|NCT01212770|69559252|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
37874556|NCT01212770|69559244|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
37874557|NCT01212770|69559245|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
37874558|NCT01212770|69559246|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
37874559|NCT01212770|69559247|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
37874560|NCT01212770|69559248|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
37874561|NCT01212770|69559249|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
37874562|NCT01212770|69559250|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
37874563|NCT01212770|69559251|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
37874564|NCT01212770|69559252|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
37874565|NCT01212770|69559244|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
37981697|NCT00308685|69668306|FG000|Overall Study|Need to administer prohibited medication|1|||
37981698|NCT00308685|69668307|FG001|Overall Study|Need to administer prohibited medication|2|||
37981699|NCT00308685|69668306|FG000|Overall Study|Other than specified|1|||
37981700|NCT00308685|69668307|FG001|Overall Study|Other than specified|3|||
37874566|NCT01212770|69559245|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
37874567|NCT01212770|69559246|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
37981701|NCT00317109|69668315|FG000|Overall Study|Withdrawal by Subject|2|||
37981702|NCT00317109|69668316|FG001|Overall Study|Withdrawal by Subject|0|||
37981703|NCT00317109|69668315|FG000|Overall Study|Migated/moved from study area|1|||
37981704|NCT00317109|69668316|FG001|Overall Study|Migated/moved from study area|0|||
37981705|NCT00316719|69668324|FG000|Overall Study|Adverse Event|0|||
37981706|NCT00316719|69668325|FG001|Overall Study|Adverse Event|6|||
37981707|NCT00316719|69668324|FG000|Overall Study|Consent withdrawn|2|||
37981708|NCT00316719|69668325|FG001|Overall Study|Consent withdrawn|0|||
37981709|NCT00422058|69668337|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
37981710|NCT00422058|69668338|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
37981711|NCT00422058|69668339|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
37981712|NCT00422058|69668340|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
37981713|NCT00422058|69668341|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
37981714|NCT00422058|69668342|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
37981715|NCT00422058|69668337|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
37981716|NCT00422058|69668338|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
37981717|NCT00422058|69668339|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
37981718|NCT00422058|69668340|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
37981719|NCT00422058|69668341|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
37981720|NCT00422058|69668342|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
37981721|NCT00422058|69668337|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
37981722|NCT00422058|69668338|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
37874568|NCT01212770|69559247|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
37874569|NCT01212770|69559248|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
37874570|NCT01212770|69559249|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
37874571|NCT01212770|69559250|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
37874572|NCT01212770|69559251|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
37874573|NCT01212770|69559252|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
37874574|NCT01212770|69559244|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
37874575|NCT01212770|69559245|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
37874576|NCT01212770|69559246|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
37874577|NCT01212770|69559247|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
37874578|NCT01212770|69559248|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
37874579|NCT01212770|69559249|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
37874580|NCT01212770|69559250|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
37874581|NCT01212770|69559251|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
37874582|NCT01212770|69559252|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
37874583|NCT01212770|69559244|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
37874584|NCT01212770|69559245|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
37874585|NCT01212770|69559246|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
37874586|NCT01212770|69559247|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
37874587|NCT01212770|69559248|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
37874588|NCT01212770|69559249|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
37874589|NCT01212770|69559250|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
37874590|NCT01212770|69559251|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
37874591|NCT01212770|69559252|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
37874592|NCT01212770|69559244|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
37874593|NCT01212770|69559245|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
37874594|NCT01212770|69559246|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
37874595|NCT01212770|69559247|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
37874596|NCT01212770|69559248|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
37874597|NCT01212770|69559249|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
37874598|NCT01212770|69559250|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
37874599|NCT01212770|69559251|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
37874600|NCT01212770|69559252|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
37874601|NCT01212770|69559244|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
37874602|NCT01212770|69559245|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
37874603|NCT01212770|69559246|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
37874604|NCT01212770|69559247|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
37874605|NCT01212770|69559248|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
37874606|NCT01212770|69559249|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
37874607|NCT01212770|69559250|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
37874608|NCT01212770|69559251|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
37874609|NCT01212770|69559252|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
37874610|NCT01212770|69559244|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
37874611|NCT01212770|69559245|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
37874612|NCT01212770|69559246|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
37874613|NCT01212770|69559247|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
37874614|NCT01212770|69559248|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
37981723|NCT00422058|69668339|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
37817392|NCT03596177|69496384|FG000|Single Blind Period|Withdrawal by Subject|1|||
37817393|NCT03596177|69496385|FG001|Single Blind Period|Withdrawal by Subject|1|||
37817394|NCT03596177|69496384|FG000|Single Blind Period|Other|1|||
37817395|NCT03596177|69496385|FG001|Single Blind Period|Other|0|||
37817396|NCT03596177|69496384|FG000|Double Blind Period|Withdrawal by Subject|0|||
37817397|NCT03596177|69496385|FG001|Double Blind Period|Withdrawal by Subject|1|||
37817398|NCT03596177|69496384|FG000|Double Blind Period|Other|0|||
37817399|NCT03596177|69496385|FG001|Double Blind Period|Other|4|||
37817400|NCT03596177|69496384|FG000|Double Blind Period|Death during safety follow-up|0|||
37817401|NCT03596177|69496385|FG001|Double Blind Period|Death during safety follow-up|1|||
37817402|NCT03579459|69496395|FG000|Overall Study|Adverse Event|7|||
37817403|NCT03579459|69496396|FG001|Overall Study|Adverse Event|6|||
37817404|NCT03579459|69496397|FG002|Overall Study|Adverse Event|2|||
37817405|NCT03579459|69496398|FG003|Overall Study|Adverse Event|6|||
37817406|NCT03579459|69496395|FG000|Overall Study|Death|1|||
37817407|NCT03579459|69496396|FG001|Overall Study|Death|0|||
37817408|NCT03579459|69496397|FG002|Overall Study|Death|1|||
37817409|NCT03579459|69496398|FG003|Overall Study|Death|2|||
37874615|NCT01212770|69559249|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
37874616|NCT01212770|69559250|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
37817410|NCT03579459|69496395|FG000|Overall Study|Lost to Follow-up|6|||
37817411|NCT03579459|69496396|FG001|Overall Study|Lost to Follow-up|2|||
37874617|NCT01212770|69559251|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
37874618|NCT01212770|69559252|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
37874619|NCT01212770|69559244|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
37874620|NCT01212770|69559245|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
37874621|NCT01212770|69559246|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
37874622|NCT01212770|69559247|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
37874623|NCT01212770|69559248|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
37874624|NCT01212770|69559249|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
37874625|NCT01212770|69559250|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
37874626|NCT01212770|69559251|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
37874627|NCT01212770|69559252|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
37874628|NCT01212770|69559244|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
37874629|NCT01212770|69559245|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
37874630|NCT01212770|69559246|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
37874631|NCT01212770|69559247|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
37874632|NCT01212770|69559248|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
37874633|NCT01212770|69559249|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
37874634|NCT01212770|69559250|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
37874635|NCT01212770|69559251|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
37874636|NCT01212770|69559252|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
37874637|NCT01212770|69559244|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
37874638|NCT01212770|69559245|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
37874639|NCT01212770|69559246|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
37874640|NCT01212770|69559247|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
37874641|NCT01212770|69559248|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
37874642|NCT01212770|69559249|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
37874643|NCT01212770|69559250|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
37874644|NCT01212770|69559251|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
37874645|NCT01212770|69559252|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
37874646|NCT01212770|69559244|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
37874647|NCT01212770|69559245|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
37874648|NCT01212770|69559246|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
37874649|NCT01212770|69559247|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
37874650|NCT01212770|69559248|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
37874651|NCT01212770|69559249|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
37874652|NCT01212770|69559250|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
37874653|NCT01212770|69559251|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
37874654|NCT01212770|69559252|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
37874655|NCT01212770|69559244|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
37874656|NCT01212770|69559245|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
37874657|NCT01212770|69559246|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
37874658|NCT01212770|69559247|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
37874659|NCT01212770|69559248|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
37874660|NCT01212770|69559249|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
37874661|NCT01212770|69559250|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
37874662|NCT01212770|69559251|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
37874663|NCT01212770|69559252|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
37874664|NCT01212770|69559244|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
37874665|NCT01212770|69559245|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
37874666|NCT01212770|69559246|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
37874667|NCT01212770|69559247|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
37874668|NCT01212770|69559248|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
37874669|NCT01212770|69559249|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
37874670|NCT01212770|69559250|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
37874671|NCT01212770|69559251|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
37874672|NCT01212770|69559252|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
37817412|NCT03579459|69496397|FG002|Overall Study|Lost to Follow-up|4|||
37817413|NCT03579459|69496398|FG003|Overall Study|Lost to Follow-up|1|||
37817414|NCT03579459|69496395|FG000|Overall Study|Physician Decision|0|||
37817415|NCT03579459|69496396|FG001|Overall Study|Physician Decision|1|||
37817416|NCT03579459|69496397|FG002|Overall Study|Physician Decision|0|||
37817417|NCT03579459|69496398|FG003|Overall Study|Physician Decision|1|||
37817418|NCT03579459|69496395|FG000|Overall Study|Protocol Violation|1|||
37817419|NCT03579459|69496396|FG001|Overall Study|Protocol Violation|2|||
37817420|NCT03579459|69496397|FG002|Overall Study|Protocol Violation|3|||
37817421|NCT03579459|69496398|FG003|Overall Study|Protocol Violation|5|||
37874673|NCT01212770|69559244|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
37874674|NCT01212770|69559245|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
37874675|NCT01212770|69559246|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
37817422|NCT03579459|69496395|FG000|Overall Study|Withdrawal by Subject|12|||
37817423|NCT03579459|69496396|FG001|Overall Study|Withdrawal by Subject|8|||
37874676|NCT01212770|69559247|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
37874677|NCT01212770|69559248|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
37874678|NCT01212770|69559249|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
37874679|NCT01212770|69559250|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
37874680|NCT01212770|69559251|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
37874681|NCT01212770|69559252|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
37874682|NCT01212770|69559244|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
37874683|NCT01212770|69559245|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
37874684|NCT01212770|69559246|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
37874685|NCT01212770|69559247|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
37874686|NCT01212770|69559248|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
37874687|NCT01212770|69559249|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
37874688|NCT01212770|69559250|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
37874689|NCT01212770|69559251|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
37874690|NCT01212770|69559252|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
37874691|NCT01212770|69559244|FG000|Long-term Safety Phase (Year 5)|Death|0|||
37874692|NCT01212770|69559245|FG001|Long-term Safety Phase (Year 5)|Death|0|||
37874693|NCT01212770|69559246|FG002|Long-term Safety Phase (Year 5)|Death|0|||
37874694|NCT01212770|69559247|FG003|Long-term Safety Phase (Year 5)|Death|0|||
37874695|NCT01212770|69559248|FG004|Long-term Safety Phase (Year 5)|Death|0|||
37874696|NCT01212770|69559249|FG005|Long-term Safety Phase (Year 5)|Death|0|||
37874697|NCT01212770|69559250|FG006|Long-term Safety Phase (Year 5)|Death|0|||
37874698|NCT01212770|69559251|FG007|Long-term Safety Phase (Year 5)|Death|1|||
37874699|NCT01212770|69559252|FG008|Long-term Safety Phase (Year 5)|Death|0|||
37874700|NCT00598273|69559277|FG000|Overall Study|Adverse Event|4|||
37874701|NCT00598273|69559278|FG001|Overall Study|Adverse Event|5|||
37874702|NCT00598273|69559279|FG002|Overall Study|Adverse Event|2|||
37874703|NCT00598273|69559277|FG000|Overall Study|Death|6|||
37874704|NCT00598273|69559278|FG001|Overall Study|Death|12|||
37874705|NCT00598273|69559279|FG002|Overall Study|Death|8|||
37874706|NCT00598273|69559277|FG000|Overall Study|Lost to Follow-up|8|||
37874707|NCT00598273|69559278|FG001|Overall Study|Lost to Follow-up|3|||
37874708|NCT00598273|69559279|FG002|Overall Study|Lost to Follow-up|5|||
37874709|NCT00598273|69559277|FG000|Overall Study|Physician Decision|0|||
37874710|NCT00598273|69559278|FG001|Overall Study|Physician Decision|0|||
37874711|NCT00598273|69559279|FG002|Overall Study|Physician Decision|1|||
37874712|NCT00598273|69559277|FG000|Overall Study|Withdrawal by Subject|12|||
37874713|NCT00598273|69559278|FG001|Overall Study|Withdrawal by Subject|10|||
37874714|NCT00598273|69559279|FG002|Overall Study|Withdrawal by Subject|10|||
37874715|NCT00598273|69559277|FG000|Overall Study|Noncompliance|3|||
37874716|NCT00598273|69559278|FG001|Overall Study|Noncompliance|2|||
37874717|NCT00598273|69559279|FG002|Overall Study|Noncompliance|3|||
37874718|NCT00598273|69559277|FG000|Overall Study|Relocation|0|||
37874719|NCT00598273|69559278|FG001|Overall Study|Relocation|2|||
37874720|NCT00598273|69559279|FG002|Overall Study|Relocation|4|||
37874721|NCT00598273|69559277|FG000|Overall Study|Renal transplant|1|||
37874722|NCT00598273|69559278|FG001|Overall Study|Renal transplant|0|||
37874723|NCT00598273|69559279|FG002|Overall Study|Renal transplant|1|||
37874724|NCT00598273|69559277|FG000|Overall Study|Site elected to close|1|||
37874725|NCT00598273|69559278|FG001|Overall Study|Site elected to close|0|||
37874726|NCT00598273|69559279|FG002|Overall Study|Site elected to close|0|||
37874727|NCT00598273|69559277|FG000|Overall Study|Started dialysis|6|||
37874728|NCT00598273|69559278|FG001|Overall Study|Started dialysis|4|||
37874729|NCT00598273|69559279|FG002|Overall Study|Started dialysis|5|||
37874730|NCT01211522|69559290|FG000|Overall Study|Withdrawal by Subject|3|||
37874731|NCT01211522|69559291|FG001|Overall Study|Withdrawal by Subject|7|||
37874732|NCT01211522|69559292|FG002|Overall Study|Withdrawal by Subject|5|||
37874733|NCT01211288|69559302|FG000|Overall Study|Lost to Follow-up|1|||
37874734|NCT01211288|69559303|FG001|Overall Study|Lost to Follow-up|1|||
37874735|NCT00883753|69559311|FG000|Overall Study|Adverse Event|37|||
37874736|NCT00883753|69559311|FG000|Overall Study|Death|2|||
37874737|NCT00883753|69559311|FG000|Overall Study|Insufficient therapeutic response|16|||
37874738|NCT00883753|69559311|FG000|Overall Study|Lost to Follow-up|4|||
37874739|NCT00883753|69559311|FG000|Overall Study|Violation of selection criteria at entry|7|||
37874740|NCT00883753|69559311|FG000|Overall Study|Protocol Violation|2|||
37874741|NCT00883753|69559311|FG000|Overall Study|Refused treatment|4|||
37874742|NCT00883753|69559311|FG000|Overall Study|Withdrew consent|10|||
37874743|NCT00883753|69559311|FG000|Overall Study|Investigator's decision|17|||
37874744|NCT00883753|69559311|FG000|Overall Study|Administrative/Other|8|||
37981724|NCT00422058|69668340|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
37981725|NCT00422058|69668341|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
37874745|NCT01210664|69559318|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
37874746|NCT01210664|69559319|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
37874747|NCT01210664|69559320|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
37874748|NCT01210664|69559321|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
37874749|NCT01210664|69559318|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
37874750|NCT01210664|69559319|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
37874751|NCT01210664|69559320|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
37874752|NCT01210664|69559321|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
37874753|NCT01210664|69559318|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
37874754|NCT01210664|69559319|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
37874755|NCT01210664|69559320|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
37981726|NCT00422058|69668342|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
37981727|NCT00422058|69668337|FG000|Double-Blind, Week 0-20|Other|11|||
37981728|NCT00422058|69668338|FG001|Double-Blind, Week 0-20|Other|3|||
37981729|NCT00422058|69668339|FG002|Double-Blind, Week 0-20|Other|8|||
37981730|NCT00422058|69668340|FG003|Double-Blind, Week 0-20|Other|8|||
37981731|NCT00422058|69668341|FG004|Double-Blind, Week 0-20|Other|4|||
37981732|NCT00422058|69668342|FG005|Double-Blind, Week 0-20|Other|10|||
37981733|NCT00422058|69668337|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
37981734|NCT00422058|69668338|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
37981735|NCT00422058|69668339|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
37981736|NCT00422058|69668340|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
37981737|NCT00422058|69668341|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
37981738|NCT00422058|69668342|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
37981739|NCT00422058|69668337|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
37981740|NCT00422058|69668338|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
37981741|NCT00422058|69668339|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
37981742|NCT00422058|69668340|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
37981743|NCT00422058|69668341|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
37981744|NCT00422058|69668342|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
37981745|NCT00422058|69668337|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
37874756|NCT01210664|69559321|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
37874757|NCT00881569|69559333|FG000|Overall Study|Disease progression|1|||
37817424|NCT03579459|69496397|FG002|Overall Study|Withdrawal by Subject|11|||
37817425|NCT03579459|69496398|FG003|Overall Study|Withdrawal by Subject|8|||
37817426|NCT03579459|69496395|FG000|Overall Study|Medication error without associated adverse event|2|||
37817427|NCT03579459|69496396|FG001|Overall Study|Medication error without associated adverse event|1|||
37817428|NCT03579459|69496397|FG002|Overall Study|Medication error without associated adverse event|1|||
37817429|NCT03579459|69496398|FG003|Overall Study|Medication error without associated adverse event|0|||
37817430|NCT03579459|69496395|FG000|Overall Study|Other|0|||
37817431|NCT03579459|69496396|FG001|Overall Study|Other|1|||
37817432|NCT03579459|69496397|FG002|Overall Study|Other|1|||
37817433|NCT03579459|69496398|FG003|Overall Study|Other|0|||
37874758|NCT00881569|69559334|FG001|Overall Study|Disease progression|1|||
37874759|NCT00881335|69559342|FG000|Overall Study|Lost to Follow-up|3|||
37874760|NCT00881335|69559343|FG001|Overall Study|Lost to Follow-up|2|||
37874761|NCT00879775|69559360|FG000|Overall Study|Lost to Follow-up|2|||
37874762|NCT00879775|69559361|FG001|Overall Study|Lost to Follow-up|1|||
37874763|NCT00894790|69559369|FG000|Overall Study|Protocol Violation|0|||
37874764|NCT00894790|69559370|FG001|Overall Study|Protocol Violation|1|||
37874765|NCT00894790|69559369|FG000|Overall Study|Lost to Follow-up|0|||
37874766|NCT00894790|69559370|FG001|Overall Study|Lost to Follow-up|1|||
37874767|NCT00894790|69559369|FG000|Overall Study|Did not meet entrance criteria|1|||
37874768|NCT00894790|69559370|FG001|Overall Study|Did not meet entrance criteria|0|||
37874769|NCT00879229|69559378|FG000|Overall Study|Study terminated by Sponsor|13|||
37874770|NCT00879229|69559379|FG001|Overall Study|Study terminated by Sponsor|12|||
37874771|NCT00879229|69559378|FG000|Overall Study|Death|4|||
37874772|NCT00879229|69559379|FG001|Overall Study|Death|2|||
37874773|NCT00879229|69559378|FG000|Overall Study|Adverse Event|2|||
37874774|NCT00879229|69559379|FG001|Overall Study|Adverse Event|0|||
37874775|NCT00879229|69559378|FG000|Overall Study|Withdrawal by Subject|1|||
37874776|NCT00879229|69559379|FG001|Overall Study|Withdrawal by Subject|0|||
37874777|NCT00879229|69559378|FG000|Overall Study|Clinical status did not improve|1|||
37981746|NCT00422058|69668338|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
37981747|NCT00422058|69668339|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
37981748|NCT00422058|69668340|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
37981749|NCT00422058|69668341|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
37981750|NCT00422058|69668342|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
37874778|NCT00879229|69559379|FG001|Overall Study|Clinical status did not improve|0|||
37874779|NCT00879229|69559378|FG000|Overall Study|Other|1|||
37874780|NCT00879229|69559379|FG001|Overall Study|Other|0|||
37874781|NCT00878995|69559387|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
37874782|NCT00878995|69559388|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
37874783|NCT00879697|69559396|FG000|Overall Study|Physician Decision|2|||
37874784|NCT00879697|69559397|FG001|Overall Study|Physician Decision|2|||
37874785|NCT00894556|69559406|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
37874786|NCT00894556|69559407|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
37874787|NCT00894556|69559408|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
37874788|NCT00894556|69559409|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
37874789|NCT00894556|69559406|FG000|Treatment Phase|Lost to Follow-up|2|||
37874790|NCT00894556|69559407|FG001|Treatment Phase|Lost to Follow-up|3|||
37874791|NCT00894556|69559408|FG002|Treatment Phase|Lost to Follow-up|1|||
37874792|NCT00894556|69559409|FG003|Treatment Phase|Lost to Follow-up|0|||
37874793|NCT00894556|69559406|FG000|Treatment Phase|Lack of Qualifying Event|2|||
37874794|NCT00894556|69559407|FG001|Treatment Phase|Lack of Qualifying Event|1|||
37874795|NCT00894556|69559408|FG002|Treatment Phase|Lack of Qualifying Event|0|||
37981751|NCT00422058|69668337|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
37981752|NCT00422058|69668338|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
37981753|NCT00422058|69668339|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
37981754|NCT00422058|69668340|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
37981755|NCT00422058|69668341|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
37981756|NCT00422058|69668342|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
37981757|NCT00422058|69668337|FG000|Open-Label Extension, Week 20-104|Other|13|||
37981758|NCT00422058|69668338|FG001|Open-Label Extension, Week 20-104|Other|14|||
37874796|NCT00894556|69559409|FG003|Treatment Phase|Lack of Qualifying Event|0|||
37874797|NCT01210352|69559425|FG000|Overall Study|Adverse Event|0|||
37874798|NCT01210352|69559426|FG001|Overall Study|Adverse Event|0|||
37874799|NCT01210352|69559427|FG002|Overall Study|Adverse Event|0|||
37874800|NCT01210352|69559428|FG003|Overall Study|Adverse Event|0|||
37874801|NCT01210352|69559429|FG004|Overall Study|Adverse Event|0|||
37874802|NCT01210352|69559430|FG005|Overall Study|Adverse Event|0|||
37874803|NCT01210352|69559431|FG006|Overall Study|Adverse Event|0|||
37874804|NCT01210352|69559432|FG007|Overall Study|Adverse Event|2|||
37874805|NCT01210352|69559433|FG008|Overall Study|Adverse Event|1|||
37874806|NCT01210352|69559425|FG000|Overall Study|Lack of Efficacy|0|||
37874807|NCT01210352|69559426|FG001|Overall Study|Lack of Efficacy|0|||
37874808|NCT01210352|69559427|FG002|Overall Study|Lack of Efficacy|0|||
37874809|NCT01210352|69559428|FG003|Overall Study|Lack of Efficacy|0|||
37874810|NCT01210352|69559429|FG004|Overall Study|Lack of Efficacy|0|||
37874811|NCT01210352|69559430|FG005|Overall Study|Lack of Efficacy|0|||
37874812|NCT01210352|69559431|FG006|Overall Study|Lack of Efficacy|1|||
37981759|NCT00422058|69668339|FG002|Open-Label Extension, Week 20-104|Other|6|||
37981760|NCT00422058|69668340|FG003|Open-Label Extension, Week 20-104|Other|13|||
37981761|NCT00422058|69668341|FG004|Open-Label Extension, Week 20-104|Other|16|||
37981762|NCT00422058|69668342|FG005|Open-Label Extension, Week 20-104|Other|18|||
37981763|NCT00413244|69668366|FG000|Overall Study|Withdrawal by Subject|10|||
37981764|NCT00413244|69668367|FG001|Overall Study|Withdrawal by Subject|1|||
37981765|NCT00420420|69668395|FG000|Overall Study|Adverse Event|5|||
37981766|NCT00420420|69668396|FG001|Overall Study|Adverse Event|3|||
37981767|NCT00420420|69668395|FG000|Overall Study|Protocol Violation|1|||
37981768|NCT00420420|69668396|FG001|Overall Study|Protocol Violation|1|||
37981769|NCT00420420|69668395|FG000|Overall Study|Withdrawal by Subject|1|||
37981770|NCT00420420|69668396|FG001|Overall Study|Withdrawal by Subject|0|||
37981771|NCT00420420|69668395|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
37981772|NCT00420420|69668396|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
37981773|NCT00420342|69668405|FG000|Overall Study|Lost to Follow-up|1|||
37981774|NCT00420342|69668406|FG001|Overall Study|Lost to Follow-up|0|||
37981775|NCT00420342|69668407|FG002|Overall Study|Lost to Follow-up|1|||
37981776|NCT00420342|69668405|FG000|Overall Study|Withdrawal by Subject|0|||
37981777|NCT00420342|69668406|FG001|Overall Study|Withdrawal by Subject|2|||
37981778|NCT00420342|69668407|FG002|Overall Study|Withdrawal by Subject|0|||
37981779|NCT00432744|69668417|FG000|Months 0-6|Withdrawal by Subject|4|||
37981780|NCT00432744|69668418|FG001|Months 0-6|Withdrawal by Subject|4|||
37981781|NCT00432744|69668417|FG000|Months 0-6|Too disabled to score|1|||
37981782|NCT00432744|69668418|FG001|Months 0-6|Too disabled to score|0|||
37981783|NCT00432744|69668417|FG000|Months 7 - 12|Withdrawal by Subject|1|||
37981784|NCT00432744|69668418|FG001|Months 7 - 12|Withdrawal by Subject|0|||
37981785|NCT00432744|69668417|FG000|Months 7 - 12|Too disabled to score|0|||
37981786|NCT00432744|69668418|FG001|Months 7 - 12|Too disabled to score|1|||
37981787|NCT00432666|69668426|FG000|Main Period|Adverse Event|1|||
37981788|NCT00432666|69668427|FG001|Main Period|Adverse Event|1|||
37981789|NCT00432666|69668426|FG000|Main Period|Consent Withdrawn|1|||
37981790|NCT00432666|69668427|FG001|Main Period|Consent Withdrawn|0|||
37981791|NCT00432666|69668426|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
37981792|NCT00432666|69668427|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
37981793|NCT00432666|69668426|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
37981794|NCT00432666|69668427|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
37981795|NCT00432666|69668426|FG000|Open-Label Extension Period|Adverse Event|5|||
37981796|NCT00432666|69668427|FG001|Open-Label Extension Period|Adverse Event|0|||
37981797|NCT00432666|69668426|FG000|Open-Label Extension Period|Consent withdrawn|10|||
37981798|NCT00432666|69668427|FG001|Open-Label Extension Period|Consent withdrawn|0|||
37981799|NCT00432666|69668426|FG000|Open-Label Extension Period|Physician Decision|3|||
37981800|NCT00432666|69668427|FG001|Open-Label Extension Period|Physician Decision|0|||
37981801|NCT00451958|69668437|FG000|CS21A (NCT00451958)|Adverse Event|21|||
37981802|NCT00451958|69668438|FG001|CS21A (NCT00451958)|Adverse Event|34|||
37981803|NCT00451958|69668439|FG002|CS21A (NCT00451958)|Adverse Event|14|||
37981804|NCT00451958|69668440|FG003|CS21A (NCT00451958)|Adverse Event|17|||
37981805|NCT00451958|69668441|FG004|CS21A (NCT00451958)|Adverse Event|0|||
37981806|NCT00451958|69668437|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
37981807|NCT00451958|69668438|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
37981808|NCT00451958|69668439|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
37981809|NCT00451958|69668440|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
37981810|NCT00451958|69668441|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
37981811|NCT00451958|69668437|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
37981812|NCT00451958|69668438|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
37981813|NCT00451958|69668439|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
37981814|NCT00451958|69668440|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
37981815|NCT00451958|69668441|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
37981816|NCT00451958|69668437|FG000|CS21A (NCT00451958)|Physician Decision|2|||
37981817|NCT00451958|69668438|FG001|CS21A (NCT00451958)|Physician Decision|4|||
37981818|NCT00451958|69668439|FG002|CS21A (NCT00451958)|Physician Decision|4|||
37981819|NCT00451958|69668440|FG003|CS21A (NCT00451958)|Physician Decision|4|||
37981820|NCT00451958|69668441|FG004|CS21A (NCT00451958)|Physician Decision|0|||
37981821|NCT00451958|69668437|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
37981822|NCT00451958|69668438|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
37981823|NCT00451958|69668439|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
37981824|NCT00451958|69668440|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
37981825|NCT00451958|69668441|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
37981826|NCT00451958|69668437|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
37981827|NCT00451958|69668438|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
37981828|NCT00451958|69668439|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
37981829|NCT00451958|69668440|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
37981830|NCT00451958|69668441|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
37981831|NCT00432276|69668457|FG000|Overall Study|Hyperglycemic Rescue|44|||
37981832|NCT00432276|69668458|FG001|Overall Study|Hyperglycemic Rescue|87|||
37981833|NCT00432276|69668457|FG000|Overall Study|Adverse Event|13|||
37981834|NCT00432276|69668458|FG001|Overall Study|Adverse Event|16|||
37981835|NCT00432276|69668457|FG000|Overall Study|Protocol Violation|25|||
37981836|NCT00432276|69668458|FG001|Overall Study|Protocol Violation|20|||
37981837|NCT00432276|69668457|FG000|Overall Study|Lost to Follow-up|6|||
37981838|NCT00432276|69668458|FG001|Overall Study|Lost to Follow-up|2|||
37981839|NCT00432276|69668457|FG000|Overall Study|Withdrawal by Subject|25|||
37981840|NCT00432276|69668458|FG001|Overall Study|Withdrawal by Subject|20|||
37981841|NCT00432276|69668457|FG000|Overall Study|Physician Decision|6|||
37981842|NCT00432276|69668458|FG001|Overall Study|Physician Decision|8|||
37981843|NCT00432276|69668457|FG000|Overall Study|Other|2|||
37981844|NCT00432276|69668458|FG001|Overall Study|Other|3|||
37981845|NCT00413010|69668466|FG000|Overall Study|Adverse Event|8|||
37981846|NCT00413010|69668467|FG001|Overall Study|Adverse Event|4|||
37981847|NCT00413010|69668466|FG000|Overall Study|Laboratory abnormality|0|||
37981848|NCT00413010|69668467|FG001|Overall Study|Laboratory abnormality|2|||
37981849|NCT00413010|69668466|FG000|Overall Study|Lack of Efficacy|0|||
37981850|NCT00413010|69668467|FG001|Overall Study|Lack of Efficacy|3|||
37981851|NCT00413010|69668466|FG000|Overall Study|Lost to Follow-up|3|||
37981852|NCT00413010|69668467|FG001|Overall Study|Lost to Follow-up|0|||
37981853|NCT00413010|69668466|FG000|Overall Study|Withdrawal by Subject|7|||
37981854|NCT00413010|69668467|FG001|Overall Study|Withdrawal by Subject|2|||
37981855|NCT00413010|69668466|FG000|Overall Study|Due to termination of the study|54|||
37981856|NCT00413010|69668467|FG001|Overall Study|Due to termination of the study|52|||
37981857|NCT00459290|69668473|FG000|Overall Study|Adverse Event|3|||
37981858|NCT00459290|69668473|FG000|Overall Study|Ineligible|2|||
37981859|NCT00443534|69668484|FG000|Overall Study|Lack of Efficacy|67|||
37981860|NCT00443534|69668484|FG000|Overall Study|Adverse Event|16|||
37981861|NCT00443534|69668484|FG000|Overall Study|Death|9|||
37981862|NCT00443534|69668484|FG000|Overall Study|Withdrawal by Subject|8|||
37981863|NCT00443534|69668484|FG000|Overall Study|Study Terminated by Sponsor|12|||
37981864|NCT00443534|69668484|FG000|Overall Study|Other|10|||
37981865|NCT00443534|69668484|FG000|Overall Study|Enrolled, Not Treated|1|||
37981866|NCT00419952|69668490|FG000|Overall Study|Adverse Event|8|||
37981867|NCT00419952|69668491|FG001|Overall Study|Adverse Event|10|||
37981868|NCT00419952|69668490|FG000|Overall Study|Withdrawal by Subject|44|||
37981869|NCT00419952|69668491|FG001|Overall Study|Withdrawal by Subject|43|||
37981870|NCT00419952|69668490|FG000|Overall Study|Lost to Follow-up|43|||
37981871|NCT00419952|69668491|FG001|Overall Study|Lost to Follow-up|34|||
37981872|NCT00419952|69668490|FG000|Overall Study|Protocol Violation|32|||
37981873|NCT00419952|69668491|FG001|Overall Study|Protocol Violation|24|||
37981874|NCT00419952|69668490|FG000|Overall Study|Pregnancy|4|||
37981875|NCT00419952|69668491|FG001|Overall Study|Pregnancy|2|||
37981876|NCT00419952|69668490|FG000|Overall Study|Physician Decision|1|||
37981877|NCT00419952|69668491|FG001|Overall Study|Physician Decision|3|||
37981878|NCT00419952|69668490|FG000|Overall Study|Incorrectly enrolled|10|||
37981879|NCT00419952|69668491|FG001|Overall Study|Incorrectly enrolled|3|||
37981880|NCT00419952|69668490|FG000|Overall Study|Intake of prohibited medication|2|||
37981881|NCT00419952|69668491|FG001|Overall Study|Intake of prohibited medication|2|||
37981882|NCT00419952|69668490|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
37981883|NCT00419952|69668491|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
37981884|NCT00419952|69668490|FG000|Overall Study|Diary or medication non-compliance|2|||
37817434|NCT03579459|69496395|FG000|Overall Study|Randomized not vaccinated|0|||
37817435|NCT03579459|69496396|FG001|Overall Study|Randomized not vaccinated|2|||
37981885|NCT00419952|69668491|FG001|Overall Study|Diary or medication non-compliance|4|||
37981886|NCT00419952|69668490|FG000|Overall Study|Abnormal ECG|1|||
37981887|NCT00419952|69668491|FG001|Overall Study|Abnormal ECG|0|||
37981888|NCT00443456|69668497|FG000|Overall Study|Adverse Event|16|||
37981889|NCT00443456|69668497|FG000|Overall Study|Move|1|||
37981890|NCT00443456|69668497|FG000|Overall Study|Withdrawal by Subject|1|||
37981891|NCT00419562|69668507|FG000|Overall Study|Lost to Follow-up|12|||
37874813|NCT01210352|69559432|FG007|Overall Study|Lack of Efficacy|0|||
37981892|NCT00419562|69668508|FG001|Overall Study|Lost to Follow-up|13|||
37981893|NCT00419562|69668507|FG000|Overall Study|Withdrawal by Subject|20|||
37981894|NCT00419562|69668508|FG001|Overall Study|Withdrawal by Subject|18|||
37981895|NCT00419562|69668507|FG000|Overall Study|Participant Institutionalized|1|||
37981896|NCT00419562|69668508|FG001|Overall Study|Participant Institutionalized|0|||
37981897|NCT00432042|69668517|FG000|Overall Study|Protocol Violation|2|||
37981898|NCT00432042|69668518|FG001|Overall Study|Protocol Violation|0|||
37981899|NCT00432042|69668519|FG002|Overall Study|Protocol Violation|0|||
37981900|NCT00432042|69668517|FG000|Overall Study|Withdrawal by Subject|0|||
37981901|NCT00432042|69668518|FG001|Overall Study|Withdrawal by Subject|0|||
37981902|NCT00432042|69668519|FG002|Overall Study|Withdrawal by Subject|2|||
37981903|NCT00432042|69668517|FG000|Overall Study|Lost to Follow-up|5|||
37981904|NCT00432042|69668518|FG001|Overall Study|Lost to Follow-up|1|||
37981905|NCT00432042|69668519|FG002|Overall Study|Lost to Follow-up|0|||
37981906|NCT00308139|69668529|FG000|Overall Study|Adverse Event|20|||
37981907|NCT00308139|69668530|FG001|Overall Study|Adverse Event|14|||
37981908|NCT00308139|69668529|FG000|Overall Study|Lost to Follow-up|13|||
37981909|NCT00308139|69668530|FG001|Overall Study|Lost to Follow-up|8|||
37981910|NCT00308139|69668529|FG000|Overall Study|Protocol Violation|3|||
37981911|NCT00308139|69668530|FG001|Overall Study|Protocol Violation|2|||
37981912|NCT00308139|69668529|FG000|Overall Study|Withdrawal of Consent|40|||
37981913|NCT00308139|69668530|FG001|Overall Study|Withdrawal of Consent|42|||
37981914|NCT00308139|69668529|FG000|Overall Study|Investigator Decision|11|||
37981915|NCT00308139|69668530|FG001|Overall Study|Investigator Decision|10|||
37981916|NCT00308139|69668529|FG000|Overall Study|Loss of Glucose Control|5|||
37981917|NCT00308139|69668530|FG001|Overall Study|Loss of Glucose Control|7|||
37981918|NCT00308139|69668529|FG000|Overall Study|Administrative|1|||
37981919|NCT00308139|69668530|FG001|Overall Study|Administrative|4|||
37981920|NCT00308139|69668529|FG000|Overall Study|Other|1|||
37981921|NCT00308139|69668530|FG001|Overall Study|Other|0|||
37981922|NCT00459134|69668558|FG000|Overall Study|Physician Decision|1|||
37981923|NCT00459134|69668559|FG001|Overall Study|Physician Decision|1|||
37981924|NCT00459134|69668558|FG000|Overall Study|Withdrawal by Subject|8|||
37981925|NCT00459134|69668559|FG001|Overall Study|Withdrawal by Subject|7|||
37981926|NCT00459134|69668558|FG000|Overall Study|Lost to Follow-up|6|||
37981927|NCT00459134|69668559|FG001|Overall Study|Lost to Follow-up|7|||
37981928|NCT00459134|69668558|FG000|Overall Study|Surgery|1|||
37981929|NCT00459134|69668559|FG001|Overall Study|Surgery|2|||
37981930|NCT00459134|69668558|FG000|Overall Study|Toxicity|4|||
37981931|NCT00459134|69668559|FG001|Overall Study|Toxicity|5|||
37981932|NCT00459134|69668558|FG000|Overall Study|Progression|1|||
37981933|NCT00459134|69668559|FG001|Overall Study|Progression|0|||
37981934|NCT00459134|69668558|FG000|Overall Study|Multiple Reasons|2|||
37981935|NCT00459134|69668559|FG001|Overall Study|Multiple Reasons|3|||
37981936|NCT00459056|69668567|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
37981937|NCT00459056|69668568|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
37981938|NCT00431964|69668576|FG000|Overall Study|Adverse Event|1|||
37981939|NCT00431964|69668577|FG001|Overall Study|Adverse Event|0|||
37981940|NCT00431964|69668576|FG000|Overall Study|Lost to Follow-up|1|||
37981941|NCT00431964|69668577|FG001|Overall Study|Lost to Follow-up|2|||
37981942|NCT00431964|69668576|FG000|Overall Study|Physician Decision|2|||
37981943|NCT00431964|69668577|FG001|Overall Study|Physician Decision|2|||
37981944|NCT00431964|69668576|FG000|Overall Study|Withdrawal by Subject|2|||
37981945|NCT00431964|69668577|FG001|Overall Study|Withdrawal by Subject|1|||
37981946|NCT00431964|69668576|FG000|Overall Study|Parental Consent Withdrawn|0|||
37981947|NCT00431964|69668577|FG001|Overall Study|Parental Consent Withdrawn|2|||
37981948|NCT00431964|69668576|FG000|Overall Study|Due to Unstable Health|0|||
37981949|NCT00431964|69668577|FG001|Overall Study|Due to Unstable Health|1|||
37981950|NCT00412854|69668585|FG000|Overall Study|Withdrawn due to adverse events|1|||
37981951|NCT00412854|69668586|FG001|Overall Study|Withdrawn due to adverse events|5|||
37981952|NCT00412854|69668585|FG000|Overall Study|Withdrawn for other reasons|13|||
37981953|NCT00412854|69668586|FG001|Overall Study|Withdrawn for other reasons|11|||
37981954|NCT00431496|69668592|FG000|Overall Study|Adverse Event|3|||
37981955|NCT00431496|69668592|FG000|Overall Study|Lost to Follow-up|1|||
37981956|NCT00431496|69668592|FG000|Overall Study|Withdrawal by Subject|2|||
37981957|NCT00431496|69668592|FG000|Overall Study|Protocol-specified criteria|5|||
37981958|NCT00316173|69668598|FG000|Run-in Phase|Adverse Event|1|||
37981959|NCT00316173|69668599|FG001|Run-in Phase|Adverse Event|0|||
37981960|NCT00316173|69668598|FG000|Run-in Phase|Protocol Violation|1|||
37981961|NCT00316173|69668599|FG001|Run-in Phase|Protocol Violation|0|||
37981962|NCT00316173|69668598|FG000|Run-in Phase|Study Follow-up Stopped|5|||
37981963|NCT00316173|69668599|FG001|Run-in Phase|Study Follow-up Stopped|0|||
37981964|NCT00316173|69668598|FG000|Treatment Phase|Adverse Event|0|||
37981965|NCT00316173|69668599|FG001|Treatment Phase|Adverse Event|1|||
37981966|NCT00316173|69668598|FG000|Treatment Phase|Lack of Efficacy|0|||
37981967|NCT00316173|69668599|FG001|Treatment Phase|Lack of Efficacy|3|||
37981968|NCT00316173|69668598|FG000|Treatment Phase|Lost to Follow-up|0|||
37981969|NCT00316173|69668599|FG001|Treatment Phase|Lost to Follow-up|3|||
37981970|NCT00316173|69668598|FG000|Treatment Phase|Withdrawal by Subject|0|||
37981971|NCT00316173|69668599|FG001|Treatment Phase|Withdrawal by Subject|1|||
37981972|NCT00316173|69668598|FG000|Treatment Phase|Study Follow-up Stopped|0|||
37981973|NCT00316173|69668599|FG001|Treatment Phase|Study Follow-up Stopped|34|||
37981974|NCT00412542|69668606|FG000|Overall Study|Withdrawal by Subject|0|||
37981975|NCT00412542|69668607|FG001|Overall Study|Withdrawal by Subject|2|||
37981976|NCT00412542|69668606|FG000|Overall Study|Not Eligible|0|||
37981977|NCT00412542|69668607|FG001|Overall Study|Not Eligible|1|||
37981978|NCT00316017|69668614|FG000|Overall Study|Protocol Violation|11|||
37981979|NCT00316017|69668615|FG001|Overall Study|Protocol Violation|13|||
37981980|NCT00316017|69668616|FG002|Overall Study|Protocol Violation|19|||
37981981|NCT00451178|69668626|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
37981982|NCT00451178|69668627|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
37981983|NCT00451178|69668626|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
37981984|NCT00451178|69668627|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
37981985|NCT00451178|69668626|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
37981986|NCT00451178|69668627|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
37981987|NCT00451178|69668626|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
37981988|NCT00451178|69668627|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
37981989|NCT00451178|69668626|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
37981990|NCT00451178|69668627|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
37981991|NCT00451178|69668626|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
37981992|NCT00451178|69668627|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
37981993|NCT00451178|69668626|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
37981994|NCT00451178|69668627|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
37981995|NCT00451178|69668626|FG000|Prior to Maintenance Therapy|PD|2|||
37981996|NCT00451178|69668627|FG001|Prior to Maintenance Therapy|PD|0|||
37981997|NCT00451178|69668626|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
37981998|NCT00451178|69668627|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
37981999|NCT00451178|69668626|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
37982000|NCT00451178|69668627|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
37982001|NCT00451178|69668626|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
37982002|NCT00451178|69668627|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
37982003|NCT00451178|69668626|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
37982004|NCT00451178|69668627|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
37982005|NCT00451178|69668626|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
37982006|NCT00451178|69668627|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
37982007|NCT00451178|69668626|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
37982008|NCT00451178|69668627|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
37982009|NCT00451178|69668626|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
37982010|NCT00451178|69668627|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
37982011|NCT00450866|69668637|FG000|Overall Study|Adverse Event|0|||
37982012|NCT00450866|69668638|FG001|Overall Study|Adverse Event|1|||
37982013|NCT00450866|69668637|FG000|Overall Study|Withdrawal by Subject|5|||
37982014|NCT00450866|69668638|FG001|Overall Study|Withdrawal by Subject|2|||
37982015|NCT00450866|69668637|FG000|Overall Study|Death|1|||
37982016|NCT00450866|69668638|FG001|Overall Study|Death|0|||
37982017|NCT00450866|69668637|FG000|Overall Study|Physician Decision|1|||
37982018|NCT00450866|69668638|FG001|Overall Study|Physician Decision|0|||
37982019|NCT00442598|69668647|FG000|Overall Study|Adverse Event|1|||
37982020|NCT00442598|69668648|FG001|Overall Study|Adverse Event|0|||
37982021|NCT00442598|69668649|FG002|Overall Study|Adverse Event|0|||
37982022|NCT00442598|69668647|FG000|Overall Study|Tumor progression|3|||
37817436|NCT03579459|69496397|FG002|Overall Study|Randomized not vaccinated|0|||
37817437|NCT03579459|69496398|FG003|Overall Study|Randomized not vaccinated|1|||
37982023|NCT00442598|69668648|FG001|Overall Study|Tumor progression|4|||
37982024|NCT00442598|69668649|FG002|Overall Study|Tumor progression|0|||
37982025|NCT00442598|69668647|FG000|Overall Study|Clinical deterioration|1|||
37982026|NCT00442598|69668648|FG001|Overall Study|Clinical deterioration|2|||
37982027|NCT00442598|69668649|FG002|Overall Study|Clinical deterioration|0|||
37982028|NCT00442598|69668647|FG000|Overall Study|CA125 progression|0|||
37982029|NCT00442598|69668648|FG001|Overall Study|CA125 progression|1|||
37982030|NCT00442598|69668649|FG002|Overall Study|CA125 progression|0|||
37982031|NCT00442598|69668647|FG000|Overall Study|Reduced creatinine clearance|1|||
37982032|NCT00442598|69668648|FG001|Overall Study|Reduced creatinine clearance|0|||
37982033|NCT00442598|69668649|FG002|Overall Study|Reduced creatinine clearance|0|||
37982034|NCT00442598|69668647|FG000|Overall Study|Death|0|||
37982035|NCT00442598|69668648|FG001|Overall Study|Death|1|||
37982036|NCT00442598|69668649|FG002|Overall Study|Death|0|||
37982037|NCT00442286|69668659|FG000|Overall Study|Death|2|||
37982038|NCT00442286|69668660|FG001|Overall Study|Death|2|||
37982039|NCT00442286|69668659|FG000|Overall Study|Lost to Follow-up|1|||
37982040|NCT00442286|69668660|FG001|Overall Study|Lost to Follow-up|0|||
37982041|NCT00442286|69668659|FG000|Overall Study|Withdrawal by Subject|2|||
37982042|NCT00442286|69668660|FG001|Overall Study|Withdrawal by Subject|0|||
37982043|NCT00442286|69668659|FG000|Overall Study|System explanted|1|||
37982044|NCT00442286|69668660|FG001|Overall Study|System explanted|0|||
37982045|NCT00442286|69668659|FG000|Overall Study|Patient Injury|1|||
37982046|NCT00442286|69668660|FG001|Overall Study|Patient Injury|0|||
37982047|NCT00441974|69668668|FG000|Overall Study|Adverse Event|6|||
37982048|NCT00441974|69668668|FG000|Overall Study|Consent Withdrawn|35|||
37982049|NCT00441974|69668668|FG000|Overall Study|Lost to Follow-up|80|||
37982050|NCT00441974|69668668|FG000|Overall Study|Protocol Violation|7|||
37982051|NCT00441584|69668675|FG000|Overall Study|Lack of Efficacy|79|||
37982052|NCT00441584|69668675|FG000|Overall Study|Withdrawal by Subject|8|||
37982053|NCT00441584|69668675|FG000|Overall Study|Adverse Event|6|||
37982054|NCT00441584|69668675|FG000|Overall Study|Protocol Violation|5|||
37982055|NCT00441584|69668675|FG000|Overall Study|Lost to Follow-up|4|||
37982056|NCT00441584|69668675|FG000|Overall Study|Failure to meet eligibility criteria|3|||
37982057|NCT00430716|69668682|FG000|Double Blind Phase|Death|1|||
37982058|NCT00430716|69668683|FG001|Double Blind Phase|Death|0|||
37982059|NCT00430716|69668684|FG002|Double Blind Phase|Death|0|||
37982060|NCT00430716|69668682|FG000|Double Blind Phase|No longer willing to participate|2|||
37982061|NCT00430716|69668683|FG001|Double Blind Phase|No longer willing to participate|1|||
37982062|NCT00430716|69668684|FG002|Double Blind Phase|No longer willing to participate|1|||
37982063|NCT00430716|69668682|FG000|Double Blind Phase|Other|0|||
37982064|NCT00430716|69668683|FG001|Double Blind Phase|Other|2|||
37982065|NCT00430716|69668684|FG002|Double Blind Phase|Other|0|||
37982066|NCT00430716|69668682|FG000|Double Blind Phase|Study terminated by sponsor|1|||
37982067|NCT00430716|69668683|FG001|Double Blind Phase|Study terminated by sponsor|1|||
37982068|NCT00430716|69668684|FG002|Double Blind Phase|Study terminated by sponsor|2|||
37982069|NCT00430716|69668682|FG000|Double Blind Phase|Adverse Event|1|||
37982070|NCT00430716|69668683|FG001|Double Blind Phase|Adverse Event|1|||
37982071|NCT00430716|69668684|FG002|Double Blind Phase|Adverse Event|3|||
37982072|NCT00430716|69668682|FG000|Double Blind Phase|Not treated|1|||
37982073|NCT00430716|69668683|FG001|Double Blind Phase|Not treated|0|||
37982074|NCT00430716|69668684|FG002|Double Blind Phase|Not treated|0|||
37982075|NCT00430716|69668682|FG000|Open Label Phase|Lost to Follow-up|1|||
37817438|NCT04449276|69496425|FG000|Overall Study|Adverse Event|1|||
37817439|NCT04449276|69496426|FG001|Overall Study|Adverse Event|2|||
37817440|NCT04449276|69496427|FG002|Overall Study|Adverse Event|0|||
37817441|NCT04449276|69496428|FG003|Overall Study|Adverse Event|0|||
37817442|NCT04449276|69496429|FG004|Overall Study|Adverse Event|2|||
37817443|NCT04449276|69496430|FG005|Overall Study|Adverse Event|0|||
37817444|NCT04449276|69496431|FG006|Overall Study|Adverse Event|0|||
37817445|NCT04449276|69496432|FG007|Overall Study|Adverse Event|1|||
37982076|NCT00430716|69668683|FG001|Open Label Phase|Lost to Follow-up|0|||
37982077|NCT00430716|69668684|FG002|Open Label Phase|Lost to Follow-up|1|||
37982078|NCT00430716|69668682|FG000|Open Label Phase|No longer willing to participate|0|||
37817446|NCT04449276|69496425|FG000|Overall Study|Withdrawal by Subject|2|||
37982079|NCT00430716|69668683|FG001|Open Label Phase|No longer willing to participate|1|||
37982080|NCT00430716|69668684|FG002|Open Label Phase|No longer willing to participate|1|||
37982081|NCT00430716|69668682|FG000|Open Label Phase|Other|3|||
37982082|NCT00430716|69668683|FG001|Open Label Phase|Other|1|||
37982083|NCT00430716|69668684|FG002|Open Label Phase|Other|1|||
37982084|NCT00430716|69668682|FG000|Open Label Phase|Protocol Violation|1|||
37817447|NCT04449276|69496426|FG001|Overall Study|Withdrawal by Subject|0|||
37817448|NCT04449276|69496427|FG002|Overall Study|Withdrawal by Subject|0|||
37817449|NCT04449276|69496428|FG003|Overall Study|Withdrawal by Subject|1|||
37817450|NCT04449276|69496429|FG004|Overall Study|Withdrawal by Subject|0|||
37817451|NCT04449276|69496430|FG005|Overall Study|Withdrawal by Subject|0|||
37817452|NCT04449276|69496431|FG006|Overall Study|Withdrawal by Subject|0|||
37817453|NCT04449276|69496432|FG007|Overall Study|Withdrawal by Subject|0|||
37817454|NCT04449276|69496425|FG000|Overall Study|Other|0|||
37817455|NCT04449276|69496426|FG001|Overall Study|Other|2|||
37817456|NCT04449276|69496427|FG002|Overall Study|Other|3|||
37817457|NCT04449276|69496428|FG003|Overall Study|Other|2|||
37817458|NCT04449276|69496429|FG004|Overall Study|Other|0|||
37817459|NCT04449276|69496430|FG005|Overall Study|Other|0|||
37817460|NCT04449276|69496431|FG006|Overall Study|Other|0|||
37817461|NCT04449276|69496432|FG007|Overall Study|Other|1|||
37817462|NCT04391894|69496472|FG000|Overall Study|Adverse Event|1|||
37817463|NCT04391894|69496473|FG001|Overall Study|Adverse Event|1|||
37817464|NCT04391894|69496474|FG002|Overall Study|Adverse Event|1|||
37874814|NCT01210352|69559433|FG008|Overall Study|Lack of Efficacy|0|||
37982085|NCT00430716|69668683|FG001|Open Label Phase|Protocol Violation|0|||
37982086|NCT00430716|69668684|FG002|Open Label Phase|Protocol Violation|0|||
37982087|NCT00430716|69668682|FG000|Open Label Phase|Study terminated by sponsor|4|||
37982088|NCT00430716|69668683|FG001|Open Label Phase|Study terminated by sponsor|5|||
37982089|NCT00430716|69668684|FG002|Open Label Phase|Study terminated by sponsor|4|||
37982090|NCT00441272|69668694|FG000|Overall Study|Study terminated prior to enrollment|25|||
37982091|NCT00441272|69668695|FG001|Overall Study|Study terminated prior to enrollment|25|||
37982092|NCT00430638|69668703|FG000|Overall Study|Adverse Event|15|||
37982093|NCT00430638|69668704|FG001|Overall Study|Adverse Event|15|||
37982094|NCT00430638|69668703|FG000|Overall Study|Uncontrolled blood pressure|48|||
37982095|NCT00430638|69668704|FG001|Overall Study|Uncontrolled blood pressure|13|||
37982096|NCT00430638|69668703|FG000|Overall Study|Lost to Follow-up|1|||
37982097|NCT00430638|69668704|FG001|Overall Study|Lost to Follow-up|7|||
37982098|NCT00430638|69668703|FG000|Overall Study|Protocol Violation|6|||
37982099|NCT00430638|69668704|FG001|Overall Study|Protocol Violation|4|||
37982100|NCT00430638|69668703|FG000|Overall Study|Withdrawal by Subject|4|||
37982101|NCT00430638|69668704|FG001|Overall Study|Withdrawal by Subject|6|||
37982102|NCT00430638|69668703|FG000|Overall Study|Non-compliant|2|||
37982103|NCT00430638|69668704|FG001|Overall Study|Non-compliant|1|||
37982104|NCT00430638|69668703|FG000|Overall Study|Other|2|||
37982105|NCT00430638|69668704|FG001|Overall Study|Other|2|||
37982106|NCT00430482|69668716|FG000|Completed Treatment|Insufficient Treatment|7|||
37982107|NCT00430482|69668717|FG001|Completed Treatment|Insufficient Treatment|11|||
37982108|NCT00449930|69668725|FG000|Overall Study|Adverse Event|9|||
37982109|NCT00449930|69668726|FG001|Overall Study|Adverse Event|19|||
37982110|NCT00449930|69668725|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
37982111|NCT00449930|69668726|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
37982112|NCT00449930|69668725|FG000|Overall Study|Lack of Efficacy|10|||
37982113|NCT00449930|69668726|FG001|Overall Study|Lack of Efficacy|1|||
37982114|NCT00449930|69668725|FG000|Overall Study|Lost to Follow-up|9|||
37982115|NCT00449930|69668726|FG001|Overall Study|Lost to Follow-up|14|||
37982116|NCT00449930|69668725|FG000|Overall Study|Physician Decision|1|||
37982117|NCT00449930|69668726|FG001|Overall Study|Physician Decision|2|||
37982118|NCT00449930|69668725|FG000|Overall Study|Protocol Violation|14|||
37982119|NCT00449930|69668726|FG001|Overall Study|Protocol Violation|15|||
37982120|NCT00449930|69668725|FG000|Overall Study|Withdrawal by Subject|16|||
37982121|NCT00449930|69668726|FG001|Overall Study|Withdrawal by Subject|23|||
37982122|NCT00449930|69668725|FG000|Overall Study|Glycemic discontinuation criteria|1|||
37982123|NCT00449930|69668726|FG001|Overall Study|Glycemic discontinuation criteria|1|||
37982124|NCT00449696|69668734|FG000|Overall Study|Other Treatment Required|6|||
37982125|NCT00449696|69668735|FG001|Overall Study|Other Treatment Required|1|||
37982126|NCT00449696|69668734|FG000|Overall Study|Withdrawal by Subject|5|||
37982127|NCT00449696|69668735|FG001|Overall Study|Withdrawal by Subject|5|||
37982128|NCT00449696|69668734|FG000|Overall Study|Lost to Follow-up|2|||
37982129|NCT00449696|69668735|FG001|Overall Study|Lost to Follow-up|3|||
37982130|NCT00449696|69668734|FG000|Overall Study|Others|7|||
37982131|NCT00449696|69668735|FG001|Overall Study|Others|0|||
37874815|NCT01210352|69559425|FG000|Overall Study|Physician Decision|0|||
37874816|NCT01210352|69559426|FG001|Overall Study|Physician Decision|0|||
37817465|NCT04391894|69496475|FG003|Overall Study|Adverse Event|1|||
37817466|NCT04391894|69496476|FG004|Overall Study|Adverse Event|1|||
37817467|NCT04391894|69496472|FG000|Overall Study|Lost to Follow-up|1|||
37817468|NCT04391894|69496473|FG001|Overall Study|Lost to Follow-up|0|||
37817469|NCT04391894|69496474|FG002|Overall Study|Lost to Follow-up|0|||
37982132|NCT00441116|69668743|FG000|Overall Study|Adverse Event|1|||
37982133|NCT00441116|69668744|FG001|Overall Study|Adverse Event|1|||
37982134|NCT00441116|69668743|FG000|Overall Study|Withdrawal by Subject|1|||
37982135|NCT00441116|69668744|FG001|Overall Study|Withdrawal by Subject|0|||
37982136|NCT00441116|69668743|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
37982137|NCT00441116|69668744|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
37982138|NCT00430248|69668753|FG000|Overall Study|Adverse Event|49|||
37982139|NCT00430248|69668754|FG001|Overall Study|Adverse Event|61|||
37982140|NCT00430248|69668755|FG002|Overall Study|Adverse Event|64|||
37982141|NCT00430248|69668753|FG000|Overall Study|Protocol Violation|10|||
37982142|NCT00430248|69668754|FG001|Overall Study|Protocol Violation|2|||
37982143|NCT00430248|69668755|FG002|Overall Study|Protocol Violation|4|||
37982144|NCT00430248|69668753|FG000|Overall Study|Personal Reasons|12|||
37982145|NCT00430248|69668754|FG001|Overall Study|Personal Reasons|24|||
37982146|NCT00430248|69668755|FG002|Overall Study|Personal Reasons|9|||
37982147|NCT00430248|69668753|FG000|Overall Study|Lost to Follow-up|28|||
37982148|NCT00430248|69668754|FG001|Overall Study|Lost to Follow-up|33|||
37982149|NCT00430248|69668755|FG002|Overall Study|Lost to Follow-up|28|||
37982150|NCT00430248|69668753|FG000|Overall Study|Therapeutic Failure|1|||
37982151|NCT00430248|69668754|FG001|Overall Study|Therapeutic Failure|1|||
37982152|NCT00430248|69668755|FG002|Overall Study|Therapeutic Failure|1|||
37982153|NCT00430248|69668753|FG000|Overall Study|Withdrawal by Subject|14|||
37982154|NCT00430248|69668754|FG001|Overall Study|Withdrawal by Subject|20|||
37982155|NCT00430248|69668755|FG002|Overall Study|Withdrawal by Subject|16|||
37982156|NCT00430248|69668753|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
37982157|NCT00430248|69668754|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
37982158|NCT00430248|69668755|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
37982159|NCT00430248|69668753|FG000|Overall Study|Gout Flare|3|||
37982160|NCT00430248|69668754|FG001|Overall Study|Gout Flare|7|||
37982161|NCT00430248|69668755|FG002|Overall Study|Gout Flare|2|||
37982162|NCT00430248|69668753|FG000|Overall Study|Reason Not Specified|8|||
37982163|NCT00430248|69668754|FG001|Overall Study|Reason Not Specified|8|||
37982164|NCT00430248|69668755|FG002|Overall Study|Reason Not Specified|11|||
37982165|NCT00449540|69668765|FG000|Pretreatment Phase|No migraine experienced|66|||
37982166|NCT00449540|69668766|FG001|Pretreatment Phase|No migraine experienced|0|||
37982167|NCT00449540|69668767|FG002|Pretreatment Phase|No migraine experienced|0|||
37982168|NCT00449540|69668765|FG000|Treatment Phase|did not experience or treat migraine|0|||
37982169|NCT00449540|69668766|FG001|Treatment Phase|did not experience or treat migraine|20|||
37982170|NCT00449540|69668767|FG002|Treatment Phase|did not experience or treat migraine|17|||
37982171|NCT00411762|69668775|FG000|Overall Study|Withdrawal by Subject|5|||
37982172|NCT00429858|69668779|FG000|Overall Study|Withdrawal by Subject|1|||
37982173|NCT00429858|69668779|FG000|Overall Study|Study Termination|1|||
37982174|NCT00449150|69668787|FG000|Overall Study|Adverse Event|11|||
37982175|NCT00449150|69668788|FG001|Overall Study|Adverse Event|18|||
37982176|NCT00449150|69668789|FG002|Overall Study|Adverse Event|9|||
37982177|NCT00449150|69668787|FG000|Overall Study|Lack of Efficacy|1|||
37982178|NCT00449150|69668788|FG001|Overall Study|Lack of Efficacy|2|||
37982179|NCT00449150|69668789|FG002|Overall Study|Lack of Efficacy|2|||
37982180|NCT00449150|69668787|FG000|Overall Study|Other|16|||
37982181|NCT00449150|69668788|FG001|Overall Study|Other|13|||
37982182|NCT00449150|69668789|FG002|Overall Study|Other|14|||
37982183|NCT00449150|69668787|FG000|Overall Study|Withdrawal by Subject|17|||
37982184|NCT00449150|69668788|FG001|Overall Study|Withdrawal by Subject|18|||
37982185|NCT00449150|69668789|FG002|Overall Study|Withdrawal by Subject|21|||
37982186|NCT00449150|69668787|FG000|Overall Study|Protocol Violation|1|||
37982187|NCT00449150|69668788|FG001|Overall Study|Protocol Violation|2|||
37982188|NCT00449150|69668789|FG002|Overall Study|Protocol Violation|1|||
37982189|NCT00428844|69668803|FG000|Completed Study Drug Treatment|Adverse Event|2|||
37982190|NCT00428844|69668804|FG001|Completed Study Drug Treatment|Adverse Event|4|||
37982191|NCT00428844|69668805|FG002|Completed Study Drug Treatment|Adverse Event|4|||
37982192|NCT00428844|69668803|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
37982193|NCT00428844|69668804|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
37982194|NCT00428844|69668805|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
37982195|NCT00428844|69668803|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
37982196|NCT00428844|69668804|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
37982197|NCT00428844|69668805|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
37982198|NCT00428844|69668803|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
37982199|NCT00428844|69668804|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
37982200|NCT00428844|69668805|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
37982201|NCT00428844|69668803|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
37874817|NCT01210352|69559427|FG002|Overall Study|Physician Decision|0|||
37874818|NCT01210352|69559428|FG003|Overall Study|Physician Decision|0|||
37982202|NCT00428844|69668804|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
37982203|NCT00428844|69668805|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
37982204|NCT00428844|69668803|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
37982205|NCT00428844|69668804|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
37982206|NCT00428844|69668805|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
37982207|NCT00428844|69668803|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
37982208|NCT00428844|69668804|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
37982209|NCT00428844|69668805|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
37982210|NCT00428844|69668803|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
37982211|NCT00428844|69668804|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
37982212|NCT00428844|69668805|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
37982213|NCT00428844|69668803|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
37982214|NCT00428844|69668804|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
37982215|NCT00428844|69668805|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
37982216|NCT00457418|69668813|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
37982217|NCT00457418|69668813|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
37982218|NCT00457418|69668813|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
37982219|NCT00457418|69668813|FG000|Post PK Maintenance|Adverse Event|10|||
37982220|NCT00457418|69668813|FG000|Post PK Maintenance|Progression of Disease|6|||
37982221|NCT00457418|69668813|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
37982222|NCT00457418|69668813|FG000|Post PK Maintenance|Lost to Follow-up|1|||
37982223|NCT00449072|69668819|FG000|Overall Study|Adverse Event|3|||
37982224|NCT00449072|69668820|FG001|Overall Study|Adverse Event|1|||
37982225|NCT00449072|69668819|FG000|Overall Study|Protocol Violation|14|||
37982226|NCT00449072|69668820|FG001|Overall Study|Protocol Violation|12|||
37982227|NCT00449072|69668819|FG000|Overall Study|Lost to Follow-up|5|||
37982228|NCT00449072|69668820|FG001|Overall Study|Lost to Follow-up|7|||
37982229|NCT00449072|69668819|FG000|Overall Study|Withdrawal by Subject|11|||
37982230|NCT00449072|69668820|FG001|Overall Study|Withdrawal by Subject|8|||
37982231|NCT00449072|69668819|FG000|Overall Study|Lack of Efficacy|1|||
37982232|NCT00449072|69668820|FG001|Overall Study|Lack of Efficacy|1|||
37982233|NCT00449072|69668819|FG000|Overall Study|Physician Decision|1|||
37982234|NCT00449072|69668820|FG001|Overall Study|Physician Decision|0|||
37982235|NCT00449072|69668819|FG000|Overall Study|Not treated|0|||
37982236|NCT00449072|69668820|FG001|Overall Study|Not treated|1|||
37982237|NCT00449072|69668819|FG000|Overall Study|Excluded medication|0|||
37982238|NCT00449072|69668820|FG001|Overall Study|Excluded medication|2|||
37982239|NCT00449072|69668819|FG000|Overall Study|Non-compliance|2|||
37982240|NCT00449072|69668820|FG001|Overall Study|Non-compliance|5|||
37982241|NCT00449072|69668819|FG000|Overall Study|Sponsor decision|1|||
37982242|NCT00449072|69668820|FG001|Overall Study|Sponsor decision|3|||
37982243|NCT00449072|69668819|FG000|Overall Study|Relocation|3|||
37982244|NCT00449072|69668820|FG001|Overall Study|Relocation|2|||
37982245|NCT00428610|69668829|FG000|Overall Study|Death Due to Adverse Event|3|||
37982246|NCT00428610|69668830|FG001|Overall Study|Death Due to Adverse Event|0|||
37982247|NCT00428610|69668831|FG002|Overall Study|Death Due to Adverse Event|5|||
37982248|NCT00428610|69668829|FG000|Overall Study|Death Due to Progressive Disease|0|||
37982249|NCT00428610|69668830|FG001|Overall Study|Death Due to Progressive Disease|0|||
37982250|NCT00428610|69668831|FG002|Overall Study|Death Due to Progressive Disease|2|||
37982251|NCT00428610|69668829|FG000|Overall Study|Adverse Event|2|||
37982252|NCT00428610|69668830|FG001|Overall Study|Adverse Event|3|||
37982253|NCT00428610|69668831|FG002|Overall Study|Adverse Event|2|||
37982254|NCT00428610|69668829|FG000|Overall Study|Investigator Decision|2|||
37982255|NCT00428610|69668830|FG001|Overall Study|Investigator Decision|1|||
37982256|NCT00428610|69668831|FG002|Overall Study|Investigator Decision|1|||
37982257|NCT00428610|69668829|FG000|Overall Study|Progressive Disease|42|||
37982258|NCT00428610|69668830|FG001|Overall Study|Progressive Disease|14|||
37982259|NCT00428610|69668831|FG002|Overall Study|Progressive Disease|22|||
37982260|NCT00428610|69668829|FG000|Overall Study|Withdrawal by Subject|4|||
37982261|NCT00428610|69668830|FG001|Overall Study|Withdrawal by Subject|0|||
37874819|NCT01210352|69559429|FG004|Overall Study|Physician Decision|0|||
37874820|NCT01210352|69559430|FG005|Overall Study|Physician Decision|0|||
37874821|NCT01210352|69559431|FG006|Overall Study|Physician Decision|0|||
37874822|NCT01210352|69559432|FG007|Overall Study|Physician Decision|1|||
37874823|NCT01210352|69559433|FG008|Overall Study|Physician Decision|2|||
37874824|NCT01210352|69559425|FG000|Overall Study|Withdrawal by Subject|0|||
37874825|NCT01210352|69559426|FG001|Overall Study|Withdrawal by Subject|0|||
37874826|NCT01210352|69559427|FG002|Overall Study|Withdrawal by Subject|1|||
37874827|NCT01210352|69559428|FG003|Overall Study|Withdrawal by Subject|0|||
37874828|NCT01210352|69559429|FG004|Overall Study|Withdrawal by Subject|0|||
37874829|NCT01210352|69559430|FG005|Overall Study|Withdrawal by Subject|0|||
37982262|NCT00428610|69668831|FG002|Overall Study|Withdrawal by Subject|0|||
37982263|NCT00419094|69668841|FG000|Overall Study|Adverse Event|3|||
37982264|NCT00419094|69668842|FG001|Overall Study|Adverse Event|7|||
37982265|NCT00419094|69668841|FG000|Overall Study|Lack of Efficacy|1|||
37982266|NCT00419094|69668842|FG001|Overall Study|Lack of Efficacy|0|||
37982267|NCT00419094|69668841|FG000|Overall Study|Lost to Follow-up|0|||
37982268|NCT00419094|69668842|FG001|Overall Study|Lost to Follow-up|2|||
37874830|NCT01210352|69559431|FG006|Overall Study|Withdrawal by Subject|1|||
37982269|NCT00419094|69668841|FG000|Overall Study|Protocol Violation|1|||
37982270|NCT00419094|69668842|FG001|Overall Study|Protocol Violation|14|||
37982271|NCT00419094|69668841|FG000|Overall Study|Withdrawal of consent|1|||
37982272|NCT00419094|69668842|FG001|Overall Study|Withdrawal of consent|5|||
37982273|NCT00419094|69668841|FG000|Overall Study|Other: Error determining exit criteria|1|||
37982274|NCT00419094|69668842|FG001|Overall Study|Other: Error determining exit criteria|0|||
37982275|NCT00419094|69668841|FG000|Overall Study|Other: Patient non-compliant|0|||
37982276|NCT00419094|69668842|FG001|Overall Study|Other: Patient non-compliant|1|||
37982277|NCT00419094|69668841|FG000|Overall Study|Other: No contact for extended period|0|||
37982278|NCT00419094|69668842|FG001|Overall Study|Other: No contact for extended period|1|||
37982279|NCT00448916|69668852|FG000|Overall Study|Adverse Event|2|||
37982280|NCT00448916|69668853|FG001|Overall Study|Adverse Event|2|||
37982281|NCT00448916|69668854|FG002|Overall Study|Adverse Event|3|||
37982282|NCT00448916|69668855|FG003|Overall Study|Adverse Event|2|||
37982283|NCT00448916|69668852|FG000|Overall Study|Lack of Efficacy|1|||
37982284|NCT00448916|69668853|FG001|Overall Study|Lack of Efficacy|0|||
37982285|NCT00448916|69668854|FG002|Overall Study|Lack of Efficacy|2|||
37982286|NCT00448916|69668855|FG003|Overall Study|Lack of Efficacy|1|||
37982287|NCT00448916|69668852|FG000|Overall Study|Withdrawal by Subject|3|||
37982288|NCT00448916|69668853|FG001|Overall Study|Withdrawal by Subject|3|||
37982289|NCT00448916|69668854|FG002|Overall Study|Withdrawal by Subject|1|||
37982290|NCT00448916|69668855|FG003|Overall Study|Withdrawal by Subject|1|||
37982291|NCT00448916|69668852|FG000|Overall Study|Other|1|||
37982292|NCT00448916|69668853|FG001|Overall Study|Other|0|||
37982293|NCT00448916|69668854|FG002|Overall Study|Other|0|||
37982294|NCT00448916|69668855|FG003|Overall Study|Other|0|||
37982295|NCT00448916|69668852|FG000|Overall Study|Lost to Follow-up|0|||
37982296|NCT00448916|69668853|FG001|Overall Study|Lost to Follow-up|1|||
37982297|NCT00448916|69668854|FG002|Overall Study|Lost to Follow-up|0|||
37982298|NCT00448916|69668855|FG003|Overall Study|Lost to Follow-up|1|||
37982299|NCT00448916|69668852|FG000|Overall Study|Protocol Violation|0|||
37982300|NCT00448916|69668853|FG001|Overall Study|Protocol Violation|0|||
37982301|NCT00448916|69668854|FG002|Overall Study|Protocol Violation|0|||
37982302|NCT00448916|69668855|FG003|Overall Study|Protocol Violation|1|||
37982303|NCT00418938|69668869|FG000|Overall Study|Reimbursement|1|||
37982304|NCT00418938|69668870|FG001|Overall Study|Reimbursement|0|||
37982305|NCT00418938|69668869|FG000|Overall Study|Administrative decision|3|||
37982306|NCT00418938|69668870|FG001|Overall Study|Administrative decision|3|||
37982307|NCT00418938|69668869|FG000|Overall Study|Withdrawal by Subject|16|||
37982308|NCT00418938|69668870|FG001|Overall Study|Withdrawal by Subject|15|||
37982309|NCT00418938|69668869|FG000|Overall Study|Lost to Follow-up|1|||
37982310|NCT00418938|69668870|FG001|Overall Study|Lost to Follow-up|3|||
37982311|NCT00418938|69668869|FG000|Overall Study|Adverse Event|1|||
37982312|NCT00418938|69668870|FG001|Overall Study|Adverse Event|1|||
37982313|NCT00418938|69668869|FG000|Overall Study|On-going|1|||
37982314|NCT00418938|69668870|FG001|Overall Study|On-going|1|||
37982315|NCT00418938|69668869|FG000|Overall Study|Ineligibility Determined|1|||
37982316|NCT00418938|69668870|FG001|Overall Study|Ineligibility Determined|0|||
37982317|NCT00448760|69668876|FG000|Overall Study|Death|3|||
37695082|NCT02405780|69171579|FG001|Period I|Non-compliance with study procedures|6|||
37695083|NCT02405780|69171580|FG002|Period I|Non-compliance with study procedures|8|||
37695084|NCT02405780|69171581|FG003|Period I|Non-compliance with study procedures|11|||
37695085|NCT02405780|69171578|FG000|Period II|Adverse Event|3|||
37695086|NCT02405780|69171579|FG001|Period II|Adverse Event|5|||
37695087|NCT02405780|69171580|FG002|Period II|Adverse Event|4|||
37695088|NCT02405780|69171581|FG003|Period II|Adverse Event|11|||
37695089|NCT02405780|69171578|FG000|Period II|Medical reason|0|||
37982318|NCT00418314|69668882|FG000|Overall Study|Withdrawal by Subject|1|||
37982319|NCT00418314|69668883|FG001|Overall Study|Withdrawal by Subject|2|||
37982320|NCT00448448|69668891|FG000|Overall Study|Withdrawal by Subject|13|||
37982321|NCT00448448|69668892|FG001|Overall Study|Withdrawal by Subject|2|||
37982322|NCT00448448|69668891|FG000|Overall Study|On protocol when study ended|83|||
37982323|NCT00448448|69668892|FG001|Overall Study|On protocol when study ended|36|||
37982324|NCT00448448|69668891|FG000|Overall Study|Lost to Follow-up|2|||
37982325|NCT00448448|69668892|FG001|Overall Study|Lost to Follow-up|1|||
37982326|NCT00448448|69668891|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
37982327|NCT00448448|69668892|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
37982328|NCT00448448|69668891|FG000|Overall Study|Signed consent lost|0|||
37982329|NCT00448448|69668892|FG001|Overall Study|Signed consent lost|1|||
37982330|NCT00405912|69668901|FG000|Overall Study|Withdrawal by Subject|12|||
37982331|NCT00405912|69668902|FG001|Overall Study|Withdrawal by Subject|11|||
37982332|NCT00405912|69668903|FG002|Overall Study|Withdrawal by Subject|12|||
37982333|NCT00405912|69668901|FG000|Overall Study|Lost to Follow-up|4|||
37982334|NCT00405912|69668902|FG001|Overall Study|Lost to Follow-up|8|||
37982335|NCT00405912|69668903|FG002|Overall Study|Lost to Follow-up|4|||
37982336|NCT00448136|69668913|FG000|Overall Study|Death|3|||
37982337|NCT00448136|69668914|FG001|Overall Study|Death|8|||
37982338|NCT00448136|69668913|FG000|Overall Study|Investigator's decision (progression)|1|||
37982339|NCT00448136|69668914|FG001|Overall Study|Investigator's decision (progression)|0|||
37982340|NCT00447902|69668922|FG000|Overall Study|Adverse Event|0|||
37982341|NCT00447902|69668923|FG001|Overall Study|Adverse Event|3|||
37982342|NCT00447902|69668922|FG000|Overall Study|Protocol Violation|1|||
37982343|NCT00447902|69668923|FG001|Overall Study|Protocol Violation|0|||
37982344|NCT00447902|69668922|FG000|Overall Study|Withdrawal by Subject|0|||
37874831|NCT01210352|69559432|FG007|Overall Study|Withdrawal by Subject|0|||
37874832|NCT01210352|69559433|FG008|Overall Study|Withdrawal by Subject|1|||
37874833|NCT01210352|69559425|FG000|Overall Study|Patient Discharged Early|0|||
37982345|NCT00447902|69668923|FG001|Overall Study|Withdrawal by Subject|1|||
37982346|NCT00447902|69668922|FG000|Overall Study|included patients who discontinued|1|||
37982347|NCT00447902|69668923|FG001|Overall Study|included patients who discontinued|1|||
37982348|NCT00447902|69668922|FG000|Overall Study|Lack of Efficacy|2|||
37982349|NCT00447902|69668923|FG001|Overall Study|Lack of Efficacy|1|||
37982350|NCT00307437|69668932|FG000|Controlled Period|Adverse Event|7|||
37982351|NCT00307437|69668933|FG001|Controlled Period|Adverse Event|2|||
37982352|NCT00307437|69668934|FG002|Controlled Period|Adverse Event|5|||
37982353|NCT00307437|69668935|FG003|Controlled Period|Adverse Event|0|||
37982354|NCT00307437|69668936|FG004|Controlled Period|Adverse Event|0|||
37982355|NCT00307437|69668937|FG005|Controlled Period|Adverse Event|0|||
37982356|NCT00307437|69668938|FG006|Controlled Period|Adverse Event|0|||
37982357|NCT00307437|69668932|FG000|Controlled Period|Death|0|||
37982358|NCT00307437|69668933|FG001|Controlled Period|Death|0|||
37982359|NCT00307437|69668934|FG002|Controlled Period|Death|1|||
37982360|NCT00307437|69668935|FG003|Controlled Period|Death|0|||
37982361|NCT00307437|69668936|FG004|Controlled Period|Death|0|||
37982362|NCT00307437|69668937|FG005|Controlled Period|Death|0|||
37982363|NCT00307437|69668938|FG006|Controlled Period|Death|0|||
37982364|NCT00307437|69668932|FG000|Controlled Period|Lack of Efficacy|2|||
37982365|NCT00307437|69668933|FG001|Controlled Period|Lack of Efficacy|0|||
37982366|NCT00307437|69668934|FG002|Controlled Period|Lack of Efficacy|0|||
37982367|NCT00307437|69668935|FG003|Controlled Period|Lack of Efficacy|0|||
37982368|NCT00307437|69668936|FG004|Controlled Period|Lack of Efficacy|0|||
37982369|NCT00307437|69668937|FG005|Controlled Period|Lack of Efficacy|0|||
37982370|NCT00307437|69668938|FG006|Controlled Period|Lack of Efficacy|0|||
37982371|NCT00307437|69668932|FG000|Controlled Period|Lost to Follow-up|2|||
37982372|NCT00307437|69668933|FG001|Controlled Period|Lost to Follow-up|3|||
37982373|NCT00307437|69668934|FG002|Controlled Period|Lost to Follow-up|0|||
37982374|NCT00307437|69668935|FG003|Controlled Period|Lost to Follow-up|0|||
37982375|NCT00307437|69668936|FG004|Controlled Period|Lost to Follow-up|0|||
37874834|NCT01210352|69559426|FG001|Overall Study|Patient Discharged Early|0|||
37982376|NCT00307437|69668937|FG005|Controlled Period|Lost to Follow-up|0|||
37982377|NCT00307437|69668938|FG006|Controlled Period|Lost to Follow-up|0|||
37982378|NCT00307437|69668932|FG000|Controlled Period|Other|5|||
37982379|NCT00307437|69668933|FG001|Controlled Period|Other|1|||
37982380|NCT00307437|69668934|FG002|Controlled Period|Other|3|||
37982381|NCT00307437|69668935|FG003|Controlled Period|Other|0|||
37982382|NCT00307437|69668936|FG004|Controlled Period|Other|0|||
37982383|NCT00307437|69668937|FG005|Controlled Period|Other|0|||
37982384|NCT00307437|69668938|FG006|Controlled Period|Other|0|||
37982385|NCT00307437|69668932|FG000|After Controlled Period|Adverse Event|0|||
37874835|NCT01210352|69559427|FG002|Overall Study|Patient Discharged Early|1|||
37874836|NCT01210352|69559428|FG003|Overall Study|Patient Discharged Early|0|||
37874837|NCT01210352|69559429|FG004|Overall Study|Patient Discharged Early|0|||
37874838|NCT01210352|69559430|FG005|Overall Study|Patient Discharged Early|0|||
37982386|NCT00307437|69668933|FG001|After Controlled Period|Adverse Event|0|||
37874839|NCT01210352|69559431|FG006|Overall Study|Patient Discharged Early|0|||
37982387|NCT00307437|69668934|FG002|After Controlled Period|Adverse Event|0|||
37982388|NCT00307437|69668935|FG003|After Controlled Period|Adverse Event|18|||
37982389|NCT00307437|69668936|FG004|After Controlled Period|Adverse Event|16|||
37982390|NCT00307437|69668937|FG005|After Controlled Period|Adverse Event|31|||
37982391|NCT00307437|69668938|FG006|After Controlled Period|Adverse Event|40|||
37982392|NCT00307437|69668932|FG000|After Controlled Period|Death|0|||
37982393|NCT00307437|69668933|FG001|After Controlled Period|Death|0|||
37982394|NCT00307437|69668934|FG002|After Controlled Period|Death|0|||
37982395|NCT00307437|69668935|FG003|After Controlled Period|Death|3|||
37982396|NCT00307437|69668936|FG004|After Controlled Period|Death|1|||
37982397|NCT00307437|69668937|FG005|After Controlled Period|Death|1|||
37982398|NCT00307437|69668938|FG006|After Controlled Period|Death|3|||
37982399|NCT00307437|69668932|FG000|After Controlled Period|Lack of Efficacy|0|||
37982400|NCT00307437|69668933|FG001|After Controlled Period|Lack of Efficacy|0|||
37982401|NCT00307437|69668934|FG002|After Controlled Period|Lack of Efficacy|0|||
37982402|NCT00307437|69668935|FG003|After Controlled Period|Lack of Efficacy|15|||
37982403|NCT00307437|69668936|FG004|After Controlled Period|Lack of Efficacy|17|||
37982404|NCT00307437|69668937|FG005|After Controlled Period|Lack of Efficacy|37|||
37982405|NCT00307437|69668938|FG006|After Controlled Period|Lack of Efficacy|24|||
37982406|NCT00307437|69668932|FG000|After Controlled Period|Lost to Follow-up|0|||
37982407|NCT00307437|69668933|FG001|After Controlled Period|Lost to Follow-up|0|||
37982408|NCT00307437|69668934|FG002|After Controlled Period|Lost to Follow-up|0|||
37982409|NCT00307437|69668935|FG003|After Controlled Period|Lost to Follow-up|7|||
37982410|NCT00307437|69668936|FG004|After Controlled Period|Lost to Follow-up|12|||
37982411|NCT00307437|69668937|FG005|After Controlled Period|Lost to Follow-up|13|||
37982412|NCT00307437|69668938|FG006|After Controlled Period|Lost to Follow-up|18|||
37982413|NCT00307437|69668932|FG000|After Controlled Period|Other|0|||
37982414|NCT00307437|69668933|FG001|After Controlled Period|Other|0|||
37982415|NCT00307437|69668934|FG002|After Controlled Period|Other|0|||
37982416|NCT00307437|69668935|FG003|After Controlled Period|Other|15|||
37982417|NCT00307437|69668936|FG004|After Controlled Period|Other|9|||
37982418|NCT00307437|69668937|FG005|After Controlled Period|Other|40|||
37982419|NCT00307437|69668938|FG006|After Controlled Period|Other|28|||
37982420|NCT00440726|69668963|FG000|Phase 1|Dose-Limiting Toxicity|0|||
37982421|NCT00440726|69668964|FG001|Phase 1|Dose-Limiting Toxicity|1|||
37982422|NCT00440726|69668965|FG002|Phase 1|Dose-Limiting Toxicity|0|||
37982423|NCT00440726|69668963|FG000|Phase 1|Physician Decision|1|||
37982424|NCT00440726|69668964|FG001|Phase 1|Physician Decision|0|||
37982425|NCT00440726|69668965|FG002|Phase 1|Physician Decision|0|||
37982426|NCT00440726|69668963|FG000|Phase 2|Death|0|||
37982427|NCT00440726|69668964|FG001|Phase 2|Death|0|||
37982428|NCT00440726|69668965|FG002|Phase 2|Death|1|||
37982429|NCT00440726|69668963|FG000|Phase 2|Adverse Event|0|||
37982430|NCT00440726|69668964|FG001|Phase 2|Adverse Event|0|||
37982431|NCT00440726|69668965|FG002|Phase 2|Adverse Event|1|||
37982432|NCT00447590|69668976|FG000|Overall Study|Withdrawal by Subject|26|||
37982433|NCT00447590|69668976|FG000|Overall Study|Lost to Follow-up|24|||
37982434|NCT00447590|69668976|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
37982435|NCT00447278|69668982|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
37982436|NCT00447278|69668983|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
37982437|NCT00447278|69668982|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
37982438|NCT00447278|69668983|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
37982439|NCT00447278|69668982|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
37982440|NCT00447278|69668983|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
37982441|NCT00447278|69668982|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
37982442|NCT00447278|69668983|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
37982443|NCT00447278|69668982|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
37982444|NCT00447278|69668983|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
37982445|NCT00447278|69668982|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
37982446|NCT00447278|69668983|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
37982447|NCT00447278|69668982|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
37982448|NCT00447278|69668983|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
37982449|NCT00447278|69668982|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
37982450|NCT00447278|69668983|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
37982451|NCT00447278|69668982|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
37982452|NCT00447278|69668983|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
37982453|NCT00447278|69668982|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
37982454|NCT00447278|69668983|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
37982455|NCT00447278|69668982|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
37982456|NCT00447278|69668983|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
37982457|NCT00447278|69668982|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
37982458|NCT00447278|69668983|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
37982459|NCT00447278|69668982|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
37982460|NCT00447278|69668983|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
37982461|NCT00447278|69668982|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
37982462|NCT00447278|69668983|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
37982463|NCT00446966|69668992|FG000|Overall Study|Lost to Follow-up|10|||
37982464|NCT00446966|69668993|FG001|Overall Study|Lost to Follow-up|7|||
37982465|NCT00446654|69669001|FG000|Overall Study|Withdrawal by Subject|1|||
37982466|NCT00446654|69669002|FG001|Overall Study|Withdrawal by Subject|0|||
37982467|NCT00446654|69669001|FG000|Overall Study|Adverse Event|1|||
37982468|NCT00446654|69669002|FG001|Overall Study|Adverse Event|0|||
37982469|NCT00405756|69669011|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
37874840|NCT01210352|69559432|FG007|Overall Study|Patient Discharged Early|0|||
37874841|NCT01210352|69559433|FG008|Overall Study|Patient Discharged Early|0|||
37874842|NCT01210118|69559540|FG000|Overall Study|Lost to Follow-up|1|||
37874843|NCT01210118|69559541|FG001|Overall Study|Lost to Follow-up|1|||
37874844|NCT01210118|69559540|FG000|Overall Study|Protocol Violation|1|||
37874845|NCT01210118|69559541|FG001|Overall Study|Protocol Violation|1|||
37874846|NCT01210118|69559540|FG000|Overall Study|Spontaneous abortion|1|||
37874847|NCT01210118|69559541|FG001|Overall Study|Spontaneous abortion|3|||
37874848|NCT01208870|69559552|FG000|Overall Study|Lost to Follow-up|2|||
37874849|NCT01208870|69559553|FG001|Overall Study|Lost to Follow-up|8|||
37874850|NCT00880555|69559564|FG000|Overall Study|Physician Decision|0|||
37874851|NCT00880555|69559565|FG001|Overall Study|Physician Decision|8|||
37874852|NCT00880555|69559566|FG002|Overall Study|Physician Decision|0|||
37874853|NCT00880555|69559567|FG003|Overall Study|Physician Decision|2|||
37874854|NCT00880555|69559568|FG004|Overall Study|Physician Decision|1|||
37874855|NCT00880555|69559569|FG005|Overall Study|Physician Decision|0|||
37874856|NCT00880555|69559564|FG000|Overall Study|Withdrawal by Subject|1|||
37874857|NCT00880555|69559565|FG001|Overall Study|Withdrawal by Subject|1|||
37874858|NCT00880555|69559566|FG002|Overall Study|Withdrawal by Subject|0|||
37874859|NCT00880555|69559567|FG003|Overall Study|Withdrawal by Subject|0|||
37874860|NCT00880555|69559568|FG004|Overall Study|Withdrawal by Subject|0|||
37874861|NCT00880555|69559569|FG005|Overall Study|Withdrawal by Subject|0|||
37874862|NCT00880555|69559564|FG000|Overall Study|Lack of resources (hired rater)|9|||
37874863|NCT00880555|69559565|FG001|Overall Study|Lack of resources (hired rater)|7|||
37874864|NCT00880555|69559566|FG002|Overall Study|Lack of resources (hired rater)|5|||
37874865|NCT00880555|69559567|FG003|Overall Study|Lack of resources (hired rater)|0|||
37874866|NCT00880555|69559568|FG004|Overall Study|Lack of resources (hired rater)|0|||
37874867|NCT00880555|69559569|FG005|Overall Study|Lack of resources (hired rater)|0|||
37874868|NCT00880555|69559564|FG000|Overall Study|Death|0|||
37874869|NCT00880555|69559565|FG001|Overall Study|Death|0|||
37874870|NCT00880555|69559566|FG002|Overall Study|Death|0|||
37874871|NCT00880555|69559567|FG003|Overall Study|Death|0|||
37874872|NCT00880555|69559568|FG004|Overall Study|Death|0|||
37874873|NCT00880555|69559569|FG005|Overall Study|Death|1|||
37874874|NCT00880555|69559564|FG000|Overall Study|Lost to Follow-up|0|||
37874875|NCT00880555|69559565|FG001|Overall Study|Lost to Follow-up|1|||
37874876|NCT00880555|69559566|FG002|Overall Study|Lost to Follow-up|0|||
37874877|NCT00880555|69559567|FG003|Overall Study|Lost to Follow-up|0|||
37874878|NCT00880555|69559568|FG004|Overall Study|Lost to Follow-up|0|||
37874879|NCT00880555|69559569|FG005|Overall Study|Lost to Follow-up|0|||
37874880|NCT01208402|69559582|FG000|Overall Study|Withdrawal by Subject|1|||
37874881|NCT01208402|69559583|FG001|Overall Study|Withdrawal by Subject|0|||
37874882|NCT01208324|69559593|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
37817470|NCT04391894|69496475|FG003|Overall Study|Lost to Follow-up|0|||
37817471|NCT04391894|69496476|FG004|Overall Study|Lost to Follow-up|0|||
37817472|NCT04391894|69496472|FG000|Overall Study|Protocol Violation|0|||
37817473|NCT04391894|69496473|FG001|Overall Study|Protocol Violation|0|||
37817474|NCT04391894|69496474|FG002|Overall Study|Protocol Violation|0|||
37817475|NCT04391894|69496475|FG003|Overall Study|Protocol Violation|1|||
37817476|NCT04391894|69496476|FG004|Overall Study|Protocol Violation|0|||
37817477|NCT04391894|69496472|FG000|Overall Study|Withdrawal by Subject|2|||
37817478|NCT04391894|69496473|FG001|Overall Study|Withdrawal by Subject|0|||
37817479|NCT04391894|69496474|FG002|Overall Study|Withdrawal by Subject|3|||
37817480|NCT04391894|69496475|FG003|Overall Study|Withdrawal by Subject|0|||
37874883|NCT01208324|69559594|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
37874884|NCT01208324|69559595|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
37874885|NCT01208324|69559596|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
37874886|NCT00880399|69559609|FG000|Overall Study|Adverse Event|4|||
37874887|NCT00880399|69559610|FG001|Overall Study|Adverse Event|6|||
37874888|NCT00880399|69559611|FG002|Overall Study|Adverse Event|5|||
37874889|NCT00880399|69559609|FG000|Overall Study|Lack of Efficacy|1|||
37874890|NCT00880399|69559610|FG001|Overall Study|Lack of Efficacy|4|||
37874891|NCT00880399|69559611|FG002|Overall Study|Lack of Efficacy|2|||
37874892|NCT00880399|69559609|FG000|Overall Study|Protocol Violation|4|||
37817481|NCT04391894|69496476|FG004|Overall Study|Withdrawal by Subject|1|||
37874893|NCT00880399|69559610|FG001|Overall Study|Protocol Violation|4|||
37874894|NCT00880399|69559611|FG002|Overall Study|Protocol Violation|6|||
37874895|NCT00880399|69559609|FG000|Overall Study|Study closed/terminated|3|||
37874896|NCT00880399|69559610|FG001|Overall Study|Study closed/terminated|7|||
37874897|NCT00880399|69559611|FG002|Overall Study|Study closed/terminated|4|||
37874898|NCT00880399|69559609|FG000|Overall Study|Lost to Follow-up|8|||
37874899|NCT00880399|69559610|FG001|Overall Study|Lost to Follow-up|5|||
37874900|NCT00880399|69559611|FG002|Overall Study|Lost to Follow-up|3|||
37874901|NCT00880399|69559609|FG000|Overall Study|Physician Decision|5|||
37874902|NCT00880399|69559610|FG001|Overall Study|Physician Decision|0|||
37874903|NCT00880399|69559611|FG002|Overall Study|Physician Decision|3|||
37874904|NCT00880399|69559609|FG000|Overall Study|Withdrawal by Subject|6|||
37982470|NCT00405756|69669012|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
37982471|NCT00405756|69669013|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
37982472|NCT00405756|69669011|FG000|Double-blind Treatment|Adverse Event|31|||
37982473|NCT00405756|69669012|FG001|Double-blind Treatment|Adverse Event|27|||
37982474|NCT00405756|69669013|FG002|Double-blind Treatment|Adverse Event|12|||
37982475|NCT00405756|69669011|FG000|Double-blind Treatment|Disease Progression|47|||
37982476|NCT00405756|69669012|FG001|Double-blind Treatment|Disease Progression|81|||
37982477|NCT00405756|69669013|FG002|Double-blind Treatment|Disease Progression|102|||
37982478|NCT00405756|69669011|FG000|Double-blind Treatment|Lack of Efficacy|1|||
37982479|NCT00405756|69669012|FG001|Double-blind Treatment|Lack of Efficacy|4|||
37982480|NCT00405756|69669013|FG002|Double-blind Treatment|Lack of Efficacy|2|||
37982481|NCT00405756|69669011|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
37982482|NCT00405756|69669012|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
37982483|NCT00405756|69669013|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
37982484|NCT00405756|69669011|FG000|Double-blind Treatment|Lost to Follow-up|1|||
37982485|NCT00405756|69669012|FG001|Double-blind Treatment|Lost to Follow-up|0|||
37874905|NCT00880399|69559610|FG001|Overall Study|Withdrawal by Subject|3|||
37874906|NCT00880399|69559611|FG002|Overall Study|Withdrawal by Subject|3|||
37874907|NCT01207388|69559619|FG000|Overall Study|Death|67|||
37874908|NCT01207388|69559619|FG000|Overall Study|Withdrawal by Subject|1|||
37874909|NCT01206764|69559631|FG000|Overall Study|Adverse Event|20|||
37874910|NCT01206764|69559631|FG000|Overall Study|Abnormal laboratory value|2|||
37874911|NCT01206764|69559631|FG000|Overall Study|Abnormal test procedure result|1|||
37874912|NCT01206764|69559631|FG000|Overall Study|Patient withdrew consent|5|||
37874913|NCT01206764|69559631|FG000|Overall Study|Lost to Follow-up|6|||
37874914|NCT01206764|69559631|FG000|Overall Study|Death|11|||
37874915|NCT01206764|69559631|FG000|Overall Study|New cancer therapy|2|||
37874916|NCT01206764|69559631|FG000|Overall Study|Disease progression|88|||
37874917|NCT01206764|69559631|FG000|Overall Study|Protocol deviation|3|||
37874918|NCT00894322|69559638|FG000|Overall Study|Withdrawal by Subject|1|||
37874919|NCT00894322|69559639|FG001|Overall Study|Withdrawal by Subject|0|||
37874920|NCT00894322|69559640|FG002|Overall Study|Withdrawal by Subject|0|||
37874921|NCT00596635|69559653|FG000|Overall Study|Lost to Follow-up|0|||
37874922|NCT00596635|69559654|FG001|Overall Study|Lost to Follow-up|2|||
37874923|NCT00596635|69559655|FG002|Overall Study|Lost to Follow-up|0|||
37874924|NCT00596635|69559653|FG000|Overall Study|Treatment for symptomatic UTI|4|||
37874925|NCT00596635|69559654|FG001|Overall Study|Treatment for symptomatic UTI|6|||
37874926|NCT00596635|69559655|FG002|Overall Study|Treatment for symptomatic UTI|3|||
37874927|NCT00596635|69559653|FG000|Overall Study|Hip fracture|2|||
37874928|NCT00596635|69559654|FG001|Overall Study|Hip fracture|3|||
37874929|NCT00596635|69559655|FG002|Overall Study|Hip fracture|3|||
37874930|NCT00596635|69559653|FG000|Overall Study|Could not provide urine specimen|1|||
37874931|NCT00596635|69559654|FG001|Overall Study|Could not provide urine specimen|2|||
37874932|NCT00596635|69559655|FG002|Overall Study|Could not provide urine specimen|2|||
37874933|NCT00894166|69559671|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
37874934|NCT00894166|69559672|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
37874935|NCT00894166|69559673|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
37874936|NCT00894166|69559674|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
37874937|NCT00894166|69559675|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
37874938|NCT00894166|69559676|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
37874939|NCT00894166|69559677|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
37874940|NCT00894166|69559678|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
37874941|NCT00894166|69559671|FG000|Overall Study|Death|0|||
37874942|NCT00894166|69559672|FG001|Overall Study|Death|0|||
37874943|NCT00894166|69559673|FG002|Overall Study|Death|0|||
37982486|NCT00405756|69669013|FG002|Double-blind Treatment|Lost to Follow-up|0|||
37982487|NCT00405756|69669011|FG000|Double-blind Treatment|Death|4|||
37982488|NCT00405756|69669012|FG001|Double-blind Treatment|Death|4|||
37874944|NCT00894166|69559674|FG003|Overall Study|Death|1|||
37874945|NCT00894166|69559675|FG004|Overall Study|Death|0|||
37874946|NCT00894166|69559676|FG005|Overall Study|Death|0|||
37874947|NCT00894166|69559677|FG006|Overall Study|Death|0|||
37874948|NCT00894166|69559678|FG007|Overall Study|Death|0|||
37874949|NCT00880165|69559703|FG000|Overall Study|Withdrawal by Subject|27|||
37874950|NCT00880165|69559704|FG001|Overall Study|Withdrawal by Subject|23|||
37874951|NCT00880165|69559703|FG000|Overall Study|Not diagnosed with OSA|14|||
37874952|NCT00880165|69559704|FG001|Overall Study|Not diagnosed with OSA|8|||
37874953|NCT00880165|69559703|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
37874954|NCT00880165|69559704|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
37874955|NCT00880165|69559703|FG000|Overall Study|Lost to follow|9|||
37874956|NCT00880165|69559704|FG001|Overall Study|Lost to follow|15|||
37874957|NCT01165229|69559712|FG000|Overall Study|Serious Adverse Event|456|||
37874958|NCT01165229|69559713|FG001|Overall Study|Serious Adverse Event|487|||
37874959|NCT01165229|69559712|FG000|Overall Study|Non-Serious Adverse Event|47|||
37874960|NCT01165229|69559713|FG001|Overall Study|Non-Serious Adverse Event|15|||
37874961|NCT01165229|69559712|FG000|Overall Study|Protocol Violation|6|||
37874962|NCT01165229|69559713|FG001|Overall Study|Protocol Violation|8|||
37874963|NCT01165229|69559712|FG000|Overall Study|Withdrawal by Subject|387|||
37874964|NCT01165229|69559713|FG001|Overall Study|Withdrawal by Subject|396|||
37874965|NCT01165229|69559712|FG000|Overall Study|Migrated/moved from study area|51|||
37874966|NCT01165229|69559713|FG001|Overall Study|Migrated/moved from study area|46|||
37874967|NCT01165229|69559712|FG000|Overall Study|Lost to Follow-up|123|||
37874968|NCT01165229|69559713|FG001|Overall Study|Lost to Follow-up|133|||
37874969|NCT01165229|69559712|FG000|Overall Study|Suspected HZ Episode|2|||
37817482|NCT04391894|69496472|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
37817483|NCT04391894|69496473|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
37817484|NCT04391894|69496474|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
37817485|NCT04391894|69496475|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
37817486|NCT04391894|69496476|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
37817487|NCT03851705|69496494|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
37817488|NCT03851705|69496495|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
37817489|NCT03851705|69496496|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
37817490|NCT03851705|69496497|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
37817491|NCT03851705|69496494|FG000|Part 1: Double-Blind Period|Other reason|1|||
37817492|NCT03851705|69496495|FG001|Part 1: Double-Blind Period|Other reason|0|||
37817493|NCT03851705|69496496|FG002|Part 1: Double-Blind Period|Other reason|0|||
37817494|NCT03851705|69496497|FG003|Part 1: Double-Blind Period|Other reason|0|||
37817495|NCT03851705|69496494|FG000|Part 2: Open-Label Period|Other reason|0|||
37874970|NCT01165229|69559713|FG001|Overall Study|Suspected HZ Episode|2|||
37874971|NCT01165229|69559712|FG000|Overall Study|No reason from the subject|108|||
37874972|NCT01165229|69559713|FG001|Overall Study|No reason from the subject|102|||
37874973|NCT01165229|69559712|FG000|Overall Study|Unknown completion status|0|||
37874974|NCT01165229|69559713|FG001|Overall Study|Unknown completion status|1|||
37874975|NCT00596011|69559751|FG000|Overall Study|Withdrawal by Subject|2|||
37874976|NCT00596011|69559752|FG001|Overall Study|Withdrawal by Subject|3|||
37817496|NCT03851705|69496495|FG001|Part 2: Open-Label Period|Other reason|0|||
37817497|NCT03851705|69496496|FG002|Part 2: Open-Label Period|Other reason|0|||
37817498|NCT03851705|69496497|FG003|Part 2: Open-Label Period|Other reason|1|||
37874977|NCT00596011|69559751|FG000|Overall Study|Adverse Event|11|||
37874978|NCT00596011|69559752|FG001|Overall Study|Adverse Event|7|||
37874979|NCT01163747|69559760|FG000|Overall Study|Adverse Event|0|||
37874980|NCT01163747|69559761|FG001|Overall Study|Adverse Event|5|||
37874981|NCT01163747|69559760|FG000|Overall Study|Insufficient Therapeutic Response|0|||
37874982|NCT01163747|69559761|FG001|Overall Study|Insufficient Therapeutic Response|1|||
37874983|NCT01163747|69559760|FG000|Overall Study|Protocol Violation|0|||
37874984|NCT01163747|69559761|FG001|Overall Study|Protocol Violation|1|||
37874985|NCT01163747|69559760|FG000|Overall Study|Refused Treatment|6|||
37874986|NCT01163747|69559761|FG001|Overall Study|Refused Treatment|4|||
37874987|NCT01163279|69559769|FG000|Overall Study|Withdrawal by Subject|2|||
37874988|NCT01163279|69559770|FG001|Overall Study|Withdrawal by Subject|0|||
37874989|NCT01162499|69559777|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
37874990|NCT01162499|69559778|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
37874991|NCT01206140|69559788|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
37874992|NCT01206140|69559789|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
37874993|NCT01162421|69559797|FG000|Overall Study|Did not receive study drug|2|||
37874994|NCT01162421|69559798|FG001|Overall Study|Did not receive study drug|1|||
37874995|NCT01162421|69559797|FG000|Overall Study|Adverse Event|2|||
37874996|NCT01162421|69559798|FG001|Overall Study|Adverse Event|5|||
37874997|NCT01162421|69559797|FG000|Overall Study|Lost to Follow-up|0|||
37874998|NCT01162421|69559798|FG001|Overall Study|Lost to Follow-up|2|||
37874999|NCT01162421|69559797|FG000|Overall Study|Lack of Efficacy|2|||
37875000|NCT01162421|69559798|FG001|Overall Study|Lack of Efficacy|2|||
37875001|NCT01162421|69559797|FG000|Overall Study|Other|2|||
37875002|NCT01162421|69559798|FG001|Overall Study|Other|3|||
37875003|NCT01162343|69559804|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
37875004|NCT01162343|69559804|FG000|Overall Study|Refused psychiatrist assessment|12|||
37875005|NCT01188551|69559812|FG000|Overall Study|Pharmacy issues|1|||
37875006|NCT01188551|69559813|FG001|Overall Study|Pharmacy issues|0|||
37875007|NCT01188551|69559814|FG002|Overall Study|Pharmacy issues|0|||
37875008|NCT01188551|69559815|FG003|Overall Study|Pharmacy issues|0|||
37875009|NCT01161407|69559827|FG000|Overall Study|Protocol Violation|3|||
37875010|NCT01161407|69559828|FG001|Overall Study|Protocol Violation|1|||
37875011|NCT01161173|69559834|FG000|Overall Study|Protocol Violation|13|||
37875012|NCT01161173|69559834|FG000|Overall Study|Lost to Follow-up|7|||
37875013|NCT01161173|69559834|FG000|Overall Study|Progressive Disease|82|||
37875014|NCT01161173|69559834|FG000|Overall Study|Withdrawal of Consent|5|||
37875015|NCT01161173|69559834|FG000|Overall Study|Unacceptable Toxicity|21|||
37875016|NCT01161173|69559834|FG000|Overall Study|Death|194|||
37875017|NCT01161173|69559834|FG000|Overall Study|End of Study|2|||
37875018|NCT01161173|69559834|FG000|Overall Study|Reasons Not Specified|23|||
37875019|NCT01159769|69559838|FG000|Overall Study|Adverse Event|1|||
37817499|NCT03851705|69496494|FG000|Part 2: Open-Label Period|Death|0|||
37817500|NCT03851705|69496495|FG001|Part 2: Open-Label Period|Death|0|||
37817501|NCT03851705|69496496|FG002|Part 2: Open-Label Period|Death|3|||
37817502|NCT03851705|69496497|FG003|Part 2: Open-Label Period|Death|0|||
37817503|NCT03851705|69496494|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
37817504|NCT03851705|69496495|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
37875020|NCT01159691|69559842|FG000|Overall Study|Lost to Follow-up|2|||
37875021|NCT01159691|69559842|FG000|Overall Study|Unknown reasons|1|||
37875022|NCT01159691|69559842|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
37875023|NCT01159691|69559842|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
37875024|NCT01159691|69559842|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
37982489|NCT00405756|69669013|FG002|Double-blind Treatment|Death|4|||
37817505|NCT03851705|69496496|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
37817506|NCT03851705|69496497|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
37817507|NCT03824366|69496510|FG000|Overall Study|Death|1|||
37817508|NCT03824366|69496510|FG000|Overall Study|Previously unidentified metal artifact|1|||
37875025|NCT01159691|69559842|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
37875026|NCT01159691|69559842|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
37875027|NCT01159691|69559842|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
37875028|NCT01157897|69559850|FG000|Overall Study|Lost to Follow-up|2|||
37875029|NCT01157897|69559851|FG001|Overall Study|Lost to Follow-up|0|||
37875030|NCT01157897|69559852|FG002|Overall Study|Lost to Follow-up|0|||
37875031|NCT01157897|69559853|FG003|Overall Study|Lost to Follow-up|1|||
37875032|NCT01157897|69559850|FG000|Overall Study|Relocated|0|||
37875033|NCT01157897|69559851|FG001|Overall Study|Relocated|2|||
37875034|NCT01157897|69559852|FG002|Overall Study|Relocated|0|||
37875035|NCT01157897|69559853|FG003|Overall Study|Relocated|0|||
37875036|NCT01185821|69559868|FG000|Overall Study|Abnormal laboratory value(s)|1|||
37875037|NCT01185821|69559869|FG001|Overall Study|Abnormal laboratory value(s)|2|||
37875038|NCT01185821|69559870|FG002|Overall Study|Abnormal laboratory value(s)|1|||
37875039|NCT01185821|69559871|FG003|Overall Study|Abnormal laboratory value(s)|0|||
37875040|NCT01185821|69559872|FG004|Overall Study|Abnormal laboratory value(s)|0|||
37875041|NCT01185821|69559868|FG000|Overall Study|Protocol Violation|0|||
37875042|NCT01185821|69559869|FG001|Overall Study|Protocol Violation|0|||
37875043|NCT01185821|69559870|FG002|Overall Study|Protocol Violation|0|||
37875044|NCT01185821|69559871|FG003|Overall Study|Protocol Violation|1|||
37875045|NCT01185821|69559872|FG004|Overall Study|Protocol Violation|1|||
37875046|NCT01185821|69559868|FG000|Overall Study|Abnormal test procedure result|0|||
37875047|NCT01185821|69559869|FG001|Overall Study|Abnormal test procedure result|0|||
37875048|NCT01185821|69559870|FG002|Overall Study|Abnormal test procedure result|0|||
37875049|NCT01185821|69559871|FG003|Overall Study|Abnormal test procedure result|0|||
37875050|NCT01185821|69559872|FG004|Overall Study|Abnormal test procedure result|1|||
37875051|NCT01185821|69559868|FG000|Overall Study|Death|0|||
37875052|NCT01185821|69559869|FG001|Overall Study|Death|1|||
37875053|NCT01185821|69559870|FG002|Overall Study|Death|0|||
37875054|NCT01185821|69559871|FG003|Overall Study|Death|0|||
37875055|NCT01185821|69559872|FG004|Overall Study|Death|0|||
37875056|NCT01185821|69559868|FG000|Overall Study|Condition no longer required study drug|0|||
37875057|NCT01185821|69559869|FG001|Overall Study|Condition no longer required study drug|0|||
37875058|NCT01185821|69559870|FG002|Overall Study|Condition no longer required study drug|0|||
37875059|NCT01185821|69559871|FG003|Overall Study|Condition no longer required study drug|0|||
37875060|NCT01185821|69559872|FG004|Overall Study|Condition no longer required study drug|1|||
37875061|NCT01185821|69559868|FG000|Overall Study|Adverse Event|2|||
37875062|NCT01185821|69559869|FG001|Overall Study|Adverse Event|3|||
37875063|NCT01185821|69559870|FG002|Overall Study|Adverse Event|1|||
37875064|NCT01185821|69559871|FG003|Overall Study|Adverse Event|2|||
37875065|NCT01185821|69559872|FG004|Overall Study|Adverse Event|5|||
37875066|NCT01185821|69559868|FG000|Overall Study|Lack of Efficacy|0|||
37875067|NCT01185821|69559869|FG001|Overall Study|Lack of Efficacy|0|||
37875068|NCT01185821|69559870|FG002|Overall Study|Lack of Efficacy|3|||
37875069|NCT01185821|69559871|FG003|Overall Study|Lack of Efficacy|0|||
37875070|NCT01185821|69559872|FG004|Overall Study|Lack of Efficacy|9|||
37875071|NCT01185821|69559868|FG000|Overall Study|Withdrawal by Subject|3|||
37875072|NCT01185821|69559869|FG001|Overall Study|Withdrawal by Subject|2|||
37875073|NCT01185821|69559870|FG002|Overall Study|Withdrawal by Subject|2|||
37875074|NCT01185821|69559871|FG003|Overall Study|Withdrawal by Subject|1|||
37875075|NCT01185821|69559872|FG004|Overall Study|Withdrawal by Subject|3|||
37875076|NCT01185821|69559868|FG000|Overall Study|Lost to Follow-up|1|||
37875077|NCT01185821|69559869|FG001|Overall Study|Lost to Follow-up|1|||
37875078|NCT01185821|69559870|FG002|Overall Study|Lost to Follow-up|2|||
37875079|NCT01185821|69559871|FG003|Overall Study|Lost to Follow-up|1|||
37875080|NCT01185821|69559872|FG004|Overall Study|Lost to Follow-up|2|||
37875081|NCT01185821|69559868|FG000|Overall Study|Administrative problems|0|||
37875082|NCT01185821|69559869|FG001|Overall Study|Administrative problems|0|||
37875083|NCT01185821|69559870|FG002|Overall Study|Administrative problems|1|||
37875084|NCT01185821|69559871|FG003|Overall Study|Administrative problems|1|||
37982490|NCT00405756|69669011|FG000|Double-blind Treatment|Protocol Violation|1|||
37875085|NCT01185821|69559872|FG004|Overall Study|Administrative problems|2|||
37875086|NCT00893464|69559894|FG000|Overall Study|Did not complete therapy/experience PD|0|||
37875087|NCT00893464|69559895|FG001|Overall Study|Did not complete therapy/experience PD|0|||
37875088|NCT00893464|69559896|FG002|Overall Study|Did not complete therapy/experience PD|0|||
37875089|NCT00893464|69559897|FG003|Overall Study|Did not complete therapy/experience PD|0|||
37875090|NCT00893464|69559898|FG004|Overall Study|Did not complete therapy/experience PD|0|||
37875091|NCT00893464|69559899|FG005|Overall Study|Did not complete therapy/experience PD|0|||
37875092|NCT00893464|69559900|FG006|Overall Study|Did not complete therapy/experience PD|2|||
37875093|NCT00893464|69559901|FG007|Overall Study|Did not complete therapy/experience PD|2|||
37982491|NCT00405756|69669012|FG001|Double-blind Treatment|Protocol Violation|0|||
37875094|NCT00891904|69559924|FG000|Overall Study|Death|1|||
37875095|NCT00891904|69559924|FG000|Overall Study|Adverse Event|1|||
37982492|NCT00405756|69669013|FG002|Double-blind Treatment|Protocol Violation|2|||
37982493|NCT00405756|69669011|FG000|Double-blind Treatment|Other|7|||
37982494|NCT00405756|69669012|FG001|Double-blind Treatment|Other|4|||
37982495|NCT00405756|69669013|FG002|Double-blind Treatment|Other|4|||
37982496|NCT00405756|69669011|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
37982497|NCT00405756|69669012|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
37982498|NCT00405756|69669013|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
37982499|NCT00405756|69669011|FG000|Open-label Extension|Adverse Event|1|||
37982500|NCT00405756|69669012|FG001|Open-label Extension|Adverse Event|3|||
37982501|NCT00405756|69669013|FG002|Open-label Extension|Adverse Event|7|||
37982502|NCT00405756|69669011|FG000|Open-label Extension|Disease Progression|8|||
37982503|NCT00405756|69669012|FG001|Open-label Extension|Disease Progression|23|||
37982504|NCT00405756|69669013|FG002|Open-label Extension|Disease Progression|26|||
37982505|NCT00405756|69669011|FG000|Open-label Extension|Withdrawal by Subject|2|||
37982506|NCT00405756|69669012|FG001|Open-label Extension|Withdrawal by Subject|3|||
37982507|NCT00405756|69669013|FG002|Open-label Extension|Withdrawal by Subject|3|||
37982508|NCT00405756|69669011|FG000|Open-label Extension|Death|1|||
37982509|NCT00405756|69669012|FG001|Open-label Extension|Death|2|||
37982510|NCT00405756|69669013|FG002|Open-label Extension|Death|4|||
37982511|NCT00405756|69669011|FG000|Open-label Extension|Other|0|||
37982512|NCT00405756|69669012|FG001|Open-label Extension|Other|1|||
37982513|NCT00405756|69669013|FG002|Open-label Extension|Other|7|||
37982514|NCT00405756|69669011|FG000|Follow-up|Ongoing in Follow-up Period|52|||
37982515|NCT00405756|69669012|FG001|Follow-up|Ongoing in Follow-up Period|51|||
37982516|NCT00405756|69669013|FG002|Follow-up|Ongoing in Follow-up Period|60|||
37982517|NCT00405756|69669011|FG000|Follow-up|Death|21|||
37982518|NCT00405756|69669012|FG001|Follow-up|Death|31|||
37982519|NCT00405756|69669013|FG002|Follow-up|Death|24|||
37982520|NCT00405756|69669011|FG000|Follow-up|Lost to Follow-up|2|||
37982521|NCT00405756|69669012|FG001|Follow-up|Lost to Follow-up|8|||
37982522|NCT00405756|69669013|FG002|Follow-up|Lost to Follow-up|4|||
37982523|NCT00456092|69669024|FG000|Extension Phase|Grade 2 or Greater AE|2|||
37982524|NCT00456092|69669025|FG001|Extension Phase|Grade 2 or Greater AE|2|||
37982525|NCT00456092|69669026|FG002|Extension Phase|Grade 2 or Greater AE|0|||
37875096|NCT01157351|69559930|FG000|Overall Study|Adverse Event|5|||
37875097|NCT01157351|69559931|FG001|Overall Study|Adverse Event|4|||
37875098|NCT01157351|69559930|FG000|Overall Study|Death|1|||
37875099|NCT01157351|69559931|FG001|Overall Study|Death|0|||
37875100|NCT01157351|69559930|FG000|Overall Study|Lost to Follow-up|53|||
37875101|NCT01157351|69559931|FG001|Overall Study|Lost to Follow-up|55|||
37875102|NCT01157351|69559930|FG000|Overall Study|Withdrawal by Subject|37|||
37982526|NCT00456092|69669027|FG003|Extension Phase|Grade 2 or Greater AE|0|||
37982527|NCT00456092|69669028|FG004|Extension Phase|Grade 2 or Greater AE|2|||
37982528|NCT00456092|69669024|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
37982529|NCT00456092|69669025|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
37982530|NCT00456092|69669026|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
37982531|NCT00456092|69669027|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
37982532|NCT00456092|69669028|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
37982533|NCT00456092|69669024|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
37982534|NCT00456092|69669025|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
37982535|NCT00456092|69669026|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
37982536|NCT00456092|69669027|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
37982537|NCT00456092|69669028|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
37982538|NCT00456092|69669024|FG000|Extension Phase|Withdrew Consent|2|||
37817509|NCT03824366|69496510|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
37817510|NCT03824366|69496510|FG000|Overall Study|Withdrawal by Subject|1|||
37817511|NCT03810313|69496516|FG000|Overall Study|Study terminated by sponsor|164|||
37875103|NCT01157351|69559931|FG001|Overall Study|Withdrawal by Subject|27|||
37982539|NCT00456092|69669025|FG001|Extension Phase|Withdrew Consent|0|||
37982540|NCT00456092|69669026|FG002|Extension Phase|Withdrew Consent|0|||
37982541|NCT00456092|69669027|FG003|Extension Phase|Withdrew Consent|0|||
37982542|NCT00456092|69669028|FG004|Extension Phase|Withdrew Consent|0|||
37982543|NCT00456092|69669024|FG000|Extension Phase|Lost to Follow-up|1|||
37982544|NCT00456092|69669025|FG001|Extension Phase|Lost to Follow-up|1|||
37982545|NCT00456092|69669026|FG002|Extension Phase|Lost to Follow-up|0|||
37982546|NCT00456092|69669027|FG003|Extension Phase|Lost to Follow-up|0|||
37982547|NCT00456092|69669028|FG004|Extension Phase|Lost to Follow-up|1|||
37982548|NCT00456092|69669024|FG000|Extension Phase|Other|2|||
37982549|NCT00456092|69669025|FG001|Extension Phase|Other|0|||
37875104|NCT01157351|69559930|FG000|Overall Study|Physician Decision|5|||
37875105|NCT01157351|69559931|FG001|Overall Study|Physician Decision|4|||
37982550|NCT00456092|69669026|FG002|Extension Phase|Other|0|||
37982551|NCT00456092|69669027|FG003|Extension Phase|Other|1|||
37982552|NCT00456092|69669028|FG004|Extension Phase|Other|1|||
37982553|NCT00456092|69669024|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
37982554|NCT00456092|69669025|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
37982555|NCT00456092|69669026|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
37982556|NCT00456092|69669027|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
37982557|NCT00456092|69669028|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
37982558|NCT00456092|69669024|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
37982559|NCT00456092|69669025|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
37982560|NCT00456092|69669026|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
37982561|NCT00456092|69669027|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
37982562|NCT00456092|69669028|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
37982563|NCT00456092|69669024|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
37982564|NCT00456092|69669025|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
37982565|NCT00456092|69669026|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
37982566|NCT00456092|69669027|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
37982567|NCT00456092|69669028|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
37982568|NCT00456092|69669024|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
37982569|NCT00456092|69669025|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
37982570|NCT00456092|69669026|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
37982571|NCT00456092|69669027|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
37982572|NCT00456092|69669028|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
37875106|NCT01157351|69559930|FG000|Overall Study|Protocol Violation|0|||
37875107|NCT01157351|69559931|FG001|Overall Study|Protocol Violation|1|||
37875108|NCT01157351|69559930|FG000|Overall Study|Other|32|||
37875109|NCT01157351|69559931|FG001|Overall Study|Other|36|||
37875110|NCT01157351|69559930|FG000|Overall Study|Noncompliance with Study Drug|0|||
37875111|NCT01157351|69559931|FG001|Overall Study|Noncompliance with Study Drug|3|||
37875112|NCT01157351|69559930|FG000|Overall Study|Randomized but not Treated|4|||
37875113|NCT01157351|69559931|FG001|Overall Study|Randomized but not Treated|2|||
37875114|NCT01157117|69559940|FG000|Overall Study|Dosing Symptoms|0|||
37875115|NCT01157117|69559941|FG001|Overall Study|Dosing Symptoms|4|||
37875116|NCT01157117|69559942|FG002|Overall Study|Dosing Symptoms|0|||
37875117|NCT01157117|69559940|FG000|Overall Study|Withdrawal by Subject|4|||
37875118|NCT01157117|69559941|FG001|Overall Study|Withdrawal by Subject|1|||
37875119|NCT01157117|69559942|FG002|Overall Study|Withdrawal by Subject|1|||
37875120|NCT01157117|69559940|FG000|Overall Study|Lack of Efficacy|1|||
37875121|NCT01157117|69559941|FG001|Overall Study|Lack of Efficacy|1|||
37875122|NCT01157117|69559942|FG002|Overall Study|Lack of Efficacy|0|||
37875123|NCT01157117|69559940|FG000|Overall Study|Lost to Follow-up|0|||
37875124|NCT01157117|69559941|FG001|Overall Study|Lost to Follow-up|0|||
37875125|NCT01157117|69559942|FG002|Overall Study|Lost to Follow-up|1|||
37875126|NCT01157117|69559940|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
37875127|NCT01157117|69559941|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
37875128|NCT01157117|69559942|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
37875129|NCT00891202|69559952|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
37875130|NCT00891202|69559953|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
37875131|NCT00891202|69559954|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
37875132|NCT00891202|69559955|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
37875133|NCT00891202|69559952|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
37875134|NCT00891202|69559953|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
37875135|NCT00891202|69559954|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
37875136|NCT00891202|69559955|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
37875137|NCT00891202|69559952|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
37875138|NCT00891202|69559953|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
37875139|NCT00891202|69559954|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
37875140|NCT00891202|69559955|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
37875141|NCT00891202|69559952|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
37875142|NCT00891202|69559953|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
37875143|NCT00891202|69559954|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
37875144|NCT00891202|69559955|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
37875145|NCT01185509|69559965|FG000|Overall Study|Progression/Relapse|9|||
37875146|NCT01185509|69559966|FG001|Overall Study|Progression/Relapse|15|||
37875147|NCT01185509|69559965|FG000|Overall Study|Physician Decision|2|||
37875148|NCT01185509|69559966|FG001|Overall Study|Physician Decision|2|||
37982573|NCT00456092|69669024|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
37982574|NCT00456092|69669025|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
37875149|NCT01185509|69559965|FG000|Overall Study|Withdrawal by Subject|0|||
37875150|NCT01185509|69559966|FG001|Overall Study|Withdrawal by Subject|1|||
37875151|NCT01185509|69559965|FG000|Overall Study|Death|0|||
37875152|NCT01185509|69559966|FG001|Overall Study|Death|1|||
37875153|NCT01185509|69559965|FG000|Overall Study|Intercurrent Illness|0|||
37875154|NCT01185509|69559966|FG001|Overall Study|Intercurrent Illness|1|||
37875155|NCT00891046|69559978|FG000|Overall Study|Protocol Violation|1|||
37875156|NCT00891046|69559979|FG001|Overall Study|Protocol Violation|1|||
37875157|NCT00891046|69559980|FG002|Overall Study|Protocol Violation|0|||
37875158|NCT00891046|69559981|FG003|Overall Study|Protocol Violation|0|||
37875159|NCT00891046|69559982|FG004|Overall Study|Protocol Violation|1|||
37875160|NCT00891046|69559978|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
37875161|NCT00891046|69559979|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
37875162|NCT00891046|69559980|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
37875163|NCT00891046|69559981|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
37875164|NCT00891046|69559982|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
37875165|NCT00891046|69559978|FG000|Overall Study|Administrative problems|0|||
37875166|NCT00891046|69559979|FG001|Overall Study|Administrative problems|0|||
37875167|NCT00891046|69559980|FG002|Overall Study|Administrative problems|0|||
37875168|NCT00891046|69559981|FG003|Overall Study|Administrative problems|0|||
37875169|NCT00891046|69559982|FG004|Overall Study|Administrative problems|1|||
37875170|NCT00891046|69559978|FG000|Overall Study|Participant no longer required drug|0|||
37875171|NCT00891046|69559979|FG001|Overall Study|Participant no longer required drug|2|||
37875172|NCT00891046|69559980|FG002|Overall Study|Participant no longer required drug|0|||
37875173|NCT00891046|69559981|FG003|Overall Study|Participant no longer required drug|0|||
37875174|NCT00891046|69559982|FG004|Overall Study|Participant no longer required drug|1|||
37875175|NCT00891046|69559978|FG000|Overall Study|Adverse Event|4|||
37875176|NCT00891046|69559979|FG001|Overall Study|Adverse Event|3|||
37875177|NCT00891046|69559980|FG002|Overall Study|Adverse Event|2|||
37875178|NCT00891046|69559981|FG003|Overall Study|Adverse Event|0|||
37875179|NCT00891046|69559982|FG004|Overall Study|Adverse Event|14|||
37875180|NCT00891046|69559978|FG000|Overall Study|Withdrawal by Subject|2|||
37875181|NCT00891046|69559979|FG001|Overall Study|Withdrawal by Subject|1|||
37875182|NCT00891046|69559980|FG002|Overall Study|Withdrawal by Subject|2|||
37875183|NCT00891046|69559981|FG003|Overall Study|Withdrawal by Subject|1|||
37875184|NCT00891046|69559982|FG004|Overall Study|Withdrawal by Subject|1|||
37875185|NCT00891046|69559978|FG000|Overall Study|Lost to Follow-up|0|||
37875186|NCT00891046|69559979|FG001|Overall Study|Lost to Follow-up|0|||
37875187|NCT00891046|69559980|FG002|Overall Study|Lost to Follow-up|0|||
37875188|NCT00891046|69559981|FG003|Overall Study|Lost to Follow-up|0|||
37875189|NCT00891046|69559982|FG004|Overall Study|Lost to Follow-up|1|||
37875190|NCT00889720|69560009|FG000|Overall Study|Withdrawal by Subject|4|||
37875191|NCT00889720|69560009|FG000|Overall Study|Other|4|||
37875192|NCT00880087|69560015|FG000|Overall Study|Lost to Follow-up|0|||
37875193|NCT00880087|69560016|FG001|Overall Study|Lost to Follow-up|2|||
37875194|NCT00889252|69560024|FG000|Overall Study|Adverse Event|2|||
37875195|NCT00889252|69560025|FG001|Overall Study|Adverse Event|4|||
37875196|NCT00889252|69560024|FG000|Overall Study|Withdrawal by Subject|3|||
37875197|NCT00889252|69560025|FG001|Overall Study|Withdrawal by Subject|0|||
37875198|NCT00889252|69560024|FG000|Overall Study|Protocol Violation|2|||
37875199|NCT00889252|69560025|FG001|Overall Study|Protocol Violation|0|||
37875200|NCT01110330|69560034|FG000|Overall Study|Adverse Event|0|||
37875201|NCT01110330|69560035|FG001|Overall Study|Adverse Event|4|||
37875202|NCT01110330|69560036|FG002|Overall Study|Adverse Event|3|||
37875203|NCT01110330|69560034|FG000|Overall Study|Lack of Efficacy|3|||
37875204|NCT01110330|69560035|FG001|Overall Study|Lack of Efficacy|1|||
37875205|NCT01110330|69560036|FG002|Overall Study|Lack of Efficacy|1|||
37875206|NCT01110330|69560034|FG000|Overall Study|Lost to Follow-up|9|||
37875207|NCT01110330|69560035|FG001|Overall Study|Lost to Follow-up|10|||
37875208|NCT01110330|69560036|FG002|Overall Study|Lost to Follow-up|15|||
37875209|NCT01110330|69560034|FG000|Overall Study|Physician Decision|0|||
37875210|NCT01110330|69560035|FG001|Overall Study|Physician Decision|1|||
37875211|NCT01110330|69560036|FG002|Overall Study|Physician Decision|0|||
37875212|NCT01110330|69560034|FG000|Overall Study|Protocol Violation|2|||
37875213|NCT01110330|69560035|FG001|Overall Study|Protocol Violation|0|||
37875214|NCT01110330|69560036|FG002|Overall Study|Protocol Violation|4|||
37875215|NCT01110330|69560034|FG000|Overall Study|Withdrawal by Subject|0|||
37875216|NCT01110330|69560035|FG001|Overall Study|Withdrawal by Subject|6|||
37875217|NCT01110330|69560036|FG002|Overall Study|Withdrawal by Subject|2|||
37875218|NCT01110330|69560034|FG000|Overall Study|Other|1|||
37875219|NCT01110330|69560035|FG001|Overall Study|Other|1|||
37875220|NCT01110330|69560036|FG002|Overall Study|Other|1|||
37875221|NCT00596947|69560046|FG000|Overall Study|study halted due to low enrollment|5|||
37875222|NCT00596947|69560047|FG001|Overall Study|study halted due to low enrollment|3|||
37875223|NCT00596947|69560046|FG000|Overall Study|Lost to Follow-up|1|||
37875224|NCT00596947|69560047|FG001|Overall Study|Lost to Follow-up|0|||
37875225|NCT00888940|69560055|FG000|Overall Study|Adverse Event|12|||
37875226|NCT00888940|69560056|FG001|Overall Study|Adverse Event|3|||
37875227|NCT00888940|69560055|FG000|Overall Study|Lost to Follow-up|5|||
37875228|NCT00888940|69560056|FG001|Overall Study|Lost to Follow-up|5|||
37875229|NCT00888940|69560055|FG000|Overall Study|Randomized Not Treated|11|||
37875230|NCT00888940|69560056|FG001|Overall Study|Randomized Not Treated|13|||
37875231|NCT00595621|69560064|FG000|Open Label Run in|Adverse Event|1|||
37875232|NCT00595621|69560065|FG001|Open Label Run in|Adverse Event|0|||
37875233|NCT00595621|69560064|FG000|Open Label Run in|Physician Decision|1|||
37875234|NCT00595621|69560065|FG001|Open Label Run in|Physician Decision|0|||
37875235|NCT00595621|69560064|FG000|Open Label Run in|Withdrawal by Subject|1|||
37875236|NCT00595621|69560065|FG001|Open Label Run in|Withdrawal by Subject|0|||
37875237|NCT00595621|69560064|FG000|Randomization and Study|Adverse Event|2|||
37875238|NCT00595621|69560065|FG001|Randomization and Study|Adverse Event|0|||
37875239|NCT00595621|69560064|FG000|Randomization and Study|Withdrawal by Subject|0|||
37875240|NCT00595621|69560065|FG001|Randomization and Study|Withdrawal by Subject|1|||
37875241|NCT00888238|69560072|FG000|Washout Period After Period 2|Adverse Event|0|||
37875242|NCT00888238|69560073|FG001|Washout Period After Period 2|Adverse Event|0|||
37875243|NCT00888238|69560074|FG002|Washout Period After Period 2|Adverse Event|1|||
37875244|NCT00595465|69560083|FG000|Overall Study|Adverse Event|4|||
37875245|NCT00595465|69560084|FG001|Overall Study|Adverse Event|3|||
37875246|NCT00595465|69560085|FG002|Overall Study|Adverse Event|3|||
37875247|NCT00595465|69560083|FG000|Overall Study|Pregnancy|0|||
37875248|NCT00595465|69560084|FG001|Overall Study|Pregnancy|0|||
37875249|NCT00595465|69560085|FG002|Overall Study|Pregnancy|1|||
37875250|NCT00595465|69560083|FG000|Overall Study|Protocol Violation|2|||
37875251|NCT00595465|69560084|FG001|Overall Study|Protocol Violation|1|||
37875252|NCT00595465|69560085|FG002|Overall Study|Protocol Violation|0|||
37875253|NCT00595465|69560083|FG000|Overall Study|Lost to Follow-up|0|||
37875254|NCT00595465|69560084|FG001|Overall Study|Lost to Follow-up|0|||
37875255|NCT00595465|69560085|FG002|Overall Study|Lost to Follow-up|2|||
37875256|NCT00595465|69560083|FG000|Overall Study|administrative reason|0|||
37875257|NCT00595465|69560084|FG001|Overall Study|administrative reason|0|||
37875258|NCT00595465|69560085|FG002|Overall Study|administrative reason|1|||
37875259|NCT01205438|69560096|FG000|Overall Study|Adverse Event|19|||
37875260|NCT01205438|69560097|FG001|Overall Study|Adverse Event|17|||
37875261|NCT01205438|69560098|FG002|Overall Study|Adverse Event|24|||
37875262|NCT01205438|69560096|FG000|Overall Study|Death|1|||
37817512|NCT03810313|69496517|FG001|Overall Study|Study terminated by sponsor|159|||
37817513|NCT03810313|69496516|FG000|Overall Study|Subject decision|10|||
37817514|NCT03810313|69496517|FG001|Overall Study|Subject decision|11|||
37817515|NCT03810313|69496516|FG000|Overall Study|Lost to Follow-up|3|||
37817516|NCT03810313|69496517|FG001|Overall Study|Lost to Follow-up|3|||
37817517|NCT03810313|69496516|FG000|Overall Study|Adverse Event|2|||
37817518|NCT03810313|69496517|FG001|Overall Study|Adverse Event|1|||
37817519|NCT03810313|69496516|FG000|Overall Study|Death|2|||
37817520|NCT03810313|69496517|FG001|Overall Study|Death|1|||
37817521|NCT03810313|69496516|FG000|Overall Study|Physician Decision|0|||
37817522|NCT03810313|69496517|FG001|Overall Study|Physician Decision|1|||
37817523|NCT03802630|69496526|FG000|Overall Study|Study terminated by sponsor|130|||
37817524|NCT03802630|69496527|FG001|Overall Study|Study terminated by sponsor|134|||
37817525|NCT03802630|69496526|FG000|Overall Study|Subject decision|16|||
37817526|NCT03802630|69496527|FG001|Overall Study|Subject decision|9|||
37817527|NCT03802630|69496526|FG000|Overall Study|Adverse Event|3|||
37817528|NCT03802630|69496527|FG001|Overall Study|Adverse Event|1|||
37817529|NCT03802630|69496526|FG000|Overall Study|Lost to Follow-up|2|||
37817530|NCT03802630|69496527|FG001|Overall Study|Lost to Follow-up|2|||
37817531|NCT03802630|69496526|FG000|Overall Study|Physician Decision|2|||
37817532|NCT03802630|69496527|FG001|Overall Study|Physician Decision|0|||
37817533|NCT03802630|69496526|FG000|Overall Study|Death|0|||
37817534|NCT03802630|69496527|FG001|Overall Study|Death|2|||
37817535|NCT03775213|69496536|FG000|Overall Study|Withdrawal by Subject|51|||
37817536|NCT03775213|69496537|FG001|Overall Study|Withdrawal by Subject|53|||
37875263|NCT01205438|69560097|FG001|Overall Study|Death|1|||
37817537|NCT03775213|69496536|FG000|Overall Study|Incomplete Survey|7|||
37817538|NCT03775213|69496537|FG001|Overall Study|Incomplete Survey|7|||
37817539|NCT03710564|69496545|FG000|Overall Study|Study Terminated by Sponsor|104|||
37817540|NCT03710564|69496546|FG001|Overall Study|Study Terminated by Sponsor|55|||
37817541|NCT03710564|69496545|FG000|Overall Study|Withdrawal by Subject|57|||
37875264|NCT01205438|69560098|FG002|Overall Study|Death|3|||
37875265|NCT01205438|69560096|FG000|Overall Study|Entry Criteria Not Met|16|||
37875266|NCT01205438|69560097|FG001|Overall Study|Entry Criteria Not Met|15|||
37875267|NCT01205438|69560098|FG002|Overall Study|Entry Criteria Not Met|13|||
37875268|NCT01205438|69560096|FG000|Overall Study|Lack of Efficacy|14|||
37817542|NCT03710564|69496546|FG001|Overall Study|Withdrawal by Subject|25|||
37817543|NCT03710564|69496545|FG000|Overall Study|Death|10|||
37817544|NCT03710564|69496546|FG001|Overall Study|Death|4|||
37875269|NCT01205438|69560097|FG001|Overall Study|Lack of Efficacy|11|||
37875270|NCT01205438|69560098|FG002|Overall Study|Lack of Efficacy|14|||
37875271|NCT01205438|69560096|FG000|Overall Study|Lost to Follow-up|6|||
37875272|NCT01205438|69560097|FG001|Overall Study|Lost to Follow-up|7|||
37875273|NCT01205438|69560098|FG002|Overall Study|Lost to Follow-up|8|||
37875274|NCT01205438|69560096|FG000|Overall Study|Withdrawal by Subject|19|||
37875275|NCT01205438|69560097|FG001|Overall Study|Withdrawal by Subject|25|||
37875276|NCT01205438|69560098|FG002|Overall Study|Withdrawal by Subject|19|||
37875277|NCT01205438|69560096|FG000|Overall Study|Physician Decision|0|||
37875278|NCT01205438|69560097|FG001|Overall Study|Physician Decision|3|||
37875279|NCT01205438|69560098|FG002|Overall Study|Physician Decision|2|||
37875280|NCT01205438|69560096|FG000|Overall Study|Protocol Violation|2|||
37875281|NCT01205438|69560097|FG001|Overall Study|Protocol Violation|7|||
37875282|NCT01205438|69560098|FG002|Overall Study|Protocol Violation|4|||
37875283|NCT01205438|69560096|FG000|Overall Study|Sponsor Decision|0|||
37875284|NCT01205438|69560097|FG001|Overall Study|Sponsor Decision|1|||
37875285|NCT01205438|69560098|FG002|Overall Study|Sponsor Decision|1|||
37875286|NCT01104870|69560112|FG000|Overall Study|Adverse Event|1|||
37875287|NCT01104870|69560113|FG001|Overall Study|Adverse Event|1|||
37875288|NCT01104870|69560114|FG002|Overall Study|Adverse Event|0|||
37875289|NCT01104870|69560112|FG000|Overall Study|Death|0|||
37982575|NCT00456092|69669026|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
37875290|NCT01104870|69560113|FG001|Overall Study|Death|0|||
37875291|NCT01104870|69560114|FG002|Overall Study|Death|1|||
37875292|NCT01104870|69560112|FG000|Overall Study|Withdrawal by Subject|0|||
37875293|NCT01104870|69560113|FG001|Overall Study|Withdrawal by Subject|0|||
37875294|NCT01104870|69560114|FG002|Overall Study|Withdrawal by Subject|1|||
37875295|NCT01104792|69560122|FG000|Overall Study|Adverse Event|77|||
37875296|NCT01104792|69560122|FG000|Overall Study|Insufficient Therapeutic Response|22|||
37875297|NCT01104792|69560122|FG000|Overall Study|Protocol Violation|45|||
37875298|NCT01104792|69560122|FG000|Overall Study|Withdrawal of Consent|179|||
37875299|NCT01104792|69560122|FG000|Overall Study|Lost to Follow-up|43|||
37875300|NCT01104792|69560122|FG000|Overall Study|Reasons Not Specified|27|||
37875301|NCT01104792|69560122|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
37875302|NCT01205126|69560128|FG000|Titration Phase|Adverse Event|5|||
37875303|NCT01205126|69560129|FG001|Titration Phase|Adverse Event|3|||
37875304|NCT01205126|69560128|FG000|Titration Phase|Withdrawal by Subject|5|||
37875305|NCT01205126|69560129|FG001|Titration Phase|Withdrawal by Subject|5|||
37875306|NCT01205126|69560128|FG000|Titration Phase|Lost to Follow-up|2|||
37875307|NCT01205126|69560129|FG001|Titration Phase|Lost to Follow-up|2|||
37875308|NCT01205126|69560128|FG000|Titration Phase|No stable titration dose|1|||
37982576|NCT00456092|69669027|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
37982577|NCT00456092|69669028|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
37982578|NCT00456092|69669024|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
37982579|NCT00456092|69669025|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
37982580|NCT00456092|69669026|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
37982581|NCT00456092|69669027|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
37982582|NCT00456092|69669028|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
37875309|NCT01205126|69560129|FG001|Titration Phase|No stable titration dose|0|||
37875310|NCT01205126|69560128|FG000|Titration Phase|More than maximum dosage required|2|||
37875311|NCT01205126|69560129|FG001|Titration Phase|More than maximum dosage required|3|||
37875312|NCT01205126|69560128|FG000|Titration Phase|Other|8|||
37875313|NCT01205126|69560129|FG001|Titration Phase|Other|6|||
37875314|NCT01205126|69560128|FG000|Between Titration & Maintenance Phase|Other|0|||
37875315|NCT01205126|69560129|FG001|Between Titration & Maintenance Phase|Other|4|||
37875316|NCT01205126|69560128|FG000|Maintenance Phase|Adverse Event|3|||
37875317|NCT01205126|69560129|FG001|Maintenance Phase|Adverse Event|7|||
37875318|NCT01205126|69560128|FG000|Maintenance Phase|Death|4|||
37875319|NCT01205126|69560129|FG001|Maintenance Phase|Death|4|||
37875320|NCT01205126|69560128|FG000|Maintenance Phase|More than the maximum dosage required|5|||
37875321|NCT01205126|69560129|FG001|Maintenance Phase|More than the maximum dosage required|5|||
37875322|NCT01205126|69560128|FG000|Maintenance Phase|Prohibited drugs used|1|||
37875323|NCT01205126|69560129|FG001|Maintenance Phase|Prohibited drugs used|0|||
37875324|NCT01205126|69560128|FG000|Maintenance Phase|Other|11|||
37875325|NCT01205126|69560129|FG001|Maintenance Phase|Other|8|||
37875326|NCT01205126|69560128|FG000|Maintenance Phase|Lost to Follow-up|5|||
37875327|NCT01205126|69560129|FG001|Maintenance Phase|Lost to Follow-up|5|||
37817545|NCT03710564|69496545|FG000|Overall Study|Lost to Follow-up|5|||
37817546|NCT03710564|69496546|FG001|Overall Study|Lost to Follow-up|4|||
37817547|NCT03710564|69496545|FG000|Overall Study|Protocol Violation|3|||
37817548|NCT03710564|69496546|FG001|Overall Study|Protocol Violation|2|||
37817549|NCT03710564|69496545|FG000|Overall Study|Adverse Event|3|||
37817550|NCT03710564|69496546|FG001|Overall Study|Adverse Event|0|||
37817551|NCT03710564|69496545|FG000|Overall Study|Physician Decision|2|||
37817552|NCT03710564|69496546|FG001|Overall Study|Physician Decision|3|||
37817553|NCT03624127|69496556|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
37875328|NCT01205126|69560128|FG000|Maintenance Phase|Withdrawal by Subject|8|||
37875329|NCT01205126|69560129|FG001|Maintenance Phase|Withdrawal by Subject|11|||
37875330|NCT00946647|69560140|FG000|Phase 1 Part|Adverse Event|2|||
37875331|NCT00946647|69560141|FG001|Phase 1 Part|Adverse Event|5|||
37875332|NCT00946647|69560142|FG002|Phase 1 Part|Adverse Event|3|||
37875333|NCT00946647|69560143|FG003|Phase 1 Part|Adverse Event|0|||
37875334|NCT00946647|69560144|FG004|Phase 1 Part|Adverse Event|0|||
37875335|NCT00946647|69560140|FG000|Phase 1 Part|Disease progression|3|||
37875336|NCT00946647|69560141|FG001|Phase 1 Part|Disease progression|6|||
37875337|NCT00946647|69560142|FG002|Phase 1 Part|Disease progression|1|||
37875338|NCT00946647|69560143|FG003|Phase 1 Part|Disease progression|0|||
37875339|NCT00946647|69560144|FG004|Phase 1 Part|Disease progression|0|||
37875340|NCT00946647|69560140|FG000|Phase 1 Part|Withdrawal by Subject|1|||
37875341|NCT00946647|69560141|FG001|Phase 1 Part|Withdrawal by Subject|4|||
37875342|NCT00946647|69560142|FG002|Phase 1 Part|Withdrawal by Subject|3|||
37875343|NCT00946647|69560143|FG003|Phase 1 Part|Withdrawal by Subject|0|||
37875344|NCT00946647|69560144|FG004|Phase 1 Part|Withdrawal by Subject|0|||
37875345|NCT00946647|69560140|FG000|Phase 1 Part|Abnormal values|0|||
37875346|NCT00946647|69560141|FG001|Phase 1 Part|Abnormal values|2|||
37875347|NCT00946647|69560142|FG002|Phase 1 Part|Abnormal values|0|||
37875348|NCT00946647|69560143|FG003|Phase 1 Part|Abnormal values|0|||
37875349|NCT00946647|69560144|FG004|Phase 1 Part|Abnormal values|0|||
37875350|NCT00946647|69560140|FG000|Phase 1 Part|Reason missing|0|||
37875351|NCT00946647|69560141|FG001|Phase 1 Part|Reason missing|1|||
37875352|NCT00946647|69560142|FG002|Phase 1 Part|Reason missing|0|||
37875353|NCT00946647|69560143|FG003|Phase 1 Part|Reason missing|0|||
37875354|NCT00946647|69560144|FG004|Phase 1 Part|Reason missing|0|||
37875355|NCT00946647|69560140|FG000|Phase ll Part|Untreated|0|||
37875356|NCT00946647|69560141|FG001|Phase ll Part|Untreated|0|||
37875357|NCT00946647|69560142|FG002|Phase ll Part|Untreated|0|||
37875358|NCT00946647|69560143|FG003|Phase ll Part|Untreated|0|||
37875359|NCT00946647|69560144|FG004|Phase ll Part|Untreated|2|||
37875360|NCT00946647|69560140|FG000|Phase ll Part|Adverse Event|0|||
37875361|NCT00946647|69560141|FG001|Phase ll Part|Adverse Event|0|||
37875362|NCT00946647|69560142|FG002|Phase ll Part|Adverse Event|0|||
37875363|NCT00946647|69560143|FG003|Phase ll Part|Adverse Event|10|||
37875364|NCT00946647|69560144|FG004|Phase ll Part|Adverse Event|6|||
37875365|NCT00946647|69560140|FG000|Phase ll Part|Withdrawal by Subject|0|||
37875366|NCT00946647|69560141|FG001|Phase ll Part|Withdrawal by Subject|0|||
37875367|NCT00946647|69560142|FG002|Phase ll Part|Withdrawal by Subject|0|||
37875368|NCT00946647|69560143|FG003|Phase ll Part|Withdrawal by Subject|8|||
37875369|NCT00946647|69560144|FG004|Phase ll Part|Withdrawal by Subject|6|||
37875370|NCT00946647|69560140|FG000|Phase ll Part|Administrative problems|0|||
37875371|NCT00946647|69560141|FG001|Phase ll Part|Administrative problems|0|||
37875372|NCT00946647|69560142|FG002|Phase ll Part|Administrative problems|0|||
37875373|NCT00946647|69560143|FG003|Phase ll Part|Administrative problems|3|||
37875374|NCT00946647|69560144|FG004|Phase ll Part|Administrative problems|8|||
37875375|NCT00946647|69560140|FG000|Phase ll Part|Death|0|||
37875376|NCT00946647|69560141|FG001|Phase ll Part|Death|0|||
37875377|NCT00946647|69560142|FG002|Phase ll Part|Death|0|||
37875378|NCT00946647|69560143|FG003|Phase ll Part|Death|7|||
37875379|NCT00946647|69560144|FG004|Phase ll Part|Death|4|||
37875380|NCT00946647|69560140|FG000|Phase ll Part|Disease progression|0|||
37875381|NCT00946647|69560141|FG001|Phase ll Part|Disease progression|0|||
37875382|NCT00946647|69560142|FG002|Phase ll Part|Disease progression|0|||
37875383|NCT00946647|69560143|FG003|Phase ll Part|Disease progression|6|||
37982583|NCT00456092|69669024|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
37875384|NCT00946647|69560144|FG004|Phase ll Part|Disease progression|14|||
37875385|NCT00946647|69560140|FG000|Phase ll Part|Protocol Violation|0|||
37875386|NCT00946647|69560141|FG001|Phase ll Part|Protocol Violation|0|||
37875387|NCT00946647|69560142|FG002|Phase ll Part|Protocol Violation|0|||
37875388|NCT00946647|69560143|FG003|Phase ll Part|Protocol Violation|4|||
37875389|NCT00946647|69560144|FG004|Phase ll Part|Protocol Violation|2|||
37875390|NCT00946647|69560140|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
37875391|NCT00946647|69560141|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
37875392|NCT00946647|69560142|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
37875393|NCT00946647|69560143|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
37875394|NCT00946647|69560144|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
37875395|NCT00946101|69560159|FG000|Overall Study|Lost to Follow-up|2|||
37875396|NCT00946101|69560160|FG001|Overall Study|Lost to Follow-up|1|||
37875397|NCT00946101|69560159|FG000|Overall Study|Withdrawal of consent|2|||
37875398|NCT00946101|69560160|FG001|Overall Study|Withdrawal of consent|0|||
37875399|NCT00946101|69560159|FG000|Overall Study|Physician Decision|0|||
37875400|NCT00946101|69560160|FG001|Overall Study|Physician Decision|1|||
37875401|NCT01109940|69560174|FG000|Overall Study|Administrative problems|2|||
37875402|NCT01109940|69560175|FG001|Overall Study|Administrative problems|0|||
37875403|NCT01109940|69560176|FG002|Overall Study|Administrative problems|0|||
37875404|NCT01109940|69560177|FG003|Overall Study|Administrative problems|0|||
37875405|NCT01109940|69560174|FG000|Overall Study|Serious Adverse Event|2|||
37875406|NCT01109940|69560175|FG001|Overall Study|Serious Adverse Event|1|||
37875407|NCT01109940|69560176|FG002|Overall Study|Serious Adverse Event|0|||
37875408|NCT01109940|69560177|FG003|Overall Study|Serious Adverse Event|0|||
37875409|NCT01109940|69560174|FG000|Overall Study|Lost to Follow-up|1|||
37875410|NCT01109940|69560175|FG001|Overall Study|Lost to Follow-up|0|||
37875411|NCT01109940|69560176|FG002|Overall Study|Lost to Follow-up|0|||
37875412|NCT01109940|69560177|FG003|Overall Study|Lost to Follow-up|0|||
37875413|NCT01109940|69560174|FG000|Overall Study|Patient withdrew consent|1|||
37875414|NCT01109940|69560175|FG001|Overall Study|Patient withdrew consent|1|||
37875415|NCT01109940|69560176|FG002|Overall Study|Patient withdrew consent|0|||
37875416|NCT01109940|69560177|FG003|Overall Study|Patient withdrew consent|0|||
37875417|NCT01109940|69560174|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
37875418|NCT01109940|69560175|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
37875419|NCT01109940|69560176|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
37875420|NCT01109940|69560177|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
37875421|NCT00595309|69560187|FG000|Overall Study|Lost to Follow-up|1|||
37875422|NCT00595309|69560187|FG000|Overall Study|planned vaccination against yellow fever|1|||
37875423|NCT00595309|69560187|FG000|Overall Study|acute infection after V0|1|||
37875424|NCT00595309|69560187|FG000|Overall Study|personal reason|1|||
37875425|NCT00595075|69560193|FG000|Overall Study|Withdrawal by Subject|1|||
37875426|NCT00595075|69560194|FG001|Overall Study|Withdrawal by Subject|0|||
37875427|NCT00887224|69560203|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
37875428|NCT00887224|69560204|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
37875429|NCT00887224|69560205|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
37875430|NCT00887224|69560203|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
37875431|NCT00887224|69560204|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
37875432|NCT00887224|69560205|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
37875433|NCT00887224|69560203|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
37875434|NCT00887224|69560204|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
37875435|NCT00887224|69560205|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
37875436|NCT00887224|69560203|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
37875437|NCT00887224|69560204|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
37875438|NCT00887224|69560205|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
37875439|NCT00887224|69560203|FG000|Open-label Response (OLR) Phase|Other|1|||
37875440|NCT00887224|69560204|FG001|Open-label Response (OLR) Phase|Other|0|||
37875441|NCT00887224|69560205|FG002|Open-label Response (OLR) Phase|Other|0|||
37875442|NCT00887224|69560203|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
37875443|NCT00887224|69560204|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
37875444|NCT00887224|69560205|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
37875445|NCT00887224|69560203|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
37875446|NCT00887224|69560204|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
37875447|NCT00887224|69560205|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
37982584|NCT00456092|69669025|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
37982585|NCT00456092|69669026|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
37982586|NCT00456092|69669027|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
37982587|NCT00456092|69669028|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
37982588|NCT00456092|69669024|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
37982589|NCT00456092|69669025|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
37982590|NCT00456092|69669026|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
37982591|NCT00456092|69669027|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
37982592|NCT00456092|69669028|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
37875448|NCT00887224|69560203|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
37982593|NCT00456092|69669024|FG000|Treatment Phase (12 Weeks)|Other|1|||
37875449|NCT00887224|69560204|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
37875450|NCT00887224|69560205|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
37982594|NCT00456092|69669025|FG001|Treatment Phase (12 Weeks)|Other|0|||
37982595|NCT00456092|69669026|FG002|Treatment Phase (12 Weeks)|Other|1|||
37982596|NCT00456092|69669027|FG003|Treatment Phase (12 Weeks)|Other|0|||
37875451|NCT00887224|69560203|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
37875452|NCT00887224|69560204|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
37875453|NCT00887224|69560205|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
37875454|NCT00887224|69560203|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
37875455|NCT00887224|69560204|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
37875456|NCT00887224|69560205|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
37875457|NCT00887224|69560203|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
37875458|NCT00887224|69560204|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
37875459|NCT00887224|69560205|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
37982597|NCT00456092|69669028|FG004|Treatment Phase (12 Weeks)|Other|0|||
37982598|NCT00411450|69669042|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
37875460|NCT00887224|69560203|FG000|Open-label Stability (OLS) Phase|Other|1|||
37875461|NCT00887224|69560204|FG001|Open-label Stability (OLS) Phase|Other|0|||
37875462|NCT00887224|69560205|FG002|Open-label Stability (OLS) Phase|Other|0|||
37875463|NCT00887224|69560203|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
37875464|NCT00887224|69560204|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
37875465|NCT00887224|69560205|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
37875466|NCT00887224|69560203|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
37875467|NCT00887224|69560204|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
37875468|NCT00887224|69560205|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
37875469|NCT00887224|69560203|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
37875470|NCT00887224|69560204|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
37875471|NCT00887224|69560205|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
37875472|NCT00887224|69560203|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
37875473|NCT00887224|69560204|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
37875474|NCT00887224|69560205|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
37875475|NCT00887224|69560203|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
37875476|NCT00887224|69560204|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
37875477|NCT00887224|69560205|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
37875478|NCT00887224|69560203|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
37875479|NCT00887224|69560204|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
37875480|NCT00887224|69560205|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
37875481|NCT00887224|69560203|FG000|OL Taper Phase / OL Follow Up|Other|30|||
37875482|NCT00887224|69560204|FG001|OL Taper Phase / OL Follow Up|Other|0|||
37875483|NCT00887224|69560205|FG002|OL Taper Phase / OL Follow Up|Other|0|||
37875484|NCT00887224|69560203|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
37875485|NCT00887224|69560204|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
37875486|NCT00887224|69560205|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
37875487|NCT00887224|69560203|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
37875488|NCT00887224|69560204|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
37875489|NCT00887224|69560205|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
37875490|NCT00887224|69560203|FG000|Double-blind (DB) Phase|Adverse Event|0|||
37875491|NCT00887224|69560204|FG001|Double-blind (DB) Phase|Adverse Event|7|||
37875492|NCT00887224|69560205|FG002|Double-blind (DB) Phase|Adverse Event|2|||
37817554|NCT03624127|69496557|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
37817555|NCT03624127|69496558|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
37817556|NCT03624127|69496556|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
37817557|NCT03624127|69496557|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
37817558|NCT03624127|69496558|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
37817559|NCT03624127|69496556|FG000|Treatment Week 0 - Week 16|Death|0|||
37817560|NCT03624127|69496557|FG001|Treatment Week 0 - Week 16|Death|1|||
37817561|NCT03624127|69496558|FG002|Treatment Week 0 - Week 16|Death|0|||
37817562|NCT03624127|69496556|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
37817563|NCT03624127|69496557|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
37817564|NCT03624127|69496558|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
37817565|NCT03624127|69496556|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
37817566|NCT03624127|69496557|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
37817567|NCT03624127|69496558|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
37817568|NCT03624127|69496556|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
37817569|NCT03624127|69496557|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
37817570|NCT03624127|69496558|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
37817571|NCT03624127|69496556|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
37817572|NCT03624127|69496557|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
37817573|NCT03624127|69496558|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
37817574|NCT03624127|69496556|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
37817575|NCT03624127|69496557|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
37817576|NCT03624127|69496558|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
37817577|NCT03624127|69496556|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
37817578|NCT03624127|69496557|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
37817579|NCT03624127|69496558|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
37817580|NCT03624127|69496556|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
37817581|NCT03624127|69496557|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
37817582|NCT03624127|69496558|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
37817583|NCT03624127|69496556|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
37817584|NCT03624127|69496557|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
37817585|NCT03624127|69496558|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
37817586|NCT03624127|69496556|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
37875493|NCT00887224|69560203|FG000|Double-blind (DB) Phase|Failed to return|0|||
37875494|NCT00887224|69560204|FG001|Double-blind (DB) Phase|Failed to return|2|||
37875495|NCT00887224|69560205|FG002|Double-blind (DB) Phase|Failed to return|2|||
37875496|NCT00887224|69560203|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
37875497|NCT00887224|69560204|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
37875498|NCT00887224|69560205|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
37875499|NCT00887224|69560203|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
37875500|NCT00887224|69560204|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
37875501|NCT00887224|69560205|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
37875502|NCT00887224|69560203|FG000|Double-blind (DB) Phase|Other|0|||
37875503|NCT00887224|69560204|FG001|Double-blind (DB) Phase|Other|2|||
37875504|NCT00887224|69560205|FG002|Double-blind (DB) Phase|Other|0|||
37875505|NCT00887224|69560203|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
37875506|NCT00887224|69560204|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
37875507|NCT00887224|69560205|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
37875508|NCT00887224|69560203|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
37875509|NCT00887224|69560204|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
37875510|NCT00887224|69560205|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
37875511|NCT00887224|69560203|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
37875512|NCT00887224|69560204|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
37875513|NCT00887224|69560205|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
37875514|NCT00887224|69560203|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
37875515|NCT00887224|69560204|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
37875516|NCT00887224|69560205|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
37817587|NCT03624127|69496557|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
37817588|NCT03624127|69496558|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
37817589|NCT03624127|69496556|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
37817590|NCT03624127|69496557|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
37817591|NCT03624127|69496558|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
37817592|NCT03624127|69496556|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
37817593|NCT03624127|69496557|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
37817594|NCT03624127|69496558|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
37817595|NCT03624127|69496556|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
37817596|NCT03624127|69496557|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
37817597|NCT03624127|69496558|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
37817598|NCT03624127|69496556|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
37817599|NCT03624127|69496557|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
37817600|NCT03624127|69496558|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
37817601|NCT03624127|69496556|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
37817602|NCT03624127|69496557|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
37817603|NCT03624127|69496558|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
37817604|NCT03624127|69496556|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
37817605|NCT03624127|69496557|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
37875517|NCT00887224|69560203|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
37875518|NCT00887224|69560204|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
37875519|NCT00887224|69560205|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
37875520|NCT00887224|69560203|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
37875521|NCT00887224|69560204|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
37875522|NCT00887224|69560205|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
37875523|NCT00887224|69560203|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
37875524|NCT00887224|69560204|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
37875525|NCT00887224|69560205|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
37875526|NCT00887224|69560203|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
37875527|NCT00887224|69560204|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
37875528|NCT00887224|69560205|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
37875529|NCT00887224|69560203|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
37875530|NCT00887224|69560204|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
37875531|NCT00887224|69560205|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
37875532|NCT01109316|69560223|FG000|Study Period 1|Adverse Event|0|||
37875533|NCT01109316|69560224|FG001|Study Period 1|Adverse Event|0|||
37875534|NCT01109316|69560225|FG002|Study Period 1|Adverse Event|1|||
37875535|NCT01109316|69560226|FG003|Study Period 1|Adverse Event|0|||
37875536|NCT01109316|69560227|FG004|Study Period 1|Adverse Event|0|||
37875537|NCT01109316|69560228|FG005|Study Period 1|Adverse Event|0|||
37875538|NCT01109316|69560223|FG000|Study Period 1|Lost to Follow-up|0|||
37875539|NCT01109316|69560224|FG001|Study Period 1|Lost to Follow-up|0|||
37875540|NCT01109316|69560225|FG002|Study Period 1|Lost to Follow-up|1|||
37875541|NCT01109316|69560226|FG003|Study Period 1|Lost to Follow-up|1|||
37982599|NCT00404820|69669050|FG000|Overall Study|Adverse Event|4|||
37817606|NCT03624127|69496558|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
37817607|NCT03624127|69496556|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
37982600|NCT00404820|69669051|FG001|Overall Study|Adverse Event|16|||
37982601|NCT00404820|69669050|FG000|Overall Study|Withdrawal by Subject|5|||
37982602|NCT00404820|69669051|FG001|Overall Study|Withdrawal by Subject|3|||
37982603|NCT00404820|69669050|FG000|Overall Study|Lost to Follow-up|7|||
37982604|NCT00404820|69669051|FG001|Overall Study|Lost to Follow-up|3|||
37982605|NCT00404820|69669050|FG000|Overall Study|Administrative problems|2|||
37817608|NCT03624127|69496557|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
37817609|NCT03624127|69496558|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
37817610|NCT03624127|69496556|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
37817611|NCT03624127|69496557|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
37817612|NCT03624127|69496558|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
37817613|NCT03624127|69496556|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
37817614|NCT03624127|69496557|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
37817615|NCT03624127|69496558|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
37817616|NCT03616912|69496576|FG000|Overall Study|Adverse Event|17|||
37817617|NCT03616912|69496577|FG001|Overall Study|Adverse Event|21|||
37817618|NCT03616912|69496578|FG002|Overall Study|Adverse Event|9|||
37817619|NCT03616912|69496579|FG003|Overall Study|Adverse Event|0|||
37817620|NCT03616912|69496580|FG004|Overall Study|Adverse Event|0|||
37817621|NCT03616912|69496581|FG005|Overall Study|Adverse Event|0|||
37817622|NCT03616912|69496576|FG000|Overall Study|Death|1|||
37817623|NCT03616912|69496577|FG001|Overall Study|Death|1|||
37817624|NCT03616912|69496578|FG002|Overall Study|Death|0|||
37817625|NCT03616912|69496579|FG003|Overall Study|Death|0|||
37817626|NCT03616912|69496580|FG004|Overall Study|Death|0|||
37817627|NCT03616912|69496581|FG005|Overall Study|Death|0|||
37817628|NCT03616912|69496576|FG000|Overall Study|Lack of Efficacy|13|||
37817629|NCT03616912|69496577|FG001|Overall Study|Lack of Efficacy|6|||
37817630|NCT03616912|69496578|FG002|Overall Study|Lack of Efficacy|8|||
37817631|NCT03616912|69496579|FG003|Overall Study|Lack of Efficacy|4|||
37817632|NCT03616912|69496580|FG004|Overall Study|Lack of Efficacy|5|||
37817633|NCT03616912|69496581|FG005|Overall Study|Lack of Efficacy|1|||
37817634|NCT03616912|69496576|FG000|Overall Study|Lost to Follow-up|1|||
37817635|NCT03616912|69496577|FG001|Overall Study|Lost to Follow-up|2|||
37817636|NCT03616912|69496578|FG002|Overall Study|Lost to Follow-up|3|||
37817637|NCT03616912|69496579|FG003|Overall Study|Lost to Follow-up|0|||
37817638|NCT03616912|69496580|FG004|Overall Study|Lost to Follow-up|0|||
37817639|NCT03616912|69496581|FG005|Overall Study|Lost to Follow-up|0|||
37817640|NCT03616912|69496576|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
37817641|NCT03616912|69496577|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
37817642|NCT03616912|69496578|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
37817643|NCT03616912|69496579|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
37817644|NCT03616912|69496580|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
37817645|NCT03616912|69496581|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
37982606|NCT00404820|69669051|FG001|Overall Study|Administrative problems|0|||
37982607|NCT00404820|69669050|FG000|Overall Study|Death|1|||
37982608|NCT00404820|69669051|FG001|Overall Study|Death|0|||
37817646|NCT03616912|69496576|FG000|Overall Study|Withdrawal by Subject|12|||
37817647|NCT03616912|69496577|FG001|Overall Study|Withdrawal by Subject|12|||
37817648|NCT03616912|69496578|FG002|Overall Study|Withdrawal by Subject|15|||
37817649|NCT03616912|69496579|FG003|Overall Study|Withdrawal by Subject|2|||
37817650|NCT03616912|69496580|FG004|Overall Study|Withdrawal by Subject|0|||
37817651|NCT03616912|69496581|FG005|Overall Study|Withdrawal by Subject|2|||
37875542|NCT01109316|69560227|FG004|Study Period 1|Lost to Follow-up|0|||
37875543|NCT01109316|69560228|FG005|Study Period 1|Lost to Follow-up|0|||
37875544|NCT01109316|69560223|FG000|Study Period 1|Withdrawal by Subject|0|||
37875545|NCT01109316|69560224|FG001|Study Period 1|Withdrawal by Subject|0|||
37875546|NCT01109316|69560225|FG002|Study Period 1|Withdrawal by Subject|1|||
37875547|NCT01109316|69560226|FG003|Study Period 1|Withdrawal by Subject|0|||
37875548|NCT01109316|69560227|FG004|Study Period 1|Withdrawal by Subject|2|||
37875549|NCT01109316|69560228|FG005|Study Period 1|Withdrawal by Subject|0|||
37875550|NCT01109316|69560223|FG000|Study Period 1|Sponsor Decision|0|||
37875551|NCT01109316|69560224|FG001|Study Period 1|Sponsor Decision|0|||
37875552|NCT01109316|69560225|FG002|Study Period 1|Sponsor Decision|0|||
37875553|NCT01109316|69560226|FG003|Study Period 1|Sponsor Decision|0|||
37875554|NCT01109316|69560227|FG004|Study Period 1|Sponsor Decision|0|||
37817652|NCT03616912|69496576|FG000|Overall Study|Study Terminated by Sponsor|0|||
37817653|NCT03616912|69496577|FG001|Overall Study|Study Terminated by Sponsor|0|||
37817654|NCT03616912|69496578|FG002|Overall Study|Study Terminated by Sponsor|0|||
37817655|NCT03616912|69496579|FG003|Overall Study|Study Terminated by Sponsor|10|||
37817656|NCT03616912|69496580|FG004|Overall Study|Study Terminated by Sponsor|9|||
37817657|NCT03616912|69496581|FG005|Overall Study|Study Terminated by Sponsor|11|||
37817658|NCT03616912|69496576|FG000|Overall Study|Protocol Deviation|1|||
37817659|NCT03616912|69496577|FG001|Overall Study|Protocol Deviation|1|||
37875555|NCT01109316|69560228|FG005|Study Period 1|Sponsor Decision|2|||
37817660|NCT03616912|69496578|FG002|Overall Study|Protocol Deviation|0|||
37817661|NCT03616912|69496579|FG003|Overall Study|Protocol Deviation|0|||
37817662|NCT03616912|69496580|FG004|Overall Study|Protocol Deviation|0|||
37875556|NCT01109316|69560223|FG000|Study Period 2|Entry Criteria Not Met|0|||
37875557|NCT01109316|69560224|FG001|Study Period 2|Entry Criteria Not Met|1|||
37875558|NCT01109316|69560225|FG002|Study Period 2|Entry Criteria Not Met|0|||
37875559|NCT01109316|69560226|FG003|Study Period 2|Entry Criteria Not Met|0|||
37875560|NCT01109316|69560227|FG004|Study Period 2|Entry Criteria Not Met|0|||
37875561|NCT01109316|69560228|FG005|Study Period 2|Entry Criteria Not Met|0|||
37875562|NCT01109316|69560223|FG000|Study Period 2|Physician Decision|0|||
37875563|NCT01109316|69560224|FG001|Study Period 2|Physician Decision|0|||
37875564|NCT01109316|69560225|FG002|Study Period 2|Physician Decision|0|||
37875565|NCT01109316|69560226|FG003|Study Period 2|Physician Decision|1|||
37875566|NCT01109316|69560227|FG004|Study Period 2|Physician Decision|0|||
37875567|NCT01109316|69560228|FG005|Study Period 2|Physician Decision|0|||
37875568|NCT01109316|69560223|FG000|Study Period 2|Protocol Violation|1|||
37875569|NCT01109316|69560224|FG001|Study Period 2|Protocol Violation|0|||
37875570|NCT01109316|69560225|FG002|Study Period 2|Protocol Violation|0|||
37875571|NCT01109316|69560226|FG003|Study Period 2|Protocol Violation|0|||
37875572|NCT01109316|69560227|FG004|Study Period 2|Protocol Violation|0|||
37875573|NCT01109316|69560228|FG005|Study Period 2|Protocol Violation|0|||
37875574|NCT01109316|69560223|FG000|Study Period 2|Withdrawal by Subject|0|||
37875575|NCT01109316|69560224|FG001|Study Period 2|Withdrawal by Subject|0|||
37875576|NCT01109316|69560225|FG002|Study Period 2|Withdrawal by Subject|1|||
37875577|NCT01109316|69560226|FG003|Study Period 2|Withdrawal by Subject|0|||
37875578|NCT01109316|69560227|FG004|Study Period 2|Withdrawal by Subject|0|||
37875579|NCT01109316|69560228|FG005|Study Period 2|Withdrawal by Subject|1|||
37875580|NCT01109316|69560223|FG000|Study Period 3|Lost to Follow-up|0|||
37875581|NCT01109316|69560224|FG001|Study Period 3|Lost to Follow-up|0|||
37875582|NCT01109316|69560225|FG002|Study Period 3|Lost to Follow-up|0|||
37875583|NCT01109316|69560226|FG003|Study Period 3|Lost to Follow-up|0|||
37982609|NCT00404820|69669050|FG000|Overall Study|Other|0|||
37982610|NCT00404820|69669051|FG001|Overall Study|Other|2|||
37982611|NCT00417612|69669059|FG000|Overall Study|Errant diagnosis|0|||
37982612|NCT00417612|69669060|FG001|Overall Study|Errant diagnosis|1|||
37982613|NCT00417612|69669059|FG000|Overall Study|Adverse Event|2|||
37982614|NCT00417612|69669060|FG001|Overall Study|Adverse Event|0|||
37875584|NCT01109316|69560227|FG004|Study Period 3|Lost to Follow-up|1|||
37875585|NCT01109316|69560228|FG005|Study Period 3|Lost to Follow-up|0|||
37875586|NCT01109316|69560223|FG000|Study Period 3|Withdrawal by Subject|1|||
37875587|NCT01109316|69560224|FG001|Study Period 3|Withdrawal by Subject|0|||
37875588|NCT01109316|69560225|FG002|Study Period 3|Withdrawal by Subject|0|||
37875589|NCT01109316|69560226|FG003|Study Period 3|Withdrawal by Subject|0|||
37875590|NCT01109316|69560227|FG004|Study Period 3|Withdrawal by Subject|1|||
37875591|NCT01109316|69560228|FG005|Study Period 3|Withdrawal by Subject|0|||
37875592|NCT00887068|69560238|FG000|Overall Study|Withdrawal by Subject|2|||
37875593|NCT00887068|69560239|FG001|Overall Study|Withdrawal by Subject|0|||
37982615|NCT00417612|69669059|FG000|Overall Study|Protocol Violation|0|||
37982616|NCT00417612|69669060|FG001|Overall Study|Protocol Violation|2|||
37982617|NCT00417612|69669059|FG000|Overall Study|Lost to Follow-up|1|||
37982618|NCT00417612|69669060|FG001|Overall Study|Lost to Follow-up|0|||
37982619|NCT00446030|69669070|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
37875594|NCT00887068|69560238|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
37875595|NCT00887068|69560239|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
37875596|NCT00941031|69560249|FG000|Induction Period|Lack of Efficacy|2|||
37875597|NCT00941031|69560250|FG001|Induction Period|Lack of Efficacy|1|||
37875598|NCT00941031|69560251|FG002|Induction Period|Lack of Efficacy|0|||
37875599|NCT00941031|69560252|FG003|Induction Period|Lack of Efficacy|5|||
37875600|NCT00941031|69560253|FG004|Induction Period|Lack of Efficacy|0|||
37875601|NCT00941031|69560254|FG005|Induction Period|Lack of Efficacy|0|||
37875602|NCT00941031|69560255|FG006|Induction Period|Lack of Efficacy|0|||
37875603|NCT00941031|69560249|FG000|Induction Period|Withdrawal by Subject|1|||
37875604|NCT00941031|69560250|FG001|Induction Period|Withdrawal by Subject|2|||
37875605|NCT00941031|69560251|FG002|Induction Period|Withdrawal by Subject|2|||
37875606|NCT00941031|69560252|FG003|Induction Period|Withdrawal by Subject|2|||
37875607|NCT00941031|69560253|FG004|Induction Period|Withdrawal by Subject|0|||
37875608|NCT00941031|69560254|FG005|Induction Period|Withdrawal by Subject|0|||
37875609|NCT00941031|69560255|FG006|Induction Period|Withdrawal by Subject|0|||
37875610|NCT00941031|69560249|FG000|Induction Period|Adminstative Problems|1|||
37875611|NCT00941031|69560250|FG001|Induction Period|Adminstative Problems|1|||
37875612|NCT00941031|69560251|FG002|Induction Period|Adminstative Problems|1|||
37982620|NCT00446030|69669071|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
37982621|NCT00446030|69669070|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
37982622|NCT00446030|69669071|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
37695090|NCT02405780|69171579|FG001|Period II|Medical reason|1|||
37695091|NCT02405780|69171580|FG002|Period II|Medical reason|0|||
37875613|NCT00941031|69560252|FG003|Induction Period|Adminstative Problems|0|||
37875614|NCT00941031|69560253|FG004|Induction Period|Adminstative Problems|0|||
37875615|NCT00941031|69560254|FG005|Induction Period|Adminstative Problems|0|||
37875616|NCT00941031|69560255|FG006|Induction Period|Adminstative Problems|0|||
37875617|NCT00941031|69560249|FG000|Induction Period|Adverse Event|1|||
37695092|NCT02405780|69171581|FG003|Period II|Medical reason|0|||
37982623|NCT00446030|69669070|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
37875618|NCT00941031|69560250|FG001|Induction Period|Adverse Event|0|||
37875619|NCT00941031|69560251|FG002|Induction Period|Adverse Event|3|||
37875620|NCT00941031|69560252|FG003|Induction Period|Adverse Event|2|||
37875621|NCT00941031|69560253|FG004|Induction Period|Adverse Event|0|||
37875622|NCT00941031|69560254|FG005|Induction Period|Adverse Event|0|||
37875623|NCT00941031|69560255|FG006|Induction Period|Adverse Event|0|||
37875624|NCT00941031|69560249|FG000|Maintenance Period|Withdrawal by Subject|0|||
37875625|NCT00941031|69560250|FG001|Maintenance Period|Withdrawal by Subject|0|||
37875626|NCT00941031|69560251|FG002|Maintenance Period|Withdrawal by Subject|0|||
37875627|NCT00941031|69560252|FG003|Maintenance Period|Withdrawal by Subject|0|||
37875628|NCT00941031|69560253|FG004|Maintenance Period|Withdrawal by Subject|6|||
37875629|NCT00941031|69560254|FG005|Maintenance Period|Withdrawal by Subject|2|||
37875630|NCT00941031|69560255|FG006|Maintenance Period|Withdrawal by Subject|13|||
37875631|NCT00941031|69560249|FG000|Maintenance Period|Administrative Problems|0|||
37875632|NCT00941031|69560250|FG001|Maintenance Period|Administrative Problems|0|||
37875633|NCT00941031|69560251|FG002|Maintenance Period|Administrative Problems|0|||
37875634|NCT00941031|69560252|FG003|Maintenance Period|Administrative Problems|0|||
37875635|NCT00941031|69560253|FG004|Maintenance Period|Administrative Problems|1|||
37875636|NCT00941031|69560254|FG005|Maintenance Period|Administrative Problems|0|||
37875637|NCT00941031|69560255|FG006|Maintenance Period|Administrative Problems|1|||
37875638|NCT00941031|69560249|FG000|Maintenance Period|Protocol Violation|0|||
37875639|NCT00941031|69560250|FG001|Maintenance Period|Protocol Violation|0|||
37875640|NCT00941031|69560251|FG002|Maintenance Period|Protocol Violation|0|||
37875641|NCT00941031|69560252|FG003|Maintenance Period|Protocol Violation|0|||
37875642|NCT00941031|69560253|FG004|Maintenance Period|Protocol Violation|0|||
37875643|NCT00941031|69560254|FG005|Maintenance Period|Protocol Violation|0|||
37875644|NCT00941031|69560255|FG006|Maintenance Period|Protocol Violation|1|||
37875645|NCT00941031|69560249|FG000|Maintenance Period|Adverse Event|0|||
37875646|NCT00941031|69560250|FG001|Maintenance Period|Adverse Event|0|||
37982624|NCT00446030|69669071|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
37982625|NCT00446030|69669070|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
37982626|NCT00446030|69669071|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
37982627|NCT00446030|69669070|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
37982628|NCT00446030|69669071|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
37982629|NCT00446030|69669070|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
37982630|NCT00446030|69669071|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
37982631|NCT00446030|69669070|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
37982632|NCT00446030|69669071|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
37982633|NCT00446030|69669070|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
37982634|NCT00446030|69669071|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
37982635|NCT00446030|69669070|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
37982636|NCT00446030|69669071|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
37982637|NCT00446030|69669070|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
37982638|NCT00446030|69669071|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
37982639|NCT00446030|69669070|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
37982640|NCT00446030|69669071|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
37817663|NCT03616912|69496581|FG005|Overall Study|Protocol Deviation|0|||
37817664|NCT03616912|69496576|FG000|Overall Study|Pregnancy|1|||
37817665|NCT03616912|69496577|FG001|Overall Study|Pregnancy|0|||
37817666|NCT03616912|69496578|FG002|Overall Study|Pregnancy|4|||
37817667|NCT03616912|69496579|FG003|Overall Study|Pregnancy|0|||
37875647|NCT00941031|69560251|FG002|Maintenance Period|Adverse Event|0|||
37875648|NCT00941031|69560252|FG003|Maintenance Period|Adverse Event|0|||
37875649|NCT00941031|69560253|FG004|Maintenance Period|Adverse Event|0|||
37875650|NCT00941031|69560254|FG005|Maintenance Period|Adverse Event|2|||
37875651|NCT00941031|69560255|FG006|Maintenance Period|Adverse Event|8|||
37875652|NCT00941031|69560249|FG000|Maintenance Period|Lost to Follow-up|0|||
37817668|NCT03616912|69496580|FG004|Overall Study|Pregnancy|0|||
37817669|NCT03616912|69496581|FG005|Overall Study|Pregnancy|0|||
37817670|NCT03616912|69496576|FG000|Overall Study|Protocol Violation|1|||
37817671|NCT03616912|69496577|FG001|Overall Study|Protocol Violation|0|||
37875653|NCT00941031|69560250|FG001|Maintenance Period|Lost to Follow-up|0|||
37875654|NCT00941031|69560251|FG002|Maintenance Period|Lost to Follow-up|0|||
37875655|NCT00941031|69560252|FG003|Maintenance Period|Lost to Follow-up|0|||
37875656|NCT00941031|69560253|FG004|Maintenance Period|Lost to Follow-up|2|||
37875657|NCT00941031|69560254|FG005|Maintenance Period|Lost to Follow-up|2|||
37982641|NCT00446030|69669070|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
37982642|NCT00446030|69669071|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
37875658|NCT00941031|69560255|FG006|Maintenance Period|Lost to Follow-up|7|||
37875659|NCT00941031|69560249|FG000|Maintenance Period|Lack of Efficacy|0|||
37817672|NCT03616912|69496578|FG002|Overall Study|Protocol Violation|2|||
37875660|NCT00941031|69560250|FG001|Maintenance Period|Lack of Efficacy|0|||
37875661|NCT00941031|69560251|FG002|Maintenance Period|Lack of Efficacy|0|||
37875662|NCT00941031|69560252|FG003|Maintenance Period|Lack of Efficacy|0|||
37875663|NCT00941031|69560253|FG004|Maintenance Period|Lack of Efficacy|0|||
37875664|NCT00941031|69560254|FG005|Maintenance Period|Lack of Efficacy|0|||
37875665|NCT00941031|69560255|FG006|Maintenance Period|Lack of Efficacy|13|||
37875666|NCT00886834|69560276|FG000|Overall Study|Protocol Violation|0|||
37875667|NCT00886834|69560277|FG001|Overall Study|Protocol Violation|3|||
37875668|NCT00880009|69560283|FG000|Overall Study|Study terminated by sponsor|14|||
37875669|NCT00880009|69560283|FG000|Overall Study|Withdrawal by Subject|1|||
37875670|NCT00880009|69560283|FG000|Overall Study|Protocol Violation|1|||
37875671|NCT01104636|69560290|FG000|Overall Study|Lack of Efficacy|43|||
37875672|NCT01104636|69560290|FG000|Overall Study|Lost to Follow-up|24|||
37875673|NCT01104636|69560290|FG000|Overall Study|Withdrawal by Subject|4|||
37875674|NCT01104636|69560290|FG000|Overall Study|Other|43|||
37875675|NCT01104636|69560290|FG000|Overall Study|Study terminated by sponsor|1|||
37875676|NCT01104636|69560290|FG000|Overall Study|Pregnancy|2|||
37875677|NCT01104636|69560290|FG000|Overall Study|Adverse Event|40|||
37875678|NCT01104636|69560290|FG000|Overall Study|Ongoing|21|||
37875679|NCT01104558|69560294|FG000|Overall Study|Protocol Violation|6|||
37875680|NCT01104558|69560294|FG000|Overall Study|Missing of primary efficacy assessment|10|||
37875681|NCT01104558|69560294|FG000|Overall Study|Missing of genetic analysis results|1|||
37817673|NCT03616912|69496579|FG003|Overall Study|Protocol Violation|0|||
37817674|NCT03616912|69496580|FG004|Overall Study|Protocol Violation|0|||
37817675|NCT03616912|69496581|FG005|Overall Study|Protocol Violation|0|||
37817676|NCT03616912|69496576|FG000|Overall Study|Physician Decision|2|||
37817677|NCT03616912|69496577|FG001|Overall Study|Physician Decision|0|||
37817678|NCT03616912|69496578|FG002|Overall Study|Physician Decision|0|||
37817679|NCT03616912|69496579|FG003|Overall Study|Physician Decision|0|||
37817680|NCT03616912|69496580|FG004|Overall Study|Physician Decision|1|||
37817681|NCT03616912|69496581|FG005|Overall Study|Physician Decision|0|||
37817682|NCT03616912|69496576|FG000|Overall Study|Randomized But Never Treated|0|||
37817683|NCT03616912|69496577|FG001|Overall Study|Randomized But Never Treated|2|||
37817684|NCT03616912|69496578|FG002|Overall Study|Randomized But Never Treated|0|||
37817685|NCT03616912|69496579|FG003|Overall Study|Randomized But Never Treated|0|||
37817686|NCT03616912|69496580|FG004|Overall Study|Randomized But Never Treated|0|||
37817687|NCT03616912|69496581|FG005|Overall Study|Randomized But Never Treated|0|||
37817688|NCT03499899|69496598|FG000|Overall Study|Adverse Event|2|||
37817689|NCT03499899|69496599|FG001|Overall Study|Adverse Event|3|||
37817690|NCT03499899|69496600|FG002|Overall Study|Adverse Event|3|||
37817691|NCT03499899|69496598|FG000|Overall Study|Death|0|||
37817692|NCT03499899|69496599|FG001|Overall Study|Death|0|||
37817693|NCT03499899|69496600|FG002|Overall Study|Death|1|||
37817694|NCT03499899|69496598|FG000|Overall Study|Physician Decision|3|||
37817695|NCT03499899|69496599|FG001|Overall Study|Physician Decision|6|||
37817696|NCT03499899|69496600|FG002|Overall Study|Physician Decision|6|||
37817697|NCT03499899|69496598|FG000|Overall Study|Progressive disease|15|||
37817698|NCT03499899|69496599|FG001|Overall Study|Progressive disease|23|||
37817699|NCT03499899|69496600|FG002|Overall Study|Progressive disease|23|||
37817700|NCT03499899|69496598|FG000|Overall Study|Patient decision|0|||
37817701|NCT03499899|69496599|FG001|Overall Study|Patient decision|1|||
37817702|NCT03499899|69496600|FG002|Overall Study|Patient decision|1|||
37817703|NCT03499899|69496598|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
37817704|NCT03499899|69496599|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
37817705|NCT03499899|69496600|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
37817706|NCT03481634|69496616|FG000|Overall Study|Withdrawal by Subject|16|||
37817707|NCT03481634|69496617|FG001|Overall Study|Withdrawal by Subject|19|||
37817708|NCT03481634|69496618|FG002|Overall Study|Withdrawal by Subject|14|||
37817709|NCT03481634|69496616|FG000|Overall Study|Protocol Violation|1|||
37817710|NCT03481634|69496617|FG001|Overall Study|Protocol Violation|0|||
37875682|NCT00886288|69560300|FG000|Overall Study|no respect of the 12 weeks period|657|||
37875683|NCT00886288|69560301|FG001|Overall Study|no respect of the 12 weeks period|227|||
37875684|NCT00886288|69560300|FG000|Overall Study|Lost to Follow-up|86|||
37875685|NCT00886288|69560301|FG001|Overall Study|Lost to Follow-up|0|||
37875686|NCT01204658|69560313|FG000|Primary Phase|Adverse Event|0|||
37875687|NCT01204658|69560314|FG001|Primary Phase|Adverse Event|0|||
37875688|NCT01204658|69560315|FG002|Primary Phase|Adverse Event|1|||
37875689|NCT01204658|69560316|FG003|Primary Phase|Adverse Event|0|||
37817711|NCT03481634|69496618|FG002|Overall Study|Protocol Violation|1|||
37817712|NCT03481634|69496616|FG000|Overall Study|Progressive disease|0|||
37817713|NCT03481634|69496617|FG001|Overall Study|Progressive disease|1|||
37817714|NCT03481634|69496618|FG002|Overall Study|Progressive disease|0|||
37817715|NCT03481634|69496616|FG000|Overall Study|Physician Decision|3|||
37817716|NCT03481634|69496617|FG001|Overall Study|Physician Decision|0|||
37875690|NCT00951483|69560331|FG000|Overall Study|Physician Decision|4|||
37817717|NCT03481634|69496618|FG002|Overall Study|Physician Decision|1|||
37817718|NCT03481634|69496616|FG000|Overall Study|Lost to Follow-up|3|||
37817719|NCT03481634|69496617|FG001|Overall Study|Lost to Follow-up|4|||
37875691|NCT00951483|69560332|FG001|Overall Study|Physician Decision|0|||
37875692|NCT00951483|69560331|FG000|Overall Study|Withdrawal by Subject|15|||
37875693|NCT00951483|69560332|FG001|Overall Study|Withdrawal by Subject|0|||
37875694|NCT01104246|69560340|FG000|Overall Study|Withdrawal by Subject|1|||
37875695|NCT01104246|69560340|FG000|Overall Study|did not meet inclusion criteria|4|||
37875696|NCT01103778|69560344|FG000|Overall Study|Lost to Follow-up|1|||
37875697|NCT01103778|69560344|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
37875698|NCT01103778|69560344|FG000|Overall Study|Screen failure|1|||
37875699|NCT01103466|69560350|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
37875700|NCT01103466|69560351|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
37875701|NCT01103466|69560352|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
37875702|NCT01103466|69560350|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
37875703|NCT01103466|69560351|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
37875704|NCT01103466|69560352|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
37875705|NCT01103466|69560350|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
37875706|NCT01103466|69560351|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
37875707|NCT01103466|69560352|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
37875708|NCT01103466|69560350|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
37875709|NCT01103466|69560351|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
37875710|NCT01103466|69560352|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
37875711|NCT01103466|69560350|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
37875712|NCT01103466|69560351|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
37875713|NCT01103466|69560352|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
37875714|NCT01103466|69560350|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
37875715|NCT01103466|69560351|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
37875716|NCT01103466|69560352|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
37817720|NCT03481634|69496618|FG002|Overall Study|Lost to Follow-up|4|||
37817721|NCT03481634|69496616|FG000|Overall Study|Death|4|||
37817722|NCT03481634|69496617|FG001|Overall Study|Death|8|||
37817723|NCT03481634|69496618|FG002|Overall Study|Death|7|||
37817724|NCT03481634|69496616|FG000|Overall Study|Adverse Event|6|||
37817725|NCT03481634|69496617|FG001|Overall Study|Adverse Event|3|||
37817726|NCT03481634|69496618|FG002|Overall Study|Adverse Event|7|||
37817727|NCT03373461|69496632|FG000|Part 2|Adverse Event|0|||
37817728|NCT03373461|69496633|FG001|Part 2|Adverse Event|1|||
37817729|NCT03373461|69496634|FG002|Part 2|Adverse Event|0|||
37817730|NCT03373461|69496635|FG003|Part 2|Adverse Event|0|||
37817731|NCT03373461|69496636|FG004|Part 2|Adverse Event|1|||
37817732|NCT03364751|69496687|FG000|Overall Study|Withdrawal by Subject|1|||
37817733|NCT03364751|69496688|FG001|Overall Study|Withdrawal by Subject|0|||
37817734|NCT03364751|69496689|FG002|Overall Study|Withdrawal by Subject|0|||
37817735|NCT03364751|69496690|FG003|Overall Study|Withdrawal by Subject|0|||
37817736|NCT03364751|69496687|FG000|Overall Study|Lost to Follow-up|0|||
37817737|NCT03364751|69496688|FG001|Overall Study|Lost to Follow-up|1|||
37817738|NCT03364751|69496689|FG002|Overall Study|Lost to Follow-up|0|||
37817739|NCT03364751|69496690|FG003|Overall Study|Lost to Follow-up|0|||
37817740|NCT02990806|69496710|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
37817741|NCT02990806|69496711|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
37817742|NCT02990806|69496712|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
37817743|NCT02990806|69496713|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
37817744|NCT02990806|69496710|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
37817745|NCT02990806|69496711|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
37817746|NCT02990806|69496712|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
37817747|NCT02990806|69496713|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
37817748|NCT02990806|69496710|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
37817749|NCT02990806|69496711|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
37817750|NCT02990806|69496712|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
37817751|NCT02990806|69496713|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
37817752|NCT02990806|69496710|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
37817753|NCT02990806|69496711|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
37817754|NCT02990806|69496712|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
37817755|NCT02990806|69496713|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
37817756|NCT02990806|69496710|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
37817757|NCT02990806|69496711|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
37875717|NCT00945945|69560362|FG000|Overall Study|Adverse Event|15|||
37875718|NCT00945945|69560363|FG001|Overall Study|Adverse Event|35|||
37875719|NCT00945945|69560362|FG000|Overall Study|Withdrawal by Subject|7|||
37875720|NCT00945945|69560363|FG001|Overall Study|Withdrawal by Subject|10|||
37817758|NCT02990806|69496712|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
37875721|NCT00945945|69560362|FG000|Overall Study|Lost to Follow-up|4|||
37875722|NCT00945945|69560363|FG001|Overall Study|Lost to Follow-up|5|||
37817759|NCT02990806|69496713|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
37817760|NCT02990806|69496710|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
37817761|NCT02990806|69496711|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
37875723|NCT00945945|69560362|FG000|Overall Study|Lack of Efficacy|6|||
37875724|NCT00945945|69560363|FG001|Overall Study|Lack of Efficacy|2|||
37875725|NCT00945945|69560362|FG000|Overall Study|Protocol Violation|4|||
37875726|NCT00945945|69560363|FG001|Overall Study|Protocol Violation|2|||
37875727|NCT00945945|69560362|FG000|Overall Study|Entry Criteria Not Met|0|||
37875728|NCT00945945|69560363|FG001|Overall Study|Entry Criteria Not Met|1|||
37875729|NCT01203956|69560369|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
37875730|NCT01203956|69560370|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
37875731|NCT01103232|69560379|FG000|Overall Study|Withdrawal by Subject|1|||
37875732|NCT01103232|69560380|FG001|Overall Study|Withdrawal by Subject|1|||
37875733|NCT01103232|69560379|FG000|Overall Study|Protocol Violation|0|||
37875734|NCT01103232|69560380|FG001|Overall Study|Protocol Violation|1|||
37875735|NCT01112982|69560386|FG000|Overall Study|Withdrawal by Subject|1|||
37875736|NCT01112982|69560386|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
37875737|NCT01203878|69560396|FG000|Overall Study|Withdrawal by Subject|0|||
37875738|NCT01203878|69560397|FG001|Overall Study|Withdrawal by Subject|0|||
37875739|NCT01203878|69560398|FG002|Overall Study|Withdrawal by Subject|1|||
37875740|NCT01203878|69560396|FG000|Overall Study|Adverse Event|0|||
37875741|NCT01203878|69560397|FG001|Overall Study|Adverse Event|0|||
37875742|NCT01203878|69560398|FG002|Overall Study|Adverse Event|2|||
37875743|NCT01112514|69560405|FG000|Overall Study|Lost to Follow-up|1|||
37875744|NCT01203098|69560412|FG000|Overall Study|Adverse Event|3|||
37875745|NCT01203098|69560413|FG001|Overall Study|Adverse Event|1|||
37875746|NCT01203098|69560414|FG002|Overall Study|Adverse Event|7|||
37875747|NCT01203098|69560412|FG000|Overall Study|Lost to Follow-up|0|||
37875748|NCT01203098|69560413|FG001|Overall Study|Lost to Follow-up|0|||
37875749|NCT01203098|69560414|FG002|Overall Study|Lost to Follow-up|1|||
37875750|NCT01203098|69560412|FG000|Overall Study|Physician Decision|2|||
37875751|NCT01203098|69560413|FG001|Overall Study|Physician Decision|2|||
37875752|NCT01203098|69560414|FG002|Overall Study|Physician Decision|0|||
37875753|NCT01203098|69560412|FG000|Overall Study|Withdrawal by Subject|1|||
37875754|NCT01203098|69560413|FG001|Overall Study|Withdrawal by Subject|1|||
37875755|NCT01203098|69560414|FG002|Overall Study|Withdrawal by Subject|3|||
37875756|NCT00945555|69560422|FG000|Overall Study|Referred to another hospital|5|||
37875757|NCT00945555|69560422|FG000|Overall Study|Worsening condition, intensive care unit|1|||
37875758|NCT00945555|69560422|FG000|Overall Study|Withdrawal by Subject|2|||
37875759|NCT00945555|69560422|FG000|Overall Study|Participant continued treatment at home|1|||
37875760|NCT00945555|69560422|FG000|Overall Study|Death|18|||
37875761|NCT00945555|69560422|FG000|Overall Study|Other|1|||
37875762|NCT01108458|69560426|FG000|Overall Study|Withdrawal by Subject|1|||
37875763|NCT01108068|69560432|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
37875764|NCT01108068|69560433|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
37875765|NCT01201850|69560440|FG000|Overall Study|Tumor progression|4|||
37875766|NCT00951171|69560446|FG000|Overall Study|Adverse Event|2|||
37875767|NCT00951171|69560447|FG001|Overall Study|Adverse Event|0|||
37875768|NCT01200992|69560455|FG000|Overall Study|Study terminated early|35|||
37817762|NCT02990806|69496712|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
37817763|NCT02990806|69496713|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
37817764|NCT02990806|69496710|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
37817765|NCT02990806|69496711|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
37817766|NCT02990806|69496712|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
37817767|NCT02990806|69496713|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
37817768|NCT02990806|69496710|FG000|Stage 1 (22 Weeks)|Death|0|||
37817769|NCT02990806|69496711|FG001|Stage 1 (22 Weeks)|Death|1|||
37817770|NCT02990806|69496712|FG002|Stage 1 (22 Weeks)|Death|0|||
37817771|NCT02990806|69496713|FG003|Stage 1 (22 Weeks)|Death|0|||
37817772|NCT02990806|69496710|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
37817773|NCT02990806|69496711|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
37817774|NCT02990806|69496712|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
37817775|NCT02990806|69496713|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
37817776|NCT02990806|69496710|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
37817777|NCT02990806|69496711|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
37817778|NCT02990806|69496712|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
37817779|NCT02990806|69496713|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
37875769|NCT01200992|69560456|FG001|Overall Study|Study terminated early|41|||
37875770|NCT01200992|69560455|FG000|Overall Study|Randomized but not treated|2|||
37875771|NCT01200992|69560456|FG001|Overall Study|Randomized but not treated|0|||
37875772|NCT00878215|69560468|FG000|Overall Study|Determined to be ineligible|0|||
37875773|NCT00878215|69560469|FG001|Overall Study|Determined to be ineligible|10|||
37875774|NCT00878215|69560470|FG002|Overall Study|Determined to be ineligible|0|||
37875775|NCT00878215|69560471|FG003|Overall Study|Determined to be ineligible|0|||
37875776|NCT01200758|69560483|FG000|Stage I|Death|0|||
37875777|NCT01200758|69560484|FG001|Stage I|Death|1|||
37817780|NCT02990806|69496710|FG000|Stage 1 (22 Weeks)|Other|1|||
37817781|NCT02990806|69496711|FG001|Stage 1 (22 Weeks)|Other|3|||
37817782|NCT02990806|69496712|FG002|Stage 1 (22 Weeks)|Other|0|||
37982643|NCT00446030|69669070|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
37982644|NCT00446030|69669071|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
37982645|NCT00446030|69669070|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
37982646|NCT00446030|69669071|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
37982647|NCT00446030|69669070|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
37982648|NCT00446030|69669071|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
37982649|NCT00446030|69669070|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
37982650|NCT00446030|69669071|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
37982651|NCT00446030|69669070|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
37982652|NCT00446030|69669071|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
37982653|NCT00446030|69669070|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
37982654|NCT00446030|69669071|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
37982655|NCT00446030|69669070|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
37982656|NCT00446030|69669071|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
37875778|NCT01200758|69560485|FG002|Stage I|Death|0|||
37875779|NCT01200758|69560486|FG003|Stage I|Death|0|||
37875780|NCT01200758|69560483|FG000|Stage I|Physician Decision|1|||
37875781|NCT01200758|69560484|FG001|Stage I|Physician Decision|1|||
37875782|NCT01200758|69560485|FG002|Stage I|Physician Decision|0|||
37875783|NCT01200758|69560486|FG003|Stage I|Physician Decision|0|||
37875784|NCT01200758|69560483|FG000|Stage I|Lack of Efficacy|2|||
37875785|NCT01200758|69560484|FG001|Stage I|Lack of Efficacy|1|||
37875786|NCT01200758|69560485|FG002|Stage I|Lack of Efficacy|0|||
37817783|NCT02990806|69496713|FG003|Stage 1 (22 Weeks)|Other|0|||
37817784|NCT02990806|69496710|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
37817785|NCT02990806|69496711|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
37817786|NCT02990806|69496712|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
37817787|NCT02990806|69496713|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
37817788|NCT02990806|69496710|FG000|Stage 2 (32 Weeks)|Death|1|||
37817789|NCT02990806|69496711|FG001|Stage 2 (32 Weeks)|Death|0|||
37817790|NCT02990806|69496712|FG002|Stage 2 (32 Weeks)|Death|0|||
37817791|NCT02990806|69496713|FG003|Stage 2 (32 Weeks)|Death|0|||
37817792|NCT02990806|69496710|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
37875787|NCT01200758|69560486|FG003|Stage I|Lack of Efficacy|0|||
37695093|NCT02405780|69171578|FG000|Period II|Pregnancy|0|||
37695094|NCT02405780|69171579|FG001|Period II|Pregnancy|0|||
37695095|NCT02405780|69171580|FG002|Period II|Pregnancy|1|||
37817793|NCT02990806|69496711|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
37695096|NCT02405780|69171581|FG003|Period II|Pregnancy|0|||
37817794|NCT02990806|69496712|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
37817795|NCT02990806|69496713|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
37817796|NCT02990806|69496710|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
37875788|NCT01200758|69560483|FG000|Stage I|Adverse Event|5|||
37875789|NCT01200758|69560484|FG001|Stage I|Adverse Event|5|||
37875790|NCT01200758|69560485|FG002|Stage I|Adverse Event|0|||
37817797|NCT02990806|69496711|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
37817798|NCT02990806|69496712|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
37875791|NCT01200758|69560486|FG003|Stage I|Adverse Event|0|||
37875792|NCT01200758|69560483|FG000|Stage I|Withdrawal by Subject|1|||
37875793|NCT01200758|69560484|FG001|Stage I|Withdrawal by Subject|2|||
37875794|NCT01200758|69560485|FG002|Stage I|Withdrawal by Subject|0|||
37875795|NCT01200758|69560486|FG003|Stage I|Withdrawal by Subject|0|||
37875796|NCT01200758|69560483|FG000|Stage I|Disease Progression|9|||
37875797|NCT01200758|69560484|FG001|Stage I|Disease Progression|7|||
37875798|NCT01200758|69560485|FG002|Stage I|Disease Progression|0|||
37875799|NCT01200758|69560486|FG003|Stage I|Disease Progression|0|||
37875800|NCT01200758|69560483|FG000|Stage 2|Disease Progression|0|||
37875801|NCT01200758|69560484|FG001|Stage 2|Disease Progression|0|||
37875802|NCT01200758|69560485|FG002|Stage 2|Disease Progression|16|||
37875803|NCT01200758|69560486|FG003|Stage 2|Disease Progression|21|||
37875804|NCT01200758|69560483|FG000|Stage 2|Lack of Efficacy|0|||
37875805|NCT01200758|69560484|FG001|Stage 2|Lack of Efficacy|0|||
37875806|NCT01200758|69560485|FG002|Stage 2|Lack of Efficacy|4|||
37875807|NCT01200758|69560486|FG003|Stage 2|Lack of Efficacy|2|||
37875808|NCT01200758|69560483|FG000|Stage 2|Physician Decision|0|||
37875809|NCT01200758|69560484|FG001|Stage 2|Physician Decision|0|||
37875810|NCT01200758|69560485|FG002|Stage 2|Physician Decision|5|||
37875811|NCT01200758|69560486|FG003|Stage 2|Physician Decision|7|||
37875812|NCT01200758|69560483|FG000|Stage 2|Adverse Event|0|||
37875813|NCT01200758|69560484|FG001|Stage 2|Adverse Event|0|||
37875814|NCT01200758|69560485|FG002|Stage 2|Adverse Event|5|||
37875815|NCT01200758|69560486|FG003|Stage 2|Adverse Event|9|||
37875816|NCT01200758|69560483|FG000|Stage 2|Withdrawal by Subject|0|||
37875817|NCT01200758|69560484|FG001|Stage 2|Withdrawal by Subject|0|||
37875818|NCT01200758|69560485|FG002|Stage 2|Withdrawal by Subject|4|||
37875819|NCT01200758|69560486|FG003|Stage 2|Withdrawal by Subject|1|||
37875820|NCT01200758|69560483|FG000|Stage 2|Lost to Follow-up|0|||
37875821|NCT01200758|69560484|FG001|Stage 2|Lost to Follow-up|0|||
37875822|NCT01200758|69560485|FG002|Stage 2|Lost to Follow-up|3|||
37875823|NCT01200758|69560486|FG003|Stage 2|Lost to Follow-up|1|||
37875824|NCT01200758|69560483|FG000|Stage 2|Protocol Violation|0|||
37875825|NCT01200758|69560484|FG001|Stage 2|Protocol Violation|0|||
37875826|NCT01200758|69560485|FG002|Stage 2|Protocol Violation|1|||
37875827|NCT01200758|69560486|FG003|Stage 2|Protocol Violation|4|||
37875828|NCT01200758|69560483|FG000|Stage 2|Death|0|||
37875829|NCT01200758|69560484|FG001|Stage 2|Death|0|||
37875830|NCT01200758|69560485|FG002|Stage 2|Death|3|||
37875831|NCT01200758|69560486|FG003|Stage 2|Death|5|||
37875832|NCT00876343|69560501|FG000|Overall Study|Adverse Event|7|||
37875833|NCT00876343|69560502|FG001|Overall Study|Adverse Event|8|||
37875834|NCT00876343|69560503|FG002|Overall Study|Adverse Event|2|||
37875835|NCT00876343|69560501|FG000|Overall Study|Withdrawal by Subject|4|||
37875836|NCT00876343|69560502|FG001|Overall Study|Withdrawal by Subject|4|||
37817799|NCT02990806|69496713|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
37817800|NCT02990806|69496710|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
37817801|NCT02990806|69496711|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
37817802|NCT02990806|69496712|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
37817803|NCT02990806|69496713|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
37817804|NCT02990806|69496710|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
37817805|NCT02990806|69496711|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
37875837|NCT00876343|69560503|FG002|Overall Study|Withdrawal by Subject|3|||
37875838|NCT00876343|69560501|FG000|Overall Study|Lack of Efficacy|0|||
37875839|NCT00876343|69560502|FG001|Overall Study|Lack of Efficacy|0|||
37875840|NCT00876343|69560503|FG002|Overall Study|Lack of Efficacy|1|||
37875841|NCT00876343|69560501|FG000|Overall Study|Protocol Violation|4|||
37875842|NCT00876343|69560502|FG001|Overall Study|Protocol Violation|1|||
37875843|NCT00876343|69560503|FG002|Overall Study|Protocol Violation|1|||
37875844|NCT00876343|69560501|FG000|Overall Study|Physician Decision|0|||
37875845|NCT00876343|69560502|FG001|Overall Study|Physician Decision|1|||
37875846|NCT00876343|69560503|FG002|Overall Study|Physician Decision|1|||
37875847|NCT00876343|69560501|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
37875848|NCT00876343|69560502|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
37875849|NCT00876343|69560503|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
37875850|NCT00876343|69560501|FG000|Overall Study|Change of residence or other commitments|2|||
37817806|NCT02990806|69496712|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
37817807|NCT02990806|69496713|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
37817808|NCT02990806|69496710|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
37817809|NCT02990806|69496711|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
37817810|NCT02990806|69496712|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
37817811|NCT02990806|69496713|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
37817812|NCT02990806|69496710|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
37817813|NCT02990806|69496711|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
37817814|NCT02990806|69496712|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
37817815|NCT02990806|69496713|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
37817816|NCT02990806|69496710|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
37817817|NCT02990806|69496711|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
37817818|NCT02990806|69496712|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
37817819|NCT02990806|69496713|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
37817820|NCT02990806|69496710|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
37817821|NCT02990806|69496711|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
37817822|NCT02990806|69496712|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
37817823|NCT02990806|69496713|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
37817824|NCT02990806|69496710|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
37817825|NCT02990806|69496711|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
37817826|NCT02990806|69496712|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
37817827|NCT02990806|69496713|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
37817828|NCT02990806|69496710|FG000|Stage 2 (32 Weeks)|Other|3|||
37817829|NCT02990806|69496711|FG001|Stage 2 (32 Weeks)|Other|0|||
37817830|NCT02990806|69496712|FG002|Stage 2 (32 Weeks)|Other|4|||
37817831|NCT02990806|69496713|FG003|Stage 2 (32 Weeks)|Other|1|||
37817832|NCT02990806|69496710|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
37817833|NCT02990806|69496711|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
37817834|NCT02990806|69496712|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
37817835|NCT02990806|69496713|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
37817836|NCT02990806|69496710|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
37817837|NCT02990806|69496711|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
37817838|NCT02990806|69496712|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
37817839|NCT02990806|69496713|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
37817840|NCT02990806|69496710|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
37817841|NCT02990806|69496711|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
37875851|NCT00876343|69560502|FG001|Overall Study|Change of residence or other commitments|2|||
37817842|NCT02990806|69496712|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
37875852|NCT00876343|69560503|FG002|Overall Study|Change of residence or other commitments|3|||
37875853|NCT01107912|69560515|FG000|Period 1|Adverse Event|0|||
37875854|NCT01107912|69560516|FG001|Period 1|Adverse Event|0|||
37875855|NCT01107912|69560517|FG002|Period 1|Adverse Event|0|||
37875856|NCT01107912|69560518|FG003|Period 1|Adverse Event|0|||
37875857|NCT01107912|69560519|FG004|Period 1|Adverse Event|2|||
37875858|NCT01107912|69560520|FG005|Period 1|Adverse Event|0|||
37875859|NCT01107912|69560515|FG000|Period 1|Physician Decision|0|||
37875860|NCT01107912|69560516|FG001|Period 1|Physician Decision|0|||
37875861|NCT01107912|69560517|FG002|Period 1|Physician Decision|0|||
37875862|NCT01107912|69560518|FG003|Period 1|Physician Decision|0|||
37875863|NCT01107912|69560519|FG004|Period 1|Physician Decision|1|||
37875864|NCT01107912|69560520|FG005|Period 1|Physician Decision|0|||
37875865|NCT01107912|69560515|FG000|Period 1|Withdrawal by Subject|1|||
37875866|NCT01107912|69560516|FG001|Period 1|Withdrawal by Subject|0|||
37875867|NCT01107912|69560517|FG002|Period 1|Withdrawal by Subject|0|||
37875868|NCT01107912|69560518|FG003|Period 1|Withdrawal by Subject|0|||
37875869|NCT01107912|69560519|FG004|Period 1|Withdrawal by Subject|0|||
37875870|NCT01107912|69560520|FG005|Period 1|Withdrawal by Subject|0|||
37875871|NCT01107912|69560515|FG000|Period 2|Physician Decision|0|||
37875872|NCT01107912|69560516|FG001|Period 2|Physician Decision|0|||
37875873|NCT01107912|69560517|FG002|Period 2|Physician Decision|1|||
37875874|NCT01107912|69560518|FG003|Period 2|Physician Decision|0|||
37875875|NCT01107912|69560519|FG004|Period 2|Physician Decision|0|||
37875876|NCT01107912|69560520|FG005|Period 2|Physician Decision|0|||
37875877|NCT01107912|69560515|FG000|Period 3|Adverse Event|0|||
37875878|NCT01107912|69560516|FG001|Period 3|Adverse Event|1|||
37875879|NCT01107912|69560517|FG002|Period 3|Adverse Event|1|||
37875880|NCT01107912|69560518|FG003|Period 3|Adverse Event|0|||
37875881|NCT01107912|69560519|FG004|Period 3|Adverse Event|0|||
37875882|NCT01107912|69560520|FG005|Period 3|Adverse Event|0|||
37875883|NCT01107912|69560515|FG000|Period 3|Withdrawal by Subject|0|||
37875884|NCT01107912|69560516|FG001|Period 3|Withdrawal by Subject|0|||
37875885|NCT01107912|69560517|FG002|Period 3|Withdrawal by Subject|0|||
37875886|NCT01107912|69560518|FG003|Period 3|Withdrawal by Subject|1|||
37875887|NCT01107912|69560519|FG004|Period 3|Withdrawal by Subject|0|||
37875888|NCT01107912|69560520|FG005|Period 3|Withdrawal by Subject|0|||
37875889|NCT01200524|69560538|FG000|Overall Study|Withdrawal by Subject|1|||
37875890|NCT01200524|69560539|FG001|Overall Study|Withdrawal by Subject|1|||
37875891|NCT01200524|69560540|FG002|Overall Study|Withdrawal by Subject|3|||
37875892|NCT01200524|69560538|FG000|Overall Study|Adverse Event|1|||
37875893|NCT01200524|69560539|FG001|Overall Study|Adverse Event|0|||
37875894|NCT01200524|69560540|FG002|Overall Study|Adverse Event|0|||
37875895|NCT01200524|69560538|FG000|Overall Study|Non availability of study nurse|0|||
37875896|NCT01200524|69560539|FG001|Overall Study|Non availability of study nurse|0|||
37875897|NCT01200524|69560540|FG002|Overall Study|Non availability of study nurse|1|||
37875898|NCT01100034|69560548|FG000|Overall Study|Lost to Follow-up|11|||
37875899|NCT01100034|69560548|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
37875900|NCT01100034|69560548|FG000|Overall Study|Withdrawal by Subject|4|||
37875901|NCT01100034|69560548|FG000|Overall Study|Sponsor decision|21|||
37875902|NCT01100034|69560548|FG000|Overall Study|Participated in another clinical trial|1|||
37875903|NCT01100034|69560548|FG000|Overall Study|Participants moved to another hospital|4|||
37875904|NCT01100034|69560548|FG000|Overall Study|Site closed due to non-responsiveness|1|||
37875905|NCT00876265|69560552|FG000|Overall Study|Miscellaneous reasons|4|||
37875906|NCT00876265|69560552|FG000|Overall Study|Lost to Follow-up|6|||
37875907|NCT00876265|69560552|FG000|Overall Study|Withdrawal by Subject|2|||
37875908|NCT01107444|69560560|FG000|Overall Study|Withdrawal by Subject|8|||
37875909|NCT01107444|69560561|FG001|Overall Study|Withdrawal by Subject|12|||
37875910|NCT01107444|69560560|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
37875911|NCT01107444|69560561|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
37875912|NCT00876187|69560575|FG000|Overall Study|Adverse Event|14|||
37875913|NCT00876187|69560576|FG001|Overall Study|Adverse Event|12|||
37875914|NCT00876187|69560577|FG002|Overall Study|Adverse Event|19|||
37875915|NCT00876187|69560578|FG003|Overall Study|Adverse Event|29|||
37875916|NCT00876187|69560579|FG004|Overall Study|Adverse Event|10|||
37875917|NCT00876187|69560575|FG000|Overall Study|Lack of Efficacy|59|||
37875918|NCT00876187|69560576|FG001|Overall Study|Lack of Efficacy|34|||
37875919|NCT00876187|69560577|FG002|Overall Study|Lack of Efficacy|45|||
37875920|NCT00876187|69560578|FG003|Overall Study|Lack of Efficacy|34|||
37875921|NCT00876187|69560579|FG004|Overall Study|Lack of Efficacy|59|||
37875922|NCT00876187|69560575|FG000|Overall Study|Lost to Follow-up|9|||
37875923|NCT00876187|69560576|FG001|Overall Study|Lost to Follow-up|10|||
37875924|NCT00876187|69560577|FG002|Overall Study|Lost to Follow-up|8|||
37875925|NCT00876187|69560578|FG003|Overall Study|Lost to Follow-up|8|||
37875926|NCT00876187|69560579|FG004|Overall Study|Lost to Follow-up|11|||
37875927|NCT00876187|69560575|FG000|Overall Study|Protocol Violation|6|||
37875928|NCT00876187|69560576|FG001|Overall Study|Protocol Violation|7|||
37875929|NCT00876187|69560577|FG002|Overall Study|Protocol Violation|7|||
37875930|NCT00876187|69560578|FG003|Overall Study|Protocol Violation|6|||
37875931|NCT00876187|69560579|FG004|Overall Study|Protocol Violation|3|||
37817843|NCT02990806|69496713|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
37817844|NCT02990806|69496710|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
37875932|NCT00876187|69560575|FG000|Overall Study|Withdrawal by Subject|16|||
37875933|NCT00876187|69560576|FG001|Overall Study|Withdrawal by Subject|26|||
37875934|NCT00876187|69560577|FG002|Overall Study|Withdrawal by Subject|32|||
37875935|NCT00876187|69560578|FG003|Overall Study|Withdrawal by Subject|38|||
37875936|NCT00876187|69560579|FG004|Overall Study|Withdrawal by Subject|37|||
37875937|NCT00876187|69560575|FG000|Overall Study|Entered extension study|101|||
37875938|NCT00876187|69560576|FG001|Overall Study|Entered extension study|120|||
37875939|NCT00876187|69560577|FG002|Overall Study|Entered extension study|156|||
37875940|NCT00876187|69560578|FG003|Overall Study|Entered extension study|151|||
37875941|NCT00876187|69560579|FG004|Overall Study|Entered extension study|144|||
37875942|NCT00876187|69560575|FG000|Overall Study|Randomized but not treated|3|||
37875943|NCT00876187|69560576|FG001|Overall Study|Randomized but not treated|1|||
37875944|NCT00876187|69560577|FG002|Overall Study|Randomized but not treated|3|||
37982657|NCT00411216|69669079|FG000|Overall Study|Ten participants were entered into the c|0|||
37982658|NCT00411216|69669080|FG001|Overall Study|Ten participants were entered into the c|2|||
37982659|NCT00410514|69669089|FG000|Overall Study|Adverse Event|2|||
37982660|NCT00410514|69669090|FG001|Overall Study|Adverse Event|2|||
37982661|NCT00410514|69669091|FG002|Overall Study|Adverse Event|2|||
37982662|NCT00410514|69669089|FG000|Overall Study|Protocol Violation|0|||
37982663|NCT00410514|69669090|FG001|Overall Study|Protocol Violation|1|||
37982664|NCT00410514|69669091|FG002|Overall Study|Protocol Violation|1|||
37982665|NCT00410514|69669089|FG000|Overall Study|Lost to Follow-up|0|||
37982666|NCT00410514|69669090|FG001|Overall Study|Lost to Follow-up|0|||
37982667|NCT00410514|69669091|FG002|Overall Study|Lost to Follow-up|2|||
37817845|NCT02990806|69496711|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
37817846|NCT02990806|69496712|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
37817847|NCT02990806|69496713|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
37817848|NCT02990806|69496710|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
37817849|NCT02990806|69496711|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
37817850|NCT02990806|69496712|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
37817851|NCT02990806|69496713|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
37817852|NCT02990806|69496710|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
37817853|NCT02990806|69496711|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
37817854|NCT02990806|69496712|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
37817855|NCT02990806|69496713|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
37817856|NCT02990806|69496710|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
37817857|NCT02990806|69496711|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
37817858|NCT02990806|69496712|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
37817859|NCT02990806|69496713|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
37817860|NCT02990806|69496710|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
37817861|NCT02990806|69496711|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
37817862|NCT02990806|69496712|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
37817863|NCT02990806|69496713|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
37817864|NCT02990806|69496710|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
37817865|NCT02990806|69496711|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
37875945|NCT00876187|69560578|FG003|Overall Study|Randomized but not treated|2|||
37875946|NCT00876187|69560579|FG004|Overall Study|Randomized but not treated|3|||
37875947|NCT00876187|69560575|FG000|Overall Study|Other|2|||
37875948|NCT00876187|69560576|FG001|Overall Study|Other|5|||
37875949|NCT00876187|69560577|FG002|Overall Study|Other|9|||
37875950|NCT00876187|69560578|FG003|Overall Study|Other|7|||
37875951|NCT00876187|69560579|FG004|Overall Study|Other|4|||
37875952|NCT01102374|69560596|FG000|Overall Study|Death|9|||
37875953|NCT01102374|69560597|FG001|Overall Study|Death|13|||
37875954|NCT01102374|69560596|FG000|Overall Study|Lost to Follow-up|7|||
37875955|NCT01102374|69560597|FG001|Overall Study|Lost to Follow-up|6|||
37875956|NCT01106976|69560603|FG000|Overall Study|Lost to Follow-up|8|||
37875957|NCT00875485|69560609|FG000|Challenge Dose Epoch|Pregnancy|1|||
37875958|NCT00875485|69560610|FG001|Challenge Dose Epoch|Pregnancy|0|||
37875959|NCT04547140|69560618|FG000|Overall Study|Adverse Event|0|||
37875960|NCT04547140|69560619|FG001|Overall Study|Adverse Event|1|||
37875961|NCT04547140|69560618|FG000|Overall Study|Withdrawal by Subject|0|||
37875962|NCT04547140|69560619|FG001|Overall Study|Withdrawal by Subject|1|||
37875963|NCT04547140|69560618|FG000|Overall Study|Lost to Follow-up|3|||
37875964|NCT04547140|69560619|FG001|Overall Study|Lost to Follow-up|1|||
37875965|NCT04547140|69560618|FG000|Overall Study|Death|2|||
37875966|NCT04547140|69560619|FG001|Overall Study|Death|1|||
37875967|NCT04547140|69560618|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
37875968|NCT04547140|69560619|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
37875969|NCT04547140|69560618|FG000|Overall Study|Pregnancy|1|||
37875970|NCT04547140|69560619|FG001|Overall Study|Pregnancy|0|||
37875971|NCT04547140|69560618|FG000|Overall Study|Reason Not Specified|4|||
37875972|NCT04547140|69560619|FG001|Overall Study|Reason Not Specified|1|||
37875973|NCT01098474|69560631|FG000|Active Phase|Other|0|||
37875974|NCT01098474|69560632|FG001|Active Phase|Other|0|||
37875975|NCT01098474|69560633|FG002|Active Phase|Other|3|||
37875976|NCT01098474|69560634|FG003|Active Phase|Other|0|||
37875977|NCT01098474|69560635|FG004|Active Phase|Other|0|||
37875978|NCT01098474|69560636|FG005|Active Phase|Other|0|||
37875979|NCT01098474|69560631|FG000|Active Phase|Withdrawal by Subject|1|||
37875980|NCT01098474|69560632|FG001|Active Phase|Withdrawal by Subject|1|||
37875981|NCT01098474|69560633|FG002|Active Phase|Withdrawal by Subject|2|||
37875982|NCT01098474|69560634|FG003|Active Phase|Withdrawal by Subject|0|||
37875983|NCT01098474|69560635|FG004|Active Phase|Withdrawal by Subject|0|||
37875984|NCT01098474|69560636|FG005|Active Phase|Withdrawal by Subject|0|||
37875985|NCT01098474|69560631|FG000|Active Phase|Lost to Follow-up|1|||
37875986|NCT01098474|69560632|FG001|Active Phase|Lost to Follow-up|0|||
37875987|NCT01098474|69560633|FG002|Active Phase|Lost to Follow-up|0|||
37875988|NCT01098474|69560634|FG003|Active Phase|Lost to Follow-up|0|||
37875989|NCT01098474|69560635|FG004|Active Phase|Lost to Follow-up|0|||
37875990|NCT01098474|69560636|FG005|Active Phase|Lost to Follow-up|0|||
37875991|NCT01098474|69560631|FG000|Follow Up Phase|Travelled out of study area|0|||
37875992|NCT01098474|69560632|FG001|Follow Up Phase|Travelled out of study area|0|||
37875993|NCT01098474|69560633|FG002|Follow Up Phase|Travelled out of study area|0|||
37875994|NCT01098474|69560634|FG003|Follow Up Phase|Travelled out of study area|0|||
37875995|NCT01098474|69560635|FG004|Follow Up Phase|Travelled out of study area|1|||
37875996|NCT01098474|69560636|FG005|Follow Up Phase|Travelled out of study area|0|||
37875997|NCT01098474|69560631|FG000|Follow Up Phase|Other|0|||
37875998|NCT01098474|69560632|FG001|Follow Up Phase|Other|0|||
37875999|NCT01098474|69560633|FG002|Follow Up Phase|Other|0|||
37876000|NCT01098474|69560634|FG003|Follow Up Phase|Other|0|||
37876001|NCT01098474|69560635|FG004|Follow Up Phase|Other|0|||
37876002|NCT01098474|69560636|FG005|Follow Up Phase|Other|4|||
37876003|NCT01098474|69560631|FG000|Follow Up Phase|Withdrawal by Subject|0|||
37876004|NCT01098474|69560632|FG001|Follow Up Phase|Withdrawal by Subject|0|||
37876005|NCT01098474|69560633|FG002|Follow Up Phase|Withdrawal by Subject|0|||
37876006|NCT01098474|69560634|FG003|Follow Up Phase|Withdrawal by Subject|2|||
37876007|NCT01098474|69560635|FG004|Follow Up Phase|Withdrawal by Subject|0|||
37876008|NCT01098474|69560636|FG005|Follow Up Phase|Withdrawal by Subject|1|||
37876009|NCT01098474|69560631|FG000|Follow Up Phase|Lost to Follow-up|0|||
37876010|NCT01098474|69560632|FG001|Follow Up Phase|Lost to Follow-up|0|||
37876011|NCT01098474|69560633|FG002|Follow Up Phase|Lost to Follow-up|0|||
37876012|NCT01098474|69560634|FG003|Follow Up Phase|Lost to Follow-up|0|||
37876013|NCT01098474|69560635|FG004|Follow Up Phase|Lost to Follow-up|1|||
37876014|NCT01098474|69560636|FG005|Follow Up Phase|Lost to Follow-up|0|||
37876015|NCT00876733|69560664|FG000|Overall Study|Adverse Event|34|||
37876016|NCT00876733|69560665|FG001|Overall Study|Adverse Event|20|||
37876017|NCT00876733|69560666|FG002|Overall Study|Adverse Event|10|||
37876018|NCT00876733|69560667|FG003|Overall Study|Adverse Event|3|||
37876019|NCT00876733|69560664|FG000|Overall Study|Lack of Efficacy|17|||
37876020|NCT00876733|69560665|FG001|Overall Study|Lack of Efficacy|9|||
37876021|NCT00876733|69560666|FG002|Overall Study|Lack of Efficacy|10|||
37876022|NCT00876733|69560667|FG003|Overall Study|Lack of Efficacy|1|||
37876023|NCT00876733|69560664|FG000|Overall Study|Lost to Follow-up|26|||
37876024|NCT00876733|69560665|FG001|Overall Study|Lost to Follow-up|10|||
37876025|NCT00876733|69560666|FG002|Overall Study|Lost to Follow-up|3|||
37876026|NCT00876733|69560667|FG003|Overall Study|Lost to Follow-up|2|||
37876027|NCT00876733|69560664|FG000|Overall Study|Data not available|14|||
37876028|NCT00876733|69560665|FG001|Overall Study|Data not available|3|||
37876029|NCT00876733|69560666|FG002|Overall Study|Data not available|7|||
37876030|NCT00876733|69560667|FG003|Overall Study|Data not available|1|||
37876031|NCT00875017|69560687|FG000|First Intervention|Withdrawal by Subject|1|||
37876032|NCT00875017|69560688|FG001|First Intervention|Withdrawal by Subject|0|||
37876033|NCT00875017|69560689|FG002|First Intervention|Withdrawal by Subject|1|||
37876034|NCT00875017|69560690|FG003|First Intervention|Withdrawal by Subject|0|||
37876035|NCT00875017|69560691|FG004|First Intervention|Withdrawal by Subject|0|||
37876036|NCT00875017|69560692|FG005|First Intervention|Withdrawal by Subject|0|||
37876037|NCT00875017|69560687|FG000|First Intervention|Adverse Event|0|||
37876038|NCT00875017|69560688|FG001|First Intervention|Adverse Event|0|||
37876039|NCT00875017|69560689|FG002|First Intervention|Adverse Event|0|||
37876040|NCT00875017|69560690|FG003|First Intervention|Adverse Event|1|||
37876041|NCT00875017|69560691|FG004|First Intervention|Adverse Event|0|||
37876042|NCT00875017|69560692|FG005|First Intervention|Adverse Event|0|||
37876043|NCT00875017|69560687|FG000|First Intervention|Problems collecting rectal effluent|1|||
37876044|NCT00875017|69560688|FG001|First Intervention|Problems collecting rectal effluent|0|||
37876045|NCT00875017|69560689|FG002|First Intervention|Problems collecting rectal effluent|0|||
37876046|NCT00875017|69560690|FG003|First Intervention|Problems collecting rectal effluent|0|||
37876047|NCT00875017|69560691|FG004|First Intervention|Problems collecting rectal effluent|0|||
37876048|NCT00875017|69560692|FG005|First Intervention|Problems collecting rectal effluent|0|||
37876049|NCT00875017|69560687|FG000|First Intervention|Intolerance to nasogastric tube|0|||
37876050|NCT00875017|69560688|FG001|First Intervention|Intolerance to nasogastric tube|0|||
37876051|NCT00875017|69560689|FG002|First Intervention|Intolerance to nasogastric tube|0|||
37876052|NCT00875017|69560690|FG003|First Intervention|Intolerance to nasogastric tube|0|||
37876053|NCT00875017|69560691|FG004|First Intervention|Intolerance to nasogastric tube|1|||
37876054|NCT00875017|69560692|FG005|First Intervention|Intolerance to nasogastric tube|0|||
37876055|NCT00875017|69560687|FG000|Washout|Problem collecting rectal effluent|0|||
37876056|NCT00875017|69560688|FG001|Washout|Problem collecting rectal effluent|0|||
37876057|NCT00875017|69560689|FG002|Washout|Problem collecting rectal effluent|1|||
37876058|NCT00875017|69560690|FG003|Washout|Problem collecting rectal effluent|0|||
37876059|NCT00875017|69560691|FG004|Washout|Problem collecting rectal effluent|0|||
37876060|NCT00875017|69560692|FG005|Washout|Problem collecting rectal effluent|0|||
37876061|NCT00875017|69560687|FG000|Second Intervention|Adverse Event|0|||
37876062|NCT00875017|69560688|FG001|Second Intervention|Adverse Event|0|||
37876063|NCT00875017|69560689|FG002|Second Intervention|Adverse Event|0|||
37876064|NCT00875017|69560690|FG003|Second Intervention|Adverse Event|1|||
37876065|NCT00875017|69560691|FG004|Second Intervention|Adverse Event|0|||
37876066|NCT00875017|69560692|FG005|Second Intervention|Adverse Event|0|||
37876067|NCT00875017|69560687|FG000|Washout|Problems collecting rectal effluent|0|||
37876068|NCT00875017|69560688|FG001|Washout|Problems collecting rectal effluent|1|||
37876069|NCT00875017|69560689|FG002|Washout|Problems collecting rectal effluent|0|||
37876070|NCT00875017|69560690|FG003|Washout|Problems collecting rectal effluent|0|||
37876071|NCT00875017|69560691|FG004|Washout|Problems collecting rectal effluent|0|||
37876072|NCT00875017|69560692|FG005|Washout|Problems collecting rectal effluent|0|||
37876073|NCT00875017|69560687|FG000|Third Intervention|Adverse Event|0|||
37876074|NCT00875017|69560688|FG001|Third Intervention|Adverse Event|1|||
37876075|NCT00875017|69560689|FG002|Third Intervention|Adverse Event|1|||
37876076|NCT00875017|69560690|FG003|Third Intervention|Adverse Event|0|||
37876077|NCT00875017|69560691|FG004|Third Intervention|Adverse Event|0|||
37876078|NCT00875017|69560692|FG005|Third Intervention|Adverse Event|0|||
37876079|NCT00875017|69560687|FG000|Washout|Withdrawal by Subject|0|||
37876080|NCT00875017|69560688|FG001|Washout|Withdrawal by Subject|0|||
37817866|NCT02990806|69496712|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
37817867|NCT02990806|69496713|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
37817868|NCT02420821|69496784|FG000|Overall Study|Lost to Follow-up|6|||
37817869|NCT02420821|69496785|FG001|Overall Study|Lost to Follow-up|6|||
37817870|NCT02420821|69496784|FG000|Overall Study|Non-compliance|0|||
37817871|NCT02420821|69496785|FG001|Overall Study|Non-compliance|2|||
37817872|NCT02420821|69496784|FG000|Overall Study|Physician Decision|6|||
37817873|NCT02420821|69496785|FG001|Overall Study|Physician Decision|2|||
37817874|NCT02420821|69496784|FG000|Overall Study|Withdrawal by Subject|32|||
37817875|NCT02420821|69496785|FG001|Overall Study|Withdrawal by Subject|25|||
37817876|NCT02420821|69496784|FG000|Overall Study|Death|270|||
37817877|NCT02420821|69496785|FG001|Overall Study|Death|263|||
37817878|NCT02420821|69496784|FG000|Overall Study|Study Terminated By Sponsor|145|||
37817879|NCT02420821|69496785|FG001|Overall Study|Study Terminated By Sponsor|149|||
37817880|NCT02420821|69496784|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
37817881|NCT02420821|69496785|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
37876081|NCT00875017|69560689|FG002|Washout|Withdrawal by Subject|0|||
37876082|NCT00875017|69560690|FG003|Washout|Withdrawal by Subject|0|||
37876083|NCT00875017|69560691|FG004|Washout|Withdrawal by Subject|1|||
37876084|NCT00875017|69560692|FG005|Washout|Withdrawal by Subject|0|||
37876085|NCT00875017|69560687|FG000|Fourth Intervention|Inability to comply with fasting|0|||
37876086|NCT00875017|69560688|FG001|Fourth Intervention|Inability to comply with fasting|0|||
37876087|NCT00875017|69560689|FG002|Fourth Intervention|Inability to comply with fasting|0|||
37876088|NCT00875017|69560690|FG003|Fourth Intervention|Inability to comply with fasting|0|||
37876089|NCT00875017|69560691|FG004|Fourth Intervention|Inability to comply with fasting|0|||
37876090|NCT00875017|69560692|FG005|Fourth Intervention|Inability to comply with fasting|1|||
37876091|NCT00875797|69560717|FG000|Overall Study|Protocol Violation|6|||
37876092|NCT00875797|69560718|FG001|Overall Study|Protocol Violation|3|||
37876093|NCT00874939|69560744|FG000|Overall Study|Study terminated|4|||
37876094|NCT00875563|69560754|FG000|Overall Study|Death|4|||
37876095|NCT00875563|69560754|FG000|Overall Study|Withdrawal by Subject|7|||
37876096|NCT00875563|69560754|FG000|Overall Study|No long-term (3-5 year) consent|6|||
37876097|NCT00875563|69560754|FG000|Overall Study|Still be eligible for follow-up|7|||
37876098|NCT01155869|69560760|FG000|Overall Study|Lost to Follow-up|3|||
37876099|NCT01155869|69560761|FG001|Overall Study|Lost to Follow-up|1|||
37695097|NCT02405780|69171578|FG000|Period II|Withdrawal by Subject|7|||
37876100|NCT01185353|69560772|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
37817882|NCT02420821|69496784|FG000|Overall Study|Adverse Event|0|||
37876101|NCT01185353|69560773|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
37876102|NCT01185353|69560774|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
37876103|NCT01185353|69560775|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
37876104|NCT01185353|69560776|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
37876105|NCT01185353|69560777|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
37876106|NCT01185353|69560778|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
37876107|NCT01185353|69560779|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
37876108|NCT01185353|69560780|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
37876109|NCT01185353|69560781|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
37876110|NCT01185353|69560772|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
37876111|NCT01185353|69560773|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
37876112|NCT01185353|69560774|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
37876113|NCT01185353|69560775|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
37876114|NCT01185353|69560776|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
37876115|NCT01185353|69560777|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
37876116|NCT01185353|69560778|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
37876117|NCT01185353|69560779|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
37876118|NCT01185353|69560780|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
37876119|NCT01185353|69560781|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
37876120|NCT01185353|69560772|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
37876121|NCT01185353|69560773|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
37876122|NCT01185353|69560774|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
37876123|NCT01185353|69560775|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
37876124|NCT01185353|69560776|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
37876125|NCT01185353|69560777|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
37876126|NCT01185353|69560778|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
37876127|NCT01185353|69560779|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
37876128|NCT01185353|69560780|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
37876129|NCT01185353|69560781|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
37876130|NCT01185353|69560772|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
37876131|NCT01185353|69560773|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
37876132|NCT01185353|69560774|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
37876133|NCT01185353|69560775|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
37876134|NCT01185353|69560776|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
37876135|NCT01185353|69560777|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
37876136|NCT01185353|69560778|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
37876137|NCT01185353|69560779|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
37876138|NCT01185353|69560780|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
37876139|NCT01185353|69560781|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
37876140|NCT01185353|69560772|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
37876141|NCT01185353|69560773|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
37876142|NCT01185353|69560774|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
37876143|NCT01185353|69560775|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
37876144|NCT01185353|69560776|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
37876145|NCT01185353|69560777|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
37876146|NCT01185353|69560778|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
37876147|NCT01185353|69560779|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
37876148|NCT01185353|69560780|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
37876149|NCT01185353|69560781|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
37876150|NCT01185353|69560772|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
37876151|NCT01185353|69560773|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
37876152|NCT01185353|69560774|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
37876153|NCT01185353|69560775|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
37876154|NCT01185353|69560776|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
37876155|NCT01185353|69560777|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
37876156|NCT01185353|69560778|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
37876157|NCT01185353|69560779|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
37876158|NCT01185353|69560780|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
37876159|NCT01185353|69560781|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
37876160|NCT01185353|69560772|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
37876161|NCT01185353|69560773|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
37876162|NCT01185353|69560774|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
37876163|NCT01185353|69560775|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
37876164|NCT01185353|69560776|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
37876165|NCT01185353|69560777|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
37876166|NCT01185353|69560778|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
37876167|NCT01185353|69560779|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
37876168|NCT01185353|69560780|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
37876169|NCT01185353|69560781|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
37876170|NCT01185353|69560772|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
37876171|NCT01185353|69560773|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
37876172|NCT01185353|69560774|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
37876173|NCT01185353|69560775|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
37876174|NCT01185353|69560776|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
37876175|NCT01185353|69560777|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
37876176|NCT01185353|69560778|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
37876177|NCT01185353|69560779|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
37876178|NCT01185353|69560780|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
37876179|NCT01185353|69560781|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
37876180|NCT01185353|69560772|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
37876181|NCT01185353|69560773|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
37876182|NCT01185353|69560774|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
37876183|NCT01185353|69560775|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
37876184|NCT01185353|69560776|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
37876185|NCT01185353|69560777|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
37876186|NCT01185353|69560778|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
37876187|NCT01185353|69560779|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
37876188|NCT01185353|69560780|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
37695098|NCT02405780|69171579|FG001|Period II|Withdrawal by Subject|4|||
37695099|NCT02405780|69171580|FG002|Period II|Withdrawal by Subject|0|||
37695100|NCT02405780|69171581|FG003|Period II|Withdrawal by Subject|3|||
37695101|NCT02405780|69171578|FG000|Period II|Non-compliance with study procedures|5|||
37695102|NCT02405780|69171579|FG001|Period II|Non-compliance with study procedures|2|||
37695103|NCT02405780|69171580|FG002|Period II|Non-compliance with study procedures|7|||
37876189|NCT01185353|69560781|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
37876190|NCT01185353|69560772|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
37876191|NCT01185353|69560773|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
37876192|NCT01185353|69560774|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
37876193|NCT01185353|69560775|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
37876194|NCT01185353|69560776|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
37876195|NCT01185353|69560777|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
37876196|NCT01185353|69560778|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
37876197|NCT01185353|69560779|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
37876198|NCT01185353|69560780|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
37876199|NCT01185353|69560781|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
37876200|NCT01185353|69560772|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
37876201|NCT01185353|69560773|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
37876202|NCT01185353|69560774|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
37876203|NCT01185353|69560775|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
37876204|NCT01185353|69560776|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
37876205|NCT01185353|69560777|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
37876206|NCT01185353|69560778|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
37876207|NCT01185353|69560779|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
37876208|NCT01185353|69560780|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
37876209|NCT01185353|69560781|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
37876210|NCT01185353|69560772|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
37876211|NCT01185353|69560773|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
37876212|NCT01185353|69560774|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
37876213|NCT01185353|69560775|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
37876214|NCT01185353|69560776|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
37817883|NCT02420821|69496785|FG001|Overall Study|Adverse Event|1|||
37817884|NCT02420821|69496784|FG000|Overall Study|Protinuria|0|||
37817885|NCT02420821|69496785|FG001|Overall Study|Protinuria|1|||
37817886|NCT02420821|69496784|FG000|Overall Study|Progressive Disease|1|||
37817887|NCT02420821|69496785|FG001|Overall Study|Progressive Disease|1|||
37817888|NCT02420821|69496784|FG000|Overall Study|Disease Progression|0|||
37817889|NCT02420821|69496785|FG001|Overall Study|Disease Progression|1|||
37817890|NCT02420821|69496784|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
37817891|NCT02420821|69496785|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
37817892|NCT02039063|69496816|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
37817893|NCT02039063|69496817|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
37817894|NCT02039063|69496818|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
37817895|NCT02039063|69496819|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
37817896|NCT02039063|69496816|FG000|Treatment Phase|Progression of disease|0|||
37876215|NCT01185353|69560777|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
37695104|NCT02405780|69171581|FG003|Period II|Non-compliance with study procedures|4|||
37695105|NCT02369510|69171609|FG000|Overall Study|Spilled Medication|1|||
37695106|NCT02369510|69171610|FG001|Overall Study|Spilled Medication|2|||
37695107|NCT02369510|69171611|FG002|Overall Study|Spilled Medication|1|||
37876216|NCT01185353|69560778|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
37876217|NCT01185353|69560779|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
37876218|NCT01185353|69560780|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
37876219|NCT01185353|69560781|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
37876220|NCT01185353|69560772|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
37876221|NCT01185353|69560773|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
37876222|NCT01185353|69560774|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
37876223|NCT01185353|69560775|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
37876224|NCT01185353|69560776|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
37876225|NCT01185353|69560777|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
37876226|NCT01185353|69560778|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
37876227|NCT01185353|69560779|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
37876228|NCT01185353|69560780|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
37876229|NCT01185353|69560781|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
37876230|NCT01185353|69560772|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
37876231|NCT01185353|69560773|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
37876232|NCT01185353|69560774|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
37876233|NCT01185353|69560775|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
37876234|NCT01185353|69560776|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
37876235|NCT01185353|69560777|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
37876236|NCT01185353|69560778|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
37876237|NCT01185353|69560779|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
37876238|NCT01185353|69560780|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
37876239|NCT01185353|69560781|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
37876240|NCT01185353|69560772|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
37876241|NCT01185353|69560773|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
37876242|NCT01185353|69560774|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
37876243|NCT01185353|69560775|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
37876244|NCT01185353|69560776|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
37876245|NCT01185353|69560777|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
37876246|NCT01185353|69560778|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
37876247|NCT01185353|69560779|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
37876248|NCT01185353|69560780|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
37876249|NCT01185353|69560781|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
37876250|NCT01185353|69560772|FG000|Part C (Weeks 24 Through 76)|Death|0|||
37876251|NCT01185353|69560773|FG001|Part C (Weeks 24 Through 76)|Death|0|||
37876252|NCT01185353|69560774|FG002|Part C (Weeks 24 Through 76)|Death|0|||
37876253|NCT01185353|69560775|FG003|Part C (Weeks 24 Through 76)|Death|0|||
37876254|NCT01185353|69560776|FG004|Part C (Weeks 24 Through 76)|Death|0|||
37876255|NCT01185353|69560777|FG005|Part C (Weeks 24 Through 76)|Death|0|||
37876256|NCT01185353|69560778|FG006|Part C (Weeks 24 Through 76)|Death|0|||
37876257|NCT01185353|69560779|FG007|Part C (Weeks 24 Through 76)|Death|0|||
37876258|NCT01185353|69560780|FG008|Part C (Weeks 24 Through 76)|Death|0|||
37876259|NCT01185353|69560781|FG009|Part C (Weeks 24 Through 76)|Death|1|||
37876260|NCT01185353|69560772|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
37876261|NCT01185353|69560773|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
37982668|NCT00410514|69669089|FG000|Overall Study|Non-compliant with study procedures|0|||
37982669|NCT00410514|69669090|FG001|Overall Study|Non-compliant with study procedures|0|||
37817897|NCT02039063|69496817|FG001|Treatment Phase|Progression of disease|0|||
37817898|NCT02039063|69496818|FG002|Treatment Phase|Progression of disease|1|||
37817899|NCT02039063|69496819|FG003|Treatment Phase|Progression of disease|1|||
37817900|NCT02039063|69496816|FG000|Extension Phase|Inadequate therapeutic effect|0|||
37817901|NCT02039063|69496817|FG001|Extension Phase|Inadequate therapeutic effect|1|||
37817902|NCT02039063|69496818|FG002|Extension Phase|Inadequate therapeutic effect|2|||
37817903|NCT02039063|69496819|FG003|Extension Phase|Inadequate therapeutic effect|0|||
37817904|NCT02039063|69496816|FG000|Extension Phase|Progression of disease|0|||
37817905|NCT02039063|69496817|FG001|Extension Phase|Progression of disease|0|||
37817906|NCT02039063|69496818|FG002|Extension Phase|Progression of disease|0|||
37817907|NCT02039063|69496819|FG003|Extension Phase|Progression of disease|1|||
37817908|NCT02039063|69496816|FG000|Extension Phase|Adverse Event|0|||
37817909|NCT02039063|69496817|FG001|Extension Phase|Adverse Event|0|||
37817910|NCT02039063|69496818|FG002|Extension Phase|Adverse Event|1|||
37817911|NCT02039063|69496819|FG003|Extension Phase|Adverse Event|0|||
37817912|NCT01746173|69496836|FG000|Overall Study|Disease Progression|2|||
37817913|NCT02995733|69496876|FG000|Overall Study|Study site closed|9|||
37817914|NCT02995733|69496877|FG001|Overall Study|Study site closed|10|||
37817915|NCT02995733|69496876|FG000|Overall Study|Death|3|||
37817916|NCT02995733|69496877|FG001|Overall Study|Death|4|||
37982670|NCT00410514|69669091|FG002|Overall Study|Non-compliant with study procedures|2|||
37982671|NCT03847610|69669099|FG000|Overall Study|Withdrawal by Subject|1|||
37982672|NCT03843632|69669107|FG000|Overall Study|Withdrawal by Subject|1|||
37982673|NCT03843632|69669108|FG001|Overall Study|Withdrawal by Subject|0|||
37982674|NCT03843632|69669109|FG002|Overall Study|Withdrawal by Subject|0|||
37982675|NCT03843632|69669110|FG003|Overall Study|Withdrawal by Subject|0|||
37982676|NCT00455858|69669120|FG000|Overall Study|Lost to Follow-up|2|||
37982677|NCT00455858|69669120|FG000|Overall Study|Protocol Violation|1|||
37982678|NCT00455858|69669120|FG000|Overall Study|Lack of Efficacy|1|||
37982679|NCT00455858|69669120|FG000|Overall Study|Well controlled FPG without insulin|1|||
37982680|NCT00455858|69669120|FG000|Overall Study|Withdrawal|1|||
37982681|NCT00439556|69669127|FG000|Overall Study|Patient was taken off study for non-comp|0|||
37982682|NCT00439556|69669128|FG001|Overall Study|Patient was taken off study for non-comp|1|||
37982683|NCT00439556|69669129|FG002|Overall Study|Patient was taken off study for non-comp|0|||
37982684|NCT00410202|69669141|FG000|On-Treatment|Continuing treatment|69|||
37982685|NCT00410202|69669142|FG001|On-Treatment|Continuing treatment|71|||
37982686|NCT00410202|69669143|FG002|On-Treatment|Continuing treatment|66|||
37982687|NCT00410202|69669141|FG000|On-Treatment|Adverse Event|1|||
37982688|NCT00410202|69669142|FG001|On-Treatment|Adverse Event|3|||
37982689|NCT00410202|69669143|FG002|On-Treatment|Adverse Event|2|||
37982690|NCT00410202|69669141|FG000|On-Treatment|Death|1|||
37982691|NCT00410202|69669142|FG001|On-Treatment|Death|0|||
37982692|NCT00410202|69669143|FG002|On-Treatment|Death|0|||
37982693|NCT00410202|69669141|FG000|On-Treatment|Lost to Follow-up|1|||
37982694|NCT00410202|69669142|FG001|On-Treatment|Lost to Follow-up|0|||
37982695|NCT00410202|69669143|FG002|On-Treatment|Lost to Follow-up|1|||
37982696|NCT00410202|69669141|FG000|On-Treatment|Lack of Efficacy|1|||
37982697|NCT00410202|69669142|FG001|On-Treatment|Lack of Efficacy|4|||
37982698|NCT00410202|69669143|FG002|On-Treatment|Lack of Efficacy|0|||
37982699|NCT00410202|69669141|FG000|On-Treatment|Withdrawal by Subject|2|||
37982700|NCT00410202|69669142|FG001|On-Treatment|Withdrawal by Subject|1|||
37982701|NCT00410202|69669143|FG002|On-Treatment|Withdrawal by Subject|1|||
37982702|NCT00410202|69669141|FG000|On-Treatment|Other Reason|0|||
37982703|NCT00410202|69669142|FG001|On-Treatment|Other Reason|0|||
37982704|NCT00410202|69669143|FG002|On-Treatment|Other Reason|1|||
37982705|NCT00410202|69669141|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
37982706|NCT00410202|69669142|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
37982707|NCT00410202|69669143|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
37982708|NCT00410202|69669141|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
37982709|NCT00410202|69669142|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
37982710|NCT00410202|69669143|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
37982711|NCT00410202|69669141|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
37982712|NCT00410202|69669142|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
37982713|NCT00410202|69669143|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
37982714|NCT00445328|69669154|FG000|Overall Study|Death|0|||
37982715|NCT00445328|69669155|FG001|Overall Study|Death|1|||
37982716|NCT00445328|69669154|FG000|Overall Study|Adverse Event|0|||
37982717|NCT00445328|69669155|FG001|Overall Study|Adverse Event|3|||
37982718|NCT00445328|69669154|FG000|Overall Study|Other|0|||
37982719|NCT00445328|69669155|FG001|Overall Study|Other|2|||
37982720|NCT00445328|69669154|FG000|Overall Study|Withdrawal by Subject|2|||
37982721|NCT00445328|69669155|FG001|Overall Study|Withdrawal by Subject|0|||
37982722|NCT00445328|69669154|FG000|Overall Study|Protocol Violation|1|||
37982723|NCT00445328|69669155|FG001|Overall Study|Protocol Violation|0|||
37982724|NCT00455312|69669163|FG000|Overall Study|Death|0|||
37982725|NCT00455312|69669164|FG001|Overall Study|Death|1|||
37982726|NCT00444626|69669170|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
37982727|NCT00444626|69669170|FG000|Initial Treatment Period|Adverse Event|1|||
37982728|NCT00444626|69669170|FG000|Initial Treatment Period|Lost to Follow-up|9|||
37982729|NCT00404352|69669197|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
37982730|NCT00404352|69669198|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
37982731|NCT00404352|69669199|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
37982732|NCT00404352|69669200|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
37982733|NCT00404352|69669201|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
37982734|NCT00404352|69669202|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
37982735|NCT00404352|69669203|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
37982736|NCT00404352|69669204|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
37982737|NCT00404352|69669205|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
37695108|NCT02369510|69171609|FG000|Overall Study|Epidural Activation|1|||
37982738|NCT00404352|69669197|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
37982739|NCT00404352|69669198|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
37982740|NCT00404352|69669199|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
37982741|NCT00404352|69669200|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
37817917|NCT02995733|69496876|FG000|Overall Study|Withdrawal by Subject|6|||
37982742|NCT00404352|69669201|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
37982743|NCT00404352|69669202|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
37982744|NCT00404352|69669203|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
37982745|NCT00404352|69669204|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
37982746|NCT00404352|69669205|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
37982747|NCT00404352|69669197|FG000|Double Blind (up to 24 Month)|Death|0|||
37982748|NCT00404352|69669198|FG001|Double Blind (up to 24 Month)|Death|0|||
37982749|NCT00404352|69669199|FG002|Double Blind (up to 24 Month)|Death|1|||
37982750|NCT00404352|69669200|FG003|Double Blind (up to 24 Month)|Death|0|||
37982751|NCT00404352|69669201|FG004|Double Blind (up to 24 Month)|Death|0|||
37982752|NCT00404352|69669202|FG005|Double Blind (up to 24 Month)|Death|0|||
37982753|NCT00404352|69669203|FG006|Double Blind (up to 24 Month)|Death|0|||
37982754|NCT00404352|69669204|FG007|Double Blind (up to 24 Month)|Death|0|||
37982755|NCT00404352|69669205|FG008|Double Blind (up to 24 Month)|Death|0|||
37982756|NCT00404352|69669197|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
37982757|NCT00404352|69669198|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
37982758|NCT00404352|69669199|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
37982759|NCT00404352|69669200|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
37982760|NCT00404352|69669201|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
37982761|NCT00404352|69669202|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
37982762|NCT00404352|69669203|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
37982763|NCT00404352|69669204|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
37982764|NCT00404352|69669205|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
37982765|NCT00404352|69669197|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
37982766|NCT00404352|69669198|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
37982767|NCT00404352|69669199|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
37982768|NCT00404352|69669200|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
37982769|NCT00404352|69669201|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
37982770|NCT00404352|69669202|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
37982771|NCT00404352|69669203|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
37982772|NCT00404352|69669204|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
37982773|NCT00404352|69669205|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
37982774|NCT00404352|69669197|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
37982775|NCT00404352|69669198|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
37982776|NCT00404352|69669199|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
37982777|NCT00404352|69669200|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
37982778|NCT00404352|69669201|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
37982779|NCT00404352|69669202|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
37982780|NCT00404352|69669203|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
37982781|NCT00404352|69669204|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
37982782|NCT00404352|69669205|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
37982783|NCT00404352|69669197|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
37982784|NCT00404352|69669198|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
37982785|NCT00404352|69669199|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
37982786|NCT00404352|69669200|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
37982787|NCT00404352|69669201|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
37982788|NCT00404352|69669202|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
37982789|NCT00404352|69669203|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
37982790|NCT00404352|69669204|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
37817918|NCT02995733|69496877|FG001|Overall Study|Withdrawal by Subject|2|||
37817919|NCT02995733|69496876|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
37817920|NCT02995733|69496877|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
37817921|NCT02995733|69496876|FG000|Overall Study|Lost to Follow-up|48|||
37817922|NCT02995733|69496877|FG001|Overall Study|Lost to Follow-up|37|||
37817923|NCT02995733|69496876|FG000|Overall Study|Other|0|||
37817924|NCT02995733|69496877|FG001|Overall Study|Other|1|||
37817925|NCT02815566|69496894|FG000|Overall Study|Adverse Event|1|||
37817926|NCT02815566|69496895|FG001|Overall Study|Adverse Event|1|||
37817927|NCT02815566|69496894|FG000|Overall Study|Withdrawal by Subject|1|||
37817928|NCT02815566|69496895|FG001|Overall Study|Withdrawal by Subject|0|||
37817929|NCT02815566|69496894|FG000|Overall Study|Lost to Follow-up|0|||
37817930|NCT02815566|69496895|FG001|Overall Study|Lost to Follow-up|1|||
37817931|NCT02525783|69496902|FG000|Overall Study|Lost to Follow-up|10|||
37817932|NCT02466243|69496918|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
37817933|NCT02466243|69496919|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
37817934|NCT02466243|69496918|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
37982791|NCT00404352|69669205|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
37982792|NCT00404352|69669197|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
37982793|NCT00404352|69669198|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
37982794|NCT00404352|69669199|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
37982795|NCT00404352|69669200|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
37982796|NCT00404352|69669201|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
37982797|NCT00404352|69669202|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
37982798|NCT00404352|69669203|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
37982799|NCT00404352|69669204|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
37982800|NCT00404352|69669205|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
37982801|NCT00404352|69669197|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
37982802|NCT00404352|69669198|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
37982803|NCT00404352|69669199|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
37982804|NCT00404352|69669200|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
37982805|NCT00404352|69669201|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
37982806|NCT00404352|69669202|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
37982807|NCT00404352|69669203|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
37982808|NCT00404352|69669204|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
37982809|NCT00404352|69669205|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
37982810|NCT00404352|69669197|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
37982811|NCT00404352|69669198|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
37982812|NCT00404352|69669199|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
37982813|NCT00404352|69669200|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
37982814|NCT00404352|69669201|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
37982815|NCT00404352|69669202|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
37982816|NCT00404352|69669203|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
37982817|NCT00404352|69669204|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
37982818|NCT00404352|69669205|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
37982819|NCT00404352|69669197|FG000|Double Blind (up to 24 Month)|Other|0|||
37982820|NCT00404352|69669198|FG001|Double Blind (up to 24 Month)|Other|1|||
37982821|NCT00404352|69669199|FG002|Double Blind (up to 24 Month)|Other|0|||
37982822|NCT00404352|69669200|FG003|Double Blind (up to 24 Month)|Other|0|||
37982823|NCT00404352|69669201|FG004|Double Blind (up to 24 Month)|Other|0|||
37982824|NCT00404352|69669202|FG005|Double Blind (up to 24 Month)|Other|0|||
37982825|NCT00404352|69669203|FG006|Double Blind (up to 24 Month)|Other|0|||
37982826|NCT00404352|69669204|FG007|Double Blind (up to 24 Month)|Other|0|||
37982827|NCT00404352|69669205|FG008|Double Blind (up to 24 Month)|Other|0|||
37982828|NCT00404352|69669197|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
37982829|NCT00404352|69669198|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
37982830|NCT00404352|69669199|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
37982831|NCT00404352|69669200|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
37982832|NCT00404352|69669201|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
37982833|NCT00404352|69669202|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
37982834|NCT00404352|69669203|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
37982835|NCT00404352|69669204|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
37982836|NCT00404352|69669205|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
37982837|NCT00404352|69669197|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
37982838|NCT00404352|69669198|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
37982839|NCT00404352|69669199|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
37982840|NCT00404352|69669200|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
37982841|NCT00404352|69669201|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
37982842|NCT00404352|69669202|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
37982843|NCT00404352|69669203|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
37982844|NCT00404352|69669204|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
37982845|NCT00404352|69669205|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
37982846|NCT00404352|69669197|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
37982847|NCT00404352|69669198|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
37982848|NCT00404352|69669199|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
37982849|NCT00404352|69669200|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
37982850|NCT00404352|69669201|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
37982851|NCT00404352|69669202|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
37982852|NCT00404352|69669203|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
37982853|NCT00404352|69669204|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
37982854|NCT00404352|69669205|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
37982855|NCT00404352|69669197|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
37982856|NCT00404352|69669198|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
37982857|NCT00404352|69669199|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
37982858|NCT00404352|69669200|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
37982859|NCT00404352|69669201|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
37982860|NCT00404352|69669202|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
37982861|NCT00404352|69669203|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
37982862|NCT00404352|69669204|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
37982863|NCT00404352|69669205|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
37982864|NCT00404352|69669197|FG000|Open Label (up to 24 Month)|Disease progression|0|||
37982865|NCT00404352|69669198|FG001|Open Label (up to 24 Month)|Disease progression|0|||
37982866|NCT00404352|69669199|FG002|Open Label (up to 24 Month)|Disease progression|0|||
37982867|NCT00404352|69669200|FG003|Open Label (up to 24 Month)|Disease progression|1|||
37982868|NCT00404352|69669201|FG004|Open Label (up to 24 Month)|Disease progression|0|||
37982869|NCT00404352|69669202|FG005|Open Label (up to 24 Month)|Disease progression|0|||
37982870|NCT00404352|69669203|FG006|Open Label (up to 24 Month)|Disease progression|0|||
37982871|NCT00404352|69669204|FG007|Open Label (up to 24 Month)|Disease progression|0|||
37982872|NCT00404352|69669205|FG008|Open Label (up to 24 Month)|Disease progression|0|||
37982873|NCT00404352|69669197|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
37982874|NCT00404352|69669198|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
37982875|NCT00404352|69669199|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
37982876|NCT00404352|69669200|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
37982877|NCT00404352|69669201|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
37982878|NCT00404352|69669202|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
37982879|NCT00404352|69669203|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
37982880|NCT00404352|69669204|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
37982881|NCT00404352|69669205|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
37982882|NCT00404352|69669197|FG000|Open Label Extension (up to 36 Months)|Other|0|||
37982883|NCT00404352|69669198|FG001|Open Label Extension (up to 36 Months)|Other|0|||
37982884|NCT00404352|69669199|FG002|Open Label Extension (up to 36 Months)|Other|0|||
37982885|NCT00404352|69669200|FG003|Open Label Extension (up to 36 Months)|Other|0|||
37982886|NCT00404352|69669201|FG004|Open Label Extension (up to 36 Months)|Other|0|||
37982887|NCT00404352|69669202|FG005|Open Label Extension (up to 36 Months)|Other|0|||
37982888|NCT00404352|69669203|FG006|Open Label Extension (up to 36 Months)|Other|0|||
37982889|NCT00404352|69669204|FG007|Open Label Extension (up to 36 Months)|Other|0|||
37982890|NCT00404352|69669205|FG008|Open Label Extension (up to 36 Months)|Other|2|||
37982891|NCT00439244|69669225|FG000|Overall Study|Adverse Event|5|||
37982892|NCT00439244|69669226|FG001|Overall Study|Adverse Event|2|||
37982893|NCT00439244|69669227|FG002|Overall Study|Adverse Event|3|||
37982894|NCT00439244|69669225|FG000|Overall Study|Withdrawal by Subject|3|||
37982895|NCT00439244|69669226|FG001|Overall Study|Withdrawal by Subject|1|||
37982896|NCT00439244|69669227|FG002|Overall Study|Withdrawal by Subject|2|||
37982897|NCT00439244|69669225|FG000|Overall Study|Lost to Follow-up|2|||
37982898|NCT00439244|69669226|FG001|Overall Study|Lost to Follow-up|1|||
37982899|NCT00439244|69669227|FG002|Overall Study|Lost to Follow-up|2|||
37982900|NCT00439244|69669225|FG000|Overall Study|Death|0|||
37982901|NCT00439244|69669226|FG001|Overall Study|Death|1|||
37982902|NCT00439244|69669227|FG002|Overall Study|Death|0|||
37982903|NCT00439244|69669225|FG000|Overall Study|Protocol Violation|0|||
37817935|NCT02466243|69496919|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
37817936|NCT02466243|69496918|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
37817937|NCT02466243|69496919|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
37817938|NCT02466243|69496918|FG000|Part B Open-label Treatment Period|Missing|2|||
37817939|NCT02466243|69496919|FG001|Part B Open-label Treatment Period|Missing|2|||
37817940|NCT02321098|69496932|FG000|12 Weeks Treament|Lost to Follow-up|1|||
37817941|NCT02321098|69496933|FG001|12 Weeks Treament|Lost to Follow-up|1|||
37817942|NCT02321098|69496934|FG002|12 Weeks Treament|Lost to Follow-up|0|||
37817943|NCT02321098|69496932|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
37817944|NCT02321098|69496933|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
37817945|NCT02321098|69496934|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
37817946|NCT02321098|69496932|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
37817947|NCT02321098|69496933|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
37817948|NCT02321098|69496934|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
37817949|NCT02321098|69496932|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
37817950|NCT02321098|69496933|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
37817951|NCT02321098|69496934|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
37817952|NCT01966731|69496943|FG000|Overall Study|Death|2|||
37817953|NCT01966731|69496943|FG000|Overall Study|Lost to Follow-up|1|||
37817954|NCT01966731|69496943|FG000|Overall Study|Physician Decision|2|||
37817955|NCT01966731|69496943|FG000|Overall Study|Follow up is not complete|600|||
37817956|NCT01966731|69496943|FG000|Overall Study|Screening Failure|29|||
37817957|NCT01966731|69496943|FG000|Overall Study|Found to be ineligible|1|||
37982904|NCT00439244|69669226|FG001|Overall Study|Protocol Violation|1|||
37982905|NCT00439244|69669227|FG002|Overall Study|Protocol Violation|0|||
37982906|NCT00439244|69669225|FG000|Overall Study|Administrative problems|1|||
37982907|NCT00439244|69669226|FG001|Overall Study|Administrative problems|0|||
37982908|NCT00439244|69669227|FG002|Overall Study|Administrative problems|0|||
37982909|NCT00438464|69669246|FG000|Overall Study|Terminated Early|14|||
37982910|NCT00438464|69669247|FG001|Overall Study|Terminated Early|5|||
37982911|NCT00438464|69669246|FG000|Overall Study|Incomplete data submission|0|||
37982912|NCT00438464|69669247|FG001|Overall Study|Incomplete data submission|2|||
37982913|NCT00437294|69669267|FG000|Overall Study|Adverse Event|5|||
37982914|NCT00437294|69669268|FG001|Overall Study|Adverse Event|4|||
37982915|NCT00437294|69669267|FG000|Overall Study|Death|5|||
37982916|NCT00437294|69669268|FG001|Overall Study|Death|2|||
37982917|NCT00437294|69669267|FG000|Overall Study|Physician Decision|0|||
37982918|NCT00437294|69669268|FG001|Overall Study|Physician Decision|3|||
37982919|NCT00437294|69669267|FG000|Overall Study|Withdrawal by Subject|5|||
37982920|NCT00437294|69669268|FG001|Overall Study|Withdrawal by Subject|0|||
37982921|NCT00437294|69669267|FG000|Overall Study|Progressive Disease|19|||
37982922|NCT00437294|69669268|FG001|Overall Study|Progressive Disease|23|||
37982923|NCT00437294|69669267|FG000|Overall Study|Sponsor Decision|8|||
37982924|NCT00437294|69669268|FG001|Overall Study|Sponsor Decision|9|||
37982925|NCT00437294|69669267|FG000|Overall Study|Protocol Violation|0|||
37982926|NCT00437294|69669268|FG001|Overall Study|Protocol Violation|1|||
37982927|NCT00437294|69669267|FG000|Overall Study|Entry criteria not met|1|||
37982928|NCT00437294|69669268|FG001|Overall Study|Entry criteria not met|1|||
37982929|NCT00436982|69669282|FG000|Overall Study|Withdrawal by Subject|3|||
37982930|NCT00436982|69669283|FG001|Overall Study|Withdrawal by Subject|1|||
37982931|NCT00436982|69669282|FG000|Overall Study|Did not receive allocated intervention|0|||
37982932|NCT00436982|69669283|FG001|Overall Study|Did not receive allocated intervention|1|||
37982933|NCT00436982|69669282|FG000|Overall Study|no RSA data|1|||
37982934|NCT00436982|69669283|FG001|Overall Study|no RSA data|2|||
37982935|NCT00443846|69669295|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
37982936|NCT00443846|69669296|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
37982937|NCT00443846|69669295|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
37982938|NCT00443846|69669296|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
37982939|NCT00443846|69669295|FG000|Overall Study|Adverse Event|0|||
37982940|NCT00443846|69669296|FG001|Overall Study|Adverse Event|1|||
37982941|NCT00443846|69669295|FG000|Overall Study|Personal reason|8|||
37982942|NCT00443846|69669296|FG001|Overall Study|Personal reason|3|||
37982943|NCT00443846|69669295|FG000|Overall Study|Lost to Follow-up|1|||
37982944|NCT00443846|69669296|FG001|Overall Study|Lost to Follow-up|2|||
37982945|NCT00436826|69669304|FG000|Double Blind Period (DBP)|Adverse Event|2|||
37982946|NCT00436826|69669305|FG001|Double Blind Period (DBP)|Adverse Event|0|||
37982947|NCT00436826|69669306|FG002|Double Blind Period (DBP)|Adverse Event|0|||
37982948|NCT00436826|69669307|FG003|Double Blind Period (DBP)|Adverse Event|0|||
37982949|NCT00436826|69669308|FG004|Double Blind Period (DBP)|Adverse Event|0|||
37982950|NCT00436826|69669309|FG005|Double Blind Period (DBP)|Adverse Event|0|||
37982951|NCT00436826|69669304|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
37982952|NCT00436826|69669305|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
37982953|NCT00436826|69669306|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
37982954|NCT00436826|69669307|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
37982955|NCT00436826|69669308|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
37982956|NCT00436826|69669309|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
37982957|NCT00436826|69669304|FG000|Double Blind Period (DBP)|Other|10|||
37982958|NCT00436826|69669305|FG001|Double Blind Period (DBP)|Other|11|||
37982959|NCT00436826|69669306|FG002|Double Blind Period (DBP)|Other|0|||
37982960|NCT00436826|69669307|FG003|Double Blind Period (DBP)|Other|0|||
37982961|NCT00436826|69669308|FG004|Double Blind Period (DBP)|Other|0|||
37982962|NCT00436826|69669309|FG005|Double Blind Period (DBP)|Other|0|||
37982963|NCT00436826|69669304|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
37982964|NCT00436826|69669305|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
37982965|NCT00436826|69669306|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
37817958|NCT01843374|69496949|FG000|Overall Study|Death|155|||
37817959|NCT01843374|69496950|FG001|Overall Study|Death|313|||
37817960|NCT01843374|69496949|FG000|Overall Study|Withdrawal by Subject|14|||
37982966|NCT00436826|69669307|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
37982967|NCT00436826|69669308|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
37982968|NCT00436826|69669309|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
37817961|NCT01843374|69496950|FG001|Overall Study|Withdrawal by Subject|20|||
37982969|NCT00436826|69669304|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
37982970|NCT00436826|69669305|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
37982971|NCT00436826|69669306|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
37982972|NCT00436826|69669307|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
37982973|NCT00436826|69669308|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
37982974|NCT00436826|69669309|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
37982975|NCT00436826|69669304|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
37982976|NCT00436826|69669305|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
37982977|NCT00436826|69669306|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
37982978|NCT00436826|69669307|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
37982979|NCT00436826|69669308|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
37982980|NCT00436826|69669309|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
37982981|NCT00410124|69669327|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
37982982|NCT00410124|69669328|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
37982983|NCT00410124|69669327|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
37982984|NCT00410124|69669328|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
37982985|NCT00410124|69669327|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
37982986|NCT00410124|69669328|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
37982987|NCT00410124|69669327|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
37982988|NCT00410124|69669328|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
37982989|NCT00410124|69669327|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
37982990|NCT00410124|69669328|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
37982991|NCT00410124|69669327|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
37982992|NCT00410124|69669328|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
37982993|NCT00410124|69669327|FG000|Core Phase Double Blind (15 Months)|Death|7|||
37982994|NCT00410124|69669328|FG001|Core Phase Double Blind (15 Months)|Death|4|||
37982995|NCT00410124|69669327|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
37982996|NCT00410124|69669328|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
37982997|NCT00410124|69669327|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
37982998|NCT00410124|69669328|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
37982999|NCT00410124|69669327|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
37983000|NCT00410124|69669328|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
37983001|NCT00410124|69669327|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
37983002|NCT00410124|69669328|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
37983003|NCT00410124|69669327|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
37983004|NCT00410124|69669328|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
37983005|NCT00410124|69669327|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
37983006|NCT00410124|69669328|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
37983007|NCT00410124|69669327|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
37983008|NCT00410124|69669328|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
37983009|NCT00410124|69669327|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
37983010|NCT00410124|69669328|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
37983011|NCT00410124|69669327|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
37983012|NCT00410124|69669328|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
37983013|NCT00410046|69669338|FG000|Overall Study|Adverse Event|3|||
37983014|NCT00410046|69669338|FG000|Overall Study|Withdrawal by Subject|1|||
37983015|NCT00410046|69669338|FG000|Overall Study|Lost to Follow-up|1|||
37983016|NCT00416624|69669347|FG000|Overall Study|Withdrawal by Subject|1|||
37983017|NCT00416624|69669348|FG001|Overall Study|Withdrawal by Subject|6|||
37983018|NCT00416624|69669349|FG002|Overall Study|Withdrawal by Subject|4|||
37983019|NCT00416624|69669350|FG003|Overall Study|Withdrawal by Subject|9|||
37983020|NCT00416624|69669347|FG000|Overall Study|Death|4|||
37983021|NCT00416624|69669348|FG001|Overall Study|Death|7|||
37817962|NCT01843374|69496949|FG000|Overall Study|Withdrawing due to Other reason|20|||
37817963|NCT01843374|69496950|FG001|Overall Study|Withdrawing due to Other reason|46|||
37817964|NCT01620944|69496972|FG000|Overall Study|Early termination of Study|2|||
37817965|NCT01620944|69496973|FG001|Overall Study|Early termination of Study|1|||
37817966|NCT01627561|69496981|FG000|Overall Study|Lost to Follow-up|1|||
37817967|NCT01627561|69496982|FG001|Overall Study|Lost to Follow-up|0|||
37817968|NCT01627561|69496981|FG000|Overall Study|Withdrawal by Subject|0|||
37983022|NCT00416624|69669349|FG002|Overall Study|Death|7|||
37817969|NCT01627561|69496982|FG001|Overall Study|Withdrawal by Subject|1|||
37817970|NCT01627561|69496981|FG000|Overall Study|Migrated/moved from study area|0|||
37817971|NCT01627561|69496982|FG001|Overall Study|Migrated/moved from study area|2|||
37817972|NCT01652534|69497016|FG000|Overall Study|Lack of Efficacy|1|||
37817973|NCT01652534|69497017|FG001|Overall Study|Lack of Efficacy|0|||
37817974|NCT04709575|69497025|FG000|Overall Study|Withdrawal by Subject|6|||
37817975|NCT04709575|69497026|FG001|Overall Study|Withdrawal by Subject|2|||
37983023|NCT00416624|69669350|FG003|Overall Study|Death|1|||
37983024|NCT00416624|69669347|FG000|Overall Study|Adverse Event|8|||
37983025|NCT00416624|69669348|FG001|Overall Study|Adverse Event|3|||
37983026|NCT00416624|69669349|FG002|Overall Study|Adverse Event|2|||
37983027|NCT00416624|69669350|FG003|Overall Study|Adverse Event|2|||
37983028|NCT00416624|69669347|FG000|Overall Study|Other|8|||
37983029|NCT00416624|69669348|FG001|Overall Study|Other|11|||
37983030|NCT00416624|69669349|FG002|Overall Study|Other|5|||
37983031|NCT00416624|69669350|FG003|Overall Study|Other|5|||
37983032|NCT00416624|69669347|FG000|Overall Study|Cancel|1|||
37983033|NCT00416624|69669348|FG001|Overall Study|Cancel|0|||
37983034|NCT00416624|69669349|FG002|Overall Study|Cancel|0|||
37983035|NCT00416624|69669350|FG003|Overall Study|Cancel|0|||
37983036|NCT00262600|69669363|FG000|Overall Study|Lost to Follow-up|17|||
37983037|NCT00262600|69669364|FG001|Overall Study|Lost to Follow-up|31|||
37817976|NCT04709575|69497025|FG000|Overall Study|Lost to Follow-up|2|||
37817977|NCT04709575|69497026|FG001|Overall Study|Lost to Follow-up|2|||
37817978|NCT04709575|69497025|FG000|Overall Study|Adverse Event|1|||
37876262|NCT01185353|69560774|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
37876263|NCT01185353|69560775|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
37876264|NCT01185353|69560776|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
37876265|NCT01185353|69560777|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
37876266|NCT01185353|69560778|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
37876267|NCT01185353|69560779|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
37876268|NCT01185353|69560780|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
37876269|NCT01185353|69560781|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
37876270|NCT01185353|69560772|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
37876271|NCT01185353|69560773|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
37876272|NCT01185353|69560774|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
37876273|NCT01185353|69560775|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
37876274|NCT01185353|69560776|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
37876275|NCT01185353|69560777|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
37876276|NCT01185353|69560778|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
37876277|NCT01185353|69560779|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
37876278|NCT01185353|69560780|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
37876279|NCT01185353|69560781|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
37876280|NCT01185353|69560772|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
37876281|NCT01185353|69560773|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
37876282|NCT01185353|69560774|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
37876283|NCT01185353|69560775|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
37876284|NCT01185353|69560776|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
37876285|NCT01185353|69560777|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
37876286|NCT01185353|69560778|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
37876287|NCT01185353|69560779|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
37876288|NCT01185353|69560780|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
37876289|NCT01185353|69560781|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
37876290|NCT01185353|69560772|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
37876291|NCT01185353|69560773|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
37876292|NCT01185353|69560774|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
37876293|NCT01185353|69560775|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
37983038|NCT00262600|69669365|FG002|Overall Study|Lost to Follow-up|41|||
37695109|NCT02369510|69171610|FG001|Overall Study|Epidural Activation|1|||
37817979|NCT04709575|69497026|FG001|Overall Study|Adverse Event|0|||
37983039|NCT00262600|69669363|FG000|Overall Study|Withdrawal by Subject|128|||
37983040|NCT00262600|69669364|FG001|Overall Study|Withdrawal by Subject|145|||
37983041|NCT00262600|69669365|FG002|Overall Study|Withdrawal by Subject|139|||
37983042|NCT00262600|69669363|FG000|Overall Study|Not Treated|32|||
37983043|NCT00262600|69669364|FG001|Overall Study|Not Treated|17|||
37817980|NCT04709575|69497025|FG000|Overall Study|Protocol Violation|1|||
37876294|NCT01185353|69560776|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
37876295|NCT01185353|69560777|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
37876296|NCT01185353|69560778|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
37876297|NCT01185353|69560779|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
37876298|NCT01185353|69560780|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
37876299|NCT01185353|69560781|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
37876300|NCT01185353|69560772|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
37876301|NCT01185353|69560773|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
37876302|NCT01185353|69560774|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
37876303|NCT01185353|69560775|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
37876304|NCT01185353|69560776|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
37876305|NCT01185353|69560777|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
37876306|NCT01185353|69560778|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
37876307|NCT01185353|69560779|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
37876308|NCT01185353|69560780|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
37876309|NCT01185353|69560781|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
37876310|NCT01185353|69560772|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
37876311|NCT01185353|69560773|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
37876312|NCT01185353|69560774|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
37876313|NCT01185353|69560775|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
37876314|NCT01185353|69560776|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
37876315|NCT01185353|69560777|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
37876316|NCT01185353|69560778|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
37876317|NCT01185353|69560779|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
37876318|NCT01185353|69560780|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
37876319|NCT01185353|69560781|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
37876320|NCT01098240|69560820|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
37876321|NCT01098240|69560821|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
37876322|NCT01098240|69560822|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
37876323|NCT01098240|69560820|FG000|Open-Label Phase|Protocol Violation|4|||
37876324|NCT01098240|69560821|FG001|Open-Label Phase|Protocol Violation|0|||
37876325|NCT01098240|69560822|FG002|Open-Label Phase|Protocol Violation|0|||
37876326|NCT01098240|69560820|FG000|Open-Label Phase|Lost to Follow-up|13|||
37876327|NCT01098240|69560821|FG001|Open-Label Phase|Lost to Follow-up|0|||
37876328|NCT01098240|69560822|FG002|Open-Label Phase|Lost to Follow-up|0|||
37876329|NCT01098240|69560820|FG000|Open-Label Phase|Other|19|||
37817981|NCT04709575|69497026|FG001|Overall Study|Protocol Violation|1|||
37817982|NCT04450407|69497035|FG000|Overall Study|Withdrawal by Subject|10|||
37817983|NCT04450407|69497036|FG001|Overall Study|Withdrawal by Subject|1|||
37817984|NCT04450407|69497037|FG002|Overall Study|Withdrawal by Subject|4|||
37817985|NCT04450407|69497035|FG000|Overall Study|Adverse Event|0|||
37817986|NCT04450407|69497036|FG001|Overall Study|Adverse Event|0|||
37817987|NCT04450407|69497037|FG002|Overall Study|Adverse Event|1|||
37817988|NCT04450407|69497035|FG000|Overall Study|Lost to Follow-up|1|||
37817989|NCT04450407|69497036|FG001|Overall Study|Lost to Follow-up|0|||
37817990|NCT04450407|69497037|FG002|Overall Study|Lost to Follow-up|0|||
37817991|NCT04450407|69497035|FG000|Overall Study|Physician Decision|0|||
37817992|NCT04450407|69497036|FG001|Overall Study|Physician Decision|0|||
37817993|NCT04450407|69497037|FG002|Overall Study|Physician Decision|1|||
37817994|NCT04450407|69497035|FG000|Overall Study|Pregnancy|1|||
37817995|NCT04450407|69497036|FG001|Overall Study|Pregnancy|0|||
37817996|NCT04450407|69497037|FG002|Overall Study|Pregnancy|0|||
37817997|NCT04450407|69497035|FG000|Overall Study|Protocol Violation|2|||
37817998|NCT04450407|69497036|FG001|Overall Study|Protocol Violation|0|||
37817999|NCT04450407|69497037|FG002|Overall Study|Protocol Violation|0|||
37876330|NCT01098240|69560821|FG001|Open-Label Phase|Other|0|||
37876331|NCT01098240|69560822|FG002|Open-Label Phase|Other|0|||
37876332|NCT01098240|69560820|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
37876333|NCT01098240|69560821|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
37876334|NCT01098240|69560822|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
37876335|NCT01098240|69560820|FG000|Open-Label Phase|Pregnancy|1|||
37876336|NCT01098240|69560821|FG001|Open-Label Phase|Pregnancy|0|||
37876337|NCT01098240|69560822|FG002|Open-Label Phase|Pregnancy|0|||
37876338|NCT01098240|69560820|FG000|Open-Label Phase|Withdrawal by Subject|9|||
37876339|NCT01098240|69560821|FG001|Open-Label Phase|Withdrawal by Subject|0|||
37876340|NCT01098240|69560822|FG002|Open-Label Phase|Withdrawal by Subject|0|||
37876341|NCT01098240|69560820|FG000|Open-Label Phase|Adverse Event|12|||
37876342|NCT01098240|69560821|FG001|Open-Label Phase|Adverse Event|0|||
37876343|NCT01098240|69560822|FG002|Open-Label Phase|Adverse Event|0|||
37876344|NCT01098240|69560820|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
37876345|NCT01098240|69560821|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
37876346|NCT01098240|69560822|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
37876347|NCT01098240|69560820|FG000|Double-Blind Phase|Protocol Violation|0|||
37876348|NCT01098240|69560821|FG001|Double-Blind Phase|Protocol Violation|2|||
37876349|NCT01098240|69560822|FG002|Double-Blind Phase|Protocol Violation|4|||
37876350|NCT01098240|69560820|FG000|Double-Blind Phase|Lost to Follow-up|0|||
37876351|NCT01098240|69560821|FG001|Double-Blind Phase|Lost to Follow-up|2|||
37876352|NCT01098240|69560822|FG002|Double-Blind Phase|Lost to Follow-up|0|||
37876353|NCT01098240|69560820|FG000|Double-Blind Phase|Other|0|||
37876354|NCT01098240|69560821|FG001|Double-Blind Phase|Other|2|||
37876355|NCT01098240|69560822|FG002|Double-Blind Phase|Other|2|||
37876356|NCT01098240|69560820|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
37876357|NCT01098240|69560821|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
37876358|NCT01098240|69560822|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
37876359|NCT01098240|69560820|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
37876360|NCT01098240|69560821|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
37876361|NCT01098240|69560822|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
37876362|NCT01098240|69560820|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
37876363|NCT01098240|69560821|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
37876364|NCT01098240|69560822|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
37876365|NCT01098240|69560820|FG000|Double-Blind Phase|Adverse Event|0|||
37876366|NCT01098240|69560821|FG001|Double-Blind Phase|Adverse Event|3|||
37876367|NCT01098240|69560822|FG002|Double-Blind Phase|Adverse Event|3|||
37876368|NCT01098162|69560829|FG000|Overall Study|Adverse Event|37|||
37876369|NCT01098162|69560829|FG000|Overall Study|Lack of Efficacy|4|||
37876370|NCT01098162|69560829|FG000|Overall Study|Wish of Patient|7|||
37876371|NCT01098162|69560829|FG000|Overall Study|Lost to Follow-up|9|||
37818000|NCT04450407|69497035|FG000|Overall Study|Investigational site terminated by sponsor|3|||
37818001|NCT04450407|69497036|FG001|Overall Study|Investigational site terminated by sponsor|0|||
37818002|NCT04450407|69497037|FG002|Overall Study|Investigational site terminated by sponsor|2|||
37818003|NCT04388826|69497046|FG000|Overall Study|Lost to Follow-up|3|||
37818004|NCT04388826|69497047|FG001|Overall Study|Lost to Follow-up|2|||
37818005|NCT04388826|69497046|FG000|Overall Study|Adverse Event|1|||
37818006|NCT04388826|69497047|FG001|Overall Study|Adverse Event|0|||
37818007|NCT04218266|69497069|FG000|Overall Study|Death|1|||
37818008|NCT04218266|69497070|FG001|Overall Study|Death|2|||
37818009|NCT04218266|69497071|FG002|Overall Study|Death|3|||
37818010|NCT04218266|69497069|FG000|Overall Study|Adverse Event|13|||
37818011|NCT04218266|69497070|FG001|Overall Study|Adverse Event|14|||
37818012|NCT04218266|69497071|FG002|Overall Study|Adverse Event|11|||
37818013|NCT04218266|69497069|FG000|Overall Study|Other|7|||
37818014|NCT04218266|69497070|FG001|Overall Study|Other|5|||
37818015|NCT04218266|69497071|FG002|Overall Study|Other|14|||
37818016|NCT04218266|69497069|FG000|Overall Study|Physician Decision|1|||
37818017|NCT04218266|69497070|FG001|Overall Study|Physician Decision|3|||
37876372|NCT01098162|69560829|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
37876373|NCT01098162|69560829|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
37876374|NCT01098162|69560829|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
37876375|NCT01098162|69560829|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
37818018|NCT04218266|69497071|FG002|Overall Study|Physician Decision|2|||
37818019|NCT04218266|69497069|FG000|Overall Study|Non-compliance with study drug|0|||
37818020|NCT04218266|69497070|FG001|Overall Study|Non-compliance with study drug|0|||
37876376|NCT01098162|69560829|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
37876377|NCT01098162|69560829|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
37876378|NCT01098162|69560829|FG000|Overall Study|Other Reason|1|||
37876379|NCT01098162|69560829|FG000|Overall Study|Reason Unknown|26|||
37876380|NCT01097694|69560835|FG000|Overall Study|Adverse Event|5|||
37876381|NCT01097694|69560836|FG001|Overall Study|Adverse Event|0|||
37876382|NCT01097694|69560835|FG000|Overall Study|Lost to Follow-up|0|||
37876383|NCT01097694|69560836|FG001|Overall Study|Lost to Follow-up|3|||
37876384|NCT01097694|69560835|FG000|Overall Study|Withdrawal by Subject|3|||
37876385|NCT01097694|69560836|FG001|Overall Study|Withdrawal by Subject|1|||
37876386|NCT01102140|69560844|FG000|Overall Study|Lost to Follow-up|1|||
37876387|NCT01102140|69560845|FG001|Overall Study|Lost to Follow-up|0|||
37876388|NCT01102140|69560844|FG000|Overall Study|Investigator terminated study|2|||
37876389|NCT01102140|69560845|FG001|Overall Study|Investigator terminated study|2|||
37876390|NCT00874549|69560857|FG000|Overall Study|Adverse Event|0|||
37876391|NCT00874549|69560858|FG001|Overall Study|Adverse Event|0|||
37876392|NCT00874549|69560859|FG002|Overall Study|Adverse Event|1|||
37876393|NCT00874549|69560860|FG003|Overall Study|Adverse Event|0|||
37876394|NCT00874549|69560857|FG000|Overall Study|Protocol Violation|1|||
37876395|NCT00874549|69560858|FG001|Overall Study|Protocol Violation|0|||
37876396|NCT00874549|69560859|FG002|Overall Study|Protocol Violation|2|||
37876397|NCT00874549|69560860|FG003|Overall Study|Protocol Violation|1|||
37876398|NCT00874549|69560857|FG000|Overall Study|Lost to Follow-up|0|||
37876399|NCT00874549|69560858|FG001|Overall Study|Lost to Follow-up|0|||
37876400|NCT00874549|69560859|FG002|Overall Study|Lost to Follow-up|1|||
37876401|NCT00874549|69560860|FG003|Overall Study|Lost to Follow-up|0|||
37876402|NCT00874549|69560857|FG000|Overall Study|Withdrawal by Subject|0|||
37876403|NCT00874549|69560858|FG001|Overall Study|Withdrawal by Subject|1|||
37876404|NCT00874549|69560859|FG002|Overall Study|Withdrawal by Subject|0|||
37876405|NCT00874549|69560860|FG003|Overall Study|Withdrawal by Subject|1|||
37876406|NCT01155479|69560875|FG000|Part I|Adverse Event|13|||
37876407|NCT01155479|69560876|FG001|Part I|Adverse Event|8|||
37876408|NCT01155479|69560877|FG002|Part I|Adverse Event|18|||
37983044|NCT00262600|69669365|FG002|Overall Study|Not Treated|24|||
37983045|NCT00262600|69669363|FG000|Overall Study|Other|58|||
37983046|NCT00262600|69669364|FG001|Overall Study|Other|59|||
37876409|NCT01155479|69560878|FG003|Part I|Adverse Event|7|||
37876410|NCT01155479|69560879|FG004|Part I|Adverse Event|6|||
37876411|NCT01155479|69560875|FG000|Part I|Administrative|2|||
37876412|NCT01155479|69560876|FG001|Part I|Administrative|2|||
37876413|NCT01155479|69560877|FG002|Part I|Administrative|2|||
37876414|NCT01155479|69560878|FG003|Part I|Administrative|0|||
37876415|NCT01155479|69560879|FG004|Part I|Administrative|0|||
37876416|NCT01155479|69560875|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
37876417|NCT01155479|69560876|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
37876418|NCT01155479|69560877|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
37876419|NCT01155479|69560878|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
37876420|NCT01155479|69560879|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
37876421|NCT01155479|69560875|FG000|Part I|Withdrawal by Subject|11|||
37983047|NCT00262600|69669365|FG002|Overall Study|Other|62|||
37983048|NCT00409578|69669377|FG000|Overall Study|Adverse Event|27|||
37983049|NCT00409578|69669378|FG001|Overall Study|Adverse Event|37|||
37983050|NCT00409578|69669379|FG002|Overall Study|Adverse Event|25|||
37983051|NCT00409578|69669380|FG003|Overall Study|Adverse Event|33|||
37983052|NCT00409578|69669377|FG000|Overall Study|Abnormal laboratory value(s)|2|||
37983053|NCT00409578|69669378|FG001|Overall Study|Abnormal laboratory value(s)|2|||
37983054|NCT00409578|69669379|FG002|Overall Study|Abnormal laboratory value(s)|2|||
37818021|NCT04218266|69497071|FG002|Overall Study|Non-compliance with study drug|1|||
37818022|NCT04218266|69497069|FG000|Overall Study|Withdrawal by Subject|1|||
37818023|NCT04218266|69497070|FG001|Overall Study|Withdrawal by Subject|3|||
37818024|NCT04218266|69497071|FG002|Overall Study|Withdrawal by Subject|1|||
37818025|NCT04218266|69497069|FG000|Overall Study|Study drug never administered|2|||
37818026|NCT04218266|69497070|FG001|Overall Study|Study drug never administered|0|||
37818027|NCT04218266|69497071|FG002|Overall Study|Study drug never administered|0|||
37818028|NCT03894904|69497093|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
37818029|NCT03894904|69497094|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
37876422|NCT01155479|69560876|FG001|Part I|Withdrawal by Subject|13|||
37876423|NCT01155479|69560877|FG002|Part I|Withdrawal by Subject|8|||
37876424|NCT01155479|69560878|FG003|Part I|Withdrawal by Subject|8|||
37983055|NCT00409578|69669380|FG003|Overall Study|Abnormal laboratory value(s)|4|||
37983056|NCT00409578|69669377|FG000|Overall Study|Lack of Efficacy|0|||
37818030|NCT03894904|69497093|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
37876425|NCT01155479|69560879|FG004|Part I|Withdrawal by Subject|9|||
37876426|NCT01155479|69560875|FG000|Part I|Lost to Follow-up|0|||
37876427|NCT01155479|69560876|FG001|Part I|Lost to Follow-up|0|||
37876428|NCT01155479|69560877|FG002|Part I|Lost to Follow-up|1|||
37876429|NCT01155479|69560878|FG003|Part I|Lost to Follow-up|1|||
37876430|NCT01155479|69560879|FG004|Part I|Lost to Follow-up|0|||
37876431|NCT01155479|69560875|FG000|Part I|Treatment Failure|3|||
37876432|NCT01155479|69560876|FG001|Part I|Treatment Failure|0|||
37876433|NCT01155479|69560877|FG002|Part I|Treatment Failure|3|||
37876434|NCT01155479|69560878|FG003|Part I|Treatment Failure|1|||
37876435|NCT01155479|69560879|FG004|Part I|Treatment Failure|2|||
37876436|NCT01155479|69560875|FG000|Part I|Did Not Receive Treatment|4|||
37876437|NCT01155479|69560876|FG001|Part I|Did Not Receive Treatment|2|||
37876438|NCT01155479|69560877|FG002|Part I|Did Not Receive Treatment|2|||
37876439|NCT01155479|69560878|FG003|Part I|Did Not Receive Treatment|6|||
37876440|NCT01155479|69560879|FG004|Part I|Did Not Receive Treatment|1|||
37876441|NCT01155479|69560875|FG000|Part I|Non-Compliance with Protocol|2|||
37876442|NCT01155479|69560876|FG001|Part I|Non-Compliance with Protocol|1|||
37876443|NCT01155479|69560877|FG002|Part I|Non-Compliance with Protocol|3|||
37876444|NCT01155479|69560878|FG003|Part I|Non-Compliance with Protocol|3|||
37876445|NCT01155479|69560879|FG004|Part I|Non-Compliance with Protocol|2|||
37876446|NCT01155479|69560875|FG000|Part II|Adverse Event|7|||
37876447|NCT01155479|69560876|FG001|Part II|Adverse Event|6|||
37876448|NCT01155479|69560877|FG002|Part II|Adverse Event|8|||
37876449|NCT01155479|69560878|FG003|Part II|Adverse Event|3|||
37876450|NCT01155479|69560879|FG004|Part II|Adverse Event|4|||
37876451|NCT01155479|69560875|FG000|Part II|Administrative|43|||
37876452|NCT01155479|69560876|FG001|Part II|Administrative|49|||
37876453|NCT01155479|69560877|FG002|Part II|Administrative|36|||
37876454|NCT01155479|69560878|FG003|Part II|Administrative|38|||
37876455|NCT01155479|69560879|FG004|Part II|Administrative|46|||
37876456|NCT01155479|69560875|FG000|Part II|Withdrawal by Subject|8|||
37876457|NCT01155479|69560876|FG001|Part II|Withdrawal by Subject|4|||
37876458|NCT01155479|69560877|FG002|Part II|Withdrawal by Subject|12|||
37876459|NCT01155479|69560878|FG003|Part II|Withdrawal by Subject|7|||
37876460|NCT01155479|69560879|FG004|Part II|Withdrawal by Subject|3|||
37876461|NCT01155479|69560875|FG000|Part II|Lost to Follow-up|1|||
37876462|NCT01155479|69560876|FG001|Part II|Lost to Follow-up|0|||
37876463|NCT01155479|69560877|FG002|Part II|Lost to Follow-up|0|||
37876464|NCT01155479|69560878|FG003|Part II|Lost to Follow-up|0|||
37876465|NCT01155479|69560879|FG004|Part II|Lost to Follow-up|1|||
37876466|NCT01155479|69560875|FG000|Part II|Treatment Failure|0|||
37876467|NCT01155479|69560876|FG001|Part II|Treatment Failure|1|||
37695110|NCT02369510|69171611|FG002|Overall Study|Epidural Activation|5|||
37876468|NCT01155479|69560877|FG002|Part II|Treatment Failure|2|||
37876469|NCT01155479|69560878|FG003|Part II|Treatment Failure|0|||
37876470|NCT01155479|69560879|FG004|Part II|Treatment Failure|1|||
37876471|NCT01155479|69560875|FG000|Part II|Non-Compliance with Protocol|0|||
37876472|NCT01155479|69560876|FG001|Part II|Non-Compliance with Protocol|1|||
37876473|NCT01155479|69560877|FG002|Part II|Non-Compliance with Protocol|0|||
37876474|NCT01155479|69560878|FG003|Part II|Non-Compliance with Protocol|2|||
37876475|NCT01155479|69560879|FG004|Part II|Non-Compliance with Protocol|0|||
37983057|NCT00409578|69669378|FG001|Overall Study|Lack of Efficacy|0|||
37876476|NCT01155323|69560907|FG000|First Intervention|exclusion criteria|1|||
37876477|NCT01155323|69560908|FG001|First Intervention|exclusion criteria|1|||
37876478|NCT01155323|69560907|FG000|Second Intervention|Lost to Follow-up|1|||
37818031|NCT03894904|69497094|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
37818032|NCT03099265|69497114|FG000|Overall Study|Adverse Event|1|||
37818033|NCT02658656|69497132|FG000|Screening|Failed eligibility criteria|0|||
37818034|NCT02658656|69497133|FG001|Screening|Failed eligibility criteria|0|||
37818035|NCT02658656|69497134|FG002|Screening|Failed eligibility criteria|263|||
37818036|NCT02658656|69497132|FG000|Randomization|Withdrawal by Subject|8|||
37818037|NCT02658656|69497133|FG001|Randomization|Withdrawal by Subject|7|||
37818038|NCT02658656|69497134|FG002|Randomization|Withdrawal by Subject|0|||
37818039|NCT02658656|69497132|FG000|Randomization|Lost to Follow-up|1|||
37818040|NCT02658656|69497133|FG001|Randomization|Lost to Follow-up|3|||
37818041|NCT02658656|69497134|FG002|Randomization|Lost to Follow-up|0|||
37818042|NCT02658656|69497132|FG000|Randomization|Adverse Event|4|||
37818043|NCT02658656|69497133|FG001|Randomization|Adverse Event|0|||
37818044|NCT02658656|69497134|FG002|Randomization|Adverse Event|0|||
37818045|NCT02658656|69497132|FG000|Randomization|Administrative Termination|3|||
37818046|NCT02658656|69497133|FG001|Randomization|Administrative Termination|1|||
37818047|NCT02658656|69497134|FG002|Randomization|Administrative Termination|0|||
37818048|NCT02658656|69497132|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
37818049|NCT02658656|69497133|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
37818050|NCT02658656|69497134|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
37818051|NCT02658656|69497132|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
37818052|NCT02658656|69497133|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
37818053|NCT02658656|69497134|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
37818054|NCT02658656|69497132|FG000|Randomization|Not eligible for Randomization|1|||
37818055|NCT02658656|69497133|FG001|Randomization|Not eligible for Randomization|0|||
37818056|NCT02658656|69497134|FG002|Randomization|Not eligible for Randomization|0|||
37818057|NCT02658656|69497132|FG000|Randomization|Protocol Violation|1|||
37818058|NCT02658656|69497133|FG001|Randomization|Protocol Violation|0|||
37818059|NCT02658656|69497134|FG002|Randomization|Protocol Violation|0|||
37818060|NCT05141175|69497192|FG000|Overall Study|Withdrawal by Subject|1|||
37818061|NCT04869345|69497198|FG000|Overall Study|Lost to Follow-up|8|||
37818062|NCT04869345|69497199|FG001|Overall Study|Lost to Follow-up|3|||
37818063|NCT03610737|69497271|FG000|Overall Study|Withdrawal by Subject|1|||
37818064|NCT03610737|69497272|FG001|Overall Study|Withdrawal by Subject|5|||
37818065|NCT03610737|69497271|FG000|Overall Study|Death|1|||
37818066|NCT03610737|69497272|FG001|Overall Study|Death|0|||
37818067|NCT03610737|69497271|FG000|Overall Study|Not treated|5|||
37818068|NCT03610737|69497272|FG001|Overall Study|Not treated|2|||
37818069|NCT03610737|69497271|FG000|Overall Study|Missed Visit|1|||
37818070|NCT03610737|69497272|FG001|Overall Study|Missed Visit|2|||
37818071|NCT03321929|69497278|FG000|Overall Study|Withdrawn prior to LUM Imaging Procedure completed|4|||
37818072|NCT03250624|69497285|FG000|Overall Study|Lack of Efficacy|1|||
37818073|NCT03250624|69497286|FG001|Overall Study|Lack of Efficacy|4|||
37818074|NCT03250624|69497285|FG000|Overall Study|Adverse Event|0|||
37818075|NCT03250624|69497286|FG001|Overall Study|Adverse Event|1|||
37818076|NCT03250624|69497285|FG000|Overall Study|Other|1|||
37876479|NCT01155323|69560908|FG001|Second Intervention|Lost to Follow-up|1|||
37876480|NCT01155167|69560916|FG000|Overall Study|Insufficient ultrasound data|2|||
37876481|NCT01155167|69560917|FG001|Overall Study|Insufficient ultrasound data|0|||
37876482|NCT01155167|69560916|FG000|Overall Study|Access site changed to femoral artery|1|||
37876483|NCT01155167|69560917|FG001|Overall Study|Access site changed to femoral artery|0|||
37876484|NCT01106586|69560925|FG000|Overall Study|Adverse Event|9|||
37876485|NCT01106586|69560926|FG001|Overall Study|Adverse Event|15|||
37876486|NCT01106586|69560925|FG000|Overall Study|Death|1|||
37876487|NCT01106586|69560926|FG001|Overall Study|Death|3|||
37876488|NCT01106586|69560925|FG000|Overall Study|Pregnancy|2|||
37876489|NCT01106586|69560926|FG001|Overall Study|Pregnancy|2|||
37876490|NCT01106586|69560925|FG000|Overall Study|Lack of Efficacy|1|||
37876491|NCT01106586|69560926|FG001|Overall Study|Lack of Efficacy|0|||
37876492|NCT01106586|69560925|FG000|Overall Study|Investigator's Discretion|5|||
37876493|NCT01106586|69560926|FG001|Overall Study|Investigator's Discretion|8|||
37876494|NCT01106586|69560925|FG000|Overall Study|Withdrew Consent|18|||
37876495|NCT01106586|69560926|FG001|Overall Study|Withdrew Consent|30|||
37876496|NCT01106586|69560925|FG000|Overall Study|Lost to Follow-up|24|||
37876497|NCT01106586|69560926|FG001|Overall Study|Lost to Follow-up|20|||
37876498|NCT01106586|69560925|FG000|Overall Study|Participant Noncompliance|12|||
37876499|NCT01106586|69560926|FG001|Overall Study|Participant Noncompliance|10|||
37876500|NCT01106586|69560925|FG000|Overall Study|Protocol Violation|1|||
37876501|NCT01106586|69560926|FG001|Overall Study|Protocol Violation|0|||
37876502|NCT01106586|69560925|FG000|Overall Study|Participant Transferred to Another Study|212|||
37876503|NCT01106586|69560926|FG001|Overall Study|Participant Transferred to Another Study|197|||
37876504|NCT01155011|69560934|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
37876505|NCT01155011|69560935|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
37876506|NCT01155011|69560934|FG000|Baseline to 6 Months|investigator decision, moved|4|||
37876507|NCT01155011|69560935|FG001|Baseline to 6 Months|investigator decision, moved|5|||
37876508|NCT01155011|69560934|FG000|Baseline to 6 Months|Death|0|||
37876509|NCT01155011|69560935|FG001|Baseline to 6 Months|Death|1|||
37876510|NCT01155011|69560934|FG000|6 to 12 Months|Withdrawal by Subject|8|||
37876511|NCT01155011|69560935|FG001|6 to 12 Months|Withdrawal by Subject|5|||
37876512|NCT01155011|69560934|FG000|6 to 12 Months|Death|1|||
37876513|NCT01155011|69560935|FG001|6 to 12 Months|Death|5|||
37876514|NCT01106430|69560947|FG000|Overall Study|Adverse Event|8|||
37876515|NCT01106430|69560948|FG001|Overall Study|Adverse Event|10|||
37876516|NCT01106430|69560947|FG000|Overall Study|Lack of Efficacy|2|||
37876517|NCT01106430|69560948|FG001|Overall Study|Lack of Efficacy|13|||
37876518|NCT01106430|69560947|FG000|Overall Study|Lost to Follow-up|5|||
37876519|NCT01106430|69560948|FG001|Overall Study|Lost to Follow-up|1|||
37876520|NCT01106430|69560947|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
37876521|NCT01106430|69560948|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
37876522|NCT01106430|69560947|FG000|Overall Study|Moved Out Of State|0|||
37876523|NCT01106430|69560948|FG001|Overall Study|Moved Out Of State|1|||
37876524|NCT01106430|69560947|FG000|Overall Study|Refused To Take Medication|0|||
37876525|NCT01106430|69560948|FG001|Overall Study|Refused To Take Medication|1|||
37876526|NCT01106430|69560947|FG000|Overall Study|Noncompliance|0|||
37876527|NCT01106430|69560948|FG001|Overall Study|Noncompliance|1|||
37876528|NCT01106430|69560947|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
37876529|NCT01106430|69560948|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
37876530|NCT01106430|69560947|FG000|Overall Study|Previous Use Of Marijuana|1|||
37876531|NCT01106430|69560948|FG001|Overall Study|Previous Use Of Marijuana|0|||
37876532|NCT01106430|69560947|FG000|Overall Study|Protocol Violation|7|||
37876533|NCT01106430|69560948|FG001|Overall Study|Protocol Violation|2|||
37876534|NCT01106430|69560947|FG000|Overall Study|Withdrawal by Subject|8|||
37876535|NCT01106430|69560948|FG001|Overall Study|Withdrawal by Subject|4|||
37876536|NCT01154231|69560954|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
37876537|NCT01154231|69560954|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
37876538|NCT01154153|69560960|FG000|Overall Study|Poor compliance to protocol|2|||
37876539|NCT01154153|69560961|FG001|Overall Study|Poor compliance to protocol|0|||
37876540|NCT01154153|69560960|FG000|Overall Study|Unable to use labs|2|||
37876541|NCT01154153|69560961|FG001|Overall Study|Unable to use labs|3|||
37876542|NCT01154153|69560960|FG000|Overall Study|Withdrew consent|1|||
37876543|NCT01154153|69560961|FG001|Overall Study|Withdrew consent|0|||
37876544|NCT00874237|69560967|FG000|Overall Study|Physician Decision|0|||
37876545|NCT00874237|69560968|FG001|Overall Study|Physician Decision|1|||
37876546|NCT00874237|69560969|FG002|Overall Study|Physician Decision|0|||
37876547|NCT00874237|69560970|FG003|Overall Study|Physician Decision|0|||
37876548|NCT00874237|69560971|FG004|Overall Study|Physician Decision|0|||
37876549|NCT00874237|69560972|FG005|Overall Study|Physician Decision|0|||
37876550|NCT00874237|69560967|FG000|Overall Study|Withdrawal by Subject|0|||
37876551|NCT00874237|69560968|FG001|Overall Study|Withdrawal by Subject|0|||
37876552|NCT00874237|69560969|FG002|Overall Study|Withdrawal by Subject|1|||
37876553|NCT00874237|69560970|FG003|Overall Study|Withdrawal by Subject|0|||
37876554|NCT00874237|69560971|FG004|Overall Study|Withdrawal by Subject|0|||
37876555|NCT00874237|69560972|FG005|Overall Study|Withdrawal by Subject|0|||
37876556|NCT01153841|69560984|FG000|Overall Study|Adverse Event|1|||
37876557|NCT01153841|69560985|FG001|Overall Study|Adverse Event|0|||
37876558|NCT01153841|69560984|FG000|Overall Study|Withdrawal by Subject|1|||
37876559|NCT01153841|69560985|FG001|Overall Study|Withdrawal by Subject|0|||
37876560|NCT01153841|69560984|FG000|Overall Study|Protocol Violation|2|||
37876561|NCT01153841|69560985|FG001|Overall Study|Protocol Violation|0|||
37876562|NCT01153841|69560984|FG000|Overall Study|Lost to Follow-up|2|||
37876563|NCT01153841|69560985|FG001|Overall Study|Lost to Follow-up|0|||
37876564|NCT01153763|69560991|FG000|Overall Study|Study Closed|16|||
37876565|NCT01153763|69560991|FG000|Overall Study|Lost to Follow-up|1|||
37876566|NCT01153763|69560991|FG000|Overall Study|Physician Decision|2|||
37876567|NCT01153763|69560991|FG000|Overall Study|Withdrawal by Subject|2|||
37876568|NCT00871741|69560997|FG000|Overall Study|Premature study termination|9|||
37876569|NCT00871741|69560998|FG001|Overall Study|Premature study termination|7|||
37876570|NCT01152437|69561007|FG000|Overall Study|Other Adverse Event|8|||
37876571|NCT01152437|69561008|FG001|Overall Study|Other Adverse Event|1|||
37876572|NCT01152437|69561009|FG002|Overall Study|Other Adverse Event|7|||
37876573|NCT01152437|69561007|FG000|Overall Study|Not treated|0|||
37876574|NCT01152437|69561008|FG001|Overall Study|Not treated|1|||
37876575|NCT01152437|69561009|FG002|Overall Study|Not treated|2|||
37876576|NCT01152437|69561007|FG000|Overall Study|Progressive disease|27|||
37876577|NCT01152437|69561008|FG001|Overall Study|Progressive disease|13|||
37876578|NCT01152437|69561009|FG002|Overall Study|Progressive disease|32|||
37876579|NCT01152437|69561007|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
37876580|NCT01152437|69561008|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
37983058|NCT00409578|69669379|FG002|Overall Study|Lack of Efficacy|0|||
37818077|NCT03250624|69497286|FG001|Overall Study|Other|2|||
37818078|NCT02507297|69497294|FG000|Overall Study|Withdrawal by Subject|1|||
37818079|NCT02507297|69497295|FG001|Overall Study|Withdrawal by Subject|0|||
37818080|NCT02507297|69497294|FG000|Overall Study|Lost to Follow-up|0|||
37818081|NCT02507297|69497295|FG001|Overall Study|Lost to Follow-up|1|||
37818082|NCT01333514|69497303|FG000|Overall Study|Withdrawal by Subject|1|||
37818083|NCT01333514|69497304|FG001|Overall Study|Withdrawal by Subject|0|||
37818084|NCT02066636|69497313|FG000|Overall Study|Disease progression|51|||
37818085|NCT02066636|69497314|FG001|Overall Study|Disease progression|60|||
37818086|NCT02066636|69497315|FG002|Overall Study|Disease progression|700|||
37818087|NCT02066636|69497313|FG000|Overall Study|Study drug toxicity|13|||
37818088|NCT02066636|69497314|FG001|Overall Study|Study drug toxicity|2|||
37818089|NCT02066636|69497315|FG002|Overall Study|Study drug toxicity|58|||
37818090|NCT02066636|69497313|FG000|Overall Study|Death|4|||
37818091|NCT02066636|69497314|FG001|Overall Study|Death|2|||
37818092|NCT02066636|69497315|FG002|Overall Study|Death|158|||
37876581|NCT01152437|69561009|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
37876582|NCT01151579|69561021|FG000|Overall Study|Physician Decision|3|||
37876583|NCT01151579|69561022|FG001|Overall Study|Physician Decision|1|||
37876584|NCT01151579|69561021|FG000|Overall Study|Withdrawal by Subject|3|||
37876585|NCT01151579|69561022|FG001|Overall Study|Withdrawal by Subject|2|||
37876586|NCT01151579|69561021|FG000|Overall Study|Not meet inclusion criteria|6|||
37876587|NCT01151579|69561022|FG001|Overall Study|Not meet inclusion criteria|4|||
37876588|NCT01097616|69561031|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
37876589|NCT01097616|69561032|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
37876590|NCT01097616|69561033|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
37876591|NCT01097616|69561034|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
37876592|NCT01097616|69561035|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
37876593|NCT01097616|69561036|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
37876594|NCT01097616|69561037|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
37876595|NCT01097616|69561038|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
37876596|NCT01097616|69561031|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
37876597|NCT01097616|69561032|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
37876598|NCT01097616|69561033|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
37876599|NCT01097616|69561034|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
37876600|NCT01097616|69561035|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
37876601|NCT01097616|69561036|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
37876602|NCT01097616|69561037|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
37876603|NCT01097616|69561038|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
37876604|NCT01097616|69561031|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
37876605|NCT01097616|69561032|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
37876606|NCT01097616|69561033|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
37983059|NCT00409578|69669380|FG003|Overall Study|Lack of Efficacy|2|||
37983060|NCT00409578|69669377|FG000|Overall Study|Subject no longer requires study drug|0|||
37876607|NCT01097616|69561034|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
37876608|NCT01097616|69561035|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
37876609|NCT01097616|69561036|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
37876610|NCT01097616|69561037|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
37876611|NCT01097616|69561038|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
37876612|NCT01097616|69561031|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
37876613|NCT01097616|69561032|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
37876614|NCT01097616|69561033|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
37876615|NCT01097616|69561034|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
37876616|NCT01097616|69561035|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
37876617|NCT01097616|69561036|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
37876618|NCT01097616|69561037|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
37876619|NCT01097616|69561038|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
37876620|NCT01097616|69561031|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
37876621|NCT01097616|69561032|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
37876622|NCT01097616|69561033|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
37876623|NCT01097616|69561034|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
37876624|NCT01097616|69561035|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
37876625|NCT01097616|69561036|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
37876626|NCT01097616|69561037|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
37876627|NCT01097616|69561038|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
37876628|NCT01097616|69561031|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
37876629|NCT01097616|69561032|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
37876630|NCT01097616|69561033|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
37876631|NCT01097616|69561034|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
37876632|NCT01097616|69561035|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
37876633|NCT01097616|69561036|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
37876634|NCT01097616|69561037|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
37876635|NCT01097616|69561038|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
37876636|NCT01097616|69561031|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
37876637|NCT01097616|69561032|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
37876638|NCT01097616|69561033|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
37876639|NCT01097616|69561034|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
37876640|NCT01097616|69561035|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
37876641|NCT01097616|69561036|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
37876642|NCT01097616|69561037|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
37876643|NCT01097616|69561038|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
37876644|NCT01097616|69561031|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
37876645|NCT01097616|69561032|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
37876646|NCT01097616|69561033|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
37983061|NCT00409578|69669378|FG001|Overall Study|Subject no longer requires study drug|0|||
37983062|NCT00409578|69669379|FG002|Overall Study|Subject no longer requires study drug|0|||
37983063|NCT00409578|69669380|FG003|Overall Study|Subject no longer requires study drug|1|||
37876647|NCT01097616|69561034|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
37876648|NCT01097616|69561035|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
37876649|NCT01097616|69561036|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
37876650|NCT01097616|69561037|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
37876651|NCT01097616|69561038|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
37876652|NCT01097616|69561031|FG000|Optional DB EXT Phase|Adverse Event|0|||
37876653|NCT01097616|69561032|FG001|Optional DB EXT Phase|Adverse Event|7|||
37876654|NCT01097616|69561033|FG002|Optional DB EXT Phase|Adverse Event|2|||
37876655|NCT01097616|69561034|FG003|Optional DB EXT Phase|Adverse Event|0|||
37876656|NCT01097616|69561035|FG004|Optional DB EXT Phase|Adverse Event|0|||
37876657|NCT01097616|69561036|FG005|Optional DB EXT Phase|Adverse Event|0|||
37876658|NCT01097616|69561037|FG006|Optional DB EXT Phase|Adverse Event|0|||
37876659|NCT01097616|69561038|FG007|Optional DB EXT Phase|Adverse Event|0|||
37876660|NCT01097616|69561031|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
37876661|NCT01097616|69561032|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
37876662|NCT01097616|69561033|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
37876663|NCT01097616|69561034|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
37876664|NCT01097616|69561035|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
37876665|NCT01097616|69561036|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
37876666|NCT01097616|69561037|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
37876667|NCT01097616|69561038|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
37876668|NCT01097616|69561031|FG000|Optional DB EXT Phase|Protocol Violation|0|||
37876669|NCT01097616|69561032|FG001|Optional DB EXT Phase|Protocol Violation|2|||
37876670|NCT01097616|69561033|FG002|Optional DB EXT Phase|Protocol Violation|3|||
37876671|NCT01097616|69561034|FG003|Optional DB EXT Phase|Protocol Violation|0|||
37876672|NCT01097616|69561035|FG004|Optional DB EXT Phase|Protocol Violation|0|||
37818093|NCT02066636|69497313|FG000|Overall Study|Adverse event unrelated to study drug|6|||
37818094|NCT02066636|69497314|FG001|Overall Study|Adverse event unrelated to study drug|4|||
37818095|NCT02066636|69497315|FG002|Overall Study|Adverse event unrelated to study drug|45|||
37818096|NCT02066636|69497313|FG000|Overall Study|Participant request to discontinue treatment|12|||
37818097|NCT02066636|69497314|FG001|Overall Study|Participant request to discontinue treatment|12|||
37818098|NCT02066636|69497315|FG002|Overall Study|Participant request to discontinue treatment|70|||
37818099|NCT02066636|69497313|FG000|Overall Study|Participant withdrew consent|10|||
37818100|NCT02066636|69497314|FG001|Overall Study|Participant withdrew consent|18|||
37818101|NCT02066636|69497315|FG002|Overall Study|Participant withdrew consent|61|||
37818102|NCT02066636|69497313|FG000|Overall Study|Lost to Follow-up|0|||
37818103|NCT02066636|69497314|FG001|Overall Study|Lost to Follow-up|2|||
37818104|NCT02066636|69497315|FG002|Overall Study|Lost to Follow-up|2|||
37818105|NCT02066636|69497313|FG000|Overall Study|Maximum clinical benefit|2|||
37818106|NCT02066636|69497314|FG001|Overall Study|Maximum clinical benefit|2|||
37818107|NCT02066636|69497315|FG002|Overall Study|Maximum clinical benefit|3|||
37818108|NCT02066636|69497313|FG000|Overall Study|Poor/non-compliance|2|||
37818109|NCT02066636|69497314|FG001|Overall Study|Poor/non-compliance|1|||
37818110|NCT02066636|69497315|FG002|Overall Study|Poor/non-compliance|1|||
37818111|NCT02066636|69497313|FG000|Overall Study|Participant no loner meets study criteria|3|||
37818112|NCT02066636|69497314|FG001|Overall Study|Participant no loner meets study criteria|2|||
37818113|NCT02066636|69497315|FG002|Overall Study|Participant no loner meets study criteria|28|||
37818114|NCT02066636|69497313|FG000|Overall Study|Administrative reasons by sponsor|8|||
37818115|NCT02066636|69497314|FG001|Overall Study|Administrative reasons by sponsor|5|||
37818116|NCT02066636|69497315|FG002|Overall Study|Administrative reasons by sponsor|0|||
37818117|NCT02066636|69497313|FG000|Overall Study|Other reasons|16|||
37818118|NCT02066636|69497314|FG001|Overall Study|Other reasons|15|||
37818119|NCT02066636|69497315|FG002|Overall Study|Other reasons|50|||
37818120|NCT01486264|69497327|FG000|Overall Study|Death|1|||
37818121|NCT01486264|69497328|FG001|Overall Study|Death|1|||
37818122|NCT01486264|69497327|FG000|Overall Study|Adverse Event|3|||
37818123|NCT01486264|69497328|FG001|Overall Study|Adverse Event|3|||
37818124|NCT01486264|69497327|FG000|Overall Study|Lack of Efficacy|6|||
37818125|NCT01486264|69497328|FG001|Overall Study|Lack of Efficacy|10|||
37818126|NCT01486264|69497327|FG000|Overall Study|Withdrawal by Subject|7|||
37818127|NCT01486264|69497328|FG001|Overall Study|Withdrawal by Subject|18|||
37818128|NCT01486264|69497327|FG000|Overall Study|Physician Decision|1|||
37818129|NCT01486264|69497328|FG001|Overall Study|Physician Decision|1|||
37818130|NCT01486264|69497327|FG000|Overall Study|Protocol Violation|3|||
37818131|NCT01486264|69497328|FG001|Overall Study|Protocol Violation|0|||
37818132|NCT01486264|69497327|FG000|Overall Study|Lost to Follow-up|3|||
37818133|NCT01486264|69497328|FG001|Overall Study|Lost to Follow-up|2|||
37818134|NCT01486264|69497327|FG000|Overall Study|Other|5|||
37818135|NCT01486264|69497328|FG001|Overall Study|Other|11|||
37818136|NCT01486264|69497327|FG000|Overall Study|Not treated|0|||
37818137|NCT01486264|69497328|FG001|Overall Study|Not treated|1|||
37876673|NCT01097616|69561036|FG005|Optional DB EXT Phase|Protocol Violation|0|||
37876674|NCT01097616|69561037|FG006|Optional DB EXT Phase|Protocol Violation|0|||
37876675|NCT01097616|69561038|FG007|Optional DB EXT Phase|Protocol Violation|0|||
37876676|NCT01097616|69561031|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
37876677|NCT01097616|69561032|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
37983064|NCT00409578|69669377|FG000|Overall Study|Withdrawal by Subject|8|||
37983065|NCT00409578|69669378|FG001|Overall Study|Withdrawal by Subject|15|||
37983066|NCT00409578|69669379|FG002|Overall Study|Withdrawal by Subject|16|||
37983067|NCT00409578|69669380|FG003|Overall Study|Withdrawal by Subject|17|||
37983068|NCT00409578|69669377|FG000|Overall Study|Lost to Follow-up|2|||
37983069|NCT00409578|69669378|FG001|Overall Study|Lost to Follow-up|0|||
37818138|NCT01323270|69497336|FG000|Overall Study|Withdrawal by Subject|19|||
37818139|NCT01323270|69497337|FG001|Overall Study|Withdrawal by Subject|10|||
37818140|NCT01323270|69497336|FG000|Overall Study|Protocol Violation|9|||
37818141|NCT01323270|69497337|FG001|Overall Study|Protocol Violation|7|||
37818142|NCT01323270|69497336|FG000|Overall Study|Lost to Follow-up|4|||
37818143|NCT01323270|69497337|FG001|Overall Study|Lost to Follow-up|6|||
37818144|NCT01323270|69497336|FG000|Overall Study|Adverse Event|8|||
37818145|NCT01323270|69497337|FG001|Overall Study|Adverse Event|0|||
37818146|NCT01323270|69497336|FG000|Overall Study|Other|0|||
37818147|NCT01323270|69497337|FG001|Overall Study|Other|3|||
37818148|NCT01323270|69497336|FG000|Overall Study|Physician Decision|0|||
37818149|NCT01323270|69497337|FG001|Overall Study|Physician Decision|2|||
37818150|NCT01323270|69497336|FG000|Overall Study|Not eligible|1|||
37818151|NCT01323270|69497337|FG001|Overall Study|Not eligible|1|||
37818152|NCT01323270|69497336|FG000|Overall Study|Death|1|||
37818153|NCT01323270|69497337|FG001|Overall Study|Death|0|||
37818154|NCT01323270|69497336|FG000|Overall Study|Randomized, but not vaccinated|1|||
37818155|NCT01323270|69497337|FG001|Overall Study|Randomized, but not vaccinated|0|||
37818156|NCT01300728|69497346|FG000|Overall Study|Withdrawal by Subject|1|||
37818157|NCT01300728|69497347|FG001|Overall Study|Withdrawal by Subject|1|||
37818158|NCT01300728|69497346|FG000|Overall Study|Physician Decision|1|||
37818159|NCT01300728|69497347|FG001|Overall Study|Physician Decision|0|||
37818160|NCT01299480|69497358|FG000|Overall Study|No longer willing to participate|19|||
37818161|NCT01299480|69497359|FG001|Overall Study|No longer willing to participate|17|||
37818162|NCT01299480|69497360|FG002|Overall Study|No longer willing to participate|14|||
37818163|NCT01299480|69497361|FG003|Overall Study|No longer willing to participate|13|||
37818164|NCT01299480|69497362|FG004|Overall Study|No longer willing to participate|10|||
37818165|NCT01299480|69497358|FG000|Overall Study|Protocol Violation|7|||
37818166|NCT01299480|69497359|FG001|Overall Study|Protocol Violation|5|||
37818167|NCT01299480|69497360|FG002|Overall Study|Protocol Violation|8|||
37818168|NCT01299480|69497361|FG003|Overall Study|Protocol Violation|1|||
37818169|NCT01299480|69497362|FG004|Overall Study|Protocol Violation|1|||
37818170|NCT01299480|69497358|FG000|Overall Study|Withdrawal by Subject|3|||
37818171|NCT01299480|69497359|FG001|Overall Study|Withdrawal by Subject|4|||
37818172|NCT01299480|69497360|FG002|Overall Study|Withdrawal by Subject|7|||
37818173|NCT01299480|69497361|FG003|Overall Study|Withdrawal by Subject|3|||
37818174|NCT01299480|69497362|FG004|Overall Study|Withdrawal by Subject|4|||
37818175|NCT01299480|69497358|FG000|Overall Study|Adverse Event|6|||
37818176|NCT01299480|69497359|FG001|Overall Study|Adverse Event|4|||
37818177|NCT01299480|69497360|FG002|Overall Study|Adverse Event|5|||
37818178|NCT01299480|69497361|FG003|Overall Study|Adverse Event|4|||
37818179|NCT01299480|69497362|FG004|Overall Study|Adverse Event|0|||
37818180|NCT01299480|69497358|FG000|Overall Study|Withdrawal due to pregnancy|0|||
37818181|NCT01299480|69497359|FG001|Overall Study|Withdrawal due to pregnancy|1|||
37818182|NCT01299480|69497360|FG002|Overall Study|Withdrawal due to pregnancy|1|||
37818183|NCT01299480|69497361|FG003|Overall Study|Withdrawal due to pregnancy|0|||
37818184|NCT01299480|69497362|FG004|Overall Study|Withdrawal due to pregnancy|0|||
37818185|NCT01299480|69497358|FG000|Overall Study|Physician Decision|1|||
37983070|NCT00409578|69669379|FG002|Overall Study|Lost to Follow-up|2|||
37818186|NCT01299480|69497359|FG001|Overall Study|Physician Decision|1|||
37818187|NCT01299480|69497360|FG002|Overall Study|Physician Decision|0|||
37818188|NCT01299480|69497361|FG003|Overall Study|Physician Decision|2|||
37983071|NCT00409578|69669380|FG003|Overall Study|Lost to Follow-up|2|||
37818189|NCT01299480|69497362|FG004|Overall Study|Physician Decision|0|||
37818190|NCT01299480|69497358|FG000|Overall Study|Lost to Follow-up|3|||
37818191|NCT01299480|69497359|FG001|Overall Study|Lost to Follow-up|1|||
37983072|NCT00409578|69669377|FG000|Overall Study|Administrative problems|8|||
37818192|NCT01299480|69497360|FG002|Overall Study|Lost to Follow-up|2|||
37818193|NCT01299480|69497361|FG003|Overall Study|Lost to Follow-up|1|||
37818194|NCT01299480|69497362|FG004|Overall Study|Lost to Follow-up|2|||
37818195|NCT01299480|69497358|FG000|Overall Study|Other|3|||
37818196|NCT01299480|69497359|FG001|Overall Study|Other|2|||
37818197|NCT01299480|69497360|FG002|Overall Study|Other|3|||
37818198|NCT01299480|69497361|FG003|Overall Study|Other|0|||
37818199|NCT01299480|69497362|FG004|Overall Study|Other|3|||
37818200|NCT01299480|69497358|FG000|Overall Study|Started, but not vaccinated|0|||
37818201|NCT01299480|69497359|FG001|Overall Study|Started, but not vaccinated|0|||
37876678|NCT01097616|69561033|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
37876679|NCT01097616|69561034|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
37876680|NCT01097616|69561035|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
37876681|NCT01097616|69561036|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
37876682|NCT01097616|69561037|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
37876683|NCT01097616|69561038|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
37876684|NCT01097616|69561031|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
37876685|NCT01097616|69561032|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
37876686|NCT01097616|69561033|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
37876687|NCT01097616|69561034|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
37876688|NCT01097616|69561035|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
37876689|NCT01097616|69561036|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
37876690|NCT01097616|69561037|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
37876691|NCT01097616|69561038|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
37876692|NCT01097616|69561031|FG000|Optional DB EXT Phase|Physician Decision|1|||
37818202|NCT01299480|69497360|FG002|Overall Study|Started, but not vaccinated|1|||
37818203|NCT01299480|69497361|FG003|Overall Study|Started, but not vaccinated|1|||
37818204|NCT01299480|69497362|FG004|Overall Study|Started, but not vaccinated|0|||
37833555|NCT01263496|69517271|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
37833556|NCT01263496|69517272|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
37833557|NCT01263496|69517273|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
37833558|NCT01263496|69517274|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
37833559|NCT01263496|69517275|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
37833560|NCT01263496|69517276|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
37833561|NCT01263496|69517268|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
37833562|NCT01263496|69517269|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
37833563|NCT01263496|69517270|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
37833564|NCT01263496|69517271|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
37833565|NCT01263496|69517272|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
37833566|NCT01263496|69517273|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
37833567|NCT01263496|69517274|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
37833568|NCT01263496|69517275|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
37833569|NCT01263496|69517276|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
37833570|NCT01263223|69517288|FG000|Period 2|Withdrawal by Subject|0|||
37833571|NCT01263223|69517289|FG001|Period 2|Withdrawal by Subject|1|||
37833572|NCT01263223|69517288|FG000|7-day Follow-up|Withdrawal by Subject|0|||
37833573|NCT01263223|69517289|FG001|7-day Follow-up|Withdrawal by Subject|1|||
37833574|NCT01263223|69517288|FG000|7-day Follow-up|Lost to Follow-up|1|||
37833575|NCT01263223|69517289|FG001|7-day Follow-up|Lost to Follow-up|0|||
37833576|NCT01263106|69517298|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
37833577|NCT01263106|69517299|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
37833578|NCT01263028|69517308|FG000|Overall Study|Withdrawal by Subject|1|||
37833579|NCT01263028|69517308|FG000|Overall Study|Adverse Event|1|||
37876693|NCT01097616|69561032|FG001|Optional DB EXT Phase|Physician Decision|0|||
37876694|NCT01097616|69561033|FG002|Optional DB EXT Phase|Physician Decision|0|||
37876695|NCT01097616|69561034|FG003|Optional DB EXT Phase|Physician Decision|0|||
37876696|NCT01097616|69561035|FG004|Optional DB EXT Phase|Physician Decision|0|||
37876697|NCT01097616|69561036|FG005|Optional DB EXT Phase|Physician Decision|0|||
37876698|NCT01097616|69561037|FG006|Optional DB EXT Phase|Physician Decision|0|||
37876699|NCT01097616|69561038|FG007|Optional DB EXT Phase|Physician Decision|0|||
37876700|NCT01097616|69561031|FG000|DB RO Phase|Adverse Event|0|||
37876701|NCT01097616|69561032|FG001|DB RO Phase|Adverse Event|0|||
37876702|NCT01097616|69561033|FG002|DB RO Phase|Adverse Event|0|||
37876703|NCT01097616|69561034|FG003|DB RO Phase|Adverse Event|0|||
37876704|NCT01097616|69561035|FG004|DB RO Phase|Adverse Event|0|||
37876705|NCT01097616|69561036|FG005|DB RO Phase|Adverse Event|0|||
37876706|NCT01097616|69561037|FG006|DB RO Phase|Adverse Event|1|||
37876707|NCT01097616|69561038|FG007|DB RO Phase|Adverse Event|0|||
37876708|NCT01097616|69561031|FG000|DB RO Phase|Withdrawal by Subject|0|||
37983073|NCT00409578|69669378|FG001|Overall Study|Administrative problems|9|||
37983074|NCT00409578|69669379|FG002|Overall Study|Administrative problems|2|||
37983075|NCT00409578|69669380|FG003|Overall Study|Administrative problems|4|||
37983076|NCT00409578|69669377|FG000|Overall Study|Death|2|||
37983077|NCT00409578|69669378|FG001|Overall Study|Death|4|||
37983078|NCT00409578|69669379|FG002|Overall Study|Death|4|||
37818205|NCT04799405|69497384|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
37818206|NCT04529499|69497394|FG000|Overall Study|Withdrawal by Subject|9|||
37818207|NCT04529499|69497395|FG001|Overall Study|Withdrawal by Subject|11|||
37818208|NCT04529499|69497394|FG000|Overall Study|Physician Decision|1|||
37818209|NCT04529499|69497395|FG001|Overall Study|Physician Decision|2|||
37818210|NCT04529499|69497394|FG000|Overall Study|Adverse Event|4|||
37818211|NCT04529499|69497395|FG001|Overall Study|Adverse Event|4|||
37818212|NCT04529499|69497394|FG000|Overall Study|Death|14|||
37818213|NCT04529499|69497395|FG001|Overall Study|Death|11|||
37818214|NCT04529499|69497394|FG000|Overall Study|Lost to Follow-up|1|||
37818215|NCT04529499|69497395|FG001|Overall Study|Lost to Follow-up|1|||
37818216|NCT04529499|69497394|FG000|Overall Study|Others|7|||
37818217|NCT04529499|69497395|FG001|Overall Study|Others|11|||
37818218|NCT04501094|69497403|FG000|Overall Study|Death (unrelated to research)|1|||
37818219|NCT04501094|69497404|FG001|Overall Study|Death (unrelated to research)|0|||
37818220|NCT04414618|69497412|FG000|Overall Study|Death|3|||
37818221|NCT04414618|69497413|FG001|Overall Study|Death|3|||
37818222|NCT04414618|69497412|FG000|Overall Study|Withdrawal by Subject|2|||
37818223|NCT04414618|69497413|FG001|Overall Study|Withdrawal by Subject|1|||
37818224|NCT04414618|69497412|FG000|Overall Study|Lost to Follow-up|2|||
37818225|NCT04414618|69497413|FG001|Overall Study|Lost to Follow-up|3|||
37818226|NCT04414618|69497412|FG000|Overall Study|Physician Decision|1|||
37818227|NCT04414618|69497413|FG001|Overall Study|Physician Decision|0|||
37818228|NCT04412057|69497422|FG000|Overall Study|Death|3|||
37818229|NCT04412057|69497423|FG001|Overall Study|Death|7|||
37818230|NCT04412057|69497422|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
37818231|NCT04412057|69497423|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
37818232|NCT04402060|69497432|FG000|Overall Study|Death|1|||
37818233|NCT04402060|69497433|FG001|Overall Study|Death|12|||
37818234|NCT04402060|69497434|FG002|Overall Study|Death|7|||
37818235|NCT04402060|69497432|FG000|Overall Study|Adverse Event|0|||
37818236|NCT04402060|69497433|FG001|Overall Study|Adverse Event|0|||
37818237|NCT04402060|69497434|FG002|Overall Study|Adverse Event|1|||
37818238|NCT04402060|69497432|FG000|Overall Study|Withdrawal by Subject|0|||
37818239|NCT04402060|69497433|FG001|Overall Study|Withdrawal by Subject|1|||
37818240|NCT04402060|69497434|FG002|Overall Study|Withdrawal by Subject|2|||
37818241|NCT04402060|69497432|FG000|Overall Study|Sponsor Request|0|||
37818242|NCT04402060|69497433|FG001|Overall Study|Sponsor Request|2|||
37818243|NCT04402060|69497434|FG002|Overall Study|Sponsor Request|0|||
37818244|NCT04402060|69497432|FG000|Overall Study|Physician Decision|0|||
37818245|NCT04402060|69497433|FG001|Overall Study|Physician Decision|0|||
37818246|NCT04402060|69497434|FG002|Overall Study|Physician Decision|1|||
37818247|NCT04402060|69497432|FG000|Overall Study|Other|0|||
37818248|NCT04402060|69497433|FG001|Overall Study|Other|1|||
37818249|NCT04402060|69497434|FG002|Overall Study|Other|0|||
37876709|NCT01097616|69561032|FG001|DB RO Phase|Withdrawal by Subject|0|||
37876710|NCT01097616|69561033|FG002|DB RO Phase|Withdrawal by Subject|0|||
37876711|NCT01097616|69561034|FG003|DB RO Phase|Withdrawal by Subject|0|||
37876712|NCT01097616|69561035|FG004|DB RO Phase|Withdrawal by Subject|0|||
37876713|NCT01097616|69561036|FG005|DB RO Phase|Withdrawal by Subject|1|||
37876714|NCT01097616|69561037|FG006|DB RO Phase|Withdrawal by Subject|0|||
37876715|NCT01097616|69561038|FG007|DB RO Phase|Withdrawal by Subject|0|||
37876716|NCT01097616|69561031|FG000|DB RO Phase|Lost to Follow-up|0|||
37876717|NCT01097616|69561032|FG001|DB RO Phase|Lost to Follow-up|0|||
37876718|NCT01097616|69561033|FG002|DB RO Phase|Lost to Follow-up|0|||
37876719|NCT01097616|69561034|FG003|DB RO Phase|Lost to Follow-up|1|||
37876720|NCT01097616|69561035|FG004|DB RO Phase|Lost to Follow-up|1|||
37876721|NCT01097616|69561036|FG005|DB RO Phase|Lost to Follow-up|0|||
37876722|NCT01097616|69561037|FG006|DB RO Phase|Lost to Follow-up|0|||
37876723|NCT01097616|69561038|FG007|DB RO Phase|Lost to Follow-up|1|||
37876724|NCT01097616|69561031|FG000|DB RO Phase|Not Treated in RO|0|||
37876725|NCT01097616|69561032|FG001|DB RO Phase|Not Treated in RO|0|||
37876726|NCT01097616|69561033|FG002|DB RO Phase|Not Treated in RO|0|||
37876727|NCT01097616|69561034|FG003|DB RO Phase|Not Treated in RO|0|||
37876728|NCT01097616|69561035|FG004|DB RO Phase|Not Treated in RO|0|||
37876729|NCT01097616|69561036|FG005|DB RO Phase|Not Treated in RO|1|||
37876730|NCT01097616|69561037|FG006|DB RO Phase|Not Treated in RO|0|||
37876731|NCT01097616|69561038|FG007|DB RO Phase|Not Treated in RO|0|||
37876732|NCT00871429|69561064|FG000|Overall Study|Lost to Follow-up|6|||
37876733|NCT00871429|69561064|FG000|Overall Study|Withdrawal by Subject|17|||
37876734|NCT00871429|69561064|FG000|Overall Study|Questionnaire not completed|1|||
37876735|NCT01151345|69561072|FG000|First Intervention Period|Protocol Violation|0|||
37876736|NCT01151345|69561073|FG001|First Intervention Period|Protocol Violation|1|||
37876737|NCT00593827|69561081|FG000|Overall Study|On Active Treatment/Pending|0|||
37983079|NCT00409578|69669380|FG003|Overall Study|Death|2|||
37983080|NCT00409578|69669377|FG000|Overall Study|Protocol Violation|3|||
37983081|NCT00409578|69669378|FG001|Overall Study|Protocol Violation|2|||
37983082|NCT00409578|69669379|FG002|Overall Study|Protocol Violation|3|||
37983083|NCT00409578|69669380|FG003|Overall Study|Protocol Violation|1|||
37983084|NCT00409578|69669377|FG000|Overall Study|Missing|0|||
37983085|NCT00409578|69669378|FG001|Overall Study|Missing|1|||
37983086|NCT00409578|69669379|FG002|Overall Study|Missing|0|||
37983087|NCT00409578|69669380|FG003|Overall Study|Missing|1|||
37983088|NCT00428090|69669394|FG000|Overall Study|Adverse Event|10|||
37983089|NCT00428090|69669395|FG001|Overall Study|Adverse Event|8|||
37983090|NCT00428090|69669396|FG002|Overall Study|Adverse Event|10|||
37983091|NCT00428090|69669397|FG003|Overall Study|Adverse Event|11|||
37983092|NCT00428090|69669394|FG000|Overall Study|Lost to Follow-up|3|||
37983093|NCT00428090|69669395|FG001|Overall Study|Lost to Follow-up|6|||
37983094|NCT00428090|69669396|FG002|Overall Study|Lost to Follow-up|1|||
37983095|NCT00428090|69669397|FG003|Overall Study|Lost to Follow-up|4|||
37983096|NCT00428090|69669394|FG000|Overall Study|Protocol Violation|3|||
37983097|NCT00428090|69669395|FG001|Overall Study|Protocol Violation|1|||
37983098|NCT00428090|69669396|FG002|Overall Study|Protocol Violation|3|||
37983099|NCT00428090|69669397|FG003|Overall Study|Protocol Violation|3|||
37983100|NCT00428090|69669394|FG000|Overall Study|Withdrawal by Subject|10|||
37983101|NCT00428090|69669395|FG001|Overall Study|Withdrawal by Subject|12|||
37983102|NCT00428090|69669396|FG002|Overall Study|Withdrawal by Subject|15|||
37983103|NCT00428090|69669397|FG003|Overall Study|Withdrawal by Subject|5|||
37983104|NCT00428090|69669394|FG000|Overall Study|Sponsor terminated study|0|||
37983105|NCT00428090|69669395|FG001|Overall Study|Sponsor terminated study|1|||
37818250|NCT04376684|69497469|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
37818251|NCT04376684|69497470|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
37818252|NCT04376684|69497471|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
37818253|NCT04376684|69497472|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
37818254|NCT04376684|69497469|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
37818255|NCT04376684|69497470|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
37818256|NCT04376684|69497471|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
37983106|NCT00428090|69669396|FG002|Overall Study|Sponsor terminated study|0|||
37983107|NCT00428090|69669397|FG003|Overall Study|Sponsor terminated study|0|||
37818257|NCT04376684|69497472|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
37818258|NCT04376684|69497469|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
37818259|NCT04376684|69497470|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
37818260|NCT04376684|69497471|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
37818261|NCT04376684|69497472|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
37818262|NCT04376684|69497469|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
37876738|NCT00593827|69561082|FG001|Overall Study|On Active Treatment/Pending|2|||
37983108|NCT00428090|69669394|FG000|Overall Study|Non-compliance|4|||
37983109|NCT00428090|69669395|FG001|Overall Study|Non-compliance|0|||
37983110|NCT00428090|69669396|FG002|Overall Study|Non-compliance|1|||
37876739|NCT01150097|69561091|FG000|Months 24 to 36 Post-transplantation|Death|2|||
37876740|NCT01150097|69561092|FG001|Months 24 to 36 Post-transplantation|Death|0|||
37876741|NCT01150097|69561093|FG002|Months 24 to 36 Post-transplantation|Death|0|||
37876742|NCT01150097|69561091|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
37876743|NCT01150097|69561092|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
37876744|NCT01150097|69561093|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
37876745|NCT01150097|69561091|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
37983111|NCT00428090|69669397|FG003|Overall Study|Non-compliance|3|||
37983112|NCT00428090|69669394|FG000|Overall Study|Par. did not returned to visit|1|||
37983113|NCT00428090|69669395|FG001|Overall Study|Par. did not returned to visit|0|||
37983114|NCT00428090|69669396|FG002|Overall Study|Par. did not returned to visit|0|||
37983115|NCT00428090|69669397|FG003|Overall Study|Par. did not returned to visit|1|||
37983116|NCT00428090|69669394|FG000|Overall Study|Follow-Up visit not possible|1|||
37983117|NCT00428090|69669395|FG001|Overall Study|Follow-Up visit not possible|0|||
37983118|NCT00428090|69669396|FG002|Overall Study|Follow-Up visit not possible|0|||
37983119|NCT00428090|69669397|FG003|Overall Study|Follow-Up visit not possible|0|||
37983120|NCT00428090|69669394|FG000|Overall Study|Prohibited medication used for SAE|1|||
37983121|NCT00428090|69669395|FG001|Overall Study|Prohibited medication used for SAE|0|||
37983122|NCT00428090|69669396|FG002|Overall Study|Prohibited medication used for SAE|0|||
37876746|NCT01150097|69561092|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
37876747|NCT01150097|69561093|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
37876748|NCT01150097|69561091|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
37876749|NCT01150097|69561092|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
37876750|NCT01150097|69561093|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
37876751|NCT01150097|69561091|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
37876752|NCT01150097|69561092|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
37876753|NCT01150097|69561093|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
37876754|NCT01150097|69561091|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
37876755|NCT01150097|69561092|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
37876756|NCT01150097|69561093|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
37876757|NCT01150097|69561091|FG000|Months 24 to 48 Post-transplantation|Death|2|||
37876758|NCT01150097|69561092|FG001|Months 24 to 48 Post-transplantation|Death|0|||
37876759|NCT01150097|69561093|FG002|Months 24 to 48 Post-transplantation|Death|0|||
37876760|NCT01149863|69561103|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
37876761|NCT01149473|69561109|FG000|First Intervention|Adverse Event|1|||
37876762|NCT01149473|69561110|FG001|First Intervention|Adverse Event|1|||
37876763|NCT01149473|69561109|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
37876764|NCT01149473|69561110|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
37876765|NCT00872989|69561118|FG000|Overall Study|Adverse Event|7|||
37876766|NCT00872989|69561119|FG001|Overall Study|Adverse Event|15|||
37876767|NCT00872989|69561118|FG000|Overall Study|Withdrawal by Subject|8|||
37876768|NCT00872989|69561119|FG001|Overall Study|Withdrawal by Subject|5|||
37876769|NCT00872989|69561118|FG000|Overall Study|Progression/relapse|47|||
37876770|NCT00872989|69561119|FG001|Overall Study|Progression/relapse|35|||
37876771|NCT00872989|69561118|FG000|Overall Study|Not protocol specified|3|||
37876772|NCT00872989|69561119|FG001|Overall Study|Not protocol specified|8|||
37983123|NCT00428090|69669397|FG003|Overall Study|Prohibited medication used for SAE|0|||
37983124|NCT00428090|69669394|FG000|Overall Study|Death of par.|1|||
37983125|NCT00428090|69669395|FG001|Overall Study|Death of par.|0|||
37983126|NCT00428090|69669396|FG002|Overall Study|Death of par.|1|||
37983127|NCT00428090|69669397|FG003|Overall Study|Death of par.|0|||
37983128|NCT00428090|69669394|FG000|Overall Study|Visit 7 exceed the visit window|0|||
37983129|NCT00428090|69669395|FG001|Overall Study|Visit 7 exceed the visit window|1|||
37818263|NCT04376684|69497470|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
37818264|NCT04376684|69497471|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
37818265|NCT04376684|69497472|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
37818266|NCT04376684|69497469|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
37818267|NCT04376684|69497470|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
37818268|NCT04376684|69497471|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
37818269|NCT04376684|69497472|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
37818270|NCT04376684|69497469|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
37818271|NCT04376684|69497470|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
37818272|NCT04376684|69497471|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
37818273|NCT04376684|69497472|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
37818274|NCT04376684|69497469|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
37818275|NCT04376684|69497470|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
37818276|NCT04376684|69497471|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
37818277|NCT04376684|69497472|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
37818278|NCT04353284|69497484|FG000|Overall Study|Adverse Event|1|||
37818279|NCT04353284|69497485|FG001|Overall Study|Adverse Event|1|||
37818280|NCT04353284|69497484|FG000|Overall Study|Lost to Follow-up|1|||
37818281|NCT04353284|69497485|FG001|Overall Study|Lost to Follow-up|0|||
37876773|NCT01148771|69561133|FG000|Washout Period|Withdrawal by Subject|0|||
37876774|NCT01148771|69561134|FG001|Washout Period|Withdrawal by Subject|1|||
37876775|NCT01148693|69561146|FG000|Overall Study|Attempts for cannulation were failed|13|||
37876776|NCT01148693|69561147|FG001|Overall Study|Attempts for cannulation were failed|10|||
37876777|NCT00872599|69561153|FG000|Second Washout Period|Adverse Event|1|||
37876778|NCT00872599|69561154|FG001|Second Washout Period|Adverse Event|1|||
37876779|NCT01148537|69561163|FG000|Overall Study|Withdrawal by Subject|1|||
37876780|NCT01148537|69561164|FG001|Overall Study|Withdrawal by Subject|0|||
37876781|NCT01148537|69561165|FG002|Overall Study|Withdrawal by Subject|2|||
37876782|NCT01148537|69561163|FG000|Overall Study|Adverse Event|2|||
37876783|NCT01148537|69561164|FG001|Overall Study|Adverse Event|0|||
37876784|NCT01148537|69561165|FG002|Overall Study|Adverse Event|1|||
37876785|NCT01148459|69561176|FG000|Overall Study|Serious Adverse Event|5|||
37876786|NCT01148459|69561177|FG001|Overall Study|Serious Adverse Event|4|||
37876787|NCT01148459|69561176|FG000|Overall Study|Withdrawal by Subject|1|||
37876788|NCT01148459|69561177|FG001|Overall Study|Withdrawal by Subject|0|||
37876789|NCT01148459|69561176|FG000|Overall Study|Migrated/moved from study area|3|||
37876790|NCT01148459|69561177|FG001|Overall Study|Migrated/moved from study area|6|||
37876791|NCT01148459|69561176|FG000|Overall Study|Lost to Follow-up|2|||
37876792|NCT01148459|69561177|FG001|Overall Study|Lost to Follow-up|0|||
37876793|NCT01148459|69561176|FG000|Overall Study|Refusal|1|||
37876794|NCT01148459|69561177|FG001|Overall Study|Refusal|0|||
37876795|NCT01148459|69561176|FG000|Overall Study|Failure to comply with study procedures|0|||
37876796|NCT01148459|69561177|FG001|Overall Study|Failure to comply with study procedures|1|||
37876797|NCT00872521|69561186|FG000|Completed PAD Induction|Patient choice|0|||
37876798|NCT00872521|69561187|FG001|Completed PAD Induction|Patient choice|1|||
37876799|NCT00872521|69561188|FG002|Completed PAD Induction|Patient choice|0|||
37876800|NCT00872521|69561186|FG000|Completed PAD Induction|Disease progression|0|||
37876801|NCT00872521|69561187|FG001|Completed PAD Induction|Disease progression|2|||
37876802|NCT00872521|69561188|FG002|Completed PAD Induction|Disease progression|0|||
37818282|NCT04294147|69497493|FG000|Overall Study|Protocol Violation|2|||
37818283|NCT04294147|69497494|FG001|Overall Study|Protocol Violation|0|||
37818284|NCT04231825|69497506|FG000|Overall Study|Protocol Violation|3|||
37818285|NCT04231825|69497507|FG001|Overall Study|Protocol Violation|3|||
37818286|NCT04231825|69497506|FG000|Overall Study|Lost to Follow-up|0|||
37818287|NCT04231825|69497507|FG001|Overall Study|Lost to Follow-up|1|||
37818288|NCT04178772|69497513|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
37818289|NCT04178772|69497513|FG000|Overall Study|study terminated early due to COVID-19|7|||
37818290|NCT04148651|69497517|FG000|Overall Study|Lost to Follow-up|2|||
37818291|NCT03924427|69497530|FG000|Overall Study|Adverse Event|4|||
37818292|NCT03924427|69497530|FG000|Overall Study|Lack of Efficacy|1|||
37818293|NCT03924427|69497530|FG000|Overall Study|Withdrawal by Subject|1|||
37818294|NCT03642132|69497574|FG000|Chemotherapy Period|Adverse Event|1|||
37818295|NCT03642132|69497575|FG001|Chemotherapy Period|Adverse Event|1|||
37818296|NCT03642132|69497576|FG002|Chemotherapy Period|Adverse Event|0|||
37818297|NCT03642132|69497574|FG000|Chemotherapy Period|Physician's decision|4|||
37818298|NCT03642132|69497575|FG001|Chemotherapy Period|Physician's decision|1|||
37818299|NCT03642132|69497576|FG002|Chemotherapy Period|Physician's decision|0|||
37818300|NCT03642132|69497574|FG000|Chemotherapy Period|Progressive disease|0|||
37818301|NCT03642132|69497575|FG001|Chemotherapy Period|Progressive disease|0|||
37818302|NCT03642132|69497576|FG002|Chemotherapy Period|Progressive disease|1|||
37876803|NCT00872521|69561186|FG000|Completed PAD Induction|Adverse Event|4|||
37876804|NCT00872521|69561187|FG001|Completed PAD Induction|Adverse Event|0|||
37876805|NCT00872521|69561188|FG002|Completed PAD Induction|Adverse Event|0|||
37876806|NCT00872521|69561186|FG000|Completed PAD Induction|Death|1|||
37876807|NCT00872521|69561187|FG001|Completed PAD Induction|Death|1|||
37876808|NCT00872521|69561188|FG002|Completed PAD Induction|Death|0|||
37876809|NCT00872521|69561186|FG000|Primary Endpoint Analysis|Other|1|||
37876810|NCT00872521|69561187|FG001|Primary Endpoint Analysis|Other|2|||
37876811|NCT00872521|69561188|FG002|Primary Endpoint Analysis|Other|0|||
37876812|NCT00872521|69561186|FG000|Primary Endpoint Analysis|Patient choice|0|||
37876813|NCT00872521|69561187|FG001|Primary Endpoint Analysis|Patient choice|1|||
37876814|NCT00872521|69561188|FG002|Primary Endpoint Analysis|Patient choice|0|||
37876815|NCT00872521|69561186|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
37876816|NCT00872521|69561187|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
37876817|NCT00872521|69561188|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
37983130|NCT00428090|69669396|FG002|Overall Study|Visit 7 exceed the visit window|0|||
37695111|NCT01650194|69171619|FG000|Overall Study|Progressive Disease (PD)|35|||
37695112|NCT01650194|69171619|FG000|Overall Study|Withdrawal by Subject|2|||
37695113|NCT01650194|69171619|FG000|Overall Study|Miscellaneous|10|||
37695114|NCT02367716|69171624|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
37695115|NCT02366936|69171629|FG000|Overall Study|Withdrawal by Subject|2|||
37695116|NCT02366936|69171629|FG000|Overall Study|Lost to Follow-up|4|||
37876818|NCT00872521|69561186|FG000|Primary Endpoint Analysis|Patient response missing|0|||
37695117|NCT02366936|69171629|FG000|Overall Study|Physician Decision|2|||
37695118|NCT01648166|69171635|FG000|Overall Study|inadequate toenail samples|53|||
37695119|NCT01648166|69171636|FG001|Overall Study|inadequate toenail samples|100|||
37983131|NCT00428090|69669397|FG003|Overall Study|Visit 7 exceed the visit window|0|||
37983132|NCT00428090|69669394|FG000|Overall Study|Medical monitor terminated par.|0|||
37818303|NCT03642132|69497574|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
37818304|NCT03642132|69497575|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
37818305|NCT03642132|69497576|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
37818306|NCT03642132|69497574|FG000|Chemotherapy Period|Other|1|||
37818307|NCT03642132|69497575|FG001|Chemotherapy Period|Other|0|||
37818308|NCT03642132|69497576|FG002|Chemotherapy Period|Other|2|||
37818309|NCT03642132|69497574|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
37818310|NCT03642132|69497575|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
37983133|NCT00428090|69669395|FG001|Overall Study|Medical monitor terminated par.|1|||
37983134|NCT00428090|69669396|FG002|Overall Study|Medical monitor terminated par.|0|||
37983135|NCT00428090|69669397|FG003|Overall Study|Medical monitor terminated par.|0|||
37983136|NCT00428090|69669394|FG000|Overall Study|Mental status of par. was|0|||
37983137|NCT00428090|69669395|FG001|Overall Study|Mental status of par. was|1|||
37818311|NCT03642132|69497576|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
37818312|NCT03642132|69497574|FG000|Maintenance Period|Adverse Event|1|||
37818313|NCT03642132|69497575|FG001|Maintenance Period|Adverse Event|2|||
37818314|NCT03642132|69497576|FG002|Maintenance Period|Adverse Event|0|||
37818315|NCT03642132|69497574|FG000|Maintenance Period|Non-compliance with study drug|0|||
37818316|NCT03642132|69497575|FG001|Maintenance Period|Non-compliance with study drug|0|||
37818317|NCT03642132|69497576|FG002|Maintenance Period|Non-compliance with study drug|1|||
37818318|NCT03642132|69497574|FG000|Maintenance Period|Physician's decision|2|||
37876819|NCT00872521|69561187|FG001|Primary Endpoint Analysis|Patient response missing|0|||
37876820|NCT00872521|69561188|FG002|Primary Endpoint Analysis|Patient response missing|1|||
37876821|NCT00872521|69561186|FG000|Completed 3-month Follow up|Other|0|||
37818319|NCT03642132|69497575|FG001|Maintenance Period|Physician's decision|2|||
37818320|NCT03642132|69497576|FG002|Maintenance Period|Physician's decision|2|||
37818321|NCT03642132|69497574|FG000|Maintenance Period|Progressive disease|9|||
37818322|NCT03642132|69497575|FG001|Maintenance Period|Progressive disease|3|||
37818323|NCT03642132|69497576|FG002|Maintenance Period|Progressive disease|6|||
37818324|NCT03642132|69497574|FG000|Maintenance Period|Other|0|||
37818325|NCT03642132|69497575|FG001|Maintenance Period|Other|0|||
37818326|NCT03642132|69497576|FG002|Maintenance Period|Other|3|||
37818327|NCT03642132|69497574|FG000|Maintenance Period|Withdrawal by Subject|1|||
37818328|NCT03642132|69497575|FG001|Maintenance Period|Withdrawal by Subject|1|||
37818329|NCT03642132|69497576|FG002|Maintenance Period|Withdrawal by Subject|2|||
37818330|NCT03642132|69497574|FG000|Follow-up Period|Other|0|||
37818331|NCT03642132|69497575|FG001|Follow-up Period|Other|0|||
37818332|NCT03642132|69497576|FG002|Follow-up Period|Other|1|||
37818333|NCT03642132|69497574|FG000|Follow-up Period|Withdrawal by Subject|1|||
37818334|NCT03642132|69497575|FG001|Follow-up Period|Withdrawal by Subject|2|||
37818335|NCT03642132|69497576|FG002|Follow-up Period|Withdrawal by Subject|0|||
37818336|NCT03642132|69497574|FG000|Follow-up Period|Study terminated by sponsor|1|||
37818337|NCT03642132|69497575|FG001|Follow-up Period|Study terminated by sponsor|0|||
37818338|NCT03642132|69497576|FG002|Follow-up Period|Study terminated by sponsor|1|||
37818339|NCT03642132|69497574|FG000|Follow-up Period|Lack of Efficacy|1|||
37818340|NCT03642132|69497575|FG001|Follow-up Period|Lack of Efficacy|0|||
37818341|NCT03642132|69497576|FG002|Follow-up Period|Lack of Efficacy|0|||
37818342|NCT03642132|69497574|FG000|Follow-up Period|Death|1|||
37818343|NCT03642132|69497575|FG001|Follow-up Period|Death|0|||
37818344|NCT03642132|69497576|FG002|Follow-up Period|Death|2|||
37818345|NCT03642132|69497574|FG000|Follow-up Period|Adverse Event|1|||
37876822|NCT00872521|69561187|FG001|Completed 3-month Follow up|Other|2|||
37876823|NCT00872521|69561188|FG002|Completed 3-month Follow up|Other|0|||
37818346|NCT03642132|69497575|FG001|Follow-up Period|Adverse Event|0|||
37818347|NCT03642132|69497576|FG002|Follow-up Period|Adverse Event|0|||
37818348|NCT03008122|69497587|FG000|Overall Study|Physician Decision|3|||
37876824|NCT00872521|69561186|FG000|Completed 3-month Follow up|Physician Decision|0|||
37876825|NCT00872521|69561187|FG001|Completed 3-month Follow up|Physician Decision|1|||
37876826|NCT00872521|69561188|FG002|Completed 3-month Follow up|Physician Decision|0|||
37876827|NCT00872521|69561186|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
37876828|NCT00872521|69561187|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
37876829|NCT00872521|69561188|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
37876830|NCT01148225|69561207|FG000|Overall Study|Other|185|||
37876831|NCT01190891|69561216|FG000|Overall Study|Protocol Violation|1|||
37876832|NCT01190891|69561217|FG001|Overall Study|Protocol Violation|0|||
37876833|NCT01190891|69561216|FG000|Overall Study|Withdrawal by Subject|5|||
37876834|NCT01190891|69561217|FG001|Overall Study|Withdrawal by Subject|0|||
37876835|NCT00871975|69561223|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
37876836|NCT00871975|69561223|FG000|Overall Study|Catheters could not be inserted|1|||
37876837|NCT00871975|69561223|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
37876838|NCT00871975|69561223|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
37876839|NCT01190813|69561229|FG000|Overall Study|Lost to Follow-up|1|||
37876840|NCT01190813|69561230|FG001|Overall Study|Lost to Follow-up|2|||
37876841|NCT01190813|69561229|FG000|Overall Study|Withdrawal by Subject|2|||
37876842|NCT01190813|69561230|FG001|Overall Study|Withdrawal by Subject|1|||
37876843|NCT01190813|69561229|FG000|Overall Study|Refused study treatment after randomized|1|||
37876844|NCT01190813|69561230|FG001|Overall Study|Refused study treatment after randomized|0|||
37876845|NCT01190813|69561229|FG000|Overall Study|Adverse Event|0|||
37876846|NCT01190813|69561230|FG001|Overall Study|Adverse Event|1|||
37876847|NCT00870727|69561252|FG000|Overall Study|Lost to Follow-up|0|||
37876848|NCT00870727|69561253|FG001|Overall Study|Lost to Follow-up|1|||
37876849|NCT00870727|69561252|FG000|Overall Study|Lack of Efficacy|1|||
37876850|NCT00870727|69561253|FG001|Overall Study|Lack of Efficacy|3|||
37983138|NCT00428090|69669396|FG002|Overall Study|Mental status of par. was|0|||
37983139|NCT00428090|69669397|FG003|Overall Study|Mental status of par. was|0|||
37983140|NCT00428090|69669394|FG000|Overall Study|Worsening of AD|0|||
37876851|NCT00870727|69561252|FG000|Overall Study|Adverse Event|0|||
37876852|NCT00870727|69561253|FG001|Overall Study|Adverse Event|1|||
37876853|NCT01147055|69561259|FG000|First Intervention Period|Lost to Follow-up|1|||
37876854|NCT01147055|69561260|FG001|First Intervention Period|Lost to Follow-up|0|||
37876855|NCT01146665|69561268|FG000|Overall Study|Withdrawal by Subject|10|||
37876856|NCT01146665|69561269|FG001|Overall Study|Withdrawal by Subject|16|||
37876857|NCT01145885|69561284|FG000|Overall Study|Progressive Disease|7|||
37876858|NCT01190267|69561296|FG000|Overall Study|Adverse Event|10|||
37876859|NCT01190267|69561297|FG001|Overall Study|Adverse Event|0|||
37876860|NCT01190267|69561296|FG000|Overall Study|Treatment Failure|8|||
37983141|NCT00428090|69669395|FG001|Overall Study|Worsening of AD|0|||
37983142|NCT00428090|69669396|FG002|Overall Study|Worsening of AD|1|||
37983143|NCT00428090|69669397|FG003|Overall Study|Worsening of AD|0|||
37983144|NCT00428090|69669394|FG000|Overall Study|Excluded for concerning QTc value|0|||
37983145|NCT00428090|69669395|FG001|Overall Study|Excluded for concerning QTc value|0|||
37983146|NCT00428090|69669396|FG002|Overall Study|Excluded for concerning QTc value|1|||
37983147|NCT00428090|69669397|FG003|Overall Study|Excluded for concerning QTc value|0|||
37818349|NCT03008122|69497588|FG001|Overall Study|Physician Decision|2|||
37818350|NCT03008122|69497589|FG002|Overall Study|Physician Decision|0|||
37818351|NCT03008122|69497587|FG000|Overall Study|Withdrawal by Subject|1|||
37818352|NCT03008122|69497588|FG001|Overall Study|Withdrawal by Subject|3|||
37818353|NCT03008122|69497589|FG002|Overall Study|Withdrawal by Subject|0|||
37818354|NCT03008122|69497587|FG000|Overall Study|Lost to Follow-up|4|||
37818355|NCT03008122|69497588|FG001|Overall Study|Lost to Follow-up|8|||
37818356|NCT03008122|69497589|FG002|Overall Study|Lost to Follow-up|3|||
37818357|NCT03008122|69497587|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
37818358|NCT03008122|69497588|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
37818359|NCT03008122|69497589|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
37818360|NCT03008122|69497587|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
37818361|NCT03008122|69497588|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
37818362|NCT03008122|69497589|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
37818363|NCT03008122|69497587|FG000|Overall Study|Death|0|||
37818364|NCT03008122|69497588|FG001|Overall Study|Death|0|||
37818365|NCT03008122|69497589|FG002|Overall Study|Death|1|||
37833580|NCT01263028|69517308|FG000|Overall Study|Study terminated due to low enrollment.|4|||
37876861|NCT01190267|69561297|FG001|Overall Study|Treatment Failure|2|||
37876862|NCT01190267|69561296|FG000|Overall Study|Lost to Follow-up|2|||
37876863|NCT01190267|69561297|FG001|Overall Study|Lost to Follow-up|0|||
37876864|NCT01190267|69561296|FG000|Overall Study|Withdrawal by Subject|13|||
37876865|NCT01190267|69561297|FG001|Overall Study|Withdrawal by Subject|1|||
37876866|NCT01190267|69561296|FG000|Overall Study|Protocol Violation|8|||
37876867|NCT01190267|69561297|FG001|Overall Study|Protocol Violation|1|||
37876868|NCT00869089|69561303|FG000|Overall Study|Lost to Follow-up|1|||
37876869|NCT00869089|69561303|FG000|Overall Study|Withdrawal by Subject|1|||
37876870|NCT00869089|69561303|FG000|Overall Study|Screen Fail|1|||
37876871|NCT01190189|69561307|FG000|Overall Study|Lost to Follow-up|4|||
37876872|NCT01190189|69561307|FG000|Overall Study|Withdrawal by Subject|1|||
37876873|NCT01190189|69561307|FG000|Overall Study|Migrated/moved from study area|1|||
37876874|NCT00871117|69561313|FG000|Overall Study|Lost to Follow-up|5|||
37876875|NCT00871117|69561314|FG001|Overall Study|Lost to Follow-up|6|||
37876876|NCT00871117|69561313|FG000|Overall Study|Other|0|||
37876877|NCT00871117|69561314|FG001|Overall Study|Other|4|||
37876878|NCT00870103|69561321|FG000|Overall Study|Physician Decision|2|||
37876879|NCT00870103|69561321|FG000|Overall Study|Lost to Follow-up|2|||
37876880|NCT01145417|69561340|FG000|Overall Study|Death|1|||
37876881|NCT01145417|69561341|FG001|Overall Study|Death|0|||
37876882|NCT01145417|69561340|FG000|Overall Study|Lost to Follow-up|2|||
37876883|NCT01145417|69561341|FG001|Overall Study|Lost to Follow-up|1|||
37876884|NCT01145417|69561340|FG000|Overall Study|Withdrawal by Subject|1|||
37876885|NCT01145417|69561341|FG001|Overall Study|Withdrawal by Subject|2|||
37876886|NCT01145417|69561340|FG000|Overall Study|Pregnancy|1|||
37876887|NCT01145417|69561341|FG001|Overall Study|Pregnancy|0|||
37876888|NCT01145417|69561340|FG000|Overall Study|Adverse Event|0|||
37876889|NCT01145417|69561341|FG001|Overall Study|Adverse Event|1|||
37876890|NCT01145417|69561340|FG000|Overall Study|Study terminated by sponsor|35|||
37876891|NCT01145417|69561341|FG001|Overall Study|Study terminated by sponsor|43|||
37876892|NCT01145417|69561340|FG000|Overall Study|Other|1|||
37876893|NCT01145417|69561341|FG001|Overall Study|Other|0|||
37876894|NCT01144715|69561349|FG000|Overall Study|Lost to Follow-up|2|||
37876895|NCT01144715|69561350|FG001|Overall Study|Lost to Follow-up|1|||
37876896|NCT01144715|69561349|FG000|Overall Study|Withdrawal by Subject|2|||
37876897|NCT01144715|69561350|FG001|Overall Study|Withdrawal by Subject|1|||
37876898|NCT01144715|69561349|FG000|Overall Study|Adverse Event|0|||
37876899|NCT01144715|69561350|FG001|Overall Study|Adverse Event|1|||
37876900|NCT01189487|69561356|FG000|Overall Study|Lack of Efficacy|2|||
37876901|NCT01189487|69561356|FG000|Overall Study|Adverse Event|1|||
37876902|NCT01106352|69561365|FG000|Overall Study|Subjects untreated|0|||
37876903|NCT01106352|69561366|FG001|Overall Study|Subjects untreated|0|||
37876904|NCT01106352|69561367|FG002|Overall Study|Subjects untreated|0|||
37876905|NCT01106352|69561368|FG003|Overall Study|Subjects untreated|3|||
37876906|NCT01106352|69561369|FG004|Overall Study|Subjects untreated|4|||
37876907|NCT01106352|69561365|FG000|Overall Study|Sponsor Decision|1|||
37876908|NCT01106352|69561366|FG001|Overall Study|Sponsor Decision|0|||
37876909|NCT01106352|69561367|FG002|Overall Study|Sponsor Decision|0|||
37876910|NCT01106352|69561368|FG003|Overall Study|Sponsor Decision|0|||
37876911|NCT01106352|69561369|FG004|Overall Study|Sponsor Decision|0|||
37876912|NCT01106352|69561365|FG000|Overall Study|Too ill to come in for the visit|0|||
37876913|NCT01106352|69561366|FG001|Overall Study|Too ill to come in for the visit|0|||
37876914|NCT01106352|69561367|FG002|Overall Study|Too ill to come in for the visit|1|||
37876915|NCT01106352|69561368|FG003|Overall Study|Too ill to come in for the visit|0|||
37876916|NCT01106352|69561369|FG004|Overall Study|Too ill to come in for the visit|0|||
37876917|NCT01106352|69561365|FG000|Overall Study|Lost to Follow-up|0|||
37876918|NCT01106352|69561366|FG001|Overall Study|Lost to Follow-up|0|||
37876919|NCT01106352|69561367|FG002|Overall Study|Lost to Follow-up|0|||
37876920|NCT01106352|69561368|FG003|Overall Study|Lost to Follow-up|0|||
37876921|NCT01106352|69561369|FG004|Overall Study|Lost to Follow-up|1|||
37876922|NCT01106352|69561365|FG000|Overall Study|Death|0|||
37876923|NCT01106352|69561366|FG001|Overall Study|Death|0|||
37876924|NCT01106352|69561367|FG002|Overall Study|Death|1|||
37876925|NCT01106352|69561368|FG003|Overall Study|Death|3|||
37876926|NCT01106352|69561369|FG004|Overall Study|Death|1|||
37876927|NCT01106352|69561365|FG000|Overall Study|Disease progression|0|||
37876928|NCT01106352|69561366|FG001|Overall Study|Disease progression|0|||
37876929|NCT01106352|69561367|FG002|Overall Study|Disease progression|0|||
37876930|NCT01106352|69561368|FG003|Overall Study|Disease progression|1|||
37876931|NCT01106352|69561369|FG004|Overall Study|Disease progression|0|||
37876932|NCT01106352|69561365|FG000|Overall Study|Withdrawal by Subject|0|||
37876933|NCT01106352|69561366|FG001|Overall Study|Withdrawal by Subject|0|||
37876934|NCT01106352|69561367|FG002|Overall Study|Withdrawal by Subject|0|||
37876935|NCT01106352|69561368|FG003|Overall Study|Withdrawal by Subject|3|||
37876936|NCT01106352|69561369|FG004|Overall Study|Withdrawal by Subject|2|||
37876937|NCT01106352|69561365|FG000|Overall Study|Went on hospice|0|||
37876938|NCT01106352|69561366|FG001|Overall Study|Went on hospice|0|||
37876939|NCT01106352|69561367|FG002|Overall Study|Went on hospice|0|||
37876940|NCT01106352|69561368|FG003|Overall Study|Went on hospice|1|||
37876941|NCT01106352|69561369|FG004|Overall Study|Went on hospice|0|||
37876942|NCT01106352|69561365|FG000|Overall Study|Subject entered hospice|0|||
37876943|NCT01106352|69561366|FG001|Overall Study|Subject entered hospice|0|||
37876944|NCT01106352|69561367|FG002|Overall Study|Subject entered hospice|0|||
37876945|NCT01106352|69561368|FG003|Overall Study|Subject entered hospice|1|||
37876946|NCT01106352|69561369|FG004|Overall Study|Subject entered hospice|0|||
37876947|NCT01106352|69561365|FG000|Overall Study|Home hospice since July 2013|0|||
37876948|NCT01106352|69561366|FG001|Overall Study|Home hospice since July 2013|0|||
37876949|NCT01106352|69561367|FG002|Overall Study|Home hospice since July 2013|0|||
37876950|NCT01106352|69561368|FG003|Overall Study|Home hospice since July 2013|1|||
37876951|NCT01106352|69561369|FG004|Overall Study|Home hospice since July 2013|0|||
37876952|NCT01144403|69561385|FG000|Overall Study|Lost to Follow-up|3|||
37876953|NCT01144403|69561385|FG000|Overall Study|Death|1|||
37983148|NCT00428090|69669394|FG000|Overall Study|Insufficient AD documentation|0|||
37983149|NCT00428090|69669395|FG001|Overall Study|Insufficient AD documentation|0|||
37983150|NCT00428090|69669396|FG002|Overall Study|Insufficient AD documentation|1|||
37983151|NCT00428090|69669397|FG003|Overall Study|Insufficient AD documentation|0|||
37876954|NCT01144403|69561385|FG000|Overall Study|Adverse Event|1|||
37876955|NCT01143389|69561392|FG000|Overall Study|Lost to Follow-up|26|||
37876956|NCT01143389|69561393|FG001|Overall Study|Lost to Follow-up|25|||
37876957|NCT00868231|69561399|FG000|Treatment Period 1|Adverse Event|0|||
37876958|NCT00868231|69561400|FG001|Treatment Period 1|Adverse Event|0|||
37876959|NCT00868231|69561401|FG002|Treatment Period 1|Adverse Event|0|||
37983152|NCT00428090|69669394|FG000|Overall Study|High MMSE scores|0|||
37983153|NCT00428090|69669395|FG001|Overall Study|High MMSE scores|0|||
37983154|NCT00428090|69669396|FG002|Overall Study|High MMSE scores|1|||
37983155|NCT00428090|69669397|FG003|Overall Study|High MMSE scores|0|||
37983156|NCT00428090|69669394|FG000|Overall Study|Deterioration of cognitive status|0|||
37876960|NCT00868231|69561402|FG003|Treatment Period 1|Adverse Event|0|||
37876961|NCT00868231|69561403|FG004|Treatment Period 1|Adverse Event|1|||
37876962|NCT00868231|69561404|FG005|Treatment Period 1|Adverse Event|0|||
37876963|NCT00868231|69561399|FG000|Treatment Period 2|Adverse Event|1|||
37876964|NCT00868231|69561400|FG001|Treatment Period 2|Adverse Event|0|||
37876965|NCT00868231|69561401|FG002|Treatment Period 2|Adverse Event|0|||
37876966|NCT00868231|69561402|FG003|Treatment Period 2|Adverse Event|0|||
37876967|NCT00868231|69561403|FG004|Treatment Period 2|Adverse Event|0|||
37876968|NCT00868231|69561404|FG005|Treatment Period 2|Adverse Event|0|||
37876969|NCT00868231|69561399|FG000|Treatment Period 3|Adverse Event|0|||
37876970|NCT00868231|69561400|FG001|Treatment Period 3|Adverse Event|0|||
37876971|NCT00868231|69561401|FG002|Treatment Period 3|Adverse Event|1|||
37876972|NCT00868231|69561402|FG003|Treatment Period 3|Adverse Event|0|||
37876973|NCT00868231|69561403|FG004|Treatment Period 3|Adverse Event|0|||
37876974|NCT00868231|69561404|FG005|Treatment Period 3|Adverse Event|0|||
37876975|NCT01143077|69561415|FG000|Overall Study|Lack of Efficacy|0|||
37876976|NCT01143077|69561416|FG001|Overall Study|Lack of Efficacy|2|||
37876977|NCT01143077|69561417|FG002|Overall Study|Lack of Efficacy|1|||
37876978|NCT01143077|69561415|FG000|Overall Study|Adverse Event|5|||
37876979|NCT01143077|69561416|FG001|Overall Study|Adverse Event|6|||
37876980|NCT01143077|69561417|FG002|Overall Study|Adverse Event|5|||
37876981|NCT01143077|69561415|FG000|Overall Study|Lost to Follow-up|2|||
37876982|NCT01143077|69561416|FG001|Overall Study|Lost to Follow-up|3|||
37876983|NCT01143077|69561417|FG002|Overall Study|Lost to Follow-up|4|||
37876984|NCT01143077|69561415|FG000|Overall Study|Protocol Violation|2|||
37876985|NCT01143077|69561416|FG001|Overall Study|Protocol Violation|0|||
37876986|NCT01143077|69561417|FG002|Overall Study|Protocol Violation|0|||
37876987|NCT01143077|69561415|FG000|Overall Study|Withdrawal by Subject|4|||
37876988|NCT01143077|69561416|FG001|Overall Study|Withdrawal by Subject|3|||
37876989|NCT01143077|69561417|FG002|Overall Study|Withdrawal by Subject|3|||
37876990|NCT01143077|69561415|FG000|Overall Study|Non-compliance with study drug|0|||
37876991|NCT01143077|69561416|FG001|Overall Study|Non-compliance with study drug|1|||
37876992|NCT01143077|69561417|FG002|Overall Study|Non-compliance with study drug|1|||
37876993|NCT01143077|69561415|FG000|Overall Study|Administrative|1|||
37876994|NCT01143077|69561416|FG001|Overall Study|Administrative|0|||
37876995|NCT01143077|69561417|FG002|Overall Study|Administrative|0|||
37876996|NCT01143077|69561415|FG000|Overall Study|Principal Investigator Decision|2|||
37876997|NCT01143077|69561416|FG001|Overall Study|Principal Investigator Decision|0|||
37876998|NCT01143077|69561417|FG002|Overall Study|Principal Investigator Decision|1|||
37983157|NCT00428090|69669395|FG001|Overall Study|Deterioration of cognitive status|0|||
37983158|NCT00428090|69669396|FG002|Overall Study|Deterioration of cognitive status|1|||
37876999|NCT01096446|69561427|FG000|Overall Study|Death|1|||
37877000|NCT01096446|69561428|FG001|Overall Study|Death|0|||
37877001|NCT01096446|69561427|FG000|Overall Study|Protocol Violation|2|||
37877002|NCT01096446|69561428|FG001|Overall Study|Protocol Violation|0|||
37877003|NCT00864721|69561433|FG000|Overall Study|Patient request|11|||
37877004|NCT00864721|69561433|FG000|Overall Study|Hospitalized|1|||
37877005|NCT00864721|69561433|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
37877006|NCT00864721|69561433|FG000|Overall Study|Adverse Event|21|||
37877007|NCT01095666|69561440|FG000|Overall Study|Lack of Efficacy|0|||
37877008|NCT01095666|69561441|FG001|Overall Study|Lack of Efficacy|0|||
37877009|NCT01095666|69561442|FG002|Overall Study|Lack of Efficacy|1|||
37877010|NCT01095666|69561440|FG000|Overall Study|Adverse Event|2|||
37877011|NCT01095666|69561441|FG001|Overall Study|Adverse Event|1|||
37877012|NCT01095666|69561442|FG002|Overall Study|Adverse Event|3|||
37877013|NCT01095666|69561440|FG000|Overall Study|Lost to Follow-up|2|||
37695120|NCT02404220|69171646|FG000|Overall Study|Adverse Event|0|||
37695121|NCT02404220|69171647|FG001|Overall Study|Adverse Event|0|||
37695122|NCT02404220|69171648|FG002|Overall Study|Adverse Event|1|||
37877014|NCT01095666|69561441|FG001|Overall Study|Lost to Follow-up|2|||
37877015|NCT01095666|69561442|FG002|Overall Study|Lost to Follow-up|0|||
37877016|NCT01095666|69561440|FG000|Overall Study|Withdrawal by Subject|6|||
37877017|NCT01095666|69561441|FG001|Overall Study|Withdrawal by Subject|6|||
37877018|NCT01095666|69561442|FG002|Overall Study|Withdrawal by Subject|1|||
37877019|NCT01095666|69561440|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
37877020|NCT01095666|69561441|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
37877021|NCT01095666|69561442|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
37877022|NCT01100658|69561450|FG000|Overall Study|Withdrawal by Subject|1|||
37877023|NCT01100502|69561456|FG000|Overall Study|Withdrawal by Subject|18|||
37877024|NCT01100502|69561457|FG001|Overall Study|Withdrawal by Subject|25|||
37877025|NCT01100502|69561456|FG000|Overall Study|Lost to Follow-up|13|||
37877026|NCT01100502|69561457|FG001|Overall Study|Lost to Follow-up|28|||
37877027|NCT01100502|69561456|FG000|Overall Study|Site request to end participation in study|0|||
37877028|NCT01100502|69561457|FG001|Overall Study|Site request to end participation in study|1|||
37877029|NCT01100502|69561456|FG000|Overall Study|Death|45|||
37877030|NCT01100502|69561457|FG001|Overall Study|Death|40|||
37877031|NCT01094886|69561463|FG000|Overall Study|Adverse Event|2|||
37877032|NCT01094886|69561463|FG000|Overall Study|Withdrawal by Subject|5|||
37877033|NCT01094808|69561470|FG000|Overall Study|Withdrawal by Subject|1|||
37877034|NCT01094808|69561471|FG001|Overall Study|Withdrawal by Subject|1|||
37877035|NCT01094808|69561472|FG002|Overall Study|Withdrawal by Subject|0|||
37877036|NCT00864253|69561482|FG000|Overall Study|Adverse Event|56|||
37877037|NCT00864253|69561483|FG001|Overall Study|Adverse Event|11|||
37877038|NCT00864253|69561482|FG000|Overall Study|Unrelated Adverse Event|3|||
37877039|NCT00864253|69561483|FG001|Overall Study|Unrelated Adverse Event|1|||
37877040|NCT00864253|69561482|FG000|Overall Study|Physician Decision|11|||
37877041|NCT00864253|69561483|FG001|Overall Study|Physician Decision|15|||
37983159|NCT00428090|69669397|FG003|Overall Study|Deterioration of cognitive status|0|||
37983160|NCT00428090|69669394|FG000|Overall Study|Serious adverse event|0|||
37983161|NCT00428090|69669395|FG001|Overall Study|Serious adverse event|0|||
37983162|NCT00428090|69669396|FG002|Overall Study|Serious adverse event|1|||
37983163|NCT00428090|69669397|FG003|Overall Study|Serious adverse event|0|||
37983164|NCT00428090|69669394|FG000|Overall Study|Excluded for heart insufficiency|0|||
37983165|NCT00428090|69669395|FG001|Overall Study|Excluded for heart insufficiency|0|||
37983166|NCT00428090|69669396|FG002|Overall Study|Excluded for heart insufficiency|1|||
37983167|NCT00428090|69669397|FG003|Overall Study|Excluded for heart insufficiency|0|||
37983168|NCT00428090|69669394|FG000|Overall Study|Raised Creatinine Value|0|||
37983169|NCT00428090|69669395|FG001|Overall Study|Raised Creatinine Value|0|||
37983170|NCT00428090|69669396|FG002|Overall Study|Raised Creatinine Value|0|||
37983171|NCT00428090|69669397|FG003|Overall Study|Raised Creatinine Value|1|||
37983172|NCT00416312|69669415|FG000|Overall Study|tumors not visible on imaging|2|||
37983173|NCT00436436|69669419|FG000|Overall Study|Progression|4|||
37983174|NCT00436436|69669419|FG000|Overall Study|Adverse Event|2|||
37877042|NCT00864253|69561482|FG000|Overall Study|Protocol Violation|0|||
37877043|NCT00864253|69561483|FG001|Overall Study|Protocol Violation|2|||
37877044|NCT00864253|69561482|FG000|Overall Study|Lost to Follow-up|1|||
37983175|NCT00436436|69669419|FG000|Overall Study|Death|6|||
37983176|NCT00262522|69669427|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
37983177|NCT00262522|69669428|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
37983178|NCT00262522|69669429|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
37983179|NCT00262522|69669430|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
37983180|NCT00262522|69669427|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
37983181|NCT00262522|69669428|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
37983182|NCT00262522|69669429|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
37983183|NCT00262522|69669430|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
37695123|NCT02404220|69171649|FG003|Overall Study|Adverse Event|0|||
37695124|NCT02404220|69171646|FG000|Overall Study|Death|5|||
37695125|NCT02404220|69171647|FG001|Overall Study|Death|5|||
37695126|NCT02404220|69171648|FG002|Overall Study|Death|3|||
37695127|NCT02404220|69171649|FG003|Overall Study|Death|8|||
37695128|NCT02404220|69171646|FG000|Overall Study|Progressive Disease|0|||
37877045|NCT00864253|69561483|FG001|Overall Study|Lost to Follow-up|1|||
37877046|NCT00864253|69561482|FG000|Overall Study|Withdrawal by Subject|18|||
37877047|NCT00864253|69561483|FG001|Overall Study|Withdrawal by Subject|18|||
37877048|NCT00864253|69561482|FG000|Overall Study|Death|1|||
37877049|NCT00864253|69561483|FG001|Overall Study|Death|0|||
37877050|NCT00864253|69561482|FG000|Overall Study|Ongoing|2|||
37877051|NCT00864253|69561483|FG001|Overall Study|Ongoing|3|||
37877052|NCT00864253|69561482|FG000|Overall Study|Untreated|7|||
37877053|NCT00864253|69561483|FG001|Overall Study|Untreated|7|||
37983184|NCT00262522|69669427|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
37983185|NCT00262522|69669428|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
37983186|NCT00262522|69669429|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
37983187|NCT00262522|69669430|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
37983188|NCT00262522|69669427|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
37983189|NCT00262522|69669428|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
37983190|NCT00262522|69669429|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
37983191|NCT00262522|69669430|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
37983192|NCT00262522|69669427|FG000|Study Start Through 8 Weeks|Death|1|||
37983193|NCT00262522|69669428|FG001|Study Start Through 8 Weeks|Death|0|||
37983194|NCT00262522|69669429|FG002|Study Start Through 8 Weeks|Death|0|||
37983195|NCT00262522|69669430|FG003|Study Start Through 8 Weeks|Death|0|||
37983196|NCT00262522|69669427|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
37983197|NCT00262522|69669428|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
37983198|NCT00262522|69669429|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
37983199|NCT00262522|69669430|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
37983200|NCT00262522|69669427|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
37983201|NCT00262522|69669428|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
37983202|NCT00262522|69669429|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
37983203|NCT00262522|69669430|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
37983204|NCT00262522|69669427|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
37983205|NCT00262522|69669428|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
37983206|NCT00262522|69669429|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
37983207|NCT00262522|69669430|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
37877054|NCT01094730|69561491|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
37877055|NCT01094730|69561492|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
37877056|NCT01094730|69561491|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
37877057|NCT01094730|69561492|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
37877058|NCT01094730|69561491|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
37877059|NCT01094730|69561492|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
37818366|NCT01817751|69497631|FG000|Overall Study|Physician Decision|1|||
37818367|NCT01349322|69497647|FG000|Overall Study|Protocol Violation|45|||
37818368|NCT01349322|69497648|FG001|Overall Study|Protocol Violation|47|||
37818369|NCT01182415|69497660|FG000|Overall Study|Lost to Follow-up|1|||
37818370|NCT01030523|69497666|FG000|Initial Study (5 Years)|Death|1|||
37818371|NCT01030523|69497667|FG001|Initial Study (5 Years)|Death|0|||
37818372|NCT01030523|69497666|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
37877060|NCT01094730|69561491|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
37877061|NCT01094730|69561492|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
37983208|NCT00262522|69669427|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
37983209|NCT00262522|69669428|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
37983210|NCT00262522|69669429|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
37983211|NCT00262522|69669430|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
37983212|NCT00262522|69669427|FG000|Study Start Through 48 Weeks|Death|2|||
37983213|NCT00262522|69669428|FG001|Study Start Through 48 Weeks|Death|0|||
37983214|NCT00262522|69669429|FG002|Study Start Through 48 Weeks|Death|1|||
37983215|NCT00262522|69669430|FG003|Study Start Through 48 Weeks|Death|0|||
37983216|NCT00262522|69669427|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
37983217|NCT00262522|69669428|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
37983218|NCT00262522|69669429|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
37983219|NCT00262522|69669430|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
37983220|NCT00262522|69669427|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
37818373|NCT01030523|69497667|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
37818374|NCT01030523|69497666|FG000|Initial Study (5 Years)|Implant failure|1|||
37818375|NCT01030523|69497667|FG001|Initial Study (5 Years)|Implant failure|0|||
37877062|NCT01094730|69561491|FG000|Period 2 (14 Days)|Protocol Violation|2|||
37877063|NCT01094730|69561492|FG001|Period 2 (14 Days)|Protocol Violation|0|||
37983221|NCT00262522|69669428|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
37983222|NCT00262522|69669429|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
37983223|NCT00262522|69669430|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
37983224|NCT00262522|69669427|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
37983225|NCT00262522|69669428|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
37983226|NCT00262522|69669429|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
37983227|NCT00262522|69669430|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
37983228|NCT00262522|69669427|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
37983229|NCT00262522|69669428|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
37877064|NCT01094730|69561491|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
37818376|NCT01030523|69497666|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
37818377|NCT01030523|69497667|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
37877065|NCT01094730|69561492|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
37877066|NCT01094730|69561491|FG000|Period 2 (14 Days)|Adverse Event|0|||
37983230|NCT00262522|69669429|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
37983231|NCT00262522|69669430|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
37983232|NCT00262522|69669427|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
37983233|NCT00262522|69669428|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
37983234|NCT00262522|69669429|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
37983235|NCT00262522|69669430|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
37983236|NCT00262522|69669427|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
37983237|NCT00262522|69669428|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
37983238|NCT00262522|69669429|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
37983239|NCT00262522|69669430|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
37983240|NCT00262522|69669427|FG000|Study Start Through 96 Weeks|Death|2|||
37983241|NCT00262522|69669428|FG001|Study Start Through 96 Weeks|Death|0|||
37983242|NCT00262522|69669429|FG002|Study Start Through 96 Weeks|Death|2|||
37983243|NCT00262522|69669430|FG003|Study Start Through 96 Weeks|Death|0|||
37983244|NCT00262522|69669427|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
37983245|NCT00262522|69669428|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
37983246|NCT00262522|69669429|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
37983247|NCT00262522|69669430|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
37983248|NCT00262522|69669427|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
37983249|NCT00262522|69669428|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
37983250|NCT00262522|69669429|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
37983251|NCT00262522|69669430|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
37983252|NCT00436280|69669438|FG000|Period 1: Induction|Adverse Event|8|||
37983253|NCT00436280|69669438|FG000|Period 1: Induction|Progressive Disease|12|||
37983254|NCT00436280|69669438|FG000|Period 1: Induction|Stable Disease|6|||
37983255|NCT00436280|69669438|FG000|Period 1: Induction|Withdrawal by Subject|1|||
37983256|NCT00436280|69669438|FG000|Period 1: Induction|Death|1|||
37983257|NCT00436280|69669438|FG000|Period 2: Consolidation|Adverse Event|1|||
37983258|NCT00436280|69669438|FG000|Period 2: Consolidation|Progressive Disease|10|||
37983259|NCT00436280|69669438|FG000|Period 2: Consolidation|Stable Disease|1|||
37983260|NCT00436280|69669438|FG000|Period 2: Consolidation|Physician Decision|2|||
37983261|NCT00436280|69669438|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
37983262|NCT00436280|69669438|FG000|Period 2: Consolidation|Death|1|||
37983263|NCT00436280|69669438|FG000|Period 3: Maintenance|Adverse Event|6|||
37983264|NCT00436280|69669438|FG000|Period 3: Maintenance|Progressive Disease|12|||
37983265|NCT00394836|69669444|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
37983266|NCT00394836|69669445|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
37983267|NCT00394836|69669444|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
37983268|NCT00394836|69669445|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
37983269|NCT00394836|69669444|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
37983270|NCT00394836|69669445|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
37983271|NCT00394836|69669444|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
37983272|NCT00394836|69669445|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
37983273|NCT00394836|69669444|FG000|Teatment or Follow-up Phase|Death|0|||
37983274|NCT00394836|69669445|FG001|Teatment or Follow-up Phase|Death|1|||
37983275|NCT00394836|69669444|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
37983276|NCT00394836|69669445|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
37983277|NCT00394836|69669444|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
37983278|NCT00394836|69669445|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
37983279|NCT00394836|69669444|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
37983280|NCT00394836|69669445|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
37983281|NCT00394836|69669444|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
37983282|NCT00394836|69669445|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
37983283|NCT00394836|69669444|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
37983284|NCT00394836|69669445|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
37983285|NCT00394836|69669444|FG000|Teatment or Follow-up Phase|Non compliance|0|||
37983286|NCT00394836|69669445|FG001|Teatment or Follow-up Phase|Non compliance|1|||
37983287|NCT00394836|69669444|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
37983288|NCT00394836|69669445|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
37983289|NCT00394836|69669444|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
37983290|NCT00394836|69669445|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
37818378|NCT01030523|69497666|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
37818379|NCT01030523|69497667|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
37818380|NCT01030523|69497666|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
37818381|NCT01030523|69497667|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
37818382|NCT03811574|69497706|FG000|Overall Study|Withdrawal by Subject|2|||
37818383|NCT03811574|69497707|FG001|Overall Study|Withdrawal by Subject|4|||
37818384|NCT03811574|69497708|FG002|Overall Study|Withdrawal by Subject|0|||
37877067|NCT01094730|69561492|FG001|Period 2 (14 Days)|Adverse Event|1|||
37877068|NCT01094730|69561491|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
37877069|NCT01094730|69561492|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
37877070|NCT00864097|69561507|FG000|Overall Study|Death|0|||
37877071|NCT00864097|69561508|FG001|Overall Study|Death|1|||
37877072|NCT00864097|69561509|FG002|Overall Study|Death|0|||
37877073|NCT00864097|69561510|FG003|Overall Study|Death|0|||
37877074|NCT00864097|69561507|FG000|Overall Study|Adverse Event|6|||
37877075|NCT00864097|69561508|FG001|Overall Study|Adverse Event|8|||
37877076|NCT00864097|69561509|FG002|Overall Study|Adverse Event|11|||
37877077|NCT00864097|69561510|FG003|Overall Study|Adverse Event|9|||
37877078|NCT00864097|69561507|FG000|Overall Study|Lack of Efficacy|9|||
37877079|NCT00864097|69561508|FG001|Overall Study|Lack of Efficacy|3|||
37877080|NCT00864097|69561509|FG002|Overall Study|Lack of Efficacy|7|||
37877081|NCT00864097|69561510|FG003|Overall Study|Lack of Efficacy|2|||
37877082|NCT00864097|69561507|FG000|Overall Study|Lost to Follow-up|0|||
37877083|NCT00864097|69561508|FG001|Overall Study|Lost to Follow-up|1|||
37877084|NCT00864097|69561509|FG002|Overall Study|Lost to Follow-up|0|||
37877085|NCT00864097|69561510|FG003|Overall Study|Lost to Follow-up|1|||
37877086|NCT00864097|69561507|FG000|Overall Study|Withdrawal by Subject|15|||
37877087|NCT00864097|69561508|FG001|Overall Study|Withdrawal by Subject|11|||
37877088|NCT00864097|69561509|FG002|Overall Study|Withdrawal by Subject|11|||
37877089|NCT00864097|69561510|FG003|Overall Study|Withdrawal by Subject|12|||
37877090|NCT00864097|69561507|FG000|Overall Study|Protocol Violation|2|||
37877091|NCT00864097|69561508|FG001|Overall Study|Protocol Violation|1|||
37877092|NCT00864097|69561509|FG002|Overall Study|Protocol Violation|0|||
37877093|NCT00864097|69561510|FG003|Overall Study|Protocol Violation|1|||
37877094|NCT00864097|69561507|FG000|Overall Study|Terminated by sponsor|105|||
37877095|NCT00864097|69561508|FG001|Overall Study|Terminated by sponsor|112|||
37877096|NCT00864097|69561509|FG002|Overall Study|Terminated by sponsor|102|||
37877097|NCT00864097|69561510|FG003|Overall Study|Terminated by sponsor|99|||
37877098|NCT00864097|69561507|FG000|Overall Study|Randomized but not treated|2|||
37877099|NCT00864097|69561508|FG001|Overall Study|Randomized but not treated|0|||
37877100|NCT00864097|69561509|FG002|Overall Study|Randomized but not treated|1|||
37877101|NCT00864097|69561510|FG003|Overall Study|Randomized but not treated|0|||
37877102|NCT00864097|69561507|FG000|Overall Study|Other|0|||
37877103|NCT00864097|69561508|FG001|Overall Study|Other|0|||
37877104|NCT00864097|69561509|FG002|Overall Study|Other|0|||
37877105|NCT00864097|69561510|FG003|Overall Study|Other|1|||
37877106|NCT01183013|69561527|FG000|Overall Study|Adverse Event|6|||
37877107|NCT01183013|69561528|FG001|Overall Study|Adverse Event|8|||
37877108|NCT01183013|69561529|FG002|Overall Study|Adverse Event|5|||
37877109|NCT01183013|69561530|FG003|Overall Study|Adverse Event|5|||
37877110|NCT01183013|69561531|FG004|Overall Study|Adverse Event|10|||
37877111|NCT01183013|69561532|FG005|Overall Study|Adverse Event|10|||
37877112|NCT01183013|69561533|FG006|Overall Study|Adverse Event|6|||
37877113|NCT01183013|69561527|FG000|Overall Study|Lack of Efficacy|3|||
37877114|NCT01183013|69561528|FG001|Overall Study|Lack of Efficacy|2|||
37877115|NCT01183013|69561529|FG002|Overall Study|Lack of Efficacy|1|||
37983291|NCT00394836|69669444|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
37818385|NCT03727750|69497731|FG000|Overall Study|Death|45|||
37818386|NCT03727750|69497731|FG000|Overall Study|Withdrawal by Subject|2|||
37818387|NCT03727750|69497731|FG000|Overall Study|Lost to Follow-up|1|||
37818388|NCT03727750|69497731|FG000|Overall Study|Other|1|||
37818389|NCT03715829|69497741|FG000|Dose Ranging Period|Adverse Event|2|||
37818390|NCT03715829|69497742|FG001|Dose Ranging Period|Adverse Event|4|||
37818391|NCT03715829|69497743|FG002|Dose Ranging Period|Adverse Event|5|||
37877116|NCT01183013|69561530|FG003|Overall Study|Lack of Efficacy|2|||
37877117|NCT01183013|69561531|FG004|Overall Study|Lack of Efficacy|1|||
37877118|NCT01183013|69561532|FG005|Overall Study|Lack of Efficacy|2|||
37877119|NCT01183013|69561533|FG006|Overall Study|Lack of Efficacy|0|||
37877120|NCT01183013|69561527|FG000|Overall Study|Protocol Violation|5|||
37818392|NCT03715829|69497744|FG003|Dose Ranging Period|Adverse Event|2|||
37818393|NCT03715829|69497745|FG004|Dose Ranging Period|Adverse Event|3|||
37818394|NCT03715829|69497746|FG005|Dose Ranging Period|Adverse Event|3|||
37818395|NCT03715829|69497747|FG006|Dose Ranging Period|Adverse Event|0|||
37877121|NCT01183013|69561528|FG001|Overall Study|Protocol Violation|2|||
37877122|NCT01183013|69561529|FG002|Overall Study|Protocol Violation|4|||
37877123|NCT01183013|69561530|FG003|Overall Study|Protocol Violation|0|||
37877124|NCT01183013|69561531|FG004|Overall Study|Protocol Violation|4|||
37877125|NCT01183013|69561532|FG005|Overall Study|Protocol Violation|3|||
37877126|NCT01183013|69561533|FG006|Overall Study|Protocol Violation|3|||
37877127|NCT01183013|69561527|FG000|Overall Study|Lost to Follow-up|7|||
37877128|NCT01183013|69561528|FG001|Overall Study|Lost to Follow-up|3|||
37877129|NCT01183013|69561529|FG002|Overall Study|Lost to Follow-up|4|||
37877130|NCT01183013|69561530|FG003|Overall Study|Lost to Follow-up|3|||
37877131|NCT01183013|69561531|FG004|Overall Study|Lost to Follow-up|2|||
37818396|NCT03715829|69497748|FG007|Dose Ranging Period|Adverse Event|0|||
37877132|NCT01183013|69561532|FG005|Overall Study|Lost to Follow-up|6|||
37877133|NCT01183013|69561533|FG006|Overall Study|Lost to Follow-up|5|||
37877134|NCT01183013|69561527|FG000|Overall Study|Withdrawal by Subject|9|||
37877135|NCT01183013|69561528|FG001|Overall Study|Withdrawal by Subject|13|||
37877136|NCT01183013|69561529|FG002|Overall Study|Withdrawal by Subject|10|||
37877137|NCT01183013|69561530|FG003|Overall Study|Withdrawal by Subject|8|||
37877138|NCT01183013|69561531|FG004|Overall Study|Withdrawal by Subject|7|||
37877139|NCT01183013|69561532|FG005|Overall Study|Withdrawal by Subject|9|||
37877140|NCT01183013|69561533|FG006|Overall Study|Withdrawal by Subject|10|||
37877141|NCT01183013|69561527|FG000|Overall Study|Reasons other than stated above|15|||
37877142|NCT01183013|69561528|FG001|Overall Study|Reasons other than stated above|11|||
37877143|NCT01183013|69561529|FG002|Overall Study|Reasons other than stated above|17|||
37877144|NCT01183013|69561530|FG003|Overall Study|Reasons other than stated above|12|||
37877145|NCT01183013|69561531|FG004|Overall Study|Reasons other than stated above|12|||
37877146|NCT01183013|69561532|FG005|Overall Study|Reasons other than stated above|15|||
37877147|NCT01183013|69561533|FG006|Overall Study|Reasons other than stated above|13|||
37877148|NCT01141283|69561557|FG000|Overall Study|Adverse Event|56|||
37877149|NCT01141283|69561557|FG000|Overall Study|Lost to Follow-up|4|||
37877150|NCT01141283|69561557|FG000|Overall Study|Withdrawal by Subject|14|||
37877151|NCT01141283|69561557|FG000|Overall Study|Administrative|4|||
37877152|NCT01141283|69561557|FG000|Overall Study|Lack of Efficacy|10|||
37877153|NCT00863707|69561563|FG000|Overall Study|Randomized, but drug not received|4|||
37877154|NCT00863707|69561564|FG001|Overall Study|Randomized, but drug not received|3|||
37877155|NCT01094184|69561572|FG000|Overall Study|Death|35|||
37877156|NCT01094184|69561573|FG001|Overall Study|Death|11|||
37877157|NCT01134731|69561582|FG000|Overall Study|Adverse Event|3|||
37877158|NCT01134731|69561583|FG001|Overall Study|Adverse Event|2|||
37877159|NCT01134731|69561584|FG002|Overall Study|Adverse Event|1|||
37877160|NCT01134731|69561582|FG000|Overall Study|Physician Decision|2|||
37877161|NCT01134731|69561583|FG001|Overall Study|Physician Decision|2|||
37877162|NCT01134731|69561584|FG002|Overall Study|Physician Decision|2|||
37877163|NCT01134731|69561582|FG000|Overall Study|Lack of Efficacy|0|||
37877164|NCT01134731|69561583|FG001|Overall Study|Lack of Efficacy|0|||
37877165|NCT01134731|69561584|FG002|Overall Study|Lack of Efficacy|1|||
37877166|NCT01134731|69561582|FG000|Overall Study|Withdrawal by Subject|3|||
37877167|NCT01134731|69561583|FG001|Overall Study|Withdrawal by Subject|3|||
37983292|NCT00394836|69669445|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
37983293|NCT00394836|69669444|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
37818397|NCT03715829|69497749|FG008|Dose Ranging Period|Adverse Event|0|||
37818398|NCT03715829|69497750|FG009|Dose Ranging Period|Adverse Event|0|||
37818399|NCT03715829|69497751|FG010|Dose Ranging Period|Adverse Event|0|||
37818400|NCT03715829|69497741|FG000|Dose Ranging Period|Lack of Efficacy|0|||
37818401|NCT03715829|69497742|FG001|Dose Ranging Period|Lack of Efficacy|1|||
37818402|NCT03715829|69497743|FG002|Dose Ranging Period|Lack of Efficacy|0|||
37818403|NCT03715829|69497744|FG003|Dose Ranging Period|Lack of Efficacy|1|||
37818404|NCT03715829|69497745|FG004|Dose Ranging Period|Lack of Efficacy|0|||
37818405|NCT03715829|69497746|FG005|Dose Ranging Period|Lack of Efficacy|0|||
37877168|NCT01134731|69561584|FG002|Overall Study|Withdrawal by Subject|1|||
37983294|NCT00394836|69669445|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
37877169|NCT01134731|69561582|FG000|Overall Study|Lost to Follow-up|5|||
37877170|NCT01134731|69561583|FG001|Overall Study|Lost to Follow-up|4|||
37877171|NCT01134731|69561584|FG002|Overall Study|Lost to Follow-up|3|||
37877172|NCT01141205|69561595|FG000|Overall Study|Physician Decision|1|||
37877173|NCT01141205|69561596|FG001|Overall Study|Physician Decision|1|||
37877174|NCT01141205|69561595|FG000|Overall Study|Lost to Follow-up|1|||
37877175|NCT01141205|69561596|FG001|Overall Study|Lost to Follow-up|0|||
37877176|NCT01141205|69561595|FG000|Overall Study|Withdrawal by Subject|1|||
37877177|NCT01141205|69561596|FG001|Overall Study|Withdrawal by Subject|1|||
37877178|NCT01140503|69561606|FG000|Overall Study|Withdrawal by Subject|1|||
37877179|NCT00863317|69561612|FG000|Overall Study|Lost to Follow-up|8|||
37877180|NCT00863317|69561613|FG001|Overall Study|Lost to Follow-up|9|||
37877181|NCT01200368|69561622|FG000|Infant Series|Adverse Event|2|||
37877182|NCT01200368|69561623|FG001|Infant Series|Adverse Event|2|||
37877183|NCT01200368|69561624|FG002|Infant Series|Adverse Event|3|||
37877184|NCT01200368|69561622|FG000|Infant Series|Withdrawal by Subject|0|||
37877185|NCT01200368|69561623|FG001|Infant Series|Withdrawal by Subject|2|||
37877186|NCT01200368|69561624|FG002|Infant Series|Withdrawal by Subject|2|||
37877187|NCT01200368|69561622|FG000|Infant Series|Did not meet entrance criteria|0|||
37983295|NCT00250588|69669456|FG000|Overall Study|Withdrawal by Subject|3|||
37983296|NCT00250588|69669457|FG001|Overall Study|Withdrawal by Subject|6|||
37983297|NCT00250588|69669458|FG002|Overall Study|Withdrawal by Subject|0|||
37983298|NCT00250588|69669456|FG000|Overall Study|Lost to Follow-up|6|||
37818406|NCT03715829|69497747|FG006|Dose Ranging Period|Lack of Efficacy|0|||
37818407|NCT03715829|69497748|FG007|Dose Ranging Period|Lack of Efficacy|0|||
37818408|NCT03715829|69497749|FG008|Dose Ranging Period|Lack of Efficacy|0|||
37818409|NCT03715829|69497750|FG009|Dose Ranging Period|Lack of Efficacy|0|||
37818410|NCT03715829|69497751|FG010|Dose Ranging Period|Lack of Efficacy|0|||
37818411|NCT03715829|69497741|FG000|Dose Ranging Period|Lost to Follow-up|2|||
37818412|NCT03715829|69497742|FG001|Dose Ranging Period|Lost to Follow-up|0|||
37818413|NCT03715829|69497743|FG002|Dose Ranging Period|Lost to Follow-up|1|||
37818414|NCT03715829|69497744|FG003|Dose Ranging Period|Lost to Follow-up|1|||
37818415|NCT03715829|69497745|FG004|Dose Ranging Period|Lost to Follow-up|1|||
37818416|NCT03715829|69497746|FG005|Dose Ranging Period|Lost to Follow-up|2|||
37818417|NCT03715829|69497747|FG006|Dose Ranging Period|Lost to Follow-up|0|||
37818418|NCT03715829|69497748|FG007|Dose Ranging Period|Lost to Follow-up|0|||
37818419|NCT03715829|69497749|FG008|Dose Ranging Period|Lost to Follow-up|0|||
37818420|NCT03715829|69497750|FG009|Dose Ranging Period|Lost to Follow-up|0|||
37818421|NCT03715829|69497751|FG010|Dose Ranging Period|Lost to Follow-up|0|||
37818422|NCT03715829|69497741|FG000|Dose Ranging Period|Protocol Violation|0|||
37818423|NCT03715829|69497742|FG001|Dose Ranging Period|Protocol Violation|0|||
37818424|NCT03715829|69497743|FG002|Dose Ranging Period|Protocol Violation|0|||
37818425|NCT03715829|69497744|FG003|Dose Ranging Period|Protocol Violation|1|||
37818426|NCT03715829|69497745|FG004|Dose Ranging Period|Protocol Violation|0|||
37818427|NCT03715829|69497746|FG005|Dose Ranging Period|Protocol Violation|0|||
37818428|NCT03715829|69497747|FG006|Dose Ranging Period|Protocol Violation|0|||
37818429|NCT03715829|69497748|FG007|Dose Ranging Period|Protocol Violation|0|||
37818430|NCT03715829|69497749|FG008|Dose Ranging Period|Protocol Violation|0|||
37818431|NCT03715829|69497750|FG009|Dose Ranging Period|Protocol Violation|0|||
37818432|NCT03715829|69497751|FG010|Dose Ranging Period|Protocol Violation|0|||
37818433|NCT03715829|69497741|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
37818434|NCT03715829|69497742|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
37818435|NCT03715829|69497743|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
37818436|NCT03715829|69497744|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
37818437|NCT03715829|69497745|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
37818438|NCT03715829|69497746|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
37818439|NCT03715829|69497747|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
37818440|NCT03715829|69497748|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
37818441|NCT03715829|69497749|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
37818442|NCT03715829|69497750|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
37818443|NCT03715829|69497751|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
37818444|NCT03715829|69497741|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
37818445|NCT03715829|69497742|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
37818446|NCT03715829|69497743|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
37818447|NCT03715829|69497744|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
37818448|NCT03715829|69497745|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
37818449|NCT03715829|69497746|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
37818450|NCT03715829|69497747|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
37818451|NCT03715829|69497748|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
37818452|NCT03715829|69497749|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
37818453|NCT03715829|69497750|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
37818454|NCT03715829|69497751|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
37818455|NCT03715829|69497741|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
37818456|NCT03715829|69497742|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
37818457|NCT03715829|69497743|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
37818458|NCT03715829|69497744|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
37877188|NCT01200368|69561623|FG001|Infant Series|Did not meet entrance criteria|1|||
37877189|NCT01200368|69561624|FG002|Infant Series|Did not meet entrance criteria|0|||
37877190|NCT01200368|69561622|FG000|Infant Series|Randomized, not vaccinated|0|||
37877191|NCT01200368|69561623|FG001|Infant Series|Randomized, not vaccinated|1|||
37983299|NCT00250588|69669457|FG001|Overall Study|Lost to Follow-up|13|||
37877192|NCT01200368|69561624|FG002|Infant Series|Randomized, not vaccinated|1|||
37877193|NCT01200368|69561622|FG000|Infant Series|Other|1|||
37877194|NCT01200368|69561623|FG001|Infant Series|Other|0|||
37877195|NCT01200368|69561624|FG002|Infant Series|Other|0|||
37877196|NCT01200368|69561622|FG000|After Infant Series|Adverse Event|6|||
37877197|NCT01200368|69561623|FG001|After Infant Series|Adverse Event|6|||
37877198|NCT01200368|69561624|FG002|After Infant Series|Adverse Event|3|||
37877199|NCT01200368|69561622|FG000|After Infant Series|Withdrawal by Subject|10|||
37877200|NCT01200368|69561623|FG001|After Infant Series|Withdrawal by Subject|8|||
37877201|NCT01200368|69561624|FG002|After Infant Series|Withdrawal by Subject|4|||
37877202|NCT01200368|69561622|FG000|After Infant Series|Lost to Follow-up|1|||
37877203|NCT01200368|69561623|FG001|After Infant Series|Lost to Follow-up|0|||
37877204|NCT01200368|69561624|FG002|After Infant Series|Lost to Follow-up|0|||
37877205|NCT01200368|69561622|FG000|After Infant Series|Other|1|||
37877206|NCT01200368|69561623|FG001|After Infant Series|Other|2|||
37983300|NCT00250588|69669458|FG002|Overall Study|Lost to Follow-up|13|||
37983301|NCT00416078|69669468|FG000|Overall Study|Death|3|||
37983302|NCT00416078|69669469|FG001|Overall Study|Death|4|||
37983303|NCT00416078|69669468|FG000|Overall Study|Withdrawal by Subject|3|||
37877207|NCT01200368|69561624|FG002|After Infant Series|Other|2|||
37877208|NCT01200368|69561622|FG000|Toddler Dose|Adverse Event|0|||
37877209|NCT01200368|69561623|FG001|Toddler Dose|Adverse Event|3|||
37877210|NCT01200368|69561624|FG002|Toddler Dose|Adverse Event|1|||
37877211|NCT01079130|69561645|FG000|Overall Study|Adverse Event|1|||
37877212|NCT01079130|69561646|FG001|Overall Study|Adverse Event|1|||
37877213|NCT01079130|69561647|FG002|Overall Study|Adverse Event|0|||
37877214|NCT01079130|69561648|FG003|Overall Study|Adverse Event|1|||
37983304|NCT00416078|69669469|FG001|Overall Study|Withdrawal by Subject|2|||
37983305|NCT00416078|69669468|FG000|Overall Study|Physician Decision|1|||
37983306|NCT00416078|69669469|FG001|Overall Study|Physician Decision|0|||
37983307|NCT00416078|69669468|FG000|Overall Study|Lost to Follow-up|4|||
37983308|NCT00416078|69669469|FG001|Overall Study|Lost to Follow-up|2|||
37983309|NCT00394524|69669477|FG000|Overall Study|Protocol Violation|2|||
37818459|NCT03715829|69497745|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
37877215|NCT01079130|69561649|FG004|Overall Study|Adverse Event|5|||
37877216|NCT01079130|69561650|FG005|Overall Study|Adverse Event|1|||
37877217|NCT01079130|69561645|FG000|Overall Study|Administrative problems|1|||
37877218|NCT01079130|69561646|FG001|Overall Study|Administrative problems|3|||
37877219|NCT01079130|69561647|FG002|Overall Study|Administrative problems|0|||
37877220|NCT01079130|69561648|FG003|Overall Study|Administrative problems|0|||
37877221|NCT01079130|69561649|FG004|Overall Study|Administrative problems|0|||
37877222|NCT01079130|69561650|FG005|Overall Study|Administrative problems|1|||
37877223|NCT01079130|69561645|FG000|Overall Study|Withdrawal by Subject|0|||
37877224|NCT01079130|69561646|FG001|Overall Study|Withdrawal by Subject|1|||
37877225|NCT01079130|69561647|FG002|Overall Study|Withdrawal by Subject|0|||
37877226|NCT01079130|69561648|FG003|Overall Study|Withdrawal by Subject|0|||
37877227|NCT01079130|69561649|FG004|Overall Study|Withdrawal by Subject|1|||
37877228|NCT01079130|69561650|FG005|Overall Study|Withdrawal by Subject|3|||
37877229|NCT01079130|69561645|FG000|Overall Study|Protocol deviation|0|||
37877230|NCT01079130|69561646|FG001|Overall Study|Protocol deviation|2|||
37877231|NCT01079130|69561647|FG002|Overall Study|Protocol deviation|1|||
37877232|NCT01079130|69561648|FG003|Overall Study|Protocol deviation|2|||
37877233|NCT01079130|69561649|FG004|Overall Study|Protocol deviation|0|||
37877234|NCT01079130|69561650|FG005|Overall Study|Protocol deviation|0|||
37877235|NCT01079130|69561645|FG000|Overall Study|Abnormal test procedure result(s)|0|||
37877236|NCT01079130|69561646|FG001|Overall Study|Abnormal test procedure result(s)|0|||
37818460|NCT03715829|69497746|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
37818461|NCT03715829|69497747|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
37818462|NCT03715829|69497748|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
37818463|NCT03715829|69497749|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
37818464|NCT03715829|69497750|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
37818465|NCT03715829|69497751|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
37877237|NCT01079130|69561647|FG002|Overall Study|Abnormal test procedure result(s)|0|||
37877238|NCT01079130|69561648|FG003|Overall Study|Abnormal test procedure result(s)|0|||
37877239|NCT01079130|69561649|FG004|Overall Study|Abnormal test procedure result(s)|1|||
37877240|NCT01079130|69561650|FG005|Overall Study|Abnormal test procedure result(s)|0|||
37877241|NCT01079130|69561645|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
37877242|NCT01079130|69561646|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
37877243|NCT01079130|69561647|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
37877244|NCT01079130|69561648|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
37818466|NCT03715829|69497741|FG000|Dose Ranging Period|Other|0|||
37877245|NCT01079130|69561649|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
37877246|NCT01079130|69561650|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
37983310|NCT00394524|69669478|FG001|Overall Study|Protocol Violation|3|||
37877247|NCT01079130|69561645|FG000|Overall Study|Lost to Follow-up|0|||
37983311|NCT00394524|69669477|FG000|Overall Study|Death|1|||
37983312|NCT00394524|69669478|FG001|Overall Study|Death|0|||
37877248|NCT01079130|69561646|FG001|Overall Study|Lost to Follow-up|0|||
37877249|NCT01079130|69561647|FG002|Overall Study|Lost to Follow-up|0|||
37877250|NCT01079130|69561648|FG003|Overall Study|Lost to Follow-up|0|||
37877251|NCT01079130|69561649|FG004|Overall Study|Lost to Follow-up|1|||
37877252|NCT01079130|69561650|FG005|Overall Study|Lost to Follow-up|0|||
37877253|NCT01078974|69561664|FG000|Overall Study|Adverse Event|3|||
37877254|NCT00869557|69561670|FG000|Randomized Phase|Lost to Follow-up|2|||
37877255|NCT00869557|69561671|FG001|Randomized Phase|Lost to Follow-up|1|||
37877256|NCT00869557|69561670|FG000|Randomized Phase|Investigator's Discretion|1|||
37877257|NCT00869557|69561671|FG001|Randomized Phase|Investigator's Discretion|0|||
37877258|NCT00869557|69561670|FG000|Randomized Phase|Withdrew Consent|0|||
37877259|NCT00869557|69561671|FG001|Randomized Phase|Withdrew Consent|1|||
37877260|NCT00869557|69561670|FG000|Extension Phase|Adverse Event|2|||
37877261|NCT00869557|69561671|FG001|Extension Phase|Adverse Event|2|||
37877262|NCT00869557|69561670|FG000|Extension Phase|Lack of Efficacy|1|||
37877263|NCT00869557|69561671|FG001|Extension Phase|Lack of Efficacy|0|||
37877264|NCT00869557|69561670|FG000|Extension Phase|Lost to Follow-up|3|||
37877265|NCT00869557|69561671|FG001|Extension Phase|Lost to Follow-up|1|||
37983313|NCT00394524|69669477|FG000|Overall Study|Withdrawal by Subject|0|||
37983314|NCT00394524|69669478|FG001|Overall Study|Withdrawal by Subject|1|||
37983315|NCT00409344|69669488|FG000|Overall Study|no enrollment|0|||
37983316|NCT00409344|69669489|FG001|Overall Study|no enrollment|0|||
37983317|NCT00415610|69669498|FG000|Overall Study|Death|3|||
37983318|NCT00415610|69669499|FG001|Overall Study|Death|2|||
37983319|NCT00415610|69669500|FG002|Overall Study|Death|5|||
37983320|NCT00394212|69669510|FG000|Overall Study|Lost to Follow-up|3|||
37983321|NCT00394212|69669511|FG001|Overall Study|Lost to Follow-up|0|||
37983322|NCT00394212|69669510|FG000|Overall Study|Withdrawal by Subject|4|||
37983323|NCT00394212|69669511|FG001|Overall Study|Withdrawal by Subject|1|||
37983324|NCT00250432|69669519|FG000|Overall Study|Adverse Event|25|||
37877266|NCT00869557|69561670|FG000|Extension Phase|Investigator's Discretion|2|||
37877267|NCT00869557|69561671|FG001|Extension Phase|Investigator's Discretion|0|||
37877268|NCT00869557|69561670|FG000|Extension Phase|Withdrew Consent|2|||
37877269|NCT00869557|69561671|FG001|Extension Phase|Withdrew Consent|0|||
37877270|NCT01200290|69561678|FG000|Treatment Period|Adverse Event|1|||
37877271|NCT01200290|69561678|FG000|Post-Treatment Follow-Up Period|Death|2|||
37877272|NCT01134263|69561687|FG000|Overall Study|Serious adverse event|2|||
37877273|NCT01134263|69561688|FG001|Overall Study|Serious adverse event|1|||
37877274|NCT01134263|69561689|FG002|Overall Study|Serious adverse event|1|||
37877275|NCT01134263|69561690|FG003|Overall Study|Serious adverse event|1|||
37877276|NCT01134263|69561691|FG004|Overall Study|Serious adverse event|1|||
37877277|NCT01134263|69561687|FG000|Overall Study|Other adverse event|1|||
37877278|NCT01134263|69561688|FG001|Overall Study|Other adverse event|2|||
37877279|NCT01134263|69561689|FG002|Overall Study|Other adverse event|5|||
37877280|NCT01134263|69561690|FG003|Overall Study|Other adverse event|3|||
37877281|NCT01134263|69561691|FG004|Overall Study|Other adverse event|0|||
37877282|NCT01134263|69561687|FG000|Overall Study|Protocol Violation|8|||
37877283|NCT01134263|69561688|FG001|Overall Study|Protocol Violation|7|||
37877284|NCT01134263|69561689|FG002|Overall Study|Protocol Violation|2|||
37877285|NCT01134263|69561690|FG003|Overall Study|Protocol Violation|4|||
37877286|NCT01134263|69561691|FG004|Overall Study|Protocol Violation|2|||
37877287|NCT01134263|69561687|FG000|Overall Study|Lost to Follow-up|4|||
37877288|NCT01134263|69561688|FG001|Overall Study|Lost to Follow-up|3|||
37877289|NCT01134263|69561689|FG002|Overall Study|Lost to Follow-up|5|||
37877290|NCT01134263|69561690|FG003|Overall Study|Lost to Follow-up|3|||
37983325|NCT00250432|69669520|FG001|Overall Study|Adverse Event|29|||
37695129|NCT02404220|69171647|FG001|Overall Study|Progressive Disease|0|||
37877291|NCT01134263|69561691|FG004|Overall Study|Lost to Follow-up|1|||
37877292|NCT01134263|69561687|FG000|Overall Study|Withdrawal by Subject|8|||
37877293|NCT01134263|69561688|FG001|Overall Study|Withdrawal by Subject|6|||
37877294|NCT01134263|69561689|FG002|Overall Study|Withdrawal by Subject|16|||
37877295|NCT01134263|69561690|FG003|Overall Study|Withdrawal by Subject|7|||
37877296|NCT01134263|69561691|FG004|Overall Study|Withdrawal by Subject|5|||
37877297|NCT01134263|69561687|FG000|Overall Study|Enrolled, but not treated|1|||
37877298|NCT01134263|69561688|FG001|Overall Study|Enrolled, but not treated|1|||
37983326|NCT00250432|69669519|FG000|Overall Study|Lack of Efficacy|2|||
37877299|NCT01134263|69561689|FG002|Overall Study|Enrolled, but not treated|0|||
37877300|NCT01134263|69561690|FG003|Overall Study|Enrolled, but not treated|1|||
37877301|NCT01134263|69561691|FG004|Overall Study|Enrolled, but not treated|0|||
37877302|NCT01199822|69561712|FG000|Overall Study|Investigator discontinued therapy|0|||
37877303|NCT01199822|69561713|FG001|Overall Study|Investigator discontinued therapy|1|||
37877304|NCT01199822|69561714|FG002|Overall Study|Investigator discontinued therapy|0|||
37877305|NCT01096056|69561731|FG000|Overall Study|Lost to Follow-up|0|||
37877306|NCT01096056|69561732|FG001|Overall Study|Lost to Follow-up|1|||
37877307|NCT00866359|69561740|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
37877308|NCT00866359|69561741|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
37983327|NCT00250432|69669520|FG001|Overall Study|Lack of Efficacy|1|||
37983328|NCT00250432|69669519|FG000|Overall Study|Lost to Follow-up|6|||
37877309|NCT00866359|69561742|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
37877310|NCT00866359|69561743|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
37877311|NCT00866359|69561740|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
37877312|NCT00866359|69561741|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
37877313|NCT00866359|69561742|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
37877314|NCT00866359|69561743|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
37877315|NCT00866359|69561740|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
37877316|NCT00866359|69561741|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
37877317|NCT00866359|69561742|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
37877318|NCT00866359|69561743|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
37877319|NCT00866359|69561740|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
37877320|NCT00866359|69561741|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
37877321|NCT00866359|69561742|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
37877322|NCT00866359|69561743|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
37877323|NCT00866359|69561740|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
37877324|NCT00866359|69561741|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
37877325|NCT00866359|69561742|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
37877326|NCT00866359|69561743|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
37877327|NCT00866359|69561740|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
37877328|NCT00866359|69561741|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
37877329|NCT00866359|69561742|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
37877330|NCT00866359|69561743|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
37877331|NCT01199198|69561772|FG000|Overall Study|Adverse Event|3|||
37877332|NCT01199198|69561773|FG001|Overall Study|Adverse Event|0|||
37877333|NCT01199198|69561772|FG000|Overall Study|Lost to Follow-up|1|||
37877334|NCT01199198|69561773|FG001|Overall Study|Lost to Follow-up|5|||
37877335|NCT01199198|69561772|FG000|Overall Study|Withdrawal by Subject|1|||
37877336|NCT01199198|69561773|FG001|Overall Study|Withdrawal by Subject|2|||
37877337|NCT01199198|69561772|FG000|Overall Study|ICU Transfer|1|||
37877338|NCT01199198|69561773|FG001|Overall Study|ICU Transfer|2|||
37877339|NCT01199198|69561772|FG000|Overall Study|Hospice-care transfer|1|||
37877340|NCT01199198|69561773|FG001|Overall Study|Hospice-care transfer|2|||
37877341|NCT01095978|69561779|FG000|Overall Study|Did not take Klacid SR|2|||
37877342|NCT01095978|69561779|FG000|Overall Study|Adverse Event|1|||
37877343|NCT01134107|69561787|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
37877344|NCT01134107|69561788|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
37983329|NCT00250432|69669520|FG001|Overall Study|Lost to Follow-up|5|||
37877345|NCT01134107|69561787|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
37877346|NCT01134107|69561788|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
37877347|NCT01134107|69561787|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
37877348|NCT01134107|69561788|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
37877349|NCT01134107|69561787|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
37877350|NCT01134107|69561788|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
37877351|NCT01134107|69561787|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
37877352|NCT01134107|69561788|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
37877353|NCT01134107|69561787|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
37877354|NCT01134107|69561788|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
37983330|NCT00250432|69669519|FG000|Overall Study|Patient Moved|0|||
37983331|NCT00250432|69669520|FG001|Overall Study|Patient Moved|1|||
37695130|NCT02404220|69171648|FG002|Overall Study|Progressive Disease|1|||
37877355|NCT01134107|69561787|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
37877356|NCT01134107|69561788|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
37877357|NCT01199042|69561794|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
37877358|NCT01199042|69561794|FG000|At Home (3 Months)|Lost to Follow-up|1|||
37877359|NCT01198574|69561807|FG000|Overall Study|Resigned from schools|4|||
37877360|NCT01198574|69561808|FG001|Overall Study|Resigned from schools|1|||
37877361|NCT01198574|69561809|FG002|Overall Study|Resigned from schools|1|||
37877362|NCT01198574|69561810|FG003|Overall Study|Resigned from schools|4|||
37983332|NCT00250432|69669519|FG000|Overall Study|Protocol Violation|0|||
37983333|NCT00250432|69669520|FG001|Overall Study|Protocol Violation|3|||
37877363|NCT01198028|69561820|FG000|Overall Study|Adverse Event|5|||
37877364|NCT01198028|69561820|FG000|Overall Study|Death|3|||
37877365|NCT01198028|69561820|FG000|Overall Study|Physician Decision|2|||
37877366|NCT01197950|69561827|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
37877367|NCT01197950|69561828|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
37877368|NCT01197950|69561829|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
37877369|NCT01092780|69561837|FG000|Washout Period 1|Adverse Event|0|||
37877370|NCT01092780|69561838|FG001|Washout Period 1|Adverse Event|1|||
37877371|NCT01092780|69561839|FG002|Washout Period 1|Adverse Event|0|||
37877372|NCT01092780|69561840|FG003|Washout Period 1|Adverse Event|0|||
37877373|NCT01092780|69561837|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
37877374|NCT01092780|69561838|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
37877375|NCT01092780|69561839|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
37877376|NCT01092780|69561840|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
37877377|NCT01092780|69561837|FG000|Washout Period 2|Adverse Event|0|||
37877378|NCT01092780|69561838|FG001|Washout Period 2|Adverse Event|1|||
37877379|NCT01092780|69561839|FG002|Washout Period 2|Adverse Event|1|||
37877380|NCT01092780|69561840|FG003|Washout Period 2|Adverse Event|0|||
37877381|NCT01092546|69561850|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
37877382|NCT01197794|69561861|FG000|Overall Study|Adverse Event|3|||
37983334|NCT00250432|69669519|FG000|Overall Study|Withdrawal by Subject|6|||
37983335|NCT00250432|69669520|FG001|Overall Study|Withdrawal by Subject|2|||
37983336|NCT00250432|69669519|FG000|Overall Study|Pt died out of posttherapy report period|6|||
37983337|NCT00250432|69669520|FG001|Overall Study|Pt died out of posttherapy report period|5|||
37983338|NCT00250432|69669519|FG000|Overall Study|Pt was considered untreatable|0|||
37983339|NCT00250432|69669520|FG001|Overall Study|Pt was considered untreatable|1|||
37983340|NCT00250276|69669530|FG000|Overall Study|Serious Adverse Event|0|||
37983341|NCT00250276|69669531|FG001|Overall Study|Serious Adverse Event|0|||
37877383|NCT01197794|69561862|FG001|Overall Study|Adverse Event|2|||
37877384|NCT01197794|69561863|FG002|Overall Study|Adverse Event|4|||
37877385|NCT01197794|69561864|FG003|Overall Study|Adverse Event|4|||
37877386|NCT01197794|69561865|FG004|Overall Study|Adverse Event|4|||
37877387|NCT01197794|69561866|FG005|Overall Study|Adverse Event|2|||
37877388|NCT01197794|69561867|FG006|Overall Study|Adverse Event|3|||
37877389|NCT01197794|69561861|FG000|Overall Study|Protocol Violation|0|||
37877390|NCT01197794|69561862|FG001|Overall Study|Protocol Violation|0|||
37877391|NCT01197794|69561863|FG002|Overall Study|Protocol Violation|0|||
37877392|NCT01197794|69561864|FG003|Overall Study|Protocol Violation|0|||
37877393|NCT01197794|69561865|FG004|Overall Study|Protocol Violation|2|||
37877394|NCT01197794|69561866|FG005|Overall Study|Protocol Violation|0|||
37877395|NCT01197794|69561867|FG006|Overall Study|Protocol Violation|1|||
37877396|NCT01197794|69561861|FG000|Overall Study|Development of study withdrawal criteria|3|||
37877397|NCT01197794|69561862|FG001|Overall Study|Development of study withdrawal criteria|0|||
37877398|NCT01197794|69561863|FG002|Overall Study|Development of study withdrawal criteria|0|||
37877399|NCT01197794|69561864|FG003|Overall Study|Development of study withdrawal criteria|1|||
37877400|NCT01197794|69561865|FG004|Overall Study|Development of study withdrawal criteria|0|||
37877401|NCT01197794|69561866|FG005|Overall Study|Development of study withdrawal criteria|0|||
37877402|NCT01197794|69561867|FG006|Overall Study|Development of study withdrawal criteria|1|||
37877403|NCT01197794|69561861|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
37877404|NCT01197794|69561862|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
37877405|NCT01197794|69561863|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
37877406|NCT01197794|69561864|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
37983342|NCT00250276|69669532|FG002|Overall Study|Serious Adverse Event|1|||
37877407|NCT01197794|69561865|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
37877408|NCT01197794|69561866|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
37877409|NCT01197794|69561867|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
37877410|NCT01197794|69561861|FG000|Overall Study|Withdrawal by Subject|3|||
37877411|NCT01197794|69561862|FG001|Overall Study|Withdrawal by Subject|3|||
37983343|NCT00250276|69669533|FG003|Overall Study|Serious Adverse Event|0|||
37983344|NCT00250276|69669530|FG000|Overall Study|Non-serious Adverse Event|2|||
37983345|NCT00250276|69669531|FG001|Overall Study|Non-serious Adverse Event|0|||
37877412|NCT01197794|69561863|FG002|Overall Study|Withdrawal by Subject|4|||
37877413|NCT01197794|69561864|FG003|Overall Study|Withdrawal by Subject|1|||
37877414|NCT01197794|69561865|FG004|Overall Study|Withdrawal by Subject|1|||
37877415|NCT01197794|69561866|FG005|Overall Study|Withdrawal by Subject|5|||
37877416|NCT01197794|69561867|FG006|Overall Study|Withdrawal by Subject|6|||
37877417|NCT01197794|69561861|FG000|Overall Study|Lost to Follow-up|1|||
37877418|NCT01197794|69561862|FG001|Overall Study|Lost to Follow-up|1|||
37877419|NCT01197794|69561863|FG002|Overall Study|Lost to Follow-up|0|||
37877420|NCT01197794|69561864|FG003|Overall Study|Lost to Follow-up|1|||
37877421|NCT01197794|69561865|FG004|Overall Study|Lost to Follow-up|0|||
37695131|NCT02404220|69171649|FG003|Overall Study|Progressive Disease|1|||
37695132|NCT02404220|69171646|FG000|Overall Study|Study Terminated by Sponsor|0|||
37695133|NCT02404220|69171647|FG001|Overall Study|Study Terminated by Sponsor|0|||
37695134|NCT02404220|69171648|FG002|Overall Study|Study Terminated by Sponsor|2|||
37695135|NCT02404220|69171649|FG003|Overall Study|Study Terminated by Sponsor|1|||
37695136|NCT02404220|69171646|FG000|Overall Study|Withdrawal by Subject|0|||
37695137|NCT02404220|69171647|FG001|Overall Study|Withdrawal by Subject|1|||
37695138|NCT02404220|69171648|FG002|Overall Study|Withdrawal by Subject|0|||
37695139|NCT02404220|69171649|FG003|Overall Study|Withdrawal by Subject|0|||
37695140|NCT02404220|69171646|FG000|Overall Study|Enrolled but Never Treated|0|||
37695141|NCT02404220|69171647|FG001|Overall Study|Enrolled but Never Treated|2|||
37695142|NCT02404220|69171648|FG002|Overall Study|Enrolled but Never Treated|0|||
37695143|NCT02404220|69171649|FG003|Overall Study|Enrolled but Never Treated|0|||
37695144|NCT02335658|69171661|FG000|Overall Study|Adverse Event|18|||
37695145|NCT02335658|69171662|FG001|Overall Study|Adverse Event|12|||
37695146|NCT02335658|69171661|FG000|Overall Study|Lack of Efficacy|4|||
37695147|NCT02335658|69171662|FG001|Overall Study|Lack of Efficacy|5|||
37695148|NCT02335658|69171661|FG000|Overall Study|Pregnancy|1|||
37695149|NCT02335658|69171662|FG001|Overall Study|Pregnancy|0|||
37695150|NCT02335658|69171661|FG000|Overall Study|Withdrawal by Subject|13|||
37695151|NCT02335658|69171662|FG001|Overall Study|Withdrawal by Subject|21|||
37695152|NCT02335658|69171661|FG000|Overall Study|non-compliance|2|||
37695153|NCT02335658|69171662|FG001|Overall Study|non-compliance|3|||
37695154|NCT02335658|69171661|FG000|Overall Study|other reason|2|||
37695155|NCT02335658|69171662|FG001|Overall Study|other reason|3|||
37695156|NCT02366468|69171672|FG000|Overall Study|Adverse Event|2|||
37695157|NCT02366468|69171673|FG001|Overall Study|Adverse Event|0|||
37695158|NCT02366468|69171672|FG000|Overall Study|Withdrawal by Subject|1|||
37695159|NCT02366468|69171673|FG001|Overall Study|Withdrawal by Subject|5|||
37695160|NCT02366468|69171672|FG000|Overall Study|Lost to Follow-up|2|||
37695161|NCT02366468|69171673|FG001|Overall Study|Lost to Follow-up|0|||
37695162|NCT02366468|69171672|FG000|Overall Study|Death|1|||
37695163|NCT02366468|69171673|FG001|Overall Study|Death|2|||
37695164|NCT02366468|69171672|FG000|Overall Study|Other|0|||
37695165|NCT02366468|69171673|FG001|Overall Study|Other|2|||
37695166|NCT02366312|69171681|FG000|Overall Study|Lost to Follow-up|0|||
37695167|NCT02366312|69171682|FG001|Overall Study|Lost to Follow-up|1|||
37695168|NCT02335346|69171688|FG000|Overall Study|Adverse Event|11|||
37877422|NCT01197794|69561866|FG005|Overall Study|Lost to Follow-up|1|||
37877423|NCT01197794|69561867|FG006|Overall Study|Lost to Follow-up|0|||
37877424|NCT01197794|69561861|FG000|Overall Study|Other|1|||
37877425|NCT01197794|69561862|FG001|Overall Study|Other|1|||
37877426|NCT01197794|69561863|FG002|Overall Study|Other|3|||
37877427|NCT01197794|69561864|FG003|Overall Study|Other|0|||
37877428|NCT01197794|69561865|FG004|Overall Study|Other|2|||
37877429|NCT01197794|69561866|FG005|Overall Study|Other|2|||
37877430|NCT01197794|69561867|FG006|Overall Study|Other|4|||
37877431|NCT01078662|69561889|FG000|Overall Study|Death|41|||
37877432|NCT01078662|69561890|FG001|Overall Study|Death|103|||
37877433|NCT01078662|69561891|FG002|Overall Study|Death|18|||
37877434|NCT01078662|69561892|FG003|Overall Study|Death|5|||
37877435|NCT01078662|69561893|FG004|Overall Study|Death|8|||
37877436|NCT01078662|69561889|FG000|Overall Study|Patients reached data cut-off|12|||
37877437|NCT01078662|69561890|FG001|Overall Study|Patients reached data cut-off|53|||
37877438|NCT01078662|69561891|FG002|Overall Study|Patients reached data cut-off|2|||
37877439|NCT01078662|69561892|FG003|Overall Study|Patients reached data cut-off|2|||
37877440|NCT01078662|69561893|FG004|Overall Study|Patients reached data cut-off|3|||
37695169|NCT02335346|69171688|FG000|Overall Study|Withdrawal by Subject|1|||
37695170|NCT02403206|69171694|FG000|Overall Study|Lost to Follow-up|4|||
37695171|NCT02403206|69171695|FG001|Overall Study|Lost to Follow-up|3|||
37695172|NCT02403206|69171694|FG000|Overall Study|Physician Decision|2|||
37695173|NCT02403206|69171695|FG001|Overall Study|Physician Decision|0|||
37877441|NCT01078662|69561889|FG000|Overall Study|Withdrawal by Subject|4|||
37695174|NCT02403206|69171694|FG000|Overall Study|Withdrawal by Subject|3|||
37877442|NCT01078662|69561890|FG001|Overall Study|Withdrawal by Subject|11|||
37877443|NCT01078662|69561891|FG002|Overall Study|Withdrawal by Subject|1|||
37877444|NCT01078662|69561892|FG003|Overall Study|Withdrawal by Subject|0|||
37877445|NCT01078662|69561893|FG004|Overall Study|Withdrawal by Subject|0|||
37877446|NCT01078662|69561889|FG000|Overall Study|Protocol Violation|0|||
37877447|NCT01078662|69561890|FG001|Overall Study|Protocol Violation|1|||
37877448|NCT01078662|69561891|FG002|Overall Study|Protocol Violation|0|||
37877449|NCT01078662|69561892|FG003|Overall Study|Protocol Violation|0|||
37695175|NCT02403206|69171695|FG001|Overall Study|Withdrawal by Subject|3|||
37695176|NCT02403206|69171694|FG000|Overall Study|Reason not given|2|||
37877450|NCT01078662|69561893|FG004|Overall Study|Protocol Violation|0|||
37983346|NCT00250276|69669532|FG002|Overall Study|Non-serious Adverse Event|0|||
37983347|NCT00250276|69669533|FG003|Overall Study|Non-serious Adverse Event|2|||
37983348|NCT00250276|69669530|FG000|Overall Study|Protocol Violation|0|||
37983349|NCT00250276|69669531|FG001|Overall Study|Protocol Violation|1|||
37983350|NCT00250276|69669532|FG002|Overall Study|Protocol Violation|0|||
37983351|NCT00250276|69669533|FG003|Overall Study|Protocol Violation|0|||
37983352|NCT00250276|69669530|FG000|Overall Study|Withdrawal by Subject|1|||
37983353|NCT00250276|69669531|FG001|Overall Study|Withdrawal by Subject|2|||
37983354|NCT00250276|69669532|FG002|Overall Study|Withdrawal by Subject|3|||
37983355|NCT00250276|69669533|FG003|Overall Study|Withdrawal by Subject|2|||
37983356|NCT00250276|69669530|FG000|Overall Study|Migrated/moved from study area|3|||
37983357|NCT00250276|69669531|FG001|Overall Study|Migrated/moved from study area|0|||
37983358|NCT00250276|69669532|FG002|Overall Study|Migrated/moved from study area|2|||
37983359|NCT00250276|69669533|FG003|Overall Study|Migrated/moved from study area|7|||
37983360|NCT00250276|69669530|FG000|Overall Study|Lost to Follow-up|11|||
37983361|NCT00250276|69669531|FG001|Overall Study|Lost to Follow-up|18|||
37983362|NCT00250276|69669532|FG002|Overall Study|Lost to Follow-up|13|||
37983363|NCT00250276|69669533|FG003|Overall Study|Lost to Follow-up|8|||
37983364|NCT00249808|69669548|FG000|Overall Study|Other|27|||
37983365|NCT00249808|69669548|FG000|Overall Study|Protocol Violation|3|||
37983366|NCT00249808|69669548|FG000|Overall Study|Lost to Follow-up|8|||
37983367|NCT00249808|69669548|FG000|Overall Study|Adverse Event|81|||
37983368|NCT00249808|69669548|FG000|Overall Study|Lack of Efficacy|52|||
37983369|NCT00249808|69669548|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
37818467|NCT03715829|69497742|FG001|Dose Ranging Period|Other|0|||
37818468|NCT03715829|69497743|FG002|Dose Ranging Period|Other|2|||
37818469|NCT03715829|69497744|FG003|Dose Ranging Period|Other|0|||
37818470|NCT03715829|69497745|FG004|Dose Ranging Period|Other|0|||
37818471|NCT03715829|69497746|FG005|Dose Ranging Period|Other|3|||
37818472|NCT03715829|69497747|FG006|Dose Ranging Period|Other|0|||
37818473|NCT03715829|69497748|FG007|Dose Ranging Period|Other|0|||
37818474|NCT03715829|69497749|FG008|Dose Ranging Period|Other|0|||
37818475|NCT03715829|69497750|FG009|Dose Ranging Period|Other|0|||
37818476|NCT03715829|69497751|FG010|Dose Ranging Period|Other|0|||
37818477|NCT03715829|69497741|FG000|Extension Period|Adverse Event|0|||
37818478|NCT03715829|69497742|FG001|Extension Period|Adverse Event|0|||
37818479|NCT03715829|69497743|FG002|Extension Period|Adverse Event|0|||
37818480|NCT03715829|69497744|FG003|Extension Period|Adverse Event|0|||
37818481|NCT03715829|69497745|FG004|Extension Period|Adverse Event|0|||
37818482|NCT03715829|69497746|FG005|Extension Period|Adverse Event|0|||
37818483|NCT03715829|69497747|FG006|Extension Period|Adverse Event|3|||
37818484|NCT03715829|69497748|FG007|Extension Period|Adverse Event|1|||
37818485|NCT03715829|69497749|FG008|Extension Period|Adverse Event|6|||
37818486|NCT03715829|69497750|FG009|Extension Period|Adverse Event|0|||
37818487|NCT03715829|69497751|FG010|Extension Period|Adverse Event|0|||
37818488|NCT03715829|69497741|FG000|Extension Period|Lack of Efficacy|0|||
37818489|NCT03715829|69497742|FG001|Extension Period|Lack of Efficacy|0|||
37818490|NCT03715829|69497743|FG002|Extension Period|Lack of Efficacy|0|||
37818491|NCT03715829|69497744|FG003|Extension Period|Lack of Efficacy|0|||
37818492|NCT03715829|69497745|FG004|Extension Period|Lack of Efficacy|0|||
37818493|NCT03715829|69497746|FG005|Extension Period|Lack of Efficacy|0|||
37818494|NCT03715829|69497747|FG006|Extension Period|Lack of Efficacy|1|||
37818495|NCT03715829|69497748|FG007|Extension Period|Lack of Efficacy|9|||
37818496|NCT03715829|69497749|FG008|Extension Period|Lack of Efficacy|2|||
37818497|NCT03715829|69497750|FG009|Extension Period|Lack of Efficacy|0|||
37818498|NCT03715829|69497751|FG010|Extension Period|Lack of Efficacy|0|||
37818499|NCT03715829|69497741|FG000|Extension Period|Lost to Follow-up|0|||
37818500|NCT03715829|69497742|FG001|Extension Period|Lost to Follow-up|0|||
37818501|NCT03715829|69497743|FG002|Extension Period|Lost to Follow-up|0|||
37818502|NCT03715829|69497744|FG003|Extension Period|Lost to Follow-up|0|||
37818503|NCT03715829|69497745|FG004|Extension Period|Lost to Follow-up|0|||
37818504|NCT03715829|69497746|FG005|Extension Period|Lost to Follow-up|0|||
37818505|NCT03715829|69497747|FG006|Extension Period|Lost to Follow-up|0|||
37818506|NCT03715829|69497748|FG007|Extension Period|Lost to Follow-up|0|||
37818507|NCT03715829|69497749|FG008|Extension Period|Lost to Follow-up|2|||
37818508|NCT03715829|69497750|FG009|Extension Period|Lost to Follow-up|0|||
37818509|NCT03715829|69497751|FG010|Extension Period|Lost to Follow-up|0|||
37818510|NCT03715829|69497741|FG000|Extension Period|Protocol Violation|0|||
37818511|NCT03715829|69497742|FG001|Extension Period|Protocol Violation|0|||
37818512|NCT03715829|69497743|FG002|Extension Period|Protocol Violation|0|||
37983370|NCT00278512|69669554|FG000|Overall Study|Death|1|||
37983371|NCT00278512|69669555|FG001|Overall Study|Death|0|||
37983372|NCT00427934|69669565|FG000|Overall Study|Adverse Event|1|||
37983373|NCT00427934|69669566|FG001|Overall Study|Adverse Event|0|||
37983374|NCT00427934|69669567|FG002|Overall Study|Adverse Event|5|||
37983375|NCT00427934|69669568|FG003|Overall Study|Adverse Event|4|||
37983376|NCT00427934|69669565|FG000|Overall Study|Lack of Efficacy|0|||
37983377|NCT00427934|69669566|FG001|Overall Study|Lack of Efficacy|0|||
37818513|NCT03715829|69497744|FG003|Extension Period|Protocol Violation|0|||
37818514|NCT03715829|69497745|FG004|Extension Period|Protocol Violation|0|||
37877451|NCT01078662|69561889|FG000|Overall Study|Lost to Follow-up|1|||
37877452|NCT01078662|69561890|FG001|Overall Study|Lost to Follow-up|0|||
37877453|NCT01078662|69561891|FG002|Overall Study|Lost to Follow-up|0|||
37877454|NCT01078662|69561892|FG003|Overall Study|Lost to Follow-up|0|||
37983378|NCT00427934|69669567|FG002|Overall Study|Lack of Efficacy|5|||
37983379|NCT00427934|69669568|FG003|Overall Study|Lack of Efficacy|2|||
37983380|NCT00427934|69669565|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
37983381|NCT00427934|69669566|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
37983382|NCT00427934|69669567|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
37983383|NCT00427934|69669568|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
37983384|NCT00427934|69669565|FG000|Overall Study|Other|0|||
37983385|NCT00427934|69669566|FG001|Overall Study|Other|0|||
37983386|NCT00427934|69669567|FG002|Overall Study|Other|11|||
37877455|NCT01078662|69561893|FG004|Overall Study|Lost to Follow-up|0|||
37877456|NCT01091454|69561902|FG000|Overall Study|Ineligible|1|||
37877457|NCT01140347|69561908|FG000|Overall Study|Lost to Follow-up|5|||
37877458|NCT01140347|69561909|FG001|Overall Study|Lost to Follow-up|6|||
37877459|NCT01140347|69561908|FG000|Overall Study|Withdrawal by Subject|13|||
37877460|NCT01140347|69561909|FG001|Overall Study|Withdrawal by Subject|8|||
37695177|NCT02403206|69171695|FG001|Overall Study|Reason not given|4|||
37695178|NCT02333630|69171704|FG000|Overall Study|Lost to Follow-up|5|||
37695179|NCT02333630|69171705|FG001|Overall Study|Lost to Follow-up|2|||
37695180|NCT02401412|69171717|FG000|Overall Study|Lost to Follow-up|1|||
37695181|NCT02401412|69171718|FG001|Overall Study|Lost to Follow-up|0|||
37695182|NCT02401412|69171717|FG000|Overall Study|Discontinued Intervention|15|||
37695183|NCT02401412|69171718|FG001|Overall Study|Discontinued Intervention|21|||
37695184|NCT02401412|69171717|FG000|Overall Study|Withdrawal by Subject|4|||
37695185|NCT02401412|69171718|FG001|Overall Study|Withdrawal by Subject|4|||
37695186|NCT02401412|69171717|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
37695187|NCT02401412|69171718|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
37695188|NCT02401412|69171717|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
37695189|NCT02401412|69171718|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
37695190|NCT02365298|69171724|FG000|Period 2|incorrect Rx dispensed|1|||
37695191|NCT02365298|69171725|FG001|Period 2|incorrect Rx dispensed|0|||
37695192|NCT02365298|69171724|FG000|Period 2|Discontinued at request of Sponsor|1|||
37695193|NCT02365298|69171725|FG001|Period 2|Discontinued at request of Sponsor|0|||
37877461|NCT01197560|69561917|FG000|Overall Study|Adverse Event|6|||
37877462|NCT01197560|69561918|FG001|Overall Study|Adverse Event|8|||
37877463|NCT01197560|69561917|FG000|Overall Study|Death|3|||
37877464|NCT01197560|69561918|FG001|Overall Study|Death|5|||
37877465|NCT01197560|69561917|FG000|Overall Study|Withdrawal by Subject|1|||
37877466|NCT01197560|69561918|FG001|Overall Study|Withdrawal by Subject|1|||
37877467|NCT01197560|69561917|FG000|Overall Study|Disease progression|40|||
37877468|NCT01197560|69561918|FG001|Overall Study|Disease progression|35|||
37877469|NCT01197560|69561917|FG000|Overall Study|Miscellaneous|4|||
37877470|NCT01197560|69561918|FG001|Overall Study|Miscellaneous|3|||
37877471|NCT01197560|69561917|FG000|Overall Study|Missing|0|||
37877472|NCT01197560|69561918|FG001|Overall Study|Missing|1|||
37877473|NCT01133405|69561935|FG000|Period 1|Withdrawal by Subject|0|||
37877474|NCT01133405|69561936|FG001|Period 1|Withdrawal by Subject|1|||
37877475|NCT01133405|69561937|FG002|Period 1|Withdrawal by Subject|0|||
37983387|NCT00427934|69669568|FG003|Overall Study|Other|5|||
37983388|NCT00427934|69669565|FG000|Overall Study|Withdrawal by Subject|0|||
37695194|NCT02365298|69171724|FG000|Period 2|Test Article longer available|0|||
37695195|NCT02365298|69171725|FG001|Period 2|Test Article longer available|1|||
37695196|NCT02365298|69171724|FG000|Period 2|Protocol Violation|0|||
37818515|NCT03715829|69497746|FG005|Extension Period|Protocol Violation|0|||
37818516|NCT03715829|69497747|FG006|Extension Period|Protocol Violation|0|||
37818517|NCT03715829|69497748|FG007|Extension Period|Protocol Violation|0|||
37818518|NCT03715829|69497749|FG008|Extension Period|Protocol Violation|1|||
37818519|NCT03715829|69497750|FG009|Extension Period|Protocol Violation|0|||
37818520|NCT03715829|69497751|FG010|Extension Period|Protocol Violation|0|||
37818521|NCT03715829|69497741|FG000|Extension Period|Withdrawal by Subject|0|||
37818522|NCT03715829|69497742|FG001|Extension Period|Withdrawal by Subject|0|||
37818523|NCT03715829|69497743|FG002|Extension Period|Withdrawal by Subject|0|||
37818524|NCT03715829|69497744|FG003|Extension Period|Withdrawal by Subject|0|||
37818525|NCT03715829|69497745|FG004|Extension Period|Withdrawal by Subject|0|||
37818526|NCT03715829|69497746|FG005|Extension Period|Withdrawal by Subject|0|||
37818527|NCT03715829|69497747|FG006|Extension Period|Withdrawal by Subject|3|||
37818528|NCT03715829|69497748|FG007|Extension Period|Withdrawal by Subject|3|||
37833581|NCT01262989|69517312|FG000|Period 1|Lost to Follow-up|1|||
37877476|NCT01133405|69561938|FG003|Period 1|Withdrawal by Subject|1|||
37877477|NCT01133405|69561939|FG004|Period 1|Withdrawal by Subject|0|||
37877478|NCT01133405|69561940|FG005|Period 1|Withdrawal by Subject|1|||
37877479|NCT01133405|69561941|FG006|Period 1|Withdrawal by Subject|0|||
37877480|NCT01133405|69561942|FG007|Period 1|Withdrawal by Subject|0|||
37877481|NCT01133405|69561943|FG008|Period 1|Withdrawal by Subject|0|||
37983389|NCT00427934|69669566|FG001|Overall Study|Withdrawal by Subject|0|||
37877482|NCT01133405|69561944|FG009|Period 1|Withdrawal by Subject|0|||
37877483|NCT01133405|69561935|FG000|Period 1|Physician Decision|0|||
37877484|NCT01133405|69561936|FG001|Period 1|Physician Decision|0|||
37877485|NCT01133405|69561937|FG002|Period 1|Physician Decision|0|||
37983390|NCT00427934|69669567|FG002|Overall Study|Withdrawal by Subject|1|||
37983391|NCT00427934|69669568|FG003|Overall Study|Withdrawal by Subject|3|||
37877486|NCT01133405|69561938|FG003|Period 1|Physician Decision|1|||
37877487|NCT01133405|69561939|FG004|Period 1|Physician Decision|0|||
37877488|NCT01133405|69561940|FG005|Period 1|Physician Decision|0|||
37877489|NCT01133405|69561941|FG006|Period 1|Physician Decision|0|||
37877490|NCT01133405|69561942|FG007|Period 1|Physician Decision|0|||
37877491|NCT01133405|69561943|FG008|Period 1|Physician Decision|0|||
37877492|NCT01133405|69561944|FG009|Period 1|Physician Decision|0|||
37877493|NCT01133405|69561935|FG000|Period 1|Discontinued after randomization|1|||
37877494|NCT01133405|69561936|FG001|Period 1|Discontinued after randomization|0|||
37877495|NCT01133405|69561937|FG002|Period 1|Discontinued after randomization|0|||
37877496|NCT01133405|69561938|FG003|Period 1|Discontinued after randomization|0|||
37877497|NCT01133405|69561939|FG004|Period 1|Discontinued after randomization|0|||
37877498|NCT01133405|69561940|FG005|Period 1|Discontinued after randomization|0|||
37877499|NCT01133405|69561941|FG006|Period 1|Discontinued after randomization|1|||
37877500|NCT01133405|69561942|FG007|Period 1|Discontinued after randomization|0|||
37877501|NCT01133405|69561943|FG008|Period 1|Discontinued after randomization|0|||
37877502|NCT01133405|69561944|FG009|Period 1|Discontinued after randomization|0|||
37877503|NCT01133405|69561935|FG000|Period 1|Received drug only in period 2|0|||
37877504|NCT01133405|69561936|FG001|Period 1|Received drug only in period 2|1|||
37877505|NCT01133405|69561937|FG002|Period 1|Received drug only in period 2|0|||
37877506|NCT01133405|69561938|FG003|Period 1|Received drug only in period 2|2|||
37877507|NCT01133405|69561939|FG004|Period 1|Received drug only in period 2|0|||
37877508|NCT01133405|69561940|FG005|Period 1|Received drug only in period 2|1|||
37877509|NCT01133405|69561941|FG006|Period 1|Received drug only in period 2|0|||
37877510|NCT01133405|69561942|FG007|Period 1|Received drug only in period 2|0|||
37877511|NCT01133405|69561943|FG008|Period 1|Received drug only in period 2|0|||
37983392|NCT00435188|69669582|FG000|Overall Study|Death|1|||
37983393|NCT00435188|69669583|FG001|Overall Study|Death|6|||
37983394|NCT00435188|69669582|FG000|Overall Study|Withdrawal by Subject|16|||
37983395|NCT00435188|69669583|FG001|Overall Study|Withdrawal by Subject|11|||
37983396|NCT00435188|69669582|FG000|Overall Study|Lost to Follow-up|5|||
37983397|NCT00435188|69669583|FG001|Overall Study|Lost to Follow-up|6|||
37983398|NCT00427778|69669591|FG000|First Intervention (4 Weeks)|no longer interested|1|||
37983399|NCT00427778|69669592|FG001|First Intervention (4 Weeks)|no longer interested|0|||
37983400|NCT00427778|69669591|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
37983401|NCT00427778|69669592|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
37983402|NCT00427778|69669591|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
37983403|NCT00427778|69669592|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
37983404|NCT00427778|69669591|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
37983405|NCT00427778|69669592|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
37983406|NCT00427700|69669613|FG000|Overall Study|Lost to Follow-up|2|||
37983407|NCT00427700|69669614|FG001|Overall Study|Lost to Follow-up|5|||
37983408|NCT00427700|69669613|FG000|Overall Study|no induction of menses|1|||
37983409|NCT00427700|69669614|FG001|Overall Study|no induction of menses|4|||
37983410|NCT00427700|69669613|FG000|Overall Study|Pregnancy|0|||
37983411|NCT00427700|69669614|FG001|Overall Study|Pregnancy|2|||
37983412|NCT00409188|69669623|FG000|Overall Study|Ongoing at data cut-off|383|||
37983413|NCT00409188|69669624|FG001|Overall Study|Ongoing at data cut-off|175|||
37983414|NCT00434954|69669632|FG000|Overall Study|Adverse Event|17|||
37983415|NCT00434954|69669633|FG001|Overall Study|Adverse Event|2|||
37983416|NCT00434954|69669632|FG000|Overall Study|Entry criteria not met|14|||
37983417|NCT00434954|69669633|FG001|Overall Study|Entry criteria not met|16|||
37983418|NCT00434954|69669632|FG000|Overall Study|Lost to Follow-up|0|||
37983419|NCT00434954|69669633|FG001|Overall Study|Lost to Follow-up|1|||
37983420|NCT00434954|69669632|FG000|Overall Study|Physician Decision|6|||
37983421|NCT00434954|69669633|FG001|Overall Study|Physician Decision|3|||
37983422|NCT00434954|69669632|FG000|Overall Study|Protocol Violation|36|||
37877512|NCT01133405|69561944|FG009|Period 1|Received drug only in period 2|0|||
37877513|NCT01133405|69561935|FG000|Period 1|Received drug only in period 3|0|||
37983423|NCT00434954|69669633|FG001|Overall Study|Protocol Violation|27|||
37877514|NCT01133405|69561936|FG001|Period 1|Received drug only in period 3|1|||
37983424|NCT00434954|69669632|FG000|Overall Study|Sponsor decision|1|||
37983425|NCT00434954|69669633|FG001|Overall Study|Sponsor decision|0|||
37983426|NCT00434954|69669632|FG000|Overall Study|Subject decision|8|||
37877515|NCT01133405|69561937|FG002|Period 1|Received drug only in period 3|1|||
37877516|NCT01133405|69561938|FG003|Period 1|Received drug only in period 3|0|||
37877517|NCT01133405|69561939|FG004|Period 1|Received drug only in period 3|0|||
37877518|NCT01133405|69561940|FG005|Period 1|Received drug only in period 3|0|||
37877519|NCT01133405|69561941|FG006|Period 1|Received drug only in period 3|0|||
37877520|NCT01133405|69561942|FG007|Period 1|Received drug only in period 3|0|||
37983427|NCT00434954|69669633|FG001|Overall Study|Subject decision|22|||
37983428|NCT00276484|69669641|FG000|Overall Study|Adverse Event|4|||
37983429|NCT00276484|69669642|FG001|Overall Study|Adverse Event|7|||
37983430|NCT00276484|69669641|FG000|Overall Study|Lost to Follow-up|1|||
37983431|NCT00276484|69669642|FG001|Overall Study|Lost to Follow-up|1|||
37983432|NCT00276484|69669641|FG000|Overall Study|Protocol Violation|0|||
37983433|NCT00276484|69669642|FG001|Overall Study|Protocol Violation|1|||
37983434|NCT00276484|69669641|FG000|Overall Study|Withdrawal by Subject|4|||
37877521|NCT01133405|69561943|FG008|Period 1|Received drug only in period 3|0|||
37877522|NCT01133405|69561944|FG009|Period 1|Received drug only in period 3|0|||
37983435|NCT00276484|69669642|FG001|Overall Study|Withdrawal by Subject|3|||
37983436|NCT00276484|69669641|FG000|Overall Study|Could not take time off work|0|||
37983437|NCT00276484|69669642|FG001|Overall Study|Could not take time off work|1|||
37983438|NCT00426842|69669648|FG000|Overall Study|Lost to Follow-up|1|||
37983439|NCT00434876|69669656|FG000|Overall Study|Lost to Follow-up|1|||
37983440|NCT00434876|69669657|FG001|Overall Study|Lost to Follow-up|1|||
37983441|NCT00276094|69669666|FG000|Overall Study|Adverse Event|15|||
37877523|NCT01133405|69561935|FG000|Period 2|Adverse Event|0|||
37877524|NCT01133405|69561936|FG001|Period 2|Adverse Event|0|||
37877525|NCT01133405|69561937|FG002|Period 2|Adverse Event|1|||
37877526|NCT01133405|69561938|FG003|Period 2|Adverse Event|0|||
37877527|NCT01133405|69561939|FG004|Period 2|Adverse Event|0|||
37877528|NCT01133405|69561940|FG005|Period 2|Adverse Event|0|||
37877529|NCT01133405|69561941|FG006|Period 2|Adverse Event|0|||
37877530|NCT01133405|69561942|FG007|Period 2|Adverse Event|0|||
37877531|NCT01133405|69561943|FG008|Period 2|Adverse Event|0|||
37877532|NCT01133405|69561944|FG009|Period 2|Adverse Event|0|||
37877533|NCT01133405|69561935|FG000|Period 2|Withdrawal by Subject|0|||
37877534|NCT01133405|69561936|FG001|Period 2|Withdrawal by Subject|0|||
37877535|NCT01133405|69561937|FG002|Period 2|Withdrawal by Subject|0|||
37877536|NCT01133405|69561938|FG003|Period 2|Withdrawal by Subject|1|||
37877537|NCT01133405|69561939|FG004|Period 2|Withdrawal by Subject|0|||
37877538|NCT01133405|69561940|FG005|Period 2|Withdrawal by Subject|1|||
37877539|NCT01133405|69561941|FG006|Period 2|Withdrawal by Subject|0|||
37877540|NCT01133405|69561942|FG007|Period 2|Withdrawal by Subject|0|||
37877541|NCT01133405|69561943|FG008|Period 2|Withdrawal by Subject|0|||
37877542|NCT01133405|69561944|FG009|Period 2|Withdrawal by Subject|0|||
37877543|NCT01133405|69561935|FG000|Period 2|Entry Criteria Not Met|0|||
37877544|NCT01133405|69561936|FG001|Period 2|Entry Criteria Not Met|1|||
37877545|NCT01133405|69561937|FG002|Period 2|Entry Criteria Not Met|0|||
37877546|NCT01133405|69561938|FG003|Period 2|Entry Criteria Not Met|0|||
37877547|NCT01133405|69561939|FG004|Period 2|Entry Criteria Not Met|0|||
37877548|NCT01133405|69561940|FG005|Period 2|Entry Criteria Not Met|0|||
37877549|NCT01133405|69561941|FG006|Period 2|Entry Criteria Not Met|0|||
37877550|NCT01133405|69561942|FG007|Period 2|Entry Criteria Not Met|0|||
37877551|NCT01133405|69561943|FG008|Period 2|Entry Criteria Not Met|0|||
37877552|NCT01133405|69561944|FG009|Period 2|Entry Criteria Not Met|0|||
37877553|NCT01133405|69561935|FG000|Period 2|Physician Decision|0|||
37877554|NCT01133405|69561936|FG001|Period 2|Physician Decision|0|||
37877555|NCT01133405|69561937|FG002|Period 2|Physician Decision|0|||
37877556|NCT01133405|69561938|FG003|Period 2|Physician Decision|0|||
37877557|NCT01133405|69561939|FG004|Period 2|Physician Decision|0|||
37877558|NCT01133405|69561940|FG005|Period 2|Physician Decision|1|||
37877559|NCT01133405|69561941|FG006|Period 2|Physician Decision|0|||
37877560|NCT01133405|69561942|FG007|Period 2|Physician Decision|0|||
37877561|NCT01133405|69561943|FG008|Period 2|Physician Decision|0|||
37877562|NCT01133405|69561944|FG009|Period 2|Physician Decision|0|||
37877563|NCT01196078|69561976|FG000|Overall Study|Withdrawal by Subject|3|||
37877564|NCT01196078|69561977|FG001|Overall Study|Withdrawal by Subject|5|||
37877565|NCT01196078|69561976|FG000|Overall Study|Adverse Event|4|||
37983442|NCT00276094|69669667|FG001|Overall Study|Adverse Event|13|||
37983443|NCT00276094|69669668|FG002|Overall Study|Adverse Event|11|||
37983444|NCT00276094|69669666|FG000|Overall Study|Withdrawal by Subject|14|||
37983445|NCT00276094|69669667|FG001|Overall Study|Withdrawal by Subject|14|||
37983446|NCT00276094|69669668|FG002|Overall Study|Withdrawal by Subject|12|||
37983447|NCT00276094|69669666|FG000|Overall Study|Protocol Violation|16|||
37877566|NCT01196078|69561977|FG001|Overall Study|Adverse Event|4|||
37877567|NCT01196078|69561976|FG000|Overall Study|Protocol Violation|2|||
37877568|NCT01196078|69561977|FG001|Overall Study|Protocol Violation|1|||
37877569|NCT01196078|69561976|FG000|Overall Study|Lack of Efficacy|17|||
37877570|NCT01196078|69561977|FG001|Overall Study|Lack of Efficacy|23|||
37983448|NCT00276094|69669667|FG001|Overall Study|Protocol Violation|7|||
37983449|NCT00276094|69669668|FG002|Overall Study|Protocol Violation|10|||
37877571|NCT01196078|69561976|FG000|Overall Study|Lost to Follow-up|1|||
37877572|NCT01196078|69561977|FG001|Overall Study|Lost to Follow-up|0|||
37877573|NCT01196078|69561976|FG000|Overall Study|Death|6|||
37877574|NCT01196078|69561977|FG001|Overall Study|Death|4|||
37877575|NCT01078584|69561983|FG000|Overall Study|Final Status Unknown|1073|||
37877576|NCT01078584|69561983|FG000|Overall Study|Lost to Follow-up|670|||
37877577|NCT01078584|69561983|FG000|Overall Study|Non-serious Adverse Event|577|||
37877578|NCT01078584|69561983|FG000|Overall Study|Withdrawal of Consent|244|||
37983450|NCT00276094|69669666|FG000|Overall Study|Lost to Follow-up|8|||
37983451|NCT00276094|69669667|FG001|Overall Study|Lost to Follow-up|6|||
37983452|NCT00276094|69669668|FG002|Overall Study|Lost to Follow-up|4|||
37983453|NCT00276094|69669666|FG000|Overall Study|Other-Subject moved out of country|1|||
37983454|NCT00276094|69669667|FG001|Overall Study|Other-Subject moved out of country|0|||
37983455|NCT00276094|69669668|FG002|Overall Study|Other-Subject moved out of country|0|||
37983456|NCT00276094|69669666|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
37983457|NCT00276094|69669667|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
37983458|NCT00276094|69669668|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
37983459|NCT00276094|69669666|FG000|Overall Study|Other-Lack of efficacy|1|||
37983460|NCT00276094|69669667|FG001|Overall Study|Other-Lack of efficacy|0|||
37983461|NCT00276094|69669668|FG002|Overall Study|Other-Lack of efficacy|0|||
37983462|NCT00276094|69669666|FG000|Overall Study|Other-Refused follow-up visit|1|||
37983463|NCT00276094|69669667|FG001|Overall Study|Other-Refused follow-up visit|0|||
37983464|NCT00276094|69669668|FG002|Overall Study|Other-Refused follow-up visit|0|||
37983465|NCT00276094|69669666|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
37983466|NCT00276094|69669667|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
37695197|NCT02365298|69171725|FG001|Period 2|Protocol Violation|1|||
37818529|NCT03715829|69497749|FG008|Extension Period|Withdrawal by Subject|12|||
37818530|NCT03715829|69497750|FG009|Extension Period|Withdrawal by Subject|3|||
37818531|NCT03715829|69497751|FG010|Extension Period|Withdrawal by Subject|0|||
37818532|NCT03715829|69497741|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
37818533|NCT03715829|69497742|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
37818534|NCT03715829|69497743|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
37818535|NCT03715829|69497744|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
37818536|NCT03715829|69497745|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
37818537|NCT03715829|69497746|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
37818538|NCT03715829|69497747|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
37818539|NCT03715829|69497748|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
37818540|NCT03715829|69497749|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
37818541|NCT03715829|69497750|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
37818542|NCT03715829|69497751|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
37818543|NCT03715829|69497741|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
37818544|NCT03715829|69497742|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
37818545|NCT03715829|69497743|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
37818546|NCT03715829|69497744|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
37818547|NCT03715829|69497745|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
37818548|NCT03715829|69497746|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
37818549|NCT03715829|69497747|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
37818550|NCT03715829|69497748|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
37818551|NCT03715829|69497749|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
37818552|NCT03715829|69497750|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
37818553|NCT03715829|69497751|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
37818554|NCT03715829|69497741|FG000|Extension Period|Other|0|||
37818555|NCT03715829|69497742|FG001|Extension Period|Other|0|||
37818556|NCT03715829|69497743|FG002|Extension Period|Other|0|||
37818557|NCT03715829|69497744|FG003|Extension Period|Other|0|||
37818558|NCT03715829|69497745|FG004|Extension Period|Other|0|||
37818559|NCT03715829|69497746|FG005|Extension Period|Other|0|||
37818560|NCT03715829|69497747|FG006|Extension Period|Other|1|||
37818561|NCT03715829|69497748|FG007|Extension Period|Other|2|||
37818562|NCT03715829|69497749|FG008|Extension Period|Other|4|||
37818563|NCT03715829|69497750|FG009|Extension Period|Other|0|||
37818564|NCT03715829|69497751|FG010|Extension Period|Other|0|||
37818565|NCT03575104|69497813|FG000|Overall Study|Adverse Event|4|||
37818566|NCT03575104|69497814|FG001|Overall Study|Adverse Event|3|||
37818567|NCT03575104|69497815|FG002|Overall Study|Adverse Event|4|||
37818568|NCT03575104|69497813|FG000|Overall Study|Withdrawal by Subject|13|||
37818569|NCT03575104|69497814|FG001|Overall Study|Withdrawal by Subject|16|||
37818570|NCT03575104|69497815|FG002|Overall Study|Withdrawal by Subject|11|||
37818571|NCT03575104|69497813|FG000|Overall Study|Other reasons|6|||
37818572|NCT03575104|69497814|FG001|Overall Study|Other reasons|8|||
37818573|NCT03575104|69497815|FG002|Overall Study|Other reasons|6|||
37818574|NCT03575104|69497813|FG000|Overall Study|Lost to Follow-up|1|||
37818575|NCT03575104|69497814|FG001|Overall Study|Lost to Follow-up|2|||
37983467|NCT00276094|69669668|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
37983468|NCT00276094|69669666|FG000|Overall Study|Other-Relocation|0|||
37877579|NCT01078584|69561983|FG000|Overall Study|Physician Withdrew from Study|90|||
37877580|NCT01078584|69561983|FG000|Overall Study|Non-compliance|67|||
37877581|NCT01078584|69561983|FG000|Overall Study|Blood Pressure Controlled|49|||
37877582|NCT01078584|69561983|FG000|Overall Study|Physician Switched Medication|26|||
37877583|NCT01078584|69561983|FG000|Overall Study|Physician Discontinued Patient|12|||
37877584|NCT01078584|69561983|FG000|Overall Study|Lack of Efficacy|98|||
37983469|NCT00276094|69669667|FG001|Overall Study|Other-Relocation|1|||
37983470|NCT00276094|69669668|FG002|Overall Study|Other-Relocation|0|||
37818576|NCT03575104|69497815|FG002|Overall Study|Lost to Follow-up|1|||
37983471|NCT00276094|69669666|FG000|Overall Study|Other-Study medication lost|0|||
37983472|NCT00276094|69669667|FG001|Overall Study|Other-Study medication lost|0|||
37983473|NCT00276094|69669668|FG002|Overall Study|Other-Study medication lost|1|||
37983474|NCT00276016|69669682|FG000|Intervention 1|Withdrawal by Subject|0|||
37983475|NCT00276016|69669683|FG001|Intervention 1|Withdrawal by Subject|1|||
37983476|NCT00276016|69669684|FG002|Intervention 1|Withdrawal by Subject|0|||
37983477|NCT00276016|69669685|FG003|Intervention 1|Withdrawal by Subject|0|||
37983478|NCT00276016|69669686|FG004|Intervention 1|Withdrawal by Subject|0|||
37818577|NCT03569475|69497826|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
37818578|NCT03569475|69497827|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
37818579|NCT03569475|69497828|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
37818580|NCT03569475|69497826|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
37818581|NCT03569475|69497827|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
37818582|NCT03569475|69497828|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
37818583|NCT03569475|69497826|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
37818584|NCT03569475|69497827|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
37818585|NCT03569475|69497828|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
37818586|NCT03569475|69497826|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
37818587|NCT03569475|69497827|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
37818588|NCT03569475|69497828|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
37818589|NCT03569475|69497826|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
37818590|NCT03569475|69497827|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
37818591|NCT03569475|69497828|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
37818592|NCT03569475|69497826|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
37818593|NCT03569475|69497827|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
37818594|NCT03569475|69497828|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
37818595|NCT03569475|69497826|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
37818596|NCT03569475|69497827|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
37818597|NCT03569475|69497828|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
37818598|NCT03569475|69497826|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
37877585|NCT01078584|69561983|FG000|Overall Study|Protocol Violation|75|||
37877586|NCT01078584|69561983|FG000|Overall Study|Serious Adverse Event|27|||
37877587|NCT01078584|69561983|FG000|Overall Study|Multiple Reasons|2|||
37983479|NCT00276016|69669687|FG005|Intervention 1|Withdrawal by Subject|0|||
37983480|NCT00434642|69669698|FG000|Blinded Treatment Phase|Adverse Event|12|||
37983481|NCT00434642|69669699|FG001|Blinded Treatment Phase|Adverse Event|58|||
37877588|NCT01133171|69562003|FG000|Overall Study|Withdrawal by Subject|1|||
37877589|NCT01133171|69562004|FG001|Overall Study|Withdrawal by Subject|2|||
37877590|NCT01133171|69562005|FG002|Overall Study|Withdrawal by Subject|0|||
37877591|NCT01195844|69562013|FG000|Overall Study|Fecal sample not collected|40|||
37877592|NCT01132547|69562029|FG000|Overall Study|Withdrawal by Subject|3|||
37877593|NCT01132547|69562030|FG001|Overall Study|Withdrawal by Subject|1|||
37877594|NCT01132547|69562029|FG000|Overall Study|Death|1|||
37877595|NCT01132547|69562030|FG001|Overall Study|Death|0|||
37877596|NCT01194830|69562038|FG000|Overall Study|Adverse Event|3|||
37877597|NCT01194830|69562039|FG001|Overall Study|Adverse Event|2|||
37877598|NCT01194830|69562038|FG000|Overall Study|Protocol Violation|5|||
37877599|NCT01194830|69562039|FG001|Overall Study|Protocol Violation|4|||
37877600|NCT01194830|69562038|FG000|Overall Study|Lost to Follow-up|9|||
37877601|NCT01194830|69562039|FG001|Overall Study|Lost to Follow-up|7|||
37877602|NCT01194830|69562038|FG000|Overall Study|Withdrawal by Subject|2|||
37877603|NCT01194830|69562039|FG001|Overall Study|Withdrawal by Subject|1|||
37877604|NCT01194830|69562038|FG000|Overall Study|Lack of Efficacy|1|||
37877605|NCT01194830|69562039|FG001|Overall Study|Lack of Efficacy|1|||
37877606|NCT01194830|69562038|FG000|Overall Study|Non-compliance issues|4|||
37877607|NCT01194830|69562039|FG001|Overall Study|Non-compliance issues|4|||
37877608|NCT01194830|69562038|FG000|Overall Study|Other Reason|12|||
37877609|NCT01194830|69562039|FG001|Overall Study|Other Reason|8|||
37877610|NCT01194440|69562045|FG000|Baseline (First Dose)|Reason not specified|4|||
37877611|NCT01194440|69562045|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
37877612|NCT01194440|69562045|FG000|Baseline (First Dose)|Change in therapy|1|||
37877613|NCT01194440|69562045|FG000|Baseline (First Dose)|Adverse Event|1|||
37877614|NCT01194440|69562045|FG000|6-months (2nd Dose)|Change in therapy|4|||
37877615|NCT00951015|69562054|FG000|Randomization Phase 96 Week|Adverse Event|1|||
37877616|NCT00951015|69562055|FG001|Randomization Phase 96 Week|Adverse Event|1|||
37877617|NCT00951015|69562056|FG002|Randomization Phase 96 Week|Adverse Event|2|||
37877618|NCT00951015|69562057|FG003|Randomization Phase 96 Week|Adverse Event|5|||
37877619|NCT00951015|69562058|FG004|Randomization Phase 96 Week|Adverse Event|0|||
37877620|NCT00951015|69562054|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
37877621|NCT00951015|69562055|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
37877622|NCT00951015|69562056|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
37877623|NCT00951015|69562057|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
37877624|NCT00951015|69562058|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
37877625|NCT00951015|69562054|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
37877626|NCT00951015|69562055|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
37818599|NCT03569475|69497827|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
37818600|NCT03569475|69497828|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
37877627|NCT00951015|69562056|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
37877628|NCT00951015|69562057|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
37877629|NCT00951015|69562058|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
37877630|NCT00951015|69562054|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
37877631|NCT00951015|69562055|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
37818601|NCT03569475|69497826|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
37818602|NCT03569475|69497827|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
37818603|NCT03569475|69497828|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
37818604|NCT03545191|69497882|FG000|Overall Study|Death|1|||
37818605|NCT03545191|69497883|FG001|Overall Study|Death|0|||
37818606|NCT03545191|69497884|FG002|Overall Study|Death|0|||
37818607|NCT03545191|69497882|FG000|Overall Study|Adverse Event|4|||
37818608|NCT03545191|69497883|FG001|Overall Study|Adverse Event|2|||
37818609|NCT03545191|69497884|FG002|Overall Study|Adverse Event|7|||
37818610|NCT03545191|69497882|FG000|Overall Study|Other reasons|3|||
37818611|NCT03545191|69497883|FG001|Overall Study|Other reasons|11|||
37818612|NCT03545191|69497884|FG002|Overall Study|Other reasons|8|||
37818613|NCT03545191|69497882|FG000|Overall Study|Withdrawal by Subject|13|||
37877632|NCT00951015|69562056|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
37877633|NCT00951015|69562057|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
37877634|NCT00951015|69562058|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
37877635|NCT00951015|69562054|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
37877636|NCT00951015|69562055|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
37877637|NCT00951015|69562056|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
37877638|NCT00951015|69562057|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
37877639|NCT00951015|69562058|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
37877640|NCT00951015|69562054|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
37877641|NCT00951015|69562055|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
37877642|NCT00951015|69562056|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
37877643|NCT00951015|69562057|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
37818614|NCT03545191|69497883|FG001|Overall Study|Withdrawal by Subject|10|||
37818615|NCT03545191|69497884|FG002|Overall Study|Withdrawal by Subject|12|||
37983482|NCT00434642|69669698|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
37983483|NCT00434642|69669699|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
37983484|NCT00434642|69669698|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
37983485|NCT00434642|69669699|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
37983486|NCT00434642|69669698|FG000|Blinded Treatment Phase|Physician Decision|19|||
37983487|NCT00434642|69669699|FG001|Blinded Treatment Phase|Physician Decision|27|||
37983488|NCT00434642|69669698|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
37983489|NCT00434642|69669699|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
37983490|NCT00434642|69669698|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
37983491|NCT00434642|69669699|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
37983492|NCT00434642|69669698|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
37983493|NCT00434642|69669699|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
37983494|NCT00434642|69669698|FG000|Open-label Treatment Phase|Adverse Event|0|||
37983495|NCT00434642|69669699|FG001|Open-label Treatment Phase|Adverse Event|5|||
37983496|NCT00434642|69669698|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
37983497|NCT00434642|69669699|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
37983498|NCT00434330|69669711|FG000|Overall Study|Adverse Event|0|||
37983499|NCT00434330|69669712|FG001|Overall Study|Adverse Event|0|||
37983500|NCT00434330|69669713|FG002|Overall Study|Adverse Event|1|||
37983501|NCT00434330|69669714|FG003|Overall Study|Adverse Event|0|||
37983502|NCT00434330|69669715|FG004|Overall Study|Adverse Event|0|||
37983503|NCT00434330|69669716|FG005|Overall Study|Adverse Event|0|||
37983504|NCT00434330|69669711|FG000|Overall Study|Death|1|||
37983505|NCT00434330|69669712|FG001|Overall Study|Death|0|||
37983506|NCT00434330|69669713|FG002|Overall Study|Death|0|||
37983507|NCT00434330|69669714|FG003|Overall Study|Death|0|||
37983508|NCT00434330|69669715|FG004|Overall Study|Death|1|||
37983509|NCT00434330|69669716|FG005|Overall Study|Death|1|||
37983510|NCT00434330|69669711|FG000|Overall Study|Withdrawal by Subject|0|||
37983511|NCT00434330|69669712|FG001|Overall Study|Withdrawal by Subject|0|||
37983512|NCT00434330|69669713|FG002|Overall Study|Withdrawal by Subject|1|||
37983513|NCT00434330|69669714|FG003|Overall Study|Withdrawal by Subject|1|||
37983514|NCT00434330|69669715|FG004|Overall Study|Withdrawal by Subject|0|||
37983515|NCT00434330|69669716|FG005|Overall Study|Withdrawal by Subject|0|||
37983516|NCT00434330|69669711|FG000|Overall Study|Renal transplant|0|||
37983517|NCT00434330|69669712|FG001|Overall Study|Renal transplant|0|||
37983518|NCT00434330|69669713|FG002|Overall Study|Renal transplant|0|||
37983519|NCT00434330|69669714|FG003|Overall Study|Renal transplant|1|||
37983520|NCT00434330|69669715|FG004|Overall Study|Renal transplant|0|||
37983521|NCT00434330|69669716|FG005|Overall Study|Renal transplant|0|||
37983522|NCT00434330|69669711|FG000|Overall Study|Subject Not Compliant With Study|0|||
37983523|NCT00434330|69669712|FG001|Overall Study|Subject Not Compliant With Study|0|||
37983524|NCT00434330|69669713|FG002|Overall Study|Subject Not Compliant With Study|1|||
37983525|NCT00434330|69669714|FG003|Overall Study|Subject Not Compliant With Study|0|||
37983526|NCT00434330|69669715|FG004|Overall Study|Subject Not Compliant With Study|0|||
37983527|NCT00434330|69669716|FG005|Overall Study|Subject Not Compliant With Study|0|||
37983528|NCT00426764|69669730|FG000|Overall Study|Protocol Violation|1|||
37983529|NCT00426764|69669730|FG000|Overall Study|Withdrawal by Subject|4|||
37983530|NCT00426764|69669730|FG000|Overall Study|Physician Decision|6|||
37983531|NCT00426764|69669730|FG000|Overall Study|Compassionate Use|1|||
37983532|NCT00426764|69669730|FG000|Overall Study|Progressive Disease|83|||
37983533|NCT00426764|69669730|FG000|Overall Study|Adverse Event|24|||
37983534|NCT00426764|69669730|FG000|Overall Study|Other|1|||
37983535|NCT00426764|69669730|FG000|Overall Study|Death|1|||
37983536|NCT00426764|69669730|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
37983537|NCT00434252|69669742|FG000|Overall Study|Lack of Efficacy|50|||
37983538|NCT00434252|69669743|FG001|Overall Study|Lack of Efficacy|100|||
37983539|NCT00434252|69669742|FG000|Overall Study|Adverse Event|6|||
37983540|NCT00434252|69669743|FG001|Overall Study|Adverse Event|13|||
37983541|NCT00434252|69669742|FG000|Overall Study|Death|1|||
37983542|NCT00434252|69669743|FG001|Overall Study|Death|2|||
37983543|NCT00434252|69669742|FG000|Overall Study|Lost to Follow-up|0|||
37983544|NCT00434252|69669743|FG001|Overall Study|Lost to Follow-up|1|||
37983545|NCT00434252|69669742|FG000|Overall Study|Physician Decision|4|||
37983546|NCT00434252|69669743|FG001|Overall Study|Physician Decision|8|||
37983547|NCT00434252|69669742|FG000|Overall Study|Withdrawal by Subject|3|||
37983548|NCT00434252|69669743|FG001|Overall Study|Withdrawal by Subject|7|||
37983549|NCT00425750|69669749|FG000|Overall Study|Death|1|||
37983550|NCT00425750|69669749|FG000|Overall Study|Withdrawal by Subject|3|||
37983551|NCT00425750|69669749|FG000|Overall Study|Adverse Event|3|||
37983552|NCT00425750|69669749|FG000|Overall Study|Progression of disease|18|||
37983553|NCT00414908|69669755|FG000|Overall Study|Protocol Violation|1|||
37983554|NCT00414908|69669756|FG001|Overall Study|Protocol Violation|1|||
37983555|NCT00242710|69669768|FG000|Core Study (up to Year 1)|Adverse Event|30|||
37983556|NCT00242710|69669769|FG001|Core Study (up to Year 1)|Adverse Event|25|||
37983557|NCT00242710|69669770|FG002|Core Study (up to Year 1)|Adverse Event|23|||
37877644|NCT00951015|69562058|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
37877645|NCT00951015|69562054|FG000|Open-label Phase|Adverse Event|0|||
37877646|NCT00951015|69562055|FG001|Open-label Phase|Adverse Event|0|||
37877647|NCT00951015|69562056|FG002|Open-label Phase|Adverse Event|0|||
37877648|NCT00951015|69562057|FG003|Open-label Phase|Adverse Event|0|||
37877649|NCT00951015|69562058|FG004|Open-label Phase|Adverse Event|3|||
37877650|NCT00951015|69562054|FG000|Open-label Phase|Lack of Efficacy|0|||
37877651|NCT00951015|69562055|FG001|Open-label Phase|Lack of Efficacy|0|||
37877652|NCT00951015|69562056|FG002|Open-label Phase|Lack of Efficacy|0|||
37877653|NCT00951015|69562057|FG003|Open-label Phase|Lack of Efficacy|0|||
37877654|NCT00951015|69562058|FG004|Open-label Phase|Lack of Efficacy|1|||
37877655|NCT00951015|69562054|FG000|Open-label Phase|Protocol Violation|0|||
37877656|NCT00951015|69562055|FG001|Open-label Phase|Protocol Violation|0|||
37877657|NCT00951015|69562056|FG002|Open-label Phase|Protocol Violation|0|||
37877658|NCT00951015|69562057|FG003|Open-label Phase|Protocol Violation|0|||
37877659|NCT00951015|69562058|FG004|Open-label Phase|Protocol Violation|12|||
37877660|NCT00951015|69562054|FG000|Open-label Phase|Lost to Follow-up|0|||
37877661|NCT00951015|69562055|FG001|Open-label Phase|Lost to Follow-up|0|||
37877662|NCT00951015|69562056|FG002|Open-label Phase|Lost to Follow-up|0|||
37877663|NCT00951015|69562057|FG003|Open-label Phase|Lost to Follow-up|0|||
37877664|NCT00951015|69562058|FG004|Open-label Phase|Lost to Follow-up|12|||
37877665|NCT00951015|69562054|FG000|Open-label Phase|Withdrawal by Subject|0|||
37877666|NCT00951015|69562055|FG001|Open-label Phase|Withdrawal by Subject|0|||
37877667|NCT00951015|69562056|FG002|Open-label Phase|Withdrawal by Subject|0|||
37877668|NCT00951015|69562057|FG003|Open-label Phase|Withdrawal by Subject|0|||
37877669|NCT00951015|69562058|FG004|Open-label Phase|Withdrawal by Subject|14|||
37877670|NCT00951015|69562054|FG000|Open-label Phase|Physician Decision|0|||
37877671|NCT00951015|69562055|FG001|Open-label Phase|Physician Decision|0|||
37877672|NCT00951015|69562056|FG002|Open-label Phase|Physician Decision|0|||
37877673|NCT00951015|69562057|FG003|Open-label Phase|Physician Decision|0|||
37877674|NCT00951015|69562058|FG004|Open-label Phase|Physician Decision|8|||
37877675|NCT01139021|69562087|FG000|Overall Study|Adverse Event|0|||
37877676|NCT01139021|69562088|FG001|Overall Study|Adverse Event|0|||
37877677|NCT01139021|69562089|FG002|Overall Study|Adverse Event|0|||
37877678|NCT01139021|69562090|FG003|Overall Study|Adverse Event|0|||
37877679|NCT01139021|69562091|FG004|Overall Study|Adverse Event|1|||
37877680|NCT01139021|69562092|FG005|Overall Study|Adverse Event|0|||
37877681|NCT01139021|69562087|FG000|Overall Study|Lost to Follow-up|0|||
37877682|NCT01139021|69562088|FG001|Overall Study|Lost to Follow-up|0|||
37877683|NCT01139021|69562089|FG002|Overall Study|Lost to Follow-up|0|||
37877684|NCT01139021|69562090|FG003|Overall Study|Lost to Follow-up|0|||
37877685|NCT01139021|69562091|FG004|Overall Study|Lost to Follow-up|2|||
37877686|NCT01139021|69562092|FG005|Overall Study|Lost to Follow-up|0|||
37877687|NCT01139021|69562087|FG000|Overall Study|Protocol Violation|1|||
37877688|NCT01139021|69562088|FG001|Overall Study|Protocol Violation|0|||
37877689|NCT01139021|69562089|FG002|Overall Study|Protocol Violation|0|||
37877690|NCT01139021|69562090|FG003|Overall Study|Protocol Violation|0|||
37877691|NCT01139021|69562091|FG004|Overall Study|Protocol Violation|2|||
37818616|NCT03545191|69497882|FG000|Overall Study|Lost to Follow-up|1|||
37818617|NCT03545191|69497883|FG001|Overall Study|Lost to Follow-up|2|||
37818618|NCT03545191|69497884|FG002|Overall Study|Lost to Follow-up|3|||
37818619|NCT03500549|69497894|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
37818620|NCT03500549|69497895|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
37818621|NCT03500549|69497894|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
37818622|NCT03500549|69497895|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
37818623|NCT03366792|69497915|FG000|Overall Study|Withdrawal by Subject|7|||
37818624|NCT03366792|69497915|FG000|Overall Study|Lost to Follow-up|2|||
37818625|NCT03366792|69497915|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
37877692|NCT01139021|69562092|FG005|Overall Study|Protocol Violation|0|||
37877693|NCT01139021|69562087|FG000|Overall Study|Withdrawal by Subject|0|||
37877694|NCT01139021|69562088|FG001|Overall Study|Withdrawal by Subject|0|||
37877695|NCT01139021|69562089|FG002|Overall Study|Withdrawal by Subject|0|||
37877696|NCT01139021|69562090|FG003|Overall Study|Withdrawal by Subject|1|||
37877697|NCT01139021|69562091|FG004|Overall Study|Withdrawal by Subject|4|||
37877698|NCT01139021|69562092|FG005|Overall Study|Withdrawal by Subject|0|||
37877699|NCT01193660|69562110|FG000|Overall Study|Withdrawal by Subject|2|||
37877700|NCT01193660|69562111|FG001|Overall Study|Withdrawal by Subject|3|||
37877701|NCT01193660|69562112|FG002|Overall Study|Withdrawal by Subject|1|||
37877702|NCT01193660|69562110|FG000|Overall Study|Death|1|||
37877703|NCT01193660|69562111|FG001|Overall Study|Death|0|||
37877704|NCT01193660|69562112|FG002|Overall Study|Death|0|||
37877705|NCT01193660|69562110|FG000|Overall Study|Physician Decision|1|||
37877706|NCT01193660|69562111|FG001|Overall Study|Physician Decision|0|||
37877707|NCT01193660|69562112|FG002|Overall Study|Physician Decision|1|||
37877708|NCT01076166|69562120|FG000|Overall Study|Adverse Event|3|||
37877709|NCT01076166|69562120|FG000|Overall Study|Symptoms improved/resolved|6|||
37877710|NCT01193582|69562131|FG000|Vaccination Series|Withdrawal by Subject|11|||
37877711|NCT01193582|69562132|FG001|Vaccination Series|Withdrawal by Subject|13|||
37877712|NCT01193582|69562133|FG002|Vaccination Series|Withdrawal by Subject|8|||
37877713|NCT01193582|69562134|FG003|Vaccination Series|Withdrawal by Subject|3|||
37877714|NCT01193582|69562131|FG000|12 Month Follow-up|Death|0|||
37877715|NCT01193582|69562132|FG001|12 Month Follow-up|Death|0|||
37877716|NCT01193582|69562133|FG002|12 Month Follow-up|Death|1|||
37877717|NCT01193582|69562134|FG003|12 Month Follow-up|Death|0|||
37877718|NCT01193582|69562131|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
37877719|NCT01193582|69562132|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
37877720|NCT01193582|69562133|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
37877721|NCT01193582|69562134|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
37877722|NCT00945477|69562146|FG000|Overall Study|Adverse Event|3|||
37877723|NCT00945477|69562146|FG000|Overall Study|Lack of Efficacy|2|||
37877724|NCT00945477|69562146|FG000|Overall Study|Withdrawal by Subject|1|||
37877725|NCT01076088|69562157|FG000|Overall Study|Adverse Event|1|||
37877726|NCT01076088|69562158|FG001|Overall Study|Adverse Event|6|||
37877727|NCT01076088|69562159|FG002|Overall Study|Adverse Event|3|||
37877728|NCT01076088|69562160|FG003|Overall Study|Adverse Event|2|||
37877729|NCT01076088|69562161|FG004|Overall Study|Adverse Event|3|||
37877730|NCT01076088|69562162|FG005|Overall Study|Adverse Event|3|||
37877731|NCT01076088|69562157|FG000|Overall Study|Lost to Follow-up|1|||
37877732|NCT01076088|69562158|FG001|Overall Study|Lost to Follow-up|1|||
37877733|NCT01076088|69562159|FG002|Overall Study|Lost to Follow-up|0|||
37877734|NCT01076088|69562160|FG003|Overall Study|Lost to Follow-up|1|||
37877735|NCT01076088|69562161|FG004|Overall Study|Lost to Follow-up|1|||
37877736|NCT01076088|69562162|FG005|Overall Study|Lost to Follow-up|2|||
37877737|NCT01076088|69562157|FG000|Overall Study|Non-compliance with study drug|0|||
37877738|NCT01076088|69562158|FG001|Overall Study|Non-compliance with study drug|0|||
37877739|NCT01076088|69562159|FG002|Overall Study|Non-compliance with study drug|0|||
37877740|NCT01076088|69562160|FG003|Overall Study|Non-compliance with study drug|1|||
37877741|NCT01076088|69562161|FG004|Overall Study|Non-compliance with study drug|0|||
37877742|NCT01076088|69562162|FG005|Overall Study|Non-compliance with study drug|0|||
37877743|NCT01076088|69562157|FG000|Overall Study|Physician Decision|1|||
37877744|NCT01076088|69562158|FG001|Overall Study|Physician Decision|3|||
37877745|NCT01076088|69562159|FG002|Overall Study|Physician Decision|0|||
37877746|NCT01076088|69562160|FG003|Overall Study|Physician Decision|1|||
37877747|NCT01076088|69562161|FG004|Overall Study|Physician Decision|1|||
37877748|NCT01076088|69562162|FG005|Overall Study|Physician Decision|0|||
37877749|NCT01076088|69562157|FG000|Overall Study|Withdrawal by Subject|8|||
37877750|NCT01076088|69562158|FG001|Overall Study|Withdrawal by Subject|8|||
37877751|NCT01076088|69562159|FG002|Overall Study|Withdrawal by Subject|14|||
37877752|NCT01076088|69562160|FG003|Overall Study|Withdrawal by Subject|10|||
37877753|NCT01076088|69562161|FG004|Overall Study|Withdrawal by Subject|11|||
37877754|NCT01076088|69562162|FG005|Overall Study|Withdrawal by Subject|17|||
37877755|NCT01076088|69562157|FG000|Overall Study|Other protocol specified criteria|0|||
37877756|NCT01076088|69562158|FG001|Overall Study|Other protocol specified criteria|0|||
37877757|NCT01076088|69562159|FG002|Overall Study|Other protocol specified criteria|0|||
37877758|NCT01076088|69562160|FG003|Overall Study|Other protocol specified criteria|0|||
37877759|NCT01076088|69562161|FG004|Overall Study|Other protocol specified criteria|0|||
37877760|NCT01076088|69562162|FG005|Overall Study|Other protocol specified criteria|1|||
37877761|NCT01193348|69562177|FG000|Screening Period|Screen Failure|5|||
37877762|NCT01193348|69562177|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
37877763|NCT01193348|69562177|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
37983558|NCT00242710|69669771|FG003|Core Study (up to Year 1)|Adverse Event|14|||
37983559|NCT00242710|69669768|FG000|Core Study (up to Year 1)|Death|0|||
37983560|NCT00242710|69669769|FG001|Core Study (up to Year 1)|Death|0|||
37983561|NCT00242710|69669770|FG002|Core Study (up to Year 1)|Death|1|||
37983562|NCT00242710|69669771|FG003|Core Study (up to Year 1)|Death|0|||
37983563|NCT00242710|69669768|FG000|Core Study (up to Year 1)|Physician Decision|0|||
37983564|NCT00242710|69669769|FG001|Core Study (up to Year 1)|Physician Decision|1|||
37983565|NCT00242710|69669770|FG002|Core Study (up to Year 1)|Physician Decision|0|||
37877764|NCT01193348|69562177|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
37877765|NCT01193348|69562177|FG000|Extension Treatment Period|Physician Decision|1|||
37877766|NCT01193348|69562177|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
37877767|NCT00945321|69562186|FG000|Period 1|Adverse Event|0|||
37877768|NCT00945321|69562187|FG001|Period 1|Adverse Event|0|||
37877769|NCT00945321|69562188|FG002|Period 1|Adverse Event|0|||
37877770|NCT00945321|69562189|FG003|Period 1|Adverse Event|0|||
37877771|NCT00945321|69562190|FG004|Period 1|Adverse Event|1|||
37877772|NCT00945321|69562191|FG005|Period 1|Adverse Event|0|||
37877773|NCT00945321|69562186|FG000|Period 4|Lost to Follow-up|0|||
37877774|NCT00945321|69562187|FG001|Period 4|Lost to Follow-up|0|||
37877775|NCT00945321|69562188|FG002|Period 4|Lost to Follow-up|0|||
37877776|NCT00945321|69562189|FG003|Period 4|Lost to Follow-up|0|||
37877777|NCT00945321|69562190|FG004|Period 4|Lost to Follow-up|0|||
37877778|NCT00945321|69562191|FG005|Period 4|Lost to Follow-up|1|||
37877779|NCT00945243|69562209|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
37877780|NCT01192412|69562215|FG000|Overall Study|Lost to Follow-up|2|||
37877781|NCT01192412|69562216|FG001|Overall Study|Lost to Follow-up|1|||
37877782|NCT01192412|69562215|FG000|Overall Study|Withdrawal by Subject|2|||
37877783|NCT01192412|69562216|FG001|Overall Study|Withdrawal by Subject|1|||
37877784|NCT01192178|69562224|FG000|Overall Study|Withdrawal by Subject|6|||
37877785|NCT01192178|69562225|FG001|Overall Study|Withdrawal by Subject|10|||
37877786|NCT01192178|69562224|FG000|Overall Study|Protocol Violation|10|||
37877787|NCT01192178|69562225|FG001|Overall Study|Protocol Violation|3|||
37983566|NCT00242710|69669771|FG003|Core Study (up to Year 1)|Physician Decision|1|||
37983567|NCT00242710|69669768|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
37983568|NCT00242710|69669769|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
37983569|NCT00242710|69669770|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
37983570|NCT00242710|69669771|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
37983571|NCT00242710|69669768|FG000|Core Study (up to Year 1)|Other|6|||
37983572|NCT00242710|69669769|FG001|Core Study (up to Year 1)|Other|1|||
37983573|NCT00242710|69669770|FG002|Core Study (up to Year 1)|Other|0|||
37818626|NCT03366792|69497915|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
37818627|NCT03342053|69497921|FG000|Overall Study|Adverse Event|2|||
37818628|NCT03342053|69497922|FG001|Overall Study|Adverse Event|0|||
37818629|NCT03342053|69497921|FG000|Overall Study|Withdrawal by Subject|0|||
37818630|NCT03342053|69497922|FG001|Overall Study|Withdrawal by Subject|1|||
37818631|NCT03325777|69497930|FG000|Overall Study|Lost to Follow-up|9|||
37818632|NCT03325777|69497931|FG001|Overall Study|Lost to Follow-up|12|||
37818633|NCT03283241|69497939|FG000|Overall Study|Adverse Event|4|||
37818634|NCT03283241|69497940|FG001|Overall Study|Adverse Event|1|||
37818635|NCT03283241|69497939|FG000|Overall Study|Withdrawal by Subject|0|||
37818636|NCT03283241|69497940|FG001|Overall Study|Withdrawal by Subject|1|||
37818637|NCT03283241|69497939|FG000|Overall Study|Subject relocated to Finland|0|||
37818638|NCT03283241|69497940|FG001|Overall Study|Subject relocated to Finland|1|||
37818639|NCT03242772|69497948|FG000|Overall Study|Lost to Follow-up|2|||
37818640|NCT03242772|69497949|FG001|Overall Study|Lost to Follow-up|0|||
37818641|NCT03242772|69497948|FG000|Overall Study|Physician Decision|0|||
37818642|NCT03242772|69497949|FG001|Overall Study|Physician Decision|1|||
37818643|NCT03242772|69497948|FG000|Overall Study|Withdrawal by Subject|1|||
37818644|NCT03242772|69497949|FG001|Overall Study|Withdrawal by Subject|0|||
37818645|NCT03236311|69497957|FG000|Overall Study|Study terminated by sponsor|0|||
37877788|NCT01192178|69562224|FG000|Overall Study|Physician Decision|2|||
37983574|NCT00242710|69669771|FG003|Core Study (up to Year 1)|Other|2|||
37983575|NCT00242710|69669768|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
37818646|NCT03236311|69497958|FG001|Overall Study|Study terminated by sponsor|2|||
37818647|NCT03236311|69497957|FG000|Overall Study|Adverse Event|0|||
37818648|NCT03236311|69497958|FG001|Overall Study|Adverse Event|1|||
37818649|NCT03192046|69497966|FG000|Overall Study|Withdrawal by Subject|1|||
37877789|NCT01192178|69562225|FG001|Overall Study|Physician Decision|4|||
37877790|NCT01192178|69562224|FG000|Overall Study|Lost to Follow-up|3|||
37877791|NCT01192178|69562225|FG001|Overall Study|Lost to Follow-up|3|||
37877792|NCT01192178|69562224|FG000|Overall Study|Adverse Event|2|||
37877793|NCT01192178|69562225|FG001|Overall Study|Adverse Event|1|||
37877794|NCT01192178|69562224|FG000|Overall Study|Lack of Efficacy|1|||
37877795|NCT01192178|69562225|FG001|Overall Study|Lack of Efficacy|2|||
37877796|NCT01192100|69562233|FG000|Overall Study|Withdrawal by Subject|0|||
37877797|NCT01192100|69562234|FG001|Overall Study|Withdrawal by Subject|0|||
37877798|NCT01192100|69562235|FG002|Overall Study|Withdrawal by Subject|0|||
37877799|NCT01192100|69562236|FG003|Overall Study|Withdrawal by Subject|0|||
37877800|NCT01192100|69562237|FG004|Overall Study|Withdrawal by Subject|1|||
37877801|NCT01192100|69562238|FG005|Overall Study|Withdrawal by Subject|0|||
37877802|NCT01192100|69562233|FG000|Overall Study|Protocol Violation|0|||
37877803|NCT01192100|69562234|FG001|Overall Study|Protocol Violation|0|||
37877804|NCT01192100|69562235|FG002|Overall Study|Protocol Violation|0|||
37877805|NCT01192100|69562236|FG003|Overall Study|Protocol Violation|1|||
37877806|NCT01192100|69562237|FG004|Overall Study|Protocol Violation|0|||
37877807|NCT01192100|69562238|FG005|Overall Study|Protocol Violation|0|||
37877808|NCT00869401|69562251|FG000|Overall Study|Withdrawal by Subject|0|||
37877809|NCT00869401|69562252|FG001|Overall Study|Withdrawal by Subject|0|||
37877810|NCT00869401|69562253|FG002|Overall Study|Withdrawal by Subject|0|||
37877811|NCT00869401|69562254|FG003|Overall Study|Withdrawal by Subject|5|||
37877812|NCT00869401|69562255|FG004|Overall Study|Withdrawal by Subject|3|||
37877813|NCT01076010|69562270|FG000|Overall Study|Death|15|||
37877814|NCT01076010|69562271|FG001|Overall Study|Death|1|||
37877815|NCT01076010|69562272|FG002|Overall Study|Death|0|||
37877816|NCT01076010|69562270|FG000|Overall Study|Adverse Event|7|||
37877817|NCT01076010|69562271|FG001|Overall Study|Adverse Event|2|||
37877818|NCT01076010|69562272|FG002|Overall Study|Adverse Event|0|||
37877819|NCT01076010|69562270|FG000|Overall Study|Progressive disease|90|||
37877820|NCT01076010|69562271|FG001|Overall Study|Progressive disease|30|||
37877821|NCT01076010|69562272|FG002|Overall Study|Progressive disease|1|||
37983576|NCT00242710|69669769|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
37983577|NCT00242710|69669770|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
37983578|NCT00242710|69669771|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
37983579|NCT00242710|69669768|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
37983580|NCT00242710|69669769|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
37983581|NCT00242710|69669770|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
37983582|NCT00242710|69669771|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
37983583|NCT00242710|69669768|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
37983584|NCT00242710|69669769|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
37983585|NCT00242710|69669770|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
37983586|NCT00242710|69669771|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
37983587|NCT00242710|69669768|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
37983588|NCT00242710|69669769|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
37983589|NCT00242710|69669770|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
37983590|NCT00242710|69669771|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
37877822|NCT01076010|69562270|FG000|Overall Study|Lack of Efficacy|4|||
37877823|NCT01076010|69562271|FG001|Overall Study|Lack of Efficacy|0|||
37877824|NCT01076010|69562272|FG002|Overall Study|Lack of Efficacy|0|||
37877825|NCT01076010|69562270|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
37877826|NCT01076010|69562271|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
37877827|NCT01076010|69562272|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
37877828|NCT01076010|69562270|FG000|Overall Study|Significant Surgical Procedure|0|||
37877829|NCT01076010|69562271|FG001|Overall Study|Significant Surgical Procedure|1|||
37877830|NCT01076010|69562272|FG002|Overall Study|Significant Surgical Procedure|0|||
37877831|NCT01076010|69562270|FG000|Overall Study|Protocol Violation|0|||
37877832|NCT01076010|69562271|FG001|Overall Study|Protocol Violation|1|||
37877833|NCT01076010|69562272|FG002|Overall Study|Protocol Violation|0|||
37877834|NCT01076010|69562270|FG000|Overall Study|Noncompliance|1|||
37877835|NCT01076010|69562271|FG001|Overall Study|Noncompliance|1|||
37877836|NCT01076010|69562272|FG002|Overall Study|Noncompliance|0|||
37877837|NCT01076010|69562270|FG000|Overall Study|Withdrawal by Subject|3|||
37877838|NCT01076010|69562271|FG001|Overall Study|Withdrawal by Subject|0|||
37877839|NCT01076010|69562272|FG002|Overall Study|Withdrawal by Subject|1|||
37877840|NCT01076010|69562270|FG000|Overall Study|Other|5|||
37983591|NCT00242710|69669768|FG000|Period Between Core Study and Extension|Adverse Event|2|||
37983592|NCT00242710|69669769|FG001|Period Between Core Study and Extension|Adverse Event|3|||
37877841|NCT01076010|69562271|FG001|Overall Study|Other|2|||
37877842|NCT01076010|69562272|FG002|Overall Study|Other|0|||
37877843|NCT01075152|69562282|FG000|Overall Study|Withdrawal by Subject|1|||
37877844|NCT01075152|69562283|FG001|Overall Study|Withdrawal by Subject|0|||
37877845|NCT01078116|69562291|FG000|Overall Study|Lost to Follow-up|17|||
37877846|NCT01078116|69562291|FG000|Overall Study|Adverse Event|5|||
37877847|NCT01078116|69562291|FG000|Overall Study|Withdrawal by Subject|8|||
37877848|NCT01078116|69562291|FG000|Overall Study|Lack of effectiveness|15|||
37877849|NCT01078116|69562291|FG000|Overall Study|Case report form not completed|3|||
37877850|NCT00950859|69562297|FG000|Overall Study|Adverse Event|3|||
37877851|NCT00950859|69562298|FG001|Overall Study|Adverse Event|3|||
37877852|NCT00950859|69562297|FG000|Overall Study|Insufficient Viral Load Response|12|||
37983593|NCT00242710|69669770|FG002|Period Between Core Study and Extension|Adverse Event|5|||
37983594|NCT00242710|69669771|FG003|Period Between Core Study and Extension|Adverse Event|2|||
37983595|NCT00242710|69669768|FG000|Period Between Core Study and Extension|Physician Decision|1|||
37983596|NCT00242710|69669769|FG001|Period Between Core Study and Extension|Physician Decision|1|||
37983597|NCT00242710|69669770|FG002|Period Between Core Study and Extension|Physician Decision|0|||
37983598|NCT00242710|69669771|FG003|Period Between Core Study and Extension|Physician Decision|0|||
37983599|NCT00242710|69669768|FG000|Period Between Core Study and Extension|Other|24|||
37983600|NCT00242710|69669769|FG001|Period Between Core Study and Extension|Other|24|||
37983601|NCT00242710|69669770|FG002|Period Between Core Study and Extension|Other|9|||
37983602|NCT00242710|69669771|FG003|Period Between Core Study and Extension|Other|11|||
37983603|NCT00242710|69669768|FG000|Period Between Core Study and Extension|Extension not Available|17|||
37983604|NCT00242710|69669769|FG001|Period Between Core Study and Extension|Extension not Available|21|||
37983605|NCT00242710|69669770|FG002|Period Between Core Study and Extension|Extension not Available|8|||
37983606|NCT00242710|69669771|FG003|Period Between Core Study and Extension|Extension not Available|7|||
37983607|NCT00242710|69669768|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
37983608|NCT00242710|69669769|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
37983609|NCT00242710|69669770|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
37983610|NCT00242710|69669771|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
37983611|NCT00242710|69669768|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
37983612|NCT00242710|69669769|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
37983613|NCT00242710|69669770|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
37983614|NCT00242710|69669771|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
37877853|NCT00950859|69562298|FG001|Overall Study|Insufficient Viral Load Response|3|||
37877854|NCT00950859|69562297|FG000|Overall Study|Protocol Violation|1|||
37877855|NCT00950859|69562298|FG001|Overall Study|Protocol Violation|1|||
37877856|NCT00950859|69562297|FG000|Overall Study|Lost to Follow-up|0|||
37877857|NCT00950859|69562298|FG001|Overall Study|Lost to Follow-up|3|||
37877858|NCT00862849|69562304|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
37877859|NCT00862849|69562305|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
37877860|NCT00862849|69562306|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
37877861|NCT00862849|69562307|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
37877862|NCT00862849|69562308|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
37877863|NCT00862849|69562309|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
37877864|NCT00862849|69562304|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
37877865|NCT00862849|69562305|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
37877866|NCT00862849|69562306|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
37877867|NCT00862849|69562307|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
37877868|NCT00862849|69562308|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
37877869|NCT00862849|69562309|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
37877870|NCT01090050|69562319|FG000|Overall Study|Lost to Follow-up|0|||
37877871|NCT01090050|69562320|FG001|Overall Study|Lost to Follow-up|1|||
37877872|NCT01090050|69562319|FG000|Overall Study|Lack of Efficacy|1|||
37877873|NCT01090050|69562320|FG001|Overall Study|Lack of Efficacy|5|||
37877874|NCT01090050|69562319|FG000|Overall Study|Physician Decision|0|||
37877875|NCT01090050|69562320|FG001|Overall Study|Physician Decision|1|||
37877876|NCT00944229|69562330|FG000|Overall Study|Withdrawal by Subject|11|||
37877877|NCT00944229|69562330|FG000|Overall Study|Physician Decision|14|||
37877878|NCT01077960|69562334|FG000|Overall Study|Adverse Event|6|||
37877879|NCT01077960|69562334|FG000|Overall Study|Protocol Violation|3|||
37877880|NCT01077960|69562334|FG000|Overall Study|Lost to Follow-up|5|||
37877881|NCT01077960|69562334|FG000|Overall Study|Subject decision|1|||
37877882|NCT01077960|69562334|FG000|Overall Study|Reason unspecified|1|||
37877883|NCT00944697|69562340|FG000|Overall Study|Withdrawal by Subject|1|||
37877884|NCT00944697|69562341|FG001|Overall Study|Withdrawal by Subject|1|||
37877885|NCT00944697|69562340|FG000|Overall Study|Adverse Event|0|||
37877886|NCT00944697|69562341|FG001|Overall Study|Adverse Event|3|||
37877887|NCT00944697|69562340|FG000|Overall Study|Administrative|1|||
37877888|NCT00944697|69562341|FG001|Overall Study|Administrative|1|||
37877889|NCT01077804|69562347|FG000|Overall Study|Unreachable|102|||
37877890|NCT01077804|69562347|FG000|Overall Study|Refused to continue|79|||
37877891|NCT01077804|69562347|FG000|Overall Study|Other|18|||
37877892|NCT01075074|69562371|FG000|Overall Study|Surgeon changed to open incisional case|1|||
37877893|NCT01075074|69562372|FG001|Overall Study|Surgeon changed to open incisional case|2|||
37877894|NCT01075074|69562373|FG002|Overall Study|Surgeon changed to open incisional case|2|||
37877895|NCT00866281|69562387|FG000|Overall Study|Adverse Event|1|||
37877896|NCT00866281|69562388|FG001|Overall Study|Adverse Event|0|||
37877897|NCT00866281|69562387|FG000|Overall Study|Withdrawal by participants|3|||
37877898|NCT00866281|69562388|FG001|Overall Study|Withdrawal by participants|0|||
37877899|NCT00866281|69562387|FG000|Overall Study|Disease progression|3|||
37877900|NCT00866281|69562388|FG001|Overall Study|Disease progression|11|||
37877901|NCT00866281|69562387|FG000|Overall Study|New cancer therapy|0|||
37877902|NCT00866281|69562388|FG001|Overall Study|New cancer therapy|4|||
37877903|NCT01077258|69562397|FG000|Overall Study|Lost to Follow-up|1390|||
37877904|NCT01077258|69562397|FG000|Overall Study|Adverse drug reaction|218|||
37877905|NCT01077258|69562397|FG000|Overall Study|Lack of Efficacy|663|||
37877906|NCT01077258|69562397|FG000|Overall Study|Clinical remission|37|||
37877907|NCT01077258|69562397|FG000|Overall Study|Other reasons|260|||
37877908|NCT00943917|69562425|FG000|Stage I|Adverse Event|1|||
37877909|NCT00943917|69562426|FG001|Stage I|Adverse Event|2|||
37877910|NCT00943917|69562427|FG002|Stage I|Adverse Event|2|||
37877911|NCT00943917|69562428|FG003|Stage I|Adverse Event|0|||
37877912|NCT00943917|69562429|FG004|Stage I|Adverse Event|0|||
37877913|NCT00943917|69562430|FG005|Stage I|Adverse Event|0|||
37877914|NCT00943917|69562431|FG006|Stage I|Adverse Event|0|||
37877915|NCT00943917|69562432|FG007|Stage I|Adverse Event|0|||
37877916|NCT00943917|69562433|FG008|Stage I|Adverse Event|0|||
37877917|NCT00943917|69562434|FG009|Stage I|Adverse Event|0|||
37877918|NCT00943917|69562435|FG010|Stage I|Adverse Event|0|||
37877919|NCT00943917|69562436|FG011|Stage I|Adverse Event|0|||
37877920|NCT00943917|69562437|FG012|Stage I|Adverse Event|0|||
37877921|NCT00943917|69562438|FG013|Stage I|Adverse Event|0|||
37877922|NCT00943917|69562439|FG014|Stage I|Adverse Event|0|||
37877923|NCT00943917|69562425|FG000|Stage I|Lost to Follow-up|0|||
37877924|NCT00943917|69562426|FG001|Stage I|Lost to Follow-up|0|||
37877925|NCT00943917|69562427|FG002|Stage I|Lost to Follow-up|1|||
37877926|NCT00943917|69562428|FG003|Stage I|Lost to Follow-up|0|||
37877927|NCT00943917|69562429|FG004|Stage I|Lost to Follow-up|0|||
37877928|NCT00943917|69562430|FG005|Stage I|Lost to Follow-up|0|||
37877929|NCT00943917|69562431|FG006|Stage I|Lost to Follow-up|0|||
37877930|NCT00943917|69562432|FG007|Stage I|Lost to Follow-up|0|||
37877931|NCT00943917|69562433|FG008|Stage I|Lost to Follow-up|0|||
37877932|NCT00943917|69562434|FG009|Stage I|Lost to Follow-up|0|||
37877933|NCT00943917|69562435|FG010|Stage I|Lost to Follow-up|0|||
37877934|NCT00943917|69562436|FG011|Stage I|Lost to Follow-up|0|||
37877935|NCT00943917|69562437|FG012|Stage I|Lost to Follow-up|0|||
37877936|NCT00943917|69562438|FG013|Stage I|Lost to Follow-up|0|||
37877937|NCT00943917|69562439|FG014|Stage I|Lost to Follow-up|0|||
37877938|NCT00943917|69562425|FG000|Stage I|hyperglycemia|0|||
37877939|NCT00943917|69562426|FG001|Stage I|hyperglycemia|0|||
37877940|NCT00943917|69562427|FG002|Stage I|hyperglycemia|1|||
37877941|NCT00943917|69562428|FG003|Stage I|hyperglycemia|0|||
37877942|NCT00943917|69562429|FG004|Stage I|hyperglycemia|0|||
37877943|NCT00943917|69562430|FG005|Stage I|hyperglycemia|0|||
37877944|NCT00943917|69562431|FG006|Stage I|hyperglycemia|0|||
37877945|NCT00943917|69562432|FG007|Stage I|hyperglycemia|0|||
37877946|NCT00943917|69562433|FG008|Stage I|hyperglycemia|0|||
37877947|NCT00943917|69562434|FG009|Stage I|hyperglycemia|0|||
37818650|NCT03192046|69497967|FG001|Overall Study|Withdrawal by Subject|1|||
37818651|NCT03190369|69497975|FG000|Overall Study|Poor compliance to protocol|0|||
37818652|NCT03190369|69497976|FG001|Overall Study|Poor compliance to protocol|1|||
37818653|NCT03190369|69497975|FG000|Overall Study|Withdraw before treatment|1|||
37818654|NCT03190369|69497976|FG001|Overall Study|Withdraw before treatment|5|||
37818655|NCT03190369|69497975|FG000|Overall Study|Randomized but not treated|0|||
37818656|NCT03190369|69497976|FG001|Overall Study|Randomized but not treated|2|||
37818657|NCT04657198|69497985|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
37818658|NCT04657198|69497986|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
37818659|NCT04657198|69497987|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
37818660|NCT04590586|69498001|FG000|Overall Study|Death|7|||
37818661|NCT04590586|69498002|FG001|Overall Study|Death|1|||
37818662|NCT04590586|69498003|FG002|Overall Study|Death|37|||
37818663|NCT04590586|69498004|FG003|Overall Study|Death|34|||
37818664|NCT04590586|69498005|FG004|Overall Study|Death|19|||
37818665|NCT04590586|69498006|FG005|Overall Study|Death|3|||
37818666|NCT04590586|69498001|FG000|Overall Study|Lost to Follow-up|3|||
37818667|NCT04590586|69498002|FG001|Overall Study|Lost to Follow-up|0|||
37818668|NCT04590586|69498003|FG002|Overall Study|Lost to Follow-up|11|||
37877948|NCT00943917|69562435|FG010|Stage I|hyperglycemia|0|||
37877949|NCT00943917|69562436|FG011|Stage I|hyperglycemia|0|||
37877950|NCT00943917|69562437|FG012|Stage I|hyperglycemia|0|||
37877951|NCT00943917|69562438|FG013|Stage I|hyperglycemia|0|||
37877952|NCT00943917|69562439|FG014|Stage I|hyperglycemia|0|||
37877953|NCT00943917|69562425|FG000|Stage I|A1C elevation|1|||
37877954|NCT00943917|69562426|FG001|Stage I|A1C elevation|0|||
37877955|NCT00943917|69562427|FG002|Stage I|A1C elevation|0|||
37877956|NCT00943917|69562428|FG003|Stage I|A1C elevation|0|||
37877957|NCT00943917|69562429|FG004|Stage I|A1C elevation|0|||
37877958|NCT00943917|69562430|FG005|Stage I|A1C elevation|0|||
37877959|NCT00943917|69562431|FG006|Stage I|A1C elevation|0|||
37877960|NCT00943917|69562432|FG007|Stage I|A1C elevation|0|||
37877961|NCT00943917|69562433|FG008|Stage I|A1C elevation|0|||
37877962|NCT00943917|69562434|FG009|Stage I|A1C elevation|0|||
37877963|NCT00943917|69562435|FG010|Stage I|A1C elevation|0|||
37877964|NCT00943917|69562436|FG011|Stage I|A1C elevation|0|||
37818669|NCT04590586|69498004|FG003|Overall Study|Lost to Follow-up|11|||
37818670|NCT04590586|69498005|FG004|Overall Study|Lost to Follow-up|6|||
37818671|NCT04590586|69498006|FG005|Overall Study|Lost to Follow-up|0|||
37818672|NCT04590586|69498001|FG000|Overall Study|Withdrawal by Subject|0|||
37818673|NCT04590586|69498002|FG001|Overall Study|Withdrawal by Subject|0|||
37818674|NCT04590586|69498003|FG002|Overall Study|Withdrawal by Subject|6|||
37818675|NCT04590586|69498004|FG003|Overall Study|Withdrawal by Subject|0|||
37818676|NCT04590586|69498005|FG004|Overall Study|Withdrawal by Subject|3|||
37818677|NCT04590586|69498006|FG005|Overall Study|Withdrawal by Subject|0|||
37818678|NCT04590586|69498001|FG000|Overall Study|Other|3|||
37818679|NCT04590586|69498002|FG001|Overall Study|Other|0|||
37818680|NCT04590586|69498003|FG002|Overall Study|Other|1|||
37818681|NCT04590586|69498004|FG003|Overall Study|Other|1|||
37818682|NCT04590586|69498005|FG004|Overall Study|Other|2|||
37818683|NCT04590586|69498006|FG005|Overall Study|Other|1|||
37818684|NCT04312009|69498032|FG000|Overall Study|Withdrawal by Subject|2|||
37818685|NCT04312009|69498033|FG001|Overall Study|Withdrawal by Subject|1|||
37818686|NCT03937466|69498048|FG000|Overall Study|not eligbile after the 2-week diary|9|||
37818687|NCT03937466|69498048|FG000|Overall Study|never returned their diary|6|||
37818688|NCT03937466|69498048|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
37818689|NCT03937466|69498048|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
37818690|NCT03850483|69498061|FG000|Treatment for Stage 1|Adverse Event|1|||
37818691|NCT03850483|69498062|FG001|Treatment for Stage 1|Adverse Event|1|||
37818692|NCT03850483|69498063|FG002|Treatment for Stage 1|Adverse Event|3|||
37818693|NCT03850483|69498064|FG003|Treatment for Stage 1|Adverse Event|0|||
37818694|NCT03850483|69498065|FG004|Treatment for Stage 1|Adverse Event|2|||
37818695|NCT03850483|69498066|FG005|Treatment for Stage 1|Adverse Event|0|||
37818696|NCT03850483|69498067|FG006|Treatment for Stage 1|Adverse Event|2|||
37818697|NCT03850483|69498068|FG007|Treatment for Stage 1|Adverse Event|2|||
37818698|NCT03850483|69498069|FG008|Treatment for Stage 1|Adverse Event|0|||
37818699|NCT03850483|69498070|FG009|Treatment for Stage 1|Adverse Event|0|||
37818700|NCT03850483|69498061|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
37818701|NCT03850483|69498062|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
37818702|NCT03850483|69498063|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
37818703|NCT03850483|69498064|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
37818704|NCT03850483|69498065|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
37818705|NCT03850483|69498066|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
37818706|NCT03850483|69498067|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
37818707|NCT03850483|69498068|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
37818708|NCT03850483|69498069|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
37818709|NCT03850483|69498070|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
37818710|NCT03850483|69498061|FG000|Treatment for Stage 1|Protocol Violation|1|||
37818711|NCT03850483|69498062|FG001|Treatment for Stage 1|Protocol Violation|0|||
37818712|NCT03850483|69498063|FG002|Treatment for Stage 1|Protocol Violation|0|||
37818713|NCT03850483|69498064|FG003|Treatment for Stage 1|Protocol Violation|0|||
37818714|NCT03850483|69498065|FG004|Treatment for Stage 1|Protocol Violation|0|||
37818715|NCT03850483|69498066|FG005|Treatment for Stage 1|Protocol Violation|0|||
37818716|NCT03850483|69498067|FG006|Treatment for Stage 1|Protocol Violation|1|||
37818717|NCT03850483|69498068|FG007|Treatment for Stage 1|Protocol Violation|0|||
37818718|NCT03850483|69498069|FG008|Treatment for Stage 1|Protocol Violation|0|||
37818719|NCT03850483|69498070|FG009|Treatment for Stage 1|Protocol Violation|0|||
37818720|NCT03850483|69498061|FG000|Treatment for Stage 1|Physician Decision|0|||
37818721|NCT03850483|69498062|FG001|Treatment for Stage 1|Physician Decision|0|||
37818722|NCT03850483|69498063|FG002|Treatment for Stage 1|Physician Decision|0|||
37818723|NCT03850483|69498064|FG003|Treatment for Stage 1|Physician Decision|0|||
37818724|NCT03850483|69498065|FG004|Treatment for Stage 1|Physician Decision|0|||
37818725|NCT03850483|69498066|FG005|Treatment for Stage 1|Physician Decision|1|||
37818726|NCT03850483|69498067|FG006|Treatment for Stage 1|Physician Decision|0|||
37818727|NCT03850483|69498068|FG007|Treatment for Stage 1|Physician Decision|0|||
37818728|NCT03850483|69498069|FG008|Treatment for Stage 1|Physician Decision|0|||
37818729|NCT03850483|69498070|FG009|Treatment for Stage 1|Physician Decision|0|||
37818730|NCT03850483|69498061|FG000|Treatment for Stage 1|Other|0|||
37818731|NCT03850483|69498062|FG001|Treatment for Stage 1|Other|0|||
37877965|NCT00943917|69562437|FG012|Stage I|A1C elevation|0|||
37877966|NCT00943917|69562438|FG013|Stage I|A1C elevation|0|||
37877967|NCT00943917|69562439|FG014|Stage I|A1C elevation|0|||
37877968|NCT00943917|69562425|FG000|Stage I|Withdrawal by Subject|2|||
37877969|NCT00943917|69562426|FG001|Stage I|Withdrawal by Subject|1|||
37877970|NCT00943917|69562427|FG002|Stage I|Withdrawal by Subject|2|||
37877971|NCT00943917|69562428|FG003|Stage I|Withdrawal by Subject|0|||
37877972|NCT00943917|69562429|FG004|Stage I|Withdrawal by Subject|0|||
37877973|NCT00943917|69562430|FG005|Stage I|Withdrawal by Subject|0|||
37877974|NCT00943917|69562431|FG006|Stage I|Withdrawal by Subject|0|||
37877975|NCT00943917|69562432|FG007|Stage I|Withdrawal by Subject|0|||
37877976|NCT00943917|69562433|FG008|Stage I|Withdrawal by Subject|0|||
37877977|NCT00943917|69562434|FG009|Stage I|Withdrawal by Subject|0|||
37877978|NCT00943917|69562435|FG010|Stage I|Withdrawal by Subject|0|||
37877979|NCT00943917|69562436|FG011|Stage I|Withdrawal by Subject|0|||
37877980|NCT00943917|69562437|FG012|Stage I|Withdrawal by Subject|0|||
37877981|NCT00943917|69562438|FG013|Stage I|Withdrawal by Subject|0|||
37877982|NCT00943917|69562439|FG014|Stage I|Withdrawal by Subject|0|||
37877983|NCT00943917|69562425|FG000|Stage II|Adverse Event|0|||
37877984|NCT00943917|69562426|FG001|Stage II|Adverse Event|0|||
37877985|NCT00943917|69562427|FG002|Stage II|Adverse Event|0|||
37877986|NCT00943917|69562428|FG003|Stage II|Adverse Event|0|||
37877987|NCT00943917|69562429|FG004|Stage II|Adverse Event|0|||
37877988|NCT00943917|69562430|FG005|Stage II|Adverse Event|1|||
37877989|NCT00943917|69562431|FG006|Stage II|Adverse Event|3|||
37877990|NCT00943917|69562432|FG007|Stage II|Adverse Event|0|||
37877991|NCT00943917|69562433|FG008|Stage II|Adverse Event|1|||
37877992|NCT00943917|69562434|FG009|Stage II|Adverse Event|0|||
37877993|NCT00943917|69562435|FG010|Stage II|Adverse Event|0|||
37877994|NCT00943917|69562436|FG011|Stage II|Adverse Event|0|||
37877995|NCT00943917|69562437|FG012|Stage II|Adverse Event|0|||
37877996|NCT00943917|69562438|FG013|Stage II|Adverse Event|0|||
37877997|NCT00943917|69562439|FG014|Stage II|Adverse Event|0|||
37877998|NCT00943917|69562425|FG000|Stage II|Withdrawal by Subject|0|||
37877999|NCT00943917|69562426|FG001|Stage II|Withdrawal by Subject|0|||
37878000|NCT00943917|69562427|FG002|Stage II|Withdrawal by Subject|0|||
37878001|NCT00943917|69562428|FG003|Stage II|Withdrawal by Subject|0|||
37878002|NCT00943917|69562429|FG004|Stage II|Withdrawal by Subject|0|||
37878003|NCT00943917|69562430|FG005|Stage II|Withdrawal by Subject|1|||
37878004|NCT00943917|69562431|FG006|Stage II|Withdrawal by Subject|0|||
37878005|NCT00943917|69562432|FG007|Stage II|Withdrawal by Subject|0|||
37878006|NCT00943917|69562433|FG008|Stage II|Withdrawal by Subject|0|||
37878007|NCT00943917|69562434|FG009|Stage II|Withdrawal by Subject|0|||
37878008|NCT00943917|69562435|FG010|Stage II|Withdrawal by Subject|0|||
37878009|NCT00943917|69562436|FG011|Stage II|Withdrawal by Subject|0|||
37878010|NCT00943917|69562437|FG012|Stage II|Withdrawal by Subject|0|||
37878011|NCT00943917|69562438|FG013|Stage II|Withdrawal by Subject|0|||
37878012|NCT00943917|69562439|FG014|Stage II|Withdrawal by Subject|0|||
37878013|NCT00943917|69562425|FG000|Stage II|Pregnancy|0|||
37878014|NCT00943917|69562426|FG001|Stage II|Pregnancy|0|||
37878015|NCT00943917|69562427|FG002|Stage II|Pregnancy|0|||
37878016|NCT00943917|69562428|FG003|Stage II|Pregnancy|0|||
37878017|NCT00943917|69562429|FG004|Stage II|Pregnancy|0|||
37878018|NCT00943917|69562430|FG005|Stage II|Pregnancy|1|||
37878019|NCT00943917|69562431|FG006|Stage II|Pregnancy|0|||
37878020|NCT00943917|69562432|FG007|Stage II|Pregnancy|0|||
37878021|NCT00943917|69562433|FG008|Stage II|Pregnancy|0|||
37878022|NCT00943917|69562434|FG009|Stage II|Pregnancy|0|||
37878023|NCT00943917|69562435|FG010|Stage II|Pregnancy|0|||
37878024|NCT00943917|69562436|FG011|Stage II|Pregnancy|0|||
37878025|NCT00943917|69562437|FG012|Stage II|Pregnancy|0|||
37983615|NCT00242710|69669768|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
37983616|NCT00242710|69669769|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
37983617|NCT00242710|69669770|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
37878026|NCT00943917|69562438|FG013|Stage II|Pregnancy|0|||
37878027|NCT00943917|69562439|FG014|Stage II|Pregnancy|0|||
37878028|NCT00943917|69562425|FG000|Stage II Continuation|Adverse Event|0|||
37878029|NCT00943917|69562426|FG001|Stage II Continuation|Adverse Event|0|||
37878030|NCT00943917|69562427|FG002|Stage II Continuation|Adverse Event|0|||
37878031|NCT00943917|69562428|FG003|Stage II Continuation|Adverse Event|0|||
37878032|NCT00943917|69562429|FG004|Stage II Continuation|Adverse Event|0|||
37878033|NCT00943917|69562430|FG005|Stage II Continuation|Adverse Event|0|||
37878034|NCT00943917|69562431|FG006|Stage II Continuation|Adverse Event|0|||
37878035|NCT00943917|69562432|FG007|Stage II Continuation|Adverse Event|0|||
37878036|NCT00943917|69562433|FG008|Stage II Continuation|Adverse Event|0|||
37878037|NCT00943917|69562434|FG009|Stage II Continuation|Adverse Event|0|||
37878038|NCT00943917|69562435|FG010|Stage II Continuation|Adverse Event|0|||
37878039|NCT00943917|69562436|FG011|Stage II Continuation|Adverse Event|1|||
37878040|NCT00943917|69562437|FG012|Stage II Continuation|Adverse Event|2|||
37878041|NCT00943917|69562438|FG013|Stage II Continuation|Adverse Event|1|||
37878042|NCT00943917|69562439|FG014|Stage II Continuation|Adverse Event|1|||
37878043|NCT00943917|69562425|FG000|Stage II Continuation|Withdrawal by Subject|0|||
37983618|NCT00242710|69669771|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
37818732|NCT03850483|69498063|FG002|Treatment for Stage 1|Other|0|||
37818733|NCT03850483|69498064|FG003|Treatment for Stage 1|Other|0|||
37818734|NCT03850483|69498065|FG004|Treatment for Stage 1|Other|2|||
37818735|NCT03850483|69498066|FG005|Treatment for Stage 1|Other|1|||
37818736|NCT03850483|69498067|FG006|Treatment for Stage 1|Other|0|||
37818737|NCT03850483|69498068|FG007|Treatment for Stage 1|Other|0|||
37818738|NCT03850483|69498069|FG008|Treatment for Stage 1|Other|0|||
37818739|NCT03850483|69498070|FG009|Treatment for Stage 1|Other|0|||
37818740|NCT03850483|69498061|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
37818741|NCT03850483|69498062|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
37818742|NCT03850483|69498063|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
37818743|NCT03850483|69498064|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
37818744|NCT03850483|69498065|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
37818745|NCT03850483|69498066|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
37818746|NCT03850483|69498067|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
37818747|NCT03850483|69498068|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
37818748|NCT03850483|69498069|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
37818749|NCT03850483|69498070|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
37818750|NCT03850483|69498061|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
37818751|NCT03850483|69498062|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
37818752|NCT03850483|69498063|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
37818753|NCT03850483|69498064|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
37818754|NCT03850483|69498065|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
37818755|NCT03850483|69498066|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
37818756|NCT03850483|69498067|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
37818757|NCT03850483|69498068|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
37818758|NCT03850483|69498069|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
37818759|NCT03850483|69498070|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
37818760|NCT03850483|69498061|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
37818761|NCT03850483|69498062|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
37818762|NCT03850483|69498063|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
37818763|NCT03850483|69498064|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
37818764|NCT03850483|69498065|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
37818765|NCT03850483|69498066|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
37818766|NCT03850483|69498067|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
37818767|NCT03850483|69498068|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
37818768|NCT03850483|69498069|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
37983619|NCT00242710|69669768|FG000|Study Extension (up to Year 2)|Death|0|||
37983620|NCT00242710|69669769|FG001|Study Extension (up to Year 2)|Death|0|||
37983621|NCT00242710|69669770|FG002|Study Extension (up to Year 2)|Death|0|||
37983622|NCT00242710|69669771|FG003|Study Extension (up to Year 2)|Death|1|||
37983623|NCT00242710|69669768|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
37983624|NCT00242710|69669769|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
37983625|NCT00242710|69669770|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
37983626|NCT00242710|69669771|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
37983627|NCT00242710|69669768|FG000|Study Extension (up to Year 2)|Other|3|||
37983628|NCT00242710|69669769|FG001|Study Extension (up to Year 2)|Other|5|||
37983629|NCT00242710|69669770|FG002|Study Extension (up to Year 2)|Other|4|||
37983630|NCT00242710|69669771|FG003|Study Extension (up to Year 2)|Other|3|||
37983631|NCT00242710|69669768|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
37983632|NCT00242710|69669769|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
37983633|NCT00242710|69669770|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
37983634|NCT00242710|69669771|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
37983635|NCT00242710|69669768|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
37878044|NCT00943917|69562426|FG001|Stage II Continuation|Withdrawal by Subject|0|||
37878045|NCT00943917|69562427|FG002|Stage II Continuation|Withdrawal by Subject|0|||
37878046|NCT00943917|69562428|FG003|Stage II Continuation|Withdrawal by Subject|0|||
37878047|NCT00943917|69562429|FG004|Stage II Continuation|Withdrawal by Subject|0|||
37878048|NCT00943917|69562430|FG005|Stage II Continuation|Withdrawal by Subject|0|||
37878049|NCT00943917|69562431|FG006|Stage II Continuation|Withdrawal by Subject|0|||
37878050|NCT00943917|69562432|FG007|Stage II Continuation|Withdrawal by Subject|0|||
37878051|NCT00943917|69562433|FG008|Stage II Continuation|Withdrawal by Subject|0|||
37878052|NCT00943917|69562434|FG009|Stage II Continuation|Withdrawal by Subject|0|||
37878053|NCT00943917|69562435|FG010|Stage II Continuation|Withdrawal by Subject|0|||
37878054|NCT00943917|69562436|FG011|Stage II Continuation|Withdrawal by Subject|0|||
37878055|NCT00943917|69562437|FG012|Stage II Continuation|Withdrawal by Subject|0|||
37878056|NCT00943917|69562438|FG013|Stage II Continuation|Withdrawal by Subject|1|||
37878057|NCT00943917|69562439|FG014|Stage II Continuation|Withdrawal by Subject|3|||
37878058|NCT00943917|69562425|FG000|Stage II Continuation|Protocol Violation|0|||
37878059|NCT00943917|69562426|FG001|Stage II Continuation|Protocol Violation|0|||
37878060|NCT00943917|69562427|FG002|Stage II Continuation|Protocol Violation|0|||
37878061|NCT00943917|69562428|FG003|Stage II Continuation|Protocol Violation|0|||
37878062|NCT00943917|69562429|FG004|Stage II Continuation|Protocol Violation|0|||
37878063|NCT00943917|69562430|FG005|Stage II Continuation|Protocol Violation|0|||
37878064|NCT00943917|69562431|FG006|Stage II Continuation|Protocol Violation|0|||
37878065|NCT00943917|69562432|FG007|Stage II Continuation|Protocol Violation|0|||
37878066|NCT00943917|69562433|FG008|Stage II Continuation|Protocol Violation|0|||
37878067|NCT00943917|69562434|FG009|Stage II Continuation|Protocol Violation|1|||
37878068|NCT00943917|69562435|FG010|Stage II Continuation|Protocol Violation|0|||
37878069|NCT00943917|69562436|FG011|Stage II Continuation|Protocol Violation|1|||
37878070|NCT00943917|69562437|FG012|Stage II Continuation|Protocol Violation|0|||
37878071|NCT00943917|69562438|FG013|Stage II Continuation|Protocol Violation|0|||
37878072|NCT00943917|69562439|FG014|Stage II Continuation|Protocol Violation|0|||
37878073|NCT00943917|69562425|FG000|Stage II Continuation|hypoglycemia|0|||
37878074|NCT00943917|69562426|FG001|Stage II Continuation|hypoglycemia|0|||
37878075|NCT00943917|69562427|FG002|Stage II Continuation|hypoglycemia|0|||
37878076|NCT00943917|69562428|FG003|Stage II Continuation|hypoglycemia|0|||
37878077|NCT00943917|69562429|FG004|Stage II Continuation|hypoglycemia|0|||
37878078|NCT00943917|69562430|FG005|Stage II Continuation|hypoglycemia|0|||
37818769|NCT03850483|69498070|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
37818770|NCT03850483|69498061|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
37818771|NCT03850483|69498062|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
37818772|NCT03850483|69498063|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
37818773|NCT03850483|69498064|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
37818774|NCT03850483|69498065|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
37818775|NCT03850483|69498066|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
37818776|NCT03850483|69498067|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
37878079|NCT00943917|69562431|FG006|Stage II Continuation|hypoglycemia|0|||
37983636|NCT00242710|69669769|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
37878080|NCT00943917|69562432|FG007|Stage II Continuation|hypoglycemia|0|||
37878081|NCT00943917|69562433|FG008|Stage II Continuation|hypoglycemia|0|||
37878082|NCT00943917|69562434|FG009|Stage II Continuation|hypoglycemia|0|||
37878083|NCT00943917|69562435|FG010|Stage II Continuation|hypoglycemia|0|||
37878084|NCT00943917|69562436|FG011|Stage II Continuation|hypoglycemia|0|||
37878085|NCT00943917|69562437|FG012|Stage II Continuation|hypoglycemia|1|||
37878086|NCT00943917|69562438|FG013|Stage II Continuation|hypoglycemia|0|||
37878087|NCT00943917|69562439|FG014|Stage II Continuation|hypoglycemia|0|||
37878088|NCT00943917|69562425|FG000|Stage II Continuation|A1C elevation|0|||
37878089|NCT00943917|69562426|FG001|Stage II Continuation|A1C elevation|0|||
37878090|NCT00943917|69562427|FG002|Stage II Continuation|A1C elevation|0|||
37878091|NCT00943917|69562428|FG003|Stage II Continuation|A1C elevation|0|||
37878092|NCT00943917|69562429|FG004|Stage II Continuation|A1C elevation|0|||
37878093|NCT00943917|69562430|FG005|Stage II Continuation|A1C elevation|0|||
37878094|NCT00943917|69562431|FG006|Stage II Continuation|A1C elevation|0|||
37878095|NCT00943917|69562432|FG007|Stage II Continuation|A1C elevation|0|||
37878096|NCT00943917|69562433|FG008|Stage II Continuation|A1C elevation|0|||
37878097|NCT00943917|69562434|FG009|Stage II Continuation|A1C elevation|0|||
37878098|NCT00943917|69562435|FG010|Stage II Continuation|A1C elevation|0|||
37878099|NCT00943917|69562436|FG011|Stage II Continuation|A1C elevation|0|||
37878100|NCT00943917|69562437|FG012|Stage II Continuation|A1C elevation|0|||
37878101|NCT00943917|69562438|FG013|Stage II Continuation|A1C elevation|1|||
37878102|NCT00943917|69562439|FG014|Stage II Continuation|A1C elevation|0|||
37878103|NCT01077024|69562474|FG000|Overall Study|Lost to Follow-up|20|||
37878104|NCT01077024|69562475|FG001|Overall Study|Lost to Follow-up|14|||
37878105|NCT01077024|69562474|FG000|Overall Study|Withdrawal by Subject|0|||
37878106|NCT01077024|69562475|FG001|Overall Study|Withdrawal by Subject|2|||
37878107|NCT01077024|69562474|FG000|Overall Study|Incarcerated|7|||
37878108|NCT01077024|69562475|FG001|Overall Study|Incarcerated|8|||
37878109|NCT01077024|69562474|FG000|Overall Study|Other|4|||
37878110|NCT01077024|69562475|FG001|Overall Study|Other|4|||
37878111|NCT01089582|69562481|FG000|Overall Study|Death|2|||
37878112|NCT01089582|69562481|FG000|Overall Study|Adverse Event|15|||
37878113|NCT01089582|69562481|FG000|Overall Study|Lost to Follow-up|8|||
37818777|NCT03850483|69498068|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
37818778|NCT03850483|69498069|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
37818779|NCT03850483|69498070|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
37818780|NCT03850483|69498061|FG000|Treatment for Stage 1|Death|0|||
37818781|NCT03850483|69498062|FG001|Treatment for Stage 1|Death|0|||
37818782|NCT03850483|69498063|FG002|Treatment for Stage 1|Death|0|||
37818783|NCT03850483|69498064|FG003|Treatment for Stage 1|Death|0|||
37818784|NCT03850483|69498065|FG004|Treatment for Stage 1|Death|0|||
37818785|NCT03850483|69498066|FG005|Treatment for Stage 1|Death|1|||
37818786|NCT03850483|69498067|FG006|Treatment for Stage 1|Death|0|||
37818787|NCT03850483|69498068|FG007|Treatment for Stage 1|Death|0|||
37818788|NCT03850483|69498069|FG008|Treatment for Stage 1|Death|0|||
37818789|NCT03850483|69498070|FG009|Treatment for Stage 1|Death|0|||
37818790|NCT03850483|69498061|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
37818791|NCT03850483|69498062|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
37818792|NCT03850483|69498063|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
37818793|NCT03850483|69498064|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
37818794|NCT03850483|69498065|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
37818795|NCT03850483|69498066|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
37818796|NCT03850483|69498067|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
37818797|NCT03850483|69498068|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
37818798|NCT03850483|69498069|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
37818799|NCT03850483|69498070|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
37818800|NCT03850483|69498061|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
37818801|NCT03850483|69498062|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
37818802|NCT03850483|69498063|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
37818803|NCT03850483|69498064|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
37818804|NCT03850483|69498065|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
37818805|NCT03850483|69498066|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
37818806|NCT03850483|69498067|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
37818807|NCT03850483|69498068|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
37818808|NCT03850483|69498069|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
37818809|NCT03850483|69498070|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
37818810|NCT03850483|69498061|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
37818811|NCT03850483|69498062|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
37878114|NCT01089582|69562481|FG000|Overall Study|Other|4|||
37878115|NCT01089582|69562481|FG000|Overall Study|Withdrawal by Subject|1|||
37878116|NCT00862459|69562488|FG000|Overall Study|Lost to Follow-up|1|||
37878117|NCT00862459|69562489|FG001|Overall Study|Lost to Follow-up|2|||
37878118|NCT00862459|69562490|FG002|Overall Study|Lost to Follow-up|2|||
37878119|NCT00862459|69562488|FG000|Overall Study|Protocol Violation|1|||
37878120|NCT00862459|69562489|FG001|Overall Study|Protocol Violation|0|||
37878121|NCT00862459|69562490|FG002|Overall Study|Protocol Violation|0|||
37878122|NCT00862459|69562488|FG000|Overall Study|Withdrawal by Subject|1|||
37878123|NCT00862459|69562489|FG001|Overall Study|Withdrawal by Subject|1|||
37878124|NCT00862459|69562490|FG002|Overall Study|Withdrawal by Subject|3|||
37878125|NCT00862459|69562488|FG000|Overall Study|Adverse Event|0|||
37878126|NCT00862459|69562489|FG001|Overall Study|Adverse Event|1|||
37878127|NCT00862459|69562490|FG002|Overall Study|Adverse Event|0|||
37878128|NCT00862459|69562488|FG000|Overall Study|Personal reasons|1|||
37878129|NCT00862459|69562489|FG001|Overall Study|Personal reasons|0|||
37878130|NCT00862459|69562490|FG002|Overall Study|Personal reasons|0|||
37878131|NCT00862459|69562488|FG000|Overall Study|Operation|1|||
37878132|NCT00862459|69562489|FG001|Overall Study|Operation|1|||
37878133|NCT00862459|69562490|FG002|Overall Study|Operation|0|||
37878134|NCT00862459|69562488|FG000|Overall Study|Intravenous (IV) site problems|1|||
37878135|NCT00862459|69562489|FG001|Overall Study|Intravenous (IV) site problems|0|||
37878136|NCT00862459|69562490|FG002|Overall Study|Intravenous (IV) site problems|1|||
37878137|NCT00862459|69562488|FG000|Overall Study|Unable to hold still for imaging|0|||
37878138|NCT00862459|69562489|FG001|Overall Study|Unable to hold still for imaging|1|||
37878139|NCT00862459|69562490|FG002|Overall Study|Unable to hold still for imaging|0|||
37878140|NCT00862459|69562488|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
37878141|NCT00862459|69562489|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
37878142|NCT00862459|69562490|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
37878143|NCT00862459|69562488|FG000|Overall Study|Administrative problems|0|||
37878144|NCT00862459|69562489|FG001|Overall Study|Administrative problems|1|||
37878145|NCT00862459|69562490|FG002|Overall Study|Administrative problems|0|||
37878146|NCT01074450|69562501|FG000|First Intervention|Emesis in Dosing Interval|0|||
37878147|NCT01074450|69562502|FG001|First Intervention|Emesis in Dosing Interval|2|||
37878148|NCT01074450|69562501|FG000|Second Intervention|Protocol Violation|1|||
37878149|NCT01074450|69562502|FG001|Second Intervention|Protocol Violation|0|||
37878150|NCT01074450|69562501|FG000|Second Intervention|Physician Decision|0|||
37878151|NCT01074450|69562502|FG001|Second Intervention|Physician Decision|1|||
37878152|NCT00943761|69562510|FG000|Overall Study|Lost to Follow-up|2|||
37878153|NCT00943761|69562511|FG001|Overall Study|Lost to Follow-up|0|||
37878154|NCT00943761|69562510|FG000|Overall Study|Withdrawal by Subject|2|||
37878155|NCT00943761|69562511|FG001|Overall Study|Withdrawal by Subject|1|||
37878156|NCT00949533|69562519|FG000|Overall Study|Lost to Follow-up|0|||
37878157|NCT00949533|69562520|FG001|Overall Study|Lost to Follow-up|1|||
37878158|NCT00866047|69562526|FG000|Treatment Period|Progressive disease|13|||
37878159|NCT00866047|69562526|FG000|Treatment Period|Adverse Event|16|||
37878160|NCT00866047|69562526|FG000|Treatment Period|Physician Decision|14|||
37878161|NCT00866047|69562526|FG000|Treatment Period|Withdrawal by Subject|5|||
37878162|NCT00866047|69562526|FG000|Follow-up Period|Lost to Follow-up|5|||
37878163|NCT00869323|69562530|FG000|Maintenance Therapy|concurrent illness|1|||
37878164|NCT01192022|69562538|FG000|Overall Study|Withdrawal of Consent|3|||
37878165|NCT01192022|69562539|FG001|Overall Study|Withdrawal of Consent|1|||
37878166|NCT01192022|69562540|FG002|Overall Study|Withdrawal of Consent|0|||
37878167|NCT01192022|69562541|FG003|Overall Study|Withdrawal of Consent|0|||
37878168|NCT01192022|69562542|FG004|Overall Study|Withdrawal of Consent|0|||
37878169|NCT01192022|69562538|FG000|Overall Study|Lost to Follow-up|4|||
37878170|NCT01192022|69562539|FG001|Overall Study|Lost to Follow-up|2|||
37878171|NCT01192022|69562540|FG002|Overall Study|Lost to Follow-up|1|||
37878172|NCT01192022|69562541|FG003|Overall Study|Lost to Follow-up|1|||
37878173|NCT01192022|69562542|FG004|Overall Study|Lost to Follow-up|0|||
37878174|NCT01192022|69562538|FG000|Overall Study|Adverse Event|1|||
37878175|NCT01192022|69562539|FG001|Overall Study|Adverse Event|0|||
37878176|NCT01192022|69562540|FG002|Overall Study|Adverse Event|0|||
37878177|NCT01192022|69562541|FG003|Overall Study|Adverse Event|0|||
37878178|NCT01192022|69562542|FG004|Overall Study|Adverse Event|0|||
37878179|NCT01192022|69562538|FG000|Overall Study|Fatal Adverse Event|4|||
37878180|NCT01192022|69562539|FG001|Overall Study|Fatal Adverse Event|6|||
37878181|NCT01192022|69562540|FG002|Overall Study|Fatal Adverse Event|0|||
37983637|NCT00242710|69669770|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
37878182|NCT01192022|69562541|FG003|Overall Study|Fatal Adverse Event|0|||
37878183|NCT01192022|69562542|FG004|Overall Study|Fatal Adverse Event|1|||
37878184|NCT01192022|69562538|FG000|Overall Study|Physician withdrew-patient hardship|1|||
37878185|NCT01192022|69562539|FG001|Overall Study|Physician withdrew-patient hardship|0|||
37878186|NCT01192022|69562540|FG002|Overall Study|Physician withdrew-patient hardship|0|||
37878187|NCT01192022|69562541|FG003|Overall Study|Physician withdrew-patient hardship|0|||
37878188|NCT01192022|69562542|FG004|Overall Study|Physician withdrew-patient hardship|0|||
37878189|NCT01192022|69562538|FG000|Overall Study|Patient too sick from chemotherapy|0|||
37878190|NCT01192022|69562539|FG001|Overall Study|Patient too sick from chemotherapy|1|||
37878191|NCT01192022|69562540|FG002|Overall Study|Patient too sick from chemotherapy|0|||
37983638|NCT00242710|69669771|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
37878192|NCT01192022|69562541|FG003|Overall Study|Patient too sick from chemotherapy|0|||
37818812|NCT03850483|69498063|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
37818813|NCT03850483|69498064|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
37818814|NCT03850483|69498065|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
37818815|NCT03850483|69498066|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
37818816|NCT03850483|69498067|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
37818817|NCT03850483|69498068|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
37818818|NCT03850483|69498069|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
37818819|NCT03850483|69498070|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
37818820|NCT03850483|69498061|FG000|Follow-up for Stage 1|Physician Decision|0|||
37818821|NCT03850483|69498062|FG001|Follow-up for Stage 1|Physician Decision|0|||
37818822|NCT03850483|69498063|FG002|Follow-up for Stage 1|Physician Decision|0|||
37818823|NCT03850483|69498064|FG003|Follow-up for Stage 1|Physician Decision|0|||
37818824|NCT03850483|69498065|FG004|Follow-up for Stage 1|Physician Decision|1|||
37818825|NCT03850483|69498066|FG005|Follow-up for Stage 1|Physician Decision|0|||
37818826|NCT03850483|69498067|FG006|Follow-up for Stage 1|Physician Decision|1|||
37818827|NCT03850483|69498068|FG007|Follow-up for Stage 1|Physician Decision|0|||
37818828|NCT03850483|69498069|FG008|Follow-up for Stage 1|Physician Decision|0|||
37818829|NCT03850483|69498070|FG009|Follow-up for Stage 1|Physician Decision|0|||
37818830|NCT03850483|69498061|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
37818831|NCT03850483|69498062|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
37818832|NCT03850483|69498063|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
37818833|NCT03850483|69498064|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
37818834|NCT03850483|69498065|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
37818835|NCT03850483|69498066|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
37818836|NCT03850483|69498067|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
37818837|NCT03850483|69498068|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
37818838|NCT03850483|69498069|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
37818839|NCT03850483|69498070|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
37818840|NCT03850483|69498061|FG000|Follow-up for Stage 1|Adverse Event|0|||
37818841|NCT03850483|69498062|FG001|Follow-up for Stage 1|Adverse Event|0|||
37818842|NCT03850483|69498063|FG002|Follow-up for Stage 1|Adverse Event|1|||
37818843|NCT03850483|69498064|FG003|Follow-up for Stage 1|Adverse Event|0|||
37818844|NCT03850483|69498065|FG004|Follow-up for Stage 1|Adverse Event|0|||
37818845|NCT03850483|69498066|FG005|Follow-up for Stage 1|Adverse Event|1|||
37818846|NCT03850483|69498067|FG006|Follow-up for Stage 1|Adverse Event|0|||
37818847|NCT03850483|69498068|FG007|Follow-up for Stage 1|Adverse Event|0|||
37818848|NCT03850483|69498069|FG008|Follow-up for Stage 1|Adverse Event|0|||
37818849|NCT03850483|69498070|FG009|Follow-up for Stage 1|Adverse Event|0|||
37818850|NCT03850483|69498061|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
37818851|NCT03850483|69498062|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
37818852|NCT03850483|69498063|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
37818853|NCT03850483|69498064|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
37818854|NCT03850483|69498065|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
37818855|NCT03850483|69498066|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
37818856|NCT03850483|69498067|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
37818857|NCT03850483|69498068|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
37818858|NCT03850483|69498069|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
37818859|NCT03850483|69498070|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
37818860|NCT03850483|69498061|FG000|Follow-up for Stage 1|Other|0|||
37818861|NCT03850483|69498062|FG001|Follow-up for Stage 1|Other|2|||
37818862|NCT03850483|69498063|FG002|Follow-up for Stage 1|Other|0|||
37818863|NCT03850483|69498064|FG003|Follow-up for Stage 1|Other|2|||
37818864|NCT03850483|69498065|FG004|Follow-up for Stage 1|Other|0|||
37818865|NCT03850483|69498066|FG005|Follow-up for Stage 1|Other|1|||
37818866|NCT03850483|69498067|FG006|Follow-up for Stage 1|Other|0|||
37818867|NCT03850483|69498068|FG007|Follow-up for Stage 1|Other|0|||
37818868|NCT03850483|69498069|FG008|Follow-up for Stage 1|Other|0|||
37818869|NCT03850483|69498070|FG009|Follow-up for Stage 1|Other|0|||
37818870|NCT03850483|69498061|FG000|Treatment for Stage 2|Adverse Event|0|||
37818871|NCT03850483|69498062|FG001|Treatment for Stage 2|Adverse Event|0|||
37818872|NCT03850483|69498063|FG002|Treatment for Stage 2|Adverse Event|0|||
37818873|NCT03850483|69498064|FG003|Treatment for Stage 2|Adverse Event|0|||
37818874|NCT03850483|69498065|FG004|Treatment for Stage 2|Adverse Event|0|||
37818875|NCT03850483|69498066|FG005|Treatment for Stage 2|Adverse Event|0|||
37818876|NCT03850483|69498067|FG006|Treatment for Stage 2|Adverse Event|0|||
37818877|NCT03850483|69498068|FG007|Treatment for Stage 2|Adverse Event|0|||
37818878|NCT03850483|69498069|FG008|Treatment for Stage 2|Adverse Event|0|||
37818879|NCT03850483|69498070|FG009|Treatment for Stage 2|Adverse Event|1|||
37818880|NCT03850483|69498061|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
37818881|NCT03850483|69498062|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
37818882|NCT03850483|69498063|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
37818883|NCT03850483|69498064|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
37818884|NCT03850483|69498065|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
37818885|NCT03850483|69498066|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
37818886|NCT03850483|69498067|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
37818887|NCT03850483|69498068|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
37818888|NCT03850483|69498069|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
37818889|NCT03850483|69498070|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
37818890|NCT03850483|69498061|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
37818891|NCT03850483|69498062|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
37818892|NCT03850483|69498063|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
37818893|NCT03850483|69498064|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
37818894|NCT03850483|69498065|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
37818895|NCT03850483|69498066|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
37818896|NCT03850483|69498067|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
37818897|NCT03850483|69498068|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
37983639|NCT00408876|69669785|FG000|Overall Study|Adverse Event|9|||
37983640|NCT00408876|69669786|FG001|Overall Study|Adverse Event|17|||
37983641|NCT00408876|69669787|FG002|Overall Study|Adverse Event|27|||
37983642|NCT00408876|69669788|FG003|Overall Study|Adverse Event|10|||
37983643|NCT00408876|69669785|FG000|Overall Study|Withdrawal by Subject|3|||
37983644|NCT00408876|69669786|FG001|Overall Study|Withdrawal by Subject|6|||
37983645|NCT00408876|69669787|FG002|Overall Study|Withdrawal by Subject|6|||
37983646|NCT00408876|69669788|FG003|Overall Study|Withdrawal by Subject|14|||
37983647|NCT00408876|69669785|FG000|Overall Study|Lack of Efficacy|2|||
37983648|NCT00408876|69669786|FG001|Overall Study|Lack of Efficacy|4|||
37983649|NCT00408876|69669787|FG002|Overall Study|Lack of Efficacy|5|||
37983650|NCT00408876|69669788|FG003|Overall Study|Lack of Efficacy|6|||
37983651|NCT00408876|69669785|FG000|Overall Study|Lost to Follow-up|1|||
37983652|NCT00408876|69669786|FG001|Overall Study|Lost to Follow-up|6|||
37983653|NCT00408876|69669787|FG002|Overall Study|Lost to Follow-up|5|||
37983654|NCT00408876|69669788|FG003|Overall Study|Lost to Follow-up|2|||
37983655|NCT00408876|69669785|FG000|Overall Study|Protocol Violation|0|||
37983656|NCT00408876|69669786|FG001|Overall Study|Protocol Violation|3|||
37983657|NCT00408876|69669787|FG002|Overall Study|Protocol Violation|4|||
37983658|NCT00408876|69669788|FG003|Overall Study|Protocol Violation|3|||
37983659|NCT00408876|69669785|FG000|Overall Study|Physician Decision|1|||
37983660|NCT00408876|69669786|FG001|Overall Study|Physician Decision|0|||
37983661|NCT00408876|69669787|FG002|Overall Study|Physician Decision|3|||
37983662|NCT00408876|69669788|FG003|Overall Study|Physician Decision|0|||
37818898|NCT03850483|69498069|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
37818899|NCT03850483|69498070|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
37983663|NCT00240994|69669798|FG000|Overall Study|Lost to Follow-up|1|||
37983664|NCT00240994|69669798|FG000|Overall Study|Protocol Violation|1|||
37983665|NCT00240994|69669798|FG000|Overall Study|Graft failure|1|||
37983666|NCT00239590|69669802|FG000|Randomized|Lost to Follow-up|0|||
37983667|NCT00239590|69669803|FG001|Randomized|Lost to Follow-up|1|||
37818900|NCT03850483|69498061|FG000|Treatment for Stage 2|Physician Decision|0|||
37818901|NCT03850483|69498062|FG001|Treatment for Stage 2|Physician Decision|0|||
37818902|NCT03850483|69498063|FG002|Treatment for Stage 2|Physician Decision|0|||
37818903|NCT03850483|69498064|FG003|Treatment for Stage 2|Physician Decision|0|||
37818904|NCT03850483|69498065|FG004|Treatment for Stage 2|Physician Decision|0|||
37878193|NCT01192022|69562542|FG004|Overall Study|Patient too sick from chemotherapy|0|||
37878194|NCT01192022|69562538|FG000|Overall Study|Patient needed surgery|0|||
37878195|NCT01192022|69562539|FG001|Overall Study|Patient needed surgery|1|||
37878196|NCT01192022|69562540|FG002|Overall Study|Patient needed surgery|0|||
37878197|NCT01192022|69562541|FG003|Overall Study|Patient needed surgery|0|||
37878198|NCT01192022|69562542|FG004|Overall Study|Patient needed surgery|0|||
37983668|NCT00239590|69669802|FG000|Randomized|Withdrawal by Subject|0|||
37983669|NCT00239590|69669803|FG001|Randomized|Withdrawal by Subject|1|||
37818905|NCT03850483|69498066|FG005|Treatment for Stage 2|Physician Decision|0|||
37878199|NCT01192022|69562538|FG000|Overall Study|Parents did not allow all follow up|0|||
37818906|NCT03850483|69498067|FG006|Treatment for Stage 2|Physician Decision|0|||
37818907|NCT03850483|69498068|FG007|Treatment for Stage 2|Physician Decision|0|||
37818908|NCT03850483|69498069|FG008|Treatment for Stage 2|Physician Decision|0|||
37878200|NCT01192022|69562539|FG001|Overall Study|Parents did not allow all follow up|0|||
37983670|NCT00239590|69669802|FG000|Completed Study Protocol|Adverse Event|1|||
37983671|NCT00239590|69669803|FG001|Completed Study Protocol|Adverse Event|1|||
37983672|NCT00239590|69669802|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
37983673|NCT00239590|69669803|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
37983674|NCT00433160|69669813|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
37983675|NCT00433160|69669814|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
37983676|NCT00433160|69669813|FG000|52-Week Double-Blind (DB) Period|Death|0|||
37983677|NCT00433160|69669814|FG001|52-Week Double-Blind (DB) Period|Death|0|||
37983678|NCT00433160|69669813|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
37983679|NCT00433160|69669814|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
37983680|NCT00433160|69669813|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
37983681|NCT00433160|69669814|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
37983682|NCT00433160|69669813|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
37983683|NCT00433160|69669814|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
37983684|NCT00433160|69669813|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
37983685|NCT00433160|69669814|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
37983686|NCT00433160|69669813|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
37983687|NCT00433160|69669814|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
37983688|NCT00433160|69669813|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
37983689|NCT00433160|69669814|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
37983690|NCT00433160|69669813|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
37983691|NCT00433160|69669814|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
37983692|NCT00433160|69669813|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
37983693|NCT00433160|69669814|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
37983694|NCT00433160|69669813|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
37983695|NCT00433160|69669814|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
37983696|NCT00433160|69669813|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
37983697|NCT00433160|69669814|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
37983698|NCT00433160|69669813|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
37983699|NCT00433160|69669814|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
37983700|NCT00433160|69669813|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
37983701|NCT00433160|69669814|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
37983702|NCT00433160|69669813|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
37983703|NCT00433160|69669814|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
37878201|NCT01192022|69562540|FG002|Overall Study|Parents did not allow all follow up|0|||
37878202|NCT01192022|69562541|FG003|Overall Study|Parents did not allow all follow up|1|||
37983704|NCT00433160|69669813|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
37983705|NCT00433160|69669814|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
37818909|NCT03850483|69498070|FG009|Treatment for Stage 2|Physician Decision|1|||
37818910|NCT03850483|69498061|FG000|Treatment for Stage 2|Protocol Violation|0|||
37818911|NCT03850483|69498062|FG001|Treatment for Stage 2|Protocol Violation|0|||
37818912|NCT03850483|69498063|FG002|Treatment for Stage 2|Protocol Violation|0|||
37878203|NCT01192022|69562542|FG004|Overall Study|Parents did not allow all follow up|0|||
37878204|NCT01191944|69562555|FG000|Overall Study|Adverse Event|11|||
37878205|NCT01191944|69562556|FG001|Overall Study|Adverse Event|12|||
37878206|NCT01191944|69562555|FG000|Overall Study|Protocol Violation|1|||
37878207|NCT01191944|69562556|FG001|Overall Study|Protocol Violation|2|||
37878208|NCT01191944|69562555|FG000|Overall Study|Withdrawal by Subject|4|||
37878209|NCT01191944|69562556|FG001|Overall Study|Withdrawal by Subject|2|||
37878210|NCT01191944|69562555|FG000|Overall Study|Other|1|||
37878211|NCT01191944|69562556|FG001|Overall Study|Other|3|||
37878212|NCT01191788|69562564|FG000|Overall Study|Lost to Follow-up|21|||
37878213|NCT01191788|69562565|FG001|Overall Study|Lost to Follow-up|22|||
37878214|NCT00940875|69562574|FG000|Treatment Phase|Adverse Event|9|||
37818913|NCT03850483|69498064|FG003|Treatment for Stage 2|Protocol Violation|0|||
37818914|NCT03850483|69498065|FG004|Treatment for Stage 2|Protocol Violation|0|||
37818915|NCT03850483|69498066|FG005|Treatment for Stage 2|Protocol Violation|0|||
37818916|NCT03850483|69498067|FG006|Treatment for Stage 2|Protocol Violation|0|||
37818917|NCT03850483|69498068|FG007|Treatment for Stage 2|Protocol Violation|0|||
37818918|NCT03850483|69498069|FG008|Treatment for Stage 2|Protocol Violation|1|||
37818919|NCT03850483|69498070|FG009|Treatment for Stage 2|Protocol Violation|0|||
37818920|NCT03850483|69498061|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
37818921|NCT03850483|69498062|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
37818922|NCT03850483|69498063|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
37818923|NCT03850483|69498064|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
37818924|NCT03850483|69498065|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
37818925|NCT03850483|69498066|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
37818926|NCT03850483|69498067|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
37818927|NCT03850483|69498068|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
37878215|NCT00940875|69562575|FG001|Treatment Phase|Adverse Event|3|||
37878216|NCT00940875|69562574|FG000|Treatment Phase|Death|3|||
37878217|NCT00940875|69562575|FG001|Treatment Phase|Death|5|||
37878218|NCT00940875|69562574|FG000|Treatment Phase|Lack of Efficacy|1|||
37878219|NCT00940875|69562575|FG001|Treatment Phase|Lack of Efficacy|0|||
37878220|NCT00940875|69562574|FG000|Treatment Phase|Withdrawal by Subject|3|||
37878221|NCT00940875|69562575|FG001|Treatment Phase|Withdrawal by Subject|0|||
37878222|NCT00940875|69562574|FG000|Treatment Phase|Disease progression|9|||
37878223|NCT00940875|69562575|FG001|Treatment Phase|Disease progression|11|||
37878224|NCT00940875|69562574|FG000|Treatment Phase|Physician Decision|1|||
37878225|NCT00940875|69562575|FG001|Treatment Phase|Physician Decision|0|||
37878226|NCT00940875|69562574|FG000|Post-Study Treatment|Death|0|||
37878227|NCT00940875|69562575|FG001|Post-Study Treatment|Death|1|||
37878228|NCT00940875|69562574|FG000|Post-Study Treatment|Disease Progression|0|||
37878229|NCT00940875|69562575|FG001|Post-Study Treatment|Disease Progression|2|||
37878230|NCT00940485|69562584|FG000|Overall Study|HBeAb positive at Baseline|3|||
37878231|NCT00940485|69562585|FG001|Overall Study|HBeAb positive at Baseline|2|||
37878232|NCT00940485|69562584|FG000|Overall Study|Lost to Follow-up|2|||
37878233|NCT00940485|69562585|FG001|Overall Study|Lost to Follow-up|3|||
37878234|NCT00940485|69562584|FG000|Overall Study|Adverse Event|8|||
37878235|NCT00940485|69562585|FG001|Overall Study|Adverse Event|0|||
37878236|NCT00940485|69562584|FG000|Overall Study|Withdrawal by Subject|1|||
37878237|NCT00940485|69562585|FG001|Overall Study|Withdrawal by Subject|1|||
37878238|NCT00940485|69562584|FG000|Overall Study|Others|1|||
37878239|NCT00940485|69562585|FG001|Overall Study|Others|1|||
37878240|NCT00943605|69562593|FG000|Overall Study|Study termination|30|||
37878241|NCT00943605|69562594|FG001|Overall Study|Study termination|30|||
37878242|NCT01132313|69562612|FG000|Overall Study|Lack of Efficacy|1|||
37878243|NCT01132313|69562613|FG001|Overall Study|Lack of Efficacy|0|||
37878244|NCT01132313|69562614|FG002|Overall Study|Lack of Efficacy|0|||
37878245|NCT01132313|69562615|FG003|Overall Study|Lack of Efficacy|0|||
37878246|NCT01132313|69562616|FG004|Overall Study|Lack of Efficacy|0|||
37878247|NCT01132313|69562617|FG005|Overall Study|Lack of Efficacy|0|||
37878248|NCT01132313|69562618|FG006|Overall Study|Lack of Efficacy|0|||
37878249|NCT01132313|69562619|FG007|Overall Study|Lack of Efficacy|3|||
37878250|NCT01132313|69562620|FG008|Overall Study|Lack of Efficacy|14|||
37878251|NCT01132313|69562621|FG009|Overall Study|Lack of Efficacy|16|||
37878252|NCT01132313|69562622|FG010|Overall Study|Lack of Efficacy|0|||
37878253|NCT01132313|69562623|FG011|Overall Study|Lack of Efficacy|0|||
37878254|NCT01132313|69562612|FG000|Overall Study|Not treated|2|||
37878255|NCT01132313|69562613|FG001|Overall Study|Not treated|0|||
37878256|NCT01132313|69562614|FG002|Overall Study|Not treated|0|||
37878257|NCT01132313|69562615|FG003|Overall Study|Not treated|0|||
37878258|NCT01132313|69562616|FG004|Overall Study|Not treated|2|||
37878259|NCT01132313|69562617|FG005|Overall Study|Not treated|1|||
37878260|NCT01132313|69562618|FG006|Overall Study|Not treated|3|||
37878261|NCT01132313|69562619|FG007|Overall Study|Not treated|0|||
37878262|NCT01132313|69562620|FG008|Overall Study|Not treated|0|||
37878263|NCT01132313|69562621|FG009|Overall Study|Not treated|0|||
37878264|NCT01132313|69562622|FG010|Overall Study|Not treated|0|||
37878265|NCT01132313|69562623|FG011|Overall Study|Not treated|0|||
37878266|NCT01132313|69562612|FG000|Overall Study|Adverse Event|0|||
37878267|NCT01132313|69562613|FG001|Overall Study|Adverse Event|0|||
37878268|NCT01132313|69562614|FG002|Overall Study|Adverse Event|4|||
37878269|NCT01132313|69562615|FG003|Overall Study|Adverse Event|10|||
37878270|NCT01132313|69562616|FG004|Overall Study|Adverse Event|19|||
37878271|NCT01132313|69562617|FG005|Overall Study|Adverse Event|6|||
37878272|NCT01132313|69562618|FG006|Overall Study|Adverse Event|5|||
37878273|NCT01132313|69562619|FG007|Overall Study|Adverse Event|3|||
37878274|NCT01132313|69562620|FG008|Overall Study|Adverse Event|7|||
37878275|NCT01132313|69562621|FG009|Overall Study|Adverse Event|2|||
37878276|NCT01132313|69562622|FG010|Overall Study|Adverse Event|0|||
37878277|NCT01132313|69562623|FG011|Overall Study|Adverse Event|0|||
37878278|NCT01132313|69562612|FG000|Overall Study|Protocol Violation|0|||
37878279|NCT01132313|69562613|FG001|Overall Study|Protocol Violation|0|||
37878280|NCT01132313|69562614|FG002|Overall Study|Protocol Violation|0|||
37878281|NCT01132313|69562615|FG003|Overall Study|Protocol Violation|1|||
37878282|NCT01132313|69562616|FG004|Overall Study|Protocol Violation|0|||
37878283|NCT01132313|69562617|FG005|Overall Study|Protocol Violation|0|||
37878284|NCT01132313|69562618|FG006|Overall Study|Protocol Violation|0|||
37878285|NCT01132313|69562619|FG007|Overall Study|Protocol Violation|0|||
37878286|NCT01132313|69562620|FG008|Overall Study|Protocol Violation|0|||
37878287|NCT01132313|69562621|FG009|Overall Study|Protocol Violation|0|||
37878288|NCT01132313|69562622|FG010|Overall Study|Protocol Violation|0|||
37878289|NCT01132313|69562623|FG011|Overall Study|Protocol Violation|0|||
37878290|NCT01132313|69562612|FG000|Overall Study|Lost to Follow-up|0|||
37878291|NCT01132313|69562613|FG001|Overall Study|Lost to Follow-up|0|||
37878292|NCT01132313|69562614|FG002|Overall Study|Lost to Follow-up|1|||
37983706|NCT00239356|69669826|FG000|Overall Study|Lack of Efficacy|1|||
37983707|NCT00239356|69669827|FG001|Overall Study|Lack of Efficacy|0|||
37878293|NCT01132313|69562615|FG003|Overall Study|Lost to Follow-up|0|||
37878294|NCT01132313|69562616|FG004|Overall Study|Lost to Follow-up|0|||
37878295|NCT01132313|69562617|FG005|Overall Study|Lost to Follow-up|0|||
37878296|NCT01132313|69562618|FG006|Overall Study|Lost to Follow-up|0|||
37878297|NCT01132313|69562619|FG007|Overall Study|Lost to Follow-up|1|||
37878298|NCT01132313|69562620|FG008|Overall Study|Lost to Follow-up|0|||
37878299|NCT01132313|69562621|FG009|Overall Study|Lost to Follow-up|0|||
37878300|NCT01132313|69562622|FG010|Overall Study|Lost to Follow-up|0|||
37878301|NCT01132313|69562623|FG011|Overall Study|Lost to Follow-up|0|||
37878302|NCT01132313|69562612|FG000|Overall Study|Withdrawal by Subject|0|||
37878303|NCT01132313|69562613|FG001|Overall Study|Withdrawal by Subject|0|||
37878304|NCT01132313|69562614|FG002|Overall Study|Withdrawal by Subject|3|||
37983708|NCT00239356|69669826|FG000|Overall Study|Adverse Event|6|||
37878305|NCT01132313|69562615|FG003|Overall Study|Withdrawal by Subject|3|||
37878306|NCT01132313|69562616|FG004|Overall Study|Withdrawal by Subject|6|||
37878307|NCT01132313|69562617|FG005|Overall Study|Withdrawal by Subject|0|||
37878308|NCT01132313|69562618|FG006|Overall Study|Withdrawal by Subject|1|||
37878309|NCT01132313|69562619|FG007|Overall Study|Withdrawal by Subject|0|||
37878310|NCT01132313|69562620|FG008|Overall Study|Withdrawal by Subject|0|||
37878311|NCT01132313|69562621|FG009|Overall Study|Withdrawal by Subject|2|||
37878312|NCT01132313|69562622|FG010|Overall Study|Withdrawal by Subject|0|||
37878313|NCT01132313|69562623|FG011|Overall Study|Withdrawal by Subject|0|||
37878314|NCT01132313|69562612|FG000|Overall Study|Lack of antiviral response|0|||
37878315|NCT01132313|69562613|FG001|Overall Study|Lack of antiviral response|0|||
37878316|NCT01132313|69562614|FG002|Overall Study|Lack of antiviral response|12|||
37878317|NCT01132313|69562615|FG003|Overall Study|Lack of antiviral response|18|||
37878318|NCT01132313|69562616|FG004|Overall Study|Lack of antiviral response|18|||
37878319|NCT01132313|69562617|FG005|Overall Study|Lack of antiviral response|18|||
37878320|NCT01132313|69562618|FG006|Overall Study|Lack of antiviral response|21|||
37878321|NCT01132313|69562619|FG007|Overall Study|Lack of antiviral response|0|||
37878322|NCT01132313|69562620|FG008|Overall Study|Lack of antiviral response|0|||
37878323|NCT01132313|69562621|FG009|Overall Study|Lack of antiviral response|0|||
37878324|NCT01132313|69562622|FG010|Overall Study|Lack of antiviral response|1|||
37878325|NCT01132313|69562623|FG011|Overall Study|Lack of antiviral response|0|||
37878326|NCT01132313|69562612|FG000|Overall Study|Other reason not defined above|0|||
37878327|NCT01132313|69562613|FG001|Overall Study|Other reason not defined above|0|||
37878328|NCT01132313|69562614|FG002|Overall Study|Other reason not defined above|0|||
37878329|NCT01132313|69562615|FG003|Overall Study|Other reason not defined above|0|||
37878330|NCT01132313|69562616|FG004|Overall Study|Other reason not defined above|0|||
37878331|NCT01132313|69562617|FG005|Overall Study|Other reason not defined above|0|||
37878332|NCT01132313|69562618|FG006|Overall Study|Other reason not defined above|0|||
37878333|NCT01132313|69562619|FG007|Overall Study|Other reason not defined above|1|||
37878334|NCT01132313|69562620|FG008|Overall Study|Other reason not defined above|0|||
37878335|NCT01132313|69562621|FG009|Overall Study|Other reason not defined above|0|||
37878336|NCT01132313|69562622|FG010|Overall Study|Other reason not defined above|0|||
37878337|NCT01132313|69562623|FG011|Overall Study|Other reason not defined above|0|||
37878338|NCT00861757|69562658|FG000|Overall Study|Adverse Event|1|||
37878339|NCT00861757|69562659|FG001|Overall Study|Adverse Event|5|||
37878340|NCT00861757|69562660|FG002|Overall Study|Adverse Event|7|||
37878341|NCT00861757|69562661|FG003|Overall Study|Adverse Event|2|||
37878342|NCT00861757|69562658|FG000|Overall Study|Entry Criteria Not Met|1|||
37878343|NCT00861757|69562659|FG001|Overall Study|Entry Criteria Not Met|2|||
37878344|NCT00861757|69562660|FG002|Overall Study|Entry Criteria Not Met|1|||
37878345|NCT00861757|69562661|FG003|Overall Study|Entry Criteria Not Met|1|||
37878346|NCT00861757|69562658|FG000|Overall Study|Lack of Efficacy|3|||
37878347|NCT00861757|69562659|FG001|Overall Study|Lack of Efficacy|1|||
37878348|NCT00861757|69562660|FG002|Overall Study|Lack of Efficacy|0|||
37878349|NCT00861757|69562661|FG003|Overall Study|Lack of Efficacy|1|||
37878350|NCT00861757|69562658|FG000|Overall Study|Lost to Follow-up|1|||
37878351|NCT00861757|69562659|FG001|Overall Study|Lost to Follow-up|0|||
37878352|NCT00861757|69562660|FG002|Overall Study|Lost to Follow-up|1|||
37878353|NCT00861757|69562661|FG003|Overall Study|Lost to Follow-up|1|||
37695198|NCT02365064|69171733|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
37818928|NCT03850483|69498069|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
37818929|NCT03850483|69498070|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
37818930|NCT03850483|69498061|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
37818931|NCT03850483|69498062|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
37818932|NCT03850483|69498063|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
37818933|NCT03850483|69498064|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
37818934|NCT03850483|69498065|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
37818935|NCT03850483|69498066|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
37818936|NCT03850483|69498067|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
37818937|NCT03850483|69498068|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
37818938|NCT03850483|69498069|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
37818939|NCT03850483|69498070|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
37818940|NCT03850483|69498061|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
37818941|NCT03850483|69498062|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
37818942|NCT03850483|69498063|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
37818943|NCT03850483|69498064|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
37818944|NCT03850483|69498065|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
37878354|NCT00861757|69562658|FG000|Overall Study|Physician Decision|0|||
37878355|NCT00861757|69562659|FG001|Overall Study|Physician Decision|0|||
37983709|NCT00239356|69669827|FG001|Overall Study|Adverse Event|0|||
37983710|NCT00239356|69669826|FG000|Overall Study|Withdrawal by Subject|15|||
37878356|NCT00861757|69562660|FG002|Overall Study|Physician Decision|0|||
37878357|NCT00861757|69562661|FG003|Overall Study|Physician Decision|1|||
37878358|NCT00861757|69562658|FG000|Overall Study|Protocol Violation|2|||
37878359|NCT00861757|69562659|FG001|Overall Study|Protocol Violation|2|||
37878360|NCT00861757|69562660|FG002|Overall Study|Protocol Violation|4|||
37878361|NCT00861757|69562661|FG003|Overall Study|Protocol Violation|1|||
37878362|NCT00861757|69562658|FG000|Overall Study|Withdrawal by Subject|1|||
37878363|NCT00861757|69562659|FG001|Overall Study|Withdrawal by Subject|5|||
37878364|NCT00861757|69562660|FG002|Overall Study|Withdrawal by Subject|5|||
37878365|NCT00861757|69562661|FG003|Overall Study|Withdrawal by Subject|2|||
37878366|NCT01131455|69562678|FG000|Overall Study|Death of PI|6|||
37878367|NCT01131455|69562679|FG001|Overall Study|Death of PI|4|||
37878368|NCT01131455|69562680|FG002|Overall Study|Death of PI|0|||
37878369|NCT01138007|69562691|FG000|Overall Study|Adverse Event|4|||
37878370|NCT01138007|69562692|FG001|Overall Study|Adverse Event|12|||
37878371|NCT01138007|69562693|FG002|Overall Study|Adverse Event|9|||
37878372|NCT01138007|69562691|FG000|Overall Study|Lack of Efficacy|2|||
37878373|NCT01138007|69562692|FG001|Overall Study|Lack of Efficacy|0|||
37878374|NCT01138007|69562693|FG002|Overall Study|Lack of Efficacy|6|||
37878375|NCT01138007|69562691|FG000|Overall Study|Protocol Violation|2|||
37878376|NCT01138007|69562692|FG001|Overall Study|Protocol Violation|3|||
37878377|NCT01138007|69562693|FG002|Overall Study|Protocol Violation|2|||
37878378|NCT01138007|69562691|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
37878379|NCT01138007|69562692|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
37878380|NCT01138007|69562693|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
37878381|NCT01138007|69562691|FG000|Overall Study|Lost to Follow-up|3|||
37878382|NCT01138007|69562692|FG001|Overall Study|Lost to Follow-up|3|||
37878383|NCT01138007|69562693|FG002|Overall Study|Lost to Follow-up|5|||
37878384|NCT01138007|69562691|FG000|Overall Study|Physician Decision|0|||
37878385|NCT01138007|69562692|FG001|Overall Study|Physician Decision|5|||
37878386|NCT01138007|69562693|FG002|Overall Study|Physician Decision|3|||
37878387|NCT01138007|69562691|FG000|Overall Study|Withdrawal by Subject|5|||
37878388|NCT01138007|69562692|FG001|Overall Study|Withdrawal by Subject|6|||
37878389|NCT01138007|69562693|FG002|Overall Study|Withdrawal by Subject|15|||
37878390|NCT00865345|69562703|FG000|Overall Study|Withdrawal by Subject|2|||
37878391|NCT01131299|69562707|FG000|Overall Study|Withdrawal by Subject|4|||
37878392|NCT01131299|69562708|FG001|Overall Study|Withdrawal by Subject|7|||
37878393|NCT01130831|69562713|FG000|Overall Study|Withdrawal by Subject|7|||
37878394|NCT01130831|69562713|FG000|Overall Study|Death|4|||
37878395|NCT01130831|69562713|FG000|Overall Study|Information was missing|3|||
37878396|NCT01130597|69562729|FG000|Overall Study|Protocol-specified (High K+)|1|||
37878397|NCT01130597|69562729|FG000|Overall Study|Adverse Event|4|||
37878398|NCT01130597|69562729|FG000|Overall Study|Death|1|||
37878399|NCT01130597|69562729|FG000|Overall Study|Protocol Violation|1|||
37878400|NCT00939003|69562735|FG000|Double-blind Treatment Period|Adverse Event|1|||
37878401|NCT00939003|69562736|FG001|Double-blind Treatment Period|Adverse Event|1|||
37878402|NCT00939003|69562735|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
37878403|NCT00939003|69562736|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
37878404|NCT00939003|69562735|FG000|Double-blind Treatment Period|Pregnancy|0|||
37878405|NCT00939003|69562736|FG001|Double-blind Treatment Period|Pregnancy|1|||
37878406|NCT00939003|69562735|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
37818945|NCT03850483|69498066|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
37878407|NCT00939003|69562736|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
37878408|NCT00939003|69562735|FG000|Open-label Treatment Period|Adverse Event|4|||
37878409|NCT00939003|69562736|FG001|Open-label Treatment Period|Adverse Event|8|||
37878410|NCT00939003|69562735|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
37878411|NCT00939003|69562736|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
37878412|NCT00939003|69562735|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
37878413|NCT00939003|69562736|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
37878414|NCT00939003|69562735|FG000|Open-label Treatment Period|Pregnancy|1|||
37878415|NCT00939003|69562736|FG001|Open-label Treatment Period|Pregnancy|1|||
37878416|NCT00939003|69562735|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
37878417|NCT00939003|69562736|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
37818946|NCT03850483|69498067|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
37818947|NCT03850483|69498068|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
37818948|NCT03850483|69498069|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
37818949|NCT03850483|69498070|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
37818950|NCT03850483|69498061|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
37818951|NCT03850483|69498062|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
37818952|NCT03850483|69498063|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
37818953|NCT03850483|69498064|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
37878418|NCT00939003|69562735|FG000|Open-label Treatment Period|Site Closure|3|||
37878419|NCT00939003|69562736|FG001|Open-label Treatment Period|Site Closure|4|||
37983711|NCT00239356|69669827|FG001|Overall Study|Withdrawal by Subject|6|||
37878420|NCT01188668|69562745|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
37878421|NCT01188668|69562745|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
37983712|NCT00239356|69669826|FG000|Overall Study|Lost to Follow-up|3|||
37983713|NCT00239356|69669827|FG001|Overall Study|Lost to Follow-up|0|||
37983714|NCT00239356|69669826|FG000|Overall Study|poor/non-compliance|2|||
37983715|NCT00239356|69669827|FG001|Overall Study|poor/non-compliance|0|||
37983716|NCT00239356|69669826|FG000|Overall Study|Pregnancy|1|||
37983717|NCT00239356|69669827|FG001|Overall Study|Pregnancy|0|||
37983718|NCT00239356|69669826|FG000|Overall Study|Administrative reason|0|||
37983719|NCT00239356|69669827|FG001|Overall Study|Administrative reason|1|||
37983720|NCT00239356|69669826|FG000|Overall Study|Drug available on market|11|||
37983721|NCT00239356|69669827|FG001|Overall Study|Drug available on market|2|||
37983722|NCT00393510|69669835|FG000|Overall Study|Physician Decision|3|||
37983723|NCT00393510|69669836|FG001|Overall Study|Physician Decision|9|||
37983724|NCT00425438|69669844|FG000|Overall Study|Termination by Sponsor|25|||
37983725|NCT00425438|69669845|FG001|Overall Study|Termination by Sponsor|27|||
37983726|NCT00275002|69669853|FG000|Overall Study|Death|1|||
37983727|NCT00275002|69669854|FG001|Overall Study|Death|0|||
37983728|NCT00275002|69669853|FG000|Overall Study|Disease progression|21|||
37983729|NCT00275002|69669854|FG001|Overall Study|Disease progression|15|||
37983730|NCT00275002|69669853|FG000|Overall Study|Adverse Event|0|||
37983731|NCT00275002|69669854|FG001|Overall Study|Adverse Event|1|||
37983732|NCT00433004|69669862|FG000|Overall Study|Lost to Follow-up|5|||
37983733|NCT00433004|69669863|FG001|Overall Study|Lost to Follow-up|7|||
37983734|NCT00238264|69669869|FG000|Overall Study|Death|7|||
37983735|NCT00238264|69669869|FG000|Overall Study|Lost to Follow-up|18|||
37983736|NCT00238264|69669869|FG000|Overall Study|Withdrawal by Subject|4|||
37983737|NCT00238264|69669869|FG000|Overall Study|Ineligible|7|||
37983738|NCT00414596|69669873|FG000|Overall Study|Protocol Violation|2|||
37983739|NCT00393042|69669877|FG000|First Intervention|Withdrawal by Subject|1|||
37983740|NCT00393042|69669878|FG001|First Intervention|Withdrawal by Subject|2|||
37983741|NCT00393042|69669877|FG000|First Intervention|Lost to Follow-up|3|||
37983742|NCT00393042|69669878|FG001|First Intervention|Lost to Follow-up|3|||
37983743|NCT00393042|69669877|FG000|First Intervention|Protocol Violation|1|||
37983744|NCT00393042|69669878|FG001|First Intervention|Protocol Violation|0|||
37983745|NCT00393042|69669877|FG000|First Intervention|Adverse Event|0|||
37983746|NCT00393042|69669878|FG001|First Intervention|Adverse Event|1|||
37983747|NCT00393042|69669877|FG000|Second Intervetion|Adverse Event|0|||
37983748|NCT00393042|69669878|FG001|Second Intervetion|Adverse Event|3|||
37983749|NCT00393042|69669877|FG000|Second Intervetion|Withdrawal by Subject|0|||
37983750|NCT00393042|69669878|FG001|Second Intervetion|Withdrawal by Subject|2|||
37983751|NCT00393042|69669877|FG000|Second Intervetion|Lack of Efficacy|1|||
37983752|NCT00393042|69669878|FG001|Second Intervetion|Lack of Efficacy|0|||
37983753|NCT00393042|69669877|FG000|Second Intervetion|Lost to Follow-up|0|||
37983754|NCT00393042|69669878|FG001|Second Intervetion|Lost to Follow-up|2|||
37983755|NCT00393042|69669877|FG000|Second Intervetion|Protocol Violation|1|||
37983756|NCT00393042|69669878|FG001|Second Intervetion|Protocol Violation|1|||
37983757|NCT00392808|69669936|FG000|Overall Study|Lost to Follow-up|3|||
37983758|NCT00392808|69669937|FG001|Overall Study|Lost to Follow-up|2|||
37983759|NCT00392808|69669938|FG002|Overall Study|Lost to Follow-up|1|||
37983760|NCT00392808|69669939|FG003|Overall Study|Lost to Follow-up|2|||
37983761|NCT00392808|69669936|FG000|Overall Study|Unable to withdraw blood|3|||
37983762|NCT00392808|69669937|FG001|Overall Study|Unable to withdraw blood|1|||
37983763|NCT00392808|69669938|FG002|Overall Study|Unable to withdraw blood|1|||
37983764|NCT00392808|69669939|FG003|Overall Study|Unable to withdraw blood|2|||
37983765|NCT00274846|69669958|FG000|Overall Study|Did not receive adequate NK cells|1|||
37983766|NCT00237796|69669965|FG000|Overall Study|Baseline and one other ILSS required|10|||
37983767|NCT00237796|69669966|FG001|Overall Study|Baseline and one other ILSS required|5|||
37983768|NCT00414440|69669975|FG000|Core Period|Withdrawal by Subject|70|||
37983769|NCT00414440|69669976|FG001|Core Period|Withdrawal by Subject|32|||
37983770|NCT00414440|69669975|FG000|Extension Period|Lost to Follow-up|44|||
37983771|NCT00414440|69669976|FG001|Extension Period|Lost to Follow-up|52|||
37983772|NCT00414440|69669975|FG000|Extension Period|Did not consent to continue follow up|61|||
37983773|NCT00414440|69669976|FG001|Extension Period|Did not consent to continue follow up|54|||
37983774|NCT00414440|69669975|FG000|Extension Period|Other|1|||
37983775|NCT00414440|69669976|FG001|Extension Period|Other|1|||
37983776|NCT00414440|69669975|FG000|Extension Period|Administrative|16|||
37983777|NCT00414440|69669976|FG001|Extension Period|Administrative|16|||
37983778|NCT00414440|69669975|FG000|Extension Period|Death|1|||
37818954|NCT03850483|69498065|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
37983779|NCT00414440|69669976|FG001|Extension Period|Death|2|||
37983780|NCT00414440|69669975|FG000|Extension Period|Withdrawal by Subject|9|||
37983781|NCT00414440|69669976|FG001|Extension Period|Withdrawal by Subject|7|||
37983782|NCT00414440|69669975|FG000|Extension Period|Not included in follow up period|18|||
37983783|NCT00414440|69669976|FG001|Extension Period|Not included in follow up period|8|||
37983784|NCT00209560|69669984|FG000|Overall Study|Lack of Efficacy|1|||
37983785|NCT00209560|69669985|FG001|Overall Study|Lack of Efficacy|0|||
37983786|NCT00236080|69669996|FG000|Overall Study|Adverse Event|0|||
37983787|NCT00236080|69669997|FG001|Overall Study|Adverse Event|0|||
37983788|NCT00236080|69669998|FG002|Overall Study|Adverse Event|3|||
37983789|NCT00236080|69669999|FG003|Overall Study|Adverse Event|1|||
37983790|NCT00236080|69670000|FG004|Overall Study|Adverse Event|0|||
37983791|NCT00236080|69669996|FG000|Overall Study|Lost to Follow-up|0|||
37983792|NCT00236080|69669997|FG001|Overall Study|Lost to Follow-up|1|||
37983793|NCT00236080|69669998|FG002|Overall Study|Lost to Follow-up|0|||
37983794|NCT00236080|69669999|FG003|Overall Study|Lost to Follow-up|0|||
37983795|NCT00236080|69670000|FG004|Overall Study|Lost to Follow-up|0|||
37983796|NCT00236080|69669996|FG000|Overall Study|Physician Decision|1|||
37983797|NCT00236080|69669997|FG001|Overall Study|Physician Decision|0|||
37983798|NCT00236080|69669998|FG002|Overall Study|Physician Decision|1|||
37983799|NCT00236080|69669999|FG003|Overall Study|Physician Decision|1|||
37983800|NCT00236080|69670000|FG004|Overall Study|Physician Decision|1|||
37983801|NCT00236080|69669996|FG000|Overall Study|Withdrawal by Subject|1|||
37983802|NCT00236080|69669997|FG001|Overall Study|Withdrawal by Subject|0|||
37878422|NCT01188668|69562745|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
37878423|NCT01130051|69562752|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
37878424|NCT01130051|69562753|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
37878425|NCT01130051|69562752|FG000|Washout Period of 14 Days|Protocol Violation|1|||
37878426|NCT01130051|69562753|FG001|Washout Period of 14 Days|Protocol Violation|1|||
37878427|NCT00865189|69562761|FG000|Overall Study|Other|1|||
37878428|NCT00865189|69562762|FG001|Overall Study|Other|2|||
37878429|NCT00865189|69562761|FG000|Overall Study|Death|4|||
37878430|NCT00865189|69562762|FG001|Overall Study|Death|11|||
37878431|NCT00865189|69562761|FG000|Overall Study|Lost to Follow-up|6|||
37878432|NCT00865189|69562762|FG001|Overall Study|Lost to Follow-up|6|||
37878433|NCT00865189|69562761|FG000|Overall Study|Withdrawal by Subject|1|||
37878434|NCT00865189|69562762|FG001|Overall Study|Withdrawal by Subject|0|||
37878435|NCT01182194|69562770|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
37878436|NCT01182194|69562771|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
37878437|NCT01181726|69562779|FG000|First Intervention|Adverse Event|1|||
37878438|NCT01181726|69562780|FG001|First Intervention|Adverse Event|0|||
37878439|NCT01137071|69562786|FG000|Overall Study|Disease Progression|11|||
37878440|NCT01137071|69562786|FG000|Overall Study|Withdrawal by Subject|2|||
37878441|NCT01137071|69562786|FG000|Overall Study|Wrongly Included|1|||
37878442|NCT00860743|69562801|FG000|Overall Study|Withdrawal by Subject|3|||
37878443|NCT00860743|69562802|FG001|Overall Study|Withdrawal by Subject|0|||
37878444|NCT01186796|69562810|FG000|Overall Study|Adverse Event|3|||
37878445|NCT01186796|69562811|FG001|Overall Study|Adverse Event|0|||
37878446|NCT01186796|69562810|FG000|Overall Study|Withdrawal by Subject|1|||
37878447|NCT01186796|69562811|FG001|Overall Study|Withdrawal by Subject|1|||
37878448|NCT01186796|69562810|FG000|Overall Study|Protocol Violation|0|||
37878449|NCT01186796|69562811|FG001|Overall Study|Protocol Violation|1|||
37878450|NCT01136915|69562819|FG000|Overall Study|Lost to Follow-up|2|||
37878451|NCT01136915|69562820|FG001|Overall Study|Lost to Follow-up|0|||
37983803|NCT00236080|69669998|FG002|Overall Study|Withdrawal by Subject|0|||
37983804|NCT00236080|69669999|FG003|Overall Study|Withdrawal by Subject|0|||
37983805|NCT00236080|69670000|FG004|Overall Study|Withdrawal by Subject|0|||
37983806|NCT00236080|69669996|FG000|Overall Study|Miscellaneous|0|||
37983807|NCT00236080|69669997|FG001|Overall Study|Miscellaneous|0|||
37983808|NCT00236080|69669998|FG002|Overall Study|Miscellaneous|1|||
37983809|NCT00236080|69669999|FG003|Overall Study|Miscellaneous|0|||
37878452|NCT01136915|69562819|FG000|Overall Study|Exclusion criterion met|0|||
37878453|NCT01136915|69562820|FG001|Overall Study|Exclusion criterion met|1|||
37878454|NCT00940017|69562828|FG000|Overall Study|did not meet entrance criteria|3|||
37878455|NCT00940017|69562828|FG000|Overall Study|Adverse Event|1|||
37878456|NCT01129583|69562834|FG000|Overall Study|Death|1|||
37878457|NCT01129583|69562835|FG001|Overall Study|Death|0|||
37878458|NCT01129583|69562834|FG000|Overall Study|Lost to Follow-up|1|||
37878459|NCT01129583|69562835|FG001|Overall Study|Lost to Follow-up|1|||
37878460|NCT01129583|69562834|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
37878461|NCT01129583|69562835|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
37878462|NCT01186328|69562841|FG000|Overall Study|Death|1|||
37878463|NCT01186328|69562842|FG001|Overall Study|Death|0|||
37878464|NCT01186328|69562843|FG002|Overall Study|Death|0|||
37878465|NCT00848497|69562850|FG000|Overall Study|Screen failure|2|||
37878466|NCT00848497|69562851|FG001|Overall Study|Screen failure|0|||
37878467|NCT00848497|69562850|FG000|Overall Study|Withdrawal by Subject|0|||
37878468|NCT00848497|69562851|FG001|Overall Study|Withdrawal by Subject|1|||
37878469|NCT00857623|69562861|FG000|Overall Study|Adverse Event|5|||
37878470|NCT00857623|69562862|FG001|Overall Study|Adverse Event|2|||
37878471|NCT00857623|69562861|FG000|Overall Study|Study-specific discontinuation criteria|5|||
37878472|NCT00857623|69562862|FG001|Overall Study|Study-specific discontinuation criteria|3|||
37878473|NCT00857623|69562861|FG000|Overall Study|Withdrawal by Subject|2|||
37878474|NCT00857623|69562862|FG001|Overall Study|Withdrawal by Subject|1|||
37878475|NCT00857623|69562861|FG000|Overall Study|Lack of Efficacy|1|||
37878476|NCT00857623|69562862|FG001|Overall Study|Lack of Efficacy|1|||
37983810|NCT00236080|69670000|FG004|Overall Study|Miscellaneous|0|||
37983811|NCT00432380|69670015|FG000|Overall Study|Migrated/moved from study area|3|||
37878477|NCT00857623|69562861|FG000|Overall Study|Severe non-compliance to protocol|1|||
37878478|NCT00857623|69562862|FG001|Overall Study|Severe non-compliance to protocol|1|||
37878479|NCT00857623|69562861|FG000|Overall Study|Intake of prohibited medication|0|||
37878480|NCT00857623|69562862|FG001|Overall Study|Intake of prohibited medication|1|||
37878481|NCT00857623|69562861|FG000|Overall Study|Positive for HEP C|0|||
37878482|NCT00857623|69562862|FG001|Overall Study|Positive for HEP C|1|||
37878483|NCT01185782|69562870|FG000|Overall Study|Adverse Event|0|||
37878484|NCT01185782|69562871|FG001|Overall Study|Adverse Event|1|||
37878485|NCT01185782|69562870|FG000|Overall Study|Protocol Violation|1|||
37878486|NCT01185782|69562871|FG001|Overall Study|Protocol Violation|0|||
37878487|NCT01185782|69562870|FG000|Overall Study|Poor Response to Treatment|3|||
37878488|NCT01185782|69562871|FG001|Overall Study|Poor Response to Treatment|1|||
37878489|NCT01185782|69562870|FG000|Overall Study|Other|2|||
37878490|NCT01185782|69562871|FG001|Overall Study|Other|5|||
37878491|NCT01185782|69562870|FG000|Overall Study|Randomized but not treated|0|||
37878492|NCT01185782|69562871|FG001|Overall Study|Randomized but not treated|4|||
37878493|NCT01129115|69562881|FG000|Overall Study|Adverse Event|1|||
37878494|NCT01129115|69562882|FG001|Overall Study|Adverse Event|2|||
37878495|NCT01129115|69562883|FG002|Overall Study|Adverse Event|3|||
37878496|NCT01129115|69562884|FG003|Overall Study|Adverse Event|3|||
37878497|NCT01129115|69562881|FG000|Overall Study|Withdrawal by Subject|1|||
37878498|NCT01129115|69562882|FG001|Overall Study|Withdrawal by Subject|3|||
37878499|NCT01129115|69562883|FG002|Overall Study|Withdrawal by Subject|1|||
37878500|NCT01129115|69562884|FG003|Overall Study|Withdrawal by Subject|4|||
37878501|NCT01129115|69562881|FG000|Overall Study|Protocol Violation|0|||
37878502|NCT01129115|69562882|FG001|Overall Study|Protocol Violation|2|||
37878503|NCT01129115|69562883|FG002|Overall Study|Protocol Violation|2|||
37878504|NCT01129115|69562884|FG003|Overall Study|Protocol Violation|2|||
37878505|NCT01185704|69562896|FG000|Overall Study|Randomized but not treated|3|||
37983812|NCT00432380|69670016|FG001|Overall Study|Migrated/moved from study area|4|||
37983813|NCT00432380|69670017|FG002|Overall Study|Migrated/moved from study area|1|||
37878506|NCT01185704|69562897|FG001|Overall Study|Randomized but not treated|3|||
37878507|NCT01185704|69562896|FG000|Overall Study|Lack of ovarian response|5|||
37878508|NCT01185704|69562897|FG001|Overall Study|Lack of ovarian response|1|||
37878509|NCT01185704|69562896|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
37878510|NCT01185704|69562897|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
37878511|NCT01185704|69562896|FG000|Overall Study|Ectopic pregnancy|0|||
37878512|NCT01185704|69562897|FG001|Overall Study|Ectopic pregnancy|1|||
37878513|NCT01128959|69562903|FG000|Lead in Period|Adverse Event|3|||
37878514|NCT01128959|69562903|FG000|Treatment Period|Adverse Event|3|||
37878515|NCT01128959|69562903|FG000|Treatment Period|Withdrawal by Subject|1|||
37878516|NCT00859573|69562911|FG000|Overall Study|Withdrawal by Subject|4|||
37878517|NCT00859573|69562912|FG001|Overall Study|Withdrawal by Subject|1|||
37878518|NCT00859573|69562911|FG000|Overall Study|Physician Decision|1|||
37878519|NCT00859573|69562912|FG001|Overall Study|Physician Decision|1|||
37878520|NCT01136291|69562920|FG000|Overall Study|Lost to Follow-up|1|||
37878521|NCT01136291|69562921|FG001|Overall Study|Lost to Follow-up|1|||
37878522|NCT01185548|69562927|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
37878523|NCT01128569|69562940|FG000|Washout Period 1|Adverse Event|0|||
37878524|NCT01128569|69562941|FG001|Washout Period 1|Adverse Event|0|||
37878525|NCT01128569|69562942|FG002|Washout Period 1|Adverse Event|1|||
37818955|NCT03850483|69498066|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
37818956|NCT03850483|69498067|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
37818957|NCT03850483|69498068|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
37818958|NCT03850483|69498069|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
37818959|NCT03850483|69498070|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
37818960|NCT03850483|69498061|FG000|Follow-up For Stage 2|Other|0|||
37818961|NCT03850483|69498062|FG001|Follow-up For Stage 2|Other|0|||
37818962|NCT03850483|69498063|FG002|Follow-up For Stage 2|Other|0|||
37818963|NCT03850483|69498064|FG003|Follow-up For Stage 2|Other|0|||
37878526|NCT01128569|69562943|FG003|Washout Period 1|Adverse Event|0|||
37878527|NCT01128569|69562944|FG004|Washout Period 1|Adverse Event|0|||
37878528|NCT01128569|69562945|FG005|Washout Period 1|Adverse Event|0|||
37878529|NCT01128569|69562940|FG000|Treatment Period 2|Withdrawal by Subject|0|||
37878530|NCT01128569|69562941|FG001|Treatment Period 2|Withdrawal by Subject|1|||
37878531|NCT01128569|69562942|FG002|Treatment Period 2|Withdrawal by Subject|0|||
37878532|NCT01128569|69562943|FG003|Treatment Period 2|Withdrawal by Subject|0|||
37878533|NCT01128569|69562944|FG004|Treatment Period 2|Withdrawal by Subject|0|||
37878534|NCT01128569|69562945|FG005|Treatment Period 2|Withdrawal by Subject|0|||
37878535|NCT01128413|69562955|FG000|Overall Study|Withdrawal by Subject|1|||
37878536|NCT01128413|69562956|FG001|Overall Study|Withdrawal by Subject|0|||
37878537|NCT01128413|69562955|FG000|Overall Study|NICOM Monitor Problems|2|||
37878538|NCT01128413|69562956|FG001|Overall Study|NICOM Monitor Problems|1|||
37878539|NCT01128413|69562955|FG000|Overall Study|Pt made DNR|1|||
37878540|NCT01128413|69562956|FG001|Overall Study|Pt made DNR|0|||
37878541|NCT01185080|69562965|FG000|Overall Study|Adverse Event|1|||
37878542|NCT01185080|69562966|FG001|Overall Study|Adverse Event|1|||
37983814|NCT00432380|69670015|FG000|Overall Study|Adverse Event|1|||
37878543|NCT01185080|69562967|FG002|Overall Study|Adverse Event|0|||
37878544|NCT01185080|69562965|FG000|Overall Study|Personal reasons|0|||
37878545|NCT01185080|69562966|FG001|Overall Study|Personal reasons|0|||
37878546|NCT01185080|69562967|FG002|Overall Study|Personal reasons|1|||
37878547|NCT01128179|69562977|FG000|Overall Study|Death|1|||
37878548|NCT01128179|69562978|FG001|Overall Study|Death|0|||
37878549|NCT01128179|69562977|FG000|Overall Study|Protocol Violation|1|||
37878550|NCT01128179|69562978|FG001|Overall Study|Protocol Violation|0|||
37878551|NCT01181102|69562986|FG000|Overall Study|Adverse Event|28|||
37878552|NCT01181102|69562987|FG001|Overall Study|Adverse Event|26|||
37878553|NCT01181102|69562986|FG000|Overall Study|Lack of Efficacy|3|||
37878554|NCT01181102|69562987|FG001|Overall Study|Lack of Efficacy|1|||
37878555|NCT01181102|69562986|FG000|Overall Study|Lost to Follow-up|2|||
37878556|NCT01181102|69562987|FG001|Overall Study|Lost to Follow-up|0|||
37878557|NCT01181102|69562986|FG000|Overall Study|Physician Decision|3|||
37878558|NCT01181102|69562987|FG001|Overall Study|Physician Decision|1|||
37878559|NCT01181102|69562986|FG000|Overall Study|Protocol Violation|5|||
37878560|NCT01181102|69562987|FG001|Overall Study|Protocol Violation|6|||
37878561|NCT01181102|69562986|FG000|Overall Study|Withdrawal by Subject|10|||
37878562|NCT01181102|69562987|FG001|Overall Study|Withdrawal by Subject|12|||
37983815|NCT00432380|69670016|FG001|Overall Study|Adverse Event|0|||
37983816|NCT00432380|69670017|FG002|Overall Study|Adverse Event|0|||
37878563|NCT00858637|69562995|FG000|Active Comparison Phase|Adverse Event|14|||
37878564|NCT00858637|69562996|FG001|Active Comparison Phase|Adverse Event|0|||
37878565|NCT00858637|69562997|FG002|Active Comparison Phase|Adverse Event|0|||
37878566|NCT00858637|69562998|FG003|Active Comparison Phase|Adverse Event|9|||
37878567|NCT00858637|69562999|FG004|Active Comparison Phase|Adverse Event|0|||
37878568|NCT00858637|69563000|FG005|Active Comparison Phase|Adverse Event|0|||
37878569|NCT00858637|69562995|FG000|Active Comparison Phase|Death|1|||
37878570|NCT00858637|69562996|FG001|Active Comparison Phase|Death|0|||
37878571|NCT00858637|69562997|FG002|Active Comparison Phase|Death|0|||
37878572|NCT00858637|69562998|FG003|Active Comparison Phase|Death|1|||
37878573|NCT00858637|69562999|FG004|Active Comparison Phase|Death|0|||
37878574|NCT00858637|69563000|FG005|Active Comparison Phase|Death|0|||
37878575|NCT00858637|69562995|FG000|Active Comparison Phase|Physician Decision|1|||
37878576|NCT00858637|69562996|FG001|Active Comparison Phase|Physician Decision|0|||
37878577|NCT00858637|69562997|FG002|Active Comparison Phase|Physician Decision|0|||
37878578|NCT00858637|69562998|FG003|Active Comparison Phase|Physician Decision|1|||
37878579|NCT00858637|69562999|FG004|Active Comparison Phase|Physician Decision|0|||
37878580|NCT00858637|69563000|FG005|Active Comparison Phase|Physician Decision|0|||
37878581|NCT00858637|69562995|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
37878582|NCT00858637|69562996|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
37878583|NCT00858637|69562997|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
37878584|NCT00858637|69562998|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
37878585|NCT00858637|69562999|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
37878586|NCT00858637|69563000|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
37878587|NCT00858637|69562995|FG000|Active Comparison Phase|Other Reasons|1|||
37878588|NCT00858637|69562996|FG001|Active Comparison Phase|Other Reasons|0|||
37878589|NCT00858637|69562997|FG002|Active Comparison Phase|Other Reasons|0|||
37878590|NCT00858637|69562998|FG003|Active Comparison Phase|Other Reasons|1|||
37878591|NCT00858637|69562999|FG004|Active Comparison Phase|Other Reasons|0|||
37878592|NCT00858637|69563000|FG005|Active Comparison Phase|Other Reasons|0|||
37983817|NCT00234052|69670026|FG000|Treatment|Withdrawal by Subject|3|||
37818964|NCT03850483|69498065|FG004|Follow-up For Stage 2|Other|0|||
37818965|NCT03850483|69498066|FG005|Follow-up For Stage 2|Other|0|||
37818966|NCT03850483|69498067|FG006|Follow-up For Stage 2|Other|0|||
37818967|NCT03850483|69498068|FG007|Follow-up For Stage 2|Other|0|||
37818968|NCT03850483|69498069|FG008|Follow-up For Stage 2|Other|0|||
37818969|NCT03850483|69498070|FG009|Follow-up For Stage 2|Other|1|||
37818970|NCT03473925|69498101|FG000|Overall Study|Death|48|||
37818971|NCT03473925|69498102|FG001|Overall Study|Death|44|||
37818972|NCT03473925|69498101|FG000|Overall Study|Sponsor Decision|2|||
37818973|NCT03473925|69498102|FG001|Overall Study|Sponsor Decision|7|||
37818974|NCT03473925|69498101|FG000|Overall Study|Withdrawal by Subject|1|||
37818975|NCT03473925|69498102|FG001|Overall Study|Withdrawal by Subject|3|||
37818976|NCT03473925|69498101|FG000|Overall Study|Not Treated|1|||
37818977|NCT03473925|69498102|FG001|Overall Study|Not Treated|1|||
37878593|NCT00858637|69562995|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
37878594|NCT00858637|69562996|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
37878595|NCT00858637|69562997|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
37878596|NCT00858637|69562998|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
37878597|NCT00858637|69562999|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
37878598|NCT00858637|69563000|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
37878599|NCT00858637|69562995|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
37878600|NCT00858637|69562996|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
37983818|NCT00234052|69670026|FG000|Treatment|Adverse Event|5|||
37983819|NCT00234052|69670026|FG000|Treatment|Death|2|||
37878601|NCT00858637|69562997|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
37878602|NCT00858637|69562998|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
37878603|NCT00858637|69562999|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
37878604|NCT00858637|69563000|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
37878605|NCT00858403|69563010|FG000|Overall Study|Withdrawal by Subject|1|||
37878606|NCT00858403|69563010|FG000|Overall Study|Death|3|||
37878607|NCT00858403|69563010|FG000|Overall Study|Disease Progression|1|||
37878608|NCT00858247|69563016|FG000|Baseline Assessment|Withdrawal by Subject|1|||
37983820|NCT00234052|69670026|FG000|Treatment|Progressive Disease|11|||
37983821|NCT00234052|69670026|FG000|Follow-up for 5 Years|Death|41|||
37983822|NCT00234052|69670026|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
37983823|NCT00234052|69670026|FG000|Follow-up for 5 Years|Other|7|||
37983824|NCT00408408|69670036|FG000|Overall Study|No follow up data|2|||
37818978|NCT03230097|69498110|FG000|Overall Study|Adverse Event|2|||
37818979|NCT03230097|69498111|FG001|Overall Study|Adverse Event|1|||
37818980|NCT03230097|69498110|FG000|Overall Study|non-compliance|0|||
37818981|NCT03230097|69498111|FG001|Overall Study|non-compliance|1|||
37818982|NCT03230097|69498110|FG000|Overall Study|Lost to Follow-up|2|||
37818983|NCT03230097|69498111|FG001|Overall Study|Lost to Follow-up|4|||
37818984|NCT03230097|69498110|FG000|Overall Study|Withdrawal by Subject|7|||
37818985|NCT03230097|69498111|FG001|Overall Study|Withdrawal by Subject|3|||
37818986|NCT03230097|69498110|FG000|Overall Study|Trial termination|4|||
37818987|NCT03230097|69498111|FG001|Overall Study|Trial termination|5|||
37818988|NCT03230097|69498110|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
37818989|NCT03230097|69498111|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
37818990|NCT03230097|69498110|FG000|Overall Study|outcome event|0|||
37818991|NCT03230097|69498111|FG001|Overall Study|outcome event|1|||
37818992|NCT02803593|69498136|FG000|Overall Study|Lost to Follow-up|17|||
37818993|NCT02803593|69498137|FG001|Overall Study|Lost to Follow-up|35|||
37818994|NCT02663908|69498145|FG000|Overall Study|Withdrawal by Subject|8|||
37818995|NCT02663908|69498146|FG001|Overall Study|Withdrawal by Subject|5|||
37818996|NCT02663908|69498145|FG000|Overall Study|Lost to Follow-up|1|||
37818997|NCT02663908|69498146|FG001|Overall Study|Lost to Follow-up|5|||
37818998|NCT02663908|69498145|FG000|Overall Study|Adverse Event|13|||
37818999|NCT02663908|69498146|FG001|Overall Study|Adverse Event|11|||
37819000|NCT02663908|69498145|FG000|Overall Study|Protocol Violation|1|||
37819001|NCT02663908|69498146|FG001|Overall Study|Protocol Violation|2|||
37819002|NCT02663908|69498145|FG000|Overall Study|Lack of therapeutic response|2|||
37819003|NCT02663908|69498146|FG001|Overall Study|Lack of therapeutic response|0|||
37819004|NCT02663908|69498145|FG000|Overall Study|COVID-19|1|||
37983825|NCT00408408|69670037|FG001|Overall Study|No follow up data|3|||
37983826|NCT00408408|69670038|FG002|Overall Study|No follow up data|0|||
37819005|NCT02663908|69498146|FG001|Overall Study|COVID-19|0|||
37819006|NCT02663908|69498145|FG000|Overall Study|Site closed|1|||
37819007|NCT02663908|69498146|FG001|Overall Study|Site closed|0|||
37819008|NCT02663908|69498145|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
37819009|NCT02663908|69498146|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
37819010|NCT02663908|69498145|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
37819011|NCT02663908|69498146|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
37819012|NCT02663908|69498145|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
37819013|NCT02663908|69498146|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
37819014|NCT02663908|69498145|FG000|Overall Study|Death|1|||
37819015|NCT02663908|69498146|FG001|Overall Study|Death|0|||
37819016|NCT02663908|69498145|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
37819017|NCT02663908|69498146|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
37819018|NCT02663908|69498145|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
37819019|NCT02663908|69498146|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
37819020|NCT02650284|69498154|FG000|Overall Study|Lost to Follow-up|3|||
37819021|NCT02650284|69498155|FG001|Overall Study|Lost to Follow-up|3|||
37819022|NCT02650284|69498154|FG000|Overall Study|Consent incorrectly taken|0|||
37819023|NCT02650284|69498155|FG001|Overall Study|Consent incorrectly taken|1|||
37819024|NCT02175030|69498163|FG000|Overall Study|Failed screen after consent|7|||
37983827|NCT00408408|69670039|FG003|Overall Study|No follow up data|7|||
37819025|NCT02175030|69498164|FG001|Overall Study|Failed screen after consent|6|||
37819026|NCT02175030|69498163|FG000|Overall Study|Failed IUD Insertion|20|||
37819027|NCT02175030|69498164|FG001|Overall Study|Failed IUD Insertion|21|||
37819028|NCT02175030|69498163|FG000|Overall Study|Physician Decision|1|||
37819029|NCT02175030|69498164|FG001|Overall Study|Physician Decision|1|||
37819030|NCT02175030|69498163|FG000|Overall Study|Lost to Follow-up|6|||
37819031|NCT02175030|69498164|FG001|Overall Study|Lost to Follow-up|6|||
37819032|NCT02175030|69498163|FG000|Overall Study|Withdrawal by Subject|1|||
37819033|NCT02175030|69498164|FG001|Overall Study|Withdrawal by Subject|4|||
37878609|NCT00858247|69563017|FG001|Baseline Assessment|Withdrawal by Subject|1|||
37983828|NCT00408408|69670040|FG004|Overall Study|No follow up data|5|||
37983829|NCT00408408|69670041|FG005|Overall Study|No follow up data|3|||
37819034|NCT03096834|69498189|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
37819035|NCT03096834|69498190|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
37819036|NCT03096834|69498191|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
37878610|NCT00858247|69563016|FG000|Baseline Assessment|Poor IV access|1|||
37983830|NCT00414050|69670059|FG000|Overall Study|Adverse Event|1|||
37983831|NCT00414050|69670060|FG001|Overall Study|Adverse Event|1|||
37983832|NCT00414050|69670061|FG002|Overall Study|Adverse Event|1|||
37983833|NCT00414050|69670062|FG003|Overall Study|Adverse Event|1|||
37983834|NCT00414050|69670059|FG000|Overall Study|Lost to Follow-up|2|||
37983835|NCT00414050|69670060|FG001|Overall Study|Lost to Follow-up|2|||
37983836|NCT00414050|69670061|FG002|Overall Study|Lost to Follow-up|1|||
37983837|NCT00414050|69670062|FG003|Overall Study|Lost to Follow-up|1|||
37983838|NCT00414050|69670059|FG000|Overall Study|Withdrawal by Subject|5|||
37983839|NCT00414050|69670060|FG001|Overall Study|Withdrawal by Subject|3|||
37983840|NCT00414050|69670061|FG002|Overall Study|Withdrawal by Subject|2|||
37983841|NCT00414050|69670062|FG003|Overall Study|Withdrawal by Subject|4|||
37983842|NCT00414050|69670059|FG000|Overall Study|Subject discontinued for other reason|1|||
37983843|NCT00414050|69670060|FG001|Overall Study|Subject discontinued for other reason|2|||
37983844|NCT00414050|69670061|FG002|Overall Study|Subject discontinued for other reason|2|||
37878611|NCT00858247|69563017|FG001|Baseline Assessment|Poor IV access|0|||
37878612|NCT00858247|69563016|FG000|Baseline Assessment|Protocol Violation|0|||
37878613|NCT00858247|69563017|FG001|Baseline Assessment|Protocol Violation|1|||
37983845|NCT00414050|69670062|FG003|Overall Study|Subject discontinued for other reason|1|||
37983846|NCT00414050|69670059|FG000|Overall Study|Subject Moved|0|||
37983847|NCT00414050|69670060|FG001|Overall Study|Subject Moved|0|||
37983848|NCT00414050|69670061|FG002|Overall Study|Subject Moved|0|||
37983849|NCT00414050|69670062|FG003|Overall Study|Subject Moved|1|||
37983850|NCT00413972|69670076|FG000|Overall Study|Adverse Event|2|||
37878614|NCT00858247|69563016|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
37878615|NCT00858247|69563017|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
37878616|NCT00838435|69563023|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
37878617|NCT00838435|69563023|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
37878618|NCT00838435|69563023|FG000|Part 2 (7 Years)|Adverse Event|2|||
37878619|NCT00838435|69563023|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
37878620|NCT00838435|69563023|FG000|Part 2 (7 Years)|Physician Decision|1|||
37878621|NCT00838435|69563023|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
37878622|NCT00838435|69563023|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
37878623|NCT00838201|69563032|FG000|Overall Study|Investigator decision, or other reasons|2|||
37878624|NCT00838201|69563033|FG001|Overall Study|Investigator decision, or other reasons|3|||
37878625|NCT00838201|69563032|FG000|Overall Study|Noncompliance|0|||
37878626|NCT00838201|69563033|FG001|Overall Study|Noncompliance|1|||
37878627|NCT00838201|69563032|FG000|Overall Study|Administrative decision|1|||
37878628|NCT00838201|69563033|FG001|Overall Study|Administrative decision|2|||
37878629|NCT00838201|69563032|FG000|Overall Study|Disease progression|3|||
37878630|NCT00838201|69563033|FG001|Overall Study|Disease progression|3|||
37878631|NCT00838201|69563032|FG000|Overall Study|Consent withdrawn|16|||
37878632|NCT00838201|69563033|FG001|Overall Study|Consent withdrawn|19|||
37878633|NCT00838201|69563032|FG000|Overall Study|Lost to Follow-up|4|||
37878634|NCT00838201|69563033|FG001|Overall Study|Lost to Follow-up|3|||
37878635|NCT00838201|69563032|FG000|Overall Study|Adverse Event|5|||
37878636|NCT00838201|69563033|FG001|Overall Study|Adverse Event|9|||
37878637|NCT00838201|69563032|FG000|Overall Study|Death|11|||
37983851|NCT00413972|69670077|FG001|Overall Study|Adverse Event|1|||
37983852|NCT00413972|69670078|FG002|Overall Study|Adverse Event|0|||
37983853|NCT00413972|69670079|FG003|Overall Study|Adverse Event|0|||
37983854|NCT00413972|69670076|FG000|Overall Study|Lost to Follow-up|1|||
37983855|NCT00413972|69670077|FG001|Overall Study|Lost to Follow-up|2|||
37983856|NCT00413972|69670078|FG002|Overall Study|Lost to Follow-up|1|||
37983857|NCT00413972|69670079|FG003|Overall Study|Lost to Follow-up|0|||
37983858|NCT00413972|69670076|FG000|Overall Study|Withdrawal by Subject|4|||
37983859|NCT00413972|69670077|FG001|Overall Study|Withdrawal by Subject|5|||
37983860|NCT00413972|69670078|FG002|Overall Study|Withdrawal by Subject|7|||
37819037|NCT03096834|69498192|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
37819038|NCT03096834|69498189|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
37819039|NCT03096834|69498190|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
37819040|NCT03096834|69498191|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
37819041|NCT03096834|69498192|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
37819042|NCT03096834|69498189|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
37878638|NCT00838201|69563033|FG001|Overall Study|Death|13|||
37878639|NCT00837967|69563039|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
37878640|NCT00837967|69563040|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
37878641|NCT02756806|69563046|FG000|Overall Study|Study terminated early|5|||
37878642|NCT00942357|69563052|FG000|Overall Study|Ineligible|37|||
37878643|NCT00942357|69563053|FG001|Overall Study|Ineligible|40|||
37878644|NCT00939783|69563059|FG000|Overall Study|Death|6|||
37983861|NCT00413972|69670079|FG003|Overall Study|Withdrawal by Subject|2|||
37983862|NCT00413972|69670076|FG000|Overall Study|Protocol Violation|0|||
37983863|NCT00413972|69670077|FG001|Overall Study|Protocol Violation|0|||
37983864|NCT00413972|69670078|FG002|Overall Study|Protocol Violation|2|||
37983865|NCT00413972|69670079|FG003|Overall Study|Protocol Violation|0|||
37983866|NCT00413972|69670076|FG000|Overall Study|Other|0|||
37983867|NCT00413972|69670077|FG001|Overall Study|Other|0|||
37983868|NCT00413972|69670078|FG002|Overall Study|Other|0|||
37983869|NCT00413972|69670079|FG003|Overall Study|Other|1|||
37983870|NCT00259012|69670091|FG000|Overall Study|Adverse Event|0|||
37878645|NCT00939783|69563059|FG000|Overall Study|Adverse Event|39|||
37983871|NCT00259012|69670092|FG001|Overall Study|Adverse Event|1|||
37983872|NCT00259012|69670091|FG000|Overall Study|Withdrawal by Subject|1|||
37878646|NCT00939783|69563059|FG000|Overall Study|Study Terminated by Sponsor|498|||
37878647|NCT00939783|69563059|FG000|Overall Study|Withdrawal by Subject|78|||
37878648|NCT00939783|69563059|FG000|Overall Study|Other|16|||
37878649|NCT00939783|69563059|FG000|Overall Study|Lost to Follow-up|8|||
37878650|NCT00939783|69563059|FG000|Overall Study|Protocol Violation|3|||
37878651|NCT00939783|69563059|FG000|Overall Study|Enrolled but not treated|1|||
37878652|NCT00939627|69563065|FG000|Overall Study|Disease Progression|16|||
37878653|NCT00939627|69563066|FG001|Overall Study|Disease Progression|12|||
37878654|NCT00939627|69563067|FG002|Overall Study|Disease Progression|0|||
37878655|NCT00939627|69563065|FG000|Overall Study|Adverse Event|6|||
37878656|NCT00939627|69563066|FG001|Overall Study|Adverse Event|7|||
37878657|NCT00939627|69563067|FG002|Overall Study|Adverse Event|0|||
37878658|NCT00939627|69563065|FG000|Overall Study|Death|0|||
37878659|NCT00939627|69563066|FG001|Overall Study|Death|2|||
37878660|NCT00939627|69563067|FG002|Overall Study|Death|0|||
37878661|NCT00939627|69563065|FG000|Overall Study|Withdrawal by Subject|2|||
37878662|NCT00939627|69563066|FG001|Overall Study|Withdrawal by Subject|4|||
37878663|NCT00939627|69563067|FG002|Overall Study|Withdrawal by Subject|0|||
37878664|NCT00939627|69563065|FG000|Overall Study|Other complicating disease|1|||
37878665|NCT00939627|69563066|FG001|Overall Study|Other complicating disease|1|||
37878666|NCT00939627|69563067|FG002|Overall Study|Other complicating disease|0|||
37878667|NCT00939627|69563065|FG000|Overall Study|Not compliant|2|||
37878668|NCT00939627|69563066|FG001|Overall Study|Not compliant|0|||
37878669|NCT00939627|69563067|FG002|Overall Study|Not compliant|0|||
37878670|NCT00939627|69563065|FG000|Overall Study|No off-tx reason given|0|||
37878671|NCT00939627|69563066|FG001|Overall Study|No off-tx reason given|2|||
37878672|NCT00939627|69563067|FG002|Overall Study|No off-tx reason given|0|||
37878673|NCT00937833|69563075|FG000|Overall Study|Protocol Violation|1|||
37878674|NCT00937833|69563076|FG001|Overall Study|Protocol Violation|2|||
37878675|NCT00937833|69563075|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
37878676|NCT00937833|69563076|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
37878677|NCT00937833|69563075|FG000|Overall Study|Lost to Follow-up|10|||
37878678|NCT00937833|69563076|FG001|Overall Study|Lost to Follow-up|8|||
37878679|NCT00937833|69563075|FG000|Overall Study|Withdrawal by Subject|4|||
37878680|NCT00937833|69563076|FG001|Overall Study|Withdrawal by Subject|6|||
37878681|NCT01135511|69563091|FG000|Overall Study|Adverse Event|0|||
37878682|NCT01135511|69563092|FG001|Overall Study|Adverse Event|1|||
37878683|NCT01135511|69563093|FG002|Overall Study|Adverse Event|2|||
37878684|NCT01135511|69563094|FG003|Overall Study|Adverse Event|0|||
37983873|NCT00259012|69670092|FG001|Overall Study|Withdrawal by Subject|0|||
37819043|NCT03096834|69498190|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
37819044|NCT03096834|69498191|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
37819045|NCT03096834|69498192|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
37819046|NCT03096834|69498189|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
37819047|NCT03096834|69498190|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
37819048|NCT03096834|69498191|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
37819049|NCT03096834|69498192|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
37819050|NCT03096834|69498189|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
37819051|NCT03096834|69498190|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
37819052|NCT03096834|69498191|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
37819053|NCT03096834|69498192|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
37833582|NCT01262989|69517313|FG001|Period 1|Lost to Follow-up|1|||
37878685|NCT01135511|69563095|FG004|Overall Study|Adverse Event|0|||
37878686|NCT01135511|69563096|FG005|Overall Study|Adverse Event|1|||
37878687|NCT01135511|69563097|FG006|Overall Study|Adverse Event|0|||
37878688|NCT01135511|69563098|FG007|Overall Study|Adverse Event|1|||
37878689|NCT01135511|69563099|FG008|Overall Study|Adverse Event|0|||
37878690|NCT01135511|69563091|FG000|Overall Study|Lack of Efficacy|0|||
37878691|NCT01135511|69563092|FG001|Overall Study|Lack of Efficacy|1|||
37878692|NCT01135511|69563093|FG002|Overall Study|Lack of Efficacy|1|||
37878693|NCT01135511|69563094|FG003|Overall Study|Lack of Efficacy|2|||
37878694|NCT01135511|69563095|FG004|Overall Study|Lack of Efficacy|0|||
37878695|NCT01135511|69563096|FG005|Overall Study|Lack of Efficacy|0|||
37983874|NCT00259012|69670091|FG000|Overall Study|Physician Decision|0|||
37983875|NCT00259012|69670092|FG001|Overall Study|Physician Decision|1|||
37983876|NCT00259012|69670091|FG000|Overall Study|Lost to Follow-up|0|||
37983877|NCT00259012|69670092|FG001|Overall Study|Lost to Follow-up|1|||
37878696|NCT01135511|69563097|FG006|Overall Study|Lack of Efficacy|0|||
37878697|NCT01135511|69563098|FG007|Overall Study|Lack of Efficacy|0|||
37878698|NCT01135511|69563099|FG008|Overall Study|Lack of Efficacy|0|||
37878699|NCT01135511|69563091|FG000|Overall Study|Protocol Violation|0|||
37878700|NCT01135511|69563092|FG001|Overall Study|Protocol Violation|0|||
37878701|NCT01135511|69563093|FG002|Overall Study|Protocol Violation|3|||
37878702|NCT01135511|69563094|FG003|Overall Study|Protocol Violation|0|||
37878703|NCT01135511|69563095|FG004|Overall Study|Protocol Violation|0|||
37878704|NCT01135511|69563096|FG005|Overall Study|Protocol Violation|0|||
37878705|NCT01135511|69563097|FG006|Overall Study|Protocol Violation|0|||
37878706|NCT01135511|69563098|FG007|Overall Study|Protocol Violation|0|||
37878707|NCT01135511|69563099|FG008|Overall Study|Protocol Violation|0|||
37878708|NCT01135511|69563091|FG000|Overall Study|Pregnancy|0|||
37878709|NCT01135511|69563092|FG001|Overall Study|Pregnancy|0|||
37878710|NCT01135511|69563093|FG002|Overall Study|Pregnancy|0|||
37878711|NCT01135511|69563094|FG003|Overall Study|Pregnancy|1|||
37878712|NCT01135511|69563095|FG004|Overall Study|Pregnancy|0|||
37878713|NCT01135511|69563096|FG005|Overall Study|Pregnancy|0|||
37878714|NCT01135511|69563097|FG006|Overall Study|Pregnancy|0|||
37878715|NCT01135511|69563098|FG007|Overall Study|Pregnancy|0|||
37878716|NCT01135511|69563099|FG008|Overall Study|Pregnancy|0|||
37878717|NCT01135511|69563091|FG000|Overall Study|could not visit the clinic|0|||
37878718|NCT01135511|69563092|FG001|Overall Study|could not visit the clinic|1|||
37878719|NCT01135511|69563093|FG002|Overall Study|could not visit the clinic|2|||
37878720|NCT01135511|69563094|FG003|Overall Study|could not visit the clinic|0|||
37878721|NCT01135511|69563095|FG004|Overall Study|could not visit the clinic|0|||
37878722|NCT01135511|69563096|FG005|Overall Study|could not visit the clinic|0|||
37878723|NCT01135511|69563097|FG006|Overall Study|could not visit the clinic|0|||
37878724|NCT01135511|69563098|FG007|Overall Study|could not visit the clinic|0|||
37878725|NCT01135511|69563099|FG008|Overall Study|could not visit the clinic|0|||
37878726|NCT01135511|69563091|FG000|Overall Study|noncompliance with study drug taken|0|||
37878727|NCT01135511|69563092|FG001|Overall Study|noncompliance with study drug taken|0|||
37878728|NCT01135511|69563093|FG002|Overall Study|noncompliance with study drug taken|0|||
37878729|NCT01135511|69563094|FG003|Overall Study|noncompliance with study drug taken|0|||
37878730|NCT01135511|69563095|FG004|Overall Study|noncompliance with study drug taken|1|||
37878731|NCT01135511|69563096|FG005|Overall Study|noncompliance with study drug taken|0|||
37878732|NCT01135511|69563097|FG006|Overall Study|noncompliance with study drug taken|0|||
37878733|NCT01135511|69563098|FG007|Overall Study|noncompliance with study drug taken|0|||
37878734|NCT01135511|69563099|FG008|Overall Study|noncompliance with study drug taken|0|||
37878735|NCT01135511|69563091|FG000|Overall Study|Withdrawal by Subject|0|||
37878736|NCT01135511|69563092|FG001|Overall Study|Withdrawal by Subject|0|||
37878737|NCT01135511|69563093|FG002|Overall Study|Withdrawal by Subject|0|||
37878738|NCT01135511|69563094|FG003|Overall Study|Withdrawal by Subject|0|||
37878739|NCT01135511|69563095|FG004|Overall Study|Withdrawal by Subject|0|||
37878740|NCT01135511|69563096|FG005|Overall Study|Withdrawal by Subject|0|||
37878741|NCT01135511|69563097|FG006|Overall Study|Withdrawal by Subject|1|||
37878742|NCT01135511|69563098|FG007|Overall Study|Withdrawal by Subject|0|||
37878743|NCT01135511|69563099|FG008|Overall Study|Withdrawal by Subject|1|||
37878744|NCT01184846|69563128|FG000|Overall Study|Adverse Event|2|||
37878745|NCT01184846|69563128|FG000|Overall Study|Insufficient response|1|||
37878746|NCT01180400|69563136|FG000|Overall Study|Withdrawal by Subject|5|||
37878747|NCT01180400|69563137|FG001|Overall Study|Withdrawal by Subject|6|||
37878748|NCT01180400|69563136|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
37878749|NCT01180400|69563137|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
37878750|NCT01180400|69563136|FG000|Overall Study|Adverse Event|12|||
37878751|NCT01180400|69563137|FG001|Overall Study|Adverse Event|10|||
37983878|NCT00259012|69670091|FG000|Overall Study|Protocol Violation|1|||
37983879|NCT00259012|69670092|FG001|Overall Study|Protocol Violation|1|||
37983880|NCT00209170|69670100|FG000|Overall Study|Adverse Event|0|||
37983881|NCT00209170|69670101|FG001|Overall Study|Adverse Event|1|||
37983882|NCT00209170|69670100|FG000|Overall Study|Withdrawal by Subject|2|||
37983883|NCT00209170|69670101|FG001|Overall Study|Withdrawal by Subject|1|||
37983884|NCT00209170|69670100|FG000|Overall Study|Lack of Efficacy|0|||
37878752|NCT01180400|69563136|FG000|Overall Study|Severe non-compliance to protocol|1|||
37878753|NCT01180400|69563137|FG001|Overall Study|Severe non-compliance to protocol|2|||
37878754|NCT01180400|69563136|FG000|Overall Study|Condition under investigation worsened|2|||
37878755|NCT01180400|69563137|FG001|Overall Study|Condition under investigation worsened|1|||
37878756|NCT01180400|69563136|FG000|Overall Study|Lack of Efficacy|2|||
37878757|NCT01180400|69563137|FG001|Overall Study|Lack of Efficacy|0|||
37878758|NCT01180400|69563136|FG000|Overall Study|Study-specific withdrawal criteria|1|||
37878759|NCT01180400|69563137|FG001|Overall Study|Study-specific withdrawal criteria|2|||
37878760|NCT01180400|69563136|FG000|Overall Study|Lost to Follow-up|2|||
37878761|NCT01180400|69563137|FG001|Overall Study|Lost to Follow-up|3|||
37878762|NCT01180400|69563136|FG000|Overall Study|Other|0|||
37878763|NCT01180400|69563137|FG001|Overall Study|Other|1|||
37983885|NCT00209170|69670101|FG001|Overall Study|Lack of Efficacy|1|||
37983886|NCT00413894|69670107|FG000|Overall Study|Withdrawal by Subject|10|||
37983887|NCT00413894|69670107|FG000|Overall Study|Administrative Reasons|1|||
37983888|NCT00413894|69670107|FG000|Overall Study|Hb <10 grams/deciliter|12|||
37983889|NCT00413894|69670107|FG000|Overall Study|Adverse Event|28|||
37983890|NCT00413894|69670107|FG000|Overall Study|Protocol Violation|11|||
37878764|NCT01180244|69563145|FG000|Overall Study|Lack of Efficacy|0|||
37878765|NCT01180244|69563146|FG001|Overall Study|Lack of Efficacy|7|||
37983891|NCT00413894|69670107|FG000|Overall Study|Other|18|||
37983892|NCT00407550|69670116|FG000|Overall Study|Adverse Event|0|||
37983893|NCT00407550|69670117|FG001|Overall Study|Adverse Event|1|||
37983894|NCT00407550|69670116|FG000|Overall Study|Withdrawal by Subject|0|||
37983895|NCT00407550|69670117|FG001|Overall Study|Withdrawal by Subject|2|||
37983896|NCT00407550|69670116|FG000|Overall Study|Death|1|||
37983897|NCT00407550|69670117|FG001|Overall Study|Death|0|||
37983898|NCT00407550|69670116|FG000|Overall Study|Insurance or Other medical condition|2|||
37983899|NCT00407550|69670117|FG001|Overall Study|Insurance or Other medical condition|1|||
37983900|NCT00209092|69670125|FG000|Overall Study|Progression of disease|7|||
37983901|NCT00209092|69670126|FG001|Overall Study|Progression of disease|1|||
37983902|NCT00209092|69670125|FG000|Overall Study|Adverse Event|0|||
37878766|NCT01180244|69563145|FG000|Overall Study|Physician Decision|3|||
37878767|NCT01180244|69563146|FG001|Overall Study|Physician Decision|0|||
37878768|NCT01180244|69563145|FG000|Overall Study|Adverse Event|1|||
37878769|NCT01180244|69563146|FG001|Overall Study|Adverse Event|0|||
37878770|NCT01180244|69563145|FG000|Overall Study|Withdrawal by Subject|0|||
37878771|NCT01180244|69563146|FG001|Overall Study|Withdrawal by Subject|1|||
37878772|NCT01180244|69563145|FG000|Overall Study|Protocol Violation|1|||
37878773|NCT01180244|69563146|FG001|Overall Study|Protocol Violation|0|||
37878774|NCT01180244|69563145|FG000|Overall Study|Lost to Follow-up|1|||
37878775|NCT01180244|69563146|FG001|Overall Study|Lost to Follow-up|0|||
37878776|NCT01191086|69563152|FG000|Overall Study|Adverse Event|20|||
37878777|NCT01191086|69563152|FG000|Overall Study|Lack of Efficacy|10|||
37878778|NCT01191086|69563152|FG000|Overall Study|Lost to Follow-up|4|||
37878779|NCT01191086|69563152|FG000|Overall Study|Physician Decision|2|||
37878780|NCT01191086|69563152|FG000|Overall Study|Withdrawal by Subject|24|||
37878781|NCT01191086|69563152|FG000|Overall Study|Discontinuation criterion met|1|||
37878782|NCT01191086|69563152|FG000|Overall Study|Other|1|||
37878783|NCT01088412|69563159|FG000|Overall Study|Adverse Event|38|||
37878784|NCT01088412|69563160|FG001|Overall Study|Adverse Event|0|||
37878785|NCT01088412|69563161|FG002|Overall Study|Adverse Event|0|||
37878786|NCT01088412|69563159|FG000|Overall Study|Death|42|||
37878787|NCT01088412|69563160|FG001|Overall Study|Death|6|||
37878788|NCT01088412|69563161|FG002|Overall Study|Death|0|||
37878789|NCT01088412|69563159|FG000|Overall Study|Other Reason per Case Report Form|2089|||
37878790|NCT01088412|69563160|FG001|Overall Study|Other Reason per Case Report Form|103|||
37878791|NCT01088412|69563161|FG002|Overall Study|Other Reason per Case Report Form|9|||
37878792|NCT01088412|69563159|FG000|Overall Study|Withdrawal by Subject|1761|||
37878793|NCT01088412|69563160|FG001|Overall Study|Withdrawal by Subject|25|||
37878794|NCT01088412|69563161|FG002|Overall Study|Withdrawal by Subject|1|||
37878795|NCT01088412|69563159|FG000|Overall Study|Received Another GH Product|79|||
37878796|NCT01088412|69563160|FG001|Overall Study|Received Another GH Product|0|||
37878797|NCT01088412|69563161|FG002|Overall Study|Received Another GH Product|0|||
37878798|NCT01088412|69563159|FG000|Overall Study|Participant Moved|601|||
37878799|NCT01088412|69563160|FG001|Overall Study|Participant Moved|21|||
37878800|NCT01088412|69563161|FG002|Overall Study|Participant Moved|2|||
37878801|NCT01088412|69563159|FG000|Overall Study|Physician Decision|1041|||
37878802|NCT01088412|69563160|FG001|Overall Study|Physician Decision|8|||
37878803|NCT01088412|69563161|FG002|Overall Study|Physician Decision|4|||
37878804|NCT01088412|69563159|FG000|Overall Study|Sponsor Decision|4467|||
37878805|NCT01088412|69563160|FG001|Overall Study|Sponsor Decision|79|||
37878806|NCT01088412|69563161|FG002|Overall Study|Sponsor Decision|23|||
37878807|NCT01088412|69563159|FG000|Overall Study|Third Party Required to Change Brand|487|||
37878808|NCT01088412|69563160|FG001|Overall Study|Third Party Required to Change Brand|0|||
37983903|NCT00209092|69670126|FG001|Overall Study|Adverse Event|1|||
37983904|NCT00209092|69670125|FG000|Overall Study|Withdrawal by Subject|1|||
37983905|NCT00209092|69670126|FG001|Overall Study|Withdrawal by Subject|0|||
37983906|NCT00403494|69670134|FG000|Overall Study|Adverse Event|10|||
37878809|NCT01088412|69563161|FG002|Overall Study|Third Party Required to Change Brand|0|||
37878810|NCT01088412|69563159|FG000|Overall Study|Lost to Follow-up|3052|||
37878811|NCT01088412|69563160|FG001|Overall Study|Lost to Follow-up|130|||
37878812|NCT01088412|69563161|FG002|Overall Study|Lost to Follow-up|11|||
37878813|NCT01088412|69563159|FG000|Overall Study|Study Summary Not Completed|4360|||
37878814|NCT01088412|69563160|FG001|Overall Study|Study Summary Not Completed|64|||
37878815|NCT01088412|69563161|FG002|Overall Study|Study Summary Not Completed|22|||
37878816|NCT01086384|69563174|FG000|2-week Run-in Period|Adverse Event|1|||
37878817|NCT01086384|69563175|FG001|2-week Run-in Period|Adverse Event|0|||
37878818|NCT01086384|69563176|FG002|2-week Run-in Period|Adverse Event|0|||
37983907|NCT00403494|69670135|FG001|Overall Study|Adverse Event|8|||
37983908|NCT00403494|69670134|FG000|Overall Study|Withdrew Consent|3|||
37983909|NCT00403494|69670135|FG001|Overall Study|Withdrew Consent|2|||
37878819|NCT01086384|69563174|FG000|2-week Run-in Period|Protocol Violation|1|||
37878820|NCT01086384|69563175|FG001|2-week Run-in Period|Protocol Violation|0|||
37878821|NCT01086384|69563176|FG002|2-week Run-in Period|Protocol Violation|0|||
37878822|NCT01086384|69563174|FG000|2-week Run-in Period|Lost to Follow-up|1|||
37878823|NCT01086384|69563175|FG001|2-week Run-in Period|Lost to Follow-up|0|||
37878824|NCT01086384|69563176|FG002|2-week Run-in Period|Lost to Follow-up|0|||
37878825|NCT01086384|69563174|FG000|2-week Run-in Period|Physician Decision|6|||
37878826|NCT01086384|69563175|FG001|2-week Run-in Period|Physician Decision|0|||
37878827|NCT01086384|69563176|FG002|2-week Run-in Period|Physician Decision|0|||
37878828|NCT01086384|69563174|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
37878829|NCT01086384|69563175|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
37878830|NCT01086384|69563176|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
37878831|NCT01086384|69563174|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
37878832|NCT01086384|69563175|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
37878833|NCT01086384|69563176|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
37878834|NCT01086384|69563174|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
37878835|NCT01086384|69563175|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
37878836|NCT01086384|69563176|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
37878837|NCT01086384|69563174|FG000|2-week Run-in Period|Randomized in Error|1|||
37878838|NCT01086384|69563175|FG001|2-week Run-in Period|Randomized in Error|0|||
37878839|NCT01086384|69563176|FG002|2-week Run-in Period|Randomized in Error|0|||
37878840|NCT01086384|69563174|FG000|Treatment Period|Withdrawal by Subject|0|||
37878841|NCT01086384|69563175|FG001|Treatment Period|Withdrawal by Subject|53|||
37878842|NCT01086384|69563176|FG002|Treatment Period|Withdrawal by Subject|55|||
37878843|NCT01086384|69563174|FG000|Treatment Period|Protocol Violation|0|||
37878844|NCT01086384|69563175|FG001|Treatment Period|Protocol Violation|26|||
37878845|NCT01086384|69563176|FG002|Treatment Period|Protocol Violation|17|||
37878846|NCT01086384|69563174|FG000|Treatment Period|Lack of Efficacy|0|||
37878847|NCT01086384|69563175|FG001|Treatment Period|Lack of Efficacy|22|||
37983910|NCT00403494|69670134|FG000|Overall Study|Inappropriately enrolled|0|||
37983911|NCT00403494|69670135|FG001|Overall Study|Inappropriately enrolled|1|||
37983912|NCT00403494|69670134|FG000|Overall Study|Lost to Follow-up|0|||
37983913|NCT00403494|69670135|FG001|Overall Study|Lost to Follow-up|2|||
37983914|NCT00403494|69670134|FG000|Overall Study|Protocol noncompliance|0|||
37983915|NCT00403494|69670135|FG001|Overall Study|Protocol noncompliance|1|||
37878848|NCT01086384|69563176|FG002|Treatment Period|Lack of Efficacy|13|||
37878849|NCT01086384|69563174|FG000|Treatment Period|Adverse Event|0|||
37878850|NCT01086384|69563175|FG001|Treatment Period|Adverse Event|19|||
37878851|NCT01086384|69563176|FG002|Treatment Period|Adverse Event|15|||
37878852|NCT01086384|69563174|FG000|Treatment Period|Lost to Follow-up|0|||
37878853|NCT01086384|69563175|FG001|Treatment Period|Lost to Follow-up|11|||
37878854|NCT01086384|69563176|FG002|Treatment Period|Lost to Follow-up|9|||
37878855|NCT01086384|69563174|FG000|Treatment Period|Physician Decision|0|||
37878856|NCT01086384|69563175|FG001|Treatment Period|Physician Decision|9|||
37878857|NCT01086384|69563176|FG002|Treatment Period|Physician Decision|6|||
37878858|NCT01086384|69563174|FG000|Treatment Period|Study Closed/Terminated|0|||
37878859|NCT01086384|69563175|FG001|Treatment Period|Study Closed/Terminated|7|||
37878860|NCT01086384|69563176|FG002|Treatment Period|Study Closed/Terminated|8|||
37878861|NCT01086384|69563174|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
37878862|NCT01086384|69563175|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
37878863|NCT01086384|69563176|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
37878864|NCT01086384|69563174|FG000|Treatment Period|Received Treatment in Error|0|||
37878865|NCT01086384|69563175|FG001|Treatment Period|Received Treatment in Error|1|||
37878866|NCT01086384|69563176|FG002|Treatment Period|Received Treatment in Error|0|||
37878867|NCT01127633|69563197|FG000|Overall Study|Adverse Event|74|||
37878868|NCT01127633|69563198|FG001|Overall Study|Adverse Event|73|||
37878869|NCT01127633|69563197|FG000|Overall Study|Death|40|||
37878870|NCT01127633|69563198|FG001|Overall Study|Death|43|||
37878871|NCT01127633|69563197|FG000|Overall Study|Lost to Follow-up|4|||
37878872|NCT01127633|69563198|FG001|Overall Study|Lost to Follow-up|0|||
37878873|NCT01127633|69563197|FG000|Overall Study|Parent/Caregiver Decision|246|||
37983916|NCT00403494|69670134|FG000|Overall Study|Death|1|||
37983917|NCT00403494|69670135|FG001|Overall Study|Death|0|||
37983918|NCT00403494|69670134|FG000|Overall Study|Sponsor Request|1|||
37983919|NCT00403494|69670135|FG001|Overall Study|Sponsor Request|0|||
37983920|NCT00403260|69670145|FG000|Overall Study|Adverse Event|5|||
37878874|NCT01127633|69563198|FG001|Overall Study|Parent/Caregiver Decision|228|||
37878875|NCT01127633|69563197|FG000|Overall Study|Physician Decision|60|||
37878876|NCT01127633|69563198|FG001|Overall Study|Physician Decision|45|||
37878877|NCT01127633|69563197|FG000|Overall Study|Withdrawal by Subject|57|||
37878878|NCT01127633|69563198|FG001|Overall Study|Withdrawal by Subject|72|||
37878879|NCT01127633|69563197|FG000|Overall Study|Sponsor Decision|163|||
37878880|NCT01127633|69563198|FG001|Overall Study|Sponsor Decision|195|||
37878881|NCT01127633|69563197|FG000|Overall Study|Protocol Violation|8|||
37878882|NCT01127633|69563198|FG001|Overall Study|Protocol Violation|16|||
37983921|NCT00403260|69670146|FG001|Overall Study|Adverse Event|4|||
37878883|NCT01127633|69563197|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
37878884|NCT01127633|69563198|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
37878885|NCT01127633|69563197|FG000|Overall Study|Not treated|1|||
37878886|NCT01127633|69563198|FG001|Overall Study|Not treated|0|||
37878887|NCT01122173|69563204|FG000|Overall Study|Lost to Follow-up|3|||
37878888|NCT01122173|69563204|FG000|Overall Study|Withdrawal by Subject|3|||
37983922|NCT00403260|69670145|FG000|Overall Study|Withdrawal by Subject|5|||
37983923|NCT00403260|69670146|FG001|Overall Study|Withdrawal by Subject|6|||
37983924|NCT00403260|69670145|FG000|Overall Study|Lost to Follow-up|49|||
37983925|NCT00403260|69670146|FG001|Overall Study|Lost to Follow-up|25|||
37983926|NCT00403260|69670145|FG000|Overall Study|Re-appearance of P. falciparum|34|||
37983927|NCT00403260|69670146|FG001|Overall Study|Re-appearance of P. falciparum|25|||
37983928|NCT00403260|69670145|FG000|Overall Study|P. vivax infection|26|||
37983929|NCT00403260|69670146|FG001|Overall Study|P. vivax infection|4|||
37983930|NCT00403260|69670145|FG000|Overall Study|Mixed infection with P. vivax|2|||
37878889|NCT01122173|69563204|FG000|Overall Study|Left study for other reasons|3|||
37878890|NCT01127165|69563211|FG000|Overall Study|Adverse Event|2|||
37878891|NCT01127165|69563212|FG001|Overall Study|Adverse Event|2|||
37878892|NCT01127165|69563211|FG000|Overall Study|Lack of Efficacy|10|||
37878893|NCT01127165|69563212|FG001|Overall Study|Lack of Efficacy|8|||
37878894|NCT01127165|69563211|FG000|Overall Study|Lost to Follow-up|3|||
37878895|NCT01127165|69563212|FG001|Overall Study|Lost to Follow-up|5|||
37878896|NCT01127165|69563211|FG000|Overall Study|Withdrawal by Subject|1|||
37878897|NCT01127165|69563212|FG001|Overall Study|Withdrawal by Subject|3|||
37878898|NCT01127165|69563211|FG000|Overall Study|Protocol Violation|0|||
37878899|NCT01127165|69563212|FG001|Overall Study|Protocol Violation|1|||
37878900|NCT01126619|69563218|FG000|Overall Study|Not eligible for the study|2|||
37878901|NCT01126619|69563218|FG000|Overall Study|Investigator decision|4|||
37878902|NCT01126619|69563218|FG000|Overall Study|Serious adverse event|1|||
37878903|NCT01126619|69563218|FG000|Overall Study|Withdrawal by Subject|9|||
37878904|NCT01126619|69563218|FG000|Overall Study|Non-compliance|1|||
37878905|NCT00941733|69563226|FG000|Overall Study|Death|24|||
37878906|NCT00941733|69563227|FG001|Overall Study|Death|10|||
37878907|NCT00941733|69563226|FG000|Overall Study|Withdrawal by Subject|14|||
37878908|NCT00941733|69563227|FG001|Overall Study|Withdrawal by Subject|6|||
37878909|NCT00941733|69563226|FG000|Overall Study|Adverse Event|20|||
37878910|NCT00941733|69563227|FG001|Overall Study|Adverse Event|4|||
37878911|NCT00941733|69563226|FG000|Overall Study|Lost to Follow-up|1|||
37878912|NCT00941733|69563227|FG001|Overall Study|Lost to Follow-up|2|||
37878913|NCT00941733|69563226|FG000|Overall Study|Protocol Violation|15|||
37878914|NCT00941733|69563227|FG001|Overall Study|Protocol Violation|6|||
37878915|NCT00941655|69563235|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
37878916|NCT00941655|69563236|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
37878917|NCT00941655|69563235|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
37878918|NCT00941655|69563236|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
37878919|NCT00941655|69563235|FG000|Overall Study|progressed while on chemo|0|||
37878920|NCT00941655|69563236|FG001|Overall Study|progressed while on chemo|2|||
37878921|NCT00941655|69563235|FG000|Overall Study|refused further treatment|0|||
37878922|NCT00941655|69563236|FG001|Overall Study|refused further treatment|1|||
37878923|NCT00941655|69563235|FG000|Overall Study|withdrew consent|0|||
37878924|NCT00941655|69563236|FG001|Overall Study|withdrew consent|1|||
37878925|NCT00941655|69563235|FG000|Overall Study|non-compliant|0|||
37878926|NCT00941655|69563236|FG001|Overall Study|non-compliant|1|||
37983931|NCT00403260|69670146|FG001|Overall Study|Mixed infection with P. vivax|0|||
37819054|NCT03096834|69498189|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
37819055|NCT03096834|69498190|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
37819056|NCT03096834|69498191|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
37819057|NCT03096834|69498192|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
37819058|NCT03096834|69498189|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
37819059|NCT03096834|69498190|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
37819060|NCT03096834|69498191|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
37819061|NCT03096834|69498192|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
37819062|NCT03096834|69498189|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
37819063|NCT03096834|69498190|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
37878927|NCT00939393|69563245|FG000|Overall Study|Withdrawal by Subject|1|||
37878928|NCT00939393|69563246|FG001|Overall Study|Withdrawal by Subject|0|||
37878929|NCT00939393|69563245|FG000|Overall Study|Lost to Follow-up|3|||
37983932|NCT00403260|69670145|FG000|Overall Study|Mixed infection with P. falciparum|1|||
37878930|NCT00939393|69563246|FG001|Overall Study|Lost to Follow-up|0|||
37878931|NCT00936117|69563263|FG000|Overall Study|Adverse Event|7|||
37878932|NCT00936117|69563263|FG000|Overall Study|Unable to continue oral medication|3|||
37878933|NCT04088500|69563268|FG000|Overall Study|Reason unknown|1|||
37878934|NCT04088500|69563268|FG000|Overall Study|Participant withdrew consent|1|||
37878935|NCT04088500|69563268|FG000|Overall Study|Disease progression|3|||
37878936|NCT01082874|69563276|FG000|Overall Study|Lost to Follow-up|10|||
37983933|NCT00403260|69670146|FG001|Overall Study|Mixed infection with P. falciparum|0|||
37878937|NCT01082874|69563277|FG001|Overall Study|Lost to Follow-up|10|||
37878938|NCT01082874|69563278|FG002|Overall Study|Lost to Follow-up|6|||
37878939|NCT01082874|69563279|FG003|Overall Study|Lost to Follow-up|10|||
37878940|NCT01082874|69563276|FG000|Overall Study|Withdrawal by Subject|1|||
37878941|NCT01082874|69563277|FG001|Overall Study|Withdrawal by Subject|2|||
37878942|NCT01082874|69563278|FG002|Overall Study|Withdrawal by Subject|5|||
37878943|NCT01082874|69563279|FG003|Overall Study|Withdrawal by Subject|3|||
37878944|NCT00933543|69563291|FG000|Overall Study|Adverse Event|2|||
37878945|NCT00933543|69563292|FG001|Overall Study|Adverse Event|1|||
37878946|NCT00933543|69563291|FG000|Overall Study|Lost to Follow-up|0|||
37878947|NCT00933543|69563292|FG001|Overall Study|Lost to Follow-up|1|||
37878948|NCT00933543|69563291|FG000|Overall Study|Withdrawal by Subject|0|||
37819064|NCT03096834|69498191|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
37878949|NCT00933543|69563292|FG001|Overall Study|Withdrawal by Subject|1|||
37878950|NCT00933543|69563291|FG000|Overall Study|Lack of Efficacy|0|||
37878951|NCT00933543|69563292|FG001|Overall Study|Lack of Efficacy|3|||
37878952|NCT00933543|69563291|FG000|Overall Study|Other|1|||
37878953|NCT00933543|69563292|FG001|Overall Study|Other|1|||
37878954|NCT01082328|69563298|FG000|Overall Study|Adverse Event|1|||
37878955|NCT01079988|69563307|FG000|Overall Study|Lost to Follow-up|0|||
37878956|NCT01079988|69563308|FG001|Overall Study|Lost to Follow-up|0|||
37878957|NCT01079988|69563309|FG002|Overall Study|Lost to Follow-up|0|||
37878958|NCT01079988|69563310|FG003|Overall Study|Lost to Follow-up|1|||
37878959|NCT01079988|69563311|FG004|Overall Study|Lost to Follow-up|0|||
37878960|NCT01079988|69563307|FG000|Overall Study|Lack of Efficacy|1|||
37819065|NCT03096834|69498192|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
37878961|NCT01079988|69563308|FG001|Overall Study|Lack of Efficacy|0|||
37878962|NCT01079988|69563309|FG002|Overall Study|Lack of Efficacy|0|||
37878963|NCT01079988|69563310|FG003|Overall Study|Lack of Efficacy|0|||
37878964|NCT01079988|69563311|FG004|Overall Study|Lack of Efficacy|0|||
37878965|NCT01079988|69563307|FG000|Overall Study|Other|0|||
37878966|NCT01079988|69563308|FG001|Overall Study|Other|0|||
37878967|NCT01079988|69563309|FG002|Overall Study|Other|0|||
37878968|NCT01079988|69563310|FG003|Overall Study|Other|2|||
37878969|NCT01079988|69563311|FG004|Overall Study|Other|1|||
37878970|NCT01074216|69563323|FG000|Overall Study|Physician Decision|1|||
37878971|NCT01074216|69563323|FG000|Overall Study|Not Treated|12|||
37878972|NCT01079832|69563327|FG000|Overall Study|Withdrawal by Subject|1|||
37878973|NCT01072344|69563333|FG000|Overall Study|Relasped-reached end point|7|||
37878974|NCT01072344|69563334|FG001|Overall Study|Relasped-reached end point|12|||
37878975|NCT01072344|69563333|FG000|Overall Study|Protocol Violation|1|||
37878976|NCT01072344|69563334|FG001|Overall Study|Protocol Violation|2|||
37878977|NCT01072344|69563333|FG000|Overall Study|Lost to Follow-up|3|||
37878978|NCT01072344|69563334|FG001|Overall Study|Lost to Follow-up|4|||
37878979|NCT01071954|69563340|FG000|Overall Study|Noncompliance|4|||
37878980|NCT01071954|69563340|FG000|Overall Study|Adverse Event|1|||
37878981|NCT01071954|69563340|FG000|Overall Study|Withdrawal by Subject|11|||
37819066|NCT03096834|69498189|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
37819067|NCT03096834|69498190|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
37819068|NCT03096834|69498191|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
37819069|NCT03096834|69498192|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
37819070|NCT03096834|69498189|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
37819071|NCT03096834|69498190|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
37819072|NCT03096834|69498191|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
37819073|NCT03096834|69498192|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
37878982|NCT01071954|69563340|FG000|Overall Study|Requirement for Alternative Therapy|5|||
37878983|NCT01071954|69563340|FG000|Overall Study|Administrative Decision|5|||
37878984|NCT01071954|69563340|FG000|Overall Study|Protocol Specified Criteria|1|||
37878985|NCT00837811|69563347|FG000|Overall Study|Adverse Event|4|||
37878986|NCT00837811|69563348|FG001|Overall Study|Adverse Event|6|||
37878987|NCT00837811|69563349|FG002|Overall Study|Adverse Event|0|||
37878988|NCT00837811|69563347|FG000|Overall Study|Death|1|||
37878989|NCT00837811|69563348|FG001|Overall Study|Death|1|||
37878990|NCT00837811|69563349|FG002|Overall Study|Death|0|||
37878991|NCT00837811|69563347|FG000|Overall Study|Lack of Efficacy|0|||
37878992|NCT00837811|69563348|FG001|Overall Study|Lack of Efficacy|11|||
37878993|NCT00837811|69563349|FG002|Overall Study|Lack of Efficacy|0|||
37878994|NCT00837811|69563347|FG000|Overall Study|Lost to Follow-up|1|||
37878995|NCT00837811|69563348|FG001|Overall Study|Lost to Follow-up|3|||
37878996|NCT00837811|69563349|FG002|Overall Study|Lost to Follow-up|0|||
37878997|NCT00837811|69563347|FG000|Overall Study|Physician Decision|0|||
37878998|NCT00837811|69563348|FG001|Overall Study|Physician Decision|2|||
37878999|NCT00837811|69563349|FG002|Overall Study|Physician Decision|1|||
37879000|NCT00837811|69563347|FG000|Overall Study|Withdrawal by Subject|1|||
37879001|NCT00837811|69563348|FG001|Overall Study|Withdrawal by Subject|9|||
37879002|NCT00837811|69563349|FG002|Overall Study|Withdrawal by Subject|0|||
37879003|NCT00837811|69563347|FG000|Overall Study|Sponsor Decision|0|||
37879004|NCT00837811|69563348|FG001|Overall Study|Sponsor Decision|2|||
37879005|NCT00837811|69563349|FG002|Overall Study|Sponsor Decision|0|||
37879006|NCT00857389|69563366|FG000|Overall Study|Did not proceed to transplant|2|||
37879007|NCT01071798|69563370|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
37879008|NCT01071798|69563370|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
37879009|NCT01071798|69563370|FG000|Participants Who Received One Cycle|Patient requirement|20|||
37879010|NCT01071798|69563370|FG000|Participants Who Received One Cycle|Death|5|||
37879011|NCT01071798|69563370|FG000|Participants Who Received One Cycle|Change of therapy|6|||
37879012|NCT01071798|69563370|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
37879013|NCT01071798|69563370|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
37879014|NCT01071798|69563370|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
37879015|NCT01071798|69563370|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
37879016|NCT01071798|69563370|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
37879017|NCT00857311|69563388|FG000|Overall Study|Lost to Follow-up|1|||
37879018|NCT00857311|69563389|FG001|Overall Study|Lost to Follow-up|0|||
37879019|NCT00857311|69563390|FG002|Overall Study|Lost to Follow-up|0|||
37879020|NCT00857311|69563391|FG003|Overall Study|Lost to Follow-up|0|||
37879021|NCT00857233|69563397|FG000|Overall Study|Adverse Event|24|||
37879022|NCT00857233|69563397|FG000|Overall Study|Lack of Efficacy|1|||
37879023|NCT00857233|69563397|FG000|Overall Study|Non-compliance|1|||
37879024|NCT00857233|69563397|FG000|Overall Study|Withdrawal of Consent|9|||
37983934|NCT00403260|69670145|FG000|Overall Study|P. vivax infection at screening|1|||
37983935|NCT00403260|69670146|FG001|Overall Study|P. vivax infection at screening|0|||
37695199|NCT02365064|69171734|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
37695200|NCT02365064|69171733|FG000|Overall Study|Withdrawal by Subject|6|||
37879025|NCT00857233|69563397|FG000|Overall Study|Lost to Follow-up|4|||
37879026|NCT00857233|69563397|FG000|Overall Study|Nursing Home Placement|14|||
37879027|NCT00857233|69563397|FG000|Overall Study|Other Reasons|2|||
37879028|NCT00856999|69563401|FG000|Overall Study|Withdrawal by Subject|5|||
37879029|NCT01071252|69563411|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
37879030|NCT01071252|69563412|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
37879031|NCT01071252|69563413|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
37879032|NCT01071252|69563414|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
37879033|NCT01071252|69563415|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
37879034|NCT01071252|69563411|FG000|Overall Study|Withdrawal by Subject|8|||
37879035|NCT01071252|69563412|FG001|Overall Study|Withdrawal by Subject|2|||
37879036|NCT01071252|69563413|FG002|Overall Study|Withdrawal by Subject|1|||
37879037|NCT01071252|69563414|FG003|Overall Study|Withdrawal by Subject|2|||
37879038|NCT01071252|69563415|FG004|Overall Study|Withdrawal by Subject|3|||
37879039|NCT01071252|69563411|FG000|Overall Study|administrative problems|1|||
37879040|NCT01071252|69563412|FG001|Overall Study|administrative problems|1|||
37879041|NCT01071252|69563413|FG002|Overall Study|administrative problems|0|||
37879042|NCT01071252|69563414|FG003|Overall Study|administrative problems|2|||
37879043|NCT01071252|69563415|FG004|Overall Study|administrative problems|1|||
37879044|NCT01071252|69563411|FG000|Overall Study|Lost to Follow-up|1|||
37879045|NCT01071252|69563412|FG001|Overall Study|Lost to Follow-up|0|||
37695201|NCT02365064|69171734|FG001|Overall Study|Withdrawal by Subject|9|||
37695202|NCT02365064|69171733|FG000|Overall Study|Treatment intolerance|2|||
37695203|NCT02365064|69171734|FG001|Overall Study|Treatment intolerance|4|||
37695204|NCT02401256|69171740|FG000|Overall Study|Adverse Event|5|||
37695205|NCT02401256|69171740|FG000|Overall Study|Withdrawal by Subject|12|||
37695206|NCT02349295|69171749|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
37695207|NCT02349295|69171750|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
37695208|NCT02349295|69171751|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
37695209|NCT02349295|69171752|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
37695210|NCT02349295|69171753|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
37695211|NCT02349295|69171754|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
37695212|NCT02349295|69171755|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
37695213|NCT02349295|69171756|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
37695214|NCT02349295|69171757|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
37695215|NCT02349295|69171758|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
37695216|NCT02349295|69171759|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
37879046|NCT01071252|69563413|FG002|Overall Study|Lost to Follow-up|1|||
37879047|NCT01071252|69563414|FG003|Overall Study|Lost to Follow-up|2|||
37879048|NCT01071252|69563415|FG004|Overall Study|Lost to Follow-up|0|||
37879049|NCT01071252|69563411|FG000|Overall Study|Adverse Event|1|||
37879050|NCT01071252|69563412|FG001|Overall Study|Adverse Event|1|||
37879051|NCT01071252|69563413|FG002|Overall Study|Adverse Event|0|||
37879052|NCT01071252|69563414|FG003|Overall Study|Adverse Event|1|||
37879053|NCT01071252|69563415|FG004|Overall Study|Adverse Event|0|||
37879054|NCT01071252|69563411|FG000|Overall Study|Death|0|||
37879055|NCT01071252|69563412|FG001|Overall Study|Death|0|||
37879056|NCT01071252|69563413|FG002|Overall Study|Death|0|||
37879057|NCT01071252|69563414|FG003|Overall Study|Death|0|||
37879058|NCT01071252|69563415|FG004|Overall Study|Death|1|||
37879059|NCT00856843|69563429|FG000|Overall Study|Withdrawal by Subject|1|||
37879060|NCT00856843|69563430|FG001|Overall Study|Withdrawal by Subject|5|||
37879061|NCT00856843|69563429|FG000|Overall Study|Lack of Efficacy|1|||
37879062|NCT00856843|69563430|FG001|Overall Study|Lack of Efficacy|0|||
37879063|NCT00856609|69563438|FG000|Overall Study|Adverse Event|1|||
37879064|NCT00856609|69563439|FG001|Overall Study|Adverse Event|0|||
37879065|NCT01071096|69563445|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
37879066|NCT01071096|69563446|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
37879067|NCT00856375|69563465|FG000|Overall Study|Other|0|||
37879068|NCT00856375|69563466|FG001|Overall Study|Other|1|||
37879069|NCT00856375|69563465|FG000|Overall Study|Death|32|||
37879070|NCT00856375|69563466|FG001|Overall Study|Death|30|||
37879071|NCT00856375|69563465|FG000|Overall Study|Sponsor Terminated Study|7|||
37879072|NCT00856375|69563466|FG001|Overall Study|Sponsor Terminated Study|7|||
37879073|NCT00856375|69563465|FG000|Overall Study|Withdrawal by Subject|2|||
37879074|NCT00856375|69563466|FG001|Overall Study|Withdrawal by Subject|1|||
37879075|NCT00856375|69563465|FG000|Overall Study|Lost to Follow-up|1|||
37879076|NCT00856375|69563466|FG001|Overall Study|Lost to Follow-up|2|||
37879077|NCT01070784|69563474|FG000|Overall Study|Withdrawal by Subject|6|||
37879078|NCT01070784|69563475|FG001|Overall Study|Withdrawal by Subject|9|||
37879079|NCT01070784|69563474|FG000|Overall Study|Adverse Event|14|||
37879080|NCT01070784|69563475|FG001|Overall Study|Adverse Event|9|||
37879081|NCT00837577|69563483|FG000|Double-blind Period|Clinical Adverse Event|1|||
37879082|NCT00837577|69563484|FG001|Double-blind Period|Clinical Adverse Event|0|||
37879083|NCT00837577|69563483|FG000|Double-blind Period|Withdrawal by Subject|1|||
37879084|NCT00837577|69563484|FG001|Double-blind Period|Withdrawal by Subject|0|||
37879085|NCT00837577|69563483|FG000|Open-label Period|Clinical Adverse Event|2|||
37879086|NCT00837577|69563484|FG001|Open-label Period|Clinical Adverse Event|2|||
37879087|NCT00837577|69563483|FG000|Open-label Period|Laboratory Adverse Event|0|||
37879088|NCT00837577|69563484|FG001|Open-label Period|Laboratory Adverse Event|1|||
37879089|NCT00837577|69563483|FG000|Open-label Period|Lack of Efficacy|4|||
37879090|NCT00837577|69563484|FG001|Open-label Period|Lack of Efficacy|3|||
37879091|NCT00837577|69563483|FG000|Open-label Period|Withdrawal by Subject|1|||
37879092|NCT00837577|69563484|FG001|Open-label Period|Withdrawal by Subject|2|||
37879093|NCT00837577|69563483|FG000|Open-label Period|Other Reason|1|||
37879094|NCT00837577|69563484|FG001|Open-label Period|Other Reason|1|||
37879095|NCT01070550|69563497|FG000|Overall Study|Adverse Event|43|||
37879096|NCT01070550|69563498|FG001|Overall Study|Adverse Event|1|||
37879097|NCT01070550|69563499|FG002|Overall Study|Adverse Event|3|||
37983936|NCT00403260|69670145|FG000|Overall Study|P. ovale infection|1|||
37983937|NCT00403260|69670146|FG001|Overall Study|P. ovale infection|0|||
37983938|NCT00403260|69670145|FG000|Overall Study|Gametocyte re-appearance|1|||
37983939|NCT00403260|69670146|FG001|Overall Study|Gametocyte re-appearance|1|||
37983940|NCT00403260|69670145|FG000|Overall Study|Withdrawn from study accidentally|0|||
37983941|NCT00403260|69670146|FG001|Overall Study|Withdrawn from study accidentally|1|||
37983942|NCT00406848|69670154|FG000|Overall Study|Withdrawal by Subject|27|||
37983943|NCT00406848|69670155|FG001|Overall Study|Withdrawal by Subject|22|||
37983944|NCT00406848|69670154|FG000|Overall Study|Adverse Event|38|||
37983945|NCT00406848|69670155|FG001|Overall Study|Adverse Event|7|||
37819074|NCT03096834|69498189|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
37819075|NCT03096834|69498190|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
37819076|NCT03096834|69498191|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
37819077|NCT03096834|69498192|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
37819078|NCT03096834|69498189|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
37819079|NCT03096834|69498190|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
37819080|NCT03096834|69498191|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
37819081|NCT03096834|69498192|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
37983946|NCT00406848|69670154|FG000|Overall Study|Lack of Efficacy|9|||
37983947|NCT00406848|69670155|FG001|Overall Study|Lack of Efficacy|14|||
37819082|NCT03012815|69498203|FG000|Overall Study|Lost to Follow-up|1|||
37819083|NCT03012815|69498204|FG001|Overall Study|Lost to Follow-up|0|||
37879098|NCT01070550|69563500|FG003|Overall Study|Adverse Event|0|||
37879099|NCT01070550|69563501|FG004|Overall Study|Adverse Event|0|||
37879100|NCT01070550|69563502|FG005|Overall Study|Adverse Event|0|||
37879101|NCT01070550|69563497|FG000|Overall Study|Death|20|||
37879102|NCT01070550|69563498|FG001|Overall Study|Death|4|||
37983948|NCT00406848|69670154|FG000|Overall Study|Protocol Violation|10|||
37983949|NCT00406848|69670155|FG001|Overall Study|Protocol Violation|6|||
37983950|NCT00406848|69670154|FG000|Overall Study|Lost to Follow-up|6|||
37819084|NCT03012815|69498203|FG000|Overall Study|Physician Decision|3|||
37879103|NCT01070550|69563499|FG002|Overall Study|Death|3|||
37879104|NCT01070550|69563500|FG003|Overall Study|Death|0|||
37879105|NCT01070550|69563501|FG004|Overall Study|Death|0|||
37879106|NCT01070550|69563502|FG005|Overall Study|Death|0|||
37983951|NCT00406848|69670155|FG001|Overall Study|Lost to Follow-up|2|||
37879107|NCT01070550|69563497|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
37879108|NCT01070550|69563498|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
37879109|NCT01070550|69563499|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
37879110|NCT01070550|69563500|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
37879111|NCT01070550|69563501|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
37879112|NCT01070550|69563502|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
37879113|NCT01070550|69563497|FG000|Overall Study|Early termination|3|||
37879114|NCT01070550|69563498|FG001|Overall Study|Early termination|0|||
37879115|NCT01070550|69563499|FG002|Overall Study|Early termination|0|||
37879116|NCT01070550|69563500|FG003|Overall Study|Early termination|0|||
37879117|NCT01070550|69563501|FG004|Overall Study|Early termination|0|||
37879118|NCT01070550|69563502|FG005|Overall Study|Early termination|0|||
37879119|NCT01070550|69563497|FG000|Overall Study|Failed to return|450|||
37879120|NCT01070550|69563498|FG001|Overall Study|Failed to return|33|||
37983952|NCT00406848|69670154|FG000|Overall Study|Physician Decision|2|||
37819085|NCT03012815|69498204|FG001|Overall Study|Physician Decision|2|||
37819086|NCT03012815|69498203|FG000|Overall Study|Adverse Event|1|||
37879121|NCT01070550|69563499|FG002|Overall Study|Failed to return|144|||
37879122|NCT01070550|69563500|FG003|Overall Study|Failed to return|40|||
37879123|NCT01070550|69563501|FG004|Overall Study|Failed to return|1|||
37879124|NCT01070550|69563502|FG005|Overall Study|Failed to return|2|||
37879125|NCT01070550|69563497|FG000|Overall Study|Incomplete treatment|2|||
37879126|NCT01070550|69563498|FG001|Overall Study|Incomplete treatment|0|||
37879127|NCT01070550|69563499|FG002|Overall Study|Incomplete treatment|0|||
37879128|NCT01070550|69563500|FG003|Overall Study|Incomplete treatment|0|||
37819087|NCT03012815|69498204|FG001|Overall Study|Adverse Event|0|||
37819088|NCT03001011|69498213|FG000|Overall Study|Adverse Event|9|||
37819089|NCT03001011|69498214|FG001|Overall Study|Adverse Event|3|||
37819090|NCT03001011|69498213|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
37819091|NCT03001011|69498214|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
37819092|NCT03001011|69498213|FG000|Overall Study|Other than specified above|3|||
37819093|NCT03001011|69498214|FG001|Overall Study|Other than specified above|8|||
37819094|NCT02993757|69498223|FG000|Overall Study|Non compliance with the protocol|155|||
37819095|NCT02993757|69498224|FG001|Overall Study|Non compliance with the protocol|170|||
37819096|NCT02993757|69498223|FG000|Overall Study|Lost to Follow-up|1|||
37819097|NCT02993757|69498224|FG001|Overall Study|Lost to Follow-up|0|||
37819098|NCT02993757|69498223|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
37819099|NCT02993757|69498224|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
37819100|NCT02979535|69498232|FG000|Overall Study|Non compliance with the protocol|78|||
37819101|NCT02979535|69498233|FG001|Overall Study|Non compliance with the protocol|82|||
37819102|NCT02979535|69498232|FG000|Overall Study|Consent withdrawn by participant|11|||
37879129|NCT01070550|69563501|FG004|Overall Study|Incomplete treatment|0|||
37879130|NCT01070550|69563502|FG005|Overall Study|Incomplete treatment|0|||
37819103|NCT02979535|69498233|FG001|Overall Study|Consent withdrawn by participant|18|||
37879131|NCT01070550|69563497|FG000|Overall Study|Lab test not done|22|||
37879132|NCT01070550|69563498|FG001|Overall Study|Lab test not done|3|||
37879133|NCT01070550|69563499|FG002|Overall Study|Lab test not done|4|||
37879134|NCT01070550|69563500|FG003|Overall Study|Lab test not done|1|||
37879135|NCT01070550|69563501|FG004|Overall Study|Lab test not done|0|||
37879136|NCT01070550|69563502|FG005|Overall Study|Lab test not done|1|||
37879137|NCT01070550|69563497|FG000|Overall Study|Lack of Efficacy|65|||
37879138|NCT01070550|69563498|FG001|Overall Study|Lack of Efficacy|1|||
37879139|NCT01070550|69563499|FG002|Overall Study|Lack of Efficacy|5|||
37879140|NCT01070550|69563500|FG003|Overall Study|Lack of Efficacy|5|||
37879141|NCT01070550|69563501|FG004|Overall Study|Lack of Efficacy|0|||
37879142|NCT01070550|69563502|FG005|Overall Study|Lack of Efficacy|1|||
37879143|NCT01070550|69563497|FG000|Overall Study|Miscellaneous|12|||
37879144|NCT01070550|69563498|FG001|Overall Study|Miscellaneous|2|||
37879145|NCT01070550|69563499|FG002|Overall Study|Miscellaneous|3|||
37879146|NCT01070550|69563500|FG003|Overall Study|Miscellaneous|1|||
37879147|NCT01070550|69563501|FG004|Overall Study|Miscellaneous|0|||
37879148|NCT01070550|69563502|FG005|Overall Study|Miscellaneous|0|||
37879149|NCT01070550|69563497|FG000|Overall Study|New treatment started|3|||
37879150|NCT01070550|69563498|FG001|Overall Study|New treatment started|1|||
37879151|NCT01070550|69563499|FG002|Overall Study|New treatment started|0|||
37879152|NCT01070550|69563500|FG003|Overall Study|New treatment started|2|||
37879153|NCT01070550|69563501|FG004|Overall Study|New treatment started|0|||
37879154|NCT01070550|69563502|FG005|Overall Study|New treatment started|0|||
37879155|NCT01070550|69563497|FG000|Overall Study|Non-responders|493|||
37879156|NCT01070550|69563498|FG001|Overall Study|Non-responders|4|||
37819104|NCT02979535|69498232|FG000|Overall Study|Lost to Follow-up|6|||
37819105|NCT02979535|69498233|FG001|Overall Study|Lost to Follow-up|1|||
37879157|NCT01070550|69563499|FG002|Overall Study|Non-responders|21|||
37879158|NCT01070550|69563500|FG003|Overall Study|Non-responders|20|||
37879159|NCT01070550|69563501|FG004|Overall Study|Non-responders|0|||
37879160|NCT01070550|69563502|FG005|Overall Study|Non-responders|2|||
37879161|NCT01070550|69563497|FG000|Overall Study|Not categorized|33|||
37879162|NCT01070550|69563498|FG001|Overall Study|Not categorized|2|||
37879163|NCT01070550|69563499|FG002|Overall Study|Not categorized|6|||
37879164|NCT01070550|69563500|FG003|Overall Study|Not categorized|1|||
37879165|NCT01070550|69563501|FG004|Overall Study|Not categorized|0|||
37879166|NCT01070550|69563502|FG005|Overall Study|Not categorized|1|||
37879167|NCT01070550|69563497|FG000|Overall Study|Protocol Violation|15|||
37879168|NCT01070550|69563498|FG001|Overall Study|Protocol Violation|1|||
37879169|NCT01070550|69563499|FG002|Overall Study|Protocol Violation|1|||
37879170|NCT01070550|69563500|FG003|Overall Study|Protocol Violation|1|||
37879171|NCT01070550|69563501|FG004|Overall Study|Protocol Violation|0|||
37879172|NCT01070550|69563502|FG005|Overall Study|Protocol Violation|0|||
37879173|NCT01070550|69563497|FG000|Overall Study|Relapse|44|||
37879174|NCT01070550|69563498|FG001|Overall Study|Relapse|5|||
37879175|NCT01070550|69563499|FG002|Overall Study|Relapse|14|||
37879176|NCT01070550|69563500|FG003|Overall Study|Relapse|4|||
37879177|NCT01070550|69563501|FG004|Overall Study|Relapse|0|||
37879178|NCT01070550|69563502|FG005|Overall Study|Relapse|0|||
37879179|NCT01070550|69563497|FG000|Overall Study|Result not available|3|||
37879180|NCT01070550|69563498|FG001|Overall Study|Result not available|1|||
37879181|NCT01070550|69563499|FG002|Overall Study|Result not available|3|||
37879182|NCT01070550|69563500|FG003|Overall Study|Result not available|0|||
37879183|NCT01070550|69563501|FG004|Overall Study|Result not available|0|||
37879184|NCT01070550|69563502|FG005|Overall Study|Result not available|0|||
37879185|NCT01070550|69563497|FG000|Overall Study|Screen failure|1|||
37819106|NCT02978716|69498242|FG000|Overall Study|Death|25|||
37819107|NCT02978716|69498243|FG001|Overall Study|Death|13|||
37819108|NCT02978716|69498244|FG002|Overall Study|Death|20|||
37819109|NCT02978716|69498242|FG000|Overall Study|Lost to Follow-up|0|||
37819110|NCT02978716|69498243|FG001|Overall Study|Lost to Follow-up|0|||
37819111|NCT02978716|69498244|FG002|Overall Study|Lost to Follow-up|1|||
37819112|NCT02978716|69498242|FG000|Overall Study|Withdrawal by Subject|6|||
37819113|NCT02978716|69498243|FG001|Overall Study|Withdrawal by Subject|4|||
37819114|NCT02978716|69498244|FG002|Overall Study|Withdrawal by Subject|5|||
37819115|NCT02978716|69498242|FG000|Overall Study|Sponsor terminated|2|||
37819116|NCT02978716|69498243|FG001|Overall Study|Sponsor terminated|13|||
37819117|NCT02978716|69498244|FG002|Overall Study|Sponsor terminated|9|||
37819118|NCT02978716|69498242|FG000|Overall Study|Other|1|||
37819119|NCT02978716|69498243|FG001|Overall Study|Other|3|||
37819120|NCT02978716|69498244|FG002|Overall Study|Other|0|||
37819121|NCT02973321|69498259|FG000|Overall Study|Other than specified|0|||
37819122|NCT02973321|69498260|FG001|Overall Study|Other than specified|5|||
37879186|NCT01070550|69563498|FG001|Overall Study|Screen failure|0|||
37879187|NCT01070550|69563499|FG002|Overall Study|Screen failure|0|||
37879188|NCT01070550|69563500|FG003|Overall Study|Screen failure|0|||
37879189|NCT01070550|69563501|FG004|Overall Study|Screen failure|0|||
37879190|NCT01070550|69563502|FG005|Overall Study|Screen failure|0|||
37879191|NCT01070550|69563497|FG000|Overall Study|Sponsor decision|1|||
37819123|NCT02973321|69498261|FG002|Overall Study|Other than specified|3|||
37819124|NCT02973321|69498262|FG003|Overall Study|Other than specified|3|||
37819125|NCT02973321|69498263|FG004|Overall Study|Other than specified|1|||
37819126|NCT02973321|69498259|FG000|Overall Study|Lack of Efficacy|0|||
37819127|NCT02973321|69498260|FG001|Overall Study|Lack of Efficacy|0|||
37819128|NCT02973321|69498261|FG002|Overall Study|Lack of Efficacy|0|||
37819129|NCT02973321|69498262|FG003|Overall Study|Lack of Efficacy|0|||
37819130|NCT02973321|69498263|FG004|Overall Study|Lack of Efficacy|1|||
37819131|NCT02973321|69498259|FG000|Overall Study|Adverse Event|1|||
37819132|NCT02973321|69498260|FG001|Overall Study|Adverse Event|10|||
37819133|NCT02973321|69498261|FG002|Overall Study|Adverse Event|11|||
37879192|NCT01070550|69563498|FG001|Overall Study|Sponsor decision|0|||
37879193|NCT01070550|69563499|FG002|Overall Study|Sponsor decision|0|||
37879194|NCT01070550|69563500|FG003|Overall Study|Sponsor decision|0|||
37879195|NCT01070550|69563501|FG004|Overall Study|Sponsor decision|0|||
37879196|NCT01070550|69563502|FG005|Overall Study|Sponsor decision|0|||
37819134|NCT02973321|69498262|FG003|Overall Study|Adverse Event|13|||
37819135|NCT02973321|69498263|FG004|Overall Study|Adverse Event|3|||
37819136|NCT02943785|69498278|FG000|Overall Study|Adverse Event|112|||
37819137|NCT02943785|69498279|FG001|Overall Study|Adverse Event|97|||
37819138|NCT02943785|69498278|FG000|Overall Study|Withdrawal by Subject|63|||
37879197|NCT01070550|69563497|FG000|Overall Study|Treatment duration shortened|1|||
37879198|NCT01070550|69563498|FG001|Overall Study|Treatment duration shortened|0|||
37879199|NCT01070550|69563499|FG002|Overall Study|Treatment duration shortened|0|||
37879200|NCT01070550|69563500|FG003|Overall Study|Treatment duration shortened|0|||
37879201|NCT01070550|69563501|FG004|Overall Study|Treatment duration shortened|0|||
37879202|NCT01070550|69563502|FG005|Overall Study|Treatment duration shortened|0|||
37879203|NCT01070550|69563497|FG000|Overall Study|Treatment interrupted|7|||
37879204|NCT01070550|69563498|FG001|Overall Study|Treatment interrupted|0|||
37879205|NCT01070550|69563499|FG002|Overall Study|Treatment interrupted|1|||
37879206|NCT01070550|69563500|FG003|Overall Study|Treatment interrupted|1|||
37879207|NCT01070550|69563501|FG004|Overall Study|Treatment interrupted|0|||
37879208|NCT01070550|69563502|FG005|Overall Study|Treatment interrupted|0|||
37879209|NCT01070550|69563497|FG000|Overall Study|Treatment not started|14|||
37879210|NCT01070550|69563498|FG001|Overall Study|Treatment not started|2|||
37879211|NCT01070550|69563499|FG002|Overall Study|Treatment not started|4|||
37879212|NCT01070550|69563500|FG003|Overall Study|Treatment not started|0|||
37879213|NCT01070550|69563501|FG004|Overall Study|Treatment not started|0|||
37879214|NCT01070550|69563502|FG005|Overall Study|Treatment not started|0|||
37879215|NCT01070550|69563497|FG000|Overall Study|Treatment restarted|0|||
37879216|NCT01070550|69563498|FG001|Overall Study|Treatment restarted|1|||
37879217|NCT01070550|69563499|FG002|Overall Study|Treatment restarted|0|||
37879218|NCT01070550|69563500|FG003|Overall Study|Treatment restarted|0|||
37879219|NCT01070550|69563501|FG004|Overall Study|Treatment restarted|0|||
37879220|NCT01070550|69563502|FG005|Overall Study|Treatment restarted|0|||
37879221|NCT01070550|69563497|FG000|Overall Study|Treatment stopped|3|||
37879222|NCT01070550|69563498|FG001|Overall Study|Treatment stopped|0|||
37879223|NCT01070550|69563499|FG002|Overall Study|Treatment stopped|0|||
37879224|NCT01070550|69563500|FG003|Overall Study|Treatment stopped|0|||
37879225|NCT01070550|69563501|FG004|Overall Study|Treatment stopped|0|||
37879226|NCT01070550|69563502|FG005|Overall Study|Treatment stopped|0|||
37879227|NCT01070550|69563497|FG000|Overall Study|Treatment unavailable|1|||
37879228|NCT01070550|69563498|FG001|Overall Study|Treatment unavailable|0|||
37879229|NCT01070550|69563499|FG002|Overall Study|Treatment unavailable|0|||
37879230|NCT01070550|69563500|FG003|Overall Study|Treatment unavailable|0|||
37879231|NCT01070550|69563501|FG004|Overall Study|Treatment unavailable|0|||
37879232|NCT01070550|69563502|FG005|Overall Study|Treatment unavailable|0|||
37879233|NCT01070550|69563497|FG000|Overall Study|Treatment was stopped early|7|||
37879234|NCT01070550|69563498|FG001|Overall Study|Treatment was stopped early|0|||
37879235|NCT01070550|69563499|FG002|Overall Study|Treatment was stopped early|0|||
37879236|NCT01070550|69563500|FG003|Overall Study|Treatment was stopped early|0|||
37879237|NCT01070550|69563501|FG004|Overall Study|Treatment was stopped early|0|||
37879238|NCT01070550|69563502|FG005|Overall Study|Treatment was stopped early|0|||
37879239|NCT01070550|69563497|FG000|Overall Study|Other|5|||
37879240|NCT01070550|69563498|FG001|Overall Study|Other|0|||
37819139|NCT02943785|69498279|FG001|Overall Study|Withdrawal by Subject|126|||
37819140|NCT02943785|69498278|FG000|Overall Study|Physician Decision|23|||
37819141|NCT02943785|69498279|FG001|Overall Study|Physician Decision|47|||
37819142|NCT02943785|69498278|FG000|Overall Study|Death|46|||
37819143|NCT02943785|69498279|FG001|Overall Study|Death|46|||
37819144|NCT02943785|69498278|FG000|Overall Study|Lost to Follow-up|1|||
37819145|NCT02943785|69498279|FG001|Overall Study|Lost to Follow-up|0|||
37819146|NCT02943785|69498278|FG000|Overall Study|Other|16|||
37819147|NCT02943785|69498279|FG001|Overall Study|Other|19|||
37819148|NCT02943785|69498278|FG000|Overall Study|Did not receive any study medication|21|||
37819149|NCT02943785|69498279|FG001|Overall Study|Did not receive any study medication|28|||
37819150|NCT02923674|69498288|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
37819151|NCT02923674|69498289|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
37819152|NCT02923674|69498290|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
37819153|NCT02923674|69498288|FG000|Overall Study|Lost to Follow-up|7|||
37819154|NCT02923674|69498289|FG001|Overall Study|Lost to Follow-up|12|||
37819155|NCT02923674|69498290|FG002|Overall Study|Lost to Follow-up|7|||
37819156|NCT02923674|69498288|FG000|Overall Study|Problem with intervention|2|||
37819157|NCT02923674|69498289|FG001|Overall Study|Problem with intervention|2|||
37819158|NCT02923674|69498290|FG002|Overall Study|Problem with intervention|1|||
37819159|NCT02923674|69498288|FG000|Overall Study|Adverse Event|3|||
37819160|NCT02923674|69498289|FG001|Overall Study|Adverse Event|1|||
37819161|NCT02923674|69498290|FG002|Overall Study|Adverse Event|1|||
37819162|NCT02923674|69498288|FG000|Overall Study|Withdrawal by Subject|2|||
37819163|NCT02923674|69498289|FG001|Overall Study|Withdrawal by Subject|2|||
37879241|NCT01070550|69563499|FG002|Overall Study|Other|0|||
37879242|NCT01070550|69563500|FG003|Overall Study|Other|1|||
37879243|NCT01070550|69563501|FG004|Overall Study|Other|0|||
37879244|NCT01070550|69563502|FG005|Overall Study|Other|0|||
37819164|NCT02923674|69498290|FG002|Overall Study|Withdrawal by Subject|2|||
37819165|NCT02921971|69498300|FG000|Overall Study|Adverse Event|1|||
37819166|NCT02921971|69498301|FG001|Overall Study|Adverse Event|2|||
37879245|NCT01070550|69563497|FG000|Overall Study|Withdrawal by Subject|35|||
37879246|NCT01070550|69563498|FG001|Overall Study|Withdrawal by Subject|0|||
37879247|NCT01070550|69563499|FG002|Overall Study|Withdrawal by Subject|3|||
37879248|NCT01070550|69563500|FG003|Overall Study|Withdrawal by Subject|0|||
37879249|NCT01070550|69563501|FG004|Overall Study|Withdrawal by Subject|0|||
37879250|NCT01070550|69563502|FG005|Overall Study|Withdrawal by Subject|0|||
37879251|NCT00848107|69563517|FG000|Overall Study|Lost to Follow-up|2|||
37879252|NCT00848107|69563517|FG000|Overall Study|Withdrawal by Subject|8|||
37879253|NCT00848107|69563517|FG000|Overall Study|Adverse Event|9|||
37879254|NCT00848107|69563517|FG000|Overall Study|Death|1|||
37879255|NCT00848107|69563517|FG000|Overall Study|Pregnancy|1|||
37879256|NCT00856297|69563526|FG000|Overall Study|Unable to classify|2|||
37879257|NCT00856297|69563527|FG001|Overall Study|Unable to classify|0|||
37879258|NCT00856297|69563528|FG002|Overall Study|Unable to classify|0|||
37879259|NCT00856297|69563529|FG003|Overall Study|Unable to classify|0|||
37879260|NCT00856297|69563530|FG004|Overall Study|Unable to classify|0|||
37879261|NCT01046136|69563549|FG000|Overall Study|Withdrawal by Subject|0|||
37879262|NCT01046136|69563550|FG001|Overall Study|Withdrawal by Subject|4|||
37879263|NCT01046136|69563549|FG000|Overall Study|Physician Decision|1|||
37879264|NCT01046136|69563550|FG001|Overall Study|Physician Decision|1|||
37879265|NCT01046136|69563549|FG000|Overall Study|Lost to Follow-up|3|||
37879266|NCT01046136|69563550|FG001|Overall Study|Lost to Follow-up|3|||
37879267|NCT01070394|69563558|FG000|Overall Study|Adverse Event|6|||
37879268|NCT01070394|69563558|FG000|Overall Study|Withdrawal by Subject|1|||
37879269|NCT00836953|69563564|FG000|Overall Study|Withdrawal by Subject|1|||
37879270|NCT00836953|69563564|FG000|Overall Study|Lost to Follow-up|1|||
37879271|NCT01070316|69563568|FG000|Extension Phase|Lack of Efficacy|3|||
37879272|NCT01070316|69563568|FG000|Extension Phase|Withdrawal by Subject|1|||
37879273|NCT01126541|69563575|FG000|Overall Study|Adverse Event|0|||
37879274|NCT01126541|69563576|FG001|Overall Study|Adverse Event|2|||
37879275|NCT01126541|69563577|FG002|Overall Study|Adverse Event|4|||
37879276|NCT01126541|69563575|FG000|Overall Study|Death|0|||
37879277|NCT01126541|69563576|FG001|Overall Study|Death|1|||
37879278|NCT01126541|69563577|FG002|Overall Study|Death|0|||
37879279|NCT01126541|69563575|FG000|Overall Study|Lack of Efficacy|6|||
37879280|NCT01126541|69563576|FG001|Overall Study|Lack of Efficacy|1|||
37879281|NCT01126541|69563577|FG002|Overall Study|Lack of Efficacy|11|||
37879282|NCT01126541|69563575|FG000|Overall Study|Lost to Follow-up|1|||
37879283|NCT01126541|69563576|FG001|Overall Study|Lost to Follow-up|2|||
37879284|NCT01126541|69563577|FG002|Overall Study|Lost to Follow-up|2|||
37879285|NCT01126541|69563575|FG000|Overall Study|Withdrawal by Subject|2|||
37879286|NCT01126541|69563576|FG001|Overall Study|Withdrawal by Subject|5|||
37879287|NCT01126541|69563577|FG002|Overall Study|Withdrawal by Subject|6|||
37879288|NCT01126541|69563575|FG000|Overall Study|Protocol Violation|0|||
37879289|NCT01126541|69563576|FG001|Overall Study|Protocol Violation|0|||
37879290|NCT01126541|69563577|FG002|Overall Study|Protocol Violation|1|||
37879291|NCT01126541|69563575|FG000|Overall Study|Administrative reason or other|1|||
37983953|NCT00406848|69670155|FG001|Overall Study|Physician Decision|2|||
37983954|NCT00406848|69670154|FG000|Overall Study|Sponsor Decision|1|||
37819167|NCT02921971|69498300|FG000|Overall Study|Lack of Efficacy|3|||
37819168|NCT02921971|69498301|FG001|Overall Study|Lack of Efficacy|1|||
37819169|NCT02921971|69498300|FG000|Overall Study|Other than specified above|2|||
37819170|NCT02921971|69498301|FG001|Overall Study|Other than specified above|1|||
37819171|NCT02886286|69498309|FG000|Overall Study|pump motor stall|0|||
37819172|NCT02886286|69498310|FG001|Overall Study|pump motor stall|1|||
37819173|NCT02865187|69498318|FG000|Overall Study|Lost to Follow-up|12|||
37819174|NCT02865187|69498319|FG001|Overall Study|Lost to Follow-up|7|||
37819175|NCT02865187|69498318|FG000|Overall Study|Adverse Event|1|||
37819176|NCT02865187|69498319|FG001|Overall Study|Adverse Event|0|||
37819177|NCT02824198|69498327|FG000|Overall Study|Non-compliance with the protocol|5|||
37879292|NCT01126541|69563576|FG001|Overall Study|Administrative reason or other|1|||
37879293|NCT01126541|69563577|FG002|Overall Study|Administrative reason or other|2|||
37879294|NCT00836875|69563589|FG000|Overall Study|Death|3|||
37879295|NCT00836875|69563590|FG001|Overall Study|Death|2|||
37819178|NCT02824198|69498328|FG001|Overall Study|Non-compliance with the protocol|1|||
37879296|NCT00836875|69563589|FG000|Overall Study|Withdrawal by Subject|0|||
37879297|NCT00836875|69563590|FG001|Overall Study|Withdrawal by Subject|1|||
37879298|NCT01125917|69563596|FG000|Overall Study|Adverse Event|43|||
37879299|NCT01125917|69563596|FG000|Overall Study|Lost to Follow-up|23|||
37879300|NCT01125917|69563596|FG000|Overall Study|Withdrawal by Subject|31|||
37879301|NCT01125917|69563596|FG000|Overall Study|Administrative|223|||
37879302|NCT01125917|69563596|FG000|Overall Study|Lack of Efficacy|19|||
37879303|NCT00847561|69563602|FG000|Overall Study|Withdrawal by Subject|4|||
37879304|NCT00847561|69563603|FG001|Overall Study|Withdrawal by Subject|3|||
37879305|NCT00847561|69563602|FG000|Overall Study|Unable to schedule|9|||
37879306|NCT00847561|69563603|FG001|Overall Study|Unable to schedule|1|||
37879307|NCT01121549|69563609|FG000|Overall Study|Adverse Event|10|||
37879308|NCT01121549|69563609|FG000|Overall Study|Lack of Efficacy|11|||
37983955|NCT00406848|69670155|FG001|Overall Study|Sponsor Decision|1|||
37879309|NCT01121549|69563609|FG000|Overall Study|Lost to Follow-up|12|||
37879310|NCT01121549|69563609|FG000|Overall Study|Did not meet entrance criteria|9|||
37879311|NCT01121549|69563609|FG000|Overall Study|Study terminated by sponsor|197|||
37879312|NCT01121549|69563609|FG000|Overall Study|Pregnancy|1|||
37879313|NCT01121549|69563609|FG000|Overall Study|Protocol Violation|33|||
37879314|NCT01121549|69563609|FG000|Overall Study|Withdrawal by Subject|16|||
37879315|NCT01121549|69563609|FG000|Overall Study|Other|58|||
37879316|NCT00847405|69563615|FG000|First Intervention|Adverse Event|0|||
37879317|NCT00847405|69563616|FG001|First Intervention|Adverse Event|1|||
37983956|NCT00406692|69670164|FG000|Overall Study|Withdrawal by Subject|4|||
37983957|NCT00406692|69670164|FG000|Overall Study|Physician Decision|1|||
37983958|NCT00406692|69670164|FG000|Overall Study|Adverse Event|1|||
37983959|NCT00406692|69670164|FG000|Overall Study|Lack of Efficacy|1|||
37983960|NCT00315705|69670170|FG000|Phase 1|Refused further treatment|1|||
37879318|NCT00847405|69563615|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
37879319|NCT00847405|69563616|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
37879320|NCT00836095|69563622|FG000|Overall Study|Physician Decision|0|||
37879321|NCT00836095|69563623|FG001|Overall Study|Physician Decision|3|||
37879322|NCT00835237|69563640|FG000|Overall Study|Lost to Follow-up|4|||
37879323|NCT00835237|69563641|FG001|Overall Study|Lost to Follow-up|0|||
37879324|NCT00835237|69563640|FG000|Overall Study|Withdrawal by Subject|2|||
37879325|NCT00835237|69563641|FG001|Overall Study|Withdrawal by Subject|0|||
37879326|NCT01072500|69563649|FG000|Overall Study|Death|2|||
37879327|NCT01072500|69563650|FG001|Overall Study|Death|2|||
37879328|NCT01072500|69563649|FG000|Overall Study|Lost to Follow-up|5|||
37879329|NCT01072500|69563650|FG001|Overall Study|Lost to Follow-up|2|||
37879330|NCT01072500|69563649|FG000|Overall Study|Withdrawal by Subject|17|||
37879331|NCT01072500|69563650|FG001|Overall Study|Withdrawal by Subject|10|||
37983961|NCT00315705|69670170|FG000|Phase 1|Failure to achieve response|8|||
37983962|NCT00315705|69670170|FG000|Phase 1|Disease relapse|4|||
37879332|NCT00847015|69563658|FG000|Overall Study|Withdrawal by Subject|1|||
37879333|NCT00847015|69563658|FG000|Overall Study|declined any surgery|1|||
37879334|NCT00847015|69563658|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
37879335|NCT00855595|69563664|FG000|Overall Study|Withdrawal by Subject|1|||
37879336|NCT00855595|69563665|FG001|Overall Study|Withdrawal by Subject|2|||
37879337|NCT00855595|69563664|FG000|Overall Study|Lost to Follow-up|3|||
37879338|NCT00855595|69563665|FG001|Overall Study|Lost to Follow-up|3|||
37879339|NCT00855595|69563664|FG000|Overall Study|Adverse Event|1|||
37879340|NCT00855595|69563665|FG001|Overall Study|Adverse Event|1|||
37879341|NCT00855595|69563664|FG000|Overall Study|patient moved out of state|1|||
37879342|NCT00855595|69563665|FG001|Overall Study|patient moved out of state|0|||
37879343|NCT00855595|69563664|FG000|Overall Study|patient left country|0|||
37879344|NCT00855595|69563665|FG001|Overall Study|patient left country|1|||
37879345|NCT00855439|69563673|FG000|Overall Study|Withdrawal by Subject|2|||
37879346|NCT00855439|69563674|FG001|Overall Study|Withdrawal by Subject|0|||
37879347|NCT00855439|69563673|FG000|Overall Study|Pregnancy|1|||
37879348|NCT00855439|69563674|FG001|Overall Study|Pregnancy|0|||
37879349|NCT01064856|69563682|FG000|Double-blind (DB) Period|Adverse Event|1|||
37879350|NCT01064856|69563683|FG001|Double-blind (DB) Period|Adverse Event|0|||
37879351|NCT01064856|69563684|FG002|Double-blind (DB) Period|Adverse Event|0|||
37879352|NCT01064856|69563685|FG003|Double-blind (DB) Period|Adverse Event|0|||
37879353|NCT01064856|69563682|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
37879354|NCT01064856|69563683|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
37879355|NCT01064856|69563684|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
37879356|NCT01064856|69563685|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
37983963|NCT00315705|69670170|FG000|Phase 1|Scheduled for transplant|9|||
37983964|NCT00315705|69670170|FG000|Phase 1|Death|3|||
37983965|NCT00315705|69670170|FG000|Phase 2|Physician Decision|4|||
37983966|NCT00315705|69670170|FG000|Phase 2|Adverse Event|1|||
37983967|NCT00315705|69670170|FG000|Phase 2|Failure to achieve response|3|||
37983968|NCT00315705|69670170|FG000|Phase 2|Disease relapse|1|||
37983969|NCT00315705|69670170|FG000|Phase 2|Scheduled for transplant|8|||
37983970|NCT00315705|69670170|FG000|Phase 2|Other|1|||
37983971|NCT00315705|69670170|FG000|Phase 2|Death|7|||
37983972|NCT00307125|69670189|FG000|Screening Phase|Adverse Event|1|||
37983973|NCT00307125|69670190|FG001|Screening Phase|Adverse Event|0|||
37983974|NCT00307125|69670191|FG002|Screening Phase|Adverse Event|0|||
37983975|NCT00307125|69670189|FG000|Screening Phase|Protocol Violation|27|||
37879357|NCT01064856|69563682|FG000|Open-label (OL) Period|Adverse Event|0|||
37879358|NCT01064856|69563683|FG001|Open-label (OL) Period|Adverse Event|0|||
37879359|NCT01064856|69563684|FG002|Open-label (OL) Period|Adverse Event|12|||
37879360|NCT01064856|69563685|FG003|Open-label (OL) Period|Adverse Event|6|||
37879361|NCT01064856|69563682|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
37879362|NCT01064856|69563683|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
37983976|NCT00307125|69670190|FG001|Screening Phase|Protocol Violation|0|||
37983977|NCT00307125|69670191|FG002|Screening Phase|Protocol Violation|0|||
37879363|NCT01064856|69563684|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
37879364|NCT01064856|69563685|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
37983978|NCT00307125|69670189|FG000|Screening Phase|Lost to Follow-up|87|||
37983979|NCT00307125|69670190|FG001|Screening Phase|Lost to Follow-up|0|||
37983980|NCT00307125|69670191|FG002|Screening Phase|Lost to Follow-up|0|||
37879365|NCT01064856|69563682|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
37879366|NCT01064856|69563683|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
37879367|NCT01064856|69563684|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
37983981|NCT00307125|69670189|FG000|Screening Phase|Death|10|||
37983982|NCT00307125|69670190|FG001|Screening Phase|Death|0|||
37879368|NCT01064856|69563685|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
37879369|NCT01064856|69563682|FG000|Open-label (OL) Period|Other|0|||
37879370|NCT01064856|69563683|FG001|Open-label (OL) Period|Other|0|||
37879371|NCT01064856|69563684|FG002|Open-label (OL) Period|Other|7|||
37879372|NCT01064856|69563685|FG003|Open-label (OL) Period|Other|7|||
37879373|NCT00846391|69563695|FG000|Overall Study|Physician Decision|0|||
37879374|NCT00846391|69563696|FG001|Overall Study|Physician Decision|0|||
37879375|NCT00846391|69563697|FG002|Overall Study|Physician Decision|1|||
37879376|NCT00846391|69563695|FG000|Overall Study|Study Terminated by Sponsor|1|||
37879377|NCT00846391|69563696|FG001|Overall Study|Study Terminated by Sponsor|2|||
37879378|NCT00846391|69563697|FG002|Overall Study|Study Terminated by Sponsor|2|||
37879379|NCT01042392|69563707|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
37879380|NCT01042392|69563708|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
37879381|NCT01042392|69563709|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
37879382|NCT01042392|69563710|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
37879383|NCT01042392|69563707|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
37879384|NCT01042392|69563708|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
37879385|NCT01042392|69563709|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
37879386|NCT01042392|69563710|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
37879387|NCT01042392|69563707|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
37879388|NCT01042392|69563708|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
37879389|NCT01042392|69563709|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
37879390|NCT01042392|69563710|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
37879391|NCT01042392|69563707|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
37983983|NCT00307125|69670191|FG002|Screening Phase|Death|0|||
37983984|NCT00307125|69670189|FG000|Screening Phase|Withdrawal by Subject|77|||
37983985|NCT00307125|69670190|FG001|Screening Phase|Withdrawal by Subject|0|||
37983986|NCT00307125|69670191|FG002|Screening Phase|Withdrawal by Subject|0|||
37983987|NCT00307125|69670189|FG000|Screening Phase|Physician Decision|26|||
37983988|NCT00307125|69670190|FG001|Screening Phase|Physician Decision|0|||
37983989|NCT00307125|69670191|FG002|Screening Phase|Physician Decision|0|||
37983990|NCT00307125|69670189|FG000|Screening Phase|Sponsor Decision|4|||
37983991|NCT00307125|69670190|FG001|Screening Phase|Sponsor Decision|0|||
37983992|NCT00307125|69670191|FG002|Screening Phase|Sponsor Decision|0|||
37983993|NCT00307125|69670189|FG000|Screening Phase|Study Terminated|17|||
37983994|NCT00307125|69670190|FG001|Screening Phase|Study Terminated|0|||
37983995|NCT00307125|69670191|FG002|Screening Phase|Study Terminated|0|||
37983996|NCT00307125|69670189|FG000|Screening Phase|Graft Loss|3|||
37983997|NCT00307125|69670190|FG001|Screening Phase|Graft Loss|0|||
37983998|NCT00307125|69670191|FG002|Screening Phase|Graft Loss|0|||
37983999|NCT00307125|69670189|FG000|Screening Phase|Graft Failure|8|||
37984000|NCT00307125|69670190|FG001|Screening Phase|Graft Failure|0|||
37984001|NCT00307125|69670191|FG002|Screening Phase|Graft Failure|0|||
37984002|NCT00307125|69670189|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
37984003|NCT00307125|69670190|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
37984004|NCT00307125|69670191|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
37984005|NCT00307125|69670189|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
37984006|NCT00307125|69670190|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
37984007|NCT00307125|69670191|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
37984008|NCT00307125|69670189|FG000|Screening Phase|Moved or transferred facilities|34|||
37984009|NCT00307125|69670190|FG001|Screening Phase|Moved or transferred facilities|0|||
37984010|NCT00307125|69670191|FG002|Screening Phase|Moved or transferred facilities|0|||
37984011|NCT00307125|69670189|FG000|Screening Phase|Received Pancreas Transplant|8|||
37879392|NCT01042392|69563708|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
37879393|NCT01042392|69563709|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
37879394|NCT01042392|69563710|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
37879395|NCT01042392|69563707|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
37879396|NCT01042392|69563708|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
37879397|NCT01042392|69563709|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
37879398|NCT01042392|69563710|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
37879399|NCT01042392|69563707|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
37879400|NCT01042392|69563708|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
37984012|NCT00307125|69670190|FG001|Screening Phase|Received Pancreas Transplant|0|||
37984013|NCT00307125|69670191|FG002|Screening Phase|Received Pancreas Transplant|0|||
37984014|NCT00307125|69670189|FG000|Screening Phase|Ineligible for pilot|4|||
37984015|NCT00307125|69670190|FG001|Screening Phase|Ineligible for pilot|0|||
37984016|NCT00307125|69670191|FG002|Screening Phase|Ineligible for pilot|0|||
37984017|NCT00307125|69670189|FG000|Screening Phase|Try to get pregnant|1|||
37984018|NCT00307125|69670190|FG001|Screening Phase|Try to get pregnant|0|||
37984019|NCT00307125|69670191|FG002|Screening Phase|Try to get pregnant|0|||
37984020|NCT00307125|69670189|FG000|Screening Phase|Developed acute leukemia|1|||
37984021|NCT00307125|69670190|FG001|Screening Phase|Developed acute leukemia|0|||
37819179|NCT02824198|69498327|FG000|Overall Study|Lost to Follow-up|5|||
37879401|NCT01042392|69563709|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
37879402|NCT01042392|69563710|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
37879403|NCT01042392|69563707|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
37879404|NCT01042392|69563708|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
37879405|NCT01042392|69563709|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
37879406|NCT01042392|69563710|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
37879407|NCT01042392|69563707|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
37879408|NCT01042392|69563708|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
37879409|NCT01042392|69563709|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
37879410|NCT01042392|69563710|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
37879411|NCT01042392|69563707|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
37879412|NCT01042392|69563708|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
37879413|NCT01042392|69563709|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
37879414|NCT01042392|69563710|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
37879415|NCT01064310|69563724|FG000|Period 1|Adverse Event|7|||
37879416|NCT01064310|69563725|FG001|Period 1|Adverse Event|10|||
37984022|NCT00307125|69670191|FG002|Screening Phase|Developed acute leukemia|0|||
37984023|NCT00307125|69670189|FG000|Screening Phase|Metastatic colon cancer|1|||
37695217|NCT02349295|69171760|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
37695218|NCT02349295|69171761|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
37695219|NCT02349295|69171762|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
37819180|NCT02824198|69498328|FG001|Overall Study|Lost to Follow-up|2|||
37819181|NCT02824198|69498327|FG000|Overall Study|Withdrawal by Subject|5|||
37819182|NCT02824198|69498328|FG001|Overall Study|Withdrawal by Subject|0|||
37819183|NCT02787551|69498338|FG000|Core Period: 26 Weeks|Adverse Event|10|||
37819184|NCT02787551|69498339|FG001|Core Period: 26 Weeks|Adverse Event|0|||
37819185|NCT02787551|69498338|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
37819186|NCT02787551|69498339|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
37819187|NCT02787551|69498338|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
37819188|NCT02787551|69498339|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
37819189|NCT02787551|69498338|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
37819190|NCT02787551|69498339|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
37819191|NCT02787551|69498338|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
37819192|NCT02787551|69498339|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
37819193|NCT02787551|69498338|FG000|Core Period: 26 Weeks|Other than specified|3|||
37819194|NCT02787551|69498339|FG001|Core Period: 26 Weeks|Other than specified|1|||
37819195|NCT02787551|69498338|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
37819196|NCT02787551|69498339|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
37819197|NCT02787551|69498338|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
37819198|NCT02787551|69498339|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
37819199|NCT02787551|69498338|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
37819200|NCT02787551|69498339|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
37819201|NCT02735044|69498359|FG000|Overall Study|Adverse Event|3|||
37819202|NCT02735044|69498360|FG001|Overall Study|Adverse Event|3|||
37819203|NCT02735044|69498359|FG000|Overall Study|Lack of Efficacy|1|||
37819204|NCT02735044|69498360|FG001|Overall Study|Lack of Efficacy|0|||
37819205|NCT02735044|69498359|FG000|Overall Study|Poor compliance to protocol|7|||
37819206|NCT02735044|69498360|FG001|Overall Study|Poor compliance to protocol|7|||
37819207|NCT02735044|69498359|FG000|Overall Study|Randomized and not treated|0|||
37819208|NCT02735044|69498360|FG001|Overall Study|Randomized and not treated|2|||
37819209|NCT02735044|69498359|FG000|Overall Study|Other, not specified above|5|||
37819210|NCT02735044|69498360|FG001|Overall Study|Other, not specified above|11|||
37819211|NCT02720744|69498368|FG000|Overall Study|Protocol Violation|0|||
37819212|NCT02720744|69498369|FG001|Overall Study|Protocol Violation|2|||
37879417|NCT01064310|69563726|FG002|Period 1|Adverse Event|0|||
37695220|NCT02349295|69171749|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
37879418|NCT01064310|69563724|FG000|Period 1|Physician Decision|1|||
37879419|NCT01064310|69563725|FG001|Period 1|Physician Decision|0|||
37879420|NCT01064310|69563726|FG002|Period 1|Physician Decision|0|||
37879421|NCT01064310|69563724|FG000|Period 1|Withdrawal by Subject|2|||
37879422|NCT01064310|69563725|FG001|Period 1|Withdrawal by Subject|2|||
37879423|NCT01064310|69563726|FG002|Period 1|Withdrawal by Subject|0|||
37879424|NCT01064310|69563724|FG000|Period 1|Lack of Efficacy|3|||
37879425|NCT01064310|69563725|FG001|Period 1|Lack of Efficacy|5|||
37879426|NCT01064310|69563726|FG002|Period 1|Lack of Efficacy|0|||
37879427|NCT01064310|69563724|FG000|Period 1|Entered Open-label Period|1|||
37879428|NCT01064310|69563725|FG001|Period 1|Entered Open-label Period|1|||
37879429|NCT01064310|69563726|FG002|Period 1|Entered Open-label Period|0|||
37879430|NCT01064310|69563724|FG000|Period 2|Adverse Event|2|||
37879431|NCT01064310|69563725|FG001|Period 2|Adverse Event|1|||
37879432|NCT01064310|69563726|FG002|Period 2|Adverse Event|0|||
37879433|NCT01064310|69563724|FG000|Period 2|Physician Decision|0|||
37879434|NCT01064310|69563725|FG001|Period 2|Physician Decision|1|||
37879435|NCT01064310|69563726|FG002|Period 2|Physician Decision|0|||
37879436|NCT01064310|69563724|FG000|Period 2|Entered Open-label Period|1|||
37879437|NCT01064310|69563725|FG001|Period 2|Entered Open-label Period|0|||
37879438|NCT01064310|69563726|FG002|Period 2|Entered Open-label Period|0|||
37879439|NCT01064310|69563724|FG000|Period 2|Lack of Efficacy|1|||
37879440|NCT01064310|69563725|FG001|Period 2|Lack of Efficacy|4|||
37879441|NCT01064310|69563726|FG002|Period 2|Lack of Efficacy|0|||
37879442|NCT01064310|69563724|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
37879443|NCT01064310|69563725|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
37879444|NCT01064310|69563726|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
37879445|NCT01064310|69563724|FG000|Open Label Pazopinib|Adverse Event|0|||
37879446|NCT01064310|69563725|FG001|Open Label Pazopinib|Adverse Event|0|||
37879447|NCT01064310|69563726|FG002|Open Label Pazopinib|Adverse Event|12|||
37879448|NCT01064310|69563724|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
37879449|NCT01064310|69563725|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
37879450|NCT01064310|69563726|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
37879451|NCT01064310|69563724|FG000|Open Label Pazopinib|Physician Decision|0|||
37879452|NCT01064310|69563725|FG001|Open Label Pazopinib|Physician Decision|0|||
37879453|NCT01064310|69563726|FG002|Open Label Pazopinib|Physician Decision|20|||
37879454|NCT01037244|69563739|FG000|Overall Study|Adverse Event|3|||
37879455|NCT01037244|69563740|FG001|Overall Study|Adverse Event|2|||
37879456|NCT01037244|69563741|FG002|Overall Study|Adverse Event|6|||
37879457|NCT01037244|69563742|FG003|Overall Study|Adverse Event|3|||
37879458|NCT01037244|69563739|FG000|Overall Study|Lack of Efficacy|1|||
37879459|NCT01037244|69563740|FG001|Overall Study|Lack of Efficacy|1|||
37879460|NCT01037244|69563741|FG002|Overall Study|Lack of Efficacy|0|||
37879461|NCT01037244|69563742|FG003|Overall Study|Lack of Efficacy|1|||
37879462|NCT01037244|69563739|FG000|Overall Study|Lost to Follow-up|3|||
37879463|NCT01037244|69563740|FG001|Overall Study|Lost to Follow-up|3|||
37879464|NCT01037244|69563741|FG002|Overall Study|Lost to Follow-up|4|||
37984024|NCT00307125|69670190|FG001|Screening Phase|Metastatic colon cancer|0|||
37984025|NCT00307125|69670191|FG002|Screening Phase|Metastatic colon cancer|0|||
37984026|NCT00307125|69670189|FG000|Screening Phase|Malignancy|1|||
37984027|NCT00307125|69670190|FG001|Screening Phase|Malignancy|0|||
37879465|NCT01037244|69563742|FG003|Overall Study|Lost to Follow-up|4|||
37879466|NCT01037244|69563739|FG000|Overall Study|Withdrawal by Subject|1|||
37879467|NCT01037244|69563740|FG001|Overall Study|Withdrawal by Subject|5|||
37879468|NCT01037244|69563741|FG002|Overall Study|Withdrawal by Subject|3|||
37879469|NCT01037244|69563742|FG003|Overall Study|Withdrawal by Subject|5|||
37879470|NCT01037244|69563739|FG000|Overall Study|Partner Withdrew Consent|2|||
37879471|NCT01037244|69563740|FG001|Overall Study|Partner Withdrew Consent|1|||
37879472|NCT01037244|69563741|FG002|Overall Study|Partner Withdrew Consent|0|||
37984028|NCT00307125|69670191|FG002|Screening Phase|Malignancy|0|||
37879473|NCT01037244|69563742|FG003|Overall Study|Partner Withdrew Consent|0|||
37879474|NCT01037244|69563739|FG000|Overall Study|Various|3|||
37879475|NCT01037244|69563740|FG001|Overall Study|Various|2|||
37879476|NCT01037244|69563741|FG002|Overall Study|Various|1|||
37879477|NCT01037244|69563742|FG003|Overall Study|Various|1|||
37879478|NCT00833989|69563756|FG000|Overall Study|Physician Decision|0|||
37879479|NCT00833989|69563757|FG001|Overall Study|Physician Decision|0|||
37879480|NCT00833989|69563758|FG002|Overall Study|Physician Decision|0|||
37879481|NCT00833989|69563759|FG003|Overall Study|Physician Decision|1|||
37879482|NCT00833989|69563756|FG000|Overall Study|Withdrawal by Subject|3|||
37879483|NCT00833989|69563757|FG001|Overall Study|Withdrawal by Subject|0|||
37879484|NCT00833989|69563758|FG002|Overall Study|Withdrawal by Subject|1|||
37879485|NCT00833989|69563759|FG003|Overall Study|Withdrawal by Subject|1|||
37879486|NCT01037088|69563772|FG000|Overall Study|Withdrawal by Subject|3|||
37879487|NCT01042236|69563781|FG000|Treatment Period 1|Adverse Event|0|||
37879488|NCT01042236|69563782|FG001|Treatment Period 1|Adverse Event|1|||
37879489|NCT01042236|69563783|FG002|Treatment Period 1|Adverse Event|0|||
37879490|NCT01042236|69563784|FG003|Treatment Period 1|Adverse Event|0|||
37879491|NCT01042236|69563785|FG004|Treatment Period 1|Adverse Event|1|||
37879492|NCT01042236|69563786|FG005|Treatment Period 1|Adverse Event|0|||
37879493|NCT01042236|69563781|FG000|Treatment Period 3|Adverse Event|0|||
37879494|NCT01042236|69563782|FG001|Treatment Period 3|Adverse Event|0|||
37879495|NCT01042236|69563783|FG002|Treatment Period 3|Adverse Event|0|||
37879496|NCT01042236|69563784|FG003|Treatment Period 3|Adverse Event|1|||
37879497|NCT01042236|69563785|FG004|Treatment Period 3|Adverse Event|0|||
37879498|NCT01042236|69563786|FG005|Treatment Period 3|Adverse Event|0|||
37984029|NCT00307125|69670189|FG000|Screening Phase|PAK|1|||
37984030|NCT00307125|69670190|FG001|Screening Phase|PAK|0|||
37984031|NCT00307125|69670191|FG002|Screening Phase|PAK|0|||
37984032|NCT00307125|69670189|FG000|Screening Phase|Ineligible|1|||
37984033|NCT00307125|69670190|FG001|Screening Phase|Ineligible|0|||
37984034|NCT00307125|69670191|FG002|Screening Phase|Ineligible|0|||
37984035|NCT00307125|69670189|FG000|Screening Phase|Screen Error|1|||
37984036|NCT00307125|69670190|FG001|Screening Phase|Screen Error|0|||
37984037|NCT00307125|69670191|FG002|Screening Phase|Screen Error|0|||
37984038|NCT00307125|69670189|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
37984039|NCT00307125|69670190|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
37984040|NCT00307125|69670191|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
37819213|NCT02720744|69498368|FG000|Overall Study|Pregnancy|2|||
37819214|NCT02720744|69498369|FG001|Overall Study|Pregnancy|0|||
37819215|NCT02720744|69498368|FG000|Overall Study|Lack of Efficacy|2|||
37819216|NCT02720744|69498369|FG001|Overall Study|Lack of Efficacy|8|||
37819217|NCT02720744|69498368|FG000|Overall Study|Adverse Event|21|||
37819218|NCT02720744|69498369|FG001|Overall Study|Adverse Event|3|||
37819219|NCT02720744|69498368|FG000|Overall Study|Withdrawal by Subject|11|||
37819220|NCT02720744|69498369|FG001|Overall Study|Withdrawal by Subject|11|||
37819221|NCT02720744|69498368|FG000|Overall Study|Lost to follow up|2|||
37819222|NCT02720744|69498369|FG001|Overall Study|Lost to follow up|0|||
37879499|NCT01042236|69563781|FG000|Treatment Period 3|Protocol Violation|0|||
37879500|NCT01042236|69563782|FG001|Treatment Period 3|Protocol Violation|0|||
37833583|NCT01262989|69517312|FG000|Period 1|Intercurrent disease|0|||
37879501|NCT01042236|69563783|FG002|Treatment Period 3|Protocol Violation|0|||
37879502|NCT01042236|69563784|FG003|Treatment Period 3|Protocol Violation|1|||
37879503|NCT01042236|69563785|FG004|Treatment Period 3|Protocol Violation|0|||
37879504|NCT01042236|69563786|FG005|Treatment Period 3|Protocol Violation|0|||
37879505|NCT00592501|69563794|FG000|Overall Study|Withdrawal by Subject|1|||
37879506|NCT00592501|69563794|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
37879507|NCT01040832|69563800|FG000|Overall Study|Adverse Event|4|||
37879508|NCT01040832|69563801|FG001|Overall Study|Adverse Event|5|||
37879509|NCT01040832|69563800|FG000|Overall Study|Death|4|||
37879510|NCT01040832|69563801|FG001|Overall Study|Death|6|||
37879511|NCT01040832|69563800|FG000|Overall Study|Withdrawal by Subject|2|||
37879512|NCT01040832|69563801|FG001|Overall Study|Withdrawal by Subject|3|||
37879513|NCT01040832|69563800|FG000|Overall Study|Progressive disease|32|||
37879514|NCT01040832|69563801|FG001|Overall Study|Progressive disease|17|||
37879515|NCT01040832|69563800|FG000|Overall Study|Symptomatic deterioration|2|||
37879516|NCT01040832|69563801|FG001|Overall Study|Symptomatic deterioration|5|||
37879517|NCT01040832|69563800|FG000|Overall Study|Other|2|||
37879518|NCT01040832|69563801|FG001|Overall Study|Other|1|||
37879519|NCT00854581|69563807|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
37879520|NCT00854581|69563807|FG000|Induction (Up to Day 21)|Death|1|||
37879521|NCT00854581|69563807|FG000|Induction (Up to Day 21)|Physician Decision|1|||
37879522|NCT00854581|69563807|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
37879523|NCT00833911|69563816|FG000|Titration|Adverse Event|18|||
37879524|NCT00833911|69563816|FG000|Titration|Withdrawal by Subject|3|||
37879525|NCT00833911|69563816|FG000|Maintenance Phase I|Adverse Event|73|||
37879526|NCT00833911|69563816|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
37879527|NCT00833911|69563816|FG000|Maintenance Phase I|Physician Decision|10|||
37879528|NCT00833911|69563816|FG000|Maintenance Phase I|Lack of Efficacy|4|||
37879529|NCT00833911|69563816|FG000|Maintenance Phase II|Adverse Event|6|||
37984041|NCT00307125|69670189|FG000|Screening Phase|AMR and treated with rituximab|1|||
37695221|NCT02349295|69171750|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
37695222|NCT02349295|69171751|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
37695223|NCT02349295|69171752|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
37879530|NCT00833911|69563816|FG000|Maintenance Phase II|Physician Decision|2|||
37879531|NCT00833911|69563816|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
37879532|NCT00833911|69563816|FG000|Maintenance Phase II|Lack of Efficacy|1|||
37879533|NCT01125293|69563830|FG000|Overall Study|Disease Progression|1|||
37879534|NCT01125293|69563831|FG001|Overall Study|Disease Progression|3|||
37879535|NCT01125293|69563832|FG002|Overall Study|Disease Progression|4|||
37879536|NCT01125293|69563833|FG003|Overall Study|Disease Progression|3|||
37879537|NCT01125293|69563834|FG004|Overall Study|Disease Progression|5|||
37879538|NCT01125293|69563835|FG005|Overall Study|Disease Progression|12|||
37879539|NCT01125293|69563830|FG000|Overall Study|Adverse Event|1|||
37879540|NCT01125293|69563831|FG001|Overall Study|Adverse Event|0|||
37879541|NCT01125293|69563832|FG002|Overall Study|Adverse Event|0|||
37879542|NCT01125293|69563833|FG003|Overall Study|Adverse Event|0|||
37879543|NCT01125293|69563834|FG004|Overall Study|Adverse Event|2|||
37879544|NCT01125293|69563835|FG005|Overall Study|Adverse Event|8|||
37879545|NCT01125293|69563830|FG000|Overall Study|Symptomatic Deterioration|1|||
37879546|NCT01125293|69563831|FG001|Overall Study|Symptomatic Deterioration|0|||
37695224|NCT02349295|69171753|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
37695225|NCT02349295|69171754|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
37695226|NCT02349295|69171755|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
37695227|NCT02349295|69171756|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
37695228|NCT02349295|69171757|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
37695229|NCT02349295|69171758|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
37695230|NCT02349295|69171759|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
37819223|NCT02720744|69498368|FG000|Overall Study|Non Compliance with Investigational Product|0|||
37819224|NCT02720744|69498369|FG001|Overall Study|Non Compliance with Investigational Product|1|||
37819225|NCT02720744|69498368|FG000|Overall Study|Excluded Concomitant Medication|0|||
37819226|NCT02720744|69498369|FG001|Overall Study|Excluded Concomitant Medication|1|||
37819227|NCT02692651|69498377|FG000|Study Treatment|Death|7|||
37819228|NCT02692651|69498378|FG001|Study Treatment|Death|3|||
37819229|NCT02692651|69498377|FG000|Study Treatment|comfort care|1|||
37819230|NCT02692651|69498378|FG001|Study Treatment|comfort care|1|||
37819231|NCT02692651|69498377|FG000|Study Treatment|Protocol violation per treating team preference|8|||
37879547|NCT01125293|69563832|FG002|Overall Study|Symptomatic Deterioration|0|||
37879548|NCT01125293|69563833|FG003|Overall Study|Symptomatic Deterioration|0|||
37879549|NCT01125293|69563834|FG004|Overall Study|Symptomatic Deterioration|0|||
37879550|NCT01125293|69563835|FG005|Overall Study|Symptomatic Deterioration|0|||
37879551|NCT01125293|69563830|FG000|Overall Study|Death|0|||
37879552|NCT01125293|69563831|FG001|Overall Study|Death|0|||
37879553|NCT01125293|69563832|FG002|Overall Study|Death|0|||
37879554|NCT01125293|69563833|FG003|Overall Study|Death|0|||
37879555|NCT01125293|69563834|FG004|Overall Study|Death|1|||
37879556|NCT01125293|69563835|FG005|Overall Study|Death|0|||
37984042|NCT00307125|69670190|FG001|Screening Phase|AMR and treated with rituximab|0|||
37984043|NCT00307125|69670191|FG002|Screening Phase|AMR and treated with rituximab|0|||
37984044|NCT00307125|69670189|FG000|Screening Phase|Coronary artery bypass|1|||
37984045|NCT00307125|69670190|FG001|Screening Phase|Coronary artery bypass|0|||
37984046|NCT00307125|69670191|FG002|Screening Phase|Coronary artery bypass|0|||
37984047|NCT00307125|69670189|FG000|Pilot Phase|Lost to Follow-up|0|||
37984048|NCT00307125|69670190|FG001|Pilot Phase|Lost to Follow-up|1|||
37984049|NCT00307125|69670191|FG002|Pilot Phase|Lost to Follow-up|0|||
37984050|NCT00307125|69670189|FG000|Pilot Phase|Withdrawal by Subject|0|||
37984051|NCT00307125|69670190|FG001|Pilot Phase|Withdrawal by Subject|1|||
37984052|NCT00307125|69670191|FG002|Pilot Phase|Withdrawal by Subject|1|||
37819232|NCT02692651|69498378|FG001|Study Treatment|Protocol violation per treating team preference|6|||
37819233|NCT02692651|69498377|FG000|Post Study Treatment Follow-up|Death|4|||
37819234|NCT02692651|69498378|FG001|Post Study Treatment Follow-up|Death|4|||
37819235|NCT02686658|69498390|FG000|Overall Study|Adverse Event|0|||
37819236|NCT02686658|69498391|FG001|Overall Study|Adverse Event|0|||
37819237|NCT02686658|69498392|FG002|Overall Study|Adverse Event|1|||
37819238|NCT02686658|69498393|FG003|Overall Study|Adverse Event|1|||
37819239|NCT02686658|69498394|FG004|Overall Study|Adverse Event|2|||
37819240|NCT02686658|69498395|FG005|Overall Study|Adverse Event|1|||
37819241|NCT02686658|69498390|FG000|Overall Study|Investigator decision|0|||
37819242|NCT02686658|69498391|FG001|Overall Study|Investigator decision|0|||
37819243|NCT02686658|69498392|FG002|Overall Study|Investigator decision|0|||
37819244|NCT02686658|69498393|FG003|Overall Study|Investigator decision|1|||
37819245|NCT02686658|69498394|FG004|Overall Study|Investigator decision|2|||
37819246|NCT02686658|69498395|FG005|Overall Study|Investigator decision|1|||
37819247|NCT02686658|69498390|FG000|Overall Study|Sponsor decision|1|||
37819248|NCT02686658|69498391|FG001|Overall Study|Sponsor decision|2|||
37819249|NCT02686658|69498392|FG002|Overall Study|Sponsor decision|1|||
37819250|NCT02686658|69498393|FG003|Overall Study|Sponsor decision|5|||
37819251|NCT02686658|69498394|FG004|Overall Study|Sponsor decision|13|||
37819252|NCT02686658|69498395|FG005|Overall Study|Sponsor decision|2|||
37819253|NCT02686658|69498390|FG000|Overall Study|Lost to Follow-up|0|||
37819254|NCT02686658|69498391|FG001|Overall Study|Lost to Follow-up|0|||
37819255|NCT02686658|69498392|FG002|Overall Study|Lost to Follow-up|2|||
37819256|NCT02686658|69498393|FG003|Overall Study|Lost to Follow-up|0|||
37819257|NCT02686658|69498394|FG004|Overall Study|Lost to Follow-up|0|||
37819258|NCT02686658|69498395|FG005|Overall Study|Lost to Follow-up|1|||
37819259|NCT02686658|69498390|FG000|Overall Study|Death|1|||
37819260|NCT02686658|69498391|FG001|Overall Study|Death|0|||
37819261|NCT02686658|69498392|FG002|Overall Study|Death|0|||
37819262|NCT02686658|69498393|FG003|Overall Study|Death|1|||
37819263|NCT02686658|69498394|FG004|Overall Study|Death|1|||
37819264|NCT02686658|69498395|FG005|Overall Study|Death|1|||
37819265|NCT02686658|69498390|FG000|Overall Study|Withdrawal by Subject|2|||
37819266|NCT02686658|69498391|FG001|Overall Study|Withdrawal by Subject|5|||
37819267|NCT02686658|69498392|FG002|Overall Study|Withdrawal by Subject|4|||
37819268|NCT02686658|69498393|FG003|Overall Study|Withdrawal by Subject|4|||
37819269|NCT02686658|69498394|FG004|Overall Study|Withdrawal by Subject|17|||
37819270|NCT02686658|69498395|FG005|Overall Study|Withdrawal by Subject|8|||
37819271|NCT02686658|69498390|FG000|Overall Study|Placed in hospice care|0|||
37819272|NCT02686658|69498391|FG001|Overall Study|Placed in hospice care|0|||
37819273|NCT02686658|69498392|FG002|Overall Study|Placed in hospice care|1|||
37819274|NCT02686658|69498393|FG003|Overall Study|Placed in hospice care|0|||
37819275|NCT02686658|69498394|FG004|Overall Study|Placed in hospice care|0|||
37819276|NCT02686658|69498395|FG005|Overall Study|Placed in hospice care|0|||
37819277|NCT02686658|69498390|FG000|Overall Study|Participant non-compliance|0|||
37819278|NCT02686658|69498391|FG001|Overall Study|Participant non-compliance|0|||
37819279|NCT02686658|69498392|FG002|Overall Study|Participant non-compliance|0|||
37819280|NCT02686658|69498393|FG003|Overall Study|Participant non-compliance|0|||
37819281|NCT02686658|69498394|FG004|Overall Study|Participant non-compliance|0|||
37819282|NCT02686658|69498395|FG005|Overall Study|Participant non-compliance|1|||
37819283|NCT02686658|69498390|FG000|Overall Study|Concern over coronavirus disease care|0|||
37819284|NCT02686658|69498391|FG001|Overall Study|Concern over coronavirus disease care|0|||
37819285|NCT02686658|69498392|FG002|Overall Study|Concern over coronavirus disease care|0|||
37819286|NCT02686658|69498393|FG003|Overall Study|Concern over coronavirus disease care|0|||
37819287|NCT02686658|69498394|FG004|Overall Study|Concern over coronavirus disease care|2|||
37819288|NCT02686658|69498395|FG005|Overall Study|Concern over coronavirus disease care|1|||
37819289|NCT02674061|69498411|FG000|Overall Study|Death|229|||
37819290|NCT02674061|69498412|FG001|Overall Study|Death|77|||
37819291|NCT02674061|69498411|FG000|Overall Study|Lost to Follow-up|3|||
37819292|NCT02674061|69498412|FG001|Overall Study|Lost to Follow-up|3|||
37819293|NCT02674061|69498411|FG000|Overall Study|Withdrawal by Subject|9|||
37984053|NCT00307047|69670203|FG000|Overall Study|Lost to Follow-up|35|||
37819294|NCT02674061|69498412|FG001|Overall Study|Withdrawal by Subject|1|||
37819295|NCT02674061|69498411|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
37984054|NCT00307047|69670204|FG001|Overall Study|Lost to Follow-up|24|||
37879557|NCT01125293|69563830|FG000|Overall Study|Withdrawal by Subject|0|||
37879558|NCT01125293|69563831|FG001|Overall Study|Withdrawal by Subject|0|||
37879559|NCT01125293|69563832|FG002|Overall Study|Withdrawal by Subject|0|||
37879560|NCT01125293|69563833|FG003|Overall Study|Withdrawal by Subject|0|||
37879561|NCT01125293|69563834|FG004|Overall Study|Withdrawal by Subject|2|||
37879562|NCT01125293|69563835|FG005|Overall Study|Withdrawal by Subject|1|||
37879563|NCT01125293|69563830|FG000|Overall Study|Physician Decision|0|||
37879564|NCT01125293|69563831|FG001|Overall Study|Physician Decision|0|||
37879565|NCT01125293|69563832|FG002|Overall Study|Physician Decision|0|||
37879566|NCT01125293|69563833|FG003|Overall Study|Physician Decision|0|||
37879567|NCT01125293|69563834|FG004|Overall Study|Physician Decision|0|||
37879568|NCT01125293|69563835|FG005|Overall Study|Physician Decision|2|||
37879569|NCT01121393|69563854|FG000|Overall Study|Progressive disease|201|||
37879570|NCT01121393|69563855|FG001|Overall Study|Progressive disease|20|||
37879571|NCT01121393|69563854|FG000|Overall Study|Other Adverse events|24|||
37879572|NCT01121393|69563855|FG001|Overall Study|Other Adverse events|45|||
37879573|NCT01121393|69563854|FG000|Overall Study|Non-compliant with protocol|0|||
37879574|NCT01121393|69563855|FG001|Overall Study|Non-compliant with protocol|3|||
37879575|NCT01121393|69563854|FG000|Overall Study|Lost to Follow-up|1|||
37879576|NCT01121393|69563855|FG001|Overall Study|Lost to Follow-up|0|||
37879577|NCT01121393|69563854|FG000|Overall Study|Refused cont. medication|7|||
37879578|NCT01121393|69563855|FG001|Overall Study|Refused cont. medication|7|||
37879579|NCT01121393|69563854|FG000|Overall Study|Not treated|3|||
37879580|NCT01121393|69563855|FG001|Overall Study|Not treated|9|||
37879581|NCT01121393|69563854|FG000|Overall Study|Other than listed|6|||
37879582|NCT01121393|69563855|FG001|Overall Study|Other than listed|0|||
37879583|NCT00937521|69563902|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
37879584|NCT00937521|69563903|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
37879585|NCT00937521|69563904|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
37879586|NCT00937521|69563905|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
37879587|NCT00937521|69563906|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
37879588|NCT00937521|69563907|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
37879589|NCT00937521|69563908|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
37879590|NCT00937521|69563909|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
37879591|NCT00937521|69563902|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
37879592|NCT00937521|69563903|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
37879593|NCT00937521|69563904|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
37879594|NCT00937521|69563905|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
37879595|NCT00937521|69563906|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
37879596|NCT00937521|69563907|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
37879597|NCT00937521|69563908|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
37879598|NCT00937521|69563909|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
37879599|NCT00937521|69563902|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
37984055|NCT00307047|69670203|FG000|Overall Study|Withdrawal by Subject|6|||
37984056|NCT00307047|69670204|FG001|Overall Study|Withdrawal by Subject|6|||
37984057|NCT00307047|69670203|FG000|Overall Study|Physician Decision|1|||
37984058|NCT00307047|69670204|FG001|Overall Study|Physician Decision|2|||
37984059|NCT00307047|69670203|FG000|Overall Study|Lost to follow-up for other reasons|0|||
37984060|NCT00307047|69670204|FG001|Overall Study|Lost to follow-up for other reasons|1|||
37984061|NCT00307047|69670203|FG000|Overall Study|All death, all MI, all Revascularization|27|||
37984062|NCT00307047|69670204|FG001|Overall Study|All death, all MI, all Revascularization|16|||
37984063|NCT00306891|69670214|FG000|Part A|Withdrawal by Subject|1|||
37984064|NCT00306891|69670215|FG001|Part A|Withdrawal by Subject|1|||
37984065|NCT00306891|69670216|FG002|Part A|Withdrawal by Subject|0|||
37984066|NCT00306891|69670217|FG003|Part A|Withdrawal by Subject|0|||
37984067|NCT00306891|69670214|FG000|Part A|Condition under investigation worsened|2|||
37984068|NCT00306891|69670215|FG001|Part A|Condition under investigation worsened|2|||
37984069|NCT00306891|69670216|FG002|Part A|Condition under investigation worsened|0|||
37984070|NCT00306891|69670217|FG003|Part A|Condition under investigation worsened|0|||
37984071|NCT00306891|69670214|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
37984072|NCT00306891|69670215|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
37984073|NCT00306891|69670216|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
37984074|NCT00306891|69670217|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
37984075|NCT00306891|69670214|FG000|Part A|Partial bowel obstruction|1|||
37984076|NCT00306891|69670215|FG001|Part A|Partial bowel obstruction|0|||
37984077|NCT00306891|69670216|FG002|Part A|Partial bowel obstruction|0|||
37879600|NCT00937521|69563903|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
37879601|NCT00937521|69563904|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
37879602|NCT00937521|69563905|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
37984078|NCT00306891|69670217|FG003|Part A|Partial bowel obstruction|0|||
37984079|NCT00306891|69670214|FG000|Part A|Reaccumul. of ascites following drainage|0|||
37984080|NCT00306891|69670215|FG001|Part A|Reaccumul. of ascites following drainage|1|||
37984081|NCT00306891|69670216|FG002|Part A|Reaccumul. of ascites following drainage|0|||
37984082|NCT00306891|69670217|FG003|Part A|Reaccumul. of ascites following drainage|0|||
37984083|NCT00306891|69670214|FG000|Part A|Suspicion of second malignancy|0|||
37984084|NCT00306891|69670215|FG001|Part A|Suspicion of second malignancy|1|||
37984085|NCT00306891|69670216|FG002|Part A|Suspicion of second malignancy|0|||
37984086|NCT00306891|69670217|FG003|Part A|Suspicion of second malignancy|0|||
37984087|NCT00306891|69670214|FG000|Part A|QTC interval outwith elig. criteria|1|||
37984088|NCT00306891|69670215|FG001|Part A|QTC interval outwith elig. criteria|0|||
37984089|NCT00306891|69670216|FG002|Part A|QTC interval outwith elig. criteria|0|||
37984090|NCT00306891|69670217|FG003|Part A|QTC interval outwith elig. criteria|0|||
37984091|NCT00306891|69670214|FG000|Part B|Death|0|||
37984092|NCT00306891|69670215|FG001|Part B|Death|0|||
37984093|NCT00306891|69670216|FG002|Part B|Death|1|||
37984094|NCT00306891|69670217|FG003|Part B|Death|2|||
37984095|NCT00306891|69670214|FG000|Part B|Adverse Event|0|||
37984096|NCT00306891|69670215|FG001|Part B|Adverse Event|0|||
37984097|NCT00306891|69670216|FG002|Part B|Adverse Event|5|||
37984098|NCT00306891|69670217|FG003|Part B|Adverse Event|5|||
37984099|NCT00306891|69670214|FG000|Part B|Withdrawal by Subject|0|||
37984100|NCT00306891|69670215|FG001|Part B|Withdrawal by Subject|0|||
37984101|NCT00306891|69670216|FG002|Part B|Withdrawal by Subject|3|||
37984102|NCT00306891|69670217|FG003|Part B|Withdrawal by Subject|1|||
37984103|NCT00306891|69670214|FG000|Part B|Condition under investigation worsened|0|||
37984104|NCT00306891|69670215|FG001|Part B|Condition under investigation worsened|0|||
37984105|NCT00306891|69670216|FG002|Part B|Condition under investigation worsened|2|||
37984106|NCT00306891|69670217|FG003|Part B|Condition under investigation worsened|8|||
37984107|NCT00306891|69670214|FG000|Part B|Development of study specific disc crit.|0|||
37984108|NCT00306891|69670215|FG001|Part B|Development of study specific disc crit.|0|||
37984109|NCT00306891|69670216|FG002|Part B|Development of study specific disc crit.|0|||
37984110|NCT00306891|69670217|FG003|Part B|Development of study specific disc crit.|1|||
37819296|NCT02674061|69498412|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
37819297|NCT02628444|69498432|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
37819298|NCT02628444|69498433|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
37819299|NCT02628444|69498434|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
37819300|NCT02628444|69498435|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
37819301|NCT02628444|69498436|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
37819302|NCT02628444|69498437|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
37819303|NCT02628444|69498438|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
37819304|NCT02628444|69498439|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
37819305|NCT02628444|69498440|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
37819306|NCT02628444|69498432|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
37819307|NCT02628444|69498433|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
37819308|NCT02628444|69498434|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
37819309|NCT02628444|69498435|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
37819310|NCT02628444|69498436|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
37819311|NCT02628444|69498437|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
37819312|NCT02628444|69498438|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
37819313|NCT02628444|69498439|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
37819314|NCT02628444|69498440|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
37819315|NCT02628444|69498432|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
37819316|NCT02628444|69498433|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
37819317|NCT02628444|69498434|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
37819318|NCT02628444|69498435|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
37819319|NCT02628444|69498436|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
37819320|NCT02628444|69498437|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
37819321|NCT02628444|69498438|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
37819322|NCT02628444|69498439|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
37819323|NCT02628444|69498440|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
37819324|NCT02628444|69498432|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
37984111|NCT00314145|69670230|FG000|Overall Study|Withdrawal by Subject|8|||
37984112|NCT00314145|69670231|FG001|Overall Study|Withdrawal by Subject|10|||
37984113|NCT00314145|69670230|FG000|Overall Study|Lost to Follow-up|5|||
37984114|NCT00314145|69670231|FG001|Overall Study|Lost to Follow-up|12|||
37879603|NCT00937521|69563906|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
37879604|NCT00937521|69563907|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
37879605|NCT00937521|69563908|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
37879606|NCT00937521|69563909|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
37879607|NCT00937521|69563902|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
37879608|NCT00937521|69563903|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
37879609|NCT00937521|69563904|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
37879610|NCT00937521|69563905|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
37879611|NCT00937521|69563906|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
37879612|NCT00937521|69563907|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
37879613|NCT00937521|69563908|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
37879614|NCT00937521|69563909|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
37879615|NCT00937521|69563902|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
37879616|NCT00937521|69563903|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
37879617|NCT00937521|69563904|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
37879618|NCT00937521|69563905|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
37879619|NCT00937521|69563906|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
37879620|NCT00937521|69563907|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
37879621|NCT00937521|69563908|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
37879622|NCT00937521|69563909|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
37879623|NCT00937521|69563902|FG000|Booster Phase|Adverse Event|0|||
37879624|NCT00937521|69563903|FG001|Booster Phase|Adverse Event|0|||
37879625|NCT00937521|69563904|FG002|Booster Phase|Adverse Event|0|||
37879626|NCT00937521|69563905|FG003|Booster Phase|Adverse Event|0|||
37879627|NCT00937521|69563906|FG004|Booster Phase|Adverse Event|0|||
37879628|NCT00937521|69563907|FG005|Booster Phase|Adverse Event|0|||
37879629|NCT00937521|69563908|FG006|Booster Phase|Adverse Event|1|||
37879630|NCT00937521|69563909|FG007|Booster Phase|Adverse Event|0|||
37879631|NCT00937521|69563902|FG000|Booster Phase|Withdrawal by Subject|1|||
37879632|NCT00937521|69563903|FG001|Booster Phase|Withdrawal by Subject|0|||
37879633|NCT00937521|69563904|FG002|Booster Phase|Withdrawal by Subject|0|||
37879634|NCT00937521|69563905|FG003|Booster Phase|Withdrawal by Subject|1|||
37879635|NCT00937521|69563906|FG004|Booster Phase|Withdrawal by Subject|0|||
37879636|NCT00937521|69563907|FG005|Booster Phase|Withdrawal by Subject|0|||
37879637|NCT00937521|69563908|FG006|Booster Phase|Withdrawal by Subject|0|||
37879638|NCT00937521|69563909|FG007|Booster Phase|Withdrawal by Subject|2|||
37879639|NCT00937521|69563902|FG000|Booster Phase|Lost to Follow-up|2|||
37879640|NCT00937521|69563903|FG001|Booster Phase|Lost to Follow-up|2|||
37879641|NCT00937521|69563904|FG002|Booster Phase|Lost to Follow-up|4|||
37879642|NCT00937521|69563905|FG003|Booster Phase|Lost to Follow-up|2|||
37879643|NCT00937521|69563906|FG004|Booster Phase|Lost to Follow-up|4|||
37879644|NCT00937521|69563907|FG005|Booster Phase|Lost to Follow-up|4|||
37879645|NCT00937521|69563908|FG006|Booster Phase|Lost to Follow-up|3|||
37879646|NCT00937521|69563909|FG007|Booster Phase|Lost to Follow-up|0|||
37879647|NCT00937521|69563902|FG000|Booster Phase|Administrative Reason|0|||
37879648|NCT00937521|69563903|FG001|Booster Phase|Administrative Reason|0|||
37879649|NCT00937521|69563904|FG002|Booster Phase|Administrative Reason|1|||
37879650|NCT00937521|69563905|FG003|Booster Phase|Administrative Reason|0|||
37984115|NCT00314145|69670230|FG000|Overall Study|Physician Decision|3|||
37984116|NCT00314145|69670231|FG001|Overall Study|Physician Decision|4|||
37984117|NCT00314145|69670230|FG000|Overall Study|Adverse Event|0|||
37984118|NCT00314145|69670231|FG001|Overall Study|Adverse Event|3|||
37984119|NCT00314145|69670230|FG000|Overall Study|Protocol Violation|3|||
37984120|NCT00314145|69670231|FG001|Overall Study|Protocol Violation|0|||
37984121|NCT00314145|69670230|FG000|Overall Study|Sponsor Decision|2|||
37984122|NCT00314145|69670231|FG001|Overall Study|Sponsor Decision|0|||
37984123|NCT00313911|69670240|FG000|Overall Study|Serious adverse event|6|||
37984124|NCT00313911|69670241|FG001|Overall Study|Serious adverse event|1|||
37984125|NCT00313911|69670240|FG000|Overall Study|Adverse Event|2|||
37984126|NCT00313911|69670241|FG001|Overall Study|Adverse Event|3|||
37984127|NCT00313911|69670240|FG000|Overall Study|Protocol Violation|19|||
37879651|NCT00937521|69563906|FG004|Booster Phase|Administrative Reason|1|||
37879652|NCT00937521|69563907|FG005|Booster Phase|Administrative Reason|1|||
37984128|NCT00313911|69670241|FG001|Overall Study|Protocol Violation|10|||
37879653|NCT00937521|69563908|FG006|Booster Phase|Administrative Reason|0|||
37879654|NCT00937521|69563909|FG007|Booster Phase|Administrative Reason|0|||
37879655|NCT00937521|69563902|FG000|Booster Phase|Protocol Deviation|0|||
37879656|NCT00937521|69563903|FG001|Booster Phase|Protocol Deviation|0|||
37879657|NCT00937521|69563904|FG002|Booster Phase|Protocol Deviation|0|||
37879658|NCT00937521|69563905|FG003|Booster Phase|Protocol Deviation|0|||
37984129|NCT00313911|69670240|FG000|Overall Study|Lost to Follow-up|27|||
37984130|NCT00313911|69670241|FG001|Overall Study|Lost to Follow-up|14|||
37984131|NCT00313911|69670240|FG000|Overall Study|Withdrawal by Subject|39|||
37984132|NCT00313911|69670241|FG001|Overall Study|Withdrawal by Subject|12|||
37984133|NCT00313911|69670240|FG000|Overall Study|Did not meet age criteria|1|||
37984134|NCT00313911|69670241|FG001|Overall Study|Did not meet age criteria|1|||
37984135|NCT00391872|69670249|FG000|Overall Study|Protocol Violation|7|||
37984136|NCT00391872|69670250|FG001|Overall Study|Protocol Violation|2|||
37984137|NCT00391872|69670249|FG000|Overall Study|Withdrawal by Subject|296|||
37984138|NCT00391872|69670250|FG001|Overall Study|Withdrawal by Subject|249|||
37984139|NCT00391872|69670249|FG000|Overall Study|Reason unknown|2|||
37984140|NCT00391872|69670250|FG001|Overall Study|Reason unknown|4|||
37984141|NCT00391872|69670249|FG000|Overall Study|Lost to Follow-up|2|||
37984142|NCT00391872|69670250|FG001|Overall Study|Lost to Follow-up|0|||
37984143|NCT00391170|69670258|FG000|Overall Study|Withdrawal by Subject|1|||
37984144|NCT00391170|69670259|FG001|Overall Study|Withdrawal by Subject|0|||
37984145|NCT00391170|69670258|FG000|Overall Study|Adverse Event|3|||
37984146|NCT00391170|69670259|FG001|Overall Study|Adverse Event|2|||
37984147|NCT00391170|69670258|FG000|Overall Study|Physician Decision|2|||
37984148|NCT00391170|69670259|FG001|Overall Study|Physician Decision|2|||
37984149|NCT00402324|69670267|FG000|Overall Study|Lost to Follow-up|11|||
37984150|NCT00402324|69670268|FG001|Overall Study|Lost to Follow-up|11|||
37984151|NCT00402324|69670267|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
37984152|NCT00402324|69670268|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
37984153|NCT00402324|69670267|FG000|Overall Study|Protocol Violation|8|||
37984154|NCT00402324|69670268|FG001|Overall Study|Protocol Violation|7|||
37984155|NCT00402324|69670267|FG000|Overall Study|Withdrawal by Subject|5|||
37984156|NCT00402324|69670268|FG001|Overall Study|Withdrawal by Subject|2|||
37984157|NCT00402324|69670267|FG000|Overall Study|Physician Decision|2|||
37984158|NCT00402324|69670268|FG001|Overall Study|Physician Decision|4|||
37984159|NCT00402324|69670267|FG000|Overall Study|Sponsor Decision|4|||
37984160|NCT00402324|69670268|FG001|Overall Study|Sponsor Decision|5|||
37984161|NCT00402324|69670267|FG000|Overall Study|Lack of Efficacy|1|||
37984162|NCT00402324|69670268|FG001|Overall Study|Lack of Efficacy|4|||
37984163|NCT00402324|69670267|FG000|Overall Study|Adverse Event|6|||
37984164|NCT00402324|69670268|FG001|Overall Study|Adverse Event|4|||
37984165|NCT00402324|69670267|FG000|Overall Study|Death|1|||
37984166|NCT00402324|69670268|FG001|Overall Study|Death|0|||
37984167|NCT00294723|69670277|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
37984168|NCT00294723|69670278|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
37984169|NCT00294723|69670279|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
37984170|NCT00294723|69670277|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
37984171|NCT00294723|69670278|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
37984172|NCT00294723|69670279|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
37984173|NCT00294723|69670277|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
37984174|NCT00294723|69670278|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
37984175|NCT00294723|69670279|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
37984176|NCT00294723|69670277|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
37984177|NCT00294723|69670278|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
37984178|NCT00294723|69670279|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
37984179|NCT00294723|69670277|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
37984180|NCT00294723|69670278|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
37984181|NCT00294723|69670279|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
37984182|NCT00294723|69670277|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
37879659|NCT00937521|69563906|FG004|Booster Phase|Protocol Deviation|0|||
37879660|NCT00937521|69563907|FG005|Booster Phase|Protocol Deviation|0|||
37879661|NCT00937521|69563908|FG006|Booster Phase|Protocol Deviation|1|||
37879662|NCT00937521|69563909|FG007|Booster Phase|Protocol Deviation|0|||
37879663|NCT00935883|69563944|FG000|Treatment Period|Physician Decision|1|||
37879664|NCT00935883|69563945|FG001|Treatment Period|Physician Decision|0|||
37879665|NCT00935883|69563944|FG000|Treatment Period|Withdrawal by Subject|0|||
37879666|NCT00935883|69563945|FG001|Treatment Period|Withdrawal by Subject|2|||
37879667|NCT00936975|69563951|FG000|Overall Study|Withdrawal by Subject|1|||
37879668|NCT00936975|69563951|FG000|Overall Study|Disease progression|3|||
37879669|NCT00936975|69563951|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
37879670|NCT00936897|69563958|FG000|Overall Study|Withdrawal by Subject|9|||
37879671|NCT00936897|69563959|FG001|Overall Study|Withdrawal by Subject|19|||
37984183|NCT00294723|69670278|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
37984184|NCT00294723|69670279|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
37984185|NCT00294723|69670277|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
37984186|NCT00294723|69670278|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
37984187|NCT00294723|69670279|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
37984188|NCT00294723|69670277|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
37879672|NCT00936897|69563958|FG000|Overall Study|Adverse Event|4|||
37879673|NCT00936897|69563959|FG001|Overall Study|Adverse Event|13|||
37984189|NCT00294723|69670278|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
37879674|NCT00936897|69563958|FG000|Overall Study|Other|3|||
37879675|NCT00936897|69563959|FG001|Overall Study|Other|9|||
37879676|NCT00936897|69563958|FG000|Overall Study|Lost to Follow-up|1|||
37879677|NCT00936897|69563959|FG001|Overall Study|Lost to Follow-up|10|||
37879678|NCT00936897|69563958|FG000|Overall Study|Administrative Decision|1|||
37879679|NCT00936897|69563959|FG001|Overall Study|Administrative Decision|2|||
37879680|NCT00936897|69563958|FG000|Overall Study|Protocol Violation|1|||
37879681|NCT00936897|69563959|FG001|Overall Study|Protocol Violation|1|||
37879682|NCT00936897|69563958|FG000|Overall Study|Ineligibility Determined|0|||
37879683|NCT00936897|69563959|FG001|Overall Study|Ineligibility Determined|3|||
37879684|NCT00936897|69563958|FG000|Overall Study|Noncompliance|0|||
37879685|NCT00936897|69563959|FG001|Overall Study|Noncompliance|2|||
37879686|NCT00936897|69563958|FG000|Overall Study|Death|0|||
37879687|NCT00936897|69563959|FG001|Overall Study|Death|1|||
37879688|NCT01120691|69563968|FG000|Overall Study|Adverse Event|59|||
37879689|NCT01120691|69563969|FG001|Overall Study|Adverse Event|67|||
37879690|NCT01120691|69563970|FG002|Overall Study|Adverse Event|47|||
37879691|NCT01120691|69563968|FG000|Overall Study|Subject withdrew consent|33|||
37879692|NCT01120691|69563969|FG001|Overall Study|Subject withdrew consent|50|||
37879693|NCT01120691|69563970|FG002|Overall Study|Subject withdrew consent|44|||
37879694|NCT01120691|69563968|FG000|Overall Study|Death|21|||
37879695|NCT01120691|69563969|FG001|Overall Study|Death|22|||
37879696|NCT01120691|69563970|FG002|Overall Study|Death|24|||
37879697|NCT01120691|69563968|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
37879698|NCT01120691|69563969|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
37984190|NCT00294723|69670279|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
37984191|NCT00294723|69670277|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
37984192|NCT00294723|69670278|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
37819325|NCT02628444|69498433|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
37819326|NCT02628444|69498434|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
37819327|NCT02628444|69498435|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
37819328|NCT02628444|69498436|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
37819329|NCT02628444|69498437|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
37819330|NCT02628444|69498438|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
37819331|NCT02628444|69498439|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
37819332|NCT02628444|69498440|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
37819333|NCT02628444|69498432|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
37819334|NCT02628444|69498433|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
37819335|NCT02628444|69498434|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
37819336|NCT02628444|69498435|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
37819337|NCT02628444|69498436|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
37819338|NCT02628444|69498437|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
37819339|NCT02628444|69498438|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
37819340|NCT02628444|69498439|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
37819341|NCT02628444|69498440|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
37819342|NCT02628444|69498432|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
37819343|NCT02628444|69498433|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
37819344|NCT02628444|69498434|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
37819345|NCT02628444|69498435|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
37819346|NCT02628444|69498436|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
37819347|NCT02628444|69498437|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
37819348|NCT02628444|69498438|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
37819349|NCT02628444|69498439|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
37819350|NCT02628444|69498440|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
37819351|NCT02628444|69498432|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
37819352|NCT02628444|69498433|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
37819353|NCT02628444|69498434|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
37819354|NCT02628444|69498435|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
37819355|NCT02628444|69498436|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
37819356|NCT02628444|69498437|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
37833584|NCT01262989|69517313|FG001|Period 1|Intercurrent disease|1|||
37879699|NCT01120691|69563970|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
37879700|NCT01120691|69563968|FG000|Overall Study|Administrative problems|15|||
37879701|NCT01120691|69563969|FG001|Overall Study|Administrative problems|8|||
37879702|NCT01120691|69563970|FG002|Overall Study|Administrative problems|9|||
37879703|NCT01120691|69563968|FG000|Overall Study|Protocol deviation|13|||
37879704|NCT01120691|69563969|FG001|Overall Study|Protocol deviation|12|||
37879705|NCT01120691|69563970|FG002|Overall Study|Protocol deviation|12|||
37879706|NCT01120691|69563968|FG000|Overall Study|Lost to Follow-up|5|||
37879707|NCT01120691|69563969|FG001|Overall Study|Lost to Follow-up|6|||
37879708|NCT01120691|69563970|FG002|Overall Study|Lost to Follow-up|4|||
37879709|NCT01120691|69563968|FG000|Overall Study|Abnormal test procedure result(s)|3|||
37879710|NCT01120691|69563969|FG001|Overall Study|Abnormal test procedure result(s)|2|||
37879711|NCT01120691|69563970|FG002|Overall Study|Abnormal test procedure result(s)|1|||
37879712|NCT01120691|69563968|FG000|Overall Study|Patient's inability to use the device|3|||
37879713|NCT01120691|69563969|FG001|Overall Study|Patient's inability to use the device|1|||
37879714|NCT01120691|69563970|FG002|Overall Study|Patient's inability to use the device|0|||
37879715|NCT01120691|69563968|FG000|Overall Study|Abnormal laboratory value(s)|1|||
37879716|NCT01120691|69563969|FG001|Overall Study|Abnormal laboratory value(s)|3|||
37879717|NCT01120691|69563970|FG002|Overall Study|Abnormal laboratory value(s)|4|||
37879718|NCT00935493|69563994|FG000|Overall Study|Lost to Follow-up|1|||
37879719|NCT00935493|69563995|FG001|Overall Study|Lost to Follow-up|1|||
37879720|NCT00935493|69563996|FG002|Overall Study|Lost to Follow-up|1|||
37879721|NCT00935493|69563994|FG000|Overall Study|Treatment Discontinued|0|||
37879722|NCT00935493|69563995|FG001|Overall Study|Treatment Discontinued|1|||
37879723|NCT00935493|69563996|FG002|Overall Study|Treatment Discontinued|0|||
37879724|NCT03856996|69564006|FG000|Overall Study|Withdrawal by Subject|1|||
37879725|NCT03856996|69564007|FG001|Overall Study|Withdrawal by Subject|0|||
37879726|NCT03856996|69564006|FG000|Overall Study|Lost to Follow-up|0|||
37879727|NCT03856996|69564007|FG001|Overall Study|Lost to Follow-up|1|||
37879728|NCT03856996|69564006|FG000|Overall Study|Adverse Event|1|||
37879729|NCT03856996|69564007|FG001|Overall Study|Adverse Event|1|||
37879730|NCT03856996|69564006|FG000|Overall Study|Other|1|||
37879731|NCT03856996|69564007|FG001|Overall Study|Other|0|||
37879732|NCT00935259|69564013|FG000|Period 1|Administrative (scheduling conflict)|1|||
37879733|NCT00935259|69564014|FG001|Period 1|Administrative (scheduling conflict)|1|||
37879734|NCT01120379|69564031|FG000|One Year Timepoint|Withdrawal by Subject|41|||
37879735|NCT01120379|69564031|FG000|One Year Timepoint|Lost to Follow-up|115|||
37879736|NCT01120379|69564031|FG000|One Year Timepoint|Death|108|||
37879737|NCT01120379|69564031|FG000|One Year Timepoint|Physician Decision|9|||
37879738|NCT01120379|69564031|FG000|One Year Timepoint|Any other reason for early termination|5|||
37879739|NCT01120379|69564031|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
37879740|NCT01120379|69564031|FG000|Two Year Timepoint|Lost to Follow-up|87|||
37879741|NCT01120379|69564031|FG000|Two Year Timepoint|Death|123|||
37879742|NCT01120379|69564031|FG000|Two Year Timepoint|Physician Decision|12|||
37879743|NCT01120379|69564031|FG000|Two Year Timepoint|Any other reason for early termination|4|||
37879744|NCT01120379|69564031|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
37879745|NCT01120379|69564031|FG000|Three Year Timepoint|Lost to Follow-up|43|||
37879746|NCT01120379|69564031|FG000|Three Year Timepoint|Death|120|||
37879747|NCT01120379|69564031|FG000|Three Year Timepoint|Physician Decision|9|||
37879748|NCT01120379|69564031|FG000|Three Year Timepoint|Any other reason for early termination|17|||
37879749|NCT01120379|69564031|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
37879750|NCT01120379|69564031|FG000|Four Year Timepoint|Lost to Follow-up|10|||
37879751|NCT01120379|69564031|FG000|Four Year Timepoint|Death|131|||
37879752|NCT01120379|69564031|FG000|Four Year Timepoint|Physician Decision|5|||
37879753|NCT01120379|69564031|FG000|Four Year Timepoint|Any other reason for early termination|217|||
37879754|NCT01120067|69564037|FG000|Overall Study|Lost to Follow-up|3|||
37879755|NCT01120067|69564038|FG001|Overall Study|Lost to Follow-up|1|||
37879756|NCT01120067|69564037|FG000|Overall Study|fail to engage >3 sessions|2|||
37879757|NCT01120067|69564038|FG001|Overall Study|fail to engage >3 sessions|0|||
37879758|NCT01124045|69564046|FG000|Overall Study|Lost to Follow-up|0|||
37879759|NCT01124045|69564047|FG001|Overall Study|Lost to Follow-up|1|||
37879760|NCT01124045|69564046|FG000|Overall Study|Physician Decision|0|||
37879761|NCT01124045|69564047|FG001|Overall Study|Physician Decision|2|||
37879762|NCT01123889|69564055|FG000|Overall Study|Lost to Follow-up|3|||
37879763|NCT01123889|69564056|FG001|Overall Study|Lost to Follow-up|1|||
37879764|NCT00934947|69564064|FG000|Overall Study|Adverse Event|0|||
37879765|NCT00934947|69564065|FG001|Overall Study|Adverse Event|2|||
37879766|NCT01123655|69564075|FG000|Overall Study|Medication for RA had to be changed|1|||
37879767|NCT01123655|69564076|FG001|Overall Study|Medication for RA had to be changed|0|||
37879768|NCT01123655|69564077|FG002|Overall Study|Medication for RA had to be changed|0|||
37879769|NCT01123655|69564075|FG000|Overall Study|new illness|0|||
37879770|NCT01123655|69564076|FG001|Overall Study|new illness|1|||
37879771|NCT01123655|69564077|FG002|Overall Study|new illness|0|||
37879772|NCT01123655|69564075|FG000|Overall Study|began prohibitive drug|0|||
37879773|NCT01123655|69564076|FG001|Overall Study|began prohibitive drug|0|||
37879774|NCT01123655|69564077|FG002|Overall Study|began prohibitive drug|1|||
37879775|NCT00934791|69564085|FG000|Overall Study|Withdrawal by Subject|1|||
37879776|NCT00934791|69564086|FG001|Overall Study|Withdrawal by Subject|0|||
37879777|NCT01119443|69564094|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
37879778|NCT01119443|69564095|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
37879779|NCT01111019|69564104|FG000|Overall Study|Withdrew Prematurely|2|||
37879780|NCT01111019|69564104|FG000|Overall Study|Other|1|||
37879781|NCT01119287|69564123|FG000|Overall Study|Patient Decision, not related to AE|0|||
37879782|NCT01119287|69564124|FG001|Overall Study|Patient Decision, not related to AE|0|||
37879783|NCT01119287|69564125|FG002|Overall Study|Patient Decision, not related to AE|2|||
37879784|NCT01119287|69564126|FG003|Overall Study|Patient Decision, not related to AE|2|||
37879785|NCT01119287|69564127|FG004|Overall Study|Patient Decision, not related to AE|1|||
37879786|NCT01119287|69564128|FG005|Overall Study|Patient Decision, not related to AE|0|||
37879787|NCT01110707|69564142|FG000|Overall Study|Protocol Violation|0|||
37879788|NCT01110707|69564143|FG001|Overall Study|Protocol Violation|3|||
37984193|NCT00294723|69670279|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
37984194|NCT00294723|69670277|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
37984195|NCT00294723|69670278|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
37984196|NCT00294723|69670279|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
37984197|NCT00294723|69670277|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
37984198|NCT00294723|69670278|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
37984199|NCT00294723|69670279|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
37984200|NCT00294723|69670277|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
37984201|NCT00294723|69670278|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
37984202|NCT00294723|69670279|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
37984203|NCT00402246|69670292|FG000|Overall Study|Death|62|||
37984204|NCT00402246|69670293|FG001|Overall Study|Death|58|||
37984205|NCT00402246|69670292|FG000|Overall Study|Lost to Follow-up|20|||
37984206|NCT00402246|69670293|FG001|Overall Study|Lost to Follow-up|28|||
37984207|NCT00402246|69670292|FG000|Overall Study|Withdrawal by Subject|72|||
37984208|NCT00402246|69670293|FG001|Overall Study|Withdrawal by Subject|87|||
37984209|NCT00402246|69670292|FG000|Overall Study|Physician Decision|24|||
37984210|NCT00402246|69670293|FG001|Overall Study|Physician Decision|26|||
37984211|NCT00402246|69670292|FG000|Overall Study|Protocol Violation|25|||
37984212|NCT00402246|69670293|FG001|Overall Study|Protocol Violation|24|||
37984213|NCT00402246|69670292|FG000|Overall Study|Missed Final Visit|1|||
37984214|NCT00402246|69670293|FG001|Overall Study|Missed Final Visit|2|||
37879789|NCT01119131|69564153|FG000|Overall Study|Adverse Event|1|||
37879790|NCT01119131|69564154|FG001|Overall Study|Adverse Event|1|||
37879791|NCT01119131|69564155|FG002|Overall Study|Adverse Event|1|||
37879792|NCT01119131|69564153|FG000|Overall Study|Non-Compliance|1|||
37879793|NCT01119131|69564154|FG001|Overall Study|Non-Compliance|0|||
37879794|NCT01119131|69564155|FG002|Overall Study|Non-Compliance|4|||
37879795|NCT01119131|69564153|FG000|Overall Study|Physician Decision|0|||
37879796|NCT01119131|69564154|FG001|Overall Study|Physician Decision|0|||
37879797|NCT01119131|69564155|FG002|Overall Study|Physician Decision|1|||
37879798|NCT01118975|69564165|FG000|Overall Study|Adverse Event|0|||
37879799|NCT01118975|69564166|FG001|Overall Study|Adverse Event|1|||
37879800|NCT01110239|69564176|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
37879801|NCT01110239|69564177|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
37879802|NCT01110239|69564178|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
37879803|NCT01110239|69564179|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
37879804|NCT01110239|69564176|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
37879805|NCT01110239|69564177|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
37695231|NCT02349295|69171760|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
37819357|NCT02628444|69498438|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
37819358|NCT02628444|69498439|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
37819359|NCT02628444|69498440|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
37819360|NCT02628444|69498432|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
37819361|NCT02628444|69498433|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
37819362|NCT02628444|69498434|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
37819363|NCT02628444|69498435|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
37819364|NCT02628444|69498436|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
37819365|NCT02628444|69498437|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
37879806|NCT01110239|69564178|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
37879807|NCT01110239|69564179|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
37879808|NCT01118663|69564192|FG000|Overall Study|Adverse Event|2|||
37879809|NCT01118663|69564193|FG001|Overall Study|Adverse Event|1|||
37879810|NCT01118663|69564192|FG000|Overall Study|Withdrawal by Subject|0|||
37879811|NCT01118663|69564193|FG001|Overall Study|Withdrawal by Subject|1|||
37879812|NCT01118351|69564199|FG000|Overall Study|Adverse Event|3|||
37879813|NCT01118351|69564199|FG000|Overall Study|Withdrawal by Subject|1|||
37879814|NCT01110005|69564205|FG000|Overall Study|ineligible|1|||
37879815|NCT01110005|69564206|FG001|Overall Study|ineligible|2|||
37879816|NCT01110005|69564205|FG000|Overall Study|missing consent|3|||
37879817|NCT01110005|69564206|FG001|Overall Study|missing consent|2|||
37879818|NCT01110005|69564205|FG000|Overall Study|Withdrawal by Subject|0|||
37879819|NCT01110005|69564206|FG001|Overall Study|Withdrawal by Subject|1|||
37879820|NCT01118117|69564229|FG000|Overall Study|Death|8|||
37879821|NCT01118117|69564230|FG001|Overall Study|Death|0|||
37879822|NCT01118117|69564229|FG000|Overall Study|Lost to Follow-up|6|||
37879823|NCT01118117|69564230|FG001|Overall Study|Lost to Follow-up|0|||
37879824|NCT01118117|69564229|FG000|Overall Study|Missed 12 Month Visit|7|||
37879825|NCT01118117|69564230|FG001|Overall Study|Missed 12 Month Visit|0|||
37879826|NCT01109849|69564238|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
37879827|NCT01109849|69564239|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
37879828|NCT01109849|69564240|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
37879829|NCT01109849|69564241|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
37879830|NCT01109849|69564242|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
37879831|NCT01109849|69564238|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
37879832|NCT01109849|69564239|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
37879833|NCT01109849|69564240|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
37879834|NCT01109849|69564241|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
37879835|NCT01109849|69564242|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
37879836|NCT01109849|69564238|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
37879837|NCT01109849|69564239|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
37879838|NCT01109849|69564240|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
37879839|NCT01109849|69564241|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
37879840|NCT01109849|69564242|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
37879841|NCT01109849|69564238|FG000|Initial Randomization: ADHD Treatment|move away|2|||
37879842|NCT01109849|69564239|FG001|Initial Randomization: ADHD Treatment|move away|7|||
37879843|NCT01109849|69564240|FG002|Initial Randomization: ADHD Treatment|move away|0|||
37879844|NCT01109849|69564241|FG003|Initial Randomization: ADHD Treatment|move away|0|||
37879845|NCT01109849|69564242|FG004|Initial Randomization: ADHD Treatment|move away|0|||
37879846|NCT01109849|69564238|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
37879847|NCT01109849|69564239|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
37879848|NCT01109849|69564240|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
37819366|NCT02628444|69498438|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
37819367|NCT02628444|69498439|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
37819368|NCT02628444|69498440|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
37819369|NCT02628444|69498432|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
37819370|NCT02628444|69498433|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
37819371|NCT02628444|69498434|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
37819372|NCT02628444|69498435|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
37819373|NCT02628444|69498436|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
37819374|NCT02628444|69498437|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
37819375|NCT02628444|69498438|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
37819376|NCT02628444|69498439|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
37819377|NCT02628444|69498440|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
37819378|NCT02628444|69498432|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
37819379|NCT02628444|69498433|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
37819380|NCT02628444|69498434|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
37819381|NCT02628444|69498435|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
37819382|NCT02628444|69498436|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
37879849|NCT01109849|69564241|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
37879850|NCT01109849|69564242|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
37879851|NCT01109849|69564238|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
37879852|NCT01109849|69564239|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
37879853|NCT01109849|69564240|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
37879854|NCT01109849|69564241|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
37879855|NCT01109849|69564242|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
37879856|NCT01061736|69564272|FG000|Overall Study|Dose regimen not selected|0|||
37879857|NCT01061736|69564273|FG001|Overall Study|Dose regimen not selected|0|||
37879858|NCT01061736|69564274|FG002|Overall Study|Dose regimen not selected|0|||
37879859|NCT01061736|69564275|FG003|Overall Study|Dose regimen not selected|0|||
37879860|NCT01061736|69564276|FG004|Overall Study|Dose regimen not selected|0|||
37879861|NCT01061736|69564277|FG005|Overall Study|Dose regimen not selected|0|||
37879862|NCT01061736|69564278|FG006|Overall Study|Dose regimen not selected|79|||
37879863|NCT01061736|69564279|FG007|Overall Study|Dose regimen not selected|0|||
37879864|NCT01061736|69564280|FG008|Overall Study|Dose regimen not selected|0|||
37879865|NCT01061736|69564281|FG009|Overall Study|Dose regimen not selected|0|||
37879866|NCT01061736|69564272|FG000|Overall Study|Adverse Event|13|||
37879867|NCT01061736|69564273|FG001|Overall Study|Adverse Event|1|||
37879868|NCT01061736|69564274|FG002|Overall Study|Adverse Event|3|||
37879869|NCT01061736|69564275|FG003|Overall Study|Adverse Event|2|||
37879870|NCT01061736|69564276|FG004|Overall Study|Adverse Event|4|||
37984215|NCT00402246|69670292|FG000|Overall Study|Insurance Issues|2|||
37984216|NCT00402246|69670293|FG001|Overall Study|Insurance Issues|1|||
37984217|NCT00402246|69670292|FG000|Overall Study|Heart Transplant|0|||
37984218|NCT00402246|69670293|FG001|Overall Study|Heart Transplant|1|||
37984219|NCT00402246|69670292|FG000|Overall Study|Patient's device explanted|6|||
37984220|NCT00402246|69670293|FG001|Overall Study|Patient's device explanted|2|||
37984221|NCT00402246|69670292|FG000|Overall Study|Center Closure|5|||
37984222|NCT00402246|69670293|FG001|Overall Study|Center Closure|3|||
37695232|NCT02349295|69171761|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
37819383|NCT02628444|69498437|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
37819384|NCT02628444|69498438|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
37819385|NCT02628444|69498439|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
37819386|NCT02628444|69498440|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
37819387|NCT02623725|69498476|FG000|Overall Study|Non compliance with protocol|9|||
37819388|NCT02623725|69498477|FG001|Overall Study|Non compliance with protocol|3|||
37819389|NCT02623725|69498476|FG000|Overall Study|Serious adverse event|0|||
37819390|NCT02623725|69498477|FG001|Overall Study|Serious adverse event|2|||
37819391|NCT02623725|69498476|FG000|Overall Study|Withdrawal by Subject|7|||
37819392|NCT02623725|69498477|FG001|Overall Study|Withdrawal by Subject|1|||
37819393|NCT02608684|69498485|FG000|Overall Study|Physician Decision|2|||
37819394|NCT02608684|69498485|FG000|Overall Study|Withdrawal by Subject|1|||
37819395|NCT02587520|69498507|FG000|Overall Study|Protocol Violation|2|||
37879871|NCT01061736|69564277|FG005|Overall Study|Adverse Event|1|||
37879872|NCT01061736|69564278|FG006|Overall Study|Adverse Event|4|||
37879873|NCT01061736|69564279|FG007|Overall Study|Adverse Event|63|||
37879874|NCT01061736|69564280|FG008|Overall Study|Adverse Event|67|||
37879875|NCT01061736|69564281|FG009|Overall Study|Adverse Event|34|||
37879876|NCT01061736|69564272|FG000|Overall Study|Lack of Efficacy|0|||
37879877|NCT01061736|69564273|FG001|Overall Study|Lack of Efficacy|2|||
37879878|NCT01061736|69564274|FG002|Overall Study|Lack of Efficacy|1|||
37879879|NCT01061736|69564275|FG003|Overall Study|Lack of Efficacy|1|||
37879880|NCT01061736|69564276|FG004|Overall Study|Lack of Efficacy|1|||
37879881|NCT01061736|69564277|FG005|Overall Study|Lack of Efficacy|2|||
37879882|NCT01061736|69564278|FG006|Overall Study|Lack of Efficacy|1|||
37984223|NCT00402246|69670292|FG000|Overall Study|Deterioriating Condition|3|||
37984224|NCT00402246|69670293|FG001|Overall Study|Deterioriating Condition|2|||
37879883|NCT01061736|69564279|FG007|Overall Study|Lack of Efficacy|9|||
37879884|NCT01061736|69564280|FG008|Overall Study|Lack of Efficacy|9|||
37879885|NCT01061736|69564281|FG009|Overall Study|Lack of Efficacy|10|||
37879886|NCT01061736|69564272|FG000|Overall Study|Poor compliance to protocol|0|||
37879887|NCT01061736|69564273|FG001|Overall Study|Poor compliance to protocol|0|||
37879888|NCT01061736|69564274|FG002|Overall Study|Poor compliance to protocol|0|||
37879889|NCT01061736|69564275|FG003|Overall Study|Poor compliance to protocol|0|||
37879890|NCT01061736|69564276|FG004|Overall Study|Poor compliance to protocol|0|||
37879891|NCT01061736|69564277|FG005|Overall Study|Poor compliance to protocol|0|||
37879892|NCT01061736|69564278|FG006|Overall Study|Poor compliance to protocol|0|||
37879893|NCT01061736|69564279|FG007|Overall Study|Poor compliance to protocol|2|||
37879894|NCT01061736|69564280|FG008|Overall Study|Poor compliance to protocol|5|||
37879895|NCT01061736|69564281|FG009|Overall Study|Poor compliance to protocol|9|||
37879896|NCT01061736|69564272|FG000|Overall Study|Not treated|0|||
37879897|NCT01061736|69564273|FG001|Overall Study|Not treated|0|||
37879898|NCT01061736|69564274|FG002|Overall Study|Not treated|0|||
37879899|NCT01061736|69564275|FG003|Overall Study|Not treated|0|||
37879900|NCT01061736|69564276|FG004|Overall Study|Not treated|1|||
37984225|NCT00375492|69670303|FG000|Overall Study|Adverse Event|4|||
37984226|NCT00375492|69670304|FG001|Overall Study|Adverse Event|5|||
37984227|NCT00375492|69670303|FG000|Overall Study|Entry Criteria Not Met|0|||
37984228|NCT00375492|69670304|FG001|Overall Study|Entry Criteria Not Met|1|||
37984229|NCT00375492|69670303|FG000|Overall Study|Loss of Glucose Control|0|||
37984230|NCT00375492|69670304|FG001|Overall Study|Loss of Glucose Control|1|||
37984231|NCT00375492|69670303|FG000|Overall Study|Lost to Follow-up|10|||
37984232|NCT00375492|69670304|FG001|Overall Study|Lost to Follow-up|5|||
37984233|NCT00375492|69670303|FG000|Overall Study|Physician Decision|0|||
37984234|NCT00375492|69670304|FG001|Overall Study|Physician Decision|4|||
37984235|NCT00375492|69670303|FG000|Overall Study|Protocol Violation|6|||
37984236|NCT00375492|69670304|FG001|Overall Study|Protocol Violation|3|||
37984237|NCT00375492|69670303|FG000|Overall Study|Sponsor Decision|0|||
37984238|NCT00375492|69670304|FG001|Overall Study|Sponsor Decision|1|||
37819396|NCT02587520|69498508|FG001|Overall Study|Protocol Violation|0|||
37819397|NCT02587520|69498509|FG002|Overall Study|Protocol Violation|0|||
37819398|NCT02587520|69498510|FG003|Overall Study|Protocol Violation|2|||
37819399|NCT02587520|69498511|FG004|Overall Study|Protocol Violation|0|||
37819400|NCT02587520|69498512|FG005|Overall Study|Protocol Violation|1|||
37819401|NCT02587520|69498513|FG006|Overall Study|Protocol Violation|1|||
37879901|NCT01061736|69564277|FG005|Overall Study|Not treated|0|||
37879902|NCT01061736|69564278|FG006|Overall Study|Not treated|0|||
37879903|NCT01061736|69564279|FG007|Overall Study|Not treated|2|||
37879904|NCT01061736|69564280|FG008|Overall Study|Not treated|1|||
37879905|NCT01061736|69564281|FG009|Overall Study|Not treated|0|||
37879906|NCT01061736|69564272|FG000|Overall Study|Other than specified above|0|||
37819402|NCT02587520|69498514|FG007|Overall Study|Protocol Violation|1|||
37819403|NCT02587520|69498515|FG008|Overall Study|Protocol Violation|3|||
37819404|NCT02587520|69498516|FG009|Overall Study|Protocol Violation|3|||
37819405|NCT02587520|69498517|FG010|Overall Study|Protocol Violation|1|||
37819406|NCT02587520|69498518|FG011|Overall Study|Protocol Violation|2|||
37819407|NCT02587520|69498519|FG012|Overall Study|Protocol Violation|0|||
37819408|NCT02587520|69498520|FG013|Overall Study|Protocol Violation|0|||
37819409|NCT02587520|69498521|FG014|Overall Study|Protocol Violation|0|||
37819410|NCT02587520|69498522|FG015|Overall Study|Protocol Violation|0|||
37819411|NCT02587520|69498523|FG016|Overall Study|Protocol Violation|0|||
37819412|NCT02587520|69498524|FG017|Overall Study|Protocol Violation|0|||
37819413|NCT02587520|69498507|FG000|Overall Study|Adverse Event|0|||
37879907|NCT01061736|69564273|FG001|Overall Study|Other than specified above|1|||
37879908|NCT01061736|69564274|FG002|Overall Study|Other than specified above|2|||
37879909|NCT01061736|69564275|FG003|Overall Study|Other than specified above|0|||
37879910|NCT01061736|69564276|FG004|Overall Study|Other than specified above|1|||
37879911|NCT01061736|69564277|FG005|Overall Study|Other than specified above|0|||
37879912|NCT01061736|69564278|FG006|Overall Study|Other than specified above|0|||
37879913|NCT01061736|69564279|FG007|Overall Study|Other than specified above|18|||
37879914|NCT01061736|69564280|FG008|Overall Study|Other than specified above|15|||
37879915|NCT01061736|69564281|FG009|Overall Study|Other than specified above|21|||
37879916|NCT01117337|69564308|FG000|Overall Study|Lost to Follow-up|4|||
37984239|NCT00375492|69670303|FG000|Overall Study|Withdrawal by Subject|6|||
37819414|NCT02587520|69498508|FG001|Overall Study|Adverse Event|0|||
37819415|NCT02587520|69498509|FG002|Overall Study|Adverse Event|0|||
37819416|NCT02587520|69498510|FG003|Overall Study|Adverse Event|0|||
37819417|NCT02587520|69498511|FG004|Overall Study|Adverse Event|0|||
37984240|NCT00375492|69670304|FG001|Overall Study|Withdrawal by Subject|6|||
37984241|NCT00306189|69670314|FG000|Overall Study|Physician Decision|0|||
37819418|NCT02587520|69498512|FG005|Overall Study|Adverse Event|0|||
37879917|NCT01117337|69564309|FG001|Overall Study|Lost to Follow-up|0|||
37879918|NCT01108523|69564319|FG000|Overall Study|Protocol Violation|4|||
37879919|NCT01035606|69564326|FG000|Overall Study|change in health, job demands,family|3|||
37879920|NCT01035606|69564327|FG001|Overall Study|change in health, job demands,family|3|||
37879921|NCT01035606|69564328|FG002|Overall Study|change in health, job demands,family|4|||
37984242|NCT00306189|69670315|FG001|Overall Study|Physician Decision|0|||
37984243|NCT00306189|69670316|FG002|Overall Study|Physician Decision|0|||
37984244|NCT00306189|69670317|FG003|Overall Study|Physician Decision|1|||
37984245|NCT00306189|69670314|FG000|Overall Study|Adverse Event|3|||
37879922|NCT01117181|69564338|FG000|Overall Study|Lost to Follow-up|1|||
37879923|NCT01117181|69564339|FG001|Overall Study|Lost to Follow-up|0|||
37879924|NCT01117181|69564338|FG000|Overall Study|Withdrawal by Subject|0|||
37879925|NCT01117181|69564339|FG001|Overall Study|Withdrawal by Subject|2|||
37879926|NCT01040130|69564347|FG000|Overall Study|Adverse Event|1|||
37879927|NCT01040130|69564348|FG001|Overall Study|Adverse Event|1|||
37879928|NCT01040130|69564349|FG002|Overall Study|Adverse Event|0|||
37984246|NCT00306189|69670315|FG001|Overall Study|Adverse Event|3|||
37984247|NCT00306189|69670316|FG002|Overall Study|Adverse Event|2|||
37879929|NCT01040130|69564350|FG003|Overall Study|Adverse Event|5|||
37879930|NCT01040130|69564351|FG004|Overall Study|Adverse Event|0|||
37879931|NCT01040130|69564352|FG005|Overall Study|Adverse Event|3|||
37879932|NCT01040130|69564347|FG000|Overall Study|Protocol Violation|0|||
37879933|NCT01040130|69564348|FG001|Overall Study|Protocol Violation|0|||
37879934|NCT01040130|69564349|FG002|Overall Study|Protocol Violation|2|||
37879935|NCT01040130|69564350|FG003|Overall Study|Protocol Violation|0|||
37879936|NCT01040130|69564351|FG004|Overall Study|Protocol Violation|0|||
37879937|NCT01040130|69564352|FG005|Overall Study|Protocol Violation|0|||
37879938|NCT01040130|69564347|FG000|Overall Study|Withdrawal by Subject|0|||
37879939|NCT01040130|69564348|FG001|Overall Study|Withdrawal by Subject|2|||
37879940|NCT01040130|69564349|FG002|Overall Study|Withdrawal by Subject|0|||
37879941|NCT01040130|69564350|FG003|Overall Study|Withdrawal by Subject|0|||
37879942|NCT01040130|69564351|FG004|Overall Study|Withdrawal by Subject|0|||
37879943|NCT01040130|69564352|FG005|Overall Study|Withdrawal by Subject|1|||
37879944|NCT01040130|69564347|FG000|Overall Study|Other reasons not listed above|2|||
37879945|NCT01040130|69564348|FG001|Overall Study|Other reasons not listed above|0|||
37879946|NCT01040130|69564349|FG002|Overall Study|Other reasons not listed above|0|||
37879947|NCT01040130|69564350|FG003|Overall Study|Other reasons not listed above|0|||
37879948|NCT01040130|69564351|FG004|Overall Study|Other reasons not listed above|0|||
37879949|NCT01040130|69564352|FG005|Overall Study|Other reasons not listed above|0|||
37879950|NCT00932451|69564362|FG000|Overall Study|Withdrawal by Subject|69|||
37879951|NCT00932451|69564362|FG000|Overall Study|Lost to Follow-up|22|||
37819419|NCT02587520|69498513|FG006|Overall Study|Adverse Event|0|||
37819420|NCT02587520|69498514|FG007|Overall Study|Adverse Event|0|||
37819421|NCT02587520|69498515|FG008|Overall Study|Adverse Event|0|||
37819422|NCT02587520|69498516|FG009|Overall Study|Adverse Event|0|||
37819423|NCT02587520|69498517|FG010|Overall Study|Adverse Event|0|||
37819424|NCT02587520|69498518|FG011|Overall Study|Adverse Event|1|||
37819425|NCT02587520|69498519|FG012|Overall Study|Adverse Event|0|||
37819426|NCT02587520|69498520|FG013|Overall Study|Adverse Event|0|||
37819427|NCT02587520|69498521|FG014|Overall Study|Adverse Event|0|||
37819428|NCT02587520|69498522|FG015|Overall Study|Adverse Event|0|||
37819429|NCT02587520|69498523|FG016|Overall Study|Adverse Event|0|||
37819430|NCT02587520|69498524|FG017|Overall Study|Adverse Event|0|||
37819431|NCT02587520|69498507|FG000|Overall Study|Withdrawal by Subject|0|||
37819432|NCT02587520|69498508|FG001|Overall Study|Withdrawal by Subject|0|||
37819433|NCT02587520|69498509|FG002|Overall Study|Withdrawal by Subject|1|||
37819434|NCT02587520|69498510|FG003|Overall Study|Withdrawal by Subject|1|||
37819435|NCT02587520|69498511|FG004|Overall Study|Withdrawal by Subject|0|||
37819436|NCT02587520|69498512|FG005|Overall Study|Withdrawal by Subject|1|||
37819437|NCT02587520|69498513|FG006|Overall Study|Withdrawal by Subject|1|||
37819438|NCT02587520|69498514|FG007|Overall Study|Withdrawal by Subject|0|||
37819439|NCT02587520|69498515|FG008|Overall Study|Withdrawal by Subject|0|||
37819440|NCT02587520|69498516|FG009|Overall Study|Withdrawal by Subject|0|||
37879952|NCT00932451|69564362|FG000|Overall Study|Death|726|||
37879953|NCT00932451|69564362|FG000|Overall Study|Other reasons|5|||
37879954|NCT01108055|69564370|FG000|Overall Study|Ineligible|11|||
37879955|NCT01108055|69564370|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
37879956|NCT01107899|69564377|FG000|Overall Study|Physician Decision|5|||
37879957|NCT01107899|69564378|FG001|Overall Study|Physician Decision|0|||
37984248|NCT00306189|69670317|FG003|Overall Study|Adverse Event|2|||
37819441|NCT02587520|69498517|FG010|Overall Study|Withdrawal by Subject|0|||
37819442|NCT02587520|69498518|FG011|Overall Study|Withdrawal by Subject|0|||
37819443|NCT02587520|69498519|FG012|Overall Study|Withdrawal by Subject|0|||
37819444|NCT02587520|69498520|FG013|Overall Study|Withdrawal by Subject|1|||
37984249|NCT00306189|69670314|FG000|Overall Study|Withdrawal by Subject|4|||
37819445|NCT02587520|69498521|FG014|Overall Study|Withdrawal by Subject|0|||
37819446|NCT02587520|69498522|FG015|Overall Study|Withdrawal by Subject|0|||
37819447|NCT02587520|69498523|FG016|Overall Study|Withdrawal by Subject|0|||
37879958|NCT01107899|69564379|FG002|Overall Study|Physician Decision|3|||
37879959|NCT01107899|69564377|FG000|Overall Study|Withdrawal by Subject|0|||
37879960|NCT01107899|69564378|FG001|Overall Study|Withdrawal by Subject|0|||
37984250|NCT00306189|69670315|FG001|Overall Study|Withdrawal by Subject|2|||
37879961|NCT01107899|69564379|FG002|Overall Study|Withdrawal by Subject|1|||
37879962|NCT01115933|69564390|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
37879963|NCT01107743|69564447|FG000|Overall Study|Protocol Violation|46|||
37879964|NCT01059864|69564496|FG000|Open-Label Run-In Phase|Adverse Event|7|||
37879965|NCT01059864|69564497|FG001|Open-Label Run-In Phase|Adverse Event|0|||
37879966|NCT01059864|69564498|FG002|Open-Label Run-In Phase|Adverse Event|0|||
37879967|NCT01059864|69564496|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
37879968|NCT01059864|69564497|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
37879969|NCT01059864|69564498|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
37879970|NCT01059864|69564496|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
37819448|NCT02587520|69498524|FG017|Overall Study|Withdrawal by Subject|0|||
37819449|NCT02587520|69498507|FG000|Overall Study|Lost to Follow-up|0|||
37819450|NCT02587520|69498508|FG001|Overall Study|Lost to Follow-up|2|||
37819451|NCT02587520|69498509|FG002|Overall Study|Lost to Follow-up|0|||
37819452|NCT02587520|69498510|FG003|Overall Study|Lost to Follow-up|2|||
37879971|NCT01059864|69564497|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
37879972|NCT01059864|69564498|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
37879973|NCT01059864|69564496|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
37879974|NCT01059864|69564497|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
37879975|NCT01059864|69564498|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
37879976|NCT01059864|69564496|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
37879977|NCT01059864|69564497|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
37879978|NCT01059864|69564498|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
37879979|NCT01059864|69564496|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
37879980|NCT01059864|69564497|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
37879981|NCT01059864|69564498|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
37879982|NCT01035138|69564508|FG000|Overall Study|Adverse Event|4|||
37879983|NCT01035138|69564509|FG001|Overall Study|Adverse Event|0|||
37879984|NCT01035138|69564510|FG002|Overall Study|Adverse Event|2|||
37879985|NCT01035138|69564508|FG000|Overall Study|Caregiver Decision|2|||
37879986|NCT01035138|69564509|FG001|Overall Study|Caregiver Decision|0|||
37879987|NCT01035138|69564510|FG002|Overall Study|Caregiver Decision|1|||
37879988|NCT01035138|69564508|FG000|Overall Study|Withdrawal by Subject|1|||
37879989|NCT01035138|69564509|FG001|Overall Study|Withdrawal by Subject|0|||
37879990|NCT01035138|69564510|FG002|Overall Study|Withdrawal by Subject|0|||
37879991|NCT01035138|69564508|FG000|Overall Study|Physician Decision|0|||
37879992|NCT01035138|69564509|FG001|Overall Study|Physician Decision|0|||
37879993|NCT01035138|69564510|FG002|Overall Study|Physician Decision|1|||
37879994|NCT01035138|69564508|FG000|Overall Study|Sponsor Decision|66|||
37879995|NCT01035138|69564509|FG001|Overall Study|Sponsor Decision|60|||
37879996|NCT01035138|69564510|FG002|Overall Study|Sponsor Decision|42|||
37879997|NCT01035138|69564508|FG000|Overall Study|Lost to Follow-up|0|||
37879998|NCT01035138|69564509|FG001|Overall Study|Lost to Follow-up|0|||
37879999|NCT01035138|69564510|FG002|Overall Study|Lost to Follow-up|1|||
37880000|NCT03739840|69564524|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
37880001|NCT03739840|69564525|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
37880002|NCT03739840|69564526|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
37880003|NCT03739840|69564527|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
37880004|NCT03739840|69564524|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
37880005|NCT03739840|69564525|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
37880006|NCT03739840|69564526|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
37880007|NCT03739840|69564527|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
37880008|NCT03739840|69564524|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
37880009|NCT03739840|69564525|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
37880010|NCT03739840|69564526|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
37880011|NCT03739840|69564527|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
37880012|NCT03739840|69564524|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
37880013|NCT03739840|69564525|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
37880014|NCT03739840|69564526|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
37880015|NCT03739840|69564527|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
37880016|NCT03739840|69564524|FG000|Treatment Period: Wk0-16|Program Termination|3|||
37880017|NCT03739840|69564525|FG001|Treatment Period: Wk0-16|Program Termination|0|||
37880018|NCT03739840|69564526|FG002|Treatment Period: Wk0-16|Program Termination|1|||
37880019|NCT03739840|69564527|FG003|Treatment Period: Wk0-16|Program Termination|1|||
37880020|NCT03739840|69564524|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
37819453|NCT02587520|69498511|FG004|Overall Study|Lost to Follow-up|0|||
37819454|NCT02587520|69498512|FG005|Overall Study|Lost to Follow-up|1|||
37819455|NCT02587520|69498513|FG006|Overall Study|Lost to Follow-up|1|||
37819456|NCT02587520|69498514|FG007|Overall Study|Lost to Follow-up|1|||
37819457|NCT02587520|69498515|FG008|Overall Study|Lost to Follow-up|0|||
37819458|NCT02587520|69498516|FG009|Overall Study|Lost to Follow-up|2|||
37819459|NCT02587520|69498517|FG010|Overall Study|Lost to Follow-up|2|||
37819460|NCT02587520|69498518|FG011|Overall Study|Lost to Follow-up|1|||
37880021|NCT03739840|69564525|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
37880022|NCT03739840|69564526|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
37880023|NCT03739840|69564527|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
37880024|NCT03739840|69564524|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
37880025|NCT03739840|69564525|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
37880026|NCT03739840|69564526|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
37880027|NCT03739840|69564527|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
37880028|NCT03739840|69564524|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
37880029|NCT03739840|69564525|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
37880030|NCT03739840|69564526|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
37880031|NCT03739840|69564527|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
37880032|NCT03739840|69564524|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
37880033|NCT03739840|69564525|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
37880034|NCT03739840|69564526|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
37880035|NCT03739840|69564527|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
37880036|NCT03739840|69564524|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
37880037|NCT03739840|69564525|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
37880038|NCT03739840|69564526|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
37880039|NCT03739840|69564527|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
37880040|NCT03739840|69564524|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
37880041|NCT03739840|69564525|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
37880042|NCT03739840|69564526|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
37880043|NCT03739840|69564527|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
37880044|NCT03739840|69564524|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
37880045|NCT03739840|69564525|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
37880046|NCT03739840|69564526|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
37880047|NCT03739840|69564527|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
37880048|NCT03739840|69564524|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
37880049|NCT03739840|69564525|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
37880050|NCT03739840|69564526|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
37880051|NCT03739840|69564527|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
37880052|NCT03739840|69564524|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
37880053|NCT03739840|69564525|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
37880054|NCT03739840|69564526|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
37880055|NCT03739840|69564527|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
37880056|NCT03739840|69564524|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
37880057|NCT03739840|69564525|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
37880058|NCT03739840|69564526|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
37880059|NCT03739840|69564527|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
37880060|NCT03739840|69564524|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
37880061|NCT03739840|69564525|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
37880062|NCT03739840|69564526|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
37880063|NCT03739840|69564527|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
37984251|NCT00306189|69670316|FG002|Overall Study|Withdrawal by Subject|8|||
37984252|NCT00306189|69670317|FG003|Overall Study|Withdrawal by Subject|1|||
37984253|NCT00306189|69670314|FG000|Overall Study|Ineligibility determined|1|||
37984254|NCT00306189|69670315|FG001|Overall Study|Ineligibility determined|1|||
37984255|NCT00306189|69670316|FG002|Overall Study|Ineligibility determined|1|||
37984256|NCT00306189|69670317|FG003|Overall Study|Ineligibility determined|1|||
37984257|NCT00306189|69670314|FG000|Overall Study|Other|1|||
37984258|NCT00306189|69670315|FG001|Overall Study|Other|0|||
37819461|NCT02587520|69498519|FG012|Overall Study|Lost to Follow-up|0|||
37819462|NCT02587520|69498520|FG013|Overall Study|Lost to Follow-up|0|||
37819463|NCT02587520|69498521|FG014|Overall Study|Lost to Follow-up|0|||
37819464|NCT02587520|69498522|FG015|Overall Study|Lost to Follow-up|0|||
37819465|NCT02587520|69498523|FG016|Overall Study|Lost to Follow-up|0|||
37819466|NCT02587520|69498524|FG017|Overall Study|Lost to Follow-up|0|||
37819467|NCT02584829|69498564|FG000|Overall Study|Physician Decision|1|||
37819468|NCT02584829|69498565|FG001|Overall Study|Physician Decision|0|||
37819469|NCT02584829|69498564|FG000|Overall Study|Withdrawal by Subject|0|||
37819470|NCT02584829|69498565|FG001|Overall Study|Withdrawal by Subject|1|||
37819471|NCT02584829|69498564|FG000|Overall Study|Progressive Disease|0|||
37880064|NCT03739840|69564524|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
37984259|NCT00306189|69670316|FG002|Overall Study|Other|0|||
37819472|NCT02584829|69498565|FG001|Overall Study|Progressive Disease|3|||
37984260|NCT00306189|69670317|FG003|Overall Study|Other|0|||
37984261|NCT00312897|69670329|FG000|Overall Study|Adverse Event|1|||
37819473|NCT02570308|69498578|FG000|Overall Study|Death|1|||
37819474|NCT02570308|69498579|FG001|Overall Study|Death|5|||
37819475|NCT02570308|69498580|FG002|Overall Study|Death|4|||
37880065|NCT03739840|69564525|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
37880066|NCT03739840|69564526|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
37880067|NCT03739840|69564527|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
37880068|NCT03739840|69564524|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
37880069|NCT03739840|69564525|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
37880070|NCT03739840|69564526|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
37880071|NCT03739840|69564527|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
37880072|NCT03739840|69564524|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
37880073|NCT03739840|69564525|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
37880074|NCT03739840|69564526|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
37880075|NCT03739840|69564527|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
37880076|NCT03739840|69564524|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
37880077|NCT03739840|69564525|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
37880078|NCT03739840|69564526|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
37880079|NCT03739840|69564527|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
37880080|NCT03739840|69564524|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
37880081|NCT03739840|69564525|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
37880082|NCT03739840|69564526|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
37880083|NCT03739840|69564527|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
37880084|NCT03739840|69564524|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
37880085|NCT03739840|69564525|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
37880086|NCT03739840|69564526|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
37880087|NCT03739840|69564527|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
37880088|NCT03739840|69564524|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
37880089|NCT03739840|69564525|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
37880090|NCT03739840|69564526|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
37880091|NCT03739840|69564527|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
37880092|NCT03739840|69564524|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
37880093|NCT03739840|69564525|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
37880094|NCT03739840|69564526|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
37880095|NCT03739840|69564527|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
37880096|NCT03739840|69564524|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
37880097|NCT03739840|69564525|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
37880098|NCT03739840|69564526|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
37880099|NCT03739840|69564527|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
37880100|NCT01035060|69564551|FG000|Overall Study|Lost to Follow-up|0|||
37880101|NCT01035060|69564552|FG001|Overall Study|Lost to Follow-up|7|||
37880102|NCT01035060|69564551|FG000|Overall Study|Did not quality after 2nd screening|14|||
37880103|NCT01035060|69564552|FG001|Overall Study|Did not quality after 2nd screening|1|||
37880104|NCT01035060|69564551|FG000|Overall Study|Withdrawal by Subject|8|||
37880105|NCT01035060|69564552|FG001|Overall Study|Withdrawal by Subject|6|||
37880106|NCT01035060|69564551|FG000|Overall Study|Physician Decision|2|||
37880107|NCT01035060|69564552|FG001|Overall Study|Physician Decision|0|||
37880108|NCT01039428|69564560|FG000|Overall Study|Protocol Violation|1|||
37880109|NCT01039428|69564561|FG001|Overall Study|Protocol Violation|0|||
37880110|NCT01039428|69564560|FG000|Overall Study|Withdrawal by Subject|1|||
37880111|NCT01039428|69564561|FG001|Overall Study|Withdrawal by Subject|0|||
37880112|NCT01034358|69564567|FG000|Overall Study|Withdrawal by Subject|1|||
37880113|NCT01034358|69564567|FG000|Overall Study|Protocol Violation|1|||
37880114|NCT01033734|69564575|FG000|Overall Study|Withdrawal by Subject|1|||
37880115|NCT01115855|69564590|FG000|Overall Study|Adverse Event|16|||
37880116|NCT01115855|69564591|FG001|Overall Study|Adverse Event|18|||
37880117|NCT01115855|69564590|FG000|Overall Study|Death|6|||
37880118|NCT01115855|69564591|FG001|Overall Study|Death|5|||
37880119|NCT01115855|69564590|FG000|Overall Study|Lab Abnormality|1|||
37880120|NCT01115855|69564591|FG001|Overall Study|Lab Abnormality|1|||
37880121|NCT01115855|69564590|FG000|Overall Study|Protocol Violation|0|||
37880122|NCT01115855|69564591|FG001|Overall Study|Protocol Violation|1|||
37880123|NCT01115855|69564590|FG000|Overall Study|Withdrawal by Subject|5|||
37880124|NCT01115855|69564591|FG001|Overall Study|Withdrawal by Subject|5|||
37880125|NCT01115855|69564590|FG000|Overall Study|Other|8|||
37880126|NCT01115855|69564591|FG001|Overall Study|Other|6|||
37880127|NCT01115309|69564601|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
37880128|NCT01115309|69564601|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
37880129|NCT01115309|69564601|FG000|Long-term Follow-up|Lost to Follow-up|6|||
37880130|NCT03638128|69564609|FG000|Overall Study|Withdrawal by Subject|1|||
37880131|NCT03638128|69564610|FG001|Overall Study|Withdrawal by Subject|7|||
37880132|NCT03638128|69564611|FG002|Overall Study|Withdrawal by Subject|6|||
37880133|NCT03638128|69564609|FG000|Overall Study|Sponsor Decision|15|||
37880134|NCT03638128|69564610|FG001|Overall Study|Sponsor Decision|12|||
37880135|NCT03638128|69564611|FG002|Overall Study|Sponsor Decision|19|||
37880136|NCT03638128|69564609|FG000|Overall Study|Lost to Follow-up|0|||
37880137|NCT03638128|69564610|FG001|Overall Study|Lost to Follow-up|0|||
37880138|NCT03638128|69564611|FG002|Overall Study|Lost to Follow-up|1|||
37880139|NCT01059630|69564624|FG000|Overall Study|Death|100|||
37880140|NCT01059630|69564625|FG001|Overall Study|Death|84|||
37880141|NCT01059630|69564624|FG000|Overall Study|Lost to Follow-up|4|||
37880142|NCT01059630|69564625|FG001|Overall Study|Lost to Follow-up|1|||
37880143|NCT01059630|69564624|FG000|Overall Study|Physician Decision|2|||
37880144|NCT01059630|69564625|FG001|Overall Study|Physician Decision|4|||
37880145|NCT01059630|69564624|FG000|Overall Study|Withdrawal by Subject|21|||
37880146|NCT01059630|69564625|FG001|Overall Study|Withdrawal by Subject|14|||
37880147|NCT00932373|69564642|FG000|Overall Study|Progressive disease|3|||
37880148|NCT00932373|69564643|FG001|Overall Study|Progressive disease|1|||
37880149|NCT00932373|69564644|FG002|Overall Study|Progressive disease|0|||
37880150|NCT00932373|69564645|FG003|Overall Study|Progressive disease|0|||
37880151|NCT00932373|69564646|FG004|Overall Study|Progressive disease|10|||
37880152|NCT00932373|69564647|FG005|Overall Study|Progressive disease|1|||
37880153|NCT00932373|69564648|FG006|Overall Study|Progressive disease|0|||
37880154|NCT00932373|69564649|FG007|Overall Study|Progressive disease|2|||
37880155|NCT00932373|69564650|FG008|Overall Study|Progressive disease|1|||
37880156|NCT00932373|69564651|FG009|Overall Study|Progressive disease|9|||
37880157|NCT00932373|69564652|FG010|Overall Study|Progressive disease|2|||
37880158|NCT00932373|69564642|FG000|Overall Study|Adverse Event|0|||
37880159|NCT00932373|69564643|FG001|Overall Study|Adverse Event|0|||
37880160|NCT00932373|69564644|FG002|Overall Study|Adverse Event|0|||
37880161|NCT00932373|69564645|FG003|Overall Study|Adverse Event|0|||
37984262|NCT00312897|69670330|FG001|Overall Study|Adverse Event|0|||
37819476|NCT02570308|69498581|FG003|Overall Study|Death|4|||
37819477|NCT02570308|69498582|FG004|Overall Study|Death|69|||
37819478|NCT02570308|69498578|FG000|Overall Study|Lost to Follow-up|0|||
37819479|NCT02570308|69498579|FG001|Overall Study|Lost to Follow-up|0|||
37819480|NCT02570308|69498580|FG002|Overall Study|Lost to Follow-up|0|||
37819481|NCT02570308|69498581|FG003|Overall Study|Lost to Follow-up|0|||
37819482|NCT02570308|69498582|FG004|Overall Study|Lost to Follow-up|2|||
37819483|NCT02570308|69498578|FG000|Overall Study|Withdrawal by Subject|0|||
37819484|NCT02570308|69498579|FG001|Overall Study|Withdrawal by Subject|0|||
37819485|NCT02570308|69498580|FG002|Overall Study|Withdrawal by Subject|0|||
37819486|NCT02570308|69498581|FG003|Overall Study|Withdrawal by Subject|0|||
37819487|NCT02570308|69498582|FG004|Overall Study|Withdrawal by Subject|1|||
37819488|NCT02570308|69498578|FG000|Overall Study|Other|0|||
37819489|NCT02570308|69498579|FG001|Overall Study|Other|0|||
37819490|NCT02570308|69498580|FG002|Overall Study|Other|0|||
37819491|NCT02570308|69498581|FG003|Overall Study|Other|0|||
37819492|NCT02570308|69498582|FG004|Overall Study|Other|2|||
37819493|NCT02497612|69498604|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
37819494|NCT02497612|69498605|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
37819495|NCT02497612|69498606|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
37819496|NCT02497612|69498607|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
37984263|NCT00312897|69670329|FG000|Overall Study|Lost to Follow-up|2|||
37819497|NCT02497612|69498604|FG000|Overall Study|Participant's request|2|||
37819498|NCT02497612|69498605|FG001|Overall Study|Participant's request|3|||
37819499|NCT02497612|69498606|FG002|Overall Study|Participant's request|4|||
37819500|NCT02497612|69498607|FG003|Overall Study|Participant's request|1|||
37819501|NCT02497612|69498604|FG000|Overall Study|Investigator's judgement|1|||
37819502|NCT02497612|69498605|FG001|Overall Study|Investigator's judgement|0|||
37880162|NCT00932373|69564646|FG004|Overall Study|Adverse Event|2|||
37880163|NCT00932373|69564647|FG005|Overall Study|Adverse Event|1|||
37880164|NCT00932373|69564648|FG006|Overall Study|Adverse Event|0|||
37984264|NCT00312897|69670330|FG001|Overall Study|Lost to Follow-up|0|||
37880165|NCT00932373|69564649|FG007|Overall Study|Adverse Event|1|||
37880166|NCT00932373|69564650|FG008|Overall Study|Adverse Event|0|||
37880167|NCT00932373|69564651|FG009|Overall Study|Adverse Event|2|||
37984265|NCT00312897|69670329|FG000|Overall Study|Physician Decision|1|||
37880168|NCT00932373|69564652|FG010|Overall Study|Adverse Event|1|||
37880169|NCT00932373|69564642|FG000|Overall Study|Physician Decision|0|||
37880170|NCT00932373|69564643|FG001|Overall Study|Physician Decision|0|||
37880171|NCT00932373|69564644|FG002|Overall Study|Physician Decision|1|||
37880172|NCT00932373|69564645|FG003|Overall Study|Physician Decision|0|||
37880173|NCT00932373|69564646|FG004|Overall Study|Physician Decision|2|||
37880174|NCT00932373|69564647|FG005|Overall Study|Physician Decision|0|||
37880175|NCT00932373|69564648|FG006|Overall Study|Physician Decision|0|||
37880176|NCT00932373|69564649|FG007|Overall Study|Physician Decision|0|||
37984266|NCT00312897|69670330|FG001|Overall Study|Physician Decision|0|||
37984267|NCT00312897|69670329|FG000|Overall Study|Withdrawal by Subject|1|||
37984268|NCT00312897|69670330|FG001|Overall Study|Withdrawal by Subject|3|||
37984269|NCT00312897|69670329|FG000|Overall Study|Pregnancy|1|||
37984270|NCT00312897|69670330|FG001|Overall Study|Pregnancy|0|||
37819503|NCT02497612|69498606|FG002|Overall Study|Investigator's judgement|0|||
37819504|NCT02497612|69498607|FG003|Overall Study|Investigator's judgement|2|||
37880177|NCT00932373|69564650|FG008|Overall Study|Physician Decision|0|||
37880178|NCT00932373|69564651|FG009|Overall Study|Physician Decision|1|||
37880179|NCT00932373|69564652|FG010|Overall Study|Physician Decision|0|||
37880180|NCT00932373|69564642|FG000|Overall Study|Dose limiting toxicity|0|||
37880181|NCT00932373|69564643|FG001|Overall Study|Dose limiting toxicity|0|||
37880182|NCT00932373|69564644|FG002|Overall Study|Dose limiting toxicity|0|||
37880183|NCT00932373|69564645|FG003|Overall Study|Dose limiting toxicity|0|||
37880184|NCT00932373|69564646|FG004|Overall Study|Dose limiting toxicity|0|||
37880185|NCT00932373|69564647|FG005|Overall Study|Dose limiting toxicity|1|||
37880186|NCT00932373|69564648|FG006|Overall Study|Dose limiting toxicity|0|||
37880187|NCT00932373|69564649|FG007|Overall Study|Dose limiting toxicity|0|||
37880188|NCT00932373|69564650|FG008|Overall Study|Dose limiting toxicity|0|||
37880189|NCT00932373|69564651|FG009|Overall Study|Dose limiting toxicity|0|||
37880190|NCT00932373|69564652|FG010|Overall Study|Dose limiting toxicity|0|||
37880191|NCT00932373|69564642|FG000|Overall Study|Withdrawal by Subject|0|||
37880192|NCT00932373|69564643|FG001|Overall Study|Withdrawal by Subject|0|||
37880193|NCT00932373|69564644|FG002|Overall Study|Withdrawal by Subject|0|||
37880194|NCT00932373|69564645|FG003|Overall Study|Withdrawal by Subject|0|||
37880195|NCT00932373|69564646|FG004|Overall Study|Withdrawal by Subject|0|||
37880196|NCT00932373|69564647|FG005|Overall Study|Withdrawal by Subject|0|||
37880197|NCT00932373|69564648|FG006|Overall Study|Withdrawal by Subject|0|||
37880198|NCT00932373|69564649|FG007|Overall Study|Withdrawal by Subject|0|||
37880199|NCT00932373|69564650|FG008|Overall Study|Withdrawal by Subject|1|||
37880200|NCT00932373|69564651|FG009|Overall Study|Withdrawal by Subject|0|||
37880201|NCT00932373|69564652|FG010|Overall Study|Withdrawal by Subject|0|||
37880202|NCT00932373|69564642|FG000|Overall Study|Clinical progression|0|||
37880203|NCT00932373|69564643|FG001|Overall Study|Clinical progression|0|||
37880204|NCT00932373|69564644|FG002|Overall Study|Clinical progression|0|||
37880205|NCT00932373|69564645|FG003|Overall Study|Clinical progression|0|||
37880206|NCT00932373|69564646|FG004|Overall Study|Clinical progression|0|||
37880207|NCT00932373|69564647|FG005|Overall Study|Clinical progression|0|||
37880208|NCT00932373|69564648|FG006|Overall Study|Clinical progression|1|||
37880209|NCT00932373|69564649|FG007|Overall Study|Clinical progression|0|||
37880210|NCT00932373|69564650|FG008|Overall Study|Clinical progression|0|||
37819505|NCT02497612|69498604|FG000|Overall Study|Adverse Event|3|||
37819506|NCT02497612|69498605|FG001|Overall Study|Adverse Event|1|||
37819507|NCT02497612|69498606|FG002|Overall Study|Adverse Event|4|||
37819508|NCT02497612|69498607|FG003|Overall Study|Adverse Event|1|||
37819509|NCT02497612|69498604|FG000|Overall Study|Lost to Follow-up|1|||
37819510|NCT02497612|69498605|FG001|Overall Study|Lost to Follow-up|1|||
37819511|NCT02497612|69498606|FG002|Overall Study|Lost to Follow-up|0|||
37819512|NCT02497612|69498607|FG003|Overall Study|Lost to Follow-up|1|||
37819513|NCT02497612|69498604|FG000|Overall Study|Other unspecified|1|||
37819514|NCT02497612|69498605|FG001|Overall Study|Other unspecified|1|||
37819515|NCT02497612|69498606|FG002|Overall Study|Other unspecified|2|||
37880211|NCT00932373|69564651|FG009|Overall Study|Clinical progression|0|||
37880212|NCT00932373|69564652|FG010|Overall Study|Clinical progression|0|||
37880213|NCT00932373|69564642|FG000|Overall Study|Lack of Efficacy|0|||
37984271|NCT00312897|69670329|FG000|Overall Study|discontinued prior to getting treatment|0|||
37819516|NCT02497612|69498607|FG003|Overall Study|Other unspecified|0|||
37819517|NCT02497612|69498604|FG000|Overall Study|Not eligible|1|||
37819518|NCT02497612|69498605|FG001|Overall Study|Not eligible|0|||
37819519|NCT02497612|69498606|FG002|Overall Study|Not eligible|0|||
37819520|NCT02497612|69498607|FG003|Overall Study|Not eligible|1|||
37880214|NCT00932373|69564643|FG001|Overall Study|Lack of Efficacy|0|||
37880215|NCT00932373|69564644|FG002|Overall Study|Lack of Efficacy|0|||
37984272|NCT00312897|69670330|FG001|Overall Study|discontinued prior to getting treatment|3|||
37984273|NCT00312663|69670339|FG000|Immunization Phase|Adverse Event|0|||
37819521|NCT02460458|69498617|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analyses|47|||
37880216|NCT00932373|69564645|FG003|Overall Study|Lack of Efficacy|0|||
37880217|NCT00932373|69564646|FG004|Overall Study|Lack of Efficacy|0|||
37880218|NCT00932373|69564647|FG005|Overall Study|Lack of Efficacy|0|||
37880219|NCT00932373|69564648|FG006|Overall Study|Lack of Efficacy|0|||
37880220|NCT00932373|69564649|FG007|Overall Study|Lack of Efficacy|0|||
37880221|NCT00932373|69564650|FG008|Overall Study|Lack of Efficacy|0|||
37880222|NCT00932373|69564651|FG009|Overall Study|Lack of Efficacy|1|||
37880223|NCT00932373|69564652|FG010|Overall Study|Lack of Efficacy|0|||
37880224|NCT01055496|69564686|FG000|Overall Study|Withdrawal by Subject|2|||
37880225|NCT01055496|69564687|FG001|Overall Study|Withdrawal by Subject|4|||
37880226|NCT01055496|69564686|FG000|Overall Study|Death|13|||
37880227|NCT01055496|69564687|FG001|Overall Study|Death|23|||
37880228|NCT01055496|69564686|FG000|Overall Study|Lost to Follow-up|0|||
37880229|NCT01055496|69564687|FG001|Overall Study|Lost to Follow-up|2|||
37984274|NCT00312663|69670340|FG001|Immunization Phase|Adverse Event|1|||
37984275|NCT00312663|69670341|FG002|Immunization Phase|Adverse Event|0|||
37984276|NCT00294645|69670352|FG000|Overall Study|Death|10|||
37984277|NCT00294645|69670353|FG001|Overall Study|Death|18|||
37984278|NCT00294645|69670352|FG000|Overall Study|Lost to Follow-up|1|||
37984279|NCT00294645|69670353|FG001|Overall Study|Lost to Follow-up|10|||
37984280|NCT00294645|69670352|FG000|Overall Study|Withdrawal by Subject|18|||
37984281|NCT00294645|69670353|FG001|Overall Study|Withdrawal by Subject|34|||
37984282|NCT00294645|69670352|FG000|Overall Study|Physician Decision|15|||
37984283|NCT00294645|69670353|FG001|Overall Study|Physician Decision|20|||
37984284|NCT00294645|69670352|FG000|Overall Study|Other|4|||
37819522|NCT02460458|69498617|FG000|Confirmatory Phase|Patients excluded due to lack of samples for central analyses|27|||
37819523|NCT02460458|69498617|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|14|||
37819524|NCT02460458|69498617|FG000|First Prospective Phase|Lost to Follow-up|16|||
37819525|NCT02460458|69498617|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|9|||
37819526|NCT02457559|69498632|FG000|Overall Study|Progressive Disease|1|||
37819527|NCT02457559|69498633|FG001|Overall Study|Progressive Disease|2|||
37819528|NCT02457559|69498634|FG002|Overall Study|Progressive Disease|3|||
37819529|NCT02457559|69498635|FG003|Overall Study|Progressive Disease|0|||
37819530|NCT02457559|69498636|FG004|Overall Study|Progressive Disease|0|||
37819531|NCT02457559|69498637|FG005|Overall Study|Progressive Disease|2|||
37819532|NCT02457559|69498638|FG006|Overall Study|Progressive Disease|1|||
37819533|NCT02457559|69498639|FG007|Overall Study|Progressive Disease|0|||
37819534|NCT02457559|69498640|FG008|Overall Study|Progressive Disease|1|||
37819535|NCT02457559|69498641|FG009|Overall Study|Progressive Disease|1|||
37819536|NCT02457559|69498642|FG010|Overall Study|Progressive Disease|1|||
37819537|NCT02457559|69498632|FG000|Overall Study|Investigator's Discretion|0|||
37819538|NCT02457559|69498633|FG001|Overall Study|Investigator's Discretion|0|||
37819539|NCT02457559|69498634|FG002|Overall Study|Investigator's Discretion|2|||
37819540|NCT02457559|69498635|FG003|Overall Study|Investigator's Discretion|0|||
37819541|NCT02457559|69498636|FG004|Overall Study|Investigator's Discretion|1|||
37819542|NCT02457559|69498637|FG005|Overall Study|Investigator's Discretion|0|||
37819543|NCT02457559|69498638|FG006|Overall Study|Investigator's Discretion|1|||
37819544|NCT02457559|69498639|FG007|Overall Study|Investigator's Discretion|0|||
37819545|NCT02457559|69498640|FG008|Overall Study|Investigator's Discretion|1|||
37880230|NCT01055496|69564686|FG000|Overall Study|Other - Unspecified|0|||
37880231|NCT01055496|69564687|FG001|Overall Study|Other - Unspecified|1|||
37880232|NCT01055262|69564714|FG000|Overall Study|Adverse Event|5|||
37880233|NCT01055262|69564714|FG000|Overall Study|Protocol Violation|3|||
37984285|NCT00294645|69670353|FG001|Overall Study|Other|10|||
37984286|NCT00305877|69670361|FG000|Overall Study|Lack of Efficacy|6|||
37984287|NCT00305877|69670362|FG001|Overall Study|Lack of Efficacy|9|||
37984288|NCT00305877|69670361|FG000|Overall Study|Adverse Event|9|||
37819546|NCT02457559|69498641|FG009|Overall Study|Investigator's Discretion|0|||
37880234|NCT01055262|69564714|FG000|Overall Study|Uncooperativeness|1|||
37880235|NCT01052844|69564720|FG000|Overall Study|Adverse Event|0|||
37880236|NCT01052844|69564721|FG001|Overall Study|Adverse Event|1|||
37880237|NCT01049412|69564729|FG000|Period I|Withdrawal by Subject|4|||
37880238|NCT01049412|69564730|FG001|Period I|Withdrawal by Subject|6|||
37880239|NCT01049412|69564729|FG000|Period I|Lost to Follow-up|2|||
37880240|NCT01049412|69564730|FG001|Period I|Lost to Follow-up|2|||
37880241|NCT01049412|69564729|FG000|Period I|Physician Decision|0|||
37880242|NCT01049412|69564730|FG001|Period I|Physician Decision|3|||
37880243|NCT01049412|69564729|FG000|Period I|Protocol Violation|1|||
37880244|NCT01049412|69564730|FG001|Period I|Protocol Violation|2|||
37880245|NCT01049412|69564729|FG000|Period I|Adverse Event|1|||
37880246|NCT01049412|69564730|FG001|Period I|Adverse Event|0|||
37880247|NCT01049412|69564729|FG000|Period II|Withdrawal by Subject|2|||
37880248|NCT01049412|69564730|FG001|Period II|Withdrawal by Subject|3|||
37880249|NCT01049412|69564729|FG000|Period II|Adverse Event|1|||
37880250|NCT01049412|69564730|FG001|Period II|Adverse Event|0|||
37880251|NCT01049412|69564729|FG000|Period II|Lost to Follow-up|1|||
37880252|NCT01049412|69564730|FG001|Period II|Lost to Follow-up|0|||
37880253|NCT00934089|69564740|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
37880254|NCT00934089|69564741|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
37880255|NCT00934089|69564740|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
37880256|NCT00934089|69564741|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
37880257|NCT01032174|69564749|FG000|Overall Study|Adverse Event|0|||
37880258|NCT01032174|69564750|FG001|Overall Study|Adverse Event|1|||
37880259|NCT00933933|69564761|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
37880260|NCT00933933|69564762|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
37880261|NCT00933933|69564763|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
37880262|NCT00933933|69564761|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
37880263|NCT00933933|69564762|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
37880264|NCT00933933|69564763|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
37880265|NCT01032018|69564781|FG000|Overall Study|Lost to Follow-up|6|||
37880266|NCT01032018|69564782|FG001|Overall Study|Lost to Follow-up|5|||
37880267|NCT01032018|69564781|FG000|Overall Study|Death|0|||
37880268|NCT01032018|69564782|FG001|Overall Study|Death|1|||
37880269|NCT01031706|69564790|FG000|Overall Study|Adverse Event|1|||
37880270|NCT01031706|69564791|FG001|Overall Study|Adverse Event|0|||
37880271|NCT01031706|69564790|FG000|Overall Study|Withdrawal by Subject|1|||
37819547|NCT02457559|69498642|FG010|Overall Study|Investigator's Discretion|1|||
37819548|NCT02457559|69498632|FG000|Overall Study|Adverse Event|0|||
37819549|NCT02457559|69498633|FG001|Overall Study|Adverse Event|1|||
37819550|NCT02457559|69498634|FG002|Overall Study|Adverse Event|2|||
37819551|NCT02457559|69498635|FG003|Overall Study|Adverse Event|0|||
37819552|NCT02457559|69498636|FG004|Overall Study|Adverse Event|0|||
37819553|NCT02457559|69498637|FG005|Overall Study|Adverse Event|0|||
37819554|NCT02457559|69498638|FG006|Overall Study|Adverse Event|0|||
37819555|NCT02457559|69498639|FG007|Overall Study|Adverse Event|0|||
37819556|NCT02457559|69498640|FG008|Overall Study|Adverse Event|0|||
37819557|NCT02457559|69498641|FG009|Overall Study|Adverse Event|0|||
37819558|NCT02457559|69498642|FG010|Overall Study|Adverse Event|0|||
37819559|NCT02457559|69498632|FG000|Overall Study|Reason not Specified|1|||
37819560|NCT02457559|69498633|FG001|Overall Study|Reason not Specified|0|||
37819561|NCT02457559|69498634|FG002|Overall Study|Reason not Specified|0|||
37819562|NCT02457559|69498635|FG003|Overall Study|Reason not Specified|0|||
37819563|NCT02457559|69498636|FG004|Overall Study|Reason not Specified|0|||
37819564|NCT02457559|69498637|FG005|Overall Study|Reason not Specified|0|||
37819565|NCT02457559|69498638|FG006|Overall Study|Reason not Specified|0|||
37819566|NCT02457559|69498639|FG007|Overall Study|Reason not Specified|0|||
37819567|NCT02457559|69498640|FG008|Overall Study|Reason not Specified|0|||
37819568|NCT02457559|69498641|FG009|Overall Study|Reason not Specified|2|||
37819569|NCT02457559|69498642|FG010|Overall Study|Reason not Specified|0|||
37819570|NCT02457559|69498632|FG000|Overall Study|Death|0|||
37880272|NCT01031706|69564791|FG001|Overall Study|Withdrawal by Subject|1|||
37880273|NCT00927069|69564799|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
37880274|NCT00927069|69564800|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
37880275|NCT00927069|69564801|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
37880276|NCT00927069|69564802|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
37880277|NCT00927069|69564799|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
37880278|NCT00927069|69564800|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
37819571|NCT02457559|69498633|FG001|Overall Study|Death|0|||
37819572|NCT02457559|69498634|FG002|Overall Study|Death|0|||
37819573|NCT02457559|69498635|FG003|Overall Study|Death|0|||
37819574|NCT02457559|69498636|FG004|Overall Study|Death|0|||
37984289|NCT00305877|69670362|FG001|Overall Study|Adverse Event|14|||
37984290|NCT00305877|69670361|FG000|Overall Study|Death|0|||
37984291|NCT00305877|69670362|FG001|Overall Study|Death|1|||
37984292|NCT00305877|69670361|FG000|Overall Study|Withdrawal by Subject|4|||
37984293|NCT00305877|69670362|FG001|Overall Study|Withdrawal by Subject|2|||
37984294|NCT00305877|69670361|FG000|Overall Study|Physician Decision|1|||
37984295|NCT00305877|69670362|FG001|Overall Study|Physician Decision|1|||
37984296|NCT00305877|69670361|FG000|Overall Study|Never start treatment|2|||
37984297|NCT00305877|69670362|FG001|Overall Study|Never start treatment|5|||
37984298|NCT00305877|69670361|FG000|Overall Study|Ineligible|2|||
37984299|NCT00305877|69670362|FG001|Overall Study|Ineligible|1|||
37984300|NCT00305877|69670361|FG000|Overall Study|Transportation issue with daily RT|0|||
37984301|NCT00305877|69670362|FG001|Overall Study|Transportation issue with daily RT|1|||
37984302|NCT00312195|69670370|FG000|Overall Study|Adverse Event|4|||
37984303|NCT00312195|69670371|FG001|Overall Study|Adverse Event|6|||
37880279|NCT00927069|69564801|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
37880280|NCT00927069|69564802|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
37880281|NCT00927069|69564799|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
37880282|NCT00927069|69564800|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
37880283|NCT00927069|69564801|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
37880284|NCT00927069|69564802|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
37880285|NCT00927069|69564799|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
37880286|NCT00927069|69564800|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
37880287|NCT00927069|69564801|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
37880288|NCT00927069|69564802|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
37880289|NCT00927069|69564799|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
37880290|NCT00927069|69564800|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
37984304|NCT00312195|69670370|FG000|Overall Study|Lost to Follow-up|1|||
37984305|NCT00312195|69670371|FG001|Overall Study|Lost to Follow-up|0|||
37984306|NCT00312195|69670370|FG000|Overall Study|Protocol Violation|1|||
37984307|NCT00312195|69670371|FG001|Overall Study|Protocol Violation|0|||
37984308|NCT00305253|69670381|FG000|Overall Study|Withdrawal by Subject|0|||
37984309|NCT00305253|69670382|FG001|Overall Study|Withdrawal by Subject|1|||
37984310|NCT00293709|69670388|FG000|Overall Study|Other|47|||
37984311|NCT00311181|69670392|FG000|Overall Study|Final DFTs were not obtained|96|||
37984312|NCT00293397|69670396|FG000|Overall Study|Death|2|||
37984313|NCT00290745|69670401|FG000|Overall Study|Withdrawal by Subject|4|||
37984314|NCT00290745|69670401|FG000|Overall Study|Physician Decision|2|||
37984315|NCT00290745|69670401|FG000|Overall Study|Surgery after 3 months for progression|3|||
37984316|NCT00290745|69670401|FG000|Overall Study|Baseline MRI not available|3|||
37984317|NCT00402168|69670407|FG000|Randomized|Lost to Follow-up|1|||
37984318|NCT00402168|69670408|FG001|Randomized|Lost to Follow-up|0|||
37984319|NCT00402168|69670407|FG000|Randomized|Withdrawal by Subject|0|||
37984320|NCT00402168|69670408|FG001|Randomized|Withdrawal by Subject|1|||
37984321|NCT00402168|69670407|FG000|Treatment (up to 12 Months)|Death|0|||
37819575|NCT02457559|69498637|FG005|Overall Study|Death|0|||
37819576|NCT02457559|69498638|FG006|Overall Study|Death|0|||
37819577|NCT02457559|69498639|FG007|Overall Study|Death|0|||
37819578|NCT02457559|69498640|FG008|Overall Study|Death|1|||
37819579|NCT02457559|69498641|FG009|Overall Study|Death|1|||
37819580|NCT02457559|69498642|FG010|Overall Study|Death|0|||
37819581|NCT02381652|69498692|FG000|Overall Study|Withdrawal by Subject|0|||
37819582|NCT02381652|69498693|FG001|Overall Study|Withdrawal by Subject|0|||
37819583|NCT02381652|69498694|FG002|Overall Study|Withdrawal by Subject|1|||
37819584|NCT02367794|69498703|FG000|Overall Study|Death|252|||
37819585|NCT02367794|69498704|FG001|Overall Study|Death|245|||
37819586|NCT02367794|69498705|FG002|Overall Study|Death|243|||
37819587|NCT02367794|69498703|FG000|Overall Study|Lost to Follow-up|1|||
37819588|NCT02367794|69498704|FG001|Overall Study|Lost to Follow-up|2|||
37819589|NCT02367794|69498705|FG002|Overall Study|Lost to Follow-up|2|||
37819590|NCT02367794|69498703|FG000|Overall Study|Physician Decision|0|||
37984322|NCT00402168|69670408|FG001|Treatment (up to 12 Months)|Death|1|||
37984323|NCT00402168|69670407|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
37984324|NCT00402168|69670408|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
37984325|NCT00402168|69670407|FG000|Treatment (up to 12 Months)|non-specified|0|||
37984326|NCT00402168|69670408|FG001|Treatment (up to 12 Months)|non-specified|1|||
37984327|NCT00402168|69670407|FG000|Long Term (LT)|Adverse Event|1|||
37819591|NCT02367794|69498704|FG001|Overall Study|Physician Decision|5|||
37819592|NCT02367794|69498705|FG002|Overall Study|Physician Decision|3|||
37819593|NCT02367794|69498703|FG000|Overall Study|Protocol Violation|1|||
37880291|NCT00927069|69564801|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
37880292|NCT00927069|69564802|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
37880293|NCT01031628|69564816|FG000|Overall Study|Study terminated early|0|||
37880294|NCT01031628|69564817|FG001|Overall Study|Study terminated early|1|||
37880295|NCT01031628|69564818|FG002|Overall Study|Study terminated early|3|||
37880296|NCT01031628|69564819|FG003|Overall Study|Study terminated early|0|||
37880297|NCT01031004|69564831|FG000|Overall Study|Protocol Violation|0|||
37880298|NCT01031004|69564832|FG001|Overall Study|Protocol Violation|1|||
37880299|NCT01031004|69564831|FG000|Overall Study|Lost to Follow-up|1|||
37880300|NCT01031004|69564832|FG001|Overall Study|Lost to Follow-up|0|||
37695233|NCT02349295|69171762|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
37695234|NCT02349295|69171749|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
37695235|NCT02349295|69171750|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
37695236|NCT02349295|69171751|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
37695237|NCT02349295|69171752|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
37695238|NCT02349295|69171753|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
37695239|NCT02349295|69171754|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
37695240|NCT02349295|69171755|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
37695241|NCT02349295|69171756|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
37695242|NCT02349295|69171757|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
37695243|NCT02349295|69171758|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
37695244|NCT02349295|69171759|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
37695245|NCT02349295|69171760|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
37819594|NCT02367794|69498704|FG001|Overall Study|Protocol Violation|0|||
37819595|NCT02367794|69498705|FG002|Overall Study|Protocol Violation|1|||
37880301|NCT00931515|69564840|FG000|Overall Study|Lost to Follow-up|2|||
37880302|NCT00931515|69564841|FG001|Overall Study|Lost to Follow-up|5|||
37880303|NCT01028352|69564847|FG000|Overall Study|Ineligible due to baseline average pain|5|||
37880304|NCT01028352|69564847|FG000|Overall Study|Withdrawal by Subject|1|||
37880305|NCT00929643|69564864|FG000|Overall Study|Protocol Violation|2|||
37880306|NCT00926367|69564870|FG000|Overall Study|Withdrawal by Subject|0|||
37880307|NCT00926367|69564871|FG001|Overall Study|Withdrawal by Subject|1|||
37880308|NCT00926367|69564870|FG000|Overall Study|Lost to Follow-up|1|||
37880309|NCT00926367|69564871|FG001|Overall Study|Lost to Follow-up|0|||
37880310|NCT00926367|69564870|FG000|Overall Study|Skin Irritation|1|||
37880311|NCT00926367|69564871|FG001|Overall Study|Skin Irritation|2|||
37880312|NCT01114529|69564882|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
37880313|NCT01114529|69564883|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
37880314|NCT01114529|69564884|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
37880315|NCT01114529|69564882|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
37880316|NCT01114529|69564883|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
37880317|NCT01114529|69564884|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
37880318|NCT01114529|69564882|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
37880319|NCT01114529|69564883|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
37880320|NCT01114529|69564884|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
37880321|NCT01114529|69564882|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
37880322|NCT01114529|69564883|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
37880323|NCT01114529|69564884|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
37880324|NCT01114529|69564882|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
37880325|NCT01114529|69564883|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
37880326|NCT01114529|69564884|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
37880327|NCT01114529|69564882|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
37880328|NCT01114529|69564883|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
37880329|NCT01114529|69564884|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
37819596|NCT02367794|69498703|FG000|Overall Study|Withdrawal by Subject|25|||
37819597|NCT02367794|69498704|FG001|Overall Study|Withdrawal by Subject|12|||
37819598|NCT02367794|69498705|FG002|Overall Study|Withdrawal by Subject|20|||
37819599|NCT02367794|69498703|FG000|Overall Study|Brain metastasis|1|||
37819600|NCT02367794|69498704|FG001|Overall Study|Brain metastasis|0|||
37819601|NCT02367794|69498705|FG002|Overall Study|Brain metastasis|0|||
37819602|NCT02367794|69498703|FG000|Overall Study|Randomized in error|0|||
37819603|NCT02367794|69498704|FG001|Overall Study|Randomized in error|0|||
37819604|NCT02367794|69498705|FG002|Overall Study|Randomized in error|1|||
37819605|NCT02367794|69498703|FG000|Overall Study|Patient unable to receive carboplatin|0|||
37880330|NCT01114529|69564882|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
37880331|NCT01114529|69564883|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
37880332|NCT01114529|69564884|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
37880333|NCT01114529|69564882|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
37880334|NCT01114529|69564883|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
37984328|NCT00402168|69670408|FG001|Long Term (LT)|Adverse Event|5|||
37984329|NCT00402168|69670407|FG000|Long Term (LT)|Withdrawal by Subject|4|||
37984330|NCT00402168|69670408|FG001|Long Term (LT)|Withdrawal by Subject|7|||
37984331|NCT00402168|69670407|FG000|Long Term (LT)|Pregnancy|0|||
37984332|NCT00402168|69670408|FG001|Long Term (LT)|Pregnancy|1|||
37984333|NCT00402168|69670407|FG000|Long Term (LT)|Lost to Follow-up|1|||
37984334|NCT00402168|69670408|FG001|Long Term (LT)|Lost to Follow-up|0|||
37984335|NCT00402168|69670407|FG000|Long Term (LT)|Death|4|||
37984336|NCT00402168|69670408|FG001|Long Term (LT)|Death|0|||
37984337|NCT00402168|69670407|FG000|Long Term (LT)|Lack of Efficacy|0|||
37984338|NCT00402168|69670408|FG001|Long Term (LT)|Lack of Efficacy|2|||
37984339|NCT00402168|69670407|FG000|Long Term (LT)|non-specified|1|||
37984340|NCT00402168|69670408|FG001|Long Term (LT)|non-specified|2|||
37984341|NCT00402168|69670407|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
37984342|NCT00402168|69670408|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
37984343|NCT00402168|69670407|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
37984344|NCT00402168|69670408|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
37984345|NCT00290589|69670424|FG000|Overall Study|Lost to Follow-up|2|||
37984346|NCT00290589|69670425|FG001|Overall Study|Lost to Follow-up|2|||
37984347|NCT00290511|69670431|FG000|Overall Study|Adverse Event|1|||
37984348|NCT00290511|69670431|FG000|Overall Study|Death|1|||
37984349|NCT00290511|69670431|FG000|Overall Study|Physician Decision|1|||
37695246|NCT02349295|69171761|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
37695247|NCT02349295|69171762|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
37695248|NCT02349295|69171749|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
37695249|NCT02349295|69171750|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
37819606|NCT02367794|69498704|FG001|Overall Study|Patient unable to receive carboplatin|0|||
37819607|NCT02367794|69498705|FG002|Overall Study|Patient unable to receive carboplatin|1|||
37819608|NCT02367794|69498703|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
37819609|NCT02367794|69498704|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
37819610|NCT02367794|69498705|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
37819611|NCT02367794|69498703|FG000|Overall Study|Adverse Event|0|||
37819612|NCT02367794|69498704|FG001|Overall Study|Adverse Event|0|||
37819613|NCT02367794|69498705|FG002|Overall Study|Adverse Event|2|||
37819614|NCT02367794|69498703|FG000|Overall Study|Study Terminated By Sponsor|0|||
37819615|NCT02367794|69498704|FG001|Overall Study|Study Terminated By Sponsor|1|||
37819616|NCT02367794|69498705|FG002|Overall Study|Study Terminated By Sponsor|1|||
37819617|NCT02367794|69498703|FG000|Overall Study|Moved to Roll-Over Study|0|||
37819618|NCT02367794|69498704|FG001|Overall Study|Moved to Roll-Over Study|15|||
37819619|NCT02367794|69498705|FG002|Overall Study|Moved to Roll-Over Study|13|||
37819620|NCT02367794|69498703|FG000|Overall Study|Sponsor Request|60|||
37819621|NCT02367794|69498704|FG001|Overall Study|Sponsor Request|57|||
37819622|NCT02367794|69498705|FG002|Overall Study|Sponsor Request|45|||
37819623|NCT02367794|69498703|FG000|Overall Study|Moved into PTAP Study|0|||
37819624|NCT02367794|69498704|FG001|Overall Study|Moved into PTAP Study|2|||
37819625|NCT02367794|69498705|FG002|Overall Study|Moved into PTAP Study|3|||
37819626|NCT02367794|69498703|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
37819627|NCT02367794|69498704|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
37819628|NCT02367794|69498705|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
37819629|NCT02367794|69498703|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
37819630|NCT02367794|69498704|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
37819631|NCT02367794|69498705|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
37819632|NCT02367794|69498703|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
37819633|NCT02367794|69498704|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
37819634|NCT02367794|69498705|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
37819635|NCT02367794|69498703|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
37819636|NCT02367794|69498704|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
37819637|NCT02367794|69498705|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
37819638|NCT02353832|69498738|FG000|Overall Study|Ineligible after enrollment|1|||
37819639|NCT02353832|69498738|FG000|Overall Study|Lost to Follow-up|1|||
37819640|NCT02353728|69498742|FG000|Overall Study|Subject non-compliance|1|||
37819641|NCT02345070|69498749|FG000|Overall Study|Adverse Event|12|||
37819642|NCT02345070|69498750|FG001|Overall Study|Adverse Event|8|||
37819643|NCT02345070|69498751|FG002|Overall Study|Adverse Event|16|||
37819644|NCT02345070|69498749|FG000|Overall Study|Poor compliance to protocol|2|||
37819645|NCT02345070|69498750|FG001|Overall Study|Poor compliance to protocol|0|||
37984350|NCT00290511|69670431|FG000|Overall Study|Withdrawal by Subject|1|||
37984351|NCT00290433|69670435|FG000|Overall Study|Disease Progression|13|||
37984352|NCT00290433|69670435|FG000|Overall Study|Adverse Event|14|||
37984353|NCT00290433|69670435|FG000|Overall Study|Withdrawal by Subject|1|||
37984354|NCT00290433|69670435|FG000|Overall Study|Non-Compliance|1|||
37984355|NCT00290433|69670435|FG000|Overall Study|Congestive Heart Failure|1|||
37880335|NCT01114529|69564884|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
37880336|NCT01114529|69564882|FG000|Completed Study Medication at Month 24|Death|2|||
37880337|NCT01114529|69564883|FG001|Completed Study Medication at Month 24|Death|1|||
37880338|NCT01114529|69564884|FG002|Completed Study Medication at Month 24|Death|2|||
37880339|NCT01114529|69564882|FG000|Completed Study Medication at Month 24|Graft loss|0|||
37880340|NCT01114529|69564883|FG001|Completed Study Medication at Month 24|Graft loss|2|||
37880341|NCT01114529|69564884|FG002|Completed Study Medication at Month 24|Graft loss|0|||
37880342|NCT01114529|69564882|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
37880343|NCT01114529|69564883|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
37880344|NCT01114529|69564884|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
37880345|NCT01114529|69564882|FG000|Completed Study Medication at Month 24|Missing|2|||
37880346|NCT01114529|69564883|FG001|Completed Study Medication at Month 24|Missing|0|||
37880347|NCT01114529|69564884|FG002|Completed Study Medication at Month 24|Missing|0|||
37880348|NCT01114529|69564882|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
37880349|NCT01114529|69564883|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
37880350|NCT01114529|69564884|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
37880351|NCT01114529|69564882|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
37984356|NCT00290433|69670435|FG000|Overall Study|Transplant in CR|5|||
37984357|NCT00290433|69670435|FG000|Overall Study|Unrelated Infection/Death|1|||
37984358|NCT00304083|69670441|FG000|Overall Study|Withdrawal by Subject|4|||
37819646|NCT02345070|69498751|FG002|Overall Study|Poor compliance to protocol|0|||
37819647|NCT02345070|69498749|FG000|Overall Study|Other than specified above|6|||
37819648|NCT02345070|69498750|FG001|Overall Study|Other than specified above|3|||
37819649|NCT02345070|69498751|FG002|Overall Study|Other than specified above|7|||
37819650|NCT02325466|69498759|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
37819651|NCT02325466|69498760|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
37819652|NCT02325466|69498761|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
37819653|NCT02325466|69498759|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
37819654|NCT02325466|69498760|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
37819655|NCT02325466|69498761|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
37819656|NCT02325466|69498759|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
37819657|NCT02325466|69498760|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
37819658|NCT02325466|69498761|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
37880352|NCT01114529|69564883|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
37880353|NCT01114529|69564884|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
37880354|NCT01114529|69564882|FG000|Completed Study Phase at Month 24|Death|8|||
37880355|NCT01114529|69564883|FG001|Completed Study Phase at Month 24|Death|5|||
37880356|NCT01114529|69564884|FG002|Completed Study Phase at Month 24|Death|4|||
37880357|NCT01114529|69564882|FG000|Completed Study Phase at Month 24|Other|2|||
37880358|NCT01114529|69564883|FG001|Completed Study Phase at Month 24|Other|0|||
37984359|NCT00304083|69670442|FG001|Overall Study|Withdrawal by Subject|2|||
37984360|NCT00304083|69670441|FG000|Overall Study|Physician Decision|8|||
37984361|NCT00304083|69670442|FG001|Overall Study|Physician Decision|3|||
37984362|NCT00304083|69670441|FG000|Overall Study|Disease Progression|5|||
37984363|NCT00304083|69670442|FG001|Overall Study|Disease Progression|1|||
37984364|NCT00304083|69670441|FG000|Overall Study|Other|5|||
37984365|NCT00304083|69670442|FG001|Overall Study|Other|2|||
37984366|NCT00293241|69670450|FG000|Overall Study|Lost to Follow-up|9|||
37984367|NCT00293241|69670451|FG001|Overall Study|Lost to Follow-up|16|||
37984368|NCT00293241|69670450|FG000|Overall Study|Physician Decision|23|||
37984369|NCT00293241|69670451|FG001|Overall Study|Physician Decision|17|||
37984370|NCT00293241|69670450|FG000|Overall Study|Withdrawal by Subject|4|||
37984371|NCT00293241|69670451|FG001|Overall Study|Withdrawal by Subject|8|||
37880359|NCT01114529|69564884|FG002|Completed Study Phase at Month 24|Other|0|||
37880360|NCT01114529|69564882|FG000|Completed Study Phase at Month 24|Missing|2|||
37984372|NCT00391092|69670462|FG000|Overall Study|Death|78|||
37984373|NCT00391092|69670463|FG001|Overall Study|Death|81|||
37819659|NCT02325466|69498759|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
37819660|NCT02325466|69498760|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
37880361|NCT01114529|69564883|FG001|Completed Study Phase at Month 24|Missing|0|||
37880362|NCT01114529|69564884|FG002|Completed Study Phase at Month 24|Missing|0|||
37880363|NCT00926289|69564896|FG000|Overall Study|Adverse Event|9|||
37880364|NCT00926289|69564897|FG001|Overall Study|Adverse Event|11|||
37880365|NCT00926289|69564896|FG000|Overall Study|Protocol Violation|8|||
37880366|NCT00926289|69564897|FG001|Overall Study|Protocol Violation|12|||
37984374|NCT00391092|69670462|FG000|Overall Study|Lost to Follow-up|13|||
37984375|NCT00391092|69670463|FG001|Overall Study|Lost to Follow-up|18|||
37984376|NCT00391092|69670462|FG000|Overall Study|Alive on treatment|29|||
37984377|NCT00391092|69670463|FG001|Overall Study|Alive on treatment|33|||
37984378|NCT00391092|69670462|FG000|Overall Study|Alive in follow-up|88|||
37880367|NCT00926289|69564896|FG000|Overall Study|Lost to Follow-up|3|||
37880368|NCT00926289|69564897|FG001|Overall Study|Lost to Follow-up|6|||
37880369|NCT00926289|69564896|FG000|Overall Study|Withdrawal by Subject|4|||
37880370|NCT00926289|69564897|FG001|Overall Study|Withdrawal by Subject|4|||
37880371|NCT00926289|69564896|FG000|Overall Study|Other|1|||
37880372|NCT00926289|69564897|FG001|Overall Study|Other|3|||
37880373|NCT03208036|69564922|FG000|Baseline Assessment|Withdrawal by Subject|1|||
37880374|NCT03208036|69564923|FG001|Baseline Assessment|Withdrawal by Subject|1|||
37880375|NCT03208036|69564922|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
37880376|NCT03208036|69564923|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
37880377|NCT03208036|69564922|FG000|Intervention|Withdrawal by Subject|3|||
37880378|NCT03208036|69564923|FG001|Intervention|Withdrawal by Subject|2|||
37880379|NCT03208036|69564922|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
37880380|NCT03208036|69564923|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
37880381|NCT00926211|69564929|FG000|Overall Study|Lost to Follow-up|1|||
37880382|NCT01114373|69564934|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
37880383|NCT01114373|69564935|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
37880384|NCT01114373|69564934|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
37880385|NCT01114373|69564935|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
37880386|NCT01114373|69564934|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
37880387|NCT01114373|69564935|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
37880388|NCT01114373|69564934|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
37880389|NCT01114373|69564935|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
37880390|NCT00925899|69564947|FG000|Part 1|Death|1|||
37880391|NCT00925899|69564948|FG001|Part 1|Death|2|||
37880392|NCT00925899|69564947|FG000|Part 1|Withdrawal by Subject|10|||
37880393|NCT00925899|69564948|FG001|Part 1|Withdrawal by Subject|9|||
37880394|NCT01114217|69564957|FG000|Overall Study|Adverse Event|5|||
37880395|NCT01114217|69564958|FG001|Overall Study|Adverse Event|3|||
37880396|NCT01114217|69564957|FG000|Overall Study|Lost to Follow-up|17|||
37880397|NCT01114217|69564958|FG001|Overall Study|Lost to Follow-up|33|||
37880398|NCT01114217|69564957|FG000|Overall Study|Withdrawal by Subject|21|||
37880399|NCT01114217|69564958|FG001|Overall Study|Withdrawal by Subject|28|||
37880400|NCT01114217|69564957|FG000|Overall Study|Other-Clerical Error|3|||
37984379|NCT00391092|69670463|FG001|Overall Study|Alive in follow-up|84|||
37880401|NCT01114217|69564958|FG001|Overall Study|Other-Clerical Error|0|||
37880402|NCT01114217|69564957|FG000|Overall Study|Other-Early termination|6|||
37880403|NCT01114217|69564958|FG001|Overall Study|Other-Early termination|10|||
37880404|NCT01114217|69564957|FG000|Overall Study|Other-Procedure|1|||
37880405|NCT01114217|69564958|FG001|Overall Study|Other-Procedure|1|||
37880406|NCT01114217|69564957|FG000|Overall Study|Other-Pregnancy|2|||
37880407|NCT01114217|69564958|FG001|Overall Study|Other-Pregnancy|4|||
37880408|NCT01114217|69564957|FG000|Overall Study|Other-Protocol Violation|1|||
37880409|NCT01114217|69564958|FG001|Overall Study|Other-Protocol Violation|3|||
37880410|NCT01114217|69564957|FG000|Overall Study|Other-Lack of Efficacy|1|||
37880411|NCT01114217|69564958|FG001|Overall Study|Other-Lack of Efficacy|0|||
37984380|NCT00374868|69670469|FG000|Overall Study|Adverse Event|12|||
37880412|NCT01114217|69564957|FG000|Overall Study|Other-Non Compliance|2|||
37880413|NCT01114217|69564958|FG001|Overall Study|Other-Non Compliance|0|||
37984381|NCT00374868|69670469|FG000|Overall Study|Progressive Disease|7|||
37984382|NCT00374868|69670469|FG000|Overall Study|Physician Decision|13|||
37880414|NCT01114217|69564957|FG000|Overall Study|Other-Physician Decision|1|||
37880415|NCT01114217|69564958|FG001|Overall Study|Other-Physician Decision|1|||
37880416|NCT01114217|69564957|FG000|Overall Study|Other-Sponsor Decision|10|||
37880417|NCT01114217|69564958|FG001|Overall Study|Other-Sponsor Decision|12|||
37880418|NCT01114217|69564957|FG000|Overall Study|Other-Study Termination|0|||
37880419|NCT01114217|69564958|FG001|Overall Study|Other-Study Termination|1|||
37880420|NCT01114217|69564957|FG000|Overall Study|Other-Study Withdrawn|1|||
37880421|NCT01114217|69564958|FG001|Overall Study|Other-Study Withdrawn|1|||
37880422|NCT01114217|69564957|FG000|Overall Study|Other-Site Stopped Communicating|2|||
37819661|NCT02325466|69498761|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
37819662|NCT02325466|69498759|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
37819663|NCT02325466|69498760|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
37819664|NCT02325466|69498761|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
37819665|NCT02325466|69498759|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
37819666|NCT02325466|69498760|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
37819667|NCT02325466|69498761|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
37819668|NCT02325466|69498759|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
37819669|NCT02325466|69498760|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
37819670|NCT02325466|69498761|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
37819671|NCT02325466|69498759|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
37819672|NCT02325466|69498760|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
37819673|NCT02325466|69498761|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
37819674|NCT02325466|69498759|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
37819675|NCT02325466|69498760|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
37819676|NCT02325466|69498761|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
37880423|NCT01114217|69564958|FG001|Overall Study|Other-Site Stopped Communicating|0|||
37880424|NCT01114217|69564957|FG000|Overall Study|Other-Lost to Follow-up|1|||
37880425|NCT01114217|69564958|FG001|Overall Study|Other-Lost to Follow-up|0|||
37880426|NCT01114217|69564957|FG000|Overall Study|Other-Withdrawal by Subject|1|||
37880427|NCT01114217|69564958|FG001|Overall Study|Other-Withdrawal by Subject|1|||
37880428|NCT01030536|69564967|FG000|Overall Study|Withdrawal by Subject|0|||
37880429|NCT01030536|69564968|FG001|Overall Study|Withdrawal by Subject|0|||
37880430|NCT01030536|69564969|FG002|Overall Study|Withdrawal by Subject|1|||
37880431|NCT01030536|69564970|FG003|Overall Study|Withdrawal by Subject|0|||
37880432|NCT01030536|69564971|FG004|Overall Study|Withdrawal by Subject|0|||
37880433|NCT01030536|69564967|FG000|Overall Study|undefined|1|||
37880434|NCT01030536|69564968|FG001|Overall Study|undefined|0|||
37880435|NCT01030536|69564969|FG002|Overall Study|undefined|1|||
37880436|NCT01030536|69564970|FG003|Overall Study|undefined|1|||
37880437|NCT01030536|69564971|FG004|Overall Study|undefined|0|||
37880438|NCT01030536|69564967|FG000|Overall Study|Adverse Event|0|||
37880439|NCT01030536|69564968|FG001|Overall Study|Adverse Event|3|||
37880440|NCT01030536|69564969|FG002|Overall Study|Adverse Event|1|||
37880441|NCT01030536|69564970|FG003|Overall Study|Adverse Event|0|||
37880442|NCT01030536|69564971|FG004|Overall Study|Adverse Event|1|||
37880443|NCT01030536|69564967|FG000|Overall Study|Progressive disease|6|||
37880444|NCT01030536|69564968|FG001|Overall Study|Progressive disease|2|||
37880445|NCT01030536|69564969|FG002|Overall Study|Progressive disease|3|||
37880446|NCT01030536|69564970|FG003|Overall Study|Progressive disease|2|||
37880447|NCT01030536|69564971|FG004|Overall Study|Progressive disease|0|||
37880448|NCT01030536|69564967|FG000|Overall Study|Death|0|||
37880449|NCT01030536|69564968|FG001|Overall Study|Death|1|||
37880450|NCT01030536|69564969|FG002|Overall Study|Death|0|||
37880451|NCT01030536|69564970|FG003|Overall Study|Death|0|||
37880452|NCT01030536|69564971|FG004|Overall Study|Death|0|||
37880453|NCT01030458|69564989|FG000|Overall Study|Lost to Follow-up|9|||
37880454|NCT01030458|69564990|FG001|Overall Study|Lost to Follow-up|10|||
37880455|NCT01030458|69564989|FG000|Overall Study|Withdrawal by Subject|2|||
37880456|NCT01030458|69564990|FG001|Overall Study|Withdrawal by Subject|3|||
37880457|NCT01030458|69564989|FG000|Overall Study|Logistical reasons|9|||
37880458|NCT01030458|69564990|FG001|Overall Study|Logistical reasons|5|||
37880459|NCT01030458|69564989|FG000|Overall Study|Moved or changed job|6|||
37880460|NCT01030458|69564990|FG001|Overall Study|Moved or changed job|13|||
37880461|NCT01030458|69564989|FG000|Overall Study|Side effect of medication|1|||
37880462|NCT01030458|69564990|FG001|Overall Study|Side effect of medication|1|||
37880463|NCT00930969|69564996|FG000|Overall Study|Death|5|||
37819677|NCT02322710|69498772|FG000|Overall Study|No efficacy assessment post-baseline|0|||
37819678|NCT02322710|69498773|FG001|Overall Study|No efficacy assessment post-baseline|1|||
37819679|NCT02322710|69498772|FG000|Overall Study|Protocol Violation|20|||
37880464|NCT00930969|69564996|FG000|Overall Study|Lost to Follow-up|1|||
37880465|NCT00930969|69564996|FG000|Overall Study|Physician Decision|13|||
37880466|NCT00930969|69564996|FG000|Overall Study|Withdrawal by Subject|19|||
37880467|NCT01114139|69565002|FG000|Overall Study|Adverse Event|3|||
37880468|NCT01114139|69565003|FG001|Overall Study|Adverse Event|2|||
37880469|NCT01114139|69565002|FG000|Overall Study|Lost to Follow-up|15|||
37880470|NCT01114139|69565003|FG001|Overall Study|Lost to Follow-up|3|||
37880471|NCT01114139|69565002|FG000|Overall Study|Withdrawal by Subject|17|||
37880472|NCT01114139|69565003|FG001|Overall Study|Withdrawal by Subject|6|||
37880473|NCT01114139|69565002|FG000|Overall Study|Other-Missed 1 visit|1|||
37880474|NCT01114139|69565003|FG001|Overall Study|Other-Missed 1 visit|0|||
37880475|NCT01114139|69565002|FG000|Overall Study|Other-Protocol Violation|1|||
37880476|NCT01114139|69565003|FG001|Overall Study|Other-Protocol Violation|0|||
37880477|NCT01114139|69565002|FG000|Overall Study|Other-Out of window for study drug dose|1|||
37880478|NCT01114139|69565003|FG001|Overall Study|Other-Out of window for study drug dose|0|||
37880479|NCT01114139|69565002|FG000|Overall Study|Other-Participant falsified records|0|||
37880480|NCT01114139|69565003|FG001|Overall Study|Other-Participant falsified records|1|||
37880481|NCT01114139|69565002|FG000|Overall Study|Other-Participant went on hospice|0|||
37880482|NCT01114139|69565003|FG001|Overall Study|Other-Participant went on hospice|1|||
37880483|NCT01114139|69565002|FG000|Overall Study|Other-Physician changed treatment|1|||
37880484|NCT01114139|69565003|FG001|Overall Study|Other-Physician changed treatment|0|||
37880485|NCT01114139|69565002|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
37880486|NCT01114139|69565003|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
37880487|NCT01027884|69565011|FG000|Overall Study|Adverse Event|2|||
37880488|NCT01027884|69565012|FG001|Overall Study|Adverse Event|1|||
37880489|NCT01027884|69565011|FG000|Overall Study|Protocol Violation|1|||
37880490|NCT01027884|69565012|FG001|Overall Study|Protocol Violation|0|||
37880491|NCT01027884|69565011|FG000|Overall Study|Non-compliance|1|||
37880492|NCT01027884|69565012|FG001|Overall Study|Non-compliance|1|||
37880493|NCT01027884|69565011|FG000|Overall Study|Withdrawal by Subject|0|||
37880494|NCT01027884|69565012|FG001|Overall Study|Withdrawal by Subject|1|||
37880495|NCT01027884|69565011|FG000|Overall Study|Lost to Follow-up|0|||
37880496|NCT01027884|69565012|FG001|Overall Study|Lost to Follow-up|1|||
37880497|NCT01027884|69565011|FG000|Overall Study|Spinal fixation surgery|0|||
37880498|NCT01027884|69565012|FG001|Overall Study|Spinal fixation surgery|3|||
37880499|NCT03387514|69565020|FG000|Overall Study|Withdrawal by Subject|2|||
37880500|NCT03387514|69565020|FG000|Overall Study|Physician Decision|1|||
37880501|NCT03387514|69565020|FG000|Overall Study|Lost to Follow-up|2|||
37880502|NCT01022580|69565035|FG000|Overall Study|Death|18|||
37880503|NCT01022580|69565036|FG001|Overall Study|Death|22|||
37880504|NCT01107353|69565050|FG000|Overall Study|Positive Drug Screen|1|||
37880505|NCT01107353|69565051|FG001|Overall Study|Positive Drug Screen|0|||
37880506|NCT01107197|69565059|FG000|Overall Study|Death|12|||
37880507|NCT01107197|69565060|FG001|Overall Study|Death|10|||
37880508|NCT01107197|69565059|FG000|Overall Study|Lost to Follow-up|5|||
37880509|NCT01107197|69565060|FG001|Overall Study|Lost to Follow-up|8|||
37880510|NCT01107197|69565059|FG000|Overall Study|Withdrawal by Subject|3|||
37880511|NCT01107197|69565060|FG001|Overall Study|Withdrawal by Subject|5|||
37880512|NCT01112579|69565077|FG000|Overall Study|Missed Visit|1|||
37880513|NCT01112579|69565078|FG001|Overall Study|Missed Visit|1|||
37880514|NCT01112579|69565077|FG000|Overall Study|Death|0|||
37880515|NCT01112579|69565078|FG001|Overall Study|Death|2|||
37880516|NCT01112267|69565086|FG000|Overall Study|Adverse Event|24|||
37880517|NCT01112267|69565087|FG001|Overall Study|Adverse Event|6|||
37880518|NCT01112267|69565086|FG000|Overall Study|Withdrawal by Subject|3|||
37880519|NCT01112267|69565087|FG001|Overall Study|Withdrawal by Subject|5|||
37880520|NCT01112267|69565086|FG000|Overall Study|Protocol Violation|5|||
37880521|NCT01112267|69565087|FG001|Overall Study|Protocol Violation|3|||
37880522|NCT01112267|69565086|FG000|Overall Study|Participants not compliant|1|||
37880523|NCT01112267|69565087|FG001|Overall Study|Participants not compliant|2|||
37880524|NCT01112267|69565086|FG000|Overall Study|Participants not receive any study drug|1|||
37880525|NCT01112267|69565087|FG001|Overall Study|Participants not receive any study drug|2|||
37880526|NCT00925587|69565095|FG000|Overall Study|Protocol Specified Criteria|6|||
37880527|NCT00925587|69565096|FG001|Overall Study|Protocol Specified Criteria|6|||
37880528|NCT00925587|69565095|FG000|Overall Study|Physician Decision|4|||
37880529|NCT00925587|69565096|FG001|Overall Study|Physician Decision|1|||
37880530|NCT00925587|69565095|FG000|Overall Study|Protocol Violation|6|||
37880531|NCT00925587|69565096|FG001|Overall Study|Protocol Violation|4|||
37880532|NCT00925587|69565095|FG000|Overall Study|Withdrawal by Subject|9|||
37880533|NCT00925587|69565096|FG001|Overall Study|Withdrawal by Subject|6|||
37880534|NCT00925587|69565095|FG000|Overall Study|Death|5|||
37880535|NCT00925587|69565096|FG001|Overall Study|Death|5|||
37880536|NCT00925587|69565095|FG000|Overall Study|Adverse Event|6|||
37880537|NCT00925587|69565096|FG001|Overall Study|Adverse Event|2|||
37880538|NCT00925587|69565095|FG000|Overall Study|Lost to Follow-up|0|||
37880539|NCT00925587|69565096|FG001|Overall Study|Lost to Follow-up|1|||
37880540|NCT00928707|69565108|FG000|Overall Study|Protocol Violation|1|||
37880541|NCT00928707|69565109|FG001|Overall Study|Protocol Violation|0|||
37880542|NCT00930813|69565117|FG000|Overall Study|Death|4|||
37880543|NCT00930813|69565118|FG001|Overall Study|Death|5|||
37880544|NCT00930813|69565117|FG000|Overall Study|Withdrawal by Subject|2|||
37880545|NCT00930813|69565118|FG001|Overall Study|Withdrawal by Subject|5|||
37984383|NCT00374868|69670469|FG000|Overall Study|Lost to Follow-up|1|||
37984384|NCT00374868|69670469|FG000|Overall Study|Death|2|||
37984385|NCT00374868|69670469|FG000|Overall Study|Other - Not Specified|1|||
37984386|NCT00374556|69670475|FG000|Overall Study|Lost to Follow-up|1|||
37984387|NCT00374556|69670476|FG001|Overall Study|Lost to Follow-up|0|||
37984388|NCT00374556|69670475|FG000|Overall Study|Removed at baseline due to medical cond|0|||
37984389|NCT00374556|69670476|FG001|Overall Study|Removed at baseline due to medical cond|1|||
37984390|NCT00290355|69670484|FG000|Overall Study|Serious adverse event|7|||
37984391|NCT00290355|69670485|FG001|Overall Study|Serious adverse event|4|||
37880546|NCT00930813|69565117|FG000|Overall Study|Lost to Follow-up|2|||
37880547|NCT00930813|69565118|FG001|Overall Study|Lost to Follow-up|4|||
37984392|NCT00290355|69670484|FG000|Overall Study|Study product reactogenicity|1|||
37984393|NCT00290355|69670485|FG001|Overall Study|Study product reactogenicity|0|||
37984394|NCT00290355|69670484|FG000|Overall Study|Protocol Violation|1|||
37984395|NCT00290355|69670485|FG001|Overall Study|Protocol Violation|0|||
37984396|NCT00290355|69670484|FG000|Overall Study|Withdrawal by Subject|2|||
37984397|NCT00290355|69670485|FG001|Overall Study|Withdrawal by Subject|0|||
37984398|NCT00290355|69670484|FG000|Overall Study|Migrated / moved from the study area|1|||
37984399|NCT00290355|69670485|FG001|Overall Study|Migrated / moved from the study area|0|||
37984400|NCT00290355|69670484|FG000|Overall Study|Lost to Follow-up|3|||
37984401|NCT00290355|69670485|FG001|Overall Study|Lost to Follow-up|1|||
37984402|NCT00290355|69670484|FG000|Overall Study|Other|2|||
37984403|NCT00290355|69670485|FG001|Overall Study|Other|0|||
37984404|NCT00374322|69670493|FG000|Overall Study|Lost to Follow-up|92|||
37880548|NCT00930579|69565126|FG000|Overall Study|Withdrawal by Subject|1|||
37880549|NCT00930579|69565126|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
37880550|NCT00925353|69565130|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
37880551|NCT01106651|69565154|FG000|Overall Study|Adverse Event|17|||
37880552|NCT01106651|69565155|FG001|Overall Study|Adverse Event|9|||
37880553|NCT01106651|69565156|FG002|Overall Study|Adverse Event|23|||
37880554|NCT01106651|69565154|FG000|Overall Study|Lost to Follow-up|8|||
37880555|NCT01106651|69565155|FG001|Overall Study|Lost to Follow-up|2|||
37880556|NCT01106651|69565156|FG002|Overall Study|Lost to Follow-up|6|||
37880557|NCT01106651|69565154|FG000|Overall Study|Physician Decision|4|||
37880558|NCT01106651|69565155|FG001|Overall Study|Physician Decision|3|||
37880559|NCT01106651|69565156|FG002|Overall Study|Physician Decision|1|||
37880560|NCT01106651|69565154|FG000|Overall Study|Protocol Violation|1|||
37880561|NCT01106651|69565155|FG001|Overall Study|Protocol Violation|2|||
37880562|NCT01106651|69565156|FG002|Overall Study|Protocol Violation|1|||
37880563|NCT01106651|69565154|FG000|Overall Study|Withdrawal by Subject|14|||
37880564|NCT01106651|69565155|FG001|Overall Study|Withdrawal by Subject|7|||
37880565|NCT01106651|69565156|FG002|Overall Study|Withdrawal by Subject|4|||
37880566|NCT01106651|69565154|FG000|Overall Study|Noncompliance with study drug|1|||
37880567|NCT01106651|69565155|FG001|Overall Study|Noncompliance with study drug|0|||
37880568|NCT01106651|69565156|FG002|Overall Study|Noncompliance with study drug|2|||
37880569|NCT01106651|69565154|FG000|Overall Study|Other|34|||
37880570|NCT01106651|69565155|FG001|Overall Study|Other|31|||
37880571|NCT01106651|69565156|FG002|Overall Study|Other|21|||
37880572|NCT01106651|69565154|FG000|Overall Study|Death|0|||
37880573|NCT01106651|69565155|FG001|Overall Study|Death|3|||
37880574|NCT01106651|69565156|FG002|Overall Study|Death|0|||
37880575|NCT01027650|69565175|FG000|Overall Study|Personal Reasons|0|||
37880576|NCT01027650|69565176|FG001|Overall Study|Personal Reasons|0|||
37880577|NCT01027650|69565177|FG002|Overall Study|Personal Reasons|0|||
37880578|NCT01027650|69565178|FG003|Overall Study|Personal Reasons|0|||
37880579|NCT01027650|69565179|FG004|Overall Study|Personal Reasons|2|||
37880580|NCT01027650|69565180|FG005|Overall Study|Personal Reasons|1|||
37880581|NCT01027650|69565181|FG006|Overall Study|Personal Reasons|0|||
37880582|NCT01027650|69565182|FG007|Overall Study|Personal Reasons|0|||
37880583|NCT01027650|69565175|FG000|Overall Study|Lost to Follow-up|0|||
37880584|NCT01027650|69565176|FG001|Overall Study|Lost to Follow-up|0|||
37984405|NCT00374322|69670494|FG001|Overall Study|Lost to Follow-up|90|||
37880585|NCT01027650|69565177|FG002|Overall Study|Lost to Follow-up|0|||
37984406|NCT00374322|69670493|FG000|Overall Study|Protocol Violation|8|||
37984407|NCT00374322|69670494|FG001|Overall Study|Protocol Violation|3|||
37984408|NCT00374322|69670493|FG000|Overall Study|Withdrawal by Subject|235|||
37880586|NCT01027650|69565178|FG003|Overall Study|Lost to Follow-up|0|||
37880587|NCT01027650|69565179|FG004|Overall Study|Lost to Follow-up|0|||
37880588|NCT01027650|69565180|FG005|Overall Study|Lost to Follow-up|0|||
37984409|NCT00374322|69670494|FG001|Overall Study|Withdrawal by Subject|167|||
37880589|NCT01027650|69565181|FG006|Overall Study|Lost to Follow-up|1|||
37880590|NCT01027650|69565182|FG007|Overall Study|Lost to Follow-up|0|||
37880591|NCT01027650|69565175|FG000|Overall Study|Lack of Efficacy|0|||
37880592|NCT01027650|69565176|FG001|Overall Study|Lack of Efficacy|0|||
37880593|NCT01027650|69565177|FG002|Overall Study|Lack of Efficacy|0|||
37880594|NCT01027650|69565178|FG003|Overall Study|Lack of Efficacy|0|||
37880595|NCT01027650|69565179|FG004|Overall Study|Lack of Efficacy|0|||
37880596|NCT01027650|69565180|FG005|Overall Study|Lack of Efficacy|1|||
37880597|NCT01027650|69565181|FG006|Overall Study|Lack of Efficacy|0|||
37880598|NCT01027650|69565182|FG007|Overall Study|Lack of Efficacy|0|||
37880599|NCT01106027|69565200|FG000|Overall Study|Lost graft early, discontinued|1|||
37880600|NCT00927927|69565219|FG000|Overall Study|Withdrawal by Subject|0|||
37880601|NCT00927927|69565220|FG001|Overall Study|Withdrawal by Subject|0|||
37880602|NCT00927927|69565221|FG002|Overall Study|Withdrawal by Subject|0|||
37880603|NCT00927927|69565222|FG003|Overall Study|Withdrawal by Subject|0|||
37880604|NCT00927927|69565223|FG004|Overall Study|Withdrawal by Subject|0|||
37880605|NCT00927927|69565224|FG005|Overall Study|Withdrawal by Subject|0|||
37880606|NCT00927927|69565225|FG006|Overall Study|Withdrawal by Subject|0|||
37880607|NCT00927927|69565226|FG007|Overall Study|Withdrawal by Subject|2|||
37880608|NCT00927927|69565227|FG008|Overall Study|Withdrawal by Subject|0|||
37880609|NCT00927927|69565228|FG009|Overall Study|Withdrawal by Subject|0|||
37880610|NCT00927927|69565229|FG010|Overall Study|Withdrawal by Subject|0|||
37880611|NCT00927927|69565230|FG011|Overall Study|Withdrawal by Subject|2|||
37819680|NCT02322710|69498773|FG001|Overall Study|Protocol Violation|25|||
37819681|NCT02234310|69498816|FG000|Overall Study|Physician Decision|1|||
37819682|NCT02234310|69498816|FG000|Overall Study|Adverse Event|1|||
37819683|NCT02234310|69498816|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
37819684|NCT02234310|69498816|FG000|Overall Study|Withdrawal by Subject|2|||
37819685|NCT02106195|69498849|FG000|Overall Study|Adverse Event|2|||
37819686|NCT02106195|69498849|FG000|Overall Study|Protocol Violation|1|||
37819687|NCT02104180|69498861|FG000|Overall Study|Protocol Violation|1|||
37880612|NCT00927927|69565231|FG012|Overall Study|Withdrawal by Subject|0|||
37880613|NCT00927927|69565232|FG013|Overall Study|Withdrawal by Subject|0|||
37880614|NCT00927927|69565233|FG014|Overall Study|Withdrawal by Subject|0|||
37880615|NCT01027416|69565267|FG000|Overall Study|Withdrawal by Subject|0|||
37880616|NCT01027416|69565268|FG001|Overall Study|Withdrawal by Subject|1|||
37880617|NCT01027416|69565267|FG000|Overall Study|Physician Decision|1|||
37880618|NCT01027416|69565268|FG001|Overall Study|Physician Decision|4|||
37880619|NCT00923559|69565276|FG000|Overall Study|Lost to Follow-up|2|||
37880620|NCT00923559|69565277|FG001|Overall Study|Lost to Follow-up|3|||
37880621|NCT01015638|69565287|FG000|Overall Study|Withdrawal by Subject|1|||
37880622|NCT01015638|69565288|FG001|Overall Study|Withdrawal by Subject|0|||
37880623|NCT01022502|69565294|FG000|Overall Study|Adverse Event|1|||
37880624|NCT01022502|69565294|FG000|Overall Study|employment related reasons|1|||
37880625|NCT01022502|69565294|FG000|Overall Study|Withdrawal by Subject|1|||
37880626|NCT01105091|69565302|FG000|Overall Study|Death|2|||
37880627|NCT01105091|69565303|FG001|Overall Study|Death|0|||
37880628|NCT00924729|69565313|FG000|Overall Study|insufficient volume for analysis|1|||
37880629|NCT00924729|69565314|FG001|Overall Study|insufficient volume for analysis|0|||
37880630|NCT00924729|69565313|FG000|Overall Study|Protocol Violation|1|||
37880631|NCT00924729|69565314|FG001|Overall Study|Protocol Violation|0|||
37880632|NCT01099709|69565322|FG000|Period 1|Withdrawal by Subject|0|||
37819688|NCT02104180|69498862|FG001|Overall Study|Protocol Violation|0|||
37880633|NCT01099709|69565323|FG001|Period 1|Withdrawal by Subject|1|||
37819689|NCT02040857|69498872|FG000|Overall Study|Adverse Event|14|||
37819690|NCT02040857|69498872|FG000|Overall Study|Physician Decision|5|||
37819691|NCT02040857|69498872|FG000|Overall Study|Withdrawal by Subject|31|||
37880634|NCT01099709|69565322|FG000|Period 1|Positive cotinine test|0|||
37880635|NCT01099709|69565323|FG001|Period 1|Positive cotinine test|1|||
37880636|NCT01099709|69565322|FG000|Period 1|Adverse Event|1|||
37880637|NCT01099709|69565323|FG001|Period 1|Adverse Event|0|||
37880638|NCT01099397|69565330|FG000|Overall Study|Lost to Follow-up|4|||
37880639|NCT01099397|69565330|FG000|Overall Study|Protocol Violation|4|||
37880640|NCT01099397|69565330|FG000|Overall Study|Withdrawal by Subject|5|||
37880641|NCT01022424|69565335|FG000|Overall Study|Adverse Event|1|||
37984410|NCT00374322|69670493|FG000|Overall Study|Sponsor Terminated Study|866|||
37984411|NCT00374322|69670494|FG001|Overall Study|Sponsor Terminated Study|990|||
37984412|NCT00374322|69670493|FG000|Overall Study|Physician Decision|36|||
37984413|NCT00374322|69670494|FG001|Overall Study|Physician Decision|32|||
37984414|NCT00374322|69670493|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
37984415|NCT00374322|69670494|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
37984416|NCT00374322|69670493|FG000|Overall Study|Sponsor Decision|2|||
37984417|NCT00374322|69670494|FG001|Overall Study|Sponsor Decision|3|||
37984418|NCT00374322|69670493|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
37984419|NCT00374322|69670494|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
37695250|NCT02349295|69171751|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
37695251|NCT02349295|69171752|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
37819692|NCT02040857|69498872|FG000|Overall Study|patient non-compliance|3|||
37819693|NCT02040857|69498872|FG000|Overall Study|Lost to Follow-up|2|||
37819694|NCT02040857|69498872|FG000|Overall Study|recurrence|4|||
37819695|NCT02040857|69498872|FG000|Overall Study|ineligible|1|||
37819696|NCT01943825|69498892|FG000|Overall Study|Lost to Follow-up|9|||
37819697|NCT01943825|69498893|FG001|Overall Study|Lost to Follow-up|3|||
37819698|NCT01943825|69498894|FG002|Overall Study|Lost to Follow-up|12|||
37819699|NCT01943825|69498895|FG003|Overall Study|Lost to Follow-up|8|||
37819700|NCT01943825|69498892|FG000|Overall Study|Withdrawal by Subject|1|||
37819701|NCT01943825|69498893|FG001|Overall Study|Withdrawal by Subject|0|||
37819702|NCT01943825|69498894|FG002|Overall Study|Withdrawal by Subject|3|||
37819703|NCT01943825|69498895|FG003|Overall Study|Withdrawal by Subject|2|||
37819704|NCT01943825|69498892|FG000|Overall Study|Other than specified above|0|||
37819705|NCT01943825|69498893|FG001|Overall Study|Other than specified above|1|||
37819706|NCT01943825|69498894|FG002|Overall Study|Other than specified above|0|||
37819707|NCT01943825|69498895|FG003|Overall Study|Other than specified above|1|||
37819708|NCT01722331|69498927|FG000|Part 1|Adverse Event|5|||
37819709|NCT01722331|69498928|FG001|Part 1|Adverse Event|0|||
37819710|NCT01722331|69498929|FG002|Part 1|Adverse Event|0|||
37819711|NCT01722331|69498930|FG003|Part 1|Adverse Event|0|||
37819712|NCT01722331|69498931|FG004|Part 1|Adverse Event|0|||
37819713|NCT01722331|69498932|FG005|Part 1|Adverse Event|0|||
37819714|NCT01722331|69498933|FG006|Part 1|Adverse Event|0|||
37819715|NCT01722331|69498927|FG000|Part 1|Lack of Efficacy|0|||
37819716|NCT01722331|69498928|FG001|Part 1|Lack of Efficacy|0|||
37819717|NCT01722331|69498929|FG002|Part 1|Lack of Efficacy|1|||
37819718|NCT01722331|69498930|FG003|Part 1|Lack of Efficacy|0|||
37819719|NCT01722331|69498931|FG004|Part 1|Lack of Efficacy|2|||
37819720|NCT01722331|69498932|FG005|Part 1|Lack of Efficacy|0|||
37819721|NCT01722331|69498933|FG006|Part 1|Lack of Efficacy|0|||
37819722|NCT01722331|69498927|FG000|Part 1|Lost to Follow-up|1|||
37819723|NCT01722331|69498928|FG001|Part 1|Lost to Follow-up|0|||
37819724|NCT01722331|69498929|FG002|Part 1|Lost to Follow-up|2|||
37819725|NCT01722331|69498930|FG003|Part 1|Lost to Follow-up|0|||
37819726|NCT01722331|69498931|FG004|Part 1|Lost to Follow-up|1|||
37819727|NCT01722331|69498932|FG005|Part 1|Lost to Follow-up|0|||
37819728|NCT01722331|69498933|FG006|Part 1|Lost to Follow-up|0|||
37819729|NCT01722331|69498927|FG000|Part 1|Physician Decision|0|||
37819730|NCT01722331|69498928|FG001|Part 1|Physician Decision|0|||
37819731|NCT01722331|69498929|FG002|Part 1|Physician Decision|3|||
37819732|NCT01722331|69498930|FG003|Part 1|Physician Decision|0|||
37819733|NCT01722331|69498931|FG004|Part 1|Physician Decision|1|||
37880642|NCT01022424|69565335|FG000|Overall Study|Physician Decision|1|||
37880643|NCT01022424|69565335|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
37819734|NCT01722331|69498932|FG005|Part 1|Physician Decision|0|||
37819735|NCT01722331|69498933|FG006|Part 1|Physician Decision|0|||
37819736|NCT01722331|69498927|FG000|Part 1|Pregnancy|1|||
37819737|NCT01722331|69498928|FG001|Part 1|Pregnancy|0|||
37819738|NCT01722331|69498929|FG002|Part 1|Pregnancy|0|||
37880644|NCT01098851|69565345|FG000|Overall Study|Equipment failure|1|||
37880645|NCT01098851|69565346|FG001|Overall Study|Equipment failure|0|||
37880646|NCT01026948|69565352|FG000|Overall Study|Physician Decision|8|||
37880647|NCT01104779|69565360|FG000|Overall Study|Protocol Violation|1|||
37984420|NCT00374322|69670493|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
37819739|NCT01722331|69498930|FG003|Part 1|Pregnancy|0|||
37819740|NCT01722331|69498931|FG004|Part 1|Pregnancy|0|||
37819741|NCT01722331|69498932|FG005|Part 1|Pregnancy|0|||
37819742|NCT01722331|69498933|FG006|Part 1|Pregnancy|0|||
37819743|NCT01722331|69498927|FG000|Part 1|Progressive Disease|0|||
37819744|NCT01722331|69498928|FG001|Part 1|Progressive Disease|0|||
37819745|NCT01722331|69498929|FG002|Part 1|Progressive Disease|0|||
37819746|NCT01722331|69498930|FG003|Part 1|Progressive Disease|0|||
37819747|NCT01722331|69498931|FG004|Part 1|Progressive Disease|1|||
37880648|NCT01104779|69565361|FG001|Overall Study|Protocol Violation|2|||
37819748|NCT01722331|69498932|FG005|Part 1|Progressive Disease|0|||
37819749|NCT01722331|69498933|FG006|Part 1|Progressive Disease|0|||
37819750|NCT01722331|69498927|FG000|Part 1|Protocol Violation|1|||
37819751|NCT01722331|69498928|FG001|Part 1|Protocol Violation|0|||
37819752|NCT01722331|69498929|FG002|Part 1|Protocol Violation|0|||
37819753|NCT01722331|69498930|FG003|Part 1|Protocol Violation|0|||
37880649|NCT01104779|69565362|FG002|Overall Study|Protocol Violation|2|||
37880650|NCT01104779|69565360|FG000|Overall Study|Lack of Efficacy|26|||
37880651|NCT01104779|69565361|FG001|Overall Study|Lack of Efficacy|12|||
37880652|NCT01104779|69565362|FG002|Overall Study|Lack of Efficacy|13|||
37880653|NCT01104779|69565360|FG000|Overall Study|Adverse Event|13|||
37880654|NCT01104779|69565361|FG001|Overall Study|Adverse Event|14|||
37880655|NCT01104779|69565362|FG002|Overall Study|Adverse Event|13|||
37880656|NCT01104779|69565360|FG000|Overall Study|Did not meet inc/exc criteria|1|||
37880657|NCT01104779|69565361|FG001|Overall Study|Did not meet inc/exc criteria|1|||
37880658|NCT01104779|69565362|FG002|Overall Study|Did not meet inc/exc criteria|1|||
37880659|NCT01104779|69565360|FG000|Overall Study|Other reasons|0|||
37880660|NCT01104779|69565361|FG001|Overall Study|Other reasons|1|||
37880661|NCT01104779|69565362|FG002|Overall Study|Other reasons|0|||
37880662|NCT01104779|69565360|FG000|Overall Study|Lost to Follow-up|2|||
37880663|NCT01104779|69565361|FG001|Overall Study|Lost to Follow-up|0|||
37880664|NCT01104779|69565362|FG002|Overall Study|Lost to Follow-up|1|||
37880665|NCT01104779|69565360|FG000|Overall Study|Withdrawal by Subject|16|||
37880666|NCT01104779|69565361|FG001|Overall Study|Withdrawal by Subject|25|||
37880667|NCT01104779|69565362|FG002|Overall Study|Withdrawal by Subject|32|||
37880668|NCT00918957|69565372|FG000|Overall Study|Adverse Event|2|||
37880669|NCT00918957|69565373|FG001|Overall Study|Adverse Event|0|||
37880670|NCT00918957|69565372|FG000|Overall Study|Withdrawal by Subject|1|||
37880671|NCT00918957|69565373|FG001|Overall Study|Withdrawal by Subject|0|||
37880672|NCT01022268|69565381|FG000|Overall Study|Withdrawal by Subject|1|||
37880673|NCT01022268|69565382|FG001|Overall Study|Withdrawal by Subject|0|||
37880674|NCT01022268|69565381|FG000|Overall Study|Withdrawal by Subject|1|||
37880675|NCT01022268|69565382|FG001|Overall Study|Withdrawal by Subject|0|||
37880676|NCT01015560|69565388|FG000|Overall Study|Adverse Event|1|||
37880677|NCT01015560|69565388|FG000|Overall Study|Not protocol specified|1|||
37880678|NCT01015560|69565388|FG000|Overall Study|Withdrawal by Subject|1|||
37880679|NCT00918879|69565394|FG000|Overall Study|Withdrawal by Subject|4|||
37880680|NCT00918879|69565395|FG001|Overall Study|Withdrawal by Subject|4|||
37880681|NCT00918879|69565394|FG000|Overall Study|Lost to Follow-up|1|||
37880682|NCT00918879|69565395|FG001|Overall Study|Lost to Follow-up|1|||
37880683|NCT00918879|69565394|FG000|Overall Study|Severe non-compliance to protocol|1|||
37819754|NCT01722331|69498931|FG004|Part 1|Protocol Violation|1|||
37880684|NCT00918879|69565395|FG001|Overall Study|Severe non-compliance to protocol|1|||
37880685|NCT01026792|69565401|FG000|Overall Study|Protocol Violation|1|||
37819755|NCT01722331|69498932|FG005|Part 1|Protocol Violation|0|||
37819756|NCT01722331|69498933|FG006|Part 1|Protocol Violation|0|||
37819757|NCT01722331|69498927|FG000|Part 1|Withdrawal by Subject|2|||
37819758|NCT01722331|69498928|FG001|Part 1|Withdrawal by Subject|0|||
37819759|NCT01722331|69498929|FG002|Part 1|Withdrawal by Subject|3|||
37819760|NCT01722331|69498930|FG003|Part 1|Withdrawal by Subject|0|||
37819761|NCT01722331|69498931|FG004|Part 1|Withdrawal by Subject|3|||
37819762|NCT01722331|69498932|FG005|Part 1|Withdrawal by Subject|0|||
37819763|NCT01722331|69498933|FG006|Part 1|Withdrawal by Subject|0|||
37819764|NCT01722331|69498927|FG000|Part 2|Adverse Event|3|||
37819765|NCT01722331|69498928|FG001|Part 2|Adverse Event|0|||
37819766|NCT01722331|69498929|FG002|Part 2|Adverse Event|0|||
37819767|NCT01722331|69498930|FG003|Part 2|Adverse Event|0|||
37880686|NCT01026324|69565408|FG000|Follow up/Survival|Withdrawal by Subject|1|||
37880687|NCT01026324|69565409|FG001|Follow up/Survival|Withdrawal by Subject|0|||
37880688|NCT01026324|69565410|FG002|Follow up/Survival|Withdrawal by Subject|0|||
37880689|NCT01098539|69565421|FG000|Overall Study|Adverse Event|26|||
37880690|NCT01098539|69565422|FG001|Overall Study|Adverse Event|26|||
37819768|NCT01722331|69498931|FG004|Part 2|Adverse Event|0|||
37819769|NCT01722331|69498932|FG005|Part 2|Adverse Event|1|||
37880691|NCT01098539|69565421|FG000|Overall Study|Protocol Violation|1|||
37880692|NCT01098539|69565422|FG001|Overall Study|Protocol Violation|4|||
37880693|NCT01098539|69565421|FG000|Overall Study|Noncompliance|3|||
37880694|NCT01098539|69565422|FG001|Overall Study|Noncompliance|5|||
37880695|NCT01098539|69565421|FG000|Overall Study|Lost to Follow-up|4|||
37880696|NCT01098539|69565422|FG001|Overall Study|Lost to Follow-up|4|||
37819770|NCT01722331|69498933|FG006|Part 2|Adverse Event|0|||
37880697|NCT01098539|69565421|FG000|Overall Study|Withdrawal by Subject|12|||
37819771|NCT01722331|69498927|FG000|Part 2|Lack of Efficacy|3|||
37819772|NCT01722331|69498928|FG001|Part 2|Lack of Efficacy|0|||
37819773|NCT01722331|69498929|FG002|Part 2|Lack of Efficacy|11|||
37880698|NCT01098539|69565422|FG001|Overall Study|Withdrawal by Subject|26|||
37880699|NCT01098539|69565421|FG000|Overall Study|Physician Decision|5|||
37880700|NCT01098539|69565422|FG001|Overall Study|Physician Decision|3|||
37880701|NCT01098461|69565432|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
37880702|NCT01098461|69565433|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
37880703|NCT01098461|69565434|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
37880704|NCT01098461|69565435|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
37695252|NCT02349295|69171753|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
37695253|NCT02349295|69171754|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
37880705|NCT01098461|69565432|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
37880706|NCT01098461|69565433|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
37880707|NCT01098461|69565434|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
37880708|NCT01098461|69565435|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
37880709|NCT01098461|69565432|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
37880710|NCT01098461|69565433|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
37880711|NCT01098461|69565434|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
37880712|NCT01098461|69565435|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
37880713|NCT01098461|69565432|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
37880714|NCT01098461|69565433|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
37880715|NCT01098461|69565434|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
37880716|NCT01098461|69565435|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
37880717|NCT01098461|69565432|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
37880718|NCT01098461|69565433|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
37880719|NCT01098461|69565434|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
37880720|NCT01098461|69565435|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
37880721|NCT01098461|69565432|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
37819774|NCT01722331|69498930|FG003|Part 2|Lack of Efficacy|0|||
37819775|NCT01722331|69498931|FG004|Part 2|Lack of Efficacy|0|||
37880722|NCT01098461|69565433|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
37880723|NCT01098461|69565434|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
37880724|NCT01098461|69565435|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
37880725|NCT01098461|69565432|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
37880726|NCT01098461|69565433|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
37880727|NCT01098461|69565434|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
37880728|NCT01098461|69565435|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
37880729|NCT01098305|69565448|FG000|Overall Study|Lost to Follow-up|31|||
37880730|NCT01098305|69565449|FG001|Overall Study|Lost to Follow-up|33|||
37880731|NCT00833833|69565461|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
37880732|NCT00833833|69565462|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
37880733|NCT00833833|69565463|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
37880734|NCT00833833|69565464|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
37880735|NCT00833833|69565465|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
37984421|NCT00374322|69670494|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
37819776|NCT01722331|69498932|FG005|Part 2|Lack of Efficacy|3|||
37819777|NCT01722331|69498933|FG006|Part 2|Lack of Efficacy|3|||
37819778|NCT01722331|69498927|FG000|Part 2|Lost to Follow-up|0|||
37819779|NCT01722331|69498928|FG001|Part 2|Lost to Follow-up|0|||
37819780|NCT01722331|69498929|FG002|Part 2|Lost to Follow-up|3|||
37819781|NCT01722331|69498930|FG003|Part 2|Lost to Follow-up|0|||
37819782|NCT01722331|69498931|FG004|Part 2|Lost to Follow-up|0|||
37819783|NCT01722331|69498932|FG005|Part 2|Lost to Follow-up|1|||
37819784|NCT01722331|69498933|FG006|Part 2|Lost to Follow-up|1|||
37880736|NCT00833833|69565466|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
37880737|NCT00833833|69565461|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
37984422|NCT00374322|69670493|FG000|Overall Study|Severe Toxicity|1|||
37984423|NCT00374322|69670494|FG001|Overall Study|Severe Toxicity|0|||
37819785|NCT01722331|69498927|FG000|Part 2|Non-Compliance with Study Drug|1|||
37819786|NCT01722331|69498928|FG001|Part 2|Non-Compliance with Study Drug|0|||
37819787|NCT01722331|69498929|FG002|Part 2|Non-Compliance with Study Drug|1|||
37819788|NCT01722331|69498930|FG003|Part 2|Non-Compliance with Study Drug|0|||
37819789|NCT01722331|69498931|FG004|Part 2|Non-Compliance with Study Drug|0|||
37880738|NCT00833833|69565462|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
37880739|NCT00833833|69565463|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
37880740|NCT00833833|69565464|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
37880741|NCT00833833|69565465|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
37880742|NCT00833833|69565466|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
37880743|NCT00833833|69565461|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
37880744|NCT00833833|69565462|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
37880745|NCT00833833|69565463|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
37880746|NCT00833833|69565464|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
37880747|NCT00833833|69565465|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
37880748|NCT00833833|69565466|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
37880749|NCT00833833|69565461|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
37880750|NCT00833833|69565462|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
37880751|NCT00833833|69565463|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
37984424|NCT00374322|69670493|FG000|Overall Study|Site Closed|2|||
37984425|NCT00374322|69670494|FG001|Overall Study|Site Closed|2|||
37984426|NCT00374322|69670493|FG000|Overall Study|Participant Changed Physician|1|||
37984427|NCT00374322|69670494|FG001|Overall Study|Participant Changed Physician|0|||
37984428|NCT00374322|69670493|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
37984429|NCT00374322|69670494|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
37984430|NCT00374322|69670493|FG000|Overall Study|Noncompliance with Study Requirements|0|||
37984431|NCT00374322|69670494|FG001|Overall Study|Noncompliance with Study Requirements|1|||
37984432|NCT00374322|69670493|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
37984433|NCT00374322|69670494|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
37880752|NCT00833833|69565464|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
37880753|NCT00833833|69565465|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
37880754|NCT00833833|69565466|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
37880755|NCT00833833|69565461|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
37880756|NCT00833833|69565462|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
37880757|NCT00833833|69565463|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
37880758|NCT00833833|69565464|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
37880759|NCT00833833|69565465|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
37880760|NCT00833833|69565466|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
37880761|NCT00833833|69565461|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
37880762|NCT00833833|69565462|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
37880763|NCT00833833|69565463|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
37880764|NCT00833833|69565464|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
37984434|NCT00374322|69670493|FG000|Overall Study|Did Not Receive Study Medication|8|||
37984435|NCT00374322|69670494|FG001|Overall Study|Did Not Receive Study Medication|6|||
37984436|NCT00303459|69670503|FG000|Overall Study|Death|33|||
37984437|NCT00303459|69670504|FG001|Overall Study|Death|44|||
37819790|NCT01722331|69498932|FG005|Part 2|Non-Compliance with Study Drug|0|||
37819791|NCT01722331|69498933|FG006|Part 2|Non-Compliance with Study Drug|0|||
37819792|NCT01722331|69498927|FG000|Part 2|Physician Decision|0|||
37819793|NCT01722331|69498928|FG001|Part 2|Physician Decision|0|||
37819794|NCT01722331|69498929|FG002|Part 2|Physician Decision|2|||
37819795|NCT01722331|69498930|FG003|Part 2|Physician Decision|0|||
37819796|NCT01722331|69498931|FG004|Part 2|Physician Decision|0|||
37819797|NCT01722331|69498932|FG005|Part 2|Physician Decision|0|||
37819798|NCT01722331|69498933|FG006|Part 2|Physician Decision|0|||
37819799|NCT01722331|69498927|FG000|Part 2|Pregnancy|0|||
37819800|NCT01722331|69498928|FG001|Part 2|Pregnancy|0|||
37819801|NCT01722331|69498929|FG002|Part 2|Pregnancy|0|||
37819802|NCT01722331|69498930|FG003|Part 2|Pregnancy|0|||
37819803|NCT01722331|69498931|FG004|Part 2|Pregnancy|0|||
37819804|NCT01722331|69498932|FG005|Part 2|Pregnancy|1|||
37819805|NCT01722331|69498933|FG006|Part 2|Pregnancy|0|||
37819806|NCT01722331|69498927|FG000|Part 2|Progressive Disease|0|||
37819807|NCT01722331|69498928|FG001|Part 2|Progressive Disease|0|||
37880765|NCT00833833|69565465|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
37984438|NCT00303459|69670503|FG000|Overall Study|Withdrawal of consent|32|||
37984439|NCT00303459|69670504|FG001|Overall Study|Withdrawal of consent|26|||
37984440|NCT00303459|69670503|FG000|Overall Study|Lost to Follow-up|5|||
37984441|NCT00303459|69670504|FG001|Overall Study|Lost to Follow-up|4|||
37984442|NCT00303459|69670503|FG000|Overall Study|Administrative reason|7|||
37984443|NCT00303459|69670504|FG001|Overall Study|Administrative reason|7|||
37880766|NCT00833833|69565466|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
37984444|NCT00303459|69670503|FG000|Overall Study|Decision by the investigator|5|||
37819808|NCT01722331|69498929|FG002|Part 2|Progressive Disease|1|||
37819809|NCT01722331|69498930|FG003|Part 2|Progressive Disease|0|||
37819810|NCT01722331|69498931|FG004|Part 2|Progressive Disease|0|||
37819811|NCT01722331|69498932|FG005|Part 2|Progressive Disease|0|||
37819812|NCT01722331|69498933|FG006|Part 2|Progressive Disease|0|||
37819813|NCT01722331|69498927|FG000|Part 2|Protocol Violation|1|||
37819814|NCT01722331|69498928|FG001|Part 2|Protocol Violation|0|||
37819815|NCT01722331|69498929|FG002|Part 2|Protocol Violation|0|||
37984445|NCT00303459|69670504|FG001|Overall Study|Decision by the investigator|7|||
37984446|NCT00303459|69670503|FG000|Overall Study|Lung transplantation|1|||
37984447|NCT00303459|69670504|FG001|Overall Study|Lung transplantation|1|||
37984448|NCT00289887|69670513|FG000|Overall Study|Adverse Event|3|||
37984449|NCT00289887|69670514|FG001|Overall Study|Adverse Event|3|||
37984450|NCT00289887|69670513|FG000|Overall Study|Lack of Efficacy|3|||
37984451|NCT00289887|69670514|FG001|Overall Study|Lack of Efficacy|11|||
37819816|NCT01722331|69498930|FG003|Part 2|Protocol Violation|0|||
37819817|NCT01722331|69498931|FG004|Part 2|Protocol Violation|0|||
37819818|NCT01722331|69498932|FG005|Part 2|Protocol Violation|0|||
37819819|NCT01722331|69498933|FG006|Part 2|Protocol Violation|0|||
37819820|NCT01722331|69498927|FG000|Part 2|Withdrawal by Subject|5|||
37819821|NCT01722331|69498928|FG001|Part 2|Withdrawal by Subject|0|||
37819822|NCT01722331|69498929|FG002|Part 2|Withdrawal by Subject|3|||
37819823|NCT01722331|69498930|FG003|Part 2|Withdrawal by Subject|0|||
37819824|NCT01722331|69498931|FG004|Part 2|Withdrawal by Subject|0|||
37819825|NCT01722331|69498932|FG005|Part 2|Withdrawal by Subject|2|||
37819826|NCT01722331|69498933|FG006|Part 2|Withdrawal by Subject|2|||
37819827|NCT01722331|69498927|FG000|Part 2|Other Protocol Specified Criteria|6|||
37819828|NCT01722331|69498928|FG001|Part 2|Other Protocol Specified Criteria|0|||
37819829|NCT01722331|69498929|FG002|Part 2|Other Protocol Specified Criteria|10|||
37819830|NCT01722331|69498930|FG003|Part 2|Other Protocol Specified Criteria|0|||
37819831|NCT01722331|69498931|FG004|Part 2|Other Protocol Specified Criteria|0|||
37819832|NCT01722331|69498932|FG005|Part 2|Other Protocol Specified Criteria|2|||
37819833|NCT01722331|69498933|FG006|Part 2|Other Protocol Specified Criteria|1|||
37819834|NCT01722331|69498927|FG000|Part 3|Adverse Event|2|||
37819835|NCT01722331|69498928|FG001|Part 3|Adverse Event|2|||
37819836|NCT01722331|69498929|FG002|Part 3|Adverse Event|0|||
37819837|NCT01722331|69498930|FG003|Part 3|Adverse Event|1|||
37819838|NCT01722331|69498931|FG004|Part 3|Adverse Event|0|||
37819839|NCT01722331|69498932|FG005|Part 3|Adverse Event|0|||
37819840|NCT01722331|69498933|FG006|Part 3|Adverse Event|0|||
37819841|NCT01722331|69498927|FG000|Part 3|Death|1|||
37819842|NCT01722331|69498928|FG001|Part 3|Death|0|||
37819843|NCT01722331|69498929|FG002|Part 3|Death|0|||
37819844|NCT01722331|69498930|FG003|Part 3|Death|0|||
37819845|NCT01722331|69498931|FG004|Part 3|Death|0|||
37819846|NCT01722331|69498932|FG005|Part 3|Death|0|||
37819847|NCT01722331|69498933|FG006|Part 3|Death|0|||
37819848|NCT01722331|69498927|FG000|Part 3|Lack of Efficacy|1|||
37819849|NCT01722331|69498928|FG001|Part 3|Lack of Efficacy|0|||
37819850|NCT01722331|69498929|FG002|Part 3|Lack of Efficacy|0|||
37819851|NCT01722331|69498930|FG003|Part 3|Lack of Efficacy|0|||
37819852|NCT01722331|69498931|FG004|Part 3|Lack of Efficacy|0|||
37819853|NCT01722331|69498932|FG005|Part 3|Lack of Efficacy|0|||
37819854|NCT01722331|69498933|FG006|Part 3|Lack of Efficacy|0|||
37819855|NCT01722331|69498927|FG000|Part 3|Lost to Follow-up|3|||
37819856|NCT01722331|69498928|FG001|Part 3|Lost to Follow-up|4|||
37819857|NCT01722331|69498929|FG002|Part 3|Lost to Follow-up|0|||
37819858|NCT01722331|69498930|FG003|Part 3|Lost to Follow-up|0|||
37819859|NCT01722331|69498931|FG004|Part 3|Lost to Follow-up|0|||
37819860|NCT01722331|69498932|FG005|Part 3|Lost to Follow-up|1|||
37819861|NCT01722331|69498933|FG006|Part 3|Lost to Follow-up|0|||
37819862|NCT01722331|69498927|FG000|Part 3|Non-Compliance with Study Drug|0|||
37819863|NCT01722331|69498928|FG001|Part 3|Non-Compliance with Study Drug|1|||
37819864|NCT01722331|69498929|FG002|Part 3|Non-Compliance with Study Drug|0|||
37819865|NCT01722331|69498930|FG003|Part 3|Non-Compliance with Study Drug|0|||
37819866|NCT01722331|69498931|FG004|Part 3|Non-Compliance with Study Drug|0|||
37819867|NCT01722331|69498932|FG005|Part 3|Non-Compliance with Study Drug|0|||
37819868|NCT01722331|69498933|FG006|Part 3|Non-Compliance with Study Drug|0|||
37819869|NCT01722331|69498927|FG000|Part 3|Physician Decision|1|||
37819870|NCT01722331|69498928|FG001|Part 3|Physician Decision|1|||
37819871|NCT01722331|69498929|FG002|Part 3|Physician Decision|0|||
37819872|NCT01722331|69498930|FG003|Part 3|Physician Decision|0|||
37819873|NCT01722331|69498931|FG004|Part 3|Physician Decision|0|||
37819874|NCT01722331|69498932|FG005|Part 3|Physician Decision|0|||
37819875|NCT01722331|69498933|FG006|Part 3|Physician Decision|1|||
37819876|NCT01722331|69498927|FG000|Part 3|Protocol Violation|2|||
37819877|NCT01722331|69498928|FG001|Part 3|Protocol Violation|1|||
37819878|NCT01722331|69498929|FG002|Part 3|Protocol Violation|0|||
37819879|NCT01722331|69498930|FG003|Part 3|Protocol Violation|0|||
37819880|NCT01722331|69498931|FG004|Part 3|Protocol Violation|0|||
37819881|NCT01722331|69498932|FG005|Part 3|Protocol Violation|0|||
37819882|NCT01722331|69498933|FG006|Part 3|Protocol Violation|0|||
37819883|NCT01722331|69498927|FG000|Part 3|Withdrawal by Subject|4|||
37819884|NCT01722331|69498928|FG001|Part 3|Withdrawal by Subject|7|||
37819885|NCT01722331|69498929|FG002|Part 3|Withdrawal by Subject|0|||
37819886|NCT01722331|69498930|FG003|Part 3|Withdrawal by Subject|0|||
37819887|NCT01722331|69498931|FG004|Part 3|Withdrawal by Subject|0|||
37819888|NCT01722331|69498932|FG005|Part 3|Withdrawal by Subject|2|||
37819889|NCT01722331|69498933|FG006|Part 3|Withdrawal by Subject|1|||
37819890|NCT01722331|69498927|FG000|Part 3|Other Protocol Specified Criteria|1|||
37819891|NCT01722331|69498928|FG001|Part 3|Other Protocol Specified Criteria|1|||
37819892|NCT01722331|69498929|FG002|Part 3|Other Protocol Specified Criteria|0|||
37880767|NCT00833833|69565461|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
37880768|NCT00833833|69565462|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
37880769|NCT00833833|69565463|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
37880770|NCT00833833|69565464|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
37880771|NCT00833833|69565465|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
37880772|NCT00833833|69565466|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
37880773|NCT00833833|69565461|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
37880774|NCT00833833|69565462|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
37880775|NCT00833833|69565463|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
37880776|NCT00833833|69565464|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
37880777|NCT00833833|69565465|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
37880778|NCT00833833|69565466|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
37880779|NCT00833833|69565461|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
37880780|NCT00833833|69565462|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
37880781|NCT00833833|69565463|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
37880782|NCT00833833|69565464|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
37880783|NCT00833833|69565465|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
37880784|NCT00833833|69565466|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
37880785|NCT00833833|69565461|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
37880786|NCT00833833|69565462|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
37880787|NCT00833833|69565463|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
37880788|NCT00833833|69565464|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
37880789|NCT00833833|69565465|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
37880790|NCT00833833|69565466|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
37880791|NCT00833833|69565461|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
37880792|NCT00833833|69565462|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
37880793|NCT00833833|69565463|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
37880794|NCT00833833|69565464|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
37880795|NCT00833833|69565465|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
37880796|NCT00833833|69565466|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
37880797|NCT00833833|69565461|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
37880798|NCT00833833|69565462|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
37880799|NCT00833833|69565463|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
37880800|NCT00833833|69565464|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
37819893|NCT01722331|69498930|FG003|Part 3|Other Protocol Specified Criteria|0|||
37819894|NCT01722331|69498931|FG004|Part 3|Other Protocol Specified Criteria|0|||
37819895|NCT01722331|69498932|FG005|Part 3|Other Protocol Specified Criteria|0|||
37880801|NCT00833833|69565465|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
37880802|NCT00833833|69565466|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
37880803|NCT00833833|69565461|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
37880804|NCT00833833|69565462|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
37880805|NCT00833833|69565463|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
37880806|NCT00833833|69565464|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
37880807|NCT00833833|69565465|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
37880808|NCT00833833|69565466|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
37880809|NCT01098071|69565486|FG000|Overall Study|Surgery (adenoidectomy)|2|||
37880810|NCT01098071|69565486|FG000|Overall Study|Lost to Follow-up|13|||
37880811|NCT01097057|69565490|FG000|Overall Study|Physician Decision|3|||
37880812|NCT01022112|69565499|FG000|Overall Study|Adverse Event|1|||
37984452|NCT00289887|69670513|FG000|Overall Study|Lost to Follow-up|3|||
37819896|NCT01722331|69498933|FG006|Part 3|Other Protocol Specified Criteria|0|||
37880813|NCT01022112|69565500|FG001|Overall Study|Adverse Event|2|||
37880814|NCT01022112|69565501|FG002|Overall Study|Adverse Event|0|||
37819897|NCT01630590|69498945|FG000|Overall Study|Adverse Event|9|||
37819898|NCT01630590|69498945|FG000|Overall Study|Lack of Efficacy|37|||
37819899|NCT01630590|69498945|FG000|Overall Study|Withdrawal by Subject|4|||
37819900|NCT01630590|69498945|FG000|Overall Study|2nd primary tumor|2|||
37819901|NCT01630590|69498945|FG000|Overall Study|Automobile accident|1|||
37819902|NCT01630590|69498945|FG000|Overall Study|Maximum benefit|4|||
37880815|NCT01022112|69565502|FG003|Overall Study|Adverse Event|1|||
37880816|NCT01022112|69565503|FG004|Overall Study|Adverse Event|0|||
37880817|NCT01022112|69565499|FG000|Overall Study|Lack of Efficacy|1|||
37880818|NCT01022112|69565500|FG001|Overall Study|Lack of Efficacy|0|||
37880819|NCT01022112|69565501|FG002|Overall Study|Lack of Efficacy|0|||
37880820|NCT01022112|69565502|FG003|Overall Study|Lack of Efficacy|0|||
37880821|NCT01022112|69565503|FG004|Overall Study|Lack of Efficacy|1|||
37880822|NCT01022112|69565499|FG000|Overall Study|Physician Decision|0|||
37880823|NCT01022112|69565500|FG001|Overall Study|Physician Decision|0|||
37880824|NCT01022112|69565501|FG002|Overall Study|Physician Decision|1|||
37880825|NCT01022112|69565502|FG003|Overall Study|Physician Decision|0|||
37880826|NCT01022112|69565503|FG004|Overall Study|Physician Decision|1|||
37880827|NCT01022112|69565499|FG000|Overall Study|Withdrawal by Subject|0|||
37880828|NCT01022112|69565500|FG001|Overall Study|Withdrawal by Subject|1|||
37880829|NCT01022112|69565501|FG002|Overall Study|Withdrawal by Subject|2|||
37880830|NCT01022112|69565502|FG003|Overall Study|Withdrawal by Subject|2|||
37880831|NCT01022112|69565503|FG004|Overall Study|Withdrawal by Subject|1|||
37984453|NCT00289887|69670514|FG001|Overall Study|Lost to Follow-up|3|||
37984454|NCT00289887|69670513|FG000|Overall Study|Protocol Violation|3|||
37984455|NCT00289887|69670514|FG001|Overall Study|Protocol Violation|1|||
37984456|NCT00289887|69670513|FG000|Overall Study|Withdrawal by Subject|3|||
37984457|NCT00289887|69670514|FG001|Overall Study|Withdrawal by Subject|8|||
37984458|NCT00289887|69670513|FG000|Overall Study|Other|7|||
37984459|NCT00289887|69670514|FG001|Overall Study|Other|3|||
37984460|NCT00303069|69670524|FG000|Overall Study|Lost to Follow-up|1|||
37984461|NCT00303069|69670525|FG001|Overall Study|Lost to Follow-up|0|||
37984462|NCT00303069|69670526|FG002|Overall Study|Lost to Follow-up|0|||
37984463|NCT00303069|69670527|FG003|Overall Study|Lost to Follow-up|2|||
37984464|NCT00303069|69670524|FG000|Overall Study|subject moved|1|||
37695254|NCT02349295|69171755|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
37880832|NCT01022112|69565499|FG000|Overall Study|Fasting plasma glucose level increased|1|||
37880833|NCT01022112|69565500|FG001|Overall Study|Fasting plasma glucose level increased|0|||
37880834|NCT01022112|69565501|FG002|Overall Study|Fasting plasma glucose level increased|0|||
37880835|NCT01022112|69565502|FG003|Overall Study|Fasting plasma glucose level increased|0|||
37880836|NCT01022112|69565503|FG004|Overall Study|Fasting plasma glucose level increased|7|||
37880837|NCT01096667|69565520|FG000|Overall Study|Lost to Follow-up|1|||
37880838|NCT01096667|69565521|FG001|Overall Study|Lost to Follow-up|1|||
37880839|NCT01096667|69565522|FG002|Overall Study|Lost to Follow-up|1|||
37880840|NCT01096667|69565523|FG003|Overall Study|Lost to Follow-up|0|||
37880841|NCT01096667|69565524|FG004|Overall Study|Lost to Follow-up|0|||
37880842|NCT01096667|69565520|FG000|Overall Study|Withdrawal by Subject|1|||
37880843|NCT01096667|69565521|FG001|Overall Study|Withdrawal by Subject|0|||
37880844|NCT01096667|69565522|FG002|Overall Study|Withdrawal by Subject|0|||
37880845|NCT01096667|69565523|FG003|Overall Study|Withdrawal by Subject|1|||
37880846|NCT01096667|69565524|FG004|Overall Study|Withdrawal by Subject|0|||
37880847|NCT01096667|69565520|FG000|Overall Study|Reason not available|0|||
37880848|NCT01096667|69565521|FG001|Overall Study|Reason not available|1|||
37880849|NCT01096667|69565522|FG002|Overall Study|Reason not available|1|||
37880850|NCT01096667|69565523|FG003|Overall Study|Reason not available|1|||
37880851|NCT01096667|69565524|FG004|Overall Study|Reason not available|0|||
37880852|NCT01096667|69565520|FG000|Overall Study|Protocol Violation|0|||
37880853|NCT01096667|69565521|FG001|Overall Study|Protocol Violation|0|||
37880854|NCT01096667|69565522|FG002|Overall Study|Protocol Violation|0|||
37880855|NCT01096667|69565523|FG003|Overall Study|Protocol Violation|1|||
37695255|NCT02349295|69171756|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
37695256|NCT02349295|69171757|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
37695257|NCT02349295|69171758|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
37695258|NCT02349295|69171759|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
37695259|NCT02349295|69171760|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
37695260|NCT02349295|69171761|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
37695261|NCT02349295|69171762|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
37695262|NCT02349295|69171749|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
37695263|NCT02349295|69171750|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
37880856|NCT01096667|69565524|FG004|Overall Study|Protocol Violation|0|||
37880857|NCT01096667|69565520|FG000|Overall Study|Not treated|1|||
37880858|NCT01096667|69565521|FG001|Overall Study|Not treated|0|||
37880859|NCT01096667|69565522|FG002|Overall Study|Not treated|0|||
37880860|NCT01096667|69565523|FG003|Overall Study|Not treated|0|||
37880861|NCT01096667|69565524|FG004|Overall Study|Not treated|0|||
37984465|NCT00303069|69670525|FG001|Overall Study|subject moved|0|||
37984466|NCT00303069|69670526|FG002|Overall Study|subject moved|0|||
37984467|NCT00303069|69670527|FG003|Overall Study|subject moved|0|||
37880862|NCT01014624|69565539|FG000|Overall Study|Adverse Event|0|||
37880863|NCT01014624|69565540|FG001|Overall Study|Adverse Event|1|||
37880864|NCT01014624|69565539|FG000|Overall Study|Protocol Violation|1|||
37984468|NCT00303069|69670524|FG000|Overall Study|Recruitment into Army Reserves|0|||
37880865|NCT01014624|69565540|FG001|Overall Study|Protocol Violation|0|||
37880866|NCT01014624|69565539|FG000|Overall Study|Withdrawal by Subject|1|||
37880867|NCT01014624|69565540|FG001|Overall Study|Withdrawal by Subject|0|||
37880868|NCT01021878|69565550|FG000|Overall Study|Lost to Follow-up|4|||
37880869|NCT01021878|69565551|FG001|Overall Study|Lost to Follow-up|3|||
37984469|NCT00303069|69670525|FG001|Overall Study|Recruitment into Army Reserves|0|||
37984470|NCT00303069|69670526|FG002|Overall Study|Recruitment into Army Reserves|1|||
37984471|NCT00303069|69670527|FG003|Overall Study|Recruitment into Army Reserves|0|||
37984472|NCT00401544|69670541|FG000|Overall Study|Adverse Event|5|||
37984473|NCT00401544|69670542|FG001|Overall Study|Adverse Event|1|||
37984474|NCT00401544|69670543|FG002|Overall Study|Adverse Event|1|||
37984475|NCT00401544|69670544|FG003|Overall Study|Adverse Event|1|||
37984476|NCT00401544|69670541|FG000|Overall Study|Death|3|||
37984477|NCT00401544|69670542|FG001|Overall Study|Death|6|||
37984478|NCT00401544|69670543|FG002|Overall Study|Death|2|||
37984479|NCT00401544|69670544|FG003|Overall Study|Death|5|||
37984480|NCT00401544|69670541|FG000|Overall Study|Lost to Follow-up|2|||
37984481|NCT00401544|69670542|FG001|Overall Study|Lost to Follow-up|0|||
37984482|NCT00401544|69670543|FG002|Overall Study|Lost to Follow-up|1|||
37984483|NCT00401544|69670544|FG003|Overall Study|Lost to Follow-up|1|||
37984484|NCT00401544|69670541|FG000|Overall Study|Withdrawal by Subject|7|||
37984485|NCT00401544|69670542|FG001|Overall Study|Withdrawal by Subject|6|||
37984486|NCT00401544|69670543|FG002|Overall Study|Withdrawal by Subject|6|||
37984487|NCT00401544|69670544|FG003|Overall Study|Withdrawal by Subject|5|||
37984488|NCT00401544|69670541|FG000|Overall Study|Physician Decision|1|||
37984489|NCT00401544|69670542|FG001|Overall Study|Physician Decision|3|||
37984490|NCT00401544|69670543|FG002|Overall Study|Physician Decision|0|||
37984491|NCT00401544|69670544|FG003|Overall Study|Physician Decision|0|||
37984492|NCT00401544|69670541|FG000|Overall Study|Ineligibility determined|0|||
37984493|NCT00401544|69670542|FG001|Overall Study|Ineligibility determined|1|||
37984494|NCT00401544|69670543|FG002|Overall Study|Ineligibility determined|0|||
37984495|NCT00401544|69670544|FG003|Overall Study|Ineligibility determined|2|||
37984496|NCT00401544|69670541|FG000|Overall Study|Disease progression|0|||
37984497|NCT00401544|69670542|FG001|Overall Study|Disease progression|1|||
37984498|NCT00401544|69670543|FG002|Overall Study|Disease progression|0|||
37984499|NCT00401544|69670544|FG003|Overall Study|Disease progression|0|||
37984500|NCT00401544|69670541|FG000|Overall Study|Other|0|||
37984501|NCT00401544|69670542|FG001|Overall Study|Other|0|||
37984502|NCT00401544|69670543|FG002|Overall Study|Other|2|||
37984503|NCT00401544|69670544|FG003|Overall Study|Other|2|||
37984504|NCT00289731|69670562|FG000|Overall Study|Adverse Event|1|||
37984505|NCT00289731|69670563|FG001|Overall Study|Adverse Event|2|||
37819903|NCT01619085|69498949|FG000|Overall Study|Adverse Event|231|||
37819904|NCT01619085|69498949|FG000|Overall Study|Protocol Violation|4|||
37819905|NCT01619085|69498949|FG000|Overall Study|Lost to Follow-up|3|||
37819906|NCT01619085|69498949|FG000|Overall Study|Withdrawal by Subject|45|||
37819907|NCT01619085|69498949|FG000|Overall Study|Other than specified|96|||
37819908|NCT01619085|69498949|FG000|Overall Study|Not treated|1|||
37819909|NCT01619085|69498949|FG000|Overall Study|Death|145|||
37819910|NCT01499095|69498962|FG000|Overall Study|Randomized But Not Treated|1|||
37819911|NCT01499095|69498963|FG001|Overall Study|Randomized But Not Treated|1|||
37819912|NCT01499095|69498962|FG000|Overall Study|Adverse Event|12|||
37819913|NCT01499095|69498963|FG001|Overall Study|Adverse Event|7|||
37819914|NCT01499095|69498962|FG000|Overall Study|Lack of Efficacy|2|||
37819915|NCT01499095|69498963|FG001|Overall Study|Lack of Efficacy|1|||
37819916|NCT01499095|69498962|FG000|Overall Study|Protocol Violation|6|||
37984506|NCT00289731|69670564|FG002|Overall Study|Adverse Event|2|||
37984507|NCT00289731|69670562|FG000|Overall Study|Other|1|||
37984508|NCT00289731|69670563|FG001|Overall Study|Other|0|||
37984509|NCT00289731|69670564|FG002|Overall Study|Other|0|||
37984510|NCT00289185|69670576|FG000|Overall Study|Withdrawal by Subject|4|||
37984511|NCT00289185|69670577|FG001|Overall Study|Withdrawal by Subject|8|||
37984512|NCT00289185|69670576|FG000|Overall Study|Lost to Follow-up|23|||
37984513|NCT00289185|69670577|FG001|Overall Study|Lost to Follow-up|17|||
37984514|NCT00289185|69670576|FG000|Overall Study|Death|1|||
37984515|NCT00289185|69670577|FG001|Overall Study|Death|1|||
37984516|NCT00292461|69670586|FG000|Overall Study|Adverse Event|4|||
37984517|NCT00292461|69670587|FG001|Overall Study|Adverse Event|2|||
37984518|NCT00292461|69670586|FG000|Overall Study|Lack of Efficacy|1|||
37984519|NCT00292461|69670587|FG001|Overall Study|Lack of Efficacy|0|||
37984520|NCT00292461|69670586|FG000|Overall Study|Withdrawal by Subject|0|||
37984521|NCT00292461|69670587|FG001|Overall Study|Withdrawal by Subject|1|||
37984522|NCT00292461|69670586|FG000|Overall Study|Protocol Violation|4|||
37984523|NCT00292461|69670587|FG001|Overall Study|Protocol Violation|3|||
37984524|NCT00292461|69670586|FG000|Overall Study|Lost to Follow-up|1|||
37984525|NCT00292461|69670587|FG001|Overall Study|Lost to Follow-up|0|||
37984526|NCT00288639|69670593|FG000|Overall Study|Adverse Event|5|||
37984527|NCT00288639|69670593|FG000|Overall Study|Lack of Efficacy|4|||
37819917|NCT01499095|69498963|FG001|Overall Study|Protocol Violation|7|||
37819918|NCT01499095|69498962|FG000|Overall Study|Received Rescue Therapy|32|||
37819919|NCT01499095|69498963|FG001|Overall Study|Received Rescue Therapy|40|||
37819920|NCT01499095|69498962|FG000|Overall Study|Diverse Reasons|22|||
37984528|NCT00288639|69670593|FG000|Overall Study|Withdrawal by Subject|2|||
37984529|NCT00288639|69670593|FG000|Overall Study|Other|1|||
37984530|NCT00390858|69670599|FG000|Overall Study|Adverse Event|6|||
37984531|NCT00390858|69670600|FG001|Overall Study|Adverse Event|2|||
37984532|NCT00390858|69670599|FG000|Overall Study|Lack of Efficacy|0|||
37984533|NCT00390858|69670600|FG001|Overall Study|Lack of Efficacy|1|||
37984534|NCT00390858|69670599|FG000|Overall Study|Withdrawal by Subject|3|||
37984535|NCT00390858|69670600|FG001|Overall Study|Withdrawal by Subject|4|||
37984536|NCT00390780|69670608|FG000|Overall Study|Not completed|10|||
37984537|NCT00390780|69670609|FG001|Overall Study|Not completed|4|||
37819921|NCT01499095|69498963|FG001|Overall Study|Diverse Reasons|25|||
37819922|NCT01499095|69498962|FG000|Overall Study|Lost to Follow-up|6|||
37819923|NCT01499095|69498963|FG001|Overall Study|Lost to Follow-up|4|||
37819924|NCT01499095|69498962|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
37819925|NCT01499095|69498963|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
37819926|NCT01499095|69498962|FG000|Overall Study|Hypoglycemia|3|||
37819927|NCT01499095|69498963|FG001|Overall Study|Hypoglycemia|1|||
37819928|NCT01499095|69498962|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
37819929|NCT01499095|69498963|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
37819930|NCT01499095|69498962|FG000|Overall Study|Change in Injection Schedule|2|||
37819931|NCT01499095|69498963|FG001|Overall Study|Change in Injection Schedule|0|||
37819932|NCT01499095|69498962|FG000|Overall Study|Perceived Lack of Efficacy|1|||
37880870|NCT01021878|69565550|FG000|Overall Study|Death|0|||
37880871|NCT01021878|69565551|FG001|Overall Study|Death|1|||
37880872|NCT01021878|69565550|FG000|Overall Study|Adverse Event|6|||
37880873|NCT01021878|69565551|FG001|Overall Study|Adverse Event|5|||
37880874|NCT01021878|69565550|FG000|Overall Study|Transplantation|6|||
37880875|NCT01021878|69565551|FG001|Overall Study|Transplantation|1|||
37880876|NCT00854113|69565571|FG000|Overall Study|Adverse Event|0|||
37880877|NCT00854113|69565572|FG001|Overall Study|Adverse Event|0|||
37880878|NCT00854113|69565573|FG002|Overall Study|Adverse Event|0|||
37880879|NCT00854113|69565574|FG003|Overall Study|Adverse Event|0|||
37880880|NCT00854113|69565575|FG004|Overall Study|Adverse Event|0|||
37880881|NCT00854113|69565576|FG005|Overall Study|Adverse Event|0|||
37880882|NCT00854113|69565577|FG006|Overall Study|Adverse Event|0|||
37880883|NCT00854113|69565578|FG007|Overall Study|Adverse Event|2|||
37880884|NCT00854113|69565579|FG008|Overall Study|Adverse Event|0|||
37880885|NCT00854113|69565580|FG009|Overall Study|Adverse Event|0|||
37880886|NCT00854113|69565581|FG010|Overall Study|Adverse Event|0|||
37880887|NCT00854113|69565571|FG000|Overall Study|Withdrawal by Subject|0|||
37880888|NCT00854113|69565572|FG001|Overall Study|Withdrawal by Subject|0|||
37880889|NCT00854113|69565573|FG002|Overall Study|Withdrawal by Subject|0|||
37880890|NCT00854113|69565574|FG003|Overall Study|Withdrawal by Subject|0|||
37880891|NCT00854113|69565575|FG004|Overall Study|Withdrawal by Subject|0|||
37880892|NCT00854113|69565576|FG005|Overall Study|Withdrawal by Subject|0|||
37880893|NCT00854113|69565577|FG006|Overall Study|Withdrawal by Subject|0|||
37880894|NCT00854113|69565578|FG007|Overall Study|Withdrawal by Subject|1|||
37880895|NCT00854113|69565579|FG008|Overall Study|Withdrawal by Subject|1|||
37880896|NCT00854113|69565580|FG009|Overall Study|Withdrawal by Subject|0|||
37880897|NCT00854113|69565581|FG010|Overall Study|Withdrawal by Subject|0|||
37880898|NCT00845845|69565607|FG000|Overall Study|Lost to Follow-up|0|||
37880899|NCT00845845|69565608|FG001|Overall Study|Lost to Follow-up|4|||
37880900|NCT01104701|69565618|FG000|Overall Study|Withdrawal by Subject|0|||
37819933|NCT01499095|69498963|FG001|Overall Study|Perceived Lack of Efficacy|1|||
37819934|NCT01499082|69498974|FG000|Overall Study|Randomized but not Treated|0|||
37819935|NCT01499082|69498975|FG001|Overall Study|Randomized but not Treated|1|||
37819936|NCT01499082|69498974|FG000|Overall Study|Adverse Event|12|||
37819937|NCT01499082|69498975|FG001|Overall Study|Adverse Event|16|||
37819938|NCT01499082|69498974|FG000|Overall Study|Lack of Efficacy|1|||
37819939|NCT01499082|69498975|FG001|Overall Study|Lack of Efficacy|1|||
37819940|NCT01499082|69498974|FG000|Overall Study|Protocol Violation|6|||
37819941|NCT01499082|69498975|FG001|Overall Study|Protocol Violation|8|||
37819942|NCT01499082|69498974|FG000|Overall Study|Diverse Reasons|18|||
37819943|NCT01499082|69498975|FG001|Overall Study|Diverse Reasons|14|||
37819944|NCT01499082|69498974|FG000|Overall Study|Site Closure for Noncompliance|5|||
37819945|NCT01499082|69498975|FG001|Overall Study|Site Closure for Noncompliance|2|||
37819946|NCT01499082|69498974|FG000|Overall Study|Hypoglycemia|2|||
37819947|NCT01499082|69498975|FG001|Overall Study|Hypoglycemia|3|||
37819948|NCT01499082|69498974|FG000|Overall Study|Lost to Follow-up|1|||
37819949|NCT01499082|69498975|FG001|Overall Study|Lost to Follow-up|3|||
37819950|NCT01488890|69498987|FG000|Overall Study|Serious adverse event|2|||
37819951|NCT01488890|69498988|FG001|Overall Study|Serious adverse event|0|||
37819952|NCT01488890|69498989|FG002|Overall Study|Serious adverse event|0|||
37819953|NCT01488890|69498990|FG003|Overall Study|Serious adverse event|0|||
37819954|NCT01488890|69498987|FG000|Overall Study|Protocol Violation|3|||
37819955|NCT01488890|69498988|FG001|Overall Study|Protocol Violation|0|||
37819956|NCT01488890|69498989|FG002|Overall Study|Protocol Violation|4|||
37695264|NCT02349295|69171751|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
37819957|NCT01488890|69498990|FG003|Overall Study|Protocol Violation|0|||
37819958|NCT01488890|69498987|FG000|Overall Study|Lost to Follow-up|13|||
37819959|NCT01488890|69498988|FG001|Overall Study|Lost to Follow-up|10|||
37819960|NCT01488890|69498989|FG002|Overall Study|Lost to Follow-up|20|||
37819961|NCT01488890|69498990|FG003|Overall Study|Lost to Follow-up|3|||
37819962|NCT01488890|69498987|FG000|Overall Study|Withdrawal by Subject|14|||
37819963|NCT01488890|69498988|FG001|Overall Study|Withdrawal by Subject|10|||
37880901|NCT01104701|69565619|FG001|Overall Study|Withdrawal by Subject|1|||
37880902|NCT01104701|69565620|FG002|Overall Study|Withdrawal by Subject|2|||
37880903|NCT01104701|69565621|FG003|Overall Study|Withdrawal by Subject|1|||
37880904|NCT01104701|69565618|FG000|Overall Study|Adverse Event|0|||
37880905|NCT01104701|69565619|FG001|Overall Study|Adverse Event|0|||
37880906|NCT01104701|69565620|FG002|Overall Study|Adverse Event|0|||
37880907|NCT01104701|69565621|FG003|Overall Study|Adverse Event|1|||
37880908|NCT01104701|69565618|FG000|Overall Study|Physician Decision|0|||
37880909|NCT01104701|69565619|FG001|Overall Study|Physician Decision|2|||
37880910|NCT01104701|69565620|FG002|Overall Study|Physician Decision|0|||
37880911|NCT01104701|69565621|FG003|Overall Study|Physician Decision|0|||
37880912|NCT00833755|69565635|FG000|Overall Study|Physician Decision|4|||
37880913|NCT00833755|69565636|FG001|Overall Study|Physician Decision|4|||
37880914|NCT00833755|69565637|FG002|Overall Study|Physician Decision|2|||
37880915|NCT00833755|69565638|FG003|Overall Study|Physician Decision|6|||
37880916|NCT00833755|69565635|FG000|Overall Study|Subject had scheduling issues|0|||
37880917|NCT00833755|69565636|FG001|Overall Study|Subject had scheduling issues|1|||
37880918|NCT00833755|69565637|FG002|Overall Study|Subject had scheduling issues|0|||
37880919|NCT00833755|69565638|FG003|Overall Study|Subject had scheduling issues|0|||
37880920|NCT01021332|69565649|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
37880921|NCT01021332|69565649|FG000|Overall Study|Adverse Event|43|||
37880922|NCT01021332|69565649|FG000|Overall Study|Lack of Efficacy|19|||
37880923|NCT01021332|69565649|FG000|Overall Study|Withdrawal of Consent|23|||
37880924|NCT01021332|69565649|FG000|Overall Study|Lost to Follow-up|4|||
37880925|NCT01021332|69565649|FG000|Overall Study|Protocol Violation|9|||
37880926|NCT01021332|69565649|FG000|Overall Study|Miscellaneous|3|||
37880927|NCT00923091|69565663|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
37880928|NCT00923091|69565664|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
37880929|NCT00923091|69565665|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
37880930|NCT00923091|69565666|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
37880931|NCT00923091|69565667|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
37984538|NCT00390780|69670608|FG000|Overall Study|Protocol Violation|6|||
37819964|NCT01488890|69498989|FG002|Overall Study|Withdrawal by Subject|11|||
37819965|NCT01488890|69498990|FG003|Overall Study|Withdrawal by Subject|2|||
37819966|NCT01436396|69499006|FG000|Overall Study|Protocol Violation|7|||
37880932|NCT00923091|69565668|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
37880933|NCT00923091|69565669|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
37880934|NCT00923091|69565670|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
37880935|NCT00923091|69565671|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
37880936|NCT00923091|69565672|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
37880937|NCT00923091|69565673|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
37880938|NCT00923091|69565674|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
37880939|NCT00923091|69565675|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
37880940|NCT00923091|69565663|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
37880941|NCT00923091|69565664|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
37880942|NCT00923091|69565665|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
37880943|NCT00923091|69565666|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
37880944|NCT00923091|69565667|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
37880945|NCT00923091|69565668|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
37880946|NCT00923091|69565669|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
37880947|NCT00923091|69565670|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
37880948|NCT00923091|69565671|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
37880949|NCT00923091|69565672|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
37880950|NCT00923091|69565673|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
37880951|NCT00923091|69565674|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
37819967|NCT01436396|69499007|FG001|Overall Study|Protocol Violation|5|||
37819968|NCT01436396|69499006|FG000|Overall Study|Adverse Event|1|||
37819969|NCT01436396|69499007|FG001|Overall Study|Adverse Event|2|||
37819970|NCT01436396|69499006|FG000|Overall Study|Withdrawal by Subject|19|||
37819971|NCT01436396|69499007|FG001|Overall Study|Withdrawal by Subject|29|||
37819972|NCT01436396|69499006|FG000|Overall Study|Serious adverse event|2|||
37819973|NCT01436396|69499007|FG001|Overall Study|Serious adverse event|3|||
37819974|NCT01436396|69499006|FG000|Overall Study|Lost to Follow-up|3|||
37819975|NCT01436396|69499007|FG001|Overall Study|Lost to Follow-up|3|||
37819976|NCT01411241|69499015|FG000|Overall Study|Protocol Violation|0|||
37819977|NCT01411241|69499016|FG001|Overall Study|Protocol Violation|5|||
37819978|NCT01411241|69499015|FG000|Overall Study|Withdrawal by Subject|9|||
37819979|NCT01411241|69499016|FG001|Overall Study|Withdrawal by Subject|10|||
37819980|NCT01411241|69499015|FG000|Overall Study|Serious Adverse Event|0|||
37819981|NCT01411241|69499016|FG001|Overall Study|Serious Adverse Event|3|||
37819982|NCT01411241|69499015|FG000|Overall Study|Lost to Follow-up|2|||
37819983|NCT01411241|69499016|FG001|Overall Study|Lost to Follow-up|4|||
37819984|NCT01374516|69499024|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
37880952|NCT00923091|69565675|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
37984539|NCT00390780|69670609|FG001|Overall Study|Protocol Violation|4|||
37984540|NCT00390780|69670608|FG000|Overall Study|Lost to Follow-up|3|||
37819985|NCT01374516|69499025|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
37819986|NCT01374516|69499024|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
37880953|NCT00923091|69565663|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
37880954|NCT00923091|69565664|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
37880955|NCT00923091|69565665|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
37880956|NCT00923091|69565666|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
37880957|NCT00923091|69565667|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
37880958|NCT00923091|69565668|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
37880959|NCT00923091|69565669|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
37880960|NCT00923091|69565670|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
37880961|NCT00923091|69565671|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
37880962|NCT00923091|69565672|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
37880963|NCT00923091|69565673|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
37880964|NCT00923091|69565674|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
37880965|NCT00923091|69565675|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
37880966|NCT00923091|69565663|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
37880967|NCT00923091|69565664|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
37880968|NCT00923091|69565665|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
37880969|NCT00923091|69565666|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
37984541|NCT00390780|69670609|FG001|Overall Study|Lost to Follow-up|6|||
37984542|NCT00390780|69670608|FG000|Overall Study|Adverse Event|2|||
37984543|NCT00390780|69670609|FG001|Overall Study|Adverse Event|3|||
37984544|NCT00390780|69670608|FG000|Overall Study|Death|1|||
37819987|NCT01374516|69499025|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
37819988|NCT01374516|69499024|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
37819989|NCT01374516|69499025|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
37819990|NCT01374516|69499024|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
37819991|NCT01374516|69499025|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
37819992|NCT01374516|69499024|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
37819993|NCT01374516|69499025|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
37819994|NCT01374516|69499024|FG000|Surveillance Expansion Period|Protocol Violation|386|||
37819995|NCT01374516|69499025|FG001|Surveillance Expansion Period|Protocol Violation|217|||
37819996|NCT01374516|69499024|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
37819997|NCT01374516|69499025|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
37819998|NCT01374516|69499024|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
37819999|NCT01374516|69499025|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
37820000|NCT01374516|69499024|FG000|Surveillance Expansion Period|Serious adverse event|20|||
37820001|NCT01374516|69499025|FG001|Surveillance Expansion Period|Serious adverse event|5|||
37820002|NCT01373281|69499040|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
37820003|NCT01373281|69499041|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
37820004|NCT01373281|69499040|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
37820005|NCT01373281|69499041|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
37820006|NCT01373281|69499040|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
37820007|NCT01373281|69499041|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
37820008|NCT01373281|69499040|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
37820009|NCT01373281|69499041|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
37820010|NCT01373281|69499040|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
37820011|NCT01373281|69499041|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
37820012|NCT01373281|69499040|FG000|Surveillance Expansion Period|Protocol Violation|9|||
37820013|NCT01373281|69499041|FG001|Surveillance Expansion Period|Protocol Violation|1|||
37820014|NCT01373281|69499040|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
37820015|NCT01373281|69499041|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
37820016|NCT01373281|69499040|FG000|Surveillance Expansion Period|Serious adverse event|3|||
37820017|NCT01373281|69499041|FG001|Surveillance Expansion Period|Serious adverse event|4|||
37820018|NCT01254422|69499056|FG000|Overall Study|Protocol Violation|1|||
37820019|NCT01254422|69499057|FG001|Overall Study|Protocol Violation|0|||
37820020|NCT01254422|69499056|FG000|Overall Study|Adverse Event|1|||
37820021|NCT01254422|69499057|FG001|Overall Study|Adverse Event|0|||
37820022|NCT01254422|69499056|FG000|Overall Study|Serious adverse event|0|||
37820023|NCT01254422|69499057|FG001|Overall Study|Serious adverse event|1|||
37820024|NCT01254422|69499056|FG000|Overall Study|Lost to Follow-up|1|||
37820025|NCT01254422|69499057|FG001|Overall Study|Lost to Follow-up|0|||
37820026|NCT01187433|69499065|FG000|Overall Study|Protocol Violation|6|||
37820027|NCT01187433|69499066|FG001|Overall Study|Protocol Violation|2|||
37820028|NCT01187433|69499065|FG000|Overall Study|Withdrawal by Subject|5|||
37820029|NCT01187433|69499066|FG001|Overall Study|Withdrawal by Subject|2|||
37820030|NCT01150045|69499076|FG000|Overall Study|Protocol Violation|0|||
37820031|NCT01150045|69499077|FG001|Overall Study|Protocol Violation|1|||
37984545|NCT00390780|69670609|FG001|Overall Study|Death|3|||
37984546|NCT00390780|69670608|FG000|Overall Study|Withdrawal by Subject|1|||
37984547|NCT00390780|69670609|FG001|Overall Study|Withdrawal by Subject|2|||
37984548|NCT00390780|69670608|FG000|Overall Study|Inclusion criteria not satisfied|0|||
37880970|NCT00923091|69565667|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
37880971|NCT00923091|69565668|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
37880972|NCT00923091|69565669|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
37880973|NCT00923091|69565670|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
37880974|NCT00923091|69565671|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
37880975|NCT00923091|69565672|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
37880976|NCT00923091|69565673|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
37880977|NCT00923091|69565674|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
37880978|NCT00923091|69565675|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
37880979|NCT00923091|69565663|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
37880980|NCT00923091|69565664|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
37880981|NCT00923091|69565665|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
37880982|NCT00923091|69565666|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
37880983|NCT00923091|69565667|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
37984549|NCT00390780|69670609|FG001|Overall Study|Inclusion criteria not satisfied|2|||
37695265|NCT02349295|69171752|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
37695266|NCT02349295|69171753|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
37695267|NCT02349295|69171754|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
37820032|NCT01150045|69499078|FG002|Overall Study|Protocol Violation|0|||
37820033|NCT01150045|69499079|FG003|Overall Study|Protocol Violation|1|||
37820034|NCT01098032|69499089|FG000|Overall Study|Withdrawal by Subject|1|||
37820035|NCT01098032|69499090|FG001|Overall Study|Withdrawal by Subject|1|||
37820036|NCT01034306|69499098|FG000|Overall Study|Adverse Event|1|||
37820037|NCT01034306|69499099|FG001|Overall Study|Adverse Event|0|||
37820038|NCT01034306|69499098|FG000|Overall Study|Lost to Follow-up|0|||
37820039|NCT01034306|69499099|FG001|Overall Study|Lost to Follow-up|1|||
37820040|NCT01034306|69499098|FG000|Overall Study|Withdrawal by Subject|2|||
37820041|NCT01034306|69499099|FG001|Overall Study|Withdrawal by Subject|2|||
37820042|NCT01034306|69499098|FG000|Overall Study|hospitalized and decided to stop|1|||
37820043|NCT01034306|69499099|FG001|Overall Study|hospitalized and decided to stop|0|||
37820044|NCT01034306|69499098|FG000|Overall Study|Noncomplience|1|||
37820045|NCT01034306|69499099|FG001|Overall Study|Noncomplience|0|||
37820046|NCT00993447|69499107|FG000|Overall Study|Withdrawal by Subject|23|||
37820047|NCT00993447|69499108|FG001|Overall Study|Withdrawal by Subject|8|||
37820048|NCT00993447|69499107|FG000|Overall Study|Protocol Violation|12|||
37820049|NCT00993447|69499108|FG001|Overall Study|Protocol Violation|8|||
37820050|NCT00993447|69499107|FG000|Overall Study|Lost to Follow-up|1|||
37820051|NCT00993447|69499108|FG001|Overall Study|Lost to Follow-up|3|||
37820052|NCT00993447|69499107|FG000|Overall Study|Adverse Event|1|||
37820053|NCT00993447|69499108|FG001|Overall Study|Adverse Event|0|||
37820054|NCT00945009|69499117|FG000|Overall Study|Lack of Efficacy|10|||
37820055|NCT00945009|69499118|FG001|Overall Study|Lack of Efficacy|0|||
37820056|NCT00945009|69499119|FG002|Overall Study|Lack of Efficacy|0|||
37820057|NCT00945009|69499117|FG000|Overall Study|Physician Decision|21|||
37820058|NCT00945009|69499118|FG001|Overall Study|Physician Decision|4|||
37820059|NCT00945009|69499119|FG002|Overall Study|Physician Decision|3|||
37820060|NCT00945009|69499117|FG000|Overall Study|Protocol Violation|6|||
37820061|NCT00945009|69499118|FG001|Overall Study|Protocol Violation|1|||
37820062|NCT00945009|69499119|FG002|Overall Study|Protocol Violation|0|||
37820063|NCT00945009|69499117|FG000|Overall Study|Withdrawal by Subject|1|||
37820064|NCT00945009|69499118|FG001|Overall Study|Withdrawal by Subject|0|||
37820065|NCT00945009|69499119|FG002|Overall Study|Withdrawal by Subject|0|||
37820066|NCT00945009|69499117|FG000|Overall Study|Ineligible|6|||
37820067|NCT00945009|69499118|FG001|Overall Study|Ineligible|1|||
37820068|NCT00945009|69499119|FG002|Overall Study|Ineligible|0|||
37820069|NCT00945009|69499117|FG000|Overall Study|Inevaluable|0|||
37820070|NCT00945009|69499118|FG001|Overall Study|Inevaluable|1|||
37820071|NCT00945009|69499119|FG002|Overall Study|Inevaluable|0|||
37820072|NCT00945009|69499117|FG000|Overall Study|Refusal of further protocol|1|||
37820073|NCT00945009|69499118|FG001|Overall Study|Refusal of further protocol|0|||
37820074|NCT00945009|69499119|FG002|Overall Study|Refusal of further protocol|0|||
37820075|NCT00942877|69499129|FG000|Overall Study|Refused further treatment|1|||
37820076|NCT00942877|69499130|FG001|Overall Study|Refused further treatment|1|||
37820077|NCT00942877|69499129|FG000|Overall Study|Patient was not treated|1|||
37880984|NCT00923091|69565668|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
37880985|NCT00923091|69565669|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
37880986|NCT00923091|69565670|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
37880987|NCT00923091|69565671|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
37880988|NCT00923091|69565672|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
37880989|NCT00923091|69565673|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
37880990|NCT00923091|69565674|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
37880991|NCT00923091|69565675|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
37880992|NCT00923091|69565663|FG000|Period III (Single-Blind)|Adverse Event|5|||
37880993|NCT00923091|69565664|FG001|Period III (Single-Blind)|Adverse Event|0|||
37880994|NCT00923091|69565665|FG002|Period III (Single-Blind)|Adverse Event|0|||
37880995|NCT00923091|69565666|FG003|Period III (Single-Blind)|Adverse Event|0|||
37880996|NCT00923091|69565667|FG004|Period III (Single-Blind)|Adverse Event|0|||
37880997|NCT00923091|69565668|FG005|Period III (Single-Blind)|Adverse Event|0|||
37880998|NCT00923091|69565669|FG006|Period III (Single-Blind)|Adverse Event|0|||
37880999|NCT00923091|69565670|FG007|Period III (Single-Blind)|Adverse Event|0|||
37881000|NCT00923091|69565671|FG008|Period III (Single-Blind)|Adverse Event|0|||
37881001|NCT00923091|69565672|FG009|Period III (Single-Blind)|Adverse Event|0|||
37881002|NCT00923091|69565673|FG010|Period III (Single-Blind)|Adverse Event|0|||
37881003|NCT00923091|69565674|FG011|Period III (Single-Blind)|Adverse Event|0|||
37881004|NCT00923091|69565675|FG012|Period III (Single-Blind)|Adverse Event|0|||
37881005|NCT00923091|69565663|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
37881006|NCT00923091|69565664|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
37881007|NCT00923091|69565665|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
37881008|NCT00923091|69565666|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
37881009|NCT00923091|69565667|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
37881010|NCT00923091|69565668|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
37881011|NCT00923091|69565669|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
37881012|NCT00923091|69565670|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
37881013|NCT00923091|69565671|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
37881014|NCT00923091|69565672|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
37881015|NCT00923091|69565673|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
37881016|NCT00923091|69565674|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
37881017|NCT00923091|69565675|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
37881018|NCT00923091|69565663|FG000|Period III (Single-Blind)|Protocol Violation|3|||
37881019|NCT00923091|69565664|FG001|Period III (Single-Blind)|Protocol Violation|0|||
37881020|NCT00923091|69565665|FG002|Period III (Single-Blind)|Protocol Violation|0|||
37881021|NCT00923091|69565666|FG003|Period III (Single-Blind)|Protocol Violation|0|||
37881022|NCT00923091|69565667|FG004|Period III (Single-Blind)|Protocol Violation|0|||
37881023|NCT00923091|69565668|FG005|Period III (Single-Blind)|Protocol Violation|0|||
37881024|NCT00923091|69565669|FG006|Period III (Single-Blind)|Protocol Violation|0|||
37881025|NCT00923091|69565670|FG007|Period III (Single-Blind)|Protocol Violation|0|||
37984550|NCT00390780|69670608|FG000|Overall Study|Lost to follow up and other reasons|0|||
37881026|NCT00923091|69565671|FG008|Period III (Single-Blind)|Protocol Violation|0|||
37984551|NCT00390780|69670609|FG001|Overall Study|Lost to follow up and other reasons|1|||
37984552|NCT00390780|69670608|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
37881027|NCT00923091|69565672|FG009|Period III (Single-Blind)|Protocol Violation|0|||
37881028|NCT00923091|69565673|FG010|Period III (Single-Blind)|Protocol Violation|0|||
37881029|NCT00923091|69565674|FG011|Period III (Single-Blind)|Protocol Violation|0|||
37881030|NCT00923091|69565675|FG012|Period III (Single-Blind)|Protocol Violation|0|||
37881031|NCT00923091|69565663|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
37881032|NCT00923091|69565664|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
37881033|NCT00923091|69565665|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
37881034|NCT00923091|69565666|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
37881035|NCT00923091|69565667|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
37881036|NCT00923091|69565668|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
37881037|NCT00923091|69565669|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
37881038|NCT00923091|69565670|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
37881039|NCT00923091|69565671|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
37881040|NCT00923091|69565672|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
37881041|NCT00923091|69565673|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
37881042|NCT00923091|69565674|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
37881043|NCT00923091|69565675|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
37881044|NCT00923091|69565663|FG000|Period IV (Double-Blind)|Adverse Event|2|||
37881045|NCT00923091|69565664|FG001|Period IV (Double-Blind)|Adverse Event|0|||
37881046|NCT00923091|69565665|FG002|Period IV (Double-Blind)|Adverse Event|0|||
37881047|NCT00923091|69565666|FG003|Period IV (Double-Blind)|Adverse Event|0|||
37881048|NCT00923091|69565667|FG004|Period IV (Double-Blind)|Adverse Event|0|||
37881049|NCT00923091|69565668|FG005|Period IV (Double-Blind)|Adverse Event|0|||
37881050|NCT00923091|69565669|FG006|Period IV (Double-Blind)|Adverse Event|0|||
37881051|NCT00923091|69565670|FG007|Period IV (Double-Blind)|Adverse Event|0|||
37881052|NCT00923091|69565671|FG008|Period IV (Double-Blind)|Adverse Event|0|||
37881053|NCT00923091|69565672|FG009|Period IV (Double-Blind)|Adverse Event|0|||
37881054|NCT00923091|69565673|FG010|Period IV (Double-Blind)|Adverse Event|0|||
37881055|NCT00923091|69565674|FG011|Period IV (Double-Blind)|Adverse Event|0|||
37881056|NCT00923091|69565675|FG012|Period IV (Double-Blind)|Adverse Event|0|||
37881057|NCT00923091|69565663|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
37881058|NCT00923091|69565664|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
37881059|NCT00923091|69565665|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
37881060|NCT00923091|69565666|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
37881061|NCT00923091|69565667|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
37881062|NCT00923091|69565668|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
37881063|NCT00923091|69565669|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
37881064|NCT00923091|69565670|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
37881065|NCT00923091|69565671|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
37881066|NCT00923091|69565672|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
37984553|NCT00390780|69670609|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
37984554|NCT00390780|69670608|FG000|Overall Study|SAE, death|0|||
37984555|NCT00390780|69670609|FG001|Overall Study|SAE, death|1|||
37984556|NCT00390546|69670617|FG000|Overall Study|Renal impairment|1|||
37984557|NCT00390546|69670618|FG001|Overall Study|Renal impairment|0|||
37984558|NCT00390546|69670617|FG000|Overall Study|Physician Decision|5|||
37984559|NCT00390546|69670618|FG001|Overall Study|Physician Decision|5|||
37984560|NCT00390468|69670625|FG000|Overall Study|Protocol Violation|2|||
37984561|NCT00390468|69670625|FG000|Overall Study|Lack of Efficacy|1|||
37984562|NCT00400764|69670634|FG000|Phase Ib|Adverse Event|1|||
37984563|NCT00400764|69670635|FG001|Phase Ib|Adverse Event|0|||
37984564|NCT00400764|69670636|FG002|Phase Ib|Adverse Event|0|||
37984565|NCT00400764|69670637|FG003|Phase Ib|Adverse Event|0|||
37984566|NCT00400764|69670638|FG004|Phase Ib|Adverse Event|0|||
37695268|NCT02349295|69171755|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
37695269|NCT02349295|69171756|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
37820078|NCT00942877|69499130|FG001|Overall Study|Patient was not treated|0|||
37820079|NCT00942877|69499129|FG000|Overall Study|Adverse Event|1|||
37820080|NCT00942877|69499130|FG001|Overall Study|Adverse Event|0|||
37820081|NCT00942877|69499129|FG000|Overall Study|Progressive disease|42|||
37820082|NCT00942877|69499130|FG001|Overall Study|Progressive disease|3|||
37820083|NCT00880893|69499145|FG000|Overall Study|Protocol Violation|13|||
37820084|NCT00880893|69499146|FG001|Overall Study|Protocol Violation|1|||
37820085|NCT00880893|69499145|FG000|Overall Study|Withdrawal by Subject|15|||
37820086|NCT00880893|69499146|FG001|Overall Study|Withdrawal by Subject|11|||
37820087|NCT00880893|69499145|FG000|Overall Study|Lost to Follow-up|76|||
37984567|NCT00400764|69670634|FG000|Phase Ib|Death|1|||
37984568|NCT00400764|69670635|FG001|Phase Ib|Death|0|||
37984569|NCT00400764|69670636|FG002|Phase Ib|Death|0|||
37984570|NCT00400764|69670637|FG003|Phase Ib|Death|0|||
37984571|NCT00400764|69670638|FG004|Phase Ib|Death|0|||
37984572|NCT00400764|69670634|FG000|Phase Ib|Disease Progression|4|||
37984573|NCT00400764|69670635|FG001|Phase Ib|Disease Progression|4|||
37984574|NCT00400764|69670636|FG002|Phase Ib|Disease Progression|0|||
37984575|NCT00400764|69670637|FG003|Phase Ib|Disease Progression|0|||
37984576|NCT00400764|69670638|FG004|Phase Ib|Disease Progression|0|||
37984577|NCT00400764|69670634|FG000|Phase II|Death|0|||
37984578|NCT00400764|69670635|FG001|Phase II|Death|0|||
37820088|NCT00880893|69499146|FG001|Overall Study|Lost to Follow-up|33|||
37820089|NCT00880893|69499145|FG000|Overall Study|Serious adverse event|3|||
37820090|NCT00880893|69499146|FG001|Overall Study|Serious adverse event|0|||
37820091|NCT00587301|69499152|FG000|Overall Study|Screen Failure|9|||
37820092|NCT00587301|69499152|FG000|Overall Study|Lost to Follow-up|22|||
37881067|NCT00923091|69565673|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
37881068|NCT00923091|69565674|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
37881069|NCT00923091|69565675|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
37881070|NCT00923091|69565663|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
37881071|NCT00923091|69565664|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
37881072|NCT00923091|69565665|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
37881073|NCT00923091|69565666|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
37881074|NCT00923091|69565667|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
37881075|NCT00923091|69565668|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
37881076|NCT00923091|69565669|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
37820093|NCT00587301|69499152|FG000|Overall Study|Withdrawal by Subject|7|||
37820094|NCT00587301|69499152|FG000|Overall Study|Protocol Violation|7|||
37820095|NCT00579527|69499156|FG000|Overall Study|Death|4|||
37881077|NCT00923091|69565670|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
37881078|NCT00923091|69565671|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
37881079|NCT00923091|69565672|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
37881080|NCT00923091|69565673|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
37881081|NCT00923091|69565674|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
37881082|NCT00923091|69565675|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
37881083|NCT00923091|69565663|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
37881084|NCT00923091|69565664|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
37881085|NCT00923091|69565665|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
37881086|NCT00923091|69565666|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
37881087|NCT00923091|69565667|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
37881088|NCT00923091|69565668|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
37881089|NCT00923091|69565669|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
37881090|NCT00923091|69565670|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
37881091|NCT00923091|69565671|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
37881092|NCT00923091|69565672|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
37984579|NCT00400764|69670636|FG002|Phase II|Death|1|||
37984580|NCT00400764|69670637|FG003|Phase II|Death|2|||
37984581|NCT00400764|69670638|FG004|Phase II|Death|0|||
37820096|NCT00576836|69499161|FG000|Overall Study|Death|0|||
37820097|NCT00576836|69499162|FG001|Overall Study|Death|1|||
37820098|NCT00576836|69499161|FG000|Overall Study|Physician Decision|0|||
37820099|NCT00576836|69499162|FG001|Overall Study|Physician Decision|1|||
37820100|NCT00576407|69499166|FG000|Overall Study|Death|7|||
37820101|NCT00576407|69499166|FG000|Overall Study|Physician Decision|1|||
37820102|NCT00531232|69499174|FG000|Overall Study|Investigator decision|0|||
37820103|NCT00531232|69499175|FG001|Overall Study|Investigator decision|0|||
37820104|NCT00531232|69499176|FG002|Overall Study|Investigator decision|4|||
37820105|NCT00531232|69499174|FG000|Overall Study|Participants refused further treatment|0|||
37820106|NCT00531232|69499175|FG001|Overall Study|Participants refused further treatment|1|||
37984582|NCT00400764|69670634|FG000|Phase II|Lost to Follow-up|0|||
37984583|NCT00400764|69670635|FG001|Phase II|Lost to Follow-up|0|||
37984584|NCT00400764|69670636|FG002|Phase II|Lost to Follow-up|1|||
37984585|NCT00400764|69670637|FG003|Phase II|Lost to Follow-up|0|||
37820107|NCT00531232|69499176|FG002|Overall Study|Participants refused further treatment|2|||
37820108|NCT00531232|69499174|FG000|Overall Study|Adverse events (AEs)|1|||
37820109|NCT00531232|69499175|FG001|Overall Study|Adverse events (AEs)|2|||
37820110|NCT00531232|69499176|FG002|Overall Study|Adverse events (AEs)|2|||
37881093|NCT00923091|69565673|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
37984586|NCT00400764|69670638|FG004|Phase II|Lost to Follow-up|0|||
37984587|NCT00400764|69670634|FG000|Phase II|Physician Decision|0|||
37984588|NCT00400764|69670635|FG001|Phase II|Physician Decision|0|||
37984589|NCT00400764|69670636|FG002|Phase II|Physician Decision|1|||
37820111|NCT00531232|69499174|FG000|Overall Study|Treatment failure|1|||
37820112|NCT00531232|69499175|FG001|Overall Study|Treatment failure|3|||
37820113|NCT00531232|69499176|FG002|Overall Study|Treatment failure|7|||
37881094|NCT00923091|69565674|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
37881095|NCT00923091|69565675|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
37881096|NCT00923091|69565663|FG000|Period V (Double -Blind)|Protocol Violation|0|||
37881097|NCT00923091|69565664|FG001|Period V (Double -Blind)|Protocol Violation|0|||
37881098|NCT00923091|69565665|FG002|Period V (Double -Blind)|Protocol Violation|0|||
37881099|NCT00923091|69565666|FG003|Period V (Double -Blind)|Protocol Violation|0|||
37881100|NCT00923091|69565667|FG004|Period V (Double -Blind)|Protocol Violation|0|||
37881101|NCT00923091|69565668|FG005|Period V (Double -Blind)|Protocol Violation|0|||
37881102|NCT00923091|69565669|FG006|Period V (Double -Blind)|Protocol Violation|0|||
37881103|NCT00923091|69565670|FG007|Period V (Double -Blind)|Protocol Violation|0|||
37820114|NCT00531232|69499174|FG000|Overall Study|Disease recurrence|0|||
37820115|NCT00531232|69499175|FG001|Overall Study|Disease recurrence|0|||
37820116|NCT00531232|69499176|FG002|Overall Study|Disease recurrence|1|||
37820117|NCT00531232|69499174|FG000|Overall Study|Deceased|2|||
37820118|NCT00531232|69499175|FG001|Overall Study|Deceased|2|||
37820119|NCT00531232|69499176|FG002|Overall Study|Deceased|2|||
37820120|NCT00531232|69499174|FG000|Overall Study|Withdrawal by Subject|0|||
37820121|NCT00531232|69499175|FG001|Overall Study|Withdrawal by Subject|1|||
37820122|NCT00531232|69499176|FG002|Overall Study|Withdrawal by Subject|2|||
37820123|NCT00531232|69499174|FG000|Overall Study|Other|0|||
37820124|NCT00531232|69499175|FG001|Overall Study|Other|0|||
37820125|NCT00531232|69499176|FG002|Overall Study|Other|5|||
37820126|NCT01701583|69499189|FG000|Overall Study|Withdrawal by Subject|2|||
37820127|NCT01701583|69499190|FG001|Overall Study|Withdrawal by Subject|0|||
37820128|NCT01714817|69499199|FG000|Year 1 Period|Lack of Efficacy|11|||
37820129|NCT01714817|69499200|FG001|Year 1 Period|Lack of Efficacy|9|||
37820130|NCT01714817|69499199|FG000|Year 1 Period|Adverse Event|20|||
37820131|NCT01714817|69499200|FG001|Year 1 Period|Adverse Event|17|||
37820132|NCT01714817|69499199|FG000|Year 1 Period|Withdrawal by Subject|6|||
37820133|NCT01714817|69499200|FG001|Year 1 Period|Withdrawal by Subject|7|||
37820134|NCT01714817|69499199|FG000|Year 1 Period|Death|1|||
37820135|NCT01714817|69499200|FG001|Year 1 Period|Death|1|||
37820136|NCT01714817|69499199|FG000|Year 1 Period|Lost to Follow-up|0|||
37820137|NCT01714817|69499200|FG001|Year 1 Period|Lost to Follow-up|2|||
37820138|NCT01714817|69499199|FG000|Year 1 Period|Poor / non-compliance|0|||
37881104|NCT00923091|69565671|FG008|Period V (Double -Blind)|Protocol Violation|0|||
37881105|NCT00923091|69565672|FG009|Period V (Double -Blind)|Protocol Violation|0|||
37820139|NCT01714817|69499200|FG001|Year 1 Period|Poor / non-compliance|1|||
37820140|NCT01714817|69499199|FG000|Year 1 Period|Pregnancy|2|||
37820141|NCT01714817|69499200|FG001|Year 1 Period|Pregnancy|0|||
37820142|NCT01714817|69499199|FG000|Year 1 Period|Participant no longer meets criteria|6|||
37820143|NCT01714817|69499200|FG001|Year 1 Period|Participant no longer meets criteria|2|||
37820144|NCT01714817|69499199|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
37820145|NCT01714817|69499200|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
37820146|NCT01714817|69499199|FG000|Year 1 Period|Change in Concomitant Medication|0|||
37820147|NCT01714817|69499200|FG001|Year 1 Period|Change in Concomitant Medication|1|||
37820148|NCT01714817|69499199|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
37820149|NCT01714817|69499200|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
37820150|NCT01714817|69499199|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
37820151|NCT01714817|69499200|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
37820152|NCT01714817|69499199|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
37820153|NCT01714817|69499200|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
37820154|NCT01714817|69499199|FG000|Year 2 Period|Lack of Efficacy|4|||
37820155|NCT01714817|69499200|FG001|Year 2 Period|Lack of Efficacy|12|||
37881106|NCT00923091|69565673|FG010|Period V (Double -Blind)|Protocol Violation|0|||
37881107|NCT00923091|69565674|FG011|Period V (Double -Blind)|Protocol Violation|0|||
37881108|NCT00923091|69565675|FG012|Period V (Double -Blind)|Protocol Violation|1|||
37881109|NCT00923091|69565663|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
37881110|NCT00923091|69565664|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
37881111|NCT00923091|69565665|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
37881112|NCT00923091|69565666|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
37881113|NCT00923091|69565667|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
37881114|NCT00923091|69565668|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
37881115|NCT00923091|69565669|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
37881116|NCT00923091|69565670|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
37881117|NCT00923091|69565671|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
37881118|NCT00923091|69565672|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
37881119|NCT00923091|69565673|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
37881120|NCT00923091|69565674|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
37881121|NCT00923091|69565675|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
37881122|NCT00923091|69565663|FG000|Period VI (Open-Label)|Adverse Event|17|||
37881123|NCT00923091|69565664|FG001|Period VI (Open-Label)|Adverse Event|0|||
37881124|NCT00923091|69565665|FG002|Period VI (Open-Label)|Adverse Event|4|||
37881125|NCT00923091|69565666|FG003|Period VI (Open-Label)|Adverse Event|1|||
37881126|NCT00923091|69565667|FG004|Period VI (Open-Label)|Adverse Event|1|||
37881127|NCT00923091|69565668|FG005|Period VI (Open-Label)|Adverse Event|0|||
37881128|NCT00923091|69565669|FG006|Period VI (Open-Label)|Adverse Event|0|||
37881129|NCT00923091|69565670|FG007|Period VI (Open-Label)|Adverse Event|0|||
37881130|NCT00923091|69565671|FG008|Period VI (Open-Label)|Adverse Event|0|||
37881131|NCT00923091|69565672|FG009|Period VI (Open-Label)|Adverse Event|0|||
37881132|NCT00923091|69565673|FG010|Period VI (Open-Label)|Adverse Event|0|||
37881133|NCT00923091|69565674|FG011|Period VI (Open-Label)|Adverse Event|0|||
37881134|NCT00923091|69565675|FG012|Period VI (Open-Label)|Adverse Event|0|||
37881135|NCT00923091|69565663|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
37881136|NCT00923091|69565664|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
37881137|NCT00923091|69565665|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
37881138|NCT00923091|69565666|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
37881139|NCT00923091|69565667|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
37881140|NCT00923091|69565668|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
37881141|NCT00923091|69565669|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
37881142|NCT00923091|69565670|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
37881143|NCT00923091|69565671|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
37881144|NCT00923091|69565672|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
37881145|NCT00923091|69565673|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
37881146|NCT00923091|69565674|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
37881147|NCT00923091|69565675|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
37881148|NCT00923091|69565663|FG000|Period VI (Open-Label)|Protocol Violation|6|||
37881149|NCT00923091|69565664|FG001|Period VI (Open-Label)|Protocol Violation|1|||
37984590|NCT00400764|69670637|FG003|Phase II|Physician Decision|1|||
37984591|NCT00400764|69670638|FG004|Phase II|Physician Decision|0|||
37984592|NCT00400764|69670634|FG000|Phase II|Sponsor's decision to terminate|0|||
37984593|NCT00400764|69670635|FG001|Phase II|Sponsor's decision to terminate|0|||
37984594|NCT00400764|69670636|FG002|Phase II|Sponsor's decision to terminate|18|||
37984595|NCT00400764|69670637|FG003|Phase II|Sponsor's decision to terminate|22|||
37984596|NCT00400764|69670638|FG004|Phase II|Sponsor's decision to terminate|11|||
37984597|NCT00400764|69670634|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
37984598|NCT00400764|69670635|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
37984599|NCT00400764|69670636|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
37984600|NCT00400764|69670637|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
37984601|NCT00400764|69670638|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
37984602|NCT00400764|69670634|FG000|Phase II|Withdrawal by Subject|0|||
37984603|NCT00400764|69670635|FG001|Phase II|Withdrawal by Subject|0|||
37984604|NCT00400764|69670636|FG002|Phase II|Withdrawal by Subject|1|||
37984605|NCT00400764|69670637|FG003|Phase II|Withdrawal by Subject|1|||
37984606|NCT00400764|69670638|FG004|Phase II|Withdrawal by Subject|0|||
37984607|NCT00302211|69670658|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
37820156|NCT01714817|69499199|FG000|Year 2 Period|Adverse Event|7|||
37820157|NCT01714817|69499200|FG001|Year 2 Period|Adverse Event|6|||
37820158|NCT01714817|69499199|FG000|Year 2 Period|Participant request to stop treatment|4|||
37820159|NCT01714817|69499200|FG001|Year 2 Period|Participant request to stop treatment|4|||
37820160|NCT01714817|69499199|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
37820161|NCT01714817|69499200|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
37820162|NCT01714817|69499199|FG000|Year 2 Period|Participant withdrew consent|1|||
37984608|NCT00302211|69670659|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
37984609|NCT00302211|69670660|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
37984610|NCT00302211|69670661|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
37695270|NCT02349295|69171757|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
37695271|NCT02349295|69171758|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
37695272|NCT02349295|69171759|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
37820163|NCT01714817|69499200|FG001|Year 2 Period|Participant withdrew consent|5|||
37881150|NCT00923091|69565665|FG002|Period VI (Open-Label)|Protocol Violation|3|||
37881151|NCT00923091|69565666|FG003|Period VI (Open-Label)|Protocol Violation|1|||
37881152|NCT00923091|69565667|FG004|Period VI (Open-Label)|Protocol Violation|4|||
37881153|NCT00923091|69565668|FG005|Period VI (Open-Label)|Protocol Violation|0|||
37881154|NCT00923091|69565669|FG006|Period VI (Open-Label)|Protocol Violation|0|||
37881155|NCT00923091|69565670|FG007|Period VI (Open-Label)|Protocol Violation|0|||
37881156|NCT00923091|69565671|FG008|Period VI (Open-Label)|Protocol Violation|0|||
37881157|NCT00923091|69565672|FG009|Period VI (Open-Label)|Protocol Violation|0|||
37881158|NCT00923091|69565673|FG010|Period VI (Open-Label)|Protocol Violation|0|||
37881159|NCT00923091|69565674|FG011|Period VI (Open-Label)|Protocol Violation|0|||
37881160|NCT00923091|69565675|FG012|Period VI (Open-Label)|Protocol Violation|0|||
37881161|NCT00923091|69565663|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
37881162|NCT00923091|69565664|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
37881163|NCT00923091|69565665|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
37881164|NCT00923091|69565666|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
37881165|NCT00923091|69565667|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
37881166|NCT00923091|69565668|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
37881167|NCT00923091|69565669|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
37881168|NCT00923091|69565670|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
37881169|NCT00923091|69565671|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
37881170|NCT00923091|69565672|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
37881171|NCT00923091|69565673|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
37881172|NCT00923091|69565674|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
37881173|NCT00923091|69565675|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
37881174|NCT00923091|69565663|FG000|Period VI (Open-Label)|Other Reason|0|||
37881175|NCT00923091|69565664|FG001|Period VI (Open-Label)|Other Reason|0|||
37881176|NCT00923091|69565665|FG002|Period VI (Open-Label)|Other Reason|0|||
37881177|NCT00923091|69565666|FG003|Period VI (Open-Label)|Other Reason|1|||
37881178|NCT00923091|69565667|FG004|Period VI (Open-Label)|Other Reason|1|||
37881179|NCT00923091|69565668|FG005|Period VI (Open-Label)|Other Reason|0|||
37881180|NCT00923091|69565669|FG006|Period VI (Open-Label)|Other Reason|0|||
37881181|NCT00923091|69565670|FG007|Period VI (Open-Label)|Other Reason|0|||
37881182|NCT00923091|69565671|FG008|Period VI (Open-Label)|Other Reason|0|||
37881183|NCT00923091|69565672|FG009|Period VI (Open-Label)|Other Reason|0|||
37881184|NCT00923091|69565673|FG010|Period VI (Open-Label)|Other Reason|0|||
37881185|NCT00923091|69565674|FG011|Period VI (Open-Label)|Other Reason|0|||
37881186|NCT00923091|69565675|FG012|Period VI (Open-Label)|Other Reason|0|||
37881187|NCT00853957|69565702|FG000|Overall Study|Adverse Event|9|||
37881188|NCT00853957|69565703|FG001|Overall Study|Adverse Event|3|||
37881189|NCT00853957|69565702|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
37881190|NCT00853957|69565703|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
37881191|NCT00853957|69565702|FG000|Overall Study|Subject withdrew consent|4|||
37881192|NCT00853957|69565703|FG001|Overall Study|Subject withdrew consent|5|||
37881193|NCT00853957|69565702|FG000|Overall Study|Lost to Follow-up|1|||
37820164|NCT01714817|69499199|FG000|Year 2 Period|Participant no longer meets criteria|1|||
37820165|NCT01714817|69499200|FG001|Year 2 Period|Participant no longer meets criteria|4|||
37820166|NCT01714817|69499199|FG000|Year 2 Period|Lost to Follow-up|2|||
37820167|NCT01714817|69499200|FG001|Year 2 Period|Lost to Follow-up|0|||
37820168|NCT01714817|69499199|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
37820169|NCT01714817|69499200|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
37820170|NCT01714817|69499199|FG000|Year 2 Period|Pregnancy|1|||
37820171|NCT01714817|69499200|FG001|Year 2 Period|Pregnancy|1|||
37820172|NCT01714817|69499199|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
37881194|NCT00853957|69565703|FG001|Overall Study|Lost to Follow-up|6|||
37881195|NCT00853957|69565702|FG000|Overall Study|Protocol deviation|0|||
37881196|NCT00853957|69565703|FG001|Overall Study|Protocol deviation|3|||
37881197|NCT01021020|69565709|FG000|Period I|Protocol Violation|1|||
37881198|NCT01021020|69565709|FG000|Period I|Withdrawal by Subject|1|||
37881199|NCT01021020|69565709|FG000|14 Day Washout Period A|Physician Decision|1|||
37881200|NCT00833053|69565723|FG000|Overall Study|Adverse Event|4|||
37881201|NCT00833053|69565724|FG001|Overall Study|Adverse Event|0|||
37881202|NCT00833053|69565723|FG000|Overall Study|Treatment Failure|3|||
37984611|NCT00302211|69670662|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
37984612|NCT00302211|69670658|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
37881203|NCT00833053|69565724|FG001|Overall Study|Treatment Failure|1|||
37881204|NCT00833053|69565723|FG000|Overall Study|Withdrawal by Subject|0|||
37881205|NCT00833053|69565724|FG001|Overall Study|Withdrawal by Subject|1|||
37881206|NCT00833053|69565723|FG000|Overall Study|Protocol Violation|2|||
37881207|NCT00833053|69565724|FG001|Overall Study|Protocol Violation|1|||
37881208|NCT00832975|69565730|FG000|Overall Study|Lost to Follow-up|7|||
37881209|NCT00832975|69565730|FG000|Overall Study|Protocol Violation|6|||
37881210|NCT00832975|69565730|FG000|Overall Study|Death|5|||
37881211|NCT00832975|69565730|FG000|Overall Study|Physician Decision|4|||
37881212|NCT00832975|69565730|FG000|Overall Study|Withdrawal by Subject|3|||
37881213|NCT00832975|69565730|FG000|Overall Study|Other reasons|14|||
37881214|NCT01020786|69565734|FG000|Induction Period|Entry Criteria Not Met|2|||
37881215|NCT01020786|69565734|FG000|Induction Period|Adverse Event|10|||
37881216|NCT01020786|69565734|FG000|Induction Period|Progressive Disease|31|||
37881217|NCT01020786|69565734|FG000|Induction Period|Investigator Decision|3|||
37881218|NCT01020786|69565734|FG000|Induction Period|Withdrawal by Subject|3|||
37881219|NCT01020786|69565734|FG000|Maintenance Period|Adverse Event|8|||
37881220|NCT01020786|69565734|FG000|Maintenance Period|Progressive Disease|43|||
37881221|NCT01020786|69565734|FG000|Maintenance Period|Withdrawal by Subject|8|||
37881222|NCT01020786|69565734|FG000|Maintenance Period|Sponsor Decision|1|||
37881223|NCT00918645|69565739|FG000|Overall Study|Withdrawal by Subject|1|||
37881224|NCT00922935|69565746|FG000|Overall Study|Protocol Violation|0|||
37881225|NCT00922935|69565747|FG001|Overall Study|Protocol Violation|3|||
37695273|NCT02349295|69171760|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
37695274|NCT02349295|69171761|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
37881226|NCT00922935|69565748|FG002|Overall Study|Protocol Violation|0|||
37881227|NCT00922935|69565746|FG000|Overall Study|Physician Decision|1|||
37881228|NCT00922935|69565747|FG001|Overall Study|Physician Decision|1|||
37881229|NCT00922935|69565748|FG002|Overall Study|Physician Decision|0|||
37881230|NCT00922935|69565746|FG000|Overall Study|Lost to Follow-up|0|||
37881231|NCT00922935|69565747|FG001|Overall Study|Lost to Follow-up|1|||
37881232|NCT00922935|69565748|FG002|Overall Study|Lost to Follow-up|0|||
37881233|NCT01020474|69565758|FG000|Overall Study|Adverse Event|4|||
37881234|NCT01020474|69565759|FG001|Overall Study|Adverse Event|4|||
37881235|NCT01020474|69565758|FG000|Overall Study|Protocol Violation|0|||
37881236|NCT01020474|69565759|FG001|Overall Study|Protocol Violation|2|||
37881237|NCT01020474|69565758|FG000|Overall Study|Withdrawal by Subject|5|||
37881238|NCT01020474|69565759|FG001|Overall Study|Withdrawal by Subject|7|||
37881239|NCT01020474|69565758|FG000|Overall Study|Other Reasons|1|||
37881240|NCT01020474|69565759|FG001|Overall Study|Other Reasons|1|||
37881241|NCT01020474|69565758|FG000|Overall Study|Insufficient Clinical Response|0|||
37881242|NCT01020474|69565759|FG001|Overall Study|Insufficient Clinical Response|3|||
37881243|NCT00922779|69565765|FG000|Overall Study|Adverse Event|67|||
37881244|NCT00922779|69565765|FG000|Overall Study|Pregnancy|7|||
37881245|NCT00922779|69565765|FG000|Overall Study|Withdrawal by Subject|308|||
37881246|NCT00922779|69565765|FG000|Overall Study|Lost to Follow-up|44|||
37881247|NCT00922779|69565765|FG000|Overall Study|Other|27|||
37984613|NCT00302211|69670659|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
37984614|NCT00302211|69670660|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
37881248|NCT00922779|69565765|FG000|Overall Study|Missing|1874|||
37881249|NCT00924651|69565771|FG000|Overall Study|Chemo started too soon|2|||
37881250|NCT00924651|69565772|FG001|Overall Study|Chemo started too soon|3|||
37881251|NCT00924651|69565771|FG000|Overall Study|No Reason|3|||
37881252|NCT00924651|69565772|FG001|Overall Study|No Reason|7|||
37881253|NCT00924651|69565771|FG000|Overall Study|Overwhelmed|6|||
37881254|NCT00924651|69565772|FG001|Overall Study|Overwhelmed|6|||
37881255|NCT00924651|69565771|FG000|Overall Study|Noncompliant|1|||
37881256|NCT00924651|69565772|FG001|Overall Study|Noncompliant|4|||
37881257|NCT00924651|69565771|FG000|Overall Study|Medical|1|||
37881258|NCT00924651|69565772|FG001|Overall Study|Medical|3|||
37881259|NCT00924651|69565771|FG000|Overall Study|Changed Mind|10|||
37881260|NCT00924651|69565772|FG001|Overall Study|Changed Mind|1|||
37881261|NCT00924651|69565771|FG000|Overall Study|Incomplete Form|2|||
37881262|NCT00924651|69565772|FG001|Overall Study|Incomplete Form|1|||
37984615|NCT00302211|69670661|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
37881263|NCT00922623|69565778|FG000|Overall Study|Other|4|||
37881264|NCT00922623|69565778|FG000|Overall Study|Lost to Follow-up|1|||
37881265|NCT01025232|69565786|FG000|Overall Study|Study drug no longer available|3|||
37881266|NCT01025232|69565787|FG001|Overall Study|Study drug no longer available|6|||
37881267|NCT01025154|69565793|FG000|Overall Study|Lost to Follow-up|1|||
37881268|NCT01025154|69565793|FG000|Overall Study|Withdrawal by Subject|1|||
37881269|NCT00832819|69565800|FG000|Overall Study|Adverse Event|0|||
37881270|NCT00832819|69565801|FG001|Overall Study|Adverse Event|1|||
37881271|NCT00832819|69565802|FG002|Overall Study|Adverse Event|0|||
37881272|NCT00832819|69565800|FG000|Overall Study|Protocol Violation|0|||
37881273|NCT00832819|69565801|FG001|Overall Study|Protocol Violation|0|||
37881274|NCT00832819|69565802|FG002|Overall Study|Protocol Violation|1|||
37881275|NCT00853723|69565811|FG000|Overall Study|Adverse Event|3|||
37881276|NCT00853723|69565812|FG001|Overall Study|Adverse Event|4|||
37881277|NCT00853723|69565813|FG002|Overall Study|Adverse Event|1|||
37881278|NCT00853723|69565811|FG000|Overall Study|Withdrawal by Subject|2|||
37881279|NCT00853723|69565812|FG001|Overall Study|Withdrawal by Subject|1|||
37881280|NCT00853723|69565813|FG002|Overall Study|Withdrawal by Subject|0|||
37881281|NCT00853723|69565811|FG000|Overall Study|Protocol Violation|1|||
37881282|NCT00853723|69565812|FG001|Overall Study|Protocol Violation|2|||
37881283|NCT00853723|69565813|FG002|Overall Study|Protocol Violation|1|||
37881284|NCT01104545|69565827|FG000|Overall Study|Adverse Event|0|||
37881285|NCT01104545|69565828|FG001|Overall Study|Adverse Event|1|||
37881286|NCT01104545|69565829|FG002|Overall Study|Adverse Event|2|||
37881287|NCT00918255|69565877|FG000|Overall Study|Adverse Event|1|||
37881288|NCT00918255|69565878|FG001|Overall Study|Adverse Event|0|||
37881289|NCT00918255|69565879|FG002|Overall Study|Adverse Event|0|||
37881290|NCT00918255|69565877|FG000|Overall Study|Withdrawal by Subject|1|||
37881291|NCT00918255|69565878|FG001|Overall Study|Withdrawal by Subject|0|||
37881292|NCT00918255|69565879|FG002|Overall Study|Withdrawal by Subject|2|||
37881293|NCT00918255|69565877|FG000|Overall Study|Lack of Efficacy|1|||
37881294|NCT00918255|69565878|FG001|Overall Study|Lack of Efficacy|0|||
37881295|NCT00918255|69565879|FG002|Overall Study|Lack of Efficacy|0|||
37881296|NCT00918255|69565877|FG000|Overall Study|Lost to Follow-up|1|||
37881297|NCT00918255|69565878|FG001|Overall Study|Lost to Follow-up|0|||
37881298|NCT00918255|69565879|FG002|Overall Study|Lost to Follow-up|2|||
37881299|NCT00918255|69565877|FG000|Overall Study|Exceeded allowed number of interventions|0|||
37881300|NCT00918255|69565878|FG001|Overall Study|Exceeded allowed number of interventions|0|||
37881301|NCT00918255|69565879|FG002|Overall Study|Exceeded allowed number of interventions|1|||
37881302|NCT00918255|69565877|FG000|Overall Study|Non-compliance|1|||
37881303|NCT00918255|69565878|FG001|Overall Study|Non-compliance|0|||
37881304|NCT00918255|69565879|FG002|Overall Study|Non-compliance|0|||
37881305|NCT00918255|69565877|FG000|Overall Study|Investigator discretion|1|||
37881306|NCT00918255|69565878|FG001|Overall Study|Investigator discretion|0|||
37881307|NCT00918255|69565879|FG002|Overall Study|Investigator discretion|0|||
37984616|NCT00302211|69670662|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
37984617|NCT00302211|69670658|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
37984618|NCT00302211|69670659|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
37984619|NCT00302211|69670660|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
37820173|NCT01714817|69499200|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
37820174|NCT01714817|69499199|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
37820175|NCT01714817|69499200|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
37820176|NCT01714817|69499199|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
37820177|NCT01714817|69499200|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
37820178|NCT01714817|69499199|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
37820179|NCT01714817|69499200|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
37820180|NCT01714817|69499199|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
37820181|NCT01714817|69499200|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
37820182|NCT01714817|69499199|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
37820183|NCT01714817|69499200|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
37820184|NCT01714817|69499199|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
37820185|NCT01714817|69499200|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
37820186|NCT01714817|69499199|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
37820187|NCT01714817|69499200|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
37820188|NCT01714817|69499199|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
37820189|NCT01714817|69499200|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
37820190|NCT01714817|69499199|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
37820191|NCT01714817|69499200|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
37820192|NCT01714817|69499199|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
37820193|NCT01714817|69499200|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
37820194|NCT01714817|69499199|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
37820195|NCT01714817|69499200|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
37820196|NCT01714817|69499199|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
37820197|NCT01714817|69499200|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
37820198|NCT01714817|69499199|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
37881308|NCT01096589|69565891|FG000|Overall Study|Adverse Event|2|||
37881309|NCT01096589|69565892|FG001|Overall Study|Adverse Event|1|||
37881310|NCT01096589|69565893|FG002|Overall Study|Adverse Event|2|||
37881311|NCT01096589|69565894|FG003|Overall Study|Adverse Event|1|||
37984620|NCT00302211|69670661|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
37984621|NCT00302211|69670662|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
37984622|NCT00302211|69670658|FG000|Double Blind Period (New Patients)|Disease progression|0|||
37984623|NCT00302211|69670659|FG001|Double Blind Period (New Patients)|Disease progression|1|||
37984624|NCT00302211|69670660|FG002|Double Blind Period (New Patients)|Disease progression|1|||
37984625|NCT00302211|69670661|FG003|Double Blind Period (New Patients)|Disease progression|0|||
37984626|NCT00302211|69670662|FG004|Double Blind Period (New Patients)|Disease progression|0|||
37984627|NCT00302211|69670658|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
37984628|NCT00302211|69670659|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
37984629|NCT00302211|69670660|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
37695275|NCT02349295|69171762|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
37695276|NCT02349295|69171749|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
37820199|NCT01714817|69499200|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
37881312|NCT01096589|69565891|FG000|Overall Study|Withdrawal by Subject|2|||
37881313|NCT01096589|69565892|FG001|Overall Study|Withdrawal by Subject|1|||
37881314|NCT01096589|69565893|FG002|Overall Study|Withdrawal by Subject|1|||
37881315|NCT01096589|69565894|FG003|Overall Study|Withdrawal by Subject|1|||
37881316|NCT01096589|69565891|FG000|Overall Study|Compliance with protocol|0|||
37881317|NCT01096589|69565892|FG001|Overall Study|Compliance with protocol|0|||
37881318|NCT01096589|69565893|FG002|Overall Study|Compliance with protocol|1|||
37881319|NCT01096589|69565894|FG003|Overall Study|Compliance with protocol|0|||
37820200|NCT01714817|69499199|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
37820201|NCT01714817|69499200|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
37881320|NCT01096589|69565891|FG000|Overall Study|found treatment exhausting|0|||
37881321|NCT01096589|69565892|FG001|Overall Study|found treatment exhausting|0|||
37881322|NCT01096589|69565893|FG002|Overall Study|found treatment exhausting|0|||
37881323|NCT01096589|69565894|FG003|Overall Study|found treatment exhausting|1|||
37881324|NCT00845065|69565910|FG000|Overall Study|Adverse Event|3|||
37881325|NCT00845065|69565911|FG001|Overall Study|Adverse Event|23|||
37881326|NCT00845065|69565910|FG000|Overall Study|Lack of Efficacy|43|||
37881327|NCT00845065|69565911|FG001|Overall Study|Lack of Efficacy|21|||
37881328|NCT00845065|69565910|FG000|Overall Study|Non-Medical Reasons|1|||
37881329|NCT00845065|69565911|FG001|Overall Study|Non-Medical Reasons|11|||
37881330|NCT00832585|69565917|FG000|Overall Study|Withdrawal by Subject|1|||
37881331|NCT00832585|69565917|FG000|Overall Study|Lost to Follow-up|1|||
37881332|NCT00918567|69565923|FG000|Overall Study|Lack of Efficacy|3|||
37881333|NCT00918567|69565924|FG001|Overall Study|Lack of Efficacy|1|||
37881334|NCT00918567|69565923|FG000|Overall Study|Withdrawal by Subject|1|||
37881335|NCT00918567|69565924|FG001|Overall Study|Withdrawal by Subject|1|||
37881336|NCT00918567|69565923|FG000|Overall Study|Adverse Event|1|||
37820202|NCT01714817|69499199|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
37820203|NCT01714817|69499200|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
37820204|NCT01755689|69499224|FG000|Overall Study|Withdrawal by Subject|1|||
37820205|NCT01755689|69499225|FG001|Overall Study|Withdrawal by Subject|3|||
37820206|NCT01755689|69499226|FG002|Overall Study|Withdrawal by Subject|2|||
37820207|NCT01755689|69499227|FG003|Overall Study|Withdrawal by Subject|1|||
37820208|NCT01755689|69499228|FG004|Overall Study|Withdrawal by Subject|1|||
37820209|NCT01755689|69499224|FG000|Overall Study|Migrated/moved from study area|0|||
37820210|NCT01755689|69499225|FG001|Overall Study|Migrated/moved from study area|1|||
37820211|NCT01755689|69499226|FG002|Overall Study|Migrated/moved from study area|1|||
37820212|NCT01755689|69499227|FG003|Overall Study|Migrated/moved from study area|1|||
37820213|NCT01755689|69499228|FG004|Overall Study|Migrated/moved from study area|1|||
37820214|NCT01755689|69499224|FG000|Overall Study|Lost to Follow-up|1|||
37820215|NCT01755689|69499225|FG001|Overall Study|Lost to Follow-up|0|||
37820216|NCT01755689|69499226|FG002|Overall Study|Lost to Follow-up|1|||
37820217|NCT01755689|69499227|FG003|Overall Study|Lost to Follow-up|0|||
37820218|NCT01755689|69499228|FG004|Overall Study|Lost to Follow-up|2|||
37820219|NCT01755689|69499224|FG000|Overall Study|Pregnancy|1|||
37820220|NCT01755689|69499225|FG001|Overall Study|Pregnancy|1|||
37820221|NCT01755689|69499226|FG002|Overall Study|Pregnancy|2|||
37881337|NCT00918567|69565924|FG001|Overall Study|Adverse Event|0|||
37881338|NCT01024920|69565932|FG000|Overall Study|Progressive disease|47|||
37881339|NCT01024920|69565933|FG001|Overall Study|Progressive disease|25|||
37881340|NCT01024920|69565932|FG000|Overall Study|Adverse Event|8|||
37881341|NCT01024920|69565933|FG001|Overall Study|Adverse Event|4|||
37984630|NCT00302211|69670661|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
37820222|NCT01755689|69499227|FG003|Overall Study|Pregnancy|4|||
37820223|NCT01755689|69499228|FG004|Overall Study|Pregnancy|2|||
37820224|NCT01762761|69499250|FG000|Overall Study|Adverse Event|15|||
37820225|NCT01762761|69499251|FG001|Overall Study|Adverse Event|17|||
37881342|NCT01024920|69565932|FG000|Overall Study|Lost to Follow-up|0|||
37881343|NCT01024920|69565933|FG001|Overall Study|Lost to Follow-up|1|||
37881344|NCT01024920|69565932|FG000|Overall Study|Patient refusal to continue|4|||
37695277|NCT02349295|69171750|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
37695278|NCT02349295|69171751|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
37695279|NCT02349295|69171752|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
37695280|NCT02349295|69171753|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
37695281|NCT02349295|69171754|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
37695282|NCT02349295|69171755|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
37695283|NCT02349295|69171756|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
37695284|NCT02349295|69171757|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
37695285|NCT02349295|69171758|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
37695286|NCT02349295|69171759|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
37695287|NCT02349295|69171760|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
37695288|NCT02349295|69171761|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
37695289|NCT02349295|69171762|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
37695290|NCT02349295|69171749|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
37695291|NCT02349295|69171750|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
37695292|NCT02349295|69171751|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
37820226|NCT01762761|69499250|FG000|Overall Study|Lack of Efficacy|9|||
37820227|NCT01762761|69499251|FG001|Overall Study|Lack of Efficacy|25|||
37820228|NCT01762761|69499250|FG000|Overall Study|Protocol Violation|1|||
37820229|NCT01762761|69499251|FG001|Overall Study|Protocol Violation|1|||
37984631|NCT00302211|69670662|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
37820230|NCT01762761|69499250|FG000|Overall Study|Study closed/terminated|0|||
37820231|NCT01762761|69499251|FG001|Overall Study|Study closed/terminated|2|||
37881345|NCT01024920|69565933|FG001|Overall Study|Patient refusal to continue|0|||
37881346|NCT01024920|69565932|FG000|Overall Study|Other than listed|5|||
37881347|NCT01024920|69565933|FG001|Overall Study|Other than listed|1|||
37881348|NCT01024920|69565932|FG000|Overall Study|Not treated|3|||
37881349|NCT01024920|69565933|FG001|Overall Study|Not treated|0|||
37881350|NCT01024920|69565932|FG000|Overall Study|Protocol Violation|0|||
37881351|NCT01024920|69565933|FG001|Overall Study|Protocol Violation|1|||
37881352|NCT00832117|69565941|FG000|Overall Study|Death|1|||
37820232|NCT01762761|69499250|FG000|Overall Study|Lost to Follow-up|3|||
37820233|NCT01762761|69499251|FG001|Overall Study|Lost to Follow-up|6|||
37820234|NCT01762761|69499250|FG000|Overall Study|Physician Decision|4|||
37820235|NCT01762761|69499251|FG001|Overall Study|Physician Decision|6|||
37820236|NCT01762761|69499250|FG000|Overall Study|Withdrawal by Subject|7|||
37820237|NCT01762761|69499251|FG001|Overall Study|Withdrawal by Subject|8|||
37820238|NCT01763788|69499262|FG000|Overall Study|Lost to Follow-up|0|||
37820239|NCT01763788|69499263|FG001|Overall Study|Lost to Follow-up|0|||
37820240|NCT01763788|69499264|FG002|Overall Study|Lost to Follow-up|1|||
37820241|NCT01763788|69499265|FG003|Overall Study|Lost to Follow-up|0|||
37820242|NCT01774370|69499275|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
37820243|NCT01774370|69499275|FG000|Overall Study|Administered prior to the contract date|4|||
37820244|NCT01774370|69499275|FG000|Overall Study|Subjects of contraindications|34|||
37820245|NCT01774370|69499275|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
37820246|NCT01774370|69499275|FG000|Overall Study|Follow-up failure|34|||
37820247|NCT01777295|69499281|FG000|Overall Study|Withdrawal by Subject|2|||
37820248|NCT01777295|69499282|FG001|Overall Study|Withdrawal by Subject|2|||
37820249|NCT01777295|69499281|FG000|Overall Study|Pregnancy|0|||
37820250|NCT01777295|69499282|FG001|Overall Study|Pregnancy|1|||
37820251|NCT01777295|69499281|FG000|Overall Study|Personal problem|1|||
37820252|NCT01777295|69499282|FG001|Overall Study|Personal problem|0|||
37820253|NCT01777295|69499281|FG000|Overall Study|Investigator call for AEs check|1|||
37820254|NCT01777295|69499282|FG001|Overall Study|Investigator call for AEs check|0|||
37820255|NCT01787552|69499319|FG000|Overall Study|Withdrawal by Subject|2|||
37820256|NCT01787552|69499320|FG001|Overall Study|Withdrawal by Subject|0|||
37820257|NCT01787552|69499321|FG002|Overall Study|Withdrawal by Subject|0|||
37820258|NCT01787552|69499322|FG003|Overall Study|Withdrawal by Subject|4|||
37820259|NCT01787552|69499319|FG000|Overall Study|Physician Decision|2|||
37881353|NCT00832117|69565941|FG000|Overall Study|Disease Progression|11|||
37820260|NCT01787552|69499320|FG001|Overall Study|Physician Decision|2|||
37695293|NCT02349295|69171752|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
37695294|NCT02349295|69171753|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
37695295|NCT02349295|69171754|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
37820261|NCT01787552|69499321|FG002|Overall Study|Physician Decision|1|||
37820262|NCT01787552|69499322|FG003|Overall Study|Physician Decision|2|||
37820263|NCT01787552|69499319|FG000|Overall Study|Death|0|||
37695296|NCT02349295|69171755|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
37820264|NCT01787552|69499320|FG001|Overall Study|Death|0|||
37820265|NCT01787552|69499321|FG002|Overall Study|Death|0|||
37820266|NCT01787552|69499322|FG003|Overall Study|Death|1|||
37881354|NCT01104311|69565950|FG000|Overall Study|Withdrawal by Subject|6|||
37881355|NCT01104311|69565951|FG001|Overall Study|Withdrawal by Subject|6|||
37881356|NCT01104311|69565950|FG000|Overall Study|Protocol Violation|0|||
37881357|NCT01104311|69565951|FG001|Overall Study|Protocol Violation|1|||
37881358|NCT01104311|69565950|FG000|Overall Study|Physician Decision|2|||
37881359|NCT01104311|69565951|FG001|Overall Study|Physician Decision|2|||
37881360|NCT01104311|69565950|FG000|Overall Study|low compliance|1|||
37881361|NCT01104311|69565951|FG001|Overall Study|low compliance|1|||
37881362|NCT01104311|69565950|FG000|Overall Study|Adverse Event|1|||
37881363|NCT01104311|69565951|FG001|Overall Study|Adverse Event|2|||
37881364|NCT00831493|69565961|FG000|Overall Study|Intractable nausea and vomiting|1|||
37881365|NCT00853567|69565968|FG000|Overall Study|Study prematurely terminated|71|||
37881366|NCT00853489|69565978|FG000|Overall Study|Lost to Follow-up|5|||
37881367|NCT00853489|69565979|FG001|Overall Study|Lost to Follow-up|2|||
37881368|NCT01019694|69565988|FG000|Overall Study|Adverse Event|12|||
37881369|NCT01019694|69565989|FG001|Overall Study|Adverse Event|16|||
37881370|NCT01019694|69565990|FG002|Overall Study|Adverse Event|19|||
37881371|NCT01019694|69565988|FG000|Overall Study|Protocol Violation|2|||
37881372|NCT01019694|69565989|FG001|Overall Study|Protocol Violation|6|||
37881373|NCT01019694|69565990|FG002|Overall Study|Protocol Violation|4|||
37881374|NCT01019694|69565988|FG000|Overall Study|Lost to Follow-up|5|||
37881375|NCT01019694|69565989|FG001|Overall Study|Lost to Follow-up|3|||
37881376|NCT01019694|69565990|FG002|Overall Study|Lost to Follow-up|3|||
37881377|NCT01019694|69565988|FG000|Overall Study|Withdrawal by Subject|4|||
37881378|NCT01019694|69565989|FG001|Overall Study|Withdrawal by Subject|6|||
37881379|NCT01019694|69565990|FG002|Overall Study|Withdrawal by Subject|12|||
37881380|NCT01019694|69565988|FG000|Overall Study|Not treated|0|||
37881381|NCT01019694|69565989|FG001|Overall Study|Not treated|2|||
37881382|NCT01019694|69565990|FG002|Overall Study|Not treated|3|||
37881383|NCT01019694|69565988|FG000|Overall Study|Other reason (not specified)|1|||
37881384|NCT01019694|69565989|FG001|Overall Study|Other reason (not specified)|5|||
37881385|NCT01019694|69565990|FG002|Overall Study|Other reason (not specified)|6|||
37881386|NCT00831415|69565998|FG000|Overall Study|Adverse Event|14|||
37881387|NCT00831415|69565998|FG000|Overall Study|Failed to return|3|||
37881388|NCT00831415|69565998|FG000|Overall Study|Physician Decision|6|||
37881389|NCT00831415|69565998|FG000|Overall Study|Lost to Follow-up|9|||
37881390|NCT00831415|69565998|FG000|Overall Study|Protocol Violation|3|||
37984632|NCT00302211|69670658|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
37984633|NCT00302211|69670659|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
37984634|NCT00302211|69670660|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
37984635|NCT00302211|69670661|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
37984636|NCT00302211|69670662|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
37984637|NCT00302211|69670658|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
37820267|NCT01787552|69499319|FG000|Overall Study|Adverse Event|2|||
37820268|NCT01787552|69499320|FG001|Overall Study|Adverse Event|5|||
37820269|NCT01787552|69499321|FG002|Overall Study|Adverse Event|2|||
37820270|NCT01787552|69499322|FG003|Overall Study|Adverse Event|16|||
37820271|NCT01787552|69499319|FG000|Overall Study|Study terminated by Sponsor|0|||
37820272|NCT01787552|69499320|FG001|Overall Study|Study terminated by Sponsor|0|||
37820273|NCT01787552|69499321|FG002|Overall Study|Study terminated by Sponsor|1|||
37820274|NCT01787552|69499322|FG003|Overall Study|Study terminated by Sponsor|3|||
37820275|NCT01787552|69499319|FG000|Overall Study|Progressive Disease|2|||
37881391|NCT00831415|69565998|FG000|Overall Study|Withdrawal by Subject|35|||
37881392|NCT00831415|69565998|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
37881393|NCT00831415|69565998|FG000|Overall Study|Death|1|||
37881394|NCT01095653|69566005|FG000|Overall Study|Lack of Efficacy|3|||
37820276|NCT01787552|69499320|FG001|Overall Study|Progressive Disease|2|||
37881395|NCT01095653|69566006|FG001|Overall Study|Lack of Efficacy|0|||
37881396|NCT01095653|69566007|FG002|Overall Study|Lack of Efficacy|0|||
37984638|NCT00302211|69670659|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
37984639|NCT00302211|69670660|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
37820277|NCT01787552|69499321|FG002|Overall Study|Progressive Disease|1|||
37820278|NCT01787552|69499322|FG003|Overall Study|Progressive Disease|1|||
37820279|NCT01808261|69499339|FG000|Overall Study|Physician Decision|0|||
37881397|NCT01095653|69566005|FG000|Overall Study|Adverse Event|1|||
37881398|NCT01095653|69566006|FG001|Overall Study|Adverse Event|4|||
37881399|NCT01095653|69566007|FG002|Overall Study|Adverse Event|4|||
37881400|NCT01095653|69566005|FG000|Overall Study|Lost to Follow-up|1|||
37881401|NCT01095653|69566006|FG001|Overall Study|Lost to Follow-up|0|||
37881402|NCT01095653|69566007|FG002|Overall Study|Lost to Follow-up|4|||
37881403|NCT01095653|69566005|FG000|Overall Study|Withdrawal by Subject|4|||
37881404|NCT01095653|69566006|FG001|Overall Study|Withdrawal by Subject|5|||
37881405|NCT01095653|69566007|FG002|Overall Study|Withdrawal by Subject|3|||
37881406|NCT01095653|69566005|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
37881407|NCT01095653|69566006|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
37881408|NCT01095653|69566007|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
37881409|NCT00920907|69566017|FG000|Induction Period|Adverse Event|0|||
37881410|NCT00920907|69566018|FG001|Induction Period|Adverse Event|2|||
37881411|NCT00920907|69566017|FG000|Induction Period|Death|1|||
37881412|NCT00920907|69566018|FG001|Induction Period|Death|1|||
37881413|NCT00920907|69566017|FG000|Induction Period|Disease Progression|12|||
37881414|NCT00920907|69566018|FG001|Induction Period|Disease Progression|11|||
37881415|NCT00920907|69566017|FG000|Induction Period|Study Drug Toxicity|8|||
37881416|NCT00920907|69566018|FG001|Induction Period|Study Drug Toxicity|6|||
37881417|NCT00920907|69566017|FG000|Induction Period|No longer meets study criteria|0|||
37881418|NCT00920907|69566018|FG001|Induction Period|No longer meets study criteria|1|||
37881419|NCT00920907|69566017|FG000|Induction Period|Withdrawal by Subject|1|||
37881420|NCT00920907|69566018|FG001|Induction Period|Withdrawal by Subject|1|||
37881421|NCT00920907|69566017|FG000|Maintenance Period|Disease Progression|3|||
37881422|NCT00920907|69566018|FG001|Maintenance Period|Disease Progression|7|||
37881423|NCT00920907|69566017|FG000|Maintenance Period|Administrative (study closure)|7|||
37881424|NCT00920907|69566018|FG001|Maintenance Period|Administrative (study closure)|2|||
37881425|NCT00920907|69566017|FG000|Maintenance Period|Study Drug Toxicity|0|||
37881426|NCT00920907|69566018|FG001|Maintenance Period|Study Drug Toxicity|2|||
37881427|NCT00920907|69566017|FG000|Maintenance Period|Death|1|||
37881428|NCT00920907|69566018|FG001|Maintenance Period|Death|1|||
37881429|NCT00920907|69566017|FG000|Maintenance Period|Withdrawal by Subject|1|||
37881430|NCT00920907|69566018|FG001|Maintenance Period|Withdrawal by Subject|0|||
37881431|NCT00920907|69566017|FG000|Maintenance Period|Adverse Event|0|||
37881432|NCT00920907|69566018|FG001|Maintenance Period|Adverse Event|1|||
37881433|NCT01103141|69566028|FG000|Overall Study|Death|0|||
37881434|NCT01103141|69566029|FG001|Overall Study|Death|1|||
37881435|NCT01103141|69566028|FG000|Overall Study|Lost to Follow-up|2|||
37881436|NCT01103141|69566029|FG001|Overall Study|Lost to Follow-up|1|||
37881437|NCT00844831|69566035|FG000|Overall Study|Withdrawal by Subject|4|||
37881438|NCT00844831|69566035|FG000|Overall Study|Adverse Event|1|||
37881439|NCT00844831|69566035|FG000|Overall Study|Physician Decision|1|||
37881440|NCT00920829|69566047|FG000|Allocation|No post randomization data|3|||
37881441|NCT00920829|69566048|FG001|Allocation|No post randomization data|1|||
37881442|NCT00920829|69566049|FG002|Allocation|No post randomization data|0|||
37881443|NCT00920829|69566050|FG003|Allocation|No post randomization data|2|||
37881444|NCT00920829|69566047|FG000|Available for Analysis|Withdrawal by Subject|6|||
37881445|NCT00920829|69566048|FG001|Available for Analysis|Withdrawal by Subject|6|||
37881446|NCT00920829|69566049|FG002|Available for Analysis|Withdrawal by Subject|6|||
37881447|NCT00920829|69566050|FG003|Available for Analysis|Withdrawal by Subject|10|||
37984640|NCT00302211|69670661|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
37984641|NCT00302211|69670662|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
37984642|NCT00302211|69670658|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
37984643|NCT00302211|69670659|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
37881448|NCT00920829|69566047|FG000|Available for Analysis|Required Medical Treatment|0|||
37881449|NCT00920829|69566048|FG001|Available for Analysis|Required Medical Treatment|1|||
37881450|NCT00920829|69566049|FG002|Available for Analysis|Required Medical Treatment|2|||
37881451|NCT00920829|69566050|FG003|Available for Analysis|Required Medical Treatment|0|||
37881452|NCT00920829|69566047|FG000|Available for Analysis|Adverse Event|1|||
37881453|NCT00920829|69566048|FG001|Available for Analysis|Adverse Event|2|||
37881454|NCT00920829|69566049|FG002|Available for Analysis|Adverse Event|1|||
37881455|NCT00920829|69566050|FG003|Available for Analysis|Adverse Event|0|||
37881456|NCT00920829|69566047|FG000|Available for Analysis|Death|1|||
37881457|NCT00920829|69566048|FG001|Available for Analysis|Death|0|||
37881458|NCT00920829|69566049|FG002|Available for Analysis|Death|0|||
37881459|NCT00920829|69566050|FG003|Available for Analysis|Death|0|||
37881460|NCT00920829|69566047|FG000|Available for Analysis|Protocol Violation|0|||
37881461|NCT00920829|69566048|FG001|Available for Analysis|Protocol Violation|0|||
37881462|NCT00920829|69566049|FG002|Available for Analysis|Protocol Violation|1|||
37881463|NCT00920829|69566050|FG003|Available for Analysis|Protocol Violation|0|||
37984644|NCT00302211|69670660|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
37881464|NCT00920829|69566047|FG000|Available for Analysis|Required more treatment|0|||
37881465|NCT00920829|69566048|FG001|Available for Analysis|Required more treatment|2|||
37881466|NCT00920829|69566049|FG002|Available for Analysis|Required more treatment|0|||
37881467|NCT00920829|69566050|FG003|Available for Analysis|Required more treatment|1|||
37881468|NCT00831181|69566060|FG000|Overall Study|Adverse Event|12|||
37881469|NCT01023672|69566065|FG000|Overall Study|Worsening disease|2|||
37881470|NCT01023672|69566065|FG000|Overall Study|Death|1|||
37881471|NCT01094171|69566069|FG000|Overall Study|Lost to Follow-up|2|||
37881472|NCT01094171|69566069|FG000|Overall Study|Informed consent withdrawal|4|||
37881473|NCT01094171|69566069|FG000|Overall Study|Migration from the study area|3|||
37881474|NCT01094171|69566069|FG000|Overall Study|Other|1|||
37881475|NCT01093625|69566075|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
37881476|NCT01093625|69566076|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
37881477|NCT01093625|69566075|FG000|2-Week Visit|Withdrawal by Subject|1|||
37881478|NCT01093625|69566076|FG001|2-Week Visit|Withdrawal by Subject|0|||
37881479|NCT01093625|69566075|FG000|1-Month Visit|Lost to Follow-up|2|||
37881480|NCT01093625|69566076|FG001|1-Month Visit|Lost to Follow-up|0|||
37881481|NCT01093625|69566075|FG000|3-Month Visit|Lost to Follow-up|2|||
37881482|NCT01093625|69566076|FG001|3-Month Visit|Lost to Follow-up|0|||
37881483|NCT01093625|69566075|FG000|6-Month Visit|Withdrawal by Subject|6|||
37881484|NCT01093625|69566076|FG001|6-Month Visit|Withdrawal by Subject|7|||
37881485|NCT01093625|69566075|FG000|6-Month Visit|Lost to Follow-up|2|||
37881486|NCT01093625|69566076|FG001|6-Month Visit|Lost to Follow-up|2|||
37881487|NCT01093625|69566075|FG000|1-Year Visit|Lost to Follow-up|5|||
37881488|NCT01093625|69566076|FG001|1-Year Visit|Lost to Follow-up|3|||
37881489|NCT01023516|69566084|FG000|Overall Study|Voluntary discontinuation|7|||
37881490|NCT01023516|69566085|FG001|Overall Study|Voluntary discontinuation|5|||
37881491|NCT01023516|69566084|FG000|Overall Study|Adverse Event|9|||
37881492|NCT01023516|69566085|FG001|Overall Study|Adverse Event|6|||
37881493|NCT01023516|69566084|FG000|Overall Study|Safety reason|0|||
37881494|NCT01023516|69566085|FG001|Overall Study|Safety reason|3|||
37881495|NCT01023516|69566084|FG000|Overall Study|Study-specific criteria|4|||
37881496|NCT01023516|69566085|FG001|Overall Study|Study-specific criteria|2|||
37881497|NCT01023516|69566084|FG000|Overall Study|Incorrect enrolment|4|||
37881498|NCT01023516|69566085|FG001|Overall Study|Incorrect enrolment|2|||
37881499|NCT00844753|69566095|FG000|Overall Study|Lack of Efficacy|1|||
37881500|NCT00844753|69566096|FG001|Overall Study|Lack of Efficacy|0|||
37881501|NCT00844753|69566097|FG002|Overall Study|Lack of Efficacy|2|||
37881502|NCT00844753|69566098|FG003|Overall Study|Lack of Efficacy|2|||
37881503|NCT00844753|69566095|FG000|Overall Study|Adverse Event|3|||
37881504|NCT00844753|69566096|FG001|Overall Study|Adverse Event|2|||
37984645|NCT00302211|69670661|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
37984646|NCT00302211|69670662|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
37984647|NCT00302211|69670658|FG000|Open Label-Patients From Double-Blind|Death|0|||
37984648|NCT00302211|69670659|FG001|Open Label-Patients From Double-Blind|Death|0|||
37984649|NCT00302211|69670660|FG002|Open Label-Patients From Double-Blind|Death|0|||
37984650|NCT00302211|69670661|FG003|Open Label-Patients From Double-Blind|Death|1|||
37984651|NCT00302211|69670662|FG004|Open Label-Patients From Double-Blind|Death|1|||
37984652|NCT00302211|69670658|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
37881505|NCT00844753|69566097|FG002|Overall Study|Adverse Event|5|||
37881506|NCT00844753|69566098|FG003|Overall Study|Adverse Event|5|||
37881507|NCT00844753|69566095|FG000|Overall Study|Lost to Follow-up|1|||
37984653|NCT00302211|69670659|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
37984654|NCT00302211|69670660|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
37984655|NCT00302211|69670661|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
37984656|NCT00302211|69670662|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
37984657|NCT00302211|69670658|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
37984658|NCT00302211|69670659|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
37984659|NCT00302211|69670660|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
37984660|NCT00302211|69670661|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
37984661|NCT00302211|69670662|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
37984662|NCT00302211|69670658|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
37984663|NCT00302211|69670659|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
37984664|NCT00302211|69670660|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
37984665|NCT00302211|69670661|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
37984666|NCT00302211|69670662|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
37984667|NCT00288015|69670674|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
37695297|NCT02349295|69171756|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
37695298|NCT02349295|69171757|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
37881508|NCT00844753|69566096|FG001|Overall Study|Lost to Follow-up|1|||
37881509|NCT00844753|69566097|FG002|Overall Study|Lost to Follow-up|0|||
37881510|NCT00844753|69566098|FG003|Overall Study|Lost to Follow-up|1|||
37881511|NCT00844753|69566095|FG000|Overall Study|could not swallow medication|2|||
37881512|NCT00844753|69566096|FG001|Overall Study|could not swallow medication|0|||
37881513|NCT00844753|69566097|FG002|Overall Study|could not swallow medication|0|||
37881514|NCT00844753|69566098|FG003|Overall Study|could not swallow medication|0|||
37881515|NCT00844753|69566095|FG000|Overall Study|Withdrawal by Subject|1|||
37881516|NCT00844753|69566096|FG001|Overall Study|Withdrawal by Subject|0|||
37881517|NCT00844753|69566097|FG002|Overall Study|Withdrawal by Subject|0|||
37881518|NCT00844753|69566098|FG003|Overall Study|Withdrawal by Subject|3|||
37881519|NCT00830947|69566108|FG000|Overall Study|Lost to Follow-up|4|||
37881520|NCT00830947|69566109|FG001|Overall Study|Lost to Follow-up|4|||
37881521|NCT01018992|69566117|FG000|Overall Study|Adverse Event|8|||
37881522|NCT01018992|69566118|FG001|Overall Study|Adverse Event|3|||
37881523|NCT01018992|69566117|FG000|Overall Study|Withdrawal by Subject|3|||
37881524|NCT01018992|69566118|FG001|Overall Study|Withdrawal by Subject|8|||
37881525|NCT01018992|69566117|FG000|Overall Study|Protocol Violation|0|||
37881526|NCT01018992|69566118|FG001|Overall Study|Protocol Violation|4|||
37881527|NCT01018992|69566117|FG000|Overall Study|Lost to Follow-up|5|||
37881528|NCT01018992|69566118|FG001|Overall Study|Lost to Follow-up|1|||
37881529|NCT00917553|69566126|FG000|Overall Study|Lost to Follow-up|2|||
37881530|NCT00917553|69566127|FG001|Overall Study|Lost to Follow-up|1|||
37881531|NCT01018680|69566135|FG000|Overall Study|Adverse Event|23|||
37881532|NCT01018680|69566136|FG001|Overall Study|Adverse Event|40|||
37881533|NCT01018680|69566135|FG000|Overall Study|Withdrawal by Subject|10|||
37881534|NCT01018680|69566136|FG001|Overall Study|Withdrawal by Subject|10|||
37881535|NCT01018680|69566135|FG000|Overall Study|Protocol Violation|5|||
37881536|NCT01018680|69566136|FG001|Overall Study|Protocol Violation|8|||
37881537|NCT01018680|69566135|FG000|Overall Study|Sponsor Decision|6|||
37881538|NCT01018680|69566136|FG001|Overall Study|Sponsor Decision|7|||
37881539|NCT01018680|69566135|FG000|Overall Study|Lack of Efficacy|8|||
37881540|NCT01018680|69566136|FG001|Overall Study|Lack of Efficacy|2|||
37881541|NCT01018680|69566135|FG000|Overall Study|Lost to Follow-up|5|||
37984668|NCT00288015|69670674|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
37984669|NCT00288015|69670674|FG000|First Response Assessment|Withdrawal by Subject|1|||
37984670|NCT00288015|69670674|FG000|First Response Assessment|Death|1|||
37984671|NCT00288015|69670674|FG000|First Response Assessment|Physician Decision|2|||
37984672|NCT00288015|69670674|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
37984673|NCT00288015|69670674|FG000|Follow up for Survival x 2 Years|Death|13|||
37984674|NCT00288015|69670674|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
37984675|NCT00288015|69670674|FG000|Follow up for Survival x 2 Years|Other|9|||
37984676|NCT00389064|69670680|FG000|Overall Study|Adverse Event|11|||
37984677|NCT00389064|69670681|FG001|Overall Study|Adverse Event|3|||
37984678|NCT00389064|69670680|FG000|Overall Study|Lack of Efficacy|3|||
37984679|NCT00389064|69670681|FG001|Overall Study|Lack of Efficacy|14|||
37984680|NCT00389064|69670680|FG000|Overall Study|Withdrawal by Subject|17|||
37984681|NCT00389064|69670681|FG001|Overall Study|Withdrawal by Subject|27|||
37984682|NCT00389064|69670680|FG000|Overall Study|Physician Decision|2|||
37984683|NCT00389064|69670681|FG001|Overall Study|Physician Decision|2|||
37984684|NCT00389064|69670680|FG000|Overall Study|Lost to Follow-up|1|||
37984685|NCT00389064|69670681|FG001|Overall Study|Lost to Follow-up|2|||
37984686|NCT00389064|69670680|FG000|Overall Study|Protocol Violation|2|||
37984687|NCT00389064|69670681|FG001|Overall Study|Protocol Violation|0|||
37984688|NCT00389064|69670680|FG000|Overall Study|Multiple Reasons|9|||
37984689|NCT00389064|69670681|FG001|Overall Study|Multiple Reasons|11|||
37984690|NCT00388674|69670689|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
37881542|NCT01018680|69566136|FG001|Overall Study|Lost to Follow-up|3|||
37984691|NCT00388674|69670690|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
37984692|NCT00388674|69670689|FG000|Initial Treatment|Adverse Event|22|||
37984693|NCT00388674|69670690|FG001|Initial Treatment|Adverse Event|87|||
37984694|NCT00388674|69670689|FG000|Initial Treatment|Death|215|||
37984695|NCT00388674|69670690|FG001|Initial Treatment|Death|216|||
37984696|NCT00388674|69670689|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
37984697|NCT00388674|69670690|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
37984698|NCT00388674|69670689|FG000|Initial Treatment|HCC|12|||
37881543|NCT01018680|69566135|FG000|Overall Study|Entry Criteria Not Met|1|||
37881544|NCT01018680|69566136|FG001|Overall Study|Entry Criteria Not Met|4|||
37881545|NCT01018680|69566135|FG000|Overall Study|Physician Decision|3|||
37984699|NCT00388674|69670690|FG001|Initial Treatment|HCC|20|||
37984700|NCT00388674|69670689|FG000|Initial Treatment|Lost to Follow-up|526|||
37984701|NCT00388674|69670690|FG001|Initial Treatment|Lost to Follow-up|624|||
37984702|NCT00388674|69670689|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
37984703|NCT00388674|69670690|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
37984704|NCT00388674|69670689|FG000|Initial Treatment|Never Treated with Study Medication|1|||
37984705|NCT00388674|69670690|FG001|Initial Treatment|Never Treated with Study Medication|7|||
37984706|NCT00388674|69670689|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
37881546|NCT01018680|69566136|FG001|Overall Study|Physician Decision|1|||
37881547|NCT01012440|69566142|FG000|Overall Study|Withdrawal by Subject|2|||
37881548|NCT00916929|69566148|FG000|Overall Study|Lost to Follow-up|1|||
37881549|NCT00916929|69566149|FG001|Overall Study|Lost to Follow-up|3|||
37881550|NCT00916929|69566148|FG000|Overall Study|Death|5|||
37881551|NCT00916929|69566149|FG001|Overall Study|Death|10|||
37881552|NCT00916929|69566148|FG000|Overall Study|Withdrawal by Subject|1|||
37881553|NCT00916929|69566149|FG001|Overall Study|Withdrawal by Subject|5|||
37881554|NCT00916929|69566148|FG000|Overall Study|Left ventricular epicardial lead|1|||
37881555|NCT00916929|69566149|FG001|Overall Study|Left ventricular epicardial lead|2|||
37881556|NCT00916929|69566148|FG000|Overall Study|Transferred to hospice care|1|||
37881557|NCT00916929|69566149|FG001|Overall Study|Transferred to hospice care|1|||
37881558|NCT00916929|69566148|FG000|Overall Study|System explant|1|||
37881559|NCT00916929|69566149|FG001|Overall Study|System explant|0|||
37881560|NCT00916929|69566148|FG000|Overall Study|Moved to another state|0|||
37881561|NCT00916929|69566149|FG001|Overall Study|Moved to another state|1|||
37881562|NCT00916929|69566148|FG000|Overall Study|Device unable to process impedance data|0|||
37881563|NCT00916929|69566149|FG001|Overall Study|Device unable to process impedance data|7|||
37881564|NCT00844597|69566163|FG000|Overall Study|Adverse Event|0|||
37881565|NCT00844597|69566164|FG001|Overall Study|Adverse Event|0|||
37881566|NCT00844597|69566165|FG002|Overall Study|Adverse Event|0|||
37881567|NCT00844597|69566166|FG003|Overall Study|Adverse Event|1|||
37881568|NCT00844597|69566167|FG004|Overall Study|Adverse Event|0|||
37881569|NCT00844597|69566168|FG005|Overall Study|Adverse Event|0|||
37881570|NCT01017120|69566186|FG000|Overall Study|Adverse Event|9|||
37881571|NCT01017120|69566187|FG001|Overall Study|Adverse Event|0|||
37881572|NCT01017120|69566186|FG000|Overall Study|Lost to Follow-up|13|||
37881573|NCT01017120|69566187|FG001|Overall Study|Lost to Follow-up|11|||
37881574|NCT01017120|69566186|FG000|Overall Study|Lack of Efficacy|1|||
37881575|NCT01017120|69566187|FG001|Overall Study|Lack of Efficacy|0|||
37881576|NCT01017120|69566186|FG000|Overall Study|Withdrawal by Subject|39|||
37881577|NCT01017120|69566187|FG001|Overall Study|Withdrawal by Subject|21|||
37881578|NCT01017120|69566186|FG000|Overall Study|Pregnancy|1|||
37881579|NCT01017120|69566187|FG001|Overall Study|Pregnancy|1|||
37881580|NCT01017120|69566186|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
37881581|NCT01017120|69566187|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
37881582|NCT01017120|69566186|FG000|Overall Study|Relocated Out of Town|0|||
37881583|NCT01017120|69566187|FG001|Overall Study|Relocated Out of Town|2|||
37881584|NCT01017120|69566186|FG000|Overall Study|Protocol Violation|1|||
37881585|NCT01017120|69566187|FG001|Overall Study|Protocol Violation|0|||
37984707|NCT00388674|69670690|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
37984708|NCT00388674|69670689|FG000|Initial Treatment|Not Defined|125|||
37984709|NCT00388674|69670690|FG001|Initial Treatment|Not Defined|172|||
37984710|NCT00388674|69670689|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
37984711|NCT00388674|69670690|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
37984712|NCT00388674|69670689|FG000|Initial Treatment|Pregnancy|26|||
37820280|NCT01808261|69499340|FG001|Overall Study|Physician Decision|2|||
37820281|NCT01808261|69499339|FG000|Overall Study|Study Closed/Terminated|25|||
37820282|NCT01808261|69499340|FG001|Overall Study|Study Closed/Terminated|23|||
37820283|NCT01808261|69499339|FG000|Overall Study|Adverse event, non-fatal|2|||
37820284|NCT01808261|69499340|FG001|Overall Study|Adverse event, non-fatal|0|||
37820285|NCT01808261|69499339|FG000|Overall Study|Consent withdrawn by subject|6|||
37820286|NCT01808261|69499340|FG001|Overall Study|Consent withdrawn by subject|7|||
37820287|NCT01808261|69499339|FG000|Overall Study|Lost to Follow-up|3|||
37820288|NCT01808261|69499340|FG001|Overall Study|Lost to Follow-up|1|||
37820289|NCT01814826|69499359|FG000|Overall Study|Other|3|||
37820290|NCT01814826|69499360|FG001|Overall Study|Other|5|||
37820291|NCT01814826|69499361|FG002|Overall Study|Other|0|||
37820292|NCT01814826|69499359|FG000|Overall Study|Death|29|||
37820293|NCT01814826|69499360|FG001|Overall Study|Death|24|||
37820294|NCT01814826|69499361|FG002|Overall Study|Death|3|||
37820295|NCT01819467|69499372|FG000|Overall Study|Physician Decision|20|||
37820296|NCT01819467|69499373|FG001|Overall Study|Physician Decision|9|||
37820297|NCT01829711|69499379|FG000|Overall Study|Lost to Follow-up|2|||
37881586|NCT01017120|69566186|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
37820298|NCT01829711|69499379|FG000|Overall Study|Withdrawal by Subject|3|||
37881587|NCT01017120|69566187|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
37881588|NCT01016964|69566195|FG000|Overall Study|Lost to Follow-up|3|||
37881589|NCT01016964|69566196|FG001|Overall Study|Lost to Follow-up|3|||
37881590|NCT02996110|69566207|FG000|Pre-Treatment|Other Reasons|0|||
37820299|NCT01829711|69499379|FG000|Overall Study|Death|4|||
37820300|NCT01829711|69499379|FG000|Overall Study|Started new therapies|17|||
37820301|NCT01829711|69499379|FG000|Overall Study|Adverse Event|3|||
37820302|NCT01829711|69499379|FG000|Overall Study|Due to progression of disease|13|||
37820303|NCT01829711|69499379|FG000|Overall Study|Due to lack of response|1|||
37881591|NCT02996110|69566208|FG001|Pre-Treatment|Other Reasons|1|||
37881592|NCT02996110|69566209|FG002|Pre-Treatment|Other Reasons|0|||
37984713|NCT00388674|69670690|FG001|Initial Treatment|Pregnancy|16|||
37984714|NCT00388674|69670689|FG000|Initial Treatment|Study Drug Toxicity|5|||
37881593|NCT02996110|69566210|FG003|Pre-Treatment|Other Reasons|0|||
37881594|NCT02996110|69566211|FG004|Pre-Treatment|Other Reasons|1|||
37881595|NCT02996110|69566207|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
37881596|NCT02996110|69566208|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
37881597|NCT02996110|69566209|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
37881598|NCT02996110|69566210|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
37881599|NCT02996110|69566211|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
37881600|NCT02996110|69566207|FG000|Track 1|Disease Progression|15|||
37881601|NCT02996110|69566208|FG001|Track 1|Disease Progression|17|||
37881602|NCT02996110|69566209|FG002|Track 1|Disease Progression|0|||
37881603|NCT02996110|69566210|FG003|Track 1|Disease Progression|0|||
37881604|NCT02996110|69566211|FG004|Track 1|Disease Progression|0|||
37881605|NCT02996110|69566207|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
37881606|NCT02996110|69566208|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
37881607|NCT02996110|69566209|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
37881608|NCT02996110|69566210|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
37881609|NCT02996110|69566211|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
37881610|NCT02996110|69566207|FG000|Track 1|Study Drug Toxicity|5|||
37881611|NCT02996110|69566208|FG001|Track 1|Study Drug Toxicity|3|||
37881612|NCT02996110|69566209|FG002|Track 1|Study Drug Toxicity|0|||
37881613|NCT02996110|69566210|FG003|Track 1|Study Drug Toxicity|0|||
37881614|NCT02996110|69566211|FG004|Track 1|Study Drug Toxicity|0|||
37881615|NCT02996110|69566207|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
37881616|NCT02996110|69566208|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
37881617|NCT02996110|69566209|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
37881618|NCT02996110|69566210|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
37881619|NCT02996110|69566211|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
37881620|NCT02996110|69566207|FG000|Track 1|Administrative Reason by Sponsor|0|||
37881621|NCT02996110|69566208|FG001|Track 1|Administrative Reason by Sponsor|1|||
37881622|NCT02996110|69566209|FG002|Track 1|Administrative Reason by Sponsor|0|||
37695299|NCT02349295|69171758|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
37695300|NCT02349295|69171759|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
37881623|NCT02996110|69566210|FG003|Track 1|Administrative Reason by Sponsor|0|||
37881624|NCT02996110|69566211|FG004|Track 1|Administrative Reason by Sponsor|0|||
37881625|NCT02996110|69566207|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
37881626|NCT02996110|69566208|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
37881627|NCT02996110|69566209|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
37881628|NCT02996110|69566210|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
37881629|NCT02996110|69566211|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
37881630|NCT02996110|69566207|FG000|Track 2|Disease Progression|33|||
37881631|NCT02996110|69566208|FG001|Track 2|Disease Progression|26|||
37881632|NCT02996110|69566209|FG002|Track 2|Disease Progression|19|||
37881633|NCT02996110|69566210|FG003|Track 2|Disease Progression|16|||
37881634|NCT02996110|69566211|FG004|Track 2|Disease Progression|15|||
37881635|NCT02996110|69566207|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
37881636|NCT02996110|69566208|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
37881637|NCT02996110|69566209|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
37881638|NCT02996110|69566210|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
37881639|NCT02996110|69566211|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
37881640|NCT02996110|69566207|FG000|Track 2|Death|0|||
37881641|NCT02996110|69566208|FG001|Track 2|Death|0|||
37881642|NCT02996110|69566209|FG002|Track 2|Death|1|||
37881643|NCT02996110|69566210|FG003|Track 2|Death|0|||
37881644|NCT02996110|69566211|FG004|Track 2|Death|1|||
37881645|NCT02996110|69566207|FG000|Track 2|Study Drug Toxicity|4|||
37881646|NCT02996110|69566208|FG001|Track 2|Study Drug Toxicity|1|||
37984715|NCT00388674|69670690|FG001|Initial Treatment|Study Drug Toxicity|92|||
37984716|NCT00388674|69670689|FG000|Initial Treatment|Participant Request|501|||
37881647|NCT02996110|69566209|FG002|Track 2|Study Drug Toxicity|4|||
37881648|NCT02996110|69566210|FG003|Track 2|Study Drug Toxicity|1|||
37881649|NCT02996110|69566211|FG004|Track 2|Study Drug Toxicity|0|||
37881650|NCT02996110|69566207|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
37881651|NCT02996110|69566208|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
37881652|NCT02996110|69566209|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
37695301|NCT02349295|69171760|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
37984717|NCT00388674|69670690|FG001|Initial Treatment|Participant Request|673|||
37881653|NCT02996110|69566210|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
37881654|NCT02996110|69566211|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
37881655|NCT02996110|69566207|FG000|Track 2|Participant Withdrew Consent|1|||
37881656|NCT02996110|69566208|FG001|Track 2|Participant Withdrew Consent|2|||
37984718|NCT00388674|69670689|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
37881657|NCT02996110|69566209|FG002|Track 2|Participant Withdrew Consent|3|||
37881658|NCT02996110|69566210|FG003|Track 2|Participant Withdrew Consent|1|||
37881659|NCT02996110|69566211|FG004|Track 2|Participant Withdrew Consent|1|||
37881660|NCT02996110|69566207|FG000|Track 2|Other Reasons|0|||
37881661|NCT02996110|69566208|FG001|Track 2|Other Reasons|0|||
37881662|NCT02996110|69566209|FG002|Track 2|Other Reasons|1|||
37881663|NCT02996110|69566210|FG003|Track 2|Other Reasons|0|||
37881664|NCT02996110|69566211|FG004|Track 2|Other Reasons|1|||
37881665|NCT00916617|69566229|FG000|Overall Study|Adverse Event|3|||
37881666|NCT00916617|69566230|FG001|Overall Study|Adverse Event|2|||
37881667|NCT00916617|69566231|FG002|Overall Study|Adverse Event|6|||
37984719|NCT00388674|69670690|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
37984720|NCT00388674|69670689|FG000|Initial Treatment|Not Reported|10|||
37984721|NCT00388674|69670690|FG001|Initial Treatment|Not Reported|12|||
37984722|NCT00388674|69670689|FG000|End of Study|Administrative Reason By Sponsor|299|||
37984723|NCT00388674|69670690|FG001|End of Study|Administrative Reason By Sponsor|253|||
37984724|NCT00388674|69670689|FG000|End of Study|Death|239|||
37984725|NCT00388674|69670690|FG001|End of Study|Death|262|||
37984726|NCT00388674|69670689|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
37984727|NCT00388674|69670690|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
37820304|NCT01846273|69499386|FG000|Overall Study|Adverse Event|9|||
37820305|NCT01846273|69499387|FG001|Overall Study|Adverse Event|7|||
37820306|NCT01846273|69499388|FG002|Overall Study|Adverse Event|0|||
37820307|NCT01846273|69499386|FG000|Overall Study|Subject withdrew consent|5|||
37820308|NCT01846273|69499387|FG001|Overall Study|Subject withdrew consent|8|||
37820309|NCT01846273|69499388|FG002|Overall Study|Subject withdrew consent|0|||
37820310|NCT01846273|69499386|FG000|Overall Study|Lost to Follow-up|2|||
37820311|NCT01846273|69499387|FG001|Overall Study|Lost to Follow-up|1|||
37820312|NCT01846273|69499388|FG002|Overall Study|Lost to Follow-up|0|||
37820313|NCT01846273|69499386|FG000|Overall Study|Administrative problems|1|||
37820314|NCT01846273|69499387|FG001|Overall Study|Administrative problems|0|||
37820315|NCT01846273|69499388|FG002|Overall Study|Administrative problems|0|||
37820316|NCT01846273|69499386|FG000|Overall Study|Death|2|||
37820317|NCT01846273|69499387|FG001|Overall Study|Death|1|||
37820318|NCT01846273|69499388|FG002|Overall Study|Death|0|||
37820319|NCT01846273|69499386|FG000|Overall Study|Disease Progression|0|||
37820320|NCT01846273|69499387|FG001|Overall Study|Disease Progression|4|||
37820321|NCT01846273|69499388|FG002|Overall Study|Disease Progression|0|||
37820322|NCT01846273|69499386|FG000|Overall Study|Protocol Deviation|2|||
37820323|NCT01846273|69499387|FG001|Overall Study|Protocol Deviation|3|||
37695302|NCT02349295|69171761|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
37820324|NCT01846273|69499388|FG002|Overall Study|Protocol Deviation|0|||
37820325|NCT01846273|69499386|FG000|Overall Study|Physician Decision|1|||
37881668|NCT00916617|69566232|FG003|Overall Study|Adverse Event|3|||
37881669|NCT00916617|69566229|FG000|Overall Study|Withdrawal by Subject|3|||
37881670|NCT00916617|69566230|FG001|Overall Study|Withdrawal by Subject|2|||
37881671|NCT00916617|69566231|FG002|Overall Study|Withdrawal by Subject|0|||
37881672|NCT00916617|69566232|FG003|Overall Study|Withdrawal by Subject|1|||
37881673|NCT00916617|69566229|FG000|Overall Study|Caregiver Request|3|||
37695303|NCT02349295|69171762|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
37984728|NCT00388674|69670689|FG000|End of Study|HCC|8|||
37984729|NCT00388674|69670690|FG001|End of Study|HCC|7|||
37984730|NCT00388674|69670689|FG000|End of Study|Lost to Follow-up|587|||
37820326|NCT01846273|69499387|FG001|Overall Study|Physician Decision|2|||
37820327|NCT01846273|69499388|FG002|Overall Study|Physician Decision|0|||
37820328|NCT01871896|69499396|FG000|Overall Study|Lost to Follow-up|1|||
37820329|NCT04752475|69499403|FG000|Overall Study|Withdrawal by Subject|1|||
37820330|NCT04752475|69499404|FG001|Overall Study|Withdrawal by Subject|1|||
37820331|NCT03846947|69499450|FG000|Overall Study|technical issues with imaging sequence|2|||
37820332|NCT03675308|69499463|FG000|Overall Study|Adverse Event|3|||
37820333|NCT03675308|69499464|FG001|Overall Study|Adverse Event|2|||
37820334|NCT03675308|69499463|FG000|Overall Study|Withdrawal by Subject|6|||
37881674|NCT00916617|69566230|FG001|Overall Study|Caregiver Request|2|||
37984731|NCT00388674|69670690|FG001|End of Study|Lost to Follow-up|715|||
37984732|NCT00388674|69670689|FG000|End of Study|Malignancy (Non-HCC)|1|||
37984733|NCT00388674|69670690|FG001|End of Study|Malignancy (Non-HCC)|1|||
37984734|NCT00388674|69670689|FG000|End of Study|Non-Study Related Comorbidities|3|||
37984735|NCT00388674|69670690|FG001|End of Study|Non-Study Related Comorbidities|4|||
37984736|NCT00388674|69670689|FG000|End of Study|Not Defined|135|||
37984737|NCT00388674|69670690|FG001|End of Study|Not Defined|214|||
37984738|NCT00388674|69670689|FG000|End of Study|Participant Withdrew Consent|437|||
37984739|NCT00388674|69670690|FG001|End of Study|Participant Withdrew Consent|673|||
37984740|NCT00388674|69670689|FG000|End of Study|No Off-Treatment Status Data|22|||
37984741|NCT00388674|69670690|FG001|End of Study|No Off-Treatment Status Data|30|||
37984742|NCT00388674|69670689|FG000|End of Study|Not Reported|0|||
37984743|NCT00388674|69670690|FG001|End of Study|Not Reported|1|||
37984744|NCT00388362|69670696|FG000|Enrolled|Ineligible|1|||
37881675|NCT00916617|69566231|FG002|Overall Study|Caregiver Request|1|||
37881676|NCT00916617|69566232|FG003|Overall Study|Caregiver Request|0|||
37881677|NCT00916617|69566229|FG000|Overall Study|Physician Decision|1|||
37881678|NCT00916617|69566230|FG001|Overall Study|Physician Decision|1|||
37881679|NCT00916617|69566231|FG002|Overall Study|Physician Decision|0|||
37881680|NCT00916617|69566232|FG003|Overall Study|Physician Decision|0|||
37881681|NCT00916617|69566229|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
37881682|NCT00916617|69566230|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
37881683|NCT00916617|69566231|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
37881684|NCT00916617|69566232|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
37881685|NCT00916617|69566229|FG000|Overall Study|Lost to Follow-up|2|||
37881686|NCT00916617|69566230|FG001|Overall Study|Lost to Follow-up|1|||
37881687|NCT00916617|69566231|FG002|Overall Study|Lost to Follow-up|0|||
37881688|NCT00916617|69566232|FG003|Overall Study|Lost to Follow-up|0|||
37881689|NCT00916617|69566229|FG000|Overall Study|Lack of Efficacy|1|||
37881690|NCT00916617|69566230|FG001|Overall Study|Lack of Efficacy|0|||
37881691|NCT00916617|69566231|FG002|Overall Study|Lack of Efficacy|0|||
37881692|NCT00916617|69566232|FG003|Overall Study|Lack of Efficacy|0|||
37881693|NCT00916617|69566229|FG000|Overall Study|Other|2|||
37881694|NCT00916617|69566230|FG001|Overall Study|Other|0|||
37881695|NCT00916617|69566231|FG002|Overall Study|Other|0|||
37881696|NCT00916617|69566232|FG003|Overall Study|Other|2|||
37881697|NCT01103063|69566244|FG000|Overall Study|Adverse Event|3|||
37881698|NCT01103063|69566245|FG001|Overall Study|Adverse Event|1|||
37881699|NCT01103063|69566244|FG000|Overall Study|Lost to Follow-up|68|||
37881700|NCT01103063|69566245|FG001|Overall Study|Lost to Follow-up|51|||
37881701|NCT01103063|69566244|FG000|Overall Study|Withdrawal by Subject|60|||
37881702|NCT01103063|69566245|FG001|Overall Study|Withdrawal by Subject|15|||
37881703|NCT01103063|69566244|FG000|Overall Study|Other|16|||
37881704|NCT01103063|69566245|FG001|Overall Study|Other|11|||
37881705|NCT01103063|69566244|FG000|Overall Study|Protocol Violation|1|||
37881706|NCT01103063|69566245|FG001|Overall Study|Protocol Violation|0|||
37881707|NCT01103063|69566244|FG000|Overall Study|Study terminated by Sponsor|326|||
37881708|NCT01103063|69566245|FG001|Overall Study|Study terminated by Sponsor|342|||
37881709|NCT01103063|69566244|FG000|Overall Study|Death|3|||
37881710|NCT01103063|69566245|FG001|Overall Study|Death|1|||
37881711|NCT01091675|69566253|FG000|Overall Study|Adverse Event|7|||
37881712|NCT01091675|69566253|FG000|Overall Study|Lack of Efficacy|27|||
37881713|NCT01091519|69566259|FG000|Overall Study|Adverse Event|12|||
37881714|NCT01091519|69566260|FG001|Overall Study|Adverse Event|16|||
37881715|NCT01091519|69566259|FG000|Overall Study|Death|1|||
37881716|NCT01091519|69566260|FG001|Overall Study|Death|0|||
37881717|NCT01091519|69566259|FG000|Overall Study|Lack of Efficacy|16|||
37881718|NCT01091519|69566260|FG001|Overall Study|Lack of Efficacy|19|||
37881719|NCT01091519|69566259|FG000|Overall Study|Lost to Follow-up|14|||
37881720|NCT01091519|69566260|FG001|Overall Study|Lost to Follow-up|24|||
37881721|NCT01091519|69566259|FG000|Overall Study|Withdrawal by Subject|2|||
37881722|NCT01091519|69566260|FG001|Overall Study|Withdrawal by Subject|2|||
37881723|NCT01091519|69566259|FG000|Overall Study|Other|6|||
37984745|NCT00388362|69670696|FG000|Enrolled|Adverse Event|9|||
37984746|NCT00388362|69670696|FG000|Enrolled|Death|1|||
37984747|NCT00388362|69670696|FG000|Enrolled|Loss insurance|1|||
37881724|NCT01091519|69566260|FG001|Overall Study|Other|8|||
37881725|NCT01091519|69566259|FG000|Overall Study|Randomized not treated|4|||
37881726|NCT01091519|69566260|FG001|Overall Study|Randomized not treated|4|||
37881727|NCT01011738|69566269|FG000|Overall Study|Death|12|||
37881728|NCT01011738|69566270|FG001|Overall Study|Death|3|||
37881729|NCT01011738|69566271|FG002|Overall Study|Death|0|||
37881730|NCT01011738|69566269|FG000|Overall Study|Unknown reasons|312|||
37881731|NCT01011738|69566270|FG001|Overall Study|Unknown reasons|291|||
37881732|NCT01011738|69566271|FG002|Overall Study|Unknown reasons|17|||
37984748|NCT00388362|69670696|FG000|Enrolled|Withdrawal by Subject|1|||
37984749|NCT00388362|69670696|FG000|Remained on Study Median of 514 Days|Death|2|||
37984750|NCT00387894|69670700|FG000|Overall Study|Withdrawal by Subject|1|||
37984751|NCT00387426|69670704|FG000|Overall Study|Lack of Response|7|||
37984752|NCT00387426|69670704|FG000|Overall Study|Toxicities|4|||
37881733|NCT00918333|69566282|FG000|Overall Study|Drug not taken per protocol|1|||
37881734|NCT00918333|69566283|FG001|Overall Study|Drug not taken per protocol|0|||
37881735|NCT00918333|69566282|FG000|Overall Study|Inadequate amount of drugs provided|1|||
37881736|NCT00918333|69566283|FG001|Overall Study|Inadequate amount of drugs provided|4|||
37881737|NCT00918333|69566282|FG000|Overall Study|Ineligible|1|||
37881738|NCT00918333|69566283|FG001|Overall Study|Ineligible|0|||
37881739|NCT00918333|69566282|FG000|Overall Study|Withdrawal by Subject|0|||
37881740|NCT00918333|69566283|FG001|Overall Study|Withdrawal by Subject|1|||
37881741|NCT01091363|69566294|FG000|Overall Study|Withdrawal by Subject|11|||
37881742|NCT01091363|69566295|FG001|Overall Study|Withdrawal by Subject|15|||
37881743|NCT01091363|69566294|FG000|Overall Study|Lost to Follow-up|2|||
37881744|NCT01091363|69566295|FG001|Overall Study|Lost to Follow-up|2|||
37881745|NCT01090973|69566301|FG000|Overall Study|Disease progression|1|||
37881746|NCT01090739|69566305|FG000|Enrollment|Withdrawal by Subject|24|||
37881747|NCT01090739|69566305|FG000|Enrollment|Protocol Violation|14|||
37881748|NCT01090739|69566305|FG000|Enrollment|Lost to Follow-up|5|||
37881749|NCT01090739|69566305|FG000|Enrollment|Physician Decision|5|||
37881750|NCT01090739|69566305|FG000|Enrollment|Sponsor termination of site|4|||
37881751|NCT01090739|69566305|FG000|Enrollment|Study implant limit reached|2|||
37881752|NCT01090739|69566305|FG000|Enrollment|Adverse Event|1|||
37881753|NCT01090739|69566305|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
37881754|NCT01090739|69566305|FG000|12 Month Follow-up|Lost to Follow-up|1|||
37881755|NCT01090739|69566305|FG000|12 Month Follow-up|Physician Decision|1|||
37881756|NCT01090739|69566305|FG000|12 Month Follow-up|Death|1|||
37881757|NCT01090739|69566305|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
37881758|NCT01090739|69566305|FG000|24 Month Follow-up|Lost to Follow-up|1|||
37881759|NCT01090739|69566305|FG000|24 Month Follow-up|Death|1|||
37881760|NCT01090739|69566305|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
37881761|NCT01090739|69566305|FG000|36 Month Follow-up|Visit still pending|17|||
37881762|NCT00916383|69566323|FG000|Overall Study|Adverse Event|1|||
37881763|NCT00916383|69566323|FG000|Overall Study|Death|1|||
37881764|NCT00916383|69566323|FG000|Overall Study|Protocol Violation|1|||
37881765|NCT00916305|69566333|FG000|Overall Study|Lost to Follow-up|21|||
37881766|NCT00916305|69566334|FG001|Overall Study|Lost to Follow-up|27|||
37881767|NCT00916305|69566333|FG000|Overall Study|Withdrawal by Subject|0|||
37881768|NCT00916305|69566334|FG001|Overall Study|Withdrawal by Subject|1|||
37881769|NCT00916149|69566343|FG000|Overall Study|Lost to Follow-up|3|||
37881770|NCT00916149|69566344|FG001|Overall Study|Lost to Follow-up|2|||
37881771|NCT00916149|69566345|FG002|Overall Study|Lost to Follow-up|0|||
37881772|NCT00916149|69566343|FG000|Overall Study|Unable to place scalp EEG leads|1|||
37881773|NCT00916149|69566344|FG001|Overall Study|Unable to place scalp EEG leads|0|||
37881774|NCT00916149|69566345|FG002|Overall Study|Unable to place scalp EEG leads|0|||
37881775|NCT01090427|69566355|FG000|After Controlled Period|Death|0|||
37881776|NCT01090427|69566356|FG001|After Controlled Period|Death|0|||
37881777|NCT01090427|69566357|FG002|After Controlled Period|Death|0|||
37881778|NCT01090427|69566358|FG003|After Controlled Period|Death|0|||
37881779|NCT01090427|69566359|FG004|After Controlled Period|Death|0|||
37881780|NCT01090427|69566360|FG005|After Controlled Period|Death|1|||
37881781|NCT01090427|69566361|FG006|After Controlled Period|Death|0|||
37881782|NCT01090427|69566355|FG000|After Controlled Period|Lack of Efficacy|0|||
37881783|NCT01090427|69566356|FG001|After Controlled Period|Lack of Efficacy|0|||
37881784|NCT01090427|69566357|FG002|After Controlled Period|Lack of Efficacy|0|||
37881785|NCT01090427|69566358|FG003|After Controlled Period|Lack of Efficacy|0|||
37820335|NCT03675308|69499464|FG001|Overall Study|Withdrawal by Subject|4|||
37820336|NCT03675308|69499463|FG000|Overall Study|Lost to Follow-up|3|||
37820337|NCT03675308|69499464|FG001|Overall Study|Lost to Follow-up|0|||
37820338|NCT03675308|69499463|FG000|Overall Study|Lack of Efficacy|1|||
37820339|NCT03675308|69499464|FG001|Overall Study|Lack of Efficacy|1|||
37820340|NCT03675308|69499463|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
37820341|NCT03675308|69499464|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
37820342|NCT03675308|69499463|FG000|Overall Study|Other|0|||
37820343|NCT03675308|69499464|FG001|Overall Study|Other|1|||
37820344|NCT03131219|69499472|FG000|Initial Evaluation Period|Adverse Event|1|||
37820345|NCT03131219|69499473|FG001|Initial Evaluation Period|Adverse Event|0|||
37881786|NCT01090427|69566359|FG004|After Controlled Period|Lack of Efficacy|0|||
37881787|NCT01090427|69566360|FG005|After Controlled Period|Lack of Efficacy|3|||
37881788|NCT01090427|69566361|FG006|After Controlled Period|Lack of Efficacy|2|||
37881789|NCT01090427|69566355|FG000|After Controlled Period|Adverse Event|0|||
37881790|NCT01090427|69566356|FG001|After Controlled Period|Adverse Event|0|||
37881791|NCT01090427|69566357|FG002|After Controlled Period|Adverse Event|0|||
37881792|NCT01090427|69566358|FG003|After Controlled Period|Adverse Event|2|||
37820346|NCT03131219|69499472|FG000|Initial Evaluation Period|Protocol Violation|1|||
37820347|NCT03131219|69499473|FG001|Initial Evaluation Period|Protocol Violation|0|||
37881793|NCT01090427|69566359|FG004|After Controlled Period|Adverse Event|0|||
37881794|NCT01090427|69566360|FG005|After Controlled Period|Adverse Event|1|||
37881795|NCT01090427|69566361|FG006|After Controlled Period|Adverse Event|0|||
37881796|NCT01016262|69566385|FG000|Double-blind Phase|Adverse Event|0|||
37881797|NCT01016262|69566386|FG001|Double-blind Phase|Adverse Event|0|||
37881798|NCT01016262|69566387|FG002|Double-blind Phase|Adverse Event|1|||
37881799|NCT01016262|69566388|FG003|Double-blind Phase|Adverse Event|0|||
37881800|NCT01016262|69566389|FG004|Double-blind Phase|Adverse Event|0|||
37820348|NCT03131219|69499472|FG000|Initial Evaluation Period|Deemed ineligible post treatment|2|||
37820349|NCT03131219|69499473|FG001|Initial Evaluation Period|Deemed ineligible post treatment|0|||
37820350|NCT02914613|69499481|FG000|Overall Study|Withdrawal by Subject|1|||
37820351|NCT02914613|69499482|FG001|Overall Study|Withdrawal by Subject|2|||
37820352|NCT02914613|69499481|FG000|Overall Study|Adverse Event|1|||
37820353|NCT02914613|69499482|FG001|Overall Study|Adverse Event|0|||
37820354|NCT02586207|69499492|FG000|Overall Study|Physician Decision|1|||
37820355|NCT02586207|69499492|FG000|Overall Study|Withdrawal by Subject|1|||
37820356|NCT02573324|69499499|FG000|Overall Study|Withdrawal by Subject|26|||
37820357|NCT02573324|69499500|FG001|Overall Study|Withdrawal by Subject|23|||
37820358|NCT02573324|69499501|FG002|Overall Study|Withdrawal by Subject|3|||
37820359|NCT02573324|69499499|FG000|Overall Study|Lost to Follow-up|4|||
37820360|NCT02573324|69499500|FG001|Overall Study|Lost to Follow-up|5|||
37820361|NCT02573324|69499501|FG002|Overall Study|Lost to Follow-up|0|||
37820362|NCT02573324|69499499|FG000|Overall Study|Study Terminated by Sponsor|107|||
37820363|NCT02573324|69499500|FG001|Overall Study|Study Terminated by Sponsor|89|||
37881801|NCT01016262|69566390|FG005|Double-blind Phase|Adverse Event|0|||
37881802|NCT01016262|69566385|FG000|Double-blind Phase|Lack of Efficacy|1|||
37881803|NCT01016262|69566386|FG001|Double-blind Phase|Lack of Efficacy|0|||
37881804|NCT01016262|69566387|FG002|Double-blind Phase|Lack of Efficacy|5|||
37881805|NCT01016262|69566388|FG003|Double-blind Phase|Lack of Efficacy|0|||
37881806|NCT01016262|69566389|FG004|Double-blind Phase|Lack of Efficacy|0|||
37881807|NCT01016262|69566390|FG005|Double-blind Phase|Lack of Efficacy|0|||
37881808|NCT01016262|69566385|FG000|Double-blind Phase|Disease Progression|0|||
37881809|NCT01016262|69566386|FG001|Double-blind Phase|Disease Progression|1|||
37881810|NCT01016262|69566387|FG002|Double-blind Phase|Disease Progression|2|||
37881811|NCT01016262|69566388|FG003|Double-blind Phase|Disease Progression|0|||
37881812|NCT01016262|69566389|FG004|Double-blind Phase|Disease Progression|0|||
37881813|NCT01016262|69566390|FG005|Double-blind Phase|Disease Progression|0|||
37881814|NCT01016262|69566385|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
37881815|NCT01016262|69566386|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
37881816|NCT01016262|69566387|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
37820364|NCT02573324|69499501|FG002|Overall Study|Study Terminated by Sponsor|2|||
37881817|NCT01016262|69566388|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
37881818|NCT01016262|69566389|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
37984753|NCT00387426|69670704|FG000|Overall Study|Disease Progression|3|||
37984754|NCT00387348|69670711|FG000|Overall Study|Death|1|||
37984755|NCT00387348|69670712|FG001|Overall Study|Death|1|||
37984756|NCT00387348|69670713|FG002|Overall Study|Death|0|||
37984757|NCT00387348|69670711|FG000|Overall Study|Physician Decision|1|||
37984758|NCT00387348|69670712|FG001|Overall Study|Physician Decision|0|||
37881819|NCT01016262|69566390|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
37881820|NCT01016262|69566385|FG000|Open-Label Phase|Adverse Event|0|||
37881821|NCT01016262|69566386|FG001|Open-Label Phase|Adverse Event|0|||
37881822|NCT01016262|69566387|FG002|Open-Label Phase|Adverse Event|0|||
37881823|NCT01016262|69566388|FG003|Open-Label Phase|Adverse Event|1|||
37984759|NCT00387348|69670713|FG002|Overall Study|Physician Decision|1|||
37984760|NCT00387348|69670711|FG000|Overall Study|Withdrawal by Subject|0|||
37984761|NCT00387348|69670712|FG001|Overall Study|Withdrawal by Subject|2|||
37984762|NCT00387348|69670713|FG002|Overall Study|Withdrawal by Subject|2|||
37984763|NCT00387348|69670711|FG000|Overall Study|Adverse Event|1|||
37984764|NCT00387348|69670712|FG001|Overall Study|Adverse Event|0|||
37984765|NCT00387348|69670713|FG002|Overall Study|Adverse Event|1|||
37820365|NCT02573324|69499499|FG000|Overall Study|Death|182|||
37820366|NCT02573324|69499500|FG001|Overall Study|Death|200|||
37881824|NCT01016262|69566389|FG004|Open-Label Phase|Adverse Event|0|||
37881825|NCT01016262|69566390|FG005|Open-Label Phase|Adverse Event|0|||
37984766|NCT00413660|69670733|FG000|Up To Week 12|Adverse Event|1|||
37984767|NCT00413660|69670734|FG001|Up To Week 12|Adverse Event|3|||
37984768|NCT00413660|69670735|FG002|Up To Week 12|Adverse Event|1|||
37984769|NCT00413660|69670736|FG003|Up To Week 12|Adverse Event|4|||
37984770|NCT00413660|69670737|FG004|Up To Week 12|Adverse Event|6|||
37820367|NCT02573324|69499501|FG002|Overall Study|Death|1|||
37820368|NCT02573324|69499499|FG000|Overall Study|Other, Not Specified|20|||
37820369|NCT02573324|69499500|FG001|Overall Study|Other, Not Specified|27|||
37820370|NCT02573324|69499501|FG002|Overall Study|Other, Not Specified|0|||
37820371|NCT02573324|69499499|FG000|Overall Study|Unknown Reason|2|||
37820372|NCT02573324|69499500|FG001|Overall Study|Unknown Reason|0|||
37820373|NCT02573324|69499501|FG002|Overall Study|Unknown Reason|0|||
37820374|NCT02296684|69499517|FG000|Overall Study|Withdrawal by Subject|0|||
37820375|NCT02296684|69499518|FG001|Overall Study|Withdrawal by Subject|1|||
37820376|NCT02296684|69499519|FG002|Overall Study|Withdrawal by Subject|1|||
37820377|NCT02296684|69499517|FG000|Overall Study|Death|2|||
37820378|NCT02296684|69499518|FG001|Overall Study|Death|0|||
37820379|NCT02296684|69499519|FG002|Overall Study|Death|0|||
37820380|NCT02107261|69499528|FG000|Washout: Weakness Back to Baseline|Lost to Follow-up|1|||
37820381|NCT02107261|69499529|FG001|Washout: Weakness Back to Baseline|Lost to Follow-up|0|||
37820382|NCT02107261|69499528|FG000|Cycle 2: Week 12-15|Withdrawal by Subject|0|||
37820383|NCT02107261|69499529|FG001|Cycle 2: Week 12-15|Withdrawal by Subject|1|||
37881826|NCT01016262|69566385|FG000|Open-Label Phase|Lost to Follow-up|0|||
37820384|NCT02014597|69499539|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
37820385|NCT02014597|69499540|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
37881827|NCT01016262|69566386|FG001|Open-Label Phase|Lost to Follow-up|0|||
37881828|NCT01016262|69566387|FG002|Open-Label Phase|Lost to Follow-up|0|||
37881829|NCT01016262|69566388|FG003|Open-Label Phase|Lost to Follow-up|0|||
37881830|NCT01016262|69566389|FG004|Open-Label Phase|Lost to Follow-up|1|||
37984771|NCT00413660|69670738|FG005|Up To Week 12|Adverse Event|4|||
37984772|NCT00413660|69670739|FG006|Up To Week 12|Adverse Event|1|||
37984773|NCT00413660|69670740|FG007|Up To Week 12|Adverse Event|0|||
37984774|NCT00413660|69670741|FG008|Up To Week 12|Adverse Event|0|||
37984775|NCT00413660|69670742|FG009|Up To Week 12|Adverse Event|0|||
37820386|NCT01342367|69499552|FG000|Overall Study|Death|1|||
37820387|NCT01342367|69499553|FG001|Overall Study|Death|0|||
37820388|NCT01342367|69499552|FG000|Overall Study|Withdrawal by Subject|1|||
37820389|NCT01342367|69499553|FG001|Overall Study|Withdrawal by Subject|2|||
37820390|NCT01185171|69499559|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
37820391|NCT01185171|69499559|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
37820392|NCT01185171|69499559|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
37820393|NCT01185171|69499559|FG000|Maintenance|Elevated liver transaminases|3|||
37820394|NCT01185171|69499559|FG000|Maintenance|Rush|2|||
37820395|NCT01185171|69499559|FG000|Maintenance|Diarrhea|1|||
37820396|NCT01185171|69499559|FG000|Maintenance|Xerostomia|1|||
37820397|NCT01185171|69499559|FG000|Maintenance|Nausea|1|||
37820398|NCT01185171|69499559|FG000|Maintenance|Comorbid Illness|2|||
37820399|NCT01185171|69499559|FG000|Maintenance|Withdrawal by Subject|1|||
37820400|NCT01185171|69499559|FG000|Maintenance|Disease Recurrence|1|||
37820401|NCT00896493|69499563|FG000|Overall Study|Early disease relapse|3|||
37820402|NCT01875185|69499578|FG000|Overall Study|study was terminated|52|||
37820403|NCT01875185|69499579|FG001|Overall Study|study was terminated|48|||
37820404|NCT01901432|69499608|FG000|Overall Study|Adverse Event|0|||
37820405|NCT01901432|69499609|FG001|Overall Study|Adverse Event|1|||
37820406|NCT01901432|69499610|FG002|Overall Study|Adverse Event|1|||
37820407|NCT01901432|69499611|FG003|Overall Study|Adverse Event|0|||
37820408|NCT01901432|69499612|FG004|Overall Study|Adverse Event|1|||
37820409|NCT01901432|69499608|FG000|Overall Study|Withdrawal by Subject|0|||
37820410|NCT01901432|69499609|FG001|Overall Study|Withdrawal by Subject|0|||
37820411|NCT01901432|69499610|FG002|Overall Study|Withdrawal by Subject|1|||
37820412|NCT01901432|69499611|FG003|Overall Study|Withdrawal by Subject|0|||
37820413|NCT01901432|69499612|FG004|Overall Study|Withdrawal by Subject|5|||
37820414|NCT01901432|69499608|FG000|Overall Study|Physician Decision|0|||
37820415|NCT01901432|69499609|FG001|Overall Study|Physician Decision|0|||
37820416|NCT01901432|69499610|FG002|Overall Study|Physician Decision|0|||
37820417|NCT01901432|69499611|FG003|Overall Study|Physician Decision|0|||
37820418|NCT01901432|69499612|FG004|Overall Study|Physician Decision|2|||
37820419|NCT01901432|69499608|FG000|Overall Study|Patient decision to stop study drug|0|||
37820420|NCT01901432|69499609|FG001|Overall Study|Patient decision to stop study drug|0|||
37820421|NCT01901432|69499610|FG002|Overall Study|Patient decision to stop study drug|0|||
37820422|NCT01901432|69499611|FG003|Overall Study|Patient decision to stop study drug|0|||
37820423|NCT01901432|69499612|FG004|Overall Study|Patient decision to stop study drug|1|||
37820424|NCT01904279|69499633|FG000|Overall Study|Lack of Efficacy|2|||
37820425|NCT01904279|69499634|FG001|Overall Study|Lack of Efficacy|3|||
37820426|NCT01904279|69499633|FG000|Overall Study|Withdrawal by Subject|1|||
37820427|NCT01904279|69499634|FG001|Overall Study|Withdrawal by Subject|0|||
37820428|NCT01917318|69499643|FG000|First Treatment|Withdrawal by Subject|0|||
37820429|NCT01917318|69499644|FG001|First Treatment|Withdrawal by Subject|1|||
37820430|NCT01923168|69499653|FG000|Overall Study|Protocol Violation|1|||
37820431|NCT01923168|69499654|FG001|Overall Study|Protocol Violation|1|||
37820432|NCT01923168|69499655|FG002|Overall Study|Protocol Violation|0|||
37820433|NCT01923168|69499653|FG000|Overall Study|Subject/guardian decision|14|||
37820434|NCT01923168|69499654|FG001|Overall Study|Subject/guardian decision|14|||
37820435|NCT01923168|69499655|FG002|Overall Study|Subject/guardian decision|4|||
37820436|NCT01923168|69499653|FG000|Overall Study|Adverse Event|12|||
37820437|NCT01923168|69499654|FG001|Overall Study|Adverse Event|12|||
37820438|NCT01923168|69499655|FG002|Overall Study|Adverse Event|0|||
37820439|NCT01923168|69499653|FG000|Overall Study|Physician Decision|6|||
37820440|NCT01923168|69499654|FG001|Overall Study|Physician Decision|9|||
37820441|NCT01923168|69499655|FG002|Overall Study|Physician Decision|5|||
37820442|NCT01923168|69499653|FG000|Overall Study|Progressive disease|4|||
37820443|NCT01923168|69499654|FG001|Overall Study|Progressive disease|3|||
37820444|NCT01923168|69499655|FG002|Overall Study|Progressive disease|7|||
37820445|NCT01923168|69499653|FG000|Overall Study|Death|0|||
37820446|NCT01923168|69499654|FG001|Overall Study|Death|0|||
37820447|NCT01923168|69499655|FG002|Overall Study|Death|1|||
37820448|NCT01931098|69499665|FG000|Overall Study|Withdrawal by Subject|0|||
37820449|NCT01931098|69499666|FG001|Overall Study|Withdrawal by Subject|1|||
37820450|NCT01931098|69499665|FG000|Overall Study|Enrolled in different protocol|0|||
37820451|NCT01931098|69499666|FG001|Overall Study|Enrolled in different protocol|1|||
37820452|NCT01931098|69499665|FG000|Overall Study|Unable to begin trmt:active infection|0|||
37820453|NCT01931098|69499666|FG001|Overall Study|Unable to begin trmt:active infection|1|||
37820454|NCT01931098|69499665|FG000|Overall Study|Refused further treatment|0|||
37820455|NCT01931098|69499666|FG001|Overall Study|Refused further treatment|1|||
37820456|NCT05097716|69499676|FG000|Period 1|Adverse Event|1|||
37820457|NCT05097716|69499676|FG000|Period 1|Close contact with highly-transmissible infection|1|||
37820458|NCT04781647|69499697|FG000|Overall Study|Study terminated by Sponsor|11|||
37820459|NCT04781647|69499698|FG001|Overall Study|Study terminated by Sponsor|9|||
37820460|NCT04781647|69499699|FG002|Overall Study|Study terminated by Sponsor|9|||
37881831|NCT01016262|69566390|FG005|Open-Label Phase|Lost to Follow-up|0|||
37881832|NCT01016262|69566385|FG000|Open-Label Phase|Lack of Efficacy|0|||
37881833|NCT01016262|69566386|FG001|Open-Label Phase|Lack of Efficacy|0|||
37881834|NCT01016262|69566387|FG002|Open-Label Phase|Lack of Efficacy|0|||
37881835|NCT01016262|69566388|FG003|Open-Label Phase|Lack of Efficacy|1|||
37881836|NCT01016262|69566389|FG004|Open-Label Phase|Lack of Efficacy|0|||
37881837|NCT01016262|69566390|FG005|Open-Label Phase|Lack of Efficacy|0|||
37881838|NCT01016262|69566385|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
37881839|NCT01016262|69566386|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
37881840|NCT01016262|69566387|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
37881841|NCT01016262|69566388|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
37881842|NCT01016262|69566389|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
37881843|NCT01016262|69566390|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
37881844|NCT01001910|69566401|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
37881845|NCT01009554|69566407|FG000|Overall Study|Adverse Event|1|||
37881846|NCT01009554|69566408|FG001|Overall Study|Adverse Event|1|||
37984776|NCT00413660|69670743|FG010|Up To Week 12|Adverse Event|0|||
37984777|NCT00413660|69670733|FG000|Up To Week 12|Lack of Efficacy|2|||
37881847|NCT01009554|69566407|FG000|Overall Study|Withdrawal by Subject|1|||
37881848|NCT01009554|69566408|FG001|Overall Study|Withdrawal by Subject|3|||
37881849|NCT01009554|69566407|FG000|Overall Study|Noncompliant with Study Product|0|||
37881850|NCT01009554|69566408|FG001|Overall Study|Noncompliant with Study Product|3|||
37695304|NCT02349295|69171749|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
37695305|NCT02349295|69171750|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
37695306|NCT02349295|69171751|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
37695307|NCT02349295|69171752|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
37695308|NCT02349295|69171753|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
37695309|NCT02349295|69171754|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
37695310|NCT02349295|69171755|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
37881851|NCT01006590|69566416|FG000|Overall Study|Adverse Event|2|||
37881852|NCT01006590|69566417|FG001|Overall Study|Adverse Event|3|||
37881853|NCT01006590|69566416|FG000|Overall Study|Death|1|||
37881854|NCT01006590|69566417|FG001|Overall Study|Death|1|||
37881855|NCT01006590|69566416|FG000|Overall Study|Lost to Follow-up|1|||
37881856|NCT01006590|69566417|FG001|Overall Study|Lost to Follow-up|1|||
37881857|NCT01006590|69566416|FG000|Overall Study|Protocol Violation|1|||
37881858|NCT01006590|69566417|FG001|Overall Study|Protocol Violation|0|||
37881859|NCT01006590|69566416|FG000|Overall Study|Withdrawal by Subject|4|||
37881860|NCT01006590|69566417|FG001|Overall Study|Withdrawal by Subject|2|||
37881861|NCT01006590|69566416|FG000|Overall Study|Study specific discontinuation criteria|16|||
37881862|NCT01006590|69566417|FG001|Overall Study|Study specific discontinuation criteria|23|||
37881863|NCT01006590|69566416|FG000|Overall Study|Other|3|||
37881864|NCT01006590|69566417|FG001|Overall Study|Other|2|||
37881865|NCT01001832|69566425|FG000|Short-term Period|Adverse Event|2|||
37881866|NCT01001832|69566426|FG001|Short-term Period|Adverse Event|3|||
37881867|NCT01001832|69566425|FG000|Long-term Period|Adverse Event|2|||
37881868|NCT01001832|69566426|FG001|Long-term Period|Adverse Event|1|||
37881869|NCT01001832|69566425|FG000|Long-term Period|Withdrawal by Subject|1|||
37881870|NCT01001832|69566426|FG001|Long-term Period|Withdrawal by Subject|0|||
37881871|NCT01001832|69566425|FG000|Long-term Period|Lack of Efficacy|0|||
37881872|NCT01001832|69566426|FG001|Long-term Period|Lack of Efficacy|2|||
37881873|NCT01001832|69566425|FG000|Long-term Period|Other|1|||
37881874|NCT01001832|69566426|FG001|Long-term Period|Other|2|||
37881875|NCT01001832|69566425|FG000|Follow-up Period|Withdrawal by Subject|1|||
37881876|NCT01001832|69566426|FG001|Follow-up Period|Withdrawal by Subject|0|||
37881877|NCT01001832|69566425|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
37881878|NCT01001832|69566426|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
37881879|NCT01001832|69566425|FG000|Follow-up Period|Other|2|||
37881880|NCT01001832|69566426|FG001|Follow-up Period|Other|1|||
37881881|NCT01001598|69566435|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
37881882|NCT01001598|69566435|FG000|Overall Study|Adverse Event|1|||
37881883|NCT01006356|69566439|FG000|Overall Study|Adverse Event|6|||
37881884|NCT01006356|69566439|FG000|Overall Study|Physician Decision|1|||
37881885|NCT01006356|69566439|FG000|Overall Study|Paticipants did not cooperate|6|||
37881886|NCT01006356|69566439|FG000|Overall Study|Withdrawal by Subject|1|||
37881887|NCT01006356|69566439|FG000|Overall Study|Choice by participants|2|||
37881888|NCT01006356|69566439|FG000|Overall Study|Protocol Violation|3|||
37881889|NCT01006356|69566439|FG000|Overall Study|Other|23|||
37881890|NCT01089725|69566448|FG000|Overall Study|Adverse Event|1|||
37881891|NCT01089725|69566449|FG001|Overall Study|Adverse Event|1|||
37984778|NCT00413660|69670734|FG001|Up To Week 12|Lack of Efficacy|0|||
37984779|NCT00413660|69670735|FG002|Up To Week 12|Lack of Efficacy|0|||
37881892|NCT01089725|69566450|FG002|Overall Study|Adverse Event|0|||
37881893|NCT01089725|69566451|FG003|Overall Study|Adverse Event|0|||
37881894|NCT01089725|69566452|FG004|Overall Study|Adverse Event|2|||
37984780|NCT00413660|69670736|FG003|Up To Week 12|Lack of Efficacy|0|||
37881895|NCT01089725|69566448|FG000|Overall Study|Lack of Efficacy|4|||
37881896|NCT01089725|69566449|FG001|Overall Study|Lack of Efficacy|3|||
37881897|NCT01089725|69566450|FG002|Overall Study|Lack of Efficacy|1|||
37881898|NCT01089725|69566451|FG003|Overall Study|Lack of Efficacy|0|||
37881899|NCT01089725|69566452|FG004|Overall Study|Lack of Efficacy|4|||
37881900|NCT01089725|69566448|FG000|Overall Study|Lost to Follow-up|2|||
37881901|NCT01089725|69566449|FG001|Overall Study|Lost to Follow-up|2|||
37881902|NCT01089725|69566450|FG002|Overall Study|Lost to Follow-up|0|||
37881903|NCT01089725|69566451|FG003|Overall Study|Lost to Follow-up|3|||
37881904|NCT01089725|69566452|FG004|Overall Study|Lost to Follow-up|0|||
37881905|NCT01089725|69566448|FG000|Overall Study|Protocol Violation|0|||
37881906|NCT01089725|69566449|FG001|Overall Study|Protocol Violation|0|||
37984781|NCT00413660|69670737|FG004|Up To Week 12|Lack of Efficacy|0|||
37984782|NCT00413660|69670738|FG005|Up To Week 12|Lack of Efficacy|0|||
37984783|NCT00413660|69670739|FG006|Up To Week 12|Lack of Efficacy|5|||
37820461|NCT04781647|69499697|FG000|Overall Study|Withdrawal by Subject|1|||
37820462|NCT04781647|69499698|FG001|Overall Study|Withdrawal by Subject|2|||
37820463|NCT04781647|69499699|FG002|Overall Study|Withdrawal by Subject|0|||
37820464|NCT04781647|69499697|FG000|Overall Study|Adverse Event|0|||
37820465|NCT04781647|69499698|FG001|Overall Study|Adverse Event|1|||
37820466|NCT04781647|69499699|FG002|Overall Study|Adverse Event|1|||
37820467|NCT04781647|69499697|FG000|Overall Study|Protocol Violation|1|||
37820468|NCT04781647|69499698|FG001|Overall Study|Protocol Violation|0|||
37820469|NCT04781647|69499699|FG002|Overall Study|Protocol Violation|0|||
37820470|NCT04781647|69499697|FG000|Overall Study|Pregnancy|0|||
37820471|NCT04781647|69499698|FG001|Overall Study|Pregnancy|0|||
37820472|NCT04781647|69499699|FG002|Overall Study|Pregnancy|1|||
37984784|NCT00413660|69670740|FG007|Up To Week 12|Lack of Efficacy|0|||
37984785|NCT00413660|69670741|FG008|Up To Week 12|Lack of Efficacy|0|||
37820473|NCT04781647|69499697|FG000|Overall Study|Virology rebounded|1|||
37820474|NCT04781647|69499698|FG001|Overall Study|Virology rebounded|0|||
37820475|NCT04781647|69499699|FG002|Overall Study|Virology rebounded|0|||
37820476|NCT04727528|69499711|FG000|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|1|||
37820477|NCT04727528|69499712|FG001|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|0|||
37820478|NCT04727528|69499711|FG000|Open-label Period|Randomized who did not receive treatment|1|||
37820479|NCT04727528|69499712|FG001|Open-label Period|Randomized who did not receive treatment|0|||
37984786|NCT00413660|69670742|FG009|Up To Week 12|Lack of Efficacy|0|||
37984787|NCT00413660|69670743|FG010|Up To Week 12|Lack of Efficacy|0|||
37984788|NCT00413660|69670733|FG000|Up To Week 12|Lost to Follow-up|0|||
37984789|NCT00413660|69670734|FG001|Up To Week 12|Lost to Follow-up|1|||
37984790|NCT00413660|69670735|FG002|Up To Week 12|Lost to Follow-up|0|||
37984791|NCT00413660|69670736|FG003|Up To Week 12|Lost to Follow-up|0|||
37984792|NCT00413660|69670737|FG004|Up To Week 12|Lost to Follow-up|1|||
37984793|NCT00413660|69670738|FG005|Up To Week 12|Lost to Follow-up|0|||
37984794|NCT00413660|69670739|FG006|Up To Week 12|Lost to Follow-up|0|||
37984795|NCT00413660|69670740|FG007|Up To Week 12|Lost to Follow-up|0|||
37984796|NCT00413660|69670741|FG008|Up To Week 12|Lost to Follow-up|0|||
37984797|NCT00413660|69670742|FG009|Up To Week 12|Lost to Follow-up|0|||
37984798|NCT00413660|69670743|FG010|Up To Week 12|Lost to Follow-up|0|||
37984799|NCT00413660|69670733|FG000|Up To Week 12|Withdrawal by Subject|0|||
37984800|NCT00413660|69670734|FG001|Up To Week 12|Withdrawal by Subject|2|||
37984801|NCT00413660|69670735|FG002|Up To Week 12|Withdrawal by Subject|0|||
37984802|NCT00413660|69670736|FG003|Up To Week 12|Withdrawal by Subject|2|||
37984803|NCT00413660|69670737|FG004|Up To Week 12|Withdrawal by Subject|0|||
37984804|NCT00413660|69670738|FG005|Up To Week 12|Withdrawal by Subject|2|||
37984805|NCT00413660|69670739|FG006|Up To Week 12|Withdrawal by Subject|2|||
37820480|NCT04727528|69499711|FG000|Double-blind Treatment Phase|Adverse Event|0|||
37820481|NCT04727528|69499712|FG001|Double-blind Treatment Phase|Adverse Event|1|||
37820482|NCT04727528|69499711|FG000|Double-blind Treatment Phase|Death|0|||
37820483|NCT04727528|69499712|FG001|Double-blind Treatment Phase|Death|1|||
37820484|NCT04727528|69499711|FG000|Double-blind Treatment Phase|Missed doses whilst in hospital|0|||
37881907|NCT01089725|69566450|FG002|Overall Study|Protocol Violation|1|||
37881908|NCT01089725|69566451|FG003|Overall Study|Protocol Violation|1|||
37881909|NCT01089725|69566452|FG004|Overall Study|Protocol Violation|0|||
37881910|NCT01089725|69566448|FG000|Overall Study|Withdrawal by Subject|5|||
37984806|NCT00413660|69670740|FG007|Up To Week 12|Withdrawal by Subject|0|||
37984807|NCT00413660|69670741|FG008|Up To Week 12|Withdrawal by Subject|0|||
37984808|NCT00413660|69670742|FG009|Up To Week 12|Withdrawal by Subject|0|||
37984809|NCT00413660|69670743|FG010|Up To Week 12|Withdrawal by Subject|0|||
37820485|NCT04727528|69499712|FG001|Double-blind Treatment Phase|Missed doses whilst in hospital|1|||
37820486|NCT04727528|69499711|FG000|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|0|||
37820487|NCT04727528|69499712|FG001|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|1|||
37820488|NCT04727528|69499711|FG000|Double-blind Treatment Phase|Physician Decision|0|||
37820489|NCT04727528|69499712|FG001|Double-blind Treatment Phase|Physician Decision|1|||
37820490|NCT04727528|69499711|FG000|Double-blind Treatment Phase|Withdrawal by Subject|1|||
37820491|NCT04727528|69499712|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
37820492|NCT04674189|69499740|FG000|Overall Study|Adverse Event|0|||
37820493|NCT04674189|69499741|FG001|Overall Study|Adverse Event|0|||
37820494|NCT04674189|69499742|FG002|Overall Study|Adverse Event|1|||
37820495|NCT04674189|69499740|FG000|Overall Study|Received Alternative Authorized Vaccine|0|||
37820496|NCT04674189|69499741|FG001|Overall Study|Received Alternative Authorized Vaccine|1|||
37984810|NCT00413660|69670733|FG000|Up To Week 12|Randomized, Not Treated|1|||
37984811|NCT00413660|69670734|FG001|Up To Week 12|Randomized, Not Treated|0|||
37984812|NCT00413660|69670735|FG002|Up To Week 12|Randomized, Not Treated|0|||
37984813|NCT00413660|69670736|FG003|Up To Week 12|Randomized, Not Treated|1|||
37984814|NCT00413660|69670737|FG004|Up To Week 12|Randomized, Not Treated|0|||
37984815|NCT00413660|69670738|FG005|Up To Week 12|Randomized, Not Treated|0|||
37984816|NCT00413660|69670739|FG006|Up To Week 12|Randomized, Not Treated|0|||
37984817|NCT00413660|69670740|FG007|Up To Week 12|Randomized, Not Treated|0|||
37984818|NCT00413660|69670741|FG008|Up To Week 12|Randomized, Not Treated|0|||
37984819|NCT00413660|69670742|FG009|Up To Week 12|Randomized, Not Treated|0|||
37820497|NCT04674189|69499742|FG002|Overall Study|Received Alternative Authorized Vaccine|17|||
37820498|NCT04674189|69499740|FG000|Overall Study|Physician Decision|1|||
37820499|NCT04674189|69499741|FG001|Overall Study|Physician Decision|0|||
37820500|NCT04674189|69499742|FG002|Overall Study|Physician Decision|0|||
37820501|NCT04674189|69499740|FG000|Overall Study|Withdrawal by Participant|83|||
37820502|NCT04674189|69499741|FG001|Overall Study|Withdrawal by Participant|71|||
37820503|NCT04674189|69499742|FG002|Overall Study|Withdrawal by Participant|142|||
37820504|NCT04674189|69499740|FG000|Overall Study|Lost to Follow-up|55|||
37820505|NCT04674189|69499741|FG001|Overall Study|Lost to Follow-up|53|||
37820506|NCT04674189|69499742|FG002|Overall Study|Lost to Follow-up|44|||
37820507|NCT04674189|69499740|FG000|Overall Study|Miscellaneous|27|||
37820508|NCT04674189|69499741|FG001|Overall Study|Miscellaneous|23|||
37820509|NCT04674189|69499742|FG002|Overall Study|Miscellaneous|207|||
37820510|NCT04674189|69499740|FG000|Overall Study|Did Not Receive Treatment|3|||
37820511|NCT04674189|69499741|FG001|Overall Study|Did Not Receive Treatment|1|||
37820512|NCT04674189|69499742|FG002|Overall Study|Did Not Receive Treatment|2|||
37820513|NCT04380857|69499774|FG000|Overall Study|Lost to Follow-up|3|||
37820514|NCT04380857|69499775|FG001|Overall Study|Lost to Follow-up|3|||
37820515|NCT04189588|69499784|FG000|Overall Study|Death|0|||
37820516|NCT04189588|69499785|FG001|Overall Study|Death|1|||
37820517|NCT04189588|69499784|FG000|Overall Study|Lost to Follow-up|0|||
37820518|NCT04189588|69499785|FG001|Overall Study|Lost to Follow-up|1|||
37820519|NCT04162210|69499793|FG000|Overall Study|Lost to Follow-up|4|||
37820520|NCT04162210|69499794|FG001|Overall Study|Lost to Follow-up|1|||
37820521|NCT04162210|69499793|FG000|Overall Study|Withdrawal by Subject|17|||
37820522|NCT04162210|69499794|FG001|Overall Study|Withdrawal by Subject|9|||
37820523|NCT04162210|69499793|FG000|Overall Study|Ongoing|113|||
37820524|NCT04162210|69499794|FG001|Overall Study|Ongoing|59|||
37820525|NCT04010461|69499800|FG000|Overall Study|COVID based withdrawal|5|||
37820526|NCT04010461|69499800|FG000|Overall Study|Withdrawal by Subject|5|||
37820527|NCT04010461|69499800|FG000|Overall Study|Adverse Event|1|||
37820528|NCT04010461|69499800|FG000|Overall Study|No Motor Threshold obtainable|1|||
37820529|NCT04010461|69499800|FG000|Overall Study|Physician Decision|1|||
37820530|NCT03985423|69499809|FG000|Overall Study|Adverse Event|1|||
37820531|NCT03985423|69499809|FG000|Overall Study|Death|2|||
37820532|NCT03985423|69499809|FG000|Overall Study|Physician Decision|1|||
37820533|NCT03985423|69499809|FG000|Overall Study|Withdrawal by Subject|2|||
37820534|NCT03985423|69499809|FG000|Overall Study|Lack of insurance and citizenship|1|||
37984820|NCT00413660|69670743|FG010|Up To Week 12|Randomized, Not Treated|0|||
37820535|NCT03875092|69499815|FG000|Overall Study|Adverse Event|2|||
37820536|NCT03875092|69499816|FG001|Overall Study|Adverse Event|5|||
37820537|NCT03875092|69499815|FG000|Overall Study|Death|28|||
37820538|NCT03875092|69499816|FG001|Overall Study|Death|41|||
37820539|NCT03875092|69499815|FG000|Overall Study|Ongoing in Study|35|||
37820540|NCT03875092|69499816|FG001|Overall Study|Ongoing in Study|14|||
37820541|NCT03634072|69499824|FG000|Overall Study|Early termination of overall study|1|||
37820542|NCT03634072|69499825|FG001|Overall Study|Early termination of overall study|0|||
37820543|NCT03474107|69499835|FG000|Overall Study|Adverse Event|42|||
37820544|NCT03474107|69499836|FG001|Overall Study|Adverse Event|46|||
37820545|NCT03474107|69499835|FG000|Overall Study|Death|2|||
37820546|NCT03474107|69499836|FG001|Overall Study|Death|2|||
37820547|NCT03474107|69499835|FG000|Overall Study|Lost to Follow-up|0|||
37820548|NCT03474107|69499836|FG001|Overall Study|Lost to Follow-up|1|||
37820549|NCT03474107|69499835|FG000|Overall Study|Progressive Disease|177|||
37820550|NCT03474107|69499836|FG001|Overall Study|Progressive Disease|180|||
37820551|NCT03474107|69499835|FG000|Overall Study|Protocol Violation|1|||
37820552|NCT03474107|69499836|FG001|Overall Study|Protocol Violation|1|||
37820553|NCT03474107|69499835|FG000|Overall Study|Withdrawal by Subject|15|||
37820554|NCT03474107|69499836|FG001|Overall Study|Withdrawal by Subject|27|||
37820555|NCT03474107|69499835|FG000|Overall Study|Physician Decision|7|||
37820556|NCT03474107|69499836|FG001|Overall Study|Physician Decision|22|||
37820557|NCT03474107|69499835|FG000|Overall Study|Miscellaneous|1|||
37820558|NCT03474107|69499836|FG001|Overall Study|Miscellaneous|6|||
37820559|NCT03471182|69499845|FG000|Overall Study|Withdrawal by Subject|1|||
37820560|NCT03471182|69499846|FG001|Overall Study|Withdrawal by Subject|1|||
37820561|NCT03471182|69499847|FG002|Overall Study|Withdrawal by Subject|0|||
37820562|NCT03471182|69499845|FG000|Overall Study|Technical failure|2|||
37820563|NCT03471182|69499846|FG001|Overall Study|Technical failure|0|||
37820564|NCT03471182|69499847|FG002|Overall Study|Technical failure|0|||
37820565|NCT03143153|69499881|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
37820566|NCT03143153|69499882|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
37984821|NCT00413660|69670733|FG000|Up To Week 12|Other|3|||
37984822|NCT00413660|69670734|FG001|Up To Week 12|Other|1|||
37984823|NCT00413660|69670735|FG002|Up To Week 12|Other|6|||
37820567|NCT03143153|69499883|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
37820568|NCT03143153|69499881|FG000|Pre-Treatment|Participant withdrew consent|0|||
37984824|NCT00413660|69670736|FG003|Up To Week 12|Other|1|||
37984825|NCT00413660|69670737|FG004|Up To Week 12|Other|2|||
37820569|NCT03143153|69499882|FG001|Pre-Treatment|Participant withdrew consent|1|||
37820570|NCT03143153|69499883|FG002|Pre-Treatment|Participant withdrew consent|12|||
37820571|NCT03143153|69499881|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
37820572|NCT03143153|69499882|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
37820573|NCT03143153|69499883|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
37820574|NCT03143153|69499881|FG000|Pre-Treatment|Other Reasons|1|||
37820575|NCT03143153|69499882|FG001|Pre-Treatment|Other Reasons|2|||
37820576|NCT03143153|69499883|FG002|Pre-Treatment|Other Reasons|1|||
37820577|NCT03143153|69499881|FG000|Pre-Treatment|Disease Progression|1|||
37820578|NCT03143153|69499882|FG001|Pre-Treatment|Disease Progression|1|||
37820579|NCT03143153|69499883|FG002|Pre-Treatment|Disease Progression|2|||
37820580|NCT03143153|69499881|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
37984826|NCT00413660|69670738|FG005|Up To Week 12|Other|4|||
37984827|NCT00413660|69670739|FG006|Up To Week 12|Other|3|||
37984828|NCT00413660|69670740|FG007|Up To Week 12|Other|0|||
37984829|NCT00413660|69670741|FG008|Up To Week 12|Other|0|||
37984830|NCT00413660|69670742|FG009|Up To Week 12|Other|0|||
37984831|NCT00413660|69670743|FG010|Up To Week 12|Other|0|||
37984832|NCT00413660|69670733|FG000|Post Week 12|Adverse Event|2|||
37820581|NCT03143153|69499882|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
37820582|NCT03143153|69499883|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
37820583|NCT03143153|69499881|FG000|Treatment|Disease progression|174|||
37820584|NCT03143153|69499882|FG001|Treatment|Disease progression|184|||
37820585|NCT03143153|69499883|FG002|Treatment|Disease progression|193|||
37820586|NCT03143153|69499881|FG000|Treatment|Study drug toxicity|59|||
37820587|NCT03143153|69499882|FG001|Treatment|Study drug toxicity|33|||
37820588|NCT03143153|69499883|FG002|Treatment|Study drug toxicity|40|||
37820589|NCT03143153|69499881|FG000|Treatment|Death|5|||
37820590|NCT03143153|69499882|FG001|Treatment|Death|3|||
37820591|NCT03143153|69499883|FG002|Treatment|Death|4|||
37820592|NCT03143153|69499881|FG000|Treatment|Adverse event unrelated to study drug|19|||
37984833|NCT00413660|69670734|FG001|Post Week 12|Adverse Event|0|||
37984834|NCT00413660|69670735|FG002|Post Week 12|Adverse Event|2|||
37984835|NCT00413660|69670736|FG003|Post Week 12|Adverse Event|1|||
37984836|NCT00413660|69670737|FG004|Post Week 12|Adverse Event|4|||
37820593|NCT03143153|69499882|FG001|Treatment|Adverse event unrelated to study drug|28|||
37820594|NCT03143153|69499883|FG002|Treatment|Adverse event unrelated to study drug|12|||
37820595|NCT03143153|69499881|FG000|Treatment|Participant request to discontinue study treatment|13|||
37820596|NCT03143153|69499882|FG001|Treatment|Participant request to discontinue study treatment|15|||
37820597|NCT03143153|69499883|FG002|Treatment|Participant request to discontinue study treatment|20|||
37820598|NCT03143153|69499881|FG000|Treatment|Participant withdrew consent|3|||
37820599|NCT03143153|69499882|FG001|Treatment|Participant withdrew consent|4|||
37820600|NCT03143153|69499883|FG002|Treatment|Participant withdrew consent|12|||
37820601|NCT03143153|69499881|FG000|Treatment|Pregnancy|1|||
37820602|NCT03143153|69499882|FG001|Treatment|Pregnancy|0|||
37820603|NCT03143153|69499883|FG002|Treatment|Pregnancy|0|||
37820604|NCT03143153|69499881|FG000|Treatment|Maximum clinical benefit|1|||
37820605|NCT03143153|69499882|FG001|Treatment|Maximum clinical benefit|3|||
37820606|NCT03143153|69499883|FG002|Treatment|Maximum clinical benefit|4|||
37820607|NCT03143153|69499881|FG000|Treatment|Completed treatment as per Protocol|13|||
37820608|NCT03143153|69499882|FG001|Treatment|Completed treatment as per Protocol|8|||
37820609|NCT03143153|69499883|FG002|Treatment|Completed treatment as per Protocol|0|||
37820610|NCT03143153|69499881|FG000|Treatment|Other reasons|12|||
37820611|NCT03143153|69499882|FG001|Treatment|Other reasons|7|||
37820612|NCT03143153|69499883|FG002|Treatment|Other reasons|15|||
37820613|NCT03143153|69499881|FG000|Treatment|Not reported|1|||
37820614|NCT03143153|69499882|FG001|Treatment|Not reported|0|||
37984837|NCT00413660|69670738|FG005|Post Week 12|Adverse Event|2|||
37984838|NCT00413660|69670739|FG006|Post Week 12|Adverse Event|2|||
37984839|NCT00413660|69670740|FG007|Post Week 12|Adverse Event|0|||
37984840|NCT00413660|69670741|FG008|Post Week 12|Adverse Event|0|||
37984841|NCT00413660|69670742|FG009|Post Week 12|Adverse Event|0|||
37984842|NCT00413660|69670743|FG010|Post Week 12|Adverse Event|0|||
37984843|NCT00413660|69670733|FG000|Post Week 12|Lack of Efficacy|0|||
37984844|NCT00413660|69670734|FG001|Post Week 12|Lack of Efficacy|0|||
37984845|NCT00413660|69670735|FG002|Post Week 12|Lack of Efficacy|1|||
37984846|NCT00413660|69670736|FG003|Post Week 12|Lack of Efficacy|0|||
37984847|NCT00413660|69670737|FG004|Post Week 12|Lack of Efficacy|0|||
37984848|NCT00413660|69670738|FG005|Post Week 12|Lack of Efficacy|0|||
37984849|NCT00413660|69670739|FG006|Post Week 12|Lack of Efficacy|0|||
37984850|NCT00413660|69670740|FG007|Post Week 12|Lack of Efficacy|0|||
37984851|NCT00413660|69670741|FG008|Post Week 12|Lack of Efficacy|0|||
37984852|NCT00413660|69670742|FG009|Post Week 12|Lack of Efficacy|1|||
37984853|NCT00413660|69670743|FG010|Post Week 12|Lack of Efficacy|0|||
37984854|NCT00413660|69670733|FG000|Post Week 12|Lost to Follow-up|0|||
37984855|NCT00413660|69670734|FG001|Post Week 12|Lost to Follow-up|1|||
37984856|NCT00413660|69670735|FG002|Post Week 12|Lost to Follow-up|1|||
37984857|NCT00413660|69670736|FG003|Post Week 12|Lost to Follow-up|0|||
37820615|NCT03143153|69499883|FG002|Treatment|Not reported|0|||
37820616|NCT03051659|69499897|FG000|Treatment Period|Withdrawal by Subject|0|||
37820617|NCT03051659|69499898|FG001|Treatment Period|Withdrawal by Subject|2|||
37820618|NCT03051659|69499897|FG000|Survival Follow-up|Lost to Follow-up|23|||
37820619|NCT03051659|69499898|FG001|Survival Follow-up|Lost to Follow-up|22|||
37820620|NCT02975882|69499908|FG000|Overall Study|Adverse Event|1|||
37820621|NCT02975882|69499909|FG001|Overall Study|Adverse Event|2|||
37820622|NCT02975882|69499910|FG002|Overall Study|Adverse Event|1|||
37820623|NCT02975882|69499911|FG003|Overall Study|Adverse Event|1|||
37820624|NCT02975882|69499908|FG000|Overall Study|Death|0|||
37820625|NCT02975882|69499909|FG001|Overall Study|Death|1|||
37820626|NCT02975882|69499910|FG002|Overall Study|Death|0|||
37820627|NCT02975882|69499911|FG003|Overall Study|Death|0|||
37820628|NCT02975882|69499908|FG000|Overall Study|Lack of Efficacy|3|||
37820629|NCT02975882|69499909|FG001|Overall Study|Lack of Efficacy|7|||
37820630|NCT02975882|69499910|FG002|Overall Study|Lack of Efficacy|4|||
37820631|NCT02975882|69499911|FG003|Overall Study|Lack of Efficacy|3|||
37820632|NCT02975882|69499908|FG000|Overall Study|Physician Decision|0|||
37820633|NCT02975882|69499909|FG001|Overall Study|Physician Decision|2|||
37820634|NCT02975882|69499910|FG002|Overall Study|Physician Decision|4|||
37820635|NCT02975882|69499911|FG003|Overall Study|Physician Decision|2|||
37820636|NCT02975882|69499908|FG000|Overall Study|Ineligible|0|||
37984858|NCT00413660|69670737|FG004|Post Week 12|Lost to Follow-up|0|||
37984859|NCT00413660|69670738|FG005|Post Week 12|Lost to Follow-up|0|||
37984860|NCT00413660|69670739|FG006|Post Week 12|Lost to Follow-up|0|||
37984861|NCT00413660|69670740|FG007|Post Week 12|Lost to Follow-up|0|||
37820637|NCT02975882|69499909|FG001|Overall Study|Ineligible|1|||
37820638|NCT02975882|69499910|FG002|Overall Study|Ineligible|0|||
37820639|NCT02975882|69499911|FG003|Overall Study|Ineligible|0|||
37820640|NCT02908672|69499923|FG000|Overall Study|Death|112|||
37820641|NCT02908672|69499924|FG001|Overall Study|Death|93|||
37984862|NCT00413660|69670741|FG008|Post Week 12|Lost to Follow-up|0|||
37984863|NCT00413660|69670742|FG009|Post Week 12|Lost to Follow-up|0|||
37984864|NCT00413660|69670743|FG010|Post Week 12|Lost to Follow-up|0|||
37984865|NCT00413660|69670733|FG000|Post Week 12|Withdrawal by Subject|0|||
37820642|NCT02908672|69499923|FG000|Overall Study|Lost to Follow-up|3|||
37820643|NCT02908672|69499924|FG001|Overall Study|Lost to Follow-up|3|||
37820644|NCT02908672|69499923|FG000|Overall Study|Other|2|||
37820645|NCT02908672|69499924|FG001|Overall Study|Other|0|||
37820646|NCT02908672|69499923|FG000|Overall Study|Protocol Violation|1|||
37820647|NCT02908672|69499924|FG001|Overall Study|Protocol Violation|1|||
37820648|NCT02908672|69499923|FG000|Overall Study|Withdrawal by Subject|13|||
37820649|NCT02908672|69499924|FG001|Overall Study|Withdrawal by Subject|18|||
37820650|NCT02908672|69499923|FG000|Overall Study|Study is ongoing|124|||
37820651|NCT02908672|69499924|FG001|Overall Study|Study is ongoing|141|||
37820652|NCT02908672|69499923|FG000|Overall Study|Discontinued the study during run-in|3|||
37820653|NCT02908672|69499924|FG001|Overall Study|Discontinued the study during run-in|0|||
37820654|NCT02775435|69499932|FG000|Overall Study|Adverse Event|48|||
37820655|NCT02775435|69499933|FG001|Overall Study|Adverse Event|25|||
37820656|NCT02775435|69499932|FG000|Overall Study|Lost to Follow-up|0|||
37820657|NCT02775435|69499933|FG001|Overall Study|Lost to Follow-up|2|||
37820658|NCT02775435|69499932|FG000|Overall Study|Physician Decision|5|||
37820659|NCT02775435|69499933|FG001|Overall Study|Physician Decision|6|||
37820660|NCT02775435|69499932|FG000|Overall Study|Withdrawal by Subject|5|||
37820661|NCT02775435|69499933|FG001|Overall Study|Withdrawal by Subject|9|||
37820662|NCT02775435|69499932|FG000|Overall Study|Progressive Disease|86|||
37820663|NCT02775435|69499933|FG001|Overall Study|Progressive Disease|140|||
37820664|NCT02775435|69499932|FG000|Overall Study|Clinical Progression|13|||
37820665|NCT02775435|69499933|FG001|Overall Study|Clinical Progression|26|||
37820666|NCT02775435|69499932|FG000|Overall Study|Ongoing in Study|121|||
37820667|NCT02775435|69499933|FG001|Overall Study|Ongoing in Study|72|||
37820668|NCT02775435|69499932|FG000|Overall Study|Not Treated|0|||
37820669|NCT02775435|69499933|FG001|Overall Study|Not Treated|1|||
37820670|NCT02685826|69499942|FG000|Overall Study|Adverse Event|2|||
37820671|NCT02685826|69499943|FG001|Overall Study|Adverse Event|0|||
37820672|NCT02685826|69499944|FG002|Overall Study|Adverse Event|1|||
37820673|NCT02685826|69499942|FG000|Overall Study|Progressive Disease|2|||
37820674|NCT02685826|69499943|FG001|Overall Study|Progressive Disease|1|||
37820675|NCT02685826|69499944|FG002|Overall Study|Progressive Disease|0|||
37820676|NCT02685826|69499942|FG000|Overall Study|Withdrawal by Subject|2|||
37820677|NCT02685826|69499943|FG001|Overall Study|Withdrawal by Subject|0|||
37820678|NCT02685826|69499944|FG002|Overall Study|Withdrawal by Subject|0|||
37820679|NCT02685826|69499942|FG000|Overall Study|Full Clinical Hold by FDA|19|||
37820680|NCT02685826|69499943|FG001|Overall Study|Full Clinical Hold by FDA|9|||
37820681|NCT02685826|69499944|FG002|Overall Study|Full Clinical Hold by FDA|20|||
37820682|NCT01177683|69499962|FG000|Study Treatment|Disease Progressions during treatment|2|||
37820683|NCT01177683|69499963|FG001|Study Treatment|Disease Progressions during treatment|0|||
37820684|NCT01177683|69499964|FG002|Study Treatment|Disease Progressions during treatment|3|||
37820685|NCT01177683|69499962|FG000|Study Treatment|Adverse Event|0|||
37820686|NCT01177683|69499963|FG001|Study Treatment|Adverse Event|1|||
37820687|NCT01177683|69499964|FG002|Study Treatment|Adverse Event|12|||
37820688|NCT01177683|69499962|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
37820689|NCT01177683|69499963|FG001|Study Treatment|Patient Withdrawal After Therapy Start|2|||
37820690|NCT01177683|69499964|FG002|Study Treatment|Patient Withdrawal After Therapy Start|1|||
37984866|NCT00413660|69670734|FG001|Post Week 12|Withdrawal by Subject|1|||
37820691|NCT01177683|69499962|FG000|Study Treatment|Alternative therapy|0|||
37820692|NCT01177683|69499963|FG001|Study Treatment|Alternative therapy|0|||
37820693|NCT01177683|69499964|FG002|Study Treatment|Alternative therapy|4|||
37820694|NCT01177683|69499962|FG000|Study Treatment|Physician Decision|1|||
37820695|NCT01177683|69499963|FG001|Study Treatment|Physician Decision|0|||
37820696|NCT01177683|69499964|FG002|Study Treatment|Physician Decision|1|||
37820697|NCT01177683|69499962|FG000|Study Treatment|Patient withdrawal before therapy start|0|||
37820698|NCT01177683|69499963|FG001|Study Treatment|Patient withdrawal before therapy start|0|||
37820699|NCT01177683|69499964|FG002|Study Treatment|Patient withdrawal before therapy start|1|||
37820700|NCT01177683|69499962|FG000|Study Treatment|Symptomatic Deterioration|0|||
37820701|NCT01177683|69499963|FG001|Study Treatment|Symptomatic Deterioration|0|||
37820702|NCT01177683|69499964|FG002|Study Treatment|Symptomatic Deterioration|1|||
37820703|NCT01177683|69499962|FG000|Study Treatment|Subject came off study without receiving any treatment.|0|||
37984867|NCT00413660|69670735|FG002|Post Week 12|Withdrawal by Subject|1|||
37984868|NCT00413660|69670736|FG003|Post Week 12|Withdrawal by Subject|0|||
37984869|NCT00413660|69670737|FG004|Post Week 12|Withdrawal by Subject|1|||
37984870|NCT00413660|69670738|FG005|Post Week 12|Withdrawal by Subject|0|||
37984871|NCT00413660|69670739|FG006|Post Week 12|Withdrawal by Subject|0|||
37984872|NCT00413660|69670740|FG007|Post Week 12|Withdrawal by Subject|0|||
37984873|NCT00413660|69670741|FG008|Post Week 12|Withdrawal by Subject|0|||
37984874|NCT00413660|69670742|FG009|Post Week 12|Withdrawal by Subject|0|||
37984875|NCT00413660|69670743|FG010|Post Week 12|Withdrawal by Subject|1|||
37984876|NCT00413660|69670733|FG000|Post Week 12|Other|1|||
37984877|NCT00413660|69670734|FG001|Post Week 12|Other|2|||
37984878|NCT00413660|69670735|FG002|Post Week 12|Other|3|||
37984879|NCT00413660|69670736|FG003|Post Week 12|Other|0|||
37984880|NCT00413660|69670737|FG004|Post Week 12|Other|1|||
37984881|NCT00413660|69670738|FG005|Post Week 12|Other|1|||
37984882|NCT00413660|69670739|FG006|Post Week 12|Other|1|||
37984883|NCT00413660|69670740|FG007|Post Week 12|Other|0|||
37984884|NCT00413660|69670741|FG008|Post Week 12|Other|0|||
37984885|NCT00413660|69670742|FG009|Post Week 12|Other|0|||
37984886|NCT00413660|69670743|FG010|Post Week 12|Other|0|||
37984887|NCT00431834|69670777|FG000|Overall Study|Withdrawal by Subject|7|||
37984888|NCT00431834|69670777|FG000|Overall Study|Death|3|||
37984889|NCT00431834|69670777|FG000|Overall Study|Missed Endpoint Visit|2|||
37984890|NCT00431834|69670777|FG000|Overall Study|Lost to Follow-up|1|||
37984891|NCT00431444|69670786|FG000|Overall Study|Protocol Violation|1|||
37984892|NCT00431444|69670787|FG001|Overall Study|Protocol Violation|4|||
37984893|NCT00431444|69670786|FG000|Overall Study|Adverse Event|2|||
37984894|NCT00431444|69670787|FG001|Overall Study|Adverse Event|1|||
37984895|NCT00431444|69670786|FG000|Overall Study|Withdrawal by Subject|1|||
37984896|NCT00431444|69670787|FG001|Overall Study|Withdrawal by Subject|1|||
37984897|NCT00431444|69670786|FG000|Overall Study|Lost to Follow-up|1|||
37984898|NCT00431444|69670787|FG001|Overall Study|Lost to Follow-up|0|||
37984899|NCT00431444|69670786|FG000|Overall Study|Administrative Problems|0|||
37984900|NCT00431444|69670787|FG001|Overall Study|Administrative Problems|1|||
37984901|NCT00430352|69670793|FG000|Overall Study|Disease progression|58|||
37984902|NCT00430352|69670793|FG000|Overall Study|Withdrawal by Subject|11|||
37984903|NCT00430352|69670793|FG000|Overall Study|Adverse Event|16|||
37984904|NCT00430352|69670793|FG000|Overall Study|Death|5|||
37984905|NCT00430352|69670793|FG000|Overall Study|Other|48|||
37984906|NCT00287469|69670799|FG000|Overall Study|serious adverse event|1|||
37984907|NCT00287469|69670800|FG001|Overall Study|serious adverse event|6|||
37984908|NCT00287469|69670799|FG000|Overall Study|Adverse Event|1|||
37984909|NCT00287469|69670800|FG001|Overall Study|Adverse Event|1|||
37984910|NCT00287469|69670799|FG000|Overall Study|moved from area|144|||
37984911|NCT00287469|69670800|FG001|Overall Study|moved from area|138|||
37984912|NCT00287469|69670799|FG000|Overall Study|Lost to Follow-up|74|||
37820704|NCT01177683|69499963|FG001|Study Treatment|Subject came off study without receiving any treatment.|0|||
37820705|NCT01177683|69499964|FG002|Study Treatment|Subject came off study without receiving any treatment.|1|||
37820706|NCT01177683|69499962|FG000|Follow up|Patient lost to follow up|0|||
37984913|NCT00287469|69670800|FG001|Overall Study|Lost to Follow-up|69|||
37984914|NCT00429572|69670808|FG000|Overall Study|Disease progression|1|||
37984915|NCT00287079|69670814|FG000|Overall Study|Qualifying relapse|12|||
37820707|NCT01177683|69499963|FG001|Follow up|Patient lost to follow up|0|||
37820708|NCT01177683|69499964|FG002|Follow up|Patient lost to follow up|2|||
37820709|NCT01177683|69499962|FG000|Follow up|Death|2|||
37820710|NCT01177683|69499963|FG001|Follow up|Death|1|||
37984916|NCT00287079|69670815|FG001|Overall Study|Qualifying relapse|1|||
37984917|NCT00287079|69670814|FG000|Overall Study|Non-qualifying relapse|1|||
37984918|NCT00287079|69670815|FG001|Overall Study|Non-qualifying relapse|0|||
37984919|NCT00287079|69670814|FG000|Overall Study|Adverse Event|5|||
37984920|NCT00287079|69670815|FG001|Overall Study|Adverse Event|0|||
37984921|NCT00287079|69670814|FG000|Overall Study|Protocol Violation|1|||
37820711|NCT01177683|69499964|FG002|Follow up|Death|7|||
37984922|NCT00287079|69670815|FG001|Overall Study|Protocol Violation|0|||
37984923|NCT00287079|69670814|FG000|Overall Study|Other|3|||
37984924|NCT00287079|69670815|FG001|Overall Study|Other|0|||
37984925|NCT00429494|69670821|FG000|Overall Study|Withdrawal by Subject|9|||
37984926|NCT00429494|69670821|FG000|Overall Study|Death|6|||
37984927|NCT00429416|69670825|FG000|Overall Study|Death|1|||
37984928|NCT00429182|69670829|FG000|Overall Study|Not evaluable, Disease Progression|2|||
37984929|NCT00429182|69670829|FG000|Overall Study|Not eligible|5|||
37984930|NCT00429104|69670833|FG000|Overall Study|Protocol Violation|1|||
37984931|NCT00429026|69670837|FG000|Overall Study|Inevaluable for response.|40|||
37984932|NCT00301821|69670841|FG000|Overall Study|Ineligible|25|||
37984933|NCT00301821|69670841|FG000|Overall Study|Cancel|1|||
37695311|NCT02349295|69171756|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
37820712|NCT01177683|69499962|FG000|Follow up|Study closed by Sponsor due slow enrollment.|1|||
37820713|NCT01177683|69499963|FG001|Follow up|Study closed by Sponsor due slow enrollment.|2|||
37820714|NCT01177683|69499964|FG002|Follow up|Study closed by Sponsor due slow enrollment.|15|||
37820715|NCT01084252|69499989|FG000|Phase 1 (120 Weeks)|Adverse Event|0|||
37820716|NCT01084252|69499990|FG001|Phase 1 (120 Weeks)|Adverse Event|0|||
37820717|NCT01084252|69499991|FG002|Phase 1 (120 Weeks)|Adverse Event|1|||
37820718|NCT01084252|69499992|FG003|Phase 1 (120 Weeks)|Adverse Event|1|||
37820719|NCT01084252|69499993|FG004|Phase 1 (120 Weeks)|Adverse Event|1|||
37820720|NCT01084252|69499994|FG005|Phase 1 (120 Weeks)|Adverse Event|0|||
37820721|NCT01084252|69499995|FG006|Phase 1 (120 Weeks)|Adverse Event|1|||
37820722|NCT01084252|69499996|FG007|Phase 1 (120 Weeks)|Adverse Event|0|||
37820723|NCT01084252|69499997|FG008|Phase 1 (120 Weeks)|Adverse Event|0|||
37820724|NCT01084252|69499998|FG009|Phase 1 (120 Weeks)|Adverse Event|0|||
37820725|NCT01084252|69499999|FG010|Phase 1 (120 Weeks)|Adverse Event|0|||
37820726|NCT01084252|69500000|FG011|Phase 1 (120 Weeks)|Adverse Event|0|||
37820727|NCT01084252|69500001|FG012|Phase 1 (120 Weeks)|Adverse Event|0|||
37820728|NCT01084252|69500002|FG013|Phase 1 (120 Weeks)|Adverse Event|0|||
37820729|NCT01084252|69499989|FG000|Phase 1 (120 Weeks)|Progressive disease|15|||
37820730|NCT01084252|69499990|FG001|Phase 1 (120 Weeks)|Progressive disease|5|||
37820731|NCT01084252|69499991|FG002|Phase 1 (120 Weeks)|Progressive disease|2|||
37820732|NCT01084252|69499992|FG003|Phase 1 (120 Weeks)|Progressive disease|22|||
37820733|NCT01084252|69499993|FG004|Phase 1 (120 Weeks)|Progressive disease|16|||
37820734|NCT01084252|69499994|FG005|Phase 1 (120 Weeks)|Progressive disease|6|||
37820735|NCT01084252|69499995|FG006|Phase 1 (120 Weeks)|Progressive disease|5|||
37820736|NCT01084252|69499996|FG007|Phase 1 (120 Weeks)|Progressive disease|6|||
37820737|NCT01084252|69499997|FG008|Phase 1 (120 Weeks)|Progressive disease|0|||
37820738|NCT01084252|69499998|FG009|Phase 1 (120 Weeks)|Progressive disease|0|||
37820739|NCT01084252|69499999|FG010|Phase 1 (120 Weeks)|Progressive disease|0|||
37820740|NCT01084252|69500000|FG011|Phase 1 (120 Weeks)|Progressive disease|0|||
37820741|NCT01084252|69500001|FG012|Phase 1 (120 Weeks)|Progressive disease|0|||
37820742|NCT01084252|69500002|FG013|Phase 1 (120 Weeks)|Progressive disease|0|||
37820743|NCT01084252|69499989|FG000|Phase 1 (120 Weeks)|Other than specified above|1|||
37820744|NCT01084252|69499990|FG001|Phase 1 (120 Weeks)|Other than specified above|1|||
37820745|NCT01084252|69499991|FG002|Phase 1 (120 Weeks)|Other than specified above|0|||
37820746|NCT01084252|69499992|FG003|Phase 1 (120 Weeks)|Other than specified above|3|||
37820747|NCT01084252|69499993|FG004|Phase 1 (120 Weeks)|Other than specified above|1|||
37820748|NCT01084252|69499994|FG005|Phase 1 (120 Weeks)|Other than specified above|0|||
37820749|NCT01084252|69499995|FG006|Phase 1 (120 Weeks)|Other than specified above|1|||
37820750|NCT01084252|69499996|FG007|Phase 1 (120 Weeks)|Other than specified above|1|||
37820751|NCT01084252|69499997|FG008|Phase 1 (120 Weeks)|Other than specified above|0|||
37820752|NCT01084252|69499998|FG009|Phase 1 (120 Weeks)|Other than specified above|0|||
37820753|NCT01084252|69499999|FG010|Phase 1 (120 Weeks)|Other than specified above|0|||
37820754|NCT01084252|69500000|FG011|Phase 1 (120 Weeks)|Other than specified above|0|||
37820755|NCT01084252|69500001|FG012|Phase 1 (120 Weeks)|Other than specified above|0|||
37820756|NCT01084252|69500002|FG013|Phase 1 (120 Weeks)|Other than specified above|0|||
37820757|NCT01084252|69499989|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
37820758|NCT01084252|69499990|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
37820759|NCT01084252|69499991|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
37820760|NCT01084252|69499992|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
37984934|NCT00372996|69670847|FG000|Overall Study|Death|11|||
37820761|NCT01084252|69499993|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
37984935|NCT00372996|69670848|FG001|Overall Study|Death|4|||
37984936|NCT00372996|69670849|FG002|Overall Study|Death|8|||
37820762|NCT01084252|69499994|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
37820763|NCT01084252|69499995|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
37881911|NCT01089725|69566449|FG001|Overall Study|Withdrawal by Subject|5|||
37984937|NCT00372996|69670850|FG003|Overall Study|Death|7|||
37984938|NCT00372996|69670847|FG000|Overall Study|Lost to Follow-up|0|||
37820764|NCT01084252|69499996|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
37820765|NCT01084252|69499997|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
37820766|NCT01084252|69499998|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|2|||
37820767|NCT01084252|69499999|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|2|||
37820768|NCT01084252|69500000|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|1|||
37820769|NCT01084252|69500001|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
37820770|NCT01084252|69500002|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
37820771|NCT01084252|69499989|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
37820772|NCT01084252|69499990|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
37820773|NCT01084252|69499991|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
37820774|NCT01084252|69499992|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
37820775|NCT01084252|69499993|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
37820776|NCT01084252|69499994|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
37820777|NCT01084252|69499995|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
37820778|NCT01084252|69499996|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
37820779|NCT01084252|69499997|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|20|||
37820780|NCT01084252|69499998|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|18|||
37820781|NCT01084252|69499999|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|17|||
37820782|NCT01084252|69500000|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|19|||
37984939|NCT00372996|69670848|FG001|Overall Study|Lost to Follow-up|2|||
37984940|NCT00372996|69670849|FG002|Overall Study|Lost to Follow-up|0|||
37984941|NCT00372996|69670850|FG003|Overall Study|Lost to Follow-up|1|||
37984942|NCT00372996|69670847|FG000|Overall Study|Withdrawal by Subject|12|||
37984943|NCT00372996|69670848|FG001|Overall Study|Withdrawal by Subject|6|||
37695312|NCT02349295|69171757|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
37695313|NCT02349295|69171758|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
37695314|NCT02349295|69171759|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
37695315|NCT02349295|69171760|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
37695316|NCT02349295|69171761|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
37695317|NCT02349295|69171762|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
37695318|NCT02349295|69171749|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
37695319|NCT02349295|69171750|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
37695320|NCT02349295|69171751|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
37695321|NCT02349295|69171752|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
37695322|NCT02349295|69171753|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
37695323|NCT02349295|69171754|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
37695324|NCT02349295|69171755|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
37695325|NCT02349295|69171756|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
37984944|NCT00372996|69670849|FG002|Overall Study|Withdrawal by Subject|9|||
37984945|NCT00372996|69670850|FG003|Overall Study|Withdrawal by Subject|5|||
37984946|NCT00372996|69670847|FG000|Overall Study|Study Terminated by Sponsor|4|||
37984947|NCT00372996|69670848|FG001|Overall Study|Study Terminated by Sponsor|0|||
37984948|NCT00372996|69670849|FG002|Overall Study|Study Terminated by Sponsor|4|||
37984949|NCT00372996|69670850|FG003|Overall Study|Study Terminated by Sponsor|0|||
37984950|NCT00372996|69670847|FG000|Overall Study|Other|10|||
37984951|NCT00372996|69670848|FG001|Overall Study|Other|2|||
37984952|NCT00372996|69670849|FG002|Overall Study|Other|7|||
37984953|NCT00372996|69670850|FG003|Overall Study|Other|7|||
37984954|NCT00399516|69670860|FG000|Overall Study|Lost to Follow-up|2|||
37984955|NCT00399360|69670868|FG000|Overall Study|Lost to Follow-up|2|||
37984956|NCT00399360|69670869|FG001|Overall Study|Lost to Follow-up|1|||
37984957|NCT00399360|69670870|FG002|Overall Study|Lost to Follow-up|2|||
37984958|NCT00399360|69670871|FG003|Overall Study|Lost to Follow-up|4|||
37984959|NCT00399360|69670868|FG000|Overall Study|Adverse Event|0|||
37984960|NCT00399360|69670869|FG001|Overall Study|Adverse Event|0|||
37984961|NCT00399360|69670870|FG002|Overall Study|Adverse Event|1|||
37984962|NCT00399360|69670871|FG003|Overall Study|Adverse Event|0|||
37695326|NCT02349295|69171757|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
37695327|NCT02349295|69171758|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
37695328|NCT02349295|69171759|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
37695329|NCT02349295|69171760|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
37695330|NCT02349295|69171761|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
37695331|NCT02349295|69171762|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
37984963|NCT00399360|69670868|FG000|Overall Study|Withdrawal by Subject|0|||
37984964|NCT00399360|69670869|FG001|Overall Study|Withdrawal by Subject|2|||
37695332|NCT02349295|69171749|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
37695333|NCT02349295|69171750|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
37984965|NCT00399360|69670870|FG002|Overall Study|Withdrawal by Subject|0|||
37984966|NCT00399360|69670871|FG003|Overall Study|Withdrawal by Subject|2|||
37695334|NCT02349295|69171751|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
37695335|NCT02349295|69171752|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
37695336|NCT02349295|69171753|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
37695337|NCT02349295|69171754|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
37695338|NCT02349295|69171755|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
37695339|NCT02349295|69171756|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
37695340|NCT02349295|69171757|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
37695341|NCT02349295|69171758|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
37695342|NCT02349295|69171759|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
37695343|NCT02349295|69171760|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
37695344|NCT02349295|69171761|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
37695345|NCT02349295|69171762|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
37695346|NCT02349295|69171749|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
37695347|NCT02349295|69171750|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
37695348|NCT02349295|69171751|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
37695349|NCT02349295|69171752|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
37695350|NCT02349295|69171753|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
37695351|NCT02349295|69171754|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
37695352|NCT02349295|69171755|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
37695353|NCT02349295|69171756|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
37695354|NCT02349295|69171757|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
37695355|NCT02349295|69171758|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
37695356|NCT02349295|69171759|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
37695357|NCT02349295|69171760|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
37695358|NCT02349295|69171761|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
37695359|NCT02349295|69171762|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
37695360|NCT02349295|69171749|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
37695361|NCT02349295|69171750|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
37695362|NCT02349295|69171751|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
37695363|NCT02349295|69171752|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
37695364|NCT02349295|69171753|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
37695365|NCT02349295|69171754|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
37695366|NCT02349295|69171755|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
37695367|NCT02349295|69171756|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
37695368|NCT02349295|69171757|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
37695369|NCT02349295|69171758|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
37695370|NCT02349295|69171759|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
37695371|NCT02349295|69171760|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
37695372|NCT02349295|69171761|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
37695373|NCT02349295|69171762|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
37695374|NCT02349295|69171749|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
37695375|NCT02349295|69171750|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
37695376|NCT02349295|69171751|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
37695377|NCT02349295|69171752|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
37695378|NCT02349295|69171753|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
37695379|NCT02349295|69171754|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
37695380|NCT02349295|69171755|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
37695381|NCT02349295|69171756|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
37695382|NCT02349295|69171757|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
37695383|NCT02349295|69171758|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
37695384|NCT02349295|69171759|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
37695385|NCT02349295|69171760|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
37984967|NCT00428948|69670888|FG000|Overall Study|Lost to Follow-up|15|||
37984968|NCT00428948|69670889|FG001|Overall Study|Lost to Follow-up|8|||
37695386|NCT02349295|69171761|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
37695387|NCT02349295|69171762|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
37695388|NCT02349295|69171749|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
37695389|NCT02349295|69171750|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
37695390|NCT02349295|69171751|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
37695391|NCT02349295|69171752|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
37695392|NCT02349295|69171753|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
37695393|NCT02349295|69171754|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
37695394|NCT02349295|69171755|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
37695395|NCT02349295|69171756|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
37695396|NCT02349295|69171757|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
37695397|NCT02349295|69171758|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
37695398|NCT02349295|69171759|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
37695399|NCT02349295|69171760|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
37695400|NCT02349295|69171761|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
37695401|NCT02349295|69171762|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
37695402|NCT02349295|69171749|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
37695403|NCT02349295|69171750|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
37695404|NCT02349295|69171751|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
37695405|NCT02349295|69171752|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
37695406|NCT02349295|69171753|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
37881912|NCT01089725|69566450|FG002|Overall Study|Withdrawal by Subject|4|||
37881913|NCT01089725|69566451|FG003|Overall Study|Withdrawal by Subject|5|||
37881914|NCT01089725|69566452|FG004|Overall Study|Withdrawal by Subject|4|||
37881915|NCT01089725|69566448|FG000|Overall Study|Study Terminated by Sponsor|51|||
37881916|NCT01089725|69566449|FG001|Overall Study|Study Terminated by Sponsor|56|||
37881917|NCT01089725|69566450|FG002|Overall Study|Study Terminated by Sponsor|53|||
37881918|NCT01089725|69566451|FG003|Overall Study|Study Terminated by Sponsor|68|||
37881919|NCT01089725|69566452|FG004|Overall Study|Study Terminated by Sponsor|68|||
37881920|NCT01089725|69566448|FG000|Overall Study|Randomized, but not treated|0|||
37881921|NCT01089725|69566449|FG001|Overall Study|Randomized, but not treated|1|||
37881922|NCT01089725|69566450|FG002|Overall Study|Randomized, but not treated|2|||
37881923|NCT01089725|69566451|FG003|Overall Study|Randomized, but not treated|1|||
37881924|NCT01089725|69566452|FG004|Overall Study|Randomized, but not treated|2|||
37881925|NCT01089725|69566448|FG000|Overall Study|Other|3|||
37881926|NCT01089725|69566449|FG001|Overall Study|Other|0|||
37881927|NCT01089725|69566450|FG002|Overall Study|Other|0|||
37881928|NCT01089725|69566451|FG003|Overall Study|Other|1|||
37881929|NCT01089725|69566452|FG004|Overall Study|Other|0|||
37881930|NCT01101191|69566468|FG000|Period 1|Withdrawal by Subject|1|||
37881931|NCT01101191|69566469|FG001|Period 1|Withdrawal by Subject|0|||
37695407|NCT02349295|69171754|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
37695408|NCT02349295|69171755|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
37695409|NCT02349295|69171756|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
37820783|NCT01084252|69500001|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
37820784|NCT01084252|69500002|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
37820785|NCT01084252|69499989|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
37820786|NCT01084252|69499990|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
37820787|NCT01084252|69499991|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
37820788|NCT01084252|69499992|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
37820789|NCT01084252|69499993|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
37820790|NCT01084252|69499994|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
37820791|NCT01084252|69499995|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
37820792|NCT01084252|69499996|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
37820793|NCT01084252|69499997|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|2|||
37820794|NCT01084252|69499998|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
37820795|NCT01084252|69499999|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|4|||
37881932|NCT01101191|69566468|FG000|Period 1|Adverse Event|1|||
37881933|NCT01101191|69566469|FG001|Period 1|Adverse Event|2|||
37881934|NCT01178762|69566476|FG000|Overall Study|Lost to Follow-up|15|||
37881935|NCT01178294|69566480|FG000|Overall Study|Adverse Event|4|||
37881936|NCT01178294|69566480|FG000|Overall Study|Lost to Follow-up|2|||
37881937|NCT01178294|69566480|FG000|Overall Study|Lack of Efficacy|1|||
37881938|NCT01178294|69566480|FG000|Overall Study|Death|1|||
37881939|NCT01178294|69566480|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
37695410|NCT02349295|69171757|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
37695411|NCT02349295|69171758|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
37695412|NCT02349295|69171759|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
37695413|NCT02349295|69171760|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
37695414|NCT02349295|69171761|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
37695415|NCT02349295|69171762|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
37695416|NCT02349295|69171749|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
37695417|NCT02349295|69171750|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
37695418|NCT02349295|69171751|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
37881940|NCT01178294|69566480|FG000|Overall Study|Subject status is terminal|1|||
37881941|NCT01178294|69566480|FG000|Overall Study|Completion status could not be verified|1|||
37695419|NCT02349295|69171752|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
37695420|NCT02349295|69171753|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
37695421|NCT02349295|69171754|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
37881942|NCT01178138|69566484|FG000|Overall Study|Lost to Follow-up|8|||
37881943|NCT01178138|69566484|FG000|Overall Study|Withdrawal by Subject|7|||
37881944|NCT01178138|69566484|FG000|Overall Study|Physician Decision|8|||
37881945|NCT01177670|69566493|FG000|Overall Study|Study Terminated|115|||
37881946|NCT01177670|69566493|FG000|Overall Study|Physician Decision|50|||
37881947|NCT01177670|69566493|FG000|Overall Study|Withdrawal by Subject|4|||
37881948|NCT01190228|69566500|FG000|Overall Study|Protocol Violation|4|||
37881949|NCT01190228|69566501|FG001|Overall Study|Protocol Violation|0|||
37881950|NCT01190228|69566502|FG002|Overall Study|Protocol Violation|0|||
37881951|NCT01190228|69566500|FG000|Overall Study|Withdrawal by Subject|1|||
37881952|NCT01190228|69566501|FG001|Overall Study|Withdrawal by Subject|0|||
37881953|NCT01190228|69566502|FG002|Overall Study|Withdrawal by Subject|0|||
37881954|NCT01009086|69566515|FG000|Overall Study|Lack of Efficacy|16|||
37881955|NCT01009086|69566516|FG001|Overall Study|Lack of Efficacy|15|||
37881956|NCT01009086|69566517|FG002|Overall Study|Lack of Efficacy|9|||
37881957|NCT01009086|69566515|FG000|Overall Study|Lost to Follow-up|4|||
37881958|NCT01009086|69566516|FG001|Overall Study|Lost to Follow-up|5|||
37881959|NCT01009086|69566517|FG002|Overall Study|Lost to Follow-up|3|||
37881960|NCT01009086|69566515|FG000|Overall Study|Adverse Event|12|||
37881961|NCT01009086|69566516|FG001|Overall Study|Adverse Event|11|||
37881962|NCT01009086|69566517|FG002|Overall Study|Adverse Event|8|||
37881963|NCT01009086|69566515|FG000|Overall Study|Withdrawal by Subject|9|||
37881964|NCT01009086|69566516|FG001|Overall Study|Withdrawal by Subject|11|||
37881965|NCT01009086|69566517|FG002|Overall Study|Withdrawal by Subject|13|||
37881966|NCT01009086|69566515|FG000|Overall Study|Other|3|||
37881967|NCT01009086|69566516|FG001|Overall Study|Other|5|||
37881968|NCT01009086|69566517|FG002|Overall Study|Other|1|||
37881969|NCT01190150|69566532|FG000|First Treatment|Withdrawal by Subject|1|||
37881970|NCT01190150|69566533|FG001|First Treatment|Withdrawal by Subject|0|||
37881971|NCT01190150|69566532|FG000|Washout|Withdrawal by Subject|0|||
37881972|NCT01190150|69566533|FG001|Washout|Withdrawal by Subject|1|||
37881973|NCT01190150|69566532|FG000|Washout|Difficulty in adherence|0|||
37881974|NCT01190150|69566533|FG001|Washout|Difficulty in adherence|1|||
37881975|NCT01001520|69566539|FG000|Medication Period 1|Withdrawal by Subject|2|||
37881976|NCT01001520|69566540|FG001|Medication Period 1|Withdrawal by Subject|2|||
37881977|NCT01001520|69566539|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
37881978|NCT01001520|69566540|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
37881979|NCT01001520|69566539|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
37881980|NCT01001520|69566540|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
37881981|NCT01001520|69566539|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
37881982|NCT01001520|69566540|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
37881983|NCT01001520|69566539|FG000|Washout Period|Withdrawal by Subject|2|||
37881984|NCT01001520|69566540|FG001|Washout Period|Withdrawal by Subject|1|||
37881985|NCT01001520|69566539|FG000|Medication Period 2|Withdrawal by Subject|0|||
37881986|NCT01001520|69566540|FG001|Medication Period 2|Withdrawal by Subject|3|||
37881987|NCT01189604|69566564|FG000|Overall Study|Impossible to visit|0|||
37881988|NCT01189604|69566565|FG001|Overall Study|Impossible to visit|0|||
37881989|NCT01189604|69566566|FG002|Overall Study|Impossible to visit|0|||
37881990|NCT01189604|69566567|FG003|Overall Study|Impossible to visit|0|||
37881991|NCT01189604|69566568|FG004|Overall Study|Impossible to visit|0|||
37881992|NCT01189604|69566569|FG005|Overall Study|Impossible to visit|1|||
37881993|NCT01189604|69566570|FG006|Overall Study|Impossible to visit|0|||
37881994|NCT01189604|69566564|FG000|Overall Study|Adverse Event|0|||
37881995|NCT01189604|69566565|FG001|Overall Study|Adverse Event|1|||
37881996|NCT01189604|69566566|FG002|Overall Study|Adverse Event|0|||
37881997|NCT01189604|69566567|FG003|Overall Study|Adverse Event|0|||
37881998|NCT01189604|69566568|FG004|Overall Study|Adverse Event|2|||
37881999|NCT01189604|69566569|FG005|Overall Study|Adverse Event|0|||
37882000|NCT01189604|69566570|FG006|Overall Study|Adverse Event|1|||
37882001|NCT01189604|69566564|FG000|Overall Study|Withdrawal by Subject|1|||
37882002|NCT01189604|69566565|FG001|Overall Study|Withdrawal by Subject|0|||
37882003|NCT01189604|69566566|FG002|Overall Study|Withdrawal by Subject|0|||
37882004|NCT01189604|69566567|FG003|Overall Study|Withdrawal by Subject|0|||
37882005|NCT01189604|69566568|FG004|Overall Study|Withdrawal by Subject|0|||
37882006|NCT01189604|69566569|FG005|Overall Study|Withdrawal by Subject|0|||
37882007|NCT01189604|69566570|FG006|Overall Study|Withdrawal by Subject|0|||
37882008|NCT01008696|69566588|FG000|Overall Study|Participant's evasion of hospital visit|5|||
37882009|NCT01008696|69566589|FG001|Overall Study|Participant's evasion of hospital visit|4|||
37882010|NCT01008696|69566588|FG000|Overall Study|Withdrawal by Subject|2|||
37882011|NCT01008696|69566589|FG001|Overall Study|Withdrawal by Subject|4|||
37882012|NCT01008696|69566588|FG000|Overall Study|Physician Decision|5|||
37882013|NCT01008696|69566589|FG001|Overall Study|Physician Decision|1|||
37882014|NCT01008696|69566588|FG000|Overall Study|Adverse Event|1|||
37882015|NCT01008696|69566589|FG001|Overall Study|Adverse Event|0|||
37882016|NCT01008696|69566588|FG000|Overall Study|Participants' non-cooperation|2|||
37882017|NCT01008696|69566589|FG001|Overall Study|Participants' non-cooperation|3|||
37882018|NCT01008696|69566588|FG000|Overall Study|Other|2|||
37882019|NCT01008696|69566589|FG001|Overall Study|Other|3|||
37882020|NCT01008696|69566588|FG000|Overall Study|Other|0|||
37882021|NCT01008696|69566589|FG001|Overall Study|Other|2|||
37882022|NCT01176968|69566608|FG000|Overall Study|Adverse Event|10|||
37882023|NCT01176968|69566609|FG001|Overall Study|Adverse Event|11|||
37882024|NCT01176968|69566608|FG000|Overall Study|Death|2|||
37882025|NCT01176968|69566609|FG001|Overall Study|Death|3|||
37882026|NCT01176968|69566608|FG000|Overall Study|Lack of Efficacy|0|||
37882027|NCT01176968|69566609|FG001|Overall Study|Lack of Efficacy|1|||
37882028|NCT01176968|69566608|FG000|Overall Study|Lost to Follow-up|16|||
37882029|NCT01176968|69566609|FG001|Overall Study|Lost to Follow-up|14|||
37882030|NCT01176968|69566608|FG000|Overall Study|Withdrawal by Subject|48|||
37882031|NCT01176968|69566609|FG001|Overall Study|Withdrawal by Subject|48|||
37882032|NCT01176968|69566608|FG000|Overall Study|Protocol Violation|2|||
37882033|NCT01176968|69566609|FG001|Overall Study|Protocol Violation|1|||
37882034|NCT01176968|69566608|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
37882035|NCT01176968|69566609|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
37882036|NCT01176968|69566608|FG000|Overall Study|Study terminated by sponsor|0|||
37882037|NCT01176968|69566609|FG001|Overall Study|Study terminated by sponsor|1|||
37882038|NCT01176968|69566608|FG000|Overall Study|Reason not defined|5|||
37882039|NCT01176968|69566609|FG001|Overall Study|Reason not defined|3|||
37882040|NCT01006122|69566620|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
37882041|NCT01006122|69566621|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
37882042|NCT01006122|69566620|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
37882043|NCT01006122|69566621|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
37882044|NCT01006122|69566620|FG000|First Double-blind Intervention Period|Pregnancy|0|||
37882045|NCT01006122|69566621|FG001|First Double-blind Intervention Period|Pregnancy|1|||
37882046|NCT01006122|69566620|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
37882047|NCT01006122|69566621|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
37882048|NCT01006122|69566620|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
37882049|NCT01006122|69566621|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
37882050|NCT01006122|69566620|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
37882051|NCT01006122|69566621|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
37882052|NCT01006122|69566620|FG000|First Double-blind Intervention Period|Other|3|||
37882053|NCT01006122|69566621|FG001|First Double-blind Intervention Period|Other|0|||
37882054|NCT01006122|69566620|FG000|First Double-blind Intervention Period|Adverse Event|0|||
37882055|NCT01006122|69566621|FG001|First Double-blind Intervention Period|Adverse Event|4|||
37820796|NCT01084252|69500000|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|3|||
37820797|NCT01084252|69500001|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
37820798|NCT01084252|69500002|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
37820799|NCT01084252|69499989|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
37820800|NCT01084252|69499990|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
37820801|NCT01084252|69499991|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
37820802|NCT01084252|69499992|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
37820803|NCT01084252|69499993|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
37820804|NCT01084252|69499994|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
37882056|NCT01006122|69566620|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
37882057|NCT01006122|69566621|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
37882058|NCT01006122|69566620|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
37882059|NCT01006122|69566621|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
37882060|NCT01006122|69566620|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
37882061|NCT01006122|69566621|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
37882062|NCT01006122|69566620|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
37882063|NCT01006122|69566621|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
37882064|NCT01006122|69566620|FG000|Second Double-blind Intervention Period|Death|0|||
37882065|NCT01006122|69566621|FG001|Second Double-blind Intervention Period|Death|1|||
37882066|NCT01005966|69566627|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
37882067|NCT01005966|69566628|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
37882068|NCT01005966|69566629|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
37882069|NCT01005966|69566630|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
37882070|NCT01005966|69566631|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
37882071|NCT01005966|69566627|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
37882072|NCT01005966|69566628|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
37882073|NCT01005966|69566629|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
37882074|NCT01005966|69566630|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
37882075|NCT01005966|69566631|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
37882076|NCT01005966|69566627|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
37882077|NCT01005966|69566628|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
37882078|NCT01005966|69566629|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
37882079|NCT01005966|69566630|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
37882080|NCT01005966|69566631|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
37882081|NCT01005966|69566627|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
37882082|NCT01005966|69566628|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
37882083|NCT01005966|69566629|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
37882084|NCT01005966|69566630|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
37882085|NCT01005966|69566631|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
37882086|NCT01005966|69566627|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
37882087|NCT01005966|69566628|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
37882088|NCT01005966|69566629|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
37882089|NCT01005966|69566630|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
37882090|NCT01005966|69566631|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
37882091|NCT01005966|69566627|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
37882092|NCT01005966|69566628|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
37882093|NCT01005966|69566629|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
37882094|NCT01005966|69566630|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
37882095|NCT01005966|69566631|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
37882096|NCT01005966|69566627|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
37882097|NCT01005966|69566628|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
37882098|NCT01005966|69566629|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
37882099|NCT01005966|69566630|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
37882100|NCT01005966|69566631|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
37882101|NCT01005966|69566627|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
37882102|NCT01005966|69566628|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
37882103|NCT01005966|69566629|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
37882104|NCT01005966|69566630|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
37882105|NCT01005966|69566631|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
37882106|NCT01005966|69566627|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
37882107|NCT01005966|69566628|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
37882108|NCT01005966|69566629|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
37882109|NCT01005966|69566630|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
37882110|NCT01005966|69566631|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
37882111|NCT01005732|69566657|FG000|Overall Study|Lost to Follow-up|10|||
37882112|NCT01005732|69566657|FG000|Overall Study|Death|1|||
37882113|NCT00603382|69566671|FG000|Overall Study|Adverse Event|0|||
37882114|NCT00603382|69566672|FG001|Overall Study|Adverse Event|1|||
37882115|NCT00603382|69566673|FG002|Overall Study|Adverse Event|1|||
37882116|NCT00603382|69566674|FG003|Overall Study|Adverse Event|2|||
37882117|NCT00603382|69566675|FG004|Overall Study|Adverse Event|1|||
37882118|NCT00603382|69566676|FG005|Overall Study|Adverse Event|2|||
37882119|NCT00603382|69566671|FG000|Overall Study|Lack of Efficacy|14|||
37882120|NCT00603382|69566672|FG001|Overall Study|Lack of Efficacy|9|||
37882121|NCT00603382|69566673|FG002|Overall Study|Lack of Efficacy|3|||
37882122|NCT00603382|69566674|FG003|Overall Study|Lack of Efficacy|6|||
37984969|NCT00428948|69670888|FG000|Overall Study|Adverse Event|148|||
37882123|NCT00603382|69566675|FG004|Overall Study|Lack of Efficacy|6|||
37882124|NCT00603382|69566676|FG005|Overall Study|Lack of Efficacy|11|||
37882125|NCT00603382|69566671|FG000|Overall Study|Protocol Violation|1|||
37984970|NCT00428948|69670889|FG001|Overall Study|Adverse Event|24|||
37984971|NCT00428948|69670888|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
37882126|NCT00603382|69566672|FG001|Overall Study|Protocol Violation|0|||
37882127|NCT00603382|69566673|FG002|Overall Study|Protocol Violation|1|||
37882128|NCT00603382|69566674|FG003|Overall Study|Protocol Violation|2|||
37882129|NCT00603382|69566675|FG004|Overall Study|Protocol Violation|1|||
37882130|NCT00603382|69566676|FG005|Overall Study|Protocol Violation|0|||
37882131|NCT00603382|69566671|FG000|Overall Study|Lost to Follow-up|0|||
37882132|NCT00603382|69566672|FG001|Overall Study|Lost to Follow-up|1|||
37882133|NCT00603382|69566673|FG002|Overall Study|Lost to Follow-up|1|||
37882134|NCT00603382|69566674|FG003|Overall Study|Lost to Follow-up|1|||
37882135|NCT00603382|69566675|FG004|Overall Study|Lost to Follow-up|0|||
37882136|NCT00603382|69566676|FG005|Overall Study|Lost to Follow-up|1|||
37882137|NCT00603382|69566671|FG000|Overall Study|Physician Decision|0|||
37882138|NCT00603382|69566672|FG001|Overall Study|Physician Decision|0|||
37882139|NCT00603382|69566673|FG002|Overall Study|Physician Decision|2|||
37882140|NCT00603382|69566674|FG003|Overall Study|Physician Decision|0|||
37882141|NCT00603382|69566675|FG004|Overall Study|Physician Decision|1|||
37882142|NCT00603382|69566676|FG005|Overall Study|Physician Decision|3|||
37882143|NCT00603382|69566671|FG000|Overall Study|Withdrawal by Subject|3|||
37882144|NCT00603382|69566672|FG001|Overall Study|Withdrawal by Subject|3|||
37882145|NCT00603382|69566673|FG002|Overall Study|Withdrawal by Subject|1|||
37882146|NCT00603382|69566674|FG003|Overall Study|Withdrawal by Subject|1|||
37882147|NCT00603382|69566675|FG004|Overall Study|Withdrawal by Subject|0|||
37882148|NCT00603382|69566676|FG005|Overall Study|Withdrawal by Subject|1|||
37984972|NCT00428948|69670889|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
37984973|NCT00428948|69670888|FG000|Overall Study|Investigator Withdrew Subject|3|||
37984974|NCT00428948|69670889|FG001|Overall Study|Investigator Withdrew Subject|4|||
37695422|NCT02349295|69171755|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
37695423|NCT02349295|69171756|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
37882149|NCT01176266|69566690|FG000|Overall Study|Death|6|||
37882150|NCT01176266|69566690|FG000|Overall Study|Withdrawal by Subject|3|||
37882151|NCT01182428|69566700|FG000|Overall Study|Physician Decision|1|||
37882152|NCT01182428|69566701|FG001|Overall Study|Physician Decision|0|||
37882153|NCT01182428|69566700|FG000|Overall Study|Lost to Follow-up|9|||
37882154|NCT01182428|69566701|FG001|Overall Study|Lost to Follow-up|1|||
37882155|NCT01182428|69566700|FG000|Overall Study|Withdrawal by Subject|1|||
37882156|NCT01182428|69566701|FG001|Overall Study|Withdrawal by Subject|0|||
37882157|NCT00603304|69566709|FG000|Overall Study|Lost to Follow-up|5|||
37882158|NCT00603304|69566710|FG001|Overall Study|Lost to Follow-up|7|||
37882159|NCT00603304|69566709|FG000|Overall Study|Withdrawal by Subject|8|||
37882160|NCT00603304|69566710|FG001|Overall Study|Withdrawal by Subject|5|||
37882161|NCT00603304|69566709|FG000|Overall Study|Protocol Violation|1|||
37882162|NCT00603304|69566710|FG001|Overall Study|Protocol Violation|0|||
37882163|NCT00603304|69566709|FG000|Overall Study|Adverse Event|4|||
37882164|NCT00603304|69566710|FG001|Overall Study|Adverse Event|2|||
37882165|NCT00603304|69566709|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
37882166|NCT00603304|69566710|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
37882167|NCT00603304|69566709|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
37882168|NCT00603304|69566710|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
37882169|NCT00603304|69566709|FG000|Overall Study|Exclusionary Medication|2|||
37882170|NCT00603304|69566710|FG001|Overall Study|Exclusionary Medication|3|||
37882171|NCT00603304|69566709|FG000|Overall Study|Non-Compliant|0|||
37882172|NCT00603304|69566710|FG001|Overall Study|Non-Compliant|1|||
37882173|NCT00603304|69566709|FG000|Overall Study|Moved Away|0|||
37882174|NCT00603304|69566710|FG001|Overall Study|Moved Away|2|||
37882175|NCT00603304|69566709|FG000|Overall Study|Other|2|||
37882176|NCT00603304|69566710|FG001|Overall Study|Other|0|||
37984975|NCT00428948|69670888|FG000|Overall Study|Subject Withdrew Consent|50|||
37695424|NCT02349295|69171757|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
37695425|NCT02349295|69171758|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
37695426|NCT02349295|69171759|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
37695427|NCT02349295|69171760|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
37695428|NCT02349295|69171761|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
37882177|NCT00603304|69566709|FG000|Overall Study|Patient Decision|2|||
37882178|NCT00603304|69566710|FG001|Overall Study|Patient Decision|0|||
37882179|NCT01176032|69566720|FG000|Overall Study|Adverse Event|1|||
37882180|NCT01176032|69566721|FG001|Overall Study|Adverse Event|0|||
37882181|NCT01176032|69566720|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
37882182|NCT01176032|69566721|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
37882183|NCT01176032|69566720|FG000|Overall Study|Protocol Violation|1|||
37882184|NCT01176032|69566721|FG001|Overall Study|Protocol Violation|0|||
37882185|NCT01176032|69566720|FG000|Overall Study|Informed consent withdrawn|3|||
37882186|NCT01176032|69566721|FG001|Overall Study|Informed consent withdrawn|0|||
37882187|NCT01176032|69566720|FG000|Overall Study|Other|1|||
37882188|NCT01176032|69566721|FG001|Overall Study|Other|0|||
37882189|NCT01008618|69566732|FG000|Period 1 (Titration Period)|Physician Decision|2|||
37882190|NCT01008618|69566733|FG001|Period 1 (Titration Period)|Physician Decision|0|||
37882191|NCT01008618|69566734|FG002|Period 1 (Titration Period)|Physician Decision|0|||
37882192|NCT01008618|69566732|FG000|Period 1 (Titration Period)|Adverse Event|33|||
37882193|NCT01008618|69566733|FG001|Period 1 (Titration Period)|Adverse Event|0|||
37882194|NCT01008618|69566734|FG002|Period 1 (Titration Period)|Adverse Event|0|||
37882195|NCT01008618|69566732|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
37882196|NCT01008618|69566733|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
37882197|NCT01008618|69566734|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
37882198|NCT01008618|69566732|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
37882199|NCT01008618|69566733|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
37984976|NCT00428948|69670889|FG001|Overall Study|Subject Withdrew Consent|30|||
37984977|NCT00428948|69670888|FG000|Overall Study|Protocol Deviation|1|||
37695429|NCT02349295|69171762|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
37695430|NCT02349295|69171749|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
37695431|NCT02349295|69171750|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
37820805|NCT01084252|69499995|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
37820806|NCT01084252|69499996|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
37820807|NCT01084252|69499997|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|1|||
37820808|NCT01084252|69499998|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|4|||
37820809|NCT01084252|69499999|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|2|||
37820810|NCT01084252|69500000|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|2|||
37820811|NCT01084252|69500001|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
37820812|NCT01084252|69500002|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
37820813|NCT01084252|69499989|FG000|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
37820814|NCT01084252|69499990|FG001|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
37820815|NCT01084252|69499991|FG002|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
37820816|NCT01084252|69499992|FG003|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
37820817|NCT01084252|69499993|FG004|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
37820818|NCT01084252|69499994|FG005|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
37820819|NCT01084252|69499995|FG006|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
37820820|NCT01084252|69499996|FG007|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
37820821|NCT01084252|69499997|FG008|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
37820822|NCT01084252|69499998|FG009|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
37820823|NCT01084252|69499999|FG010|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
37820824|NCT01084252|69500000|FG011|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
37820825|NCT01084252|69500001|FG012|Phase 2 Stage 2 (97 Weeks)|Adverse Event|13|||
37820826|NCT01084252|69500002|FG013|Phase 2 Stage 2 (97 Weeks)|Adverse Event|5|||
37820827|NCT01084252|69499989|FG000|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
37820828|NCT01084252|69499990|FG001|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
37820829|NCT01084252|69499991|FG002|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
37820830|NCT01084252|69499992|FG003|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
37820831|NCT01084252|69499993|FG004|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
37820832|NCT01084252|69499994|FG005|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
37820833|NCT01084252|69499995|FG006|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
37820834|NCT01084252|69499996|FG007|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
37820835|NCT01084252|69499997|FG008|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
37820836|NCT01084252|69499998|FG009|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
37820837|NCT01084252|69499999|FG010|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
37820838|NCT01084252|69500000|FG011|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
37882200|NCT01008618|69566734|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
37882201|NCT01008618|69566732|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
37882202|NCT01008618|69566733|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
37882203|NCT01008618|69566734|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
37882204|NCT01008618|69566732|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
37882205|NCT01008618|69566733|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
37882206|NCT01008618|69566734|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
37882207|NCT01008618|69566732|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
37882208|NCT01008618|69566733|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
37882209|NCT01008618|69566734|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
37882210|NCT01008618|69566732|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
37882211|NCT01008618|69566733|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
37882212|NCT01008618|69566734|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
37882213|NCT01008618|69566732|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
37882214|NCT01008618|69566733|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
37882215|NCT01008618|69566734|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
37882216|NCT01008618|69566732|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
37882217|NCT01008618|69566733|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
37882218|NCT01008618|69566734|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
37882219|NCT01008618|69566732|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
37882220|NCT01008618|69566733|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
37882221|NCT01008618|69566734|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
37882222|NCT01008618|69566732|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
37882223|NCT01008618|69566733|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
37882224|NCT01008618|69566734|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
37882225|NCT01001208|69566745|FG000|Overall Study|Adverse Event|10|||
37882226|NCT01001208|69566746|FG001|Overall Study|Adverse Event|5|||
37882227|NCT01001208|69566745|FG000|Overall Study|Lost to Follow-up|5|||
37882228|NCT01001208|69566746|FG001|Overall Study|Lost to Follow-up|9|||
37882229|NCT01001208|69566745|FG000|Overall Study|Physician Decision|1|||
37882230|NCT01001208|69566746|FG001|Overall Study|Physician Decision|0|||
37882231|NCT01001208|69566745|FG000|Overall Study|Withdrawal by Subject|4|||
37882232|NCT01001208|69566746|FG001|Overall Study|Withdrawal by Subject|5|||
37882233|NCT01001208|69566745|FG000|Overall Study|Ineligibility Determined|4|||
37882234|NCT01001208|69566746|FG001|Overall Study|Ineligibility Determined|2|||
37882235|NCT01001208|69566745|FG000|Overall Study|Noncompliance|4|||
37882236|NCT01001208|69566746|FG001|Overall Study|Noncompliance|7|||
37882237|NCT01001208|69566745|FG000|Overall Study|Disease Progression|0|||
37882238|NCT01001208|69566746|FG001|Overall Study|Disease Progression|3|||
37882239|NCT01001208|69566745|FG000|Overall Study|Other|0|||
37882240|NCT01001208|69566746|FG001|Overall Study|Other|2|||
37882241|NCT01000974|69566755|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
37882242|NCT01000974|69566756|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
37882243|NCT01000974|69566757|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
37882244|NCT01000974|69566755|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
37882245|NCT01000974|69566756|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
37882246|NCT01000974|69566757|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
37882247|NCT01000974|69566755|FG000|Primary Vaccination Phase|Protocol Violation|40|||
37882248|NCT01000974|69566756|FG001|Primary Vaccination Phase|Protocol Violation|3|||
37882249|NCT01000974|69566757|FG002|Primary Vaccination Phase|Protocol Violation|2|||
37882250|NCT01000974|69566755|FG000|Primary Vaccination Phase|Adverse Event|14|||
37882251|NCT01000974|69566756|FG001|Primary Vaccination Phase|Adverse Event|2|||
37882252|NCT01000974|69566757|FG002|Primary Vaccination Phase|Adverse Event|2|||
37882253|NCT01000974|69566755|FG000|Primary Vaccination Phase|Other|4|||
37882254|NCT01000974|69566756|FG001|Primary Vaccination Phase|Other|9|||
37882255|NCT01000974|69566757|FG002|Primary Vaccination Phase|Other|12|||
37882256|NCT01000974|69566755|FG000|Booster Vaccination Phase|Protocol Violation|0|||
37882257|NCT01000974|69566756|FG001|Booster Vaccination Phase|Protocol Violation|0|||
37882258|NCT01000974|69566757|FG002|Booster Vaccination Phase|Protocol Violation|2|||
37882259|NCT01000974|69566755|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
37882260|NCT01000974|69566756|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
37882261|NCT01000974|69566757|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
37882262|NCT01000974|69566755|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
37882263|NCT01000974|69566756|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
37882264|NCT01000974|69566757|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
37882265|NCT01000974|69566755|FG000|Booster Vaccination Phase|Other|24|||
37882266|NCT01000974|69566756|FG001|Booster Vaccination Phase|Other|6|||
37882267|NCT01000974|69566757|FG002|Booster Vaccination Phase|Other|4|||
37882268|NCT01004406|69566770|FG000|Overall Study|Withdrawal by Subject|2|||
37984978|NCT00428948|69670889|FG001|Overall Study|Protocol Deviation|1|||
37984979|NCT00428792|69670897|FG000|Overall Study|Lack of Efficacy|1|||
37984980|NCT00428792|69670898|FG001|Overall Study|Lack of Efficacy|3|||
37984981|NCT00428792|69670897|FG000|Overall Study|Lost to Follow-up|0|||
37984982|NCT00428792|69670898|FG001|Overall Study|Lost to Follow-up|1|||
37984983|NCT00300885|69670906|FG000|Treatment|Adverse Event|134|||
37984984|NCT00300885|69670907|FG001|Treatment|Adverse Event|82|||
37984985|NCT00300885|69670906|FG000|Treatment|Death|20|||
37984986|NCT00300885|69670907|FG001|Treatment|Death|7|||
37984987|NCT00300885|69670906|FG000|Treatment|Lack of Efficacy|1|||
37984988|NCT00300885|69670907|FG001|Treatment|Lack of Efficacy|1|||
37984989|NCT00300885|69670906|FG000|Treatment|Lost to Follow-up|3|||
37984990|NCT00300885|69670907|FG001|Treatment|Lost to Follow-up|2|||
37984991|NCT00300885|69670906|FG000|Treatment|Physician Decision|4|||
37984992|NCT00300885|69670907|FG001|Treatment|Physician Decision|5|||
37984993|NCT00300885|69670906|FG000|Treatment|Protocol Violation|11|||
37984994|NCT00300885|69670907|FG001|Treatment|Protocol Violation|11|||
37984995|NCT00300885|69670906|FG000|Treatment|Withdrawal by Subject|26|||
37984996|NCT00300885|69670907|FG001|Treatment|Withdrawal by Subject|23|||
37984997|NCT00300885|69670906|FG000|Treatment|Disease progression|171|||
37984998|NCT00300885|69670907|FG001|Treatment|Disease progression|238|||
37984999|NCT00300885|69670906|FG000|Treatment|Random code broken (subject died)|0|||
37985000|NCT00300885|69670907|FG001|Treatment|Random code broken (subject died)|1|||
37985001|NCT00300885|69670906|FG000|Treatment|Non-compliant with study medication|3|||
37985002|NCT00300885|69670907|FG001|Treatment|Non-compliant with study medication|4|||
37985003|NCT00300885|69670906|FG000|Follow-up|Death|141|||
37985004|NCT00300885|69670907|FG001|Follow-up|Death|163|||
37985005|NCT00300885|69670906|FG000|Follow-up|Lost to Follow-up|11|||
37985006|NCT00300885|69670907|FG001|Follow-up|Lost to Follow-up|7|||
37985007|NCT00300885|69670906|FG000|Follow-up|Withdrawal by Subject|26|||
37985008|NCT00300885|69670907|FG001|Follow-up|Withdrawal by Subject|25|||
37985009|NCT00386334|69670915|FG000|Double Blind Period|Adverse Event|9|||
37985010|NCT00386334|69670916|FG001|Double Blind Period|Adverse Event|14|||
37985011|NCT00386334|69670915|FG000|Double Blind Period|Protocol Violation|1|||
37985012|NCT00386334|69670916|FG001|Double Blind Period|Protocol Violation|1|||
37985013|NCT00386334|69670915|FG000|Double Blind Period|Withdrawal by Subject|9|||
37985014|NCT00386334|69670916|FG001|Double Blind Period|Withdrawal by Subject|13|||
37985015|NCT00386334|69670915|FG000|Double Blind Period|Lack of Efficacy|20|||
37985016|NCT00386334|69670916|FG001|Double Blind Period|Lack of Efficacy|11|||
37985017|NCT00386334|69670915|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
37985018|NCT00386334|69670916|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
37985019|NCT00386334|69670915|FG000|Double Blind Period|Other|3|||
37985020|NCT00386334|69670916|FG001|Double Blind Period|Other|3|||
37985021|NCT00386334|69670915|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
37985022|NCT00386334|69670916|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
37985023|NCT00428714|69670933|FG000|Overall Study|Progressive Disease|28|||
37985024|NCT00428714|69670934|FG001|Overall Study|Progressive Disease|36|||
37985025|NCT00428714|69670933|FG000|Overall Study|Withdrawal by Subject|0|||
37985026|NCT00428714|69670934|FG001|Overall Study|Withdrawal by Subject|3|||
37985027|NCT00428714|69670933|FG000|Overall Study|Adverse Event|0|||
37985028|NCT00428714|69670934|FG001|Overall Study|Adverse Event|2|||
37985029|NCT00428714|69670933|FG000|Overall Study|Physician Decision|1|||
37985030|NCT00428714|69670934|FG001|Overall Study|Physician Decision|1|||
37985031|NCT00428714|69670933|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
37985032|NCT00428714|69670934|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
37985033|NCT00428714|69670933|FG000|Overall Study|Death due to other then PD|1|||
37985034|NCT00428714|69670934|FG001|Overall Study|Death due to other then PD|0|||
37985035|NCT00292227|69670943|FG000|Patch Period|Adverse Event|1|||
37985036|NCT00292227|69670944|FG001|Patch Period|Adverse Event|0|||
37985037|NCT00292227|69670945|FG002|Patch Period|Adverse Event|2|||
37985038|NCT00292227|69670943|FG000|Patch Period|Withdrawal by Subject|0|||
37985039|NCT00292227|69670944|FG001|Patch Period|Withdrawal by Subject|0|||
37985040|NCT00292227|69670945|FG002|Patch Period|Withdrawal by Subject|1|||
37985041|NCT00386100|69670955|FG000|Overall Study|Did not receive study medication|6|||
37985042|NCT00386100|69670956|FG001|Overall Study|Did not receive study medication|4|||
37985043|NCT00386100|69670955|FG000|Overall Study|Adverse Event|15|||
37985044|NCT00386100|69670956|FG001|Overall Study|Adverse Event|25|||
37985045|NCT00386100|69670955|FG000|Overall Study|Death|0|||
37985046|NCT00386100|69670956|FG001|Overall Study|Death|1|||
37985047|NCT00386100|69670955|FG000|Overall Study|Insufficient therapeutic effect|30|||
37985048|NCT00386100|69670956|FG001|Overall Study|Insufficient therapeutic effect|6|||
37985049|NCT00386100|69670955|FG000|Overall Study|Lost to Follow-up|29|||
37985050|NCT00386100|69670956|FG001|Overall Study|Lost to Follow-up|29|||
37985051|NCT00386100|69670955|FG000|Overall Study|Non-compliance|18|||
37985052|NCT00386100|69670956|FG001|Overall Study|Non-compliance|19|||
37985053|NCT00386100|69670955|FG000|Overall Study|Protocol Violation|5|||
37695432|NCT02349295|69171751|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
37985054|NCT00386100|69670956|FG001|Overall Study|Protocol Violation|3|||
37985055|NCT00386100|69670955|FG000|Overall Study|Withdrawal by Subject|32|||
37985056|NCT00386100|69670956|FG001|Overall Study|Withdrawal by Subject|31|||
37985057|NCT00386100|69670955|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
37985058|NCT00386100|69670956|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
37985059|NCT00386100|69670955|FG000|Overall Study|BMD <2.5|1|||
37985060|NCT00386100|69670956|FG001|Overall Study|BMD <2.5|0|||
37985061|NCT00386100|69670955|FG000|Overall Study|Consecutive elevated Hba1C|1|||
37985062|NCT00386100|69670956|FG001|Overall Study|Consecutive elevated Hba1C|0|||
37985063|NCT00386100|69670955|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
37985064|NCT00386100|69670956|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
37985065|NCT00386100|69670955|FG000|Overall Study|Laboratory findings|1|||
37985066|NCT00386100|69670956|FG001|Overall Study|Laboratory findings|0|||
37985067|NCT00386100|69670955|FG000|Overall Study|Participant's concern due to CPK levels|1|||
37985068|NCT00386100|69670956|FG001|Overall Study|Participant's concern due to CPK levels|0|||
37985069|NCT00386100|69670955|FG000|Overall Study|Participant moving out of state|2|||
37985070|NCT00386100|69670956|FG001|Overall Study|Participant moving out of state|0|||
37985071|NCT00386100|69670955|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
37985072|NCT00386100|69670956|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
37985073|NCT00386100|69670955|FG000|Overall Study|Didn't meet entry criteria|1|||
37985074|NCT00386100|69670956|FG001|Overall Study|Didn't meet entry criteria|1|||
37985075|NCT00386100|69670955|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
37985076|NCT00386100|69670956|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
37985077|NCT00386100|69670955|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
37985078|NCT00386100|69670956|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
37985079|NCT00386100|69670955|FG000|Overall Study|Bad metabolic control & patient security|1|||
37985080|NCT00386100|69670956|FG001|Overall Study|Bad metabolic control & patient security|0|||
37985081|NCT00386100|69670955|FG000|Overall Study|Bone loss by DXA bone scan|1|||
37985082|NCT00386100|69670956|FG001|Overall Study|Bone loss by DXA bone scan|0|||
37985083|NCT00386100|69670955|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
37985084|NCT00386100|69670956|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
37985085|NCT00386100|69670955|FG000|Overall Study|7.6% bone loss|1|||
37985086|NCT00386100|69670956|FG001|Overall Study|7.6% bone loss|0|||
37985087|NCT00386100|69670955|FG000|Overall Study|Osteoporosis|0|||
37985088|NCT00386100|69670956|FG001|Overall Study|Osteoporosis|1|||
37985089|NCT00386100|69670955|FG000|Overall Study|Positive pregnancy test|1|||
37985090|NCT00386100|69670956|FG001|Overall Study|Positive pregnancy test|3|||
37985091|NCT00386100|69670955|FG000|Overall Study|Out of country for 5 months|1|||
37985092|NCT00386100|69670956|FG001|Overall Study|Out of country for 5 months|0|||
37985093|NCT00386100|69670955|FG000|Overall Study|Hb1Ac >8%|0|||
37985094|NCT00386100|69670956|FG001|Overall Study|Hb1Ac >8%|1|||
37985095|NCT00386100|69670955|FG000|Overall Study|Participant randomized in error|1|||
37985096|NCT00386100|69670956|FG001|Overall Study|Participant randomized in error|0|||
37985097|NCT00300495|69670964|FG000|Overall Study|Protocol Violation|4|||
37985098|NCT00300495|69670965|FG001|Overall Study|Protocol Violation|1|||
37985099|NCT00386022|69670973|FG000|Plus Estrogen|Lost to Follow-up|2|||
37985100|NCT00386022|69670974|FG001|Plus Estrogen|Lost to Follow-up|0|||
37985101|NCT00386022|69670973|FG000|Plus Estrogen|Adverse Event|0|||
37985102|NCT00386022|69670974|FG001|Plus Estrogen|Adverse Event|1|||
37985103|NCT00286455|69670985|FG000|Overall Study|Hyperglycemia rescue|19|||
37985104|NCT00286455|69670986|FG001|Overall Study|Hyperglycemia rescue|13|||
37985105|NCT00286455|69670987|FG002|Overall Study|Hyperglycemia rescue|10|||
37985106|NCT00286455|69670985|FG000|Overall Study|Adverse Event|1|||
37985107|NCT00286455|69670986|FG001|Overall Study|Adverse Event|3|||
37985108|NCT00286455|69670987|FG002|Overall Study|Adverse Event|2|||
37985109|NCT00286455|69670985|FG000|Overall Study|Lost to Follow-up|0|||
37985110|NCT00286455|69670986|FG001|Overall Study|Lost to Follow-up|3|||
37985111|NCT00286455|69670987|FG002|Overall Study|Lost to Follow-up|3|||
37985112|NCT00286455|69670985|FG000|Overall Study|Physician Decision|3|||
37985113|NCT00286455|69670986|FG001|Overall Study|Physician Decision|0|||
37695433|NCT02349295|69171752|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
37820839|NCT01084252|69500001|FG012|Phase 2 Stage 2 (97 Weeks)|Progressive disease|70|||
37820840|NCT01084252|69500002|FG013|Phase 2 Stage 2 (97 Weeks)|Progressive disease|33|||
37985114|NCT00286455|69670987|FG002|Overall Study|Physician Decision|2|||
37985115|NCT00286455|69670985|FG000|Overall Study|Protocol Violation|1|||
37985116|NCT00286455|69670986|FG001|Overall Study|Protocol Violation|1|||
37985117|NCT00286455|69670987|FG002|Overall Study|Protocol Violation|0|||
37985118|NCT00286455|69670985|FG000|Overall Study|Participant Non-compliance|1|||
37985119|NCT00286455|69670986|FG001|Overall Study|Participant Non-compliance|0|||
37985120|NCT00286455|69670987|FG002|Overall Study|Participant Non-compliance|0|||
37985121|NCT00286455|69670985|FG000|Overall Study|Withdrawal by Subject|0|||
37985122|NCT00286455|69670986|FG001|Overall Study|Withdrawal by Subject|8|||
37985123|NCT00286455|69670987|FG002|Overall Study|Withdrawal by Subject|7|||
37985124|NCT00385944|69670997|FG000|1st Maintenance Dose Period|Physician Decision|1|||
37985125|NCT00385944|69670998|FG001|1st Maintenance Dose Period|Physician Decision|0|||
37985126|NCT00385944|69670999|FG002|1st Maintenance Dose Period|Physician Decision|0|||
37985127|NCT00385944|69670997|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
37985128|NCT00385944|69670998|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
37985129|NCT00385944|69670999|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
37985130|NCT00385944|69670997|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
37985131|NCT00385944|69670998|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
37985132|NCT00385944|69670999|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
37985133|NCT00385944|69670997|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
37985134|NCT00385944|69670998|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
37985135|NCT00385944|69670999|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
37985136|NCT00286221|69671018|FG000|Overall Study|Protocol Violation|2|||
37985137|NCT00286221|69671019|FG001|Overall Study|Protocol Violation|1|||
37985138|NCT00286221|69671020|FG002|Overall Study|Protocol Violation|6|||
37985139|NCT00286221|69671021|FG003|Overall Study|Protocol Violation|4|||
37985140|NCT00286221|69671018|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
37985141|NCT00286221|69671019|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
37985142|NCT00286221|69671020|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
37985143|NCT00286221|69671021|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
37985144|NCT00286221|69671018|FG000|Overall Study|Inability to trigger PCA|2|||
37985145|NCT00286221|69671019|FG001|Overall Study|Inability to trigger PCA|0|||
37985146|NCT00286221|69671020|FG002|Overall Study|Inability to trigger PCA|0|||
37985147|NCT00286221|69671021|FG003|Overall Study|Inability to trigger PCA|0|||
37985148|NCT00286221|69671018|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
37985149|NCT00286221|69671019|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
37985150|NCT00286221|69671020|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
37985151|NCT00286221|69671021|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
37985152|NCT00285207|69671033|FG000|Overall Study|Lost to Follow-up|3|||
37985153|NCT00285207|69671034|FG001|Overall Study|Lost to Follow-up|2|||
37985154|NCT00285207|69671033|FG000|Overall Study|Withdrawal by Subject|5|||
37985155|NCT00285207|69671034|FG001|Overall Study|Withdrawal by Subject|2|||
37985156|NCT00285207|69671033|FG000|Overall Study|Pregnancy|1|||
37985157|NCT00285207|69671034|FG001|Overall Study|Pregnancy|1|||
37985158|NCT00285207|69671033|FG000|Overall Study|non-compliance|0|||
37985159|NCT00285207|69671034|FG001|Overall Study|non-compliance|1|||
37985160|NCT00398112|69671040|FG000|Overall Study|Adverse Event|4|||
37985161|NCT00398112|69671040|FG000|Overall Study|Disease progression|9|||
37985162|NCT00398112|69671040|FG000|Overall Study|Alternative treatment|1|||
37985163|NCT00398112|69671040|FG000|Overall Study|Withdrawal by Subject|3|||
37985164|NCT00398112|69671040|FG000|Overall Study|Death|1|||
37985165|NCT00424346|69671048|FG000|Core Study|Adverse Event|5|||
37985166|NCT00424346|69671049|FG001|Core Study|Adverse Event|3|||
37985167|NCT00424346|69671050|FG002|Core Study|Adverse Event|1|||
37985168|NCT00424346|69671051|FG003|Core Study|Adverse Event|1|||
37985169|NCT00424346|69671048|FG000|Core Study|Abnormal Laboratory Values|0|||
37985170|NCT00424346|69671049|FG001|Core Study|Abnormal Laboratory Values|1|||
37985171|NCT00424346|69671050|FG002|Core Study|Abnormal Laboratory Values|0|||
37985172|NCT00424346|69671051|FG003|Core Study|Abnormal Laboratory Values|0|||
37985173|NCT00424346|69671048|FG000|Core Study|Lack of Efficacy|1|||
37985174|NCT00424346|69671049|FG001|Core Study|Lack of Efficacy|3|||
37985175|NCT00424346|69671050|FG002|Core Study|Lack of Efficacy|0|||
37985176|NCT00424346|69671051|FG003|Core Study|Lack of Efficacy|4|||
37985177|NCT00424346|69671048|FG000|Core Study|Withdrawal by Subject|1|||
37985178|NCT00424346|69671049|FG001|Core Study|Withdrawal by Subject|0|||
37985179|NCT00424346|69671050|FG002|Core Study|Withdrawal by Subject|0|||
37985180|NCT00424346|69671051|FG003|Core Study|Withdrawal by Subject|2|||
37985181|NCT00424346|69671048|FG000|Core Study|Lost to Follow-up|1|||
37985182|NCT00424346|69671049|FG001|Core Study|Lost to Follow-up|1|||
37985183|NCT00424346|69671050|FG002|Core Study|Lost to Follow-up|0|||
37985184|NCT00424346|69671051|FG003|Core Study|Lost to Follow-up|0|||
37985185|NCT00424346|69671048|FG000|Core Study|Administrative Problems|1|||
37985186|NCT00424346|69671049|FG001|Core Study|Administrative Problems|0|||
37985187|NCT00424346|69671050|FG002|Core Study|Administrative Problems|1|||
37985188|NCT00424346|69671051|FG003|Core Study|Administrative Problems|0|||
37985189|NCT00424346|69671048|FG000|Core Study|Protocol Violation|0|||
37985190|NCT00424346|69671049|FG001|Core Study|Protocol Violation|0|||
37985191|NCT00424346|69671050|FG002|Core Study|Protocol Violation|2|||
37985192|NCT00424346|69671051|FG003|Core Study|Protocol Violation|0|||
37985193|NCT00424346|69671048|FG000|Extension Phase|Adverse Event|0|||
37985194|NCT00424346|69671049|FG001|Extension Phase|Adverse Event|9|||
37985195|NCT00424346|69671050|FG002|Extension Phase|Adverse Event|5|||
37985196|NCT00424346|69671051|FG003|Extension Phase|Adverse Event|4|||
37985197|NCT00424346|69671048|FG000|Extension Phase|Lack of Efficacy|0|||
37985198|NCT00424346|69671049|FG001|Extension Phase|Lack of Efficacy|16|||
37985199|NCT00424346|69671050|FG002|Extension Phase|Lack of Efficacy|14|||
37985200|NCT00424346|69671051|FG003|Extension Phase|Lack of Efficacy|11|||
37985201|NCT00424346|69671048|FG000|Extension Phase|Withdrawal by Subject|0|||
37985202|NCT00424346|69671049|FG001|Extension Phase|Withdrawal by Subject|5|||
37985203|NCT00424346|69671050|FG002|Extension Phase|Withdrawal by Subject|3|||
37985204|NCT00424346|69671051|FG003|Extension Phase|Withdrawal by Subject|4|||
37985205|NCT00424346|69671048|FG000|Extension Phase|Lost to Follow-up|0|||
37985206|NCT00424346|69671049|FG001|Extension Phase|Lost to Follow-up|2|||
37985207|NCT00424346|69671050|FG002|Extension Phase|Lost to Follow-up|0|||
37985208|NCT00424346|69671051|FG003|Extension Phase|Lost to Follow-up|0|||
37985209|NCT00424346|69671048|FG000|Extension Phase|Administrative Problems|0|||
37985210|NCT00424346|69671049|FG001|Extension Phase|Administrative Problems|69|||
37985211|NCT00424346|69671050|FG002|Extension Phase|Administrative Problems|32|||
37985212|NCT00424346|69671051|FG003|Extension Phase|Administrative Problems|35|||
37985213|NCT00424346|69671048|FG000|Extension Phase|Death|0|||
37985214|NCT00424346|69671049|FG001|Extension Phase|Death|0|||
37985215|NCT00424346|69671050|FG002|Extension Phase|Death|0|||
37985216|NCT00424346|69671051|FG003|Extension Phase|Death|1|||
37985217|NCT00424346|69671048|FG000|Extension Phase|Protocol Violation|0|||
37985218|NCT00424346|69671049|FG001|Extension Phase|Protocol Violation|1|||
37985219|NCT00424346|69671050|FG002|Extension Phase|Protocol Violation|1|||
37985220|NCT00424346|69671051|FG003|Extension Phase|Protocol Violation|0|||
37985221|NCT00283959|69671064|FG000|Extension Period|Low Compliance|1|||
37985222|NCT00372528|69671068|FG000|Overall Study|Lack of Efficacy|1|||
37985223|NCT00372528|69671068|FG000|Overall Study|Adverse Event|1|||
37985224|NCT00372528|69671068|FG000|Overall Study|Study Terminated by Sponsor|18|||
37985225|NCT00372528|69671068|FG000|Overall Study|Other|1|||
37985226|NCT00283803|69671072|FG000|Overall Study|Physician Decision|9|||
37985227|NCT00283803|69671072|FG000|Overall Study|Withdrawal by Subject|4|||
37985228|NCT00397488|69671076|FG000|Overall Study|Withdrawal by Subject|3|||
37985229|NCT00397488|69671076|FG000|Overall Study|Adverse Event|3|||
37985230|NCT00397488|69671076|FG000|Overall Study|Death|1|||
37985231|NCT00424190|69671082|FG000|Overall Study|Withdrew consent|3|||
37985232|NCT00424190|69671083|FG001|Overall Study|Withdrew consent|4|||
37985233|NCT00424190|69671082|FG000|Overall Study|Death|3|||
37985234|NCT00424190|69671083|FG001|Overall Study|Death|0|||
37985235|NCT00424190|69671082|FG000|Overall Study|Noncompliance|1|||
37985236|NCT00424190|69671083|FG001|Overall Study|Noncompliance|2|||
37985237|NCT00424190|69671082|FG000|Overall Study|Request of sponsor or investigator|0|||
37985238|NCT00424190|69671083|FG001|Overall Study|Request of sponsor or investigator|2|||
37985239|NCT00424190|69671082|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
37985240|NCT00424190|69671083|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
37985241|NCT00424190|69671082|FG000|Overall Study|Other|15|||
37985242|NCT00424190|69671083|FG001|Overall Study|Other|21|||
37985243|NCT00428246|69671092|FG000|Overall Study|Withdrawal by Subject|0|||
37985244|NCT00428246|69671093|FG001|Overall Study|Withdrawal by Subject|0|||
37985245|NCT00428246|69671094|FG002|Overall Study|Withdrawal by Subject|1|||
37985246|NCT00428246|69671092|FG000|Overall Study|Adverse Event|1|||
37985247|NCT00428246|69671093|FG001|Overall Study|Adverse Event|0|||
37985248|NCT00428246|69671094|FG002|Overall Study|Adverse Event|0|||
37985249|NCT00274287|69671102|FG000|Overall Study|Withdrawal by Subject|1|||
37985250|NCT00274287|69671102|FG000|Overall Study|subject non-compliance|1|||
37985251|NCT00423800|69671109|FG000|Overall Study|Protocol Violation|0|||
37985252|NCT00423800|69671110|FG001|Overall Study|Protocol Violation|1|||
37985253|NCT00405548|69671119|FG000|Overall Study|Cognitive Memory problems on study day|1|||
37985254|NCT00405548|69671120|FG001|Overall Study|Cognitive Memory problems on study day|0|||
37985255|NCT00405548|69671119|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
37820841|NCT01084252|69499989|FG000|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
37820842|NCT01084252|69499990|FG001|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
37985256|NCT00405548|69671120|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
37985257|NCT00405548|69671119|FG000|Overall Study|Unable to self-administer shots|1|||
37985258|NCT00405548|69671120|FG001|Overall Study|Unable to self-administer shots|0|||
37985259|NCT00405548|69671119|FG000|Overall Study|Venous access failed during study day|1|||
37985260|NCT00405548|69671120|FG001|Overall Study|Venous access failed during study day|0|||
37985261|NCT00405548|69671119|FG000|Overall Study|Withdrawal by Subject|1|||
37985262|NCT00405548|69671120|FG001|Overall Study|Withdrawal by Subject|0|||
37985263|NCT00405392|69671128|FG000|Overall Study|Adverse Event|15|||
37985264|NCT00405392|69671129|FG001|Overall Study|Adverse Event|14|||
37985265|NCT00405392|69671128|FG000|Overall Study|Did not meet Eligibility criteria|7|||
37985266|NCT00405392|69671129|FG001|Overall Study|Did not meet Eligibility criteria|2|||
37985267|NCT00405392|69671128|FG000|Overall Study|Withdrawal by Subject|4|||
37985268|NCT00405392|69671129|FG001|Overall Study|Withdrawal by Subject|3|||
37985269|NCT00405392|69671128|FG000|Overall Study|Lost to Follow-up|1|||
37985270|NCT00405392|69671129|FG001|Overall Study|Lost to Follow-up|2|||
37985271|NCT00405392|69671128|FG000|Overall Study|Data missing|2|||
37985272|NCT00405392|69671129|FG001|Overall Study|Data missing|0|||
37985273|NCT00405392|69671128|FG000|Overall Study|Non-compliance|0|||
37985274|NCT00405392|69671129|FG001|Overall Study|Non-compliance|1|||
37985275|NCT00405392|69671128|FG000|Overall Study|Other|1|||
37985276|NCT00405392|69671129|FG001|Overall Study|Other|5|||
37985277|NCT00282243|69671135|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
37985278|NCT00282243|69671135|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
37985279|NCT00282243|69671135|FG000|Extension Treatment Period|Adverse Event|15|||
37985280|NCT00282243|69671135|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
37985281|NCT00282243|69671135|FG000|Extension Treatment Period|Non-compliance|2|||
37985282|NCT00282243|69671135|FG000|Extension Treatment Period|Physician Decision|1|||
37985283|NCT00272961|69671144|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
37985284|NCT00272961|69671145|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
37985285|NCT00272961|69671146|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
37985286|NCT00272961|69671147|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
37985287|NCT00272961|69671148|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
37985288|NCT00272961|69671144|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
37985289|NCT00272961|69671145|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
37985290|NCT00272961|69671146|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
37985291|NCT00272961|69671147|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
37985292|NCT00272961|69671148|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
37985293|NCT00272961|69671144|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
37985294|NCT00272961|69671145|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
37985295|NCT00272961|69671146|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
37985296|NCT00272961|69671147|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
37985297|NCT00272961|69671148|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
37985298|NCT00272961|69671144|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
37985299|NCT00272961|69671145|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
37985300|NCT00272961|69671146|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
37985301|NCT00272961|69671147|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
37985302|NCT00272961|69671148|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
37985303|NCT00272961|69671144|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
37985304|NCT00272961|69671145|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
37985305|NCT00272961|69671146|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
37882269|NCT01004406|69566771|FG001|Overall Study|Withdrawal by Subject|0|||
37882270|NCT01004406|69566770|FG000|Overall Study|Lost to Follow-up|1|||
37882271|NCT01004406|69566771|FG001|Overall Study|Lost to Follow-up|0|||
37882272|NCT01182350|69566786|FG000|Overall Study|Adverse Event|5|||
37882273|NCT01182350|69566787|FG001|Overall Study|Adverse Event|0|||
37882274|NCT01182350|69566788|FG002|Overall Study|Adverse Event|0|||
37985306|NCT00272961|69671147|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
37985307|NCT00272961|69671148|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
37882275|NCT01182350|69566789|FG003|Overall Study|Adverse Event|0|||
37882276|NCT01182350|69566790|FG004|Overall Study|Adverse Event|0|||
37882277|NCT01182350|69566786|FG000|Overall Study|Disease Progression|15|||
37882278|NCT01182350|69566787|FG001|Overall Study|Disease Progression|12|||
37882279|NCT01182350|69566788|FG002|Overall Study|Disease Progression|0|||
37882280|NCT01182350|69566789|FG003|Overall Study|Disease Progression|1|||
37882281|NCT01182350|69566790|FG004|Overall Study|Disease Progression|0|||
37882282|NCT01182350|69566786|FG000|Overall Study|Death|0|||
37882283|NCT01182350|69566787|FG001|Overall Study|Death|1|||
37882284|NCT01182350|69566788|FG002|Overall Study|Death|1|||
37882285|NCT01182350|69566789|FG003|Overall Study|Death|0|||
37882286|NCT01182350|69566790|FG004|Overall Study|Death|0|||
37882287|NCT01182350|69566786|FG000|Overall Study|Withdrawal by Subject|3|||
37985308|NCT00272961|69671144|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
37985309|NCT00272961|69671145|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
37985310|NCT00272961|69671146|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
37985311|NCT00272961|69671147|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
37985312|NCT00272961|69671148|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
37882288|NCT01182350|69566787|FG001|Overall Study|Withdrawal by Subject|1|||
37882289|NCT01182350|69566788|FG002|Overall Study|Withdrawal by Subject|0|||
37882290|NCT01182350|69566789|FG003|Overall Study|Withdrawal by Subject|1|||
37820843|NCT01084252|69499991|FG002|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
37820844|NCT01084252|69499992|FG003|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
37820845|NCT01084252|69499993|FG004|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
37820846|NCT01084252|69499994|FG005|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
37820847|NCT01084252|69499995|FG006|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
37820848|NCT01084252|69499996|FG007|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
37820849|NCT01084252|69499997|FG008|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
37820850|NCT01084252|69499998|FG009|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
37820851|NCT01084252|69499999|FG010|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
37985313|NCT00272961|69671144|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
37985314|NCT00272961|69671145|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
37985315|NCT00272961|69671146|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
37985316|NCT00272961|69671147|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
37985317|NCT00272961|69671148|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
37985318|NCT00272961|69671144|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
37985319|NCT00272961|69671145|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
37985320|NCT00272961|69671146|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
37985321|NCT00272961|69671147|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
37985322|NCT00272961|69671148|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
37985323|NCT00282087|69671160|FG000|Overall Study|Death|1|||
37985324|NCT00404924|69671167|FG000|Overall Study|Adverse Event|75|||
37985325|NCT00404924|69671168|FG001|Overall Study|Adverse Event|16|||
37985326|NCT00404924|69671167|FG000|Overall Study|Condition under investigation worsened|475|||
37985327|NCT00404924|69671168|FG001|Overall Study|Condition under investigation worsened|264|||
37985328|NCT00404924|69671167|FG000|Overall Study|Lost to Follow-up|1|||
37985329|NCT00404924|69671168|FG001|Overall Study|Lost to Follow-up|1|||
37985330|NCT00404924|69671167|FG000|Overall Study|Withdrawal by Subject|26|||
37985331|NCT00404924|69671168|FG001|Overall Study|Withdrawal by Subject|13|||
37882291|NCT01182350|69566790|FG004|Overall Study|Withdrawal by Subject|0|||
37882292|NCT01182350|69566786|FG000|Overall Study|Alternative Therapy|2|||
37882293|NCT01182350|69566787|FG001|Overall Study|Alternative Therapy|0|||
37882294|NCT01182350|69566788|FG002|Overall Study|Alternative Therapy|1|||
37882295|NCT01182350|69566789|FG003|Overall Study|Alternative Therapy|0|||
37882296|NCT01182350|69566790|FG004|Overall Study|Alternative Therapy|0|||
37882297|NCT01182350|69566786|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
37882298|NCT01182350|69566787|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
37882299|NCT01182350|69566788|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
37882300|NCT01182350|69566789|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
37882301|NCT01182350|69566790|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
37882302|NCT01182350|69566786|FG000|Overall Study|Unevaluable for Biopsy|0|||
37882303|NCT01182350|69566787|FG001|Overall Study|Unevaluable for Biopsy|0|||
37882304|NCT01182350|69566788|FG002|Overall Study|Unevaluable for Biopsy|0|||
37882305|NCT01182350|69566789|FG003|Overall Study|Unevaluable for Biopsy|0|||
37882306|NCT01182350|69566790|FG004|Overall Study|Unevaluable for Biopsy|3|||
37882307|NCT01163474|69566806|FG000|Overall Study|Withdrawal by Subject|1|||
37882308|NCT01163474|69566806|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
37882309|NCT01163474|69566806|FG000|Overall Study|Lost to Follow-up|3|||
37882310|NCT00603538|69566816|FG000|Overall Study|Adverse Event|0|||
37882311|NCT00603538|69566817|FG001|Overall Study|Adverse Event|4|||
37882312|NCT00603538|69566818|FG002|Overall Study|Adverse Event|2|||
37882313|NCT00603538|69566816|FG000|Overall Study|Objective progression or relapse|3|||
37882314|NCT00603538|69566817|FG001|Overall Study|Objective progression or relapse|0|||
37882315|NCT00603538|69566818|FG002|Overall Study|Objective progression or relapse|0|||
37882316|NCT01163318|69566829|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
37882317|NCT01163318|69566829|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
37882318|NCT01163318|69566829|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
37882319|NCT01163318|69566829|FG000|Overall Study|Participants Without Case Report Form|7|||
37882320|NCT01163318|69566829|FG000|Overall Study|Multiple Reasons Per Participant|224|||
37882321|NCT01162304|69566833|FG000|Overall Study|Beck scale to high|11|||
37882322|NCT04515394|69566839|FG000|Overall Study|Participant did not receive treatment|1|||
37882323|NCT01175018|69566845|FG000|Overall Study|Adverse Event|3|||
37882324|NCT01175018|69566846|FG001|Overall Study|Adverse Event|1|||
37882325|NCT01174784|69566854|FG000|Overall Study|Screen fails|4|||
37882326|NCT01174550|69566861|FG000|Overall Study|Death|75|||
37985332|NCT00404924|69671167|FG000|Overall Study|Other|25|||
37882327|NCT01174550|69566862|FG001|Overall Study|Death|74|||
37882328|NCT01174550|69566861|FG000|Overall Study|Lost to Follow-up|652|||
37882329|NCT01174550|69566862|FG001|Overall Study|Lost to Follow-up|510|||
37882330|NCT01174550|69566861|FG000|Overall Study|Withdrawal by Subject|543|||
37882331|NCT01174550|69566862|FG001|Overall Study|Withdrawal by Subject|289|||
37882332|NCT01008150|69566872|FG000|Overall Study|did not receive study drug|1|||
37985333|NCT00404924|69671168|FG001|Overall Study|Other|11|||
37985334|NCT00404924|69671167|FG000|Overall Study|Randomised but not received treatment|1|||
37985335|NCT00404924|69671168|FG001|Overall Study|Randomised but not received treatment|1|||
37985336|NCT00281697|69671176|FG000|Overall Study|> 60 days since last dose of study drug|4|||
37985337|NCT00281697|69671177|FG001|Overall Study|> 60 days since last dose of study drug|4|||
37985338|NCT00281697|69671176|FG000|Overall Study|Adverse Event|54|||
37985339|NCT00281697|69671177|FG001|Overall Study|Adverse Event|15|||
37985340|NCT00281697|69671176|FG000|Overall Study|Death|8|||
37985341|NCT00281697|69671177|FG001|Overall Study|Death|3|||
37985342|NCT00281697|69671176|FG000|Overall Study|Disease progression|279|||
37985343|NCT00281697|69671177|FG001|Overall Study|Disease progression|149|||
37985344|NCT00281697|69671176|FG000|Overall Study|Other|5|||
37985345|NCT00281697|69671177|FG001|Overall Study|Other|6|||
37985346|NCT00281697|69671176|FG000|Overall Study|Physician's decision to withdraw|15|||
37985347|NCT00281697|69671177|FG001|Overall Study|Physician's decision to withdraw|12|||
37985348|NCT00281697|69671176|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
37985349|NCT00281697|69671177|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
37985350|NCT00281697|69671176|FG000|Overall Study|Did not receive study drug|3|||
37985351|NCT00281697|69671177|FG001|Overall Study|Did not receive study drug|2|||
37985352|NCT00271947|69671183|FG000|Overall Study|Lost to Follow-up|1|||
37985353|NCT00232180|69671189|FG000|Double-blind (DB) Phase|Death|186|||
37985354|NCT00232180|69671190|FG001|Double-blind (DB) Phase|Death|222|||
37985355|NCT00232180|69671191|FG002|Double-blind (DB) Phase|Death|0|||
37985356|NCT00232180|69671189|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
37985357|NCT00232180|69671190|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
37985358|NCT00232180|69671191|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
37985359|NCT00232180|69671189|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
37985360|NCT00232180|69671190|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
37985361|NCT00232180|69671191|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
37985362|NCT00232180|69671189|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
37985363|NCT00232180|69671190|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
37985364|NCT00232180|69671191|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
37985365|NCT00232180|69671189|FG000|Double-blind (DB) Phase|Adverse Event|83|||
37985366|NCT00232180|69671190|FG001|Double-blind (DB) Phase|Adverse Event|100|||
37985367|NCT00232180|69671191|FG002|Double-blind (DB) Phase|Adverse Event|0|||
37985368|NCT00232180|69671189|FG000|Double-blind (DB) Phase|Other|70|||
37985369|NCT00232180|69671190|FG001|Double-blind (DB) Phase|Other|75|||
37985370|NCT00232180|69671191|FG002|Double-blind (DB) Phase|Other|0|||
37985371|NCT00232180|69671189|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
37985372|NCT00232180|69671190|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
37985373|NCT00232180|69671191|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
37985374|NCT00232180|69671189|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
37985375|NCT00232180|69671190|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
37985376|NCT00232180|69671191|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
37985377|NCT00232180|69671189|FG000|Open Label Phase|Death|0|||
37985378|NCT00232180|69671190|FG001|Open Label Phase|Death|0|||
37985379|NCT00232180|69671191|FG002|Open Label Phase|Death|48|||
37985380|NCT00232180|69671189|FG000|Open Label Phase|Lost to Follow-up|0|||
37985381|NCT00232180|69671190|FG001|Open Label Phase|Lost to Follow-up|0|||
37985382|NCT00232180|69671191|FG002|Open Label Phase|Lost to Follow-up|5|||
37985383|NCT00232180|69671189|FG000|Open Label Phase|Protocol Violation|0|||
37985384|NCT00232180|69671190|FG001|Open Label Phase|Protocol Violation|0|||
37985385|NCT00232180|69671191|FG002|Open Label Phase|Protocol Violation|3|||
37985386|NCT00232180|69671189|FG000|Open Label Phase|Study terminated by sponsor|0|||
37985387|NCT00232180|69671190|FG001|Open Label Phase|Study terminated by sponsor|0|||
37985388|NCT00232180|69671191|FG002|Open Label Phase|Study terminated by sponsor|3|||
37985389|NCT00232180|69671189|FG000|Open Label Phase|Withdrawal by Subject|0|||
37985390|NCT00232180|69671190|FG001|Open Label Phase|Withdrawal by Subject|0|||
37985391|NCT00232180|69671191|FG002|Open Label Phase|Withdrawal by Subject|37|||
37985392|NCT00232180|69671189|FG000|Open Label Phase|Other|0|||
37820852|NCT01084252|69500000|FG011|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
37820853|NCT01084252|69500001|FG012|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|1|||
37820854|NCT01084252|69500002|FG013|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
37820855|NCT01084252|69499989|FG000|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
37820856|NCT01084252|69499990|FG001|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
37820857|NCT01084252|69499991|FG002|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
37985393|NCT00232180|69671190|FG001|Open Label Phase|Other|0|||
37985394|NCT00232180|69671191|FG002|Open Label Phase|Other|16|||
37985395|NCT00232180|69671189|FG000|Open Label Phase|Adverse Event|0|||
37985396|NCT00232180|69671190|FG001|Open Label Phase|Adverse Event|0|||
37985397|NCT00232180|69671191|FG002|Open Label Phase|Adverse Event|25|||
37985398|NCT00232180|69671189|FG000|Open Label Phase|Laboratory abnormality|0|||
37985399|NCT00232180|69671190|FG001|Open Label Phase|Laboratory abnormality|0|||
37985400|NCT00232180|69671191|FG002|Open Label Phase|Laboratory abnormality|10|||
37882333|NCT01008150|69566873|FG001|Overall Study|did not receive study drug|1|||
37882334|NCT01008150|69566874|FG002|Overall Study|did not receive study drug|1|||
37882335|NCT01008150|69566875|FG003|Overall Study|did not receive study drug|0|||
37882336|NCT01007916|69566886|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
37882337|NCT01007916|69566887|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
37882338|NCT01007916|69566886|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
37882339|NCT01007916|69566887|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
37882340|NCT01007838|69566897|FG000|Overall Study|Withdrawal by Subject|1|||
37882341|NCT01007838|69566898|FG001|Overall Study|Withdrawal by Subject|0|||
37882342|NCT01007838|69566899|FG002|Overall Study|Withdrawal by Subject|0|||
37882343|NCT01007838|69566900|FG003|Overall Study|Withdrawal by Subject|0|||
37882344|NCT01007838|69566897|FG000|Overall Study|Physician Decision|1|||
37882345|NCT01007838|69566898|FG001|Overall Study|Physician Decision|0|||
37882346|NCT01007838|69566899|FG002|Overall Study|Physician Decision|0|||
37882347|NCT01007838|69566900|FG003|Overall Study|Physician Decision|0|||
37882348|NCT01007838|69566897|FG000|Overall Study|Started home haemodialysis|1|||
37882349|NCT01007838|69566898|FG001|Overall Study|Started home haemodialysis|0|||
37882350|NCT01007838|69566899|FG002|Overall Study|Started home haemodialysis|0|||
37882351|NCT01007838|69566900|FG003|Overall Study|Started home haemodialysis|0|||
37882352|NCT01007448|69566912|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
37882353|NCT01007448|69566913|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
37882354|NCT01007448|69566912|FG000|Overall Study|Staph Skin Infection Flare|1|||
37882355|NCT01007448|69566913|FG001|Overall Study|Staph Skin Infection Flare|0|||
37882356|NCT01007448|69566912|FG000|Overall Study|Participant Leaving the Country|1|||
37882357|NCT01007448|69566913|FG001|Overall Study|Participant Leaving the Country|0|||
37882358|NCT01007448|69566912|FG000|Overall Study|Participant Given Prohibited Medication|1|||
37882359|NCT01007448|69566913|FG001|Overall Study|Participant Given Prohibited Medication|0|||
37882360|NCT01007448|69566912|FG000|Overall Study|Progressive Disease|1|||
37882361|NCT01007448|69566913|FG001|Overall Study|Progressive Disease|2|||
37882362|NCT01007448|69566912|FG000|Overall Study|Lack of Efficacy|2|||
37882363|NCT01007448|69566913|FG001|Overall Study|Lack of Efficacy|0|||
37882364|NCT01007448|69566912|FG000|Overall Study|Withdrawal by Subject|2|||
37882365|NCT01007448|69566913|FG001|Overall Study|Withdrawal by Subject|3|||
37882366|NCT01007448|69566912|FG000|Overall Study|Adverse Event|1|||
37882367|NCT01007448|69566913|FG001|Overall Study|Adverse Event|4|||
37882368|NCT03538756|69566919|FG000|Long-Term Follow-up|Adverse Event|0|||
37882369|NCT03538756|69566920|FG001|Long-Term Follow-up|Adverse Event|0|||
37882370|NCT03538756|69566921|FG002|Long-Term Follow-up|Adverse Event|6|||
37882371|NCT03538756|69566919|FG000|Long-Term Follow-up|Death|0|||
37882372|NCT03538756|69566920|FG001|Long-Term Follow-up|Death|0|||
37882373|NCT03538756|69566921|FG002|Long-Term Follow-up|Death|1|||
37882374|NCT03538756|69566919|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
37882375|NCT03538756|69566920|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
37882376|NCT03538756|69566921|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
37882377|NCT03538756|69566919|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
37882378|NCT03538756|69566920|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
37882379|NCT03538756|69566921|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
37882380|NCT03538756|69566919|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
37882381|NCT03538756|69566920|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
37882382|NCT03538756|69566921|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
37882383|NCT01004250|69566931|FG000|Induction Therapy Period|Adverse Event|10|||
37882384|NCT01004250|69566931|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
37882385|NCT01004250|69566931|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
37882386|NCT01004250|69566931|FG000|Induction Therapy Period|Physician Decision|2|||
37882387|NCT01004250|69566931|FG000|Maintenance Therapy Period|Adverse Event|15|||
37882388|NCT01004250|69566931|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
37820858|NCT01084252|69499992|FG003|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
37820859|NCT01084252|69499993|FG004|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
37820860|NCT01084252|69499994|FG005|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
37820861|NCT01084252|69499995|FG006|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
37820862|NCT01084252|69499996|FG007|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
37820863|NCT01084252|69499997|FG008|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
37820864|NCT01084252|69499998|FG009|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
37820865|NCT01084252|69499999|FG010|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
37820866|NCT01084252|69500000|FG011|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
37820867|NCT01084252|69500001|FG012|Phase 2 Stage 2 (97 Weeks)|Other than specified above|12|||
37820868|NCT01084252|69500002|FG013|Phase 2 Stage 2 (97 Weeks)|Other than specified above|2|||
37820869|NCT01084252|69499989|FG000|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
37820870|NCT01084252|69499990|FG001|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
37820871|NCT01084252|69499991|FG002|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
37820872|NCT01084252|69499992|FG003|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
37882389|NCT01004250|69566931|FG000|Maintenance Therapy Period|Protocol Violation|1|||
37882390|NCT01004250|69566931|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
37882391|NCT01004250|69566931|FG000|Maintenance Therapy Period|Physician Decision|4|||
37882392|NCT01004250|69566931|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
37882393|NCT01004172|69566939|FG000|Overall Study|Progressive Disease in CNS Only|16|||
37820873|NCT01084252|69499993|FG004|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
37820874|NCT01084252|69499994|FG005|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
37820875|NCT01084252|69499995|FG006|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
37882394|NCT01004172|69566939|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
37882395|NCT01004172|69566939|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
37882396|NCT01004172|69566939|FG000|Overall Study|Adverse Event|1|||
37882397|NCT01004172|69566939|FG000|Overall Study|Physician Decision|1|||
37882398|NCT01004172|69566939|FG000|Overall Study|Symptomatic Deterioration|2|||
37882399|NCT01161524|69566946|FG000|Core Study (23 Weeks)|Adverse Event|3|||
37882400|NCT01161524|69566947|FG001|Core Study (23 Weeks)|Adverse Event|0|||
37882401|NCT01161524|69566948|FG002|Core Study (23 Weeks)|Adverse Event|0|||
37882402|NCT01161524|69566946|FG000|Core Study (23 Weeks)|Other|1|||
37882403|NCT01161524|69566947|FG001|Core Study (23 Weeks)|Other|0|||
37882404|NCT01161524|69566948|FG002|Core Study (23 Weeks)|Other|0|||
37882405|NCT01161524|69566946|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
37882406|NCT01161524|69566947|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
37882407|NCT01161524|69566948|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
37882408|NCT01161524|69566946|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
37882409|NCT01161524|69566947|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
37882410|NCT01161524|69566948|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
37882411|NCT01161524|69566946|FG000|Core Study (23 Weeks)|Subject Choice|3|||
37882412|NCT01161524|69566947|FG001|Core Study (23 Weeks)|Subject Choice|2|||
37882413|NCT01161524|69566948|FG002|Core Study (23 Weeks)|Subject Choice|0|||
37882414|NCT01161524|69566946|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
37882415|NCT01161524|69566947|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
37882416|NCT01161524|69566948|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
37882417|NCT01161524|69566946|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
37882418|NCT01161524|69566947|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
37882419|NCT01161524|69566948|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
37882420|NCT01161524|69566946|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
37882421|NCT01161524|69566947|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
37882422|NCT01161524|69566948|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
37882423|NCT01161524|69566946|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
37882424|NCT01161524|69566947|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
37882425|NCT01161524|69566948|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
37882426|NCT01161524|69566946|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
37882427|NCT01161524|69566947|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
37882428|NCT01161524|69566948|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
37882429|NCT01000506|69566961|FG000|Overall Study|Adverse Event|6|||
37882430|NCT01000506|69566962|FG001|Overall Study|Adverse Event|5|||
37882431|NCT01000506|69566963|FG002|Overall Study|Adverse Event|8|||
37882432|NCT01000506|69566964|FG003|Overall Study|Adverse Event|9|||
37882433|NCT01000506|69566961|FG000|Overall Study|Lack of Efficacy|8|||
37882434|NCT01000506|69566962|FG001|Overall Study|Lack of Efficacy|6|||
37882435|NCT01000506|69566963|FG002|Overall Study|Lack of Efficacy|4|||
37882436|NCT01000506|69566964|FG003|Overall Study|Lack of Efficacy|4|||
37882437|NCT01000506|69566961|FG000|Overall Study|Protocol Violation|1|||
37882438|NCT01000506|69566962|FG001|Overall Study|Protocol Violation|1|||
37882439|NCT01000506|69566963|FG002|Overall Study|Protocol Violation|0|||
37882440|NCT01000506|69566964|FG003|Overall Study|Protocol Violation|0|||
37820876|NCT01084252|69499996|FG007|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
37820877|NCT01084252|69499997|FG008|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
37820878|NCT01084252|69499998|FG009|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
37820879|NCT01084252|69499999|FG010|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
37820880|NCT01084252|69500000|FG011|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
37820881|NCT01084252|69500001|FG012|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|13|||
37820882|NCT01084252|69500002|FG013|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|15|||
37820883|NCT01084252|69499989|FG000|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
37820884|NCT01084252|69499990|FG001|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
37820885|NCT01084252|69499991|FG002|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
37820886|NCT01084252|69499992|FG003|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
37882441|NCT01000506|69566961|FG000|Overall Study|Lost to Follow-up|1|||
37882442|NCT01000506|69566962|FG001|Overall Study|Lost to Follow-up|1|||
37882443|NCT01000506|69566963|FG002|Overall Study|Lost to Follow-up|4|||
37882444|NCT01000506|69566964|FG003|Overall Study|Lost to Follow-up|0|||
37882445|NCT01000506|69566961|FG000|Overall Study|Physician Decision|1|||
37882446|NCT01000506|69566962|FG001|Overall Study|Physician Decision|3|||
37882447|NCT01000506|69566963|FG002|Overall Study|Physician Decision|3|||
37882448|NCT01000506|69566964|FG003|Overall Study|Physician Decision|3|||
37882449|NCT01000506|69566961|FG000|Overall Study|Withdrawal by Subject|11|||
37882450|NCT01000506|69566962|FG001|Overall Study|Withdrawal by Subject|8|||
37882451|NCT01000506|69566963|FG002|Overall Study|Withdrawal by Subject|2|||
37882452|NCT01000506|69566964|FG003|Overall Study|Withdrawal by Subject|7|||
37882453|NCT01174238|69566974|FG000|Overall Study|Lost to Follow-up|2|||
37882454|NCT01174160|69566983|FG000|Overall Study|Adverse Event|1|||
37882455|NCT01174160|69566984|FG001|Overall Study|Adverse Event|0|||
37882456|NCT01174160|69566983|FG000|Overall Study|Lost to Follow-up|1|||
37882457|NCT01174160|69566984|FG001|Overall Study|Lost to Follow-up|0|||
37882458|NCT01174160|69566983|FG000|Overall Study|Physician Decision|1|||
37882459|NCT01174160|69566984|FG001|Overall Study|Physician Decision|0|||
37882460|NCT01174160|69566983|FG000|Overall Study|Protocol Violation|4|||
37985401|NCT00232180|69671189|FG000|Open Label Phase|Randomized but not treated|0|||
37985402|NCT00232180|69671190|FG001|Open Label Phase|Randomized but not treated|0|||
37985403|NCT00232180|69671191|FG002|Open Label Phase|Randomized but not treated|1|||
37985404|NCT00280683|69671202|FG000|Overall Study|Withdrawal by Subject|1|||
37985405|NCT00280683|69671203|FG001|Overall Study|Withdrawal by Subject|2|||
37985406|NCT00280683|69671202|FG000|Overall Study|Adverse Event|1|||
37985407|NCT00280683|69671203|FG001|Overall Study|Adverse Event|1|||
37985408|NCT00270855|69671213|FG000|Overall Study|Withdrawal by Subject|8|||
37985409|NCT00270855|69671214|FG001|Overall Study|Withdrawal by Subject|8|||
37985410|NCT00404768|69671226|FG000|Part A and B|Withdrawn due to labor progression|1|||
37985411|NCT00404768|69671227|FG001|Part A and B|Withdrawn due to labor progression|0|||
37985412|NCT00404768|69671228|FG002|Part A and B|Withdrawn due to labor progression|0|||
37985413|NCT00404768|69671229|FG003|Part A and B|Withdrawn due to labor progression|0|||
37985414|NCT00404768|69671226|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
37985415|NCT00404768|69671227|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
37985416|NCT00404768|69671228|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
37985417|NCT00404768|69671229|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
37985418|NCT00404768|69671226|FG000|Part C|Adverse Event|0|||
37985419|NCT00404768|69671227|FG001|Part C|Adverse Event|0|||
37985420|NCT00404768|69671228|FG002|Part C|Adverse Event|0|||
37985421|NCT00404768|69671229|FG003|Part C|Adverse Event|3|||
37985422|NCT00404768|69671226|FG000|Part C|Lost to Follow-up|0|||
37985423|NCT00404768|69671227|FG001|Part C|Lost to Follow-up|0|||
37985424|NCT00404768|69671228|FG002|Part C|Lost to Follow-up|3|||
37985425|NCT00404768|69671229|FG003|Part C|Lost to Follow-up|1|||
37985426|NCT00404768|69671226|FG000|Part C|Withdrawal by Subject|0|||
37985427|NCT00404768|69671227|FG001|Part C|Withdrawal by Subject|0|||
37985428|NCT00404768|69671228|FG002|Part C|Withdrawal by Subject|2|||
37985429|NCT00404768|69671229|FG003|Part C|Withdrawal by Subject|1|||
37985430|NCT00404768|69671226|FG000|Part C|Early withdrawal from study medication|0|||
37985431|NCT00404768|69671227|FG001|Part C|Early withdrawal from study medication|0|||
37985432|NCT00404768|69671228|FG002|Part C|Early withdrawal from study medication|1|||
37985433|NCT00404768|69671229|FG003|Part C|Early withdrawal from study medication|0|||
37985434|NCT00404768|69671226|FG000|Part C|Participant did not respond to therapy|0|||
37985435|NCT00404768|69671227|FG001|Part C|Participant did not respond to therapy|0|||
37985436|NCT00404768|69671228|FG002|Part C|Participant did not respond to therapy|1|||
37985437|NCT00404768|69671229|FG003|Part C|Participant did not respond to therapy|1|||
37985438|NCT00404768|69671226|FG000|Part C|Physician withdrew the study medication|0|||
37985439|NCT00404768|69671227|FG001|Part C|Physician withdrew the study medication|0|||
37985440|NCT00404768|69671228|FG002|Part C|Physician withdrew the study medication|1|||
37985441|NCT00404768|69671229|FG003|Part C|Physician withdrew the study medication|0|||
37985442|NCT00404768|69671226|FG000|Part C|Participant delivered baby|0|||
37820887|NCT01084252|69499993|FG004|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
37820888|NCT01084252|69499994|FG005|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
37820889|NCT01084252|69499995|FG006|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
37820890|NCT01084252|69499996|FG007|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
37820891|NCT01084252|69499997|FG008|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
37820892|NCT01084252|69499998|FG009|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
37820893|NCT01084252|69499999|FG010|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
37820894|NCT01084252|69500000|FG011|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
37820895|NCT01084252|69500001|FG012|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|1|||
37820896|NCT01084252|69500002|FG013|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
37820897|NCT00993044|69500066|FG000|Irinotecan 50 mg|Physician Decision|1|||
37820898|NCT00676715|69500075|FG000|Overall Study|Withdrawal by Subject|7|||
37820899|NCT00676715|69500076|FG001|Overall Study|Withdrawal by Subject|9|||
37820900|NCT00676715|69500077|FG002|Overall Study|Withdrawal by Subject|10|||
37820901|NCT00676715|69500078|FG003|Overall Study|Withdrawal by Subject|10|||
37820902|NCT00676715|69500075|FG000|Overall Study|Other|2|||
37820903|NCT00676715|69500076|FG001|Overall Study|Other|6|||
37820904|NCT00676715|69500077|FG002|Overall Study|Other|4|||
37820905|NCT00676715|69500078|FG003|Overall Study|Other|3|||
37820906|NCT00676715|69500075|FG000|Overall Study|Lost to Follow-up|1|||
37882461|NCT01174160|69566984|FG001|Overall Study|Protocol Violation|6|||
37985443|NCT00404768|69671227|FG001|Part C|Participant delivered baby|0|||
37985444|NCT00404768|69671228|FG002|Part C|Participant delivered baby|0|||
37985445|NCT00404768|69671229|FG003|Part C|Participant delivered baby|1|||
37985446|NCT00404768|69671226|FG000|Part C|Unsatisfactory uterine response to IP|0|||
37985447|NCT00404768|69671227|FG001|Part C|Unsatisfactory uterine response to IP|0|||
37985448|NCT00404768|69671228|FG002|Part C|Unsatisfactory uterine response to IP|0|||
37985449|NCT00404768|69671229|FG003|Part C|Unsatisfactory uterine response to IP|1|||
37985450|NCT00404768|69671226|FG000|Part C|Active labor|0|||
37985451|NCT00404768|69671227|FG001|Part C|Active labor|0|||
37985452|NCT00404768|69671228|FG002|Part C|Active labor|0|||
37985453|NCT00404768|69671229|FG003|Part C|Active labor|1|||
37985454|NCT00404768|69671226|FG000|Part C|Lack of Efficacy|0|||
37985455|NCT00404768|69671227|FG001|Part C|Lack of Efficacy|0|||
37985456|NCT00404768|69671228|FG002|Part C|Lack of Efficacy|0|||
37985457|NCT00404768|69671229|FG003|Part C|Lack of Efficacy|2|||
37985458|NCT00404768|69671226|FG000|Part C|Treatment failure|0|||
37985459|NCT00404768|69671227|FG001|Part C|Treatment failure|0|||
37985460|NCT00404768|69671228|FG002|Part C|Treatment failure|0|||
37985461|NCT00404768|69671229|FG003|Part C|Treatment failure|1|||
37985462|NCT00404768|69671226|FG000|Part C|Investigator discretion|0|||
37985463|NCT00404768|69671227|FG001|Part C|Investigator discretion|0|||
37985464|NCT00404768|69671228|FG002|Part C|Investigator discretion|0|||
37985465|NCT00404768|69671229|FG003|Part C|Investigator discretion|1|||
37985466|NCT00404768|69671226|FG000|Part C|Researcher suspended study medication|0|||
37985467|NCT00404768|69671227|FG001|Part C|Researcher suspended study medication|0|||
37985468|NCT00404768|69671228|FG002|Part C|Researcher suspended study medication|0|||
37985469|NCT00404768|69671229|FG003|Part C|Researcher suspended study medication|1|||
37985470|NCT00270231|69671244|FG000|First Intervention|Lost to Follow-up|1|||
37985471|NCT00270231|69671245|FG001|First Intervention|Lost to Follow-up|1|||
37985472|NCT00270231|69671244|FG000|Washout Period|Lost to Follow-up|1|||
37985473|NCT00270231|69671245|FG001|Washout Period|Lost to Follow-up|0|||
37985474|NCT00270231|69671244|FG000|Second Intervention|Lost to Follow-up|0|||
37820907|NCT00676715|69500076|FG001|Overall Study|Lost to Follow-up|1|||
37820908|NCT00676715|69500077|FG002|Overall Study|Lost to Follow-up|7|||
37820909|NCT00676715|69500078|FG003|Overall Study|Lost to Follow-up|3|||
37820910|NCT00676715|69500075|FG000|Overall Study|Death|1|||
37820911|NCT00676715|69500076|FG001|Overall Study|Death|1|||
37820912|NCT00676715|69500077|FG002|Overall Study|Death|1|||
37820913|NCT00676715|69500078|FG003|Overall Study|Death|0|||
37820914|NCT00676715|69500075|FG000|Overall Study|Adverse Event|0|||
37820915|NCT00676715|69500076|FG001|Overall Study|Adverse Event|1|||
37820916|NCT00676715|69500077|FG002|Overall Study|Adverse Event|2|||
37820917|NCT00676715|69500078|FG003|Overall Study|Adverse Event|0|||
37820918|NCT00676715|69500075|FG000|Overall Study|Participants Ongoing|29|||
37820919|NCT00676715|69500076|FG001|Overall Study|Participants Ongoing|29|||
37985475|NCT00270231|69671245|FG001|Second Intervention|Lost to Follow-up|1|||
37985476|NCT00258856|69671255|FG000|Overall Study|Lost to Follow-up|1|||
37985477|NCT00258856|69671256|FG001|Overall Study|Lost to Follow-up|0|||
37985478|NCT00258856|69671257|FG002|Overall Study|Lost to Follow-up|2|||
37985479|NCT00258856|69671258|FG003|Overall Study|Lost to Follow-up|0|||
37985480|NCT00258856|69671255|FG000|Overall Study|Non-compliance|2|||
37985481|NCT00258856|69671256|FG001|Overall Study|Non-compliance|0|||
37985482|NCT00258856|69671257|FG002|Overall Study|Non-compliance|0|||
37985483|NCT00258856|69671258|FG003|Overall Study|Non-compliance|1|||
37985484|NCT00269919|69671268|FG000|Overall Study|Other|26|||
37882462|NCT01174160|69566983|FG000|Overall Study|Withdrawal by Subject|1|||
37882463|NCT01174160|69566984|FG001|Overall Study|Withdrawal by Subject|0|||
37882464|NCT01161446|69566992|FG000|Overall Study|Lost to Follow-up|18|||
37882465|NCT01161446|69566993|FG001|Overall Study|Lost to Follow-up|14|||
37882466|NCT01161446|69566992|FG000|Overall Study|Withdrawal by Subject|0|||
37882467|NCT01161446|69566993|FG001|Overall Study|Withdrawal by Subject|1|||
37882468|NCT01174004|69567001|FG000|Overall Study|Adverse Event|2|||
37882469|NCT01174004|69567002|FG001|Overall Study|Adverse Event|10|||
37882470|NCT01174004|69567001|FG000|Overall Study|Withdrawal by Subject|2|||
37882471|NCT01174004|69567002|FG001|Overall Study|Withdrawal by Subject|3|||
37882472|NCT01174004|69567001|FG000|Overall Study|At Discretion of Sponsor|2|||
37882473|NCT01174004|69567002|FG001|Overall Study|At Discretion of Sponsor|2|||
37882474|NCT01174004|69567001|FG000|Overall Study|Protocol Violation|0|||
37882475|NCT01174004|69567002|FG001|Overall Study|Protocol Violation|1|||
37882476|NCT01174004|69567001|FG000|Overall Study|Physician Decision|1|||
37882477|NCT01174004|69567002|FG001|Overall Study|Physician Decision|0|||
37882478|NCT01173692|69567010|FG000|Overall Study|Adverse Event|1|||
37882479|NCT01173692|69567011|FG001|Overall Study|Adverse Event|2|||
37882480|NCT01173692|69567010|FG000|Overall Study|Withdrawal by Subject|1|||
37882481|NCT01173692|69567011|FG001|Overall Study|Withdrawal by Subject|3|||
37882482|NCT01101035|69567019|FG000|Overall Study|Adverse Event|191|||
37882483|NCT01101035|69567020|FG001|Overall Study|Adverse Event|172|||
37882484|NCT01101035|69567019|FG000|Overall Study|Major Protocol Deviation|52|||
37882485|NCT01101035|69567020|FG001|Overall Study|Major Protocol Deviation|46|||
37882486|NCT01101035|69567019|FG000|Overall Study|Lost to Follow-up|226|||
37882487|NCT01101035|69567020|FG001|Overall Study|Lost to Follow-up|223|||
37882488|NCT01101035|69567019|FG000|Overall Study|Voluntary Withdrawal|595|||
37882489|NCT01101035|69567020|FG001|Overall Study|Voluntary Withdrawal|587|||
37882490|NCT01101035|69567019|FG000|Overall Study|Reason not Specified|333|||
37882491|NCT01101035|69567020|FG001|Overall Study|Reason not Specified|363|||
37882492|NCT01100567|69567028|FG000|Overall Study|Withdrawal by Subject|5|||
37882493|NCT01100567|69567029|FG001|Overall Study|Withdrawal by Subject|8|||
37882494|NCT01100567|69567028|FG000|Overall Study|Early Hospital Discharge|6|||
37820920|NCT00676715|69500077|FG002|Overall Study|Participants Ongoing|17|||
37820921|NCT00676715|69500078|FG003|Overall Study|Participants Ongoing|24|||
37820922|NCT00116272|69500090|FG000|Overall Study|Lost to Follow-up|11|||
37820923|NCT00116272|69500091|FG001|Overall Study|Lost to Follow-up|6|||
37820924|NCT01945021|69500099|FG000|Overall Study|Adverse Event|1|||
37820925|NCT01945021|69500099|FG000|Overall Study|Withdrawal of consent|12|||
37820926|NCT01945021|69500099|FG000|Overall Study|Lost to Follow-up|5|||
37820927|NCT01945021|69500099|FG000|Overall Study|Death|65|||
37820928|NCT01945060|69500105|FG000|Overall Study|Lost to follow up|1|||
37820929|NCT01945060|69500106|FG001|Overall Study|Lost to follow up|0|||
37820930|NCT01945060|69500105|FG000|Overall Study|Distress related to IV access|0|||
37820931|NCT01945060|69500106|FG001|Overall Study|Distress related to IV access|1|||
37820932|NCT03951077|69500149|FG000|Overall Study|Adverse Event|1|||
37820933|NCT03951077|69500150|FG001|Overall Study|Adverse Event|0|||
37820934|NCT03951077|69500151|FG002|Overall Study|Adverse Event|0|||
37820935|NCT03951077|69500152|FG003|Overall Study|Adverse Event|0|||
37820936|NCT03951077|69500153|FG004|Overall Study|Adverse Event|0|||
37820937|NCT03951077|69500154|FG005|Overall Study|Adverse Event|0|||
37882495|NCT01100567|69567029|FG001|Overall Study|Early Hospital Discharge|4|||
37882496|NCT01100567|69567028|FG000|Overall Study|Lost to Follow-up|1|||
37882497|NCT01100567|69567029|FG001|Overall Study|Lost to Follow-up|2|||
37882498|NCT01100567|69567028|FG000|Overall Study|Physician Decision|0|||
37882499|NCT01100567|69567029|FG001|Overall Study|Physician Decision|1|||
37882500|NCT01100567|69567028|FG000|Overall Study|Deemed ineligible after consent|0|||
37882501|NCT01100567|69567029|FG001|Overall Study|Deemed ineligible after consent|1|||
37882502|NCT01160822|69567042|FG000|Overall Study|Adverse Event|0|||
37882503|NCT01160822|69567043|FG001|Overall Study|Adverse Event|0|||
37882504|NCT01160822|69567044|FG002|Overall Study|Adverse Event|0|||
37882505|NCT01160822|69567045|FG003|Overall Study|Adverse Event|0|||
37882506|NCT01160822|69567046|FG004|Overall Study|Adverse Event|1|||
37882507|NCT01160822|69567047|FG005|Overall Study|Adverse Event|2|||
37882508|NCT01160822|69567048|FG006|Overall Study|Adverse Event|5|||
37882509|NCT01160822|69567042|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
37882510|NCT01160822|69567043|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
37882511|NCT01160822|69567044|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
37882512|NCT01160822|69567045|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
37882513|NCT01160822|69567046|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
37882514|NCT01160822|69567047|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
37882515|NCT01160822|69567048|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
37882516|NCT01160822|69567042|FG000|Overall Study|Withdrawal by Subject|0|||
37882517|NCT01160822|69567043|FG001|Overall Study|Withdrawal by Subject|0|||
37882518|NCT01160822|69567044|FG002|Overall Study|Withdrawal by Subject|0|||
37882519|NCT01160822|69567045|FG003|Overall Study|Withdrawal by Subject|0|||
37882520|NCT01160822|69567046|FG004|Overall Study|Withdrawal by Subject|0|||
37882521|NCT01160822|69567047|FG005|Overall Study|Withdrawal by Subject|0|||
37882522|NCT01160822|69567048|FG006|Overall Study|Withdrawal by Subject|1|||
37882523|NCT01160822|69567042|FG000|Overall Study|Lost to Follow-up|0|||
37882524|NCT01160822|69567043|FG001|Overall Study|Lost to Follow-up|0|||
37882525|NCT01160822|69567044|FG002|Overall Study|Lost to Follow-up|0|||
37882526|NCT01160822|69567045|FG003|Overall Study|Lost to Follow-up|0|||
37882527|NCT01160822|69567046|FG004|Overall Study|Lost to Follow-up|1|||
37882528|NCT01160822|69567047|FG005|Overall Study|Lost to Follow-up|0|||
37882529|NCT01160822|69567048|FG006|Overall Study|Lost to Follow-up|0|||
37882530|NCT01160822|69567042|FG000|Overall Study|Administrative problems|0|||
37882531|NCT01160822|69567043|FG001|Overall Study|Administrative problems|0|||
37882532|NCT01160822|69567044|FG002|Overall Study|Administrative problems|0|||
37882533|NCT01160822|69567045|FG003|Overall Study|Administrative problems|0|||
37882534|NCT01160822|69567046|FG004|Overall Study|Administrative problems|1|||
37882535|NCT01160822|69567047|FG005|Overall Study|Administrative problems|0|||
37820938|NCT03951077|69500149|FG000|Overall Study|Withdrawal by Subject|3|||
37820939|NCT03951077|69500150|FG001|Overall Study|Withdrawal by Subject|3|||
37882536|NCT01160822|69567048|FG006|Overall Study|Administrative problems|0|||
37882537|NCT01160822|69567042|FG000|Overall Study|Protocol deviation|0|||
37882538|NCT01160822|69567043|FG001|Overall Study|Protocol deviation|0|||
37882539|NCT01160822|69567044|FG002|Overall Study|Protocol deviation|0|||
37882540|NCT01160822|69567045|FG003|Overall Study|Protocol deviation|0|||
37882541|NCT01160822|69567046|FG004|Overall Study|Protocol deviation|2|||
37820940|NCT03951077|69500151|FG002|Overall Study|Withdrawal by Subject|0|||
37820941|NCT03951077|69500152|FG003|Overall Study|Withdrawal by Subject|3|||
37820942|NCT03951077|69500153|FG004|Overall Study|Withdrawal by Subject|3|||
37820943|NCT03951077|69500154|FG005|Overall Study|Withdrawal by Subject|2|||
37820944|NCT03951077|69500149|FG000|Overall Study|Lost to Follow-up|1|||
37820945|NCT03951077|69500150|FG001|Overall Study|Lost to Follow-up|1|||
37820946|NCT03951077|69500151|FG002|Overall Study|Lost to Follow-up|2|||
37820947|NCT03951077|69500152|FG003|Overall Study|Lost to Follow-up|3|||
37820948|NCT03951077|69500153|FG004|Overall Study|Lost to Follow-up|2|||
37820949|NCT03951077|69500154|FG005|Overall Study|Lost to Follow-up|3|||
37820950|NCT03951077|69500149|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
37882542|NCT01160822|69567047|FG005|Overall Study|Protocol deviation|0|||
37882543|NCT01160822|69567048|FG006|Overall Study|Protocol deviation|0|||
37882544|NCT01006980|69567067|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
37882545|NCT01006980|69567068|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
37882546|NCT01006980|69567067|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
37882547|NCT01006980|69567068|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
37882548|NCT01006980|69567067|FG000|Vemurafenib and Dacarbazine|Death|13|||
37882549|NCT01006980|69567068|FG001|Vemurafenib and Dacarbazine|Death|12|||
37882550|NCT01006980|69567067|FG000|Vemurafenib and Dacarbazine|Progression|257|||
37820951|NCT03951077|69500150|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
37820952|NCT03951077|69500151|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
37820953|NCT03951077|69500152|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
37820954|NCT03951077|69500153|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
37820955|NCT03951077|69500154|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
37820956|NCT03951077|69500149|FG000|Overall Study|Other, Not Specified|12|||
37820957|NCT03951077|69500150|FG001|Overall Study|Other, Not Specified|10|||
37820958|NCT03951077|69500151|FG002|Overall Study|Other, Not Specified|10|||
37820959|NCT03951077|69500152|FG003|Overall Study|Other, Not Specified|5|||
37820960|NCT03951077|69500153|FG004|Overall Study|Other, Not Specified|9|||
37820961|NCT03951077|69500154|FG005|Overall Study|Other, Not Specified|6|||
37820962|NCT03951077|69500149|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
37820963|NCT03951077|69500150|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
37820964|NCT03951077|69500151|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
37820965|NCT03951077|69500152|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
37820966|NCT03951077|69500153|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
37820967|NCT03951077|69500154|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
37820968|NCT03873246|69500171|FG000|Overall Study|Adverse Event|1|||
37820969|NCT03873246|69500172|FG001|Overall Study|Adverse Event|3|||
37820970|NCT03873246|69500173|FG002|Overall Study|Adverse Event|3|||
37820971|NCT03873246|69500171|FG000|Overall Study|Lost to Follow-up|4|||
37820972|NCT03873246|69500172|FG001|Overall Study|Lost to Follow-up|4|||
37820973|NCT03873246|69500173|FG002|Overall Study|Lost to Follow-up|5|||
37820974|NCT03873246|69500171|FG000|Overall Study|Protocol Violation|0|||
37820975|NCT03873246|69500172|FG001|Overall Study|Protocol Violation|1|||
37820976|NCT03873246|69500173|FG002|Overall Study|Protocol Violation|0|||
37820977|NCT03873246|69500171|FG000|Overall Study|Withdrawal by Subject|0|||
37820978|NCT03873246|69500172|FG001|Overall Study|Withdrawal by Subject|4|||
37820979|NCT03873246|69500173|FG002|Overall Study|Withdrawal by Subject|1|||
37820980|NCT03769649|69500182|FG000|Overall Study|Lost to Follow-up|4|||
37820981|NCT02862548|69500208|FG000|Randomized Phase (Up to Week 48)|Death|0|||
37820982|NCT02862548|69500209|FG001|Randomized Phase (Up to Week 48)|Death|1|||
37820983|NCT02862548|69500208|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
37820984|NCT02862548|69500209|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
37820985|NCT02862548|69500208|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
37820986|NCT02862548|69500209|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
37820987|NCT02862548|69500208|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
37820988|NCT02862548|69500209|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
37820989|NCT02335099|69500228|FG000|Treatment|Withdrawal by Subject|1|||
37820990|NCT02335099|69500229|FG001|Treatment|Withdrawal by Subject|3|||
37820991|NCT02335099|69500228|FG000|Treatment|Lost to Follow-up|2|||
37820992|NCT02335099|69500229|FG001|Treatment|Lost to Follow-up|0|||
37820993|NCT02335099|69500228|FG000|Treatment|Death|1|||
37820994|NCT02335099|69500229|FG001|Treatment|Death|0|||
37820995|NCT02335099|69500228|FG000|Treatment|Adverse Event|1|||
37820996|NCT02335099|69500229|FG001|Treatment|Adverse Event|2|||
37820997|NCT02335099|69500228|FG000|Follow-up|Death|0|||
37820998|NCT02335099|69500229|FG001|Follow-up|Death|1|||
37820999|NCT02330562|69500246|FG000|Overall Study|Adverse Event|0|||
37821000|NCT02330562|69500247|FG001|Overall Study|Adverse Event|0|||
37821001|NCT02330562|69500248|FG002|Overall Study|Adverse Event|3|||
37821002|NCT02330562|69500249|FG003|Overall Study|Adverse Event|0|||
37821003|NCT02330562|69500250|FG004|Overall Study|Adverse Event|3|||
37821004|NCT02330562|69500251|FG005|Overall Study|Adverse Event|1|||
37821005|NCT02330562|69500252|FG006|Overall Study|Adverse Event|0|||
37821006|NCT02330562|69500253|FG007|Overall Study|Adverse Event|0|||
37821007|NCT02330562|69500254|FG008|Overall Study|Adverse Event|0|||
37821008|NCT02330562|69500255|FG009|Overall Study|Adverse Event|1|||
37821009|NCT02330562|69500256|FG010|Overall Study|Adverse Event|1|||
37821010|NCT02330562|69500246|FG000|Overall Study|Participant decision|1|||
37821011|NCT02330562|69500247|FG001|Overall Study|Participant decision|0|||
37821012|NCT02330562|69500248|FG002|Overall Study|Participant decision|4|||
37821013|NCT02330562|69500249|FG003|Overall Study|Participant decision|1|||
37882551|NCT01006980|69567068|FG001|Vemurafenib and Dacarbazine|Progression|218|||
37882552|NCT01006980|69567067|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
37882553|NCT01006980|69567068|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
37882554|NCT01006980|69567067|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
37882555|NCT01006980|69567068|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
37882556|NCT01006980|69567067|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
37882557|NCT01006980|69567068|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
37882558|NCT01006980|69567067|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
37882559|NCT01006980|69567068|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
37882560|NCT01006980|69567067|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
37882561|NCT01006980|69567068|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
37882562|NCT01006980|69567067|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
37882563|NCT01006980|69567068|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
37882564|NCT01006980|69567067|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
37882565|NCT01006980|69567068|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
37882566|NCT01006980|69567067|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
37882567|NCT01006980|69567068|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
37985485|NCT00269919|69671268|FG000|Overall Study|Started but not treated|1|||
37985486|NCT00258154|69671275|FG000|Overall Study|Adverse Event|1|||
37985487|NCT00258154|69671276|FG001|Overall Study|Adverse Event|0|||
37985488|NCT00258154|69671275|FG000|Overall Study|Lost to Follow-up|0|||
37985489|NCT00258154|69671276|FG001|Overall Study|Lost to Follow-up|1|||
37985490|NCT00258154|69671275|FG000|Overall Study|Protocol Violation|2|||
37985491|NCT00258154|69671276|FG001|Overall Study|Protocol Violation|1|||
37985492|NCT00258154|69671275|FG000|Overall Study|Withdrawal by Subject|3|||
37985493|NCT00258154|69671276|FG001|Overall Study|Withdrawal by Subject|4|||
37985494|NCT00258154|69671275|FG000|Overall Study|Patient Moved|3|||
37985495|NCT00258154|69671276|FG001|Overall Study|Patient Moved|1|||
37985496|NCT00257920|69671284|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
37985497|NCT00257920|69671285|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
37985498|NCT00257920|69671284|FG000|Period: Second Intervention|Other|2|||
37882568|NCT01006980|69567067|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
37882569|NCT01006980|69567068|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
37882570|NCT00887926|69567079|FG000|Overall Study|Withdrawal by Subject|0|||
37882571|NCT00887926|69567080|FG001|Overall Study|Withdrawal by Subject|1|||
37882572|NCT00887926|69567081|FG002|Overall Study|Withdrawal by Subject|0|||
37882573|NCT00887926|69567082|FG003|Overall Study|Withdrawal by Subject|0|||
37882574|NCT00998400|69567100|FG000|Overall Study|Lack of interest/motivation|1|||
37882575|NCT00998400|69567101|FG001|Overall Study|Lack of interest/motivation|2|||
37882576|NCT00998400|69567100|FG000|Overall Study|Logistical problems|1|||
37882577|NCT00998400|69567101|FG001|Overall Study|Logistical problems|0|||
37882578|NCT00997386|69567108|FG000|Overall Study|Death|7|||
37882579|NCT00996996|69567112|FG000|Overall Study|Progressive Disease|10|||
37882580|NCT00996996|69567112|FG000|Overall Study|Non-compliance|8|||
37882581|NCT00996996|69567112|FG000|Overall Study|Lost to Follow-up|9|||
37882582|NCT00996996|69567112|FG000|Overall Study|Death|5|||
37882583|NCT00996996|69567112|FG000|Overall Study|Did Not Receive Study Medications|1|||
37882584|NCT00996918|69567121|FG000|Overall Study|Lack of Efficacy|1|||
37882585|NCT00996918|69567122|FG001|Overall Study|Lack of Efficacy|1|||
37985499|NCT00257920|69671285|FG001|Period: Second Intervention|Other|1|||
37985500|NCT00268983|69671294|FG000|Overall Study|Death|3|||
37985501|NCT00268983|69671295|FG001|Overall Study|Death|0|||
37985502|NCT00257608|69671303|FG000|Chemotherapy Phase|Adverse Event|138|||
37985503|NCT00257608|69671304|FG001|Chemotherapy Phase|Adverse Event|0|||
37985504|NCT00257608|69671305|FG002|Chemotherapy Phase|Adverse Event|0|||
37882586|NCT00996918|69567123|FG002|Overall Study|Lack of Efficacy|2|||
37882587|NCT00996918|69567124|FG003|Overall Study|Lack of Efficacy|2|||
37882588|NCT00996918|69567125|FG004|Overall Study|Lack of Efficacy|0|||
37882589|NCT00996918|69567121|FG000|Overall Study|Adverse Event|2|||
37882590|NCT00996918|69567122|FG001|Overall Study|Adverse Event|5|||
37882591|NCT00996918|69567123|FG002|Overall Study|Adverse Event|2|||
37985505|NCT00257608|69671303|FG000|Chemotherapy Phase|Disease progression|139|||
37985506|NCT00257608|69671304|FG001|Chemotherapy Phase|Disease progression|0|||
37985507|NCT00257608|69671305|FG002|Chemotherapy Phase|Disease progression|0|||
37985508|NCT00257608|69671303|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
37882592|NCT00996918|69567124|FG003|Overall Study|Adverse Event|6|||
37882593|NCT00996918|69567125|FG004|Overall Study|Adverse Event|0|||
37985509|NCT00257608|69671304|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
37985510|NCT00257608|69671305|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
37985511|NCT00257608|69671303|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
37985512|NCT00257608|69671304|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
37985513|NCT00257608|69671305|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
37985514|NCT00257608|69671303|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
37985515|NCT00257608|69671304|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
37985516|NCT00257608|69671305|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
37985517|NCT00257608|69671303|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
37985518|NCT00257608|69671304|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
37882594|NCT00996918|69567121|FG000|Overall Study|Withdrawal by Subject|1|||
37882595|NCT00996918|69567122|FG001|Overall Study|Withdrawal by Subject|4|||
37882596|NCT00996918|69567123|FG002|Overall Study|Withdrawal by Subject|3|||
37882597|NCT00996918|69567124|FG003|Overall Study|Withdrawal by Subject|3|||
37882598|NCT00996918|69567125|FG004|Overall Study|Withdrawal by Subject|2|||
37882599|NCT00996918|69567121|FG000|Overall Study|Physician Decision|1|||
37882600|NCT00996918|69567122|FG001|Overall Study|Physician Decision|0|||
37882601|NCT00996918|69567123|FG002|Overall Study|Physician Decision|0|||
37882602|NCT00996918|69567124|FG003|Overall Study|Physician Decision|0|||
37882603|NCT00996918|69567125|FG004|Overall Study|Physician Decision|0|||
37882604|NCT00996918|69567121|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
37882605|NCT00996918|69567122|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
37882606|NCT00996918|69567123|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
37882607|NCT00996918|69567124|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
37882608|NCT00996918|69567125|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
37882609|NCT00996918|69567121|FG000|Overall Study|Loss of Caregiver|0|||
37985519|NCT00257608|69671305|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
37882610|NCT00996918|69567122|FG001|Overall Study|Loss of Caregiver|1|||
37882611|NCT00996918|69567123|FG002|Overall Study|Loss of Caregiver|0|||
37882612|NCT00996918|69567124|FG003|Overall Study|Loss of Caregiver|0|||
37882613|NCT00996918|69567125|FG004|Overall Study|Loss of Caregiver|0|||
37882614|NCT00996918|69567121|FG000|Overall Study|Other|3|||
37882615|NCT00996918|69567122|FG001|Overall Study|Other|1|||
37882616|NCT00996918|69567123|FG002|Overall Study|Other|0|||
37985520|NCT00257608|69671303|FG000|Chemotherapy Phase|Physician Decision|28|||
37985521|NCT00257608|69671304|FG001|Chemotherapy Phase|Physician Decision|0|||
37985522|NCT00257608|69671305|FG002|Chemotherapy Phase|Physician Decision|0|||
37985523|NCT00257608|69671303|FG000|Post Chemotherapy Phase|Adverse Event|0|||
37985524|NCT00257608|69671304|FG001|Post Chemotherapy Phase|Adverse Event|34|||
37821014|NCT02330562|69500250|FG004|Overall Study|Participant decision|5|||
37821015|NCT02330562|69500251|FG005|Overall Study|Participant decision|2|||
37821016|NCT02330562|69500252|FG006|Overall Study|Participant decision|0|||
37821017|NCT02330562|69500253|FG007|Overall Study|Participant decision|0|||
37985525|NCT00257608|69671305|FG002|Post Chemotherapy Phase|Adverse Event|38|||
37985526|NCT00257608|69671303|FG000|Post Chemotherapy Phase|Disease progression|0|||
37985527|NCT00257608|69671304|FG001|Post Chemotherapy Phase|Disease progression|204|||
37985528|NCT00257608|69671305|FG002|Post Chemotherapy Phase|Disease progression|168|||
37985529|NCT00257608|69671303|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
37985530|NCT00257608|69671304|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
37985531|NCT00257608|69671305|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
37985532|NCT00257608|69671303|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
37985533|NCT00257608|69671304|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
37985534|NCT00257608|69671305|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
37985535|NCT00257608|69671303|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
37985536|NCT00257608|69671304|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
37985537|NCT00257608|69671305|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
37985538|NCT00257608|69671303|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
37821018|NCT02330562|69500254|FG008|Overall Study|Participant decision|0|||
37821019|NCT02330562|69500255|FG009|Overall Study|Participant decision|3|||
37821020|NCT02330562|69500256|FG010|Overall Study|Participant decision|0|||
37821021|NCT02330562|69500246|FG000|Overall Study|Disease progression|5|||
37821022|NCT02330562|69500247|FG001|Overall Study|Disease progression|3|||
37821023|NCT02330562|69500248|FG002|Overall Study|Disease progression|20|||
37821024|NCT02330562|69500249|FG003|Overall Study|Disease progression|28|||
37821025|NCT02330562|69500250|FG004|Overall Study|Disease progression|23|||
37821026|NCT02330562|69500251|FG005|Overall Study|Disease progression|7|||
37821027|NCT02330562|69500252|FG006|Overall Study|Disease progression|1|||
37882617|NCT00996918|69567124|FG003|Overall Study|Other|0|||
37882618|NCT00996918|69567125|FG004|Overall Study|Other|0|||
37882619|NCT01160744|69567141|FG000|Overall Study|Withdrawal by Subject|11|||
37882620|NCT01160744|69567142|FG001|Overall Study|Withdrawal by Subject|5|||
37985539|NCT00257608|69671304|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
37985540|NCT00257608|69671305|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
37985541|NCT00257608|69671303|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
37985542|NCT00257608|69671304|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
37985543|NCT00257608|69671305|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
37985544|NCT00257608|69671303|FG000|Post Chemotherapy Phase|Physician Decision|0|||
37821028|NCT02330562|69500253|FG007|Overall Study|Disease progression|1|||
37821029|NCT02330562|69500254|FG008|Overall Study|Disease progression|1|||
37821030|NCT02330562|69500255|FG009|Overall Study|Disease progression|0|||
37821031|NCT02330562|69500256|FG010|Overall Study|Disease progression|5|||
37821032|NCT02330562|69500246|FG000|Overall Study|Other reasons|0|||
37821033|NCT02330562|69500247|FG001|Overall Study|Other reasons|0|||
37821034|NCT02330562|69500248|FG002|Overall Study|Other reasons|0|||
37882621|NCT01160744|69567143|FG002|Overall Study|Withdrawal by Subject|6|||
37882622|NCT01160744|69567144|FG003|Overall Study|Withdrawal by Subject|4|||
37882623|NCT01160744|69567141|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
37882624|NCT01160744|69567142|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
37882625|NCT01160744|69567143|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
37882626|NCT01160744|69567144|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
37882627|NCT01160354|69567159|FG000|Overall Study|Death|0|||
37882628|NCT01160354|69567160|FG001|Overall Study|Death|1|||
37882629|NCT01160354|69567161|FG002|Overall Study|Death|1|||
37882630|NCT01160198|69567172|FG000|Overall Study|Withdrawal by Subject|2|||
37882631|NCT01160198|69567173|FG001|Overall Study|Withdrawal by Subject|1|||
37882632|NCT01160198|69567174|FG002|Overall Study|Withdrawal by Subject|0|||
37882633|NCT01160198|69567172|FG000|Overall Study|Adverse Event|0|||
37882634|NCT01160198|69567173|FG001|Overall Study|Adverse Event|1|||
37882635|NCT01160198|69567174|FG002|Overall Study|Adverse Event|0|||
37882636|NCT01160198|69567172|FG000|Overall Study|Lost to Follow-up|0|||
37882637|NCT01160198|69567173|FG001|Overall Study|Lost to Follow-up|1|||
37882638|NCT01160198|69567174|FG002|Overall Study|Lost to Follow-up|0|||
37882639|NCT01160198|69567172|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
37882640|NCT01160198|69567173|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
37882641|NCT01160198|69567174|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
37882642|NCT01159574|69567182|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
37882643|NCT01159574|69567182|FG000|Treatment Phase|Adverse Event|3|||
37882644|NCT01159574|69567182|FG000|Treatment Phase|Death|6|||
37882645|NCT01159574|69567182|FG000|Treatment Phase|Physician Decision|2|||
37882646|NCT01159574|69567182|FG000|Treatment Phase|Withdrawal by Subject|7|||
37882647|NCT01159574|69567182|FG000|Treatment Phase|still on treatment|2|||
37882648|NCT01159574|69567182|FG000|Follow Up Phase|Lost to Follow-up|2|||
37882649|NCT01159574|69567182|FG000|Follow Up Phase|still being followed for overall surviva|18|||
37882650|NCT01158950|69567186|FG000|1st Intervention (1 Day)|Physician Decision|1|||
37882651|NCT01158950|69567187|FG001|1st Intervention (1 Day)|Physician Decision|2|||
37882652|NCT01172288|69567194|FG000|Overall Study|Adverse Event|1|||
37882653|NCT01172288|69567195|FG001|Overall Study|Adverse Event|0|||
37882654|NCT01172288|69567194|FG000|Overall Study|Protocol Violation|0|||
37882655|NCT01172288|69567195|FG001|Overall Study|Protocol Violation|1|||
37882656|NCT00996840|69567206|FG000|Overall Study|Adverse Event|0|||
37882657|NCT00996840|69567207|FG001|Overall Study|Adverse Event|1|||
37882658|NCT00996840|69567208|FG002|Overall Study|Adverse Event|0|||
37882659|NCT00996840|69567209|FG003|Overall Study|Adverse Event|0|||
37882660|NCT00996840|69567210|FG004|Overall Study|Adverse Event|0|||
37882661|NCT00996840|69567206|FG000|Overall Study|Physician Decision|0|||
37882662|NCT00996840|69567207|FG001|Overall Study|Physician Decision|0|||
37882663|NCT00996840|69567208|FG002|Overall Study|Physician Decision|1|||
37882664|NCT00996840|69567209|FG003|Overall Study|Physician Decision|1|||
37882665|NCT00996840|69567210|FG004|Overall Study|Physician Decision|2|||
37882666|NCT00996840|69567206|FG000|Overall Study|Withdrawal by Subject|1|||
37821035|NCT02330562|69500249|FG003|Overall Study|Other reasons|1|||
37882667|NCT00996840|69567207|FG001|Overall Study|Withdrawal by Subject|1|||
37821036|NCT02330562|69500250|FG004|Overall Study|Other reasons|0|||
37821037|NCT02330562|69500251|FG005|Overall Study|Other reasons|0|||
37821038|NCT02330562|69500252|FG006|Overall Study|Other reasons|0|||
37882668|NCT00996840|69567208|FG002|Overall Study|Withdrawal by Subject|0|||
37882669|NCT00996840|69567209|FG003|Overall Study|Withdrawal by Subject|0|||
37882670|NCT00996840|69567210|FG004|Overall Study|Withdrawal by Subject|0|||
37882671|NCT00998946|69567226|FG000|Overall Study|Lost to Follow-up|1|||
37882672|NCT00998946|69567226|FG000|Overall Study|Withdrawal by Subject|1|||
37882673|NCT00998946|69567226|FG000|Overall Study|Death|2|||
37985545|NCT00257608|69671304|FG001|Post Chemotherapy Phase|Physician Decision|8|||
37882674|NCT00998946|69567226|FG000|Overall Study|Reason Unspecified|3|||
37882675|NCT00998946|69567226|FG000|Overall Study|Enrolled but not Dosed|2|||
37882676|NCT01158404|69567238|FG000|Overall Study|Withdrawal by Subject|0|||
37882677|NCT01158404|69567239|FG001|Overall Study|Withdrawal by Subject|1|||
37882678|NCT01158404|69567240|FG002|Overall Study|Withdrawal by Subject|0|||
37882679|NCT01158404|69567241|FG003|Overall Study|Withdrawal by Subject|0|||
37882680|NCT01158404|69567242|FG004|Overall Study|Withdrawal by Subject|3|||
37882681|NCT01158404|69567243|FG005|Overall Study|Withdrawal by Subject|1|||
37882682|NCT01158404|69567244|FG006|Overall Study|Withdrawal by Subject|0|||
37882683|NCT01158404|69567245|FG007|Overall Study|Withdrawal by Subject|1|||
37882684|NCT01158404|69567238|FG000|Overall Study|Physician Decision|0|||
37882685|NCT01158404|69567239|FG001|Overall Study|Physician Decision|0|||
37882686|NCT01158404|69567240|FG002|Overall Study|Physician Decision|0|||
37882687|NCT01158404|69567241|FG003|Overall Study|Physician Decision|0|||
37882688|NCT01158404|69567242|FG004|Overall Study|Physician Decision|0|||
37882689|NCT01158404|69567243|FG005|Overall Study|Physician Decision|0|||
37882690|NCT01158404|69567244|FG006|Overall Study|Physician Decision|0|||
37882691|NCT01158404|69567245|FG007|Overall Study|Physician Decision|1|||
37882692|NCT01158404|69567238|FG000|Overall Study|Progressive Disease|0|||
37882693|NCT01158404|69567239|FG001|Overall Study|Progressive Disease|0|||
37882694|NCT01158404|69567240|FG002|Overall Study|Progressive Disease|0|||
37882695|NCT01158404|69567241|FG003|Overall Study|Progressive Disease|0|||
37882696|NCT01158404|69567242|FG004|Overall Study|Progressive Disease|0|||
37882697|NCT01158404|69567243|FG005|Overall Study|Progressive Disease|0|||
37882698|NCT01158404|69567244|FG006|Overall Study|Progressive Disease|1|||
37882699|NCT01158404|69567245|FG007|Overall Study|Progressive Disease|0|||
37882700|NCT00998790|69567265|FG000|Overall Study|Withdrawal by Subject|21|||
37882701|NCT01001988|69567269|FG000|Overall Study|Protocol Violation|84|||
37882702|NCT01001988|69567269|FG000|Overall Study|Withdrawal by Subject|18|||
37882703|NCT01001988|69567269|FG000|Overall Study|Lost to Follow-up|15|||
37882704|NCT00996606|69567273|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
37882705|NCT00996606|69567273|FG000|Overall Study|Insufficient Therapeutic Response|2|||
37882706|NCT00996606|69567273|FG000|Overall Study|Protocol Violation|1|||
37882707|NCT00996606|69567273|FG000|Overall Study|Withdrawal by Subject|3|||
37882708|NCT00995436|69567280|FG000|Overall Study|Withdrawal by Subject|2|||
37882709|NCT00995436|69567281|FG001|Overall Study|Withdrawal by Subject|5|||
37985546|NCT00257608|69671305|FG002|Post Chemotherapy Phase|Physician Decision|11|||
37985547|NCT00257608|69671303|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
37985548|NCT00257608|69671304|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
37985549|NCT00257608|69671305|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
37985550|NCT00257608|69671303|FG000|Post Chemotherapy Phase|Not treated|0|||
37985551|NCT00257608|69671304|FG001|Post Chemotherapy Phase|Not treated|4|||
37985552|NCT00257608|69671305|FG002|Post Chemotherapy Phase|Not treated|7|||
37985553|NCT00231478|69671320|FG000|Overall Study|Protocol Violation|3|||
37985554|NCT00231478|69671321|FG001|Overall Study|Protocol Violation|2|||
37985555|NCT00231478|69671320|FG000|Overall Study|Refused Treatment|1|||
37985556|NCT00231478|69671321|FG001|Overall Study|Refused Treatment|1|||
37985557|NCT00231478|69671320|FG000|Overall Study|Withdrawal by Subject|1|||
37985558|NCT00231478|69671321|FG001|Overall Study|Withdrawal by Subject|0|||
37882710|NCT00995436|69567282|FG002|Overall Study|Withdrawal by Subject|0|||
37882711|NCT00994890|69567293|FG000|Overall Study|Adverse Event|13|||
37882712|NCT00994890|69567294|FG001|Overall Study|Adverse Event|9|||
37882713|NCT00994890|69567295|FG002|Overall Study|Adverse Event|11|||
37882714|NCT00994890|69567293|FG000|Overall Study|Lack of Efficacy|0|||
37882715|NCT00994890|69567294|FG001|Overall Study|Lack of Efficacy|0|||
37882716|NCT00994890|69567295|FG002|Overall Study|Lack of Efficacy|1|||
37882717|NCT00994890|69567293|FG000|Overall Study|Lost to Follow-up|6|||
37882718|NCT00994890|69567294|FG001|Overall Study|Lost to Follow-up|1|||
37882719|NCT00994890|69567295|FG002|Overall Study|Lost to Follow-up|3|||
37985559|NCT00231478|69671320|FG000|Overall Study|Adverse Event|0|||
37985560|NCT00231478|69671321|FG001|Overall Study|Adverse Event|1|||
37985561|NCT00231478|69671320|FG000|Overall Study|Administrative|3|||
37695434|NCT02349295|69171753|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
37821039|NCT02330562|69500253|FG007|Overall Study|Other reasons|0|||
37882720|NCT00994890|69567293|FG000|Overall Study|No longer willing to participate|8|||
37882721|NCT00994890|69567294|FG001|Overall Study|No longer willing to participate|5|||
37882722|NCT00994890|69567295|FG002|Overall Study|No longer willing to participate|13|||
37882723|NCT00994890|69567293|FG000|Overall Study|Protocol Violation|2|||
37985562|NCT00231478|69671321|FG001|Overall Study|Administrative|2|||
37985563|NCT00413192|69671331|FG000|Overall Study|Disease progression|26|||
37821040|NCT02330562|69500254|FG008|Overall Study|Other reasons|0|||
37821041|NCT02330562|69500255|FG009|Overall Study|Other reasons|0|||
37821042|NCT02330562|69500256|FG010|Overall Study|Other reasons|0|||
37821043|NCT02330562|69500246|FG000|Overall Study|Withdrawal by Subject|0|||
37821044|NCT02330562|69500247|FG001|Overall Study|Withdrawal by Subject|0|||
37821045|NCT02330562|69500248|FG002|Overall Study|Withdrawal by Subject|0|||
37821046|NCT02330562|69500249|FG003|Overall Study|Withdrawal by Subject|0|||
37882724|NCT00994890|69567294|FG001|Overall Study|Protocol Violation|4|||
37882725|NCT00994890|69567295|FG002|Overall Study|Protocol Violation|0|||
37882726|NCT00994890|69567293|FG000|Overall Study|Study terminated by sponsor|199|||
37882727|NCT00994890|69567294|FG001|Overall Study|Study terminated by sponsor|201|||
37882728|NCT00994890|69567295|FG002|Overall Study|Study terminated by sponsor|197|||
37882729|NCT00994890|69567293|FG000|Overall Study|Randomized, but not treated|1|||
37882730|NCT00994890|69567294|FG001|Overall Study|Randomized, but not treated|0|||
37882731|NCT00994890|69567295|FG002|Overall Study|Randomized, but not treated|0|||
37882732|NCT00994890|69567293|FG000|Overall Study|Other|2|||
37882733|NCT00994890|69567294|FG001|Overall Study|Other|2|||
37882734|NCT00994890|69567295|FG002|Overall Study|Other|1|||
37882735|NCT00994422|69567305|FG000|Overall Study|Lost to Follow-up|7|||
37882736|NCT00994422|69567306|FG001|Overall Study|Lost to Follow-up|1|||
37882737|NCT01171976|69567317|FG000|Overall Study|Protocol Violation|0|||
37882738|NCT01171976|69567318|FG001|Overall Study|Protocol Violation|0|||
37882739|NCT01171976|69567319|FG002|Overall Study|Protocol Violation|1|||
37882740|NCT01171976|69567317|FG000|Overall Study|Death|2|||
37985564|NCT00413192|69671332|FG001|Overall Study|Disease progression|31|||
37985565|NCT00413192|69671333|FG002|Overall Study|Disease progression|16|||
37985566|NCT00413192|69671334|FG003|Overall Study|Disease progression|25|||
37985567|NCT00413192|69671331|FG000|Overall Study|Toxicity|3|||
37985568|NCT00413192|69671332|FG001|Overall Study|Toxicity|2|||
37985569|NCT00413192|69671333|FG002|Overall Study|Toxicity|2|||
37882741|NCT01171976|69567318|FG001|Overall Study|Death|4|||
37985570|NCT00413192|69671334|FG003|Overall Study|Toxicity|2|||
37985571|NCT00413192|69671331|FG000|Overall Study|Withdrawal by Subject|3|||
37985572|NCT00413192|69671332|FG001|Overall Study|Withdrawal by Subject|5|||
37985573|NCT00413192|69671333|FG002|Overall Study|Withdrawal by Subject|0|||
37882742|NCT01171976|69567319|FG002|Overall Study|Death|1|||
37985574|NCT00413192|69671334|FG003|Overall Study|Withdrawal by Subject|1|||
37985575|NCT00413192|69671331|FG000|Overall Study|Intercurrent illness|0|||
37985576|NCT00413192|69671332|FG001|Overall Study|Intercurrent illness|0|||
37985577|NCT00413192|69671333|FG002|Overall Study|Intercurrent illness|0|||
37985578|NCT00413192|69671334|FG003|Overall Study|Intercurrent illness|1|||
37985579|NCT00413192|69671331|FG000|Overall Study|Intercurrent death|0|||
37695435|NCT02349295|69171754|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
37821047|NCT02330562|69500250|FG004|Overall Study|Withdrawal by Subject|0|||
37821048|NCT02330562|69500251|FG005|Overall Study|Withdrawal by Subject|0|||
37821049|NCT02330562|69500252|FG006|Overall Study|Withdrawal by Subject|0|||
37821050|NCT02330562|69500253|FG007|Overall Study|Withdrawal by Subject|0|||
37821051|NCT02330562|69500254|FG008|Overall Study|Withdrawal by Subject|0|||
37821052|NCT02330562|69500255|FG009|Overall Study|Withdrawal by Subject|1|||
37821053|NCT02330562|69500256|FG010|Overall Study|Withdrawal by Subject|0|||
37821054|NCT03703102|69500370|FG000|Overall Study|Adverse Event|4|||
37821055|NCT03703102|69500371|FG001|Overall Study|Adverse Event|3|||
37821056|NCT03703102|69500372|FG002|Overall Study|Adverse Event|7|||
37821057|NCT03703102|69500373|FG003|Overall Study|Adverse Event|3|||
37821058|NCT03703102|69500374|FG004|Overall Study|Adverse Event|13|||
37821059|NCT03703102|69500370|FG000|Overall Study|Lack of Efficacy|4|||
37821060|NCT03703102|69500371|FG001|Overall Study|Lack of Efficacy|0|||
37821061|NCT03703102|69500372|FG002|Overall Study|Lack of Efficacy|1|||
37821062|NCT03703102|69500373|FG003|Overall Study|Lack of Efficacy|4|||
37821063|NCT03703102|69500374|FG004|Overall Study|Lack of Efficacy|1|||
37821064|NCT03703102|69500370|FG000|Overall Study|Lost to Follow-up|0|||
37821065|NCT03703102|69500371|FG001|Overall Study|Lost to Follow-up|0|||
37821066|NCT03703102|69500372|FG002|Overall Study|Lost to Follow-up|1|||
37821067|NCT03703102|69500373|FG003|Overall Study|Lost to Follow-up|2|||
37882743|NCT01171976|69567317|FG000|Overall Study|Lost to Follow-up|4|||
37882744|NCT01171976|69567318|FG001|Overall Study|Lost to Follow-up|0|||
37882745|NCT01171976|69567319|FG002|Overall Study|Lost to Follow-up|2|||
37821068|NCT03703102|69500374|FG004|Overall Study|Lost to Follow-up|2|||
37821069|NCT03703102|69500370|FG000|Overall Study|Physician Decision|2|||
37821070|NCT03703102|69500371|FG001|Overall Study|Physician Decision|2|||
37882746|NCT01171976|69567317|FG000|Overall Study|Withdrawal by Subject|1|||
37985580|NCT00413192|69671332|FG001|Overall Study|Intercurrent death|1|||
37985581|NCT00413192|69671333|FG002|Overall Study|Intercurrent death|0|||
37882747|NCT01171976|69567318|FG001|Overall Study|Withdrawal by Subject|5|||
37882748|NCT01171976|69567319|FG002|Overall Study|Withdrawal by Subject|6|||
37882749|NCT01171976|69567317|FG000|Overall Study|Abnormal test result|1|||
37882750|NCT01171976|69567318|FG001|Overall Study|Abnormal test result|0|||
37882751|NCT01171976|69567319|FG002|Overall Study|Abnormal test result|0|||
37882752|NCT01171976|69567317|FG000|Overall Study|Adverse Event|6|||
37882753|NCT01171976|69567318|FG001|Overall Study|Adverse Event|2|||
37882754|NCT01171976|69567319|FG002|Overall Study|Adverse Event|5|||
37882755|NCT00996216|69567327|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
37882756|NCT00996216|69567327|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
37882757|NCT00996216|69567327|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
37882758|NCT00830869|69567344|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
37882759|NCT00830869|69567345|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
37882760|NCT00830869|69567346|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
37882761|NCT00830869|69567347|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
37985582|NCT00413192|69671334|FG003|Overall Study|Intercurrent death|0|||
37985583|NCT00413192|69671331|FG000|Overall Study|Other|5|||
37985584|NCT00413192|69671332|FG001|Overall Study|Other|1|||
37985585|NCT00413192|69671333|FG002|Overall Study|Other|1|||
37985586|NCT00413192|69671334|FG003|Overall Study|Other|2|||
37985587|NCT00413192|69671331|FG000|Overall Study|Not treated|0|||
37985588|NCT00413192|69671332|FG001|Overall Study|Not treated|0|||
37985589|NCT00413192|69671333|FG002|Overall Study|Not treated|0|||
37985590|NCT00413192|69671334|FG003|Overall Study|Not treated|1|||
37985591|NCT00207142|69671347|FG000|Induction Phase|Adverse Event|9|||
37985592|NCT00207142|69671348|FG001|Induction Phase|Adverse Event|0|||
37821071|NCT03703102|69500372|FG002|Overall Study|Physician Decision|2|||
37821072|NCT03703102|69500373|FG003|Overall Study|Physician Decision|2|||
37821073|NCT03703102|69500374|FG004|Overall Study|Physician Decision|4|||
37882762|NCT00830869|69567348|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
37882763|NCT00830869|69567349|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
37882764|NCT00830869|69567350|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
37882765|NCT00830869|69567351|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
37882766|NCT00830869|69567352|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
37882767|NCT00830869|69567353|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
37882768|NCT00830869|69567354|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
37882769|NCT00830869|69567355|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
37882770|NCT00830869|69567344|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
37882771|NCT00830869|69567345|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
37821074|NCT03703102|69500370|FG000|Overall Study|Withdrawal by Subject|7|||
37821075|NCT03703102|69500371|FG001|Overall Study|Withdrawal by Subject|5|||
37821076|NCT03703102|69500372|FG002|Overall Study|Withdrawal by Subject|5|||
37821077|NCT03703102|69500373|FG003|Overall Study|Withdrawal by Subject|5|||
37821078|NCT03703102|69500374|FG004|Overall Study|Withdrawal by Subject|9|||
37821079|NCT03703102|69500370|FG000|Overall Study|Ineligibility|0|||
37821080|NCT03703102|69500371|FG001|Overall Study|Ineligibility|0|||
37821081|NCT03703102|69500372|FG002|Overall Study|Ineligibility|1|||
37821082|NCT03703102|69500373|FG003|Overall Study|Ineligibility|0|||
37821083|NCT03703102|69500374|FG004|Overall Study|Ineligibility|0|||
37821084|NCT03703102|69500370|FG000|Overall Study|Protocol Deviation|4|||
37821085|NCT03703102|69500371|FG001|Overall Study|Protocol Deviation|4|||
37821086|NCT03703102|69500372|FG002|Overall Study|Protocol Deviation|3|||
37821087|NCT03703102|69500373|FG003|Overall Study|Protocol Deviation|0|||
37821088|NCT03703102|69500374|FG004|Overall Study|Protocol Deviation|0|||
37821089|NCT03703102|69500370|FG000|Overall Study|Non-Compliance with Study Drug|1|||
37821090|NCT03703102|69500371|FG001|Overall Study|Non-Compliance with Study Drug|1|||
37821091|NCT03703102|69500372|FG002|Overall Study|Non-Compliance with Study Drug|2|||
37821092|NCT03703102|69500373|FG003|Overall Study|Non-Compliance with Study Drug|1|||
37821093|NCT03703102|69500374|FG004|Overall Study|Non-Compliance with Study Drug|4|||
37882772|NCT00830869|69567346|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
37882773|NCT00830869|69567347|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
37821094|NCT03395704|69500393|FG000|Overall Study|Adverse Event|2|||
37821095|NCT03395704|69500394|FG001|Overall Study|Adverse Event|1|||
37821096|NCT03395704|69500393|FG000|Overall Study|Withdrawal by Subject|2|||
37821097|NCT03395704|69500394|FG001|Overall Study|Withdrawal by Subject|1|||
37821098|NCT03395704|69500393|FG000|Overall Study|Physician Decision|0|||
37821099|NCT03395704|69500394|FG001|Overall Study|Physician Decision|1|||
37882774|NCT00830869|69567348|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
37882775|NCT00830869|69567349|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
37985593|NCT00207142|69671349|FG002|Induction Phase|Adverse Event|0|||
37985594|NCT00207142|69671350|FG003|Induction Phase|Adverse Event|0|||
37985595|NCT00207142|69671347|FG000|Induction Phase|Death|1|||
37985596|NCT00207142|69671348|FG001|Induction Phase|Death|0|||
37985597|NCT00207142|69671349|FG002|Induction Phase|Death|0|||
37882776|NCT00830869|69567350|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
37882777|NCT00830869|69567351|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
37882778|NCT00830869|69567352|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
37882779|NCT00830869|69567353|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
37882780|NCT00830869|69567354|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
37882781|NCT00830869|69567355|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
37882782|NCT00830869|69567344|FG000|Period 1: Part 1|Adverse Event|0|||
37882783|NCT00830869|69567345|FG001|Period 1: Part 1|Adverse Event|0|||
37882784|NCT00830869|69567346|FG002|Period 1: Part 1|Adverse Event|0|||
37882785|NCT00830869|69567347|FG003|Period 1: Part 1|Adverse Event|0|||
37882786|NCT00830869|69567348|FG004|Period 1: Part 1|Adverse Event|0|||
37882787|NCT00830869|69567349|FG005|Period 1: Part 1|Adverse Event|1|||
37882788|NCT00830869|69567350|FG006|Period 1: Part 1|Adverse Event|1|||
37882789|NCT00830869|69567351|FG007|Period 1: Part 1|Adverse Event|0|||
37882790|NCT00830869|69567352|FG008|Period 1: Part 1|Adverse Event|0|||
37882791|NCT00830869|69567353|FG009|Period 1: Part 1|Adverse Event|0|||
37882792|NCT00830869|69567354|FG010|Period 1: Part 1|Adverse Event|0|||
37882793|NCT00830869|69567355|FG011|Period 1: Part 1|Adverse Event|0|||
37882794|NCT00830869|69567344|FG000|Period 1: Part 1|Progressive disease|1|||
37985598|NCT00207142|69671350|FG003|Induction Phase|Death|0|||
37985599|NCT00207142|69671347|FG000|Induction Phase|Lack of Efficacy|1|||
37985600|NCT00207142|69671348|FG001|Induction Phase|Lack of Efficacy|0|||
37985601|NCT00207142|69671349|FG002|Induction Phase|Lack of Efficacy|0|||
37985602|NCT00207142|69671350|FG003|Induction Phase|Lack of Efficacy|0|||
37985603|NCT00207142|69671347|FG000|Induction Phase|Lost to Follow-up|5|||
37985604|NCT00207142|69671348|FG001|Induction Phase|Lost to Follow-up|0|||
37985605|NCT00207142|69671349|FG002|Induction Phase|Lost to Follow-up|0|||
37882795|NCT00830869|69567345|FG001|Period 1: Part 1|Progressive disease|0|||
37882796|NCT00830869|69567346|FG002|Period 1: Part 1|Progressive disease|1|||
37882797|NCT00830869|69567347|FG003|Period 1: Part 1|Progressive disease|6|||
37882798|NCT00830869|69567348|FG004|Period 1: Part 1|Progressive disease|4|||
37882799|NCT00830869|69567349|FG005|Period 1: Part 1|Progressive disease|4|||
37882800|NCT00830869|69567350|FG006|Period 1: Part 1|Progressive disease|1|||
37882801|NCT00830869|69567351|FG007|Period 1: Part 1|Progressive disease|0|||
37882802|NCT00830869|69567352|FG008|Period 1: Part 1|Progressive disease|0|||
37882803|NCT00830869|69567353|FG009|Period 1: Part 1|Progressive disease|0|||
37882804|NCT00830869|69567354|FG010|Period 1: Part 1|Progressive disease|0|||
37882805|NCT00830869|69567355|FG011|Period 1: Part 1|Progressive disease|0|||
37882806|NCT00830869|69567344|FG000|Period 2: Part 2|Protocol Violation|0|||
37882807|NCT00830869|69567345|FG001|Period 2: Part 2|Protocol Violation|0|||
37882808|NCT00830869|69567346|FG002|Period 2: Part 2|Protocol Violation|0|||
37882809|NCT00830869|69567347|FG003|Period 2: Part 2|Protocol Violation|0|||
37882810|NCT00830869|69567348|FG004|Period 2: Part 2|Protocol Violation|0|||
37882811|NCT00830869|69567349|FG005|Period 2: Part 2|Protocol Violation|0|||
37882812|NCT00830869|69567350|FG006|Period 2: Part 2|Protocol Violation|0|||
37882813|NCT00830869|69567351|FG007|Period 2: Part 2|Protocol Violation|1|||
37882814|NCT00830869|69567352|FG008|Period 2: Part 2|Protocol Violation|0|||
37882815|NCT00830869|69567353|FG009|Period 2: Part 2|Protocol Violation|1|||
37882816|NCT00830869|69567354|FG010|Period 2: Part 2|Protocol Violation|0|||
37882817|NCT00830869|69567355|FG011|Period 2: Part 2|Protocol Violation|0|||
37882818|NCT00830869|69567344|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
37882819|NCT00830869|69567345|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
37985606|NCT00207142|69671350|FG003|Induction Phase|Lost to Follow-up|0|||
37985607|NCT00207142|69671347|FG000|Induction Phase|Physician Decision|2|||
37985608|NCT00207142|69671348|FG001|Induction Phase|Physician Decision|0|||
37985609|NCT00207142|69671349|FG002|Induction Phase|Physician Decision|0|||
37985610|NCT00207142|69671350|FG003|Induction Phase|Physician Decision|0|||
37985611|NCT00207142|69671347|FG000|Induction Phase|Poor/noncompliance|2|||
37985612|NCT00207142|69671348|FG001|Induction Phase|Poor/noncompliance|0|||
37985613|NCT00207142|69671349|FG002|Induction Phase|Poor/noncompliance|0|||
37882820|NCT00830869|69567346|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
37985614|NCT00207142|69671350|FG003|Induction Phase|Poor/noncompliance|0|||
37985615|NCT00207142|69671347|FG000|Induction Phase|Pregnancy|1|||
37985616|NCT00207142|69671348|FG001|Induction Phase|Pregnancy|0|||
37985617|NCT00207142|69671349|FG002|Induction Phase|Pregnancy|0|||
37882821|NCT00830869|69567347|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
37882822|NCT00830869|69567348|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
37882823|NCT00830869|69567349|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
37882824|NCT00830869|69567350|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
37882825|NCT00830869|69567351|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
37985618|NCT00207142|69671350|FG003|Induction Phase|Pregnancy|0|||
37882826|NCT00830869|69567352|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
37882827|NCT00830869|69567353|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
37985619|NCT00207142|69671347|FG000|Induction Phase|Subject no longer meets study criteria|3|||
37882828|NCT00830869|69567354|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
37882829|NCT00830869|69567355|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
37882830|NCT00830869|69567344|FG000|Period 2: Part 2|Adverse Event|0|||
37882831|NCT00830869|69567345|FG001|Period 2: Part 2|Adverse Event|0|||
37882832|NCT00830869|69567346|FG002|Period 2: Part 2|Adverse Event|0|||
37882833|NCT00830869|69567347|FG003|Period 2: Part 2|Adverse Event|0|||
37882834|NCT00830869|69567348|FG004|Period 2: Part 2|Adverse Event|0|||
37882835|NCT00830869|69567349|FG005|Period 2: Part 2|Adverse Event|0|||
37882836|NCT00830869|69567350|FG006|Period 2: Part 2|Adverse Event|0|||
37882837|NCT00830869|69567351|FG007|Period 2: Part 2|Adverse Event|4|||
37882838|NCT00830869|69567352|FG008|Period 2: Part 2|Adverse Event|3|||
37882839|NCT00830869|69567353|FG009|Period 2: Part 2|Adverse Event|2|||
37882840|NCT00830869|69567354|FG010|Period 2: Part 2|Adverse Event|2|||
37882841|NCT00830869|69567355|FG011|Period 2: Part 2|Adverse Event|0|||
37882842|NCT00830869|69567344|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
37882843|NCT00830869|69567345|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
37985620|NCT00207142|69671348|FG001|Induction Phase|Subject no longer meets study criteria|0|||
37985621|NCT00207142|69671349|FG002|Induction Phase|Subject no longer meets study criteria|0|||
37985622|NCT00207142|69671350|FG003|Induction Phase|Subject no longer meets study criteria|0|||
37985623|NCT00207142|69671347|FG000|Induction Phase|Withdrawal by Subject|4|||
37985624|NCT00207142|69671348|FG001|Induction Phase|Withdrawal by Subject|0|||
37985625|NCT00207142|69671349|FG002|Induction Phase|Withdrawal by Subject|0|||
37985626|NCT00207142|69671350|FG003|Induction Phase|Withdrawal by Subject|0|||
37985627|NCT00207142|69671347|FG000|Induction Phase|Incarceration|1|||
37882844|NCT00830869|69567346|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
37882845|NCT00830869|69567347|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
37882846|NCT00830869|69567348|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
37882847|NCT00830869|69567349|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
37882848|NCT00830869|69567350|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
37882849|NCT00830869|69567351|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
37882850|NCT00830869|69567352|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
37882851|NCT00830869|69567353|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
37882852|NCT00830869|69567354|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
37882853|NCT00830869|69567355|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
37882854|NCT00830869|69567344|FG000|Period 2: Part 2|Progressive disease|0|||
37882855|NCT00830869|69567345|FG001|Period 2: Part 2|Progressive disease|0|||
37985628|NCT00207142|69671348|FG001|Induction Phase|Incarceration|0|||
37985629|NCT00207142|69671349|FG002|Induction Phase|Incarceration|0|||
37985630|NCT00207142|69671350|FG003|Induction Phase|Incarceration|0|||
37985631|NCT00207142|69671347|FG000|Induction Phase|Missing lab data|1|||
37985632|NCT00207142|69671348|FG001|Induction Phase|Missing lab data|0|||
37821100|NCT03335813|69500400|FG000|Overall Study|Withdrawal by Subject|1|||
37821101|NCT03246503|69500404|FG000|Overall Study|Lost to Follow-up|23|||
37821102|NCT03246503|69500404|FG000|Overall Study|Withdrawal by Subject|20|||
37821103|NCT03246503|69500404|FG000|Overall Study|Physician Decision|5|||
37821104|NCT03246503|69500404|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
37821105|NCT02514447|69500465|FG000|Overall Study|Withdrawal by Subject|3|||
37821106|NCT02514447|69500466|FG001|Overall Study|Withdrawal by Subject|1|||
37821107|NCT02514447|69500467|FG002|Overall Study|Withdrawal by Subject|1|||
37821108|NCT02514447|69500468|FG003|Overall Study|Withdrawal by Subject|0|||
37821109|NCT02514447|69500469|FG004|Overall Study|Withdrawal by Subject|0|||
37821110|NCT02514447|69500470|FG005|Overall Study|Withdrawal by Subject|0|||
37821111|NCT02514447|69500471|FG006|Overall Study|Withdrawal by Subject|0|||
37821112|NCT02514447|69500472|FG007|Overall Study|Withdrawal by Subject|1|||
37821113|NCT02514447|69500473|FG008|Overall Study|Withdrawal by Subject|1|||
37821114|NCT02514447|69500465|FG000|Overall Study|Death|24|||
37882856|NCT00830869|69567346|FG002|Period 2: Part 2|Progressive disease|0|||
37882857|NCT00830869|69567347|FG003|Period 2: Part 2|Progressive disease|0|||
37882858|NCT00830869|69567348|FG004|Period 2: Part 2|Progressive disease|0|||
37882859|NCT00830869|69567349|FG005|Period 2: Part 2|Progressive disease|0|||
37882860|NCT00830869|69567350|FG006|Period 2: Part 2|Progressive disease|0|||
37985633|NCT00207142|69671349|FG002|Induction Phase|Missing lab data|0|||
37882861|NCT00830869|69567351|FG007|Period 2: Part 2|Progressive disease|14|||
37882862|NCT00830869|69567352|FG008|Period 2: Part 2|Progressive disease|11|||
37882863|NCT00830869|69567353|FG009|Period 2: Part 2|Progressive disease|12|||
37882864|NCT00830869|69567354|FG010|Period 2: Part 2|Progressive disease|8|||
37882865|NCT00830869|69567355|FG011|Period 2: Part 2|Progressive disease|15|||
37882866|NCT00830869|69567344|FG000|Period 2: Part 2|Other|0|||
37882867|NCT00830869|69567345|FG001|Period 2: Part 2|Other|0|||
37882868|NCT00830869|69567346|FG002|Period 2: Part 2|Other|0|||
37882869|NCT00830869|69567347|FG003|Period 2: Part 2|Other|0|||
37882870|NCT00830869|69567348|FG004|Period 2: Part 2|Other|0|||
37882871|NCT00830869|69567349|FG005|Period 2: Part 2|Other|0|||
37882872|NCT00830869|69567350|FG006|Period 2: Part 2|Other|0|||
37882873|NCT00830869|69567351|FG007|Period 2: Part 2|Other|0|||
37882874|NCT00830869|69567352|FG008|Period 2: Part 2|Other|0|||
37882875|NCT00830869|69567353|FG009|Period 2: Part 2|Other|1|||
37882876|NCT00830869|69567354|FG010|Period 2: Part 2|Other|0|||
37882877|NCT00830869|69567355|FG011|Period 2: Part 2|Other|0|||
37882878|NCT00844519|69567384|FG000|Overall Study|Withdrawal by Subject|1|||
37882879|NCT00844519|69567385|FG001|Overall Study|Withdrawal by Subject|1|||
37882880|NCT00844519|69567384|FG000|Overall Study|Adverse Event|1|||
37882881|NCT00844519|69567385|FG001|Overall Study|Adverse Event|0|||
37882882|NCT01171820|69567393|FG000|Overall Study|Death|3|||
37882883|NCT01171820|69567394|FG001|Overall Study|Death|3|||
37882884|NCT01171820|69567393|FG000|Overall Study|Lost to Follow-up|0|||
37882885|NCT01171820|69567394|FG001|Overall Study|Lost to Follow-up|1|||
37882886|NCT01171820|69567393|FG000|Overall Study|Withdrawal by Subject|2|||
37882887|NCT01171820|69567394|FG001|Overall Study|Withdrawal by Subject|0|||
37985634|NCT00207142|69671350|FG003|Induction Phase|Missing lab data|0|||
37985635|NCT00207142|69671347|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
37985636|NCT00207142|69671348|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
37985637|NCT00207142|69671349|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
37985638|NCT00207142|69671350|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
37985639|NCT00207142|69671347|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
37695436|NCT02349295|69171755|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
37695437|NCT02349295|69171756|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
37821115|NCT02514447|69500466|FG001|Overall Study|Death|28|||
37821116|NCT02514447|69500467|FG002|Overall Study|Death|29|||
37821117|NCT02514447|69500468|FG003|Overall Study|Death|0|||
37821118|NCT02514447|69500469|FG004|Overall Study|Death|3|||
37821119|NCT02514447|69500470|FG005|Overall Study|Death|4|||
37821120|NCT02514447|69500471|FG006|Overall Study|Death|8|||
37821121|NCT02514447|69500472|FG007|Overall Study|Death|6|||
37821122|NCT02514447|69500473|FG008|Overall Study|Death|5|||
37821123|NCT02514447|69500465|FG000|Overall Study|Lost to Follow-up|1|||
37821124|NCT02514447|69500466|FG001|Overall Study|Lost to Follow-up|0|||
37821125|NCT02514447|69500467|FG002|Overall Study|Lost to Follow-up|0|||
37821126|NCT02514447|69500468|FG003|Overall Study|Lost to Follow-up|0|||
37821127|NCT02514447|69500469|FG004|Overall Study|Lost to Follow-up|0|||
37821128|NCT02514447|69500470|FG005|Overall Study|Lost to Follow-up|0|||
37821129|NCT02514447|69500471|FG006|Overall Study|Lost to Follow-up|0|||
37821130|NCT02514447|69500472|FG007|Overall Study|Lost to Follow-up|0|||
37821131|NCT02514447|69500473|FG008|Overall Study|Lost to Follow-up|1|||
37821132|NCT02514447|69500465|FG000|Overall Study|Sponsor Termination of Study|0|||
37821133|NCT02514447|69500466|FG001|Overall Study|Sponsor Termination of Study|1|||
37821134|NCT02514447|69500467|FG002|Overall Study|Sponsor Termination of Study|1|||
37821135|NCT02514447|69500468|FG003|Overall Study|Sponsor Termination of Study|0|||
37821136|NCT02514447|69500469|FG004|Overall Study|Sponsor Termination of Study|0|||
37821137|NCT02514447|69500470|FG005|Overall Study|Sponsor Termination of Study|0|||
37821138|NCT02514447|69500471|FG006|Overall Study|Sponsor Termination of Study|0|||
37821139|NCT02514447|69500472|FG007|Overall Study|Sponsor Termination of Study|0|||
37821140|NCT02514447|69500473|FG008|Overall Study|Sponsor Termination of Study|0|||
37821141|NCT02514447|69500465|FG000|Overall Study|Study completion per Investigator|1|||
37821142|NCT02514447|69500466|FG001|Overall Study|Study completion per Investigator|0|||
37882888|NCT01171820|69567393|FG000|Overall Study|Physician Decision|0|||
37882889|NCT01171820|69567394|FG001|Overall Study|Physician Decision|1|||
37882890|NCT01171820|69567393|FG000|Overall Study|1-Year Missed Visit|1|||
37882891|NCT01171820|69567394|FG001|Overall Study|1-Year Missed Visit|1|||
37882892|NCT00994110|69567402|FG000|Overall Study|Withdrawal by Subject|9|||
37882893|NCT00994110|69567403|FG001|Overall Study|Withdrawal by Subject|9|||
37882894|NCT00994110|69567402|FG000|Overall Study|Not Treated|4|||
37882895|NCT00994110|69567403|FG001|Overall Study|Not Treated|8|||
37821143|NCT02514447|69500467|FG002|Overall Study|Study completion per Investigator|1|||
37821144|NCT02514447|69500468|FG003|Overall Study|Study completion per Investigator|2|||
37821145|NCT02514447|69500469|FG004|Overall Study|Study completion per Investigator|0|||
37821146|NCT02514447|69500470|FG005|Overall Study|Study completion per Investigator|0|||
37882896|NCT00994110|69567402|FG000|Overall Study|Adverse Event|1|||
37882897|NCT00994110|69567403|FG001|Overall Study|Adverse Event|0|||
37882898|NCT00994110|69567402|FG000|Overall Study|Patient not resected|41|||
37882899|NCT00994110|69567403|FG001|Overall Study|Patient not resected|52|||
37882900|NCT00994110|69567402|FG000|Overall Study|Pt not eligible|10|||
37882901|NCT00994110|69567403|FG001|Overall Study|Pt not eligible|5|||
37882902|NCT00993954|69567411|FG000|Overall Study|Protocol Violation|21|||
37882903|NCT00993954|69567412|FG001|Overall Study|Protocol Violation|2|||
37882904|NCT01157234|69567420|FG000|Overall Study|Withdrawal by Subject|1|||
37882905|NCT01157234|69567421|FG001|Overall Study|Withdrawal by Subject|0|||
37882906|NCT00991302|69567436|FG000|Overall Study|Death|0|||
37882907|NCT00991302|69567437|FG001|Overall Study|Death|1|||
37882908|NCT00991302|69567436|FG000|Overall Study|Lost to Follow-up|14|||
37882909|NCT00991302|69567437|FG001|Overall Study|Lost to Follow-up|12|||
37882910|NCT00995670|69567446|FG000|Overall Study|Failed arterial cannulation|1|||
37882911|NCT00995670|69567447|FG001|Overall Study|Failed arterial cannulation|0|||
37882912|NCT00995670|69567448|FG002|Overall Study|Failed arterial cannulation|3|||
37882913|NCT00601354|69567458|FG000|Overall Study|Lost to Follow-up|4|||
37882914|NCT00601354|69567459|FG001|Overall Study|Lost to Follow-up|5|||
37882915|NCT00853099|69567468|FG000|Double-blind Period|Adverse Event|7|||
37882916|NCT00853099|69567469|FG001|Double-blind Period|Adverse Event|9|||
37882917|NCT00853099|69567470|FG002|Double-blind Period|Adverse Event|13|||
37882918|NCT00853099|69567471|FG003|Double-blind Period|Adverse Event|0|||
37882919|NCT00853099|69567468|FG000|Double-blind Period|Withdrawal by Subject|2|||
37882920|NCT00853099|69567469|FG001|Double-blind Period|Withdrawal by Subject|3|||
37882921|NCT00853099|69567470|FG002|Double-blind Period|Withdrawal by Subject|0|||
37882922|NCT00853099|69567471|FG003|Double-blind Period|Withdrawal by Subject|0|||
37882923|NCT00853099|69567468|FG000|Double-blind Period|Lack of Efficacy|14|||
37882924|NCT00853099|69567469|FG001|Double-blind Period|Lack of Efficacy|17|||
37882925|NCT00853099|69567470|FG002|Double-blind Period|Lack of Efficacy|16|||
37882926|NCT00853099|69567471|FG003|Double-blind Period|Lack of Efficacy|0|||
37882927|NCT00853099|69567468|FG000|Double-blind Period|Other|0|||
37882928|NCT00853099|69567469|FG001|Double-blind Period|Other|0|||
37882929|NCT00853099|69567470|FG002|Double-blind Period|Other|1|||
37985640|NCT00207142|69671348|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
37985641|NCT00207142|69671349|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
37882930|NCT00853099|69567471|FG003|Double-blind Period|Other|0|||
37882931|NCT00853099|69567468|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
37882932|NCT00853099|69567469|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
37882933|NCT00853099|69567470|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
37882934|NCT00853099|69567471|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
37882935|NCT00853099|69567468|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
37882936|NCT00853099|69567469|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
37882937|NCT00853099|69567470|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
37985642|NCT00207142|69671350|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
37985643|NCT00207142|69671347|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
37985644|NCT00207142|69671348|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
37985645|NCT00207142|69671349|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
37985646|NCT00207142|69671350|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
37985647|NCT00207142|69671347|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
37985648|NCT00207142|69671348|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
37985649|NCT00207142|69671349|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
37985650|NCT00207142|69671350|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
37985651|NCT00207142|69671347|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
37695438|NCT02349295|69171757|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
37695439|NCT02349295|69171758|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
37882938|NCT00853099|69567471|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
37882939|NCT00853099|69567468|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
37882940|NCT00853099|69567469|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
37882941|NCT00853099|69567470|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
37882942|NCT00853099|69567471|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
37882943|NCT00853099|69567468|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
37882944|NCT00853099|69567469|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
37882945|NCT00853099|69567470|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
37985652|NCT00207142|69671348|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
37985653|NCT00207142|69671349|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
37985654|NCT00207142|69671350|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
37882946|NCT00853099|69567471|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
37882947|NCT00853099|69567468|FG000|Double-blind + Open-label Periods|Other|0|||
37882948|NCT00853099|69567469|FG001|Double-blind + Open-label Periods|Other|0|||
37882949|NCT00853099|69567470|FG002|Double-blind + Open-label Periods|Other|0|||
37882950|NCT00853099|69567471|FG003|Double-blind + Open-label Periods|Other|6|||
37882951|NCT00992784|69567484|FG000|Overall Study|Adverse Event|2|||
37882952|NCT00992784|69567485|FG001|Overall Study|Adverse Event|1|||
37882953|NCT00992784|69567486|FG002|Overall Study|Adverse Event|0|||
37882954|NCT00992784|69567484|FG000|Overall Study|Withdrawal by Subject|1|||
37882955|NCT00992784|69567485|FG001|Overall Study|Withdrawal by Subject|1|||
37882956|NCT00992784|69567486|FG002|Overall Study|Withdrawal by Subject|1|||
37882957|NCT00830167|69567496|FG000|Overall Study|Lack of Efficacy|26|||
37882958|NCT00830167|69567497|FG001|Overall Study|Lack of Efficacy|10|||
37882959|NCT00830167|69567496|FG000|Overall Study|Adverse Event|8|||
37985655|NCT00207142|69671347|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
37985656|NCT00207142|69671348|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
37985657|NCT00207142|69671349|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
37985658|NCT00207142|69671350|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
37985659|NCT00207142|69671347|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
37985660|NCT00207142|69671348|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
37985661|NCT00207142|69671349|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
37985662|NCT00207142|69671350|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
37985663|NCT00207142|69671347|FG000|Maintenance Phase/Rescue Phase|Death|0|||
37985664|NCT00207142|69671348|FG001|Maintenance Phase/Rescue Phase|Death|0|||
37985665|NCT00207142|69671349|FG002|Maintenance Phase/Rescue Phase|Death|0|||
37882960|NCT00830167|69567497|FG001|Overall Study|Adverse Event|24|||
37882961|NCT00830167|69567496|FG000|Overall Study|Not meeting entrance criteria|2|||
37985666|NCT00207142|69671350|FG003|Maintenance Phase/Rescue Phase|Death|1|||
37985667|NCT00207142|69671347|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
37985668|NCT00207142|69671348|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
37985669|NCT00207142|69671349|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
37985670|NCT00207142|69671350|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
37985671|NCT00268905|69671368|FG000|Overall Study|Adverse Event|3|||
37985672|NCT00268905|69671369|FG001|Overall Study|Adverse Event|0|||
37985673|NCT00268905|69671370|FG002|Overall Study|Adverse Event|4|||
37985674|NCT00268905|69671368|FG000|Overall Study|Lost to Follow-up|0|||
37985675|NCT00268905|69671369|FG001|Overall Study|Lost to Follow-up|1|||
37985676|NCT00268905|69671370|FG002|Overall Study|Lost to Follow-up|0|||
37985677|NCT00268905|69671368|FG000|Overall Study|Withdrawal by Subject|0|||
37985678|NCT00268905|69671369|FG001|Overall Study|Withdrawal by Subject|0|||
37985679|NCT00268905|69671370|FG002|Overall Study|Withdrawal by Subject|3|||
37985680|NCT00268905|69671368|FG000|Overall Study|Progressive Disease|28|||
37985681|NCT00268905|69671369|FG001|Overall Study|Progressive Disease|4|||
37985682|NCT00268905|69671370|FG002|Overall Study|Progressive Disease|3|||
37985683|NCT00268905|69671368|FG000|Overall Study|Physician Decision|3|||
37985684|NCT00268905|69671369|FG001|Overall Study|Physician Decision|0|||
37985685|NCT00268905|69671370|FG002|Overall Study|Physician Decision|1|||
37985686|NCT00268905|69671368|FG000|Overall Study|Clinical Progression|9|||
37985687|NCT00268905|69671369|FG001|Overall Study|Clinical Progression|4|||
37985688|NCT00268905|69671370|FG002|Overall Study|Clinical Progression|1|||
37985689|NCT00206518|69671380|FG000|Overall Study|Lack of Efficacy|6|||
37985690|NCT00206518|69671381|FG001|Overall Study|Lack of Efficacy|4|||
37985691|NCT00206518|69671380|FG000|Overall Study|Adverse Event|2|||
37985692|NCT00206518|69671381|FG001|Overall Study|Adverse Event|1|||
37985693|NCT00206518|69671380|FG000|Overall Study|Physician Decision|1|||
37882962|NCT00830167|69567497|FG001|Overall Study|Not meeting entrance criteria|5|||
37882963|NCT00830167|69567496|FG000|Overall Study|Withdrawal by Subject|2|||
37882964|NCT00830167|69567497|FG001|Overall Study|Withdrawal by Subject|0|||
37985694|NCT00206518|69671381|FG001|Overall Study|Physician Decision|0|||
37985695|NCT00206518|69671380|FG000|Overall Study|Protocol Violation|1|||
37985696|NCT00206518|69671381|FG001|Overall Study|Protocol Violation|1|||
37985697|NCT00423722|69671389|FG000|Overall Study|Death|4|||
37985698|NCT00423722|69671390|FG001|Overall Study|Death|4|||
37985699|NCT00423722|69671389|FG000|Overall Study|Declined to participate|2|||
37985700|NCT00423722|69671390|FG001|Overall Study|Declined to participate|3|||
37985701|NCT00423722|69671389|FG000|Overall Study|Unable to complete questionnaires|4|||
37882965|NCT00830167|69567496|FG000|Overall Study|Lost to Follow-up|0|||
37882966|NCT00830167|69567497|FG001|Overall Study|Lost to Follow-up|1|||
37882967|NCT00830167|69567496|FG000|Overall Study|Protocol Violation|0|||
37882968|NCT00830167|69567497|FG001|Overall Study|Protocol Violation|1|||
37882969|NCT00830167|69567496|FG000|Overall Study|Other|2|||
37882970|NCT00830167|69567497|FG001|Overall Study|Other|2|||
37882971|NCT00992394|69567505|FG000|Overall Study|Lack of Efficacy|6|||
37882972|NCT00992394|69567506|FG001|Overall Study|Lack of Efficacy|3|||
37882973|NCT00992394|69567505|FG000|Overall Study|Adverse Event|4|||
37882974|NCT00992394|69567506|FG001|Overall Study|Adverse Event|5|||
37882975|NCT00992394|69567505|FG000|Overall Study|Withdrawal by Subject|8|||
37882976|NCT00992394|69567506|FG001|Overall Study|Withdrawal by Subject|2|||
37882977|NCT00992394|69567505|FG000|Overall Study|Physician Decision|1|||
37821147|NCT02514447|69500471|FG006|Overall Study|Study completion per Investigator|0|||
37882978|NCT00992394|69567506|FG001|Overall Study|Physician Decision|0|||
37882979|NCT00992394|69567505|FG000|Overall Study|Protocol Violation|2|||
37882980|NCT00992394|69567506|FG001|Overall Study|Protocol Violation|4|||
37821148|NCT02514447|69500472|FG007|Overall Study|Study completion per Investigator|0|||
37821149|NCT02514447|69500473|FG008|Overall Study|Study completion per Investigator|1|||
37882981|NCT00992394|69567505|FG000|Overall Study|Lost to Follow-up|2|||
37882982|NCT00992394|69567506|FG001|Overall Study|Lost to Follow-up|0|||
37882983|NCT00992394|69567505|FG000|Overall Study|Other event|1|||
37882984|NCT00992394|69567506|FG001|Overall Study|Other event|0|||
37882985|NCT00829933|69567516|FG000|Overall Study|Adverse Event|2|||
37882986|NCT00829933|69567517|FG001|Overall Study|Adverse Event|3|||
37882987|NCT00829933|69567518|FG002|Overall Study|Adverse Event|2|||
37882988|NCT00829933|69567519|FG003|Overall Study|Adverse Event|1|||
37821150|NCT01785563|69500517|FG000|Overall Study|Physician Decision|10|||
37821151|NCT01785563|69500517|FG000|Overall Study|Withdrawal by Subject|1|||
37821152|NCT01785563|69500517|FG000|Overall Study|Protocol Violation|2|||
37821153|NCT01434290|69500523|FG000|Overall Study|Protocol Violation|6|||
37821154|NCT01434290|69500524|FG001|Overall Study|Protocol Violation|3|||
37821155|NCT01434290|69500523|FG000|Overall Study|No protocol treatment|2|||
37821156|NCT01434290|69500524|FG001|Overall Study|No protocol treatment|4|||
37821157|NCT00750269|69500536|FG000|Overall Study|Protocol Violation|0|||
37821158|NCT00750269|69500537|FG001|Overall Study|Protocol Violation|1|||
37821159|NCT00750269|69500538|FG002|Overall Study|Protocol Violation|1|||
37821160|NCT00750269|69500539|FG003|Overall Study|Protocol Violation|2|||
37821161|NCT00750269|69500540|FG004|Overall Study|Protocol Violation|4|||
37821162|NCT00750269|69500536|FG000|Overall Study|Withdrawal by Subject|0|||
37821163|NCT00750269|69500537|FG001|Overall Study|Withdrawal by Subject|0|||
37821164|NCT00750269|69500538|FG002|Overall Study|Withdrawal by Subject|2|||
37821165|NCT00750269|69500539|FG003|Overall Study|Withdrawal by Subject|2|||
37821166|NCT00750269|69500540|FG004|Overall Study|Withdrawal by Subject|2|||
37821167|NCT00750269|69500536|FG000|Overall Study|Physician Decision|0|||
37821168|NCT00750269|69500537|FG001|Overall Study|Physician Decision|0|||
37882989|NCT00829933|69567516|FG000|Overall Study|Death|0|||
37882990|NCT00829933|69567517|FG001|Overall Study|Death|0|||
37882991|NCT00829933|69567518|FG002|Overall Study|Death|1|||
37882992|NCT00829933|69567519|FG003|Overall Study|Death|1|||
37821169|NCT00750269|69500538|FG002|Overall Study|Physician Decision|0|||
37882993|NCT00829933|69567516|FG000|Overall Study|Lack of Efficacy|0|||
37882994|NCT00829933|69567517|FG001|Overall Study|Lack of Efficacy|1|||
37821170|NCT00750269|69500539|FG003|Overall Study|Physician Decision|0|||
37882995|NCT00829933|69567518|FG002|Overall Study|Lack of Efficacy|0|||
37882996|NCT00829933|69567519|FG003|Overall Study|Lack of Efficacy|0|||
37882997|NCT00829933|69567516|FG000|Overall Study|Physician Decision|5|||
37882998|NCT00829933|69567517|FG001|Overall Study|Physician Decision|7|||
37882999|NCT00829933|69567518|FG002|Overall Study|Physician Decision|8|||
37883000|NCT00829933|69567519|FG003|Overall Study|Physician Decision|1|||
37883001|NCT00829933|69567516|FG000|Overall Study|Pregnancy|0|||
37883002|NCT00829933|69567517|FG001|Overall Study|Pregnancy|0|||
37883003|NCT00829933|69567518|FG002|Overall Study|Pregnancy|0|||
37883004|NCT00829933|69567519|FG003|Overall Study|Pregnancy|2|||
37883005|NCT00829933|69567516|FG000|Overall Study|Protocol Violation|2|||
37883006|NCT00829933|69567517|FG001|Overall Study|Protocol Violation|1|||
37883007|NCT00829933|69567518|FG002|Overall Study|Protocol Violation|0|||
37883008|NCT00829933|69567519|FG003|Overall Study|Protocol Violation|0|||
37883009|NCT00829933|69567516|FG000|Overall Study|withdrew before treatment started|5|||
37883010|NCT00829933|69567517|FG001|Overall Study|withdrew before treatment started|1|||
37883011|NCT00829933|69567518|FG002|Overall Study|withdrew before treatment started|2|||
37883012|NCT00829933|69567519|FG003|Overall Study|withdrew before treatment started|9|||
37883013|NCT01170962|69567532|FG000|Treatment Period|Lack of Efficacy|96|||
37883014|NCT01170962|69567533|FG001|Treatment Period|Lack of Efficacy|91|||
37883015|NCT01170962|69567534|FG002|Treatment Period|Lack of Efficacy|7|||
37883016|NCT01170962|69567532|FG000|Treatment Period|Adverse Event|11|||
37883017|NCT01170962|69567533|FG001|Treatment Period|Adverse Event|12|||
37883018|NCT01170962|69567534|FG002|Treatment Period|Adverse Event|3|||
37883019|NCT01170962|69567532|FG000|Treatment Period|Withdrawal by Subject|2|||
37883020|NCT01170962|69567533|FG001|Treatment Period|Withdrawal by Subject|1|||
37883021|NCT01170962|69567534|FG002|Treatment Period|Withdrawal by Subject|0|||
37883022|NCT01170962|69567532|FG000|Treatment Period|Lost to Follow-up|1|||
37883023|NCT01170962|69567533|FG001|Treatment Period|Lost to Follow-up|1|||
37883024|NCT01170962|69567534|FG002|Treatment Period|Lost to Follow-up|1|||
37883025|NCT01170962|69567532|FG000|Treatment Period|Participant no longer meets criteria|0|||
37883026|NCT01170962|69567533|FG001|Treatment Period|Participant no longer meets criteria|1|||
37883027|NCT01170962|69567534|FG002|Treatment Period|Participant no longer meets criteria|0|||
37821171|NCT00750269|69500540|FG004|Overall Study|Physician Decision|2|||
37883028|NCT01170962|69567532|FG000|Treatment Period|Request to discontinue treatment|7|||
37985702|NCT00423722|69671390|FG001|Overall Study|Unable to complete questionnaires|4|||
37985703|NCT00423722|69671389|FG000|Overall Study|Withdrawal by Subject|4|||
37985704|NCT00423722|69671390|FG001|Overall Study|Withdrawal by Subject|2|||
37985705|NCT00206440|69671404|FG000|Overall Study|Protocol Violation|1|||
37985706|NCT00206440|69671405|FG001|Overall Study|Protocol Violation|2|||
37985707|NCT00206440|69671404|FG000|Overall Study|Adverse Event|4|||
37985708|NCT00206440|69671405|FG001|Overall Study|Adverse Event|2|||
37821172|NCT00750269|69500536|FG000|Overall Study|Patient too large for positioning|0|||
37821173|NCT00750269|69500537|FG001|Overall Study|Patient too large for positioning|0|||
37821174|NCT00750269|69500538|FG002|Overall Study|Patient too large for positioning|1|||
37821175|NCT00750269|69500539|FG003|Overall Study|Patient too large for positioning|0|||
37821176|NCT00750269|69500540|FG004|Overall Study|Patient too large for positioning|0|||
37821177|NCT00750269|69500536|FG000|Overall Study|Site error|0|||
37821178|NCT00750269|69500537|FG001|Overall Study|Site error|0|||
37821179|NCT00750269|69500538|FG002|Overall Study|Site error|0|||
37821180|NCT00750269|69500539|FG003|Overall Study|Site error|1|||
37821181|NCT00750269|69500540|FG004|Overall Study|Site error|0|||
37821182|NCT00750269|69500536|FG000|Overall Study|SBRT plan could not be drawn|0|||
37985709|NCT00268437|69671411|FG000|Overall Study|Ineligible|1|||
37985710|NCT00423488|69671418|FG000|Overall Study|No evidence of study drug intake|2|||
37985711|NCT00423488|69671419|FG001|Overall Study|No evidence of study drug intake|1|||
37821183|NCT00750269|69500537|FG001|Overall Study|SBRT plan could not be drawn|0|||
37821184|NCT00750269|69500538|FG002|Overall Study|SBRT plan could not be drawn|0|||
37883029|NCT01170962|69567533|FG001|Treatment Period|Request to discontinue treatment|3|||
37883030|NCT01170962|69567534|FG002|Treatment Period|Request to discontinue treatment|1|||
37883031|NCT01170962|69567532|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
37883032|NCT01170962|69567533|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
37883033|NCT01170962|69567534|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
37883034|NCT01170962|69567532|FG000|Follow up Period|Withdrawal by Subject|14|||
37883035|NCT01170962|69567533|FG001|Follow up Period|Withdrawal by Subject|10|||
37883036|NCT01170962|69567534|FG002|Follow up Period|Withdrawal by Subject|2|||
37883037|NCT01170962|69567532|FG000|Follow up Period|Lost to Follow-up|13|||
37985712|NCT00423488|69671418|FG000|Overall Study|No post baseline data|3|||
37883038|NCT01170962|69567533|FG001|Follow up Period|Lost to Follow-up|8|||
37883039|NCT01170962|69567534|FG002|Follow up Period|Lost to Follow-up|1|||
37883040|NCT01170962|69567532|FG000|Follow up Period|Death|2|||
37883041|NCT01170962|69567533|FG001|Follow up Period|Death|2|||
37883042|NCT01170962|69567534|FG002|Follow up Period|Death|0|||
37821185|NCT00750269|69500539|FG003|Overall Study|SBRT plan could not be drawn|0|||
37821186|NCT00750269|69500540|FG004|Overall Study|SBRT plan could not be drawn|1|||
37821187|NCT00750269|69500536|FG000|Overall Study|Fiducials could not be placed|0|||
37821188|NCT00750269|69500537|FG001|Overall Study|Fiducials could not be placed|0|||
37821189|NCT00750269|69500538|FG002|Overall Study|Fiducials could not be placed|0|||
37821190|NCT00750269|69500539|FG003|Overall Study|Fiducials could not be placed|0|||
37821191|NCT00750269|69500540|FG004|Overall Study|Fiducials could not be placed|1|||
37821192|NCT00712322|69500562|FG000|Overall Study|Protocol deviation|0|||
37821193|NCT00712322|69500563|FG001|Overall Study|Protocol deviation|1|||
37821194|NCT00712322|69500564|FG002|Overall Study|Protocol deviation|0|||
37821195|NCT00323856|69500572|FG000|Overall Study|Withdrawal by Subject|1|||
37821196|NCT00323856|69500572|FG000|Overall Study|Was uncooperative and noncompliant|1|||
37821197|NCT00323856|69500572|FG000|Overall Study|Reason not specified|1|||
37821198|NCT00323856|69500572|FG000|Overall Study|Missing|2|||
37821199|NCT04594941|69500587|FG000|Overall Study|Other|0|||
37821200|NCT04594941|69500588|FG001|Overall Study|Other|3|||
37821201|NCT04594941|69500589|FG002|Overall Study|Other|1|||
37821202|NCT04594941|69500590|FG003|Overall Study|Other|0|||
37883043|NCT01170962|69567532|FG000|Follow up Period|Others|10|||
37883044|NCT01170962|69567533|FG001|Follow up Period|Others|7|||
37883045|NCT01170962|69567534|FG002|Follow up Period|Others|3|||
37883046|NCT00843193|69567553|FG000|Overall Study|Adverse Event|2|||
37883047|NCT00843193|69567554|FG001|Overall Study|Adverse Event|4|||
37883048|NCT00843193|69567553|FG000|Overall Study|Lack of Efficacy|1|||
37883049|NCT00843193|69567554|FG001|Overall Study|Lack of Efficacy|1|||
37883050|NCT00843193|69567553|FG000|Overall Study|Protocol Violation|1|||
37883051|NCT00843193|69567554|FG001|Overall Study|Protocol Violation|2|||
37883052|NCT00843193|69567553|FG000|Overall Study|Lost to Follow-up|1|||
37883053|NCT00843193|69567554|FG001|Overall Study|Lost to Follow-up|0|||
37883054|NCT00843193|69567553|FG000|Overall Study|Physician Decision|0|||
37883055|NCT00843193|69567554|FG001|Overall Study|Physician Decision|1|||
37883056|NCT00843193|69567553|FG000|Overall Study|Withdrawal by Subject|3|||
37883057|NCT00843193|69567554|FG001|Overall Study|Withdrawal by Subject|3|||
37883058|NCT00829621|69567563|FG000|Overall Study|Death|1|||
37883059|NCT00829621|69567564|FG001|Overall Study|Death|0|||
37883060|NCT00829621|69567563|FG000|Overall Study|Lost to Follow-up|3|||
37883061|NCT00829621|69567564|FG001|Overall Study|Lost to Follow-up|4|||
37883062|NCT01157078|69567572|FG000|Overall Study|Withdrawal by Subject|12|||
37883063|NCT01157078|69567573|FG001|Overall Study|Withdrawal by Subject|14|||
37883064|NCT01157078|69567572|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
37883065|NCT01157078|69567573|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
37883066|NCT01157078|69567572|FG000|Overall Study|Adverse Event|6|||
37883067|NCT01157078|69567573|FG001|Overall Study|Adverse Event|6|||
37985713|NCT00423488|69671419|FG001|Overall Study|No post baseline data|0|||
37985714|NCT00404066|69671425|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
37985715|NCT00404066|69671425|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
37985716|NCT00423332|69671431|FG000|Overall Study|Adverse Event|6|||
37985717|NCT00423332|69671432|FG001|Overall Study|Adverse Event|2|||
37985718|NCT00423332|69671431|FG000|Overall Study|Withdrawal by Subject|1|||
37985719|NCT00423332|69671432|FG001|Overall Study|Withdrawal by Subject|0|||
37985720|NCT00423332|69671431|FG000|Overall Study|Condition under investigation worsened|1|||
37985721|NCT00423332|69671432|FG001|Overall Study|Condition under investigation worsened|1|||
37985722|NCT00423332|69671431|FG000|Overall Study|Progressive at Week 6|0|||
37985723|NCT00423332|69671432|FG001|Overall Study|Progressive at Week 6|1|||
37985724|NCT00423332|69671431|FG000|Overall Study|Unblinded before 12 weeks|1|||
37985725|NCT00423332|69671432|FG001|Overall Study|Unblinded before 12 weeks|3|||
37985726|NCT00413036|69671439|FG000|Overall Study|Adverse Event|44|||
37985727|NCT00413036|69671439|FG000|Overall Study|Lack of Efficacy|129|||
37985728|NCT00413036|69671439|FG000|Overall Study|Withdrawal by Subject|7|||
37985729|NCT00413036|69671439|FG000|Overall Study|Death|9|||
37883068|NCT01157078|69567572|FG000|Overall Study|Severe non-compliance to protocol|2|||
37883069|NCT01157078|69567573|FG001|Overall Study|Severe non-compliance to protocol|4|||
37883070|NCT01157078|69567572|FG000|Overall Study|Condition under investigation worsened|0|||
37883071|NCT01157078|69567573|FG001|Overall Study|Condition under investigation worsened|1|||
37883072|NCT01157078|69567572|FG000|Overall Study|Lack of Efficacy|2|||
37883073|NCT01157078|69567573|FG001|Overall Study|Lack of Efficacy|0|||
37883074|NCT01157078|69567572|FG000|Overall Study|Study-specific withdrawal criteria|2|||
37883075|NCT01157078|69567573|FG001|Overall Study|Study-specific withdrawal criteria|2|||
37883076|NCT01157078|69567572|FG000|Overall Study|Lost to Follow-up|7|||
37883077|NCT01157078|69567573|FG001|Overall Study|Lost to Follow-up|5|||
37883078|NCT01157078|69567572|FG000|Overall Study|Other|2|||
37883079|NCT01157078|69567573|FG001|Overall Study|Other|4|||
37883080|NCT00591721|69567581|FG000|Overall Study|Withdrawal by Subject|10|||
37883081|NCT00591721|69567582|FG001|Overall Study|Withdrawal by Subject|10|||
37883082|NCT00591721|69567581|FG000|Overall Study|Lost to Follow-up|1|||
37883083|NCT00591721|69567582|FG001|Overall Study|Lost to Follow-up|4|||
37883084|NCT00591721|69567581|FG000|Overall Study|Intervention not received|10|||
37883085|NCT00591721|69567582|FG001|Overall Study|Intervention not received|8|||
37883086|NCT01156844|69567592|FG000|Overall Study|Adverse Event|0|||
37883087|NCT01156844|69567593|FG001|Overall Study|Adverse Event|0|||
37883088|NCT01156844|69567594|FG002|Overall Study|Adverse Event|1|||
37883089|NCT01156844|69567595|FG003|Overall Study|Adverse Event|1|||
37883090|NCT01156844|69567592|FG000|Overall Study|Abnormal test procedure result(s)|0|||
37883091|NCT01156844|69567593|FG001|Overall Study|Abnormal test procedure result(s)|1|||
37883092|NCT01156844|69567594|FG002|Overall Study|Abnormal test procedure result(s)|2|||
37985730|NCT00413036|69671439|FG000|Overall Study|Other|26|||
37883093|NCT01156844|69567595|FG003|Overall Study|Abnormal test procedure result(s)|2|||
37883094|NCT01156844|69567592|FG000|Overall Study|Withdrawal by Subject|0|||
37985731|NCT00413036|69671439|FG000|Overall Study|Missing|2|||
37883095|NCT01156844|69567593|FG001|Overall Study|Withdrawal by Subject|0|||
37883096|NCT01156844|69567594|FG002|Overall Study|Withdrawal by Subject|2|||
37985732|NCT00412958|69671447|FG000|Overall Study|Withdrawal by Subject|3|||
37985733|NCT00412958|69671448|FG001|Overall Study|Withdrawal by Subject|0|||
37883097|NCT01156844|69567595|FG003|Overall Study|Withdrawal by Subject|2|||
37883098|NCT01156844|69567592|FG000|Overall Study|Lost to Follow-up|0|||
37883099|NCT01156844|69567593|FG001|Overall Study|Lost to Follow-up|0|||
37883100|NCT01156844|69567594|FG002|Overall Study|Lost to Follow-up|1|||
37883101|NCT01156844|69567595|FG003|Overall Study|Lost to Follow-up|0|||
37883102|NCT01156844|69567592|FG000|Overall Study|Administrative problems|0|||
37883103|NCT01156844|69567593|FG001|Overall Study|Administrative problems|1|||
37883104|NCT01156844|69567594|FG002|Overall Study|Administrative problems|0|||
37883105|NCT01156844|69567595|FG003|Overall Study|Administrative problems|1|||
37883106|NCT01156844|69567592|FG000|Overall Study|Protocol deviation|2|||
37883107|NCT01156844|69567593|FG001|Overall Study|Protocol deviation|0|||
37883108|NCT01156844|69567594|FG002|Overall Study|Protocol deviation|0|||
37883109|NCT01156844|69567595|FG003|Overall Study|Protocol deviation|0|||
37883110|NCT00853021|69567608|FG000|Overall Study|Adverse Event|2|||
37883111|NCT00853021|69567608|FG000|Overall Study|Withdrawal by Subject|2|||
37883112|NCT00853021|69567608|FG000|Overall Study|Death|1|||
37883113|NCT01156532|69567612|FG000|Overall Study|Family Reasons|1|||
37883114|NCT01156532|69567612|FG000|Overall Study|Lost to Follow-up|1|||
37883115|NCT00843115|69567616|FG000|Overall Study|Death|4|||
37883116|NCT00843115|69567616|FG000|Overall Study|Adverse Event|30|||
37883117|NCT00843115|69567616|FG000|Overall Study|Lost to Follow-up|4|||
37883118|NCT00843115|69567616|FG000|Overall Study|Withdrawal by Subject|17|||
37883119|NCT00843115|69567616|FG000|Overall Study|Family wanted meds stopped|1|||
37883120|NCT00843115|69567616|FG000|Overall Study|Family does not want continuation|1|||
37883121|NCT00843115|69567616|FG000|Overall Study|Patient forgot to take meds|1|||
37883122|NCT00843115|69567616|FG000|Overall Study|Does not meet entrance criteria|1|||
37883123|NCT00843115|69567616|FG000|Overall Study|Physician Decision|1|||
37883124|NCT00843115|69567616|FG000|Overall Study|Family discontinued meds|1|||
37883125|NCT00843115|69567616|FG000|Overall Study|patient took for 2 days then stopped|1|||
37883126|NCT00843115|69567616|FG000|Overall Study|patient never took the medication|1|||
37883127|NCT00843115|69567616|FG000|Overall Study|hospitalized due to deterioration|1|||
37883128|NCT00843115|69567616|FG000|Overall Study|week 12 not done|1|||
37883129|NCT00843115|69567616|FG000|Overall Study|Syndrome De Glissement|1|||
37883130|NCT01156376|69567623|FG000|Overall Study|Adverse Event|1|||
37883131|NCT01156376|69567624|FG001|Overall Study|Adverse Event|0|||
37883132|NCT01156376|69567625|FG002|Overall Study|Adverse Event|1|||
37883133|NCT01156376|69567623|FG000|Overall Study|Withdrawal by Subject|0|||
37883134|NCT01156376|69567624|FG001|Overall Study|Withdrawal by Subject|0|||
37883135|NCT01156376|69567625|FG002|Overall Study|Withdrawal by Subject|3|||
37883136|NCT00829387|69567635|FG000|Overall Study|Withdrawal by Subject|2|||
37883137|NCT00829387|69567636|FG001|Overall Study|Withdrawal by Subject|3|||
37985734|NCT00412958|69671449|FG002|Overall Study|Withdrawal by Subject|0|||
37985735|NCT00412958|69671450|FG003|Overall Study|Withdrawal by Subject|1|||
37695440|NCT02349295|69171759|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
37821203|NCT04524663|69500608|FG000|Overall Study|Withdrawal by Subject|0|||
37821204|NCT04524663|69500609|FG001|Overall Study|Withdrawal by Subject|2|||
37821205|NCT03738423|69500638|FG000|Overall Study|Withdrawal by Subject|9|||
37821206|NCT03738423|69500639|FG001|Overall Study|Withdrawal by Subject|12|||
37821207|NCT03738423|69500640|FG002|Overall Study|Withdrawal by Subject|9|||
37821208|NCT03738423|69500641|FG003|Overall Study|Withdrawal by Subject|12|||
37821209|NCT03738423|69500642|FG004|Overall Study|Withdrawal by Subject|10|||
37821210|NCT03738423|69500638|FG000|Overall Study|Lack of Efficacy|3|||
37821211|NCT03738423|69500639|FG001|Overall Study|Lack of Efficacy|1|||
37821212|NCT03738423|69500640|FG002|Overall Study|Lack of Efficacy|1|||
37821213|NCT03738423|69500641|FG003|Overall Study|Lack of Efficacy|1|||
37821214|NCT03738423|69500642|FG004|Overall Study|Lack of Efficacy|2|||
37821215|NCT03738423|69500638|FG000|Overall Study|Lost to Follow-up|1|||
37821216|NCT03738423|69500639|FG001|Overall Study|Lost to Follow-up|0|||
37821217|NCT03738423|69500640|FG002|Overall Study|Lost to Follow-up|1|||
37821218|NCT03738423|69500641|FG003|Overall Study|Lost to Follow-up|1|||
37821219|NCT03738423|69500642|FG004|Overall Study|Lost to Follow-up|0|||
37821220|NCT03738423|69500638|FG000|Overall Study|Protocol Violation|1|||
37883138|NCT00829387|69567635|FG000|Overall Study|Disqualified by PI|1|||
37883139|NCT00829387|69567636|FG001|Overall Study|Disqualified by PI|0|||
37883140|NCT01156142|69567644|FG000|Overall Study|Withdrawal by Subject|8|||
37883141|NCT01156142|69567645|FG001|Overall Study|Withdrawal by Subject|6|||
37883142|NCT01156142|69567644|FG000|Overall Study|Ineligible|0|||
37883143|NCT01156142|69567645|FG001|Overall Study|Ineligible|1|||
37883144|NCT00842257|69567651|FG000|Overall Study|Adverse Event|1|||
37883145|NCT00852475|69567657|FG000|Overall Study|Lost to Follow-up|3|||
37883146|NCT00852475|69567658|FG001|Overall Study|Lost to Follow-up|4|||
37883147|NCT01155284|69567668|FG000|Overall Study|Withdrawal by Subject|4|||
37883148|NCT01155284|69567669|FG001|Overall Study|Withdrawal by Subject|3|||
37883149|NCT01155284|69567668|FG000|Overall Study|Lost to Follow-up|1|||
37883150|NCT01155284|69567669|FG001|Overall Study|Lost to Follow-up|2|||
37821221|NCT03738423|69500639|FG001|Overall Study|Protocol Violation|0|||
37821222|NCT03738423|69500640|FG002|Overall Study|Protocol Violation|0|||
37821223|NCT03738423|69500641|FG003|Overall Study|Protocol Violation|0|||
37883151|NCT01155284|69567668|FG000|Overall Study|Physician Decision|1|||
37883152|NCT01155284|69567669|FG001|Overall Study|Physician Decision|0|||
37883153|NCT01155284|69567668|FG000|Overall Study|Adverse Event|1|||
37883154|NCT01155284|69567669|FG001|Overall Study|Adverse Event|0|||
37883155|NCT00852397|69567680|FG000|Overall Study|Adverse Event|4|||
37883156|NCT00852397|69567681|FG001|Overall Study|Adverse Event|6|||
37883157|NCT00852397|69567682|FG002|Overall Study|Adverse Event|4|||
37985736|NCT00412958|69671447|FG000|Overall Study|Adverse Event|0|||
37985737|NCT00412958|69671448|FG001|Overall Study|Adverse Event|1|||
37883158|NCT00852397|69567680|FG000|Overall Study|Death|0|||
37883159|NCT00852397|69567681|FG001|Overall Study|Death|0|||
37883160|NCT00852397|69567682|FG002|Overall Study|Death|1|||
37883161|NCT00852397|69567680|FG000|Overall Study|Withdrawal by Subject|4|||
37883162|NCT00852397|69567681|FG001|Overall Study|Withdrawal by Subject|1|||
37883163|NCT00852397|69567682|FG002|Overall Study|Withdrawal by Subject|2|||
37883164|NCT00852397|69567680|FG000|Overall Study|Study terminated by sponsor|2|||
37883165|NCT00852397|69567681|FG001|Overall Study|Study terminated by sponsor|1|||
37883166|NCT00852397|69567682|FG002|Overall Study|Study terminated by sponsor|6|||
37883167|NCT00852397|69567680|FG000|Overall Study|Difficulty in study site visit|1|||
37883168|NCT00852397|69567681|FG001|Overall Study|Difficulty in study site visit|0|||
37883169|NCT00852397|69567682|FG002|Overall Study|Difficulty in study site visit|0|||
37883170|NCT00852397|69567680|FG000|Overall Study|Protocol Violation|0|||
37883171|NCT00852397|69567681|FG001|Overall Study|Protocol Violation|0|||
37883172|NCT00852397|69567682|FG002|Overall Study|Protocol Violation|1|||
37883173|NCT00841321|69567692|FG000|Overall Study|Lost to Follow-up|1|||
37883174|NCT00841321|69567693|FG001|Overall Study|Lost to Follow-up|1|||
37883175|NCT00841321|69567692|FG000|Overall Study|Adverse Event|0|||
37883176|NCT00841321|69567693|FG001|Overall Study|Adverse Event|2|||
37883177|NCT00986232|69567705|FG000|Overall Study|Adverse Event|1|||
37883178|NCT00986232|69567706|FG001|Overall Study|Adverse Event|2|||
37883179|NCT00986232|69567707|FG002|Overall Study|Adverse Event|3|||
37883180|NCT00986232|69567708|FG003|Overall Study|Adverse Event|0|||
37883181|NCT00986232|69567705|FG000|Overall Study|Lost to Follow-up|19|||
37883182|NCT00986232|69567706|FG001|Overall Study|Lost to Follow-up|12|||
37883183|NCT00986232|69567707|FG002|Overall Study|Lost to Follow-up|12|||
37883184|NCT00986232|69567708|FG003|Overall Study|Lost to Follow-up|7|||
37883185|NCT00986232|69567705|FG000|Overall Study|Protocol Violation|2|||
37883186|NCT00986232|69567706|FG001|Overall Study|Protocol Violation|3|||
37883187|NCT00986232|69567707|FG002|Overall Study|Protocol Violation|0|||
37883188|NCT00986232|69567708|FG003|Overall Study|Protocol Violation|1|||
37883189|NCT00986232|69567705|FG000|Overall Study|Withdrawal by Subject|13|||
37883190|NCT00986232|69567706|FG001|Overall Study|Withdrawal by Subject|16|||
37883191|NCT00986232|69567707|FG002|Overall Study|Withdrawal by Subject|12|||
37883192|NCT00986232|69567708|FG003|Overall Study|Withdrawal by Subject|3|||
37883193|NCT00986232|69567705|FG000|Overall Study|Missed one or more bleeds|13|||
37883194|NCT00986232|69567706|FG001|Overall Study|Missed one or more bleeds|10|||
37883195|NCT00986232|69567707|FG002|Overall Study|Missed one or more bleeds|6|||
37985738|NCT00412958|69671449|FG002|Overall Study|Adverse Event|0|||
37985739|NCT00412958|69671450|FG003|Overall Study|Adverse Event|0|||
37883196|NCT00986232|69567708|FG003|Overall Study|Missed one or more bleeds|7|||
37883197|NCT00986232|69567705|FG000|Overall Study|Incomplete safety follow-up|3|||
37883198|NCT00986232|69567706|FG001|Overall Study|Incomplete safety follow-up|7|||
37883199|NCT00986232|69567707|FG002|Overall Study|Incomplete safety follow-up|2|||
37883200|NCT00986232|69567708|FG003|Overall Study|Incomplete safety follow-up|2|||
37883201|NCT00852241|69567724|FG000|Overall Study|Physician Decision|18|||
37883202|NCT01169636|69567733|FG000|Overall Study|Adverse Event|0|||
37883203|NCT01169636|69567734|FG001|Overall Study|Adverse Event|0|||
37883204|NCT01169636|69567735|FG002|Overall Study|Adverse Event|1|||
37821224|NCT03738423|69500642|FG004|Overall Study|Protocol Violation|1|||
37821225|NCT03738423|69500638|FG000|Overall Study|Physician Decision|0|||
37821226|NCT03738423|69500639|FG001|Overall Study|Physician Decision|0|||
37821227|NCT03738423|69500640|FG002|Overall Study|Physician Decision|1|||
37821228|NCT03738423|69500641|FG003|Overall Study|Physician Decision|0|||
37821229|NCT03738423|69500642|FG004|Overall Study|Physician Decision|1|||
37821230|NCT03738423|69500638|FG000|Overall Study|Death|0|||
37821231|NCT03738423|69500639|FG001|Overall Study|Death|0|||
37883205|NCT01169636|69567736|FG003|Overall Study|Adverse Event|1|||
37883206|NCT01169636|69567737|FG004|Overall Study|Adverse Event|0|||
37883207|NCT01169636|69567733|FG000|Overall Study|Screen failure|0|||
37883208|NCT01169636|69567734|FG001|Overall Study|Screen failure|0|||
37883209|NCT01169636|69567735|FG002|Overall Study|Screen failure|2|||
37821232|NCT03738423|69500640|FG002|Overall Study|Death|0|||
37883210|NCT01169636|69567736|FG003|Overall Study|Screen failure|0|||
37883211|NCT01169636|69567737|FG004|Overall Study|Screen failure|0|||
37883212|NCT01169636|69567733|FG000|Overall Study|Withdrawal by Subject|0|||
37883213|NCT01169636|69567734|FG001|Overall Study|Withdrawal by Subject|0|||
37985740|NCT00412958|69671447|FG000|Overall Study|Lost to Follow-up|0|||
37821233|NCT03738423|69500641|FG003|Overall Study|Death|0|||
37883214|NCT01169636|69567735|FG002|Overall Study|Withdrawal by Subject|0|||
37883215|NCT01169636|69567736|FG003|Overall Study|Withdrawal by Subject|0|||
37883216|NCT01169636|69567737|FG004|Overall Study|Withdrawal by Subject|3|||
37883217|NCT01169558|69567747|FG000|Overall Study|Disease progression|98|||
37883218|NCT01169558|69567747|FG000|Overall Study|Adverse Event|25|||
37883219|NCT01169558|69567747|FG000|Overall Study|Withdrawal of Consent|8|||
37883220|NCT01169558|69567747|FG000|Overall Study|Medical Decision|7|||
37883221|NCT01169558|69567747|FG000|Overall Study|Stable Disease|4|||
37985741|NCT00412958|69671448|FG001|Overall Study|Lost to Follow-up|1|||
37985742|NCT00412958|69671449|FG002|Overall Study|Lost to Follow-up|0|||
37985743|NCT00412958|69671450|FG003|Overall Study|Lost to Follow-up|0|||
37985744|NCT00412958|69671447|FG000|Overall Study|Death|0|||
37985745|NCT00412958|69671448|FG001|Overall Study|Death|1|||
37985746|NCT00412958|69671449|FG002|Overall Study|Death|0|||
37985747|NCT00412958|69671450|FG003|Overall Study|Death|0|||
37985748|NCT00412958|69671447|FG000|Overall Study|Transport issue|0|||
37821234|NCT03738423|69500642|FG004|Overall Study|Death|1|||
37821235|NCT03738423|69500638|FG000|Overall Study|Randomized but never treated|0|||
37821236|NCT03738423|69500639|FG001|Overall Study|Randomized but never treated|0|||
37821237|NCT03738423|69500640|FG002|Overall Study|Randomized but never treated|1|||
37821238|NCT03738423|69500641|FG003|Overall Study|Randomized but never treated|1|||
37821239|NCT03738423|69500642|FG004|Overall Study|Randomized but never treated|0|||
37821240|NCT03712228|69500660|FG000|Treatment Period 1|Lack of Efficacy|0|||
37821241|NCT03712228|69500661|FG001|Treatment Period 1|Lack of Efficacy|0|||
37821242|NCT03712228|69500662|FG002|Treatment Period 1|Lack of Efficacy|0|||
37821243|NCT03712228|69500663|FG003|Treatment Period 1|Lack of Efficacy|0|||
37821244|NCT03712228|69500664|FG004|Treatment Period 1|Lack of Efficacy|0|||
37821245|NCT03712228|69500665|FG005|Treatment Period 1|Lack of Efficacy|1|||
37821246|NCT03712228|69500660|FG000|Treatment Period 2|Pregnancy|0|||
37821247|NCT03712228|69500661|FG001|Treatment Period 2|Pregnancy|0|||
37821248|NCT03712228|69500662|FG002|Treatment Period 2|Pregnancy|0|||
37883222|NCT01169558|69567747|FG000|Overall Study|Lost to Follow-up|4|||
37883223|NCT01169558|69567747|FG000|Overall Study|Need for Surgery|4|||
37883224|NCT01169558|69567747|FG000|Overall Study|Non-compliance|2|||
37883225|NCT01169558|69567747|FG000|Overall Study|Protocol Violation|2|||
37883226|NCT01169558|69567747|FG000|Overall Study|Partial response|2|||
37883227|NCT00840463|69567753|FG000|Overall Study|Adverse Event|1|||
37883228|NCT00840463|69567754|FG001|Overall Study|Adverse Event|0|||
37883229|NCT01155050|69567764|FG000|Overall Study|Lost to Follow-up|15|||
37985749|NCT00412958|69671448|FG001|Overall Study|Transport issue|1|||
37985750|NCT00412958|69671449|FG002|Overall Study|Transport issue|0|||
37985751|NCT00412958|69671450|FG003|Overall Study|Transport issue|0|||
37695441|NCT02349295|69171760|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
37695442|NCT02349295|69171761|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
37821249|NCT03712228|69500663|FG003|Treatment Period 2|Pregnancy|1|||
37883230|NCT01155050|69567765|FG001|Overall Study|Lost to Follow-up|20|||
37883231|NCT01155050|69567766|FG002|Overall Study|Lost to Follow-up|19|||
37883232|NCT01155050|69567767|FG003|Overall Study|Lost to Follow-up|22|||
37883233|NCT01168856|69567779|FG000|Overall Study|Lost to Follow-up|4|||
37883234|NCT01168856|69567780|FG001|Overall Study|Lost to Follow-up|34|||
37985752|NCT00423176|69671462|FG000|Overall Study|Adverse Event|4|||
37985753|NCT00423176|69671463|FG001|Overall Study|Adverse Event|6|||
37985754|NCT00423176|69671462|FG000|Overall Study|Treatment Failure|1|||
37883235|NCT01168856|69567779|FG000|Overall Study|Withdrawal by Subject|6|||
37883236|NCT01168856|69567780|FG001|Overall Study|Withdrawal by Subject|8|||
37883237|NCT01168856|69567779|FG000|Overall Study|Physician Decision|2|||
37883238|NCT01168856|69567780|FG001|Overall Study|Physician Decision|1|||
37883239|NCT01168856|69567779|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
37883240|NCT01168856|69567780|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
37883241|NCT01168856|69567779|FG000|Overall Study|Participant received anti-HCV treatment|1|||
37883242|NCT01168856|69567780|FG001|Overall Study|Participant received anti-HCV treatment|0|||
37883243|NCT01168856|69567779|FG000|Overall Study|Death|0|||
37883244|NCT01168856|69567780|FG001|Overall Study|Death|2|||
37883245|NCT01168856|69567779|FG000|Overall Study|Other|1|||
37883246|NCT01168856|69567780|FG001|Overall Study|Other|291|||
37883247|NCT01168856|69567779|FG000|Overall Study|Protocol Violation|4|||
37883248|NCT01168856|69567780|FG001|Overall Study|Protocol Violation|6|||
37883249|NCT00828451|69567791|FG000|Overall Study|Death|2|||
37883250|NCT00828451|69567791|FG000|Overall Study|Lack of intravenous line|7|||
37883251|NCT00828451|69567791|FG000|Overall Study|Withdrawal by Subject|1|||
37883252|NCT00828451|69567791|FG000|Overall Study|Deterioration in clinical status|1|||
37883253|NCT00839917|69567797|FG000|Overall Study|Lost to Follow-up|1|||
37883254|NCT00839917|69567798|FG001|Overall Study|Lost to Follow-up|0|||
37883255|NCT00839917|69567797|FG000|Overall Study|Did not receive vaccine|0|||
37883256|NCT00839917|69567798|FG001|Overall Study|Did not receive vaccine|1|||
37883257|NCT00839527|69567807|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
37883258|NCT00839527|69567808|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
37883259|NCT00839527|69567809|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
37883260|NCT00839527|69567807|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
37883261|NCT00839527|69567808|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
37883262|NCT00839527|69567809|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
37883263|NCT00839527|69567807|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
37883264|NCT00839527|69567808|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
37985755|NCT00423176|69671463|FG001|Overall Study|Treatment Failure|6|||
37985756|NCT00423176|69671462|FG000|Overall Study|Lost to Follow-up|4|||
37985757|NCT00423176|69671463|FG001|Overall Study|Lost to Follow-up|7|||
37985758|NCT00423176|69671462|FG000|Overall Study|Withdrawal by Subject|4|||
37985759|NCT00423176|69671463|FG001|Overall Study|Withdrawal by Subject|3|||
37695443|NCT02349295|69171762|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
37695444|NCT02349295|69171749|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
37883265|NCT00839527|69567809|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
37985760|NCT00423176|69671462|FG000|Overall Study|Protocol Violation|1|||
37985761|NCT00423176|69671463|FG001|Overall Study|Protocol Violation|3|||
37985762|NCT00423176|69671462|FG000|Overall Study|Did not meet protocol eligibility|2|||
37695445|NCT02349295|69171750|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
37695446|NCT02349295|69171751|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
37821250|NCT03712228|69500664|FG004|Treatment Period 2|Pregnancy|0|||
37821251|NCT03712228|69500665|FG005|Treatment Period 2|Pregnancy|0|||
37821252|NCT03712228|69500660|FG000|Treatment Period 2|Withdrawal by Subject|0|||
37821253|NCT03712228|69500661|FG001|Treatment Period 2|Withdrawal by Subject|0|||
37821254|NCT03712228|69500662|FG002|Treatment Period 2|Withdrawal by Subject|0|||
37821255|NCT03712228|69500663|FG003|Treatment Period 2|Withdrawal by Subject|1|||
37821256|NCT03712228|69500664|FG004|Treatment Period 2|Withdrawal by Subject|0|||
37821257|NCT03712228|69500665|FG005|Treatment Period 2|Withdrawal by Subject|0|||
37821258|NCT03600818|69500684|FG000|Overall Study|Adverse Event|4|||
37821259|NCT03600818|69500685|FG001|Overall Study|Adverse Event|7|||
37821260|NCT03600818|69500684|FG000|Overall Study|Lack of Efficacy|9|||
37821261|NCT03600818|69500685|FG001|Overall Study|Lack of Efficacy|4|||
37821262|NCT03600818|69500684|FG000|Overall Study|Withdrawal by Subject|4|||
37821263|NCT03600818|69500685|FG001|Overall Study|Withdrawal by Subject|3|||
37821264|NCT03600818|69500684|FG000|Overall Study|Other-unspecified|5|||
37821265|NCT03600818|69500685|FG001|Overall Study|Other-unspecified|3|||
37821266|NCT03600818|69500684|FG000|Overall Study|Randomized and not treated|0|||
37821267|NCT03600818|69500685|FG001|Overall Study|Randomized and not treated|1|||
37821268|NCT03578276|69500694|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
37821269|NCT03578276|69500695|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
37821270|NCT02034110|69500760|FG000|Overall Study|Physician Decision|0|||
37821271|NCT02034110|69500761|FG001|Overall Study|Physician Decision|0|||
37883266|NCT00839527|69567807|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
37883267|NCT00839527|69567808|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
37883268|NCT00839527|69567809|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
37985763|NCT00423176|69671463|FG001|Overall Study|Did not meet protocol eligibility|4|||
37821272|NCT02034110|69500762|FG002|Overall Study|Physician Decision|0|||
37821273|NCT02034110|69500763|FG003|Overall Study|Physician Decision|0|||
37821274|NCT02034110|69500764|FG004|Overall Study|Physician Decision|2|||
37821275|NCT02034110|69500765|FG005|Overall Study|Physician Decision|0|||
37985764|NCT00412880|69671469|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
37985765|NCT00412880|69671469|FG000|Overall Study|Consent withdrawn|1|||
37883269|NCT00839527|69567807|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
37883270|NCT00839527|69567808|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
37883271|NCT00839527|69567809|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
37883272|NCT00839527|69567807|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
37883273|NCT00839527|69567808|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
37883274|NCT00839527|69567809|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
37883275|NCT00839527|69567807|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
37883276|NCT00839527|69567808|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
37883277|NCT00839527|69567809|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
37883278|NCT00839527|69567807|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
37883279|NCT00839527|69567808|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
37883280|NCT00839527|69567809|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
37883281|NCT00839527|69567807|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
37883282|NCT00839527|69567808|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
37883283|NCT00839527|69567809|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
37883284|NCT00839527|69567807|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
37883285|NCT00839527|69567808|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
37883286|NCT00839527|69567809|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
37883287|NCT00839527|69567807|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
37883288|NCT00839527|69567808|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
37883289|NCT00839527|69567809|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
37883290|NCT00839527|69567807|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
37883291|NCT00839527|69567808|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
37883292|NCT00839527|69567809|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
37883293|NCT00839527|69567807|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
37883294|NCT00839527|69567808|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
37883295|NCT00839527|69567809|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
37883296|NCT00839527|69567807|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
37883297|NCT00839527|69567808|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
37883298|NCT00839527|69567809|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
37883299|NCT00839527|69567807|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
37883300|NCT00839527|69567808|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
37883301|NCT00839527|69567809|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
37883302|NCT00839527|69567807|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
37883303|NCT00839527|69567808|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
37883304|NCT00839527|69567809|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
37883305|NCT00839527|69567807|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
37883306|NCT00839527|69567808|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
37883307|NCT00839527|69567809|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
37883308|NCT00839527|69567807|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
37883309|NCT00839527|69567808|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
37883310|NCT00839527|69567809|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
37883311|NCT00839527|69567807|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
37883312|NCT00839527|69567808|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
37883313|NCT00839527|69567809|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
37883314|NCT00839527|69567807|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
37883315|NCT00839527|69567808|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
37883316|NCT00839527|69567809|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
37883317|NCT00839527|69567807|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
37883318|NCT00839527|69567808|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
37883319|NCT00839527|69567809|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
37883320|NCT00839527|69567807|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
37883321|NCT00839527|69567808|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
37883322|NCT00839527|69567809|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
37883323|NCT00839527|69567807|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
37883324|NCT00839527|69567808|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
37883325|NCT00839527|69567809|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
37883326|NCT00839527|69567807|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
37883327|NCT00839527|69567808|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
37883328|NCT00839527|69567809|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
37883329|NCT00600886|69567821|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
37985766|NCT00412880|69671469|FG000|Overall Study|Adverse Event|1|||
37883330|NCT00600886|69567822|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
37883331|NCT00600886|69567821|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
37883332|NCT00600886|69567822|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
37883333|NCT00600886|69567821|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
37883334|NCT00600886|69567822|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
37883335|NCT00600886|69567821|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
37883336|NCT00600886|69567822|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
37883337|NCT00600886|69567821|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
37883338|NCT00600886|69567822|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
37883339|NCT00600886|69567821|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
37883340|NCT00600886|69567822|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
37883341|NCT00600886|69567821|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
37883342|NCT00600886|69567822|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
37883343|NCT00600886|69567821|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
37883344|NCT00600886|69567822|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
37883345|NCT00600886|69567821|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
37883346|NCT00600886|69567822|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
37883347|NCT00600886|69567821|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
37883348|NCT00600886|69567822|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
37883349|NCT00600886|69567821|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
37883350|NCT00600886|69567822|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
37883351|NCT00600886|69567821|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
37883352|NCT00600886|69567822|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
37883353|NCT00600886|69567821|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
37883354|NCT00600886|69567822|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
37883355|NCT00600886|69567821|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
37883356|NCT00600886|69567822|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
37883357|NCT00600886|69567821|FG000|Extension - Same Treatment (FAS)|Death|1|||
37883358|NCT00600886|69567822|FG001|Extension - Same Treatment (FAS)|Death|1|||
37883359|NCT00600886|69567821|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
37883360|NCT00600886|69567822|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
37883361|NCT00600886|69567821|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
37883362|NCT00600886|69567822|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
37883363|NCT00600886|69567821|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
37883364|NCT00600886|69567822|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
37883365|NCT00600886|69567821|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
37883366|NCT00600886|69567822|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
37883367|NCT00600886|69567821|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
37883368|NCT00600886|69567822|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
37821276|NCT02034110|69500766|FG006|Overall Study|Physician Decision|1|||
37821277|NCT02034110|69500767|FG007|Overall Study|Physician Decision|0|||
37821278|NCT02034110|69500760|FG000|Overall Study|Lost to Follow-up|1|||
37821279|NCT02034110|69500761|FG001|Overall Study|Lost to Follow-up|0|||
37821280|NCT02034110|69500762|FG002|Overall Study|Lost to Follow-up|0|||
37985767|NCT00412880|69671469|FG000|Overall Study|Progressive disease|20|||
37985768|NCT00268203|69671473|FG000|Overall Study|Lost to Follow-up|92|||
37985769|NCT00268203|69671473|FG000|Overall Study|Withdrawal by Subject|9|||
37985770|NCT00268203|69671473|FG000|Overall Study|Received Other NHL Therapy|7|||
37821281|NCT02034110|69500763|FG003|Overall Study|Lost to Follow-up|0|||
37821282|NCT02034110|69500764|FG004|Overall Study|Lost to Follow-up|1|||
37883369|NCT00600886|69567821|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
37883370|NCT00600886|69567822|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
37883371|NCT00600886|69567821|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
37985771|NCT00268203|69671473|FG000|Overall Study|Progressive Disease|359|||
37985772|NCT00268203|69671473|FG000|Overall Study|Death|84|||
37985773|NCT00268203|69671473|FG000|Overall Study|Reason Not Specified|34|||
37985774|NCT00268203|69671473|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
37821283|NCT02034110|69500765|FG005|Overall Study|Lost to Follow-up|0|||
37985775|NCT00384930|69671482|FG000|Overall Study|Adverse Event|5|||
37985776|NCT00384930|69671483|FG001|Overall Study|Adverse Event|4|||
37985777|NCT00384930|69671484|FG002|Overall Study|Adverse Event|12|||
37821284|NCT02034110|69500766|FG006|Overall Study|Lost to Follow-up|1|||
37821285|NCT02034110|69500767|FG007|Overall Study|Lost to Follow-up|0|||
37821286|NCT02034110|69500760|FG000|Overall Study|Withdrawal by Subject|5|||
37821287|NCT02034110|69500761|FG001|Overall Study|Withdrawal by Subject|7|||
37821288|NCT02034110|69500762|FG002|Overall Study|Withdrawal by Subject|0|||
37821289|NCT02034110|69500763|FG003|Overall Study|Withdrawal by Subject|3|||
37821290|NCT02034110|69500764|FG004|Overall Study|Withdrawal by Subject|7|||
37821291|NCT02034110|69500765|FG005|Overall Study|Withdrawal by Subject|0|||
37883372|NCT00600886|69567822|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
37883373|NCT00600886|69567821|FG000|Extension - After Crossover (CAS)|Death|1|||
37883374|NCT00600886|69567822|FG001|Extension - After Crossover (CAS)|Death|0|||
37883375|NCT00838903|69567846|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
37883376|NCT00838903|69567847|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
37883377|NCT00838903|69567848|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
37883378|NCT00838903|69567849|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
37883379|NCT00838903|69567846|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
37883380|NCT00838903|69567847|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
37883381|NCT00838903|69567848|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
37985778|NCT00384930|69671485|FG003|Overall Study|Adverse Event|11|||
37985779|NCT00384930|69671486|FG004|Overall Study|Adverse Event|14|||
37985780|NCT00384930|69671482|FG000|Overall Study|Entry Criteria Not Met|2|||
37883382|NCT00838903|69567849|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
37883383|NCT00838903|69567846|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
37883384|NCT00838903|69567847|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
37883385|NCT00838903|69567848|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
37883386|NCT00838903|69567849|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
37883387|NCT00838903|69567846|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
37883388|NCT00838903|69567847|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
37883389|NCT00838903|69567848|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
37883390|NCT00838903|69567849|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
37883391|NCT00838903|69567846|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
37883392|NCT00838903|69567847|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
37883393|NCT00838903|69567848|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
37883394|NCT00838903|69567849|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
37883395|NCT00838903|69567846|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
37883396|NCT00838903|69567847|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
37883397|NCT00838903|69567848|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
37883398|NCT00838903|69567849|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
37883399|NCT00838903|69567846|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
37883400|NCT00838903|69567847|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
37883401|NCT00838903|69567848|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
37883402|NCT00838903|69567849|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
37883403|NCT00838903|69567846|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
37883404|NCT00838903|69567847|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
37883405|NCT00838903|69567848|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
37883406|NCT00838903|69567849|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
37883407|NCT00838903|69567846|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
37883408|NCT00838903|69567847|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
37883409|NCT00838903|69567848|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
37883410|NCT00838903|69567849|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
37883411|NCT00838903|69567846|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
37883412|NCT00838903|69567847|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
37883413|NCT00838903|69567848|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
37883414|NCT00838903|69567849|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
37883415|NCT00838903|69567846|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
37985781|NCT00384930|69671483|FG001|Overall Study|Entry Criteria Not Met|6|||
37985782|NCT00384930|69671484|FG002|Overall Study|Entry Criteria Not Met|7|||
37821292|NCT02034110|69500766|FG006|Overall Study|Withdrawal by Subject|3|||
37985783|NCT00384930|69671485|FG003|Overall Study|Entry Criteria Not Met|8|||
37821293|NCT02034110|69500767|FG007|Overall Study|Withdrawal by Subject|1|||
37821294|NCT02034110|69500760|FG000|Overall Study|Study closed by sponsor|6|||
37821295|NCT02034110|69500761|FG001|Overall Study|Study closed by sponsor|2|||
37821296|NCT02034110|69500762|FG002|Overall Study|Study closed by sponsor|0|||
37821297|NCT02034110|69500763|FG003|Overall Study|Study closed by sponsor|6|||
37821298|NCT02034110|69500764|FG004|Overall Study|Study closed by sponsor|7|||
37821299|NCT02034110|69500765|FG005|Overall Study|Study closed by sponsor|0|||
37821300|NCT02034110|69500766|FG006|Overall Study|Study closed by sponsor|42|||
37821301|NCT02034110|69500767|FG007|Overall Study|Study closed by sponsor|0|||
37821302|NCT01627574|69500815|FG000|Overall Study|Withdrawal by Subject|8|||
37883416|NCT00838903|69567847|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
37883417|NCT00838903|69567848|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
37883418|NCT00838903|69567849|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
37821303|NCT01627574|69500816|FG001|Overall Study|Withdrawal by Subject|5|||
37821304|NCT01627574|69500815|FG000|Overall Study|Lost to Follow-up|13|||
37985784|NCT00384930|69671486|FG004|Overall Study|Entry Criteria Not Met|4|||
37985785|NCT00384930|69671482|FG000|Overall Study|Lack of Efficacy|1|||
37821305|NCT01627574|69500816|FG001|Overall Study|Lost to Follow-up|13|||
37883419|NCT00838903|69567846|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
37883420|NCT00838903|69567847|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
37883421|NCT00838903|69567848|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
37883422|NCT00838903|69567849|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
37883423|NCT00838903|69567846|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
37883424|NCT00838903|69567847|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
37883425|NCT00838903|69567848|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
37883426|NCT00838903|69567849|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
37883427|NCT00838903|69567846|FG000|Treatment Period (156 Weeks)|Site closed|0|||
37883428|NCT00838903|69567847|FG001|Treatment Period (156 Weeks)|Site closed|0|||
37883429|NCT00838903|69567848|FG002|Treatment Period (156 Weeks)|Site closed|1|||
37883430|NCT00838903|69567849|FG003|Treatment Period (156 Weeks)|Site closed|0|||
37883431|NCT00838903|69567846|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
37821306|NCT01498458|69500822|FG000|Overall Study|Adverse Event|4|||
37883432|NCT00838903|69567847|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
37883433|NCT00838903|69567848|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
37883434|NCT00838903|69567849|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
37883435|NCT00838903|69567846|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
37883436|NCT00838903|69567847|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
37883437|NCT00838903|69567848|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
37883438|NCT00838903|69567849|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
37883439|NCT00838903|69567846|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
37883440|NCT00838903|69567847|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
37883441|NCT00838903|69567848|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
37883442|NCT00838903|69567849|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
37883443|NCT00838903|69567846|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
37883444|NCT00838903|69567847|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
37883445|NCT00838903|69567848|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
37883446|NCT00838903|69567849|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
37883447|NCT00838903|69567846|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
37883448|NCT00838903|69567847|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
37883449|NCT00838903|69567848|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
37883450|NCT00838903|69567849|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
37883451|NCT00838903|69567846|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
37883452|NCT00838903|69567847|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
37883453|NCT00838903|69567848|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
37883454|NCT00838903|69567849|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
37883455|NCT00838903|69567846|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
37883456|NCT00838903|69567847|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
37821307|NCT01498458|69500822|FG000|Overall Study|Physician Decision|3|||
37821308|NCT01427712|69500831|FG000|Overall Study|Transfer to a different hospital|2|||
37821309|NCT01427712|69500831|FG000|Overall Study|Lost to Follow-up|1|||
37821310|NCT01427712|69500831|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
37821311|NCT01427712|69500831|FG000|Overall Study|Failure to visit|1|||
37821312|NCT01369147|69500838|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
37821313|NCT01369147|69500839|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
37821314|NCT01369147|69500840|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
37821315|NCT04846231|69500856|FG000|Overall Study|Lost to Follow-up|1|||
37821316|NCT04846231|69500857|FG001|Overall Study|Lost to Follow-up|0|||
37821317|NCT04846231|69500858|FG002|Overall Study|Lost to Follow-up|0|||
37821318|NCT04846231|69500859|FG003|Overall Study|Lost to Follow-up|0|||
37985786|NCT00384930|69671483|FG001|Overall Study|Lack of Efficacy|1|||
37985787|NCT00384930|69671484|FG002|Overall Study|Lack of Efficacy|2|||
37985788|NCT00384930|69671485|FG003|Overall Study|Lack of Efficacy|1|||
37985789|NCT00384930|69671486|FG004|Overall Study|Lack of Efficacy|2|||
37985790|NCT00384930|69671482|FG000|Overall Study|Lost to Follow-up|5|||
37985791|NCT00384930|69671483|FG001|Overall Study|Lost to Follow-up|3|||
37985792|NCT00384930|69671484|FG002|Overall Study|Lost to Follow-up|0|||
37985793|NCT00384930|69671485|FG003|Overall Study|Lost to Follow-up|4|||
37985794|NCT00384930|69671486|FG004|Overall Study|Lost to Follow-up|6|||
37821319|NCT04846231|69500860|FG004|Overall Study|Lost to Follow-up|0|||
37821320|NCT04846231|69500861|FG005|Overall Study|Lost to Follow-up|0|||
37821321|NCT04846231|69500862|FG006|Overall Study|Lost to Follow-up|0|||
37821322|NCT04846231|69500863|FG007|Overall Study|Lost to Follow-up|1|||
37883457|NCT00838903|69567848|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
37985795|NCT00384930|69671482|FG000|Overall Study|Physician Decision|0|||
37985796|NCT00384930|69671483|FG001|Overall Study|Physician Decision|1|||
37821323|NCT04846231|69500856|FG000|Overall Study|Withdrawal by Subject|0|||
37821324|NCT04846231|69500857|FG001|Overall Study|Withdrawal by Subject|1|||
37985797|NCT00384930|69671484|FG002|Overall Study|Physician Decision|1|||
37821325|NCT04846231|69500858|FG002|Overall Study|Withdrawal by Subject|2|||
37883458|NCT00838903|69567849|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
37883459|NCT00838903|69567846|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
37883460|NCT00838903|69567847|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
37883461|NCT00838903|69567848|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
37883462|NCT00838903|69567849|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
37883463|NCT00838903|69567846|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
37883464|NCT00838903|69567847|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
37883465|NCT00838903|69567848|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
37883466|NCT00838903|69567849|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
37883467|NCT00838903|69567846|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
37883468|NCT00838903|69567847|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
37883469|NCT00838903|69567848|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
37883470|NCT00838903|69567849|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
37883471|NCT00838903|69567846|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
37883472|NCT00838903|69567847|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
37883473|NCT00838903|69567848|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
37883474|NCT00838903|69567849|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
37883475|NCT00838903|69567846|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
37883476|NCT00838903|69567847|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
37883477|NCT00838903|69567848|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
37883478|NCT00838903|69567849|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
37883479|NCT00838903|69567846|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
37883480|NCT00838903|69567847|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
37883481|NCT00838903|69567848|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
37883482|NCT00838903|69567849|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
37883483|NCT00838903|69567846|FG000|Follow-up Period (8 Weeks)|Missing|1|||
37883484|NCT00838903|69567847|FG001|Follow-up Period (8 Weeks)|Missing|2|||
37883485|NCT00838903|69567848|FG002|Follow-up Period (8 Weeks)|Missing|1|||
37883486|NCT00838903|69567849|FG003|Follow-up Period (8 Weeks)|Missing|1|||
37883487|NCT00828139|69567863|FG000|Overall Study|Adverse Event|8|||
37883488|NCT00828139|69567864|FG001|Overall Study|Adverse Event|1|||
37883489|NCT00828139|69567865|FG002|Overall Study|Adverse Event|10|||
37883490|NCT00828139|69567866|FG003|Overall Study|Adverse Event|5|||
37883491|NCT00828139|69567863|FG000|Overall Study|Death|2|||
37883492|NCT00828139|69567864|FG001|Overall Study|Death|1|||
37883493|NCT00828139|69567865|FG002|Overall Study|Death|0|||
37883494|NCT00828139|69567866|FG003|Overall Study|Death|2|||
37883495|NCT00828139|69567863|FG000|Overall Study|Refusal unrelated to toxicity|3|||
37883496|NCT00828139|69567864|FG001|Overall Study|Refusal unrelated to toxicity|4|||
37883497|NCT00828139|69567865|FG002|Overall Study|Refusal unrelated to toxicity|5|||
37883498|NCT00828139|69567866|FG003|Overall Study|Refusal unrelated to toxicity|3|||
37883499|NCT00828139|69567863|FG000|Overall Study|Disease Progression|24|||
37883500|NCT00828139|69567864|FG001|Overall Study|Disease Progression|33|||
37883501|NCT00828139|69567865|FG002|Overall Study|Disease Progression|35|||
37883502|NCT00828139|69567866|FG003|Overall Study|Disease Progression|39|||
37883503|NCT00828139|69567863|FG000|Overall Study|Other|4|||
37883504|NCT00828139|69567864|FG001|Overall Study|Other|2|||
37883505|NCT00828139|69567865|FG002|Overall Study|Other|5|||
37883506|NCT00828139|69567866|FG003|Overall Study|Other|2|||
37883507|NCT00838513|69567876|FG000|Screening Period|Screen Failure|3|||
37883508|NCT00838513|69567876|FG000|Extension Treatment Period|Death|1|||
37883509|NCT00838513|69567876|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
37883510|NCT00600106|69567882|FG000|Overall Study|Withdrawal by Subject|1|||
37883511|NCT00600106|69567883|FG001|Overall Study|Withdrawal by Subject|1|||
37883512|NCT00850993|69567893|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
37883513|NCT00850993|69567894|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
37883514|NCT00850993|69567895|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
37883515|NCT00850993|69567896|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
37883516|NCT00818779|69567908|FG000|Overall Study|Protocol Violation|1|||
37883517|NCT00818779|69567909|FG001|Overall Study|Protocol Violation|0|||
37883518|NCT00818779|69567908|FG000|Overall Study|Lost to Follow-up|1|||
37883519|NCT00818779|69567909|FG001|Overall Study|Lost to Follow-up|0|||
37883520|NCT00818779|69567908|FG000|Overall Study|Adverse Event|4|||
37883521|NCT00818779|69567909|FG001|Overall Study|Adverse Event|1|||
37883522|NCT00850759|69567919|FG000|Overall Study|Lost to Follow-up|7|||
37883523|NCT00850759|69567920|FG001|Overall Study|Lost to Follow-up|5|||
37883524|NCT00850759|69567921|FG002|Overall Study|Lost to Follow-up|5|||
37883525|NCT00850759|69567922|FG003|Overall Study|Lost to Follow-up|3|||
37883526|NCT00827827|69567934|FG000|Overall Study|Lost to Follow-up|3|||
37883527|NCT00827827|69567935|FG001|Overall Study|Lost to Follow-up|0|||
37883528|NCT00827827|69567934|FG000|Overall Study|Fall at home- hospitalization|1|||
37883529|NCT00827827|69567935|FG001|Overall Study|Fall at home- hospitalization|0|||
37883530|NCT00827827|69567934|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
37985798|NCT00384930|69671485|FG003|Overall Study|Physician Decision|0|||
37985799|NCT00384930|69671486|FG004|Overall Study|Physician Decision|1|||
37883531|NCT00827827|69567935|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
37883532|NCT00827827|69567934|FG000|Overall Study|Gout|1|||
37883533|NCT00827827|69567935|FG001|Overall Study|Gout|0|||
37883534|NCT00827827|69567934|FG000|Overall Study|Transportation issues|1|||
37883535|NCT00827827|69567935|FG001|Overall Study|Transportation issues|0|||
37883536|NCT00827827|69567934|FG000|Overall Study|Burned with water at home|1|||
37883537|NCT00827827|69567935|FG001|Overall Study|Burned with water at home|0|||
37883538|NCT00600028|69567944|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
37883539|NCT00600028|69567945|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
37883540|NCT00600028|69567944|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
37883541|NCT00600028|69567945|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
37883542|NCT00600028|69567944|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
37883543|NCT00600028|69567945|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
37883544|NCT03542266|69567954|FG000|Treatment Phase|Withdrawal by Subject|1|||
37883545|NCT03542266|69567954|FG000|Treatment Phase|Adverse Event|1|||
37883546|NCT03542266|69567954|FG000|Treatment Phase|PD|1|||
37883547|NCT00818623|69567966|FG000|Overall Study|Adverse Event|1|||
37883548|NCT00818623|69567967|FG001|Overall Study|Adverse Event|0|||
37883549|NCT00818623|69567968|FG002|Overall Study|Adverse Event|1|||
37883550|NCT00818623|69567969|FG003|Overall Study|Adverse Event|0|||
37883551|NCT00818623|69567970|FG004|Overall Study|Adverse Event|0|||
37883552|NCT00818623|69567971|FG005|Overall Study|Adverse Event|1|||
37883553|NCT00818623|69567972|FG006|Overall Study|Adverse Event|0|||
37883554|NCT00818623|69567973|FG007|Overall Study|Adverse Event|0|||
37883555|NCT00818623|69567966|FG000|Overall Study|Bad prostate specific antigen response|0|||
37883556|NCT00818623|69567967|FG001|Overall Study|Bad prostate specific antigen response|3|||
37985800|NCT00384930|69671482|FG000|Overall Study|Protocol Violation|1|||
37985801|NCT00384930|69671483|FG001|Overall Study|Protocol Violation|0|||
37821326|NCT04846231|69500859|FG003|Overall Study|Withdrawal by Subject|1|||
37821327|NCT04846231|69500860|FG004|Overall Study|Withdrawal by Subject|0|||
37821328|NCT04846231|69500861|FG005|Overall Study|Withdrawal by Subject|0|||
37821329|NCT04846231|69500862|FG006|Overall Study|Withdrawal by Subject|0|||
37821330|NCT04846231|69500863|FG007|Overall Study|Withdrawal by Subject|0|||
37821331|NCT04846231|69500856|FG000|Overall Study|Protocol Violation|0|||
37821332|NCT04846231|69500857|FG001|Overall Study|Protocol Violation|1|||
37821333|NCT04846231|69500858|FG002|Overall Study|Protocol Violation|0|||
37821334|NCT04846231|69500859|FG003|Overall Study|Protocol Violation|0|||
37821335|NCT04846231|69500860|FG004|Overall Study|Protocol Violation|0|||
37821336|NCT04846231|69500861|FG005|Overall Study|Protocol Violation|0|||
37821337|NCT04846231|69500862|FG006|Overall Study|Protocol Violation|0|||
37821338|NCT04846231|69500863|FG007|Overall Study|Protocol Violation|0|||
37821339|NCT04846231|69500856|FG000|Overall Study|Adverse Event|0|||
37821340|NCT04846231|69500857|FG001|Overall Study|Adverse Event|0|||
37821341|NCT04846231|69500858|FG002|Overall Study|Adverse Event|0|||
37821342|NCT04846231|69500859|FG003|Overall Study|Adverse Event|0|||
37821343|NCT04846231|69500860|FG004|Overall Study|Adverse Event|0|||
37821344|NCT04846231|69500861|FG005|Overall Study|Adverse Event|0|||
37821345|NCT04846231|69500862|FG006|Overall Study|Adverse Event|1|||
37821346|NCT04846231|69500863|FG007|Overall Study|Adverse Event|1|||
37821347|NCT04533594|69500889|FG000|Overall Study|Death|26|||
37821348|NCT04533438|69500895|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
37821349|NCT04533438|69500896|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
37821350|NCT04447846|69500904|FG000|Overall Study|Withdrew due to moderate side effects (fatigue)|1|||
37821351|NCT04405245|69500911|FG000|Overall Study|Adverse Event|0|||
37821352|NCT04405245|69500912|FG001|Overall Study|Adverse Event|1|||
37821353|NCT04405245|69500913|FG002|Overall Study|Adverse Event|0|||
37821354|NCT04277507|69500921|FG000|Overall Study|Lost to Follow-up|17|||
37821355|NCT04277507|69500921|FG000|Overall Study|Completed through 24M but not interested in extension to 36M|3|||
37821356|NCT04277507|69500921|FG000|Overall Study|Received Treatment Outside of Study that could affect study results|2|||
37821357|NCT04277507|69500921|FG000|Overall Study|Withdrawal by Subject|3|||
37821358|NCT04277507|69500921|FG000|Overall Study|Death due to COVID-19|1|||
37821359|NCT04277507|69500921|FG000|Overall Study|Data missing for full evaluation|5|||
37821360|NCT04198805|69500942|FG000|Overall Study|Death|0|||
37821361|NCT04198805|69500943|FG001|Overall Study|Death|0|||
37883557|NCT00818623|69567968|FG002|Overall Study|Bad prostate specific antigen response|2|||
37883558|NCT00818623|69567969|FG003|Overall Study|Bad prostate specific antigen response|5|||
37985802|NCT00384930|69671484|FG002|Overall Study|Protocol Violation|1|||
37883559|NCT00818623|69567970|FG004|Overall Study|Bad prostate specific antigen response|0|||
37985803|NCT00384930|69671485|FG003|Overall Study|Protocol Violation|6|||
37985804|NCT00384930|69671486|FG004|Overall Study|Protocol Violation|4|||
37985805|NCT00384930|69671482|FG000|Overall Study|Sponsor Decision|3|||
37985806|NCT00384930|69671483|FG001|Overall Study|Sponsor Decision|4|||
37985807|NCT00384930|69671484|FG002|Overall Study|Sponsor Decision|0|||
37985808|NCT00384930|69671485|FG003|Overall Study|Sponsor Decision|5|||
37985809|NCT00384930|69671486|FG004|Overall Study|Sponsor Decision|0|||
37985810|NCT00384930|69671482|FG000|Overall Study|Withdrawal by Subject|9|||
37985811|NCT00384930|69671483|FG001|Overall Study|Withdrawal by Subject|7|||
37985812|NCT00384930|69671484|FG002|Overall Study|Withdrawal by Subject|7|||
37985813|NCT00384930|69671485|FG003|Overall Study|Withdrawal by Subject|6|||
37985814|NCT00384930|69671486|FG004|Overall Study|Withdrawal by Subject|16|||
37985815|NCT00384930|69671482|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
37985816|NCT00384930|69671483|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
37985817|NCT00384930|69671484|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
37985818|NCT00384930|69671485|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
37985819|NCT00384930|69671486|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
37985820|NCT00423098|69671503|FG000|Overall Study|Adverse Event|1|||
37985821|NCT00423098|69671504|FG001|Overall Study|Adverse Event|2|||
37985822|NCT00423098|69671503|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
37985823|NCT00423098|69671504|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
37985824|NCT00423098|69671503|FG000|Overall Study|Administrative problems|0|||
37985825|NCT00423098|69671504|FG001|Overall Study|Administrative problems|1|||
37985826|NCT00423098|69671503|FG000|Overall Study|Death|2|||
37985827|NCT00423098|69671504|FG001|Overall Study|Death|0|||
37985828|NCT00750698|69671512|FG000|Overall Study|Withdrawal by Subject|1|||
37985829|NCT00750698|69671513|FG001|Overall Study|Withdrawal by Subject|0|||
37985830|NCT00750698|69671512|FG000|Overall Study|Progressive disease|5|||
37985831|NCT00750698|69671513|FG001|Overall Study|Progressive disease|2|||
37985832|NCT00411788|69671519|FG000|Overall Study|Protocol Violation|1|||
37985833|NCT00411788|69671519|FG000|Overall Study|Adverse Event|1|||
37985834|NCT00422942|69671523|FG000|Overall Study|Study terminated by Sponsor|3|||
37985835|NCT00422162|69671529|FG000|Overall Study|Adverse Event|11|||
37985836|NCT00422162|69671530|FG001|Overall Study|Adverse Event|9|||
37985837|NCT00422162|69671529|FG000|Overall Study|Lack of Efficacy|4|||
37985838|NCT00422162|69671530|FG001|Overall Study|Lack of Efficacy|10|||
37883560|NCT00818623|69567971|FG005|Overall Study|Bad prostate specific antigen response|1|||
37883561|NCT00818623|69567972|FG006|Overall Study|Bad prostate specific antigen response|0|||
37883562|NCT00818623|69567973|FG007|Overall Study|Bad prostate specific antigen response|0|||
37883563|NCT00818623|69567966|FG000|Overall Study|Withdrawal by Subject|0|||
37883564|NCT00818623|69567967|FG001|Overall Study|Withdrawal by Subject|1|||
37883565|NCT00818623|69567968|FG002|Overall Study|Withdrawal by Subject|1|||
37883566|NCT00818623|69567969|FG003|Overall Study|Withdrawal by Subject|0|||
37883567|NCT00818623|69567970|FG004|Overall Study|Withdrawal by Subject|0|||
37883568|NCT00818623|69567971|FG005|Overall Study|Withdrawal by Subject|1|||
37883569|NCT00818623|69567972|FG006|Overall Study|Withdrawal by Subject|1|||
37883570|NCT00818623|69567973|FG007|Overall Study|Withdrawal by Subject|1|||
37883571|NCT00818623|69567966|FG000|Overall Study|Protocol Violation|1|||
37985839|NCT00422162|69671529|FG000|Overall Study|Withdrawal by Subject|7|||
37985840|NCT00422162|69671530|FG001|Overall Study|Withdrawal by Subject|6|||
37985841|NCT00422162|69671529|FG000|Overall Study|Lost to Follow-up|1|||
37985842|NCT00422162|69671530|FG001|Overall Study|Lost to Follow-up|2|||
37985843|NCT00422162|69671529|FG000|Overall Study|Non-Compliant with Protocol|1|||
37985844|NCT00422162|69671530|FG001|Overall Study|Non-Compliant with Protocol|1|||
37985845|NCT00422162|69671529|FG000|Overall Study|Other|0|||
37985846|NCT00422162|69671530|FG001|Overall Study|Other|1|||
37883572|NCT00818623|69567967|FG001|Overall Study|Protocol Violation|0|||
37985847|NCT00422162|69671529|FG000|Overall Study|Didn't Receive Treatment|0|||
37985848|NCT00422162|69671530|FG001|Overall Study|Didn't Receive Treatment|1|||
37985849|NCT00411632|69671546|FG000|Overall Study|Death|1|||
37985850|NCT00422084|69671552|FG000|Overall Study|Adverse Event|21|||
37985851|NCT00422084|69671553|FG001|Overall Study|Adverse Event|7|||
37985852|NCT00422084|69671552|FG000|Overall Study|Withdrawal by Subject|12|||
37883573|NCT00818623|69567968|FG002|Overall Study|Protocol Violation|0|||
37985853|NCT00422084|69671553|FG001|Overall Study|Withdrawal by Subject|9|||
37985854|NCT00422084|69671552|FG000|Overall Study|Lost to Follow-up|14|||
37985855|NCT00422084|69671553|FG001|Overall Study|Lost to Follow-up|9|||
37985856|NCT00422084|69671552|FG000|Overall Study|Protocol Violation|4|||
37985857|NCT00422084|69671553|FG001|Overall Study|Protocol Violation|1|||
37985858|NCT00422084|69671552|FG000|Overall Study|Lack of Efficacy|40|||
37883574|NCT00818623|69567969|FG003|Overall Study|Protocol Violation|0|||
37883575|NCT00818623|69567970|FG004|Overall Study|Protocol Violation|1|||
37883576|NCT00818623|69567971|FG005|Overall Study|Protocol Violation|0|||
37883577|NCT00818623|69567972|FG006|Overall Study|Protocol Violation|1|||
37883578|NCT00818623|69567973|FG007|Overall Study|Protocol Violation|0|||
37883579|NCT00818623|69567966|FG000|Overall Study|Need of additional treatment|0|||
37883580|NCT00818623|69567967|FG001|Overall Study|Need of additional treatment|0|||
37883581|NCT00818623|69567968|FG002|Overall Study|Need of additional treatment|0|||
37883582|NCT00818623|69567969|FG003|Overall Study|Need of additional treatment|0|||
37883583|NCT00818623|69567970|FG004|Overall Study|Need of additional treatment|1|||
37883584|NCT00818623|69567971|FG005|Overall Study|Need of additional treatment|0|||
37883585|NCT00818623|69567972|FG006|Overall Study|Need of additional treatment|0|||
37883586|NCT00818623|69567973|FG007|Overall Study|Need of additional treatment|0|||
37883587|NCT00818623|69567966|FG000|Overall Study|Lack of trial drug at site|0|||
37883588|NCT00818623|69567967|FG001|Overall Study|Lack of trial drug at site|0|||
37883589|NCT00818623|69567968|FG002|Overall Study|Lack of trial drug at site|0|||
37883590|NCT00818623|69567969|FG003|Overall Study|Lack of trial drug at site|0|||
37883591|NCT00818623|69567970|FG004|Overall Study|Lack of trial drug at site|2|||
37883592|NCT00818623|69567971|FG005|Overall Study|Lack of trial drug at site|0|||
37883593|NCT00818623|69567972|FG006|Overall Study|Lack of trial drug at site|1|||
37883594|NCT00818623|69567973|FG007|Overall Study|Lack of trial drug at site|0|||
37985859|NCT00422084|69671553|FG001|Overall Study|Lack of Efficacy|42|||
37985860|NCT00422084|69671552|FG000|Overall Study|P. vivax infection|3|||
37985861|NCT00422084|69671553|FG001|Overall Study|P. vivax infection|6|||
37985862|NCT00422084|69671552|FG000|Overall Study|Cyesis|1|||
37883595|NCT00818623|69567966|FG000|Overall Study|Disease progression|0|||
37883596|NCT00818623|69567967|FG001|Overall Study|Disease progression|0|||
37883597|NCT00818623|69567968|FG002|Overall Study|Disease progression|0|||
37883598|NCT00818623|69567969|FG003|Overall Study|Disease progression|0|||
37883599|NCT00818623|69567970|FG004|Overall Study|Disease progression|0|||
37883600|NCT00818623|69567971|FG005|Overall Study|Disease progression|0|||
37883601|NCT00818623|69567972|FG006|Overall Study|Disease progression|1|||
37883602|NCT00818623|69567973|FG007|Overall Study|Disease progression|0|||
37883603|NCT00827359|69567991|FG000|Overall Study|Progressive Diseas|19|||
37883604|NCT00827359|69567991|FG000|Overall Study|Unacceptable Toxicity|5|||
37883605|NCT00827359|69567991|FG000|Overall Study|Ineligible|1|||
37883606|NCT00818389|69567997|FG000|Overall Study|Death|1|||
37883607|NCT00818389|69567998|FG001|Overall Study|Death|3|||
37883608|NCT00818389|69567997|FG000|Overall Study|ALS Disease Progression|1|||
37883609|NCT00818389|69567998|FG001|Overall Study|ALS Disease Progression|0|||
37883610|NCT00818389|69567997|FG000|Overall Study|Withdrawal by Subject|2|||
37883611|NCT00818389|69567998|FG001|Overall Study|Withdrawal by Subject|2|||
37883612|NCT00818389|69567997|FG000|Overall Study|Adverse Event|0|||
37883613|NCT00818389|69567998|FG001|Overall Study|Adverse Event|1|||
37883614|NCT00850135|69568004|FG000|Overall Study|Physician Decision|1|||
37883615|NCT01154816|69568022|FG000|Overall Study|Withdrawal by Subject|1|||
37883616|NCT01154816|69568023|FG001|Overall Study|Withdrawal by Subject|0|||
37985863|NCT00422084|69671553|FG001|Overall Study|Cyesis|0|||
37985864|NCT00422084|69671552|FG000|Overall Study|Withdrawn from study accidentally|1|||
37821362|NCT04198805|69500944|FG002|Overall Study|Death|0|||
37821363|NCT04198805|69500945|FG003|Overall Study|Death|1|||
37821364|NCT04198805|69500942|FG000|Overall Study|Early Termination|8|||
37821365|NCT04198805|69500943|FG001|Overall Study|Early Termination|4|||
37821366|NCT04198805|69500944|FG002|Overall Study|Early Termination|6|||
37821367|NCT04198805|69500945|FG003|Overall Study|Early Termination|9|||
37821368|NCT04179890|69500961|FG000|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|3|||
37821369|NCT04179890|69500962|FG001|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|0|||
37821370|NCT04179890|69500961|FG000|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|1|||
37821371|NCT04179890|69500962|FG001|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|0|||
37821372|NCT04179890|69500961|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|3|||
37821373|NCT04179890|69500962|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|0|||
37821374|NCT04179890|69500961|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|2|||
37833585|NCT01262989|69517312|FG000|Period 1|Positive answer for exclusion criteria|0|||
37883617|NCT01154816|69568024|FG002|Overall Study|Withdrawal by Subject|0|||
37883618|NCT01154816|69568025|FG003|Overall Study|Withdrawal by Subject|1|||
37883619|NCT01154816|69568026|FG004|Overall Study|Withdrawal by Subject|0|||
37883620|NCT01154816|69568027|FG005|Overall Study|Withdrawal by Subject|0|||
37883621|NCT01154816|69568028|FG006|Overall Study|Withdrawal by Subject|0|||
37883622|NCT01154816|69568029|FG007|Overall Study|Withdrawal by Subject|0|||
37883623|NCT01154816|69568030|FG008|Overall Study|Withdrawal by Subject|1|||
37883624|NCT01154816|69568031|FG009|Overall Study|Withdrawal by Subject|3|||
37883625|NCT01154816|69568032|FG010|Overall Study|Withdrawal by Subject|0|||
37883626|NCT01154816|69568033|FG011|Overall Study|Withdrawal by Subject|0|||
37883627|NCT01154816|69568022|FG000|Overall Study|Progressive Disease|13|||
37883628|NCT01154816|69568023|FG001|Overall Study|Progressive Disease|8|||
37883629|NCT01154816|69568024|FG002|Overall Study|Progressive Disease|9|||
37883630|NCT01154816|69568025|FG003|Overall Study|Progressive Disease|9|||
37883631|NCT01154816|69568026|FG004|Overall Study|Progressive Disease|8|||
37883632|NCT01154816|69568027|FG005|Overall Study|Progressive Disease|8|||
37883633|NCT01154816|69568028|FG006|Overall Study|Progressive Disease|5|||
37883634|NCT01154816|69568029|FG007|Overall Study|Progressive Disease|6|||
37883635|NCT01154816|69568030|FG008|Overall Study|Progressive Disease|8|||
37883636|NCT01154816|69568031|FG009|Overall Study|Progressive Disease|6|||
37883637|NCT01154816|69568032|FG010|Overall Study|Progressive Disease|10|||
37883638|NCT01154816|69568033|FG011|Overall Study|Progressive Disease|3|||
37883639|NCT01154816|69568022|FG000|Overall Study|Physician Decision|1|||
37883640|NCT01154816|69568023|FG001|Overall Study|Physician Decision|0|||
37883641|NCT01154816|69568024|FG002|Overall Study|Physician Decision|1|||
37883642|NCT01154816|69568025|FG003|Overall Study|Physician Decision|0|||
37883643|NCT01154816|69568026|FG004|Overall Study|Physician Decision|2|||
37883644|NCT01154816|69568027|FG005|Overall Study|Physician Decision|0|||
37883645|NCT01154816|69568028|FG006|Overall Study|Physician Decision|0|||
37883646|NCT01154816|69568029|FG007|Overall Study|Physician Decision|0|||
37883647|NCT01154816|69568030|FG008|Overall Study|Physician Decision|0|||
37883648|NCT01154816|69568031|FG009|Overall Study|Physician Decision|1|||
37883649|NCT01154816|69568032|FG010|Overall Study|Physician Decision|1|||
37883650|NCT01154816|69568033|FG011|Overall Study|Physician Decision|1|||
37883651|NCT01154816|69568022|FG000|Overall Study|Adverse Event|5|||
37883652|NCT01154816|69568023|FG001|Overall Study|Adverse Event|2|||
37883653|NCT01154816|69568024|FG002|Overall Study|Adverse Event|0|||
37883654|NCT01154816|69568025|FG003|Overall Study|Adverse Event|0|||
37883655|NCT01154816|69568026|FG004|Overall Study|Adverse Event|0|||
37883656|NCT01154816|69568027|FG005|Overall Study|Adverse Event|0|||
37883657|NCT01154816|69568028|FG006|Overall Study|Adverse Event|1|||
37883658|NCT01154816|69568029|FG007|Overall Study|Adverse Event|1|||
37883659|NCT01154816|69568030|FG008|Overall Study|Adverse Event|0|||
37883660|NCT01154816|69568031|FG009|Overall Study|Adverse Event|0|||
37883661|NCT01154816|69568032|FG010|Overall Study|Adverse Event|0|||
37883662|NCT01154816|69568033|FG011|Overall Study|Adverse Event|0|||
37883663|NCT00849901|69568079|FG000|Acute Treatment Phase|Adverse Event|9|||
37883664|NCT00849901|69568080|FG001|Acute Treatment Phase|Adverse Event|1|||
37883665|NCT00849901|69568081|FG002|Acute Treatment Phase|Adverse Event|3|||
37883666|NCT00849901|69568079|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
37883667|NCT00849901|69568080|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
37883668|NCT00849901|69568081|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
37883669|NCT00849901|69568079|FG000|Acute Treatment Phase|Protocol Violation|0|||
37883670|NCT00849901|69568080|FG001|Acute Treatment Phase|Protocol Violation|2|||
37883671|NCT00849901|69568081|FG002|Acute Treatment Phase|Protocol Violation|1|||
37883672|NCT00849901|69568079|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
37883673|NCT00849901|69568080|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
37883674|NCT00849901|69568081|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
37883675|NCT00849901|69568079|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
37883676|NCT00849901|69568080|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
37883677|NCT00849901|69568081|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
37883678|NCT00849901|69568079|FG000|Acute Treatment Phase|Physician Decision|1|||
37883679|NCT00849901|69568080|FG001|Acute Treatment Phase|Physician Decision|1|||
37883680|NCT00849901|69568081|FG002|Acute Treatment Phase|Physician Decision|1|||
37883681|NCT00849901|69568079|FG000|Acute Treatment Phase|Sponsor Decision|1|||
37883682|NCT00849901|69568080|FG001|Acute Treatment Phase|Sponsor Decision|0|||
37883683|NCT00849901|69568081|FG002|Acute Treatment Phase|Sponsor Decision|0|||
37883684|NCT00849901|69568079|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
37883685|NCT00849901|69568080|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
37883686|NCT00849901|69568081|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
37883687|NCT00849901|69568079|FG000|Extension Phase|Adverse Event|2|||
37883688|NCT00849901|69568080|FG001|Extension Phase|Adverse Event|8|||
37883689|NCT00849901|69568081|FG002|Extension Phase|Adverse Event|4|||
37883690|NCT00849901|69568079|FG000|Extension Phase|Lost to Follow-up|3|||
37883691|NCT00849901|69568080|FG001|Extension Phase|Lost to Follow-up|0|||
37883692|NCT00849901|69568081|FG002|Extension Phase|Lost to Follow-up|1|||
37883693|NCT00849901|69568079|FG000|Extension Phase|Protocol Violation|2|||
37883694|NCT00849901|69568080|FG001|Extension Phase|Protocol Violation|2|||
37883695|NCT00849901|69568081|FG002|Extension Phase|Protocol Violation|4|||
37883696|NCT00849901|69568079|FG000|Extension Phase|Withdrawal by Subject|7|||
37883697|NCT00849901|69568080|FG001|Extension Phase|Withdrawal by Subject|6|||
37883698|NCT00849901|69568081|FG002|Extension Phase|Withdrawal by Subject|3|||
37883699|NCT00849901|69568079|FG000|Extension Phase|Parent or Caregiver Decision|10|||
37883700|NCT00849901|69568080|FG001|Extension Phase|Parent or Caregiver Decision|4|||
37883701|NCT00849901|69568081|FG002|Extension Phase|Parent or Caregiver Decision|4|||
37883702|NCT00849901|69568079|FG000|Extension Phase|Physician Decision|1|||
37883703|NCT00849901|69568080|FG001|Extension Phase|Physician Decision|2|||
37883704|NCT00849901|69568081|FG002|Extension Phase|Physician Decision|0|||
37883705|NCT00849901|69568079|FG000|Extension Phase|Lack of Efficacy|2|||
37883706|NCT00849901|69568080|FG001|Extension Phase|Lack of Efficacy|4|||
37883707|NCT00849901|69568081|FG002|Extension Phase|Lack of Efficacy|1|||
37883708|NCT01168232|69568095|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
37883709|NCT01168232|69568095|FG000|Overall Study|Ineligible- Wrong cell type|6|||
37883710|NCT01168232|69568095|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
37883711|NCT00817531|69568099|FG000|Overall Study|Adverse Event|1|||
37883712|NCT00817531|69568099|FG000|Overall Study|Lack of Efficacy|1|||
37883713|NCT00817063|69568105|FG000|Overall Study|Adverse Event|32|||
37883714|NCT00817063|69568106|FG001|Overall Study|Adverse Event|13|||
37883715|NCT00817063|69568105|FG000|Overall Study|Death|1|||
37883716|NCT00817063|69568106|FG001|Overall Study|Death|1|||
37883717|NCT00817063|69568105|FG000|Overall Study|Lack of Efficacy|33|||
37883718|NCT00817063|69568106|FG001|Overall Study|Lack of Efficacy|86|||
37883719|NCT00817063|69568105|FG000|Overall Study|Failure to Return|13|||
37883720|NCT00817063|69568106|FG001|Overall Study|Failure to Return|12|||
37883721|NCT00817063|69568105|FG000|Overall Study|Violation of Selection at Entry|7|||
37883722|NCT00817063|69568106|FG001|Overall Study|Violation of Selection at Entry|4|||
37883723|NCT00817063|69568105|FG000|Overall Study|Protocol Violation|3|||
37883724|NCT00817063|69568106|FG001|Overall Study|Protocol Violation|8|||
37883725|NCT00817063|69568105|FG000|Overall Study|Withdrawal by Subject|17|||
37883726|NCT00817063|69568106|FG001|Overall Study|Withdrawal by Subject|37|||
37883727|NCT00817063|69568105|FG000|Overall Study|Early Improvement|19|||
37883728|NCT00817063|69568106|FG001|Overall Study|Early Improvement|4|||
37883729|NCT00817063|69568105|FG000|Overall Study|Administrative|10|||
37883730|NCT00817063|69568106|FG001|Overall Study|Administrative|4|||
37883731|NCT00817063|69568105|FG000|Overall Study|Abnormality of Laboratory Test|2|||
37883732|NCT00817063|69568106|FG001|Overall Study|Abnormality of Laboratory Test|1|||
37883733|NCT01167140|69568112|FG000|Overall Study|Withdrawal by Subject|1|||
37883734|NCT01166750|69568118|FG000|Overall Study|Lost to Follow-up|1|||
37883735|NCT01166750|69568119|FG001|Overall Study|Lost to Follow-up|0|||
37883736|NCT00826267|69568128|FG000|Overall Study|Other Adverse Event|1|||
37883737|NCT00826267|69568129|FG001|Overall Study|Other Adverse Event|0|||
37883738|NCT00826267|69568130|FG002|Overall Study|Other Adverse Event|0|||
37883739|NCT00986154|69568141|FG000|Overall Study|Death|136|||
37883740|NCT00986154|69568142|FG001|Overall Study|Death|127|||
37883741|NCT00986154|69568141|FG000|Overall Study|Lost to Follow-up|7|||
37883742|NCT00986154|69568142|FG001|Overall Study|Lost to Follow-up|4|||
37883743|NCT00986154|69568141|FG000|Overall Study|Withdrawal by Subject|32|||
37883744|NCT00986154|69568142|FG001|Overall Study|Withdrawal by Subject|33|||
37883745|NCT00986154|69568141|FG000|Overall Study|investigator/subject decide not continue|6|||
37883746|NCT00986154|69568142|FG001|Overall Study|investigator/subject decide not continue|3|||
37883747|NCT00986154|69568141|FG000|Overall Study|never received study drug|25|||
37883748|NCT00986154|69568142|FG001|Overall Study|never received study drug|27|||
37883749|NCT00848965|69568148|FG000|Overall Study|Adverse Event|1|||
37883750|NCT00848965|69568148|FG000|Overall Study|Withdrawal by Subject|1|||
37883751|NCT01154036|69568167|FG000|Phase I|Physician Decision|0|||
37883752|NCT01154036|69568168|FG001|Phase I|Physician Decision|1|||
37883753|NCT01154036|69568169|FG002|Phase I|Physician Decision|0|||
37883754|NCT01154036|69568170|FG003|Phase I|Physician Decision|0|||
37883755|NCT01154036|69568171|FG004|Phase I|Physician Decision|0|||
37883756|NCT01154036|69568172|FG005|Phase I|Physician Decision|0|||
37883757|NCT01154036|69568173|FG006|Phase I|Physician Decision|0|||
37883758|NCT01154036|69568174|FG007|Phase I|Physician Decision|0|||
37883759|NCT01154036|69568167|FG000|Phase I|Lost to Follow-up|0|||
37883760|NCT01154036|69568168|FG001|Phase I|Lost to Follow-up|3|||
37883761|NCT01154036|69568169|FG002|Phase I|Lost to Follow-up|6|||
37883762|NCT01154036|69568170|FG003|Phase I|Lost to Follow-up|0|||
37985865|NCT00422084|69671553|FG001|Overall Study|Withdrawn from study accidentally|0|||
37883763|NCT01154036|69568171|FG004|Phase I|Lost to Follow-up|0|||
37883764|NCT01154036|69568172|FG005|Phase I|Lost to Follow-up|0|||
37883765|NCT01154036|69568173|FG006|Phase I|Lost to Follow-up|0|||
37883766|NCT01154036|69568174|FG007|Phase I|Lost to Follow-up|0|||
37883767|NCT01154036|69568167|FG000|Phase I|Protocol Violation|0|||
37883768|NCT01154036|69568168|FG001|Phase I|Protocol Violation|3|||
37883769|NCT01154036|69568169|FG002|Phase I|Protocol Violation|9|||
37883770|NCT01154036|69568170|FG003|Phase I|Protocol Violation|0|||
37883771|NCT01154036|69568171|FG004|Phase I|Protocol Violation|0|||
37883772|NCT01154036|69568172|FG005|Phase I|Protocol Violation|0|||
37883773|NCT01154036|69568173|FG006|Phase I|Protocol Violation|0|||
37883774|NCT01154036|69568174|FG007|Phase I|Protocol Violation|0|||
37883775|NCT01154036|69568167|FG000|Phase I|Withdrawal by Subject|2|||
37883776|NCT01154036|69568168|FG001|Phase I|Withdrawal by Subject|10|||
37883777|NCT01154036|69568169|FG002|Phase I|Withdrawal by Subject|29|||
37883778|NCT01154036|69568170|FG003|Phase I|Withdrawal by Subject|0|||
37883779|NCT01154036|69568171|FG004|Phase I|Withdrawal by Subject|0|||
37883780|NCT01154036|69568172|FG005|Phase I|Withdrawal by Subject|0|||
37883781|NCT01154036|69568173|FG006|Phase I|Withdrawal by Subject|0|||
37883782|NCT01154036|69568174|FG007|Phase I|Withdrawal by Subject|0|||
37883783|NCT01154036|69568167|FG000|Phase I|Adverse Event|1|||
37883784|NCT01154036|69568168|FG001|Phase I|Adverse Event|11|||
37883785|NCT01154036|69568169|FG002|Phase I|Adverse Event|12|||
37883786|NCT01154036|69568170|FG003|Phase I|Adverse Event|0|||
37883787|NCT01154036|69568171|FG004|Phase I|Adverse Event|0|||
37883788|NCT01154036|69568172|FG005|Phase I|Adverse Event|0|||
37985866|NCT00422084|69671552|FG000|Overall Study|Non-compliance|1|||
37985867|NCT00422084|69671553|FG001|Overall Study|Non-compliance|0|||
37985868|NCT00422084|69671552|FG000|Overall Study|Re-location|0|||
37985869|NCT00422084|69671553|FG001|Overall Study|Re-location|1|||
37821375|NCT04179890|69500962|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|0|||
37821376|NCT04179890|69500961|FG000|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|0|||
37821377|NCT04179890|69500962|FG001|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|8|||
37985870|NCT00422084|69671552|FG000|Overall Study|Not defined|1|||
37821378|NCT04179890|69500961|FG000|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|0|||
37821379|NCT04179890|69500962|FG001|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|4|||
37821380|NCT04179890|69500961|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|0|||
37883789|NCT01154036|69568173|FG006|Phase I|Adverse Event|0|||
37883790|NCT01154036|69568174|FG007|Phase I|Adverse Event|0|||
37883791|NCT01154036|69568167|FG000|Phase II|Adverse Event|0|||
37883792|NCT01154036|69568168|FG001|Phase II|Adverse Event|0|||
37985871|NCT00422084|69671553|FG001|Overall Study|Not defined|1|||
37883793|NCT01154036|69568169|FG002|Phase II|Adverse Event|0|||
37883794|NCT01154036|69568170|FG003|Phase II|Adverse Event|0|||
37985872|NCT00421928|69671562|FG000|Overall Study|Adverse Event|61|||
37985873|NCT00421928|69671563|FG001|Overall Study|Adverse Event|140|||
37985874|NCT00421928|69671564|FG002|Overall Study|Adverse Event|22|||
37985875|NCT00421928|69671562|FG000|Overall Study|Lost to Follow-up|5|||
37985876|NCT00421928|69671563|FG001|Overall Study|Lost to Follow-up|0|||
37985877|NCT00421928|69671564|FG002|Overall Study|Lost to Follow-up|3|||
37883795|NCT01154036|69568171|FG004|Phase II|Adverse Event|1|||
37883796|NCT01154036|69568172|FG005|Phase II|Adverse Event|1|||
37883797|NCT01154036|69568173|FG006|Phase II|Adverse Event|1|||
37883798|NCT01154036|69568174|FG007|Phase II|Adverse Event|1|||
37883799|NCT01154036|69568167|FG000|Phase II|Physician Decision|0|||
37883800|NCT01154036|69568168|FG001|Phase II|Physician Decision|0|||
37883801|NCT01154036|69568169|FG002|Phase II|Physician Decision|0|||
37883802|NCT01154036|69568170|FG003|Phase II|Physician Decision|0|||
37883803|NCT01154036|69568171|FG004|Phase II|Physician Decision|0|||
37883804|NCT01154036|69568172|FG005|Phase II|Physician Decision|0|||
37883805|NCT01154036|69568173|FG006|Phase II|Physician Decision|1|||
37883806|NCT01154036|69568174|FG007|Phase II|Physician Decision|0|||
37883807|NCT01154036|69568167|FG000|Phase II|Lost to Follow-up|0|||
37883808|NCT01154036|69568168|FG001|Phase II|Lost to Follow-up|0|||
37883809|NCT01154036|69568169|FG002|Phase II|Lost to Follow-up|0|||
37883810|NCT01154036|69568170|FG003|Phase II|Lost to Follow-up|1|||
37883811|NCT01154036|69568171|FG004|Phase II|Lost to Follow-up|2|||
37883812|NCT01154036|69568172|FG005|Phase II|Lost to Follow-up|0|||
37883813|NCT01154036|69568173|FG006|Phase II|Lost to Follow-up|2|||
37883814|NCT01154036|69568174|FG007|Phase II|Lost to Follow-up|1|||
37883815|NCT01154036|69568167|FG000|Phase II|Protocol Violation|0|||
37883816|NCT01154036|69568168|FG001|Phase II|Protocol Violation|0|||
37883817|NCT01154036|69568169|FG002|Phase II|Protocol Violation|0|||
37883818|NCT01154036|69568170|FG003|Phase II|Protocol Violation|0|||
37883819|NCT01154036|69568171|FG004|Phase II|Protocol Violation|1|||
37883820|NCT01154036|69568172|FG005|Phase II|Protocol Violation|2|||
37883821|NCT01154036|69568173|FG006|Phase II|Protocol Violation|0|||
37883822|NCT01154036|69568174|FG007|Phase II|Protocol Violation|0|||
37883823|NCT01154036|69568167|FG000|Phase II|Withdrawal by Subject|0|||
37985878|NCT00421928|69671562|FG000|Overall Study|Withdrawal by Subject|50|||
37821381|NCT04179890|69500962|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|2|||
37821382|NCT04179890|69500961|FG000|Overall Study|Patients without common EGFR mutations (Del19, L858R)|0|||
37821383|NCT04179890|69500962|FG001|Overall Study|Patients without common EGFR mutations (Del19, L858R)|1|||
37821384|NCT04179890|69500961|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|0|||
37821385|NCT04179890|69500962|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|1|||
37821386|NCT03721016|69501003|FG000|Overall Study|Adverse Event|0|||
37821387|NCT03721016|69501004|FG001|Overall Study|Adverse Event|1|||
37821388|NCT03721016|69501005|FG002|Overall Study|Adverse Event|1|||
37821389|NCT03721016|69501003|FG000|Overall Study|Withdrawal by Subject|8|||
37821390|NCT03721016|69501004|FG001|Overall Study|Withdrawal by Subject|16|||
37821391|NCT03721016|69501005|FG002|Overall Study|Withdrawal by Subject|13|||
37821392|NCT03721016|69501003|FG000|Overall Study|Lost to Follow-up|4|||
37821393|NCT03721016|69501004|FG001|Overall Study|Lost to Follow-up|6|||
37821394|NCT03721016|69501005|FG002|Overall Study|Lost to Follow-up|5|||
37821395|NCT03721016|69501003|FG000|Overall Study|Physician Decision|0|||
37821396|NCT03721016|69501004|FG001|Overall Study|Physician Decision|1|||
37821397|NCT03721016|69501005|FG002|Overall Study|Physician Decision|2|||
37821398|NCT03721016|69501003|FG000|Overall Study|Protocol Violation|0|||
37821399|NCT03721016|69501004|FG001|Overall Study|Protocol Violation|1|||
37821400|NCT03721016|69501005|FG002|Overall Study|Protocol Violation|0|||
37821401|NCT03721016|69501003|FG000|Overall Study|Site terminated by sponsor|3|||
37821402|NCT03721016|69501004|FG001|Overall Study|Site terminated by sponsor|7|||
37821403|NCT03721016|69501005|FG002|Overall Study|Site terminated by sponsor|6|||
37821404|NCT03721016|69501003|FG000|Overall Study|Subject exited early due to COVID-19|1|||
37821405|NCT03721016|69501004|FG001|Overall Study|Subject exited early due to COVID-19|0|||
37821406|NCT03721016|69501005|FG002|Overall Study|Subject exited early due to COVID-19|0|||
37821407|NCT03117998|69501041|FG000|Overall Study|Adverse Event|1|||
37883824|NCT01154036|69568168|FG001|Phase II|Withdrawal by Subject|0|||
37883825|NCT01154036|69568169|FG002|Phase II|Withdrawal by Subject|0|||
37883826|NCT01154036|69568170|FG003|Phase II|Withdrawal by Subject|0|||
37883827|NCT01154036|69568171|FG004|Phase II|Withdrawal by Subject|4|||
37883828|NCT01154036|69568172|FG005|Phase II|Withdrawal by Subject|2|||
37883829|NCT01154036|69568173|FG006|Phase II|Withdrawal by Subject|5|||
37883830|NCT01154036|69568174|FG007|Phase II|Withdrawal by Subject|4|||
37883831|NCT00816595|69568196|FG000|Overall Study|Withdrawal by Subject|2|||
37883832|NCT00816595|69568197|FG001|Overall Study|Withdrawal by Subject|0|||
37883833|NCT01166438|69568207|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
37883834|NCT01166438|69568208|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
37883835|NCT01166438|69568207|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
37883836|NCT01166438|69568208|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
37883837|NCT01166438|69568207|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
37883838|NCT01166438|69568208|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
37883839|NCT01166438|69568207|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
37883840|NCT01166438|69568208|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
37883841|NCT01166438|69568207|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
37883842|NCT01166438|69568208|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
37883843|NCT01166438|69568207|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
37883844|NCT01166438|69568208|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
37883845|NCT01153958|69568217|FG000|Overall Study|Study Terminated|36|||
37883846|NCT01153958|69568218|FG001|Overall Study|Study Terminated|32|||
37883847|NCT00599638|69568228|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
37883848|NCT00599638|69568229|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
37883849|NCT00599638|69568230|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
37883850|NCT00599638|69568231|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
37883851|NCT00599638|69568228|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
37883852|NCT00599638|69568229|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
37883853|NCT00599638|69568230|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
37883854|NCT00599638|69568231|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
37883855|NCT00599638|69568228|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
37883856|NCT00599638|69568229|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
37883857|NCT00599638|69568230|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
37883858|NCT00599638|69568231|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
37883859|NCT00599638|69568228|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
37883860|NCT00599638|69568229|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
37883861|NCT00599638|69568230|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
37883862|NCT00599638|69568231|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
37883863|NCT00599638|69568228|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
37883864|NCT00599638|69568229|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
37883865|NCT00599638|69568230|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
37883866|NCT00599638|69568231|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
37883867|NCT00599638|69568228|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
37883868|NCT00599638|69568229|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
37883869|NCT00599638|69568230|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
37883870|NCT00599638|69568231|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
37883871|NCT00599638|69568228|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
37883872|NCT00599638|69568229|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
37883873|NCT00599638|69568230|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
37883874|NCT00599638|69568231|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
37883875|NCT00599638|69568228|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
37883876|NCT00599638|69568229|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
37883877|NCT00599638|69568230|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
37883878|NCT00599638|69568231|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
37883879|NCT00599638|69568228|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
37883880|NCT00599638|69568229|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
37883881|NCT00599638|69568230|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
37883882|NCT00599638|69568231|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
37883883|NCT01166282|69568241|FG000|Open-label Period|Adverse Event|0|||
37883884|NCT01166282|69568242|FG001|Open-label Period|Adverse Event|0|||
37883885|NCT01166282|69568243|FG002|Open-label Period|Adverse Event|6|||
37883886|NCT01166282|69568241|FG000|Open-label Period|Withdrawal by Subject|0|||
37883887|NCT01166282|69568242|FG001|Open-label Period|Withdrawal by Subject|0|||
37883888|NCT01166282|69568243|FG002|Open-label Period|Withdrawal by Subject|4|||
37883889|NCT01166282|69568241|FG000|Open-label Period|Lack of Efficacy|0|||
37883890|NCT01166282|69568242|FG001|Open-label Period|Lack of Efficacy|0|||
37883891|NCT01166282|69568243|FG002|Open-label Period|Lack of Efficacy|2|||
37883892|NCT01166282|69568241|FG000|Open-label Period|Remission|0|||
37883893|NCT01166282|69568242|FG001|Open-label Period|Remission|0|||
37883894|NCT01166282|69568243|FG002|Open-label Period|Remission|4|||
37883895|NCT01166282|69568241|FG000|Open-label Period|Irregular Compliance|0|||
37883896|NCT01166282|69568242|FG001|Open-label Period|Irregular Compliance|0|||
37883897|NCT01166282|69568243|FG002|Open-label Period|Irregular Compliance|1|||
37883898|NCT01153724|69568251|FG000|Treatment Period 1|Withdrawal by Subject|1|||
37883899|NCT01153724|69568251|FG000|Treatment Period 2|Adverse Event|1|||
37883900|NCT01153724|69568251|FG000|Treatment Period 2|Other reason not defined above|1|||
37883901|NCT01152788|69568259|FG000|Overall Study|Withdrawal by Subject|0|||
37883902|NCT01152788|69568260|FG001|Overall Study|Withdrawal by Subject|3|||
37883903|NCT01152788|69568259|FG000|Overall Study|No treatment|0|||
37883904|NCT01152788|69568260|FG001|Overall Study|No treatment|1|||
37883905|NCT01165424|69568266|FG000|Overall Study|Clinical adverse experiences|1|||
37883906|NCT01165424|69568266|FG000|Overall Study|Laboratory adverse experiences|1|||
37883907|NCT01165424|69568266|FG000|Overall Study|Did not meet entry criteria|1|||
37883908|NCT01165424|69568266|FG000|Overall Study|Participant moved (relocated)|1|||
37883909|NCT01152554|69568272|FG000|Overall Study|Withdrawal by Subject|73|||
37883910|NCT01152554|69568273|FG001|Overall Study|Withdrawal by Subject|28|||
37883911|NCT01152554|69568272|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
37883912|NCT01152554|69568273|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
37883913|NCT01152554|69568272|FG000|Overall Study|Adverse Event|67|||
37883914|NCT01152554|69568273|FG001|Overall Study|Adverse Event|14|||
37883915|NCT01152554|69568272|FG000|Overall Study|Severe non-compliance to protocol|36|||
37883916|NCT01152554|69568273|FG001|Overall Study|Severe non-compliance to protocol|14|||
37883917|NCT01152554|69568272|FG000|Overall Study|Condition under investigation worsened|5|||
37883918|NCT01152554|69568273|FG001|Overall Study|Condition under investigation worsened|2|||
37883919|NCT01152554|69568272|FG000|Overall Study|Lack of Efficacy|20|||
37883920|NCT01152554|69568273|FG001|Overall Study|Lack of Efficacy|3|||
37883921|NCT01152554|69568272|FG000|Overall Study|Study-specific withdrawal criteria|17|||
37883922|NCT01152554|69568273|FG001|Overall Study|Study-specific withdrawal criteria|8|||
37883923|NCT01152554|69568272|FG000|Overall Study|Lost to Follow-up|87|||
37883924|NCT01152554|69568273|FG001|Overall Study|Lost to Follow-up|32|||
37883925|NCT01152554|69568272|FG000|Overall Study|Other|28|||
37883926|NCT01152554|69568273|FG001|Overall Study|Other|8|||
37883927|NCT01152554|69568272|FG000|Overall Study|Death|1|||
37883928|NCT01152554|69568273|FG001|Overall Study|Death|1|||
37883929|NCT00598702|69568287|FG000|Overall Study|Other|0|||
37883930|NCT00598702|69568288|FG001|Overall Study|Other|2|||
37883931|NCT00598702|69568289|FG002|Overall Study|Other|0|||
37883932|NCT00598702|69568290|FG003|Overall Study|Other|0|||
37883933|NCT00598702|69568291|FG004|Overall Study|Other|0|||
37883934|NCT00598702|69568292|FG005|Overall Study|Other|1|||
37883935|NCT00598702|69568293|FG006|Overall Study|Other|0|||
37883936|NCT00598702|69568294|FG007|Overall Study|Other|0|||
37883937|NCT00598702|69568287|FG000|Overall Study|Early discharge from hospital|0|||
37883938|NCT00598702|69568288|FG001|Overall Study|Early discharge from hospital|0|||
37883939|NCT00598702|69568289|FG002|Overall Study|Early discharge from hospital|2|||
37883940|NCT00598702|69568290|FG003|Overall Study|Early discharge from hospital|5|||
37883941|NCT00598702|69568291|FG004|Overall Study|Early discharge from hospital|0|||
37883942|NCT00598702|69568292|FG005|Overall Study|Early discharge from hospital|10|||
37883943|NCT00598702|69568293|FG006|Overall Study|Early discharge from hospital|1|||
37883944|NCT00598702|69568294|FG007|Overall Study|Early discharge from hospital|0|||
37883945|NCT00598702|69568287|FG000|Overall Study|Adverse Event|0|||
37883946|NCT00598702|69568288|FG001|Overall Study|Adverse Event|0|||
37883947|NCT00598702|69568289|FG002|Overall Study|Adverse Event|0|||
37883948|NCT00598702|69568290|FG003|Overall Study|Adverse Event|1|||
37883949|NCT00598702|69568291|FG004|Overall Study|Adverse Event|0|||
37883950|NCT00598702|69568292|FG005|Overall Study|Adverse Event|0|||
37883951|NCT00598702|69568293|FG006|Overall Study|Adverse Event|0|||
37883952|NCT00598702|69568294|FG007|Overall Study|Adverse Event|0|||
37883953|NCT00598702|69568287|FG000|Overall Study|Withdrawal by Subject|0|||
37883954|NCT00598702|69568288|FG001|Overall Study|Withdrawal by Subject|0|||
37883955|NCT00598702|69568289|FG002|Overall Study|Withdrawal by Subject|0|||
37883956|NCT00598702|69568290|FG003|Overall Study|Withdrawal by Subject|1|||
37883957|NCT00598702|69568291|FG004|Overall Study|Withdrawal by Subject|1|||
37883958|NCT00598702|69568292|FG005|Overall Study|Withdrawal by Subject|0|||
37883959|NCT00598702|69568293|FG006|Overall Study|Withdrawal by Subject|0|||
37883960|NCT00598702|69568294|FG007|Overall Study|Withdrawal by Subject|0|||
37883961|NCT00598702|69568287|FG000|Overall Study|Physician Decision|0|||
37883962|NCT00598702|69568288|FG001|Overall Study|Physician Decision|0|||
37883963|NCT00598702|69568289|FG002|Overall Study|Physician Decision|0|||
37883964|NCT00598702|69568290|FG003|Overall Study|Physician Decision|0|||
37883965|NCT00598702|69568291|FG004|Overall Study|Physician Decision|1|||
37883966|NCT00598702|69568292|FG005|Overall Study|Physician Decision|0|||
37883967|NCT00598702|69568293|FG006|Overall Study|Physician Decision|0|||
37883968|NCT00598702|69568294|FG007|Overall Study|Physician Decision|0|||
37883969|NCT00598702|69568287|FG000|Overall Study|Dose limiting toxicity|0|||
37883970|NCT00598702|69568288|FG001|Overall Study|Dose limiting toxicity|0|||
37883971|NCT00598702|69568289|FG002|Overall Study|Dose limiting toxicity|0|||
37883972|NCT00598702|69568290|FG003|Overall Study|Dose limiting toxicity|1|||
37883973|NCT00598702|69568291|FG004|Overall Study|Dose limiting toxicity|1|||
37883974|NCT00598702|69568292|FG005|Overall Study|Dose limiting toxicity|1|||
37985879|NCT00421928|69671563|FG001|Overall Study|Withdrawal by Subject|48|||
37985880|NCT00421928|69671564|FG002|Overall Study|Withdrawal by Subject|43|||
37985881|NCT00421928|69671562|FG000|Overall Study|Lack of Efficacy|15|||
37985882|NCT00421928|69671563|FG001|Overall Study|Lack of Efficacy|7|||
37985883|NCT00421928|69671564|FG002|Overall Study|Lack of Efficacy|35|||
37985884|NCT00421928|69671562|FG000|Overall Study|Study drug non-compliant|6|||
37985885|NCT00421928|69671563|FG001|Overall Study|Study drug non-compliant|7|||
37985886|NCT00421928|69671564|FG002|Overall Study|Study drug non-compliant|4|||
37985887|NCT00421928|69671562|FG000|Overall Study|All other|26|||
37985888|NCT00421928|69671563|FG001|Overall Study|All other|21|||
37985889|NCT00421928|69671564|FG002|Overall Study|All other|27|||
37985890|NCT00421928|69671562|FG000|Overall Study|Death|0|||
37985891|NCT00421928|69671563|FG001|Overall Study|Death|1|||
37985892|NCT00421928|69671564|FG002|Overall Study|Death|0|||
37985893|NCT00383292|69671575|FG000|Overall Study|Adverse Event|4|||
37985894|NCT00383292|69671576|FG001|Overall Study|Adverse Event|1|||
37985895|NCT00383292|69671577|FG002|Overall Study|Adverse Event|2|||
37985896|NCT00383292|69671575|FG000|Overall Study|Death|3|||
37985897|NCT00383292|69671576|FG001|Overall Study|Death|3|||
37985898|NCT00383292|69671577|FG002|Overall Study|Death|3|||
37985899|NCT00383292|69671575|FG000|Overall Study|Physician Decision|4|||
37985900|NCT00383292|69671576|FG001|Overall Study|Physician Decision|0|||
37985901|NCT00383292|69671577|FG002|Overall Study|Physician Decision|1|||
37985902|NCT00383292|69671575|FG000|Overall Study|Withdrawal by Subject|3|||
37985903|NCT00383292|69671576|FG001|Overall Study|Withdrawal by Subject|2|||
37985904|NCT00383292|69671577|FG002|Overall Study|Withdrawal by Subject|2|||
37985905|NCT00383292|69671575|FG000|Overall Study|Other|1|||
37985906|NCT00383292|69671576|FG001|Overall Study|Other|0|||
37985907|NCT00383292|69671577|FG002|Overall Study|Other|0|||
37985908|NCT00372060|69671588|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
37985909|NCT00372060|69671589|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
37985910|NCT00372060|69671588|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
37985911|NCT00372060|69671589|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
37985912|NCT00372060|69671588|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
37985913|NCT00372060|69671589|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
37985914|NCT00372060|69671588|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
37985915|NCT00372060|69671589|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
37985916|NCT00372060|69671588|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
37985917|NCT00372060|69671589|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
37821408|NCT03117998|69501042|FG001|Overall Study|Adverse Event|0|||
37821409|NCT03117998|69501043|FG002|Overall Study|Adverse Event|0|||
37821410|NCT03117998|69501044|FG003|Overall Study|Adverse Event|0|||
37821411|NCT03117998|69501045|FG004|Overall Study|Adverse Event|0|||
37985918|NCT00372060|69671588|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
37985919|NCT00372060|69671589|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
37821412|NCT03117998|69501046|FG005|Overall Study|Adverse Event|0|||
37985920|NCT00421304|69671601|FG000|Overall Study|Lost to Follow-up|5|||
37985921|NCT00421304|69671602|FG001|Overall Study|Lost to Follow-up|2|||
37695447|NCT02349295|69171752|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
37695448|NCT02349295|69171753|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
37695449|NCT02349295|69171754|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
37695450|NCT02349295|69171755|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
37695451|NCT02349295|69171756|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
37695452|NCT02349295|69171757|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
37695453|NCT02349295|69171758|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
37695454|NCT02349295|69171759|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
37821413|NCT03117998|69501041|FG000|Overall Study|Withdrawal by Subject|0|||
37821414|NCT03117998|69501042|FG001|Overall Study|Withdrawal by Subject|0|||
37821415|NCT03117998|69501043|FG002|Overall Study|Withdrawal by Subject|2|||
37821416|NCT03117998|69501044|FG003|Overall Study|Withdrawal by Subject|3|||
37821417|NCT03117998|69501045|FG004|Overall Study|Withdrawal by Subject|3|||
37821418|NCT03117998|69501046|FG005|Overall Study|Withdrawal by Subject|0|||
37821419|NCT03117998|69501041|FG000|Overall Study|Physician Decision|0|||
37821420|NCT03117998|69501042|FG001|Overall Study|Physician Decision|1|||
37821421|NCT03117998|69501043|FG002|Overall Study|Physician Decision|1|||
37821422|NCT03117998|69501044|FG003|Overall Study|Physician Decision|0|||
37821423|NCT03117998|69501045|FG004|Overall Study|Physician Decision|0|||
37821424|NCT03117998|69501046|FG005|Overall Study|Physician Decision|0|||
37821425|NCT03117998|69501041|FG000|Overall Study|Lost to Follow-up|0|||
37821426|NCT03117998|69501042|FG001|Overall Study|Lost to Follow-up|0|||
37821427|NCT03117998|69501043|FG002|Overall Study|Lost to Follow-up|0|||
37985922|NCT00421304|69671603|FG002|Overall Study|Lost to Follow-up|5|||
37985923|NCT00421304|69671601|FG000|Overall Study|Withdrawal by Subject|2|||
37985924|NCT00421304|69671602|FG001|Overall Study|Withdrawal by Subject|2|||
37985925|NCT00421304|69671603|FG002|Overall Study|Withdrawal by Subject|2|||
37985926|NCT00421304|69671601|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
37985927|NCT00421304|69671602|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
37821428|NCT03117998|69501044|FG003|Overall Study|Lost to Follow-up|1|||
37821429|NCT03117998|69501045|FG004|Overall Study|Lost to Follow-up|4|||
37821430|NCT03117998|69501046|FG005|Overall Study|Lost to Follow-up|0|||
37821431|NCT03117998|69501041|FG000|Overall Study|Subject noncompliance|0|||
37985928|NCT00421304|69671603|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
37985929|NCT00421304|69671601|FG000|Overall Study|Did not attend Day 360 visit|0|||
37985930|NCT00421304|69671602|FG001|Overall Study|Did not attend Day 360 visit|0|||
37985931|NCT00421304|69671603|FG002|Overall Study|Did not attend Day 360 visit|1|||
37985932|NCT00396630|69671615|FG000|Overall Study|Lost to Follow-up|1|||
37985933|NCT00396630|69671616|FG001|Overall Study|Lost to Follow-up|1|||
37985934|NCT00396630|69671615|FG000|Overall Study|Withdrawal by Subject|1|||
37883975|NCT00598702|69568293|FG006|Overall Study|Dose limiting toxicity|0|||
37883976|NCT00598702|69568294|FG007|Overall Study|Dose limiting toxicity|0|||
37883977|NCT01148810|69568314|FG000|Overall Study|Adverse Event|0|||
37883978|NCT01148810|69568315|FG001|Overall Study|Adverse Event|2|||
37883979|NCT01148810|69568314|FG000|Overall Study|Lack of Efficacy|0|||
37883980|NCT01148810|69568315|FG001|Overall Study|Lack of Efficacy|1|||
37883981|NCT01148810|69568314|FG000|Overall Study|Withdrawal by Subject|0|||
37883982|NCT01148810|69568315|FG001|Overall Study|Withdrawal by Subject|2|||
37883983|NCT01148810|69568314|FG000|Overall Study|Protocol Violation|1|||
37883984|NCT01148810|69568315|FG001|Overall Study|Protocol Violation|0|||
37883985|NCT01151618|69568322|FG000|Overall Study|Adverse Event|2|||
37883986|NCT01151618|69568322|FG000|Overall Study|Withdrawal by Subject|7|||
37883987|NCT01164956|69568326|FG000|Overall Study|Side Effects|1|||
37883988|NCT01164956|69568327|FG001|Overall Study|Side Effects|0|||
37883989|NCT01164956|69568328|FG002|Overall Study|Side Effects|1|||
37883990|NCT01164722|69568338|FG000|Overall Study|Adverse Event|0|||
37985935|NCT00396630|69671616|FG001|Overall Study|Withdrawal by Subject|1|||
37985936|NCT00396630|69671615|FG000|Overall Study|Not vaccinated at Visit 3|3|||
37985937|NCT00396630|69671616|FG001|Overall Study|Not vaccinated at Visit 3|3|||
37985938|NCT00396318|69671623|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
37985939|NCT00396162|69671629|FG000|Overall Study|Withdrawal by Subject|2|||
37985940|NCT00396162|69671630|FG001|Overall Study|Withdrawal by Subject|3|||
37985941|NCT00381888|69671640|FG000|Overall Study|Death|1|||
37985942|NCT00381888|69671640|FG000|Overall Study|Withdrawal by Subject|1|||
37985943|NCT00381888|69671640|FG000|Overall Study|Physician Decision|1|||
37985944|NCT00381888|69671640|FG000|Overall Study|Protocol Violation|9|||
37985945|NCT00381888|69671640|FG000|Overall Study|Had laparoscopic surgery|2|||
37985946|NCT00381888|69671640|FG000|Overall Study|Surgery was cancelled|2|||
37985947|NCT00381888|69671640|FG000|Overall Study|Adverse Event|1|||
37985948|NCT00267969|69671647|FG000|Controlled Period|Adverse Event|6|||
37985949|NCT00267969|69671648|FG001|Controlled Period|Adverse Event|0|||
37985950|NCT00267969|69671649|FG002|Controlled Period|Adverse Event|2|||
37985951|NCT00267969|69671650|FG003|Controlled Period|Adverse Event|0|||
37985952|NCT00267969|69671651|FG004|Controlled Period|Adverse Event|0|||
37985953|NCT00267969|69671652|FG005|Controlled Period|Adverse Event|0|||
37985954|NCT00267969|69671653|FG006|Controlled Period|Adverse Event|0|||
37985955|NCT00267969|69671647|FG000|Controlled Period|Lack of Efficacy|3|||
37985956|NCT00267969|69671648|FG001|Controlled Period|Lack of Efficacy|0|||
37985957|NCT00267969|69671649|FG002|Controlled Period|Lack of Efficacy|1|||
37985958|NCT00267969|69671650|FG003|Controlled Period|Lack of Efficacy|0|||
37695455|NCT02349295|69171760|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
37695456|NCT02349295|69171761|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
37695457|NCT02349295|69171762|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
37821432|NCT03117998|69501042|FG001|Overall Study|Subject noncompliance|0|||
37821433|NCT03117998|69501043|FG002|Overall Study|Subject noncompliance|1|||
37821434|NCT03117998|69501044|FG003|Overall Study|Subject noncompliance|0|||
37821435|NCT03117998|69501045|FG004|Overall Study|Subject noncompliance|0|||
37821436|NCT03117998|69501046|FG005|Overall Study|Subject noncompliance|2|||
37821437|NCT03117998|69501041|FG000|Overall Study|Protocol Violation|0|||
37883991|NCT01164722|69568339|FG001|Overall Study|Adverse Event|1|||
37883992|NCT01164722|69568338|FG000|Overall Study|Withdrawal by Subject|3|||
37883993|NCT01164722|69568339|FG001|Overall Study|Withdrawal by Subject|4|||
37883994|NCT01164722|69568338|FG000|Overall Study|Lost to Follow-up|3|||
37985959|NCT00267969|69671651|FG004|Controlled Period|Lack of Efficacy|0|||
37985960|NCT00267969|69671652|FG005|Controlled Period|Lack of Efficacy|0|||
37985961|NCT00267969|69671653|FG006|Controlled Period|Lack of Efficacy|0|||
37985962|NCT00267969|69671647|FG000|Controlled Period|Lost to Follow-up|1|||
37985963|NCT00267969|69671648|FG001|Controlled Period|Lost to Follow-up|0|||
37985964|NCT00267969|69671649|FG002|Controlled Period|Lost to Follow-up|1|||
37985965|NCT00267969|69671650|FG003|Controlled Period|Lost to Follow-up|0|||
37883995|NCT01164722|69568339|FG001|Overall Study|Lost to Follow-up|6|||
37883996|NCT01164722|69568338|FG000|Overall Study|met protocol criteria for non-treatment|11|||
37883997|NCT01164722|69568339|FG001|Overall Study|met protocol criteria for non-treatment|1|||
37883998|NCT01164722|69568338|FG000|Overall Study|enrolled on other study, concomitant med|1|||
37883999|NCT01164722|69568339|FG001|Overall Study|enrolled on other study, concomitant med|3|||
37884000|NCT01151540|69568345|FG000|Overall Study|Other|2|||
37884001|NCT01151540|69568345|FG000|Overall Study|Adverse event, non-fatal|4|||
37884002|NCT01151540|69568345|FG000|Overall Study|Withdrawal by Subject|7|||
37884003|NCT01163786|69568349|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
37884004|NCT01163786|69568349|FG000|Treatment With Bortezomib|Adverse Event|2|||
37884005|NCT01163786|69568349|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
37884006|NCT00984282|69568355|FG000|Double Blind Treatment|Adverse Event|40|||
37884007|NCT00984282|69568356|FG001|Double Blind Treatment|Adverse Event|6|||
37884008|NCT00984282|69568355|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
37884009|NCT00984282|69568356|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
37884010|NCT00984282|69568355|FG000|Double Blind Treatment|Physician Decision|1|||
37884011|NCT00984282|69568356|FG001|Double Blind Treatment|Physician Decision|2|||
37884012|NCT00984282|69568355|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
37884013|NCT00984282|69568356|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
37884014|NCT00984282|69568355|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
37884015|NCT00984282|69568356|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
37884016|NCT00984282|69568355|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
37884017|NCT00984282|69568356|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
37884018|NCT00984282|69568355|FG000|Double Blind Treatment|Lost to Follow-up|3|||
37884019|NCT00984282|69568356|FG001|Double Blind Treatment|Lost to Follow-up|0|||
37884020|NCT00984282|69568355|FG000|Double Blind Treatment|Death|8|||
37884021|NCT00984282|69568356|FG001|Double Blind Treatment|Death|4|||
37884022|NCT00984282|69568355|FG000|Double Blind Treatment|Not treated|0|||
37884023|NCT00984282|69568356|FG001|Double Blind Treatment|Not treated|1|||
37884024|NCT00984282|69568355|FG000|Double Blind Treatment|Switched to commercial drug|6|||
37884025|NCT00984282|69568356|FG001|Double Blind Treatment|Switched to commercial drug|1|||
37884026|NCT00984282|69568355|FG000|Double Blind Treatment|protocol driven decision point|1|||
37884027|NCT00984282|69568356|FG001|Double Blind Treatment|protocol driven decision point|1|||
37884028|NCT00984282|69568355|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
37884029|NCT00984282|69568356|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
37884030|NCT00984282|69568355|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
37884031|NCT00984282|69568356|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
37985966|NCT00267969|69671651|FG004|Controlled Period|Lost to Follow-up|0|||
37884032|NCT00984282|69568355|FG000|Open-label Treatment|Adverse Event|20|||
37884033|NCT00984282|69568356|FG001|Open-label Treatment|Adverse Event|30|||
37884034|NCT00984282|69568355|FG000|Open-label Treatment|Withdrawal by Subject|6|||
37884035|NCT00984282|69568356|FG001|Open-label Treatment|Withdrawal by Subject|21|||
37884036|NCT00984282|69568355|FG000|Open-label Treatment|Death|7|||
37884037|NCT00984282|69568356|FG001|Open-label Treatment|Death|15|||
37884038|NCT00984282|69568355|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
37985967|NCT00267969|69671652|FG005|Controlled Period|Lost to Follow-up|0|||
37985968|NCT00267969|69671653|FG006|Controlled Period|Lost to Follow-up|0|||
37985969|NCT00267969|69671647|FG000|Controlled Period|Randomized but not treated|0|||
37985970|NCT00267969|69671648|FG001|Controlled Period|Randomized but not treated|0|||
37985971|NCT00267969|69671649|FG002|Controlled Period|Randomized but not treated|1|||
37985972|NCT00267969|69671650|FG003|Controlled Period|Randomized but not treated|0|||
37985973|NCT00267969|69671651|FG004|Controlled Period|Randomized but not treated|0|||
37884039|NCT00984282|69568356|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
37884040|NCT00984282|69568355|FG000|Open-label Treatment|Lost to Follow-up|1|||
37884041|NCT00984282|69568356|FG001|Open-label Treatment|Lost to Follow-up|1|||
37884042|NCT00984282|69568355|FG000|Open-label Treatment|Patient convenience|1|||
37884043|NCT00984282|69568356|FG001|Open-label Treatment|Patient convenience|0|||
37884044|NCT00984282|69568355|FG000|Open-label Treatment|Non-compliant with study medication|1|||
37985974|NCT00267969|69671652|FG005|Controlled Period|Randomized but not treated|0|||
37884045|NCT00984282|69568356|FG001|Open-label Treatment|Non-compliant with study medication|0|||
37884046|NCT00984282|69568355|FG000|Open-label Treatment|Target lesion removed|0|||
37884047|NCT00984282|69568356|FG001|Open-label Treatment|Target lesion removed|1|||
37884048|NCT00984282|69568355|FG000|Open-label Treatment|Protocol driven decision point|1|||
37884049|NCT00984282|69568356|FG001|Open-label Treatment|Protocol driven decision point|1|||
37884050|NCT00984282|69568355|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
37884051|NCT00984282|69568356|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
37884052|NCT00984282|69568355|FG000|Open-label Treatment|Switched to commercial drug|6|||
37884053|NCT00984282|69568356|FG001|Open-label Treatment|Switched to commercial drug|7|||
37884054|NCT00984282|69568355|FG000|Open-label Treatment|Physician Decision|1|||
37884055|NCT00984282|69568356|FG001|Open-label Treatment|Physician Decision|0|||
37884056|NCT00984282|69568355|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
37884057|NCT00984282|69568356|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
37884058|NCT00984282|69568355|FG000|Long Term Follow-up|Death|27|||
37884059|NCT00984282|69568356|FG001|Long Term Follow-up|Death|68|||
37884060|NCT00984282|69568355|FG000|Long Term Follow-up|Lost to Follow-up|3|||
37884061|NCT00984282|69568356|FG001|Long Term Follow-up|Lost to Follow-up|6|||
37884062|NCT00984282|69568355|FG000|Long Term Follow-up|Protocol driven decision point|25|||
37884063|NCT00984282|69568356|FG001|Long Term Follow-up|Protocol driven decision point|26|||
37884064|NCT00984282|69568355|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
37884065|NCT00984282|69568356|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
37884066|NCT00984282|69568355|FG000|Long Term Follow-up|Switched to commercial drug|4|||
37884067|NCT00984282|69568356|FG001|Long Term Follow-up|Switched to commercial drug|2|||
37884068|NCT00984282|69568355|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
37884069|NCT00984282|69568356|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
37884070|NCT01147874|69568364|FG000|Overall Study|Adverse Event|5|||
37884071|NCT01147874|69568364|FG000|Overall Study|Investigator's Request|1|||
37884072|NCT01147874|69568364|FG000|Overall Study|Lost to Follow-up|25|||
37884073|NCT01147874|69568364|FG000|Overall Study|Other|5|||
37884074|NCT01147874|69568364|FG000|Overall Study|Protocol Violation|5|||
37884075|NCT01147874|69568364|FG000|Overall Study|Sponsor's Decision|2|||
37884076|NCT01147874|69568364|FG000|Overall Study|Withdrawal by Subject|24|||
37884077|NCT01147640|69568370|FG000|Overall Study|Adverse Event|2|||
37884078|NCT01147640|69568371|FG001|Overall Study|Adverse Event|0|||
37884079|NCT01147640|69568370|FG000|Overall Study|Physician Decision|1|||
37884080|NCT01147640|69568371|FG001|Overall Study|Physician Decision|0|||
37884081|NCT01147640|69568370|FG000|Overall Study|Withdrawal by Subject|1|||
37884082|NCT01147640|69568371|FG001|Overall Study|Withdrawal by Subject|0|||
37884083|NCT01147640|69568370|FG000|Overall Study|Lost to Follow-up|0|||
37884084|NCT01147640|69568371|FG001|Overall Study|Lost to Follow-up|1|||
37884085|NCT01147640|69568370|FG000|Overall Study|Didn't meet eligibility criteria|1|||
37884086|NCT01147640|69568371|FG001|Overall Study|Didn't meet eligibility criteria|0|||
37884087|NCT01121900|69568377|FG000|First Intervention Period|Adverse Event|1|||
37884088|NCT01121900|69568378|FG001|First Intervention Period|Adverse Event|1|||
37884089|NCT01121900|69568377|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
37884090|NCT01121900|69568378|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
37884091|NCT01121666|69568386|FG000|Overall Study|Protocol Violation|29|||
37884092|NCT01121666|69568387|FG001|Overall Study|Protocol Violation|10|||
37884093|NCT00984126|69568397|FG000|Overall Study|Protocol Violation|0|||
37884094|NCT00984126|69568398|FG001|Overall Study|Protocol Violation|0|||
37985975|NCT00267969|69671653|FG006|Controlled Period|Randomized but not treated|0|||
37985976|NCT00267969|69671647|FG000|Controlled Period|Other|2|||
37985977|NCT00267969|69671648|FG001|Controlled Period|Other|1|||
37985978|NCT00267969|69671649|FG002|Controlled Period|Other|6|||
37985979|NCT00267969|69671650|FG003|Controlled Period|Other|0|||
37985980|NCT00267969|69671651|FG004|Controlled Period|Other|0|||
37985981|NCT00267969|69671652|FG005|Controlled Period|Other|0|||
37985982|NCT00267969|69671653|FG006|Controlled Period|Other|0|||
37985983|NCT00267969|69671647|FG000|After Controlled Period|Adverse Event|0|||
37884095|NCT00984126|69568399|FG002|Overall Study|Protocol Violation|1|||
37884096|NCT00984126|69568400|FG003|Overall Study|Protocol Violation|2|||
37884097|NCT00984126|69568397|FG000|Overall Study|Adverse Event|0|||
37884098|NCT00984126|69568398|FG001|Overall Study|Adverse Event|0|||
37884099|NCT00984126|69568399|FG002|Overall Study|Adverse Event|0|||
37884100|NCT00984126|69568400|FG003|Overall Study|Adverse Event|2|||
37884101|NCT00984126|69568397|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
37884102|NCT00984126|69568398|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
37985984|NCT00267969|69671648|FG001|After Controlled Period|Adverse Event|0|||
37985985|NCT00267969|69671649|FG002|After Controlled Period|Adverse Event|0|||
37985986|NCT00267969|69671650|FG003|After Controlled Period|Adverse Event|7|||
37985987|NCT00267969|69671651|FG004|After Controlled Period|Adverse Event|8|||
37985988|NCT00267969|69671652|FG005|After Controlled Period|Adverse Event|23|||
37985989|NCT00267969|69671653|FG006|After Controlled Period|Adverse Event|21|||
37985990|NCT00267969|69671647|FG000|After Controlled Period|Death|0|||
37985991|NCT00267969|69671648|FG001|After Controlled Period|Death|0|||
37985992|NCT00267969|69671649|FG002|After Controlled Period|Death|0|||
37985993|NCT00267969|69671650|FG003|After Controlled Period|Death|1|||
37985994|NCT00267969|69671651|FG004|After Controlled Period|Death|2|||
37985995|NCT00267969|69671652|FG005|After Controlled Period|Death|0|||
37985996|NCT00267969|69671653|FG006|After Controlled Period|Death|1|||
37985997|NCT00267969|69671647|FG000|After Controlled Period|Lack of Efficacy|0|||
37985998|NCT00267969|69671648|FG001|After Controlled Period|Lack of Efficacy|0|||
37985999|NCT00267969|69671649|FG002|After Controlled Period|Lack of Efficacy|0|||
37986000|NCT00267969|69671650|FG003|After Controlled Period|Lack of Efficacy|10|||
37986001|NCT00267969|69671651|FG004|After Controlled Period|Lack of Efficacy|6|||
37986002|NCT00267969|69671652|FG005|After Controlled Period|Lack of Efficacy|28|||
37986003|NCT00267969|69671653|FG006|After Controlled Period|Lack of Efficacy|15|||
37986004|NCT00267969|69671647|FG000|After Controlled Period|Lost to Follow-up|0|||
37986005|NCT00267969|69671648|FG001|After Controlled Period|Lost to Follow-up|0|||
37884103|NCT00984126|69568399|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
37884104|NCT00984126|69568400|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
37884105|NCT00984126|69568397|FG000|Overall Study|Withdrawal criteria|0|||
37884106|NCT00984126|69568398|FG001|Overall Study|Withdrawal criteria|1|||
37884107|NCT00984126|69568399|FG002|Overall Study|Withdrawal criteria|3|||
37884108|NCT00984126|69568400|FG003|Overall Study|Withdrawal criteria|9|||
37884109|NCT00979602|69568421|FG000|Overall Study|Serious Adverse Event|5|||
37884110|NCT00979602|69568422|FG001|Overall Study|Serious Adverse Event|3|||
37884111|NCT00979602|69568421|FG000|Overall Study|Protocol Violation|3|||
37884112|NCT00979602|69568422|FG001|Overall Study|Protocol Violation|0|||
37884113|NCT00979602|69568421|FG000|Overall Study|Withdrawal by Subject|31|||
37884114|NCT00979602|69568422|FG001|Overall Study|Withdrawal by Subject|25|||
37986006|NCT00267969|69671649|FG002|After Controlled Period|Lost to Follow-up|0|||
37986007|NCT00267969|69671650|FG003|After Controlled Period|Lost to Follow-up|5|||
37986008|NCT00267969|69671651|FG004|After Controlled Period|Lost to Follow-up|8|||
37986009|NCT00267969|69671652|FG005|After Controlled Period|Lost to Follow-up|9|||
37884115|NCT00979602|69568421|FG000|Overall Study|Lost to Follow-up|100|||
37884116|NCT00979602|69568422|FG001|Overall Study|Lost to Follow-up|96|||
37884117|NCT00979602|69568421|FG000|Overall Study|Migrated/moved from study area|3|||
37884118|NCT00979602|69568422|FG001|Overall Study|Migrated/moved from study area|6|||
37884119|NCT00979602|69568421|FG000|Overall Study|Others|3|||
37884120|NCT00979602|69568422|FG001|Overall Study|Others|3|||
37884121|NCT00816361|69568447|FG000|Overall Study|Withdrawal by Subject|0|||
37884122|NCT00816361|69568448|FG001|Overall Study|Withdrawal by Subject|0|||
37884123|NCT00816361|69568449|FG002|Overall Study|Withdrawal by Subject|0|||
37986010|NCT00267969|69671653|FG006|After Controlled Period|Lost to Follow-up|10|||
37986011|NCT00267969|69671647|FG000|After Controlled Period|Other|0|||
37986012|NCT00267969|69671648|FG001|After Controlled Period|Other|0|||
37986013|NCT00267969|69671649|FG002|After Controlled Period|Other|0|||
37986014|NCT00267969|69671650|FG003|After Controlled Period|Other|13|||
37884124|NCT00816361|69568450|FG003|Overall Study|Withdrawal by Subject|0|||
37884125|NCT00816361|69568451|FG004|Overall Study|Withdrawal by Subject|1|||
37884126|NCT00816361|69568452|FG005|Overall Study|Withdrawal by Subject|2|||
37884127|NCT00816361|69568453|FG006|Overall Study|Withdrawal by Subject|0|||
37884128|NCT00816361|69568454|FG007|Overall Study|Withdrawal by Subject|2|||
37884129|NCT00816361|69568455|FG008|Overall Study|Withdrawal by Subject|1|||
37884130|NCT00816361|69568447|FG000|Overall Study|Death|4|||
37884131|NCT00816361|69568448|FG001|Overall Study|Death|3|||
37884132|NCT00816361|69568449|FG002|Overall Study|Death|3|||
37884133|NCT00816361|69568450|FG003|Overall Study|Death|3|||
37884134|NCT00816361|69568451|FG004|Overall Study|Death|1|||
37884135|NCT00816361|69568452|FG005|Overall Study|Death|1|||
37884136|NCT00816361|69568453|FG006|Overall Study|Death|3|||
37884137|NCT00816361|69568454|FG007|Overall Study|Death|7|||
37884138|NCT00816361|69568455|FG008|Overall Study|Death|8|||
37884139|NCT00816361|69568447|FG000|Overall Study|Other|0|||
37884140|NCT00816361|69568448|FG001|Overall Study|Other|0|||
37884141|NCT00816361|69568449|FG002|Overall Study|Other|0|||
37884142|NCT00816361|69568450|FG003|Overall Study|Other|0|||
37884143|NCT00816361|69568451|FG004|Overall Study|Other|0|||
37884144|NCT00816361|69568452|FG005|Overall Study|Other|0|||
37884145|NCT00816361|69568453|FG006|Overall Study|Other|0|||
37884146|NCT00816361|69568454|FG007|Overall Study|Other|0|||
37884147|NCT00816361|69568455|FG008|Overall Study|Other|1|||
37884148|NCT00826111|69568478|FG000|Overall Study|Lost to Follow-up|0|||
37884149|NCT00826111|69568479|FG001|Overall Study|Lost to Follow-up|1|||
37884150|NCT00826111|69568478|FG000|Overall Study|Protocol Violation|1|||
37884151|NCT00826111|69568479|FG001|Overall Study|Protocol Violation|0|||
37884152|NCT00826111|69568478|FG000|Overall Study|Withdrawal by Subject|5|||
37884153|NCT00826111|69568479|FG001|Overall Study|Withdrawal by Subject|0|||
37884154|NCT00826111|69568478|FG000|Overall Study|Physician Decision|1|||
37884155|NCT00826111|69568479|FG001|Overall Study|Physician Decision|1|||
37884156|NCT00982644|69568490|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
37884157|NCT00982644|69568491|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
37884158|NCT00982644|69568490|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
37884159|NCT00982644|69568491|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
37884160|NCT00982644|69568490|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
37884161|NCT00982644|69568491|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
37884162|NCT00982644|69568490|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
37884163|NCT00982644|69568491|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
37884164|NCT00982644|69568490|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
37884165|NCT00982644|69568491|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
37884166|NCT00982644|69568490|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
37884167|NCT00982644|69568491|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
37884168|NCT00982644|69568490|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
37884169|NCT00982644|69568491|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
37884170|NCT00982644|69568490|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
37884171|NCT00982644|69568491|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
37884172|NCT00982644|69568490|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
37884173|NCT00982644|69568491|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
37884174|NCT00982644|69568490|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
37884175|NCT00982644|69568491|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
37884176|NCT00815659|69568497|FG000|Overall Study|Adverse Event|9|||
37884177|NCT00815659|69568497|FG000|Overall Study|Withdrawal by Subject|9|||
37884178|NCT00815659|69568497|FG000|Overall Study|Lost to Follow-up|4|||
37884179|NCT00815659|69568497|FG000|Overall Study|Protocol Violation|1|||
37884180|NCT00825175|69568503|FG000|Overall Study|Withdrawal by Subject|0|||
37884181|NCT00825175|69568504|FG001|Overall Study|Withdrawal by Subject|5|||
37884182|NCT00824473|69568512|FG000|Overall Study|Adverse Event|4|||
37884183|NCT00824473|69568513|FG001|Overall Study|Adverse Event|5|||
37884184|NCT00824473|69568512|FG000|Overall Study|Lack of Efficacy|2|||
37884185|NCT00824473|69568513|FG001|Overall Study|Lack of Efficacy|2|||
37884186|NCT00824473|69568512|FG000|Overall Study|Protocol Violation|2|||
37884187|NCT00824473|69568513|FG001|Overall Study|Protocol Violation|0|||
37884188|NCT00824473|69568512|FG000|Overall Study|Non-Compliance|4|||
37884189|NCT00824473|69568513|FG001|Overall Study|Non-Compliance|2|||
37884190|NCT00824473|69568512|FG000|Overall Study|Withdrawal by Subject|2|||
37884191|NCT00824473|69568513|FG001|Overall Study|Withdrawal by Subject|3|||
37884192|NCT00824473|69568512|FG000|Overall Study|Other|1|||
37884193|NCT00824473|69568513|FG001|Overall Study|Other|1|||
37884194|NCT00815191|69568525|FG000|Overall Study|Protocol Violation|1|||
37884195|NCT00815191|69568526|FG001|Overall Study|Protocol Violation|1|||
37884196|NCT00812929|69568532|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
37884197|NCT00812929|69568533|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
37884198|NCT00812929|69568534|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
37884199|NCT00812929|69568535|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
37884200|NCT00812929|69568536|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
37884201|NCT00812929|69568537|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
37884202|NCT00812929|69568538|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
37884203|NCT00812929|69568539|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
37884204|NCT00812929|69568540|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
37884205|NCT00812929|69568541|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
37884206|NCT00812929|69568532|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
37884207|NCT00812929|69568533|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
37884208|NCT00812929|69568534|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
37884209|NCT00812929|69568535|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
37884210|NCT00812929|69568536|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
37884211|NCT00812929|69568537|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
37884212|NCT00812929|69568538|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
37884213|NCT00812929|69568539|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
37884214|NCT00812929|69568540|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
37884215|NCT00812929|69568541|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
37884216|NCT00812929|69568532|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
37884217|NCT00812929|69568533|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
37884218|NCT00812929|69568534|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
37884219|NCT00812929|69568535|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
37884220|NCT00812929|69568536|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
37884221|NCT00812929|69568537|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
37884222|NCT00812929|69568538|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
37884223|NCT00812929|69568539|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
37884224|NCT00812929|69568540|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
37884225|NCT00812929|69568541|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
37884226|NCT00824161|69568558|FG000|Overall Study|Withdrawal by Subject|1|||
37884227|NCT00824161|69568558|FG000|Overall Study|Screen Failure|1|||
37884228|NCT00979134|69568567|FG000|Overall Study|Disease progression|18|||
37884229|NCT00979134|69568568|FG001|Overall Study|Disease progression|2|||
37884230|NCT00979134|69568569|FG002|Overall Study|Disease progression|5|||
37884231|NCT00979134|69568567|FG000|Overall Study|Adverse Event|0|||
37884232|NCT00979134|69568568|FG001|Overall Study|Adverse Event|0|||
37884233|NCT00979134|69568569|FG002|Overall Study|Adverse Event|2|||
37884234|NCT00979134|69568567|FG000|Overall Study|Withdrawal by Subject|1|||
37884235|NCT00979134|69568568|FG001|Overall Study|Withdrawal by Subject|1|||
37884236|NCT00979134|69568569|FG002|Overall Study|Withdrawal by Subject|2|||
37884237|NCT00979134|69568567|FG000|Overall Study|Lost to Follow-up|2|||
37884238|NCT00979134|69568568|FG001|Overall Study|Lost to Follow-up|2|||
37884239|NCT00979134|69568569|FG002|Overall Study|Lost to Follow-up|0|||
37884240|NCT00979134|69568567|FG000|Overall Study|Death|4|||
37884241|NCT00979134|69568568|FG001|Overall Study|Death|0|||
37884242|NCT00979134|69568569|FG002|Overall Study|Death|26|||
37884243|NCT00979134|69568567|FG000|Overall Study|Other|8|||
37884244|NCT00979134|69568568|FG001|Overall Study|Other|1|||
37884245|NCT00979134|69568569|FG002|Overall Study|Other|5|||
37884246|NCT00824005|69568584|FG000|Overall Study|Death|0|||
37884247|NCT00824005|69568585|FG001|Overall Study|Death|1|||
37884248|NCT00824005|69568584|FG000|Overall Study|Lost to Follow-up|0|||
37884249|NCT00824005|69568585|FG001|Overall Study|Lost to Follow-up|1|||
37884250|NCT00814879|69568593|FG000|By Week 24|Cancer Diagnosis|1|||
37884251|NCT00814879|69568594|FG001|By Week 24|Cancer Diagnosis|0|||
37884252|NCT00814879|69568593|FG000|By Week 24|Incarceration|0|||
37884253|NCT00814879|69568594|FG001|By Week 24|Incarceration|1|||
37884254|NCT00814879|69568593|FG000|By Week 48|Lost to Follow-up|2|||
37884255|NCT00814879|69568594|FG001|By Week 48|Lost to Follow-up|2|||
37884256|NCT00814879|69568593|FG000|By Week 48|Death|0|||
37884257|NCT00814879|69568594|FG001|By Week 48|Death|1|||
37884258|NCT03347422|69568603|FG000|Part A (26 Weeks)|Adverse Event|3|||
37884259|NCT03347422|69568604|FG001|Part A (26 Weeks)|Adverse Event|0|||
37884260|NCT03347422|69568603|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
37884261|NCT03347422|69568604|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
37884262|NCT03347422|69568603|FG000|Part B (149 Weeks)|Adverse Event|0|||
37884263|NCT03347422|69568604|FG001|Part B (149 Weeks)|Adverse Event|1|||
37884264|NCT03347422|69568603|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
37884265|NCT03347422|69568604|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
37884266|NCT03347422|69568603|FG000|Part B (149 Weeks)|Other|1|||
37884267|NCT03347422|69568604|FG001|Part B (149 Weeks)|Other|0|||
37884268|NCT00814801|69568620|FG000|Overall Study|Adverse Event|15|||
37884269|NCT00814801|69568621|FG001|Overall Study|Adverse Event|16|||
37884270|NCT00814801|69568622|FG002|Overall Study|Adverse Event|19|||
37884271|NCT00814801|69568620|FG000|Overall Study|Withdrawal by Subject|9|||
37884272|NCT00814801|69568621|FG001|Overall Study|Withdrawal by Subject|11|||
37884273|NCT00814801|69568622|FG002|Overall Study|Withdrawal by Subject|14|||
37884274|NCT00814801|69568620|FG000|Overall Study|Inappropriate as a subject|1|||
37884275|NCT00814801|69568621|FG001|Overall Study|Inappropriate as a subject|1|||
37884276|NCT00814801|69568622|FG002|Overall Study|Inappropriate as a subject|1|||
37884277|NCT00814801|69568620|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
37884278|NCT00814801|69568621|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
37884279|NCT00814801|69568622|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
37884280|NCT00814801|69568620|FG000|Overall Study|Missing or change of caregiver|6|||
37884281|NCT00814801|69568621|FG001|Overall Study|Missing or change of caregiver|2|||
37884282|NCT00814801|69568622|FG002|Overall Study|Missing or change of caregiver|4|||
37884283|NCT00814801|69568620|FG000|Overall Study|Non-compliance|0|||
37884284|NCT00814801|69568621|FG001|Overall Study|Non-compliance|1|||
37884285|NCT00814801|69568622|FG002|Overall Study|Non-compliance|1|||
37884286|NCT00814801|69568620|FG000|Overall Study|Other|2|||
37884287|NCT00814801|69568621|FG001|Overall Study|Other|6|||
37884288|NCT00814801|69568622|FG002|Overall Study|Other|4|||
37884289|NCT00823615|69568630|FG000|Period 2|Lost to Follow-up|2|||
37884290|NCT00823615|69568631|FG001|Period 2|Lost to Follow-up|0|||
37884291|NCT00823615|69568630|FG000|Period 2|Time/Job Conflict|1|||
37884292|NCT00823615|69568631|FG001|Period 2|Time/Job Conflict|2|||
37884293|NCT00812461|69568639|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
37884294|NCT00812461|69568640|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
37884295|NCT00812461|69568639|FG000|All Treated Patients|Adverse Event|8|||
37884296|NCT00812461|69568640|FG001|All Treated Patients|Adverse Event|15|||
37884297|NCT00812461|69568639|FG000|All Treated Patients|Lack of Efficacy|13|||
37884298|NCT00812461|69568640|FG001|All Treated Patients|Lack of Efficacy|7|||
37884299|NCT00812461|69568639|FG000|All Treated Patients|Non-compliance|6|||
37884300|NCT00812461|69568640|FG001|All Treated Patients|Non-compliance|9|||
37884301|NCT00812461|69568639|FG000|All Treated Patients|Protocol Violation|36|||
37884302|NCT00812461|69568640|FG001|All Treated Patients|Protocol Violation|27|||
37884303|NCT00812461|69568639|FG000|All Treated Patients|Withdrawal by Subject|45|||
37884304|NCT00812461|69568640|FG001|All Treated Patients|Withdrawal by Subject|54|||
37884305|NCT00812461|69568639|FG000|All Treated Patients|Lost to Follow-up|11|||
37884306|NCT00812461|69568640|FG001|All Treated Patients|Lost to Follow-up|14|||
37884307|NCT00812461|69568639|FG000|All Treated Patients|Other Reason|13|||
37884308|NCT00812461|69568640|FG001|All Treated Patients|Other Reason|21|||
37884309|NCT00599326|69568646|FG000|Overall Study|Lost to Follow-up|1|||
37884310|NCT00599326|69568646|FG000|Overall Study|Noncompliant|1|||
37884311|NCT00978432|69568653|FG000|Overall Study|Withdrawal by Subject|0|||
37986015|NCT00267969|69671651|FG004|After Controlled Period|Other|11|||
37986016|NCT00267969|69671652|FG005|After Controlled Period|Other|22|||
37986017|NCT00267969|69671653|FG006|After Controlled Period|Other|25|||
37986018|NCT00280293|69671673|FG000|Overall Study|Protocol Violation|3|||
37986019|NCT00280293|69671674|FG001|Overall Study|Protocol Violation|0|||
37986020|NCT00280293|69671673|FG000|Overall Study|Physician Decision|5|||
37986021|NCT00280293|69671674|FG001|Overall Study|Physician Decision|4|||
37986022|NCT00280293|69671673|FG000|Overall Study|Lost to Follow-up|14|||
37986023|NCT00280293|69671674|FG001|Overall Study|Lost to Follow-up|12|||
37986024|NCT00280293|69671673|FG000|Overall Study|Withdrawal by Subject|3|||
37986025|NCT00280293|69671674|FG001|Overall Study|Withdrawal by Subject|5|||
37986026|NCT00280293|69671673|FG000|Overall Study|Incarceration/Legal Reasons|1|||
37986027|NCT00280293|69671674|FG001|Overall Study|Incarceration/Legal Reasons|1|||
37986028|NCT00280293|69671673|FG000|Overall Study|Adverse Event|0|||
37986029|NCT00280293|69671674|FG001|Overall Study|Adverse Event|1|||
37986030|NCT00421148|69671700|FG000|Overall Study|Lost to Follow-up|0|||
37986031|NCT00421148|69671701|FG001|Overall Study|Lost to Follow-up|0|||
37986032|NCT00421148|69671702|FG002|Overall Study|Lost to Follow-up|0|||
37986033|NCT00421148|69671703|FG003|Overall Study|Lost to Follow-up|0|||
37986034|NCT00421148|69671704|FG004|Overall Study|Lost to Follow-up|0|||
37986035|NCT00421148|69671705|FG005|Overall Study|Lost to Follow-up|0|||
37986036|NCT00421148|69671706|FG006|Overall Study|Lost to Follow-up|0|||
37986037|NCT00421148|69671707|FG007|Overall Study|Lost to Follow-up|0|||
37986038|NCT00421148|69671708|FG008|Overall Study|Lost to Follow-up|0|||
37986039|NCT00421148|69671709|FG009|Overall Study|Lost to Follow-up|0|||
37986040|NCT00421148|69671710|FG010|Overall Study|Lost to Follow-up|0|||
37986041|NCT00421148|69671711|FG011|Overall Study|Lost to Follow-up|0|||
37986042|NCT00421148|69671712|FG012|Overall Study|Lost to Follow-up|0|||
37986043|NCT00421148|69671713|FG013|Overall Study|Lost to Follow-up|0|||
37884312|NCT00978432|69568654|FG001|Overall Study|Withdrawal by Subject|0|||
37884313|NCT00978432|69568655|FG002|Overall Study|Withdrawal by Subject|1|||
37884314|NCT00978432|69568653|FG000|Overall Study|Lack of Efficacy|1|||
37884315|NCT00978432|69568654|FG001|Overall Study|Lack of Efficacy|1|||
37986044|NCT00421148|69671714|FG014|Overall Study|Lost to Follow-up|0|||
37986045|NCT00421148|69671715|FG015|Overall Study|Lost to Follow-up|0|||
37884316|NCT00978432|69568655|FG002|Overall Study|Lack of Efficacy|3|||
37884317|NCT00978432|69568653|FG000|Overall Study|Adverse Event|2|||
37986046|NCT00421148|69671716|FG016|Overall Study|Lost to Follow-up|0|||
37986047|NCT00421148|69671717|FG017|Overall Study|Lost to Follow-up|1|||
37986048|NCT00421148|69671718|FG018|Overall Study|Lost to Follow-up|0|||
37986049|NCT00421148|69671719|FG019|Overall Study|Lost to Follow-up|0|||
37986050|NCT00421148|69671700|FG000|Overall Study|Withdrawal by Subject|0|||
37986051|NCT00421148|69671701|FG001|Overall Study|Withdrawal by Subject|0|||
37884318|NCT00978432|69568654|FG001|Overall Study|Adverse Event|0|||
37884319|NCT00978432|69568655|FG002|Overall Study|Adverse Event|1|||
37884320|NCT00975780|69568665|FG000|Follow Up|Death|88|||
37884321|NCT00975780|69568666|FG001|Follow Up|Death|122|||
37986052|NCT00421148|69671702|FG002|Overall Study|Withdrawal by Subject|0|||
37986053|NCT00421148|69671703|FG003|Overall Study|Withdrawal by Subject|0|||
37986054|NCT00421148|69671704|FG004|Overall Study|Withdrawal by Subject|0|||
37986055|NCT00421148|69671705|FG005|Overall Study|Withdrawal by Subject|0|||
37986056|NCT00421148|69671706|FG006|Overall Study|Withdrawal by Subject|0|||
37884322|NCT00975780|69568665|FG000|Follow Up|Facility Withdrawal|7|||
37884323|NCT00975780|69568666|FG001|Follow Up|Facility Withdrawal|23|||
37884324|NCT00975780|69568665|FG000|Follow Up|Discharged from Facility|7|||
37884325|NCT00975780|69568666|FG001|Follow Up|Discharged from Facility|12|||
37884326|NCT00814489|69568675|FG000|Overall Study|Other|2|||
37884327|NCT00814489|69568676|FG001|Overall Study|Other|0|||
37884328|NCT00814489|69568677|FG002|Overall Study|Other|1|||
37884329|NCT00814333|69568689|FG000|Enrollment|Lost to Follow-up|1|||
37884330|NCT00814333|69568690|FG001|Enrollment|Lost to Follow-up|0|||
37884331|NCT01147250|69568698|FG000|Overall Study|Lost to Follow-up|14|||
37884332|NCT01147250|69568699|FG001|Overall Study|Lost to Follow-up|11|||
37884333|NCT01147250|69568698|FG000|Overall Study|Withdrawal by Subject|83|||
37884334|NCT01147250|69568699|FG001|Overall Study|Withdrawal by Subject|88|||
37884335|NCT01147250|69568698|FG000|Overall Study|Site termination by sponsor|13|||
37884336|NCT01147250|69568699|FG001|Overall Study|Site termination by sponsor|5|||
37884337|NCT01147250|69568698|FG000|Overall Study|Other than specified|0|||
37884338|NCT01147250|69568699|FG001|Overall Study|Other than specified|1|||
37884339|NCT00813943|69568708|FG000|Overall Study|Ongoing at cut-off date|5|||
37884340|NCT00813943|69568709|FG001|Overall Study|Ongoing at cut-off date|5|||
37884341|NCT00813943|69568710|FG002|Overall Study|Ongoing at cut-off date|3|||
37884342|NCT00821509|69568722|FG000|Overall Study|Withdrawal by Subject|12|||
37884343|NCT00821509|69568723|FG001|Overall Study|Withdrawal by Subject|11|||
37884344|NCT00821509|69568724|FG002|Overall Study|Withdrawal by Subject|34|||
37884345|NCT00821431|69568734|FG000|Overall Study|Adverse Event|6|||
37884346|NCT00821431|69568735|FG001|Overall Study|Adverse Event|3|||
37884347|NCT00821431|69568734|FG000|Overall Study|Withdrawal by Subject|5|||
37884348|NCT00821431|69568735|FG001|Overall Study|Withdrawal by Subject|0|||
37884349|NCT00821431|69568734|FG000|Overall Study|Lost to Follow-up|1|||
37884350|NCT00821431|69568735|FG001|Overall Study|Lost to Follow-up|0|||
37884351|NCT00821431|69568734|FG000|Overall Study|Protocol Violation|3|||
37884352|NCT00821431|69568735|FG001|Overall Study|Protocol Violation|1|||
37884353|NCT00821431|69568734|FG000|Overall Study|Physician Decision|0|||
37884354|NCT00821431|69568735|FG001|Overall Study|Physician Decision|1|||
37884355|NCT03982368|69568744|FG000|Overall Study|Adverse Event|6|||
37884356|NCT03982368|69568745|FG001|Overall Study|Adverse Event|4|||
37884357|NCT03982368|69568746|FG002|Overall Study|Adverse Event|3|||
37884358|NCT03982368|69568744|FG000|Overall Study|Lost to Follow-up|2|||
37884359|NCT03982368|69568745|FG001|Overall Study|Lost to Follow-up|1|||
37884360|NCT03982368|69568746|FG002|Overall Study|Lost to Follow-up|0|||
37884361|NCT03982368|69568744|FG000|Overall Study|Withdrawal by Subject|1|||
37884362|NCT03982368|69568745|FG001|Overall Study|Withdrawal by Subject|2|||
37884363|NCT03982368|69568746|FG002|Overall Study|Withdrawal by Subject|0|||
37986057|NCT00421148|69671707|FG007|Overall Study|Withdrawal by Subject|0|||
37986058|NCT00421148|69671708|FG008|Overall Study|Withdrawal by Subject|0|||
37986059|NCT00421148|69671709|FG009|Overall Study|Withdrawal by Subject|0|||
37986060|NCT00421148|69671710|FG010|Overall Study|Withdrawal by Subject|0|||
37986061|NCT00421148|69671711|FG011|Overall Study|Withdrawal by Subject|0|||
37986062|NCT00421148|69671712|FG012|Overall Study|Withdrawal by Subject|0|||
37986063|NCT00421148|69671713|FG013|Overall Study|Withdrawal by Subject|0|||
37986064|NCT00421148|69671714|FG014|Overall Study|Withdrawal by Subject|0|||
37695458|NCT02281357|69171789|FG000|Overall Study|Adverse Event|2|||
37821438|NCT03117998|69501042|FG001|Overall Study|Protocol Violation|0|||
37821439|NCT03117998|69501043|FG002|Overall Study|Protocol Violation|0|||
37884364|NCT03982368|69568744|FG000|Overall Study|unknow|4|||
37884365|NCT03982368|69568745|FG001|Overall Study|unknow|0|||
37884366|NCT03982368|69568746|FG002|Overall Study|unknow|2|||
37821440|NCT03117998|69501044|FG003|Overall Study|Protocol Violation|0|||
37821441|NCT03117998|69501045|FG004|Overall Study|Protocol Violation|0|||
37821442|NCT03117998|69501046|FG005|Overall Study|Protocol Violation|1|||
37821443|NCT03100370|69501071|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
37821444|NCT03100370|69501072|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
37821445|NCT03100370|69501073|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
37884367|NCT00813865|69568757|FG000|Overall Study|Failure to Respond|3|||
37884368|NCT00813865|69568757|FG000|Overall Study|Lost to Follow-up|3|||
37884369|NCT00813865|69568757|FG000|Overall Study|Withdrawal by Subject|1|||
37884370|NCT01147172|69568761|FG000|Overall Study|Withdrawal by Subject|2|||
37986065|NCT00421148|69671715|FG015|Overall Study|Withdrawal by Subject|0|||
37986066|NCT00421148|69671716|FG016|Overall Study|Withdrawal by Subject|0|||
37986067|NCT00421148|69671717|FG017|Overall Study|Withdrawal by Subject|1|||
37884371|NCT01147172|69568761|FG000|Overall Study|Lost to Follow-up|2|||
37884372|NCT01120964|69568769|FG000|Overall Study|Did not receive full treatment|1|||
37884373|NCT01120964|69568770|FG001|Overall Study|Did not receive full treatment|0|||
37884374|NCT01146860|69568778|FG000|Overall Study|Withdrawal by Subject|0|||
37884375|NCT01146860|69568779|FG001|Overall Study|Withdrawal by Subject|1|||
37884376|NCT00591565|69568785|FG000|Overall Study|lost follow up, withdrawn|5|||
37884377|NCT01146782|69568789|FG000|Screening Cohort|Screen Failure|187|||
37884378|NCT01146782|69568789|FG000|Screening Cohort|Lost to Follow-up|4|||
37884379|NCT01146782|69568789|FG000|Screening Cohort|Physician Decision|1|||
37884380|NCT01146782|69568789|FG000|Screening Cohort|Withdrawal by Subject|29|||
37884381|NCT01146782|69568789|FG000|Safety Cohort|Screen Failure|61|||
37884382|NCT01146782|69568789|FG000|Safety Cohort|Withdrawal by Subject|4|||
37884383|NCT01146782|69568789|FG000|Safety Cohort|Control AHI <5|4|||
37884384|NCT01146782|69568789|FG000|Safety Cohort|TST <4 hrs|14|||
37884385|NCT01146782|69568789|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
37884386|NCT01146782|69568789|FG000|Primary Endpoint Cohort|Physician Decision|1|||
37884387|NCT00978120|69568798|FG000|Overall Study|Death|0|||
37884388|NCT00978120|69568799|FG001|Overall Study|Death|0|||
37884389|NCT00978120|69568800|FG002|Overall Study|Death|0|||
37884390|NCT00978120|69568801|FG003|Overall Study|Death|1|||
37884391|NCT00978120|69568798|FG000|Overall Study|Lost to Follow-up|0|||
37986068|NCT00421148|69671718|FG018|Overall Study|Withdrawal by Subject|0|||
37986069|NCT00421148|69671719|FG019|Overall Study|Withdrawal by Subject|0|||
37986070|NCT00421148|69671700|FG000|Overall Study|Protocol Violation|0|||
37986071|NCT00421148|69671701|FG001|Overall Study|Protocol Violation|0|||
37986072|NCT00421148|69671702|FG002|Overall Study|Protocol Violation|0|||
37986073|NCT00421148|69671703|FG003|Overall Study|Protocol Violation|0|||
37884392|NCT00978120|69568799|FG001|Overall Study|Lost to Follow-up|0|||
37884393|NCT00978120|69568800|FG002|Overall Study|Lost to Follow-up|3|||
37884394|NCT00978120|69568801|FG003|Overall Study|Lost to Follow-up|0|||
37884395|NCT00978120|69568798|FG000|Overall Study|Withdrawal by Subject|2|||
37884396|NCT00978120|69568799|FG001|Overall Study|Withdrawal by Subject|0|||
37884397|NCT00978120|69568800|FG002|Overall Study|Withdrawal by Subject|0|||
37884398|NCT00978120|69568801|FG003|Overall Study|Withdrawal by Subject|0|||
37884399|NCT00978120|69568798|FG000|Overall Study|Moved out of state|0|||
37884400|NCT00978120|69568799|FG001|Overall Study|Moved out of state|0|||
37884401|NCT00978120|69568800|FG002|Overall Study|Moved out of state|0|||
37884402|NCT00978120|69568801|FG003|Overall Study|Moved out of state|1|||
37884403|NCT00978042|69568817|FG000|Initial Treatment Period|Treated in Error|0|||
37884404|NCT00978042|69568818|FG001|Initial Treatment Period|Treated in Error|3|||
37884405|NCT00978042|69568817|FG000|Initial Treatment Period|Ineligibility|1|||
37986074|NCT00421148|69671704|FG004|Overall Study|Protocol Violation|0|||
37986075|NCT00421148|69671705|FG005|Overall Study|Protocol Violation|1|||
37986076|NCT00421148|69671706|FG006|Overall Study|Protocol Violation|0|||
37986077|NCT00421148|69671707|FG007|Overall Study|Protocol Violation|0|||
37986078|NCT00421148|69671708|FG008|Overall Study|Protocol Violation|0|||
37986079|NCT00421148|69671709|FG009|Overall Study|Protocol Violation|0|||
37986080|NCT00421148|69671710|FG010|Overall Study|Protocol Violation|0|||
37986081|NCT00421148|69671711|FG011|Overall Study|Protocol Violation|0|||
37986082|NCT00421148|69671712|FG012|Overall Study|Protocol Violation|0|||
37986083|NCT00421148|69671713|FG013|Overall Study|Protocol Violation|0|||
37986084|NCT00421148|69671714|FG014|Overall Study|Protocol Violation|0|||
37986085|NCT00421148|69671715|FG015|Overall Study|Protocol Violation|0|||
37986086|NCT00421148|69671716|FG016|Overall Study|Protocol Violation|0|||
37986087|NCT00421148|69671717|FG017|Overall Study|Protocol Violation|0|||
37986088|NCT00421148|69671718|FG018|Overall Study|Protocol Violation|1|||
37986089|NCT00421148|69671719|FG019|Overall Study|Protocol Violation|0|||
37986090|NCT00403754|69671761|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
37986091|NCT00403754|69671762|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
37986092|NCT00403754|69671763|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
37884406|NCT00978042|69568818|FG001|Initial Treatment Period|Ineligibility|0|||
37986093|NCT00403754|69671764|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
37986094|NCT00403754|69671761|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
37986095|NCT00403754|69671762|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
37884407|NCT00978042|69568817|FG000|Initial Treatment Period|Lost to Follow-up|21|||
37884408|NCT00978042|69568818|FG001|Initial Treatment Period|Lost to Follow-up|3|||
37884409|NCT00978042|69568817|FG000|Initial Treatment Period|Adverse Event|2|||
37884410|NCT00978042|69568818|FG001|Initial Treatment Period|Adverse Event|0|||
37986096|NCT00403754|69671763|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
37986097|NCT00403754|69671764|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
37986098|NCT00280059|69671778|FG000|Efficacy Assessment Phase|Death|2|||
37986099|NCT00280059|69671779|FG001|Efficacy Assessment Phase|Death|0|||
37986100|NCT00280059|69671778|FG000|Efficacy Assessment Phase|Adverse Event|33|||
37986101|NCT00280059|69671779|FG001|Efficacy Assessment Phase|Adverse Event|31|||
37884411|NCT00978042|69568817|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
37884412|NCT00978042|69568818|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
37884413|NCT00978042|69568817|FG000|Initial Treatment Period|Consent withdrawn|22|||
37884414|NCT00978042|69568818|FG001|Initial Treatment Period|Consent withdrawn|9|||
37884415|NCT00978042|69568817|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
37884416|NCT00978042|69568818|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
37884417|NCT01133678|69568826|FG000|Overall Study|Death|1|||
37884418|NCT01133678|69568827|FG001|Overall Study|Death|1|||
37884419|NCT01133522|69568843|FG000|Overall Study|Withdrawal by Subject|0|||
37884420|NCT01133522|69568844|FG001|Overall Study|Withdrawal by Subject|1|||
37884421|NCT01133522|69568845|FG002|Overall Study|Withdrawal by Subject|0|||
37884422|NCT01133522|69568846|FG003|Overall Study|Withdrawal by Subject|1|||
37884423|NCT01133522|69568847|FG004|Overall Study|Withdrawal by Subject|0|||
37884424|NCT01133522|69568848|FG005|Overall Study|Withdrawal by Subject|0|||
37884425|NCT01133522|69568849|FG006|Overall Study|Withdrawal by Subject|0|||
37884426|NCT01133522|69568850|FG007|Overall Study|Withdrawal by Subject|0|||
37884427|NCT01133522|69568851|FG008|Overall Study|Withdrawal by Subject|0|||
37884428|NCT01133522|69568852|FG009|Overall Study|Withdrawal by Subject|0|||
37884429|NCT01133522|69568843|FG000|Overall Study|Physician Decision|0|||
37884430|NCT01133522|69568844|FG001|Overall Study|Physician Decision|0|||
37884431|NCT01133522|69568845|FG002|Overall Study|Physician Decision|0|||
37884432|NCT01133522|69568846|FG003|Overall Study|Physician Decision|0|||
37884433|NCT01133522|69568847|FG004|Overall Study|Physician Decision|1|||
37884434|NCT01133522|69568848|FG005|Overall Study|Physician Decision|0|||
37884435|NCT01133522|69568849|FG006|Overall Study|Physician Decision|0|||
37884436|NCT01133522|69568850|FG007|Overall Study|Physician Decision|0|||
37884437|NCT01133522|69568851|FG008|Overall Study|Physician Decision|0|||
37884438|NCT01133522|69568852|FG009|Overall Study|Physician Decision|0|||
37884439|NCT01133288|69568881|FG000|Eligibility Assessment|met exclusion criteria|5|||
37884440|NCT01133288|69568881|FG000|Intervention Allocation|study terminated|2|||
37884441|NCT00883090|69568889|FG000|Overall Study|Sponsor's decision|1|||
37884442|NCT00883090|69568889|FG000|Overall Study|Withdrawal by Subject|1|||
37884443|NCT01132820|69568893|FG000|Overall Study|Ineligible: wrong cell type|1|||
37884444|NCT01132820|69568893|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
37884445|NCT01132820|69568893|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
37884446|NCT01132820|69568893|FG000|Overall Study|Never treated|1|||
37884447|NCT01132820|69568893|FG000|Overall Study|Inadequate data|1|||
37884448|NCT00885352|69568912|FG000|Overall Study|Adverse Event|2|||
37884449|NCT00885352|69568913|FG001|Overall Study|Adverse Event|3|||
37884450|NCT00885352|69568912|FG000|Overall Study|Lost to Follow-up|2|||
37884451|NCT00885352|69568913|FG001|Overall Study|Lost to Follow-up|2|||
37884452|NCT00885352|69568912|FG000|Overall Study|Physician Decision|0|||
37884453|NCT00885352|69568913|FG001|Overall Study|Physician Decision|3|||
37884454|NCT00885352|69568912|FG000|Overall Study|Protocol Violation|0|||
37884455|NCT00885352|69568913|FG001|Overall Study|Protocol Violation|2|||
37884456|NCT00885352|69568912|FG000|Overall Study|Withdrawal by Subject|1|||
37884457|NCT00885352|69568913|FG001|Overall Study|Withdrawal by Subject|5|||
37884458|NCT00885352|69568912|FG000|Overall Study|Contradiction to study medication|0|||
37884459|NCT00885352|69568913|FG001|Overall Study|Contradiction to study medication|2|||
37884460|NCT00885352|69568912|FG000|Overall Study|Excluded medication|2|||
37884461|NCT00885352|69568913|FG001|Overall Study|Excluded medication|2|||
37884462|NCT00885352|69568912|FG000|Overall Study|Lab abnormalities|1|||
37884463|NCT00885352|69568913|FG001|Overall Study|Lab abnormalities|1|||
37884464|NCT00885118|69568924|FG000|Overall Study|Adverse Event|1|||
37884465|NCT00885118|69568925|FG001|Overall Study|Adverse Event|0|||
37884466|NCT00885118|69568926|FG002|Overall Study|Adverse Event|0|||
37884467|NCT00885118|69568927|FG003|Overall Study|Adverse Event|0|||
37884468|NCT00885118|69568928|FG004|Overall Study|Adverse Event|0|||
37884469|NCT00885118|69568924|FG000|Overall Study|Withdrawal by Subject|0|||
37884470|NCT00885118|69568925|FG001|Overall Study|Withdrawal by Subject|0|||
37884471|NCT00885118|69568926|FG002|Overall Study|Withdrawal by Subject|0|||
37884472|NCT00885118|69568927|FG003|Overall Study|Withdrawal by Subject|0|||
37884473|NCT00885118|69568928|FG004|Overall Study|Withdrawal by Subject|1|||
37884474|NCT00885118|69568924|FG000|Overall Study|Other reason not defined above|0|||
37884475|NCT00885118|69568925|FG001|Overall Study|Other reason not defined above|0|||
37884476|NCT00885118|69568926|FG002|Overall Study|Other reason not defined above|1|||
37884477|NCT00885118|69568927|FG003|Overall Study|Other reason not defined above|0|||
37884478|NCT00885118|69568928|FG004|Overall Study|Other reason not defined above|0|||
37884479|NCT00880906|69568946|FG000|Overall Study|Lost to Follow-up|0|||
37884480|NCT00880906|69568947|FG001|Overall Study|Lost to Follow-up|1|||
37884481|NCT00880906|69568946|FG000|Overall Study|Did not meet criteria following patholog|12|||
37884482|NCT00880906|69568947|FG001|Overall Study|Did not meet criteria following patholog|6|||
37884483|NCT00882310|69568953|FG000|Overall Study|Screen Failure|10|||
37884484|NCT00882310|69568953|FG000|Overall Study|Never received treatment|1|||
37884485|NCT00882310|69568953|FG000|Overall Study|Death|6|||
37884486|NCT00882310|69568953|FG000|Overall Study|Progression of disease|4|||
37986102|NCT00280059|69671778|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
37986103|NCT00280059|69671779|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
37986104|NCT00280059|69671778|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
37986105|NCT00280059|69671779|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
37986106|NCT00280059|69671778|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
37986107|NCT00280059|69671779|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
37986108|NCT00280059|69671778|FG000|Efficacy Assessment Phase|Other|7|||
37986109|NCT00280059|69671779|FG001|Efficacy Assessment Phase|Other|8|||
37986110|NCT00280059|69671778|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
37986111|NCT00280059|69671779|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
37986112|NCT00403130|69671793|FG000|2 Years From Start of Treatment|Not Eligible|3|||
37986113|NCT00403130|69671793|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
37986114|NCT00403130|69671793|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
37986115|NCT00403130|69671793|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
37986116|NCT00402740|69671797|FG000|Overall Study|Withdrawal by Subject|18|||
37986117|NCT00402740|69671797|FG000|Overall Study|Death|50|||
37986118|NCT00402740|69671797|FG000|Overall Study|Lost to Follow-up|6|||
37986119|NCT00402740|69671797|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
37986120|NCT00402740|69671797|FG000|Overall Study|Subject disposition unknown.|1|||
37986121|NCT00420290|69671807|FG000|Overall Study|Adverse Event|3|||
37986122|NCT00420290|69671808|FG001|Overall Study|Adverse Event|1|||
37986123|NCT00420290|69671807|FG000|Overall Study|Withdrawal by Subject|0|||
37986124|NCT00420290|69671808|FG001|Overall Study|Withdrawal by Subject|2|||
37695459|NCT02281357|69171790|FG001|Overall Study|Adverse Event|1|||
37986125|NCT00420290|69671807|FG000|Overall Study|did not meet inclusion/exclusion|1|||
37986126|NCT00420290|69671808|FG001|Overall Study|did not meet inclusion/exclusion|1|||
37986127|NCT00267189|69671816|FG000|Overall Study|Patient withdrew consent|1|||
37986128|NCT00267189|69671817|FG001|Overall Study|Patient withdrew consent|1|||
37986129|NCT00267189|69671816|FG000|Overall Study|Death|1|||
37986130|NCT00267189|69671817|FG001|Overall Study|Death|0|||
37986131|NCT00267189|69671816|FG000|Overall Study|Missing|3|||
37986132|NCT00267189|69671817|FG001|Overall Study|Missing|0|||
37986133|NCT03834350|69671823|FG000|Overall Study|Withdrawal by Subject|1|||
37986134|NCT00402116|69671831|FG000|Overall Study|Jaw infection after surgery-other|1|||
37986135|NCT00402116|69671832|FG001|Overall Study|Jaw infection after surgery-other|0|||
37986136|NCT00402116|69671833|FG002|Overall Study|Jaw infection after surgery-other|0|||
37986137|NCT00402116|69671831|FG000|Overall Study|Withdrawal by Subject|1|||
37986138|NCT00402116|69671832|FG001|Overall Study|Withdrawal by Subject|0|||
37986139|NCT00402116|69671833|FG002|Overall Study|Withdrawal by Subject|5|||
37986140|NCT00402116|69671831|FG000|Overall Study|Treatment completed per protocol|1|||
37986141|NCT00402116|69671832|FG001|Overall Study|Treatment completed per protocol|1|||
37986142|NCT00402116|69671833|FG002|Overall Study|Treatment completed per protocol|2|||
37986143|NCT00402116|69671831|FG000|Overall Study|other complicating disease|0|||
37986144|NCT00402116|69671832|FG001|Overall Study|other complicating disease|0|||
37986145|NCT00402116|69671833|FG002|Overall Study|other complicating disease|2|||
37986146|NCT00402116|69671831|FG000|Overall Study|Disease Progression|0|||
37986147|NCT00402116|69671832|FG001|Overall Study|Disease Progression|4|||
37986148|NCT00402116|69671833|FG002|Overall Study|Disease Progression|38|||
37986149|NCT00402116|69671831|FG000|Overall Study|mistaken thrombocytopenia|0|||
37986150|NCT00402116|69671832|FG001|Overall Study|mistaken thrombocytopenia|0|||
37986151|NCT00402116|69671833|FG002|Overall Study|mistaken thrombocytopenia|1|||
37986152|NCT00402116|69671831|FG000|Overall Study|decline related hyponatremia/tumor|0|||
37986153|NCT00402116|69671832|FG001|Overall Study|decline related hyponatremia/tumor|0|||
37986154|NCT00402116|69671833|FG002|Overall Study|decline related hyponatremia/tumor|1|||
37986155|NCT00402116|69671831|FG000|Overall Study|Adverse Event|0|||
37986156|NCT00402116|69671832|FG001|Overall Study|Adverse Event|1|||
37986157|NCT00402116|69671833|FG002|Overall Study|Adverse Event|6|||
37986158|NCT00401960|69671863|FG000|Overall Study|Lost to Follow-up|3|||
37986159|NCT00401960|69671864|FG001|Overall Study|Lost to Follow-up|0|||
37986160|NCT00401960|69671863|FG000|Overall Study|Death|2|||
37986161|NCT00401960|69671864|FG001|Overall Study|Death|0|||
37986162|NCT00401726|69671874|FG000|Overall Study|Adverse Event|34|||
37986163|NCT00401726|69671875|FG001|Overall Study|Adverse Event|45|||
37986164|NCT00401726|69671874|FG000|Overall Study|Death|0|||
37986165|NCT00401726|69671875|FG001|Overall Study|Death|3|||
37986166|NCT00401726|69671874|FG000|Overall Study|Sponsor Request|0|||
37986167|NCT00401726|69671875|FG001|Overall Study|Sponsor Request|1|||
37986168|NCT00401726|69671874|FG000|Overall Study|Physician Decision|3|||
37986169|NCT00401726|69671875|FG001|Overall Study|Physician Decision|6|||
37986170|NCT00401726|69671874|FG000|Overall Study|Lost to Follow-up|23|||
37986171|NCT00401726|69671875|FG001|Overall Study|Lost to Follow-up|20|||
37884487|NCT00882310|69568953|FG000|Overall Study|Adverse Event|1|||
37884488|NCT00884650|69568959|FG000|Overall Study|Did not return complete pain diaries|7|||
37884489|NCT00884650|69568960|FG001|Overall Study|Did not return complete pain diaries|7|||
37884490|NCT00884650|69568959|FG000|Overall Study|Admitted Post-Op|1|||
37884491|NCT00884650|69568960|FG001|Overall Study|Admitted Post-Op|0|||
37884492|NCT00884650|69568959|FG000|Overall Study|Femoral Stress Fracture|1|||
37884493|NCT00884650|69568960|FG001|Overall Study|Femoral Stress Fracture|0|||
37884494|NCT00884650|69568959|FG000|Overall Study|Pain Pump Complication|0|||
37884495|NCT00884650|69568960|FG001|Overall Study|Pain Pump Complication|1|||
37884496|NCT00881608|69568972|FG000|Overall Study|Study prematurely terminated|11|||
37884497|NCT01088399|69568987|FG000|Overall Study|Adverse Event|211|||
37884498|NCT01088399|69568988|FG001|Overall Study|Adverse Event|16|||
37884499|NCT01088399|69568989|FG002|Overall Study|Adverse Event|0|||
37884500|NCT01088399|69568987|FG000|Overall Study|Death|204|||
37884501|NCT01088399|69568988|FG001|Overall Study|Death|45|||
37884502|NCT01088399|69568989|FG002|Overall Study|Death|0|||
37884503|NCT01088399|69568987|FG000|Overall Study|Lack of Efficacy|298|||
37884504|NCT01088399|69568988|FG001|Overall Study|Lack of Efficacy|7|||
37884505|NCT01088399|69568989|FG002|Overall Study|Lack of Efficacy|5|||
37884506|NCT01088399|69568987|FG000|Overall Study|Lost to Follow-up|1070|||
37884507|NCT01088399|69568988|FG001|Overall Study|Lost to Follow-up|278|||
37884508|NCT01088399|69568989|FG002|Overall Study|Lost to Follow-up|58|||
37884509|NCT01088399|69568987|FG000|Overall Study|Physician Decision|531|||
37884510|NCT01088399|69568988|FG001|Overall Study|Physician Decision|88|||
37884511|NCT01088399|69568989|FG002|Overall Study|Physician Decision|16|||
37884512|NCT01088399|69568987|FG000|Overall Study|Withdrawal by Subject|544|||
37884513|NCT01088399|69568988|FG001|Overall Study|Withdrawal by Subject|195|||
37884514|NCT01088399|69568989|FG002|Overall Study|Withdrawal by Subject|33|||
37884515|NCT01088399|69568987|FG000|Overall Study|Change to or start of somatropin therapy|234|||
37884516|NCT01088399|69568988|FG001|Overall Study|Change to or start of somatropin therapy|17|||
37884517|NCT01088399|69568989|FG002|Overall Study|Change to or start of somatropin therapy|12|||
37884518|NCT01088399|69568987|FG000|Overall Study|Sponsor decision|1573|||
37884519|NCT01088399|69568988|FG001|Overall Study|Sponsor decision|298|||
37884520|NCT01088399|69568989|FG002|Overall Study|Sponsor decision|7|||
37884521|NCT01088399|69568987|FG000|Overall Study|Protocol Violation|10|||
37884522|NCT01088399|69568988|FG001|Overall Study|Protocol Violation|1|||
37884523|NCT01088399|69568989|FG002|Overall Study|Protocol Violation|0|||
37884524|NCT01088399|69568987|FG000|Overall Study|Enrollment criteria not met|48|||
37884525|NCT01088399|69568988|FG001|Overall Study|Enrollment criteria not met|119|||
37884526|NCT01088399|69568989|FG002|Overall Study|Enrollment criteria not met|70|||
37884527|NCT01088399|69568987|FG000|Overall Study|Study summary visit not completed|2398|||
37884528|NCT01088399|69568988|FG001|Overall Study|Study summary visit not completed|283|||
37884529|NCT01088399|69568989|FG002|Overall Study|Study summary visit not completed|80|||
37884530|NCT00598078|69568997|FG000|Period 2 (Day 2)|Adverse Event|1|||
37884531|NCT00598078|69568998|FG001|Period 2 (Day 2)|Adverse Event|0|||
37884532|NCT01079195|69569006|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
37884533|NCT01079195|69569006|FG000|Overall Study|No Documentation Available|437|||
37884534|NCT01079195|69569006|FG000|Overall Study|Adverse Event|157|||
37884535|NCT01079195|69569006|FG000|Overall Study|Reason Unknown|39|||
37884536|NCT01079195|69569006|FG000|Overall Study|Withdrawal by Subject|18|||
37884537|NCT01079195|69569006|FG000|Overall Study|Financial Reasons|15|||
37884538|NCT01079195|69569006|FG000|Overall Study|Lack of Effectiveness|12|||
37884539|NCT01079195|69569006|FG000|Overall Study|Physician Decision|4|||
37884540|NCT01079195|69569006|FG000|Overall Study|Improved Status of Participant|4|||
37884541|NCT01079195|69569006|FG000|Overall Study|No Follow-up Documentation Available|4|||
37884542|NCT01079195|69569006|FG000|Overall Study|Non-compliance|2|||
37695460|NCT02281357|69171789|FG000|Overall Study|Lost to Follow-up|1|||
37884543|NCT00883558|69569010|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
37884544|NCT00883558|69569011|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
37884545|NCT00883558|69569012|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
37884546|NCT00883558|69569010|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
37884547|NCT00883558|69569011|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
37884548|NCT00883558|69569012|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
37884549|NCT00883558|69569010|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
37884550|NCT00883558|69569011|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
37884551|NCT00883558|69569012|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
37884552|NCT00883558|69569010|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
37884553|NCT00883558|69569011|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
37884554|NCT00883558|69569012|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
37884555|NCT00883558|69569010|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
37884556|NCT00883558|69569011|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
37884557|NCT00883558|69569012|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
37884558|NCT00880750|69569020|FG000|First Intervention|Adverse Event|1|||
37884559|NCT00880750|69569021|FG001|First Intervention|Adverse Event|0|||
37884560|NCT00880750|69569020|FG000|First Intervention|Unable to collect urine|4|||
37884561|NCT00880750|69569021|FG001|First Intervention|Unable to collect urine|0|||
37884562|NCT00880750|69569020|FG000|First Intervention|Non-compliance with meals|0|||
37884563|NCT00880750|69569021|FG001|First Intervention|Non-compliance with meals|1|||
37884564|NCT00880750|69569020|FG000|First Intervention|Withdrawal by Subject|2|||
37884565|NCT00880750|69569021|FG001|First Intervention|Withdrawal by Subject|0|||
37884566|NCT00880750|69569020|FG000|First Intervention|Lost to Follow-up|2|||
37884567|NCT00880750|69569021|FG001|First Intervention|Lost to Follow-up|0|||
37884568|NCT00880750|69569020|FG000|Second Intervention|Withdrawal by Subject|2|||
37884569|NCT00880750|69569021|FG001|Second Intervention|Withdrawal by Subject|2|||
37884570|NCT00880750|69569020|FG000|Second Intervention|Protocol Violation|1|||
37884571|NCT00880750|69569021|FG001|Second Intervention|Protocol Violation|0|||
37884572|NCT00880750|69569020|FG000|Second Intervention|Unable to collect urine|1|||
37884573|NCT00880750|69569021|FG001|Second Intervention|Unable to collect urine|0|||
37884574|NCT00597766|69569030|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
37884575|NCT00597766|69569031|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
37884576|NCT00597766|69569032|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
37884577|NCT00597766|69569030|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
37884578|NCT00597766|69569031|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
37884579|NCT00597766|69569032|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
37884580|NCT00979992|69569040|FG000|Overall Study|Ineligible - inadequate pathology|1|||
37884581|NCT00979992|69569040|FG000|Overall Study|Ineligible - wrong cell type|2|||
37884582|NCT00979992|69569040|FG000|Overall Study|Refused - Never Treated|2|||
37884583|NCT01079741|69569049|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
37884584|NCT01079741|69569050|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
37884585|NCT01079741|69569051|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
37884586|NCT01079741|69569052|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
37884587|NCT01079741|69569053|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
37884588|NCT01079741|69569049|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
37884589|NCT01079741|69569050|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
37884590|NCT01079741|69569051|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
37884591|NCT01079741|69569052|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
37884592|NCT01079741|69569053|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
37884593|NCT01079663|69569067|FG000|Overall Study|Adverse Event|0|||
37884594|NCT01079663|69569068|FG001|Overall Study|Adverse Event|2|||
37884595|NCT01079663|69569067|FG000|Overall Study|Protocol Violation|0|||
37884596|NCT01079663|69569068|FG001|Overall Study|Protocol Violation|2|||
37884597|NCT00879814|69569078|FG000|Overall Study|Adverse Event|0|||
37884598|NCT00879814|69569079|FG001|Overall Study|Adverse Event|1|||
37884599|NCT00879814|69569080|FG002|Overall Study|Adverse Event|0|||
37884600|NCT00879814|69569081|FG003|Overall Study|Adverse Event|0|||
37884601|NCT00879814|69569078|FG000|Overall Study|Lost to Follow-up|1|||
37884602|NCT00879814|69569079|FG001|Overall Study|Lost to Follow-up|0|||
37884603|NCT00879814|69569080|FG002|Overall Study|Lost to Follow-up|0|||
37884604|NCT00879814|69569081|FG003|Overall Study|Lost to Follow-up|2|||
37884605|NCT00879814|69569078|FG000|Overall Study|Participant Failed to Return|0|||
37884606|NCT00879814|69569079|FG001|Overall Study|Participant Failed to Return|0|||
37884607|NCT00879814|69569080|FG002|Overall Study|Participant Failed to Return|0|||
37884608|NCT00879814|69569081|FG003|Overall Study|Participant Failed to Return|1|||
37884609|NCT00879814|69569078|FG000|Overall Study|Withdrawal by Subject|3|||
37884610|NCT00879814|69569079|FG001|Overall Study|Withdrawal by Subject|1|||
37884611|NCT00879814|69569080|FG002|Overall Study|Withdrawal by Subject|1|||
37884612|NCT00879814|69569081|FG003|Overall Study|Withdrawal by Subject|2|||
37884613|NCT00879814|69569078|FG000|Overall Study|Physician Decision|0|||
37884614|NCT00879814|69569079|FG001|Overall Study|Physician Decision|0|||
37884615|NCT00879814|69569080|FG002|Overall Study|Physician Decision|1|||
37695461|NCT02281357|69171790|FG001|Overall Study|Lost to Follow-up|0|||
37821446|NCT03100370|69501074|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
37821447|NCT03100370|69501075|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
37821448|NCT03100370|69501076|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
37821449|NCT02920008|69501086|FG000|Overall Study|Death|117|||
37821450|NCT02920008|69501087|FG001|Overall Study|Death|127|||
37821451|NCT02920008|69501086|FG000|Overall Study|Withdrawal by Subject|3|||
37821452|NCT02920008|69501087|FG001|Overall Study|Withdrawal by Subject|6|||
37884616|NCT00879814|69569081|FG003|Overall Study|Physician Decision|0|||
37884617|NCT00879814|69569078|FG000|Overall Study|Other|0|||
37884618|NCT00879814|69569079|FG001|Overall Study|Other|0|||
37884619|NCT00879814|69569080|FG002|Overall Study|Other|1|||
37986172|NCT00401726|69671874|FG000|Overall Study|Protocol Violation|6|||
37986173|NCT00401726|69671875|FG001|Overall Study|Protocol Violation|3|||
37986174|NCT00401726|69671874|FG000|Overall Study|Withdrawal by Subject|18|||
37986175|NCT00401726|69671875|FG001|Overall Study|Withdrawal by Subject|24|||
37884620|NCT00879814|69569081|FG003|Overall Study|Other|0|||
37884621|NCT01132664|69569096|FG000|Phase lb|Adverse Event|0|||
37884622|NCT01132664|69569097|FG001|Phase lb|Adverse Event|1|||
37884623|NCT01132664|69569098|FG002|Phase lb|Adverse Event|0|||
37884624|NCT01132664|69569099|FG003|Phase lb|Adverse Event|0|||
37884625|NCT01132664|69569100|FG004|Phase lb|Adverse Event|0|||
37884626|NCT01132664|69569096|FG000|Phase lb|Withdrawal by Subject|1|||
37884627|NCT01132664|69569097|FG001|Phase lb|Withdrawal by Subject|2|||
37884628|NCT01132664|69569098|FG002|Phase lb|Withdrawal by Subject|0|||
37884629|NCT01132664|69569099|FG003|Phase lb|Withdrawal by Subject|0|||
37884630|NCT01132664|69569100|FG004|Phase lb|Withdrawal by Subject|0|||
37884631|NCT01132664|69569096|FG000|Phase lb|Disease Progression|4|||
37884632|NCT01132664|69569097|FG001|Phase lb|Disease Progression|9|||
37884633|NCT01132664|69569098|FG002|Phase lb|Disease Progression|0|||
37884634|NCT01132664|69569099|FG003|Phase lb|Disease Progression|0|||
37884635|NCT01132664|69569100|FG004|Phase lb|Disease Progression|0|||
37884636|NCT01132664|69569096|FG000|Phase ll|Death|0|||
37884637|NCT01132664|69569097|FG001|Phase ll|Death|0|||
37884638|NCT01132664|69569098|FG002|Phase ll|Death|2|||
37884639|NCT01132664|69569099|FG003|Phase ll|Death|0|||
37884640|NCT01132664|69569100|FG004|Phase ll|Death|0|||
37884641|NCT01132664|69569096|FG000|Phase ll|Adverse Event|0|||
37884642|NCT01132664|69569097|FG001|Phase ll|Adverse Event|0|||
37884643|NCT01132664|69569098|FG002|Phase ll|Adverse Event|10|||
37884644|NCT01132664|69569099|FG003|Phase ll|Adverse Event|0|||
37986176|NCT00401726|69671874|FG000|Overall Study|Lack of Efficacy|4|||
37884645|NCT01132664|69569100|FG004|Phase ll|Adverse Event|0|||
37884646|NCT01132664|69569096|FG000|Phase ll|Withdrawal by Subject|0|||
37884647|NCT01132664|69569097|FG001|Phase ll|Withdrawal by Subject|0|||
37884648|NCT01132664|69569098|FG002|Phase ll|Withdrawal by Subject|3|||
37884649|NCT01132664|69569099|FG003|Phase ll|Withdrawal by Subject|0|||
37884650|NCT01132664|69569100|FG004|Phase ll|Withdrawal by Subject|0|||
37884651|NCT01132664|69569096|FG000|Phase ll|Disease progression|0|||
37884652|NCT01132664|69569097|FG001|Phase ll|Disease progression|0|||
37884653|NCT01132664|69569098|FG002|Phase ll|Disease progression|35|||
37884654|NCT01132664|69569099|FG003|Phase ll|Disease progression|0|||
37884655|NCT01132664|69569100|FG004|Phase ll|Disease progression|0|||
37884656|NCT01132664|69569096|FG000|BM Cohort|Disease progression|0|||
37884657|NCT01132664|69569097|FG001|BM Cohort|Disease progression|0|||
37884658|NCT01132664|69569098|FG002|BM Cohort|Disease progression|0|||
37986177|NCT00401726|69671875|FG001|Overall Study|Lack of Efficacy|6|||
37986178|NCT00401726|69671874|FG000|Overall Study|Protocol Deviation|9|||
37986179|NCT00401726|69671875|FG001|Overall Study|Protocol Deviation|4|||
37986180|NCT00371826|69671884|FG000|Core Phase (12 Months)|Adverse Event|15|||
37986181|NCT00371826|69671885|FG001|Core Phase (12 Months)|Adverse Event|4|||
37986182|NCT00371826|69671886|FG002|Core Phase (12 Months)|Adverse Event|9|||
37986183|NCT00371826|69671884|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
37986184|NCT00371826|69671885|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
37986185|NCT00371826|69671886|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
37986186|NCT00371826|69671884|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
37986187|NCT00371826|69671885|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
37986188|NCT00371826|69671886|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
37986189|NCT00371826|69671884|FG000|Core Phase (12 Months)|Protocol Violation|1|||
37884659|NCT01132664|69569099|FG003|BM Cohort|Disease progression|3|||
37884660|NCT01132664|69569100|FG004|BM Cohort|Disease progression|4|||
37986190|NCT00371826|69671885|FG001|Core Phase (12 Months)|Protocol Violation|0|||
37986191|NCT00371826|69671886|FG002|Core Phase (12 Months)|Protocol Violation|1|||
37986192|NCT00371826|69671884|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
37986193|NCT00371826|69671885|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
37821453|NCT02920008|69501086|FG000|Overall Study|Lost to Follow-up|0|||
37821454|NCT02920008|69501087|FG001|Overall Study|Lost to Follow-up|1|||
37821455|NCT02766335|69501095|FG000|Initial Registration|Adverse Event|6|||
37821456|NCT02766335|69501096|FG001|Initial Registration|Adverse Event|3|||
37821457|NCT02766335|69501097|FG002|Initial Registration|Adverse Event|0|||
37821458|NCT02766335|69501095|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
37821459|NCT02766335|69501096|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
37821460|NCT02766335|69501097|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
37821461|NCT02766335|69501095|FG000|Initial Registration|Progression/relapse|49|||
37821462|NCT02766335|69501096|FG001|Initial Registration|Progression/relapse|15|||
37821463|NCT02766335|69501097|FG002|Initial Registration|Progression/relapse|0|||
37884661|NCT01132664|69569096|FG000|BM Cohort|Adverse Event|0|||
37884662|NCT01132664|69569097|FG001|BM Cohort|Adverse Event|0|||
37884663|NCT01132664|69569098|FG002|BM Cohort|Adverse Event|0|||
37884664|NCT01132664|69569099|FG003|BM Cohort|Adverse Event|0|||
37884665|NCT01132664|69569100|FG004|BM Cohort|Adverse Event|1|||
37884666|NCT01132664|69569096|FG000|BM Cohort|Withdrawal by Subject|0|||
37884667|NCT01132664|69569097|FG001|BM Cohort|Withdrawal by Subject|0|||
37884668|NCT01132664|69569098|FG002|BM Cohort|Withdrawal by Subject|0|||
37884669|NCT01132664|69569099|FG003|BM Cohort|Withdrawal by Subject|0|||
37884670|NCT01132664|69569100|FG004|BM Cohort|Withdrawal by Subject|1|||
37884671|NCT00591409|69569122|FG000|Overall Study|Not Treated|0|||
37884672|NCT00591409|69569123|FG001|Overall Study|Not Treated|0|||
37884673|NCT00591409|69569124|FG002|Overall Study|Not Treated|0|||
37884674|NCT00591409|69569125|FG003|Overall Study|Not Treated|0|||
37884675|NCT00591409|69569126|FG004|Overall Study|Not Treated|1|||
37884676|NCT00591409|69569127|FG005|Overall Study|Not Treated|0|||
37884677|NCT00591409|69569128|FG006|Overall Study|Not Treated|0|||
37884678|NCT00591409|69569129|FG007|Overall Study|Not Treated|0|||
37884679|NCT00591409|69569130|FG008|Overall Study|Not Treated|0|||
37884680|NCT00591409|69569131|FG009|Overall Study|Not Treated|1|||
37884681|NCT01078805|69569153|FG000|Overall Study|Clinically significant abnormal lab|5|||
37884682|NCT01078805|69569153|FG000|Overall Study|Death|134|||
37884683|NCT01078805|69569153|FG000|Overall Study|Lost to Follow-up|676|||
37884684|NCT01078805|69569153|FG000|Overall Study|Physician Decision|169|||
37884685|NCT01078805|69569153|FG000|Overall Study|Serious adverse event|26|||
37884686|NCT01078805|69569153|FG000|Overall Study|Sponsor decision|46|||
37884687|NCT01078805|69569153|FG000|Overall Study|Withdrawal by Subject|739|||
37884688|NCT01078805|69569153|FG000|Overall Study|Other|173|||
37884689|NCT01078805|69569153|FG000|Overall Study|Didn't take study drug|82|||
37884690|NCT00820027|69569161|FG000|Overall Study|Adverse Event|15|||
37884691|NCT00820027|69569162|FG001|Overall Study|Adverse Event|8|||
37884692|NCT00820027|69569163|FG002|Overall Study|Adverse Event|10|||
37884693|NCT00820027|69569164|FG003|Overall Study|Adverse Event|5|||
37884694|NCT00820027|69569161|FG000|Overall Study|Lack of Efficacy|2|||
37884695|NCT00820027|69569162|FG001|Overall Study|Lack of Efficacy|1|||
37884696|NCT00820027|69569163|FG002|Overall Study|Lack of Efficacy|2|||
37884697|NCT00820027|69569164|FG003|Overall Study|Lack of Efficacy|2|||
37884698|NCT00820027|69569161|FG000|Overall Study|Physician Decision|0|||
37884699|NCT00820027|69569162|FG001|Overall Study|Physician Decision|1|||
37884700|NCT00820027|69569163|FG002|Overall Study|Physician Decision|1|||
37884701|NCT00820027|69569164|FG003|Overall Study|Physician Decision|0|||
37884702|NCT00820027|69569161|FG000|Overall Study|Protocol Violation|3|||
37884703|NCT00820027|69569162|FG001|Overall Study|Protocol Violation|0|||
37884704|NCT00820027|69569163|FG002|Overall Study|Protocol Violation|4|||
37884705|NCT00820027|69569164|FG003|Overall Study|Protocol Violation|0|||
37884706|NCT00820027|69569161|FG000|Overall Study|Withdrawal by Subject|6|||
37884707|NCT00820027|69569162|FG001|Overall Study|Withdrawal by Subject|4|||
37884708|NCT00820027|69569163|FG002|Overall Study|Withdrawal by Subject|4|||
37884709|NCT00820027|69569164|FG003|Overall Study|Withdrawal by Subject|6|||
37884710|NCT01076153|69569175|FG000|Overall Study|Symptoms improved/resolved|10|||
37884711|NCT01076153|69569175|FG000|Overall Study|Adverse Event|1|||
37884712|NCT01076075|69569185|FG000|Overall Study|Adverse Event|3|||
37884713|NCT01076075|69569186|FG001|Overall Study|Adverse Event|9|||
37884714|NCT01076075|69569185|FG000|Overall Study|Lack of Efficacy|5|||
37884715|NCT01076075|69569186|FG001|Overall Study|Lack of Efficacy|4|||
37884716|NCT01076075|69569185|FG000|Overall Study|Lost to Follow-up|6|||
37986194|NCT00371826|69671886|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
37986195|NCT00371826|69671884|FG000|Core Phase (12 Months)|Administrative problems|1|||
37986196|NCT00371826|69671885|FG001|Core Phase (12 Months)|Administrative problems|0|||
37986197|NCT00371826|69671886|FG002|Core Phase (12 Months)|Administrative problems|8|||
37986198|NCT00371826|69671884|FG000|Core Phase (12 Months)|Graft Loss|0|||
37986199|NCT00371826|69671885|FG001|Core Phase (12 Months)|Graft Loss|1|||
37986200|NCT00371826|69671886|FG002|Core Phase (12 Months)|Graft Loss|0|||
37884717|NCT01076075|69569186|FG001|Overall Study|Lost to Follow-up|5|||
37884718|NCT01076075|69569185|FG000|Overall Study|other|19|||
37884719|NCT01076075|69569186|FG001|Overall Study|other|9|||
37884720|NCT01076075|69569185|FG000|Overall Study|Protocol Violation|0|||
37884721|NCT01076075|69569186|FG001|Overall Study|Protocol Violation|1|||
37884722|NCT01076075|69569185|FG000|Overall Study|Withdrawal by Subject|8|||
37884723|NCT01076075|69569186|FG001|Overall Study|Withdrawal by Subject|19|||
37884724|NCT01075763|69569197|FG000|Overall Study|Lost to Follow-up|2|||
37884725|NCT01075763|69569198|FG001|Overall Study|Lost to Follow-up|1|||
37884726|NCT01075763|69569197|FG000|Overall Study|Lack of Efficacy|0|||
37986201|NCT00371826|69671884|FG000|Extension Phase (24 Months)|Adverse Event|4|||
37986202|NCT00371826|69671885|FG001|Extension Phase (24 Months)|Adverse Event|5|||
37986203|NCT00371826|69671886|FG002|Extension Phase (24 Months)|Adverse Event|0|||
37884727|NCT01075763|69569198|FG001|Overall Study|Lack of Efficacy|1|||
37884728|NCT01075763|69569197|FG000|Overall Study|Withdrawal by Subject|2|||
37884729|NCT01075763|69569198|FG001|Overall Study|Withdrawal by Subject|2|||
37884730|NCT00881530|69569210|FG000|Overall Study|Adverse Event|5|||
37884731|NCT00881530|69569211|FG001|Overall Study|Adverse Event|1|||
37884732|NCT00881530|69569212|FG002|Overall Study|Adverse Event|1|||
37884733|NCT00881530|69569213|FG003|Overall Study|Adverse Event|4|||
37884734|NCT00881530|69569214|FG004|Overall Study|Adverse Event|10|||
37884735|NCT00881530|69569215|FG005|Overall Study|Adverse Event|2|||
37884736|NCT00881530|69569210|FG000|Overall Study|Lack of Efficacy|1|||
37884737|NCT00881530|69569211|FG001|Overall Study|Lack of Efficacy|0|||
37884738|NCT00881530|69569212|FG002|Overall Study|Lack of Efficacy|0|||
37884739|NCT00881530|69569213|FG003|Overall Study|Lack of Efficacy|0|||
37884740|NCT00881530|69569214|FG004|Overall Study|Lack of Efficacy|1|||
37884741|NCT00881530|69569215|FG005|Overall Study|Lack of Efficacy|1|||
37884742|NCT00881530|69569210|FG000|Overall Study|Not compliant with the protocol|0|||
37884743|NCT00881530|69569211|FG001|Overall Study|Not compliant with the protocol|0|||
37884744|NCT00881530|69569212|FG002|Overall Study|Not compliant with the protocol|0|||
37884745|NCT00881530|69569213|FG003|Overall Study|Not compliant with the protocol|0|||
37884746|NCT00881530|69569214|FG004|Overall Study|Not compliant with the protocol|2|||
37884747|NCT00881530|69569215|FG005|Overall Study|Not compliant with the protocol|0|||
37884748|NCT00881530|69569210|FG000|Overall Study|Lost to Follow-up|0|||
37884749|NCT00881530|69569211|FG001|Overall Study|Lost to Follow-up|1|||
37884750|NCT00881530|69569212|FG002|Overall Study|Lost to Follow-up|1|||
37884751|NCT00881530|69569213|FG003|Overall Study|Lost to Follow-up|3|||
37884752|NCT00881530|69569214|FG004|Overall Study|Lost to Follow-up|1|||
37884753|NCT00881530|69569215|FG005|Overall Study|Lost to Follow-up|0|||
37884754|NCT00881530|69569210|FG000|Overall Study|Refused to continue medication|7|||
37884755|NCT00881530|69569211|FG001|Overall Study|Refused to continue medication|2|||
37884756|NCT00881530|69569212|FG002|Overall Study|Refused to continue medication|1|||
37884757|NCT00881530|69569213|FG003|Overall Study|Refused to continue medication|2|||
37884758|NCT00881530|69569214|FG004|Overall Study|Refused to continue medication|0|||
37884759|NCT00881530|69569215|FG005|Overall Study|Refused to continue medication|0|||
37884760|NCT00881530|69569210|FG000|Overall Study|Other reason not defined above|1|||
37884761|NCT00881530|69569211|FG001|Overall Study|Other reason not defined above|1|||
37884762|NCT00881530|69569212|FG002|Overall Study|Other reason not defined above|2|||
37884763|NCT00881530|69569213|FG003|Overall Study|Other reason not defined above|0|||
37884764|NCT00881530|69569214|FG004|Overall Study|Other reason not defined above|0|||
37695462|NCT02281357|69171789|FG000|Overall Study|Withdrawal by Subject|4|||
37695463|NCT02281357|69171790|FG001|Overall Study|Withdrawal by Subject|3|||
37695464|NCT02284243|69171798|FG000|Overall Study|Lack of Efficacy|3|||
37695465|NCT02284243|69171799|FG001|Overall Study|Lack of Efficacy|3|||
37695466|NCT02284243|69171798|FG000|Overall Study|Adverse Event|1|||
37695467|NCT02284243|69171799|FG001|Overall Study|Adverse Event|0|||
37986204|NCT00371826|69671884|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
37986205|NCT00371826|69671885|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
37986206|NCT00371826|69671886|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
37986207|NCT00371826|69671884|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
37986208|NCT00371826|69671885|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
37986209|NCT00371826|69671886|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
37986210|NCT00371826|69671884|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
37695468|NCT02284009|69171807|FG000|Overall Study|Adverse Event|3|||
37695469|NCT02284009|69171808|FG001|Overall Study|Adverse Event|0|||
37695470|NCT02284009|69171807|FG000|Overall Study|Lost to Follow-up|1|||
37695471|NCT02284009|69171808|FG001|Overall Study|Lost to Follow-up|3|||
37695472|NCT02284009|69171807|FG000|Overall Study|Physician Decision|0|||
37695473|NCT02284009|69171808|FG001|Overall Study|Physician Decision|2|||
37695474|NCT02284009|69171807|FG000|Overall Study|Withdrawal by Subject|2|||
37695475|NCT02284009|69171808|FG001|Overall Study|Withdrawal by Subject|5|||
37695476|NCT02280499|69171816|FG000|Overall Study|Death|14|||
37695477|NCT02280499|69171816|FG000|Overall Study|Lost to Follow-up|42|||
37695478|NCT02280499|69171816|FG000|Overall Study|Adverse Event|5|||
37695479|NCT02400476|69171826|FG000|Overall Study|Adverse Event|57|||
37695480|NCT02400476|69171827|FG001|Overall Study|Adverse Event|10|||
37986211|NCT00371826|69671885|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
37986212|NCT00371826|69671886|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
37986213|NCT00371826|69671884|FG000|Extension Phase (24 Months)|Administrative problems|0|||
37695481|NCT02400476|69171828|FG002|Overall Study|Adverse Event|22|||
37695482|NCT02400476|69171829|FG003|Overall Study|Adverse Event|19|||
37695483|NCT02400476|69171830|FG004|Overall Study|Adverse Event|5|||
37695484|NCT02400476|69171831|FG005|Overall Study|Adverse Event|8|||
37695485|NCT02400476|69171826|FG000|Overall Study|Withdrawal by Subject|4|||
37695486|NCT02400476|69171827|FG001|Overall Study|Withdrawal by Subject|1|||
37695487|NCT02400476|69171828|FG002|Overall Study|Withdrawal by Subject|12|||
37695488|NCT02400476|69171829|FG003|Overall Study|Withdrawal by Subject|7|||
37695489|NCT02400476|69171830|FG004|Overall Study|Withdrawal by Subject|5|||
37695490|NCT02400476|69171831|FG005|Overall Study|Withdrawal by Subject|5|||
37695491|NCT02400476|69171826|FG000|Overall Study|Lost to Follow-up|0|||
37695492|NCT02400476|69171827|FG001|Overall Study|Lost to Follow-up|0|||
37695493|NCT02400476|69171828|FG002|Overall Study|Lost to Follow-up|0|||
37695494|NCT02400476|69171829|FG003|Overall Study|Lost to Follow-up|1|||
37695495|NCT02400476|69171830|FG004|Overall Study|Lost to Follow-up|3|||
37695496|NCT02400476|69171831|FG005|Overall Study|Lost to Follow-up|1|||
37695497|NCT02400476|69171826|FG000|Overall Study|Physician Decision|0|||
37695498|NCT02400476|69171827|FG001|Overall Study|Physician Decision|0|||
37695499|NCT02400476|69171828|FG002|Overall Study|Physician Decision|1|||
37695500|NCT02400476|69171829|FG003|Overall Study|Physician Decision|1|||
37695501|NCT02400476|69171830|FG004|Overall Study|Physician Decision|0|||
37695502|NCT02400476|69171831|FG005|Overall Study|Physician Decision|1|||
37695503|NCT02400476|69171826|FG000|Overall Study|Other, Disease Progression|0|||
37695504|NCT02400476|69171827|FG001|Overall Study|Other, Disease Progression|1|||
37695505|NCT02400476|69171828|FG002|Overall Study|Other, Disease Progression|2|||
37695506|NCT02400476|69171829|FG003|Overall Study|Other, Disease Progression|1|||
37695507|NCT02400476|69171830|FG004|Overall Study|Other, Disease Progression|2|||
37695508|NCT02400476|69171831|FG005|Overall Study|Other, Disease Progression|1|||
37695509|NCT02400476|69171826|FG000|Overall Study|Other, Decreased Quality of Life|0|||
37695510|NCT02400476|69171827|FG001|Overall Study|Other, Decreased Quality of Life|0|||
37695511|NCT02400476|69171828|FG002|Overall Study|Other, Decreased Quality of Life|2|||
37695512|NCT02400476|69171829|FG003|Overall Study|Other, Decreased Quality of Life|0|||
37695513|NCT02400476|69171830|FG004|Overall Study|Other, Decreased Quality of Life|0|||
37695514|NCT02400476|69171831|FG005|Overall Study|Other, Decreased Quality of Life|0|||
37695515|NCT02400476|69171826|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
37695516|NCT02400476|69171827|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
37695517|NCT02400476|69171828|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
37821464|NCT02766335|69501095|FG000|Initial Registration|Death|1|||
37821465|NCT02766335|69501096|FG001|Initial Registration|Death|3|||
37821466|NCT02766335|69501097|FG002|Initial Registration|Death|0|||
37821467|NCT02766335|69501095|FG000|Initial Registration|not protocol specified|1|||
37821468|NCT02766335|69501096|FG001|Initial Registration|not protocol specified|9|||
37821469|NCT02766335|69501097|FG002|Initial Registration|not protocol specified|0|||
37821470|NCT02766335|69501095|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
37821471|NCT02766335|69501096|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
37884765|NCT00881530|69569215|FG005|Overall Study|Other reason not defined above|2|||
37884766|NCT01075685|69569231|FG000|Overall Study|Protocol Violation|9|||
37884767|NCT01075685|69569232|FG001|Overall Study|Protocol Violation|1|||
37884768|NCT01075685|69569231|FG000|Overall Study|Withdrawal by Subject|20|||
37884769|NCT01075685|69569232|FG001|Overall Study|Withdrawal by Subject|5|||
37884770|NCT01075685|69569231|FG000|Overall Study|Lost to Follow-up|563|||
37884771|NCT01075685|69569232|FG001|Overall Study|Lost to Follow-up|220|||
37884772|NCT01075217|69569240|FG000|Overall Study|Adverse Event|1|||
37884773|NCT01075217|69569241|FG001|Overall Study|Adverse Event|1|||
37884774|NCT01075217|69569240|FG000|Overall Study|Physician Decision|1|||
37884775|NCT01075217|69569241|FG001|Overall Study|Physician Decision|0|||
37884776|NCT01078571|69569255|FG000|Overall Study|Adverse Event|36|||
37986214|NCT00371826|69671885|FG001|Extension Phase (24 Months)|Administrative problems|0|||
37986215|NCT00371826|69671886|FG002|Extension Phase (24 Months)|Administrative problems|2|||
37986216|NCT00396084|69671900|FG000|Overall Study|Adverse Event|0|||
37986217|NCT00396084|69671901|FG001|Overall Study|Adverse Event|0|||
37986218|NCT00396084|69671902|FG002|Overall Study|Adverse Event|0|||
37986219|NCT00396084|69671903|FG003|Overall Study|Adverse Event|0|||
37986220|NCT00396084|69671904|FG004|Overall Study|Adverse Event|1|||
37986221|NCT00396084|69671905|FG005|Overall Study|Adverse Event|2|||
37986222|NCT00396084|69671900|FG000|Overall Study|Withdrawal by Subject|0|||
37986223|NCT00396084|69671901|FG001|Overall Study|Withdrawal by Subject|0|||
37884777|NCT01078571|69569255|FG000|Overall Study|Lack of effectiveness|36|||
37884778|NCT01078571|69569255|FG000|Overall Study|Reason not reported|21|||
37986224|NCT00396084|69671902|FG002|Overall Study|Withdrawal by Subject|0|||
37986225|NCT00396084|69671903|FG003|Overall Study|Withdrawal by Subject|1|||
37986226|NCT00396084|69671904|FG004|Overall Study|Withdrawal by Subject|0|||
37986227|NCT00396084|69671905|FG005|Overall Study|Withdrawal by Subject|0|||
37986228|NCT00395850|69671927|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
37986229|NCT00395850|69671928|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
37986230|NCT00395850|69671929|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
37986231|NCT00395850|69671930|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
37986232|NCT00395850|69671927|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
37986233|NCT00395850|69671928|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
37986234|NCT00395850|69671929|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
37986235|NCT00395850|69671930|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
37986236|NCT00395850|69671927|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
37986237|NCT00395850|69671928|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
37986238|NCT00395850|69671929|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
37986239|NCT00395850|69671930|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
37986240|NCT00395850|69671927|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
37986241|NCT00395850|69671928|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
37986242|NCT00395850|69671929|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
37986243|NCT00395850|69671930|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
37986244|NCT00395850|69671927|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
37986245|NCT00395850|69671928|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
37986246|NCT00395850|69671929|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
37986247|NCT00395850|69671930|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
37884779|NCT01078571|69569255|FG000|Overall Study|Withdrawal by Subject|12|||
37884780|NCT01078571|69569255|FG000|Overall Study|Lost to Follow-up|8|||
37884781|NCT01078571|69569255|FG000|Overall Study|Protocol Violation|2|||
37986248|NCT00395850|69671927|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
37986249|NCT00395850|69671928|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
37986250|NCT00395850|69671929|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
37986251|NCT00395850|69671930|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
37986252|NCT00395850|69671927|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
37986253|NCT00395850|69671928|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
37986254|NCT00395850|69671929|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
37986255|NCT00395850|69671930|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
37986256|NCT00420212|69671943|FG000|Overall Study|Adverse Event|22|||
37986257|NCT00420212|69671944|FG001|Overall Study|Adverse Event|40|||
37986258|NCT00420212|69671945|FG002|Overall Study|Adverse Event|36|||
37986259|NCT00420212|69671943|FG000|Overall Study|Lost to Follow-up|9|||
37884782|NCT00977106|69569266|FG000|Overall Study|Adverse Event|5|||
37884783|NCT00977106|69569267|FG001|Overall Study|Adverse Event|6|||
37884784|NCT00977106|69569266|FG000|Overall Study|Withdrawal by Subject|2|||
37884785|NCT00977106|69569267|FG001|Overall Study|Withdrawal by Subject|2|||
37884786|NCT00977106|69569266|FG000|Overall Study|Lack of Efficacy|2|||
37884787|NCT00977106|69569267|FG001|Overall Study|Lack of Efficacy|2|||
37884788|NCT00977106|69569266|FG000|Overall Study|Protocol Violation|0|||
37884789|NCT00977106|69569267|FG001|Overall Study|Protocol Violation|1|||
37884790|NCT00977106|69569266|FG000|Overall Study|Other|1|||
37884791|NCT00977106|69569267|FG001|Overall Study|Other|0|||
37884792|NCT01077713|69569277|FG000|Overall Study|Withdrawal by Subject|1|||
37884793|NCT01077713|69569278|FG001|Overall Study|Withdrawal by Subject|2|||
37884794|NCT01077713|69569277|FG000|Overall Study|Progressive Disease (PD)|0|||
37884795|NCT01077713|69569278|FG001|Overall Study|Progressive Disease (PD)|1|||
37884796|NCT01077713|69569277|FG000|Overall Study|Death|28|||
37884797|NCT01077713|69569278|FG001|Overall Study|Death|29|||
37884798|NCT01077713|69569277|FG000|Overall Study|Lost to Follow-up|1|||
37884799|NCT01077713|69569278|FG001|Overall Study|Lost to Follow-up|1|||
37884800|NCT01077713|69569277|FG000|Overall Study|Adverse Event|2|||
37884801|NCT01077713|69569278|FG001|Overall Study|Adverse Event|1|||
37884802|NCT01077713|69569277|FG000|Overall Study|Other|4|||
37884803|NCT01077713|69569278|FG001|Overall Study|Other|2|||
37884804|NCT00813709|69569287|FG000|Double Blind Period|Adverse Event|4|||
37884805|NCT00813709|69569288|FG001|Double Blind Period|Adverse Event|1|||
37884806|NCT00813709|69569289|FG002|Double Blind Period|Adverse Event|4|||
37884807|NCT00813709|69569290|FG003|Double Blind Period|Adverse Event|0|||
37884808|NCT00813709|69569291|FG004|Double Blind Period|Adverse Event|0|||
37884809|NCT00813709|69569292|FG005|Double Blind Period|Adverse Event|0|||
37884810|NCT00813709|69569287|FG000|Double Blind Period|Lost to Follow-up|3|||
37884811|NCT00813709|69569288|FG001|Double Blind Period|Lost to Follow-up|2|||
37884812|NCT00813709|69569289|FG002|Double Blind Period|Lost to Follow-up|2|||
37884813|NCT00813709|69569290|FG003|Double Blind Period|Lost to Follow-up|0|||
37884814|NCT00813709|69569291|FG004|Double Blind Period|Lost to Follow-up|0|||
37884815|NCT00813709|69569292|FG005|Double Blind Period|Lost to Follow-up|0|||
37884816|NCT00813709|69569287|FG000|Double Blind Period|Switched to open label phase|9|||
37884817|NCT00813709|69569288|FG001|Double Blind Period|Switched to open label phase|26|||
37884818|NCT00813709|69569289|FG002|Double Blind Period|Switched to open label phase|18|||
37884819|NCT00813709|69569290|FG003|Double Blind Period|Switched to open label phase|0|||
37986260|NCT00420212|69671944|FG001|Overall Study|Lost to Follow-up|11|||
37884820|NCT00813709|69569291|FG004|Double Blind Period|Switched to open label phase|0|||
37884821|NCT00813709|69569292|FG005|Double Blind Period|Switched to open label phase|0|||
37986261|NCT00420212|69671945|FG002|Overall Study|Lost to Follow-up|11|||
37986262|NCT00420212|69671943|FG000|Overall Study|Withdrawal by Subject|31|||
37884822|NCT00813709|69569287|FG000|Double Blind Period|Randomized but not treated|1|||
37884823|NCT00813709|69569288|FG001|Double Blind Period|Randomized but not treated|3|||
37884824|NCT00813709|69569289|FG002|Double Blind Period|Randomized but not treated|1|||
37884825|NCT00813709|69569290|FG003|Double Blind Period|Randomized but not treated|0|||
37884826|NCT00813709|69569291|FG004|Double Blind Period|Randomized but not treated|0|||
37884827|NCT00813709|69569292|FG005|Double Blind Period|Randomized but not treated|0|||
37884828|NCT00813709|69569287|FG000|Double Blind Period|Other|14|||
37884829|NCT00813709|69569288|FG001|Double Blind Period|Other|9|||
37986263|NCT00420212|69671944|FG001|Overall Study|Withdrawal by Subject|22|||
37986264|NCT00420212|69671945|FG002|Overall Study|Withdrawal by Subject|19|||
37986265|NCT00420212|69671943|FG000|Overall Study|Physician Decision|4|||
37986266|NCT00420212|69671944|FG001|Overall Study|Physician Decision|4|||
37884830|NCT00813709|69569289|FG002|Double Blind Period|Other|6|||
37884831|NCT00813709|69569290|FG003|Double Blind Period|Other|0|||
37884832|NCT00813709|69569291|FG004|Double Blind Period|Other|0|||
37884833|NCT00813709|69569292|FG005|Double Blind Period|Other|0|||
37884834|NCT00813709|69569287|FG000|Open Label Period|Adverse Event|0|||
37884835|NCT00813709|69569288|FG001|Open Label Period|Adverse Event|0|||
37884836|NCT00813709|69569289|FG002|Open Label Period|Adverse Event|0|||
37884837|NCT00813709|69569290|FG003|Open Label Period|Adverse Event|5|||
37884838|NCT00813709|69569291|FG004|Open Label Period|Adverse Event|4|||
37884839|NCT00813709|69569292|FG005|Open Label Period|Adverse Event|3|||
37884840|NCT00813709|69569287|FG000|Open Label Period|Lack of Efficacy|0|||
37884841|NCT00813709|69569288|FG001|Open Label Period|Lack of Efficacy|0|||
37884842|NCT00813709|69569289|FG002|Open Label Period|Lack of Efficacy|0|||
37884843|NCT00813709|69569290|FG003|Open Label Period|Lack of Efficacy|3|||
37884844|NCT00813709|69569291|FG004|Open Label Period|Lack of Efficacy|1|||
37884845|NCT00813709|69569292|FG005|Open Label Period|Lack of Efficacy|1|||
37884846|NCT00813709|69569287|FG000|Open Label Period|Randomized but not treated|0|||
37986267|NCT00420212|69671945|FG002|Overall Study|Physician Decision|3|||
37986268|NCT00420212|69671943|FG000|Overall Study|Protocol Violation|4|||
37986269|NCT00420212|69671944|FG001|Overall Study|Protocol Violation|4|||
37986270|NCT00420212|69671945|FG002|Overall Study|Protocol Violation|8|||
37986271|NCT00420212|69671943|FG000|Overall Study|Death|0|||
37986272|NCT00420212|69671944|FG001|Overall Study|Death|0|||
37986273|NCT00420212|69671945|FG002|Overall Study|Death|1|||
37986274|NCT00420212|69671943|FG000|Overall Study|Other-Unspecified|21|||
37884847|NCT00813709|69569288|FG001|Open Label Period|Randomized but not treated|0|||
37884848|NCT00813709|69569289|FG002|Open Label Period|Randomized but not treated|0|||
37884849|NCT00813709|69569290|FG003|Open Label Period|Randomized but not treated|1|||
37884850|NCT00813709|69569291|FG004|Open Label Period|Randomized but not treated|0|||
37884851|NCT00813709|69569292|FG005|Open Label Period|Randomized but not treated|1|||
37884852|NCT00813709|69569287|FG000|Open Label Period|Other|0|||
37884853|NCT00813709|69569288|FG001|Open Label Period|Other|0|||
37986275|NCT00420212|69671944|FG001|Overall Study|Other-Unspecified|14|||
37986276|NCT00420212|69671945|FG002|Overall Study|Other-Unspecified|18|||
37884854|NCT00813709|69569289|FG002|Open Label Period|Other|0|||
37884855|NCT00813709|69569290|FG003|Open Label Period|Other|11|||
37986277|NCT00401258|69671956|FG000|Overall Study|Adverse Event|7|||
37986278|NCT00380874|69671962|FG000|Overall Study|Adverse Event|7|||
37986279|NCT00380874|69671963|FG001|Overall Study|Adverse Event|7|||
37986280|NCT00380874|69671962|FG000|Overall Study|Death|1|||
37884856|NCT00813709|69569291|FG004|Open Label Period|Other|5|||
37884857|NCT00813709|69569292|FG005|Open Label Period|Other|6|||
37986281|NCT00380874|69671963|FG001|Overall Study|Death|0|||
37986282|NCT00380874|69671962|FG000|Overall Study|Withdrawal by Subject|2|||
37986283|NCT00380874|69671963|FG001|Overall Study|Withdrawal by Subject|1|||
37884858|NCT01077323|69569324|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
37986284|NCT00380874|69671962|FG000|Overall Study|Not related to study drug|3|||
37986285|NCT00380874|69671963|FG001|Overall Study|Not related to study drug|2|||
37884859|NCT01077323|69569325|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
37884860|NCT01077323|69569326|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
37884861|NCT01077323|69569324|FG000|Overall Study|Dispensing of drug in baseline period|0|||
37884862|NCT01077323|69569325|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
37884863|NCT01077323|69569326|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
37884864|NCT01077323|69569324|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
37884865|NCT01077323|69569325|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
37884866|NCT01077323|69569326|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
37884867|NCT00976950|69569334|FG000|Overall Study|Adverse Event|3|||
37884868|NCT00976950|69569334|FG000|Overall Study|Events with no relationship to Aptivus|3|||
37884869|NCT00976716|69569338|FG000|Overall Study|Adverse Event|1|||
37884870|NCT00973674|69569345|FG000|Overall Study|Protocol Violation|2|||
37884871|NCT00973674|69569346|FG001|Overall Study|Protocol Violation|0|||
37884872|NCT00819091|69569355|FG000|Overall Study|Adverse Event|3|||
37884873|NCT00819091|69569356|FG001|Overall Study|Adverse Event|5|||
37884874|NCT00819091|69569355|FG000|Overall Study|Protocol Violation|0|||
37884875|NCT00819091|69569356|FG001|Overall Study|Protocol Violation|1|||
37884876|NCT00819091|69569355|FG000|Overall Study|Lost to Follow-up|2|||
37884877|NCT00819091|69569356|FG001|Overall Study|Lost to Follow-up|0|||
37884878|NCT00819091|69569355|FG000|Overall Study|Withdrawal by Subject|1|||
37884879|NCT00819091|69569356|FG001|Overall Study|Withdrawal by Subject|2|||
37884880|NCT00819091|69569355|FG000|Overall Study|Other|1|||
37884881|NCT00819091|69569356|FG001|Overall Study|Other|2|||
37884882|NCT00973362|69569364|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
37986286|NCT00420056|69671969|FG000|Overall Study|Objective progression or relapse|17|||
37986287|NCT00411554|69671975|FG000|Overall Study|Adverse Event|2|||
37986288|NCT00411554|69671976|FG001|Overall Study|Adverse Event|4|||
37986289|NCT00411554|69671975|FG000|Overall Study|Lack of Efficacy|2|||
37986290|NCT00411554|69671976|FG001|Overall Study|Lack of Efficacy|5|||
37986291|NCT00411554|69671975|FG000|Overall Study|Withdrawal by Subject|3|||
37986292|NCT00411554|69671976|FG001|Overall Study|Withdrawal by Subject|0|||
37986293|NCT00411554|69671975|FG000|Overall Study|Patient Moved|1|||
37884883|NCT00973362|69569365|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
37884884|NCT00973362|69569364|FG000|Baseline Evaluation|No colposcopy visit|62|||
37884885|NCT00973362|69569365|FG001|Baseline Evaluation|No colposcopy visit|0|||
37884886|NCT00973362|69569364|FG000|Baseline Evaluation|Inevaluable|686|||
37884887|NCT00973362|69569365|FG001|Baseline Evaluation|Inevaluable|223|||
37884888|NCT00973362|69569364|FG000|3-Year Follow-up|Lost to Follow-up|17|||
37884889|NCT00973362|69569365|FG001|3-Year Follow-up|Lost to Follow-up|0|||
37884890|NCT00819013|69569378|FG000|Overall Study|Not meeting continuing study eligibility|2|||
37884891|NCT00819013|69569379|FG001|Overall Study|Not meeting continuing study eligibility|1|||
37884892|NCT00819013|69569380|FG002|Overall Study|Not meeting continuing study eligibility|2|||
37884893|NCT00819013|69569381|FG003|Overall Study|Not meeting continuing study eligibility|1|||
37884894|NCT00819013|69569378|FG000|Overall Study|Adverse Event|0|||
37986294|NCT00411554|69671976|FG001|Overall Study|Patient Moved|0|||
37884895|NCT00819013|69569379|FG001|Overall Study|Adverse Event|0|||
37884896|NCT00819013|69569380|FG002|Overall Study|Adverse Event|1|||
37884897|NCT00819013|69569381|FG003|Overall Study|Adverse Event|0|||
37884898|NCT00819013|69569378|FG000|Overall Study|Withdrawal by Subject|1|||
37986295|NCT00400712|69671984|FG000|Overall Study|Death|1|||
37986296|NCT00400712|69671985|FG001|Overall Study|Death|0|||
37986297|NCT00400712|69671984|FG000|Overall Study|Withdrawal by Subject|11|||
37986298|NCT00400712|69671985|FG001|Overall Study|Withdrawal by Subject|12|||
37986299|NCT00400712|69671984|FG000|Overall Study|Physician Decision|5|||
37986300|NCT00400712|69671985|FG001|Overall Study|Physician Decision|4|||
37884899|NCT00819013|69569379|FG001|Overall Study|Withdrawal by Subject|0|||
37884900|NCT00819013|69569380|FG002|Overall Study|Withdrawal by Subject|1|||
37884901|NCT00819013|69569381|FG003|Overall Study|Withdrawal by Subject|0|||
37884902|NCT00819013|69569378|FG000|Overall Study|Lost to Follow-up|0|||
37884903|NCT00819013|69569379|FG001|Overall Study|Lost to Follow-up|0|||
37884904|NCT00819013|69569380|FG002|Overall Study|Lost to Follow-up|1|||
37884905|NCT00819013|69569381|FG003|Overall Study|Lost to Follow-up|2|||
37884906|NCT00819013|69569378|FG000|Overall Study|Death|0|||
37884907|NCT00819013|69569379|FG001|Overall Study|Death|0|||
37884908|NCT00819013|69569380|FG002|Overall Study|Death|0|||
37884909|NCT00819013|69569381|FG003|Overall Study|Death|1|||
37884910|NCT00976560|69569393|FG000|Overall Study|Adverse Event|5|||
37884911|NCT00976560|69569394|FG001|Overall Study|Adverse Event|5|||
37884912|NCT00976560|69569393|FG000|Overall Study|Lack of Efficacy|3|||
37884913|NCT00976560|69569394|FG001|Overall Study|Lack of Efficacy|5|||
37884914|NCT00976560|69569393|FG000|Overall Study|Protocol Violation|1|||
37884915|NCT00976560|69569394|FG001|Overall Study|Protocol Violation|0|||
37884916|NCT00976560|69569393|FG000|Overall Study|Lost to Follow-up|1|||
37884917|NCT00976560|69569394|FG001|Overall Study|Lost to Follow-up|0|||
37884918|NCT00976560|69569393|FG000|Overall Study|Physician Decision|2|||
37884919|NCT00976560|69569394|FG001|Overall Study|Physician Decision|0|||
37884920|NCT00976560|69569393|FG000|Overall Study|Withdrawal by Subject|2|||
37884921|NCT00976560|69569394|FG001|Overall Study|Withdrawal by Subject|3|||
37884922|NCT00976482|69569400|FG000|Overall Study|Death|208|||
37884923|NCT00976482|69569400|FG000|Overall Study|Withdrawal by Subject|45|||
37884924|NCT00976482|69569400|FG000|Overall Study|Center terminated|1|||
37884925|NCT00976482|69569400|FG000|Overall Study|Protocol Violation|5|||
37884926|NCT00975156|69569406|FG000|Overall Study|Protocol Violation|0|||
37884927|NCT00975156|69569407|FG001|Overall Study|Protocol Violation|1|||
37884928|NCT00810043|69569419|FG000|Overall Study|Withdrawal by Subject|1|||
37884929|NCT00810043|69569420|FG001|Overall Study|Withdrawal by Subject|0|||
37884930|NCT00810043|69569421|FG002|Overall Study|Withdrawal by Subject|2|||
37986301|NCT00380718|69671993|FG000|Overall Study|Adverse Event|1|||
37695518|NCT02400476|69171829|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
37884931|NCT00810043|69569419|FG000|Overall Study|Lost to Follow-up|1|||
37986302|NCT00380718|69671993|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
37884932|NCT00810043|69569420|FG001|Overall Study|Lost to Follow-up|0|||
37884933|NCT00810043|69569421|FG002|Overall Study|Lost to Follow-up|0|||
37884934|NCT00810043|69569419|FG000|Overall Study|Physician Decision|0|||
37884935|NCT00810043|69569420|FG001|Overall Study|Physician Decision|0|||
37884936|NCT00810043|69569421|FG002|Overall Study|Physician Decision|2|||
37986303|NCT00380250|69671999|FG000|Overall Study|Withdrawal by Subject|39|||
37884937|NCT00810043|69569419|FG000|Overall Study|Death|2|||
37884938|NCT00810043|69569420|FG001|Overall Study|Death|0|||
37884939|NCT00810043|69569421|FG002|Overall Study|Death|0|||
37884940|NCT00810043|69569419|FG000|Overall Study|Unrelated medical problem|0|||
37986304|NCT00380250|69672000|FG001|Overall Study|Withdrawal by Subject|28|||
37986305|NCT00380250|69671999|FG000|Overall Study|Adverse Event|20|||
37986306|NCT00380250|69672000|FG001|Overall Study|Adverse Event|9|||
37986307|NCT00380250|69671999|FG000|Overall Study|Lack of Efficacy|10|||
37986308|NCT00380250|69672000|FG001|Overall Study|Lack of Efficacy|8|||
37986309|NCT00380250|69671999|FG000|Overall Study|Protocol Violation|15|||
37986310|NCT00380250|69672000|FG001|Overall Study|Protocol Violation|5|||
37986311|NCT00380250|69671999|FG000|Overall Study|Lost to Follow-up|14|||
37986312|NCT00380250|69672000|FG001|Overall Study|Lost to Follow-up|5|||
37986313|NCT00380250|69671999|FG000|Overall Study|Physician Decision|1|||
37986314|NCT00380250|69672000|FG001|Overall Study|Physician Decision|0|||
37986315|NCT00400400|69672008|FG000|Overall Study|Adverse Event|9|||
37986316|NCT00400400|69672009|FG001|Overall Study|Adverse Event|8|||
37986317|NCT00400400|69672008|FG000|Overall Study|Protocol Violation|2|||
37986318|NCT00400400|69672009|FG001|Overall Study|Protocol Violation|0|||
37986319|NCT00400400|69672008|FG000|Overall Study|Withdrawal by Subject|1|||
37986320|NCT00400400|69672009|FG001|Overall Study|Withdrawal by Subject|3|||
37986321|NCT00400400|69672008|FG000|Overall Study|Administrative Problem|1|||
37986322|NCT00400400|69672009|FG001|Overall Study|Administrative Problem|0|||
37986323|NCT00400400|69672008|FG000|Overall Study|Lost to Follow-up|0|||
37986324|NCT00400400|69672009|FG001|Overall Study|Lost to Follow-up|1|||
37986325|NCT00400400|69672008|FG000|Overall Study|Did not receive study drug|1|||
37986326|NCT00400400|69672009|FG001|Overall Study|Did not receive study drug|3|||
37986327|NCT00395694|69672017|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
37986328|NCT00395694|69672018|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
37986329|NCT00395694|69672017|FG000|Continuation Phase|Adverse Event|1|||
37986330|NCT00395694|69672018|FG001|Continuation Phase|Adverse Event|0|||
37986331|NCT00395694|69672017|FG000|Continuation Phase|Lack of Efficacy|12|||
37986332|NCT00395694|69672018|FG001|Continuation Phase|Lack of Efficacy|11|||
37986333|NCT00395694|69672017|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
37986334|NCT00395694|69672018|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
37986335|NCT00395694|69672017|FG000|Continuation Phase|Poor Compliance|1|||
37821472|NCT02766335|69501097|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
37821473|NCT02766335|69501095|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
37821474|NCT02766335|69501096|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
37821475|NCT02766335|69501097|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
37821476|NCT02577523|69501105|FG000|Overall Study|Adverse Event|1|||
37821477|NCT02577523|69501106|FG001|Overall Study|Adverse Event|1|||
37821478|NCT02577523|69501105|FG000|Overall Study|Lack of Efficacy|1|||
37821479|NCT02577523|69501106|FG001|Overall Study|Lack of Efficacy|1|||
37821480|NCT02577523|69501105|FG000|Overall Study|Withdrawal by Subject|1|||
37821481|NCT02577523|69501106|FG001|Overall Study|Withdrawal by Subject|0|||
37821482|NCT02499328|69501131|FG000|Overall Study|Withdrawal by Subject|1|||
37821483|NCT02499328|69501132|FG001|Overall Study|Withdrawal by Subject|1|||
37821484|NCT02499328|69501133|FG002|Overall Study|Withdrawal by Subject|5|||
37821485|NCT02499328|69501134|FG003|Overall Study|Withdrawal by Subject|3|||
37821486|NCT02499328|69501135|FG004|Overall Study|Withdrawal by Subject|5|||
37821487|NCT02499328|69501136|FG005|Overall Study|Withdrawal by Subject|0|||
37821488|NCT02499328|69501137|FG006|Overall Study|Withdrawal by Subject|0|||
37821489|NCT02499328|69501138|FG007|Overall Study|Withdrawal by Subject|0|||
37821490|NCT02499328|69501139|FG008|Overall Study|Withdrawal by Subject|2|||
37821491|NCT02499328|69501140|FG009|Overall Study|Withdrawal by Subject|2|||
37821492|NCT02499328|69501141|FG010|Overall Study|Withdrawal by Subject|0|||
37821493|NCT02499328|69501142|FG011|Overall Study|Withdrawal by Subject|3|||
37821494|NCT02499328|69501143|FG012|Overall Study|Withdrawal by Subject|7|||
37821495|NCT02499328|69501144|FG013|Overall Study|Withdrawal by Subject|3|||
37821496|NCT02499328|69501145|FG014|Overall Study|Withdrawal by Subject|1|||
37821497|NCT02499328|69501146|FG015|Overall Study|Withdrawal by Subject|0|||
37821498|NCT02499328|69501147|FG016|Overall Study|Withdrawal by Subject|0|||
37821499|NCT02499328|69501148|FG017|Overall Study|Withdrawal by Subject|3|||
37821500|NCT02499328|69501149|FG018|Overall Study|Withdrawal by Subject|0|||
37821501|NCT02499328|69501131|FG000|Overall Study|Lost to Follow-up|0|||
37821502|NCT02499328|69501132|FG001|Overall Study|Lost to Follow-up|1|||
37884941|NCT00810043|69569420|FG001|Overall Study|Unrelated medical problem|1|||
37884942|NCT00810043|69569421|FG002|Overall Study|Unrelated medical problem|0|||
37884943|NCT00810043|69569419|FG000|Overall Study|Non-medical problem|0|||
37884944|NCT00810043|69569420|FG001|Overall Study|Non-medical problem|0|||
37884945|NCT00810043|69569421|FG002|Overall Study|Non-medical problem|1|||
37884946|NCT00810043|69569419|FG000|Overall Study|No longer met enrollment criteria|0|||
37884947|NCT00810043|69569420|FG001|Overall Study|No longer met enrollment criteria|0|||
37884948|NCT00810043|69569421|FG002|Overall Study|No longer met enrollment criteria|3|||
37884949|NCT01120184|69569433|FG000|Overall Study|Adverse Event|0|||
37884950|NCT01120184|69569434|FG001|Overall Study|Adverse Event|1|||
37884951|NCT01120184|69569435|FG002|Overall Study|Adverse Event|0|||
37884952|NCT01120184|69569433|FG000|Overall Study|Lost to Follow-up|13|||
37884953|NCT01120184|69569434|FG001|Overall Study|Lost to Follow-up|13|||
37884954|NCT01120184|69569435|FG002|Overall Study|Lost to Follow-up|11|||
37884955|NCT01120184|69569433|FG000|Overall Study|Physician Decision|9|||
37884956|NCT01120184|69569434|FG001|Overall Study|Physician Decision|1|||
37884957|NCT01120184|69569435|FG002|Overall Study|Physician Decision|3|||
37884958|NCT01120184|69569433|FG000|Overall Study|Reason not Specified|8|||
37884959|NCT01120184|69569434|FG001|Overall Study|Reason not Specified|3|||
37884960|NCT01120184|69569435|FG002|Overall Study|Reason not Specified|12|||
37884961|NCT01120184|69569433|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
37884962|NCT01120184|69569434|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
37884963|NCT01120184|69569435|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
37884964|NCT01120184|69569433|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
37884965|NCT01120184|69569434|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
37884966|NCT01120184|69569435|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
37884967|NCT01120184|69569433|FG000|Overall Study|Death|170|||
37884968|NCT01120184|69569434|FG001|Overall Study|Death|176|||
37884969|NCT01120184|69569435|FG002|Overall Study|Death|169|||
37884970|NCT01120028|69569447|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
37884971|NCT01120028|69569448|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
37884972|NCT01120028|69569449|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
37884973|NCT01120028|69569450|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
37884974|NCT01120028|69569447|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
37884975|NCT01120028|69569448|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
37884976|NCT01120028|69569449|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
37884977|NCT01120028|69569450|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
37986336|NCT00395694|69672018|FG001|Continuation Phase|Poor Compliance|0|||
37986337|NCT00395694|69672017|FG000|Continuation Phase|Withdrawal by Subject|0|||
37884978|NCT00878800|69569466|FG000|Overall Study|Adverse Event|0|||
37884979|NCT00878800|69569467|FG001|Overall Study|Adverse Event|0|||
37884980|NCT00878800|69569468|FG002|Overall Study|Adverse Event|2|||
37884981|NCT00878800|69569469|FG003|Overall Study|Adverse Event|0|||
37884982|NCT00878800|69569470|FG004|Overall Study|Adverse Event|1|||
37986338|NCT00395694|69672018|FG001|Continuation Phase|Withdrawal by Subject|2|||
37821503|NCT02499328|69501133|FG002|Overall Study|Lost to Follow-up|1|||
37821504|NCT02499328|69501134|FG003|Overall Study|Lost to Follow-up|2|||
37884983|NCT00878800|69569466|FG000|Overall Study|Progressive disease|1|||
37884984|NCT00878800|69569467|FG001|Overall Study|Progressive disease|5|||
37884985|NCT00878800|69569468|FG002|Overall Study|Progressive disease|6|||
37884986|NCT00878800|69569469|FG003|Overall Study|Progressive disease|5|||
37884987|NCT00878800|69569470|FG004|Overall Study|Progressive disease|13|||
37884988|NCT00878800|69569466|FG000|Overall Study|Withdrew consent|1|||
37884989|NCT00878800|69569467|FG001|Overall Study|Withdrew consent|1|||
37986339|NCT00419744|69672030|FG000|Overall Study|Adverse Event|39|||
37986340|NCT00419744|69672031|FG001|Overall Study|Adverse Event|40|||
37986341|NCT00419744|69672032|FG002|Overall Study|Adverse Event|50|||
37821505|NCT02499328|69501135|FG004|Overall Study|Lost to Follow-up|0|||
37821506|NCT02499328|69501136|FG005|Overall Study|Lost to Follow-up|0|||
37821507|NCT02499328|69501137|FG006|Overall Study|Lost to Follow-up|0|||
37821508|NCT02499328|69501138|FG007|Overall Study|Lost to Follow-up|2|||
37821509|NCT02499328|69501139|FG008|Overall Study|Lost to Follow-up|3|||
37821510|NCT02499328|69501140|FG009|Overall Study|Lost to Follow-up|0|||
37821511|NCT02499328|69501141|FG010|Overall Study|Lost to Follow-up|0|||
37884990|NCT00878800|69569468|FG002|Overall Study|Withdrew consent|0|||
37884991|NCT00878800|69569469|FG003|Overall Study|Withdrew consent|1|||
37884992|NCT00878800|69569470|FG004|Overall Study|Withdrew consent|1|||
37884993|NCT00878800|69569466|FG000|Overall Study|Death|0|||
37821512|NCT02499328|69501142|FG011|Overall Study|Lost to Follow-up|0|||
37821513|NCT02499328|69501143|FG012|Overall Study|Lost to Follow-up|0|||
37884994|NCT00878800|69569467|FG001|Overall Study|Death|0|||
37884995|NCT00878800|69569468|FG002|Overall Study|Death|1|||
37884996|NCT00878800|69569469|FG003|Overall Study|Death|0|||
37884997|NCT00878800|69569470|FG004|Overall Study|Death|0|||
37986342|NCT00419744|69672030|FG000|Overall Study|Withdrawal by Subject|45|||
37884998|NCT00878800|69569466|FG000|Overall Study|Other|1|||
37884999|NCT00878800|69569467|FG001|Overall Study|Other|1|||
37986343|NCT00419744|69672031|FG001|Overall Study|Withdrawal by Subject|49|||
37986344|NCT00419744|69672032|FG002|Overall Study|Withdrawal by Subject|52|||
37986345|NCT00419744|69672030|FG000|Overall Study|Lost to Follow-up|8|||
37986346|NCT00419744|69672031|FG001|Overall Study|Lost to Follow-up|10|||
37821514|NCT02499328|69501144|FG013|Overall Study|Lost to Follow-up|0|||
37821515|NCT02499328|69501145|FG014|Overall Study|Lost to Follow-up|0|||
37821516|NCT02499328|69501146|FG015|Overall Study|Lost to Follow-up|0|||
37821517|NCT02499328|69501147|FG016|Overall Study|Lost to Follow-up|0|||
37821518|NCT02499328|69501148|FG017|Overall Study|Lost to Follow-up|0|||
37821519|NCT02499328|69501149|FG018|Overall Study|Lost to Follow-up|1|||
37821520|NCT02499328|69501131|FG000|Overall Study|Death|0|||
37821521|NCT02499328|69501132|FG001|Overall Study|Death|3|||
37821522|NCT02499328|69501133|FG002|Overall Study|Death|3|||
37821523|NCT02499328|69501134|FG003|Overall Study|Death|2|||
37821524|NCT02499328|69501135|FG004|Overall Study|Death|4|||
37821525|NCT02499328|69501136|FG005|Overall Study|Death|7|||
37821526|NCT02499328|69501137|FG006|Overall Study|Death|3|||
37821527|NCT02499328|69501138|FG007|Overall Study|Death|0|||
37821528|NCT02499328|69501139|FG008|Overall Study|Death|2|||
37821529|NCT02499328|69501140|FG009|Overall Study|Death|6|||
37821530|NCT02499328|69501141|FG010|Overall Study|Death|6|||
37821531|NCT02499328|69501142|FG011|Overall Study|Death|20|||
37821532|NCT02499328|69501143|FG012|Overall Study|Death|9|||
37821533|NCT02499328|69501144|FG013|Overall Study|Death|7|||
37821534|NCT02499328|69501145|FG014|Overall Study|Death|3|||
37821535|NCT02499328|69501146|FG015|Overall Study|Death|1|||
37821536|NCT02499328|69501147|FG016|Overall Study|Death|1|||
37821537|NCT02499328|69501148|FG017|Overall Study|Death|16|||
37821538|NCT02499328|69501149|FG018|Overall Study|Death|5|||
37821539|NCT02499328|69501131|FG000|Overall Study|"Other"|2|||
37821540|NCT02499328|69501132|FG001|Overall Study|"Other"|2|||
37821541|NCT02499328|69501133|FG002|Overall Study|"Other"|1|||
37821542|NCT02499328|69501134|FG003|Overall Study|"Other"|3|||
37821543|NCT02499328|69501135|FG004|Overall Study|"Other"|6|||
37821544|NCT02499328|69501136|FG005|Overall Study|"Other"|2|||
37821545|NCT02499328|69501137|FG006|Overall Study|"Other"|3|||
37821546|NCT02499328|69501138|FG007|Overall Study|"Other"|4|||
37821547|NCT02499328|69501139|FG008|Overall Study|"Other"|6|||
37821548|NCT02499328|69501140|FG009|Overall Study|"Other"|16|||
37821549|NCT02499328|69501141|FG010|Overall Study|"Other"|13|||
37821550|NCT02499328|69501142|FG011|Overall Study|"Other"|31|||
37821551|NCT02499328|69501143|FG012|Overall Study|"Other"|8|||
37821552|NCT02499328|69501144|FG013|Overall Study|"Other"|7|||
37821553|NCT02499328|69501145|FG014|Overall Study|"Other"|6|||
37821554|NCT02499328|69501146|FG015|Overall Study|"Other"|0|||
37821555|NCT02499328|69501147|FG016|Overall Study|"Other"|0|||
37821556|NCT02499328|69501148|FG017|Overall Study|"Other"|34|||
37821557|NCT02499328|69501149|FG018|Overall Study|"Other"|43|||
37821558|NCT02499328|69501131|FG000|Overall Study|Disease Progression|0|||
37821559|NCT02499328|69501132|FG001|Overall Study|Disease Progression|0|||
37821560|NCT02499328|69501133|FG002|Overall Study|Disease Progression|0|||
37821561|NCT02499328|69501134|FG003|Overall Study|Disease Progression|0|||
37821562|NCT02499328|69501135|FG004|Overall Study|Disease Progression|0|||
37821563|NCT02499328|69501136|FG005|Overall Study|Disease Progression|0|||
37821564|NCT02499328|69501137|FG006|Overall Study|Disease Progression|1|||
37821565|NCT02499328|69501138|FG007|Overall Study|Disease Progression|0|||
37821566|NCT02499328|69501139|FG008|Overall Study|Disease Progression|1|||
37821567|NCT02499328|69501140|FG009|Overall Study|Disease Progression|0|||
37821568|NCT02499328|69501141|FG010|Overall Study|Disease Progression|1|||
37821569|NCT02499328|69501142|FG011|Overall Study|Disease Progression|0|||
37821570|NCT02499328|69501143|FG012|Overall Study|Disease Progression|0|||
37821571|NCT02499328|69501144|FG013|Overall Study|Disease Progression|0|||
37821572|NCT02499328|69501145|FG014|Overall Study|Disease Progression|0|||
37821573|NCT02499328|69501146|FG015|Overall Study|Disease Progression|0|||
37821574|NCT02499328|69501147|FG016|Overall Study|Disease Progression|0|||
37821575|NCT02499328|69501148|FG017|Overall Study|Disease Progression|2|||
37821576|NCT02499328|69501149|FG018|Overall Study|Disease Progression|0|||
37821577|NCT02499328|69501131|FG000|Overall Study|Adverse Event|1|||
37821578|NCT02499328|69501132|FG001|Overall Study|Adverse Event|0|||
37821579|NCT02499328|69501133|FG002|Overall Study|Adverse Event|0|||
37821580|NCT02499328|69501134|FG003|Overall Study|Adverse Event|1|||
37821581|NCT02499328|69501135|FG004|Overall Study|Adverse Event|0|||
37821582|NCT02499328|69501136|FG005|Overall Study|Adverse Event|0|||
37821583|NCT02499328|69501137|FG006|Overall Study|Adverse Event|0|||
37885000|NCT00878800|69569468|FG002|Overall Study|Other|0|||
37821584|NCT02499328|69501138|FG007|Overall Study|Adverse Event|0|||
37821585|NCT02499328|69501139|FG008|Overall Study|Adverse Event|0|||
37821586|NCT02499328|69501140|FG009|Overall Study|Adverse Event|0|||
37821587|NCT02499328|69501141|FG010|Overall Study|Adverse Event|0|||
37821588|NCT02499328|69501142|FG011|Overall Study|Adverse Event|0|||
37821589|NCT02499328|69501143|FG012|Overall Study|Adverse Event|1|||
37885001|NCT00878800|69569469|FG003|Overall Study|Other|0|||
37885002|NCT00878800|69569470|FG004|Overall Study|Other|1|||
37885003|NCT01119950|69569481|FG000|Overall Study|Adverse Event|25|||
37885004|NCT01119950|69569481|FG000|Overall Study|Withdrawal by Subject|9|||
37885005|NCT01119950|69569481|FG000|Overall Study|Protocol Violation|5|||
37885006|NCT01119950|69569481|FG000|Overall Study|Lost to Follow-up|4|||
37885007|NCT01119950|69569481|FG000|Overall Study|Administrative|2|||
37885008|NCT01119950|69569481|FG000|Overall Study|Abnormal lab value|1|||
37885009|NCT01119950|69569481|FG000|Overall Study|Death|1|||
37885010|NCT01145222|69569511|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
37885011|NCT01145222|69569512|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
37885012|NCT01145222|69569513|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
37885013|NCT01145222|69569514|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
37885014|NCT01145222|69569511|FG000|Overall Study|Poor bowel preparation|0|||
37885015|NCT01145222|69569512|FG001|Overall Study|Poor bowel preparation|0|||
37885016|NCT01145222|69569513|FG002|Overall Study|Poor bowel preparation|0|||
37885017|NCT01145222|69569514|FG003|Overall Study|Poor bowel preparation|1|||
37885018|NCT01145066|69569527|FG000|Overall Study|To resume NSAIDs|2|||
37885019|NCT01145066|69569528|FG001|Overall Study|To resume NSAIDs|2|||
37885020|NCT01145066|69569529|FG002|Overall Study|To resume NSAIDs|1|||
37885021|NCT01145066|69569527|FG000|Overall Study|Non-related surgery|0|||
37885022|NCT01145066|69569528|FG001|Overall Study|Non-related surgery|0|||
37885023|NCT01145066|69569529|FG002|Overall Study|Non-related surgery|1|||
37885024|NCT01145066|69569527|FG000|Overall Study|Withdrawal by Subject|0|||
37885025|NCT01145066|69569528|FG001|Overall Study|Withdrawal by Subject|0|||
37885026|NCT01145066|69569529|FG002|Overall Study|Withdrawal by Subject|2|||
37885027|NCT01145066|69569527|FG000|Overall Study|To start new med|1|||
37885028|NCT01145066|69569528|FG001|Overall Study|To start new med|0|||
37885029|NCT01145066|69569529|FG002|Overall Study|To start new med|0|||
37885030|NCT01145066|69569527|FG000|Overall Study|problems swallowing capsule|1|||
37885031|NCT01145066|69569528|FG001|Overall Study|problems swallowing capsule|0|||
37885032|NCT01145066|69569529|FG002|Overall Study|problems swallowing capsule|0|||
37885033|NCT01145066|69569527|FG000|Overall Study|Abdominal discomfort|0|||
37885034|NCT01145066|69569528|FG001|Overall Study|Abdominal discomfort|1|||
37885035|NCT01145066|69569529|FG002|Overall Study|Abdominal discomfort|0|||
37885036|NCT01145066|69569527|FG000|Overall Study|Low platelet count|0|||
37885037|NCT01145066|69569528|FG001|Overall Study|Low platelet count|1|||
37885038|NCT01145066|69569529|FG002|Overall Study|Low platelet count|0|||
37885039|NCT01132118|69569539|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
37885040|NCT01132118|69569540|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
37885041|NCT01132118|69569539|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
37885042|NCT01132118|69569540|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
37885043|NCT01132118|69569539|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
37885044|NCT01132118|69569540|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
37885045|NCT00972816|69569554|FG000|Overall Study|Adverse Event|0|||
37885046|NCT00972816|69569555|FG001|Overall Study|Adverse Event|0|||
37885047|NCT00972816|69569556|FG002|Overall Study|Adverse Event|1|||
37885048|NCT00972816|69569557|FG003|Overall Study|Adverse Event|0|||
37885049|NCT00972816|69569558|FG004|Overall Study|Adverse Event|0|||
37885050|NCT00972816|69569559|FG005|Overall Study|Adverse Event|0|||
37885051|NCT00972816|69569560|FG006|Overall Study|Adverse Event|0|||
37885052|NCT00972816|69569561|FG007|Overall Study|Adverse Event|0|||
37885053|NCT00972816|69569554|FG000|Overall Study|Withdrawal by Subject|4|||
37885054|NCT00972816|69569555|FG001|Overall Study|Withdrawal by Subject|2|||
37885055|NCT00972816|69569556|FG002|Overall Study|Withdrawal by Subject|1|||
37885056|NCT00972816|69569557|FG003|Overall Study|Withdrawal by Subject|3|||
37885057|NCT00972816|69569558|FG004|Overall Study|Withdrawal by Subject|0|||
37885058|NCT00972816|69569559|FG005|Overall Study|Withdrawal by Subject|1|||
37885059|NCT00972816|69569560|FG006|Overall Study|Withdrawal by Subject|1|||
37885060|NCT00972816|69569561|FG007|Overall Study|Withdrawal by Subject|2|||
37885061|NCT00972816|69569554|FG000|Overall Study|Lost to Follow-up|11|||
37885062|NCT00972816|69569555|FG001|Overall Study|Lost to Follow-up|9|||
37885063|NCT00972816|69569556|FG002|Overall Study|Lost to Follow-up|7|||
37885064|NCT00972816|69569557|FG003|Overall Study|Lost to Follow-up|5|||
37885065|NCT00972816|69569558|FG004|Overall Study|Lost to Follow-up|11|||
37885066|NCT00972816|69569559|FG005|Overall Study|Lost to Follow-up|10|||
37885067|NCT00972816|69569560|FG006|Overall Study|Lost to Follow-up|7|||
37885068|NCT00972816|69569561|FG007|Overall Study|Lost to Follow-up|7|||
37885069|NCT00972816|69569554|FG000|Overall Study|Inappropriate enrolment|0|||
37885070|NCT00972816|69569555|FG001|Overall Study|Inappropriate enrolment|0|||
37885071|NCT00972816|69569556|FG002|Overall Study|Inappropriate enrolment|0|||
37885072|NCT00972816|69569557|FG003|Overall Study|Inappropriate enrolment|0|||
37885073|NCT00972816|69569558|FG004|Overall Study|Inappropriate enrolment|0|||
37885074|NCT00972816|69569559|FG005|Overall Study|Inappropriate enrolment|0|||
37885075|NCT00972816|69569560|FG006|Overall Study|Inappropriate enrolment|2|||
37885076|NCT00972816|69569561|FG007|Overall Study|Inappropriate enrolment|0|||
37885077|NCT00972816|69569554|FG000|Overall Study|Unable to classify|2|||
37885078|NCT00972816|69569555|FG001|Overall Study|Unable to classify|0|||
37885079|NCT00972816|69569556|FG002|Overall Study|Unable to classify|0|||
37885080|NCT00972816|69569557|FG003|Overall Study|Unable to classify|0|||
37885081|NCT00972816|69569558|FG004|Overall Study|Unable to classify|1|||
37885082|NCT00972816|69569559|FG005|Overall Study|Unable to classify|0|||
37885083|NCT00972816|69569560|FG006|Overall Study|Unable to classify|0|||
37885084|NCT00972816|69569561|FG007|Overall Study|Unable to classify|0|||
37885085|NCT00969618|69569579|FG000|Overall Study|Adverse Event|29|||
37885086|NCT00969618|69569579|FG000|Overall Study|Entry Criteria Not Met|3|||
37885087|NCT00969618|69569579|FG000|Overall Study|Lack of Efficacy|2|||
37885088|NCT00969618|69569579|FG000|Overall Study|Lost to Follow-up|7|||
37885089|NCT00969618|69569579|FG000|Overall Study|Physician Decision|1|||
37885090|NCT00969618|69569579|FG000|Overall Study|Protocol Violation|9|||
37885091|NCT00969618|69569579|FG000|Overall Study|Withdrawal by Subject|27|||
37885092|NCT00969540|69569585|FG000|Overall Study|Lost to Follow-up|1|||
37885093|NCT00969540|69569586|FG001|Overall Study|Lost to Follow-up|1|||
37885094|NCT00975000|69569606|FG000|Overall Study|Other|1|||
37885095|NCT00975000|69569607|FG001|Overall Study|Other|0|||
37885096|NCT00975000|69569606|FG000|Overall Study|Adverse Event|1|||
37885097|NCT00975000|69569607|FG001|Overall Study|Adverse Event|1|||
37885098|NCT00975000|69569606|FG000|Overall Study|Withdrawal by Subject|2|||
37885099|NCT00975000|69569607|FG001|Overall Study|Withdrawal by Subject|2|||
37885100|NCT00975000|69569606|FG000|Overall Study|Lost to Follow-up|0|||
37885101|NCT00975000|69569607|FG001|Overall Study|Lost to Follow-up|1|||
37885102|NCT00975000|69569606|FG000|Overall Study|Protocol-specified Criteria|1|||
37885103|NCT00975000|69569607|FG001|Overall Study|Protocol-specified Criteria|0|||
37885104|NCT00975000|69569606|FG000|Overall Study|Non-compliance|0|||
37885105|NCT00975000|69569607|FG001|Overall Study|Non-compliance|1|||
37885106|NCT00974922|69569613|FG000|Overall Study|study terminated|24|||
37885107|NCT00972504|69569617|FG000|Overall Study|Adverse Event|2|||
37885108|NCT00972504|69569617|FG000|Overall Study|Investigator discretion|1|||
37885109|NCT00969228|69569629|FG000|Overall Study|Adverse Event|1|||
37885110|NCT00969228|69569630|FG001|Overall Study|Adverse Event|0|||
37885111|NCT00969228|69569629|FG000|Overall Study|Withdrawal by Subject|4|||
37885112|NCT00969228|69569630|FG001|Overall Study|Withdrawal by Subject|0|||
37885113|NCT00969228|69569629|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
37885114|NCT00969228|69569630|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
37885115|NCT00969150|69569638|FG000|Overall Study|Adverse Event|4|||
37885116|NCT00969150|69569639|FG001|Overall Study|Adverse Event|14|||
37885117|NCT00969150|69569638|FG000|Overall Study|Lack of Efficacy|1|||
37885118|NCT00969150|69569639|FG001|Overall Study|Lack of Efficacy|1|||
37885119|NCT00969150|69569638|FG000|Overall Study|Protocol Violation|9|||
37885120|NCT00969150|69569639|FG001|Overall Study|Protocol Violation|12|||
37885121|NCT00969150|69569638|FG000|Overall Study|Withdrawal by Subject|13|||
37885122|NCT00969150|69569639|FG001|Overall Study|Withdrawal by Subject|9|||
37986347|NCT00419744|69672032|FG002|Overall Study|Lost to Follow-up|6|||
37986348|NCT00419744|69672030|FG000|Overall Study|Protocol Violation|4|||
37986349|NCT00419744|69672031|FG001|Overall Study|Protocol Violation|7|||
37821590|NCT02499328|69501144|FG013|Overall Study|Adverse Event|0|||
37821591|NCT02499328|69501145|FG014|Overall Study|Adverse Event|0|||
37821592|NCT02499328|69501146|FG015|Overall Study|Adverse Event|0|||
37821593|NCT02499328|69501147|FG016|Overall Study|Adverse Event|0|||
37821594|NCT02499328|69501148|FG017|Overall Study|Adverse Event|0|||
37821595|NCT02499328|69501149|FG018|Overall Study|Adverse Event|0|||
37821596|NCT02177695|69501245|FG000|ITT Analysis|Ineligible|5|||
37821597|NCT02177695|69501246|FG001|ITT Analysis|Ineligible|5|||
37821598|NCT02177695|69501245|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
37821599|NCT02177695|69501246|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
37821600|NCT02177695|69501245|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
37821601|NCT02177695|69501246|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
37821602|NCT02177695|69501245|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
37821603|NCT02177695|69501246|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
37821604|NCT01719237|69501261|FG000|Overall Study|Physician Decision|0|||
37821605|NCT01719237|69501262|FG001|Overall Study|Physician Decision|1|||
37821606|NCT01956669|69501285|FG000|Overall Study|Disease Progression|12|||
37821607|NCT01956669|69501286|FG001|Overall Study|Disease Progression|7|||
37821608|NCT01956669|69501287|FG002|Overall Study|Disease Progression|7|||
37821609|NCT01956669|69501288|FG003|Overall Study|Disease Progression|8|||
37821610|NCT01956669|69501289|FG004|Overall Study|Disease Progression|4|||
37821611|NCT01956669|69501290|FG005|Overall Study|Disease Progression|3|||
37885123|NCT00969150|69569638|FG000|Overall Study|Lost to Follow-up|5|||
37885124|NCT00969150|69569639|FG001|Overall Study|Lost to Follow-up|4|||
37885125|NCT00969150|69569638|FG000|Overall Study|Other reasons|1|||
37885126|NCT00969150|69569639|FG001|Overall Study|Other reasons|0|||
37885127|NCT00974220|69569647|FG000|Treatment Period 1|Adverse Event|2|||
37885128|NCT00974220|69569648|FG001|Treatment Period 1|Adverse Event|1|||
37885129|NCT00974220|69569647|FG000|Treatment Period 1|noncompliant subjects|0|||
37885130|NCT00974220|69569648|FG001|Treatment Period 1|noncompliant subjects|1|||
37885131|NCT00971178|69569657|FG000|Overall Study|Lost to Follow-up|2|||
37885132|NCT00971178|69569658|FG001|Overall Study|Lost to Follow-up|2|||
37885133|NCT00971178|69569659|FG002|Overall Study|Lost to Follow-up|2|||
37885134|NCT03670602|69569669|FG000|Overall Study|Lost to Follow-up|1|||
37885135|NCT03670602|69569670|FG001|Overall Study|Lost to Follow-up|0|||
37885136|NCT03670602|69569669|FG000|Overall Study|Withdrawal by Subject|0|||
37885137|NCT03670602|69569670|FG001|Overall Study|Withdrawal by Subject|3|||
37885138|NCT00968526|69569678|FG000|Overall Study|Adverse Event|2|||
37885139|NCT00968526|69569679|FG001|Overall Study|Adverse Event|0|||
37885140|NCT00968526|69569678|FG000|Overall Study|Migrated/moved from study area|1|||
37885141|NCT00968526|69569679|FG001|Overall Study|Migrated/moved from study area|0|||
37885142|NCT03664674|69569696|FG000|Overall Study|Adverse Event|1|||
37885143|NCT03664674|69569697|FG001|Overall Study|Adverse Event|1|||
37885144|NCT03664674|69569696|FG000|Overall Study|Physician Decision|0|||
37885145|NCT03664674|69569697|FG001|Overall Study|Physician Decision|1|||
37885146|NCT03664674|69569696|FG000|Overall Study|Withdrawal by Subject|2|||
37885147|NCT03664674|69569697|FG001|Overall Study|Withdrawal by Subject|0|||
37885148|NCT00967668|69569708|FG000|Overall Study|Withdrawal by Subject|13|||
37885149|NCT00967668|69569709|FG001|Overall Study|Withdrawal by Subject|8|||
37885150|NCT00967668|69569710|FG002|Overall Study|Withdrawal by Subject|8|||
37885151|NCT00967668|69569708|FG000|Overall Study|Death|0|||
37885152|NCT00967668|69569709|FG001|Overall Study|Death|2|||
37885153|NCT00967668|69569710|FG002|Overall Study|Death|4|||
37885154|NCT00967668|69569708|FG000|Overall Study|Removed due to behavior|1|||
37885155|NCT00967668|69569709|FG001|Overall Study|Removed due to behavior|1|||
37885156|NCT00967668|69569710|FG002|Overall Study|Removed due to behavior|2|||
37885157|NCT00967668|69569708|FG000|Overall Study|Refused Year 2|11|||
37885158|NCT00967668|69569709|FG001|Overall Study|Refused Year 2|6|||
37885159|NCT00967668|69569710|FG002|Overall Study|Refused Year 2|4|||
37885160|NCT00967668|69569708|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
37885161|NCT00967668|69569709|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
37885162|NCT00967668|69569710|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
37885163|NCT00967668|69569708|FG000|Overall Study|Lost to Follow-up|15|||
37885164|NCT00967668|69569709|FG001|Overall Study|Lost to Follow-up|9|||
37885165|NCT00967668|69569710|FG002|Overall Study|Lost to Follow-up|16|||
37885166|NCT00967668|69569708|FG000|Overall Study|Refused 12-mo assessment|3|||
37885167|NCT00967668|69569709|FG001|Overall Study|Refused 12-mo assessment|1|||
37885168|NCT00967668|69569710|FG002|Overall Study|Refused 12-mo assessment|9|||
37885169|NCT00967668|69569708|FG000|Overall Study|Pregnancy|1|||
37885170|NCT00967668|69569709|FG001|Overall Study|Pregnancy|0|||
37885171|NCT00967668|69569710|FG002|Overall Study|Pregnancy|0|||
37885172|NCT00970944|69569723|FG000|Overall Study|Death|1|||
37885173|NCT00970944|69569724|FG001|Overall Study|Death|0|||
37885174|NCT00970944|69569723|FG000|Overall Study|Physician Decision|0|||
37885175|NCT00970944|69569724|FG001|Overall Study|Physician Decision|2|||
37885176|NCT04839289|69569733|FG000|Overall Study|Withdrawal by Subject|1|||
37885177|NCT04839289|69569734|FG001|Overall Study|Withdrawal by Subject|0|||
37885178|NCT04440813|69569742|FG000|Overall Study|Lost to Follow-up|5|||
37885179|NCT04440813|69569743|FG001|Overall Study|Lost to Follow-up|5|||
37885180|NCT04233073|69569757|FG000|Overall Study|Death|5|||
37885181|NCT04120116|69569765|FG000|Overall Study|Lost to Follow-up|0|||
37885182|NCT04120116|69569766|FG001|Overall Study|Lost to Follow-up|1|||
37885183|NCT04120116|69569767|FG002|Overall Study|Lost to Follow-up|0|||
37885184|NCT04120116|69569768|FG003|Overall Study|Lost to Follow-up|2|||
37885185|NCT04120116|69569765|FG000|Overall Study|Withdrawal by Subject|1|||
37885186|NCT04120116|69569766|FG001|Overall Study|Withdrawal by Subject|0|||
37885187|NCT04120116|69569767|FG002|Overall Study|Withdrawal by Subject|1|||
37885188|NCT04120116|69569768|FG003|Overall Study|Withdrawal by Subject|1|||
37885189|NCT04120116|69569765|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
37885190|NCT04120116|69569766|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
37885191|NCT04120116|69569767|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
37986350|NCT00419744|69672032|FG002|Overall Study|Protocol Violation|8|||
37986351|NCT00419744|69672030|FG000|Overall Study|Randomized in error|9|||
37986352|NCT00419744|69672031|FG001|Overall Study|Randomized in error|6|||
37986353|NCT00419744|69672032|FG002|Overall Study|Randomized in error|7|||
37885192|NCT04120116|69569768|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
37885193|NCT03657810|69569791|FG000|Overall Study|Adverse Event|0|||
37885194|NCT03657810|69569792|FG001|Overall Study|Adverse Event|1|||
37885195|NCT03657810|69569793|FG002|Overall Study|Adverse Event|0|||
37885196|NCT03657810|69569791|FG000|Overall Study|Lack of Efficacy|4|||
37885197|NCT03657810|69569792|FG001|Overall Study|Lack of Efficacy|1|||
37885198|NCT03657810|69569793|FG002|Overall Study|Lack of Efficacy|3|||
37885199|NCT03657810|69569791|FG000|Overall Study|Protocol Violation|1|||
37885200|NCT03657810|69569792|FG001|Overall Study|Protocol Violation|0|||
37885201|NCT03657810|69569793|FG002|Overall Study|Protocol Violation|0|||
37885202|NCT03657810|69569791|FG000|Overall Study|Lost to Follow-up|0|||
37885203|NCT03657810|69569792|FG001|Overall Study|Lost to Follow-up|1|||
37821612|NCT01956669|69501291|FG006|Overall Study|Disease Progression|5|||
37821613|NCT01956669|69501285|FG000|Overall Study|Adverse Event|0|||
37821614|NCT01956669|69501286|FG001|Overall Study|Adverse Event|2|||
37821615|NCT01956669|69501287|FG002|Overall Study|Adverse Event|2|||
37821616|NCT01956669|69501288|FG003|Overall Study|Adverse Event|1|||
37821617|NCT01956669|69501289|FG004|Overall Study|Adverse Event|0|||
37821618|NCT01956669|69501290|FG005|Overall Study|Adverse Event|0|||
37821619|NCT01956669|69501291|FG006|Overall Study|Adverse Event|0|||
37821620|NCT01956669|69501285|FG000|Overall Study|Physician Decision|0|||
37821621|NCT01956669|69501286|FG001|Overall Study|Physician Decision|2|||
37821622|NCT01956669|69501287|FG002|Overall Study|Physician Decision|0|||
37821623|NCT01956669|69501288|FG003|Overall Study|Physician Decision|0|||
37821624|NCT01956669|69501289|FG004|Overall Study|Physician Decision|0|||
37821625|NCT01956669|69501290|FG005|Overall Study|Physician Decision|1|||
37821626|NCT01956669|69501291|FG006|Overall Study|Physician Decision|0|||
37821627|NCT01956669|69501285|FG000|Overall Study|Withdrawal by Subject|0|||
37821628|NCT01956669|69501286|FG001|Overall Study|Withdrawal by Subject|0|||
37821629|NCT01956669|69501287|FG002|Overall Study|Withdrawal by Subject|1|||
37821630|NCT01956669|69501288|FG003|Overall Study|Withdrawal by Subject|1|||
37821631|NCT01956669|69501289|FG004|Overall Study|Withdrawal by Subject|0|||
37821632|NCT01956669|69501290|FG005|Overall Study|Withdrawal by Subject|0|||
37821633|NCT01956669|69501291|FG006|Overall Study|Withdrawal by Subject|1|||
37821634|NCT01967823|69501320|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
37821635|NCT01982760|69501330|FG000|Overall Study|Physician Decision|1|||
37821636|NCT01982760|69501331|FG001|Overall Study|Physician Decision|0|||
37821637|NCT01985022|69501339|FG000|Overall Study|Lost to Follow-up|0|||
37821638|NCT01985022|69501340|FG001|Overall Study|Lost to Follow-up|1|||
37821639|NCT01985022|69501339|FG000|Overall Study|Protocol Violation|0|||
37821640|NCT01985022|69501340|FG001|Overall Study|Protocol Violation|1|||
37821641|NCT01985022|69501339|FG000|Overall Study|Withdrawal by Subject|4|||
37821642|NCT01985022|69501340|FG001|Overall Study|Withdrawal by Subject|1|||
37821643|NCT01989676|69501348|FG000|Overall Study|Death|52|||
37821644|NCT01989676|69501349|FG001|Overall Study|Death|60|||
37821645|NCT01989676|69501348|FG000|Overall Study|Protocol Violation|2|||
37821646|NCT01989676|69501349|FG001|Overall Study|Protocol Violation|1|||
37821647|NCT01989676|69501348|FG000|Overall Study|Lost to Follow-up|8|||
37821648|NCT01989676|69501349|FG001|Overall Study|Lost to Follow-up|18|||
37821649|NCT01989676|69501348|FG000|Overall Study|No longer willing to participate in study|26|||
37821650|NCT01989676|69501349|FG001|Overall Study|No longer willing to participate in study|26|||
37821651|NCT01989676|69501348|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
37821652|NCT01989676|69501349|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
37821653|NCT01989676|69501348|FG000|Overall Study|Other|4|||
37821654|NCT01989676|69501349|FG001|Overall Study|Other|3|||
37821655|NCT02001974|69501359|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
37821656|NCT02001974|69501360|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
37821657|NCT02001974|69501361|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
37821658|NCT02001974|69501359|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
37821659|NCT02001974|69501360|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
37821660|NCT02001974|69501361|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
37821661|NCT02001974|69501359|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
37821662|NCT02001974|69501360|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
37821663|NCT02001974|69501361|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
37821664|NCT02001974|69501359|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
37821665|NCT02001974|69501360|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
37885204|NCT03657810|69569793|FG002|Overall Study|Lost to Follow-up|0|||
37821666|NCT02001974|69501361|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
37821667|NCT05229406|69501399|FG000|Overall Study|Withdrawal by Subject|1|||
37821668|NCT05229406|69501400|FG001|Overall Study|Withdrawal by Subject|2|||
37821669|NCT04971187|69501415|FG000|Overall Study|Screen failures|2|||
37821670|NCT04756154|69501440|FG000|Overall Study|Did not meet treatment day baseline|30|||
37821671|NCT04756154|69501441|FG001|Overall Study|Did not meet treatment day baseline|28|||
37821672|NCT04756154|69501442|FG002|Overall Study|Did not meet treatment day baseline|7|||
37821673|NCT04756154|69501440|FG000|Overall Study|Did not return for final sample collection|1|||
37821674|NCT04756154|69501441|FG001|Overall Study|Did not return for final sample collection|1|||
37885205|NCT03657810|69569791|FG000|Overall Study|Not provided|0|||
37885206|NCT03657810|69569792|FG001|Overall Study|Not provided|1|||
37885207|NCT03657810|69569793|FG002|Overall Study|Not provided|0|||
37885208|NCT03370341|69569815|FG000|Overall Study|Lost to Follow-up|0|||
37885209|NCT03370341|69569816|FG001|Overall Study|Lost to Follow-up|1|||
37885210|NCT02544074|69569885|FG000|Overall Study|Withdrawal by Subject|0|||
37885211|NCT02544074|69569886|FG001|Overall Study|Withdrawal by Subject|1|||
37885212|NCT02544074|69569887|FG002|Overall Study|Withdrawal by Subject|0|||
37885213|NCT02544074|69569888|FG003|Overall Study|Withdrawal by Subject|0|||
37885214|NCT02544074|69569889|FG004|Overall Study|Withdrawal by Subject|0|||
37885215|NCT02544074|69569890|FG005|Overall Study|Withdrawal by Subject|0|||
37885216|NCT02544074|69569891|FG006|Overall Study|Withdrawal by Subject|0|||
37885217|NCT02544074|69569892|FG007|Overall Study|Withdrawal by Subject|0|||
37885218|NCT02544074|69569893|FG008|Overall Study|Withdrawal by Subject|0|||
37885219|NCT02544074|69569894|FG009|Overall Study|Withdrawal by Subject|0|||
37885220|NCT02544074|69569895|FG010|Overall Study|Withdrawal by Subject|0|||
37885221|NCT02544074|69569896|FG011|Overall Study|Withdrawal by Subject|0|||
37885222|NCT02544074|69569897|FG012|Overall Study|Withdrawal by Subject|0|||
37885223|NCT02544074|69569898|FG013|Overall Study|Withdrawal by Subject|0|||
37885224|NCT02544074|69569899|FG014|Overall Study|Withdrawal by Subject|0|||
37821675|NCT04756154|69501442|FG002|Overall Study|Did not return for final sample collection|0|||
37821676|NCT04614246|69501460|FG000|Overall Study|Adverse Event|0|||
37821677|NCT04614246|69501461|FG001|Overall Study|Adverse Event|1|||
37821678|NCT04614246|69501462|FG002|Overall Study|Adverse Event|1|||
37821679|NCT04614246|69501463|FG003|Overall Study|Adverse Event|2|||
37821680|NCT04614246|69501464|FG004|Overall Study|Adverse Event|1|||
37821681|NCT04614246|69501460|FG000|Overall Study|Lost to Follow-up|0|||
37821682|NCT04614246|69501461|FG001|Overall Study|Lost to Follow-up|1|||
37821683|NCT04614246|69501462|FG002|Overall Study|Lost to Follow-up|0|||
37821684|NCT04614246|69501463|FG003|Overall Study|Lost to Follow-up|1|||
37821685|NCT04614246|69501464|FG004|Overall Study|Lost to Follow-up|3|||
37821686|NCT04614246|69501460|FG000|Overall Study|Other reason|0|||
37821687|NCT04614246|69501461|FG001|Overall Study|Other reason|1|||
37821688|NCT04614246|69501462|FG002|Overall Study|Other reason|2|||
37821689|NCT04614246|69501463|FG003|Overall Study|Other reason|0|||
37821690|NCT04614246|69501464|FG004|Overall Study|Other reason|0|||
37821691|NCT04614246|69501460|FG000|Overall Study|Withdrawal by Subject|4|||
37821692|NCT04614246|69501461|FG001|Overall Study|Withdrawal by Subject|2|||
37821693|NCT04614246|69501462|FG002|Overall Study|Withdrawal by Subject|4|||
37821694|NCT04614246|69501463|FG003|Overall Study|Withdrawal by Subject|3|||
37695519|NCT02400476|69171830|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
37695520|NCT02400476|69171831|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
37695521|NCT02363738|69171847|FG000|Overall Study|Adverse Event|5|||
37695522|NCT02363738|69171848|FG001|Overall Study|Adverse Event|2|||
37695523|NCT02363738|69171847|FG000|Overall Study|Lack of Efficacy|1|||
37695524|NCT02363738|69171848|FG001|Overall Study|Lack of Efficacy|2|||
37821695|NCT04614246|69501464|FG004|Overall Study|Withdrawal by Subject|4|||
37885225|NCT02544074|69569900|FG015|Overall Study|Withdrawal by Subject|0|||
37885226|NCT02544074|69569901|FG016|Overall Study|Withdrawal by Subject|0|||
37885227|NCT02544074|69569902|FG017|Overall Study|Withdrawal by Subject|0|||
37885228|NCT02544074|69569903|FG018|Overall Study|Withdrawal by Subject|0|||
37885229|NCT02544074|69569904|FG019|Overall Study|Withdrawal by Subject|0|||
37885230|NCT02544074|69569905|FG020|Overall Study|Withdrawal by Subject|0|||
37885231|NCT02544074|69569885|FG000|Overall Study|Tablet error|0|||
37885232|NCT02544074|69569886|FG001|Overall Study|Tablet error|0|||
37885233|NCT02544074|69569887|FG002|Overall Study|Tablet error|0|||
37885234|NCT02544074|69569888|FG003|Overall Study|Tablet error|0|||
37885235|NCT02544074|69569889|FG004|Overall Study|Tablet error|0|||
37885236|NCT02544074|69569890|FG005|Overall Study|Tablet error|1|||
37695525|NCT02363738|69171847|FG000|Overall Study|Lost to Follow-up|2|||
37821696|NCT04614246|69501460|FG000|Overall Study|Physician Decision|0|||
37821697|NCT04614246|69501461|FG001|Overall Study|Physician Decision|2|||
37821698|NCT04614246|69501462|FG002|Overall Study|Physician Decision|1|||
37821699|NCT04614246|69501463|FG003|Overall Study|Physician Decision|0|||
37821700|NCT04614246|69501464|FG004|Overall Study|Physician Decision|0|||
37821701|NCT04614246|69501460|FG000|Overall Study|Study terminated by sponsor|10|||
37885237|NCT02544074|69569891|FG006|Overall Study|Tablet error|0|||
37885238|NCT02544074|69569892|FG007|Overall Study|Tablet error|0|||
37885239|NCT02544074|69569893|FG008|Overall Study|Tablet error|0|||
37885240|NCT02544074|69569894|FG009|Overall Study|Tablet error|1|||
37885241|NCT02544074|69569895|FG010|Overall Study|Tablet error|0|||
37885242|NCT02544074|69569896|FG011|Overall Study|Tablet error|0|||
37885243|NCT02544074|69569897|FG012|Overall Study|Tablet error|0|||
37885244|NCT02544074|69569898|FG013|Overall Study|Tablet error|0|||
37885245|NCT02544074|69569899|FG014|Overall Study|Tablet error|0|||
37885246|NCT02544074|69569900|FG015|Overall Study|Tablet error|0|||
37885247|NCT02544074|69569901|FG016|Overall Study|Tablet error|0|||
37885248|NCT02544074|69569902|FG017|Overall Study|Tablet error|0|||
37885249|NCT02544074|69569903|FG018|Overall Study|Tablet error|0|||
37885250|NCT02544074|69569904|FG019|Overall Study|Tablet error|0|||
37885251|NCT02544074|69569905|FG020|Overall Study|Tablet error|0|||
37885252|NCT02502799|69569943|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
37885253|NCT02502799|69569944|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
37885254|NCT02502799|69569945|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
37885255|NCT02502799|69569946|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
37885256|NCT02502799|69569943|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
37885257|NCT02502799|69569944|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
37885258|NCT02502799|69569945|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
37885259|NCT02502799|69569946|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
37885260|NCT02502799|69569943|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
37885261|NCT02502799|69569944|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
37885262|NCT02502799|69569945|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
37885263|NCT02502799|69569946|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
37885264|NCT02502799|69569943|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
37885265|NCT02502799|69569944|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
37885266|NCT02502799|69569945|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
37885267|NCT02502799|69569946|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
37885268|NCT02502799|69569943|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
37885269|NCT02502799|69569944|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
37885270|NCT02502799|69569945|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
37885271|NCT02502799|69569946|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
37885272|NCT02086448|69569959|FG000|Overall Study|Withdrawal by Subject|1|||
37885273|NCT02086448|69569960|FG001|Overall Study|Withdrawal by Subject|0|||
37885274|NCT02086448|69569961|FG002|Overall Study|Withdrawal by Subject|0|||
37885275|NCT02086448|69569962|FG003|Overall Study|Withdrawal by Subject|2|||
37885276|NCT01993836|69569975|FG000|Overall Study|Surgery Cancelled|3|||
37885277|NCT01993836|69569976|FG001|Overall Study|Surgery Cancelled|0|||
37885278|NCT01993836|69569977|FG002|Overall Study|Surgery Cancelled|0|||
37885279|NCT01993836|69569975|FG000|Overall Study|Physician Decision|2|||
37885280|NCT01993836|69569976|FG001|Overall Study|Physician Decision|1|||
37885281|NCT01993836|69569977|FG002|Overall Study|Physician Decision|0|||
37885282|NCT01993836|69569975|FG000|Overall Study|Death|0|||
37885283|NCT01993836|69569976|FG001|Overall Study|Death|2|||
37885284|NCT01993836|69569977|FG002|Overall Study|Death|0|||
37885285|NCT01993836|69569975|FG000|Overall Study|Withdrawal by Subject|12|||
37885286|NCT01993836|69569976|FG001|Overall Study|Withdrawal by Subject|10|||
37885287|NCT01993836|69569977|FG002|Overall Study|Withdrawal by Subject|5|||
37885288|NCT00753545|69569992|FG000|Overall Study|Death|98|||
37885289|NCT00753545|69569993|FG001|Overall Study|Death|112|||
37885290|NCT00753545|69569992|FG000|Overall Study|Lost to Follow-up|2|||
37885291|NCT00753545|69569993|FG001|Overall Study|Lost to Follow-up|3|||
37885292|NCT00753545|69569992|FG000|Overall Study|Protocol Violation|1|||
37885293|NCT00753545|69569993|FG001|Overall Study|Protocol Violation|0|||
37885294|NCT00753545|69569992|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
37885295|NCT00753545|69569993|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
37885296|NCT00278915|69570008|FG000|Overall Study|Lack of Efficacy|1|||
37885297|NCT00970632|69570015|FG000|Overall Study|Adverse Event|2|||
37885298|NCT00970632|69570016|FG001|Overall Study|Adverse Event|2|||
37885299|NCT00970632|69570017|FG002|Overall Study|Adverse Event|1|||
37885300|NCT00970632|69570015|FG000|Overall Study|Lack of Efficacy|3|||
37885301|NCT00970632|69570016|FG001|Overall Study|Lack of Efficacy|0|||
37885302|NCT00970632|69570017|FG002|Overall Study|Lack of Efficacy|0|||
37885303|NCT00970632|69570015|FG000|Overall Study|Lost to Follow-up|3|||
37885304|NCT00970632|69570016|FG001|Overall Study|Lost to Follow-up|0|||
37885305|NCT00970632|69570017|FG002|Overall Study|Lost to Follow-up|2|||
37885306|NCT00970632|69570015|FG000|Overall Study|Protocol Violation|8|||
37885307|NCT00970632|69570016|FG001|Overall Study|Protocol Violation|5|||
37885308|NCT00970632|69570017|FG002|Overall Study|Protocol Violation|8|||
37885309|NCT00970632|69570015|FG000|Overall Study|Withdrawal by Subject|7|||
37885310|NCT00970632|69570016|FG001|Overall Study|Withdrawal by Subject|6|||
37885311|NCT00970632|69570017|FG002|Overall Study|Withdrawal by Subject|4|||
37885312|NCT00970632|69570015|FG000|Overall Study|Entry criteria not met|0|||
37885313|NCT00970632|69570016|FG001|Overall Study|Entry criteria not met|2|||
37885314|NCT00970632|69570017|FG002|Overall Study|Entry criteria not met|2|||
37885315|NCT00970632|69570015|FG000|Overall Study|Sponsor decision|1|||
37885316|NCT00970632|69570016|FG001|Overall Study|Sponsor decision|0|||
37885317|NCT00970632|69570017|FG002|Overall Study|Sponsor decision|1|||
37885318|NCT01144364|69570027|FG000|Induction Phase|Disease progression|14|||
37885319|NCT01144364|69570028|FG001|Induction Phase|Disease progression|0|||
37885320|NCT01144364|69570029|FG002|Induction Phase|Disease progression|0|||
37885321|NCT01144364|69570027|FG000|Induction Phase|Adverse Event|9|||
37885322|NCT01144364|69570028|FG001|Induction Phase|Adverse Event|0|||
37885323|NCT01144364|69570029|FG002|Induction Phase|Adverse Event|0|||
37885324|NCT01144364|69570027|FG000|Induction Phase|Death|1|||
37885325|NCT01144364|69570028|FG001|Induction Phase|Death|0|||
37885326|NCT01144364|69570029|FG002|Induction Phase|Death|0|||
37885327|NCT01144364|69570027|FG000|Induction Phase|Withdrawal by Subject|1|||
37885328|NCT01144364|69570028|FG001|Induction Phase|Withdrawal by Subject|0|||
37885329|NCT01144364|69570029|FG002|Induction Phase|Withdrawal by Subject|0|||
37885330|NCT01144364|69570027|FG000|Induction Phase|Lost to Follow-up|2|||
37885331|NCT01144364|69570028|FG001|Induction Phase|Lost to Follow-up|0|||
37885332|NCT01144364|69570029|FG002|Induction Phase|Lost to Follow-up|0|||
37885333|NCT01144364|69570027|FG000|Induction Phase|Physician Decision|1|||
37885334|NCT01144364|69570028|FG001|Induction Phase|Physician Decision|0|||
37885335|NCT01144364|69570029|FG002|Induction Phase|Physician Decision|0|||
37885336|NCT01144364|69570027|FG000|Induction Phase|Stable disease|2|||
37885337|NCT01144364|69570028|FG001|Induction Phase|Stable disease|0|||
37885338|NCT01144364|69570029|FG002|Induction Phase|Stable disease|0|||
37885339|NCT01144364|69570027|FG000|Induction Phase|Secondary neoplasia|1|||
37885340|NCT01144364|69570028|FG001|Induction Phase|Secondary neoplasia|0|||
37885341|NCT01144364|69570029|FG002|Induction Phase|Secondary neoplasia|0|||
37885342|NCT01144364|69570027|FG000|Induction Phase|Protocol Violation|1|||
37885343|NCT01144364|69570028|FG001|Induction Phase|Protocol Violation|0|||
37885344|NCT01144364|69570029|FG002|Induction Phase|Protocol Violation|0|||
37885345|NCT01144364|69570027|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
37885346|NCT01144364|69570028|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
37885347|NCT01144364|69570029|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
37885348|NCT01144364|69570027|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
37885349|NCT01144364|69570028|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
37885350|NCT01144364|69570029|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
37885351|NCT01144364|69570027|FG000|Follow-Up/Maintenance Phase|Death|0|||
37885352|NCT01144364|69570028|FG001|Follow-Up/Maintenance Phase|Death|2|||
37885353|NCT01144364|69570029|FG002|Follow-Up/Maintenance Phase|Death|0|||
37885354|NCT01144364|69570027|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
37885355|NCT01144364|69570028|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
37885356|NCT01144364|69570029|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
37885357|NCT01144364|69570027|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
37885358|NCT01144364|69570028|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
37885359|NCT01144364|69570029|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
37885360|NCT01144364|69570027|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
37885361|NCT01144364|69570028|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
37885362|NCT01144364|69570029|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
37885363|NCT01144364|69570027|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
37885364|NCT01144364|69570028|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
37885365|NCT01144364|69570029|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
37885366|NCT01119248|69570039|FG000|Overall Study|Physician Decision|5|||
37885367|NCT01131494|69570044|FG000|Overall Study|Withdrawal by Subject|2|||
37885368|NCT01131260|69570051|FG000|Overall Study|Randomization error|5|||
37986354|NCT00419744|69672030|FG000|Overall Study|Moving out of state|2|||
37986355|NCT00419744|69672031|FG001|Overall Study|Moving out of state|0|||
37986356|NCT00419744|69672032|FG002|Overall Study|Moving out of state|1|||
37885369|NCT01131260|69570052|FG001|Overall Study|Randomization error|1|||
37885370|NCT01131260|69570051|FG000|Overall Study|Declined to continue participation|8|||
37885371|NCT01131260|69570052|FG001|Overall Study|Declined to continue participation|13|||
37885372|NCT01131260|69570051|FG000|Overall Study|Physician Decision|22|||
37885373|NCT01131260|69570052|FG001|Overall Study|Physician Decision|24|||
37885374|NCT01131260|69570051|FG000|Overall Study|Technical problems|7|||
37885375|NCT01131260|69570052|FG001|Overall Study|Technical problems|6|||
37885376|NCT01131260|69570051|FG000|Overall Study|Staff error|2|||
37885377|NCT01131260|69570052|FG001|Overall Study|Staff error|1|||
37885378|NCT01131260|69570051|FG000|Overall Study|Ineligible|0|||
37885379|NCT01131260|69570052|FG001|Overall Study|Ineligible|2|||
37885380|NCT00965094|69570062|FG000|Overall Study|Adverse Event|5|||
37885381|NCT00965094|69570063|FG001|Overall Study|Adverse Event|0|||
37885382|NCT00965094|69570062|FG000|Overall Study|Lost to Follow-up|0|||
37885383|NCT00965094|69570063|FG001|Overall Study|Lost to Follow-up|1|||
37885384|NCT01131182|69570072|FG000|Overall Study|Withdrawal by Subject|1|||
37885385|NCT01131182|69570073|FG001|Overall Study|Withdrawal by Subject|1|||
37885386|NCT01131182|69570072|FG000|Overall Study|Lost to Follow-up|14|||
37885387|NCT01131182|69570073|FG001|Overall Study|Lost to Follow-up|15|||
37885388|NCT01131182|69570072|FG000|Overall Study|Other Reason|1|||
37885389|NCT01131182|69570073|FG001|Overall Study|Other Reason|0|||
37986357|NCT00419744|69672030|FG000|Overall Study|Physician Decision|10|||
37986358|NCT00419744|69672031|FG001|Overall Study|Physician Decision|5|||
37986359|NCT00419744|69672032|FG002|Overall Study|Physician Decision|6|||
37986360|NCT00419744|69672030|FG000|Overall Study|Spirometry mouthpiece issues|0|||
37986361|NCT00419744|69672031|FG001|Overall Study|Spirometry mouthpiece issues|1|||
37986362|NCT00419744|69672032|FG002|Overall Study|Spirometry mouthpiece issues|2|||
37986363|NCT00419744|69672030|FG000|Overall Study|Incorrect medication kit dispensed|0|||
37986364|NCT00419744|69672031|FG001|Overall Study|Incorrect medication kit dispensed|0|||
37986365|NCT00419744|69672032|FG002|Overall Study|Incorrect medication kit dispensed|1|||
37986366|NCT00395538|69672043|FG000|Overall Study|Did not re-consent to revised protocol|1|||
37986367|NCT00395538|69672044|FG001|Overall Study|Did not re-consent to revised protocol|10|||
37821702|NCT04614246|69501461|FG001|Overall Study|Study terminated by sponsor|15|||
37821703|NCT04614246|69501462|FG002|Overall Study|Study terminated by sponsor|12|||
37821704|NCT04614246|69501463|FG003|Overall Study|Study terminated by sponsor|13|||
37821705|NCT04614246|69501464|FG004|Overall Study|Study terminated by sponsor|9|||
37821706|NCT04614246|69501460|FG000|Overall Study|Pregnancy|2|||
37821707|NCT04614246|69501461|FG001|Overall Study|Pregnancy|0|||
37821708|NCT04614246|69501462|FG002|Overall Study|Pregnancy|1|||
37821709|NCT04614246|69501463|FG003|Overall Study|Pregnancy|0|||
37821710|NCT04614246|69501464|FG004|Overall Study|Pregnancy|0|||
37821711|NCT04593823|69501482|FG000|Overall Study|Withdrawal by Subject|1|||
37821712|NCT04593823|69501483|FG001|Overall Study|Withdrawal by Subject|1|||
37821713|NCT04593823|69501482|FG000|Overall Study|Lost to Follow-up|0|||
37885390|NCT00964860|69570081|FG000|Overall Study|Withdrawal by Subject|0|||
37821714|NCT04593823|69501483|FG001|Overall Study|Lost to Follow-up|1|||
37885391|NCT00964860|69570082|FG001|Overall Study|Withdrawal by Subject|1|||
37885392|NCT01131104|69570088|FG000|Overall Study|Withdrawal by Subject|3|||
37885393|NCT01131104|69570088|FG000|Overall Study|Physician Decision|4|||
37821715|NCT04556383|69501503|FG000|PCP|Lack of Efficacy|28|||
37821716|NCT04556383|69501504|FG001|PCP|Lack of Efficacy|23|||
37821717|NCT04556383|69501505|FG002|PCP|Lack of Efficacy|23|||
37821718|NCT04556383|69501506|FG003|PCP|Lack of Efficacy|0|||
37986368|NCT00395538|69672045|FG002|Overall Study|Did not re-consent to revised protocol|0|||
37986369|NCT00395538|69672043|FG000|Overall Study|FDA partial hold on PTH|0|||
37986370|NCT00395538|69672044|FG001|Overall Study|FDA partial hold on PTH|0|||
37986371|NCT00395538|69672045|FG002|Overall Study|FDA partial hold on PTH|11|||
37986372|NCT00395538|69672043|FG000|Overall Study|Failed screening|0|||
37885394|NCT01131104|69570088|FG000|Overall Study|Information Not Available|5|||
37885395|NCT01131104|69570088|FG000|Overall Study|No Information on Index Date of Onset|1|||
37986373|NCT00395538|69672044|FG001|Overall Study|Failed screening|0|||
37986374|NCT00395538|69672045|FG002|Overall Study|Failed screening|4|||
37986375|NCT00395538|69672043|FG000|Overall Study|Switch to Natpara|0|||
37986376|NCT00395538|69672044|FG001|Overall Study|Switch to Natpara|0|||
37986377|NCT00395538|69672045|FG002|Overall Study|Switch to Natpara|3|||
37986378|NCT00395538|69672043|FG000|Overall Study|Adverse Event|1|||
37986379|NCT00395538|69672044|FG001|Overall Study|Adverse Event|0|||
37986380|NCT00395538|69672045|FG002|Overall Study|Adverse Event|2|||
37986381|NCT00395538|69672043|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
37986382|NCT00395538|69672044|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
37885396|NCT01118780|69570094|FG000|Overall Study|Adverse Event|15|||
37885397|NCT01118780|69570095|FG001|Overall Study|Adverse Event|15|||
37885398|NCT01118780|69570094|FG000|Overall Study|Death|1|||
37885399|NCT01118780|69570095|FG001|Overall Study|Death|0|||
37885400|NCT01118780|69570094|FG000|Overall Study|Lack of Efficacy|2|||
37885401|NCT01118780|69570095|FG001|Overall Study|Lack of Efficacy|6|||
37885402|NCT01118780|69570094|FG000|Overall Study|Physician Decision|2|||
37885403|NCT01118780|69570095|FG001|Overall Study|Physician Decision|0|||
37885404|NCT01118780|69570094|FG000|Overall Study|Protocol Violation|3|||
37885405|NCT01118780|69570095|FG001|Overall Study|Protocol Violation|6|||
37885406|NCT01118780|69570094|FG000|Overall Study|Withdrawal by Subject|13|||
37821719|NCT04556383|69501503|FG000|PCP|Study terminated by sponsor|15|||
37821720|NCT04556383|69501504|FG001|PCP|Study terminated by sponsor|13|||
37821721|NCT04556383|69501505|FG002|PCP|Study terminated by sponsor|16|||
37821722|NCT04556383|69501506|FG003|PCP|Study terminated by sponsor|0|||
37885407|NCT01118780|69570095|FG001|Overall Study|Withdrawal by Subject|8|||
37885408|NCT00964782|69570106|FG000|Overall Study|Lost to Follow-up|1|||
37885409|NCT00964782|69570107|FG001|Overall Study|Lost to Follow-up|0|||
37885410|NCT00966654|69570115|FG000|Overall Study|Study was terminated,PI left institution|12|||
37885411|NCT03262116|69570127|FG000|Overall Study|Physician Decision|0|||
37821723|NCT04556383|69501503|FG000|PCP|Withdrawal by Subject|8|||
37885412|NCT03262116|69570128|FG001|Overall Study|Physician Decision|2|||
37885413|NCT03262116|69570129|FG002|Overall Study|Physician Decision|1|||
37885414|NCT03262116|69570130|FG003|Overall Study|Physician Decision|1|||
37986383|NCT00395538|69672045|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
37885415|NCT03262116|69570131|FG004|Overall Study|Physician Decision|1|||
37885416|NCT03262116|69570132|FG005|Overall Study|Physician Decision|2|||
37885417|NCT01130168|69570140|FG000|Period 1|Withdrawal by Subject|0|||
37885418|NCT01130168|69570141|FG001|Period 1|Withdrawal by Subject|1|||
37885419|NCT01130168|69570142|FG002|Period 1|Withdrawal by Subject|0|||
37885420|NCT01130168|69570143|FG003|Period 1|Withdrawal by Subject|1|||
37885421|NCT01130168|69570144|FG004|Period 1|Withdrawal by Subject|0|||
37885422|NCT01130168|69570145|FG005|Period 1|Withdrawal by Subject|0|||
37885423|NCT01130168|69570140|FG000|Period 1|Discontinued For Other Reason|0|||
37885424|NCT01130168|69570141|FG001|Period 1|Discontinued For Other Reason|0|||
37885425|NCT01130168|69570142|FG002|Period 1|Discontinued For Other Reason|1|||
37885426|NCT01130168|69570143|FG003|Period 1|Discontinued For Other Reason|1|||
37885427|NCT01130168|69570144|FG004|Period 1|Discontinued For Other Reason|0|||
37885428|NCT01130168|69570145|FG005|Period 1|Discontinued For Other Reason|0|||
37885429|NCT01130168|69570140|FG000|Period 1|Adverse Event|0|||
37885430|NCT01130168|69570141|FG001|Period 1|Adverse Event|0|||
37885431|NCT01130168|69570142|FG002|Period 1|Adverse Event|0|||
37885432|NCT01130168|69570143|FG003|Period 1|Adverse Event|1|||
37885433|NCT01130168|69570144|FG004|Period 1|Adverse Event|0|||
37885434|NCT01130168|69570145|FG005|Period 1|Adverse Event|0|||
37885435|NCT01144052|69570156|FG000|Overall Study|Withdrawal by Subject|1|||
37885436|NCT01144052|69570157|FG001|Overall Study|Withdrawal by Subject|1|||
37885437|NCT01143896|69570167|FG000|Overall Study|Did not complete Baseline Interview|5|||
37885438|NCT01143896|69570168|FG001|Overall Study|Did not complete Baseline Interview|4|||
37885439|NCT01143896|69570167|FG000|Overall Study|Lost to Follow-up|18|||
37885440|NCT01143896|69570168|FG001|Overall Study|Lost to Follow-up|13|||
37885441|NCT01143896|69570167|FG000|Overall Study|Withdrawal by Subject|13|||
37885442|NCT01143896|69570168|FG001|Overall Study|Withdrawal by Subject|5|||
37885443|NCT01143896|69570167|FG000|Overall Study|Death|6|||
37885444|NCT01143896|69570168|FG001|Overall Study|Death|3|||
37885445|NCT01118312|69570177|FG000|Overall Study|Lost to Follow-up|33|||
37885446|NCT01118312|69570178|FG001|Overall Study|Lost to Follow-up|32|||
37885447|NCT01118312|69570177|FG000|Overall Study|Withdrawal by Subject|1|||
37885448|NCT01118312|69570178|FG001|Overall Study|Withdrawal by Subject|3|||
37885449|NCT01117766|69570184|FG000|First Intervention|Adverse Event|0|||
37885450|NCT01117766|69570185|FG001|First Intervention|Adverse Event|1|||
37885451|NCT01117766|69570184|FG000|First Intervention|Protocol Violation|1|||
37986384|NCT00395538|69672043|FG000|Overall Study|Non-compliance with study protocol|0|||
37986385|NCT00395538|69672044|FG001|Overall Study|Non-compliance with study protocol|1|||
37986386|NCT00395538|69672045|FG002|Overall Study|Non-compliance with study protocol|0|||
37986387|NCT00395538|69672043|FG000|Overall Study|PTH resistance|0|||
37986388|NCT00395538|69672044|FG001|Overall Study|PTH resistance|0|||
37986389|NCT00395538|69672045|FG002|Overall Study|PTH resistance|1|||
37821724|NCT04556383|69501504|FG001|PCP|Withdrawal by Subject|6|||
37821725|NCT04556383|69501505|FG002|PCP|Withdrawal by Subject|6|||
37821726|NCT04556383|69501506|FG003|PCP|Withdrawal by Subject|0|||
37821727|NCT04556383|69501503|FG000|PCP|Adverse Event|1|||
37821728|NCT04556383|69501504|FG001|PCP|Adverse Event|7|||
37821729|NCT04556383|69501505|FG002|PCP|Adverse Event|7|||
37821730|NCT04556383|69501506|FG003|PCP|Adverse Event|0|||
37821731|NCT04556383|69501503|FG000|PCP|Other, Not Specified|1|||
37821732|NCT04556383|69501504|FG001|PCP|Other, Not Specified|2|||
37821733|NCT04556383|69501505|FG002|PCP|Other, Not Specified|1|||
37821734|NCT04556383|69501506|FG003|PCP|Other, Not Specified|0|||
37821735|NCT04556383|69501503|FG000|PCP|Protocol Violation|1|||
37821736|NCT04556383|69501504|FG001|PCP|Protocol Violation|0|||
37821737|NCT04556383|69501505|FG002|PCP|Protocol Violation|1|||
37821738|NCT04556383|69501506|FG003|PCP|Protocol Violation|0|||
37821739|NCT04556383|69501503|FG000|PCP|Lost to Follow-up|1|||
37821740|NCT04556383|69501504|FG001|PCP|Lost to Follow-up|0|||
37821741|NCT04556383|69501505|FG002|PCP|Lost to Follow-up|0|||
37821742|NCT04556383|69501506|FG003|PCP|Lost to Follow-up|0|||
37885452|NCT01117766|69570185|FG001|First Intervention|Protocol Violation|0|||
37885453|NCT01117766|69570184|FG000|Washout Period|Protocol Violation|0|||
37885454|NCT01117766|69570185|FG001|Washout Period|Protocol Violation|2|||
37885455|NCT01117766|69570184|FG000|Second Intervention|Lost to Follow-up|1|||
37885456|NCT01117766|69570185|FG001|Second Intervention|Lost to Follow-up|0|||
37885457|NCT01117766|69570184|FG000|Second Intervention|Other|1|||
37885458|NCT01117766|69570185|FG001|Second Intervention|Other|2|||
37885459|NCT01117766|69570184|FG000|Second Intervention|Adverse Event|0|||
37821743|NCT04556383|69501503|FG000|PCP|Physician Decision|0|||
37821744|NCT04556383|69501504|FG001|PCP|Physician Decision|1|||
37821745|NCT04556383|69501505|FG002|PCP|Physician Decision|0|||
37821746|NCT04556383|69501506|FG003|PCP|Physician Decision|0|||
37821747|NCT04556383|69501503|FG000|PCP|Site terminated by sponsor|0|||
37821748|NCT04556383|69501504|FG001|PCP|Site terminated by sponsor|1|||
37821749|NCT04556383|69501505|FG002|PCP|Site terminated by sponsor|0|||
37885460|NCT01117766|69570185|FG001|Second Intervention|Adverse Event|2|||
37885461|NCT01117766|69570184|FG000|Second Intervention|Withdrawal by Subject|0|||
37885462|NCT01117766|69570185|FG001|Second Intervention|Withdrawal by Subject|1|||
37885463|NCT01117454|69570193|FG000|Overall Study|Pregnancy|0|||
37885464|NCT01117454|69570194|FG001|Overall Study|Pregnancy|1|||
37885465|NCT01116440|69570202|FG000|Treatment|Withdrawal by Subject|2|||
37885466|NCT01116440|69570203|FG001|Treatment|Withdrawal by Subject|2|||
37885467|NCT01116440|69570202|FG000|Treatment|Lost to Follow-up|1|||
37885468|NCT01116440|69570203|FG001|Treatment|Lost to Follow-up|1|||
37885469|NCT01116440|69570202|FG000|Treatment|Protocol Violation|0|||
37885470|NCT01116440|69570203|FG001|Treatment|Protocol Violation|2|||
37885471|NCT01116440|69570202|FG000|Treatment|Lack of Efficacy|0|||
37885472|NCT01116440|69570203|FG001|Treatment|Lack of Efficacy|1|||
37885473|NCT01116440|69570202|FG000|Treatment|Adverse Event|0|||
37885474|NCT01116440|69570203|FG001|Treatment|Adverse Event|1|||
37885475|NCT01116440|69570202|FG000|Withdrawal|Withdrawal by Subject|0|||
37885476|NCT01116440|69570203|FG001|Withdrawal|Withdrawal by Subject|1|||
37885477|NCT01116440|69570202|FG000|Withdrawal|Lost to Follow-up|0|||
37885478|NCT01116440|69570203|FG001|Withdrawal|Lost to Follow-up|1|||
37885479|NCT01116440|69570202|FG000|Follow-up|Lost to Follow-up|0|||
37885480|NCT01116440|69570203|FG001|Follow-up|Lost to Follow-up|1|||
37885481|NCT01116440|69570202|FG000|Follow-up|Withdrawal by Subject|0|||
37885482|NCT01116440|69570203|FG001|Follow-up|Withdrawal by Subject|1|||
37885483|NCT01129622|69570211|FG000|Overall Study|Withdrawal by Subject|2|||
37885484|NCT01128842|69570216|FG000|Overall Study|Adverse Event|1|||
37885485|NCT01128842|69570216|FG000|Overall Study|Disease Progression|6|||
37885486|NCT01143038|69570221|FG000|Overall Study|Withdrawal by Subject|4|||
37885487|NCT01143038|69570221|FG000|Overall Study|Requirement for alternative therapy|5|||
37885488|NCT01143038|69570221|FG000|Overall Study|Adverse Event|3|||
37885489|NCT01143038|69570221|FG000|Overall Study|Lost to Follow-up|2|||
37885490|NCT01143038|69570221|FG000|Overall Study|Protocol Deviation|1|||
37885491|NCT01143038|69570221|FG000|Overall Study|Death|1|||
37885492|NCT00966264|69570227|FG000|Overall Study|Lost to Follow-up|4|||
37885493|NCT00966264|69570228|FG001|Overall Study|Lost to Follow-up|3|||
37885494|NCT00915525|69570236|FG000|Overall Study|Protocol Violation|9|||
37885495|NCT00915525|69570237|FG001|Overall Study|Protocol Violation|4|||
37885496|NCT00915525|69570236|FG000|Overall Study|Withdrawal by Subject|59|||
37885497|NCT00915525|69570237|FG001|Overall Study|Withdrawal by Subject|21|||
37885498|NCT00915525|69570236|FG000|Overall Study|Lost to Follow-up|27|||
37885499|NCT00915525|69570237|FG001|Overall Study|Lost to Follow-up|16|||
37885500|NCT00915525|69570236|FG000|Overall Study|Pregnancy|2|||
37885501|NCT00915525|69570237|FG001|Overall Study|Pregnancy|0|||
37885502|NCT00915525|69570236|FG000|Overall Study|Lack of Efficacy|15|||
37885503|NCT00915525|69570237|FG001|Overall Study|Lack of Efficacy|32|||
37885504|NCT00915525|69570236|FG000|Overall Study|Adverse Event|29|||
37885505|NCT00915525|69570237|FG001|Overall Study|Adverse Event|13|||
37885506|NCT00915525|69570236|FG000|Overall Study|Missing|12|||
37885507|NCT00915525|69570237|FG001|Overall Study|Missing|1|||
37885508|NCT00915525|69570236|FG000|Overall Study|Other Reason|35|||
37821750|NCT04556383|69501506|FG003|PCP|Site terminated by sponsor|0|||
37821751|NCT04556383|69501503|FG000|OLE|Study terminated by sponsor|0|||
37821752|NCT04556383|69501504|FG001|OLE|Study terminated by sponsor|0|||
37821753|NCT04556383|69501505|FG002|OLE|Study terminated by sponsor|0|||
37821754|NCT04556383|69501506|FG003|OLE|Study terminated by sponsor|68|||
37821755|NCT04556383|69501503|FG000|OLE|Withdrawal by Subject|0|||
37821756|NCT04556383|69501504|FG001|OLE|Withdrawal by Subject|0|||
37821757|NCT04556383|69501505|FG002|OLE|Withdrawal by Subject|0|||
37821758|NCT04556383|69501506|FG003|OLE|Withdrawal by Subject|10|||
37821759|NCT04556383|69501503|FG000|OLE|Lack of Efficacy|0|||
37821760|NCT04556383|69501504|FG001|OLE|Lack of Efficacy|0|||
37821761|NCT04556383|69501505|FG002|OLE|Lack of Efficacy|0|||
37821762|NCT04556383|69501506|FG003|OLE|Lack of Efficacy|7|||
37821763|NCT04556383|69501503|FG000|OLE|Adverse Event|0|||
37821764|NCT04556383|69501504|FG001|OLE|Adverse Event|0|||
37821765|NCT04556383|69501505|FG002|OLE|Adverse Event|0|||
37885509|NCT00915525|69570237|FG001|Overall Study|Other Reason|12|||
37885510|NCT00915525|69570236|FG000|Overall Study|Site Closed|27|||
37885511|NCT00915525|69570237|FG001|Overall Study|Site Closed|9|||
37885512|NCT00915525|69570236|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
37885513|NCT00915525|69570237|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
37986390|NCT00395538|69672043|FG000|Overall Study|Pregnancy|1|||
37821766|NCT04556383|69501506|FG003|OLE|Adverse Event|2|||
37821767|NCT04556383|69501503|FG000|OLE|Other, Not Specified|0|||
37821768|NCT04556383|69501504|FG001|OLE|Other, Not Specified|0|||
37821769|NCT04556383|69501505|FG002|OLE|Other, Not Specified|0|||
37821770|NCT04556383|69501506|FG003|OLE|Other, Not Specified|2|||
37885514|NCT00915525|69570236|FG000|Overall Study|Study Burden|28|||
37885515|NCT00915525|69570237|FG001|Overall Study|Study Burden|12|||
37885516|NCT00915525|69570236|FG000|Overall Study|Non-Compliance|3|||
37885517|NCT00915525|69570237|FG001|Overall Study|Non-Compliance|1|||
37885518|NCT00915525|69570236|FG000|Overall Study|Patient Moved|15|||
37885519|NCT00915525|69570237|FG001|Overall Study|Patient Moved|9|||
37885520|NCT01074047|69570265|FG000|Treatment Phase|Adverse Event|89|||
37885521|NCT01074047|69570266|FG001|Treatment Phase|Adverse Event|66|||
37885522|NCT01074047|69570265|FG000|Treatment Phase|Disease Progression|16|||
37885523|NCT01074047|69570266|FG001|Treatment Phase|Disease Progression|21|||
37885524|NCT01074047|69570265|FG000|Treatment Phase|Withdrawal by Subject|27|||
37885525|NCT01074047|69570266|FG001|Treatment Phase|Withdrawal by Subject|48|||
37885526|NCT01074047|69570265|FG000|Treatment Phase|Death|53|||
37885527|NCT01074047|69570266|FG001|Treatment Phase|Death|58|||
37885528|NCT01074047|69570265|FG000|Treatment Phase|Lost to Follow-up|0|||
37885529|NCT01074047|69570266|FG001|Treatment Phase|Lost to Follow-up|1|||
37885530|NCT01074047|69570265|FG000|Treatment Phase|Protocol Violation|0|||
37885531|NCT01074047|69570266|FG001|Treatment Phase|Protocol Violation|1|||
37885532|NCT01074047|69570265|FG000|Treatment Phase|Miscellaneous|32|||
37885533|NCT01074047|69570266|FG001|Treatment Phase|Miscellaneous|39|||
37885534|NCT01074047|69570265|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
37885535|NCT01074047|69570266|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
37885536|NCT01074047|69570265|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
37885537|NCT01074047|69570266|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
37885538|NCT01074047|69570265|FG000|Survival Follow-Up Phase|Death|116|||
37885539|NCT01074047|69570266|FG001|Survival Follow-Up Phase|Death|124|||
37885540|NCT01074047|69570265|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
37885541|NCT01074047|69570266|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
37885542|NCT01074047|69570265|FG000|Extension Phase|Physician Decision|1|||
37986391|NCT00395538|69672044|FG001|Overall Study|Pregnancy|0|||
37885543|NCT01074047|69570266|FG001|Extension Phase|Physician Decision|0|||
37885544|NCT01074047|69570265|FG000|Extension Phase|Adverse Event|5|||
37885545|NCT01074047|69570266|FG001|Extension Phase|Adverse Event|0|||
37885546|NCT01074047|69570265|FG000|Extension Phase|Disease Progression|9|||
37986392|NCT00395538|69672045|FG002|Overall Study|Pregnancy|0|||
37986393|NCT00395538|69672043|FG000|Overall Study|Partial recovery of parathyroid function|0|||
37986394|NCT00395538|69672044|FG001|Overall Study|Partial recovery of parathyroid function|0|||
37986395|NCT00395538|69672045|FG002|Overall Study|Partial recovery of parathyroid function|1|||
37986396|NCT00395538|69672043|FG000|Overall Study|Participant elected to discontinue|0|||
37986397|NCT00395538|69672044|FG001|Overall Study|Participant elected to discontinue|0|||
37986398|NCT00395538|69672045|FG002|Overall Study|Participant elected to discontinue|1|||
37986399|NCT00395460|69672055|FG000|Overall Study|Withdrawal by Subject|1|||
37986400|NCT00395460|69672056|FG001|Overall Study|Withdrawal by Subject|0|||
37986401|NCT00395304|69672062|FG000|Treatment Period 1|Withdrawal by Subject|0|||
37986402|NCT00395304|69672063|FG001|Treatment Period 1|Withdrawal by Subject|3|||
37986403|NCT00395304|69672064|FG002|Treatment Period 1|Withdrawal by Subject|0|||
37986404|NCT00395304|69672065|FG003|Treatment Period 1|Withdrawal by Subject|2|||
37986405|NCT00395304|69672066|FG004|Treatment Period 1|Withdrawal by Subject|1|||
37986406|NCT00395304|69672067|FG005|Treatment Period 1|Withdrawal by Subject|1|||
37885547|NCT01074047|69570266|FG001|Extension Phase|Disease Progression|0|||
37885548|NCT01074047|69570265|FG000|Extension Phase|Withdrawal by Subject|2|||
37885549|NCT01074047|69570266|FG001|Extension Phase|Withdrawal by Subject|0|||
37885550|NCT01074047|69570265|FG000|Extension Phase|Death|5|||
37885551|NCT01074047|69570266|FG001|Extension Phase|Death|0|||
37885552|NCT01142726|69570282|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
37885553|NCT01142726|69570283|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
37885554|NCT01142726|69570284|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
37885555|NCT01142726|69570282|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
37885556|NCT01142726|69570283|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
37885557|NCT01142726|69570284|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
37885558|NCT01142726|69570282|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
37885559|NCT01142726|69570283|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
37885560|NCT01142726|69570284|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
37885561|NCT01142726|69570282|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
37885562|NCT01142726|69570283|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
37885563|NCT01142726|69570284|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
37986407|NCT00395304|69672062|FG000|Treatment Period 1|Lost to Follow-up|1|||
37986408|NCT00395304|69672063|FG001|Treatment Period 1|Lost to Follow-up|0|||
37986409|NCT00395304|69672064|FG002|Treatment Period 1|Lost to Follow-up|0|||
37986410|NCT00395304|69672065|FG003|Treatment Period 1|Lost to Follow-up|1|||
37986411|NCT00395304|69672066|FG004|Treatment Period 1|Lost to Follow-up|0|||
37885564|NCT01142726|69570282|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
37885565|NCT01142726|69570283|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
37885566|NCT01142726|69570284|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
37885567|NCT01142726|69570282|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
37885568|NCT01142726|69570283|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
37885569|NCT01142726|69570284|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
37885570|NCT01142726|69570282|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
37885571|NCT01142726|69570283|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
37885572|NCT01142726|69570284|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
37885573|NCT01142726|69570282|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
37885574|NCT01142726|69570283|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
37885575|NCT01142726|69570284|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
37885576|NCT01142726|69570282|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
37885577|NCT01142726|69570283|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
37885578|NCT01142726|69570284|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
37885579|NCT01142726|69570282|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
37885580|NCT01142726|69570283|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
37885581|NCT01142726|69570284|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
37885582|NCT01142726|69570282|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
37885583|NCT01142726|69570283|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
37885584|NCT01142726|69570284|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
37885585|NCT01142726|69570282|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
37885586|NCT01142726|69570283|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
37885587|NCT01142726|69570284|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
37885588|NCT01142726|69570282|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
37885589|NCT01142726|69570283|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
37885590|NCT01142726|69570284|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
37885591|NCT01142726|69570282|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
37885592|NCT01142726|69570283|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
37885593|NCT01142726|69570284|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
37885594|NCT01142726|69570282|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
37885595|NCT01142726|69570283|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
37885596|NCT01142726|69570284|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
37885597|NCT01142726|69570282|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
37885598|NCT01142726|69570283|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
37885599|NCT01142726|69570284|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
37885600|NCT01073267|69570300|FG000|Overall Study|Disease Progression|3|||
37885601|NCT01142336|69570306|FG000|Overall Study|Adverse Event|1|||
37885602|NCT01142336|69570307|FG001|Overall Study|Adverse Event|1|||
37885603|NCT01142336|69570306|FG000|Overall Study|Lost to Follow-up|0|||
37885604|NCT01142336|69570307|FG001|Overall Study|Lost to Follow-up|1|||
37885605|NCT00915681|69570316|FG000|Overall Study|Screening failures|46|||
37885606|NCT01128296|69570320|FG000|Overall Study|Physician Decision|0|||
37885607|NCT01128296|69570321|FG001|Overall Study|Physician Decision|0|||
37885608|NCT01128296|69570322|FG002|Overall Study|Physician Decision|0|||
37885609|NCT01128296|69570323|FG003|Overall Study|Physician Decision|0|||
37885610|NCT01128296|69570324|FG004|Overall Study|Physician Decision|0|||
37885611|NCT01128296|69570325|FG005|Overall Study|Physician Decision|3|||
37885612|NCT01128296|69570320|FG000|Overall Study|Withdrawal by Subject|0|||
37885613|NCT01128296|69570321|FG001|Overall Study|Withdrawal by Subject|0|||
37885614|NCT01128296|69570322|FG002|Overall Study|Withdrawal by Subject|0|||
37885615|NCT01128296|69570323|FG003|Overall Study|Withdrawal by Subject|0|||
37885616|NCT01128296|69570324|FG004|Overall Study|Withdrawal by Subject|0|||
37885617|NCT01128296|69570325|FG005|Overall Study|Withdrawal by Subject|2|||
37885618|NCT01115738|69570339|FG000|Overall Study|Death|1|||
37885619|NCT01115738|69570340|FG001|Overall Study|Death|0|||
37885620|NCT01115738|69570341|FG002|Overall Study|Death|0|||
37885621|NCT01115738|69570339|FG000|Overall Study|Lost to Follow-up|0|||
37885622|NCT01115738|69570340|FG001|Overall Study|Lost to Follow-up|0|||
37885623|NCT01115738|69570341|FG002|Overall Study|Lost to Follow-up|1|||
37885624|NCT01115738|69570339|FG000|Overall Study|Physician Decision|18|||
37885625|NCT01115738|69570340|FG001|Overall Study|Physician Decision|15|||
37885626|NCT01115738|69570341|FG002|Overall Study|Physician Decision|17|||
37885627|NCT01115738|69570339|FG000|Overall Study|Withdrawal by Subject|6|||
37885628|NCT01115738|69570340|FG001|Overall Study|Withdrawal by Subject|6|||
37986412|NCT00395304|69672067|FG005|Treatment Period 1|Lost to Follow-up|1|||
37986413|NCT00395304|69672062|FG000|Treatment Period 1|Physician Decision|0|||
37885629|NCT01115738|69570341|FG002|Overall Study|Withdrawal by Subject|9|||
37885630|NCT01141478|69570359|FG000|Overall Study|Withdrawal by Subject|1|||
37885631|NCT01141478|69570360|FG001|Overall Study|Withdrawal by Subject|1|||
37885632|NCT01114880|69570368|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
37885633|NCT01114880|69570369|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
37885634|NCT01114880|69570368|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
37885635|NCT01114880|69570369|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
37885636|NCT01114880|69570368|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
37885637|NCT01114880|69570369|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
37885638|NCT01114880|69570368|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
37885639|NCT01114880|69570369|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
37885640|NCT01114880|69570368|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
37885641|NCT01114880|69570369|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
37885642|NCT01114880|69570368|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
37885643|NCT01114880|69570369|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
37885644|NCT01114724|69570377|FG000|Overall Study|Death|8|||
37885645|NCT01114724|69570377|FG000|Overall Study|Lost to Follow-up|1|||
37885646|NCT01114724|69570377|FG000|Overall Study|Withdrawal by Subject|1|||
37885647|NCT00964392|69570384|FG000|Overall Study|Withdrawal by Subject|4|||
37885648|NCT00964392|69570385|FG001|Overall Study|Withdrawal by Subject|6|||
37885649|NCT00964392|69570384|FG000|Overall Study|Lost to Follow-up|4|||
37885650|NCT00964392|69570385|FG001|Overall Study|Lost to Follow-up|10|||
37885651|NCT00964392|69570384|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
37885652|NCT00964392|69570385|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
37885653|NCT00964392|69570384|FG000|Overall Study|Not completed|44|||
37885654|NCT00964392|69570385|FG001|Overall Study|Not completed|168|||
37885655|NCT00914589|69570394|FG000|Overall Study|Adverse Event|1|||
37885656|NCT00914589|69570395|FG001|Overall Study|Adverse Event|0|||
37885657|NCT00914589|69570396|FG002|Overall Study|Adverse Event|1|||
37885658|NCT00914589|69570394|FG000|Overall Study|Protocol Violation|8|||
37885659|NCT00914589|69570395|FG001|Overall Study|Protocol Violation|6|||
37885660|NCT00914589|69570396|FG002|Overall Study|Protocol Violation|3|||
37885661|NCT00914589|69570394|FG000|Overall Study|unclassified|16|||
37885662|NCT00914589|69570395|FG001|Overall Study|unclassified|9|||
37885663|NCT00914589|69570396|FG002|Overall Study|unclassified|7|||
37885664|NCT00914589|69570394|FG000|Overall Study|Death|0|||
37885665|NCT00914589|69570395|FG001|Overall Study|Death|1|||
37885666|NCT00914589|69570396|FG002|Overall Study|Death|1|||
37885667|NCT00912405|69570404|FG000|Overall Study|Lost to Follow-up|5|||
37885668|NCT00878722|69570416|FG000|Overall Study|Progressive disease|3|||
37885669|NCT00878722|69570417|FG001|Overall Study|Progressive disease|3|||
37885670|NCT00878722|69570418|FG002|Overall Study|Progressive disease|3|||
37885671|NCT00878722|69570419|FG003|Overall Study|Progressive disease|7|||
37885672|NCT00878722|69570420|FG004|Overall Study|Progressive disease|7|||
37885673|NCT00878722|69570421|FG005|Overall Study|Progressive disease|1|||
37885674|NCT00878722|69570422|FG006|Overall Study|Progressive disease|4|||
37885675|NCT00878722|69570423|FG007|Overall Study|Progressive disease|3|||
37885676|NCT00878722|69570416|FG000|Overall Study|Death|0|||
37885677|NCT00878722|69570417|FG001|Overall Study|Death|0|||
37885678|NCT00878722|69570418|FG002|Overall Study|Death|0|||
37885679|NCT00878722|69570419|FG003|Overall Study|Death|1|||
37885680|NCT00878722|69570420|FG004|Overall Study|Death|0|||
37885681|NCT00878722|69570421|FG005|Overall Study|Death|1|||
37885682|NCT00878722|69570422|FG006|Overall Study|Death|0|||
37885683|NCT00878722|69570423|FG007|Overall Study|Death|2|||
37885684|NCT00878722|69570416|FG000|Overall Study|Adverse Event|0|||
37885685|NCT00878722|69570417|FG001|Overall Study|Adverse Event|0|||
37885686|NCT00878722|69570418|FG002|Overall Study|Adverse Event|0|||
37885687|NCT00878722|69570419|FG003|Overall Study|Adverse Event|0|||
37885688|NCT00878722|69570420|FG004|Overall Study|Adverse Event|0|||
37885689|NCT00878722|69570421|FG005|Overall Study|Adverse Event|0|||
37885690|NCT00878722|69570422|FG006|Overall Study|Adverse Event|2|||
37885691|NCT00878722|69570423|FG007|Overall Study|Adverse Event|0|||
37885692|NCT00878722|69570416|FG000|Overall Study|Withdrawal by Subject|0|||
37885693|NCT00878722|69570417|FG001|Overall Study|Withdrawal by Subject|0|||
37885694|NCT00878722|69570418|FG002|Overall Study|Withdrawal by Subject|0|||
37885695|NCT00878722|69570419|FG003|Overall Study|Withdrawal by Subject|0|||
37885696|NCT00878722|69570420|FG004|Overall Study|Withdrawal by Subject|0|||
37885697|NCT00878722|69570421|FG005|Overall Study|Withdrawal by Subject|0|||
37885698|NCT00878722|69570422|FG006|Overall Study|Withdrawal by Subject|0|||
37885699|NCT00878722|69570423|FG007|Overall Study|Withdrawal by Subject|2|||
37885700|NCT00878722|69570416|FG000|Overall Study|Relapse|0|||
37885701|NCT00878722|69570417|FG001|Overall Study|Relapse|0|||
37885702|NCT00878722|69570418|FG002|Overall Study|Relapse|0|||
37885703|NCT00878722|69570419|FG003|Overall Study|Relapse|1|||
37885704|NCT00878722|69570420|FG004|Overall Study|Relapse|0|||
37885705|NCT00878722|69570421|FG005|Overall Study|Relapse|0|||
37885706|NCT00878722|69570422|FG006|Overall Study|Relapse|0|||
37885707|NCT00878722|69570423|FG007|Overall Study|Relapse|0|||
37885708|NCT00964158|69570451|FG000|Overall Study|Lost to Follow-up|0|||
37885709|NCT00964158|69570452|FG001|Overall Study|Lost to Follow-up|1|||
37885710|NCT00964158|69570453|FG002|Overall Study|Lost to Follow-up|2|||
37885711|NCT00964158|69570451|FG000|Overall Study|Withdrawal by Subject|0|||
37885712|NCT00964158|69570452|FG001|Overall Study|Withdrawal by Subject|0|||
37885713|NCT00964158|69570453|FG002|Overall Study|Withdrawal by Subject|6|||
37885714|NCT00961350|69570466|FG000|Overall Study|Adverse Event|18|||
37885715|NCT00961350|69570467|FG001|Overall Study|Adverse Event|33|||
37986414|NCT00395304|69672063|FG001|Treatment Period 1|Physician Decision|1|||
37885716|NCT00961350|69570466|FG000|Overall Study|Withdrawal by Subject|10|||
37885717|NCT00961350|69570467|FG001|Overall Study|Withdrawal by Subject|10|||
37885718|NCT00961350|69570466|FG000|Overall Study|Lost to Follow-up|3|||
37885719|NCT00961350|69570467|FG001|Overall Study|Lost to Follow-up|3|||
37885720|NCT00961350|69570466|FG000|Overall Study|Misc|16|||
37885721|NCT00961350|69570467|FG001|Overall Study|Misc|21|||
37885722|NCT00963924|69570475|FG000|Overall Study|Adverse Event|1|||
37885723|NCT00963924|69570476|FG001|Overall Study|Adverse Event|0|||
37885724|NCT00963924|69570475|FG000|Overall Study|Withdrawal by Subject|0|||
37885725|NCT00963924|69570476|FG001|Overall Study|Withdrawal by Subject|1|||
37885726|NCT00963924|69570475|FG000|Overall Study|Changed antipsychotic|0|||
37885727|NCT00963924|69570476|FG001|Overall Study|Changed antipsychotic|1|||
37885728|NCT00963924|69570475|FG000|Overall Study|Lost to Follow-up|0|||
37885729|NCT00963924|69570476|FG001|Overall Study|Lost to Follow-up|1|||
37885730|NCT03265665|69570486|FG000|24-week Data Collection|Withdrawal by Subject|2|||
37885731|NCT03265665|69570487|FG001|24-week Data Collection|Withdrawal by Subject|2|||
37885732|NCT03265665|69570486|FG000|24-week Data Collection|Lost to Follow-up|4|||
37885733|NCT03265665|69570487|FG001|24-week Data Collection|Lost to Follow-up|5|||
37885734|NCT03265665|69570486|FG000|36-week Data Collection|Lost to Follow-up|6|||
37885735|NCT03265665|69570487|FG001|36-week Data Collection|Lost to Follow-up|8|||
37885736|NCT01114646|69570497|FG000|Overall Study|Withdrawal by Subject|3|||
37885737|NCT01114646|69570498|FG001|Overall Study|Withdrawal by Subject|2|||
37885738|NCT00965562|69570507|FG000|Overall Study|Lost to Follow-up|1|||
37885739|NCT00965562|69570508|FG001|Overall Study|Lost to Follow-up|2|||
37885740|NCT00965562|69570509|FG002|Overall Study|Lost to Follow-up|3|||
37885741|NCT00965562|69570507|FG000|Overall Study|Withdrawal by Subject|2|||
37885742|NCT00965562|69570508|FG001|Overall Study|Withdrawal by Subject|2|||
37885743|NCT00965562|69570509|FG002|Overall Study|Withdrawal by Subject|0|||
37885744|NCT00912093|69570523|FG000|The Controlled Phase|Death|0|||
37885745|NCT00912093|69570524|FG001|The Controlled Phase|Death|1|||
37885746|NCT00912093|69570525|FG002|The Controlled Phase|Death|0|||
37885747|NCT00912093|69570526|FG003|The Controlled Phase|Death|0|||
37885748|NCT00912093|69570527|FG004|The Controlled Phase|Death|0|||
37885749|NCT00912093|69570523|FG000|The Controlled Phase|Medical Condition|0|||
37885750|NCT00912093|69570524|FG001|The Controlled Phase|Medical Condition|1|||
37885751|NCT00912093|69570525|FG002|The Controlled Phase|Medical Condition|0|||
37885752|NCT00912093|69570526|FG003|The Controlled Phase|Medical Condition|0|||
37885753|NCT00912093|69570527|FG004|The Controlled Phase|Medical Condition|0|||
37885754|NCT00912093|69570523|FG000|The Controlled Phase|Lost to Follow-up|0|||
37885755|NCT00912093|69570524|FG001|The Controlled Phase|Lost to Follow-up|0|||
37885756|NCT00912093|69570525|FG002|The Controlled Phase|Lost to Follow-up|0|||
37885757|NCT00912093|69570526|FG003|The Controlled Phase|Lost to Follow-up|0|||
37885758|NCT00912093|69570527|FG004|The Controlled Phase|Lost to Follow-up|1|||
37885759|NCT00965484|69570535|FG000|Overall Study|Protocol Violation|1|||
37885760|NCT00965484|69570535|FG000|Overall Study|Withdrawal by Subject|1|||
37885761|NCT00961116|69570539|FG000|Washout Period of 7 Days|Adverse Event|1|||
37885762|NCT00961116|69570540|FG001|Washout Period of 7 Days|Adverse Event|1|||
37885763|NCT00961116|69570539|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
37885764|NCT00961116|69570540|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
37885765|NCT00961116|69570539|FG000|Washout Period of 7 Days|Protocol Violation|0|||
37885766|NCT00961116|69570540|FG001|Washout Period of 7 Days|Protocol Violation|1|||
37885767|NCT00912015|69570551|FG000|Overall Study|Lack of Efficacy|1|||
37885768|NCT00912015|69570552|FG001|Overall Study|Lack of Efficacy|0|||
37885769|NCT00912015|69570553|FG002|Overall Study|Lack of Efficacy|0|||
37885770|NCT00912015|69570554|FG003|Overall Study|Lack of Efficacy|0|||
37885771|NCT00912015|69570551|FG000|Overall Study|Withdrawal by Subject|8|||
37885772|NCT00912015|69570552|FG001|Overall Study|Withdrawal by Subject|8|||
37885773|NCT00912015|69570553|FG002|Overall Study|Withdrawal by Subject|3|||
37885774|NCT00912015|69570554|FG003|Overall Study|Withdrawal by Subject|0|||
37885775|NCT00912015|69570551|FG000|Overall Study|Protocol Violation|1|||
37885776|NCT00912015|69570552|FG001|Overall Study|Protocol Violation|0|||
37885777|NCT00912015|69570553|FG002|Overall Study|Protocol Violation|0|||
37885778|NCT00912015|69570554|FG003|Overall Study|Protocol Violation|1|||
37885779|NCT00912015|69570551|FG000|Overall Study|Adverse Event|6|||
37885780|NCT00912015|69570552|FG001|Overall Study|Adverse Event|0|||
37885781|NCT00912015|69570553|FG002|Overall Study|Adverse Event|0|||
37885782|NCT00912015|69570554|FG003|Overall Study|Adverse Event|1|||
37885783|NCT00960804|69570567|FG000|Overall Study|Adverse Event|1|||
37986415|NCT00395304|69672064|FG002|Treatment Period 1|Physician Decision|0|||
37885784|NCT00960804|69570568|FG001|Overall Study|Adverse Event|0|||
37885785|NCT00960804|69570569|FG002|Overall Study|Adverse Event|0|||
37885786|NCT00960804|69570567|FG000|Overall Study|Withdrawal by Subject|1|||
37885787|NCT00960804|69570568|FG001|Overall Study|Withdrawal by Subject|0|||
37885788|NCT00960804|69570569|FG002|Overall Study|Withdrawal by Subject|0|||
37885789|NCT00960804|69570567|FG000|Overall Study|Study terminated by the sponsor|5|||
37885790|NCT00960804|69570568|FG001|Overall Study|Study terminated by the sponsor|4|||
37885791|NCT00960804|69570569|FG002|Overall Study|Study terminated by the sponsor|10|||
37885792|NCT01126580|69570580|FG000|Overall Study|Adverse Event|14|||
37885793|NCT01126580|69570581|FG001|Overall Study|Adverse Event|8|||
37885794|NCT01126580|69570582|FG002|Overall Study|Adverse Event|12|||
37885795|NCT01126580|69570580|FG000|Overall Study|Withdrawal by Subject|11|||
37885796|NCT01126580|69570581|FG001|Overall Study|Withdrawal by Subject|19|||
37885797|NCT01126580|69570582|FG002|Overall Study|Withdrawal by Subject|14|||
37885798|NCT01126580|69570580|FG000|Overall Study|Sponsor Decision|5|||
37885799|NCT01126580|69570581|FG001|Overall Study|Sponsor Decision|4|||
37885800|NCT01126580|69570582|FG002|Overall Study|Sponsor Decision|7|||
37885801|NCT01126580|69570580|FG000|Overall Study|Physician Decision|1|||
37885802|NCT01126580|69570581|FG001|Overall Study|Physician Decision|1|||
37885803|NCT01126580|69570582|FG002|Overall Study|Physician Decision|2|||
37885804|NCT01126580|69570580|FG000|Overall Study|Entry Criteria Not Met|1|||
37885805|NCT01126580|69570581|FG001|Overall Study|Entry Criteria Not Met|1|||
37885806|NCT01126580|69570582|FG002|Overall Study|Entry Criteria Not Met|2|||
37885807|NCT01126580|69570580|FG000|Overall Study|Lack of Efficacy|2|||
37885808|NCT01126580|69570581|FG001|Overall Study|Lack of Efficacy|3|||
37885809|NCT01126580|69570582|FG002|Overall Study|Lack of Efficacy|4|||
37885810|NCT01126580|69570580|FG000|Overall Study|Protocol Violation|0|||
37885811|NCT01126580|69570581|FG001|Overall Study|Protocol Violation|1|||
37885812|NCT01126580|69570582|FG002|Overall Study|Protocol Violation|2|||
37885813|NCT01126580|69570580|FG000|Overall Study|Lost to Follow-up|15|||
37885814|NCT01126580|69570581|FG001|Overall Study|Lost to Follow-up|13|||
37885815|NCT01126580|69570582|FG002|Overall Study|Lost to Follow-up|9|||
37885816|NCT01126580|69570580|FG000|Overall Study|Treatment Non-compliance|0|||
37885817|NCT01126580|69570581|FG001|Overall Study|Treatment Non-compliance|2|||
37885818|NCT01126580|69570582|FG002|Overall Study|Treatment Non-compliance|3|||
37885819|NCT00911157|69570593|FG000|Overall Study|Adverse Event|4|||
37885820|NCT00911157|69570594|FG001|Overall Study|Adverse Event|1|||
37885821|NCT00911157|69570593|FG000|Overall Study|Withdrawal by Subject|1|||
37885822|NCT00911157|69570594|FG001|Overall Study|Withdrawal by Subject|1|||
37885823|NCT00911157|69570593|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
37885824|NCT00911157|69570594|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
37885825|NCT00911157|69570593|FG000|Overall Study|Need to treat for lung cancer|1|||
37885826|NCT00911157|69570594|FG001|Overall Study|Need to treat for lung cancer|0|||
37885827|NCT00960570|69570600|FG000|21 Day Washout Period|Adverse Event|1|||
37885828|NCT00960570|69570600|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
37885829|NCT00960570|69570600|FG000|1 Day Period Between Dosing|Adverse Event|2|||
37885830|NCT00960570|69570600|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
37885831|NCT01126424|69570613|FG000|Overall Study|Adverse Event|0|||
37885832|NCT01126424|69570614|FG001|Overall Study|Adverse Event|0|||
37885833|NCT01126424|69570615|FG002|Overall Study|Adverse Event|0|||
37885834|NCT01126424|69570616|FG003|Overall Study|Adverse Event|0|||
37885835|NCT01126424|69570617|FG004|Overall Study|Adverse Event|1|||
37885836|NCT01126424|69570618|FG005|Overall Study|Adverse Event|0|||
37885837|NCT01126424|69570613|FG000|Overall Study|Withdrawal by Subject|0|||
37885838|NCT01126424|69570614|FG001|Overall Study|Withdrawal by Subject|0|||
37885839|NCT01126424|69570615|FG002|Overall Study|Withdrawal by Subject|1|||
37885840|NCT01126424|69570616|FG003|Overall Study|Withdrawal by Subject|3|||
37885841|NCT01126424|69570617|FG004|Overall Study|Withdrawal by Subject|1|||
37885842|NCT01126424|69570618|FG005|Overall Study|Withdrawal by Subject|0|||
37885843|NCT01126268|69570626|FG000|Overall Study|Adverse Event|1|||
37885844|NCT00879658|69570637|FG000|Overall Study|Abnormal laboratory value(s)|3|||
37821771|NCT04556383|69501503|FG000|OLE|Death|0|||
37821772|NCT04556383|69501504|FG001|OLE|Death|0|||
37821773|NCT04556383|69501505|FG002|OLE|Death|0|||
37821774|NCT04556383|69501506|FG003|OLE|Death|1|||
37821775|NCT04556383|69501503|FG000|OLE|Lost to Follow-up|0|||
37821776|NCT04556383|69501504|FG001|OLE|Lost to Follow-up|0|||
37821777|NCT04556383|69501505|FG002|OLE|Lost to Follow-up|0|||
37821778|NCT04556383|69501506|FG003|OLE|Lost to Follow-up|1|||
37821779|NCT04444752|69501540|FG000|Overall Study|Adverse Event|1|||
37885845|NCT00879658|69570638|FG001|Overall Study|Abnormal laboratory value(s)|0|||
37885846|NCT00879658|69570639|FG002|Overall Study|Abnormal laboratory value(s)|0|||
37885847|NCT00879658|69570640|FG003|Overall Study|Abnormal laboratory value(s)|1|||
37885848|NCT00879658|69570641|FG004|Overall Study|Abnormal laboratory value(s)|0|||
37885849|NCT00879658|69570642|FG005|Overall Study|Abnormal laboratory value(s)|0|||
37821780|NCT04444752|69501541|FG001|Overall Study|Adverse Event|0|||
37821781|NCT04444752|69501542|FG002|Overall Study|Adverse Event|0|||
37821782|NCT04444752|69501543|FG003|Overall Study|Adverse Event|2|||
37695526|NCT02363738|69171848|FG001|Overall Study|Lost to Follow-up|1|||
37695527|NCT02331680|69171857|FG000|Overall Study|Adverse Event|3|||
37695528|NCT02331680|69171858|FG001|Overall Study|Adverse Event|0|||
37821783|NCT04444752|69501540|FG000|Overall Study|Lost to Follow-up|2|||
37821784|NCT04444752|69501541|FG001|Overall Study|Lost to Follow-up|6|||
37821785|NCT04444752|69501542|FG002|Overall Study|Lost to Follow-up|2|||
37821786|NCT04444752|69501543|FG003|Overall Study|Lost to Follow-up|5|||
37821787|NCT04444752|69501540|FG000|Overall Study|Physician Decision|0|||
37821788|NCT04444752|69501541|FG001|Overall Study|Physician Decision|0|||
37821789|NCT04444752|69501542|FG002|Overall Study|Physician Decision|0|||
37821790|NCT04444752|69501543|FG003|Overall Study|Physician Decision|2|||
37986416|NCT00395304|69672065|FG003|Treatment Period 1|Physician Decision|0|||
37986417|NCT00395304|69672066|FG004|Treatment Period 1|Physician Decision|0|||
37986418|NCT00395304|69672067|FG005|Treatment Period 1|Physician Decision|0|||
37986419|NCT00395304|69672062|FG000|Treatment Period 2|Withdrawal by Subject|0|||
37821791|NCT04444752|69501540|FG000|Overall Study|Pregnancy|0|||
37821792|NCT04444752|69501541|FG001|Overall Study|Pregnancy|0|||
37821793|NCT04444752|69501542|FG002|Overall Study|Pregnancy|0|||
37821794|NCT04444752|69501543|FG003|Overall Study|Pregnancy|1|||
37821795|NCT04444752|69501540|FG000|Overall Study|Withdrawal by Subject|6|||
37821796|NCT04444752|69501541|FG001|Overall Study|Withdrawal by Subject|5|||
37821797|NCT04444752|69501542|FG002|Overall Study|Withdrawal by Subject|3|||
37821798|NCT04444752|69501543|FG003|Overall Study|Withdrawal by Subject|4|||
37821799|NCT04444752|69501540|FG000|Overall Study|Protocol Violation|1|||
37821800|NCT04444752|69501541|FG001|Overall Study|Protocol Violation|1|||
37821801|NCT04444752|69501542|FG002|Overall Study|Protocol Violation|0|||
37821802|NCT04444752|69501543|FG003|Overall Study|Protocol Violation|0|||
37821803|NCT04444752|69501540|FG000|Overall Study|Patient moving out of town|1|||
37821804|NCT04444752|69501541|FG001|Overall Study|Patient moving out of town|0|||
37986420|NCT00395304|69672063|FG001|Treatment Period 2|Withdrawal by Subject|0|||
37695529|NCT02331680|69171859|FG002|Overall Study|Adverse Event|2|||
37695530|NCT02331680|69171857|FG000|Overall Study|Physician Decision|1|||
37821805|NCT04444752|69501542|FG002|Overall Study|Patient moving out of town|0|||
37821806|NCT04444752|69501543|FG003|Overall Study|Patient moving out of town|1|||
37821807|NCT04444752|69501540|FG000|Overall Study|Lack of Efficacy|0|||
37821808|NCT04444752|69501541|FG001|Overall Study|Lack of Efficacy|0|||
37821809|NCT04444752|69501542|FG002|Overall Study|Lack of Efficacy|0|||
37885850|NCT00879658|69570643|FG006|Overall Study|Abnormal laboratory value(s)|0|||
37885851|NCT00879658|69570637|FG000|Overall Study|Administrative problems|2|||
37885852|NCT00879658|69570638|FG001|Overall Study|Administrative problems|1|||
37885853|NCT00879658|69570639|FG002|Overall Study|Administrative problems|0|||
37885854|NCT00879658|69570640|FG003|Overall Study|Administrative problems|1|||
37885855|NCT00879658|69570641|FG004|Overall Study|Administrative problems|0|||
37885856|NCT00879658|69570642|FG005|Overall Study|Administrative problems|0|||
37885857|NCT00879658|69570643|FG006|Overall Study|Administrative problems|0|||
37885858|NCT00879658|69570637|FG000|Overall Study|Adverse Event|6|||
37885859|NCT00879658|69570638|FG001|Overall Study|Adverse Event|4|||
37885860|NCT00879658|69570639|FG002|Overall Study|Adverse Event|3|||
37885861|NCT00879658|69570640|FG003|Overall Study|Adverse Event|1|||
37885862|NCT00879658|69570641|FG004|Overall Study|Adverse Event|2|||
37885863|NCT00879658|69570642|FG005|Overall Study|Adverse Event|0|||
37885864|NCT00879658|69570643|FG006|Overall Study|Adverse Event|0|||
37885865|NCT00879658|69570637|FG000|Overall Study|Protocol Violation|1|||
37885866|NCT00879658|69570638|FG001|Overall Study|Protocol Violation|0|||
37885867|NCT00879658|69570639|FG002|Overall Study|Protocol Violation|0|||
37885868|NCT00879658|69570640|FG003|Overall Study|Protocol Violation|0|||
37885869|NCT00879658|69570641|FG004|Overall Study|Protocol Violation|0|||
37885870|NCT00879658|69570642|FG005|Overall Study|Protocol Violation|0|||
37885871|NCT00879658|69570643|FG006|Overall Study|Protocol Violation|0|||
37885872|NCT00879658|69570637|FG000|Overall Study|Withdrawal by Subject|3|||
37885873|NCT00879658|69570638|FG001|Overall Study|Withdrawal by Subject|0|||
37885874|NCT00879658|69570639|FG002|Overall Study|Withdrawal by Subject|2|||
37885875|NCT00879658|69570640|FG003|Overall Study|Withdrawal by Subject|0|||
37885876|NCT00879658|69570641|FG004|Overall Study|Withdrawal by Subject|0|||
37885877|NCT00879658|69570642|FG005|Overall Study|Withdrawal by Subject|1|||
37885878|NCT00879658|69570643|FG006|Overall Study|Withdrawal by Subject|0|||
37885879|NCT00879658|69570637|FG000|Overall Study|Lack of Efficacy|0|||
37885880|NCT00879658|69570638|FG001|Overall Study|Lack of Efficacy|0|||
37885881|NCT00879658|69570639|FG002|Overall Study|Lack of Efficacy|2|||
37885882|NCT00879658|69570640|FG003|Overall Study|Lack of Efficacy|0|||
37885883|NCT00879658|69570641|FG004|Overall Study|Lack of Efficacy|0|||
37885884|NCT00879658|69570642|FG005|Overall Study|Lack of Efficacy|0|||
37885885|NCT00879658|69570643|FG006|Overall Study|Lack of Efficacy|0|||
37885886|NCT00879658|69570637|FG000|Overall Study|misrandomized (never received study med)|0|||
37885887|NCT00879658|69570638|FG001|Overall Study|misrandomized (never received study med)|0|||
37885888|NCT00879658|69570639|FG002|Overall Study|misrandomized (never received study med)|0|||
37885889|NCT00879658|69570640|FG003|Overall Study|misrandomized (never received study med)|1|||
37885890|NCT00879658|69570641|FG004|Overall Study|misrandomized (never received study med)|0|||
37885891|NCT00879658|69570642|FG005|Overall Study|misrandomized (never received study med)|0|||
37885892|NCT00879658|69570643|FG006|Overall Study|misrandomized (never received study med)|0|||
37885893|NCT00959946|69570673|FG000|Overall Study|Adverse Event|0|||
37885894|NCT00959946|69570674|FG001|Overall Study|Adverse Event|0|||
37885895|NCT00959946|69570675|FG002|Overall Study|Adverse Event|2|||
37885896|NCT00959946|69570676|FG003|Overall Study|Adverse Event|1|||
37885897|NCT00959946|69570677|FG004|Overall Study|Adverse Event|0|||
37885898|NCT00959946|69570678|FG005|Overall Study|Adverse Event|1|||
37821810|NCT04444752|69501543|FG003|Overall Study|Lack of Efficacy|1|||
37821811|NCT04444752|69501540|FG000|Overall Study|Death|0|||
37885899|NCT00959946|69570679|FG006|Overall Study|Adverse Event|0|||
37885900|NCT00959946|69570680|FG007|Overall Study|Adverse Event|0|||
37885901|NCT00959946|69570673|FG000|Overall Study|Death|0|||
37885902|NCT00959946|69570674|FG001|Overall Study|Death|0|||
37885903|NCT00959946|69570675|FG002|Overall Study|Death|0|||
37885904|NCT00959946|69570676|FG003|Overall Study|Death|0|||
37885905|NCT00959946|69570677|FG004|Overall Study|Death|0|||
37821812|NCT04444752|69501541|FG001|Overall Study|Death|0|||
37821813|NCT04444752|69501542|FG002|Overall Study|Death|1|||
37821814|NCT04444752|69501543|FG003|Overall Study|Death|0|||
37821815|NCT04429022|69501555|FG000|Overall Study|Protocol Violation|18|||
37821816|NCT04429022|69501556|FG001|Overall Study|Protocol Violation|1|||
37821817|NCT04351373|69501586|FG000|Overall Study|Intraoperative diagnosis of facial nerve schwannoma|1|||
37821818|NCT04239924|69501599|FG000|Overall Study|Lost to Follow-up|2|||
37885906|NCT00959946|69570678|FG005|Overall Study|Death|1|||
37885907|NCT00959946|69570679|FG006|Overall Study|Death|0|||
37885908|NCT00959946|69570680|FG007|Overall Study|Death|0|||
37821819|NCT04154904|69501611|FG000|At Home Period (28 Days)|Withdrawal by Subject|0|||
37885909|NCT00959946|69570673|FG000|Overall Study|Disease Progression|2|||
37885910|NCT00959946|69570674|FG001|Overall Study|Disease Progression|4|||
37885911|NCT00959946|69570675|FG002|Overall Study|Disease Progression|2|||
37885912|NCT00959946|69570676|FG003|Overall Study|Disease Progression|4|||
37885913|NCT00959946|69570677|FG004|Overall Study|Disease Progression|4|||
37885914|NCT00959946|69570678|FG005|Overall Study|Disease Progression|6|||
37885915|NCT00959946|69570679|FG006|Overall Study|Disease Progression|2|||
37885916|NCT00959946|69570680|FG007|Overall Study|Disease Progression|2|||
37821820|NCT04154904|69501612|FG001|At Home Period (28 Days)|Withdrawal by Subject|0|||
37885917|NCT00959946|69570673|FG000|Overall Study|Withdrawal by Subject|0|||
37885918|NCT00959946|69570674|FG001|Overall Study|Withdrawal by Subject|0|||
37885919|NCT00959946|69570675|FG002|Overall Study|Withdrawal by Subject|0|||
37885920|NCT00959946|69570676|FG003|Overall Study|Withdrawal by Subject|0|||
37885921|NCT00959946|69570677|FG004|Overall Study|Withdrawal by Subject|0|||
37885922|NCT00959946|69570678|FG005|Overall Study|Withdrawal by Subject|1|||
37885923|NCT00959946|69570679|FG006|Overall Study|Withdrawal by Subject|0|||
37885924|NCT00959946|69570680|FG007|Overall Study|Withdrawal by Subject|0|||
37885925|NCT00911937|69570705|FG000|Overall Study|Death|1|||
37885926|NCT00911937|69570706|FG001|Overall Study|Death|0|||
37885927|NCT00911937|69570705|FG000|Overall Study|Lost to Follow-up|8|||
37885928|NCT00911937|69570706|FG001|Overall Study|Lost to Follow-up|5|||
37885929|NCT00911937|69570705|FG000|Overall Study|Withdrawal by Subject|10|||
37885930|NCT00911937|69570706|FG001|Overall Study|Withdrawal by Subject|7|||
37885931|NCT00911937|69570705|FG000|Overall Study|Withdrawn due to pregnancy|1|||
37986421|NCT00395304|69672064|FG002|Treatment Period 2|Withdrawal by Subject|0|||
37986422|NCT00395304|69672065|FG003|Treatment Period 2|Withdrawal by Subject|1|||
37986423|NCT00395304|69672066|FG004|Treatment Period 2|Withdrawal by Subject|0|||
37986424|NCT00395304|69672067|FG005|Treatment Period 2|Withdrawal by Subject|2|||
37986425|NCT00395304|69672062|FG000|Treatment Period 2|Lost to Follow-up|0|||
37986426|NCT00395304|69672063|FG001|Treatment Period 2|Lost to Follow-up|3|||
37821821|NCT04154904|69501613|FG002|At Home Period (28 Days)|Withdrawal by Subject|1|||
37885932|NCT00911937|69570706|FG001|Overall Study|Withdrawn due to pregnancy|0|||
37885933|NCT00911937|69570705|FG000|Overall Study|Adverse Event|11|||
37885934|NCT00911937|69570706|FG001|Overall Study|Adverse Event|25|||
37885935|NCT00911937|69570705|FG000|Overall Study|Lack of Efficacy|11|||
37885936|NCT00911937|69570706|FG001|Overall Study|Lack of Efficacy|6|||
37885937|NCT00911937|69570705|FG000|Overall Study|Did not meet inclusion criteria|9|||
37885938|NCT00911937|69570706|FG001|Overall Study|Did not meet inclusion criteria|11|||
37885939|NCT00911937|69570705|FG000|Overall Study|Protocol Violation|14|||
37885940|NCT00911937|69570706|FG001|Overall Study|Protocol Violation|23|||
37885941|NCT00911937|69570705|FG000|Overall Study|Randomized but not treated|13|||
37885942|NCT00911937|69570706|FG001|Overall Study|Randomized but not treated|13|||
37885943|NCT00911937|69570705|FG000|Overall Study|Other|9|||
37885944|NCT00911937|69570706|FG001|Overall Study|Other|5|||
37885945|NCT00880048|69570715|FG000|Overall Study|Adverse Event|2|||
37885946|NCT00880048|69570716|FG001|Overall Study|Adverse Event|3|||
37885947|NCT00880048|69570717|FG002|Overall Study|Adverse Event|5|||
37885948|NCT00880048|69570715|FG000|Overall Study|Lack of Efficacy|1|||
37885949|NCT00880048|69570716|FG001|Overall Study|Lack of Efficacy|2|||
37986427|NCT00395304|69672064|FG002|Treatment Period 2|Lost to Follow-up|0|||
37986428|NCT00395304|69672065|FG003|Treatment Period 2|Lost to Follow-up|0|||
37821822|NCT04114656|69501625|FG000|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|0|||
37821823|NCT04114656|69501626|FG001|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|1|||
37821824|NCT04114656|69501625|FG000|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|0|||
37821825|NCT04114656|69501626|FG001|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|2|||
37821826|NCT04114656|69501625|FG000|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
37821827|NCT04114656|69501626|FG001|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
37821828|NCT04114656|69501625|FG000|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|1|||
37821829|NCT04114656|69501626|FG001|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|0|||
37821830|NCT04114656|69501625|FG000|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
37821831|NCT04114656|69501626|FG001|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
37821832|NCT04034238|69501644|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
37821833|NCT04034238|69501645|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
37821834|NCT04034238|69501646|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
37821835|NCT04034238|69501647|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
37821836|NCT04034238|69501644|FG000|Dose Escalation Phase|Screen failures|0|||
37821837|NCT04034238|69501645|FG001|Dose Escalation Phase|Screen failures|0|||
37821838|NCT04034238|69501646|FG002|Dose Escalation Phase|Screen failures|0|||
37821839|NCT04034238|69501647|FG003|Dose Escalation Phase|Screen failures|2|||
37821840|NCT04034238|69501644|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
37821841|NCT04034238|69501645|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
37821842|NCT04034238|69501646|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
37821843|NCT04034238|69501647|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
37821844|NCT04034238|69501644|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
37885950|NCT00880048|69570717|FG002|Overall Study|Lack of Efficacy|2|||
37885951|NCT00880048|69570715|FG000|Overall Study|Protocol Violation|4|||
37885952|NCT00880048|69570716|FG001|Overall Study|Protocol Violation|6|||
37885953|NCT00880048|69570717|FG002|Overall Study|Protocol Violation|5|||
37885954|NCT00880048|69570715|FG000|Overall Study|Lost to Follow-up|6|||
37885955|NCT00880048|69570716|FG001|Overall Study|Lost to Follow-up|6|||
37885956|NCT00880048|69570717|FG002|Overall Study|Lost to Follow-up|5|||
37885957|NCT00880048|69570715|FG000|Overall Study|Physician Decision|1|||
37885958|NCT00880048|69570716|FG001|Overall Study|Physician Decision|1|||
37885959|NCT00880048|69570717|FG002|Overall Study|Physician Decision|7|||
37885960|NCT00880048|69570715|FG000|Overall Study|Withdrawal by Subject|5|||
37885961|NCT00880048|69570716|FG001|Overall Study|Withdrawal by Subject|8|||
37885962|NCT00880048|69570717|FG002|Overall Study|Withdrawal by Subject|5|||
37986429|NCT00395304|69672066|FG004|Treatment Period 2|Lost to Follow-up|0|||
37986430|NCT00395304|69672067|FG005|Treatment Period 2|Lost to Follow-up|0|||
37986431|NCT00395304|69672062|FG000|Treatment Period 2|Physician Decision|0|||
37986432|NCT00395304|69672063|FG001|Treatment Period 2|Physician Decision|0|||
37986433|NCT00395304|69672064|FG002|Treatment Period 2|Physician Decision|1|||
37986434|NCT00395304|69672065|FG003|Treatment Period 2|Physician Decision|0|||
37986435|NCT00395304|69672066|FG004|Treatment Period 2|Physician Decision|0|||
37986436|NCT00395304|69672067|FG005|Treatment Period 2|Physician Decision|0|||
37986437|NCT00395304|69672062|FG000|Treatment Period 2|Other|0|||
37986438|NCT00395304|69672063|FG001|Treatment Period 2|Other|1|||
37986439|NCT00395304|69672064|FG002|Treatment Period 2|Other|0|||
37986440|NCT00395304|69672065|FG003|Treatment Period 2|Other|0|||
37986441|NCT00395304|69672066|FG004|Treatment Period 2|Other|0|||
37986442|NCT00395304|69672067|FG005|Treatment Period 2|Other|0|||
37986443|NCT00395304|69672062|FG000|Treatment Period 3|Withdrawal by Subject|0|||
37986444|NCT00395304|69672063|FG001|Treatment Period 3|Withdrawal by Subject|0|||
37986445|NCT00395304|69672064|FG002|Treatment Period 3|Withdrawal by Subject|0|||
37986446|NCT00395304|69672065|FG003|Treatment Period 3|Withdrawal by Subject|1|||
37986447|NCT00395304|69672066|FG004|Treatment Period 3|Withdrawal by Subject|0|||
37986448|NCT00395304|69672067|FG005|Treatment Period 3|Withdrawal by Subject|1|||
37986449|NCT00395304|69672062|FG000|Treatment Period 3|Lost to Follow-up|1|||
37986450|NCT00395304|69672063|FG001|Treatment Period 3|Lost to Follow-up|1|||
37986451|NCT00395304|69672064|FG002|Treatment Period 3|Lost to Follow-up|0|||
37986452|NCT00395304|69672065|FG003|Treatment Period 3|Lost to Follow-up|0|||
37986453|NCT00395304|69672066|FG004|Treatment Period 3|Lost to Follow-up|0|||
37986454|NCT00395304|69672067|FG005|Treatment Period 3|Lost to Follow-up|0|||
37986455|NCT00395304|69672062|FG000|Treatment Period 3|Physician Decision|0|||
37986456|NCT00395304|69672063|FG001|Treatment Period 3|Physician Decision|1|||
37986457|NCT00395304|69672064|FG002|Treatment Period 3|Physician Decision|0|||
37986458|NCT00395304|69672065|FG003|Treatment Period 3|Physician Decision|0|||
37986459|NCT00395304|69672066|FG004|Treatment Period 3|Physician Decision|0|||
37821845|NCT04034238|69501645|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
37821846|NCT04034238|69501646|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
37986460|NCT00395304|69672067|FG005|Treatment Period 3|Physician Decision|0|||
37986461|NCT00395304|69672062|FG000|Treatment Period 3|Other|0|||
37986462|NCT00395304|69672063|FG001|Treatment Period 3|Other|0|||
37986463|NCT00395304|69672064|FG002|Treatment Period 3|Other|0|||
37986464|NCT00395304|69672065|FG003|Treatment Period 3|Other|1|||
37986465|NCT00395304|69672066|FG004|Treatment Period 3|Other|0|||
37986466|NCT00395304|69672067|FG005|Treatment Period 3|Other|0|||
37986467|NCT00395226|69672076|FG000|Overall Study|Adverse Event|4|||
37986468|NCT00395226|69672077|FG001|Overall Study|Adverse Event|3|||
37986469|NCT00395226|69672076|FG000|Overall Study|Withdrawal by Subject|0|||
37986470|NCT00395226|69672077|FG001|Overall Study|Withdrawal by Subject|1|||
37986471|NCT00395226|69672076|FG000|Overall Study|Lost to Follow-up|0|||
37821847|NCT04034238|69501647|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
37821848|NCT03956056|69501658|FG000|Overall Study|Cannot make vaccine due to lack of tissue variants|2|||
37821849|NCT03956056|69501658|FG000|Overall Study|Lack of Efficacy|1|||
37821850|NCT03926195|69501664|FG000|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|0|||
37885963|NCT00880048|69570715|FG000|Overall Study|Study closed/terminated|9|||
37986472|NCT00395226|69672077|FG001|Overall Study|Lost to Follow-up|1|||
37986473|NCT00394914|69672085|FG000|Treatment Period|Adverse Event|0|||
37986474|NCT00394914|69672086|FG001|Treatment Period|Adverse Event|3|||
37986475|NCT00394914|69672087|FG002|Treatment Period|Adverse Event|1|||
37986476|NCT00394914|69672085|FG000|Treatment Period|Lost to Follow-up|0|||
37986477|NCT00394914|69672086|FG001|Treatment Period|Lost to Follow-up|1|||
37986478|NCT00394914|69672087|FG002|Treatment Period|Lost to Follow-up|0|||
37986479|NCT00394914|69672085|FG000|Treatment Period|Withdrawal by Subject|0|||
37986480|NCT00394914|69672086|FG001|Treatment Period|Withdrawal by Subject|2|||
37986481|NCT00394914|69672087|FG002|Treatment Period|Withdrawal by Subject|2|||
37986482|NCT00394914|69672085|FG000|Treatment Period|Noncompliance with protocol|0|||
37986483|NCT00394914|69672086|FG001|Treatment Period|Noncompliance with protocol|3|||
37986484|NCT00394914|69672087|FG002|Treatment Period|Noncompliance with protocol|2|||
37986485|NCT00394914|69672085|FG000|Treatment Period|Did not meet protocol eligibility|0|||
37986486|NCT00394914|69672086|FG001|Treatment Period|Did not meet protocol eligibility|1|||
37986487|NCT00394914|69672087|FG002|Treatment Period|Did not meet protocol eligibility|1|||
37986488|NCT00366444|69672095|FG000|Overall Study|Withdrawal by Subject|1|||
37986489|NCT00366444|69672096|FG001|Overall Study|Withdrawal by Subject|1|||
37986490|NCT00366444|69672095|FG000|Overall Study|Lack of Efficacy|0|||
37986491|NCT00366444|69672096|FG001|Overall Study|Lack of Efficacy|1|||
37986492|NCT00365976|69672104|FG000|Overall Study|Withdrawal by Subject|1|||
37986493|NCT00365976|69672105|FG001|Overall Study|Withdrawal by Subject|5|||
37986494|NCT00379236|69672113|FG000|Double-blind|Adverse Event|11|||
37986495|NCT00379236|69672114|FG001|Double-blind|Adverse Event|6|||
37885964|NCT00880048|69570716|FG001|Overall Study|Study closed/terminated|7|||
37885965|NCT00880048|69570717|FG002|Overall Study|Study closed/terminated|6|||
37885966|NCT00962208|69570727|FG000|Overall Study|Could not achieve good vision|9|||
37885967|NCT00962208|69570728|FG001|Overall Study|Could not achieve good vision|0|||
37885968|NCT00962208|69570727|FG000|Overall Study|Contraindicated to continue study|5|||
37885969|NCT00962208|69570728|FG001|Overall Study|Contraindicated to continue study|1|||
37885970|NCT00962208|69570727|FG000|Overall Study|Lost to Follow-up|0|||
37885971|NCT00962208|69570728|FG001|Overall Study|Lost to Follow-up|9|||
37885972|NCT01076543|69570740|FG000|Overall Study|Withdrawal by Subject|2|||
37885973|NCT01076543|69570741|FG001|Overall Study|Withdrawal by Subject|0|||
37885974|NCT01076543|69570742|FG002|Overall Study|Withdrawal by Subject|0|||
37885975|NCT01076543|69570743|FG003|Overall Study|Withdrawal by Subject|0|||
37885976|NCT01076543|69570744|FG004|Overall Study|Withdrawal by Subject|0|||
37885977|NCT01076543|69570745|FG005|Overall Study|Withdrawal by Subject|0|||
37885978|NCT01072877|69570765|FG000|Overall Study|Lost to Follow-up|1|||
37885979|NCT01072877|69570766|FG001|Overall Study|Lost to Follow-up|1|||
37885980|NCT01072877|69570767|FG002|Overall Study|Lost to Follow-up|0|||
37885981|NCT01072877|69570768|FG003|Overall Study|Lost to Follow-up|2|||
37885982|NCT01072877|69570769|FG004|Overall Study|Lost to Follow-up|0|||
37885983|NCT00961896|69570786|FG000|Overall Study|Abnormal laboratory value|0|||
37885984|NCT00961896|69570787|FG001|Overall Study|Abnormal laboratory value|0|||
37885985|NCT00961896|69570788|FG002|Overall Study|Abnormal laboratory value|1|||
37885986|NCT00957528|69570802|FG000|Overall Study|Protocol Violation|0|||
37885987|NCT00957528|69570803|FG001|Overall Study|Protocol Violation|1|||
37885988|NCT00957528|69570804|FG002|Overall Study|Protocol Violation|0|||
37885989|NCT00957528|69570802|FG000|Overall Study|Withdrawal by Subject|0|||
37885990|NCT00957528|69570803|FG001|Overall Study|Withdrawal by Subject|0|||
37885991|NCT00957528|69570804|FG002|Overall Study|Withdrawal by Subject|1|||
37885992|NCT00958776|69570814|FG000|Overall Study|Adverse Event|0|||
37885993|NCT00958776|69570815|FG001|Overall Study|Adverse Event|1|||
37885994|NCT00958776|69570814|FG000|Overall Study|Physician Decision|1|||
37885995|NCT00958776|69570815|FG001|Overall Study|Physician Decision|0|||
37885996|NCT00958776|69570814|FG000|Overall Study|Lost to Follow-up|2|||
37986496|NCT00379236|69672115|FG002|Double-blind|Adverse Event|0|||
37885997|NCT00958776|69570815|FG001|Overall Study|Lost to Follow-up|6|||
37885998|NCT00958776|69570814|FG000|Overall Study|Withdrawal by Subject|7|||
37986497|NCT00379236|69672113|FG000|Double-blind|Protocol Violation|3|||
37986498|NCT00379236|69672114|FG001|Double-blind|Protocol Violation|3|||
37986499|NCT00379236|69672115|FG002|Double-blind|Protocol Violation|0|||
37986500|NCT00379236|69672113|FG000|Double-blind|Withdrawal by Subject|12|||
37986501|NCT00379236|69672114|FG001|Double-blind|Withdrawal by Subject|13|||
37986502|NCT00379236|69672115|FG002|Double-blind|Withdrawal by Subject|0|||
37986503|NCT00379236|69672113|FG000|Double-blind|Lost to Follow-up|4|||
37986504|NCT00379236|69672114|FG001|Double-blind|Lost to Follow-up|3|||
37986505|NCT00379236|69672115|FG002|Double-blind|Lost to Follow-up|0|||
37986506|NCT00379236|69672113|FG000|Double-blind|Use of exclusionary medication|1|||
37986507|NCT00379236|69672114|FG001|Double-blind|Use of exclusionary medication|2|||
37986508|NCT00379236|69672115|FG002|Double-blind|Use of exclusionary medication|0|||
37986509|NCT00379236|69672113|FG000|Double-blind|Other|3|||
37986510|NCT00379236|69672114|FG001|Double-blind|Other|7|||
37986511|NCT00379236|69672115|FG002|Double-blind|Other|0|||
37986512|NCT00379236|69672113|FG000|Double-blind|Data could not be retrieved|2|||
37986513|NCT00379236|69672114|FG001|Double-blind|Data could not be retrieved|2|||
37885999|NCT00958776|69570815|FG001|Overall Study|Withdrawal by Subject|16|||
37886000|NCT00958776|69570814|FG000|Overall Study|Protocol Violation|1|||
37986514|NCT00379236|69672115|FG002|Double-blind|Data could not be retrieved|0|||
37986515|NCT00379236|69672113|FG000|Open-label Extension|Adverse Event|0|||
37886001|NCT00958776|69570815|FG001|Overall Study|Protocol Violation|1|||
37886002|NCT00958776|69570814|FG000|Overall Study|Death|2|||
37886003|NCT00958776|69570815|FG001|Overall Study|Death|1|||
37886004|NCT00958776|69570814|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
37886005|NCT00958776|69570815|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
37886006|NCT00958776|69570814|FG000|Overall Study|Missing|1|||
37886007|NCT00958776|69570815|FG001|Overall Study|Missing|1|||
37886008|NCT00596830|69570824|FG000|Overall Study|Death|258|||
37886009|NCT00596830|69570825|FG001|Overall Study|Death|247|||
37886010|NCT00596830|69570824|FG000|Overall Study|Lost to Follow-up|7|||
37886011|NCT00596830|69570825|FG001|Overall Study|Lost to Follow-up|11|||
37695531|NCT02331680|69171858|FG001|Overall Study|Physician Decision|1|||
37821851|NCT03926195|69501665|FG001|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|2|||
37821852|NCT03926195|69501664|FG000|EXT Phase (Through Week 26)|Ongoing in the study|29|||
37821853|NCT03926195|69501665|FG001|EXT Phase (Through Week 26)|Ongoing in the study|36|||
37821854|NCT03926195|69501664|FG000|EXT Phase (Through Week 26)|Adverse Event|5|||
37821855|NCT03926195|69501665|FG001|EXT Phase (Through Week 26)|Adverse Event|0|||
37821856|NCT03926195|69501664|FG000|EXT Phase (Through Week 26)|Pre-Specified Decrease In Sperm Parameters|12|||
37821857|NCT03926195|69501665|FG001|EXT Phase (Through Week 26)|Pre-Specified Decrease In Sperm Parameters|11|||
37821858|NCT03926195|69501664|FG000|EXT Phase (Through Week 26)|Withdrawal by Subject|0|||
37821859|NCT03926195|69501665|FG001|EXT Phase (Through Week 26)|Withdrawal by Subject|2|||
37821860|NCT03908476|69501680|FG000|Overall Study|Death|3|||
37886012|NCT00596830|69570824|FG000|Overall Study|Withdrawal by Subject|22|||
37886013|NCT00596830|69570825|FG001|Overall Study|Withdrawal by Subject|12|||
37886014|NCT00596830|69570824|FG000|Overall Study|Study terminated by sponsor|51|||
37821861|NCT03908476|69501681|FG001|Overall Study|Death|0|||
37886015|NCT00596830|69570825|FG001|Overall Study|Study terminated by sponsor|62|||
37886016|NCT00596830|69570824|FG000|Overall Study|Follow-up was discontinued|1|||
37886017|NCT00596830|69570825|FG001|Overall Study|Follow-up was discontinued|0|||
37886018|NCT00596830|69570824|FG000|Overall Study|Randomized but not treated|3|||
37886019|NCT00596830|69570825|FG001|Overall Study|Randomized but not treated|7|||
37886020|NCT00957372|69570834|FG000|PART I|Lost to Follow-up|0|||
37886021|NCT00957372|69570835|FG001|PART I|Lost to Follow-up|0|||
37986516|NCT00379236|69672114|FG001|Open-label Extension|Adverse Event|0|||
37986517|NCT00379236|69672115|FG002|Open-label Extension|Adverse Event|13|||
37986518|NCT00379236|69672113|FG000|Open-label Extension|Protocol Violation|0|||
37986519|NCT00379236|69672114|FG001|Open-label Extension|Protocol Violation|0|||
37986520|NCT00379236|69672115|FG002|Open-label Extension|Protocol Violation|7|||
37986521|NCT00379236|69672113|FG000|Open-label Extension|Withdrawal by Subject|0|||
37986522|NCT00379236|69672114|FG001|Open-label Extension|Withdrawal by Subject|0|||
37986523|NCT00379236|69672115|FG002|Open-label Extension|Withdrawal by Subject|13|||
37986524|NCT00379236|69672113|FG000|Open-label Extension|Lost to Follow-up|0|||
37986525|NCT00379236|69672114|FG001|Open-label Extension|Lost to Follow-up|0|||
37986526|NCT00379236|69672115|FG002|Open-label Extension|Lost to Follow-up|12|||
37986527|NCT00379236|69672113|FG000|Open-label Extension|Use of exclusionary medication|0|||
37695532|NCT02331680|69171859|FG002|Overall Study|Physician Decision|2|||
37695533|NCT02331680|69171857|FG000|Overall Study|Withdrawal by Subject|0|||
37886022|NCT00957372|69570836|FG002|PART I|Lost to Follow-up|1|||
37886023|NCT00957372|69570837|FG003|PART I|Lost to Follow-up|0|||
37886024|NCT00957372|69570834|FG000|PART II|Withdrawal by Subject|0|||
37886025|NCT00957372|69570835|FG001|PART II|Withdrawal by Subject|0|||
37886026|NCT00957372|69570836|FG002|PART II|Withdrawal by Subject|0|||
37886027|NCT00957372|69570837|FG003|PART II|Withdrawal by Subject|8|||
37886028|NCT00957372|69570834|FG000|PART II|Physician Decision|0|||
37886029|NCT00957372|69570835|FG001|PART II|Physician Decision|0|||
37886030|NCT00957372|69570836|FG002|PART II|Physician Decision|0|||
37886031|NCT00957372|69570837|FG003|PART II|Physician Decision|1|||
37886032|NCT00957372|69570834|FG000|PART II|Pregnancy|0|||
37886033|NCT00957372|69570835|FG001|PART II|Pregnancy|0|||
37886034|NCT00957372|69570836|FG002|PART II|Pregnancy|0|||
37886035|NCT00957372|69570837|FG003|PART II|Pregnancy|1|||
37886036|NCT00957372|69570834|FG000|PART II|Not Know|0|||
37886037|NCT00957372|69570835|FG001|PART II|Not Know|0|||
37886038|NCT00957372|69570836|FG002|PART II|Not Know|0|||
37886039|NCT00957372|69570837|FG003|PART II|Not Know|20|||
37886040|NCT00957372|69570834|FG000|PART II|Adverse Event|0|||
37886041|NCT00957372|69570835|FG001|PART II|Adverse Event|0|||
37886042|NCT00957372|69570836|FG002|PART II|Adverse Event|0|||
37886043|NCT00957372|69570837|FG003|PART II|Adverse Event|10|||
37886044|NCT00957372|69570834|FG000|PART II|Patient non-compliance|0|||
37886045|NCT00957372|69570835|FG001|PART II|Patient non-compliance|0|||
37886046|NCT00957372|69570836|FG002|PART II|Patient non-compliance|0|||
37886047|NCT00957372|69570837|FG003|PART II|Patient non-compliance|4|||
37886048|NCT00952848|69570853|FG000|Overall Study|Withdrawal by Subject|4|||
37886049|NCT00952614|69570857|FG000|Overall Study|Death|3|||
37886050|NCT00952614|69570857|FG000|Overall Study|Lost to Follow-up|3|||
37886051|NCT00952614|69570857|FG000|Overall Study|other reason|1|||
37886052|NCT00911859|69570865|FG000|Treatment Period|Adverse Event|3|||
37886053|NCT00911859|69570866|FG001|Treatment Period|Adverse Event|3|||
37886054|NCT00911859|69570867|FG002|Treatment Period|Adverse Event|7|||
37886055|NCT00911859|69570865|FG000|Treatment Period|Death|1|||
37886056|NCT00911859|69570866|FG001|Treatment Period|Death|3|||
37886057|NCT00911859|69570867|FG002|Treatment Period|Death|5|||
37886058|NCT00911859|69570865|FG000|Treatment Period|Lack of Efficacy|1|||
37886059|NCT00911859|69570866|FG001|Treatment Period|Lack of Efficacy|7|||
37886060|NCT00911859|69570867|FG002|Treatment Period|Lack of Efficacy|5|||
37886061|NCT00911859|69570865|FG000|Treatment Period|Physician Decision|3|||
37886062|NCT00911859|69570866|FG001|Treatment Period|Physician Decision|3|||
37886063|NCT00911859|69570867|FG002|Treatment Period|Physician Decision|3|||
37886064|NCT00911859|69570865|FG000|Treatment Period|Withdrawal by Subject|0|||
37886065|NCT00911859|69570866|FG001|Treatment Period|Withdrawal by Subject|4|||
37886066|NCT00911859|69570867|FG002|Treatment Period|Withdrawal by Subject|5|||
37886067|NCT00911859|69570865|FG000|Treatment Period|Did not receive study treatment|0|||
37886068|NCT00911859|69570866|FG001|Treatment Period|Did not receive study treatment|1|||
37886069|NCT00911859|69570867|FG002|Treatment Period|Did not receive study treatment|0|||
37695534|NCT02331680|69171858|FG001|Overall Study|Withdrawal by Subject|1|||
37695535|NCT02331680|69171859|FG002|Overall Study|Withdrawal by Subject|2|||
37886070|NCT00911859|69570865|FG000|Maintainance Period|Lack of Efficacy|0|||
37986528|NCT00379236|69672114|FG001|Open-label Extension|Use of exclusionary medication|0|||
37695536|NCT02331680|69171857|FG000|Overall Study|Met withdrawal criteria|2|||
37695537|NCT02331680|69171858|FG001|Overall Study|Met withdrawal criteria|2|||
37886071|NCT00911859|69570866|FG001|Maintainance Period|Lack of Efficacy|0|||
37886072|NCT00911859|69570867|FG002|Maintainance Period|Lack of Efficacy|9|||
37886073|NCT00911859|69570865|FG000|Maintainance Period|Physician Decision|0|||
37886074|NCT00911859|69570866|FG001|Maintainance Period|Physician Decision|0|||
37886075|NCT00911859|69570867|FG002|Maintainance Period|Physician Decision|9|||
37886076|NCT00911859|69570865|FG000|Maintainance Period|Withdrawal by Subject|0|||
37886077|NCT00911859|69570866|FG001|Maintainance Period|Withdrawal by Subject|0|||
37886078|NCT00911859|69570867|FG002|Maintainance Period|Withdrawal by Subject|3|||
37886079|NCT00911859|69570865|FG000|Follow-up Period|Death|5|||
37886080|NCT00911859|69570866|FG001|Follow-up Period|Death|8|||
37886081|NCT00911859|69570867|FG002|Follow-up Period|Death|10|||
37886082|NCT00911859|69570865|FG000|Follow-up Period|Lost to Follow-up|1|||
37886083|NCT00911859|69570866|FG001|Follow-up Period|Lost to Follow-up|1|||
37886084|NCT00911859|69570867|FG002|Follow-up Period|Lost to Follow-up|0|||
37886085|NCT00911859|69570865|FG000|Follow-up Period|Withdrawal by Subject|0|||
37886086|NCT00911859|69570866|FG001|Follow-up Period|Withdrawal by Subject|4|||
37886087|NCT00911859|69570867|FG002|Follow-up Period|Withdrawal by Subject|4|||
37886088|NCT00911859|69570865|FG000|Follow-up Period|Study terminated by sponsor|5|||
37886089|NCT00911859|69570866|FG001|Follow-up Period|Study terminated by sponsor|33|||
37695538|NCT02331680|69171859|FG002|Overall Study|Met withdrawal criteria|5|||
37695539|NCT02331680|69171857|FG000|Overall Study|Non-compliance with study drug|0|||
37886090|NCT00911859|69570867|FG002|Follow-up Period|Study terminated by sponsor|27|||
37886091|NCT00956592|69570877|FG000|Overall Study|Protocol Violation|1|||
37886092|NCT00956592|69570878|FG001|Overall Study|Protocol Violation|3|||
37886093|NCT02725593|69570888|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
37695540|NCT02331680|69171858|FG001|Overall Study|Non-compliance with study drug|0|||
37695541|NCT02331680|69171859|FG002|Overall Study|Non-compliance with study drug|1|||
37695542|NCT02331680|69171857|FG000|Overall Study|Protocol Violation|0|||
37695543|NCT02331680|69171858|FG001|Overall Study|Protocol Violation|0|||
37695544|NCT02331680|69171859|FG002|Overall Study|Protocol Violation|3|||
37695545|NCT02331446|69171871|FG000|Overall Study|Lost to Follow-up|2|||
37695546|NCT02331446|69171872|FG001|Overall Study|Lost to Follow-up|1|||
37695547|NCT02331446|69171873|FG002|Overall Study|Lost to Follow-up|0|||
37695548|NCT02331446|69171874|FG003|Overall Study|Lost to Follow-up|1|||
37695549|NCT02331446|69171871|FG000|Overall Study|Personal Problem|2|||
37695550|NCT02331446|69171872|FG001|Overall Study|Personal Problem|0|||
37695551|NCT02331446|69171873|FG002|Overall Study|Personal Problem|0|||
37695552|NCT02331446|69171874|FG003|Overall Study|Personal Problem|0|||
37695553|NCT02331446|69171871|FG000|Overall Study|Disease|0|||
37695554|NCT02331446|69171872|FG001|Overall Study|Disease|2|||
37695555|NCT02331446|69171873|FG002|Overall Study|Disease|2|||
37695556|NCT02331446|69171874|FG003|Overall Study|Disease|1|||
37695557|NCT02331446|69171871|FG000|Overall Study|Physician Decision|0|||
37695558|NCT02331446|69171872|FG001|Overall Study|Physician Decision|1|||
37695559|NCT02331446|69171873|FG002|Overall Study|Physician Decision|0|||
37695560|NCT02331446|69171874|FG003|Overall Study|Physician Decision|1|||
37695561|NCT02331446|69171871|FG000|Overall Study|Lost before baseline analysis|0|||
37695562|NCT02331446|69171872|FG001|Overall Study|Lost before baseline analysis|1|||
37695563|NCT02331446|69171873|FG002|Overall Study|Lost before baseline analysis|1|||
37695564|NCT02331446|69171874|FG003|Overall Study|Lost before baseline analysis|0|||
37821862|NCT03908476|69501680|FG000|Overall Study|Lost to Follow-up|3|||
37821863|NCT03908476|69501681|FG001|Overall Study|Lost to Follow-up|1|||
37821864|NCT03908476|69501680|FG000|Overall Study|Withdrawal by Subject|7|||
37821865|NCT03908476|69501681|FG001|Overall Study|Withdrawal by Subject|1|||
37821866|NCT03908476|69501680|FG000|Overall Study|Physician Decision|2|||
37821867|NCT03908476|69501681|FG001|Overall Study|Physician Decision|0|||
37695565|NCT02349061|69171886|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
37695566|NCT02349061|69171887|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
37695567|NCT02349061|69171888|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
37821868|NCT03908476|69501680|FG000|Overall Study|System Explanted and not Replaced|4|||
37821869|NCT03908476|69501681|FG001|Overall Study|System Explanted and not Replaced|0|||
37821870|NCT03908476|69501680|FG000|Overall Study|Intrathecal Pump|1|||
37821871|NCT03908476|69501681|FG001|Overall Study|Intrathecal Pump|0|||
37821872|NCT03908476|69501680|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
37821873|NCT03908476|69501681|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
37821874|NCT03830866|69501689|FG000|Overall Study|Ongoing study at DCO|312|||
37821875|NCT03830866|69501690|FG001|Overall Study|Ongoing study at DCO|295|||
37821876|NCT03830866|69501689|FG000|Overall Study|Death|58|||
37821877|NCT03830866|69501690|FG001|Overall Study|Death|74|||
37986529|NCT00379236|69672115|FG002|Open-label Extension|Use of exclusionary medication|3|||
37986530|NCT00379236|69672113|FG000|Open-label Extension|Other|0|||
37986531|NCT00379236|69672114|FG001|Open-label Extension|Other|0|||
37986532|NCT00379236|69672115|FG002|Open-label Extension|Other|7|||
37986533|NCT00379080|69672130|FG000|Overall Study|Withdrawal by Subject|0|||
37986534|NCT00379080|69672131|FG001|Overall Study|Withdrawal by Subject|4|||
37986535|NCT00379080|69672132|FG002|Overall Study|Withdrawal by Subject|0|||
37986536|NCT00378534|69672157|FG000|Overall Study|Participants did not receive transplant|3|||
37986537|NCT00378534|69672158|FG001|Overall Study|Participants did not receive transplant|0|||
37986538|NCT00377676|69672165|FG000|Overall Study|Adverse Event|498|||
37986539|NCT00377676|69672166|FG001|Overall Study|Adverse Event|107|||
37986540|NCT00377676|69672165|FG000|Overall Study|Protocol Violation|33|||
37695568|NCT02349061|69171886|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
37695569|NCT02349061|69171887|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
37886094|NCT02725593|69570889|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
37886095|NCT02725593|69570888|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
37886096|NCT02725593|69570889|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
37986541|NCT00377676|69672166|FG001|Overall Study|Protocol Violation|27|||
37986542|NCT00377676|69672165|FG000|Overall Study|Death|5|||
37986543|NCT00377676|69672166|FG001|Overall Study|Death|2|||
37986544|NCT00377676|69672165|FG000|Overall Study|Withdrawal by Subject|187|||
37986545|NCT00377676|69672166|FG001|Overall Study|Withdrawal by Subject|72|||
37986546|NCT00377676|69672165|FG000|Overall Study|Lost to Follow-up|120|||
37986547|NCT00377676|69672166|FG001|Overall Study|Lost to Follow-up|56|||
37986548|NCT00377676|69672165|FG000|Overall Study|Other|118|||
37986549|NCT00377676|69672166|FG001|Overall Study|Other|58|||
37986550|NCT00377520|69672172|FG000|Overall Study|Ineligible (Prior radiation)|1|||
37986551|NCT00377364|69672178|FG000|Overall Study|Lost to Follow-up|1|||
37986552|NCT00377364|69672179|FG001|Overall Study|Lost to Follow-up|0|||
37986553|NCT00377364|69672178|FG000|Overall Study|Withdrawal by Subject|1|||
37886097|NCT02725593|69570888|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
37986554|NCT00377364|69672179|FG001|Overall Study|Withdrawal by Subject|0|||
37986555|NCT03831282|69672187|FG000|Overall Study|Could not place sensor|1|||
37986556|NCT00365508|69672193|FG000|Overall Study|Lost to Follow-up|139|||
37986557|NCT00365508|69672194|FG001|Overall Study|Lost to Follow-up|154|||
37986558|NCT00365352|69672203|FG000|Overall Study|Adverse Event|6|||
37986559|NCT00365352|69672204|FG001|Overall Study|Adverse Event|7|||
37986560|NCT00365352|69672205|FG002|Overall Study|Adverse Event|8|||
37986561|NCT00365352|69672203|FG000|Overall Study|Participant Withdrew Consent|8|||
37986562|NCT00365352|69672204|FG001|Overall Study|Participant Withdrew Consent|3|||
37986563|NCT00365352|69672205|FG002|Overall Study|Participant Withdrew Consent|4|||
37986564|NCT00365352|69672203|FG000|Overall Study|Lack of Efficacy|3|||
37986565|NCT00365352|69672204|FG001|Overall Study|Lack of Efficacy|0|||
37886098|NCT02725593|69570889|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
37986566|NCT00365352|69672205|FG002|Overall Study|Lack of Efficacy|0|||
37986567|NCT00365352|69672203|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
37886099|NCT02725593|69570888|FG000|Long Term Extension|Withdrawal by Subject|1|||
37886100|NCT02725593|69570889|FG001|Long Term Extension|Withdrawal by Subject|3|||
37886101|NCT00911625|69570897|FG000|Overall Study|Lost to Follow-up|7|||
37886102|NCT00911625|69570898|FG001|Overall Study|Lost to Follow-up|0|||
37886103|NCT00596752|69570906|FG000|Overall Study|Other Reason|44|||
37886104|NCT00596752|69570907|FG001|Overall Study|Other Reason|49|||
37886105|NCT00596752|69570906|FG000|Overall Study|Adverse Event|34|||
37986568|NCT00365352|69672204|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
37986569|NCT00365352|69672205|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
37695570|NCT02349061|69171888|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
37886106|NCT00596752|69570907|FG001|Overall Study|Adverse Event|34|||
37986570|NCT00365352|69672203|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
37986571|NCT00365352|69672204|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
37986572|NCT00365352|69672205|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
37986573|NCT00365352|69672203|FG000|Overall Study|Lost to Follow-up|1|||
37986574|NCT00365352|69672204|FG001|Overall Study|Lost to Follow-up|1|||
37986575|NCT00365352|69672205|FG002|Overall Study|Lost to Follow-up|0|||
37986576|NCT00365352|69672203|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
37695571|NCT02349061|69171886|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
37986577|NCT00365352|69672204|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
37886107|NCT00596752|69570906|FG000|Overall Study|Lost to Follow-up|22|||
37886108|NCT00596752|69570907|FG001|Overall Study|Lost to Follow-up|38|||
37886109|NCT00596752|69570906|FG000|Overall Study|Withdrawal by Subject|12|||
37886110|NCT00596752|69570907|FG001|Overall Study|Withdrawal by Subject|9|||
37986578|NCT00365352|69672205|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
37986579|NCT00376506|69672218|FG000|Overall Study|Death|0|||
37695572|NCT02349061|69171887|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
37986580|NCT00376506|69672219|FG001|Overall Study|Death|2|||
37986581|NCT00410384|69672231|FG000|Overall Study|Withdrawal by Subject|28|||
37986582|NCT00410384|69672232|FG001|Overall Study|Withdrawal by Subject|17|||
37986583|NCT00410384|69672233|FG002|Overall Study|Withdrawal by Subject|20|||
37986584|NCT00410384|69672231|FG000|Overall Study|Adverse Event|23|||
37986585|NCT00410384|69672232|FG001|Overall Study|Adverse Event|18|||
37986586|NCT00410384|69672233|FG002|Overall Study|Adverse Event|23|||
37986587|NCT00410384|69672231|FG000|Overall Study|Lack of Efficacy|20|||
37986588|NCT00410384|69672232|FG001|Overall Study|Lack of Efficacy|12|||
37986589|NCT00410384|69672233|FG002|Overall Study|Lack of Efficacy|17|||
37986590|NCT00410384|69672231|FG000|Overall Study|Lack of Compliance|2|||
37986591|NCT00410384|69672232|FG001|Overall Study|Lack of Compliance|2|||
37986592|NCT00410384|69672233|FG002|Overall Study|Lack of Compliance|2|||
37986593|NCT00410384|69672231|FG000|Overall Study|Lost to Follow-up|4|||
37986594|NCT00410384|69672232|FG001|Overall Study|Lost to Follow-up|6|||
37986595|NCT00410384|69672233|FG002|Overall Study|Lost to Follow-up|6|||
37986596|NCT00410384|69672231|FG000|Overall Study|Protocol Violation|6|||
37986597|NCT00410384|69672232|FG001|Overall Study|Protocol Violation|6|||
37886111|NCT00596752|69570906|FG000|Overall Study|Unsatisfactory Compliance|9|||
37695573|NCT02349061|69171888|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
37695574|NCT02349061|69171886|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
37886112|NCT00596752|69570907|FG001|Overall Study|Unsatisfactory Compliance|6|||
37886113|NCT00596752|69570906|FG000|Overall Study|Lack of Efficacy|4|||
37886114|NCT00596752|69570907|FG001|Overall Study|Lack of Efficacy|7|||
37986598|NCT00410384|69672233|FG002|Overall Study|Protocol Violation|6|||
37986599|NCT00410384|69672231|FG000|Overall Study|Physician Decision|3|||
37986600|NCT00410384|69672232|FG001|Overall Study|Physician Decision|3|||
37986601|NCT00410384|69672233|FG002|Overall Study|Physician Decision|4|||
37986602|NCT00410384|69672231|FG000|Overall Study|Other|3|||
37986603|NCT00410384|69672232|FG001|Overall Study|Other|8|||
37986604|NCT00410384|69672233|FG002|Overall Study|Other|4|||
37986605|NCT00370032|69672243|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
37986606|NCT00370032|69672244|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
37986607|NCT00370032|69672243|FG000|Washout Period|Withdrawal by Subject|0|||
37695575|NCT02349061|69171887|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
37695576|NCT02349061|69171888|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
37695577|NCT02349061|69171886|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
37986608|NCT00370032|69672244|FG001|Washout Period|Withdrawal by Subject|1|||
37986609|NCT00370032|69672243|FG000|Washout Period|Lost to Follow-up|0|||
37986610|NCT00370032|69672244|FG001|Washout Period|Lost to Follow-up|1|||
37986611|NCT00370032|69672243|FG000|Washout Period|Adverse Event|1|||
37986612|NCT00370032|69672244|FG001|Washout Period|Adverse Event|0|||
37821878|NCT03830866|69501689|FG000|Overall Study|Lost to Follow-up|0|||
37821879|NCT03830866|69501690|FG001|Overall Study|Lost to Follow-up|1|||
37821880|NCT03830866|69501689|FG000|Overall Study|Withdrawal by Subject|15|||
37821881|NCT03830866|69501690|FG001|Overall Study|Withdrawal by Subject|13|||
37821882|NCT03830866|69501689|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
37821883|NCT03830866|69501690|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
37821884|NCT03830866|69501689|FG000|Overall Study|Other|0|||
37986613|NCT00370032|69672243|FG000|Follow-up Period|Withdrawal by Subject|1|||
37986614|NCT00370032|69672244|FG001|Follow-up Period|Withdrawal by Subject|0|||
37986615|NCT00410072|69672261|FG000|Day 1 to Week 48|Adverse Event|1|||
37821885|NCT03830866|69501690|FG001|Overall Study|Other|1|||
37821886|NCT03699007|69501707|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
37821887|NCT03699007|69501708|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
37821888|NCT03699007|69501707|FG000|6-month Follow Up|Lost to Follow-up|2|||
37821889|NCT03699007|69501708|FG001|6-month Follow Up|Lost to Follow-up|3|||
37821890|NCT03581188|69501718|FG000|Overall Study|Inclusion criteria not met|3|||
37821891|NCT03581188|69501719|FG001|Overall Study|Inclusion criteria not met|2|||
37821892|NCT03581188|69501718|FG000|Overall Study|Lost to Follow-up|5|||
37821893|NCT03581188|69501719|FG001|Overall Study|Lost to Follow-up|5|||
37821894|NCT03581188|69501718|FG000|Overall Study|Discontinued intervention|11|||
37886115|NCT00596752|69570906|FG000|Overall Study|Protocol Violation|1|||
37886116|NCT00596752|69570907|FG001|Overall Study|Protocol Violation|0|||
37886117|NCT00958074|69570915|FG000|Overall Study|Withdrawal by Subject|0|||
37886118|NCT00958074|69570916|FG001|Overall Study|Withdrawal by Subject|1|||
37886119|NCT00809965|69570925|FG000|Overall Study|Death|194|||
37886120|NCT00809965|69570926|FG001|Overall Study|Death|147|||
37821895|NCT03581188|69501719|FG001|Overall Study|Discontinued intervention|8|||
37821896|NCT03576131|69501736|FG000|Overall Study|Investigator decision|0|||
37886121|NCT00809965|69570927|FG002|Overall Study|Death|196|||
37886122|NCT00809965|69570925|FG000|Overall Study|Lost to Follow-up|17|||
37886123|NCT00809965|69570926|FG001|Overall Study|Lost to Follow-up|10|||
37886124|NCT00809965|69570927|FG002|Overall Study|Lost to Follow-up|18|||
37886125|NCT00809965|69570925|FG000|Overall Study|Withdrawal by Subject|405|||
37886126|NCT00809965|69570926|FG001|Overall Study|Withdrawal by Subject|448|||
37886127|NCT00809965|69570927|FG002|Overall Study|Withdrawal by Subject|441|||
37886128|NCT00809965|69570925|FG000|Overall Study|Other Reason|167|||
37886129|NCT00809965|69570926|FG001|Overall Study|Other Reason|170|||
37886130|NCT00809965|69570927|FG002|Overall Study|Other Reason|189|||
37886131|NCT00597376|69570937|FG000|Overall Study|Withdrawal by Subject|4|||
37821897|NCT03576131|69501737|FG001|Overall Study|Investigator decision|0|||
37886132|NCT00597376|69570938|FG001|Overall Study|Withdrawal by Subject|3|||
37986616|NCT00410072|69672262|FG001|Day 1 to Week 48|Adverse Event|2|||
37986617|NCT00410072|69672261|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
37986618|NCT00410072|69672262|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
37986619|NCT00410072|69672261|FG000|Day 1 to Week 48|Other|0|||
37986620|NCT00410072|69672262|FG001|Day 1 to Week 48|Other|1|||
37986621|NCT00410072|69672261|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
37986622|NCT00410072|69672262|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
37986623|NCT00410072|69672261|FG000|Day 1 to Week 48|Pregnancy|0|||
37986624|NCT00410072|69672262|FG001|Day 1 to Week 48|Pregnancy|2|||
37986625|NCT00410072|69672261|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
37986626|NCT00410072|69672262|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
37986627|NCT00410072|69672261|FG000|After Week 48 to Week 96|Adverse Event|1|||
37986628|NCT00410072|69672262|FG001|After Week 48 to Week 96|Adverse Event|2|||
37986629|NCT00410072|69672261|FG000|After Week 48 to Week 96|Death|0|||
37986630|NCT00410072|69672262|FG001|After Week 48 to Week 96|Death|1|||
37986631|NCT00410072|69672261|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
37986632|NCT00410072|69672262|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
37986633|NCT00410072|69672261|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
37986634|NCT00410072|69672262|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
37986635|NCT00410072|69672261|FG000|After Week 48 to Week 96|Other|2|||
37986636|NCT00410072|69672262|FG001|After Week 48 to Week 96|Other|0|||
37986637|NCT00410072|69672261|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
37986638|NCT00410072|69672262|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
37986639|NCT00410072|69672261|FG000|After Week 48 to Week 96|Pregnancy|0|||
37986640|NCT00410072|69672262|FG001|After Week 48 to Week 96|Pregnancy|2|||
37986641|NCT00410072|69672261|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
37986642|NCT00410072|69672262|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
37986643|NCT00409838|69672270|FG000|Short-term Period|Adverse Event|0|||
37986644|NCT00409838|69672271|FG001|Short-term Period|Adverse Event|1|||
37986645|NCT00409838|69672270|FG000|Short-term Period|Lost to Follow-up|0|||
37986646|NCT00409838|69672271|FG001|Short-term Period|Lost to Follow-up|1|||
37986647|NCT00409838|69672270|FG000|Short-term Period|Withdrawal by Subject|2|||
37986648|NCT00409838|69672271|FG001|Short-term Period|Withdrawal by Subject|3|||
37986649|NCT00409838|69672270|FG000|Short-term Period|Never Treated|1|||
37986650|NCT00409838|69672271|FG001|Short-term Period|Never Treated|0|||
37986651|NCT00409838|69672270|FG000|Long-term Extension Period|Adverse Event|10|||
37986652|NCT00409838|69672271|FG001|Long-term Extension Period|Adverse Event|0|||
37986653|NCT00409838|69672270|FG000|Long-term Extension Period|Death|1|||
37986654|NCT00409838|69672271|FG001|Long-term Extension Period|Death|0|||
37986655|NCT00409838|69672270|FG000|Long-term Extension Period|Lack of Efficacy|2|||
37986656|NCT00409838|69672271|FG001|Long-term Extension Period|Lack of Efficacy|0|||
37986657|NCT00409838|69672270|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
37986658|NCT00409838|69672271|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
37986659|NCT00409838|69672270|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
37986660|NCT00409838|69672271|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
37986661|NCT00409838|69672270|FG000|Long-term Extension Period|Pregnancy|1|||
37986662|NCT00409838|69672271|FG001|Long-term Extension Period|Pregnancy|0|||
37986663|NCT00399542|69672296|FG000|Overall Study|Adverse Event|18|||
37986664|NCT00399542|69672297|FG001|Overall Study|Adverse Event|15|||
37986665|NCT00399542|69672296|FG000|Overall Study|Protocol Violation|13|||
37986666|NCT00399542|69672297|FG001|Overall Study|Protocol Violation|3|||
37986667|NCT00399542|69672296|FG000|Overall Study|Withdrawal by Subject|28|||
37986668|NCT00399542|69672297|FG001|Overall Study|Withdrawal by Subject|10|||
37986669|NCT00399542|69672296|FG000|Overall Study|Lack of Efficacy|18|||
37986670|NCT00399542|69672297|FG001|Overall Study|Lack of Efficacy|8|||
37986671|NCT00399542|69672296|FG000|Overall Study|Lost to Follow-up|6|||
37986672|NCT00399542|69672297|FG001|Overall Study|Lost to Follow-up|6|||
37986673|NCT00399542|69672296|FG000|Overall Study|Other|1|||
37986674|NCT00399542|69672297|FG001|Overall Study|Other|0|||
37986675|NCT00399542|69672296|FG000|Overall Study|Physician Decision|0|||
37986676|NCT00399542|69672297|FG001|Overall Study|Physician Decision|1|||
37986677|NCT00409682|69672306|FG000|Open-label Induction Period|Adverse Event|1|||
37986678|NCT00409682|69672307|FG001|Open-label Induction Period|Adverse Event|0|||
37986679|NCT00409682|69672308|FG002|Open-label Induction Period|Adverse Event|0|||
37986680|NCT00409682|69672306|FG000|Open-label Induction Period|Lack of Efficacy|1|||
37986681|NCT00409682|69672307|FG001|Open-label Induction Period|Lack of Efficacy|0|||
37986682|NCT00409682|69672308|FG002|Open-label Induction Period|Lack of Efficacy|0|||
37986683|NCT00409682|69672306|FG000|Open-label Induction Period|Protocol Violation|1|||
37986684|NCT00409682|69672307|FG001|Open-label Induction Period|Protocol Violation|0|||
37986685|NCT00409682|69672308|FG002|Open-label Induction Period|Protocol Violation|0|||
37986686|NCT00409682|69672306|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
37986687|NCT00409682|69672307|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
37986688|NCT00409682|69672308|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
37986689|NCT00409682|69672306|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
37986690|NCT00409682|69672307|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
37986691|NCT00409682|69672308|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
37986692|NCT00409682|69672306|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
37986693|NCT00409682|69672307|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
37986694|NCT00409682|69672308|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
37986695|NCT00409682|69672306|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
37886133|NCT00597376|69570937|FG000|Overall Study|Adverse Event|4|||
37986696|NCT00409682|69672307|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
37986697|NCT00409682|69672308|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
37986698|NCT00409682|69672306|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
37986699|NCT00409682|69672307|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
37986700|NCT00409682|69672308|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
37986701|NCT00409682|69672306|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
37986702|NCT00409682|69672307|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
37986703|NCT00409682|69672308|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
37986704|NCT00409682|69672306|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
37986705|NCT00409682|69672307|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
37986706|NCT00409682|69672308|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
37986707|NCT00398216|69672320|FG000|Overall Study|Adverse Event|4|||
37986708|NCT00398216|69672321|FG001|Overall Study|Adverse Event|2|||
37986709|NCT00398216|69672322|FG002|Overall Study|Adverse Event|5|||
37986710|NCT00398216|69672323|FG003|Overall Study|Adverse Event|7|||
37986711|NCT00398216|69672324|FG004|Overall Study|Adverse Event|2|||
37986712|NCT00398216|69672320|FG000|Overall Study|Protocol Violation|2|||
37986713|NCT00398216|69672321|FG001|Overall Study|Protocol Violation|4|||
37986714|NCT00398216|69672322|FG002|Overall Study|Protocol Violation|5|||
37986715|NCT00398216|69672323|FG003|Overall Study|Protocol Violation|7|||
37986716|NCT00398216|69672324|FG004|Overall Study|Protocol Violation|5|||
37986717|NCT00398216|69672320|FG000|Overall Study|Lost to Follow-up|1|||
37986718|NCT00398216|69672321|FG001|Overall Study|Lost to Follow-up|6|||
37986719|NCT00398216|69672322|FG002|Overall Study|Lost to Follow-up|4|||
37986720|NCT00398216|69672323|FG003|Overall Study|Lost to Follow-up|4|||
37986721|NCT00398216|69672324|FG004|Overall Study|Lost to Follow-up|1|||
37986722|NCT00398216|69672320|FG000|Overall Study|Death|0|||
37986723|NCT00398216|69672321|FG001|Overall Study|Death|3|||
37986724|NCT00398216|69672322|FG002|Overall Study|Death|0|||
37986725|NCT00398216|69672323|FG003|Overall Study|Death|0|||
37986726|NCT00398216|69672324|FG004|Overall Study|Death|0|||
37986727|NCT00398216|69672320|FG000|Overall Study|Withdrawal by Subject|1|||
37986728|NCT00398216|69672321|FG001|Overall Study|Withdrawal by Subject|0|||
37986729|NCT00398216|69672322|FG002|Overall Study|Withdrawal by Subject|3|||
37986730|NCT00398216|69672323|FG003|Overall Study|Withdrawal by Subject|1|||
37986731|NCT00398216|69672324|FG004|Overall Study|Withdrawal by Subject|2|||
37986732|NCT00398216|69672320|FG000|Overall Study|administrative reasons|3|||
37886134|NCT00597376|69570938|FG001|Overall Study|Adverse Event|1|||
37986733|NCT00398216|69672321|FG001|Overall Study|administrative reasons|4|||
37986734|NCT00398216|69672322|FG002|Overall Study|administrative reasons|4|||
37986735|NCT00398216|69672323|FG003|Overall Study|administrative reasons|3|||
37986736|NCT00398216|69672324|FG004|Overall Study|administrative reasons|3|||
37986737|NCT00398216|69672320|FG000|Overall Study|entrance criteria|0|||
37986738|NCT00398216|69672321|FG001|Overall Study|entrance criteria|0|||
37986739|NCT00398216|69672322|FG002|Overall Study|entrance criteria|0|||
37986740|NCT00398216|69672323|FG003|Overall Study|entrance criteria|0|||
37986741|NCT00398216|69672324|FG004|Overall Study|entrance criteria|2|||
37986742|NCT00398138|69672336|FG000|Overall Study|Adverse Event|2|||
37986743|NCT00397982|69672340|FG000|Overall Study|Withdrawal by Subject|1|||
37986744|NCT00397982|69672340|FG000|Overall Study|Adverse Event|1|||
37986745|NCT00397982|69672340|FG000|Overall Study|noncompliance|1|||
37986746|NCT00397982|69672340|FG000|Overall Study|Unrelated health issues|1|||
37695578|NCT02349061|69171887|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
37821898|NCT03576131|69501738|FG002|Overall Study|Investigator decision|0|||
37821899|NCT03576131|69501739|FG003|Overall Study|Investigator decision|1|||
37821900|NCT03576131|69501740|FG004|Overall Study|Investigator decision|0|||
37821901|NCT03576131|69501741|FG005|Overall Study|Investigator decision|1|||
37821902|NCT03576131|69501742|FG006|Overall Study|Investigator decision|0|||
37821903|NCT03576131|69501743|FG007|Overall Study|Investigator decision|0|||
37821904|NCT03576131|69501736|FG000|Overall Study|Withdrawal by Subject|1|||
37821905|NCT03576131|69501737|FG001|Overall Study|Withdrawal by Subject|1|||
37821906|NCT03576131|69501738|FG002|Overall Study|Withdrawal by Subject|0|||
37986747|NCT00408902|69672345|FG000|Overall Study|Lack of Efficacy|7|||
37986748|NCT00408902|69672345|FG000|Overall Study|Adverse Event|3|||
37986749|NCT00397514|69672350|FG000|Overall Study|Withdrawal by Subject|1|||
37821907|NCT03576131|69501739|FG003|Overall Study|Withdrawal by Subject|1|||
37986750|NCT00397514|69672350|FG000|Overall Study|Pacing wire malfunction|1|||
37986751|NCT00397514|69672350|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
37986752|NCT00397514|69672350|FG000|Overall Study|early extubation|2|||
37986753|NCT00397514|69672350|FG000|Overall Study|poor echocardiographic windows|1|||
37986754|NCT00397046|69672364|FG000|Overall Study|Disease Progression|3|||
37986755|NCT00397046|69672365|FG001|Overall Study|Disease Progression|3|||
37886135|NCT00910689|69570974|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
37886136|NCT00910689|69570975|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
37886137|NCT00910689|69570976|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
37886138|NCT00910689|69570977|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
37886139|NCT00910689|69570974|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
37886140|NCT00910689|69570975|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
37886141|NCT00910689|69570976|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
37886142|NCT00910689|69570977|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
37886143|NCT00910689|69570974|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
37886144|NCT00910689|69570975|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
37886145|NCT00910689|69570976|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
37886146|NCT00910689|69570977|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
37886147|NCT00910689|69570974|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
37886148|NCT00910689|69570975|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
37886149|NCT00910689|69570976|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
37886150|NCT00910689|69570977|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
37986756|NCT00397046|69672366|FG002|Overall Study|Disease Progression|10|||
37886151|NCT00910689|69570974|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
37886152|NCT00910689|69570975|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
37886153|NCT00910689|69570976|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
37886154|NCT00910689|69570977|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
37886155|NCT00910689|69570974|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
37886156|NCT00910689|69570975|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
37886157|NCT00910689|69570976|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
37886158|NCT00910689|69570977|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
37886159|NCT00910689|69570974|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
37886160|NCT00910689|69570975|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
37886161|NCT00910689|69570976|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
37886162|NCT00910689|69570977|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
37886163|NCT00910689|69570974|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
37886164|NCT00910689|69570975|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
37886165|NCT00910689|69570976|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
37886166|NCT00910689|69570977|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
37886167|NCT00910689|69570974|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
37886168|NCT00910689|69570975|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
37886169|NCT00910689|69570976|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
37886170|NCT00910689|69570977|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
37886171|NCT00910689|69570974|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
37886172|NCT00910689|69570975|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
37886173|NCT00910689|69570976|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
37886174|NCT00910689|69570977|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
37886175|NCT00910689|69570974|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
37886176|NCT00910689|69570975|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
37886177|NCT00910689|69570976|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
37886178|NCT00910689|69570977|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
37886179|NCT00910689|69570974|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
37886180|NCT00910689|69570975|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
37886181|NCT00910689|69570976|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
37886182|NCT00910689|69570977|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
37886183|NCT00910689|69570974|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
37886184|NCT00910689|69570975|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
37886185|NCT00910689|69570976|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
37886186|NCT00910689|69570977|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
37986757|NCT00397046|69672367|FG003|Overall Study|Disease Progression|5|||
37986758|NCT00396812|69672378|FG000|Overall Study|Physician Decision|1|||
37986759|NCT00396656|69672382|FG000|First Treatment Period|Withdrawal by Subject|0|||
37986760|NCT00396656|69672383|FG001|First Treatment Period|Withdrawal by Subject|2|||
37886187|NCT00910689|69570974|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
37886188|NCT00910689|69570975|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
37886189|NCT00910689|69570976|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
37886190|NCT00910689|69570977|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
37886191|NCT00910689|69570974|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
37986761|NCT00396656|69672382|FG000|Second Treatment Period|Adverse Event|0|||
37986762|NCT00396656|69672383|FG001|Second Treatment Period|Adverse Event|1|||
37986763|NCT00408434|69672396|FG000|Overall Study|Adverse Event|0|||
37986764|NCT00408434|69672397|FG001|Overall Study|Adverse Event|0|||
37986765|NCT00408434|69672398|FG002|Overall Study|Adverse Event|1|||
37986766|NCT00408434|69672399|FG003|Overall Study|Adverse Event|0|||
37986767|NCT00408434|69672400|FG004|Overall Study|Adverse Event|0|||
37986768|NCT00408434|69672401|FG005|Overall Study|Adverse Event|0|||
37986769|NCT00408434|69672402|FG006|Overall Study|Adverse Event|0|||
37986770|NCT00408434|69672396|FG000|Overall Study|Progressive disease|6|||
37986771|NCT00408434|69672397|FG001|Overall Study|Progressive disease|3|||
37821908|NCT03576131|69501740|FG004|Overall Study|Withdrawal by Subject|2|||
37821909|NCT03576131|69501741|FG005|Overall Study|Withdrawal by Subject|3|||
37821910|NCT03576131|69501742|FG006|Overall Study|Withdrawal by Subject|1|||
37821911|NCT03576131|69501743|FG007|Overall Study|Withdrawal by Subject|0|||
37821912|NCT03576131|69501736|FG000|Overall Study|Death|3|||
37821913|NCT03576131|69501737|FG001|Overall Study|Death|3|||
37821914|NCT03576131|69501738|FG002|Overall Study|Death|1|||
37821915|NCT03576131|69501739|FG003|Overall Study|Death|5|||
37821916|NCT03576131|69501740|FG004|Overall Study|Death|4|||
37821917|NCT03576131|69501741|FG005|Overall Study|Death|1|||
37821918|NCT03576131|69501742|FG006|Overall Study|Death|0|||
37821919|NCT03576131|69501743|FG007|Overall Study|Death|1|||
37821920|NCT03576131|69501736|FG000|Overall Study|New anti-cancer treatment|5|||
37821921|NCT03576131|69501737|FG001|Overall Study|New anti-cancer treatment|1|||
37821922|NCT03576131|69501738|FG002|Overall Study|New anti-cancer treatment|2|||
37821923|NCT03576131|69501739|FG003|Overall Study|New anti-cancer treatment|3|||
37821924|NCT03576131|69501740|FG004|Overall Study|New anti-cancer treatment|0|||
37821925|NCT03576131|69501741|FG005|Overall Study|New anti-cancer treatment|0|||
37821926|NCT03576131|69501742|FG006|Overall Study|New anti-cancer treatment|0|||
37821927|NCT03576131|69501743|FG007|Overall Study|New anti-cancer treatment|0|||
37821928|NCT03576131|69501736|FG000|Overall Study|Unspecified reason|0|||
37821929|NCT03576131|69501737|FG001|Overall Study|Unspecified reason|0|||
37821930|NCT03576131|69501738|FG002|Overall Study|Unspecified reason|1|||
37821931|NCT03576131|69501739|FG003|Overall Study|Unspecified reason|1|||
37821932|NCT03576131|69501740|FG004|Overall Study|Unspecified reason|1|||
37821933|NCT03576131|69501741|FG005|Overall Study|Unspecified reason|1|||
37821934|NCT03576131|69501742|FG006|Overall Study|Unspecified reason|0|||
37821935|NCT03576131|69501743|FG007|Overall Study|Unspecified reason|0|||
37821936|NCT03576131|69501736|FG000|Overall Study|Subject non-compliance|0|||
37821937|NCT03576131|69501737|FG001|Overall Study|Subject non-compliance|0|||
37821938|NCT03576131|69501738|FG002|Overall Study|Subject non-compliance|0|||
37821939|NCT03576131|69501739|FG003|Overall Study|Subject non-compliance|0|||
37821940|NCT03576131|69501740|FG004|Overall Study|Subject non-compliance|0|||
37821941|NCT03576131|69501741|FG005|Overall Study|Subject non-compliance|1|||
37986772|NCT00408434|69672398|FG002|Overall Study|Progressive disease|4|||
37821942|NCT03576131|69501742|FG006|Overall Study|Subject non-compliance|0|||
37821943|NCT03576131|69501743|FG007|Overall Study|Subject non-compliance|0|||
37821944|NCT03454529|69501780|FG000|Overall Study|Did not receive treatment|6|||
37821945|NCT03454529|69501780|FG000|Overall Study|Received < 80% doses|1|||
37821946|NCT03409731|69501784|FG000|Overall Study|Withdrawal by Subject|1|||
37821947|NCT03409731|69501784|FG000|Overall Study|Death|4|||
37821948|NCT03246061|69501799|FG000|Overall Study|Still in follow-up|15|||
37821949|NCT03246061|69501800|FG001|Overall Study|Still in follow-up|21|||
37821950|NCT02988817|69501837|FG000|Overall Study|Withdrawal by Subject|1|||
37821951|NCT02988817|69501838|FG001|Overall Study|Withdrawal by Subject|0|||
37986773|NCT00408434|69672399|FG003|Overall Study|Progressive disease|3|||
37886192|NCT00910689|69570975|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
37886193|NCT00910689|69570976|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
37886194|NCT00910689|69570977|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
37886195|NCT00910689|69570974|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
37886196|NCT00910689|69570975|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
37886197|NCT00910689|69570976|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
37886198|NCT00910689|69570977|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
37886199|NCT00910689|69570974|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
37886200|NCT00910689|69570975|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
37886201|NCT00910689|69570976|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
37886202|NCT00910689|69570977|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
37886203|NCT00910689|69570974|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
37886204|NCT00910689|69570975|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
37886205|NCT00910689|69570976|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
37886206|NCT00910689|69570977|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
37886207|NCT00910689|69570974|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
37886208|NCT00910689|69570975|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
37886209|NCT00910689|69570976|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
37986774|NCT00408434|69672400|FG004|Overall Study|Progressive disease|3|||
37821952|NCT02988817|69501839|FG002|Overall Study|Withdrawal by Subject|0|||
37821953|NCT02988817|69501840|FG003|Overall Study|Withdrawal by Subject|1|||
37821954|NCT02988817|69501841|FG004|Overall Study|Withdrawal by Subject|3|||
37821955|NCT02988817|69501842|FG005|Overall Study|Withdrawal by Subject|1|||
37821956|NCT02988817|69501843|FG006|Overall Study|Withdrawal by Subject|2|||
37821957|NCT02988817|69501844|FG007|Overall Study|Withdrawal by Subject|1|||
37821958|NCT02988817|69501845|FG008|Overall Study|Withdrawal by Subject|1|||
37821959|NCT02988817|69501846|FG009|Overall Study|Withdrawal by Subject|1|||
37821960|NCT02988817|69501847|FG010|Overall Study|Withdrawal by Subject|1|||
37821961|NCT02988817|69501848|FG011|Overall Study|Withdrawal by Subject|12|||
37821962|NCT02988817|69501849|FG012|Overall Study|Withdrawal by Subject|6|||
37821963|NCT02988817|69501850|FG013|Overall Study|Withdrawal by Subject|6|||
37821964|NCT02988817|69501851|FG014|Overall Study|Withdrawal by Subject|4|||
37821965|NCT02988817|69501852|FG015|Overall Study|Withdrawal by Subject|5|||
37821966|NCT02988817|69501853|FG016|Overall Study|Withdrawal by Subject|4|||
37821967|NCT02988817|69501854|FG017|Overall Study|Withdrawal by Subject|11|||
37821968|NCT02988817|69501855|FG018|Overall Study|Withdrawal by Subject|4|||
37821969|NCT02988817|69501856|FG019|Overall Study|Withdrawal by Subject|2|||
37821970|NCT02988817|69501837|FG000|Overall Study|Death|0|||
37821971|NCT02988817|69501838|FG001|Overall Study|Death|1|||
37821972|NCT02988817|69501839|FG002|Overall Study|Death|3|||
37821973|NCT02988817|69501840|FG003|Overall Study|Death|1|||
37821974|NCT02988817|69501841|FG004|Overall Study|Death|6|||
37821975|NCT02988817|69501842|FG005|Overall Study|Death|10|||
37821976|NCT02988817|69501843|FG006|Overall Study|Death|1|||
37821977|NCT02988817|69501844|FG007|Overall Study|Death|2|||
37886210|NCT00910689|69570977|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
37886211|NCT00910689|69570974|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
37886212|NCT00910689|69570975|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
37886213|NCT00910689|69570976|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
37986775|NCT00408434|69672401|FG005|Overall Study|Progressive disease|1|||
37986776|NCT00408434|69672402|FG006|Overall Study|Progressive disease|4|||
37986777|NCT00408434|69672396|FG000|Overall Study|Other|0|||
37821978|NCT02988817|69501845|FG008|Overall Study|Death|1|||
37821979|NCT02988817|69501846|FG009|Overall Study|Death|5|||
37821980|NCT02988817|69501847|FG010|Overall Study|Death|1|||
37821981|NCT02988817|69501848|FG011|Overall Study|Death|8|||
37821982|NCT02988817|69501849|FG012|Overall Study|Death|9|||
37821983|NCT02988817|69501850|FG013|Overall Study|Death|17|||
37821984|NCT02988817|69501851|FG014|Overall Study|Death|18|||
37821985|NCT02988817|69501852|FG015|Overall Study|Death|30|||
37821986|NCT02988817|69501853|FG016|Overall Study|Death|17|||
37886214|NCT00910689|69570977|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
37886215|NCT00910689|69570974|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
37886216|NCT00910689|69570975|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
37886217|NCT00910689|69570976|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
37886218|NCT00910689|69570977|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
37886219|NCT00807001|69570992|FG000|Overall Study|Non-compliance|0|||
37886220|NCT00807001|69570993|FG001|Overall Study|Non-compliance|1|||
37886221|NCT00807001|69570994|FG002|Overall Study|Non-compliance|0|||
37886222|NCT00807001|69570995|FG003|Overall Study|Non-compliance|0|||
37886223|NCT00807001|69570996|FG004|Overall Study|Non-compliance|0|||
37886224|NCT00809341|69571010|FG000|Overall Study|Physician Decision|0|||
37886225|NCT00809341|69571011|FG001|Overall Study|Physician Decision|1|||
37886226|NCT01125800|69571022|FG000|Phase I|Protocol Violation|0|||
37886227|NCT01125800|69571023|FG001|Phase I|Protocol Violation|3|||
37886228|NCT01125800|69571024|FG002|Phase I|Protocol Violation|1|||
37886229|NCT01125800|69571025|FG003|Phase I|Protocol Violation|1|||
37886230|NCT01125800|69571026|FG004|Phase I|Protocol Violation|0|||
37886231|NCT01125800|69571022|FG000|Phase I|Adverse Event|2|||
37886232|NCT01125800|69571023|FG001|Phase I|Adverse Event|2|||
37886233|NCT01125800|69571024|FG002|Phase I|Adverse Event|1|||
37986778|NCT00408434|69672397|FG001|Overall Study|Other|0|||
37986779|NCT00408434|69672398|FG002|Overall Study|Other|1|||
37986780|NCT00408434|69672399|FG003|Overall Study|Other|0|||
37986781|NCT00408434|69672400|FG004|Overall Study|Other|2|||
37986782|NCT00408434|69672401|FG005|Overall Study|Other|1|||
37986783|NCT00408434|69672402|FG006|Overall Study|Other|0|||
37986784|NCT00408434|69672396|FG000|Overall Study|Terminated by Investigator|0|||
37986785|NCT00408434|69672397|FG001|Overall Study|Terminated by Investigator|0|||
37986786|NCT00408434|69672398|FG002|Overall Study|Terminated by Investigator|0|||
37986787|NCT00408434|69672399|FG003|Overall Study|Terminated by Investigator|0|||
37986788|NCT00408434|69672400|FG004|Overall Study|Terminated by Investigator|1|||
37886234|NCT01125800|69571025|FG003|Phase I|Adverse Event|7|||
37886235|NCT01125800|69571026|FG004|Phase I|Adverse Event|0|||
37886236|NCT01125800|69571022|FG000|Phase I|Administrative problems|1|||
37886237|NCT01125800|69571023|FG001|Phase I|Administrative problems|0|||
37886238|NCT01125800|69571024|FG002|Phase I|Administrative problems|0|||
37886239|NCT01125800|69571025|FG003|Phase I|Administrative problems|0|||
37886240|NCT01125800|69571026|FG004|Phase I|Administrative problems|0|||
37886241|NCT01125800|69571022|FG000|Phase I|Withdrawal by Subject|0|||
37886242|NCT01125800|69571023|FG001|Phase I|Withdrawal by Subject|0|||
37886243|NCT01125800|69571024|FG002|Phase I|Withdrawal by Subject|1|||
37886244|NCT01125800|69571025|FG003|Phase I|Withdrawal by Subject|0|||
37886245|NCT01125800|69571026|FG004|Phase I|Withdrawal by Subject|0|||
37886246|NCT01125800|69571022|FG000|Phase I|Disease progression|5|||
37886247|NCT01125800|69571023|FG001|Phase I|Disease progression|4|||
37886248|NCT01125800|69571024|FG002|Phase I|Disease progression|1|||
37886249|NCT01125800|69571025|FG003|Phase I|Disease progression|3|||
37886250|NCT01125800|69571026|FG004|Phase I|Disease progression|0|||
37886251|NCT01125800|69571022|FG000|Phase II|Protocol Violation|0|||
37886252|NCT01125800|69571023|FG001|Phase II|Protocol Violation|0|||
37886253|NCT01125800|69571024|FG002|Phase II|Protocol Violation|0|||
37886254|NCT01125800|69571025|FG003|Phase II|Protocol Violation|0|||
37886255|NCT01125800|69571026|FG004|Phase II|Protocol Violation|1|||
37886256|NCT01125800|69571022|FG000|Phase II|Adverse Event|0|||
37886257|NCT01125800|69571023|FG001|Phase II|Adverse Event|0|||
37886258|NCT01125800|69571024|FG002|Phase II|Adverse Event|0|||
37886259|NCT01125800|69571025|FG003|Phase II|Adverse Event|0|||
37986789|NCT00408434|69672401|FG005|Overall Study|Terminated by Investigator|1|||
37986790|NCT00408434|69672402|FG006|Overall Study|Terminated by Investigator|0|||
37986791|NCT00418184|69672421|FG000|Double-blind Phase|Withdrawal by Subject|22|||
37986792|NCT00418184|69672422|FG001|Double-blind Phase|Withdrawal by Subject|9|||
37886260|NCT01125800|69571026|FG004|Phase II|Adverse Event|2|||
37886261|NCT01125800|69571022|FG000|Phase II|Disease progression|0|||
37886262|NCT01125800|69571023|FG001|Phase II|Disease progression|0|||
37886263|NCT01125800|69571024|FG002|Phase II|Disease progression|0|||
37886264|NCT01125800|69571025|FG003|Phase II|Disease progression|1|||
37886265|NCT01125800|69571026|FG004|Phase II|Disease progression|8|||
37886266|NCT01125722|69571043|FG000|Overall Study|Withdrawal by Subject|2|||
37886267|NCT01125722|69571044|FG001|Overall Study|Withdrawal by Subject|1|||
37886268|NCT01125722|69571043|FG000|Overall Study|Lost to Follow-up|1|||
37986793|NCT00418184|69672421|FG000|Double-blind Phase|Adverse Event|2|||
37986794|NCT00418184|69672422|FG001|Double-blind Phase|Adverse Event|1|||
37986795|NCT00418184|69672421|FG000|Double-blind Phase|Poor compliance|3|||
37886269|NCT01125722|69571044|FG001|Overall Study|Lost to Follow-up|0|||
37886270|NCT00811135|69571050|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
37886271|NCT00811135|69571050|FG000|Overall Study|Death|3|||
37986796|NCT00418184|69672422|FG001|Double-blind Phase|Poor compliance|1|||
37886272|NCT00811135|69571050|FG000|Overall Study|Protocol Violation|2|||
37886273|NCT00811135|69571050|FG000|Overall Study|Violation of Selection Criteria|1|||
37886274|NCT00811135|69571050|FG000|Overall Study|Refused Treatment|1|||
37886275|NCT00811135|69571050|FG000|Overall Study|Withdrawal by Subject|3|||
37886276|NCT00811135|69571050|FG000|Overall Study|Administrative/Other Unspecified|11|||
37886277|NCT00811135|69571050|FG000|Overall Study|Ongoing|59|||
37886278|NCT00811057|69571057|FG000|Overall Study|Protocol Violation|5|||
37821987|NCT02988817|69501854|FG017|Overall Study|Death|38|||
37886279|NCT00811057|69571058|FG001|Overall Study|Protocol Violation|10|||
37886280|NCT00811057|69571059|FG002|Overall Study|Protocol Violation|10|||
37886281|NCT00879970|69571070|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
37886282|NCT00879970|69571071|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
37886283|NCT00879970|69571072|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
37886284|NCT00879970|69571073|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
37886285|NCT00879970|69571074|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
37886286|NCT00879970|69571070|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
37886287|NCT00879970|69571071|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
37886288|NCT00879970|69571072|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
37886289|NCT00879970|69571073|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
37886290|NCT00879970|69571074|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
37886291|NCT00879970|69571070|FG000|Period 1 TZD Randomization|Death|2|||
37886292|NCT00879970|69571071|FG001|Period 1 TZD Randomization|Death|1|||
37886293|NCT00879970|69571072|FG002|Period 1 TZD Randomization|Death|0|||
37695579|NCT02349061|69171888|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
37821988|NCT02988817|69501855|FG018|Overall Study|Death|14|||
37821989|NCT02988817|69501856|FG019|Overall Study|Death|16|||
37821990|NCT02988817|69501837|FG000|Overall Study|Other|0|||
37821991|NCT02988817|69501838|FG001|Overall Study|Other|0|||
37821992|NCT02988817|69501839|FG002|Overall Study|Other|0|||
37821993|NCT02988817|69501840|FG003|Overall Study|Other|1|||
37821994|NCT02988817|69501841|FG004|Overall Study|Other|1|||
37821995|NCT02988817|69501842|FG005|Overall Study|Other|0|||
37821996|NCT02988817|69501843|FG006|Overall Study|Other|0|||
37821997|NCT02988817|69501844|FG007|Overall Study|Other|0|||
37821998|NCT02988817|69501845|FG008|Overall Study|Other|0|||
37821999|NCT02988817|69501846|FG009|Overall Study|Other|0|||
37822000|NCT02988817|69501847|FG010|Overall Study|Other|0|||
37822001|NCT02988817|69501848|FG011|Overall Study|Other|0|||
37822002|NCT02988817|69501849|FG012|Overall Study|Other|0|||
37822003|NCT02988817|69501850|FG013|Overall Study|Other|0|||
37822004|NCT02988817|69501851|FG014|Overall Study|Other|0|||
37822005|NCT02988817|69501852|FG015|Overall Study|Other|1|||
37822006|NCT02988817|69501853|FG016|Overall Study|Other|0|||
37822007|NCT02988817|69501854|FG017|Overall Study|Other|0|||
37822008|NCT02988817|69501855|FG018|Overall Study|Other|0|||
37822009|NCT02988817|69501856|FG019|Overall Study|Other|0|||
37822010|NCT02988817|69501837|FG000|Overall Study|Lost to Follow-up|0|||
37822011|NCT02988817|69501838|FG001|Overall Study|Lost to Follow-up|0|||
37822012|NCT02988817|69501839|FG002|Overall Study|Lost to Follow-up|0|||
37822013|NCT02988817|69501840|FG003|Overall Study|Lost to Follow-up|0|||
37822014|NCT02988817|69501841|FG004|Overall Study|Lost to Follow-up|0|||
37822015|NCT02988817|69501842|FG005|Overall Study|Lost to Follow-up|0|||
37822016|NCT02988817|69501843|FG006|Overall Study|Lost to Follow-up|0|||
37822017|NCT02988817|69501844|FG007|Overall Study|Lost to Follow-up|0|||
37822018|NCT02988817|69501845|FG008|Overall Study|Lost to Follow-up|1|||
37822019|NCT02988817|69501846|FG009|Overall Study|Lost to Follow-up|0|||
37822020|NCT02988817|69501847|FG010|Overall Study|Lost to Follow-up|1|||
37822021|NCT02988817|69501848|FG011|Overall Study|Lost to Follow-up|1|||
37822022|NCT02988817|69501849|FG012|Overall Study|Lost to Follow-up|0|||
37886294|NCT00879970|69571073|FG003|Period 1 TZD Randomization|Death|0|||
37886295|NCT00879970|69571074|FG004|Period 1 TZD Randomization|Death|0|||
37886296|NCT00879970|69571070|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
37695580|NCT02349061|69171886|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
37695581|NCT02349061|69171887|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
37695582|NCT02349061|69171888|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
37695583|NCT02349061|69171886|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
37822023|NCT02988817|69501850|FG013|Overall Study|Lost to Follow-up|0|||
37695584|NCT02349061|69171887|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
37695585|NCT02349061|69171888|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
37822024|NCT02988817|69501851|FG014|Overall Study|Lost to Follow-up|1|||
37822025|NCT02988817|69501852|FG015|Overall Study|Lost to Follow-up|1|||
37822026|NCT02988817|69501853|FG016|Overall Study|Lost to Follow-up|2|||
37822027|NCT02988817|69501854|FG017|Overall Study|Lost to Follow-up|3|||
37822028|NCT02988817|69501855|FG018|Overall Study|Lost to Follow-up|0|||
37822029|NCT02988817|69501856|FG019|Overall Study|Lost to Follow-up|0|||
37822030|NCT02988817|69501837|FG000|Overall Study|Sponsor decision|0|||
37886297|NCT00879970|69571071|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
37886298|NCT00879970|69571072|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
37886299|NCT00879970|69571073|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
37986797|NCT00407030|69672431|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
37986798|NCT00407030|69672432|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
37986799|NCT00407030|69672433|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
37986800|NCT00407030|69672431|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
37986801|NCT00407030|69672432|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
37986802|NCT00407030|69672433|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
37986803|NCT00407030|69672431|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
37986804|NCT00407030|69672432|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
37986805|NCT00407030|69672433|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
37986806|NCT00407030|69672431|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
37886300|NCT00879970|69571074|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
37886301|NCT00879970|69571070|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
37886302|NCT00879970|69571071|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
37886303|NCT00879970|69571072|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
37886304|NCT00879970|69571073|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
37886305|NCT00879970|69571074|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
37886306|NCT00879970|69571070|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
37886307|NCT00879970|69571071|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
37886308|NCT00879970|69571072|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
37886309|NCT00879970|69571073|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
37886310|NCT00879970|69571074|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
37886311|NCT00879970|69571070|FG000|Period 2 Vitamin D Randomization|Death|0|||
37886312|NCT00879970|69571071|FG001|Period 2 Vitamin D Randomization|Death|0|||
37886313|NCT00879970|69571072|FG002|Period 2 Vitamin D Randomization|Death|0|||
37886314|NCT00879970|69571073|FG003|Period 2 Vitamin D Randomization|Death|2|||
37986807|NCT00407030|69672432|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
37822031|NCT02988817|69501838|FG001|Overall Study|Sponsor decision|0|||
37822032|NCT02988817|69501839|FG002|Overall Study|Sponsor decision|0|||
37822033|NCT02988817|69501840|FG003|Overall Study|Sponsor decision|0|||
37822034|NCT02988817|69501841|FG004|Overall Study|Sponsor decision|0|||
37986808|NCT00407030|69672433|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
37822035|NCT02988817|69501842|FG005|Overall Study|Sponsor decision|0|||
37822036|NCT02988817|69501843|FG006|Overall Study|Sponsor decision|0|||
37822037|NCT02988817|69501844|FG007|Overall Study|Sponsor decision|0|||
37822038|NCT02988817|69501845|FG008|Overall Study|Sponsor decision|0|||
37822039|NCT02988817|69501846|FG009|Overall Study|Sponsor decision|0|||
37822040|NCT02988817|69501847|FG010|Overall Study|Sponsor decision|0|||
37822041|NCT02988817|69501848|FG011|Overall Study|Sponsor decision|1|||
37822042|NCT02988817|69501849|FG012|Overall Study|Sponsor decision|1|||
37822043|NCT02988817|69501850|FG013|Overall Study|Sponsor decision|2|||
37822044|NCT02988817|69501851|FG014|Overall Study|Sponsor decision|2|||
37822045|NCT02988817|69501852|FG015|Overall Study|Sponsor decision|6|||
37822046|NCT02988817|69501853|FG016|Overall Study|Sponsor decision|2|||
37822047|NCT02988817|69501854|FG017|Overall Study|Sponsor decision|3|||
37822048|NCT02988817|69501855|FG018|Overall Study|Sponsor decision|2|||
37822049|NCT02988817|69501856|FG019|Overall Study|Sponsor decision|7|||
37822050|NCT02988817|69501837|FG000|Overall Study|Physician Decision|0|||
37822051|NCT02988817|69501838|FG001|Overall Study|Physician Decision|0|||
37822052|NCT02988817|69501839|FG002|Overall Study|Physician Decision|0|||
37822053|NCT02988817|69501840|FG003|Overall Study|Physician Decision|0|||
37822054|NCT02988817|69501841|FG004|Overall Study|Physician Decision|0|||
37822055|NCT02988817|69501842|FG005|Overall Study|Physician Decision|0|||
37822056|NCT02988817|69501843|FG006|Overall Study|Physician Decision|0|||
37822057|NCT02988817|69501844|FG007|Overall Study|Physician Decision|0|||
37822058|NCT02988817|69501845|FG008|Overall Study|Physician Decision|0|||
37822059|NCT02988817|69501846|FG009|Overall Study|Physician Decision|0|||
37822060|NCT02988817|69501847|FG010|Overall Study|Physician Decision|0|||
37886315|NCT00879970|69571074|FG004|Period 2 Vitamin D Randomization|Death|0|||
37886316|NCT00808639|69571092|FG000|Overall Study|Disease progression before surgery.|1|||
37886317|NCT00810901|69571098|FG000|Overall Study|Lost to Follow-up|88|||
37822061|NCT02988817|69501848|FG011|Overall Study|Physician Decision|0|||
37822062|NCT02988817|69501849|FG012|Overall Study|Physician Decision|0|||
37822063|NCT02988817|69501850|FG013|Overall Study|Physician Decision|0|||
37822064|NCT02988817|69501851|FG014|Overall Study|Physician Decision|0|||
37822065|NCT02988817|69501852|FG015|Overall Study|Physician Decision|1|||
37822066|NCT02988817|69501853|FG016|Overall Study|Physician Decision|0|||
37822067|NCT02988817|69501854|FG017|Overall Study|Physician Decision|0|||
37822068|NCT02988817|69501855|FG018|Overall Study|Physician Decision|1|||
37822069|NCT02988817|69501856|FG019|Overall Study|Physician Decision|1|||
37822070|NCT02960659|69501911|FG000|Overall Study|Withdrawal by Subject|1|||
37822071|NCT02960659|69501912|FG001|Overall Study|Withdrawal by Subject|0|||
37822072|NCT02960659|69501911|FG000|Overall Study|Poor compliance|0|||
37822073|NCT02960659|69501912|FG001|Overall Study|Poor compliance|1|||
37822074|NCT02844933|69501920|FG000|Overall Study|Discontinued due to premature termination of study|3|||
37822075|NCT02844933|69501921|FG001|Overall Study|Discontinued due to premature termination of study|2|||
37822076|NCT02831764|69501929|FG000|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
37822077|NCT02831764|69501930|FG001|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|2|||
37822078|NCT02831764|69501931|FG002|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
37822079|NCT02831764|69501932|FG003|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
37822080|NCT02831764|69501933|FG004|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
37822081|NCT02831764|69501929|FG000|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
37822082|NCT02831764|69501930|FG001|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
37822083|NCT02831764|69501931|FG002|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
37822084|NCT02831764|69501932|FG003|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
37822085|NCT02831764|69501933|FG004|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
37822086|NCT02831764|69501929|FG000|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
37822087|NCT02831764|69501930|FG001|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
37822088|NCT02831764|69501931|FG002|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
37822089|NCT02831764|69501932|FG003|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
37822090|NCT02831764|69501933|FG004|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
37886318|NCT00810901|69571099|FG001|Overall Study|Lost to Follow-up|58|||
37886319|NCT00910299|69571107|FG000|Overall Study|Withdrawal by Subject|16|||
37822091|NCT02831764|69501929|FG000|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|9|||
37822092|NCT02831764|69501930|FG001|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|7|||
37886320|NCT00910299|69571108|FG001|Overall Study|Withdrawal by Subject|13|||
37886321|NCT00910299|69571107|FG000|Overall Study|Sponsor Decision|58|||
37886322|NCT00910299|69571108|FG001|Overall Study|Sponsor Decision|60|||
37886323|NCT00910299|69571107|FG000|Overall Study|Didn't receive any study drug|2|||
37886324|NCT00910299|69571108|FG001|Overall Study|Didn't receive any study drug|1|||
37886325|NCT00595504|69571116|FG000|Overall Study|Withdrawal by Subject|1|||
37886326|NCT00595504|69571117|FG001|Overall Study|Withdrawal by Subject|3|||
37886327|NCT00595504|69571116|FG000|Overall Study|Physician Decision|1|||
37886328|NCT00595504|69571117|FG001|Overall Study|Physician Decision|0|||
37886329|NCT00808483|69571125|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
37886330|NCT00808483|69571126|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
37886331|NCT00808483|69571125|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
37886332|NCT00808483|69571126|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
37886333|NCT00808483|69571125|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
37886334|NCT00808483|69571126|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
37886335|NCT00810511|69571141|FG000|Overall Study|Protocol Violation|0|||
37986809|NCT00407030|69672431|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
37986810|NCT00407030|69672432|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
37986811|NCT00407030|69672433|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
37695586|NCT02349061|69171886|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
37695587|NCT02349061|69171887|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
37695588|NCT02349061|69171888|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
37695589|NCT02349061|69171886|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
37695590|NCT02349061|69171887|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
37695591|NCT02349061|69171888|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
37695592|NCT02349061|69171886|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
37695593|NCT02349061|69171887|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
37695594|NCT02349061|69171888|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
37695595|NCT02349061|69171886|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
37886336|NCT00810511|69571142|FG001|Overall Study|Protocol Violation|1|||
37986812|NCT00407030|69672431|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
37986813|NCT00407030|69672432|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
37695596|NCT02349061|69171887|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
37886337|NCT00810511|69571141|FG000|Overall Study|Lack of Efficacy|9|||
37886338|NCT00810511|69571142|FG001|Overall Study|Lack of Efficacy|1|||
37886339|NCT00810511|69571141|FG000|Overall Study|death in the family|0|||
37886340|NCT00810511|69571142|FG001|Overall Study|death in the family|1|||
37886341|NCT00810511|69571141|FG000|Overall Study|Lost to Follow-up|1|||
37886342|NCT00810511|69571142|FG001|Overall Study|Lost to Follow-up|0|||
37986814|NCT00407030|69672433|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
37886343|NCT00810511|69571141|FG000|Overall Study|deposits on contact lens|0|||
37886344|NCT00810511|69571142|FG001|Overall Study|deposits on contact lens|1|||
37986815|NCT00407030|69672431|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
37695597|NCT02349061|69171888|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
37695598|NCT02349061|69171886|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
37695599|NCT02349061|69171887|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
37695600|NCT02349061|69171888|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
37695601|NCT02349061|69171886|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
37695602|NCT02349061|69171887|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
37695603|NCT02349061|69171888|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
37695604|NCT02331368|69171898|FG000|Overall Study|Withdrawal by Subject|3|||
37886345|NCT00596362|69571148|FG000|Overall Study|Progressive Disease|1|||
37886346|NCT00907803|69571155|FG000|Overall Study|Withdrawal of consent - long commute|1|||
37886347|NCT00907803|69571156|FG001|Overall Study|Withdrawal of consent - long commute|0|||
37886348|NCT00907803|69571157|FG002|Overall Study|Withdrawal of consent - long commute|0|||
37886349|NCT00907803|69571155|FG000|Overall Study|Adverse Event|2|||
37886350|NCT00907803|69571156|FG001|Overall Study|Adverse Event|0|||
37886351|NCT00907803|69571157|FG002|Overall Study|Adverse Event|0|||
37986816|NCT00407030|69672432|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
37886352|NCT00907803|69571155|FG000|Overall Study|Withdrawal by Subject|0|||
37886353|NCT00907803|69571156|FG001|Overall Study|Withdrawal by Subject|1|||
37886354|NCT00907803|69571157|FG002|Overall Study|Withdrawal by Subject|0|||
37886355|NCT00907803|69571155|FG000|Overall Study|Lost to Follow-up|0|||
37886356|NCT00907803|69571156|FG001|Overall Study|Lost to Follow-up|1|||
37886357|NCT00907803|69571157|FG002|Overall Study|Lost to Follow-up|0|||
37886358|NCT00907803|69571155|FG000|Overall Study|Protocol Violation|0|||
37886359|NCT00907803|69571156|FG001|Overall Study|Protocol Violation|1|||
37886360|NCT00907803|69571157|FG002|Overall Study|Protocol Violation|0|||
37886361|NCT00808249|69571169|FG000|Overall Study|Adverse Event|4|||
37886362|NCT00808249|69571170|FG001|Overall Study|Adverse Event|7|||
37886363|NCT00808249|69571171|FG002|Overall Study|Adverse Event|10|||
37886364|NCT00808249|69571172|FG003|Overall Study|Adverse Event|6|||
37886365|NCT00808249|69571169|FG000|Overall Study|Lost to Follow-up|2|||
37886366|NCT00808249|69571170|FG001|Overall Study|Lost to Follow-up|3|||
37886367|NCT00808249|69571171|FG002|Overall Study|Lost to Follow-up|3|||
37886368|NCT00808249|69571172|FG003|Overall Study|Lost to Follow-up|5|||
37886369|NCT00808249|69571169|FG000|Overall Study|Withdrawal by Subject|4|||
37886370|NCT00808249|69571170|FG001|Overall Study|Withdrawal by Subject|0|||
37886371|NCT00808249|69571171|FG002|Overall Study|Withdrawal by Subject|2|||
37886372|NCT00808249|69571172|FG003|Overall Study|Withdrawal by Subject|4|||
37886373|NCT00808249|69571169|FG000|Overall Study|Protocol Violation|3|||
37886374|NCT00808249|69571170|FG001|Overall Study|Protocol Violation|3|||
37886375|NCT00808249|69571171|FG002|Overall Study|Protocol Violation|3|||
37886376|NCT00808249|69571172|FG003|Overall Study|Protocol Violation|0|||
37886377|NCT00808249|69571169|FG000|Overall Study|Lack of Efficacy|1|||
37886378|NCT00808249|69571170|FG001|Overall Study|Lack of Efficacy|1|||
37886379|NCT00808249|69571171|FG002|Overall Study|Lack of Efficacy|0|||
37886380|NCT00808249|69571172|FG003|Overall Study|Lack of Efficacy|0|||
37886381|NCT00808249|69571169|FG000|Overall Study|study specific discontinuation criteria|1|||
37886382|NCT00808249|69571170|FG001|Overall Study|study specific discontinuation criteria|0|||
37886383|NCT00808249|69571171|FG002|Overall Study|study specific discontinuation criteria|1|||
37986817|NCT00407030|69672433|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
37986818|NCT00407030|69672431|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
37986819|NCT00407030|69672432|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
37986820|NCT00407030|69672433|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
37695605|NCT02362724|69171904|FG000|Overall Study|Withdrawal by Subject|3|||
37695606|NCT02362724|69171905|FG001|Overall Study|Withdrawal by Subject|1|||
37886384|NCT00808249|69571172|FG003|Overall Study|study specific discontinuation criteria|0|||
37886385|NCT00808249|69571169|FG000|Overall Study|All other reasons|2|||
37986821|NCT00407030|69672431|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
37886386|NCT00808249|69571170|FG001|Overall Study|All other reasons|1|||
37886387|NCT00808249|69571171|FG002|Overall Study|All other reasons|3|||
37986822|NCT00407030|69672432|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
37886388|NCT00808249|69571172|FG003|Overall Study|All other reasons|1|||
37886389|NCT00908895|69571184|FG000|Overall Study|Lost to Follow-up|1|||
37886390|NCT00908895|69571185|FG001|Overall Study|Lost to Follow-up|3|||
37886391|NCT00908895|69571184|FG000|Overall Study|algodystrophy|2|||
37886392|NCT00908895|69571185|FG001|Overall Study|algodystrophy|2|||
37886393|NCT00908895|69571184|FG000|Overall Study|Adverse Event|1|||
37886394|NCT00908895|69571185|FG001|Overall Study|Adverse Event|1|||
37886395|NCT00591253|69571194|FG000|Overall Study|Adverse Event|3|||
37886396|NCT00591253|69571195|FG001|Overall Study|Adverse Event|3|||
37886397|NCT00591253|69571196|FG002|Overall Study|Adverse Event|1|||
37886398|NCT00591253|69571194|FG000|Overall Study|Protocol Violation|2|||
37886399|NCT00591253|69571195|FG001|Overall Study|Protocol Violation|2|||
37986823|NCT00407030|69672433|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
37986824|NCT00407030|69672431|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
37986825|NCT00407030|69672432|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
37986826|NCT00407030|69672433|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
37986827|NCT00407030|69672431|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
37986828|NCT00407030|69672432|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
37986829|NCT00407030|69672433|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
37986830|NCT00407030|69672431|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
37986831|NCT00407030|69672432|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
37986832|NCT00407030|69672433|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
37986833|NCT00407030|69672431|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
37886400|NCT00591253|69571196|FG002|Overall Study|Protocol Violation|2|||
37886401|NCT00591253|69571194|FG000|Overall Study|Lost to Follow-up|2|||
37886402|NCT00591253|69571195|FG001|Overall Study|Lost to Follow-up|4|||
37886403|NCT00591253|69571196|FG002|Overall Study|Lost to Follow-up|0|||
37886404|NCT00591253|69571194|FG000|Overall Study|Withdrawal by Subject|1|||
37886405|NCT00591253|69571195|FG001|Overall Study|Withdrawal by Subject|7|||
37886406|NCT00591253|69571196|FG002|Overall Study|Withdrawal by Subject|6|||
37886407|NCT00591253|69571194|FG000|Overall Study|Lack of Efficacy|1|||
37886408|NCT00591253|69571195|FG001|Overall Study|Lack of Efficacy|0|||
37886409|NCT00591253|69571196|FG002|Overall Study|Lack of Efficacy|3|||
37886410|NCT00591253|69571194|FG000|Overall Study|Other|5|||
37886411|NCT00591253|69571195|FG001|Overall Study|Other|5|||
37886412|NCT00591253|69571196|FG002|Overall Study|Other|3|||
37886413|NCT00908583|69571204|FG000|Phase 1|Withdrawal by Subject|1|||
37886414|NCT00908583|69571204|FG000|Phase 1|Adverse Event|4|||
37886415|NCT00908583|69571204|FG000|Phase 2|Physician Decision|1|||
37986834|NCT00407030|69672432|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
37986835|NCT00407030|69672433|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
37886416|NCT00908583|69571204|FG000|Phase 2|Adverse Event|1|||
37886417|NCT00908583|69571204|FG000|Phase 3|Adverse Event|2|||
37886418|NCT00908583|69571204|FG000|Phase 4|Adverse Event|1|||
37886419|NCT00908583|69571204|FG000|Phase 4|Physician Decision|1|||
37886420|NCT00908583|69571204|FG000|Phase 5|Adverse Event|3|||
37886421|NCT00909363|69571225|FG000|Overall Study|Withdrawal by Subject|1|||
37986836|NCT00406718|69672446|FG000|Overall Study|Withdrawal by Subject|2|||
37822093|NCT02831764|69501931|FG002|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
37822094|NCT02831764|69501932|FG003|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
37822095|NCT02831764|69501933|FG004|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
37822096|NCT02831764|69501929|FG000|Double-blind Phase (Day1 to Week 96)|Adverse Event|10|||
37822097|NCT02831764|69501930|FG001|Double-blind Phase (Day1 to Week 96)|Adverse Event|6|||
37822098|NCT02831764|69501931|FG002|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
37822099|NCT02831764|69501932|FG003|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
37822100|NCT02831764|69501933|FG004|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
37822101|NCT02831764|69501929|FG000|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|5|||
37822102|NCT02831764|69501930|FG001|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|2|||
37822103|NCT02831764|69501931|FG002|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
37822104|NCT02831764|69501932|FG003|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
37822105|NCT02831764|69501933|FG004|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
37822106|NCT02831764|69501929|FG000|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|5|||
37822107|NCT02831764|69501930|FG001|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|3|||
37822108|NCT02831764|69501931|FG002|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
37822109|NCT02831764|69501932|FG003|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
37822110|NCT02831764|69501933|FG004|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
37886422|NCT00909363|69571226|FG001|Overall Study|Withdrawal by Subject|0|||
37886423|NCT00909363|69571227|FG002|Overall Study|Withdrawal by Subject|0|||
37886424|NCT00909363|69571225|FG000|Overall Study|Lack of Efficacy|1|||
37886425|NCT00909363|69571226|FG001|Overall Study|Lack of Efficacy|0|||
37886426|NCT00909363|69571227|FG002|Overall Study|Lack of Efficacy|0|||
37886427|NCT00810355|69571241|FG000|Overall Study|Lost to Follow-up|13|||
37886428|NCT00810355|69571242|FG001|Overall Study|Lost to Follow-up|17|||
37886429|NCT00810355|69571243|FG002|Overall Study|Lost to Follow-up|11|||
37886430|NCT00810355|69571241|FG000|Overall Study|Withdrawal by Subject|1|||
37886431|NCT00810355|69571242|FG001|Overall Study|Withdrawal by Subject|0|||
37886432|NCT00810355|69571243|FG002|Overall Study|Withdrawal by Subject|0|||
37886433|NCT00908349|69571251|FG000|Overall Study|Adverse Event|10|||
37886434|NCT00908349|69571251|FG000|Overall Study|Withdrawal by Subject|9|||
37886435|NCT00908349|69571251|FG000|Overall Study|Physician Decision|5|||
37886436|NCT00908349|69571251|FG000|Overall Study|Lost to Follow-up|5|||
37886437|NCT00908349|69571251|FG000|Overall Study|Various|6|||
37886438|NCT01125566|69571257|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
37886439|NCT01125566|69571258|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
37886440|NCT01125566|69571259|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
37886441|NCT01125566|69571257|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
37886442|NCT01125566|69571258|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
37886443|NCT01125566|69571259|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
37886444|NCT01125566|69571257|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
37886445|NCT01125566|69571258|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
37886446|NCT01125566|69571259|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
37886447|NCT01125566|69571257|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
37886448|NCT01125566|69571258|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
37886449|NCT01125566|69571259|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
37886450|NCT01125566|69571257|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
37886451|NCT01125566|69571258|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
37886452|NCT01125566|69571259|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
37886453|NCT01125566|69571257|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
37886454|NCT01125566|69571258|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
37886455|NCT01125566|69571259|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
37886456|NCT01125566|69571257|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
37886457|NCT01125566|69571258|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
37886458|NCT01125566|69571259|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
37886459|NCT01125566|69571257|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
37886460|NCT01125566|69571258|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
37886461|NCT01125566|69571259|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
37886462|NCT01125566|69571257|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
37886463|NCT01125566|69571258|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
37886464|NCT01125566|69571259|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
37886465|NCT01125566|69571257|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
37986837|NCT00406718|69672447|FG001|Overall Study|Withdrawal by Subject|9|||
37986838|NCT00406718|69672448|FG002|Overall Study|Withdrawal by Subject|4|||
37886466|NCT01125566|69571258|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
37886467|NCT01125566|69571259|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
37886468|NCT01125566|69571257|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
37886469|NCT01125566|69571258|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
37886470|NCT01125566|69571259|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
37822111|NCT02831764|69501929|FG000|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
37822112|NCT02831764|69501930|FG001|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|3|||
37822113|NCT02831764|69501931|FG002|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
37822114|NCT02831764|69501932|FG003|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
37822115|NCT02831764|69501933|FG004|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
37822116|NCT02831764|69501929|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
37822117|NCT02831764|69501930|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
37822118|NCT02831764|69501931|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|1|||
37822119|NCT02831764|69501932|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
37822120|NCT02831764|69501933|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
37822121|NCT02831764|69501929|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
37822122|NCT02831764|69501930|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
37822123|NCT02831764|69501931|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
37822124|NCT02831764|69501932|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
37822125|NCT02831764|69501933|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
37822126|NCT02831764|69501929|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
37822127|NCT02831764|69501930|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
37822128|NCT02831764|69501931|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
37822129|NCT02831764|69501932|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
37822130|NCT02831764|69501933|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
37822131|NCT02831764|69501929|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
37822132|NCT02831764|69501930|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
37822133|NCT02831764|69501931|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|1|||
37822134|NCT02831764|69501932|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
37822135|NCT02831764|69501933|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
37822136|NCT02831764|69501929|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
37822137|NCT02831764|69501930|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
37822138|NCT02831764|69501931|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|4|||
37822139|NCT02831764|69501932|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
37822140|NCT02831764|69501933|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
37822141|NCT02831764|69501929|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
37822142|NCT02831764|69501930|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
37822143|NCT02831764|69501931|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
37822144|NCT02831764|69501932|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|3|||
37822145|NCT02831764|69501933|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
37822146|NCT02831764|69501929|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
37822147|NCT02831764|69501930|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
37822148|NCT02831764|69501931|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|7|||
37822149|NCT02831764|69501932|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|9|||
37822150|NCT02831764|69501933|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
37822151|NCT02831764|69501929|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
37822152|NCT02831764|69501930|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
37822153|NCT02831764|69501931|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
37822154|NCT02831764|69501932|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
37822155|NCT02831764|69501933|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
37822156|NCT02831764|69501929|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
37822157|NCT02831764|69501930|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
37822158|NCT02831764|69501931|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
37886471|NCT01125566|69571257|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
37886472|NCT01125566|69571258|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
37886473|NCT01125566|69571259|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
37886474|NCT00810277|69571266|FG000|Overall Study|Adverse Event|1|||
37886475|NCT00595582|69571270|FG000|Overall Study|Pilot study that PI terminated|2|||
37886476|NCT00595582|69571270|FG000|Overall Study|Lost to Follow-up|1|||
37886477|NCT00595582|69571270|FG000|Overall Study|Adverse Event|2|||
37886478|NCT00595582|69571270|FG000|Overall Study|Physician Decision|5|||
37886479|NCT00808015|69571274|FG000|Overall Study|Death|1|||
37822159|NCT02831764|69501932|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
37822160|NCT02831764|69501933|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|2|||
37822161|NCT02831764|69501929|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
37822162|NCT02831764|69501930|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
37822163|NCT02831764|69501931|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
37886480|NCT00808015|69571274|FG000|Overall Study|Lack of Efficacy|58|||
37886481|NCT00808015|69571274|FG000|Overall Study|Lost to Follow-up|76|||
37886482|NCT00808015|69571274|FG000|Overall Study|Participants not willing to participate|158|||
37822164|NCT02831764|69501932|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
37822165|NCT02831764|69501933|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|5|||
37822166|NCT02831764|69501929|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
37822167|NCT02831764|69501930|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
37822168|NCT02831764|69501931|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
37822169|NCT02831764|69501932|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
37822170|NCT02831764|69501933|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|5|||
37822171|NCT02499835|69501965|FG000|Overall Study|Withdrawal by Subject|1|||
37822172|NCT02499835|69501966|FG001|Overall Study|Withdrawal by Subject|0|||
37822173|NCT02499835|69501967|FG002|Overall Study|Withdrawal by Subject|0|||
37822174|NCT02499835|69501968|FG003|Overall Study|Withdrawal by Subject|1|||
37822175|NCT02499835|69501965|FG000|Overall Study|Physician Decision|0|||
37822176|NCT02499835|69501966|FG001|Overall Study|Physician Decision|3|||
37822177|NCT02499835|69501967|FG002|Overall Study|Physician Decision|18|||
37822178|NCT02499835|69501968|FG003|Overall Study|Physician Decision|7|||
37822179|NCT02499835|69501965|FG000|Overall Study|Adverse Event|0|||
37822180|NCT02499835|69501966|FG001|Overall Study|Adverse Event|0|||
37822181|NCT02499835|69501967|FG002|Overall Study|Adverse Event|0|||
37822182|NCT02499835|69501968|FG003|Overall Study|Adverse Event|1|||
37822183|NCT02499835|69501965|FG000|Overall Study|Disease progression|2|||
37822184|NCT02499835|69501966|FG001|Overall Study|Disease progression|1|||
37822185|NCT02499835|69501967|FG002|Overall Study|Disease progression|0|||
37822186|NCT02499835|69501968|FG003|Overall Study|Disease progression|7|||
37822187|NCT02460497|69501980|FG000|Overall Study|Participant Requested Withdrawal|4|||
37822188|NCT02460497|69501980|FG000|Overall Study|Non-Compliance|1|||
37822189|NCT02460497|69501980|FG000|Overall Study|Did not Meet Protocol Criteria|1|||
37822190|NCT02460497|69501980|FG000|Overall Study|Lost to Follow-up|2|||
37822191|NCT02460497|69501980|FG000|Overall Study|Investigator Decision|1|||
37822192|NCT02460289|69501984|FG000|Overall Study|Adverse Event|1|||
37822193|NCT02460289|69501984|FG000|Overall Study|Withdrawal by Subject|8|||
37822194|NCT02460289|69501984|FG000|Overall Study|Lost to Follow-up|1|||
37822195|NCT02354651|69501995|FG000|Overall Study|Withdrawal by Subject|2|||
37822196|NCT02354651|69501995|FG000|Overall Study|Physician Decision|1|||
37822197|NCT02253316|69502002|FG000|Consolidation|Progression|4|||
37822198|NCT02253316|69502003|FG001|Consolidation|Progression|0|||
37822199|NCT02253316|69502004|FG002|Consolidation|Progression|0|||
37822200|NCT02253316|69502002|FG000|Consolidation|Non-Compliance|1|||
37822201|NCT02253316|69502003|FG001|Consolidation|Non-Compliance|0|||
37822202|NCT02253316|69502004|FG002|Consolidation|Non-Compliance|0|||
37822203|NCT02253316|69502002|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
37886483|NCT00808015|69571274|FG000|Overall Study|Adverse Event|22|||
37886484|NCT00808015|69571274|FG000|Overall Study|Other|25|||
37886485|NCT00808015|69571274|FG000|Overall Study|Enrolled but not treated|4|||
37886486|NCT00810199|69571280|FG000|Overall Study|Adverse Event|24|||
37886487|NCT00810199|69571281|FG001|Overall Study|Adverse Event|26|||
37886488|NCT00810199|69571280|FG000|Overall Study|Death|4|||
37886489|NCT00810199|69571281|FG001|Overall Study|Death|6|||
37886490|NCT00810199|69571280|FG000|Overall Study|Withdrew consent|9|||
37886491|NCT00810199|69571281|FG001|Overall Study|Withdrew consent|12|||
37886492|NCT00810199|69571280|FG000|Overall Study|Insufficient therapeutic response|5|||
37886493|NCT00810199|69571281|FG001|Overall Study|Insufficient therapeutic response|14|||
37886494|NCT00810199|69571280|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
37886495|NCT00810199|69571281|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
37886496|NCT00810199|69571280|FG000|Overall Study|Administrative/Other|5|||
37886497|NCT00810199|69571281|FG001|Overall Study|Administrative/Other|6|||
37886498|NCT00810199|69571280|FG000|Overall Study|Protocol Violation|2|||
37886499|NCT00810199|69571281|FG001|Overall Study|Protocol Violation|6|||
37886500|NCT00810199|69571280|FG000|Overall Study|Failure to return|1|||
37886501|NCT00810199|69571281|FG001|Overall Study|Failure to return|4|||
37886502|NCT00810199|69571280|FG000|Overall Study|Did not receive study drug|2|||
37886503|NCT00810199|69571281|FG001|Overall Study|Did not receive study drug|1|||
37886504|NCT00877006|69571295|FG000|Treatment Period|Death|2|||
37886505|NCT00877006|69571296|FG001|Treatment Period|Death|1|||
37986839|NCT00406718|69672446|FG000|Overall Study|Lost to Follow-up|2|||
37986840|NCT00406718|69672447|FG001|Overall Study|Lost to Follow-up|5|||
37986841|NCT00406718|69672448|FG002|Overall Study|Lost to Follow-up|4|||
37986842|NCT00406640|69672460|FG000|Acute Phase|Adverse Event|18|||
37986843|NCT00406640|69672461|FG001|Acute Phase|Adverse Event|13|||
37986844|NCT00406640|69672460|FG000|Acute Phase|Failed to Return|5|||
37986845|NCT00406640|69672461|FG001|Acute Phase|Failed to Return|1|||
37695607|NCT02362724|69171904|FG000|Overall Study|Adverse Event|3|||
37695608|NCT02362724|69171905|FG001|Overall Study|Adverse Event|0|||
37695609|NCT02362646|69171913|FG000|Overall Study|Death|15|||
37695610|NCT02362646|69171914|FG001|Overall Study|Death|8|||
37695611|NCT02362646|69171913|FG000|Overall Study|Withdrawal by Subject|2|||
37695612|NCT02362646|69171914|FG001|Overall Study|Withdrawal by Subject|2|||
37822204|NCT02253316|69502003|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
37822205|NCT02253316|69502004|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
37822206|NCT02253316|69502002|FG000|Consolidation|Secondary Malignancy|2|||
37822207|NCT02253316|69502003|FG001|Consolidation|Secondary Malignancy|0|||
37822208|NCT02253316|69502004|FG002|Consolidation|Secondary Malignancy|0|||
37822209|NCT02253316|69502002|FG000|Consolidation|Adverse Event|7|||
37822210|NCT02253316|69502003|FG001|Consolidation|Adverse Event|0|||
37822211|NCT02253316|69502004|FG002|Consolidation|Adverse Event|0|||
37822212|NCT02253316|69502002|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
37822213|NCT02253316|69502003|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
37986846|NCT00406640|69672460|FG000|Acute Phase|Physician Decision|0|||
37822214|NCT02253316|69502004|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
37822215|NCT02253316|69502002|FG000|Maintenance|Physician Decision|0|||
37822216|NCT02253316|69502003|FG001|Maintenance|Physician Decision|5|||
37822217|NCT02253316|69502004|FG002|Maintenance|Physician Decision|16|||
37695613|NCT02362646|69171913|FG000|Overall Study|received transplant|21|||
37822218|NCT02253316|69502002|FG000|Maintenance|Non-Compliance|0|||
37886506|NCT00877006|69571295|FG000|Treatment Period|Adverse Event|10|||
37886507|NCT00877006|69571296|FG001|Treatment Period|Adverse Event|3|||
37886508|NCT00877006|69571295|FG000|Treatment Period|Withdrawal by Subject|2|||
37886509|NCT00877006|69571296|FG001|Treatment Period|Withdrawal by Subject|3|||
37986847|NCT00406640|69672461|FG001|Acute Phase|Physician Decision|1|||
37986848|NCT00406640|69672460|FG000|Acute Phase|Lost to Follow-up|7|||
37986849|NCT00406640|69672461|FG001|Acute Phase|Lost to Follow-up|4|||
37986850|NCT00406640|69672460|FG000|Acute Phase|Protocol deviation|4|||
37986851|NCT00406640|69672461|FG001|Acute Phase|Protocol deviation|10|||
37986852|NCT00406640|69672460|FG000|Acute Phase|Protocol Violation|3|||
37986853|NCT00406640|69672461|FG001|Acute Phase|Protocol Violation|2|||
37986854|NCT00406640|69672460|FG000|Acute Phase|Withdrawal by Subject|11|||
37986855|NCT00406640|69672461|FG001|Acute Phase|Withdrawal by Subject|9|||
37986856|NCT00406640|69672460|FG000|Acute Phase|Lack of Efficacy|3|||
37986857|NCT00406640|69672461|FG001|Acute Phase|Lack of Efficacy|3|||
37986858|NCT00406640|69672460|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
37986859|NCT00406640|69672461|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
37986860|NCT00406640|69672460|FG000|DB Continuation Phase for Responders|Death|1|||
37986861|NCT00406640|69672461|FG001|DB Continuation Phase for Responders|Death|0|||
37986862|NCT00406640|69672460|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
37986863|NCT00406640|69672461|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
37986864|NCT00406640|69672460|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
37986865|NCT00406640|69672461|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
37986866|NCT00406640|69672460|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
37986867|NCT00406640|69672461|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
37986868|NCT00406640|69672460|FG000|DB Continuation Phase for Responders|non-compliance|7|||
37986869|NCT00406640|69672461|FG001|DB Continuation Phase for Responders|non-compliance|5|||
37986870|NCT00406640|69672460|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
37986871|NCT00406640|69672461|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
37986872|NCT00406640|69672460|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
37986873|NCT00406640|69672461|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
37986874|NCT00406640|69672460|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
37986875|NCT00406640|69672461|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
37986876|NCT00406640|69672460|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
37986877|NCT00406640|69672461|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
37986878|NCT00406640|69672460|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
37886510|NCT00877006|69571295|FG000|Treatment Period|Protocol Violation|1|||
37986879|NCT00406640|69672461|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
37986880|NCT00406640|69672460|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
37986881|NCT00406640|69672461|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
37986882|NCT00406640|69672460|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
37986883|NCT00406640|69672461|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
37986884|NCT00406640|69672460|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
37986885|NCT00406640|69672461|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
37986886|NCT00406640|69672460|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
37986887|NCT00406640|69672461|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
37986888|NCT00406640|69672460|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
37986889|NCT00406640|69672461|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
37986890|NCT00394706|69672481|FG000|Overall Study|Withdrawal by Subject|2|||
37986891|NCT00394706|69672482|FG001|Overall Study|Withdrawal by Subject|0|||
37886511|NCT00877006|69571296|FG001|Treatment Period|Protocol Violation|0|||
37886512|NCT00877006|69571295|FG000|Treatment Period|Lost to Follow-up|0|||
37886513|NCT00877006|69571296|FG001|Treatment Period|Lost to Follow-up|1|||
37886514|NCT00877006|69571295|FG000|Treatment Period|Disease Progression|1|||
37886515|NCT00877006|69571296|FG001|Treatment Period|Disease Progression|2|||
37886516|NCT00877006|69571295|FG000|Treatment Period|Started New Treatment Regimen|2|||
37886517|NCT00877006|69571296|FG001|Treatment Period|Started New Treatment Regimen|5|||
37886518|NCT00877006|69571295|FG000|Treatment Period|Other|4|||
37886519|NCT00877006|69571296|FG001|Treatment Period|Other|4|||
37886520|NCT00877006|69571295|FG000|Treatment Period|Randomized but Not Treated|3|||
37886521|NCT00877006|69571296|FG001|Treatment Period|Randomized but Not Treated|8|||
37886522|NCT00877006|69571295|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
37886523|NCT00877006|69571296|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
37886524|NCT00877006|69571295|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
37886525|NCT00877006|69571296|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
37886526|NCT00877006|69571295|FG000|Long-Term Follow-up Period|Death|26|||
37886527|NCT00877006|69571296|FG001|Long-Term Follow-up Period|Death|18|||
37886528|NCT00877006|69571295|FG000|Long-Term Follow-up Period|Other|7|||
37886529|NCT00877006|69571296|FG001|Long-Term Follow-up Period|Other|9|||
37886530|NCT00876928|69571306|FG000|Overall Study|Lost to Follow-up|2|||
37886531|NCT00876928|69571307|FG001|Overall Study|Lost to Follow-up|5|||
37886532|NCT00876928|69571306|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
37886533|NCT00876928|69571307|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
37886534|NCT00807937|69571317|FG000|Overall Study|Adverse Event|12|||
37886535|NCT00807937|69571318|FG001|Overall Study|Adverse Event|12|||
37886536|NCT00807937|69571319|FG002|Overall Study|Adverse Event|5|||
37986892|NCT00394706|69672483|FG002|Overall Study|Withdrawal by Subject|1|||
37986893|NCT00394706|69672484|FG003|Overall Study|Withdrawal by Subject|0|||
37986894|NCT00394706|69672485|FG004|Overall Study|Withdrawal by Subject|0|||
37986895|NCT00394706|69672486|FG005|Overall Study|Withdrawal by Subject|2|||
37986896|NCT00394706|69672487|FG006|Overall Study|Withdrawal by Subject|1|||
37986897|NCT00394706|69672488|FG007|Overall Study|Withdrawal by Subject|0|||
37986898|NCT00394706|69672481|FG000|Overall Study|Lost to Follow-up|2|||
37986899|NCT00394706|69672482|FG001|Overall Study|Lost to Follow-up|2|||
37986900|NCT00394706|69672483|FG002|Overall Study|Lost to Follow-up|8|||
37986901|NCT00394706|69672484|FG003|Overall Study|Lost to Follow-up|1|||
37986902|NCT00394706|69672485|FG004|Overall Study|Lost to Follow-up|2|||
37986903|NCT00394706|69672486|FG005|Overall Study|Lost to Follow-up|5|||
37986904|NCT00394706|69672487|FG006|Overall Study|Lost to Follow-up|2|||
37986905|NCT00394706|69672488|FG007|Overall Study|Lost to Follow-up|0|||
37986906|NCT00394472|69672504|FG000|Overall Study|Protocol Violation|1|||
37986907|NCT00394472|69672505|FG001|Overall Study|Protocol Violation|3|||
37986908|NCT00394472|69672504|FG000|Overall Study|incorrect enrolment|4|||
37986909|NCT00394472|69672505|FG001|Overall Study|incorrect enrolment|2|||
37986910|NCT00394472|69672504|FG000|Overall Study|Adverse Event|4|||
37986911|NCT00394472|69672505|FG001|Overall Study|Adverse Event|2|||
37986912|NCT00394472|69672504|FG000|Overall Study|Withdrawal by Subject|0|||
37986913|NCT00394472|69672505|FG001|Overall Study|Withdrawal by Subject|2|||
37986914|NCT00394472|69672504|FG000|Overall Study|Physician Decision|0|||
37986915|NCT00394472|69672505|FG001|Overall Study|Physician Decision|1|||
37986916|NCT00394472|69672504|FG000|Overall Study|Lost to Follow-up|0|||
37986917|NCT00394472|69672505|FG001|Overall Study|Lost to Follow-up|1|||
37986918|NCT00419120|69672511|FG000|Long Term Follow up Period|study ongoing|10|||
37986919|NCT00395642|69672515|FG000|Overall Study|Death|4|||
37986920|NCT00395642|69672515|FG000|Overall Study|Lost to Follow-up|1|||
37986921|NCT00395642|69672515|FG000|Overall Study|Physician Decision|7|||
37822219|NCT02253316|69502003|FG001|Maintenance|Non-Compliance|1|||
37822220|NCT02253316|69502004|FG002|Maintenance|Non-Compliance|1|||
37822221|NCT02253316|69502002|FG000|Maintenance|Secondary Malignancy|0|||
37822222|NCT02253316|69502003|FG001|Maintenance|Secondary Malignancy|2|||
37822223|NCT02253316|69502004|FG002|Maintenance|Secondary Malignancy|5|||
37822224|NCT02253316|69502002|FG000|Maintenance|Adverse Event|0|||
37822225|NCT02253316|69502003|FG001|Maintenance|Adverse Event|8|||
37822226|NCT02253316|69502004|FG002|Maintenance|Adverse Event|12|||
37822227|NCT02253316|69502002|FG000|Maintenance|Still receiving active treatment|0|||
37822228|NCT02253316|69502003|FG001|Maintenance|Still receiving active treatment|8|||
37822229|NCT02253316|69502004|FG002|Maintenance|Still receiving active treatment|1|||
37822230|NCT02214160|69502015|FG000|Overall Study|Withdrawal by Subject|1|||
37822231|NCT02214160|69502016|FG001|Overall Study|Withdrawal by Subject|0|||
37822232|NCT02214160|69502017|FG002|Overall Study|Withdrawal by Subject|6|||
37822233|NCT02214160|69502015|FG000|Overall Study|Death|2|||
37822234|NCT02214160|69502016|FG001|Overall Study|Death|2|||
37822235|NCT02214160|69502017|FG002|Overall Study|Death|1|||
37822236|NCT02214160|69502015|FG000|Overall Study|Subject Non-Compliance|0|||
37822237|NCT02214160|69502016|FG001|Overall Study|Subject Non-Compliance|3|||
37822238|NCT02214160|69502017|FG002|Overall Study|Subject Non-Compliance|1|||
37822239|NCT02214160|69502015|FG000|Overall Study|Adverse Event|0|||
37822240|NCT02214160|69502016|FG001|Overall Study|Adverse Event|1|||
37822241|NCT02214160|69502017|FG002|Overall Study|Adverse Event|1|||
37822242|NCT02214160|69502015|FG000|Overall Study|Sponsor Decision|0|||
37822243|NCT02214160|69502016|FG001|Overall Study|Sponsor Decision|2|||
37822244|NCT02214160|69502017|FG002|Overall Study|Sponsor Decision|0|||
37822245|NCT02214160|69502015|FG000|Overall Study|Protocol Violation|1|||
37822246|NCT02214160|69502016|FG001|Overall Study|Protocol Violation|0|||
37822247|NCT02214160|69502017|FG002|Overall Study|Protocol Violation|0|||
37822248|NCT02214160|69502015|FG000|Overall Study|Physician Decision|0|||
37822249|NCT02214160|69502016|FG001|Overall Study|Physician Decision|0|||
37822250|NCT02214160|69502017|FG002|Overall Study|Physician Decision|1|||
37822251|NCT02059265|69502046|FG000|Overall Study|Ineligible|4|||
37822252|NCT04983589|69502073|FG000|Overall Study|Withdrawal by Subject|0|||
37822253|NCT04983589|69502074|FG001|Overall Study|Withdrawal by Subject|3|||
37986922|NCT00395642|69672515|FG000|Overall Study|Withdrawal by Subject|1|||
37986923|NCT00395486|69672521|FG000|Overall Study|Adverse Event|1|||
37986924|NCT00395486|69672522|FG001|Overall Study|Adverse Event|2|||
37986925|NCT00395486|69672521|FG000|Overall Study|Withdrawal by Subject|5|||
37986926|NCT00395486|69672522|FG001|Overall Study|Withdrawal by Subject|2|||
37986927|NCT00395486|69672521|FG000|Overall Study|Lost to Follow-up|0|||
37822254|NCT04983589|69502073|FG000|Overall Study|COVID-19 Infection|1|||
37986928|NCT00395486|69672522|FG001|Overall Study|Lost to Follow-up|1|||
37986929|NCT00395018|69672528|FG000|On-Treatment|Death|4|||
37986930|NCT00395018|69672528|FG000|On-Treatment|Other Reason|2|||
37986931|NCT00395018|69672528|FG000|On-Treatment|Poor/non-compliance|2|||
37695614|NCT02362646|69171914|FG001|Overall Study|received transplant|14|||
37695615|NCT02280421|69171924|FG000|Washout (2 Weeks)|Adverse Event|0|||
37695616|NCT02280421|69171925|FG001|Washout (2 Weeks)|Adverse Event|1|||
37695617|NCT02280421|69171924|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
37695618|NCT02280421|69171925|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
37695619|NCT02362412|69171943|FG000|Treatment Period III|Lost to Follow-up|0|||
37695620|NCT02362412|69171944|FG001|Treatment Period III|Lost to Follow-up|1|||
37695621|NCT02280187|69171956|FG000|Overall Study|Lost to Follow-up|218|||
37695622|NCT02347813|69171962|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
37695623|NCT02347813|69171963|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
37695624|NCT02347813|69171962|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
37695625|NCT02347813|69171963|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
37695626|NCT02329730|69171973|FG000|Overall Study|Protocol Violation|0|||
37695627|NCT02329730|69171974|FG001|Overall Study|Protocol Violation|0|||
37695628|NCT02329730|69171975|FG002|Overall Study|Protocol Violation|0|||
37695629|NCT02329730|69171976|FG003|Overall Study|Protocol Violation|0|||
37695630|NCT02329730|69171977|FG004|Overall Study|Protocol Violation|2|||
37695631|NCT02329730|69171978|FG005|Overall Study|Protocol Violation|2|||
37695632|NCT02329730|69171979|FG006|Overall Study|Protocol Violation|0|||
37695633|NCT02329730|69171980|FG007|Overall Study|Protocol Violation|0|||
37695634|NCT02329730|69171981|FG008|Overall Study|Protocol Violation|0|||
37695635|NCT02329730|69171982|FG009|Overall Study|Protocol Violation|0|||
37695636|NCT02329730|69171983|FG010|Overall Study|Protocol Violation|0|||
37695637|NCT02329730|69171984|FG011|Overall Study|Protocol Violation|0|||
37695638|NCT02329730|69171973|FG000|Overall Study|Withdrawal by Subject|0|||
37695639|NCT02329730|69171974|FG001|Overall Study|Withdrawal by Subject|0|||
37695640|NCT02329730|69171975|FG002|Overall Study|Withdrawal by Subject|0|||
37695641|NCT02329730|69171976|FG003|Overall Study|Withdrawal by Subject|0|||
37695642|NCT02329730|69171977|FG004|Overall Study|Withdrawal by Subject|1|||
37695643|NCT02329730|69171978|FG005|Overall Study|Withdrawal by Subject|0|||
37886537|NCT00807937|69571320|FG003|Overall Study|Adverse Event|4|||
37886538|NCT00807937|69571317|FG000|Overall Study|Protocol Violation|4|||
37886539|NCT00807937|69571318|FG001|Overall Study|Protocol Violation|5|||
37886540|NCT00807937|69571319|FG002|Overall Study|Protocol Violation|3|||
37886541|NCT00807937|69571320|FG003|Overall Study|Protocol Violation|3|||
37886542|NCT00807937|69571317|FG000|Overall Study|Withdrawal by Subject|5|||
37986932|NCT00395018|69672528|FG000|On-Treatment|Subject no longer meets study criteria|2|||
37986933|NCT00395018|69672528|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
37986934|NCT00395018|69672528|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
37986935|NCT00395018|69672528|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
37986936|NCT00375518|69672534|FG000|Overall Study|Withdrawal by Subject|2|||
37886543|NCT00807937|69571318|FG001|Overall Study|Withdrawal by Subject|4|||
37886544|NCT00807937|69571319|FG002|Overall Study|Withdrawal by Subject|1|||
37886545|NCT00807937|69571320|FG003|Overall Study|Withdrawal by Subject|4|||
37886546|NCT00807937|69571317|FG000|Overall Study|Lost to Follow-up|4|||
37886547|NCT00807937|69571318|FG001|Overall Study|Lost to Follow-up|0|||
37886548|NCT00807937|69571319|FG002|Overall Study|Lost to Follow-up|2|||
37886549|NCT00807937|69571320|FG003|Overall Study|Lost to Follow-up|1|||
37886550|NCT00807937|69571317|FG000|Overall Study|Lack of Efficacy|0|||
37886551|NCT00807937|69571318|FG001|Overall Study|Lack of Efficacy|0|||
37886552|NCT00807937|69571319|FG002|Overall Study|Lack of Efficacy|1|||
37886553|NCT00807937|69571320|FG003|Overall Study|Lack of Efficacy|2|||
37886554|NCT00807937|69571317|FG000|Overall Study|Intake of prohibited medicine|0|||
37886555|NCT00807937|69571318|FG001|Overall Study|Intake of prohibited medicine|0|||
37886556|NCT00807937|69571319|FG002|Overall Study|Intake of prohibited medicine|2|||
37886557|NCT00807937|69571320|FG003|Overall Study|Intake of prohibited medicine|0|||
37886558|NCT00807937|69571317|FG000|Overall Study|All other reasons (not provided)|2|||
37886559|NCT00807937|69571318|FG001|Overall Study|All other reasons (not provided)|4|||
37886560|NCT00807937|69571319|FG002|Overall Study|All other reasons (not provided)|0|||
37886561|NCT00807937|69571320|FG003|Overall Study|All other reasons (not provided)|1|||
37886562|NCT00906945|69571335|FG000|Overall Study|Found to be not eligible|0|||
37886563|NCT00906945|69571336|FG001|Overall Study|Found to be not eligible|0|||
37886564|NCT00906945|69571337|FG002|Overall Study|Found to be not eligible|0|||
37986937|NCT00375518|69672535|FG001|Overall Study|Withdrawal by Subject|10|||
37986938|NCT00375518|69672534|FG000|Overall Study|Patient Not Treated|6|||
37986939|NCT00375518|69672535|FG001|Overall Study|Patient Not Treated|6|||
37695644|NCT02329730|69171979|FG006|Overall Study|Withdrawal by Subject|1|||
37695645|NCT02329730|69171980|FG007|Overall Study|Withdrawal by Subject|1|||
37695646|NCT02329730|69171981|FG008|Overall Study|Withdrawal by Subject|1|||
37886565|NCT00906945|69571338|FG003|Overall Study|Found to be not eligible|1|||
37886566|NCT00906945|69571339|FG004|Overall Study|Found to be not eligible|1|||
37886567|NCT00906945|69571340|FG005|Overall Study|Found to be not eligible|1|||
37986940|NCT00375518|69672534|FG000|Overall Study|Death|0|||
37986941|NCT00375518|69672535|FG001|Overall Study|Death|1|||
37695647|NCT02329730|69171982|FG009|Overall Study|Withdrawal by Subject|1|||
37886568|NCT00906945|69571335|FG000|Overall Study|Physician Decision|0|||
37886569|NCT00906945|69571336|FG001|Overall Study|Physician Decision|0|||
37886570|NCT00906945|69571337|FG002|Overall Study|Physician Decision|0|||
37886571|NCT00906945|69571338|FG003|Overall Study|Physician Decision|0|||
37886572|NCT00906945|69571339|FG004|Overall Study|Physician Decision|0|||
37886573|NCT00906945|69571340|FG005|Overall Study|Physician Decision|1|||
37886574|NCT00807235|69571358|FG000|Overall Study|Adverse Event|1|||
37886575|NCT00807235|69571359|FG001|Overall Study|Adverse Event|0|||
37886576|NCT00876694|69571367|FG000|Overall Study|Adverse Event|10|||
37886577|NCT00876694|69571368|FG001|Overall Study|Adverse Event|7|||
37886578|NCT00876694|69571367|FG000|Overall Study|Subject withdrew consent|6|||
37886579|NCT00876694|69571368|FG001|Overall Study|Subject withdrew consent|4|||
37886580|NCT00876694|69571367|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
37886581|NCT00876694|69571368|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
37886582|NCT00876694|69571367|FG000|Overall Study|Abnormal test procedure result(s)|1|||
37886583|NCT00876694|69571368|FG001|Overall Study|Abnormal test procedure result(s)|0|||
37886584|NCT00876694|69571367|FG000|Overall Study|Administrative problems|1|||
37886585|NCT00876694|69571368|FG001|Overall Study|Administrative problems|1|||
37886586|NCT00876694|69571367|FG000|Overall Study|Death|1|||
37886587|NCT00876694|69571368|FG001|Overall Study|Death|0|||
37886588|NCT00805441|69571376|FG000|Overall Study|Adverse Event|5|||
37886589|NCT00805441|69571377|FG001|Overall Study|Adverse Event|2|||
37886590|NCT00805441|69571376|FG000|Overall Study|Lack of Efficacy|0|||
37886591|NCT00805441|69571377|FG001|Overall Study|Lack of Efficacy|2|||
37886592|NCT00805441|69571376|FG000|Overall Study|Protocol Violation|4|||
37886593|NCT00805441|69571377|FG001|Overall Study|Protocol Violation|8|||
37986942|NCT00256750|69672544|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
37986943|NCT00256750|69672545|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
37986944|NCT00256750|69672546|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
37986945|NCT00256750|69672544|FG000|Transplanted Pre-Treatment|Other|2|||
37986946|NCT00256750|69672545|FG001|Transplanted Pre-Treatment|Other|0|||
37986947|NCT00256750|69672546|FG002|Transplanted Pre-Treatment|Other|0|||
37986948|NCT00256750|69672544|FG000|Transplanted Pre-Treatment|Death|1|||
37986949|NCT00256750|69672545|FG001|Transplanted Pre-Treatment|Death|0|||
37986950|NCT00256750|69672546|FG002|Transplanted Pre-Treatment|Death|0|||
37986951|NCT00256750|69672544|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
37986952|NCT00256750|69672545|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
37986953|NCT00256750|69672546|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
37986954|NCT00256750|69672544|FG000|Post-Transplant Treated (12 Months)|Death|3|||
37886594|NCT00805441|69571376|FG000|Overall Study|Lost to Follow-up|10|||
37886595|NCT00805441|69571377|FG001|Overall Study|Lost to Follow-up|13|||
37886596|NCT00805441|69571376|FG000|Overall Study|Withdrawal by Subject|15|||
37886597|NCT00805441|69571377|FG001|Overall Study|Withdrawal by Subject|9|||
37886598|NCT00805441|69571376|FG000|Overall Study|Physician Decision|0|||
37886599|NCT00805441|69571377|FG001|Overall Study|Physician Decision|1|||
37886600|NCT00805441|69571376|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
37886601|NCT00805441|69571377|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
37886602|NCT00590317|69571385|FG000|Overall Study|Lack of Efficacy|1|||
37886603|NCT00590317|69571386|FG001|Overall Study|Lack of Efficacy|5|||
37886604|NCT01139762|69571395|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
37886605|NCT01139762|69571396|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
37886606|NCT01139762|69571397|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
37886607|NCT01139762|69571395|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
37886608|NCT01139762|69571396|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
37886609|NCT01139762|69571397|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
37886610|NCT01139762|69571395|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
37886611|NCT01139762|69571396|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
37886612|NCT01139762|69571397|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
37886613|NCT01139762|69571395|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
37886614|NCT01139762|69571396|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
37886615|NCT01139762|69571397|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
37886616|NCT01139762|69571395|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
37886617|NCT01139762|69571396|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
37886618|NCT01139762|69571397|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
37886619|NCT01139762|69571395|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
37886620|NCT01139762|69571396|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
37886621|NCT01139762|69571397|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
37886622|NCT01139762|69571395|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
37886623|NCT01139762|69571396|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
37886624|NCT01139762|69571397|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
37886625|NCT01139762|69571395|FG000|Double-Blind Randomized Active Treatment|Death|0|||
37886626|NCT01139762|69571396|FG001|Double-Blind Randomized Active Treatment|Death|1|||
37886627|NCT01139762|69571397|FG002|Double-Blind Randomized Active Treatment|Death|1|||
37886628|NCT01139762|69571395|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
37886629|NCT01139762|69571396|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
37886630|NCT01139762|69571397|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
37886631|NCT01139762|69571395|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
37886632|NCT01139762|69571396|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
37886633|NCT01139762|69571397|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
37886634|NCT01139762|69571395|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
37886635|NCT01139762|69571396|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
37886636|NCT01139762|69571397|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
37886637|NCT01139762|69571395|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
37886638|NCT01139762|69571396|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
37886639|NCT01139762|69571397|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
37822255|NCT04983589|69502074|FG001|Overall Study|COVID-19 Infection|0|||
37822256|NCT04983589|69502073|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
37822257|NCT04983589|69502074|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
37822258|NCT04783389|69502095|FG000|Overall Study|Withdrawal by Subject|2|||
37822259|NCT04783389|69502096|FG001|Overall Study|Withdrawal by Subject|0|||
37822260|NCT04783389|69502097|FG002|Overall Study|Withdrawal by Subject|0|||
37822261|NCT04783389|69502095|FG000|Overall Study|Termination of Study by Sponsor|10|||
37886640|NCT01139762|69571395|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
37886641|NCT01139762|69571396|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
37886642|NCT01139762|69571397|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
37886643|NCT01139762|69571395|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
37886644|NCT01139762|69571396|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
37886645|NCT01139762|69571397|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
37886646|NCT01139762|69571395|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
37886647|NCT01139762|69571396|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
37886648|NCT01139762|69571397|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
37886649|NCT00805285|69571404|FG000|Overall Study|Lack of Efficacy|1|||
37886650|NCT01139450|69571411|FG000|Overall Study|Withdrawal by Subject|7|||
37886651|NCT01139450|69571412|FG001|Overall Study|Withdrawal by Subject|10|||
37886652|NCT01139450|69571413|FG002|Overall Study|Withdrawal by Subject|13|||
37886653|NCT01139450|69571411|FG000|Overall Study|Lack of Efficacy|3|||
37886654|NCT01139450|69571412|FG001|Overall Study|Lack of Efficacy|1|||
37886655|NCT01139450|69571413|FG002|Overall Study|Lack of Efficacy|8|||
37695648|NCT02329730|69171983|FG010|Overall Study|Withdrawal by Subject|0|||
37695649|NCT02329730|69171984|FG011|Overall Study|Withdrawal by Subject|0|||
37695650|NCT02328326|69172004|FG000|Overall Study|Withdrawal by Subject|10|||
37822262|NCT04783389|69502096|FG001|Overall Study|Termination of Study by Sponsor|12|||
37822263|NCT04783389|69502097|FG002|Overall Study|Termination of Study by Sponsor|14|||
37822264|NCT04556591|69502118|FG000|Overall Study|Lost to Follow-up|1|||
37822265|NCT04556591|69502119|FG001|Overall Study|Lost to Follow-up|0|||
37822266|NCT04556591|69502118|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
37822267|NCT04556591|69502119|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
37822268|NCT04428034|69502128|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
37822269|NCT04364984|69502139|FG000|Overall Study|Death|2|||
37822270|NCT04364984|69502140|FG001|Overall Study|Death|2|||
37822271|NCT04364984|69502141|FG002|Overall Study|Death|0|||
37822272|NCT04294095|69502151|FG000|Overall Study|Adverse Event|1|||
37886656|NCT01139450|69571411|FG000|Overall Study|Protocol Violation|6|||
37886657|NCT01139450|69571412|FG001|Overall Study|Protocol Violation|5|||
37886658|NCT01139450|69571413|FG002|Overall Study|Protocol Violation|2|||
37886659|NCT01139450|69571411|FG000|Overall Study|Lost to Follow-up|9|||
37886660|NCT01139450|69571412|FG001|Overall Study|Lost to Follow-up|7|||
37886661|NCT01139450|69571413|FG002|Overall Study|Lost to Follow-up|11|||
37886662|NCT01139450|69571411|FG000|Overall Study|Administrative|0|||
37886663|NCT01139450|69571412|FG001|Overall Study|Administrative|0|||
37886664|NCT01139450|69571413|FG002|Overall Study|Administrative|1|||
37886665|NCT01139450|69571411|FG000|Overall Study|Adverse Event|2|||
37886666|NCT01139450|69571412|FG001|Overall Study|Adverse Event|2|||
37886667|NCT01139450|69571413|FG002|Overall Study|Adverse Event|3|||
37886668|NCT00805207|69571430|FG000|Overall Study|Protocol Violation|0|||
37886669|NCT00805207|69571431|FG001|Overall Study|Protocol Violation|0|||
37886670|NCT00805207|69571432|FG002|Overall Study|Protocol Violation|1|||
37886671|NCT00805207|69571433|FG003|Overall Study|Protocol Violation|0|||
37886672|NCT00805207|69571434|FG004|Overall Study|Protocol Violation|0|||
37886673|NCT00805207|69571435|FG005|Overall Study|Protocol Violation|0|||
37886674|NCT00805207|69571436|FG006|Overall Study|Protocol Violation|0|||
37886675|NCT00805207|69571437|FG007|Overall Study|Protocol Violation|0|||
37886676|NCT00805207|69571438|FG008|Overall Study|Protocol Violation|0|||
37886677|NCT00805207|69571430|FG000|Overall Study|Physician Decision|0|||
37886678|NCT00805207|69571431|FG001|Overall Study|Physician Decision|1|||
37886679|NCT00805207|69571432|FG002|Overall Study|Physician Decision|0|||
37886680|NCT00805207|69571433|FG003|Overall Study|Physician Decision|0|||
37886681|NCT00805207|69571434|FG004|Overall Study|Physician Decision|0|||
37886682|NCT00805207|69571435|FG005|Overall Study|Physician Decision|1|||
37886683|NCT00805207|69571436|FG006|Overall Study|Physician Decision|0|||
37886684|NCT00805207|69571437|FG007|Overall Study|Physician Decision|0|||
37886685|NCT00805207|69571438|FG008|Overall Study|Physician Decision|0|||
37886686|NCT00805207|69571430|FG000|Overall Study|Withdrawal by Subject|0|||
37886687|NCT00805207|69571431|FG001|Overall Study|Withdrawal by Subject|1|||
37886688|NCT00805207|69571432|FG002|Overall Study|Withdrawal by Subject|0|||
37886689|NCT00805207|69571433|FG003|Overall Study|Withdrawal by Subject|0|||
37886690|NCT00805207|69571434|FG004|Overall Study|Withdrawal by Subject|1|||
37886691|NCT00805207|69571435|FG005|Overall Study|Withdrawal by Subject|2|||
37886692|NCT00805207|69571436|FG006|Overall Study|Withdrawal by Subject|0|||
37886693|NCT00805207|69571437|FG007|Overall Study|Withdrawal by Subject|0|||
37886694|NCT00805207|69571438|FG008|Overall Study|Withdrawal by Subject|0|||
37886695|NCT00805675|69571465|FG000|Overall Study|Adverse Event|0|||
37886696|NCT00805675|69571466|FG001|Overall Study|Adverse Event|0|||
37886697|NCT00805675|69571467|FG002|Overall Study|Adverse Event|1|||
37886698|NCT00589303|69571481|FG000|Overall Study|Withdrawal by Subject|2|||
37695651|NCT02328326|69172005|FG001|Overall Study|Withdrawal by Subject|3|||
37695652|NCT02328326|69172004|FG000|Overall Study|Death|2|||
37822273|NCT04294095|69502152|FG001|Overall Study|Adverse Event|0|||
37822274|NCT04266028|69502168|FG000|Overall Study|Adverse Event|0|||
37822275|NCT04266028|69502169|FG001|Overall Study|Adverse Event|0|||
37822276|NCT04266028|69502170|FG002|Overall Study|Adverse Event|1|||
37822277|NCT04266028|69502171|FG003|Overall Study|Adverse Event|0|||
37822278|NCT04266028|69502172|FG004|Overall Study|Adverse Event|1|||
37822279|NCT04266028|69502173|FG005|Overall Study|Adverse Event|0|||
37822280|NCT04266028|69502174|FG006|Overall Study|Adverse Event|2|||
37822281|NCT04266028|69502175|FG007|Overall Study|Adverse Event|0|||
37822282|NCT04266028|69502168|FG000|Overall Study|temporary halt of the study|0|||
37822283|NCT04266028|69502169|FG001|Overall Study|temporary halt of the study|0|||
37822284|NCT04266028|69502170|FG002|Overall Study|temporary halt of the study|0|||
37886699|NCT00589303|69571482|FG001|Overall Study|Withdrawal by Subject|1|||
37886700|NCT00952380|69571493|FG000|Overall Study|Other|0|||
37886701|NCT00952380|69571494|FG001|Overall Study|Other|0|||
37886702|NCT00952380|69571495|FG002|Overall Study|Other|0|||
37886703|NCT00952380|69571496|FG003|Overall Study|Other|0|||
37886704|NCT00952380|69571497|FG004|Overall Study|Other|1|||
37886705|NCT00952380|69571493|FG000|Overall Study|Withdrawal by Subject|0|||
37886706|NCT00952380|69571494|FG001|Overall Study|Withdrawal by Subject|0|||
37886707|NCT00952380|69571495|FG002|Overall Study|Withdrawal by Subject|1|||
37886708|NCT00952380|69571496|FG003|Overall Study|Withdrawal by Subject|0|||
37886709|NCT00952380|69571497|FG004|Overall Study|Withdrawal by Subject|2|||
37886710|NCT00952380|69571493|FG000|Overall Study|Adverse Event|0|||
37886711|NCT00952380|69571494|FG001|Overall Study|Adverse Event|1|||
37886712|NCT00952380|69571495|FG002|Overall Study|Adverse Event|0|||
37886713|NCT00952380|69571496|FG003|Overall Study|Adverse Event|0|||
37886714|NCT00952380|69571497|FG004|Overall Study|Adverse Event|3|||
37886715|NCT00952380|69571493|FG000|Overall Study|Physician Decision|0|||
37886716|NCT00952380|69571494|FG001|Overall Study|Physician Decision|0|||
37886717|NCT00952380|69571495|FG002|Overall Study|Physician Decision|1|||
37886718|NCT00952380|69571496|FG003|Overall Study|Physician Decision|2|||
37886719|NCT00952380|69571497|FG004|Overall Study|Physician Decision|0|||
37886720|NCT00952380|69571493|FG000|Overall Study|Non-compliant to protocol|0|||
37886721|NCT00952380|69571494|FG001|Overall Study|Non-compliant to protocol|0|||
37886722|NCT00952380|69571495|FG002|Overall Study|Non-compliant to protocol|0|||
37886723|NCT00952380|69571496|FG003|Overall Study|Non-compliant to protocol|1|||
37886724|NCT00952380|69571497|FG004|Overall Study|Non-compliant to protocol|0|||
37886725|NCT00803179|69571514|FG000|Overall Study|Lost to Follow-up|3|||
37886726|NCT00804193|69571521|FG000|Overall Study|Lack of baseline fungus|32|||
37886727|NCT00804193|69571522|FG001|Overall Study|Lack of baseline fungus|31|||
37886728|NCT00804193|69571523|FG002|Overall Study|Lack of baseline fungus|19|||
37886729|NCT00804193|69571521|FG000|Overall Study|Adverse Event|0|||
37886730|NCT00804193|69571522|FG001|Overall Study|Adverse Event|0|||
37886731|NCT00804193|69571523|FG002|Overall Study|Adverse Event|2|||
37886732|NCT00804193|69571521|FG000|Overall Study|Lack of Efficacy|1|||
37886733|NCT00804193|69571522|FG001|Overall Study|Lack of Efficacy|1|||
37886734|NCT00804193|69571523|FG002|Overall Study|Lack of Efficacy|3|||
37886735|NCT00804193|69571521|FG000|Overall Study|Protocol Violation|0|||
37986955|NCT00256750|69672545|FG001|Post-Transplant Treated (12 Months)|Death|2|||
37986956|NCT00256750|69672546|FG002|Post-Transplant Treated (12 Months)|Death|4|||
37986957|NCT00256750|69672544|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
37986958|NCT00256750|69672545|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
37986959|NCT00256750|69672546|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
37986960|NCT00256750|69672544|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
37986961|NCT00256750|69672545|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
37986962|NCT00256750|69672546|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
37986963|NCT00256750|69672544|FG000|Post-Transplant Treated (12 Months)|Other|5|||
37986964|NCT00256750|69672545|FG001|Post-Transplant Treated (12 Months)|Other|4|||
37986965|NCT00256750|69672546|FG002|Post-Transplant Treated (12 Months)|Other|2|||
37986966|NCT00256750|69672544|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
37986967|NCT00256750|69672545|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
37986968|NCT00256750|69672546|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
37986969|NCT00256750|69672544|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
37986970|NCT00256750|69672545|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
37986971|NCT00256750|69672546|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
37986972|NCT00256750|69672544|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
37822285|NCT04266028|69502171|FG003|Overall Study|temporary halt of the study|0|||
37822286|NCT04266028|69502172|FG004|Overall Study|temporary halt of the study|0|||
37822287|NCT04266028|69502173|FG005|Overall Study|temporary halt of the study|0|||
37822288|NCT04266028|69502174|FG006|Overall Study|temporary halt of the study|2|||
37822289|NCT04266028|69502175|FG007|Overall Study|temporary halt of the study|1|||
37822290|NCT04266028|69502168|FG000|Overall Study|Onset of birch pollen season|0|||
37822291|NCT04266028|69502169|FG001|Overall Study|Onset of birch pollen season|0|||
37822292|NCT04266028|69502170|FG002|Overall Study|Onset of birch pollen season|0|||
37822293|NCT04266028|69502171|FG003|Overall Study|Onset of birch pollen season|0|||
37822294|NCT04266028|69502172|FG004|Overall Study|Onset of birch pollen season|1|||
37822295|NCT04266028|69502173|FG005|Overall Study|Onset of birch pollen season|0|||
37822296|NCT04266028|69502174|FG006|Overall Study|Onset of birch pollen season|0|||
37822297|NCT04266028|69502175|FG007|Overall Study|Onset of birch pollen season|0|||
37822298|NCT03994731|69502225|FG000|Pegloticase + IMM Period|Death|2|||
37822299|NCT03994731|69502226|FG001|Pegloticase + IMM Period|Death|0|||
37822300|NCT03994731|69502225|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
37822301|NCT03994731|69502226|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
37822302|NCT03994731|69502225|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
37822303|NCT03994731|69502226|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
37886736|NCT00804193|69571522|FG001|Overall Study|Protocol Violation|8|||
37886737|NCT00804193|69571523|FG002|Overall Study|Protocol Violation|2|||
37695653|NCT02328326|69172005|FG001|Overall Study|Death|1|||
37886738|NCT00804193|69571521|FG000|Overall Study|Lost to Follow-up|3|||
37886739|NCT00804193|69571522|FG001|Overall Study|Lost to Follow-up|3|||
37886740|NCT00804193|69571523|FG002|Overall Study|Lost to Follow-up|4|||
37986973|NCT00256750|69672545|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
37986974|NCT00256750|69672546|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
37986975|NCT00256750|69672544|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
37986976|NCT00256750|69672545|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
37986977|NCT00256750|69672546|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
37986978|NCT00256750|69672544|FG000|Post-Transplant Treated (24 Months)|Death|3|||
37886741|NCT00804193|69571521|FG000|Overall Study|Withdrawal by Subject|3|||
37886742|NCT00804193|69571522|FG001|Overall Study|Withdrawal by Subject|1|||
37886743|NCT00804193|69571523|FG002|Overall Study|Withdrawal by Subject|2|||
37886744|NCT00957996|69571533|FG000|Overall Study|Death|4|||
37886745|NCT00957996|69571534|FG001|Overall Study|Death|10|||
37886746|NCT00957996|69571533|FG000|Overall Study|Lost to Follow-up|4|||
37886747|NCT00957996|69571534|FG001|Overall Study|Lost to Follow-up|7|||
37886748|NCT00957996|69571533|FG000|Overall Study|Withdrawal by Subject|9|||
37886749|NCT00957996|69571534|FG001|Overall Study|Withdrawal by Subject|2|||
37886750|NCT00957996|69571533|FG000|Overall Study|Adverse Event|2|||
37886751|NCT00957996|69571534|FG001|Overall Study|Adverse Event|1|||
37886752|NCT00957996|69571533|FG000|Overall Study|Physician Decision|1|||
37886753|NCT00957996|69571534|FG001|Overall Study|Physician Decision|1|||
37886754|NCT00957996|69571533|FG000|Overall Study|Influenza-related complication|0|||
37886755|NCT00957996|69571534|FG001|Overall Study|Influenza-related complication|1|||
37822304|NCT03801915|69502238|FG000|Overall Study|Screen failure|0|||
37822305|NCT03801915|69502239|FG001|Overall Study|Screen failure|0|||
37822306|NCT03801915|69502240|FG002|Overall Study|Screen failure|1|||
37822307|NCT03801915|69502238|FG000|Overall Study|Ineligible|1|||
37822308|NCT03801915|69502239|FG001|Overall Study|Ineligible|0|||
37822309|NCT03801915|69502240|FG002|Overall Study|Ineligible|0|||
37822310|NCT03801915|69502238|FG000|Overall Study|Physician Decision|2|||
37822311|NCT03801915|69502239|FG001|Overall Study|Physician Decision|1|||
37822312|NCT03801915|69502240|FG002|Overall Study|Physician Decision|0|||
37822313|NCT03581305|69502254|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
37822314|NCT03581305|69502255|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
37822315|NCT03581305|69502254|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
37886756|NCT00957996|69571533|FG000|Overall Study|Missing|1|||
37886757|NCT00957996|69571534|FG001|Overall Study|Missing|0|||
37886758|NCT00957996|69571533|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
37886759|NCT00957996|69571534|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
37886760|NCT00589693|69571544|FG000|Overall Study|randomized in error|12|||
37886761|NCT00589693|69571545|FG001|Overall Study|randomized in error|6|||
37886762|NCT00589693|69571544|FG000|Overall Study|Adverse Event|4|||
37886763|NCT00589693|69571545|FG001|Overall Study|Adverse Event|4|||
37886764|NCT00589693|69571544|FG000|Overall Study|Death|26|||
37886765|NCT00589693|69571545|FG001|Overall Study|Death|16|||
37886766|NCT00589693|69571544|FG000|Overall Study|Lack of Efficacy|0|||
37886767|NCT00589693|69571545|FG001|Overall Study|Lack of Efficacy|1|||
37886768|NCT00589693|69571544|FG000|Overall Study|Lost to Follow-up|1|||
37886769|NCT00589693|69571545|FG001|Overall Study|Lost to Follow-up|0|||
37886770|NCT00589693|69571544|FG000|Overall Study|Physician Decision|0|||
37886771|NCT00589693|69571545|FG001|Overall Study|Physician Decision|1|||
37886772|NCT00589693|69571544|FG000|Overall Study|Protocol Violation|1|||
37886773|NCT00589693|69571545|FG001|Overall Study|Protocol Violation|1|||
37886774|NCT00803101|69571553|FG000|Overall Study|Death / Serious Adverse Event|4|||
37886775|NCT00803101|69571554|FG001|Overall Study|Death / Serious Adverse Event|6|||
37886776|NCT00803101|69571553|FG000|Overall Study|Withdrawal by Subject|6|||
37886777|NCT00803101|69571554|FG001|Overall Study|Withdrawal by Subject|4|||
37886778|NCT00803101|69571553|FG000|Overall Study|Lost to Follow-up|2|||
37886779|NCT00803101|69571554|FG001|Overall Study|Lost to Follow-up|2|||
37886780|NCT00803101|69571553|FG000|Overall Study|Protocol Violation|1|||
37886781|NCT00803101|69571554|FG001|Overall Study|Protocol Violation|7|||
37886782|NCT00803101|69571553|FG000|Overall Study|Surgery finished outside protocol window|1|||
37886783|NCT00803101|69571554|FG001|Overall Study|Surgery finished outside protocol window|1|||
37886784|NCT00803101|69571553|FG000|Overall Study|Patient died outside SAE report period|1|||
37886785|NCT00803101|69571554|FG001|Overall Study|Patient died outside SAE report period|0|||
37886786|NCT00803101|69571553|FG000|Overall Study|Patient did not attend scheduled visit|2|||
37822316|NCT03581305|69502255|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
37822317|NCT03581305|69502254|FG000|Serotonergic Study|Withdrawal by Subject|5|||
37822318|NCT03581305|69502255|FG001|Serotonergic Study|Withdrawal by Subject|1|||
37886787|NCT00803101|69571554|FG001|Overall Study|Patient did not attend scheduled visit|1|||
37886788|NCT00803101|69571553|FG000|Overall Study|Patient did not have surgery|1|||
37886789|NCT00803101|69571554|FG001|Overall Study|Patient did not have surgery|1|||
37886790|NCT00801229|69571562|FG000|Signed Consent|Withdrawal by Subject|2|||
37886791|NCT00801229|69571563|FG001|Signed Consent|Withdrawal by Subject|2|||
37886792|NCT00801229|69571562|FG000|Signed Consent|Found Ineligible|1|||
37886793|NCT00801229|69571563|FG001|Signed Consent|Found Ineligible|1|||
37886794|NCT00801229|69571562|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
37822319|NCT03556202|69502266|FG000|Extension Treatment Period|Adverse Event|18|||
37822320|NCT03556202|69502267|FG001|Extension Treatment Period|Adverse Event|14|||
37822321|NCT03556202|69502268|FG002|Extension Treatment Period|Adverse Event|9|||
37822322|NCT03556202|69502266|FG000|Extension Treatment Period|Death|2|||
37822323|NCT03556202|69502267|FG001|Extension Treatment Period|Death|6|||
37822324|NCT03556202|69502268|FG002|Extension Treatment Period|Death|0|||
37822325|NCT03556202|69502266|FG000|Extension Treatment Period|Lack of Efficacy|5|||
37822326|NCT03556202|69502267|FG001|Extension Treatment Period|Lack of Efficacy|12|||
37822327|NCT03556202|69502268|FG002|Extension Treatment Period|Lack of Efficacy|18|||
37822328|NCT03556202|69502266|FG000|Extension Treatment Period|Lost to Follow-up|9|||
37822329|NCT03556202|69502267|FG001|Extension Treatment Period|Lost to Follow-up|20|||
37822330|NCT03556202|69502268|FG002|Extension Treatment Period|Lost to Follow-up|2|||
37822331|NCT03556202|69502266|FG000|Extension Treatment Period|Pregnancy|2|||
37822332|NCT03556202|69502267|FG001|Extension Treatment Period|Pregnancy|4|||
37822333|NCT03556202|69502268|FG002|Extension Treatment Period|Pregnancy|3|||
37822334|NCT03556202|69502266|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
37822335|NCT03556202|69502267|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
37822336|NCT03556202|69502268|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
37822337|NCT03556202|69502266|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
37822338|NCT03556202|69502267|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
37886795|NCT00801229|69571563|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
37886796|NCT00801229|69571562|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
37822339|NCT03556202|69502268|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
37886797|NCT00801229|69571563|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
37886798|NCT00801229|69571562|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
37886799|NCT00801229|69571563|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
37695654|NCT02328326|69172004|FG000|Overall Study|Lost to Follow-up|10|||
37822340|NCT03556202|69502266|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
37822341|NCT03556202|69502267|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
37822342|NCT03556202|69502268|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
37822343|NCT03556202|69502266|FG000|Extension Treatment Period|Physician Decision|0|||
37822344|NCT03556202|69502267|FG001|Extension Treatment Period|Physician Decision|8|||
37822345|NCT03556202|69502268|FG002|Extension Treatment Period|Physician Decision|2|||
37822346|NCT03556202|69502266|FG000|Extension Treatment Period|Protocol Violation|0|||
37822347|NCT03556202|69502267|FG001|Extension Treatment Period|Protocol Violation|1|||
37822348|NCT03556202|69502268|FG002|Extension Treatment Period|Protocol Violation|1|||
37822349|NCT03556202|69502266|FG000|Extension Treatment Period|Sponsor Decision|0|||
37822350|NCT03556202|69502267|FG001|Extension Treatment Period|Sponsor Decision|1|||
37822351|NCT03556202|69502268|FG002|Extension Treatment Period|Sponsor Decision|0|||
37822352|NCT03556202|69502266|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
37822353|NCT03556202|69502267|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
37822354|NCT03556202|69502268|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
37822355|NCT03556202|69502266|FG000|Follow-Up Period (12 Weeks)|Death|1|||
37886800|NCT00801229|69571562|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
37886801|NCT00801229|69571563|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
37886802|NCT00801229|69571562|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
37886803|NCT00801229|69571563|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
37886804|NCT00801229|69571562|FG000|Received Study Drug/Placebo|Adverse Event|1|||
37886805|NCT00801229|69571563|FG001|Received Study Drug/Placebo|Adverse Event|1|||
37886806|NCT00948246|69571569|FG000|Overall Study|Lost to Follow-up|11|||
37886807|NCT00948246|69571569|FG000|Overall Study|Adverse Event|11|||
37886808|NCT00948246|69571569|FG000|Overall Study|Death|1|||
37886809|NCT00948246|69571569|FG000|Overall Study|Withdrawal by Subject|1|||
37886810|NCT00800683|69571575|FG000|Overall Study|Adverse Event|11|||
37886811|NCT00800683|69571576|FG001|Overall Study|Adverse Event|8|||
37886812|NCT00800683|69571575|FG000|Overall Study|Lost to Follow-up|3|||
37886813|NCT00800683|69571576|FG001|Overall Study|Lost to Follow-up|1|||
37886814|NCT00800683|69571575|FG000|Overall Study|Withdrawal by Subject|1|||
37886815|NCT00800683|69571576|FG001|Overall Study|Withdrawal by Subject|7|||
37886816|NCT00800683|69571575|FG000|Overall Study|Lack of Efficacy|1|||
37886817|NCT00800683|69571576|FG001|Overall Study|Lack of Efficacy|1|||
37886818|NCT00800683|69571575|FG000|Overall Study|Other|1|||
37886819|NCT00800683|69571576|FG001|Overall Study|Other|2|||
37886820|NCT01124864|69571588|FG000|Overall Study|Follow up phase competed as per protocol|18|||
37886821|NCT01124864|69571589|FG001|Overall Study|Follow up phase competed as per protocol|22|||
37886822|NCT01124864|69571590|FG002|Overall Study|Follow up phase competed as per protocol|24|||
37886823|NCT01124864|69571591|FG003|Overall Study|Follow up phase competed as per protocol|18|||
37886824|NCT01124864|69571592|FG004|Overall Study|Follow up phase competed as per protocol|26|||
37886825|NCT01124864|69571593|FG005|Overall Study|Follow up phase competed as per protocol|2|||
37695655|NCT02328326|69172005|FG001|Overall Study|Lost to Follow-up|4|||
37695656|NCT01649804|69172013|FG000|Overall Study|Administrative/Other|8|||
37822356|NCT03556202|69502267|FG001|Follow-Up Period (12 Weeks)|Death|0|||
37886826|NCT01124864|69571588|FG000|Overall Study|Death|6|||
37886827|NCT01124864|69571589|FG001|Overall Study|Death|9|||
37886828|NCT01124864|69571590|FG002|Overall Study|Death|6|||
37822357|NCT03556202|69502268|FG002|Follow-Up Period (12 Weeks)|Death|0|||
37886829|NCT01124864|69571591|FG003|Overall Study|Death|2|||
37886830|NCT01124864|69571592|FG004|Overall Study|Death|1|||
37886831|NCT01124864|69571593|FG005|Overall Study|Death|0|||
37886832|NCT01124864|69571588|FG000|Overall Study|Withdrawal by Subject|2|||
37886833|NCT01124864|69571589|FG001|Overall Study|Withdrawal by Subject|3|||
37886834|NCT01124864|69571590|FG002|Overall Study|Withdrawal by Subject|4|||
37886835|NCT01124864|69571591|FG003|Overall Study|Withdrawal by Subject|0|||
37886836|NCT01124864|69571592|FG004|Overall Study|Withdrawal by Subject|2|||
37886837|NCT01124864|69571593|FG005|Overall Study|Withdrawal by Subject|1|||
37986979|NCT00256750|69672545|FG001|Post-Transplant Treated (24 Months)|Death|0|||
37886838|NCT01124864|69571588|FG000|Overall Study|Lost to Follow-up|1|||
37886839|NCT01124864|69571589|FG001|Overall Study|Lost to Follow-up|1|||
37886840|NCT01124864|69571590|FG002|Overall Study|Lost to Follow-up|0|||
37886841|NCT01124864|69571591|FG003|Overall Study|Lost to Follow-up|1|||
37886842|NCT01124864|69571592|FG004|Overall Study|Lost to Follow-up|0|||
37886843|NCT01124864|69571593|FG005|Overall Study|Lost to Follow-up|0|||
37886844|NCT01124864|69571588|FG000|Overall Study|Protocol Violation|1|||
37886845|NCT01124864|69571589|FG001|Overall Study|Protocol Violation|0|||
37886846|NCT01124864|69571590|FG002|Overall Study|Protocol Violation|0|||
37886847|NCT01124864|69571591|FG003|Overall Study|Protocol Violation|0|||
37886848|NCT01124864|69571592|FG004|Overall Study|Protocol Violation|1|||
37886849|NCT01124864|69571593|FG005|Overall Study|Protocol Violation|0|||
37886850|NCT01113710|69571609|FG000|Overall Study|Adverse Event|64|||
37886851|NCT01113710|69571609|FG000|Overall Study|Lack of Efficacy|41|||
37886852|NCT01113710|69571609|FG000|Overall Study|No Information Available|40|||
37886853|NCT01113710|69571609|FG000|Overall Study|Withdrawal by Subject|28|||
37886854|NCT01113710|69571609|FG000|Overall Study|Lost to Follow-up|20|||
37886855|NCT01113710|69571609|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
37886856|NCT01113710|69571609|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
37886857|NCT01113710|69571609|FG000|Overall Study|Lack of Patient's Compliance|8|||
37886858|NCT01113710|69571609|FG000|Overall Study|Other|7|||
37886859|NCT01113710|69571609|FG000|Overall Study|Adverse Event/Other|5|||
37886860|NCT01113710|69571609|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
37886861|NCT01113710|69571609|FG000|Overall Study|Lack of Efficacy/Other|4|||
37886862|NCT01113710|69571609|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
37886863|NCT01113710|69571609|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
37886864|NCT01113710|69571609|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
37886865|NCT01113710|69571609|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
37886866|NCT01113710|69571609|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
37886867|NCT01113710|69571609|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
37886868|NCT01113710|69571609|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
37886869|NCT01113710|69571609|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
37886870|NCT01113710|69571609|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
37886871|NCT01113710|69571609|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
37886872|NCT01113710|69571609|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
37886873|NCT01113710|69571609|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
37886874|NCT01113710|69571609|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
37886875|NCT01124162|69571615|FG000|First Intervention|Adverse Event|2|||
37886876|NCT01124162|69571616|FG001|First Intervention|Adverse Event|0|||
37886877|NCT01124162|69571615|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
37886878|NCT01124162|69571616|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
37886879|NCT00906399|69571625|FG000|Year 1|Randomized But Not Treated|0|||
37886880|NCT00906399|69571626|FG001|Year 1|Randomized But Not Treated|1|||
37886881|NCT00906399|69571627|FG002|Year 1|Randomized But Not Treated|3|||
37886882|NCT00906399|69571628|FG003|Year 1|Randomized But Not Treated|0|||
37886883|NCT00906399|69571629|FG004|Year 1|Randomized But Not Treated|0|||
37886884|NCT00906399|69571630|FG005|Year 1|Randomized But Not Treated|0|||
37886885|NCT00906399|69571631|FG006|Year 1|Randomized But Not Treated|0|||
37886886|NCT00906399|69571625|FG000|Year 1|Adverse Event|4|||
37886887|NCT00906399|69571626|FG001|Year 1|Adverse Event|22|||
37886888|NCT00906399|69571627|FG002|Year 1|Adverse Event|24|||
37886889|NCT00906399|69571628|FG003|Year 1|Adverse Event|0|||
37886890|NCT00906399|69571629|FG004|Year 1|Adverse Event|0|||
37886891|NCT00906399|69571630|FG005|Year 1|Adverse Event|0|||
37886892|NCT00906399|69571631|FG006|Year 1|Adverse Event|0|||
37886893|NCT00906399|69571625|FG000|Year 1|Lost to Follow-up|4|||
37886894|NCT00906399|69571626|FG001|Year 1|Lost to Follow-up|4|||
37886895|NCT00906399|69571627|FG002|Year 1|Lost to Follow-up|2|||
37886896|NCT00906399|69571628|FG003|Year 1|Lost to Follow-up|0|||
37886897|NCT00906399|69571629|FG004|Year 1|Lost to Follow-up|0|||
37886898|NCT00906399|69571630|FG005|Year 1|Lost to Follow-up|0|||
37886899|NCT00906399|69571631|FG006|Year 1|Lost to Follow-up|0|||
37886900|NCT00906399|69571625|FG000|Year 1|Withdrawal by Subject|30|||
37886901|NCT00906399|69571626|FG001|Year 1|Withdrawal by Subject|32|||
37886902|NCT00906399|69571627|FG002|Year 1|Withdrawal by Subject|36|||
37886903|NCT00906399|69571628|FG003|Year 1|Withdrawal by Subject|0|||
37886904|NCT00906399|69571629|FG004|Year 1|Withdrawal by Subject|0|||
37886905|NCT00906399|69571630|FG005|Year 1|Withdrawal by Subject|0|||
37886906|NCT00906399|69571631|FG006|Year 1|Withdrawal by Subject|0|||
37886907|NCT00906399|69571625|FG000|Year 1|Physician Decision|0|||
37886908|NCT00906399|69571626|FG001|Year 1|Physician Decision|1|||
37886909|NCT00906399|69571627|FG002|Year 1|Physician Decision|3|||
37886910|NCT00906399|69571628|FG003|Year 1|Physician Decision|0|||
37886911|NCT00906399|69571629|FG004|Year 1|Physician Decision|0|||
37886912|NCT00906399|69571630|FG005|Year 1|Physician Decision|0|||
37986980|NCT00256750|69672546|FG002|Post-Transplant Treated (24 Months)|Death|0|||
37986981|NCT00256750|69672544|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
37986982|NCT00256750|69672545|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
37986983|NCT00256750|69672546|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
37886913|NCT00906399|69571631|FG006|Year 1|Physician Decision|0|||
37886914|NCT00906399|69571625|FG000|Year 1|Death|2|||
37886915|NCT00906399|69571626|FG001|Year 1|Death|1|||
37886916|NCT00906399|69571627|FG002|Year 1|Death|1|||
37886917|NCT00906399|69571628|FG003|Year 1|Death|0|||
37886918|NCT00906399|69571629|FG004|Year 1|Death|0|||
37886919|NCT00906399|69571630|FG005|Year 1|Death|0|||
37886920|NCT00906399|69571631|FG006|Year 1|Death|0|||
37886921|NCT00906399|69571625|FG000|Year 1|Other|4|||
37886922|NCT00906399|69571626|FG001|Year 1|Other|2|||
37886923|NCT00906399|69571627|FG002|Year 1|Other|7|||
37886924|NCT00906399|69571628|FG003|Year 1|Other|0|||
37886925|NCT00906399|69571629|FG004|Year 1|Other|0|||
37886926|NCT00906399|69571630|FG005|Year 1|Other|0|||
37886927|NCT00906399|69571631|FG006|Year 1|Other|0|||
37886928|NCT00906399|69571625|FG000|Year 2|Adverse Event|0|||
37886929|NCT00906399|69571626|FG001|Year 2|Adverse Event|0|||
37886930|NCT00906399|69571627|FG002|Year 2|Adverse Event|0|||
37886931|NCT00906399|69571628|FG003|Year 2|Adverse Event|9|||
37886932|NCT00906399|69571629|FG004|Year 2|Adverse Event|8|||
37886933|NCT00906399|69571630|FG005|Year 2|Adverse Event|11|||
37886934|NCT00906399|69571631|FG006|Year 2|Adverse Event|6|||
37886935|NCT00906399|69571625|FG000|Year 2|Lost to Follow-up|0|||
37886936|NCT00906399|69571626|FG001|Year 2|Lost to Follow-up|0|||
37886937|NCT00906399|69571627|FG002|Year 2|Lost to Follow-up|0|||
37886938|NCT00906399|69571628|FG003|Year 2|Lost to Follow-up|1|||
37886939|NCT00906399|69571629|FG004|Year 2|Lost to Follow-up|4|||
37886940|NCT00906399|69571630|FG005|Year 2|Lost to Follow-up|2|||
37886941|NCT00906399|69571631|FG006|Year 2|Lost to Follow-up|4|||
37886942|NCT00906399|69571625|FG000|Year 2|Withdrawal by Subject|0|||
37886943|NCT00906399|69571626|FG001|Year 2|Withdrawal by Subject|0|||
37886944|NCT00906399|69571627|FG002|Year 2|Withdrawal by Subject|0|||
37886945|NCT00906399|69571628|FG003|Year 2|Withdrawal by Subject|17|||
37886946|NCT00906399|69571629|FG004|Year 2|Withdrawal by Subject|18|||
37886947|NCT00906399|69571630|FG005|Year 2|Withdrawal by Subject|27|||
37886948|NCT00906399|69571631|FG006|Year 2|Withdrawal by Subject|13|||
37886949|NCT00906399|69571625|FG000|Year 2|Physician Decision|0|||
37886950|NCT00906399|69571626|FG001|Year 2|Physician Decision|0|||
37886951|NCT00906399|69571627|FG002|Year 2|Physician Decision|0|||
37886952|NCT00906399|69571628|FG003|Year 2|Physician Decision|0|||
37986984|NCT00256750|69672544|FG000|Post-Transplant Treated (24 Months)|Other|2|||
37986985|NCT00256750|69672545|FG001|Post-Transplant Treated (24 Months)|Other|0|||
37986986|NCT00256750|69672546|FG002|Post-Transplant Treated (24 Months)|Other|1|||
37822358|NCT03556202|69502266|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
37822359|NCT03556202|69502267|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
37822360|NCT03556202|69502268|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
37822361|NCT03556202|69502266|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
37822362|NCT03556202|69502267|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
37822363|NCT03556202|69502268|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
37822364|NCT03556202|69502266|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
37822365|NCT03556202|69502267|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
37822366|NCT03556202|69502268|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
37822367|NCT03556202|69502266|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
37822368|NCT03556202|69502267|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
37822369|NCT03556202|69502268|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
37822370|NCT03556202|69502266|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
37822371|NCT03556202|69502267|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
37886953|NCT00906399|69571629|FG004|Year 2|Physician Decision|2|||
37886954|NCT00906399|69571630|FG005|Year 2|Physician Decision|6|||
37886955|NCT00906399|69571631|FG006|Year 2|Physician Decision|3|||
37886956|NCT00906399|69571625|FG000|Year 2|Death|0|||
37886957|NCT00906399|69571626|FG001|Year 2|Death|0|||
37886958|NCT00906399|69571627|FG002|Year 2|Death|0|||
37822372|NCT03556202|69502268|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
37886959|NCT00906399|69571628|FG003|Year 2|Death|1|||
37886960|NCT00906399|69571629|FG004|Year 2|Death|0|||
37886961|NCT00906399|69571630|FG005|Year 2|Death|0|||
37886962|NCT00906399|69571631|FG006|Year 2|Death|3|||
37886963|NCT00906399|69571625|FG000|Year 2|Other|0|||
37886964|NCT00906399|69571626|FG001|Year 2|Other|0|||
37886965|NCT00906399|69571627|FG002|Year 2|Other|0|||
37886966|NCT00906399|69571628|FG003|Year 2|Other|2|||
37886967|NCT00906399|69571629|FG004|Year 2|Other|3|||
37886968|NCT00906399|69571630|FG005|Year 2|Other|1|||
37886969|NCT00906399|69571631|FG006|Year 2|Other|0|||
37986987|NCT00256750|69672544|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
37986988|NCT00256750|69672545|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
37986989|NCT00256750|69672546|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
37986990|NCT00256750|69672544|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
37986991|NCT00256750|69672545|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
37986992|NCT00256750|69672546|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
37986993|NCT00256750|69672544|FG000|Post-Transplant Treated (36 Months)|Death|0|||
37986994|NCT00256750|69672545|FG001|Post-Transplant Treated (36 Months)|Death|2|||
37986995|NCT00256750|69672546|FG002|Post-Transplant Treated (36 Months)|Death|1|||
37986996|NCT00256750|69672544|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
37986997|NCT00256750|69672545|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
37986998|NCT00256750|69672546|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
37986999|NCT00256750|69672544|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
37987000|NCT00256750|69672545|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
37987001|NCT00256750|69672546|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
37987002|NCT00256750|69672544|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
37987003|NCT00256750|69672545|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
37987004|NCT00256750|69672546|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
37987005|NCT00256750|69672544|FG000|Post-Transplant Treated (36 Months)|Other|0|||
37987006|NCT00256750|69672545|FG001|Post-Transplant Treated (36 Months)|Other|1|||
37886970|NCT01111838|69571643|FG000|Overall Study|Patient Ineligible|2|||
37987007|NCT00256750|69672546|FG002|Post-Transplant Treated (36 Months)|Other|1|||
37987008|NCT00256750|69672544|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
37987009|NCT00256750|69672545|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
37987010|NCT00256750|69672546|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
37987011|NCT00256750|69672544|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
37987012|NCT00256750|69672545|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
37987013|NCT00256750|69672546|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
37987014|NCT00256750|69672544|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
37987015|NCT00256750|69672545|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
37987016|NCT00256750|69672546|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
37987017|NCT00256750|69672544|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
37987018|NCT00256750|69672545|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
37987019|NCT00256750|69672546|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
37987020|NCT00256750|69672544|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
37987021|NCT00256750|69672545|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
37987022|NCT00256750|69672546|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
37987023|NCT00256750|69672544|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
37822373|NCT03556202|69502266|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
37822374|NCT03556202|69502267|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
37822375|NCT03556202|69502268|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
37822376|NCT03556202|69502266|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
37822377|NCT03556202|69502267|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
37822378|NCT03556202|69502268|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
37822379|NCT03556202|69502266|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
37822380|NCT03556202|69502267|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
37822381|NCT03556202|69502268|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
37822382|NCT03556202|69502266|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
37987024|NCT00256750|69672545|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
37987025|NCT00256750|69672546|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
37886971|NCT01111838|69571643|FG000|Overall Study|Not Treated|3|||
37886972|NCT01111838|69571643|FG000|Overall Study|Clinical deterioration|1|||
37886973|NCT01111838|69571643|FG000|Overall Study|Other Complicating Disease|1|||
37987026|NCT00256750|69672544|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
37987027|NCT00256750|69672545|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
37987028|NCT00256750|69672546|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
37987029|NCT00256750|69672544|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
37987030|NCT00256750|69672545|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
37987031|NCT00256750|69672546|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
37987032|NCT00256750|69672544|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
37987033|NCT00256750|69672545|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
37987034|NCT00256750|69672546|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
37987035|NCT00279201|69672557|FG000|Initiation|Death|1|||
37987036|NCT00279201|69672558|FG001|Initiation|Death|5|||
37987037|NCT00279201|69672559|FG002|Initiation|Death|0|||
37987038|NCT00279201|69672560|FG003|Initiation|Death|0|||
37987039|NCT00279201|69672561|FG004|Initiation|Death|0|||
37987040|NCT00279201|69672562|FG005|Initiation|Death|0|||
37987041|NCT00279201|69672557|FG000|Initiation|Adverse Event|6|||
37987042|NCT00279201|69672558|FG001|Initiation|Adverse Event|15|||
37987043|NCT00279201|69672559|FG002|Initiation|Adverse Event|0|||
37987044|NCT00279201|69672560|FG003|Initiation|Adverse Event|0|||
37987045|NCT00279201|69672561|FG004|Initiation|Adverse Event|0|||
37987046|NCT00279201|69672562|FG005|Initiation|Adverse Event|0|||
37987047|NCT00279201|69672557|FG000|Initiation|Lost to Follow-up|42|||
37987048|NCT00279201|69672558|FG001|Initiation|Lost to Follow-up|41|||
37987049|NCT00279201|69672559|FG002|Initiation|Lost to Follow-up|0|||
37987050|NCT00279201|69672560|FG003|Initiation|Lost to Follow-up|0|||
37987051|NCT00279201|69672561|FG004|Initiation|Lost to Follow-up|0|||
37987052|NCT00279201|69672562|FG005|Initiation|Lost to Follow-up|0|||
37987053|NCT00279201|69672557|FG000|Initiation|Entry Criteria Exclusion|7|||
37987054|NCT00279201|69672558|FG001|Initiation|Entry Criteria Exclusion|9|||
37987055|NCT00279201|69672559|FG002|Initiation|Entry Criteria Exclusion|0|||
37987056|NCT00279201|69672560|FG003|Initiation|Entry Criteria Exclusion|0|||
37987057|NCT00279201|69672561|FG004|Initiation|Entry Criteria Exclusion|0|||
37987058|NCT00279201|69672562|FG005|Initiation|Entry Criteria Exclusion|0|||
37987059|NCT00279201|69672557|FG000|Initiation|Protocol Violation|9|||
37987060|NCT00279201|69672558|FG001|Initiation|Protocol Violation|10|||
37987061|NCT00279201|69672559|FG002|Initiation|Protocol Violation|0|||
37987062|NCT00279201|69672560|FG003|Initiation|Protocol Violation|0|||
37987063|NCT00279201|69672561|FG004|Initiation|Protocol Violation|0|||
37987064|NCT00279201|69672562|FG005|Initiation|Protocol Violation|0|||
37987065|NCT00279201|69672557|FG000|Initiation|Withdrawal by Subject|35|||
37987066|NCT00279201|69672558|FG001|Initiation|Withdrawal by Subject|41|||
37987067|NCT00279201|69672559|FG002|Initiation|Withdrawal by Subject|0|||
37987068|NCT00279201|69672560|FG003|Initiation|Withdrawal by Subject|0|||
37987069|NCT00279201|69672561|FG004|Initiation|Withdrawal by Subject|0|||
37987070|NCT00279201|69672562|FG005|Initiation|Withdrawal by Subject|0|||
37987071|NCT00279201|69672557|FG000|Initiation|Physician Decision|15|||
37987072|NCT00279201|69672558|FG001|Initiation|Physician Decision|18|||
37987073|NCT00279201|69672559|FG002|Initiation|Physician Decision|0|||
37987074|NCT00279201|69672560|FG003|Initiation|Physician Decision|0|||
37886974|NCT00947856|69571649|FG000|Treatment Period|Progressive Disease|33|||
37886975|NCT00947856|69571650|FG001|Treatment Period|Progressive Disease|12|||
37886976|NCT00947856|69571649|FG000|Treatment Period|Adverse Event|15|||
37886977|NCT00947856|69571650|FG001|Treatment Period|Adverse Event|9|||
37886978|NCT00947856|69571649|FG000|Treatment Period|Physician Decision|14|||
37886979|NCT00947856|69571650|FG001|Treatment Period|Physician Decision|6|||
37886980|NCT00947856|69571649|FG000|Treatment Period|Study Stopped by Sponsor|4|||
37886981|NCT00947856|69571650|FG001|Treatment Period|Study Stopped by Sponsor|4|||
37886982|NCT00947856|69571649|FG000|Treatment Period|Withdrawal by Subject|12|||
37886983|NCT00947856|69571650|FG001|Treatment Period|Withdrawal by Subject|1|||
37886984|NCT00947856|69571649|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
37886985|NCT00947856|69571650|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
37886986|NCT00947856|69571649|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
37886987|NCT00947856|69571650|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
37987075|NCT00279201|69672561|FG004|Initiation|Physician Decision|0|||
37987076|NCT00279201|69672562|FG005|Initiation|Physician Decision|0|||
37987077|NCT00279201|69672557|FG000|Initiation|Sponsor Decision|13|||
37987078|NCT00279201|69672558|FG001|Initiation|Sponsor Decision|5|||
37987079|NCT00279201|69672559|FG002|Initiation|Sponsor Decision|0|||
37987080|NCT00279201|69672560|FG003|Initiation|Sponsor Decision|0|||
37987081|NCT00279201|69672561|FG004|Initiation|Sponsor Decision|0|||
37987082|NCT00279201|69672562|FG005|Initiation|Sponsor Decision|0|||
37987083|NCT00279201|69672557|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
37987084|NCT00279201|69672558|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
37987085|NCT00279201|69672559|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
37987086|NCT00279201|69672560|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
37886988|NCT00947856|69571649|FG000|Follow-up Period|Lost to Follow-up|7|||
37886989|NCT00947856|69571650|FG001|Follow-up Period|Lost to Follow-up|0|||
37886990|NCT00947856|69571649|FG000|Follow-up Period|Patient unavailable for site visits|1|||
37886991|NCT00947856|69571650|FG001|Follow-up Period|Patient unavailable for site visits|0|||
37886992|NCT00947856|69571649|FG000|Follow-up Period|Withdrawal by Subject|1|||
37886993|NCT00947856|69571650|FG001|Follow-up Period|Withdrawal by Subject|0|||
37886994|NCT00947544|69571665|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
37886995|NCT00947544|69571666|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
37886996|NCT00907335|69571678|FG000|Overall Study|Withdrawal by Subject|2|||
37886997|NCT00907335|69571679|FG001|Overall Study|Withdrawal by Subject|0|||
37886998|NCT00907335|69571678|FG000|Overall Study|Adverse Event|4|||
37886999|NCT00907335|69571679|FG001|Overall Study|Adverse Event|1|||
37887000|NCT00907335|69571678|FG000|Overall Study|Lost to Follow-up|2|||
37887001|NCT00907335|69571679|FG001|Overall Study|Lost to Follow-up|0|||
37887002|NCT00947154|69571685|FG000|Overall Study|Lost to Follow-up|1|||
37887003|NCT01124006|69571693|FG000|Overall Study|Withdrawal by Subject|2|||
37822383|NCT03556202|69502267|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
37822384|NCT03556202|69502268|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
37822385|NCT03556202|69502266|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
37822386|NCT03556202|69502267|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
37822387|NCT03556202|69502268|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
37822388|NCT03556202|69502266|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
37822389|NCT03556202|69502267|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
37822390|NCT03556202|69502268|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
37822391|NCT03556202|69502266|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
37822392|NCT03556202|69502267|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
37822393|NCT03556202|69502268|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
37822394|NCT03541174|69502282|FG000|Part 1 Double-Blind|Adverse Event|6|||
37822395|NCT03541174|69502283|FG001|Part 1 Double-Blind|Adverse Event|5|||
37822396|NCT03541174|69502284|FG002|Part 1 Double-Blind|Adverse Event|2|||
37822397|NCT03541174|69502285|FG003|Part 1 Double-Blind|Adverse Event|0|||
37822398|NCT03541174|69502286|FG004|Part 1 Double-Blind|Adverse Event|0|||
37822399|NCT03541174|69502287|FG005|Part 1 Double-Blind|Adverse Event|0|||
37822400|NCT03541174|69502282|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
37822401|NCT03541174|69502283|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
37822402|NCT03541174|69502284|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
37822403|NCT03541174|69502285|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
37822404|NCT03541174|69502286|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
37822405|NCT03541174|69502287|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
37822406|NCT03541174|69502282|FG000|Part 1 Double-Blind|Other reasons|3|||
37822407|NCT03541174|69502283|FG001|Part 1 Double-Blind|Other reasons|2|||
37822408|NCT03541174|69502284|FG002|Part 1 Double-Blind|Other reasons|3|||
37822409|NCT03541174|69502285|FG003|Part 1 Double-Blind|Other reasons|0|||
37822410|NCT03541174|69502286|FG004|Part 1 Double-Blind|Other reasons|0|||
37822411|NCT03541174|69502287|FG005|Part 1 Double-Blind|Other reasons|0|||
37822412|NCT03541174|69502282|FG000|Part 2 Single-Blind|Adverse Event|0|||
37822413|NCT03541174|69502283|FG001|Part 2 Single-Blind|Adverse Event|0|||
37822414|NCT03541174|69502284|FG002|Part 2 Single-Blind|Adverse Event|0|||
37822415|NCT03541174|69502285|FG003|Part 2 Single-Blind|Adverse Event|25|||
37822416|NCT03541174|69502286|FG004|Part 2 Single-Blind|Adverse Event|0|||
37822417|NCT03541174|69502287|FG005|Part 2 Single-Blind|Adverse Event|0|||
37822418|NCT03541174|69502282|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
37822419|NCT03541174|69502283|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
37822420|NCT03541174|69502284|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
37822421|NCT03541174|69502285|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
37822422|NCT03541174|69502286|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
37822423|NCT03541174|69502287|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
37822424|NCT03541174|69502282|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
37822425|NCT03541174|69502283|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
37822426|NCT03541174|69502284|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
37822427|NCT03541174|69502285|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
37822428|NCT03541174|69502286|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
37822429|NCT03541174|69502287|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
37822430|NCT03541174|69502282|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
37822431|NCT03541174|69502283|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
37822432|NCT03541174|69502284|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
37822433|NCT03541174|69502285|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
37822434|NCT03541174|69502286|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
37822435|NCT03541174|69502287|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
37887004|NCT01124006|69571694|FG001|Overall Study|Withdrawal by Subject|2|||
37887005|NCT01124006|69571695|FG002|Overall Study|Withdrawal by Subject|0|||
37887006|NCT01124006|69571693|FG000|Overall Study|Lost to Follow-up|1|||
37887007|NCT01124006|69571694|FG001|Overall Study|Lost to Follow-up|0|||
37887008|NCT01124006|69571695|FG002|Overall Study|Lost to Follow-up|1|||
37887009|NCT01124006|69571693|FG000|Overall Study|Other|0|||
37887010|NCT01124006|69571694|FG001|Overall Study|Other|0|||
37887011|NCT01124006|69571695|FG002|Overall Study|Other|1|||
37910955|NCT00741819|69597427|FG000|Overall Study|Withdrawal by Subject|3|||
37822436|NCT03541174|69502282|FG000|Part 2 Single-Blind|Death|0|||
37822437|NCT03541174|69502283|FG001|Part 2 Single-Blind|Death|0|||
37822438|NCT03541174|69502284|FG002|Part 2 Single-Blind|Death|0|||
37822439|NCT03541174|69502285|FG003|Part 2 Single-Blind|Death|5|||
37822440|NCT03541174|69502286|FG004|Part 2 Single-Blind|Death|0|||
37822441|NCT03541174|69502287|FG005|Part 2 Single-Blind|Death|0|||
37910956|NCT00741819|69597427|FG000|Overall Study|Death|1|||
37910957|NCT00741819|69597427|FG000|Overall Study|Disease progression|1|||
37910958|NCT00924443|69597433|FG000|Overall Study|Physician Decision|2|||
37910959|NCT00924443|69597433|FG000|Overall Study|Protocol Violation|1|||
37910960|NCT00924287|69597437|FG000|Overall Study|Death|1|||
37910961|NCT00923975|69597441|FG000|Overall Study|Did not meet inclusion criteria|1|||
37910962|NCT00918203|69597477|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
37910963|NCT00918203|69597478|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
37822442|NCT03541174|69502282|FG000|Part 2 Single-Blind|Pregnancy|0|||
37822443|NCT03541174|69502283|FG001|Part 2 Single-Blind|Pregnancy|0|||
37822444|NCT03541174|69502284|FG002|Part 2 Single-Blind|Pregnancy|0|||
37822445|NCT03541174|69502285|FG003|Part 2 Single-Blind|Pregnancy|1|||
37910964|NCT00918203|69597479|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
37910965|NCT00918203|69597477|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
37910966|NCT00918203|69597478|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
37910967|NCT00918203|69597479|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
37910968|NCT00918203|69597477|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
37910969|NCT00918203|69597478|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
37822446|NCT03541174|69502286|FG004|Part 2 Single-Blind|Pregnancy|0|||
37822447|NCT03541174|69502287|FG005|Part 2 Single-Blind|Pregnancy|0|||
37987087|NCT00279201|69672561|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
37987088|NCT00279201|69672562|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
37987089|NCT00279201|69672557|FG000|Maintenance|Lack of Efficacy|32|||
37987090|NCT00279201|69672558|FG001|Maintenance|Lack of Efficacy|30|||
37987091|NCT00279201|69672559|FG002|Maintenance|Lack of Efficacy|0|||
37987092|NCT00279201|69672560|FG003|Maintenance|Lack of Efficacy|0|||
37987093|NCT00279201|69672561|FG004|Maintenance|Lack of Efficacy|0|||
37987094|NCT00279201|69672562|FG005|Maintenance|Lack of Efficacy|0|||
37987095|NCT00279201|69672557|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
37987096|NCT00279201|69672558|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
37987097|NCT00279201|69672559|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
37987098|NCT00279201|69672560|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
37987099|NCT00279201|69672561|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
37987100|NCT00279201|69672562|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
37987101|NCT00279201|69672557|FG000|Maintenance|Adverse Event|4|||
37987102|NCT00279201|69672558|FG001|Maintenance|Adverse Event|4|||
37987103|NCT00279201|69672559|FG002|Maintenance|Adverse Event|0|||
37987104|NCT00279201|69672560|FG003|Maintenance|Adverse Event|0|||
37987105|NCT00279201|69672561|FG004|Maintenance|Adverse Event|0|||
37887012|NCT00952068|69571703|FG000|Overall Study|Adverse Event|3|||
37887013|NCT00952068|69571703|FG000|Overall Study|Withdrawal by Subject|4|||
37887014|NCT01123850|69571707|FG000|Overall Study|Slow enrollment|45|||
37887015|NCT01123382|69571713|FG000|Overall Study|Withdrawal by Subject|1|||
37887016|NCT01123382|69571714|FG001|Overall Study|Withdrawal by Subject|4|||
37887017|NCT01123382|69571713|FG000|Overall Study|Lost to Follow-up|1|||
37887018|NCT01123382|69571714|FG001|Overall Study|Lost to Follow-up|2|||
37887019|NCT00951912|69571723|FG000|Overall Study|Lack of Efficacy|1|||
37887020|NCT00951912|69571724|FG001|Overall Study|Lack of Efficacy|0|||
37887021|NCT00951912|69571725|FG002|Overall Study|Lack of Efficacy|0|||
37887022|NCT00951912|69571723|FG000|Overall Study|Adverse Event|0|||
37887023|NCT00951912|69571724|FG001|Overall Study|Adverse Event|1|||
37887024|NCT00951912|69571725|FG002|Overall Study|Adverse Event|1|||
37887025|NCT00951912|69571723|FG000|Overall Study|Lost to Follow-up|2|||
37887026|NCT00951912|69571724|FG001|Overall Study|Lost to Follow-up|2|||
37887027|NCT00951912|69571725|FG002|Overall Study|Lost to Follow-up|0|||
37887028|NCT00951912|69571723|FG000|Overall Study|Physician Decision|1|||
37887029|NCT00951912|69571724|FG001|Overall Study|Physician Decision|0|||
37887030|NCT00951912|69571725|FG002|Overall Study|Physician Decision|1|||
37887031|NCT00951912|69571723|FG000|Overall Study|Withdrawal by Subject|1|||
37887032|NCT00951912|69571724|FG001|Overall Study|Withdrawal by Subject|1|||
37887033|NCT00951912|69571725|FG002|Overall Study|Withdrawal by Subject|0|||
37887034|NCT00951912|69571723|FG000|Overall Study|Other:Depression|1|||
37887035|NCT00951912|69571724|FG001|Overall Study|Other:Depression|0|||
37887036|NCT00951912|69571725|FG002|Overall Study|Other:Depression|0|||
37987106|NCT00279201|69672562|FG005|Maintenance|Adverse Event|0|||
37987107|NCT00279201|69672557|FG000|Maintenance|Death|4|||
37987108|NCT00279201|69672558|FG001|Maintenance|Death|4|||
37987109|NCT00279201|69672559|FG002|Maintenance|Death|0|||
37987110|NCT00279201|69672560|FG003|Maintenance|Death|0|||
37987111|NCT00279201|69672561|FG004|Maintenance|Death|0|||
37987112|NCT00279201|69672562|FG005|Maintenance|Death|0|||
37822448|NCT03541174|69502282|FG000|Part 2 Single-Blind|Other reasons|0|||
37822449|NCT03541174|69502283|FG001|Part 2 Single-Blind|Other reasons|0|||
37822450|NCT03541174|69502284|FG002|Part 2 Single-Blind|Other reasons|0|||
37822451|NCT03541174|69502285|FG003|Part 2 Single-Blind|Other reasons|32|||
37822452|NCT03541174|69502286|FG004|Part 2 Single-Blind|Other reasons|0|||
37822453|NCT03541174|69502287|FG005|Part 2 Single-Blind|Other reasons|0|||
37822454|NCT03541174|69502282|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
37822455|NCT03541174|69502283|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
37822456|NCT03541174|69502284|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
37887037|NCT00951912|69571723|FG000|Overall Study|Other: Colon cancer|1|||
37887038|NCT00951912|69571724|FG001|Overall Study|Other: Colon cancer|0|||
37887039|NCT00951912|69571725|FG002|Overall Study|Other: Colon cancer|0|||
37887040|NCT00951912|69571723|FG000|Overall Study|Other: Stroke|0|||
37887041|NCT00951912|69571724|FG001|Overall Study|Other: Stroke|1|||
37887042|NCT00951912|69571725|FG002|Overall Study|Other: Stroke|0|||
37987113|NCT00279201|69672557|FG000|Maintenance|Lost to Follow-up|17|||
37987114|NCT00279201|69672558|FG001|Maintenance|Lost to Follow-up|13|||
37987115|NCT00279201|69672559|FG002|Maintenance|Lost to Follow-up|0|||
37987116|NCT00279201|69672560|FG003|Maintenance|Lost to Follow-up|0|||
37987117|NCT00279201|69672561|FG004|Maintenance|Lost to Follow-up|0|||
37822457|NCT03541174|69502285|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
37822458|NCT03541174|69502286|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
37887043|NCT01123148|69571733|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
37887044|NCT01123148|69571733|FG000|Overall Study|Didn't meet milestone criteria|1|||
37987118|NCT00279201|69672562|FG005|Maintenance|Lost to Follow-up|0|||
37987119|NCT00279201|69672557|FG000|Maintenance|Entry Criteria Exclusion|1|||
37887045|NCT01123070|69571741|FG000|Part B Double Blind Period|Protocol Violation|0|||
37887046|NCT01123070|69571742|FG001|Part B Double Blind Period|Protocol Violation|0|||
37887047|NCT01123070|69571743|FG002|Part B Double Blind Period|Protocol Violation|0|||
37887048|NCT01123070|69571744|FG003|Part B Double Blind Period|Protocol Violation|1|||
37887049|NCT01123070|69571741|FG000|Part B Double Blind Period|Adverse Event|0|||
37887050|NCT01123070|69571742|FG001|Part B Double Blind Period|Adverse Event|0|||
37887051|NCT01123070|69571743|FG002|Part B Double Blind Period|Adverse Event|2|||
37887052|NCT01123070|69571744|FG003|Part B Double Blind Period|Adverse Event|0|||
37987120|NCT00279201|69672558|FG001|Maintenance|Entry Criteria Exclusion|4|||
37987121|NCT00279201|69672559|FG002|Maintenance|Entry Criteria Exclusion|0|||
37987122|NCT00279201|69672560|FG003|Maintenance|Entry Criteria Exclusion|0|||
37987123|NCT00279201|69672561|FG004|Maintenance|Entry Criteria Exclusion|0|||
37987124|NCT00279201|69672562|FG005|Maintenance|Entry Criteria Exclusion|0|||
37987125|NCT00279201|69672557|FG000|Maintenance|Protocol Violation|16|||
37987126|NCT00279201|69672558|FG001|Maintenance|Protocol Violation|24|||
37987127|NCT00279201|69672559|FG002|Maintenance|Protocol Violation|0|||
37987128|NCT00279201|69672560|FG003|Maintenance|Protocol Violation|0|||
37987129|NCT00279201|69672561|FG004|Maintenance|Protocol Violation|0|||
37987130|NCT00279201|69672562|FG005|Maintenance|Protocol Violation|0|||
37822459|NCT03541174|69502287|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
37822460|NCT03541174|69502282|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
37822461|NCT03541174|69502283|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
37822462|NCT03541174|69502284|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
37822463|NCT03541174|69502285|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
37822464|NCT03541174|69502286|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
37822465|NCT03541174|69502287|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
37822466|NCT03541174|69502282|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
37822467|NCT03541174|69502283|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
37822468|NCT03541174|69502284|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
37822469|NCT03541174|69502285|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
37822470|NCT03541174|69502286|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
37822471|NCT03541174|69502287|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
37822472|NCT03541174|69502282|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
37822473|NCT03541174|69502283|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
37822474|NCT03541174|69502284|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
37822475|NCT03541174|69502285|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
37822476|NCT03541174|69502286|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
37822477|NCT03541174|69502287|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
37822478|NCT03541174|69502282|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
37822479|NCT03541174|69502283|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
37822480|NCT03541174|69502284|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
37822481|NCT03541174|69502285|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
37833586|NCT01262989|69517313|FG001|Period 1|Positive answer for exclusion criteria|1|||
37887053|NCT01123070|69571741|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
37987131|NCT00279201|69672557|FG000|Maintenance|Withdrawal by Subject|18|||
37987132|NCT00279201|69672558|FG001|Maintenance|Withdrawal by Subject|18|||
37987133|NCT00279201|69672559|FG002|Maintenance|Withdrawal by Subject|0|||
37987134|NCT00279201|69672560|FG003|Maintenance|Withdrawal by Subject|0|||
37987135|NCT00279201|69672561|FG004|Maintenance|Withdrawal by Subject|0|||
37987136|NCT00279201|69672562|FG005|Maintenance|Withdrawal by Subject|0|||
37987137|NCT00279201|69672557|FG000|Maintenance|Physician Decision|9|||
37987138|NCT00279201|69672558|FG001|Maintenance|Physician Decision|9|||
37987139|NCT00279201|69672559|FG002|Maintenance|Physician Decision|0|||
37887054|NCT01123070|69571742|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
37887055|NCT01123070|69571743|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
37887056|NCT01123070|69571744|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
37887057|NCT01122680|69571755|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
37887058|NCT01122680|69571756|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
37887059|NCT01122680|69571757|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
37887060|NCT01122680|69571758|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
37887061|NCT01122680|69571755|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
37887062|NCT01122680|69571756|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
37887063|NCT01122680|69571757|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
37887064|NCT01122680|69571758|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
37887065|NCT01122680|69571755|FG000|Period 1 (4 Weeks)|Other|1|||
37887066|NCT01122680|69571756|FG001|Period 1 (4 Weeks)|Other|1|||
37887067|NCT01122680|69571757|FG002|Period 1 (4 Weeks)|Other|0|||
37887068|NCT01122680|69571758|FG003|Period 1 (4 Weeks)|Other|0|||
37887069|NCT01122680|69571755|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
37887070|NCT01122680|69571756|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
37887071|NCT01122680|69571757|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
37887072|NCT01122680|69571758|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
37887073|NCT01122680|69571755|FG000|Period 2 (4 Weeks)|Other|1|||
37887074|NCT01122680|69571756|FG001|Period 2 (4 Weeks)|Other|0|||
37887075|NCT01122680|69571757|FG002|Period 2 (4 Weeks)|Other|0|||
37887076|NCT01122680|69571758|FG003|Period 2 (4 Weeks)|Other|0|||
37887077|NCT01122680|69571755|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
37887078|NCT01122680|69571756|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
37887079|NCT01122680|69571757|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
37887080|NCT01122680|69571758|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
37887081|NCT01122680|69571755|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
37887082|NCT01122680|69571756|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
37887083|NCT01122680|69571757|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
37987140|NCT00279201|69672560|FG003|Maintenance|Physician Decision|0|||
37822482|NCT03541174|69502286|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
37822483|NCT03541174|69502287|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
37822484|NCT03289039|69502319|FG000|Overall Study|Withdrawal by Subject|0|||
37822485|NCT03289039|69502320|FG001|Overall Study|Withdrawal by Subject|1|||
37822486|NCT03289039|69502319|FG000|Overall Study|Became ineligible prior to treatment start|0|||
37822487|NCT03289039|69502320|FG001|Overall Study|Became ineligible prior to treatment start|1|||
37822488|NCT03289039|69502319|FG000|Overall Study|progressed before treatment start|1|||
37822489|NCT03289039|69502320|FG001|Overall Study|progressed before treatment start|0|||
37822490|NCT03281304|69502328|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
37822491|NCT03281304|69502329|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
37887084|NCT01122680|69571758|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
37887085|NCT00946998|69571770|FG000|Overall Study|Exited prior to first outcome assessment|5|||
37887086|NCT00946998|69571771|FG001|Overall Study|Exited prior to first outcome assessment|3|||
37987141|NCT00279201|69672561|FG004|Maintenance|Physician Decision|0|||
37887087|NCT01138826|69571777|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
37887088|NCT01138826|69571778|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
37887089|NCT01138826|69571779|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
37887090|NCT01138826|69571780|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
37887091|NCT01138826|69571781|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
37887092|NCT01138826|69571782|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
37887093|NCT00906087|69571790|FG000|Initial Washout|Withdrawal by Subject|1|||
37887094|NCT00906087|69571790|FG000|Initial Washout|Physician Decision|1|||
37887095|NCT00907257|69571799|FG000|Overall Study|Adverse Event|0|||
37887096|NCT00907257|69571800|FG001|Overall Study|Adverse Event|4|||
37887097|NCT00907257|69571799|FG000|Overall Study|Protocol Violation|1|||
37822492|NCT03281304|69502328|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
37822493|NCT03281304|69502329|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
37822494|NCT03281304|69502328|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
37822495|NCT03281304|69502329|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
37822496|NCT03281304|69502328|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
37822497|NCT03281304|69502329|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
37822498|NCT03281304|69502328|FG000|Treatment Phase (up to 42 Months)|Death|0|||
37822499|NCT03281304|69502329|FG001|Treatment Phase (up to 42 Months)|Death|1|||
37822500|NCT03281304|69502328|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
37822501|NCT03281304|69502329|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
37822502|NCT03281304|69502328|FG000|Treatment Phase (up to 42 Months)|Other|0|||
37822503|NCT03281304|69502329|FG001|Treatment Phase (up to 42 Months)|Other|2|||
37822504|NCT03281304|69502328|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
37822505|NCT03281304|69502329|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
37822506|NCT03204305|69502338|FG000|Overall Study|Lost to Follow-up|6|||
37822507|NCT03204305|69502339|FG001|Overall Study|Lost to Follow-up|4|||
37822508|NCT03204305|69502340|FG002|Overall Study|Lost to Follow-up|0|||
37822509|NCT03204305|69502341|FG003|Overall Study|Lost to Follow-up|0|||
37822510|NCT03204305|69502338|FG000|Overall Study|Physician Decision|1|||
37822511|NCT03204305|69502339|FG001|Overall Study|Physician Decision|0|||
37822512|NCT03204305|69502340|FG002|Overall Study|Physician Decision|0|||
37822513|NCT03204305|69502341|FG003|Overall Study|Physician Decision|0|||
37822514|NCT03204305|69502338|FG000|Overall Study|failure to place arterial line|2|||
37822515|NCT03204305|69502339|FG001|Overall Study|failure to place arterial line|1|||
37822516|NCT03204305|69502340|FG002|Overall Study|failure to place arterial line|0|||
37822517|NCT03204305|69502341|FG003|Overall Study|failure to place arterial line|0|||
37822518|NCT03204305|69502338|FG000|Overall Study|Withdrawal by Subject|2|||
37822519|NCT03204305|69502339|FG001|Overall Study|Withdrawal by Subject|0|||
37822520|NCT03204305|69502340|FG002|Overall Study|Withdrawal by Subject|0|||
37822521|NCT03204305|69502341|FG003|Overall Study|Withdrawal by Subject|0|||
37822522|NCT03200717|69502353|FG000|Overall Study|Progressive disease|24|||
37822523|NCT03200717|69502354|FG001|Overall Study|Progressive disease|5|||
37822524|NCT03200717|69502353|FG000|Overall Study|Adverse Event|11|||
37822525|NCT03200717|69502354|FG001|Overall Study|Adverse Event|8|||
37822526|NCT03200717|69502353|FG000|Overall Study|Physician Decision|3|||
37822527|NCT03200717|69502354|FG001|Overall Study|Physician Decision|2|||
37822528|NCT03200717|69502353|FG000|Overall Study|Death|2|||
37822529|NCT03200717|69502354|FG001|Overall Study|Death|0|||
37822530|NCT03200717|69502353|FG000|Overall Study|Subject/Guardian Decision|1|||
37822531|NCT03200717|69502354|FG001|Overall Study|Subject/Guardian Decision|0|||
37822532|NCT03105700|69502363|FG000|Overall Study|screen fail|3|||
37822533|NCT03105700|69502363|FG000|Overall Study|Lost to Follow-up|4|||
37822534|NCT02738853|69502386|FG000|Enrollment|Inclusion/Exclusion not met|21|||
37822535|NCT02738853|69502386|FG000|Enrollment|Withdrawal by Subject|3|||
37822536|NCT02738853|69502386|FG000|Enrollment|Subject treated with commercially available device|6|||
37822537|NCT02738853|69502386|FG000|Enrollment|Study Enrollment Closed|3|||
37822538|NCT02738853|69502386|FG000|Procedure|Death|1|||
37822539|NCT02738853|69502386|FG000|1 Month|Death|2|||
37822540|NCT02738853|69502386|FG000|6 Month|Death|4|||
37822541|NCT02738853|69502386|FG000|6 Month|Withdrawal by Subject|2|||
37822542|NCT02738853|69502386|FG000|1 Year|Death|6|||
37822543|NCT02738853|69502386|FG000|1 Year|Withdrawal by Subject|1|||
37822544|NCT02738853|69502386|FG000|2 Year|Death|2|||
37887098|NCT00907257|69571800|FG001|Overall Study|Protocol Violation|2|||
37887099|NCT00907257|69571799|FG000|Overall Study|Lost to Follow-up|3|||
37887100|NCT00907257|69571800|FG001|Overall Study|Lost to Follow-up|3|||
37887101|NCT00907257|69571799|FG000|Overall Study|Withdrawal by Subject|1|||
37822545|NCT02738853|69502386|FG000|2 Year|Lost to Follow-up|1|||
37822546|NCT02738853|69502386|FG000|3 Year|Death|2|||
37822547|NCT02738853|69502386|FG000|3 Year|Withdrawal by Subject|1|||
37822548|NCT02738853|69502386|FG000|4 Year|Death|9|||
37822549|NCT02738853|69502386|FG000|5 Year|Lost to Follow-up|4|||
37822550|NCT02358538|69502394|FG000|Through Week 26|Adverse Event|0|||
37887102|NCT00907257|69571800|FG001|Overall Study|Withdrawal by Subject|2|||
37887103|NCT00907257|69571799|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
37822551|NCT02358538|69502395|FG001|Through Week 26|Adverse Event|1|||
37822552|NCT02358538|69502396|FG002|Through Week 26|Adverse Event|1|||
37822553|NCT02358538|69502397|FG003|Through Week 26|Adverse Event|2|||
37822554|NCT02358538|69502394|FG000|Through Week 26|Lack of Efficacy|1|||
37822555|NCT02358538|69502395|FG001|Through Week 26|Lack of Efficacy|1|||
37887104|NCT00907257|69571800|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
37887105|NCT00907257|69571799|FG000|Overall Study|Moved|1|||
37887106|NCT00907257|69571800|FG001|Overall Study|Moved|0|||
37887107|NCT00907257|69571799|FG000|Overall Study|Personal Reasons|6|||
37887108|NCT00907257|69571800|FG001|Overall Study|Personal Reasons|1|||
37887109|NCT01138046|69571806|FG000|Overall Study|Withdrawal due to death|6|||
37887110|NCT00876460|69571818|FG000|Combination Therapy Phase|Progressive disease|2|||
37887111|NCT00876460|69571819|FG001|Combination Therapy Phase|Progressive disease|3|||
37887112|NCT00876460|69571820|FG002|Combination Therapy Phase|Progressive disease|3|||
37887113|NCT00876460|69571821|FG003|Combination Therapy Phase|Progressive disease|3|||
37887114|NCT00876460|69571822|FG004|Combination Therapy Phase|Progressive disease|3|||
37887115|NCT00876460|69571823|FG005|Combination Therapy Phase|Progressive disease|1|||
37987142|NCT00279201|69672562|FG005|Maintenance|Physician Decision|0|||
37987143|NCT00279201|69672557|FG000|Maintenance|Sponsor Decision|4|||
37987144|NCT00279201|69672558|FG001|Maintenance|Sponsor Decision|0|||
37987145|NCT00279201|69672559|FG002|Maintenance|Sponsor Decision|0|||
37987146|NCT00279201|69672560|FG003|Maintenance|Sponsor Decision|0|||
37987147|NCT00279201|69672561|FG004|Maintenance|Sponsor Decision|0|||
37987148|NCT00279201|69672562|FG005|Maintenance|Sponsor Decision|0|||
37987149|NCT00279201|69672557|FG000|Maintenance|HbA1c>7.5%|123|||
37987150|NCT00279201|69672558|FG001|Maintenance|HbA1c>7.5%|126|||
37887116|NCT00876460|69571824|FG006|Combination Therapy Phase|Progressive disease|1|||
37887117|NCT00876460|69571825|FG007|Combination Therapy Phase|Progressive disease|1|||
37887118|NCT00876460|69571818|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
37887119|NCT00876460|69571819|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
37887120|NCT00876460|69571820|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
37887121|NCT00876460|69571821|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
37887122|NCT00876460|69571822|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
37887123|NCT00876460|69571823|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
37887124|NCT00876460|69571824|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
37887125|NCT00876460|69571825|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
37887126|NCT00876460|69571818|FG000|Combination Therapy Phase|Adverse Event|0|||
37887127|NCT00876460|69571819|FG001|Combination Therapy Phase|Adverse Event|2|||
37887128|NCT00876460|69571820|FG002|Combination Therapy Phase|Adverse Event|0|||
37987151|NCT00279201|69672559|FG002|Maintenance|HbA1c>7.5%|0|||
37987152|NCT00279201|69672560|FG003|Maintenance|HbA1c>7.5%|0|||
37987153|NCT00279201|69672561|FG004|Maintenance|HbA1c>7.5%|0|||
37987154|NCT00279201|69672562|FG005|Maintenance|HbA1c>7.5%|0|||
37887129|NCT00876460|69571821|FG003|Combination Therapy Phase|Adverse Event|2|||
37987155|NCT00279201|69672557|FG000|Intensification Addendum|Withdrawal by Subject|0|||
37887130|NCT00876460|69571822|FG004|Combination Therapy Phase|Adverse Event|2|||
37887131|NCT00876460|69571823|FG005|Combination Therapy Phase|Adverse Event|0|||
37887132|NCT00876460|69571824|FG006|Combination Therapy Phase|Adverse Event|3|||
37887133|NCT00876460|69571825|FG007|Combination Therapy Phase|Adverse Event|2|||
37887134|NCT00876460|69571818|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
37887135|NCT00876460|69571819|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
37887136|NCT00876460|69571820|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
37887137|NCT00876460|69571821|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
37887138|NCT00876460|69571822|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
37987156|NCT00279201|69672558|FG001|Intensification Addendum|Withdrawal by Subject|0|||
37987157|NCT00279201|69672559|FG002|Intensification Addendum|Withdrawal by Subject|12|||
37987158|NCT00279201|69672560|FG003|Intensification Addendum|Withdrawal by Subject|14|||
37987159|NCT00279201|69672561|FG004|Intensification Addendum|Withdrawal by Subject|9|||
37987160|NCT00279201|69672562|FG005|Intensification Addendum|Withdrawal by Subject|18|||
37987161|NCT00279201|69672557|FG000|Intensification Addendum|Lost to Follow-up|0|||
37987162|NCT00279201|69672558|FG001|Intensification Addendum|Lost to Follow-up|0|||
37987163|NCT00279201|69672559|FG002|Intensification Addendum|Lost to Follow-up|4|||
37987164|NCT00279201|69672560|FG003|Intensification Addendum|Lost to Follow-up|6|||
37987165|NCT00279201|69672561|FG004|Intensification Addendum|Lost to Follow-up|7|||
37987166|NCT00279201|69672562|FG005|Intensification Addendum|Lost to Follow-up|7|||
37987167|NCT00279201|69672557|FG000|Intensification Addendum|Protocol Violation|0|||
37987168|NCT00279201|69672558|FG001|Intensification Addendum|Protocol Violation|0|||
37987169|NCT00279201|69672559|FG002|Intensification Addendum|Protocol Violation|2|||
37987170|NCT00279201|69672560|FG003|Intensification Addendum|Protocol Violation|2|||
37987171|NCT00279201|69672561|FG004|Intensification Addendum|Protocol Violation|6|||
37987172|NCT00279201|69672562|FG005|Intensification Addendum|Protocol Violation|6|||
37987173|NCT00279201|69672557|FG000|Intensification Addendum|Adverse Event|0|||
37987174|NCT00279201|69672558|FG001|Intensification Addendum|Adverse Event|0|||
37987175|NCT00279201|69672559|FG002|Intensification Addendum|Adverse Event|0|||
37987176|NCT00279201|69672560|FG003|Intensification Addendum|Adverse Event|4|||
37987177|NCT00279201|69672561|FG004|Intensification Addendum|Adverse Event|1|||
37987178|NCT00279201|69672562|FG005|Intensification Addendum|Adverse Event|3|||
37987179|NCT00279201|69672557|FG000|Intensification Addendum|Physician Decision|0|||
37987180|NCT00279201|69672558|FG001|Intensification Addendum|Physician Decision|0|||
37987181|NCT00279201|69672559|FG002|Intensification Addendum|Physician Decision|4|||
37987182|NCT00279201|69672560|FG003|Intensification Addendum|Physician Decision|1|||
37987183|NCT00279201|69672561|FG004|Intensification Addendum|Physician Decision|3|||
37987184|NCT00279201|69672562|FG005|Intensification Addendum|Physician Decision|2|||
37987185|NCT00279201|69672557|FG000|Intensification Addendum|Sponsor Decision|0|||
37987186|NCT00279201|69672558|FG001|Intensification Addendum|Sponsor Decision|0|||
37987187|NCT00279201|69672559|FG002|Intensification Addendum|Sponsor Decision|0|||
37987188|NCT00279201|69672560|FG003|Intensification Addendum|Sponsor Decision|0|||
37987189|NCT00279201|69672561|FG004|Intensification Addendum|Sponsor Decision|1|||
37987190|NCT00279201|69672562|FG005|Intensification Addendum|Sponsor Decision|1|||
37987191|NCT00279201|69672557|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
37987192|NCT00279201|69672558|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
37987193|NCT00279201|69672559|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
37987194|NCT00279201|69672560|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
37987195|NCT00279201|69672561|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
37987196|NCT00279201|69672562|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
37987197|NCT00279201|69672557|FG000|Intensification Addendum|Lack of Efficacy|0|||
37987198|NCT00279201|69672558|FG001|Intensification Addendum|Lack of Efficacy|0|||
37987199|NCT00279201|69672559|FG002|Intensification Addendum|Lack of Efficacy|0|||
37987200|NCT00279201|69672560|FG003|Intensification Addendum|Lack of Efficacy|1|||
37987201|NCT00279201|69672561|FG004|Intensification Addendum|Lack of Efficacy|1|||
37987202|NCT00279201|69672562|FG005|Intensification Addendum|Lack of Efficacy|0|||
37987203|NCT00279201|69672557|FG000|Intensification Addendum|Death|0|||
37987204|NCT00279201|69672558|FG001|Intensification Addendum|Death|0|||
37987205|NCT00279201|69672559|FG002|Intensification Addendum|Death|0|||
37987206|NCT00279201|69672560|FG003|Intensification Addendum|Death|0|||
37987207|NCT00279201|69672561|FG004|Intensification Addendum|Death|1|||
37987208|NCT00279201|69672562|FG005|Intensification Addendum|Death|0|||
37987209|NCT00203476|69672598|FG000|Overall Study|Lost to Follow-up|1|||
37987210|NCT00203476|69672599|FG001|Overall Study|Lost to Follow-up|0|||
37987211|NCT00203476|69672600|FG002|Overall Study|Lost to Follow-up|0|||
37987212|NCT00203476|69672598|FG000|Overall Study|Withdrawal by Subject|0|||
37887139|NCT00876460|69571823|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
37887140|NCT00876460|69571824|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
37987213|NCT00203476|69672599|FG001|Overall Study|Withdrawal by Subject|1|||
37987214|NCT00203476|69672600|FG002|Overall Study|Withdrawal by Subject|0|||
37987215|NCT00203242|69672608|FG000|Overall Study|Lost to Follow-up|1|||
37987216|NCT00200356|69672614|FG000|Overall Study|Lack of Efficacy|3|||
37987217|NCT00200356|69672615|FG001|Overall Study|Lack of Efficacy|3|||
37887141|NCT00876460|69571825|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
37887142|NCT00876460|69571818|FG000|Combination Therapy Phase|Other reason not defined above|0|||
37887143|NCT00876460|69571819|FG001|Combination Therapy Phase|Other reason not defined above|0|||
37887144|NCT00876460|69571820|FG002|Combination Therapy Phase|Other reason not defined above|0|||
37887145|NCT00876460|69571821|FG003|Combination Therapy Phase|Other reason not defined above|0|||
37887146|NCT00876460|69571822|FG004|Combination Therapy Phase|Other reason not defined above|0|||
37887147|NCT00876460|69571823|FG005|Combination Therapy Phase|Other reason not defined above|0|||
37887148|NCT00876460|69571824|FG006|Combination Therapy Phase|Other reason not defined above|1|||
37887149|NCT00876460|69571825|FG007|Combination Therapy Phase|Other reason not defined above|2|||
37887150|NCT00876460|69571818|FG000|Combination Therapy Phase|Not treated|0|||
37887151|NCT00876460|69571819|FG001|Combination Therapy Phase|Not treated|0|||
37887152|NCT00876460|69571820|FG002|Combination Therapy Phase|Not treated|0|||
37887153|NCT00876460|69571821|FG003|Combination Therapy Phase|Not treated|0|||
37887154|NCT00876460|69571822|FG004|Combination Therapy Phase|Not treated|0|||
37887155|NCT00876460|69571823|FG005|Combination Therapy Phase|Not treated|0|||
37887156|NCT00876460|69571824|FG006|Combination Therapy Phase|Not treated|1|||
37887157|NCT00876460|69571825|FG007|Combination Therapy Phase|Not treated|0|||
37887158|NCT00876460|69571818|FG000|Mono Therapy Phase|Progressive disease|0|||
37887159|NCT00876460|69571819|FG001|Mono Therapy Phase|Progressive disease|0|||
37887160|NCT00876460|69571820|FG002|Mono Therapy Phase|Progressive disease|0|||
37887161|NCT00876460|69571821|FG003|Mono Therapy Phase|Progressive disease|0|||
37887162|NCT00876460|69571822|FG004|Mono Therapy Phase|Progressive disease|2|||
37887163|NCT00876460|69571823|FG005|Mono Therapy Phase|Progressive disease|0|||
37887164|NCT00876460|69571824|FG006|Mono Therapy Phase|Progressive disease|1|||
37887165|NCT00876460|69571825|FG007|Mono Therapy Phase|Progressive disease|3|||
37887166|NCT00876460|69571818|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
37887167|NCT00876460|69571819|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
37887168|NCT00876460|69571820|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
37887169|NCT00876460|69571821|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
37887170|NCT00876460|69571822|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
37887171|NCT00876460|69571823|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
37887172|NCT00876460|69571824|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
37987218|NCT00200356|69672614|FG000|Overall Study|Protocol Violation|4|||
37887173|NCT00876460|69571825|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
37887174|NCT00876460|69571818|FG000|Mono Therapy Phase|Adverse Event|0|||
37887175|NCT00876460|69571819|FG001|Mono Therapy Phase|Adverse Event|0|||
37887176|NCT00876460|69571820|FG002|Mono Therapy Phase|Adverse Event|0|||
37887177|NCT00876460|69571821|FG003|Mono Therapy Phase|Adverse Event|1|||
37887178|NCT00876460|69571822|FG004|Mono Therapy Phase|Adverse Event|0|||
37887179|NCT00876460|69571823|FG005|Mono Therapy Phase|Adverse Event|0|||
37887180|NCT00876460|69571824|FG006|Mono Therapy Phase|Adverse Event|0|||
37887181|NCT00876460|69571825|FG007|Mono Therapy Phase|Adverse Event|0|||
37887182|NCT00908115|69571855|FG000|Overall Study|Other|14|||
37887183|NCT01137812|69571861|FG000|Overall Study|Adverse Event|21|||
37887184|NCT01137812|69571862|FG001|Overall Study|Adverse Event|14|||
37887185|NCT01137812|69571861|FG000|Overall Study|Lost to Follow-up|6|||
37887186|NCT01137812|69571862|FG001|Overall Study|Lost to Follow-up|8|||
37887187|NCT01137812|69571861|FG000|Overall Study|Physician Decision|25|||
37887188|NCT01137812|69571862|FG001|Overall Study|Physician Decision|17|||
37887189|NCT01137812|69571861|FG000|Overall Study|Protocol Violation|5|||
37887190|NCT01137812|69571862|FG001|Overall Study|Protocol Violation|4|||
37887191|NCT01137812|69571861|FG000|Overall Study|Withdrawal by Subject|5|||
37887192|NCT01137812|69571862|FG001|Overall Study|Withdrawal by Subject|13|||
37887193|NCT01137812|69571861|FG000|Overall Study|Death|2|||
37887194|NCT01137812|69571862|FG001|Overall Study|Death|0|||
37887195|NCT01137812|69571861|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
37887196|NCT01137812|69571862|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
37887197|NCT01137812|69571861|FG000|Overall Study|Other|19|||
37887198|NCT01137812|69571862|FG001|Overall Study|Other|27|||
37887199|NCT01137578|69571868|FG000|Overall Study|Participant requested to Discontinue|3|||
37887200|NCT01137578|69571869|FG001|Overall Study|Participant requested to Discontinue|0|||
37695657|NCT02397278|69172019|FG000|Overall Study|Withdrawal by Subject|0|||
37887201|NCT01137578|69571870|FG002|Overall Study|Participant requested to Discontinue|0|||
37887202|NCT01137578|69571868|FG000|Overall Study|Withdrawal by Subject|1|||
37887203|NCT01137578|69571869|FG001|Overall Study|Withdrawal by Subject|0|||
37887204|NCT01137578|69571870|FG002|Overall Study|Withdrawal by Subject|0|||
37887205|NCT01137578|69571868|FG000|Overall Study|Other|12|||
37887206|NCT01137578|69571869|FG001|Overall Study|Other|2|||
37887207|NCT01137578|69571870|FG002|Overall Study|Other|6|||
37887208|NCT00946920|69571900|FG000|Overall Study|Withdrawal by Subject|28|||
37887209|NCT00946920|69571901|FG001|Overall Study|Withdrawal by Subject|15|||
37887210|NCT00946920|69571900|FG000|Overall Study|Lost to Follow-up|2|||
37887211|NCT00946920|69571901|FG001|Overall Study|Lost to Follow-up|2|||
37887212|NCT00946920|69571900|FG000|Overall Study|Physician Decision|5|||
37887213|NCT00946920|69571901|FG001|Overall Study|Physician Decision|2|||
37887214|NCT00946920|69571900|FG000|Overall Study|Adverse Event|41|||
37887215|NCT00946920|69571901|FG001|Overall Study|Adverse Event|14|||
37887216|NCT00946920|69571900|FG000|Overall Study|Protocol Violation|16|||
37887217|NCT00946920|69571901|FG001|Overall Study|Protocol Violation|8|||
37887218|NCT00946920|69571900|FG000|Overall Study|Miscellaneous reasons|18|||
37887219|NCT00946920|69571901|FG001|Overall Study|Miscellaneous reasons|3|||
37887220|NCT00946530|69571911|FG000|Overall Study|Withdrawal by Subject|0|||
37887221|NCT00946530|69571912|FG001|Overall Study|Withdrawal by Subject|3|||
37887222|NCT00946530|69571913|FG002|Overall Study|Withdrawal by Subject|0|||
37887223|NCT00946530|69571914|FG003|Overall Study|Withdrawal by Subject|3|||
37887224|NCT00946530|69571911|FG000|Overall Study|Physician Decision|1|||
37887225|NCT00946530|69571912|FG001|Overall Study|Physician Decision|1|||
37887226|NCT00946530|69571913|FG002|Overall Study|Physician Decision|1|||
37887227|NCT00946530|69571914|FG003|Overall Study|Physician Decision|1|||
37887228|NCT00946296|69571930|FG000|Overall Study|Physician Decision|3|||
37887229|NCT00946296|69571931|FG001|Overall Study|Physician Decision|0|||
37887230|NCT00945906|69571937|FG000|Overall Study|Withdrawal by Subject|1|||
37887231|NCT00945906|69571937|FG000|Overall Study|Did not want to return for last visit|2|||
37987219|NCT00200356|69672615|FG001|Overall Study|Protocol Violation|4|||
37887232|NCT00945906|69571937|FG000|Overall Study|Unable to return for last visit|2|||
37887233|NCT00945906|69571937|FG000|Overall Study|Moved to another country|2|||
37887234|NCT00594646|69571941|FG000|Overall Study|Withdrawal by Subject|1|||
37987220|NCT00200356|69672614|FG000|Overall Study|Nontreatment|1|||
37987221|NCT00200356|69672615|FG001|Overall Study|Nontreatment|0|||
37987222|NCT00227344|69672623|FG000|Overall Study|study terminated early|12|||
37987223|NCT00227344|69672624|FG001|Overall Study|study terminated early|5|||
37987224|NCT00227266|69672633|FG000|Overall Study|Withdrawal by Subject|0|||
37987225|NCT00227266|69672634|FG001|Overall Study|Withdrawal by Subject|0|||
37987226|NCT00227266|69672635|FG002|Overall Study|Withdrawal by Subject|1|||
37987227|NCT00227266|69672633|FG000|Overall Study|Protocol Violation|1|||
37987228|NCT00227266|69672634|FG001|Overall Study|Protocol Violation|0|||
37822556|NCT02358538|69502396|FG002|Through Week 26|Lack of Efficacy|3|||
37822557|NCT02358538|69502397|FG003|Through Week 26|Lack of Efficacy|3|||
37822558|NCT02358538|69502394|FG000|Through Week 26|Withdrawal by Subject|1|||
37822559|NCT02358538|69502395|FG001|Through Week 26|Withdrawal by Subject|0|||
37822560|NCT02358538|69502396|FG002|Through Week 26|Withdrawal by Subject|0|||
37822561|NCT02358538|69502397|FG003|Through Week 26|Withdrawal by Subject|0|||
37822562|NCT02358538|69502394|FG000|Through Week 26|Non-Compliance|0|||
37822563|NCT02358538|69502395|FG001|Through Week 26|Non-Compliance|0|||
37822564|NCT02358538|69502396|FG002|Through Week 26|Non-Compliance|1|||
37822565|NCT02358538|69502397|FG003|Through Week 26|Non-Compliance|0|||
37822566|NCT02358538|69502394|FG000|Through Week 26|Family did not see benefit from IP|1|||
37887235|NCT00594646|69571941|FG000|Overall Study|Lost to Follow-up|15|||
37887236|NCT01111604|69571949|FG000|Overall Study|Lost to Follow-up|0|||
37887237|NCT01111604|69571950|FG001|Overall Study|Lost to Follow-up|0|||
37887238|NCT01111604|69571951|FG002|Overall Study|Lost to Follow-up|1|||
37887239|NCT01111604|69571949|FG000|Overall Study|Withdrew Consent|3|||
37887240|NCT01111604|69571950|FG001|Overall Study|Withdrew Consent|0|||
37887241|NCT01111604|69571951|FG002|Overall Study|Withdrew Consent|2|||
37987229|NCT00227266|69672635|FG002|Overall Study|Protocol Violation|1|||
37822567|NCT02358538|69502395|FG001|Through Week 26|Family did not see benefit from IP|0|||
37887242|NCT01111604|69571949|FG000|Overall Study|Withdrawal by Subject|2|||
37887243|NCT01111604|69571950|FG001|Overall Study|Withdrawal by Subject|0|||
37887244|NCT01111604|69571951|FG002|Overall Study|Withdrawal by Subject|0|||
37887245|NCT01111604|69571949|FG000|Overall Study|Death|1|||
37887246|NCT01111604|69571950|FG001|Overall Study|Death|0|||
37987230|NCT00227266|69672633|FG000|Overall Study|Excessive weight gain|0|||
37987231|NCT00227266|69672634|FG001|Overall Study|Excessive weight gain|0|||
37987232|NCT00227266|69672635|FG002|Overall Study|Excessive weight gain|2|||
37987233|NCT00256282|69672646|FG000|Overall Study|Disease progression, relapse during acti|12|||
37987234|NCT00256282|69672646|FG000|Overall Study|Adverse Event|3|||
37987235|NCT00256282|69672646|FG000|Overall Study|Physician Decision|1|||
37987236|NCT00266877|69672653|FG000|Overall Study|Death|1|||
37987237|NCT00266877|69672654|FG001|Overall Study|Death|1|||
37987238|NCT00266877|69672655|FG002|Overall Study|Death|1|||
37987239|NCT00266877|69672653|FG000|Overall Study|Adverse Event|6|||
37987240|NCT00266877|69672654|FG001|Overall Study|Adverse Event|4|||
37987241|NCT00266877|69672655|FG002|Overall Study|Adverse Event|1|||
37987242|NCT00266877|69672653|FG000|Overall Study|Physician Decision|2|||
37987243|NCT00266877|69672654|FG001|Overall Study|Physician Decision|1|||
37987244|NCT00266877|69672655|FG002|Overall Study|Physician Decision|1|||
37987245|NCT00266877|69672653|FG000|Overall Study|Withdrawal by Subject|3|||
37987246|NCT00266877|69672654|FG001|Overall Study|Withdrawal by Subject|1|||
37987247|NCT00266877|69672655|FG002|Overall Study|Withdrawal by Subject|1|||
37987248|NCT00266877|69672653|FG000|Overall Study|Disease Progression|72|||
37987249|NCT00266877|69672654|FG001|Overall Study|Disease Progression|37|||
37887247|NCT01111604|69571951|FG002|Overall Study|Death|0|||
37887248|NCT01111604|69571949|FG000|Overall Study|Met Exclusion Criteria|2|||
37887249|NCT01111604|69571950|FG001|Overall Study|Met Exclusion Criteria|0|||
37887250|NCT01111604|69571951|FG002|Overall Study|Met Exclusion Criteria|0|||
37987250|NCT00266877|69672655|FG002|Overall Study|Disease Progression|23|||
37887251|NCT00950742|69571979|FG000|Overall Study|Other Adverse Event|1|||
37887252|NCT00950742|69571980|FG001|Overall Study|Other Adverse Event|0|||
37887253|NCT00950742|69571979|FG000|Overall Study|Withdrawal by Subject|3|||
37887254|NCT00950742|69571980|FG001|Overall Study|Withdrawal by Subject|0|||
37887255|NCT00950742|69571979|FG000|Overall Study|Progressive Disease|6|||
37887256|NCT00950742|69571980|FG001|Overall Study|Progressive Disease|2|||
37887257|NCT00950742|69571979|FG000|Overall Study|Dose limiting toxicity|6|||
37887258|NCT00950742|69571980|FG001|Overall Study|Dose limiting toxicity|0|||
37695658|NCT02397278|69172020|FG001|Overall Study|Withdrawal by Subject|2|||
37695659|NCT02397278|69172019|FG000|Overall Study|Deemed ineligible following surgery|1|||
37695660|NCT02397278|69172020|FG001|Overall Study|Deemed ineligible following surgery|1|||
37695661|NCT02360228|69172029|FG000|Overall Study|Withdrawal by Subject|1|||
37695662|NCT02360228|69172030|FG001|Overall Study|Withdrawal by Subject|0|||
37695663|NCT02360228|69172031|FG002|Overall Study|Withdrawal by Subject|0|||
37695664|NCT02360228|69172029|FG000|Overall Study|Self-discontinued medication|0|||
37822568|NCT02358538|69502396|FG002|Through Week 26|Family did not see benefit from IP|0|||
37822569|NCT02358538|69502397|FG003|Through Week 26|Family did not see benefit from IP|0|||
37822570|NCT02358538|69502394|FG000|52 Week Extension Period|Lack of Efficacy|0|||
37822571|NCT02358538|69502395|FG001|52 Week Extension Period|Lack of Efficacy|0|||
37822572|NCT02358538|69502396|FG002|52 Week Extension Period|Lack of Efficacy|2|||
37822573|NCT02358538|69502397|FG003|52 Week Extension Period|Lack of Efficacy|4|||
37822574|NCT02056119|69502432|FG000|Overall Study|Death|1|||
37822575|NCT02056119|69502433|FG001|Overall Study|Death|2|||
37822576|NCT02056119|69502432|FG000|Overall Study|Intubated for less than 24 hrs|2|||
37822577|NCT02056119|69502433|FG001|Overall Study|Intubated for less than 24 hrs|7|||
37822578|NCT02056119|69502432|FG000|Overall Study|No aerosol treatments were given.|3|||
37822579|NCT02056119|69502433|FG001|Overall Study|No aerosol treatments were given.|2|||
37822580|NCT02056119|69502432|FG000|Overall Study|Received Metaneb treatment|0|||
37987251|NCT00266877|69672653|FG000|Overall Study|Symptomatic Deterioration|6|||
37987252|NCT00266877|69672654|FG001|Overall Study|Symptomatic Deterioration|3|||
37987253|NCT00266877|69672655|FG002|Overall Study|Symptomatic Deterioration|1|||
37822581|NCT02056119|69502433|FG001|Overall Study|Received Metaneb treatment|2|||
37822582|NCT02056119|69502432|FG000|Overall Study|Protocol Violation|4|||
37822583|NCT02056119|69502433|FG001|Overall Study|Protocol Violation|7|||
37987254|NCT00266877|69672653|FG000|Overall Study|Hospitalization|1|||
37987255|NCT00266877|69672654|FG001|Overall Study|Hospitalization|0|||
37987256|NCT00266877|69672655|FG002|Overall Study|Hospitalization|0|||
37695665|NCT02360228|69172030|FG001|Overall Study|Self-discontinued medication|1|||
37695666|NCT02360228|69172031|FG002|Overall Study|Self-discontinued medication|0|||
37695667|NCT02360228|69172029|FG000|Overall Study|Unstable symptoms during screening|0|||
37695668|NCT02360228|69172030|FG001|Overall Study|Unstable symptoms during screening|0|||
37695669|NCT02360228|69172031|FG002|Overall Study|Unstable symptoms during screening|1|||
37695670|NCT02359994|69172041|FG000|Overall Population Study|Adverse Event|1|||
37695671|NCT02359994|69172042|FG001|Overall Population Study|Adverse Event|1|||
37695672|NCT02359994|69172041|FG000|Overall Population Study|Death|1|||
37695673|NCT02359994|69172042|FG001|Overall Population Study|Death|5|||
37695674|NCT02359994|69172041|FG000|Overall Population Study|Lost to Follow-up|1|||
37695675|NCT02359994|69172042|FG001|Overall Population Study|Lost to Follow-up|1|||
37695676|NCT02359994|69172041|FG000|Overall Population Study|Withdrawal by Subject|1|||
37695677|NCT02359994|69172042|FG001|Overall Population Study|Withdrawal by Subject|0|||
37695678|NCT02359994|69172041|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
37695679|NCT02359994|69172042|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
37695680|NCT02359994|69172041|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
37695681|NCT02359994|69172042|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
37695682|NCT02359994|69172041|FG000|Extended Oncology 24-Month Survival|Death|19|||
37822584|NCT02038452|69502441|FG000|Overall Study|Withdrawal by Subject|7|||
37822585|NCT02038452|69502442|FG001|Overall Study|Withdrawal by Subject|9|||
37822586|NCT02038452|69502441|FG000|Overall Study|Lost to Follow-up|31|||
37822587|NCT02038452|69502442|FG001|Overall Study|Lost to Follow-up|28|||
37822588|NCT01238172|69502481|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
37822589|NCT01238172|69502482|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
37822590|NCT01238172|69502481|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
37822591|NCT01238172|69502482|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
37822592|NCT00967005|69502490|FG000|Overall Study|Lost to Follow-up|7|||
37822593|NCT00967005|69502491|FG001|Overall Study|Lost to Follow-up|10|||
37822594|NCT00203996|69502549|FG000|Overall Study|Lost to Follow-up|0|||
37822595|NCT00203996|69502550|FG001|Overall Study|Lost to Follow-up|0|||
37822596|NCT00203996|69502551|FG002|Overall Study|Lost to Follow-up|0|||
37822597|NCT00203996|69502552|FG003|Overall Study|Lost to Follow-up|1|||
37822598|NCT00203996|69502553|FG004|Overall Study|Lost to Follow-up|0|||
37822599|NCT00203996|69502554|FG005|Overall Study|Lost to Follow-up|0|||
37822600|NCT00203996|69502555|FG006|Overall Study|Lost to Follow-up|0|||
37822601|NCT00203996|69502556|FG007|Overall Study|Lost to Follow-up|0|||
37822602|NCT00203996|69502557|FG008|Overall Study|Lost to Follow-up|0|||
37822603|NCT00203996|69502558|FG009|Overall Study|Lost to Follow-up|0|||
37822604|NCT00203996|69502549|FG000|Overall Study|Protocol Violation|0|||
37822605|NCT00203996|69502550|FG001|Overall Study|Protocol Violation|0|||
37822606|NCT00203996|69502551|FG002|Overall Study|Protocol Violation|0|||
37822607|NCT00203996|69502552|FG003|Overall Study|Protocol Violation|6|||
37822608|NCT00203996|69502553|FG004|Overall Study|Protocol Violation|1|||
37822609|NCT00203996|69502554|FG005|Overall Study|Protocol Violation|0|||
37822610|NCT00203996|69502555|FG006|Overall Study|Protocol Violation|0|||
37987257|NCT00266877|69672653|FG000|Overall Study|Concomitant Radiotherapy|0|||
37987258|NCT00266877|69672654|FG001|Overall Study|Concomitant Radiotherapy|1|||
37987259|NCT00266877|69672655|FG002|Overall Study|Concomitant Radiotherapy|0|||
37987260|NCT00256204|69672667|FG000|Overall Study|Adverse Event|10|||
37987261|NCT00256204|69672668|FG001|Overall Study|Adverse Event|14|||
37987262|NCT00256204|69672669|FG002|Overall Study|Adverse Event|16|||
37987263|NCT00256204|69672670|FG003|Overall Study|Adverse Event|14|||
37987264|NCT00256204|69672667|FG000|Overall Study|Death|0|||
37987265|NCT00256204|69672668|FG001|Overall Study|Death|1|||
37987266|NCT00256204|69672669|FG002|Overall Study|Death|0|||
37987267|NCT00256204|69672670|FG003|Overall Study|Death|0|||
37987268|NCT00256204|69672667|FG000|Overall Study|Lost to Follow-up|1|||
37987269|NCT00256204|69672668|FG001|Overall Study|Lost to Follow-up|1|||
37987270|NCT00256204|69672669|FG002|Overall Study|Lost to Follow-up|1|||
37987271|NCT00256204|69672670|FG003|Overall Study|Lost to Follow-up|2|||
37987272|NCT00256204|69672667|FG000|Overall Study|Protocol Violation|1|||
37987273|NCT00256204|69672668|FG001|Overall Study|Protocol Violation|0|||
37987274|NCT00256204|69672669|FG002|Overall Study|Protocol Violation|2|||
37822611|NCT00203996|69502556|FG007|Overall Study|Protocol Violation|0|||
37822612|NCT00203996|69502557|FG008|Overall Study|Protocol Violation|0|||
37822613|NCT00203996|69502558|FG009|Overall Study|Protocol Violation|0|||
37887259|NCT00955110|69571990|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
37987275|NCT00256204|69672670|FG003|Overall Study|Protocol Violation|1|||
37987276|NCT00256204|69672667|FG000|Overall Study|Physician Decision|0|||
37987277|NCT00256204|69672668|FG001|Overall Study|Physician Decision|0|||
37987278|NCT00256204|69672669|FG002|Overall Study|Physician Decision|1|||
37987279|NCT00256204|69672670|FG003|Overall Study|Physician Decision|2|||
37987280|NCT00256204|69672667|FG000|Overall Study|Withdrawal by Subject|17|||
37987281|NCT00256204|69672668|FG001|Overall Study|Withdrawal by Subject|6|||
37987282|NCT00256204|69672669|FG002|Overall Study|Withdrawal by Subject|7|||
37987283|NCT00256204|69672670|FG003|Overall Study|Withdrawal by Subject|5|||
37987284|NCT00256204|69672667|FG000|Overall Study|Need for additional prohibited treatment|38|||
37987285|NCT00256204|69672668|FG001|Overall Study|Need for additional prohibited treatment|28|||
37987286|NCT00256204|69672669|FG002|Overall Study|Need for additional prohibited treatment|27|||
37987287|NCT00256204|69672670|FG003|Overall Study|Need for additional prohibited treatment|25|||
37987288|NCT00256126|69672685|FG000|Overall Study|Adverse Event|1|||
37987289|NCT00256126|69672686|FG001|Overall Study|Adverse Event|0|||
37987290|NCT00256126|69672685|FG000|Overall Study|Other|1|||
37987291|NCT00256126|69672686|FG001|Overall Study|Other|2|||
37987292|NCT00278889|69672695|FG000|Overall Study|Withdrawal by Subject|0|||
37987293|NCT00278889|69672696|FG001|Overall Study|Withdrawal by Subject|5|||
37987294|NCT00278889|69672697|FG002|Overall Study|Withdrawal by Subject|3|||
37987295|NCT00278889|69672695|FG000|Overall Study|Lost to Follow-up|1|||
37987296|NCT00278889|69672696|FG001|Overall Study|Lost to Follow-up|1|||
37987297|NCT00278889|69672697|FG002|Overall Study|Lost to Follow-up|0|||
37987298|NCT00278889|69672695|FG000|Overall Study|Death|24|||
37987299|NCT00278889|69672696|FG001|Overall Study|Death|21|||
37987300|NCT00278889|69672697|FG002|Overall Study|Death|17|||
37987301|NCT00278109|69672705|FG000|Overall Study|Adverse Event|3|||
37987302|NCT00278109|69672705|FG000|Overall Study|social circumstances|1|||
37987303|NCT00296517|69672711|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
37987304|NCT00296517|69672712|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
37987305|NCT00296517|69672711|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
37987306|NCT00296517|69672712|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
37987307|NCT00296517|69672711|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
37822614|NCT00203996|69502549|FG000|Overall Study|Physician Decision|0|||
37822615|NCT00203996|69502550|FG001|Overall Study|Physician Decision|0|||
37887260|NCT00955110|69571990|FG000|Treatment Phase|Adverse Event|2|||
37887261|NCT00955110|69571990|FG000|Treatment Phase|Administrative reasons|2|||
37887262|NCT00955110|69571990|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
37887263|NCT00955110|69571990|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
37887264|NCT00950664|69572004|FG000|First Intervention|Lost to Follow-up|1|||
37887265|NCT00950664|69572005|FG001|First Intervention|Lost to Follow-up|3|||
37887266|NCT00950664|69572004|FG000|First Intervention|Withdrawal by Subject|2|||
37887267|NCT00950664|69572005|FG001|First Intervention|Withdrawal by Subject|2|||
37887268|NCT01111526|69572011|FG000|Overall Study|GVHD Disease Progression|0|||
37887269|NCT01111526|69572012|FG001|Overall Study|GVHD Disease Progression|1|||
37887270|NCT01111526|69572013|FG002|Overall Study|GVHD Disease Progression|2|||
37887271|NCT01111292|69572019|FG000|Treatment|Physician Decision|1|||
37887272|NCT01111292|69572020|FG001|Treatment|Physician Decision|1|||
37887273|NCT00944658|69572028|FG000|Treatment 12 Weeks|Adverse Event|0|||
37822616|NCT00203996|69502551|FG002|Overall Study|Physician Decision|0|||
37822617|NCT00203996|69502552|FG003|Overall Study|Physician Decision|2|||
37822618|NCT00203996|69502553|FG004|Overall Study|Physician Decision|0|||
37822619|NCT00203996|69502554|FG005|Overall Study|Physician Decision|0|||
37822620|NCT00203996|69502555|FG006|Overall Study|Physician Decision|0|||
37822621|NCT00203996|69502556|FG007|Overall Study|Physician Decision|0|||
37822622|NCT00203996|69502557|FG008|Overall Study|Physician Decision|0|||
37887274|NCT00944658|69572029|FG001|Treatment 12 Weeks|Adverse Event|2|||
37887275|NCT01110200|69572037|FG000|Overall Study|Adverse Event|28|||
37887276|NCT01110200|69572038|FG001|Overall Study|Adverse Event|28|||
37887277|NCT01110200|69572037|FG000|Overall Study|Withdrawal by Subject|25|||
37887278|NCT01110200|69572038|FG001|Overall Study|Withdrawal by Subject|32|||
37987308|NCT00296517|69672712|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
37987309|NCT00296517|69672711|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
37987310|NCT00296517|69672712|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
37987311|NCT00296517|69672711|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
37987312|NCT00296517|69672712|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
37822623|NCT00203996|69502558|FG009|Overall Study|Physician Decision|1|||
37822624|NCT00203996|69502549|FG000|Overall Study|CPAP machine malfunction|0|||
37822625|NCT00203996|69502550|FG001|Overall Study|CPAP machine malfunction|0|||
37887279|NCT01110200|69572037|FG000|Overall Study|Lack of Efficacy|16|||
37887280|NCT01110200|69572038|FG001|Overall Study|Lack of Efficacy|25|||
37887281|NCT01110200|69572037|FG000|Overall Study|Protocol Violation|14|||
37887282|NCT01110200|69572038|FG001|Overall Study|Protocol Violation|12|||
37887283|NCT01110200|69572037|FG000|Overall Study|Physician Decision|13|||
37887284|NCT01110200|69572038|FG001|Overall Study|Physician Decision|17|||
37887285|NCT01110200|69572037|FG000|Overall Study|Lost to Follow-up|10|||
37887286|NCT01110200|69572038|FG001|Overall Study|Lost to Follow-up|7|||
37887287|NCT01108796|69572048|FG000|Overall Study|Adverse Event|0|||
37887288|NCT01108796|69572049|FG001|Overall Study|Adverse Event|1|||
37887289|NCT01108796|69572048|FG000|Overall Study|Lost to Follow-up|7|||
37887290|NCT01108796|69572049|FG001|Overall Study|Lost to Follow-up|6|||
37887291|NCT01108718|69572059|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
37887292|NCT01108718|69572060|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
37887293|NCT01137110|69572067|FG000|Overall Study|Protocol Violation|1|||
37887294|NCT01137110|69572068|FG001|Overall Study|Protocol Violation|0|||
37887295|NCT01136954|69572076|FG000|Overall Study|Adverse Event|3|||
37887296|NCT01136954|69572077|FG001|Overall Study|Adverse Event|2|||
37887297|NCT01136954|69572076|FG000|Overall Study|Withdrawal by Subject|6|||
37887298|NCT01136954|69572077|FG001|Overall Study|Withdrawal by Subject|2|||
37887299|NCT01136954|69572076|FG000|Overall Study|Lack of Efficacy|14|||
37887300|NCT01136954|69572077|FG001|Overall Study|Lack of Efficacy|13|||
37887301|NCT01136954|69572076|FG000|Overall Study|Physician Decision|0|||
37887302|NCT01136954|69572077|FG001|Overall Study|Physician Decision|1|||
37887303|NCT01136954|69572076|FG000|Overall Study|Other|1|||
37987313|NCT00296517|69672711|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
37987314|NCT00296517|69672712|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
37987315|NCT00296517|69672711|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
37987316|NCT00296517|69672712|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
37987317|NCT00296517|69672711|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
37987318|NCT00296517|69672712|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
37695683|NCT02359994|69172042|FG001|Extended Oncology 24-Month Survival|Death|21|||
37695684|NCT02359994|69172041|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
37695685|NCT02359994|69172042|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
37822626|NCT00203996|69502551|FG002|Overall Study|CPAP machine malfunction|0|||
37822627|NCT00203996|69502552|FG003|Overall Study|CPAP machine malfunction|1|||
37822628|NCT00203996|69502553|FG004|Overall Study|CPAP machine malfunction|0|||
37822629|NCT00203996|69502554|FG005|Overall Study|CPAP machine malfunction|0|||
37822630|NCT00203996|69502555|FG006|Overall Study|CPAP machine malfunction|0|||
37822631|NCT00203996|69502556|FG007|Overall Study|CPAP machine malfunction|0|||
37822632|NCT00203996|69502557|FG008|Overall Study|CPAP machine malfunction|0|||
37822633|NCT00203996|69502558|FG009|Overall Study|CPAP machine malfunction|0|||
37822634|NCT00203996|69502549|FG000|Overall Study|Scheduling issue|0|||
37822635|NCT00203996|69502550|FG001|Overall Study|Scheduling issue|0|||
37822636|NCT00203996|69502551|FG002|Overall Study|Scheduling issue|0|||
37822637|NCT00203996|69502552|FG003|Overall Study|Scheduling issue|0|||
37822638|NCT00203996|69502553|FG004|Overall Study|Scheduling issue|0|||
37822639|NCT00203996|69502554|FG005|Overall Study|Scheduling issue|0|||
37822640|NCT00203996|69502555|FG006|Overall Study|Scheduling issue|0|||
37822641|NCT00203996|69502556|FG007|Overall Study|Scheduling issue|2|||
37822642|NCT00203996|69502557|FG008|Overall Study|Scheduling issue|0|||
37822643|NCT00203996|69502558|FG009|Overall Study|Scheduling issue|0|||
37822644|NCT02014558|69502587|FG000|Overall Study|Never Received Study Drug|0|||
37822645|NCT02014558|69502588|FG001|Overall Study|Never Received Study Drug|0|||
37822646|NCT02014558|69502589|FG002|Overall Study|Never Received Study Drug|0|||
37822647|NCT02014558|69502590|FG003|Overall Study|Never Received Study Drug|0|||
37822648|NCT02014558|69502591|FG004|Overall Study|Never Received Study Drug|1|||
37822649|NCT02014558|69502592|FG005|Overall Study|Never Received Study Drug|0|||
37887304|NCT01136954|69572077|FG001|Overall Study|Other|3|||
37887305|NCT01136876|69572086|FG000|Overall Study|Lost to Follow-up|0|||
37887306|NCT01136876|69572087|FG001|Overall Study|Lost to Follow-up|1|||
37822650|NCT02014558|69502593|FG006|Overall Study|Never Received Study Drug|1|||
37822651|NCT02014558|69502594|FG007|Overall Study|Never Received Study Drug|0|||
37822652|NCT02014558|69502595|FG008|Overall Study|Never Received Study Drug|2|||
37887307|NCT01136876|69572086|FG000|Overall Study|Physician Decision|3|||
37887308|NCT01136876|69572087|FG001|Overall Study|Physician Decision|5|||
37887309|NCT01136876|69572086|FG000|Overall Study|Missing NGAL measurement|2|||
37887310|NCT01136876|69572087|FG001|Overall Study|Missing NGAL measurement|5|||
37887311|NCT01105130|69572098|FG000|Overall Study|Withdrawal by Subject|4|||
37887312|NCT01105130|69572099|FG001|Overall Study|Withdrawal by Subject|6|||
37887313|NCT01105130|69572100|FG002|Overall Study|Withdrawal by Subject|2|||
37987319|NCT00296517|69672711|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
37987320|NCT00296517|69672712|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
37822653|NCT02014558|69502596|FG009|Overall Study|Never Received Study Drug|0|||
37822654|NCT02014558|69502597|FG010|Overall Study|Never Received Study Drug|2|||
37822655|NCT02014558|69502598|FG011|Overall Study|Never Received Study Drug|2|||
37822656|NCT02014558|69502599|FG012|Overall Study|Never Received Study Drug|0|||
37695686|NCT02326298|69172051|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
37695687|NCT02326298|69172052|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
37695688|NCT02326298|69172053|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
37695689|NCT02326298|69172054|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
37695690|NCT02326298|69172055|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
37695691|NCT02326298|69172056|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
37695692|NCT02326298|69172057|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
37695693|NCT02326298|69172058|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
37695694|NCT02326298|69172059|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
37695695|NCT02326298|69172060|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
37695696|NCT02326298|69172061|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
37695697|NCT02326298|69172062|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
37695698|NCT02326298|69172063|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
37695699|NCT02326298|69172064|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
37695700|NCT02326298|69172051|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
37695701|NCT02326298|69172052|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
37695702|NCT02326298|69172053|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
37695703|NCT02326298|69172054|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
37695704|NCT02326298|69172055|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
37695705|NCT02326298|69172056|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
37695706|NCT02326298|69172057|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
37695707|NCT02326298|69172058|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
37695708|NCT02326298|69172059|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
37887314|NCT01105130|69572098|FG000|Overall Study|Never Started|2|||
37695709|NCT02326298|69172060|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
37695710|NCT02326298|69172061|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
37695711|NCT02326298|69172062|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
37695712|NCT02326298|69172063|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
37695713|NCT02326298|69172064|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
37695714|NCT02326298|69172051|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
37695715|NCT02326298|69172052|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
37695716|NCT02326298|69172053|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
37695717|NCT02326298|69172054|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
37695718|NCT02326298|69172055|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
37695719|NCT02326298|69172056|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
37695720|NCT02326298|69172057|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
37695721|NCT02326298|69172058|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
37695722|NCT02326298|69172059|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
37695723|NCT02326298|69172060|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
37695724|NCT02326298|69172061|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
37695725|NCT02326298|69172062|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
37695726|NCT02326298|69172063|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
37695727|NCT02326298|69172064|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
37695728|NCT02326298|69172051|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
37695729|NCT02326298|69172052|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
37695730|NCT02326298|69172053|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
37695731|NCT02326298|69172054|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
37695732|NCT02326298|69172055|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
37695733|NCT02326298|69172056|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
37695734|NCT02326298|69172057|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
37695735|NCT02326298|69172058|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
37887315|NCT01105130|69572099|FG001|Overall Study|Never Started|2|||
37887316|NCT01105130|69572100|FG002|Overall Study|Never Started|4|||
37887317|NCT01105130|69572098|FG000|Overall Study|Toxicity|1|||
37887318|NCT01105130|69572099|FG001|Overall Study|Toxicity|3|||
37887319|NCT01105130|69572100|FG002|Overall Study|Toxicity|2|||
37887320|NCT01105130|69572098|FG000|Overall Study|Multiple Reasons|3|||
37887321|NCT01105130|69572099|FG001|Overall Study|Multiple Reasons|0|||
37887322|NCT01105130|69572100|FG002|Overall Study|Multiple Reasons|2|||
37887323|NCT01108094|69572112|FG000|Overall Study|Adverse Event|2|||
37887324|NCT01108094|69572113|FG001|Overall Study|Adverse Event|0|||
37887325|NCT01108094|69572114|FG002|Overall Study|Adverse Event|0|||
37887326|NCT01108094|69572115|FG003|Overall Study|Adverse Event|0|||
37887327|NCT01108094|69572112|FG000|Overall Study|Withdrawal by Subject|1|||
37887328|NCT01108094|69572113|FG001|Overall Study|Withdrawal by Subject|0|||
37887329|NCT01108094|69572114|FG002|Overall Study|Withdrawal by Subject|0|||
37695736|NCT02326298|69172059|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
37695737|NCT02326298|69172060|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
37695738|NCT02326298|69172061|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
37695739|NCT02326298|69172062|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
37987321|NCT00224770|69672721|FG000|Overall Study|Lost to Follow-up|4|||
37987322|NCT00224770|69672722|FG001|Overall Study|Lost to Follow-up|2|||
37987323|NCT00224770|69672723|FG002|Overall Study|Lost to Follow-up|0|||
37987324|NCT00266409|69672736|FG000|Overall Study|Lack of Efficacy|2|||
37987325|NCT00266409|69672737|FG001|Overall Study|Lack of Efficacy|6|||
37695740|NCT02326298|69172063|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
37695741|NCT02326298|69172064|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
37695742|NCT02326298|69172051|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
37695743|NCT02326298|69172052|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
37987326|NCT00266409|69672738|FG002|Overall Study|Lack of Efficacy|1|||
37987327|NCT00266409|69672739|FG003|Overall Study|Lack of Efficacy|2|||
37987328|NCT00266409|69672736|FG000|Overall Study|Adverse Event|7|||
37987329|NCT00266409|69672737|FG001|Overall Study|Adverse Event|2|||
37987330|NCT00266409|69672738|FG002|Overall Study|Adverse Event|1|||
37987331|NCT00266409|69672739|FG003|Overall Study|Adverse Event|1|||
37987332|NCT00266409|69672736|FG000|Overall Study|Lost to Follow-up|18|||
37822657|NCT02014558|69502587|FG000|Overall Study|Adverse Event|0|||
37822658|NCT02014558|69502588|FG001|Overall Study|Adverse Event|0|||
37887330|NCT01108094|69572115|FG003|Overall Study|Withdrawal by Subject|0|||
37887331|NCT00954174|69572132|FG000|Overall Study|Adverse Event|28|||
37822659|NCT02014558|69502589|FG002|Overall Study|Adverse Event|0|||
37822660|NCT02014558|69502590|FG003|Overall Study|Adverse Event|0|||
37822661|NCT02014558|69502591|FG004|Overall Study|Adverse Event|1|||
37822662|NCT02014558|69502592|FG005|Overall Study|Adverse Event|0|||
37822663|NCT02014558|69502593|FG006|Overall Study|Adverse Event|0|||
37822664|NCT02014558|69502594|FG007|Overall Study|Adverse Event|0|||
37822665|NCT02014558|69502595|FG008|Overall Study|Adverse Event|2|||
37822666|NCT02014558|69502596|FG009|Overall Study|Adverse Event|2|||
37822667|NCT02014558|69502597|FG010|Overall Study|Adverse Event|5|||
37822668|NCT02014558|69502598|FG011|Overall Study|Adverse Event|21|||
37822669|NCT02014558|69502599|FG012|Overall Study|Adverse Event|3|||
37822670|NCT02014558|69502587|FG000|Overall Study|Death|1|||
37822671|NCT02014558|69502588|FG001|Overall Study|Death|0|||
37822672|NCT02014558|69502589|FG002|Overall Study|Death|0|||
37822673|NCT02014558|69502590|FG003|Overall Study|Death|0|||
37822674|NCT02014558|69502591|FG004|Overall Study|Death|0|||
37822675|NCT02014558|69502592|FG005|Overall Study|Death|0|||
37822676|NCT02014558|69502593|FG006|Overall Study|Death|1|||
37822677|NCT02014558|69502594|FG007|Overall Study|Death|1|||
37822678|NCT02014558|69502595|FG008|Overall Study|Death|2|||
37822679|NCT02014558|69502596|FG009|Overall Study|Death|5|||
37822680|NCT02014558|69502597|FG010|Overall Study|Death|5|||
37822681|NCT02014558|69502598|FG011|Overall Study|Death|19|||
37887332|NCT00954174|69572133|FG001|Overall Study|Adverse Event|23|||
37987333|NCT00266409|69672737|FG001|Overall Study|Lost to Follow-up|21|||
37987334|NCT00266409|69672738|FG002|Overall Study|Lost to Follow-up|6|||
37822682|NCT02014558|69502599|FG012|Overall Study|Death|2|||
37822683|NCT02014558|69502587|FG000|Overall Study|Lack of Efficacy|1|||
37822684|NCT02014558|69502588|FG001|Overall Study|Lack of Efficacy|2|||
37887333|NCT00954174|69572134|FG002|Overall Study|Adverse Event|4|||
37887334|NCT00954174|69572135|FG003|Overall Study|Adverse Event|9|||
37987335|NCT00266409|69672739|FG003|Overall Study|Lost to Follow-up|8|||
37987336|NCT00266409|69672736|FG000|Overall Study|Withdrawal by Subject|6|||
37987337|NCT00266409|69672737|FG001|Overall Study|Withdrawal by Subject|10|||
37822685|NCT02014558|69502589|FG002|Overall Study|Lack of Efficacy|1|||
37887335|NCT00954174|69572132|FG000|Overall Study|Death|4|||
37987338|NCT00266409|69672738|FG002|Overall Study|Withdrawal by Subject|3|||
37887336|NCT00954174|69572133|FG001|Overall Study|Death|2|||
37987339|NCT00266409|69672739|FG003|Overall Study|Withdrawal by Subject|9|||
37822686|NCT02014558|69502590|FG003|Overall Study|Lack of Efficacy|1|||
37822687|NCT02014558|69502591|FG004|Overall Study|Lack of Efficacy|0|||
37822688|NCT02014558|69502592|FG005|Overall Study|Lack of Efficacy|0|||
37822689|NCT02014558|69502593|FG006|Overall Study|Lack of Efficacy|1|||
37887337|NCT00954174|69572134|FG002|Overall Study|Death|0|||
37887338|NCT00954174|69572135|FG003|Overall Study|Death|0|||
37887339|NCT00954174|69572132|FG000|Overall Study|Lack of Efficacy|32|||
37887340|NCT00954174|69572133|FG001|Overall Study|Lack of Efficacy|22|||
37887341|NCT00954174|69572134|FG002|Overall Study|Lack of Efficacy|8|||
37887342|NCT00954174|69572135|FG003|Overall Study|Lack of Efficacy|6|||
37987340|NCT00266409|69672736|FG000|Overall Study|Protocol Violation|5|||
37987341|NCT00266409|69672737|FG001|Overall Study|Protocol Violation|3|||
37987342|NCT00266409|69672738|FG002|Overall Study|Protocol Violation|4|||
37987343|NCT00266409|69672739|FG003|Overall Study|Protocol Violation|2|||
37987344|NCT00266409|69672736|FG000|Overall Study|Other|7|||
37987345|NCT00266409|69672737|FG001|Overall Study|Other|4|||
37987346|NCT00266409|69672738|FG002|Overall Study|Other|2|||
37987347|NCT00266409|69672739|FG003|Overall Study|Other|0|||
37987348|NCT00277095|69672749|FG000|Overall Study|Death|2|||
37987349|NCT00277095|69672749|FG000|Overall Study|Explanted|7|||
37987350|NCT00277095|69672749|FG000|Overall Study|Lost to Follow-up|2|||
37987351|NCT00277095|69672749|FG000|Overall Study|Missed Follow-up|9|||
37987352|NCT00277095|69672749|FG000|Overall Study|Physician Decision|1|||
37987353|NCT00265785|69672753|FG000|Overall Study|Adverse Event|4|||
37987354|NCT00265785|69672753|FG000|Overall Study|Withdrawal by Subject|3|||
37987355|NCT00265785|69672753|FG000|Overall Study|Progression/Relapse|15|||
37987356|NCT00265785|69672753|FG000|Overall Study|Not protocol specified|2|||
37987357|NCT00265785|69672753|FG000|Overall Study|Ineligible|1|||
37987358|NCT00265785|69672753|FG000|Overall Study|Did not receive protocol treatment|2|||
37987359|NCT00276159|69672757|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
37987360|NCT00265395|69672763|FG000|Overall Study|Adverse Event|3|||
37987361|NCT00265395|69672764|FG001|Overall Study|Adverse Event|6|||
37987362|NCT00265395|69672763|FG000|Overall Study|Lost to Follow-up|2|||
37987363|NCT00265395|69672764|FG001|Overall Study|Lost to Follow-up|1|||
37987364|NCT00265395|69672763|FG000|Overall Study|Withdrawal by Subject|1|||
37987365|NCT00265395|69672764|FG001|Overall Study|Withdrawal by Subject|6|||
37987366|NCT00265395|69672763|FG000|Overall Study|Protocol Violation|2|||
37695744|NCT02326298|69172053|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
37695745|NCT02326298|69172054|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
37695746|NCT02326298|69172055|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
37695747|NCT02326298|69172056|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
37695748|NCT02326298|69172057|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
37695749|NCT02326298|69172058|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
37887343|NCT00954174|69572132|FG000|Overall Study|Withdrawal by Subject|14|||
37887344|NCT00954174|69572133|FG001|Overall Study|Withdrawal by Subject|10|||
37987367|NCT00265395|69672764|FG001|Overall Study|Protocol Violation|2|||
37695750|NCT02326298|69172059|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
37695751|NCT02326298|69172060|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
37695752|NCT02326298|69172061|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
37695753|NCT02326298|69172062|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
37822690|NCT02014558|69502594|FG007|Overall Study|Lack of Efficacy|3|||
37822691|NCT02014558|69502595|FG008|Overall Study|Lack of Efficacy|3|||
37822692|NCT02014558|69502596|FG009|Overall Study|Lack of Efficacy|3|||
37822693|NCT02014558|69502597|FG010|Overall Study|Lack of Efficacy|16|||
37822694|NCT02014558|69502598|FG011|Overall Study|Lack of Efficacy|8|||
37822695|NCT02014558|69502599|FG012|Overall Study|Lack of Efficacy|5|||
37822696|NCT02014558|69502587|FG000|Overall Study|Lost to Follow-up|0|||
37822697|NCT02014558|69502588|FG001|Overall Study|Lost to Follow-up|0|||
37822698|NCT02014558|69502589|FG002|Overall Study|Lost to Follow-up|0|||
37822699|NCT02014558|69502590|FG003|Overall Study|Lost to Follow-up|0|||
37822700|NCT02014558|69502591|FG004|Overall Study|Lost to Follow-up|0|||
37822701|NCT02014558|69502592|FG005|Overall Study|Lost to Follow-up|0|||
37822702|NCT02014558|69502593|FG006|Overall Study|Lost to Follow-up|0|||
37822703|NCT02014558|69502594|FG007|Overall Study|Lost to Follow-up|0|||
37822704|NCT02014558|69502595|FG008|Overall Study|Lost to Follow-up|0|||
37822705|NCT02014558|69502596|FG009|Overall Study|Lost to Follow-up|0|||
37887345|NCT00954174|69572134|FG002|Overall Study|Withdrawal by Subject|4|||
37887346|NCT00954174|69572135|FG003|Overall Study|Withdrawal by Subject|3|||
37987368|NCT00265395|69672763|FG000|Overall Study|Lack of Efficacy|0|||
37987369|NCT00265395|69672764|FG001|Overall Study|Lack of Efficacy|1|||
37987370|NCT00265395|69672763|FG000|Overall Study|Administrative|0|||
37887347|NCT00954174|69572132|FG000|Overall Study|Medical Reason|4|||
37987371|NCT00265395|69672764|FG001|Overall Study|Administrative|1|||
37987372|NCT00195442|69672769|FG000|Overall Study|Less than expected therapeutic effect|38|||
37987373|NCT00195442|69672769|FG000|Overall Study|Lost to Follow-up|27|||
37822706|NCT02014558|69502597|FG010|Overall Study|Lost to Follow-up|1|||
37822707|NCT02014558|69502598|FG011|Overall Study|Lost to Follow-up|0|||
37822708|NCT02014558|69502599|FG012|Overall Study|Lost to Follow-up|0|||
37822709|NCT02014558|69502587|FG000|Overall Study|Progressive Disease|1|||
37822710|NCT02014558|69502588|FG001|Overall Study|Progressive Disease|0|||
37887348|NCT00954174|69572133|FG001|Overall Study|Medical Reason|2|||
37887349|NCT00954174|69572134|FG002|Overall Study|Medical Reason|1|||
37887350|NCT00954174|69572135|FG003|Overall Study|Medical Reason|0|||
37887351|NCT00954174|69572132|FG000|Overall Study|Ineligible|40|||
37887352|NCT00954174|69572133|FG001|Overall Study|Ineligible|47|||
37887353|NCT00954174|69572134|FG002|Overall Study|Ineligible|7|||
37887354|NCT00954174|69572135|FG003|Overall Study|Ineligible|4|||
37887355|NCT00954174|69572132|FG000|Overall Study|Never Treated|4|||
37887356|NCT00954174|69572133|FG001|Overall Study|Never Treated|17|||
37887357|NCT00954174|69572134|FG002|Overall Study|Never Treated|0|||
37887358|NCT00954174|69572135|FG003|Overall Study|Never Treated|3|||
37887359|NCT01136408|69572151|FG000|Overall Study|Adverse Event|4|||
37887360|NCT01136408|69572152|FG001|Overall Study|Adverse Event|8|||
37887361|NCT01136408|69572153|FG002|Overall Study|Adverse Event|4|||
37887362|NCT01136408|69572151|FG000|Overall Study|Protocol Violation|1|||
37887363|NCT01136408|69572152|FG001|Overall Study|Protocol Violation|1|||
37887364|NCT01136408|69572153|FG002|Overall Study|Protocol Violation|1|||
37887365|NCT01136174|69572169|FG000|Overall Study|Adverse Event|0|||
37887366|NCT01136174|69572170|FG001|Overall Study|Adverse Event|0|||
37887367|NCT01136174|69572171|FG002|Overall Study|Adverse Event|0|||
37887368|NCT01136174|69572172|FG003|Overall Study|Adverse Event|4|||
37887369|NCT01135394|69572191|FG000|Screening|Lost to Follow-up|2|||
37887370|NCT01135394|69572191|FG000|Screening|Withdrawal by Subject|10|||
37887371|NCT01135394|69572191|FG000|Screening|Screening failure|16|||
37887372|NCT01135394|69572191|FG000|Screening|Physician Decision|5|||
37887373|NCT01135394|69572191|FG000|Baseline Assessment|Withdrawal by Subject|9|||
37887374|NCT01135394|69572191|FG000|Baseline Assessment|Physician Decision|3|||
37887375|NCT01135394|69572191|FG000|Baseline Assessment|Lost to Follow-up|2|||
37887376|NCT01135394|69572191|FG000|Baseline Assessment|Adverse Event|1|||
37887377|NCT01135394|69572191|FG000|Study Treatment|Withdrawal by Subject|1|||
37887378|NCT01135394|69572191|FG000|Study Treatment|Physician Decision|1|||
37887379|NCT01135394|69572191|FG000|Study Treatment|Adverse Event|2|||
37887380|NCT00949884|69572198|FG000|Overall Study|Adverse Event|14|||
37887381|NCT00949884|69572199|FG001|Overall Study|Adverse Event|3|||
37887382|NCT00949884|69572200|FG002|Overall Study|Adverse Event|12|||
37887383|NCT00949884|69572198|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
37887384|NCT00949884|69572199|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
37887385|NCT00949884|69572200|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
37887386|NCT00949884|69572198|FG000|Overall Study|Lost to Follow-up|7|||
37887387|NCT00949884|69572199|FG001|Overall Study|Lost to Follow-up|5|||
37887388|NCT00949884|69572200|FG002|Overall Study|Lost to Follow-up|5|||
37887389|NCT00949884|69572198|FG000|Overall Study|Physician Decision|5|||
37887390|NCT00949884|69572199|FG001|Overall Study|Physician Decision|0|||
37887391|NCT00949884|69572200|FG002|Overall Study|Physician Decision|6|||
37887392|NCT00949884|69572198|FG000|Overall Study|Treatment non-compliance|5|||
37887393|NCT00949884|69572199|FG001|Overall Study|Treatment non-compliance|0|||
37887394|NCT00949884|69572200|FG002|Overall Study|Treatment non-compliance|8|||
37887395|NCT00949884|69572198|FG000|Overall Study|Withdrawal by Subject|13|||
37887396|NCT00949884|69572199|FG001|Overall Study|Withdrawal by Subject|4|||
37887397|NCT00949884|69572200|FG002|Overall Study|Withdrawal by Subject|16|||
37887398|NCT00949884|69572198|FG000|Overall Study|Lack of Efficacy|4|||
37887399|NCT00949884|69572199|FG001|Overall Study|Lack of Efficacy|2|||
37887400|NCT00949884|69572200|FG002|Overall Study|Lack of Efficacy|7|||
37887401|NCT00949884|69572198|FG000|Overall Study|Study terminated by sponsor|0|||
37887402|NCT00949884|69572199|FG001|Overall Study|Study terminated by sponsor|0|||
37887403|NCT00949884|69572200|FG002|Overall Study|Study terminated by sponsor|1|||
37887404|NCT00949650|69572211|FG000|Overall Study|Progressive disease|188|||
37887405|NCT00949650|69572212|FG001|Overall Study|Progressive disease|19|||
37887406|NCT00949650|69572211|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
37887407|NCT00949650|69572212|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
37887408|NCT00949650|69572211|FG000|Overall Study|Other Adverse Event (AE)|28|||
37887409|NCT00949650|69572212|FG001|Overall Study|Other Adverse Event (AE)|17|||
37887410|NCT00949650|69572211|FG000|Overall Study|Protocol Violation|1|||
37887411|NCT00949650|69572212|FG001|Overall Study|Protocol Violation|4|||
37887412|NCT00949650|69572211|FG000|Overall Study|Refusal to continue medication|7|||
37887413|NCT00949650|69572212|FG001|Overall Study|Refusal to continue medication|11|||
37887414|NCT00949650|69572211|FG000|Overall Study|Not treated|1|||
37887415|NCT00949650|69572212|FG001|Overall Study|Not treated|4|||
37887416|NCT00949650|69572211|FG000|Overall Study|Other not specified above|5|||
37887417|NCT00949650|69572212|FG001|Overall Study|Other not specified above|0|||
37887418|NCT00908037|69572229|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
37887419|NCT00908037|69572230|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
37887420|NCT00908037|69572231|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
37887421|NCT00908037|69572232|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
37887422|NCT00908037|69572233|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
37887423|NCT00908037|69572234|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
37887424|NCT00908037|69572235|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
37887425|NCT00908037|69572236|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
37887426|NCT00908037|69572237|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
37887427|NCT00908037|69572238|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
37887428|NCT00908037|69572239|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
37887429|NCT00908037|69572240|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
37887430|NCT00908037|69572229|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
37887431|NCT00908037|69572230|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
37887432|NCT00908037|69572231|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
37887433|NCT00908037|69572232|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
37887434|NCT00908037|69572233|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
37887435|NCT00908037|69572234|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
37887436|NCT00908037|69572235|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
37887437|NCT00908037|69572236|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
37887438|NCT00908037|69572237|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
37887439|NCT00908037|69572238|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
37887440|NCT00908037|69572239|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
37887441|NCT00908037|69572240|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
37887442|NCT00908037|69572229|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
37987374|NCT00195442|69672769|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
37987375|NCT00195442|69672769|FG000|Overall Study|Intermittent product shortage|21|||
37887443|NCT00908037|69572230|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
37887444|NCT00908037|69572231|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
37887445|NCT00908037|69572232|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
37887446|NCT00908037|69572233|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
37887447|NCT00908037|69572234|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
37887448|NCT00908037|69572235|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
37887449|NCT00908037|69572236|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
37887450|NCT00908037|69572237|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
37987376|NCT00195442|69672769|FG000|Overall Study|Death|7|||
37987377|NCT00195442|69672769|FG000|Overall Study|No reason specified|4|||
37987378|NCT00195442|69672769|FG000|Overall Study|Poor cooperation|2|||
37987379|NCT00195442|69672769|FG000|Overall Study|Other|14|||
37987380|NCT00275301|69672773|FG000|Overall Study|Adverse Event|5|||
37987381|NCT00251745|69672780|FG000|Overall Study|Adverse Event|7|||
37987382|NCT00251745|69672781|FG001|Overall Study|Adverse Event|9|||
37987383|NCT00251745|69672782|FG002|Overall Study|Adverse Event|11|||
37987384|NCT00251745|69672780|FG000|Overall Study|Lost to Follow-up|4|||
37987385|NCT00251745|69672781|FG001|Overall Study|Lost to Follow-up|2|||
37987386|NCT00251745|69672782|FG002|Overall Study|Lost to Follow-up|5|||
37987387|NCT00251745|69672780|FG000|Overall Study|Withdrawal by Subject|13|||
37987388|NCT00251745|69672781|FG001|Overall Study|Withdrawal by Subject|7|||
37987389|NCT00251745|69672782|FG002|Overall Study|Withdrawal by Subject|3|||
37987390|NCT00251745|69672780|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
37987391|NCT00251745|69672781|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
37987392|NCT00251745|69672782|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
37987393|NCT00251745|69672780|FG000|Overall Study|Lack of Efficacy|3|||
37987394|NCT00251745|69672781|FG001|Overall Study|Lack of Efficacy|0|||
37695754|NCT02326298|69172063|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
37695755|NCT02326298|69172064|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
37695756|NCT02326298|69172051|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
37695757|NCT02326298|69172052|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
37695758|NCT02326298|69172053|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
37695759|NCT02326298|69172054|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
37822711|NCT02014558|69502589|FG002|Overall Study|Progressive Disease|1|||
37822712|NCT02014558|69502590|FG003|Overall Study|Progressive Disease|1|||
37822713|NCT02014558|69502591|FG004|Overall Study|Progressive Disease|1|||
37822714|NCT02014558|69502592|FG005|Overall Study|Progressive Disease|2|||
37822715|NCT02014558|69502593|FG006|Overall Study|Progressive Disease|1|||
37822716|NCT02014558|69502594|FG007|Overall Study|Progressive Disease|6|||
37822717|NCT02014558|69502595|FG008|Overall Study|Progressive Disease|5|||
37822718|NCT02014558|69502596|FG009|Overall Study|Progressive Disease|6|||
37822719|NCT02014558|69502597|FG010|Overall Study|Progressive Disease|22|||
37822720|NCT02014558|69502598|FG011|Overall Study|Progressive Disease|31|||
37822721|NCT02014558|69502599|FG012|Overall Study|Progressive Disease|6|||
37822722|NCT02014558|69502587|FG000|Overall Study|Withdrawal by Subject|0|||
37822723|NCT02014558|69502588|FG001|Overall Study|Withdrawal by Subject|0|||
37822724|NCT02014558|69502589|FG002|Overall Study|Withdrawal by Subject|0|||
37822725|NCT02014558|69502590|FG003|Overall Study|Withdrawal by Subject|0|||
37822726|NCT02014558|69502591|FG004|Overall Study|Withdrawal by Subject|1|||
37822727|NCT02014558|69502592|FG005|Overall Study|Withdrawal by Subject|0|||
37822728|NCT02014558|69502593|FG006|Overall Study|Withdrawal by Subject|0|||
37822729|NCT02014558|69502594|FG007|Overall Study|Withdrawal by Subject|0|||
37822730|NCT02014558|69502595|FG008|Overall Study|Withdrawal by Subject|0|||
37822731|NCT02014558|69502596|FG009|Overall Study|Withdrawal by Subject|2|||
37822732|NCT02014558|69502597|FG010|Overall Study|Withdrawal by Subject|6|||
37822733|NCT02014558|69502598|FG011|Overall Study|Withdrawal by Subject|10|||
37822734|NCT02014558|69502599|FG012|Overall Study|Withdrawal by Subject|0|||
37822735|NCT02014558|69502587|FG000|Overall Study|Miscellaneous|2|||
37822736|NCT02014558|69502588|FG001|Overall Study|Miscellaneous|1|||
37822737|NCT02014558|69502589|FG002|Overall Study|Miscellaneous|1|||
37822738|NCT02014558|69502590|FG003|Overall Study|Miscellaneous|1|||
37822739|NCT02014558|69502591|FG004|Overall Study|Miscellaneous|0|||
37822740|NCT02014558|69502592|FG005|Overall Study|Miscellaneous|1|||
37822741|NCT02014558|69502593|FG006|Overall Study|Miscellaneous|0|||
37822742|NCT02014558|69502594|FG007|Overall Study|Miscellaneous|1|||
37822743|NCT02014558|69502595|FG008|Overall Study|Miscellaneous|1|||
37822744|NCT02014558|69502596|FG009|Overall Study|Miscellaneous|3|||
37822745|NCT02014558|69502597|FG010|Overall Study|Miscellaneous|12|||
37822746|NCT02014558|69502598|FG011|Overall Study|Miscellaneous|11|||
37822747|NCT02014558|69502599|FG012|Overall Study|Miscellaneous|1|||
37822748|NCT02024555|69502654|FG000|Overall Study|Lost to Follow-up|1|||
37822749|NCT02024555|69502655|FG001|Overall Study|Lost to Follow-up|1|||
37822750|NCT02024555|69502654|FG000|Overall Study|Withdrawal by Subject|5|||
37822751|NCT02024555|69502655|FG001|Overall Study|Withdrawal by Subject|1|||
37822752|NCT02040584|69502663|FG000|Overall Study|Adverse Event|13|||
37822753|NCT02040584|69502664|FG001|Overall Study|Adverse Event|6|||
37822754|NCT02040584|69502663|FG000|Overall Study|Protocol Violation|9|||
37822755|NCT02040584|69502664|FG001|Overall Study|Protocol Violation|11|||
37822756|NCT02040584|69502663|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
37987395|NCT00251745|69672782|FG002|Overall Study|Lack of Efficacy|0|||
37987396|NCT00251745|69672780|FG000|Overall Study|Noncompliant|0|||
37987397|NCT00251745|69672781|FG001|Overall Study|Noncompliant|2|||
37695760|NCT02326298|69172055|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
37695761|NCT02326298|69172056|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
37695762|NCT02326298|69172057|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
37695763|NCT02326298|69172058|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
37695764|NCT02326298|69172059|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
37695765|NCT02326298|69172060|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
37695766|NCT02326298|69172061|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
37695767|NCT02326298|69172062|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
37695768|NCT02326298|69172063|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
37695769|NCT02326298|69172064|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
37695770|NCT02326298|69172051|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
37695771|NCT02326298|69172052|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
37695772|NCT02326298|69172053|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
37695773|NCT02326298|69172054|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
37695774|NCT02326298|69172055|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
37695775|NCT02326298|69172056|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
37822757|NCT02040584|69502664|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
37822758|NCT02040584|69502663|FG000|Overall Study|Death|6|||
37822759|NCT02040584|69502664|FG001|Overall Study|Death|3|||
37822760|NCT02040584|69502663|FG000|Overall Study|Transplant rejection/retransplant|0|||
37887451|NCT00908037|69572238|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
37887452|NCT00908037|69572239|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
37887453|NCT00908037|69572240|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
37887454|NCT00908037|69572229|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
37887455|NCT00908037|69572230|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
37887456|NCT00908037|69572231|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
37887457|NCT00908037|69572232|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
37887458|NCT00908037|69572233|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
37887459|NCT00908037|69572234|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
37887460|NCT00908037|69572235|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
37887461|NCT00908037|69572236|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
37887462|NCT00908037|69572237|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
37887463|NCT00908037|69572238|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
37987398|NCT00251745|69672782|FG002|Overall Study|Noncompliant|2|||
37987399|NCT00251745|69672780|FG000|Overall Study|Pregnancy|0|||
37822761|NCT02040584|69502664|FG001|Overall Study|Transplant rejection/retransplant|1|||
37822762|NCT02040584|69502663|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
37822763|NCT02040584|69502664|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
37822764|NCT02045797|69502683|FG000|Overall Study|Adverse Event|3|||
37822765|NCT02045797|69502684|FG001|Overall Study|Adverse Event|1|||
37822766|NCT02045797|69502685|FG002|Overall Study|Adverse Event|0|||
37822767|NCT02045797|69502683|FG000|Overall Study|Lack of Efficacy|1|||
37822768|NCT02045797|69502684|FG001|Overall Study|Lack of Efficacy|0|||
37822769|NCT02045797|69502685|FG002|Overall Study|Lack of Efficacy|0|||
37822770|NCT02045797|69502683|FG000|Overall Study|Lost to Follow-up|2|||
37822771|NCT02045797|69502684|FG001|Overall Study|Lost to Follow-up|3|||
37822772|NCT02045797|69502685|FG002|Overall Study|Lost to Follow-up|1|||
37822773|NCT02045797|69502683|FG000|Overall Study|Physician Decision|0|||
37822774|NCT02045797|69502684|FG001|Overall Study|Physician Decision|1|||
37822775|NCT02045797|69502685|FG002|Overall Study|Physician Decision|0|||
37822776|NCT02045797|69502683|FG000|Overall Study|Withdrawal by Subject|1|||
37822777|NCT02045797|69502684|FG001|Overall Study|Withdrawal by Subject|2|||
37822778|NCT02045797|69502685|FG002|Overall Study|Withdrawal by Subject|0|||
37822779|NCT03385239|69502715|FG000|Overall Study|Voluntary Withdrawal|2|||
37822780|NCT03385239|69502716|FG001|Overall Study|Voluntary Withdrawal|3|||
37822781|NCT03385239|69502717|FG002|Overall Study|Voluntary Withdrawal|2|||
37822782|NCT03385239|69502718|FG003|Overall Study|Voluntary Withdrawal|3|||
37822783|NCT03385239|69502719|FG004|Overall Study|Voluntary Withdrawal|0|||
37822784|NCT03385239|69502715|FG000|Overall Study|Adverse Event|0|||
37822785|NCT03385239|69502716|FG001|Overall Study|Adverse Event|0|||
37822786|NCT03385239|69502717|FG002|Overall Study|Adverse Event|1|||
37822787|NCT03385239|69502718|FG003|Overall Study|Adverse Event|0|||
37822788|NCT03385239|69502719|FG004|Overall Study|Adverse Event|0|||
37887464|NCT00908037|69572239|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
37822789|NCT03385239|69502715|FG000|Overall Study|Other|0|||
37822790|NCT03385239|69502716|FG001|Overall Study|Other|0|||
37822791|NCT03385239|69502717|FG002|Overall Study|Other|0|||
37822792|NCT03385239|69502718|FG003|Overall Study|Other|1|||
37822793|NCT03385239|69502719|FG004|Overall Study|Other|0|||
37822794|NCT03020160|69502737|FG000|Overall Study|Withdrawal by Subject|1|||
37887465|NCT00908037|69572240|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
37887466|NCT00908037|69572229|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
37887467|NCT00908037|69572230|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
37887468|NCT00908037|69572231|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
37887469|NCT00908037|69572232|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
37887470|NCT00908037|69572233|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
37887471|NCT00908037|69572234|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
37887472|NCT00908037|69572235|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
37887473|NCT00908037|69572236|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
37887474|NCT00908037|69572237|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
37887475|NCT00908037|69572238|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
37887476|NCT00908037|69572239|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
37887477|NCT00908037|69572240|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
37887478|NCT00908037|69572229|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
37887479|NCT00908037|69572230|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
37887480|NCT00908037|69572231|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
37887481|NCT00908037|69572232|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
37887482|NCT00908037|69572233|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
37887483|NCT00908037|69572234|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
37887484|NCT00908037|69572235|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
37887485|NCT00908037|69572236|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
37887486|NCT00908037|69572237|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
37987400|NCT00251745|69672781|FG001|Overall Study|Pregnancy|1|||
37887487|NCT00908037|69572238|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
37887488|NCT00908037|69572239|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
37887489|NCT00908037|69572240|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
37887490|NCT00908037|69572229|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
37887491|NCT00908037|69572230|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
37887492|NCT00908037|69572231|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
37887493|NCT00908037|69572232|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
37887494|NCT00908037|69572233|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
37887495|NCT00908037|69572234|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
37887496|NCT00908037|69572235|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
37887497|NCT00908037|69572236|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
37987401|NCT00251745|69672782|FG002|Overall Study|Pregnancy|0|||
37987402|NCT00251745|69672780|FG000|Overall Study|Per Subject Request|0|||
37987403|NCT00251745|69672781|FG001|Overall Study|Per Subject Request|0|||
37987404|NCT00251745|69672782|FG002|Overall Study|Per Subject Request|1|||
37987405|NCT00251745|69672780|FG000|Overall Study|Per Investigator Request|1|||
37987406|NCT00251745|69672781|FG001|Overall Study|Per Investigator Request|0|||
37987407|NCT00251745|69672782|FG002|Overall Study|Per Investigator Request|0|||
37987408|NCT00255190|69672792|FG000|Overall Study|Adverse Event|17|||
37987409|NCT00255190|69672793|FG001|Overall Study|Adverse Event|36|||
37987410|NCT00255190|69672792|FG000|Overall Study|Protocol Violation|2|||
37987411|NCT00255190|69672793|FG001|Overall Study|Protocol Violation|2|||
37987412|NCT00255190|69672792|FG000|Overall Study|Lost to Follow-up|10|||
37987413|NCT00255190|69672793|FG001|Overall Study|Lost to Follow-up|27|||
37987414|NCT00255190|69672792|FG000|Overall Study|Withdrew Consent|17|||
37987415|NCT00255190|69672793|FG001|Overall Study|Withdrew Consent|48|||
37987416|NCT00255190|69672792|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
37987417|NCT00255190|69672793|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
37987418|NCT00255190|69672792|FG000|Overall Study|Erosive esophagitis not healed|0|||
37822795|NCT03020160|69502738|FG001|Overall Study|Withdrawal by Subject|0|||
37822796|NCT02593110|69502749|FG000|Overall Study|Withdrawal by Subject|0|||
37822797|NCT02593110|69502750|FG001|Overall Study|Withdrawal by Subject|3|||
37822798|NCT02593110|69502751|FG002|Overall Study|Withdrawal by Subject|3|||
37822799|NCT02593110|69502752|FG003|Overall Study|Withdrawal by Subject|2|||
37822800|NCT02593110|69502749|FG000|Overall Study|Death|0|||
37822801|NCT02593110|69502750|FG001|Overall Study|Death|0|||
37822802|NCT02593110|69502751|FG002|Overall Study|Death|1|||
37822803|NCT02593110|69502752|FG003|Overall Study|Death|0|||
37822804|NCT02373813|69502765|FG000|Run-In Period|Other, Not Specified|5|||
37822805|NCT02373813|69502766|FG001|Run-In Period|Other, Not Specified|0|||
37822806|NCT02373813|69502767|FG002|Run-In Period|Other, Not Specified|0|||
37822807|NCT02373813|69502768|FG003|Run-In Period|Other, Not Specified|0|||
37822808|NCT02373813|69502765|FG000|Run-In Period|Withdrawal by Subject|16|||
37887498|NCT00908037|69572237|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
37887499|NCT00908037|69572238|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
37887500|NCT00908037|69572239|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
37887501|NCT00908037|69572240|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
37887502|NCT00908037|69572229|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
37887503|NCT00908037|69572230|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
37887504|NCT00908037|69572231|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
37887505|NCT00908037|69572232|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
37887506|NCT00908037|69572233|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
37887507|NCT00908037|69572234|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
37887508|NCT00908037|69572235|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
37887509|NCT00908037|69572236|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
37887510|NCT00908037|69572237|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
37695776|NCT02326298|69172057|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
37695777|NCT02326298|69172058|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
37695778|NCT02326298|69172059|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
37695779|NCT02326298|69172060|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
37695780|NCT02326298|69172061|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
37695781|NCT02326298|69172062|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
37695782|NCT02326298|69172063|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
37695783|NCT02326298|69172064|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
37695784|NCT02326298|69172051|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
37695785|NCT02326298|69172052|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
37695786|NCT02326298|69172053|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
37695787|NCT02326298|69172054|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
37695788|NCT02326298|69172055|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
37695789|NCT02326298|69172056|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
37695790|NCT02326298|69172057|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
37695791|NCT02326298|69172058|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
37695792|NCT02326298|69172059|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
37695793|NCT02326298|69172060|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
37695794|NCT02326298|69172061|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
37695795|NCT02326298|69172062|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
37695796|NCT02326298|69172063|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
37695797|NCT02326298|69172064|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
37887511|NCT00908037|69572238|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
37887512|NCT00908037|69572239|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
37887513|NCT00908037|69572240|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
37887514|NCT00908037|69572229|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
37695798|NCT02326298|69172051|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
37695799|NCT02326298|69172052|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
37695800|NCT02326298|69172053|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
37695801|NCT02326298|69172054|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
37695802|NCT02326298|69172055|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
37695803|NCT02326298|69172056|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
37695804|NCT02326298|69172057|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
37695805|NCT02326298|69172058|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
37822809|NCT02373813|69502766|FG001|Run-In Period|Withdrawal by Subject|0|||
37822810|NCT02373813|69502767|FG002|Run-In Period|Withdrawal by Subject|0|||
37822811|NCT02373813|69502768|FG003|Run-In Period|Withdrawal by Subject|0|||
37822812|NCT02373813|69502765|FG000|Run-In Period|Decision by Sponsor|11|||
37822813|NCT02373813|69502766|FG001|Run-In Period|Decision by Sponsor|0|||
37822814|NCT02373813|69502767|FG002|Run-In Period|Decision by Sponsor|0|||
37822815|NCT02373813|69502768|FG003|Run-In Period|Decision by Sponsor|0|||
37822816|NCT02373813|69502765|FG000|Run-In Period|Protocol Violation|75|||
37822817|NCT02373813|69502766|FG001|Run-In Period|Protocol Violation|0|||
37822818|NCT02373813|69502767|FG002|Run-In Period|Protocol Violation|0|||
37822819|NCT02373813|69502768|FG003|Run-In Period|Protocol Violation|0|||
37822820|NCT02373813|69502765|FG000|Run-In Period|Lost to Follow-up|2|||
37987419|NCT00255190|69672793|FG001|Overall Study|Erosive esophagitis not healed|20|||
37822821|NCT02373813|69502766|FG001|Run-In Period|Lost to Follow-up|0|||
37822822|NCT02373813|69502767|FG002|Run-In Period|Lost to Follow-up|0|||
37822823|NCT02373813|69502768|FG003|Run-In Period|Lost to Follow-up|0|||
37695806|NCT02326298|69172059|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
37695807|NCT02326298|69172060|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
37695808|NCT02326298|69172061|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
37887515|NCT00908037|69572230|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
37887516|NCT00908037|69572231|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
37887517|NCT00908037|69572232|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
37887518|NCT00908037|69572233|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
37887519|NCT00908037|69572234|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
37887520|NCT00908037|69572235|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
37887521|NCT00908037|69572236|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
37887522|NCT00908037|69572237|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
37887523|NCT00908037|69572238|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
37887524|NCT00908037|69572239|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
37887525|NCT00908037|69572240|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
37887526|NCT00904215|69572292|FG000|Overall Study|Adverse Event|25|||
37887527|NCT00904215|69572292|FG000|Overall Study|Protocol Violation|10|||
37887528|NCT00904215|69572292|FG000|Overall Study|Lost to Follow-up|63|||
37695809|NCT02326298|69172062|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
37822824|NCT02373813|69502765|FG000|Run-In Period|Adverse Event|3|||
37887529|NCT00904215|69572292|FG000|Overall Study|Withdrawal by Subject|9|||
37887530|NCT00904215|69572292|FG000|Overall Study|Other|28|||
37887531|NCT00905307|69572302|FG000|Overall Study|Switched to Open Label Rescue|7|||
37887532|NCT00905307|69572303|FG001|Overall Study|Switched to Open Label Rescue|17|||
37887533|NCT00905307|69572304|FG002|Overall Study|Switched to Open Label Rescue|11|||
37887534|NCT00905307|69572305|FG003|Overall Study|Switched to Open Label Rescue|11|||
37887535|NCT00905307|69572306|FG004|Overall Study|Switched to Open Label Rescue|4|||
37887536|NCT00905307|69572307|FG005|Overall Study|Switched to Open Label Rescue|15|||
37887537|NCT00905307|69572302|FG000|Overall Study|Lost to Follow-up|0|||
37887538|NCT00905307|69572303|FG001|Overall Study|Lost to Follow-up|0|||
37887539|NCT00905307|69572304|FG002|Overall Study|Lost to Follow-up|0|||
37887540|NCT00905307|69572305|FG003|Overall Study|Lost to Follow-up|0|||
37887541|NCT00905307|69572306|FG004|Overall Study|Lost to Follow-up|1|||
37887542|NCT00905307|69572307|FG005|Overall Study|Lost to Follow-up|1|||
37822825|NCT02373813|69502766|FG001|Run-In Period|Adverse Event|0|||
37822826|NCT02373813|69502767|FG002|Run-In Period|Adverse Event|0|||
37822827|NCT02373813|69502768|FG003|Run-In Period|Adverse Event|0|||
37822828|NCT02373813|69502765|FG000|Run-In Period|Noncompliance|1|||
37822829|NCT02373813|69502766|FG001|Run-In Period|Noncompliance|0|||
37822830|NCT02373813|69502767|FG002|Run-In Period|Noncompliance|0|||
37822831|NCT02373813|69502768|FG003|Run-In Period|Noncompliance|0|||
37822832|NCT02373813|69502765|FG000|Run-In Period|Ineligibility Determined|3|||
37695810|NCT02326298|69172063|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
37822833|NCT02373813|69502766|FG001|Run-In Period|Ineligibility Determined|0|||
37822834|NCT02373813|69502767|FG002|Run-In Period|Ineligibility Determined|0|||
37822835|NCT02373813|69502768|FG003|Run-In Period|Ineligibility Determined|0|||
37822836|NCT02373813|69502765|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
37822837|NCT02373813|69502766|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
37822838|NCT02373813|69502767|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
37822839|NCT02373813|69502768|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
37822840|NCT02373813|69502765|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
37822841|NCT02373813|69502766|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
37887543|NCT00905307|69572302|FG000|Overall Study|Adverse Event|3|||
37987420|NCT00255190|69672792|FG000|Overall Study|Various|4|||
37695811|NCT02326298|69172064|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
37695812|NCT02326298|69172051|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
37822842|NCT02373813|69502767|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
37822843|NCT02373813|69502768|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
37822844|NCT02373813|69502765|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
37887544|NCT00905307|69572303|FG001|Overall Study|Adverse Event|4|||
37822845|NCT02373813|69502766|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
37822846|NCT02373813|69502767|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
37887545|NCT00905307|69572304|FG002|Overall Study|Adverse Event|5|||
37887546|NCT00905307|69572305|FG003|Overall Study|Adverse Event|11|||
37887547|NCT00905307|69572306|FG004|Overall Study|Adverse Event|3|||
37887548|NCT00905307|69572307|FG005|Overall Study|Adverse Event|5|||
37887549|NCT00905307|69572302|FG000|Overall Study|Withdrawal by Subject|5|||
37887550|NCT00905307|69572303|FG001|Overall Study|Withdrawal by Subject|13|||
37887551|NCT00905307|69572304|FG002|Overall Study|Withdrawal by Subject|15|||
37887552|NCT00905307|69572305|FG003|Overall Study|Withdrawal by Subject|11|||
37887553|NCT00905307|69572306|FG004|Overall Study|Withdrawal by Subject|4|||
37887554|NCT00905307|69572307|FG005|Overall Study|Withdrawal by Subject|13|||
37887555|NCT00905307|69572302|FG000|Overall Study|Protocol Violation|1|||
37887556|NCT00905307|69572303|FG001|Overall Study|Protocol Violation|0|||
37887557|NCT00905307|69572304|FG002|Overall Study|Protocol Violation|1|||
37887558|NCT00905307|69572305|FG003|Overall Study|Protocol Violation|0|||
37887559|NCT00905307|69572306|FG004|Overall Study|Protocol Violation|0|||
37887560|NCT00905307|69572307|FG005|Overall Study|Protocol Violation|0|||
37887561|NCT00905307|69572302|FG000|Overall Study|Lack of Efficacy|6|||
37887562|NCT00905307|69572303|FG001|Overall Study|Lack of Efficacy|3|||
37887563|NCT00905307|69572304|FG002|Overall Study|Lack of Efficacy|5|||
37887564|NCT00905307|69572305|FG003|Overall Study|Lack of Efficacy|4|||
37887565|NCT00905307|69572306|FG004|Overall Study|Lack of Efficacy|4|||
37887566|NCT00905307|69572307|FG005|Overall Study|Lack of Efficacy|8|||
37887567|NCT00907881|69572334|FG000|Overall Study|Lost to Follow-up|59|||
37887568|NCT00907881|69572334|FG000|Overall Study|Noncompliance|5|||
37887569|NCT00907881|69572334|FG000|Overall Study|Withdrawal by Subject|5|||
37887570|NCT00907881|69572334|FG000|Overall Study|Protocol Violation|1|||
37887571|NCT00907881|69572334|FG000|Overall Study|Missing discontinuation information|15|||
37887572|NCT00904917|69572342|FG000|Overall Study|Lost to Follow-up|2|||
37887573|NCT00904917|69572343|FG001|Overall Study|Lost to Follow-up|2|||
37887574|NCT00904917|69572344|FG002|Overall Study|Lost to Follow-up|2|||
37887575|NCT00904917|69572345|FG003|Overall Study|Lost to Follow-up|2|||
37887576|NCT00904839|69572360|FG000|Overall Study|Adverse Event|0|||
37887577|NCT00904839|69572361|FG001|Overall Study|Adverse Event|5|||
37887578|NCT00904839|69572362|FG002|Overall Study|Adverse Event|4|||
37887579|NCT00904839|69572360|FG000|Overall Study|Protocol Violation|0|||
37887580|NCT00904839|69572361|FG001|Overall Study|Protocol Violation|1|||
37887581|NCT00904839|69572362|FG002|Overall Study|Protocol Violation|1|||
37887582|NCT00904839|69572360|FG000|Overall Study|Lost to Follow-up|0|||
37887583|NCT00904839|69572361|FG001|Overall Study|Lost to Follow-up|1|||
37887584|NCT00904839|69572362|FG002|Overall Study|Lost to Follow-up|2|||
37887585|NCT00904839|69572360|FG000|Overall Study|Withdrawal by Subject|0|||
37887586|NCT00904839|69572361|FG001|Overall Study|Withdrawal by Subject|2|||
37887587|NCT00904839|69572362|FG002|Overall Study|Withdrawal by Subject|0|||
37887588|NCT00904839|69572360|FG000|Overall Study|Not treated|1|||
37887589|NCT00904839|69572361|FG001|Overall Study|Not treated|0|||
37887590|NCT00904839|69572362|FG002|Overall Study|Not treated|1|||
37887591|NCT00904839|69572360|FG000|Overall Study|Other than above|0|||
37887592|NCT00904839|69572361|FG001|Overall Study|Other than above|9|||
37887593|NCT00904839|69572362|FG002|Overall Study|Other than above|7|||
37887594|NCT00903357|69572373|FG000|First Intervention|Withdrawal by Subject|5|||
37887595|NCT00903357|69572374|FG001|First Intervention|Withdrawal by Subject|3|||
37887596|NCT00903357|69572373|FG000|First Intervention|Flu|0|||
37887597|NCT00903357|69572374|FG001|First Intervention|Flu|1|||
37987421|NCT00255190|69672793|FG001|Overall Study|Various|23|||
37987422|NCT00359424|69672801|FG000|Overall Study|Death|99|||
37987423|NCT00359424|69672802|FG001|Overall Study|Death|58|||
37987424|NCT00359424|69672801|FG000|Overall Study|Lost to Follow-up|19|||
37987425|NCT00359424|69672802|FG001|Overall Study|Lost to Follow-up|7|||
37987426|NCT00359424|69672801|FG000|Overall Study|Withdrawal by Subject|10|||
37887598|NCT00903357|69572373|FG000|Wash Out Period of 2 Weeks|Flu|0|||
37887599|NCT00903357|69572374|FG001|Wash Out Period of 2 Weeks|Flu|1|||
37887600|NCT00903357|69572373|FG000|Second Intervention|Lost to Follow-up|1|||
37887601|NCT00903357|69572374|FG001|Second Intervention|Lost to Follow-up|0|||
37887602|NCT00904371|69572384|FG000|Overall Study|Adverse Event|2|||
37887603|NCT00904371|69572384|FG000|Overall Study|Lost to Follow-up|4|||
37887604|NCT00904371|69572384|FG000|Overall Study|Discontinued at target blood pressure|2|||
37887605|NCT00904371|69572384|FG000|Overall Study|Continued with Tritace|1|||
37987427|NCT00359424|69672802|FG001|Overall Study|Withdrawal by Subject|2|||
37887606|NCT01104662|69572396|FG000|Overall Study|Adverse Event|2|||
37987428|NCT00359424|69672801|FG000|Overall Study|follow up not conducted|2|||
37987429|NCT00359424|69672802|FG001|Overall Study|follow up not conducted|0|||
37887607|NCT01104662|69572397|FG001|Overall Study|Adverse Event|2|||
37887608|NCT01104662|69572398|FG002|Overall Study|Adverse Event|0|||
37887609|NCT01104662|69572399|FG003|Overall Study|Adverse Event|1|||
37887610|NCT01104662|69572400|FG004|Overall Study|Adverse Event|1|||
37887611|NCT01104662|69572401|FG005|Overall Study|Adverse Event|1|||
37887612|NCT01104662|69572402|FG006|Overall Study|Adverse Event|0|||
37887613|NCT01104662|69572403|FG007|Overall Study|Adverse Event|0|||
37987430|NCT00255034|69672810|FG000|Overall Study|Withdrawal by Subject|15|||
37887614|NCT01104662|69572396|FG000|Overall Study|Clinical Failure|1|||
37887615|NCT01104662|69572397|FG001|Overall Study|Clinical Failure|0|||
37887616|NCT01104662|69572398|FG002|Overall Study|Clinical Failure|0|||
37887617|NCT01104662|69572399|FG003|Overall Study|Clinical Failure|0|||
37987431|NCT00255034|69672811|FG001|Overall Study|Withdrawal by Subject|38|||
37987432|NCT00254566|69672819|FG000|Overall Study|Death|1|||
37987433|NCT00254566|69672820|FG001|Overall Study|Death|0|||
37987434|NCT00254566|69672819|FG000|Overall Study|Adverse Event|5|||
37987435|NCT00254566|69672820|FG001|Overall Study|Adverse Event|4|||
37987436|NCT00254566|69672819|FG000|Overall Study|Lack of Efficacy|12|||
37987437|NCT00254566|69672820|FG001|Overall Study|Lack of Efficacy|9|||
37987438|NCT00254566|69672819|FG000|Overall Study|Other|1|||
37987439|NCT00254566|69672820|FG001|Overall Study|Other|5|||
37987440|NCT00254566|69672819|FG000|Overall Study|Withdrawal by Subject|5|||
37987441|NCT00254566|69672820|FG001|Overall Study|Withdrawal by Subject|6|||
37987442|NCT00254566|69672819|FG000|Overall Study|Lost to Follow-up|7|||
37987443|NCT00254566|69672820|FG001|Overall Study|Lost to Follow-up|2|||
37887618|NCT01104662|69572400|FG004|Overall Study|Clinical Failure|0|||
37887619|NCT01104662|69572401|FG005|Overall Study|Clinical Failure|1|||
37887620|NCT01104662|69572402|FG006|Overall Study|Clinical Failure|0|||
37887621|NCT01104662|69572403|FG007|Overall Study|Clinical Failure|0|||
37887622|NCT01104662|69572396|FG000|Overall Study|Participant left investigator's care|1|||
37887623|NCT01104662|69572397|FG001|Overall Study|Participant left investigator's care|1|||
37887624|NCT01104662|69572398|FG002|Overall Study|Participant left investigator's care|0|||
37887625|NCT01104662|69572399|FG003|Overall Study|Participant left investigator's care|0|||
37887626|NCT01104662|69572400|FG004|Overall Study|Participant left investigator's care|0|||
37887627|NCT01104662|69572401|FG005|Overall Study|Participant left investigator's care|0|||
37887628|NCT01104662|69572402|FG006|Overall Study|Participant left investigator's care|0|||
37887629|NCT01104662|69572403|FG007|Overall Study|Participant left investigator's care|0|||
37887630|NCT01104662|69572396|FG000|Overall Study|Reason not specified|3|||
37887631|NCT01104662|69572397|FG001|Overall Study|Reason not specified|3|||
37887632|NCT01104662|69572398|FG002|Overall Study|Reason not specified|0|||
37887633|NCT01104662|69572399|FG003|Overall Study|Reason not specified|0|||
37887634|NCT01104662|69572400|FG004|Overall Study|Reason not specified|0|||
37887635|NCT01104662|69572401|FG005|Overall Study|Reason not specified|1|||
37887636|NCT01104662|69572402|FG006|Overall Study|Reason not specified|0|||
37887637|NCT01104662|69572403|FG007|Overall Study|Reason not specified|0|||
37887638|NCT01104662|69572396|FG000|Overall Study|Randomized but not treated|3|||
37887639|NCT01104662|69572397|FG001|Overall Study|Randomized but not treated|4|||
37887640|NCT01104662|69572398|FG002|Overall Study|Randomized but not treated|1|||
37887641|NCT01104662|69572399|FG003|Overall Study|Randomized but not treated|0|||
37887642|NCT01104662|69572400|FG004|Overall Study|Randomized but not treated|0|||
37887643|NCT01104662|69572401|FG005|Overall Study|Randomized but not treated|1|||
37822847|NCT02373813|69502768|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
37822848|NCT02373813|69502765|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
37822849|NCT02373813|69502766|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
37822850|NCT02373813|69502767|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
37822851|NCT02373813|69502768|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
37822852|NCT01853748|69502785|FG000|Allocation|Withdrawal by Subject|1|||
37822853|NCT01853748|69502786|FG001|Allocation|Withdrawal by Subject|13|||
37822854|NCT01853748|69502785|FG000|Allocation|not sufficient to receive intervention|0|||
37822855|NCT01853748|69502786|FG001|Allocation|not sufficient to receive intervention|1|||
37822856|NCT01853748|69502785|FG000|Follow-Up|Withdrawal by Subject|7|||
37822857|NCT01853748|69502786|FG001|Follow-Up|Withdrawal by Subject|6|||
37822858|NCT01853748|69502785|FG000|Follow-Up|Adverse Event|67|||
37822859|NCT01853748|69502786|FG001|Follow-Up|Adverse Event|7|||
37822860|NCT01853748|69502785|FG000|Follow-Up|not available for data collection|16|||
37822861|NCT01853748|69502786|FG001|Follow-Up|not available for data collection|4|||
37822862|NCT03863509|69502821|FG000|Overall Study|COVID-19 shutdown period|0|||
37822863|NCT03863509|69502822|FG001|Overall Study|COVID-19 shutdown period|4|||
37887644|NCT01104662|69572402|FG006|Overall Study|Randomized but not treated|0|||
37887645|NCT01104662|69572403|FG007|Overall Study|Randomized but not treated|0|||
37887646|NCT01104584|69572422|FG000|Overall Study|Study drug never administered|21|||
37887647|NCT01104584|69572422|FG000|Overall Study|Study prematurely discontinued|2|||
37822864|NCT03863509|69502823|FG002|Overall Study|COVID-19 shutdown period|0|||
37822865|NCT03863509|69502821|FG000|Overall Study|Missed V2 visit- outside protocol window|4|||
37833587|NCT01262989|69517312|FG000|Period 2|Intercurrent disease|0|||
37987444|NCT00358956|69672826|FG000|Overall Study|Adverse Event|3|||
37987445|NCT00358956|69672826|FG000|Overall Study|condition under investigation worsened|4|||
37987446|NCT00358956|69672826|FG000|Overall Study|Withdrawal by Subject|1|||
37987447|NCT03830892|69672832|FG000|Overall Study|Physician Decision|2|||
37987448|NCT03830892|69672833|FG001|Overall Study|Physician Decision|3|||
37887648|NCT01103960|69572446|FG000|Overall Study|Adverse Event|2|||
37887649|NCT01103960|69572447|FG001|Overall Study|Adverse Event|1|||
37887650|NCT01103960|69572446|FG000|Overall Study|Withdrawal by Subject|2|||
37987449|NCT03830892|69672832|FG000|Overall Study|Study terminated due to COVID|4|||
37987450|NCT03830892|69672833|FG001|Overall Study|Study terminated due to COVID|0|||
37987451|NCT03830892|69672832|FG000|Overall Study|Protocol Violation|0|||
37987452|NCT03830892|69672833|FG001|Overall Study|Protocol Violation|1|||
37987453|NCT03830892|69672832|FG000|Overall Study|Withdrawal by Subject|0|||
37987454|NCT03830892|69672833|FG001|Overall Study|Withdrawal by Subject|2|||
37987455|NCT00253630|69672839|FG000|Overall Study|ineligible|2|||
37987456|NCT00358644|69672843|FG000|Overall Study|Progressive Disease|21|||
37987457|NCT00358644|69672843|FG000|Overall Study|Adverse Event|7|||
37987458|NCT00358644|69672843|FG000|Overall Study|Death|11|||
37987459|NCT00358644|69672843|FG000|Overall Study|Withdrawal by Subject|4|||
37987460|NCT00358644|69672843|FG000|Overall Study|Physician Decision|6|||
37987461|NCT00358644|69672843|FG000|Overall Study|Patient not eligible for study|1|||
37987462|NCT00364182|69672850|FG000|First Intervention|Secondary prophylaxis|1|||
37987463|NCT00364182|69672851|FG001|First Intervention|Secondary prophylaxis|0|||
37987464|NCT00364182|69672852|FG002|First Intervention|Secondary prophylaxis|0|||
37987465|NCT00364182|69672850|FG000|First Intervention|Withdrawal by Subject|2|||
37987466|NCT00364182|69672851|FG001|First Intervention|Withdrawal by Subject|0|||
37987467|NCT00364182|69672852|FG002|First Intervention|Withdrawal by Subject|0|||
37987468|NCT00364182|69672850|FG000|Second Intervention|non-compliance|0|||
37987469|NCT00364182|69672851|FG001|Second Intervention|non-compliance|1|||
37987470|NCT00364182|69672852|FG002|Second Intervention|non-compliance|1|||
37987471|NCT00364182|69672850|FG000|Second Intervention|Protocol Violation|0|||
37987472|NCT00364182|69672851|FG001|Second Intervention|Protocol Violation|1|||
37987473|NCT00364182|69672852|FG002|Second Intervention|Protocol Violation|0|||
37987474|NCT00364182|69672850|FG000|Second Intervention|Adverse Event|0|||
37987475|NCT00364182|69672851|FG001|Second Intervention|Adverse Event|0|||
37987476|NCT00364182|69672852|FG002|Second Intervention|Adverse Event|1|||
37987477|NCT00364182|69672850|FG000|Third Intervention|non-compliance|0|||
37987478|NCT00364182|69672851|FG001|Third Intervention|non-compliance|1|||
37987479|NCT00364182|69672852|FG002|Third Intervention|non-compliance|0|||
37987480|NCT00364182|69672850|FG000|Third Intervention|Lost to Follow-up|0|||
37987481|NCT00364182|69672851|FG001|Third Intervention|Lost to Follow-up|0|||
37987482|NCT00364182|69672852|FG002|Third Intervention|Lost to Follow-up|1|||
37987483|NCT00369486|69672867|FG000|4-Week Visit|Missed visit|2|||
37987484|NCT00369486|69672868|FG001|4-Week Visit|Missed visit|2|||
37987485|NCT00369486|69672869|FG002|4-Week Visit|Missed visit|0|||
37987486|NCT00369486|69672870|FG003|4-Week Visit|Missed visit|2|||
37987487|NCT00369486|69672871|FG004|4-Week Visit|Missed visit|1|||
37987488|NCT00369486|69672867|FG000|4-Week Visit|Dropped|0|||
37987489|NCT00369486|69672868|FG001|4-Week Visit|Dropped|0|||
37987490|NCT00369486|69672869|FG002|4-Week Visit|Dropped|1|||
37987491|NCT00369486|69672870|FG003|4-Week Visit|Dropped|0|||
37987492|NCT00369486|69672871|FG004|4-Week Visit|Dropped|0|||
37987493|NCT00369486|69672867|FG000|8-Week Visit|Missed visit|0|||
37987494|NCT00369486|69672868|FG001|8-Week Visit|Missed visit|1|||
37987495|NCT00369486|69672869|FG002|8-Week Visit|Missed visit|0|||
37987496|NCT00369486|69672870|FG003|8-Week Visit|Missed visit|0|||
37987497|NCT00369486|69672871|FG004|8-Week Visit|Missed visit|1|||
37987498|NCT00369486|69672867|FG000|8-Week Visit|Dropped|0|||
37887651|NCT01103960|69572447|FG001|Overall Study|Withdrawal by Subject|1|||
37887652|NCT01103960|69572446|FG000|Overall Study|Other|1|||
37887653|NCT01103960|69572447|FG001|Overall Study|Other|0|||
37887654|NCT01107392|69572455|FG000|Overall Study|Adverse Event|2|||
37887655|NCT01107392|69572456|FG001|Overall Study|Adverse Event|0|||
37887656|NCT01107392|69572455|FG000|Overall Study|Personal Reasons|2|||
37887657|NCT01107392|69572456|FG001|Overall Study|Personal Reasons|3|||
37887658|NCT01107392|69572455|FG000|Overall Study|Administrative decision|1|||
37987499|NCT00369486|69672868|FG001|8-Week Visit|Dropped|0|||
37987500|NCT00369486|69672869|FG002|8-Week Visit|Dropped|0|||
37987501|NCT00369486|69672870|FG003|8-Week Visit|Dropped|1|||
37987502|NCT00369486|69672871|FG004|8-Week Visit|Dropped|0|||
37987503|NCT00369486|69672867|FG000|17-Week Visit|Missed visit|0|||
37987504|NCT00369486|69672868|FG001|17-Week Visit|Missed visit|0|||
37987505|NCT00369486|69672869|FG002|17-Week Visit|Missed visit|1|||
37987506|NCT00369486|69672870|FG003|17-Week Visit|Missed visit|1|||
37987507|NCT00369486|69672871|FG004|17-Week Visit|Missed visit|1|||
37987508|NCT00369486|69672867|FG000|34-Week Visit|Dropped|0|||
37987509|NCT00369486|69672868|FG001|34-Week Visit|Dropped|1|||
37987510|NCT00369486|69672869|FG002|34-Week Visit|Dropped|1|||
37887659|NCT01107392|69572456|FG001|Overall Study|Administrative decision|0|||
37887660|NCT01106846|69572464|FG000|Overall Study|Change in surgical procedure|0|||
37887661|NCT01106846|69572465|FG001|Overall Study|Change in surgical procedure|1|||
37987511|NCT00369486|69672870|FG003|34-Week Visit|Dropped|3|||
37987512|NCT00369486|69672871|FG004|34-Week Visit|Dropped|3|||
37987513|NCT00363480|69672883|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
37887662|NCT00902577|69572471|FG000|Overall Study|Withdrawal by Subject|6|||
37987514|NCT00363480|69672883|FG000|Overall Study|Adverse Event|4|||
37887663|NCT00902577|69572471|FG000|Overall Study|FMISO production failure|2|||
37887664|NCT01106690|69572506|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
37887665|NCT01106690|69572507|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
37887666|NCT01106690|69572508|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
37887667|NCT01106690|69572506|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
37887668|NCT01106690|69572507|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
37887669|NCT01106690|69572508|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
37887670|NCT01106690|69572506|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
37887671|NCT01106690|69572507|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
37887672|NCT01106690|69572508|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
37887673|NCT01106690|69572506|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
37887674|NCT01106690|69572507|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
37887675|NCT01106690|69572508|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
37887676|NCT01106690|69572506|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
37887677|NCT01106690|69572507|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
37887678|NCT01106690|69572508|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
37887679|NCT01106690|69572506|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
37887680|NCT01106690|69572507|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
37887681|NCT01106690|69572508|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
37887682|NCT01106690|69572506|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
37887683|NCT01106690|69572507|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
37887684|NCT01106690|69572508|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
37887685|NCT01106690|69572506|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
37887686|NCT01106690|69572507|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
37887687|NCT01106690|69572508|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
37887688|NCT01106690|69572506|FG000|Core Period: Baseline to Week 26|Other|10|||
37887689|NCT01106690|69572507|FG001|Core Period: Baseline to Week 26|Other|2|||
37887690|NCT01106690|69572508|FG002|Core Period: Baseline to Week 26|Other|6|||
37887691|NCT01106690|69572506|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
37887692|NCT01106690|69572507|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
37887693|NCT01106690|69572508|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
37887694|NCT01106690|69572506|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
37887695|NCT01106690|69572507|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
37887696|NCT01106690|69572508|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
37887697|NCT01106690|69572506|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
37887698|NCT01106690|69572507|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
37887699|NCT01106690|69572508|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
37887700|NCT01106690|69572506|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
37887701|NCT01106690|69572507|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
37887702|NCT01106690|69572508|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
37887703|NCT01106690|69572506|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
37887704|NCT01106690|69572507|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
37887705|NCT01106690|69572508|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
37887706|NCT01106690|69572506|FG000|Extension Period: Week 26 to Week 52|Other|8|||
37887707|NCT01106690|69572507|FG001|Extension Period: Week 26 to Week 52|Other|3|||
37887708|NCT01106690|69572508|FG002|Extension Period: Week 26 to Week 52|Other|4|||
37887709|NCT01106690|69572506|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
37887710|NCT01106690|69572507|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
37887711|NCT01106690|69572508|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
37887712|NCT01103180|69572538|FG000|Overall Study|Withdrawal by Subject|8|||
37887713|NCT01103180|69572539|FG001|Overall Study|Withdrawal by Subject|13|||
37887714|NCT01103180|69572538|FG000|Overall Study|Lost to Follow-up|13|||
37887715|NCT01103180|69572539|FG001|Overall Study|Lost to Follow-up|7|||
37887716|NCT01103180|69572538|FG000|Overall Study|Physician Decision|1|||
37887717|NCT01103180|69572539|FG001|Overall Study|Physician Decision|0|||
37887718|NCT01103180|69572538|FG000|Overall Study|Protocol Violation|0|||
37887719|NCT01103180|69572539|FG001|Overall Study|Protocol Violation|1|||
37887720|NCT00944034|69572557|FG000|Overall Study|Inappropriate enrollment|0|||
37887721|NCT00944034|69572558|FG001|Overall Study|Inappropriate enrollment|1|||
37887722|NCT00944034|69572559|FG002|Overall Study|Inappropriate enrollment|0|||
37887723|NCT00944034|69572560|FG003|Overall Study|Inappropriate enrollment|1|||
37695813|NCT02326298|69172052|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
37887724|NCT00944034|69572561|FG004|Overall Study|Inappropriate enrollment|2|||
37987515|NCT00363480|69672883|FG000|Overall Study|Lost to Follow-up|5|||
37695814|NCT02326298|69172053|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
37987516|NCT00363480|69672883|FG000|Overall Study|Withdrawal by Subject|5|||
37695815|NCT02326298|69172054|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
37695816|NCT02326298|69172055|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
37695817|NCT02326298|69172056|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
37695818|NCT02326298|69172057|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
37695819|NCT02326298|69172058|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
37695820|NCT02326298|69172059|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
37695821|NCT02326298|69172060|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
37695822|NCT02326298|69172061|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
37695823|NCT02326298|69172062|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
37695824|NCT02326298|69172063|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
37695825|NCT02326298|69172064|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
37695826|NCT02326298|69172051|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
37695827|NCT02326298|69172052|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
37695828|NCT02326298|69172053|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
37695829|NCT02326298|69172054|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
37695830|NCT02326298|69172055|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
37695831|NCT02326298|69172056|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
37695832|NCT02326298|69172057|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
37695833|NCT02326298|69172058|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
37695834|NCT02326298|69172059|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
37887725|NCT00944034|69572562|FG005|Overall Study|Inappropriate enrollment|1|||
37887726|NCT00944034|69572563|FG006|Overall Study|Inappropriate enrollment|0|||
37887727|NCT00944034|69572564|FG007|Overall Study|Inappropriate enrollment|0|||
37887728|NCT00944034|69572565|FG008|Overall Study|Inappropriate enrollment|1|||
37887729|NCT00944034|69572566|FG009|Overall Study|Inappropriate enrollment|1|||
37887730|NCT00944034|69572567|FG010|Overall Study|Inappropriate enrollment|0|||
37887731|NCT00944034|69572568|FG011|Overall Study|Inappropriate enrollment|0|||
37887732|NCT00944034|69572557|FG000|Overall Study|Withdrawal by Subject|3|||
37887733|NCT00944034|69572558|FG001|Overall Study|Withdrawal by Subject|2|||
37887734|NCT00944034|69572559|FG002|Overall Study|Withdrawal by Subject|6|||
37887735|NCT00944034|69572560|FG003|Overall Study|Withdrawal by Subject|2|||
37887736|NCT00944034|69572561|FG004|Overall Study|Withdrawal by Subject|5|||
37887737|NCT00944034|69572562|FG005|Overall Study|Withdrawal by Subject|8|||
37887738|NCT00944034|69572563|FG006|Overall Study|Withdrawal by Subject|2|||
37887739|NCT00944034|69572564|FG007|Overall Study|Withdrawal by Subject|2|||
37887740|NCT00944034|69572565|FG008|Overall Study|Withdrawal by Subject|3|||
37887741|NCT00944034|69572566|FG009|Overall Study|Withdrawal by Subject|4|||
37887742|NCT00944034|69572567|FG010|Overall Study|Withdrawal by Subject|0|||
37887743|NCT00944034|69572568|FG011|Overall Study|Withdrawal by Subject|4|||
37887744|NCT00944034|69572557|FG000|Overall Study|Lost to Follow-up|0|||
37887745|NCT00944034|69572558|FG001|Overall Study|Lost to Follow-up|4|||
37887746|NCT00944034|69572559|FG002|Overall Study|Lost to Follow-up|2|||
37887747|NCT00944034|69572560|FG003|Overall Study|Lost to Follow-up|0|||
37887748|NCT00944034|69572561|FG004|Overall Study|Lost to Follow-up|5|||
37887749|NCT00944034|69572562|FG005|Overall Study|Lost to Follow-up|7|||
37887750|NCT00944034|69572563|FG006|Overall Study|Lost to Follow-up|0|||
37887751|NCT00944034|69572564|FG007|Overall Study|Lost to Follow-up|1|||
37887752|NCT00944034|69572565|FG008|Overall Study|Lost to Follow-up|5|||
37887753|NCT00944034|69572566|FG009|Overall Study|Lost to Follow-up|1|||
37887754|NCT00944034|69572567|FG010|Overall Study|Lost to Follow-up|1|||
37887755|NCT00944034|69572568|FG011|Overall Study|Lost to Follow-up|0|||
37887756|NCT00944034|69572557|FG000|Overall Study|Death|0|||
37887757|NCT00944034|69572558|FG001|Overall Study|Death|0|||
37887758|NCT00944034|69572559|FG002|Overall Study|Death|1|||
37887759|NCT00944034|69572560|FG003|Overall Study|Death|0|||
37887760|NCT00944034|69572561|FG004|Overall Study|Death|0|||
37887761|NCT00944034|69572562|FG005|Overall Study|Death|0|||
37887762|NCT00944034|69572563|FG006|Overall Study|Death|0|||
37887763|NCT00944034|69572564|FG007|Overall Study|Death|0|||
37887764|NCT00944034|69572565|FG008|Overall Study|Death|0|||
37887765|NCT00944034|69572566|FG009|Overall Study|Death|0|||
37887766|NCT00944034|69572567|FG010|Overall Study|Death|0|||
37887767|NCT00944034|69572568|FG011|Overall Study|Death|0|||
37887768|NCT00944034|69572557|FG000|Overall Study|Protocol Violation|2|||
37887769|NCT00944034|69572558|FG001|Overall Study|Protocol Violation|0|||
37987517|NCT00363480|69672883|FG000|Overall Study|Non-compliance of subject|1|||
37887770|NCT00944034|69572559|FG002|Overall Study|Protocol Violation|0|||
37887771|NCT00944034|69572560|FG003|Overall Study|Protocol Violation|1|||
37887772|NCT00944034|69572561|FG004|Overall Study|Protocol Violation|2|||
37887773|NCT00944034|69572562|FG005|Overall Study|Protocol Violation|3|||
37887774|NCT00944034|69572563|FG006|Overall Study|Protocol Violation|0|||
37887775|NCT00944034|69572564|FG007|Overall Study|Protocol Violation|1|||
37887776|NCT00944034|69572565|FG008|Overall Study|Protocol Violation|1|||
37887777|NCT00944034|69572566|FG009|Overall Study|Protocol Violation|4|||
37887778|NCT00944034|69572567|FG010|Overall Study|Protocol Violation|0|||
37987518|NCT00363480|69672883|FG000|Overall Study|Participant discontinued on its own|1|||
37987519|NCT00363246|69672887|FG000|Overall Study|Death|40|||
37987520|NCT00363246|69672887|FG000|Overall Study|Withdrawal by Subject|19|||
37987521|NCT00363246|69672887|FG000|Overall Study|Lost to Follow-up|14|||
37987522|NCT00363246|69672887|FG000|Overall Study|Bad health|6|||
37987523|NCT00363246|69672887|FG000|Overall Study|Stopped using wheelchair|11|||
37987524|NCT00363246|69672887|FG000|Overall Study|Subject expressed security concerns|2|||
37987525|NCT00363246|69672887|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
37987526|NCT00223990|69672894|FG000|Overall Study|Moved from area|2|||
37987527|NCT00223990|69672895|FG001|Overall Study|Moved from area|1|||
37987528|NCT00223990|69672894|FG000|Overall Study|Withdrawal by Subject|4|||
37987529|NCT00223990|69672895|FG001|Overall Study|Withdrawal by Subject|8|||
37987530|NCT00223990|69672894|FG000|Overall Study|Lost to Follow-up|1|||
37987531|NCT00223990|69672895|FG001|Overall Study|Lost to Follow-up|0|||
37987532|NCT00221104|69672903|FG000|Overall Study|Adverse Event|1|||
37987533|NCT00221104|69672904|FG001|Overall Study|Adverse Event|0|||
37695835|NCT02326298|69172060|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
37695836|NCT02326298|69172061|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
37695837|NCT02326298|69172062|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
37695838|NCT02326298|69172063|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
37695839|NCT02326298|69172064|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
37695840|NCT02326298|69172051|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
37695841|NCT02326298|69172052|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
37695842|NCT02326298|69172053|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
37695843|NCT02326298|69172054|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
37695844|NCT02326298|69172055|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
37695845|NCT02326298|69172056|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
37695846|NCT02326298|69172057|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
37695847|NCT02326298|69172058|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
37695848|NCT02326298|69172059|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
37695849|NCT02326298|69172060|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
37695850|NCT02326298|69172061|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
37695851|NCT02326298|69172062|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
37695852|NCT02326298|69172063|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
37695853|NCT02326298|69172064|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
37695854|NCT02326298|69172051|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
37822866|NCT03863509|69502822|FG001|Overall Study|Missed V2 visit- outside protocol window|3|||
37822867|NCT03863509|69502823|FG002|Overall Study|Missed V2 visit- outside protocol window|1|||
37822868|NCT03863509|69502821|FG000|Overall Study|Lost to Follow-up|8|||
37822869|NCT03863509|69502822|FG001|Overall Study|Lost to Follow-up|0|||
37822870|NCT03863509|69502823|FG002|Overall Study|Lost to Follow-up|2|||
37822871|NCT03863509|69502821|FG000|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|10|||
37822872|NCT03863509|69502822|FG001|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|20|||
37822873|NCT03863509|69502823|FG002|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|2|||
37822874|NCT03863509|69502821|FG000|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
37822875|NCT03863509|69502822|FG001|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|1|||
37822876|NCT03863509|69502823|FG002|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
37822877|NCT03116347|69502852|FG000|Overall Study|Withdrawal by Subject|1|||
37822878|NCT03116347|69502853|FG001|Overall Study|Withdrawal by Subject|2|||
37822879|NCT00001213|69502899|FG000|Overall Study|Death|18|||
37822880|NCT00000135|69502905|FG000|Overall Study|Death|27|||
37822881|NCT00000135|69502906|FG001|Overall Study|Death|14|||
37822882|NCT00001723|69502914|FG000|Overall Study|Lack of Efficacy|6|||
37822883|NCT00001723|69502915|FG001|Overall Study|Lack of Efficacy|7|||
37822884|NCT00001723|69502914|FG000|Overall Study|Lack of family interest|4|||
37822885|NCT00001723|69502915|FG001|Overall Study|Lack of family interest|5|||
37887779|NCT00944034|69572568|FG011|Overall Study|Protocol Violation|0|||
37987534|NCT00221104|69672903|FG000|Overall Study|Physician Decision|1|||
37987535|NCT00221104|69672904|FG001|Overall Study|Physician Decision|0|||
37987536|NCT00221104|69672903|FG000|Overall Study|Protocol Violation|2|||
37822886|NCT00001723|69502914|FG000|Overall Study|Lost to Follow-up|2|||
37822887|NCT00001723|69502915|FG001|Overall Study|Lost to Follow-up|2|||
37887780|NCT00944034|69572557|FG000|Overall Study|Unable to classify|0|||
37987537|NCT00221104|69672904|FG001|Overall Study|Protocol Violation|0|||
37987538|NCT00221104|69672903|FG000|Overall Study|Withdrawal by Subject|42|||
37987539|NCT00221104|69672904|FG001|Overall Study|Withdrawal by Subject|29|||
37695855|NCT02326298|69172052|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
37695856|NCT02326298|69172053|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
37695857|NCT02326298|69172054|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
37695858|NCT02326298|69172055|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
37695859|NCT02326298|69172056|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
37695860|NCT02326298|69172057|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
37695861|NCT02326298|69172058|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
37695862|NCT02326298|69172059|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
37822888|NCT00001723|69502914|FG000|Overall Study|medication intolerance|1|||
37822889|NCT00001723|69502915|FG001|Overall Study|medication intolerance|2|||
37822890|NCT00000378|69502927|FG000|Overall Study|Lack of Efficacy|16|||
37822891|NCT00000378|69502928|FG001|Overall Study|Lack of Efficacy|14|||
37822892|NCT01350115|69502936|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
37822893|NCT01350115|69502937|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
37887781|NCT00944034|69572558|FG001|Overall Study|Unable to classify|0|||
37887782|NCT00944034|69572559|FG002|Overall Study|Unable to classify|0|||
37987540|NCT00221104|69672903|FG000|Overall Study|Others|37|||
37987541|NCT00221104|69672904|FG001|Overall Study|Others|47|||
37822894|NCT01350115|69502936|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
37987542|NCT00189202|69672912|FG000|Overall Study|Physician Decision|5|||
37822895|NCT01350115|69502937|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
37822896|NCT01350115|69502936|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
37822897|NCT01350115|69502937|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
37987543|NCT00187486|69672916|FG000|Overall Study|Protocol Violation|1|||
37987544|NCT00220636|69672920|FG000|Overall Study|Withdrawal by Subject|4|||
37987545|NCT00362232|69672927|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
37987546|NCT00362232|69672928|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
37987547|NCT00362232|69672927|FG000|Treatment (12 +/- 2 Days)|Death|1|||
37822898|NCT04142983|69502945|FG000|Overall Study|Lost to Follow-up|73|||
37822899|NCT04142983|69502945|FG000|Overall Study|Withdrawal by Subject|10|||
37822900|NCT04142983|69502945|FG000|Overall Study|Physician Decision|1|||
37822901|NCT04142983|69502945|FG000|Overall Study|Adverse Event|1|||
37822902|NCT04142983|69502945|FG000|Overall Study|No longer eligible|4|||
37822903|NCT04142983|69502945|FG000|Overall Study|Screen Failure|10|||
37822904|NCT03801031|69502952|FG000|Overall Study|Lost to Follow-up|1|||
37822905|NCT03801031|69502953|FG001|Overall Study|Lost to Follow-up|0|||
37822906|NCT03801031|69502952|FG000|Overall Study|Unable to comply|1|||
37822907|NCT03801031|69502953|FG001|Overall Study|Unable to comply|0|||
37822908|NCT03801031|69502952|FG000|Overall Study|Withdrawal by Subject|0|||
37822909|NCT03801031|69502953|FG001|Overall Study|Withdrawal by Subject|1|||
37822910|NCT03357952|69502961|FG000|Overall Study|Withdrawal by Subject|0|||
37822911|NCT03357952|69502962|FG001|Overall Study|Withdrawal by Subject|1|||
37822912|NCT03357952|69502961|FG000|Overall Study|Sponsor Decision|9|||
37822913|NCT03357952|69502962|FG001|Overall Study|Sponsor Decision|0|||
37822914|NCT03055858|69502968|FG000|Overall Study|Death|9|||
37822915|NCT03055858|69502968|FG000|Overall Study|Withdrawal by Subject|11|||
37822916|NCT03055858|69502968|FG000|Overall Study|Lost to Follow-up|6|||
37822917|NCT03055858|69502968|FG000|Overall Study|Missed Follow-Up Visits|18|||
37822918|NCT02393716|69502993|FG000|Overall Study|Death|29|||
37822919|NCT02393716|69502993|FG000|Overall Study|Withdrawal by Subject|8|||
37822920|NCT02393716|69502993|FG000|Overall Study|Device Explanted|8|||
37822921|NCT02393716|69502993|FG000|Overall Study|Missed visit|16|||
37822922|NCT01804816|69502998|FG000|No Acupuncture (Initial 5 Weeks)|Withdrawal by Subject|3|||
37822923|NCT01804816|69502998|FG000|Acupuncture (Second 5 Weeks)|Physician Decision|1|||
37822924|NCT00584233|69503005|FG000|Overall Study|Withdrawal by Subject|5|||
37822925|NCT00584233|69503005|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
37822926|NCT00001566|69503017|FG000|Overall Study|patients' choice to discontinue protocol|3|||
37822927|NCT00001566|69503017|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
37822928|NCT00001566|69503017|FG000|Overall Study|Death|13|||
37822929|NCT00001566|69503017|FG000|Overall Study|Lost to Follow-up|1|||
37822930|NCT00001566|69503017|FG000|Overall Study|unable to complete initial apheresis|1|||
37822931|NCT00001575|69503021|FG000|Overall Study|Screening failures-Ph I portion|22|||
37822932|NCT00001575|69503021|FG000|Overall Study|Withdrawn/deaths|23|||
37887783|NCT00944034|69572560|FG003|Overall Study|Unable to classify|0|||
37987548|NCT00362232|69672928|FG001|Treatment (12 +/- 2 Days)|Death|3|||
37822933|NCT00001596|69503027|FG000|Overall Study|Death|1|||
37822934|NCT00001596|69503028|FG001|Overall Study|Death|0|||
37822935|NCT00001596|69503027|FG000|Overall Study|Withdrawal by Subject|3|||
37822936|NCT00001596|69503028|FG001|Overall Study|Withdrawal by Subject|1|||
37822937|NCT00001596|69503027|FG000|Overall Study|Study Termination|12|||
37822938|NCT00001596|69503028|FG001|Overall Study|Study Termination|9|||
37822939|NCT00001596|69503027|FG000|Overall Study|Adverse Event|1|||
37887784|NCT00944034|69572561|FG004|Overall Study|Unable to classify|0|||
37887785|NCT00944034|69572562|FG005|Overall Study|Unable to classify|1|||
37887786|NCT00944034|69572563|FG006|Overall Study|Unable to classify|1|||
37887787|NCT00944034|69572564|FG007|Overall Study|Unable to classify|1|||
37887788|NCT00944034|69572565|FG008|Overall Study|Unable to classify|0|||
37887789|NCT00944034|69572566|FG009|Overall Study|Unable to classify|0|||
37887790|NCT00944034|69572567|FG010|Overall Study|Unable to classify|0|||
37887791|NCT00944034|69572568|FG011|Overall Study|Unable to classify|0|||
37887792|NCT00944034|69572557|FG000|Overall Study|Administrative reason|0|||
37887793|NCT00944034|69572558|FG001|Overall Study|Administrative reason|0|||
37887794|NCT00944034|69572559|FG002|Overall Study|Administrative reason|0|||
37887795|NCT00944034|69572560|FG003|Overall Study|Administrative reason|0|||
37887796|NCT00944034|69572561|FG004|Overall Study|Administrative reason|0|||
37887797|NCT00944034|69572562|FG005|Overall Study|Administrative reason|0|||
37887798|NCT00944034|69572563|FG006|Overall Study|Administrative reason|1|||
37887799|NCT00944034|69572564|FG007|Overall Study|Administrative reason|0|||
37887800|NCT00944034|69572565|FG008|Overall Study|Administrative reason|0|||
37887801|NCT00944034|69572566|FG009|Overall Study|Administrative reason|0|||
37887802|NCT00944034|69572567|FG010|Overall Study|Administrative reason|0|||
37887803|NCT00944034|69572568|FG011|Overall Study|Administrative reason|0|||
37887804|NCT00941304|69572616|FG000|Overall Study|Lost to Follow-up|1|||
37887805|NCT00941304|69572617|FG001|Overall Study|Lost to Follow-up|0|||
37887806|NCT00941304|69572618|FG002|Overall Study|Lost to Follow-up|0|||
37887807|NCT00941304|69572619|FG003|Overall Study|Lost to Follow-up|0|||
37887808|NCT00941304|69572620|FG004|Overall Study|Lost to Follow-up|0|||
37887809|NCT00941070|69572632|FG000|Overall Study|Patient non-compliant|1|||
37887810|NCT01098812|69572641|FG000|Overall Study|Death|2|||
37887811|NCT01098812|69572642|FG001|Overall Study|Death|0|||
37887812|NCT01098812|69572643|FG002|Overall Study|Death|1|||
37887813|NCT01098812|69572641|FG000|Overall Study|Lost to Follow-up|0|||
37887814|NCT01098812|69572642|FG001|Overall Study|Lost to Follow-up|1|||
37887815|NCT01098812|69572643|FG002|Overall Study|Lost to Follow-up|0|||
37887816|NCT00903201|69572653|FG000|Overall Study|Adverse Event|1|||
37887817|NCT00903201|69572654|FG001|Overall Study|Adverse Event|4|||
37887818|NCT00903201|69572655|FG002|Overall Study|Adverse Event|0|||
37887819|NCT00903201|69572653|FG000|Overall Study|Protocol Violation|2|||
37887820|NCT00903201|69572654|FG001|Overall Study|Protocol Violation|1|||
37887821|NCT00903201|69572655|FG002|Overall Study|Protocol Violation|0|||
37887822|NCT00903201|69572653|FG000|Overall Study|Lost to Follow-up|0|||
37887823|NCT00903201|69572654|FG001|Overall Study|Lost to Follow-up|1|||
37887824|NCT00903201|69572655|FG002|Overall Study|Lost to Follow-up|0|||
37887825|NCT00903201|69572653|FG000|Overall Study|Physician Decision|1|||
37887826|NCT00903201|69572654|FG001|Overall Study|Physician Decision|0|||
37887827|NCT00903201|69572655|FG002|Overall Study|Physician Decision|1|||
37887828|NCT00903201|69572653|FG000|Overall Study|Withdrawal by Subject|1|||
37887829|NCT00903201|69572654|FG001|Overall Study|Withdrawal by Subject|0|||
37887830|NCT00903201|69572655|FG002|Overall Study|Withdrawal by Subject|1|||
37887831|NCT00902265|69572665|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
37887832|NCT00902265|69572665|FG000|Overall Study|Adverse Event|2|||
37887833|NCT00902265|69572665|FG000|Overall Study|Lack of Efficacy|2|||
37822940|NCT00001596|69503028|FG001|Overall Study|Adverse Event|0|||
37822941|NCT01349803|69503065|FG000|Overall Study|Adverse Event|0|||
37887834|NCT00902265|69572665|FG000|Overall Study|Protocol Violation|1|||
37887835|NCT00943722|69572683|FG000|Base Study|Adverse Event|0|||
37887836|NCT00943722|69572684|FG001|Base Study|Adverse Event|0|||
37887837|NCT00943722|69572685|FG002|Base Study|Adverse Event|0|||
37887838|NCT00943722|69572686|FG003|Base Study|Adverse Event|1|||
37887839|NCT00943722|69572687|FG004|Base Study|Adverse Event|0|||
37887840|NCT00943722|69572688|FG005|Base Study|Adverse Event|0|||
37887841|NCT00943722|69572689|FG006|Base Study|Adverse Event|0|||
37887842|NCT00943722|69572683|FG000|Base Study|Lost to Follow-up|12|||
37887843|NCT00943722|69572684|FG001|Base Study|Lost to Follow-up|8|||
37822942|NCT01349803|69503066|FG001|Overall Study|Adverse Event|0|||
37822943|NCT01349803|69503067|FG002|Overall Study|Adverse Event|0|||
37822944|NCT01349803|69503068|FG003|Overall Study|Adverse Event|2|||
37822945|NCT01349803|69503065|FG000|Overall Study|Withdrawal by Subject|1|||
37822946|NCT01349803|69503066|FG001|Overall Study|Withdrawal by Subject|0|||
37822947|NCT01349803|69503067|FG002|Overall Study|Withdrawal by Subject|0|||
37822948|NCT01349803|69503068|FG003|Overall Study|Withdrawal by Subject|0|||
37822949|NCT01349803|69503065|FG000|Overall Study|Protocol-specified criteria|0|||
37822950|NCT01349803|69503066|FG001|Overall Study|Protocol-specified criteria|1|||
37887844|NCT00943722|69572685|FG002|Base Study|Lost to Follow-up|10|||
37987549|NCT00362232|69672927|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
37822951|NCT01349803|69503067|FG002|Overall Study|Protocol-specified criteria|3|||
37887845|NCT00943722|69572686|FG003|Base Study|Lost to Follow-up|8|||
37887846|NCT00943722|69572687|FG004|Base Study|Lost to Follow-up|11|||
37887847|NCT00943722|69572688|FG005|Base Study|Lost to Follow-up|0|||
37887848|NCT00943722|69572689|FG006|Base Study|Lost to Follow-up|0|||
37887849|NCT00943722|69572683|FG000|Base Study|Physician Decision|1|||
37887850|NCT00943722|69572684|FG001|Base Study|Physician Decision|0|||
37887851|NCT00943722|69572685|FG002|Base Study|Physician Decision|0|||
37887852|NCT00943722|69572686|FG003|Base Study|Physician Decision|0|||
37887853|NCT00943722|69572687|FG004|Base Study|Physician Decision|1|||
37887854|NCT00943722|69572688|FG005|Base Study|Physician Decision|0|||
37887855|NCT00943722|69572689|FG006|Base Study|Physician Decision|0|||
37887856|NCT00943722|69572683|FG000|Base Study|Pregnancy|0|||
37887857|NCT00943722|69572684|FG001|Base Study|Pregnancy|0|||
37887858|NCT00943722|69572685|FG002|Base Study|Pregnancy|1|||
37887859|NCT00943722|69572686|FG003|Base Study|Pregnancy|0|||
37887860|NCT00943722|69572687|FG004|Base Study|Pregnancy|2|||
37695863|NCT02326298|69172060|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
37822952|NCT01349803|69503068|FG003|Overall Study|Protocol-specified criteria|0|||
37887861|NCT00943722|69572688|FG005|Base Study|Pregnancy|0|||
37887862|NCT00943722|69572689|FG006|Base Study|Pregnancy|0|||
37887863|NCT00943722|69572683|FG000|Base Study|Protocol Violation|0|||
37887864|NCT00943722|69572684|FG001|Base Study|Protocol Violation|1|||
37822953|NCT04059146|69503181|FG000|Overall Study|Withdrawal by Subject|0|||
37822954|NCT04059146|69503182|FG001|Overall Study|Withdrawal by Subject|1|||
37822955|NCT03969641|69503203|FG000|Overall Study|Lost to Follow-up|5|||
37822956|NCT03969641|69503204|FG001|Overall Study|Lost to Follow-up|3|||
37822957|NCT03969641|69503203|FG000|Overall Study|Withdrawal by Subject|1|||
37822958|NCT03969641|69503204|FG001|Overall Study|Withdrawal by Subject|2|||
37822959|NCT03969641|69503203|FG000|Overall Study|Found to be ineligible|1|||
37822960|NCT03969641|69503204|FG001|Overall Study|Found to be ineligible|1|||
37822961|NCT03969641|69503203|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
37822962|NCT03969641|69503204|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
37822963|NCT03969641|69503203|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
37822964|NCT03969641|69503204|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
37822965|NCT03969641|69503203|FG000|Overall Study|Elective termination|0|||
37822966|NCT03969641|69503204|FG001|Overall Study|Elective termination|1|||
37822967|NCT03721172|69503254|FG000|Placebo-controlled Phase|Adverse Event|7|||
37822968|NCT03721172|69503255|FG001|Placebo-controlled Phase|Adverse Event|7|||
37822969|NCT03721172|69503256|FG002|Placebo-controlled Phase|Adverse Event|0|||
37822970|NCT03721172|69503254|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
37822971|NCT03721172|69503255|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
37822972|NCT03721172|69503256|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
37822973|NCT03721172|69503254|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
37822974|NCT03721172|69503255|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
37822975|NCT03721172|69503256|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
37822976|NCT03721172|69503254|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
37822977|NCT03721172|69503255|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
37822978|NCT03721172|69503256|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
37822979|NCT03721172|69503254|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
37822980|NCT03721172|69503255|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
37822981|NCT03721172|69503256|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
37822982|NCT03721172|69503254|FG000|Placebo-controlled Phase|Other|3|||
37822983|NCT03721172|69503255|FG001|Placebo-controlled Phase|Other|0|||
37822984|NCT03721172|69503256|FG002|Placebo-controlled Phase|Other|0|||
37822985|NCT03721172|69503254|FG000|Apremilast Extension Phase|Adverse Event|0|||
37822986|NCT03721172|69503255|FG001|Apremilast Extension Phase|Adverse Event|0|||
37822987|NCT03721172|69503256|FG002|Apremilast Extension Phase|Adverse Event|10|||
37822988|NCT03721172|69503254|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
37822989|NCT03721172|69503255|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
37822990|NCT03721172|69503256|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
37822991|NCT03721172|69503254|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
37822992|NCT03721172|69503255|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
37822993|NCT03721172|69503256|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
37822994|NCT03721172|69503254|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
37822995|NCT03721172|69503255|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
37822996|NCT03721172|69503256|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
37822997|NCT03721172|69503254|FG000|Apremilast Extension Phase|Protocol Violation|0|||
37822998|NCT03721172|69503255|FG001|Apremilast Extension Phase|Protocol Violation|0|||
37822999|NCT03721172|69503256|FG002|Apremilast Extension Phase|Protocol Violation|1|||
37823000|NCT03721172|69503254|FG000|Apremilast Extension Phase|Physician Decision|0|||
37887865|NCT00943722|69572685|FG002|Base Study|Protocol Violation|0|||
37887866|NCT00943722|69572686|FG003|Base Study|Protocol Violation|0|||
37887867|NCT00943722|69572687|FG004|Base Study|Protocol Violation|2|||
37887868|NCT00943722|69572688|FG005|Base Study|Protocol Violation|0|||
37887869|NCT00943722|69572689|FG006|Base Study|Protocol Violation|0|||
37823001|NCT03721172|69503255|FG001|Apremilast Extension Phase|Physician Decision|0|||
37823002|NCT03721172|69503256|FG002|Apremilast Extension Phase|Physician Decision|1|||
37833588|NCT01262989|69517313|FG001|Period 2|Intercurrent disease|1|||
37887870|NCT00943722|69572683|FG000|Base Study|Withdrawal by Subject|12|||
37887871|NCT00943722|69572684|FG001|Base Study|Withdrawal by Subject|13|||
37887872|NCT00943722|69572685|FG002|Base Study|Withdrawal by Subject|2|||
37887873|NCT00943722|69572686|FG003|Base Study|Withdrawal by Subject|13|||
37695864|NCT02326298|69172061|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
37695865|NCT02326298|69172062|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
37695866|NCT02326298|69172063|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
37695867|NCT02326298|69172064|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
37695868|NCT02326298|69172051|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
37695869|NCT02326298|69172052|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
37695870|NCT02326298|69172053|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
37695871|NCT02326298|69172054|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
37695872|NCT02326298|69172055|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
37695873|NCT02326298|69172056|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
37695874|NCT02326298|69172057|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
37695875|NCT02326298|69172058|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
37695876|NCT02326298|69172059|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
37695877|NCT02326298|69172060|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
37695878|NCT02326298|69172061|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
37695879|NCT02326298|69172062|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
37695880|NCT02326298|69172063|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
37695881|NCT02326298|69172064|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
37695882|NCT02326298|69172051|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
37695883|NCT02326298|69172052|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
37695884|NCT02326298|69172053|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
37695885|NCT02326298|69172054|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
37695886|NCT02326298|69172055|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
37695887|NCT02326298|69172056|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
37695888|NCT02326298|69172057|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
37695889|NCT02326298|69172058|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
37695890|NCT02326298|69172059|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
37695891|NCT02326298|69172060|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
37695892|NCT02326298|69172061|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
37695893|NCT02326298|69172062|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
37695894|NCT02326298|69172063|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
37695895|NCT02326298|69172064|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
37695896|NCT02326298|69172051|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
37695897|NCT02326298|69172052|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
37695898|NCT02326298|69172053|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
37695899|NCT02326298|69172054|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
37695900|NCT02326298|69172055|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
37695901|NCT02326298|69172056|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
37695902|NCT02326298|69172057|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
37695903|NCT02326298|69172058|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
37695904|NCT02326298|69172059|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
37695905|NCT02326298|69172060|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
37695906|NCT02326298|69172061|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
37695907|NCT02326298|69172062|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
37695908|NCT02326298|69172063|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
37695909|NCT02326298|69172064|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
37823003|NCT03721172|69503254|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
37823004|NCT03721172|69503255|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
37823005|NCT03721172|69503256|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
37823006|NCT03721172|69503254|FG000|Apremilast Extension Phase|Other|0|||
37823007|NCT03721172|69503255|FG001|Apremilast Extension Phase|Other|0|||
37695910|NCT02326298|69172051|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
37695911|NCT02326298|69172052|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
37695912|NCT02326298|69172053|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
37695913|NCT02326298|69172054|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
37695914|NCT02326298|69172055|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
37695915|NCT02326298|69172056|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
37695916|NCT02326298|69172057|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
37695917|NCT02326298|69172058|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
37695918|NCT02326298|69172059|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
37695919|NCT02326298|69172060|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
37695920|NCT02326298|69172061|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
37695921|NCT02326298|69172062|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
37695922|NCT02326298|69172063|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
37987550|NCT00362232|69672928|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
37695923|NCT02326298|69172064|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
37695924|NCT02326298|69172051|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
37695925|NCT02326298|69172052|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
37695926|NCT02326298|69172053|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
37695927|NCT02326298|69172054|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
37695928|NCT02326298|69172055|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
37695929|NCT02326298|69172056|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
37695930|NCT02326298|69172057|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
37695931|NCT02326298|69172058|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
37695932|NCT02326298|69172059|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
37823008|NCT03721172|69503256|FG002|Apremilast Extension Phase|Other|3|||
37823009|NCT03721172|69503254|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
37823010|NCT03721172|69503255|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
37887874|NCT00943722|69572687|FG004|Base Study|Withdrawal by Subject|8|||
37887875|NCT00943722|69572688|FG005|Base Study|Withdrawal by Subject|0|||
37887876|NCT00943722|69572689|FG006|Base Study|Withdrawal by Subject|0|||
37887877|NCT00943722|69572683|FG000|Base Study|Month 12 visit not completed|0|||
37887878|NCT00943722|69572684|FG001|Base Study|Month 12 visit not completed|0|||
37987551|NCT00362232|69672927|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
37987552|NCT00362232|69672928|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
37987553|NCT00362232|69672927|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
37987554|NCT00362232|69672928|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
37887879|NCT00943722|69572685|FG002|Base Study|Month 12 visit not completed|0|||
37887880|NCT00943722|69572686|FG003|Base Study|Month 12 visit not completed|0|||
37887881|NCT00943722|69572687|FG004|Base Study|Month 12 visit not completed|2|||
37887882|NCT00943722|69572688|FG005|Base Study|Month 12 visit not completed|0|||
37887883|NCT00943722|69572689|FG006|Base Study|Month 12 visit not completed|0|||
37887884|NCT00943722|69572683|FG000|First Extension Study: EXT 1|Adverse Event|0|||
37887885|NCT00943722|69572684|FG001|First Extension Study: EXT 1|Adverse Event|0|||
37887886|NCT00943722|69572685|FG002|First Extension Study: EXT 1|Adverse Event|0|||
37887887|NCT00943722|69572686|FG003|First Extension Study: EXT 1|Adverse Event|0|||
37695933|NCT02326298|69172060|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
37823011|NCT03721172|69503256|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
37823012|NCT04540887|69503312|FG000|Overall Study|Withdrawal by Subject|2|||
37823013|NCT04294680|69503323|FG000|Overall Study|Withdrawal by Subject|2|||
37823014|NCT04294680|69503324|FG001|Overall Study|Withdrawal by Subject|1|||
37823015|NCT04294680|69503323|FG000|Overall Study|Follow-up visits completed outside of window|1|||
37823016|NCT04294680|69503324|FG001|Overall Study|Follow-up visits completed outside of window|0|||
37823017|NCT01350102|69503334|FG000|Overall Study|Adverse Event|0|||
37823018|NCT01350102|69503335|FG001|Overall Study|Adverse Event|0|||
37823019|NCT01350102|69503336|FG002|Overall Study|Adverse Event|1|||
37823020|NCT01350102|69503337|FG003|Overall Study|Adverse Event|0|||
37823021|NCT04059549|69503351|FG000|Overall Study|Withdrawal by Subject|2|||
37823022|NCT04059549|69503352|FG001|Overall Study|Withdrawal by Subject|0|||
37823023|NCT04041570|69503364|FG000|Overall Study|Moved from Area|0|||
37823024|NCT04041570|69503365|FG001|Overall Study|Moved from Area|2|||
37887888|NCT00943722|69572687|FG004|First Extension Study: EXT 1|Adverse Event|0|||
37887889|NCT00943722|69572688|FG005|First Extension Study: EXT 1|Adverse Event|1|||
37887890|NCT00943722|69572689|FG006|First Extension Study: EXT 1|Adverse Event|0|||
37823025|NCT03879408|69503377|FG000|Overall Study|Lost to Follow-up|0|||
37823026|NCT03879408|69503378|FG001|Overall Study|Lost to Follow-up|3|||
37823027|NCT03879408|69503379|FG002|Overall Study|Lost to Follow-up|2|||
37823028|NCT03879408|69503380|FG003|Overall Study|Lost to Follow-up|1|||
37823029|NCT03879408|69503381|FG004|Overall Study|Lost to Follow-up|0|||
37887891|NCT00943722|69572683|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
37887892|NCT00943722|69572684|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
37887893|NCT00943722|69572685|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
37887894|NCT00943722|69572686|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
37887895|NCT00943722|69572687|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
37887896|NCT00943722|69572688|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
37887897|NCT00943722|69572689|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
37887898|NCT00943722|69572683|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
37887899|NCT00943722|69572684|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
37887900|NCT00943722|69572685|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
37887901|NCT00943722|69572686|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
37887902|NCT00943722|69572687|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
37887903|NCT00943722|69572688|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
37887904|NCT00943722|69572689|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
37887905|NCT00943722|69572683|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
37887906|NCT00943722|69572684|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
37887907|NCT00943722|69572685|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
37887908|NCT00943722|69572686|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
37887909|NCT00943722|69572687|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
37887910|NCT00943722|69572688|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
37887911|NCT00943722|69572689|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
37987555|NCT00362232|69672927|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
37987556|NCT00362232|69672928|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
37987557|NCT00362232|69672927|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
37987558|NCT00362232|69672928|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
37887912|NCT00943722|69572683|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
37887913|NCT00943722|69572684|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
37887914|NCT00943722|69572685|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
37887915|NCT00943722|69572686|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
37887916|NCT00943722|69572687|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
37887917|NCT00943722|69572688|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
37887918|NCT00943722|69572689|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
37887919|NCT00943722|69572683|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
37887920|NCT00943722|69572684|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
37887921|NCT00943722|69572685|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
37887922|NCT00943722|69572686|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
37887923|NCT00943722|69572687|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
37887924|NCT00943722|69572688|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
37887925|NCT00943722|69572689|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
37887926|NCT00943722|69572683|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
37887927|NCT00943722|69572684|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
37887928|NCT00943722|69572685|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
37887929|NCT00943722|69572686|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
37887930|NCT00943722|69572687|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
37887931|NCT00943722|69572688|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
37887932|NCT00943722|69572689|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
37887933|NCT00943722|69572683|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
37887934|NCT00943722|69572684|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
37887935|NCT00943722|69572685|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
37887936|NCT00943722|69572686|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
37887937|NCT00943722|69572687|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
37887938|NCT00943722|69572688|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
37887939|NCT00943722|69572689|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
37887940|NCT00943722|69572683|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
37887941|NCT00943722|69572684|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
37887942|NCT00943722|69572685|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
37887943|NCT00943722|69572686|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
37887944|NCT00943722|69572687|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
37987559|NCT00362232|69672927|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
37987560|NCT00362232|69672928|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
37887945|NCT00943722|69572688|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
37887946|NCT00943722|69572689|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
37887947|NCT00901485|69572712|FG000|Overall Study|Lack of Efficacy|0|||
37887948|NCT00901485|69572713|FG001|Overall Study|Lack of Efficacy|2|||
37887949|NCT00901485|69572712|FG000|Overall Study|Withdrawal by Subject|1|||
37987561|NCT00362232|69672927|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
37987562|NCT00362232|69672928|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
37887950|NCT00901485|69572713|FG001|Overall Study|Withdrawal by Subject|2|||
37887951|NCT00896337|69572719|FG000|Overall Study|Death|7|||
37887952|NCT00896337|69572719|FG000|Overall Study|Withdrawal by Subject|7|||
37887953|NCT00896337|69572719|FG000|Overall Study|Lost to Follow-up|11|||
37887954|NCT00953706|69572730|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
37887955|NCT00953706|69572731|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
37887956|NCT00953706|69572732|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
37887957|NCT00953706|69572733|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
37887958|NCT00953706|69572730|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
37887959|NCT00953706|69572731|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
37887960|NCT00953706|69572732|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
37887961|NCT00953706|69572733|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
37887962|NCT00953706|69572730|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
37887963|NCT00953706|69572731|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
37887964|NCT00953706|69572732|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
37887965|NCT00953706|69572733|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
37887966|NCT00953706|69572730|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
37887967|NCT00953706|69572731|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
37887968|NCT00953706|69572732|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
37887969|NCT00953706|69572733|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
37887970|NCT00953706|69572730|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
37887971|NCT00953706|69572731|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
37887972|NCT00953706|69572732|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
37887973|NCT00953706|69572733|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
37887974|NCT00953706|69572730|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
37887975|NCT00953706|69572731|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
37887976|NCT00953706|69572732|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
37887977|NCT00953706|69572733|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
37887978|NCT00953706|69572730|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
37887979|NCT00953706|69572731|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
37887980|NCT00953706|69572732|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
37887981|NCT00953706|69572733|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
37887982|NCT00953706|69572730|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
37887983|NCT00953706|69572731|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
37887984|NCT00953706|69572732|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
37887985|NCT00953706|69572733|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
37887986|NCT00953706|69572730|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
37887987|NCT00953706|69572731|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
37887988|NCT00953706|69572732|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
37887989|NCT00953706|69572733|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
37987563|NCT00362232|69672927|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
37987564|NCT00362232|69672928|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
37987565|NCT00362232|69672927|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
37987566|NCT00362232|69672928|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
37987567|NCT00362232|69672927|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
37987568|NCT00362232|69672928|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
37987569|NCT00362232|69672927|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
37987570|NCT00362232|69672928|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
37987571|NCT00219544|69672934|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
37987572|NCT00219544|69672935|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
37887990|NCT00953706|69572730|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
37887991|NCT00953706|69572731|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
37887992|NCT00953706|69572732|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
37887993|NCT00953706|69572733|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
37887994|NCT00953706|69572730|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
37887995|NCT00953706|69572731|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
37887996|NCT00953706|69572732|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
37887997|NCT00953706|69572733|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
37987573|NCT00219544|69672934|FG000|Single Blind Treatment Period|Adverse Event|9|||
37987574|NCT00219544|69672935|FG001|Single Blind Treatment Period|Adverse Event|0|||
37987575|NCT00219544|69672934|FG000|Single Blind Treatment Period|Protocol Violation|4|||
37987576|NCT00219544|69672935|FG001|Single Blind Treatment Period|Protocol Violation|0|||
37887998|NCT00940992|69572746|FG000|Overall Study|Adverse Event|2|||
37887999|NCT00940992|69572747|FG001|Overall Study|Adverse Event|0|||
37888000|NCT00940992|69572748|FG002|Overall Study|Adverse Event|1|||
37888001|NCT00940992|69572746|FG000|Overall Study|subject request|2|||
37888002|NCT00940992|69572747|FG001|Overall Study|subject request|1|||
37888003|NCT00940992|69572748|FG002|Overall Study|subject request|0|||
37888004|NCT00940992|69572746|FG000|Overall Study|Lost to Follow-up|0|||
37888005|NCT00940992|69572747|FG001|Overall Study|Lost to Follow-up|1|||
37888006|NCT00940992|69572748|FG002|Overall Study|Lost to Follow-up|1|||
37888007|NCT00938964|69572758|FG000|Overall Study|Death|3|||
37888008|NCT00938964|69572759|FG001|Overall Study|Death|3|||
37888009|NCT00938964|69572758|FG000|Overall Study|Lost to Follow-up|2|||
37888010|NCT00938964|69572759|FG001|Overall Study|Lost to Follow-up|3|||
37888011|NCT00938964|69572758|FG000|Overall Study|Withdrawal by Subject|22|||
37888012|NCT00938964|69572759|FG001|Overall Study|Withdrawal by Subject|18|||
37888013|NCT00938964|69572758|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
37888014|NCT00938964|69572759|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
37888015|NCT00938886|69572767|FG000|Overall Study|Death|0|||
37888016|NCT00938886|69572768|FG001|Overall Study|Death|1|||
37888017|NCT00938886|69572767|FG000|Overall Study|Withdrawal by Subject|4|||
37888018|NCT00938886|69572768|FG001|Overall Study|Withdrawal by Subject|7|||
37888019|NCT00938886|69572767|FG000|Overall Study|Lost to Follow-up|3|||
37888020|NCT00938886|69572768|FG001|Overall Study|Lost to Follow-up|2|||
37888021|NCT00942708|69572774|FG000|Overall Study|Withdrawal by Subject|1|||
37888022|NCT00937950|69572779|FG000|Overall Study|Withdrawal by Subject|23|||
37888023|NCT00937950|69572779|FG000|Overall Study|Migrated/moved from study area|27|||
37888024|NCT00937950|69572779|FG000|Overall Study|Lost to Follow-up|144|||
37888025|NCT00937950|69572779|FG000|Overall Study|Missing confirmed|4|||
37888026|NCT00937950|69572779|FG000|Overall Study|Other|18|||
37888027|NCT00942162|69572786|FG000|Overall Study|Death|45|||
37888028|NCT00942162|69572787|FG001|Overall Study|Death|35|||
37888029|NCT00942162|69572788|FG002|Overall Study|Death|0|||
37888030|NCT00942162|69572786|FG000|Overall Study|Withdrawal by Subject|7|||
37888031|NCT00942162|69572787|FG001|Overall Study|Withdrawal by Subject|2|||
37888032|NCT00942162|69572788|FG002|Overall Study|Withdrawal by Subject|0|||
37888033|NCT00942162|69572786|FG000|Overall Study|Lost to Follow-up|4|||
37888034|NCT00942162|69572787|FG001|Overall Study|Lost to Follow-up|0|||
37888035|NCT00942162|69572788|FG002|Overall Study|Lost to Follow-up|0|||
37888036|NCT00942162|69572786|FG000|Overall Study|Other|14|||
37888037|NCT00942162|69572787|FG001|Overall Study|Other|13|||
37888038|NCT00942162|69572788|FG002|Overall Study|Other|2|||
37888039|NCT00942084|69572798|FG000|Overall Study|Death|2|||
37888040|NCT00941928|69572802|FG000|Overall Study|Withdrawal by Subject|1|||
37888041|NCT00941928|69572802|FG000|Overall Study|Disease Progression|1|||
37888042|NCT00937560|69572806|FG000|Initial Treatment|Death|6|||
37888043|NCT00937560|69572806|FG000|Initial Treatment|Withdraw consent|3|||
37888044|NCT00937560|69572806|FG000|Initial Treatment|Adverse Event|1|||
37888045|NCT00937560|69572806|FG000|Initial Treatment|Lost to Follow-up|1|||
37987577|NCT00219544|69672934|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
37987578|NCT00219544|69672935|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
37888046|NCT00937560|69572806|FG000|Initial Treatment|No end of study page|10|||
37888047|NCT00937560|69572806|FG000|Maintenance Treatment|Death|12|||
37888048|NCT00937560|69572806|FG000|Maintenance Treatment|Withdraw consent|5|||
37888049|NCT00937560|69572806|FG000|Maintenance Treatment|According to protocol|1|||
37888050|NCT00594568|69572813|FG000|Initial Treatment|Adverse Event|51|||
37888051|NCT00594568|69572814|FG001|Initial Treatment|Adverse Event|121|||
37888052|NCT00594568|69572815|FG002|Initial Treatment|Adverse Event|144|||
37888053|NCT00594568|69572813|FG000|Initial Treatment|Death|6|||
37888054|NCT00594568|69572814|FG001|Initial Treatment|Death|11|||
37888055|NCT00594568|69572815|FG002|Initial Treatment|Death|15|||
37987579|NCT00219544|69672934|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
37888056|NCT00594568|69572813|FG000|Initial Treatment|Lost to Follow-up|4|||
37888057|NCT00594568|69572814|FG001|Initial Treatment|Lost to Follow-up|1|||
37888058|NCT00594568|69572815|FG002|Initial Treatment|Lost to Follow-up|4|||
37888059|NCT00594568|69572813|FG000|Initial Treatment|Physician Decision|3|||
37888060|NCT00594568|69572814|FG001|Initial Treatment|Physician Decision|2|||
37888061|NCT00594568|69572815|FG002|Initial Treatment|Physician Decision|4|||
37987580|NCT00219544|69672935|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
37888062|NCT00594568|69572813|FG000|Initial Treatment|Protocol Violation|2|||
37888063|NCT00594568|69572814|FG001|Initial Treatment|Protocol Violation|2|||
37888064|NCT00594568|69572815|FG002|Initial Treatment|Protocol Violation|5|||
37888065|NCT00594568|69572813|FG000|Initial Treatment|Withdrawal by Subject|25|||
37888066|NCT00594568|69572814|FG001|Initial Treatment|Withdrawal by Subject|31|||
37888067|NCT00594568|69572815|FG002|Initial Treatment|Withdrawal by Subject|46|||
37888068|NCT00594568|69572813|FG000|Initial Treatment|Sponsor decision|193|||
37888069|NCT00594568|69572814|FG001|Initial Treatment|Sponsor decision|142|||
37888070|NCT00594568|69572815|FG002|Initial Treatment|Sponsor decision|147|||
37888071|NCT00594568|69572813|FG000|Initial Treatment|Caregiver decision|21|||
37888072|NCT00594568|69572814|FG001|Initial Treatment|Caregiver decision|36|||
37888073|NCT00594568|69572815|FG002|Initial Treatment|Caregiver decision|36|||
37888074|NCT00594568|69572813|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
37888075|NCT00594568|69572814|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
37888076|NCT00594568|69572815|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
37888077|NCT00594568|69572813|FG000|Initial Treatment|Entry criteria exclusion|0|||
37888078|NCT00594568|69572814|FG001|Initial Treatment|Entry criteria exclusion|1|||
37888079|NCT00594568|69572815|FG002|Initial Treatment|Entry criteria exclusion|1|||
37888080|NCT00594568|69572813|FG000|Delayed Start|Death|0|||
37888081|NCT00594568|69572814|FG001|Delayed Start|Death|0|||
37888082|NCT00594568|69572815|FG002|Delayed Start|Death|1|||
37888083|NCT00594568|69572813|FG000|Delayed Start|Adverse Event|12|||
37888084|NCT00594568|69572814|FG001|Delayed Start|Adverse Event|2|||
37888085|NCT00594568|69572815|FG002|Delayed Start|Adverse Event|2|||
37888086|NCT00594568|69572813|FG000|Delayed Start|Withdrawal by Subject|4|||
37888087|NCT00594568|69572814|FG001|Delayed Start|Withdrawal by Subject|3|||
37888088|NCT00594568|69572815|FG002|Delayed Start|Withdrawal by Subject|0|||
37888089|NCT00594568|69572813|FG000|Delayed Start|Physician Decision|0|||
37888090|NCT00594568|69572814|FG001|Delayed Start|Physician Decision|0|||
37888091|NCT00594568|69572815|FG002|Delayed Start|Physician Decision|1|||
37888092|NCT00594568|69572813|FG000|Delayed Start|Lost to Follow-up|0|||
37888093|NCT00594568|69572814|FG001|Delayed Start|Lost to Follow-up|0|||
37888094|NCT00594568|69572815|FG002|Delayed Start|Lost to Follow-up|1|||
37888095|NCT00594568|69572813|FG000|Delayed Start|Caregiver Decision|5|||
37888096|NCT00594568|69572814|FG001|Delayed Start|Caregiver Decision|6|||
37888097|NCT00594568|69572815|FG002|Delayed Start|Caregiver Decision|2|||
37888098|NCT00594568|69572813|FG000|Delayed Start|Sponsor Decision|77|||
37888099|NCT00594568|69572814|FG001|Delayed Start|Sponsor Decision|66|||
37888100|NCT00594568|69572815|FG002|Delayed Start|Sponsor Decision|59|||
37888101|NCT00594568|69572813|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
37888102|NCT00594568|69572814|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
37888103|NCT00594568|69572815|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
37888104|NCT00594568|69572813|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
37888105|NCT00594568|69572814|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
37888106|NCT00594568|69572815|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
37888107|NCT00594568|69572813|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
37888108|NCT00594568|69572814|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
37888109|NCT00594568|69572815|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
37888110|NCT00594568|69572813|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
37888111|NCT00594568|69572814|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
37888112|NCT00594568|69572815|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
37888113|NCT00594568|69572813|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
37888114|NCT00594568|69572814|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
37888115|NCT00594568|69572815|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
37888116|NCT00594568|69572813|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
37888117|NCT00594568|69572814|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
37888118|NCT00594568|69572815|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
37888119|NCT00875056|69572843|FG000|Overall Study|Adverse Event|6|||
37888120|NCT00875056|69572844|FG001|Overall Study|Adverse Event|1|||
37888121|NCT00875056|69572845|FG002|Overall Study|Adverse Event|2|||
37888122|NCT00875056|69572843|FG000|Overall Study|Progressive Disease|14|||
37888123|NCT00875056|69572844|FG001|Overall Study|Progressive Disease|8|||
37888124|NCT00875056|69572845|FG002|Overall Study|Progressive Disease|3|||
37888125|NCT00875056|69572843|FG000|Overall Study|Withdrawal by Subject|3|||
37888126|NCT00875056|69572844|FG001|Overall Study|Withdrawal by Subject|0|||
37888127|NCT00875056|69572845|FG002|Overall Study|Withdrawal by Subject|1|||
37888128|NCT00940602|69572855|FG000|Overall Study|Administrative problems|1|||
37888129|NCT00940602|69572856|FG001|Overall Study|Administrative problems|1|||
37888130|NCT00940602|69572855|FG000|Overall Study|Patient/guardian decision|13|||
37888131|NCT00940602|69572856|FG001|Overall Study|Patient/guardian decision|28|||
37888132|NCT00940602|69572855|FG000|Overall Study|Physician Decision|8|||
37888133|NCT00940602|69572856|FG001|Overall Study|Physician Decision|5|||
37888134|NCT00940602|69572855|FG000|Overall Study|Pregnancy|1|||
37888135|NCT00940602|69572856|FG001|Overall Study|Pregnancy|0|||
37888136|NCT00940602|69572855|FG000|Overall Study|Protocol Deviation (untreated)|1|||
37888137|NCT00940602|69572856|FG001|Overall Study|Protocol Deviation (untreated)|0|||
37888138|NCT00940602|69572855|FG000|Overall Study|Disease progression|8|||
37888139|NCT00940602|69572856|FG001|Overall Study|Disease progression|2|||
37888140|NCT00940602|69572855|FG000|Overall Study|Death|38|||
37888141|NCT00940602|69572856|FG001|Overall Study|Death|19|||
37888142|NCT00940602|69572855|FG000|Overall Study|Lost to Follow-up|3|||
37888143|NCT00940602|69572856|FG001|Overall Study|Lost to Follow-up|1|||
37888144|NCT00940602|69572855|FG000|Overall Study|Patient withdrew consent|26|||
37888145|NCT00940602|69572856|FG001|Overall Study|Patient withdrew consent|13|||
37888146|NCT00940602|69572855|FG000|Overall Study|Adverse Event|7|||
37888147|NCT00940602|69572856|FG001|Overall Study|Adverse Event|2|||
37888148|NCT00940602|69572855|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
37888149|NCT00940602|69572856|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
37888150|NCT00875524|69572865|FG000|Overall Study|Serious adverse event|0|||
37888151|NCT00875524|69572866|FG001|Overall Study|Serious adverse event|1|||
37888152|NCT00875524|69572865|FG000|Overall Study|Protocol Violation|4|||
37888153|NCT00875524|69572866|FG001|Overall Study|Protocol Violation|0|||
37888154|NCT00875524|69572865|FG000|Overall Study|Lost to Follow-up|1|||
37888155|NCT00875524|69572866|FG001|Overall Study|Lost to Follow-up|0|||
37888156|NCT00875524|69572865|FG000|Overall Study|Withdrawal by Subject|3|||
37888157|NCT00875524|69572866|FG001|Overall Study|Withdrawal by Subject|5|||
37888158|NCT01094288|69572880|FG000|Overall Study|Adverse Event|0|||
37888159|NCT01094288|69572881|FG001|Overall Study|Adverse Event|3|||
37888160|NCT01094288|69572882|FG002|Overall Study|Adverse Event|1|||
37888161|NCT01094288|69572883|FG003|Overall Study|Adverse Event|1|||
37888162|NCT01094288|69572884|FG004|Overall Study|Adverse Event|0|||
37888163|NCT01094288|69572885|FG005|Overall Study|Adverse Event|0|||
37888164|NCT01094288|69572886|FG006|Overall Study|Adverse Event|0|||
37888165|NCT01094288|69572887|FG007|Overall Study|Adverse Event|0|||
37888166|NCT01094288|69572880|FG000|Overall Study|Withdrawal by Subject|0|||
37888167|NCT01094288|69572881|FG001|Overall Study|Withdrawal by Subject|1|||
37888168|NCT01094288|69572882|FG002|Overall Study|Withdrawal by Subject|2|||
37888169|NCT01094288|69572883|FG003|Overall Study|Withdrawal by Subject|0|||
37888170|NCT01094288|69572884|FG004|Overall Study|Withdrawal by Subject|0|||
37888171|NCT01094288|69572885|FG005|Overall Study|Withdrawal by Subject|0|||
37888172|NCT01094288|69572886|FG006|Overall Study|Withdrawal by Subject|0|||
37888173|NCT01094288|69572887|FG007|Overall Study|Withdrawal by Subject|2|||
37888174|NCT01094288|69572880|FG000|Overall Study|Initiation of Alternative Therapy|0|||
37888175|NCT01094288|69572881|FG001|Overall Study|Initiation of Alternative Therapy|0|||
37888176|NCT01094288|69572882|FG002|Overall Study|Initiation of Alternative Therapy|1|||
37888177|NCT01094288|69572883|FG003|Overall Study|Initiation of Alternative Therapy|0|||
37888178|NCT01094288|69572884|FG004|Overall Study|Initiation of Alternative Therapy|0|||
37888179|NCT01094288|69572885|FG005|Overall Study|Initiation of Alternative Therapy|0|||
37888180|NCT01094288|69572886|FG006|Overall Study|Initiation of Alternative Therapy|0|||
37888181|NCT01094288|69572887|FG007|Overall Study|Initiation of Alternative Therapy|0|||
37888182|NCT01094288|69572880|FG000|Overall Study|Reason not Specified|2|||
37888183|NCT01094288|69572881|FG001|Overall Study|Reason not Specified|3|||
37888184|NCT01094288|69572882|FG002|Overall Study|Reason not Specified|0|||
37888185|NCT01094288|69572883|FG003|Overall Study|Reason not Specified|1|||
37888186|NCT01094288|69572884|FG004|Overall Study|Reason not Specified|0|||
37888187|NCT01094288|69572885|FG005|Overall Study|Reason not Specified|0|||
37888188|NCT01094288|69572886|FG006|Overall Study|Reason not Specified|0|||
37888189|NCT01094288|69572887|FG007|Overall Study|Reason not Specified|0|||
37695934|NCT02326298|69172061|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
37888190|NCT01094288|69572880|FG000|Overall Study|Ongoing Participants|0|||
37888191|NCT01094288|69572881|FG001|Overall Study|Ongoing Participants|3|||
37823030|NCT03879408|69503377|FG000|Overall Study|Withdrawal by Subject|2|||
37823031|NCT03879408|69503378|FG001|Overall Study|Withdrawal by Subject|1|||
37888192|NCT01094288|69572882|FG002|Overall Study|Ongoing Participants|0|||
37888193|NCT01094288|69572883|FG003|Overall Study|Ongoing Participants|0|||
37888194|NCT01094288|69572884|FG004|Overall Study|Ongoing Participants|0|||
37888195|NCT01094288|69572885|FG005|Overall Study|Ongoing Participants|0|||
37888196|NCT01094288|69572886|FG006|Overall Study|Ongoing Participants|0|||
37888197|NCT01094288|69572887|FG007|Overall Study|Ongoing Participants|0|||
37888198|NCT00874120|69572911|FG000|First Intervention|Adverse Event|0|||
37888199|NCT00874120|69572912|FG001|First Intervention|Adverse Event|1|||
37888200|NCT00874120|69572911|FG000|First Intervention|Withdrawal by Subject|2|||
37888201|NCT00874120|69572912|FG001|First Intervention|Withdrawal by Subject|0|||
37888202|NCT00874120|69572911|FG000|First Intervention|Lost to Follow-up|0|||
37888203|NCT00874120|69572912|FG001|First Intervention|Lost to Follow-up|1|||
37888204|NCT00874120|69572911|FG000|First Intervention|Protocol Violation|3|||
37888205|NCT00874120|69572912|FG001|First Intervention|Protocol Violation|0|||
37888206|NCT00874120|69572911|FG000|First Intervention|positive drug test|1|||
37888207|NCT00874120|69572912|FG001|First Intervention|positive drug test|0|||
37888208|NCT00874120|69572911|FG000|Second Intervention|Withdrawal by Subject|1|||
37888209|NCT00874120|69572912|FG001|Second Intervention|Withdrawal by Subject|0|||
37888210|NCT00874120|69572911|FG000|Second Intervention|Protocol Violation|1|||
37888211|NCT00874120|69572912|FG001|Second Intervention|Protocol Violation|0|||
37987581|NCT00219544|69672934|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
37987582|NCT00219544|69672935|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
37987583|NCT00357552|69672943|FG000|Screening|Did not meet eligibility criteria|84|||
37987584|NCT00357552|69672943|FG000|Weeks 0 to 24|Death|1|||
37987585|NCT00357552|69672943|FG000|Weeks 24 to 104|Death|3|||
37987586|NCT00357552|69672943|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
37888212|NCT00939822|69572920|FG000|Overall Study|Lost to Follow-up|1|||
37888213|NCT00939822|69572921|FG001|Overall Study|Lost to Follow-up|0|||
37888214|NCT00939822|69572920|FG000|Overall Study|withdrew from study due to busy schedule|1|||
37888215|NCT00939822|69572921|FG001|Overall Study|withdrew from study due to busy schedule|1|||
37888216|NCT00939822|69572920|FG000|Overall Study|Mental health issues|0|||
37888217|NCT00939822|69572921|FG001|Overall Study|Mental health issues|2|||
37888218|NCT00939510|69572927|FG000|Overall Study|Withdrawal by Subject|1|||
37888219|NCT01098266|69572933|FG000|Overall Study|Physician Decision|1|||
37888220|NCT01098266|69572934|FG001|Overall Study|Physician Decision|0|||
37888221|NCT01098266|69572933|FG000|Overall Study|Death|3|||
37888222|NCT01098266|69572934|FG001|Overall Study|Death|2|||
37888223|NCT01098266|69572933|FG000|Overall Study|Withdrawal by Subject|3|||
37888224|NCT01098266|69572934|FG001|Overall Study|Withdrawal by Subject|5|||
37823032|NCT03879408|69503379|FG002|Overall Study|Withdrawal by Subject|1|||
37888225|NCT00935532|69572942|FG000|Overall Study|Adverse Event|11|||
37888226|NCT00935532|69572943|FG001|Overall Study|Adverse Event|6|||
37987587|NCT00187096|69672954|FG000|Overall Study|unacceptable toxicity|0|||
37987588|NCT00187096|69672955|FG001|Overall Study|unacceptable toxicity|0|||
37823033|NCT03879408|69503380|FG003|Overall Study|Withdrawal by Subject|0|||
37823034|NCT03879408|69503381|FG004|Overall Study|Withdrawal by Subject|1|||
37823035|NCT00819780|69503399|FG000|Overall Study|Did not receive study drug|3|||
37823036|NCT00819780|69503400|FG001|Overall Study|Did not receive study drug|4|||
37823037|NCT00819780|69503399|FG000|Overall Study|Still in treatment|25|||
37823038|NCT00819780|69503400|FG001|Overall Study|Still in treatment|17|||
37888227|NCT00935532|69572942|FG000|Overall Study|Death|1|||
37888228|NCT00935532|69572943|FG001|Overall Study|Death|0|||
37987589|NCT00187096|69672956|FG002|Overall Study|unacceptable toxicity|1|||
37987590|NCT00357396|69672966|FG000|Overall Study|Adverse Event|1|||
37987591|NCT00357396|69672967|FG001|Overall Study|Adverse Event|0|||
37695935|NCT02326298|69172062|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
37823039|NCT00000620|69503492|FG000|Overall Study|Death|86|||
37888229|NCT00935532|69572942|FG000|Overall Study|Lost to Follow-up|1|||
37888230|NCT00935532|69572943|FG001|Overall Study|Lost to Follow-up|0|||
37888231|NCT00935532|69572942|FG000|Overall Study|Physician Decision|1|||
37888232|NCT00935532|69572943|FG001|Overall Study|Physician Decision|2|||
37888233|NCT00935532|69572942|FG000|Overall Study|Protocol Violation|2|||
37888234|NCT00935532|69572943|FG001|Overall Study|Protocol Violation|1|||
37888235|NCT00935532|69572942|FG000|Overall Study|Subject Decision|2|||
37888236|NCT00935532|69572943|FG001|Overall Study|Subject Decision|1|||
37888237|NCT00935532|69572942|FG000|Overall Study|Sponsor Decision|0|||
37888238|NCT00935532|69572943|FG001|Overall Study|Sponsor Decision|1|||
37888239|NCT00935532|69572942|FG000|Overall Study|Loss Glucose Control|4|||
37888240|NCT00935532|69572943|FG001|Overall Study|Loss Glucose Control|0|||
37888241|NCT01093586|69572949|FG000|Overall Study|Failed to engraft|3|||
37888242|NCT00937404|69572953|FG000|Overall Study|Protocol Violation|1|||
37888243|NCT00937404|69572953|FG000|Overall Study|Withdrawal by Subject|1|||
37888244|NCT01098110|69572960|FG000|Overall Study|Withdrawal by Subject|14|||
37888245|NCT01098110|69572961|FG001|Overall Study|Withdrawal by Subject|24|||
37888246|NCT01098110|69572962|FG002|Overall Study|Withdrawal by Subject|19|||
37888247|NCT01098110|69572960|FG000|Overall Study|Adverse Event|30|||
37987592|NCT00186628|69672972|FG000|Overall Study|Death|2|||
37888248|NCT01098110|69572961|FG001|Overall Study|Adverse Event|32|||
37987593|NCT00186628|69672972|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
37888249|NCT01098110|69572962|FG002|Overall Study|Adverse Event|43|||
37888250|NCT01098110|69572960|FG000|Overall Study|Lack of Efficacy|13|||
37888251|NCT01098110|69572961|FG001|Overall Study|Lack of Efficacy|9|||
37888252|NCT01098110|69572962|FG002|Overall Study|Lack of Efficacy|27|||
37888253|NCT01098110|69572960|FG000|Overall Study|Other|4|||
37888254|NCT01098110|69572961|FG001|Overall Study|Other|7|||
37888255|NCT01098110|69572962|FG002|Overall Study|Other|5|||
37888256|NCT01098110|69572960|FG000|Overall Study|Untreated|1|||
37888257|NCT01098110|69572961|FG001|Overall Study|Untreated|1|||
37888258|NCT01098110|69572962|FG002|Overall Study|Untreated|0|||
37888259|NCT01092728|69572972|FG000|Overall Study|Withdrawal by Subject|2|||
37888260|NCT01092728|69572973|FG001|Overall Study|Withdrawal by Subject|0|||
37888261|NCT01092728|69572972|FG000|Overall Study|Adverse Event|0|||
37695936|NCT02326298|69172063|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
37888262|NCT01092728|69572973|FG001|Overall Study|Adverse Event|1|||
37888263|NCT01092728|69572972|FG000|Overall Study|Disease Progression|1|||
37888264|NCT01092728|69572973|FG001|Overall Study|Disease Progression|13|||
37888265|NCT01092728|69572972|FG000|Overall Study|Prohibited Concomitant Medications|1|||
37888266|NCT01092728|69572973|FG001|Overall Study|Prohibited Concomitant Medications|0|||
37888267|NCT01096550|69572981|FG000|Overall Study|discontinued site|10|||
37987594|NCT00368550|69672980|FG000|Overall Study|Adverse Event|7|||
37888268|NCT01096550|69572982|FG001|Overall Study|discontinued site|11|||
37888269|NCT01096550|69572981|FG000|Overall Study|non-regular treatment track at clinic|1|||
37888270|NCT01096550|69572982|FG001|Overall Study|non-regular treatment track at clinic|1|||
37888271|NCT01096550|69572981|FG000|Overall Study|clinic readmission|1|||
37888272|NCT01096550|69572982|FG001|Overall Study|clinic readmission|1|||
37888273|NCT01096550|69572981|FG000|Overall Study|Withdrawal by Subject|0|||
37888274|NCT01096550|69572982|FG001|Overall Study|Withdrawal by Subject|1|||
37888275|NCT01096550|69572981|FG000|Overall Study|non-African American participant|13|||
37888276|NCT01096550|69572982|FG001|Overall Study|non-African American participant|6|||
37823040|NCT00000620|69503493|FG001|Overall Study|Death|67|||
37888277|NCT01096550|69572981|FG000|Overall Study|Lost to Follow-up|12|||
37888278|NCT01096550|69572982|FG001|Overall Study|Lost to Follow-up|9|||
37888279|NCT01101542|69572988|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
37888280|NCT01101542|69572988|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
37888281|NCT01101542|69572988|FG000|Year 4 Surveillance Period|Other|287|||
37888282|NCT01101542|69572988|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
37888283|NCT01101542|69572988|FG000|Year 5 Surveillance Period|Pregnancy|1|||
37888284|NCT01101542|69572988|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
37888285|NCT01101542|69572988|FG000|Year 6 Surveillance Period|Pregnancy|1|||
37888286|NCT01101542|69572988|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
37987595|NCT00368550|69672981|FG001|Overall Study|Adverse Event|4|||
37823041|NCT00000620|69503494|FG002|Overall Study|Death|112|||
37823042|NCT00000620|69503495|FG003|Overall Study|Death|126|||
37823043|NCT00000620|69503496|FG004|Overall Study|Death|64|||
37823044|NCT00000620|69503497|FG005|Overall Study|Death|77|||
37823045|NCT00000620|69503498|FG006|Overall Study|Death|91|||
37823046|NCT00000620|69503499|FG007|Overall Study|Death|95|||
37823047|NCT00000620|69503492|FG000|Overall Study|Lost to Follow-up|14|||
37823048|NCT00000620|69503493|FG001|Overall Study|Lost to Follow-up|14|||
37823049|NCT00000620|69503494|FG002|Overall Study|Lost to Follow-up|14|||
37823050|NCT00000620|69503495|FG003|Overall Study|Lost to Follow-up|14|||
37823051|NCT00000620|69503496|FG004|Overall Study|Lost to Follow-up|15|||
37823052|NCT00000620|69503497|FG005|Overall Study|Lost to Follow-up|15|||
37823053|NCT00000620|69503498|FG006|Overall Study|Lost to Follow-up|13|||
37823054|NCT00000620|69503499|FG007|Overall Study|Lost to Follow-up|14|||
37823055|NCT00000620|69503492|FG000|Overall Study|Withdrawal by Subject|40|||
37823056|NCT00000620|69503493|FG001|Overall Study|Withdrawal by Subject|27|||
37823057|NCT00000620|69503494|FG002|Overall Study|Withdrawal by Subject|28|||
37823058|NCT00000620|69503495|FG003|Overall Study|Withdrawal by Subject|27|||
37823059|NCT00000620|69503496|FG004|Overall Study|Withdrawal by Subject|30|||
37823060|NCT00000620|69503497|FG005|Overall Study|Withdrawal by Subject|32|||
37823061|NCT00000620|69503498|FG006|Overall Study|Withdrawal by Subject|32|||
37823062|NCT00000620|69503499|FG007|Overall Study|Withdrawal by Subject|21|||
37823063|NCT00000620|69503492|FG000|Overall Study|missed closeout visit|22|||
37823064|NCT00000620|69503493|FG001|Overall Study|missed closeout visit|28|||
37823065|NCT00000620|69503494|FG002|Overall Study|missed closeout visit|16|||
37823066|NCT00000620|69503495|FG003|Overall Study|missed closeout visit|11|||
37823067|NCT00000620|69503496|FG004|Overall Study|missed closeout visit|26|||
37823068|NCT00000620|69503497|FG005|Overall Study|missed closeout visit|28|||
37823069|NCT00000620|69503498|FG006|Overall Study|missed closeout visit|13|||
37823070|NCT00000620|69503499|FG007|Overall Study|missed closeout visit|16|||
37823071|NCT00001262|69503562|FG000|Overall Study|Death|10|||
37823072|NCT00001262|69503563|FG001|Overall Study|Death|11|||
37823073|NCT00001262|69503564|FG002|Overall Study|Death|0|||
37823074|NCT00001262|69503562|FG000|Overall Study|Withdrawal by Subject|0|||
37823075|NCT00001262|69503563|FG001|Overall Study|Withdrawal by Subject|3|||
37823076|NCT00001262|69503564|FG002|Overall Study|Withdrawal by Subject|0|||
37823077|NCT00001277|69503581|FG000|Overall Study|Adverse Event|0|||
37888287|NCT00937326|69572997|FG000|Overall Study|Adverse Event|0|||
37888288|NCT00937326|69572998|FG001|Overall Study|Adverse Event|3|||
37888289|NCT00937326|69572999|FG002|Overall Study|Adverse Event|1|||
37888290|NCT00937326|69573000|FG003|Overall Study|Adverse Event|1|||
37823078|NCT00001277|69503582|FG001|Overall Study|Adverse Event|0|||
37823079|NCT00001277|69503583|FG002|Overall Study|Adverse Event|1|||
37987596|NCT00368550|69672980|FG000|Overall Study|Lack of Efficacy|4|||
37987597|NCT00368550|69672981|FG001|Overall Study|Lack of Efficacy|9|||
37888291|NCT00937326|69573001|FG004|Overall Study|Adverse Event|2|||
37888292|NCT00937326|69572997|FG000|Overall Study|Death|0|||
37888293|NCT00937326|69572998|FG001|Overall Study|Death|0|||
37888294|NCT00937326|69572999|FG002|Overall Study|Death|1|||
37888295|NCT00937326|69573000|FG003|Overall Study|Death|0|||
37888296|NCT00937326|69573001|FG004|Overall Study|Death|0|||
37888297|NCT00937326|69572997|FG000|Overall Study|Withdrawal by Subject|3|||
37888298|NCT00937326|69572998|FG001|Overall Study|Withdrawal by Subject|4|||
37888299|NCT00937326|69572999|FG002|Overall Study|Withdrawal by Subject|1|||
37888300|NCT00937326|69573000|FG003|Overall Study|Withdrawal by Subject|4|||
37987598|NCT00368550|69672980|FG000|Overall Study|Withdrawal by Subject|17|||
37888301|NCT00937326|69573001|FG004|Overall Study|Withdrawal by Subject|3|||
37888302|NCT00937326|69572997|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
37888303|NCT00937326|69572998|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
37888304|NCT00937326|69572999|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
37888305|NCT00937326|69573000|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
37888306|NCT00937326|69573001|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
37888307|NCT00873730|69573020|FG000|Overall Study|Protocol Deviation|5|||
37888308|NCT00873730|69573021|FG001|Overall Study|Protocol Deviation|2|||
37888309|NCT00873730|69573020|FG000|Overall Study|Adverse Event|0|||
37888310|NCT00873730|69573021|FG001|Overall Study|Adverse Event|2|||
37888311|NCT00873730|69573020|FG000|Overall Study|Withdrawal by Subject|0|||
37888312|NCT00873730|69573021|FG001|Overall Study|Withdrawal by Subject|1|||
37987599|NCT00368550|69672981|FG001|Overall Study|Withdrawal by Subject|10|||
37695937|NCT02326298|69172064|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
37695938|NCT02326298|69172051|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
37823080|NCT00001277|69503581|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
37823081|NCT00001277|69503582|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
37888313|NCT00873730|69573020|FG000|Overall Study|Sponsor decision|1|||
37888314|NCT00873730|69573021|FG001|Overall Study|Sponsor decision|0|||
37888315|NCT00874432|69573031|FG000|Overall Study|Withdrawal by Subject|1|||
37888316|NCT00874432|69573032|FG001|Overall Study|Withdrawal by Subject|0|||
37987600|NCT00368472|69672987|FG000|Overall Study|Adverse Event|22|||
37987601|NCT00368472|69672987|FG000|Overall Study|Medication non-compliance|4|||
37987602|NCT00368472|69672987|FG000|Overall Study|Protocol Violation|2|||
37987603|NCT00368472|69672987|FG000|Overall Study|Request of Investigator or Sponsor|3|||
37823082|NCT00001277|69503583|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
37823083|NCT00001703|69503625|FG000|Overall Study|progressed disease|2|||
37823084|NCT00001703|69503625|FG000|Overall Study|No evidence of disease|1|||
37823085|NCT00001703|69503625|FG000|Overall Study|recurrent disease|2|||
37823086|NCT01349907|69503649|FG000|Overall Study|Adverse Event|37|||
37823087|NCT01349907|69503650|FG001|Overall Study|Adverse Event|11|||
37823088|NCT01349907|69503649|FG000|Overall Study|Treatment failure|13|||
37823089|NCT01349907|69503650|FG001|Overall Study|Treatment failure|4|||
37823090|NCT01349907|69503649|FG000|Overall Study|Lost to Follow-up|25|||
37823091|NCT01349907|69503650|FG001|Overall Study|Lost to Follow-up|6|||
37823092|NCT01349907|69503649|FG000|Overall Study|Withdrawal by Subject|30|||
37823093|NCT01349907|69503650|FG001|Overall Study|Withdrawal by Subject|8|||
37823094|NCT01349907|69503649|FG000|Overall Study|Protocol Violation|33|||
37823095|NCT01349907|69503650|FG001|Overall Study|Protocol Violation|13|||
37823096|NCT01349907|69503649|FG000|Overall Study|Administrative|1|||
37823097|NCT01349907|69503650|FG001|Overall Study|Administrative|1|||
37823098|NCT04847141|69503667|FG000|Overall Study|Adverse Event|1|||
37823099|NCT04847141|69503668|FG001|Overall Study|Adverse Event|0|||
37823100|NCT04847141|69503669|FG002|Overall Study|Adverse Event|1|||
37823101|NCT04847141|69503667|FG000|Overall Study|Withdrawal by Subject|2|||
37823102|NCT04847141|69503668|FG001|Overall Study|Withdrawal by Subject|4|||
37823103|NCT04847141|69503669|FG002|Overall Study|Withdrawal by Subject|3|||
37823104|NCT04847141|69503667|FG000|Overall Study|Lost to Follow-up|7|||
37987604|NCT00368472|69672987|FG000|Overall Study|Withdrawal by Subject|40|||
37695939|NCT02326298|69172052|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
37823105|NCT04847141|69503668|FG001|Overall Study|Lost to Follow-up|5|||
37823106|NCT04847141|69503669|FG002|Overall Study|Lost to Follow-up|7|||
37823107|NCT04847141|69503667|FG000|Overall Study|Reason not Specified|0|||
37823108|NCT04847141|69503668|FG001|Overall Study|Reason not Specified|1|||
37823109|NCT04847141|69503669|FG002|Overall Study|Reason not Specified|0|||
37823110|NCT01349829|69503679|FG000|Overall Study|Lost to Follow-up|4|||
37823111|NCT01349829|69503680|FG001|Overall Study|Lost to Follow-up|8|||
37823112|NCT01349829|69503679|FG000|Overall Study|Consent withdrawal|3|||
37888317|NCT00874432|69573033|FG002|Overall Study|Withdrawal by Subject|0|||
37888318|NCT00874432|69573034|FG003|Overall Study|Withdrawal by Subject|0|||
37888319|NCT00874432|69573031|FG000|Overall Study|Physician Decision|1|||
37888320|NCT00874432|69573032|FG001|Overall Study|Physician Decision|0|||
37888321|NCT00874432|69573033|FG002|Overall Study|Physician Decision|0|||
37888322|NCT00874432|69573034|FG003|Overall Study|Physician Decision|0|||
37888323|NCT00874432|69573031|FG000|Overall Study|Other|1|||
37888324|NCT00874432|69573032|FG001|Overall Study|Other|2|||
37888325|NCT00874432|69573033|FG002|Overall Study|Other|8|||
37888326|NCT00874432|69573034|FG003|Overall Study|Other|3|||
37888327|NCT00935220|69573046|FG000|Overall Study|Adverse Event|1|||
37888328|NCT00935220|69573046|FG000|Overall Study|Other reason (not specified)|1|||
37987605|NCT00368472|69672987|FG000|Overall Study|Diary non-compliance|1|||
37987606|NCT00368472|69672987|FG000|Overall Study|Other|32|||
37987607|NCT00368472|69672987|FG000|Overall Study|Missing Final Disposition Date|1|||
37987608|NCT00357006|69672994|FG000|Overall Study|Lost to Follow-up|1|||
37987609|NCT00357006|69672995|FG001|Overall Study|Lost to Follow-up|2|||
37987610|NCT00357006|69672996|FG002|Overall Study|Lost to Follow-up|1|||
37987611|NCT00357006|69672994|FG000|Overall Study|Withdrawal by Subject|1|||
37987612|NCT00357006|69672995|FG001|Overall Study|Withdrawal by Subject|3|||
37987613|NCT00357006|69672996|FG002|Overall Study|Withdrawal by Subject|2|||
37987614|NCT00165646|69673007|FG000|Overall Study|Adverse Event|1|||
37987615|NCT00165646|69673008|FG001|Overall Study|Adverse Event|1|||
37987616|NCT00165646|69673009|FG002|Overall Study|Adverse Event|1|||
37987617|NCT00165646|69673007|FG000|Overall Study|Lack of Efficacy|1|||
37987618|NCT00165646|69673008|FG001|Overall Study|Lack of Efficacy|2|||
37987619|NCT00165646|69673009|FG002|Overall Study|Lack of Efficacy|0|||
37987620|NCT00165646|69673007|FG000|Overall Study|Withdrawal by Subject|0|||
37987621|NCT00165646|69673008|FG001|Overall Study|Withdrawal by Subject|2|||
37987622|NCT00165646|69673009|FG002|Overall Study|Withdrawal by Subject|1|||
37987623|NCT00165646|69673007|FG000|Overall Study|Physician Decision|2|||
37987624|NCT00165646|69673008|FG001|Overall Study|Physician Decision|0|||
37987625|NCT00165646|69673009|FG002|Overall Study|Physician Decision|2|||
37987626|NCT00165646|69673007|FG000|Overall Study|Protocol Violation|1|||
37987627|NCT00165646|69673008|FG001|Overall Study|Protocol Violation|0|||
37987628|NCT00165646|69673009|FG002|Overall Study|Protocol Violation|0|||
37987629|NCT00367770|69673017|FG000|Overall Study|Adverse Event|1|||
37987630|NCT00367770|69673017|FG000|Overall Study|Withdrawal by Subject|1|||
37987631|NCT00185614|69673021|FG000|Inter-treatment Period|Physician Decision|1|||
37987632|NCT00185614|69673021|FG000|Inter-treatment Period|Relapse|2|||
37987633|NCT00185614|69673021|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
37987634|NCT00162370|69673025|FG000|Efficacy Population|Lost to Follow-up|51|||
37987635|NCT00361842|69673034|FG000|Overall Study|Withdrawal by Subject|2|||
37987636|NCT00361842|69673035|FG001|Overall Study|Withdrawal by Subject|3|||
37987637|NCT00361842|69673034|FG000|Overall Study|Death|2|||
37987638|NCT00361842|69673035|FG001|Overall Study|Death|1|||
37987639|NCT00361842|69673034|FG000|Overall Study|Disease progression|19|||
37987640|NCT00361842|69673035|FG001|Overall Study|Disease progression|20|||
37987641|NCT00361842|69673034|FG000|Overall Study|Adverse Event|2|||
37987642|NCT00361842|69673035|FG001|Overall Study|Adverse Event|3|||
37987643|NCT00361842|69673034|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
37987644|NCT00361842|69673035|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
37987645|NCT00361842|69673034|FG000|Overall Study|Other|1|||
37987646|NCT00361842|69673035|FG001|Overall Study|Other|0|||
37987647|NCT00361842|69673034|FG000|Overall Study|Other|0|||
37987648|NCT00361842|69673035|FG001|Overall Study|Other|2|||
37888329|NCT00874276|69573052|FG000|Overall Study|Withdrawal by Subject|1|||
37888330|NCT00874276|69573053|FG001|Overall Study|Withdrawal by Subject|1|||
37888331|NCT00594958|69573064|FG000|Overall Study|Withdrawal by Subject|1|||
37888332|NCT00594958|69573065|FG001|Overall Study|Withdrawal by Subject|0|||
37888333|NCT00594958|69573066|FG002|Overall Study|Withdrawal by Subject|1|||
37987649|NCT00361296|69673043|FG000|Overall Study|Physician Decision|1|||
37987650|NCT00361296|69673043|FG000|Overall Study|Lack of Efficacy|2|||
37987651|NCT00356148|69673049|FG000|Overall Study|Reoperation within 30 days|2|||
37695940|NCT02326298|69172053|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
37987652|NCT00356148|69673050|FG001|Overall Study|Reoperation within 30 days|1|||
37987653|NCT00361218|69673057|FG000|Overall Study|Lost to Follow-up|11|||
37987654|NCT00361218|69673057|FG000|Overall Study|Personal Reasons|7|||
37987655|NCT00361218|69673057|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
37987656|NCT00367458|69673063|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
37987657|NCT00367458|69673064|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
37695941|NCT02326298|69172054|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
37695942|NCT02326298|69172055|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
37695943|NCT02326298|69172056|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
37695944|NCT02326298|69172057|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
37695945|NCT02326298|69172058|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
37695946|NCT02326298|69172059|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
37888334|NCT00594958|69573064|FG000|Overall Study|Adverse Event|4|||
37823113|NCT01349829|69503680|FG001|Overall Study|Consent withdrawal|8|||
37823114|NCT01349829|69503679|FG000|Overall Study|Migrated/moved|2|||
37888335|NCT00594958|69573065|FG001|Overall Study|Adverse Event|1|||
37888336|NCT00594958|69573066|FG002|Overall Study|Adverse Event|2|||
37888337|NCT00594958|69573064|FG000|Overall Study|Pregnancy|0|||
37888338|NCT00594958|69573065|FG001|Overall Study|Pregnancy|2|||
37888339|NCT00594958|69573066|FG002|Overall Study|Pregnancy|0|||
37888340|NCT00594958|69573064|FG000|Overall Study|Protocol Violation|1|||
37888341|NCT00594958|69573065|FG001|Overall Study|Protocol Violation|0|||
37888342|NCT00594958|69573066|FG002|Overall Study|Protocol Violation|2|||
37888343|NCT00594958|69573064|FG000|Overall Study|Lost to Follow-up|5|||
37888344|NCT00594958|69573065|FG001|Overall Study|Lost to Follow-up|0|||
37888345|NCT00594958|69573066|FG002|Overall Study|Lost to Follow-up|3|||
37888346|NCT00594958|69573064|FG000|Overall Study|administrative|3|||
37888347|NCT00594958|69573065|FG001|Overall Study|administrative|0|||
37888348|NCT00594958|69573066|FG002|Overall Study|administrative|2|||
37823115|NCT01349829|69503680|FG001|Overall Study|Migrated/moved|7|||
37823116|NCT01350128|69503688|FG000|Overall Study|Withdrawal by Subject|3|||
37823117|NCT01350128|69503688|FG000|Overall Study|Protocol discontinuation criteria|8|||
37823118|NCT01350128|69503688|FG000|Overall Study|Physician Decision|1|||
37823119|NCT01350128|69503688|FG000|Overall Study|Lost to Follow-up|2|||
37823120|NCT03893825|69503747|FG000|Overall Study|Death|2|||
37823121|NCT03893825|69503748|FG001|Overall Study|Death|1|||
37823122|NCT03893825|69503747|FG000|Overall Study|Adverse Event|0|||
37823123|NCT03893825|69503748|FG001|Overall Study|Adverse Event|2|||
37823124|NCT03893825|69503747|FG000|Overall Study|Withdrawal by Subject|19|||
37823125|NCT03893825|69503748|FG001|Overall Study|Withdrawal by Subject|21|||
37823126|NCT03893825|69503747|FG000|Overall Study|Protocol deviation|1|||
37823127|NCT03893825|69503748|FG001|Overall Study|Protocol deviation|0|||
37823128|NCT03893825|69503747|FG000|Overall Study|Lost to Follow-up|10|||
37823129|NCT03893825|69503748|FG001|Overall Study|Lost to Follow-up|10|||
37823130|NCT03893825|69503747|FG000|Overall Study|Other than specified|7|||
37888349|NCT00594880|69573076|FG000|Overall Study|Withdrawal by Subject|1|||
37888350|NCT00594880|69573077|FG001|Overall Study|Withdrawal by Subject|1|||
37888351|NCT00594880|69573076|FG000|Overall Study|Lost to Follow-up|1|||
37888352|NCT00594880|69573077|FG001|Overall Study|Lost to Follow-up|0|||
37888353|NCT00871858|69573089|FG000|Overall Study|Protocol Violation|3|||
37888354|NCT00871858|69573090|FG001|Overall Study|Protocol Violation|4|||
37888355|NCT00871858|69573089|FG000|Overall Study|Adverse Event|1|||
37888356|NCT00871858|69573090|FG001|Overall Study|Adverse Event|1|||
37888357|NCT00871858|69573089|FG000|Overall Study|Withdrawal by Subject|1|||
37888358|NCT00871858|69573090|FG001|Overall Study|Withdrawal by Subject|1|||
37888359|NCT00871858|69573089|FG000|Overall Study|Lost to Follow-up|0|||
37888360|NCT00871858|69573090|FG001|Overall Study|Lost to Follow-up|1|||
37888361|NCT00871780|69573096|FG000|Overall Study|Enrolled But Not Treated|6|||
37888362|NCT00871780|69573096|FG000|Overall Study|Withdrawal by Subject|9|||
37888363|NCT00871780|69573096|FG000|Overall Study|Adverse Event|6|||
37888364|NCT00871780|69573096|FG000|Overall Study|Voluntary Discontinuation|4|||
37823131|NCT03893825|69503748|FG001|Overall Study|Other than specified|6|||
37823132|NCT03890666|69503756|FG000|Overall Study|Withdrawal by Subject|0|||
37823133|NCT03890666|69503757|FG001|Overall Study|Withdrawal by Subject|1|||
37823134|NCT03890666|69503756|FG000|Overall Study|Protocol deviation|1|||
37823135|NCT03890666|69503757|FG001|Overall Study|Protocol deviation|4|||
37823136|NCT03890666|69503756|FG000|Overall Study|Lost to Follow-up|2|||
37823137|NCT03890666|69503757|FG001|Overall Study|Lost to Follow-up|5|||
37888365|NCT00871780|69573096|FG000|Overall Study|Death|1|||
37888366|NCT00871780|69573096|FG000|Overall Study|Physician Decision|1|||
37888367|NCT00594178|69573103|FG000|Overall Study|Physician Decision|5|||
37888368|NCT00933270|69573107|FG000|Overall Study|Withdrawal by Subject|26|||
37888369|NCT00933270|69573107|FG000|Overall Study|Insufficient Follow-up|10|||
37888370|NCT00933270|69573107|FG000|Overall Study|Lost to Follow-up|14|||
37888371|NCT00933270|69573107|FG000|Overall Study|Adverse Event|1|||
37888372|NCT00933270|69573107|FG000|Overall Study|Missed Visit|2|||
37888373|NCT00933270|69573107|FG000|Overall Study|Death|24|||
37888374|NCT00933270|69573107|FG000|Overall Study|Moved or would not return|10|||
37888375|NCT00936858|69573112|FG000|Overall Study|Death|3|||
37888376|NCT00936858|69573112|FG000|Overall Study|Progression|29|||
37888377|NCT00936858|69573112|FG000|Overall Study|Withdrawal by Subject|5|||
37888378|NCT00936858|69573112|FG000|Overall Study|Adverse Event|1|||
37888379|NCT00936858|69573112|FG000|Overall Study|Physician Decision|7|||
37888380|NCT00936858|69573112|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
37888381|NCT00936858|69573112|FG000|Overall Study|Lost to Follow-up|1|||
37888382|NCT00872170|69573119|FG000|Overall Study|Adverse Event|1|||
37888383|NCT00872170|69573120|FG001|Overall Study|Adverse Event|0|||
37888384|NCT00936702|69573125|FG000|Overall Study|Disease progression|34|||
37888385|NCT00936702|69573125|FG000|Overall Study|Adverse Event|8|||
37888386|NCT00936702|69573125|FG000|Overall Study|Withdrawal by Subject|2|||
37888387|NCT00936702|69573125|FG000|Overall Study|Alternative Treatment|1|||
37888388|NCT00936702|69573125|FG000|Overall Study|Other|1|||
37888389|NCT00594100|69573129|FG000|Procedure|Technical Failure|9|||
37888390|NCT00594100|69573129|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
37888391|NCT00594100|69573129|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
37888392|NCT00594100|69573129|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
37888393|NCT01092182|69573136|FG000|Overall Study|Death|0|||
37888394|NCT01092182|69573137|FG001|Overall Study|Death|5|||
37888395|NCT01092182|69573138|FG002|Overall Study|Death|3|||
37695947|NCT02326298|69172060|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
37695948|NCT02326298|69172061|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
37695949|NCT02326298|69172062|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
37695950|NCT02326298|69172063|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
37695951|NCT02326298|69172064|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
37888396|NCT01092182|69573136|FG000|Overall Study|participant safety|1|||
37888397|NCT01092182|69573137|FG001|Overall Study|participant safety|2|||
37888398|NCT01092182|69573138|FG002|Overall Study|participant safety|0|||
37888399|NCT01092182|69573136|FG000|Overall Study|Physician Decision|0|||
37888400|NCT01092182|69573137|FG001|Overall Study|Physician Decision|6|||
37695952|NCT02326298|69172051|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
37888401|NCT01092182|69573138|FG002|Overall Study|Physician Decision|0|||
37823138|NCT03890666|69503756|FG000|Overall Study|Other than specified|1|||
37888402|NCT01092182|69573136|FG000|Overall Study|Did not meet criteria|0|||
37888403|NCT01092182|69573137|FG001|Overall Study|Did not meet criteria|0|||
37888404|NCT01092182|69573138|FG002|Overall Study|Did not meet criteria|25|||
37888405|NCT01092182|69573136|FG000|Overall Study|Non-compliance|0|||
37888406|NCT01092182|69573137|FG001|Overall Study|Non-compliance|3|||
37888407|NCT01092182|69573138|FG002|Overall Study|Non-compliance|0|||
37888408|NCT01092182|69573136|FG000|Overall Study|Participant refused follow-up|0|||
37888409|NCT01092182|69573137|FG001|Overall Study|Participant refused follow-up|2|||
37888410|NCT01092182|69573138|FG002|Overall Study|Participant refused follow-up|0|||
37888411|NCT00932646|69573146|FG000|Overall Study|Adverse Event|2|||
37888412|NCT00932646|69573147|FG001|Overall Study|Adverse Event|1|||
37823139|NCT03890666|69503757|FG001|Overall Study|Other than specified|8|||
37888413|NCT00932646|69573148|FG002|Overall Study|Adverse Event|1|||
37888414|NCT00932646|69573149|FG003|Overall Study|Adverse Event|1|||
37888415|NCT00932646|69573146|FG000|Overall Study|Lost to Follow-up|2|||
37888416|NCT00932646|69573147|FG001|Overall Study|Lost to Follow-up|1|||
37888417|NCT00932646|69573148|FG002|Overall Study|Lost to Follow-up|0|||
37888418|NCT00932646|69573149|FG003|Overall Study|Lost to Follow-up|0|||
37888419|NCT00932646|69573146|FG000|Overall Study|Withdrawal by Subject|1|||
37888420|NCT00932646|69573147|FG001|Overall Study|Withdrawal by Subject|1|||
37888421|NCT00932646|69573148|FG002|Overall Study|Withdrawal by Subject|3|||
37888422|NCT00932646|69573149|FG003|Overall Study|Withdrawal by Subject|0|||
37888423|NCT00871234|69573163|FG000|Overall Study|Adverse Event|2|||
37888424|NCT00871234|69573163|FG000|Overall Study|Lost to Follow-up|3|||
37888425|NCT01091246|69573170|FG000|Overall Study|Lost to Follow-up|23|||
37888426|NCT01091246|69573171|FG001|Overall Study|Lost to Follow-up|11|||
37888427|NCT01091246|69573172|FG002|Overall Study|Lost to Follow-up|7|||
37888428|NCT01091246|69573170|FG000|Overall Study|Adverse Event|1|||
37888429|NCT01091246|69573171|FG001|Overall Study|Adverse Event|0|||
37888430|NCT01091246|69573172|FG002|Overall Study|Adverse Event|1|||
37888431|NCT01091246|69573170|FG000|Overall Study|Withdrawal by Subject|9|||
37888432|NCT01091246|69573171|FG001|Overall Study|Withdrawal by Subject|5|||
37888433|NCT01091246|69573172|FG002|Overall Study|Withdrawal by Subject|4|||
37888434|NCT01091246|69573170|FG000|Overall Study|Subject not dosed|2|||
37888435|NCT01091246|69573171|FG001|Overall Study|Subject not dosed|0|||
37888436|NCT01091246|69573172|FG002|Overall Study|Subject not dosed|1|||
37823140|NCT03090737|69503795|FG000|Overall Study|Other reasons|1|||
37823141|NCT03090737|69503795|FG000|Overall Study|Completed treatment as per protocol|17|||
37823142|NCT03090737|69503795|FG000|Overall Study|Maximum clinical benefit|2|||
37823143|NCT03090737|69503795|FG000|Overall Study|Adverse event unrelated to study drug|7|||
37823144|NCT03090737|69503795|FG000|Overall Study|Study drug toxicity|4|||
37823145|NCT03090737|69503795|FG000|Overall Study|Disease progression|98|||
37823146|NCT03004976|69503840|FG000|Overall Study|Lost to Follow-up|7|||
37823147|NCT03004976|69503841|FG001|Overall Study|Lost to Follow-up|5|||
37823148|NCT03004976|69503840|FG000|Overall Study|Physician Decision|1|||
37823149|NCT03004976|69503841|FG001|Overall Study|Physician Decision|0|||
37823150|NCT03004976|69503840|FG000|Overall Study|Withdrawal by Subject|1|||
37823151|NCT03004976|69503841|FG001|Overall Study|Withdrawal by Subject|0|||
37823152|NCT03004976|69503840|FG000|Overall Study|Death|4|||
37888437|NCT01097330|69573184|FG000|Overall Study|Study terminated early|7|||
37888438|NCT01097330|69573185|FG001|Overall Study|Study terminated early|5|||
37888439|NCT00934440|69573191|FG000|Overall Study|Lost to Follow-up|1|||
37888440|NCT00934362|69573198|FG000|Overall Study|Adverse Event|1|||
37888441|NCT00934362|69573199|FG001|Overall Study|Adverse Event|0|||
37888442|NCT00934128|69573207|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
37888443|NCT00934128|69573208|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
37888444|NCT00934128|69573207|FG000|First Intervention (2 Hours)|Adverse Event|4|||
37888445|NCT00934128|69573208|FG001|First Intervention (2 Hours)|Adverse Event|1|||
37888446|NCT00934128|69573207|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
37888447|NCT00934128|69573208|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
37888448|NCT00934128|69573207|FG000|Washout Period (1 Hour)|Patient preference|1|||
37823153|NCT03004976|69503841|FG001|Overall Study|Death|1|||
37823154|NCT02985866|69503849|FG000|Overall Study|Poor CGM data|1|||
37823155|NCT02985866|69503850|FG001|Overall Study|Poor CGM data|1|||
37888449|NCT00934128|69573208|FG001|Washout Period (1 Hour)|Patient preference|3|||
37823156|NCT02762981|69503875|FG000|Overall Study|Adverse Event|2|||
37823157|NCT02762981|69503876|FG001|Overall Study|Adverse Event|3|||
37888450|NCT00934128|69573207|FG000|Washout Period (1 Hour)|Pain|1|||
37888451|NCT00934128|69573208|FG001|Washout Period (1 Hour)|Pain|0|||
37888452|NCT00934128|69573207|FG000|Washout Period (1 Hour)|Too tired|1|||
37888453|NCT00934128|69573208|FG001|Washout Period (1 Hour)|Too tired|0|||
37888454|NCT00934128|69573207|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
37888455|NCT00934128|69573208|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
37888456|NCT00934128|69573207|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
37987658|NCT00162136|69673076|FG000|Overall Study|Adverse Event|1|||
37987659|NCT00162136|69673076|FG000|Overall Study|Death|1|||
37987660|NCT00162136|69673076|FG000|Overall Study|Disease Progression/Relapse|23|||
37987661|NCT00162136|69673076|FG000|Overall Study|Investigator Request|5|||
37987662|NCT00162136|69673076|FG000|Overall Study|Study Drug Toxicity|4|||
37987663|NCT00162136|69673076|FG000|Overall Study|Withdrawal by Subject|1|||
37987664|NCT00252694|69673102|FG000|Overall Study|Withdrawal by Subject|83|||
37987665|NCT00252694|69673103|FG001|Overall Study|Withdrawal by Subject|91|||
37987666|NCT00252694|69673102|FG000|Overall Study|Death|36|||
37987667|NCT00252694|69673103|FG001|Overall Study|Death|34|||
37695953|NCT02326298|69172052|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
37695954|NCT02326298|69172053|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
37695955|NCT02326298|69172054|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
37695956|NCT02326298|69172055|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
37695957|NCT02326298|69172056|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
37695958|NCT02326298|69172057|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
37987668|NCT00252694|69673102|FG000|Overall Study|Mostly Lost to Follow Up|8|||
37987669|NCT00252694|69673103|FG001|Overall Study|Mostly Lost to Follow Up|13|||
37987670|NCT00252694|69673102|FG000|Overall Study|Patient Moving|17|||
37888457|NCT00934128|69573208|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
37888458|NCT00871000|69573216|FG000|Overall Study|Withdrawal by Subject|1|||
37888459|NCT00871000|69573217|FG001|Overall Study|Withdrawal by Subject|0|||
37987671|NCT00252694|69673103|FG001|Overall Study|Patient Moving|16|||
37823158|NCT02762981|69503877|FG002|Overall Study|Adverse Event|1|||
37823159|NCT02762981|69503878|FG003|Overall Study|Adverse Event|1|||
37823160|NCT02762981|69503879|FG004|Overall Study|Adverse Event|3|||
37823161|NCT02762981|69503875|FG000|Overall Study|Physician Decision|0|||
37823162|NCT02762981|69503876|FG001|Overall Study|Physician Decision|1|||
37823163|NCT02762981|69503877|FG002|Overall Study|Physician Decision|0|||
37823164|NCT02762981|69503878|FG003|Overall Study|Physician Decision|0|||
37823165|NCT02762981|69503879|FG004|Overall Study|Physician Decision|1|||
37823166|NCT02762981|69503875|FG000|Overall Study|Disease progression|11|||
37823167|NCT02762981|69503876|FG001|Overall Study|Disease progression|23|||
37823168|NCT02762981|69503877|FG002|Overall Study|Disease progression|4|||
37823169|NCT02762981|69503878|FG003|Overall Study|Disease progression|10|||
37823170|NCT02762981|69503879|FG004|Overall Study|Disease progression|1|||
37823171|NCT02762981|69503875|FG000|Overall Study|Enrolled not treated|1|||
37823172|NCT02762981|69503876|FG001|Overall Study|Enrolled not treated|5|||
37987672|NCT00185458|69673109|FG000|Contraception Phase|Adverse Event|37|||
37987673|NCT00185458|69673109|FG000|Contraception Phase|Lost to Follow-up|10|||
37987674|NCT00185458|69673109|FG000|Contraception Phase|Protocol Violation|2|||
37823173|NCT02762981|69503877|FG002|Overall Study|Enrolled not treated|0|||
37823174|NCT02762981|69503878|FG003|Overall Study|Enrolled not treated|2|||
37823175|NCT02762981|69503879|FG004|Overall Study|Enrolled not treated|0|||
37823176|NCT02762981|69503875|FG000|Overall Study|Other|2|||
37823177|NCT02762981|69503876|FG001|Overall Study|Other|3|||
37823178|NCT02762981|69503877|FG002|Overall Study|Other|1|||
37823179|NCT02762981|69503878|FG003|Overall Study|Other|0|||
37823180|NCT02762981|69503879|FG004|Overall Study|Other|0|||
37823181|NCT02762981|69503875|FG000|Overall Study|Missing|1|||
37888460|NCT01096784|69573225|FG000|Overall Study|Withdrawal by Subject|2|||
37888461|NCT01096784|69573226|FG001|Overall Study|Withdrawal by Subject|1|||
37987675|NCT00185458|69673109|FG000|Contraception Phase|Physician Decision|2|||
37888462|NCT01096784|69573225|FG000|Overall Study|Adverse Event|11|||
37888463|NCT01096784|69573226|FG001|Overall Study|Adverse Event|9|||
37888464|NCT01096784|69573225|FG000|Overall Study|Protocol Deviation|2|||
37888465|NCT01096784|69573226|FG001|Overall Study|Protocol Deviation|2|||
37888466|NCT01096784|69573225|FG000|Overall Study|Administrative Decision|0|||
37888467|NCT01096784|69573226|FG001|Overall Study|Administrative Decision|1|||
37888468|NCT01096784|69573225|FG000|Overall Study|Other Unspecified|0|||
37888469|NCT01096784|69573226|FG001|Overall Study|Other Unspecified|1|||
37888470|NCT00934050|69573240|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
37888471|NCT00934050|69573241|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
37888472|NCT00934050|69573242|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
37888473|NCT00934050|69573243|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
37888474|NCT00934050|69573244|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
37888475|NCT00934050|69573245|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
37987676|NCT00185458|69673109|FG000|Contraception Phase|Withdrawal by Subject|7|||
37987677|NCT00185458|69673109|FG000|HRT Phase|Adverse Event|18|||
37987678|NCT00185458|69673109|FG000|HRT Phase|Lost to Follow-up|4|||
37987679|NCT00185458|69673109|FG000|HRT Phase|Protocol Violation|2|||
37823182|NCT02762981|69503876|FG001|Overall Study|Missing|0|||
37823183|NCT02762981|69503877|FG002|Overall Study|Missing|0|||
37823184|NCT02762981|69503878|FG003|Overall Study|Missing|0|||
37823185|NCT02762981|69503879|FG004|Overall Study|Missing|0|||
37823186|NCT02762981|69503875|FG000|Overall Study|Withdrawal by Subject|0|||
37823187|NCT02762981|69503876|FG001|Overall Study|Withdrawal by Subject|5|||
37823188|NCT02762981|69503877|FG002|Overall Study|Withdrawal by Subject|1|||
37823189|NCT02762981|69503878|FG003|Overall Study|Withdrawal by Subject|3|||
37823190|NCT02762981|69503879|FG004|Overall Study|Withdrawal by Subject|0|||
37823191|NCT00001832|69503959|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
37823192|NCT00001832|69503960|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
37823193|NCT00001832|69503961|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
37823194|NCT00001832|69503962|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
37823195|NCT00001832|69503963|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
37823196|NCT00001832|69503964|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
37823197|NCT00001832|69503965|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
37823198|NCT00001832|69503966|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
37823199|NCT00001832|69503967|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
37823200|NCT00001832|69503968|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
37823201|NCT00001832|69503969|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
37823202|NCT00001832|69503970|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
37823203|NCT00001832|69503971|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
37823204|NCT00001832|69503972|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
37823205|NCT00001832|69503973|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
37823206|NCT00001832|69503959|FG000|Treatment Period|Death during treatment|0|||
37823207|NCT00001832|69503960|FG001|Treatment Period|Death during treatment|0|||
37823208|NCT00001832|69503961|FG002|Treatment Period|Death during treatment|0|||
37823209|NCT00001832|69503962|FG003|Treatment Period|Death during treatment|0|||
37823210|NCT00001832|69503963|FG004|Treatment Period|Death during treatment|0|||
37823211|NCT00001832|69503964|FG005|Treatment Period|Death during treatment|1|||
37823212|NCT00001832|69503965|FG006|Treatment Period|Death during treatment|0|||
37823213|NCT00001832|69503966|FG007|Treatment Period|Death during treatment|0|||
37823214|NCT00001832|69503967|FG008|Treatment Period|Death during treatment|0|||
37823215|NCT00001832|69503968|FG009|Treatment Period|Death during treatment|0|||
37823216|NCT00001832|69503969|FG010|Treatment Period|Death during treatment|0|||
37888476|NCT00934050|69573240|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
37888477|NCT00934050|69573241|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
37987680|NCT00185458|69673109|FG000|HRT Phase|Withdrawal by Subject|3|||
37987681|NCT00185380|69673124|FG000|Overall Study|Adverse Event|41|||
37823217|NCT00001832|69503970|FG011|Treatment Period|Death during treatment|0|||
37823218|NCT00001832|69503971|FG012|Treatment Period|Death during treatment|0|||
37823219|NCT00001832|69503972|FG013|Treatment Period|Death during treatment|0|||
37823220|NCT00001832|69503973|FG014|Treatment Period|Death during treatment|0|||
37823221|NCT00001832|69503959|FG000|Treatment Period|Not treated|0|||
37888478|NCT00934050|69573242|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
37888479|NCT00934050|69573243|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
37888480|NCT00934050|69573244|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
37888481|NCT00934050|69573245|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
37987682|NCT00185380|69673125|FG001|Overall Study|Adverse Event|43|||
37987683|NCT00185380|69673126|FG002|Overall Study|Adverse Event|48|||
37987684|NCT00185380|69673124|FG000|Overall Study|Lost to Follow-up|0|||
37987685|NCT00185380|69673125|FG001|Overall Study|Lost to Follow-up|4|||
37987686|NCT00185380|69673126|FG002|Overall Study|Lost to Follow-up|3|||
37987687|NCT00185380|69673124|FG000|Overall Study|Pregnancy|1|||
37987688|NCT00185380|69673125|FG001|Overall Study|Pregnancy|4|||
37987689|NCT00185380|69673126|FG002|Overall Study|Pregnancy|0|||
37987690|NCT00185380|69673124|FG000|Overall Study|Protocol Violation|2|||
37987691|NCT00185380|69673125|FG001|Overall Study|Protocol Violation|2|||
37987692|NCT00185380|69673126|FG002|Overall Study|Protocol Violation|1|||
37987693|NCT00185380|69673124|FG000|Overall Study|Withdrawal by Subject|1|||
37987694|NCT00185380|69673125|FG001|Overall Study|Withdrawal by Subject|2|||
37987695|NCT00185380|69673126|FG002|Overall Study|Withdrawal by Subject|0|||
37888482|NCT00934050|69573240|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
37888483|NCT00934050|69573241|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
37888484|NCT00934050|69573242|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
37888485|NCT00934050|69573243|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
37888486|NCT00934050|69573244|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
37888487|NCT00934050|69573245|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
37888488|NCT00934050|69573240|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
37888489|NCT00934050|69573241|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
37987696|NCT00185380|69673124|FG000|Overall Study|Failed insertion|1|||
37987697|NCT00185380|69673125|FG001|Overall Study|Failed insertion|1|||
37987698|NCT00185380|69673126|FG002|Overall Study|Failed insertion|2|||
37987699|NCT00185380|69673124|FG000|Overall Study|Planned pregnancy|9|||
37823222|NCT00001832|69503960|FG001|Treatment Period|Not treated|0|||
37823223|NCT00001832|69503961|FG002|Treatment Period|Not treated|0|||
37823224|NCT00001832|69503962|FG003|Treatment Period|Not treated|0|||
37823225|NCT00001832|69503963|FG004|Treatment Period|Not treated|0|||
37823226|NCT00001832|69503964|FG005|Treatment Period|Not treated|0|||
37823227|NCT00001832|69503965|FG006|Treatment Period|Not treated|0|||
37823228|NCT00001832|69503966|FG007|Treatment Period|Not treated|1|||
37823229|NCT00001832|69503967|FG008|Treatment Period|Not treated|0|||
37823230|NCT00001832|69503968|FG009|Treatment Period|Not treated|0|||
37823231|NCT00001832|69503969|FG010|Treatment Period|Not treated|0|||
37823232|NCT00001832|69503970|FG011|Treatment Period|Not treated|0|||
37823233|NCT00001832|69503971|FG012|Treatment Period|Not treated|0|||
37823234|NCT00001832|69503972|FG013|Treatment Period|Not treated|0|||
37823235|NCT00001832|69503973|FG014|Treatment Period|Not treated|0|||
37823236|NCT01349816|69504198|FG000|Overall Study|Withdrawal by Subject|4|||
37823237|NCT01349816|69504198|FG000|Overall Study|Physician Decision|1|||
37823238|NCT01349816|69504198|FG000|Overall Study|Adverse Event|14|||
37823239|NCT01349816|69504198|FG000|Overall Study|Lost to Follow-up|2|||
37823240|NCT01349816|69504198|FG000|Overall Study|Protocol Violation|1|||
37823241|NCT01349816|69504198|FG000|Overall Study|Protocol-specified criteria|8|||
37823242|NCT05201807|69504377|FG000|Overall Study|Adverse Event|1|||
37823243|NCT05201807|69504377|FG000|Overall Study|COVID-19 Related|1|||
37823244|NCT04978337|69504383|FG000|Overall Study|Withdrawal by Subject|0|||
37823245|NCT04978337|69504384|FG001|Overall Study|Withdrawal by Subject|1|||
37823246|NCT04828707|69504393|FG000|Overall Study|Lost to Follow-up|3|||
37823247|NCT04828707|69504394|FG001|Overall Study|Lost to Follow-up|2|||
37823248|NCT04828707|69504393|FG000|Overall Study|Withdrawal by Subject|2|||
37823249|NCT04828707|69504394|FG001|Overall Study|Withdrawal by Subject|1|||
37823250|NCT04629534|69504402|FG000|Overall Study|Physician Decision|1|||
37823251|NCT04629534|69504403|FG001|Overall Study|Physician Decision|0|||
37823252|NCT04629534|69504402|FG000|Overall Study|Protocol Violation|0|||
37823253|NCT04629534|69504403|FG001|Overall Study|Protocol Violation|2|||
37823254|NCT04481191|69504415|FG000|Overall Study|Withdrawn by parent/guardian|15|||
37987700|NCT00185380|69673125|FG001|Overall Study|Planned pregnancy|12|||
37987701|NCT00185380|69673126|FG002|Overall Study|Planned pregnancy|12|||
37823255|NCT04481191|69504416|FG001|Overall Study|Withdrawn by parent/guardian|10|||
37823256|NCT03695185|69504439|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
37833589|NCT01262872|69517327|FG000|Step 2|Death|0|||
37888490|NCT00934050|69573242|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
37888491|NCT00934050|69573243|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
37888492|NCT00934050|69573244|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
37888493|NCT00934050|69573245|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
37888494|NCT00934050|69573240|FG000|Enrolled After 15 Dec 2009|Death|0|||
37888495|NCT00934050|69573241|FG001|Enrolled After 15 Dec 2009|Death|0|||
37888496|NCT00934050|69573242|FG002|Enrolled After 15 Dec 2009|Death|0|||
37888497|NCT00934050|69573243|FG003|Enrolled After 15 Dec 2009|Death|0|||
37888498|NCT00934050|69573244|FG004|Enrolled After 15 Dec 2009|Death|0|||
37888499|NCT00934050|69573245|FG005|Enrolled After 15 Dec 2009|Death|1|||
37888500|NCT00934050|69573240|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
37888501|NCT00934050|69573241|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
37888502|NCT00934050|69573242|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
37888503|NCT00934050|69573243|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
37888504|NCT00934050|69573244|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
37888505|NCT00934050|69573245|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
37888506|NCT00934050|69573240|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
37888507|NCT00934050|69573241|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
37888508|NCT00934050|69573242|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
37888509|NCT00934050|69573243|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
37888510|NCT00934050|69573244|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
37888511|NCT00934050|69573245|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
37888512|NCT01091168|69573257|FG000|Overall Study|Progressive disease|250|||
37888513|NCT01091168|69573258|FG001|Overall Study|Progressive disease|234|||
37888514|NCT01091168|69573257|FG000|Overall Study|Adverse Event|21|||
37888515|NCT01091168|69573258|FG001|Overall Study|Adverse Event|24|||
37888516|NCT01091168|69573257|FG000|Overall Study|Lost to Follow-up|0|||
37888517|NCT01091168|69573258|FG001|Overall Study|Lost to Follow-up|1|||
37888518|NCT01091168|69573257|FG000|Overall Study|Physician, patient's decision, other|27|||
37888519|NCT01091168|69573258|FG001|Overall Study|Physician, patient's decision, other|37|||
37888520|NCT00864916|69573266|FG000|Overall Study|Lost to Follow-up|4|||
37888521|NCT00864916|69573267|FG001|Overall Study|Lost to Follow-up|4|||
37888522|NCT00864916|69573266|FG000|Overall Study|Protocol Violation|1|||
37888523|NCT00864916|69573267|FG001|Overall Study|Protocol Violation|0|||
37888524|NCT00864916|69573266|FG000|Overall Study|Withdrawal by Subject|1|||
37888525|NCT00864916|69573267|FG001|Overall Study|Withdrawal by Subject|0|||
37888526|NCT00864682|69573276|FG000|Overall Study|Protocol Violation|2|||
37888527|NCT00864682|69573277|FG001|Overall Study|Protocol Violation|1|||
37888528|NCT00864682|69573278|FG002|Overall Study|Protocol Violation|2|||
37888529|NCT00931944|69573286|FG000|Overall Study|Adverse Event|4|||
37888530|NCT00931944|69573286|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
37888531|NCT00931944|69573286|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
37888532|NCT00931944|69573286|FG000|Overall Study|Death|28|||
37987702|NCT00185380|69673124|FG000|Overall Study|No need for contraception|3|||
37888533|NCT00931944|69573286|FG000|Overall Study|Other|2|||
37987703|NCT00185380|69673125|FG001|Overall Study|No need for contraception|3|||
37987704|NCT00185380|69673126|FG002|Overall Study|No need for contraception|3|||
37987705|NCT00185380|69673124|FG000|Overall Study|Could not attend visits|2|||
37987706|NCT00185380|69673125|FG001|Overall Study|Could not attend visits|0|||
37987707|NCT00185380|69673126|FG002|Overall Study|Could not attend visits|4|||
37987708|NCT00185380|69673124|FG000|Overall Study|personal reason|6|||
37987709|NCT00185380|69673125|FG001|Overall Study|personal reason|1|||
37987710|NCT00185380|69673126|FG002|Overall Study|personal reason|1|||
37987711|NCT00160654|69673134|FG000|Overall Study|Adverse Event|14|||
37987712|NCT00160654|69673134|FG000|Overall Study|Lack of Efficacy|4|||
37987713|NCT00160654|69673134|FG000|Overall Study|Lost to Follow-up|2|||
37987714|NCT00160654|69673134|FG000|Overall Study|Intake of expired drug|7|||
37987715|NCT00160654|69673134|FG000|Overall Study|Psychological trauma|1|||
37987716|NCT00160654|69673134|FG000|Overall Study|Sponsor decision|1|||
37987717|NCT00160654|69673134|FG000|Overall Study|Patient met exclusion criteria|1|||
37987718|NCT00160654|69673134|FG000|Overall Study|Patient decision|1|||
37987719|NCT00160654|69673134|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
37987720|NCT00160654|69673134|FG000|Overall Study|Met exclusion criteria|1|||
37987721|NCT00366678|69673140|FG000|Infant Series|Withdrawal by Subject|8|||
37987722|NCT00366678|69673141|FG001|Infant Series|Withdrawal by Subject|6|||
37987723|NCT00366678|69673142|FG002|Infant Series|Withdrawal by Subject|0|||
37987724|NCT00366678|69673140|FG000|Infant Series|Protocol Violation|4|||
37987725|NCT00366678|69673141|FG001|Infant Series|Protocol Violation|3|||
37987726|NCT00366678|69673142|FG002|Infant Series|Protocol Violation|0|||
37987727|NCT00366678|69673140|FG000|Infant Series|Failed to return|1|||
37987728|NCT00366678|69673141|FG001|Infant Series|Failed to return|1|||
37987729|NCT00366678|69673142|FG002|Infant Series|Failed to return|0|||
37987730|NCT00366678|69673140|FG000|Infant Series|Adverse Event|1|||
37987731|NCT00366678|69673141|FG001|Infant Series|Adverse Event|0|||
37987732|NCT00366678|69673142|FG002|Infant Series|Adverse Event|0|||
37987733|NCT00366678|69673140|FG000|After Infant|Withdrawal by Subject|8|||
37987734|NCT00366678|69673141|FG001|After Infant|Withdrawal by Subject|4|||
37987735|NCT00366678|69673142|FG002|After Infant|Withdrawal by Subject|0|||
37987736|NCT00366678|69673140|FG000|After Infant|Lost to Follow-up|2|||
37987737|NCT00366678|69673141|FG001|After Infant|Lost to Follow-up|1|||
37987738|NCT00366678|69673142|FG002|After Infant|Lost to Follow-up|0|||
37987739|NCT00366678|69673140|FG000|After Infant|Failed to return|5|||
37987740|NCT00366678|69673141|FG001|After Infant|Failed to return|5|||
37987741|NCT00366678|69673142|FG002|After Infant|Failed to return|0|||
37987742|NCT00366678|69673140|FG000|After Infant|Adverse Event|1|||
37987743|NCT00366678|69673141|FG001|After Infant|Adverse Event|0|||
37987744|NCT00366678|69673142|FG002|After Infant|Adverse Event|0|||
37987745|NCT00366678|69673140|FG000|After Infant|Protocol Violation|1|||
37987746|NCT00366678|69673141|FG001|After Infant|Protocol Violation|0|||
37987747|NCT00366678|69673142|FG002|After Infant|Protocol Violation|0|||
37987748|NCT00366678|69673140|FG000|Toddler Dose|Protocol Violation|2|||
37987749|NCT00366678|69673141|FG001|Toddler Dose|Protocol Violation|1|||
37987750|NCT00366678|69673142|FG002|Toddler Dose|Protocol Violation|0|||
37987751|NCT00366678|69673140|FG000|Toddler Dose|Failed to return|1|||
37823257|NCT03695185|69504439|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
37823258|NCT03695185|69504439|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
37823259|NCT03695185|69504439|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
37823260|NCT03695185|69504439|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
37823261|NCT03695185|69504439|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
37823262|NCT03596164|69504446|FG000|Overall Study|Adverse Event|0|||
37823263|NCT03596164|69504447|FG001|Overall Study|Adverse Event|1|||
37823264|NCT03596164|69504446|FG000|Overall Study|Death|1|||
37823265|NCT03596164|69504447|FG001|Overall Study|Death|0|||
37823266|NCT02990468|69504458|FG000|Phase 2: MTD|Change in treatment|0|||
37823267|NCT02990468|69504459|FG001|Phase 2: MTD|Change in treatment|0|||
37987752|NCT00366678|69673141|FG001|Toddler Dose|Failed to return|0|||
37987753|NCT00366678|69673142|FG002|Toddler Dose|Failed to return|0|||
37823268|NCT02990468|69504460|FG002|Phase 2: MTD|Change in treatment|1|||
37987754|NCT00366678|69673140|FG000|Toddler Dose|Withdrawal by Subject|1|||
37987755|NCT00366678|69673141|FG001|Toddler Dose|Withdrawal by Subject|0|||
37987756|NCT00366678|69673142|FG002|Toddler Dose|Withdrawal by Subject|0|||
37987757|NCT00366678|69673140|FG000|Toddler Dose|protocol deviation|1|||
37987758|NCT00366678|69673141|FG001|Toddler Dose|protocol deviation|0|||
37987759|NCT00366678|69673142|FG002|Toddler Dose|protocol deviation|0|||
37987760|NCT00355368|69673189|FG000|Overall Study|Protocol Violation|8|||
37987761|NCT00355368|69673190|FG001|Overall Study|Protocol Violation|7|||
37987762|NCT00355368|69673189|FG000|Overall Study|cardiac arrest prior to intubation|2|||
37987763|NCT00355368|69673190|FG001|Overall Study|cardiac arrest prior to intubation|2|||
37987764|NCT00360282|69673196|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
37987765|NCT00360282|69673197|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
37987766|NCT00360282|69673198|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
37987767|NCT00360282|69673199|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
37987768|NCT00360282|69673196|FG000|Second Intervention|Adverse Event|0|||
37987769|NCT00360282|69673197|FG001|Second Intervention|Adverse Event|1|||
37987770|NCT00360282|69673198|FG002|Second Intervention|Adverse Event|0|||
37987771|NCT00360282|69673199|FG003|Second Intervention|Adverse Event|0|||
37987772|NCT00373958|69673209|FG000|Infant Series|Withdrawal by Subject|13|||
37987773|NCT00373958|69673210|FG001|Infant Series|Withdrawal by Subject|15|||
37987774|NCT00373958|69673209|FG000|Infant Series|Failed to return|8|||
37987775|NCT00373958|69673210|FG001|Infant Series|Failed to return|13|||
37987776|NCT00373958|69673209|FG000|Infant Series|Lost to Follow-up|6|||
37987777|NCT00373958|69673210|FG001|Infant Series|Lost to Follow-up|5|||
37987778|NCT00373958|69673209|FG000|Infant Series|Protocol Violation|3|||
37987779|NCT00373958|69673210|FG001|Infant Series|Protocol Violation|7|||
37987780|NCT00373958|69673209|FG000|Infant Series|Lost Kaiser coverage|4|||
37888534|NCT00929994|69573290|FG000|Overall Study|Withdrawal by Subject|1|||
37888535|NCT00929994|69573290|FG000|Overall Study|medical issue unrelated to intervention|4|||
37888536|NCT00929994|69573290|FG000|Overall Study|employment|1|||
37888537|NCT01090310|69573301|FG000|Core Study|Adverse Event|2|||
37888538|NCT01090310|69573302|FG001|Core Study|Adverse Event|2|||
37888539|NCT01090310|69573303|FG002|Core Study|Adverse Event|1|||
37987781|NCT00373958|69673210|FG001|Infant Series|Lost Kaiser coverage|0|||
37695959|NCT02326298|69172058|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
37695960|NCT02326298|69172059|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
37987782|NCT00373958|69673209|FG000|Infant Series|Child relocated|1|||
37987783|NCT00373958|69673210|FG001|Infant Series|Child relocated|0|||
37987784|NCT00373958|69673209|FG000|Infant Series|Consent was not received|1|||
37987785|NCT00373958|69673210|FG001|Infant Series|Consent was not received|0|||
37987786|NCT00373958|69673209|FG000|Infant Series|Adverse Event|3|||
37987787|NCT00373958|69673210|FG001|Infant Series|Adverse Event|1|||
37987788|NCT00373958|69673209|FG000|Infant Series|Physician Decision|1|||
37987789|NCT00373958|69673210|FG001|Infant Series|Physician Decision|1|||
37987790|NCT00373958|69673209|FG000|Toddler Dose|Lost to Follow-up|5|||
37987791|NCT00373958|69673210|FG001|Toddler Dose|Lost to Follow-up|8|||
37695961|NCT02326298|69172060|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
37695962|NCT02326298|69172061|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
37695963|NCT02326298|69172062|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
37695964|NCT02326298|69172063|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
37695965|NCT02326298|69172064|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
37695966|NCT02396420|69172073|FG000|Overall Study|Death|1|||
37888540|NCT01090310|69573304|FG003|Core Study|Adverse Event|1|||
37888541|NCT01090310|69573301|FG000|Core Study|Subject withdrew consent|0|||
37987792|NCT00373958|69673209|FG000|Toddler Dose|Withdrawal by Subject|2|||
37987793|NCT00373958|69673210|FG001|Toddler Dose|Withdrawal by Subject|2|||
37987794|NCT00373958|69673209|FG000|Toddler Dose|Failed to return|1|||
37987795|NCT00373958|69673210|FG001|Toddler Dose|Failed to return|2|||
37987796|NCT00373958|69673209|FG000|Toddler Dose|Protocol Violation|0|||
37987797|NCT00373958|69673210|FG001|Toddler Dose|Protocol Violation|1|||
37987798|NCT00373958|69673209|FG000|Toddler Dose|Withdrawn after infant series|22|||
37987799|NCT00373958|69673210|FG001|Toddler Dose|Withdrawn after infant series|25|||
37987800|NCT00373880|69673239|FG000|Overall Study|Physician Decision|3|||
37987801|NCT00373880|69673239|FG000|Overall Study|Arrested|1|||
37987802|NCT00373880|69673239|FG000|Overall Study|Protocol Violation|14|||
37987803|NCT00184600|69673254|FG000|Overall Study|Adverse Event|9|||
37987804|NCT00184600|69673255|FG001|Overall Study|Adverse Event|0|||
37987805|NCT00184600|69673256|FG002|Overall Study|Adverse Event|5|||
37987806|NCT00184600|69673254|FG000|Overall Study|Death|3|||
37987807|NCT00184600|69673255|FG001|Overall Study|Death|9|||
37888542|NCT01090310|69573302|FG001|Core Study|Subject withdrew consent|3|||
37888543|NCT01090310|69573303|FG002|Core Study|Subject withdrew consent|1|||
37888544|NCT01090310|69573304|FG003|Core Study|Subject withdrew consent|1|||
37888545|NCT01090310|69573301|FG000|Core Study|Abnormal test procedure result|0|||
37888546|NCT01090310|69573302|FG001|Core Study|Abnormal test procedure result|0|||
37888547|NCT01090310|69573303|FG002|Core Study|Abnormal test procedure result|1|||
37888548|NCT01090310|69573304|FG003|Core Study|Abnormal test procedure result|0|||
37888549|NCT01090310|69573301|FG000|Core Study|Administrative reasons|5|||
37888550|NCT01090310|69573302|FG001|Core Study|Administrative reasons|6|||
37888551|NCT01090310|69573303|FG002|Core Study|Administrative reasons|4|||
37888552|NCT01090310|69573304|FG003|Core Study|Administrative reasons|4|||
37888553|NCT01090310|69573301|FG000|Core Study|Protocol deviation|1|||
37888554|NCT01090310|69573302|FG001|Core Study|Protocol deviation|0|||
37888555|NCT01090310|69573303|FG002|Core Study|Protocol deviation|0|||
37888556|NCT01090310|69573304|FG003|Core Study|Protocol deviation|1|||
37888557|NCT01090310|69573301|FG000|Extension Study|Aministrative problems|13|||
37888558|NCT01090310|69573302|FG001|Extension Study|Aministrative problems|15|||
37888559|NCT01090310|69573303|FG002|Extension Study|Aministrative problems|14|||
37888560|NCT01090310|69573304|FG003|Extension Study|Aministrative problems|18|||
37888561|NCT01090310|69573301|FG000|Extension Study|Adverse Event|0|||
37888562|NCT01090310|69573302|FG001|Extension Study|Adverse Event|0|||
37888563|NCT01090310|69573303|FG002|Extension Study|Adverse Event|0|||
37888564|NCT01090310|69573304|FG003|Extension Study|Adverse Event|1|||
37888565|NCT01090310|69573301|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
37888566|NCT01090310|69573302|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
37888567|NCT01090310|69573303|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
37888568|NCT01090310|69573304|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
37888569|NCT01090310|69573301|FG000|Extension Study|Subject withdrew consent|0|||
37888570|NCT01090310|69573302|FG001|Extension Study|Subject withdrew consent|1|||
37888571|NCT01090310|69573303|FG002|Extension Study|Subject withdrew consent|0|||
37888572|NCT01090310|69573304|FG003|Extension Study|Subject withdrew consent|0|||
37888573|NCT01090076|69573316|FG000|Overall Study|Death|1|||
37888574|NCT01090076|69573317|FG001|Overall Study|Death|1|||
37888575|NCT01090076|69573316|FG000|Overall Study|Withdrawal by Subject|0|||
37888576|NCT01090076|69573317|FG001|Overall Study|Withdrawal by Subject|1|||
37888577|NCT00869050|69573325|FG000|Overall Study|Screen Failure|3|||
37888578|NCT00927186|69573331|FG000|12 Months Primary Study|Adverse Event|5|||
37823269|NCT02855944|69504470|FG000|Period 1: Treatment|Ongoing|14|||
37823270|NCT02855944|69504471|FG001|Period 1: Treatment|Ongoing|0|||
37823271|NCT02855944|69504470|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
37823272|NCT02855944|69504471|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
37823273|NCT02855944|69504470|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
37823274|NCT02855944|69504471|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
37823275|NCT02681055|69504478|FG000|Weeks 5-12|Adverse Event|1|||
37823276|NCT02409342|69504485|FG000|Overall Study|Death|211|||
37823277|NCT02409342|69504486|FG001|Overall Study|Death|201|||
37823278|NCT02409342|69504485|FG000|Overall Study|Withdrawal by Subject|24|||
37823279|NCT02409342|69504486|FG001|Overall Study|Withdrawal by Subject|17|||
37823280|NCT02409342|69504485|FG000|Overall Study|Study Terminated By Sponsor|48|||
37823281|NCT02409342|69504486|FG001|Overall Study|Study Terminated By Sponsor|59|||
37823282|NCT02409342|69504485|FG000|Overall Study|Lost to Follow-up|3|||
37823283|NCT02409342|69504486|FG001|Overall Study|Lost to Follow-up|5|||
37823284|NCT02409342|69504485|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
37987808|NCT00184600|69673256|FG002|Overall Study|Death|7|||
37823285|NCT02409342|69504486|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
37823286|NCT02409342|69504485|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
37833590|NCT01262872|69517328|FG001|Step 2|Death|0|||
37888579|NCT00927186|69573332|FG001|12 Months Primary Study|Adverse Event|2|||
37888580|NCT00927186|69573331|FG000|12 Months Primary Study|Lost to Follow-up|1|||
37888581|NCT00927186|69573332|FG001|12 Months Primary Study|Lost to Follow-up|0|||
37888582|NCT00927186|69573331|FG000|12 Months Primary Study|Protocol Violation|0|||
37888583|NCT00927186|69573332|FG001|12 Months Primary Study|Protocol Violation|1|||
37888584|NCT00927186|69573331|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
37888585|NCT00927186|69573332|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
37888586|NCT00593554|69573343|FG000|Overall Study|Death|1|||
37987809|NCT00184600|69673254|FG000|Overall Study|Lack of Efficacy|3|||
37987810|NCT00184600|69673255|FG001|Overall Study|Lack of Efficacy|1|||
37987811|NCT00184600|69673256|FG002|Overall Study|Lack of Efficacy|3|||
37987812|NCT00184600|69673254|FG000|Overall Study|Lost to Follow-up|4|||
37888587|NCT00593554|69573344|FG001|Overall Study|Death|2|||
37888588|NCT00593554|69573343|FG000|Overall Study|Physician Decision|0|||
37987813|NCT00184600|69673255|FG001|Overall Study|Lost to Follow-up|6|||
37987814|NCT00184600|69673256|FG002|Overall Study|Lost to Follow-up|1|||
37987815|NCT00184600|69673254|FG000|Overall Study|Protocol Violation|2|||
37987816|NCT00184600|69673255|FG001|Overall Study|Protocol Violation|2|||
37987817|NCT00184600|69673256|FG002|Overall Study|Protocol Violation|3|||
37987818|NCT00184600|69673254|FG000|Overall Study|Withdrawal by Subject|20|||
37987819|NCT00184600|69673255|FG001|Overall Study|Withdrawal by Subject|28|||
37987820|NCT00184600|69673256|FG002|Overall Study|Withdrawal by Subject|12|||
37987821|NCT00184600|69673254|FG000|Overall Study|Unclassified|4|||
37987822|NCT00184600|69673255|FG001|Overall Study|Unclassified|5|||
37987823|NCT00184600|69673256|FG002|Overall Study|Unclassified|3|||
37987824|NCT00265317|69673268|FG000|Lead-In|Objective progression or relapse|6|||
37695967|NCT02279719|69172085|FG000|Overall Study|Patients randomized but never treated|0|||
37695968|NCT02279719|69172086|FG001|Overall Study|Patients randomized but never treated|0|||
37695969|NCT02279719|69172087|FG002|Overall Study|Patients randomized but never treated|0|||
37695970|NCT02279719|69172088|FG003|Overall Study|Patients randomized but never treated|0|||
37695971|NCT02279719|69172089|FG004|Overall Study|Patients randomized but never treated|3|||
37695972|NCT02279719|69172090|FG005|Overall Study|Patients randomized but never treated|0|||
37695973|NCT02279719|69172091|FG006|Overall Study|Patients randomized but never treated|3|||
37695974|NCT02279407|69172128|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
37695975|NCT02279407|69172129|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
37695976|NCT02279407|69172130|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
37823287|NCT02409342|69504486|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
37823288|NCT02409342|69504485|FG000|Overall Study|Sponsor Decision|1|||
37823289|NCT02409342|69504486|FG001|Overall Study|Sponsor Decision|0|||
37823290|NCT02336503|69504498|FG000|Overall Study|Lost to Follow-up|0|||
37823291|NCT02336503|69504499|FG001|Overall Study|Lost to Follow-up|3|||
37823292|NCT02336503|69504500|FG002|Overall Study|Lost to Follow-up|0|||
37987825|NCT00265317|69673269|FG001|Lead-In|Objective progression or relapse|11|||
37987826|NCT00265317|69673270|FG002|Lead-In|Objective progression or relapse|0|||
37987827|NCT00265317|69673271|FG003|Lead-In|Objective progression or relapse|0|||
37987828|NCT00265317|69673268|FG000|Lead-In|Adverse Event|2|||
37987829|NCT00265317|69673269|FG001|Lead-In|Adverse Event|1|||
37987830|NCT00265317|69673270|FG002|Lead-In|Adverse Event|0|||
37987831|NCT00265317|69673271|FG003|Lead-In|Adverse Event|0|||
37987832|NCT00265317|69673268|FG000|Lead-In|Death|3|||
37987833|NCT00265317|69673269|FG001|Lead-In|Death|5|||
37987834|NCT00265317|69673270|FG002|Lead-In|Death|0|||
37987835|NCT00265317|69673271|FG003|Lead-In|Death|0|||
37987836|NCT00265317|69673268|FG000|Lead-In|Withdrawal/other than adverse event|1|||
37987837|NCT00265317|69673269|FG001|Lead-In|Withdrawal/other than adverse event|0|||
37987838|NCT00265317|69673270|FG002|Lead-In|Withdrawal/other than adverse event|0|||
37987839|NCT00265317|69673271|FG003|Lead-In|Withdrawal/other than adverse event|0|||
37987840|NCT00265317|69673268|FG000|Phase 2|Objective progression or relapse|0|||
37987841|NCT00265317|69673269|FG001|Phase 2|Objective progression or relapse|0|||
37987842|NCT00265317|69673270|FG002|Phase 2|Objective progression or relapse|37|||
37987843|NCT00265317|69673271|FG003|Phase 2|Objective progression or relapse|38|||
37987844|NCT00265317|69673268|FG000|Phase 2|Global deterioration of health status|0|||
37987845|NCT00265317|69673269|FG001|Phase 2|Global deterioration of health status|0|||
37823293|NCT02336503|69504501|FG003|Overall Study|Lost to Follow-up|2|||
37987846|NCT00265317|69673270|FG002|Phase 2|Global deterioration of health status|3|||
37987847|NCT00265317|69673271|FG003|Phase 2|Global deterioration of health status|0|||
37987848|NCT00265317|69673268|FG000|Phase 2|Adverse Event|0|||
37987849|NCT00265317|69673269|FG001|Phase 2|Adverse Event|0|||
37695977|NCT02279407|69172131|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
37695978|NCT02279407|69172128|FG000|Overall Study|Withdrawal by Subject|1|||
37823294|NCT02336503|69504498|FG000|Overall Study|Withdrawal by Subject|2|||
37823295|NCT02336503|69504499|FG001|Overall Study|Withdrawal by Subject|0|||
37833591|NCT01262872|69517329|FG002|Step 2|Death|0|||
37987850|NCT00265317|69673270|FG002|Phase 2|Adverse Event|7|||
37987851|NCT00265317|69673271|FG003|Phase 2|Adverse Event|5|||
37987852|NCT00265317|69673268|FG000|Phase 2|Death|0|||
37987853|NCT00265317|69673269|FG001|Phase 2|Death|0|||
37987854|NCT00265317|69673270|FG002|Phase 2|Death|12|||
37987855|NCT00265317|69673271|FG003|Phase 2|Death|15|||
37987856|NCT00265317|69673268|FG000|Phase 2|Protocol Violation|0|||
37987857|NCT00265317|69673269|FG001|Phase 2|Protocol Violation|0|||
37987858|NCT00265317|69673270|FG002|Phase 2|Protocol Violation|1|||
37987859|NCT00265317|69673271|FG003|Phase 2|Protocol Violation|4|||
37987860|NCT00265317|69673268|FG000|Phase 2|Lost to Follow-up|0|||
37888589|NCT00593554|69573344|FG001|Overall Study|Physician Decision|1|||
37888590|NCT00593554|69573343|FG000|Overall Study|Withdrawal by Subject|1|||
37888591|NCT00593554|69573344|FG001|Overall Study|Withdrawal by Subject|0|||
37888592|NCT00593554|69573343|FG000|Overall Study|Disease Progression|1|||
37888593|NCT00593554|69573344|FG001|Overall Study|Disease Progression|2|||
37888594|NCT01101308|69573350|FG000|Period 1|Adverse Event|2|||
37888595|NCT01101308|69573351|FG001|Period 1|Adverse Event|1|||
37987861|NCT00265317|69673269|FG001|Phase 2|Lost to Follow-up|0|||
37987862|NCT00265317|69673270|FG002|Phase 2|Lost to Follow-up|0|||
37987863|NCT00265317|69673271|FG003|Phase 2|Lost to Follow-up|1|||
37987864|NCT00265317|69673268|FG000|Phase 2|Withdrawal/other than adverse event|0|||
37987865|NCT00265317|69673269|FG001|Phase 2|Withdrawal/other than adverse event|0|||
37987866|NCT00265317|69673270|FG002|Phase 2|Withdrawal/other than adverse event|2|||
37987867|NCT00265317|69673271|FG003|Phase 2|Withdrawal/other than adverse event|1|||
37987868|NCT00265317|69673268|FG000|Phase 2|Study terminated by sponsor|0|||
37987869|NCT00265317|69673269|FG001|Phase 2|Study terminated by sponsor|0|||
37987870|NCT00265317|69673270|FG002|Phase 2|Study terminated by sponsor|1|||
37987871|NCT00265317|69673271|FG003|Phase 2|Study terminated by sponsor|0|||
37823296|NCT02336503|69504500|FG002|Overall Study|Withdrawal by Subject|0|||
37823297|NCT02336503|69504501|FG003|Overall Study|Withdrawal by Subject|4|||
37823298|NCT02336503|69504498|FG000|Overall Study|Adverse Event|0|||
37823299|NCT02336503|69504499|FG001|Overall Study|Adverse Event|0|||
37823300|NCT02336503|69504500|FG002|Overall Study|Adverse Event|1|||
37823301|NCT02336503|69504501|FG003|Overall Study|Adverse Event|0|||
37823302|NCT02255409|69504517|FG000|Overall Study|Administrative Reason|3|||
37823303|NCT02255409|69504518|FG001|Overall Study|Administrative Reason|7|||
37823304|NCT02255409|69504517|FG000|Overall Study|Withdrawal by Subject|1|||
37823305|NCT02255409|69504518|FG001|Overall Study|Withdrawal by Subject|5|||
37823306|NCT02255409|69504517|FG000|Overall Study|Lost to Follow-up|10|||
37823307|NCT02255409|69504518|FG001|Overall Study|Lost to Follow-up|19|||
37823308|NCT00630032|69504549|FG000|Overall Study|Death|55|||
37823309|NCT00630032|69504550|FG001|Overall Study|Death|49|||
37823310|NCT00630032|69504549|FG000|Overall Study|Withdrawal by Subject|3|||
37823311|NCT00630032|69504550|FG001|Overall Study|Withdrawal by Subject|2|||
37888596|NCT01101308|69573350|FG000|Period 1|Positive for cotinine|1|||
37888597|NCT01101308|69573351|FG001|Period 1|Positive for cotinine|0|||
37987872|NCT00265317|69673268|FG000|Phase 2|Other|0|||
37987873|NCT00265317|69673269|FG001|Phase 2|Other|0|||
37987874|NCT00265317|69673270|FG002|Phase 2|Other|1|||
37987875|NCT00265317|69673271|FG003|Phase 2|Other|1|||
37987876|NCT00373490|69673292|FG000|Overall Study|Adverse Event|0|||
37987877|NCT00373490|69673293|FG001|Overall Study|Adverse Event|1|||
37987878|NCT00373490|69673292|FG000|Overall Study|Lack of Efficacy|9|||
37987879|NCT00373490|69673293|FG001|Overall Study|Lack of Efficacy|4|||
37987880|NCT00373490|69673292|FG000|Overall Study|Withdrawal by Subject|0|||
37987881|NCT00373490|69673293|FG001|Overall Study|Withdrawal by Subject|1|||
37987882|NCT00251589|69673303|FG000|Overall Study|Adverse Event|5|||
37987883|NCT00251589|69673304|FG001|Overall Study|Adverse Event|1|||
37987884|NCT00251589|69673305|FG002|Overall Study|Adverse Event|2|||
37987885|NCT00251589|69673306|FG003|Overall Study|Adverse Event|1|||
37888598|NCT00926796|69573360|FG000|Overall Study|Did not receive randomized treatment|4|||
37888599|NCT00926796|69573361|FG001|Overall Study|Did not receive randomized treatment|7|||
37888600|NCT00926796|69573360|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
37888601|NCT00926796|69573361|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
37888602|NCT00926796|69573360|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
37888603|NCT00926796|69573361|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
37888604|NCT00926796|69573360|FG000|Overall Study|Adverse Event|7|||
37888605|NCT00926796|69573361|FG001|Overall Study|Adverse Event|14|||
37888606|NCT00926796|69573360|FG000|Overall Study|Lost to Follow-up|22|||
37888607|NCT00926796|69573361|FG001|Overall Study|Lost to Follow-up|13|||
37888608|NCT00926796|69573360|FG000|Overall Study|Protocol Violation|15|||
37888609|NCT00926796|69573361|FG001|Overall Study|Protocol Violation|11|||
37888610|NCT00926796|69573360|FG000|Overall Study|Withdrawal by Subject|1|||
37888611|NCT00926796|69573361|FG001|Overall Study|Withdrawal by Subject|0|||
37888612|NCT01087736|69573371|FG000|Overall Study|Lost to Follow-up|1|||
37888613|NCT01087736|69573372|FG001|Overall Study|Lost to Follow-up|0|||
37987886|NCT00251589|69673303|FG000|Overall Study|Withdrawal by Subject|1|||
37987887|NCT00251589|69673304|FG001|Overall Study|Withdrawal by Subject|1|||
37888614|NCT01087736|69573371|FG000|Overall Study|Death|0|||
37888615|NCT01087736|69573372|FG001|Overall Study|Death|1|||
37888616|NCT01087736|69573371|FG000|Overall Study|Withdrawal by Subject|0|||
37888617|NCT01087736|69573372|FG001|Overall Study|Withdrawal by Subject|1|||
37888618|NCT01079936|69573382|FG000|Phase I: MTD|First Remission Status|2|||
37888619|NCT01079936|69573383|FG001|Phase I: MTD|First Remission Status|0|||
37987888|NCT00251589|69673305|FG002|Overall Study|Withdrawal by Subject|0|||
37987889|NCT00251589|69673306|FG003|Overall Study|Withdrawal by Subject|0|||
37987890|NCT00251589|69673303|FG000|Overall Study|Discontinued due to progressive disease|9|||
37823312|NCT00630032|69504549|FG000|Overall Study|Lost to Follow-up|18|||
37823313|NCT00630032|69504550|FG001|Overall Study|Lost to Follow-up|31|||
37823314|NCT00630032|69504549|FG000|Overall Study|Protocol Violation|1|||
37823315|NCT00630032|69504550|FG001|Overall Study|Protocol Violation|0|||
37823316|NCT00630032|69504549|FG000|Overall Study|Patient has moved|1|||
37823317|NCT00630032|69504550|FG001|Overall Study|Patient has moved|1|||
37823318|NCT00630032|69504549|FG000|Overall Study|Disease progression|1|||
37823319|NCT00630032|69504550|FG001|Overall Study|Disease progression|1|||
37823320|NCT00630032|69504549|FG000|Overall Study|End of monitoring in US centers|11|||
37823321|NCT00630032|69504550|FG001|Overall Study|End of monitoring in US centers|11|||
37823322|NCT00465517|69504558|FG000|Overall Study|Adverse Event|7|||
37888620|NCT01079936|69573384|FG002|Phase I: MTD|First Remission Status|0|||
37888621|NCT01079936|69573385|FG003|Phase I: MTD|First Remission Status|0|||
37888622|NCT01079936|69573386|FG004|Phase I: MTD|First Remission Status|0|||
37888623|NCT01079936|69573382|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
37888624|NCT01079936|69573383|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
37888625|NCT01079936|69573384|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
37987891|NCT00251589|69673304|FG001|Overall Study|Discontinued due to progressive disease|1|||
37823323|NCT00465517|69504559|FG001|Overall Study|Adverse Event|3|||
37823324|NCT00465517|69504558|FG000|Overall Study|Lost to Follow-up|1|||
37823325|NCT00465517|69504559|FG001|Overall Study|Lost to Follow-up|0|||
37823326|NCT00465517|69504558|FG000|Overall Study|Withdrawal by Subject|4|||
37823327|NCT00465517|69504559|FG001|Overall Study|Withdrawal by Subject|1|||
37823328|NCT05050578|69504567|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
37823329|NCT05050578|69504568|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
37823330|NCT05050578|69504567|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
37823331|NCT05050578|69504568|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
37987892|NCT00251589|69673305|FG002|Overall Study|Discontinued due to progressive disease|0|||
37823332|NCT05050578|69504567|FG000|Period 2, 30 Days|Protocol Violation|0|||
37888626|NCT01079936|69573385|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
37888627|NCT01079936|69573386|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
37888628|NCT01079936|69573382|FG000|Phase II|Adverse Event|0|||
37888629|NCT01079936|69573383|FG001|Phase II|Adverse Event|0|||
37888630|NCT01079936|69573384|FG002|Phase II|Adverse Event|1|||
37987893|NCT00251589|69673306|FG003|Overall Study|Discontinued due to progressive disease|1|||
37823333|NCT05050578|69504568|FG001|Period 2, 30 Days|Protocol Violation|1|||
37823334|NCT04490278|69504577|FG000|Overall Study|Lost to Follow-up|6|||
37888631|NCT01079936|69573385|FG003|Phase II|Adverse Event|0|||
37888632|NCT01079936|69573386|FG004|Phase II|Adverse Event|0|||
37888633|NCT01079936|69573382|FG000|Phase II|Insurance Issue|0|||
37823335|NCT04004221|69504581|FG000|Overall Study|Death|89|||
37888634|NCT01079936|69573383|FG001|Phase II|Insurance Issue|0|||
37888635|NCT01079936|69573384|FG002|Phase II|Insurance Issue|0|||
37888636|NCT01079936|69573385|FG003|Phase II|Insurance Issue|0|||
37888637|NCT01079936|69573386|FG004|Phase II|Insurance Issue|1|||
37888638|NCT00931710|69573399|FG000|Overall Study|Adverse Event|16|||
37987894|NCT00265239|69673318|FG000|Overall Study|Adverse Event|2|||
37987895|NCT00265239|69673319|FG001|Overall Study|Adverse Event|1|||
37888639|NCT00931710|69573400|FG001|Overall Study|Adverse Event|10|||
37888640|NCT00931710|69573399|FG000|Overall Study|Abnormal test procedure results|2|||
37987896|NCT00350298|69673327|FG000|Overall Study|Death|7|||
37987897|NCT00350298|69673328|FG001|Overall Study|Death|8|||
37987898|NCT00350298|69673327|FG000|Overall Study|Lost to Follow-up|1|||
37987899|NCT00350298|69673328|FG001|Overall Study|Lost to Follow-up|2|||
37888641|NCT00931710|69573400|FG001|Overall Study|Abnormal test procedure results|0|||
37888642|NCT00931710|69573399|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
37888643|NCT00931710|69573400|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
37888644|NCT00931710|69573399|FG000|Overall Study|Patient withdrew consent|4|||
37888645|NCT00931710|69573400|FG001|Overall Study|Patient withdrew consent|9|||
37888646|NCT00931710|69573399|FG000|Overall Study|Lost to Follow-up|6|||
37987900|NCT00350298|69673327|FG000|Overall Study|Withdrawal by Subject|1|||
37987901|NCT00350298|69673328|FG001|Overall Study|Withdrawal by Subject|3|||
37987902|NCT00159874|69673341|FG000|Overall Study|Adverse Event|2|||
37987903|NCT00159874|69673342|FG001|Overall Study|Adverse Event|2|||
37987904|NCT00159874|69673343|FG002|Overall Study|Adverse Event|5|||
37987905|NCT00159874|69673344|FG003|Overall Study|Adverse Event|1|||
37987906|NCT00159874|69673345|FG004|Overall Study|Adverse Event|1|||
37987907|NCT00159874|69673346|FG005|Overall Study|Adverse Event|2|||
37987908|NCT00159874|69673347|FG006|Overall Study|Adverse Event|0|||
37987909|NCT00159874|69673341|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
37987910|NCT00159874|69673342|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
37987911|NCT00159874|69673343|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
37987912|NCT00159874|69673344|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
37987913|NCT00159874|69673345|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
37987914|NCT00159874|69673346|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
37987915|NCT00159874|69673347|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
37888647|NCT00931710|69573400|FG001|Overall Study|Lost to Follow-up|5|||
37888648|NCT00931710|69573399|FG000|Overall Study|Protocol deviation|1|||
37987916|NCT00159874|69673341|FG000|Overall Study|Lack of Efficacy|2|||
37987917|NCT00159874|69673342|FG001|Overall Study|Lack of Efficacy|0|||
37987918|NCT00159874|69673343|FG002|Overall Study|Lack of Efficacy|1|||
37987919|NCT00159874|69673344|FG003|Overall Study|Lack of Efficacy|1|||
37987920|NCT00159874|69673345|FG004|Overall Study|Lack of Efficacy|0|||
37888649|NCT00931710|69573400|FG001|Overall Study|Protocol deviation|2|||
37888650|NCT01100528|69573406|FG000|Overall Study|Death|1|||
37888651|NCT01100528|69573406|FG000|Overall Study|Withdrawal by Subject|2|||
37987921|NCT00159874|69673346|FG005|Overall Study|Lack of Efficacy|3|||
37987922|NCT00159874|69673347|FG006|Overall Study|Lack of Efficacy|0|||
37987923|NCT00159874|69673341|FG000|Overall Study|Lost to Follow-up|1|||
37987924|NCT00159874|69673342|FG001|Overall Study|Lost to Follow-up|0|||
37987925|NCT00159874|69673343|FG002|Overall Study|Lost to Follow-up|3|||
37987926|NCT00159874|69673344|FG003|Overall Study|Lost to Follow-up|0|||
37987927|NCT00159874|69673345|FG004|Overall Study|Lost to Follow-up|1|||
37987928|NCT00159874|69673346|FG005|Overall Study|Lost to Follow-up|2|||
37987929|NCT00159874|69673347|FG006|Overall Study|Lost to Follow-up|1|||
37987930|NCT00159874|69673341|FG000|Overall Study|Other|8|||
37987931|NCT00159874|69673342|FG001|Overall Study|Other|8|||
37987932|NCT00159874|69673343|FG002|Overall Study|Other|8|||
37987933|NCT00159874|69673344|FG003|Overall Study|Other|0|||
37987934|NCT00159874|69673345|FG004|Overall Study|Other|2|||
37987935|NCT00159874|69673346|FG005|Overall Study|Other|1|||
37987936|NCT00159874|69673347|FG006|Overall Study|Other|3|||
37987937|NCT00159874|69673341|FG000|Overall Study|Protocol Violation|0|||
37987938|NCT00159874|69673342|FG001|Overall Study|Protocol Violation|5|||
37987939|NCT00159874|69673343|FG002|Overall Study|Protocol Violation|2|||
37987940|NCT00159874|69673344|FG003|Overall Study|Protocol Violation|0|||
37987941|NCT00159874|69673345|FG004|Overall Study|Protocol Violation|0|||
37987942|NCT00159874|69673346|FG005|Overall Study|Protocol Violation|0|||
37987943|NCT00159874|69673347|FG006|Overall Study|Protocol Violation|0|||
37987944|NCT00159874|69673341|FG000|Overall Study|Death|3|||
37987945|NCT00159874|69673342|FG001|Overall Study|Death|8|||
37987946|NCT00159874|69673343|FG002|Overall Study|Death|15|||
37987947|NCT00159874|69673344|FG003|Overall Study|Death|0|||
37987948|NCT00159874|69673345|FG004|Overall Study|Death|1|||
37987949|NCT00159874|69673346|FG005|Overall Study|Death|2|||
37987950|NCT00159874|69673347|FG006|Overall Study|Death|0|||
37987951|NCT00159874|69673341|FG000|Overall Study|Withdrawal by Subject|2|||
37987952|NCT00159874|69673342|FG001|Overall Study|Withdrawal by Subject|6|||
37987953|NCT00159874|69673343|FG002|Overall Study|Withdrawal by Subject|8|||
37987954|NCT00159874|69673344|FG003|Overall Study|Withdrawal by Subject|4|||
37888652|NCT01079234|69573413|FG000|Main: Week 0 to 26|Adverse Event|5|||
37888653|NCT01079234|69573414|FG001|Main: Week 0 to 26|Adverse Event|4|||
37888654|NCT01079234|69573415|FG002|Main: Week 0 to 26|Adverse Event|1|||
37888655|NCT01079234|69573416|FG003|Main: Week 0 to 26|Adverse Event|0|||
37888656|NCT01079234|69573413|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
37888657|NCT01079234|69573414|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
37888658|NCT01079234|69573415|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
37888659|NCT01079234|69573416|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
37888660|NCT01079234|69573413|FG000|Main: Week 0 to 26|Protocol Violation|6|||
37888661|NCT01079234|69573414|FG001|Main: Week 0 to 26|Protocol Violation|2|||
37888662|NCT01079234|69573415|FG002|Main: Week 0 to 26|Protocol Violation|4|||
37888663|NCT01079234|69573416|FG003|Main: Week 0 to 26|Protocol Violation|0|||
37888664|NCT01079234|69573413|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
37888665|NCT01079234|69573414|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
37888666|NCT01079234|69573415|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
37888667|NCT01079234|69573416|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
37888668|NCT01079234|69573413|FG000|Main: Week 0 to 26|Unclassified|7|||
37888669|NCT01079234|69573414|FG001|Main: Week 0 to 26|Unclassified|13|||
37888670|NCT01079234|69573415|FG002|Main: Week 0 to 26|Unclassified|4|||
37888671|NCT01079234|69573416|FG003|Main: Week 0 to 26|Unclassified|0|||
37888672|NCT01079234|69573413|FG000|Extension: Week 27 to 52|Adverse Event|0|||
37888673|NCT01079234|69573414|FG001|Extension: Week 27 to 52|Adverse Event|0|||
37888674|NCT01079234|69573415|FG002|Extension: Week 27 to 52|Adverse Event|1|||
37888675|NCT01079234|69573416|FG003|Extension: Week 27 to 52|Adverse Event|0|||
37888676|NCT01079234|69573413|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
37888677|NCT01079234|69573414|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
37888678|NCT01079234|69573415|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
37888679|NCT01079234|69573416|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
37888680|NCT01079234|69573413|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
37888681|NCT01079234|69573414|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
37888682|NCT01079234|69573415|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
37888683|NCT01079234|69573416|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
37888684|NCT01079234|69573413|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
37987955|NCT00159874|69673345|FG004|Overall Study|Withdrawal by Subject|3|||
37987956|NCT00159874|69673346|FG005|Overall Study|Withdrawal by Subject|2|||
37987957|NCT00159874|69673347|FG006|Overall Study|Withdrawal by Subject|1|||
37987958|NCT00159874|69673341|FG000|Overall Study|Pregnancy|1|||
37987959|NCT00159874|69673342|FG001|Overall Study|Pregnancy|1|||
37888685|NCT01079234|69573414|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
37987960|NCT00159874|69673343|FG002|Overall Study|Pregnancy|0|||
37987961|NCT00159874|69673344|FG003|Overall Study|Pregnancy|0|||
37987962|NCT00159874|69673345|FG004|Overall Study|Pregnancy|0|||
37823336|NCT04004221|69504581|FG000|Overall Study|Withdrawal by Subject|5|||
37987963|NCT00159874|69673346|FG005|Overall Study|Pregnancy|0|||
37987964|NCT00159874|69673347|FG006|Overall Study|Pregnancy|0|||
37987965|NCT00349908|69673365|FG000|Overall Study|Withdrawal by Subject|0|||
37987966|NCT00349908|69673366|FG001|Overall Study|Withdrawal by Subject|4|||
37987967|NCT00184054|69673373|FG000|Overall Study|Adverse Event|1|||
37987968|NCT00183430|69673379|FG000|Overall Study|Adverse Event|1|||
37987969|NCT00183430|69673380|FG001|Overall Study|Adverse Event|0|||
37987970|NCT00183430|69673379|FG000|Overall Study|Lost to Follow-up|3|||
37987971|NCT00183430|69673380|FG001|Overall Study|Lost to Follow-up|0|||
37987972|NCT00183430|69673379|FG000|Overall Study|did not meet inclusion criteria|1|||
37987973|NCT00183430|69673380|FG001|Overall Study|did not meet inclusion criteria|0|||
37987974|NCT00183430|69673379|FG000|Overall Study|Withdrawal by Subject|1|||
37987975|NCT00183430|69673380|FG001|Overall Study|Withdrawal by Subject|0|||
37987976|NCT00183274|69673386|FG000|Phase 1: Open-Label|Adverse Event|31|||
37987977|NCT00183274|69673387|FG001|Phase 1: Open-Label|Adverse Event|0|||
37987978|NCT00183274|69673388|FG002|Phase 1: Open-Label|Adverse Event|0|||
37987979|NCT00183274|69673389|FG003|Phase 1: Open-Label|Adverse Event|0|||
37987980|NCT00183274|69673390|FG004|Phase 1: Open-Label|Adverse Event|0|||
37987981|NCT00183274|69673391|FG005|Phase 1: Open-Label|Adverse Event|0|||
37987982|NCT00183274|69673386|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
37987983|NCT00183274|69673387|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
37987984|NCT00183274|69673388|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
37987985|NCT00183274|69673389|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
37987986|NCT00183274|69673390|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
37987987|NCT00183274|69673391|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
37987988|NCT00183274|69673386|FG000|Phase 1: Open-Label|Protocol Violation|11|||
37987989|NCT00183274|69673387|FG001|Phase 1: Open-Label|Protocol Violation|0|||
37987990|NCT00183274|69673388|FG002|Phase 1: Open-Label|Protocol Violation|0|||
37987991|NCT00183274|69673389|FG003|Phase 1: Open-Label|Protocol Violation|0|||
37987992|NCT00183274|69673390|FG004|Phase 1: Open-Label|Protocol Violation|0|||
37987993|NCT00183274|69673391|FG005|Phase 1: Open-Label|Protocol Violation|0|||
37987994|NCT00183274|69673386|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
37987995|NCT00183274|69673387|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
37987996|NCT00183274|69673388|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
37823337|NCT04004221|69504581|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
37987997|NCT00183274|69673389|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
37823338|NCT04004221|69504581|FG000|Overall Study|Sponsor Decision|9|||
37823339|NCT04004221|69504581|FG000|Overall Study|Participant refused to enter LTE|1|||
37823340|NCT03775512|69504591|FG000|Overall Study|Death|1|||
37823341|NCT03775512|69504592|FG001|Overall Study|Death|1|||
37823342|NCT03775512|69504591|FG000|Overall Study|Withdrawal by Subject|7|||
37823343|NCT03775512|69504592|FG001|Overall Study|Withdrawal by Subject|4|||
37823344|NCT03775512|69504591|FG000|Overall Study|Lost to Follow-up|5|||
37823345|NCT03775512|69504592|FG001|Overall Study|Lost to Follow-up|5|||
37823346|NCT03775512|69504591|FG000|Overall Study|Excluded before Catheter insertion|14|||
37823347|NCT03775512|69504592|FG001|Overall Study|Excluded before Catheter insertion|5|||
37823348|NCT03775512|69504591|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
37823349|NCT03775512|69504592|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
37823350|NCT03775512|69504591|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
37823351|NCT03775512|69504592|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
37823352|NCT03620747|69504598|FG000|Overall Study|Participant decision|7|||
37823353|NCT03620747|69504598|FG000|Overall Study|Adverse Event|6|||
37823354|NCT03620747|69504598|FG000|Overall Study|Lack of Efficacy|1|||
37823355|NCT03620747|69504598|FG000|Overall Study|Poor compliance to protocol|2|||
37823356|NCT03620747|69504598|FG000|Overall Study|Other-unspecified|3|||
37823357|NCT03338790|69504623|FG000|Overall Study|Disease Progression|65|||
37823358|NCT03338790|69504624|FG001|Overall Study|Disease Progression|43|||
37823359|NCT03338790|69504625|FG002|Overall Study|Disease Progression|50|||
37823360|NCT03338790|69504626|FG003|Overall Study|Disease Progression|37|||
37823361|NCT03338790|69504623|FG000|Overall Study|Study Drug Toxicity|9|||
37823362|NCT03338790|69504624|FG001|Overall Study|Study Drug Toxicity|8|||
37823363|NCT03338790|69504625|FG002|Overall Study|Study Drug Toxicity|15|||
37823364|NCT03338790|69504626|FG003|Overall Study|Study Drug Toxicity|0|||
37823365|NCT03338790|69504623|FG000|Overall Study|Death|1|||
37823366|NCT03338790|69504624|FG001|Overall Study|Death|1|||
37823367|NCT03338790|69504625|FG002|Overall Study|Death|1|||
37823368|NCT03338790|69504626|FG003|Overall Study|Death|0|||
37987998|NCT00183274|69673390|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
37987999|NCT00183274|69673391|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
37988000|NCT00183274|69673386|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
37988001|NCT00183274|69673387|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
37988002|NCT00183274|69673388|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
37988003|NCT00183274|69673389|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
37988004|NCT00183274|69673390|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
37888686|NCT01079234|69573415|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
37888687|NCT01079234|69573416|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
37888688|NCT01079234|69573413|FG000|Extension: Week 27 to 52|Unclassified|0|||
37888689|NCT01079234|69573414|FG001|Extension: Week 27 to 52|Unclassified|0|||
37888690|NCT01079234|69573415|FG002|Extension: Week 27 to 52|Unclassified|4|||
37888691|NCT01079234|69573416|FG003|Extension: Week 27 to 52|Unclassified|7|||
37888692|NCT00931632|69573427|FG000|Overall Study|Withdrawal by Subject|2|||
37888693|NCT00931632|69573428|FG001|Overall Study|Withdrawal by Subject|3|||
37888694|NCT00931632|69573427|FG000|Overall Study|Adverse Event|19|||
37888695|NCT00931632|69573428|FG001|Overall Study|Adverse Event|15|||
37888696|NCT01078922|69573434|FG000|Overall Study|Adverse Event|1|||
37888697|NCT00863746|69573441|FG000|Treatment|Not treated|4|||
37888698|NCT00863746|69573442|FG001|Treatment|Not treated|2|||
37888699|NCT00863746|69573441|FG000|Treatment|Adverse Event|41|||
37888700|NCT00863746|69573442|FG001|Treatment|Adverse Event|16|||
37888701|NCT00863746|69573441|FG000|Treatment|non-compliant with study medication|4|||
37888702|NCT00863746|69573442|FG001|Treatment|non-compliant with study medication|0|||
37888703|NCT00863746|69573441|FG000|Treatment|Consent withdrawn|15|||
37888704|NCT00863746|69573442|FG001|Treatment|Consent withdrawn|14|||
37888705|NCT00863746|69573441|FG000|Treatment|Lost to Follow-up|1|||
37888706|NCT00863746|69573442|FG001|Treatment|Lost to Follow-up|0|||
37888707|NCT00863746|69573441|FG000|Treatment|Protocol Violation|5|||
37888708|NCT00863746|69573442|FG001|Treatment|Protocol Violation|3|||
37888709|NCT00863746|69573441|FG000|Treatment|Other|1|||
37888710|NCT00863746|69573442|FG001|Treatment|Other|0|||
37888711|NCT00863746|69573441|FG000|Survival Follow up|Death|244|||
37888712|NCT00863746|69573442|FG001|Survival Follow up|Death|271|||
37888713|NCT00863746|69573441|FG000|Survival Follow up|Lost to Follow-up|2|||
37888714|NCT00863746|69573442|FG001|Survival Follow up|Lost to Follow-up|1|||
37888715|NCT00863746|69573441|FG000|Survival Follow up|Consent Withdrawn|7|||
37888716|NCT00863746|69573442|FG001|Survival Follow up|Consent Withdrawn|8|||
37888717|NCT00926328|69573450|FG000|Overall Study|Lost to Follow-up|12|||
37888718|NCT00926328|69573451|FG001|Overall Study|Lost to Follow-up|14|||
37888719|NCT00863512|69573459|FG000|Overall Study|Adverse Event|2|||
37888720|NCT00863512|69573460|FG001|Overall Study|Adverse Event|0|||
37888721|NCT00863512|69573459|FG000|Overall Study|Withdrawal by Subject|11|||
37888722|NCT00863512|69573460|FG001|Overall Study|Withdrawal by Subject|0|||
37888723|NCT00863512|69573459|FG000|Overall Study|Physician Decision|1|||
37888724|NCT00863512|69573460|FG001|Overall Study|Physician Decision|0|||
37888725|NCT00868192|69573466|FG000|Overall Study|Ineligible|4|||
37888726|NCT00930930|69573472|FG000|Overall Study|Death|1|||
37888727|NCT00930930|69573473|FG001|Overall Study|Death|0|||
37888728|NCT00930930|69573472|FG000|Overall Study|Physician Decision|1|||
37888729|NCT00930930|69573473|FG001|Overall Study|Physician Decision|0|||
37888730|NCT00930930|69573472|FG000|Overall Study|Adverse Event|13|||
37888731|NCT00930930|69573473|FG001|Overall Study|Adverse Event|3|||
37888732|NCT00930930|69573472|FG000|Overall Study|Withdrawal by Subject|3|||
37888733|NCT00930930|69573473|FG001|Overall Study|Withdrawal by Subject|1|||
37988005|NCT00183274|69673391|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
37988006|NCT00183274|69673386|FG000|Phase 1: Open-Label|Other|9|||
37988007|NCT00183274|69673387|FG001|Phase 1: Open-Label|Other|0|||
37988008|NCT00183274|69673388|FG002|Phase 1: Open-Label|Other|0|||
37988009|NCT00183274|69673389|FG003|Phase 1: Open-Label|Other|0|||
37988010|NCT00183274|69673390|FG004|Phase 1: Open-Label|Other|0|||
37988011|NCT00183274|69673391|FG005|Phase 1: Open-Label|Other|0|||
37988012|NCT00183274|69673386|FG000|Phase 2: Double-Blind|Relapsed|0|||
37988013|NCT00183274|69673387|FG001|Phase 2: Double-Blind|Relapsed|8|||
37988014|NCT00183274|69673388|FG002|Phase 2: Double-Blind|Relapsed|29|||
37988015|NCT00183274|69673389|FG003|Phase 2: Double-Blind|Relapsed|0|||
37988016|NCT00183274|69673390|FG004|Phase 2: Double-Blind|Relapsed|0|||
37988017|NCT00183274|69673391|FG005|Phase 2: Double-Blind|Relapsed|0|||
37988018|NCT00183274|69673386|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
37988019|NCT00183274|69673387|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
37988020|NCT00183274|69673388|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
37988021|NCT00183274|69673389|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
37988022|NCT00183274|69673390|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
37888734|NCT00930930|69573472|FG000|Overall Study|Disease progression|2|||
37888735|NCT00930930|69573473|FG001|Overall Study|Disease progression|3|||
37888736|NCT00930930|69573472|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
37888737|NCT00930930|69573473|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
37888738|NCT00930930|69573472|FG000|Overall Study|patients not compliant|1|||
37888739|NCT00930930|69573473|FG001|Overall Study|patients not compliant|1|||
37888740|NCT00862654|69573483|FG000|Overall Study|Lack of Efficacy|1|||
37888741|NCT00862654|69573484|FG001|Overall Study|Lack of Efficacy|0|||
37888742|NCT00862654|69573485|FG002|Overall Study|Lack of Efficacy|1|||
37988023|NCT00183274|69673391|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
37988024|NCT00183274|69673386|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
37988025|NCT00183274|69673387|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
37988026|NCT00183274|69673388|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
37988027|NCT00183274|69673389|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
37988028|NCT00183274|69673390|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
37988029|NCT00183274|69673391|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
37988030|NCT00183274|69673386|FG000|Phase 3: Double-Blind|Relapsed|0|||
37888743|NCT00862654|69573486|FG003|Overall Study|Lack of Efficacy|0|||
37888744|NCT00862654|69573483|FG000|Overall Study|Lost to Follow-up|1|||
37888745|NCT00862654|69573484|FG001|Overall Study|Lost to Follow-up|2|||
37888746|NCT00862654|69573485|FG002|Overall Study|Lost to Follow-up|1|||
37888747|NCT00862654|69573486|FG003|Overall Study|Lost to Follow-up|3|||
37888748|NCT00862654|69573483|FG000|Overall Study|Adverse Event|0|||
37888749|NCT00862654|69573484|FG001|Overall Study|Adverse Event|1|||
37888750|NCT00862654|69573485|FG002|Overall Study|Adverse Event|1|||
37888751|NCT00862654|69573486|FG003|Overall Study|Adverse Event|0|||
37888752|NCT00862654|69573483|FG000|Overall Study|Pregnancy|1|||
37988031|NCT00183274|69673387|FG001|Phase 3: Double-Blind|Relapsed|0|||
37988032|NCT00183274|69673388|FG002|Phase 3: Double-Blind|Relapsed|0|||
37988033|NCT00183274|69673389|FG003|Phase 3: Double-Blind|Relapsed|1|||
37988034|NCT00183274|69673390|FG004|Phase 3: Double-Blind|Relapsed|11|||
37988035|NCT00183274|69673391|FG005|Phase 3: Double-Blind|Relapsed|2|||
37988036|NCT00183196|69673409|FG000|Overall Study|Withdrawal by Subject|18|||
37988037|NCT00183196|69673410|FG001|Overall Study|Withdrawal by Subject|11|||
37988038|NCT00183196|69673411|FG002|Overall Study|Withdrawal by Subject|13|||
37988039|NCT00183196|69673409|FG000|Overall Study|Adverse Event|1|||
37988040|NCT00183196|69673410|FG001|Overall Study|Adverse Event|2|||
37988041|NCT00183196|69673411|FG002|Overall Study|Adverse Event|2|||
37988042|NCT00183196|69673409|FG000|Overall Study|Legal event|1|||
37988043|NCT00183196|69673410|FG001|Overall Study|Legal event|1|||
37988044|NCT00183196|69673411|FG002|Overall Study|Legal event|1|||
37888753|NCT00862654|69573484|FG001|Overall Study|Pregnancy|1|||
37888754|NCT00862654|69573485|FG002|Overall Study|Pregnancy|0|||
37888755|NCT00862654|69573486|FG003|Overall Study|Pregnancy|0|||
37888756|NCT00862654|69573483|FG000|Overall Study|Withdrawal by Subject|2|||
37888757|NCT00862654|69573484|FG001|Overall Study|Withdrawal by Subject|2|||
37888758|NCT00862654|69573485|FG002|Overall Study|Withdrawal by Subject|2|||
37888759|NCT00862654|69573486|FG003|Overall Study|Withdrawal by Subject|3|||
37888760|NCT00862654|69573483|FG000|Overall Study|Subject mistake|0|||
37888761|NCT00862654|69573484|FG001|Overall Study|Subject mistake|1|||
37888762|NCT00862654|69573485|FG002|Overall Study|Subject mistake|0|||
37888763|NCT00862654|69573486|FG003|Overall Study|Subject mistake|0|||
37888764|NCT00862654|69573483|FG000|Overall Study|Familly constraint|0|||
37888765|NCT00862654|69573484|FG001|Overall Study|Familly constraint|1|||
37888766|NCT00862654|69573485|FG002|Overall Study|Familly constraint|0|||
37888767|NCT00862654|69573486|FG003|Overall Study|Familly constraint|0|||
37888768|NCT00862654|69573483|FG000|Overall Study|Never used study drugs|1|||
37988045|NCT00183196|69673409|FG000|Overall Study|Required more intensive care|0|||
37988046|NCT00183196|69673410|FG001|Overall Study|Required more intensive care|1|||
37888769|NCT00862654|69573484|FG001|Overall Study|Never used study drugs|0|||
37888770|NCT00862654|69573485|FG002|Overall Study|Never used study drugs|0|||
37888771|NCT00862654|69573486|FG003|Overall Study|Never used study drugs|0|||
37988047|NCT00183196|69673411|FG002|Overall Study|Required more intensive care|2|||
37988048|NCT00349752|69673421|FG000|Overall Study|Adverse Event|8|||
37988049|NCT00349752|69673422|FG001|Overall Study|Adverse Event|12|||
37988050|NCT00349752|69673421|FG000|Overall Study|Lack of Efficacy|37|||
37988051|NCT00349752|69673422|FG001|Overall Study|Lack of Efficacy|42|||
37823369|NCT03338790|69504623|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
37823370|NCT03338790|69504624|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
37823371|NCT03338790|69504625|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
37823372|NCT03338790|69504626|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
37823373|NCT03338790|69504623|FG000|Overall Study|Participant request to discontinue study treatment|3|||
37823374|NCT03338790|69504624|FG001|Overall Study|Participant request to discontinue study treatment|3|||
37823375|NCT03338790|69504625|FG002|Overall Study|Participant request to discontinue study treatment|2|||
37823376|NCT03338790|69504626|FG003|Overall Study|Participant request to discontinue study treatment|1|||
37823377|NCT03338790|69504623|FG000|Overall Study|Poor/non-compliance|0|||
37888772|NCT00862654|69573483|FG000|Overall Study|Included after end of inclusions|0|||
37888773|NCT00862654|69573484|FG001|Overall Study|Included after end of inclusions|0|||
37988052|NCT00349752|69673421|FG000|Overall Study|Lost to Follow-up|4|||
37988053|NCT00349752|69673422|FG001|Overall Study|Lost to Follow-up|2|||
37888774|NCT00862654|69573485|FG002|Overall Study|Included after end of inclusions|1|||
37888775|NCT00862654|69573486|FG003|Overall Study|Included after end of inclusions|0|||
37888776|NCT00867490|69573496|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
37888777|NCT00867490|69573496|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
37888778|NCT00867490|69573496|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
37888779|NCT00867490|69573496|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
37888780|NCT00867490|69573496|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
37888781|NCT00930774|69573507|FG000|Overall Study|Withdrawal by Subject|1|||
37888782|NCT00930774|69573508|FG001|Overall Study|Withdrawal by Subject|9|||
37888783|NCT00930774|69573509|FG002|Overall Study|Withdrawal by Subject|2|||
37888784|NCT00930774|69573510|FG003|Overall Study|Withdrawal by Subject|0|||
37888785|NCT00867334|69573523|FG000|Overall Study|Withdrawal by Subject|0|||
37888786|NCT00867334|69573524|FG001|Overall Study|Withdrawal by Subject|1|||
37888787|NCT00867334|69573523|FG000|Overall Study|Withdrawal by Subject|1|||
37888788|NCT00867334|69573524|FG001|Overall Study|Withdrawal by Subject|0|||
37888789|NCT00867334|69573523|FG000|Overall Study|Withdrawal by Subject|1|||
37888790|NCT00867334|69573524|FG001|Overall Study|Withdrawal by Subject|0|||
37888791|NCT00925704|69573536|FG000|First Intervention|Withdrew consent|0|||
37888792|NCT00925704|69573537|FG001|First Intervention|Withdrew consent|0|||
37888793|NCT00925704|69573538|FG002|First Intervention|Withdrew consent|0|||
37888794|NCT00925704|69573539|FG003|First Intervention|Withdrew consent|1|||
37888795|NCT00925704|69573540|FG004|First Intervention|Withdrew consent|1|||
37888796|NCT00925704|69573541|FG005|First Intervention|Withdrew consent|0|||
37888797|NCT00925704|69573536|FG000|Second Intervention|Withdrawal by Subject|1|||
37888798|NCT00925704|69573537|FG001|Second Intervention|Withdrawal by Subject|0|||
37888799|NCT00925704|69573538|FG002|Second Intervention|Withdrawal by Subject|0|||
37888800|NCT00925704|69573539|FG003|Second Intervention|Withdrawal by Subject|0|||
37988054|NCT00349752|69673421|FG000|Overall Study|Personal reasons|6|||
37988055|NCT00349752|69673422|FG001|Overall Study|Personal reasons|5|||
37988056|NCT00349752|69673421|FG000|Overall Study|Other: Required exclusionary medication|0|||
37988057|NCT00349752|69673422|FG001|Overall Study|Other: Required exclusionary medication|1|||
37988058|NCT00349752|69673421|FG000|Overall Study|Other: Non compliance|0|||
37988059|NCT00349752|69673422|FG001|Overall Study|Other: Non compliance|1|||
37988060|NCT00349752|69673421|FG000|Overall Study|Other: Patient stopped steroids|0|||
37988061|NCT00349752|69673422|FG001|Overall Study|Other: Patient stopped steroids|1|||
37988062|NCT00349752|69673421|FG000|Overall Study|Other: Patient's steroid use|1|||
37823378|NCT03338790|69504624|FG001|Overall Study|Poor/non-compliance|1|||
37823379|NCT03338790|69504625|FG002|Overall Study|Poor/non-compliance|0|||
37888801|NCT00925704|69573540|FG004|Second Intervention|Withdrawal by Subject|1|||
37888802|NCT00925704|69573541|FG005|Second Intervention|Withdrawal by Subject|0|||
37888803|NCT00925704|69573536|FG000|Third Intervention|Withdrew consent|0|||
37888804|NCT00925704|69573537|FG001|Third Intervention|Withdrew consent|0|||
37888805|NCT00925704|69573538|FG002|Third Intervention|Withdrew consent|0|||
37888806|NCT00925704|69573539|FG003|Third Intervention|Withdrew consent|0|||
37888807|NCT00925704|69573540|FG004|Third Intervention|Withdrew consent|0|||
37888808|NCT00925704|69573541|FG005|Third Intervention|Withdrew consent|1|||
37888809|NCT01076192|69573552|FG000|Overall Study|Other|197|||
37888810|NCT01076036|69573557|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
37888811|NCT01075958|69573561|FG000|Overall Study|Blood sample could not be obtained|44|||
37888812|NCT01096316|69573567|FG000|Overall Study|Lost to Follow-up|15|||
37888813|NCT01096316|69573568|FG001|Overall Study|Lost to Follow-up|9|||
37888814|NCT00925548|69573576|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
37888815|NCT00925548|69573577|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
37888816|NCT00866788|69573588|FG000|Overall Study|Adverse Event|0|||
37888817|NCT00866788|69573589|FG001|Overall Study|Adverse Event|2|||
37888818|NCT00866788|69573590|FG002|Overall Study|Adverse Event|0|||
37888819|NCT00866788|69573591|FG003|Overall Study|Adverse Event|1|||
37888820|NCT00866788|69573588|FG000|Overall Study|Lost to Follow-up|1|||
37888821|NCT00866788|69573589|FG001|Overall Study|Lost to Follow-up|1|||
37988063|NCT00349752|69673422|FG001|Overall Study|Other: Patient's steroid use|0|||
37988064|NCT00349752|69673421|FG000|Overall Study|Other: Ineligible|1|||
37988065|NCT00349752|69673422|FG001|Overall Study|Other: Ineligible|0|||
37988066|NCT00349752|69673421|FG000|Overall Study|Other: Inadvertently unblinded|1|||
37823380|NCT03338790|69504626|FG003|Overall Study|Poor/non-compliance|0|||
37823381|NCT03338790|69504623|FG000|Overall Study|Participant withdrew consent|1|||
37823382|NCT03338790|69504624|FG001|Overall Study|Participant withdrew consent|0|||
37823383|NCT03338790|69504625|FG002|Overall Study|Participant withdrew consent|1|||
37823384|NCT03338790|69504626|FG003|Overall Study|Participant withdrew consent|1|||
37888822|NCT00866788|69573590|FG002|Overall Study|Lost to Follow-up|0|||
37888823|NCT00866788|69573591|FG003|Overall Study|Lost to Follow-up|2|||
37988067|NCT00349752|69673422|FG001|Overall Study|Other: Inadvertently unblinded|0|||
37988068|NCT00349752|69673421|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
37823385|NCT03338790|69504623|FG000|Overall Study|Other reasons|0|||
37823386|NCT03338790|69504624|FG001|Overall Study|Other reasons|5|||
37888824|NCT00866788|69573588|FG000|Overall Study|Withdrawal by Subject|2|||
37888825|NCT00866788|69573589|FG001|Overall Study|Withdrawal by Subject|1|||
37888826|NCT00866788|69573590|FG002|Overall Study|Withdrawal by Subject|0|||
37823387|NCT03338790|69504625|FG002|Overall Study|Other reasons|0|||
37888827|NCT00866788|69573591|FG003|Overall Study|Withdrawal by Subject|1|||
37888828|NCT00866788|69573588|FG000|Overall Study|Pregnancy|0|||
37888829|NCT00866788|69573589|FG001|Overall Study|Pregnancy|1|||
37888830|NCT00866788|69573590|FG002|Overall Study|Pregnancy|0|||
37888831|NCT00866788|69573591|FG003|Overall Study|Pregnancy|0|||
37888832|NCT00866788|69573588|FG000|Overall Study|Disease progression|3|||
37888833|NCT00866788|69573589|FG001|Overall Study|Disease progression|1|||
37888834|NCT00866788|69573590|FG002|Overall Study|Disease progression|1|||
37888835|NCT00866788|69573591|FG003|Overall Study|Disease progression|0|||
37888836|NCT00866788|69573588|FG000|Overall Study|Physician Decision|0|||
37888837|NCT00866788|69573589|FG001|Overall Study|Physician Decision|0|||
37888838|NCT00866788|69573590|FG002|Overall Study|Physician Decision|1|||
37888839|NCT00866788|69573591|FG003|Overall Study|Physician Decision|1|||
37888840|NCT00860470|69573606|FG000|Overall Study|Death|6|||
37888841|NCT00860470|69573607|FG001|Overall Study|Death|10|||
37888842|NCT00860470|69573606|FG000|Overall Study|Moved away|8|||
37888843|NCT00860470|69573607|FG001|Overall Study|Moved away|10|||
37888844|NCT00860470|69573606|FG000|Overall Study|Lost to Follow-up|34|||
37888845|NCT00860470|69573607|FG001|Overall Study|Lost to Follow-up|39|||
37888846|NCT00923364|69573613|FG000|Overall Study|Death|3|||
37888847|NCT00923364|69573614|FG001|Overall Study|Death|0|||
37888848|NCT00923364|69573613|FG000|Overall Study|Did not go to transplant|1|||
37888849|NCT00923364|69573614|FG001|Overall Study|Did not go to transplant|0|||
37888850|NCT01096160|69573629|FG000|Overall Study|Adverse Event|0|||
37888851|NCT01096160|69573630|FG001|Overall Study|Adverse Event|0|||
37888852|NCT01096160|69573631|FG002|Overall Study|Adverse Event|1|||
37888853|NCT01096160|69573632|FG003|Overall Study|Adverse Event|0|||
37888854|NCT01096160|69573633|FG004|Overall Study|Adverse Event|0|||
37888855|NCT01096160|69573634|FG005|Overall Study|Adverse Event|0|||
37888856|NCT01096160|69573635|FG006|Overall Study|Adverse Event|0|||
37888857|NCT01096160|69573636|FG007|Overall Study|Adverse Event|0|||
37888858|NCT01096160|69573637|FG008|Overall Study|Adverse Event|0|||
37888859|NCT01096160|69573638|FG009|Overall Study|Adverse Event|1|||
37888860|NCT01096160|69573629|FG000|Overall Study|Met stopping criteria per protocol|0|||
37888861|NCT01096160|69573630|FG001|Overall Study|Met stopping criteria per protocol|0|||
37888862|NCT01096160|69573631|FG002|Overall Study|Met stopping criteria per protocol|0|||
37888863|NCT01096160|69573632|FG003|Overall Study|Met stopping criteria per protocol|0|||
37888864|NCT01096160|69573633|FG004|Overall Study|Met stopping criteria per protocol|1|||
37888865|NCT01096160|69573634|FG005|Overall Study|Met stopping criteria per protocol|0|||
37888866|NCT01096160|69573635|FG006|Overall Study|Met stopping criteria per protocol|2|||
37888867|NCT01096160|69573636|FG007|Overall Study|Met stopping criteria per protocol|0|||
37888868|NCT01096160|69573637|FG008|Overall Study|Met stopping criteria per protocol|2|||
37888869|NCT01096160|69573638|FG009|Overall Study|Met stopping criteria per protocol|0|||
37888870|NCT00860158|69573673|FG000|Overall Study|Study Terminated|1|||
37888871|NCT00929526|69573679|FG000|Overall Study|Withdrawal by Subject|1|||
37888872|NCT00929526|69573680|FG001|Overall Study|Withdrawal by Subject|11|||
37888873|NCT00929526|69573679|FG000|Overall Study|Lost to Follow-up|8|||
37888874|NCT00929526|69573680|FG001|Overall Study|Lost to Follow-up|12|||
37888875|NCT00929526|69573679|FG000|Overall Study|Other|8|||
37888876|NCT00929526|69573680|FG001|Overall Study|Other|6|||
37888877|NCT00859456|69573686|FG000|Overall Study|Adverse Event|3|||
37888878|NCT00859456|69573686|FG000|Overall Study|Progressive disease|2|||
37888879|NCT00859456|69573686|FG000|Overall Study|Non-compliance|3|||
37888880|NCT01075646|69573694|FG000|Overall Study|Lost to Follow-up|4|||
37888881|NCT01075646|69573695|FG001|Overall Study|Lost to Follow-up|3|||
37888882|NCT01075646|69573696|FG002|Overall Study|Lost to Follow-up|1|||
37888883|NCT01075646|69573697|FG003|Overall Study|Lost to Follow-up|2|||
37888884|NCT01075412|69573709|FG000|Overall Study|Withdrawal by Subject|0|||
37888885|NCT01075412|69573710|FG001|Overall Study|Withdrawal by Subject|1|||
37888886|NCT00799903|69573717|FG000|Overall Study|Investigator Site Closed|25|||
37888887|NCT00799903|69573718|FG001|Overall Study|Investigator Site Closed|23|||
37888888|NCT00799903|69573717|FG000|Overall Study|Withdrawal by Subject|179|||
37888889|NCT00799903|69573718|FG001|Overall Study|Withdrawal by Subject|175|||
37888890|NCT00799903|69573717|FG000|Overall Study|Lost to Follow-up|69|||
37888891|NCT00799903|69573718|FG001|Overall Study|Lost to Follow-up|80|||
37888892|NCT01075256|69573727|FG000|Overall Study|Withdrawal by Subject|1|||
37888893|NCT01075256|69573728|FG001|Overall Study|Withdrawal by Subject|0|||
37888894|NCT01075256|69573729|FG002|Overall Study|Withdrawal by Subject|0|||
37888895|NCT00923130|69573742|FG000|Overall Study|Stopped treatment due to progression|17|||
37888896|NCT00923130|69573742|FG000|Overall Study|Death|1|||
37888897|NCT00923130|69573742|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
37888898|NCT00923130|69573742|FG000|Overall Study|Switched to alternative treatment|2|||
37888899|NCT00923130|69573742|FG000|Overall Study|Refused further treatment|2|||
37888900|NCT03253627|69573748|FG000|Overall Study|Lost to Follow-up|1|||
37888901|NCT03253627|69573749|FG001|Overall Study|Lost to Follow-up|2|||
37888902|NCT03253627|69573748|FG000|Overall Study|Withdrawal by Subject|0|||
37888903|NCT03253627|69573749|FG001|Overall Study|Withdrawal by Subject|2|||
37888904|NCT03253627|69573748|FG000|Overall Study|Inability to complete MRI|1|||
37888905|NCT03253627|69573749|FG001|Overall Study|Inability to complete MRI|0|||
37888906|NCT01075178|69573757|FG000|Subject Matching|eligible but not matched|130|||
37888907|NCT01075178|69573758|FG001|Subject Matching|eligible but not matched|403|||
37888908|NCT01075178|69573757|FG000|Subject Chart Review|died before chart review period|0|||
37888909|NCT01075178|69573758|FG001|Subject Chart Review|died before chart review period|2|||
37888910|NCT01075178|69573757|FG000|Subject Chart Review|no data collected due to site closure|3|||
37888911|NCT01075178|69573758|FG001|Subject Chart Review|no data collected due to site closure|4|||
37888912|NCT01075178|69573757|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
37888913|NCT01075178|69573758|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
37888914|NCT00799825|69573764|FG000|Overall Study|Adverse Event|1|||
37888915|NCT00799825|69573764|FG000|Overall Study|Withdrawal by Subject|6|||
37888916|NCT00799825|69573764|FG000|Overall Study|Lost to Follow-up|38|||
37888917|NCT00799825|69573764|FG000|Overall Study|Pregnancy|3|||
37888918|NCT00799591|69573768|FG000|Overall Study|De-escalation of doses|20|||
37888919|NCT00799591|69573768|FG000|Overall Study|Death|14|||
37888920|NCT00799591|69573768|FG000|Overall Study|Technical failure|12|||
37888921|NCT00799591|69573768|FG000|Overall Study|Resistant germ|11|||
37888922|NCT00799591|69573768|FG000|Overall Study|New infection|4|||
37888923|NCT00799591|69573768|FG000|Overall Study|Resistance germ and technical failure|2|||
37888924|NCT00799591|69573768|FG000|Overall Study|Persistance of fever undetermined origin|1|||
37888925|NCT00799591|69573768|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
37888926|NCT00799591|69573768|FG000|Overall Study|Infectious origin not probable|1|||
37888927|NCT01075100|69573774|FG000|Overall Study|Adverse Event|15|||
37888928|NCT01075100|69573775|FG001|Overall Study|Adverse Event|18|||
37888929|NCT01075100|69573774|FG000|Overall Study|Patient Request|4|||
37888930|NCT01075100|69573775|FG001|Overall Study|Patient Request|4|||
37888931|NCT01075100|69573774|FG000|Overall Study|Investigator Request|2|||
37888932|NCT01075100|69573775|FG001|Overall Study|Investigator Request|1|||
37888933|NCT01075100|69573774|FG000|Overall Study|Disease Progression|25|||
37888934|NCT01075100|69573775|FG001|Overall Study|Disease Progression|29|||
37888935|NCT01075100|69573774|FG000|Overall Study|Other|3|||
37888936|NCT01075100|69573775|FG001|Overall Study|Other|1|||
37888937|NCT00803023|69573787|FG000|Overall Study|Adverse Event|5|||
37888938|NCT00803023|69573788|FG001|Overall Study|Adverse Event|4|||
37888939|NCT00803023|69573789|FG002|Overall Study|Adverse Event|8|||
37888940|NCT00803023|69573790|FG003|Overall Study|Adverse Event|6|||
37888941|NCT00803023|69573787|FG000|Overall Study|Withdrawal by Subject|0|||
37888942|NCT00803023|69573788|FG001|Overall Study|Withdrawal by Subject|2|||
37888943|NCT00803023|69573789|FG002|Overall Study|Withdrawal by Subject|0|||
37888944|NCT00803023|69573790|FG003|Overall Study|Withdrawal by Subject|0|||
37888945|NCT00803023|69573787|FG000|Overall Study|Lost to Follow-up|0|||
37888946|NCT00803023|69573788|FG001|Overall Study|Lost to Follow-up|1|||
37888947|NCT00803023|69573789|FG002|Overall Study|Lost to Follow-up|2|||
37888948|NCT00803023|69573790|FG003|Overall Study|Lost to Follow-up|1|||
37888949|NCT00803023|69573787|FG000|Overall Study|Lack of Efficacy|0|||
37888950|NCT00803023|69573788|FG001|Overall Study|Lack of Efficacy|1|||
37888951|NCT00803023|69573789|FG002|Overall Study|Lack of Efficacy|1|||
37888952|NCT00803023|69573790|FG003|Overall Study|Lack of Efficacy|1|||
37888953|NCT00859222|69573803|FG000|Overall Study|Adverse Event|2|||
37888954|NCT00859222|69573804|FG001|Overall Study|Adverse Event|3|||
37888955|NCT00859222|69573805|FG002|Overall Study|Adverse Event|6|||
37888956|NCT00859222|69573806|FG003|Overall Study|Adverse Event|24|||
37888957|NCT00859222|69573807|FG004|Overall Study|Adverse Event|15|||
37888958|NCT00859222|69573803|FG000|Overall Study|DLT|1|||
37888959|NCT00859222|69573804|FG001|Overall Study|DLT|0|||
37888960|NCT00859222|69573805|FG002|Overall Study|DLT|0|||
37888961|NCT00859222|69573806|FG003|Overall Study|DLT|0|||
37888962|NCT00859222|69573807|FG004|Overall Study|DLT|0|||
37888963|NCT01072448|69573824|FG000|Overall Study|Adverse Event|9|||
37888964|NCT01072448|69573825|FG001|Overall Study|Adverse Event|10|||
37888965|NCT01072448|69573824|FG000|Overall Study|Subject withdrew consent|4|||
37888966|NCT01072448|69573825|FG001|Overall Study|Subject withdrew consent|9|||
37888967|NCT01072448|69573824|FG000|Overall Study|Protocol deviation|3|||
37888968|NCT01072448|69573825|FG001|Overall Study|Protocol deviation|4|||
37888969|NCT01072448|69573824|FG000|Overall Study|Abnormal test procedure result(s)|1|||
37888970|NCT01072448|69573825|FG001|Overall Study|Abnormal test procedure result(s)|0|||
37888971|NCT01072448|69573824|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
37888972|NCT01072448|69573825|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
37888973|NCT01072448|69573824|FG000|Overall Study|Lost to Follow-up|1|||
37888974|NCT01072448|69573825|FG001|Overall Study|Lost to Follow-up|1|||
37888975|NCT01072448|69573824|FG000|Overall Study|Abnormal laboratory value(s)|0|||
37888976|NCT01072448|69573825|FG001|Overall Study|Abnormal laboratory value(s)|1|||
37888977|NCT01072448|69573824|FG000|Overall Study|Death|0|||
37888978|NCT01072448|69573825|FG001|Overall Study|Death|2|||
37888979|NCT00922974|69573834|FG000|Phase II Component|Protocol Violation|2|||
37888980|NCT00922974|69573835|FG001|Phase II Component|Protocol Violation|0|||
37888981|NCT00922974|69573834|FG000|Phase II Component|Not evaluable for treatment review|5|||
37888982|NCT00922974|69573835|FG001|Phase II Component|Not evaluable for treatment review|0|||
37888983|NCT00922974|69573834|FG000|Phase III Component|Protocol Violation|8|||
37888984|NCT00922974|69573835|FG001|Phase III Component|Protocol Violation|6|||
37888985|NCT00858988|69573845|FG000|Analysis|Lactulose unable to be detected in urine|2|||
37888986|NCT00858988|69573846|FG001|Analysis|Lactulose unable to be detected in urine|1|||
37888987|NCT00858832|69573854|FG000|Overall Study|became ineligible: delivered vaginally|1|||
37888988|NCT00858832|69573855|FG001|Overall Study|became ineligible: delivered vaginally|0|||
37888989|NCT00858832|69573854|FG000|Overall Study|Adverse Event|0|||
37888990|NCT00858832|69573855|FG001|Overall Study|Adverse Event|1|||
37888991|NCT01071512|69573861|FG000|Overall Study|Adverse Event|1|||
37888992|NCT01071512|69573861|FG000|Overall Study|Development of antibodies to drug|2|||
37888993|NCT01071512|69573861|FG000|Overall Study|positive anti-JC virus antibody test|2|||
37888994|NCT00858442|69573867|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
37888995|NCT00858442|69573868|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
37888996|NCT01071278|69573875|FG000|Overall Study|Premature Discontinuation|254|||
37888997|NCT01071278|69573875|FG000|Overall Study|Completion Status Unknown|459|||
37888998|NCT00858208|69573881|FG000|Overall Study|Adverse Event|3|||
37888999|NCT00858208|69573881|FG000|Overall Study|Lost to Follow-up|26|||
37889000|NCT00858208|69573881|FG000|Overall Study|Participant refused|40|||
37889001|NCT00858208|69573881|FG000|Overall Study|Other|10|||
37889002|NCT01071200|69573887|FG000|Overall Study|Lack of ovarian response|1|||
37889003|NCT01071200|69573888|FG001|Overall Study|Lack of ovarian response|1|||
37889004|NCT01071200|69573887|FG000|Overall Study|No fertilization|4|||
37889005|NCT01071200|69573888|FG001|Overall Study|No fertilization|0|||
37889006|NCT01071200|69573887|FG000|Overall Study|No oocytes retrieved|1|||
37889007|NCT01071200|69573888|FG001|Overall Study|No oocytes retrieved|1|||
37889008|NCT01071200|69573887|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
37889009|NCT01071200|69573888|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
37889010|NCT01071200|69573887|FG000|Overall Study|No viable embryos|0|||
37889011|NCT01071200|69573888|FG001|Overall Study|No viable embryos|1|||
37889012|NCT02207569|69573894|FG000|1-Month|Death|6|||
37889013|NCT02207569|69573894|FG000|1-Month|Withdrawal by Subject|2|||
37889014|NCT02207569|69573894|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
37889015|NCT02207569|69573894|FG000|6-Month|Death|8|||
37889016|NCT02207569|69573894|FG000|6-Month|Withdrawal by Subject|2|||
37889017|NCT02207569|69573894|FG000|12-Month|Death|14|||
37988069|NCT00349752|69673422|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
37988070|NCT00174460|69673430|FG000|Overall Study|Withdrawal by Subject|0|||
37988071|NCT00174460|69673431|FG001|Overall Study|Withdrawal by Subject|1|||
37988072|NCT00348816|69673438|FG000|Overall Study|Noncompliance with radiation treatment|1|||
37988073|NCT00265083|69673447|FG000|Overall Study|Adverse Event|5|||
37988074|NCT00265083|69673448|FG001|Overall Study|Adverse Event|13|||
37988075|NCT00265083|69673449|FG002|Overall Study|Adverse Event|15|||
37889018|NCT02207569|69573894|FG000|12-Month|Withdrawal by Subject|2|||
37889019|NCT02207569|69573894|FG000|24-Month|Death|23|||
37889020|NCT02207569|69573894|FG000|24-Month|Withdrawal by Subject|3|||
37889021|NCT02207569|69573894|FG000|36-Month|Death|23|||
37889022|NCT02207569|69573894|FG000|36-Month|Withdrawal by Subject|4|||
37889023|NCT02207569|69573894|FG000|48-Month|Death|25|||
37988076|NCT00265083|69673447|FG000|Overall Study|Lost to Follow-up|3|||
37889024|NCT02207569|69573894|FG000|48-Month|Withdrawal by Subject|2|||
37889025|NCT02207569|69573894|FG000|48-Month|Lost to Follow-up|4|||
37889026|NCT02207569|69573894|FG000|60-Month|Death|1|||
37889027|NCT02207569|69573894|FG000|60-Month|Lost to Follow-up|1|||
37889028|NCT02207569|69573894|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
37889029|NCT02207569|69573894|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
37889030|NCT01070966|69573898|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
37889031|NCT01070966|69573898|FG000|Participants for Safety Evaluation|Off-label use|9|||
37889032|NCT01070966|69573898|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
37889033|NCT01070966|69573898|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
37889034|NCT01070966|69573898|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
37889035|NCT01070966|69573898|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
37889036|NCT01070966|69573898|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
37889037|NCT01070966|69573898|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
37889038|NCT01070888|69573911|FG000|First Intervention (14 Days)|Adverse Event|0|||
37889039|NCT01070888|69573912|FG001|First Intervention (14 Days)|Adverse Event|1|||
37889040|NCT01070888|69573911|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
37889041|NCT01070888|69573912|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
37889042|NCT01070888|69573911|FG000|Washout (14 Days)|Physician Decision|1|||
37889043|NCT01070888|69573912|FG001|Washout (14 Days)|Physician Decision|0|||
37889044|NCT00857896|69573918|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
37889045|NCT00857818|69573925|FG000|Overall Study|Lack of Efficacy|1|||
37889046|NCT00857818|69573926|FG001|Overall Study|Lack of Efficacy|0|||
37889047|NCT00857818|69573925|FG000|Overall Study|Adverse Event|3|||
37889048|NCT00857818|69573926|FG001|Overall Study|Adverse Event|0|||
37988077|NCT00265083|69673448|FG001|Overall Study|Lost to Follow-up|4|||
37988078|NCT00265083|69673449|FG002|Overall Study|Lost to Follow-up|4|||
37889049|NCT00857818|69573925|FG000|Overall Study|Withdrawal by Subject|0|||
37889050|NCT00857818|69573926|FG001|Overall Study|Withdrawal by Subject|4|||
37889051|NCT00857818|69573925|FG000|Overall Study|Sponsor terminated study|6|||
37889052|NCT00857818|69573926|FG001|Overall Study|Sponsor terminated study|4|||
37889053|NCT00857818|69573925|FG000|Overall Study|Investigator decision|1|||
37889054|NCT00857818|69573926|FG001|Overall Study|Investigator decision|0|||
37988079|NCT00265083|69673447|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
37695979|NCT02279407|69172129|FG001|Overall Study|Withdrawal by Subject|0|||
37889055|NCT01074944|69573932|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
37889056|NCT01074944|69573933|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
37889057|NCT01074944|69573934|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
37889058|NCT01074944|69573935|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
37889059|NCT01074944|69573936|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
37889060|NCT01074944|69573932|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
37889061|NCT01074944|69573933|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
37988080|NCT00265083|69673448|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
37988081|NCT00265083|69673449|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
37988082|NCT00265083|69673447|FG000|Overall Study|Other|1|||
37988083|NCT00265083|69673448|FG001|Overall Study|Other|12|||
37988084|NCT00265083|69673449|FG002|Overall Study|Other|9|||
37988085|NCT00264849|69673460|FG000|Overall Study|Adverse Event|7|||
37988086|NCT00264849|69673461|FG001|Overall Study|Adverse Event|2|||
37988087|NCT00264849|69673460|FG000|Overall Study|Withdrawal by Subject|7|||
37988088|NCT00264849|69673461|FG001|Overall Study|Withdrawal by Subject|11|||
37988089|NCT00264849|69673460|FG000|Overall Study|Protocol Violation|5|||
37988090|NCT00264849|69673461|FG001|Overall Study|Protocol Violation|3|||
37988091|NCT00264849|69673460|FG000|Overall Study|Lack of Efficacy|1|||
37988092|NCT00264849|69673461|FG001|Overall Study|Lack of Efficacy|6|||
37988093|NCT00264849|69673460|FG000|Overall Study|Lost to Follow-up|0|||
37988094|NCT00264849|69673461|FG001|Overall Study|Lost to Follow-up|2|||
37988095|NCT00264849|69673460|FG000|Overall Study|Death|0|||
37988096|NCT00264849|69673461|FG001|Overall Study|Death|1|||
37988097|NCT00264849|69673460|FG000|Overall Study|Administrative Problems|2|||
37988098|NCT00264849|69673461|FG001|Overall Study|Administrative Problems|0|||
37988099|NCT00211809|69673467|FG000|Overall Study|Lack of Efficacy|1|||
37988100|NCT00211809|69673467|FG000|Overall Study|Lost to Follow-up|2|||
37988101|NCT00211809|69673467|FG000|Overall Study|Pregnancy|1|||
37988102|NCT00211809|69673467|FG000|Overall Study|side effects|2|||
37988103|NCT00129766|69673475|FG000|Overall Study|Death|3|||
37988104|NCT00129766|69673476|FG001|Overall Study|Death|8|||
37988105|NCT00129766|69673475|FG000|Overall Study|Withdrawal of consent|31|||
37988106|NCT00129766|69673476|FG001|Overall Study|Withdrawal of consent|30|||
37988107|NCT00129766|69673475|FG000|Overall Study|Lost to Follow-up|26|||
37988108|NCT00129766|69673476|FG001|Overall Study|Lost to Follow-up|21|||
37988109|NCT00150592|69673485|FG000|Overall Study|Adverse Event|4|||
37988110|NCT00150592|69673486|FG001|Overall Study|Adverse Event|1|||
37988111|NCT00150592|69673485|FG000|Overall Study|Protocol Violation|1|||
37988112|NCT00150592|69673486|FG001|Overall Study|Protocol Violation|0|||
37988113|NCT00150592|69673485|FG000|Overall Study|Withdrawal by Subject|1|||
37988114|NCT00150592|69673486|FG001|Overall Study|Withdrawal by Subject|2|||
37988115|NCT00150592|69673485|FG000|Overall Study|Non-compliance|1|||
37988116|NCT00150592|69673486|FG001|Overall Study|Non-compliance|0|||
37823388|NCT03338790|69504626|FG003|Overall Study|Other reasons|2|||
37823389|NCT03338790|69504623|FG000|Overall Study|Not reported|0|||
37823390|NCT03338790|69504624|FG001|Overall Study|Not reported|0|||
37823391|NCT03338790|69504625|FG002|Overall Study|Not reported|1|||
37823392|NCT03338790|69504626|FG003|Overall Study|Not reported|0|||
37823393|NCT03338790|69504623|FG000|Overall Study|Completed treatment period|1|||
37823394|NCT03338790|69504624|FG001|Overall Study|Completed treatment period|2|||
37823395|NCT03338790|69504625|FG002|Overall Study|Completed treatment period|0|||
37823396|NCT03338790|69504626|FG003|Overall Study|Completed treatment period|0|||
37823397|NCT02954536|69504653|FG000|Overall Study|Adverse Event|2|||
37823398|NCT02954536|69504653|FG000|Overall Study|Death|12|||
37988117|NCT00149890|69673494|FG000|Overall Study|Adverse Event|1|||
37988118|NCT00149890|69673495|FG001|Overall Study|Adverse Event|8|||
37988119|NCT00149890|69673494|FG000|Overall Study|Lack of Efficacy|8|||
37823399|NCT02919670|69504659|FG000|Overall Study|Only 17 participants met compliance|43|||
37823400|NCT02919670|69504660|FG001|Overall Study|Only 17 participants met compliance|39|||
37988120|NCT00149890|69673495|FG001|Overall Study|Lack of Efficacy|9|||
37988121|NCT00149890|69673494|FG000|Overall Study|Protocol Violation|1|||
37988122|NCT00149890|69673495|FG001|Overall Study|Protocol Violation|0|||
37988123|NCT00149890|69673494|FG000|Overall Study|Lost to Follow-up|1|||
37988124|NCT00149890|69673495|FG001|Overall Study|Lost to Follow-up|0|||
37988125|NCT00149890|69673494|FG000|Overall Study|Graft Loss|2|||
37988126|NCT00149890|69673495|FG001|Overall Study|Graft Loss|1|||
37988127|NCT00174382|69673501|FG000|Overall Study|Death|2|||
37988128|NCT00174382|69673501|FG000|Overall Study|Adverse Event|19|||
37988129|NCT00174382|69673501|FG000|Overall Study|Withdrawal by Subject|6|||
37988130|NCT00174382|69673501|FG000|Overall Study|Protocol Violation|3|||
37889062|NCT01074944|69573934|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
37889063|NCT01074944|69573935|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
37889064|NCT01074944|69573936|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
37889065|NCT01074944|69573932|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
37889066|NCT01074944|69573933|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
37889067|NCT01074944|69573934|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
37889068|NCT01074944|69573935|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
37889069|NCT01074944|69573936|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
37889070|NCT01074944|69573932|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
37889071|NCT01074944|69573933|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
37889072|NCT01074944|69573934|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
37889073|NCT01074944|69573935|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
37889074|NCT01074944|69573936|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
37889075|NCT01074944|69573932|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
37889076|NCT01074944|69573933|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
37889077|NCT01074944|69573934|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
37889078|NCT01074944|69573935|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
37889079|NCT01074944|69573936|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
37889080|NCT01074944|69573932|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
37889081|NCT01074944|69573933|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
37889082|NCT01074944|69573934|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
37988131|NCT00174382|69673501|FG000|Overall Study|Arrived early for last visit in error|1|||
37988132|NCT00174382|69673501|FG000|Overall Study|Subject felt pill not effective enough|1|||
37988133|NCT00174382|69673501|FG000|Overall Study|Lost to Follow-up|1|||
37988134|NCT00355134|69673510|FG000|Core Phase|Withdrawal by Subject|35|||
37988135|NCT00355134|69673511|FG001|Core Phase|Withdrawal by Subject|24|||
37988136|NCT00355134|69673512|FG002|Core Phase|Withdrawal by Subject|35|||
37988137|NCT00355134|69673513|FG003|Core Phase|Withdrawal by Subject|0|||
37988138|NCT00355134|69673514|FG004|Core Phase|Withdrawal by Subject|0|||
37988139|NCT00355134|69673510|FG000|Core Phase|Adverse Event|28|||
37988140|NCT00355134|69673511|FG001|Core Phase|Adverse Event|22|||
37988141|NCT00355134|69673512|FG002|Core Phase|Adverse Event|16|||
37988142|NCT00355134|69673513|FG003|Core Phase|Adverse Event|0|||
37988143|NCT00355134|69673514|FG004|Core Phase|Adverse Event|0|||
37988144|NCT00355134|69673510|FG000|Core Phase|Lost to Follow-up|17|||
37988145|NCT00355134|69673511|FG001|Core Phase|Lost to Follow-up|13|||
37988146|NCT00355134|69673512|FG002|Core Phase|Lost to Follow-up|21|||
37988147|NCT00355134|69673513|FG003|Core Phase|Lost to Follow-up|0|||
37988148|NCT00355134|69673514|FG004|Core Phase|Lost to Follow-up|0|||
37988149|NCT00355134|69673510|FG000|Core Phase|Abnormal laboratory value(s)|19|||
37889083|NCT01074944|69573935|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
37889084|NCT01074944|69573936|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
37889085|NCT01074944|69573932|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
37889086|NCT01074944|69573933|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
37889087|NCT01074944|69573934|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
37889088|NCT01074944|69573935|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
37889089|NCT01074944|69573936|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
37889090|NCT01074944|69573932|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
37889091|NCT01074944|69573933|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
37889092|NCT01074944|69573934|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
37889093|NCT01074944|69573935|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
37889094|NCT01074944|69573936|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
37889095|NCT01074944|69573932|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
37889096|NCT01074944|69573933|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
37889097|NCT01074944|69573934|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
37889098|NCT01074944|69573935|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
37889099|NCT01074944|69573936|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
37889100|NCT01074944|69573932|FG000|Long Term Treatment|Adverse Event|0|||
37988150|NCT00355134|69673511|FG001|Core Phase|Abnormal laboratory value(s)|14|||
37988151|NCT00355134|69673512|FG002|Core Phase|Abnormal laboratory value(s)|2|||
37988152|NCT00355134|69673513|FG003|Core Phase|Abnormal laboratory value(s)|0|||
37988153|NCT00355134|69673514|FG004|Core Phase|Abnormal laboratory value(s)|0|||
37988154|NCT00355134|69673510|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
37988155|NCT00355134|69673511|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
37889101|NCT01074944|69573933|FG001|Long Term Treatment|Adverse Event|0|||
37889102|NCT01074944|69573934|FG002|Long Term Treatment|Adverse Event|0|||
37889103|NCT01074944|69573935|FG003|Long Term Treatment|Adverse Event|3|||
37889104|NCT01074944|69573936|FG004|Long Term Treatment|Adverse Event|0|||
37889105|NCT01074944|69573932|FG000|Long Term Treatment|Lost to Follow-up|0|||
37889106|NCT01074944|69573933|FG001|Long Term Treatment|Lost to Follow-up|0|||
37889107|NCT01074944|69573934|FG002|Long Term Treatment|Lost to Follow-up|0|||
37889108|NCT01074944|69573935|FG003|Long Term Treatment|Lost to Follow-up|2|||
37889109|NCT01074944|69573936|FG004|Long Term Treatment|Lost to Follow-up|0|||
37889110|NCT01074944|69573932|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
37889111|NCT01074944|69573933|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
37889112|NCT01074944|69573934|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
37889113|NCT01074944|69573935|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
37889114|NCT01074944|69573936|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
37889115|NCT01074944|69573932|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
37889116|NCT01074944|69573933|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
37889117|NCT01074944|69573934|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
37889118|NCT01074944|69573935|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
37889119|NCT01074944|69573936|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
37889120|NCT01074944|69573932|FG000|Long Term Treatment|Withdrawal by Subject|0|||
37889121|NCT01074944|69573933|FG001|Long Term Treatment|Withdrawal by Subject|0|||
37889122|NCT01074944|69573934|FG002|Long Term Treatment|Withdrawal by Subject|0|||
37889123|NCT01074944|69573935|FG003|Long Term Treatment|Withdrawal by Subject|2|||
37889124|NCT01074944|69573936|FG004|Long Term Treatment|Withdrawal by Subject|0|||
37889125|NCT01074944|69573932|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
37889126|NCT01074944|69573933|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
37889127|NCT01074944|69573934|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
37889128|NCT01074944|69573935|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
37889129|NCT01074944|69573936|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
37889130|NCT01074944|69573932|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
37889131|NCT01074944|69573933|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
37889132|NCT01074944|69573934|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
37889133|NCT01074944|69573935|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
37889134|NCT01074944|69573936|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
37889135|NCT00802945|69573946|FG000|Overall Study|Death|27|||
37889136|NCT00802945|69573947|FG001|Overall Study|Death|23|||
37889137|NCT00802945|69573946|FG000|Overall Study|Terminated by sponsor|8|||
37889138|NCT00802945|69573947|FG001|Overall Study|Terminated by sponsor|12|||
37889139|NCT01074554|69573957|FG000|Overall Study|Adverse Event|3|||
37889140|NCT01074554|69573958|FG001|Overall Study|Adverse Event|3|||
37889141|NCT01074554|69573957|FG000|Overall Study|Lost to Follow-up|0|||
37889142|NCT01074554|69573958|FG001|Overall Study|Lost to Follow-up|1|||
37889143|NCT00857584|69573966|FG000|Overall Study|Lack of Efficacy|1|||
37889144|NCT00857584|69573967|FG001|Overall Study|Lack of Efficacy|2|||
37889145|NCT00857584|69573966|FG000|Overall Study|Adverse Event|2|||
37889146|NCT00857584|69573967|FG001|Overall Study|Adverse Event|2|||
37889147|NCT00857584|69573966|FG000|Overall Study|Physician Decision|1|||
37889148|NCT00857584|69573967|FG001|Overall Study|Physician Decision|1|||
37889149|NCT00798967|69573975|FG000|Overall Study|Adverse Event|2|||
37889150|NCT00798967|69573976|FG001|Overall Study|Adverse Event|3|||
37889151|NCT00798967|69573975|FG000|Overall Study|Withdrawal by Subject|0|||
37889152|NCT00798967|69573976|FG001|Overall Study|Withdrawal by Subject|1|||
37889153|NCT00798967|69573975|FG000|Overall Study|Physician Decision|1|||
37889154|NCT00798967|69573976|FG001|Overall Study|Physician Decision|0|||
37889155|NCT00798967|69573975|FG000|Overall Study|Randomized in error by site|1|||
37889156|NCT00798967|69573976|FG001|Overall Study|Randomized in error by site|0|||
37889157|NCT01074242|69573983|FG000|Overall Study|Case report before date of contract|40|||
37889158|NCT01074242|69573983|FG000|Overall Study|Lost to Follow-up|1|||
37889159|NCT01074242|69573983|FG000|Overall Study|Case report unclear|6|||
37988156|NCT00355134|69673512|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
37988157|NCT00355134|69673513|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
37988158|NCT00355134|69673514|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
37988159|NCT00355134|69673510|FG000|Core Phase|Administrative problems|5|||
37889160|NCT01074242|69573983|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
37889161|NCT01074242|69573983|FG000|Overall Study|Duplicate Case Report Form|5|||
37889162|NCT00798889|69573987|FG000|Overall Study|Adverse Event|53|||
37889163|NCT00798889|69573987|FG000|Overall Study|Protocol Violation|2|||
37889164|NCT00798889|69573987|FG000|Overall Study|Withdrawal by Subject|31|||
37889165|NCT00798889|69573987|FG000|Overall Study|Lost to Follow-up|1|||
37889166|NCT00798889|69573987|FG000|Overall Study|Lack of Efficacy|213|||
37889167|NCT00798889|69573987|FG000|Overall Study|Decision of Sponsor|11|||
37889168|NCT00798889|69573987|FG000|Overall Study|Enrolled, Not treated|3|||
37889169|NCT00796861|69573991|FG000|Overall Study|Withdrawal by Subject|2|||
37889170|NCT00796861|69573991|FG000|Overall Study|Death|2|||
37889171|NCT00802867|69573995|FG000|Overall Study|Lost to Follow-up|6|||
37889172|NCT00802867|69573995|FG000|Overall Study|Protocol Violation|6|||
37889173|NCT00802867|69573995|FG000|Overall Study|Withdrawal by Subject|1|||
37889174|NCT00798655|69573999|FG000|Overall Study|Did not receive at least one dose of pan|2|||
37889175|NCT00796549|69574003|FG000|Overall Study|Adverse Event|11|||
37889176|NCT00796549|69574003|FG000|Overall Study|not entered|149|||
37889177|NCT00796549|69574003|FG000|Overall Study|Other|2|||
37889178|NCT00796549|69574003|FG000|Overall Study|Progressive disease|56|||
37889179|NCT00856492|69574012|FG000|Overall Study|Ineligible or withdrew consent|1|||
37889180|NCT00856492|69574013|FG001|Overall Study|Ineligible or withdrew consent|1|||
37889181|NCT00856492|69574014|FG002|Overall Study|Ineligible or withdrew consent|2|||
37889182|NCT00856180|69574025|FG000|Overall Study|Adverse Event|4|||
37889183|NCT00856180|69574025|FG000|Overall Study|Progressive Disease|16|||
37889184|NCT00900627|69574037|FG000|Overall Study|Condition under investigation worsened|4|||
37889185|NCT00900627|69574038|FG001|Overall Study|Condition under investigation worsened|0|||
37889186|NCT00900627|69574039|FG002|Overall Study|Condition under investigation worsened|5|||
37889187|NCT00900627|69574040|FG003|Overall Study|Condition under investigation worsened|3|||
37889188|NCT00900627|69574041|FG004|Overall Study|Condition under investigation worsened|0|||
37889189|NCT00900627|69574042|FG005|Overall Study|Condition under investigation worsened|0|||
37889190|NCT00900627|69574037|FG000|Overall Study|Withdrawal by Subject|1|||
37889191|NCT00900627|69574038|FG001|Overall Study|Withdrawal by Subject|0|||
37889192|NCT00900627|69574039|FG002|Overall Study|Withdrawal by Subject|1|||
37889193|NCT00900627|69574040|FG003|Overall Study|Withdrawal by Subject|0|||
37889194|NCT00900627|69574041|FG004|Overall Study|Withdrawal by Subject|1|||
37889195|NCT00900627|69574042|FG005|Overall Study|Withdrawal by Subject|2|||
37889196|NCT00900627|69574037|FG000|Overall Study|Adverse Event|1|||
37889197|NCT00900627|69574038|FG001|Overall Study|Adverse Event|2|||
37889198|NCT00900627|69574039|FG002|Overall Study|Adverse Event|0|||
37889199|NCT00900627|69574040|FG003|Overall Study|Adverse Event|3|||
37889200|NCT00900627|69574041|FG004|Overall Study|Adverse Event|0|||
37889201|NCT00900627|69574042|FG005|Overall Study|Adverse Event|0|||
37889202|NCT00900627|69574037|FG000|Overall Study|Death|0|||
37889203|NCT00900627|69574038|FG001|Overall Study|Death|0|||
37889204|NCT00900627|69574039|FG002|Overall Study|Death|0|||
37889205|NCT00900627|69574040|FG003|Overall Study|Death|0|||
37889206|NCT00900627|69574041|FG004|Overall Study|Death|28|||
37889207|NCT00900627|69574042|FG005|Overall Study|Death|24|||
37889208|NCT00866320|69574056|FG000|Overall Study|Withdrawal by Subject|4|||
37889209|NCT00866320|69574056|FG000|Overall Study|Death|2|||
37889210|NCT00869518|69574064|FG000|Overall Study|Lost to Follow-up|1|||
37889211|NCT00869518|69574065|FG001|Overall Study|Lost to Follow-up|1|||
37889212|NCT00797563|69574071|FG000|Overall Study|Adverse Event|1|||
37889213|NCT00869440|69574079|FG000|Overall Study|Withdrawal by Subject|1|||
37889214|NCT00869440|69574080|FG001|Overall Study|Withdrawal by Subject|0|||
37889215|NCT00869440|69574081|FG002|Overall Study|Withdrawal by Subject|0|||
37889216|NCT00869440|69574082|FG003|Overall Study|Withdrawal by Subject|0|||
37889217|NCT00869440|69574079|FG000|Overall Study|Physician Decision|1|||
37889218|NCT00869440|69574080|FG001|Overall Study|Physician Decision|1|||
37889219|NCT00869440|69574081|FG002|Overall Study|Physician Decision|0|||
37889220|NCT00869440|69574082|FG003|Overall Study|Physician Decision|0|||
37889221|NCT00895947|69574094|FG000|Overall Study|Adverse Event|3|||
37889222|NCT00895947|69574095|FG001|Overall Study|Adverse Event|4|||
37889223|NCT00895947|69574094|FG000|Overall Study|Lost to Follow-up|3|||
37889224|NCT00895947|69574095|FG001|Overall Study|Lost to Follow-up|4|||
37889225|NCT00895947|69574094|FG000|Overall Study|Protocol Violation|4|||
37889226|NCT00895947|69574095|FG001|Overall Study|Protocol Violation|2|||
37889227|NCT00895947|69574094|FG000|Overall Study|Withdrawal by Subject|2|||
37889228|NCT00895947|69574095|FG001|Overall Study|Withdrawal by Subject|0|||
37889229|NCT00869362|69574103|FG000|Overall Study|Death|0|||
37889230|NCT00869362|69574104|FG001|Overall Study|Death|2|||
37889231|NCT00869362|69574103|FG000|Overall Study|Lost to Follow-up|1|||
37889232|NCT00869362|69574104|FG001|Overall Study|Lost to Follow-up|3|||
37889233|NCT00588445|69574111|FG000|Overall Study|Protocol Violation|1|||
37889234|NCT00588445|69574111|FG000|Overall Study|Withdrawal by Subject|3|||
37889235|NCT00588445|69574111|FG000|Overall Study|Disease Progression|1|||
37889236|NCT00588445|69574111|FG000|Overall Study|Not Treated|10|||
37889237|NCT00796315|69574117|FG000|Overall Study|Protocol Violation|0|||
37889238|NCT00796315|69574118|FG001|Overall Study|Protocol Violation|1|||
37889239|NCT00796315|69574119|FG002|Overall Study|Protocol Violation|0|||
37889240|NCT00855166|69574132|FG000|Overall Study|Adverse Event|0|||
37889241|NCT00855166|69574133|FG001|Overall Study|Adverse Event|2|||
37889242|NCT00855166|69574132|FG000|Overall Study|Death|0|||
37889243|NCT00855166|69574133|FG001|Overall Study|Death|1|||
37889244|NCT00855166|69574132|FG000|Overall Study|Withdrawal by Subject|1|||
37695980|NCT02279407|69172130|FG002|Overall Study|Withdrawal by Subject|1|||
37695981|NCT02279407|69172131|FG003|Overall Study|Withdrawal by Subject|1|||
37695982|NCT02279407|69172128|FG000|Overall Study|Adverse Event|1|||
37695983|NCT02279407|69172129|FG001|Overall Study|Adverse Event|1|||
37695984|NCT02279407|69172130|FG002|Overall Study|Adverse Event|2|||
37695985|NCT02279407|69172131|FG003|Overall Study|Adverse Event|0|||
37695986|NCT02326220|69172143|FG000|Double-blind Treatment Period|Adverse Event|1|||
37695987|NCT02326220|69172144|FG001|Double-blind Treatment Period|Adverse Event|2|||
37823401|NCT02250326|69504759|FG000|Treatment Period|Death|1|||
37823402|NCT02250326|69504760|FG001|Treatment Period|Death|12|||
37823403|NCT02250326|69504761|FG002|Treatment Period|Death|2|||
37823404|NCT02250326|69504759|FG000|Treatment Period|Adverse Event|8|||
37823405|NCT02250326|69504760|FG001|Treatment Period|Adverse Event|4|||
37823406|NCT02250326|69504761|FG002|Treatment Period|Adverse Event|8|||
37823407|NCT02250326|69504759|FG000|Treatment Period|Progressive Disease|42|||
37823408|NCT02250326|69504760|FG001|Treatment Period|Progressive Disease|36|||
37823409|NCT02250326|69504761|FG002|Treatment Period|Progressive Disease|45|||
37823410|NCT02250326|69504759|FG000|Treatment Period|Symptomatic Deterioration|9|||
37823411|NCT02250326|69504760|FG001|Treatment Period|Symptomatic Deterioration|4|||
37823412|NCT02250326|69504761|FG002|Treatment Period|Symptomatic Deterioration|10|||
37823413|NCT02250326|69504759|FG000|Treatment Period|Withdrawal by Subject|11|||
37823414|NCT02250326|69504760|FG001|Treatment Period|Withdrawal by Subject|5|||
37823415|NCT02250326|69504761|FG002|Treatment Period|Withdrawal by Subject|4|||
37823416|NCT02250326|69504759|FG000|Treatment Period|Miscellaneous|8|||
37823417|NCT02250326|69504760|FG001|Treatment Period|Miscellaneous|2|||
37823418|NCT02250326|69504761|FG002|Treatment Period|Miscellaneous|7|||
37823419|NCT02250326|69504759|FG000|Treatment Period|Randomized or assigned; not treated|2|||
37823420|NCT02250326|69504760|FG001|Treatment Period|Randomized or assigned; not treated|1|||
37823421|NCT02250326|69504761|FG002|Treatment Period|Randomized or assigned; not treated|1|||
37823422|NCT02250326|69504759|FG000|Follow-Up Period|Death|46|||
37823423|NCT02250326|69504760|FG001|Follow-Up Period|Death|26|||
37823424|NCT02250326|69504761|FG002|Follow-Up Period|Death|32|||
37823425|NCT02250326|69504759|FG000|Follow-Up Period|Unknown or Missing|2|||
37823426|NCT02250326|69504760|FG001|Follow-Up Period|Unknown or Missing|3|||
37823427|NCT02250326|69504761|FG002|Follow-Up Period|Unknown or Missing|3|||
37823428|NCT02250326|69504759|FG000|Follow-Up Period|Lost to Follow-up|1|||
37823429|NCT02250326|69504760|FG001|Follow-Up Period|Lost to Follow-up|1|||
37823430|NCT02250326|69504761|FG002|Follow-Up Period|Lost to Follow-up|3|||
37823431|NCT01567722|69504773|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
37823432|NCT01567722|69504774|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
37823433|NCT01567722|69504775|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
37823434|NCT01567722|69504773|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
37823435|NCT01567722|69504774|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
37823436|NCT01567722|69504775|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
37823437|NCT01567722|69504773|FG000|Overall Study|Protocol closure by the OCG|2|||
37823438|NCT01567722|69504774|FG001|Overall Study|Protocol closure by the OCG|0|||
37823439|NCT01567722|69504775|FG002|Overall Study|Protocol closure by the OCG|0|||
37823440|NCT01567722|69504773|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
37823441|NCT01567722|69504774|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
37823442|NCT01567722|69504775|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
37823443|NCT01349790|69504800|FG000|Overall Study|Investigator Judgement|3|||
37823444|NCT01349790|69504800|FG000|Overall Study|Death|2|||
37889245|NCT00855166|69574133|FG001|Overall Study|Withdrawal by Subject|4|||
37889246|NCT00855166|69574132|FG000|Overall Study|Poor/non-compliance|2|||
37889247|NCT00855166|69574133|FG001|Overall Study|Poor/non-compliance|0|||
37889248|NCT00855166|69574132|FG000|Overall Study|Administrative reasons by sponsor|1|||
37695988|NCT02326220|69172145|FG002|Double-blind Treatment Period|Adverse Event|0|||
37695989|NCT02326220|69172143|FG000|Double-blind Treatment Period|Protocol Violation|0|||
37988160|NCT00355134|69673511|FG001|Core Phase|Administrative problems|3|||
37988161|NCT00355134|69673512|FG002|Core Phase|Administrative problems|5|||
37988162|NCT00355134|69673513|FG003|Core Phase|Administrative problems|0|||
37988163|NCT00355134|69673514|FG004|Core Phase|Administrative problems|0|||
37988164|NCT00355134|69673510|FG000|Core Phase|Protocol Violation|3|||
37988165|NCT00355134|69673511|FG001|Core Phase|Protocol Violation|2|||
37988166|NCT00355134|69673512|FG002|Core Phase|Protocol Violation|2|||
37988167|NCT00355134|69673513|FG003|Core Phase|Protocol Violation|0|||
37988168|NCT00355134|69673514|FG004|Core Phase|Protocol Violation|0|||
37988169|NCT00355134|69673510|FG000|Core Phase|Abnormal test procedure result(s)|1|||
37988170|NCT00355134|69673511|FG001|Core Phase|Abnormal test procedure result(s)|2|||
37889249|NCT00855166|69574133|FG001|Overall Study|Administrative reasons by sponsor|0|||
37889250|NCT00855166|69574132|FG000|Overall Study|Subject no longer meets study criteria|1|||
37889251|NCT00855166|69574133|FG001|Overall Study|Subject no longer meets study criteria|1|||
37889252|NCT00587587|69574143|FG000|Overall Study|Lost to Follow-up|6|||
37889253|NCT00587587|69574144|FG001|Overall Study|Lost to Follow-up|1|||
37889254|NCT00854620|69574152|FG000|Overall Study|Adverse Event|1|||
37889255|NCT00793585|69574158|FG000|Overall Study|Adverse Event|1|||
37889256|NCT00793585|69574159|FG001|Overall Study|Adverse Event|1|||
37889257|NCT00793585|69574158|FG000|Overall Study|Protocol Violation|1|||
37889258|NCT00793585|69574159|FG001|Overall Study|Protocol Violation|2|||
37889259|NCT00898443|69574167|FG000|Overall Study|Withdrawal by Subject|1|||
37889260|NCT00898443|69574168|FG001|Overall Study|Withdrawal by Subject|0|||
37889261|NCT00900159|69574176|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
37889262|NCT00900159|69574177|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
37889263|NCT00854308|69574196|FG000|Overall Study|Disease progression|42|||
37889264|NCT00854308|69574197|FG001|Overall Study|Disease progression|50|||
37889265|NCT00854308|69574196|FG000|Overall Study|Adverse Event|8|||
37889266|NCT00854308|69574197|FG001|Overall Study|Adverse Event|3|||
37889267|NCT00854308|69574196|FG000|Overall Study|Death|2|||
37889268|NCT00854308|69574197|FG001|Overall Study|Death|5|||
37889269|NCT00854308|69574196|FG000|Overall Study|Physician Decision|6|||
37889270|NCT00854308|69574197|FG001|Overall Study|Physician Decision|6|||
37889271|NCT00854308|69574196|FG000|Overall Study|Withdrawal by Subject|4|||
37889272|NCT00854308|69574197|FG001|Overall Study|Withdrawal by Subject|2|||
37889273|NCT00854308|69574196|FG000|Overall Study|Sponsor's decision to terminate study|0|||
37889274|NCT00854308|69574197|FG001|Overall Study|Sponsor's decision to terminate study|1|||
37889275|NCT00592852|69574203|FG000|Overall Study|Non-compliance|1|||
37889276|NCT00592852|69574203|FG000|Overall Study|Adverse Event|3|||
37889277|NCT00592852|69574203|FG000|Overall Study|Found ineligible|1|||
37889278|NCT00592852|69574203|FG000|Overall Study|Withdrawal by Subject|1|||
37889279|NCT00895245|69574207|FG000|Overall Study|Lack of Efficacy|6|||
37889280|NCT00865306|69574213|FG000|Controlled Trial|Lost to Follow-up|1|||
37889281|NCT00865306|69574214|FG001|Controlled Trial|Lost to Follow-up|1|||
37889282|NCT00865306|69574213|FG000|Controlled Trial|Difficulty commuting|2|||
37889283|NCT00865306|69574214|FG001|Controlled Trial|Difficulty commuting|0|||
37889284|NCT00865306|69574213|FG000|Controlled Trial|Improved btw baseline and first session|1|||
37889285|NCT00865306|69574214|FG001|Controlled Trial|Improved btw baseline and first session|0|||
37889286|NCT00865306|69574213|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
37889287|NCT00865306|69574214|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
37889288|NCT00865306|69574213|FG000|Controlled Trial|Withdrawal by Subject|0|||
37889289|NCT00865306|69574214|FG001|Controlled Trial|Withdrawal by Subject|1|||
37889290|NCT00896649|69574220|FG000|Overall Study|Physician Decision|1|||
37889291|NCT00896649|69574220|FG000|Overall Study|Pregnancy|1|||
37889292|NCT00896649|69574220|FG000|Overall Study|missing documentation|1|||
37889293|NCT00896649|69574220|FG000|Overall Study|technical difficulties|2|||
37889294|NCT00796003|69574227|FG000|Overall Study|Disease Progression|2|||
37889295|NCT00796003|69574228|FG001|Overall Study|Disease Progression|13|||
37889296|NCT00796003|69574227|FG000|Overall Study|Adverse Event|1|||
37889297|NCT00796003|69574228|FG001|Overall Study|Adverse Event|7|||
37889298|NCT00796003|69574227|FG000|Overall Study|Specified organ function not met|0|||
37889299|NCT00796003|69574228|FG001|Overall Study|Specified organ function not met|1|||
37889300|NCT00796003|69574227|FG000|Overall Study|Physician Decision|0|||
37889301|NCT00796003|69574228|FG001|Overall Study|Physician Decision|4|||
37988171|NCT00355134|69673512|FG002|Core Phase|Abnormal test procedure result(s)|1|||
37988172|NCT00355134|69673513|FG003|Core Phase|Abnormal test procedure result(s)|0|||
37988173|NCT00355134|69673514|FG004|Core Phase|Abnormal test procedure result(s)|0|||
37988174|NCT00355134|69673510|FG000|Core Phase|Condition no longer requires study drug|1|||
37889302|NCT00796003|69574227|FG000|Overall Study|Withdrawal by Subject|0|||
37988175|NCT00355134|69673511|FG001|Core Phase|Condition no longer requires study drug|0|||
37889303|NCT00796003|69574228|FG001|Overall Study|Withdrawal by Subject|1|||
37889304|NCT00796003|69574227|FG000|Overall Study|Other|0|||
37889305|NCT00796003|69574228|FG001|Overall Study|Other|1|||
37988176|NCT00355134|69673512|FG002|Core Phase|Condition no longer requires study drug|1|||
37988177|NCT00355134|69673513|FG003|Core Phase|Condition no longer requires study drug|0|||
37889306|NCT00796003|69574227|FG000|Overall Study|Participants Not treated|0|||
37889307|NCT00796003|69574228|FG001|Overall Study|Participants Not treated|2|||
37889308|NCT00895011|69574240|FG000|Overall Study|Withdrawal by Subject|14|||
37889309|NCT00895011|69574241|FG001|Overall Study|Withdrawal by Subject|7|||
37889310|NCT00895011|69574242|FG002|Overall Study|Withdrawal by Subject|2|||
37889311|NCT00895011|69574240|FG000|Overall Study|Lost to Follow-up|5|||
37889312|NCT00895011|69574241|FG001|Overall Study|Lost to Follow-up|4|||
37889313|NCT00895011|69574242|FG002|Overall Study|Lost to Follow-up|1|||
37889314|NCT00895011|69574240|FG000|Overall Study|Protocol Violation|3|||
37889315|NCT00895011|69574241|FG001|Overall Study|Protocol Violation|1|||
37889316|NCT00895011|69574242|FG002|Overall Study|Protocol Violation|3|||
37889317|NCT00895011|69574240|FG000|Overall Study|Adverse Event|1|||
37889318|NCT00895011|69574241|FG001|Overall Study|Adverse Event|2|||
37889319|NCT00895011|69574242|FG002|Overall Study|Adverse Event|2|||
37889320|NCT00895011|69574240|FG000|Overall Study|schedule conflict|1|||
37889321|NCT00895011|69574241|FG001|Overall Study|schedule conflict|0|||
37889322|NCT00895011|69574242|FG002|Overall Study|schedule conflict|0|||
37889323|NCT00899847|69574251|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
37889324|NCT00795535|69574257|FG000|Overall Study|incomplete data and technical problems|20|||
37889325|NCT00853762|69574265|FG000|Overall Study|Premature Termination|16|||
37889326|NCT00853762|69574266|FG001|Overall Study|Premature Termination|15|||
37889327|NCT00853762|69574267|FG002|Overall Study|Premature Termination|14|||
37889328|NCT00853762|69574268|FG003|Overall Study|Premature Termination|21|||
37889329|NCT00853762|69574265|FG000|Overall Study|Protocol Violation|0|||
37889330|NCT00853762|69574266|FG001|Overall Study|Protocol Violation|0|||
37889331|NCT00853762|69574267|FG002|Overall Study|Protocol Violation|0|||
37889332|NCT00853762|69574268|FG003|Overall Study|Protocol Violation|1|||
37889333|NCT00853762|69574265|FG000|Overall Study|Withdrawal by Subject|0|||
37889334|NCT00853762|69574266|FG001|Overall Study|Withdrawal by Subject|0|||
37889335|NCT00853762|69574267|FG002|Overall Study|Withdrawal by Subject|1|||
37889336|NCT00853762|69574268|FG003|Overall Study|Withdrawal by Subject|0|||
37889337|NCT00853762|69574265|FG000|Overall Study|Other|0|||
37889338|NCT00853762|69574266|FG001|Overall Study|Other|2|||
37889339|NCT00853762|69574267|FG002|Overall Study|Other|0|||
37889340|NCT00853762|69574268|FG003|Overall Study|Other|0|||
37889341|NCT00853762|69574265|FG000|Overall Study|Randomised but not Treated|0|||
37889342|NCT00853762|69574266|FG001|Overall Study|Randomised but not Treated|2|||
37889343|NCT00853762|69574267|FG002|Overall Study|Randomised but not Treated|2|||
37889344|NCT00853762|69574268|FG003|Overall Study|Randomised but not Treated|0|||
37889345|NCT00789529|69574280|FG000|Overall Study|Withdrawal by Subject|0|||
37889346|NCT00789529|69574281|FG001|Overall Study|Withdrawal by Subject|1|||
37889347|NCT00789529|69574280|FG000|Overall Study|Other Reason|1|||
37889348|NCT00789529|69574281|FG001|Overall Study|Other Reason|0|||
37889349|NCT00894933|69574287|FG000|Overall Study|Lost to Follow-up|2|||
37889350|NCT00894933|69574287|FG000|Overall Study|Cancelled Procedure|1|||
37889351|NCT00894933|69574287|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
37889352|NCT00792805|69574294|FG000|Overall Study|Adverse Event|12|||
37889353|NCT00792805|69574295|FG001|Overall Study|Adverse Event|10|||
37889354|NCT00792805|69574296|FG002|Overall Study|Adverse Event|10|||
37889355|NCT00792805|69574294|FG000|Overall Study|Subject withdrew consent|5|||
37889356|NCT00792805|69574295|FG001|Overall Study|Subject withdrew consent|6|||
37889357|NCT00792805|69574296|FG002|Overall Study|Subject withdrew consent|5|||
37833592|NCT01262872|69517330|FG003|Step 2|Death|1|||
37833593|NCT01262872|69517331|FG004|Step 2|Death|0|||
37833594|NCT01262872|69517332|FG005|Step 2|Death|2|||
37833595|NCT01262872|69517333|FG006|Step 2|Death|2|||
37833596|NCT01262872|69517334|FG007|Step 2|Death|1|||
37833597|NCT01262872|69517327|FG000|Step 2|Protocol Violation|0|||
37833598|NCT01262872|69517328|FG001|Step 2|Protocol Violation|0|||
37833599|NCT01262872|69517329|FG002|Step 2|Protocol Violation|1|||
37833600|NCT01262872|69517330|FG003|Step 2|Protocol Violation|0|||
37833601|NCT01262872|69517331|FG004|Step 2|Protocol Violation|0|||
37833602|NCT01262872|69517332|FG005|Step 2|Protocol Violation|0|||
37833603|NCT01262872|69517333|FG006|Step 2|Protocol Violation|3|||
37833604|NCT01262872|69517334|FG007|Step 2|Protocol Violation|1|||
37833605|NCT01262872|69517327|FG000|Step 2|Withdrawal by Subject|0|||
37833606|NCT01262872|69517328|FG001|Step 2|Withdrawal by Subject|0|||
37833607|NCT01262872|69517329|FG002|Step 2|Withdrawal by Subject|4|||
37833608|NCT01262872|69517330|FG003|Step 2|Withdrawal by Subject|6|||
37833609|NCT01262872|69517331|FG004|Step 2|Withdrawal by Subject|3|||
37833610|NCT01262872|69517332|FG005|Step 2|Withdrawal by Subject|1|||
37833611|NCT01262872|69517333|FG006|Step 2|Withdrawal by Subject|2|||
37833612|NCT01262872|69517334|FG007|Step 2|Withdrawal by Subject|1|||
37833613|NCT01262872|69517327|FG000|Step 2|Migrated/moved from study area|0|||
37833614|NCT01262872|69517328|FG001|Step 2|Migrated/moved from study area|0|||
37833615|NCT01262872|69517329|FG002|Step 2|Migrated/moved from study area|4|||
37833616|NCT01262872|69517330|FG003|Step 2|Migrated/moved from study area|3|||
37889358|NCT00792805|69574294|FG000|Overall Study|Administrative problems|2|||
37889359|NCT00792805|69574295|FG001|Overall Study|Administrative problems|0|||
37889360|NCT00792805|69574296|FG002|Overall Study|Administrative problems|4|||
37889361|NCT00792805|69574294|FG000|Overall Study|Abnormal test procedure result(s)|1|||
37889362|NCT00792805|69574295|FG001|Overall Study|Abnormal test procedure result(s)|2|||
37889363|NCT00792805|69574296|FG002|Overall Study|Abnormal test procedure result(s)|0|||
37889364|NCT00792805|69574294|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
37889365|NCT00792805|69574295|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
37889366|NCT00792805|69574296|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
37889367|NCT00792805|69574294|FG000|Overall Study|Lost to Follow-up|1|||
37889368|NCT00792805|69574295|FG001|Overall Study|Lost to Follow-up|1|||
37889369|NCT00792805|69574296|FG002|Overall Study|Lost to Follow-up|6|||
37889370|NCT00792805|69574294|FG000|Overall Study|Abnormal laboratory value(s)|0|||
37889371|NCT00792805|69574295|FG001|Overall Study|Abnormal laboratory value(s)|0|||
37889372|NCT00792805|69574296|FG002|Overall Study|Abnormal laboratory value(s)|1|||
37889373|NCT00792805|69574294|FG000|Overall Study|Protocol deviation|0|||
37889374|NCT00792805|69574295|FG001|Overall Study|Protocol deviation|1|||
37889375|NCT00792805|69574296|FG002|Overall Study|Protocol deviation|1|||
37889376|NCT00925002|69574307|FG000|Overall Study|Other|1|||
37889377|NCT00925002|69574308|FG001|Overall Study|Other|4|||
37889378|NCT00925002|69574309|FG002|Overall Study|Other|0|||
37889379|NCT00925002|69574307|FG000|Overall Study|Death|1|||
37889380|NCT00925002|69574308|FG001|Overall Study|Death|1|||
37889381|NCT00925002|69574309|FG002|Overall Study|Death|5|||
37889382|NCT00925002|69574307|FG000|Overall Study|Adverse Event|3|||
37889383|NCT00925002|69574308|FG001|Overall Study|Adverse Event|1|||
37889384|NCT00925002|69574309|FG002|Overall Study|Adverse Event|2|||
37889385|NCT00925002|69574307|FG000|Overall Study|Participant withdrew consent|1|||
37889386|NCT00925002|69574308|FG001|Overall Study|Participant withdrew consent|3|||
37889387|NCT00925002|69574309|FG002|Overall Study|Participant withdrew consent|3|||
37889388|NCT00928746|69574318|FG000|Overall Study|Adverse Event|2|||
37889389|NCT00928746|69574318|FG000|Overall Study|Protocol Violation|1|||
37889390|NCT00928746|69574318|FG000|Overall Study|Withdrawal by Subject|1|||
37889391|NCT00928746|69574318|FG000|Overall Study|Other|2|||
37889392|NCT00922428|69574324|FG000|Overall Study|retrospective/extremely implausible data|2|||
37889393|NCT00922428|69574324|FG000|Overall Study|no medication use or questionable use|13|||
37889394|NCT00894543|69574336|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
37889395|NCT00894543|69574337|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
37889396|NCT00894543|69574336|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
37889397|NCT00894543|69574337|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
37889398|NCT00922272|69574343|FG000|Open-label Phase|Adverse Event|5|||
37889399|NCT00922272|69574344|FG001|Open-label Phase|Adverse Event|0|||
37889400|NCT00922272|69574343|FG000|Open-label Phase|Protocol Violation|1|||
37889401|NCT00922272|69574344|FG001|Open-label Phase|Protocol Violation|0|||
37889402|NCT00922272|69574343|FG000|Open-label Phase|Withdrawal by Subject|11|||
37889403|NCT00922272|69574344|FG001|Open-label Phase|Withdrawal by Subject|0|||
37889404|NCT00922272|69574343|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
37889405|NCT00922272|69574344|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
37889406|NCT00922272|69574343|FG000|Open-label Phase|Withdrawal criteria met|5|||
37889407|NCT00922272|69574344|FG001|Open-label Phase|Withdrawal criteria met|0|||
37988178|NCT00355134|69673514|FG004|Core Phase|Condition no longer requires study drug|0|||
37988179|NCT00355134|69673510|FG000|Extension Phase|Withdrawal by Subject|7|||
37988180|NCT00355134|69673511|FG001|Extension Phase|Withdrawal by Subject|11|||
37988181|NCT00355134|69673512|FG002|Extension Phase|Withdrawal by Subject|0|||
37988182|NCT00355134|69673513|FG003|Extension Phase|Withdrawal by Subject|7|||
37988183|NCT00355134|69673514|FG004|Extension Phase|Withdrawal by Subject|5|||
37823445|NCT01349790|69504800|FG000|Overall Study|Withdrawal by Patient|2|||
37823446|NCT01349790|69504800|FG000|Overall Study|Adverse Event|1|||
37823447|NCT01349790|69504800|FG000|Overall Study|Lost to Follow-up|1|||
37823448|NCT01349595|69504806|FG000|Overall Study|Lack of funding|2|||
37823449|NCT01349595|69504807|FG001|Overall Study|Lack of funding|2|||
37823450|NCT01349673|69504817|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
37823451|NCT01349673|69504817|FG000|Overall Study|No Longer Qualified For Study|1|||
37823452|NCT01349673|69504817|FG000|Overall Study|Site Closure|10|||
37889408|NCT00922272|69574343|FG000|Double-blind Phase|Adverse Event|1|||
37889409|NCT00922272|69574344|FG001|Double-blind Phase|Adverse Event|1|||
37889410|NCT00922272|69574343|FG000|Double-blind Phase|Withdrawal by Subject|1|||
37889411|NCT00922272|69574344|FG001|Double-blind Phase|Withdrawal by Subject|1|||
37889412|NCT00922272|69574343|FG000|Double-blind Phase|Lost to Follow-up|2|||
37823453|NCT01349673|69504817|FG000|Overall Study|Withdrawal by Subject|21|||
37889413|NCT00922272|69574344|FG001|Double-blind Phase|Lost to Follow-up|1|||
37889414|NCT00922272|69574343|FG000|Double-blind Phase|Withdrawal criteria met|1|||
37889415|NCT00922272|69574344|FG001|Double-blind Phase|Withdrawal criteria met|1|||
37889416|NCT00922272|69574343|FG000|Double-blind Phase|Noncompliance|1|||
37889417|NCT00922272|69574344|FG001|Double-blind Phase|Noncompliance|1|||
37889418|NCT00922272|69574343|FG000|Double-blind Phase|Positive urine drug screen|1|||
37889419|NCT00922272|69574344|FG001|Double-blind Phase|Positive urine drug screen|1|||
37889420|NCT00853372|69574354|FG000|Overall Study|Death|30|||
37889421|NCT00853372|69574355|FG001|Overall Study|Death|26|||
37889422|NCT00853372|69574354|FG000|Overall Study|Lost to Follow-up|1|||
37889423|NCT00853372|69574355|FG001|Overall Study|Lost to Follow-up|2|||
37889424|NCT00853372|69574354|FG000|Overall Study|Full Consent Withdrawn|1|||
37889425|NCT00853372|69574355|FG001|Overall Study|Full Consent Withdrawn|1|||
37889426|NCT00848536|69574363|FG000|Overall Study|Adverse Event|2|||
37889427|NCT00848536|69574364|FG001|Overall Study|Adverse Event|2|||
37889428|NCT00848536|69574363|FG000|Overall Study|Withdrawal by Subject|0|||
37889429|NCT00848536|69574364|FG001|Overall Study|Withdrawal by Subject|1|||
37889430|NCT00848536|69574363|FG000|Overall Study|Protocol Violation|0|||
37889431|NCT00848536|69574364|FG001|Overall Study|Protocol Violation|1|||
37889432|NCT00848536|69574363|FG000|Overall Study|Noncompliance|1|||
37889433|NCT00848536|69574364|FG001|Overall Study|Noncompliance|0|||
37889434|NCT00848536|69574363|FG000|Overall Study|Inadequate Control of IOP|1|||
37889435|NCT00848536|69574364|FG001|Overall Study|Inadequate Control of IOP|1|||
37889436|NCT00848536|69574363|FG000|Overall Study|Patient Moved|0|||
37889437|NCT00848536|69574364|FG001|Overall Study|Patient Moved|2|||
37889438|NCT00922116|69574370|FG000|Overall Study|Adverse Event|4|||
37889439|NCT00922116|69574370|FG000|Overall Study|Death|1|||
37889440|NCT00922116|69574370|FG000|Overall Study|Lost to Follow-up|1|||
37889441|NCT00922116|69574370|FG000|Overall Study|Withdrawal by Subject|4|||
37889442|NCT00922116|69574370|FG000|Overall Study|Other|5|||
37889443|NCT00921024|69574376|FG000|Overall Study|Lost to Follow-up|2|||
37889444|NCT00921024|69574377|FG001|Overall Study|Lost to Follow-up|0|||
37889445|NCT00921024|69574376|FG000|Overall Study|Received concomittant therapy|2|||
37889446|NCT00921024|69574377|FG001|Overall Study|Received concomittant therapy|0|||
37889447|NCT00921024|69574376|FG000|Overall Study|Withdrawal by Subject|0|||
37889448|NCT00921024|69574377|FG001|Overall Study|Withdrawal by Subject|3|||
37889449|NCT00928668|69574383|FG000|Overall Study|Adverse Event|1|||
37889450|NCT00928668|69574384|FG001|Overall Study|Adverse Event|0|||
37889451|NCT00928668|69574385|FG002|Overall Study|Adverse Event|0|||
37889452|NCT00928668|69574386|FG003|Overall Study|Adverse Event|0|||
37889453|NCT00928668|69574387|FG004|Overall Study|Adverse Event|0|||
37889454|NCT00928668|69574383|FG000|Overall Study|Protocol Violation|0|||
37889455|NCT00928668|69574384|FG001|Overall Study|Protocol Violation|0|||
37988184|NCT00355134|69673510|FG000|Extension Phase|Adverse Event|13|||
37988185|NCT00355134|69673511|FG001|Extension Phase|Adverse Event|9|||
37988186|NCT00355134|69673512|FG002|Extension Phase|Adverse Event|0|||
37889456|NCT00928668|69574385|FG002|Overall Study|Protocol Violation|0|||
37889457|NCT00928668|69574386|FG003|Overall Study|Protocol Violation|0|||
37889458|NCT00928668|69574387|FG004|Overall Study|Protocol Violation|1|||
37889459|NCT00928668|69574383|FG000|Overall Study|Withdrawal by Subject|0|||
37889460|NCT00928668|69574384|FG001|Overall Study|Withdrawal by Subject|1|||
37889461|NCT00928668|69574385|FG002|Overall Study|Withdrawal by Subject|1|||
37889462|NCT00928668|69574386|FG003|Overall Study|Withdrawal by Subject|0|||
37889463|NCT00928668|69574387|FG004|Overall Study|Withdrawal by Subject|0|||
37988187|NCT00355134|69673513|FG003|Extension Phase|Adverse Event|3|||
37988188|NCT00355134|69673514|FG004|Extension Phase|Adverse Event|5|||
37988189|NCT00355134|69673510|FG000|Extension Phase|Lost to Follow-up|2|||
37988190|NCT00355134|69673511|FG001|Extension Phase|Lost to Follow-up|6|||
37988191|NCT00355134|69673512|FG002|Extension Phase|Lost to Follow-up|0|||
37988192|NCT00355134|69673513|FG003|Extension Phase|Lost to Follow-up|2|||
37889464|NCT00928668|69574383|FG000|Overall Study|Other reasons not listed above|0|||
37889465|NCT00928668|69574384|FG001|Overall Study|Other reasons not listed above|0|||
37889466|NCT00928668|69574385|FG002|Overall Study|Other reasons not listed above|0|||
37889467|NCT00928668|69574386|FG003|Overall Study|Other reasons not listed above|1|||
37889468|NCT00928668|69574387|FG004|Overall Study|Other reasons not listed above|0|||
37889469|NCT00592774|69574409|FG000|Overall Study|Adverse Event|5|||
37889470|NCT00592774|69574410|FG001|Overall Study|Adverse Event|19|||
37889471|NCT00592774|69574411|FG002|Overall Study|Adverse Event|2|||
37889472|NCT00592774|69574412|FG003|Overall Study|Adverse Event|14|||
37889473|NCT00592774|69574413|FG004|Overall Study|Adverse Event|8|||
37889474|NCT00592774|69574409|FG000|Overall Study|Protocol Violation|0|||
37889475|NCT00592774|69574410|FG001|Overall Study|Protocol Violation|1|||
37988193|NCT00355134|69673514|FG004|Extension Phase|Lost to Follow-up|4|||
37889476|NCT00592774|69574411|FG002|Overall Study|Protocol Violation|0|||
37889477|NCT00592774|69574412|FG003|Overall Study|Protocol Violation|0|||
37889478|NCT00592774|69574413|FG004|Overall Study|Protocol Violation|1|||
37889479|NCT00592774|69574409|FG000|Overall Study|Withdrawal by Subject|3|||
37889480|NCT00592774|69574410|FG001|Overall Study|Withdrawal by Subject|7|||
37889481|NCT00592774|69574411|FG002|Overall Study|Withdrawal by Subject|0|||
37889482|NCT00592774|69574412|FG003|Overall Study|Withdrawal by Subject|0|||
37988194|NCT00355134|69673510|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
37988195|NCT00355134|69673511|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
37889483|NCT00592774|69574413|FG004|Overall Study|Withdrawal by Subject|0|||
37889484|NCT00592774|69574409|FG000|Overall Study|Lack of Efficacy|3|||
37889485|NCT00592774|69574410|FG001|Overall Study|Lack of Efficacy|3|||
37889486|NCT00592774|69574411|FG002|Overall Study|Lack of Efficacy|0|||
37889487|NCT00592774|69574412|FG003|Overall Study|Lack of Efficacy|0|||
37889488|NCT00592774|69574413|FG004|Overall Study|Lack of Efficacy|2|||
37889489|NCT00592774|69574409|FG000|Overall Study|Physician Decision|0|||
37889490|NCT00592774|69574410|FG001|Overall Study|Physician Decision|1|||
37889491|NCT00592774|69574411|FG002|Overall Study|Physician Decision|1|||
37889492|NCT00592774|69574412|FG003|Overall Study|Physician Decision|0|||
37889493|NCT00592774|69574413|FG004|Overall Study|Physician Decision|1|||
37889494|NCT00592774|69574409|FG000|Overall Study|Other|0|||
37889495|NCT00592774|69574410|FG001|Overall Study|Other|1|||
37889496|NCT00592774|69574411|FG002|Overall Study|Other|1|||
37889497|NCT00592774|69574412|FG003|Overall Study|Other|0|||
37889498|NCT00592774|69574413|FG004|Overall Study|Other|2|||
37889499|NCT00837694|69574431|FG000|Overall Study|Lost to Follow-up|2|||
37889500|NCT00837694|69574432|FG001|Overall Study|Lost to Follow-up|0|||
37889501|NCT00837694|69574433|FG002|Overall Study|Lost to Follow-up|2|||
37889502|NCT00837694|69574434|FG003|Overall Study|Lost to Follow-up|1|||
37889503|NCT00837694|69574435|FG004|Overall Study|Lost to Follow-up|1|||
37889504|NCT00837694|69574436|FG005|Overall Study|Lost to Follow-up|1|||
37889505|NCT00852202|69574453|FG000|Overall Study|Adverse Event|2|||
37889506|NCT00852202|69574454|FG001|Overall Study|Adverse Event|3|||
37889507|NCT00852202|69574455|FG002|Overall Study|Adverse Event|7|||
37889508|NCT00852202|69574453|FG000|Overall Study|Lack of Efficacy|4|||
37889509|NCT00852202|69574454|FG001|Overall Study|Lack of Efficacy|1|||
37889510|NCT00852202|69574455|FG002|Overall Study|Lack of Efficacy|2|||
37889511|NCT00852202|69574453|FG000|Overall Study|Protocol Violation|2|||
37889512|NCT00852202|69574454|FG001|Overall Study|Protocol Violation|2|||
37889513|NCT00852202|69574455|FG002|Overall Study|Protocol Violation|7|||
37889514|NCT00852202|69574453|FG000|Overall Study|Withdrawal by Subject|3|||
37889515|NCT00852202|69574454|FG001|Overall Study|Withdrawal by Subject|1|||
37889516|NCT00852202|69574455|FG002|Overall Study|Withdrawal by Subject|2|||
37889517|NCT00852202|69574453|FG000|Overall Study|Lost to Follow-up|5|||
37889518|NCT00852202|69574454|FG001|Overall Study|Lost to Follow-up|5|||
37889519|NCT00852202|69574455|FG002|Overall Study|Lost to Follow-up|6|||
37889520|NCT00852202|69574453|FG000|Overall Study|pregnancy,moving away and surgery|1|||
37988196|NCT00355134|69673512|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
37988197|NCT00355134|69673513|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
37988198|NCT00355134|69673514|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
37889521|NCT00852202|69574454|FG001|Overall Study|pregnancy,moving away and surgery|0|||
37889522|NCT00852202|69574455|FG002|Overall Study|pregnancy,moving away and surgery|2|||
37889523|NCT01074008|69574473|FG000|Overall Study|Adverse Event|0|||
37889524|NCT01074008|69574474|FG001|Overall Study|Adverse Event|1|||
37889525|NCT01074008|69574475|FG002|Overall Study|Adverse Event|0|||
37889526|NCT01074008|69574476|FG003|Overall Study|Adverse Event|0|||
37889527|NCT01074008|69574477|FG004|Overall Study|Adverse Event|0|||
37889528|NCT01074008|69574478|FG005|Overall Study|Adverse Event|0|||
37889529|NCT01074008|69574479|FG006|Overall Study|Adverse Event|0|||
37889530|NCT01074008|69574480|FG007|Overall Study|Adverse Event|0|||
37889531|NCT01074008|69574481|FG008|Overall Study|Adverse Event|0|||
37889532|NCT01074008|69574473|FG000|Overall Study|Withdrawal by Subject|1|||
37889533|NCT01074008|69574474|FG001|Overall Study|Withdrawal by Subject|1|||
37889534|NCT01074008|69574475|FG002|Overall Study|Withdrawal by Subject|1|||
37889535|NCT01074008|69574476|FG003|Overall Study|Withdrawal by Subject|0|||
37988199|NCT00355134|69673510|FG000|Extension Phase|Administrative problems|2|||
37988200|NCT00355134|69673511|FG001|Extension Phase|Administrative problems|4|||
37988201|NCT00355134|69673512|FG002|Extension Phase|Administrative problems|0|||
37988202|NCT00355134|69673513|FG003|Extension Phase|Administrative problems|1|||
37988203|NCT00355134|69673514|FG004|Extension Phase|Administrative problems|1|||
37988204|NCT00355134|69673510|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
37988205|NCT00355134|69673511|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
37889536|NCT01074008|69574477|FG004|Overall Study|Withdrawal by Subject|1|||
37889537|NCT01074008|69574478|FG005|Overall Study|Withdrawal by Subject|0|||
37889538|NCT01074008|69574479|FG006|Overall Study|Withdrawal by Subject|0|||
37889539|NCT01074008|69574480|FG007|Overall Study|Withdrawal by Subject|0|||
37889540|NCT01074008|69574481|FG008|Overall Study|Withdrawal by Subject|0|||
37889541|NCT01074008|69574473|FG000|Overall Study|Lost to Follow-up|0|||
37889542|NCT01074008|69574474|FG001|Overall Study|Lost to Follow-up|1|||
37889543|NCT01074008|69574475|FG002|Overall Study|Lost to Follow-up|1|||
37889544|NCT01074008|69574476|FG003|Overall Study|Lost to Follow-up|1|||
37889545|NCT01074008|69574477|FG004|Overall Study|Lost to Follow-up|1|||
37889546|NCT01074008|69574478|FG005|Overall Study|Lost to Follow-up|0|||
37889547|NCT01074008|69574479|FG006|Overall Study|Lost to Follow-up|1|||
37889548|NCT01074008|69574480|FG007|Overall Study|Lost to Follow-up|0|||
37889549|NCT01074008|69574481|FG008|Overall Study|Lost to Follow-up|4|||
37889550|NCT01073930|69574512|FG000|Overall Study|Withdrawal by Subject|3|||
37988206|NCT00355134|69673512|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
37889551|NCT01073930|69574513|FG001|Overall Study|Withdrawal by Subject|2|||
37889552|NCT01073930|69574512|FG000|Overall Study|Lost to Follow-up|0|||
37889553|NCT01073930|69574513|FG001|Overall Study|Lost to Follow-up|1|||
37889554|NCT01073930|69574512|FG000|Overall Study|Adverse Event|0|||
37889555|NCT01073930|69574513|FG001|Overall Study|Adverse Event|1|||
37889556|NCT01073930|69574512|FG000|Overall Study|Noncompliance with study drug|0|||
37889557|NCT01073930|69574513|FG001|Overall Study|Noncompliance with study drug|1|||
37889558|NCT01073930|69574512|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
37889559|NCT01073930|69574513|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
37889560|NCT01073618|69574519|FG000|Overall Study|Death|208|||
37889561|NCT01073618|69574519|FG000|Overall Study|Adverse Event|19|||
37889562|NCT01073618|69574519|FG000|Overall Study|Other|80|||
37889563|NCT01073462|69574523|FG000|Overall Study|Death|14|||
37889564|NCT01073462|69574523|FG000|Overall Study|Kidney transplant|10|||
37889565|NCT01073462|69574523|FG000|Overall Study|Low parathyroid hormone levels|8|||
37889566|NCT01073462|69574523|FG000|Overall Study|Serious adverse event|2|||
37889567|NCT01073462|69574523|FG000|Overall Study|Lost to Follow-up|7|||
37889568|NCT00789373|69574527|FG000|Induction|Adverse Event|64|||
37889569|NCT00789373|69574528|FG001|Induction|Adverse Event|0|||
37889570|NCT00789373|69574529|FG002|Induction|Adverse Event|0|||
37889571|NCT00789373|69574527|FG000|Induction|Death Due to study disease|24|||
37889572|NCT00789373|69574528|FG001|Induction|Death Due to study disease|0|||
37889573|NCT00789373|69574529|FG002|Induction|Death Due to study disease|0|||
37889574|NCT00789373|69574527|FG000|Induction|Death due to adverse event|19|||
37889575|NCT00789373|69574528|FG001|Induction|Death due to adverse event|0|||
37889576|NCT00789373|69574529|FG002|Induction|Death due to adverse event|0|||
37889577|NCT00789373|69574527|FG000|Induction|Death due to toxicity|11|||
37889578|NCT00789373|69574528|FG001|Induction|Death due to toxicity|0|||
37889579|NCT00789373|69574529|FG002|Induction|Death due to toxicity|0|||
37889580|NCT00789373|69574527|FG000|Induction|Death due to procedure|1|||
37889581|NCT00789373|69574528|FG001|Induction|Death due to procedure|0|||
37889582|NCT00789373|69574529|FG002|Induction|Death due to procedure|0|||
37889583|NCT00789373|69574527|FG000|Induction|Investigator decision|7|||
37889584|NCT00789373|69574528|FG001|Induction|Investigator decision|0|||
37889585|NCT00789373|69574529|FG002|Induction|Investigator decision|0|||
37889586|NCT00789373|69574527|FG000|Induction|Protocol entry criteria not met|9|||
37889587|NCT00789373|69574528|FG001|Induction|Protocol entry criteria not met|0|||
37889588|NCT00789373|69574529|FG002|Induction|Protocol entry criteria not met|0|||
37889589|NCT00789373|69574527|FG000|Induction|Lost to Follow-up|6|||
37889590|NCT00789373|69574528|FG001|Induction|Lost to Follow-up|0|||
37889591|NCT00789373|69574529|FG002|Induction|Lost to Follow-up|0|||
37889592|NCT00789373|69574527|FG000|Induction|Protocol Violation|1|||
37889593|NCT00789373|69574528|FG001|Induction|Protocol Violation|0|||
37889594|NCT00789373|69574529|FG002|Induction|Protocol Violation|0|||
37889595|NCT00789373|69574527|FG000|Induction|Progressive Disease|220|||
37889596|NCT00789373|69574528|FG001|Induction|Progressive Disease|0|||
37889597|NCT00789373|69574529|FG002|Induction|Progressive Disease|0|||
37889598|NCT00789373|69574527|FG000|Induction|Withdrawal by Subject|37|||
37889599|NCT00789373|69574528|FG001|Induction|Withdrawal by Subject|0|||
37889600|NCT00789373|69574529|FG002|Induction|Withdrawal by Subject|0|||
37889601|NCT00789373|69574527|FG000|Maintenance|Adverse Event|0|||
37889602|NCT00789373|69574528|FG001|Maintenance|Adverse Event|65|||
37889603|NCT00789373|69574529|FG002|Maintenance|Adverse Event|12|||
37889604|NCT00789373|69574527|FG000|Maintenance|Death due to study disease|0|||
37889605|NCT00789373|69574528|FG001|Maintenance|Death due to study disease|3|||
37889606|NCT00789373|69574529|FG002|Maintenance|Death due to study disease|1|||
37889607|NCT00789373|69574527|FG000|Maintenance|Death due to adverse event|0|||
37889608|NCT00789373|69574528|FG001|Maintenance|Death due to adverse event|4|||
37988207|NCT00355134|69673513|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
37988208|NCT00355134|69673514|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
37988209|NCT00355134|69673510|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
37988210|NCT00355134|69673511|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
37988211|NCT00355134|69673512|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
37988212|NCT00355134|69673513|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
37988213|NCT00355134|69673514|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
37988214|NCT00355134|69673510|FG000|Extension Phase|Protocol Violation|0|||
37889609|NCT00789373|69574529|FG002|Maintenance|Death due to adverse event|1|||
37889610|NCT00789373|69574527|FG000|Maintenance|Death due to toxicity|0|||
37889611|NCT00789373|69574528|FG001|Maintenance|Death due to toxicity|1|||
37889612|NCT00789373|69574529|FG002|Maintenance|Death due to toxicity|2|||
37889613|NCT00789373|69574527|FG000|Maintenance|Investigator Decision|0|||
37889614|NCT00789373|69574528|FG001|Maintenance|Investigator Decision|4|||
37889615|NCT00789373|69574529|FG002|Maintenance|Investigator Decision|2|||
37889616|NCT00789373|69574527|FG000|Maintenance|Protocol entry criteria not met|0|||
37889617|NCT00789373|69574528|FG001|Maintenance|Protocol entry criteria not met|2|||
37889618|NCT00789373|69574529|FG002|Maintenance|Protocol entry criteria not met|0|||
37889619|NCT00789373|69574527|FG000|Maintenance|Lost to Follow-up|0|||
37988215|NCT00355134|69673511|FG001|Extension Phase|Protocol Violation|0|||
37889620|NCT00789373|69574528|FG001|Maintenance|Lost to Follow-up|2|||
37889621|NCT00789373|69574529|FG002|Maintenance|Lost to Follow-up|0|||
37889622|NCT00789373|69574527|FG000|Maintenance|Progressive Disease|0|||
37889623|NCT00789373|69574528|FG001|Maintenance|Progressive Disease|253|||
37889624|NCT00789373|69574529|FG002|Maintenance|Progressive Disease|152|||
37889625|NCT00789373|69574527|FG000|Maintenance|Withdrawal by Subject|0|||
37889626|NCT00789373|69574528|FG001|Maintenance|Withdrawal by Subject|21|||
37889627|NCT00789373|69574529|FG002|Maintenance|Withdrawal by Subject|8|||
37889628|NCT00789373|69574527|FG000|Maintenance|Sponsor Decision|0|||
37889629|NCT00789373|69574528|FG001|Maintenance|Sponsor Decision|0|||
37889630|NCT00789373|69574529|FG002|Maintenance|Sponsor Decision|2|||
37889631|NCT00789373|69574527|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
37889632|NCT00789373|69574528|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
37889633|NCT00789373|69574529|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
37889634|NCT00851890|69574544|FG000|Overall Study|Lost to Follow-up|0|||
37889635|NCT00851890|69574545|FG001|Overall Study|Lost to Follow-up|1|||
37889636|NCT00851890|69574546|FG002|Overall Study|Lost to Follow-up|0|||
37889637|NCT00851890|69574547|FG003|Overall Study|Lost to Follow-up|1|||
37889638|NCT00788827|69574557|FG000|Overall Study|Lack of Efficacy|2|||
37889639|NCT00592072|69574563|FG000|Wash Out Period|Lost to Follow-up|1|||
37889640|NCT00592072|69574564|FG001|Wash Out Period|Lost to Follow-up|1|||
37889641|NCT00792571|69574570|FG000|Overall Study|Death|1|||
37889642|NCT00792571|69574570|FG000|Overall Study|Adverse Event|4|||
37889643|NCT00792571|69574570|FG000|Overall Study|Withdrawal by Subject|1|||
37889644|NCT00792571|69574570|FG000|Overall Study|Other|4|||
37889645|NCT01069484|69574576|FG000|Overall Study|Death-in-near-family|1|||
37889646|NCT01069484|69574577|FG001|Overall Study|Death-in-near-family|0|||
37889647|NCT01069484|69574576|FG000|Overall Study|No specific reason|8|||
37889648|NCT01069484|69574577|FG001|Overall Study|No specific reason|2|||
37889649|NCT01069484|69574576|FG000|Overall Study|Illness mother or child|3|||
37889650|NCT01069484|69574577|FG001|Overall Study|Illness mother or child|1|||
37889651|NCT00794365|69574584|FG000|Overall Study|Lost to Follow-up|38|||
37889652|NCT00794365|69574584|FG000|Overall Study|Other|17|||
37889653|NCT00794365|69574584|FG000|Overall Study|Poor Compliance|11|||
37889654|NCT00794365|69574584|FG000|Overall Study|Adverse Event|10|||
37889655|NCT00794365|69574584|FG000|Overall Study|Lack of Efficacy|3|||
37889656|NCT01067144|69574590|FG000|Treatment|Did not receive allocated intervention|4|||
37889657|NCT01067144|69574591|FG001|Treatment|Did not receive allocated intervention|7|||
37889658|NCT01067144|69574590|FG000|Follow-up|Lost to Follow-up|22|||
37889659|NCT01067144|69574591|FG001|Follow-up|Lost to Follow-up|12|||
37889660|NCT01067144|69574590|FG000|Follow-up|Censored owing to second surgery|19|||
37889661|NCT01067144|69574591|FG001|Follow-up|Censored owing to second surgery|28|||
37889662|NCT01067144|69574590|FG000|Follow-up|Withdrawal by Subject|18|||
37889663|NCT01067144|69574591|FG001|Follow-up|Withdrawal by Subject|14|||
37889664|NCT01067144|69574590|FG000|Follow-up|Surgery cancelled|0|||
37889665|NCT01067144|69574591|FG001|Follow-up|Surgery cancelled|1|||
37889666|NCT01067144|69574590|FG000|Follow-up|Death|0|||
37889667|NCT01067144|69574591|FG001|Follow-up|Death|1|||
37889668|NCT01078298|69574599|FG000|Overall Study|Lost to Follow-up|12|||
37889669|NCT01078298|69574600|FG001|Overall Study|Lost to Follow-up|13|||
37889670|NCT01078298|69574599|FG000|Overall Study|Withdrawal by Subject|31|||
37889671|NCT01078298|69574600|FG001|Overall Study|Withdrawal by Subject|33|||
37889672|NCT01078298|69574599|FG000|Overall Study|Protocol Violation|6|||
37889673|NCT01078298|69574600|FG001|Overall Study|Protocol Violation|6|||
37889674|NCT01078298|69574599|FG000|Overall Study|Adverse Event|6|||
37889675|NCT01078298|69574600|FG001|Overall Study|Adverse Event|5|||
37889676|NCT01078298|69574599|FG000|Overall Study|Death|2|||
37889677|NCT01078298|69574600|FG001|Overall Study|Death|0|||
37889678|NCT01078298|69574599|FG000|Overall Study|Did not meet entrance criteria|0|||
37889679|NCT01078298|69574600|FG001|Overall Study|Did not meet entrance criteria|1|||
37889680|NCT01078298|69574599|FG000|Overall Study|Other|24|||
37889681|NCT01078298|69574600|FG001|Overall Study|Other|32|||
37889682|NCT00788593|69574606|FG000|Placebo Run-in Phase|Adverse Event|2|||
37889683|NCT00788593|69574607|FG001|Placebo Run-in Phase|Adverse Event|0|||
37889684|NCT00788593|69574608|FG002|Placebo Run-in Phase|Adverse Event|0|||
37889685|NCT00788593|69574606|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
37889686|NCT00788593|69574607|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
37889687|NCT00788593|69574608|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
37889688|NCT00788593|69574606|FG000|Placebo Run-in Phase|Protocol Violation|2|||
37889689|NCT00788593|69574607|FG001|Placebo Run-in Phase|Protocol Violation|0|||
37889690|NCT00788593|69574608|FG002|Placebo Run-in Phase|Protocol Violation|0|||
37889691|NCT00788593|69574606|FG000|First Intervention Period|Adverse Event|0|||
37889692|NCT00788593|69574607|FG001|First Intervention Period|Adverse Event|1|||
37889693|NCT00788593|69574608|FG002|First Intervention Period|Adverse Event|0|||
37889694|NCT00788593|69574606|FG000|Second Intervention Period|Lost to Follow-up|0|||
37889695|NCT00788593|69574607|FG001|Second Intervention Period|Lost to Follow-up|1|||
37889696|NCT00788593|69574608|FG002|Second Intervention Period|Lost to Follow-up|0|||
37889697|NCT00788593|69574606|FG000|Second Intervention Period|Other|0|||
37889698|NCT00788593|69574607|FG001|Second Intervention Period|Other|0|||
37889699|NCT00788593|69574608|FG002|Second Intervention Period|Other|1|||
37889700|NCT00793819|69574620|FG000|Overall Study|Adverse Event|8|||
37889701|NCT00793819|69574621|FG001|Overall Study|Adverse Event|4|||
37889702|NCT00793819|69574620|FG000|Overall Study|Lack of Efficacy|1|||
37889703|NCT00793819|69574621|FG001|Overall Study|Lack of Efficacy|1|||
37889704|NCT00793819|69574620|FG000|Overall Study|Withdrawal by Subject|4|||
37889705|NCT00793819|69574621|FG001|Overall Study|Withdrawal by Subject|3|||
37889706|NCT00793819|69574620|FG000|Overall Study|Lost to Follow-up|1|||
37889707|NCT00793819|69574621|FG001|Overall Study|Lost to Follow-up|1|||
37889708|NCT00792259|69574630|FG000|Overall Study|Poor Quality Scans|1|||
37889709|NCT00792259|69574631|FG001|Overall Study|Poor Quality Scans|0|||
37889710|NCT00792259|69574632|FG002|Overall Study|Poor Quality Scans|0|||
37889711|NCT00894387|69574642|FG000|Overall Study|Adverse Event|44|||
37889712|NCT00894387|69574643|FG001|Overall Study|Adverse Event|45|||
37889713|NCT00894387|69574642|FG000|Overall Study|Abnormal Laboratory values|2|||
37889714|NCT00894387|69574643|FG001|Overall Study|Abnormal Laboratory values|2|||
37889715|NCT00894387|69574642|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
37889716|NCT00894387|69574643|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
37889717|NCT00894387|69574642|FG000|Overall Study|Lost to Follow-up|3|||
37889718|NCT00894387|69574643|FG001|Overall Study|Lost to Follow-up|5|||
37889719|NCT00894387|69574642|FG000|Overall Study|Administrative problems|2|||
37889720|NCT00894387|69574643|FG001|Overall Study|Administrative problems|2|||
37889721|NCT00894387|69574642|FG000|Overall Study|Death|77|||
37889722|NCT00894387|69574643|FG001|Overall Study|Death|76|||
37889723|NCT00894387|69574642|FG000|Overall Study|Protocol Deviation|4|||
37889724|NCT00894387|69574643|FG001|Overall Study|Protocol Deviation|0|||
37889725|NCT00894387|69574642|FG000|Overall Study|Patient's request|25|||
37823454|NCT01349673|69504817|FG000|Overall Study|Lost to Follow-up|6|||
37823455|NCT01349673|69504817|FG000|Overall Study|Adverse Event|17|||
37823456|NCT01349673|69504817|FG000|Overall Study|Study Terminated By Sponsor|50|||
37889726|NCT00894387|69574643|FG001|Overall Study|Patient's request|30|||
37889727|NCT00894387|69574642|FG000|Overall Study|Other (Missing)|5|||
37889728|NCT00894387|69574643|FG001|Overall Study|Other (Missing)|3|||
37889729|NCT00894387|69574642|FG000|Overall Study|Mis-randomized|13|||
37889730|NCT00894387|69574643|FG001|Overall Study|Mis-randomized|9|||
37889731|NCT00894387|69574642|FG000|Overall Study|GCP non-compliance|0|||
37889732|NCT00894387|69574643|FG001|Overall Study|GCP non-compliance|2|||
37889733|NCT00928512|69574654|FG000|Overall Study|Adverse Event|4|||
37889734|NCT00928512|69574655|FG001|Overall Study|Adverse Event|3|||
37889735|NCT00928512|69574656|FG002|Overall Study|Adverse Event|2|||
37889736|NCT00928512|69574657|FG003|Overall Study|Adverse Event|8|||
37889737|NCT00928512|69574658|FG004|Overall Study|Adverse Event|6|||
37889738|NCT00928512|69574654|FG000|Overall Study|Lack of Efficacy|2|||
37889739|NCT00928512|69574655|FG001|Overall Study|Lack of Efficacy|0|||
37889740|NCT00928512|69574656|FG002|Overall Study|Lack of Efficacy|4|||
37823457|NCT01349673|69504817|FG000|Overall Study|Lack of Efficacy|8|||
37823458|NCT04725682|69504847|FG000|Overall Study|Withdrawal by Subject|7|||
37823459|NCT04725682|69504848|FG001|Overall Study|Withdrawal by Subject|5|||
37823460|NCT04725682|69504847|FG000|Overall Study|Failed to comply with the requirements|2|||
37823461|NCT04725682|69504848|FG001|Overall Study|Failed to comply with the requirements|1|||
37823462|NCT04725682|69504847|FG000|Overall Study|Adverse Event|1|||
37889741|NCT00928512|69574657|FG003|Overall Study|Lack of Efficacy|7|||
37889742|NCT00928512|69574658|FG004|Overall Study|Lack of Efficacy|3|||
37889743|NCT00928512|69574654|FG000|Overall Study|Protocol Violation|0|||
37889744|NCT00928512|69574655|FG001|Overall Study|Protocol Violation|1|||
37889745|NCT00928512|69574656|FG002|Overall Study|Protocol Violation|0|||
37823463|NCT04725682|69504848|FG001|Overall Study|Adverse Event|1|||
37823464|NCT04725682|69504847|FG000|Overall Study|Death|0|||
37889746|NCT00928512|69574657|FG003|Overall Study|Protocol Violation|1|||
37889747|NCT00928512|69574658|FG004|Overall Study|Protocol Violation|3|||
37889748|NCT00928512|69574654|FG000|Overall Study|Withdrawal by Subject|3|||
37889749|NCT00928512|69574655|FG001|Overall Study|Withdrawal by Subject|0|||
37889750|NCT00928512|69574656|FG002|Overall Study|Withdrawal by Subject|3|||
37889751|NCT00928512|69574657|FG003|Overall Study|Withdrawal by Subject|4|||
37889752|NCT00928512|69574658|FG004|Overall Study|Withdrawal by Subject|0|||
37889753|NCT00928512|69574654|FG000|Overall Study|Lost to Follow-up|1|||
37889754|NCT00928512|69574655|FG001|Overall Study|Lost to Follow-up|1|||
37889755|NCT00928512|69574656|FG002|Overall Study|Lost to Follow-up|2|||
37889756|NCT00928512|69574657|FG003|Overall Study|Lost to Follow-up|1|||
37889757|NCT00928512|69574658|FG004|Overall Study|Lost to Follow-up|3|||
37889758|NCT00928512|69574654|FG000|Overall Study|Administrative Problems|0|||
37889759|NCT00928512|69574655|FG001|Overall Study|Administrative Problems|1|||
37889760|NCT00928512|69574656|FG002|Overall Study|Administrative Problems|0|||
37889761|NCT00928512|69574657|FG003|Overall Study|Administrative Problems|0|||
37889762|NCT00928512|69574658|FG004|Overall Study|Administrative Problems|0|||
37889763|NCT00787891|69574676|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
37889764|NCT00787891|69574677|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
37889765|NCT00787891|69574676|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
37889766|NCT00787891|69574677|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
37889767|NCT00787891|69574676|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
37889768|NCT00787891|69574677|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
37889769|NCT00787891|69574676|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
37889770|NCT00787891|69574677|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
37889771|NCT00787891|69574676|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
37889772|NCT00787891|69574677|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
37889773|NCT00787891|69574676|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
37889774|NCT00787891|69574677|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
37889775|NCT00787891|69574676|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
37889776|NCT00787891|69574677|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
37889777|NCT00787891|69574676|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
37889778|NCT00787891|69574677|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
37889779|NCT00787891|69574676|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
37889780|NCT00787891|69574677|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
37889781|NCT00787891|69574676|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
37889782|NCT00787891|69574677|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
37889783|NCT00892437|69574687|FG000|Randomized Phase|Randomized but not treated|6|||
37889784|NCT00892437|69574688|FG001|Randomized Phase|Randomized but not treated|0|||
37889785|NCT00892437|69574687|FG000|Randomized Phase|Adverse Event|2|||
37889786|NCT00892437|69574688|FG001|Randomized Phase|Adverse Event|2|||
37889787|NCT00892437|69574687|FG000|Randomized Phase|Lost to Follow-up|1|||
37889788|NCT00892437|69574688|FG001|Randomized Phase|Lost to Follow-up|3|||
37889789|NCT00892437|69574687|FG000|Randomized Phase|Investigator's Discretion|1|||
37889790|NCT00892437|69574688|FG001|Randomized Phase|Investigator's Discretion|0|||
37889791|NCT00892437|69574687|FG000|Randomized Phase|Withdrew Consent|1|||
37889792|NCT00892437|69574688|FG001|Randomized Phase|Withdrew Consent|0|||
37889793|NCT00892437|69574687|FG000|Open-Label Extension Phase|Adverse Event|4|||
37889794|NCT00892437|69574688|FG001|Open-Label Extension Phase|Adverse Event|2|||
37889795|NCT00892437|69574687|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
37889796|NCT00892437|69574688|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
37889797|NCT00892437|69574687|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
37889798|NCT00892437|69574688|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
37889799|NCT00892437|69574687|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
37889800|NCT00892437|69574688|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
37889801|NCT00892437|69574687|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
37889802|NCT00892437|69574688|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
37889803|NCT00792103|69574695|FG000|Overall Study|Enrolled, not treated|15|||
37889804|NCT00792103|69574695|FG000|Overall Study|Lost to Follow-up|17|||
37889805|NCT00792103|69574695|FG000|Overall Study|Adverse Event|25|||
37889806|NCT00792103|69574695|FG000|Overall Study|Withdrawal by Subject|52|||
37889807|NCT00792103|69574695|FG000|Overall Study|Protocol Violation|10|||
37889808|NCT00792103|69574695|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
37889809|NCT00892281|69574701|FG000|Overall Study|Adverse Event|65|||
37889810|NCT00892281|69574702|FG001|Overall Study|Adverse Event|8|||
37889811|NCT00892281|69574701|FG000|Overall Study|Lost to Follow-up|81|||
37889812|NCT00892281|69574702|FG001|Overall Study|Lost to Follow-up|8|||
37889813|NCT00892281|69574701|FG000|Overall Study|Pregnancy|1|||
37889814|NCT00892281|69574702|FG001|Overall Study|Pregnancy|0|||
37889815|NCT00892281|69574701|FG000|Overall Study|Protocol Violation|7|||
37889816|NCT00892281|69574702|FG001|Overall Study|Protocol Violation|2|||
37889817|NCT00892281|69574701|FG000|Overall Study|Withdrawal by Subject|86|||
37889818|NCT00892281|69574702|FG001|Overall Study|Withdrawal by Subject|14|||
37889819|NCT00892281|69574701|FG000|Overall Study|Subject failed to return for final visit|2|||
37889820|NCT00892281|69574702|FG001|Overall Study|Subject failed to return for final visit|0|||
37889821|NCT00892281|69574701|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
37889822|NCT00892281|69574702|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
37889823|NCT00892281|69574701|FG000|Overall Study|Final visit completed 4 weeks late|0|||
37889824|NCT00892281|69574702|FG001|Overall Study|Final visit completed 4 weeks late|1|||
37889825|NCT00892281|69574701|FG000|Overall Study|Subject completed day after study closed|1|||
37889826|NCT00892281|69574702|FG001|Overall Study|Subject completed day after study closed|0|||
37889827|NCT00892281|69574701|FG000|Overall Study|Family emergency|1|||
37889828|NCT00892281|69574702|FG001|Overall Study|Family emergency|0|||
37889829|NCT00892281|69574701|FG000|Overall Study|Last visit not done - death in family|1|||
37889830|NCT00892281|69574702|FG001|Overall Study|Last visit not done - death in family|0|||
37889831|NCT00892281|69574701|FG000|Overall Study|Did not meet incl/excl criteria|1|||
37889832|NCT00892281|69574702|FG001|Overall Study|Did not meet incl/excl criteria|0|||
37889833|NCT00892281|69574701|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
37889834|NCT00892281|69574702|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
37889835|NCT00892281|69574701|FG000|Overall Study|Unable to redeem the drug voucher|1|||
37889836|NCT00892281|69574702|FG001|Overall Study|Unable to redeem the drug voucher|0|||
37889837|NCT00892281|69574701|FG000|Overall Study|Subject not good candidate for study|1|||
37889838|NCT00892281|69574702|FG001|Overall Study|Subject not good candidate for study|0|||
37889839|NCT00892281|69574701|FG000|Overall Study|Subject did not return for any visits|1|||
37889840|NCT00892281|69574702|FG001|Overall Study|Subject did not return for any visits|0|||
37889841|NCT00892281|69574701|FG000|Overall Study|Subject missed several visits/lost meds|1|||
37889842|NCT00892281|69574702|FG001|Overall Study|Subject missed several visits/lost meds|0|||
37889843|NCT00892281|69574701|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
37889844|NCT00892281|69574702|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
37889845|NCT00892281|69574701|FG000|Overall Study|Scheduled for knee replacement|0|||
37889846|NCT00892281|69574702|FG001|Overall Study|Scheduled for knee replacement|1|||
37889847|NCT00892281|69574701|FG000|Overall Study|PI complained of inadequate compensation|3|||
37889848|NCT00892281|69574702|FG001|Overall Study|PI complained of inadequate compensation|0|||
37889849|NCT00892281|69574701|FG000|Overall Study|Subject lost interest in program|0|||
37889850|NCT00892281|69574702|FG001|Overall Study|Subject lost interest in program|1|||
37889851|NCT00892281|69574701|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
37889852|NCT00892281|69574702|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
37889853|NCT00892281|69574701|FG000|Overall Study|Death in family|1|||
37889854|NCT00892281|69574702|FG001|Overall Study|Death in family|0|||
37889855|NCT00892281|69574701|FG000|Overall Study|Lack of efficacy of study product|2|||
37889856|NCT00892281|69574702|FG001|Overall Study|Lack of efficacy of study product|0|||
37889857|NCT00892281|69574701|FG000|Overall Study|Subject not seen by PI at final visit|1|||
37889858|NCT00892281|69574702|FG001|Overall Study|Subject not seen by PI at final visit|0|||
37889859|NCT00892281|69574701|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
37889860|NCT00892281|69574702|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
37889861|NCT00892281|69574701|FG000|Overall Study|Missed multiple visits|1|||
37889862|NCT00892281|69574702|FG001|Overall Study|Missed multiple visits|0|||
37889863|NCT00892281|69574701|FG000|Overall Study|Missed visits rescheduled out of window|1|||
37988216|NCT00355134|69673512|FG002|Extension Phase|Protocol Violation|0|||
37889864|NCT00892281|69574702|FG001|Overall Study|Missed visits rescheduled out of window|0|||
37889865|NCT00892281|69574701|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
37889866|NCT00892281|69574702|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
37889867|NCT00892281|69574701|FG000|Overall Study|Subject had history of drug abuse|1|||
37889868|NCT00892281|69574702|FG001|Overall Study|Subject had history of drug abuse|0|||
37889869|NCT00892281|69574701|FG000|Overall Study|Rash on hand|1|||
37889870|NCT00892281|69574702|FG001|Overall Study|Rash on hand|0|||
37889871|NCT00892281|69574701|FG000|Overall Study|Visit 4 date out of window|1|||
37889872|NCT00892281|69574702|FG001|Overall Study|Visit 4 date out of window|0|||
37988217|NCT00355134|69673513|FG003|Extension Phase|Protocol Violation|1|||
37889873|NCT00784693|69574710|FG000|Overall Study|Lost to Follow-up|0|||
37889874|NCT00784693|69574711|FG001|Overall Study|Lost to Follow-up|1|||
37889875|NCT00784693|69574710|FG000|Overall Study|Lack of Efficacy|1|||
37889876|NCT00784693|69574711|FG001|Overall Study|Lack of Efficacy|1|||
37889877|NCT00784693|69574710|FG000|Overall Study|Withdrawal by Subject|0|||
37889878|NCT00784693|69574711|FG001|Overall Study|Withdrawal by Subject|4|||
37889879|NCT00784693|69574710|FG000|Overall Study|Randomized but not Treated|1|||
37889880|NCT00784693|69574711|FG001|Overall Study|Randomized but not Treated|0|||
37889881|NCT00784693|69574710|FG000|Overall Study|Other|1|||
37889882|NCT00784693|69574711|FG001|Overall Study|Other|0|||
37889883|NCT00893763|69574719|FG000|Overall Study|extubated|110|||
37889884|NCT00893763|69574720|FG001|Overall Study|extubated|110|||
37889885|NCT00892047|69574730|FG000|Overall Study|Adverse Event|2|||
37889886|NCT00892047|69574731|FG001|Overall Study|Adverse Event|2|||
37889887|NCT00892047|69574730|FG000|Overall Study|subject burden|2|||
37889888|NCT00892047|69574731|FG001|Overall Study|subject burden|3|||
37889889|NCT00892047|69574730|FG000|Overall Study|Lack of Efficacy|0|||
37889890|NCT00892047|69574731|FG001|Overall Study|Lack of Efficacy|2|||
37889891|NCT00787267|69574739|FG000|Overall Study|Screen failure/Ineligible|10|||
37889892|NCT00787267|69574739|FG000|Overall Study|No Reason Provided|1|||
37889893|NCT00787267|69574739|FG000|Overall Study|Withdrawal by Subject|1|||
37889894|NCT00928434|69574746|FG000|Overall Study|Adverse Event|14|||
37889895|NCT00928434|69574747|FG001|Overall Study|Adverse Event|5|||
37889896|NCT00928434|69574748|FG002|Overall Study|Adverse Event|18|||
37889897|NCT00928434|69574746|FG000|Overall Study|Protocol Violation|5|||
37889898|NCT00928434|69574747|FG001|Overall Study|Protocol Violation|0|||
37889899|NCT00928434|69574748|FG002|Overall Study|Protocol Violation|8|||
37889900|NCT00928434|69574746|FG000|Overall Study|Physician Decision|2|||
37889901|NCT00928434|69574747|FG001|Overall Study|Physician Decision|0|||
37889902|NCT00928434|69574748|FG002|Overall Study|Physician Decision|3|||
37889903|NCT00928434|69574746|FG000|Overall Study|Lost to Follow-up|1|||
37889904|NCT00928434|69574747|FG001|Overall Study|Lost to Follow-up|0|||
37889905|NCT00928434|69574748|FG002|Overall Study|Lost to Follow-up|3|||
37889906|NCT00928434|69574746|FG000|Overall Study|Withdrawal by Subject|5|||
37889907|NCT00928434|69574747|FG001|Overall Study|Withdrawal by Subject|3|||
37889908|NCT00928434|69574748|FG002|Overall Study|Withdrawal by Subject|2|||
37889909|NCT00928434|69574746|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
37889910|NCT00928434|69574747|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
37889911|NCT00928434|69574748|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
37889912|NCT00928434|69574746|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
37889913|NCT00928434|69574747|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
37889914|NCT00928434|69574748|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
37889915|NCT00928434|69574746|FG000|Overall Study|Other (not meeting above criteria)|5|||
37889916|NCT00928434|69574747|FG001|Overall Study|Other (not meeting above criteria)|1|||
37889917|NCT00928434|69574748|FG002|Overall Study|Other (not meeting above criteria)|2|||
37889918|NCT00787189|69574766|FG000|Overall Study|Lost to Follow-up|2|||
37889919|NCT00787189|69574767|FG001|Overall Study|Lost to Follow-up|2|||
37889920|NCT00784459|69574775|FG000|Overall Study|Adverse Event|0|||
37889921|NCT00784459|69574776|FG001|Overall Study|Adverse Event|2|||
37889922|NCT00786799|69574784|FG000|Overall Study|Lost to Follow-up|1|||
37889923|NCT00786799|69574785|FG001|Overall Study|Lost to Follow-up|1|||
37889924|NCT00786565|69574796|FG000|Enrollment Prior to Surgery|Site Closed|3|||
37889925|NCT00786565|69574796|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
37889926|NCT00786565|69574796|FG000|Post Surgery|Abnormal macular pucker|1|||
37889927|NCT00786565|69574796|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
37889928|NCT00784147|69574804|FG000|Overall Study|Lost to Follow-up|2|||
37889929|NCT00784147|69574805|FG001|Overall Study|Lost to Follow-up|4|||
37889930|NCT00784147|69574804|FG000|Overall Study|Withdrawal by Subject|1|||
37889931|NCT00784147|69574805|FG001|Overall Study|Withdrawal by Subject|3|||
37889932|NCT00784147|69574804|FG000|Overall Study|Physician Decision|2|||
37889933|NCT00784147|69574805|FG001|Overall Study|Physician Decision|1|||
37889934|NCT00784147|69574804|FG000|Overall Study|Protocol Violation|1|||
37889935|NCT00784147|69574805|FG001|Overall Study|Protocol Violation|1|||
37889936|NCT00784147|69574804|FG000|Overall Study|Death|2|||
37889937|NCT00784147|69574805|FG001|Overall Study|Death|0|||
37889938|NCT00891813|69574811|FG000|Overall Study|Adverse Event|3|||
37889939|NCT00891813|69574811|FG000|Overall Study|Withdrawal by Subject|1|||
37889940|NCT00891813|69574811|FG000|Overall Study|Patient Noncompliance|6|||
37889941|NCT00891813|69574811|FG000|Overall Study|Protocol Violation|2|||
37889942|NCT00783835|69574828|FG000|Overall Study|Adverse Event|3|||
37889943|NCT00783835|69574828|FG000|Overall Study|Medical Criteria|1|||
37889944|NCT00783835|69574828|FG000|Overall Study|Withdrawal by Subject|2|||
37889945|NCT00783835|69574828|FG000|Overall Study|Lost to Follow-up|1|||
37889946|NCT00783835|69574828|FG000|Overall Study|Participant not Adherent|3|||
37889947|NCT00783289|69574836|FG000|Overall Study|Protocol Violation|0|||
37889948|NCT00783289|69574837|FG001|Overall Study|Protocol Violation|1|||
37889949|NCT00783289|69574838|FG002|Overall Study|Protocol Violation|0|||
37889950|NCT00783289|69574839|FG003|Overall Study|Protocol Violation|0|||
37889951|NCT00847912|69574854|FG000|Overall Study|Protocol Violation|6|||
37889952|NCT00847912|69574855|FG001|Overall Study|Protocol Violation|7|||
37889953|NCT00847912|69574854|FG000|Overall Study|Withdrawal by Subject|3|||
37889954|NCT00847912|69574855|FG001|Overall Study|Withdrawal by Subject|6|||
37889955|NCT00850564|69574862|FG000|Overall Study|Withdrawal by Subject|2|||
37889956|NCT00837148|69574866|FG000|Overall Study|Adverse Event|1|||
37889957|NCT00837148|69574866|FG000|Overall Study|Death|1|||
37889958|NCT00849940|69574870|FG000|Overall Study|Physician Decision|4|||
37889959|NCT00849472|69574874|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
37889960|NCT00849472|69574874|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
37889961|NCT00849472|69574874|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
37889962|NCT00849472|69574874|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
37889963|NCT00849472|69574874|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
37889964|NCT00849472|69574874|FG000|Weekly Paclitaxel|Disease Progression|1|||
37889965|NCT00849472|69574874|FG000|Weekly Paclitaxel|Adverse Event|11|||
37889966|NCT00849472|69574874|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
37889967|NCT00849472|69574874|FG000|Weekly Paclitaxel|Physician Decision|3|||
37889968|NCT00849472|69574874|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
37889969|NCT00849472|69574874|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
37889970|NCT00849472|69574874|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
37889971|NCT00849472|69574874|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
37889972|NCT00849472|69574874|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
37889973|NCT00849472|69574874|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
37889974|NCT00849472|69574874|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
37889975|NCT00849472|69574874|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
37889976|NCT00782509|69574882|FG000|Overall Study|Adverse Event|20|||
37889977|NCT00782509|69574883|FG001|Overall Study|Adverse Event|10|||
37889978|NCT00782509|69574884|FG002|Overall Study|Adverse Event|20|||
37889979|NCT00782509|69574882|FG000|Overall Study|Lost to Follow-up|1|||
37889980|NCT00782509|69574883|FG001|Overall Study|Lost to Follow-up|2|||
37889981|NCT00782509|69574884|FG002|Overall Study|Lost to Follow-up|3|||
37889982|NCT00782509|69574882|FG000|Overall Study|Withdrawal by Subject|3|||
37889983|NCT00782509|69574883|FG001|Overall Study|Withdrawal by Subject|5|||
37889984|NCT00782509|69574884|FG002|Overall Study|Withdrawal by Subject|8|||
37889985|NCT00782509|69574882|FG000|Overall Study|Non compliance with protocol|2|||
37889986|NCT00782509|69574883|FG001|Overall Study|Non compliance with protocol|0|||
37889987|NCT00782509|69574884|FG002|Overall Study|Non compliance with protocol|0|||
37889988|NCT00782509|69574882|FG000|Overall Study|Other reasons not stated above|5|||
37889989|NCT00782509|69574883|FG001|Overall Study|Other reasons not stated above|2|||
37889990|NCT00782509|69574884|FG002|Overall Study|Other reasons not stated above|3|||
37889991|NCT00782509|69574882|FG000|Overall Study|Lack of Efficacy|10|||
37889992|NCT00782509|69574883|FG001|Overall Study|Lack of Efficacy|5|||
37889993|NCT00782509|69574884|FG002|Overall Study|Lack of Efficacy|2|||
37889994|NCT00927810|69574903|FG000|Overall Study|Withdrawal by Subject|0|||
37889995|NCT00927810|69574904|FG001|Overall Study|Withdrawal by Subject|3|||
37889996|NCT00927810|69574905|FG002|Overall Study|Withdrawal by Subject|0|||
37889997|NCT00927810|69574906|FG003|Overall Study|Withdrawal by Subject|1|||
37889998|NCT00927810|69574903|FG000|Overall Study|Lost to Follow-up|0|||
37889999|NCT00927810|69574904|FG001|Overall Study|Lost to Follow-up|2|||
37890000|NCT00927810|69574905|FG002|Overall Study|Lost to Follow-up|1|||
37890001|NCT00927810|69574906|FG003|Overall Study|Lost to Follow-up|1|||
37890002|NCT00927810|69574903|FG000|Overall Study|Death|0|||
37890003|NCT00927810|69574904|FG001|Overall Study|Death|2|||
37890004|NCT00927810|69574905|FG002|Overall Study|Death|0|||
37890005|NCT00927810|69574906|FG003|Overall Study|Death|0|||
37890006|NCT00927810|69574903|FG000|Overall Study|Abnormal laboratory value(s)|0|||
37890007|NCT00927810|69574904|FG001|Overall Study|Abnormal laboratory value(s)|1|||
37890008|NCT00927810|69574905|FG002|Overall Study|Abnormal laboratory value(s)|0|||
37890009|NCT00927810|69574906|FG003|Overall Study|Abnormal laboratory value(s)|0|||
37890010|NCT00848926|69574924|FG000|Treatment Period|Progressive disease|45|||
37890011|NCT00848926|69574924|FG000|Treatment Period|Adverse Event|20|||
37988218|NCT00355134|69673514|FG004|Extension Phase|Protocol Violation|0|||
37890012|NCT00848926|69574924|FG000|Treatment Period|Physician Decision|12|||
37890013|NCT00848926|69574924|FG000|Treatment Period|Withdrawal by Subject|7|||
37988219|NCT00171730|69673524|FG000|Overall Study|Adverse Event|3|||
37890014|NCT00848926|69574924|FG000|Follow-up Period|Lost to Follow-up|7|||
37890015|NCT00848926|69574924|FG000|Follow-up Period|Withdrawal by Subject|3|||
37890016|NCT00848926|69574924|FG000|Follow-up Period|Other|2|||
37890017|NCT00847132|69574930|FG000|Overall Study|Death|1|||
37890018|NCT00847132|69574931|FG001|Overall Study|Death|1|||
37988220|NCT00171730|69673524|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
37988221|NCT00171730|69673524|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
37823465|NCT04725682|69504848|FG001|Overall Study|Death|1|||
37823466|NCT01349660|69504880|FG000|Overall Study|Still Receiving Study Treatment|0|||
37823467|NCT01349660|69504881|FG001|Overall Study|Still Receiving Study Treatment|0|||
37823468|NCT01349660|69504882|FG002|Overall Study|Still Receiving Study Treatment|1|||
37823469|NCT01349660|69504880|FG000|Overall Study|Disease Progression|2|||
37823470|NCT01349660|69504881|FG001|Overall Study|Disease Progression|4|||
37823471|NCT01349660|69504882|FG002|Overall Study|Disease Progression|50|||
37823472|NCT01349660|69504880|FG000|Overall Study|Adverse Event|1|||
37988222|NCT00171730|69673524|FG000|Overall Study|Withdrawal by Subject|3|||
37988223|NCT00355056|69673536|FG000|Randomization Period|Early Termination|4|||
37988224|NCT00355056|69673537|FG001|Randomization Period|Early Termination|6|||
37988225|NCT00348348|69673553|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
37988226|NCT00348348|69673554|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
37890019|NCT00918138|69574939|FG000|Overall Study|Subject withdrew consent|1|||
37890020|NCT00918138|69574940|FG001|Overall Study|Subject withdrew consent|1|||
37890021|NCT00918138|69574939|FG000|Overall Study|Death|1|||
37890022|NCT00918138|69574940|FG001|Overall Study|Death|0|||
37890023|NCT00782275|69574946|FG000|Overall Study|Adverse Event|11|||
37890024|NCT00782275|69574946|FG000|Overall Study|Withdrawal by Subject|1|||
37890025|NCT00782275|69574946|FG000|Overall Study|Progressive Disease|21|||
37890026|NCT00782275|69574946|FG000|Overall Study|Physician Decision|4|||
37890027|NCT00782275|69574946|FG000|Overall Study|Not started treatment|1|||
37890028|NCT00782275|69574946|FG000|Overall Study|Other|3|||
37890029|NCT00791557|69574950|FG000|Overall Study|Adverse Event|1|||
37890030|NCT00920790|69574954|FG000|Overall Study|aggravation of general condition|14|||
37890031|NCT00781963|69574960|FG000|Overall Study|Death|3|||
37988227|NCT00348348|69673553|FG000|Overall Study|Lack of Efficacy|1|||
37823473|NCT01349660|69504881|FG001|Overall Study|Adverse Event|1|||
37823474|NCT01349660|69504882|FG002|Overall Study|Adverse Event|12|||
37823475|NCT01349660|69504880|FG000|Overall Study|Withdrawal by Subject|2|||
37823476|NCT01349660|69504881|FG001|Overall Study|Withdrawal by Subject|0|||
37823477|NCT01349660|69504882|FG002|Overall Study|Withdrawal by Subject|9|||
37823478|NCT01349660|69504880|FG000|Overall Study|Death|1|||
37823479|NCT01349660|69504881|FG001|Overall Study|Death|1|||
37823480|NCT01349660|69504882|FG002|Overall Study|Death|0|||
37823481|NCT01349660|69504880|FG000|Overall Study|Non-Permitted Interventions|0|||
37823482|NCT01349660|69504881|FG001|Overall Study|Non-Permitted Interventions|0|||
37823483|NCT01349660|69504882|FG002|Overall Study|Non-Permitted Interventions|2|||
37823484|NCT01349660|69504880|FG000|Overall Study|Study Compliance|0|||
37823485|NCT01349660|69504881|FG001|Overall Study|Study Compliance|0|||
37823486|NCT01349660|69504882|FG002|Overall Study|Study Compliance|1|||
37823487|NCT01349660|69504880|FG000|Overall Study|Declining Performance Status|0|||
37823488|NCT01349660|69504881|FG001|Overall Study|Declining Performance Status|0|||
37823489|NCT01349660|69504882|FG002|Overall Study|Declining Performance Status|1|||
37823490|NCT01349569|69504901|FG000|Overall Study|Lack of Efficacy|4|||
37823491|NCT05221749|69504952|FG000|Overall Study|Lost to Follow-up|2|||
37823492|NCT05221749|69504953|FG001|Overall Study|Lost to Follow-up|3|||
37890032|NCT00781963|69574961|FG001|Overall Study|Death|0|||
37890033|NCT00781963|69574960|FG000|Overall Study|Lost to Follow-up|2|||
37823493|NCT04965389|69505007|FG000|Overall Study|Other reasons|1|||
37823494|NCT04965389|69505008|FG001|Overall Study|Other reasons|0|||
37988228|NCT00348348|69673554|FG001|Overall Study|Lack of Efficacy|1|||
37890034|NCT00781963|69574961|FG001|Overall Study|Lost to Follow-up|1|||
37890035|NCT00781963|69574960|FG000|Overall Study|Withdrawal by Subject|3|||
37890036|NCT00781963|69574961|FG001|Overall Study|Withdrawal by Subject|1|||
37890037|NCT00781963|69574960|FG000|Overall Study|Refused follow-up|9|||
37890038|NCT00781963|69574961|FG001|Overall Study|Refused follow-up|0|||
37890039|NCT00920556|69574967|FG000|Overall Study|Adverse Event|16|||
37890040|NCT00920556|69574967|FG000|Overall Study|Physician Decision|7|||
37890041|NCT00920556|69574967|FG000|Overall Study|Withdrawal by Subject|1|||
37890042|NCT00781885|69574975|FG000|Overall Study|Physician Decision|1|||
37890043|NCT00918684|69574979|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
37890044|NCT00918684|69574979|FG000|Treatment Phase|Lack of Efficacy|6|||
37890045|NCT00918684|69574979|FG000|Treatment Phase|Lost to Follow-up|2|||
37890046|NCT00918684|69574979|FG000|Treatment Phase|Physician Decision|8|||
37890047|NCT00918684|69574979|FG000|Treatment Phase|Protocol Violation|1|||
37890048|NCT00918684|69574979|FG000|Treatment Phase|Withdrawal by Subject|8|||
37890049|NCT00786409|69574983|FG000|Overall Study|Withdrawal by Subject|2|||
37890050|NCT00786409|69574983|FG000|Overall Study|Adverse Event|2|||
37890051|NCT00786409|69574983|FG000|Overall Study|Pregnancy|2|||
37890052|NCT00786409|69574983|FG000|Overall Study|Lost to Follow-up|1|||
37890053|NCT00919854|69574987|FG000|Overall Study|Adverse Event|1|||
37890054|NCT00891735|69574995|FG000|Overall Study|Adverse Event|2|||
37890055|NCT00891735|69574996|FG001|Overall Study|Adverse Event|0|||
37890056|NCT00891735|69574997|FG002|Overall Study|Adverse Event|2|||
37890057|NCT00891735|69574998|FG003|Overall Study|Adverse Event|0|||
37890058|NCT00891735|69574995|FG000|Overall Study|Death|8|||
37890059|NCT00891735|69574996|FG001|Overall Study|Death|5|||
37890060|NCT00891735|69574997|FG002|Overall Study|Death|4|||
37890061|NCT00891735|69574998|FG003|Overall Study|Death|5|||
37890062|NCT00891735|69574995|FG000|Overall Study|Lost to Follow-up|2|||
37890063|NCT00891735|69574996|FG001|Overall Study|Lost to Follow-up|2|||
37890064|NCT00891735|69574997|FG002|Overall Study|Lost to Follow-up|2|||
37890065|NCT00891735|69574998|FG003|Overall Study|Lost to Follow-up|2|||
37890066|NCT00891735|69574995|FG000|Overall Study|Physician's decision to withdraw patient|1|||
37890067|NCT00891735|69574996|FG001|Overall Study|Physician's decision to withdraw patient|0|||
37890068|NCT00891735|69574997|FG002|Overall Study|Physician's decision to withdraw patient|0|||
37890069|NCT00891735|69574998|FG003|Overall Study|Physician's decision to withdraw patient|0|||
37890070|NCT00891735|69574995|FG000|Overall Study|Patient's decision to withdraw|4|||
37890071|NCT00891735|69574996|FG001|Overall Study|Patient's decision to withdraw|9|||
37890072|NCT00891735|69574997|FG002|Overall Study|Patient's decision to withdraw|4|||
37890073|NCT00891735|69574998|FG003|Overall Study|Patient's decision to withdraw|8|||
37890074|NCT00891657|69575010|FG000|Overall Study|Withdrawal by Subject|1|||
37890075|NCT00891657|69575011|FG001|Overall Study|Withdrawal by Subject|1|||
37890076|NCT00917124|69575019|FG000|Overall Study|Protocol Violation|4|||
37890077|NCT00917124|69575020|FG001|Overall Study|Protocol Violation|6|||
37890078|NCT00889863|69575026|FG000|Part I: Open Label|Death|1|||
37890079|NCT00889863|69575027|FG001|Part I: Open Label|Death|0|||
37823495|NCT04965389|69505009|FG002|Overall Study|Other reasons|0|||
37823496|NCT04965389|69505010|FG003|Overall Study|Other reasons|0|||
37823497|NCT04965389|69505007|FG000|Overall Study|Participant withdrew consent|0|||
37823498|NCT04965389|69505008|FG001|Overall Study|Participant withdrew consent|1|||
37823499|NCT04965389|69505009|FG002|Overall Study|Participant withdrew consent|0|||
37823500|NCT04965389|69505010|FG003|Overall Study|Participant withdrew consent|0|||
37823501|NCT04965389|69505007|FG000|Overall Study|Poor/Non-compliance|0|||
37823502|NCT04965389|69505008|FG001|Overall Study|Poor/Non-compliance|1|||
37823503|NCT04965389|69505009|FG002|Overall Study|Poor/Non-compliance|0|||
37823504|NCT04965389|69505010|FG003|Overall Study|Poor/Non-compliance|0|||
37823505|NCT04935931|69505027|FG000|Overall Study|Withdrawal by Subject|1|||
37890080|NCT00889863|69575026|FG000|Part I: Open Label|Adverse Event|4|||
37890081|NCT00889863|69575027|FG001|Part I: Open Label|Adverse Event|0|||
37890082|NCT00889863|69575026|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
37890083|NCT00889863|69575027|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
37890084|NCT00889863|69575026|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
37890085|NCT00889863|69575027|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
37890086|NCT00889863|69575026|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
37890087|NCT00889863|69575027|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
37890088|NCT00889863|69575026|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
37890089|NCT00889863|69575027|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
37890090|NCT00889863|69575026|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
37890091|NCT00889863|69575027|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
37890092|NCT00915018|69575037|FG000|Overall Study|Death|75|||
37890093|NCT00915018|69575038|FG001|Overall Study|Death|70|||
37890094|NCT00915018|69575037|FG000|Overall Study|Lost to Follow-up|10|||
37890095|NCT00915018|69575038|FG001|Overall Study|Lost to Follow-up|5|||
37890096|NCT00915018|69575037|FG000|Overall Study|Withdrawal by Subject|38|||
37890097|NCT00915018|69575038|FG001|Overall Study|Withdrawal by Subject|27|||
37890098|NCT00915018|69575037|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
37890099|NCT00915018|69575038|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
37890100|NCT00916578|69575044|FG000|Overall Study|Physician Decision|2|||
37890101|NCT00916578|69575044|FG000|Overall Study|Withdrawal by Subject|3|||
37890102|NCT00916578|69575044|FG000|Overall Study|Insurance Denial|2|||
37890103|NCT00889707|69575050|FG000|Overall Study|Adverse Event|1|||
37890104|NCT00889707|69575051|FG001|Overall Study|Adverse Event|0|||
37890105|NCT00889707|69575050|FG000|Overall Study|Withdrawal by Subject|4|||
37890106|NCT00889707|69575051|FG001|Overall Study|Withdrawal by Subject|3|||
37890107|NCT00889707|69575050|FG000|Overall Study|Lost to Follow-up|0|||
37890108|NCT00889707|69575051|FG001|Overall Study|Lost to Follow-up|2|||
37890109|NCT00889707|69575050|FG000|Overall Study|Lack of Efficacy|2|||
37890110|NCT00889707|69575051|FG001|Overall Study|Lack of Efficacy|5|||
37890111|NCT00914940|69575057|FG000|D0 to D100 Post-transplant|Death|2|||
37890112|NCT00914940|69575057|FG000|D101 to 2 Years Post-transplant|Death|8|||
37890113|NCT00914940|69575057|FG000|2 Years to 5 Years Post-transplant|Death|3|||
37890114|NCT00835978|69575065|FG000|Overall Study|Death|33|||
37890115|NCT00835978|69575066|FG001|Overall Study|Death|40|||
37890116|NCT00835978|69575067|FG002|Overall Study|Death|49|||
37890117|NCT00835978|69575068|FG003|Overall Study|Death|4|||
37890118|NCT00835978|69575065|FG000|Overall Study|Lost to Follow-up|3|||
37890119|NCT00835978|69575066|FG001|Overall Study|Lost to Follow-up|4|||
37890120|NCT00835978|69575067|FG002|Overall Study|Lost to Follow-up|2|||
37890121|NCT00835978|69575068|FG003|Overall Study|Lost to Follow-up|1|||
37890122|NCT00835978|69575065|FG000|Overall Study|Other|5|||
37890123|NCT00835978|69575066|FG001|Overall Study|Other|1|||
37890124|NCT00835978|69575067|FG002|Overall Study|Other|8|||
37890125|NCT00835978|69575068|FG003|Overall Study|Other|0|||
37890126|NCT00835978|69575065|FG000|Overall Study|Objective progression or relapse|2|||
37890127|NCT00835978|69575066|FG001|Overall Study|Objective progression or relapse|0|||
37890128|NCT00835978|69575067|FG002|Overall Study|Objective progression or relapse|1|||
37890129|NCT00835978|69575068|FG003|Overall Study|Objective progression or relapse|0|||
37890130|NCT00835978|69575065|FG000|Overall Study|Adverse Event|1|||
37890131|NCT00835978|69575066|FG001|Overall Study|Adverse Event|0|||
37890132|NCT00835978|69575067|FG002|Overall Study|Adverse Event|1|||
37890133|NCT00835978|69575068|FG003|Overall Study|Adverse Event|0|||
37890134|NCT00835978|69575065|FG000|Overall Study|Withdrawal by Subject|0|||
37890135|NCT00835978|69575066|FG001|Overall Study|Withdrawal by Subject|3|||
37890136|NCT00835978|69575067|FG002|Overall Study|Withdrawal by Subject|0|||
37890137|NCT00835978|69575068|FG003|Overall Study|Withdrawal by Subject|5|||
37890138|NCT00835978|69575065|FG000|Overall Study|Study terminated by sponsor|12|||
37890139|NCT00835978|69575066|FG001|Overall Study|Study terminated by sponsor|8|||
37890140|NCT00835978|69575067|FG002|Overall Study|Study terminated by sponsor|30|||
37890141|NCT00835978|69575068|FG003|Overall Study|Study terminated by sponsor|0|||
37890142|NCT00914628|69575085|FG000|Overall Study|Death|35|||
37890143|NCT00914628|69575086|FG001|Overall Study|Death|17|||
37890144|NCT00914628|69575085|FG000|Overall Study|Medical decision|4|||
37890145|NCT00914628|69575086|FG001|Overall Study|Medical decision|0|||
37890146|NCT00914628|69575085|FG000|Overall Study|Protocol Violation|1|||
37823506|NCT04839393|69505039|FG000|Overall Study|Adverse Event|0|||
37823507|NCT04839393|69505040|FG001|Overall Study|Adverse Event|0|||
37823508|NCT04839393|69505041|FG002|Overall Study|Adverse Event|2|||
37890147|NCT00914628|69575086|FG001|Overall Study|Protocol Violation|0|||
37890148|NCT00914628|69575085|FG000|Overall Study|Lack of Efficacy|1|||
37890149|NCT00914628|69575086|FG001|Overall Study|Lack of Efficacy|0|||
37890150|NCT00914628|69575085|FG000|Overall Study|non-randomized|1|||
37890151|NCT00914628|69575086|FG001|Overall Study|non-randomized|0|||
37890152|NCT00914628|69575085|FG000|Overall Study|Relapse|1|||
37823509|NCT04839393|69505039|FG000|Overall Study|Withdrawal by participant|0|||
37823510|NCT04839393|69505040|FG001|Overall Study|Withdrawal by participant|0|||
37823511|NCT04839393|69505041|FG002|Overall Study|Withdrawal by participant|1|||
37823512|NCT04677712|69505108|FG000|Overall Study|Lost to Follow-up|0|||
37823513|NCT04677712|69505109|FG001|Overall Study|Lost to Follow-up|1|||
37823514|NCT04677712|69505110|FG002|Overall Study|Lost to Follow-up|0|||
37823515|NCT04677712|69505111|FG003|Overall Study|Lost to Follow-up|0|||
37823516|NCT04677712|69505112|FG004|Overall Study|Lost to Follow-up|0|||
37823517|NCT04677712|69505113|FG005|Overall Study|Lost to Follow-up|0|||
37823518|NCT04630002|69505136|FG000|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
37823519|NCT04630002|69505137|FG001|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
37823520|NCT04630002|69505138|FG002|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
37823521|NCT04630002|69505136|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|1|||
37823522|NCT04630002|69505137|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
37823523|NCT04630002|69505138|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
37823524|NCT04630002|69505136|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
37890153|NCT00914628|69575086|FG001|Overall Study|Relapse|2|||
37890154|NCT00914628|69575085|FG000|Overall Study|Study terminated by Sponsor|14|||
37890155|NCT00914628|69575086|FG001|Overall Study|Study terminated by Sponsor|8|||
37890156|NCT00914628|69575085|FG000|Overall Study|Patients who did not receive a single dose|7|||
37988229|NCT00348348|69673553|FG000|Overall Study|Lost to Follow-up|8|||
37988230|NCT00348348|69673554|FG001|Overall Study|Lost to Follow-up|10|||
37988231|NCT00348348|69673553|FG000|Overall Study|Withdrawal by Subject|4|||
37988232|NCT00348348|69673554|FG001|Overall Study|Withdrawal by Subject|1|||
37988233|NCT00348348|69673553|FG000|Overall Study|Other|7|||
37890157|NCT00914628|69575086|FG001|Overall Study|Patients who did not receive a single dose|1|||
37890158|NCT01077518|69575098|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
37890159|NCT01077518|69575099|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
37890160|NCT01077518|69575100|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
37988234|NCT00348348|69673554|FG001|Overall Study|Other|4|||
37890161|NCT01077518|69575098|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
37890162|NCT01077518|69575099|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
37890163|NCT01077518|69575100|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
37890164|NCT01077518|69575098|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
37890165|NCT01077518|69575099|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
37890166|NCT01077518|69575100|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
37890167|NCT01077518|69575098|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
37988235|NCT00348348|69673553|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
37988236|NCT00348348|69673554|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
37988237|NCT00348348|69673553|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
37988238|NCT00348348|69673554|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
37988239|NCT00348348|69673553|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
37988240|NCT00348348|69673554|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
37988241|NCT00348348|69673553|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
37988242|NCT00348348|69673554|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
37988243|NCT00348348|69673553|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
37988244|NCT00348348|69673554|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
37988245|NCT00348348|69673553|FG000|Overall Study|Adverse event probably related to study|1|||
37890168|NCT01077518|69575099|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
37890169|NCT01077518|69575100|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
37890170|NCT01077518|69575098|FG000|Optional Ofa Phase|Physician Decision|0|||
37890171|NCT01077518|69575099|FG001|Optional Ofa Phase|Physician Decision|0|||
37988246|NCT00348348|69673554|FG001|Overall Study|Adverse event probably related to study|0|||
37988247|NCT00347958|69673560|FG000|Overall Study|Adverse Event|1|||
37988248|NCT00347958|69673560|FG000|Overall Study|Protocol Violation|2|||
37823525|NCT04630002|69505137|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
37890172|NCT01077518|69575100|FG002|Optional Ofa Phase|Physician Decision|1|||
37890173|NCT01077518|69575098|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
37890174|NCT01077518|69575099|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
37988249|NCT00347958|69673560|FG000|Overall Study|Withdrawal by Subject|1|||
37988250|NCT00354744|69673564|FG000|Overall Study|Adverse Event|2|||
37988251|NCT00354744|69673564|FG000|Overall Study|Death|2|||
37890175|NCT01077518|69575100|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
37890176|NCT01077518|69575098|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
37890177|NCT01077518|69575099|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
37890178|NCT01077518|69575100|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
37890179|NCT00835120|69575109|FG000|Overall Study|Lack of Efficacy|1|||
37890180|NCT00835120|69575109|FG000|Overall Study|Lost to Follow-up|3|||
37890181|NCT00835120|69575109|FG000|Overall Study|Adverse Event|2|||
37890182|NCT00835120|69575109|FG000|Overall Study|Withdrawal by Subject|2|||
37890183|NCT00914316|69575117|FG000|Phase 1|Physician Decision|4|||
37890184|NCT00914316|69575118|FG001|Phase 1|Physician Decision|0|||
37890185|NCT00914316|69575119|FG002|Phase 1|Physician Decision|1|||
37890186|NCT00914316|69575120|FG003|Phase 1|Physician Decision|2|||
37890187|NCT00914316|69575117|FG000|Phase 1|Withdrawal by Subject|0|||
37890188|NCT00914316|69575118|FG001|Phase 1|Withdrawal by Subject|2|||
37890189|NCT00914316|69575119|FG002|Phase 1|Withdrawal by Subject|4|||
37890190|NCT00914316|69575120|FG003|Phase 1|Withdrawal by Subject|0|||
37890191|NCT00914316|69575117|FG000|Phase 1|Adverse Event|1|||
37890192|NCT00914316|69575118|FG001|Phase 1|Adverse Event|0|||
37890193|NCT00914316|69575119|FG002|Phase 1|Adverse Event|0|||
37890194|NCT00914316|69575120|FG003|Phase 1|Adverse Event|0|||
37890195|NCT00914316|69575117|FG000|Phase 2|Withdrawal by Subject|1|||
37890196|NCT00914316|69575118|FG001|Phase 2|Withdrawal by Subject|0|||
37890197|NCT00914316|69575119|FG002|Phase 2|Withdrawal by Subject|1|||
37890198|NCT00914316|69575120|FG003|Phase 2|Withdrawal by Subject|0|||
37890199|NCT00827632|69575132|FG000|Overall Study|Lost to Follow-up|8|||
37890200|NCT00827632|69575133|FG001|Overall Study|Lost to Follow-up|12|||
37890201|NCT00827632|69575132|FG000|Overall Study|Early withdrawal|14|||
37890202|NCT00827632|69575133|FG001|Overall Study|Early withdrawal|11|||
37890203|NCT00827242|69575141|FG000|Overall Study|Withdrawal by Subject|2|||
37823526|NCT04630002|69505138|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
37823527|NCT04630002|69505136|FG000|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
37823528|NCT04630002|69505137|FG001|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
37823529|NCT04630002|69505138|FG002|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
37823530|NCT04630002|69505136|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
37823531|NCT04630002|69505137|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|2|||
37823532|NCT04630002|69505138|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
37823533|NCT04630002|69505136|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
37823534|NCT04630002|69505137|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
37823535|NCT04630002|69505138|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
37823536|NCT04630002|69505136|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
37823537|NCT04630002|69505137|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
37823538|NCT04630002|69505138|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|1|||
37823539|NCT04630002|69505136|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
37823540|NCT04630002|69505137|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
37823541|NCT04630002|69505138|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|1|||
37823542|NCT04576923|69505171|FG000|Overall Study|15 had scans that were determined to be invalid and these are not reported within the results.|15|||
37890204|NCT00827242|69575142|FG001|Overall Study|Withdrawal by Subject|4|||
37890205|NCT00827242|69575141|FG000|Overall Study|Protocol Violation|1|||
37890206|NCT00827242|69575142|FG001|Overall Study|Protocol Violation|3|||
37890207|NCT00827242|69575141|FG000|Overall Study|Lost to Follow-up|0|||
37890208|NCT00827242|69575142|FG001|Overall Study|Lost to Follow-up|3|||
37988252|NCT00354744|69673564|FG000|Overall Study|Lack of Efficacy|11|||
37890209|NCT00827242|69575141|FG000|Overall Study|Adverse Event Excluding Death|2|||
37890210|NCT00827242|69575142|FG001|Overall Study|Adverse Event Excluding Death|1|||
37890211|NCT00827242|69575141|FG000|Overall Study|Entry Criteria Not Met|4|||
37890212|NCT00827242|69575142|FG001|Overall Study|Entry Criteria Not Met|1|||
37890213|NCT00827242|69575141|FG000|Overall Study|Physician Decision|2|||
37890214|NCT00827242|69575142|FG001|Overall Study|Physician Decision|0|||
37890215|NCT00827242|69575141|FG000|Overall Study|Death|1|||
37890216|NCT00827242|69575142|FG001|Overall Study|Death|0|||
37823543|NCT04526197|69505185|FG000|Period 1|Adverse Event|0|||
37823544|NCT04526197|69505186|FG001|Period 1|Adverse Event|1|||
37823545|NCT04526197|69505185|FG000|Period 1|Withdrawal by Subject|1|||
37823546|NCT04526197|69505186|FG001|Period 1|Withdrawal by Subject|0|||
37823547|NCT04526197|69505185|FG000|Period 2|Adverse Event|0|||
37823548|NCT04526197|69505186|FG001|Period 2|Adverse Event|1|||
37890217|NCT00827242|69575141|FG000|Overall Study|Lack of Efficacy|1|||
37890218|NCT00827242|69575142|FG001|Overall Study|Lack of Efficacy|0|||
37890219|NCT01077362|69575151|FG000|Overall Study|Lack of Efficacy|13|||
37890220|NCT01077362|69575152|FG001|Overall Study|Lack of Efficacy|8|||
37890221|NCT01077362|69575153|FG002|Overall Study|Lack of Efficacy|10|||
37890222|NCT01077362|69575151|FG000|Overall Study|Lost to Follow-up|1|||
37890223|NCT01077362|69575152|FG001|Overall Study|Lost to Follow-up|0|||
37890224|NCT01077362|69575153|FG002|Overall Study|Lost to Follow-up|3|||
37890225|NCT01077362|69575151|FG000|Overall Study|Adverse Event|12|||
37890226|NCT01077362|69575152|FG001|Overall Study|Adverse Event|7|||
37890227|NCT01077362|69575153|FG002|Overall Study|Adverse Event|4|||
37890228|NCT01077362|69575151|FG000|Overall Study|Withdrawal by Subject|5|||
37890229|NCT01077362|69575152|FG001|Overall Study|Withdrawal by Subject|3|||
37890230|NCT01077362|69575153|FG002|Overall Study|Withdrawal by Subject|5|||
37890231|NCT01077362|69575151|FG000|Overall Study|Other|0|||
37890232|NCT01077362|69575152|FG001|Overall Study|Other|1|||
37890233|NCT01077362|69575153|FG002|Overall Study|Other|2|||
37890234|NCT00846586|69575168|FG000|Overall Study|Adverse Event|20|||
37890235|NCT00846586|69575169|FG001|Overall Study|Adverse Event|10|||
37890236|NCT00846586|69575168|FG000|Overall Study|Subject withdrew consent|8|||
37890237|NCT00846586|69575169|FG001|Overall Study|Subject withdrew consent|10|||
37890238|NCT00846586|69575168|FG000|Overall Study|Administrative problems|5|||
37890239|NCT00846586|69575169|FG001|Overall Study|Administrative problems|4|||
37823549|NCT04526197|69505185|FG000|Period 2|Withdrawal by Subject|0|||
37823550|NCT04526197|69505186|FG001|Period 2|Withdrawal by Subject|1|||
37823551|NCT04412668|69505196|FG000|Overall Study|Death - multiple comorbidities|2|||
37823552|NCT04412668|69505197|FG001|Overall Study|Death - multiple comorbidities|0|||
37823553|NCT04412668|69505198|FG002|Overall Study|Death - multiple comorbidities|0|||
37823554|NCT04412668|69505196|FG000|Overall Study|Withdrawal by Subject|3|||
37890240|NCT00846586|69575168|FG000|Overall Study|Death|2|||
37890241|NCT00846586|69575169|FG001|Overall Study|Death|0|||
37890242|NCT00846586|69575168|FG000|Overall Study|Protocol deviation|2|||
37890243|NCT00846586|69575169|FG001|Overall Study|Protocol deviation|6|||
37890244|NCT00846586|69575168|FG000|Overall Study|Abnormal test procedure result(s)|1|||
37823555|NCT04412668|69505197|FG001|Overall Study|Withdrawal by Subject|0|||
37890245|NCT00846586|69575169|FG001|Overall Study|Abnormal test procedure result(s)|0|||
37988253|NCT00354744|69673564|FG000|Overall Study|Lost to Follow-up|2|||
37988254|NCT00354744|69673564|FG000|Overall Study|Physician Decision|11|||
37988255|NCT00354744|69673564|FG000|Overall Study|Withdrawal by Subject|14|||
37988256|NCT00373256|69673572|FG000|Overall Study|Adverse Event (AE)|1|||
37988257|NCT00373256|69673573|FG001|Overall Study|Adverse Event (AE)|5|||
37988258|NCT00373256|69673572|FG000|Overall Study|Lost to Follow-up|2|||
37988259|NCT00373256|69673573|FG001|Overall Study|Lost to Follow-up|1|||
37988260|NCT00373256|69673572|FG000|Overall Study|Death|9|||
37988261|NCT00373256|69673573|FG001|Overall Study|Death|8|||
37988262|NCT00373256|69673572|FG000|Overall Study|Objective Progression or Relapse|111|||
37988263|NCT00373256|69673573|FG001|Overall Study|Objective Progression or Relapse|104|||
37988264|NCT00373256|69673572|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
37988265|NCT00373256|69673573|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
37988266|NCT00373256|69673572|FG000|Overall Study|Other|73|||
37988267|NCT00373256|69673573|FG001|Overall Study|Other|107|||
37988268|NCT00373256|69673572|FG000|Overall Study|Protocol Violation|0|||
37988269|NCT00373256|69673573|FG001|Overall Study|Protocol Violation|2|||
37988270|NCT00373256|69673572|FG000|Overall Study|Study Terminated by Sponsor|41|||
37988271|NCT00373256|69673573|FG001|Overall Study|Study Terminated by Sponsor|13|||
37988272|NCT00394082|69673579|FG000|Overall Study|Unacceptable toxicity|15|||
37988273|NCT00394082|69673579|FG000|Overall Study|Adverse Event|4|||
37988274|NCT00394082|69673579|FG000|Overall Study|Physician Decision|4|||
37988275|NCT00394082|69673579|FG000|Overall Study|Withdrawal by Subject|2|||
37988276|NCT00394082|69673579|FG000|Overall Study|Other|1|||
37988277|NCT00393848|69673587|FG000|Overall Study|Surgical schedule|0|||
37988278|NCT00393848|69673588|FG001|Overall Study|Surgical schedule|0|||
37988279|NCT00393848|69673589|FG002|Overall Study|Surgical schedule|0|||
37988280|NCT00393848|69673590|FG003|Overall Study|Surgical schedule|1|||
37988281|NCT00393848|69673587|FG000|Overall Study|Personal reasons|0|||
37988282|NCT00393848|69673588|FG001|Overall Study|Personal reasons|0|||
37988283|NCT00393848|69673589|FG002|Overall Study|Personal reasons|2|||
37988284|NCT00393848|69673590|FG003|Overall Study|Personal reasons|0|||
37988285|NCT00393458|69673605|FG000|Overall Study|Adverse Event|35|||
37988286|NCT00393458|69673606|FG001|Overall Study|Adverse Event|24|||
37988287|NCT00393458|69673607|FG002|Overall Study|Adverse Event|40|||
37988288|NCT00393458|69673608|FG003|Overall Study|Adverse Event|35|||
37823556|NCT04412668|69505198|FG002|Overall Study|Withdrawal by Subject|0|||
37823557|NCT04412668|69505196|FG000|Overall Study|Other than Specified|2|||
37823558|NCT04412668|69505197|FG001|Overall Study|Other than Specified|0|||
37823559|NCT04412668|69505198|FG002|Overall Study|Other than Specified|0|||
37823560|NCT04360551|69505208|FG000|Overall Study|Withdrawal by Subject|1|||
37823561|NCT04360551|69505209|FG001|Overall Study|Withdrawal by Subject|0|||
37823562|NCT04299087|69505217|FG000|Overall Study|Lost to Follow-up|2|||
37823563|NCT04299087|69505218|FG001|Overall Study|Lost to Follow-up|1|||
37823564|NCT04288778|69505224|FG000|Overall Study|Withdrawal by Subject|2|||
37823565|NCT04288778|69505224|FG000|Overall Study|Adverse Event|5|||
37988289|NCT00393458|69673605|FG000|Overall Study|Subject withdrew consent|27|||
37988290|NCT00393458|69673606|FG001|Overall Study|Subject withdrew consent|40|||
37988291|NCT00393458|69673607|FG002|Overall Study|Subject withdrew consent|33|||
37988292|NCT00393458|69673608|FG003|Overall Study|Subject withdrew consent|50|||
37988293|NCT00393458|69673605|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
37988294|NCT00393458|69673606|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
37988295|NCT00393458|69673607|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
37988296|NCT00393458|69673608|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
37890246|NCT00846586|69575168|FG000|Overall Study|Lost to Follow-up|1|||
37890247|NCT00846586|69575169|FG001|Overall Study|Lost to Follow-up|4|||
37890248|NCT00846586|69575168|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
37890249|NCT00846586|69575169|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
37890250|NCT00785785|69575177|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
37988297|NCT00393458|69673605|FG000|Overall Study|Protocol deviation|11|||
37988298|NCT00393458|69673606|FG001|Overall Study|Protocol deviation|11|||
37988299|NCT00393458|69673607|FG002|Overall Study|Protocol deviation|11|||
37988300|NCT00393458|69673608|FG003|Overall Study|Protocol deviation|10|||
37988301|NCT00393458|69673605|FG000|Overall Study|Administrative problems|7|||
37988302|NCT00393458|69673606|FG001|Overall Study|Administrative problems|8|||
37988303|NCT00393458|69673607|FG002|Overall Study|Administrative problems|5|||
37988304|NCT00393458|69673608|FG003|Overall Study|Administrative problems|2|||
37988305|NCT00393458|69673605|FG000|Overall Study|Lost to Follow-up|5|||
37988306|NCT00393458|69673606|FG001|Overall Study|Lost to Follow-up|6|||
37890251|NCT00785785|69575178|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
37890252|NCT00785785|69575177|FG000|Core Phase up to 36 Months|Adverse Event|31|||
37890253|NCT00785785|69575178|FG001|Core Phase up to 36 Months|Adverse Event|21|||
37890254|NCT00785785|69575177|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
37890255|NCT00785785|69575178|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
37890256|NCT00785785|69575177|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
37890257|NCT00785785|69575178|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
37890258|NCT00785785|69575177|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
37890259|NCT00785785|69575178|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
37988307|NCT00393458|69673607|FG002|Overall Study|Lost to Follow-up|5|||
37988308|NCT00393458|69673608|FG003|Overall Study|Lost to Follow-up|3|||
37988309|NCT00393458|69673605|FG000|Overall Study|Abnormal laboratory value(s)|1|||
37988310|NCT00393458|69673606|FG001|Overall Study|Abnormal laboratory value(s)|1|||
37890260|NCT00785785|69575177|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
37890261|NCT00785785|69575178|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
37988311|NCT00393458|69673607|FG002|Overall Study|Abnormal laboratory value(s)|0|||
37988312|NCT00393458|69673608|FG003|Overall Study|Abnormal laboratory value(s)|0|||
37890262|NCT00785785|69575177|FG000|Core Phase up to 36 Months|Administrative problems|3|||
37890263|NCT00785785|69575178|FG001|Core Phase up to 36 Months|Administrative problems|3|||
37890264|NCT00785785|69575177|FG000|Core Phase up to 36 Months|Death|5|||
37890265|NCT00785785|69575178|FG001|Core Phase up to 36 Months|Death|8|||
37890266|NCT00785785|69575177|FG000|Core Phase up to 36 Months|Disease progression|139|||
37890267|NCT00785785|69575178|FG001|Core Phase up to 36 Months|Disease progression|119|||
37890268|NCT00785785|69575177|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
37890269|NCT00785785|69575178|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
37890270|NCT00785785|69575177|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
37890271|NCT00785785|69575178|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
37890272|NCT00785785|69575177|FG000|Optional Extension Phase|Adverse Event|4|||
37890273|NCT00785785|69575178|FG001|Optional Extension Phase|Adverse Event|5|||
37890274|NCT00785785|69575177|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
37890275|NCT00785785|69575178|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
37890276|NCT00785785|69575177|FG000|Optional Extension Phase|Lost to Follow-up|1|||
37890277|NCT00785785|69575178|FG001|Optional Extension Phase|Lost to Follow-up|0|||
37890278|NCT00785785|69575177|FG000|Optional Extension Phase|Administrative problems|2|||
37890279|NCT00785785|69575178|FG001|Optional Extension Phase|Administrative problems|0|||
37890280|NCT00785785|69575177|FG000|Optional Extension Phase|Death|1|||
37890281|NCT00785785|69575178|FG001|Optional Extension Phase|Death|5|||
37890282|NCT00785785|69575177|FG000|Optional Extension Phase|Disease progression|22|||
37890283|NCT00785785|69575178|FG001|Optional Extension Phase|Disease progression|70|||
37890284|NCT00785785|69575177|FG000|Optional Extension Phase|Protocol deviation|0|||
37890285|NCT00785785|69575178|FG001|Optional Extension Phase|Protocol deviation|2|||
37890286|NCT00785785|69575177|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
37890287|NCT00785785|69575178|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
37890288|NCT01077284|69575189|FG000|Overall Study|Adverse Event|2|||
37890289|NCT01077284|69575190|FG001|Overall Study|Adverse Event|0|||
37890290|NCT01077284|69575191|FG002|Overall Study|Adverse Event|1|||
37890291|NCT01077284|69575189|FG000|Overall Study|Lost to Follow-up|1|||
37890292|NCT01077284|69575190|FG001|Overall Study|Lost to Follow-up|2|||
37890293|NCT01077284|69575191|FG002|Overall Study|Lost to Follow-up|0|||
37890294|NCT01077284|69575189|FG000|Overall Study|Withdrawal by Subject|2|||
37988313|NCT00393458|69673605|FG000|Overall Study|Death|1|||
37988314|NCT00393458|69673606|FG001|Overall Study|Death|1|||
37890295|NCT01077284|69575190|FG001|Overall Study|Withdrawal by Subject|3|||
37890296|NCT01077284|69575191|FG002|Overall Study|Withdrawal by Subject|1|||
37890297|NCT01077284|69575189|FG000|Overall Study|Other|0|||
37890298|NCT01077284|69575190|FG001|Overall Study|Other|0|||
37890299|NCT01077284|69575191|FG002|Overall Study|Other|1|||
37890300|NCT00826618|69575199|FG000|Overall Study|Withdrawal by Subject|1|||
37890301|NCT01077128|69575203|FG000|Overall Study|Adverse Event|8|||
37890302|NCT01077128|69575203|FG000|Overall Study|Lack of Efficacy|1|||
37890303|NCT01077128|69575203|FG000|Overall Study|Disease exacerbation|1|||
37890304|NCT01077128|69575203|FG000|Overall Study|Adverse event and consent withdrawal|1|||
37890305|NCT01077128|69575203|FG000|Overall Study|Adverse event and disease exacerbation|1|||
37890306|NCT01077128|69575203|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
37890307|NCT01077128|69575203|FG000|Overall Study|Other|54|||
37890308|NCT00826540|69575257|FG000|Overall Study|ineligible|3|||
37890309|NCT00826540|69575257|FG000|Overall Study|Withdrawal by Subject|1|||
37890310|NCT01077050|69575261|FG000|Overall Study|Subjects signed ICF could not be located|1|||
37890311|NCT01077050|69575261|FG000|Overall Study|Screen failure|8|||
37890312|NCT00592384|69575267|FG000|Overall Study|Withdrawal by Subject|5|||
37890313|NCT00592384|69575268|FG001|Overall Study|Withdrawal by Subject|6|||
37890314|NCT00846040|69575277|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
37890315|NCT00846040|69575278|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
37890316|NCT00846040|69575279|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
37890317|NCT00846040|69575277|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
37890318|NCT00846040|69575278|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
37890319|NCT00846040|69575279|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
37890320|NCT00826228|69575288|FG000|Overall Study|Withdrawal by Subject|1|||
37890321|NCT00825994|69575293|FG000|Overall Study|Withdrawal by Subject|2|||
37890322|NCT00825994|69575293|FG000|Overall Study|Lost to Follow-up|1|||
37890323|NCT00825994|69575293|FG000|Overall Study|Protocol Violation|1|||
37890324|NCT00825994|69575293|FG000|Overall Study|Placebo Responder at V2|1|||
37890325|NCT00825916|69575300|FG000|Overall Study|Lost to Follow-up|4|||
37890326|NCT00825916|69575301|FG001|Overall Study|Lost to Follow-up|2|||
37890327|NCT00825916|69575302|FG002|Overall Study|Lost to Follow-up|1|||
37890328|NCT00791479|69575349|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
37890329|NCT00791479|69575350|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
37890330|NCT00791479|69575351|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
37890331|NCT00791479|69575352|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
37890332|NCT00791479|69575353|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
37890333|NCT00791479|69575354|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
37890334|NCT00791479|69575349|FG000|Overall Study|Adverse Event|0|||
37890335|NCT00791479|69575350|FG001|Overall Study|Adverse Event|1|||
37890336|NCT00791479|69575351|FG002|Overall Study|Adverse Event|0|||
37890337|NCT00791479|69575352|FG003|Overall Study|Adverse Event|2|||
37890338|NCT00791479|69575353|FG004|Overall Study|Adverse Event|0|||
37890339|NCT00791479|69575354|FG005|Overall Study|Adverse Event|1|||
37890340|NCT00791479|69575349|FG000|Overall Study|Lost to Follow-up|0|||
37890341|NCT00791479|69575350|FG001|Overall Study|Lost to Follow-up|1|||
37890342|NCT00791479|69575351|FG002|Overall Study|Lost to Follow-up|0|||
37823566|NCT04288778|69505224|FG000|Overall Study|Non-Compliance With Study Drug|1|||
37823567|NCT04288778|69505224|FG000|Overall Study|Other|1|||
37823568|NCT04288778|69505224|FG000|Overall Study|Started but not treated|2|||
37890343|NCT00791479|69575352|FG003|Overall Study|Lost to Follow-up|0|||
37823569|NCT04233164|69505243|FG000|Overall Study|Unable to obtain specimen|0|||
37823570|NCT04233164|69505244|FG001|Overall Study|Unable to obtain specimen|1|||
37823571|NCT04147195|69505260|FG000|Overall Study|Adverse Event|0|||
37823572|NCT04147195|69505261|FG001|Overall Study|Adverse Event|3|||
37823573|NCT04147195|69505260|FG000|Overall Study|Study Terminated by Sponsor|4|||
37823574|NCT04147195|69505261|FG001|Overall Study|Study Terminated by Sponsor|2|||
37823575|NCT04147195|69505260|FG000|Overall Study|Withdrawal by Subject|0|||
37823576|NCT04147195|69505261|FG001|Overall Study|Withdrawal by Subject|1|||
37823577|NCT04092816|69505274|FG000|Overall Study|Lost to Follow-up|1|||
37823578|NCT04092816|69505275|FG001|Overall Study|Lost to Follow-up|2|||
37823579|NCT03985878|69505292|FG000|Overall Study|Transitioned to Another Sarepta Study|2|||
37823580|NCT03985878|69505292|FG000|Overall Study|Study Terminated by Sponsor|12|||
37823581|NCT03985878|69505292|FG000|Overall Study|Withdrawal by Subject|1|||
37823582|NCT03946670|69505357|FG000|Overall Study|Progressive Disease|26|||
37823583|NCT03946670|69505358|FG001|Overall Study|Progressive Disease|23|||
37823584|NCT03946670|69505357|FG000|Overall Study|Adverse Event|7|||
37823585|NCT03946670|69505358|FG001|Overall Study|Adverse Event|9|||
37823586|NCT03946670|69505357|FG000|Overall Study|Death|5|||
37823587|NCT03946670|69505358|FG001|Overall Study|Death|6|||
37823588|NCT03946670|69505357|FG000|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|5|||
37823589|NCT03946670|69505358|FG001|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|6|||
37823590|NCT03946670|69505357|FG000|Overall Study|Subject Decision|4|||
37823591|NCT03946670|69505358|FG001|Overall Study|Subject Decision|4|||
37823592|NCT03946670|69505357|FG000|Overall Study|Physician Decision|3|||
37823593|NCT03946670|69505358|FG001|Overall Study|Physician Decision|3|||
37823594|NCT03946670|69505357|FG000|Overall Study|New Therapy for Study Indication|1|||
37823595|NCT03946670|69505358|FG001|Overall Study|New Therapy for Study Indication|0|||
37823596|NCT03946670|69505357|FG000|Overall Study|Not treated|1|||
37823597|NCT03946670|69505358|FG001|Overall Study|Not treated|1|||
37823598|NCT03774394|69505383|FG000|Overall Study|Withdrawal by Subject|2|||
37823599|NCT03774394|69505384|FG001|Overall Study|Withdrawal by Subject|0|||
37823600|NCT03765788|69505392|FG000|Overall Study|Subject decision|2|||
37823601|NCT03765788|69505393|FG001|Overall Study|Subject decision|3|||
37823602|NCT03765788|69505392|FG000|Overall Study|Physician Decision|2|||
37823603|NCT03765788|69505393|FG001|Overall Study|Physician Decision|4|||
37823604|NCT03765788|69505392|FG000|Overall Study|Death|0|||
37823605|NCT03765788|69505393|FG001|Overall Study|Death|1|||
37823606|NCT03765788|69505392|FG000|Overall Study|Lost to Follow-up|1|||
37823607|NCT03765788|69505393|FG001|Overall Study|Lost to Follow-up|0|||
37823608|NCT03692403|69505404|FG000|Overall Study|Withdrawal by Subject|1|||
37823609|NCT03692403|69505405|FG001|Overall Study|Withdrawal by Subject|0|||
37823610|NCT03692403|69505406|FG002|Overall Study|Withdrawal by Subject|1|||
37823611|NCT03692403|69505407|FG003|Overall Study|Withdrawal by Subject|0|||
37823612|NCT03692403|69505404|FG000|Overall Study|Adverse Event|0|||
37823613|NCT03692403|69505405|FG001|Overall Study|Adverse Event|0|||
37823614|NCT03692403|69505406|FG002|Overall Study|Adverse Event|0|||
37823615|NCT03692403|69505407|FG003|Overall Study|Adverse Event|1|||
37823616|NCT03692403|69505404|FG000|Overall Study|Pregnancy|0|||
37890344|NCT00791479|69575353|FG004|Overall Study|Lost to Follow-up|0|||
37890345|NCT00791479|69575354|FG005|Overall Study|Lost to Follow-up|1|||
37890346|NCT00791479|69575349|FG000|Overall Study|Protocol Violation|2|||
37890347|NCT00791479|69575350|FG001|Overall Study|Protocol Violation|1|||
37823617|NCT03692403|69505405|FG001|Overall Study|Pregnancy|1|||
37823618|NCT03692403|69505406|FG002|Overall Study|Pregnancy|0|||
37823619|NCT03692403|69505407|FG003|Overall Study|Pregnancy|0|||
37823620|NCT03692403|69505404|FG000|Overall Study|Other|0|||
37823621|NCT03692403|69505405|FG001|Overall Study|Other|0|||
37823622|NCT03692403|69505406|FG002|Overall Study|Other|1|||
37823623|NCT03692403|69505407|FG003|Overall Study|Other|0|||
37823624|NCT03654651|69505422|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
37823625|NCT03654651|69505423|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
37823626|NCT03649230|69505430|FG000|Overall Study|Adverse Event|12|||
37823627|NCT03649230|69505430|FG000|Overall Study|Death|8|||
37823628|NCT03649230|69505430|FG000|Overall Study|Withdrawal by Subject|6|||
37823629|NCT03649230|69505430|FG000|Overall Study|Physician Decision|5|||
37823630|NCT03649230|69505430|FG000|Overall Study|Disease progression|5|||
37823631|NCT03649230|69505430|FG000|Overall Study|Switched to non-HEC|5|||
37823632|NCT03649230|69505430|FG000|Overall Study|Chemotherapy discontinued|4|||
37823633|NCT03649230|69505430|FG000|Overall Study|Received only 3 HEC cycles|4|||
37823634|NCT03649230|69505430|FG000|Overall Study|Screen Failure|3|||
37823635|NCT03649230|69505430|FG000|Overall Study|Patient stopped treatment|2|||
37890348|NCT00791479|69575351|FG002|Overall Study|Protocol Violation|0|||
37890349|NCT00791479|69575352|FG003|Overall Study|Protocol Violation|1|||
37890350|NCT00791479|69575353|FG004|Overall Study|Protocol Violation|0|||
37890351|NCT00791479|69575354|FG005|Overall Study|Protocol Violation|0|||
37890352|NCT00791479|69575349|FG000|Overall Study|Withdrawal by Subject|0|||
37890353|NCT00791479|69575350|FG001|Overall Study|Withdrawal by Subject|0|||
37890354|NCT00791479|69575351|FG002|Overall Study|Withdrawal by Subject|0|||
37890355|NCT00791479|69575352|FG003|Overall Study|Withdrawal by Subject|1|||
37890356|NCT00791479|69575353|FG004|Overall Study|Withdrawal by Subject|0|||
37890357|NCT00791479|69575354|FG005|Overall Study|Withdrawal by Subject|1|||
37890358|NCT00890097|69575378|FG000|Overall Study|Adverse Event|21|||
37890359|NCT00890097|69575379|FG001|Overall Study|Adverse Event|32|||
37890360|NCT00890097|69575380|FG002|Overall Study|Adverse Event|28|||
37890361|NCT00890097|69575378|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
37890362|NCT00890097|69575379|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
37890363|NCT00890097|69575380|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
37890364|NCT00890097|69575378|FG000|Overall Study|Withdrew Consent|9|||
37890365|NCT00890097|69575379|FG001|Overall Study|Withdrew Consent|6|||
37890366|NCT00890097|69575380|FG002|Overall Study|Withdrew Consent|9|||
37890367|NCT00890097|69575378|FG000|Overall Study|Lost to Follow-up|5|||
37890368|NCT00890097|69575379|FG001|Overall Study|Lost to Follow-up|5|||
37890369|NCT00890097|69575380|FG002|Overall Study|Lost to Follow-up|5|||
37890370|NCT00890097|69575378|FG000|Overall Study|Noncompliance|0|||
37890371|NCT00890097|69575379|FG001|Overall Study|Noncompliance|4|||
37890372|NCT00890097|69575380|FG002|Overall Study|Noncompliance|4|||
37890373|NCT00890097|69575378|FG000|Overall Study|Sponsor Decision|7|||
37890374|NCT00890097|69575379|FG001|Overall Study|Sponsor Decision|11|||
37890375|NCT00890097|69575380|FG002|Overall Study|Sponsor Decision|7|||
37890376|NCT00890097|69575378|FG000|Overall Study|Did not attend final visit|2|||
37890377|NCT00890097|69575379|FG001|Overall Study|Did not attend final visit|3|||
37890378|NCT00890097|69575380|FG002|Overall Study|Did not attend final visit|0|||
37890379|NCT00890097|69575378|FG000|Overall Study|Subject Decision|3|||
37890380|NCT00890097|69575379|FG001|Overall Study|Subject Decision|2|||
37890381|NCT00890097|69575380|FG002|Overall Study|Subject Decision|6|||
37890382|NCT00890097|69575378|FG000|Overall Study|Randomization Error|2|||
37890383|NCT00890097|69575379|FG001|Overall Study|Randomization Error|0|||
37890384|NCT00890097|69575380|FG002|Overall Study|Randomization Error|0|||
37890385|NCT00890097|69575378|FG000|Overall Study|Failed inclusion criteria|3|||
37890386|NCT00890097|69575379|FG001|Overall Study|Failed inclusion criteria|4|||
37890387|NCT00890097|69575380|FG002|Overall Study|Failed inclusion criteria|0|||
37823636|NCT03649230|69505430|FG000|Overall Study|Protocol Violation|1|||
37823637|NCT03649230|69505430|FG000|Overall Study|Non-compliance|1|||
37823638|NCT03649230|69505430|FG000|Overall Study|Patient Received Cisplatin days 1-3 q 3 weeks|1|||
37823639|NCT03626545|69505441|FG000|Overall Study|Progressive disease|3|||
37823640|NCT03626545|69505442|FG001|Overall Study|Progressive disease|82|||
37823641|NCT03626545|69505443|FG002|Overall Study|Progressive disease|85|||
37823642|NCT03626545|69505441|FG000|Overall Study|Adverse Event|3|||
37823643|NCT03626545|69505442|FG001|Overall Study|Adverse Event|13|||
37823644|NCT03626545|69505443|FG002|Overall Study|Adverse Event|10|||
37823645|NCT03626545|69505441|FG000|Overall Study|Physician Decision|1|||
37823646|NCT03626545|69505442|FG001|Overall Study|Physician Decision|18|||
37823647|NCT03626545|69505443|FG002|Overall Study|Physician Decision|14|||
37823648|NCT03626545|69505441|FG000|Overall Study|Subject Decision|0|||
37890388|NCT00890097|69575378|FG000|Overall Study|Transportation|0|||
37890389|NCT00890097|69575379|FG001|Overall Study|Transportation|2|||
37890390|NCT00890097|69575380|FG002|Overall Study|Transportation|0|||
37890391|NCT00890097|69575378|FG000|Overall Study|Subject Moved|0|||
37890392|NCT00890097|69575379|FG001|Overall Study|Subject Moved|4|||
37890393|NCT00890097|69575380|FG002|Overall Study|Subject Moved|0|||
37890394|NCT00890097|69575378|FG000|Overall Study|Protocol Deviation|1|||
37890395|NCT00890097|69575379|FG001|Overall Study|Protocol Deviation|1|||
37890396|NCT00890097|69575380|FG002|Overall Study|Protocol Deviation|1|||
37890397|NCT00913458|69575388|FG000|Phase 1|Non-Responder|54|||
37890398|NCT00913458|69575389|FG001|Phase 1|Non-Responder|0|||
37890399|NCT00913458|69575390|FG002|Phase 1|Non-Responder|0|||
37890400|NCT00913458|69575391|FG003|Phase 1|Non-Responder|0|||
37890401|NCT00913458|69575392|FG004|Phase 1|Non-Responder|0|||
37890402|NCT00913458|69575393|FG005|Phase 1|Non-Responder|0|||
37890403|NCT00913458|69575394|FG006|Phase 1|Non-Responder|0|||
37890404|NCT00913458|69575388|FG000|Phase 1|Subject Request|17|||
37890405|NCT00913458|69575389|FG001|Phase 1|Subject Request|0|||
37890406|NCT00913458|69575390|FG002|Phase 1|Subject Request|0|||
37890407|NCT00913458|69575391|FG003|Phase 1|Subject Request|0|||
37890408|NCT00913458|69575392|FG004|Phase 1|Subject Request|0|||
37890409|NCT00913458|69575393|FG005|Phase 1|Subject Request|0|||
37890410|NCT00913458|69575394|FG006|Phase 1|Subject Request|0|||
37823649|NCT03626545|69505442|FG001|Overall Study|Subject Decision|5|||
37823650|NCT03626545|69505443|FG002|Overall Study|Subject Decision|5|||
37823651|NCT03626545|69505441|FG000|Overall Study|Death|1|||
37823652|NCT03626545|69505442|FG001|Overall Study|Death|1|||
37823653|NCT03626545|69505443|FG002|Overall Study|Death|1|||
37823654|NCT03626545|69505441|FG000|Overall Study|Protocol Deviation|0|||
37823655|NCT03626545|69505442|FG001|Overall Study|Protocol Deviation|1|||
37823656|NCT03626545|69505443|FG002|Overall Study|Protocol Deviation|1|||
37823657|NCT03626545|69505441|FG000|Overall Study|Guardian Decision|0|||
37823658|NCT03626545|69505442|FG001|Overall Study|Guardian Decision|0|||
37823659|NCT03626545|69505443|FG002|Overall Study|Guardian Decision|1|||
37823660|NCT03575143|69505460|FG000|Overall Study|Lost to Follow-up|0|||
37890411|NCT00913458|69575388|FG000|Phase 1|Adverse Event|20|||
37890412|NCT00913458|69575389|FG001|Phase 1|Adverse Event|0|||
37823661|NCT03575143|69505461|FG001|Overall Study|Lost to Follow-up|0|||
37823662|NCT03575143|69505462|FG002|Overall Study|Lost to Follow-up|4|||
37823663|NCT03575143|69505460|FG000|Overall Study|Withdrawal by Subject|0|||
37823664|NCT03575143|69505461|FG001|Overall Study|Withdrawal by Subject|0|||
37823665|NCT03575143|69505462|FG002|Overall Study|Withdrawal by Subject|5|||
37823666|NCT03575143|69505460|FG000|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
37890413|NCT00913458|69575390|FG002|Phase 1|Adverse Event|0|||
37890414|NCT00913458|69575391|FG003|Phase 1|Adverse Event|0|||
37890415|NCT00913458|69575392|FG004|Phase 1|Adverse Event|0|||
37890416|NCT00913458|69575393|FG005|Phase 1|Adverse Event|0|||
37890417|NCT00913458|69575394|FG006|Phase 1|Adverse Event|0|||
37890418|NCT00913458|69575388|FG000|Phase 1|Lost to Follow-up|2|||
37890419|NCT00913458|69575389|FG001|Phase 1|Lost to Follow-up|0|||
37890420|NCT00913458|69575390|FG002|Phase 1|Lost to Follow-up|0|||
37890421|NCT00913458|69575391|FG003|Phase 1|Lost to Follow-up|0|||
37988315|NCT00393458|69673607|FG002|Overall Study|Death|5|||
37988316|NCT00393458|69673608|FG003|Overall Study|Death|5|||
37988317|NCT00393458|69673605|FG000|Overall Study|Abnormal test procedure result(s)|0|||
37988318|NCT00393458|69673606|FG001|Overall Study|Abnormal test procedure result(s)|1|||
37988319|NCT00393458|69673607|FG002|Overall Study|Abnormal test procedure result(s)|1|||
37988320|NCT00393458|69673608|FG003|Overall Study|Abnormal test procedure result(s)|2|||
37988321|NCT00393458|69673605|FG000|Overall Study|Subject no longer requires study drug|0|||
37988322|NCT00393458|69673606|FG001|Overall Study|Subject no longer requires study drug|1|||
37988323|NCT00393458|69673607|FG002|Overall Study|Subject no longer requires study drug|0|||
37988324|NCT00393458|69673608|FG003|Overall Study|Subject no longer requires study drug|0|||
37988325|NCT00417482|69673621|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
37988326|NCT00417482|69673622|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
37988327|NCT00417482|69673623|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
37988328|NCT00417482|69673621|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
37988329|NCT00417482|69673622|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
37988330|NCT00417482|69673623|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
37988331|NCT00417482|69673621|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
37988332|NCT00417482|69673622|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
37988333|NCT00417482|69673623|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
37988334|NCT00417482|69673621|FG000|Phase B 1st 16 Weeks|Death|1|||
37988335|NCT00417482|69673622|FG001|Phase B 1st 16 Weeks|Death|0|||
37988336|NCT00417482|69673623|FG002|Phase B 1st 16 Weeks|Death|0|||
37988337|NCT00417482|69673621|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
37988338|NCT00417482|69673622|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
37988339|NCT00417482|69673623|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
37988340|NCT00417482|69673621|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
37823667|NCT03575143|69505461|FG001|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
37823668|NCT03575143|69505462|FG002|Overall Study|new information provide after consent, no longer met inclusion criteria|2|||
37823669|NCT03548064|69505480|FG000|Overall Study|Withdrawal by Subject|0|||
37823670|NCT03548064|69505481|FG001|Overall Study|Withdrawal by Subject|0|||
37823671|NCT03548064|69505482|FG002|Overall Study|Withdrawal by Subject|0|||
37823672|NCT03548064|69505483|FG003|Overall Study|Withdrawal by Subject|1|||
37823673|NCT03548064|69505484|FG004|Overall Study|Withdrawal by Subject|0|||
37823674|NCT03548064|69505485|FG005|Overall Study|Withdrawal by Subject|0|||
37823675|NCT03548064|69505486|FG006|Overall Study|Withdrawal by Subject|0|||
37823676|NCT03548064|69505487|FG007|Overall Study|Withdrawal by Subject|0|||
37823677|NCT03548064|69505480|FG000|Overall Study|Lost to Follow-up|0|||
37823678|NCT03548064|69505481|FG001|Overall Study|Lost to Follow-up|0|||
37823679|NCT03548064|69505482|FG002|Overall Study|Lost to Follow-up|0|||
37823680|NCT03548064|69505483|FG003|Overall Study|Lost to Follow-up|0|||
37823681|NCT03548064|69505484|FG004|Overall Study|Lost to Follow-up|2|||
37823682|NCT03548064|69505485|FG005|Overall Study|Lost to Follow-up|0|||
37823683|NCT03548064|69505486|FG006|Overall Study|Lost to Follow-up|0|||
37823684|NCT03548064|69505487|FG007|Overall Study|Lost to Follow-up|0|||
37823685|NCT03548064|69505480|FG000|Overall Study|Covid-19 Pandemic|0|||
37823686|NCT03548064|69505481|FG001|Overall Study|Covid-19 Pandemic|0|||
37823687|NCT03548064|69505482|FG002|Overall Study|Covid-19 Pandemic|0|||
37823688|NCT03548064|69505483|FG003|Overall Study|Covid-19 Pandemic|0|||
37823689|NCT03548064|69505484|FG004|Overall Study|Covid-19 Pandemic|10|||
37823690|NCT03548064|69505485|FG005|Overall Study|Covid-19 Pandemic|3|||
37823691|NCT03548064|69505486|FG006|Overall Study|Covid-19 Pandemic|0|||
37823692|NCT03548064|69505487|FG007|Overall Study|Covid-19 Pandemic|0|||
37823693|NCT03512197|69505513|FG000|Overall Study|Guardian decision|1|||
37823694|NCT03512197|69505514|FG001|Overall Study|Guardian decision|1|||
37823695|NCT03512197|69505513|FG000|Overall Study|Lack of Efficacy|19|||
37823696|NCT03512197|69505514|FG001|Overall Study|Lack of Efficacy|11|||
37988341|NCT00417482|69673622|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
37988342|NCT00417482|69673623|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
37988343|NCT00417482|69673621|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
37823697|NCT03512197|69505513|FG000|Overall Study|New Therapy for Study Indication|16|||
37823698|NCT03512197|69505514|FG001|Overall Study|New Therapy for Study Indication|16|||
37823699|NCT03512197|69505513|FG000|Overall Study|Physician Decision|60|||
37823700|NCT03512197|69505514|FG001|Overall Study|Physician Decision|60|||
37988344|NCT00417482|69673622|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
37988345|NCT00417482|69673623|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
37988346|NCT00417482|69673621|FG000|Phase B 2nd 16 Weeks|Death|1|||
37988347|NCT00417482|69673622|FG001|Phase B 2nd 16 Weeks|Death|1|||
37988348|NCT00417482|69673623|FG002|Phase B 2nd 16 Weeks|Death|0|||
37890422|NCT00913458|69575392|FG004|Phase 1|Lost to Follow-up|0|||
37890423|NCT00913458|69575393|FG005|Phase 1|Lost to Follow-up|0|||
37890424|NCT00913458|69575394|FG006|Phase 1|Lost to Follow-up|0|||
37890425|NCT00913458|69575388|FG000|Phase 1|Protocol Violation|10|||
37890426|NCT00913458|69575389|FG001|Phase 1|Protocol Violation|0|||
37890427|NCT00913458|69575390|FG002|Phase 1|Protocol Violation|0|||
37890428|NCT00913458|69575391|FG003|Phase 1|Protocol Violation|0|||
37890429|NCT00913458|69575392|FG004|Phase 1|Protocol Violation|0|||
37890430|NCT00913458|69575393|FG005|Phase 1|Protocol Violation|0|||
37890431|NCT00913458|69575394|FG006|Phase 1|Protocol Violation|0|||
37890432|NCT00913458|69575388|FG000|Phase 1|Sponsor|2|||
37890433|NCT00913458|69575389|FG001|Phase 1|Sponsor|0|||
37890434|NCT00913458|69575390|FG002|Phase 1|Sponsor|0|||
37890435|NCT00913458|69575391|FG003|Phase 1|Sponsor|0|||
37988349|NCT00417248|69673637|FG000|Overall Study|Study Terminated|6|||
37988350|NCT00417248|69673637|FG000|Overall Study|Death|1|||
37988351|NCT00417248|69673637|FG000|Overall Study|Lack of Efficacy|1|||
37988352|NCT00392288|69673645|FG000|Overall Study|Adverse Event|17|||
37988353|NCT00392288|69673646|FG001|Overall Study|Adverse Event|7|||
37988354|NCT00392288|69673647|FG002|Overall Study|Adverse Event|8|||
37988355|NCT00392288|69673645|FG000|Overall Study|Lack of Efficacy|8|||
37988356|NCT00392288|69673646|FG001|Overall Study|Lack of Efficacy|5|||
37988357|NCT00392288|69673647|FG002|Overall Study|Lack of Efficacy|3|||
37988358|NCT00392288|69673645|FG000|Overall Study|Protocol Violation|1|||
37988359|NCT00392288|69673646|FG001|Overall Study|Protocol Violation|3|||
37890436|NCT00913458|69575392|FG004|Phase 1|Sponsor|0|||
37890437|NCT00913458|69575393|FG005|Phase 1|Sponsor|0|||
37890438|NCT00913458|69575394|FG006|Phase 1|Sponsor|0|||
37890439|NCT00913458|69575388|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
37890440|NCT00913458|69575389|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
37890441|NCT00913458|69575390|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
37890442|NCT00913458|69575391|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
37890443|NCT00913458|69575392|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
37890444|NCT00913458|69575393|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
37890445|NCT00913458|69575394|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
37890446|NCT00913458|69575388|FG000|Phase 2|Non-Responder|0|||
37890447|NCT00913458|69575389|FG001|Phase 2|Non-Responder|5|||
37890448|NCT00913458|69575390|FG002|Phase 2|Non-Responder|7|||
37890449|NCT00913458|69575391|FG003|Phase 2|Non-Responder|12|||
37890450|NCT00913458|69575392|FG004|Phase 2|Non-Responder|0|||
37988360|NCT00392288|69673647|FG002|Overall Study|Protocol Violation|1|||
37988361|NCT00392288|69673645|FG000|Overall Study|Lost to Follow-up|1|||
37988362|NCT00392288|69673646|FG001|Overall Study|Lost to Follow-up|1|||
37988363|NCT00392288|69673647|FG002|Overall Study|Lost to Follow-up|1|||
37988364|NCT00392288|69673645|FG000|Overall Study|Withdrawal by Subject|1|||
37890451|NCT00913458|69575393|FG005|Phase 2|Non-Responder|0|||
37890452|NCT00913458|69575394|FG006|Phase 2|Non-Responder|0|||
37890453|NCT00913458|69575388|FG000|Phase 2|Subject Request|0|||
37890454|NCT00913458|69575389|FG001|Phase 2|Subject Request|0|||
37890455|NCT00913458|69575390|FG002|Phase 2|Subject Request|1|||
37890456|NCT00913458|69575391|FG003|Phase 2|Subject Request|2|||
37890457|NCT00913458|69575392|FG004|Phase 2|Subject Request|0|||
37890458|NCT00913458|69575393|FG005|Phase 2|Subject Request|0|||
37890459|NCT00913458|69575394|FG006|Phase 2|Subject Request|0|||
37890460|NCT00913458|69575388|FG000|Phase 2|Adverse Event|0|||
37988365|NCT00392288|69673646|FG001|Overall Study|Withdrawal by Subject|0|||
37988366|NCT00392288|69673647|FG002|Overall Study|Withdrawal by Subject|2|||
37890461|NCT00913458|69575389|FG001|Phase 2|Adverse Event|3|||
37890462|NCT00913458|69575390|FG002|Phase 2|Adverse Event|0|||
37890463|NCT00913458|69575391|FG003|Phase 2|Adverse Event|1|||
37890464|NCT00913458|69575392|FG004|Phase 2|Adverse Event|0|||
37890465|NCT00913458|69575393|FG005|Phase 2|Adverse Event|0|||
37890466|NCT00913458|69575394|FG006|Phase 2|Adverse Event|0|||
37890467|NCT00913458|69575388|FG000|Phase 2|Lost to Follow-up|0|||
37890468|NCT00913458|69575389|FG001|Phase 2|Lost to Follow-up|0|||
37988367|NCT00392288|69673645|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
37988368|NCT00392288|69673646|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
37988369|NCT00392288|69673647|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
37988370|NCT00392288|69673645|FG000|Overall Study|Other|3|||
37988371|NCT00392288|69673646|FG001|Overall Study|Other|4|||
37988372|NCT00392288|69673647|FG002|Overall Study|Other|1|||
37988373|NCT00417170|69673657|FG000|Overall Study|Adverse Event|1|||
37823701|NCT03512197|69505513|FG000|Overall Study|Protocol Violation|0|||
37823702|NCT03512197|69505514|FG001|Overall Study|Protocol Violation|2|||
37823703|NCT03512197|69505513|FG000|Overall Study|Terminated by Sponsored|46|||
37823704|NCT03512197|69505514|FG001|Overall Study|Terminated by Sponsored|50|||
37823705|NCT03512197|69505513|FG000|Overall Study|Subject Decision|15|||
37823706|NCT03512197|69505514|FG001|Overall Study|Subject Decision|12|||
37823707|NCT03512197|69505513|FG000|Overall Study|Withdrawal of informed consent|20|||
37823708|NCT03512197|69505514|FG001|Overall Study|Withdrawal of informed consent|14|||
37823709|NCT03512197|69505513|FG000|Overall Study|Adverse Event|30|||
37823710|NCT03512197|69505514|FG001|Overall Study|Adverse Event|34|||
37823711|NCT03512197|69505513|FG000|Overall Study|Death|14|||
37823712|NCT03512197|69505514|FG001|Overall Study|Death|9|||
37823713|NCT03512197|69505513|FG000|Overall Study|Failure to meet Continuation Criteria|24|||
37823714|NCT03512197|69505514|FG001|Overall Study|Failure to meet Continuation Criteria|28|||
37823715|NCT03512197|69505513|FG000|Overall Study|Missing|3|||
37823716|NCT03512197|69505514|FG001|Overall Study|Missing|13|||
37823717|NCT03502330|69505534|FG000|Overall Study|Adverse Event|2|||
37823718|NCT03502330|69505535|FG001|Overall Study|Adverse Event|1|||
37823719|NCT03502330|69505536|FG002|Overall Study|Adverse Event|0|||
37823720|NCT03502330|69505537|FG003|Overall Study|Adverse Event|0|||
37823721|NCT03502330|69505538|FG004|Overall Study|Adverse Event|1|||
37988374|NCT00417170|69673658|FG001|Overall Study|Adverse Event|1|||
37988375|NCT00417170|69673657|FG000|Overall Study|Withdrawal by Subject|1|||
37823722|NCT03502330|69505539|FG005|Overall Study|Adverse Event|0|||
37823723|NCT03502330|69505540|FG006|Overall Study|Adverse Event|1|||
37823724|NCT03502330|69505541|FG007|Overall Study|Adverse Event|1|||
37890469|NCT00913458|69575390|FG002|Phase 2|Lost to Follow-up|0|||
37890470|NCT00913458|69575391|FG003|Phase 2|Lost to Follow-up|1|||
37823725|NCT03502330|69505542|FG008|Overall Study|Adverse Event|0|||
37890471|NCT00913458|69575392|FG004|Phase 2|Lost to Follow-up|0|||
37890472|NCT00913458|69575393|FG005|Phase 2|Lost to Follow-up|0|||
37890473|NCT00913458|69575394|FG006|Phase 2|Lost to Follow-up|0|||
37890474|NCT00913458|69575388|FG000|Phase 2|Protocol Violation|0|||
37890475|NCT00913458|69575389|FG001|Phase 2|Protocol Violation|2|||
37890476|NCT00913458|69575390|FG002|Phase 2|Protocol Violation|0|||
37890477|NCT00913458|69575391|FG003|Phase 2|Protocol Violation|0|||
37890478|NCT00913458|69575392|FG004|Phase 2|Protocol Violation|0|||
37890479|NCT00913458|69575393|FG005|Phase 2|Protocol Violation|0|||
37890480|NCT00913458|69575394|FG006|Phase 2|Protocol Violation|0|||
37890481|NCT00913458|69575388|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
37890482|NCT00913458|69575389|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
37890483|NCT00913458|69575390|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
37988376|NCT00417170|69673658|FG001|Overall Study|Withdrawal by Subject|1|||
37988377|NCT00417170|69673657|FG000|Overall Study|Lost to Follow-up|0|||
37988378|NCT00417170|69673658|FG001|Overall Study|Lost to Follow-up|1|||
37890484|NCT00913458|69575391|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
37890485|NCT00913458|69575392|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
37890486|NCT00913458|69575393|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
37890487|NCT00913458|69575394|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
37890488|NCT00913458|69575388|FG000|Phase 3|Adverse Event|0|||
37890489|NCT00913458|69575389|FG001|Phase 3|Adverse Event|0|||
37890490|NCT00913458|69575390|FG002|Phase 3|Adverse Event|0|||
37890491|NCT00913458|69575391|FG003|Phase 3|Adverse Event|0|||
37890492|NCT00913458|69575392|FG004|Phase 3|Adverse Event|5|||
37890493|NCT00913458|69575393|FG005|Phase 3|Adverse Event|4|||
37890494|NCT00913458|69575394|FG006|Phase 3|Adverse Event|1|||
37890495|NCT00913458|69575388|FG000|Phase 3|Lost to Follow-up|0|||
37890496|NCT00913458|69575389|FG001|Phase 3|Lost to Follow-up|0|||
37890497|NCT00913458|69575390|FG002|Phase 3|Lost to Follow-up|0|||
37890498|NCT00913458|69575391|FG003|Phase 3|Lost to Follow-up|0|||
37890499|NCT00913458|69575392|FG004|Phase 3|Lost to Follow-up|2|||
37890500|NCT00913458|69575393|FG005|Phase 3|Lost to Follow-up|0|||
37988379|NCT00392990|69673666|FG000|Treatment on Study|Adverse Event|3|||
37890501|NCT00913458|69575394|FG006|Phase 3|Lost to Follow-up|0|||
37890502|NCT00913458|69575388|FG000|Phase 3|Non-Responder|0|||
37890503|NCT00913458|69575389|FG001|Phase 3|Non-Responder|0|||
37988380|NCT00392990|69673667|FG001|Treatment on Study|Adverse Event|1|||
37988381|NCT00392990|69673666|FG000|Follow up for 2 Years|Death|4|||
37890504|NCT00913458|69575390|FG002|Phase 3|Non-Responder|0|||
37890505|NCT00913458|69575391|FG003|Phase 3|Non-Responder|0|||
37988382|NCT00392990|69673667|FG001|Follow up for 2 Years|Death|0|||
37988383|NCT00249873|69673675|FG000|Overall Study|Not treated|7|||
37890506|NCT00913458|69575392|FG004|Phase 3|Non-Responder|0|||
37890507|NCT00913458|69575393|FG005|Phase 3|Non-Responder|1|||
37890508|NCT00913458|69575394|FG006|Phase 3|Non-Responder|3|||
37890509|NCT00913458|69575388|FG000|Phase 3|Withdrawal by Subject|0|||
37890510|NCT00913458|69575389|FG001|Phase 3|Withdrawal by Subject|0|||
37890511|NCT00913458|69575390|FG002|Phase 3|Withdrawal by Subject|0|||
37890512|NCT00913458|69575391|FG003|Phase 3|Withdrawal by Subject|0|||
37890513|NCT00913458|69575392|FG004|Phase 3|Withdrawal by Subject|1|||
37890514|NCT00913458|69575393|FG005|Phase 3|Withdrawal by Subject|2|||
37890515|NCT00913458|69575394|FG006|Phase 3|Withdrawal by Subject|0|||
37890516|NCT00913458|69575388|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
37890517|NCT00913458|69575389|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
37890518|NCT00913458|69575390|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
37890519|NCT00913458|69575391|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
37890520|NCT00913458|69575392|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
37890521|NCT00913458|69575393|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
37890522|NCT00913458|69575394|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
37988384|NCT00249873|69673676|FG001|Overall Study|Not treated|8|||
37988385|NCT00249873|69673675|FG000|Overall Study|Significant thrombocytopenia|9|||
37988386|NCT00249873|69673676|FG001|Overall Study|Significant thrombocytopenia|8|||
37988387|NCT00249873|69673675|FG000|Overall Study|Severe allergic reaction|8|||
37988388|NCT00249873|69673676|FG001|Overall Study|Severe allergic reaction|1|||
37988389|NCT00249873|69673675|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
37988390|NCT00249873|69673676|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
37988391|NCT00249873|69673675|FG000|Overall Study|Other Serious Adverse Event|86|||
37988392|NCT00249873|69673676|FG001|Overall Study|Other Serious Adverse Event|97|||
37988393|NCT00249873|69673675|FG000|Overall Study|Qualifying condition not present|20|||
37988394|NCT00249873|69673676|FG001|Overall Study|Qualifying condition not present|23|||
37988395|NCT00249873|69673675|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
37988396|NCT00249873|69673676|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
37988397|NCT00249873|69673675|FG000|Overall Study|Withdrawal by Subject|504|||
37988398|NCT00249873|69673676|FG001|Overall Study|Withdrawal by Subject|466|||
37823726|NCT03502330|69505534|FG000|Overall Study|Lack of Efficacy|1|||
37823727|NCT03502330|69505535|FG001|Overall Study|Lack of Efficacy|5|||
37823728|NCT03502330|69505536|FG002|Overall Study|Lack of Efficacy|3|||
37823729|NCT03502330|69505537|FG003|Overall Study|Lack of Efficacy|5|||
37823730|NCT03502330|69505538|FG004|Overall Study|Lack of Efficacy|1|||
37823731|NCT03502330|69505539|FG005|Overall Study|Lack of Efficacy|5|||
37823732|NCT03502330|69505540|FG006|Overall Study|Lack of Efficacy|5|||
37823733|NCT03502330|69505541|FG007|Overall Study|Lack of Efficacy|6|||
37823734|NCT03502330|69505542|FG008|Overall Study|Lack of Efficacy|0|||
37823735|NCT03502330|69505534|FG000|Overall Study|Physician Decision|0|||
37823736|NCT03502330|69505535|FG001|Overall Study|Physician Decision|0|||
37823737|NCT03502330|69505536|FG002|Overall Study|Physician Decision|0|||
37823738|NCT03502330|69505537|FG003|Overall Study|Physician Decision|0|||
37823739|NCT03502330|69505538|FG004|Overall Study|Physician Decision|1|||
37823740|NCT03502330|69505539|FG005|Overall Study|Physician Decision|0|||
37823741|NCT03502330|69505540|FG006|Overall Study|Physician Decision|0|||
37890523|NCT00785707|69575411|FG000|Overall Study|Lost to Follow-up|7|||
37890524|NCT00913380|69575417|FG000|Clinical Outcomes|Lost to Follow-up|6|||
37988399|NCT00249873|69673675|FG000|Overall Study|Lost to Follow-up|4|||
37890525|NCT00913380|69575418|FG001|Clinical Outcomes|Lost to Follow-up|6|||
37988400|NCT00249873|69673676|FG001|Overall Study|Lost to Follow-up|7|||
37988401|NCT00249873|69673675|FG000|Overall Study|Minor bleeding|99|||
37823742|NCT03502330|69505541|FG007|Overall Study|Physician Decision|0|||
37823743|NCT03502330|69505542|FG008|Overall Study|Physician Decision|0|||
37823744|NCT03502330|69505534|FG000|Overall Study|Withdrawal by Subject|0|||
37890526|NCT00785629|69575428|FG000|Overall Study|Adverse Event|2|||
37988402|NCT00249873|69673676|FG001|Overall Study|Minor bleeding|37|||
37988403|NCT00249873|69673675|FG000|Overall Study|Non-compliance|41|||
37823745|NCT03502330|69505535|FG001|Overall Study|Withdrawal by Subject|0|||
37823746|NCT03502330|69505536|FG002|Overall Study|Withdrawal by Subject|0|||
37823747|NCT03502330|69505537|FG003|Overall Study|Withdrawal by Subject|0|||
37823748|NCT03502330|69505538|FG004|Overall Study|Withdrawal by Subject|0|||
37823749|NCT03502330|69505539|FG005|Overall Study|Withdrawal by Subject|1|||
37823750|NCT03502330|69505540|FG006|Overall Study|Withdrawal by Subject|0|||
37823751|NCT03502330|69505541|FG007|Overall Study|Withdrawal by Subject|1|||
37823752|NCT03502330|69505542|FG008|Overall Study|Withdrawal by Subject|0|||
37823753|NCT03502330|69505534|FG000|Overall Study|Death|0|||
37823754|NCT03502330|69505535|FG001|Overall Study|Death|0|||
37890527|NCT00785629|69575429|FG001|Overall Study|Adverse Event|1|||
37823755|NCT03502330|69505536|FG002|Overall Study|Death|0|||
37823756|NCT03502330|69505537|FG003|Overall Study|Death|0|||
37988404|NCT00249873|69673676|FG001|Overall Study|Non-compliance|46|||
37988405|NCT00249873|69673675|FG000|Overall Study|Other non serious Adverse Event|112|||
37823757|NCT03502330|69505538|FG004|Overall Study|Death|0|||
37823758|NCT03502330|69505539|FG005|Overall Study|Death|0|||
37823759|NCT03502330|69505540|FG006|Overall Study|Death|2|||
37823760|NCT03502330|69505541|FG007|Overall Study|Death|0|||
37823761|NCT03502330|69505542|FG008|Overall Study|Death|0|||
37823762|NCT03460756|69505564|FG000|Overall Study|Adverse Event|0|||
37823763|NCT03460756|69505565|FG001|Overall Study|Adverse Event|0|||
37823764|NCT03460756|69505566|FG002|Overall Study|Adverse Event|0|||
37823765|NCT03460756|69505567|FG003|Overall Study|Adverse Event|1|||
37890528|NCT00785629|69575430|FG002|Overall Study|Adverse Event|1|||
37890529|NCT00785629|69575431|FG003|Overall Study|Adverse Event|5|||
37988406|NCT00249873|69673676|FG001|Overall Study|Other non serious Adverse Event|108|||
37988407|NCT00249873|69673675|FG000|Overall Study|Other contraindicated medication|1|||
37890530|NCT00785629|69575428|FG000|Overall Study|Protocol Violation|1|||
37823766|NCT03460756|69505564|FG000|Overall Study|Lack of Efficacy|0|||
37890531|NCT00785629|69575429|FG001|Overall Study|Protocol Violation|2|||
37988408|NCT00249873|69673676|FG001|Overall Study|Other contraindicated medication|0|||
37988409|NCT00249873|69673675|FG000|Overall Study|Patient not wish to continue after May08|3|||
37988410|NCT00249873|69673676|FG001|Overall Study|Patient not wish to continue after May08|4|||
37988411|NCT00249873|69673675|FG000|Overall Study|Physician withdrew consent|59|||
37988412|NCT00249873|69673676|FG001|Overall Study|Physician withdrew consent|60|||
37988413|NCT00249873|69673675|FG000|Overall Study|Open label clopidogrel required|31|||
37988414|NCT00249873|69673676|FG001|Overall Study|Open label clopidogrel required|42|||
37988415|NCT00249873|69673675|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
37988416|NCT00249873|69673676|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
37695990|NCT02326220|69172144|FG001|Double-blind Treatment Period|Protocol Violation|1|||
37695991|NCT02326220|69172145|FG002|Double-blind Treatment Period|Protocol Violation|0|||
37695992|NCT02326220|69172143|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
37695993|NCT02326220|69172144|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
37695994|NCT02326220|69172145|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
37695995|NCT02326220|69172143|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
37695996|NCT02326220|69172144|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
37823767|NCT03460756|69505565|FG001|Overall Study|Lack of Efficacy|0|||
37823768|NCT03460756|69505566|FG002|Overall Study|Lack of Efficacy|0|||
37823769|NCT03460756|69505567|FG003|Overall Study|Lack of Efficacy|2|||
37823770|NCT03460756|69505564|FG000|Overall Study|Lost to Follow-up|0|||
37823771|NCT03460756|69505565|FG001|Overall Study|Lost to Follow-up|1|||
37823772|NCT03460756|69505566|FG002|Overall Study|Lost to Follow-up|2|||
37823773|NCT03460756|69505567|FG003|Overall Study|Lost to Follow-up|1|||
37823774|NCT03460756|69505564|FG000|Overall Study|Pregnancy|0|||
37823775|NCT03460756|69505565|FG001|Overall Study|Pregnancy|0|||
37823776|NCT03460756|69505566|FG002|Overall Study|Pregnancy|0|||
37890532|NCT00785629|69575430|FG002|Overall Study|Protocol Violation|4|||
37890533|NCT00785629|69575431|FG003|Overall Study|Protocol Violation|5|||
37890534|NCT00785629|69575428|FG000|Overall Study|administrative decision|5|||
37890535|NCT00785629|69575429|FG001|Overall Study|administrative decision|1|||
37890536|NCT00785629|69575430|FG002|Overall Study|administrative decision|3|||
37890537|NCT00785629|69575431|FG003|Overall Study|administrative decision|4|||
37890538|NCT00785629|69575428|FG000|Overall Study|Withdrawal by Subject|0|||
37823777|NCT03460756|69505567|FG003|Overall Study|Pregnancy|1|||
37823778|NCT03460756|69505564|FG000|Overall Study|Protocol Violation|0|||
37823779|NCT03460756|69505565|FG001|Overall Study|Protocol Violation|0|||
37823780|NCT03460756|69505566|FG002|Overall Study|Protocol Violation|0|||
37823781|NCT03460756|69505567|FG003|Overall Study|Protocol Violation|1|||
37823782|NCT03460756|69505564|FG000|Overall Study|Withdrawal by Subject|0|||
37823783|NCT03460756|69505565|FG001|Overall Study|Withdrawal by Subject|4|||
37890539|NCT00785629|69575429|FG001|Overall Study|Withdrawal by Subject|1|||
37890540|NCT00785629|69575430|FG002|Overall Study|Withdrawal by Subject|2|||
37890541|NCT00785629|69575431|FG003|Overall Study|Withdrawal by Subject|2|||
37823784|NCT03460756|69505566|FG002|Overall Study|Withdrawal by Subject|7|||
37823785|NCT03460756|69505567|FG003|Overall Study|Withdrawal by Subject|3|||
37823786|NCT03459443|69505579|FG000|Overall Study|Lack of Efficacy|3|||
37890542|NCT00916344|69575439|FG000|Overall Study|Death|2|||
37890543|NCT00916344|69575439|FG000|Overall Study|ICD upgrade|1|||
37890544|NCT00916344|69575439|FG000|Overall Study|Drop-out|5|||
37890545|NCT00913770|69575446|FG000|Overall Study|Unable to contact|24|||
37890546|NCT00913770|69575447|FG001|Overall Study|Unable to contact|19|||
37890547|NCT00913770|69575448|FG002|Overall Study|Unable to contact|13|||
37890548|NCT00913770|69575446|FG000|Overall Study|Refused|11|||
37890549|NCT00913770|69575447|FG001|Overall Study|Refused|10|||
37890550|NCT00913770|69575448|FG002|Overall Study|Refused|8|||
37988417|NCT00249873|69673675|FG000|Overall Study|Oral anticoagulant required|159|||
37988418|NCT00249873|69673676|FG001|Overall Study|Oral anticoagulant required|157|||
37823787|NCT03459443|69505579|FG000|Overall Study|Adverse Event|1|||
37890551|NCT00780559|69575458|FG000|Overall Study|Lost to Follow-up|2|||
37890552|NCT00780559|69575459|FG001|Overall Study|Lost to Follow-up|7|||
37890553|NCT00780559|69575458|FG000|Overall Study|Death|1|||
37823788|NCT03459443|69505579|FG000|Overall Study|Sponsor's decision to close the study|18|||
37890554|NCT00780559|69575459|FG001|Overall Study|Death|0|||
37890555|NCT00912912|69575467|FG000|Overall Study|Withdrawal by Subject|1|||
37823789|NCT03316885|69505592|FG000|Overall Study|Adverse Event|1|||
37823790|NCT03316885|69505592|FG000|Overall Study|Death|10|||
37823791|NCT03316885|69505592|FG000|Overall Study|Lost to Follow-up|4|||
37823792|NCT03316885|69505592|FG000|Overall Study|Withdrawal by Subject|9|||
37823793|NCT03316885|69505592|FG000|Overall Study|COVID related|8|||
37823794|NCT03259074|69505624|FG000|Overall Study|Adverse Event|9|||
37890556|NCT00912912|69575467|FG000|Overall Study|Disease Progression|3|||
37890557|NCT00889005|69575473|FG000|Overall Study|Lost to Follow-up|4|||
37890558|NCT00889005|69575474|FG001|Overall Study|Lost to Follow-up|2|||
37823795|NCT03259074|69505625|FG001|Overall Study|Adverse Event|12|||
37823796|NCT03259074|69505626|FG002|Overall Study|Adverse Event|8|||
37823797|NCT03259074|69505624|FG000|Overall Study|Death|1|||
37823798|NCT03259074|69505625|FG001|Overall Study|Death|1|||
37823799|NCT03259074|69505626|FG002|Overall Study|Death|3|||
37823800|NCT03259074|69505624|FG000|Overall Study|Lost to Follow-up|2|||
37890559|NCT00889005|69575473|FG000|Overall Study|Withdrawal by Subject|4|||
37988419|NCT00249873|69673675|FG000|Overall Study|Study drug intolerance|5|||
37988420|NCT00249873|69673676|FG001|Overall Study|Study drug intolerance|0|||
37988421|NCT00249873|69673675|FG000|Overall Study|Surgery/ procedure|9|||
37988422|NCT00249873|69673676|FG001|Overall Study|Surgery/ procedure|9|||
37988423|NCT00249873|69673675|FG000|Overall Study|Event related to cardiac condition|12|||
37988424|NCT00249873|69673676|FG001|Overall Study|Event related to cardiac condition|21|||
37988425|NCT00249873|69673675|FG000|Overall Study|Thromboembolic/outcome event|82|||
37988426|NCT00249873|69673676|FG001|Overall Study|Thromboembolic/outcome event|122|||
37988427|NCT00392210|69673684|FG000|First Voiding Trial|Physician Decision|2|||
37988428|NCT00392210|69673685|FG001|First Voiding Trial|Physician Decision|2|||
37988429|NCT00391976|69673694|FG000|Overall Study|Adverse Event|0|||
37988430|NCT00391976|69673695|FG001|Overall Study|Adverse Event|0|||
37988431|NCT00391976|69673696|FG002|Overall Study|Adverse Event|1|||
37988432|NCT00391976|69673694|FG000|Overall Study|Withdrawal of consent|0|||
37890560|NCT00889005|69575474|FG001|Overall Study|Withdrawal by Subject|0|||
37890561|NCT00779857|69575480|FG000|Overall Study|Death|1|||
37890562|NCT00779857|69575480|FG000|Overall Study|Withdrawal by Subject|3|||
37890563|NCT00779857|69575480|FG000|Overall Study|Missed Visit|2|||
37890564|NCT00913692|69575484|FG000|Screening (4 Months)|Physician Decision|3|||
37890565|NCT00913692|69575484|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
37890566|NCT00913692|69575484|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
37890567|NCT00784927|69575491|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
37890568|NCT00784927|69575491|FG000|Overall Study|Protocol Violation|1|||
37890569|NCT00784927|69575491|FG000|Overall Study|Ineligible|1|||
37890570|NCT00779779|69575496|FG000|Overall Study|Adverse Event|1|||
37890571|NCT00779779|69575496|FG000|Overall Study|Protocol Violation|14|||
37890572|NCT00779779|69575496|FG000|Overall Study|Withdrawal by Subject|4|||
37890573|NCT00779779|69575496|FG000|Overall Study|Lost to Follow-up|5|||
37890574|NCT00845728|69575502|FG000|Overall Study|Abnormal laboratory value (s)|2|||
37890575|NCT00845728|69575503|FG001|Overall Study|Abnormal laboratory value (s)|2|||
37890576|NCT00845728|69575502|FG000|Overall Study|Patient's inability to use the device|4|||
37890577|NCT00845728|69575503|FG001|Overall Study|Patient's inability to use the device|6|||
37890578|NCT00845728|69575502|FG000|Overall Study|Abnormal test procedure result (s)|7|||
37890579|NCT00845728|69575503|FG001|Overall Study|Abnormal test procedure result (s)|2|||
37890580|NCT00845728|69575502|FG000|Overall Study|Lost to Follow-up|22|||
37890581|NCT00845728|69575503|FG001|Overall Study|Lost to Follow-up|13|||
37890582|NCT00845728|69575502|FG000|Overall Study|Death|24|||
37890583|NCT00845728|69575503|FG001|Overall Study|Death|26|||
37890584|NCT00845728|69575502|FG000|Overall Study|Administrative Problems|34|||
37890585|NCT00845728|69575503|FG001|Overall Study|Administrative Problems|26|||
37890586|NCT00845728|69575502|FG000|Overall Study|Protocol Violation|36|||
37823801|NCT03259074|69505625|FG001|Overall Study|Lost to Follow-up|4|||
37823802|NCT03259074|69505626|FG002|Overall Study|Lost to Follow-up|3|||
37823803|NCT03259074|69505624|FG000|Overall Study|New Therapy For Study Indication|1|||
37823804|NCT03259074|69505625|FG001|Overall Study|New Therapy For Study Indication|2|||
37823805|NCT03259074|69505626|FG002|Overall Study|New Therapy For Study Indication|2|||
37823806|NCT03259074|69505624|FG000|Overall Study|Physician Decision|4|||
37823807|NCT03259074|69505625|FG001|Overall Study|Physician Decision|12|||
37823808|NCT03259074|69505626|FG002|Overall Study|Physician Decision|10|||
37823809|NCT03259074|69505624|FG000|Overall Study|Pregnancy|1|||
37823810|NCT03259074|69505625|FG001|Overall Study|Pregnancy|1|||
37823811|NCT03259074|69505626|FG002|Overall Study|Pregnancy|0|||
37823812|NCT03259074|69505624|FG000|Overall Study|Progressive Disease|1|||
37823813|NCT03259074|69505625|FG001|Overall Study|Progressive Disease|0|||
37823814|NCT03259074|69505626|FG002|Overall Study|Progressive Disease|0|||
37823815|NCT03259074|69505624|FG000|Overall Study|Protocol Deviation|1|||
37890587|NCT00845728|69575503|FG001|Overall Study|Protocol Violation|24|||
37890588|NCT00845728|69575502|FG000|Overall Study|Lack of Efficacy|51|||
37890589|NCT00845728|69575503|FG001|Overall Study|Lack of Efficacy|39|||
37988433|NCT00391976|69673695|FG001|Overall Study|Withdrawal of consent|1|||
37823816|NCT03259074|69505625|FG001|Overall Study|Protocol Deviation|1|||
37823817|NCT03259074|69505626|FG002|Overall Study|Protocol Deviation|3|||
37823818|NCT03259074|69505624|FG000|Overall Study|Subject/Guardian Decision|13|||
37823819|NCT03259074|69505625|FG001|Overall Study|Subject/Guardian Decision|16|||
37823820|NCT03259074|69505626|FG002|Overall Study|Subject/Guardian Decision|14|||
37823821|NCT03159104|69505636|FG000|Overall Study|Violation of inclusion criteria|1|||
37890590|NCT00845728|69575502|FG000|Overall Study|Adverse Event|101|||
37890591|NCT00845728|69575503|FG001|Overall Study|Adverse Event|96|||
37890592|NCT00845728|69575502|FG000|Overall Study|Withdrawal by Subject|105|||
37890593|NCT00845728|69575503|FG001|Overall Study|Withdrawal by Subject|108|||
37890594|NCT00779467|69575513|FG000|Overall Study|Lack of Efficacy|11|||
37890595|NCT00779467|69575514|FG001|Overall Study|Lack of Efficacy|2|||
37890596|NCT00779467|69575515|FG002|Overall Study|Lack of Efficacy|6|||
37890597|NCT00779467|69575516|FG003|Overall Study|Lack of Efficacy|11|||
37890598|NCT00779467|69575513|FG000|Overall Study|failed inclusion criteria|3|||
37890599|NCT00779467|69575514|FG001|Overall Study|failed inclusion criteria|3|||
37890600|NCT00779467|69575515|FG002|Overall Study|failed inclusion criteria|1|||
37890601|NCT00779467|69575516|FG003|Overall Study|failed inclusion criteria|2|||
37890602|NCT00779467|69575513|FG000|Overall Study|missing data|1|||
37890603|NCT00779467|69575514|FG001|Overall Study|missing data|0|||
37890604|NCT00779467|69575515|FG002|Overall Study|missing data|1|||
37890605|NCT00779467|69575516|FG003|Overall Study|missing data|4|||
37890606|NCT00779467|69575513|FG000|Overall Study|technical issue|0|||
37890607|NCT00779467|69575514|FG001|Overall Study|technical issue|0|||
37890608|NCT00779467|69575515|FG002|Overall Study|technical issue|2|||
37890609|NCT00779467|69575516|FG003|Overall Study|technical issue|1|||
37890610|NCT00779467|69575513|FG000|Overall Study|unavailable research staff|0|||
37890611|NCT00779467|69575514|FG001|Overall Study|unavailable research staff|0|||
37890612|NCT00779467|69575515|FG002|Overall Study|unavailable research staff|0|||
37890613|NCT00779467|69575516|FG003|Overall Study|unavailable research staff|1|||
37890614|NCT00778921|69575529|FG000|Overall Study|Adverse Event|9|||
37890615|NCT00778921|69575530|FG001|Overall Study|Adverse Event|10|||
37890616|NCT00778921|69575531|FG002|Overall Study|Adverse Event|14|||
37890617|NCT00778921|69575529|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
37890618|NCT00778921|69575530|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
37890619|NCT00778921|69575531|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
37988434|NCT00391976|69673696|FG002|Overall Study|Withdrawal of consent|1|||
37988435|NCT00391976|69673694|FG000|Overall Study|Lost to Follow-up|1|||
37988436|NCT00391976|69673695|FG001|Overall Study|Lost to Follow-up|2|||
37988437|NCT00391976|69673696|FG002|Overall Study|Lost to Follow-up|0|||
37823822|NCT03159104|69505637|FG001|Overall Study|Violation of inclusion criteria|2|||
37823823|NCT03149237|69505645|FG000|Overall Study|Withdrawal by Subject|4|||
37890620|NCT00778921|69575529|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
37890621|NCT00778921|69575530|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
37890622|NCT00778921|69575531|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
37890623|NCT00778921|69575529|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
37890624|NCT00778921|69575530|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
37890625|NCT00778921|69575531|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
37890626|NCT00778921|69575529|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
37890627|NCT00778921|69575530|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
37890628|NCT00778921|69575531|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
37890629|NCT00778921|69575529|FG000|Overall Study|Patient withdrew request|3|||
37890630|NCT00778921|69575530|FG001|Overall Study|Patient withdrew request|1|||
37823824|NCT03149237|69505646|FG001|Overall Study|Withdrawal by Subject|5|||
37890631|NCT00778921|69575531|FG002|Overall Study|Patient withdrew request|6|||
37988438|NCT00391976|69673694|FG000|Overall Study|Inappropriate enrollment|1|||
37988439|NCT00391976|69673695|FG001|Overall Study|Inappropriate enrollment|1|||
37988440|NCT00391976|69673696|FG002|Overall Study|Inappropriate enrollment|0|||
37988441|NCT00391976|69673694|FG000|Overall Study|Protocol deviation/violation|4|||
37988442|NCT00391976|69673695|FG001|Overall Study|Protocol deviation/violation|2|||
37988443|NCT00391976|69673696|FG002|Overall Study|Protocol deviation/violation|1|||
37988444|NCT00391976|69673694|FG000|Overall Study|Recurrence/no eradication of infection|21|||
37988445|NCT00391976|69673695|FG001|Overall Study|Recurrence/no eradication of infection|19|||
37988446|NCT00391976|69673696|FG002|Overall Study|Recurrence/no eradication of infection|0|||
37890632|NCT00778921|69575529|FG000|Overall Study|Lost to Follow-up|0|||
37890633|NCT00778921|69575530|FG001|Overall Study|Lost to Follow-up|2|||
37890634|NCT00778921|69575531|FG002|Overall Study|Lost to Follow-up|1|||
37890635|NCT00778921|69575529|FG000|Overall Study|Administrative Problems|1|||
37890636|NCT00778921|69575530|FG001|Overall Study|Administrative Problems|2|||
37890637|NCT00778921|69575531|FG002|Overall Study|Administrative Problems|0|||
37890638|NCT00778921|69575529|FG000|Overall Study|Protocol Violation|3|||
37890639|NCT00778921|69575530|FG001|Overall Study|Protocol Violation|0|||
37890640|NCT00778921|69575531|FG002|Overall Study|Protocol Violation|2|||
37890641|NCT00778921|69575529|FG000|Overall Study|Not treated|0|||
37890642|NCT00778921|69575530|FG001|Overall Study|Not treated|2|||
37890643|NCT00778921|69575531|FG002|Overall Study|Not treated|2|||
37890644|NCT00915876|69575541|FG000|Overall Study|Adverse Event|0|||
37890645|NCT00915876|69575542|FG001|Overall Study|Adverse Event|1|||
37890646|NCT00776659|69575548|FG000|Overall Study|Lost to Follow-up|15|||
37890647|NCT00776659|69575548|FG000|Overall Study|Withdrawal by Subject|10|||
37890648|NCT00776659|69575548|FG000|Overall Study|Study Terminated by Sponsor|1|||
37890649|NCT00825682|69575554|FG000|Overall Study|personal reasons/ inconvenience|13|||
37988447|NCT00391976|69673694|FG000|Overall Study|Unable to classify|0|||
37988448|NCT00391976|69673695|FG001|Overall Study|Unable to classify|0|||
37988449|NCT00391976|69673696|FG002|Overall Study|Unable to classify|1|||
37988450|NCT00391976|69673694|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
37988451|NCT00391976|69673695|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
37988452|NCT00391976|69673696|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
37988453|NCT00391898|69673708|FG000|Overall Study|Adverse Event|3|||
37988454|NCT00391898|69673709|FG001|Overall Study|Adverse Event|0|||
37823825|NCT03132467|69505652|FG000|Overall Study|Adverse Event|2|||
37823826|NCT03132467|69505652|FG000|Overall Study|Withdrawal by Subject|2|||
37823827|NCT03127852|69505659|FG000|Overall Study|Withdrawal by Subject|4|||
37823828|NCT03127852|69505660|FG001|Overall Study|Withdrawal by Subject|1|||
37823829|NCT03127852|69505659|FG000|Overall Study|Death|1|||
37823830|NCT03127852|69505660|FG001|Overall Study|Death|1|||
37823831|NCT03107793|69505666|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
37823832|NCT03107793|69505667|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
37823833|NCT03107793|69505668|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
37890650|NCT00825682|69575555|FG001|Overall Study|personal reasons/ inconvenience|5|||
37890651|NCT00833794|69575564|FG000|Open-label Phase|Adverse Event|225|||
37890652|NCT00833794|69575565|FG001|Open-label Phase|Adverse Event|0|||
37890653|NCT00833794|69575564|FG000|Open-label Phase|Lack of Efficacy|28|||
37890654|NCT00833794|69575565|FG001|Open-label Phase|Lack of Efficacy|0|||
37890655|NCT00833794|69575564|FG000|Open-label Phase|Withdrawal by Subject|48|||
37890656|NCT00833794|69575565|FG001|Open-label Phase|Withdrawal by Subject|0|||
37988455|NCT00391898|69673708|FG000|Overall Study|Other|8|||
37988456|NCT00391898|69673709|FG001|Overall Study|Other|10|||
37988457|NCT00391586|69673715|FG000|Overall Study|Progressive disease|13|||
37890657|NCT00833794|69575564|FG000|Open-label Phase|Physician Decision|20|||
37823834|NCT03107793|69505669|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
37823835|NCT03107793|69505670|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
37823836|NCT03107793|69505666|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
37988458|NCT00391586|69673715|FG000|Overall Study|Adverse Event|5|||
37988459|NCT00391586|69673715|FG000|Overall Study|Physician Decision|2|||
37890658|NCT00833794|69575565|FG001|Open-label Phase|Physician Decision|0|||
37890659|NCT00833794|69575564|FG000|Open-label Phase|Administrative reason|1|||
37890660|NCT00833794|69575565|FG001|Open-label Phase|Administrative reason|0|||
37890661|NCT00833794|69575564|FG000|Open-label Phase|Protocol Violation|47|||
37890662|NCT00833794|69575565|FG001|Open-label Phase|Protocol Violation|0|||
37890663|NCT00833794|69575564|FG000|Open-label Phase|Did not complete wash-out period|12|||
37890664|NCT00833794|69575565|FG001|Open-label Phase|Did not complete wash-out period|0|||
37890665|NCT00833794|69575564|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
37890666|NCT00833794|69575565|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
37890667|NCT00833794|69575564|FG000|Double-blind Phase|Adverse Event|44|||
37890668|NCT00833794|69575565|FG001|Double-blind Phase|Adverse Event|11|||
37890669|NCT00833794|69575564|FG000|Double-blind Phase|Lack of Efficacy|34|||
37890670|NCT00833794|69575565|FG001|Double-blind Phase|Lack of Efficacy|22|||
37890671|NCT00833794|69575564|FG000|Double-blind Phase|Withdrawal by Subject|23|||
37890672|NCT00833794|69575565|FG001|Double-blind Phase|Withdrawal by Subject|6|||
37988460|NCT00391586|69673715|FG000|Overall Study|Death|4|||
37988461|NCT00391430|69673722|FG000|Overall Study|Withdrawal by Subject|3|||
37890673|NCT00833794|69575564|FG000|Double-blind Phase|Physician Decision|4|||
37890674|NCT00833794|69575565|FG001|Double-blind Phase|Physician Decision|7|||
37890675|NCT00833794|69575564|FG000|Double-blind Phase|Administrative reason|1|||
37890676|NCT00833794|69575565|FG001|Double-blind Phase|Administrative reason|3|||
37890677|NCT00912288|69575575|FG000|Overall Study|Death|0|||
37890678|NCT00912288|69575576|FG001|Overall Study|Death|1|||
37890679|NCT00912288|69575575|FG000|Overall Study|Adverse Event|1|||
37890680|NCT00912288|69575576|FG001|Overall Study|Adverse Event|1|||
37890681|NCT00912288|69575575|FG000|Overall Study|Lost to Follow-up|1|||
37890682|NCT00912288|69575576|FG001|Overall Study|Lost to Follow-up|0|||
37890683|NCT00912288|69575575|FG000|Overall Study|Protocol Violation|1|||
37890684|NCT00912288|69575576|FG001|Overall Study|Protocol Violation|0|||
37890685|NCT00912288|69575575|FG000|Overall Study|Withdrawal by Subject|3|||
37890686|NCT00912288|69575576|FG001|Overall Study|Withdrawal by Subject|3|||
37890687|NCT00912288|69575575|FG000|Overall Study|Study terminated by sponsor|34|||
37890688|NCT00912288|69575576|FG001|Overall Study|Study terminated by sponsor|35|||
37890689|NCT00912288|69575575|FG000|Overall Study|Other|1|||
37890690|NCT00912288|69575576|FG001|Overall Study|Other|0|||
37988462|NCT00391430|69673723|FG001|Overall Study|Withdrawal by Subject|0|||
37988463|NCT00391430|69673724|FG002|Overall Study|Withdrawal by Subject|12|||
37988464|NCT00391274|69673734|FG000|Overall Study|Death Due to Study Disease|55|||
37988465|NCT00391274|69673735|FG001|Overall Study|Death Due to Study Disease|45|||
37823837|NCT03107793|69505667|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
37823838|NCT03107793|69505668|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
37988466|NCT00391274|69673734|FG000|Overall Study|Lost to Follow-up|0|||
37988467|NCT00391274|69673735|FG001|Overall Study|Lost to Follow-up|3|||
37988468|NCT00391274|69673734|FG000|Overall Study|Physician Decision|4|||
37988469|NCT00391274|69673735|FG001|Overall Study|Physician Decision|2|||
37988470|NCT00391274|69673734|FG000|Overall Study|Withdrawal by Subject|0|||
37988471|NCT00391274|69673735|FG001|Overall Study|Withdrawal by Subject|3|||
37823839|NCT03107793|69505669|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
37823840|NCT03107793|69505670|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
37823841|NCT03107793|69505666|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
37823842|NCT03107793|69505667|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
37823843|NCT03107793|69505668|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
37823844|NCT03107793|69505669|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
37823845|NCT03107793|69505670|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
37823846|NCT03107793|69505666|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
37823847|NCT03107793|69505667|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
37988472|NCT00391274|69673734|FG000|Overall Study|Death Due to Adverse Event|1|||
37988473|NCT00391274|69673735|FG001|Overall Study|Death Due to Adverse Event|3|||
37988474|NCT00391274|69673734|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
37823848|NCT03107793|69505668|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
37823849|NCT03107793|69505669|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
37823850|NCT03107793|69505670|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
37890691|NCT00778375|69575582|FG000|Overall Study|Ineligible|3|||
37890692|NCT00777829|69575588|FG000|Overall Study|Withdrawal by Subject|0|||
37890693|NCT00777829|69575589|FG001|Overall Study|Withdrawal by Subject|2|||
37890694|NCT00775021|69575597|FG000|First Intervention|Lost to Follow-up|1|||
37988475|NCT00391274|69673735|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
37890695|NCT00775021|69575598|FG001|First Intervention|Lost to Follow-up|0|||
37988476|NCT00391274|69673734|FG000|Overall Study|Death Not Study Related|0|||
37988477|NCT00391274|69673735|FG001|Overall Study|Death Not Study Related|1|||
37988478|NCT00391118|69673744|FG000|Overall Study|Adverse Event|3|||
37988479|NCT00391118|69673745|FG001|Overall Study|Adverse Event|10|||
37988480|NCT00391118|69673746|FG002|Overall Study|Adverse Event|7|||
37988481|NCT00391118|69673744|FG000|Overall Study|Lost to Follow-up|0|||
37988482|NCT00391118|69673745|FG001|Overall Study|Lost to Follow-up|2|||
37988483|NCT00391118|69673746|FG002|Overall Study|Lost to Follow-up|3|||
37988484|NCT00391118|69673744|FG000|Overall Study|Withdrawal by Subject|0|||
37988485|NCT00391118|69673745|FG001|Overall Study|Withdrawal by Subject|9|||
37988486|NCT00391118|69673746|FG002|Overall Study|Withdrawal by Subject|1|||
37823851|NCT03107793|69505666|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
37823852|NCT03107793|69505667|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
37823853|NCT03107793|69505668|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
37823854|NCT03107793|69505669|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
37823855|NCT03107793|69505670|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
37890696|NCT00775021|69575597|FG000|Second Intervention|Adverse Event|0|||
37890697|NCT00775021|69575598|FG001|Second Intervention|Adverse Event|1|||
37823856|NCT03107793|69505666|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
37823857|NCT03107793|69505667|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
37823858|NCT03107793|69505668|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
37823859|NCT03107793|69505669|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
37823860|NCT03107793|69505670|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
37823861|NCT03107793|69505666|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
37823862|NCT03107793|69505667|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
37890698|NCT00777205|69575606|FG000|Overall Study|Lost to Follow-up|25|||
37890699|NCT00777205|69575607|FG001|Overall Study|Lost to Follow-up|9|||
37890700|NCT00777205|69575606|FG000|Overall Study|Withdrawal by Subject|6|||
37890701|NCT00777205|69575607|FG001|Overall Study|Withdrawal by Subject|4|||
37890702|NCT00777205|69575606|FG000|Overall Study|Death|0|||
37890703|NCT00777205|69575607|FG001|Overall Study|Death|2|||
37890704|NCT00777205|69575606|FG000|Overall Study|Protocol Violation|0|||
37890705|NCT00777205|69575607|FG001|Overall Study|Protocol Violation|56|||
37890706|NCT00833638|69575618|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
37890707|NCT00833638|69575619|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
37890708|NCT00833638|69575620|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
37890709|NCT00833638|69575618|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
37890710|NCT00833638|69575619|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
37890711|NCT00833638|69575620|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
37890712|NCT00833638|69575618|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
37890713|NCT00833638|69575619|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
37890714|NCT00833638|69575620|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
37890715|NCT00833638|69575618|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
37890716|NCT00833638|69575619|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
37890717|NCT00833638|69575620|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
37890718|NCT00833638|69575618|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
37890719|NCT00833638|69575619|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
37890720|NCT00833638|69575620|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
37890721|NCT00833638|69575618|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
37890722|NCT00833638|69575619|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
37890723|NCT00833638|69575620|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
37890724|NCT00833638|69575618|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
37890725|NCT00833638|69575619|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
37890726|NCT00833638|69575620|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
37890727|NCT00833638|69575618|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
37890728|NCT00833638|69575619|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
37890729|NCT00833638|69575620|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
37890730|NCT00833638|69575618|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
37890731|NCT00833638|69575619|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
37890732|NCT00833638|69575620|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
37890733|NCT01041404|69575638|FG000|Overall Study|Adverse Event|45|||
37890734|NCT01041404|69575639|FG001|Overall Study|Adverse Event|35|||
37890735|NCT01041404|69575638|FG000|Overall Study|Lack of Efficacy|200|||
37988487|NCT00391118|69673744|FG000|Overall Study|Death|0|||
37988488|NCT00391118|69673745|FG001|Overall Study|Death|1|||
37988489|NCT00391118|69673746|FG002|Overall Study|Death|0|||
37988490|NCT00391118|69673744|FG000|Overall Study|Physician Decision|0|||
37988491|NCT00391118|69673745|FG001|Overall Study|Physician Decision|3|||
37988492|NCT00391118|69673746|FG002|Overall Study|Physician Decision|0|||
37823863|NCT03107793|69505668|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
37823864|NCT03107793|69505669|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
37988493|NCT00391118|69673744|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
37988494|NCT00391118|69673745|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
37890736|NCT01041404|69575639|FG001|Overall Study|Lack of Efficacy|210|||
37890737|NCT01041404|69575638|FG000|Overall Study|Violation of Selection Criteria|0|||
37890738|NCT01041404|69575639|FG001|Overall Study|Violation of Selection Criteria|1|||
37890739|NCT01041404|69575638|FG000|Overall Study|Protocol Violation|4|||
37890740|NCT01041404|69575639|FG001|Overall Study|Protocol Violation|0|||
37890741|NCT01041404|69575638|FG000|Overall Study|Withdrawal by Subject|29|||
37890742|NCT01041404|69575639|FG001|Overall Study|Withdrawal by Subject|23|||
37988495|NCT00391118|69673746|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
37988496|NCT00391118|69673744|FG000|Overall Study|Progressive Disease|7|||
37988497|NCT00391118|69673745|FG001|Overall Study|Progressive Disease|26|||
37988498|NCT00391118|69673746|FG002|Overall Study|Progressive Disease|43|||
37890743|NCT01041404|69575638|FG000|Overall Study|Failure to Return|1|||
37890744|NCT01041404|69575639|FG001|Overall Study|Failure to Return|2|||
37890745|NCT01041404|69575638|FG000|Overall Study|Other|11|||
37890746|NCT01041404|69575639|FG001|Overall Study|Other|23|||
37890747|NCT00777049|69575650|FG000|Overall Study|Withdrawal by Subject|1|||
37890748|NCT00777049|69575651|FG001|Overall Study|Withdrawal by Subject|0|||
37890749|NCT00777049|69575650|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
37890750|NCT00777049|69575651|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
37890751|NCT00774787|69575657|FG000|Overall Study|Lost to Follow-up|1|||
37890752|NCT00888927|69575665|FG000|Overall Study|Adverse Event|0|||
37890753|NCT00888927|69575666|FG001|Overall Study|Adverse Event|0|||
37890754|NCT00888927|69575667|FG002|Overall Study|Adverse Event|0|||
37890755|NCT00888927|69575668|FG003|Overall Study|Adverse Event|1|||
37890756|NCT00888927|69575665|FG000|Overall Study|Withdrawal of consent|0|||
37890757|NCT00888927|69575666|FG001|Overall Study|Withdrawal of consent|0|||
37890758|NCT00888927|69575667|FG002|Overall Study|Withdrawal of consent|0|||
37890759|NCT00888927|69575668|FG003|Overall Study|Withdrawal of consent|1|||
37890760|NCT01040780|69575680|FG000|Overall Study|Protocol Violation|1|||
37890761|NCT01040780|69575681|FG001|Overall Study|Protocol Violation|3|||
37890762|NCT00888849|69575692|FG000|Overall Study|Death|4|||
37890763|NCT00888849|69575693|FG001|Overall Study|Death|7|||
37890764|NCT00888849|69575692|FG000|Overall Study|Lost to Follow-up|1|||
37890765|NCT00888849|69575693|FG001|Overall Study|Lost to Follow-up|2|||
37890766|NCT01059812|69575701|FG000|Overall Study|Adverse Event|9|||
37890767|NCT01059812|69575702|FG001|Overall Study|Adverse Event|5|||
37890768|NCT01059812|69575701|FG000|Overall Study|Lack of Efficacy|2|||
37890769|NCT01059812|69575702|FG001|Overall Study|Lack of Efficacy|2|||
37890770|NCT01059812|69575701|FG000|Overall Study|Protocol Violation|3|||
37890771|NCT01059812|69575702|FG001|Overall Study|Protocol Violation|1|||
37890772|NCT01059812|69575701|FG000|Overall Study|Withdrawal Criteria|9|||
37890773|NCT01059812|69575702|FG001|Overall Study|Withdrawal Criteria|4|||
37890774|NCT01059812|69575701|FG000|Overall Study|Unclassified|14|||
37890775|NCT01059812|69575702|FG001|Overall Study|Unclassified|4|||
37890776|NCT00888615|69575708|FG000|Overall Study|No treatment|2|||
37988499|NCT00391118|69673744|FG000|Overall Study|Sponsor Decision|0|||
37988500|NCT00391118|69673745|FG001|Overall Study|Sponsor Decision|1|||
37890777|NCT00845650|69575718|FG000|Overall Study|Withdrawal by Subject|0|||
37890778|NCT00845650|69575719|FG001|Overall Study|Withdrawal by Subject|0|||
37890779|NCT00845650|69575720|FG002|Overall Study|Withdrawal by Subject|0|||
37890780|NCT00845650|69575721|FG003|Overall Study|Withdrawal by Subject|0|||
37890781|NCT00845650|69575722|FG004|Overall Study|Withdrawal by Subject|2|||
37890782|NCT00845650|69575723|FG005|Overall Study|Withdrawal by Subject|0|||
37988501|NCT00391118|69673746|FG002|Overall Study|Sponsor Decision|3|||
37890783|NCT00845650|69575718|FG000|Overall Study|Lost to Follow-up|0|||
37890784|NCT00845650|69575719|FG001|Overall Study|Lost to Follow-up|0|||
37890785|NCT00845650|69575720|FG002|Overall Study|Lost to Follow-up|3|||
37890786|NCT00845650|69575721|FG003|Overall Study|Lost to Follow-up|1|||
37890787|NCT00845650|69575722|FG004|Overall Study|Lost to Follow-up|0|||
37890788|NCT00845650|69575723|FG005|Overall Study|Lost to Follow-up|1|||
37890789|NCT00845650|69575718|FG000|Overall Study|Sponsor hold on dosing|0|||
37890790|NCT00845650|69575719|FG001|Overall Study|Sponsor hold on dosing|0|||
37890791|NCT00845650|69575720|FG002|Overall Study|Sponsor hold on dosing|0|||
37988502|NCT00391118|69673744|FG000|Overall Study|Protocol Violation|1|||
37988503|NCT00391118|69673745|FG001|Overall Study|Protocol Violation|0|||
37988504|NCT00391118|69673746|FG002|Overall Study|Protocol Violation|0|||
37988505|NCT00390884|69673759|FG000|Overall Study|Withdrawal by Subject|2|||
37890792|NCT00845650|69575721|FG003|Overall Study|Sponsor hold on dosing|0|||
37890793|NCT00845650|69575722|FG004|Overall Study|Sponsor hold on dosing|1|||
37890794|NCT00845650|69575723|FG005|Overall Study|Sponsor hold on dosing|1|||
37890795|NCT00845650|69575718|FG000|Overall Study|Unable to access IV line|1|||
37890796|NCT00845650|69575719|FG001|Overall Study|Unable to access IV line|0|||
37890797|NCT00845650|69575720|FG002|Overall Study|Unable to access IV line|0|||
37890798|NCT00845650|69575721|FG003|Overall Study|Unable to access IV line|0|||
37890799|NCT00845650|69575722|FG004|Overall Study|Unable to access IV line|0|||
37890800|NCT00845650|69575723|FG005|Overall Study|Unable to access IV line|0|||
37890801|NCT00888381|69575741|FG000|Overall Study|Lost to Follow-up|0|||
37890802|NCT00888381|69575742|FG001|Overall Study|Lost to Follow-up|1|||
37890803|NCT00887913|69575748|FG000|Overall Study|Withdrawal by Subject|6|||
37890804|NCT00833560|69575752|FG000|Overall Study|Toxicity|13|||
37890805|NCT00833560|69575752|FG000|Overall Study|Adverse Event|11|||
37890806|NCT00833560|69575752|FG000|Overall Study|Protocol Violation|6|||
37890807|NCT00833560|69575752|FG000|Overall Study|Lack of Efficacy|4|||
37890808|NCT00833560|69575752|FG000|Overall Study|Death|2|||
37988506|NCT00390884|69673760|FG001|Overall Study|Withdrawal by Subject|2|||
37988507|NCT00365846|69673766|FG000|Overall Study|Lost to Follow-up|1|||
37988508|NCT00264537|69673776|FG000|Overall Study|Death|0|||
37988509|NCT00264537|69673777|FG001|Overall Study|Death|3|||
37988510|NCT00264537|69673778|FG002|Overall Study|Death|3|||
37988511|NCT00264537|69673779|FG003|Overall Study|Death|2|||
37988512|NCT00264537|69673776|FG000|Overall Study|Lost to Follow-up|3|||
37988513|NCT00264537|69673777|FG001|Overall Study|Lost to Follow-up|4|||
37890809|NCT00833560|69575752|FG000|Overall Study|Pregression of other disease|1|||
37890810|NCT00833560|69575752|FG000|Overall Study|Other|5|||
37890811|NCT00887679|69575756|FG000|Overall Study|Withdrawal by Subject|1|||
37890812|NCT00887679|69575756|FG000|Overall Study|Lost to Follow-up|4|||
37890813|NCT00887679|69575756|FG000|Overall Study|Physician Decision|5|||
37890814|NCT00833482|69575763|FG000|Days 11-20|Adverse Event|0|||
37890815|NCT00833482|69575764|FG001|Days 11-20|Adverse Event|2|||
37890816|NCT00833482|69575765|FG002|Days 11-20|Adverse Event|0|||
37890817|NCT00833482|69575766|FG003|Days 11-20|Adverse Event|0|||
37890818|NCT00833482|69575767|FG004|Days 11-20|Adverse Event|0|||
37890819|NCT00833482|69575768|FG005|Days 11-20|Adverse Event|0|||
37890820|NCT00833482|69575763|FG000|Days 11-20|Withdrawal by Subject|0|||
37890821|NCT00833482|69575764|FG001|Days 11-20|Withdrawal by Subject|1|||
37890822|NCT00833482|69575765|FG002|Days 11-20|Withdrawal by Subject|0|||
37890823|NCT00833482|69575766|FG003|Days 11-20|Withdrawal by Subject|0|||
37890824|NCT00833482|69575767|FG004|Days 11-20|Withdrawal by Subject|0|||
37890825|NCT00833482|69575768|FG005|Days 11-20|Withdrawal by Subject|0|||
37890826|NCT00833482|69575763|FG000|Days 21-30|Adverse Event|0|||
37890827|NCT00833482|69575764|FG001|Days 21-30|Adverse Event|0|||
37890828|NCT00833482|69575765|FG002|Days 21-30|Adverse Event|1|||
37890829|NCT00833482|69575766|FG003|Days 21-30|Adverse Event|0|||
37890830|NCT00833482|69575767|FG004|Days 21-30|Adverse Event|0|||
37890831|NCT00833482|69575768|FG005|Days 21-30|Adverse Event|0|||
37890832|NCT00833482|69575763|FG000|Days 21-30|Withdrawal by Subject|0|||
37890833|NCT00833482|69575764|FG001|Days 21-30|Withdrawal by Subject|0|||
37890834|NCT00833482|69575765|FG002|Days 21-30|Withdrawal by Subject|0|||
37890835|NCT00833482|69575766|FG003|Days 21-30|Withdrawal by Subject|0|||
37890836|NCT00833482|69575767|FG004|Days 21-30|Withdrawal by Subject|1|||
37890837|NCT00833482|69575768|FG005|Days 21-30|Withdrawal by Subject|0|||
37890838|NCT00845182|69575793|FG000|Overall Study|Lost to Follow-up|3|||
37890839|NCT00845182|69575794|FG001|Overall Study|Lost to Follow-up|3|||
37890840|NCT00845182|69575795|FG002|Overall Study|Lost to Follow-up|4|||
37890841|NCT00845182|69575793|FG000|Overall Study|Adverse Event|0|||
37890842|NCT00845182|69575794|FG001|Overall Study|Adverse Event|1|||
37890843|NCT00845182|69575795|FG002|Overall Study|Adverse Event|1|||
37988514|NCT00264537|69673778|FG002|Overall Study|Lost to Follow-up|7|||
37988515|NCT00264537|69673779|FG003|Overall Study|Lost to Follow-up|6|||
37890844|NCT00845182|69575793|FG000|Overall Study|Physician Decision|0|||
37890845|NCT00845182|69575794|FG001|Overall Study|Physician Decision|0|||
37890846|NCT00845182|69575795|FG002|Overall Study|Physician Decision|1|||
37890847|NCT00833248|69575809|FG000|Overall Study|Adverse Event|3|||
37890848|NCT00833248|69575810|FG001|Overall Study|Adverse Event|0|||
37890849|NCT00833248|69575809|FG000|Overall Study|Protocol Violation|1|||
37890850|NCT00833248|69575810|FG001|Overall Study|Protocol Violation|2|||
37890851|NCT00833248|69575809|FG000|Overall Study|Withdrawal by Subject|0|||
37890852|NCT00833248|69575810|FG001|Overall Study|Withdrawal by Subject|1|||
37890853|NCT00887289|69575816|FG000|Overall Study|Lack of Efficacy|14|||
37890854|NCT00887289|69575816|FG000|Overall Study|Adverse Event|27|||
37890855|NCT00887289|69575816|FG000|Overall Study|Withdrawal by Subject|26|||
37890856|NCT00887289|69575816|FG000|Overall Study|Lost to Follow-up|8|||
37890857|NCT00887289|69575816|FG000|Overall Study|Other|20|||
37988516|NCT00264537|69673776|FG000|Overall Study|Adverse Event|21|||
37988517|NCT00264537|69673777|FG001|Overall Study|Adverse Event|32|||
37988518|NCT00264537|69673778|FG002|Overall Study|Adverse Event|24|||
37890858|NCT00833092|69575822|FG000|Overall Study|Withdrawal by Subject|2|||
37890859|NCT00833092|69575823|FG001|Overall Study|Withdrawal by Subject|3|||
37890860|NCT00833092|69575822|FG000|Overall Study|Protocol Violation|2|||
37890861|NCT00833092|69575823|FG001|Overall Study|Protocol Violation|1|||
37890862|NCT00833092|69575822|FG000|Overall Study|Diarrhea|0|||
37890863|NCT00833092|69575823|FG001|Overall Study|Diarrhea|2|||
37890864|NCT00833092|69575822|FG000|Overall Study|constipation|0|||
37890865|NCT00833092|69575823|FG001|Overall Study|constipation|1|||
37890866|NCT00823264|69575831|FG000|Overall Study|Protocol Violation|2|||
37890867|NCT00823264|69575832|FG001|Overall Study|Protocol Violation|0|||
37890868|NCT00832780|69575838|FG000|Overall Study|Death|16|||
37890869|NCT00832780|69575838|FG000|Overall Study|Lost to Follow-up|4|||
37890870|NCT00832780|69575838|FG000|Overall Study|no reason given|2|||
37890871|NCT00832780|69575838|FG000|Overall Study|other complicating condition|2|||
37890872|NCT00832780|69575838|FG000|Overall Study|Physician Decision|1|||
37890873|NCT00591838|69575847|FG000|Overall Study|Withdrawal by Subject|0|||
37890874|NCT00591838|69575848|FG001|Overall Study|Withdrawal by Subject|0|||
37890875|NCT00591838|69575849|FG002|Overall Study|Withdrawal by Subject|0|||
37890876|NCT00591838|69575850|FG003|Overall Study|Withdrawal by Subject|1|||
37890877|NCT00591838|69575851|FG004|Overall Study|Withdrawal by Subject|0|||
37890878|NCT00832624|69575864|FG000|Overall Study|Study Terminated|10|||
37890879|NCT00832078|69575868|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
37890880|NCT00832078|69575869|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
37890881|NCT00832078|69575868|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
37890882|NCT00832078|69575869|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
37890883|NCT00822172|69575877|FG000|Overall Study|Adverse Event|10|||
37890884|NCT00822172|69575878|FG001|Overall Study|Adverse Event|12|||
37890885|NCT00822172|69575877|FG000|Overall Study|Death|1|||
37890886|NCT00822172|69575878|FG001|Overall Study|Death|0|||
37890887|NCT00822172|69575877|FG000|Overall Study|Lost to Follow-up|3|||
37890888|NCT00822172|69575878|FG001|Overall Study|Lost to Follow-up|1|||
37890889|NCT00822172|69575877|FG000|Overall Study|Withdrawal by Subject|1|||
37890890|NCT00822172|69575878|FG001|Overall Study|Withdrawal by Subject|4|||
37988519|NCT00264537|69673779|FG003|Overall Study|Adverse Event|34|||
37988520|NCT00264537|69673776|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
37988521|NCT00264537|69673777|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
37890891|NCT00822172|69575877|FG000|Overall Study|site closed|0|||
37890892|NCT00822172|69575878|FG001|Overall Study|site closed|1|||
37890893|NCT00822172|69575877|FG000|Overall Study|Other|0|||
37890894|NCT00822172|69575878|FG001|Overall Study|Other|1|||
37890895|NCT00832000|69575884|FG000|Overall Study|Adverse Event|2|||
37890896|NCT00832000|69575885|FG001|Overall Study|Adverse Event|0|||
37890897|NCT00832000|69575884|FG000|Overall Study|Withdrawal by Subject|1|||
37890898|NCT00832000|69575885|FG001|Overall Study|Withdrawal by Subject|0|||
37890899|NCT00832000|69575884|FG000|Overall Study|No calls to IVR in either period|1|||
37890900|NCT00832000|69575885|FG001|Overall Study|No calls to IVR in either period|1|||
37823865|NCT03107793|69505670|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
37823866|NCT03107793|69505666|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
37823867|NCT03107793|69505667|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
37823868|NCT03107793|69505668|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
37823869|NCT03107793|69505669|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
37823870|NCT03107793|69505670|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
37823871|NCT03107793|69505666|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
37823872|NCT03107793|69505667|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
37823873|NCT03107793|69505668|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
37890901|NCT00832000|69575884|FG000|Overall Study|No calls to IVR in period 2|2|||
37890902|NCT00832000|69575885|FG001|Overall Study|No calls to IVR in period 2|0|||
37890903|NCT00911508|69575922|FG000|Overall Study|Lost to Follow-up|27|||
37890904|NCT00911508|69575923|FG001|Overall Study|Lost to Follow-up|18|||
37890905|NCT00911508|69575922|FG000|Overall Study|Withdrawal by Subject|79|||
37890906|NCT00911508|69575923|FG001|Overall Study|Withdrawal by Subject|112|||
37988522|NCT00264537|69673778|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
37823874|NCT03107793|69505669|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
37823875|NCT03107793|69505670|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
37823876|NCT03107793|69505666|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
37890907|NCT00774397|69575949|FG000|Overall Study|Adverse Event|1|||
37890908|NCT00774397|69575950|FG001|Overall Study|Adverse Event|3|||
37890909|NCT00774397|69575951|FG002|Overall Study|Adverse Event|16|||
37890910|NCT00774397|69575952|FG003|Overall Study|Adverse Event|8|||
37890911|NCT00774397|69575953|FG004|Overall Study|Adverse Event|8|||
37890912|NCT00774397|69575954|FG005|Overall Study|Adverse Event|3|||
37890913|NCT00774397|69575955|FG006|Overall Study|Adverse Event|16|||
37890914|NCT00774397|69575949|FG000|Overall Study|Lack of Efficacy|11|||
37890915|NCT00774397|69575950|FG001|Overall Study|Lack of Efficacy|4|||
37890916|NCT00774397|69575951|FG002|Overall Study|Lack of Efficacy|5|||
37890917|NCT00774397|69575952|FG003|Overall Study|Lack of Efficacy|3|||
37890918|NCT00774397|69575953|FG004|Overall Study|Lack of Efficacy|27|||
37890919|NCT00774397|69575954|FG005|Overall Study|Lack of Efficacy|15|||
37890920|NCT00774397|69575955|FG006|Overall Study|Lack of Efficacy|9|||
37890921|NCT00774397|69575949|FG000|Overall Study|Protocol Violation|0|||
37890922|NCT00774397|69575950|FG001|Overall Study|Protocol Violation|1|||
37890923|NCT00774397|69575951|FG002|Overall Study|Protocol Violation|3|||
37890924|NCT00774397|69575952|FG003|Overall Study|Protocol Violation|1|||
37890925|NCT00774397|69575953|FG004|Overall Study|Protocol Violation|2|||
37890926|NCT00774397|69575954|FG005|Overall Study|Protocol Violation|1|||
37890927|NCT00774397|69575955|FG006|Overall Study|Protocol Violation|0|||
37890928|NCT00774397|69575949|FG000|Overall Study|Lost to Follow-up|0|||
37890929|NCT00774397|69575950|FG001|Overall Study|Lost to Follow-up|1|||
37890930|NCT00774397|69575951|FG002|Overall Study|Lost to Follow-up|1|||
37890931|NCT00774397|69575952|FG003|Overall Study|Lost to Follow-up|1|||
37890932|NCT00774397|69575953|FG004|Overall Study|Lost to Follow-up|0|||
37890933|NCT00774397|69575954|FG005|Overall Study|Lost to Follow-up|1|||
37890934|NCT00774397|69575955|FG006|Overall Study|Lost to Follow-up|0|||
37890935|NCT00774397|69575949|FG000|Overall Study|Refused to continue trial medication|1|||
37890936|NCT00774397|69575950|FG001|Overall Study|Refused to continue trial medication|3|||
37890937|NCT00774397|69575951|FG002|Overall Study|Refused to continue trial medication|2|||
37890938|NCT00774397|69575952|FG003|Overall Study|Refused to continue trial medication|2|||
37890939|NCT00774397|69575953|FG004|Overall Study|Refused to continue trial medication|6|||
37890940|NCT00774397|69575954|FG005|Overall Study|Refused to continue trial medication|2|||
37890941|NCT00774397|69575955|FG006|Overall Study|Refused to continue trial medication|3|||
37890942|NCT00774397|69575949|FG000|Overall Study|Not treated|0|||
37823877|NCT03107793|69505667|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
37823878|NCT03107793|69505668|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
37823879|NCT03107793|69505669|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
37823880|NCT03107793|69505670|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
37823881|NCT03107793|69505666|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
37823882|NCT03107793|69505667|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
37823883|NCT03107793|69505668|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
37823884|NCT03107793|69505669|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
37823885|NCT03107793|69505670|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
37823886|NCT03107793|69505666|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
37823887|NCT03107793|69505667|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
37823888|NCT03107793|69505668|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
37823889|NCT03107793|69505669|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
37823890|NCT03107793|69505670|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
37823891|NCT03107793|69505666|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
37823892|NCT03107793|69505667|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
37823893|NCT03107793|69505668|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
37823894|NCT03107793|69505669|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
37823895|NCT03107793|69505670|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
37823896|NCT03107793|69505666|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
37823897|NCT03107793|69505667|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
37823898|NCT03107793|69505668|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
37823899|NCT03107793|69505669|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
37823900|NCT03107793|69505670|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
37823901|NCT03107793|69505666|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
37823902|NCT03107793|69505667|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
37890943|NCT00774397|69575950|FG001|Overall Study|Not treated|0|||
37890944|NCT00774397|69575951|FG002|Overall Study|Not treated|0|||
37890945|NCT00774397|69575952|FG003|Overall Study|Not treated|0|||
37890946|NCT00774397|69575953|FG004|Overall Study|Not treated|1|||
37890947|NCT00774397|69575954|FG005|Overall Study|Not treated|0|||
37890948|NCT00774397|69575955|FG006|Overall Study|Not treated|1|||
37890949|NCT00774397|69575949|FG000|Overall Study|Other than those stated above|1|||
37890950|NCT00774397|69575950|FG001|Overall Study|Other than those stated above|1|||
37890951|NCT00774397|69575951|FG002|Overall Study|Other than those stated above|3|||
37890952|NCT00774397|69575952|FG003|Overall Study|Other than those stated above|2|||
37890953|NCT00774397|69575953|FG004|Overall Study|Other than those stated above|2|||
37890954|NCT00774397|69575954|FG005|Overall Study|Other than those stated above|0|||
37890955|NCT00774397|69575955|FG006|Overall Study|Other than those stated above|1|||
37890956|NCT00909870|69576010|FG000|Overall Study|Adverse Event|13|||
37988523|NCT00264537|69673779|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
37988524|NCT00264537|69673776|FG000|Overall Study|Other|21|||
37988525|NCT00264537|69673777|FG001|Overall Study|Other|11|||
37988526|NCT00264537|69673778|FG002|Overall Study|Other|10|||
37988527|NCT00264537|69673779|FG003|Overall Study|Other|11|||
37988528|NCT00264537|69673776|FG000|Overall Study|Not treated|0|||
37988529|NCT00264537|69673777|FG001|Overall Study|Not treated|2|||
37988530|NCT00264537|69673778|FG002|Overall Study|Not treated|1|||
37890957|NCT00909870|69576011|FG001|Overall Study|Adverse Event|7|||
37890958|NCT00909870|69576010|FG000|Overall Study|Protocol Violation|1|||
37890959|NCT00909870|69576011|FG001|Overall Study|Protocol Violation|2|||
37890960|NCT00909870|69576010|FG000|Overall Study|Withdrawal by Subject|5|||
37890961|NCT00909870|69576011|FG001|Overall Study|Withdrawal by Subject|8|||
37890962|NCT00909870|69576010|FG000|Overall Study|Lost to Follow-up|3|||
37890963|NCT00909870|69576011|FG001|Overall Study|Lost to Follow-up|3|||
37695997|NCT02326220|69172145|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
37695998|NCT02326220|69172143|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
37890964|NCT00909870|69576010|FG000|Overall Study|Physician Decision|0|||
37890965|NCT00909870|69576011|FG001|Overall Study|Physician Decision|2|||
37890966|NCT00909870|69576010|FG000|Overall Study|Other|1|||
37890967|NCT00909870|69576011|FG001|Overall Study|Other|5|||
37890968|NCT00768469|69576020|FG000|Overall Study|Adverse Event|0|||
37890969|NCT00768469|69576021|FG001|Overall Study|Adverse Event|2|||
37890970|NCT00768469|69576020|FG000|Overall Study|Disease Progression|3|||
37890971|NCT00768469|69576021|FG001|Overall Study|Disease Progression|4|||
37890972|NCT00768469|69576020|FG000|Overall Study|Withdrawal by Subject|0|||
37890973|NCT00768469|69576021|FG001|Overall Study|Withdrawal by Subject|1|||
37890974|NCT00886821|69576042|FG000|Stage 2|Adverse Event|0|||
37988531|NCT00264537|69673779|FG003|Overall Study|Not treated|0|||
37988532|NCT00371462|69673793|FG000|Overall Study|Withdrawal by Subject|1|||
37890975|NCT00886821|69576043|FG001|Stage 2|Adverse Event|0|||
37890976|NCT00886821|69576044|FG002|Stage 2|Adverse Event|0|||
37890977|NCT00886821|69576045|FG003|Stage 2|Adverse Event|0|||
37890978|NCT00886821|69576046|FG004|Stage 2|Adverse Event|0|||
37890979|NCT00886821|69576047|FG005|Stage 2|Adverse Event|0|||
37988533|NCT00371462|69673794|FG001|Overall Study|Withdrawal by Subject|0|||
37988534|NCT00371462|69673793|FG000|Overall Study|Other|7|||
37988535|NCT00371462|69673794|FG001|Overall Study|Other|8|||
37988536|NCT00371150|69673802|FG000|Overall Study|Lost to Follow-up|3|||
37988537|NCT00371150|69673803|FG001|Overall Study|Lost to Follow-up|2|||
37988538|NCT00264303|69673815|FG000|Overall Study|Adverse Event|4|||
37988539|NCT00264303|69673816|FG001|Overall Study|Adverse Event|3|||
37890980|NCT00886821|69576048|FG006|Stage 2|Adverse Event|0|||
37890981|NCT00886821|69576049|FG007|Stage 2|Adverse Event|0|||
37890982|NCT00886821|69576050|FG008|Stage 2|Adverse Event|0|||
37890983|NCT00886821|69576051|FG009|Stage 2|Adverse Event|0|||
37988540|NCT00264303|69673815|FG000|Overall Study|Lack of Efficacy|10|||
37988541|NCT00264303|69673816|FG001|Overall Study|Lack of Efficacy|13|||
37988542|NCT00264303|69673815|FG000|Overall Study|Lost to Follow-up|3|||
37988543|NCT00264303|69673816|FG001|Overall Study|Lost to Follow-up|3|||
37988544|NCT00264303|69673815|FG000|Overall Study|Withdrawal by Subject|2|||
37823903|NCT03107793|69505668|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
37988545|NCT00264303|69673816|FG001|Overall Study|Withdrawal by Subject|3|||
37823904|NCT03107793|69505669|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
37823905|NCT03107793|69505670|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
37823906|NCT03107793|69505666|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
37823907|NCT03107793|69505667|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
37823908|NCT03107793|69505668|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
37823909|NCT03107793|69505669|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
37890984|NCT00886821|69576052|FG010|Stage 2|Adverse Event|0|||
37890985|NCT00886821|69576053|FG011|Stage 2|Adverse Event|1|||
37890986|NCT00886821|69576054|FG012|Stage 2|Adverse Event|3|||
37890987|NCT00886821|69576055|FG013|Stage 2|Adverse Event|0|||
37890988|NCT00886821|69576042|FG000|Stage 2|Lost to Follow-up|0|||
37890989|NCT00886821|69576043|FG001|Stage 2|Lost to Follow-up|0|||
37890990|NCT00886821|69576044|FG002|Stage 2|Lost to Follow-up|0|||
37890991|NCT00886821|69576045|FG003|Stage 2|Lost to Follow-up|0|||
37890992|NCT00886821|69576046|FG004|Stage 2|Lost to Follow-up|0|||
37890993|NCT00886821|69576047|FG005|Stage 2|Lost to Follow-up|0|||
37890994|NCT00886821|69576048|FG006|Stage 2|Lost to Follow-up|0|||
37890995|NCT00886821|69576049|FG007|Stage 2|Lost to Follow-up|0|||
37890996|NCT00886821|69576050|FG008|Stage 2|Lost to Follow-up|0|||
37890997|NCT00886821|69576051|FG009|Stage 2|Lost to Follow-up|0|||
37890998|NCT00886821|69576052|FG010|Stage 2|Lost to Follow-up|0|||
37890999|NCT00886821|69576053|FG011|Stage 2|Lost to Follow-up|0|||
37891000|NCT00886821|69576054|FG012|Stage 2|Lost to Follow-up|2|||
37891001|NCT00886821|69576055|FG013|Stage 2|Lost to Follow-up|1|||
37891002|NCT00886743|69576099|FG000|Overall Study|Adverse Event|3|||
37891003|NCT00886743|69576099|FG000|Overall Study|Other|1|||
37891004|NCT00886587|69576105|FG000|Overall Study|Adverse Event|2|||
37891005|NCT00886587|69576106|FG001|Overall Study|Adverse Event|1|||
37891006|NCT00886587|69576105|FG000|Overall Study|Protocol Violation|2|||
37891007|NCT00886587|69576106|FG001|Overall Study|Protocol Violation|0|||
37891008|NCT00886587|69576105|FG000|Overall Study|Withdrawal by Subject|0|||
37891009|NCT00886587|69576106|FG001|Overall Study|Withdrawal by Subject|1|||
37891010|NCT00886119|69576112|FG000|Period 1|Did not meet inclusion criteria|1|||
37891011|NCT00886119|69576113|FG001|Period 1|Did not meet inclusion criteria|0|||
37891012|NCT00768079|69576122|FG000|Overall Study|Lost to Follow-up|2|||
37891013|NCT00768079|69576123|FG001|Overall Study|Lost to Follow-up|0|||
37891014|NCT00768079|69576124|FG002|Overall Study|Lost to Follow-up|4|||
37891015|NCT00768079|69576122|FG000|Overall Study|Participant incarcerated|0|||
37695999|NCT02326220|69172144|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
37696000|NCT02326220|69172145|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
37696001|NCT02279173|69172155|FG000|Overall Study|Protocol-specified Criteria|67|||
37891016|NCT00768079|69576123|FG001|Overall Study|Participant incarcerated|1|||
37891017|NCT00768079|69576124|FG002|Overall Study|Participant incarcerated|0|||
37891018|NCT00767455|69576134|FG000|Overall Study|Investigator error|19|||
37891019|NCT00766831|69576140|FG000|Overall Study|Withdrawal by Subject|4|||
37891020|NCT00766831|69576140|FG000|Overall Study|Lost to Follow-up|3|||
37891021|NCT00766831|69576140|FG000|Overall Study|Adverse Event|20|||
37891022|NCT00766831|69576140|FG000|Overall Study|Protocol Violation|15|||
37891023|NCT00766831|69576140|FG000|Overall Study|Physician Decision|5|||
37891024|NCT00766831|69576140|FG000|Overall Study|Withdrawal of consent|26|||
37891025|NCT00766831|69576140|FG000|Overall Study|Non cooperation by participants|14|||
37891026|NCT00766831|69576140|FG000|Overall Study|Other|28|||
37891027|NCT00766675|69576144|FG000|Overall Study|Adverse Event|16|||
37891028|NCT00766675|69576144|FG000|Overall Study|Lost to Follow-up|2|||
37891029|NCT00766675|69576144|FG000|Overall Study|Withdrawal by Subject|11|||
37891030|NCT00766675|69576144|FG000|Overall Study|Protocol Violation|8|||
37891031|NCT00766675|69576144|FG000|Overall Study|Participant took prohibited medication|1|||
37891032|NCT00766675|69576144|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
37891033|NCT00766675|69576144|FG000|Overall Study|Insufficient therapy|1|||
37891034|NCT00766597|69576148|FG000|Overall Study|Unexpected closure of study|4|||
37891035|NCT00766597|69576148|FG000|Overall Study|Without CCR5-tropic virus|5|||
37891036|NCT00910962|69576157|FG000|Overall Study|Adverse Event|5|||
37891037|NCT00910962|69576158|FG001|Overall Study|Adverse Event|20|||
37891038|NCT00910962|69576159|FG002|Overall Study|Adverse Event|17|||
37891039|NCT00910962|69576157|FG000|Overall Study|Protocol Violation|1|||
37891040|NCT00910962|69576158|FG001|Overall Study|Protocol Violation|3|||
37696002|NCT02279173|69172155|FG000|Overall Study|Withdrawal by Subject|20|||
37696003|NCT02279173|69172155|FG000|Overall Study|Decision by Sponsor|4|||
37891041|NCT00910962|69576159|FG002|Overall Study|Protocol Violation|3|||
37891042|NCT00910962|69576157|FG000|Overall Study|Lost to Follow-up|0|||
37891043|NCT00910962|69576158|FG001|Overall Study|Lost to Follow-up|3|||
37891044|NCT00910962|69576159|FG002|Overall Study|Lost to Follow-up|1|||
37891045|NCT00910962|69576157|FG000|Overall Study|Physician Decision|0|||
37891046|NCT00910962|69576158|FG001|Overall Study|Physician Decision|6|||
37891047|NCT00910962|69576159|FG002|Overall Study|Physician Decision|6|||
37696004|NCT02279173|69172155|FG000|Overall Study|Lost to Follow-up|3|||
37891048|NCT00910962|69576157|FG000|Overall Study|Withdrawal by Subject|25|||
37891049|NCT00910962|69576158|FG001|Overall Study|Withdrawal by Subject|32|||
37891050|NCT00910962|69576159|FG002|Overall Study|Withdrawal by Subject|32|||
37891051|NCT00910962|69576157|FG000|Overall Study|Reached defined stopping criteria|12|||
37891052|NCT00910962|69576158|FG001|Overall Study|Reached defined stopping criteria|14|||
37891053|NCT00910962|69576159|FG002|Overall Study|Reached defined stopping criteria|17|||
37891054|NCT00773461|69576171|FG000|Overall Study|Adverse Event|1|||
37891055|NCT00773461|69576172|FG001|Overall Study|Adverse Event|3|||
37891056|NCT00773461|69576171|FG000|Overall Study|Withdrawal by Subject|4|||
37891057|NCT00773461|69576172|FG001|Overall Study|Withdrawal by Subject|1|||
37891058|NCT00773383|69576179|FG000|Overall Study|Adverse Event|4|||
37891059|NCT00773383|69576179|FG000|Overall Study|Death|1|||
37891060|NCT00773383|69576179|FG000|Overall Study|Progression of Disease|23|||
37891061|NCT00773383|69576179|FG000|Overall Study|Other|2|||
37891062|NCT00773383|69576179|FG000|Overall Study|No study dose received|1|||
37891063|NCT00757003|69576187|FG000|Overall Study|Death|33|||
37891064|NCT00757003|69576187|FG000|Overall Study|Lost to Follow-up|9|||
37891065|NCT00757003|69576187|FG000|Overall Study|Withdrawal by Subject|4|||
37891066|NCT00757003|69576187|FG000|Overall Study|Surgically explanted|2|||
37891067|NCT00757003|69576187|FG000|Overall Study|Not implanted|1|||
37891068|NCT00766363|69576196|FG000|Overall Study|Withdrawal by Subject|1|||
37891069|NCT00766363|69576197|FG001|Overall Study|Withdrawal by Subject|0|||
37891070|NCT00766363|69576198|FG002|Overall Study|Withdrawal by Subject|0|||
37891071|NCT00766363|69576199|FG003|Overall Study|Withdrawal by Subject|0|||
37891072|NCT00766363|69576196|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
37891073|NCT00766363|69576197|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
37891074|NCT00766363|69576198|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
37891075|NCT00766363|69576199|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
37891076|NCT02636946|69576212|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
37988546|NCT00264303|69673815|FG000|Overall Study|Various reasons listed in study report|6|||
37988547|NCT00264303|69673816|FG001|Overall Study|Various reasons listed in study report|7|||
37988548|NCT00370682|69673825|FG000|Overall Study|Moved from area|0|||
37988549|NCT00370682|69673826|FG001|Overall Study|Moved from area|2|||
37988550|NCT00370682|69673827|FG002|Overall Study|Moved from area|0|||
37988551|NCT00370682|69673825|FG000|Overall Study|Lost to Follow-up|0|||
37988552|NCT00370682|69673826|FG001|Overall Study|Lost to Follow-up|1|||
37988553|NCT00370682|69673827|FG002|Overall Study|Lost to Follow-up|1|||
37823910|NCT03107793|69505670|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
37823911|NCT03107793|69505666|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
37823912|NCT03107793|69505667|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
37823913|NCT03107793|69505668|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
37823914|NCT03107793|69505669|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
37823915|NCT03107793|69505670|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
37823916|NCT03107793|69505666|FG000|Extension Period (Week 48- Week 104)|Death|0|||
37823917|NCT03107793|69505667|FG001|Extension Period (Week 48- Week 104)|Death|0|||
37823918|NCT03107793|69505668|FG002|Extension Period (Week 48- Week 104)|Death|0|||
37823919|NCT03107793|69505669|FG003|Extension Period (Week 48- Week 104)|Death|0|||
37823920|NCT03107793|69505670|FG004|Extension Period (Week 48- Week 104)|Death|1|||
37823921|NCT03107793|69505666|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
37823922|NCT03107793|69505667|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
37823923|NCT03107793|69505668|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
37823924|NCT03107793|69505669|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
37823925|NCT03107793|69505670|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
37823926|NCT03107793|69505666|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
37823927|NCT03107793|69505667|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
37823928|NCT03107793|69505668|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
37823929|NCT03107793|69505669|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
37823930|NCT03107793|69505670|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
37823931|NCT03107793|69505666|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
37823932|NCT03107793|69505667|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
37823933|NCT03107793|69505668|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
37823934|NCT03107793|69505669|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
37823935|NCT03107793|69505670|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
37823936|NCT03107793|69505666|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
37833617|NCT01262872|69517331|FG004|Step 2|Migrated/moved from study area|2|||
37891077|NCT02636946|69576213|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
37891078|NCT02636946|69576212|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
37988554|NCT00264147|69673844|FG000|Treatment I Period|Adverse Event|3|||
37891079|NCT02636946|69576213|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
37891080|NCT02636946|69576212|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
37891081|NCT02636946|69576213|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
37988555|NCT00264147|69673845|FG001|Treatment I Period|Adverse Event|6|||
37988556|NCT00264147|69673846|FG002|Treatment I Period|Adverse Event|3|||
37988557|NCT00264147|69673847|FG003|Treatment I Period|Adverse Event|5|||
37988558|NCT00264147|69673848|FG004|Treatment I Period|Adverse Event|7|||
37988559|NCT00264147|69673849|FG005|Treatment I Period|Adverse Event|0|||
37988560|NCT00264147|69673844|FG000|Treatment I Period|Laboratory Adverse Event|0|||
37988561|NCT00264147|69673845|FG001|Treatment I Period|Laboratory Adverse Event|0|||
37988562|NCT00264147|69673846|FG002|Treatment I Period|Laboratory Adverse Event|0|||
37988563|NCT00264147|69673847|FG003|Treatment I Period|Laboratory Adverse Event|1|||
37988564|NCT00264147|69673848|FG004|Treatment I Period|Laboratory Adverse Event|0|||
37988565|NCT00264147|69673849|FG005|Treatment I Period|Laboratory Adverse Event|0|||
37988566|NCT00264147|69673844|FG000|Treatment I Period|Lack of Efficacy|6|||
37988567|NCT00264147|69673845|FG001|Treatment I Period|Lack of Efficacy|2|||
37988568|NCT00264147|69673846|FG002|Treatment I Period|Lack of Efficacy|8|||
37988569|NCT00264147|69673847|FG003|Treatment I Period|Lack of Efficacy|0|||
37988570|NCT00264147|69673848|FG004|Treatment I Period|Lack of Efficacy|1|||
37988571|NCT00264147|69673849|FG005|Treatment I Period|Lack of Efficacy|0|||
37988572|NCT00264147|69673844|FG000|Treatment I Period|Lost to Follow-up|1|||
37988573|NCT00264147|69673845|FG001|Treatment I Period|Lost to Follow-up|0|||
37988574|NCT00264147|69673846|FG002|Treatment I Period|Lost to Follow-up|0|||
37988575|NCT00264147|69673847|FG003|Treatment I Period|Lost to Follow-up|1|||
37988576|NCT00264147|69673848|FG004|Treatment I Period|Lost to Follow-up|1|||
37988577|NCT00264147|69673849|FG005|Treatment I Period|Lost to Follow-up|0|||
37988578|NCT00264147|69673844|FG000|Treatment I Period|Protocol Violation|2|||
37988579|NCT00264147|69673845|FG001|Treatment I Period|Protocol Violation|2|||
37988580|NCT00264147|69673846|FG002|Treatment I Period|Protocol Violation|0|||
37988581|NCT00264147|69673847|FG003|Treatment I Period|Protocol Violation|0|||
37988582|NCT00264147|69673848|FG004|Treatment I Period|Protocol Violation|0|||
37988583|NCT00264147|69673849|FG005|Treatment I Period|Protocol Violation|0|||
37988584|NCT00264147|69673844|FG000|Treatment I Period|Withdrawal by Subject|2|||
37988585|NCT00264147|69673845|FG001|Treatment I Period|Withdrawal by Subject|0|||
37988586|NCT00264147|69673846|FG002|Treatment I Period|Withdrawal by Subject|0|||
37988587|NCT00264147|69673847|FG003|Treatment I Period|Withdrawal by Subject|2|||
37988588|NCT00264147|69673848|FG004|Treatment I Period|Withdrawal by Subject|2|||
37988589|NCT00264147|69673849|FG005|Treatment I Period|Withdrawal by Subject|0|||
37988590|NCT00264147|69673844|FG000|Treatment I Period|Patient out of town for an extended time|0|||
37988591|NCT00264147|69673845|FG001|Treatment I Period|Patient out of town for an extended time|1|||
37988592|NCT00264147|69673846|FG002|Treatment I Period|Patient out of town for an extended time|0|||
37988593|NCT00264147|69673847|FG003|Treatment I Period|Patient out of town for an extended time|0|||
37988594|NCT00264147|69673848|FG004|Treatment I Period|Patient out of town for an extended time|0|||
37988595|NCT00264147|69673849|FG005|Treatment I Period|Patient out of town for an extended time|0|||
37988596|NCT00264147|69673844|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
37988597|NCT00264147|69673845|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
37988598|NCT00264147|69673846|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
37988599|NCT00264147|69673847|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
37988600|NCT00264147|69673848|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
37988601|NCT00264147|69673849|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
37988602|NCT00264147|69673844|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
37988603|NCT00264147|69673845|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
37988604|NCT00264147|69673846|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
37988605|NCT00264147|69673847|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
37988606|NCT00264147|69673848|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
37988607|NCT00264147|69673849|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
37988608|NCT00264147|69673844|FG000|Treatment II Period|Adverse Event|0|||
37988609|NCT00264147|69673845|FG001|Treatment II Period|Adverse Event|0|||
37988610|NCT00264147|69673846|FG002|Treatment II Period|Adverse Event|0|||
37988611|NCT00264147|69673847|FG003|Treatment II Period|Adverse Event|0|||
37988612|NCT00264147|69673848|FG004|Treatment II Period|Adverse Event|9|||
37988613|NCT00264147|69673849|FG005|Treatment II Period|Adverse Event|9|||
37988614|NCT00264147|69673844|FG000|Treatment II Period|Laboratory Adverse Event|0|||
37988615|NCT00264147|69673845|FG001|Treatment II Period|Laboratory Adverse Event|0|||
37988616|NCT00264147|69673846|FG002|Treatment II Period|Laboratory Adverse Event|0|||
37988617|NCT00264147|69673847|FG003|Treatment II Period|Laboratory Adverse Event|0|||
37988618|NCT00264147|69673848|FG004|Treatment II Period|Laboratory Adverse Event|0|||
37988619|NCT00264147|69673849|FG005|Treatment II Period|Laboratory Adverse Event|1|||
37988620|NCT00264147|69673844|FG000|Treatment II Period|Lack of Efficacy|0|||
37988621|NCT00264147|69673845|FG001|Treatment II Period|Lack of Efficacy|0|||
37988622|NCT00264147|69673846|FG002|Treatment II Period|Lack of Efficacy|0|||
37891082|NCT02636946|69576212|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
37891083|NCT02636946|69576213|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
37891084|NCT02636946|69576212|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
37891085|NCT02636946|69576213|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
37891086|NCT02636946|69576212|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
37891087|NCT02636946|69576213|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
37891088|NCT00766051|69576221|FG000|Overall Study|Withdrawal by Subject|2|||
37891089|NCT00766051|69576222|FG001|Overall Study|Withdrawal by Subject|0|||
37891090|NCT00909792|69576230|FG000|Period 1|Did not meet inclusion criteria|0|||
37891091|NCT00909792|69576231|FG001|Period 1|Did not meet inclusion criteria|1|||
37891092|NCT00909792|69576230|FG000|Period 2|Biomicroscopy|1|||
37891093|NCT00909792|69576231|FG001|Period 2|Biomicroscopy|0|||
37891094|NCT00909792|69576230|FG000|Period 2|Lost to Follow-up|0|||
37891095|NCT00909792|69576231|FG001|Period 2|Lost to Follow-up|1|||
37891096|NCT00765817|69576239|FG000|Overall Study|Adverse Event|13|||
37891097|NCT00765817|69576240|FG001|Overall Study|Adverse Event|1|||
37891098|NCT00765817|69576239|FG000|Overall Study|Death|0|||
37891099|NCT00765817|69576240|FG001|Overall Study|Death|1|||
37891100|NCT00765817|69576239|FG000|Overall Study|Entry criteria not met|2|||
37891101|NCT00765817|69576240|FG001|Overall Study|Entry criteria not met|2|||
37891102|NCT00765817|69576239|FG000|Overall Study|Loss of glucose control|0|||
37891103|NCT00765817|69576240|FG001|Overall Study|Loss of glucose control|2|||
37891104|NCT00765817|69576239|FG000|Overall Study|Lost to Follow-up|1|||
37891105|NCT00765817|69576240|FG001|Overall Study|Lost to Follow-up|3|||
37891106|NCT00765817|69576239|FG000|Overall Study|Physician Decision|2|||
37891107|NCT00765817|69576240|FG001|Overall Study|Physician Decision|1|||
37891108|NCT00765817|69576239|FG000|Overall Study|Protocol Violation|1|||
37891109|NCT00765817|69576240|FG001|Overall Study|Protocol Violation|1|||
37891110|NCT00765817|69576239|FG000|Overall Study|Subject decision|7|||
37891111|NCT00765817|69576240|FG001|Overall Study|Subject decision|11|||
37891112|NCT00772603|69576249|FG000|Overall Study|Withdrawal by Subject|11|||
37823937|NCT03107793|69505667|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
37823938|NCT03107793|69505668|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
37823939|NCT03107793|69505669|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
37823940|NCT03107793|69505670|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
37823941|NCT03107793|69505666|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
37823942|NCT03107793|69505667|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
37823943|NCT03107793|69505668|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
37823944|NCT03107793|69505669|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
37823945|NCT03107793|69505670|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
37823946|NCT03107793|69505666|FG000|Extension Period (Week 48- Week 104)|Other|0|||
37823947|NCT03107793|69505667|FG001|Extension Period (Week 48- Week 104)|Other|0|||
37823948|NCT03107793|69505668|FG002|Extension Period (Week 48- Week 104)|Other|0|||
37823949|NCT03107793|69505669|FG003|Extension Period (Week 48- Week 104)|Other|1|||
37823950|NCT03107793|69505670|FG004|Extension Period (Week 48- Week 104)|Other|3|||
37891113|NCT00772603|69576250|FG001|Overall Study|Withdrawal by Subject|10|||
37891114|NCT00772603|69576251|FG002|Overall Study|Withdrawal by Subject|6|||
37891115|NCT00772603|69576249|FG000|Overall Study|Adverse Event|37|||
37891116|NCT00772603|69576250|FG001|Overall Study|Adverse Event|18|||
37891117|NCT00772603|69576251|FG002|Overall Study|Adverse Event|10|||
37891118|NCT00772603|69576249|FG000|Overall Study|Subject Non-compliance|1|||
37891119|NCT00772603|69576250|FG001|Overall Study|Subject Non-compliance|6|||
37988623|NCT00264147|69673847|FG003|Treatment II Period|Lack of Efficacy|0|||
37891120|NCT00772603|69576251|FG002|Overall Study|Subject Non-compliance|4|||
37891121|NCT00772603|69576249|FG000|Overall Study|Protocol Violation|0|||
37891122|NCT00772603|69576250|FG001|Overall Study|Protocol Violation|1|||
37891123|NCT00772603|69576251|FG002|Overall Study|Protocol Violation|1|||
37891124|NCT00772603|69576249|FG000|Overall Study|Lost to Follow-up|1|||
37891125|NCT00772603|69576250|FG001|Overall Study|Lost to Follow-up|5|||
37891126|NCT00772603|69576251|FG002|Overall Study|Lost to Follow-up|2|||
37891127|NCT00772603|69576249|FG000|Overall Study|Physician Decision|0|||
37891128|NCT00772603|69576250|FG001|Overall Study|Physician Decision|0|||
37891129|NCT00772603|69576251|FG002|Overall Study|Physician Decision|1|||
37891130|NCT00772603|69576249|FG000|Overall Study|Other|2|||
37891131|NCT00772603|69576250|FG001|Overall Study|Other|0|||
37891132|NCT00772603|69576251|FG002|Overall Study|Other|2|||
37891133|NCT00772447|69576264|FG000|Overall Study|Withdrawal by Subject|9|||
37891134|NCT00772447|69576265|FG001|Overall Study|Withdrawal by Subject|5|||
37891135|NCT00772447|69576264|FG000|Overall Study|Physician Decision|4|||
37988624|NCT00264147|69673848|FG004|Treatment II Period|Lack of Efficacy|20|||
37988625|NCT00264147|69673849|FG005|Treatment II Period|Lack of Efficacy|19|||
37823951|NCT03107793|69505666|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
37823952|NCT03107793|69505667|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
37823953|NCT03107793|69505668|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
37823954|NCT03107793|69505669|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
37823955|NCT03107793|69505670|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
37823956|NCT03013543|69505689|FG000|Overall Study|Withdrawal by Subject|0|||
37823957|NCT03013543|69505690|FG001|Overall Study|Withdrawal by Subject|2|||
37823958|NCT03013543|69505691|FG002|Overall Study|Withdrawal by Subject|0|||
37823959|NCT03013543|69505692|FG003|Overall Study|Withdrawal by Subject|5|||
37823960|NCT03013543|69505693|FG004|Overall Study|Withdrawal by Subject|6|||
37823961|NCT03013543|69505694|FG005|Overall Study|Withdrawal by Subject|2|||
37823962|NCT03013543|69505695|FG006|Overall Study|Withdrawal by Subject|3|||
37823963|NCT03013543|69505696|FG007|Overall Study|Withdrawal by Subject|1|||
37823964|NCT03013543|69505697|FG008|Overall Study|Withdrawal by Subject|0|||
37823965|NCT03013543|69505698|FG009|Overall Study|Withdrawal by Subject|4|||
37823966|NCT03013543|69505689|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
37823967|NCT03013543|69505690|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
37823968|NCT03013543|69505691|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
37823969|NCT03013543|69505692|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
37823970|NCT03013543|69505693|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
37823971|NCT03013543|69505694|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
37823972|NCT03013543|69505695|FG006|Overall Study|Withdrawal By Parent/Guardian|0|||
37823973|NCT03013543|69505696|FG007|Overall Study|Withdrawal By Parent/Guardian|0|||
37823974|NCT03013543|69505697|FG008|Overall Study|Withdrawal By Parent/Guardian|1|||
37823975|NCT03013543|69505698|FG009|Overall Study|Withdrawal By Parent/Guardian|1|||
37823976|NCT03013543|69505689|FG000|Overall Study|Other|0|||
37823977|NCT03013543|69505690|FG001|Overall Study|Other|0|||
37823978|NCT03013543|69505691|FG002|Overall Study|Other|2|||
37823979|NCT03013543|69505692|FG003|Overall Study|Other|0|||
37823980|NCT03013543|69505693|FG004|Overall Study|Other|2|||
37823981|NCT03013543|69505694|FG005|Overall Study|Other|0|||
37823982|NCT03013543|69505695|FG006|Overall Study|Other|0|||
37823983|NCT03013543|69505696|FG007|Overall Study|Other|0|||
37823984|NCT03013543|69505697|FG008|Overall Study|Other|1|||
37823985|NCT03013543|69505698|FG009|Overall Study|Other|0|||
37823986|NCT03013543|69505689|FG000|Overall Study|Adverse Event|0|||
37823987|NCT03013543|69505690|FG001|Overall Study|Adverse Event|0|||
37823988|NCT03013543|69505691|FG002|Overall Study|Adverse Event|0|||
37823989|NCT03013543|69505692|FG003|Overall Study|Adverse Event|3|||
37823990|NCT03013543|69505693|FG004|Overall Study|Adverse Event|2|||
37823991|NCT03013543|69505694|FG005|Overall Study|Adverse Event|1|||
37823992|NCT03013543|69505695|FG006|Overall Study|Adverse Event|3|||
37823993|NCT03013543|69505696|FG007|Overall Study|Adverse Event|8|||
37823994|NCT03013543|69505697|FG008|Overall Study|Adverse Event|0|||
37823995|NCT03013543|69505698|FG009|Overall Study|Adverse Event|2|||
37823996|NCT03013543|69505689|FG000|Overall Study|Death|0|||
37823997|NCT03013543|69505690|FG001|Overall Study|Death|0|||
37823998|NCT03013543|69505691|FG002|Overall Study|Death|0|||
37823999|NCT03013543|69505692|FG003|Overall Study|Death|1|||
37824000|NCT03013543|69505693|FG004|Overall Study|Death|0|||
37891136|NCT00772447|69576265|FG001|Overall Study|Physician Decision|8|||
37891137|NCT00772447|69576264|FG000|Overall Study|Lost to Follow-up|2|||
37891138|NCT00772447|69576265|FG001|Overall Study|Lost to Follow-up|4|||
37891139|NCT00772447|69576264|FG000|Overall Study|incorrect enrolment|3|||
37891140|NCT00772447|69576265|FG001|Overall Study|incorrect enrolment|4|||
37988626|NCT00264147|69673844|FG000|Treatment II Period|Lost to Follow-up|0|||
37988627|NCT00264147|69673845|FG001|Treatment II Period|Lost to Follow-up|0|||
37988628|NCT00264147|69673846|FG002|Treatment II Period|Lost to Follow-up|0|||
37988629|NCT00264147|69673847|FG003|Treatment II Period|Lost to Follow-up|0|||
37988630|NCT00264147|69673848|FG004|Treatment II Period|Lost to Follow-up|1|||
37988631|NCT00264147|69673849|FG005|Treatment II Period|Lost to Follow-up|1|||
37988632|NCT00264147|69673844|FG000|Treatment II Period|Withdrawal by Subject|0|||
37988633|NCT00264147|69673845|FG001|Treatment II Period|Withdrawal by Subject|0|||
37988634|NCT00264147|69673846|FG002|Treatment II Period|Withdrawal by Subject|0|||
37988635|NCT00264147|69673847|FG003|Treatment II Period|Withdrawal by Subject|0|||
37988636|NCT00264147|69673848|FG004|Treatment II Period|Withdrawal by Subject|3|||
37988637|NCT00264147|69673849|FG005|Treatment II Period|Withdrawal by Subject|2|||
37891141|NCT00772447|69576264|FG000|Overall Study|Protocol Violation|0|||
37891142|NCT00772447|69576265|FG001|Overall Study|Protocol Violation|1|||
37891143|NCT00772447|69576264|FG000|Overall Study|all others|2|||
37891144|NCT00772447|69576265|FG001|Overall Study|all others|2|||
37891145|NCT00765037|69576272|FG000|Overall Study|Lost to Follow-up|5|||
37891146|NCT00765037|69576272|FG000|Overall Study|Adverse Event|1|||
37891147|NCT00831844|69576286|FG000|Overall Study|Adverse Event|2|||
37891148|NCT00831844|69576287|FG001|Overall Study|Adverse Event|0|||
37891149|NCT00831844|69576288|FG002|Overall Study|Adverse Event|0|||
37891150|NCT00831844|69576289|FG003|Overall Study|Adverse Event|0|||
37891151|NCT00831844|69576290|FG004|Overall Study|Adverse Event|1|||
37891152|NCT00831844|69576291|FG005|Overall Study|Adverse Event|1|||
37891153|NCT00831844|69576292|FG006|Overall Study|Adverse Event|2|||
37891154|NCT00831844|69576293|FG007|Overall Study|Adverse Event|0|||
37891155|NCT00831844|69576294|FG008|Overall Study|Adverse Event|0|||
37891156|NCT00831844|69576295|FG009|Overall Study|Adverse Event|0|||
37891157|NCT00831844|69576286|FG000|Overall Study|Death|0|||
37891158|NCT00831844|69576287|FG001|Overall Study|Death|0|||
37891159|NCT00831844|69576288|FG002|Overall Study|Death|0|||
37891160|NCT00831844|69576289|FG003|Overall Study|Death|1|||
37891161|NCT00831844|69576290|FG004|Overall Study|Death|0|||
37891162|NCT00831844|69576291|FG005|Overall Study|Death|0|||
37891163|NCT00831844|69576292|FG006|Overall Study|Death|0|||
37891164|NCT00831844|69576293|FG007|Overall Study|Death|0|||
37891165|NCT00831844|69576294|FG008|Overall Study|Death|0|||
37891166|NCT00831844|69576295|FG009|Overall Study|Death|0|||
37891167|NCT00831844|69576286|FG000|Overall Study|Lack of Efficacy|8|||
37891168|NCT00831844|69576287|FG001|Overall Study|Lack of Efficacy|10|||
37891169|NCT00831844|69576288|FG002|Overall Study|Lack of Efficacy|15|||
37891170|NCT00831844|69576289|FG003|Overall Study|Lack of Efficacy|8|||
37891171|NCT00831844|69576290|FG004|Overall Study|Lack of Efficacy|11|||
37891172|NCT00831844|69576291|FG005|Overall Study|Lack of Efficacy|17|||
37891173|NCT00831844|69576292|FG006|Overall Study|Lack of Efficacy|8|||
37891174|NCT00831844|69576293|FG007|Overall Study|Lack of Efficacy|9|||
37988638|NCT00264147|69673844|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
37891175|NCT00831844|69576294|FG008|Overall Study|Lack of Efficacy|7|||
37891176|NCT00831844|69576295|FG009|Overall Study|Lack of Efficacy|0|||
37891177|NCT00831844|69576286|FG000|Overall Study|Physician Decision|0|||
37891178|NCT00831844|69576287|FG001|Overall Study|Physician Decision|1|||
37988639|NCT00264147|69673845|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
37988640|NCT00264147|69673846|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
37891179|NCT00831844|69576288|FG002|Overall Study|Physician Decision|3|||
37891180|NCT00831844|69576289|FG003|Overall Study|Physician Decision|1|||
37891181|NCT00831844|69576290|FG004|Overall Study|Physician Decision|1|||
37891182|NCT00831844|69576291|FG005|Overall Study|Physician Decision|1|||
37891183|NCT00831844|69576292|FG006|Overall Study|Physician Decision|0|||
37891184|NCT00831844|69576293|FG007|Overall Study|Physician Decision|0|||
37988641|NCT00264147|69673847|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
37891185|NCT00831844|69576294|FG008|Overall Study|Physician Decision|1|||
37891186|NCT00831844|69576295|FG009|Overall Study|Physician Decision|0|||
37891187|NCT00831844|69576286|FG000|Overall Study|Withdrawal by Subject|0|||
37891188|NCT00831844|69576287|FG001|Overall Study|Withdrawal by Subject|0|||
37891189|NCT00831844|69576288|FG002|Overall Study|Withdrawal by Subject|1|||
37891190|NCT00831844|69576289|FG003|Overall Study|Withdrawal by Subject|0|||
37891191|NCT00831844|69576290|FG004|Overall Study|Withdrawal by Subject|0|||
37891192|NCT00831844|69576291|FG005|Overall Study|Withdrawal by Subject|0|||
37891193|NCT00831844|69576292|FG006|Overall Study|Withdrawal by Subject|0|||
37891194|NCT00831844|69576293|FG007|Overall Study|Withdrawal by Subject|1|||
37891195|NCT00831844|69576294|FG008|Overall Study|Withdrawal by Subject|1|||
37891196|NCT00831844|69576295|FG009|Overall Study|Withdrawal by Subject|0|||
37891197|NCT00831844|69576286|FG000|Overall Study|Ineligible|0|||
37891198|NCT00831844|69576287|FG001|Overall Study|Ineligible|1|||
37891199|NCT00831844|69576288|FG002|Overall Study|Ineligible|1|||
37891200|NCT00831844|69576289|FG003|Overall Study|Ineligible|0|||
37891201|NCT00831844|69576290|FG004|Overall Study|Ineligible|1|||
37891202|NCT00831844|69576291|FG005|Overall Study|Ineligible|0|||
37988642|NCT00264147|69673848|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
37988643|NCT00264147|69673849|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
37988644|NCT00263757|69673865|FG000|Overall Study|Withdrawal by Subject|5|||
37988645|NCT00263757|69673866|FG001|Overall Study|Withdrawal by Subject|4|||
37988646|NCT00263757|69673865|FG000|Overall Study|Screen failure|0|||
37988647|NCT00263757|69673866|FG001|Overall Study|Screen failure|1|||
37988648|NCT00263757|69673865|FG000|Overall Study|Adverse Event|3|||
37988649|NCT00263757|69673866|FG001|Overall Study|Adverse Event|3|||
37988650|NCT00263211|69673874|FG000|Overall Study|Death|1|||
37988651|NCT00263211|69673875|FG001|Overall Study|Death|0|||
37988652|NCT00263211|69673874|FG000|Overall Study|Withdrawal by Subject|3|||
37988653|NCT00263211|69673875|FG001|Overall Study|Withdrawal by Subject|0|||
37988654|NCT00263211|69673874|FG000|Overall Study|Protocol Violation|1|||
37988655|NCT00263211|69673875|FG001|Overall Study|Protocol Violation|0|||
37988656|NCT00263211|69673874|FG000|Overall Study|Disease Progression|0|||
37988657|NCT00263211|69673875|FG001|Overall Study|Disease Progression|1|||
37988658|NCT00248625|69673886|FG000|Overall Study|Withdrawal by Subject|0|||
37988659|NCT00248625|69673887|FG001|Overall Study|Withdrawal by Subject|2|||
37824001|NCT03013543|69505694|FG005|Overall Study|Death|0|||
37824002|NCT03013543|69505695|FG006|Overall Study|Death|0|||
37824003|NCT03013543|69505696|FG007|Overall Study|Death|0|||
37824004|NCT03013543|69505697|FG008|Overall Study|Death|0|||
37824005|NCT03013543|69505698|FG009|Overall Study|Death|0|||
37824006|NCT03013543|69505689|FG000|Overall Study|Lack of Efficacy|0|||
37824007|NCT03013543|69505690|FG001|Overall Study|Lack of Efficacy|0|||
37824008|NCT03013543|69505691|FG002|Overall Study|Lack of Efficacy|0|||
37824009|NCT03013543|69505692|FG003|Overall Study|Lack of Efficacy|1|||
37824010|NCT03013543|69505693|FG004|Overall Study|Lack of Efficacy|0|||
37891203|NCT00831844|69576292|FG006|Overall Study|Ineligible|0|||
37891204|NCT00831844|69576293|FG007|Overall Study|Ineligible|0|||
37891205|NCT00831844|69576294|FG008|Overall Study|Ineligible|0|||
37891206|NCT00831844|69576295|FG009|Overall Study|Ineligible|0|||
37891207|NCT00764881|69576319|FG000|Overall Study|Adverse Event|5|||
37988660|NCT00262821|69673895|FG000|Overall Study|Ineligible - wrong stage|0|||
37988661|NCT00262821|69673896|FG001|Overall Study|Ineligible - wrong stage|3|||
37988662|NCT00262821|69673895|FG000|Overall Study|Ineligible - wrong cell type|2|||
37988663|NCT00262821|69673896|FG001|Overall Study|Ineligible - wrong cell type|2|||
37988664|NCT00262821|69673895|FG000|Overall Study|Ineligible - wrong primary|0|||
37988665|NCT00262821|69673896|FG001|Overall Study|Ineligible - wrong primary|1|||
37988666|NCT00262821|69673895|FG000|Overall Study|Ineligible - inadequate pathology|1|||
37988667|NCT00262821|69673896|FG001|Overall Study|Ineligible - inadequate pathology|3|||
37988668|NCT00262821|69673895|FG000|Overall Study|Ineligible - elevated creatinine|0|||
37988669|NCT00262821|69673896|FG001|Overall Study|Ineligible - elevated creatinine|2|||
37988670|NCT00262821|69673895|FG000|Overall Study|Ineligible - required test not done|1|||
37988671|NCT00262821|69673896|FG001|Overall Study|Ineligible - required test not done|4|||
37988672|NCT00262821|69673895|FG000|Overall Study|Inevaluable - inadequate data|0|||
37988673|NCT00262821|69673896|FG001|Overall Study|Inevaluable - inadequate data|4|||
37988674|NCT00262743|69673904|FG000|Overall Study|Adverse Event|0|||
37988675|NCT00262743|69673905|FG001|Overall Study|Adverse Event|9|||
37988676|NCT00262743|69673904|FG000|Overall Study|Disease progression|0|||
37988677|NCT00262743|69673905|FG001|Overall Study|Disease progression|3|||
37988678|NCT00262119|69673912|FG000|Overall Study|Lost to Follow-up|38|||
37988679|NCT00262119|69673913|FG001|Overall Study|Lost to Follow-up|51|||
37988680|NCT00262119|69673914|FG002|Overall Study|Lost to Follow-up|42|||
37988681|NCT00262119|69673912|FG000|Overall Study|Death|20|||
37988682|NCT00262119|69673913|FG001|Overall Study|Death|19|||
37988683|NCT00262119|69673914|FG002|Overall Study|Death|16|||
37988684|NCT00170950|69673924|FG000|Overall Study|Death|236|||
37988685|NCT00170950|69673925|FG001|Overall Study|Death|274|||
37988686|NCT00170950|69673924|FG000|Overall Study|Withdrawal by Subject|496|||
37988687|NCT00170950|69673925|FG001|Overall Study|Withdrawal by Subject|498|||
37988688|NCT00170950|69673924|FG000|Overall Study|Lost to Follow-up|134|||
37988689|NCT00170950|69673925|FG001|Overall Study|Lost to Follow-up|115|||
37988690|NCT00170950|69673924|FG000|Overall Study|Missing|2|||
37988691|NCT00170950|69673925|FG001|Overall Study|Missing|1|||
37988692|NCT00170950|69673924|FG000|Overall Study|Termination Data Not Recorded|17|||
37696005|NCT02282917|69172161|FG000|Overall Study|Withdrawal by Subject|1|||
37891208|NCT00764881|69576320|FG001|Overall Study|Adverse Event|1|||
37891209|NCT00764881|69576319|FG000|Overall Study|Withdrawal by Subject|1|||
37891210|NCT00764881|69576320|FG001|Overall Study|Withdrawal by Subject|3|||
37891211|NCT00764881|69576319|FG000|Overall Study|Protocol Violation|2|||
37891212|NCT00764881|69576320|FG001|Overall Study|Protocol Violation|2|||
37891213|NCT00764881|69576319|FG000|Overall Study|Lost to Follow-up|2|||
37891214|NCT00764881|69576320|FG001|Overall Study|Lost to Follow-up|0|||
37891215|NCT00764881|69576319|FG000|Overall Study|Noncompliant|1|||
37891216|NCT00764881|69576320|FG001|Overall Study|Noncompliant|0|||
37891217|NCT00764881|69576319|FG000|Overall Study|Accidentally discontinued study drug|1|||
37891218|NCT00764881|69576320|FG001|Overall Study|Accidentally discontinued study drug|0|||
37891219|NCT00764881|69576319|FG000|Overall Study|Wished to become pregnant|1|||
37891220|NCT00764881|69576320|FG001|Overall Study|Wished to become pregnant|0|||
37891221|NCT00764881|69576319|FG000|Overall Study|Carcinoma detected|1|||
37891222|NCT00764881|69576320|FG001|Overall Study|Carcinoma detected|0|||
37891223|NCT00764881|69576319|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
37891224|NCT00764881|69576320|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
37824011|NCT03013543|69505694|FG005|Overall Study|Lack of Efficacy|0|||
37824012|NCT03013543|69505695|FG006|Overall Study|Lack of Efficacy|0|||
37824013|NCT03013543|69505696|FG007|Overall Study|Lack of Efficacy|0|||
37824014|NCT03013543|69505697|FG008|Overall Study|Lack of Efficacy|0|||
37824015|NCT03013543|69505698|FG009|Overall Study|Lack of Efficacy|0|||
37824016|NCT03013543|69505689|FG000|Overall Study|Lost to Follow-up|0|||
37824017|NCT03013543|69505690|FG001|Overall Study|Lost to Follow-up|0|||
37824018|NCT03013543|69505691|FG002|Overall Study|Lost to Follow-up|0|||
37824019|NCT03013543|69505692|FG003|Overall Study|Lost to Follow-up|1|||
37824020|NCT03013543|69505693|FG004|Overall Study|Lost to Follow-up|0|||
37824021|NCT03013543|69505694|FG005|Overall Study|Lost to Follow-up|0|||
37824022|NCT03013543|69505695|FG006|Overall Study|Lost to Follow-up|1|||
37824023|NCT03013543|69505696|FG007|Overall Study|Lost to Follow-up|0|||
37891225|NCT00764881|69576319|FG000|Overall Study|no treatment or no observation|2|||
37891226|NCT00764881|69576320|FG001|Overall Study|no treatment or no observation|2|||
37891227|NCT00844558|69576328|FG000|Overall Study|Withdrawal by Subject|9|||
37891228|NCT00844558|69576329|FG001|Overall Study|Withdrawal by Subject|2|||
37891229|NCT00844558|69576328|FG000|Overall Study|Death|1|||
37891230|NCT00844558|69576329|FG001|Overall Study|Death|0|||
37891231|NCT00844558|69576328|FG000|Overall Study|Protocol Violation|1|||
37891232|NCT00844558|69576329|FG001|Overall Study|Protocol Violation|1|||
37988693|NCT00170950|69673925|FG001|Overall Study|Termination Data Not Recorded|22|||
37988694|NCT00239577|69673935|FG000|Primary Phase|Adverse Event|0|||
37824024|NCT03013543|69505697|FG008|Overall Study|Lost to Follow-up|0|||
37824025|NCT03013543|69505698|FG009|Overall Study|Lost to Follow-up|2|||
37824026|NCT03013543|69505689|FG000|Overall Study|Non-Compliance With Study Drug|0|||
37824027|NCT03013543|69505690|FG001|Overall Study|Non-Compliance With Study Drug|0|||
37988695|NCT00239577|69673936|FG001|Primary Phase|Adverse Event|0|||
37988696|NCT00239577|69673937|FG002|Primary Phase|Adverse Event|1|||
37988697|NCT00239577|69673938|FG003|Primary Phase|Adverse Event|0|||
37988698|NCT00239577|69673935|FG000|Primary Phase|Other|5|||
37891233|NCT00844558|69576328|FG000|Overall Study|Lost to Follow-up|0|||
37891234|NCT00844558|69576329|FG001|Overall Study|Lost to Follow-up|1|||
37891235|NCT00844558|69576328|FG000|Overall Study|Physician Decision|1|||
37891236|NCT00844558|69576329|FG001|Overall Study|Physician Decision|0|||
37891237|NCT00772369|69576340|FG000|Overall Study|Did not return record release form|1|||
37891238|NCT00821236|69576347|FG000|Overall Study|Lost to Follow-up|3|||
37891239|NCT00756457|69576357|FG000|Overall Study|Lost to Follow-up|1|||
37891240|NCT00756457|69576358|FG001|Overall Study|Lost to Follow-up|2|||
37891241|NCT00844480|69576382|FG000|Overall Study|Withdrawal by Subject|2|||
37891242|NCT00844480|69576383|FG001|Overall Study|Withdrawal by Subject|3|||
37891243|NCT00771901|69576392|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
37891244|NCT00771901|69576393|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
37891245|NCT00771901|69576394|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
37891246|NCT00843856|69576404|FG000|Overall Study|Lost to Follow-up|1|||
37891247|NCT00843856|69576405|FG001|Overall Study|Lost to Follow-up|2|||
37891248|NCT00764491|69576413|FG000|Overall Study|Lost to Follow-up|35|||
37891249|NCT00764491|69576414|FG001|Overall Study|Lost to Follow-up|17|||
37891250|NCT00843778|69576420|FG000|Overall Study|Adverse Event|15|||
37891251|NCT00843778|69576420|FG000|Overall Study|Lack of Efficacy|14|||
37891252|NCT00843778|69576420|FG000|Overall Study|Loss of efficacy|2|||
37891253|NCT00843778|69576420|FG000|Overall Study|Withdrawal by Subject|4|||
37891254|NCT00910728|69576433|FG000|Overall Study|Lack of Efficacy|2|||
37988699|NCT00239577|69673936|FG001|Primary Phase|Other|3|||
37988700|NCT00239577|69673937|FG002|Primary Phase|Other|2|||
37891255|NCT00910728|69576434|FG001|Overall Study|Lack of Efficacy|3|||
37891256|NCT00910728|69576435|FG002|Overall Study|Lack of Efficacy|1|||
37891257|NCT00910728|69576436|FG003|Overall Study|Lack of Efficacy|2|||
37891258|NCT00910728|69576437|FG004|Overall Study|Lack of Efficacy|1|||
37891259|NCT00910728|69576438|FG005|Overall Study|Lack of Efficacy|0|||
37891260|NCT00910728|69576439|FG006|Overall Study|Lack of Efficacy|2|||
37824028|NCT03013543|69505691|FG002|Overall Study|Non-Compliance With Study Drug|0|||
37824029|NCT03013543|69505692|FG003|Overall Study|Non-Compliance With Study Drug|0|||
37824030|NCT03013543|69505693|FG004|Overall Study|Non-Compliance With Study Drug|0|||
37824031|NCT03013543|69505694|FG005|Overall Study|Non-Compliance With Study Drug|0|||
37824032|NCT03013543|69505695|FG006|Overall Study|Non-Compliance With Study Drug|0|||
37824033|NCT03013543|69505696|FG007|Overall Study|Non-Compliance With Study Drug|0|||
37824034|NCT03013543|69505697|FG008|Overall Study|Non-Compliance With Study Drug|1|||
37824035|NCT03013543|69505698|FG009|Overall Study|Non-Compliance With Study Drug|0|||
37824036|NCT03013543|69505689|FG000|Overall Study|Physician Decision|0|||
37824037|NCT03013543|69505690|FG001|Overall Study|Physician Decision|0|||
37824038|NCT03013543|69505691|FG002|Overall Study|Physician Decision|0|||
37824039|NCT03013543|69505692|FG003|Overall Study|Physician Decision|0|||
37824040|NCT03013543|69505693|FG004|Overall Study|Physician Decision|1|||
37891261|NCT00910728|69576440|FG007|Overall Study|Lack of Efficacy|2|||
37891262|NCT00910728|69576441|FG008|Overall Study|Lack of Efficacy|2|||
37891263|NCT00910728|69576433|FG000|Overall Study|Withdrawal by Subject|0|||
37891264|NCT00910728|69576434|FG001|Overall Study|Withdrawal by Subject|0|||
37891265|NCT00910728|69576435|FG002|Overall Study|Withdrawal by Subject|0|||
37891266|NCT00910728|69576436|FG003|Overall Study|Withdrawal by Subject|0|||
37891267|NCT00910728|69576437|FG004|Overall Study|Withdrawal by Subject|3|||
37891268|NCT00910728|69576438|FG005|Overall Study|Withdrawal by Subject|1|||
37891269|NCT00910728|69576439|FG006|Overall Study|Withdrawal by Subject|2|||
37891270|NCT00910728|69576440|FG007|Overall Study|Withdrawal by Subject|0|||
37891271|NCT00910728|69576441|FG008|Overall Study|Withdrawal by Subject|0|||
37988701|NCT00239577|69673938|FG003|Primary Phase|Other|0|||
37988702|NCT00262041|69673954|FG000|Overall Study|Withdrawal by Subject|0|||
37988703|NCT00262041|69673955|FG001|Overall Study|Withdrawal by Subject|3|||
37988704|NCT00262041|69673956|FG002|Overall Study|Withdrawal by Subject|1|||
37988705|NCT00262041|69673954|FG000|Overall Study|Lost to Follow-up|1|||
37988706|NCT00262041|69673955|FG001|Overall Study|Lost to Follow-up|1|||
37988707|NCT00262041|69673956|FG002|Overall Study|Lost to Follow-up|5|||
37988708|NCT00262041|69673954|FG000|Overall Study|Unable to classify|1|||
37988709|NCT00262041|69673955|FG001|Overall Study|Unable to classify|0|||
37988710|NCT00262041|69673956|FG002|Overall Study|Unable to classify|0|||
37891272|NCT00910728|69576433|FG000|Overall Study|(not specified)|2|||
37891273|NCT00910728|69576434|FG001|Overall Study|(not specified)|0|||
37891274|NCT00910728|69576435|FG002|Overall Study|(not specified)|1|||
37891275|NCT00910728|69576436|FG003|Overall Study|(not specified)|0|||
37891276|NCT00910728|69576437|FG004|Overall Study|(not specified)|1|||
37891277|NCT00910728|69576438|FG005|Overall Study|(not specified)|0|||
37891278|NCT00910728|69576439|FG006|Overall Study|(not specified)|0|||
37891279|NCT00910728|69576440|FG007|Overall Study|(not specified)|0|||
37891280|NCT00910728|69576441|FG008|Overall Study|(not specified)|0|||
37891281|NCT00910728|69576433|FG000|Overall Study|Adverse Event|2|||
37891282|NCT00910728|69576434|FG001|Overall Study|Adverse Event|0|||
37891283|NCT00910728|69576435|FG002|Overall Study|Adverse Event|1|||
37891284|NCT00910728|69576436|FG003|Overall Study|Adverse Event|1|||
37891285|NCT00910728|69576437|FG004|Overall Study|Adverse Event|0|||
37891286|NCT00910728|69576438|FG005|Overall Study|Adverse Event|0|||
37891287|NCT00910728|69576439|FG006|Overall Study|Adverse Event|2|||
37891288|NCT00910728|69576440|FG007|Overall Study|Adverse Event|1|||
37988711|NCT00208767|69673972|FG000|Overall Study|Adverse Event|9|||
37891289|NCT00910728|69576441|FG008|Overall Study|Adverse Event|1|||
37891290|NCT00820222|69576463|FG000|Overall Study|Lost to Follow-up|10|||
37891291|NCT00820222|69576464|FG001|Overall Study|Lost to Follow-up|9|||
37988712|NCT00208767|69673973|FG001|Overall Study|Adverse Event|1|||
37988713|NCT00208767|69673972|FG000|Overall Study|Withdrawal by Subject|14|||
37891292|NCT00820222|69576463|FG000|Overall Study|Withdrawal by Subject|19|||
37988714|NCT00208767|69673973|FG001|Overall Study|Withdrawal by Subject|3|||
37891293|NCT00820222|69576464|FG001|Overall Study|Withdrawal by Subject|21|||
37988715|NCT00208767|69673972|FG000|Overall Study|Death|1|||
37988716|NCT00208767|69673973|FG001|Overall Study|Death|0|||
37988717|NCT00208767|69673972|FG000|Overall Study|Lost to Follow-up|3|||
37988718|NCT00208767|69673973|FG001|Overall Study|Lost to Follow-up|3|||
37988719|NCT00390806|69673981|FG000|Overall Study|Lost to Follow-up|7|||
37988720|NCT00390806|69673982|FG001|Overall Study|Lost to Follow-up|6|||
37988721|NCT00390806|69673981|FG000|Overall Study|Protocol Violation|2|||
37988722|NCT00390806|69673982|FG001|Overall Study|Protocol Violation|2|||
37988723|NCT00390806|69673981|FG000|Overall Study|Withdrawal by Subject|12|||
37988724|NCT00390806|69673982|FG001|Overall Study|Withdrawal by Subject|15|||
37988725|NCT00390806|69673981|FG000|Overall Study|Investigator Decision|4|||
37988726|NCT00390806|69673982|FG001|Overall Study|Investigator Decision|6|||
37988727|NCT00390806|69673981|FG000|Overall Study|Death|1|||
37988728|NCT00390806|69673982|FG001|Overall Study|Death|0|||
37988729|NCT00390806|69673981|FG000|Overall Study|Physician Decision|0|||
37988730|NCT00390806|69673982|FG001|Overall Study|Physician Decision|1|||
37988731|NCT00390806|69673981|FG000|Overall Study|Ongoing|4|||
37988732|NCT00390806|69673982|FG001|Overall Study|Ongoing|2|||
37988733|NCT00390572|69673990|FG000|Overall Study|Lost to Follow-up|8|||
37988734|NCT00390572|69673991|FG001|Overall Study|Lost to Follow-up|4|||
37988735|NCT00390572|69673990|FG000|Overall Study|health condition|0|||
37988736|NCT00390572|69673991|FG001|Overall Study|health condition|1|||
37988737|NCT00390416|69674001|FG000|Overall Study|Withdrawal by Subject|1|||
37988738|NCT00390416|69674001|FG000|Overall Study|Not treated|3|||
37988739|NCT00261495|69674007|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
37988740|NCT00261495|69674008|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
37988741|NCT00261495|69674007|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
37988742|NCT00261495|69674008|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
37988743|NCT00261495|69674007|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
37988744|NCT00261495|69674008|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
37988745|NCT00261495|69674007|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
37988746|NCT00261495|69674008|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
37988747|NCT00261495|69674007|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
37988748|NCT00261495|69674008|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
37988749|NCT00261495|69674007|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
37988750|NCT00261495|69674008|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
37988751|NCT00261495|69674007|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
37988752|NCT00261495|69674008|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
37988753|NCT00261495|69674007|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
37988754|NCT00261495|69674008|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
37988755|NCT00261495|69674007|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
37988756|NCT00261495|69674008|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
37988757|NCT00261495|69674007|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
37988758|NCT00261495|69674008|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
37988759|NCT00261495|69674007|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
37824041|NCT03013543|69505694|FG005|Overall Study|Physician Decision|0|||
37988760|NCT00261495|69674008|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
37988761|NCT00261495|69674007|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
37988762|NCT00261495|69674008|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
37988763|NCT00261495|69674007|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
37988764|NCT00261495|69674008|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
37988765|NCT00261495|69674007|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
37988766|NCT00261495|69674008|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
37988767|NCT00261495|69674007|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
37988768|NCT00261495|69674008|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
37988769|NCT00261495|69674007|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
37988770|NCT00261495|69674008|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
37988771|NCT00261495|69674007|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
37988772|NCT00261495|69674008|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
37988773|NCT00261495|69674007|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
37988774|NCT00261495|69674008|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
37988775|NCT00261495|69674007|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
37988776|NCT00261495|69674008|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
37988777|NCT00261495|69674007|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
37988778|NCT00261495|69674008|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
37988779|NCT00261495|69674007|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
37988780|NCT00261495|69674008|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
37988781|NCT00168844|69674017|FG000|Overall Study|Adverse Event|31|||
37988782|NCT00168844|69674018|FG001|Overall Study|Adverse Event|32|||
37988783|NCT00168844|69674019|FG002|Overall Study|Adverse Event|48|||
37988784|NCT00168844|69674017|FG000|Overall Study|Lost to Follow-up|4|||
37988785|NCT00168844|69674018|FG001|Overall Study|Lost to Follow-up|5|||
37988786|NCT00168844|69674019|FG002|Overall Study|Lost to Follow-up|11|||
37988787|NCT00168844|69674017|FG000|Overall Study|Withdrawal by Subject|12|||
37988788|NCT00168844|69674018|FG001|Overall Study|Withdrawal by Subject|9|||
37988789|NCT00168844|69674019|FG002|Overall Study|Withdrawal by Subject|19|||
37891294|NCT00820222|69576463|FG000|Overall Study|Physician Decision|93|||
37988790|NCT00168844|69674017|FG000|Overall Study|Protocol Violation|2|||
37988791|NCT00168844|69674018|FG001|Overall Study|Protocol Violation|2|||
37988792|NCT00168844|69674019|FG002|Overall Study|Protocol Violation|4|||
37988793|NCT00168844|69674017|FG000|Overall Study|Other|6|||
37988794|NCT00168844|69674018|FG001|Overall Study|Other|7|||
37988795|NCT00168844|69674019|FG002|Overall Study|Other|9|||
37988796|NCT00365456|69674027|FG000|Trial Period I (12 Months)|Adverse Event|84|||
37988797|NCT00365456|69674028|FG001|Trial Period I (12 Months)|Adverse Event|0|||
37891295|NCT00820222|69576464|FG001|Overall Study|Physician Decision|88|||
37891296|NCT00820222|69576463|FG000|Overall Study|Sponsor Terminated Study|43|||
37891297|NCT00820222|69576464|FG001|Overall Study|Sponsor Terminated Study|65|||
37891298|NCT00820222|69576463|FG000|Overall Study|Unkown|11|||
37891299|NCT00820222|69576464|FG001|Overall Study|Unkown|7|||
37891300|NCT01039688|69576473|FG000|Overall Study|Adverse Event|38|||
37891301|NCT01039688|69576474|FG001|Overall Study|Adverse Event|39|||
37891302|NCT01039688|69576475|FG002|Overall Study|Adverse Event|24|||
37891303|NCT01039688|69576473|FG000|Overall Study|Lack of Efficacy|20|||
37891304|NCT01039688|69576474|FG001|Overall Study|Lack of Efficacy|11|||
37891305|NCT01039688|69576475|FG002|Overall Study|Lack of Efficacy|26|||
37891306|NCT01039688|69576473|FG000|Overall Study|Lost to Follow-up|11|||
37891307|NCT01039688|69576474|FG001|Overall Study|Lost to Follow-up|9|||
37891308|NCT01039688|69576475|FG002|Overall Study|Lost to Follow-up|5|||
37891309|NCT01039688|69576473|FG000|Overall Study|Other|13|||
37891310|NCT01039688|69576474|FG001|Overall Study|Other|25|||
37891311|NCT01039688|69576475|FG002|Overall Study|Other|12|||
37891312|NCT01039688|69576473|FG000|Overall Study|Withdrawal by Subject|23|||
37891313|NCT01039688|69576474|FG001|Overall Study|Withdrawal by Subject|27|||
37891314|NCT01039688|69576475|FG002|Overall Study|Withdrawal by Subject|13|||
37891315|NCT01039688|69576473|FG000|Overall Study|Death|2|||
37891316|NCT01039688|69576474|FG001|Overall Study|Death|0|||
37891317|NCT01039688|69576475|FG002|Overall Study|Death|0|||
37891318|NCT02237508|69576496|FG000|Overall Study|Withdrawal by Subject|0|||
37891319|NCT02237508|69576497|FG001|Overall Study|Withdrawal by Subject|2|||
37891320|NCT02237508|69576498|FG002|Overall Study|Withdrawal by Subject|0|||
37891321|NCT02237508|69576499|FG003|Overall Study|Withdrawal by Subject|1|||
37891322|NCT02237508|69576500|FG004|Overall Study|Withdrawal by Subject|0|||
37891323|NCT02237508|69576501|FG005|Overall Study|Withdrawal by Subject|1|||
37891324|NCT02237508|69576502|FG006|Overall Study|Withdrawal by Subject|1|||
37891325|NCT02237508|69576503|FG007|Overall Study|Withdrawal by Subject|0|||
37891326|NCT02237508|69576504|FG008|Overall Study|Withdrawal by Subject|1|||
37891327|NCT02237508|69576505|FG009|Overall Study|Withdrawal by Subject|0|||
37891328|NCT02237508|69576496|FG000|Overall Study|Physician Decision|0|||
37988798|NCT00365456|69674027|FG000|Trial Period I (12 Months)|Non-compliance|3|||
37988799|NCT00365456|69674028|FG001|Trial Period I (12 Months)|Non-compliance|0|||
37696006|NCT02282917|69172161|FG000|Overall Study|Screen Failure/Not Eligible|1|||
37891329|NCT02237508|69576497|FG001|Overall Study|Physician Decision|1|||
37891330|NCT02237508|69576498|FG002|Overall Study|Physician Decision|0|||
37988800|NCT00365456|69674027|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
37988801|NCT00365456|69674028|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
37988802|NCT00365456|69674027|FG000|Trial Period I (12 Months)|Other|11|||
37891331|NCT02237508|69576499|FG003|Overall Study|Physician Decision|0|||
37891332|NCT02237508|69576500|FG004|Overall Study|Physician Decision|0|||
37891333|NCT02237508|69576501|FG005|Overall Study|Physician Decision|0|||
37891334|NCT02237508|69576502|FG006|Overall Study|Physician Decision|0|||
37891335|NCT02237508|69576503|FG007|Overall Study|Physician Decision|0|||
37891336|NCT02237508|69576504|FG008|Overall Study|Physician Decision|0|||
37891337|NCT02237508|69576505|FG009|Overall Study|Physician Decision|0|||
37891338|NCT02237508|69576496|FG000|Overall Study|Protocol Violation|0|||
37891339|NCT02237508|69576497|FG001|Overall Study|Protocol Violation|0|||
37891340|NCT02237508|69576498|FG002|Overall Study|Protocol Violation|1|||
37891341|NCT02237508|69576499|FG003|Overall Study|Protocol Violation|0|||
37891342|NCT02237508|69576500|FG004|Overall Study|Protocol Violation|0|||
37891343|NCT02237508|69576501|FG005|Overall Study|Protocol Violation|0|||
37891344|NCT02237508|69576502|FG006|Overall Study|Protocol Violation|0|||
37891345|NCT02237508|69576503|FG007|Overall Study|Protocol Violation|0|||
37891346|NCT02237508|69576504|FG008|Overall Study|Protocol Violation|0|||
37891347|NCT02237508|69576505|FG009|Overall Study|Protocol Violation|0|||
37891348|NCT00909090|69576525|FG000|Overall Study|Lost to Follow-up|17|||
37891349|NCT00909090|69576526|FG001|Overall Study|Lost to Follow-up|17|||
37891350|NCT00909480|69576537|FG000|Overall Study|Adverse Event|5|||
37891351|NCT00909480|69576538|FG001|Overall Study|Adverse Event|3|||
37988803|NCT00365456|69674028|FG001|Trial Period I (12 Months)|Other|0|||
37988804|NCT00365456|69674027|FG000|Trial Period II (12 Months)|Adverse Event|0|||
37988805|NCT00365456|69674028|FG001|Trial Period II (12 Months)|Adverse Event|6|||
37988806|NCT00365456|69674027|FG000|Trial Period II (12 Months)|Non-compliance|0|||
37988807|NCT00365456|69674028|FG001|Trial Period II (12 Months)|Non-compliance|2|||
37988808|NCT00365456|69674027|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
37988809|NCT00365456|69674028|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
37988810|NCT00365456|69674027|FG000|Trial Period II (12 Months)|Other|0|||
37696007|NCT02358668|69172168|FG000|Overall Study|Adverse Event|2|||
37824042|NCT03013543|69505695|FG006|Overall Study|Physician Decision|0|||
37824043|NCT03013543|69505696|FG007|Overall Study|Physician Decision|0|||
37824044|NCT03013543|69505697|FG008|Overall Study|Physician Decision|0|||
37824045|NCT03013543|69505698|FG009|Overall Study|Physician Decision|0|||
37824046|NCT03013543|69505689|FG000|Overall Study|Protocol Violation|0|||
37824047|NCT03013543|69505690|FG001|Overall Study|Protocol Violation|0|||
37824048|NCT03013543|69505691|FG002|Overall Study|Protocol Violation|0|||
37824049|NCT03013543|69505692|FG003|Overall Study|Protocol Violation|0|||
37824050|NCT03013543|69505693|FG004|Overall Study|Protocol Violation|0|||
37824051|NCT03013543|69505694|FG005|Overall Study|Protocol Violation|0|||
37891352|NCT00909480|69576537|FG000|Overall Study|Protocol Violation|6|||
37891353|NCT00909480|69576538|FG001|Overall Study|Protocol Violation|8|||
37891354|NCT00909480|69576537|FG000|Overall Study|Withdrawal criteria|9|||
37891355|NCT00909480|69576538|FG001|Overall Study|Withdrawal criteria|11|||
37891356|NCT00909480|69576537|FG000|Overall Study|Unclassified|18|||
37891357|NCT00909480|69576538|FG001|Overall Study|Unclassified|19|||
37891358|NCT01058096|69576546|FG000|Double-blind Treatment Phase|Adverse Event|11|||
37891359|NCT01058096|69576547|FG001|Double-blind Treatment Phase|Adverse Event|15|||
37891360|NCT01058096|69576546|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
37891361|NCT01058096|69576547|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
37988811|NCT00365456|69674028|FG001|Trial Period II (12 Months)|Other|1|||
37824052|NCT03013543|69505695|FG006|Overall Study|Protocol Violation|0|||
37891362|NCT01058096|69576546|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
37824053|NCT03013543|69505696|FG007|Overall Study|Protocol Violation|0|||
37824054|NCT03013543|69505697|FG008|Overall Study|Protocol Violation|0|||
37891363|NCT01058096|69576547|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
37891364|NCT01058096|69576546|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
37988812|NCT00365456|69674027|FG000|Trial Period III (12 Months)|Adverse Event|13|||
37824055|NCT03013543|69505698|FG009|Overall Study|Protocol Violation|1|||
37988813|NCT00365456|69674028|FG001|Trial Period III (12 Months)|Adverse Event|3|||
37988814|NCT00365456|69674027|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
37988815|NCT00365456|69674028|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
37988816|NCT00365456|69674027|FG000|Trial Period III (12 Months)|Other|1|||
37891365|NCT01058096|69576547|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
37891366|NCT01058096|69576546|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
37891367|NCT01058096|69576547|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
37891368|NCT01058096|69576546|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
37891369|NCT01058096|69576547|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
37891370|NCT01057862|69576555|FG000|Overall Study|Withdrawal by Subject|1|||
37891371|NCT01057862|69576556|FG001|Overall Study|Withdrawal by Subject|2|||
37988817|NCT00365456|69674028|FG001|Trial Period III (12 Months)|Other|1|||
37988818|NCT00147238|69674034|FG000|Overall Study|Inevaluable|8|||
37891372|NCT01038128|69576562|FG000|Overall Study|Lack of Efficacy|1|||
37891373|NCT01038128|69576562|FG000|Overall Study|Lost to Follow-up|1|||
37891374|NCT01038128|69576562|FG000|Overall Study|Withdrawal by Subject|2|||
37891375|NCT00842530|69576583|FG000|Overall Study|Serious adverse event|0|||
37891376|NCT00842530|69576584|FG001|Overall Study|Serious adverse event|6|||
37891377|NCT00842530|69576583|FG000|Overall Study|Other adverse event|6|||
37891378|NCT00842530|69576584|FG001|Overall Study|Other adverse event|1|||
37891379|NCT00842530|69576583|FG000|Overall Study|Protocol Violation|32|||
37891380|NCT00842530|69576584|FG001|Overall Study|Protocol Violation|14|||
37891381|NCT00842530|69576583|FG000|Overall Study|Lost to Follow-up|6|||
37988819|NCT00206427|69674038|FG000|Overall Study|Adverse Event|2|||
37988820|NCT00146848|69674045|FG000|Pre-randomization|Death|19|||
37988821|NCT00146848|69674046|FG001|Pre-randomization|Death|0|||
37891382|NCT00842530|69576584|FG001|Overall Study|Lost to Follow-up|8|||
37891383|NCT00842530|69576583|FG000|Overall Study|Withdrawal by Subject|73|||
37891384|NCT00842530|69576584|FG001|Overall Study|Withdrawal by Subject|28|||
37891385|NCT00819910|69576595|FG000|Overall Study|Adverse Event|0|||
37891386|NCT00819910|69576596|FG001|Overall Study|Adverse Event|0|||
37891387|NCT00819910|69576597|FG002|Overall Study|Adverse Event|2|||
37891388|NCT00819910|69576598|FG003|Overall Study|Adverse Event|1|||
37891389|NCT00819910|69576595|FG000|Overall Study|Withdrawal by Subject|1|||
37891390|NCT00819910|69576596|FG001|Overall Study|Withdrawal by Subject|1|||
37891391|NCT00819910|69576597|FG002|Overall Study|Withdrawal by Subject|1|||
37891392|NCT00819910|69576598|FG003|Overall Study|Withdrawal by Subject|0|||
37891393|NCT00819910|69576595|FG000|Overall Study|Lost to Follow-up|1|||
37891394|NCT00819910|69576596|FG001|Overall Study|Lost to Follow-up|0|||
37891395|NCT00819910|69576597|FG002|Overall Study|Lost to Follow-up|0|||
37891396|NCT00819910|69576598|FG003|Overall Study|Lost to Follow-up|0|||
37891397|NCT00830518|69576612|FG000|Overall Study|Progressive Disease|18|||
37891398|NCT00830518|69576613|FG001|Overall Study|Progressive Disease|8|||
37891399|NCT00830518|69576612|FG000|Overall Study|Symptomatic Deterioration|4|||
37988822|NCT00146848|69674047|FG002|Pre-randomization|Death|0|||
37988823|NCT00146848|69674045|FG000|Pre-randomization|Lost to Follow-up|70|||
37891400|NCT00830518|69576613|FG001|Overall Study|Symptomatic Deterioration|1|||
37891401|NCT00830518|69576612|FG000|Overall Study|Adverse Event|14|||
37891402|NCT00830518|69576613|FG001|Overall Study|Adverse Event|1|||
37988824|NCT00146848|69674046|FG001|Pre-randomization|Lost to Follow-up|0|||
37891403|NCT00830518|69576612|FG000|Overall Study|Withdrawal by Patient|2|||
37891404|NCT00830518|69576613|FG001|Overall Study|Withdrawal by Patient|0|||
37891405|NCT00830518|69576612|FG000|Overall Study|Reason not Specified|8|||
37891406|NCT00830518|69576613|FG001|Overall Study|Reason not Specified|1|||
37891407|NCT00908544|69576622|FG000|Overall Study|Withdrawal by Subject|2|||
37988825|NCT00146848|69674047|FG002|Pre-randomization|Lost to Follow-up|0|||
37988826|NCT00146848|69674045|FG000|Pre-randomization|Physician Decision|8|||
37988827|NCT00146848|69674046|FG001|Pre-randomization|Physician Decision|0|||
37988828|NCT00146848|69674047|FG002|Pre-randomization|Physician Decision|0|||
37988829|NCT00146848|69674045|FG000|Pre-randomization|Protocol Violation|172|||
37988830|NCT00146848|69674046|FG001|Pre-randomization|Protocol Violation|0|||
37988831|NCT00146848|69674047|FG002|Pre-randomization|Protocol Violation|0|||
37988832|NCT00146848|69674045|FG000|Pre-randomization|Withdrawal by Subject|40|||
37988833|NCT00146848|69674046|FG001|Pre-randomization|Withdrawal by Subject|0|||
37988834|NCT00146848|69674047|FG002|Pre-randomization|Withdrawal by Subject|0|||
37988835|NCT00146848|69674045|FG000|Post-randomization|Lost to Follow-up|12|||
37988836|NCT00146848|69674046|FG001|Post-randomization|Lost to Follow-up|15|||
37891408|NCT00908544|69576623|FG001|Overall Study|Withdrawal by Subject|4|||
37988837|NCT00146848|69674047|FG002|Post-randomization|Lost to Follow-up|12|||
37988838|NCT00146848|69674045|FG000|Post-randomization|Withdrawn|26|||
37988839|NCT00146848|69674046|FG001|Post-randomization|Withdrawn|32|||
37988840|NCT00146848|69674047|FG002|Post-randomization|Withdrawn|27|||
37891409|NCT00908544|69576622|FG000|Overall Study|Lack of Efficacy|0|||
37891410|NCT00908544|69576623|FG001|Overall Study|Lack of Efficacy|1|||
37891411|NCT00908544|69576622|FG000|Overall Study|Pregnancy|1|||
37891412|NCT00908544|69576623|FG001|Overall Study|Pregnancy|0|||
37891413|NCT00908544|69576622|FG000|Overall Study|Relocation abroad|1|||
37891414|NCT00908544|69576623|FG001|Overall Study|Relocation abroad|1|||
37891415|NCT00908544|69576622|FG000|Overall Study|Unable to visit sutdy center|1|||
37891416|NCT00908544|69576623|FG001|Overall Study|Unable to visit sutdy center|0|||
37891417|NCT00830440|69576631|FG000|Overall Study|Protocol Violation|1|||
37891418|NCT00830440|69576632|FG001|Overall Study|Protocol Violation|0|||
37891419|NCT00830440|69576631|FG000|Overall Study|Withdrawal by Subject|1|||
37891420|NCT00830440|69576632|FG001|Overall Study|Withdrawal by Subject|0|||
37891421|NCT00830440|69576631|FG000|Overall Study|unsuccessful procedure|4|||
37891422|NCT00830440|69576632|FG001|Overall Study|unsuccessful procedure|0|||
37891423|NCT00830440|69576631|FG000|Overall Study|Adverse Event|2|||
37891424|NCT00830440|69576632|FG001|Overall Study|Adverse Event|0|||
37891425|NCT00908310|69576639|FG000|Overall Study|Death|37|||
37891426|NCT00908310|69576639|FG000|Overall Study|Withdrawal by Subject|7|||
37891427|NCT00908310|69576639|FG000|Overall Study|Lost to Follow-up|7|||
37891428|NCT00908310|69576639|FG000|Overall Study|Screening failure|5|||
37891429|NCT00908310|69576639|FG000|Overall Study|Other reasons|4|||
37891430|NCT00830128|69576643|FG000|Overall Study|Adverse Event|5|||
37891431|NCT00830128|69576643|FG000|Overall Study|Lack of Efficacy|7|||
37891432|NCT00830128|69576643|FG000|Overall Study|Protocol Violation|1|||
37891433|NCT00830128|69576643|FG000|Overall Study|Withdrawal by Subject|2|||
37891434|NCT00830128|69576643|FG000|Overall Study|Family obligation|1|||
37891435|NCT00830128|69576643|FG000|Overall Study|Relocation|1|||
37891436|NCT00830128|69576643|FG000|Overall Study|Work obligation|1|||
37891437|NCT00830128|69576643|FG000|Overall Study|Operating a vehicle|1|||
37891438|NCT00841906|69576649|FG000|Overall Study|Withdrawal by Subject|2|||
37891439|NCT00841906|69576650|FG001|Overall Study|Withdrawal by Subject|0|||
37891440|NCT00771667|69576662|FG000|Induction Phase|Adverse Event|5|||
37891441|NCT00771667|69576663|FG001|Induction Phase|Adverse Event|2|||
37891442|NCT00771667|69576664|FG002|Induction Phase|Adverse Event|4|||
37988841|NCT00205881|69674055|FG000|Overall Study|Withdrawal by Subject|16|||
37891443|NCT00771667|69576665|FG003|Induction Phase|Adverse Event|1|||
37891444|NCT00771667|69576666|FG004|Induction Phase|Adverse Event|0|||
37891445|NCT00771667|69576667|FG005|Induction Phase|Adverse Event|0|||
37988842|NCT00365378|69674062|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
37988843|NCT00365378|69674063|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
37891446|NCT00771667|69576668|FG006|Induction Phase|Adverse Event|0|||
37891447|NCT00771667|69576669|FG007|Induction Phase|Adverse Event|0|||
37891448|NCT00771667|69576670|FG008|Induction Phase|Adverse Event|0|||
37891449|NCT00771667|69576671|FG009|Induction Phase|Adverse Event|0|||
37891450|NCT00771667|69576662|FG000|Induction Phase|Lack of Efficacy|9|||
37891451|NCT00771667|69576663|FG001|Induction Phase|Lack of Efficacy|2|||
37891452|NCT00771667|69576664|FG002|Induction Phase|Lack of Efficacy|4|||
37891453|NCT00771667|69576665|FG003|Induction Phase|Lack of Efficacy|3|||
37891454|NCT00771667|69576666|FG004|Induction Phase|Lack of Efficacy|0|||
37891455|NCT00771667|69576667|FG005|Induction Phase|Lack of Efficacy|0|||
37891456|NCT00771667|69576668|FG006|Induction Phase|Lack of Efficacy|0|||
37891457|NCT00771667|69576669|FG007|Induction Phase|Lack of Efficacy|0|||
37891458|NCT00771667|69576670|FG008|Induction Phase|Lack of Efficacy|0|||
37891459|NCT00771667|69576671|FG009|Induction Phase|Lack of Efficacy|0|||
37891460|NCT00771667|69576662|FG000|Induction Phase|Lost to Follow-up|1|||
37891461|NCT00771667|69576663|FG001|Induction Phase|Lost to Follow-up|0|||
37891462|NCT00771667|69576664|FG002|Induction Phase|Lost to Follow-up|1|||
37891463|NCT00771667|69576665|FG003|Induction Phase|Lost to Follow-up|0|||
37891464|NCT00771667|69576666|FG004|Induction Phase|Lost to Follow-up|0|||
37891465|NCT00771667|69576667|FG005|Induction Phase|Lost to Follow-up|0|||
37891466|NCT00771667|69576668|FG006|Induction Phase|Lost to Follow-up|0|||
37891467|NCT00771667|69576669|FG007|Induction Phase|Lost to Follow-up|0|||
37891468|NCT00771667|69576670|FG008|Induction Phase|Lost to Follow-up|0|||
37891469|NCT00771667|69576671|FG009|Induction Phase|Lost to Follow-up|0|||
37891470|NCT00771667|69576662|FG000|Induction Phase|Other|4|||
37891471|NCT00771667|69576663|FG001|Induction Phase|Other|6|||
37891472|NCT00771667|69576664|FG002|Induction Phase|Other|3|||
37891473|NCT00771667|69576665|FG003|Induction Phase|Other|4|||
37891474|NCT00771667|69576666|FG004|Induction Phase|Other|0|||
37891475|NCT00771667|69576667|FG005|Induction Phase|Other|0|||
37891476|NCT00771667|69576668|FG006|Induction Phase|Other|0|||
37891477|NCT00771667|69576669|FG007|Induction Phase|Other|0|||
37891478|NCT00771667|69576670|FG008|Induction Phase|Other|0|||
37824056|NCT02811549|69505724|FG000|Overall Study|Lost to Follow-up|1|||
37824057|NCT02811549|69505724|FG000|Overall Study|Withdrawal by Subject|3|||
37824058|NCT02811549|69505724|FG000|Overall Study|Subject screen failed|4|||
37824059|NCT02811549|69505724|FG000|Overall Study|Surgery denied by subject's insurance carrier|2|||
37824060|NCT02773849|69505730|FG000|Overall Study|Adverse Event|3|||
37824061|NCT02773849|69505730|FG000|Overall Study|Lack of Efficacy|89|||
37824062|NCT02773849|69505730|FG000|Overall Study|Withdrawal by Subject|1|||
37824063|NCT02773849|69505730|FG000|Overall Study|Withdrawal of Consent|1|||
37824064|NCT02426125|69505778|FG000|Overall Study|Lost to Follow-up|14|||
37824065|NCT02426125|69505779|FG001|Overall Study|Lost to Follow-up|12|||
37824066|NCT02426125|69505778|FG000|Overall Study|Withdrawal by Subject|13|||
37824067|NCT02426125|69505779|FG001|Overall Study|Withdrawal by Subject|14|||
37824068|NCT02426125|69505778|FG000|Overall Study|Death|185|||
37824069|NCT02426125|69505779|FG001|Overall Study|Death|200|||
37824070|NCT02426125|69505778|FG000|Overall Study|Randomized, But Never Treated|5|||
37824071|NCT02426125|69505779|FG001|Overall Study|Randomized, But Never Treated|2|||
37824072|NCT02331277|69505807|FG000|Overall Study|Withdrawal by Subject|1|||
37824073|NCT02331277|69505808|FG001|Overall Study|Withdrawal by Subject|0|||
37824074|NCT02120365|69505826|FG000|Overall Study|Withdrawal by Subject|0|||
37824075|NCT02120365|69505827|FG001|Overall Study|Withdrawal by Subject|0|||
37824076|NCT02120365|69505828|FG002|Overall Study|Withdrawal by Subject|2|||
37824077|NCT02120365|69505829|FG003|Overall Study|Withdrawal by Subject|4|||
37824078|NCT02120365|69505830|FG004|Overall Study|Withdrawal by Subject|0|||
37824079|NCT02120365|69505831|FG005|Overall Study|Withdrawal by Subject|2|||
37824080|NCT01854775|69505872|FG000|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
37824081|NCT01854775|69505873|FG001|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
37824082|NCT01854775|69505874|FG002|Treatment Phase (48 Weeks)|Withdrawal by Subject|0|||
37824083|NCT01854775|69505872|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
37824084|NCT01854775|69505873|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
37824085|NCT01854775|69505874|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
37824086|NCT01854775|69505872|FG000|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
37824087|NCT01854775|69505873|FG001|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
37824088|NCT01854775|69505874|FG002|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9|||
37824089|NCT01854775|69505872|FG000|Extension Phase|Pregnancy|3|||
37824090|NCT01854775|69505873|FG001|Extension Phase|Pregnancy|0|||
37824091|NCT01854775|69505874|FG002|Extension Phase|Pregnancy|0|||
37824092|NCT01854775|69505872|FG000|Extension Phase|Investigator's Discretion|1|||
37824093|NCT01854775|69505873|FG001|Extension Phase|Investigator's Discretion|0|||
37824094|NCT01854775|69505874|FG002|Extension Phase|Investigator's Discretion|0|||
37824095|NCT01854775|69505872|FG000|Extension Phase|Non-Compliance with Study Drug|1|||
37824096|NCT01854775|69505873|FG001|Extension Phase|Non-Compliance with Study Drug|0|||
37824097|NCT01854775|69505874|FG002|Extension Phase|Non-Compliance with Study Drug|0|||
37824098|NCT01854775|69505872|FG000|Extension Phase|Lost to Follow-up|2|||
37824099|NCT01854775|69505873|FG001|Extension Phase|Lost to Follow-up|0|||
37891479|NCT00771667|69576671|FG009|Induction Phase|Other|0|||
37891480|NCT00771667|69576662|FG000|Maintenance Phase|Adverse Event|0|||
37891481|NCT00771667|69576663|FG001|Maintenance Phase|Adverse Event|0|||
37891482|NCT00771667|69576664|FG002|Maintenance Phase|Adverse Event|0|||
37891483|NCT00771667|69576665|FG003|Maintenance Phase|Adverse Event|0|||
37891484|NCT00771667|69576666|FG004|Maintenance Phase|Adverse Event|1|||
37891485|NCT00771667|69576667|FG005|Maintenance Phase|Adverse Event|3|||
37891486|NCT00771667|69576668|FG006|Maintenance Phase|Adverse Event|5|||
37891487|NCT00771667|69576669|FG007|Maintenance Phase|Adverse Event|1|||
37891488|NCT00771667|69576670|FG008|Maintenance Phase|Adverse Event|8|||
37891489|NCT00771667|69576671|FG009|Maintenance Phase|Adverse Event|7|||
37891490|NCT00771667|69576662|FG000|Maintenance Phase|Lack of Efficacy|0|||
37891491|NCT00771667|69576663|FG001|Maintenance Phase|Lack of Efficacy|0|||
37891492|NCT00771667|69576664|FG002|Maintenance Phase|Lack of Efficacy|0|||
37891493|NCT00771667|69576665|FG003|Maintenance Phase|Lack of Efficacy|0|||
37891494|NCT00771667|69576666|FG004|Maintenance Phase|Lack of Efficacy|1|||
37891495|NCT00771667|69576667|FG005|Maintenance Phase|Lack of Efficacy|3|||
37891496|NCT00771667|69576668|FG006|Maintenance Phase|Lack of Efficacy|3|||
37891497|NCT00771667|69576669|FG007|Maintenance Phase|Lack of Efficacy|2|||
37891498|NCT00771667|69576670|FG008|Maintenance Phase|Lack of Efficacy|11|||
37891499|NCT00771667|69576671|FG009|Maintenance Phase|Lack of Efficacy|7|||
37891500|NCT00771667|69576662|FG000|Maintenance Phase|Other|0|||
37891501|NCT00771667|69576663|FG001|Maintenance Phase|Other|0|||
37891502|NCT00771667|69576664|FG002|Maintenance Phase|Other|0|||
37891503|NCT00771667|69576665|FG003|Maintenance Phase|Other|0|||
37891504|NCT00771667|69576666|FG004|Maintenance Phase|Other|0|||
37891505|NCT00771667|69576667|FG005|Maintenance Phase|Other|1|||
37891506|NCT00771667|69576668|FG006|Maintenance Phase|Other|2|||
37891507|NCT00771667|69576669|FG007|Maintenance Phase|Other|2|||
37891508|NCT00771667|69576670|FG008|Maintenance Phase|Other|3|||
37891509|NCT00771667|69576671|FG009|Maintenance Phase|Other|3|||
37891510|NCT00770965|69576693|FG000|Safety Set|Withdrawal by Subject|0|||
37891511|NCT00770965|69576694|FG001|Safety Set|Withdrawal by Subject|0|||
37891512|NCT00770965|69576695|FG002|Safety Set|Withdrawal by Subject|0|||
37891513|NCT00770965|69576696|FG003|Safety Set|Withdrawal by Subject|1|||
37891514|NCT00770965|69576693|FG000|Safety Set|Protocol deviation|0|||
37891515|NCT00770965|69576694|FG001|Safety Set|Protocol deviation|0|||
37891516|NCT00770965|69576695|FG002|Safety Set|Protocol deviation|1|||
37891517|NCT00770965|69576696|FG003|Safety Set|Protocol deviation|0|||
37891518|NCT00770965|69576693|FG000|Excluded Set|Administrative problems|14|||
37891519|NCT00770965|69576694|FG001|Excluded Set|Administrative problems|12|||
37891520|NCT00770965|69576695|FG002|Excluded Set|Administrative problems|12|||
37891521|NCT00770965|69576696|FG003|Excluded Set|Administrative problems|10|||
37891522|NCT00770965|69576693|FG000|Excluded Set|Withdrawal by Subject|1|||
37891523|NCT00770965|69576694|FG001|Excluded Set|Withdrawal by Subject|1|||
37891524|NCT00770965|69576695|FG002|Excluded Set|Withdrawal by Subject|2|||
37891525|NCT00770965|69576696|FG003|Excluded Set|Withdrawal by Subject|3|||
37891526|NCT00763555|69576708|FG000|Overall Study|Adverse Event|2|||
37891527|NCT00763555|69576709|FG001|Overall Study|Adverse Event|1|||
37891528|NCT00763555|69576708|FG000|Overall Study|Withdrawal by Subject|2|||
37891529|NCT00763555|69576709|FG001|Overall Study|Withdrawal by Subject|6|||
37891530|NCT00763555|69576708|FG000|Overall Study|Lost to Follow-up|0|||
37891531|NCT00763555|69576709|FG001|Overall Study|Lost to Follow-up|3|||
37891532|NCT00763321|69576718|FG000|Open-label Period|Adverse Event|24|||
37891533|NCT00763321|69576719|FG001|Open-label Period|Adverse Event|0|||
37891534|NCT00763321|69576720|FG002|Open-label Period|Adverse Event|0|||
37891535|NCT00763321|69576718|FG000|Open-label Period|Lost to Follow-up|14|||
37891536|NCT00763321|69576719|FG001|Open-label Period|Lost to Follow-up|0|||
37891537|NCT00763321|69576720|FG002|Open-label Period|Lost to Follow-up|0|||
37891538|NCT00763321|69576718|FG000|Open-label Period|Withdrawal by Subject|7|||
37891539|NCT00763321|69576719|FG001|Open-label Period|Withdrawal by Subject|0|||
37891540|NCT00763321|69576720|FG002|Open-label Period|Withdrawal by Subject|0|||
37891541|NCT00763321|69576718|FG000|Open-label Period|Subject noncompliant|7|||
37891542|NCT00763321|69576719|FG001|Open-label Period|Subject noncompliant|0|||
37891543|NCT00763321|69576720|FG002|Open-label Period|Subject noncompliant|0|||
37891544|NCT00763321|69576718|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
37891545|NCT00763321|69576719|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
37891546|NCT00763321|69576720|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
37891547|NCT00763321|69576718|FG000|Open-label Period|Lack of Efficacy|2|||
37891548|NCT00763321|69576719|FG001|Open-label Period|Lack of Efficacy|0|||
37891549|NCT00763321|69576720|FG002|Open-label Period|Lack of Efficacy|0|||
37891550|NCT00763321|69576718|FG000|Open-label Period|Other|4|||
37891551|NCT00763321|69576719|FG001|Open-label Period|Other|0|||
37891552|NCT00763321|69576720|FG002|Open-label Period|Other|0|||
37891553|NCT00763321|69576718|FG000|Double-blind Period|Lack of Efficacy|0|||
37891554|NCT00763321|69576719|FG001|Double-blind Period|Lack of Efficacy|9|||
37891555|NCT00763321|69576720|FG002|Double-blind Period|Lack of Efficacy|17|||
37891556|NCT00763321|69576718|FG000|Double-blind Period|Adverse Event|0|||
37891557|NCT00763321|69576719|FG001|Double-blind Period|Adverse Event|4|||
37891558|NCT00763321|69576720|FG002|Double-blind Period|Adverse Event|4|||
37891559|NCT00763321|69576718|FG000|Double-blind Period|Lost to Follow-up|0|||
37891560|NCT00763321|69576719|FG001|Double-blind Period|Lost to Follow-up|4|||
37891561|NCT00763321|69576720|FG002|Double-blind Period|Lost to Follow-up|2|||
37891562|NCT00763321|69576718|FG000|Double-blind Period|Withdrawal by Subject|0|||
37891563|NCT00763321|69576719|FG001|Double-blind Period|Withdrawal by Subject|2|||
37891564|NCT00763321|69576720|FG002|Double-blind Period|Withdrawal by Subject|3|||
37891565|NCT00763321|69576718|FG000|Double-blind Period|Other|0|||
37891566|NCT00763321|69576719|FG001|Double-blind Period|Other|2|||
37891567|NCT00763321|69576720|FG002|Double-blind Period|Other|3|||
37891568|NCT00770653|69576729|FG000|Overall Study|Adverse Event|13|||
37891569|NCT00770653|69576730|FG001|Overall Study|Adverse Event|5|||
37891570|NCT00770653|69576729|FG000|Overall Study|Protocol Violation|8|||
37891571|NCT00770653|69576730|FG001|Overall Study|Protocol Violation|6|||
37891572|NCT00770653|69576729|FG000|Overall Study|Withdrawal by Subject|4|||
37891573|NCT00770653|69576730|FG001|Overall Study|Withdrawal by Subject|7|||
37891574|NCT00770653|69576729|FG000|Overall Study|Lack of Compliance|1|||
37891575|NCT00770653|69576730|FG001|Overall Study|Lack of Compliance|4|||
37891576|NCT00770653|69576729|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
37891577|NCT00770653|69576730|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
37891578|NCT00770653|69576729|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
37891579|NCT00770653|69576730|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
37891580|NCT00770653|69576729|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
37891581|NCT00770653|69576730|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
37891582|NCT00770653|69576729|FG000|Overall Study|Lost to Follow-up|1|||
37891583|NCT00770653|69576730|FG001|Overall Study|Lost to Follow-up|2|||
37891584|NCT00770653|69576729|FG000|Overall Study|Physician Decision|1|||
37891585|NCT00770653|69576730|FG001|Overall Study|Physician Decision|0|||
37988844|NCT00365378|69674064|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
37988845|NCT00365378|69674062|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
37988846|NCT00365378|69674063|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
37696008|NCT02358668|69172169|FG001|Overall Study|Adverse Event|0|||
37891586|NCT00819052|69576738|FG000|Overall Study|Adverse Event|0|||
37891587|NCT00819052|69576739|FG001|Overall Study|Adverse Event|5|||
37891588|NCT00819052|69576738|FG000|Overall Study|Protocol Violation|1|||
37891589|NCT00819052|69576739|FG001|Overall Study|Protocol Violation|2|||
37891590|NCT00819052|69576738|FG000|Overall Study|Lost to Follow-up|1|||
37891591|NCT00819052|69576739|FG001|Overall Study|Lost to Follow-up|2|||
37891592|NCT00819052|69576738|FG000|Overall Study|Withdrawal by Subject|1|||
37891593|NCT00819052|69576739|FG001|Overall Study|Withdrawal by Subject|2|||
37891594|NCT00819052|69576738|FG000|Overall Study|Lack of Efficacy|1|||
37891595|NCT00819052|69576739|FG001|Overall Study|Lack of Efficacy|1|||
37891596|NCT00819052|69576738|FG000|Overall Study|Pregnancy|1|||
37891597|NCT00819052|69576739|FG001|Overall Study|Pregnancy|2|||
37891598|NCT00819052|69576738|FG000|Overall Study|Death or events leading to death|1|||
37891599|NCT00819052|69576739|FG001|Overall Study|Death or events leading to death|0|||
37891600|NCT00763009|69576748|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
37891601|NCT00841672|69576755|FG000|Overall Study|Adverse Event|7|||
37891602|NCT00841672|69576756|FG001|Overall Study|Adverse Event|16|||
37891603|NCT00841672|69576755|FG000|Overall Study|Abnormal test procedure result(s)|0|||
37891604|NCT00841672|69576756|FG001|Overall Study|Abnormal test procedure result(s)|1|||
37891605|NCT00841672|69576755|FG000|Overall Study|Subject withdrew consent|2|||
37891606|NCT00841672|69576756|FG001|Overall Study|Subject withdrew consent|4|||
37891607|NCT00841672|69576755|FG000|Overall Study|Lost to Follow-up|1|||
37891608|NCT00841672|69576756|FG001|Overall Study|Lost to Follow-up|1|||
37891609|NCT00841672|69576755|FG000|Overall Study|Administrative problems|9|||
37891610|NCT00841672|69576756|FG001|Overall Study|Administrative problems|9|||
37891611|NCT00841672|69576755|FG000|Overall Study|Misrandomized|1|||
37891612|NCT00841672|69576756|FG001|Overall Study|Misrandomized|0|||
37891613|NCT00841672|69576755|FG000|Overall Study|Protocol Deviation|0|||
37891614|NCT00841672|69576756|FG001|Overall Study|Protocol Deviation|1|||
37988847|NCT00365378|69674064|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
37988848|NCT00365378|69674062|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
37824100|NCT01854775|69505874|FG002|Extension Phase|Lost to Follow-up|0|||
37824101|NCT01854775|69505872|FG000|Extension Phase|Still on Study|32|||
37824102|NCT01854775|69505873|FG001|Extension Phase|Still on Study|47|||
37824103|NCT01854775|69505874|FG002|Extension Phase|Still on Study|18|||
37891615|NCT00908232|69576762|FG000|Cycle 1 to 4|Death|5|||
37891616|NCT00908232|69576763|FG001|Cycle 1 to 4|Death|0|||
37696009|NCT02358668|69172170|FG002|Overall Study|Adverse Event|0|||
37696010|NCT02358668|69172168|FG000|Overall Study|Withdrawal by Subject|0|||
37696011|NCT02358668|69172169|FG001|Overall Study|Withdrawal by Subject|1|||
37696012|NCT02358668|69172170|FG002|Overall Study|Withdrawal by Subject|0|||
37696013|NCT02282605|69172181|FG000|Overall Study|negative SA result on Day -1|3|||
37696014|NCT02282605|69172182|FG001|Overall Study|negative SA result on Day -1|0|||
37696015|NCT02282605|69172183|FG002|Overall Study|negative SA result on Day -1|0|||
37696016|NCT02282527|69172193|FG000|Overall Study|Lost to Follow-up|0|||
37696017|NCT02282527|69172194|FG001|Overall Study|Lost to Follow-up|1|||
37696018|NCT02282527|69172193|FG000|Overall Study|Lack of home health aid|1|||
37696019|NCT02282527|69172194|FG001|Overall Study|Lack of home health aid|0|||
37696020|NCT02278939|69172205|FG000|Overall Study|lack of time|1|||
37696021|NCT02278939|69172206|FG001|Overall Study|lack of time|0|||
37696022|NCT02278939|69172205|FG000|Overall Study|Lost to Follow-up|1|||
37696023|NCT02278939|69172206|FG001|Overall Study|Lost to Follow-up|1|||
37696024|NCT02278939|69172205|FG000|Overall Study|death in family|1|||
37696025|NCT02278939|69172206|FG001|Overall Study|death in family|0|||
37696026|NCT02278939|69172205|FG000|Overall Study|family emergency unable to commit|2|||
37696027|NCT02278939|69172206|FG001|Overall Study|family emergency unable to commit|0|||
37696028|NCT02278471|69172214|FG000|Overall Study|Lost to Follow-up|6|||
37696029|NCT02278471|69172215|FG001|Overall Study|Lost to Follow-up|15|||
37696030|NCT02278471|69172214|FG000|Overall Study|Death|2|||
37696031|NCT02278471|69172215|FG001|Overall Study|Death|2|||
37696032|NCT02278471|69172214|FG000|Overall Study|Withdrawal by Subject|0|||
37696033|NCT02278471|69172215|FG001|Overall Study|Withdrawal by Subject|3|||
37696034|NCT02278003|69172224|FG000|Overall Study|Withdrawal by Subject|11|||
37824120|NCT01199575|69505906|FG000|Overall Study|Withdrawal by Subject|5|||
37824121|NCT00938340|69505941|FG000|Overall Study|Withdrawal by Subject|3|||
37824122|NCT00938340|69505941|FG000|Overall Study|Protocol Violation|1|||
37824123|NCT00938340|69505941|FG000|Overall Study|Adverse Event|1|||
37824124|NCT00539643|69505998|FG000|Overall Study|Adverse Event|1|||
37824125|NCT00539643|69505999|FG001|Overall Study|Adverse Event|0|||
37824126|NCT00539643|69505998|FG000|Overall Study|Death|2|||
37824127|NCT00539643|69505999|FG001|Overall Study|Death|1|||
37824128|NCT00539643|69505998|FG000|Overall Study|Physician Decision|3|||
37824129|NCT00539643|69505999|FG001|Overall Study|Physician Decision|1|||
37824130|NCT00539643|69505998|FG000|Overall Study|Withdrawal by Subject|0|||
37824131|NCT00539643|69505999|FG001|Overall Study|Withdrawal by Subject|1|||
37824132|NCT00039130|69506014|FG000|Overall Study|Adverse Event|11|||
37824133|NCT00039130|69506014|FG000|Overall Study|Death|9|||
37696035|NCT02278003|69172225|FG001|Overall Study|Withdrawal by Subject|0|||
37696036|NCT02278003|69172224|FG000|Overall Study|Not Treated|1|||
37696037|NCT02278003|69172225|FG001|Overall Study|Not Treated|0|||
37696038|NCT02278003|69172224|FG000|Overall Study|Recognition task improperly completed|7|||
37696039|NCT02278003|69172225|FG001|Overall Study|Recognition task improperly completed|0|||
37696040|NCT02277769|69172234|FG000|Overall Study|Protocol Violation|3|||
37696041|NCT02277769|69172235|FG001|Overall Study|Protocol Violation|3|||
37988849|NCT00365378|69674063|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
37988850|NCT00365378|69674064|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
37988851|NCT00365378|69674062|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
37988852|NCT00365378|69674063|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
37988853|NCT00365378|69674064|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
37988854|NCT00365378|69674062|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
37988855|NCT00365378|69674063|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
37988856|NCT00365378|69674064|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
37988857|NCT00365378|69674062|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
37824134|NCT00039130|69506014|FG000|Overall Study|Withdrawal by Subject|3|||
37891617|NCT00908232|69576764|FG002|Cycle 1 to 4|Death|0|||
37891618|NCT00908232|69576765|FG003|Cycle 1 to 4|Death|0|||
37891619|NCT00908232|69576762|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
37891620|NCT00908232|69576763|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
37988858|NCT00365378|69674063|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
37988859|NCT00365378|69674064|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
37988860|NCT00365378|69674062|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
37988861|NCT00365378|69674063|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
37988862|NCT00365378|69674064|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
37988863|NCT00365378|69674062|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
37988864|NCT00365378|69674063|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
37988865|NCT00365378|69674064|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
37988866|NCT00365378|69674062|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
37891621|NCT00908232|69576764|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
37988867|NCT00365378|69674063|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
37696042|NCT02277769|69172236|FG002|Overall Study|Protocol Violation|5|||
37824135|NCT00039130|69506014|FG000|Overall Study|Progression|2|||
37824136|NCT00039130|69506014|FG000|Overall Study|Subsequent treatment|2|||
37824137|NCT00039130|69506014|FG000|Overall Study|Physician Decision|3|||
37824138|NCT00005957|69506020|FG000|Overall Study|No treated|3|||
37824139|NCT00005957|69506021|FG001|Overall Study|No treated|9|||
37824140|NCT00005957|69506020|FG000|Overall Study|Crossover to the other arm|5|||
37824141|NCT00005957|69506021|FG001|Overall Study|Crossover to the other arm|19|||
37824142|NCT04920916|69506107|FG000|Phase IIa 60 Day Study|Death|2|||
37824143|NCT04920916|69506108|FG001|Phase IIa 60 Day Study|Death|5|||
37824144|NCT04920916|69506107|FG000|1 Year Follow up (Phone Call)|Death|1|||
37824145|NCT04920916|69506108|FG001|1 Year Follow up (Phone Call)|Death|3|||
37824146|NCT04920916|69506107|FG000|1 Year Follow up Visits|Lost to Follow-up|6|||
37824147|NCT04920916|69506108|FG001|1 Year Follow up Visits|Lost to Follow-up|7|||
37891622|NCT00908232|69576765|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
37988868|NCT00365378|69674064|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
37696043|NCT02277769|69172234|FG000|Overall Study|Lack of Efficacy|17|||
37988869|NCT00365378|69674062|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
37824148|NCT04642079|69506121|FG000|Overall Study|Lost to Follow-up|2|||
37824149|NCT04642079|69506122|FG001|Overall Study|Lost to Follow-up|5|||
37824150|NCT04642079|69506123|FG002|Overall Study|Lost to Follow-up|2|||
37824151|NCT04642079|69506124|FG003|Overall Study|Lost to Follow-up|0|||
37824152|NCT04642079|69506121|FG000|Overall Study|Withdrawal by Subject|0|||
37891623|NCT00908232|69576762|FG000|Cycle 1 to 4|Progressive Disease|6|||
37891624|NCT00908232|69576763|FG001|Cycle 1 to 4|Progressive Disease|0|||
37891625|NCT00908232|69576764|FG002|Cycle 1 to 4|Progressive Disease|0|||
37891626|NCT00908232|69576765|FG003|Cycle 1 to 4|Progressive Disease|0|||
37891627|NCT00908232|69576762|FG000|Cycle 1 to 4|Adverse Event|12|||
37891628|NCT00908232|69576763|FG001|Cycle 1 to 4|Adverse Event|0|||
37891629|NCT00908232|69576764|FG002|Cycle 1 to 4|Adverse Event|0|||
37891630|NCT00908232|69576765|FG003|Cycle 1 to 4|Adverse Event|0|||
37891631|NCT00908232|69576762|FG000|Cycle 1 to 4|Other|1|||
37891632|NCT00908232|69576763|FG001|Cycle 1 to 4|Other|0|||
37891633|NCT00908232|69576764|FG002|Cycle 1 to 4|Other|0|||
37891634|NCT00908232|69576765|FG003|Cycle 1 to 4|Other|0|||
37891635|NCT00908232|69576762|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
37891636|NCT00908232|69576763|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
37891637|NCT00908232|69576764|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
37891638|NCT00908232|69576765|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
37891639|NCT00908232|69576762|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
37891640|NCT00908232|69576763|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
37891641|NCT00908232|69576764|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
37891642|NCT00908232|69576765|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
37891643|NCT00908232|69576762|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
37891644|NCT00908232|69576763|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
37891645|NCT00908232|69576764|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
37891646|NCT00908232|69576765|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
37891647|NCT00908232|69576762|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
37891648|NCT00908232|69576763|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
37891649|NCT00908232|69576764|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
37891650|NCT00908232|69576765|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
37891651|NCT00908232|69576762|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
37891652|NCT00908232|69576763|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
37891653|NCT00908232|69576764|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
37891654|NCT00908232|69576765|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
37891655|NCT00908232|69576762|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
37891656|NCT00908232|69576763|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
37891657|NCT00908232|69576764|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
37891658|NCT00908232|69576765|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
37891659|NCT00908232|69576762|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
37891660|NCT00908232|69576763|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
37891661|NCT00908232|69576764|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
37891662|NCT00908232|69576765|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
37891663|NCT00908232|69576762|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
37891664|NCT00908232|69576763|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
37891665|NCT00908232|69576764|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
37891666|NCT00908232|69576765|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
37891667|NCT00770341|69576774|FG000|Overall Study|Did not meet eligibility criteria|1|||
37891668|NCT00770341|69576775|FG001|Overall Study|Did not meet eligibility criteria|0|||
37891669|NCT00770341|69576776|FG002|Overall Study|Did not meet eligibility criteria|0|||
37891670|NCT00770341|69576774|FG000|Overall Study|Withdrawal by Subject|0|||
37891671|NCT00770341|69576775|FG001|Overall Study|Withdrawal by Subject|1|||
37891672|NCT00770341|69576776|FG002|Overall Study|Withdrawal by Subject|0|||
37824153|NCT04642079|69506122|FG001|Overall Study|Withdrawal by Subject|4|||
37824154|NCT04642079|69506123|FG002|Overall Study|Withdrawal by Subject|1|||
37824155|NCT04642079|69506124|FG003|Overall Study|Withdrawal by Subject|2|||
37824156|NCT04642079|69506121|FG000|Overall Study|Other|0|||
37824157|NCT04642079|69506122|FG001|Overall Study|Other|0|||
37824158|NCT04642079|69506123|FG002|Overall Study|Other|0|||
37824159|NCT04642079|69506124|FG003|Overall Study|Other|1|||
37824160|NCT04642079|69506121|FG000|Overall Study|No longer met eligibility criteria|1|||
37824161|NCT04642079|69506122|FG001|Overall Study|No longer met eligibility criteria|0|||
37824162|NCT04642079|69506123|FG002|Overall Study|No longer met eligibility criteria|1|||
37824163|NCT04642079|69506124|FG003|Overall Study|No longer met eligibility criteria|1|||
37824164|NCT04419493|69506143|FG000|Wash-out After Period 1|Adverse Event|1|||
37891673|NCT00770341|69576774|FG000|Overall Study|Clinical Adverse Event|3|||
37824165|NCT04419493|69506144|FG001|Wash-out After Period 1|Adverse Event|2|||
37824166|NCT04419493|69506145|FG002|Wash-out After Period 1|Adverse Event|1|||
37824167|NCT04419493|69506146|FG003|Wash-out After Period 1|Adverse Event|0|||
37824168|NCT04359901|69506159|FG000|Overall Study|Withdrawal by Subject|0|||
37891674|NCT00770341|69576775|FG001|Overall Study|Clinical Adverse Event|1|||
37891675|NCT00770341|69576776|FG002|Overall Study|Clinical Adverse Event|2|||
37891676|NCT00770341|69576774|FG000|Overall Study|Laboratory adverse event|3|||
37891677|NCT00770341|69576775|FG001|Overall Study|Laboratory adverse event|3|||
37824169|NCT04359901|69506160|FG001|Overall Study|Withdrawal by Subject|1|||
37824170|NCT04359901|69506159|FG000|Overall Study|Death|6|||
37891678|NCT00770341|69576776|FG002|Overall Study|Laboratory adverse event|0|||
37891679|NCT00770341|69576774|FG000|Overall Study|Lack of Efficacy|3|||
37891680|NCT00770341|69576775|FG001|Overall Study|Lack of Efficacy|0|||
37891681|NCT00770341|69576776|FG002|Overall Study|Lack of Efficacy|1|||
37891682|NCT00770341|69576774|FG000|Overall Study|Other|1|||
37891683|NCT00770341|69576775|FG001|Overall Study|Other|0|||
37891684|NCT00770341|69576776|FG002|Overall Study|Other|0|||
37891685|NCT00770341|69576774|FG000|Overall Study|Not treated|1|||
37891686|NCT00770341|69576775|FG001|Overall Study|Not treated|0|||
37891687|NCT00770341|69576776|FG002|Overall Study|Not treated|0|||
37891688|NCT00762463|69576793|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
37891689|NCT00762463|69576794|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
37891690|NCT00762463|69576795|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
37891691|NCT00762463|69576796|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
37891692|NCT00762463|69576793|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
37988870|NCT00365378|69674063|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
37988871|NCT00365378|69674064|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
37988872|NCT00365378|69674062|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
37891693|NCT00762463|69576794|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
37891694|NCT00762463|69576795|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
37891695|NCT00762463|69576796|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
37891696|NCT00762463|69576793|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
37891697|NCT00762463|69576794|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
37891698|NCT00762463|69576795|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
37891699|NCT00762463|69576796|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
37891700|NCT00762463|69576793|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
37988873|NCT00365378|69674063|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
37988874|NCT00365378|69674064|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
37988875|NCT00365378|69674062|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
37988876|NCT00365378|69674063|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
37988877|NCT00365378|69674064|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
37988878|NCT00365378|69674062|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
37988879|NCT00365378|69674063|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
37988880|NCT00365378|69674064|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
37824171|NCT04359901|69506160|FG001|Overall Study|Death|2|||
37824172|NCT04147611|69506183|FG000|Overall Study|Physician Decision|0|||
37824173|NCT04147611|69506184|FG001|Overall Study|Physician Decision|1|||
37824174|NCT03603964|69506215|FG000|Overall Study|Death|9|||
37824175|NCT03603964|69506215|FG000|Overall Study|Withdrawal by participant|7|||
37824176|NCT03603964|69506215|FG000|Overall Study|Study terminated by Sponsor|19|||
37824177|NCT03191864|69506235|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
37824178|NCT03191864|69506236|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
37824179|NCT03191864|69506237|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
37824180|NCT03191864|69506238|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
37824181|NCT03191864|69506239|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
37824182|NCT03191864|69506240|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
37824183|NCT03191864|69506235|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
37824184|NCT03191864|69506236|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
37824185|NCT03191864|69506237|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
37824186|NCT03191864|69506238|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
37824187|NCT03191864|69506239|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
37824188|NCT03191864|69506240|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
37891701|NCT00762463|69576794|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
37891702|NCT00762463|69576795|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
37891703|NCT00762463|69576796|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
37891704|NCT00762463|69576793|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
37891705|NCT00762463|69576794|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
37891706|NCT00762463|69576795|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
37891707|NCT00762463|69576796|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
37891708|NCT00762463|69576793|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
37891709|NCT00762463|69576794|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
37891710|NCT00762463|69576795|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
37891711|NCT00762463|69576796|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
37891712|NCT00762463|69576793|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
37891713|NCT00762463|69576794|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
37891714|NCT00762463|69576795|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
37891715|NCT00762463|69576796|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
37891716|NCT00762463|69576793|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
37891717|NCT00762463|69576794|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
37891718|NCT00762463|69576795|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
37824189|NCT03191864|69506235|FG000|Baseline Symptom Assessment|Adverse Event|0|||
37891719|NCT00762463|69576796|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
37891720|NCT00762385|69576809|FG000|First Intervention|Lens Issue|1|||
37891721|NCT00762385|69576810|FG001|First Intervention|Lens Issue|1|||
37891722|NCT00762385|69576809|FG000|First Intervention|Lost to Follow-up|0|||
37891723|NCT00762385|69576810|FG001|First Intervention|Lost to Follow-up|2|||
37891724|NCT00762385|69576809|FG000|First Intervention|Ineligible|1|||
37891725|NCT00762385|69576810|FG001|First Intervention|Ineligible|0|||
37891726|NCT00762385|69576809|FG000|First Intervention|Protocol Violation|0|||
37891727|NCT00762385|69576810|FG001|First Intervention|Protocol Violation|1|||
37891728|NCT00762385|69576809|FG000|Second Intervention|Protocol Violation|3|||
37891729|NCT00762385|69576810|FG001|Second Intervention|Protocol Violation|3|||
37891730|NCT00906282|69576819|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
37891731|NCT00906282|69576819|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
37891732|NCT00906282|69576819|FG000|Preoperative Chemotherapy|Progressive disease|6|||
37891733|NCT00906282|69576819|FG000|Preoperative Chemotherapy|Toxicity|1|||
37891734|NCT00762229|69576826|FG000|Overall Study|Lost to Follow-up|1|||
37891735|NCT00762229|69576827|FG001|Overall Study|Lost to Follow-up|1|||
37891736|NCT00762229|69576826|FG000|Overall Study|did not recveive intervention|0|||
37891737|NCT00762229|69576827|FG001|Overall Study|did not recveive intervention|1|||
37891738|NCT00907374|69576835|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
37824190|NCT03191864|69506236|FG001|Baseline Symptom Assessment|Adverse Event|0|||
37824191|NCT03191864|69506237|FG002|Baseline Symptom Assessment|Adverse Event|0|||
37824192|NCT03191864|69506238|FG003|Baseline Symptom Assessment|Adverse Event|0|||
37824193|NCT03191864|69506239|FG004|Baseline Symptom Assessment|Adverse Event|0|||
37891739|NCT00907374|69576836|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
37891740|NCT00818662|69576846|FG000|Overall Study|Adverse Event|5|||
37891741|NCT00818662|69576847|FG001|Overall Study|Adverse Event|14|||
37891742|NCT00818662|69576848|FG002|Overall Study|Adverse Event|4|||
37891743|NCT00818662|69576849|FG003|Overall Study|Adverse Event|3|||
37891744|NCT00818662|69576846|FG000|Overall Study|Withdrawal by Subject|5|||
37891745|NCT00818662|69576847|FG001|Overall Study|Withdrawal by Subject|4|||
37891746|NCT00818662|69576848|FG002|Overall Study|Withdrawal by Subject|2|||
37891747|NCT00818662|69576849|FG003|Overall Study|Withdrawal by Subject|2|||
37891748|NCT00818662|69576846|FG000|Overall Study|Death|1|||
37891749|NCT00818662|69576847|FG001|Overall Study|Death|3|||
37891750|NCT00818662|69576848|FG002|Overall Study|Death|0|||
37891751|NCT00818662|69576849|FG003|Overall Study|Death|0|||
37891752|NCT00818662|69576846|FG000|Overall Study|Physician Decision|1|||
37891753|NCT00818662|69576847|FG001|Overall Study|Physician Decision|0|||
37891754|NCT00818662|69576848|FG002|Overall Study|Physician Decision|0|||
37824194|NCT03191864|69506240|FG005|Baseline Symptom Assessment|Adverse Event|2|||
37824195|NCT03191864|69506235|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
37824196|NCT03191864|69506236|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
37824197|NCT03191864|69506237|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
37824198|NCT03191864|69506238|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
37824199|NCT03191864|69506239|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
37824200|NCT03191864|69506240|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
37824201|NCT03191864|69506235|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
37891755|NCT00818662|69576849|FG003|Overall Study|Physician Decision|0|||
37891756|NCT00818662|69576846|FG000|Overall Study|Lost to Follow-up|0|||
37891757|NCT00818662|69576847|FG001|Overall Study|Lost to Follow-up|0|||
37891758|NCT00818662|69576848|FG002|Overall Study|Lost to Follow-up|0|||
37891759|NCT00818662|69576849|FG003|Overall Study|Lost to Follow-up|1|||
37891760|NCT00818662|69576846|FG000|Overall Study|Unwilling or Unable to Participate|4|||
37891761|NCT00818662|69576847|FG001|Overall Study|Unwilling or Unable to Participate|6|||
37891762|NCT00818662|69576848|FG002|Overall Study|Unwilling or Unable to Participate|2|||
37988881|NCT00365378|69674062|FG000|Extension|Adverse Event|0|||
37988882|NCT00365378|69674063|FG001|Extension|Adverse Event|0|||
37988883|NCT00365378|69674064|FG002|Extension|Adverse Event|1|||
37988884|NCT00365378|69674062|FG000|Extension|Moved|0|||
37988885|NCT00365378|69674063|FG001|Extension|Moved|0|||
37988886|NCT00365378|69674064|FG002|Extension|Moved|8|||
37988887|NCT00365378|69674062|FG000|Extension|Lost to Follow-up|0|||
37988888|NCT00365378|69674063|FG001|Extension|Lost to Follow-up|0|||
37988889|NCT00365378|69674064|FG002|Extension|Lost to Follow-up|57|||
37824202|NCT03191864|69506236|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
37891763|NCT00818662|69576849|FG003|Overall Study|Unwilling or Unable to Participate|4|||
37891764|NCT00818662|69576846|FG000|Overall Study|Protocol Violation|1|||
37891765|NCT00818662|69576847|FG001|Overall Study|Protocol Violation|1|||
37891766|NCT00818662|69576848|FG002|Overall Study|Protocol Violation|0|||
37891767|NCT00818662|69576849|FG003|Overall Study|Protocol Violation|0|||
37891768|NCT00818662|69576846|FG000|Overall Study|Requires a Prohibited Medication|1|||
37891769|NCT00818662|69576847|FG001|Overall Study|Requires a Prohibited Medication|0|||
37891770|NCT00818662|69576848|FG002|Overall Study|Requires a Prohibited Medication|0|||
37891771|NCT00818662|69576849|FG003|Overall Study|Requires a Prohibited Medication|0|||
37891772|NCT00818662|69576846|FG000|Overall Study|Safety Risk|1|||
37891773|NCT00818662|69576847|FG001|Overall Study|Safety Risk|1|||
37891774|NCT00818662|69576848|FG002|Overall Study|Safety Risk|0|||
37891775|NCT00818662|69576849|FG003|Overall Study|Safety Risk|1|||
37891776|NCT00818662|69576846|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
37891777|NCT00818662|69576847|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
37891778|NCT00818662|69576848|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
37891779|NCT00818662|69576849|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
37891780|NCT00818662|69576846|FG000|Overall Study|Participant's health declined|0|||
37891781|NCT00818662|69576847|FG001|Overall Study|Participant's health declined|0|||
37891782|NCT00818662|69576848|FG002|Overall Study|Participant's health declined|0|||
37891783|NCT00818662|69576849|FG003|Overall Study|Participant's health declined|1|||
37891784|NCT00818662|69576846|FG000|Overall Study|Caregiver to pursue other treatment|0|||
37891785|NCT00818662|69576847|FG001|Overall Study|Caregiver to pursue other treatment|1|||
37891786|NCT00818662|69576848|FG002|Overall Study|Caregiver to pursue other treatment|0|||
37891787|NCT00818662|69576849|FG003|Overall Study|Caregiver to pursue other treatment|0|||
37891788|NCT00818662|69576846|FG000|Overall Study|Moving out of state|0|||
37891789|NCT00818662|69576847|FG001|Overall Study|Moving out of state|0|||
37891790|NCT00818662|69576848|FG002|Overall Study|Moving out of state|0|||
37891791|NCT00818662|69576849|FG003|Overall Study|Moving out of state|1|||
37891792|NCT00818662|69576846|FG000|Overall Study|Declined move to another study site|1|||
37891793|NCT00818662|69576847|FG001|Overall Study|Declined move to another study site|0|||
37891794|NCT00818662|69576848|FG002|Overall Study|Declined move to another study site|0|||
37891795|NCT00818662|69576849|FG003|Overall Study|Declined move to another study site|0|||
37988890|NCT00365378|69674062|FG000|Extension|Protocol Violation|0|||
37988891|NCT00365378|69674063|FG001|Extension|Protocol Violation|0|||
37824203|NCT03191864|69506237|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
37824204|NCT03191864|69506238|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
37824205|NCT03191864|69506239|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
37824206|NCT03191864|69506240|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
37824207|NCT03191864|69506235|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
37824208|NCT03191864|69506236|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
37824209|NCT03191864|69506237|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
37824210|NCT03191864|69506238|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
37824211|NCT03191864|69506239|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
37824212|NCT03191864|69506240|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
37891796|NCT00818662|69576846|FG000|Overall Study|Change in living situation|0|||
37891797|NCT00818662|69576847|FG001|Overall Study|Change in living situation|0|||
37891798|NCT00818662|69576848|FG002|Overall Study|Change in living situation|0|||
37891799|NCT00818662|69576849|FG003|Overall Study|Change in living situation|1|||
37891800|NCT00818662|69576846|FG000|Overall Study|Study partner decision|0|||
37891801|NCT00818662|69576847|FG001|Overall Study|Study partner decision|0|||
37891802|NCT00818662|69576848|FG002|Overall Study|Study partner decision|0|||
37988892|NCT00365378|69674064|FG002|Extension|Protocol Violation|2|||
37988893|NCT00365378|69674062|FG000|Extension|Withdrawal by Subject|0|||
37696044|NCT02277769|69172235|FG001|Overall Study|Lack of Efficacy|0|||
37696045|NCT02277769|69172236|FG002|Overall Study|Lack of Efficacy|4|||
37696046|NCT02277769|69172234|FG000|Overall Study|Adverse Event|14|||
37988894|NCT00365378|69674063|FG001|Extension|Withdrawal by Subject|0|||
37696047|NCT02277769|69172235|FG001|Overall Study|Adverse Event|2|||
37891803|NCT00818662|69576849|FG003|Overall Study|Study partner decision|1|||
37891804|NCT00818662|69576846|FG000|Overall Study|Admitted to long term nursing care|0|||
37891805|NCT00818662|69576847|FG001|Overall Study|Admitted to long term nursing care|1|||
37891806|NCT00818662|69576848|FG002|Overall Study|Admitted to long term nursing care|0|||
37891807|NCT00818662|69576849|FG003|Overall Study|Admitted to long term nursing care|0|||
37891808|NCT00903786|69576860|FG000|Overall Study|Physician Decision|6|||
37891809|NCT00903786|69576860|FG000|Overall Study|Lack of Efficacy|5|||
37891810|NCT00903786|69576860|FG000|Overall Study|Reason other than lack of efficacy|4|||
37891811|NCT00762073|69576869|FG000|Overall Study|Lack of Efficacy|1|||
37891812|NCT00762073|69576870|FG001|Overall Study|Lack of Efficacy|1|||
37891813|NCT00762073|69576871|FG002|Overall Study|Lack of Efficacy|0|||
37891814|NCT00762073|69576872|FG003|Overall Study|Lack of Efficacy|0|||
37891815|NCT00762073|69576869|FG000|Overall Study|Adverse Event|1|||
37891816|NCT00762073|69576870|FG001|Overall Study|Adverse Event|0|||
37891817|NCT00762073|69576871|FG002|Overall Study|Adverse Event|1|||
37891818|NCT00762073|69576872|FG003|Overall Study|Adverse Event|1|||
37891819|NCT00762073|69576869|FG000|Overall Study|Significant Subject Noncompliance|0|||
37891820|NCT00762073|69576870|FG001|Overall Study|Significant Subject Noncompliance|1|||
37891821|NCT00762073|69576871|FG002|Overall Study|Significant Subject Noncompliance|0|||
37891822|NCT00762073|69576872|FG003|Overall Study|Significant Subject Noncompliance|1|||
37891823|NCT00762073|69576869|FG000|Overall Study|Withdrawal by Subject|1|||
37891824|NCT00762073|69576870|FG001|Overall Study|Withdrawal by Subject|2|||
37891825|NCT00762073|69576871|FG002|Overall Study|Withdrawal by Subject|1|||
37891826|NCT00762073|69576872|FG003|Overall Study|Withdrawal by Subject|1|||
37891827|NCT00762073|69576869|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
37891828|NCT00762073|69576870|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
37891829|NCT00762073|69576871|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
37891830|NCT00762073|69576872|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
37891831|NCT00761761|69576891|FG000|Overall Study|Lost to Follow-up|3|||
37891832|NCT00761761|69576892|FG001|Overall Study|Lost to Follow-up|1|||
37891833|NCT00761761|69576891|FG000|Overall Study|Withdrawal by Subject|3|||
37891834|NCT00761761|69576892|FG001|Overall Study|Withdrawal by Subject|0|||
37891835|NCT00761605|69576900|FG000|Overall Study|Adverse Event|26|||
37988895|NCT00365378|69674064|FG002|Extension|Withdrawal by Subject|98|||
37988896|NCT00365378|69674062|FG000|Extension|Other|0|||
37988897|NCT00365378|69674063|FG001|Extension|Other|0|||
37696048|NCT02277769|69172236|FG002|Overall Study|Adverse Event|4|||
37824213|NCT03191864|69506235|FG000|Part 1 - Induction|Adverse Event|0|||
37824214|NCT03191864|69506236|FG001|Part 1 - Induction|Adverse Event|2|||
37824215|NCT03191864|69506237|FG002|Part 1 - Induction|Adverse Event|0|||
37824216|NCT03191864|69506238|FG003|Part 1 - Induction|Adverse Event|1|||
37824217|NCT03191864|69506239|FG004|Part 1 - Induction|Adverse Event|0|||
37824218|NCT03191864|69506240|FG005|Part 1 - Induction|Adverse Event|2|||
37824219|NCT03191864|69506235|FG000|Part 1 - Induction|Randomized but never dosed|0|||
37824220|NCT03191864|69506236|FG001|Part 1 - Induction|Randomized but never dosed|0|||
37824221|NCT03191864|69506237|FG002|Part 1 - Induction|Randomized but never dosed|1|||
37824222|NCT03191864|69506238|FG003|Part 1 - Induction|Randomized but never dosed|0|||
37824223|NCT03191864|69506239|FG004|Part 1 - Induction|Randomized but never dosed|0|||
37824224|NCT03191864|69506240|FG005|Part 1 - Induction|Randomized but never dosed|0|||
37891836|NCT00761605|69576900|FG000|Overall Study|Death|2|||
37891837|NCT00761605|69576900|FG000|Overall Study|Lack of Efficacy|26|||
37891838|NCT00761605|69576900|FG000|Overall Study|Lost to Follow-up|29|||
37891839|NCT00761605|69576900|FG000|Overall Study|Withdrawal by Subject|37|||
37891840|NCT00761605|69576900|FG000|Overall Study|Other|21|||
37988898|NCT00365378|69674064|FG002|Extension|Other|31|||
37988899|NCT00389324|69674071|FG000|Run-In Phase|Adverse Event|1|||
37988900|NCT00389324|69674071|FG000|Run-In Phase|Lost to Follow-up|1|||
37988901|NCT00389324|69674071|FG000|Run-In Phase|Withdrawal by Subject|1|||
37988902|NCT00389324|69674071|FG000|Subcutaneous Phase|Adverse Event|2|||
37824225|NCT03191864|69506235|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
37824226|NCT03191864|69506236|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
37824227|NCT03191864|69506237|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
37824228|NCT03191864|69506238|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
37824229|NCT03191864|69506239|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
37824230|NCT03191864|69506240|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
37824231|NCT03191864|69506235|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
37824232|NCT03191864|69506236|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
37824233|NCT03191864|69506237|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
37824234|NCT03191864|69506238|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
37824235|NCT03191864|69506239|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
37824236|NCT03191864|69506240|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
37824237|NCT03191864|69506235|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
37824238|NCT03191864|69506236|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
37824239|NCT03191864|69506237|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
37824240|NCT03191864|69506238|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
37824241|NCT03191864|69506239|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
37824242|NCT03191864|69506240|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
37891841|NCT00761527|69576908|FG000|Overall Study|Adverse Event|3|||
37824243|NCT03191864|69506235|FG000|Part 2 - Maintenance|Physician Decision|1|||
37891842|NCT00761527|69576908|FG000|Overall Study|Poor Compliance|8|||
37891843|NCT00761527|69576908|FG000|Overall Study|Lost to Follow-up|9|||
37988903|NCT00389324|69674071|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
37891844|NCT00761527|69576908|FG000|Overall Study|Unknown reason|2|||
37891845|NCT00770029|69576914|FG000|Overall Study|Lost to Follow-up|2|||
37891846|NCT00770029|69576915|FG001|Overall Study|Lost to Follow-up|0|||
37891847|NCT00770029|69576914|FG000|Overall Study|Withdrawal by Subject|3|||
37891848|NCT00770029|69576915|FG001|Overall Study|Withdrawal by Subject|3|||
37891849|NCT00770029|69576914|FG000|Overall Study|Adverse Event|1|||
37891850|NCT00770029|69576915|FG001|Overall Study|Adverse Event|0|||
37891851|NCT00817414|69576926|FG000|Overall Study|Adverse Event|1|||
37891852|NCT00817414|69576927|FG001|Overall Study|Adverse Event|1|||
37891853|NCT00817414|69576928|FG002|Overall Study|Adverse Event|1|||
37891854|NCT00817414|69576929|FG003|Overall Study|Adverse Event|0|||
37891855|NCT00817414|69576930|FG004|Overall Study|Adverse Event|0|||
37891856|NCT00817414|69576926|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
37891857|NCT00817414|69576927|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
37891858|NCT00817414|69576928|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
37891859|NCT00817414|69576929|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
37891860|NCT00817414|69576930|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
37891861|NCT00817414|69576926|FG000|Overall Study|Withdrawal by Subject|1|||
37891862|NCT00817414|69576927|FG001|Overall Study|Withdrawal by Subject|1|||
37824244|NCT03191864|69506236|FG001|Part 2 - Maintenance|Physician Decision|0|||
37824245|NCT03191864|69506237|FG002|Part 2 - Maintenance|Physician Decision|0|||
37824246|NCT03191864|69506238|FG003|Part 2 - Maintenance|Physician Decision|0|||
37824247|NCT03191864|69506239|FG004|Part 2 - Maintenance|Physician Decision|0|||
37824248|NCT03191864|69506240|FG005|Part 2 - Maintenance|Physician Decision|0|||
37824249|NCT03191864|69506235|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
37824250|NCT03191864|69506236|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
37824251|NCT03191864|69506237|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
37824252|NCT03191864|69506238|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
37824253|NCT03191864|69506239|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
37824254|NCT03191864|69506240|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
37824255|NCT03191864|69506235|FG000|Part 2 - Maintenance|Adverse Event|0|||
37891863|NCT00817414|69576928|FG002|Overall Study|Withdrawal by Subject|0|||
37891864|NCT00817414|69576929|FG003|Overall Study|Withdrawal by Subject|0|||
37696049|NCT02277769|69172234|FG000|Overall Study|Other than specified above|12|||
37824256|NCT03191864|69506236|FG001|Part 2 - Maintenance|Adverse Event|0|||
37824257|NCT03191864|69506237|FG002|Part 2 - Maintenance|Adverse Event|0|||
37891865|NCT00817414|69576930|FG004|Overall Study|Withdrawal by Subject|0|||
37891866|NCT00817414|69576926|FG000|Overall Study|Lost to Follow-up|0|||
37891867|NCT00817414|69576927|FG001|Overall Study|Lost to Follow-up|0|||
37891868|NCT00817414|69576928|FG002|Overall Study|Lost to Follow-up|1|||
37891869|NCT00817414|69576929|FG003|Overall Study|Lost to Follow-up|1|||
37891870|NCT00817414|69576930|FG004|Overall Study|Lost to Follow-up|1|||
37891871|NCT00817414|69576926|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
37891872|NCT00817414|69576927|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
37891873|NCT00817414|69576928|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
37891874|NCT00817414|69576929|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
37891875|NCT00817414|69576930|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
37891876|NCT00817414|69576926|FG000|Overall Study|Protocol Violation|0|||
37891877|NCT00817414|69576927|FG001|Overall Study|Protocol Violation|0|||
37824258|NCT03191864|69506238|FG003|Part 2 - Maintenance|Adverse Event|0|||
37824259|NCT03191864|69506239|FG004|Part 2 - Maintenance|Adverse Event|1|||
37891878|NCT00817414|69576928|FG002|Overall Study|Protocol Violation|0|||
37824260|NCT03191864|69506240|FG005|Part 2 - Maintenance|Adverse Event|0|||
37824261|NCT03191864|69506235|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
37824262|NCT03191864|69506236|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
37824263|NCT03191864|69506237|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
37824264|NCT03191864|69506238|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
37824265|NCT03191864|69506239|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
37891879|NCT00817414|69576929|FG003|Overall Study|Protocol Violation|0|||
37824266|NCT03191864|69506240|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
37824267|NCT03191864|69506235|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
37824268|NCT03191864|69506236|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
37824269|NCT03191864|69506237|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
37824270|NCT03191864|69506238|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
37824271|NCT03191864|69506239|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
37824272|NCT03191864|69506240|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
37824273|NCT02636725|69506304|FG000|Baseline|Adverse Event|1|||
37891880|NCT00817414|69576930|FG004|Overall Study|Protocol Violation|1|||
37891881|NCT00769561|69576949|FG000|Overall Study|Withdrawal by Subject|2|||
37891882|NCT00769561|69576950|FG001|Overall Study|Withdrawal by Subject|2|||
37891883|NCT00769561|69576949|FG000|Overall Study|Lost to Follow-up|1|||
37891884|NCT00769561|69576950|FG001|Overall Study|Lost to Follow-up|3|||
37891885|NCT00817336|69576958|FG000|Overall Study|Withdrawal by Subject|1|||
37891886|NCT00817336|69576959|FG001|Overall Study|Withdrawal by Subject|1|||
37891887|NCT00761215|69576967|FG000|Overall Study|Randomized but didn't receive drug|1|||
37891888|NCT00761215|69576968|FG001|Overall Study|Randomized but didn't receive drug|1|||
37891889|NCT00761215|69576969|FG002|Overall Study|Randomized but didn't receive drug|2|||
37891890|NCT00761215|69576967|FG000|Overall Study|Lost to Follow-up|6|||
37891891|NCT00761215|69576968|FG001|Overall Study|Lost to Follow-up|3|||
37891892|NCT00761215|69576969|FG002|Overall Study|Lost to Follow-up|6|||
37891893|NCT00761215|69576967|FG000|Overall Study|Withdrawal by Subject|1|||
37891894|NCT00761215|69576968|FG001|Overall Study|Withdrawal by Subject|0|||
37891895|NCT00761215|69576969|FG002|Overall Study|Withdrawal by Subject|0|||
37891896|NCT00761215|69576967|FG000|Overall Study|Bacteremia|1|||
37891897|NCT00761215|69576968|FG001|Overall Study|Bacteremia|0|||
37891898|NCT00761215|69576969|FG002|Overall Study|Bacteremia|0|||
37891899|NCT05101122|69577002|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
37824274|NCT02636725|69506304|FG000|Baseline|Lack of Efficacy|2|||
37891900|NCT05101122|69577002|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
37891901|NCT05101122|69577002|FG000|AD313 80/5|Withdrawal by Subject|1|||
37891902|NCT05101122|69577002|FG000|AD313 80/10|Physician Decision|1|||
37891903|NCT05038163|69577015|FG000|Stage 1|Did not complete survey|374|||
37891904|NCT05038163|69577016|FG001|Stage 1|Did not complete survey|0|||
37891905|NCT05038163|69577017|FG002|Stage 1|Did not complete survey|0|||
37891906|NCT05038163|69577018|FG003|Stage 1|Did not complete survey|0|||
37891907|NCT05038163|69577019|FG004|Stage 1|Did not complete survey|0|||
37891908|NCT05038163|69577020|FG005|Stage 1|Did not complete survey|0|||
37891909|NCT05038163|69577015|FG000|Stage 2|Did not complete Stage 2 survey|0|||
37891910|NCT05038163|69577016|FG001|Stage 2|Did not complete Stage 2 survey|29|||
37891911|NCT05038163|69577017|FG002|Stage 2|Did not complete Stage 2 survey|30|||
37891912|NCT05038163|69577018|FG003|Stage 2|Did not complete Stage 2 survey|24|||
37891913|NCT05038163|69577019|FG004|Stage 2|Did not complete Stage 2 survey|21|||
37891914|NCT05038163|69577020|FG005|Stage 2|Did not complete Stage 2 survey|100|||
37891915|NCT04516746|69577048|FG000|Overall Study|Ongoing in the study at clinical DCO for the primary analysis.|21090|||
37891916|NCT04516746|69577049|FG001|Overall Study|Ongoing in the study at clinical DCO for the primary analysis.|10305|||
37891917|NCT04516746|69577048|FG000|Overall Study|Withdrawal by Subject|362|||
37891918|NCT04516746|69577049|FG001|Overall Study|Withdrawal by Subject|408|||
37891919|NCT04516746|69577048|FG000|Overall Study|Lost to Follow-up|157|||
37824275|NCT02573493|69506312|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
37824276|NCT02573493|69506313|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
37824277|NCT02573493|69506314|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
37824278|NCT02573493|69506315|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
37824279|NCT02327078|69506348|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
37824280|NCT02327078|69506349|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
37824281|NCT02327078|69506350|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
37824282|NCT02327078|69506351|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
37824283|NCT02327078|69506352|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
37891920|NCT04516746|69577049|FG001|Overall Study|Lost to Follow-up|86|||
37891921|NCT04516746|69577048|FG000|Overall Study|Protocol deviation|18|||
37891922|NCT04516746|69577049|FG001|Overall Study|Protocol deviation|7|||
37824284|NCT02327078|69506353|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
37824285|NCT02327078|69506354|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
37824286|NCT02327078|69506355|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
37824287|NCT02327078|69506356|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
37824288|NCT02327078|69506348|FG000|Overall Study|Death|2|||
37824289|NCT02327078|69506349|FG001|Overall Study|Death|4|||
37824290|NCT02327078|69506350|FG002|Overall Study|Death|10|||
37824291|NCT02327078|69506351|FG003|Overall Study|Death|6|||
37824292|NCT02327078|69506352|FG004|Overall Study|Death|4|||
37891923|NCT04516746|69577048|FG000|Overall Study|Death|8|||
37891924|NCT04516746|69577049|FG001|Overall Study|Death|7|||
37891925|NCT04516746|69577048|FG000|Overall Study|Physician Decision|0|||
37891926|NCT04516746|69577049|FG001|Overall Study|Physician Decision|2|||
37891927|NCT04516746|69577048|FG000|Overall Study|Other|0|||
37891928|NCT04516746|69577049|FG001|Overall Study|Other|1|||
37891929|NCT04413617|69577079|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
37891930|NCT04413617|69577080|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
37988904|NCT00389324|69674071|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
37891931|NCT04413617|69577081|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
37891932|NCT04413617|69577082|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
37891933|NCT04413617|69577083|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
37891934|NCT04413617|69577079|FG000|Overall Study|Protocol Violation|0|||
37891935|NCT04413617|69577080|FG001|Overall Study|Protocol Violation|1|||
37891936|NCT04413617|69577081|FG002|Overall Study|Protocol Violation|0|||
37891937|NCT04413617|69577082|FG003|Overall Study|Protocol Violation|0|||
37891938|NCT04413617|69577083|FG004|Overall Study|Protocol Violation|1|||
37891939|NCT04413617|69577079|FG000|Overall Study|Lack of Efficacy|2|||
37891940|NCT04413617|69577080|FG001|Overall Study|Lack of Efficacy|0|||
37891941|NCT04413617|69577081|FG002|Overall Study|Lack of Efficacy|2|||
37891942|NCT04413617|69577082|FG003|Overall Study|Lack of Efficacy|1|||
37891943|NCT04413617|69577083|FG004|Overall Study|Lack of Efficacy|0|||
37891944|NCT04413617|69577079|FG000|Overall Study|Withdrawal by Subject|3|||
37891945|NCT04413617|69577080|FG001|Overall Study|Withdrawal by Subject|4|||
37891946|NCT04413617|69577081|FG002|Overall Study|Withdrawal by Subject|2|||
37891947|NCT04413617|69577082|FG003|Overall Study|Withdrawal by Subject|5|||
37891948|NCT04413617|69577083|FG004|Overall Study|Withdrawal by Subject|3|||
37891949|NCT04413617|69577079|FG000|Overall Study|Death|1|||
37891950|NCT04413617|69577080|FG001|Overall Study|Death|0|||
37891951|NCT04413617|69577081|FG002|Overall Study|Death|0|||
37891952|NCT04413617|69577082|FG003|Overall Study|Death|0|||
37891953|NCT04413617|69577083|FG004|Overall Study|Death|0|||
37891954|NCT04413617|69577079|FG000|Overall Study|Adverse Event|1|||
37824293|NCT02327078|69506353|FG005|Overall Study|Death|3|||
37824294|NCT02327078|69506354|FG006|Overall Study|Death|2|||
37824295|NCT02327078|69506355|FG007|Overall Study|Death|51|||
37824296|NCT02327078|69506356|FG008|Overall Study|Death|97|||
37824297|NCT02327078|69506348|FG000|Overall Study|Lost to Follow-up|0|||
37824298|NCT02327078|69506349|FG001|Overall Study|Lost to Follow-up|1|||
37891955|NCT04413617|69577080|FG001|Overall Study|Adverse Event|0|||
37824299|NCT02327078|69506350|FG002|Overall Study|Lost to Follow-up|1|||
37824300|NCT02327078|69506351|FG003|Overall Study|Lost to Follow-up|0|||
37824301|NCT02327078|69506352|FG004|Overall Study|Lost to Follow-up|0|||
37824302|NCT02327078|69506353|FG005|Overall Study|Lost to Follow-up|0|||
37824303|NCT02327078|69506354|FG006|Overall Study|Lost to Follow-up|0|||
37824304|NCT02327078|69506355|FG007|Overall Study|Lost to Follow-up|2|||
37824305|NCT02327078|69506356|FG008|Overall Study|Lost to Follow-up|5|||
37824306|NCT02327078|69506348|FG000|Overall Study|Site Terminated by Sponsor|1|||
37824307|NCT02327078|69506349|FG001|Overall Study|Site Terminated by Sponsor|0|||
37891956|NCT04413617|69577081|FG002|Overall Study|Adverse Event|0|||
37891957|NCT04413617|69577082|FG003|Overall Study|Adverse Event|1|||
37891958|NCT04413617|69577083|FG004|Overall Study|Adverse Event|1|||
37891959|NCT04413617|69577079|FG000|Overall Study|COVID-19|0|||
37891960|NCT04413617|69577080|FG001|Overall Study|COVID-19|1|||
37891961|NCT04413617|69577081|FG002|Overall Study|COVID-19|0|||
37988905|NCT00389324|69674071|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
37988906|NCT00365300|69674080|FG000|Open-label Phase|Adverse Event|4|||
37988907|NCT00365300|69674081|FG001|Open-label Phase|Adverse Event|0|||
37891962|NCT04413617|69577082|FG003|Overall Study|COVID-19|0|||
37891963|NCT04413617|69577083|FG004|Overall Study|COVID-19|0|||
37891964|NCT04055116|69577115|FG000|First Intervention|Physician Decision|2|||
37988908|NCT00365300|69674080|FG000|Open-label Phase|Failed to Return|1|||
37824308|NCT02327078|69506350|FG002|Overall Study|Site Terminated by Sponsor|1|||
37824309|NCT02327078|69506351|FG003|Overall Study|Site Terminated by Sponsor|4|||
37891965|NCT04055116|69577116|FG001|First Intervention|Physician Decision|7|||
37891966|NCT03512262|69577162|FG000|Overall Study|Adverse Event|8|||
37824310|NCT02327078|69506352|FG004|Overall Study|Site Terminated by Sponsor|0|||
37824311|NCT02327078|69506353|FG005|Overall Study|Site Terminated by Sponsor|0|||
37824312|NCT02327078|69506354|FG006|Overall Study|Site Terminated by Sponsor|0|||
37891967|NCT03512262|69577163|FG001|Overall Study|Adverse Event|3|||
37891968|NCT03512262|69577162|FG000|Overall Study|Death (non-treatment emergent)|1|||
37988909|NCT00365300|69674081|FG001|Open-label Phase|Failed to Return|0|||
37891969|NCT03512262|69577163|FG001|Overall Study|Death (non-treatment emergent)|0|||
37891970|NCT03512262|69577162|FG000|Overall Study|Withdrawal by Subject|17|||
37891971|NCT03512262|69577163|FG001|Overall Study|Withdrawal by Subject|9|||
37891972|NCT03512262|69577162|FG000|Overall Study|Lost to Follow-up|7|||
37891973|NCT03512262|69577163|FG001|Overall Study|Lost to Follow-up|1|||
37891974|NCT03512262|69577162|FG000|Overall Study|Other than Specified|2|||
37891975|NCT03512262|69577163|FG001|Overall Study|Other than Specified|2|||
37891976|NCT03499600|69577171|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
37891977|NCT03499600|69577172|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
37891978|NCT03007979|69577186|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
37891979|NCT02960893|69577192|FG000|Randomization Phase (8-week)|Adverse Event|5|||
37891980|NCT02960893|69577193|FG001|Randomization Phase (8-week)|Adverse Event|0|||
37891981|NCT02960893|69577192|FG000|Randomization Phase (8-week)|Withdrawal by Subject|2|||
37891982|NCT02960893|69577193|FG001|Randomization Phase (8-week)|Withdrawal by Subject|1|||
37891983|NCT02960893|69577192|FG000|Randomization Phase (8-week)|Reason Not Specified|0|||
37891984|NCT02960893|69577193|FG001|Randomization Phase (8-week)|Reason Not Specified|1|||
37891985|NCT02960893|69577192|FG000|Extension Phase (48-week)|Adverse Event|2|||
37891986|NCT02960893|69577193|FG001|Extension Phase (48-week)|Adverse Event|3|||
37891987|NCT02960893|69577192|FG000|Extension Phase (48-week)|Withdrawal by Subject|8|||
37891988|NCT02960893|69577193|FG001|Extension Phase (48-week)|Withdrawal by Subject|8|||
37891989|NCT02960893|69577192|FG000|Extension Phase (48-week)|Other Reason|2|||
37891990|NCT02960893|69577193|FG001|Extension Phase (48-week)|Other Reason|1|||
37891991|NCT02960893|69577192|FG000|Extension Phase (48-week)|Lost to Follow-up|1|||
37891992|NCT02960893|69577193|FG001|Extension Phase (48-week)|Lost to Follow-up|1|||
37891993|NCT02960893|69577192|FG000|Extension Phase (48-week)|Sponsors Decision|1|||
37891994|NCT02960893|69577193|FG001|Extension Phase (48-week)|Sponsors Decision|0|||
37891995|NCT02867813|69577208|FG000|Overall Study|Withdrawal by Subject|57|||
37891996|NCT02867813|69577209|FG001|Overall Study|Withdrawal by Subject|56|||
37988910|NCT00365300|69674080|FG000|Open-label Phase|Physician Decision|1|||
37988911|NCT00365300|69674081|FG001|Open-label Phase|Physician Decision|0|||
37988912|NCT00365300|69674080|FG000|Open-label Phase|Noncompliance|9|||
37824313|NCT02327078|69506355|FG007|Overall Study|Site Terminated by Sponsor|11|||
37824314|NCT02327078|69506356|FG008|Overall Study|Site Terminated by Sponsor|25|||
37824315|NCT02327078|69506348|FG000|Overall Study|Physician Decision|0|||
37824316|NCT02327078|69506349|FG001|Overall Study|Physician Decision|0|||
37824317|NCT02327078|69506350|FG002|Overall Study|Physician Decision|0|||
37824318|NCT02327078|69506351|FG003|Overall Study|Physician Decision|1|||
37824319|NCT02327078|69506352|FG004|Overall Study|Physician Decision|0|||
37824320|NCT02327078|69506353|FG005|Overall Study|Physician Decision|0|||
37824321|NCT02327078|69506354|FG006|Overall Study|Physician Decision|0|||
37824322|NCT02327078|69506355|FG007|Overall Study|Physician Decision|0|||
37824323|NCT02327078|69506356|FG008|Overall Study|Physician Decision|1|||
37824324|NCT02327078|69506348|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
37824325|NCT02327078|69506349|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
37824326|NCT02327078|69506350|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
37824327|NCT02327078|69506351|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
37891997|NCT02867813|69577208|FG000|Overall Study|Decision by Sponsor|7|||
37891998|NCT02867813|69577209|FG001|Overall Study|Decision by Sponsor|7|||
37891999|NCT02867813|69577208|FG000|Overall Study|Lost to Follow-up|91|||
37892000|NCT02867813|69577209|FG001|Overall Study|Lost to Follow-up|78|||
37988913|NCT00365300|69674081|FG001|Open-label Phase|Noncompliance|0|||
37824328|NCT02327078|69506352|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
37892001|NCT02867813|69577208|FG000|Overall Study|Missing|2|||
37892002|NCT02867813|69577209|FG001|Overall Study|Missing|1|||
37892003|NCT02867813|69577208|FG000|Overall Study|Death|294|||
37892004|NCT02867813|69577209|FG001|Overall Study|Death|268|||
37892005|NCT02278055|69577221|FG000|Overall Study|Adverse Event|1|||
37892006|NCT02278055|69577221|FG000|Overall Study|Lost to Follow-up|1|||
37892007|NCT02278055|69577221|FG000|Overall Study|Withdrawal by Subject|2|||
37892008|NCT02278055|69577221|FG000|Overall Study|Progressive Disease|4|||
37824329|NCT02327078|69506353|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
37824330|NCT02327078|69506354|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
37892009|NCT02231879|69577227|FG000|Overall Study|Adverse Event|2|||
37892010|NCT02231879|69577228|FG001|Overall Study|Adverse Event|1|||
37988914|NCT00365300|69674080|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
37824331|NCT02327078|69506355|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
37892011|NCT02231879|69577227|FG000|Overall Study|Lack of Efficacy|0|||
37892012|NCT02231879|69577228|FG001|Overall Study|Lack of Efficacy|1|||
37892013|NCT01833806|69577249|FG000|Overall Study|Alternative treatment|2|||
37892014|NCT01833806|69577249|FG000|Overall Study|Death|5|||
37892015|NCT01833806|69577249|FG000|Overall Study|Physician Decision|1|||
37892016|NCT01833806|69577249|FG000|Overall Study|Lost to Follow-up|1|||
37892017|NCT01712490|69577255|FG000|Overall Study|Ongoing|601|||
37892018|NCT01712490|69577256|FG001|Overall Study|Ongoing|586|||
37892019|NCT01712490|69577255|FG000|Overall Study|Other|11|||
37892020|NCT01712490|69577256|FG001|Overall Study|Other|11|||
37892021|NCT01712490|69577255|FG000|Overall Study|Withdrawal by Subject|36|||
37892022|NCT01712490|69577256|FG001|Overall Study|Withdrawal by Subject|44|||
37892023|NCT01712490|69577255|FG000|Overall Study|Lost to Follow-up|16|||
37892024|NCT01712490|69577256|FG001|Overall Study|Lost to Follow-up|29|||
37892025|NCT01439802|69577262|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
37892026|NCT01439802|69577262|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
37892027|NCT00816556|69577273|FG000|Overall Study|Adverse Event|1|||
37988915|NCT00365300|69674081|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
37988916|NCT00365300|69674080|FG000|Open-label Phase|Protocol Violation|1|||
37988917|NCT00365300|69674081|FG001|Open-label Phase|Protocol Violation|0|||
37824332|NCT02327078|69506356|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
37824333|NCT02327078|69506348|FG000|Overall Study|Reason not Specified|0|||
37824334|NCT02327078|69506349|FG001|Overall Study|Reason not Specified|0|||
37824335|NCT02327078|69506350|FG002|Overall Study|Reason not Specified|0|||
37824336|NCT02327078|69506351|FG003|Overall Study|Reason not Specified|0|||
37824337|NCT02327078|69506352|FG004|Overall Study|Reason not Specified|0|||
37824338|NCT02327078|69506353|FG005|Overall Study|Reason not Specified|0|||
37824339|NCT02327078|69506354|FG006|Overall Study|Reason not Specified|0|||
37824340|NCT02327078|69506355|FG007|Overall Study|Reason not Specified|5|||
37824341|NCT02327078|69506356|FG008|Overall Study|Reason not Specified|12|||
37824342|NCT02304458|69506399|FG000|Overall Study|Adverse Event|0|||
37824343|NCT02304458|69506400|FG001|Overall Study|Adverse Event|0|||
37824344|NCT02304458|69506401|FG002|Overall Study|Adverse Event|7|||
37824345|NCT02304458|69506402|FG003|Overall Study|Adverse Event|0|||
37824346|NCT02304458|69506403|FG004|Overall Study|Adverse Event|0|||
37824347|NCT02304458|69506404|FG005|Overall Study|Adverse Event|0|||
37824348|NCT02304458|69506405|FG006|Overall Study|Adverse Event|3|||
37824349|NCT02304458|69506406|FG007|Overall Study|Adverse Event|4|||
37824350|NCT02304458|69506399|FG000|Overall Study|Death|0|||
37824351|NCT02304458|69506400|FG001|Overall Study|Death|0|||
37824352|NCT02304458|69506401|FG002|Overall Study|Death|2|||
37824353|NCT02304458|69506402|FG003|Overall Study|Death|0|||
37824354|NCT02304458|69506403|FG004|Overall Study|Death|0|||
37824355|NCT02304458|69506404|FG005|Overall Study|Death|0|||
37824356|NCT02304458|69506405|FG006|Overall Study|Death|1|||
37824357|NCT02304458|69506406|FG007|Overall Study|Death|0|||
37824358|NCT02304458|69506399|FG000|Overall Study|Lack of Efficacy|4|||
37892028|NCT00816556|69577274|FG001|Overall Study|Adverse Event|1|||
37824359|NCT02304458|69506400|FG001|Overall Study|Lack of Efficacy|6|||
37824360|NCT02304458|69506401|FG002|Overall Study|Lack of Efficacy|38|||
37824361|NCT02304458|69506402|FG003|Overall Study|Lack of Efficacy|5|||
37892029|NCT00816556|69577275|FG002|Overall Study|Adverse Event|1|||
37892030|NCT00816556|69577273|FG000|Overall Study|Withdrawal by Subject|1|||
37988918|NCT00365300|69674080|FG000|Open-label Phase|Lack of Efficacy|1|||
37824362|NCT02304458|69506403|FG004|Overall Study|Lack of Efficacy|6|||
37892031|NCT00816556|69577274|FG001|Overall Study|Withdrawal by Subject|1|||
37892032|NCT00816556|69577275|FG002|Overall Study|Withdrawal by Subject|1|||
37892033|NCT00816556|69577273|FG000|Overall Study|Lost to Follow-up|0|||
37824363|NCT02304458|69506404|FG005|Overall Study|Lack of Efficacy|6|||
37824364|NCT02304458|69506405|FG006|Overall Study|Lack of Efficacy|21|||
37824365|NCT02304458|69506406|FG007|Overall Study|Lack of Efficacy|4|||
37892034|NCT00816556|69577274|FG001|Overall Study|Lost to Follow-up|0|||
37892035|NCT00816556|69577275|FG002|Overall Study|Lost to Follow-up|1|||
37892036|NCT00760747|69577285|FG000|Study Period II|Adverse Event|3|||
37892037|NCT00760747|69577286|FG001|Study Period II|Adverse Event|4|||
37892038|NCT00760747|69577285|FG000|Study Period II|Lack of Efficacy|0|||
37892039|NCT00760747|69577286|FG001|Study Period II|Lack of Efficacy|6|||
37892040|NCT00760747|69577285|FG000|Study Period II|Parent/Caregiver Decision|3|||
37892041|NCT00760747|69577286|FG001|Study Period II|Parent/Caregiver Decision|0|||
37892042|NCT00760747|69577285|FG000|Study Period II|Protocol Violation|6|||
37892043|NCT00760747|69577286|FG001|Study Period II|Protocol Violation|3|||
37892044|NCT00760747|69577285|FG000|Study Period II|Withdrawal by Subject|1|||
37892045|NCT00760747|69577286|FG001|Study Period II|Withdrawal by Subject|0|||
37892046|NCT00760747|69577285|FG000|Study Period II|No drug administered|0|||
37892047|NCT00760747|69577286|FG001|Study Period II|No drug administered|1|||
37892048|NCT00760747|69577285|FG000|Study Period III|Adverse Event|1|||
37892049|NCT00760747|69577286|FG001|Study Period III|Adverse Event|0|||
37892050|NCT00760747|69577285|FG000|Study Period III|Lack of Efficacy|1|||
37892051|NCT00760747|69577286|FG001|Study Period III|Lack of Efficacy|0|||
37892052|NCT00760747|69577285|FG000|Study Period III|Parent/Caregiver Decision|0|||
37892053|NCT00760747|69577286|FG001|Study Period III|Parent/Caregiver Decision|1|||
37892054|NCT00760747|69577285|FG000|Study Period III|Protocol Violation|1|||
37892055|NCT00760747|69577286|FG001|Study Period III|Protocol Violation|1|||
37892056|NCT00760747|69577285|FG000|Study Period III|Physician Decision|0|||
37892057|NCT00760747|69577286|FG001|Study Period III|Physician Decision|1|||
37892058|NCT00760669|69577292|FG000|Overall Study|Not assessed for overall improvement|18|||
37892059|NCT00760669|69577292|FG000|Overall Study|Participants missing efficacy assessment|6|||
37892060|NCT00760669|69577292|FG000|Overall Study|Participants with overlapping cases|1|||
37892061|NCT00760669|69577292|FG000|Overall Study|Took drug before entering in contract|5|||
37892062|NCT00769483|69577302|FG000|Overall Study|Withdrawal by Subject|0|||
37892063|NCT00769483|69577303|FG001|Overall Study|Withdrawal by Subject|1|||
37892064|NCT00769483|69577304|FG002|Overall Study|Withdrawal by Subject|0|||
37892065|NCT00769483|69577305|FG003|Overall Study|Withdrawal by Subject|0|||
37892066|NCT00769483|69577306|FG004|Overall Study|Withdrawal by Subject|1|||
37892067|NCT00769483|69577307|FG005|Overall Study|Withdrawal by Subject|0|||
37892068|NCT00760513|69577325|FG000|Overall Study|Withdrawal by Subject|5|||
37892069|NCT00760513|69577326|FG001|Overall Study|Withdrawal by Subject|7|||
37892070|NCT00907296|69577344|FG000|Overall Study|Ineligibility Determined|1|||
37892071|NCT00907296|69577345|FG001|Overall Study|Ineligibility Determined|0|||
37892072|NCT00907296|69577346|FG002|Overall Study|Ineligibility Determined|0|||
37892073|NCT00907296|69577347|FG003|Overall Study|Ineligibility Determined|1|||
37892074|NCT00907296|69577348|FG004|Overall Study|Ineligibility Determined|0|||
37892075|NCT00907296|69577349|FG005|Overall Study|Ineligibility Determined|0|||
37892076|NCT00907296|69577350|FG006|Overall Study|Ineligibility Determined|0|||
37892077|NCT00907296|69577351|FG007|Overall Study|Ineligibility Determined|1|||
37892078|NCT00907296|69577352|FG008|Overall Study|Ineligibility Determined|0|||
37892079|NCT00907296|69577353|FG009|Overall Study|Ineligibility Determined|0|||
37892080|NCT00907296|69577344|FG000|Overall Study|Protocol Deviation|0|||
37892081|NCT00907296|69577345|FG001|Overall Study|Protocol Deviation|1|||
37988919|NCT00365300|69674081|FG001|Open-label Phase|Lack of Efficacy|0|||
37988920|NCT00365300|69674080|FG000|Open-label Phase|Patient skipped open label phase|1|||
37988921|NCT00365300|69674081|FG001|Open-label Phase|Patient skipped open label phase|0|||
37892082|NCT00907296|69577346|FG002|Overall Study|Protocol Deviation|0|||
37892083|NCT00907296|69577347|FG003|Overall Study|Protocol Deviation|0|||
37892084|NCT00907296|69577348|FG004|Overall Study|Protocol Deviation|0|||
37892085|NCT00907296|69577349|FG005|Overall Study|Protocol Deviation|0|||
37988922|NCT00365300|69674080|FG000|Double-blind Phase|Failed to return|1|||
37988923|NCT00365300|69674081|FG001|Double-blind Phase|Failed to return|0|||
37988924|NCT00365300|69674080|FG000|Double-blind Phase|Noncompliance|1|||
37824366|NCT02304458|69506399|FG000|Overall Study|Physician Decision|2|||
37824367|NCT02304458|69506400|FG001|Overall Study|Physician Decision|0|||
37824368|NCT02304458|69506401|FG002|Overall Study|Physician Decision|16|||
37824369|NCT02304458|69506402|FG003|Overall Study|Physician Decision|1|||
37824370|NCT02304458|69506403|FG004|Overall Study|Physician Decision|0|||
37824371|NCT02304458|69506404|FG005|Overall Study|Physician Decision|0|||
37824372|NCT02304458|69506405|FG006|Overall Study|Physician Decision|3|||
37824373|NCT02304458|69506406|FG007|Overall Study|Physician Decision|0|||
37824374|NCT02304458|69506399|FG000|Overall Study|Protocol Violation|0|||
37824375|NCT02304458|69506400|FG001|Overall Study|Protocol Violation|0|||
37824376|NCT02304458|69506401|FG002|Overall Study|Protocol Violation|1|||
37824377|NCT02304458|69506402|FG003|Overall Study|Protocol Violation|0|||
37824378|NCT02304458|69506403|FG004|Overall Study|Protocol Violation|0|||
37824379|NCT02304458|69506404|FG005|Overall Study|Protocol Violation|0|||
37824380|NCT02304458|69506405|FG006|Overall Study|Protocol Violation|0|||
37824381|NCT02304458|69506406|FG007|Overall Study|Protocol Violation|0|||
37892086|NCT00907296|69577350|FG006|Overall Study|Protocol Deviation|0|||
37892087|NCT00907296|69577351|FG007|Overall Study|Protocol Deviation|0|||
37892088|NCT00907296|69577352|FG008|Overall Study|Protocol Deviation|0|||
37892089|NCT00907296|69577353|FG009|Overall Study|Protocol Deviation|0|||
37892090|NCT00907296|69577344|FG000|Overall Study|Noncompliance|1|||
37892091|NCT00907296|69577345|FG001|Overall Study|Noncompliance|1|||
37892092|NCT00907296|69577346|FG002|Overall Study|Noncompliance|1|||
37892093|NCT00907296|69577347|FG003|Overall Study|Noncompliance|0|||
37892094|NCT00907296|69577348|FG004|Overall Study|Noncompliance|0|||
37892095|NCT00907296|69577349|FG005|Overall Study|Noncompliance|1|||
37892096|NCT00907296|69577350|FG006|Overall Study|Noncompliance|0|||
37892097|NCT00907296|69577351|FG007|Overall Study|Noncompliance|2|||
37892098|NCT00907296|69577352|FG008|Overall Study|Noncompliance|0|||
37892099|NCT00907296|69577353|FG009|Overall Study|Noncompliance|0|||
37824382|NCT02304458|69506399|FG000|Overall Study|Withdrawal by Subject|1|||
37824383|NCT02304458|69506400|FG001|Overall Study|Withdrawal by Subject|0|||
37824384|NCT02304458|69506401|FG002|Overall Study|Withdrawal by Subject|7|||
37824385|NCT02304458|69506402|FG003|Overall Study|Withdrawal by Subject|0|||
37824386|NCT02304458|69506403|FG004|Overall Study|Withdrawal by Subject|0|||
37824387|NCT02304458|69506404|FG005|Overall Study|Withdrawal by Subject|0|||
37824388|NCT02304458|69506405|FG006|Overall Study|Withdrawal by Subject|1|||
37824389|NCT02304458|69506406|FG007|Overall Study|Withdrawal by Subject|0|||
37824390|NCT02187224|69506442|FG000|Overall Study|Did not show up for test day|1|||
37824391|NCT02187224|69506443|FG001|Overall Study|Did not show up for test day|0|||
37824392|NCT02176226|69506453|FG000|Overall Study|Lost to Follow-up|3|||
37824393|NCT02176226|69506453|FG000|Overall Study|Withdrew prior to treatment|6|||
37824394|NCT01958021|69506459|FG000|Overall Study|Progressive disease|87|||
37824395|NCT01958021|69506460|FG001|Overall Study|Progressive disease|146|||
37824396|NCT01958021|69506459|FG000|Overall Study|Adverse Event|25|||
37824397|NCT01958021|69506460|FG001|Overall Study|Adverse Event|7|||
37824398|NCT01958021|69506459|FG000|Overall Study|Subject/guardian decision|12|||
37824399|NCT01958021|69506460|FG001|Overall Study|Subject/guardian decision|13|||
37824400|NCT01958021|69506459|FG000|Overall Study|Physician Decision|10|||
37824401|NCT01958021|69506460|FG001|Overall Study|Physician Decision|13|||
37824402|NCT01958021|69506459|FG000|Overall Study|Protocol Violation|3|||
37824403|NCT01958021|69506460|FG001|Overall Study|Protocol Violation|1|||
37824404|NCT01958021|69506459|FG000|Overall Study|Death|2|||
37824405|NCT01958021|69506460|FG001|Overall Study|Death|0|||
37824406|NCT05059600|69506466|FG000|Overall Study|Enrolled but not Treated|10|||
37824407|NCT04608448|69506479|FG000|Overall Study|Withdrawal by Subject|1|||
37824408|NCT04608448|69506479|FG000|Overall Study|Adverse Event|1|||
37824409|NCT04530344|69506489|FG000|Overall Study|Lost to Follow-up|3|||
37824410|NCT04530344|69506490|FG001|Overall Study|Lost to Follow-up|3|||
37824411|NCT04530344|69506491|FG002|Overall Study|Lost to Follow-up|3|||
37824412|NCT04530344|69506492|FG003|Overall Study|Lost to Follow-up|10|||
37892100|NCT00907296|69577344|FG000|Overall Study|Adverse Event|2|||
37892101|NCT00907296|69577345|FG001|Overall Study|Adverse Event|0|||
37824413|NCT04530344|69506489|FG000|Overall Study|Withdrawal by Subject|14|||
37824414|NCT04530344|69506490|FG001|Overall Study|Withdrawal by Subject|5|||
37824415|NCT04530344|69506491|FG002|Overall Study|Withdrawal by Subject|18|||
37824416|NCT04530344|69506492|FG003|Overall Study|Withdrawal by Subject|33|||
37892102|NCT00907296|69577346|FG002|Overall Study|Adverse Event|0|||
37892103|NCT00907296|69577347|FG003|Overall Study|Adverse Event|0|||
37892104|NCT00907296|69577348|FG004|Overall Study|Adverse Event|0|||
37892105|NCT00907296|69577349|FG005|Overall Study|Adverse Event|0|||
37892106|NCT00907296|69577350|FG006|Overall Study|Adverse Event|1|||
37892107|NCT00907296|69577351|FG007|Overall Study|Adverse Event|0|||
37892108|NCT00907296|69577352|FG008|Overall Study|Adverse Event|0|||
37892109|NCT00907296|69577353|FG009|Overall Study|Adverse Event|1|||
37892110|NCT00907296|69577344|FG000|Overall Study|Withdrawal by Subject|7|||
37892111|NCT00907296|69577345|FG001|Overall Study|Withdrawal by Subject|2|||
37892112|NCT00907296|69577346|FG002|Overall Study|Withdrawal by Subject|1|||
37892113|NCT00907296|69577347|FG003|Overall Study|Withdrawal by Subject|1|||
37892114|NCT00907296|69577348|FG004|Overall Study|Withdrawal by Subject|1|||
37892115|NCT00907296|69577349|FG005|Overall Study|Withdrawal by Subject|5|||
37892116|NCT00907296|69577350|FG006|Overall Study|Withdrawal by Subject|3|||
37892117|NCT00907296|69577351|FG007|Overall Study|Withdrawal by Subject|2|||
37892118|NCT00907296|69577352|FG008|Overall Study|Withdrawal by Subject|4|||
37892119|NCT00907296|69577353|FG009|Overall Study|Withdrawal by Subject|2|||
37892120|NCT00907296|69577344|FG000|Overall Study|Lost to Follow-up|9|||
37892121|NCT00907296|69577345|FG001|Overall Study|Lost to Follow-up|1|||
37892122|NCT00907296|69577346|FG002|Overall Study|Lost to Follow-up|0|||
37892123|NCT00907296|69577347|FG003|Overall Study|Lost to Follow-up|2|||
37892124|NCT00907296|69577348|FG004|Overall Study|Lost to Follow-up|0|||
37892125|NCT00907296|69577349|FG005|Overall Study|Lost to Follow-up|3|||
37892126|NCT00907296|69577350|FG006|Overall Study|Lost to Follow-up|2|||
37988925|NCT00365300|69674081|FG001|Double-blind Phase|Noncompliance|1|||
37988926|NCT00365300|69674080|FG000|Double-blind Phase|Withdrawal by Subject|0|||
37988927|NCT00365300|69674081|FG001|Double-blind Phase|Withdrawal by Subject|1|||
37988928|NCT00365300|69674080|FG000|Double-blind Phase|Protocol Violation|3|||
37988929|NCT00365300|69674081|FG001|Double-blind Phase|Protocol Violation|1|||
37988930|NCT00365300|69674080|FG000|Double-blind Phase|Lack of Efficacy|6|||
37988931|NCT00365300|69674081|FG001|Double-blind Phase|Lack of Efficacy|6|||
37988932|NCT00370292|69674092|FG000|Overall Study|Disease Progression|4|||
37988933|NCT00370292|69674092|FG000|Overall Study|Adverse Event|7|||
37988934|NCT00370292|69674092|FG000|Overall Study|Physician Decision|2|||
37988935|NCT00369824|69674109|FG000|Overall Study|Adverse Event|0|||
37988936|NCT00369824|69674110|FG001|Overall Study|Adverse Event|2|||
37988937|NCT00369824|69674111|FG002|Overall Study|Adverse Event|0|||
37988938|NCT00369824|69674112|FG003|Overall Study|Adverse Event|0|||
37988939|NCT00369824|69674113|FG004|Overall Study|Adverse Event|1|||
37988940|NCT00369824|69674114|FG005|Overall Study|Adverse Event|0|||
37988941|NCT00369824|69674109|FG000|Overall Study|Protocol Violation|0|||
37988942|NCT00369824|69674110|FG001|Overall Study|Protocol Violation|1|||
37988943|NCT00369824|69674111|FG002|Overall Study|Protocol Violation|0|||
37988944|NCT00369824|69674112|FG003|Overall Study|Protocol Violation|1|||
37988945|NCT00369824|69674113|FG004|Overall Study|Protocol Violation|1|||
37988946|NCT00369824|69674114|FG005|Overall Study|Protocol Violation|0|||
37988947|NCT00369824|69674109|FG000|Overall Study|Withdrawal by Subject|9|||
37988948|NCT00369824|69674110|FG001|Overall Study|Withdrawal by Subject|5|||
37696050|NCT02277769|69172235|FG001|Overall Study|Other than specified above|8|||
37824417|NCT04530344|69506489|FG000|Overall Study|Adverse Event|0|||
37824418|NCT04530344|69506490|FG001|Overall Study|Adverse Event|0|||
37824419|NCT04530344|69506491|FG002|Overall Study|Adverse Event|0|||
37824420|NCT04530344|69506492|FG003|Overall Study|Adverse Event|1|||
37824421|NCT04530344|69506489|FG000|Overall Study|Lack of Efficacy|0|||
37824422|NCT04530344|69506490|FG001|Overall Study|Lack of Efficacy|0|||
37824423|NCT04530344|69506491|FG002|Overall Study|Lack of Efficacy|0|||
37824424|NCT04530344|69506492|FG003|Overall Study|Lack of Efficacy|1|||
37824425|NCT04530344|69506489|FG000|Overall Study|Physician Decision|0|||
37824426|NCT04530344|69506490|FG001|Overall Study|Physician Decision|0|||
37824427|NCT04530344|69506491|FG002|Overall Study|Physician Decision|1|||
37824428|NCT04530344|69506492|FG003|Overall Study|Physician Decision|1|||
37824429|NCT04530344|69506489|FG000|Overall Study|Pregnancy|0|||
37824430|NCT04530344|69506490|FG001|Overall Study|Pregnancy|0|||
37892127|NCT00907296|69577351|FG007|Overall Study|Lost to Follow-up|2|||
37892128|NCT00907296|69577352|FG008|Overall Study|Lost to Follow-up|0|||
37892129|NCT00907296|69577353|FG009|Overall Study|Lost to Follow-up|4|||
37892130|NCT00816400|69577384|FG000|Overall Study|Death|2|||
37892131|NCT00816400|69577385|FG001|Overall Study|Death|3|||
37892132|NCT00816400|69577386|FG002|Overall Study|Death|3|||
37892133|NCT00816400|69577387|FG003|Overall Study|Death|3|||
37696051|NCT02277769|69172236|FG002|Overall Study|Other than specified above|5|||
37824431|NCT04530344|69506491|FG002|Overall Study|Pregnancy|2|||
37988949|NCT00369824|69674111|FG002|Overall Study|Withdrawal by Subject|5|||
37988950|NCT00369824|69674112|FG003|Overall Study|Withdrawal by Subject|4|||
37696052|NCT01641991|69172248|FG000|Overall Study|Physician Decision|0|||
37696053|NCT01641991|69172249|FG001|Overall Study|Physician Decision|1|||
37824432|NCT04530344|69506492|FG003|Overall Study|Pregnancy|1|||
37824433|NCT04530344|69506489|FG000|Overall Study|Protocol Violation|0|||
37892134|NCT00816400|69577388|FG004|Overall Study|Death|2|||
37988951|NCT00369824|69674113|FG004|Overall Study|Withdrawal by Subject|6|||
37824434|NCT04530344|69506490|FG001|Overall Study|Protocol Violation|0|||
37892135|NCT00816400|69577389|FG005|Overall Study|Death|3|||
37892136|NCT00816400|69577390|FG006|Overall Study|Death|2|||
37892137|NCT00816400|69577391|FG007|Overall Study|Death|5|||
37892138|NCT00816400|69577392|FG008|Overall Study|Death|6|||
37892139|NCT00816400|69577384|FG000|Overall Study|In hospice care at the end of the study|0|||
37892140|NCT00816400|69577385|FG001|Overall Study|In hospice care at the end of the study|0|||
37892141|NCT00816400|69577386|FG002|Overall Study|In hospice care at the end of the study|2|||
37892142|NCT00816400|69577387|FG003|Overall Study|In hospice care at the end of the study|0|||
37892143|NCT00816400|69577388|FG004|Overall Study|In hospice care at the end of the study|0|||
37892144|NCT00816400|69577389|FG005|Overall Study|In hospice care at the end of the study|0|||
37892145|NCT00816400|69577390|FG006|Overall Study|In hospice care at the end of the study|0|||
37892146|NCT00816400|69577391|FG007|Overall Study|In hospice care at the end of the study|0|||
37892147|NCT00816400|69577392|FG008|Overall Study|In hospice care at the end of the study|0|||
37892148|NCT00906204|69577415|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
37892149|NCT00906204|69577416|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
37892150|NCT00906204|69577415|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
37892151|NCT00906204|69577416|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
37892152|NCT00906204|69577415|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
37892153|NCT00906204|69577416|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
37892154|NCT00906204|69577415|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
37892155|NCT00906204|69577416|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
37892156|NCT00906204|69577415|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
37892157|NCT00906204|69577416|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
37892158|NCT00905424|69577453|FG000|Overall Study|Lost to Follow-up|3|||
37892159|NCT00905424|69577454|FG001|Overall Study|Lost to Follow-up|3|||
37892160|NCT00905424|69577453|FG000|Overall Study|Withdrawal by Subject|1|||
37892161|NCT00905424|69577454|FG001|Overall Study|Withdrawal by Subject|2|||
37892162|NCT00905424|69577453|FG000|Overall Study|Adverse Event|4|||
37892163|NCT00905424|69577454|FG001|Overall Study|Adverse Event|2|||
37892164|NCT00905424|69577453|FG000|Overall Study|Non-compliance with study medication|2|||
37892165|NCT00905424|69577454|FG001|Overall Study|Non-compliance with study medication|0|||
37892166|NCT00905424|69577453|FG000|Overall Study|Sponsor decision|1|||
37892167|NCT00905424|69577454|FG001|Overall Study|Sponsor decision|0|||
37892168|NCT00905424|69577453|FG000|Overall Study|Positive urine drug screen|0|||
37892169|NCT00905424|69577454|FG001|Overall Study|Positive urine drug screen|1|||
37892170|NCT00905424|69577453|FG000|Overall Study|Non-adherence to visit schedule|0|||
37892171|NCT00905424|69577454|FG001|Overall Study|Non-adherence to visit schedule|1|||
37892172|NCT00816166|69577464|FG000|Overall Study|Lost to Follow-up|6|||
37892173|NCT00816166|69577465|FG001|Overall Study|Lost to Follow-up|10|||
37892174|NCT00816166|69577464|FG000|Overall Study|Death|4|||
37892175|NCT00816166|69577465|FG001|Overall Study|Death|2|||
37892176|NCT00815308|69577471|FG000|Overall Study|Adverse Event|4|||
37892177|NCT00815308|69577471|FG000|Overall Study|Withdrawal by Subject|0|||
37892178|NCT00815308|69577471|FG000|Overall Study|Protocol Violation|6|||
37892179|NCT01039376|69577477|FG000|Overall Study|Lost to Follow-up|5|||
37892180|NCT01039376|69577478|FG001|Overall Study|Lost to Follow-up|12|||
37892181|NCT01039376|69577477|FG000|Overall Study|Physician Decision|15|||
37892182|NCT01039376|69577478|FG001|Overall Study|Physician Decision|10|||
37892183|NCT01039376|69577477|FG000|Overall Study|Withdrawal by Subject|20|||
37892184|NCT01039376|69577478|FG001|Overall Study|Withdrawal by Subject|32|||
37892185|NCT01039376|69577477|FG000|Overall Study|Study terminated by Sponsor|90|||
37892186|NCT01039376|69577478|FG001|Overall Study|Study terminated by Sponsor|72|||
37892187|NCT00905034|69577485|FG000|Overall Study|Withdrawal by Subject|1|||
37892188|NCT00828568|69577492|FG000|Randomized|Withdrawal by Subject|1|||
37892189|NCT00828568|69577493|FG001|Randomized|Withdrawal by Subject|0|||
37892190|NCT00828568|69577494|FG002|Randomized|Withdrawal by Subject|2|||
37892191|NCT00828568|69577492|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
37892192|NCT00828568|69577493|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
37892193|NCT00828568|69577494|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
37892194|NCT00828568|69577492|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
37892195|NCT00828568|69577493|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
37892196|NCT00828568|69577494|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
37892197|NCT00828568|69577492|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
37892198|NCT00828568|69577493|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
37892199|NCT00828568|69577494|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
37892200|NCT00828568|69577492|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
37892201|NCT00828568|69577493|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
37892202|NCT00828568|69577494|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
37892203|NCT01038752|69577505|FG000|Overall Study|Tumor Progression|2|||
37892204|NCT01038752|69577506|FG001|Overall Study|Tumor Progression|2|||
37892205|NCT01038752|69577505|FG000|Overall Study|Lost to Follow-up|3|||
37892206|NCT01038752|69577506|FG001|Overall Study|Lost to Follow-up|3|||
37892207|NCT00903630|69577515|FG000|Phase 2|Adverse Event|0|||
37892208|NCT00903630|69577516|FG001|Phase 2|Adverse Event|0|||
37892209|NCT00903630|69577517|FG002|Phase 2|Adverse Event|1|||
37892210|NCT01037114|69577527|FG000|Year 20|Others|1|||
37892211|NCT00840970|69577531|FG000|Overall Study|Adverse Event|0|||
37892212|NCT00840970|69577532|FG001|Overall Study|Adverse Event|0|||
37892213|NCT00840970|69577533|FG002|Overall Study|Adverse Event|1|||
37892214|NCT01054820|69577543|FG000|Overall Study|Withdrawal by Subject|2|||
37892215|NCT00840658|69577551|FG000|Overall Study|Death|2|||
37892216|NCT00840658|69577552|FG001|Overall Study|Death|2|||
37892217|NCT00840658|69577553|FG002|Overall Study|Death|3|||
37892218|NCT00840658|69577554|FG003|Overall Study|Death|3|||
37892219|NCT00840658|69577551|FG000|Overall Study|Lost to Follow-up|3|||
37892220|NCT00840658|69577552|FG001|Overall Study|Lost to Follow-up|1|||
37892221|NCT00840658|69577553|FG002|Overall Study|Lost to Follow-up|2|||
37892222|NCT00840658|69577554|FG003|Overall Study|Lost to Follow-up|1|||
37892223|NCT01036724|69577570|FG000|Overall Study|Adverse Event|1|||
37892224|NCT01036724|69577571|FG001|Overall Study|Adverse Event|2|||
37892225|NCT01036724|69577570|FG000|Overall Study|Lack of Efficacy|1|||
37892226|NCT01036724|69577571|FG001|Overall Study|Lack of Efficacy|1|||
37892227|NCT01036724|69577570|FG000|Overall Study|Protocol Violation|4|||
37892228|NCT01036724|69577571|FG001|Overall Study|Protocol Violation|5|||
37892229|NCT01052714|69577579|FG000|Overall Study|Adverse Event|6|||
37892230|NCT01052714|69577580|FG001|Overall Study|Adverse Event|3|||
37892231|NCT01052714|69577581|FG002|Overall Study|Adverse Event|0|||
37892232|NCT01052714|69577579|FG000|Overall Study|Death|1|||
37892233|NCT01052714|69577580|FG001|Overall Study|Death|2|||
37892234|NCT01052714|69577581|FG002|Overall Study|Death|0|||
37892235|NCT01052714|69577579|FG000|Overall Study|Lost to Follow-up|2|||
37696054|NCT01641991|69172250|FG002|Overall Study|Physician Decision|7|||
37696055|NCT01641991|69172251|FG003|Overall Study|Physician Decision|5|||
37696056|NCT01641991|69172248|FG000|Overall Study|Withdrawal by Subject|4|||
37824435|NCT04530344|69506491|FG002|Overall Study|Protocol Violation|0|||
37824436|NCT04530344|69506492|FG003|Overall Study|Protocol Violation|1|||
37824437|NCT04530344|69506489|FG000|Overall Study|Site Closed Due to Noncompliance|0|||
37824438|NCT04530344|69506490|FG001|Overall Study|Site Closed Due to Noncompliance|0|||
37824439|NCT04530344|69506491|FG002|Overall Study|Site Closed Due to Noncompliance|0|||
37824440|NCT04530344|69506492|FG003|Overall Study|Site Closed Due to Noncompliance|1|||
37824441|NCT04530344|69506489|FG000|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
37824442|NCT04530344|69506490|FG001|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
37824443|NCT04530344|69506491|FG002|Overall Study|Discontinued due to COVID-19 Pandemic|1|||
37824444|NCT04530344|69506492|FG003|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
37824445|NCT04530344|69506489|FG000|Overall Study|Missed Safety Follow-up Visit|0|||
37824446|NCT04530344|69506490|FG001|Overall Study|Missed Safety Follow-up Visit|0|||
37824447|NCT04530344|69506491|FG002|Overall Study|Missed Safety Follow-up Visit|1|||
37824448|NCT04530344|69506492|FG003|Overall Study|Missed Safety Follow-up Visit|0|||
37892236|NCT01052714|69577580|FG001|Overall Study|Lost to Follow-up|3|||
37988952|NCT00369824|69674114|FG005|Overall Study|Withdrawal by Subject|2|||
37824449|NCT04530344|69506489|FG000|Overall Study|Personal Reasons|0|||
37824450|NCT04530344|69506490|FG001|Overall Study|Personal Reasons|0|||
37824451|NCT04530344|69506491|FG002|Overall Study|Personal Reasons|0|||
37824452|NCT04530344|69506492|FG003|Overall Study|Personal Reasons|1|||
37696057|NCT01641991|69172249|FG001|Overall Study|Withdrawal by Subject|2|||
37892237|NCT01052714|69577581|FG002|Overall Study|Lost to Follow-up|0|||
37892238|NCT01052714|69577579|FG000|Overall Study|Physician Decision|9|||
37892239|NCT01052714|69577580|FG001|Overall Study|Physician Decision|9|||
37892240|NCT01052714|69577581|FG002|Overall Study|Physician Decision|1|||
37892241|NCT01052714|69577579|FG000|Overall Study|Withdrawal by Subject|7|||
37892242|NCT01052714|69577580|FG001|Overall Study|Withdrawal by Subject|12|||
37892243|NCT01052714|69577581|FG002|Overall Study|Withdrawal by Subject|1|||
37892244|NCT01052480|69577598|FG000|Overall Study|Lost to Follow-up|3|||
37892245|NCT01052480|69577599|FG001|Overall Study|Lost to Follow-up|3|||
37892246|NCT01052480|69577598|FG000|Overall Study|Protocol Violation|1|||
37892247|NCT01052480|69577599|FG001|Overall Study|Protocol Violation|0|||
37892248|NCT01052480|69577598|FG000|Overall Study|Withdrawal by Subject|3|||
37892249|NCT01052480|69577599|FG001|Overall Study|Withdrawal by Subject|7|||
37892250|NCT01052480|69577598|FG000|Overall Study|Physician Decision|0|||
37892251|NCT01052480|69577599|FG001|Overall Study|Physician Decision|2|||
37824453|NCT04530344|69506489|FG000|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
37892252|NCT01052480|69577598|FG000|Overall Study|Death|1|||
37892253|NCT01052480|69577599|FG001|Overall Study|Death|5|||
37892254|NCT00904722|69577605|FG000|Overall Study|Physician Decision|1|||
37892255|NCT01029782|69577611|FG000|Overall Study|Lost to Follow-up|2|||
37892256|NCT01029782|69577612|FG001|Overall Study|Lost to Follow-up|2|||
37892257|NCT01029782|69577611|FG000|Overall Study|Diagnosis changed|1|||
37892258|NCT01029782|69577612|FG001|Overall Study|Diagnosis changed|1|||
37892259|NCT01029782|69577611|FG000|Overall Study|Adverse Event|0|||
37892260|NCT01029782|69577612|FG001|Overall Study|Adverse Event|1|||
37892261|NCT01029782|69577611|FG000|Overall Study|Physician Decision|0|||
37892262|NCT01029782|69577612|FG001|Overall Study|Physician Decision|1|||
37892263|NCT01029782|69577611|FG000|Overall Study|Protocol Violation|0|||
37892264|NCT01029782|69577612|FG001|Overall Study|Protocol Violation|2|||
37892265|NCT01029782|69577611|FG000|Overall Study|Withdrawal by Subject|0|||
37892266|NCT01029782|69577612|FG001|Overall Study|Withdrawal by Subject|1|||
37892267|NCT01029704|69577627|FG000|Overall Study|Adverse Event|0|||
37824454|NCT04530344|69506490|FG001|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
37892268|NCT01029704|69577628|FG001|Overall Study|Adverse Event|0|||
37892269|NCT01029704|69577629|FG002|Overall Study|Adverse Event|0|||
37892270|NCT01029704|69577630|FG003|Overall Study|Adverse Event|0|||
37892271|NCT01029704|69577631|FG004|Overall Study|Adverse Event|0|||
37892272|NCT01029704|69577632|FG005|Overall Study|Adverse Event|0|||
37892273|NCT01029704|69577633|FG006|Overall Study|Adverse Event|1|||
37892274|NCT01029704|69577634|FG007|Overall Study|Adverse Event|1|||
37892275|NCT01029704|69577635|FG008|Overall Study|Adverse Event|0|||
37892276|NCT01029704|69577627|FG000|Overall Study|Withdrawal by Subject|0|||
37892277|NCT01029704|69577628|FG001|Overall Study|Withdrawal by Subject|0|||
37892278|NCT01029704|69577629|FG002|Overall Study|Withdrawal by Subject|0|||
37892279|NCT01029704|69577630|FG003|Overall Study|Withdrawal by Subject|0|||
37892280|NCT01029704|69577631|FG004|Overall Study|Withdrawal by Subject|2|||
37892281|NCT01029704|69577632|FG005|Overall Study|Withdrawal by Subject|1|||
37892282|NCT01029704|69577633|FG006|Overall Study|Withdrawal by Subject|1|||
37892283|NCT01029704|69577634|FG007|Overall Study|Withdrawal by Subject|1|||
37892284|NCT01029704|69577635|FG008|Overall Study|Withdrawal by Subject|0|||
37892285|NCT01029704|69577627|FG000|Overall Study|Lost to Follow-up|0|||
37892286|NCT01029704|69577628|FG001|Overall Study|Lost to Follow-up|0|||
37892287|NCT01029704|69577629|FG002|Overall Study|Lost to Follow-up|0|||
37892288|NCT01029704|69577630|FG003|Overall Study|Lost to Follow-up|0|||
37824455|NCT04530344|69506491|FG002|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
37824456|NCT04530344|69506492|FG003|Overall Study|Not Compliant with Protocol-specific Visit Window|1|||
37824457|NCT04058886|69506517|FG000|Overall Study|Withdrawal by Subject|4|||
37824458|NCT04058886|69506517|FG000|Overall Study|Inadequate deafness interpreter service|1|||
37824459|NCT03704194|69506540|FG000|Overall Study|Withdrawal by Subject|0|||
37824460|NCT03704194|69506541|FG001|Overall Study|Withdrawal by Subject|1|||
37824461|NCT03451422|69506555|FG000|Overall Study|Lost to Follow-up|0|||
37824462|NCT03451422|69506556|FG001|Overall Study|Lost to Follow-up|0|||
37824463|NCT03451422|69506557|FG002|Overall Study|Lost to Follow-up|0|||
37824464|NCT03451422|69506558|FG003|Overall Study|Lost to Follow-up|0|||
37824465|NCT03451422|69506559|FG004|Overall Study|Lost to Follow-up|0|||
37824466|NCT03451422|69506560|FG005|Overall Study|Lost to Follow-up|1|||
37824467|NCT03451422|69506555|FG000|Overall Study|Decision by sponsor|1|||
37824468|NCT03451422|69506556|FG001|Overall Study|Decision by sponsor|0|||
37824469|NCT03451422|69506557|FG002|Overall Study|Decision by sponsor|1|||
37892289|NCT01029704|69577631|FG004|Overall Study|Lost to Follow-up|0|||
37892290|NCT01029704|69577632|FG005|Overall Study|Lost to Follow-up|0|||
37892291|NCT01029704|69577633|FG006|Overall Study|Lost to Follow-up|1|||
37824470|NCT03451422|69506558|FG003|Overall Study|Decision by sponsor|0|||
37892292|NCT01029704|69577634|FG007|Overall Study|Lost to Follow-up|1|||
37892293|NCT01029704|69577635|FG008|Overall Study|Lost to Follow-up|1|||
37892294|NCT01029704|69577627|FG000|Overall Study|Lack of Efficacy|0|||
37892295|NCT01029704|69577628|FG001|Overall Study|Lack of Efficacy|0|||
37892296|NCT01029704|69577629|FG002|Overall Study|Lack of Efficacy|0|||
37892297|NCT01029704|69577630|FG003|Overall Study|Lack of Efficacy|0|||
37892298|NCT01029704|69577631|FG004|Overall Study|Lack of Efficacy|2|||
37892299|NCT01029704|69577632|FG005|Overall Study|Lack of Efficacy|3|||
37892300|NCT01029704|69577633|FG006|Overall Study|Lack of Efficacy|1|||
37892301|NCT01029704|69577634|FG007|Overall Study|Lack of Efficacy|2|||
37892302|NCT01029704|69577635|FG008|Overall Study|Lack of Efficacy|0|||
37892303|NCT01029704|69577627|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
37892304|NCT01029704|69577628|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
37892305|NCT01029704|69577629|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
37892306|NCT01029704|69577630|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
37892307|NCT01029704|69577631|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
37892308|NCT01029704|69577632|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
37892309|NCT01029704|69577633|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
37892310|NCT01029704|69577634|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
37892311|NCT01029704|69577635|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
37892312|NCT00840034|69577657|FG000|Acute Treatment Phase|Adverse Event|6|||
37892313|NCT00840034|69577658|FG001|Acute Treatment Phase|Adverse Event|8|||
37892314|NCT00840034|69577657|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
37892315|NCT00840034|69577658|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
37892316|NCT00840034|69577657|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
37892317|NCT00840034|69577658|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
37892318|NCT00840034|69577657|FG000|Acute Treatment Phase|Physician Decision|0|||
37892319|NCT00840034|69577658|FG001|Acute Treatment Phase|Physician Decision|1|||
37892320|NCT00840034|69577657|FG000|Acute Treatment Phase|Protocol Violation|2|||
37892321|NCT00840034|69577658|FG001|Acute Treatment Phase|Protocol Violation|4|||
37988953|NCT00369824|69674109|FG000|Overall Study|Lost to Follow-up|6|||
37988954|NCT00369824|69674110|FG001|Overall Study|Lost to Follow-up|11|||
37988955|NCT00369824|69674111|FG002|Overall Study|Lost to Follow-up|7|||
37988956|NCT00369824|69674112|FG003|Overall Study|Lost to Follow-up|8|||
37988957|NCT00369824|69674113|FG004|Overall Study|Lost to Follow-up|9|||
37988958|NCT00369824|69674114|FG005|Overall Study|Lost to Follow-up|6|||
37988959|NCT00369824|69674109|FG000|Overall Study|Other|0|||
37988960|NCT00369824|69674110|FG001|Overall Study|Other|0|||
37988961|NCT00369824|69674111|FG002|Overall Study|Other|0|||
37988962|NCT00369824|69674112|FG003|Overall Study|Other|2|||
37988963|NCT00369824|69674113|FG004|Overall Study|Other|1|||
37988964|NCT00369824|69674114|FG005|Overall Study|Other|3|||
37988965|NCT00369668|69674131|FG000|Overall Study|Lack of Efficacy|4|||
37988966|NCT00369668|69674132|FG001|Overall Study|Lack of Efficacy|5|||
37988967|NCT00369668|69674133|FG002|Overall Study|Lack of Efficacy|7|||
37988968|NCT00388154|69674144|FG000|Overall Study|Withdrawal by Subject|1|||
37988969|NCT00387764|69674148|FG000|Overall Study|Adverse Event|12|||
37892322|NCT00840034|69577657|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
37892323|NCT00840034|69577658|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
37988970|NCT00387764|69674148|FG000|Overall Study|Withdrawal by Subject|8|||
37988971|NCT00387764|69674148|FG000|Overall Study|Sponsor Terminated Study|1|||
37988972|NCT00387764|69674148|FG000|Overall Study|Physician Decision|1|||
37988973|NCT00387764|69674148|FG000|Overall Study|Other|2|||
37988974|NCT00387764|69674148|FG000|Overall Study|Death|7|||
37988975|NCT00386360|69674154|FG000|Overall Study|Adverse Event|4|||
37988976|NCT00386360|69674155|FG001|Overall Study|Adverse Event|2|||
37988977|NCT00386360|69674154|FG000|Overall Study|Physician Decision|2|||
37988978|NCT00386360|69674155|FG001|Overall Study|Physician Decision|2|||
37988979|NCT00386360|69674154|FG000|Overall Study|Lost to Follow-up|0|||
37988980|NCT00386360|69674155|FG001|Overall Study|Lost to Follow-up|2|||
37988981|NCT00386360|69674154|FG000|Overall Study|Protocol Violation|0|||
37988982|NCT00386360|69674155|FG001|Overall Study|Protocol Violation|3|||
37988983|NCT00386360|69674154|FG000|Overall Study|Withdrawal by Subject|3|||
37988984|NCT00386360|69674155|FG001|Overall Study|Withdrawal by Subject|6|||
37988985|NCT00386360|69674154|FG000|Overall Study|Did not take any study medication|0|||
37892324|NCT00840034|69577657|FG000|Taper Phase|Adverse Event|1|||
37892325|NCT00840034|69577658|FG001|Taper Phase|Adverse Event|0|||
37892326|NCT00840034|69577657|FG000|Taper Phase|Lost to Follow-up|1|||
37892327|NCT00840034|69577658|FG001|Taper Phase|Lost to Follow-up|1|||
37892328|NCT00840034|69577657|FG000|Taper Phase|Withdrawal by Subject|1|||
37988986|NCT00386360|69674155|FG001|Overall Study|Did not take any study medication|2|||
37988987|NCT00369278|69674163|FG000|Overall Study|Adverse Event|14|||
37988988|NCT00369278|69674164|FG001|Overall Study|Adverse Event|11|||
37988989|NCT00369278|69674163|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
37988990|NCT00369278|69674164|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
37988991|NCT00369278|69674163|FG000|Overall Study|Protocol Violation|2|||
37988992|NCT00369278|69674164|FG001|Overall Study|Protocol Violation|1|||
37988993|NCT00369278|69674163|FG000|Overall Study|Withdrawal by Subject|2|||
37988994|NCT00369278|69674164|FG001|Overall Study|Withdrawal by Subject|2|||
37988995|NCT00369278|69674163|FG000|Overall Study|Lost to Follow-up|1|||
37892329|NCT00840034|69577658|FG001|Taper Phase|Withdrawal by Subject|1|||
37892330|NCT00813904|69577666|FG000|Overall Study|Death|1|||
37892331|NCT00839956|69577670|FG000|Overall Study|Adverse Event|2|||
37892332|NCT00839956|69577670|FG000|Overall Study|Lack of Efficacy|6|||
37892333|NCT00839956|69577670|FG000|Overall Study|Physician Decision|1|||
37892334|NCT00839956|69577670|FG000|Overall Study|Withdrawal by Subject|3|||
37892335|NCT00839800|69577676|FG000|Overall Study|Adverse Event|8|||
37892336|NCT00839800|69577677|FG001|Overall Study|Adverse Event|12|||
37892337|NCT00839800|69577676|FG000|Overall Study|Lost to Follow-up|31|||
37892338|NCT00839800|69577677|FG001|Overall Study|Lost to Follow-up|26|||
37824471|NCT03451422|69506559|FG004|Overall Study|Decision by sponsor|0|||
37824472|NCT03451422|69506560|FG005|Overall Study|Decision by sponsor|0|||
37824473|NCT03451422|69506555|FG000|Overall Study|Withdrawal by Subject|0|||
37824474|NCT03451422|69506556|FG001|Overall Study|Withdrawal by Subject|0|||
37824475|NCT03451422|69506557|FG002|Overall Study|Withdrawal by Subject|2|||
37824476|NCT03451422|69506558|FG003|Overall Study|Withdrawal by Subject|3|||
37824477|NCT03451422|69506559|FG004|Overall Study|Withdrawal by Subject|2|||
37824478|NCT03451422|69506560|FG005|Overall Study|Withdrawal by Subject|1|||
37824479|NCT03446573|69506581|FG000|Early Switch Phase (Day 1 to Week 148)|Adverse Event|23|||
37892339|NCT00839800|69577676|FG000|Overall Study|Withdrawal by Subject|28|||
37892340|NCT00839800|69577677|FG001|Overall Study|Withdrawal by Subject|34|||
37988996|NCT00369278|69674164|FG001|Overall Study|Lost to Follow-up|0|||
37824480|NCT03446573|69506582|FG001|Early Switch Phase (Day 1 to Week 148)|Adverse Event|7|||
37892341|NCT00839800|69577676|FG000|Overall Study|Incorrect Enrolment|3|||
37892342|NCT00839800|69577677|FG001|Overall Study|Incorrect Enrolment|3|||
37892343|NCT00839800|69577676|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
37988997|NCT00369278|69674163|FG000|Overall Study|Graft loss|1|||
37892344|NCT00839800|69577677|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
37892345|NCT00839800|69577676|FG000|Overall Study|Safety Reasons|2|||
37892346|NCT00839800|69577677|FG001|Overall Study|Safety Reasons|1|||
37892347|NCT00839800|69577676|FG000|Overall Study|Other|8|||
37892348|NCT00839800|69577677|FG001|Overall Study|Other|14|||
37892349|NCT00839800|69577676|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
37892350|NCT00839800|69577677|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
37892351|NCT00753415|69577711|FG000|Part A|Disease progression|1|||
37892352|NCT00753415|69577712|FG001|Part A|Disease progression|0|||
37892353|NCT00753415|69577713|FG002|Part A|Disease progression|1|||
37892354|NCT00753415|69577714|FG003|Part A|Disease progression|2|||
37892355|NCT00753415|69577715|FG004|Part A|Disease progression|0|||
37892356|NCT00753415|69577716|FG005|Part A|Disease progression|0|||
37892357|NCT00753415|69577717|FG006|Part A|Disease progression|0|||
37892358|NCT00753415|69577718|FG007|Part A|Disease progression|0|||
37892359|NCT00753415|69577719|FG008|Part A|Disease progression|0|||
37892360|NCT00753415|69577720|FG009|Part A|Disease progression|0|||
37892361|NCT00753415|69577711|FG000|Part A|Withdrawal by Subject|0|||
37892362|NCT00753415|69577712|FG001|Part A|Withdrawal by Subject|0|||
37892363|NCT00753415|69577713|FG002|Part A|Withdrawal by Subject|1|||
37892364|NCT00753415|69577714|FG003|Part A|Withdrawal by Subject|0|||
37892365|NCT00753415|69577715|FG004|Part A|Withdrawal by Subject|0|||
37892366|NCT00753415|69577716|FG005|Part A|Withdrawal by Subject|0|||
37892367|NCT00753415|69577717|FG006|Part A|Withdrawal by Subject|0|||
37892368|NCT00753415|69577718|FG007|Part A|Withdrawal by Subject|0|||
37892369|NCT00753415|69577719|FG008|Part A|Withdrawal by Subject|0|||
37892370|NCT00753415|69577720|FG009|Part A|Withdrawal by Subject|0|||
37892371|NCT00753415|69577711|FG000|Part B|Lost to Follow-up|0|||
37988998|NCT00369278|69674164|FG001|Overall Study|Graft loss|2|||
37696058|NCT01641991|69172250|FG002|Overall Study|Withdrawal by Subject|1|||
37696059|NCT01641991|69172251|FG003|Overall Study|Withdrawal by Subject|5|||
37696060|NCT01641991|69172248|FG000|Overall Study|Adverse Event|2|||
37696061|NCT01641991|69172249|FG001|Overall Study|Adverse Event|1|||
37696062|NCT01641991|69172250|FG002|Overall Study|Adverse Event|2|||
37696063|NCT01641991|69172251|FG003|Overall Study|Adverse Event|1|||
37696064|NCT01641991|69172248|FG000|Overall Study|Lost to Follow-up|0|||
37696065|NCT01641991|69172249|FG001|Overall Study|Lost to Follow-up|2|||
37696066|NCT01641991|69172250|FG002|Overall Study|Lost to Follow-up|3|||
37696067|NCT01641991|69172251|FG003|Overall Study|Lost to Follow-up|1|||
37696068|NCT01641991|69172248|FG000|Overall Study|Protocol Violation|1|||
37696069|NCT01641991|69172249|FG001|Overall Study|Protocol Violation|1|||
37696070|NCT01641991|69172250|FG002|Overall Study|Protocol Violation|3|||
37696071|NCT01641991|69172251|FG003|Overall Study|Protocol Violation|0|||
37696072|NCT01641991|69172248|FG000|Overall Study|Pregnancy|0|||
37696073|NCT01641991|69172249|FG001|Overall Study|Pregnancy|0|||
37696074|NCT01641991|69172250|FG002|Overall Study|Pregnancy|1|||
37696075|NCT01641991|69172251|FG003|Overall Study|Pregnancy|0|||
37696076|NCT01641991|69172248|FG000|Overall Study|no longer eligible|2|||
37696077|NCT01641991|69172249|FG001|Overall Study|no longer eligible|1|||
37696078|NCT01641991|69172250|FG002|Overall Study|no longer eligible|0|||
37696079|NCT01641991|69172251|FG003|Overall Study|no longer eligible|4|||
37696080|NCT02277691|69172264|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
37892372|NCT00753415|69577712|FG001|Part B|Lost to Follow-up|0|||
37892373|NCT00753415|69577713|FG002|Part B|Lost to Follow-up|0|||
37892374|NCT00753415|69577714|FG003|Part B|Lost to Follow-up|0|||
37892375|NCT00753415|69577715|FG004|Part B|Lost to Follow-up|0|||
37892376|NCT00753415|69577716|FG005|Part B|Lost to Follow-up|0|||
37892377|NCT00753415|69577717|FG006|Part B|Lost to Follow-up|0|||
37892378|NCT00753415|69577718|FG007|Part B|Lost to Follow-up|1|||
37892379|NCT00753415|69577719|FG008|Part B|Lost to Follow-up|1|||
37892380|NCT00753415|69577720|FG009|Part B|Lost to Follow-up|0|||
37892381|NCT00753415|69577711|FG000|Part B|Disease progression|0|||
37892382|NCT00753415|69577712|FG001|Part B|Disease progression|0|||
37892383|NCT00753415|69577713|FG002|Part B|Disease progression|0|||
37892384|NCT00753415|69577714|FG003|Part B|Disease progression|0|||
37892385|NCT00753415|69577715|FG004|Part B|Disease progression|0|||
37892386|NCT00753415|69577716|FG005|Part B|Disease progression|0|||
37892387|NCT00753415|69577717|FG006|Part B|Disease progression|0|||
37892388|NCT00753415|69577718|FG007|Part B|Disease progression|0|||
37892389|NCT00753415|69577719|FG008|Part B|Disease progression|2|||
37892390|NCT00753415|69577720|FG009|Part B|Disease progression|1|||
37892391|NCT00754741|69577747|FG000|Overall Study|Died or disenrolled|57|||
37892392|NCT00754741|69577748|FG001|Overall Study|Died or disenrolled|69|||
37892393|NCT00754741|69577749|FG002|Overall Study|Died or disenrolled|54|||
37892394|NCT00752791|69577757|FG000|Overall Study|Adverse Event|7|||
37892395|NCT00752791|69577757|FG000|Overall Study|Withdrawal by Subject|1|||
37988999|NCT00529373|69674172|FG000|Base Study|Adverse Event|525|||
37989000|NCT00529373|69674173|FG001|Base Study|Adverse Event|470|||
37892396|NCT00752791|69577757|FG000|Overall Study|Physician Decision|1|||
37892397|NCT00752791|69577757|FG000|Overall Study|Death|1|||
37892398|NCT00752791|69577757|FG000|Overall Study|Renal transplant|3|||
37892399|NCT00752791|69577757|FG000|Overall Study|Switched to hemodialysis|2|||
37892400|NCT00752791|69577757|FG000|Overall Study|Protocol deviation|1|||
37892401|NCT00902304|69577768|FG000|Overall Study|Adverse Event|4|||
37892402|NCT00902304|69577769|FG001|Overall Study|Adverse Event|10|||
37892403|NCT00902304|69577770|FG002|Overall Study|Adverse Event|25|||
37892404|NCT00902304|69577768|FG000|Overall Study|Investigator discretion|3|||
37892405|NCT00902304|69577769|FG001|Overall Study|Investigator discretion|5|||
37892406|NCT00902304|69577770|FG002|Overall Study|Investigator discretion|13|||
37892407|NCT00902304|69577768|FG000|Overall Study|Lost to Follow-up|7|||
37892408|NCT00902304|69577769|FG001|Overall Study|Lost to Follow-up|7|||
37892409|NCT00902304|69577770|FG002|Overall Study|Lost to Follow-up|7|||
37892410|NCT00902304|69577768|FG000|Overall Study|Protocol Violation|9|||
37892411|NCT00902304|69577769|FG001|Overall Study|Protocol Violation|18|||
37892412|NCT00902304|69577770|FG002|Overall Study|Protocol Violation|20|||
37892413|NCT00902304|69577768|FG000|Overall Study|Withdrawal by Subject|32|||
37892414|NCT00902304|69577769|FG001|Overall Study|Withdrawal by Subject|22|||
37989001|NCT00529373|69674172|FG000|Base Study|Lack of Efficacy|16|||
37989002|NCT00529373|69674173|FG001|Base Study|Lack of Efficacy|75|||
37989003|NCT00529373|69674172|FG000|Base Study|Lost to Follow-up|221|||
37989004|NCT00529373|69674173|FG001|Base Study|Lost to Follow-up|208|||
37696081|NCT02277691|69172264|FG000|Overall Study|Voluntary Withdrawal|7|||
37824481|NCT03446573|69506581|FG000|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|0|||
37824482|NCT03446573|69506582|FG001|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|6|||
37824483|NCT03446573|69506581|FG000|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|5|||
37824484|NCT03446573|69506582|FG001|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|6|||
37824485|NCT03446573|69506581|FG000|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|4|||
37824486|NCT03446573|69506582|FG001|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|10|||
37824487|NCT03446573|69506581|FG000|Early Switch Phase (Day 1 to Week 148)|Physician Decision|2|||
37824488|NCT03446573|69506582|FG001|Early Switch Phase (Day 1 to Week 148)|Physician Decision|11|||
37824489|NCT03446573|69506581|FG000|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|16|||
37824490|NCT03446573|69506582|FG001|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|33|||
37824491|NCT03446573|69506581|FG000|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|2|||
37824492|NCT03446573|69506582|FG001|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|0|||
37824493|NCT03446573|69506581|FG000|Late Switch Phase (Week 148 to Week 196)|Adverse Event|2|||
37892415|NCT00902304|69577770|FG002|Overall Study|Withdrawal by Subject|43|||
37696082|NCT02277691|69172264|FG000|Overall Study|Lack of Efficacy|5|||
37892416|NCT00902304|69577768|FG000|Overall Study|includes pregnancy|3|||
37892417|NCT00902304|69577769|FG001|Overall Study|includes pregnancy|9|||
37892418|NCT00902304|69577770|FG002|Overall Study|includes pregnancy|2|||
37892419|NCT00759109|69577781|FG000|Overall Study|Adverse Event|17|||
37892420|NCT00759109|69577782|FG001|Overall Study|Adverse Event|12|||
37892421|NCT00759109|69577781|FG000|Overall Study|Inability to comply|1|||
37892422|NCT00759109|69577782|FG001|Overall Study|Inability to comply|1|||
37892423|NCT00759109|69577781|FG000|Overall Study|Withdrawal by Subject|9|||
37892424|NCT00759109|69577782|FG001|Overall Study|Withdrawal by Subject|5|||
37892425|NCT00759109|69577781|FG000|Overall Study|Death|4|||
37989005|NCT00529373|69674172|FG000|Base Study|Other Protocol Specified Criteria|19|||
37892426|NCT00759109|69577782|FG001|Overall Study|Death|3|||
37892427|NCT00759109|69577781|FG000|Overall Study|Lost to Follow-up|4|||
37892428|NCT00759109|69577782|FG001|Overall Study|Lost to Follow-up|6|||
37892429|NCT00759109|69577781|FG000|Overall Study|Started new therapy|2|||
37892430|NCT00759109|69577782|FG001|Overall Study|Started new therapy|6|||
37892431|NCT00759109|69577781|FG000|Overall Study|HCV RNA negative|1|||
37892432|NCT00759109|69577782|FG001|Overall Study|HCV RNA negative|0|||
37892433|NCT00759109|69577781|FG000|Overall Study|Participant moved to a different city|0|||
37892434|NCT00759109|69577782|FG001|Overall Study|Participant moved to a different city|1|||
37892435|NCT00759109|69577781|FG000|Overall Study|Participant had a liver transplant|0|||
37892436|NCT00759109|69577782|FG001|Overall Study|Participant had a liver transplant|1|||
37892437|NCT00759109|69577781|FG000|Overall Study|Lost during study|1|||
37892438|NCT00759109|69577782|FG001|Overall Study|Lost during study|0|||
37892439|NCT00759031|69577790|FG000|First Intervention (1 Day)|Physician Decision|1|||
37892440|NCT00759031|69577791|FG001|First Intervention (1 Day)|Physician Decision|0|||
37892441|NCT00759031|69577790|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
37892442|NCT00759031|69577791|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
37892443|NCT00759031|69577790|FG000|First Intervention (1 Day)|Screening failure|1|||
37892444|NCT00759031|69577791|FG001|First Intervention (1 Day)|Screening failure|0|||
37892445|NCT00758485|69577799|FG000|Overall Study|Lost to Follow-up|0|||
37892446|NCT00758485|69577800|FG001|Overall Study|Lost to Follow-up|1|||
37892447|NCT00758485|69577799|FG000|Overall Study|Not Treated|1|||
37892448|NCT00758485|69577800|FG001|Overall Study|Not Treated|2|||
37892449|NCT00757783|69577809|FG000|Overall Study|Adverse Event|0|||
37892450|NCT00757783|69577810|FG001|Overall Study|Adverse Event|2|||
37892451|NCT00757783|69577809|FG000|Overall Study|Lost to Follow-up|1|||
37892452|NCT00757783|69577810|FG001|Overall Study|Lost to Follow-up|1|||
37892453|NCT00757783|69577809|FG000|Overall Study|Protocol Violation|1|||
37892454|NCT00757783|69577810|FG001|Overall Study|Protocol Violation|0|||
37892455|NCT00757783|69577809|FG000|Overall Study|Withdrawal by Subject|2|||
37892456|NCT00757783|69577810|FG001|Overall Study|Withdrawal by Subject|1|||
37892457|NCT00757783|69577809|FG000|Overall Study|Other|1|||
37892458|NCT00757783|69577810|FG001|Overall Study|Other|2|||
37892459|NCT00757705|69577816|FG000|Overall Study|Adverse Event|19|||
37892460|NCT00757705|69577816|FG000|Overall Study|Lost to Follow-up|16|||
37892461|NCT00757705|69577816|FG000|Overall Study|Withdrawal by Subject|25|||
37892462|NCT00757705|69577816|FG000|Overall Study|Insufficient Response|26|||
37892463|NCT00757705|69577816|FG000|Overall Study|Ineligible to continue|8|||
37892464|NCT00757705|69577816|FG000|Overall Study|Non-compliant|9|||
37892465|NCT00757705|69577816|FG000|Overall Study|Other|18|||
37892466|NCT00757627|69577820|FG000|Overall Study|Adverse Event|15|||
37892467|NCT00757627|69577820|FG000|Overall Study|Lack of Efficacy|10|||
37892468|NCT00757627|69577820|FG000|Overall Study|Lost to Follow-up|28|||
37892469|NCT00757627|69577820|FG000|Overall Study|Withdrawal by Subject|27|||
37892470|NCT00757627|69577820|FG000|Overall Study|Other|1|||
37892471|NCT01023308|69577831|FG000|Overall Study|Abnormal test proceedure results|3|||
37892472|NCT01023308|69577832|FG001|Overall Study|Abnormal test proceedure results|8|||
37892473|NCT01023308|69577831|FG000|Overall Study|Administrative problems|2|||
37892474|NCT01023308|69577832|FG001|Overall Study|Administrative problems|1|||
37892475|NCT01023308|69577831|FG000|Overall Study|Adverse Event|130|||
37892476|NCT01023308|69577832|FG001|Overall Study|Adverse Event|66|||
37892477|NCT01023308|69577831|FG000|Overall Study|Death|21|||
37892478|NCT01023308|69577832|FG001|Overall Study|Death|17|||
37892479|NCT01023308|69577831|FG000|Overall Study|Disease progression|82|||
37892480|NCT01023308|69577832|FG001|Overall Study|Disease progression|153|||
37892481|NCT01023308|69577831|FG000|Overall Study|New Cancer therapy|4|||
37989006|NCT00529373|69674173|FG001|Base Study|Other Protocol Specified Criteria|20|||
37892482|NCT01023308|69577832|FG001|Overall Study|New Cancer therapy|7|||
37892483|NCT01023308|69577831|FG000|Overall Study|Protocol Violation|3|||
37892484|NCT01023308|69577832|FG001|Overall Study|Protocol Violation|4|||
37892485|NCT01023308|69577831|FG000|Overall Study|Untreated|5|||
37892486|NCT01023308|69577832|FG001|Overall Study|Untreated|5|||
37892487|NCT01023308|69577831|FG000|Overall Study|Lost to Follow-up|1|||
37892488|NCT01023308|69577832|FG001|Overall Study|Lost to Follow-up|0|||
37892489|NCT01023308|69577831|FG000|Overall Study|Withdrawal by Subject|34|||
37892490|NCT01023308|69577832|FG001|Overall Study|Withdrawal by Subject|18|||
37892491|NCT01022996|69577838|FG000|Overall Study|Adverse Event|14|||
37892492|NCT01022996|69577838|FG000|Overall Study|Withdrawal by Subject|3|||
37892493|NCT01022996|69577838|FG000|Overall Study|Lost to Follow-up|1|||
37892494|NCT01022996|69577838|FG000|Overall Study|Administrative problems|6|||
37892495|NCT01022996|69577838|FG000|Overall Study|Disease Progression|32|||
37892496|NCT01022996|69577838|FG000|Overall Study|Protocol Violation|1|||
37892497|NCT00757237|69577844|FG000|Overall Study|Lost to Follow-up|0|||
37892498|NCT00757237|69577845|FG001|Overall Study|Lost to Follow-up|1|||
37892499|NCT00757237|69577844|FG000|Overall Study|Protocol Violation|0|||
37892500|NCT00757237|69577845|FG001|Overall Study|Protocol Violation|2|||
37892501|NCT00757237|69577844|FG000|Overall Study|Physician Decision|2|||
37892502|NCT00757237|69577845|FG001|Overall Study|Physician Decision|3|||
37892503|NCT00757237|69577844|FG000|Overall Study|Withdrawal by Subject|8|||
37892504|NCT00757237|69577845|FG001|Overall Study|Withdrawal by Subject|12|||
37892505|NCT00757237|69577844|FG000|Overall Study|Safety or Tolerability|3|||
37892506|NCT00757237|69577845|FG001|Overall Study|Safety or Tolerability|5|||
37892507|NCT00757237|69577844|FG000|Overall Study|Other|0|||
37892508|NCT00757237|69577845|FG001|Overall Study|Other|2|||
37892509|NCT01029392|69577853|FG000|Overall Study|Withdrawal by Subject|18|||
37892510|NCT01029392|69577854|FG001|Overall Study|Withdrawal by Subject|11|||
37892511|NCT01029392|69577853|FG000|Overall Study|Physician Decision|2|||
37892512|NCT01029392|69577854|FG001|Overall Study|Physician Decision|0|||
37989007|NCT00529373|69674172|FG000|Base Study|Physician Decision|60|||
37989008|NCT00529373|69674173|FG001|Base Study|Physician Decision|52|||
37989009|NCT00529373|69674172|FG000|Base Study|Protocol Violation|48|||
37989010|NCT00529373|69674173|FG001|Base Study|Protocol Violation|38|||
37989011|NCT00529373|69674172|FG000|Base Study|Withdrawal by Subject|1062|||
37989012|NCT00529373|69674173|FG001|Base Study|Withdrawal by Subject|967|||
37989013|NCT00529373|69674172|FG000|Base Study|Did not continue into Extension|1795|||
37989014|NCT00529373|69674173|FG001|Base Study|Did not continue into Extension|2238|||
37989015|NCT00529373|69674172|FG000|First Extension Study|Adverse Event|162|||
37989016|NCT00529373|69674173|FG001|First Extension Study|Adverse Event|142|||
37989017|NCT00529373|69674172|FG000|First Extension Study|Lack of Efficacy|65|||
37989018|NCT00529373|69674173|FG001|First Extension Study|Lack of Efficacy|427|||
37989019|NCT00529373|69674172|FG000|First Extension Study|Lost to Follow-up|41|||
37989020|NCT00529373|69674173|FG001|First Extension Study|Lost to Follow-up|37|||
37989021|NCT00529373|69674172|FG000|First Extension Study|Other|27|||
37989022|NCT00529373|69674173|FG001|First Extension Study|Other|47|||
37989023|NCT00529373|69674172|FG000|First Extension Study|Physician Decision|50|||
37989024|NCT00529373|69674173|FG001|First Extension Study|Physician Decision|45|||
37989025|NCT00529373|69674172|FG000|First Extension Study|Protocol Violation|16|||
37989026|NCT00529373|69674173|FG001|First Extension Study|Protocol Violation|13|||
37892513|NCT00903006|69577866|FG000|Overall Study|Withdrawal by Subject|2|||
37892514|NCT00903006|69577867|FG001|Overall Study|Withdrawal by Subject|0|||
37892515|NCT00903006|69577868|FG002|Overall Study|Withdrawal by Subject|0|||
37892516|NCT00903006|69577869|FG003|Overall Study|Withdrawal by Subject|0|||
37892517|NCT00903006|69577866|FG000|Overall Study|Progressive Disease|0|||
37892518|NCT00903006|69577867|FG001|Overall Study|Progressive Disease|3|||
37892519|NCT00903006|69577868|FG002|Overall Study|Progressive Disease|1|||
37892520|NCT00903006|69577869|FG003|Overall Study|Progressive Disease|0|||
37892521|NCT00839332|69577882|FG000|Phase 1|Disease Progression|38|||
37892522|NCT00839332|69577883|FG001|Phase 1|Disease Progression|0|||
37892523|NCT00839332|69577884|FG002|Phase 1|Disease Progression|0|||
37892524|NCT00839332|69577882|FG000|Phase 1|Adverse Event|6|||
37892525|NCT00839332|69577883|FG001|Phase 1|Adverse Event|0|||
37892526|NCT00839332|69577884|FG002|Phase 1|Adverse Event|0|||
37892527|NCT00839332|69577882|FG000|Phase 1|Withdrawal by Subject|4|||
37892528|NCT00839332|69577883|FG001|Phase 1|Withdrawal by Subject|0|||
37892529|NCT00839332|69577884|FG002|Phase 1|Withdrawal by Subject|0|||
37892530|NCT00839332|69577882|FG000|Phase 1|Physician Decision|2|||
37892531|NCT00839332|69577883|FG001|Phase 1|Physician Decision|0|||
37892532|NCT00839332|69577884|FG002|Phase 1|Physician Decision|0|||
37892533|NCT00839332|69577882|FG000|Phase 2|Protocol Violation|0|||
37892534|NCT00839332|69577883|FG001|Phase 2|Protocol Violation|1|||
37892535|NCT00839332|69577884|FG002|Phase 2|Protocol Violation|0|||
37892536|NCT00839332|69577882|FG000|Phase 2|Disease Progression|0|||
37989027|NCT00529373|69674172|FG000|First Extension Study|Withdrawal by Subject|296|||
37989028|NCT00529373|69674173|FG001|First Extension Study|Withdrawal by Subject|287|||
37989029|NCT00529373|69674172|FG000|First Extension Study|Disposition record non-existing|0|||
37989030|NCT00529373|69674173|FG001|First Extension Study|Disposition record non-existing|1|||
37989031|NCT00529373|69674172|FG000|First Extension Study|Discontinued after 5 years completion|208|||
37989032|NCT00529373|69674173|FG001|First Extension Study|Discontinued after 5 years completion|346|||
37989033|NCT00529373|69674172|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
37989034|NCT00529373|69674173|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
37824494|NCT03446573|69506582|FG001|Late Switch Phase (Week 148 to Week 196)|Adverse Event|9|||
37824495|NCT03446573|69506581|FG000|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
37824496|NCT03446573|69506582|FG001|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
37824497|NCT03446573|69506581|FG000|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|0|||
37989035|NCT00529373|69674172|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
37989036|NCT00529373|69674173|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
37989037|NCT00529373|69674172|FG000|Second Extension Study|Adverse Event|101|||
37989038|NCT00529373|69674173|FG001|Second Extension Study|Adverse Event|51|||
37989039|NCT00529373|69674172|FG000|Second Extension Study|Lack of Efficacy|7|||
37989040|NCT00529373|69674173|FG001|Second Extension Study|Lack of Efficacy|15|||
37989041|NCT00529373|69674172|FG000|Second Extension Study|Lost to Follow-up|18|||
37989042|NCT00529373|69674173|FG001|Second Extension Study|Lost to Follow-up|12|||
37824498|NCT03446573|69506582|FG001|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|1|||
37824499|NCT03446573|69506581|FG000|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|5|||
37824500|NCT03446573|69506582|FG001|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|6|||
37824501|NCT03446573|69506581|FG000|Late Switch Phase (Week 148 to Week 196)|Physician Decision|0|||
37824502|NCT03446573|69506582|FG001|Late Switch Phase (Week 148 to Week 196)|Physician Decision|1|||
37892537|NCT00839332|69577883|FG001|Phase 2|Disease Progression|46|||
37892538|NCT00839332|69577884|FG002|Phase 2|Disease Progression|21|||
37892539|NCT00839332|69577882|FG000|Phase 2|Adverse Event|0|||
37892540|NCT00839332|69577883|FG001|Phase 2|Adverse Event|8|||
37892541|NCT00839332|69577884|FG002|Phase 2|Adverse Event|6|||
37892542|NCT00839332|69577882|FG000|Phase 2|Death|0|||
37824503|NCT03446573|69506581|FG000|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|4|||
37824504|NCT03446573|69506582|FG001|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|6|||
37824505|NCT03422536|69506600|FG000|Randomized|Physician Decision|1|||
37824506|NCT03422536|69506601|FG001|Randomized|Physician Decision|1|||
37824507|NCT03422536|69506600|FG000|Allocation - Received Intervention|Disease progression|19|||
37824508|NCT03422536|69506601|FG001|Allocation - Received Intervention|Disease progression|25|||
37824509|NCT03422536|69506600|FG000|Allocation - Received Intervention|Death|1|||
37824510|NCT03422536|69506601|FG001|Allocation - Received Intervention|Death|3|||
37824511|NCT03422536|69506600|FG000|Allocation - Received Intervention|Adverse Event|1|||
37824512|NCT03422536|69506601|FG001|Allocation - Received Intervention|Adverse Event|0|||
37824513|NCT03422536|69506600|FG000|Allocation - Received Intervention|Physician Decision|1|||
37824514|NCT03422536|69506601|FG001|Allocation - Received Intervention|Physician Decision|1|||
37824515|NCT03422536|69506600|FG000|Allocation - Received Intervention|Withdrawal by Subject|3|||
37892543|NCT00839332|69577883|FG001|Phase 2|Death|4|||
37892544|NCT00839332|69577884|FG002|Phase 2|Death|2|||
37892545|NCT00839332|69577882|FG000|Phase 2|Withdrawal by Subject|0|||
37892546|NCT00839332|69577883|FG001|Phase 2|Withdrawal by Subject|5|||
37892547|NCT00839332|69577884|FG002|Phase 2|Withdrawal by Subject|8|||
37892548|NCT00839332|69577882|FG000|Phase 2|Physician Decision|0|||
37824516|NCT03422536|69506601|FG001|Allocation - Received Intervention|Withdrawal by Subject|2|||
37824517|NCT03422536|69506600|FG000|Allocation - Received Intervention|Lost to Follow-up|1|||
37824518|NCT03422536|69506601|FG001|Allocation - Received Intervention|Lost to Follow-up|0|||
37892549|NCT00839332|69577883|FG001|Phase 2|Physician Decision|4|||
37989043|NCT00529373|69674172|FG000|Second Extension Study|Other|7|||
37892550|NCT00839332|69577884|FG002|Phase 2|Physician Decision|1|||
37892551|NCT00839332|69577882|FG000|Phase 2|Lost to Follow-up|0|||
37892552|NCT00839332|69577883|FG001|Phase 2|Lost to Follow-up|0|||
37824519|NCT03228394|69506615|FG000|Overall Study|Lost to Follow-up|0|||
37892553|NCT00839332|69577884|FG002|Phase 2|Lost to Follow-up|1|||
37892554|NCT00902850|69577895|FG000|Overall Study|Physician Decision|2|||
37892555|NCT00902850|69577896|FG001|Overall Study|Physician Decision|2|||
37989044|NCT00529373|69674173|FG001|Second Extension Study|Other|12|||
37989045|NCT00529373|69674172|FG000|Second Extension Study|Physician Decision|63|||
37989046|NCT00529373|69674173|FG001|Second Extension Study|Physician Decision|26|||
37989047|NCT00529373|69674172|FG000|Second Extension Study|Protocol Violation|2|||
37989048|NCT00529373|69674173|FG001|Second Extension Study|Protocol Violation|1|||
37989049|NCT00529373|69674172|FG000|Second Extension Study|Withdrawal by Subject|97|||
37989050|NCT00529373|69674173|FG001|Second Extension Study|Withdrawal by Subject|75|||
37989051|NCT00529373|69674172|FG000|Second Extension Study|Status Missing|5|||
37989052|NCT00529373|69674173|FG001|Second Extension Study|Status Missing|5|||
37989053|NCT00369122|69674187|FG000|Overall Study|Ineligible|10|||
37989054|NCT00369122|69674187|FG000|Overall Study|No protocol treatment|1|||
37989055|NCT03687125|69674193|FG000|Overall Study|Progressive Disease|2|||
37989056|NCT03687125|69674194|FG001|Overall Study|Progressive Disease|1|||
37989057|NCT03687125|69674193|FG000|Overall Study|Protocol Violation|1|||
37989058|NCT03687125|69674194|FG001|Overall Study|Protocol Violation|0|||
37989059|NCT03872843|69674204|FG000|Overall Study|Lost to Follow-up|5|||
37989060|NCT03872843|69674205|FG001|Overall Study|Lost to Follow-up|7|||
37989061|NCT00146770|69674213|FG000|Overall Study|Adverse Event|2|||
37989062|NCT00146770|69674214|FG001|Overall Study|Adverse Event|0|||
37989063|NCT00146770|69674213|FG000|Overall Study|Pregnancy|1|||
37989064|NCT00146770|69674214|FG001|Overall Study|Pregnancy|0|||
37989065|NCT00146770|69674213|FG000|Overall Study|Withdrawal by Subject|2|||
37989066|NCT00146770|69674214|FG001|Overall Study|Withdrawal by Subject|0|||
37989067|NCT03874013|69674222|FG000|Overall Study|Adverse Event|0|||
37989068|NCT03874013|69674223|FG001|Overall Study|Adverse Event|1|||
37989069|NCT00168064|69674231|FG000|Overall Study|Adverse Event|26|||
37989070|NCT00168064|69674232|FG001|Overall Study|Adverse Event|22|||
37989071|NCT00168064|69674231|FG000|Overall Study|Withdrawal by Subject|3|||
37989072|NCT00168064|69674232|FG001|Overall Study|Withdrawal by Subject|4|||
37989073|NCT00168064|69674231|FG000|Overall Study|Lack of Efficacy|4|||
37989074|NCT00168064|69674232|FG001|Overall Study|Lack of Efficacy|4|||
37989075|NCT00168064|69674231|FG000|Overall Study|Lost to Follow-up|4|||
37989076|NCT00168064|69674232|FG001|Overall Study|Lost to Follow-up|3|||
37989077|NCT00168064|69674231|FG000|Overall Study|Non-compliance|2|||
37989078|NCT00168064|69674232|FG001|Overall Study|Non-compliance|3|||
37824520|NCT03228394|69506616|FG001|Overall Study|Lost to Follow-up|0|||
37824521|NCT03228394|69506617|FG002|Overall Study|Lost to Follow-up|1|||
37824522|NCT03228394|69506618|FG003|Overall Study|Lost to Follow-up|1|||
37824523|NCT03228394|69506619|FG004|Overall Study|Lost to Follow-up|0|||
37824524|NCT03228394|69506620|FG005|Overall Study|Lost to Follow-up|0|||
37824525|NCT03228394|69506621|FG006|Overall Study|Lost to Follow-up|2|||
37824526|NCT03228394|69506622|FG007|Overall Study|Lost to Follow-up|0|||
37824527|NCT03228394|69506615|FG000|Overall Study|Withdrawal by Subject|0|||
37824528|NCT03228394|69506616|FG001|Overall Study|Withdrawal by Subject|0|||
37824529|NCT03228394|69506617|FG002|Overall Study|Withdrawal by Subject|1|||
37824530|NCT03228394|69506618|FG003|Overall Study|Withdrawal by Subject|0|||
37824531|NCT03228394|69506619|FG004|Overall Study|Withdrawal by Subject|0|||
37824532|NCT03228394|69506620|FG005|Overall Study|Withdrawal by Subject|0|||
37824533|NCT03228394|69506621|FG006|Overall Study|Withdrawal by Subject|1|||
37824534|NCT03228394|69506622|FG007|Overall Study|Withdrawal by Subject|3|||
37824535|NCT03228394|69506615|FG000|Overall Study|Protocol Violation|0|||
37824536|NCT03228394|69506616|FG001|Overall Study|Protocol Violation|0|||
37824537|NCT03228394|69506617|FG002|Overall Study|Protocol Violation|0|||
37824538|NCT03228394|69506618|FG003|Overall Study|Protocol Violation|1|||
37824539|NCT03228394|69506619|FG004|Overall Study|Protocol Violation|0|||
37824540|NCT03228394|69506620|FG005|Overall Study|Protocol Violation|0|||
37824541|NCT03228394|69506621|FG006|Overall Study|Protocol Violation|0|||
37824542|NCT03228394|69506622|FG007|Overall Study|Protocol Violation|0|||
37892556|NCT00902538|69577905|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
37989079|NCT00168064|69674231|FG000|Overall Study|Concurrent Illness|4|||
37989080|NCT00168064|69674232|FG001|Overall Study|Concurrent Illness|3|||
37989081|NCT00168064|69674231|FG000|Overall Study|Subject's Best interest|2|||
37989082|NCT00168064|69674232|FG001|Overall Study|Subject's Best interest|2|||
37989083|NCT00168064|69674231|FG000|Overall Study|Various|4|||
37989084|NCT00168064|69674232|FG001|Overall Study|Various|3|||
37989085|NCT00166114|69674242|FG000|Overall Study|Protocol Violation|2|||
37892557|NCT00902538|69577906|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
37892558|NCT00902538|69577907|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
37892559|NCT00902538|69577908|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
37892560|NCT00902538|69577909|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
37892561|NCT00902538|69577910|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
37892562|NCT00902538|69577905|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
37892563|NCT00902538|69577906|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
37892564|NCT00902538|69577907|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
37892565|NCT00902538|69577908|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
37892566|NCT00902538|69577909|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
37892567|NCT00902538|69577910|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
37892568|NCT00902538|69577905|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
37892569|NCT00902538|69577906|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
37892570|NCT00902538|69577907|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
37892571|NCT00902538|69577908|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
37892572|NCT00902538|69577909|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
37892573|NCT00902538|69577910|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
37892574|NCT00902538|69577905|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
37892575|NCT00902538|69577906|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
37892576|NCT00902538|69577907|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
37892577|NCT00902538|69577908|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
37892578|NCT00902538|69577909|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
37892579|NCT00902538|69577910|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
37892580|NCT00902538|69577905|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
37892581|NCT00902538|69577906|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
37892582|NCT00902538|69577907|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
37892583|NCT00902538|69577908|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
37892584|NCT00902538|69577909|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
37892585|NCT00902538|69577910|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
37892586|NCT00902538|69577905|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
37892587|NCT00902538|69577906|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
37892588|NCT00902538|69577907|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
37892589|NCT00902538|69577908|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
37892590|NCT00902538|69577909|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
37892591|NCT00902538|69577910|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
37892592|NCT00902538|69577905|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
37892593|NCT00902538|69577906|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
37892594|NCT00902538|69577907|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
37892595|NCT00902538|69577908|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
37892596|NCT00902538|69577909|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
37892597|NCT00902538|69577910|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
37892598|NCT00902538|69577905|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
37892599|NCT00902538|69577906|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
37892600|NCT00902538|69577907|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
37892601|NCT00902538|69577908|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
37892602|NCT00902538|69577909|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
37892603|NCT00902538|69577910|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
37892604|NCT00902538|69577905|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
37892605|NCT00902538|69577906|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
37892606|NCT00902538|69577907|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
37892607|NCT00902538|69577908|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
37892608|NCT00902538|69577909|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
37892609|NCT00902538|69577910|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
37892610|NCT00902538|69577905|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
37892611|NCT00902538|69577906|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
37892612|NCT00902538|69577907|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
37892613|NCT00902538|69577908|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
37892614|NCT00902538|69577909|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
37989086|NCT00166114|69674243|FG001|Overall Study|Protocol Violation|1|||
37989087|NCT00166114|69674242|FG000|Overall Study|Withdrawal by Subject|10|||
37989088|NCT00166114|69674243|FG001|Overall Study|Withdrawal by Subject|4|||
37989089|NCT00166114|69674242|FG000|Overall Study|Adverse Event|2|||
37989090|NCT00166114|69674243|FG001|Overall Study|Adverse Event|1|||
37989091|NCT03686969|69674251|FG000|Overall Study|Study terminated|1|||
37989092|NCT03686969|69674252|FG001|Overall Study|Study terminated|0|||
37989093|NCT00145600|69674262|FG000|Overall Study|Death|1|||
37989094|NCT00145600|69674263|FG001|Overall Study|Death|2|||
37989095|NCT00145600|69674264|FG002|Overall Study|Death|2|||
37989096|NCT00145600|69674265|FG003|Overall Study|Death|6|||
37989097|NCT00145600|69674262|FG000|Overall Study|Ineligible|3|||
37989098|NCT00145600|69674263|FG001|Overall Study|Ineligible|0|||
37989099|NCT00145600|69674264|FG002|Overall Study|Ineligible|1|||
37989100|NCT00145600|69674265|FG003|Overall Study|Ineligible|5|||
37989101|NCT00145600|69674262|FG000|Overall Study|Lost to Follow-up|2|||
37989102|NCT00145600|69674263|FG001|Overall Study|Lost to Follow-up|6|||
37989103|NCT00145600|69674264|FG002|Overall Study|Lost to Follow-up|2|||
37989104|NCT00145600|69674265|FG003|Overall Study|Lost to Follow-up|4|||
37989105|NCT00145600|69674262|FG000|Overall Study|Noncompliance|1|||
37989106|NCT00145600|69674263|FG001|Overall Study|Noncompliance|0|||
37892615|NCT00902538|69577910|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
37892616|NCT00902538|69577905|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
37892617|NCT00902538|69577906|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
37892618|NCT00902538|69577907|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
37892619|NCT00902538|69577908|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
37892620|NCT00902538|69577909|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
37892621|NCT00902538|69577910|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
37892622|NCT00902538|69577905|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
37892623|NCT00902538|69577906|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
37892624|NCT00902538|69577907|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
37892625|NCT00902538|69577908|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
37892626|NCT00902538|69577909|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
37892627|NCT00902538|69577910|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
37892628|NCT00902538|69577905|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
37892629|NCT00902538|69577906|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
37892630|NCT00902538|69577907|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
37892631|NCT00902538|69577908|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
37892632|NCT00902538|69577909|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
37892633|NCT00902538|69577910|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
37892634|NCT00902538|69577905|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
37892635|NCT00902538|69577906|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
37892636|NCT00902538|69577907|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
37892637|NCT00902538|69577908|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
37892638|NCT00902538|69577909|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
37892639|NCT00902538|69577910|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
37892640|NCT00902538|69577905|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
37892641|NCT00902538|69577906|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
37892642|NCT00902538|69577907|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
37892643|NCT00902538|69577908|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
37892644|NCT00902538|69577909|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
37892645|NCT00902538|69577910|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
37892646|NCT00902538|69577905|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
37892647|NCT00902538|69577906|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
37892648|NCT00902538|69577907|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
37892649|NCT00902538|69577908|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
37892650|NCT00902538|69577909|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
37892651|NCT00902538|69577910|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
37892652|NCT00902538|69577905|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
37892653|NCT00902538|69577906|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
37892654|NCT00902538|69577907|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
37892655|NCT00902538|69577908|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
37892656|NCT00902538|69577909|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
37892657|NCT00902538|69577910|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
37892658|NCT01036022|69577932|FG000|Overall Study|Adverse Event|1|||
37989107|NCT00145600|69674264|FG002|Overall Study|Noncompliance|0|||
37989108|NCT00145600|69674265|FG003|Overall Study|Noncompliance|0|||
37892659|NCT01036022|69577933|FG001|Overall Study|Adverse Event|3|||
37989109|NCT00145600|69674262|FG000|Overall Study|Withdrawal by Subject|1|||
37989110|NCT00145600|69674263|FG001|Overall Study|Withdrawal by Subject|2|||
37989111|NCT00145600|69674264|FG002|Overall Study|Withdrawal by Subject|0|||
37989112|NCT00145600|69674265|FG003|Overall Study|Withdrawal by Subject|1|||
37989113|NCT00129376|69674289|FG000|Overall Study|Adverse Event|1|||
37892660|NCT01036022|69577934|FG002|Overall Study|Adverse Event|2|||
37892661|NCT01036022|69577935|FG003|Overall Study|Adverse Event|1|||
37892662|NCT01036022|69577936|FG004|Overall Study|Adverse Event|0|||
37892663|NCT01036022|69577937|FG005|Overall Study|Adverse Event|2|||
37892664|NCT01036022|69577932|FG000|Overall Study|Lack of Efficacy|1|||
37892665|NCT01036022|69577933|FG001|Overall Study|Lack of Efficacy|1|||
37892666|NCT01036022|69577934|FG002|Overall Study|Lack of Efficacy|1|||
37892667|NCT01036022|69577935|FG003|Overall Study|Lack of Efficacy|0|||
37892668|NCT01036022|69577936|FG004|Overall Study|Lack of Efficacy|1|||
37892669|NCT01036022|69577937|FG005|Overall Study|Lack of Efficacy|1|||
37892670|NCT01036022|69577932|FG000|Overall Study|Physician Decision|0|||
37892671|NCT01036022|69577933|FG001|Overall Study|Physician Decision|0|||
37892672|NCT01036022|69577934|FG002|Overall Study|Physician Decision|1|||
37892673|NCT01036022|69577935|FG003|Overall Study|Physician Decision|0|||
37892674|NCT01036022|69577936|FG004|Overall Study|Physician Decision|0|||
37892675|NCT01036022|69577937|FG005|Overall Study|Physician Decision|0|||
37892676|NCT01036022|69577932|FG000|Overall Study|Withdrawal by Subject|0|||
37892677|NCT01036022|69577933|FG001|Overall Study|Withdrawal by Subject|0|||
37892678|NCT01036022|69577934|FG002|Overall Study|Withdrawal by Subject|0|||
37892679|NCT01036022|69577935|FG003|Overall Study|Withdrawal by Subject|1|||
37892680|NCT01036022|69577936|FG004|Overall Study|Withdrawal by Subject|2|||
37892681|NCT01036022|69577937|FG005|Overall Study|Withdrawal by Subject|0|||
37892682|NCT00752557|69577962|FG000|Overall Study|Withdrawal by Subject|4|||
37892683|NCT00752557|69577963|FG001|Overall Study|Withdrawal by Subject|3|||
37892684|NCT00752557|69577964|FG002|Overall Study|Withdrawal by Subject|3|||
37892685|NCT00752557|69577962|FG000|Overall Study|Unspecified resaons|0|||
37892686|NCT00752557|69577963|FG001|Overall Study|Unspecified resaons|2|||
37892687|NCT00752557|69577964|FG002|Overall Study|Unspecified resaons|2|||
37892688|NCT00752557|69577962|FG000|Overall Study|Lost to Follow-up|1|||
37892689|NCT00752557|69577963|FG001|Overall Study|Lost to Follow-up|0|||
37892690|NCT00752557|69577964|FG002|Overall Study|Lost to Follow-up|1|||
37892691|NCT00747643|69577976|FG000|Overall Study|Withdrawal by Subject|36|||
37892692|NCT00747643|69577977|FG001|Overall Study|Withdrawal by Subject|27|||
37892693|NCT01022762|69577985|FG000|Overall Study|Adverse Event|3|||
37892694|NCT01022762|69577986|FG001|Overall Study|Adverse Event|1|||
37892695|NCT01022762|69577985|FG000|Overall Study|Lack of Efficacy|0|||
37892696|NCT01022762|69577986|FG001|Overall Study|Lack of Efficacy|1|||
37892697|NCT01022762|69577985|FG000|Overall Study|Protocol Violation|7|||
37892698|NCT01022762|69577986|FG001|Overall Study|Protocol Violation|6|||
37892699|NCT01022762|69577985|FG000|Overall Study|Unclassified|12|||
37892700|NCT01022762|69577986|FG001|Overall Study|Unclassified|20|||
37892701|NCT01028378|69577992|FG000|Overall Study|Lost to Follow-up|12|||
37892702|NCT01028378|69577992|FG000|Overall Study|Withdrawal by Subject|1|||
37892703|NCT01028378|69577992|FG000|Overall Study|Adminstrative Reasons|4|||
37892704|NCT00747565|69577998|FG000|Overall Study|Withdrawal by Subject|10|||
37892705|NCT00747565|69577999|FG001|Overall Study|Withdrawal by Subject|6|||
37892706|NCT00747565|69577998|FG000|Overall Study|Lost to Follow-up|4|||
37892707|NCT00747565|69577999|FG001|Overall Study|Lost to Follow-up|1|||
37892708|NCT01028300|69578005|FG000|Overall Study|Study Terminated|4|||
37892709|NCT00752089|69578009|FG000|Overall Study|Adverse Event|1|||
37892710|NCT00752089|69578009|FG000|Overall Study|Protocol Deviation|2|||
37892711|NCT00752089|69578009|FG000|Overall Study|Could not attend visit 9|1|||
37892712|NCT00752089|69578009|FG000|Overall Study|Not capable of wearing partial denture|1|||
37892713|NCT00752089|69578009|FG000|Overall Study|Cannot continue the study|1|||
37892714|NCT00751933|69578020|FG000|Overall Study|Withdrawal by Subject|0|||
37892715|NCT00751933|69578021|FG001|Overall Study|Withdrawal by Subject|1|||
37892716|NCT00751933|69578022|FG002|Overall Study|Withdrawal by Subject|0|||
37892717|NCT00751933|69578023|FG003|Overall Study|Withdrawal by Subject|0|||
37892718|NCT00751933|69578020|FG000|Overall Study|Physician Decision|0|||
37892719|NCT00751933|69578021|FG001|Overall Study|Physician Decision|0|||
37892720|NCT00751933|69578022|FG002|Overall Study|Physician Decision|1|||
37892721|NCT00751933|69578023|FG003|Overall Study|Physician Decision|1|||
37892722|NCT00751621|69578027|FG000|Overall Study|Adverse Event|1|||
37892723|NCT00751621|69578027|FG000|Overall Study|Withdrawal by Subject|1|||
37892724|NCT00751621|69578027|FG000|Overall Study|Subject moved to another country|1|||
37892725|NCT00751621|69578027|FG000|Overall Study|Poor adherence to asthma treatment|1|||
37892726|NCT01028222|69578035|FG000|Overall Study|Protocol deviation|1|||
37892727|NCT01028222|69578036|FG001|Overall Study|Protocol deviation|0|||
37892728|NCT01028222|69578035|FG000|Overall Study|Disease progression|33|||
37892729|NCT01028222|69578036|FG001|Overall Study|Disease progression|9|||
37892730|NCT01028222|69578035|FG000|Overall Study|Administrative problems|1|||
37892731|NCT01028222|69578036|FG001|Overall Study|Administrative problems|1|||
37892732|NCT01028222|69578035|FG000|Overall Study|Lost to Follow-up|0|||
37892733|NCT01028222|69578036|FG001|Overall Study|Lost to Follow-up|1|||
37892734|NCT01028222|69578035|FG000|Overall Study|Withdrawal by Subject|1|||
37892735|NCT01028222|69578036|FG001|Overall Study|Withdrawal by Subject|0|||
37892736|NCT01028222|69578035|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
37892737|NCT01028222|69578036|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
37892738|NCT01028222|69578035|FG000|Overall Study|Adverse Event|2|||
37892739|NCT01028222|69578036|FG001|Overall Study|Adverse Event|0|||
37892740|NCT00586495|69578043|FG000|Treatment Period|Adverse Event|11|||
37892741|NCT00586495|69578043|FG000|Treatment Period|Death|1|||
37892742|NCT00586495|69578043|FG000|Treatment Period|Protocol Violation|1|||
37892743|NCT00586495|69578043|FG000|Treatment Period|Withdrawal by Subject|1|||
37892744|NCT00586495|69578043|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
37892745|NCT00586495|69578043|FG000|Treatment Period|Switch to commercial drug|10|||
37892746|NCT00586495|69578043|FG000|Follow-up|Death|40|||
37892747|NCT00586495|69578043|FG000|Follow-up|Lost to Follow-up|1|||
37892748|NCT00586495|69578043|FG000|Follow-up|Withdrawal by Subject|4|||
37892749|NCT00586495|69578043|FG000|Follow-up|Protocol driven decision point|37|||
37892750|NCT00586495|69578043|FG000|Follow-up|Switch to commercial drug|10|||
37892751|NCT01027754|69578049|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
37892752|NCT01027754|69578050|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
37892753|NCT01027754|69578049|FG000|Overall Study|Withdrawal by Subject|0|||
37892754|NCT01027754|69578050|FG001|Overall Study|Withdrawal by Subject|5|||
37892755|NCT01034540|69578062|FG000|Overall Study|Adverse Event|0|||
37892756|NCT01034540|69578063|FG001|Overall Study|Adverse Event|1|||
37892757|NCT00774930|69578073|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
37892758|NCT00774930|69578074|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
37892759|NCT00774930|69578073|FG000|DB Phase|Adverse Event|1|||
37892760|NCT00774930|69578074|FG001|DB Phase|Adverse Event|2|||
37892761|NCT00774930|69578073|FG000|DB Phase|Subject Decision|1|||
37892762|NCT00774930|69578074|FG001|DB Phase|Subject Decision|5|||
37892763|NCT00774930|69578073|FG000|DB Phase|Sponsor Decision|0|||
37892764|NCT00774930|69578074|FG001|DB Phase|Sponsor Decision|1|||
37892765|NCT00774930|69578073|FG000|DB Phase|Disease Progression|1|||
37892766|NCT00774930|69578074|FG001|DB Phase|Disease Progression|1|||
37892767|NCT00774930|69578073|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
37892768|NCT00774930|69578074|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
37892769|NCT00774930|69578073|FG000|IOL Phase|Adverse Event|1|||
37892770|NCT00774930|69578074|FG001|IOL Phase|Adverse Event|1|||
37892771|NCT00774930|69578073|FG000|IOL Phase|Subject Decision|4|||
37892772|NCT00774930|69578074|FG001|IOL Phase|Subject Decision|3|||
37892773|NCT00774930|69578073|FG000|IOL Phase|Physician Decision|3|||
37892774|NCT00774930|69578074|FG001|IOL Phase|Physician Decision|2|||
37892775|NCT00774930|69578073|FG000|IOL Phase|Sponsor Decision|1|||
37892776|NCT00774930|69578074|FG001|IOL Phase|Sponsor Decision|0|||
37892777|NCT00774930|69578073|FG000|IOL Phase|Disease Progression|2|||
37892778|NCT00774930|69578074|FG001|IOL Phase|Disease Progression|1|||
37892779|NCT00774930|69578073|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
37892780|NCT00774930|69578074|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
37892781|NCT00774930|69578073|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
37892782|NCT00774930|69578074|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
37892783|NCT00774930|69578073|FG000|IOL Phase|Other|1|||
37892784|NCT00774930|69578074|FG001|IOL Phase|Other|0|||
37892785|NCT00774930|69578073|FG000|IOL Phase|Brain radiation|0|||
37892786|NCT00774930|69578074|FG001|IOL Phase|Brain radiation|1|||
37892787|NCT00774930|69578073|FG000|LTOLE Phase|Adverse Event|7|||
37892788|NCT00774930|69578074|FG001|LTOLE Phase|Adverse Event|3|||
37892789|NCT00774930|69578073|FG000|LTOLE Phase|Subject decision|0|||
37892790|NCT00774930|69578074|FG001|LTOLE Phase|Subject decision|5|||
37892791|NCT00774930|69578073|FG000|LTOLE Phase|Physician Decision|4|||
37892792|NCT00774930|69578074|FG001|LTOLE Phase|Physician Decision|1|||
37892793|NCT00774930|69578073|FG000|LTOLE Phase|Sponsor decision|2|||
37892794|NCT00774930|69578074|FG001|LTOLE Phase|Sponsor decision|1|||
37892795|NCT00774930|69578073|FG000|LTOLE Phase|Disease Progression|2|||
37696083|NCT02277691|69172264|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
37696084|NCT02395172|69172270|FG000|Overall Study|Participants randomized but not treated|3|||
37892796|NCT00774930|69578074|FG001|LTOLE Phase|Disease Progression|5|||
37892797|NCT00774930|69578073|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
37892798|NCT00774930|69578074|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
37892799|NCT00774930|69578073|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
37892800|NCT00774930|69578074|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
37892801|NCT01027364|69578095|FG000|Overall Study|Adverse Event|1|||
37892802|NCT01027364|69578096|FG001|Overall Study|Adverse Event|0|||
37892803|NCT01027364|69578097|FG002|Overall Study|Adverse Event|1|||
37892804|NCT01027364|69578098|FG003|Overall Study|Adverse Event|0|||
37892805|NCT01027364|69578095|FG000|Overall Study|Lost to Follow-up|1|||
37892806|NCT01027364|69578096|FG001|Overall Study|Lost to Follow-up|0|||
37892807|NCT01027364|69578097|FG002|Overall Study|Lost to Follow-up|0|||
37892808|NCT01027364|69578098|FG003|Overall Study|Lost to Follow-up|0|||
37892809|NCT01027364|69578095|FG000|Overall Study|Protocol Violation|1|||
37892810|NCT01027364|69578096|FG001|Overall Study|Protocol Violation|0|||
37892811|NCT01027364|69578097|FG002|Overall Study|Protocol Violation|0|||
37892812|NCT01027364|69578098|FG003|Overall Study|Protocol Violation|1|||
37892813|NCT01027364|69578095|FG000|Overall Study|Withdrawal by Subject|1|||
37892814|NCT01027364|69578096|FG001|Overall Study|Withdrawal by Subject|2|||
37892815|NCT01027364|69578097|FG002|Overall Study|Withdrawal by Subject|0|||
37892816|NCT01027364|69578098|FG003|Overall Study|Withdrawal by Subject|0|||
37892817|NCT01027286|69578126|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
37892818|NCT01027286|69578127|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
37892819|NCT01027286|69578126|FG000|Overall Study|Lost to Follow-up|0|||
37892820|NCT01027286|69578127|FG001|Overall Study|Lost to Follow-up|1|||
37892821|NCT01026974|69578137|FG000|Overall Study|Withdrawal by Subject|0|||
37892822|NCT01026974|69578138|FG001|Overall Study|Withdrawal by Subject|1|||
37892823|NCT01026974|69578139|FG002|Overall Study|Withdrawal by Subject|7|||
37892824|NCT01026974|69578140|FG003|Overall Study|Withdrawal by Subject|2|||
37892825|NCT01026974|69578137|FG000|Overall Study|Lost to Follow-up|1|||
37892826|NCT01026974|69578138|FG001|Overall Study|Lost to Follow-up|1|||
37892827|NCT01026974|69578139|FG002|Overall Study|Lost to Follow-up|4|||
37892828|NCT01026974|69578140|FG003|Overall Study|Lost to Follow-up|0|||
37892829|NCT01026974|69578137|FG000|Overall Study|Adverse Event|0|||
37892830|NCT01026974|69578138|FG001|Overall Study|Adverse Event|0|||
37892831|NCT01026974|69578139|FG002|Overall Study|Adverse Event|0|||
37892832|NCT01026974|69578140|FG003|Overall Study|Adverse Event|1|||
37892833|NCT01026974|69578137|FG000|Overall Study|Inappropriate enrollment|0|||
37892834|NCT01026974|69578138|FG001|Overall Study|Inappropriate enrollment|0|||
37892835|NCT01026974|69578139|FG002|Overall Study|Inappropriate enrollment|1|||
37892836|NCT01026974|69578140|FG003|Overall Study|Inappropriate enrollment|0|||
37892837|NCT00897390|69578155|FG000|Overall Study|Adverse Event|2|||
37892838|NCT00897390|69578155|FG000|Overall Study|No Longer Met Study Criteria|1|||
37892839|NCT00897390|69578155|FG000|Overall Study|Personal Reasons|1|||
37892840|NCT00897390|69578155|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
37892841|NCT01034462|69578168|FG000|Overall Study|Adverse Event|7|||
37892842|NCT01034462|69578169|FG001|Overall Study|Adverse Event|17|||
37892843|NCT01034462|69578168|FG000|Overall Study|Lack of Efficacy|4|||
37892844|NCT01034462|69578169|FG001|Overall Study|Lack of Efficacy|4|||
37892845|NCT01034462|69578168|FG000|Overall Study|Protocol Violation|10|||
37892846|NCT01034462|69578169|FG001|Overall Study|Protocol Violation|7|||
37989114|NCT00129376|69674289|FG000|Overall Study|Lack of Efficacy|1|||
37989115|NCT00129220|69674296|FG000|Study Period II|Adverse Event|9|||
37892847|NCT01034462|69578168|FG000|Overall Study|Withdrawal by Subject|9|||
37892848|NCT01034462|69578169|FG001|Overall Study|Withdrawal by Subject|8|||
37892849|NCT01034462|69578168|FG000|Overall Study|Lost to Follow-up|14|||
37892850|NCT01034462|69578169|FG001|Overall Study|Lost to Follow-up|16|||
37892851|NCT01034462|69578168|FG000|Overall Study|Other reasons|1|||
37892852|NCT01034462|69578169|FG001|Overall Study|Other reasons|2|||
37892853|NCT01033448|69578177|FG000|Overall Study|Withdrawal by Subject|4|||
37892854|NCT01033448|69578177|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
37892855|NCT01033448|69578177|FG000|Overall Study|Lost to Follow-up|3|||
37892856|NCT01033448|69578177|FG000|Overall Study|Withdrew due to other reasons|3|||
37892857|NCT01033448|69578177|FG000|Overall Study|Unknown disposition|1|||
37989116|NCT00129220|69674297|FG001|Study Period II|Adverse Event|5|||
37989117|NCT00129220|69674298|FG002|Study Period II|Adverse Event|7|||
37989118|NCT00129220|69674296|FG000|Study Period II|Lack of Efficacy|15|||
37989119|NCT00129220|69674297|FG001|Study Period II|Lack of Efficacy|1|||
37696085|NCT02395172|69172271|FG001|Overall Study|Participants randomized but not treated|31|||
37696086|NCT02276053|69172277|FG000|Overall Study|Death|2|||
37892858|NCT00746941|69578187|FG000|Overall Study|Death|2|||
37892859|NCT00746941|69578188|FG001|Overall Study|Death|0|||
37989120|NCT00129220|69674298|FG002|Study Period II|Lack of Efficacy|28|||
37696087|NCT02276053|69172277|FG000|Overall Study|Adverse Event|5|||
37696088|NCT02276053|69172277|FG000|Overall Study|Lack of Efficacy|2|||
37696089|NCT02276053|69172277|FG000|Overall Study|Withdrawal by Subject|1|||
37696090|NCT02276053|69172277|FG000|Overall Study|Patient does not meet selection criteria|3|||
37696091|NCT02276053|69172277|FG000|Overall Study|Patient needs to increase baseline AED|1|||
37696092|NCT02275819|69172284|FG000|Overall Study|Adverse Event|0|||
37696093|NCT02275819|69172285|FG001|Overall Study|Adverse Event|1|||
37696094|NCT02358044|69172293|FG000|Overall Study|Adverse Event|0|||
37696095|NCT02358044|69172294|FG001|Overall Study|Adverse Event|1|||
37696096|NCT02358044|69172293|FG000|Overall Study|Lost to Follow-up|2|||
37696097|NCT02358044|69172294|FG001|Overall Study|Lost to Follow-up|1|||
37696098|NCT02358044|69172293|FG000|Overall Study|Physician Decision|0|||
37696099|NCT02358044|69172294|FG001|Overall Study|Physician Decision|1|||
37696100|NCT02358044|69172293|FG000|Overall Study|Withdrawal by Subject|0|||
37892860|NCT00746941|69578189|FG002|Overall Study|Death|0|||
37892861|NCT00746941|69578190|FG003|Overall Study|Death|6|||
37892862|NCT00746941|69578187|FG000|Overall Study|Physician Decision|0|||
37892863|NCT00746941|69578188|FG001|Overall Study|Physician Decision|0|||
37892864|NCT00746941|69578189|FG002|Overall Study|Physician Decision|2|||
37892865|NCT00746941|69578190|FG003|Overall Study|Physician Decision|0|||
37892866|NCT00746941|69578187|FG000|Overall Study|Withdrawal by Subject|3|||
37892867|NCT00746941|69578188|FG001|Overall Study|Withdrawal by Subject|0|||
37892868|NCT00746941|69578189|FG002|Overall Study|Withdrawal by Subject|0|||
37892869|NCT00746941|69578190|FG003|Overall Study|Withdrawal by Subject|2|||
37892870|NCT00746941|69578187|FG000|Overall Study|Other, reason not provided|2|||
37892871|NCT00746941|69578188|FG001|Overall Study|Other, reason not provided|4|||
37892872|NCT00746941|69578189|FG002|Overall Study|Other, reason not provided|0|||
37892873|NCT00746941|69578190|FG003|Overall Study|Other, reason not provided|4|||
37892874|NCT00746941|69578187|FG000|Overall Study|Adverse Event|0|||
37892875|NCT00746941|69578188|FG001|Overall Study|Adverse Event|0|||
37892876|NCT00746941|69578189|FG002|Overall Study|Adverse Event|0|||
37892877|NCT00746941|69578190|FG003|Overall Study|Adverse Event|1|||
37892878|NCT00746785|69578202|FG000|Overall Study|Lost to Follow-up|29|||
37892879|NCT00746785|69578203|FG001|Overall Study|Lost to Follow-up|25|||
37892880|NCT00746785|69578204|FG002|Overall Study|Lost to Follow-up|27|||
37892881|NCT00750919|69578212|FG000|Overall Study|Adverse Event|9|||
37892882|NCT00750919|69578212|FG000|Overall Study|Withdrawal by Subject|1|||
37892883|NCT00750919|69578212|FG000|Overall Study|Lack of Efficacy|8|||
37892884|NCT00750919|69578212|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
37892885|NCT00750919|69578212|FG000|Overall Study|Other|36|||
37892886|NCT00746551|69578218|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
37892887|NCT00746551|69578219|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
37892888|NCT00746551|69578218|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
37892889|NCT00746551|69578219|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
37892890|NCT00746551|69578218|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
37892891|NCT00746551|69578219|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
37892892|NCT00753649|69578227|FG000|Overall Study|Migrated/moved from study area|1|||
37892893|NCT00753649|69578228|FG001|Overall Study|Migrated/moved from study area|0|||
37892894|NCT00753649|69578227|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
37892895|NCT00753649|69578228|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
37892896|NCT00753649|69578227|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
37892897|NCT00753649|69578228|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
37892898|NCT00753649|69578227|FG000|Overall Study|Protocol Violation|2|||
37892899|NCT00753649|69578228|FG001|Overall Study|Protocol Violation|0|||
37892900|NCT00750139|69578238|FG000|Overall Study|Adverse Event|1|||
37892901|NCT00750139|69578239|FG001|Overall Study|Adverse Event|2|||
37892902|NCT00750139|69578240|FG002|Overall Study|Adverse Event|0|||
37892903|NCT00750139|69578241|FG003|Overall Study|Adverse Event|1|||
37892904|NCT00750139|69578238|FG000|Overall Study|Lost to Follow-up|17|||
37892905|NCT00750139|69578239|FG001|Overall Study|Lost to Follow-up|12|||
37892906|NCT00750139|69578240|FG002|Overall Study|Lost to Follow-up|15|||
37892907|NCT00750139|69578241|FG003|Overall Study|Lost to Follow-up|6|||
37892908|NCT00750139|69578238|FG000|Overall Study|Withdrawal by Subject|3|||
37892909|NCT00750139|69578239|FG001|Overall Study|Withdrawal by Subject|2|||
37892910|NCT00750139|69578240|FG002|Overall Study|Withdrawal by Subject|6|||
37892911|NCT00750139|69578241|FG003|Overall Study|Withdrawal by Subject|2|||
37892912|NCT00750139|69578238|FG000|Overall Study|Physician Decision|1|||
37892913|NCT00750139|69578239|FG001|Overall Study|Physician Decision|1|||
37892914|NCT00750139|69578240|FG002|Overall Study|Physician Decision|0|||
37892915|NCT00750139|69578241|FG003|Overall Study|Physician Decision|0|||
37892916|NCT00750139|69578238|FG000|Overall Study|Non-compliance|1|||
37892917|NCT00750139|69578239|FG001|Overall Study|Non-compliance|0|||
37892918|NCT00750139|69578240|FG002|Overall Study|Non-compliance|1|||
37892919|NCT00750139|69578241|FG003|Overall Study|Non-compliance|3|||
37892920|NCT00750139|69578238|FG000|Overall Study|Termination by sponsor|4|||
37892921|NCT00750139|69578239|FG001|Overall Study|Termination by sponsor|0|||
37696101|NCT02358044|69172294|FG001|Overall Study|Withdrawal by Subject|4|||
37696102|NCT02275117|69172305|FG000|Overall Study|Adverse Event|0|||
37824543|NCT03228394|69506615|FG000|Overall Study|Physician Decision|0|||
37824544|NCT03228394|69506616|FG001|Overall Study|Physician Decision|0|||
37824545|NCT03228394|69506617|FG002|Overall Study|Physician Decision|0|||
37824546|NCT03228394|69506618|FG003|Overall Study|Physician Decision|0|||
37824547|NCT03228394|69506619|FG004|Overall Study|Physician Decision|0|||
37824548|NCT03228394|69506620|FG005|Overall Study|Physician Decision|0|||
37824549|NCT03228394|69506621|FG006|Overall Study|Physician Decision|1|||
37892922|NCT00750139|69578240|FG002|Overall Study|Termination by sponsor|0|||
37892923|NCT00750139|69578241|FG003|Overall Study|Termination by sponsor|1|||
37892924|NCT00750139|69578238|FG000|Overall Study|Non-specific|62|||
37892925|NCT00750139|69578239|FG001|Overall Study|Non-specific|42|||
37892926|NCT00750139|69578240|FG002|Overall Study|Non-specific|79|||
37892927|NCT00750139|69578241|FG003|Overall Study|Non-specific|33|||
37824550|NCT03228394|69506622|FG007|Overall Study|Physician Decision|0|||
37824551|NCT03228394|69506615|FG000|Overall Study|Noncompliance|0|||
37824552|NCT03228394|69506616|FG001|Overall Study|Noncompliance|0|||
37892928|NCT00750061|69578255|FG000|Overall Study|Adverse Event|2|||
37892929|NCT00750061|69578256|FG001|Overall Study|Adverse Event|0|||
37892930|NCT00750061|69578255|FG000|Overall Study|Withdrawal by Subject|0|||
37892931|NCT00750061|69578256|FG001|Overall Study|Withdrawal by Subject|1|||
37892932|NCT00750061|69578255|FG000|Overall Study|Physician Decision|0|||
37892933|NCT00750061|69578256|FG001|Overall Study|Physician Decision|1|||
37892934|NCT00744757|69578262|FG000|Overall Study|Objective disease progression|7|||
37892935|NCT00744757|69578262|FG000|Overall Study|Physician Decision|5|||
37892936|NCT00744757|69578262|FG000|Overall Study|Withdrawal by Subject|1|||
37892937|NCT00744757|69578262|FG000|Overall Study|Death|6|||
37892938|NCT00744757|69578262|FG000|Overall Study|Adverse Event|2|||
37892939|NCT00745849|69578266|FG000|First Intervention|Withdrawal by Subject|0|||
37892940|NCT00745849|69578267|FG001|First Intervention|Withdrawal by Subject|1|||
37892941|NCT00745849|69578266|FG000|First Intervention|Lost to Follow-up|1|||
37892942|NCT00745849|69578267|FG001|First Intervention|Lost to Follow-up|1|||
37892943|NCT00745849|69578266|FG000|Second Intervention|Lost to Follow-up|2|||
37892944|NCT00745849|69578267|FG001|Second Intervention|Lost to Follow-up|1|||
37892945|NCT00749203|69578284|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
37892946|NCT00749203|69578285|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
37892947|NCT00749203|69578284|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
37892948|NCT00749203|69578285|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
37892949|NCT00749203|69578284|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
37892950|NCT00749203|69578285|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
37892951|NCT00749203|69578284|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
37892952|NCT00749203|69578285|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
37892953|NCT00749203|69578284|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
37892954|NCT00749203|69578285|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
37892955|NCT00749203|69578284|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
37892956|NCT00749203|69578285|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
37892957|NCT00748969|69578293|FG000|Overall Study|Withdrawal by Subject|1|||
37892958|NCT00748969|69578294|FG001|Overall Study|Withdrawal by Subject|0|||
37892959|NCT00748969|69578293|FG000|Overall Study|Withdrawal by Subject|0|||
37892960|NCT00748969|69578294|FG001|Overall Study|Withdrawal by Subject|1|||
37892961|NCT00745615|69578304|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
37892962|NCT00745615|69578305|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
37892963|NCT00745615|69578306|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
37892964|NCT00745615|69578307|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
37892965|NCT00745615|69578308|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
37892966|NCT00745615|69578309|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
37892967|NCT00745615|69578304|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
37892968|NCT00745615|69578305|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
37892969|NCT00745615|69578306|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
37892970|NCT00745615|69578307|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
37892971|NCT00745615|69578308|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
37892972|NCT00745615|69578309|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
37892973|NCT00745615|69578304|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
37989121|NCT00129220|69674296|FG000|Study Period II|Entry Criteria Not Met|2|||
37989122|NCT00129220|69674297|FG001|Study Period II|Entry Criteria Not Met|0|||
37989123|NCT00129220|69674298|FG002|Study Period II|Entry Criteria Not Met|2|||
37696103|NCT02275117|69172306|FG001|Overall Study|Adverse Event|0|||
37696104|NCT02275117|69172307|FG002|Overall Study|Adverse Event|0|||
37696105|NCT02275117|69172308|FG003|Overall Study|Adverse Event|0|||
37696106|NCT02275117|69172309|FG004|Overall Study|Adverse Event|1|||
37696107|NCT02275117|69172305|FG000|Overall Study|Lack of Efficacy|6|||
37696108|NCT02275117|69172306|FG001|Overall Study|Lack of Efficacy|7|||
37824553|NCT03228394|69506617|FG002|Overall Study|Noncompliance|0|||
37824554|NCT03228394|69506618|FG003|Overall Study|Noncompliance|0|||
37824555|NCT03228394|69506619|FG004|Overall Study|Noncompliance|0|||
37824556|NCT03228394|69506620|FG005|Overall Study|Noncompliance|0|||
37824557|NCT03228394|69506621|FG006|Overall Study|Noncompliance|1|||
37824558|NCT03228394|69506622|FG007|Overall Study|Noncompliance|0|||
37824559|NCT03008070|69506644|FG000|Overall Study|Adverse Event|3|||
37824560|NCT03008070|69506645|FG001|Overall Study|Adverse Event|3|||
37892974|NCT00745615|69578305|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
37696109|NCT02275117|69172307|FG002|Overall Study|Lack of Efficacy|5|||
37696110|NCT02275117|69172308|FG003|Overall Study|Lack of Efficacy|2|||
37696111|NCT02275117|69172309|FG004|Overall Study|Lack of Efficacy|10|||
37696112|NCT02275117|69172305|FG000|Overall Study|Lost to Follow-up|11|||
37696113|NCT02275117|69172306|FG001|Overall Study|Lost to Follow-up|16|||
37696114|NCT02275117|69172307|FG002|Overall Study|Lost to Follow-up|15|||
37696115|NCT02275117|69172308|FG003|Overall Study|Lost to Follow-up|16|||
37696116|NCT02275117|69172309|FG004|Overall Study|Lost to Follow-up|8|||
37696117|NCT02275117|69172305|FG000|Overall Study|Physician Decision|0|||
37696118|NCT02275117|69172306|FG001|Overall Study|Physician Decision|1|||
37696119|NCT02275117|69172307|FG002|Overall Study|Physician Decision|1|||
37696120|NCT02275117|69172308|FG003|Overall Study|Physician Decision|0|||
37824561|NCT03008070|69506646|FG002|Overall Study|Adverse Event|3|||
37696121|NCT02275117|69172309|FG004|Overall Study|Physician Decision|1|||
37824562|NCT03008070|69506644|FG000|Overall Study|Lost to Follow-up|1|||
37824563|NCT03008070|69506645|FG001|Overall Study|Lost to Follow-up|1|||
37824564|NCT03008070|69506646|FG002|Overall Study|Lost to Follow-up|0|||
37824565|NCT03008070|69506644|FG000|Overall Study|Non compliance|0|||
37824566|NCT03008070|69506645|FG001|Overall Study|Non compliance|1|||
37824567|NCT03008070|69506646|FG002|Overall Study|Non compliance|1|||
37892975|NCT00745615|69578306|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
37892976|NCT00745615|69578307|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
37892977|NCT00745615|69578308|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
37892978|NCT00745615|69578309|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
37892979|NCT00745615|69578304|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
37892980|NCT00745615|69578305|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
37892981|NCT00745615|69578306|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
37892982|NCT00745615|69578307|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
37892983|NCT00745615|69578308|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
37989124|NCT00129220|69674296|FG000|Study Period II|Protocol Violation|4|||
37989125|NCT00129220|69674297|FG001|Study Period II|Protocol Violation|2|||
37892984|NCT00745615|69578309|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
37892985|NCT00745615|69578304|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
37892986|NCT00745615|69578305|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
37892987|NCT00745615|69578306|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
37892988|NCT00745615|69578307|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
37892989|NCT00745615|69578308|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
37892990|NCT00745615|69578309|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
37892991|NCT00745615|69578304|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
37892992|NCT00745615|69578305|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
37989126|NCT00129220|69674298|FG002|Study Period II|Protocol Violation|1|||
37989127|NCT00129220|69674296|FG000|Study Period II|Physician Decision|0|||
37989128|NCT00129220|69674297|FG001|Study Period II|Physician Decision|1|||
37989129|NCT00129220|69674298|FG002|Study Period II|Physician Decision|0|||
37989130|NCT00129220|69674296|FG000|Study Period II|Withdrawal by Subject|1|||
37989131|NCT00129220|69674297|FG001|Study Period II|Withdrawal by Subject|3|||
37989132|NCT00129220|69674298|FG002|Study Period II|Withdrawal by Subject|4|||
37989133|NCT00129220|69674296|FG000|Study Period II|Reason Not Specified|2|||
37989134|NCT00129220|69674297|FG001|Study Period II|Reason Not Specified|0|||
37989135|NCT00129220|69674298|FG002|Study Period II|Reason Not Specified|5|||
37989136|NCT00129220|69674296|FG000|Study Period III|Adverse Event|1|||
37989137|NCT00129220|69674297|FG001|Study Period III|Adverse Event|0|||
37989138|NCT00129220|69674298|FG002|Study Period III|Adverse Event|3|||
37989139|NCT00129220|69674296|FG000|Study Period III|Protocol Violation|1|||
37989140|NCT00129220|69674297|FG001|Study Period III|Protocol Violation|1|||
37989141|NCT00129220|69674298|FG002|Study Period III|Protocol Violation|2|||
37989142|NCT00129220|69674296|FG000|Study Period III|Withdrawal by Subject|1|||
37989143|NCT00129220|69674297|FG001|Study Period III|Withdrawal by Subject|0|||
37989144|NCT00129220|69674298|FG002|Study Period III|Withdrawal by Subject|3|||
37989145|NCT00129220|69674296|FG000|Study Period III|Sponsor Decision|1|||
37989146|NCT00129220|69674297|FG001|Study Period III|Sponsor Decision|0|||
37989147|NCT00129220|69674298|FG002|Study Period III|Sponsor Decision|0|||
37989148|NCT00129220|69674296|FG000|Study Period III|Reason Not Specified|9|||
37989149|NCT00129220|69674297|FG001|Study Period III|Reason Not Specified|0|||
37989150|NCT00129220|69674298|FG002|Study Period III|Reason Not Specified|2|||
37989151|NCT00128830|69674318|FG000|Overall Study|Adverse Event|10|||
37989152|NCT00128830|69674318|FG000|Overall Study|Withdrawal by Subject|14|||
37989153|NCT00128830|69674318|FG000|Overall Study|Lost to Follow-up|4|||
37989154|NCT00128830|69674318|FG000|Overall Study|Reached a virologic endpoint|29|||
37989155|NCT00128830|69674318|FG000|Overall Study|Non-compliant|4|||
37989156|NCT00128830|69674318|FG000|Overall Study|Discontinued or ineligible for study|2|||
37989157|NCT00128830|69674318|FG000|Overall Study|Other|9|||
37824568|NCT03008070|69506644|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
37824569|NCT03008070|69506645|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
37824570|NCT03008070|69506646|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
37824571|NCT03008070|69506644|FG000|Overall Study|Withdrawal by Subject|2|||
37824572|NCT03008070|69506645|FG001|Overall Study|Withdrawal by Subject|0|||
37824573|NCT03008070|69506646|FG002|Overall Study|Withdrawal by Subject|1|||
37824574|NCT03008070|69506644|FG000|Overall Study|Use of prohibited drug|0|||
37824575|NCT03008070|69506645|FG001|Overall Study|Use of prohibited drug|0|||
37824576|NCT03008070|69506646|FG002|Overall Study|Use of prohibited drug|2|||
37824577|NCT02979353|69506658|FG000|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|24|||
37989158|NCT03686033|69674324|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
37989159|NCT03686033|69674325|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
37989160|NCT03686033|69674326|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
37989161|NCT03686033|69674327|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
37989162|NCT03686033|69674328|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
37989163|NCT03686033|69674329|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
37989164|NCT00128206|69674345|FG000|Overall Study|Lost to Follow-up|137|||
37989165|NCT00128206|69674346|FG001|Overall Study|Lost to Follow-up|118|||
37989166|NCT00128206|69674345|FG000|Overall Study|Adverse Event|0|||
37989167|NCT00128206|69674346|FG001|Overall Study|Adverse Event|2|||
37989168|NCT03685643|69674354|FG000|Overall Study|Lost to Follow-up|14|||
37989169|NCT03685643|69674355|FG001|Overall Study|Lost to Follow-up|22|||
37989170|NCT03823378|69674367|FG000|Overall Study|Adverse Event|2|||
37989171|NCT03823378|69674368|FG001|Overall Study|Adverse Event|2|||
37989172|NCT03823378|69674369|FG002|Overall Study|Adverse Event|0|||
37989173|NCT03823378|69674370|FG003|Overall Study|Adverse Event|0|||
37989174|NCT03823378|69674371|FG004|Overall Study|Adverse Event|0|||
37989175|NCT03823378|69674372|FG005|Overall Study|Adverse Event|0|||
37989176|NCT03823378|69674367|FG000|Overall Study|Lost to Follow-up|0|||
37989177|NCT03823378|69674368|FG001|Overall Study|Lost to Follow-up|1|||
37989178|NCT03823378|69674369|FG002|Overall Study|Lost to Follow-up|0|||
37989179|NCT03823378|69674370|FG003|Overall Study|Lost to Follow-up|0|||
37892993|NCT00745615|69578306|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
37892994|NCT00745615|69578307|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
37892995|NCT00745615|69578308|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
37892996|NCT00745615|69578309|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
37892997|NCT00745615|69578304|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
37892998|NCT00745615|69578305|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
37892999|NCT00745615|69578306|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
37893000|NCT00745615|69578307|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
37893001|NCT00745615|69578308|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
37893002|NCT00745615|69578309|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
37893003|NCT00745615|69578304|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
37893004|NCT00745615|69578305|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
37893005|NCT00745615|69578306|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
37893006|NCT00745615|69578307|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
37893007|NCT00745615|69578308|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
37893008|NCT00745615|69578309|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
37893009|NCT00745615|69578304|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
37893010|NCT00745615|69578305|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
37893011|NCT00745615|69578306|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
37893012|NCT00745615|69578307|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
37893013|NCT00745615|69578308|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
37893014|NCT00745615|69578309|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
37893015|NCT00745615|69578304|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
37893016|NCT00745615|69578305|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
37893017|NCT00745615|69578306|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
37893018|NCT00745615|69578307|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
37893019|NCT00745615|69578308|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
37989180|NCT03823378|69674371|FG004|Overall Study|Lost to Follow-up|1|||
37989181|NCT03823378|69674372|FG005|Overall Study|Lost to Follow-up|0|||
37824578|NCT02979353|69506659|FG001|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|29|||
37824579|NCT02979353|69506658|FG000|Overall Study|Withdrawal by Subject|16|||
37824580|NCT02979353|69506659|FG001|Overall Study|Withdrawal by Subject|12|||
37824581|NCT02979353|69506658|FG000|Overall Study|Death|10|||
37824582|NCT02979353|69506659|FG001|Overall Study|Death|11|||
37824583|NCT02979353|69506658|FG000|Overall Study|Transfer to Hospice Care|19|||
37824584|NCT02979353|69506659|FG001|Overall Study|Transfer to Hospice Care|14|||
37824585|NCT02979353|69506658|FG000|Overall Study|Lost to Follow-up|1|||
37824586|NCT02979353|69506659|FG001|Overall Study|Lost to Follow-up|5|||
37824587|NCT02633397|69506678|FG000|Overall Study|Adverse Event|8|||
37824588|NCT02633397|69506679|FG001|Overall Study|Adverse Event|8|||
37824589|NCT02633397|69506678|FG000|Overall Study|Study Burden|4|||
37824590|NCT02633397|69506679|FG001|Overall Study|Study Burden|1|||
37824591|NCT02633397|69506678|FG000|Overall Study|Treatment interruption|2|||
37824592|NCT02633397|69506679|FG001|Overall Study|Treatment interruption|5|||
37824593|NCT02633397|69506678|FG000|Overall Study|Death|2|||
37824594|NCT02633397|69506679|FG001|Overall Study|Death|2|||
37824595|NCT02633397|69506678|FG000|Overall Study|Physician Decision|0|||
37824596|NCT02633397|69506679|FG001|Overall Study|Physician Decision|1|||
37893020|NCT00745615|69578309|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
37989182|NCT03823378|69674367|FG000|Overall Study|Withdrawal by Subject|0|||
37989183|NCT03823378|69674368|FG001|Overall Study|Withdrawal by Subject|1|||
37824597|NCT02592707|69506689|FG000|Overall Study|Consent Withdrawn|0|||
37893021|NCT00745615|69578304|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
37989184|NCT03823378|69674369|FG002|Overall Study|Withdrawal by Subject|4|||
37989185|NCT03823378|69674370|FG003|Overall Study|Withdrawal by Subject|2|||
37989186|NCT03823378|69674371|FG004|Overall Study|Withdrawal by Subject|0|||
37989187|NCT03823378|69674372|FG005|Overall Study|Withdrawal by Subject|1|||
37989188|NCT03823378|69674367|FG000|Overall Study|Other, not specified|19|||
37989189|NCT03823378|69674368|FG001|Overall Study|Other, not specified|12|||
37989190|NCT03823378|69674369|FG002|Overall Study|Other, not specified|6|||
37989191|NCT03823378|69674370|FG003|Overall Study|Other, not specified|8|||
37989192|NCT03823378|69674371|FG004|Overall Study|Other, not specified|17|||
37989193|NCT03823378|69674372|FG005|Overall Study|Other, not specified|7|||
37989194|NCT00142792|69674389|FG000|Overall Study|Death|0|||
37989195|NCT00142792|69674390|FG001|Overall Study|Death|0|||
37989196|NCT00142792|69674391|FG002|Overall Study|Death|1|||
37989197|NCT00142792|69674389|FG000|Overall Study|Withdrawal by Subject|3|||
37989198|NCT00142792|69674390|FG001|Overall Study|Withdrawal by Subject|2|||
37989199|NCT00142792|69674391|FG002|Overall Study|Withdrawal by Subject|3|||
37989200|NCT00142792|69674389|FG000|Overall Study|Lost to Follow-up|8|||
37989201|NCT00142792|69674390|FG001|Overall Study|Lost to Follow-up|11|||
37989202|NCT00142792|69674391|FG002|Overall Study|Lost to Follow-up|7|||
37989203|NCT00142792|69674389|FG000|Overall Study|No category|1|||
37989204|NCT00142792|69674390|FG001|Overall Study|No category|2|||
37989205|NCT00142792|69674391|FG002|Overall Study|No category|1|||
37989206|NCT00141778|69674402|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
37989207|NCT00141778|69674403|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
37989208|NCT00141778|69674404|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
37989209|NCT00141778|69674402|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
37989210|NCT00141778|69674403|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
37989211|NCT00141778|69674404|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
37989212|NCT00141778|69674402|FG000|Started Study Medication|Withdrawal by Subject|0|||
37989213|NCT00141778|69674403|FG001|Started Study Medication|Withdrawal by Subject|2|||
37989214|NCT00141778|69674404|FG002|Started Study Medication|Withdrawal by Subject|0|||
37989215|NCT00141778|69674402|FG000|Started Study Medication|Difficulty Swallowing|0|||
37893022|NCT00745615|69578305|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
37893023|NCT00745615|69578306|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
37989216|NCT00141778|69674403|FG001|Started Study Medication|Difficulty Swallowing|1|||
37989217|NCT00141778|69674404|FG002|Started Study Medication|Difficulty Swallowing|0|||
37989218|NCT00141778|69674402|FG000|Started Study Medication|Chest Discomfort|0|||
37989219|NCT00141778|69674403|FG001|Started Study Medication|Chest Discomfort|0|||
37989220|NCT00141778|69674404|FG002|Started Study Medication|Chest Discomfort|1|||
37989221|NCT00127660|69674416|FG000|Overall Study|Protocol Violation|3|||
37989222|NCT00127660|69674417|FG001|Overall Study|Protocol Violation|3|||
37989223|NCT00127660|69674418|FG002|Overall Study|Protocol Violation|5|||
37989224|NCT00127660|69674419|FG003|Overall Study|Protocol Violation|0|||
37989225|NCT03817528|69674429|FG000|Overall Study|Withdrawal by Subject|1|||
37989226|NCT03817528|69674429|FG000|Overall Study|Adverse Event|2|||
37989227|NCT00115336|69674435|FG000|Overall Study|Hospital discharge before study drug|0|||
37989228|NCT00115336|69674436|FG001|Overall Study|Hospital discharge before study drug|1|||
37989229|NCT00205803|69674446|FG000|Infant Series|Lost to Follow-up|10|||
37989230|NCT00205803|69674447|FG001|Infant Series|Lost to Follow-up|4|||
37989231|NCT00205803|69674446|FG000|Infant Series|Withdrawal by Subject|2|||
37989232|NCT00205803|69674447|FG001|Infant Series|Withdrawal by Subject|5|||
37989233|NCT00205803|69674446|FG000|Infant Series|Physician Decision|3|||
37989234|NCT00205803|69674447|FG001|Infant Series|Physician Decision|1|||
37989235|NCT00205803|69674446|FG000|Infant Series|Protocol Violation|1|||
37989236|NCT00205803|69674447|FG001|Infant Series|Protocol Violation|0|||
37989237|NCT00205803|69674446|FG000|Infant Series|Lost Kaiser coverage|0|||
37989238|NCT00205803|69674447|FG001|Infant Series|Lost Kaiser coverage|1|||
37989239|NCT00205803|69674446|FG000|Infant Series|Non-compliant|1|||
37989240|NCT00205803|69674447|FG001|Infant Series|Non-compliant|0|||
37989241|NCT00205803|69674446|FG000|Infant Series|Sponsor request|1|||
37989242|NCT00205803|69674447|FG001|Infant Series|Sponsor request|0|||
37989243|NCT00205803|69674446|FG000|After Infant Series|Adverse Event|1|||
37824598|NCT02592707|69506690|FG001|Overall Study|Consent Withdrawn|1|||
37824599|NCT02592707|69506691|FG002|Overall Study|Consent Withdrawn|2|||
37824600|NCT02592707|69506692|FG003|Overall Study|Consent Withdrawn|0|||
37824601|NCT02592707|69506689|FG000|Overall Study|Death|1|||
37824602|NCT02592707|69506690|FG001|Overall Study|Death|0|||
37824603|NCT02592707|69506691|FG002|Overall Study|Death|0|||
37824604|NCT02592707|69506692|FG003|Overall Study|Death|0|||
37824605|NCT02592707|69506689|FG000|Overall Study|Progressive Disease|4|||
37989244|NCT00205803|69674447|FG001|After Infant Series|Adverse Event|1|||
37989245|NCT00205803|69674446|FG000|After Infant Series|Protocol Violation|1|||
37824606|NCT02592707|69506690|FG001|Overall Study|Progressive Disease|4|||
37989246|NCT00205803|69674447|FG001|After Infant Series|Protocol Violation|1|||
37989247|NCT00205803|69674446|FG000|After Infant Series|Lost to Follow-up|2|||
37989248|NCT00205803|69674447|FG001|After Infant Series|Lost to Follow-up|1|||
37989249|NCT00205803|69674446|FG000|After Infant Series|Physician Decision|3|||
37989250|NCT00205803|69674447|FG001|After Infant Series|Physician Decision|2|||
37989251|NCT00205803|69674446|FG000|After Infant Series|Withdrawal by Subject|1|||
37893024|NCT00745615|69578307|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
37893025|NCT00745615|69578308|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
37893026|NCT00745615|69578309|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
37893027|NCT00745615|69578304|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
37893028|NCT00745615|69578305|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
37893029|NCT00745615|69578306|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
37893030|NCT00745615|69578307|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
37893031|NCT00745615|69578308|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
37893032|NCT00745615|69578309|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
37893033|NCT00745615|69578304|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
37893034|NCT00745615|69578305|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
37893035|NCT00745615|69578306|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
37893036|NCT00745615|69578307|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
37893037|NCT00745615|69578308|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
37893038|NCT00745615|69578309|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
37893039|NCT00745615|69578304|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
37893040|NCT00745615|69578305|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
37893041|NCT00745615|69578306|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
37893042|NCT00745615|69578307|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
37893043|NCT00745615|69578308|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
37893044|NCT00745615|69578309|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
37893045|NCT00744523|69578323|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
37893046|NCT00744523|69578324|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
37893047|NCT04517253|69578335|FG000|Overall Study|Adverse Event|1|||
37893048|NCT04517253|69578336|FG001|Overall Study|Adverse Event|0|||
37893049|NCT04517253|69578337|FG002|Overall Study|Adverse Event|0|||
37893050|NCT04517253|69578335|FG000|Overall Study|Death|0|||
37893051|NCT04517253|69578336|FG001|Overall Study|Death|1|||
37989252|NCT00205803|69674447|FG001|After Infant Series|Withdrawal by Subject|4|||
37989253|NCT00205803|69674446|FG000|After Infant Series|Other|10|||
37989254|NCT00205803|69674447|FG001|After Infant Series|Other|4|||
37989255|NCT00205803|69674446|FG000|Toddler Dose|Lost to Follow-up|2|||
37989256|NCT00205803|69674447|FG001|Toddler Dose|Lost to Follow-up|3|||
37989257|NCT00127192|69674476|FG000|Overall Study|Adverse Event|0|||
37893052|NCT04517253|69578337|FG002|Overall Study|Death|0|||
37893053|NCT00744991|69578347|FG000|Overall Study|Progressive Disease|11|||
37989258|NCT00127192|69674477|FG001|Overall Study|Adverse Event|1|||
37989259|NCT00127192|69674478|FG002|Overall Study|Adverse Event|1|||
37989260|NCT00127192|69674479|FG003|Overall Study|Adverse Event|1|||
37989261|NCT00127192|69674480|FG004|Overall Study|Adverse Event|0|||
37989262|NCT00127192|69674476|FG000|Overall Study|Lack of Efficacy|2|||
37989263|NCT00127192|69674477|FG001|Overall Study|Lack of Efficacy|0|||
37989264|NCT00127192|69674478|FG002|Overall Study|Lack of Efficacy|0|||
37893054|NCT00744991|69578347|FG000|Overall Study|Withdrawal by Subject|8|||
37893055|NCT00744991|69578347|FG000|Overall Study|Physician Decision|3|||
37893056|NCT00744991|69578347|FG000|Overall Study|Adverse Event|2|||
37893057|NCT00744991|69578347|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
37893058|NCT00839254|69578371|FG000|Overall Study|Protocol Violation|0|||
37893059|NCT00839254|69578372|FG001|Overall Study|Protocol Violation|1|||
37893060|NCT00839254|69578373|FG002|Overall Study|Protocol Violation|1|||
37893061|NCT00839254|69578374|FG003|Overall Study|Protocol Violation|1|||
37893062|NCT00839254|69578375|FG004|Overall Study|Protocol Violation|0|||
37893063|NCT00839254|69578376|FG005|Overall Study|Protocol Violation|0|||
37893064|NCT00839254|69578377|FG006|Overall Study|Protocol Violation|1|||
37893065|NCT00839254|69578378|FG007|Overall Study|Protocol Violation|2|||
37893066|NCT00839254|69578371|FG000|Overall Study|Physician Decision|0|||
37893067|NCT00839254|69578372|FG001|Overall Study|Physician Decision|1|||
37893068|NCT00839254|69578373|FG002|Overall Study|Physician Decision|0|||
37893069|NCT00839254|69578374|FG003|Overall Study|Physician Decision|0|||
37989265|NCT00127192|69674479|FG003|Overall Study|Lack of Efficacy|0|||
37989266|NCT00127192|69674480|FG004|Overall Study|Lack of Efficacy|2|||
37989267|NCT00127192|69674476|FG000|Overall Study|Withdrawal by Subject|0|||
37989268|NCT00127192|69674477|FG001|Overall Study|Withdrawal by Subject|0|||
37893070|NCT00839254|69578375|FG004|Overall Study|Physician Decision|0|||
37893071|NCT00839254|69578376|FG005|Overall Study|Physician Decision|0|||
37989269|NCT00127192|69674478|FG002|Overall Study|Withdrawal by Subject|1|||
37989270|NCT00127192|69674479|FG003|Overall Study|Withdrawal by Subject|0|||
37893072|NCT00839254|69578377|FG006|Overall Study|Physician Decision|0|||
37893073|NCT00839254|69578378|FG007|Overall Study|Physician Decision|1|||
37893074|NCT00839254|69578371|FG000|Overall Study|Wrong treatment number allocation|0|||
37989271|NCT00127192|69674480|FG004|Overall Study|Withdrawal by Subject|3|||
37893075|NCT00839254|69578372|FG001|Overall Study|Wrong treatment number allocation|1|||
37989272|NCT00127192|69674476|FG000|Overall Study|Adverse event in pre-treatment period|1|||
37989273|NCT00127192|69674477|FG001|Overall Study|Adverse event in pre-treatment period|0|||
37989274|NCT00127192|69674478|FG002|Overall Study|Adverse event in pre-treatment period|0|||
37893076|NCT00839254|69578373|FG002|Overall Study|Wrong treatment number allocation|0|||
37893077|NCT00839254|69578374|FG003|Overall Study|Wrong treatment number allocation|0|||
37893078|NCT00839254|69578375|FG004|Overall Study|Wrong treatment number allocation|0|||
37893079|NCT00839254|69578376|FG005|Overall Study|Wrong treatment number allocation|1|||
37893080|NCT00839254|69578377|FG006|Overall Study|Wrong treatment number allocation|0|||
37893081|NCT00839254|69578378|FG007|Overall Study|Wrong treatment number allocation|0|||
37893082|NCT00839254|69578371|FG000|Overall Study|Adverse Event|12|||
37893083|NCT00839254|69578372|FG001|Overall Study|Adverse Event|6|||
37893084|NCT00839254|69578373|FG002|Overall Study|Adverse Event|3|||
37893085|NCT00839254|69578374|FG003|Overall Study|Adverse Event|5|||
37893086|NCT00839254|69578375|FG004|Overall Study|Adverse Event|2|||
37893087|NCT00839254|69578376|FG005|Overall Study|Adverse Event|1|||
37893088|NCT00839254|69578377|FG006|Overall Study|Adverse Event|0|||
37893089|NCT00839254|69578378|FG007|Overall Study|Adverse Event|1|||
37893090|NCT00839254|69578371|FG000|Overall Study|Withdrawal by Subject|87|||
37893091|NCT00839254|69578372|FG001|Overall Study|Withdrawal by Subject|53|||
37893092|NCT00839254|69578373|FG002|Overall Study|Withdrawal by Subject|54|||
37893093|NCT00839254|69578374|FG003|Overall Study|Withdrawal by Subject|32|||
37893094|NCT00839254|69578375|FG004|Overall Study|Withdrawal by Subject|27|||
37893095|NCT00839254|69578376|FG005|Overall Study|Withdrawal by Subject|15|||
37893096|NCT00839254|69578377|FG006|Overall Study|Withdrawal by Subject|22|||
37893097|NCT00839254|69578378|FG007|Overall Study|Withdrawal by Subject|9|||
37893098|NCT00839254|69578371|FG000|Overall Study|Wrong group allocation|0|||
37893099|NCT00839254|69578372|FG001|Overall Study|Wrong group allocation|0|||
37893100|NCT00839254|69578373|FG002|Overall Study|Wrong group allocation|0|||
37893101|NCT00839254|69578374|FG003|Overall Study|Wrong group allocation|0|||
37893102|NCT00839254|69578375|FG004|Overall Study|Wrong group allocation|0|||
37893103|NCT00839254|69578376|FG005|Overall Study|Wrong group allocation|0|||
37893104|NCT00839254|69578377|FG006|Overall Study|Wrong group allocation|1|||
37893105|NCT00839254|69578378|FG007|Overall Study|Wrong group allocation|0|||
37893106|NCT00839254|69578371|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
37893107|NCT00839254|69578372|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
37893108|NCT00839254|69578373|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
37893109|NCT00839254|69578374|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
37893110|NCT00839254|69578375|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
37893111|NCT00839254|69578376|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
37893112|NCT00839254|69578377|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
37893113|NCT00839254|69578378|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
37893114|NCT00839254|69578371|FG000|Overall Study|Withdrawn due to non-compliance|2|||
37893115|NCT00839254|69578372|FG001|Overall Study|Withdrawn due to non-compliance|0|||
37893116|NCT00839254|69578373|FG002|Overall Study|Withdrawn due to non-compliance|0|||
37893117|NCT00839254|69578374|FG003|Overall Study|Withdrawn due to non-compliance|0|||
37893118|NCT00839254|69578375|FG004|Overall Study|Withdrawn due to non-compliance|0|||
37893119|NCT00839254|69578376|FG005|Overall Study|Withdrawn due to non-compliance|0|||
37893120|NCT00839254|69578377|FG006|Overall Study|Withdrawn due to non-compliance|0|||
37893121|NCT00839254|69578378|FG007|Overall Study|Withdrawn due to non-compliance|0|||
37893122|NCT00839254|69578371|FG000|Overall Study|Lost to Follow-up|51|||
37893123|NCT00839254|69578372|FG001|Overall Study|Lost to Follow-up|30|||
37893124|NCT00839254|69578373|FG002|Overall Study|Lost to Follow-up|32|||
37893125|NCT00839254|69578374|FG003|Overall Study|Lost to Follow-up|24|||
37893126|NCT00839254|69578375|FG004|Overall Study|Lost to Follow-up|8|||
37893127|NCT00839254|69578376|FG005|Overall Study|Lost to Follow-up|8|||
37893128|NCT00839254|69578377|FG006|Overall Study|Lost to Follow-up|4|||
37893129|NCT00839254|69578378|FG007|Overall Study|Lost to Follow-up|2|||
37893130|NCT00586339|69578430|FG000|Overall Study|Withdrawal by Subject|1|||
37893131|NCT00586339|69578431|FG001|Overall Study|Withdrawal by Subject|3|||
37893132|NCT00586339|69578432|FG002|Overall Study|Withdrawal by Subject|1|||
37893133|NCT00586339|69578430|FG000|Overall Study|Migrated/moved from study area|3|||
37696122|NCT02275117|69172305|FG000|Overall Study|Protocol Violation|1|||
37696123|NCT02275117|69172306|FG001|Overall Study|Protocol Violation|0|||
37696124|NCT02275117|69172307|FG002|Overall Study|Protocol Violation|1|||
37696125|NCT02275117|69172308|FG003|Overall Study|Protocol Violation|1|||
37893134|NCT00586339|69578431|FG001|Overall Study|Migrated/moved from study area|2|||
37893135|NCT00586339|69578432|FG002|Overall Study|Migrated/moved from study area|4|||
37893136|NCT00586339|69578430|FG000|Overall Study|Lost to Follow-up|3|||
37893137|NCT00586339|69578431|FG001|Overall Study|Lost to Follow-up|2|||
37893138|NCT00586339|69578432|FG002|Overall Study|Lost to Follow-up|1|||
37893139|NCT00812968|69578440|FG000|Overall Study|Relapse after erythroid response|6|||
37893140|NCT00812968|69578440|FG000|Overall Study|Disease progression|1|||
37893141|NCT00812968|69578440|FG000|Overall Study|No further treatment required|1|||
37696126|NCT02275117|69172309|FG004|Overall Study|Protocol Violation|0|||
37696127|NCT02275117|69172305|FG000|Overall Study|Withdrawal by Subject|6|||
37893142|NCT00812968|69578440|FG000|Overall Study|Study closed due to marketing approval|3|||
37893143|NCT00839098|69578449|FG000|Overall Study|Withdrawal by Subject|2|||
37893144|NCT00839098|69578450|FG001|Overall Study|Withdrawal by Subject|1|||
37893145|NCT00839098|69578451|FG002|Overall Study|Withdrawal by Subject|7|||
37893146|NCT00813748|69578461|FG000|Skin Test Substudy|Physician Decision|0|||
37893147|NCT00813748|69578462|FG001|Skin Test Substudy|Physician Decision|1|||
37893148|NCT00813592|69578470|FG000|Overall Study|Disease assessment was not completed per|2|||
37893149|NCT00813358|69578475|FG000|Overall Study|Death|32|||
37893150|NCT00813358|69578475|FG000|Overall Study|Lost to Follow-up|12|||
37893151|NCT00813358|69578475|FG000|Overall Study|other endpoints|5|||
37893152|NCT00813358|69578475|FG000|Overall Study|Withdrawal by Subject|20|||
37893153|NCT00812812|69578481|FG000|Overall Study|Adverse Event|2|||
37893154|NCT00812812|69578482|FG001|Overall Study|Adverse Event|1|||
37893155|NCT00812812|69578481|FG000|Overall Study|Lack of Efficacy|1|||
37893156|NCT00812812|69578482|FG001|Overall Study|Lack of Efficacy|0|||
37893157|NCT00812812|69578481|FG000|Overall Study|Lost to Follow-up|0|||
37893158|NCT00812812|69578482|FG001|Overall Study|Lost to Follow-up|1|||
37893159|NCT00812812|69578481|FG000|Overall Study|Withdrawal by Subject|0|||
37989275|NCT00127192|69674479|FG003|Overall Study|Adverse event in pre-treatment period|0|||
37989276|NCT00127192|69674480|FG004|Overall Study|Adverse event in pre-treatment period|0|||
37989277|NCT00205179|69674494|FG000|Overall Study|Death|0|||
37989278|NCT00205179|69674495|FG001|Overall Study|Death|2|||
37989279|NCT00205179|69674494|FG000|Overall Study|Physician Decision|1|||
37989280|NCT00205179|69674495|FG001|Overall Study|Physician Decision|1|||
37989281|NCT00205179|69674494|FG000|Overall Study|Adverse Event|1|||
37989282|NCT00205179|69674495|FG001|Overall Study|Adverse Event|1|||
37989283|NCT00127036|69674504|FG000|Overall Study|Insufficient Data for Analysis|6|||
37989284|NCT00127036|69674505|FG001|Overall Study|Insufficient Data for Analysis|11|||
37989285|NCT00127036|69674504|FG000|Overall Study|Screen Failure|2|||
37989286|NCT00127036|69674505|FG001|Overall Study|Screen Failure|0|||
37989287|NCT00259857|69674513|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
37989288|NCT00259857|69674514|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
37989289|NCT00259857|69674513|FG000|24 Months Treatment|Lost to Follow-up|0|||
37989290|NCT00259857|69674514|FG001|24 Months Treatment|Lost to Follow-up|3|||
37989291|NCT00203307|69674522|FG000|First Intervention|Adverse Event|2|||
37989292|NCT00203307|69674523|FG001|First Intervention|Adverse Event|0|||
37989293|NCT00126568|69674529|FG000|Overall Study|Death|2|||
37989294|NCT00114634|69674534|FG000|Overall Study|failure to return forms|3|||
37989295|NCT00202839|69674542|FG000|Overall Study|Adverse Event|1|||
37989296|NCT00202839|69674543|FG001|Overall Study|Adverse Event|5|||
37989297|NCT00202839|69674542|FG000|Overall Study|Physician Decision|12|||
37989298|NCT00202839|69674543|FG001|Overall Study|Physician Decision|0|||
37989299|NCT00202839|69674542|FG000|Overall Study|Withdrawal by Subject|6|||
37989300|NCT00202839|69674543|FG001|Overall Study|Withdrawal by Subject|2|||
37989301|NCT00202839|69674542|FG000|Overall Study|Protocol Violation|2|||
37989302|NCT00202839|69674543|FG001|Overall Study|Protocol Violation|1|||
37989303|NCT00202839|69674542|FG000|Overall Study|Lost to Follow-up|3|||
37989304|NCT00202839|69674543|FG001|Overall Study|Lost to Follow-up|2|||
37989305|NCT00201201|69674551|FG000|Overall Study|Death|0|||
37989306|NCT00201201|69674552|FG001|Overall Study|Death|2|||
37989307|NCT00201201|69674551|FG000|Overall Study|Withdrawal by Subject|5|||
37989308|NCT00201201|69674552|FG001|Overall Study|Withdrawal by Subject|5|||
37989309|NCT00126490|69674558|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
37989310|NCT00346632|69674564|FG000|Overall Study|Progressive Disease|2|||
37989311|NCT00346632|69674565|FG001|Overall Study|Progressive Disease|2|||
37989312|NCT00346632|69674566|FG002|Overall Study|Progressive Disease|4|||
37824607|NCT02592707|69506691|FG002|Overall Study|Progressive Disease|3|||
37824608|NCT02592707|69506692|FG003|Overall Study|Progressive Disease|3|||
37824609|NCT02592707|69506689|FG000|Overall Study|Other|0|||
37824610|NCT02592707|69506690|FG001|Overall Study|Other|0|||
37824611|NCT02592707|69506691|FG002|Overall Study|Other|1|||
37824612|NCT02592707|69506692|FG003|Overall Study|Other|2|||
37824613|NCT02592707|69506689|FG000|Overall Study|Never entered LTFU period|1|||
37824614|NCT02592707|69506690|FG001|Overall Study|Never entered LTFU period|0|||
37824615|NCT02592707|69506691|FG002|Overall Study|Never entered LTFU period|0|||
37824616|NCT02592707|69506692|FG003|Overall Study|Never entered LTFU period|2|||
37824617|NCT01423812|69506720|FG000|Overall Study|Lost to Follow-up|2|||
37824618|NCT01423812|69506721|FG001|Overall Study|Lost to Follow-up|2|||
37824619|NCT01423812|69506720|FG000|Overall Study|Withdrawal by Subject|1|||
37824620|NCT01423812|69506721|FG001|Overall Study|Withdrawal by Subject|2|||
37824621|NCT00965718|69506729|FG000|Overall Study|Withdrawal by Subject|4|||
37824622|NCT00792740|69506744|FG000|Overall Study|Disease Worsening|3|||
37989313|NCT00346632|69674567|FG003|Overall Study|Progressive Disease|3|||
37989314|NCT00346632|69674568|FG004|Overall Study|Progressive Disease|3|||
37989315|NCT00346632|69674569|FG005|Overall Study|Progressive Disease|1|||
37989316|NCT00346632|69674570|FG006|Overall Study|Progressive Disease|2|||
37893160|NCT00812812|69578482|FG001|Overall Study|Withdrawal by Subject|2|||
37893161|NCT00810082|69578492|FG000|Overall Study|Lost to Follow-up|0|||
37893162|NCT00810082|69578493|FG001|Overall Study|Lost to Follow-up|4|||
37893163|NCT00748189|69578501|FG000|Overall Study|Death|99|||
37989317|NCT00346632|69674571|FG007|Overall Study|Progressive Disease|2|||
37989318|NCT00346632|69674572|FG008|Overall Study|Progressive Disease|2|||
37989319|NCT00346632|69674573|FG009|Overall Study|Progressive Disease|2|||
37989320|NCT00346632|69674564|FG000|Overall Study|Adverse Event|0|||
37989321|NCT00346632|69674565|FG001|Overall Study|Adverse Event|0|||
37989322|NCT00346632|69674566|FG002|Overall Study|Adverse Event|0|||
37989323|NCT00346632|69674567|FG003|Overall Study|Adverse Event|0|||
37989324|NCT00346632|69674568|FG004|Overall Study|Adverse Event|1|||
37989325|NCT00346632|69674569|FG005|Overall Study|Adverse Event|1|||
37989326|NCT00346632|69674570|FG006|Overall Study|Adverse Event|1|||
37989327|NCT00346632|69674571|FG007|Overall Study|Adverse Event|0|||
37989328|NCT00346632|69674572|FG008|Overall Study|Adverse Event|0|||
37989329|NCT00346632|69674573|FG009|Overall Study|Adverse Event|0|||
37989330|NCT00346632|69674564|FG000|Overall Study|Death|0|||
37989331|NCT00346632|69674565|FG001|Overall Study|Death|0|||
37989332|NCT00346632|69674566|FG002|Overall Study|Death|1|||
37989333|NCT00346632|69674567|FG003|Overall Study|Death|0|||
37989334|NCT00346632|69674568|FG004|Overall Study|Death|0|||
37989335|NCT00346632|69674569|FG005|Overall Study|Death|0|||
37989336|NCT00346632|69674570|FG006|Overall Study|Death|0|||
37989337|NCT00346632|69674571|FG007|Overall Study|Death|0|||
37989338|NCT00346632|69674572|FG008|Overall Study|Death|0|||
37989339|NCT00346632|69674573|FG009|Overall Study|Death|0|||
37989340|NCT00346632|69674564|FG000|Overall Study|Protocol Violation|0|||
37989341|NCT00346632|69674565|FG001|Overall Study|Protocol Violation|0|||
37989342|NCT00346632|69674566|FG002|Overall Study|Protocol Violation|0|||
37893164|NCT00748189|69578502|FG001|Overall Study|Death|84|||
37893165|NCT00748189|69578501|FG000|Overall Study|Withdrawal by Subject|23|||
37893166|NCT00748189|69578502|FG001|Overall Study|Withdrawal by Subject|29|||
37893167|NCT00748189|69578501|FG000|Overall Study|Physician Decision|16|||
37893168|NCT00748189|69578502|FG001|Overall Study|Physician Decision|5|||
37893169|NCT00748189|69578501|FG000|Overall Study|Lost to Follow-up|8|||
37893170|NCT00748189|69578502|FG001|Overall Study|Lost to Follow-up|15|||
37893171|NCT00748189|69578501|FG000|Overall Study|Study terminated by Sponsor|70|||
37893172|NCT00748189|69578502|FG001|Overall Study|Study terminated by Sponsor|79|||
37893173|NCT00744055|69578515|FG000|Overall Study|Withdrawal by Subject|6|||
37893174|NCT00744055|69578516|FG001|Overall Study|Withdrawal by Subject|9|||
37893175|NCT00744055|69578515|FG000|Overall Study|Lack of Efficacy|0|||
37893176|NCT00744055|69578516|FG001|Overall Study|Lack of Efficacy|1|||
37893177|NCT00744055|69578515|FG000|Overall Study|Physician Decision|0|||
37893178|NCT00744055|69578516|FG001|Overall Study|Physician Decision|2|||
37893179|NCT00744055|69578515|FG000|Overall Study|Protocol Violation|1|||
37893180|NCT00744055|69578516|FG001|Overall Study|Protocol Violation|1|||
37893181|NCT00744055|69578515|FG000|Overall Study|Lost to Follow-up|0|||
37893182|NCT00744055|69578516|FG001|Overall Study|Lost to Follow-up|1|||
37893183|NCT00748033|69578524|FG000|Overall Study|Adverse Event|0|||
37893184|NCT00748033|69578525|FG001|Overall Study|Adverse Event|1|||
37893185|NCT00735553|69578542|FG000|Overall Study|Study prematurely terminated|77|||
37893186|NCT00740779|69578553|FG000|Overall Study|Adverse Event|4|||
37893187|NCT00740779|69578554|FG001|Overall Study|Adverse Event|6|||
37893188|NCT00740779|69578555|FG002|Overall Study|Adverse Event|3|||
37893189|NCT00740779|69578553|FG000|Overall Study|Protocol Violation|1|||
37893190|NCT00740779|69578554|FG001|Overall Study|Protocol Violation|1|||
37893191|NCT00740779|69578555|FG002|Overall Study|Protocol Violation|1|||
37893192|NCT00740779|69578553|FG000|Overall Study|Lack of Efficacy|0|||
37893193|NCT00740779|69578554|FG001|Overall Study|Lack of Efficacy|0|||
37989343|NCT00346632|69674567|FG003|Overall Study|Protocol Violation|0|||
37989344|NCT00346632|69674568|FG004|Overall Study|Protocol Violation|0|||
37989345|NCT00346632|69674569|FG005|Overall Study|Protocol Violation|0|||
37989346|NCT00346632|69674570|FG006|Overall Study|Protocol Violation|1|||
37989347|NCT00346632|69674571|FG007|Overall Study|Protocol Violation|0|||
37824623|NCT00792740|69506745|FG001|Overall Study|Disease Worsening|2|||
37824624|NCT00792740|69506744|FG000|Overall Study|Personal Reason|1|||
37824625|NCT00792740|69506745|FG001|Overall Study|Personal Reason|0|||
37824626|NCT00792740|69506744|FG000|Overall Study|Adverse Event|1|||
37824627|NCT00792740|69506745|FG001|Overall Study|Adverse Event|3|||
37824628|NCT00792740|69506744|FG000|Overall Study|Patient's withdrawal of consent|0|||
37696128|NCT02275117|69172306|FG001|Overall Study|Withdrawal by Subject|4|||
37824629|NCT00792740|69506745|FG001|Overall Study|Patient's withdrawal of consent|1|||
37824630|NCT00792740|69506744|FG000|Overall Study|Termination of the trial by the Sponsor|2|||
37824631|NCT00792740|69506745|FG001|Overall Study|Termination of the trial by the Sponsor|0|||
37893194|NCT00740779|69578555|FG002|Overall Study|Lack of Efficacy|2|||
37893195|NCT00740779|69578553|FG000|Overall Study|Withdrawal by Subject|2|||
37893196|NCT00740779|69578554|FG001|Overall Study|Withdrawal by Subject|4|||
37989348|NCT00346632|69674572|FG008|Overall Study|Protocol Violation|0|||
37893197|NCT00740779|69578555|FG002|Overall Study|Withdrawal by Subject|2|||
37989349|NCT00346632|69674573|FG009|Overall Study|Protocol Violation|0|||
37989350|NCT00346632|69674564|FG000|Overall Study|Withdrawal by Subject|0|||
37893198|NCT00740779|69578553|FG000|Overall Study|Lost to Follow-up|2|||
37893199|NCT00740779|69578554|FG001|Overall Study|Lost to Follow-up|3|||
37893200|NCT00740779|69578555|FG002|Overall Study|Lost to Follow-up|5|||
37893201|NCT00735475|69578565|FG000|Overall Study|Adverse Event|0|||
37893202|NCT00735475|69578566|FG001|Overall Study|Adverse Event|1|||
37893203|NCT00735475|69578565|FG000|Overall Study|Death|1|||
37893204|NCT00735475|69578566|FG001|Overall Study|Death|1|||
37893205|NCT00735475|69578565|FG000|Overall Study|Lost to Follow-up|3|||
37893206|NCT00735475|69578566|FG001|Overall Study|Lost to Follow-up|3|||
37893207|NCT00735475|69578565|FG000|Overall Study|Physician Decision|0|||
37893208|NCT00735475|69578566|FG001|Overall Study|Physician Decision|1|||
37893209|NCT00735475|69578565|FG000|Overall Study|Withdrawal by Subject|4|||
37893210|NCT00735475|69578566|FG001|Overall Study|Withdrawal by Subject|5|||
37893211|NCT01026818|69578575|FG000|Screening Period|Entry Criteria Not Met|105|||
37893212|NCT01026818|69578576|FG001|Screening Period|Entry Criteria Not Met|0|||
37893213|NCT01026818|69578577|FG002|Screening Period|Entry Criteria Not Met|0|||
37893214|NCT01026818|69578578|FG003|Screening Period|Entry Criteria Not Met|0|||
37893215|NCT01026818|69578575|FG000|Screening Period|Withdrawal by Subject|49|||
37893216|NCT01026818|69578576|FG001|Screening Period|Withdrawal by Subject|0|||
37893217|NCT01026818|69578577|FG002|Screening Period|Withdrawal by Subject|0|||
37893218|NCT01026818|69578578|FG003|Screening Period|Withdrawal by Subject|0|||
37893219|NCT01026818|69578575|FG000|Screening Period|Protocol Deviation|3|||
37893220|NCT01026818|69578576|FG001|Screening Period|Protocol Deviation|0|||
37893221|NCT01026818|69578577|FG002|Screening Period|Protocol Deviation|0|||
37893222|NCT01026818|69578578|FG003|Screening Period|Protocol Deviation|0|||
37893223|NCT01026818|69578575|FG000|Screening Period|Adverse Event|2|||
37893224|NCT01026818|69578576|FG001|Screening Period|Adverse Event|0|||
37893225|NCT01026818|69578577|FG002|Screening Period|Adverse Event|0|||
37893226|NCT01026818|69578578|FG003|Screening Period|Adverse Event|0|||
37893227|NCT01026818|69578575|FG000|Screening Period|Physician Decision|1|||
37893228|NCT01026818|69578576|FG001|Screening Period|Physician Decision|0|||
37893229|NCT01026818|69578577|FG002|Screening Period|Physician Decision|0|||
37893230|NCT01026818|69578578|FG003|Screening Period|Physician Decision|0|||
37893231|NCT01026818|69578575|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
37893232|NCT01026818|69578576|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
37893233|NCT01026818|69578577|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
37893234|NCT01026818|69578578|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
37893235|NCT01026818|69578575|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
37893236|NCT01026818|69578576|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
37893237|NCT01026818|69578577|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
37893238|NCT01026818|69578578|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
37893239|NCT01026818|69578575|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
37893240|NCT01026818|69578576|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
37893241|NCT01026818|69578577|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
37893242|NCT01026818|69578578|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
37893243|NCT01026818|69578575|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
37893244|NCT01026818|69578576|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
37893245|NCT01026818|69578577|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
37893246|NCT01026818|69578578|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
37893247|NCT01026818|69578575|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
37893248|NCT01026818|69578576|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
37893249|NCT01026818|69578577|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
37893250|NCT01026818|69578578|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
37893251|NCT01026818|69578575|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
37893252|NCT01026818|69578576|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
37893253|NCT01026818|69578577|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
37893254|NCT01026818|69578578|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
37893255|NCT01026818|69578575|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
37893256|NCT01026818|69578576|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
37893257|NCT01026818|69578577|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
37893258|NCT01026818|69578578|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
37893259|NCT01026818|69578575|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
37893260|NCT01026818|69578576|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
37893261|NCT01026818|69578577|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
37893262|NCT01026818|69578578|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
37893263|NCT01026818|69578575|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
37893264|NCT01026818|69578576|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
37893265|NCT01026818|69578577|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
37893266|NCT01026818|69578578|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
37893267|NCT01026818|69578575|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
37893268|NCT01026818|69578576|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
37893269|NCT01026818|69578577|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
37893270|NCT01026818|69578578|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
37893271|NCT01026818|69578575|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
37893272|NCT01026818|69578576|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
37893273|NCT01026818|69578577|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
37893274|NCT01026818|69578578|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
37989351|NCT00346632|69674565|FG001|Overall Study|Withdrawal by Subject|0|||
37989352|NCT00346632|69674566|FG002|Overall Study|Withdrawal by Subject|0|||
37989353|NCT00346632|69674567|FG003|Overall Study|Withdrawal by Subject|0|||
37893275|NCT01026818|69578575|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
37893276|NCT01026818|69578576|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
37893277|NCT01026818|69578577|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
37893278|NCT01026818|69578578|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
37893279|NCT01026818|69578575|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
37893280|NCT01026818|69578576|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
37893281|NCT01026818|69578577|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
37893282|NCT01026818|69578578|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
37893283|NCT01026818|69578575|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
37893284|NCT01026818|69578576|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
37893285|NCT01026818|69578577|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
37893286|NCT01026818|69578578|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
37893287|NCT01026818|69578575|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
37893288|NCT01026818|69578576|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
37893289|NCT01026818|69578577|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
37893290|NCT01026818|69578578|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
37989354|NCT00346632|69674568|FG004|Overall Study|Withdrawal by Subject|0|||
37989355|NCT00346632|69674569|FG005|Overall Study|Withdrawal by Subject|0|||
37989356|NCT00346632|69674570|FG006|Overall Study|Withdrawal by Subject|1|||
37989357|NCT00346632|69674571|FG007|Overall Study|Withdrawal by Subject|0|||
37989358|NCT00346632|69674572|FG008|Overall Study|Withdrawal by Subject|0|||
37989359|NCT00346632|69674573|FG009|Overall Study|Withdrawal by Subject|0|||
37989360|NCT00346632|69674564|FG000|Overall Study|Switched to alternative treatment|0|||
37989361|NCT00346632|69674565|FG001|Overall Study|Switched to alternative treatment|0|||
37989362|NCT00346632|69674566|FG002|Overall Study|Switched to alternative treatment|1|||
37989363|NCT00346632|69674567|FG003|Overall Study|Switched to alternative treatment|0|||
37989364|NCT00346632|69674568|FG004|Overall Study|Switched to alternative treatment|0|||
37989365|NCT00346632|69674569|FG005|Overall Study|Switched to alternative treatment|0|||
37989366|NCT00346632|69674570|FG006|Overall Study|Switched to alternative treatment|0|||
37989367|NCT00346632|69674571|FG007|Overall Study|Switched to alternative treatment|0|||
37989368|NCT00346632|69674572|FG008|Overall Study|Switched to alternative treatment|0|||
37989369|NCT00346632|69674573|FG009|Overall Study|Switched to alternative treatment|0|||
37824632|NCT00792740|69506744|FG000|Overall Study|Other reasons|0|||
37824633|NCT00792740|69506745|FG001|Overall Study|Other reasons|1|||
37824634|NCT00567580|69506764|FG000|Overall Study|Protocol Violation|28|||
37824635|NCT00567580|69506765|FG001|Overall Study|Protocol Violation|24|||
37824636|NCT00567580|69506766|FG002|Overall Study|Protocol Violation|24|||
37824637|NCT01058863|69506777|FG000|Overall Study|Lost to Follow-up|1|||
37824638|NCT01058863|69506777|FG000|Overall Study|Withdrawal by Subject|1|||
37824639|NCT01058863|69506777|FG000|Overall Study|Sponsor requested withdrawal|1|||
37824640|NCT01058863|69506777|FG000|Overall Study|Randomized in error|1|||
37824641|NCT01058395|69506792|FG000|Overall Study|Death|2|||
37824642|NCT01058395|69506793|FG001|Overall Study|Death|1|||
37824643|NCT01058395|69506792|FG000|Overall Study|Lost to Follow-up|1|||
37824644|NCT01058395|69506793|FG001|Overall Study|Lost to Follow-up|0|||
37824645|NCT01058356|69506799|FG000|Overall Study|Adverse Event|5|||
37824646|NCT01058356|69506799|FG000|Overall Study|Administration of contraindicated drugs|12|||
37824647|NCT01058356|69506799|FG000|Overall Study|Withdrawal by Subject|21|||
37824648|NCT01058356|69506799|FG000|Overall Study|Lost to Follow-up|4|||
37824649|NCT01058005|69506806|FG000|Overall Study|Adverse Event|0|||
37824650|NCT01058005|69506807|FG001|Overall Study|Adverse Event|2|||
37893291|NCT01026818|69578575|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
37893292|NCT01026818|69578576|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
37989370|NCT00346632|69674564|FG000|Overall Study|Not Stated|1|||
37824651|NCT01058005|69506808|FG002|Overall Study|Adverse Event|1|||
37824652|NCT01058005|69506806|FG000|Overall Study|Physician Decision|2|||
37824653|NCT01058005|69506807|FG001|Overall Study|Physician Decision|2|||
37989371|NCT00346632|69674565|FG001|Overall Study|Not Stated|1|||
37989372|NCT00346632|69674566|FG002|Overall Study|Not Stated|0|||
37989373|NCT00346632|69674567|FG003|Overall Study|Not Stated|0|||
37989374|NCT00346632|69674568|FG004|Overall Study|Not Stated|0|||
37989375|NCT00346632|69674569|FG005|Overall Study|Not Stated|0|||
37989376|NCT00346632|69674570|FG006|Overall Study|Not Stated|0|||
37989377|NCT00346632|69674571|FG007|Overall Study|Not Stated|2|||
37989378|NCT00346632|69674572|FG008|Overall Study|Not Stated|2|||
37989379|NCT00346632|69674573|FG009|Overall Study|Not Stated|1|||
37989380|NCT00200967|69674637|FG000|First Treatment Period|Withdrawal by Subject|5|||
37989381|NCT00200967|69674638|FG001|First Treatment Period|Withdrawal by Subject|1|||
37989382|NCT00200967|69674637|FG000|First Treatment Period|Pregnancy|1|||
37989383|NCT00200967|69674638|FG001|First Treatment Period|Pregnancy|0|||
37989384|NCT00200967|69674637|FG000|Wash-out Period|Lost to Follow-up|0|||
37989385|NCT00200967|69674638|FG001|Wash-out Period|Lost to Follow-up|1|||
37989386|NCT00200967|69674637|FG000|Second Treatment Period|Withdrawal by Subject|1|||
37989387|NCT00200967|69674638|FG001|Second Treatment Period|Withdrawal by Subject|2|||
37989388|NCT00200967|69674637|FG000|Run-out Period|Lost to Follow-up|1|||
37893293|NCT01026818|69578577|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
37893294|NCT01026818|69578578|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
37893295|NCT01026818|69578575|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
37893296|NCT01026818|69578576|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
37893297|NCT01026818|69578577|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
37893298|NCT01026818|69578578|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
37893299|NCT01026818|69578575|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
37893300|NCT01026818|69578576|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
37893301|NCT01026818|69578577|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
37893302|NCT01026818|69578578|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
37893303|NCT01026818|69578575|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
37893304|NCT01026818|69578576|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
37893305|NCT01026818|69578577|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
37893306|NCT01026818|69578578|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
37893307|NCT00735397|69578590|FG000|Overall Study|Adverse Event|194|||
37893308|NCT00735397|69578590|FG000|Overall Study|Lost to Follow-up|33|||
37989389|NCT00200967|69674638|FG001|Run-out Period|Lost to Follow-up|0|||
37989390|NCT00354432|69674648|FG000|Overall Study|Adverse Event|3|||
37989391|NCT00354432|69674649|FG001|Overall Study|Adverse Event|1|||
37989392|NCT00354432|69674650|FG002|Overall Study|Adverse Event|5|||
37989393|NCT00354432|69674651|FG003|Overall Study|Adverse Event|5|||
37893309|NCT00735397|69578590|FG000|Overall Study|Participant choice|252|||
37893310|NCT00735397|69578590|FG000|Overall Study|Inadequate therapeutic effect|202|||
37893311|NCT00735397|69578590|FG000|Overall Study|Administrative/Other|502|||
37989394|NCT00354432|69674648|FG000|Overall Study|Off/Toxicity|3|||
37824654|NCT01058005|69506808|FG002|Overall Study|Physician Decision|0|||
37824655|NCT01058005|69506806|FG000|Overall Study|Withdrawal by Subject|4|||
37824656|NCT01058005|69506807|FG001|Overall Study|Withdrawal by Subject|5|||
37824657|NCT01058005|69506808|FG002|Overall Study|Withdrawal by Subject|11|||
37824658|NCT01058005|69506806|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
37824659|NCT01058005|69506807|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
37824660|NCT01058005|69506808|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
37824661|NCT01058005|69506806|FG000|Overall Study|Reason Missing|5|||
37824662|NCT01058005|69506807|FG001|Overall Study|Reason Missing|3|||
37824663|NCT01058005|69506808|FG002|Overall Study|Reason Missing|1|||
37824664|NCT01056640|69506818|FG000|Overall Study|Withdrawal by Subject|11|||
37824665|NCT01056640|69506819|FG001|Overall Study|Withdrawal by Subject|8|||
37824666|NCT01056640|69506818|FG000|Overall Study|Death|15|||
37824667|NCT01056640|69506819|FG001|Overall Study|Death|4|||
37824668|NCT01056484|69506827|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
37824669|NCT01056484|69506828|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
37824670|NCT01056484|69506827|FG000|Randomized Controlled Trial|Physician Decision|1|||
37824671|NCT01056484|69506828|FG001|Randomized Controlled Trial|Physician Decision|0|||
37893312|NCT00735007|69578597|FG000|Overall Study|Adverse Event|4|||
37893313|NCT00735007|69578597|FG000|Overall Study|Protocol Violation|1|||
37893314|NCT00743509|69578601|FG000|Overall Study|Withdrawal by Subject|2|||
37989395|NCT00354432|69674649|FG001|Overall Study|Off/Toxicity|7|||
37989396|NCT00354432|69674650|FG002|Overall Study|Off/Toxicity|5|||
37989397|NCT00354432|69674651|FG003|Overall Study|Off/Toxicity|5|||
37989398|NCT00140140|69674664|FG000|Overall Study|Unacceptable toxicity|1|||
37696129|NCT02275117|69172307|FG002|Overall Study|Withdrawal by Subject|7|||
37824672|NCT01056484|69506827|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
37824673|NCT01056484|69506828|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
37893315|NCT00734929|69578607|FG000|Overall Study|Lost to Follow-up|1|||
37893316|NCT00734929|69578608|FG001|Overall Study|Lost to Follow-up|2|||
37893317|NCT00734929|69578607|FG000|Overall Study|No intervention/ screen fail|5|||
37893318|NCT00734929|69578608|FG001|Overall Study|No intervention/ screen fail|3|||
37989399|NCT00140140|69674665|FG001|Overall Study|Unacceptable toxicity|1|||
37989400|NCT00140140|69674666|FG002|Overall Study|Unacceptable toxicity|2|||
37989401|NCT00140140|69674664|FG000|Overall Study|Physician Decision|1|||
37893319|NCT00734851|69578616|FG000|Overall Study|Withdrawal by Subject|2|||
37893320|NCT00734851|69578616|FG000|Overall Study|Lost to Follow-up|1|||
37893321|NCT00734851|69578616|FG000|Overall Study|Physician Decision|18|||
37893322|NCT00734617|69578622|FG000|Overall Study|Adverse Event|4|||
37893323|NCT00734617|69578623|FG001|Overall Study|Adverse Event|7|||
37893324|NCT00734617|69578622|FG000|Overall Study|Withdrawal by Subject|103|||
37989402|NCT00140140|69674665|FG001|Overall Study|Physician Decision|1|||
37989403|NCT00140140|69674666|FG002|Overall Study|Physician Decision|0|||
37989404|NCT00346398|69674675|FG000|Overall Study|Lost to Follow-up|3|||
37989405|NCT00346398|69674676|FG001|Overall Study|Lost to Follow-up|0|||
37989406|NCT00346398|69674675|FG000|Overall Study|Withdrawal by Subject|0|||
37989407|NCT00346398|69674676|FG001|Overall Study|Withdrawal by Subject|2|||
37989408|NCT00346164|69674686|FG000|Overall Study|Adverse Event|0|||
37989409|NCT00346164|69674687|FG001|Overall Study|Adverse Event|0|||
37893325|NCT00734617|69578623|FG001|Overall Study|Withdrawal by Subject|95|||
37893326|NCT00743431|69578629|FG000|Overall Study|Toxicity|6|||
37989410|NCT00346164|69674688|FG002|Overall Study|Adverse Event|0|||
37989411|NCT00346164|69674689|FG003|Overall Study|Adverse Event|1|||
37989412|NCT00346164|69674686|FG000|Overall Study|Lack of Efficacy|0|||
37989413|NCT00346164|69674687|FG001|Overall Study|Lack of Efficacy|1|||
37989414|NCT00346164|69674688|FG002|Overall Study|Lack of Efficacy|7|||
37989415|NCT00346164|69674689|FG003|Overall Study|Lack of Efficacy|25|||
37989416|NCT00346164|69674686|FG000|Overall Study|Physician Decision|0|||
37824674|NCT01055314|69506837|FG000|Overall Study|Adverse Event|7|||
37824675|NCT01055314|69506838|FG001|Overall Study|Adverse Event|4|||
37824676|NCT01055314|69506837|FG000|Overall Study|Death|2|||
37824677|NCT01055314|69506838|FG001|Overall Study|Death|1|||
37824678|NCT01055314|69506837|FG000|Overall Study|Lack of Efficacy|11|||
37824679|NCT01055314|69506838|FG001|Overall Study|Lack of Efficacy|19|||
37824680|NCT01055314|69506837|FG000|Overall Study|Physician Decision|10|||
37824681|NCT01055314|69506838|FG001|Overall Study|Physician Decision|5|||
37824682|NCT01055314|69506837|FG000|Overall Study|Withdrawal by Subject|1|||
37824683|NCT01055314|69506838|FG001|Overall Study|Withdrawal by Subject|0|||
37824684|NCT01055314|69506837|FG000|Overall Study|Ineligible|3|||
37824685|NCT01055314|69506838|FG001|Overall Study|Ineligible|5|||
37824686|NCT01055314|69506837|FG000|Overall Study|Refusal of further protocol therapy|10|||
37824687|NCT01055314|69506838|FG001|Overall Study|Refusal of further protocol therapy|4|||
37824688|NCT01055314|69506837|FG000|Overall Study|No treatment|1|||
37824689|NCT01055314|69506838|FG001|Overall Study|No treatment|0|||
37824690|NCT01055197|69506847|FG000|Overall Study|Protocol Violation|7|||
37824691|NCT01055197|69506848|FG001|Overall Study|Protocol Violation|2|||
37824692|NCT01055197|69506847|FG000|Overall Study|Withdrawal by Subject|2|||
37824693|NCT01055197|69506848|FG001|Overall Study|Withdrawal by Subject|0|||
37824694|NCT01054885|69506860|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
37824695|NCT01054885|69506861|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
37824696|NCT01054885|69506862|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
37824697|NCT01054885|69506863|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
37824698|NCT01054885|69506864|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
37824699|NCT01054885|69506865|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
37824700|NCT01054885|69506866|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
37989417|NCT00346164|69674687|FG001|Overall Study|Physician Decision|1|||
37824701|NCT01054885|69506860|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
37824702|NCT01054885|69506861|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
37893327|NCT00743431|69578629|FG000|Overall Study|Tumor progression|56|||
37893328|NCT00743431|69578629|FG000|Overall Study|Withdrawal by Subject|13|||
37893329|NCT00743431|69578629|FG000|Overall Study|Death|9|||
37893330|NCT00743431|69578629|FG000|Overall Study|Reason for discontinuation not specified|29|||
37989418|NCT00346164|69674688|FG002|Overall Study|Physician Decision|2|||
37989419|NCT00346164|69674689|FG003|Overall Study|Physician Decision|27|||
37893331|NCT00743431|69578629|FG000|Overall Study|No documentation available|13|||
37893332|NCT00734539|69578635|FG000|Main Study|Death|33|||
37893333|NCT00734539|69578636|FG001|Main Study|Death|32|||
37893334|NCT00734539|69578635|FG000|Main Study|Physician Decision|2|||
37893335|NCT00734539|69578636|FG001|Main Study|Physician Decision|0|||
37893336|NCT00734539|69578635|FG000|Main Study|Withdrawal by Subject|1|||
37893337|NCT00734539|69578636|FG001|Main Study|Withdrawal by Subject|3|||
37893338|NCT00734539|69578635|FG000|Main Study|Enrolled in error; ineligible|1|||
37893339|NCT00734539|69578636|FG001|Main Study|Enrolled in error; ineligible|0|||
37893340|NCT00743275|69578647|FG000|Overall Study|Protocol Violation|0|||
37893341|NCT00743275|69578648|FG001|Overall Study|Protocol Violation|1|||
37893342|NCT00743197|69578656|FG000|Overall Study|Study terminated due to departure of PI.|1|||
37893343|NCT00743197|69578657|FG001|Overall Study|Study terminated due to departure of PI.|2|||
37893344|NCT00734071|69578665|FG000|Overall Study|Adverse Event|4|||
37893345|NCT00734071|69578666|FG001|Overall Study|Adverse Event|3|||
37893346|NCT00734071|69578665|FG000|Overall Study|Lack of Efficacy|3|||
37893347|NCT00734071|69578666|FG001|Overall Study|Lack of Efficacy|1|||
37893348|NCT00734071|69578665|FG000|Overall Study|Noncompliance|2|||
37893349|NCT00734071|69578666|FG001|Overall Study|Noncompliance|2|||
37893350|NCT00734071|69578665|FG000|Overall Study|Protocol Deviations|3|||
37893351|NCT00734071|69578666|FG001|Overall Study|Protocol Deviations|4|||
37893352|NCT00734071|69578665|FG000|Overall Study|Voluntary Withdrawal|9|||
37893353|NCT00734071|69578666|FG001|Overall Study|Voluntary Withdrawal|7|||
37893354|NCT00734071|69578665|FG000|Overall Study|Lost to Follow-up|16|||
37893355|NCT00734071|69578666|FG001|Overall Study|Lost to Follow-up|8|||
37893356|NCT00734071|69578665|FG000|Overall Study|Other|1|||
37893357|NCT00734071|69578666|FG001|Overall Study|Other|2|||
37893358|NCT00739297|69578672|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
37893359|NCT00739297|69578673|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
37893360|NCT00739297|69578674|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
37893361|NCT00739297|69578675|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
37893362|NCT00739297|69578676|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
37893363|NCT00739297|69578677|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
37893364|NCT00739297|69578678|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
37893365|NCT00739297|69578672|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
37893366|NCT00739297|69578673|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
37893367|NCT00739297|69578674|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
37893368|NCT00739297|69578675|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
37893369|NCT00739297|69578676|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
37893370|NCT00739297|69578677|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
37893371|NCT00739297|69578678|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
37893372|NCT00739063|69578694|FG000|Overall Study|Screen failures|8|||
37893373|NCT01026194|69578700|FG000|Period 1：Double Blind Period|Adverse Event|2|||
37893374|NCT01026194|69578701|FG001|Period 1：Double Blind Period|Adverse Event|1|||
37893375|NCT01026194|69578700|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
37893376|NCT01026194|69578701|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
37893377|NCT01026194|69578700|FG000|Period 1：Double Blind Period|Physician Decision|0|||
37893378|NCT01026194|69578701|FG001|Period 1：Double Blind Period|Physician Decision|4|||
37824703|NCT01054885|69506862|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
37824704|NCT01054885|69506863|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
37824705|NCT01054885|69506864|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
37824706|NCT01054885|69506865|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
37824707|NCT01054885|69506866|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
37824708|NCT01054885|69506860|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
37824709|NCT01054885|69506861|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
37824710|NCT01054885|69506862|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
37824711|NCT01054885|69506863|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
37893379|NCT01026194|69578700|FG000|Period 2：Open-label Period|Adverse Event|4|||
37893380|NCT01026194|69578701|FG001|Period 2：Open-label Period|Adverse Event|5|||
37893381|NCT01026194|69578700|FG000|Period 2：Open-label Period|Physician Decision|3|||
37893382|NCT01026194|69578701|FG001|Period 2：Open-label Period|Physician Decision|1|||
37893383|NCT01026194|69578700|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
37893384|NCT01026194|69578701|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
37893385|NCT01033136|69578711|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
37696130|NCT02275117|69172308|FG003|Overall Study|Withdrawal by Subject|3|||
37696131|NCT02275117|69172309|FG004|Overall Study|Withdrawal by Subject|3|||
37893386|NCT01033136|69578712|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
37893387|NCT00738673|69578722|FG000|Overall Study|Adverse Event|1|||
37893388|NCT00738673|69578723|FG001|Overall Study|Adverse Event|0|||
37893389|NCT00738673|69578722|FG000|Overall Study|Lack of Efficacy|19|||
37893390|NCT00738673|69578723|FG001|Overall Study|Lack of Efficacy|8|||
37893391|NCT00738673|69578722|FG000|Overall Study|Protocol Violation|1|||
37893392|NCT00738673|69578723|FG001|Overall Study|Protocol Violation|2|||
37893393|NCT00738673|69578722|FG000|Overall Study|Withdrawal by Subject|3|||
37893394|NCT00738673|69578723|FG001|Overall Study|Withdrawal by Subject|1|||
37893395|NCT00811954|69578732|FG000|Overall Study|Death|10|||
37893396|NCT00811954|69578733|FG001|Overall Study|Death|6|||
37893397|NCT00811954|69578734|FG002|Overall Study|Death|13|||
37893398|NCT00811954|69578732|FG000|Overall Study|Lost to Follow-up|29|||
37893399|NCT00811954|69578733|FG001|Overall Study|Lost to Follow-up|23|||
37989420|NCT00346164|69674686|FG000|Overall Study|Protocol Violation|6|||
37989421|NCT00346164|69674687|FG001|Overall Study|Protocol Violation|2|||
37989422|NCT00346164|69674688|FG002|Overall Study|Protocol Violation|10|||
37989423|NCT00346164|69674689|FG003|Overall Study|Protocol Violation|4|||
37989424|NCT00346164|69674686|FG000|Overall Study|Withdrawal by Subject|0|||
37989425|NCT00346164|69674687|FG001|Overall Study|Withdrawal by Subject|0|||
37989426|NCT00346164|69674688|FG002|Overall Study|Withdrawal by Subject|2|||
37989427|NCT00346164|69674689|FG003|Overall Study|Withdrawal by Subject|0|||
37989428|NCT00346164|69674686|FG000|Overall Study|Ineligible|11|||
37989429|NCT00346164|69674687|FG001|Overall Study|Ineligible|2|||
37989430|NCT00346164|69674688|FG002|Overall Study|Ineligible|2|||
37989431|NCT00346164|69674689|FG003|Overall Study|Ineligible|23|||
37989432|NCT00346164|69674686|FG000|Overall Study|Refusal of further protocol therapy|0|||
37989433|NCT00346164|69674687|FG001|Overall Study|Refusal of further protocol therapy|1|||
37989434|NCT00346164|69674688|FG002|Overall Study|Refusal of further protocol therapy|3|||
37989435|NCT00346164|69674689|FG003|Overall Study|Refusal of further protocol therapy|15|||
37989436|NCT00346164|69674686|FG000|Overall Study|Inability to start week 16 tx on time|0|||
37989437|NCT00346164|69674687|FG001|Overall Study|Inability to start week 16 tx on time|0|||
37989438|NCT00346164|69674688|FG002|Overall Study|Inability to start week 16 tx on time|0|||
37989439|NCT00346164|69674689|FG003|Overall Study|Inability to start week 16 tx on time|11|||
37989440|NCT00114244|69674717|FG000|Overall Study|Adverse Event|2|||
37989441|NCT00114244|69674718|FG001|Overall Study|Adverse Event|5|||
37989442|NCT00114244|69674717|FG000|Overall Study|Withdrawal by Subject|0|||
37989443|NCT00114244|69674718|FG001|Overall Study|Withdrawal by Subject|2|||
37989444|NCT00138658|69674724|FG000|Overall Study|Adverse Event|23|||
37989445|NCT00138658|69674724|FG000|Overall Study|Death|1|||
37989446|NCT00138658|69674724|FG000|Overall Study|Disease Progression|21|||
37893400|NCT00811954|69578734|FG002|Overall Study|Lost to Follow-up|34|||
37893401|NCT00811954|69578732|FG000|Overall Study|Not able to get to clinic|28|||
37893402|NCT00811954|69578733|FG001|Overall Study|Not able to get to clinic|35|||
37893403|NCT00811954|69578734|FG002|Overall Study|Not able to get to clinic|30|||
37893404|NCT00811954|69578732|FG000|Overall Study|Not willing to adhere to requirements|12|||
37893405|NCT00811954|69578733|FG001|Overall Study|Not willing to adhere to requirements|2|||
37893406|NCT00811954|69578734|FG002|Overall Study|Not willing to adhere to requirements|16|||
37893407|NCT00811954|69578732|FG000|Overall Study|Withdraw consent prior study completion|4|||
37893408|NCT00811954|69578733|FG001|Overall Study|Withdraw consent prior study completion|6|||
37893409|NCT00811954|69578734|FG002|Overall Study|Withdraw consent prior study completion|5|||
37893410|NCT00811954|69578732|FG000|Overall Study|Site Closure|4|||
37893411|NCT00811954|69578733|FG001|Overall Study|Site Closure|0|||
37893412|NCT00811954|69578734|FG002|Overall Study|Site Closure|1|||
37893413|NCT00811954|69578732|FG000|Overall Study|Severe Debilitation|2|||
37893414|NCT00811954|69578733|FG001|Overall Study|Severe Debilitation|0|||
37893415|NCT00811954|69578734|FG002|Overall Study|Severe Debilitation|1|||
37893416|NCT00811954|69578732|FG000|Overall Study|Complete Protocol: No follow-up|0|||
37989447|NCT00138658|69674724|FG000|Overall Study|Physician Decision|11|||
37989448|NCT00138658|69674724|FG000|Overall Study|Withdrawal by Subject|5|||
37989449|NCT00337662|69674733|FG000|Study Period II|Lost to Follow-up|0|||
37989450|NCT00337662|69674734|FG001|Study Period II|Lost to Follow-up|0|||
37989451|NCT00337662|69674735|FG002|Study Period II|Lost to Follow-up|0|||
37989452|NCT00337662|69674736|FG003|Study Period II|Lost to Follow-up|35|||
37989453|NCT00337662|69674733|FG000|Study Period II|Withdrawal by Subject|0|||
37989454|NCT00337662|69674734|FG001|Study Period II|Withdrawal by Subject|0|||
37989455|NCT00337662|69674735|FG002|Study Period II|Withdrawal by Subject|0|||
37989456|NCT00337662|69674736|FG003|Study Period II|Withdrawal by Subject|20|||
37989457|NCT00337662|69674733|FG000|Study Period II|Adverse Event|0|||
37989458|NCT00337662|69674734|FG001|Study Period II|Adverse Event|0|||
37989459|NCT00337662|69674735|FG002|Study Period II|Adverse Event|0|||
37893417|NCT00811954|69578733|FG001|Overall Study|Complete Protocol: No follow-up|0|||
37893418|NCT00811954|69578734|FG002|Overall Study|Complete Protocol: No follow-up|1|||
37893419|NCT01032200|69578744|FG000|Overall Study|Death|1|||
37893420|NCT01032200|69578745|FG001|Overall Study|Death|1|||
37893421|NCT01032200|69578744|FG000|Overall Study|Withdrawal by Subject|1|||
37893422|NCT01032200|69578745|FG001|Overall Study|Withdrawal by Subject|3|||
37989460|NCT00337662|69674736|FG003|Study Period II|Adverse Event|16|||
37989461|NCT00337662|69674733|FG000|Study Period II|Physician Decision|0|||
37989462|NCT00337662|69674734|FG001|Study Period II|Physician Decision|0|||
37989463|NCT00337662|69674735|FG002|Study Period II|Physician Decision|0|||
37989464|NCT00337662|69674736|FG003|Study Period II|Physician Decision|13|||
37989465|NCT00337662|69674733|FG000|Study Period II|Entry Criteria Not Met|0|||
37989466|NCT00337662|69674734|FG001|Study Period II|Entry Criteria Not Met|0|||
37989467|NCT00337662|69674735|FG002|Study Period II|Entry Criteria Not Met|0|||
37989468|NCT00337662|69674736|FG003|Study Period II|Entry Criteria Not Met|6|||
37989469|NCT00337662|69674733|FG000|Study Period II|Protocol Violation|0|||
37989470|NCT00337662|69674734|FG001|Study Period II|Protocol Violation|0|||
37989471|NCT00337662|69674735|FG002|Study Period II|Protocol Violation|0|||
37989472|NCT00337662|69674736|FG003|Study Period II|Protocol Violation|6|||
37893423|NCT01032200|69578744|FG000|Overall Study|Toxicity|0|||
37893424|NCT01032200|69578745|FG001|Overall Study|Toxicity|2|||
37893425|NCT01032200|69578744|FG000|Overall Study|Progression|1|||
37893426|NCT01032200|69578745|FG001|Overall Study|Progression|0|||
37893427|NCT01032200|69578744|FG000|Overall Study|Multiple|1|||
37893428|NCT01032200|69578745|FG001|Overall Study|Multiple|1|||
37893429|NCT00738283|69578751|FG000|Overall Study|Death|1|||
37893430|NCT00738283|69578751|FG000|Overall Study|Transfer to another facility|2|||
37893431|NCT00738283|69578751|FG000|Overall Study|Discharge home prior to end of study|1|||
37893432|NCT00586105|69578764|FG000|Overall Study|Adverse Event|4|||
37893433|NCT00586105|69578764|FG000|Overall Study|Death|2|||
37893434|NCT00586105|69578764|FG000|Overall Study|Protocol Violation|1|||
37893435|NCT00586105|69578764|FG000|Overall Study|Withdrawal by Subject|3|||
37893436|NCT00586105|69578764|FG000|Overall Study|Disease progression|19|||
37893437|NCT00586105|69578764|FG000|Overall Study|Switched to commercial drug|9|||
37893438|NCT00586105|69578764|FG000|Overall Study|Reason not reported|1|||
37893439|NCT00743119|69578768|FG000|Overall Study|unreliable|3|||
37893440|NCT00743119|69578768|FG000|Overall Study|Withdrawal by Subject|1|||
37893441|NCT00733369|69578782|FG000|Overall Study|Lost to Follow-up|2|||
37893442|NCT00733369|69578783|FG001|Overall Study|Lost to Follow-up|1|||
37893443|NCT00733369|69578782|FG000|Overall Study|Adverse Event|4|||
37893444|NCT00733369|69578783|FG001|Overall Study|Adverse Event|4|||
37893445|NCT00733369|69578782|FG000|Overall Study|Protocol Violation|4|||
37893446|NCT00733369|69578783|FG001|Overall Study|Protocol Violation|4|||
37893447|NCT00813124|69578789|FG000|Overall Study|Death|2|||
37893448|NCT00813124|69578789|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
37893449|NCT00813124|69578789|FG000|Overall Study|Withdrawal by Subject|1|||
37893450|NCT00733291|69578795|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
37893451|NCT00733291|69578796|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
37893452|NCT00733291|69578797|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
37893453|NCT00733291|69578798|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
37893454|NCT00732199|69578811|FG000|Overall Study|Withdrawal by Subject|25|||
37893455|NCT00732199|69578812|FG001|Overall Study|Withdrawal by Subject|18|||
37893456|NCT00732199|69578811|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
37893457|NCT00732199|69578812|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
37893458|NCT00807040|69578823|FG000|Overall Study|Death|24|||
37893459|NCT00807040|69578824|FG001|Overall Study|Death|29|||
37893460|NCT00807040|69578823|FG000|Overall Study|Withdrawal by Subject|8|||
37893461|NCT00807040|69578824|FG001|Overall Study|Withdrawal by Subject|6|||
37893462|NCT00807040|69578823|FG000|Overall Study|Lost to Follow-up|4|||
37893463|NCT00807040|69578824|FG001|Overall Study|Lost to Follow-up|6|||
37893464|NCT00811720|69578832|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
37893465|NCT00811720|69578833|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
37893466|NCT00811720|69578832|FG000|All Treated Patients|Adverse Event|20|||
37893467|NCT00811720|69578833|FG001|All Treated Patients|Adverse Event|62|||
37893468|NCT00811720|69578832|FG000|All Treated Patients|Lack of Efficacy|22|||
37893469|NCT00811720|69578833|FG001|All Treated Patients|Lack of Efficacy|18|||
37893470|NCT00811720|69578832|FG000|All Treated Patients|Non-compliance|0|||
37893471|NCT00811720|69578833|FG001|All Treated Patients|Non-compliance|14|||
37893472|NCT00811720|69578832|FG000|All Treated Patients|Protocol Violation|9|||
37893473|NCT00811720|69578833|FG001|All Treated Patients|Protocol Violation|16|||
37893474|NCT00811720|69578832|FG000|All Treated Patients|Withdrawal by Subject|28|||
37893475|NCT00811720|69578833|FG001|All Treated Patients|Withdrawal by Subject|34|||
37893476|NCT00811720|69578832|FG000|All Treated Patients|Lost to Follow-up|10|||
37893477|NCT00811720|69578833|FG001|All Treated Patients|Lost to Follow-up|16|||
37893478|NCT00811720|69578832|FG000|All Treated Patients|Other Reason|7|||
37893479|NCT00811720|69578833|FG001|All Treated Patients|Other Reason|4|||
37893480|NCT04202679|69578841|FG000|Overall Study|Adverse Event|2|||
37989473|NCT00337662|69674733|FG000|Study Period II|Lack of Efficacy|0|||
37989474|NCT00337662|69674734|FG001|Study Period II|Lack of Efficacy|0|||
37893481|NCT04202679|69578842|FG001|Overall Study|Adverse Event|0|||
37893482|NCT04202679|69578841|FG000|Overall Study|Poor compliance to protocol|1|||
37893483|NCT04202679|69578842|FG001|Overall Study|Poor compliance to protocol|0|||
37893484|NCT04202679|69578841|FG000|Overall Study|Withdrawal by Subject|23|||
37893485|NCT04202679|69578842|FG001|Overall Study|Withdrawal by Subject|6|||
37893486|NCT00811642|69578849|FG000|Overall Study|Adverse Event|3|||
37893487|NCT00811642|69578849|FG000|Overall Study|Protocol Violation|1|||
37893488|NCT00811642|69578849|FG000|Overall Study|Death|2|||
37893489|NCT00811642|69578849|FG000|Overall Study|Withdrawal by Subject|7|||
37893490|NCT00811642|69578849|FG000|Overall Study|Cumulative use of antifungal agent|2|||
37893491|NCT00809926|69578855|FG000|Overall Study|Adverse Event|18|||
37893492|NCT00809926|69578856|FG001|Overall Study|Adverse Event|10|||
37893493|NCT00809926|69578855|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
37893494|NCT00809926|69578856|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
37893495|NCT00809926|69578855|FG000|Overall Study|Patient withdrew consent|8|||
37893496|NCT00809926|69578856|FG001|Overall Study|Patient withdrew consent|6|||
37893497|NCT00809926|69578855|FG000|Overall Study|Lost to Follow-up|2|||
37893498|NCT00809926|69578856|FG001|Overall Study|Lost to Follow-up|1|||
37893499|NCT00809926|69578855|FG000|Overall Study|Administrative Problems|0|||
37893500|NCT00809926|69578856|FG001|Overall Study|Administrative Problems|1|||
37893501|NCT00809926|69578855|FG000|Overall Study|Protocol deviation|0|||
37893502|NCT00809926|69578856|FG001|Overall Study|Protocol deviation|2|||
37893503|NCT00590980|69578862|FG000|Overall Study|Did not meet all inclusion criteria|10|||
37893504|NCT00590824|69578870|FG000|Overall Study|Disease could not be resected|0|||
37893505|NCT00590824|69578871|FG001|Overall Study|Disease could not be resected|2|||
37893506|NCT00590824|69578872|FG002|Overall Study|Disease could not be resected|1|||
37893507|NCT00590824|69578873|FG003|Overall Study|Disease could not be resected|0|||
37893508|NCT00590824|69578870|FG000|Overall Study|Adverse Event|0|||
37893509|NCT00590824|69578871|FG001|Overall Study|Adverse Event|0|||
37893510|NCT00590824|69578872|FG002|Overall Study|Adverse Event|0|||
37893511|NCT00590824|69578873|FG003|Overall Study|Adverse Event|1|||
37893512|NCT00590590|69578886|FG000|Overall Study|Lack of Efficacy|1|||
37893513|NCT00590590|69578887|FG001|Overall Study|Lack of Efficacy|2|||
37893514|NCT00590590|69578888|FG002|Overall Study|Lack of Efficacy|0|||
37893515|NCT00590590|69578886|FG000|Overall Study|Adverse Event|1|||
37893516|NCT00590590|69578887|FG001|Overall Study|Adverse Event|0|||
37893517|NCT00590590|69578888|FG002|Overall Study|Adverse Event|0|||
37893518|NCT00590590|69578886|FG000|Overall Study|Protocol Violation|0|||
37893519|NCT00590590|69578887|FG001|Overall Study|Protocol Violation|0|||
37893520|NCT00590590|69578888|FG002|Overall Study|Protocol Violation|2|||
37893521|NCT00590590|69578886|FG000|Overall Study|Lost to Follow-up|4|||
37893522|NCT00590590|69578887|FG001|Overall Study|Lost to Follow-up|1|||
37893523|NCT00590590|69578888|FG002|Overall Study|Lost to Follow-up|2|||
37893524|NCT00590590|69578886|FG000|Overall Study|Withdrawal by Subject|0|||
37893525|NCT00590590|69578887|FG001|Overall Study|Withdrawal by Subject|1|||
37893526|NCT00590590|69578888|FG002|Overall Study|Withdrawal by Subject|1|||
37893527|NCT00590590|69578886|FG000|Overall Study|Did not complete due to study closure|1|||
37893528|NCT00590590|69578887|FG001|Overall Study|Did not complete due to study closure|1|||
37893529|NCT00590590|69578888|FG002|Overall Study|Did not complete due to study closure|1|||
37893530|NCT00590590|69578886|FG000|Overall Study|Did not complete study|0|||
37893531|NCT00590590|69578887|FG001|Overall Study|Did not complete study|1|||
37893532|NCT00590590|69578888|FG002|Overall Study|Did not complete study|0|||
37893533|NCT00809614|69578898|FG000|Overall Study|Lack of Efficacy|2|||
37893534|NCT00809614|69578899|FG001|Overall Study|Lack of Efficacy|3|||
37893535|NCT00809614|69578898|FG000|Overall Study|Withdrawal by Subject|1|||
37893536|NCT00809614|69578899|FG001|Overall Study|Withdrawal by Subject|1|||
37893537|NCT00731731|69578908|FG000|Overall Study|Protocol Violation|0|||
37893538|NCT00731731|69578909|FG001|Overall Study|Protocol Violation|0|||
37893539|NCT00731731|69578910|FG002|Overall Study|Protocol Violation|1|||
37893540|NCT00731731|69578908|FG000|Overall Study|Cancel prior to treatment|0|||
37893541|NCT00731731|69578909|FG001|Overall Study|Cancel prior to treatment|0|||
37893542|NCT00731731|69578910|FG002|Overall Study|Cancel prior to treatment|2|||
37893543|NCT00806494|69578923|FG000|Overall Study|Adverse Event|29|||
37893544|NCT00806494|69578923|FG000|Overall Study|Lack of Efficacy|6|||
37893545|NCT00806494|69578923|FG000|Overall Study|Lost to Follow-up|10|||
37893546|NCT00806494|69578923|FG000|Overall Study|Other|30|||
37893547|NCT00806494|69578923|FG000|Overall Study|Withdrawal by Subject|5|||
37893548|NCT00806416|69578930|FG000|Period 1 - Part I|Adverse Event|0|||
37893549|NCT00806416|69578931|FG001|Period 1 - Part I|Adverse Event|1|||
37893550|NCT00806416|69578932|FG002|Period 1 - Part I|Adverse Event|0|||
37893551|NCT00806416|69578933|FG003|Period 1 - Part I|Adverse Event|0|||
37893552|NCT00806416|69578930|FG000|Period 1 - Part I|Lost to Follow-up|0|||
37893553|NCT00806416|69578931|FG001|Period 1 - Part I|Lost to Follow-up|2|||
37893554|NCT00806416|69578932|FG002|Period 1 - Part I|Lost to Follow-up|0|||
37893555|NCT00806416|69578933|FG003|Period 1 - Part I|Lost to Follow-up|0|||
37893556|NCT00806416|69578930|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
37893557|NCT00806416|69578931|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
37893558|NCT00806416|69578932|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
37893559|NCT00806416|69578933|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
37893560|NCT00806416|69578930|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
37893561|NCT00806416|69578931|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
37893562|NCT00806416|69578932|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
37893563|NCT00806416|69578933|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
37893564|NCT02724969|69578943|FG000|Overall Study|Lost to Follow-up|12|||
37893565|NCT02724969|69578944|FG001|Overall Study|Lost to Follow-up|6|||
37893566|NCT02724969|69578943|FG000|Overall Study|Withdrawal by Subject|3|||
37893567|NCT02724969|69578944|FG001|Overall Study|Withdrawal by Subject|3|||
37893568|NCT02724969|69578943|FG000|Overall Study|Infant demise|0|||
37893569|NCT02724969|69578944|FG001|Overall Study|Infant demise|2|||
37893570|NCT00811252|69578953|FG000|Overall Study|Adverse Event|6|||
37893571|NCT00811252|69578954|FG001|Overall Study|Adverse Event|10|||
37893572|NCT00811252|69578955|FG002|Overall Study|Adverse Event|15|||
37893573|NCT00811252|69578953|FG000|Overall Study|Lack of Efficacy|7|||
37893574|NCT00811252|69578954|FG001|Overall Study|Lack of Efficacy|2|||
37893575|NCT00811252|69578955|FG002|Overall Study|Lack of Efficacy|0|||
37893576|NCT00811252|69578953|FG000|Overall Study|Protocol Violation|3|||
37893577|NCT00811252|69578954|FG001|Overall Study|Protocol Violation|3|||
37893578|NCT00811252|69578955|FG002|Overall Study|Protocol Violation|2|||
37893579|NCT00811252|69578953|FG000|Overall Study|Withdrawal of Consent|1|||
37893580|NCT00811252|69578954|FG001|Overall Study|Withdrawal of Consent|2|||
37893581|NCT00811252|69578955|FG002|Overall Study|Withdrawal of Consent|2|||
37893582|NCT00811252|69578953|FG000|Overall Study|Lost to Follow-up|0|||
37893583|NCT00811252|69578954|FG001|Overall Study|Lost to Follow-up|0|||
37893584|NCT00811252|69578955|FG002|Overall Study|Lost to Follow-up|2|||
37893585|NCT00811252|69578953|FG000|Overall Study|Administrative or Other Reasons|0|||
37893586|NCT00811252|69578954|FG001|Overall Study|Administrative or Other Reasons|3|||
37893587|NCT00811252|69578955|FG002|Overall Study|Administrative or Other Reasons|2|||
37893588|NCT00736957|69578972|FG000|Overall Study|Adverse Event|43|||
37893589|NCT00736957|69578972|FG000|Overall Study|Withdrawal by Subject|49|||
37893590|NCT00736957|69578972|FG000|Overall Study|violation of eligibility criteria|2|||
37893591|NCT00736957|69578972|FG000|Overall Study|did not attend hospital appointments|1|||
37893592|NCT00736957|69578972|FG000|Overall Study|not eligible for Treatment Period I|22|||
37893593|NCT00736957|69578972|FG000|Overall Study|Physician Decision|5|||
37893594|NCT00736879|69578980|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
37893595|NCT00736879|69578981|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
37893596|NCT00736879|69578982|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
37696132|NCT02275117|69172305|FG000|Overall Study|Terminated by Sponsor|4|||
37893597|NCT00736879|69578983|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
37893598|NCT00736879|69578980|FG000|Double Blind Treatment Period|Adverse Event|0|||
37893599|NCT00736879|69578981|FG001|Double Blind Treatment Period|Adverse Event|1|||
37893600|NCT00736879|69578982|FG002|Double Blind Treatment Period|Adverse Event|1|||
37893601|NCT00736879|69578983|FG003|Double Blind Treatment Period|Adverse Event|0|||
37893602|NCT00736879|69578980|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
37893603|NCT00736879|69578981|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
37893604|NCT00736879|69578982|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
37893605|NCT00736879|69578983|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
37893606|NCT00736879|69578980|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
37893607|NCT00736879|69578981|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
37893608|NCT00736879|69578982|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
37893609|NCT00736879|69578983|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
37893610|NCT00736879|69578980|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
37893611|NCT00736879|69578981|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
37893612|NCT00736879|69578982|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
37893613|NCT00736879|69578983|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
37893614|NCT00736879|69578980|FG000|Double Blind Treatment Period|No longer met criteria|0|||
37893615|NCT00736879|69578981|FG001|Double Blind Treatment Period|No longer met criteria|1|||
37893616|NCT00736879|69578982|FG002|Double Blind Treatment Period|No longer met criteria|0|||
37893617|NCT00736879|69578983|FG003|Double Blind Treatment Period|No longer met criteria|0|||
37893618|NCT00736879|69578980|FG000|Double Blind Treatment Period|non-specified|0|||
37893619|NCT00736879|69578981|FG001|Double Blind Treatment Period|non-specified|1|||
37893620|NCT00736879|69578982|FG002|Double Blind Treatment Period|non-specified|0|||
37893621|NCT00736879|69578983|FG003|Double Blind Treatment Period|non-specified|0|||
37893622|NCT00736879|69578980|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
37893623|NCT00736879|69578981|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
37893624|NCT00736879|69578982|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
37893625|NCT00736879|69578983|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
37893626|NCT00736879|69578980|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
37893627|NCT00736879|69578981|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
37893628|NCT00736879|69578982|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
37893629|NCT00736879|69578983|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
37893630|NCT00806260|69579002|FG000|Period 1 (1 Day)|Adverse Event|0|||
37893631|NCT00806260|69579003|FG001|Period 1 (1 Day)|Adverse Event|0|||
37893632|NCT00806260|69579004|FG002|Period 1 (1 Day)|Adverse Event|0|||
37893633|NCT00806260|69579005|FG003|Period 1 (1 Day)|Adverse Event|0|||
37893634|NCT00806260|69579006|FG004|Period 1 (1 Day)|Adverse Event|3|||
37893635|NCT00806260|69579007|FG005|Period 1 (1 Day)|Adverse Event|0|||
37893636|NCT00806260|69579002|FG000|Period 2|Adverse Event|0|||
37893637|NCT00806260|69579003|FG001|Period 2|Adverse Event|0|||
37893638|NCT00806260|69579004|FG002|Period 2|Adverse Event|0|||
37893639|NCT00806260|69579005|FG003|Period 2|Adverse Event|1|||
37893640|NCT00806260|69579006|FG004|Period 2|Adverse Event|0|||
37893641|NCT00806260|69579007|FG005|Period 2|Adverse Event|0|||
37893642|NCT00806260|69579002|FG000|Period 2|Protocol Violation|1|||
37893643|NCT00806260|69579003|FG001|Period 2|Protocol Violation|0|||
37893644|NCT00806260|69579004|FG002|Period 2|Protocol Violation|1|||
37893645|NCT00806260|69579005|FG003|Period 2|Protocol Violation|0|||
37893646|NCT00806260|69579006|FG004|Period 2|Protocol Violation|0|||
37893647|NCT00806260|69579007|FG005|Period 2|Protocol Violation|0|||
37893648|NCT00806260|69579002|FG000|Period 2|Need to take concomitant medication|1|||
37893649|NCT00806260|69579003|FG001|Period 2|Need to take concomitant medication|0|||
37893650|NCT00806260|69579004|FG002|Period 2|Need to take concomitant medication|0|||
37893651|NCT00806260|69579005|FG003|Period 2|Need to take concomitant medication|0|||
37893652|NCT00806260|69579006|FG004|Period 2|Need to take concomitant medication|0|||
37893653|NCT00806260|69579007|FG005|Period 2|Need to take concomitant medication|0|||
37893654|NCT00806260|69579002|FG000|Period 2|sponsor request|0|||
37893655|NCT00806260|69579003|FG001|Period 2|sponsor request|0|||
37893656|NCT00806260|69579004|FG002|Period 2|sponsor request|1|||
37893657|NCT00806260|69579005|FG003|Period 2|sponsor request|1|||
37893658|NCT00806260|69579006|FG004|Period 2|sponsor request|0|||
37893659|NCT00806260|69579007|FG005|Period 2|sponsor request|0|||
37893660|NCT00806260|69579002|FG000|Period 3|Protocol Violation|0|||
37893661|NCT00806260|69579003|FG001|Period 3|Protocol Violation|1|||
37893662|NCT00806260|69579004|FG002|Period 3|Protocol Violation|1|||
37893663|NCT00806260|69579005|FG003|Period 3|Protocol Violation|0|||
37696133|NCT02275117|69172306|FG001|Overall Study|Terminated by Sponsor|4|||
37696134|NCT02275117|69172307|FG002|Overall Study|Terminated by Sponsor|4|||
37893664|NCT00806260|69579006|FG004|Period 3|Protocol Violation|0|||
37893665|NCT00806260|69579007|FG005|Period 3|Protocol Violation|0|||
37893666|NCT00806260|69579002|FG000|Period 3|Pregnancy|1|||
37893667|NCT00806260|69579003|FG001|Period 3|Pregnancy|0|||
37893668|NCT00806260|69579004|FG002|Period 3|Pregnancy|0|||
37893669|NCT00806260|69579005|FG003|Period 3|Pregnancy|0|||
37893670|NCT00806260|69579006|FG004|Period 3|Pregnancy|0|||
37893671|NCT00806260|69579007|FG005|Period 3|Pregnancy|0|||
37893672|NCT00742885|69579021|FG000|Overall Study|Lost to Follow-up|1|||
37893673|NCT00742885|69579022|FG001|Overall Study|Lost to Follow-up|0|||
37893674|NCT00811174|69579031|FG000|Overall Study|Protocol Violation|2|||
37893675|NCT00811174|69579031|FG000|Overall Study|Sponsors Decision|1|||
37893676|NCT00730405|69579040|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
37893677|NCT00730405|69579041|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
37893678|NCT00730405|69579042|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
37989475|NCT00337662|69674735|FG002|Study Period II|Lack of Efficacy|0|||
37893679|NCT00730405|69579043|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
37893680|NCT00730405|69579044|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
37893681|NCT00730405|69579040|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
37893682|NCT00730405|69579041|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
37893683|NCT00730405|69579042|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
37893684|NCT00730405|69579043|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
37893685|NCT00730405|69579044|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
37893686|NCT00730405|69579040|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
37893687|NCT00730405|69579041|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
37893688|NCT00730405|69579042|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
37893689|NCT00730405|69579043|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
37893690|NCT00730405|69579044|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
37893691|NCT00730405|69579040|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
37893692|NCT00730405|69579041|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
37893693|NCT00730405|69579042|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
37893694|NCT00730405|69579043|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
37893695|NCT00730405|69579044|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
37893696|NCT00730405|69579040|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
37893697|NCT00730405|69579041|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
37893698|NCT00730405|69579042|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
37893699|NCT00730405|69579043|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
37893700|NCT00730405|69579044|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
37893701|NCT00730405|69579040|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
37893702|NCT00730405|69579041|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
37893703|NCT00730405|69579042|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
37893704|NCT00730405|69579043|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
37893705|NCT00730405|69579044|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
37893706|NCT00730405|69579040|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
37893707|NCT00730405|69579041|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
37893708|NCT00730405|69579042|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
37893709|NCT00730405|69579043|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
37893710|NCT00730405|69579044|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
37893711|NCT00730405|69579040|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
37893712|NCT00730405|69579041|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
37893713|NCT00730405|69579042|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
37893714|NCT00730405|69579043|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
37893715|NCT00730405|69579044|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
37893716|NCT00730405|69579040|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
37893717|NCT00730405|69579041|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
37893718|NCT00730405|69579042|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
37893719|NCT00730405|69579043|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
37893720|NCT00730405|69579044|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
37893721|NCT00730405|69579040|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
37893722|NCT00730405|69579041|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
37893723|NCT00730405|69579042|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
37893724|NCT00730405|69579043|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
37893725|NCT00730405|69579044|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
37893726|NCT00730405|69579040|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
37893727|NCT00730405|69579041|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
37893728|NCT00730405|69579042|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
37893729|NCT00730405|69579043|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
37893730|NCT00730405|69579044|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
37893731|NCT00730405|69579040|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
37893732|NCT00730405|69579041|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
37893733|NCT00730405|69579042|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
37893734|NCT00730405|69579043|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
37893735|NCT00730405|69579044|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
37893736|NCT00730405|69579040|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
37696135|NCT02275117|69172308|FG003|Overall Study|Terminated by Sponsor|6|||
37696136|NCT02275117|69172309|FG004|Overall Study|Terminated by Sponsor|4|||
37893737|NCT00730405|69579041|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
37893738|NCT00730405|69579042|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
37696137|NCT02275117|69172305|FG000|Overall Study|Worsening of Study Indication|0|||
37893739|NCT00730405|69579043|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
37893740|NCT00730405|69579044|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
37893741|NCT00730405|69579040|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
37893742|NCT00730405|69579041|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
37893743|NCT00730405|69579042|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
37893744|NCT00730405|69579043|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
37893745|NCT00730405|69579044|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
37893746|NCT00730405|69579040|FG000|Overall Study-Treatment Phase|Change of location|0|||
37989476|NCT00337662|69674736|FG003|Study Period II|Lack of Efficacy|7|||
37989477|NCT00337662|69674733|FG000|Study Period II|Sponsor Decision|0|||
37989478|NCT00337662|69674734|FG001|Study Period II|Sponsor Decision|0|||
37989479|NCT00337662|69674735|FG002|Study Period II|Sponsor Decision|0|||
37989480|NCT00337662|69674736|FG003|Study Period II|Sponsor Decision|2|||
37989481|NCT00337662|69674733|FG000|Study Period II|Parent/Caregiver Decision|0|||
37989482|NCT00337662|69674734|FG001|Study Period II|Parent/Caregiver Decision|0|||
37989483|NCT00337662|69674735|FG002|Study Period II|Parent/Caregiver Decision|0|||
37989484|NCT00337662|69674736|FG003|Study Period II|Parent/Caregiver Decision|1|||
37989485|NCT00337662|69674733|FG000|Study Period III|Lost to Follow-up|14|||
37989486|NCT00337662|69674734|FG001|Study Period III|Lost to Follow-up|16|||
37989487|NCT00337662|69674735|FG002|Study Period III|Lost to Follow-up|14|||
37989488|NCT00337662|69674736|FG003|Study Period III|Lost to Follow-up|0|||
37989489|NCT00337662|69674733|FG000|Study Period III|Withdrawal by Subject|18|||
37989490|NCT00337662|69674734|FG001|Study Period III|Withdrawal by Subject|14|||
37989491|NCT00337662|69674735|FG002|Study Period III|Withdrawal by Subject|12|||
37989492|NCT00337662|69674736|FG003|Study Period III|Withdrawal by Subject|0|||
37989493|NCT00337662|69674733|FG000|Study Period III|Adverse Event|9|||
37989494|NCT00337662|69674734|FG001|Study Period III|Adverse Event|10|||
37989495|NCT00337662|69674735|FG002|Study Period III|Adverse Event|8|||
37989496|NCT00337662|69674736|FG003|Study Period III|Adverse Event|0|||
37989497|NCT00337662|69674733|FG000|Study Period III|Protocol Violation|3|||
37989498|NCT00337662|69674734|FG001|Study Period III|Protocol Violation|8|||
37989499|NCT00337662|69674735|FG002|Study Period III|Protocol Violation|2|||
37989500|NCT00337662|69674736|FG003|Study Period III|Protocol Violation|0|||
37989501|NCT00337662|69674733|FG000|Study Period III|Physician Decision|6|||
37989502|NCT00337662|69674734|FG001|Study Period III|Physician Decision|5|||
37989503|NCT00337662|69674735|FG002|Study Period III|Physician Decision|0|||
37989504|NCT00337662|69674736|FG003|Study Period III|Physician Decision|0|||
37989505|NCT00337662|69674733|FG000|Study Period III|Entry Criteria Not Met|4|||
37989506|NCT00337662|69674734|FG001|Study Period III|Entry Criteria Not Met|1|||
37893747|NCT00730405|69579041|FG001|Overall Study-Treatment Phase|Change of location|0|||
37893748|NCT00730405|69579042|FG002|Overall Study-Treatment Phase|Change of location|0|||
37893749|NCT00730405|69579043|FG003|Overall Study-Treatment Phase|Change of location|1|||
37893750|NCT00730405|69579044|FG004|Overall Study-Treatment Phase|Change of location|0|||
37893751|NCT00730405|69579040|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
37893752|NCT00730405|69579041|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
37893753|NCT00730405|69579042|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
37893754|NCT00730405|69579043|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
37893755|NCT00730405|69579044|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
37893756|NCT00730405|69579040|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
37893757|NCT00730405|69579041|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
37893758|NCT00730405|69579042|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
37893759|NCT00730405|69579043|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
37893760|NCT00730405|69579044|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
37989507|NCT00337662|69674735|FG002|Study Period III|Entry Criteria Not Met|3|||
37989508|NCT00337662|69674736|FG003|Study Period III|Entry Criteria Not Met|0|||
37989509|NCT00337662|69674733|FG000|Study Period III|Lack of Efficacy|4|||
37989510|NCT00337662|69674734|FG001|Study Period III|Lack of Efficacy|4|||
37989511|NCT00337662|69674735|FG002|Study Period III|Lack of Efficacy|2|||
37989512|NCT00337662|69674736|FG003|Study Period III|Lack of Efficacy|0|||
37989513|NCT00337662|69674733|FG000|Study Period III|Parent/Caregiver Decision|0|||
37989514|NCT00337662|69674734|FG001|Study Period III|Parent/Caregiver Decision|0|||
37989515|NCT00337662|69674735|FG002|Study Period III|Parent/Caregiver Decision|2|||
37696138|NCT02275117|69172306|FG001|Overall Study|Worsening of Study Indication|1|||
37893761|NCT00730405|69579040|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
37989516|NCT00337662|69674736|FG003|Study Period III|Parent/Caregiver Decision|0|||
37989517|NCT00337662|69674733|FG000|Study Period III|Sponsor Decision|1|||
37989518|NCT00337662|69674734|FG001|Study Period III|Sponsor Decision|0|||
37989519|NCT00337662|69674735|FG002|Study Period III|Sponsor Decision|1|||
37893762|NCT00730405|69579041|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
37989520|NCT00337662|69674736|FG003|Study Period III|Sponsor Decision|0|||
37989521|NCT00337662|69674733|FG000|Study Period III|Clinical Relapse|1|||
37696139|NCT02275117|69172307|FG002|Overall Study|Worsening of Study Indication|2|||
37893763|NCT00730405|69579042|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
37893764|NCT00730405|69579043|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
37893765|NCT00730405|69579044|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
37893766|NCT00730405|69579040|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
37893767|NCT00730405|69579041|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
37893768|NCT00730405|69579042|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
37893769|NCT00730405|69579043|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
37893770|NCT00730405|69579044|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
37893771|NCT00730405|69579040|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
37893772|NCT00730405|69579041|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
37893773|NCT00730405|69579042|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
37893774|NCT00730405|69579043|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
37893775|NCT00730405|69579044|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
37893776|NCT00730405|69579040|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
37989522|NCT00337662|69674734|FG001|Study Period III|Clinical Relapse|0|||
37989523|NCT00337662|69674735|FG002|Study Period III|Clinical Relapse|0|||
37989524|NCT00337662|69674736|FG003|Study Period III|Clinical Relapse|0|||
37989525|NCT00138424|69674751|FG000|Overall Study|Physician Decision|0|||
37989526|NCT00138424|69674752|FG001|Overall Study|Physician Decision|1|||
37989527|NCT00138424|69674753|FG002|Overall Study|Physician Decision|0|||
37989528|NCT00138424|69674754|FG003|Overall Study|Physician Decision|0|||
37989529|NCT00368966|69674768|FG000|Infant Series|Withdrawal by Subject|11|||
37989530|NCT00368966|69674769|FG001|Infant Series|Withdrawal by Subject|6|||
37989531|NCT00368966|69674768|FG000|Infant Series|Protocol Violation|2|||
37989532|NCT00368966|69674769|FG001|Infant Series|Protocol Violation|1|||
37989533|NCT00368966|69674768|FG000|Infant Series|Lost to Follow-up|2|||
37989534|NCT00368966|69674769|FG001|Infant Series|Lost to Follow-up|0|||
37989535|NCT00368966|69674768|FG000|Infant Series|Randomization error|0|||
37989536|NCT00368966|69674769|FG001|Infant Series|Randomization error|1|||
37989537|NCT00368966|69674768|FG000|Infant Series|Failed to meet eligibility criteria|0|||
37989538|NCT00368966|69674769|FG001|Infant Series|Failed to meet eligibility criteria|1|||
37989539|NCT00368966|69674768|FG000|Infant Series|Adverse Event|0|||
37989540|NCT00368966|69674769|FG001|Infant Series|Adverse Event|1|||
37989541|NCT00368966|69674768|FG000|Infant Series|Failed to return|1|||
37989542|NCT00368966|69674769|FG001|Infant Series|Failed to return|0|||
37989543|NCT00368966|69674768|FG000|After Infant|Failed to return|3|||
37893777|NCT00730405|69579041|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
37893778|NCT00730405|69579042|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
37893779|NCT00730405|69579043|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
37893780|NCT00730405|69579044|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
37893781|NCT00730405|69579040|FG000|Overall Study-follow-up Phase|Death|0|||
37893782|NCT00730405|69579041|FG001|Overall Study-follow-up Phase|Death|1|||
37893783|NCT00730405|69579042|FG002|Overall Study-follow-up Phase|Death|0|||
37893784|NCT00730405|69579043|FG003|Overall Study-follow-up Phase|Death|1|||
37893785|NCT00730405|69579044|FG004|Overall Study-follow-up Phase|Death|0|||
37893786|NCT00730405|69579040|FG000|Overall Study-follow-up Phase|Change of location|1|||
37893787|NCT00730405|69579041|FG001|Overall Study-follow-up Phase|Change of location|1|||
37989544|NCT00368966|69674769|FG001|After Infant|Failed to return|1|||
37989545|NCT00368966|69674768|FG000|After Infant|Adverse Event|1|||
37989546|NCT00368966|69674769|FG001|After Infant|Adverse Event|2|||
37989547|NCT00368966|69674768|FG000|After Infant|Withdrawal by Subject|1|||
37989548|NCT00368966|69674769|FG001|After Infant|Withdrawal by Subject|1|||
37989549|NCT00368966|69674768|FG000|After Infant|Death|1|||
37989550|NCT00368966|69674769|FG001|After Infant|Death|0|||
37989551|NCT00368966|69674768|FG000|After Infant|Lost to Follow-up|0|||
37989552|NCT00368966|69674769|FG001|After Infant|Lost to Follow-up|1|||
37989553|NCT00368966|69674768|FG000|Toddler Dose|Withdrawal by Subject|1|||
37989554|NCT00368966|69674769|FG001|Toddler Dose|Withdrawal by Subject|1|||
37989555|NCT00368966|69674768|FG000|Toddler Dose|Lost to Follow-up|0|||
37989556|NCT00368966|69674769|FG001|Toddler Dose|Lost to Follow-up|2|||
37989557|NCT00114166|69674802|FG000|Overall Study|Wrong primary|0|||
37824712|NCT01054885|69506864|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
37989558|NCT00114166|69674803|FG001|Overall Study|Wrong primary|1|||
37824713|NCT01054885|69506865|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
37824714|NCT01054885|69506866|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
37824715|NCT01054885|69506860|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
37824716|NCT01054885|69506861|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
37824717|NCT01054885|69506862|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
37824718|NCT01054885|69506863|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
37824719|NCT01054885|69506864|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
37824720|NCT01054885|69506865|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
37989559|NCT00125242|69674813|FG000|Overall Study|did not qualify|7|||
37989560|NCT00125242|69674814|FG001|Overall Study|did not qualify|2|||
37989561|NCT00337428|69674821|FG000|Overall Study|Withdrawal by Subject|1|||
37989562|NCT00337428|69674822|FG001|Overall Study|Withdrawal by Subject|2|||
37989563|NCT00337428|69674821|FG000|Overall Study|Lack of Time|1|||
37989564|NCT00337428|69674822|FG001|Overall Study|Lack of Time|1|||
37989565|NCT00337428|69674821|FG000|Overall Study|Unwilling to Continue|1|||
37989566|NCT00337428|69674822|FG001|Overall Study|Unwilling to Continue|0|||
37989567|NCT00337428|69674821|FG000|Overall Study|Anorexia|1|||
37893788|NCT00730405|69579042|FG002|Overall Study-follow-up Phase|Change of location|0|||
37893789|NCT00730405|69579043|FG003|Overall Study-follow-up Phase|Change of location|1|||
37893790|NCT00730405|69579044|FG004|Overall Study-follow-up Phase|Change of location|0|||
37893791|NCT00730405|69579040|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
37989568|NCT00337428|69674822|FG001|Overall Study|Anorexia|0|||
37989569|NCT00235989|69674832|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
37989570|NCT00235989|69674833|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
37989571|NCT00235989|69674834|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
37989572|NCT00235989|69674835|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
37989573|NCT00235989|69674836|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
37989574|NCT00235989|69674837|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
37989575|NCT00235989|69674832|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
37989576|NCT00235989|69674833|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
37989577|NCT00235989|69674834|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
37989578|NCT00235989|69674835|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
37989579|NCT00235989|69674836|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
37989580|NCT00235989|69674837|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
37989581|NCT00235989|69674832|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
37989582|NCT00235989|69674833|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
37989583|NCT00235989|69674834|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
37989584|NCT00235989|69674835|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
37989585|NCT00235989|69674836|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
37989586|NCT00235989|69674837|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
37989587|NCT00235989|69674832|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
37989588|NCT00235989|69674833|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
37893792|NCT00730405|69579041|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
37893793|NCT00730405|69579042|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
37893794|NCT00730405|69579043|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
37893795|NCT00730405|69579044|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
37893796|NCT00730405|69579040|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
37893797|NCT00730405|69579041|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
37893798|NCT00730405|69579042|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
37893799|NCT00730405|69579043|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
37893800|NCT00730405|69579044|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
37893801|NCT00730405|69579040|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
37893802|NCT00730405|69579041|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
37893803|NCT00730405|69579042|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
37893804|NCT00730405|69579043|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
37893805|NCT00730405|69579044|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
37893806|NCT00730405|69579040|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
37893807|NCT00730405|69579041|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
37989589|NCT00235989|69674834|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
37989590|NCT00235989|69674835|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
37989591|NCT00235989|69674836|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
37989592|NCT00235989|69674837|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
37989593|NCT00235989|69674832|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
37989594|NCT00235989|69674833|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
37989595|NCT00235989|69674834|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
37989596|NCT00235989|69674835|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
37989597|NCT00235989|69674836|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
37989598|NCT00235989|69674837|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
37989599|NCT00113386|69674849|FG000|Overall Study|Withdrawal by Subject|1|||
37989600|NCT00113386|69674850|FG001|Overall Study|Withdrawal by Subject|0|||
37989601|NCT00113386|69674849|FG000|Overall Study|Physician Decision|0|||
37893808|NCT00730405|69579042|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
37989602|NCT00113386|69674850|FG001|Overall Study|Physician Decision|1|||
37989603|NCT00113386|69674849|FG000|Overall Study|Toxicity|3|||
37989604|NCT00113386|69674850|FG001|Overall Study|Toxicity|0|||
37893809|NCT00730405|69579043|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
37893810|NCT00730405|69579044|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
37893811|NCT00730405|69579040|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
37893812|NCT00730405|69579041|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
37893813|NCT00730405|69579042|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
37893814|NCT00730405|69579043|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
37893815|NCT00730405|69579044|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
37893816|NCT00730405|69579040|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
37893817|NCT00730405|69579041|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
37893818|NCT00730405|69579042|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
37893819|NCT00730405|69579043|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
37893820|NCT00730405|69579044|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
37893821|NCT00730405|69579040|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
37893822|NCT00730405|69579041|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
37893823|NCT00730405|69579042|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
37893824|NCT00730405|69579043|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
37893825|NCT00730405|69579044|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
37893826|NCT00730405|69579040|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
37893827|NCT00730405|69579041|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
37893828|NCT00730405|69579042|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
37893829|NCT00730405|69579043|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
37893830|NCT00730405|69579044|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
37893831|NCT00730405|69579040|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
37893832|NCT00730405|69579041|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
37893833|NCT00730405|69579042|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
37893834|NCT00730405|69579043|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
37893835|NCT00730405|69579044|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
37893836|NCT00730405|69579040|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
37893837|NCT00730405|69579041|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
37893838|NCT00730405|69579042|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
37893839|NCT00730405|69579043|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
37893840|NCT00730405|69579044|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
37893841|NCT00730405|69579040|FG000|Overall Study-follow-up Phase|Missing|0|||
37893842|NCT00730405|69579041|FG001|Overall Study-follow-up Phase|Missing|0|||
37893843|NCT00730405|69579042|FG002|Overall Study-follow-up Phase|Missing|2|||
37893844|NCT00730405|69579043|FG003|Overall Study-follow-up Phase|Missing|0|||
37893845|NCT00730405|69579044|FG004|Overall Study-follow-up Phase|Missing|0|||
37893846|NCT00730405|69579040|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
37893847|NCT00730405|69579041|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
37989605|NCT00113386|69674849|FG000|Overall Study|Ineligible|1|||
37989606|NCT00113386|69674850|FG001|Overall Study|Ineligible|2|||
37989607|NCT00113386|69674849|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
37989608|NCT00113386|69674850|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
37989609|NCT00353262|69674856|FG000|Overall Study|Adverse Event|8|||
37989610|NCT00353262|69674856|FG000|Overall Study|Withdrawal by Subject|2|||
37989611|NCT00353262|69674856|FG000|Overall Study|Insufficient Therapeutic Response|13|||
37989612|NCT00353262|69674856|FG000|Overall Study|Progression|1|||
37989613|NCT00353262|69674856|FG000|Overall Study|Surgery|4|||
37989614|NCT00353262|69674856|FG000|Overall Study|Break from Chemotherapy|1|||
37989615|NCT00337272|69674862|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
37989616|NCT00337272|69674863|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
37989617|NCT00337272|69674862|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
37989618|NCT00337272|69674863|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
37989619|NCT00337272|69674862|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
37989620|NCT00337272|69674863|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
37893848|NCT00730405|69579042|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
37893849|NCT00730405|69579043|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
37893850|NCT00730405|69579044|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
37893851|NCT00730405|69579040|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
37893852|NCT00730405|69579041|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
37893853|NCT00730405|69579042|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
37893854|NCT00730405|69579043|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
37893855|NCT00730405|69579044|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
37893856|NCT00730405|69579040|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
37893857|NCT00730405|69579041|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
37893858|NCT00730405|69579042|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
37893859|NCT00730405|69579043|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
37893860|NCT00730405|69579044|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
37893861|NCT00730405|69579040|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
37893862|NCT00730405|69579041|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
37893863|NCT00730405|69579042|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
37893864|NCT00730405|69579043|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
37893865|NCT00730405|69579044|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
37893866|NCT00730405|69579040|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
37893867|NCT00730405|69579041|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
37893868|NCT00730405|69579042|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
37893869|NCT00730405|69579043|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
37893870|NCT00730405|69579044|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
37893871|NCT00730405|69579040|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
37893872|NCT00730405|69579041|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
37893873|NCT00730405|69579042|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
37893874|NCT00730405|69579043|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
37893875|NCT00730405|69579044|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
37893876|NCT00736723|69579060|FG000|Overall Study|Withdrawal by Subject|4|||
37893877|NCT00736723|69579061|FG001|Overall Study|Withdrawal by Subject|3|||
37893878|NCT00736645|69579071|FG000|Overall Study|Adverse Event|0|||
37893879|NCT00736645|69579072|FG001|Overall Study|Adverse Event|2|||
37893880|NCT00736645|69579073|FG002|Overall Study|Adverse Event|0|||
37893881|NCT00736645|69579074|FG003|Overall Study|Adverse Event|0|||
37893882|NCT00736489|69579084|FG000|Period 1|Lost to Follow-up|1|||
37893883|NCT00736489|69579085|FG001|Period 1|Lost to Follow-up|0|||
37893884|NCT00736489|69579086|FG002|Period 1|Lost to Follow-up|0|||
37893885|NCT00736489|69579087|FG003|Period 1|Lost to Follow-up|0|||
37893886|NCT00736489|69579088|FG004|Period 1|Lost to Follow-up|0|||
37893887|NCT00736489|69579089|FG005|Period 1|Lost to Follow-up|0|||
37893888|NCT00736489|69579084|FG000|Period 1|Withdrawal by Subject|0|||
37893889|NCT00736489|69579085|FG001|Period 1|Withdrawal by Subject|0|||
37893890|NCT00736489|69579086|FG002|Period 1|Withdrawal by Subject|0|||
37893891|NCT00736489|69579087|FG003|Period 1|Withdrawal by Subject|0|||
37893892|NCT00736489|69579088|FG004|Period 1|Withdrawal by Subject|0|||
37893893|NCT00736489|69579089|FG005|Period 1|Withdrawal by Subject|1|||
37893894|NCT00730327|69579121|FG000|Overall Study|Lost to Follow-up|14|||
37893895|NCT00730327|69579122|FG001|Overall Study|Lost to Follow-up|16|||
37893896|NCT00730327|69579121|FG000|Overall Study|Adverse Event|8|||
37893897|NCT00730327|69579122|FG001|Overall Study|Adverse Event|1|||
37893898|NCT00730327|69579121|FG000|Overall Study|Withdrawal by Subject|3|||
37893899|NCT00730327|69579122|FG001|Overall Study|Withdrawal by Subject|13|||
37893900|NCT00730327|69579121|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
37893901|NCT00730327|69579122|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
37893902|NCT00742417|69579137|FG000|Randomized|Withdrawal by legal representative|0|||
37893903|NCT00742417|69579138|FG001|Randomized|Withdrawal by legal representative|1|||
37893904|NCT00742417|69579137|FG000|Randomized|Withdrawal by Subject|1|||
37893905|NCT00742417|69579138|FG001|Randomized|Withdrawal by Subject|0|||
37893906|NCT00742417|69579137|FG000|Randomized|Physician Decision|1|||
37893907|NCT00742417|69579138|FG001|Randomized|Physician Decision|0|||
37893908|NCT00742417|69579137|FG000|Intensive Period|Withdrawal by Subject|1|||
37893909|NCT00742417|69579138|FG001|Intensive Period|Withdrawal by Subject|1|||
37893910|NCT00742417|69579137|FG000|Intensive Period|Adverse Event|2|||
37989621|NCT00337272|69674862|FG000|Treatment Period|Non-compliance|1|||
37989622|NCT00337272|69674863|FG001|Treatment Period|Non-compliance|1|||
37989623|NCT00337272|69674862|FG000|Treatment Period|Withdrawal by Subject|0|||
37893911|NCT00742417|69579138|FG001|Intensive Period|Adverse Event|0|||
37989624|NCT00337272|69674863|FG001|Treatment Period|Withdrawal by Subject|1|||
37989625|NCT00337272|69674862|FG000|Withdrawal Period|Non-compliance|0|||
37893912|NCT00811018|69579146|FG000|Overall Study|Additional Chronic Treatment|31|||
37893913|NCT00811018|69579146|FG000|Overall Study|Adverse Event|79|||
37893914|NCT00811018|69579146|FG000|Overall Study|Death|147|||
37893915|NCT00811018|69579146|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
37893916|NCT00811018|69579146|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
37893917|NCT00811018|69579146|FG000|Overall Study|Investigator Decision|57|||
37893918|NCT00811018|69579146|FG000|Overall Study|Lost to Follow-up|19|||
37893919|NCT00811018|69579146|FG000|Overall Study|Pregnancy|6|||
37893920|NCT00811018|69579146|FG000|Overall Study|Sponsor Decision|450|||
37893921|NCT00811018|69579146|FG000|Overall Study|Withdrawal by Subject|70|||
37893922|NCT00811018|69579146|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
37893923|NCT00811018|69579146|FG000|Overall Study|Other|26|||
37893924|NCT00730171|69579155|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
37893925|NCT00730171|69579155|FG000|Overall Study|Adverse Event|193|||
37893926|NCT00730171|69579155|FG000|Overall Study|Protocol Violation|48|||
37893927|NCT00730171|69579155|FG000|Overall Study|Withdrawal by Subject|202|||
37893928|NCT00730171|69579155|FG000|Overall Study|Lost to Follow-up|121|||
37893929|NCT00730171|69579155|FG000|Overall Study|Insufficient Therapeutic Response|141|||
37893930|NCT00730171|69579155|FG000|Overall Study|Other|61|||
37893931|NCT00730015|69579166|FG000|Overall Study|Adverse Event|11|||
37893932|NCT00730015|69579167|FG001|Overall Study|Adverse Event|10|||
37893933|NCT00730015|69579168|FG002|Overall Study|Adverse Event|8|||
37893934|NCT00730015|69579166|FG000|Overall Study|Protocol Violation|2|||
37893935|NCT00730015|69579167|FG001|Overall Study|Protocol Violation|6|||
37893936|NCT00730015|69579168|FG002|Overall Study|Protocol Violation|4|||
37893937|NCT00730015|69579166|FG000|Overall Study|Withdrawal by Subject|12|||
37893938|NCT00730015|69579167|FG001|Overall Study|Withdrawal by Subject|12|||
37893939|NCT00730015|69579168|FG002|Overall Study|Withdrawal by Subject|8|||
37893940|NCT00730015|69579166|FG000|Overall Study|Lost to Follow-up|4|||
37893941|NCT00730015|69579167|FG001|Overall Study|Lost to Follow-up|10|||
37893942|NCT00730015|69579168|FG002|Overall Study|Lost to Follow-up|3|||
37893943|NCT00730015|69579166|FG000|Overall Study|Lack of Efficacy|1|||
37893944|NCT00730015|69579167|FG001|Overall Study|Lack of Efficacy|2|||
37893945|NCT00730015|69579168|FG002|Overall Study|Lack of Efficacy|8|||
37893946|NCT00730015|69579166|FG000|Overall Study|Other Reason|1|||
37893947|NCT00730015|69579167|FG001|Overall Study|Other Reason|0|||
37893948|NCT00730015|69579168|FG002|Overall Study|Other Reason|1|||
37893949|NCT00806026|69579187|FG000|Overall Study|Death|0|||
37893950|NCT00806026|69579188|FG001|Overall Study|Death|0|||
37893951|NCT00806026|69579189|FG002|Overall Study|Death|0|||
37893952|NCT00806026|69579190|FG003|Overall Study|Death|1|||
37893953|NCT00806026|69579191|FG004|Overall Study|Death|0|||
37893954|NCT00806026|69579192|FG005|Overall Study|Death|0|||
37893955|NCT00806026|69579187|FG000|Overall Study|Did not meet entrance criteria|4|||
37893956|NCT00806026|69579188|FG001|Overall Study|Did not meet entrance criteria|1|||
37893957|NCT00806026|69579189|FG002|Overall Study|Did not meet entrance criteria|2|||
37893958|NCT00806026|69579190|FG003|Overall Study|Did not meet entrance criteria|1|||
37893959|NCT00806026|69579191|FG004|Overall Study|Did not meet entrance criteria|0|||
37893960|NCT00806026|69579192|FG005|Overall Study|Did not meet entrance criteria|0|||
37893961|NCT00806026|69579187|FG000|Overall Study|Lack of Efficacy|5|||
37893962|NCT00806026|69579188|FG001|Overall Study|Lack of Efficacy|18|||
37893963|NCT00806026|69579189|FG002|Overall Study|Lack of Efficacy|13|||
37893964|NCT00806026|69579190|FG003|Overall Study|Lack of Efficacy|4|||
37893965|NCT00806026|69579191|FG004|Overall Study|Lack of Efficacy|8|||
37893966|NCT00806026|69579192|FG005|Overall Study|Lack of Efficacy|7|||
37893967|NCT00806026|69579187|FG000|Overall Study|Lost to Follow-up|8|||
37893968|NCT00806026|69579188|FG001|Overall Study|Lost to Follow-up|15|||
37893969|NCT00806026|69579189|FG002|Overall Study|Lost to Follow-up|8|||
37893970|NCT00806026|69579190|FG003|Overall Study|Lost to Follow-up|2|||
37893971|NCT00806026|69579191|FG004|Overall Study|Lost to Follow-up|6|||
37893972|NCT00806026|69579192|FG005|Overall Study|Lost to Follow-up|6|||
37893973|NCT00806026|69579187|FG000|Overall Study|Withdrawal by Subject|14|||
37893974|NCT00806026|69579188|FG001|Overall Study|Withdrawal by Subject|17|||
37893975|NCT00806026|69579189|FG002|Overall Study|Withdrawal by Subject|9|||
37893976|NCT00806026|69579190|FG003|Overall Study|Withdrawal by Subject|2|||
37893977|NCT00806026|69579191|FG004|Overall Study|Withdrawal by Subject|5|||
37893978|NCT00806026|69579192|FG005|Overall Study|Withdrawal by Subject|3|||
37893979|NCT00806026|69579187|FG000|Overall Study|Other|3|||
37893980|NCT00806026|69579188|FG001|Overall Study|Other|6|||
37893981|NCT00806026|69579189|FG002|Overall Study|Other|8|||
37893982|NCT00806026|69579190|FG003|Overall Study|Other|2|||
37893983|NCT00806026|69579191|FG004|Overall Study|Other|0|||
37893984|NCT00806026|69579192|FG005|Overall Study|Other|4|||
37893985|NCT00806026|69579187|FG000|Overall Study|Protocol Violation|6|||
37893986|NCT00806026|69579188|FG001|Overall Study|Protocol Violation|9|||
37893987|NCT00806026|69579189|FG002|Overall Study|Protocol Violation|9|||
37893988|NCT00806026|69579190|FG003|Overall Study|Protocol Violation|0|||
37893989|NCT00806026|69579191|FG004|Overall Study|Protocol Violation|2|||
37893990|NCT00806026|69579192|FG005|Overall Study|Protocol Violation|3|||
37893991|NCT00806026|69579187|FG000|Overall Study|Adverse Event|52|||
37893992|NCT00806026|69579188|FG001|Overall Study|Adverse Event|35|||
37893993|NCT00806026|69579189|FG002|Overall Study|Adverse Event|44|||
37893994|NCT00806026|69579190|FG003|Overall Study|Adverse Event|17|||
37893995|NCT00806026|69579191|FG004|Overall Study|Adverse Event|9|||
37893996|NCT00806026|69579192|FG005|Overall Study|Adverse Event|9|||
37893997|NCT04026165|69579207|FG000|Run-in Placebo Period|Enrollment Error|13|||
37893998|NCT04026165|69579208|FG001|Run-in Placebo Period|Enrollment Error|0|||
37893999|NCT04026165|69579209|FG002|Run-in Placebo Period|Enrollment Error|0|||
37894000|NCT04026165|69579210|FG003|Run-in Placebo Period|Enrollment Error|0|||
37894001|NCT04026165|69579207|FG000|Run-in Placebo Period|Run-in Failure|4|||
37894002|NCT04026165|69579208|FG001|Run-in Placebo Period|Run-in Failure|0|||
37894003|NCT04026165|69579209|FG002|Run-in Placebo Period|Run-in Failure|0|||
37894004|NCT04026165|69579210|FG003|Run-in Placebo Period|Run-in Failure|0|||
37894005|NCT04026165|69579207|FG000|Run-in Placebo Period|Protocol Violation|2|||
37894006|NCT04026165|69579208|FG001|Run-in Placebo Period|Protocol Violation|0|||
37894007|NCT04026165|69579209|FG002|Run-in Placebo Period|Protocol Violation|0|||
37894008|NCT04026165|69579210|FG003|Run-in Placebo Period|Protocol Violation|0|||
37894009|NCT04026165|69579207|FG000|Run-in Placebo Period|Withdrew Consent|2|||
37894010|NCT04026165|69579208|FG001|Run-in Placebo Period|Withdrew Consent|0|||
37894011|NCT04026165|69579209|FG002|Run-in Placebo Period|Withdrew Consent|0|||
37894012|NCT04026165|69579210|FG003|Run-in Placebo Period|Withdrew Consent|0|||
37894013|NCT04026165|69579207|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
37894014|NCT04026165|69579208|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
37894015|NCT04026165|69579209|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
37894016|NCT04026165|69579210|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
37894017|NCT04026165|69579207|FG000|Run-in SEL Period|Run-in Failure|0|||
37894018|NCT04026165|69579208|FG001|Run-in SEL Period|Run-in Failure|26|||
37989626|NCT00337272|69674863|FG001|Withdrawal Period|Non-compliance|1|||
37989627|NCT00125164|69674873|FG000|Overall Study|Adverse Event|0|||
37894019|NCT04026165|69579209|FG002|Run-in SEL Period|Run-in Failure|0|||
37894020|NCT04026165|69579210|FG003|Run-in SEL Period|Run-in Failure|0|||
37894021|NCT04026165|69579207|FG000|Run-in SEL Period|Withdrew Consent|0|||
37894022|NCT04026165|69579208|FG001|Run-in SEL Period|Withdrew Consent|10|||
37989628|NCT00125164|69674874|FG001|Overall Study|Adverse Event|0|||
37989629|NCT00125164|69674875|FG002|Overall Study|Adverse Event|2|||
37989630|NCT00125164|69674876|FG003|Overall Study|Adverse Event|4|||
37989631|NCT00125164|69674873|FG000|Overall Study|Lost to Follow-up|0|||
37989632|NCT00125164|69674874|FG001|Overall Study|Lost to Follow-up|0|||
37989633|NCT00125164|69674875|FG002|Overall Study|Lost to Follow-up|1|||
37989634|NCT00125164|69674876|FG003|Overall Study|Lost to Follow-up|1|||
37989635|NCT00125164|69674873|FG000|Overall Study|Withdrawal by Subject|2|||
37989636|NCT00125164|69674874|FG001|Overall Study|Withdrawal by Subject|0|||
37989637|NCT00125164|69674875|FG002|Overall Study|Withdrawal by Subject|1|||
37989638|NCT00125164|69674876|FG003|Overall Study|Withdrawal by Subject|1|||
37989639|NCT00136318|69674888|FG000|Overall Study|Adverse Event|5|||
37894023|NCT04026165|69579209|FG002|Run-in SEL Period|Withdrew Consent|0|||
37894024|NCT04026165|69579210|FG003|Run-in SEL Period|Withdrew Consent|0|||
37989640|NCT00136318|69674889|FG001|Overall Study|Adverse Event|5|||
37989641|NCT00136318|69674888|FG000|Overall Study|Withdrawal by Subject|2|||
37989642|NCT00136318|69674889|FG001|Overall Study|Withdrawal by Subject|2|||
37989643|NCT00136084|69674898|FG000|Overall Study|Death|12|||
37894025|NCT04026165|69579207|FG000|Run-in SEL Period|Enrollment Error|0|||
37894026|NCT04026165|69579208|FG001|Run-in SEL Period|Enrollment Error|4|||
37894027|NCT04026165|69579209|FG002|Run-in SEL Period|Enrollment Error|0|||
37894028|NCT04026165|69579210|FG003|Run-in SEL Period|Enrollment Error|0|||
37894029|NCT04026165|69579207|FG000|Run-in SEL Period|Protocol Violation|0|||
37989644|NCT00136084|69674899|FG001|Overall Study|Death|5|||
37989645|NCT00136084|69674898|FG000|Overall Study|Unacceptable toxicity|8|||
37989646|NCT00136084|69674899|FG001|Overall Study|Unacceptable toxicity|11|||
37989647|NCT00136084|69674898|FG000|Overall Study|Relapse|20|||
37989648|NCT00136084|69674899|FG001|Overall Study|Relapse|23|||
37989649|NCT00136084|69674898|FG000|Overall Study|Lost to Follow-up|2|||
37989650|NCT00136084|69674899|FG001|Overall Study|Lost to Follow-up|0|||
37989651|NCT00136084|69674898|FG000|Overall Study|No Response|1|||
37989652|NCT00136084|69674899|FG001|Overall Study|No Response|2|||
37989653|NCT00136084|69674898|FG000|Overall Study|Withdrawal by Subject|5|||
37989654|NCT00136084|69674899|FG001|Overall Study|Withdrawal by Subject|1|||
37989655|NCT00364832|69674920|FG000|Core Period|Early Withdrawals|2|||
37989656|NCT00364832|69674921|FG001|Core Period|Early Withdrawals|2|||
37989657|NCT00364832|69674922|FG002|Core Period|Early Withdrawals|1|||
37989658|NCT00364832|69674923|FG003|Core Period|Early Withdrawals|1|||
37989659|NCT00364832|69674924|FG004|Core Period|Early Withdrawals|0|||
37989660|NCT00364832|69674925|FG005|Core Period|Early Withdrawals|0|||
37989661|NCT00364832|69674926|FG006|Core Period|Early Withdrawals|4|||
37989662|NCT00364832|69674927|FG007|Core Period|Early Withdrawals|1|||
37989663|NCT00364832|69674928|FG008|Core Period|Early Withdrawals|0|||
37989664|NCT00364832|69674929|FG009|Core Period|Early Withdrawals|0|||
37989665|NCT00364832|69674930|FG010|Core Period|Early Withdrawals|0|||
37989666|NCT00364832|69674931|FG011|Core Period|Early Withdrawals|0|||
37989667|NCT00364832|69674920|FG000|Extension Year 1|Early Withdrawals|0|||
37989668|NCT00364832|69674921|FG001|Extension Year 1|Early Withdrawals|0|||
37989669|NCT00364832|69674922|FG002|Extension Year 1|Early Withdrawals|0|||
37989670|NCT00364832|69674923|FG003|Extension Year 1|Early Withdrawals|0|||
37989671|NCT00364832|69674924|FG004|Extension Year 1|Early Withdrawals|0|||
37989672|NCT00364832|69674925|FG005|Extension Year 1|Early Withdrawals|0|||
37989673|NCT00364832|69674926|FG006|Extension Year 1|Early Withdrawals|0|||
37989674|NCT00364832|69674927|FG007|Extension Year 1|Early Withdrawals|0|||
37989675|NCT00364832|69674928|FG008|Extension Year 1|Early Withdrawals|0|||
37989676|NCT00364832|69674929|FG009|Extension Year 1|Early Withdrawals|4|||
37989677|NCT00364832|69674930|FG010|Extension Year 1|Early Withdrawals|2|||
37989678|NCT00364832|69674931|FG011|Extension Year 1|Early Withdrawals|10|||
37989679|NCT00364832|69674920|FG000|Extension Year 2|Early Withdrawals|0|||
37989680|NCT00364832|69674921|FG001|Extension Year 2|Early Withdrawals|0|||
37989681|NCT00364832|69674922|FG002|Extension Year 2|Early Withdrawals|0|||
37989682|NCT00364832|69674923|FG003|Extension Year 2|Early Withdrawals|0|||
37894030|NCT04026165|69579208|FG001|Run-in SEL Period|Protocol Violation|3|||
37894031|NCT04026165|69579209|FG002|Run-in SEL Period|Protocol Violation|0|||
37894032|NCT04026165|69579210|FG003|Run-in SEL Period|Protocol Violation|0|||
37894033|NCT04026165|69579207|FG000|Run-in SEL Period|Investigator's Discretion|0|||
37894034|NCT04026165|69579208|FG001|Run-in SEL Period|Investigator's Discretion|2|||
37894035|NCT04026165|69579209|FG002|Run-in SEL Period|Investigator's Discretion|0|||
37894036|NCT04026165|69579210|FG003|Run-in SEL Period|Investigator's Discretion|0|||
37894037|NCT04026165|69579207|FG000|Run-in SEL Period|Death|0|||
37894038|NCT04026165|69579208|FG001|Run-in SEL Period|Death|1|||
37894039|NCT04026165|69579209|FG002|Run-in SEL Period|Death|0|||
37894040|NCT04026165|69579210|FG003|Run-in SEL Period|Death|0|||
37894041|NCT04026165|69579207|FG000|Randomized Period|Withdrew Consent|0|||
37894042|NCT04026165|69579208|FG001|Randomized Period|Withdrew Consent|0|||
37894043|NCT04026165|69579209|FG002|Randomized Period|Withdrew Consent|5|||
37894044|NCT04026165|69579210|FG003|Randomized Period|Withdrew Consent|8|||
37894045|NCT04026165|69579207|FG000|Randomized Period|Death|0|||
37894046|NCT04026165|69579208|FG001|Randomized Period|Death|0|||
37894047|NCT04026165|69579209|FG002|Randomized Period|Death|5|||
37894048|NCT04026165|69579210|FG003|Randomized Period|Death|7|||
37894049|NCT04026165|69579207|FG000|Randomized Period|Investigator's Discretion|0|||
37894050|NCT04026165|69579208|FG001|Randomized Period|Investigator's Discretion|0|||
37894051|NCT04026165|69579209|FG002|Randomized Period|Investigator's Discretion|2|||
37894052|NCT04026165|69579210|FG003|Randomized Period|Investigator's Discretion|2|||
37894053|NCT04026165|69579207|FG000|Randomized Period|Lost to Follow-up|0|||
37894054|NCT04026165|69579208|FG001|Randomized Period|Lost to Follow-up|0|||
37894055|NCT04026165|69579209|FG002|Randomized Period|Lost to Follow-up|2|||
37894056|NCT04026165|69579210|FG003|Randomized Period|Lost to Follow-up|2|||
37894057|NCT00805792|69579218|FG000|Overall Study|Death|3|||
37894058|NCT00805792|69579218|FG000|Overall Study|Lost to Follow-up|2|||
37894059|NCT00590044|69579224|FG000|Overall Study|Withdrawal by Subject|2|||
37989683|NCT00364832|69674924|FG004|Extension Year 2|Early Withdrawals|0|||
37989684|NCT00364832|69674925|FG005|Extension Year 2|Early Withdrawals|0|||
37989685|NCT00364832|69674926|FG006|Extension Year 2|Early Withdrawals|0|||
37989686|NCT00364832|69674927|FG007|Extension Year 2|Early Withdrawals|0|||
37989687|NCT00364832|69674928|FG008|Extension Year 2|Early Withdrawals|0|||
37894060|NCT00590044|69579225|FG001|Overall Study|Withdrawal by Subject|2|||
37989688|NCT00364832|69674929|FG009|Extension Year 2|Early Withdrawals|5|||
37989689|NCT00364832|69674930|FG010|Extension Year 2|Early Withdrawals|5|||
37989690|NCT00364832|69674931|FG011|Extension Year 2|Early Withdrawals|3|||
37989691|NCT00235755|69674951|FG000|4-Week Titration Phase|Adverse Event|6|||
37989692|NCT00235755|69674952|FG001|4-Week Titration Phase|Adverse Event|14|||
37989693|NCT00235755|69674953|FG002|4-Week Titration Phase|Adverse Event|20|||
37989694|NCT00235755|69674951|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
37989695|NCT00235755|69674952|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
37989696|NCT00235755|69674953|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
37989697|NCT00235755|69674951|FG000|4-Week Titration Phase|Protocol Violation|2|||
37989698|NCT00235755|69674952|FG001|4-Week Titration Phase|Protocol Violation|2|||
37989699|NCT00235755|69674953|FG002|4-Week Titration Phase|Protocol Violation|1|||
37989700|NCT00235755|69674951|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
37989701|NCT00235755|69674952|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
37989702|NCT00235755|69674953|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
37989703|NCT00235755|69674951|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
37989704|NCT00235755|69674952|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
37989705|NCT00235755|69674953|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
37989706|NCT00235755|69674951|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
37989707|NCT00235755|69674952|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
37989708|NCT00235755|69674953|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
37989709|NCT00235755|69674951|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
37989710|NCT00235755|69674952|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
37989711|NCT00235755|69674953|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
37989712|NCT00235755|69674951|FG000|12-Week Maintenance Phase|Adverse Event|8|||
37989713|NCT00235755|69674952|FG001|12-Week Maintenance Phase|Adverse Event|12|||
37989714|NCT00235755|69674953|FG002|12-Week Maintenance Phase|Adverse Event|26|||
37989715|NCT00235755|69674951|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
37989716|NCT00235755|69674952|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
37989717|NCT00235755|69674953|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
37989718|NCT00235755|69674951|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
37989719|NCT00235755|69674952|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
37989720|NCT00235755|69674953|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
37989721|NCT00235755|69674951|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
37989722|NCT00235755|69674952|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
37989723|NCT00235755|69674953|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
37989724|NCT00235755|69674951|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
37989725|NCT00235755|69674952|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
37989726|NCT00235755|69674953|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
37989727|NCT00235755|69674951|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
37989728|NCT00235755|69674952|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
37989729|NCT00235755|69674953|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
37989730|NCT00337194|69674978|FG000|Overall Study|Adverse Event|5|||
37989731|NCT00337194|69674979|FG001|Overall Study|Adverse Event|1|||
37989732|NCT00337194|69674978|FG000|Overall Study|Death|2|||
37989733|NCT00337194|69674979|FG001|Overall Study|Death|0|||
37989734|NCT00337194|69674978|FG000|Overall Study|Withdrawal by Subject|1|||
37989735|NCT00337194|69674979|FG001|Overall Study|Withdrawal by Subject|0|||
37989736|NCT00337194|69674978|FG000|Overall Study|Disease progression|1|||
37989737|NCT00337194|69674979|FG001|Overall Study|Disease progression|2|||
37989738|NCT00337194|69674978|FG000|Overall Study|Subsequent non-protocol therapy|3|||
37989739|NCT00337194|69674979|FG001|Overall Study|Subsequent non-protocol therapy|1|||
37989740|NCT03826914|69674989|FG000|Overall Study|Withdrawal by Subject|1|||
37989741|NCT03826914|69674990|FG001|Overall Study|Withdrawal by Subject|1|||
37989742|NCT00385736|69675001|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
37989743|NCT00385736|69675002|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
37989744|NCT00385736|69675003|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
37989745|NCT00385736|69675001|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
37989746|NCT00385736|69675002|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
37989747|NCT00385736|69675003|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
37989748|NCT00385736|69675001|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
37989749|NCT00385736|69675002|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
37989750|NCT00385736|69675003|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
37989751|NCT00385736|69675001|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
37989752|NCT00385736|69675002|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
37989753|NCT00385736|69675003|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
37989754|NCT00385736|69675001|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
37989755|NCT00385736|69675002|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
37989756|NCT00385736|69675003|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
37989757|NCT00385736|69675001|FG000|Efficacy Analysis Set - Induction|Other|0|||
37989758|NCT00385736|69675002|FG001|Efficacy Analysis Set - Induction|Other|0|||
37989759|NCT00385736|69675003|FG002|Efficacy Analysis Set - Induction|Other|1|||
37989760|NCT00385736|69675001|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
37989761|NCT00385736|69675002|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
37989762|NCT00385736|69675003|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
37989763|NCT00385736|69675001|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
37989764|NCT00385736|69675002|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
37989765|NCT00385736|69675003|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
37989766|NCT00385736|69675001|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
37989767|NCT00385736|69675002|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
37989768|NCT00385736|69675003|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
37989769|NCT00385736|69675001|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
37989770|NCT00385736|69675002|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
37989771|NCT00385736|69675003|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
37989772|NCT00385736|69675001|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
37989773|NCT00385736|69675002|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
37989774|NCT00385736|69675003|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
37989775|NCT00385736|69675001|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
37989776|NCT00385736|69675002|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
37989777|NCT00385736|69675003|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
37989778|NCT00385736|69675001|FG000|Safety Analysis Set|Adverse Event|23|||
37989779|NCT00385736|69675002|FG001|Safety Analysis Set|Adverse Event|15|||
37894061|NCT00590044|69579224|FG000|Overall Study|wrong insulin arm assigned|1|||
37894062|NCT00590044|69579225|FG001|Overall Study|wrong insulin arm assigned|0|||
37894063|NCT00590044|69579224|FG000|Overall Study|Protocol Violation|1|||
37894064|NCT00590044|69579225|FG001|Overall Study|Protocol Violation|0|||
37894065|NCT00805480|69579238|FG000|Overall Study|Withdrawal by Subject|13|||
37894066|NCT00805480|69579239|FG001|Overall Study|Withdrawal by Subject|5|||
37894067|NCT00805480|69579240|FG002|Overall Study|Withdrawal by Subject|11|||
37894068|NCT00805480|69579241|FG003|Overall Study|Withdrawal by Subject|5|||
37894069|NCT00805480|69579238|FG000|Overall Study|Lost to Follow-up|1|||
37894070|NCT00805480|69579239|FG001|Overall Study|Lost to Follow-up|2|||
37894071|NCT00805480|69579240|FG002|Overall Study|Lost to Follow-up|0|||
37894072|NCT00805480|69579241|FG003|Overall Study|Lost to Follow-up|0|||
37894073|NCT00805480|69579238|FG000|Overall Study|Adverse Event|0|||
37894074|NCT00805480|69579239|FG001|Overall Study|Adverse Event|0|||
37894075|NCT00805480|69579240|FG002|Overall Study|Adverse Event|1|||
37894076|NCT00805480|69579241|FG003|Overall Study|Adverse Event|0|||
37894077|NCT00729937|69579257|FG000|Overall Study|Lost to Follow-up|49|||
37894078|NCT00729937|69579258|FG001|Overall Study|Lost to Follow-up|58|||
37894079|NCT00729937|69579259|FG002|Overall Study|Lost to Follow-up|18|||
37894080|NCT00729937|69579260|FG003|Overall Study|Lost to Follow-up|33|||
37894081|NCT00729937|69579261|FG004|Overall Study|Lost to Follow-up|18|||
37989780|NCT00385736|69675003|FG002|Safety Analysis Set|Adverse Event|23|||
37989781|NCT00385736|69675001|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
37989782|NCT00385736|69675002|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
37989783|NCT00385736|69675003|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
37894082|NCT00729937|69579262|FG005|Overall Study|Lost to Follow-up|23|||
37894083|NCT00729937|69579257|FG000|Overall Study|Physician Decision|7|||
37894084|NCT00729937|69579258|FG001|Overall Study|Physician Decision|16|||
37894085|NCT00729937|69579259|FG002|Overall Study|Physician Decision|2|||
37894086|NCT00729937|69579260|FG003|Overall Study|Physician Decision|0|||
37894087|NCT00729937|69579261|FG004|Overall Study|Physician Decision|5|||
37894088|NCT00729937|69579262|FG005|Overall Study|Physician Decision|8|||
37894089|NCT00729937|69579257|FG000|Overall Study|Death|1|||
37894090|NCT00729937|69579258|FG001|Overall Study|Death|0|||
37989784|NCT00385736|69675001|FG000|Safety Analysis Set|Lost to Follow-up|0|||
37894091|NCT00729937|69579259|FG002|Overall Study|Death|1|||
37894092|NCT00729937|69579260|FG003|Overall Study|Death|0|||
37894093|NCT00729937|69579261|FG004|Overall Study|Death|0|||
37989785|NCT00385736|69675002|FG001|Safety Analysis Set|Lost to Follow-up|2|||
37989786|NCT00385736|69675003|FG002|Safety Analysis Set|Lost to Follow-up|2|||
37989787|NCT00385736|69675001|FG000|Safety Analysis Set|Lack of Efficacy|38|||
37989788|NCT00385736|69675002|FG001|Safety Analysis Set|Lack of Efficacy|16|||
37894094|NCT00729937|69579262|FG005|Overall Study|Death|1|||
37894095|NCT00729937|69579257|FG000|Overall Study|Withdrawal by Subject|3|||
37894096|NCT00729937|69579258|FG001|Overall Study|Withdrawal by Subject|5|||
37894097|NCT00729937|69579259|FG002|Overall Study|Withdrawal by Subject|6|||
37894098|NCT00729937|69579260|FG003|Overall Study|Withdrawal by Subject|0|||
37894099|NCT00729937|69579261|FG004|Overall Study|Withdrawal by Subject|4|||
37824721|NCT01054885|69506866|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
37824722|NCT01054885|69506860|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
37824723|NCT01054885|69506861|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
37824724|NCT01054885|69506862|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
37824725|NCT01054885|69506863|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
37824726|NCT01054885|69506864|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
37824727|NCT01054885|69506865|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
37824728|NCT01054885|69506866|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
37824729|NCT01054885|69506860|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
37824730|NCT01054885|69506861|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
37824731|NCT01054885|69506862|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
37824732|NCT01054885|69506863|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
37824733|NCT01054885|69506864|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
37824734|NCT01054885|69506865|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
37824735|NCT01054885|69506866|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
37824736|NCT01054885|69506860|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
37824737|NCT01054885|69506861|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
37824738|NCT01054885|69506862|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
37824739|NCT01054885|69506863|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
37824740|NCT01054885|69506864|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
37824741|NCT01054885|69506865|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
37824742|NCT01054885|69506866|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
37824743|NCT01054885|69506860|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
37824744|NCT01054885|69506861|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
37824745|NCT01054885|69506862|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
37824746|NCT01054885|69506863|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
37824747|NCT01054885|69506864|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
37824748|NCT01054885|69506865|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
37824749|NCT01054885|69506866|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
37824750|NCT01054885|69506860|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
37824751|NCT01054885|69506861|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
37824752|NCT01054885|69506862|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
37824753|NCT01054885|69506863|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
37824754|NCT01054885|69506864|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
37824755|NCT01054885|69506865|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
37824756|NCT01054885|69506866|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
37824757|NCT01054885|69506860|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
37824758|NCT01054885|69506861|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
37824759|NCT01054885|69506862|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
37824760|NCT01054885|69506863|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
37824761|NCT01054885|69506864|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
37824762|NCT01054885|69506865|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
37824763|NCT01054885|69506866|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
37824764|NCT01054885|69506860|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
37894100|NCT00729937|69579262|FG005|Overall Study|Withdrawal by Subject|2|||
37894101|NCT00729937|69579257|FG000|Overall Study|Randomized but not treated|12|||
37894102|NCT00729937|69579258|FG001|Overall Study|Randomized but not treated|6|||
37894103|NCT00729937|69579259|FG002|Overall Study|Randomized but not treated|1|||
37696140|NCT02275117|69172308|FG003|Overall Study|Worsening of Study Indication|0|||
37696141|NCT02275117|69172309|FG004|Overall Study|Worsening of Study Indication|0|||
37696142|NCT02275117|69172305|FG000|Overall Study|Study Burden|5|||
37696143|NCT02275117|69172306|FG001|Overall Study|Study Burden|4|||
37696144|NCT02275117|69172307|FG002|Overall Study|Study Burden|7|||
37696145|NCT02275117|69172308|FG003|Overall Study|Study Burden|5|||
37824765|NCT01054885|69506861|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
37824766|NCT01054885|69506862|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
37824767|NCT01054885|69506863|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
37824768|NCT01054885|69506864|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
37824769|NCT01054885|69506865|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
37894104|NCT00729937|69579260|FG003|Overall Study|Randomized but not treated|0|||
37894105|NCT00729937|69579261|FG004|Overall Study|Randomized but not treated|1|||
37894106|NCT00729937|69579262|FG005|Overall Study|Randomized but not treated|3|||
37894107|NCT00729937|69579257|FG000|Overall Study|Did not meet eligibility criteria|2|||
37894108|NCT00729937|69579258|FG001|Overall Study|Did not meet eligibility criteria|1|||
37894109|NCT00729937|69579259|FG002|Overall Study|Did not meet eligibility criteria|0|||
37894110|NCT00729937|69579260|FG003|Overall Study|Did not meet eligibility criteria|0|||
37894111|NCT00729937|69579261|FG004|Overall Study|Did not meet eligibility criteria|0|||
37894112|NCT00729937|69579262|FG005|Overall Study|Did not meet eligibility criteria|0|||
37894113|NCT00729937|69579257|FG000|Overall Study|Incarcerated|0|||
37894114|NCT00729937|69579258|FG001|Overall Study|Incarcerated|2|||
37894115|NCT00729937|69579259|FG002|Overall Study|Incarcerated|1|||
37894116|NCT00729937|69579260|FG003|Overall Study|Incarcerated|1|||
37894117|NCT00729937|69579261|FG004|Overall Study|Incarcerated|0|||
37894118|NCT00729937|69579262|FG005|Overall Study|Incarcerated|0|||
37894119|NCT00729859|69579279|FG000|Overall Study|Adverse Event|0|||
37894120|NCT00729859|69579280|FG001|Overall Study|Adverse Event|1|||
37894121|NCT00729859|69579281|FG002|Overall Study|Adverse Event|0|||
37894122|NCT00729859|69579279|FG000|Overall Study|Withdrawal by Subject|0|||
37894123|NCT00729859|69579280|FG001|Overall Study|Withdrawal by Subject|1|||
37894124|NCT00729859|69579281|FG002|Overall Study|Withdrawal by Subject|0|||
37894125|NCT00810394|69579297|FG000|Overall Study|Withdrawal by Subject|3|||
37894126|NCT00736333|69579301|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
37894127|NCT00736333|69579301|FG000|Overall Study|Data Missing|2|||
37894128|NCT00736333|69579301|FG000|Overall Study|Tumor Progression|75|||
37894129|NCT00736333|69579301|FG000|Overall Study|Toxicity|6|||
37894130|NCT00736333|69579301|FG000|Overall Study|Withdrawal by Subject|10|||
37894131|NCT00736333|69579301|FG000|Overall Study|Death|7|||
37894132|NCT00736333|69579301|FG000|Overall Study|Other|4|||
37894133|NCT00736255|69579307|FG000|Overall Study|Adverse Event|1|||
37894134|NCT00736255|69579308|FG001|Overall Study|Adverse Event|0|||
37894135|NCT00736255|69579307|FG000|Overall Study|Physician Decision|1|||
37894136|NCT00736255|69579308|FG001|Overall Study|Physician Decision|0|||
37894137|NCT00736255|69579307|FG000|Overall Study|Non-compliance|1|||
37894138|NCT00736255|69579308|FG001|Overall Study|Non-compliance|1|||
37894139|NCT03920254|69579317|FG000|Overall Study|Adverse Event|1|||
37989789|NCT00385736|69675003|FG002|Safety Analysis Set|Lack of Efficacy|31|||
37989790|NCT00385736|69675001|FG000|Safety Analysis Set|Protocol Violation|2|||
37824770|NCT01054885|69506866|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
37824771|NCT01054885|69506860|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
37824772|NCT01054885|69506861|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
37824773|NCT01054885|69506862|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
37824774|NCT01054885|69506863|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
37894140|NCT03920254|69579318|FG001|Overall Study|Adverse Event|0|||
37894141|NCT03920254|69579319|FG002|Overall Study|Adverse Event|0|||
37894142|NCT03920254|69579317|FG000|Overall Study|Physician Decision|0|||
37894143|NCT03920254|69579318|FG001|Overall Study|Physician Decision|1|||
37894144|NCT03920254|69579319|FG002|Overall Study|Physician Decision|2|||
37894145|NCT03920254|69579317|FG000|Overall Study|Study Terminated By Sponsor|12|||
37894146|NCT03920254|69579318|FG001|Overall Study|Study Terminated By Sponsor|17|||
37894147|NCT03920254|69579319|FG002|Overall Study|Study Terminated By Sponsor|12|||
37894148|NCT03920254|69579317|FG000|Overall Study|Withdrawal by Subject|0|||
37894149|NCT03920254|69579318|FG001|Overall Study|Withdrawal by Subject|0|||
37696146|NCT02275117|69172309|FG004|Overall Study|Study Burden|7|||
37696147|NCT02275117|69172305|FG000|Overall Study|Other|1|||
37824775|NCT01054885|69506864|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
37824776|NCT01054885|69506865|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
37824777|NCT01054885|69506866|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
37824778|NCT01054885|69506860|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
37824779|NCT01054885|69506861|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
37824780|NCT01054885|69506862|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
37824781|NCT01054885|69506863|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
37894150|NCT03920254|69579319|FG002|Overall Study|Withdrawal by Subject|1|||
37894151|NCT00729469|69579329|FG000|Overall Study|Adverse Event|14|||
37894152|NCT00729469|69579330|FG001|Overall Study|Adverse Event|25|||
37894153|NCT00729469|69579329|FG000|Overall Study|Lost to Follow-up|9|||
37894154|NCT00729469|69579330|FG001|Overall Study|Lost to Follow-up|9|||
37894155|NCT00729469|69579329|FG000|Overall Study|Protocol Violation|2|||
37894156|NCT00729469|69579330|FG001|Overall Study|Protocol Violation|1|||
37894157|NCT00729469|69579329|FG000|Overall Study|Withdrawal by Subject|19|||
37894158|NCT00729469|69579330|FG001|Overall Study|Withdrawal by Subject|8|||
37894159|NCT00729469|69579329|FG000|Overall Study|Other-Not mentioned|9|||
37894160|NCT00729469|69579330|FG001|Overall Study|Other-Not mentioned|4|||
37894161|NCT00742183|69579338|FG000|Overall Study|Adverse Event|2|||
37894162|NCT00742183|69579339|FG001|Overall Study|Adverse Event|2|||
37894163|NCT00742183|69579338|FG000|Overall Study|Death|1|||
37894164|NCT00742183|69579339|FG001|Overall Study|Death|0|||
37894165|NCT00742183|69579338|FG000|Overall Study|Physician Decision|0|||
37894166|NCT00742183|69579339|FG001|Overall Study|Physician Decision|2|||
37894167|NCT00742183|69579338|FG000|Overall Study|Lost to Follow-up|4|||
37894168|NCT00742183|69579339|FG001|Overall Study|Lost to Follow-up|4|||
37894169|NCT00742183|69579338|FG000|Overall Study|Required skin-graft|1|||
37894170|NCT00742183|69579339|FG001|Overall Study|Required skin-graft|1|||
37894171|NCT00742183|69579338|FG000|Overall Study|Withdrawal by Subject|1|||
37894172|NCT00742183|69579339|FG001|Overall Study|Withdrawal by Subject|0|||
37894173|NCT00742183|69579338|FG000|Overall Study|Lack of Efficacy|0|||
37894174|NCT00742183|69579339|FG001|Overall Study|Lack of Efficacy|3|||
37894175|NCT00808444|69579347|FG000|Overall Study|Withdrawal by Subject|1|||
37894176|NCT00808444|69579348|FG001|Overall Study|Withdrawal by Subject|0|||
37894177|NCT00808444|69579347|FG000|Overall Study|Lost to Follow-up|0|||
37894178|NCT00808444|69579348|FG001|Overall Study|Lost to Follow-up|1|||
37894179|NCT00742027|69579354|FG000|Overall Study|Disease Progression|76|||
37894180|NCT00742027|69579354|FG000|Overall Study|New Cancer Therapy|19|||
37894181|NCT00742027|69579354|FG000|Overall Study|Withdrawal by Subject|18|||
37894182|NCT00742027|69579354|FG000|Overall Study|Death|7|||
37894183|NCT00742027|69579354|FG000|Overall Study|Lost to Follow-up|4|||
37894184|NCT00742027|69579354|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
37894185|NCT00742027|69579354|FG000|Overall Study|Missing|2|||
37894186|NCT00742027|69579354|FG000|Overall Study|Administrative Problems|1|||
37894187|NCT03996369|69579360|FG000|Overall Study|Protocol deviation|1|||
37894188|NCT03996369|69579361|FG001|Overall Study|Protocol deviation|1|||
37894189|NCT03996369|69579360|FG000|Overall Study|Physician Decision|4|||
37894190|NCT03996369|69579361|FG001|Overall Study|Physician Decision|2|||
37894191|NCT03996369|69579360|FG000|Overall Study|Participant decision|0|||
37894192|NCT03996369|69579361|FG001|Overall Study|Participant decision|1|||
37894193|NCT03996369|69579360|FG000|Overall Study|Lack of Efficacy|4|||
37894194|NCT03996369|69579361|FG001|Overall Study|Lack of Efficacy|0|||
37894195|NCT03996369|69579360|FG000|Overall Study|Adverse Event|9|||
37894196|NCT03996369|69579361|FG001|Overall Study|Adverse Event|0|||
37894197|NCT03996369|69579360|FG000|Overall Study|Withdrawal by Subject|6|||
37894198|NCT03996369|69579361|FG001|Overall Study|Withdrawal by Subject|8|||
37894199|NCT03996369|69579360|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
37894200|NCT03996369|69579361|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
37894201|NCT03996369|69579360|FG000|Overall Study|Lost to Follow-up|0|||
37894202|NCT03996369|69579361|FG001|Overall Study|Lost to Follow-up|1|||
37894203|NCT00808210|69579369|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
37894204|NCT00808210|69579370|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
37894205|NCT00808210|69579369|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
37894206|NCT00808210|69579370|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
37894207|NCT00808210|69579369|FG000|Double-Blind TX Period|Adverse Event|0|||
37894208|NCT00808210|69579370|FG001|Double-Blind TX Period|Adverse Event|1|||
37894209|NCT00808210|69579369|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
37894210|NCT00808210|69579370|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
37894211|NCT00808210|69579369|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
37894212|NCT00808210|69579370|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
37894213|NCT00808210|69579369|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
37894214|NCT00808210|69579370|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
37894215|NCT00736099|69579378|FG000|Overall Study|Adverse Event|61|||
37894216|NCT00736099|69579379|FG001|Overall Study|Adverse Event|18|||
37894217|NCT00736099|69579378|FG000|Overall Study|Protocol Violation|10|||
37894218|NCT00736099|69579379|FG001|Overall Study|Protocol Violation|4|||
37894219|NCT00736099|69579378|FG000|Overall Study|Lost to Follow-up|12|||
37894220|NCT00736099|69579379|FG001|Overall Study|Lost to Follow-up|5|||
37894221|NCT00736099|69579378|FG000|Overall Study|Withdrawal by Subject|42|||
37894222|NCT00736099|69579379|FG001|Overall Study|Withdrawal by Subject|13|||
37894223|NCT00736099|69579378|FG000|Overall Study|Lack of Efficacy|15|||
37894224|NCT00736099|69579379|FG001|Overall Study|Lack of Efficacy|8|||
37894225|NCT00736099|69579378|FG000|Overall Study|Other reason|43|||
37894226|NCT00736099|69579379|FG001|Overall Study|Other reason|10|||
37894227|NCT00735943|69579385|FG000|Overall Study|Lost to Follow-up|1|||
37894228|NCT00735943|69579385|FG000|Overall Study|Adverse Event|1|||
37894229|NCT00735709|69579393|FG000|Overall Study|Adverse Event|2|||
37894230|NCT00735709|69579394|FG001|Overall Study|Adverse Event|3|||
37894231|NCT00735709|69579395|FG002|Overall Study|Adverse Event|1|||
37894232|NCT00735709|69579396|FG003|Overall Study|Adverse Event|5|||
37894233|NCT00735709|69579393|FG000|Overall Study|Lack of Efficacy|8|||
37894234|NCT00735709|69579394|FG001|Overall Study|Lack of Efficacy|4|||
37894235|NCT00735709|69579395|FG002|Overall Study|Lack of Efficacy|2|||
37894236|NCT00735709|69579396|FG003|Overall Study|Lack of Efficacy|3|||
37894237|NCT00735709|69579393|FG000|Overall Study|Noncompliance|0|||
37894238|NCT00735709|69579394|FG001|Overall Study|Noncompliance|0|||
37894239|NCT00735709|69579395|FG002|Overall Study|Noncompliance|1|||
37894240|NCT00735709|69579396|FG003|Overall Study|Noncompliance|0|||
37894241|NCT00735709|69579393|FG000|Overall Study|Protocol deviations|1|||
37894242|NCT00735709|69579394|FG001|Overall Study|Protocol deviations|2|||
37894243|NCT00735709|69579395|FG002|Overall Study|Protocol deviations|1|||
37894244|NCT00735709|69579396|FG003|Overall Study|Protocol deviations|1|||
37894245|NCT00735709|69579393|FG000|Overall Study|Voluntary Withdrawal|1|||
37894246|NCT00735709|69579394|FG001|Overall Study|Voluntary Withdrawal|3|||
37894247|NCT00735709|69579395|FG002|Overall Study|Voluntary Withdrawal|5|||
37894248|NCT00735709|69579396|FG003|Overall Study|Voluntary Withdrawal|7|||
37824782|NCT01054885|69506864|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
37824783|NCT01054885|69506865|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
37824784|NCT01054885|69506866|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
37824785|NCT01054885|69506860|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
37824786|NCT01054885|69506861|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
37824787|NCT01054885|69506862|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
37824788|NCT01054885|69506863|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
37824789|NCT01054885|69506864|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
37824790|NCT01054885|69506865|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
37824791|NCT01054885|69506866|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
37824792|NCT01054885|69506860|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
37824793|NCT01054885|69506861|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
37824794|NCT01054885|69506862|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
37824795|NCT01054885|69506863|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
37894249|NCT00735709|69579393|FG000|Overall Study|Lost to Follow-up|0|||
37894250|NCT00735709|69579394|FG001|Overall Study|Lost to Follow-up|1|||
37894251|NCT00735709|69579395|FG002|Overall Study|Lost to Follow-up|1|||
37894252|NCT00735709|69579396|FG003|Overall Study|Lost to Follow-up|1|||
37894253|NCT00735709|69579393|FG000|Overall Study|Excluded medication|1|||
37894254|NCT00735709|69579394|FG001|Overall Study|Excluded medication|0|||
37894255|NCT00735709|69579395|FG002|Overall Study|Excluded medication|0|||
37894256|NCT00735709|69579396|FG003|Overall Study|Excluded medication|1|||
37894257|NCT00729157|69579406|FG000|Overall Study|Withdrawal by Subject|1|||
37894258|NCT00728689|69579412|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
37894259|NCT00728689|69579413|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
37894260|NCT00727909|69579421|FG000|Overall Study|Withdrawal by Subject|5|||
37894261|NCT00727909|69579422|FG001|Overall Study|Withdrawal by Subject|11|||
37894262|NCT00727909|69579423|FG002|Overall Study|Withdrawal by Subject|8|||
37894263|NCT00727909|69579424|FG003|Overall Study|Withdrawal by Subject|5|||
37894264|NCT00727909|69579421|FG000|Overall Study|Death|0|||
37894265|NCT00727909|69579422|FG001|Overall Study|Death|0|||
37894266|NCT00727909|69579423|FG002|Overall Study|Death|1|||
37894267|NCT00727909|69579424|FG003|Overall Study|Death|0|||
37894268|NCT00726895|69579428|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
37894269|NCT00726895|69579429|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
37894270|NCT00585325|69579438|FG000|Overall Study|Withdrawal by Subject|1|||
37894271|NCT00585325|69579439|FG001|Overall Study|Withdrawal by Subject|1|||
37894272|NCT00726661|69579447|FG000|Overall Study|Lost to Follow-up|36|||
37894273|NCT00726661|69579448|FG001|Overall Study|Lost to Follow-up|11|||
37894274|NCT00726661|69579447|FG000|Overall Study|Withdrawal by Subject|17|||
37894275|NCT00726661|69579448|FG001|Overall Study|Withdrawal by Subject|13|||
37894276|NCT00726661|69579447|FG000|Overall Study|Trial terminated by sponsor|214|||
37894277|NCT00726661|69579448|FG001|Overall Study|Trial terminated by sponsor|187|||
37894278|NCT00726661|69579447|FG000|Overall Study|Death|475|||
37894279|NCT00726661|69579448|FG001|Overall Study|Death|159|||
37894280|NCT00726661|69579447|FG000|Overall Study|Physician Decision|25|||
37894281|NCT00726661|69579448|FG001|Overall Study|Physician Decision|13|||
37894282|NCT00726661|69579447|FG000|Overall Study|Other|47|||
37894283|NCT00726661|69579448|FG001|Overall Study|Other|35|||
37894284|NCT00741091|69579464|FG000|Overall Study|Death|13|||
37894285|NCT00741091|69579464|FG000|Overall Study|Lost to Follow-up|16|||
37894286|NCT00741091|69579464|FG000|Overall Study|Withdrawal by Subject|6|||
37696148|NCT02275117|69172306|FG001|Overall Study|Other|0|||
37696149|NCT02275117|69172307|FG002|Overall Study|Other|0|||
37696150|NCT02275117|69172308|FG003|Overall Study|Other|0|||
37696151|NCT02275117|69172309|FG004|Overall Study|Other|2|||
37696152|NCT02274493|69172321|FG000|Overall Study|Withdrawal by Subject|1|||
37696153|NCT02273167|69172328|FG000|Overall Study|Adverse Event|1|||
37696154|NCT02273167|69172329|FG001|Overall Study|Adverse Event|0|||
37894287|NCT00741091|69579464|FG000|Overall Study|Missed Visit|22|||
37696155|NCT02273167|69172330|FG002|Overall Study|Adverse Event|0|||
37894288|NCT00741013|69579471|FG000|Overall Study|Adverse Event|1|||
37894289|NCT00741013|69579472|FG001|Overall Study|Adverse Event|0|||
37894290|NCT00741013|69579473|FG002|Overall Study|Adverse Event|0|||
37894291|NCT00741013|69579471|FG000|Overall Study|Withdrawal by Subject|0|||
37894292|NCT00741013|69579472|FG001|Overall Study|Withdrawal by Subject|0|||
37696156|NCT02273167|69172328|FG000|Overall Study|Protocol Violation|3|||
37894293|NCT00741013|69579473|FG002|Overall Study|Withdrawal by Subject|1|||
37894294|NCT00741013|69579471|FG000|Overall Study|Discovered failed screen after enrolled|0|||
37989791|NCT00385736|69675002|FG001|Safety Analysis Set|Protocol Violation|1|||
37989792|NCT00385736|69675003|FG002|Safety Analysis Set|Protocol Violation|6|||
37989793|NCT00385736|69675001|FG000|Safety Analysis Set|Other|1|||
37989794|NCT00385736|69675002|FG001|Safety Analysis Set|Other|4|||
37989795|NCT00385736|69675003|FG002|Safety Analysis Set|Other|4|||
37989796|NCT00195819|69675014|FG000|Double-Blind|Withdrawal by Subject|1|||
37989797|NCT00195819|69675015|FG001|Double-Blind|Withdrawal by Subject|0|||
37989798|NCT00195819|69675014|FG000|Double-Blind|Moved|1|||
37989799|NCT00195819|69675015|FG001|Double-Blind|Moved|0|||
37696157|NCT02273167|69172329|FG001|Overall Study|Protocol Violation|1|||
37696158|NCT02273167|69172330|FG002|Overall Study|Protocol Violation|1|||
37696159|NCT02273167|69172328|FG000|Overall Study|Lost to Follow-up|0|||
37696160|NCT02273167|69172329|FG001|Overall Study|Lost to Follow-up|1|||
37696161|NCT02273167|69172330|FG002|Overall Study|Lost to Follow-up|1|||
37696162|NCT02273167|69172328|FG000|Overall Study|Withdrawal by Subject|10|||
37696163|NCT02273167|69172329|FG001|Overall Study|Withdrawal by Subject|12|||
37696164|NCT02273167|69172330|FG002|Overall Study|Withdrawal by Subject|11|||
37696165|NCT02273167|69172328|FG000|Overall Study|Various|10|||
37696166|NCT02273167|69172329|FG001|Overall Study|Various|9|||
37696167|NCT02273167|69172330|FG002|Overall Study|Various|8|||
37696168|NCT02272777|69172341|FG000|Overall Study|Adverse Event|0|||
37696169|NCT02272777|69172342|FG001|Overall Study|Adverse Event|1|||
37824796|NCT01054885|69506864|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
37824797|NCT01054885|69506865|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
37824798|NCT01054885|69506866|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
37824799|NCT01054846|69506883|FG000|Overall Study|Lost to Follow-up|76|||
37824800|NCT01054846|69506884|FG001|Overall Study|Lost to Follow-up|17|||
37894295|NCT00741013|69579472|FG001|Overall Study|Discovered failed screen after enrolled|2|||
37894296|NCT00741013|69579473|FG002|Overall Study|Discovered failed screen after enrolled|0|||
37824801|NCT01054729|69506893|FG000|Overall Study|Randomized but Not Treated|0|||
37824802|NCT01054729|69506894|FG001|Overall Study|Randomized but Not Treated|1|||
37824803|NCT01054729|69506895|FG002|Overall Study|Randomized but Not Treated|0|||
37824804|NCT01054729|69506896|FG003|Overall Study|Randomized but Not Treated|0|||
37824805|NCT01054729|69506893|FG000|Overall Study|Adverse Event|1|||
37824806|NCT01054729|69506894|FG001|Overall Study|Adverse Event|1|||
37824807|NCT01054729|69506895|FG002|Overall Study|Adverse Event|2|||
37824808|NCT01054729|69506896|FG003|Overall Study|Adverse Event|1|||
37824809|NCT01054729|69506893|FG000|Overall Study|Withdrawal by Subject|1|||
37824810|NCT01054729|69506894|FG001|Overall Study|Withdrawal by Subject|0|||
37894297|NCT00740857|69579484|FG000|Overall Study|Withdrawal by Subject|1|||
37894298|NCT00740857|69579485|FG001|Overall Study|Withdrawal by Subject|0|||
37894299|NCT00740857|69579486|FG002|Overall Study|Withdrawal by Subject|0|||
37894300|NCT00808132|69579499|FG000|Overall Study|Adverse Event|34|||
37894301|NCT00808132|69579500|FG001|Overall Study|Adverse Event|33|||
37894302|NCT00808132|69579501|FG002|Overall Study|Adverse Event|16|||
37894303|NCT00808132|69579502|FG003|Overall Study|Adverse Event|31|||
37894304|NCT00808132|69579503|FG004|Overall Study|Adverse Event|33|||
37894305|NCT00808132|69579499|FG000|Overall Study|Death|0|||
37894306|NCT00808132|69579500|FG001|Overall Study|Death|0|||
37894307|NCT00808132|69579501|FG002|Overall Study|Death|0|||
37894308|NCT00808132|69579502|FG003|Overall Study|Death|0|||
37894309|NCT00808132|69579503|FG004|Overall Study|Death|1|||
37894310|NCT00808132|69579499|FG000|Overall Study|Physician Decision|0|||
37894311|NCT00808132|69579500|FG001|Overall Study|Physician Decision|1|||
37894312|NCT00808132|69579501|FG002|Overall Study|Physician Decision|0|||
37894313|NCT00808132|69579502|FG003|Overall Study|Physician Decision|0|||
37894314|NCT00808132|69579503|FG004|Overall Study|Physician Decision|0|||
37894315|NCT00808132|69579499|FG000|Overall Study|Lost to Follow-up|8|||
37894316|NCT00808132|69579500|FG001|Overall Study|Lost to Follow-up|10|||
37894317|NCT00808132|69579501|FG002|Overall Study|Lost to Follow-up|11|||
37894318|NCT00808132|69579502|FG003|Overall Study|Lost to Follow-up|8|||
37894319|NCT00808132|69579503|FG004|Overall Study|Lost to Follow-up|9|||
37989800|NCT00195819|69675014|FG000|Open-label|Adverse Event|0|||
37894320|NCT00808132|69579499|FG000|Overall Study|Protocol Violation|8|||
37696170|NCT02272777|69172341|FG000|Overall Study|Withdrawal by Subject|0|||
37824811|NCT01054729|69506895|FG002|Overall Study|Withdrawal by Subject|1|||
37894321|NCT00808132|69579500|FG001|Overall Study|Protocol Violation|9|||
37894322|NCT00808132|69579501|FG002|Overall Study|Protocol Violation|4|||
37894323|NCT00808132|69579502|FG003|Overall Study|Protocol Violation|9|||
37894324|NCT00808132|69579503|FG004|Overall Study|Protocol Violation|5|||
37696171|NCT02272777|69172342|FG001|Overall Study|Withdrawal by Subject|3|||
37696172|NCT02272777|69172341|FG000|Overall Study|Lost to Follow-up|2|||
37894325|NCT00808132|69579499|FG000|Overall Study|Withdrawal by Subject|27|||
37894326|NCT00808132|69579500|FG001|Overall Study|Withdrawal by Subject|18|||
37894327|NCT00808132|69579501|FG002|Overall Study|Withdrawal by Subject|2|||
37894328|NCT00808132|69579502|FG003|Overall Study|Withdrawal by Subject|7|||
37894329|NCT00808132|69579503|FG004|Overall Study|Withdrawal by Subject|16|||
37894330|NCT00808132|69579499|FG000|Overall Study|Other|6|||
37894331|NCT00808132|69579500|FG001|Overall Study|Other|4|||
37894332|NCT00808132|69579501|FG002|Overall Study|Other|6|||
37894333|NCT00808132|69579502|FG003|Overall Study|Other|2|||
37894334|NCT00808132|69579503|FG004|Overall Study|Other|15|||
37894335|NCT00808132|69579499|FG000|Overall Study|Randomized, but not treated|10|||
37894336|NCT00808132|69579500|FG001|Overall Study|Randomized, but not treated|7|||
37894337|NCT00808132|69579501|FG002|Overall Study|Randomized, but not treated|9|||
37894338|NCT00808132|69579502|FG003|Overall Study|Randomized, but not treated|8|||
37894339|NCT00808132|69579503|FG004|Overall Study|Randomized, but not treated|9|||
37894340|NCT00808132|69579499|FG000|Overall Study|Unsatisfactory response|5|||
37894341|NCT00808132|69579500|FG001|Overall Study|Unsatisfactory response|6|||
37894342|NCT00808132|69579501|FG002|Overall Study|Unsatisfactory response|6|||
37894343|NCT00808132|69579502|FG003|Overall Study|Unsatisfactory response|4|||
37894344|NCT00808132|69579503|FG004|Overall Study|Unsatisfactory response|12|||
37894345|NCT00727441|69579518|FG000|Overall Study|Disease Progression|11|||
37894346|NCT00727441|69579519|FG001|Overall Study|Disease Progression|14|||
37894347|NCT00727441|69579520|FG002|Overall Study|Disease Progression|17|||
37894348|NCT00727441|69579518|FG000|Overall Study|Eligibility|7|||
37894349|NCT00727441|69579519|FG001|Overall Study|Eligibility|5|||
37894350|NCT00727441|69579520|FG002|Overall Study|Eligibility|7|||
37894351|NCT00727441|69579518|FG000|Overall Study|Death|0|||
37989801|NCT00195819|69675015|FG001|Open-label|Adverse Event|9|||
37989802|NCT00195819|69675014|FG000|Open-label|Lack of Efficacy|0|||
37989803|NCT00195819|69675015|FG001|Open-label|Lack of Efficacy|2|||
37989804|NCT00195819|69675014|FG000|Open-label|Pregnancy|0|||
37989805|NCT00195819|69675015|FG001|Open-label|Pregnancy|1|||
37989806|NCT00195819|69675014|FG000|Open-label|Protocol Violation|0|||
37989807|NCT00195819|69675015|FG001|Open-label|Protocol Violation|2|||
37989808|NCT00195819|69675014|FG000|Open-label|Moved|0|||
37989809|NCT00195819|69675015|FG001|Open-label|Moved|1|||
37989810|NCT00195819|69675014|FG000|Open-label|Withdrawal by Subject|0|||
37989811|NCT00195819|69675015|FG001|Open-label|Withdrawal by Subject|5|||
37989812|NCT00527735|69675030|FG000|Overall Study|Disease progression|47|||
37989813|NCT00527735|69675031|FG001|Overall Study|Disease progression|61|||
37989814|NCT00527735|69675032|FG002|Overall Study|Disease progression|53|||
37989815|NCT00527735|69675030|FG000|Overall Study|Death|23|||
37989816|NCT00527735|69675031|FG001|Overall Study|Death|13|||
37989817|NCT00527735|69675032|FG002|Overall Study|Death|15|||
37989818|NCT00527735|69675030|FG000|Overall Study|Completed treatment in treatment phase|14|||
37989819|NCT00527735|69675031|FG001|Overall Study|Completed treatment in treatment phase|13|||
37989820|NCT00527735|69675032|FG002|Overall Study|Completed treatment in treatment phase|18|||
37989821|NCT00527735|69675030|FG000|Overall Study|Adverse Event|10|||
37989822|NCT00527735|69675031|FG001|Overall Study|Adverse Event|6|||
37989823|NCT00527735|69675032|FG002|Overall Study|Adverse Event|7|||
37989824|NCT00527735|69675030|FG000|Overall Study|Not identified|5|||
37989825|NCT00527735|69675031|FG001|Overall Study|Not identified|5|||
37989826|NCT00527735|69675032|FG002|Overall Study|Not identified|5|||
37989827|NCT00527735|69675030|FG000|Overall Study|Withdrawal by Subject|5|||
37989828|NCT00527735|69675031|FG001|Overall Study|Withdrawal by Subject|4|||
37989829|NCT00527735|69675032|FG002|Overall Study|Withdrawal by Subject|3|||
37989830|NCT00527735|69675030|FG000|Overall Study|No longer met study criteria|2|||
37989831|NCT00527735|69675031|FG001|Overall Study|No longer met study criteria|2|||
37989832|NCT00527735|69675032|FG002|Overall Study|No longer met study criteria|1|||
37989833|NCT00527735|69675030|FG000|Overall Study|Lost to Follow-up|0|||
37989834|NCT00527735|69675031|FG001|Overall Study|Lost to Follow-up|0|||
37989835|NCT00527735|69675032|FG002|Overall Study|Lost to Follow-up|3|||
37989836|NCT00527735|69675030|FG000|Overall Study|Poor compliance or noncompliance|0|||
37696173|NCT02272777|69172342|FG001|Overall Study|Lost to Follow-up|0|||
37989837|NCT00527735|69675031|FG001|Overall Study|Poor compliance or noncompliance|1|||
37989838|NCT00527735|69675032|FG002|Overall Study|Poor compliance or noncompliance|1|||
37989839|NCT00527735|69675030|FG000|Overall Study|Completed treatment during maintenance|2|||
37989840|NCT00527735|69675031|FG001|Overall Study|Completed treatment during maintenance|2|||
37989841|NCT00527735|69675032|FG002|Overall Study|Completed treatment during maintenance|1|||
37989842|NCT00336492|69675055|FG000|Overall Study|Adverse Event|4|||
37989843|NCT00336492|69675056|FG001|Overall Study|Adverse Event|3|||
37989844|NCT00336492|69675057|FG002|Overall Study|Adverse Event|6|||
37989845|NCT00336492|69675055|FG000|Overall Study|Lack of Efficacy|6|||
37894352|NCT00727441|69579519|FG001|Overall Study|Death|1|||
37894353|NCT00727441|69579520|FG002|Overall Study|Death|1|||
37894354|NCT00727441|69579518|FG000|Overall Study|Physician Decision|0|||
37894355|NCT00727441|69579519|FG001|Overall Study|Physician Decision|1|||
37894356|NCT00727441|69579520|FG002|Overall Study|Physician Decision|0|||
37894357|NCT00727441|69579518|FG000|Overall Study|Withdrawal by Subject|0|||
37894358|NCT00727441|69579519|FG001|Overall Study|Withdrawal by Subject|1|||
37894359|NCT00727441|69579520|FG002|Overall Study|Withdrawal by Subject|0|||
37894360|NCT00717769|69579534|FG000|Overall Study|Adverse Event|9|||
37894361|NCT00717769|69579535|FG001|Overall Study|Adverse Event|6|||
37894362|NCT00717769|69579536|FG002|Overall Study|Adverse Event|1|||
37894363|NCT00717769|69579534|FG000|Overall Study|Lack of compliance|0|||
37894364|NCT00717769|69579535|FG001|Overall Study|Lack of compliance|2|||
37894365|NCT00717769|69579536|FG002|Overall Study|Lack of compliance|0|||
37894366|NCT00717769|69579534|FG000|Overall Study|Lost to Follow-up|3|||
37894367|NCT00717769|69579535|FG001|Overall Study|Lost to Follow-up|4|||
37894368|NCT00717769|69579536|FG002|Overall Study|Lost to Follow-up|0|||
37894369|NCT00717769|69579534|FG000|Overall Study|Lack of Efficacy|1|||
37894370|NCT00717769|69579535|FG001|Overall Study|Lack of Efficacy|2|||
37894371|NCT00717769|69579536|FG002|Overall Study|Lack of Efficacy|0|||
37894372|NCT00717769|69579534|FG000|Overall Study|Protocol Violation|0|||
37894373|NCT00717769|69579535|FG001|Overall Study|Protocol Violation|2|||
37894374|NCT00717769|69579536|FG002|Overall Study|Protocol Violation|0|||
37894375|NCT00717769|69579534|FG000|Overall Study|Sponsor decision|1|||
37894376|NCT00717769|69579535|FG001|Overall Study|Sponsor decision|0|||
37894377|NCT00717769|69579536|FG002|Overall Study|Sponsor decision|10|||
37989846|NCT00336492|69675056|FG001|Overall Study|Lack of Efficacy|1|||
37989847|NCT00336492|69675057|FG002|Overall Study|Lack of Efficacy|4|||
37989848|NCT00336492|69675055|FG000|Overall Study|Other|5|||
37989849|NCT00336492|69675056|FG001|Overall Study|Other|0|||
37989850|NCT00336492|69675057|FG002|Overall Study|Other|1|||
37989851|NCT00194025|69675065|FG000|Overall Study|Adverse Event|1|||
37989852|NCT00194025|69675065|FG000|Overall Study|non-adherence with study medication|4|||
37989853|NCT00368108|69675072|FG000|Overall Study|Adverse Event|38|||
37989854|NCT00368108|69675073|FG001|Overall Study|Adverse Event|26|||
37989855|NCT00368108|69675074|FG002|Overall Study|Adverse Event|44|||
37989856|NCT00368108|69675072|FG000|Overall Study|Abnormal Laboratory Value|0|||
37989857|NCT00368108|69675073|FG001|Overall Study|Abnormal Laboratory Value|0|||
37989858|NCT00368108|69675074|FG002|Overall Study|Abnormal Laboratory Value|3|||
37989859|NCT00368108|69675072|FG000|Overall Study|Protocol Violation|5|||
37989860|NCT00368108|69675073|FG001|Overall Study|Protocol Violation|9|||
37989861|NCT00368108|69675074|FG002|Overall Study|Protocol Violation|9|||
37989862|NCT00368108|69675072|FG000|Overall Study|Withdrawal by Subject|9|||
37989863|NCT00368108|69675073|FG001|Overall Study|Withdrawal by Subject|3|||
37989864|NCT00368108|69675074|FG002|Overall Study|Withdrawal by Subject|5|||
37989865|NCT00368108|69675072|FG000|Overall Study|Lack of Efficacy|7|||
37989866|NCT00368108|69675073|FG001|Overall Study|Lack of Efficacy|8|||
37989867|NCT00368108|69675074|FG002|Overall Study|Lack of Efficacy|5|||
37989868|NCT00368108|69675072|FG000|Overall Study|Physician Decision|2|||
37894378|NCT00717769|69579534|FG000|Overall Study|Withdrew consent|2|||
37894379|NCT00717769|69579535|FG001|Overall Study|Withdrew consent|2|||
37894380|NCT00717769|69579536|FG002|Overall Study|Withdrew consent|0|||
37894381|NCT04153929|69579554|FG000|Overall Study|Other than listed|2|||
37894382|NCT04153929|69579555|FG001|Overall Study|Other than listed|2|||
37824812|NCT01054729|69506896|FG003|Overall Study|Withdrawal by Subject|0|||
37824813|NCT01054729|69506893|FG000|Overall Study|Lost to Follow-up|0|||
37824814|NCT01054729|69506894|FG001|Overall Study|Lost to Follow-up|1|||
37824815|NCT01054729|69506895|FG002|Overall Study|Lost to Follow-up|0|||
37824816|NCT01054729|69506896|FG003|Overall Study|Lost to Follow-up|0|||
37824817|NCT01054729|69506893|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
37824818|NCT01054729|69506894|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
37824819|NCT01054729|69506895|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
37824820|NCT01054729|69506896|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
37824821|NCT01054729|69506893|FG000|Overall Study|Non-responder|1|||
37824822|NCT01054729|69506894|FG001|Overall Study|Non-responder|0|||
37824823|NCT01054729|69506895|FG002|Overall Study|Non-responder|1|||
37824824|NCT01054729|69506896|FG003|Overall Study|Non-responder|1|||
37824825|NCT01054729|69506893|FG000|Overall Study|PEG/RBV Non-responder|1|||
37894383|NCT04153929|69579556|FG002|Overall Study|Other than listed|0|||
37894384|NCT04153929|69579557|FG003|Overall Study|Other than listed|1|||
37894385|NCT04153929|69579558|FG004|Overall Study|Other than listed|0|||
37989869|NCT00368108|69675073|FG001|Overall Study|Physician Decision|0|||
37989870|NCT00368108|69675074|FG002|Overall Study|Physician Decision|1|||
37989871|NCT00368108|69675072|FG000|Overall Study|Other|3|||
37824826|NCT01054729|69506894|FG001|Overall Study|PEG/RBV Non-responder|0|||
37824827|NCT01054729|69506895|FG002|Overall Study|PEG/RBV Non-responder|1|||
37894386|NCT04153929|69579559|FG005|Overall Study|Other than listed|2|||
37894387|NCT04153929|69579560|FG006|Overall Study|Other than listed|2|||
37894388|NCT04153929|69579561|FG007|Overall Study|Other than listed|1|||
37989872|NCT00368108|69675073|FG001|Overall Study|Other|7|||
37989873|NCT00368108|69675074|FG002|Overall Study|Other|1|||
37894389|NCT04153929|69579554|FG000|Overall Study|Lost to Follow-up|2|||
37989874|NCT00364130|69675084|FG000|Intervention Period|Lost to Follow-up|4|||
37894390|NCT04153929|69579555|FG001|Overall Study|Lost to Follow-up|1|||
37894391|NCT04153929|69579556|FG002|Overall Study|Lost to Follow-up|0|||
37894392|NCT04153929|69579557|FG003|Overall Study|Lost to Follow-up|1|||
37894393|NCT04153929|69579558|FG004|Overall Study|Lost to Follow-up|1|||
37894394|NCT04153929|69579559|FG005|Overall Study|Lost to Follow-up|0|||
37989875|NCT00364130|69675085|FG001|Intervention Period|Lost to Follow-up|3|||
37989876|NCT00364130|69675084|FG000|Intervention Period|Pregnancy|1|||
37989877|NCT00364130|69675085|FG001|Intervention Period|Pregnancy|0|||
37989878|NCT00364130|69675084|FG000|Intervention Period|Withdrawal by Subject|4|||
37989879|NCT00364130|69675085|FG001|Intervention Period|Withdrawal by Subject|5|||
37989880|NCT00364130|69675084|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
37989881|NCT00364130|69675085|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
37824828|NCT01054729|69506896|FG003|Overall Study|PEG/RBV Non-responder|0|||
37824829|NCT01054729|69506893|FG000|Overall Study|Personal/Obligations|0|||
37824830|NCT01054729|69506894|FG001|Overall Study|Personal/Obligations|1|||
37824831|NCT01054729|69506895|FG002|Overall Study|Personal/Obligations|0|||
37824832|NCT01054729|69506896|FG003|Overall Study|Personal/Obligations|0|||
37824833|NCT01054729|69506893|FG000|Overall Study|Subject moved|0|||
37824834|NCT01054729|69506894|FG001|Overall Study|Subject moved|0|||
37894395|NCT04153929|69579560|FG006|Overall Study|Lost to Follow-up|0|||
37894396|NCT04153929|69579561|FG007|Overall Study|Lost to Follow-up|0|||
37894397|NCT04153929|69579554|FG000|Overall Study|Withdrawal by Subject|3|||
37894398|NCT04153929|69579555|FG001|Overall Study|Withdrawal by Subject|1|||
37894399|NCT04153929|69579556|FG002|Overall Study|Withdrawal by Subject|0|||
37894400|NCT04153929|69579557|FG003|Overall Study|Withdrawal by Subject|3|||
37894401|NCT04153929|69579558|FG004|Overall Study|Withdrawal by Subject|1|||
37894402|NCT04153929|69579559|FG005|Overall Study|Withdrawal by Subject|0|||
37894403|NCT04153929|69579560|FG006|Overall Study|Withdrawal by Subject|1|||
37894404|NCT04153929|69579561|FG007|Overall Study|Withdrawal by Subject|0|||
37894405|NCT04153929|69579554|FG000|Overall Study|Protocol Violation|0|||
37894406|NCT04153929|69579555|FG001|Overall Study|Protocol Violation|0|||
37894407|NCT04153929|69579556|FG002|Overall Study|Protocol Violation|0|||
37894408|NCT04153929|69579557|FG003|Overall Study|Protocol Violation|0|||
37894409|NCT04153929|69579558|FG004|Overall Study|Protocol Violation|0|||
37894410|NCT04153929|69579559|FG005|Overall Study|Protocol Violation|0|||
37894411|NCT04153929|69579560|FG006|Overall Study|Protocol Violation|1|||
37894412|NCT04153929|69579561|FG007|Overall Study|Protocol Violation|2|||
37894413|NCT04153929|69579554|FG000|Overall Study|Adverse Event|3|||
37894414|NCT04153929|69579555|FG001|Overall Study|Adverse Event|5|||
37894415|NCT04153929|69579556|FG002|Overall Study|Adverse Event|5|||
37894416|NCT04153929|69579557|FG003|Overall Study|Adverse Event|11|||
37894417|NCT04153929|69579558|FG004|Overall Study|Adverse Event|15|||
37894418|NCT04153929|69579559|FG005|Overall Study|Adverse Event|4|||
37894419|NCT04153929|69579560|FG006|Overall Study|Adverse Event|8|||
37894420|NCT04153929|69579561|FG007|Overall Study|Adverse Event|2|||
37894421|NCT04153929|69579554|FG000|Overall Study|Not treated|1|||
37894422|NCT04153929|69579555|FG001|Overall Study|Not treated|0|||
37894423|NCT04153929|69579556|FG002|Overall Study|Not treated|0|||
37894424|NCT04153929|69579557|FG003|Overall Study|Not treated|0|||
37894425|NCT04153929|69579558|FG004|Overall Study|Not treated|0|||
37894426|NCT04153929|69579559|FG005|Overall Study|Not treated|0|||
37894427|NCT04153929|69579560|FG006|Overall Study|Not treated|1|||
37894428|NCT04153929|69579561|FG007|Overall Study|Not treated|0|||
37894429|NCT00591214|69579579|FG000|Overall Study|Physician Decision|7|||
37894430|NCT00591214|69579579|FG000|Overall Study|Withdrawal by Subject|1|||
37894431|NCT00725725|69579586|FG000|Overall Study|Adverse Event|1|||
37894432|NCT00725725|69579587|FG001|Overall Study|Adverse Event|3|||
37894433|NCT00725725|69579588|FG002|Overall Study|Adverse Event|2|||
37894434|NCT00725725|69579586|FG000|Overall Study|Lost to Follow-up|2|||
37989882|NCT00521339|69675093|FG000|Treatment Phase|Adverse Event|2|||
37989883|NCT00521339|69675094|FG001|Treatment Phase|Adverse Event|0|||
37989884|NCT00521339|69675095|FG002|Treatment Phase|Adverse Event|0|||
37989885|NCT00521339|69675093|FG000|Treatment Phase|Intolerability to study drug|2|||
37824835|NCT01054729|69506895|FG002|Overall Study|Subject moved|1|||
37894435|NCT00725725|69579587|FG001|Overall Study|Lost to Follow-up|0|||
37894436|NCT00725725|69579588|FG002|Overall Study|Lost to Follow-up|2|||
37824836|NCT01054729|69506896|FG003|Overall Study|Subject moved|0|||
37894437|NCT00725725|69579586|FG000|Overall Study|Withdrawal by Subject|1|||
37894438|NCT00725725|69579587|FG001|Overall Study|Withdrawal by Subject|0|||
37894439|NCT00725725|69579588|FG002|Overall Study|Withdrawal by Subject|1|||
37894440|NCT00725725|69579586|FG000|Overall Study|Protocol Violation|0|||
37894441|NCT00725725|69579587|FG001|Overall Study|Protocol Violation|1|||
37894442|NCT00725725|69579588|FG002|Overall Study|Protocol Violation|0|||
37894443|NCT00725101|69579596|FG000|Overall Study|Death|3|||
37894444|NCT00725101|69579596|FG000|Overall Study|Lost to Follow-up|353|||
37894445|NCT00725101|69579596|FG000|Overall Study|Protocol Violation|1|||
37894446|NCT00725101|69579596|FG000|Overall Study|Withdrawal by Subject|127|||
37894447|NCT00725101|69579596|FG000|Overall Study|not specified/no reason given|11|||
37894448|NCT00585169|69579600|FG000|Overall Study|Withdrawal by Subject|1|||
37989886|NCT00521339|69675094|FG001|Treatment Phase|Intolerability to study drug|0|||
37696174|NCT02272777|69172341|FG000|Overall Study|Other|2|||
37824837|NCT01054729|69506893|FG000|Overall Study|Lack of Efficacy|0|||
37824838|NCT01054729|69506894|FG001|Overall Study|Lack of Efficacy|0|||
37824839|NCT01054729|69506895|FG002|Overall Study|Lack of Efficacy|0|||
37824840|NCT01054729|69506896|FG003|Overall Study|Lack of Efficacy|1|||
37824841|NCT01054573|69506910|FG000|Overall Study|Adverse Event|1|||
37824842|NCT01054573|69506911|FG001|Overall Study|Adverse Event|0|||
37824843|NCT01054573|69506912|FG002|Overall Study|Adverse Event|1|||
37824844|NCT01054573|69506913|FG003|Overall Study|Adverse Event|1|||
37824845|NCT01054573|69506910|FG000|Overall Study|Lost to Follow-up|0|||
37824846|NCT01054573|69506911|FG001|Overall Study|Lost to Follow-up|2|||
37824847|NCT01054573|69506912|FG002|Overall Study|Lost to Follow-up|0|||
37824848|NCT01054573|69506913|FG003|Overall Study|Lost to Follow-up|0|||
37824849|NCT01054573|69506910|FG000|Overall Study|Withdrawal by Subject|0|||
37824850|NCT01054573|69506911|FG001|Overall Study|Withdrawal by Subject|2|||
37824851|NCT01054573|69506912|FG002|Overall Study|Withdrawal by Subject|2|||
37824852|NCT01054573|69506913|FG003|Overall Study|Withdrawal by Subject|1|||
37824853|NCT01054456|69506932|FG000|Overall Study|Other|1|||
37824854|NCT01054300|69506938|FG000|Period 1|Adverse Event|1|||
37824855|NCT01054300|69506939|FG001|Period 1|Adverse Event|0|||
37824856|NCT01054300|69506940|FG002|Period 1|Adverse Event|0|||
37824857|NCT01054300|69506941|FG003|Period 1|Adverse Event|0|||
37824858|NCT01054300|69506938|FG000|Period 2|Withdrawal by Subject|0|||
37824859|NCT01054300|69506939|FG001|Period 2|Withdrawal by Subject|0|||
37824860|NCT01054300|69506940|FG002|Period 2|Withdrawal by Subject|1|||
37824861|NCT01054300|69506941|FG003|Period 2|Withdrawal by Subject|0|||
37894449|NCT00807742|69579608|FG000|Overall Study|Death|9|||
37696175|NCT02272777|69172342|FG001|Overall Study|Other|0|||
37824862|NCT01053988|69506956|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
37824863|NCT01053988|69506957|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
37824864|NCT01053988|69506958|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
37989887|NCT00521339|69675095|FG002|Treatment Phase|Intolerability to study drug|0|||
37989888|NCT00521339|69675093|FG000|Treatment Phase|Lack of Efficacy|3|||
37989889|NCT00521339|69675094|FG001|Treatment Phase|Lack of Efficacy|0|||
37989890|NCT00521339|69675095|FG002|Treatment Phase|Lack of Efficacy|0|||
37989891|NCT00521339|69675093|FG000|Treatment Phase|Withdrawal by Subject|3|||
37989892|NCT00521339|69675094|FG001|Treatment Phase|Withdrawal by Subject|0|||
37894450|NCT00807742|69579609|FG001|Overall Study|Death|2|||
37894451|NCT00807742|69579608|FG000|Overall Study|Withdrawal by Subject|2|||
37894452|NCT00807742|69579609|FG001|Overall Study|Withdrawal by Subject|1|||
37894453|NCT00807742|69579608|FG000|Overall Study|Lost to Follow-up|35|||
37894454|NCT00807742|69579609|FG001|Overall Study|Lost to Follow-up|51|||
37894455|NCT00724945|69579615|FG000|Period 1|non-compliance|1|||
37894456|NCT00724945|69579616|FG001|Period 1|non-compliance|0|||
37894457|NCT00724945|69579615|FG000|Period 1|Adverse Event|1|||
37894458|NCT00724945|69579616|FG001|Period 1|Adverse Event|1|||
37894459|NCT00724945|69579615|FG000|Period 1|Lost to Follow-up|1|||
37894460|NCT00724945|69579616|FG001|Period 1|Lost to Follow-up|0|||
37894461|NCT00724945|69579615|FG000|Period 2|lens comfort issue|3|||
37894462|NCT00724945|69579616|FG001|Period 2|lens comfort issue|0|||
37894463|NCT00724945|69579615|FG000|Period 2|lens physiology issue|1|||
37894464|NCT00724945|69579616|FG001|Period 2|lens physiology issue|0|||
37894465|NCT00803452|69579624|FG000|Overall Study|Adverse Event|0|||
37894466|NCT00803452|69579625|FG001|Overall Study|Adverse Event|2|||
37894467|NCT00803452|69579624|FG000|Overall Study|Lost to Follow-up|0|||
37894468|NCT00803452|69579625|FG001|Overall Study|Lost to Follow-up|3|||
37894469|NCT00589108|69579634|FG000|Overall Study|Lost to Follow-up|1|||
37894470|NCT00589108|69579635|FG001|Overall Study|Lost to Follow-up|1|||
37894471|NCT00589108|69579636|FG002|Overall Study|Lost to Follow-up|1|||
37894472|NCT00589108|69579634|FG000|Overall Study|Death|3|||
37894473|NCT00589108|69579635|FG001|Overall Study|Death|3|||
37894474|NCT00589108|69579636|FG002|Overall Study|Death|4|||
37894475|NCT00717067|69579649|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
37894476|NCT00717067|69579650|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
37894477|NCT00717067|69579651|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
37894478|NCT00717067|69579652|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
37894479|NCT00717067|69579653|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
37894480|NCT00802438|69579675|FG000|Overall Study|Screen Failure|20|||
37894481|NCT00802438|69579675|FG000|Overall Study|Withdrawal by Subject|7|||
37894482|NCT00802438|69579675|FG000|Overall Study|Physician Decision|1|||
37894483|NCT00588952|69579685|FG000|Overall Study|Adverse Event|0|||
37894484|NCT00588952|69579686|FG001|Overall Study|Adverse Event|2|||
37894485|NCT00588952|69579685|FG000|Overall Study|Withdrawal by Subject|3|||
37894486|NCT00588952|69579686|FG001|Overall Study|Withdrawal by Subject|5|||
37894487|NCT01021748|69579701|FG000|Overall Study|Adverse Event|2|||
37894488|NCT01021748|69579702|FG001|Overall Study|Adverse Event|1|||
37894489|NCT01021748|69579703|FG002|Overall Study|Adverse Event|2|||
37894490|NCT01021748|69579704|FG003|Overall Study|Adverse Event|0|||
37894491|NCT01021748|69579705|FG004|Overall Study|Adverse Event|2|||
37894492|NCT01021748|69579706|FG005|Overall Study|Adverse Event|0|||
37894493|NCT01021748|69579707|FG006|Overall Study|Adverse Event|1|||
37894494|NCT01021748|69579708|FG007|Overall Study|Adverse Event|0|||
37894495|NCT01021748|69579709|FG008|Overall Study|Adverse Event|7|||
37894496|NCT01021748|69579701|FG000|Overall Study|Physician Decision|1|||
37894497|NCT01021748|69579702|FG001|Overall Study|Physician Decision|0|||
37894498|NCT01021748|69579703|FG002|Overall Study|Physician Decision|1|||
37894499|NCT01021748|69579704|FG003|Overall Study|Physician Decision|1|||
37894500|NCT01021748|69579705|FG004|Overall Study|Physician Decision|0|||
37894501|NCT01021748|69579706|FG005|Overall Study|Physician Decision|0|||
37989893|NCT00521339|69675095|FG002|Treatment Phase|Withdrawal by Subject|0|||
37696176|NCT02357810|69172348|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
37824865|NCT01053988|69506959|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
37824866|NCT01053988|69506960|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
37824867|NCT01053988|69506961|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
37824868|NCT01053988|69506956|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
37824869|NCT01053988|69506957|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
37824870|NCT01053988|69506958|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
37824871|NCT01053988|69506959|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
37824872|NCT01053988|69506960|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
37894502|NCT01021748|69579707|FG006|Overall Study|Physician Decision|1|||
37894503|NCT01021748|69579708|FG007|Overall Study|Physician Decision|1|||
37894504|NCT01021748|69579709|FG008|Overall Study|Physician Decision|2|||
37894505|NCT01021748|69579701|FG000|Overall Study|Progressive Disease|3|||
37894506|NCT01021748|69579702|FG001|Overall Study|Progressive Disease|3|||
37894507|NCT01021748|69579703|FG002|Overall Study|Progressive Disease|4|||
37989894|NCT00521339|69675093|FG000|Treatment Phase|Lost to Follow-up|1|||
37989895|NCT00521339|69675094|FG001|Treatment Phase|Lost to Follow-up|0|||
37989896|NCT00521339|69675095|FG002|Treatment Phase|Lost to Follow-up|0|||
37989897|NCT00521339|69675093|FG000|Treatment Phase|Protocol Violation|1|||
37989898|NCT00521339|69675094|FG001|Treatment Phase|Protocol Violation|0|||
37989899|NCT00521339|69675095|FG002|Treatment Phase|Protocol Violation|0|||
37989900|NCT00521339|69675093|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
37989901|NCT00521339|69675094|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
37989902|NCT00521339|69675095|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
37989903|NCT00521339|69675093|FG000|Treatment Extension Phase|Death|0|||
37989904|NCT00521339|69675094|FG001|Treatment Extension Phase|Death|0|||
37989905|NCT00521339|69675095|FG002|Treatment Extension Phase|Death|1|||
37989906|NCT00363896|69675118|FG000|Overall Study|Withdrawal by Subject|29|||
37989907|NCT00363896|69675119|FG001|Overall Study|Withdrawal by Subject|16|||
37989908|NCT00363896|69675118|FG000|Overall Study|Adverse Event|24|||
37989909|NCT00363896|69675119|FG001|Overall Study|Adverse Event|13|||
37894508|NCT01021748|69579704|FG003|Overall Study|Progressive Disease|6|||
37894509|NCT01021748|69579705|FG004|Overall Study|Progressive Disease|7|||
37894510|NCT01021748|69579706|FG005|Overall Study|Progressive Disease|3|||
37894511|NCT01021748|69579707|FG006|Overall Study|Progressive Disease|0|||
37894512|NCT01021748|69579708|FG007|Overall Study|Progressive Disease|5|||
37894513|NCT01021748|69579709|FG008|Overall Study|Progressive Disease|6|||
37894514|NCT01021748|69579701|FG000|Overall Study|Withdrawal by Subject|0|||
37894515|NCT01021748|69579702|FG001|Overall Study|Withdrawal by Subject|0|||
37894516|NCT01021748|69579703|FG002|Overall Study|Withdrawal by Subject|0|||
37989910|NCT00363896|69675118|FG000|Overall Study|COPD exacerbation|13|||
37989911|NCT00363896|69675119|FG001|Overall Study|COPD exacerbation|7|||
37989912|NCT00363896|69675118|FG000|Overall Study|Lack of Efficacy|12|||
37989913|NCT00363896|69675119|FG001|Overall Study|Lack of Efficacy|8|||
37989914|NCT00363896|69675118|FG000|Overall Study|Protocol Violation|6|||
37989915|NCT00363896|69675119|FG001|Overall Study|Protocol Violation|1|||
37989916|NCT00363896|69675118|FG000|Overall Study|Lost to Follow-up|3|||
37989917|NCT00363896|69675119|FG001|Overall Study|Lost to Follow-up|0|||
37989918|NCT00363896|69675118|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
37989919|NCT00363896|69675119|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
37989920|NCT00363896|69675118|FG000|Overall Study|Other|1|||
37989921|NCT00363896|69675119|FG001|Overall Study|Other|2|||
37989922|NCT00527423|69675128|FG000|Overall Study|Protocol Violation|1|||
37989923|NCT00527423|69675128|FG000|Overall Study|Adverse Event|5|||
37989924|NCT00527423|69675128|FG000|Overall Study|Physician Decision|4|||
37989925|NCT00527423|69675128|FG000|Overall Study|Withdrawal by Subject|10|||
37989926|NCT00527423|69675128|FG000|Overall Study|Lost to Follow-up|4|||
37989927|NCT00527423|69675128|FG000|Overall Study|OTHER|4|||
37989928|NCT00527423|69675128|FG000|Overall Study|Death|9|||
37989929|NCT00527111|69675136|FG000|Overall Study|Adverse Event|14|||
37989930|NCT00527111|69675137|FG001|Overall Study|Adverse Event|13|||
37989931|NCT00527111|69675136|FG000|Overall Study|Death|0|||
37989932|NCT00527111|69675137|FG001|Overall Study|Death|1|||
37894517|NCT01021748|69579704|FG003|Overall Study|Withdrawal by Subject|0|||
37894518|NCT01021748|69579705|FG004|Overall Study|Withdrawal by Subject|0|||
37989933|NCT00527111|69675136|FG000|Overall Study|Investigator Request|2|||
37989934|NCT00527111|69675137|FG001|Overall Study|Investigator Request|1|||
37989935|NCT00527111|69675136|FG000|Overall Study|Patient Request|2|||
37824873|NCT01053988|69506961|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
37824874|NCT01053988|69506956|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
37824875|NCT01053988|69506957|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
37824876|NCT01053988|69506958|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
37824877|NCT01053988|69506959|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
37824878|NCT01053988|69506960|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
37824879|NCT01053988|69506961|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
37824880|NCT01053988|69506956|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
37824881|NCT01053988|69506957|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
37824882|NCT01053988|69506958|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
37824883|NCT01053988|69506959|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
37824884|NCT01053988|69506960|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
37824885|NCT01053988|69506961|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
37824886|NCT01053988|69506956|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
37824887|NCT01053988|69506957|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
37824888|NCT01053988|69506958|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
37894519|NCT01021748|69579706|FG005|Overall Study|Withdrawal by Subject|0|||
37894520|NCT01021748|69579707|FG006|Overall Study|Withdrawal by Subject|1|||
37989936|NCT00527111|69675137|FG001|Overall Study|Patient Request|5|||
37989937|NCT00527111|69675136|FG000|Overall Study|Other|2|||
37894521|NCT01021748|69579708|FG007|Overall Study|Withdrawal by Subject|0|||
37894522|NCT01021748|69579709|FG008|Overall Study|Withdrawal by Subject|1|||
37894523|NCT01021748|69579701|FG000|Overall Study|Not Treated|0|||
37894524|NCT01021748|69579702|FG001|Overall Study|Not Treated|1|||
37894525|NCT01021748|69579703|FG002|Overall Study|Not Treated|0|||
37989938|NCT00527111|69675137|FG001|Overall Study|Other|2|||
37989939|NCT00384956|69675143|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
37989940|NCT00367640|69675151|FG000|Overall Study|Adverse Event|3|||
37989941|NCT00367640|69675152|FG001|Overall Study|Adverse Event|6|||
37894526|NCT01021748|69579704|FG003|Overall Study|Not Treated|0|||
37894527|NCT01021748|69579705|FG004|Overall Study|Not Treated|0|||
37894528|NCT01021748|69579706|FG005|Overall Study|Not Treated|0|||
37894529|NCT01021748|69579707|FG006|Overall Study|Not Treated|0|||
37894530|NCT01021748|69579708|FG007|Overall Study|Not Treated|0|||
37894531|NCT01021748|69579709|FG008|Overall Study|Not Treated|0|||
37894532|NCT00802360|69579733|FG000|Overall Study|Stimulation failure|4|||
37894533|NCT00802360|69579734|FG001|Overall Study|Stimulation failure|0|||
37894534|NCT00802360|69579735|FG002|Overall Study|Stimulation failure|3|||
37894535|NCT00802360|69579736|FG003|Overall Study|Stimulation failure|3|||
37894536|NCT00802360|69579733|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
37894537|NCT00802360|69579734|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
37894538|NCT00802360|69579735|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
37894539|NCT00802360|69579736|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
37894540|NCT00802360|69579733|FG000|Overall Study|Cycle cancelled|0|||
37894541|NCT00802360|69579734|FG001|Overall Study|Cycle cancelled|1|||
37894542|NCT00802360|69579735|FG002|Overall Study|Cycle cancelled|1|||
37894543|NCT00802360|69579736|FG003|Overall Study|Cycle cancelled|1|||
37989942|NCT00367640|69675153|FG002|Overall Study|Adverse Event|8|||
37989943|NCT00367640|69675154|FG003|Overall Study|Adverse Event|0|||
37989944|NCT00367640|69675151|FG000|Overall Study|Withdrawal by Subject|8|||
37989945|NCT00367640|69675152|FG001|Overall Study|Withdrawal by Subject|11|||
37989946|NCT00367640|69675153|FG002|Overall Study|Withdrawal by Subject|8|||
37989947|NCT00367640|69675154|FG003|Overall Study|Withdrawal by Subject|6|||
37989948|NCT00367640|69675151|FG000|Overall Study|Any other reason not above-mentioned|7|||
37989949|NCT00367640|69675152|FG001|Overall Study|Any other reason not above-mentioned|5|||
37989950|NCT00367640|69675153|FG002|Overall Study|Any other reason not above-mentioned|3|||
37989951|NCT00367640|69675154|FG003|Overall Study|Any other reason not above-mentioned|4|||
37989952|NCT00367484|69675164|FG000|Overall Study|Adverse Event|7|||
37989953|NCT00367484|69675164|FG000|Overall Study|Withdrew informed consent|5|||
37989954|NCT00367484|69675164|FG000|Overall Study|Travel to USA|1|||
37989955|NCT00367484|69675164|FG000|Overall Study|Lost to Follow-up|1|||
37989956|NCT00367484|69675164|FG000|Overall Study|Protocol Violation|1|||
37989957|NCT00367484|69675164|FG000|Overall Study|The choice of the patient|1|||
37989958|NCT00367484|69675164|FG000|Overall Study|Lack of Efficacy|1|||
37989959|NCT00526799|69675170|FG000|Overall Study|Withdrawal by Subject|1|||
37989960|NCT00526799|69675171|FG001|Overall Study|Withdrawal by Subject|0|||
37989961|NCT00526799|69675170|FG000|Overall Study|Intercurrent Complicating Disease|0|||
37989962|NCT00526799|69675171|FG001|Overall Study|Intercurrent Complicating Disease|1|||
37989963|NCT00526331|69675177|FG000|Overall Study|Sponsor Termination|55|||
37989964|NCT00520481|69675183|FG000|Overall Study|Adverse Event|4|||
37989965|NCT00520481|69675184|FG001|Overall Study|Adverse Event|1|||
37989966|NCT00520481|69675183|FG000|Overall Study|Withdrawal by Subject|3|||
37989967|NCT00520481|69675184|FG001|Overall Study|Withdrawal by Subject|0|||
37989968|NCT00520403|69675192|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
37989969|NCT00520403|69675192|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
37989970|NCT00520403|69675192|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
37989971|NCT00520403|69675192|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
37989972|NCT00520403|69675192|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
37989973|NCT00520403|69675192|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
37989974|NCT00520403|69675192|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
37989975|NCT00520403|69675192|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
37989976|NCT00520013|69675199|FG000|Overall Study|Withdrawal by Subject|0|||
37989977|NCT00520013|69675200|FG001|Overall Study|Withdrawal by Subject|0|||
37989978|NCT00520013|69675201|FG002|Overall Study|Withdrawal by Subject|1|||
37989979|NCT00520013|69675199|FG000|Overall Study|Adverse Event|2|||
37894544|NCT00802360|69579733|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
37894545|NCT00802360|69579734|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
37894546|NCT00802360|69579735|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
37894547|NCT00802360|69579736|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
37894548|NCT00802360|69579733|FG000|Overall Study|No positive serum pregnancy|17|||
37989980|NCT00520013|69675200|FG001|Overall Study|Adverse Event|10|||
37989981|NCT00520013|69675201|FG002|Overall Study|Adverse Event|7|||
37989982|NCT00520013|69675199|FG000|Overall Study|Progressive Disease|7|||
37989983|NCT00520013|69675200|FG001|Overall Study|Progressive Disease|3|||
37989984|NCT00520013|69675201|FG002|Overall Study|Progressive Disease|0|||
37989985|NCT00520013|69675199|FG000|Overall Study|Clinical Progression|3|||
37989986|NCT00520013|69675200|FG001|Overall Study|Clinical Progression|1|||
37989987|NCT00520013|69675201|FG002|Overall Study|Clinical Progression|0|||
37894549|NCT00802360|69579734|FG001|Overall Study|No positive serum pregnancy|20|||
37894550|NCT00802360|69579735|FG002|Overall Study|No positive serum pregnancy|14|||
37894551|NCT00802360|69579736|FG003|Overall Study|No positive serum pregnancy|10|||
37894552|NCT00802360|69579733|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
37894553|NCT00802360|69579734|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
37894554|NCT00802360|69579735|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
37894555|NCT00802360|69579736|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
37894556|NCT00802360|69579733|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
37894557|NCT00802360|69579734|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
37894558|NCT00802360|69579735|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
37894559|NCT00802360|69579736|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
37894560|NCT00802360|69579733|FG000|Overall Study|Other|2|||
37894561|NCT00802360|69579734|FG001|Overall Study|Other|3|||
37894562|NCT00802360|69579735|FG002|Overall Study|Other|6|||
37894563|NCT00802360|69579736|FG003|Overall Study|Other|3|||
37894564|NCT01026038|69579751|FG000|Overall Study|Lost to Follow-up|1|||
37894565|NCT01026038|69579752|FG001|Overall Study|Lost to Follow-up|1|||
37894566|NCT01026038|69579753|FG002|Overall Study|Lost to Follow-up|0|||
37894567|NCT00801892|69579772|FG000|Main Study Period|Withdrawal by Subject|0|||
37894568|NCT00801892|69579773|FG001|Main Study Period|Withdrawal by Subject|1|||
37894569|NCT00801892|69579772|FG000|Sham Crossover Period|Lost to Follow-up|0|||
37894570|NCT00801892|69579773|FG001|Sham Crossover Period|Lost to Follow-up|2|||
37989988|NCT00520013|69675199|FG000|Overall Study|Death|0|||
37989989|NCT00520013|69675200|FG001|Overall Study|Death|1|||
37989990|NCT00520013|69675201|FG002|Overall Study|Death|0|||
37989991|NCT00520013|69675199|FG000|Overall Study|Physician Decision|0|||
37989992|NCT00520013|69675200|FG001|Overall Study|Physician Decision|0|||
37989993|NCT00520013|69675201|FG002|Overall Study|Physician Decision|3|||
37989994|NCT00519779|69675209|FG000|Overall Study|Withdrawal by Subject|0|||
37989995|NCT00519779|69675210|FG001|Overall Study|Withdrawal by Subject|1|||
37989996|NCT00526097|69675218|FG000|Overall Study|Adverse Event|6|||
37989997|NCT00526097|69675219|FG001|Overall Study|Adverse Event|44|||
37989998|NCT00526097|69675218|FG000|Overall Study|Protocol Violation|4|||
37989999|NCT00526097|69675219|FG001|Overall Study|Protocol Violation|10|||
37990000|NCT00526097|69675218|FG000|Overall Study|Withdrawal by Subject|3|||
37990001|NCT00526097|69675219|FG001|Overall Study|Withdrawal by Subject|1|||
37990002|NCT00526097|69675218|FG000|Overall Study|Other|2|||
37990003|NCT00526097|69675219|FG001|Overall Study|Other|1|||
37990004|NCT00525785|69675225|FG000|Overall Study|Withdrawal by Subject|1|||
37990005|NCT00525785|69675225|FG000|Overall Study|Lack of Efficacy|1|||
37990006|NCT00525785|69675225|FG000|Overall Study|Physician Decision|1|||
37990007|NCT00525161|69675229|FG000|Overall Study|Adverse Event|1|||
37990008|NCT00524771|69675235|FG000|Overall Study|Protocol Violation|220|||
37990009|NCT00524771|69675236|FG001|Overall Study|Protocol Violation|585|||
37990010|NCT00135694|69675246|FG000|Overall Study|Adverse Event|17|||
37990011|NCT00135694|69675247|FG001|Overall Study|Adverse Event|4|||
37990012|NCT00135694|69675248|FG002|Overall Study|Adverse Event|0|||
37990013|NCT00135694|69675246|FG000|Overall Study|Death|14|||
37990014|NCT00135694|69675247|FG001|Overall Study|Death|1|||
37990015|NCT00135694|69675248|FG002|Overall Study|Death|2|||
37990016|NCT00135694|69675246|FG000|Overall Study|Lost to Follow-up|8|||
37990017|NCT00135694|69675247|FG001|Overall Study|Lost to Follow-up|7|||
37990018|NCT00135694|69675248|FG002|Overall Study|Lost to Follow-up|1|||
37990019|NCT00135694|69675246|FG000|Overall Study|Withdrawal by Subject|41|||
37990020|NCT00135694|69675247|FG001|Overall Study|Withdrawal by Subject|7|||
37990021|NCT00135694|69675248|FG002|Overall Study|Withdrawal by Subject|4|||
37894571|NCT02680587|69579787|FG000|Overall Study|Withdrawal by Subject|1|||
37894572|NCT02680587|69579788|FG001|Overall Study|Withdrawal by Subject|0|||
37894573|NCT00589420|69579798|FG000|Overall Study|screen failure|1|||
37894574|NCT01025336|69579807|FG000|Overall Study|Protocol Violation|0|||
37990022|NCT00135694|69675246|FG000|Overall Study|Protocol Violation|19|||
37990023|NCT00135694|69675247|FG001|Overall Study|Protocol Violation|1|||
37990024|NCT00135694|69675248|FG002|Overall Study|Protocol Violation|0|||
37990025|NCT00135694|69675246|FG000|Overall Study|Hepatitis C related reasons|39|||
37990026|NCT00135694|69675247|FG001|Overall Study|Hepatitis C related reasons|1|||
37990027|NCT00135694|69675248|FG002|Overall Study|Hepatitis C related reasons|0|||
37990028|NCT00135694|69675246|FG000|Overall Study|Ineligible for Random assignment|42|||
37894575|NCT01025336|69579808|FG001|Overall Study|Protocol Violation|0|||
37894576|NCT01025336|69579809|FG002|Overall Study|Protocol Violation|0|||
37894577|NCT01025336|69579810|FG003|Overall Study|Protocol Violation|2|||
37894578|NCT01025336|69579811|FG004|Overall Study|Protocol Violation|0|||
37990029|NCT00135694|69675247|FG001|Overall Study|Ineligible for Random assignment|0|||
37990030|NCT00135694|69675248|FG002|Overall Study|Ineligible for Random assignment|0|||
37824889|NCT01053988|69506959|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
37824890|NCT01053988|69506960|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
37824891|NCT01053988|69506961|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
37824892|NCT01053988|69506956|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
37824893|NCT01053988|69506957|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
37824894|NCT01053988|69506958|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
37824895|NCT01053988|69506959|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
37824896|NCT01053988|69506960|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
37824897|NCT01053988|69506961|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
37824898|NCT01053988|69506956|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
37824899|NCT01053988|69506957|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
37824900|NCT01053988|69506958|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
37824901|NCT01053988|69506959|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
37824902|NCT01053988|69506960|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
37824903|NCT01053988|69506961|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
37824904|NCT01053988|69506956|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
37824905|NCT01053988|69506957|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
37824906|NCT01053988|69506958|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
37824907|NCT01053988|69506959|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
37824908|NCT01053988|69506960|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
37824909|NCT01053988|69506961|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
37824910|NCT01053988|69506956|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
37824911|NCT01053988|69506957|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
37824912|NCT01053988|69506958|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
37824913|NCT01053988|69506959|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
37824914|NCT01053988|69506960|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
37824915|NCT01053988|69506961|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
37824916|NCT01053988|69506956|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
37824917|NCT01053988|69506957|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
37824918|NCT01053988|69506958|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
37824919|NCT01053988|69506959|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
37824920|NCT01053988|69506960|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
37824921|NCT01053988|69506961|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
37824922|NCT01053988|69506956|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
37824923|NCT01053988|69506957|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
37824924|NCT01053988|69506958|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
37824925|NCT01053988|69506959|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
37824926|NCT01053988|69506960|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
37824927|NCT01053988|69506961|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
37824928|NCT01053988|69506956|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
37824929|NCT01053988|69506957|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
37824930|NCT01053988|69506958|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
37824931|NCT01053988|69506959|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
37824932|NCT01053988|69506960|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
37824933|NCT01053988|69506961|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
37824934|NCT01053988|69506956|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
37824935|NCT01053988|69506957|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
37824936|NCT01053988|69506958|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
37824937|NCT01053988|69506959|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
37824938|NCT01053988|69506960|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
37824939|NCT01053988|69506961|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
37824940|NCT01053988|69506956|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
37894579|NCT00796978|69579845|FG000|Overall Study|Cardiac adverse event|5|||
37894580|NCT00796978|69579845|FG000|Overall Study|Adverse Event|4|||
37894581|NCT00796978|69579845|FG000|Overall Study|Withdrawal by Subject|3|||
37894582|NCT00796822|69579851|FG000|Overall Study|Lost to Follow-up|2|||
37894583|NCT00796822|69579852|FG001|Overall Study|Lost to Follow-up|0|||
37990031|NCT00524459|69675256|FG000|Overall Study|Withdrawal by Subject|1|||
37894584|NCT00796822|69579851|FG000|Overall Study|Adverse Event|1|||
37894585|NCT00796822|69579852|FG001|Overall Study|Adverse Event|0|||
37990032|NCT00524459|69675256|FG000|Overall Study|Other|1|||
37990033|NCT00519623|69675260|FG000|Overall Study|Adverse Event|1|||
37894586|NCT01020812|69579858|FG000|Overall Study|Physician Decision|1|||
37894587|NCT01020812|69579858|FG000|Overall Study|Withdrawal by Subject|1|||
37894588|NCT01020812|69579858|FG000|Overall Study|Protocol Violation|1|||
37990034|NCT00519077|69675264|FG000|Overall Study|Death|6|||
37990035|NCT00519077|69675264|FG000|Overall Study|Other|2|||
37990036|NCT00124618|69675268|FG000|Overall Study|Ineligible|1|||
37990037|NCT00124462|69675274|FG000|Overall Study|Lost to Follow-up|3|||
37990038|NCT00124462|69675275|FG001|Overall Study|Lost to Follow-up|3|||
37990039|NCT00124462|69675274|FG000|Overall Study|Physician Decision|3|||
37990040|NCT00124462|69675275|FG001|Overall Study|Physician Decision|4|||
37990041|NCT00124462|69675274|FG000|Overall Study|Withdrawal by Subject|4|||
37990042|NCT00124462|69675275|FG001|Overall Study|Withdrawal by Subject|5|||
37990043|NCT00124462|69675274|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
37990044|NCT00124462|69675275|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
37990045|NCT00124072|69675285|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
37990046|NCT00124072|69675286|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
37990047|NCT00124072|69675287|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
37990048|NCT00124072|69675288|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
37990049|NCT00124072|69675285|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
37990050|NCT00124072|69675286|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
37990051|NCT00124072|69675287|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
37990052|NCT00124072|69675288|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
37990053|NCT00124072|69675285|FG000|Overall Study|Death|499|||
37990054|NCT00124072|69675286|FG001|Overall Study|Death|484|||
37990055|NCT00124072|69675287|FG002|Overall Study|Death|471|||
37990056|NCT00124072|69675288|FG003|Overall Study|Death|480|||
37990057|NCT00362648|69675302|FG000|Overall Study|Adverse Event|12|||
37990058|NCT00362648|69675303|FG001|Overall Study|Adverse Event|21|||
37990059|NCT00362648|69675304|FG002|Overall Study|Adverse Event|1|||
37990060|NCT00362648|69675305|FG003|Overall Study|Adverse Event|0|||
37990061|NCT00362648|69675302|FG000|Overall Study|Lost to Follow-up|62|||
37990062|NCT00362648|69675303|FG001|Overall Study|Lost to Follow-up|69|||
37990063|NCT00362648|69675304|FG002|Overall Study|Lost to Follow-up|4|||
37990064|NCT00362648|69675305|FG003|Overall Study|Lost to Follow-up|3|||
37990065|NCT00362648|69675302|FG000|Overall Study|Protocol Violation|4|||
37990066|NCT00362648|69675303|FG001|Overall Study|Protocol Violation|2|||
37990067|NCT00362648|69675304|FG002|Overall Study|Protocol Violation|2|||
37990068|NCT00362648|69675305|FG003|Overall Study|Protocol Violation|2|||
37990069|NCT00362648|69675302|FG000|Overall Study|Withdrawal by Subject|48|||
37990070|NCT00362648|69675303|FG001|Overall Study|Withdrawal by Subject|42|||
37990071|NCT00362648|69675304|FG002|Overall Study|Withdrawal by Subject|2|||
37990072|NCT00362648|69675305|FG003|Overall Study|Withdrawal by Subject|6|||
37990073|NCT00524303|69675322|FG000|Overall Study|Lost to Follow-up|6|||
37990074|NCT00524303|69675323|FG001|Overall Study|Lost to Follow-up|0|||
37824941|NCT01053988|69506957|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
37824942|NCT01053988|69506958|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
37824943|NCT01053988|69506959|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
37824944|NCT01053988|69506960|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
37824945|NCT01053988|69506961|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
37824946|NCT01053247|69506976|FG000|Overall Study|Withdrawal by Subject|9|||
37824947|NCT01053247|69506977|FG001|Overall Study|Withdrawal by Subject|4|||
37894589|NCT01032044|69579864|FG000|Overall Study|Protocol Violation|14|||
37894590|NCT01032044|69579865|FG001|Overall Study|Protocol Violation|8|||
37894591|NCT01032044|69579864|FG000|Overall Study|Adverse Event|0|||
37894592|NCT01032044|69579865|FG001|Overall Study|Adverse Event|1|||
37894593|NCT01032044|69579864|FG000|Overall Study|Lost to Follow-up|11|||
37894594|NCT01032044|69579865|FG001|Overall Study|Lost to Follow-up|11|||
37894595|NCT01024946|69579871|FG000|Overall Study|Screen Failure|3|||
37894596|NCT01024946|69579871|FG000|Overall Study|Withdrawal by Subject|1|||
37894597|NCT01024946|69579871|FG000|Overall Study|Adverse Event|1|||
37894598|NCT00724867|69579875|FG000|Overall Study|Adverse Event|25|||
37894599|NCT00724867|69579875|FG000|Overall Study|Lack of Efficacy|14|||
37894600|NCT00724867|69579875|FG000|Overall Study|Lost to Follow-up|12|||
37894601|NCT00724867|69579875|FG000|Overall Study|Non-compliance with study drug|6|||
37894602|NCT00724867|69579875|FG000|Overall Study|Physician Decision|17|||
37894603|NCT00724867|69579875|FG000|Overall Study|Protocol Violation|1|||
37894604|NCT00724867|69579875|FG000|Overall Study|Withdrawal by Subject|31|||
37894605|NCT00724867|69579875|FG000|Overall Study|Sponsor decision to end study|14|||
37894606|NCT00724867|69579875|FG000|Overall Study|Subject incarcerated|1|||
37990075|NCT00524303|69675324|FG002|Overall Study|Lost to Follow-up|3|||
37990076|NCT00524303|69675322|FG000|Overall Study|Protocol Violation|0|||
37990077|NCT00524303|69675323|FG001|Overall Study|Protocol Violation|1|||
37990078|NCT00524303|69675324|FG002|Overall Study|Protocol Violation|1|||
37990079|NCT00524303|69675322|FG000|Overall Study|Withdrawal by Subject|3|||
37990080|NCT00524303|69675323|FG001|Overall Study|Withdrawal by Subject|0|||
37990081|NCT00524303|69675324|FG002|Overall Study|Withdrawal by Subject|4|||
37990082|NCT00524303|69675322|FG000|Overall Study|Death|0|||
37990083|NCT00524303|69675323|FG001|Overall Study|Death|2|||
37990084|NCT00524303|69675324|FG002|Overall Study|Death|3|||
37990085|NCT00524303|69675322|FG000|Overall Study|Adverse Event|1|||
37990086|NCT00524303|69675323|FG001|Overall Study|Adverse Event|2|||
37990087|NCT00524303|69675324|FG002|Overall Study|Adverse Event|3|||
37990088|NCT00524303|69675322|FG000|Overall Study|Did not Complete Study Dosing|1|||
37990089|NCT00524303|69675323|FG001|Overall Study|Did not Complete Study Dosing|0|||
37990090|NCT00524303|69675324|FG002|Overall Study|Did not Complete Study Dosing|0|||
37990091|NCT00524303|69675322|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
37990092|NCT00524303|69675323|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
37990093|NCT00524303|69675324|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
37990094|NCT00524303|69675322|FG000|Overall Study|Disease Progression|0|||
37990095|NCT00524303|69675323|FG001|Overall Study|Disease Progression|4|||
37990096|NCT00524303|69675324|FG002|Overall Study|Disease Progression|1|||
37990097|NCT00524303|69675322|FG000|Overall Study|Disease Recurrence|0|||
37990098|NCT00524303|69675323|FG001|Overall Study|Disease Recurrence|1|||
37990099|NCT00524303|69675324|FG002|Overall Study|Disease Recurrence|0|||
37990100|NCT00524303|69675322|FG000|Overall Study|Sponsor Request|0|||
37990101|NCT00524303|69675323|FG001|Overall Study|Sponsor Request|0|||
37990102|NCT00524303|69675324|FG002|Overall Study|Sponsor Request|1|||
37990103|NCT00524303|69675322|FG000|Overall Study|Physician Decision|0|||
37990104|NCT00524303|69675323|FG001|Overall Study|Physician Decision|0|||
37990105|NCT00524303|69675324|FG002|Overall Study|Physician Decision|1|||
37990106|NCT00524303|69675322|FG000|Overall Study|Completed 5 years|0|||
37990107|NCT00524303|69675323|FG001|Overall Study|Completed 5 years|0|||
37990108|NCT00524303|69675324|FG002|Overall Study|Completed 5 years|1|||
37990109|NCT00335556|69675341|FG000|Overall Study|Death|0|||
37990110|NCT00335556|69675342|FG001|Overall Study|Death|5|||
37990111|NCT00335556|69675343|FG002|Overall Study|Death|0|||
37990112|NCT00335556|69675344|FG003|Overall Study|Death|0|||
37990113|NCT00335556|69675345|FG004|Overall Study|Death|1|||
37990114|NCT00335556|69675346|FG005|Overall Study|Death|0|||
37990115|NCT00335556|69675341|FG000|Overall Study|Lack of Efficacy|0|||
37990116|NCT00335556|69675342|FG001|Overall Study|Lack of Efficacy|19|||
37990117|NCT00335556|69675343|FG002|Overall Study|Lack of Efficacy|3|||
37990118|NCT00335556|69675344|FG003|Overall Study|Lack of Efficacy|3|||
37990119|NCT00335556|69675345|FG004|Overall Study|Lack of Efficacy|0|||
37696177|NCT02357810|69172348|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
37696178|NCT02357810|69172348|FG000|Reached 12 Weeks Response|Adverse Event|5|||
37696179|NCT02357810|69172348|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
37696180|NCT02357810|69172348|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
37696181|NCT02357810|69172348|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
37696182|NCT02357810|69172348|FG000|Reached 12 Weeks Response|Death|1|||
37696183|NCT02357810|69172348|FG000|Reached 12 Weeks Response|Physician Decision|1|||
37696184|NCT02357810|69172348|FG000|Reached 12 Weeks Response|Other|1|||
37696185|NCT02357810|69172348|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
37696186|NCT02357810|69172348|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
37696187|NCT02357810|69172348|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
37696188|NCT02357810|69172348|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
37696189|NCT02357810|69172348|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
37696190|NCT02357810|69172348|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
37696191|NCT02357576|69172354|FG000|Treatment Period|Withdrawal by Subject|0|||
37696192|NCT02357576|69172355|FG001|Treatment Period|Withdrawal by Subject|1|||
37696193|NCT02357576|69172354|FG000|Treatment Period|Physician Decision|0|||
37696194|NCT02357576|69172355|FG001|Treatment Period|Physician Decision|1|||
37824948|NCT01053247|69506978|FG002|Overall Study|Withdrawal by Subject|15|||
37824949|NCT01053247|69506976|FG000|Overall Study|Lack of Efficacy|1|||
37824950|NCT01053247|69506977|FG001|Overall Study|Lack of Efficacy|0|||
37824951|NCT01053247|69506978|FG002|Overall Study|Lack of Efficacy|1|||
37824952|NCT01053247|69506976|FG000|Overall Study|Protocol Violation|2|||
37824953|NCT01053247|69506977|FG001|Overall Study|Protocol Violation|1|||
37824954|NCT01053247|69506978|FG002|Overall Study|Protocol Violation|2|||
37824955|NCT01053247|69506976|FG000|Overall Study|Lost to Follow-up|8|||
37824956|NCT01053247|69506977|FG001|Overall Study|Lost to Follow-up|5|||
37824957|NCT01053247|69506978|FG002|Overall Study|Lost to Follow-up|7|||
37824958|NCT01053247|69506976|FG000|Overall Study|Adverse Event|0|||
37824959|NCT01053247|69506977|FG001|Overall Study|Adverse Event|9|||
37824960|NCT01053247|69506978|FG002|Overall Study|Adverse Event|3|||
37824961|NCT01052662|69506989|FG000|Overall Study|Lost to Follow-up|15|||
37824962|NCT01052662|69506990|FG001|Overall Study|Lost to Follow-up|13|||
37824963|NCT01052662|69506991|FG002|Overall Study|Lost to Follow-up|18|||
37824964|NCT01052662|69506989|FG000|Overall Study|Withdrawal by Subject|3|||
37824965|NCT01052662|69506990|FG001|Overall Study|Withdrawal by Subject|2|||
37824966|NCT01052662|69506991|FG002|Overall Study|Withdrawal by Subject|1|||
37990120|NCT00335556|69675346|FG005|Overall Study|Lack of Efficacy|1|||
37990121|NCT00335556|69675341|FG000|Overall Study|Physician Decision|0|||
37990122|NCT00335556|69675342|FG001|Overall Study|Physician Decision|6|||
37696195|NCT02357576|69172354|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
37696196|NCT02357576|69172355|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
37894607|NCT00724867|69579875|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
37894608|NCT00724867|69579875|FG000|Overall Study|Subject moved out of state|1|||
37894609|NCT00724867|69579875|FG000|Overall Study|Elected to exit due to site closure|2|||
37894610|NCT00724711|69579884|FG000|Overall Study|Adverse Event|7|||
37894611|NCT00724711|69579885|FG001|Overall Study|Adverse Event|3|||
37894612|NCT00724711|69579884|FG000|Overall Study|Pregnancy|0|||
37696197|NCT02357576|69172354|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
37696198|NCT02357576|69172355|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
37696199|NCT02357576|69172354|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
37696200|NCT02357576|69172355|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
37696201|NCT02357576|69172354|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
37696202|NCT02357576|69172355|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
37696203|NCT01850446|69172363|FG000|Overall Study|Lack of Efficacy|1|||
37696204|NCT01850446|69172364|FG001|Overall Study|Lack of Efficacy|0|||
37696205|NCT01850446|69172363|FG000|Overall Study|Withdrawal by Subject|4|||
37696206|NCT01850446|69172364|FG001|Overall Study|Withdrawal by Subject|0|||
37696207|NCT01850446|69172363|FG000|Overall Study|Protocol Violation|0|||
37696208|NCT01850446|69172364|FG001|Overall Study|Protocol Violation|2|||
37696209|NCT02465567|69172374|FG000|Overall Study|Adverse Event|118|||
37894613|NCT00724711|69579885|FG001|Overall Study|Pregnancy|1|||
37894614|NCT00724711|69579884|FG000|Overall Study|Lack of Efficacy|0|||
37824967|NCT01052662|69506989|FG000|Overall Study|Pharmacy issue|1|||
37894615|NCT00724711|69579885|FG001|Overall Study|Lack of Efficacy|1|||
37894616|NCT00724711|69579884|FG000|Overall Study|Physician Decision|0|||
37990123|NCT00335556|69675343|FG002|Overall Study|Physician Decision|2|||
37990124|NCT00335556|69675344|FG003|Overall Study|Physician Decision|1|||
37824968|NCT01052662|69506990|FG001|Overall Study|Pharmacy issue|3|||
37824969|NCT01052662|69506991|FG002|Overall Study|Pharmacy issue|3|||
37824970|NCT01052662|69506989|FG000|Overall Study|Adverse Event|1|||
37990125|NCT00335556|69675345|FG004|Overall Study|Physician Decision|0|||
37990126|NCT00335556|69675346|FG005|Overall Study|Physician Decision|0|||
37990127|NCT00335556|69675341|FG000|Overall Study|Ineligible|2|||
37990128|NCT00335556|69675342|FG001|Overall Study|Ineligible|0|||
37990129|NCT00335556|69675343|FG002|Overall Study|Ineligible|0|||
37990130|NCT00335556|69675344|FG003|Overall Study|Ineligible|0|||
37990131|NCT00335556|69675345|FG004|Overall Study|Ineligible|0|||
37990132|NCT00335556|69675346|FG005|Overall Study|Ineligible|0|||
37990133|NCT00335556|69675341|FG000|Overall Study|Refusal of further protocol therapy|0|||
37990134|NCT00335556|69675342|FG001|Overall Study|Refusal of further protocol therapy|4|||
37990135|NCT00335556|69675343|FG002|Overall Study|Refusal of further protocol therapy|0|||
37990136|NCT00335556|69675344|FG003|Overall Study|Refusal of further protocol therapy|1|||
37990137|NCT00335556|69675345|FG004|Overall Study|Refusal of further protocol therapy|0|||
37990138|NCT00335556|69675346|FG005|Overall Study|Refusal of further protocol therapy|0|||
37990139|NCT00518687|69675367|FG000|Overall Study|Adverse Event|201|||
37990140|NCT00518687|69675368|FG001|Overall Study|Adverse Event|177|||
37990141|NCT00518687|69675367|FG000|Overall Study|Lost to Follow-up|144|||
37990142|NCT00518687|69675368|FG001|Overall Study|Lost to Follow-up|155|||
37990143|NCT00518687|69675367|FG000|Overall Study|Physician Decision|42|||
37990144|NCT00518687|69675368|FG001|Overall Study|Physician Decision|48|||
37990145|NCT00518687|69675367|FG000|Overall Study|Progressive disease|2|||
37990146|NCT00518687|69675368|FG001|Overall Study|Progressive disease|2|||
37824971|NCT01052662|69506990|FG001|Overall Study|Adverse Event|1|||
37824972|NCT01052662|69506991|FG002|Overall Study|Adverse Event|0|||
37824973|NCT01052662|69506989|FG000|Overall Study|Legal Problem|2|||
37824974|NCT01052662|69506990|FG001|Overall Study|Legal Problem|0|||
37990147|NCT00518687|69675367|FG000|Overall Study|Protocol Violation|8|||
37990148|NCT00518687|69675368|FG001|Overall Study|Protocol Violation|10|||
37990149|NCT00518687|69675367|FG000|Overall Study|Study terminated by sponsor|930|||
37990150|NCT00518687|69675368|FG001|Overall Study|Study terminated by sponsor|918|||
37990151|NCT00518687|69675367|FG000|Overall Study|Withdrawal by Subject|110|||
37696210|NCT02465567|69172375|FG001|Overall Study|Adverse Event|113|||
37696211|NCT02465567|69172376|FG002|Overall Study|Adverse Event|147|||
37696212|NCT02465567|69172377|FG003|Overall Study|Adverse Event|138|||
37696213|NCT02465567|69172374|FG000|Overall Study|Lack of Efficacy|103|||
37696214|NCT02465567|69172375|FG001|Overall Study|Lack of Efficacy|102|||
37696215|NCT02465567|69172376|FG002|Overall Study|Lack of Efficacy|171|||
37824975|NCT01052662|69506991|FG002|Overall Study|Legal Problem|0|||
37990152|NCT00518687|69675368|FG001|Overall Study|Withdrawal by Subject|110|||
37990153|NCT00134056|69675376|FG000|Randomization|Not eligible for assigned treatment|22|||
37696216|NCT02465567|69172377|FG003|Overall Study|Lack of Efficacy|135|||
37824976|NCT01052662|69506989|FG000|Overall Study|Administrative|0|||
37990154|NCT00134056|69675377|FG001|Randomization|Not eligible for assigned treatment|20|||
37894617|NCT00724711|69579885|FG001|Overall Study|Physician Decision|3|||
37894618|NCT00724711|69579884|FG000|Overall Study|Withdrawal by Subject|5|||
37990155|NCT00134056|69675376|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
37990156|NCT00134056|69675377|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
37990157|NCT00134056|69675376|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
37990158|NCT00134056|69675377|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
37990159|NCT00134056|69675376|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
37990160|NCT00134056|69675377|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
37990161|NCT00134056|69675376|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
37990162|NCT00134056|69675377|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
37990163|NCT00518531|69675388|FG000|Treatment Period 1|Adverse Event|5|||
37990164|NCT00518531|69675389|FG001|Treatment Period 1|Adverse Event|0|||
37990165|NCT00518531|69675388|FG000|Treatment Period 1|Lost to Follow-up|5|||
37990166|NCT00518531|69675389|FG001|Treatment Period 1|Lost to Follow-up|3|||
37990167|NCT00518531|69675388|FG000|Treatment Period 1|Physician Decision|1|||
37990168|NCT00518531|69675389|FG001|Treatment Period 1|Physician Decision|0|||
37990169|NCT00518531|69675388|FG000|Treatment Period 1|Protocol Violation|2|||
37990170|NCT00518531|69675389|FG001|Treatment Period 1|Protocol Violation|0|||
37990171|NCT00518531|69675388|FG000|Treatment Period 1|Withdrawal by Subject|4|||
37990172|NCT00518531|69675389|FG001|Treatment Period 1|Withdrawal by Subject|6|||
37990173|NCT00518531|69675388|FG000|Treatment Period 1|Early crossover|1|||
37990174|NCT00518531|69675389|FG001|Treatment Period 1|Early crossover|3|||
37990175|NCT00518531|69675388|FG000|Treatment Period 2|Withdrawal by Subject|0|||
37990176|NCT00518531|69675389|FG001|Treatment Period 2|Withdrawal by Subject|8|||
37990177|NCT00518531|69675388|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
37990178|NCT00518531|69675389|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
37990179|NCT00518531|69675388|FG000|Treatment Period 2|Adverse Event|1|||
37894619|NCT00724711|69579885|FG001|Overall Study|Withdrawal by Subject|4|||
37894620|NCT00724711|69579884|FG000|Overall Study|Lost to Follow-up|4|||
37894621|NCT00724711|69579885|FG001|Overall Study|Lost to Follow-up|5|||
37894622|NCT00724711|69579884|FG000|Overall Study|Protocol Violation|1|||
37894623|NCT00724711|69579885|FG001|Overall Study|Protocol Violation|0|||
37894624|NCT01024244|69579896|FG000|Overall Study|Adverse Event|1|||
37894625|NCT01024244|69579897|FG001|Overall Study|Adverse Event|2|||
37894626|NCT01024244|69579898|FG002|Overall Study|Adverse Event|0|||
37894627|NCT01024244|69579899|FG003|Overall Study|Adverse Event|1|||
37894628|NCT01024244|69579900|FG004|Overall Study|Adverse Event|2|||
37894629|NCT01024244|69579896|FG000|Overall Study|Entry Criteria Not Met|0|||
37894630|NCT01024244|69579897|FG001|Overall Study|Entry Criteria Not Met|1|||
37894631|NCT01024244|69579898|FG002|Overall Study|Entry Criteria Not Met|0|||
37894632|NCT01024244|69579899|FG003|Overall Study|Entry Criteria Not Met|0|||
37894633|NCT01024244|69579900|FG004|Overall Study|Entry Criteria Not Met|0|||
37894634|NCT01024244|69579896|FG000|Overall Study|Lack of Efficacy|1|||
37894635|NCT01024244|69579897|FG001|Overall Study|Lack of Efficacy|0|||
37894636|NCT01024244|69579898|FG002|Overall Study|Lack of Efficacy|0|||
37894637|NCT01024244|69579899|FG003|Overall Study|Lack of Efficacy|0|||
37894638|NCT01024244|69579900|FG004|Overall Study|Lack of Efficacy|0|||
37894639|NCT01024244|69579896|FG000|Overall Study|Protocol Violation|1|||
37894640|NCT01024244|69579897|FG001|Overall Study|Protocol Violation|0|||
37894641|NCT01024244|69579898|FG002|Overall Study|Protocol Violation|0|||
37894642|NCT01024244|69579899|FG003|Overall Study|Protocol Violation|0|||
37894643|NCT01024244|69579900|FG004|Overall Study|Protocol Violation|2|||
37894644|NCT01024244|69579896|FG000|Overall Study|Sponsor Decision|14|||
37894645|NCT01024244|69579897|FG001|Overall Study|Sponsor Decision|7|||
37894646|NCT01024244|69579898|FG002|Overall Study|Sponsor Decision|14|||
37894647|NCT01024244|69579899|FG003|Overall Study|Sponsor Decision|12|||
37894648|NCT01024244|69579900|FG004|Overall Study|Sponsor Decision|10|||
37894649|NCT01024244|69579896|FG000|Overall Study|Withdrawal by Subject|0|||
37894650|NCT01024244|69579897|FG001|Overall Study|Withdrawal by Subject|1|||
37990180|NCT00518531|69675389|FG001|Treatment Period 2|Adverse Event|7|||
37990181|NCT00518531|69675388|FG000|Treatment Period 2|Protocol-specified criteria|0|||
37990182|NCT00518531|69675389|FG001|Treatment Period 2|Protocol-specified criteria|1|||
37990183|NCT00518531|69675388|FG000|Treatment Period 2|Non-compliance|1|||
37990184|NCT00518531|69675389|FG001|Treatment Period 2|Non-compliance|2|||
37894651|NCT01024244|69579898|FG002|Overall Study|Withdrawal by Subject|0|||
37990185|NCT00351468|69675397|FG000|Overall Study|Adverse Event|42|||
37894652|NCT01024244|69579899|FG003|Overall Study|Withdrawal by Subject|0|||
37894653|NCT01024244|69579900|FG004|Overall Study|Withdrawal by Subject|0|||
37894654|NCT00721279|69579914|FG000|Overall Study|Lack of Efficacy|6|||
37894655|NCT00721279|69579915|FG001|Overall Study|Lack of Efficacy|3|||
37894656|NCT00721279|69579914|FG000|Overall Study|Tolerability insufficient|5|||
37894657|NCT00721279|69579915|FG001|Overall Study|Tolerability insufficient|2|||
37894658|NCT00721279|69579914|FG000|Overall Study|Withdrawal by Subject|13|||
37894659|NCT00721279|69579915|FG001|Overall Study|Withdrawal by Subject|3|||
37894660|NCT00721279|69579914|FG000|Overall Study|Other|12|||
37894661|NCT00721279|69579915|FG001|Overall Study|Other|16|||
37894662|NCT01030952|69579924|FG000|Overall Study|Protocol Violation|0|||
37894663|NCT01030952|69579925|FG001|Overall Study|Protocol Violation|1|||
37894664|NCT01030952|69579924|FG000|Overall Study|Informed consent withdrawal|1|||
37894665|NCT01030952|69579925|FG001|Overall Study|Informed consent withdrawal|0|||
37894666|NCT01030952|69579924|FG000|Overall Study|Lost to Follow-up|0|||
37894667|NCT01030952|69579925|FG001|Overall Study|Lost to Follow-up|1|||
37894668|NCT01030952|69579924|FG000|Overall Study|Unexplained|1|||
37894669|NCT01030952|69579925|FG001|Overall Study|Unexplained|1|||
37894670|NCT01030874|69579935|FG000|Overall Study|Withdrawal by Subject|1|||
37894671|NCT01030874|69579936|FG001|Overall Study|Withdrawal by Subject|0|||
37894672|NCT01030874|69579935|FG000|Overall Study|Discharged in first 2 weeks|17|||
37894673|NCT01030874|69579936|FG001|Overall Study|Discharged in first 2 weeks|16|||
37894674|NCT03611751|69579945|FG000|Pre-treatment|Randomized but not treated|1|||
37894675|NCT03611751|69579946|FG001|Pre-treatment|Randomized but not treated|1|||
37894676|NCT03611751|69579947|FG002|Pre-treatment|Randomized but not treated|0|||
37894677|NCT03611751|69579945|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
37894678|NCT03611751|69579946|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
37894679|NCT03611751|69579947|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
37894680|NCT03611751|69579945|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
37894681|NCT03611751|69579946|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
37894682|NCT03611751|69579947|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
37894683|NCT03611751|69579945|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
37894684|NCT03611751|69579946|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
37894685|NCT03611751|69579947|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
37894686|NCT03611751|69579945|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
37894687|NCT03611751|69579946|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
37894688|NCT03611751|69579947|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
37894689|NCT03611751|69579945|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
37894690|NCT03611751|69579946|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
37894691|NCT03611751|69579947|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
37894692|NCT03611751|69579945|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
37894693|NCT03611751|69579946|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
37894694|NCT03611751|69579947|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
37894695|NCT03611751|69579945|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
37894696|NCT03611751|69579946|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
37894697|NCT03611751|69579947|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
37990186|NCT00351468|69675397|FG000|Overall Study|Withdrawal by Subject|39|||
37894698|NCT03611751|69579945|FG000|Treatment Week 0 - Week 16|Death|0|||
37894699|NCT03611751|69579946|FG001|Treatment Week 0 - Week 16|Death|0|||
37990187|NCT00351468|69675397|FG000|Overall Study|Various -follow up w clinical team|39|||
37990188|NCT00351468|69675397|FG000|Overall Study|Lack of Efficacy|32|||
37990189|NCT00351468|69675397|FG000|Overall Study|Non-compliance|8|||
37990190|NCT00351468|69675397|FG000|Overall Study|Lost to Follow-up|4|||
37990191|NCT00351468|69675397|FG000|Overall Study|Protocol Violation|3|||
37990192|NCT00523991|69675404|FG000|Overall Study|Adverse Event|6|||
37990193|NCT00523991|69675405|FG001|Overall Study|Adverse Event|5|||
37990194|NCT00523991|69675404|FG000|Overall Study|Protocol Violation|1|||
37990195|NCT00523991|69675405|FG001|Overall Study|Protocol Violation|4|||
37990196|NCT00523991|69675404|FG000|Overall Study|Lost to Follow-up|4|||
37990197|NCT00523991|69675405|FG001|Overall Study|Lost to Follow-up|1|||
37990198|NCT00523991|69675404|FG000|Overall Study|Withdrawal by Subject|7|||
37990199|NCT00523991|69675405|FG001|Overall Study|Withdrawal by Subject|17|||
37990200|NCT00523991|69675404|FG000|Overall Study|Other reason (not specified)|3|||
37990201|NCT00523991|69675405|FG001|Overall Study|Other reason (not specified)|0|||
37990202|NCT00350844|69675411|FG000|Overall Study|Lost to Follow-up|1|||
37990203|NCT00345540|69675415|FG000|Overall Study|Withdrawal by Subject|1|||
37990204|NCT00335322|69675422|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
37990205|NCT00335322|69675423|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
37894700|NCT03611751|69579947|FG002|Treatment Week 0 - Week 16|Death|1|||
37894701|NCT03611751|69579945|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
37894702|NCT03611751|69579946|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
37990206|NCT00335322|69675424|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
37696217|NCT02465567|69172374|FG000|Overall Study|Withdrawal by Subject|104|||
37894703|NCT03611751|69579947|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
37894704|NCT03611751|69579945|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
37894705|NCT03611751|69579946|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
37894706|NCT03611751|69579947|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
37894707|NCT03611751|69579945|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
37990207|NCT00523367|69675435|FG000|Overall Study|19 screen failures|19|||
37990208|NCT00523367|69675435|FG000|Overall Study|4 Withdrawn by PI|4|||
37894708|NCT03611751|69579946|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
37990209|NCT03755765|69675442|FG000|Overall Study|Withdrawal by Subject|2|||
37990210|NCT03755765|69675443|FG001|Overall Study|Withdrawal by Subject|4|||
37990211|NCT03755765|69675444|FG002|Overall Study|Withdrawal by Subject|4|||
37990212|NCT00344448|69675452|FG000|Screening|Withdrawal by Subject|0|||
37990213|NCT00344448|69675453|FG001|Screening|Withdrawal by Subject|1|||
37990214|NCT00344448|69675452|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
37990215|NCT00344448|69675453|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
37990216|NCT00344448|69675452|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
37990217|NCT00344448|69675453|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
37990218|NCT00344448|69675452|FG000|Open Label|Withdrawal by Subject|1|||
37990219|NCT00344448|69675453|FG001|Open Label|Withdrawal by Subject|1|||
37990220|NCT00344448|69675452|FG000|Open Label|Study terminated|1|||
37990221|NCT00344448|69675453|FG001|Open Label|Study terminated|0|||
37990222|NCT00324168|69675461|FG000|Overall Study|Lost to Follow-up|19|||
37990223|NCT00324168|69675462|FG001|Overall Study|Lost to Follow-up|18|||
37990224|NCT00324168|69675461|FG000|Overall Study|Death|3|||
37990225|NCT00324168|69675462|FG001|Overall Study|Death|3|||
37990226|NCT00324168|69675461|FG000|Overall Study|Patient did not visit in f/u window|6|||
37990227|NCT00324168|69675462|FG001|Overall Study|Patient did not visit in f/u window|9|||
37990228|NCT00517829|69675470|FG000|Overall Study|Adverse Event|22|||
37990229|NCT00517829|69675471|FG001|Overall Study|Adverse Event|34|||
37990230|NCT00517829|69675470|FG000|Overall Study|Disease Progression|39|||
37990231|NCT00517829|69675471|FG001|Overall Study|Disease Progression|32|||
37990232|NCT00517829|69675470|FG000|Overall Study|Patient Request|6|||
37990233|NCT00517829|69675471|FG001|Overall Study|Patient Request|5|||
37990234|NCT00517829|69675470|FG000|Overall Study|Investigator Request|5|||
37990235|NCT00517829|69675471|FG001|Overall Study|Investigator Request|3|||
37990236|NCT00517829|69675470|FG000|Overall Study|Other|3|||
37990237|NCT00517829|69675471|FG001|Overall Study|Other|1|||
37990238|NCT00343512|69675477|FG000|Overall Study|Withdrawal by Subject|2|||
37990239|NCT00334542|69675482|FG000|Overall Study|Adverse Event|3|||
37990240|NCT00334542|69675482|FG000|Overall Study|Withdrawal by Subject|1|||
37990241|NCT00334542|69675482|FG000|Overall Study|New cancer diagnosis|1|||
37990242|NCT00112294|69675489|FG000|Overall Study|Still on study|5|||
37990243|NCT00112294|69675490|FG001|Overall Study|Still on study|0|||
37990244|NCT00235443|69675502|FG000|Overall Study|Adverse Event|4|||
37990245|NCT00235443|69675503|FG001|Overall Study|Adverse Event|12|||
37990246|NCT00235443|69675504|FG002|Overall Study|Adverse Event|17|||
37990247|NCT00235443|69675505|FG003|Overall Study|Adverse Event|44|||
37990248|NCT00235443|69675506|FG004|Overall Study|Adverse Event|10|||
37990249|NCT00235443|69675507|FG005|Overall Study|Adverse Event|15|||
37990250|NCT00235443|69675502|FG000|Overall Study|Lack of Efficacy|0|||
37990251|NCT00235443|69675503|FG001|Overall Study|Lack of Efficacy|1|||
37990252|NCT00235443|69675504|FG002|Overall Study|Lack of Efficacy|5|||
37990253|NCT00235443|69675505|FG003|Overall Study|Lack of Efficacy|12|||
37990254|NCT00235443|69675506|FG004|Overall Study|Lack of Efficacy|2|||
37990255|NCT00235443|69675507|FG005|Overall Study|Lack of Efficacy|9|||
37990256|NCT00235443|69675502|FG000|Overall Study|Withdrawal by Subject|3|||
37990257|NCT00235443|69675503|FG001|Overall Study|Withdrawal by Subject|9|||
37990258|NCT00235443|69675504|FG002|Overall Study|Withdrawal by Subject|25|||
37990259|NCT00235443|69675505|FG003|Overall Study|Withdrawal by Subject|24|||
37990260|NCT00235443|69675506|FG004|Overall Study|Withdrawal by Subject|10|||
37990261|NCT00235443|69675507|FG005|Overall Study|Withdrawal by Subject|12|||
37824977|NCT01052662|69506990|FG001|Overall Study|Administrative|3|||
37824978|NCT01052662|69506991|FG002|Overall Study|Administrative|0|||
37824979|NCT01052116|69507001|FG000|Overall Study|Lost to Follow-up|11|||
37824980|NCT01052116|69507002|FG001|Overall Study|Lost to Follow-up|17|||
37824981|NCT01052116|69507001|FG000|Overall Study|Withdrawal by Subject|3|||
37824982|NCT01052116|69507002|FG001|Overall Study|Withdrawal by Subject|6|||
37824983|NCT01052116|69507001|FG000|Overall Study|Spirometry not performed|0|||
37824984|NCT01052116|69507002|FG001|Overall Study|Spirometry not performed|4|||
37824985|NCT01052077|69507010|FG000|Phase A|Lost to Follow-up|22|||
37990262|NCT00235443|69675502|FG000|Overall Study|Lost to Follow-up|0|||
37990263|NCT00235443|69675503|FG001|Overall Study|Lost to Follow-up|8|||
37990264|NCT00235443|69675504|FG002|Overall Study|Lost to Follow-up|6|||
37990265|NCT00235443|69675505|FG003|Overall Study|Lost to Follow-up|6|||
37990266|NCT00235443|69675506|FG004|Overall Study|Lost to Follow-up|4|||
37990267|NCT00235443|69675507|FG005|Overall Study|Lost to Follow-up|3|||
37990268|NCT00235443|69675502|FG000|Overall Study|Unsatisfactory compliance|0|||
37824986|NCT01052077|69507011|FG001|Phase A|Lost to Follow-up|0|||
37824987|NCT01052077|69507012|FG002|Phase A|Lost to Follow-up|0|||
37824988|NCT01052077|69507013|FG003|Phase A|Lost to Follow-up|0|||
37824989|NCT01052077|69507010|FG000|Phase A|Adverse Event|32|||
37824990|NCT01052077|69507011|FG001|Phase A|Adverse Event|0|||
37824991|NCT01052077|69507012|FG002|Phase A|Adverse Event|0|||
37990269|NCT00235443|69675503|FG001|Overall Study|Unsatisfactory compliance|2|||
37990270|NCT00235443|69675504|FG002|Overall Study|Unsatisfactory compliance|3|||
37990271|NCT00235443|69675505|FG003|Overall Study|Unsatisfactory compliance|4|||
37990272|NCT00235443|69675506|FG004|Overall Study|Unsatisfactory compliance|1|||
37990273|NCT00235443|69675507|FG005|Overall Study|Unsatisfactory compliance|0|||
37990274|NCT00235443|69675502|FG000|Overall Study|Other reasons for premature termination|1|||
37990275|NCT00235443|69675503|FG001|Overall Study|Other reasons for premature termination|6|||
37990276|NCT00235443|69675504|FG002|Overall Study|Other reasons for premature termination|6|||
37990277|NCT00235443|69675505|FG003|Overall Study|Other reasons for premature termination|7|||
37990278|NCT00235443|69675506|FG004|Overall Study|Other reasons for premature termination|3|||
37990279|NCT00235443|69675507|FG005|Overall Study|Other reasons for premature termination|6|||
37990280|NCT00234039|69675523|FG000|Overall Study|Adverse Event|2|||
37990281|NCT00234039|69675523|FG000|Overall Study|Progression/relapse|34|||
37990282|NCT00234039|69675523|FG000|Overall Study|Other - Not Protocol Specified|3|||
37990283|NCT00234039|69675523|FG000|Overall Study|Ineligible|9|||
37990284|NCT00234039|69675523|FG000|Overall Study|No Protocol Treatment Received|2|||
37990285|NCT00323622|69675535|FG000|Overall Study|Other|30|||
37990286|NCT00323622|69675536|FG001|Overall Study|Other|91|||
37990287|NCT00323622|69675537|FG002|Overall Study|Other|4|||
37990288|NCT00323622|69675538|FG003|Overall Study|Other|12|||
37894709|NCT03611751|69579947|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
37894710|NCT03611751|69579945|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
37894711|NCT03611751|69579946|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
37894712|NCT03611751|69579947|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
37894713|NCT03611751|69579945|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
37894714|NCT03611751|69579946|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
37894715|NCT03611751|69579947|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
37894716|NCT03611751|69579945|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
37894717|NCT03611751|69579946|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
37990289|NCT00323622|69675539|FG004|Overall Study|Other|32|||
37990290|NCT00323622|69675540|FG005|Overall Study|Other|74|||
37990291|NCT00323622|69675541|FG006|Overall Study|Other|5|||
37990292|NCT00323622|69675542|FG007|Overall Study|Other|13|||
37990293|NCT00323622|69675535|FG000|Overall Study|Death|1|||
37990294|NCT00323622|69675536|FG001|Overall Study|Death|1|||
37990295|NCT00323622|69675537|FG002|Overall Study|Death|0|||
37990296|NCT00323622|69675538|FG003|Overall Study|Death|0|||
37990297|NCT00323622|69675539|FG004|Overall Study|Death|7|||
37990298|NCT00323622|69675540|FG005|Overall Study|Death|0|||
37990299|NCT00323622|69675541|FG006|Overall Study|Death|0|||
37990300|NCT00323622|69675542|FG007|Overall Study|Death|2|||
37894718|NCT03611751|69579947|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
37894719|NCT03611751|69579945|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
37894720|NCT03611751|69579946|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
37894721|NCT03611751|69579947|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
37894722|NCT03611751|69579945|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
37894723|NCT03611751|69579946|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
37990301|NCT00189423|69675570|FG000|Overall Study|Death|746|||
37990302|NCT00189423|69675571|FG001|Overall Study|Death|747|||
37990303|NCT00189423|69675570|FG000|Overall Study|Withdrawal by Subject|9|||
37990304|NCT00189423|69675571|FG001|Overall Study|Withdrawal by Subject|9|||
37990305|NCT00189423|69675570|FG000|Overall Study|Lost to Follow-up|10|||
37990306|NCT00189423|69675571|FG001|Overall Study|Lost to Follow-up|10|||
37990307|NCT00323310|69675577|FG000|Overall Study|Withdrawal by Subject|1|||
37990308|NCT00323310|69675577|FG000|Overall Study|a parent refused blood draw|1|||
37990309|NCT00323310|69675577|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
37894724|NCT03611751|69579947|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
37894725|NCT03611751|69579945|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
37894726|NCT03611751|69579946|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
37894727|NCT03611751|69579947|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
37894728|NCT03611751|69579945|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
37894729|NCT03611751|69579946|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
37894730|NCT03611751|69579947|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
37990310|NCT00186537|69675584|FG000|Overall Study|Withdrawal by Subject|4|||
37990311|NCT00186537|69675585|FG001|Overall Study|Withdrawal by Subject|0|||
37990312|NCT00186537|69675586|FG002|Overall Study|Withdrawal by Subject|3|||
37990313|NCT00186537|69675584|FG000|Overall Study|ALT > 1.5 x ULN|3|||
37990314|NCT00186537|69675585|FG001|Overall Study|ALT > 1.5 x ULN|0|||
37990315|NCT00186537|69675586|FG002|Overall Study|ALT > 1.5 x ULN|0|||
37990316|NCT00517751|69675594|FG000|Overall Study|Death|3|||
37990317|NCT00517751|69675594|FG000|Overall Study|Withdrawal by Subject|37|||
37990318|NCT00517751|69675594|FG000|Overall Study|Lost to Follow-up|4|||
37990319|NCT00517751|69675594|FG000|Overall Study|patient not over due|6|||
37990320|NCT00517751|69675594|FG000|Overall Study|Patient not due for visit|76|||
37990321|NCT00517751|69675594|FG000|Overall Study|Missing|3|||
37990322|NCT00322842|69675600|FG000|Overall Study|Withdrawal by Subject|0|||
37990323|NCT00322842|69675601|FG001|Overall Study|Withdrawal by Subject|1|||
37990324|NCT00322842|69675600|FG000|Overall Study|Lost to Follow-up|0|||
37990325|NCT00322842|69675601|FG001|Overall Study|Lost to Follow-up|1|||
37990326|NCT00322842|69675600|FG000|Overall Study|Refused transplant|1|||
37990327|NCT00322842|69675601|FG001|Overall Study|Refused transplant|0|||
37990328|NCT00322842|69675600|FG000|Overall Study|Death|1|||
37990329|NCT00322842|69675601|FG001|Overall Study|Death|0|||
37990330|NCT00255723|69675610|FG000|Overall Study|Adverse Event|1|||
37990331|NCT00255723|69675611|FG001|Overall Study|Adverse Event|1|||
37990332|NCT00255723|69675610|FG000|Overall Study|Death|0|||
37990333|NCT00255723|69675611|FG001|Overall Study|Death|1|||
37990334|NCT00255723|69675610|FG000|Overall Study|Response Data Not Available|1|||
37990335|NCT00255723|69675611|FG001|Overall Study|Response Data Not Available|0|||
37990336|NCT00132808|69675620|FG000|Stratum I|Adverse Event|2|||
37990337|NCT00132808|69675621|FG001|Stratum I|Adverse Event|1|||
37990338|NCT00132808|69675622|FG002|Stratum I|Adverse Event|0|||
37990339|NCT00132808|69675620|FG000|Stratum I|Lost to Follow-up|3|||
37990340|NCT00132808|69675621|FG001|Stratum I|Lost to Follow-up|4|||
37990341|NCT00132808|69675622|FG002|Stratum I|Lost to Follow-up|1|||
37990342|NCT00132808|69675620|FG000|Stratum I|Withdrawal by Subject|4|||
37990343|NCT00132808|69675621|FG001|Stratum I|Withdrawal by Subject|7|||
37990344|NCT00132808|69675622|FG002|Stratum I|Withdrawal by Subject|3|||
37990345|NCT00132808|69675620|FG000|Stratum I|Abnormal test procedure result (s)|0|||
37990346|NCT00132808|69675621|FG001|Stratum I|Abnormal test procedure result (s)|0|||
37990347|NCT00132808|69675622|FG002|Stratum I|Abnormal test procedure result (s)|1|||
37990348|NCT00132808|69675620|FG000|Stratum II|Adverse Event|1|||
37990349|NCT00132808|69675621|FG001|Stratum II|Adverse Event|2|||
37990350|NCT00132808|69675622|FG002|Stratum II|Adverse Event|1|||
37990351|NCT00132808|69675620|FG000|Stratum II|Death|1|||
37990352|NCT00132808|69675621|FG001|Stratum II|Death|0|||
37990353|NCT00132808|69675622|FG002|Stratum II|Death|0|||
37990354|NCT00132808|69675620|FG000|Stratum II|Lost to Follow-up|2|||
37990355|NCT00132808|69675621|FG001|Stratum II|Lost to Follow-up|2|||
37990356|NCT00132808|69675622|FG002|Stratum II|Lost to Follow-up|1|||
37990357|NCT00132808|69675620|FG000|Stratum II|Protocol Violation|0|||
37990358|NCT00132808|69675621|FG001|Stratum II|Protocol Violation|2|||
37990359|NCT00132808|69675622|FG002|Stratum II|Protocol Violation|1|||
37990360|NCT00132808|69675620|FG000|Stratum II|Withdrawal by Subject|4|||
37990361|NCT00132808|69675621|FG001|Stratum II|Withdrawal by Subject|9|||
37990362|NCT00132808|69675622|FG002|Stratum II|Withdrawal by Subject|6|||
37990363|NCT00517361|69675630|FG000|Overall Study|Death|6|||
37990364|NCT00517361|69675630|FG000|Overall Study|The study was terminated|5|||
37990365|NCT00516893|69675634|FG000|Overall Study|Lost to Follow-up|4|||
37990366|NCT00516893|69675634|FG000|Overall Study|Adverse Event|3|||
37990367|NCT00516893|69675634|FG000|Overall Study|Withdrawal by Subject|2|||
37990368|NCT00516893|69675634|FG000|Overall Study|Noncompliance|2|||
37990369|NCT00516893|69675634|FG000|Overall Study|Death|1|||
37990370|NCT00516893|69675634|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
37824992|NCT01052077|69507013|FG003|Phase A|Adverse Event|0|||
37824993|NCT01052077|69507010|FG000|Phase A|Met Withdrawal Criteria|26|||
37824994|NCT01052077|69507011|FG001|Phase A|Met Withdrawal Criteria|0|||
37824995|NCT01052077|69507012|FG002|Phase A|Met Withdrawal Criteria|0|||
37824996|NCT01052077|69507013|FG003|Phase A|Met Withdrawal Criteria|0|||
37824997|NCT01052077|69507010|FG000|Phase A|Physician Decision|10|||
37824998|NCT01052077|69507011|FG001|Phase A|Physician Decision|0|||
37824999|NCT01052077|69507012|FG002|Phase A|Physician Decision|0|||
37825000|NCT01052077|69507013|FG003|Phase A|Physician Decision|0|||
37825001|NCT01052077|69507010|FG000|Phase A|Withdrawal by Subject|29|||
37825002|NCT01052077|69507011|FG001|Phase A|Withdrawal by Subject|0|||
37696218|NCT02465567|69172375|FG001|Overall Study|Withdrawal by Subject|94|||
37825003|NCT01052077|69507012|FG002|Phase A|Withdrawal by Subject|0|||
37825004|NCT01052077|69507013|FG003|Phase A|Withdrawal by Subject|0|||
37990371|NCT00516893|69675634|FG000|Overall Study|Relocated|1|||
37990372|NCT00516893|69675634|FG000|Overall Study|Pregnancy|1|||
37990373|NCT00516893|69675634|FG000|Overall Study|Received Medication From Another Study|1|||
37990374|NCT00522431|69675638|FG000|Overall Study|Adverse Event|5|||
37990375|NCT00522431|69675638|FG000|Overall Study|Protocol Violation|2|||
37990376|NCT00522431|69675638|FG000|Overall Study|Withdrawal by Subject|2|||
37990377|NCT00522431|69675638|FG000|Overall Study|Subject non-compliance|1|||
37990378|NCT00522431|69675638|FG000|Overall Study|Other/unknown|1|||
37825005|NCT01052077|69507010|FG000|Phase A|Protocol Deviation|27|||
37825006|NCT01052077|69507011|FG001|Phase A|Protocol Deviation|0|||
37990379|NCT00185211|69675644|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
37990380|NCT00185211|69675645|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
37990381|NCT00185211|69675644|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
37990382|NCT00185211|69675645|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
37990383|NCT00185211|69675644|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
37990384|NCT00185211|69675645|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
37990385|NCT00185211|69675644|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
37990386|NCT00185211|69675645|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
37990387|NCT00185211|69675644|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
37990388|NCT00185211|69675645|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
37990389|NCT00185211|69675644|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
37990390|NCT00185211|69675645|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
37990391|NCT00185211|69675644|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
37990392|NCT00185211|69675645|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
37990393|NCT00185211|69675644|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
37990394|NCT00185211|69675645|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
37990395|NCT00185211|69675644|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
37990396|NCT00185211|69675645|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
37990397|NCT00185211|69675644|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
37990398|NCT00185211|69675645|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
37990399|NCT00185211|69675644|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
37990400|NCT00185211|69675645|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
37990401|NCT00185211|69675644|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
37990402|NCT00185211|69675645|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
37990403|NCT00516737|69675654|FG000|Overall Study|Lost to Follow-up|2|||
37990404|NCT00516737|69675655|FG001|Overall Study|Lost to Follow-up|0|||
37990405|NCT00516737|69675654|FG000|Overall Study|Physician Decision|0|||
37990406|NCT00516737|69675655|FG001|Overall Study|Physician Decision|1|||
37990407|NCT00516737|69675654|FG000|Overall Study|Withdrawal by Subject|0|||
37990408|NCT00516737|69675655|FG001|Overall Study|Withdrawal by Subject|1|||
37990409|NCT00516737|69675654|FG000|Overall Study|Lack of Qualifying Event|9|||
37990410|NCT00516737|69675655|FG001|Overall Study|Lack of Qualifying Event|6|||
37990411|NCT00132730|69675665|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
37990412|NCT00132730|69675666|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
37990413|NCT00132730|69675667|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
37990414|NCT00132730|69675668|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
37990415|NCT00132730|69675669|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
37990416|NCT00132730|69675670|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
37990417|NCT00132730|69675665|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
37990418|NCT00132730|69675666|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
37990419|NCT00132730|69675667|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
37990420|NCT00132730|69675668|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
37990421|NCT00132730|69675669|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
37990422|NCT00132730|69675670|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
37990423|NCT00132730|69675665|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
37990424|NCT00132730|69675666|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
37990425|NCT00132730|69675667|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
37990426|NCT00132730|69675668|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
37990427|NCT00132730|69675669|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
37990428|NCT00132730|69675670|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
37990429|NCT00132730|69675665|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
37990430|NCT00132730|69675666|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
37990431|NCT00132730|69675667|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
37990432|NCT00132730|69675668|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
37990433|NCT00132730|69675669|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
37990434|NCT00132730|69675670|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
37990435|NCT00132730|69675665|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
37990436|NCT00132730|69675666|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
37990437|NCT00132730|69675667|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
37990438|NCT00132730|69675668|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
37990439|NCT00132730|69675669|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
37990440|NCT00132730|69675670|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
37696219|NCT02465567|69172376|FG002|Overall Study|Withdrawal by Subject|123|||
37696220|NCT02465567|69172377|FG003|Overall Study|Withdrawal by Subject|130|||
37696221|NCT02465567|69172374|FG000|Overall Study|Physician Decision|23|||
37990441|NCT00132730|69675665|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
37990442|NCT00132730|69675666|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
37990443|NCT00132730|69675667|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
37990444|NCT00132730|69675668|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
37990445|NCT00132730|69675669|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
37990446|NCT00132730|69675670|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
37990447|NCT00132730|69675665|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
37990448|NCT00132730|69675666|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
37990449|NCT00132730|69675667|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
37990450|NCT00132730|69675668|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
37990451|NCT00132730|69675669|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
37990452|NCT00132730|69675670|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
37990453|NCT00132730|69675665|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
37990454|NCT00132730|69675666|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
37990455|NCT00132730|69675667|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
37990456|NCT00132730|69675668|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
37990457|NCT00132730|69675669|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
37990458|NCT00132730|69675670|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
37990459|NCT00132730|69675665|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
37894731|NCT03611751|69579945|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
37894732|NCT03611751|69579946|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
37894733|NCT03611751|69579947|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
37894734|NCT03611751|69579945|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
37894735|NCT03611751|69579946|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
37894736|NCT03611751|69579947|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
37894737|NCT03611751|69579945|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
37894738|NCT03611751|69579946|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
37894739|NCT03611751|69579947|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
37894740|NCT03611751|69579945|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
37894741|NCT03611751|69579946|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
37894742|NCT03611751|69579947|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
37894743|NCT00721123|69579964|FG000|Overall Study|Adverse Event|96|||
37894744|NCT00721123|69579964|FG000|Overall Study|Death|10|||
37894745|NCT00721123|69579964|FG000|Overall Study|Insufficient Therapeutic Response|21|||
37894746|NCT00721123|69579964|FG000|Overall Study|Protocol Violation|1|||
37894747|NCT00721123|69579964|FG000|Overall Study|Refused Treatment|41|||
37894748|NCT00721123|69579964|FG000|Overall Study|Failure to Return|9|||
37894749|NCT00721123|69579964|FG000|Overall Study|Withdrawal by Subject|5|||
37894750|NCT00720499|69579984|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
37894751|NCT00720499|69579985|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
37894752|NCT00720499|69579984|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
37894753|NCT00720499|69579985|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
37894754|NCT00720499|69579984|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
37894755|NCT00720499|69579985|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
37894756|NCT00724243|69579992|FG000|Overall Study|Lack of Efficacy|10|||
37894757|NCT00724243|69579992|FG000|Overall Study|Adverse Event|5|||
37894758|NCT00720343|69579996|FG000|Overall Study|Physician Decision|3|||
37894759|NCT00720343|69579996|FG000|Overall Study|No data|3|||
37894760|NCT00720109|69580002|FG000|Induction Period|Did not meet eligibility criteria|3|||
37894761|NCT00720109|69580003|FG001|Induction Period|Did not meet eligibility criteria|0|||
37894762|NCT00720109|69580004|FG002|Induction Period|Did not meet eligibility criteria|0|||
37894763|NCT00720109|69580002|FG000|Induction Period|Bone Marrow Transplant|2|||
37894764|NCT00720109|69580003|FG001|Induction Period|Bone Marrow Transplant|0|||
37894765|NCT00720109|69580004|FG002|Induction Period|Bone Marrow Transplant|0|||
37894766|NCT00720109|69580002|FG000|Induction Period|Physician Decision|1|||
37894767|NCT00720109|69580003|FG001|Induction Period|Physician Decision|0|||
37894768|NCT00720109|69580004|FG002|Induction Period|Physician Decision|0|||
37894769|NCT00720109|69580002|FG000|Risk Stratification Period|Adverse Event|0|||
37894770|NCT00720109|69580003|FG001|Risk Stratification Period|Adverse Event|1|||
37894771|NCT00720109|69580004|FG002|Risk Stratification Period|Adverse Event|0|||
37894772|NCT00720109|69580002|FG000|Risk Stratification Period|Physician Decision|0|||
37894773|NCT00720109|69580003|FG001|Risk Stratification Period|Physician Decision|2|||
37894774|NCT00720109|69580004|FG002|Risk Stratification Period|Physician Decision|1|||
37894775|NCT00720109|69580002|FG000|Risk Stratification Period|Bone marrow transplant|0|||
37894776|NCT00720109|69580003|FG001|Risk Stratification Period|Bone marrow transplant|9|||
37894777|NCT00720109|69580004|FG002|Risk Stratification Period|Bone marrow transplant|7|||
38043855|NCT02048813|69731900|FG000|Overall Study|Withdrawal by Subject|7|||
38043856|NCT02048813|69731901|FG001|Overall Study|Withdrawal by Subject|8|||
38043857|NCT02048813|69731900|FG000|Overall Study|Death|2|||
38043858|NCT02048813|69731901|FG001|Overall Study|Death|1|||
37894778|NCT00720109|69580002|FG000|Risk Stratification Period|Disease progression or relapse|0|||
37894779|NCT00720109|69580003|FG001|Risk Stratification Period|Disease progression or relapse|2|||
37894780|NCT00720109|69580004|FG002|Risk Stratification Period|Disease progression or relapse|0|||
37894781|NCT00720109|69580002|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
37894782|NCT00720109|69580003|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
37894783|NCT00720109|69580004|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
37894784|NCT01015118|69580015|FG000|Overall Study|Protocol Violation|5|||
37894785|NCT01015118|69580016|FG001|Overall Study|Protocol Violation|6|||
37894786|NCT01015118|69580015|FG000|Overall Study|Withdrawal by Subject|103|||
37894787|NCT01015118|69580016|FG001|Overall Study|Withdrawal by Subject|27|||
37894788|NCT01015118|69580015|FG000|Overall Study|Other Adverse Event (AE)|141|||
37894789|NCT01015118|69580016|FG001|Overall Study|Other Adverse Event (AE)|33|||
37894790|NCT01015118|69580015|FG000|Overall Study|Worsening or AE of underlying disease|5|||
37894791|NCT01015118|69580016|FG001|Overall Study|Worsening or AE of underlying disease|4|||
37894792|NCT01015118|69580015|FG000|Overall Study|Progressive disease|364|||
37894793|NCT01015118|69580016|FG001|Overall Study|Progressive disease|229|||
37990460|NCT00132730|69675666|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
37990461|NCT00132730|69675667|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
37990462|NCT00132730|69675668|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
37990463|NCT00132730|69675669|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
37990464|NCT00132730|69675670|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
37990465|NCT00132730|69675665|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
37990466|NCT00132730|69675666|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
37990467|NCT00132730|69675667|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
37990468|NCT00132730|69675668|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
37990469|NCT00132730|69675669|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
37990470|NCT00132730|69675670|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
37990471|NCT00132730|69675665|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
37990472|NCT00132730|69675666|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
37990473|NCT00132730|69675667|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
37990474|NCT00132730|69675668|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
37990475|NCT00132730|69675669|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
37990476|NCT00132730|69675670|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
37990477|NCT00132730|69675665|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
37990478|NCT00132730|69675666|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
37990479|NCT00132730|69675667|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
37990480|NCT00132730|69675668|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
37990481|NCT00132730|69675669|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
37990482|NCT00132730|69675670|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
37990483|NCT00232557|69675686|FG000|Overall Study|Lost to Follow-up|3|||
37990484|NCT00232557|69675687|FG001|Overall Study|Lost to Follow-up|5|||
37990485|NCT00522275|69675693|FG000|Overall Study|Adverse Event|35|||
37990486|NCT00522275|69675693|FG000|Overall Study|Lack of Efficacy|80|||
37990487|NCT00522275|69675693|FG000|Overall Study|Subject withdrew consent|16|||
37990488|NCT00522275|69675693|FG000|Overall Study|Protocol deviation|1|||
37990489|NCT00522275|69675693|FG000|Overall Study|Unsatisfactory compliance|11|||
37990490|NCT00522275|69675693|FG000|Overall Study|Lost to Follow-up|8|||
37825007|NCT01052077|69507012|FG002|Phase A|Protocol Deviation|0|||
37990491|NCT00522275|69675693|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
37990492|NCT00522275|69675693|FG000|Overall Study|Other: Subject is pregnant|2|||
37990493|NCT00522275|69675693|FG000|Overall Study|Other: Subject relocated|2|||
37990494|NCT00522275|69675693|FG000|Overall Study|Other: Subject arrested|1|||
37825008|NCT01052077|69507013|FG003|Phase A|Protocol Deviation|0|||
37825009|NCT01052077|69507010|FG000|Phase B|Lost to Follow-up|0|||
37825010|NCT01052077|69507011|FG001|Phase B|Lost to Follow-up|2|||
37825011|NCT01052077|69507012|FG002|Phase B|Lost to Follow-up|3|||
37825012|NCT01052077|69507013|FG003|Phase B|Lost to Follow-up|0|||
37825013|NCT01052077|69507010|FG000|Phase B|Adverse Event|0|||
37825014|NCT01052077|69507011|FG001|Phase B|Adverse Event|9|||
37825015|NCT01052077|69507012|FG002|Phase B|Adverse Event|2|||
37825016|NCT01052077|69507013|FG003|Phase B|Adverse Event|0|||
37894794|NCT01015118|69580015|FG000|Overall Study|Not treated|9|||
37894795|NCT01015118|69580016|FG001|Overall Study|Not treated|5|||
38043859|NCT02048813|69731900|FG000|Overall Study|Complication|2|||
38043860|NCT02048813|69731901|FG001|Overall Study|Complication|2|||
38043861|NCT02048813|69731900|FG000|Overall Study|Non-protocol therapy|0|||
38043862|NCT02048813|69731901|FG001|Overall Study|Non-protocol therapy|1|||
38043863|NCT02048813|69731900|FG000|Overall Study|Second primary cancer|2|||
38043864|NCT02048813|69731901|FG001|Overall Study|Second primary cancer|0|||
38043865|NCT02048813|69731900|FG000|Overall Study|Insurance|2|||
37825017|NCT01052077|69507010|FG000|Phase B|Met Withdrawal Criteria|0|||
37825018|NCT01052077|69507011|FG001|Phase B|Met Withdrawal Criteria|2|||
37825019|NCT01052077|69507012|FG002|Phase B|Met Withdrawal Criteria|1|||
37825020|NCT01052077|69507013|FG003|Phase B|Met Withdrawal Criteria|0|||
37825021|NCT01052077|69507010|FG000|Phase B|Physician Decision|0|||
37825022|NCT01052077|69507011|FG001|Phase B|Physician Decision|1|||
37825023|NCT01052077|69507012|FG002|Phase B|Physician Decision|1|||
37825024|NCT01052077|69507013|FG003|Phase B|Physician Decision|0|||
37825025|NCT01052077|69507010|FG000|Phase B|Withdrawal by Subject|0|||
37894796|NCT01015118|69580015|FG000|Overall Study|Other than stated above|42|||
37894797|NCT01015118|69580016|FG001|Overall Study|Other than stated above|23|||
37894798|NCT00800176|69580028|FG000|Overall Study|Adverse Event|2|||
37894799|NCT00800176|69580029|FG001|Overall Study|Adverse Event|1|||
37894800|NCT00800176|69580030|FG002|Overall Study|Adverse Event|0|||
37894801|NCT00800176|69580031|FG003|Overall Study|Adverse Event|2|||
37894802|NCT00800176|69580032|FG004|Overall Study|Adverse Event|1|||
37894803|NCT00800176|69580033|FG005|Overall Study|Adverse Event|1|||
37894804|NCT00800176|69580028|FG000|Overall Study|Refused treatment|3|||
37894805|NCT00800176|69580029|FG001|Overall Study|Refused treatment|2|||
37825026|NCT01052077|69507011|FG001|Phase B|Withdrawal by Subject|0|||
37894806|NCT00800176|69580030|FG002|Overall Study|Refused treatment|0|||
37894807|NCT00800176|69580031|FG003|Overall Study|Refused treatment|0|||
37894808|NCT00800176|69580032|FG004|Overall Study|Refused treatment|1|||
37825027|NCT01052077|69507012|FG002|Phase B|Withdrawal by Subject|5|||
37825028|NCT01052077|69507013|FG003|Phase B|Withdrawal by Subject|0|||
37825029|NCT01052077|69507010|FG000|Phase B|Protocol Deviation|0|||
37825030|NCT01052077|69507011|FG001|Phase B|Protocol Deviation|3|||
37825031|NCT01052077|69507012|FG002|Phase B|Protocol Deviation|4|||
37825032|NCT01052077|69507013|FG003|Phase B|Protocol Deviation|0|||
37825033|NCT01052077|69507010|FG000|Phase B|Lack of Efficacy|0|||
37990495|NCT00522275|69675693|FG000|Overall Study|Other: Site / clinic closed|4|||
37990496|NCT00522275|69675693|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
37990497|NCT00522275|69675693|FG000|Overall Study|Other: Sponsor request|2|||
37990498|NCT00522275|69675693|FG000|Overall Study|Other: Subject ran out of medication|1|||
37990499|NCT00522275|69675693|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
37990500|NCT00522041|69675699|FG000|Overall Study|Adverse Event|9|||
37990501|NCT00522041|69675700|FG001|Overall Study|Adverse Event|3|||
37990502|NCT00522041|69675699|FG000|Overall Study|Protocol Violation|2|||
37990503|NCT00522041|69675700|FG001|Overall Study|Protocol Violation|0|||
37990504|NCT00522041|69675699|FG000|Overall Study|Lost to Follow-up|1|||
37990505|NCT00522041|69675700|FG001|Overall Study|Lost to Follow-up|4|||
37990506|NCT00522041|69675699|FG000|Overall Study|Voluntary withdrawal|5|||
37990507|NCT00522041|69675700|FG001|Overall Study|Voluntary withdrawal|4|||
37990508|NCT00522041|69675699|FG000|Overall Study|Did not receive treatment|0|||
37990509|NCT00522041|69675700|FG001|Overall Study|Did not receive treatment|1|||
37990510|NCT00122980|69675709|FG000|Overall Study|Death|0|||
37990511|NCT00122980|69675710|FG001|Overall Study|Death|1|||
37990512|NCT00122980|69675709|FG000|Overall Study|Physician Decision|2|||
37990513|NCT00122980|69675710|FG001|Overall Study|Physician Decision|0|||
37990514|NCT00122980|69675709|FG000|Overall Study|Protocol Violation|5|||
37990515|NCT00122980|69675710|FG001|Overall Study|Protocol Violation|1|||
37990516|NCT00122980|69675709|FG000|Overall Study|Withdrawal by Subject|2|||
37990517|NCT00122980|69675710|FG001|Overall Study|Withdrawal by Subject|3|||
37990518|NCT00122980|69675709|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
37990519|NCT00122980|69675710|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
37990520|NCT00122980|69675709|FG000|Overall Study|Study termination|27|||
37990521|NCT00122980|69675710|FG001|Overall Study|Study termination|35|||
37990522|NCT03868631|69675718|FG000|Baseline to Week 6|Adverse Event|0|||
37990523|NCT03868631|69675719|FG001|Baseline to Week 6|Adverse Event|3|||
37990524|NCT03868631|69675718|FG000|Baseline to Week 6|Protocol Violation|1|||
37990525|NCT03868631|69675719|FG001|Baseline to Week 6|Protocol Violation|1|||
37990526|NCT03868631|69675718|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
37990527|NCT03868631|69675719|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
37990528|NCT03868631|69675718|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
37990529|NCT03868631|69675719|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
37990530|NCT03868631|69675718|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
37990531|NCT03868631|69675719|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
37990532|NCT03868631|69675718|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
37990533|NCT03868631|69675719|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
37990534|NCT00340704|69675734|FG000|PK Study|Adverse Event|0|||
37990535|NCT00340704|69675735|FG001|PK Study|Adverse Event|1|||
37990536|NCT00340704|69675736|FG002|PK Study|Adverse Event|0|||
37990537|NCT00340704|69675737|FG003|PK Study|Adverse Event|0|||
37990538|NCT00340704|69675738|FG004|PK Study|Adverse Event|0|||
37990539|NCT00340704|69675739|FG005|PK Study|Adverse Event|0|||
37990540|NCT00340704|69675740|FG006|PK Study|Adverse Event|0|||
37990541|NCT00340704|69675741|FG007|PK Study|Adverse Event|0|||
37990542|NCT00340704|69675742|FG008|PK Study|Adverse Event|0|||
37990543|NCT00340704|69675734|FG000|PK Study|Not treated|0|||
37990544|NCT00340704|69675735|FG001|PK Study|Not treated|0|||
37990545|NCT00340704|69675736|FG002|PK Study|Not treated|1|||
37990546|NCT00340704|69675737|FG003|PK Study|Not treated|0|||
37990547|NCT00340704|69675738|FG004|PK Study|Not treated|0|||
37990548|NCT00340704|69675739|FG005|PK Study|Not treated|0|||
37990549|NCT00340704|69675740|FG006|PK Study|Not treated|0|||
37990550|NCT00340704|69675741|FG007|PK Study|Not treated|0|||
37990551|NCT00340704|69675742|FG008|PK Study|Not treated|0|||
37990552|NCT00340704|69675734|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
37990553|NCT00340704|69675735|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
37990554|NCT00340704|69675736|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
37990555|NCT00340704|69675737|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
37990556|NCT00340704|69675738|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
37990557|NCT00340704|69675739|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
37990558|NCT00340704|69675740|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
37990559|NCT00340704|69675741|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
37990560|NCT00340704|69675742|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
37990561|NCT00340704|69675734|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
37990562|NCT00340704|69675735|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
37990563|NCT00340704|69675736|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
37990564|NCT00340704|69675737|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
37825034|NCT01052077|69507011|FG001|Phase B|Lack of Efficacy|1|||
37990565|NCT00340704|69675738|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
37990566|NCT00340704|69675739|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
37990567|NCT00340704|69675740|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
37990568|NCT00340704|69675741|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
37894809|NCT00800176|69580033|FG005|Overall Study|Refused treatment|4|||
37894810|NCT00800176|69580028|FG000|Overall Study|Failure to return|3|||
37894811|NCT00800176|69580029|FG001|Overall Study|Failure to return|3|||
37894812|NCT00800176|69580030|FG002|Overall Study|Failure to return|0|||
37894813|NCT00800176|69580031|FG003|Overall Study|Failure to return|2|||
37894814|NCT00800176|69580032|FG004|Overall Study|Failure to return|0|||
37894815|NCT00800176|69580033|FG005|Overall Study|Failure to return|0|||
37894816|NCT00800176|69580028|FG000|Overall Study|Other|1|||
37894817|NCT00800176|69580029|FG001|Overall Study|Other|0|||
37894818|NCT00800176|69580030|FG002|Overall Study|Other|0|||
37894819|NCT00800176|69580031|FG003|Overall Study|Other|0|||
37894820|NCT00800176|69580032|FG004|Overall Study|Other|2|||
37894821|NCT00800176|69580033|FG005|Overall Study|Other|0|||
37894822|NCT00715429|69580049|FG000|Overall Study|Did not complete the study diary|0|||
37894823|NCT00715429|69580050|FG001|Overall Study|Did not complete the study diary|1|||
37894824|NCT00715117|69580072|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
37894825|NCT00715117|69580073|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
37894826|NCT00723229|69580086|FG000|First Intervention|Lost to Follow-up|7|||
37894827|NCT00723229|69580087|FG001|First Intervention|Lost to Follow-up|3|||
37894828|NCT01030718|69580102|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
37894829|NCT01030718|69580103|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
37990569|NCT00340704|69675742|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
37990570|NCT00340704|69675734|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
37990571|NCT00340704|69675735|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
37990572|NCT00340704|69675736|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
37990573|NCT00340704|69675737|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
37990574|NCT00340704|69675738|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
37825035|NCT01052077|69507012|FG002|Phase B|Lack of Efficacy|0|||
37825036|NCT01052077|69507013|FG003|Phase B|Lack of Efficacy|0|||
37825037|NCT01052077|69507010|FG000|Phase A+|Lost to Follow-up|0|||
37825038|NCT01052077|69507011|FG001|Phase A+|Lost to Follow-up|0|||
37825039|NCT01052077|69507012|FG002|Phase A+|Lost to Follow-up|0|||
37825040|NCT01052077|69507013|FG003|Phase A+|Lost to Follow-up|8|||
37825041|NCT01052077|69507010|FG000|Phase A+|Adverse Event|0|||
37825042|NCT01052077|69507011|FG001|Phase A+|Adverse Event|0|||
37825043|NCT01052077|69507012|FG002|Phase A+|Adverse Event|0|||
37825044|NCT01052077|69507013|FG003|Phase A+|Adverse Event|4|||
37825045|NCT01052077|69507010|FG000|Phase A+|Met Withdrawal Criteria|0|||
37825046|NCT01052077|69507011|FG001|Phase A+|Met Withdrawal Criteria|0|||
37825047|NCT01052077|69507012|FG002|Phase A+|Met Withdrawal Criteria|0|||
37894830|NCT01030718|69580104|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
37894831|NCT01030718|69580102|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
37894832|NCT01030718|69580103|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
37894833|NCT01030718|69580104|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
37894834|NCT01030718|69580102|FG000|Studies CA180-031 and -036 Combined|Death|0|||
37825048|NCT01052077|69507013|FG003|Phase A+|Met Withdrawal Criteria|2|||
37825049|NCT01052077|69507010|FG000|Phase A+|Withdrawal by Subject|0|||
37825050|NCT01052077|69507011|FG001|Phase A+|Withdrawal by Subject|0|||
37825051|NCT01052077|69507012|FG002|Phase A+|Withdrawal by Subject|0|||
37825052|NCT01052077|69507013|FG003|Phase A+|Withdrawal by Subject|7|||
37894835|NCT01030718|69580103|FG001|Studies CA180-031 and -036 Combined|Death|1|||
37894836|NCT01030718|69580104|FG002|Studies CA180-031 and -036 Combined|Death|0|||
37894837|NCT01030718|69580102|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
37894838|NCT01030718|69580103|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
37894839|NCT01030718|69580104|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
37894840|NCT01030718|69580102|FG000|Study CA180-036 Only|insufficient effect|1|||
37894841|NCT01030718|69580103|FG001|Study CA180-036 Only|insufficient effect|1|||
37894842|NCT01030718|69580104|FG002|Study CA180-036 Only|insufficient effect|5|||
37990575|NCT00340704|69675739|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
37990576|NCT00340704|69675740|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
37990577|NCT00340704|69675741|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
37894843|NCT01030718|69580102|FG000|Study CA180-036 Only|Adverse Event|2|||
37894844|NCT01030718|69580103|FG001|Study CA180-036 Only|Adverse Event|3|||
37990578|NCT00340704|69675742|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
37990579|NCT00340704|69675734|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
37990580|NCT00340704|69675735|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
37894845|NCT01030718|69580104|FG002|Study CA180-036 Only|Adverse Event|0|||
37894846|NCT01030718|69580102|FG000|Study CA180-036 Only|Death|0|||
37894847|NCT01030718|69580103|FG001|Study CA180-036 Only|Death|1|||
37894848|NCT01030718|69580104|FG002|Study CA180-036 Only|Death|0|||
37894849|NCT01030718|69580102|FG000|Study CA180-036 Only|Other Reasons|0|||
37894850|NCT01030718|69580103|FG001|Study CA180-036 Only|Other Reasons|2|||
37894851|NCT01030718|69580104|FG002|Study CA180-036 Only|Other Reasons|0|||
37894852|NCT00722761|69580124|FG000|Overall Study|Lost to Follow-up|1|||
37894853|NCT00722761|69580125|FG001|Overall Study|Lost to Follow-up|4|||
37894854|NCT00722761|69580124|FG000|Overall Study|Withdrawal by Subject|5|||
37894855|NCT00722761|69580125|FG001|Overall Study|Withdrawal by Subject|2|||
37894856|NCT00719953|69580131|FG000|Overall Study|Adverse Event|4|||
37894857|NCT01019486|69580138|FG000|Overall Study|Withdrawal by Subject|1|||
37894858|NCT01019486|69580139|FG001|Overall Study|Withdrawal by Subject|1|||
37894859|NCT01019486|69580140|FG002|Overall Study|Withdrawal by Subject|1|||
37894860|NCT02803203|69580149|FG000|Overall Study|Adverse Event|4|||
37894861|NCT02803203|69580149|FG000|Overall Study|Death|4|||
37894862|NCT02803203|69580149|FG000|Overall Study|Progressive disease|29|||
37894863|NCT02803203|69580149|FG000|Overall Study|Withdrawal by Subject|8|||
37894864|NCT02803203|69580149|FG000|Overall Study|Complete resection of target disease|2|||
37894865|NCT02803203|69580149|FG000|Overall Study|Switched to commercial Osi|1|||
37894866|NCT02803203|69580149|FG000|Overall Study|Participant moved away|1|||
37894867|NCT00714493|69580154|FG000|Overall Study|Adverse Event|11|||
37894868|NCT00714493|69580154|FG000|Overall Study|Death|3|||
37894869|NCT00714493|69580154|FG000|Overall Study|Lack of Efficacy|10|||
37894870|NCT00714493|69580154|FG000|Overall Study|Lost to Follow-up|3|||
37894871|NCT00714493|69580154|FG000|Overall Study|Protocol Violation|12|||
37894872|NCT00714493|69580154|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
37894873|NCT00714493|69580154|FG000|Overall Study|OTHER|2|||
37894874|NCT01019252|69580160|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
37894875|NCT01019252|69580161|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
37894876|NCT01019252|69580160|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
37894877|NCT01019252|69580161|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
37894878|NCT01019252|69580160|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
37894879|NCT01019252|69580161|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
37894880|NCT01019252|69580160|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
37894881|NCT01019252|69580161|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
37894882|NCT01013870|69580169|FG000|Overall Study|Lost to Follow-up|1|||
37894883|NCT01013870|69580170|FG001|Overall Study|Lost to Follow-up|3|||
37894884|NCT01013792|69580178|FG000|Overall Study|Study suspended|2|||
37894885|NCT01013792|69580179|FG001|Overall Study|Study suspended|1|||
37894886|NCT01013792|69580178|FG000|Overall Study|Adverse Event|0|||
37894887|NCT01013792|69580179|FG001|Overall Study|Adverse Event|3|||
37894888|NCT01013792|69580178|FG000|Overall Study|Lost to Follow-up|0|||
37894889|NCT01013792|69580179|FG001|Overall Study|Lost to Follow-up|1|||
37990581|NCT00340704|69675736|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
37894890|NCT01018862|69580188|FG000|Overall Study|Adverse Event|2|||
37894891|NCT01018862|69580189|FG001|Overall Study|Adverse Event|0|||
37894892|NCT01018862|69580190|FG002|Overall Study|Adverse Event|6|||
37894893|NCT01018862|69580188|FG000|Overall Study|Lack of Efficacy|1|||
37894894|NCT01018862|69580189|FG001|Overall Study|Lack of Efficacy|0|||
37894895|NCT01018862|69580190|FG002|Overall Study|Lack of Efficacy|2|||
37894896|NCT01018862|69580188|FG000|Overall Study|Lost to Follow-up|3|||
37894897|NCT01018862|69580189|FG001|Overall Study|Lost to Follow-up|1|||
37894898|NCT01018862|69580190|FG002|Overall Study|Lost to Follow-up|0|||
37894899|NCT01018862|69580188|FG000|Overall Study|Protocol Violation|1|||
37894900|NCT01018862|69580189|FG001|Overall Study|Protocol Violation|3|||
37894901|NCT01018862|69580190|FG002|Overall Study|Protocol Violation|3|||
37894902|NCT01018862|69580188|FG000|Overall Study|Withdrawal by Subject|1|||
37894903|NCT01018862|69580189|FG001|Overall Study|Withdrawal by Subject|2|||
37894904|NCT01018862|69580190|FG002|Overall Study|Withdrawal by Subject|1|||
37894905|NCT01018862|69580188|FG000|Overall Study|administrative problems|5|||
37894906|NCT01018862|69580189|FG001|Overall Study|administrative problems|4|||
37894907|NCT01018862|69580190|FG002|Overall Study|administrative problems|4|||
37894908|NCT01018394|69580200|FG000|Overall Study|Withdrawal by Subject|5|||
37894909|NCT01018394|69580201|FG001|Overall Study|Withdrawal by Subject|5|||
37894910|NCT01018394|69580200|FG000|Overall Study|Lost to Follow-up|4|||
37894911|NCT01018394|69580201|FG001|Overall Study|Lost to Follow-up|3|||
37894912|NCT01017146|69580209|FG000|Overall Study|Adverse Event|11|||
37894913|NCT01017146|69580210|FG001|Overall Study|Adverse Event|1|||
37894914|NCT01017146|69580209|FG000|Overall Study|Lost to Follow-up|14|||
37894915|NCT01017146|69580210|FG001|Overall Study|Lost to Follow-up|14|||
37894916|NCT01017146|69580209|FG000|Overall Study|Noncompliance with Study Product|1|||
37894917|NCT01017146|69580210|FG001|Overall Study|Noncompliance with Study Product|1|||
37990582|NCT00340704|69675737|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
37990583|NCT00340704|69675738|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
37990584|NCT00340704|69675739|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
37990585|NCT00340704|69675740|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
37990586|NCT00340704|69675741|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
37990587|NCT00340704|69675742|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
37990588|NCT00132496|69675770|FG000|Overall Study|Withdrawal by Subject|1|||
37990589|NCT00132496|69675771|FG001|Overall Study|Withdrawal by Subject|2|||
37990590|NCT00132496|69675770|FG000|Overall Study|Physician Decision|1|||
37990591|NCT00132496|69675771|FG001|Overall Study|Physician Decision|0|||
37990592|NCT00231777|69675779|FG000|Overall Study|Lost to Follow-up|3|||
37990593|NCT00231777|69675780|FG001|Overall Study|Lost to Follow-up|0|||
37990594|NCT00231777|69675779|FG000|Overall Study|Other|3|||
37990595|NCT00231777|69675780|FG001|Overall Study|Other|2|||
37990596|NCT00231465|69675786|FG000|Overall Study|Completed only one cycle|1|||
37990597|NCT00231465|69675786|FG000|Overall Study|Did not have follow up CT scans|1|||
37990598|NCT00254397|69675794|FG000|Overall Study|Disease Progression|4|||
37990599|NCT00254397|69675795|FG001|Overall Study|Disease Progression|1|||
37990600|NCT00254397|69675796|FG002|Overall Study|Disease Progression|16|||
37990601|NCT00254397|69675797|FG003|Overall Study|Disease Progression|23|||
37990602|NCT00254397|69675794|FG000|Overall Study|Non-Compliant|0|||
37990603|NCT00254397|69675795|FG001|Overall Study|Non-Compliant|0|||
37990604|NCT00254397|69675796|FG002|Overall Study|Non-Compliant|0|||
37990605|NCT00254397|69675797|FG003|Overall Study|Non-Compliant|1|||
37990606|NCT00254397|69675794|FG000|Overall Study|Adverse Event|2|||
37990607|NCT00254397|69675795|FG001|Overall Study|Adverse Event|0|||
37825053|NCT01052038|69507022|FG000|Overall Study|Lost to Follow-up|2|||
37825054|NCT01052038|69507023|FG001|Overall Study|Lost to Follow-up|3|||
37825055|NCT01052038|69507024|FG002|Overall Study|Lost to Follow-up|1|||
37825056|NCT01052038|69507022|FG000|Overall Study|Protocol Violation|2|||
37825057|NCT01052038|69507023|FG001|Overall Study|Protocol Violation|3|||
37825058|NCT01052038|69507024|FG002|Overall Study|Protocol Violation|3|||
37825059|NCT01051960|69507032|FG000|Overall Study|Adverse Event|1|||
37825060|NCT01051921|69507036|FG000|Overall Study|Physician Decision|9|||
37825061|NCT01051921|69507036|FG000|Overall Study|Adverse Event|8|||
37825062|NCT01051921|69507036|FG000|Overall Study|Withdrawal by Subject|7|||
37825063|NCT01051921|69507036|FG000|Overall Study|Lost to Follow-up|4|||
37894918|NCT01017146|69580209|FG000|Overall Study|Withdrawal by Subject|32|||
37894919|NCT01017146|69580210|FG001|Overall Study|Withdrawal by Subject|16|||
37894920|NCT01017146|69580209|FG000|Overall Study|Relocation|0|||
37894921|NCT01017146|69580210|FG001|Overall Study|Relocation|4|||
37894922|NCT01017146|69580209|FG000|Overall Study|Pregnancy|2|||
37894923|NCT01017146|69580210|FG001|Overall Study|Pregnancy|1|||
37825064|NCT01051921|69507036|FG000|Overall Study|virological failure|1|||
37825065|NCT01051921|69507036|FG000|Overall Study|patient moved|1|||
37894924|NCT01017146|69580209|FG000|Overall Study|Protocol Violation|2|||
37990608|NCT00254397|69675796|FG002|Overall Study|Adverse Event|3|||
37990609|NCT00254397|69675797|FG003|Overall Study|Adverse Event|1|||
37696222|NCT02465567|69172375|FG001|Overall Study|Physician Decision|33|||
37696223|NCT02465567|69172376|FG002|Overall Study|Physician Decision|38|||
37990610|NCT00254163|69675808|FG000|Overall Study|Adverse Event|29|||
37990611|NCT00254163|69675809|FG001|Overall Study|Adverse Event|26|||
37990612|NCT00254163|69675808|FG000|Overall Study|Patient request/withdrew consent|6|||
37990613|NCT00254163|69675809|FG001|Overall Study|Patient request/withdrew consent|4|||
37990614|NCT00254163|69675808|FG000|Overall Study|Investigator request|1|||
37990615|NCT00254163|69675809|FG001|Overall Study|Investigator request|3|||
37990616|NCT00254163|69675808|FG000|Overall Study|Failed entry|1|||
37990617|NCT00254163|69675809|FG001|Overall Study|Failed entry|3|||
37990618|NCT00254163|69675808|FG000|Overall Study|Progressive disease|0|||
37990619|NCT00254163|69675809|FG001|Overall Study|Progressive disease|1|||
37990620|NCT00254163|69675808|FG000|Overall Study|Death|0|||
37990621|NCT00254163|69675809|FG001|Overall Study|Death|1|||
37990622|NCT00254163|69675808|FG000|Overall Study|Other|8|||
37990623|NCT00254163|69675809|FG001|Overall Study|Other|8|||
37990624|NCT03869333|69675819|FG000|Overall Study|Lost to Follow-up|1|||
37990625|NCT03869333|69675820|FG001|Overall Study|Lost to Follow-up|0|||
37990626|NCT03869333|69675821|FG002|Overall Study|Lost to Follow-up|0|||
37990627|NCT03869333|69675822|FG003|Overall Study|Lost to Follow-up|0|||
37990628|NCT03869333|69675819|FG000|Overall Study|Pregnancy|1|||
37990629|NCT03869333|69675820|FG001|Overall Study|Pregnancy|0|||
37990630|NCT03869333|69675821|FG002|Overall Study|Pregnancy|0|||
37990631|NCT03869333|69675822|FG003|Overall Study|Pregnancy|0|||
37990632|NCT03869333|69675819|FG000|Overall Study|Physician Decision|0|||
37990633|NCT03869333|69675820|FG001|Overall Study|Physician Decision|1|||
37990634|NCT03869333|69675821|FG002|Overall Study|Physician Decision|0|||
37990635|NCT03869333|69675822|FG003|Overall Study|Physician Decision|0|||
37990636|NCT00110890|69675834|FG000|Overall Study|Adverse Event|30|||
37990637|NCT00110890|69675835|FG001|Overall Study|Adverse Event|7|||
37990638|NCT00110890|69675834|FG000|Overall Study|Death|16|||
37990639|NCT00110890|69675835|FG001|Overall Study|Death|9|||
37990640|NCT00110890|69675834|FG000|Overall Study|Lost to Follow-up|3|||
37990641|NCT00110890|69675835|FG001|Overall Study|Lost to Follow-up|1|||
37990642|NCT00110890|69675834|FG000|Overall Study|Physician Decision|4|||
37990643|NCT00110890|69675835|FG001|Overall Study|Physician Decision|5|||
37696224|NCT02465567|69172377|FG003|Overall Study|Physician Decision|28|||
37825066|NCT01051063|69507042|FG000|Overall Study|Death|2|||
37825067|NCT01051063|69507043|FG001|Overall Study|Death|2|||
37825068|NCT01051063|69507042|FG000|Overall Study|Withdrawal by Subject|1|||
37825069|NCT01051063|69507043|FG001|Overall Study|Withdrawal by Subject|1|||
37825070|NCT01051063|69507042|FG000|Overall Study|Termination of the study|5|||
37825071|NCT01051063|69507043|FG001|Overall Study|Termination of the study|0|||
37825072|NCT01051063|69507042|FG000|Overall Study|Moved from the study site area|1|||
37825073|NCT01051063|69507043|FG001|Overall Study|Moved from the study site area|0|||
37825074|NCT01051063|69507042|FG000|Overall Study|Other|1|||
37825075|NCT01051063|69507043|FG001|Overall Study|Other|0|||
37894925|NCT01017146|69580210|FG001|Overall Study|Protocol Violation|0|||
37894926|NCT01017146|69580209|FG000|Overall Study|Took Excluded Medication|2|||
37894927|NCT01017146|69580210|FG001|Overall Study|Took Excluded Medication|0|||
37894928|NCT01017146|69580209|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
37894929|NCT01017146|69580210|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
37894930|NCT01017146|69580209|FG000|Overall Study|Change in Work Situation|1|||
37894931|NCT01017146|69580210|FG001|Overall Study|Change in Work Situation|0|||
37894932|NCT01010750|69580222|FG000|Second Intervention|Adverse Event|0|||
37894933|NCT01010750|69580223|FG001|Second Intervention|Adverse Event|1|||
37894934|NCT01010750|69580224|FG002|Second Intervention|Adverse Event|0|||
37894935|NCT01010750|69580225|FG003|Second Intervention|Adverse Event|0|||
37894936|NCT01010750|69580226|FG004|Second Intervention|Adverse Event|0|||
37894937|NCT01010750|69580227|FG005|Second Intervention|Adverse Event|0|||
37894938|NCT01012622|69580235|FG000|Overall Study|Withdrawal by Subject|6|||
37990644|NCT00110890|69675834|FG000|Overall Study|Withdrawal by Subject|17|||
37990645|NCT00110890|69675835|FG001|Overall Study|Withdrawal by Subject|5|||
37990646|NCT00110890|69675834|FG000|Overall Study|Protocol Deviation|1|||
37990647|NCT00110890|69675835|FG001|Overall Study|Protocol Deviation|0|||
37696225|NCT02465567|69172374|FG000|Overall Study|Major Protocol Deviation|24|||
37696226|NCT02465567|69172375|FG001|Overall Study|Major Protocol Deviation|26|||
37825076|NCT01051063|69507042|FG000|Overall Study|Lost to Follow-up|0|||
37825077|NCT01051063|69507043|FG001|Overall Study|Lost to Follow-up|1|||
37894939|NCT01012622|69580235|FG000|Overall Study|Lost to Follow-up|5|||
37894940|NCT01012622|69580235|FG000|Overall Study|Adverse Event|7|||
37990648|NCT00110890|69675834|FG000|Overall Study|Noncompliance|10|||
37990649|NCT00110890|69675835|FG001|Overall Study|Noncompliance|0|||
37990650|NCT00110890|69675834|FG000|Overall Study|Kidney Transplant|16|||
37990651|NCT00110890|69675835|FG001|Overall Study|Kidney Transplant|12|||
37990652|NCT00110890|69675834|FG000|Overall Study|Invest. Product Commercially Available|217|||
37990653|NCT00110890|69675835|FG001|Overall Study|Invest. Product Commercially Available|110|||
37990654|NCT00110890|69675834|FG000|Overall Study|Other|34|||
37894941|NCT01012622|69580235|FG000|Overall Study|non-compliance with the drug|9|||
37990655|NCT00110890|69675835|FG001|Overall Study|Other|23|||
37990656|NCT00110890|69675834|FG000|Overall Study|Ineligibility determined|3|||
37990657|NCT00110890|69675835|FG001|Overall Study|Ineligibility determined|0|||
37990658|NCT00110890|69675834|FG000|Overall Study|Requirement for alternative therapy|0|||
37990659|NCT00110890|69675835|FG001|Overall Study|Requirement for alternative therapy|1|||
37990660|NCT00110890|69675834|FG000|Overall Study|Disease progression|0|||
37990661|NCT00110890|69675835|FG001|Overall Study|Disease progression|1|||
37990662|NCT00110890|69675834|FG000|Overall Study|Parathyroidectomy|0|||
37990663|NCT00110890|69675835|FG001|Overall Study|Parathyroidectomy|1|||
37990664|NCT00110890|69675834|FG000|Overall Study|Did not enter follow-up phase|10|||
37990665|NCT00110890|69675835|FG001|Overall Study|Did not enter follow-up phase|4|||
37990666|NCT00182637|69675841|FG000|Overall Study|Adverse Event|2|||
37990667|NCT00182637|69675841|FG000|Overall Study|Disease Progression|1|||
37990668|NCT00182325|69675848|FG000|Overall Study|Lost to Follow-up|7|||
37990669|NCT00182325|69675849|FG001|Overall Study|Lost to Follow-up|7|||
37990670|NCT00182325|69675848|FG000|Overall Study|Miscarriage|5|||
37990671|NCT00182325|69675849|FG001|Overall Study|Miscarriage|3|||
37990672|NCT00182325|69675848|FG000|Overall Study|Did not complete survey|22|||
37990673|NCT00182325|69675849|FG001|Overall Study|Did not complete survey|43|||
37990674|NCT00122278|69675857|FG000|Overall Study|Lost to Follow-up|2|||
37990675|NCT00122278|69675858|FG001|Overall Study|Lost to Follow-up|0|||
37990676|NCT00182091|69675868|FG000|Overall Study|Withdrawal by Subject|1|||
37990677|NCT00182091|69675869|FG001|Overall Study|Withdrawal by Subject|0|||
37990678|NCT00182091|69675870|FG002|Overall Study|Withdrawal by Subject|0|||
37990679|NCT00182091|69675871|FG003|Overall Study|Withdrawal by Subject|0|||
37990680|NCT00181155|69675879|FG000|Overall Study|Physician Decision|1|||
37990681|NCT00181155|69675880|FG001|Overall Study|Physician Decision|0|||
37990682|NCT00181155|69675879|FG000|Overall Study|Withdrawal by Subject|1|||
37990683|NCT00181155|69675880|FG001|Overall Study|Withdrawal by Subject|0|||
37990684|NCT00322452|69675889|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
37990685|NCT00322452|69675890|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
37990686|NCT00322452|69675889|FG000|Overall Study|Lost to Follow-up|5|||
37990687|NCT00322452|69675890|FG001|Overall Study|Lost to Follow-up|2|||
37990688|NCT00322452|69675889|FG000|Overall Study|Withdrawal by Subject|19|||
37990689|NCT00322452|69675890|FG001|Overall Study|Withdrawal by Subject|46|||
37990690|NCT00322452|69675889|FG000|Overall Study|Death|223|||
37990691|NCT00322452|69675890|FG001|Overall Study|Death|227|||
37990692|NCT00110812|69675899|FG000|Main Study|Death|0|||
37990693|NCT00110812|69675900|FG001|Main Study|Death|0|||
37990694|NCT00110812|69675901|FG002|Main Study|Death|2|||
37990695|NCT00110812|69675899|FG000|Main Study|Withdrawal by Subject|0|||
37990696|NCT00110812|69675900|FG001|Main Study|Withdrawal by Subject|0|||
37990697|NCT00110812|69675901|FG002|Main Study|Withdrawal by Subject|1|||
37990698|NCT00110812|69675899|FG000|Main Study|Lost to Follow-up|8|||
37990699|NCT00110812|69675900|FG001|Main Study|Lost to Follow-up|11|||
37990700|NCT00110812|69675901|FG002|Main Study|Lost to Follow-up|10|||
37990701|NCT00110812|69675899|FG000|Extended Follow-up|Death|1|||
37894942|NCT01012622|69580235|FG000|Overall Study|Other|1|||
37894943|NCT01012622|69580235|FG000|Overall Study|screening failure|1|||
37894944|NCT01012622|69580235|FG000|Overall Study|withdrawal of consent by a parent|2|||
37894945|NCT00722371|69580246|FG000|Overall Study|Adverse Event|6|||
37894946|NCT00722371|69580247|FG001|Overall Study|Adverse Event|13|||
37894947|NCT00722371|69580248|FG002|Overall Study|Adverse Event|9|||
37894948|NCT00722371|69580249|FG003|Overall Study|Adverse Event|10|||
37894949|NCT00722371|69580250|FG004|Overall Study|Adverse Event|6|||
37894950|NCT00722371|69580251|FG005|Overall Study|Adverse Event|8|||
37894951|NCT00722371|69580252|FG006|Overall Study|Adverse Event|4|||
37894952|NCT00722371|69580246|FG000|Overall Study|Contraindication|0|||
37894953|NCT00722371|69580247|FG001|Overall Study|Contraindication|0|||
37894954|NCT00722371|69580248|FG002|Overall Study|Contraindication|1|||
37990702|NCT00110812|69675900|FG001|Extended Follow-up|Death|0|||
37990703|NCT00110812|69675901|FG002|Extended Follow-up|Death|3|||
37990704|NCT00110812|69675899|FG000|Extended Follow-up|Withdrawal by Subject|0|||
37990705|NCT00110812|69675900|FG001|Extended Follow-up|Withdrawal by Subject|1|||
37990706|NCT00110812|69675901|FG002|Extended Follow-up|Withdrawal by Subject|0|||
37990707|NCT00110812|69675899|FG000|Extended Follow-up|Lost to Follow-up|1|||
37894955|NCT00722371|69580249|FG003|Overall Study|Contraindication|0|||
37990708|NCT00110812|69675900|FG001|Extended Follow-up|Lost to Follow-up|3|||
37990709|NCT00110812|69675901|FG002|Extended Follow-up|Lost to Follow-up|1|||
37990710|NCT00516269|69675916|FG000|Overall Study|Adverse Event|2|||
37990711|NCT00516269|69675917|FG001|Overall Study|Adverse Event|1|||
37990712|NCT00516269|69675916|FG000|Overall Study|Lost to Follow-up|0|||
37894956|NCT00722371|69580250|FG004|Overall Study|Contraindication|0|||
37894957|NCT00722371|69580251|FG005|Overall Study|Contraindication|0|||
37990713|NCT00516269|69675917|FG001|Overall Study|Lost to Follow-up|1|||
37990714|NCT00516269|69675916|FG000|Overall Study|Protocol Violation|0|||
37894958|NCT00722371|69580252|FG006|Overall Study|Contraindication|0|||
37894959|NCT00722371|69580246|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
37894960|NCT00722371|69580247|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
37894961|NCT00722371|69580248|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
37894962|NCT00722371|69580249|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
37894963|NCT00722371|69580250|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
37990715|NCT00516269|69675917|FG001|Overall Study|Protocol Violation|1|||
37990716|NCT00229203|69675925|FG000|Overall Study|Progressive disease|18|||
37990717|NCT00229203|69675926|FG001|Overall Study|Progressive disease|9|||
37990718|NCT00229203|69675925|FG000|Overall Study|Toxicity|6|||
37990719|NCT00229203|69675926|FG001|Overall Study|Toxicity|1|||
37990720|NCT00229203|69675925|FG000|Overall Study|Death|4|||
37990721|NCT00229203|69675926|FG001|Overall Study|Death|2|||
37990722|NCT00229203|69675925|FG000|Overall Study|Other|3|||
37990723|NCT00229203|69675926|FG001|Overall Study|Other|3|||
37990724|NCT00229203|69675925|FG000|Overall Study|Withdrawal by Subject|1|||
37990725|NCT00229203|69675926|FG001|Overall Study|Withdrawal by Subject|4|||
37990726|NCT00228813|69675932|FG000|Overall Study|Death|4|||
37990727|NCT00322374|69675939|FG000|Starting Dose|Physician Decision|2|||
37990728|NCT00322374|69675940|FG001|Starting Dose|Physician Decision|0|||
37990729|NCT00322374|69675941|FG002|Starting Dose|Physician Decision|0|||
37990730|NCT00322374|69675942|FG003|Starting Dose|Physician Decision|0|||
37990731|NCT00322374|69675939|FG000|Starting Dose|Study Drug Toxicity|4|||
37990732|NCT00322374|69675940|FG001|Starting Dose|Study Drug Toxicity|0|||
37990733|NCT00322374|69675941|FG002|Starting Dose|Study Drug Toxicity|0|||
37990734|NCT00322374|69675942|FG003|Starting Dose|Study Drug Toxicity|0|||
37990735|NCT00322374|69675939|FG000|First Escalation|Documented Disease Progression|0|||
37990736|NCT00322374|69675940|FG001|First Escalation|Documented Disease Progression|6|||
37990737|NCT00322374|69675941|FG002|First Escalation|Documented Disease Progression|0|||
37990738|NCT00322374|69675942|FG003|First Escalation|Documented Disease Progression|0|||
37990739|NCT00322374|69675939|FG000|First Escalation|Physician Decision|0|||
37990740|NCT00322374|69675940|FG001|First Escalation|Physician Decision|12|||
37990741|NCT00322374|69675941|FG002|First Escalation|Physician Decision|0|||
37990742|NCT00322374|69675942|FG003|First Escalation|Physician Decision|0|||
37990743|NCT00322374|69675939|FG000|First Escalation|Study Drug Toxicity|0|||
37990744|NCT00322374|69675940|FG001|First Escalation|Study Drug Toxicity|11|||
37990745|NCT00322374|69675941|FG002|First Escalation|Study Drug Toxicity|0|||
37990746|NCT00322374|69675942|FG003|First Escalation|Study Drug Toxicity|0|||
37990747|NCT00322374|69675939|FG000|First Escalation|Participant Request|0|||
37990748|NCT00322374|69675940|FG001|First Escalation|Participant Request|1|||
37990749|NCT00322374|69675941|FG002|First Escalation|Participant Request|0|||
37990750|NCT00322374|69675942|FG003|First Escalation|Participant Request|0|||
37990751|NCT00322374|69675939|FG000|Second Escalation|Physician Decision|0|||
37894964|NCT00722371|69580251|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
37894965|NCT00722371|69580252|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
37894966|NCT00722371|69580246|FG000|Overall Study|Excluded medication|0|||
37894967|NCT00722371|69580247|FG001|Overall Study|Excluded medication|1|||
37894968|NCT00722371|69580248|FG002|Overall Study|Excluded medication|1|||
37894969|NCT00722371|69580249|FG003|Overall Study|Excluded medication|0|||
37894970|NCT00722371|69580250|FG004|Overall Study|Excluded medication|0|||
37894971|NCT00722371|69580251|FG005|Overall Study|Excluded medication|0|||
37894972|NCT00722371|69580252|FG006|Overall Study|Excluded medication|1|||
37894973|NCT00722371|69580246|FG000|Overall Study|Hyperglycemia|2|||
37894974|NCT00722371|69580247|FG001|Overall Study|Hyperglycemia|6|||
37894975|NCT00722371|69580248|FG002|Overall Study|Hyperglycemia|4|||
37894976|NCT00722371|69580249|FG003|Overall Study|Hyperglycemia|2|||
37894977|NCT00722371|69580250|FG004|Overall Study|Hyperglycemia|5|||
37990752|NCT00322374|69675940|FG001|Second Escalation|Physician Decision|0|||
37990753|NCT00322374|69675941|FG002|Second Escalation|Physician Decision|5|||
37894978|NCT00722371|69580251|FG005|Overall Study|Hyperglycemia|1|||
37990754|NCT00322374|69675942|FG003|Second Escalation|Physician Decision|0|||
37990755|NCT00322374|69675939|FG000|Second Escalation|Study Drug Toxicity|0|||
37990756|NCT00322374|69675940|FG001|Second Escalation|Study Drug Toxicity|0|||
37894979|NCT00722371|69580252|FG006|Overall Study|Hyperglycemia|1|||
37894980|NCT00722371|69580246|FG000|Overall Study|Hypoglycemia|1|||
37990757|NCT00322374|69675941|FG002|Second Escalation|Study Drug Toxicity|1|||
37990758|NCT00322374|69675942|FG003|Second Escalation|Study Drug Toxicity|0|||
37990759|NCT00174447|69675955|FG000|Overall Study|Adverse Event|19|||
37990760|NCT00174447|69675955|FG000|Overall Study|Withdrawal by Subject|15|||
37990761|NCT00174447|69675955|FG000|Overall Study|Protocol Violation|1|||
37990762|NCT00174447|69675955|FG000|Overall Study|Lack of Efficacy|1|||
37990763|NCT00174447|69675955|FG000|Overall Study|Administrative reason/Other|2|||
37990764|NCT00321984|69675962|FG000|Overall Study|Adverse Event|9|||
37894981|NCT00722371|69580247|FG001|Overall Study|Hypoglycemia|0|||
37894982|NCT00722371|69580248|FG002|Overall Study|Hypoglycemia|0|||
37894983|NCT00722371|69580249|FG003|Overall Study|Hypoglycemia|0|||
37894984|NCT00722371|69580250|FG004|Overall Study|Hypoglycemia|0|||
37894985|NCT00722371|69580251|FG005|Overall Study|Hypoglycemia|0|||
37894986|NCT00722371|69580252|FG006|Overall Study|Hypoglycemia|0|||
37894987|NCT00722371|69580246|FG000|Overall Study|Lack of Efficacy|4|||
37894988|NCT00722371|69580247|FG001|Overall Study|Lack of Efficacy|6|||
37894989|NCT00722371|69580248|FG002|Overall Study|Lack of Efficacy|6|||
37894990|NCT00722371|69580249|FG003|Overall Study|Lack of Efficacy|6|||
37894991|NCT00722371|69580250|FG004|Overall Study|Lack of Efficacy|2|||
37894992|NCT00722371|69580251|FG005|Overall Study|Lack of Efficacy|3|||
37894993|NCT00722371|69580252|FG006|Overall Study|Lack of Efficacy|0|||
37894994|NCT00722371|69580246|FG000|Overall Study|Lost to Follow-up|11|||
37894995|NCT00722371|69580247|FG001|Overall Study|Lost to Follow-up|14|||
37894996|NCT00722371|69580248|FG002|Overall Study|Lost to Follow-up|21|||
37894997|NCT00722371|69580249|FG003|Overall Study|Lost to Follow-up|13|||
37894998|NCT00722371|69580250|FG004|Overall Study|Lost to Follow-up|8|||
37894999|NCT00722371|69580251|FG005|Overall Study|Lost to Follow-up|16|||
37895000|NCT00722371|69580252|FG006|Overall Study|Lost to Follow-up|13|||
37895001|NCT00722371|69580246|FG000|Overall Study|Physician Decision|5|||
37895002|NCT00722371|69580247|FG001|Overall Study|Physician Decision|2|||
37895003|NCT00722371|69580248|FG002|Overall Study|Physician Decision|2|||
37895004|NCT00722371|69580249|FG003|Overall Study|Physician Decision|5|||
37895005|NCT00722371|69580250|FG004|Overall Study|Physician Decision|2|||
37895006|NCT00722371|69580251|FG005|Overall Study|Physician Decision|3|||
37895007|NCT00722371|69580252|FG006|Overall Study|Physician Decision|4|||
37895008|NCT00722371|69580246|FG000|Overall Study|Pregnancy|1|||
37895009|NCT00722371|69580247|FG001|Overall Study|Pregnancy|1|||
37895010|NCT00722371|69580248|FG002|Overall Study|Pregnancy|0|||
37895011|NCT00722371|69580249|FG003|Overall Study|Pregnancy|0|||
37895012|NCT00722371|69580250|FG004|Overall Study|Pregnancy|0|||
37895013|NCT00722371|69580251|FG005|Overall Study|Pregnancy|1|||
37895014|NCT00722371|69580252|FG006|Overall Study|Pregnancy|0|||
37895015|NCT00722371|69580246|FG000|Overall Study|Protocol Violation|6|||
37895016|NCT00722371|69580247|FG001|Overall Study|Protocol Violation|1|||
37895017|NCT00722371|69580248|FG002|Overall Study|Protocol Violation|0|||
37895018|NCT00722371|69580249|FG003|Overall Study|Protocol Violation|1|||
37895019|NCT00722371|69580250|FG004|Overall Study|Protocol Violation|4|||
37895020|NCT00722371|69580251|FG005|Overall Study|Protocol Violation|2|||
37895021|NCT00722371|69580252|FG006|Overall Study|Protocol Violation|1|||
37895022|NCT00722371|69580246|FG000|Overall Study|Withdrawal by Subject|18|||
37895023|NCT00722371|69580247|FG001|Overall Study|Withdrawal by Subject|27|||
37895024|NCT00722371|69580248|FG002|Overall Study|Withdrawal by Subject|19|||
37895025|NCT00722371|69580249|FG003|Overall Study|Withdrawal by Subject|23|||
37895026|NCT00722371|69580250|FG004|Overall Study|Withdrawal by Subject|19|||
37895027|NCT00722371|69580251|FG005|Overall Study|Withdrawal by Subject|18|||
37895028|NCT00722371|69580252|FG006|Overall Study|Withdrawal by Subject|26|||
37895029|NCT00722137|69580270|FG000|Overall Study|Overt Disease Progression|5|||
37895030|NCT00722137|69580271|FG001|Overall Study|Overt Disease Progression|4|||
37895031|NCT00722137|69580270|FG000|Overall Study|Adverse Event|17|||
37895032|NCT00722137|69580271|FG001|Overall Study|Adverse Event|21|||
37895033|NCT00722137|69580270|FG000|Overall Study|Death|12|||
37895034|NCT00722137|69580271|FG001|Overall Study|Death|7|||
37895035|NCT00722137|69580270|FG000|Overall Study|Withdrawal by Subject|6|||
37895036|NCT00722137|69580271|FG001|Overall Study|Withdrawal by Subject|9|||
37895037|NCT00722137|69580270|FG000|Overall Study|Other Reason Unknown|3|||
37895038|NCT00722137|69580271|FG001|Overall Study|Other Reason Unknown|4|||
37895039|NCT00722137|69580270|FG000|Overall Study|Randomized But Not Treated|2|||
37895040|NCT00722137|69580271|FG001|Overall Study|Randomized But Not Treated|3|||
37895041|NCT00796666|69580285|FG000|Overall Study|Death|2|||
37895042|NCT00796666|69580286|FG001|Overall Study|Death|4|||
37895043|NCT00796666|69580285|FG000|Overall Study|Withdrawal by Subject|2|||
37895044|NCT00796666|69580286|FG001|Overall Study|Withdrawal by Subject|0|||
37990765|NCT00321984|69675963|FG001|Overall Study|Adverse Event|6|||
37990766|NCT00321984|69675964|FG002|Overall Study|Adverse Event|8|||
37895045|NCT00796666|69580285|FG000|Overall Study|Adverse Event|7|||
37895046|NCT00796666|69580286|FG001|Overall Study|Adverse Event|5|||
37895047|NCT00796666|69580285|FG000|Overall Study|Protocol Violation|1|||
37895048|NCT00796666|69580286|FG001|Overall Study|Protocol Violation|0|||
37895049|NCT00796666|69580285|FG000|Overall Study|Other|1|||
37895050|NCT00796666|69580286|FG001|Overall Study|Other|0|||
37895051|NCT00796666|69580285|FG000|Overall Study|Terminated by sponsor|53|||
37895052|NCT00796666|69580286|FG001|Overall Study|Terminated by sponsor|55|||
37895053|NCT00796666|69580285|FG000|Overall Study|Randomized and not treated|1|||
37895054|NCT00796666|69580286|FG001|Overall Study|Randomized and not treated|0|||
37990767|NCT00321984|69675962|FG000|Overall Study|Protocol Violation|0|||
37990768|NCT00321984|69675963|FG001|Overall Study|Protocol Violation|1|||
37990769|NCT00321984|69675964|FG002|Overall Study|Protocol Violation|1|||
37990770|NCT00321984|69675962|FG000|Overall Study|Lost to Follow-up|2|||
37990771|NCT00321984|69675963|FG001|Overall Study|Lost to Follow-up|4|||
37990772|NCT00321984|69675964|FG002|Overall Study|Lost to Follow-up|2|||
37990773|NCT00321984|69675962|FG000|Overall Study|Withdrawal by Subject|8|||
37990774|NCT00321984|69675963|FG001|Overall Study|Withdrawal by Subject|6|||
37990775|NCT00321984|69675964|FG002|Overall Study|Withdrawal by Subject|5|||
37990776|NCT00321984|69675962|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
37990777|NCT00321984|69675963|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
37990778|NCT00321984|69675964|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
37990779|NCT00321984|69675962|FG000|Overall Study|Lack of Efficacy|3|||
37990780|NCT00321984|69675963|FG001|Overall Study|Lack of Efficacy|1|||
37990781|NCT00321984|69675964|FG002|Overall Study|Lack of Efficacy|3|||
37895055|NCT00799708|69580295|FG000|Overall Study|non-compliance|1|||
37895056|NCT00799708|69580296|FG001|Overall Study|non-compliance|0|||
37895057|NCT00799708|69580297|FG002|Overall Study|non-compliance|0|||
37895058|NCT00796510|69580309|FG000|Overall Study|Death|1|||
37895059|NCT00796510|69580310|FG001|Overall Study|Death|0|||
37895060|NCT00796510|69580309|FG000|Overall Study|Study Terminated|2|||
37895061|NCT00796510|69580310|FG001|Overall Study|Study Terminated|0|||
37895062|NCT00588640|69580316|FG000|Overall Study|Physician Decision|1|||
37895063|NCT00588640|69580316|FG000|Overall Study|Ineligible Patient|1|||
37895064|NCT01016912|69580325|FG000|End of Treatment Period|Lack of Efficacy|0|||
37895065|NCT01016912|69580326|FG001|End of Treatment Period|Lack of Efficacy|1|||
37895066|NCT01016912|69580327|FG002|End of Treatment Period|Lack of Efficacy|0|||
37895067|NCT01016912|69580328|FG003|End of Treatment Period|Lack of Efficacy|4|||
37895068|NCT01016912|69580329|FG004|End of Treatment Period|Lack of Efficacy|4|||
37895069|NCT01016912|69580325|FG000|End of Treatment Period|Adverse Event|0|||
37895070|NCT01016912|69580326|FG001|End of Treatment Period|Adverse Event|1|||
37895071|NCT01016912|69580327|FG002|End of Treatment Period|Adverse Event|1|||
37895072|NCT01016912|69580328|FG003|End of Treatment Period|Adverse Event|0|||
37895073|NCT01016912|69580329|FG004|End of Treatment Period|Adverse Event|0|||
37895074|NCT01016912|69580325|FG000|End of Treatment Period|Completed double-blind period only|0|||
37895075|NCT01016912|69580326|FG001|End of Treatment Period|Completed double-blind period only|1|||
37895076|NCT01016912|69580327|FG002|End of Treatment Period|Completed double-blind period only|0|||
37895077|NCT01016912|69580328|FG003|End of Treatment Period|Completed double-blind period only|0|||
37895078|NCT01016912|69580329|FG004|End of Treatment Period|Completed double-blind period only|0|||
37895079|NCT01016912|69580325|FG000|Follow-up Period|Other reason|0|||
37895080|NCT01016912|69580326|FG001|Follow-up Period|Other reason|0|||
37895081|NCT01016912|69580327|FG002|Follow-up Period|Other reason|1|||
37895082|NCT01016912|69580328|FG003|Follow-up Period|Other reason|1|||
37895083|NCT01016912|69580329|FG004|Follow-up Period|Other reason|0|||
37895084|NCT00802672|69580364|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
37895085|NCT00802672|69580365|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
37895086|NCT00802672|69580366|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
37895087|NCT00802672|69580364|FG000|Overall Study|Adverse Event|1|||
37895088|NCT00802672|69580365|FG001|Overall Study|Adverse Event|1|||
37895089|NCT00802672|69580366|FG002|Overall Study|Adverse Event|1|||
37895090|NCT00802672|69580364|FG000|Overall Study|Protocol Violation|2|||
37895091|NCT00802672|69580365|FG001|Overall Study|Protocol Violation|1|||
37895092|NCT00802672|69580366|FG002|Overall Study|Protocol Violation|1|||
37895093|NCT00802672|69580364|FG000|Overall Study|Lost to Follow-up|5|||
37895094|NCT00802672|69580365|FG001|Overall Study|Lost to Follow-up|5|||
37895095|NCT00802672|69580366|FG002|Overall Study|Lost to Follow-up|3|||
37895096|NCT00802672|69580364|FG000|Overall Study|Withdrawal by Subject|1|||
37895097|NCT00802672|69580365|FG001|Overall Study|Withdrawal by Subject|1|||
37895098|NCT00802672|69580366|FG002|Overall Study|Withdrawal by Subject|2|||
37990782|NCT00321984|69675962|FG000|Overall Study|Noncompliant|0|||
37990783|NCT00321984|69675963|FG001|Overall Study|Noncompliant|0|||
37990784|NCT00321984|69675964|FG002|Overall Study|Noncompliant|2|||
37990785|NCT00321984|69675962|FG000|Overall Study|Pregnancy|0|||
37990786|NCT00321984|69675963|FG001|Overall Study|Pregnancy|1|||
37895099|NCT00802672|69580364|FG000|Overall Study|other|3|||
37895100|NCT00802672|69580365|FG001|Overall Study|other|1|||
37895101|NCT00802672|69580366|FG002|Overall Study|other|2|||
37895102|NCT00714415|69580376|FG000|Overall Study|Lack of Efficacy|1|||
37895103|NCT00714415|69580377|FG001|Overall Study|Lack of Efficacy|0|||
37895104|NCT00714415|69580376|FG000|Overall Study|Death|1|||
37895105|NCT00714415|69580377|FG001|Overall Study|Death|0|||
37990787|NCT00321984|69675964|FG002|Overall Study|Pregnancy|0|||
37990788|NCT00321984|69675962|FG000|Overall Study|Per Subject Request|1|||
37990789|NCT00321984|69675963|FG001|Overall Study|Per Subject Request|0|||
37990790|NCT00321984|69675964|FG002|Overall Study|Per Subject Request|0|||
37990791|NCT00321984|69675962|FG000|Overall Study|Per Investigator Request|1|||
37990792|NCT00321984|69675963|FG001|Overall Study|Per Investigator Request|0|||
37990793|NCT00321984|69675964|FG002|Overall Study|Per Investigator Request|0|||
37990794|NCT00321984|69675962|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
37990795|NCT00321984|69675963|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
37990796|NCT00321984|69675964|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
37990797|NCT00515099|69675974|FG000|Overall Study|Lost to Follow-up|0|||
37990798|NCT00515099|69675975|FG001|Overall Study|Lost to Follow-up|4|||
37990799|NCT00515099|69675974|FG000|Overall Study|Withdrawal by Subject|2|||
37990800|NCT00515099|69675975|FG001|Overall Study|Withdrawal by Subject|0|||
37990801|NCT00515099|69675974|FG000|Overall Study|IRB Recommendation|1|||
37990802|NCT00515099|69675975|FG001|Overall Study|IRB Recommendation|0|||
37990803|NCT00110266|69675981|FG000|Overall Study|Adverse Event|27|||
37990804|NCT00110266|69675981|FG000|Overall Study|Abnormal laboratory value|15|||
37990805|NCT00110266|69675981|FG000|Overall Study|Withdrawal by Subject|16|||
37990806|NCT00110266|69675981|FG000|Overall Study|Death|17|||
37990807|NCT00110266|69675981|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
37990808|NCT00110266|69675981|FG000|Overall Study|Participant condition no longer requires study drug|1|||
37990809|NCT00174291|69675988|FG000|Overall Study|Lost to Follow-up|1|||
37990810|NCT00174291|69675989|FG001|Overall Study|Lost to Follow-up|1|||
37990811|NCT00174291|69675988|FG000|Overall Study|Protocol Violation|0|||
37990812|NCT00174291|69675989|FG001|Overall Study|Protocol Violation|2|||
37990813|NCT00174291|69675988|FG000|Overall Study|Study terminated by sponsor|1|||
37990814|NCT00174291|69675989|FG001|Overall Study|Study terminated by sponsor|0|||
37895106|NCT00714259|69580383|FG000|Overall Study|Death|2|||
37895107|NCT00796120|69580389|FG000|Overall Study|Death|3|||
37895108|NCT00796120|69580390|FG001|Overall Study|Death|0|||
37895109|NCT00796120|69580389|FG000|Overall Study|Adverse Event|11|||
37895110|NCT00796120|69580390|FG001|Overall Study|Adverse Event|6|||
37895111|NCT00796120|69580389|FG000|Overall Study|Progressive disease|22|||
37895112|NCT00796120|69580390|FG001|Overall Study|Progressive disease|13|||
37895113|NCT00796120|69580389|FG000|Overall Study|Participant refusal|3|||
37895114|NCT00796120|69580390|FG001|Overall Study|Participant refusal|4|||
37895115|NCT00796120|69580389|FG000|Overall Study|Other|6|||
37895116|NCT00796120|69580390|FG001|Overall Study|Other|17|||
37895117|NCT00796120|69580389|FG000|Overall Study|Physician Decision|16|||
37895118|NCT00796120|69580390|FG001|Overall Study|Physician Decision|17|||
37895119|NCT00796120|69580389|FG000|Overall Study|Randomized but not treated|0|||
37895120|NCT00796120|69580390|FG001|Overall Study|Randomized but not treated|3|||
37895121|NCT00795886|69580396|FG000|Overall Study|Death|10|||
37895122|NCT00719563|69580403|FG000|Overall Study|Adverse Event|16|||
37895123|NCT00719563|69580404|FG001|Overall Study|Adverse Event|13|||
37895124|NCT00719563|69580403|FG000|Overall Study|Medical condition changed|3|||
37895125|NCT00719563|69580404|FG001|Overall Study|Medical condition changed|5|||
37895126|NCT00719563|69580403|FG000|Overall Study|Lack of Efficacy|3|||
37895127|NCT00719563|69580404|FG001|Overall Study|Lack of Efficacy|7|||
37895128|NCT00719563|69580403|FG000|Overall Study|Personal reasons|6|||
37895129|NCT00719563|69580404|FG001|Overall Study|Personal reasons|7|||
37895130|NCT00719563|69580403|FG000|Overall Study|Unknown reasons|4|||
37895131|NCT00719563|69580404|FG001|Overall Study|Unknown reasons|6|||
37895132|NCT00719563|69580403|FG000|Overall Study|Noncompliant|1|||
37895133|NCT00719563|69580404|FG001|Overall Study|Noncompliant|1|||
37895134|NCT00719563|69580403|FG000|Overall Study|Lost to Follow-up|5|||
37990815|NCT00174291|69675988|FG000|Overall Study|Withdrawal by Subject|3|||
37990816|NCT00174291|69675989|FG001|Overall Study|Withdrawal by Subject|3|||
37990817|NCT00366548|69675997|FG000|Infant Series|Adverse Event|1|||
37990818|NCT00366548|69675998|FG001|Infant Series|Adverse Event|3|||
37990819|NCT00366548|69675997|FG000|Infant Series|Protocol Violation|0|||
37895135|NCT00719563|69580404|FG001|Overall Study|Lost to Follow-up|3|||
37895136|NCT00795184|69580411|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
37990820|NCT00366548|69675998|FG001|Infant Series|Protocol Violation|1|||
37990821|NCT00366548|69675997|FG000|Infant Series|Withdrawal by Subject|3|||
37990822|NCT00366548|69675998|FG001|Infant Series|Withdrawal by Subject|1|||
37990823|NCT00366548|69675997|FG000|After Infant Series|Withdrawal by Subject|3|||
37990824|NCT00366548|69675998|FG001|After Infant Series|Withdrawal by Subject|1|||
37990825|NCT00366548|69675997|FG000|After Infant Series|Adverse Event|2|||
37990826|NCT00366548|69675998|FG001|After Infant Series|Adverse Event|0|||
37990827|NCT00366548|69675997|FG000|After Infant Series|Lost to Follow-up|1|||
37990828|NCT00366548|69675998|FG001|After Infant Series|Lost to Follow-up|0|||
37990829|NCT00252057|69676024|FG000|Overall Study|Withdrawal by Subject|2|||
37990830|NCT00252057|69676025|FG001|Overall Study|Withdrawal by Subject|5|||
37990831|NCT00252057|69676024|FG000|Overall Study|Death|1|||
37990832|NCT00252057|69676025|FG001|Overall Study|Death|2|||
37990833|NCT00252057|69676024|FG000|Overall Study|Participant previously enrolled|0|||
37990834|NCT00252057|69676025|FG001|Overall Study|Participant previously enrolled|1|||
37990835|NCT00132028|69676031|FG000|Overall Study|Adverse Event|7|||
37990836|NCT00132028|69676031|FG000|Overall Study|Death|2|||
37990837|NCT00132028|69676031|FG000|Overall Study|Lack of Efficacy|11|||
37990838|NCT00132028|69676031|FG000|Overall Study|Withdrawal by Subject|2|||
37990839|NCT00132028|69676031|FG000|Overall Study|not eligible|2|||
37990840|NCT00132028|69676031|FG000|Overall Study|Physician Decision|3|||
37990841|NCT00131248|69676035|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
37990842|NCT00131248|69676036|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
37990843|NCT00362414|69676042|FG000|Overall Study|Death|2|||
37990844|NCT00362414|69676042|FG000|Overall Study|Adverse Event|1|||
37990845|NCT00096382|69676051|FG000|Overall Study|Not treated|1|||
37990846|NCT00096382|69676052|FG001|Overall Study|Not treated|0|||
37990847|NCT00096382|69676051|FG000|Overall Study|Death during treatment|1|||
37990848|NCT00096382|69676052|FG001|Overall Study|Death during treatment|0|||
37990849|NCT00359294|69676063|FG000|Overall Study|Progressive disease|1|||
37990850|NCT00359294|69676064|FG001|Overall Study|Progressive disease|1|||
37990851|NCT00359294|69676065|FG002|Overall Study|Progressive disease|2|||
37990852|NCT00359294|69676066|FG003|Overall Study|Progressive disease|3|||
37990853|NCT00359294|69676067|FG004|Overall Study|Progressive disease|2|||
37990854|NCT00359294|69676063|FG000|Overall Study|Withdrawal by Subject|0|||
37990855|NCT00359294|69676064|FG001|Overall Study|Withdrawal by Subject|0|||
37990856|NCT00359294|69676065|FG002|Overall Study|Withdrawal by Subject|0|||
37990857|NCT00359294|69676066|FG003|Overall Study|Withdrawal by Subject|0|||
37990858|NCT00359294|69676067|FG004|Overall Study|Withdrawal by Subject|1|||
37990859|NCT00359294|69676063|FG000|Overall Study|Not treated|0|||
37990860|NCT00359294|69676064|FG001|Overall Study|Not treated|0|||
37990861|NCT00359294|69676065|FG002|Overall Study|Not treated|0|||
37990862|NCT00359294|69676066|FG003|Overall Study|Not treated|1|||
37990863|NCT00359294|69676067|FG004|Overall Study|Not treated|0|||
37990864|NCT00359294|69676063|FG000|Overall Study|Physician Decision|0|||
37990865|NCT00359294|69676064|FG001|Overall Study|Physician Decision|0|||
37990866|NCT00359294|69676065|FG002|Overall Study|Physician Decision|1|||
37990867|NCT00359294|69676066|FG003|Overall Study|Physician Decision|0|||
37990868|NCT00359294|69676067|FG004|Overall Study|Physician Decision|0|||
37990869|NCT00384332|69676077|FG000|Overall Study|Lost to Follow-up|4|||
37990870|NCT00384332|69676078|FG001|Overall Study|Lost to Follow-up|0|||
37990871|NCT00096226|69676086|FG000|Overall Study|Ineligible|2|||
37990872|NCT00096226|69676086|FG000|Overall Study|Protocol treatment not started|1|||
37990873|NCT00105508|69676092|FG000|Overall Study|Prephase Dropout|1|||
37990874|NCT00105508|69676093|FG001|Overall Study|Prephase Dropout|0|||
37990875|NCT00105508|69676092|FG000|Overall Study|Adverse Event|16|||
37990876|NCT00105508|69676093|FG001|Overall Study|Adverse Event|19|||
37990877|NCT00105508|69676092|FG000|Overall Study|Insufficient Efficacy|1|||
37990878|NCT00105508|69676093|FG001|Overall Study|Insufficient Efficacy|0|||
37990879|NCT00105508|69676092|FG000|Overall Study|Withdrawal by Subject|10|||
37990880|NCT00105508|69676093|FG001|Overall Study|Withdrawal by Subject|6|||
37990881|NCT00105508|69676092|FG000|Overall Study|Lost to Follow-up|3|||
37990882|NCT00105508|69676093|FG001|Overall Study|Lost to Follow-up|0|||
37990883|NCT00105508|69676092|FG000|Overall Study|Protocol Violation|1|||
37990884|NCT00105508|69676093|FG001|Overall Study|Protocol Violation|2|||
37990885|NCT00105508|69676092|FG000|Overall Study|Other|8|||
37990886|NCT00105508|69676093|FG001|Overall Study|Other|9|||
37990887|NCT00105196|69676101|FG000|Overall Study|Lack of Efficacy|2|||
37990888|NCT00105196|69676102|FG001|Overall Study|Lack of Efficacy|3|||
37990889|NCT00105196|69676101|FG000|Overall Study|Adverse Event|11|||
37990890|NCT00105196|69676102|FG001|Overall Study|Adverse Event|3|||
37990891|NCT00105196|69676101|FG000|Overall Study|Withdrawal by Subject|6|||
37990892|NCT00105196|69676102|FG001|Overall Study|Withdrawal by Subject|6|||
37990893|NCT00105196|69676101|FG000|Overall Study|Lost to Follow-up|3|||
37990894|NCT00105196|69676102|FG001|Overall Study|Lost to Follow-up|2|||
37990895|NCT00105196|69676101|FG000|Overall Study|Poor/noncompliance|3|||
37990896|NCT00105196|69676102|FG001|Overall Study|Poor/noncompliance|4|||
37990897|NCT00105196|69676101|FG000|Overall Study|Protocol Violation|5|||
37990898|NCT00105196|69676102|FG001|Overall Study|Protocol Violation|2|||
37990899|NCT00105196|69676101|FG000|Overall Study|pending surgery|0|||
37990900|NCT00105196|69676102|FG001|Overall Study|pending surgery|1|||
37990901|NCT00105196|69676101|FG000|Overall Study|marijuana use|0|||
37990902|NCT00105196|69676102|FG001|Overall Study|marijuana use|1|||
37990903|NCT00105196|69676101|FG000|Overall Study|Subject became unblinded|0|||
37990904|NCT00105196|69676102|FG001|Overall Study|Subject became unblinded|1|||
37990905|NCT03820024|69676110|FG000|Overall Study|Physician Decision|1|||
37990906|NCT03820024|69676111|FG001|Overall Study|Physician Decision|2|||
37990907|NCT03819634|69676117|FG000|Overall Study|Physician Decision|2|||
37990908|NCT00104572|69676124|FG000|Overall Study|Withdrawal by Subject|3|||
37990909|NCT00104572|69676125|FG001|Overall Study|Withdrawal by Subject|3|||
37990910|NCT00104572|69676126|FG002|Overall Study|Withdrawal by Subject|0|||
37990911|NCT00514943|69676136|FG000|Stage 1|Progressive disease|4|||
37990912|NCT00514943|69676137|FG001|Stage 1|Progressive disease|8|||
37990913|NCT00514943|69676136|FG000|Stage 1|Other Adverse Event|16|||
37990914|NCT00514943|69676137|FG001|Stage 1|Other Adverse Event|6|||
37990915|NCT00514943|69676136|FG000|Stage 1|Not treated|1|||
37990916|NCT00514943|69676137|FG001|Stage 1|Not treated|2|||
37990917|NCT00514943|69676136|FG000|Stage 1|Patient refused to continue study meds|8|||
37990918|NCT00514943|69676137|FG001|Stage 1|Patient refused to continue study meds|3|||
37990919|NCT00514943|69676136|FG000|Stage 1|Other than stated above|1|||
37990920|NCT00514943|69676137|FG001|Stage 1|Other than stated above|7|||
37990921|NCT00514943|69676136|FG000|Stage 2|Progressive disease|27|||
37990922|NCT00514943|69676137|FG001|Stage 2|Progressive disease|24|||
37990923|NCT00514943|69676136|FG000|Stage 2|Other Adverse Event|3|||
37990924|NCT00514943|69676137|FG001|Stage 2|Other Adverse Event|10|||
37990925|NCT00514943|69676136|FG000|Stage 2|Patient refused to continue study meds|2|||
37990926|NCT00514943|69676137|FG001|Stage 2|Patient refused to continue study meds|0|||
37990927|NCT00514943|69676136|FG000|Stage 2|Other than stated above|0|||
37990928|NCT00514943|69676137|FG001|Stage 2|Other than stated above|2|||
37990929|NCT03864653|69676158|FG000|Overall Study|Withdrawal by Subject|1|||
37990930|NCT00103402|69676164|FG000|Overall Study|Adverse Event|3|||
37990931|NCT00103402|69676165|FG001|Overall Study|Adverse Event|4|||
37990932|NCT00103402|69676164|FG000|Overall Study|Lost to Follow-up|8|||
37990933|NCT00103402|69676165|FG001|Overall Study|Lost to Follow-up|7|||
37990934|NCT00103402|69676164|FG000|Overall Study|Dissatisfied/No longer interested|6|||
37990935|NCT00103402|69676165|FG001|Overall Study|Dissatisfied/No longer interested|6|||
37990936|NCT00103402|69676164|FG000|Overall Study|Personal constraints/Other|5|||
37990937|NCT00103402|69676165|FG001|Overall Study|Personal constraints/Other|0|||
37990938|NCT03864341|69676171|FG000|Overall Study|Withdrawal by Subject|1|||
37990939|NCT00095836|69676175|FG000|Overall Study|Lost to Follow-up|1|||
37990940|NCT00095836|69676175|FG000|Overall Study|Adverse Event|1|||
37990941|NCT00095836|69676175|FG000|Overall Study|Death|2|||
37990942|NCT00168831|69676182|FG000|Overall Study|Adverse Event|36|||
37990943|NCT00168831|69676183|FG001|Overall Study|Adverse Event|47|||
37990944|NCT00168831|69676184|FG002|Overall Study|Adverse Event|74|||
37990945|NCT00168831|69676182|FG000|Overall Study|Lost to Follow-up|5|||
37990946|NCT00168831|69676183|FG001|Overall Study|Lost to Follow-up|6|||
37990947|NCT00168831|69676184|FG002|Overall Study|Lost to Follow-up|4|||
37696227|NCT02465567|69172376|FG002|Overall Study|Major Protocol Deviation|22|||
37895137|NCT00795184|69580412|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
37895138|NCT00718861|69580423|FG000|Overall Study|Withdrawal by Subject|15|||
37895139|NCT00718861|69580424|FG001|Overall Study|Withdrawal by Subject|10|||
37895140|NCT00718861|69580423|FG000|Overall Study|Adverse Event|2|||
37895141|NCT00718861|69580424|FG001|Overall Study|Adverse Event|1|||
37895142|NCT00718861|69580423|FG000|Overall Study|Lost to Follow-up|2|||
37895143|NCT00718861|69580424|FG001|Overall Study|Lost to Follow-up|1|||
37895144|NCT00718861|69580423|FG000|Overall Study|Administrative Problems|1|||
37895145|NCT00718861|69580424|FG001|Overall Study|Administrative Problems|1|||
37895146|NCT00718861|69580423|FG000|Overall Study|Death|1|||
37895147|NCT00718861|69580424|FG001|Overall Study|Death|5|||
37895148|NCT01016600|69580434|FG000|Overall Study|Did not start treatment|1|||
37895149|NCT01016600|69580435|FG001|Overall Study|Did not start treatment|0|||
37895150|NCT01016600|69580436|FG002|Overall Study|Did not start treatment|0|||
37895151|NCT01016600|69580437|FG003|Overall Study|Did not start treatment|0|||
37895152|NCT01016132|69580448|FG000|Overall Study|Discomfort|1|||
37990948|NCT00168831|69676182|FG000|Overall Study|Withdrawal by Subject|7|||
37990949|NCT00168831|69676183|FG001|Overall Study|Withdrawal by Subject|14|||
37990950|NCT00168831|69676184|FG002|Overall Study|Withdrawal by Subject|19|||
37990951|NCT00168831|69676182|FG000|Overall Study|Protocol Violation|6|||
37895153|NCT01015820|69580454|FG000|Overall Study|Suboptimal measurements|1|||
37990952|NCT00168831|69676183|FG001|Overall Study|Protocol Violation|11|||
37990953|NCT00168831|69676184|FG002|Overall Study|Protocol Violation|11|||
37990954|NCT00168831|69676182|FG000|Overall Study|Other|6|||
37895154|NCT01015820|69580455|FG001|Overall Study|Suboptimal measurements|0|||
37895155|NCT01010204|69580478|FG000|Overall Study|Lost to Follow-up|2|||
37990955|NCT00168831|69676183|FG001|Overall Study|Other|3|||
37990956|NCT00168831|69676184|FG002|Overall Study|Other|6|||
37990957|NCT00103012|69676195|FG000|Overall Study|Withdrawal by Subject|2|||
37990958|NCT00103012|69676196|FG001|Overall Study|Withdrawal by Subject|1|||
37990959|NCT00103012|69676197|FG002|Overall Study|Withdrawal by Subject|2|||
37990960|NCT00103012|69676195|FG000|Overall Study|Pregnancy|1|||
37895156|NCT01010204|69580479|FG001|Overall Study|Lost to Follow-up|2|||
37895157|NCT01010204|69580478|FG000|Overall Study|Adverse Event|1|||
37895158|NCT01010204|69580479|FG001|Overall Study|Adverse Event|3|||
37895159|NCT01010204|69580478|FG000|Overall Study|Withdrawal by Subject|2|||
37895160|NCT01010204|69580479|FG001|Overall Study|Withdrawal by Subject|3|||
37990961|NCT00103012|69676196|FG001|Overall Study|Pregnancy|0|||
37990962|NCT00103012|69676197|FG002|Overall Study|Pregnancy|0|||
37990963|NCT00103012|69676195|FG000|Overall Study|Adverse Event|0|||
37990964|NCT00103012|69676196|FG001|Overall Study|Adverse Event|0|||
37990965|NCT00103012|69676197|FG002|Overall Study|Adverse Event|1|||
37990966|NCT00103012|69676195|FG000|Overall Study|Subject non-compliant with medications|0|||
37990967|NCT00103012|69676196|FG001|Overall Study|Subject non-compliant with medications|0|||
37990968|NCT00103012|69676197|FG002|Overall Study|Subject non-compliant with medications|1|||
37990969|NCT00512135|69676205|FG000|Overall Study|Not Treated|5|||
37990970|NCT00512135|69676205|FG000|Overall Study|Lack of Efficacy|2|||
37990971|NCT00512135|69676205|FG000|Overall Study|Adverse Event|6|||
37990972|NCT00512135|69676205|FG000|Overall Study|Withdrawal by Subject|22|||
37990973|NCT00512135|69676205|FG000|Overall Study|Lost to Follow-up|27|||
37990974|NCT00512135|69676205|FG000|Overall Study|Other|22|||
37990975|NCT00251979|69676212|FG000|Overall Study|Protocol Violation|3|||
37990976|NCT00251979|69676213|FG001|Overall Study|Protocol Violation|5|||
37990977|NCT00251979|69676212|FG000|Overall Study|Adverse Event|11|||
37990978|NCT00251979|69676213|FG001|Overall Study|Adverse Event|17|||
37895161|NCT01010204|69580478|FG000|Overall Study|psychiatric hospitalization|2|||
37895162|NCT01010204|69580479|FG001|Overall Study|psychiatric hospitalization|1|||
37895163|NCT00718549|69580485|FG000|Induction Phase|Disease Progression|1|||
37895164|NCT00718549|69580486|FG001|Induction Phase|Disease Progression|0|||
37895165|NCT00718549|69580487|FG002|Induction Phase|Disease Progression|0|||
37895166|NCT00718549|69580485|FG000|Induction Phase|Eligibility Criteria Violation|2|||
37895167|NCT00718549|69580486|FG001|Induction Phase|Eligibility Criteria Violation|0|||
37895168|NCT00718549|69580487|FG002|Induction Phase|Eligibility Criteria Violation|0|||
37895169|NCT00718549|69580485|FG000|Induction Phase|Early Termination - No Additional Info|59|||
37895170|NCT00718549|69580486|FG001|Induction Phase|Early Termination - No Additional Info|0|||
37895171|NCT00718549|69580487|FG002|Induction Phase|Early Termination - No Additional Info|0|||
37895172|NCT00718549|69580485|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
37895173|NCT00718549|69580486|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
37895174|NCT00718549|69580487|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
37895175|NCT00718549|69580485|FG000|Maintenance/ Observation Phase|Death|0|||
37895176|NCT00718549|69580486|FG001|Maintenance/ Observation Phase|Death|1|||
37895177|NCT00718549|69580487|FG002|Maintenance/ Observation Phase|Death|2|||
37895178|NCT00718549|69580485|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
37895179|NCT00718549|69580486|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
37895180|NCT00718549|69580487|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
37895181|NCT00718549|69580485|FG000|Maintenance/ Observation Phase|Progression|0|||
37895182|NCT00718549|69580486|FG001|Maintenance/ Observation Phase|Progression|5|||
37895183|NCT00718549|69580487|FG002|Maintenance/ Observation Phase|Progression|14|||
37895184|NCT00718549|69580485|FG000|Maintenance/ Observation Phase|Relapse|0|||
37895185|NCT00718549|69580486|FG001|Maintenance/ Observation Phase|Relapse|3|||
37895186|NCT00718549|69580487|FG002|Maintenance/ Observation Phase|Relapse|2|||
37895187|NCT00793624|69580504|FG000|Overall Study|Adverse Event|18|||
37895188|NCT00793624|69580505|FG001|Overall Study|Adverse Event|16|||
37895189|NCT00793624|69580506|FG002|Overall Study|Adverse Event|15|||
37895190|NCT00793624|69580507|FG003|Overall Study|Adverse Event|20|||
37895191|NCT00793624|69580504|FG000|Overall Study|Lost to Follow-up|2|||
37895192|NCT00793624|69580505|FG001|Overall Study|Lost to Follow-up|2|||
37895193|NCT00793624|69580506|FG002|Overall Study|Lost to Follow-up|4|||
37990979|NCT00251979|69676212|FG000|Overall Study|Withdrawal by Subject|13|||
37990980|NCT00251979|69676213|FG001|Overall Study|Withdrawal by Subject|7|||
37990981|NCT00251979|69676212|FG000|Overall Study|Lost to Follow-up|8|||
37990982|NCT00251979|69676213|FG001|Overall Study|Lost to Follow-up|6|||
37990983|NCT00251979|69676212|FG000|Overall Study|Death|3|||
37990984|NCT00251979|69676213|FG001|Overall Study|Death|5|||
37990985|NCT00511901|69676221|FG000|Overall Study|Withdrawal by Subject|1|||
37990986|NCT00511901|69676222|FG001|Overall Study|Withdrawal by Subject|3|||
37990987|NCT03862625|69676230|FG000|Overall Study|Lost to Follow-up|0|||
37990988|NCT03862625|69676231|FG001|Overall Study|Lost to Follow-up|1|||
37990989|NCT00163215|69676237|FG000|Overall Study|Lack of Efficacy|3|||
37990990|NCT00163215|69676237|FG000|Overall Study|Withdrawal by Subject|5|||
37990991|NCT00163215|69676237|FG000|Overall Study|Other|7|||
37990992|NCT00228423|69676243|FG000|Overall Study|Adverse Event|2|||
37990993|NCT00228423|69676244|FG001|Overall Study|Adverse Event|5|||
37990994|NCT00228423|69676243|FG000|Overall Study|Withdrawal by Subject|7|||
37990995|NCT00228423|69676244|FG001|Overall Study|Withdrawal by Subject|3|||
37990996|NCT00228423|69676243|FG000|Overall Study|Protocol Violation|1|||
37990997|NCT00228423|69676244|FG001|Overall Study|Protocol Violation|3|||
37990998|NCT00228423|69676243|FG000|Overall Study|Physician Decision|0|||
37990999|NCT00228423|69676244|FG001|Overall Study|Physician Decision|1|||
37991000|NCT00511667|69676252|FG000|Overall Study|Adverse Event|1|||
37991001|NCT00511667|69676253|FG001|Overall Study|Adverse Event|0|||
37991002|NCT00511667|69676252|FG000|Overall Study|Protocol Violation|1|||
37991003|NCT00511667|69676253|FG001|Overall Study|Protocol Violation|1|||
37991004|NCT00511667|69676252|FG000|Overall Study|Withdrawal by Subject|2|||
37991005|NCT00511667|69676253|FG001|Overall Study|Withdrawal by Subject|0|||
37991006|NCT00511667|69676252|FG000|Overall Study|Site terminated|6|||
37991007|NCT00511667|69676253|FG001|Overall Study|Site terminated|1|||
37991008|NCT00511667|69676252|FG000|Overall Study|Other|2|||
37991009|NCT00511667|69676253|FG001|Overall Study|Other|1|||
37991010|NCT00227877|69676269|FG000|Pre-visit Assessment|Technical difficulties|7|||
37991011|NCT00227877|69676270|FG001|Pre-visit Assessment|Technical difficulties|3|||
37991012|NCT00227877|69676271|FG002|Pre-visit Assessment|Technical difficulties|0|||
37991013|NCT00227877|69676272|FG003|Pre-visit Assessment|Technical difficulties|0|||
37991014|NCT00227877|69676269|FG000|Post-visit Checklist|Lost to Follow-up|24|||
37991015|NCT00227877|69676270|FG001|Post-visit Checklist|Lost to Follow-up|13|||
37991016|NCT00227877|69676271|FG002|Post-visit Checklist|Lost to Follow-up|1|||
37991017|NCT00227877|69676272|FG003|Post-visit Checklist|Lost to Follow-up|0|||
37991018|NCT00227877|69676269|FG000|3-months Follow-up|Completed late|135|||
37991019|NCT00227877|69676270|FG001|3-months Follow-up|Completed late|128|||
37991020|NCT00227877|69676271|FG002|3-months Follow-up|Completed late|34|||
37991021|NCT00227877|69676272|FG003|3-months Follow-up|Completed late|8|||
37991022|NCT00227877|69676269|FG000|3-months Follow-up|Lost to Follow-up|178|||
37991023|NCT00227877|69676270|FG001|3-months Follow-up|Lost to Follow-up|139|||
37991024|NCT00227877|69676271|FG002|3-months Follow-up|Lost to Follow-up|18|||
37991025|NCT00227877|69676272|FG003|3-months Follow-up|Lost to Follow-up|13|||
37895194|NCT00793624|69580507|FG003|Overall Study|Lost to Follow-up|0|||
37895195|NCT00793624|69580504|FG000|Overall Study|Withdrawal by Subject|20|||
37895196|NCT00793624|69580505|FG001|Overall Study|Withdrawal by Subject|9|||
37895197|NCT00793624|69580506|FG002|Overall Study|Withdrawal by Subject|11|||
37895198|NCT00793624|69580507|FG003|Overall Study|Withdrawal by Subject|14|||
37895199|NCT00793624|69580504|FG000|Overall Study|Lack of Efficacy|9|||
37895200|NCT00793624|69580505|FG001|Overall Study|Lack of Efficacy|2|||
37895201|NCT00793624|69580506|FG002|Overall Study|Lack of Efficacy|1|||
37895202|NCT00793624|69580507|FG003|Overall Study|Lack of Efficacy|3|||
37895203|NCT00793624|69580504|FG000|Overall Study|Non compliance with protocol|2|||
37895204|NCT00793624|69580505|FG001|Overall Study|Non compliance with protocol|3|||
37895205|NCT00793624|69580506|FG002|Overall Study|Non compliance with protocol|2|||
37895206|NCT00793624|69580507|FG003|Overall Study|Non compliance with protocol|3|||
37895207|NCT00793624|69580504|FG000|Overall Study|Other reason not described above|6|||
37895208|NCT00793624|69580505|FG001|Overall Study|Other reason not described above|4|||
37895209|NCT00793624|69580506|FG002|Overall Study|Other reason not described above|6|||
37895210|NCT00793624|69580507|FG003|Overall Study|Other reason not described above|3|||
37895211|NCT00794950|69580525|FG000|BCG Induction|Withdrawal by Subject|2|||
37895212|NCT00794950|69580525|FG000|BCG Induction|ineligible|3|||
37895213|NCT00794950|69580525|FG000|BCG Induction|noncompliant w. BCG|1|||
37895214|NCT00794950|69580525|FG000|BCG Induction|Adverse Event|1|||
37895215|NCT00794950|69580525|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
37895216|NCT00794950|69580525|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
37895217|NCT00794950|69580525|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
37895218|NCT00794950|69580525|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
37895219|NCT00793546|69580532|FG000|Overall Study|Death|3|||
37895220|NCT00793546|69580533|FG001|Overall Study|Death|0|||
37895221|NCT00793546|69580532|FG000|Overall Study|Lost to Follow-up|1|||
37895222|NCT00793546|69580533|FG001|Overall Study|Lost to Follow-up|0|||
37895223|NCT00793546|69580532|FG000|Overall Study|Withdrawal by Subject|1|||
37991026|NCT00227877|69676269|FG000|12-months Follow-up|Completed late|78|||
37991027|NCT00227877|69676270|FG001|12-months Follow-up|Completed late|74|||
37991028|NCT00227877|69676271|FG002|12-months Follow-up|Completed late|1|||
37991029|NCT00227877|69676272|FG003|12-months Follow-up|Completed late|0|||
37991030|NCT00227877|69676269|FG000|12-months Follow-up|Lost to Follow-up|232|||
37991031|NCT00227877|69676270|FG001|12-months Follow-up|Lost to Follow-up|189|||
37991032|NCT00227877|69676271|FG002|12-months Follow-up|Lost to Follow-up|30|||
37991033|NCT00227877|69676272|FG003|12-months Follow-up|Lost to Follow-up|26|||
37991034|NCT00513695|69676284|FG000|Overall Study|Discontinued therapy|2|||
37991035|NCT00513695|69676284|FG000|Overall Study|Progression prior to surgery|3|||
37991036|NCT00162981|69676290|FG000|Overall Study|Adverse Event|2|||
37991037|NCT00162981|69676291|FG001|Overall Study|Adverse Event|5|||
37991038|NCT00162981|69676290|FG000|Overall Study|Withdrawal by Subject|1|||
37991039|NCT00162981|69676291|FG001|Overall Study|Withdrawal by Subject|1|||
37895224|NCT00793546|69580533|FG001|Overall Study|Withdrawal by Subject|1|||
37895225|NCT00793546|69580532|FG000|Overall Study|Study Terminated by Sponsor|8|||
37895226|NCT00793546|69580533|FG001|Overall Study|Study Terminated by Sponsor|27|||
37991040|NCT00162981|69676290|FG000|Overall Study|Physician Decision|1|||
37991041|NCT00162981|69676291|FG001|Overall Study|Physician Decision|0|||
37991042|NCT00511433|69676299|FG000|Overall Study|Adverse Event|5|||
37991043|NCT00511433|69676300|FG001|Overall Study|Adverse Event|0|||
37991044|NCT00511433|69676299|FG000|Overall Study|Other Reason|1|||
37991045|NCT00511433|69676300|FG001|Overall Study|Other Reason|1|||
37991046|NCT00099268|69676310|FG000|Overall Study|Withdrawal by Subject|46|||
37991047|NCT00099268|69676311|FG001|Overall Study|Withdrawal by Subject|28|||
37991048|NCT00099268|69676310|FG000|Overall Study|Adverse Event|19|||
37991049|NCT00099268|69676311|FG001|Overall Study|Adverse Event|19|||
37991050|NCT00099268|69676310|FG000|Overall Study|Protocol Violation|9|||
37991051|NCT00099268|69676311|FG001|Overall Study|Protocol Violation|8|||
37991052|NCT00099268|69676310|FG000|Overall Study|Lost to Follow-up|6|||
37991053|NCT00099268|69676311|FG001|Overall Study|Lost to Follow-up|4|||
37991054|NCT00099268|69676310|FG000|Overall Study|Lack of Efficacy|5|||
37991055|NCT00099268|69676311|FG001|Overall Study|Lack of Efficacy|18|||
37991056|NCT00099268|69676310|FG000|Overall Study|Administrative problems|4|||
37991057|NCT00099268|69676311|FG001|Overall Study|Administrative problems|4|||
37991058|NCT00099268|69676310|FG000|Overall Study|Death|3|||
37991059|NCT00099268|69676311|FG001|Overall Study|Death|1|||
37991060|NCT00511355|69676319|FG000|Overall Study|Adverse Event|4|||
37991061|NCT00511355|69676320|FG001|Overall Study|Adverse Event|4|||
37991062|NCT00511355|69676319|FG000|Overall Study|Pregnancy Wish|1|||
37991063|NCT00511355|69676320|FG001|Overall Study|Pregnancy Wish|0|||
37991064|NCT00511355|69676319|FG000|Overall Study|Lost to Follow-up|2|||
37991065|NCT00511355|69676320|FG001|Overall Study|Lost to Follow-up|1|||
37991066|NCT00511355|69676319|FG000|Overall Study|Other Reason|0|||
37991067|NCT00511355|69676320|FG001|Overall Study|Other Reason|1|||
37991068|NCT00511355|69676319|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
37991069|NCT00511355|69676320|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
37895227|NCT00793546|69580532|FG000|Overall Study|Other|1|||
37895228|NCT00793546|69580533|FG001|Overall Study|Other|0|||
37991070|NCT00511355|69676319|FG000|Overall Study|Withdrawal of informed consent|0|||
37991071|NCT00511355|69676320|FG001|Overall Study|Withdrawal of informed consent|1|||
37991072|NCT00511355|69676319|FG000|Overall Study|Other reason pre-treatment|0|||
37991073|NCT00511355|69676320|FG001|Overall Study|Other reason pre-treatment|1|||
37991074|NCT00095212|69676330|FG000|Overall Study|Withdrawal by Subject|1|||
37991075|NCT00095212|69676331|FG001|Overall Study|Withdrawal by Subject|3|||
37991076|NCT00120874|69676339|FG000|Overall Study|Death|0|||
37991077|NCT00120874|69676340|FG001|Overall Study|Death|1|||
37991078|NCT00120406|69676348|FG000|Overall Study|Death|9|||
37991079|NCT00120406|69676349|FG001|Overall Study|Death|4|||
37895229|NCT00798694|69580543|FG000|Overall Study|Lost to Follow-up|1|||
37895230|NCT00798694|69580544|FG001|Overall Study|Lost to Follow-up|1|||
37895231|NCT00798694|69580543|FG000|Overall Study|Physician Decision|1|||
37895232|NCT00798694|69580544|FG001|Overall Study|Physician Decision|0|||
37895233|NCT00718315|69580559|FG000|Overall Study|Adverse Event|1|||
37895234|NCT00718315|69580560|FG001|Overall Study|Adverse Event|2|||
37895235|NCT00718315|69580561|FG002|Overall Study|Adverse Event|3|||
37895236|NCT00718315|69580559|FG000|Overall Study|Death|6|||
37895237|NCT00718315|69580560|FG001|Overall Study|Death|6|||
37991080|NCT00120406|69676348|FG000|Overall Study|Withdrawal by Subject|5|||
37991081|NCT00120406|69676349|FG001|Overall Study|Withdrawal by Subject|7|||
37991082|NCT00120406|69676348|FG000|Overall Study|Lost to Follow-up|5|||
37991083|NCT00120406|69676349|FG001|Overall Study|Lost to Follow-up|2|||
37991084|NCT00120406|69676348|FG000|Overall Study|received non-study stent|0|||
37991085|NCT00120406|69676349|FG001|Overall Study|received non-study stent|2|||
37991086|NCT00120406|69676348|FG000|Overall Study|patient moved but has not withdrawn|0|||
37991087|NCT00120406|69676349|FG001|Overall Study|patient moved but has not withdrawn|1|||
37895238|NCT00718315|69580561|FG002|Overall Study|Death|5|||
37895239|NCT00718315|69580559|FG000|Overall Study|Lost to Follow-up|2|||
37895240|NCT00718315|69580560|FG001|Overall Study|Lost to Follow-up|3|||
37895241|NCT00718315|69580561|FG002|Overall Study|Lost to Follow-up|4|||
37991088|NCT00120250|69676355|FG000|Overall Study|Lost to Follow-up|1|||
37991089|NCT00120250|69676356|FG001|Overall Study|Lost to Follow-up|1|||
37991090|NCT00120250|69676355|FG000|Overall Study|Protocol Violation|0|||
37991091|NCT00120250|69676356|FG001|Overall Study|Protocol Violation|1|||
37991092|NCT00511199|69676365|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
37895242|NCT00718315|69580559|FG000|Overall Study|Protocol Violation|5|||
37895243|NCT00718315|69580560|FG001|Overall Study|Protocol Violation|5|||
37895244|NCT00718315|69580561|FG002|Overall Study|Protocol Violation|3|||
37895245|NCT00718315|69580559|FG000|Overall Study|Erlotinib dose decreased|4|||
37895246|NCT00718315|69580560|FG001|Overall Study|Erlotinib dose decreased|3|||
37895247|NCT00718315|69580561|FG002|Overall Study|Erlotinib dose decreased|1|||
37895248|NCT00718315|69580559|FG000|Overall Study|Use of Minocyclin|1|||
37895249|NCT00718315|69580560|FG001|Overall Study|Use of Minocyclin|1|||
37991093|NCT00511199|69676366|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
37991094|NCT00511199|69676365|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
37991095|NCT00511199|69676366|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
37991096|NCT00511199|69676365|FG000|Overall Study|Withdrawal of Informed Consent|19|||
37895250|NCT00718315|69580561|FG002|Overall Study|Use of Minocyclin|1|||
37991097|NCT00511199|69676366|FG001|Overall Study|Withdrawal of Informed Consent|4|||
37991098|NCT00511199|69676365|FG000|Overall Study|Pregnancy|6|||
37991099|NCT00511199|69676366|FG001|Overall Study|Pregnancy|3|||
37991100|NCT00511199|69676365|FG000|Overall Study|Pregnancy Wish|16|||
37991101|NCT00511199|69676366|FG001|Overall Study|Pregnancy Wish|8|||
37991102|NCT00511199|69676365|FG000|Overall Study|Lost to Follow-up|40|||
37991103|NCT00511199|69676366|FG001|Overall Study|Lost to Follow-up|17|||
37991104|NCT00511199|69676365|FG000|Overall Study|Other Reason|78|||
37991105|NCT00511199|69676366|FG001|Overall Study|Other Reason|37|||
37991106|NCT00384176|69676377|FG000|Overall Study|Death|239|||
37991107|NCT00384176|69676378|FG001|Overall Study|Death|247|||
37991108|NCT00384176|69676379|FG002|Overall Study|Death|105|||
37991109|NCT00384176|69676377|FG000|Overall Study|Withdrawal by Subject|52|||
37991110|NCT00384176|69676378|FG001|Overall Study|Withdrawal by Subject|48|||
37991111|NCT00384176|69676379|FG002|Overall Study|Withdrawal by Subject|22|||
37991112|NCT00384176|69676377|FG000|Overall Study|Lost to Follow-up|16|||
37991113|NCT00384176|69676378|FG001|Overall Study|Lost to Follow-up|18|||
37991114|NCT00384176|69676379|FG002|Overall Study|Lost to Follow-up|4|||
37991115|NCT00384176|69676377|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
37991116|NCT00384176|69676378|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
37991117|NCT00384176|69676379|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
37991118|NCT00384176|69676377|FG000|Overall Study|Longer QTC as Visit 1|1|||
37991119|NCT00384176|69676378|FG001|Overall Study|Longer QTC as Visit 1|0|||
37991120|NCT00384176|69676379|FG002|Overall Study|Longer QTC as Visit 1|0|||
37991121|NCT00384176|69676377|FG000|Overall Study|Toxicity of treatment|1|||
37991122|NCT00384176|69676378|FG001|Overall Study|Toxicity of treatment|0|||
37991123|NCT00384176|69676379|FG002|Overall Study|Toxicity of treatment|0|||
37991124|NCT00384176|69676377|FG000|Overall Study|Did not receive study treatment|0|||
37991125|NCT00384176|69676378|FG001|Overall Study|Did not receive study treatment|1|||
37991126|NCT00384176|69676379|FG002|Overall Study|Did not receive study treatment|1|||
37991127|NCT00384176|69676377|FG000|Overall Study|Physician Decision|0|||
37696228|NCT02465567|69172377|FG003|Overall Study|Major Protocol Deviation|25|||
37895251|NCT00718315|69580559|FG000|Overall Study|Disease progression|0|||
37895252|NCT00718315|69580560|FG001|Overall Study|Disease progression|1|||
37895253|NCT00718315|69580561|FG002|Overall Study|Disease progression|1|||
37895254|NCT00718315|69580559|FG000|Overall Study|Other|0|||
37895255|NCT00718315|69580560|FG001|Overall Study|Other|0|||
37895256|NCT00718315|69580561|FG002|Overall Study|Other|1|||
37895257|NCT00718315|69580559|FG000|Overall Study|Use of ATB and Corticoids|0|||
37895258|NCT00718315|69580560|FG001|Overall Study|Use of ATB and Corticoids|1|||
37895259|NCT00718315|69580561|FG002|Overall Study|Use of ATB and Corticoids|2|||
37895260|NCT00798304|69580572|FG000|Overall Study|Adverse Event|0|||
37895261|NCT00798304|69580573|FG001|Overall Study|Adverse Event|1|||
37895262|NCT00798304|69580574|FG002|Overall Study|Adverse Event|1|||
37895263|NCT00798304|69580572|FG000|Overall Study|Discontinuation by Sponsor|14|||
37895264|NCT00798304|69580573|FG001|Overall Study|Discontinuation by Sponsor|21|||
37895265|NCT00798304|69580574|FG002|Overall Study|Discontinuation by Sponsor|9|||
37991128|NCT00384176|69676378|FG001|Overall Study|Physician Decision|2|||
37991129|NCT00384176|69676379|FG002|Overall Study|Physician Decision|0|||
37991130|NCT00384176|69676377|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
37991131|NCT00384176|69676378|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
37895266|NCT00718237|69580584|FG000|Overall Study|Adverse Event|1|||
37895267|NCT00718237|69580585|FG001|Overall Study|Adverse Event|3|||
37991132|NCT00384176|69676379|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
37895268|NCT00718237|69580584|FG000|Overall Study|Lost to Follow-up|2|||
37895269|NCT00718237|69580585|FG001|Overall Study|Lost to Follow-up|2|||
37895270|NCT00718237|69580584|FG000|Overall Study|Physician Decision|1|||
37895271|NCT00718237|69580585|FG001|Overall Study|Physician Decision|0|||
37991133|NCT00513305|69676389|FG000|Overall Study|Adverse Event|6|||
37991134|NCT00513305|69676390|FG001|Overall Study|Adverse Event|2|||
37991135|NCT00513305|69676389|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
37991136|NCT00513305|69676390|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
37895272|NCT00718237|69580584|FG000|Overall Study|Withdrawal by Subject|9|||
37895273|NCT00718237|69580585|FG001|Overall Study|Withdrawal by Subject|10|||
37895274|NCT00793780|69580595|FG000|Overall Study|Withdrawal by Subject|2|||
37895275|NCT00793780|69580596|FG001|Overall Study|Withdrawal by Subject|1|||
37895276|NCT02643303|69580611|FG000|Overall Study|Progressive Disease|4|||
37895277|NCT02643303|69580612|FG001|Overall Study|Progressive Disease|4|||
37895278|NCT02643303|69580613|FG002|Overall Study|Progressive Disease|1|||
37991137|NCT00513305|69676389|FG000|Overall Study|Lack of Efficacy|8|||
37991138|NCT00513305|69676390|FG001|Overall Study|Lack of Efficacy|13|||
37991139|NCT00513305|69676389|FG000|Overall Study|Withdrawal by Subject|1|||
37991140|NCT00513305|69676390|FG001|Overall Study|Withdrawal by Subject|2|||
37991141|NCT00513305|69676389|FG000|Overall Study|Disease progression|8|||
37991142|NCT00513305|69676390|FG001|Overall Study|Disease progression|5|||
37991143|NCT00513305|69676389|FG000|Overall Study|Eligible for stem cell transplant|1|||
37991144|NCT00513305|69676390|FG001|Overall Study|Eligible for stem cell transplant|0|||
37991145|NCT00513305|69676389|FG000|Overall Study|Hematologic counts did not recover|1|||
37991146|NCT00513305|69676390|FG001|Overall Study|Hematologic counts did not recover|0|||
37991147|NCT00513305|69676389|FG000|Overall Study|Physician Decision|1|||
37991148|NCT00513305|69676390|FG001|Overall Study|Physician Decision|0|||
37991149|NCT00513305|69676389|FG000|Overall Study|Persistent hypocellularity|0|||
37991150|NCT00513305|69676390|FG001|Overall Study|Persistent hypocellularity|1|||
37991151|NCT00513305|69676389|FG000|Overall Study|Sponsor Decision|0|||
37991152|NCT00513305|69676390|FG001|Overall Study|Sponsor Decision|2|||
37991153|NCT00513071|69676396|FG000|Overall Study|Adverse Event|1|||
37991154|NCT00513071|69676396|FG000|Overall Study|Withdrawal by Subject|1|||
37991155|NCT00513071|69676396|FG000|Overall Study|Physician Decision|3|||
37991156|NCT00510887|69676400|FG000|Overall Study|Lost to Follow-up|1|||
37991157|NCT00358826|69676408|FG000|Core Study|Adverse Event|1|||
37991158|NCT00358826|69676409|FG001|Core Study|Adverse Event|3|||
37991159|NCT00358826|69676410|FG002|Core Study|Adverse Event|1|||
37991160|NCT00358826|69676411|FG003|Core Study|Adverse Event|1|||
37991161|NCT00358826|69676412|FG004|Core Study|Adverse Event|0|||
37991162|NCT00358826|69676413|FG005|Core Study|Adverse Event|0|||
37991163|NCT00358826|69676414|FG006|Core Study|Adverse Event|0|||
37991164|NCT00358826|69676415|FG007|Core Study|Adverse Event|0|||
37991165|NCT00358826|69676408|FG000|Core Study|Withdrawal by Subject|2|||
37991166|NCT00358826|69676409|FG001|Core Study|Withdrawal by Subject|2|||
37991167|NCT00358826|69676410|FG002|Core Study|Withdrawal by Subject|0|||
37991168|NCT00358826|69676411|FG003|Core Study|Withdrawal by Subject|0|||
37991169|NCT00358826|69676412|FG004|Core Study|Withdrawal by Subject|0|||
37991170|NCT00358826|69676413|FG005|Core Study|Withdrawal by Subject|0|||
37991171|NCT00358826|69676414|FG006|Core Study|Withdrawal by Subject|0|||
37991172|NCT00358826|69676415|FG007|Core Study|Withdrawal by Subject|0|||
37991173|NCT00358826|69676408|FG000|Core Study|Lost to Follow-up|0|||
37991174|NCT00358826|69676409|FG001|Core Study|Lost to Follow-up|0|||
37991175|NCT00358826|69676410|FG002|Core Study|Lost to Follow-up|0|||
37991176|NCT00358826|69676411|FG003|Core Study|Lost to Follow-up|1|||
37991177|NCT00358826|69676412|FG004|Core Study|Lost to Follow-up|0|||
37991178|NCT00358826|69676413|FG005|Core Study|Lost to Follow-up|0|||
37991179|NCT00358826|69676414|FG006|Core Study|Lost to Follow-up|0|||
37895279|NCT02643303|69580614|FG003|Overall Study|Progressive Disease|12|||
37895280|NCT02643303|69580615|FG004|Overall Study|Progressive Disease|6|||
37895281|NCT02643303|69580616|FG005|Overall Study|Progressive Disease|4|||
37895282|NCT02643303|69580617|FG006|Overall Study|Progressive Disease|8|||
37895283|NCT02643303|69580618|FG007|Overall Study|Progressive Disease|2|||
37895284|NCT02643303|69580619|FG008|Overall Study|Progressive Disease|6|||
37895285|NCT02643303|69580611|FG000|Overall Study|Adverse Event|0|||
37895286|NCT02643303|69580612|FG001|Overall Study|Adverse Event|1|||
37895287|NCT02643303|69580613|FG002|Overall Study|Adverse Event|0|||
37895288|NCT02643303|69580614|FG003|Overall Study|Adverse Event|0|||
37895289|NCT02643303|69580615|FG004|Overall Study|Adverse Event|1|||
37895290|NCT02643303|69580616|FG005|Overall Study|Adverse Event|0|||
37895291|NCT02643303|69580617|FG006|Overall Study|Adverse Event|0|||
37895292|NCT02643303|69580618|FG007|Overall Study|Adverse Event|0|||
37895293|NCT02643303|69580619|FG008|Overall Study|Adverse Event|0|||
37895294|NCT02643303|69580611|FG000|Overall Study|Withdrawal by Subject|0|||
37991180|NCT00358826|69676415|FG007|Core Study|Lost to Follow-up|0|||
37991181|NCT00358826|69676408|FG000|Core Study|Physician Decision|0|||
37991182|NCT00358826|69676409|FG001|Core Study|Physician Decision|0|||
37895295|NCT02643303|69580612|FG001|Overall Study|Withdrawal by Subject|0|||
37895296|NCT02643303|69580613|FG002|Overall Study|Withdrawal by Subject|0|||
37895297|NCT02643303|69580614|FG003|Overall Study|Withdrawal by Subject|1|||
37895298|NCT02643303|69580615|FG004|Overall Study|Withdrawal by Subject|0|||
37991183|NCT00358826|69676410|FG002|Core Study|Physician Decision|1|||
37991184|NCT00358826|69676411|FG003|Core Study|Physician Decision|0|||
37991185|NCT00358826|69676412|FG004|Core Study|Physician Decision|0|||
37991186|NCT00358826|69676413|FG005|Core Study|Physician Decision|0|||
37991187|NCT00358826|69676414|FG006|Core Study|Physician Decision|0|||
37991188|NCT00358826|69676415|FG007|Core Study|Physician Decision|0|||
37991189|NCT00358826|69676408|FG000|MDCT Substudy|Adverse Event|0|||
37991190|NCT00358826|69676409|FG001|MDCT Substudy|Adverse Event|0|||
37991191|NCT00358826|69676410|FG002|MDCT Substudy|Adverse Event|0|||
37991192|NCT00358826|69676411|FG003|MDCT Substudy|Adverse Event|0|||
37991193|NCT00358826|69676412|FG004|MDCT Substudy|Adverse Event|1|||
37991194|NCT00358826|69676413|FG005|MDCT Substudy|Adverse Event|0|||
37991195|NCT00358826|69676414|FG006|MDCT Substudy|Adverse Event|0|||
37991196|NCT00358826|69676415|FG007|MDCT Substudy|Adverse Event|0|||
37991197|NCT00358826|69676408|FG000|MDCT Substudy|Lost to Follow-up|0|||
37991198|NCT00358826|69676409|FG001|MDCT Substudy|Lost to Follow-up|0|||
37991199|NCT00358826|69676410|FG002|MDCT Substudy|Lost to Follow-up|0|||
37991200|NCT00358826|69676411|FG003|MDCT Substudy|Lost to Follow-up|0|||
37991201|NCT00358826|69676412|FG004|MDCT Substudy|Lost to Follow-up|0|||
37991202|NCT00358826|69676413|FG005|MDCT Substudy|Lost to Follow-up|1|||
37991203|NCT00358826|69676414|FG006|MDCT Substudy|Lost to Follow-up|0|||
37991204|NCT00358826|69676415|FG007|MDCT Substudy|Lost to Follow-up|0|||
37991205|NCT00358826|69676408|FG000|MDCT Substudy|Withdrawal by Subject|0|||
37991206|NCT00358826|69676409|FG001|MDCT Substudy|Withdrawal by Subject|0|||
37991207|NCT00358826|69676410|FG002|MDCT Substudy|Withdrawal by Subject|0|||
37991208|NCT00358826|69676411|FG003|MDCT Substudy|Withdrawal by Subject|0|||
37991209|NCT00358826|69676412|FG004|MDCT Substudy|Withdrawal by Subject|0|||
37991210|NCT00358826|69676413|FG005|MDCT Substudy|Withdrawal by Subject|1|||
37991211|NCT00358826|69676414|FG006|MDCT Substudy|Withdrawal by Subject|0|||
37991212|NCT00358826|69676415|FG007|MDCT Substudy|Withdrawal by Subject|0|||
37991213|NCT00510653|69676429|FG000|Overall Study|Withdrawal by Subject|8|||
37991214|NCT00510653|69676429|FG000|Overall Study|Monetary|3|||
37991215|NCT00362336|69676436|FG000|Overall Study|Serious Adverse Event|1|||
37991216|NCT00362336|69676437|FG001|Overall Study|Serious Adverse Event|0|||
37991217|NCT00362336|69676438|FG002|Overall Study|Serious Adverse Event|1|||
37991218|NCT00362336|69676436|FG000|Overall Study|Protocol Violation|0|||
37991219|NCT00362336|69676437|FG001|Overall Study|Protocol Violation|0|||
37991220|NCT00362336|69676438|FG002|Overall Study|Protocol Violation|1|||
37991221|NCT00362336|69676436|FG000|Overall Study|Lost to Follow-up|6|||
37991222|NCT00362336|69676437|FG001|Overall Study|Lost to Follow-up|4|||
37991223|NCT00362336|69676438|FG002|Overall Study|Lost to Follow-up|0|||
37991224|NCT00362336|69676436|FG000|Overall Study|Withdrawal by Subject|3|||
37991225|NCT00362336|69676437|FG001|Overall Study|Withdrawal by Subject|3|||
37991226|NCT00362336|69676438|FG002|Overall Study|Withdrawal by Subject|1|||
37991227|NCT00506285|69676455|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
37991228|NCT00506285|69676456|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
37991229|NCT00506285|69676455|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
37991230|NCT00506285|69676456|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
37991231|NCT00506285|69676455|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
37991232|NCT00506285|69676456|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
37991233|NCT00506285|69676455|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
37991234|NCT00506285|69676456|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
37895299|NCT02643303|69580616|FG005|Overall Study|Withdrawal by Subject|0|||
37895300|NCT02643303|69580617|FG006|Overall Study|Withdrawal by Subject|1|||
37895301|NCT02643303|69580618|FG007|Overall Study|Withdrawal by Subject|1|||
37895302|NCT02643303|69580619|FG008|Overall Study|Withdrawal by Subject|1|||
37895303|NCT00790036|69580641|FG000|Overall Study|Abnormal lab values|3|||
37895304|NCT00790036|69580642|FG001|Overall Study|Abnormal lab values|2|||
37895305|NCT00790036|69580641|FG000|Overall Study|Administrative problems|5|||
37895306|NCT00790036|69580642|FG001|Overall Study|Administrative problems|9|||
37895307|NCT00790036|69580641|FG000|Overall Study|Adverse Event|113|||
37895308|NCT00790036|69580642|FG001|Overall Study|Adverse Event|44|||
37895309|NCT00790036|69580641|FG000|Overall Study|Death|1|||
37895310|NCT00790036|69580642|FG001|Overall Study|Death|0|||
37895311|NCT00790036|69580641|FG000|Overall Study|Disease progression|24|||
37895312|NCT00790036|69580642|FG001|Overall Study|Disease progression|48|||
37895313|NCT00790036|69580641|FG000|Overall Study|Lost to Follow-up|1|||
37895314|NCT00790036|69580642|FG001|Overall Study|Lost to Follow-up|2|||
37991235|NCT00506285|69676455|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
37991236|NCT00506285|69676456|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
37991237|NCT00506129|69676464|FG000|Overall Study|Disease Progression/Relapse|15|||
37991238|NCT00506129|69676464|FG000|Overall Study|Death|7|||
37991239|NCT00358670|69676470|FG000|Overall Study|Adverse Event|26|||
37895315|NCT00790036|69580641|FG000|Overall Study|Protocol Violation|10|||
37895316|NCT00790036|69580642|FG001|Overall Study|Protocol Violation|2|||
37895317|NCT00790036|69580641|FG000|Overall Study|Withdrawal by Subject|18|||
37895318|NCT00790036|69580642|FG001|Overall Study|Withdrawal by Subject|7|||
37991240|NCT00358670|69676471|FG001|Overall Study|Adverse Event|29|||
37991241|NCT00358670|69676470|FG000|Overall Study|Lack of Efficacy|20|||
37895319|NCT00790036|69580641|FG000|Overall Study|Subject/guardian decision|20|||
37895320|NCT00790036|69580642|FG001|Overall Study|Subject/guardian decision|7|||
37895321|NCT00789958|69580649|FG000|Overall Study|Adverse Event|3|||
37895322|NCT00789958|69580649|FG000|Overall Study|Withdrawal by Subject|4|||
37895323|NCT00789958|69580649|FG000|Overall Study|Progression|3|||
37895324|NCT00789958|69580649|FG000|Overall Study|not protocol specified|1|||
37895325|NCT00789958|69580649|FG000|Overall Study|Not eligible/not analyzable|26|||
37895326|NCT00789880|69580661|FG000|Overall Study|Adverse Event|0|||
37895327|NCT00789880|69580662|FG001|Overall Study|Adverse Event|0|||
37895328|NCT00789880|69580663|FG002|Overall Study|Adverse Event|0|||
37895329|NCT00789880|69580664|FG003|Overall Study|Adverse Event|0|||
37895330|NCT00789880|69580665|FG004|Overall Study|Adverse Event|1|||
37895331|NCT00789880|69580666|FG005|Overall Study|Adverse Event|0|||
37895332|NCT00789880|69580661|FG000|Overall Study|Protocol Violation|0|||
37895333|NCT00789880|69580662|FG001|Overall Study|Protocol Violation|1|||
37895334|NCT00789880|69580663|FG002|Overall Study|Protocol Violation|0|||
37895335|NCT00789880|69580664|FG003|Overall Study|Protocol Violation|1|||
37895336|NCT00789880|69580665|FG004|Overall Study|Protocol Violation|0|||
37895337|NCT00789880|69580666|FG005|Overall Study|Protocol Violation|0|||
37895338|NCT00789880|69580661|FG000|Overall Study|Withdrawal by Subject|1|||
37895339|NCT00789880|69580662|FG001|Overall Study|Withdrawal by Subject|0|||
37895340|NCT00789880|69580663|FG002|Overall Study|Withdrawal by Subject|0|||
37895341|NCT00789880|69580664|FG003|Overall Study|Withdrawal by Subject|0|||
37895342|NCT00789880|69580665|FG004|Overall Study|Withdrawal by Subject|2|||
37895343|NCT00789880|69580666|FG005|Overall Study|Withdrawal by Subject|0|||
37895344|NCT00792298|69580680|FG000|Treatment Period 1|Adverse Event|0|||
37895345|NCT00792298|69580681|FG001|Treatment Period 1|Adverse Event|1|||
37895346|NCT00792298|69580682|FG002|Treatment Period 1|Adverse Event|0|||
37895347|NCT00792298|69580683|FG003|Treatment Period 1|Adverse Event|1|||
37895348|NCT00792298|69580684|FG004|Treatment Period 1|Adverse Event|0|||
37895349|NCT00792298|69580685|FG005|Treatment Period 1|Adverse Event|1|||
37895350|NCT00792298|69580686|FG006|Treatment Period 1|Adverse Event|1|||
37895351|NCT00792298|69580687|FG007|Treatment Period 1|Adverse Event|0|||
37895352|NCT00792298|69580680|FG000|Treatment Period 1|Lack of Efficacy|0|||
37895353|NCT00792298|69580681|FG001|Treatment Period 1|Lack of Efficacy|0|||
37895354|NCT00792298|69580682|FG002|Treatment Period 1|Lack of Efficacy|1|||
37895355|NCT00792298|69580683|FG003|Treatment Period 1|Lack of Efficacy|0|||
37895356|NCT00792298|69580684|FG004|Treatment Period 1|Lack of Efficacy|0|||
37895357|NCT00792298|69580685|FG005|Treatment Period 1|Lack of Efficacy|0|||
37895358|NCT00792298|69580686|FG006|Treatment Period 1|Lack of Efficacy|0|||
37895359|NCT00792298|69580687|FG007|Treatment Period 1|Lack of Efficacy|0|||
37895360|NCT00792298|69580680|FG000|Treatment Period 1|Withdrawal by Subject|1|||
37895361|NCT00792298|69580681|FG001|Treatment Period 1|Withdrawal by Subject|0|||
37895362|NCT00792298|69580682|FG002|Treatment Period 1|Withdrawal by Subject|1|||
37895363|NCT00792298|69580683|FG003|Treatment Period 1|Withdrawal by Subject|2|||
37895364|NCT00792298|69580684|FG004|Treatment Period 1|Withdrawal by Subject|0|||
37895365|NCT00792298|69580685|FG005|Treatment Period 1|Withdrawal by Subject|2|||
37895366|NCT00792298|69580686|FG006|Treatment Period 1|Withdrawal by Subject|1|||
37895367|NCT00792298|69580687|FG007|Treatment Period 1|Withdrawal by Subject|0|||
37895368|NCT00792298|69580680|FG000|Treatment Period 1|Lost to Follow-up|0|||
37895369|NCT00792298|69580681|FG001|Treatment Period 1|Lost to Follow-up|0|||
37895370|NCT00792298|69580682|FG002|Treatment Period 1|Lost to Follow-up|0|||
37895371|NCT00792298|69580683|FG003|Treatment Period 1|Lost to Follow-up|0|||
37991242|NCT00358670|69676471|FG001|Overall Study|Lack of Efficacy|23|||
37991243|NCT00358670|69676470|FG000|Overall Study|Protocol Violation|6|||
37696229|NCT02465567|69172374|FG000|Overall Study|Lost to Follow-up|25|||
37895372|NCT00792298|69580684|FG004|Treatment Period 1|Lost to Follow-up|0|||
37895373|NCT00792298|69580685|FG005|Treatment Period 1|Lost to Follow-up|0|||
37895374|NCT00792298|69580686|FG006|Treatment Period 1|Lost to Follow-up|1|||
37895375|NCT00792298|69580687|FG007|Treatment Period 1|Lost to Follow-up|0|||
37895376|NCT00792298|69580680|FG000|Treatment Period 1|Physician Decision|0|||
37895377|NCT00792298|69580681|FG001|Treatment Period 1|Physician Decision|0|||
37895378|NCT00792298|69580682|FG002|Treatment Period 1|Physician Decision|0|||
37895379|NCT00792298|69580683|FG003|Treatment Period 1|Physician Decision|1|||
37895380|NCT00792298|69580684|FG004|Treatment Period 1|Physician Decision|0|||
37895381|NCT00792298|69580685|FG005|Treatment Period 1|Physician Decision|0|||
37991244|NCT00358670|69676471|FG001|Overall Study|Protocol Violation|9|||
37991245|NCT00358670|69676470|FG000|Overall Study|Lost to Follow-up|4|||
37991246|NCT00358670|69676471|FG001|Overall Study|Lost to Follow-up|5|||
37991247|NCT00358670|69676470|FG000|Overall Study|Withdrawal by Subject|13|||
37991248|NCT00358670|69676471|FG001|Overall Study|Withdrawal by Subject|24|||
37991249|NCT00358670|69676470|FG000|Overall Study|Protocol Defined Clinical Event|0|||
37991250|NCT00358670|69676471|FG001|Overall Study|Protocol Defined Clinical Event|1|||
37991251|NCT00358670|69676470|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
37991252|NCT00358670|69676471|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
37991253|NCT00358670|69676470|FG000|Overall Study|Administrative|153|||
37991254|NCT00358670|69676471|FG001|Overall Study|Administrative|125|||
37991255|NCT00505661|69676477|FG000|Overall Study|Not Eligible|4|||
37991256|NCT00383786|69676483|FG000|Overall Study|Protocol Violation|2|||
37991257|NCT00383786|69676484|FG001|Overall Study|Protocol Violation|6|||
37991258|NCT00383786|69676483|FG000|Overall Study|Withdrawal by Subject|2|||
37991259|NCT00383786|69676484|FG001|Overall Study|Withdrawal by Subject|5|||
37991260|NCT00383786|69676483|FG000|Overall Study|Physician Decision|0|||
37825078|NCT01050790|69507050|FG000|Overall Study|Adverse Event|1|||
37825079|NCT01050673|69507057|FG000|Overall Study|Physician Decision|4|||
37825080|NCT01050673|69507058|FG001|Overall Study|Physician Decision|5|||
37895382|NCT00792298|69580686|FG006|Treatment Period 1|Physician Decision|1|||
37895383|NCT00792298|69580687|FG007|Treatment Period 1|Physician Decision|0|||
37895384|NCT00792298|69580680|FG000|Treatment Period 1|Protocol Violation|0|||
37895385|NCT00792298|69580681|FG001|Treatment Period 1|Protocol Violation|0|||
37895386|NCT00792298|69580682|FG002|Treatment Period 1|Protocol Violation|0|||
37895387|NCT00792298|69580683|FG003|Treatment Period 1|Protocol Violation|0|||
37895388|NCT00792298|69580684|FG004|Treatment Period 1|Protocol Violation|0|||
37895389|NCT00792298|69580685|FG005|Treatment Period 1|Protocol Violation|0|||
37895390|NCT00792298|69580686|FG006|Treatment Period 1|Protocol Violation|0|||
37895391|NCT00792298|69580687|FG007|Treatment Period 1|Protocol Violation|1|||
37895392|NCT00792298|69580680|FG000|Washout|Adverse Event|0|||
37895393|NCT00792298|69580681|FG001|Washout|Adverse Event|0|||
37895394|NCT00792298|69580682|FG002|Washout|Adverse Event|0|||
37895395|NCT00792298|69580683|FG003|Washout|Adverse Event|0|||
37895396|NCT00792298|69580684|FG004|Washout|Adverse Event|0|||
37895397|NCT00792298|69580685|FG005|Washout|Adverse Event|1|||
37895398|NCT00792298|69580686|FG006|Washout|Adverse Event|0|||
37895399|NCT00792298|69580687|FG007|Washout|Adverse Event|0|||
37895400|NCT00792298|69580680|FG000|Washout|Withdrawal by Subject|0|||
37895401|NCT00792298|69580681|FG001|Washout|Withdrawal by Subject|0|||
37895402|NCT00792298|69580682|FG002|Washout|Withdrawal by Subject|1|||
37895403|NCT00792298|69580683|FG003|Washout|Withdrawal by Subject|0|||
37895404|NCT00792298|69580684|FG004|Washout|Withdrawal by Subject|0|||
37895405|NCT00792298|69580685|FG005|Washout|Withdrawal by Subject|1|||
37895406|NCT00792298|69580686|FG006|Washout|Withdrawal by Subject|0|||
37895407|NCT00792298|69580687|FG007|Washout|Withdrawal by Subject|0|||
37895408|NCT00792298|69580680|FG000|Treatment Period 2|Lack of Efficacy|0|||
37895409|NCT00792298|69580681|FG001|Treatment Period 2|Lack of Efficacy|0|||
37895410|NCT00792298|69580682|FG002|Treatment Period 2|Lack of Efficacy|0|||
37895411|NCT00792298|69580683|FG003|Treatment Period 2|Lack of Efficacy|0|||
37895412|NCT00792298|69580684|FG004|Treatment Period 2|Lack of Efficacy|1|||
37895413|NCT00792298|69580685|FG005|Treatment Period 2|Lack of Efficacy|0|||
37895414|NCT00792298|69580686|FG006|Treatment Period 2|Lack of Efficacy|0|||
37895415|NCT00792298|69580687|FG007|Treatment Period 2|Lack of Efficacy|0|||
37895416|NCT00792298|69580680|FG000|Treatment Period 2|Physician Decision|0|||
37895417|NCT00792298|69580681|FG001|Treatment Period 2|Physician Decision|0|||
37895418|NCT00792298|69580682|FG002|Treatment Period 2|Physician Decision|0|||
37825081|NCT01050205|69507066|FG000|Overall Study|Lost to Follow-up|7|||
37825082|NCT01050205|69507067|FG001|Overall Study|Lost to Follow-up|1|||
37825083|NCT01050205|69507066|FG000|Overall Study|Withdrawal by Subject|1|||
37825084|NCT01050205|69507067|FG001|Overall Study|Withdrawal by Subject|1|||
37825085|NCT01050205|69507066|FG000|Overall Study|Relocated from area|1|||
37825086|NCT01050205|69507067|FG001|Overall Study|Relocated from area|2|||
37825087|NCT01050205|69507066|FG000|Overall Study|Discontinued Intervention|2|||
37825088|NCT01050205|69507067|FG001|Overall Study|Discontinued Intervention|0|||
37991261|NCT00383786|69676484|FG001|Overall Study|Physician Decision|1|||
37991262|NCT00383708|69676490|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
37991263|NCT00383708|69676490|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
37825089|NCT01059448|69507077|FG000|Overall Study|Adverse Event|1|||
37895419|NCT00792298|69580683|FG003|Treatment Period 2|Physician Decision|0|||
37895420|NCT00792298|69580684|FG004|Treatment Period 2|Physician Decision|0|||
37895421|NCT00792298|69580685|FG005|Treatment Period 2|Physician Decision|0|||
37895422|NCT00792298|69580686|FG006|Treatment Period 2|Physician Decision|1|||
37895423|NCT00792298|69580687|FG007|Treatment Period 2|Physician Decision|0|||
37895424|NCT00792298|69580680|FG000|Treatment Period 2|Pregnancy|0|||
37895425|NCT00792298|69580681|FG001|Treatment Period 2|Pregnancy|0|||
37895426|NCT00792298|69580682|FG002|Treatment Period 2|Pregnancy|1|||
37991264|NCT00383708|69676490|FG000|Run-in Period|Protocol Violation|4|||
37991265|NCT00383708|69676490|FG000|Run-in Period|Adverse Event|2|||
37991266|NCT00383708|69676490|FG000|Run-in Period|Claustrophobia|1|||
37991267|NCT00383708|69676490|FG000|Co-administration Period|Adverse Event|5|||
37991268|NCT00504881|69676497|FG000|Overall Study|Lack of Efficacy|1|||
37991269|NCT00504881|69676498|FG001|Overall Study|Lack of Efficacy|5|||
37991270|NCT00504881|69676497|FG000|Overall Study|Lost to Follow-up|0|||
37991271|NCT00504881|69676498|FG001|Overall Study|Lost to Follow-up|2|||
37991272|NCT00504881|69676497|FG000|Overall Study|Withdrawal by Subject|1|||
37991273|NCT00504881|69676498|FG001|Overall Study|Withdrawal by Subject|4|||
37991274|NCT00504881|69676497|FG000|Overall Study|Non-Compliance|1|||
37991275|NCT00504881|69676498|FG001|Overall Study|Non-Compliance|0|||
37991276|NCT00504881|69676497|FG000|Overall Study|No Birth Control|0|||
37991277|NCT00504881|69676498|FG001|Overall Study|No Birth Control|1|||
37991278|NCT00504881|69676497|FG000|Overall Study|Safety Visit not performed|0|||
37991279|NCT00504881|69676498|FG001|Overall Study|Safety Visit not performed|1|||
37991280|NCT00504881|69676497|FG000|Overall Study|AE, serious fatal|0|||
37991281|NCT00504881|69676498|FG001|Overall Study|AE, serious fatal|1|||
37991282|NCT00504881|69676497|FG000|Overall Study|SAE, non-fatal|2|||
37991283|NCT00504881|69676498|FG001|Overall Study|SAE, non-fatal|6|||
37991284|NCT00504881|69676497|FG000|Overall Study|AE, non-serious non-fatal|4|||
37991285|NCT00504881|69676498|FG001|Overall Study|AE, non-serious non-fatal|14|||
37991286|NCT00504881|69676497|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
37991287|NCT00504881|69676498|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
37991288|NCT00504881|69676497|FG000|Overall Study|AE of unknown type|1|||
37991289|NCT00504881|69676498|FG001|Overall Study|AE of unknown type|0|||
37991290|NCT00504725|69676508|FG000|Overall Study|Protocol Violation|1|||
37991291|NCT00504725|69676509|FG001|Overall Study|Protocol Violation|0|||
37991292|NCT00383240|69676519|FG000|Overall Study|Adverse Event|4|||
37991293|NCT00383240|69676520|FG001|Overall Study|Adverse Event|6|||
37991294|NCT00383240|69676521|FG002|Overall Study|Adverse Event|9|||
37991295|NCT00383240|69676522|FG003|Overall Study|Adverse Event|7|||
37991296|NCT00383240|69676519|FG000|Overall Study|Treatment Failure|8|||
37991297|NCT00383240|69676520|FG001|Overall Study|Treatment Failure|13|||
37991298|NCT00383240|69676521|FG002|Overall Study|Treatment Failure|47|||
37991299|NCT00383240|69676522|FG003|Overall Study|Treatment Failure|46|||
37991300|NCT00383240|69676519|FG000|Overall Study|Lost to Follow-up|3|||
37991301|NCT00383240|69676520|FG001|Overall Study|Lost to Follow-up|0|||
37991302|NCT00383240|69676521|FG002|Overall Study|Lost to Follow-up|0|||
37991303|NCT00383240|69676522|FG003|Overall Study|Lost to Follow-up|2|||
37991304|NCT00383240|69676519|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
37991305|NCT00383240|69676520|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
37991306|NCT00383240|69676521|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
37991307|NCT00383240|69676522|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
37991308|NCT00383240|69676519|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
37991309|NCT00383240|69676520|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
37991310|NCT00383240|69676521|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
37991311|NCT00383240|69676522|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
37895427|NCT00792298|69580683|FG003|Treatment Period 2|Pregnancy|0|||
37895428|NCT00792298|69580684|FG004|Treatment Period 2|Pregnancy|0|||
37895429|NCT00792298|69580685|FG005|Treatment Period 2|Pregnancy|0|||
37895430|NCT00792298|69580686|FG006|Treatment Period 2|Pregnancy|0|||
37895431|NCT00792298|69580687|FG007|Treatment Period 2|Pregnancy|0|||
37895432|NCT00792298|69580680|FG000|Treatment Period 2|Withdrawal by Subject|1|||
37895433|NCT00792298|69580681|FG001|Treatment Period 2|Withdrawal by Subject|1|||
37895434|NCT00792298|69580682|FG002|Treatment Period 2|Withdrawal by Subject|0|||
37895435|NCT00792298|69580683|FG003|Treatment Period 2|Withdrawal by Subject|2|||
37895436|NCT00792298|69580684|FG004|Treatment Period 2|Withdrawal by Subject|1|||
37895437|NCT00792298|69580685|FG005|Treatment Period 2|Withdrawal by Subject|0|||
37895438|NCT00792298|69580686|FG006|Treatment Period 2|Withdrawal by Subject|0|||
37895439|NCT00792298|69580687|FG007|Treatment Period 2|Withdrawal by Subject|2|||
37895440|NCT00718159|69580711|FG000|Overall Study|Progressive Disease|3|||
37895441|NCT00718159|69580712|FG001|Overall Study|Progressive Disease|3|||
37895442|NCT00718159|69580713|FG002|Overall Study|Progressive Disease|2|||
37991312|NCT00383240|69676519|FG000|Overall Study|Protocol Violation|4|||
37991313|NCT00383240|69676520|FG001|Overall Study|Protocol Violation|5|||
37991314|NCT00383240|69676521|FG002|Overall Study|Protocol Violation|9|||
37991315|NCT00383240|69676522|FG003|Overall Study|Protocol Violation|6|||
37991316|NCT00383240|69676519|FG000|Overall Study|Did not meet protocol eligibility|9|||
37991317|NCT00383240|69676520|FG001|Overall Study|Did not meet protocol eligibility|4|||
37895443|NCT00718159|69580714|FG003|Overall Study|Progressive Disease|0|||
37895444|NCT00718159|69580715|FG004|Overall Study|Progressive Disease|6|||
37991318|NCT00383240|69676521|FG002|Overall Study|Did not meet protocol eligibility|9|||
37991319|NCT00383240|69676522|FG003|Overall Study|Did not meet protocol eligibility|3|||
37991320|NCT00383240|69676519|FG000|Overall Study|Administrative|1|||
37991321|NCT00383240|69676520|FG001|Overall Study|Administrative|1|||
37991322|NCT00383240|69676521|FG002|Overall Study|Administrative|0|||
37991323|NCT00383240|69676522|FG003|Overall Study|Administrative|0|||
37991324|NCT00362180|69676542|FG000|Treated Period|Withdrawal by Subject|1|||
37991325|NCT00362180|69676543|FG001|Treated Period|Withdrawal by Subject|0|||
37991326|NCT00362180|69676544|FG002|Treated Period|Withdrawal by Subject|0|||
37991327|NCT00362180|69676545|FG003|Treated Period|Withdrawal by Subject|0|||
37991328|NCT00362180|69676546|FG004|Treated Period|Withdrawal by Subject|0|||
37991329|NCT00362180|69676547|FG005|Treated Period|Withdrawal by Subject|0|||
37991330|NCT00362180|69676548|FG006|Treated Period|Withdrawal by Subject|0|||
37991331|NCT00362180|69676549|FG007|Treated Period|Withdrawal by Subject|0|||
37991332|NCT00362180|69676550|FG008|Treated Period|Withdrawal by Subject|0|||
37991333|NCT00362180|69676542|FG000|Treated Period|Adverse Event|0|||
37991334|NCT00362180|69676543|FG001|Treated Period|Adverse Event|0|||
37991335|NCT00362180|69676544|FG002|Treated Period|Adverse Event|0|||
37991336|NCT00362180|69676545|FG003|Treated Period|Adverse Event|0|||
37991337|NCT00362180|69676546|FG004|Treated Period|Adverse Event|0|||
37991338|NCT00362180|69676547|FG005|Treated Period|Adverse Event|1|||
37991339|NCT00362180|69676548|FG006|Treated Period|Adverse Event|0|||
37991340|NCT00362180|69676549|FG007|Treated Period|Adverse Event|1|||
37991341|NCT00362180|69676550|FG008|Treated Period|Adverse Event|0|||
37991342|NCT00383162|69676568|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
37991343|NCT00383162|69676569|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
37991344|NCT00383162|69676568|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
37991345|NCT00383162|69676569|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
37991346|NCT00383162|69676568|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
37991347|NCT00383162|69676569|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
37991348|NCT00383162|69676568|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
37991349|NCT00383162|69676569|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
37991350|NCT00383162|69676568|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
37991351|NCT00383162|69676569|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
37991352|NCT00383162|69676568|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
37991353|NCT00383162|69676569|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
37991354|NCT00383162|69676568|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
37991355|NCT00383162|69676569|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
37991356|NCT00383162|69676568|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
37991357|NCT00383162|69676569|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
37991358|NCT00383162|69676568|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
37991359|NCT00383162|69676569|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
37991360|NCT00358436|69676577|FG000|Overall Study|Adverse Event|29|||
37991361|NCT00358436|69676578|FG001|Overall Study|Adverse Event|13|||
37991362|NCT00358436|69676577|FG000|Overall Study|Lack of Efficacy|34|||
37991363|NCT00358436|69676578|FG001|Overall Study|Lack of Efficacy|36|||
37991364|NCT00358436|69676577|FG000|Overall Study|Lost to Follow-up|11|||
37991365|NCT00358436|69676578|FG001|Overall Study|Lost to Follow-up|6|||
37991366|NCT00358436|69676577|FG000|Overall Study|Protocol Violation|8|||
37991367|NCT00358436|69676578|FG001|Overall Study|Protocol Violation|3|||
37991368|NCT00358436|69676577|FG000|Overall Study|Withdrawal by Subject|40|||
37991369|NCT00358436|69676578|FG001|Overall Study|Withdrawal by Subject|17|||
37991370|NCT00358436|69676577|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
37991371|NCT00358436|69676578|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
37991372|NCT00358436|69676577|FG000|Overall Study|COPD exacerbation|22|||
37991373|NCT00358436|69676578|FG001|Overall Study|COPD exacerbation|10|||
37991374|NCT00358436|69676577|FG000|Overall Study|Other|6|||
37991375|NCT00358436|69676578|FG001|Overall Study|Other|1|||
37991376|NCT00383084|69676588|FG000|Overall Study|Withdrawal by Subject|12|||
37991377|NCT00383084|69676589|FG001|Overall Study|Withdrawal by Subject|10|||
37991378|NCT00361634|69676595|FG000|Overall Study|Lost to Follow-up|1|||
37991379|NCT00361634|69676595|FG000|Overall Study|Withdrawal by Subject|1|||
37991380|NCT00357968|69676601|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
37991381|NCT00357968|69676602|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
37991382|NCT00357968|69676601|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
37991383|NCT00357968|69676602|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
37991384|NCT00357656|69676625|FG000|Overall Study|Other, No surgery performed|0|||
37991385|NCT00357656|69676626|FG001|Overall Study|Other, No surgery performed|3|||
37991386|NCT00357500|69676644|FG000|Overall Study|Adverse Event|3|||
37991387|NCT00357500|69676644|FG000|Overall Study|Withdrawal by Subject|5|||
37991388|NCT00357500|69676644|FG000|Overall Study|Progressive Disease|65|||
37991389|NCT00357500|69676644|FG000|Overall Study|Not Started Protocol Therapy|4|||
37991390|NCT00357110|69676650|FG000|Overall Study|Early study termination|5|||
37991391|NCT00357110|69676651|FG001|Overall Study|Early study termination|5|||
37991392|NCT00098722|69676660|FG000|Double Blind Phase|Adverse Event|7|||
37991393|NCT00098722|69676661|FG001|Double Blind Phase|Adverse Event|7|||
37991394|NCT00098722|69676662|FG002|Double Blind Phase|Adverse Event|3|||
37991395|NCT00098722|69676663|FG003|Double Blind Phase|Adverse Event|0|||
37991396|NCT00098722|69676664|FG004|Double Blind Phase|Adverse Event|0|||
37991397|NCT00098722|69676665|FG005|Double Blind Phase|Adverse Event|0|||
37991398|NCT00098722|69676666|FG006|Double Blind Phase|Adverse Event|0|||
37991399|NCT00098722|69676660|FG000|Double Blind Phase|Death|2|||
37991400|NCT00098722|69676661|FG001|Double Blind Phase|Death|5|||
37991401|NCT00098722|69676662|FG002|Double Blind Phase|Death|0|||
37991402|NCT00098722|69676663|FG003|Double Blind Phase|Death|0|||
37991403|NCT00098722|69676664|FG004|Double Blind Phase|Death|0|||
37991404|NCT00098722|69676665|FG005|Double Blind Phase|Death|0|||
37991405|NCT00098722|69676666|FG006|Double Blind Phase|Death|0|||
37991406|NCT00098722|69676660|FG000|Double Blind Phase|Lack of Efficacy|21|||
37991407|NCT00098722|69676661|FG001|Double Blind Phase|Lack of Efficacy|23|||
37991408|NCT00098722|69676662|FG002|Double Blind Phase|Lack of Efficacy|15|||
37991409|NCT00098722|69676663|FG003|Double Blind Phase|Lack of Efficacy|0|||
37991410|NCT00098722|69676664|FG004|Double Blind Phase|Lack of Efficacy|0|||
37991411|NCT00098722|69676665|FG005|Double Blind Phase|Lack of Efficacy|0|||
37991412|NCT00098722|69676666|FG006|Double Blind Phase|Lack of Efficacy|0|||
37991413|NCT00098722|69676660|FG000|Double Blind Phase|Participant defaulted|16|||
37991414|NCT00098722|69676661|FG001|Double Blind Phase|Participant defaulted|11|||
37991415|NCT00098722|69676662|FG002|Double Blind Phase|Participant defaulted|9|||
37991416|NCT00098722|69676663|FG003|Double Blind Phase|Participant defaulted|0|||
37991417|NCT00098722|69676664|FG004|Double Blind Phase|Participant defaulted|0|||
37991418|NCT00098722|69676665|FG005|Double Blind Phase|Participant defaulted|0|||
37991419|NCT00098722|69676666|FG006|Double Blind Phase|Participant defaulted|0|||
37991420|NCT00098722|69676660|FG000|Double Blind Phase|Pregnancy|1|||
37991421|NCT00098722|69676661|FG001|Double Blind Phase|Pregnancy|0|||
37991422|NCT00098722|69676662|FG002|Double Blind Phase|Pregnancy|0|||
37991423|NCT00098722|69676663|FG003|Double Blind Phase|Pregnancy|0|||
37991424|NCT00098722|69676664|FG004|Double Blind Phase|Pregnancy|0|||
37991425|NCT00098722|69676665|FG005|Double Blind Phase|Pregnancy|0|||
37991426|NCT00098722|69676666|FG006|Double Blind Phase|Pregnancy|0|||
37991427|NCT00098722|69676660|FG000|Double Blind Phase|Randomized, not treated|4|||
37991428|NCT00098722|69676661|FG001|Double Blind Phase|Randomized, not treated|3|||
37991429|NCT00098722|69676662|FG002|Double Blind Phase|Randomized, not treated|3|||
37991430|NCT00098722|69676663|FG003|Double Blind Phase|Randomized, not treated|0|||
37991431|NCT00098722|69676664|FG004|Double Blind Phase|Randomized, not treated|0|||
37991432|NCT00098722|69676665|FG005|Double Blind Phase|Randomized, not treated|0|||
37991433|NCT00098722|69676666|FG006|Double Blind Phase|Randomized, not treated|0|||
37991434|NCT00098722|69676660|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
37991435|NCT00098722|69676661|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
37991436|NCT00098722|69676662|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
37991437|NCT00098722|69676663|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
37991438|NCT00098722|69676664|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
37991439|NCT00098722|69676665|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
37991440|NCT00098722|69676666|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
37991441|NCT00098722|69676660|FG000|Double Blind Phase|Other|7|||
37991442|NCT00098722|69676661|FG001|Double Blind Phase|Other|8|||
37991443|NCT00098722|69676662|FG002|Double Blind Phase|Other|7|||
37991444|NCT00098722|69676663|FG003|Double Blind Phase|Other|0|||
37991445|NCT00098722|69676664|FG004|Double Blind Phase|Other|0|||
37991446|NCT00098722|69676665|FG005|Double Blind Phase|Other|0|||
37991447|NCT00098722|69676666|FG006|Double Blind Phase|Other|0|||
37991448|NCT00098722|69676660|FG000|Open Label Phase|Adverse Event|0|||
37991449|NCT00098722|69676661|FG001|Open Label Phase|Adverse Event|0|||
37991450|NCT00098722|69676662|FG002|Open Label Phase|Adverse Event|0|||
37991451|NCT00098722|69676663|FG003|Open Label Phase|Adverse Event|5|||
37991452|NCT00098722|69676664|FG004|Open Label Phase|Adverse Event|0|||
37991453|NCT00098722|69676665|FG005|Open Label Phase|Adverse Event|0|||
37991454|NCT00098722|69676666|FG006|Open Label Phase|Adverse Event|0|||
37991455|NCT00098722|69676660|FG000|Open Label Phase|Death|0|||
37991456|NCT00098722|69676661|FG001|Open Label Phase|Death|0|||
37991457|NCT00098722|69676662|FG002|Open Label Phase|Death|0|||
37991458|NCT00098722|69676663|FG003|Open Label Phase|Death|2|||
37991459|NCT00098722|69676664|FG004|Open Label Phase|Death|0|||
37991460|NCT00098722|69676665|FG005|Open Label Phase|Death|0|||
37991461|NCT00098722|69676666|FG006|Open Label Phase|Death|0|||
37991462|NCT00098722|69676660|FG000|Open Label Phase|Lack of Efficacy|0|||
37991463|NCT00098722|69676661|FG001|Open Label Phase|Lack of Efficacy|0|||
37991464|NCT00098722|69676662|FG002|Open Label Phase|Lack of Efficacy|0|||
37991465|NCT00098722|69676663|FG003|Open Label Phase|Lack of Efficacy|8|||
37991466|NCT00098722|69676664|FG004|Open Label Phase|Lack of Efficacy|0|||
37991467|NCT00098722|69676665|FG005|Open Label Phase|Lack of Efficacy|0|||
37991468|NCT00098722|69676666|FG006|Open Label Phase|Lack of Efficacy|0|||
37991469|NCT00098722|69676660|FG000|Open Label Phase|Pregnancy|0|||
37991470|NCT00098722|69676661|FG001|Open Label Phase|Pregnancy|0|||
37991471|NCT00098722|69676662|FG002|Open Label Phase|Pregnancy|0|||
37991472|NCT00098722|69676663|FG003|Open Label Phase|Pregnancy|1|||
37991473|NCT00098722|69676664|FG004|Open Label Phase|Pregnancy|0|||
37991474|NCT00098722|69676665|FG005|Open Label Phase|Pregnancy|0|||
37991475|NCT00098722|69676666|FG006|Open Label Phase|Pregnancy|0|||
37991476|NCT00098722|69676660|FG000|Open Label Phase|Participant defaulted|0|||
37991477|NCT00098722|69676661|FG001|Open Label Phase|Participant defaulted|0|||
37991478|NCT00098722|69676662|FG002|Open Label Phase|Participant defaulted|0|||
37991479|NCT00098722|69676663|FG003|Open Label Phase|Participant defaulted|18|||
37991480|NCT00098722|69676664|FG004|Open Label Phase|Participant defaulted|0|||
37895445|NCT00718159|69580716|FG005|Overall Study|Progressive Disease|0|||
37895446|NCT00718159|69580717|FG006|Overall Study|Progressive Disease|0|||
37895447|NCT00718159|69580711|FG000|Overall Study|Death due to Adverse Event|0|||
37991481|NCT00098722|69676665|FG005|Open Label Phase|Participant defaulted|0|||
37991482|NCT00098722|69676666|FG006|Open Label Phase|Participant defaulted|0|||
37991483|NCT00098722|69676660|FG000|Open Label Phase|Ongoing at cut-off date|0|||
37991484|NCT00098722|69676661|FG001|Open Label Phase|Ongoing at cut-off date|0|||
37991485|NCT00098722|69676662|FG002|Open Label Phase|Ongoing at cut-off date|0|||
37991486|NCT00098722|69676663|FG003|Open Label Phase|Ongoing at cut-off date|220|||
37991487|NCT00098722|69676664|FG004|Open Label Phase|Ongoing at cut-off date|50|||
37991488|NCT00098722|69676665|FG005|Open Label Phase|Ongoing at cut-off date|0|||
37991489|NCT00098722|69676666|FG006|Open Label Phase|Ongoing at cut-off date|0|||
37991490|NCT00098722|69676660|FG000|Open Label Phase|Other|0|||
37991491|NCT00098722|69676661|FG001|Open Label Phase|Other|0|||
37991492|NCT00098722|69676662|FG002|Open Label Phase|Other|0|||
37991493|NCT00098722|69676663|FG003|Open Label Phase|Other|18|||
37991494|NCT00098722|69676664|FG004|Open Label Phase|Other|0|||
37825090|NCT01059448|69507078|FG001|Overall Study|Adverse Event|3|||
37825091|NCT01059448|69507079|FG002|Overall Study|Adverse Event|0|||
37825092|NCT01059448|69507080|FG003|Overall Study|Adverse Event|1|||
37825093|NCT01059448|69507077|FG000|Overall Study|Withdrawal by Subject|2|||
37825094|NCT01059448|69507078|FG001|Overall Study|Withdrawal by Subject|0|||
37825095|NCT01059448|69507079|FG002|Overall Study|Withdrawal by Subject|2|||
37825096|NCT01059448|69507080|FG003|Overall Study|Withdrawal by Subject|4|||
37825097|NCT01059448|69507077|FG000|Overall Study|Disease Progression|2|||
37825098|NCT01059448|69507078|FG001|Overall Study|Disease Progression|1|||
37825099|NCT01059448|69507079|FG002|Overall Study|Disease Progression|4|||
37825100|NCT01059448|69507080|FG003|Overall Study|Disease Progression|2|||
37895448|NCT00718159|69580712|FG001|Overall Study|Death due to Adverse Event|0|||
37895449|NCT00718159|69580713|FG002|Overall Study|Death due to Adverse Event|0|||
37895450|NCT00718159|69580714|FG003|Overall Study|Death due to Adverse Event|2|||
37895451|NCT00718159|69580715|FG004|Overall Study|Death due to Adverse Event|2|||
37895452|NCT00718159|69580716|FG005|Overall Study|Death due to Adverse Event|0|||
37895453|NCT00718159|69580717|FG006|Overall Study|Death due to Adverse Event|0|||
37895454|NCT00718159|69580711|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
37895455|NCT00718159|69580712|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
37895456|NCT00718159|69580713|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
37895457|NCT00718159|69580714|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
37895458|NCT00718159|69580715|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
37895459|NCT00718159|69580716|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
37895460|NCT00718159|69580717|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
37895461|NCT00718159|69580711|FG000|Overall Study|Investigator Decision|0|||
37895462|NCT00718159|69580712|FG001|Overall Study|Investigator Decision|0|||
37895463|NCT00718159|69580713|FG002|Overall Study|Investigator Decision|0|||
37895464|NCT00718159|69580714|FG003|Overall Study|Investigator Decision|0|||
37895465|NCT00718159|69580715|FG004|Overall Study|Investigator Decision|0|||
37895466|NCT00718159|69580716|FG005|Overall Study|Investigator Decision|1|||
37895467|NCT00718159|69580717|FG006|Overall Study|Investigator Decision|1|||
37895468|NCT00718081|69580736|FG000|Overall Study|Adverse Event|0|||
37895469|NCT00718081|69580737|FG001|Overall Study|Adverse Event|1|||
37895470|NCT00718081|69580738|FG002|Overall Study|Adverse Event|0|||
37895471|NCT00718081|69580736|FG000|Overall Study|Lack of Efficacy|7|||
37895472|NCT00718081|69580737|FG001|Overall Study|Lack of Efficacy|3|||
37895473|NCT00718081|69580738|FG002|Overall Study|Lack of Efficacy|21|||
37825101|NCT01059448|69507077|FG000|Overall Study|Administrative Decision|43|||
37825102|NCT01059448|69507078|FG001|Overall Study|Administrative Decision|49|||
37895474|NCT00788710|69580749|FG000|Overall Study|Adverse Event|1|||
37895475|NCT00788710|69580750|FG001|Overall Study|Adverse Event|3|||
37991495|NCT00098722|69676665|FG005|Open Label Phase|Other|0|||
37991496|NCT00098722|69676666|FG006|Open Label Phase|Other|0|||
37991497|NCT00098722|69676660|FG000|Observation Phase|Death|0|||
37825103|NCT01059448|69507079|FG002|Overall Study|Administrative Decision|45|||
37895476|NCT00788710|69580751|FG002|Overall Study|Adverse Event|4|||
37991498|NCT00098722|69676661|FG001|Observation Phase|Death|0|||
37991499|NCT00098722|69676662|FG002|Observation Phase|Death|0|||
37991500|NCT00098722|69676663|FG003|Observation Phase|Death|0|||
37991501|NCT00098722|69676664|FG004|Observation Phase|Death|0|||
37991502|NCT00098722|69676665|FG005|Observation Phase|Death|5|||
37991503|NCT00098722|69676666|FG006|Observation Phase|Death|3|||
37991504|NCT00098722|69676660|FG000|Observation Phase|Lack of Efficacy|0|||
37991505|NCT00098722|69676661|FG001|Observation Phase|Lack of Efficacy|0|||
37991506|NCT00098722|69676662|FG002|Observation Phase|Lack of Efficacy|0|||
37991507|NCT00098722|69676663|FG003|Observation Phase|Lack of Efficacy|0|||
37991508|NCT00098722|69676664|FG004|Observation Phase|Lack of Efficacy|0|||
37991509|NCT00098722|69676665|FG005|Observation Phase|Lack of Efficacy|2|||
37991510|NCT00098722|69676666|FG006|Observation Phase|Lack of Efficacy|0|||
37991511|NCT00098722|69676660|FG000|Observation Phase|Participant defaulted|0|||
37991512|NCT00098722|69676661|FG001|Observation Phase|Participant defaulted|0|||
37991513|NCT00098722|69676662|FG002|Observation Phase|Participant defaulted|0|||
37991514|NCT00098722|69676663|FG003|Observation Phase|Participant defaulted|0|||
37991515|NCT00098722|69676664|FG004|Observation Phase|Participant defaulted|0|||
37991516|NCT00098722|69676665|FG005|Observation Phase|Participant defaulted|17|||
37991517|NCT00098722|69676666|FG006|Observation Phase|Participant defaulted|4|||
37991518|NCT00098722|69676660|FG000|Observation Phase|Other|0|||
37991519|NCT00098722|69676661|FG001|Observation Phase|Other|0|||
37991520|NCT00098722|69676662|FG002|Observation Phase|Other|0|||
37895477|NCT00788710|69580749|FG000|Overall Study|Lack of Efficacy|0|||
37895478|NCT00788710|69580750|FG001|Overall Study|Lack of Efficacy|0|||
37991521|NCT00098722|69676663|FG003|Observation Phase|Other|0|||
37991522|NCT00098722|69676664|FG004|Observation Phase|Other|0|||
37991523|NCT00098722|69676665|FG005|Observation Phase|Other|21|||
37991524|NCT00098722|69676666|FG006|Observation Phase|Other|10|||
37991525|NCT00098254|69676678|FG000|Overall Study|Adverse Event|2|||
37991526|NCT00098254|69676678|FG000|Overall Study|Death|1|||
37991527|NCT00095056|69676684|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
37895479|NCT00788710|69580751|FG002|Overall Study|Lack of Efficacy|1|||
37895480|NCT00788710|69580749|FG000|Overall Study|Lost to Follow-up|0|||
37895481|NCT00788710|69580750|FG001|Overall Study|Lost to Follow-up|1|||
37895482|NCT00788710|69580751|FG002|Overall Study|Lost to Follow-up|0|||
37991528|NCT00095056|69676685|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
37991529|NCT00095056|69676684|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
37991530|NCT00095056|69676685|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
37991531|NCT00095056|69676684|FG000|Phase A (Weeks 0-12)|Death|1|||
37991532|NCT00095056|69676685|FG001|Phase A (Weeks 0-12)|Death|0|||
37991533|NCT00095056|69676684|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
37991534|NCT00095056|69676685|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
37825104|NCT01059448|69507080|FG003|Overall Study|Administrative Decision|46|||
37825105|NCT01059448|69507077|FG000|Overall Study|Lost to Follow-up|0|||
37825106|NCT01059448|69507078|FG001|Overall Study|Lost to Follow-up|0|||
37825107|NCT01059448|69507079|FG002|Overall Study|Lost to Follow-up|2|||
37825108|NCT01059448|69507080|FG003|Overall Study|Lost to Follow-up|0|||
37825109|NCT01059448|69507077|FG000|Overall Study|Death|0|||
37991535|NCT00095056|69676684|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
37991536|NCT00095056|69676685|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
37991537|NCT00095056|69676684|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
37991538|NCT00095056|69676685|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
37895483|NCT00788710|69580749|FG000|Overall Study|Physician Decision|2|||
37895484|NCT00788710|69580750|FG001|Overall Study|Physician Decision|1|||
37895485|NCT00788710|69580751|FG002|Overall Study|Physician Decision|0|||
37895486|NCT00788710|69580749|FG000|Overall Study|Protocol Violation|0|||
37895487|NCT00788710|69580750|FG001|Overall Study|Protocol Violation|1|||
37895488|NCT00788710|69580751|FG002|Overall Study|Protocol Violation|1|||
37895489|NCT00788710|69580749|FG000|Overall Study|Withdrawal by Subject|2|||
37895490|NCT00788710|69580750|FG001|Overall Study|Withdrawal by Subject|2|||
37895491|NCT00788710|69580751|FG002|Overall Study|Withdrawal by Subject|0|||
37895492|NCT00787930|69580759|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
37991539|NCT00095056|69676684|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
37991540|NCT00095056|69676685|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
37991541|NCT00095056|69676684|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
37991542|NCT00095056|69676685|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
37991543|NCT00095056|69676684|FG000|Phase B (Weeks 12-54)|Death|3|||
37991544|NCT00095056|69676685|FG001|Phase B (Weeks 12-54)|Death|1|||
37991545|NCT00095056|69676684|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
37991546|NCT00095056|69676685|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
37895493|NCT00588094|69580769|FG000|Overall Study|Adverse Event|3|||
37895494|NCT00588094|69580769|FG000|Overall Study|Progression of Disease|2|||
37991547|NCT00095056|69676684|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
37825110|NCT01059448|69507078|FG001|Overall Study|Death|1|||
37895495|NCT03373383|69580778|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
38043866|NCT02048813|69731901|FG001|Overall Study|Insurance|0|||
38043867|NCT02048813|69731900|FG000|Overall Study|Wound infection/healing|2|||
37825111|NCT01059448|69507079|FG002|Overall Study|Death|0|||
37825112|NCT01059448|69507080|FG003|Overall Study|Death|0|||
37991548|NCT00095056|69676685|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
37991549|NCT00098020|69676691|FG000|Overall Study|Adverse Event|2|||
37991550|NCT00098020|69676691|FG000|Overall Study|Lost to Follow-up|1|||
37991551|NCT00098020|69676691|FG000|Overall Study|elevated liver enzymes|1|||
37991552|NCT00098020|69676691|FG000|Overall Study|Low urine PCR|1|||
37991553|NCT00098020|69676691|FG000|Overall Study|Low epidermal growth factor receptor|1|||
37991554|NCT00381680|69676697|FG000|Overall Study|Adverse Event|9|||
37991555|NCT00381680|69676698|FG001|Overall Study|Adverse Event|3|||
37991556|NCT00381680|69676697|FG000|Overall Study|Death|10|||
37991557|NCT00381680|69676698|FG001|Overall Study|Death|7|||
37991558|NCT00381680|69676697|FG000|Overall Study|Lost to Follow-up|3|||
37991559|NCT00381680|69676698|FG001|Overall Study|Lost to Follow-up|2|||
37991560|NCT00381680|69676697|FG000|Overall Study|Physician Decision|25|||
37991561|NCT00381680|69676698|FG001|Overall Study|Physician Decision|6|||
37991562|NCT00381680|69676697|FG000|Overall Study|Withdrawal by Subject|3|||
37991563|NCT00381680|69676698|FG001|Overall Study|Withdrawal by Subject|1|||
37991564|NCT00381680|69676697|FG000|Overall Study|Entry onto another COG Trial|1|||
37991565|NCT00381680|69676698|FG001|Overall Study|Entry onto another COG Trial|2|||
37991566|NCT00381680|69676697|FG000|Overall Study|Alternative Therapy|11|||
37991567|NCT00381680|69676698|FG001|Overall Study|Alternative Therapy|5|||
37991568|NCT00381680|69676697|FG000|Overall Study|Secondary Malignancy|3|||
37991569|NCT00381680|69676698|FG001|Overall Study|Secondary Malignancy|0|||
37991570|NCT00381680|69676697|FG000|Overall Study|Delay initiation|1|||
37991571|NCT00381680|69676698|FG001|Overall Study|Delay initiation|0|||
37991572|NCT00381680|69676697|FG000|Overall Study|Stem Cell Transplant|26|||
37991573|NCT00381680|69676698|FG001|Overall Study|Stem Cell Transplant|10|||
37991574|NCT00381680|69676697|FG000|Overall Study|Relapse|18|||
37991575|NCT00381680|69676698|FG001|Overall Study|Relapse|9|||
37991576|NCT00381680|69676697|FG000|Overall Study|Induction Failure|4|||
37991577|NCT00381680|69676698|FG001|Overall Study|Induction Failure|1|||
37991578|NCT00381680|69676697|FG000|Overall Study|Progression|1|||
37991579|NCT00381680|69676698|FG001|Overall Study|Progression|1|||
37991580|NCT00381680|69676697|FG000|Overall Study|Other not otherwise specified|7|||
37991581|NCT00381680|69676698|FG001|Overall Study|Other not otherwise specified|2|||
37991582|NCT00381680|69676697|FG000|Overall Study|Ineligible|3|||
37991583|NCT00381680|69676698|FG001|Overall Study|Ineligible|1|||
37991584|NCT00360698|69676710|FG000|Run-In|Physician Decision|0|||
37991585|NCT00360698|69676711|FG001|Run-In|Physician Decision|1|||
37991586|NCT00360698|69676710|FG000|Run-In|Withdrawal by Subject|0|||
37991587|NCT00360698|69676711|FG001|Run-In|Withdrawal by Subject|2|||
37991588|NCT00360698|69676710|FG000|Run-In|Non compliance with treatment procedure|0|||
37991589|NCT00360698|69676711|FG001|Run-In|Non compliance with treatment procedure|1|||
37991590|NCT00360698|69676710|FG000|Run-In|Sponsor request|0|||
37991591|NCT00360698|69676711|FG001|Run-In|Sponsor request|2|||
37991592|NCT00360698|69676710|FG000|Run-In|Patient did not meet inclusion criteria|0|||
37991593|NCT00360698|69676711|FG001|Run-In|Patient did not meet inclusion criteria|1|||
37991594|NCT00360698|69676710|FG000|Run-In|Patient personal reasons|0|||
37991595|NCT00360698|69676711|FG001|Run-In|Patient personal reasons|2|||
37991596|NCT00360698|69676710|FG000|Run-In|Need of insulin with meals|0|||
37991597|NCT00360698|69676711|FG001|Run-In|Need of insulin with meals|1|||
37991598|NCT00360698|69676710|FG000|Treatment Period|Non compliance with treatment procedure|1|||
37991599|NCT00360698|69676711|FG001|Treatment Period|Non compliance with treatment procedure|0|||
37991600|NCT00360698|69676710|FG000|Treatment Period|Early termination by error|0|||
37991601|NCT00360698|69676711|FG001|Treatment Period|Early termination by error|1|||
37991602|NCT00380978|69676719|FG000|Overall Study|Refused allocated intervention|0|||
37991603|NCT00380978|69676720|FG001|Overall Study|Refused allocated intervention|6|||
37991604|NCT00380978|69676719|FG000|Overall Study|Wrong study envelope|0|||
37991605|NCT00380978|69676720|FG001|Overall Study|Wrong study envelope|2|||
37991606|NCT00380978|69676719|FG000|Overall Study|Allocation prior to analgesia request|1|||
37991607|NCT00380978|69676720|FG001|Overall Study|Allocation prior to analgesia request|2|||
37991608|NCT00380978|69676719|FG000|Overall Study|Parous patient|1|||
37991609|NCT00380978|69676720|FG001|Overall Study|Parous patient|0|||
37991610|NCT00162123|69676734|FG000|Overall Study|Disease progression|27|||
37825113|NCT01059448|69507077|FG000|Overall Study|Other|1|||
37825114|NCT01059448|69507078|FG001|Overall Study|Other|1|||
37825115|NCT01059448|69507079|FG002|Overall Study|Other|0|||
37825116|NCT01059448|69507080|FG003|Overall Study|Other|1|||
37825117|NCT01058707|69507101|FG000|Overall Study|Disease Progression|15|||
37825118|NCT01058707|69507102|FG001|Overall Study|Disease Progression|20|||
37825119|NCT01058707|69507103|FG002|Overall Study|Disease Progression|20|||
37991611|NCT00162123|69676735|FG001|Overall Study|Disease progression|19|||
37991612|NCT00162123|69676736|FG002|Overall Study|Disease progression|10|||
37991613|NCT00162123|69676737|FG003|Overall Study|Disease progression|4|||
37991614|NCT00162123|69676738|FG004|Overall Study|Disease progression|8|||
37991615|NCT00162123|69676739|FG005|Overall Study|Disease progression|3|||
37991616|NCT00162123|69676740|FG006|Overall Study|Disease progression|1|||
37991617|NCT00162123|69676741|FG007|Overall Study|Disease progression|0|||
37991618|NCT00162123|69676734|FG000|Overall Study|Study drug toxicity|6|||
37991619|NCT00162123|69676735|FG001|Overall Study|Study drug toxicity|1|||
37991620|NCT00162123|69676736|FG002|Overall Study|Study drug toxicity|5|||
37991621|NCT00162123|69676737|FG003|Overall Study|Study drug toxicity|0|||
37991622|NCT00162123|69676738|FG004|Overall Study|Study drug toxicity|4|||
37991623|NCT00162123|69676739|FG005|Overall Study|Study drug toxicity|1|||
37991624|NCT00162123|69676740|FG006|Overall Study|Study drug toxicity|1|||
37991625|NCT00162123|69676741|FG007|Overall Study|Study drug toxicity|0|||
37991626|NCT00162123|69676734|FG000|Overall Study|Death|3|||
37991627|NCT00162123|69676735|FG001|Overall Study|Death|3|||
37991628|NCT00162123|69676736|FG002|Overall Study|Death|1|||
37991629|NCT00162123|69676737|FG003|Overall Study|Death|1|||
37991630|NCT00162123|69676738|FG004|Overall Study|Death|1|||
37991631|NCT00162123|69676739|FG005|Overall Study|Death|1|||
37991632|NCT00162123|69676740|FG006|Overall Study|Death|0|||
37991633|NCT00162123|69676741|FG007|Overall Study|Death|0|||
37991634|NCT00162123|69676734|FG000|Overall Study|Withdrawal by Subject|2|||
37991635|NCT00162123|69676735|FG001|Overall Study|Withdrawal by Subject|0|||
37991636|NCT00162123|69676736|FG002|Overall Study|Withdrawal by Subject|2|||
37991637|NCT00162123|69676737|FG003|Overall Study|Withdrawal by Subject|1|||
37991638|NCT00162123|69676738|FG004|Overall Study|Withdrawal by Subject|1|||
37991639|NCT00162123|69676739|FG005|Overall Study|Withdrawal by Subject|2|||
37991640|NCT00162123|69676740|FG006|Overall Study|Withdrawal by Subject|1|||
37991641|NCT00162123|69676741|FG007|Overall Study|Withdrawal by Subject|0|||
37991642|NCT00162123|69676734|FG000|Overall Study|Deterioration without progression|2|||
37991643|NCT00162123|69676735|FG001|Overall Study|Deterioration without progression|2|||
37991644|NCT00162123|69676736|FG002|Overall Study|Deterioration without progression|3|||
37991645|NCT00162123|69676737|FG003|Overall Study|Deterioration without progression|0|||
37991646|NCT00162123|69676738|FG004|Overall Study|Deterioration without progression|1|||
37991647|NCT00162123|69676739|FG005|Overall Study|Deterioration without progression|0|||
37991648|NCT00162123|69676740|FG006|Overall Study|Deterioration without progression|0|||
37991649|NCT00162123|69676741|FG007|Overall Study|Deterioration without progression|0|||
37991650|NCT00162123|69676734|FG000|Overall Study|Adverse Event|1|||
37991651|NCT00162123|69676735|FG001|Overall Study|Adverse Event|2|||
37991652|NCT00162123|69676736|FG002|Overall Study|Adverse Event|0|||
37895496|NCT03373383|69580779|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
37895497|NCT03373383|69580780|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
37895498|NCT03373383|69580781|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
37895499|NCT03373383|69580782|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
37895500|NCT03373383|69580778|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
37895501|NCT03373383|69580779|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
37895502|NCT03373383|69580780|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
37895503|NCT03373383|69580781|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
37895504|NCT03373383|69580782|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
37895505|NCT03373383|69580778|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
37895506|NCT03373383|69580779|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
37895507|NCT03373383|69580780|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
37895508|NCT03373383|69580781|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
37895509|NCT03373383|69580782|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
37895510|NCT03373383|69580778|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
37895511|NCT03373383|69580779|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
37895512|NCT03373383|69580780|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
37895513|NCT03373383|69580781|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
37895514|NCT03373383|69580782|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
37895515|NCT03373383|69580778|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
37895516|NCT03373383|69580779|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
37895517|NCT03373383|69580780|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
37895518|NCT03373383|69580781|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
37895519|NCT03373383|69580782|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
37895520|NCT03373383|69580778|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
37991653|NCT00162123|69676737|FG003|Overall Study|Adverse Event|2|||
37991654|NCT00162123|69676738|FG004|Overall Study|Adverse Event|1|||
37991655|NCT00162123|69676739|FG005|Overall Study|Adverse Event|0|||
37991656|NCT00162123|69676740|FG006|Overall Study|Adverse Event|0|||
37991657|NCT00162123|69676741|FG007|Overall Study|Adverse Event|0|||
37895521|NCT03373383|69580779|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
37895522|NCT03373383|69580780|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
37991658|NCT00162123|69676734|FG000|Overall Study|Not specified (before treatment)|2|||
37991659|NCT00162123|69676735|FG001|Overall Study|Not specified (before treatment)|0|||
37991660|NCT00162123|69676736|FG002|Overall Study|Not specified (before treatment)|0|||
37991661|NCT00162123|69676737|FG003|Overall Study|Not specified (before treatment)|0|||
37991662|NCT00162123|69676738|FG004|Overall Study|Not specified (before treatment)|12|||
37991663|NCT00162123|69676739|FG005|Overall Study|Not specified (before treatment)|1|||
37895523|NCT03373383|69580781|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
37895524|NCT03373383|69580782|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
37895525|NCT03373383|69580778|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
37895526|NCT03373383|69580779|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
37895527|NCT03373383|69580780|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
37895528|NCT03373383|69580781|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
37895529|NCT03373383|69580782|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
37895530|NCT03373383|69580778|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
37895531|NCT03373383|69580779|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
37895532|NCT03373383|69580780|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
37895533|NCT03373383|69580781|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
37895534|NCT03373383|69580782|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
37895535|NCT03373383|69580778|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
37895536|NCT03373383|69580779|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
37895537|NCT03373383|69580780|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
37895538|NCT03373383|69580781|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
37895539|NCT03373383|69580782|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
37895540|NCT00784654|69580809|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
37895541|NCT00784654|69580810|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
37895542|NCT00784654|69580811|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
37895543|NCT00784654|69580809|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
37895544|NCT00784654|69580810|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
37895545|NCT00784654|69580811|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
37895546|NCT00784654|69580809|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
37895547|NCT00784654|69580810|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
37895548|NCT00784654|69580811|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
37895549|NCT00784654|69580809|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
37895550|NCT00784654|69580810|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
37895551|NCT00784654|69580811|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
37895552|NCT00784654|69580809|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
37895553|NCT00784654|69580810|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
37895554|NCT00784654|69580811|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
37895555|NCT00784654|69580809|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
37895556|NCT00784654|69580810|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
37895557|NCT00784654|69580811|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
37895558|NCT00784654|69580809|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
37895559|NCT00784654|69580810|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
37895560|NCT00784654|69580811|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
37895561|NCT00784654|69580809|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
37895562|NCT00784654|69580810|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
37895563|NCT00784654|69580811|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
37895564|NCT00784654|69580809|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
37895565|NCT00784654|69580810|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
37895566|NCT00784654|69580811|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
37895567|NCT00784654|69580809|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
37895568|NCT00784654|69580810|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
37895569|NCT00784654|69580811|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
37825120|NCT01058707|69507104|FG003|Overall Study|Disease Progression|15|||
37825121|NCT01058707|69507105|FG004|Overall Study|Disease Progression|23|||
37825122|NCT01058707|69507106|FG005|Overall Study|Disease Progression|10|||
37825123|NCT01058707|69507107|FG006|Overall Study|Disease Progression|12|||
37825124|NCT01058707|69507101|FG000|Overall Study|Adverse Event|11|||
37825125|NCT01058707|69507102|FG001|Overall Study|Adverse Event|4|||
37825126|NCT01058707|69507103|FG002|Overall Study|Adverse Event|7|||
37825127|NCT01058707|69507104|FG003|Overall Study|Adverse Event|6|||
37825128|NCT01058707|69507105|FG004|Overall Study|Adverse Event|7|||
37825129|NCT01058707|69507106|FG005|Overall Study|Adverse Event|3|||
37895570|NCT00784654|69580809|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
37895571|NCT00784654|69580810|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
37895572|NCT00784654|69580811|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
37895573|NCT00784654|69580809|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
37895574|NCT00784654|69580810|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
37825130|NCT01058707|69507107|FG006|Overall Study|Adverse Event|1|||
37825131|NCT01058707|69507101|FG000|Overall Study|Subject Decision|5|||
37895575|NCT00784654|69580811|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
37895576|NCT00784654|69580809|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
37895577|NCT00784654|69580810|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
37991664|NCT00162123|69676740|FG006|Overall Study|Not specified (before treatment)|0|||
37991665|NCT00162123|69676741|FG007|Overall Study|Not specified (before treatment)|0|||
37991666|NCT00162123|69676734|FG000|Overall Study|Not specified (after start of treatment)|0|||
37991667|NCT00162123|69676735|FG001|Overall Study|Not specified (after start of treatment)|0|||
37991668|NCT00162123|69676736|FG002|Overall Study|Not specified (after start of treatment)|0|||
37991669|NCT00162123|69676737|FG003|Overall Study|Not specified (after start of treatment)|0|||
37991670|NCT00162123|69676738|FG004|Overall Study|Not specified (after start of treatment)|3|||
37991671|NCT00162123|69676739|FG005|Overall Study|Not specified (after start of treatment)|0|||
37991672|NCT00162123|69676740|FG006|Overall Study|Not specified (after start of treatment)|0|||
37991673|NCT00162123|69676741|FG007|Overall Study|Not specified (after start of treatment)|0|||
37991674|NCT00162123|69676734|FG000|Overall Study|Physician Decision|1|||
37991675|NCT00162123|69676735|FG001|Overall Study|Physician Decision|2|||
37991676|NCT00162123|69676736|FG002|Overall Study|Physician Decision|0|||
37991677|NCT00162123|69676737|FG003|Overall Study|Physician Decision|0|||
37991678|NCT00162123|69676738|FG004|Overall Study|Physician Decision|0|||
37991679|NCT00162123|69676739|FG005|Overall Study|Physician Decision|1|||
37991680|NCT00162123|69676740|FG006|Overall Study|Physician Decision|1|||
37895578|NCT00784654|69580811|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
37895579|NCT00784654|69580809|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
37895580|NCT00784654|69580810|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
37895581|NCT00784654|69580811|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
37895582|NCT00784654|69580809|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
37895583|NCT00784654|69580810|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
37895584|NCT00784654|69580811|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
37895585|NCT00784654|69580809|FG000|Randomized Withdrawal Period|Adverse Event|0|||
37895586|NCT00784654|69580810|FG001|Randomized Withdrawal Period|Adverse Event|1|||
37895587|NCT00784654|69580811|FG002|Randomized Withdrawal Period|Adverse Event|1|||
37895588|NCT00784654|69580809|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
37895589|NCT00784654|69580810|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
37895590|NCT00784654|69580811|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
37895591|NCT00784654|69580809|FG000|Randomized Withdrawal Period|Family reasons|0|||
37895592|NCT00784654|69580810|FG001|Randomized Withdrawal Period|Family reasons|0|||
37895593|NCT00784654|69580811|FG002|Randomized Withdrawal Period|Family reasons|1|||
37895594|NCT00787150|69580825|FG000|Overall Study|Adverse Event|4|||
37895595|NCT00787150|69580826|FG001|Overall Study|Adverse Event|4|||
37895596|NCT00787150|69580827|FG002|Overall Study|Adverse Event|4|||
37895597|NCT00787150|69580825|FG000|Overall Study|Physician Decision|1|||
37895598|NCT00787150|69580826|FG001|Overall Study|Physician Decision|2|||
37895599|NCT00787150|69580827|FG002|Overall Study|Physician Decision|1|||
37895600|NCT00787150|69580825|FG000|Overall Study|Withdrawal by Subject|2|||
37895601|NCT00787150|69580826|FG001|Overall Study|Withdrawal by Subject|1|||
37895602|NCT00787150|69580827|FG002|Overall Study|Withdrawal by Subject|0|||
37895603|NCT00787150|69580825|FG000|Overall Study|Dosing incorrect study durg|2|||
37895604|NCT00787150|69580826|FG001|Overall Study|Dosing incorrect study durg|0|||
37895605|NCT00787150|69580827|FG002|Overall Study|Dosing incorrect study durg|0|||
37895606|NCT00786838|69580837|FG000|Overall Study|Physician Decision|4|||
37895607|NCT00786838|69580837|FG000|Overall Study|Death|4|||
37895608|NCT00786838|69580837|FG000|Overall Study|Adverse Event|6|||
37895609|NCT00786838|69580837|FG000|Overall Study|Progressive disease|31|||
37895610|NCT00786838|69580837|FG000|Overall Study|Withdrawal by Subject|4|||
37895611|NCT00785980|69580846|FG000|7 Day Washout Period|Protocol Violation|3|||
37895612|NCT00791518|69580853|FG000|Overall Study|Protocol Violation|93|||
37895613|NCT00785512|69580874|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
37895614|NCT00785512|69580875|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
37895615|NCT00785512|69580874|FG000|Overall Study|Adverse Event|0|||
37895616|NCT00785512|69580875|FG001|Overall Study|Adverse Event|0|||
37895617|NCT00785512|69580874|FG000|Overall Study|Lack of Efficacy|0|||
37895618|NCT00785512|69580875|FG001|Overall Study|Lack of Efficacy|2|||
37895619|NCT00785512|69580874|FG000|Overall Study|Withdrawal by Subject|0|||
37895620|NCT00785512|69580875|FG001|Overall Study|Withdrawal by Subject|1|||
37895621|NCT00785512|69580874|FG000|Overall Study|Lost to Follow-up|3|||
37895622|NCT00785512|69580875|FG001|Overall Study|Lost to Follow-up|0|||
37991681|NCT00162123|69676741|FG007|Overall Study|Physician Decision|0|||
37991682|NCT00162123|69676734|FG000|Overall Study|Tumor assessment only (not treated)|0|||
37895623|NCT00785512|69580874|FG000|Overall Study|Precedure Refused|0|||
37895624|NCT00785512|69580875|FG001|Overall Study|Precedure Refused|0|||
37895625|NCT00785512|69580874|FG000|Overall Study|IVRS Programing Error|0|||
37895626|NCT00785512|69580875|FG001|Overall Study|IVRS Programing Error|0|||
37895627|NCT00785512|69580874|FG000|Overall Study|Physician Decision|0|||
37895628|NCT00785512|69580875|FG001|Overall Study|Physician Decision|0|||
37991683|NCT00162123|69676735|FG001|Overall Study|Tumor assessment only (not treated)|0|||
37895629|NCT00785512|69580874|FG000|Overall Study|Lack of compliance|0|||
37895630|NCT00785512|69580875|FG001|Overall Study|Lack of compliance|1|||
37895631|NCT00785356|69580885|FG000|Overall Study|Study prematurely terminated|8|||
37991684|NCT00162123|69676736|FG002|Overall Study|Tumor assessment only (not treated)|0|||
37991685|NCT00162123|69676737|FG003|Overall Study|Tumor assessment only (not treated)|0|||
37991686|NCT00162123|69676738|FG004|Overall Study|Tumor assessment only (not treated)|0|||
37991687|NCT00162123|69676739|FG005|Overall Study|Tumor assessment only (not treated)|0|||
37991688|NCT00162123|69676740|FG006|Overall Study|Tumor assessment only (not treated)|0|||
37991689|NCT00162123|69676741|FG007|Overall Study|Tumor assessment only (not treated)|1|||
37991690|NCT00162123|69676734|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
37991691|NCT00162123|69676735|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
37991692|NCT00162123|69676736|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
37991693|NCT00162123|69676737|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
37895632|NCT00785044|69580893|FG000|Overall Study|Dosed at non-participating sites|152|||
37895633|NCT00785044|69580893|FG000|Overall Study|Death|77|||
37895634|NCT00785044|69580893|FG000|Overall Study|Lost to Follow-up|266|||
37895635|NCT00785044|69580893|FG000|Overall Study|Withdrawal by Subject|1|||
37895636|NCT00784810|69580900|FG000|Overall Study|Adverse Event|32|||
37895637|NCT00784810|69580901|FG001|Overall Study|Adverse Event|20|||
37895638|NCT00784810|69580900|FG000|Overall Study|Lack of Efficacy|14|||
37895639|NCT00784810|69580901|FG001|Overall Study|Lack of Efficacy|11|||
37895640|NCT00784810|69580900|FG000|Overall Study|Withdrawal by Subject|11|||
37895641|NCT00784810|69580901|FG001|Overall Study|Withdrawal by Subject|9|||
37895642|NCT00784810|69580900|FG000|Overall Study|Administrative|5|||
37895643|NCT00784810|69580901|FG001|Overall Study|Administrative|8|||
37895644|NCT00784810|69580900|FG000|Overall Study|Lost to Follow-up|1|||
37895645|NCT00784810|69580901|FG001|Overall Study|Lost to Follow-up|1|||
37895646|NCT00791128|69580907|FG000|Overall Study|Adverse Event|4|||
37895647|NCT00791128|69580907|FG000|Overall Study|Device migration|2|||
37895648|NCT00791128|69580907|FG000|Overall Study|non-compliance by subject|2|||
37895649|NCT00791128|69580907|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
37895650|NCT00776230|69580927|FG000|Overall Study|Lost to Follow-up|2|||
37895651|NCT00776230|69580928|FG001|Overall Study|Lost to Follow-up|1|||
37895652|NCT00776230|69580929|FG002|Overall Study|Lost to Follow-up|5|||
37895653|NCT00776230|69580927|FG000|Overall Study|Not vaccinated at Day 0|1|||
37895654|NCT00776230|69580928|FG001|Overall Study|Not vaccinated at Day 0|0|||
37895655|NCT00776230|69580929|FG002|Overall Study|Not vaccinated at Day 0|0|||
37895656|NCT00776230|69580927|FG000|Overall Study|Withdrawal by Subject|0|||
37895657|NCT00776230|69580928|FG001|Overall Study|Withdrawal by Subject|1|||
37991694|NCT00162123|69676738|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
37991695|NCT00162123|69676739|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
37991696|NCT00162123|69676740|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
37991697|NCT00162123|69676741|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
37991698|NCT00227721|69676760|FG000|Overall Study|On study, but never treated.|1|||
37991699|NCT00226941|69676768|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
37991700|NCT00226941|69676769|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
37991701|NCT00226941|69676770|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
37991702|NCT00226941|69676771|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
37991703|NCT00226941|69676768|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
37991704|NCT00226941|69676769|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
37991705|NCT00226941|69676770|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
37991706|NCT00226941|69676771|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
37991707|NCT00356408|69676791|FG000|Overall Study|Adverse Event|9|||
37825132|NCT01058707|69507102|FG001|Overall Study|Subject Decision|3|||
37825133|NCT01058707|69507103|FG002|Overall Study|Subject Decision|3|||
37825134|NCT01058707|69507104|FG003|Overall Study|Subject Decision|1|||
37825135|NCT01058707|69507105|FG004|Overall Study|Subject Decision|2|||
37825136|NCT01058707|69507106|FG005|Overall Study|Subject Decision|3|||
37825137|NCT01058707|69507107|FG006|Overall Study|Subject Decision|6|||
37825138|NCT01058707|69507101|FG000|Overall Study|Lost to Follow-up|0|||
37825139|NCT01058707|69507102|FG001|Overall Study|Lost to Follow-up|0|||
37895658|NCT00776230|69580929|FG002|Overall Study|Withdrawal by Subject|0|||
37895659|NCT00776230|69580927|FG000|Overall Study|Subject missed Visit 4|0|||
37895660|NCT00776230|69580928|FG001|Overall Study|Subject missed Visit 4|1|||
37895661|NCT00776230|69580929|FG002|Overall Study|Subject missed Visit 4|0|||
37895662|NCT00775606|69580939|FG000|Overall Study|Study sponsor terminated funding|3|||
37895663|NCT00775606|69580940|FG001|Overall Study|Study sponsor terminated funding|0|||
37991708|NCT00356408|69676791|FG000|Overall Study|Lack of Efficacy|36|||
37895664|NCT02960763|69580959|FG000|Step 1|Withdrawal by Subject|10|||
37825140|NCT01058707|69507103|FG002|Overall Study|Lost to Follow-up|1|||
37825141|NCT01058707|69507104|FG003|Overall Study|Lost to Follow-up|0|||
37991709|NCT00356408|69676791|FG000|Overall Study|Lost to Follow-up|2|||
37991710|NCT00356408|69676791|FG000|Overall Study|Withdrawal by Subject|6|||
37991711|NCT00356408|69676791|FG000|Overall Study|Other: Principal investigator discretion|3|||
37991712|NCT00356408|69676791|FG000|Overall Study|Other: Sponsor request|1|||
37991713|NCT00356408|69676791|FG000|Overall Study|Other: Azathioprine stopped|1|||
37991714|NCT00356408|69676791|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
37991715|NCT00356408|69676791|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
37991716|NCT00509795|69676806|FG000|Overall Study|Adverse Event|4|||
37991717|NCT00509795|69676807|FG001|Overall Study|Adverse Event|3|||
37991718|NCT00509795|69676808|FG002|Overall Study|Adverse Event|5|||
37991719|NCT00509795|69676809|FG003|Overall Study|Adverse Event|4|||
37991720|NCT00509795|69676806|FG000|Overall Study|Death|3|||
37991721|NCT00509795|69676807|FG001|Overall Study|Death|1|||
37991722|NCT00509795|69676808|FG002|Overall Study|Death|2|||
37991723|NCT00509795|69676809|FG003|Overall Study|Death|7|||
37991724|NCT00509795|69676806|FG000|Overall Study|Lack of Efficacy|0|||
37991725|NCT00509795|69676807|FG001|Overall Study|Lack of Efficacy|0|||
37991726|NCT00509795|69676808|FG002|Overall Study|Lack of Efficacy|2|||
37991727|NCT00509795|69676809|FG003|Overall Study|Lack of Efficacy|2|||
37991728|NCT00509795|69676806|FG000|Overall Study|Lost to Follow-up|1|||
37991729|NCT00509795|69676807|FG001|Overall Study|Lost to Follow-up|2|||
37991730|NCT00509795|69676808|FG002|Overall Study|Lost to Follow-up|4|||
37991731|NCT00509795|69676809|FG003|Overall Study|Lost to Follow-up|4|||
37991732|NCT00509795|69676806|FG000|Overall Study|OTHER|1|||
37991733|NCT00509795|69676807|FG001|Overall Study|OTHER|0|||
37991734|NCT00509795|69676808|FG002|Overall Study|OTHER|4|||
37991735|NCT00509795|69676809|FG003|Overall Study|OTHER|1|||
37991736|NCT00509795|69676806|FG000|Overall Study|Protocol Violation|3|||
37991737|NCT00509795|69676807|FG001|Overall Study|Protocol Violation|0|||
37991738|NCT00509795|69676808|FG002|Overall Study|Protocol Violation|3|||
37991739|NCT00509795|69676809|FG003|Overall Study|Protocol Violation|1|||
37991740|NCT00509795|69676806|FG000|Overall Study|Withdrawal by Subject|10|||
37991741|NCT00509795|69676807|FG001|Overall Study|Withdrawal by Subject|5|||
37991742|NCT00509795|69676808|FG002|Overall Study|Withdrawal by Subject|7|||
37991743|NCT00509795|69676809|FG003|Overall Study|Withdrawal by Subject|8|||
37991744|NCT00165789|69676824|FG000|Overall Study|Adverse Event|0|||
37991745|NCT00165789|69676825|FG001|Overall Study|Adverse Event|3|||
37991746|NCT00165789|69676826|FG002|Overall Study|Adverse Event|0|||
37991747|NCT00165789|69676827|FG003|Overall Study|Adverse Event|12|||
37991748|NCT00165789|69676824|FG000|Overall Study|Withdrawal by Subject|0|||
37991749|NCT00165789|69676825|FG001|Overall Study|Withdrawal by Subject|1|||
37991750|NCT00165789|69676826|FG002|Overall Study|Withdrawal by Subject|1|||
37991751|NCT00165789|69676827|FG003|Overall Study|Withdrawal by Subject|2|||
37991752|NCT00504257|69676837|FG000|Overall Study|Withdrawal by Subject|2|||
37991753|NCT00504257|69676837|FG000|Overall Study|ineligible histology|2|||
37991754|NCT00509093|69676841|FG000|Overall Study|Adverse Event|10|||
37991755|NCT00509093|69676841|FG000|Overall Study|Disease Progression|9|||
37991756|NCT00509093|69676841|FG000|Overall Study|Transformed into MDS|1|||
37991757|NCT00509093|69676841|FG000|Overall Study|Withdrawal by Subject|3|||
37991758|NCT00509093|69676841|FG000|Overall Study|Physician Decision|1|||
37991759|NCT00160641|69676845|FG000|Overall Study|Adverse Event|102|||
37991760|NCT00160641|69676845|FG000|Overall Study|Withdrawal by Subject|87|||
37991761|NCT00160641|69676845|FG000|Overall Study|Lost to Follow-up|8|||
37991762|NCT00160641|69676845|FG000|Overall Study|Lack of Efficacy|12|||
37825142|NCT01058707|69507105|FG004|Overall Study|Lost to Follow-up|0|||
37825143|NCT01058707|69507106|FG005|Overall Study|Lost to Follow-up|0|||
37825144|NCT01058707|69507107|FG006|Overall Study|Lost to Follow-up|0|||
37825145|NCT01058707|69507101|FG000|Overall Study|Reason Not Specified|0|||
37825146|NCT01058707|69507102|FG001|Overall Study|Reason Not Specified|3|||
37991763|NCT00160641|69676845|FG000|Overall Study|Protocol Violation|3|||
37991764|NCT00160641|69676845|FG000|Overall Study|Other|9|||
37991765|NCT00493025|69676849|FG000|Overall Study|Physician Decision|19|||
37991766|NCT00160563|69676857|FG000|Overall Study|Adverse Event|1|||
37991767|NCT00160563|69676858|FG001|Overall Study|Adverse Event|1|||
37991768|NCT00160563|69676859|FG002|Overall Study|Adverse Event|1|||
37825147|NCT01058707|69507103|FG002|Overall Study|Reason Not Specified|2|||
37991769|NCT00160563|69676857|FG000|Overall Study|Lost to Follow-up|1|||
37991770|NCT00160563|69676858|FG001|Overall Study|Lost to Follow-up|1|||
37991771|NCT00160563|69676859|FG002|Overall Study|Lost to Follow-up|2|||
37991772|NCT00160563|69676857|FG000|Overall Study|Protocol Violation|0|||
37991773|NCT00160563|69676858|FG001|Overall Study|Protocol Violation|0|||
37991774|NCT00160563|69676859|FG002|Overall Study|Protocol Violation|3|||
37991775|NCT00160563|69676857|FG000|Overall Study|Withdrawal by Subject|1|||
37991776|NCT00160563|69676858|FG001|Overall Study|Withdrawal by Subject|2|||
37991777|NCT00160563|69676859|FG002|Overall Study|Withdrawal by Subject|3|||
37991778|NCT00160563|69676857|FG000|Overall Study|Other (listed in the study report)|48|||
37991779|NCT00160563|69676858|FG001|Overall Study|Other (listed in the study report)|40|||
37825148|NCT01058707|69507104|FG003|Overall Study|Reason Not Specified|0|||
37825149|NCT01058707|69507105|FG004|Overall Study|Reason Not Specified|7|||
37991780|NCT00160563|69676859|FG002|Overall Study|Other (listed in the study report)|81|||
37991781|NCT00160563|69676857|FG000|Overall Study|Missing reason|0|||
37991782|NCT00160563|69676858|FG001|Overall Study|Missing reason|1|||
37991783|NCT00160563|69676859|FG002|Overall Study|Missing reason|0|||
37991784|NCT00380744|69676875|FG000|Overall Study|Death|0|||
37991785|NCT00380744|69676876|FG001|Overall Study|Death|0|||
37991786|NCT00380744|69676877|FG002|Overall Study|Death|0|||
37991787|NCT00380744|69676878|FG003|Overall Study|Death|0|||
37991788|NCT00380744|69676879|FG004|Overall Study|Death|0|||
37991789|NCT00380744|69676880|FG005|Overall Study|Death|0|||
37991790|NCT00380744|69676881|FG006|Overall Study|Death|1|||
37991791|NCT00380744|69676875|FG000|Overall Study|Withdrawal by Subject|1|||
37991792|NCT00380744|69676876|FG001|Overall Study|Withdrawal by Subject|0|||
37991793|NCT00380744|69676877|FG002|Overall Study|Withdrawal by Subject|0|||
37991794|NCT00380744|69676878|FG003|Overall Study|Withdrawal by Subject|0|||
37991795|NCT00380744|69676879|FG004|Overall Study|Withdrawal by Subject|0|||
37991796|NCT00380744|69676880|FG005|Overall Study|Withdrawal by Subject|0|||
37991797|NCT00380744|69676881|FG006|Overall Study|Withdrawal by Subject|0|||
37991798|NCT00380588|69676900|FG000|Overall Study|Unequivocal Disease Progression|25|||
37991799|NCT00380588|69676901|FG001|Overall Study|Unequivocal Disease Progression|34|||
37991800|NCT00380588|69676900|FG000|Overall Study|Next Cycle Not Started|4|||
37991801|NCT00380588|69676901|FG001|Overall Study|Next Cycle Not Started|0|||
37991802|NCT00380588|69676900|FG000|Overall Study|Adverse Event|7|||
37991803|NCT00380588|69676901|FG001|Overall Study|Adverse Event|3|||
37991804|NCT00380588|69676900|FG000|Overall Study|Withdrawal by Subject|1|||
37991805|NCT00380588|69676901|FG001|Overall Study|Withdrawal by Subject|3|||
37991806|NCT00380588|69676900|FG000|Overall Study|Physician Decision|2|||
37991807|NCT00380588|69676901|FG001|Overall Study|Physician Decision|0|||
37991808|NCT00379808|69676907|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
37991809|NCT00379808|69676908|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
37991810|NCT00355784|69676917|FG000|Overall Study|Withdrawal by Subject|0|||
37991811|NCT00355784|69676918|FG001|Overall Study|Withdrawal by Subject|0|||
37991812|NCT00355784|69676919|FG002|Overall Study|Withdrawal by Subject|2|||
37991813|NCT00355472|69676928|FG000|Overall Study|Physician Decision|1|||
37991814|NCT00492557|69676942|FG000|Overall Study|Subject request|12|||
37991815|NCT00492557|69676943|FG001|Overall Study|Subject request|11|||
37991816|NCT00492557|69676942|FG000|Overall Study|Protocol Violation|7|||
37991817|NCT00492557|69676943|FG001|Overall Study|Protocol Violation|8|||
37991818|NCT00492557|69676942|FG000|Overall Study|Other|2|||
37991819|NCT00492557|69676943|FG001|Overall Study|Other|2|||
37991820|NCT00492557|69676942|FG000|Overall Study|Death|1|||
37991821|NCT00492557|69676943|FG001|Overall Study|Death|1|||
37991822|NCT00492557|69676942|FG000|Overall Study|Adverse Event|1|||
37991823|NCT00492557|69676943|FG001|Overall Study|Adverse Event|0|||
37991824|NCT00492557|69676942|FG000|Overall Study|Failed to return|1|||
37991825|NCT00492557|69676943|FG001|Overall Study|Failed to return|0|||
37991826|NCT00492557|69676942|FG000|Overall Study|Lost to Follow-up|0|||
37991827|NCT00492557|69676943|FG001|Overall Study|Lost to Follow-up|1|||
37991828|NCT00508391|69676954|FG000|First Treatment|Withdrawal by Subject|6|||
37991829|NCT00508391|69676955|FG001|First Treatment|Withdrawal by Subject|3|||
37991830|NCT00508391|69676954|FG000|Second Treatment|Withdrawal by Subject|2|||
37991831|NCT00508391|69676955|FG001|Second Treatment|Withdrawal by Subject|0|||
37991832|NCT00508157|69676965|FG000|Overall Study|Adverse Event|0|||
37991833|NCT00508157|69676966|FG001|Overall Study|Adverse Event|1|||
37991834|NCT00508157|69676965|FG000|Overall Study|Subject Withdrew Consent|1|||
37991835|NCT00508157|69676966|FG001|Overall Study|Subject Withdrew Consent|0|||
37991836|NCT00508157|69676965|FG000|Overall Study|Lost to Follow-up|1|||
37991837|NCT00508157|69676966|FG001|Overall Study|Lost to Follow-up|0|||
37991838|NCT00508157|69676965|FG000|Overall Study|Subject no longer met study criteria|0|||
37991839|NCT00508157|69676966|FG001|Overall Study|Subject no longer met study criteria|1|||
37991840|NCT00508157|69676965|FG000|Overall Study|Other known cause|0|||
37991841|NCT00508157|69676966|FG001|Overall Study|Other known cause|1|||
37991842|NCT00378560|69676974|FG000|Overall Study|Adverse Event|1|||
37991843|NCT00378560|69676975|FG001|Overall Study|Adverse Event|0|||
37696230|NCT02465567|69172375|FG001|Overall Study|Lost to Follow-up|21|||
37895665|NCT02960763|69580960|FG001|Step 1|Withdrawal by Subject|8|||
37991844|NCT00378560|69676974|FG000|Overall Study|Lost to Follow-up|24|||
37991845|NCT00378560|69676975|FG001|Overall Study|Lost to Follow-up|29|||
37696231|NCT02465567|69172376|FG002|Overall Study|Lost to Follow-up|19|||
37991846|NCT00378560|69676974|FG000|Overall Study|Protocol Violation|2|||
37991847|NCT00378560|69676975|FG001|Overall Study|Protocol Violation|0|||
37991848|NCT00378560|69676974|FG000|Overall Study|Withdrawal by Subject|17|||
37991849|NCT00378560|69676975|FG001|Overall Study|Withdrawal by Subject|21|||
37991850|NCT00378560|69676974|FG000|Overall Study|Moved|4|||
37991851|NCT00378560|69676975|FG001|Overall Study|Moved|3|||
37991852|NCT00378560|69676974|FG000|Overall Study|Pregnancy|7|||
37991853|NCT00378560|69676975|FG001|Overall Study|Pregnancy|5|||
37991854|NCT00378560|69676974|FG000|Overall Study|Laboratory test values abnormal|1|||
37991855|NCT00378560|69676975|FG001|Overall Study|Laboratory test values abnormal|0|||
37991856|NCT00508001|69676984|FG000|Overall Study|Adverse Event|2|||
37991857|NCT00508001|69676985|FG001|Overall Study|Adverse Event|0|||
37991858|NCT00508001|69676986|FG002|Overall Study|Adverse Event|4|||
37991859|NCT00508001|69676984|FG000|Overall Study|condition under investigation worsened|13|||
37991860|NCT00508001|69676985|FG001|Overall Study|condition under investigation worsened|7|||
37991861|NCT00508001|69676986|FG002|Overall Study|condition under investigation worsened|1|||
37991862|NCT00508001|69676984|FG000|Overall Study|Death|0|||
37991863|NCT00508001|69676985|FG001|Overall Study|Death|1|||
37991864|NCT00508001|69676986|FG002|Overall Study|Death|1|||
37991865|NCT00508001|69676984|FG000|Overall Study|Withdrawal by Subject|4|||
37991866|NCT00508001|69676985|FG001|Overall Study|Withdrawal by Subject|4|||
37991867|NCT00508001|69676986|FG002|Overall Study|Withdrawal by Subject|1|||
37991868|NCT00507689|69676997|FG000|Pre-Randomization Period|Adverse Event|1|||
37991869|NCT00507689|69676998|FG001|Pre-Randomization Period|Adverse Event|0|||
37991870|NCT00507689|69676997|FG000|Pre-Randomization Period|Physician Decision|1|||
37991871|NCT00507689|69676998|FG001|Pre-Randomization Period|Physician Decision|0|||
37991872|NCT00507689|69676997|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
37991873|NCT00507689|69676998|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
37991874|NCT00507689|69676997|FG000|Randomized Period|Adverse Event|1|||
37991875|NCT00507689|69676998|FG001|Randomized Period|Adverse Event|1|||
37991876|NCT00507689|69676997|FG000|Randomized Period|Withdrawal by Subject|0|||
37991877|NCT00507689|69676998|FG001|Randomized Period|Withdrawal by Subject|1|||
37991878|NCT00491387|69677005|FG000|Overall Study|study terminated|20|||
37991879|NCT00491075|69677009|FG000|Overall Study|Withdrawal by Subject|1|||
37991880|NCT00491075|69677009|FG000|Overall Study|Physician Decision|1|||
37991881|NCT00507455|69677016|FG000|Overall Study|Adverse Event|3|||
37991882|NCT00507455|69677017|FG001|Overall Study|Adverse Event|3|||
37991883|NCT00507455|69677018|FG002|Overall Study|Adverse Event|6|||
37991884|NCT00507455|69677016|FG000|Overall Study|Withdrawal by Subject|2|||
37991885|NCT00507455|69677017|FG001|Overall Study|Withdrawal by Subject|1|||
37991886|NCT00507455|69677018|FG002|Overall Study|Withdrawal by Subject|2|||
37991887|NCT00507455|69677016|FG000|Overall Study|Protocol Violation|4|||
37991888|NCT00507455|69677017|FG001|Overall Study|Protocol Violation|1|||
37991889|NCT00507455|69677018|FG002|Overall Study|Protocol Violation|1|||
37991890|NCT00507455|69677016|FG000|Overall Study|Lost to Follow-up|2|||
37825150|NCT01058707|69507106|FG005|Overall Study|Reason Not Specified|1|||
37895666|NCT02960763|69580961|FG002|Step 1|Withdrawal by Subject|13|||
37895667|NCT02960763|69580962|FG003|Step 1|Withdrawal by Subject|0|||
37895668|NCT02960763|69580963|FG004|Step 1|Withdrawal by Subject|0|||
37895669|NCT02960763|69580959|FG000|Step 1|Lost to Follow-up|7|||
37895670|NCT02960763|69580960|FG001|Step 1|Lost to Follow-up|9|||
37895671|NCT02960763|69580961|FG002|Step 1|Lost to Follow-up|12|||
37895672|NCT02960763|69580962|FG003|Step 1|Lost to Follow-up|0|||
37895673|NCT02960763|69580963|FG004|Step 1|Lost to Follow-up|0|||
37991891|NCT00507455|69677017|FG001|Overall Study|Lost to Follow-up|0|||
37991892|NCT00507455|69677018|FG002|Overall Study|Lost to Follow-up|2|||
37991893|NCT00507455|69677016|FG000|Overall Study|Lack of Efficacy|0|||
37991894|NCT00507455|69677017|FG001|Overall Study|Lack of Efficacy|1|||
37696232|NCT02465567|69172377|FG003|Overall Study|Lost to Follow-up|15|||
37825151|NCT01058707|69507107|FG006|Overall Study|Reason Not Specified|7|||
37825152|NCT01054144|69507145|FG000|Overall Study|Death|2|||
37825153|NCT00105586|69507154|FG000|Overall Study|Adverse Event|4|||
37825154|NCT00105586|69507155|FG001|Overall Study|Adverse Event|3|||
37825155|NCT00105586|69507154|FG000|Overall Study|Physician Decision|13|||
37825156|NCT00105586|69507155|FG001|Overall Study|Physician Decision|13|||
37825157|NCT01059643|69507163|FG000|Overall Study|Adverse Event|3|||
37825158|NCT01059643|69507163|FG000|Overall Study|Withdrawal by Subject|2|||
37825159|NCT01059643|69507163|FG000|Overall Study|Physician Decision|1|||
37825160|NCT01059565|69507172|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
37825161|NCT01059565|69507173|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
37825162|NCT01059565|69507172|FG000|24-Week Randomized Phase|Adverse Event|5|||
37825163|NCT01059565|69507173|FG001|24-Week Randomized Phase|Adverse Event|0|||
37895674|NCT02960763|69580959|FG000|Step 1|Death|1|||
37991895|NCT00507455|69677018|FG002|Overall Study|Lack of Efficacy|0|||
37991896|NCT00507455|69677016|FG000|Overall Study|Other - miscellaneous reason|1|||
37991897|NCT00507455|69677017|FG001|Overall Study|Other - miscellaneous reason|0|||
37991898|NCT00507455|69677018|FG002|Overall Study|Other - miscellaneous reason|1|||
37991899|NCT00506831|69677026|FG000|Overall Study|Death|1|||
37991900|NCT00506831|69677026|FG000|Overall Study|Withdrawal by Subject|1|||
37991901|NCT00506753|69677032|FG000|Overall Study|Lost to Follow-up|21|||
37991902|NCT00506753|69677033|FG001|Overall Study|Lost to Follow-up|15|||
37991903|NCT00490919|69677041|FG000|Open-label Run-in Period|Adverse Event|239|||
37991904|NCT00490919|69677042|FG001|Open-label Run-in Period|Adverse Event|0|||
37991905|NCT00490919|69677043|FG002|Open-label Run-in Period|Adverse Event|0|||
37991906|NCT00490919|69677041|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
37991907|NCT00490919|69677042|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
37991908|NCT00490919|69677043|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
37991909|NCT00490919|69677041|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
37991910|NCT00490919|69677042|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
37991911|NCT00490919|69677043|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
37991912|NCT00490919|69677041|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
37991913|NCT00490919|69677042|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
37991914|NCT00490919|69677043|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
37991915|NCT00490919|69677041|FG000|Open-label Run-in Period|Administrative|40|||
37991916|NCT00490919|69677042|FG001|Open-label Run-in Period|Administrative|0|||
37991917|NCT00490919|69677043|FG002|Open-label Run-in Period|Administrative|0|||
37991918|NCT00490919|69677041|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
37991919|NCT00490919|69677042|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
37991920|NCT00490919|69677043|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
37991921|NCT00490919|69677041|FG000|Double-blind Phase|Adverse Event|0|||
37991922|NCT00490919|69677042|FG001|Double-blind Phase|Adverse Event|40|||
37991923|NCT00490919|69677043|FG002|Double-blind Phase|Adverse Event|20|||
37991924|NCT00490919|69677041|FG000|Double-blind Phase|Withdrawal by Subject|0|||
37991925|NCT00490919|69677042|FG001|Double-blind Phase|Withdrawal by Subject|10|||
37991926|NCT00490919|69677043|FG002|Double-blind Phase|Withdrawal by Subject|11|||
37991927|NCT00490919|69677041|FG000|Double-blind Phase|Lost to Follow-up|0|||
37991928|NCT00490919|69677042|FG001|Double-blind Phase|Lost to Follow-up|8|||
37991929|NCT00490919|69677043|FG002|Double-blind Phase|Lost to Follow-up|11|||
37991930|NCT00490919|69677041|FG000|Double-blind Phase|Lack of Efficacy|0|||
37991931|NCT00490919|69677042|FG001|Double-blind Phase|Lack of Efficacy|22|||
37991932|NCT00490919|69677043|FG002|Double-blind Phase|Lack of Efficacy|36|||
37991933|NCT00490919|69677041|FG000|Double-blind Phase|Administrative|0|||
37991934|NCT00490919|69677042|FG001|Double-blind Phase|Administrative|6|||
37991935|NCT00490919|69677043|FG002|Double-blind Phase|Administrative|6|||
37991936|NCT00503867|69677050|FG000|Overall Study|Lost to Follow-up|1|||
37991937|NCT00503867|69677050|FG000|Overall Study|Adverse Event|1|||
37991938|NCT00503399|69677056|FG000|Overall Study|Death|2|||
37991939|NCT00503399|69677057|FG001|Overall Study|Death|1|||
37991940|NCT00503399|69677056|FG000|Overall Study|Protocol Violation|1|||
37825164|NCT01059565|69507172|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
37825165|NCT01059565|69507173|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
37825166|NCT01059565|69507172|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
37825167|NCT01059565|69507173|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
37825168|NCT01059565|69507172|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
37825169|NCT01059565|69507173|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
37825170|NCT01059565|69507172|FG000|24-Week Open-Label Phase|Adverse Event|2|||
37825171|NCT01059565|69507173|FG001|24-Week Open-Label Phase|Adverse Event|0|||
37825172|NCT01059565|69507172|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
37825173|NCT01059565|69507173|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
37825174|NCT01059565|69507172|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
37825175|NCT01059565|69507173|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
37825176|NCT01059565|69507172|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
37825177|NCT01059565|69507173|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
37825178|NCT01059565|69507172|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
37825179|NCT01059565|69507173|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
37825180|NCT01059565|69507172|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
37825181|NCT01059565|69507173|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
37895675|NCT02960763|69580960|FG001|Step 1|Death|1|||
37895676|NCT02960763|69580961|FG002|Step 1|Death|1|||
37895677|NCT02960763|69580962|FG003|Step 1|Death|0|||
37895678|NCT02960763|69580963|FG004|Step 1|Death|0|||
37895679|NCT02960763|69580959|FG000|Step 1|Investigator discretion|1|||
37895680|NCT02960763|69580960|FG001|Step 1|Investigator discretion|0|||
37895681|NCT02960763|69580961|FG002|Step 1|Investigator discretion|1|||
37991941|NCT00503399|69677057|FG001|Overall Study|Protocol Violation|0|||
37991942|NCT00503399|69677056|FG000|Overall Study|Withdrawal by Subject|4|||
37991943|NCT00503399|69677057|FG001|Overall Study|Withdrawal by Subject|2|||
37991944|NCT00503399|69677056|FG000|Overall Study|Adverse Event|0|||
37825182|NCT01059526|69507183|FG000|Overall Study|Patient enrolled but not treated|20|||
37825183|NCT01059526|69507184|FG001|Overall Study|Patient enrolled but not treated|17|||
37895682|NCT02960763|69580962|FG003|Step 1|Investigator discretion|0|||
37895683|NCT02960763|69580963|FG004|Step 1|Investigator discretion|0|||
37991945|NCT00503399|69677057|FG001|Overall Study|Adverse Event|3|||
37991946|NCT00503399|69677056|FG000|Overall Study|Lost to Follow-up|0|||
37991947|NCT00503399|69677057|FG001|Overall Study|Lost to Follow-up|2|||
37991948|NCT00506519|69677066|FG000|Overall Study|Death|4|||
37991949|NCT00506519|69677067|FG001|Overall Study|Death|6|||
37991950|NCT00506519|69677068|FG002|Overall Study|Death|0|||
37991951|NCT00506519|69677066|FG000|Overall Study|Adverse Event|1|||
37991952|NCT00506519|69677067|FG001|Overall Study|Adverse Event|0|||
37991953|NCT00506519|69677068|FG002|Overall Study|Adverse Event|0|||
37991954|NCT00503009|69677082|FG000|Overall Study|Protocol Violation|1|||
37991955|NCT00503009|69677083|FG001|Overall Study|Protocol Violation|0|||
37895684|NCT02960763|69580959|FG000|Step 1|Other|0|||
37895685|NCT02960763|69580960|FG001|Step 1|Other|0|||
37895686|NCT02960763|69580961|FG002|Step 1|Other|1|||
37991956|NCT00503009|69677084|FG002|Overall Study|Protocol Violation|1|||
37991957|NCT00503009|69677082|FG000|Overall Study|Withdrawal by Subject|0|||
37991958|NCT00503009|69677083|FG001|Overall Study|Withdrawal by Subject|1|||
37991959|NCT00503009|69677084|FG002|Overall Study|Withdrawal by Subject|1|||
37991960|NCT00503009|69677082|FG000|Overall Study|Physician Decision|0|||
37991961|NCT00503009|69677083|FG001|Overall Study|Physician Decision|1|||
37991962|NCT00503009|69677084|FG002|Overall Study|Physician Decision|1|||
37991963|NCT00160251|69677098|FG000|Prior to Amendment 2|Adverse Event|2|||
37991964|NCT00160251|69677099|FG001|Prior to Amendment 2|Adverse Event|1|||
37991965|NCT00160251|69677100|FG002|Prior to Amendment 2|Adverse Event|3|||
37991966|NCT00160251|69677101|FG003|Prior to Amendment 2|Adverse Event|1|||
37991967|NCT00160251|69677102|FG004|Prior to Amendment 2|Adverse Event|1|||
37991968|NCT00160251|69677103|FG005|Prior to Amendment 2|Adverse Event|1|||
37991969|NCT00160251|69677104|FG006|Prior to Amendment 2|Adverse Event|1|||
37991970|NCT00160251|69677105|FG007|Prior to Amendment 2|Adverse Event|0|||
37991971|NCT00160251|69677098|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
37991972|NCT00160251|69677099|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
37991973|NCT00160251|69677100|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
37991974|NCT00160251|69677101|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
37991975|NCT00160251|69677102|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
37991976|NCT00160251|69677103|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
37991977|NCT00160251|69677104|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
37991978|NCT00160251|69677105|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
37991979|NCT00160251|69677098|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
37991980|NCT00160251|69677099|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
37991981|NCT00160251|69677100|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
37991982|NCT00160251|69677101|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
37991983|NCT00160251|69677102|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
37991984|NCT00160251|69677103|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
37991985|NCT00160251|69677104|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
37991986|NCT00160251|69677105|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
37991987|NCT00160251|69677098|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
37991988|NCT00160251|69677099|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
37991989|NCT00160251|69677100|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
37991990|NCT00160251|69677101|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
37991991|NCT00160251|69677102|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
37895687|NCT02960763|69580962|FG003|Step 1|Other|0|||
37895688|NCT02960763|69580963|FG004|Step 1|Other|0|||
37895689|NCT02960763|69580959|FG000|Step 2|Withdrawal by Subject|0|||
37895690|NCT02960763|69580960|FG001|Step 2|Withdrawal by Subject|0|||
37895691|NCT02960763|69580961|FG002|Step 2|Withdrawal by Subject|0|||
37895692|NCT02960763|69580962|FG003|Step 2|Withdrawal by Subject|7|||
37895693|NCT02960763|69580963|FG004|Step 2|Withdrawal by Subject|3|||
37895694|NCT02960763|69580959|FG000|Step 2|Lost to Follow-up|0|||
37895695|NCT02960763|69580960|FG001|Step 2|Lost to Follow-up|0|||
37895696|NCT02960763|69580961|FG002|Step 2|Lost to Follow-up|0|||
37895697|NCT02960763|69580962|FG003|Step 2|Lost to Follow-up|4|||
37895698|NCT02960763|69580963|FG004|Step 2|Lost to Follow-up|1|||
37895699|NCT02960763|69580959|FG000|Step 2|Investigator discretion|0|||
37991992|NCT00160251|69677103|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
37991993|NCT00160251|69677104|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
37991994|NCT00160251|69677105|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
37991995|NCT00160251|69677098|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
37895700|NCT02960763|69580960|FG001|Step 2|Investigator discretion|0|||
37895701|NCT02960763|69580961|FG002|Step 2|Investigator discretion|0|||
37895702|NCT02960763|69580962|FG003|Step 2|Investigator discretion|0|||
37895703|NCT02960763|69580963|FG004|Step 2|Investigator discretion|1|||
37895704|NCT00775528|69580975|FG000|Overall Study|Protocol Violation|1|||
37991996|NCT00160251|69677099|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
37991997|NCT00160251|69677100|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
37991998|NCT00160251|69677101|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
37991999|NCT00160251|69677102|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
37895705|NCT00775450|69580984|FG000|Overall Study|Serious Adverse Event|2|||
37895706|NCT00775450|69580985|FG001|Overall Study|Serious Adverse Event|0|||
37895707|NCT00775450|69580986|FG002|Overall Study|Serious Adverse Event|0|||
37895708|NCT00775450|69580987|FG003|Overall Study|Serious Adverse Event|0|||
37895709|NCT00775450|69580988|FG004|Overall Study|Serious Adverse Event|0|||
37895710|NCT00775450|69580984|FG000|Overall Study|Protocol Violation|0|||
37895711|NCT00775450|69580985|FG001|Overall Study|Protocol Violation|0|||
37895712|NCT00775450|69580986|FG002|Overall Study|Protocol Violation|0|||
37895713|NCT00775450|69580987|FG003|Overall Study|Protocol Violation|0|||
37895714|NCT00775450|69580988|FG004|Overall Study|Protocol Violation|1|||
37895715|NCT00775450|69580984|FG000|Overall Study|Withdrawal by Subject|1|||
37992000|NCT00160251|69677103|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
37992001|NCT00160251|69677104|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
37992002|NCT00160251|69677105|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
37992003|NCT00160251|69677098|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
37992004|NCT00160251|69677099|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
37992005|NCT00160251|69677100|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
37992006|NCT00160251|69677101|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
37992007|NCT00160251|69677102|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
37992008|NCT00160251|69677103|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
37992009|NCT00160251|69677104|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
37992010|NCT00160251|69677105|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
37992011|NCT00160251|69677098|FG000|Post-amendment 2|Adverse Event|0|||
37992012|NCT00160251|69677099|FG001|Post-amendment 2|Adverse Event|0|||
37992013|NCT00160251|69677100|FG002|Post-amendment 2|Adverse Event|0|||
37992014|NCT00160251|69677101|FG003|Post-amendment 2|Adverse Event|0|||
37992015|NCT00160251|69677102|FG004|Post-amendment 2|Adverse Event|0|||
37992016|NCT00160251|69677103|FG005|Post-amendment 2|Adverse Event|0|||
37992017|NCT00160251|69677104|FG006|Post-amendment 2|Adverse Event|0|||
37992018|NCT00160251|69677105|FG007|Post-amendment 2|Adverse Event|20|||
37992019|NCT00160251|69677098|FG000|Post-amendment 2|Lack of Efficacy|0|||
37992020|NCT00160251|69677099|FG001|Post-amendment 2|Lack of Efficacy|0|||
37992021|NCT00160251|69677100|FG002|Post-amendment 2|Lack of Efficacy|0|||
37825184|NCT01059526|69507183|FG000|Overall Study|Adverse Event|2|||
37992022|NCT00160251|69677101|FG003|Post-amendment 2|Lack of Efficacy|0|||
37992023|NCT00160251|69677102|FG004|Post-amendment 2|Lack of Efficacy|0|||
37992024|NCT00160251|69677103|FG005|Post-amendment 2|Lack of Efficacy|0|||
37992025|NCT00160251|69677104|FG006|Post-amendment 2|Lack of Efficacy|0|||
37992026|NCT00160251|69677105|FG007|Post-amendment 2|Lack of Efficacy|24|||
37992027|NCT00160251|69677098|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
37992028|NCT00160251|69677099|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
37825185|NCT01059526|69507184|FG001|Overall Study|Adverse Event|2|||
37825186|NCT01059526|69507183|FG000|Overall Study|Protocol Violation|0|||
37825187|NCT01059526|69507184|FG001|Overall Study|Protocol Violation|1|||
37825188|NCT01059526|69507183|FG000|Overall Study|Withdrawal by Subject|3|||
37825189|NCT01059526|69507184|FG001|Overall Study|Withdrawal by Subject|1|||
37825190|NCT01059526|69507183|FG000|Overall Study|Lost to Follow-up|4|||
37825191|NCT01059526|69507184|FG001|Overall Study|Lost to Follow-up|1|||
37825192|NCT01059526|69507183|FG000|Overall Study|Patient found to be dermatographic|1|||
37825193|NCT01059526|69507184|FG001|Overall Study|Patient found to be dermatographic|0|||
37825194|NCT03277261|69507192|FG000|Overall Study|Adverse Event|17|||
37825195|NCT03277261|69507193|FG001|Overall Study|Adverse Event|1|||
37825196|NCT03277261|69507192|FG000|Overall Study|Participant Withdrawal of Consent|6|||
37825197|NCT03277261|69507193|FG001|Overall Study|Participant Withdrawal of Consent|15|||
37825198|NCT03277261|69507192|FG000|Overall Study|Investigator / Sponsor Decision|4|||
37825199|NCT03277261|69507193|FG001|Overall Study|Investigator / Sponsor Decision|2|||
37825200|NCT03277261|69507192|FG000|Overall Study|Pregnancy|2|||
37825201|NCT03277261|69507193|FG001|Overall Study|Pregnancy|0|||
37825202|NCT03277261|69507192|FG000|Overall Study|Lost to Follow-up|2|||
37825203|NCT03277261|69507193|FG001|Overall Study|Lost to Follow-up|2|||
37992029|NCT00160251|69677100|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
37825204|NCT03277261|69507192|FG000|Overall Study|Lack of Efficacy|2|||
37895716|NCT00775450|69580985|FG001|Overall Study|Withdrawal by Subject|0|||
37992030|NCT00160251|69677101|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
37992031|NCT00160251|69677102|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
37825205|NCT03277261|69507193|FG001|Overall Study|Lack of Efficacy|2|||
37825206|NCT03277261|69507192|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
37825207|NCT03277261|69507193|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
37825208|NCT03277690|69507215|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
37992032|NCT00160251|69677103|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
37992033|NCT00160251|69677104|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
37992034|NCT00160251|69677105|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
37992035|NCT00506441|69677162|FG000|Period 1; Open-label Period|Adverse Event|21|||
37992036|NCT00506441|69677163|FG001|Period 1; Open-label Period|Adverse Event|0|||
37992037|NCT00506441|69677162|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
37992038|NCT00506441|69677163|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
37992039|NCT00506441|69677162|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
37992040|NCT00506441|69677163|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
37992041|NCT00506441|69677162|FG000|Period 1; Open-label Period|Physician Decision|5|||
37992042|NCT00506441|69677163|FG001|Period 1; Open-label Period|Physician Decision|0|||
37992043|NCT00506441|69677162|FG000|Period 1; Open-label Period|Protocol Violation|9|||
37992044|NCT00506441|69677163|FG001|Period 1; Open-label Period|Protocol Violation|0|||
37992045|NCT00506441|69677162|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
37992046|NCT00506441|69677163|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
37992047|NCT00506441|69677162|FG000|Period 1; Open-label Period|Other Reasons|13|||
37992048|NCT00506441|69677163|FG001|Period 1; Open-label Period|Other Reasons|0|||
37992049|NCT00506441|69677162|FG000|Period 2; Double-blind Period|Adverse Event|0|||
37992050|NCT00506441|69677163|FG001|Period 2; Double-blind Period|Adverse Event|1|||
37992051|NCT00506441|69677162|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
37992052|NCT00506441|69677163|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
37992053|NCT00506441|69677162|FG000|Period 2; Double-blind Period|Physician Decision|1|||
37992054|NCT00506441|69677163|FG001|Period 2; Double-blind Period|Physician Decision|1|||
37992055|NCT00506441|69677162|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
37992056|NCT00506441|69677163|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
37992057|NCT00506441|69677162|FG000|Period 2; Double-blind Period|Other Reason|1|||
37992058|NCT00506441|69677163|FG001|Period 2; Double-blind Period|Other Reason|1|||
37992059|NCT00378014|69677190|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
37992060|NCT00378014|69677191|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
37992061|NCT00378014|69677190|FG000|Core (Randomization to Month 11)|Graft loss|1|||
37992062|NCT00378014|69677191|FG001|Core (Randomization to Month 11)|Graft loss|2|||
37825209|NCT03277690|69507216|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
37825210|NCT03277690|69507215|FG000|Dose Titration and Maintenance|Physician Decision|1|||
37825211|NCT03277690|69507216|FG001|Dose Titration and Maintenance|Physician Decision|0|||
37895717|NCT00775450|69580986|FG002|Overall Study|Withdrawal by Subject|0|||
37895718|NCT00775450|69580987|FG003|Overall Study|Withdrawal by Subject|0|||
37895719|NCT00775450|69580988|FG004|Overall Study|Withdrawal by Subject|1|||
37895720|NCT00775138|69581004|FG000|Overall Study|Withdrawal by Subject|0|||
37895721|NCT00775138|69581005|FG001|Overall Study|Withdrawal by Subject|0|||
37895722|NCT00775138|69581006|FG002|Overall Study|Withdrawal by Subject|2|||
37895723|NCT00775138|69581007|FG003|Overall Study|Withdrawal by Subject|2|||
37895724|NCT00775138|69581004|FG000|Overall Study|Adverse Event|0|||
37895725|NCT00775138|69581005|FG001|Overall Study|Adverse Event|0|||
37895726|NCT00775138|69581006|FG002|Overall Study|Adverse Event|1|||
37825212|NCT03277690|69507215|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
37825213|NCT03277690|69507216|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
37825214|NCT03277690|69507215|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
37825215|NCT03277690|69507216|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
37825216|NCT03277690|69507215|FG000|Dose Titration and Maintenance|Adverse Event|15|||
37825217|NCT03277690|69507216|FG001|Dose Titration and Maintenance|Adverse Event|0|||
37825218|NCT03277690|69507215|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
37825219|NCT03277690|69507216|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
37825220|NCT03277690|69507215|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
37825221|NCT03277690|69507216|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
37895727|NCT00775138|69581007|FG003|Overall Study|Adverse Event|0|||
37992063|NCT00378014|69677190|FG000|Core (Randomization to Month 11)|Death|5|||
37992064|NCT00378014|69677191|FG001|Core (Randomization to Month 11)|Death|3|||
37895728|NCT04605991|69581019|FG000|Overall Study|Adverse Event|5|||
37992065|NCT00378014|69677190|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
37992066|NCT00378014|69677191|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
37992067|NCT00378014|69677190|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
37992068|NCT00378014|69677191|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
37992069|NCT00378014|69677190|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
37992070|NCT00378014|69677191|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
37992071|NCT00378014|69677190|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
37992072|NCT00378014|69677191|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
37992073|NCT00378014|69677190|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
37992074|NCT00378014|69677191|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
37992075|NCT00378014|69677190|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
37992076|NCT00378014|69677191|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
37992077|NCT00378014|69677190|FG000|Extension (Month 12 to Month 59)|Death|1|||
37992078|NCT00378014|69677191|FG001|Extension (Month 12 to Month 59)|Death|2|||
37696233|NCT02465567|69172374|FG000|Overall Study|Protocol Specified Criteria|20|||
37696234|NCT02465567|69172375|FG001|Overall Study|Protocol Specified Criteria|10|||
37992079|NCT00378014|69677190|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
37992080|NCT00378014|69677191|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
37992081|NCT00378014|69677190|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
37992082|NCT00378014|69677191|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
37992083|NCT00378014|69677190|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
37992084|NCT00378014|69677191|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
37992085|NCT00378014|69677190|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
37992086|NCT00378014|69677191|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
37992087|NCT00485303|69677199|FG000|Overall Study|Adverse Event|5|||
37992088|NCT00485303|69677199|FG000|Overall Study|Progressive Disease|44|||
37992089|NCT00485303|69677199|FG000|Overall Study|Other|3|||
37992090|NCT00485303|69677199|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
37992091|NCT00485303|69677199|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
37992092|NCT00490841|69677203|FG000|Overall Study|Death|5|||
37992093|NCT00490841|69677203|FG000|Overall Study|Withdrawal by Subject|4|||
37992094|NCT00490841|69677203|FG000|Overall Study|Lost to Follow-up|1|||
37992095|NCT00490841|69677203|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
37992096|NCT00377858|69677210|FG000|Overall Study|Withdrawal by Subject|12|||
37992097|NCT00377858|69677211|FG001|Overall Study|Withdrawal by Subject|11|||
37992098|NCT00377858|69677210|FG000|Overall Study|Lost to Follow-up|6|||
37992099|NCT00377858|69677211|FG001|Overall Study|Lost to Follow-up|1|||
37992100|NCT00377858|69677210|FG000|Overall Study|Physician Decision|5|||
37992101|NCT00377858|69677211|FG001|Overall Study|Physician Decision|5|||
37992102|NCT00377858|69677210|FG000|Overall Study|Protocol Violation|3|||
37992103|NCT00377858|69677211|FG001|Overall Study|Protocol Violation|4|||
37992104|NCT00377858|69677210|FG000|Overall Study|Adverse Event|2|||
37992105|NCT00377858|69677211|FG001|Overall Study|Adverse Event|1|||
37992106|NCT00377858|69677210|FG000|Overall Study|Entry Criteria Not Met|2|||
37992107|NCT00377858|69677211|FG001|Overall Study|Entry Criteria Not Met|0|||
37992108|NCT00377858|69677210|FG000|Overall Study|Sponsor Decision|1|||
37992109|NCT00377858|69677211|FG001|Overall Study|Sponsor Decision|2|||
37992110|NCT00377858|69677210|FG000|Overall Study|Death|0|||
37992111|NCT00377858|69677211|FG001|Overall Study|Death|3|||
37992112|NCT00502775|69677220|FG000|Overall Study|Adverse Event|1|||
37992113|NCT00502775|69677221|FG001|Overall Study|Adverse Event|2|||
37992114|NCT00502775|69677222|FG002|Overall Study|Adverse Event|1|||
37992115|NCT00502775|69677220|FG000|Overall Study|Protocol Violation|1|||
37992116|NCT00502775|69677221|FG001|Overall Study|Protocol Violation|5|||
37992117|NCT00502775|69677222|FG002|Overall Study|Protocol Violation|2|||
37992118|NCT00502775|69677220|FG000|Overall Study|Withdrawal by Subject|1|||
37992119|NCT00502775|69677221|FG001|Overall Study|Withdrawal by Subject|1|||
37992120|NCT00502775|69677222|FG002|Overall Study|Withdrawal by Subject|2|||
37992121|NCT00502775|69677220|FG000|Overall Study|Sponsor Terminated Study|1|||
37992122|NCT00502775|69677221|FG001|Overall Study|Sponsor Terminated Study|0|||
37992123|NCT00502775|69677222|FG002|Overall Study|Sponsor Terminated Study|1|||
37992124|NCT00502775|69677220|FG000|Overall Study|Non-compliance with eDiary|4|||
37992125|NCT00502775|69677221|FG001|Overall Study|Non-compliance with eDiary|1|||
37992126|NCT00502775|69677222|FG002|Overall Study|Non-compliance with eDiary|1|||
37992127|NCT00502775|69677220|FG000|Overall Study|Subject unable to swallow capsule|1|||
37992128|NCT00502775|69677221|FG001|Overall Study|Subject unable to swallow capsule|0|||
37992129|NCT00502775|69677222|FG002|Overall Study|Subject unable to swallow capsule|1|||
37992130|NCT00502775|69677220|FG000|Overall Study|Logpad compliance <80%|1|||
37992131|NCT00502775|69677221|FG001|Overall Study|Logpad compliance <80%|0|||
37992132|NCT00502775|69677222|FG002|Overall Study|Logpad compliance <80%|0|||
37992133|NCT00502775|69677220|FG000|Overall Study|Randomized in error|0|||
37992134|NCT00502775|69677221|FG001|Overall Study|Randomized in error|1|||
37992135|NCT00502775|69677222|FG002|Overall Study|Randomized in error|1|||
37992136|NCT00502775|69677220|FG000|Overall Study|Non-compliance|0|||
37992137|NCT00502775|69677221|FG001|Overall Study|Non-compliance|2|||
37992138|NCT00502775|69677222|FG002|Overall Study|Non-compliance|2|||
37992139|NCT00502775|69677220|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
37992140|NCT00502775|69677221|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
37992141|NCT00502775|69677222|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
37992142|NCT00502775|69677220|FG000|Overall Study|Declining pollen counts|0|||
37992143|NCT00502775|69677221|FG001|Overall Study|Declining pollen counts|1|||
37992144|NCT00502775|69677222|FG002|Overall Study|Declining pollen counts|1|||
37992145|NCT00502775|69677220|FG000|Overall Study|Subject in jail|0|||
37992146|NCT00502775|69677221|FG001|Overall Study|Subject in jail|1|||
37992147|NCT00502775|69677222|FG002|Overall Study|Subject in jail|0|||
37992148|NCT00502775|69677220|FG000|Overall Study|Subject took disallowed drug|0|||
37992149|NCT00502775|69677221|FG001|Overall Study|Subject took disallowed drug|0|||
37992150|NCT00502775|69677222|FG002|Overall Study|Subject took disallowed drug|1|||
37825222|NCT03271021|69507225|FG000|Overall Study|Adverse Event|3|||
37992151|NCT00502697|69677232|FG000|Overall Study|Withdrawal by Subject|3|||
37992152|NCT00502697|69677233|FG001|Overall Study|Withdrawal by Subject|1|||
37992153|NCT00502697|69677232|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
37992154|NCT00502697|69677233|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
37992155|NCT00502697|69677232|FG000|Overall Study|found not to meet eligibility criteria|3|||
37992156|NCT00502697|69677233|FG001|Overall Study|found not to meet eligibility criteria|4|||
37992157|NCT00502697|69677232|FG000|Overall Study|did not meet assignment criteria|4|||
37992158|NCT00502697|69677233|FG001|Overall Study|did not meet assignment criteria|2|||
37992159|NCT00485069|69677241|FG000|Overall Study|Adverse Event|10|||
37992160|NCT00485069|69677242|FG001|Overall Study|Adverse Event|4|||
37992161|NCT00485069|69677241|FG000|Overall Study|Lack of Efficacy|2|||
37992162|NCT00485069|69677242|FG001|Overall Study|Lack of Efficacy|1|||
37992163|NCT00485069|69677241|FG000|Overall Study|Protocol Violation|0|||
37992164|NCT00485069|69677242|FG001|Overall Study|Protocol Violation|1|||
37992165|NCT00485069|69677241|FG000|Overall Study|Withdrawal by Subject|6|||
37992166|NCT00485069|69677242|FG001|Overall Study|Withdrawal by Subject|6|||
37992167|NCT00355082|69677257|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
37992168|NCT00355082|69677258|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
37992169|NCT00355082|69677259|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
37992170|NCT00355082|69677257|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
37992171|NCT00355082|69677258|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
37992172|NCT00355082|69677259|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
37992173|NCT00355082|69677257|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
37992174|NCT00355082|69677258|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
37992175|NCT00355082|69677259|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
37992176|NCT00355082|69677257|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
37992177|NCT00355082|69677258|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
37992178|NCT00355082|69677259|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
37992179|NCT00355082|69677257|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
37992180|NCT00355082|69677258|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
37992181|NCT00355082|69677259|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
37992182|NCT00355082|69677257|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
37992183|NCT00355082|69677258|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
37992184|NCT00355082|69677259|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
37992185|NCT00355082|69677257|FG000|Continuation Phase|Adverse Event|2|||
37992186|NCT00355082|69677258|FG001|Continuation Phase|Adverse Event|0|||
37992187|NCT00355082|69677259|FG002|Continuation Phase|Adverse Event|1|||
37992188|NCT00355082|69677257|FG000|Continuation Phase|Lost to Follow-up|2|||
37992189|NCT00355082|69677258|FG001|Continuation Phase|Lost to Follow-up|0|||
37992190|NCT00355082|69677259|FG002|Continuation Phase|Lost to Follow-up|1|||
37992191|NCT00355082|69677257|FG000|Continuation Phase|Protocol Violation|1|||
37992192|NCT00355082|69677258|FG001|Continuation Phase|Protocol Violation|0|||
37992193|NCT00355082|69677259|FG002|Continuation Phase|Protocol Violation|1|||
37992194|NCT00355082|69677257|FG000|Continuation Phase|Withdrawal by Subject|4|||
37992195|NCT00355082|69677258|FG001|Continuation Phase|Withdrawal by Subject|0|||
37992196|NCT00355082|69677259|FG002|Continuation Phase|Withdrawal by Subject|0|||
37992197|NCT00355082|69677257|FG000|Continuation Phase|Lack of Efficacy|5|||
37992198|NCT00355082|69677258|FG001|Continuation Phase|Lack of Efficacy|0|||
37992199|NCT00355082|69677259|FG002|Continuation Phase|Lack of Efficacy|0|||
37992200|NCT00355082|69677257|FG000|Continuation Phase|Site Closed by Sponsor|8|||
37992201|NCT00355082|69677258|FG001|Continuation Phase|Site Closed by Sponsor|0|||
37992202|NCT00355082|69677259|FG002|Continuation Phase|Site Closed by Sponsor|0|||
37992203|NCT00355082|69677257|FG000|Continuation Phase|Scheduling Error|1|||
37992204|NCT00355082|69677258|FG001|Continuation Phase|Scheduling Error|0|||
37992205|NCT00355082|69677259|FG002|Continuation Phase|Scheduling Error|0|||
37992206|NCT00355082|69677257|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
37825223|NCT03271021|69507226|FG001|Overall Study|Adverse Event|2|||
37825224|NCT03271021|69507225|FG000|Overall Study|Withdrawal by Subject|36|||
37825225|NCT03271021|69507226|FG001|Overall Study|Withdrawal by Subject|53|||
37825226|NCT03271021|69507225|FG000|Overall Study|Lost to Follow-up|34|||
37825227|NCT03271021|69507226|FG001|Overall Study|Lost to Follow-up|39|||
37825228|NCT03271021|69507225|FG000|Overall Study|Protocol Violation|6|||
37825229|NCT03271021|69507226|FG001|Overall Study|Protocol Violation|4|||
37825230|NCT03271021|69507225|FG000|Overall Study|Abnormal Lab Results|1|||
37825231|NCT03271021|69507226|FG001|Overall Study|Abnormal Lab Results|0|||
37825232|NCT03271021|69507225|FG000|Overall Study|Miscellaneous|9|||
37825233|NCT03271021|69507226|FG001|Overall Study|Miscellaneous|8|||
37825234|NCT01249651|69507247|FG000|Overall Study|Withdrawal by Subject|4|||
37825235|NCT01249651|69507247|FG000|Overall Study|Adverse Event|1|||
37825236|NCT01249651|69507247|FG000|Overall Study|Protocol Violation|1|||
37825237|NCT01249651|69507247|FG000|Overall Study|Sponsor Decision|1|||
37825238|NCT01249417|69507254|FG000|Randomised Population|Study treatment not received|0|||
37825239|NCT01249417|69507255|FG001|Randomised Population|Study treatment not received|0|||
37992207|NCT00355082|69677258|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
37992208|NCT00355082|69677259|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
37992209|NCT00502307|69677270|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
37992210|NCT00502307|69677271|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
37992211|NCT00502307|69677272|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
37992212|NCT00502307|69677270|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
37992213|NCT00502307|69677271|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
37992214|NCT00502307|69677272|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
37992215|NCT00502307|69677270|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
37992216|NCT00502307|69677271|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
37992217|NCT00502307|69677272|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
37992218|NCT00502307|69677270|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
37992219|NCT00502307|69677271|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
37992220|NCT00502307|69677272|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
37992221|NCT00502307|69677270|FG000|Maintenance Period|Progressive disease|80|||
37992222|NCT00502307|69677271|FG001|Maintenance Period|Progressive disease|0|||
37992223|NCT00502307|69677272|FG002|Maintenance Period|Progressive disease|0|||
37992224|NCT00502307|69677270|FG000|Maintenance Period|Discontinued due to other reasons|68|||
37992225|NCT00502307|69677271|FG001|Maintenance Period|Discontinued due to other reasons|0|||
37992226|NCT00502307|69677272|FG002|Maintenance Period|Discontinued due to other reasons|0|||
37992227|NCT00484679|69677289|FG000|Overall Study|Withdrawal by Subject|3|||
37992228|NCT00377312|69677295|FG000|Overall Study|Adverse Event|1|||
37992229|NCT00377312|69677296|FG001|Overall Study|Adverse Event|1|||
37992230|NCT00377234|69677304|FG000|Overall Study|Adverse Event|14|||
37992231|NCT00377234|69677305|FG001|Overall Study|Adverse Event|17|||
37992232|NCT00377234|69677304|FG000|Overall Study|Withdrawal by Subject|11|||
37992233|NCT00377234|69677305|FG001|Overall Study|Withdrawal by Subject|9|||
37992234|NCT00377234|69677304|FG000|Overall Study|Lost to Follow-up|4|||
37992235|NCT00377234|69677305|FG001|Overall Study|Lost to Follow-up|2|||
37992236|NCT00377234|69677304|FG000|Overall Study|Administrative|2|||
37992237|NCT00377234|69677305|FG001|Overall Study|Administrative|1|||
37992238|NCT00377234|69677304|FG000|Overall Study|Not assigned|3|||
37992239|NCT00377234|69677305|FG001|Overall Study|Not assigned|2|||
37992240|NCT00377156|69677319|FG000|Overall Study|Death|23|||
37992241|NCT00377156|69677320|FG001|Overall Study|Death|19|||
37992242|NCT00377156|69677319|FG000|Overall Study|Withdrawal by Subject|16|||
37992243|NCT00377156|69677320|FG001|Overall Study|Withdrawal by Subject|24|||
37992244|NCT00377156|69677319|FG000|Overall Study|Had follow-up <90 d|3|||
37992245|NCT00377156|69677320|FG001|Overall Study|Had follow-up <90 d|6|||
37992246|NCT00377156|69677319|FG000|Overall Study|Cancellation|1|||
37992247|NCT00377156|69677320|FG001|Overall Study|Cancellation|0|||
37992248|NCT00377156|69677319|FG000|Overall Study|Refused testing|0|||
37992249|NCT00377156|69677320|FG001|Overall Study|Refused testing|1|||
37992250|NCT00377156|69677319|FG000|Overall Study|Ineligible|0|||
37992251|NCT00377156|69677320|FG001|Overall Study|Ineligible|1|||
37992252|NCT00377156|69677319|FG000|Overall Study|Disability or language problem|0|||
37992253|NCT00377156|69677320|FG001|Overall Study|Disability or language problem|1|||
37992254|NCT00377156|69677319|FG000|Overall Study|Other|5|||
37992255|NCT00377156|69677320|FG001|Overall Study|Other|2|||
37992256|NCT00376688|69677328|FG000|Overall Study|Adverse Event|3|||
37992257|NCT00376688|69677328|FG000|Overall Study|Death|1|||
37992258|NCT00376532|69677334|FG000|Overall Study|Lack sufficient blood sample|6|||
37992259|NCT00376532|69677335|FG001|Overall Study|Lack sufficient blood sample|6|||
37992260|NCT00376220|69677343|FG000|Overall Study|Lost to Follow-up|7|||
37992261|NCT00376220|69677344|FG001|Overall Study|Lost to Follow-up|10|||
37992262|NCT00376220|69677343|FG000|Overall Study|Withdrawal by Subject|3|||
37992263|NCT00376220|69677344|FG001|Overall Study|Withdrawal by Subject|2|||
37992264|NCT00375752|69677352|FG000|Overall Study|Lack of Efficacy|4|||
37992265|NCT00375752|69677353|FG001|Overall Study|Lack of Efficacy|4|||
37992266|NCT00375752|69677352|FG000|Overall Study|Adverse Event|1|||
37992267|NCT00375752|69677353|FG001|Overall Study|Adverse Event|6|||
37992268|NCT00375752|69677352|FG000|Overall Study|Withdrawal by Subject|6|||
37992269|NCT00375752|69677353|FG001|Overall Study|Withdrawal by Subject|1|||
37992270|NCT00375752|69677352|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
37992271|NCT00375752|69677353|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
37992272|NCT00375752|69677352|FG000|Overall Study|Protocol Violation|0|||
37992273|NCT00375752|69677353|FG001|Overall Study|Protocol Violation|2|||
37992274|NCT00375752|69677352|FG000|Overall Study|Administrative Problems|0|||
37992275|NCT00375752|69677353|FG001|Overall Study|Administrative Problems|1|||
37992276|NCT00484289|69677362|FG000|Long Term Phase|Adverse Event|1|||
37992277|NCT00484289|69677363|FG001|Long Term Phase|Adverse Event|17|||
37992278|NCT00484289|69677364|FG002|Long Term Phase|Adverse Event|5|||
37992279|NCT00484289|69677362|FG000|Long Term Phase|Withdrawal by Subject|0|||
37992280|NCT00484289|69677363|FG001|Long Term Phase|Withdrawal by Subject|7|||
37992281|NCT00484289|69677364|FG002|Long Term Phase|Withdrawal by Subject|6|||
37992282|NCT00484289|69677362|FG000|Long Term Phase|Inadequate response|2|||
37992283|NCT00484289|69677363|FG001|Long Term Phase|Inadequate response|7|||
37992284|NCT00484289|69677364|FG002|Long Term Phase|Inadequate response|4|||
37992285|NCT00484289|69677362|FG000|Long Term Phase|Other Reason|0|||
37992286|NCT00484289|69677363|FG001|Long Term Phase|Other Reason|5|||
37992287|NCT00484289|69677364|FG002|Long Term Phase|Other Reason|1|||
37992288|NCT00484289|69677362|FG000|Post Marketing Phase|Adverse Event|0|||
37992289|NCT00484289|69677363|FG001|Post Marketing Phase|Adverse Event|1|||
37992290|NCT00484289|69677364|FG002|Post Marketing Phase|Adverse Event|0|||
37992291|NCT00490529|69677373|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
37992292|NCT00490529|69677373|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
37992293|NCT00490529|69677373|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
37992294|NCT00490529|69677373|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
37992295|NCT00490529|69677373|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
37895729|NCT04605991|69581019|FG000|Overall Study|Lack of Efficacy|1|||
37895730|NCT04605991|69581019|FG000|Overall Study|Lost to Follow-up|8|||
37895731|NCT04605991|69581019|FG000|Overall Study|Physician Decision|4|||
37895732|NCT04605991|69581019|FG000|Overall Study|Withdrawal by Subject|14|||
37895733|NCT04605991|69581019|FG000|Overall Study|Non-compliance with study|1|||
37895734|NCT00783796|69581023|FG000|Overall Study|Did not receive any stent|4|||
37895735|NCT00783796|69581023|FG000|Overall Study|Received non-XIENCE V stent|1|||
37895736|NCT00783796|69581023|FG000|Overall Study|Received commercial XIENCE V stent|1|||
37895737|NCT00783718|69581032|FG000|Induction Phase|Adverse Event|4|||
37895738|NCT00783718|69581033|FG001|Induction Phase|Adverse Event|0|||
37895739|NCT00783718|69581034|FG002|Induction Phase|Adverse Event|7|||
37895740|NCT00783718|69581035|FG003|Induction Phase|Adverse Event|0|||
37895741|NCT00783718|69581036|FG004|Induction Phase|Adverse Event|0|||
37895742|NCT00783718|69581037|FG005|Induction Phase|Adverse Event|0|||
37895743|NCT00783718|69581038|FG006|Induction Phase|Adverse Event|0|||
37895744|NCT00783718|69581032|FG000|Induction Phase|Protocol Violation|1|||
37895745|NCT00783718|69581033|FG001|Induction Phase|Protocol Violation|1|||
37992296|NCT00490529|69677373|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
37992297|NCT00333840|69677379|FG000|First-line Treatment Period|Adverse Event|38|||
37992298|NCT00333840|69677380|FG001|First-line Treatment Period|Adverse Event|37|||
37992299|NCT00333840|69677381|FG002|First-line Treatment Period|Adverse Event|0|||
37992300|NCT00333840|69677382|FG003|First-line Treatment Period|Adverse Event|0|||
37992301|NCT00333840|69677379|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
37992302|NCT00333840|69677380|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
37992303|NCT00333840|69677381|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
37992304|NCT00333840|69677382|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
37992305|NCT00333840|69677379|FG000|First-line Treatment Period|Abnormal procedure|2|||
37992306|NCT00333840|69677380|FG001|First-line Treatment Period|Abnormal procedure|0|||
37992307|NCT00333840|69677381|FG002|First-line Treatment Period|Abnormal procedure|0|||
37992308|NCT00333840|69677382|FG003|First-line Treatment Period|Abnormal procedure|0|||
37992309|NCT00333840|69677379|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
37992310|NCT00333840|69677380|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
37992311|NCT00333840|69677381|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
37992312|NCT00333840|69677382|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
37992313|NCT00333840|69677379|FG000|First-line Treatment Period|No longer required study drug|21|||
37992314|NCT00333840|69677380|FG001|First-line Treatment Period|No longer required study drug|8|||
37992315|NCT00333840|69677381|FG002|First-line Treatment Period|No longer required study drug|0|||
37992316|NCT00333840|69677382|FG003|First-line Treatment Period|No longer required study drug|0|||
37895746|NCT00783718|69581034|FG002|Induction Phase|Protocol Violation|6|||
37895747|NCT00783718|69581035|FG003|Induction Phase|Protocol Violation|0|||
37895748|NCT00783718|69581036|FG004|Induction Phase|Protocol Violation|0|||
37992317|NCT00333840|69677379|FG000|First-line Treatment Period|Protocol Violation|17|||
37992318|NCT00333840|69677380|FG001|First-line Treatment Period|Protocol Violation|17|||
37992319|NCT00333840|69677381|FG002|First-line Treatment Period|Protocol Violation|0|||
37992320|NCT00333840|69677382|FG003|First-line Treatment Period|Protocol Violation|0|||
37992321|NCT00333840|69677379|FG000|First-line Treatment Period|Subject withdrew consent|57|||
37992322|NCT00333840|69677380|FG001|First-line Treatment Period|Subject withdrew consent|77|||
37992323|NCT00333840|69677381|FG002|First-line Treatment Period|Subject withdrew consent|0|||
37992324|NCT00333840|69677382|FG003|First-line Treatment Period|Subject withdrew consent|0|||
37992325|NCT00333840|69677379|FG000|First-line Treatment Period|Lost to Follow-up|15|||
37992326|NCT00333840|69677380|FG001|First-line Treatment Period|Lost to Follow-up|6|||
37992327|NCT00333840|69677381|FG002|First-line Treatment Period|Lost to Follow-up|0|||
37992328|NCT00333840|69677382|FG003|First-line Treatment Period|Lost to Follow-up|0|||
37992329|NCT00333840|69677379|FG000|First-line Treatment Period|Administrative problems|12|||
37992330|NCT00333840|69677380|FG001|First-line Treatment Period|Administrative problems|6|||
37992331|NCT00333840|69677381|FG002|First-line Treatment Period|Administrative problems|0|||
37992332|NCT00333840|69677382|FG003|First-line Treatment Period|Administrative problems|0|||
37992333|NCT00333840|69677379|FG000|First-line Treatment Period|Death|19|||
37992334|NCT00333840|69677380|FG001|First-line Treatment Period|Death|2|||
37992335|NCT00333840|69677381|FG002|First-line Treatment Period|Death|0|||
37992336|NCT00333840|69677382|FG003|First-line Treatment Period|Death|0|||
37992337|NCT00333840|69677379|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
37992338|NCT00333840|69677380|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
37992339|NCT00333840|69677381|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
37992340|NCT00333840|69677382|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
37992341|NCT00333840|69677379|FG000|Second-line Treatment Period|Adverse Event|0|||
37992342|NCT00333840|69677380|FG001|Second-line Treatment Period|Adverse Event|0|||
37992343|NCT00333840|69677381|FG002|Second-line Treatment Period|Adverse Event|3|||
37992344|NCT00333840|69677382|FG003|Second-line Treatment Period|Adverse Event|34|||
37992345|NCT00333840|69677379|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
37992346|NCT00333840|69677380|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
37992347|NCT00333840|69677381|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
37992348|NCT00333840|69677382|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
37992349|NCT00333840|69677379|FG000|Second-line Treatment Period|Abnormal procedure|0|||
37992350|NCT00333840|69677380|FG001|Second-line Treatment Period|Abnormal procedure|0|||
37992351|NCT00333840|69677381|FG002|Second-line Treatment Period|Abnormal procedure|0|||
37992352|NCT00333840|69677382|FG003|Second-line Treatment Period|Abnormal procedure|1|||
37992353|NCT00333840|69677379|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
37992354|NCT00333840|69677380|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
37992355|NCT00333840|69677381|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
37992356|NCT00333840|69677382|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
37992357|NCT00333840|69677379|FG000|Second-line Treatment Period|No longer required study drug|0|||
37992358|NCT00333840|69677380|FG001|Second-line Treatment Period|No longer required study drug|0|||
37992359|NCT00333840|69677381|FG002|Second-line Treatment Period|No longer required study drug|1|||
37992360|NCT00333840|69677382|FG003|Second-line Treatment Period|No longer required study drug|14|||
37992361|NCT00333840|69677379|FG000|Second-line Treatment Period|Protocol Violation|0|||
37992362|NCT00333840|69677380|FG001|Second-line Treatment Period|Protocol Violation|0|||
37992363|NCT00333840|69677381|FG002|Second-line Treatment Period|Protocol Violation|1|||
37992364|NCT00333840|69677382|FG003|Second-line Treatment Period|Protocol Violation|10|||
37992365|NCT00333840|69677379|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
37992366|NCT00333840|69677380|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
37992367|NCT00333840|69677381|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
37992368|NCT00333840|69677382|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
37992369|NCT00333840|69677379|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
37992370|NCT00333840|69677380|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
37992371|NCT00333840|69677381|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
37992372|NCT00333840|69677382|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
37992373|NCT00333840|69677379|FG000|Second-line Treatment Period|Administrative problems|0|||
37992374|NCT00333840|69677380|FG001|Second-line Treatment Period|Administrative problems|0|||
37992375|NCT00333840|69677381|FG002|Second-line Treatment Period|Administrative problems|0|||
37992376|NCT00333840|69677382|FG003|Second-line Treatment Period|Administrative problems|7|||
37992377|NCT00333840|69677379|FG000|Second-line Treatment Period|Death|0|||
37992378|NCT00333840|69677380|FG001|Second-line Treatment Period|Death|0|||
37992379|NCT00333840|69677381|FG002|Second-line Treatment Period|Death|0|||
37895749|NCT00783718|69581037|FG005|Induction Phase|Protocol Violation|0|||
37895750|NCT00783718|69581038|FG006|Induction Phase|Protocol Violation|0|||
37992380|NCT00333840|69677382|FG003|Second-line Treatment Period|Death|9|||
37992381|NCT00490451|69677398|FG000|Overall Study|Adverse Event|3|||
37992382|NCT00490451|69677399|FG001|Overall Study|Adverse Event|3|||
37992383|NCT00490451|69677398|FG000|Overall Study|Death|3|||
37992384|NCT00490451|69677399|FG001|Overall Study|Death|1|||
37992385|NCT00490451|69677398|FG000|Overall Study|Withdrawal by Subject|2|||
37992386|NCT00490451|69677399|FG001|Overall Study|Withdrawal by Subject|0|||
37992387|NCT00490451|69677398|FG000|Overall Study|Investigator Decision|1|||
37992388|NCT00490451|69677399|FG001|Overall Study|Investigator Decision|0|||
37992389|NCT00490451|69677398|FG000|Overall Study|Protocol Violation|1|||
37992390|NCT00490451|69677399|FG001|Overall Study|Protocol Violation|0|||
37992391|NCT00490451|69677398|FG000|Overall Study|Progressive Disease|53|||
37992392|NCT00490451|69677399|FG001|Overall Study|Progressive Disease|34|||
37992393|NCT00321906|69677407|FG000|Overall Study|Adverse Event|36|||
37992394|NCT00321906|69677408|FG001|Overall Study|Adverse Event|44|||
37992395|NCT00321906|69677407|FG000|Overall Study|Death|9|||
37992396|NCT00321906|69677408|FG001|Overall Study|Death|6|||
37992397|NCT00321906|69677407|FG000|Overall Study|Lost to Follow-up|1|||
37992398|NCT00321906|69677408|FG001|Overall Study|Lost to Follow-up|2|||
37992399|NCT00321906|69677407|FG000|Overall Study|Withdrawal by Subject|0|||
37992400|NCT00321906|69677408|FG001|Overall Study|Withdrawal by Subject|4|||
37992401|NCT00339144|69677417|FG000|Overall Study|Disease progression|5|||
37992402|NCT00339144|69677418|FG001|Overall Study|Disease progression|2|||
37992403|NCT00339144|69677419|FG002|Overall Study|Disease progression|2|||
37992404|NCT00339144|69677417|FG000|Overall Study|Study drug toxicity|3|||
37992405|NCT00339144|69677418|FG001|Overall Study|Study drug toxicity|1|||
37992406|NCT00339144|69677419|FG002|Overall Study|Study drug toxicity|1|||
37992407|NCT00339144|69677417|FG000|Overall Study|Participant's request to discontinuation|1|||
37992408|NCT00339144|69677418|FG001|Overall Study|Participant's request to discontinuation|0|||
37992409|NCT00339144|69677419|FG002|Overall Study|Participant's request to discontinuation|1|||
37992410|NCT00321828|69677428|FG000|Overall Study|Ineligible|3|||
37992411|NCT00321828|69677428|FG000|Overall Study|No follow up data|1|||
37992412|NCT00333138|69677435|FG000|Core Study (6 Months)|Adverse Event|4|||
37992413|NCT00333138|69677436|FG001|Core Study (6 Months)|Adverse Event|5|||
37992414|NCT00333138|69677437|FG002|Core Study (6 Months)|Adverse Event|8|||
37992415|NCT00333138|69677435|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
37992416|NCT00333138|69677436|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
37992417|NCT00333138|69677437|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
37992418|NCT00333138|69677435|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
37992419|NCT00333138|69677436|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
37992420|NCT00333138|69677437|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
37992421|NCT00333138|69677435|FG000|Core Study (6 Months)|Protocol Violation|1|||
37992422|NCT00333138|69677436|FG001|Core Study (6 Months)|Protocol Violation|0|||
37992423|NCT00333138|69677437|FG002|Core Study (6 Months)|Protocol Violation|1|||
37992424|NCT00333138|69677435|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
37992425|NCT00333138|69677436|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
37992426|NCT00333138|69677437|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
37992427|NCT00333138|69677435|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
37992428|NCT00333138|69677436|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
37992429|NCT00333138|69677437|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
37992430|NCT00333138|69677435|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
37992431|NCT00333138|69677436|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
37992432|NCT00333138|69677437|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
37992433|NCT00333138|69677435|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
37992434|NCT00333138|69677436|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
37825240|NCT01249417|69507256|FG002|Randomised Population|Study treatment not received|2|||
37825241|NCT01249417|69507254|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
37825242|NCT01249417|69507255|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
37825243|NCT01249417|69507256|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
37825244|NCT01249417|69507254|FG000|Treatment Phase - ITT Population|Other|0|||
37825245|NCT01249417|69507255|FG001|Treatment Phase - ITT Population|Other|0|||
37825246|NCT01249417|69507256|FG002|Treatment Phase - ITT Population|Other|1|||
37825247|NCT01249417|69507254|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
37825248|NCT01249417|69507255|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
37825249|NCT01249417|69507256|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
37825250|NCT01249417|69507254|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
37825251|NCT01249417|69507255|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
37825252|NCT01249417|69507256|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
37825253|NCT01249417|69507254|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
37825254|NCT01249417|69507255|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
37825255|NCT01249417|69507256|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
37895751|NCT00783718|69581032|FG000|Induction Phase|Lack of Efficacy|5|||
37992435|NCT00333138|69677437|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
37696235|NCT02465567|69172376|FG002|Overall Study|Protocol Specified Criteria|9|||
37696236|NCT02465567|69172377|FG003|Overall Study|Protocol Specified Criteria|12|||
37992436|NCT00333138|69677435|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
37992437|NCT00333138|69677436|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
37992438|NCT00333138|69677437|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
37992439|NCT00333138|69677435|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
37992440|NCT00333138|69677436|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
37992441|NCT00333138|69677437|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
37992442|NCT00333138|69677435|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
37992443|NCT00333138|69677436|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
37992444|NCT00333138|69677437|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
37992445|NCT00333138|69677435|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
37992446|NCT00333138|69677436|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
37992447|NCT00333138|69677437|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
37992448|NCT00333138|69677435|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
37992449|NCT00333138|69677436|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
37992450|NCT00333138|69677437|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
37992451|NCT00333138|69677435|FG000|Extension Study (Month6 to End of Study)|Death|0|||
37992452|NCT00333138|69677436|FG001|Extension Study (Month6 to End of Study)|Death|1|||
37992453|NCT00333138|69677437|FG002|Extension Study (Month6 to End of Study)|Death|0|||
37992454|NCT00332202|69677449|FG000|Overall Study|Adverse Event|72|||
37992455|NCT00332202|69677450|FG001|Overall Study|Adverse Event|28|||
37992456|NCT00332202|69677449|FG000|Overall Study|Lost to Follow-up|2|||
37992457|NCT00332202|69677450|FG001|Overall Study|Lost to Follow-up|1|||
37992458|NCT00332202|69677449|FG000|Overall Study|Physician Decision|6|||
37992459|NCT00332202|69677450|FG001|Overall Study|Physician Decision|8|||
37992460|NCT00332202|69677449|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
37992461|NCT00332202|69677450|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
37992462|NCT00332202|69677449|FG000|Overall Study|Protocol Violation|7|||
37992463|NCT00332202|69677450|FG001|Overall Study|Protocol Violation|2|||
37992464|NCT00332202|69677449|FG000|Overall Study|Sponsor Decision|1|||
37992465|NCT00332202|69677450|FG001|Overall Study|Sponsor Decision|2|||
37992466|NCT00332202|69677449|FG000|Overall Study|Withdrawal by Subject|36|||
37992467|NCT00332202|69677450|FG001|Overall Study|Withdrawal by Subject|17|||
37992468|NCT00332202|69677449|FG000|Overall Study|Progressive Disease|106|||
37992469|NCT00332202|69677450|FG001|Overall Study|Progressive Disease|60|||
37992470|NCT00332202|69677449|FG000|Overall Study|Death|5|||
37992471|NCT00332202|69677450|FG001|Overall Study|Death|2|||
37992472|NCT00331422|69677465|FG000|Overall Study|Did not receive entire study regimen|5|||
37992473|NCT00331344|69677470|FG000|Phase I|Adverse Event|0|||
37992474|NCT00331344|69677471|FG001|Phase I|Adverse Event|0|||
37992475|NCT00331344|69677472|FG002|Phase I|Adverse Event|0|||
37992476|NCT00331344|69677473|FG003|Phase I|Adverse Event|1|||
37992477|NCT00331344|69677474|FG004|Phase I|Adverse Event|2|||
37992478|NCT00331344|69677475|FG005|Phase I|Adverse Event|2|||
37895752|NCT00783718|69581033|FG001|Induction Phase|Lack of Efficacy|2|||
37895753|NCT00783718|69581034|FG002|Induction Phase|Lack of Efficacy|14|||
37895754|NCT00783718|69581035|FG003|Induction Phase|Lack of Efficacy|0|||
37895755|NCT00783718|69581036|FG004|Induction Phase|Lack of Efficacy|0|||
37895756|NCT00783718|69581037|FG005|Induction Phase|Lack of Efficacy|0|||
37895757|NCT00783718|69581038|FG006|Induction Phase|Lack of Efficacy|0|||
37895758|NCT00783718|69581032|FG000|Induction Phase|Withdrawal by Subject|3|||
37895759|NCT00783718|69581033|FG001|Induction Phase|Withdrawal by Subject|4|||
37895760|NCT00783718|69581034|FG002|Induction Phase|Withdrawal by Subject|8|||
37895761|NCT00783718|69581035|FG003|Induction Phase|Withdrawal by Subject|0|||
37895762|NCT00783718|69581036|FG004|Induction Phase|Withdrawal by Subject|0|||
37895763|NCT00783718|69581037|FG005|Induction Phase|Withdrawal by Subject|0|||
37895764|NCT00783718|69581038|FG006|Induction Phase|Withdrawal by Subject|0|||
37895765|NCT00783718|69581032|FG000|Induction Phase|Lost to Follow-up|1|||
37895766|NCT00783718|69581033|FG001|Induction Phase|Lost to Follow-up|0|||
37895767|NCT00783718|69581034|FG002|Induction Phase|Lost to Follow-up|1|||
37895768|NCT00783718|69581035|FG003|Induction Phase|Lost to Follow-up|0|||
37992479|NCT00331344|69677476|FG006|Phase I|Adverse Event|0|||
37992480|NCT00331344|69677477|FG007|Phase I|Adverse Event|1|||
37895769|NCT00783718|69581036|FG004|Induction Phase|Lost to Follow-up|0|||
37895770|NCT00783718|69581037|FG005|Induction Phase|Lost to Follow-up|0|||
37992481|NCT00331344|69677478|FG008|Phase I|Adverse Event|0|||
37992482|NCT00331344|69677470|FG000|Phase II|Death|0|||
37992483|NCT00331344|69677471|FG001|Phase II|Death|0|||
37992484|NCT00331344|69677472|FG002|Phase II|Death|0|||
37992485|NCT00331344|69677473|FG003|Phase II|Death|0|||
37992486|NCT00331344|69677474|FG004|Phase II|Death|0|||
37895771|NCT00783718|69581038|FG006|Induction Phase|Lost to Follow-up|0|||
37895772|NCT00783718|69581032|FG000|Maintenance Phase|Adverse Event|12|||
37895773|NCT00783718|69581033|FG001|Maintenance Phase|Adverse Event|0|||
37895774|NCT00783718|69581034|FG002|Maintenance Phase|Adverse Event|0|||
37895775|NCT00783718|69581035|FG003|Maintenance Phase|Adverse Event|15|||
37992487|NCT00331344|69677475|FG005|Phase II|Death|0|||
37992488|NCT00331344|69677476|FG006|Phase II|Death|0|||
37992489|NCT00331344|69677477|FG007|Phase II|Death|0|||
37992490|NCT00331344|69677478|FG008|Phase II|Death|4|||
37992491|NCT00321672|69677495|FG000|Overall Study|Withdrawal by Subject|5|||
37992492|NCT00321672|69677496|FG001|Overall Study|Withdrawal by Subject|1|||
37992493|NCT00321672|69677497|FG002|Overall Study|Withdrawal by Subject|2|||
37992494|NCT00321672|69677498|FG003|Overall Study|Withdrawal by Subject|0|||
37992495|NCT00321672|69677495|FG000|Overall Study|Noncompliance|1|||
37992496|NCT00321672|69677496|FG001|Overall Study|Noncompliance|2|||
37992497|NCT00321672|69677497|FG002|Overall Study|Noncompliance|1|||
37992498|NCT00321672|69677498|FG003|Overall Study|Noncompliance|0|||
37992499|NCT00321672|69677495|FG000|Overall Study|Adverse Event|1|||
37992500|NCT00321672|69677496|FG001|Overall Study|Adverse Event|1|||
37992501|NCT00321672|69677497|FG002|Overall Study|Adverse Event|0|||
37992502|NCT00321672|69677498|FG003|Overall Study|Adverse Event|0|||
37992503|NCT00321672|69677495|FG000|Overall Study|Lack of Efficacy|1|||
37992504|NCT00321672|69677496|FG001|Overall Study|Lack of Efficacy|1|||
37992505|NCT00321672|69677497|FG002|Overall Study|Lack of Efficacy|0|||
37992506|NCT00321672|69677498|FG003|Overall Study|Lack of Efficacy|0|||
37992507|NCT00321672|69677495|FG000|Overall Study|Lost to Follow-up|2|||
37992508|NCT00321672|69677496|FG001|Overall Study|Lost to Follow-up|0|||
37992509|NCT00321672|69677497|FG002|Overall Study|Lost to Follow-up|4|||
37992510|NCT00321672|69677498|FG003|Overall Study|Lost to Follow-up|2|||
37992511|NCT00321672|69677495|FG000|Overall Study|Death|1|||
37992512|NCT00321672|69677496|FG001|Overall Study|Death|0|||
37992513|NCT00321672|69677497|FG002|Overall Study|Death|0|||
37992514|NCT00321672|69677498|FG003|Overall Study|Death|0|||
37992515|NCT00321672|69677495|FG000|Overall Study|Too far to travel for visits|1|||
37895776|NCT00783718|69581036|FG004|Maintenance Phase|Adverse Event|7|||
37895777|NCT00783718|69581037|FG005|Maintenance Phase|Adverse Event|6|||
37992516|NCT00321672|69677496|FG001|Overall Study|Too far to travel for visits|0|||
37992517|NCT00321672|69677497|FG002|Overall Study|Too far to travel for visits|0|||
37992518|NCT00321672|69677498|FG003|Overall Study|Too far to travel for visits|0|||
37992519|NCT00321672|69677495|FG000|Overall Study|Incarcerated|0|||
37992520|NCT00321672|69677496|FG001|Overall Study|Incarcerated|0|||
37992521|NCT00321672|69677497|FG002|Overall Study|Incarcerated|2|||
37992522|NCT00321672|69677498|FG003|Overall Study|Incarcerated|0|||
37992523|NCT00321672|69677495|FG000|Overall Study|Moved out of state|0|||
37992524|NCT00321672|69677496|FG001|Overall Study|Moved out of state|1|||
37992525|NCT00321672|69677497|FG002|Overall Study|Moved out of state|1|||
37992526|NCT00321672|69677498|FG003|Overall Study|Moved out of state|0|||
37992527|NCT00321672|69677495|FG000|Overall Study|Protocol Violation|0|||
37992528|NCT00321672|69677496|FG001|Overall Study|Protocol Violation|0|||
37992529|NCT00321672|69677497|FG002|Overall Study|Protocol Violation|1|||
37992530|NCT00321672|69677498|FG003|Overall Study|Protocol Violation|0|||
37992531|NCT00321672|69677495|FG000|Overall Study|Diagnosis of testicular cancer|0|||
37992532|NCT00321672|69677496|FG001|Overall Study|Diagnosis of testicular cancer|1|||
37992533|NCT00321672|69677497|FG002|Overall Study|Diagnosis of testicular cancer|0|||
37992534|NCT00321672|69677498|FG003|Overall Study|Diagnosis of testicular cancer|0|||
37992535|NCT00321672|69677495|FG000|Overall Study|Extensive travel required for new job|0|||
37992536|NCT00321672|69677496|FG001|Overall Study|Extensive travel required for new job|1|||
37992537|NCT00321672|69677497|FG002|Overall Study|Extensive travel required for new job|0|||
37992538|NCT00321672|69677498|FG003|Overall Study|Extensive travel required for new job|0|||
37992539|NCT00321048|69677514|FG000|Overall Study|Withdrawal by Subject|6|||
37992540|NCT00321048|69677515|FG001|Overall Study|Withdrawal by Subject|8|||
37992541|NCT00330174|69677523|FG000|Overall Study|Withdrawal by Subject|7|||
37895778|NCT00783718|69581038|FG006|Maintenance Phase|Adverse Event|16|||
37992542|NCT00330174|69677524|FG001|Overall Study|Withdrawal by Subject|7|||
37992543|NCT00330174|69677523|FG000|Overall Study|Lost to Follow-up|4|||
37992544|NCT00330174|69677524|FG001|Overall Study|Lost to Follow-up|1|||
37992545|NCT00330174|69677523|FG000|Overall Study|Clinical deterioration|1|||
37992546|NCT00330174|69677524|FG001|Overall Study|Clinical deterioration|2|||
37992547|NCT00330174|69677523|FG000|Overall Study|Excessive missed visits|3|||
37992548|NCT00330174|69677524|FG001|Overall Study|Excessive missed visits|8|||
37992549|NCT00330174|69677523|FG000|Overall Study|Miscellaneous reasons|7|||
37992550|NCT00330174|69677524|FG001|Overall Study|Miscellaneous reasons|1|||
37895779|NCT00783718|69581032|FG000|Maintenance Phase|Protocol Violation|1|||
37992551|NCT00320424|69677530|FG000|Overall Study|Adverse Event|3|||
37992552|NCT00320424|69677530|FG000|Overall Study|Other|3|||
37992553|NCT00338286|69677536|FG000|Overall Study|Withdrawal by Subject|50|||
37992554|NCT00338286|69677537|FG001|Overall Study|Withdrawal by Subject|54|||
37992555|NCT00338286|69677536|FG000|Overall Study|Lost to Follow-up|80|||
37992556|NCT00338286|69677537|FG001|Overall Study|Lost to Follow-up|66|||
37992557|NCT00338286|69677536|FG000|Overall Study|Other|103|||
37992558|NCT00338286|69677537|FG001|Overall Study|Other|93|||
37992559|NCT00329784|69677547|FG000|Overall Study|Lost to Follow-up|0|||
37992560|NCT00329784|69677548|FG001|Overall Study|Lost to Follow-up|1|||
37992561|NCT00329784|69677549|FG002|Overall Study|Lost to Follow-up|0|||
37992562|NCT00329784|69677550|FG003|Overall Study|Lost to Follow-up|0|||
37992563|NCT00329784|69677547|FG000|Overall Study|Withdrawal by Subject|4|||
37992564|NCT00329784|69677548|FG001|Overall Study|Withdrawal by Subject|2|||
37992565|NCT00329784|69677549|FG002|Overall Study|Withdrawal by Subject|0|||
37992566|NCT00329784|69677550|FG003|Overall Study|Withdrawal by Subject|0|||
37992567|NCT00329784|69677547|FG000|Overall Study|Other|1|||
37992568|NCT00329784|69677548|FG001|Overall Study|Other|2|||
37992569|NCT00329784|69677549|FG002|Overall Study|Other|0|||
37992570|NCT00329784|69677550|FG003|Overall Study|Other|0|||
37992571|NCT00337818|69677565|FG000|Overall Study|Lost to Follow-up|289|||
37992572|NCT00337818|69677566|FG001|Overall Study|Lost to Follow-up|91|||
37992573|NCT00337818|69677567|FG002|Overall Study|Lost to Follow-up|107|||
37992574|NCT00329550|69677578|FG000|Overall Study|Adverse Event|3|||
37992575|NCT00329550|69677579|FG001|Overall Study|Adverse Event|4|||
37992576|NCT00329550|69677580|FG002|Overall Study|Adverse Event|2|||
37992577|NCT00329550|69677578|FG000|Overall Study|Withdrawal of Consent|1|||
37992578|NCT00329550|69677579|FG001|Overall Study|Withdrawal of Consent|0|||
37992579|NCT00329550|69677580|FG002|Overall Study|Withdrawal of Consent|1|||
37992580|NCT00329550|69677578|FG000|Overall Study|Due to Relocation|0|||
37992581|NCT00329550|69677579|FG001|Overall Study|Due to Relocation|0|||
37992582|NCT00329550|69677580|FG002|Overall Study|Due to Relocation|1|||
37992583|NCT00375674|69677592|FG000|Overall Study|Other|26|||
37895780|NCT00783718|69581033|FG001|Maintenance Phase|Protocol Violation|0|||
37895781|NCT00783718|69581034|FG002|Maintenance Phase|Protocol Violation|0|||
37895782|NCT00783718|69581035|FG003|Maintenance Phase|Protocol Violation|0|||
37895783|NCT00783718|69581036|FG004|Maintenance Phase|Protocol Violation|0|||
37895784|NCT00783718|69581037|FG005|Maintenance Phase|Protocol Violation|0|||
37895785|NCT00783718|69581038|FG006|Maintenance Phase|Protocol Violation|2|||
37895786|NCT00783718|69581032|FG000|Maintenance Phase|Lack of Efficacy|83|||
37895787|NCT00783718|69581033|FG001|Maintenance Phase|Lack of Efficacy|0|||
37895788|NCT00783718|69581034|FG002|Maintenance Phase|Lack of Efficacy|0|||
37895789|NCT00783718|69581035|FG003|Maintenance Phase|Lack of Efficacy|61|||
37895790|NCT00783718|69581036|FG004|Maintenance Phase|Lack of Efficacy|31|||
37895791|NCT00783718|69581037|FG005|Maintenance Phase|Lack of Efficacy|33|||
37895792|NCT00783718|69581038|FG006|Maintenance Phase|Lack of Efficacy|155|||
37895793|NCT00783718|69581032|FG000|Maintenance Phase|Withdrawal by Subject|6|||
37895794|NCT00783718|69581033|FG001|Maintenance Phase|Withdrawal by Subject|0|||
37895795|NCT00783718|69581034|FG002|Maintenance Phase|Withdrawal by Subject|0|||
37895796|NCT00783718|69581035|FG003|Maintenance Phase|Withdrawal by Subject|2|||
37895797|NCT00783718|69581036|FG004|Maintenance Phase|Withdrawal by Subject|5|||
37992584|NCT00375674|69677593|FG001|Overall Study|Other|18|||
37992585|NCT00375674|69677592|FG000|Overall Study|Death|67|||
37992586|NCT00375674|69677593|FG001|Overall Study|Death|76|||
37992587|NCT00375674|69677592|FG000|Overall Study|Participants refused further follow-up|31|||
37992588|NCT00375674|69677593|FG001|Overall Study|Participants refused further follow-up|30|||
37992589|NCT00375674|69677592|FG000|Overall Study|Lost to Follow-up|17|||
37992590|NCT00375674|69677593|FG001|Overall Study|Lost to Follow-up|15|||
37992591|NCT00375674|69677592|FG000|Overall Study|Enrolled but not treated|3|||
37992592|NCT00375674|69677593|FG001|Overall Study|Enrolled but not treated|2|||
37992593|NCT00350402|69677601|FG000|Overall Study|Lost to Follow-up|1|||
37992594|NCT00350402|69677602|FG001|Overall Study|Lost to Follow-up|1|||
37992595|NCT00320190|69677616|FG000|First 12 Months|Completed but did not enter extension|5|||
37992596|NCT00320190|69677617|FG001|First 12 Months|Completed but did not enter extension|3|||
37992597|NCT00320190|69677616|FG000|First 12 Months|Sponsor terminated study|2|||
37992598|NCT00320190|69677617|FG001|First 12 Months|Sponsor terminated study|2|||
37992599|NCT00320190|69677616|FG000|First 12 Months|Lost to Follow-up|0|||
37992600|NCT00320190|69677617|FG001|First 12 Months|Lost to Follow-up|1|||
37895798|NCT00783718|69581037|FG005|Maintenance Phase|Withdrawal by Subject|2|||
37895799|NCT00783718|69581038|FG006|Maintenance Phase|Withdrawal by Subject|20|||
37895800|NCT00783718|69581032|FG000|Maintenance Phase|Lost to Follow-up|3|||
37895801|NCT00783718|69581033|FG001|Maintenance Phase|Lost to Follow-up|0|||
37992601|NCT00320190|69677616|FG000|First 12 Months|Enrollment failure|0|||
37992602|NCT00320190|69677617|FG001|First 12 Months|Enrollment failure|1|||
37992603|NCT00320190|69677616|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
37992604|NCT00320190|69677617|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
37992605|NCT00320190|69677616|FG000|First 12 Months|Investigator request|0|||
37895802|NCT00783718|69581034|FG002|Maintenance Phase|Lost to Follow-up|0|||
37992606|NCT00320190|69677617|FG001|First 12 Months|Investigator request|1|||
37992607|NCT00320190|69677616|FG000|First 12 Months|Study drug toxicity|0|||
37992608|NCT00320190|69677617|FG001|First 12 Months|Study drug toxicity|1|||
37992609|NCT00320190|69677616|FG000|First 12 Months|Withdrawal by Subject|0|||
37895803|NCT00783718|69581035|FG003|Maintenance Phase|Lost to Follow-up|0|||
37992610|NCT00320190|69677617|FG001|First 12 Months|Withdrawal by Subject|1|||
37992611|NCT00320190|69677616|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
37992612|NCT00320190|69677617|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
37992613|NCT00320190|69677616|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
37992614|NCT00320190|69677617|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
37992615|NCT00320190|69677616|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
37992616|NCT00320190|69677617|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
37895804|NCT00783718|69581036|FG004|Maintenance Phase|Lost to Follow-up|2|||
37895805|NCT00783718|69581037|FG005|Maintenance Phase|Lost to Follow-up|0|||
37895806|NCT00783718|69581038|FG006|Maintenance Phase|Lost to Follow-up|2|||
37992617|NCT00320112|69677625|FG000|Overall Study|Lost to Follow-up|3|||
37992618|NCT00320112|69677626|FG001|Overall Study|Lost to Follow-up|4|||
37992619|NCT00320112|69677625|FG000|Overall Study|Withdrawal by Subject|3|||
37992620|NCT00320112|69677626|FG001|Overall Study|Withdrawal by Subject|0|||
37992621|NCT00320112|69677625|FG000|Overall Study|Death|2|||
37992622|NCT00320112|69677626|FG001|Overall Study|Death|1|||
37992623|NCT00319956|69677640|FG000|Overall Study|Death|20|||
37992624|NCT00319956|69677641|FG001|Overall Study|Death|24|||
37992625|NCT00349622|69677649|FG000|Overall Study|Death|168|||
37992626|NCT00349622|69677650|FG001|Overall Study|Death|86|||
37992627|NCT00349622|69677649|FG000|Overall Study|Lost to Follow-up|5|||
37992628|NCT00349622|69677650|FG001|Overall Study|Lost to Follow-up|1|||
37992629|NCT00349622|69677649|FG000|Overall Study|Withdrawal by Subject|5|||
37992630|NCT00349622|69677650|FG001|Overall Study|Withdrawal by Subject|9|||
37992631|NCT00354614|69677656|FG000|Overall Study|Lack of Efficacy|28|||
37992632|NCT00360308|69677663|FG000|Overall Study|Adverse Event|15|||
37992633|NCT00360308|69677664|FG001|Overall Study|Adverse Event|14|||
37992634|NCT00360308|69677665|FG002|Overall Study|Adverse Event|25|||
37992635|NCT00360308|69677663|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
37992636|NCT00360308|69677664|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
37992637|NCT00360308|69677665|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
37992638|NCT00360308|69677663|FG000|Overall Study|Protocol Violation|2|||
37992639|NCT00360308|69677664|FG001|Overall Study|Protocol Violation|1|||
37992640|NCT00360308|69677665|FG002|Overall Study|Protocol Violation|2|||
37992641|NCT00360308|69677663|FG000|Overall Study|Withdrawal by Subject|11|||
37992642|NCT00360308|69677664|FG001|Overall Study|Withdrawal by Subject|7|||
37992643|NCT00360308|69677665|FG002|Overall Study|Withdrawal by Subject|14|||
37992644|NCT00360308|69677663|FG000|Overall Study|Lack of Efficacy|3|||
37992645|NCT00360308|69677664|FG001|Overall Study|Lack of Efficacy|0|||
37825256|NCT01249261|69507266|FG000|Overall Study|Withdrawal by Subject|1|||
37825257|NCT01249261|69507267|FG001|Overall Study|Withdrawal by Subject|0|||
37825258|NCT01248949|69507283|FG000|Overall Study|Lost to Follow-up|2|||
37825259|NCT01248949|69507284|FG001|Overall Study|Lost to Follow-up|2|||
37825260|NCT01248949|69507285|FG002|Overall Study|Lost to Follow-up|2|||
37825261|NCT01248949|69507286|FG003|Overall Study|Lost to Follow-up|1|||
37825262|NCT01248949|69507287|FG004|Overall Study|Lost to Follow-up|0|||
37825263|NCT01248949|69507283|FG000|Overall Study|Withdrawal by Subject|5|||
37895807|NCT00774748|69581057|FG000|Overall Study|Lost to Follow-up|3|||
37895808|NCT00587860|69581067|FG000|Overall Study|Lost to Follow-up|2|||
37895809|NCT00587860|69581068|FG001|Overall Study|Lost to Follow-up|2|||
37895810|NCT00587860|69581067|FG000|Overall Study|Withdrawal by Subject|3|||
37895811|NCT00587860|69581068|FG001|Overall Study|Withdrawal by Subject|3|||
37895812|NCT00583453|69581076|FG000|Overall Study|discontinued intervention|0|||
37895813|NCT00583453|69581077|FG001|Overall Study|discontinued intervention|2|||
37895814|NCT00583219|69581085|FG000|Phase 2|Withdrawal by Subject|1|||
37895815|NCT01072175|69581105|FG000|Part A (Drug-Drug Interaction)|Death|1|||
37895816|NCT01072175|69581106|FG001|Part A (Drug-Drug Interaction)|Death|0|||
37895817|NCT01072175|69581107|FG002|Part A (Drug-Drug Interaction)|Death|0|||
37895818|NCT01072175|69581108|FG003|Part A (Drug-Drug Interaction)|Death|0|||
37895819|NCT01072175|69581109|FG004|Part A (Drug-Drug Interaction)|Death|0|||
37895820|NCT01072175|69581110|FG005|Part A (Drug-Drug Interaction)|Death|0|||
37895821|NCT01072175|69581111|FG006|Part A (Drug-Drug Interaction)|Death|0|||
37825264|NCT01248949|69507284|FG001|Overall Study|Withdrawal by Subject|3|||
37825265|NCT01248949|69507285|FG002|Overall Study|Withdrawal by Subject|11|||
37895822|NCT01072175|69581112|FG007|Part A (Drug-Drug Interaction)|Death|0|||
37992646|NCT00360308|69677665|FG002|Overall Study|Lack of Efficacy|2|||
37992647|NCT00360308|69677663|FG000|Overall Study|Other|2|||
37992648|NCT00360308|69677664|FG001|Overall Study|Other|1|||
37992649|NCT00360308|69677665|FG002|Overall Study|Other|1|||
37992650|NCT00360308|69677663|FG000|Overall Study|Study termination by sponsor|43|||
37825266|NCT01248949|69507286|FG003|Overall Study|Withdrawal by Subject|3|||
37825267|NCT01248949|69507287|FG004|Overall Study|Withdrawal by Subject|1|||
37825268|NCT01248949|69507283|FG000|Overall Study|Death|22|||
37825269|NCT01248949|69507284|FG001|Overall Study|Death|7|||
37895823|NCT01072175|69581113|FG008|Part A (Drug-Drug Interaction)|Death|0|||
37895824|NCT01072175|69581114|FG009|Part A (Drug-Drug Interaction)|Death|0|||
37992651|NCT00360308|69677664|FG001|Overall Study|Study termination by sponsor|55|||
37992652|NCT00360308|69677665|FG002|Overall Study|Study termination by sponsor|44|||
37992653|NCT00348686|69677677|FG000|Overall Study|Withdrawal by Subject|45|||
37992654|NCT00348686|69677677|FG000|Overall Study|Adverse Event|5|||
37992655|NCT00348686|69677677|FG000|Overall Study|Protocol Violation|6|||
37992656|NCT00348686|69677677|FG000|Overall Study|Lost to Follow-up|2|||
37992657|NCT00348686|69677677|FG000|Overall Study|Multiple Reasons|8|||
37992658|NCT00360230|69677688|FG000|Overall Study|Withdrawal by Subject|1|||
37992659|NCT00360230|69677689|FG001|Overall Study|Withdrawal by Subject|1|||
37992660|NCT00360230|69677690|FG002|Overall Study|Withdrawal by Subject|0|||
37992661|NCT00360230|69677691|FG003|Overall Study|Withdrawal by Subject|1|||
37992662|NCT00360230|69677692|FG004|Overall Study|Withdrawal by Subject|1|||
37992663|NCT00360230|69677693|FG005|Overall Study|Withdrawal by Subject|1|||
37992664|NCT00360230|69677694|FG006|Overall Study|Withdrawal by Subject|0|||
37992665|NCT00360230|69677688|FG000|Overall Study|Migrated|4|||
37992666|NCT00360230|69677689|FG001|Overall Study|Migrated|1|||
37992667|NCT00360230|69677690|FG002|Overall Study|Migrated|3|||
37992668|NCT00360230|69677691|FG003|Overall Study|Migrated|1|||
37992669|NCT00360230|69677692|FG004|Overall Study|Migrated|4|||
37992670|NCT00360230|69677693|FG005|Overall Study|Migrated|1|||
37992671|NCT00360230|69677694|FG006|Overall Study|Migrated|1|||
37992672|NCT00360230|69677688|FG000|Overall Study|Other|1|||
37992673|NCT00360230|69677689|FG001|Overall Study|Other|0|||
37992674|NCT00360230|69677690|FG002|Overall Study|Other|0|||
37992675|NCT00360230|69677691|FG003|Overall Study|Other|0|||
37992676|NCT00360230|69677692|FG004|Overall Study|Other|0|||
37992677|NCT00360230|69677693|FG005|Overall Study|Other|0|||
37895825|NCT01072175|69581115|FG010|Part A (Drug-Drug Interaction)|Death|0|||
37895826|NCT01072175|69581116|FG011|Part A (Drug-Drug Interaction)|Death|0|||
37895827|NCT01072175|69581117|FG012|Part A (Drug-Drug Interaction)|Death|0|||
37895828|NCT01072175|69581105|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
37895829|NCT01072175|69581106|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
37895830|NCT01072175|69581107|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
37895831|NCT01072175|69581108|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
37895832|NCT01072175|69581109|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
37895833|NCT01072175|69581110|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
37895834|NCT01072175|69581111|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
37895835|NCT01072175|69581112|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
37895836|NCT01072175|69581113|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
37895837|NCT01072175|69581114|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
37895838|NCT01072175|69581115|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
37895839|NCT01072175|69581116|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
37895840|NCT01072175|69581117|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
37895841|NCT01072175|69581105|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
37895842|NCT01072175|69581106|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
37895843|NCT01072175|69581107|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
37895844|NCT01072175|69581108|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
37895845|NCT01072175|69581109|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
37895846|NCT01072175|69581110|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
37895847|NCT01072175|69581111|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
37895848|NCT01072175|69581112|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
37895849|NCT01072175|69581113|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
37895850|NCT01072175|69581114|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
37895851|NCT01072175|69581115|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
37895852|NCT01072175|69581116|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
37895853|NCT01072175|69581117|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
37895854|NCT01072175|69581105|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
37895855|NCT01072175|69581106|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
37895856|NCT01072175|69581107|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
37895857|NCT01072175|69581108|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
37895858|NCT01072175|69581109|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
37895859|NCT01072175|69581110|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
37895860|NCT01072175|69581111|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
37895861|NCT01072175|69581112|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
37992678|NCT00360230|69677694|FG006|Overall Study|Other|0|||
37992679|NCT00360230|69677688|FG000|Overall Study|Protocol Violation|0|||
37992680|NCT00360230|69677689|FG001|Overall Study|Protocol Violation|0|||
37992681|NCT00360230|69677690|FG002|Overall Study|Protocol Violation|0|||
37992682|NCT00360230|69677691|FG003|Overall Study|Protocol Violation|0|||
37992683|NCT00360230|69677692|FG004|Overall Study|Protocol Violation|0|||
37992684|NCT00360230|69677693|FG005|Overall Study|Protocol Violation|1|||
37992685|NCT00360230|69677694|FG006|Overall Study|Protocol Violation|0|||
37992686|NCT00360230|69677688|FG000|Overall Study|Death|0|||
37992687|NCT00360230|69677689|FG001|Overall Study|Death|1|||
37992688|NCT00360230|69677690|FG002|Overall Study|Death|0|||
37992689|NCT00360230|69677691|FG003|Overall Study|Death|0|||
37992690|NCT00360230|69677692|FG004|Overall Study|Death|0|||
37992691|NCT00360230|69677693|FG005|Overall Study|Death|1|||
37992692|NCT00360230|69677694|FG006|Overall Study|Death|1|||
37992693|NCT00348374|69677714|FG000|Overall Study|Adverse Event|1|||
37992694|NCT00348374|69677715|FG001|Overall Study|Adverse Event|4|||
37992695|NCT00348374|69677714|FG000|Overall Study|Lost to Follow-up|1|||
37992696|NCT00348374|69677715|FG001|Overall Study|Lost to Follow-up|3|||
37992697|NCT00348374|69677714|FG000|Overall Study|Withdrawal by Subject|5|||
37992698|NCT00348374|69677715|FG001|Overall Study|Withdrawal by Subject|5|||
37992699|NCT00348374|69677714|FG000|Overall Study|Other|11|||
37992700|NCT00348374|69677715|FG001|Overall Study|Other|12|||
37992701|NCT00348374|69677714|FG000|Overall Study|ongoing at date of cutoff|1|||
37992702|NCT00348374|69677715|FG001|Overall Study|ongoing at date of cutoff|1|||
37992703|NCT00348374|69677714|FG000|Overall Study|randomized but did not receive treatment|0|||
37992704|NCT00348374|69677715|FG001|Overall Study|randomized but did not receive treatment|7|||
37992705|NCT00353366|69677722|FG000|Overall Study|Adverse Event|8|||
37992706|NCT00353366|69677722|FG000|Overall Study|Protocol Violation|12|||
37992707|NCT00353366|69677722|FG000|Overall Study|Withdrawal by Subject|12|||
37992708|NCT00353366|69677722|FG000|Overall Study|Lost to Follow-up|92|||
37992709|NCT00353366|69677722|FG000|Overall Study|Other|19|||
37992710|NCT00352664|69677728|FG000|Overall Study|Withdrawal by Subject|7|||
37992711|NCT00352664|69677729|FG001|Overall Study|Withdrawal by Subject|0|||
37992712|NCT00490139|69677739|FG000|Overall Study|Death|106|||
37992713|NCT00490139|69677740|FG001|Overall Study|Death|119|||
37992714|NCT00490139|69677741|FG002|Overall Study|Death|168|||
37992715|NCT00490139|69677742|FG003|Overall Study|Death|135|||
37992716|NCT00490139|69677739|FG000|Overall Study|Lost to Follow-up|56|||
37992717|NCT00490139|69677740|FG001|Overall Study|Lost to Follow-up|46|||
37992718|NCT00490139|69677741|FG002|Overall Study|Lost to Follow-up|58|||
37992719|NCT00490139|69677742|FG003|Overall Study|Lost to Follow-up|56|||
37992720|NCT00490139|69677739|FG000|Overall Study|Participant Withdrew Consent|146|||
37992721|NCT00490139|69677740|FG001|Overall Study|Participant Withdrew Consent|110|||
37992722|NCT00490139|69677741|FG002|Overall Study|Participant Withdrew Consent|208|||
37992723|NCT00490139|69677742|FG003|Overall Study|Participant Withdrew Consent|116|||
37992724|NCT00348140|69677757|FG000|Overall Study|Adverse Event|46|||
37992725|NCT00348140|69677758|FG001|Overall Study|Adverse Event|49|||
37992726|NCT00348140|69677759|FG002|Overall Study|Adverse Event|78|||
37992727|NCT00348140|69677757|FG000|Overall Study|Lost to Follow-up|4|||
37992728|NCT00348140|69677758|FG001|Overall Study|Lost to Follow-up|4|||
37992729|NCT00348140|69677759|FG002|Overall Study|Lost to Follow-up|4|||
37992730|NCT00348140|69677757|FG000|Overall Study|Protocol Violation|12|||
37825270|NCT01248949|69507285|FG002|Overall Study|Death|21|||
37825271|NCT01248949|69507286|FG003|Overall Study|Death|6|||
37825272|NCT01248949|69507287|FG004|Overall Study|Death|2|||
37825273|NCT01248949|69507283|FG000|Overall Study|Alternative Therapy|1|||
37825274|NCT01248949|69507284|FG001|Overall Study|Alternative Therapy|0|||
37825275|NCT01248949|69507285|FG002|Overall Study|Alternative Therapy|0|||
37895862|NCT01072175|69581113|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
37895863|NCT01072175|69581114|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
37895864|NCT01072175|69581115|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
37895865|NCT01072175|69581116|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
37895866|NCT01072175|69581117|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
37895867|NCT01072175|69581105|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
37895868|NCT01072175|69581106|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
37992731|NCT00348140|69677758|FG001|Overall Study|Protocol Violation|13|||
37825276|NCT01248949|69507286|FG003|Overall Study|Alternative Therapy|0|||
37825277|NCT01248949|69507287|FG004|Overall Study|Alternative Therapy|0|||
37825278|NCT01248949|69507283|FG000|Overall Study|Alternative Therapy.|1|||
37825279|NCT01248949|69507284|FG001|Overall Study|Alternative Therapy.|0|||
37825280|NCT01248949|69507285|FG002|Overall Study|Alternative Therapy.|0|||
37992732|NCT00348140|69677759|FG002|Overall Study|Protocol Violation|14|||
37992733|NCT00348140|69677757|FG000|Overall Study|Withdrawal by Subject|32|||
37992734|NCT00348140|69677758|FG001|Overall Study|Withdrawal by Subject|40|||
37992735|NCT00348140|69677759|FG002|Overall Study|Withdrawal by Subject|40|||
37992736|NCT00348140|69677757|FG000|Overall Study|Non-compliance|8|||
37992737|NCT00348140|69677758|FG001|Overall Study|Non-compliance|13|||
37825281|NCT01248949|69507286|FG003|Overall Study|Alternative Therapy.|0|||
37992738|NCT00348140|69677759|FG002|Overall Study|Non-compliance|5|||
37992739|NCT00348140|69677757|FG000|Overall Study|Participant at risk due to study drug|2|||
37992740|NCT00348140|69677758|FG001|Overall Study|Participant at risk due to study drug|0|||
37992741|NCT00348140|69677759|FG002|Overall Study|Participant at risk due to study drug|0|||
37992742|NCT00348140|69677757|FG000|Overall Study|Conditional medication increased dose|1|||
37992743|NCT00348140|69677758|FG001|Overall Study|Conditional medication increased dose|0|||
37992744|NCT00348140|69677759|FG002|Overall Study|Conditional medication increased dose|0|||
37895869|NCT01072175|69581107|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
37895870|NCT01072175|69581108|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
37895871|NCT01072175|69581109|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
37895872|NCT01072175|69581110|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
37895873|NCT01072175|69581111|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
37895874|NCT01072175|69581112|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
37895875|NCT01072175|69581113|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
37895876|NCT01072175|69581114|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
37895877|NCT01072175|69581115|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
37895878|NCT01072175|69581116|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
37895879|NCT01072175|69581117|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
37895880|NCT01072175|69581105|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
37895881|NCT01072175|69581106|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
37895882|NCT01072175|69581107|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
37895883|NCT01072175|69581108|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
37895884|NCT01072175|69581109|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
37895885|NCT01072175|69581110|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
37895886|NCT01072175|69581111|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
37895887|NCT01072175|69581112|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
37895888|NCT01072175|69581113|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
37895889|NCT01072175|69581114|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
37895890|NCT01072175|69581115|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
37895891|NCT01072175|69581116|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
37895892|NCT01072175|69581117|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
37895893|NCT01072175|69581105|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
37895894|NCT01072175|69581106|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
37895895|NCT01072175|69581107|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
37895896|NCT01072175|69581108|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
37895897|NCT01072175|69581109|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
37895898|NCT01072175|69581110|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
37895899|NCT01072175|69581111|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
37895900|NCT01072175|69581112|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
37895901|NCT01072175|69581113|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
37895902|NCT01072175|69581114|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
37992745|NCT00348140|69677757|FG000|Overall Study|Caregiver related|4|||
37992746|NCT00348140|69677758|FG001|Overall Study|Caregiver related|7|||
37992747|NCT00348140|69677759|FG002|Overall Study|Caregiver related|3|||
37992748|NCT00348140|69677757|FG000|Overall Study|Participant hospitalised|3|||
37992749|NCT00348140|69677758|FG001|Overall Study|Participant hospitalised|0|||
37992750|NCT00348140|69677759|FG002|Overall Study|Participant hospitalised|0|||
37992751|NCT00348140|69677757|FG000|Overall Study|Efficacy related|1|||
37992752|NCT00348140|69677758|FG001|Overall Study|Efficacy related|1|||
37992753|NCT00348140|69677759|FG002|Overall Study|Efficacy related|0|||
37992754|NCT00348140|69677757|FG000|Overall Study|Administration related|3|||
37992755|NCT00348140|69677758|FG001|Overall Study|Administration related|1|||
37992756|NCT00348140|69677759|FG002|Overall Study|Administration related|1|||
37992757|NCT00348140|69677757|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
37992758|NCT00348140|69677758|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
37992759|NCT00348140|69677759|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
37992760|NCT00348140|69677757|FG000|Overall Study|Participant unwell|1|||
37825282|NCT01248949|69507287|FG004|Overall Study|Alternative Therapy.|0|||
37825283|NCT01248949|69507283|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
37825284|NCT01248949|69507284|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
37825285|NCT01248949|69507285|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
37825286|NCT01248949|69507286|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
37825287|NCT01248949|69507287|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
37825288|NCT01248949|69507283|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
37825289|NCT01248949|69507284|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
37825290|NCT01248949|69507285|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
37825291|NCT01248949|69507286|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
37825292|NCT01248949|69507287|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
37895903|NCT01072175|69581115|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
37895904|NCT01072175|69581116|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
37992761|NCT00348140|69677758|FG001|Overall Study|Participant unwell|0|||
37992762|NCT00348140|69677759|FG002|Overall Study|Participant unwell|0|||
37992763|NCT00348140|69677757|FG000|Overall Study|Screen failure|1|||
37696237|NCT02465567|69172374|FG000|Overall Study|Administrative Reasons|12|||
37992764|NCT00348140|69677758|FG001|Overall Study|Screen failure|0|||
37992765|NCT00348140|69677759|FG002|Overall Study|Screen failure|0|||
37992766|NCT00348140|69677757|FG000|Overall Study|Investigator decided to discontinue|4|||
37992767|NCT00348140|69677758|FG001|Overall Study|Investigator decided to discontinue|1|||
37992768|NCT00348140|69677759|FG002|Overall Study|Investigator decided to discontinue|4|||
37992769|NCT00348140|69677757|FG000|Overall Study|Decided to discontinue on their own|1|||
37992770|NCT00348140|69677758|FG001|Overall Study|Decided to discontinue on their own|4|||
37825293|NCT01248949|69507283|FG000|Overall Study|Participant Went To Hospice|0|||
37825294|NCT01248949|69507284|FG001|Overall Study|Participant Went To Hospice|0|||
37825295|NCT01248949|69507285|FG002|Overall Study|Participant Went To Hospice|1|||
37825296|NCT01248949|69507286|FG003|Overall Study|Participant Went To Hospice|0|||
37825297|NCT01248949|69507287|FG004|Overall Study|Participant Went To Hospice|0|||
37825298|NCT01248949|69507283|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
37825299|NCT01248949|69507284|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
37825300|NCT01248949|69507285|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
37895905|NCT01072175|69581117|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
37895906|NCT01072175|69581105|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
37895907|NCT01072175|69581106|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
37895908|NCT01072175|69581107|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
37895909|NCT01072175|69581108|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
37895910|NCT01072175|69581109|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
37895911|NCT01072175|69581110|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
37895912|NCT01072175|69581111|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
37895913|NCT01072175|69581112|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
37895914|NCT01072175|69581113|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
37895915|NCT01072175|69581114|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
37895916|NCT01072175|69581115|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
37895917|NCT01072175|69581116|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
37895918|NCT01072175|69581117|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
37895919|NCT01072175|69581105|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
37895920|NCT01072175|69581106|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
37895921|NCT01072175|69581107|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
37895922|NCT01072175|69581108|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
37895923|NCT01072175|69581109|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
37895924|NCT01072175|69581110|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
37895925|NCT01072175|69581111|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
37895926|NCT01072175|69581112|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
37895927|NCT01072175|69581113|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
37895928|NCT01072175|69581114|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
37895929|NCT01072175|69581115|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
37895930|NCT01072175|69581116|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
37895931|NCT01072175|69581117|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
37895932|NCT01072175|69581105|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
37895933|NCT01072175|69581106|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
37895934|NCT01072175|69581107|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
37895935|NCT01072175|69581108|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
37895936|NCT01072175|69581109|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
37895937|NCT01072175|69581110|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
37895938|NCT01072175|69581111|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
37895939|NCT01072175|69581112|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
37895940|NCT01072175|69581113|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
37895941|NCT01072175|69581114|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
37895942|NCT01072175|69581115|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
37895943|NCT01072175|69581116|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
37895944|NCT01072175|69581117|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
37895945|NCT01072175|69581105|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
37895946|NCT01072175|69581106|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
37895947|NCT01072175|69581107|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
37895948|NCT01072175|69581108|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
37895949|NCT01072175|69581109|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
37895950|NCT01072175|69581110|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
37895951|NCT01072175|69581111|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
37895952|NCT01072175|69581112|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
37895953|NCT01072175|69581113|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
37992771|NCT00348140|69677759|FG002|Overall Study|Decided to discontinue on their own|1|||
37992772|NCT00348140|69677757|FG000|Overall Study|Use of prohibited drug|1|||
37992773|NCT00348140|69677758|FG001|Overall Study|Use of prohibited drug|0|||
37992774|NCT00348140|69677759|FG002|Overall Study|Use of prohibited drug|2|||
37992775|NCT00348140|69677757|FG000|Overall Study|Disease progression|1|||
37992776|NCT00348140|69677758|FG001|Overall Study|Disease progression|2|||
37992777|NCT00348140|69677759|FG002|Overall Study|Disease progression|5|||
37992778|NCT00348140|69677757|FG000|Overall Study|Increased risk of cardiac infarction|0|||
37992779|NCT00348140|69677758|FG001|Overall Study|Increased risk of cardiac infarction|1|||
37992780|NCT00348140|69677759|FG002|Overall Study|Increased risk of cardiac infarction|0|||
37992781|NCT00348140|69677757|FG000|Overall Study|Serious adverse event|0|||
37992782|NCT00348140|69677758|FG001|Overall Study|Serious adverse event|1|||
37992783|NCT00348140|69677759|FG002|Overall Study|Serious adverse event|0|||
37992784|NCT00348140|69677757|FG000|Overall Study|Abnormal ECG|0|||
37992785|NCT00348140|69677758|FG001|Overall Study|Abnormal ECG|1|||
37992786|NCT00348140|69677759|FG002|Overall Study|Abnormal ECG|3|||
37992787|NCT00348140|69677757|FG000|Overall Study|Participant died|0|||
37992788|NCT00348140|69677758|FG001|Overall Study|Participant died|1|||
37992789|NCT00348140|69677759|FG002|Overall Study|Participant died|0|||
37992790|NCT00348140|69677757|FG000|Overall Study|Exclusion criteria met|0|||
37992791|NCT00348140|69677758|FG001|Overall Study|Exclusion criteria met|0|||
37992792|NCT00348140|69677759|FG002|Overall Study|Exclusion criteria met|1|||
37992793|NCT00348140|69677757|FG000|Overall Study|Memory declined|0|||
37992794|NCT00348140|69677758|FG001|Overall Study|Memory declined|0|||
37992795|NCT00348140|69677759|FG002|Overall Study|Memory declined|1|||
37992796|NCT00490061|69677768|FG000|Overall Study|Physician Decision|1|||
37992797|NCT00483119|69677774|FG000|Overall Study|Adverse Event|0|||
37992798|NCT00483119|69677775|FG001|Overall Study|Adverse Event|1|||
37992799|NCT00483119|69677774|FG000|Overall Study|Physician Decision|1|||
37992800|NCT00483119|69677775|FG001|Overall Study|Physician Decision|0|||
37992801|NCT00483041|69677783|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
37992802|NCT00483041|69677784|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
37992803|NCT00501293|69677792|FG000|Optimization Period|Enrolled in error|1|||
37992804|NCT00501293|69677793|FG001|Optimization Period|Enrolled in error|0|||
37992805|NCT00501293|69677792|FG000|Maintenance Period|Withdrawal by Subject|14|||
37992806|NCT00501293|69677793|FG001|Maintenance Period|Withdrawal by Subject|13|||
37992807|NCT00501293|69677792|FG000|Maintenance Period|Lost to Follow-up|12|||
37992808|NCT00501293|69677793|FG001|Maintenance Period|Lost to Follow-up|7|||
37992809|NCT00501293|69677792|FG000|Maintenance Period|Adverse Event|6|||
37992810|NCT00501293|69677793|FG001|Maintenance Period|Adverse Event|6|||
37992811|NCT00501293|69677792|FG000|Maintenance Period|Protocol Violation|2|||
37992812|NCT00501293|69677793|FG001|Maintenance Period|Protocol Violation|1|||
37992813|NCT00501293|69677792|FG000|Maintenance Period|Lack of Efficacy|4|||
37992814|NCT00501293|69677793|FG001|Maintenance Period|Lack of Efficacy|1|||
37992815|NCT00501293|69677792|FG000|Maintenance Period|Noncompliant with study medication|5|||
37992816|NCT00501293|69677793|FG001|Maintenance Period|Noncompliant with study medication|0|||
37992817|NCT00501293|69677792|FG000|Maintenance Period|Went into rehabilitation|1|||
37992818|NCT00501293|69677793|FG001|Maintenance Period|Went into rehabilitation|0|||
37992819|NCT00501293|69677792|FG000|Maintenance Period|Would not wear patch|1|||
37992820|NCT00501293|69677793|FG001|Maintenance Period|Would not wear patch|0|||
37992821|NCT00501293|69677792|FG000|Maintenance Period|Application site reaction|1|||
37992822|NCT00501293|69677793|FG001|Maintenance Period|Application site reaction|0|||
37992823|NCT00482729|69677802|FG000|Overall Study|Adverse Event|29|||
37992824|NCT00482729|69677803|FG001|Overall Study|Adverse Event|33|||
37992825|NCT00482729|69677802|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
37992826|NCT00482729|69677803|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
37992827|NCT00482729|69677802|FG000|Overall Study|Hyperglycemia Criteria|7|||
37992828|NCT00482729|69677803|FG001|Overall Study|Hyperglycemia Criteria|5|||
37992829|NCT00482729|69677802|FG000|Overall Study|Lack of Efficacy|4|||
37992830|NCT00482729|69677803|FG001|Overall Study|Lack of Efficacy|16|||
37992831|NCT00482729|69677802|FG000|Overall Study|Lost to Follow-up|86|||
37992832|NCT00482729|69677803|FG001|Overall Study|Lost to Follow-up|66|||
37992833|NCT00482729|69677802|FG000|Overall Study|Physician Decision|10|||
37992834|NCT00482729|69677803|FG001|Overall Study|Physician Decision|7|||
37992835|NCT00482729|69677802|FG000|Overall Study|Pregnancy|4|||
37992836|NCT00482729|69677803|FG001|Overall Study|Pregnancy|2|||
37992837|NCT00482729|69677802|FG000|Overall Study|Protocol Violation|10|||
37992838|NCT00482729|69677803|FG001|Overall Study|Protocol Violation|18|||
37992839|NCT00482729|69677802|FG000|Overall Study|Withdrawal by Subject|67|||
37992840|NCT00482729|69677803|FG001|Overall Study|Withdrawal by Subject|69|||
37992841|NCT00359762|69677811|FG000|Period II|Adverse Event|17|||
37992842|NCT00359762|69677812|FG001|Period II|Adverse Event|0|||
37696238|NCT02465567|69172375|FG001|Overall Study|Administrative Reasons|9|||
37992843|NCT00359762|69677813|FG002|Period II|Adverse Event|0|||
37992844|NCT00359762|69677814|FG003|Period II|Adverse Event|0|||
37992845|NCT00359762|69677815|FG004|Period II|Adverse Event|49|||
37992846|NCT00359762|69677811|FG000|Period II|Protocol Violation|18|||
37992847|NCT00359762|69677812|FG001|Period II|Protocol Violation|0|||
37992848|NCT00359762|69677813|FG002|Period II|Protocol Violation|0|||
37895954|NCT01072175|69581114|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
37895955|NCT01072175|69581115|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
37895956|NCT01072175|69581116|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
37895957|NCT01072175|69581117|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
37895958|NCT01072175|69581105|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
37895959|NCT01072175|69581106|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
37895960|NCT01072175|69581107|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
37895961|NCT01072175|69581108|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
37895962|NCT01072175|69581109|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
37895963|NCT01072175|69581110|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
37895964|NCT01072175|69581111|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
37895965|NCT01072175|69581112|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
37895966|NCT01072175|69581113|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
37895967|NCT01072175|69581114|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
37895968|NCT01072175|69581115|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
37895969|NCT01072175|69581116|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
37895970|NCT01072175|69581117|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
37992849|NCT00359762|69677814|FG003|Period II|Protocol Violation|0|||
37992850|NCT00359762|69677815|FG004|Period II|Protocol Violation|11|||
37992851|NCT00359762|69677811|FG000|Period II|Physician Decision|17|||
37992852|NCT00359762|69677812|FG001|Period II|Physician Decision|0|||
37992853|NCT00359762|69677813|FG002|Period II|Physician Decision|0|||
37992854|NCT00359762|69677814|FG003|Period II|Physician Decision|0|||
37992855|NCT00359762|69677815|FG004|Period II|Physician Decision|23|||
37992856|NCT00359762|69677811|FG000|Period II|Death|2|||
37992857|NCT00359762|69677812|FG001|Period II|Death|0|||
37992858|NCT00359762|69677813|FG002|Period II|Death|0|||
37992859|NCT00359762|69677814|FG003|Period II|Death|0|||
37992860|NCT00359762|69677815|FG004|Period II|Death|4|||
37992861|NCT00359762|69677811|FG000|Period II|Lack of Efficacy|11|||
37992862|NCT00359762|69677812|FG001|Period II|Lack of Efficacy|0|||
37992863|NCT00359762|69677813|FG002|Period II|Lack of Efficacy|0|||
37992864|NCT00359762|69677814|FG003|Period II|Lack of Efficacy|0|||
37992865|NCT00359762|69677815|FG004|Period II|Lack of Efficacy|8|||
37992866|NCT00359762|69677811|FG000|Period II|Lost to follow up|5|||
37992867|NCT00359762|69677812|FG001|Period II|Lost to follow up|0|||
37992868|NCT00359762|69677813|FG002|Period II|Lost to follow up|0|||
37696239|NCT02465567|69172376|FG002|Overall Study|Administrative Reasons|11|||
37696240|NCT02465567|69172377|FG003|Overall Study|Administrative Reasons|5|||
37696241|NCT02465567|69172374|FG000|Overall Study|Randomized but not treated|1|||
37696242|NCT02465567|69172375|FG001|Overall Study|Randomized but not treated|5|||
37992869|NCT00359762|69677814|FG003|Period II|Lost to follow up|0|||
37992870|NCT00359762|69677815|FG004|Period II|Lost to follow up|5|||
37992871|NCT00359762|69677811|FG000|Period II|Entry Criteria Not Met|8|||
37992872|NCT00359762|69677812|FG001|Period II|Entry Criteria Not Met|0|||
37992873|NCT00359762|69677813|FG002|Period II|Entry Criteria Not Met|0|||
37992874|NCT00359762|69677814|FG003|Period II|Entry Criteria Not Met|0|||
37992875|NCT00359762|69677815|FG004|Period II|Entry Criteria Not Met|4|||
37992876|NCT00359762|69677811|FG000|Period II|Subject Decision|50|||
37992877|NCT00359762|69677812|FG001|Period II|Subject Decision|0|||
37992878|NCT00359762|69677813|FG002|Period II|Subject Decision|0|||
37992879|NCT00359762|69677814|FG003|Period II|Subject Decision|0|||
37992880|NCT00359762|69677815|FG004|Period II|Subject Decision|70|||
37696243|NCT02465567|69172376|FG002|Overall Study|Randomized but not treated|4|||
37696244|NCT02465567|69172377|FG003|Overall Study|Randomized but not treated|5|||
37696245|NCT02465567|69172374|FG000|Overall Study|enrolled in >1 studies|18|||
37825301|NCT01248949|69507286|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
37825302|NCT01248949|69507287|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
37825303|NCT01248949|69507283|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
37825304|NCT01248949|69507284|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
37825305|NCT01248949|69507285|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
37825306|NCT01248949|69507286|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
37825307|NCT01248949|69507287|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
37825308|NCT01248949|69507283|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
37992881|NCT00359762|69677811|FG000|Period III|Protocol Violation|0|||
37992882|NCT00359762|69677812|FG001|Period III|Protocol Violation|5|||
37992883|NCT00359762|69677813|FG002|Period III|Protocol Violation|3|||
37992884|NCT00359762|69677814|FG003|Period III|Protocol Violation|8|||
37992885|NCT00359762|69677815|FG004|Period III|Protocol Violation|0|||
37992886|NCT00359762|69677811|FG000|Period III|Adverse Event|0|||
37992887|NCT00359762|69677812|FG001|Period III|Adverse Event|3|||
37992888|NCT00359762|69677813|FG002|Period III|Adverse Event|4|||
37992889|NCT00359762|69677814|FG003|Period III|Adverse Event|10|||
37895971|NCT01072175|69581105|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
37895972|NCT01072175|69581106|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
37895973|NCT01072175|69581107|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
37895974|NCT01072175|69581108|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
37895975|NCT01072175|69581109|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
37895976|NCT01072175|69581110|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
37895977|NCT01072175|69581111|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
37895978|NCT01072175|69581112|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
37895979|NCT01072175|69581113|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
37895980|NCT01072175|69581114|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
37895981|NCT01072175|69581115|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
37895982|NCT01072175|69581116|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
37895983|NCT01072175|69581117|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
37895984|NCT01072175|69581105|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
37895985|NCT01072175|69581106|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
37895986|NCT01072175|69581107|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
37895987|NCT01072175|69581108|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
37895988|NCT01072175|69581109|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
37895989|NCT01072175|69581110|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
37895990|NCT01072175|69581111|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
37895991|NCT01072175|69581112|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
37895992|NCT01072175|69581113|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
37895993|NCT01072175|69581114|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
37696246|NCT02465567|69172375|FG001|Overall Study|enrolled in >1 studies|11|||
37696247|NCT02465567|69172376|FG002|Overall Study|enrolled in >1 studies|19|||
37825309|NCT01248949|69507284|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
37895994|NCT01072175|69581115|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
37895995|NCT01072175|69581116|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
37895996|NCT01072175|69581117|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
37895997|NCT01072175|69581105|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
37895998|NCT01072175|69581106|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
37895999|NCT01072175|69581107|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
37896000|NCT01072175|69581108|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
37896001|NCT01072175|69581109|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
37696248|NCT02465567|69172377|FG003|Overall Study|enrolled in >1 studies|15|||
37825310|NCT01248949|69507285|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
37825311|NCT01248949|69507286|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
37825312|NCT01248949|69507287|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
37825313|NCT01248949|69507283|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
37825314|NCT01248949|69507284|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
37825315|NCT01248949|69507285|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
37825316|NCT01248949|69507286|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
37825317|NCT01248949|69507287|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
37825318|NCT01248793|69507301|FG000|Overall Study|Lost to Follow-up|0|||
37825319|NCT01248793|69507302|FG001|Overall Study|Lost to Follow-up|1|||
37825320|NCT01248793|69507301|FG000|Overall Study|Adverse Event|1|||
37825321|NCT01248793|69507302|FG001|Overall Study|Adverse Event|1|||
37825322|NCT01248793|69507301|FG000|Overall Study|Protocol Violation|0|||
37825323|NCT01248793|69507302|FG001|Overall Study|Protocol Violation|1|||
37825324|NCT01248793|69507301|FG000|Overall Study|Withdrawal by Subject|3|||
37825325|NCT01248793|69507302|FG001|Overall Study|Withdrawal by Subject|3|||
37825326|NCT01248364|69507312|FG000|Overall Study|Adverse Event|0|||
37825327|NCT01248364|69507313|FG001|Overall Study|Adverse Event|1|||
37825328|NCT01248364|69507314|FG002|Overall Study|Adverse Event|0|||
37825329|NCT01248364|69507315|FG003|Overall Study|Adverse Event|0|||
37825330|NCT01248130|69507327|FG000|Overall Study|Protocol Violation|1|||
37825331|NCT01248130|69507328|FG001|Overall Study|Protocol Violation|0|||
37825332|NCT01248130|69507327|FG000|Overall Study|Ineligible|1|||
37896002|NCT01072175|69581110|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
37896003|NCT01072175|69581111|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
37696249|NCT02465567|69172374|FG000|Overall Study|missing PI Signature|1|||
37825333|NCT01248130|69507328|FG001|Overall Study|Ineligible|0|||
37825334|NCT01248013|69507334|FG000|Overall Study|Withdrawal by Subject|14|||
37896004|NCT01072175|69581112|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
37896005|NCT01072175|69581113|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
37896006|NCT01072175|69581114|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
37896007|NCT01072175|69581115|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
37896008|NCT01072175|69581116|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
37896009|NCT01072175|69581117|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
37896010|NCT01072175|69581105|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
37896011|NCT01072175|69581106|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
37896012|NCT01072175|69581107|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
37896013|NCT01072175|69581108|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
37896014|NCT01072175|69581109|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
37896015|NCT01072175|69581110|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
37896016|NCT01072175|69581111|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
37896017|NCT01072175|69581112|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
37896018|NCT01072175|69581113|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
37896019|NCT01072175|69581114|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
37992890|NCT00359762|69677815|FG004|Period III|Adverse Event|0|||
37992891|NCT00359762|69677811|FG000|Period III|Physician Decision|0|||
37992892|NCT00359762|69677812|FG001|Period III|Physician Decision|5|||
37992893|NCT00359762|69677813|FG002|Period III|Physician Decision|9|||
37992894|NCT00359762|69677814|FG003|Period III|Physician Decision|15|||
37992895|NCT00359762|69677815|FG004|Period III|Physician Decision|0|||
37992896|NCT00359762|69677811|FG000|Period III|Lack of Efficacy|0|||
37992897|NCT00359762|69677812|FG001|Period III|Lack of Efficacy|7|||
37992898|NCT00359762|69677813|FG002|Period III|Lack of Efficacy|5|||
37992899|NCT00359762|69677814|FG003|Period III|Lack of Efficacy|9|||
37992900|NCT00359762|69677815|FG004|Period III|Lack of Efficacy|0|||
37992901|NCT00359762|69677811|FG000|Period III|Lost to follow up|0|||
37992902|NCT00359762|69677812|FG001|Period III|Lost to follow up|1|||
37992903|NCT00359762|69677813|FG002|Period III|Lost to follow up|1|||
37992904|NCT00359762|69677814|FG003|Period III|Lost to follow up|2|||
37992905|NCT00359762|69677815|FG004|Period III|Lost to follow up|0|||
37992906|NCT00359762|69677811|FG000|Period III|Entry Criteria Not Met|0|||
37992907|NCT00359762|69677812|FG001|Period III|Entry Criteria Not Met|1|||
37992908|NCT00359762|69677813|FG002|Period III|Entry Criteria Not Met|0|||
37992909|NCT00359762|69677814|FG003|Period III|Entry Criteria Not Met|1|||
37992910|NCT00359762|69677815|FG004|Period III|Entry Criteria Not Met|0|||
37992911|NCT00359762|69677811|FG000|Period III|Subject Decision|0|||
37992912|NCT00359762|69677812|FG001|Period III|Subject Decision|7|||
37992913|NCT00359762|69677813|FG002|Period III|Subject Decision|8|||
37992914|NCT00359762|69677814|FG003|Period III|Subject Decision|20|||
37992915|NCT00359762|69677815|FG004|Period III|Subject Decision|0|||
37992916|NCT00347438|69677829|FG000|Overall Study|Withdrawal by Subject|1|||
37992917|NCT00347438|69677829|FG000|Overall Study|Physician Decision|1|||
37992918|NCT00329238|69677835|FG000|Overall Study|Adverse Event|147|||
37992919|NCT00329238|69677836|FG001|Overall Study|Adverse Event|129|||
37992920|NCT00329238|69677835|FG000|Overall Study|Protocol Violation|23|||
37992921|NCT00329238|69677836|FG001|Overall Study|Protocol Violation|34|||
37992922|NCT00329238|69677835|FG000|Overall Study|Lost to Follow-up|2|||
37992923|NCT00329238|69677836|FG001|Overall Study|Lost to Follow-up|6|||
37992924|NCT00329238|69677835|FG000|Overall Study|Withdrawal by Subject|64|||
37992925|NCT00329238|69677836|FG001|Overall Study|Withdrawal by Subject|58|||
37992926|NCT00329238|69677835|FG000|Overall Study|Other reason (not specified)|40|||
37992927|NCT00329238|69677836|FG001|Overall Study|Other reason (not specified)|54|||
37992928|NCT00329160|69677844|FG000|Overall Study|Adverse Event|27|||
37825335|NCT01247350|69507343|FG000|Overall Study|Adverse Event|0|||
37825336|NCT01247350|69507344|FG001|Overall Study|Adverse Event|0|||
37825337|NCT01247350|69507345|FG002|Overall Study|Adverse Event|1|||
37825338|NCT01247350|69507346|FG003|Overall Study|Adverse Event|0|||
37825339|NCT01247350|69507347|FG004|Overall Study|Adverse Event|0|||
37825340|NCT01247350|69507343|FG000|Overall Study|Withdrawal by Subject|0|||
37825341|NCT01247350|69507344|FG001|Overall Study|Withdrawal by Subject|0|||
37825342|NCT01247350|69507345|FG002|Overall Study|Withdrawal by Subject|0|||
37825343|NCT01247350|69507346|FG003|Overall Study|Withdrawal by Subject|1|||
37825344|NCT01247350|69507347|FG004|Overall Study|Withdrawal by Subject|0|||
37825345|NCT01247350|69507343|FG000|Overall Study|Entry criteria not met|0|||
37825346|NCT01247350|69507344|FG001|Overall Study|Entry criteria not met|0|||
37992929|NCT00329160|69677844|FG000|Overall Study|Withdrawal by Subject|13|||
37992930|NCT00329160|69677844|FG000|Overall Study|Protocol Violation|2|||
37992931|NCT00329160|69677844|FG000|Overall Study|Did not Receive Study Drug|1|||
37992932|NCT00329160|69677844|FG000|Overall Study|Incomplete IVUS|45|||
37992933|NCT00328926|69677851|FG000|Overall Study|Pregnancy|2|||
37992934|NCT00328926|69677852|FG001|Overall Study|Pregnancy|1|||
37992935|NCT00328926|69677853|FG002|Overall Study|Pregnancy|0|||
37992936|NCT00328926|69677851|FG000|Overall Study|Lost to Follow-up|0|||
37696250|NCT02465567|69172375|FG001|Overall Study|missing PI Signature|0|||
37896020|NCT01072175|69581115|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
37896021|NCT01072175|69581116|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
37896022|NCT01072175|69581117|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
37896023|NCT01072175|69581105|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
37896024|NCT01072175|69581106|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
37896025|NCT01072175|69581107|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
37896026|NCT01072175|69581108|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
37896027|NCT01072175|69581109|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
37992937|NCT00328926|69677852|FG001|Overall Study|Lost to Follow-up|1|||
37992938|NCT00328926|69677853|FG002|Overall Study|Lost to Follow-up|0|||
37992939|NCT00328926|69677851|FG000|Overall Study|Death|0|||
37896028|NCT01072175|69581110|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
37896029|NCT01072175|69581111|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
37896030|NCT01072175|69581112|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
37896031|NCT01072175|69581113|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
37896032|NCT01072175|69581114|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
37896033|NCT01072175|69581115|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
37896034|NCT01072175|69581116|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
37896035|NCT01072175|69581117|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
37896036|NCT01072175|69581105|FG000|Part D (HPMC Capsules)|Death|0|||
37896037|NCT01072175|69581106|FG001|Part D (HPMC Capsules)|Death|0|||
37896038|NCT01072175|69581107|FG002|Part D (HPMC Capsules)|Death|0|||
37896039|NCT01072175|69581108|FG003|Part D (HPMC Capsules)|Death|0|||
37896040|NCT01072175|69581109|FG004|Part D (HPMC Capsules)|Death|0|||
37896041|NCT01072175|69581110|FG005|Part D (HPMC Capsules)|Death|0|||
37896042|NCT01072175|69581111|FG006|Part D (HPMC Capsules)|Death|0|||
37896043|NCT01072175|69581112|FG007|Part D (HPMC Capsules)|Death|0|||
37896044|NCT01072175|69581113|FG008|Part D (HPMC Capsules)|Death|0|||
37896045|NCT01072175|69581114|FG009|Part D (HPMC Capsules)|Death|10|||
37896046|NCT01072175|69581115|FG010|Part D (HPMC Capsules)|Death|12|||
37896047|NCT01072175|69581116|FG011|Part D (HPMC Capsules)|Death|28|||
37896048|NCT01072175|69581117|FG012|Part D (HPMC Capsules)|Death|26|||
37896049|NCT01072175|69581105|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
37896050|NCT01072175|69581106|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
37896051|NCT01072175|69581107|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
37896052|NCT01072175|69581108|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
37896053|NCT01072175|69581109|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
37896054|NCT01072175|69581110|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
37896055|NCT01072175|69581111|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
37896056|NCT01072175|69581112|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
37896057|NCT01072175|69581113|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
37896058|NCT01072175|69581114|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
37896059|NCT01072175|69581115|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
37896060|NCT01072175|69581116|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
37896061|NCT01072175|69581117|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
37896062|NCT01072175|69581105|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
37896063|NCT01072175|69581106|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
37896064|NCT01072175|69581107|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
37896065|NCT01072175|69581108|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
37896066|NCT01072175|69581109|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
37896067|NCT01072175|69581110|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
37896068|NCT01072175|69581111|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
37896069|NCT01072175|69581112|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
37896070|NCT01072175|69581113|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
37896071|NCT01072175|69581114|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
37896072|NCT01072175|69581115|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
37896073|NCT01072175|69581116|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
37896074|NCT01072175|69581117|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
37896075|NCT01072175|69581105|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
37896076|NCT01072175|69581106|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
37896077|NCT01072175|69581107|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
37896078|NCT01072175|69581108|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
37896079|NCT01072175|69581109|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
37896080|NCT01072175|69581110|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
37896081|NCT01072175|69581111|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
37896082|NCT01072175|69581112|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
37992940|NCT00328926|69677852|FG001|Overall Study|Death|0|||
37696251|NCT02465567|69172376|FG002|Overall Study|missing PI Signature|0|||
37896083|NCT01072175|69581113|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
37896084|NCT01072175|69581114|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
37896085|NCT01072175|69581115|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
37992941|NCT00328926|69677853|FG002|Overall Study|Death|1|||
37992942|NCT00328926|69677851|FG000|Overall Study|In vitro fertilization treatment|0|||
37992943|NCT00328926|69677852|FG001|Overall Study|In vitro fertilization treatment|0|||
37992944|NCT00328926|69677853|FG002|Overall Study|In vitro fertilization treatment|1|||
37992945|NCT00328926|69677851|FG000|Overall Study|Lack of ovarian response|0|||
37992946|NCT00328926|69677852|FG001|Overall Study|Lack of ovarian response|1|||
37992947|NCT00328926|69677853|FG002|Overall Study|Lack of ovarian response|0|||
37992948|NCT00319254|69677861|FG000|Overall Study|Withdrawal by Subject|4|||
37992949|NCT00319254|69677861|FG000|Overall Study|Death|46|||
37992950|NCT00319254|69677861|FG000|Overall Study|Lost to Follow-up|2|||
37992951|NCT00319254|69677861|FG000|Overall Study|Enrolled, Not Treated|2|||
37992952|NCT00319098|69677869|FG000|Overall Study|Serious adverse event|3|||
37992953|NCT00319098|69677870|FG001|Overall Study|Serious adverse event|0|||
37992954|NCT00319098|69677869|FG000|Overall Study|Adverse Event|20|||
37992955|NCT00319098|69677870|FG001|Overall Study|Adverse Event|1|||
37992956|NCT00319098|69677869|FG000|Overall Study|Withdrawal by Subject|37|||
37992957|NCT00319098|69677870|FG001|Overall Study|Withdrawal by Subject|8|||
37992958|NCT00319098|69677869|FG000|Overall Study|Migrated/moved from study area|2|||
37992959|NCT00319098|69677870|FG001|Overall Study|Migrated/moved from study area|1|||
37992960|NCT00319098|69677869|FG000|Overall Study|Lost to Follow-up|37|||
37992961|NCT00319098|69677870|FG001|Overall Study|Lost to Follow-up|13|||
37992962|NCT00319098|69677869|FG000|Overall Study|Others|33|||
37992963|NCT00319098|69677870|FG001|Overall Study|Others|8|||
37992964|NCT00319098|69677869|FG000|Overall Study|Protocol Violation|3|||
37896086|NCT01072175|69581116|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
37896087|NCT01072175|69581117|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
37896088|NCT01072175|69581105|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
37896089|NCT01072175|69581106|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
37896090|NCT01072175|69581107|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
37896091|NCT01072175|69581108|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
37896092|NCT01072175|69581109|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
37896093|NCT01072175|69581110|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
37896094|NCT01072175|69581111|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
37896095|NCT01072175|69581112|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
37896096|NCT01072175|69581113|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
37896097|NCT01072175|69581114|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
37896098|NCT01072175|69581115|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
37896099|NCT01072175|69581116|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
37896100|NCT01072175|69581117|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
37896101|NCT01071317|69581151|FG000|Overall Study|Lost to Follow-up|2|||
37896102|NCT01071317|69581152|FG001|Overall Study|Lost to Follow-up|2|||
37896103|NCT00783094|69581169|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
37896104|NCT00783094|69581170|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
37896105|NCT00783094|69581171|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
37896106|NCT00783094|69581169|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
37896107|NCT00783094|69581170|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
37896108|NCT00783094|69581171|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
37896109|NCT00783094|69581169|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
37896110|NCT00783094|69581170|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
37896111|NCT00783094|69581171|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
37896112|NCT00783094|69581169|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
37896113|NCT00783094|69581170|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
37896114|NCT00783094|69581171|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
37896115|NCT00783094|69581169|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
37992965|NCT00319098|69677870|FG001|Overall Study|Protocol Violation|1|||
37992966|NCT00347360|69677895|FG000|Overall Study|Adverse Event|1|||
37992967|NCT00347360|69677896|FG001|Overall Study|Adverse Event|2|||
37992968|NCT00347360|69677897|FG002|Overall Study|Adverse Event|0|||
37992969|NCT00347360|69677898|FG003|Overall Study|Adverse Event|4|||
37992970|NCT00347360|69677899|FG004|Overall Study|Adverse Event|1|||
37992971|NCT00347360|69677900|FG005|Overall Study|Adverse Event|2|||
37992972|NCT00347360|69677901|FG006|Overall Study|Adverse Event|2|||
37992973|NCT00347360|69677902|FG007|Overall Study|Adverse Event|0|||
37896116|NCT00783094|69581170|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
37896117|NCT00783094|69581171|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
37992974|NCT00347360|69677903|FG008|Overall Study|Adverse Event|2|||
37992975|NCT00347360|69677904|FG009|Overall Study|Adverse Event|3|||
37992976|NCT00347360|69677905|FG010|Overall Study|Adverse Event|3|||
37896118|NCT00783094|69581169|FG000|Open-Label Extension Period|Adverse Event|12|||
37896119|NCT00783094|69581170|FG001|Open-Label Extension Period|Adverse Event|7|||
37992977|NCT00347360|69677906|FG011|Overall Study|Adverse Event|1|||
37992978|NCT00347360|69677907|FG012|Overall Study|Adverse Event|3|||
37992979|NCT00347360|69677908|FG013|Overall Study|Adverse Event|2|||
37992980|NCT00347360|69677909|FG014|Overall Study|Adverse Event|2|||
37992981|NCT00347360|69677895|FG000|Overall Study|Lost to Follow-up|0|||
37992982|NCT00347360|69677896|FG001|Overall Study|Lost to Follow-up|0|||
37992983|NCT00347360|69677897|FG002|Overall Study|Lost to Follow-up|0|||
37992984|NCT00347360|69677898|FG003|Overall Study|Lost to Follow-up|2|||
37992985|NCT00347360|69677899|FG004|Overall Study|Lost to Follow-up|1|||
37992986|NCT00347360|69677900|FG005|Overall Study|Lost to Follow-up|1|||
37992987|NCT00347360|69677901|FG006|Overall Study|Lost to Follow-up|0|||
37992988|NCT00347360|69677902|FG007|Overall Study|Lost to Follow-up|1|||
37992989|NCT00347360|69677903|FG008|Overall Study|Lost to Follow-up|1|||
37992990|NCT00347360|69677904|FG009|Overall Study|Lost to Follow-up|2|||
37992991|NCT00347360|69677905|FG010|Overall Study|Lost to Follow-up|0|||
37992992|NCT00347360|69677906|FG011|Overall Study|Lost to Follow-up|0|||
37992993|NCT00347360|69677907|FG012|Overall Study|Lost to Follow-up|1|||
37992994|NCT00347360|69677908|FG013|Overall Study|Lost to Follow-up|0|||
37992995|NCT00347360|69677909|FG014|Overall Study|Lost to Follow-up|0|||
37992996|NCT00347360|69677895|FG000|Overall Study|Protocol Violation|2|||
37992997|NCT00347360|69677896|FG001|Overall Study|Protocol Violation|3|||
37896120|NCT00783094|69581171|FG002|Open-Label Extension Period|Adverse Event|16|||
37896121|NCT00783094|69581169|FG000|Open-Label Extension Period|Death|0|||
37896122|NCT00783094|69581170|FG001|Open-Label Extension Period|Death|0|||
37896123|NCT00783094|69581171|FG002|Open-Label Extension Period|Death|1|||
37896124|NCT00783094|69581169|FG000|Open-Label Extension Period|Protocol Violation|4|||
37896125|NCT00783094|69581170|FG001|Open-Label Extension Period|Protocol Violation|5|||
37896126|NCT00783094|69581171|FG002|Open-Label Extension Period|Protocol Violation|7|||
37896127|NCT00783094|69581169|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
37896128|NCT00783094|69581170|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
37896129|NCT00783094|69581171|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
37896130|NCT00783094|69581169|FG000|Open-Label Extension Period|Physician Decision|4|||
37896131|NCT00783094|69581170|FG001|Open-Label Extension Period|Physician Decision|2|||
37896132|NCT00783094|69581171|FG002|Open-Label Extension Period|Physician Decision|3|||
37896133|NCT00783094|69581169|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
37896134|NCT00783094|69581170|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
37896135|NCT00783094|69581171|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
37896136|NCT00790582|69581184|FG000|Overall Study|Death|14|||
37896137|NCT00790582|69581185|FG001|Overall Study|Death|32|||
37992998|NCT00347360|69677897|FG002|Overall Study|Protocol Violation|1|||
37992999|NCT00347360|69677898|FG003|Overall Study|Protocol Violation|2|||
37993000|NCT00347360|69677899|FG004|Overall Study|Protocol Violation|1|||
37993001|NCT00347360|69677900|FG005|Overall Study|Protocol Violation|2|||
37993002|NCT00347360|69677901|FG006|Overall Study|Protocol Violation|0|||
37993003|NCT00347360|69677902|FG007|Overall Study|Protocol Violation|0|||
37993004|NCT00347360|69677903|FG008|Overall Study|Protocol Violation|1|||
37993005|NCT00347360|69677904|FG009|Overall Study|Protocol Violation|2|||
37993006|NCT00347360|69677905|FG010|Overall Study|Protocol Violation|0|||
37993007|NCT00347360|69677906|FG011|Overall Study|Protocol Violation|0|||
37993008|NCT00347360|69677907|FG012|Overall Study|Protocol Violation|0|||
37993009|NCT00347360|69677908|FG013|Overall Study|Protocol Violation|1|||
37993010|NCT00347360|69677909|FG014|Overall Study|Protocol Violation|0|||
37993011|NCT00347360|69677895|FG000|Overall Study|Withdrawal by Subject|0|||
37993012|NCT00347360|69677896|FG001|Overall Study|Withdrawal by Subject|1|||
37993013|NCT00347360|69677897|FG002|Overall Study|Withdrawal by Subject|2|||
37993014|NCT00347360|69677898|FG003|Overall Study|Withdrawal by Subject|4|||
37993015|NCT00347360|69677899|FG004|Overall Study|Withdrawal by Subject|1|||
37993016|NCT00347360|69677900|FG005|Overall Study|Withdrawal by Subject|2|||
37993017|NCT00347360|69677901|FG006|Overall Study|Withdrawal by Subject|1|||
37993018|NCT00347360|69677902|FG007|Overall Study|Withdrawal by Subject|1|||
37993019|NCT00347360|69677903|FG008|Overall Study|Withdrawal by Subject|1|||
37993020|NCT00347360|69677904|FG009|Overall Study|Withdrawal by Subject|1|||
37993021|NCT00347360|69677905|FG010|Overall Study|Withdrawal by Subject|0|||
37993022|NCT00347360|69677906|FG011|Overall Study|Withdrawal by Subject|3|||
37896138|NCT00790582|69581184|FG000|Overall Study|Physician Decision|7|||
37896139|NCT00790582|69581185|FG001|Overall Study|Physician Decision|1|||
37993023|NCT00347360|69677907|FG012|Overall Study|Withdrawal by Subject|4|||
37896140|NCT00790582|69581184|FG000|Overall Study|Lost to Follow-up|3|||
37993024|NCT00347360|69677908|FG013|Overall Study|Withdrawal by Subject|2|||
37993025|NCT00347360|69677909|FG014|Overall Study|Withdrawal by Subject|1|||
37993026|NCT00347360|69677895|FG000|Overall Study|Lack of Efficacy|1|||
37993027|NCT00347360|69677896|FG001|Overall Study|Lack of Efficacy|1|||
37993028|NCT00347360|69677897|FG002|Overall Study|Lack of Efficacy|3|||
37993029|NCT00347360|69677898|FG003|Overall Study|Lack of Efficacy|1|||
37993030|NCT00347360|69677899|FG004|Overall Study|Lack of Efficacy|0|||
37993031|NCT00347360|69677900|FG005|Overall Study|Lack of Efficacy|1|||
37993032|NCT00347360|69677901|FG006|Overall Study|Lack of Efficacy|0|||
37993033|NCT00347360|69677902|FG007|Overall Study|Lack of Efficacy|1|||
37993034|NCT00347360|69677903|FG008|Overall Study|Lack of Efficacy|1|||
37993035|NCT00347360|69677904|FG009|Overall Study|Lack of Efficacy|0|||
37993036|NCT00347360|69677905|FG010|Overall Study|Lack of Efficacy|0|||
37993037|NCT00347360|69677906|FG011|Overall Study|Lack of Efficacy|0|||
37993038|NCT00347360|69677907|FG012|Overall Study|Lack of Efficacy|0|||
37993039|NCT00347360|69677908|FG013|Overall Study|Lack of Efficacy|0|||
37993040|NCT00347360|69677909|FG014|Overall Study|Lack of Efficacy|0|||
37993041|NCT00347360|69677895|FG000|Overall Study|Reason not listed/blank|1|||
37993042|NCT00347360|69677896|FG001|Overall Study|Reason not listed/blank|0|||
37993043|NCT00347360|69677897|FG002|Overall Study|Reason not listed/blank|0|||
37993044|NCT00347360|69677898|FG003|Overall Study|Reason not listed/blank|0|||
37993045|NCT00347360|69677899|FG004|Overall Study|Reason not listed/blank|0|||
37993046|NCT00347360|69677900|FG005|Overall Study|Reason not listed/blank|0|||
37993047|NCT00347360|69677901|FG006|Overall Study|Reason not listed/blank|1|||
37993048|NCT00347360|69677902|FG007|Overall Study|Reason not listed/blank|0|||
37993049|NCT00347360|69677903|FG008|Overall Study|Reason not listed/blank|0|||
37993050|NCT00347360|69677904|FG009|Overall Study|Reason not listed/blank|0|||
37993051|NCT00347360|69677905|FG010|Overall Study|Reason not listed/blank|0|||
37993052|NCT00347360|69677906|FG011|Overall Study|Reason not listed/blank|0|||
37993053|NCT00347360|69677907|FG012|Overall Study|Reason not listed/blank|0|||
37993054|NCT00347360|69677908|FG013|Overall Study|Reason not listed/blank|1|||
37993055|NCT00347360|69677909|FG014|Overall Study|Reason not listed/blank|0|||
37993056|NCT00347360|69677895|FG000|Overall Study|Per sponsors instruction|0|||
37993057|NCT00347360|69677896|FG001|Overall Study|Per sponsors instruction|1|||
37993058|NCT00347360|69677897|FG002|Overall Study|Per sponsors instruction|0|||
37993059|NCT00347360|69677898|FG003|Overall Study|Per sponsors instruction|0|||
37993060|NCT00347360|69677899|FG004|Overall Study|Per sponsors instruction|0|||
37993061|NCT00347360|69677900|FG005|Overall Study|Per sponsors instruction|0|||
37993062|NCT00347360|69677901|FG006|Overall Study|Per sponsors instruction|0|||
37993063|NCT00347360|69677902|FG007|Overall Study|Per sponsors instruction|0|||
37993064|NCT00347360|69677903|FG008|Overall Study|Per sponsors instruction|0|||
37993065|NCT00347360|69677904|FG009|Overall Study|Per sponsors instruction|0|||
37993066|NCT00347360|69677905|FG010|Overall Study|Per sponsors instruction|0|||
37993067|NCT00347360|69677906|FG011|Overall Study|Per sponsors instruction|0|||
37993068|NCT00347360|69677907|FG012|Overall Study|Per sponsors instruction|0|||
37993069|NCT00347360|69677908|FG013|Overall Study|Per sponsors instruction|0|||
37993070|NCT00347360|69677909|FG014|Overall Study|Per sponsors instruction|0|||
37993071|NCT00347360|69677895|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
37993072|NCT00347360|69677896|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
37993073|NCT00347360|69677897|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
37993074|NCT00347360|69677898|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
37993075|NCT00347360|69677899|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
37993076|NCT00347360|69677900|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
37993077|NCT00347360|69677901|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
37993078|NCT00347360|69677902|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
37993079|NCT00347360|69677903|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
37993080|NCT00347360|69677904|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
37896141|NCT00790582|69581185|FG001|Overall Study|Lost to Follow-up|3|||
37896142|NCT00790582|69581184|FG000|Overall Study|Withdrawal by Subject|7|||
37896143|NCT00790582|69581185|FG001|Overall Study|Withdrawal by Subject|51|||
37896144|NCT01048541|69581193|FG000|Overall Study|Withdrawal by Subject|1|||
37896145|NCT01048541|69581194|FG001|Overall Study|Withdrawal by Subject|0|||
37896146|NCT00774046|69581200|FG000|Screening|Not eligible|56|||
37896147|NCT00774046|69581200|FG000|Enrollment|Desired other therapy/refused|28|||
37896148|NCT00774046|69581200|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
37896149|NCT01046903|69581204|FG000|Overall Study|Lost to Follow-up|16|||
37896150|NCT01046903|69581204|FG000|Overall Study|Adverse Event|4|||
37896151|NCT01046903|69581204|FG000|Overall Study|Withdrawal by Subject|3|||
37896152|NCT01046903|69581204|FG000|Overall Study|Other|5|||
37993081|NCT00347360|69677905|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
37993082|NCT00347360|69677906|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
37993083|NCT00347360|69677907|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
37993084|NCT00347360|69677908|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
37993085|NCT00347360|69677909|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
37993086|NCT00347360|69677895|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
37993087|NCT00347360|69677896|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
37896153|NCT00773968|69581208|FG000|Overall Study|Adverse Event|2|||
37896154|NCT00773968|69581208|FG000|Overall Study|Death|1|||
37993088|NCT00347360|69677897|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
37993089|NCT00347360|69677898|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
37993090|NCT00347360|69677899|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
37993091|NCT00347360|69677900|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
37993092|NCT00347360|69677901|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
37993093|NCT00347360|69677902|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
37993094|NCT00347360|69677903|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
37993095|NCT00347360|69677904|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
37993096|NCT00347360|69677905|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
37993097|NCT00347360|69677906|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
37993098|NCT00347360|69677907|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
37993099|NCT00347360|69677908|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
37993100|NCT00347360|69677909|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
37993101|NCT00347360|69677895|FG000|Overall Study|Abnormal lab values|0|||
37993102|NCT00347360|69677896|FG001|Overall Study|Abnormal lab values|0|||
37993103|NCT00347360|69677897|FG002|Overall Study|Abnormal lab values|0|||
37993104|NCT00347360|69677898|FG003|Overall Study|Abnormal lab values|0|||
37993105|NCT00347360|69677899|FG004|Overall Study|Abnormal lab values|0|||
37993106|NCT00347360|69677900|FG005|Overall Study|Abnormal lab values|0|||
37993107|NCT00347360|69677901|FG006|Overall Study|Abnormal lab values|1|||
37993108|NCT00347360|69677902|FG007|Overall Study|Abnormal lab values|0|||
37993109|NCT00347360|69677903|FG008|Overall Study|Abnormal lab values|0|||
37993110|NCT00347360|69677904|FG009|Overall Study|Abnormal lab values|0|||
37993111|NCT00347360|69677905|FG010|Overall Study|Abnormal lab values|0|||
37993112|NCT00347360|69677906|FG011|Overall Study|Abnormal lab values|0|||
37993113|NCT00347360|69677907|FG012|Overall Study|Abnormal lab values|0|||
37993114|NCT00347360|69677908|FG013|Overall Study|Abnormal lab values|0|||
37993115|NCT00347360|69677909|FG014|Overall Study|Abnormal lab values|0|||
37993116|NCT00347360|69677895|FG000|Overall Study|PI recommended early withdrawal|0|||
37993117|NCT00347360|69677896|FG001|Overall Study|PI recommended early withdrawal|0|||
37993118|NCT00347360|69677897|FG002|Overall Study|PI recommended early withdrawal|0|||
37993119|NCT00347360|69677898|FG003|Overall Study|PI recommended early withdrawal|0|||
37993120|NCT00347360|69677899|FG004|Overall Study|PI recommended early withdrawal|0|||
37993121|NCT00347360|69677900|FG005|Overall Study|PI recommended early withdrawal|0|||
37993122|NCT00347360|69677901|FG006|Overall Study|PI recommended early withdrawal|0|||
37993123|NCT00347360|69677902|FG007|Overall Study|PI recommended early withdrawal|0|||
37993124|NCT00347360|69677903|FG008|Overall Study|PI recommended early withdrawal|0|||
37993125|NCT00347360|69677904|FG009|Overall Study|PI recommended early withdrawal|1|||
37993126|NCT00347360|69677905|FG010|Overall Study|PI recommended early withdrawal|0|||
37993127|NCT00347360|69677906|FG011|Overall Study|PI recommended early withdrawal|0|||
37993128|NCT00347360|69677907|FG012|Overall Study|PI recommended early withdrawal|0|||
37993129|NCT00347360|69677908|FG013|Overall Study|PI recommended early withdrawal|0|||
37993130|NCT00347360|69677909|FG014|Overall Study|PI recommended early withdrawal|0|||
37993131|NCT00347360|69677895|FG000|Overall Study|Did not meet criteria before ABPM|0|||
37993132|NCT00347360|69677896|FG001|Overall Study|Did not meet criteria before ABPM|0|||
37993133|NCT00347360|69677897|FG002|Overall Study|Did not meet criteria before ABPM|0|||
37993134|NCT00347360|69677898|FG003|Overall Study|Did not meet criteria before ABPM|0|||
37993135|NCT00347360|69677899|FG004|Overall Study|Did not meet criteria before ABPM|0|||
37993136|NCT00347360|69677900|FG005|Overall Study|Did not meet criteria before ABPM|0|||
37993137|NCT00347360|69677901|FG006|Overall Study|Did not meet criteria before ABPM|0|||
37993138|NCT00347360|69677902|FG007|Overall Study|Did not meet criteria before ABPM|0|||
37993139|NCT00347360|69677903|FG008|Overall Study|Did not meet criteria before ABPM|0|||
37993140|NCT00347360|69677904|FG009|Overall Study|Did not meet criteria before ABPM|0|||
37993141|NCT00347360|69677905|FG010|Overall Study|Did not meet criteria before ABPM|1|||
37993142|NCT00347360|69677906|FG011|Overall Study|Did not meet criteria before ABPM|0|||
37993143|NCT00347360|69677907|FG012|Overall Study|Did not meet criteria before ABPM|0|||
37993144|NCT00347360|69677908|FG013|Overall Study|Did not meet criteria before ABPM|0|||
37993145|NCT00347360|69677909|FG014|Overall Study|Did not meet criteria before ABPM|0|||
37993146|NCT00347360|69677895|FG000|Overall Study|Randomized in error|0|||
37993147|NCT00347360|69677896|FG001|Overall Study|Randomized in error|0|||
37993148|NCT00347360|69677897|FG002|Overall Study|Randomized in error|0|||
37993149|NCT00347360|69677898|FG003|Overall Study|Randomized in error|0|||
37993150|NCT00347360|69677899|FG004|Overall Study|Randomized in error|0|||
37993151|NCT00347360|69677900|FG005|Overall Study|Randomized in error|0|||
37696252|NCT02465567|69172377|FG003|Overall Study|missing PI Signature|0|||
37993152|NCT00347360|69677901|FG006|Overall Study|Randomized in error|0|||
37993153|NCT00347360|69677902|FG007|Overall Study|Randomized in error|0|||
37993154|NCT00347360|69677903|FG008|Overall Study|Randomized in error|0|||
37993155|NCT00347360|69677904|FG009|Overall Study|Randomized in error|0|||
37993156|NCT00347360|69677905|FG010|Overall Study|Randomized in error|0|||
37993157|NCT00347360|69677906|FG011|Overall Study|Randomized in error|1|||
37993158|NCT00347360|69677907|FG012|Overall Study|Randomized in error|0|||
37993159|NCT00347360|69677908|FG013|Overall Study|Randomized in error|0|||
37993160|NCT00347360|69677909|FG014|Overall Study|Randomized in error|0|||
37993161|NCT00347360|69677895|FG000|Overall Study|Failed inclusion criteria #4|0|||
37993162|NCT00347360|69677896|FG001|Overall Study|Failed inclusion criteria #4|0|||
37993163|NCT00347360|69677897|FG002|Overall Study|Failed inclusion criteria #4|0|||
37993164|NCT00347360|69677898|FG003|Overall Study|Failed inclusion criteria #4|0|||
37993165|NCT00347360|69677899|FG004|Overall Study|Failed inclusion criteria #4|0|||
37993166|NCT00347360|69677900|FG005|Overall Study|Failed inclusion criteria #4|0|||
37993167|NCT00347360|69677901|FG006|Overall Study|Failed inclusion criteria #4|0|||
37993168|NCT00347360|69677902|FG007|Overall Study|Failed inclusion criteria #4|0|||
37993169|NCT00347360|69677903|FG008|Overall Study|Failed inclusion criteria #4|0|||
37993170|NCT00347360|69677904|FG009|Overall Study|Failed inclusion criteria #4|0|||
37993171|NCT00347360|69677905|FG010|Overall Study|Failed inclusion criteria #4|0|||
37993172|NCT00347360|69677906|FG011|Overall Study|Failed inclusion criteria #4|1|||
37993173|NCT00347360|69677907|FG012|Overall Study|Failed inclusion criteria #4|0|||
37993174|NCT00347360|69677908|FG013|Overall Study|Failed inclusion criteria #4|0|||
37993175|NCT00347360|69677909|FG014|Overall Study|Failed inclusion criteria #4|0|||
37993176|NCT00347360|69677895|FG000|Overall Study|Prolonged duration between visits|0|||
37993177|NCT00347360|69677896|FG001|Overall Study|Prolonged duration between visits|0|||
37993178|NCT00347360|69677897|FG002|Overall Study|Prolonged duration between visits|0|||
37993179|NCT00347360|69677898|FG003|Overall Study|Prolonged duration between visits|0|||
37993180|NCT00347360|69677899|FG004|Overall Study|Prolonged duration between visits|0|||
37993181|NCT00347360|69677900|FG005|Overall Study|Prolonged duration between visits|0|||
37993182|NCT00347360|69677901|FG006|Overall Study|Prolonged duration between visits|0|||
37993183|NCT00347360|69677902|FG007|Overall Study|Prolonged duration between visits|0|||
37993184|NCT00347360|69677903|FG008|Overall Study|Prolonged duration between visits|0|||
37993185|NCT00347360|69677904|FG009|Overall Study|Prolonged duration between visits|0|||
37993186|NCT00347360|69677905|FG010|Overall Study|Prolonged duration between visits|0|||
37993187|NCT00347360|69677906|FG011|Overall Study|Prolonged duration between visits|0|||
37993188|NCT00347360|69677907|FG012|Overall Study|Prolonged duration between visits|1|||
37993189|NCT00347360|69677908|FG013|Overall Study|Prolonged duration between visits|0|||
37993190|NCT00347360|69677909|FG014|Overall Study|Prolonged duration between visits|0|||
37896155|NCT00773968|69581208|FG000|Overall Study|Failure to Return|2|||
37896156|NCT00773968|69581208|FG000|Overall Study|Lack of Efficacy|3|||
37896157|NCT00773968|69581208|FG000|Overall Study|Protocol Violation|1|||
37896158|NCT00773968|69581208|FG000|Overall Study|Withdrawal by Subject|11|||
37896159|NCT00773968|69581208|FG000|Overall Study|Screen Failure|17|||
37896160|NCT00773968|69581208|FG000|Overall Study|Other|8|||
37896161|NCT00782626|69581212|FG000|Overall Study|Adverse Event|1|||
37896162|NCT00782626|69581212|FG000|Overall Study|Progressive Disease|5|||
37896163|NCT00782626|69581212|FG000|Overall Study|Other Complicating Disease|1|||
37896164|NCT01071083|69581221|FG000|Overall Study|Adverse Event|1|||
37896165|NCT01071083|69581222|FG001|Overall Study|Adverse Event|0|||
37896166|NCT01071083|69581223|FG002|Overall Study|Adverse Event|1|||
37896167|NCT01071083|69581224|FG003|Overall Study|Adverse Event|0|||
37896168|NCT01071083|69581225|FG004|Overall Study|Adverse Event|1|||
37896169|NCT01071083|69581221|FG000|Overall Study|Withdrawal by Subject|3|||
37896170|NCT01071083|69581222|FG001|Overall Study|Withdrawal by Subject|0|||
37896171|NCT01071083|69581223|FG002|Overall Study|Withdrawal by Subject|2|||
37896172|NCT01071083|69581224|FG003|Overall Study|Withdrawal by Subject|0|||
37993191|NCT00347360|69677895|FG000|Overall Study|Subject left town, ran out of study drug|0|||
37825347|NCT01247350|69507345|FG002|Overall Study|Entry criteria not met|0|||
37825348|NCT01247350|69507346|FG003|Overall Study|Entry criteria not met|0|||
37825349|NCT01247350|69507347|FG004|Overall Study|Entry criteria not met|1|||
37825350|NCT01246999|69507377|FG000|Overall Study|Lost to Follow-up|0|||
37825351|NCT01246999|69507378|FG001|Overall Study|Lost to Follow-up|1|||
37825352|NCT01246999|69507379|FG002|Overall Study|Lost to Follow-up|0|||
37825353|NCT01246999|69507380|FG003|Overall Study|Lost to Follow-up|0|||
37825354|NCT01246999|69507377|FG000|Overall Study|Withdrawal by Subject|0|||
37825355|NCT01246999|69507378|FG001|Overall Study|Withdrawal by Subject|0|||
37825356|NCT01246999|69507379|FG002|Overall Study|Withdrawal by Subject|0|||
37825357|NCT01246999|69507380|FG003|Overall Study|Withdrawal by Subject|2|||
37825358|NCT01245751|69507402|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
37825359|NCT01245751|69507403|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
37825360|NCT01245751|69507404|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
37825361|NCT01245751|69507405|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
37825362|NCT01245751|69507402|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
37896173|NCT01071083|69581225|FG004|Overall Study|Withdrawal by Subject|3|||
37896174|NCT01071083|69581221|FG000|Overall Study|Physician Decision|1|||
37825363|NCT01245751|69507403|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
37896175|NCT01071083|69581222|FG001|Overall Study|Physician Decision|0|||
37825364|NCT01245751|69507404|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
37825365|NCT01245751|69507405|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
37896176|NCT01071083|69581223|FG002|Overall Study|Physician Decision|0|||
37993192|NCT00347360|69677896|FG001|Overall Study|Subject left town, ran out of study drug|0|||
37993193|NCT00347360|69677897|FG002|Overall Study|Subject left town, ran out of study drug|0|||
37993194|NCT00347360|69677898|FG003|Overall Study|Subject left town, ran out of study drug|0|||
37993195|NCT00347360|69677899|FG004|Overall Study|Subject left town, ran out of study drug|0|||
37993196|NCT00347360|69677900|FG005|Overall Study|Subject left town, ran out of study drug|0|||
37993197|NCT00347360|69677901|FG006|Overall Study|Subject left town, ran out of study drug|0|||
37993198|NCT00347360|69677902|FG007|Overall Study|Subject left town, ran out of study drug|0|||
37993199|NCT00347360|69677903|FG008|Overall Study|Subject left town, ran out of study drug|0|||
37993200|NCT00347360|69677904|FG009|Overall Study|Subject left town, ran out of study drug|0|||
37993201|NCT00347360|69677905|FG010|Overall Study|Subject left town, ran out of study drug|0|||
37993202|NCT00347360|69677906|FG011|Overall Study|Subject left town, ran out of study drug|0|||
37993203|NCT00347360|69677907|FG012|Overall Study|Subject left town, ran out of study drug|0|||
37993204|NCT00347360|69677908|FG013|Overall Study|Subject left town, ran out of study drug|1|||
37993205|NCT00347360|69677909|FG014|Overall Study|Subject left town, ran out of study drug|0|||
37993206|NCT00347360|69677895|FG000|Overall Study|Subject refuse to sign updated consent|0|||
37993207|NCT00347360|69677896|FG001|Overall Study|Subject refuse to sign updated consent|0|||
37993208|NCT00347360|69677897|FG002|Overall Study|Subject refuse to sign updated consent|0|||
37993209|NCT00347360|69677898|FG003|Overall Study|Subject refuse to sign updated consent|0|||
37993210|NCT00347360|69677899|FG004|Overall Study|Subject refuse to sign updated consent|0|||
37993211|NCT00347360|69677900|FG005|Overall Study|Subject refuse to sign updated consent|0|||
37993212|NCT00347360|69677901|FG006|Overall Study|Subject refuse to sign updated consent|0|||
37993213|NCT00347360|69677902|FG007|Overall Study|Subject refuse to sign updated consent|0|||
37993214|NCT00347360|69677903|FG008|Overall Study|Subject refuse to sign updated consent|0|||
37993215|NCT00347360|69677904|FG009|Overall Study|Subject refuse to sign updated consent|0|||
37993216|NCT00347360|69677905|FG010|Overall Study|Subject refuse to sign updated consent|0|||
37993217|NCT00347360|69677906|FG011|Overall Study|Subject refuse to sign updated consent|0|||
37993218|NCT00347360|69677907|FG012|Overall Study|Subject refuse to sign updated consent|0|||
37993219|NCT00347360|69677908|FG013|Overall Study|Subject refuse to sign updated consent|0|||
37696253|NCT01644175|69172389|FG000|Overall Study|Randomized But Not Treated|0|||
37896177|NCT01071083|69581224|FG003|Overall Study|Physician Decision|1|||
37896178|NCT01071083|69581225|FG004|Overall Study|Physician Decision|1|||
37896179|NCT01071083|69581221|FG000|Overall Study|Early Rescue|1|||
37896180|NCT01071083|69581222|FG001|Overall Study|Early Rescue|0|||
37896181|NCT01071083|69581223|FG002|Overall Study|Early Rescue|0|||
37896182|NCT01071083|69581224|FG003|Overall Study|Early Rescue|0|||
37896183|NCT01071083|69581225|FG004|Overall Study|Early Rescue|1|||
37896184|NCT01071083|69581221|FG000|Overall Study|Subject Moved|0|||
37896185|NCT01071083|69581222|FG001|Overall Study|Subject Moved|1|||
37896186|NCT01071083|69581223|FG002|Overall Study|Subject Moved|0|||
37896187|NCT01071083|69581224|FG003|Overall Study|Subject Moved|0|||
37696254|NCT01644175|69172390|FG001|Overall Study|Randomized But Not Treated|2|||
37696255|NCT01644175|69172389|FG000|Overall Study|Adverse Event|8|||
37825366|NCT01245751|69507402|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
37825367|NCT01245751|69507403|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
37825368|NCT01245751|69507404|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
37825369|NCT01245751|69507405|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
37825370|NCT01245673|69507416|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
37825371|NCT01245283|69507423|FG000|Overall Study|Lost to Follow-up|14|||
37825372|NCT01245283|69507424|FG001|Overall Study|Lost to Follow-up|11|||
37825373|NCT01245283|69507425|FG002|Overall Study|Lost to Follow-up|11|||
37825374|NCT01245049|69507438|FG000|Overall Study|Migrated/moved from study area|0|||
37825375|NCT01245049|69507439|FG001|Overall Study|Migrated/moved from study area|1|||
37825376|NCT01245049|69507438|FG000|Overall Study|Withdrawal by Subject|0|||
37825377|NCT01245049|69507439|FG001|Overall Study|Withdrawal by Subject|1|||
37825378|NCT01245049|69507438|FG000|Overall Study|Lost to Follow-up|1|||
37825379|NCT01245049|69507439|FG001|Overall Study|Lost to Follow-up|2|||
37825380|NCT01244893|69507445|FG000|Baseline|Protocol Violation|0|||
37825381|NCT01244893|69507446|FG001|Baseline|Protocol Violation|1|||
37825382|NCT01244893|69507445|FG000|1-Week Follow Up|Lost to Follow-up|1|||
37825383|NCT01244893|69507446|FG001|1-Week Follow Up|Lost to Follow-up|0|||
37825384|NCT01244815|69507461|FG000|Overall Study|Not Treated|0|||
37825385|NCT01244815|69507462|FG001|Overall Study|Not Treated|1|||
37825386|NCT01244815|69507463|FG002|Overall Study|Not Treated|0|||
37825387|NCT01244815|69507464|FG003|Overall Study|Not Treated|0|||
37825388|NCT01244815|69507461|FG000|Overall Study|Adverse Event|4|||
37825389|NCT01244815|69507462|FG001|Overall Study|Adverse Event|7|||
37825390|NCT01244815|69507463|FG002|Overall Study|Adverse Event|5|||
37825391|NCT01244815|69507464|FG003|Overall Study|Adverse Event|5|||
37825392|NCT01244815|69507461|FG000|Overall Study|Treatment Failure|0|||
37825393|NCT01244815|69507462|FG001|Overall Study|Treatment Failure|0|||
37896188|NCT01071083|69581225|FG004|Overall Study|Subject Moved|0|||
37696256|NCT01644175|69172390|FG001|Overall Study|Adverse Event|13|||
37993220|NCT00347360|69677909|FG014|Overall Study|Subject refuse to sign updated consent|1|||
37993221|NCT00347360|69677895|FG000|Overall Study|Visits conflicted with new job|0|||
37993222|NCT00347360|69677896|FG001|Overall Study|Visits conflicted with new job|0|||
37993223|NCT00347360|69677897|FG002|Overall Study|Visits conflicted with new job|0|||
37993224|NCT00347360|69677898|FG003|Overall Study|Visits conflicted with new job|0|||
37993225|NCT00347360|69677899|FG004|Overall Study|Visits conflicted with new job|0|||
37993226|NCT00347360|69677900|FG005|Overall Study|Visits conflicted with new job|0|||
37993227|NCT00347360|69677901|FG006|Overall Study|Visits conflicted with new job|1|||
37993228|NCT00347360|69677902|FG007|Overall Study|Visits conflicted with new job|0|||
37993229|NCT00347360|69677903|FG008|Overall Study|Visits conflicted with new job|0|||
37993230|NCT00347360|69677904|FG009|Overall Study|Visits conflicted with new job|0|||
37993231|NCT00347360|69677905|FG010|Overall Study|Visits conflicted with new job|0|||
37993232|NCT00347360|69677906|FG011|Overall Study|Visits conflicted with new job|0|||
37993233|NCT00347360|69677907|FG012|Overall Study|Visits conflicted with new job|0|||
37993234|NCT00347360|69677908|FG013|Overall Study|Visits conflicted with new job|0|||
37993235|NCT00347360|69677909|FG014|Overall Study|Visits conflicted with new job|0|||
37993236|NCT00319020|69677943|FG000|Overall Study|Death|2|||
37993237|NCT00319020|69677944|FG001|Overall Study|Death|2|||
37993238|NCT00319020|69677943|FG000|Overall Study|Withdrawal by Subject|4|||
37993239|NCT00319020|69677944|FG001|Overall Study|Withdrawal by Subject|1|||
37993240|NCT00319020|69677943|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
37993241|NCT00319020|69677944|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
37993242|NCT00319020|69677943|FG000|Overall Study|Administrative reason|0|||
37993243|NCT00319020|69677944|FG001|Overall Study|Administrative reason|5|||
37993244|NCT00319020|69677943|FG000|Overall Study|Disease progression|0|||
37993245|NCT00319020|69677944|FG001|Overall Study|Disease progression|2|||
37993246|NCT00319020|69677943|FG000|Overall Study|Transplant|0|||
37993247|NCT00319020|69677944|FG001|Overall Study|Transplant|1|||
37993248|NCT00319020|69677943|FG000|Overall Study|Treatment failure|0|||
37993249|NCT00319020|69677944|FG001|Overall Study|Treatment failure|1|||
37993250|NCT00319020|69677943|FG000|Overall Study|Adverse Event|0|||
37993251|NCT00319020|69677944|FG001|Overall Study|Adverse Event|1|||
37993252|NCT00352118|69677952|FG000|Overall Study|Physician Decision|4|||
37993253|NCT00318474|69677958|FG000|Overall Study|Adverse Event|1|||
37993254|NCT00318474|69677959|FG001|Overall Study|Adverse Event|1|||
37993255|NCT00318474|69677958|FG000|Overall Study|Lost to Follow-up|0|||
37993256|NCT00318474|69677959|FG001|Overall Study|Lost to Follow-up|1|||
37993257|NCT00318474|69677958|FG000|Overall Study|Pregnancy|0|||
37993258|NCT00318474|69677959|FG001|Overall Study|Pregnancy|2|||
37993259|NCT00318474|69677958|FG000|Overall Study|Protocol Violation|1|||
37993260|NCT00318474|69677959|FG001|Overall Study|Protocol Violation|0|||
37993261|NCT00318474|69677958|FG000|Overall Study|Withdrawal by Subject|3|||
37993262|NCT00318474|69677959|FG001|Overall Study|Withdrawal by Subject|2|||
37993263|NCT00318474|69677958|FG000|Overall Study|Fall in GFR|3|||
37993264|NCT00318474|69677959|FG001|Overall Study|Fall in GFR|3|||
37993265|NCT00318474|69677958|FG000|Overall Study|Post-therapy hyperflycemia|0|||
37993266|NCT00318474|69677959|FG001|Overall Study|Post-therapy hyperflycemia|1|||
37993267|NCT00318474|69677958|FG000|Overall Study|Trial terminated|10|||
37993268|NCT00318474|69677959|FG001|Overall Study|Trial terminated|7|||
37993269|NCT00350870|69677969|FG000|Overall Study|Withdrawal by Subject|21|||
37993270|NCT00350870|69677970|FG001|Overall Study|Withdrawal by Subject|17|||
37993271|NCT00350870|69677971|FG002|Overall Study|Withdrawal by Subject|15|||
37993272|NCT00350870|69677972|FG003|Overall Study|Withdrawal by Subject|14|||
37993273|NCT00350870|69677969|FG000|Overall Study|Physician Decision|1|||
37896189|NCT01071083|69581221|FG000|Overall Study|Images Not Usable (Motion)|0|||
37896190|NCT01071083|69581222|FG001|Overall Study|Images Not Usable (Motion)|1|||
37896191|NCT01071083|69581223|FG002|Overall Study|Images Not Usable (Motion)|0|||
37896192|NCT01071083|69581224|FG003|Overall Study|Images Not Usable (Motion)|0|||
37896193|NCT01071083|69581225|FG004|Overall Study|Images Not Usable (Motion)|0|||
37896194|NCT01071083|69581221|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
37896195|NCT01071083|69581222|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
37896196|NCT01071083|69581223|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
37896197|NCT01071083|69581224|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
37896198|NCT01071083|69581225|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
37896199|NCT01071083|69581221|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
37993274|NCT00350870|69677970|FG001|Overall Study|Physician Decision|0|||
37993275|NCT00350870|69677971|FG002|Overall Study|Physician Decision|1|||
37993276|NCT00350870|69677972|FG003|Overall Study|Physician Decision|1|||
37993277|NCT00350792|69677982|FG000|Overall Study|Adverse Event|11|||
37993278|NCT00350792|69677982|FG000|Overall Study|Death from Study Disease|1|||
37993279|NCT00350792|69677982|FG000|Overall Study|Death from Study Drug Toxicity|1|||
37993280|NCT00350792|69677982|FG000|Overall Study|Death Not Study Drug Related|2|||
37993281|NCT00350792|69677982|FG000|Overall Study|Protocol Violation|1|||
37696257|NCT01644175|69172389|FG000|Overall Study|Death|1|||
37993282|NCT00350792|69677982|FG000|Overall Study|Withdrawal by Subject|4|||
37993283|NCT00350792|69677982|FG000|Overall Study|Physician Decision|2|||
37993284|NCT00350792|69677982|FG000|Overall Study|Lack of Efficacy|11|||
37993285|NCT00317772|69677990|FG000|Overall Study|Adverse Event|0|||
37993286|NCT00317772|69677991|FG001|Overall Study|Adverse Event|0|||
37993287|NCT00317772|69677992|FG002|Overall Study|Adverse Event|0|||
37993288|NCT00317772|69677993|FG003|Overall Study|Adverse Event|2|||
37993289|NCT00317772|69677990|FG000|Overall Study|Disease Progression|2|||
37993290|NCT00317772|69677991|FG001|Overall Study|Disease Progression|2|||
37993291|NCT00317772|69677992|FG002|Overall Study|Disease Progression|1|||
37993292|NCT00317772|69677993|FG003|Overall Study|Disease Progression|7|||
37993293|NCT00350636|69678006|FG000|Overall Study|Adverse Event|19|||
37993294|NCT00350636|69678007|FG001|Overall Study|Adverse Event|13|||
37993295|NCT00350636|69678006|FG000|Overall Study|Protocol Violation|1|||
37993296|NCT00350636|69678007|FG001|Overall Study|Protocol Violation|3|||
37993297|NCT00350636|69678006|FG000|Overall Study|Withdrawal by Subject|13|||
37993298|NCT00350636|69678007|FG001|Overall Study|Withdrawal by Subject|17|||
37993299|NCT00350636|69678006|FG000|Overall Study|Lost to Follow-up|9|||
37993300|NCT00350636|69678007|FG001|Overall Study|Lost to Follow-up|8|||
37993301|NCT00350636|69678006|FG000|Overall Study|Physician Decision|0|||
37993302|NCT00350636|69678007|FG001|Overall Study|Physician Decision|2|||
37993303|NCT00350636|69678006|FG000|Overall Study|Other|1|||
37993304|NCT00350636|69678007|FG001|Overall Study|Other|2|||
37993305|NCT00346268|69678015|FG000|Overall Study|Adverse Event|1|||
37993306|NCT00346268|69678016|FG001|Overall Study|Adverse Event|0|||
37993307|NCT00346268|69678015|FG000|Overall Study|Protocol Violation|1|||
37993308|NCT00346268|69678016|FG001|Overall Study|Protocol Violation|0|||
37993309|NCT00346268|69678015|FG000|Overall Study|Participant refused|0|||
37993310|NCT00346268|69678016|FG001|Overall Study|Participant refused|3|||
37993311|NCT00327444|69678024|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
37993312|NCT00327444|69678025|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
37993313|NCT00327444|69678024|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
37993314|NCT00327444|69678025|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
37993315|NCT00327444|69678024|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
37993316|NCT00327444|69678025|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
37993317|NCT00327444|69678024|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
37993318|NCT00327444|69678025|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
37993319|NCT00327444|69678024|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
37993320|NCT00327444|69678025|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
37993321|NCT00327444|69678024|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
37993322|NCT00327444|69678025|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
37993323|NCT00327444|69678024|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
37993324|NCT00327444|69678025|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
37993325|NCT00327444|69678024|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
37993326|NCT00327444|69678025|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
37993327|NCT00337610|69678035|FG000|Overall Study|Adverse Event|2|||
37993328|NCT00337610|69678036|FG001|Overall Study|Adverse Event|2|||
37993329|NCT00337610|69678035|FG000|Overall Study|Death|0|||
37993330|NCT00337610|69678036|FG001|Overall Study|Death|1|||
37825394|NCT01244815|69507463|FG002|Overall Study|Treatment Failure|0|||
37896200|NCT01071083|69581222|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
37993331|NCT00337610|69678035|FG000|Overall Study|Lack of Efficacy|6|||
37993332|NCT00337610|69678036|FG001|Overall Study|Lack of Efficacy|3|||
37993333|NCT00337610|69678035|FG000|Overall Study|Lost to Follow-up|3|||
37993334|NCT00337610|69678036|FG001|Overall Study|Lost to Follow-up|3|||
37993335|NCT00337610|69678035|FG000|Overall Study|Withdrawal by Subject|6|||
37993336|NCT00337610|69678036|FG001|Overall Study|Withdrawal by Subject|5|||
37993337|NCT00316914|69678044|FG000|Overall Study|Withdrawal by Subject|5|||
37993338|NCT00316914|69678045|FG001|Overall Study|Withdrawal by Subject|3|||
37993339|NCT00316914|69678044|FG000|Overall Study|Adverse Event|8|||
37825395|NCT01244815|69507464|FG003|Overall Study|Treatment Failure|1|||
37825396|NCT01244815|69507461|FG000|Overall Study|Lost to Follow-up|3|||
37825397|NCT01244815|69507462|FG001|Overall Study|Lost to Follow-up|2|||
37825398|NCT01244815|69507463|FG002|Overall Study|Lost to Follow-up|3|||
37825399|NCT01244815|69507464|FG003|Overall Study|Lost to Follow-up|2|||
37825400|NCT01244815|69507461|FG000|Overall Study|Withdrawal by Subject|0|||
37825401|NCT01244815|69507462|FG001|Overall Study|Withdrawal by Subject|2|||
37825402|NCT01244815|69507463|FG002|Overall Study|Withdrawal by Subject|0|||
37825403|NCT01244815|69507464|FG003|Overall Study|Withdrawal by Subject|3|||
37825404|NCT01244815|69507461|FG000|Overall Study|Protocol Violation|7|||
37825405|NCT01244815|69507462|FG001|Overall Study|Protocol Violation|4|||
37825406|NCT01244815|69507463|FG002|Overall Study|Protocol Violation|3|||
37825407|NCT01244815|69507464|FG003|Overall Study|Protocol Violation|1|||
37825408|NCT01244815|69507461|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
37825409|NCT01244815|69507462|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
37825410|NCT01244815|69507463|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
37825411|NCT01244815|69507464|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
37825412|NCT01244425|69507476|FG000|Overall Study|Withdrawal by Subject|2|||
37896201|NCT01071083|69581223|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
37896202|NCT01071083|69581224|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
37896203|NCT01071083|69581225|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
37896204|NCT01071083|69581221|FG000|Overall Study|Subject Refused to Continue|1|||
37896205|NCT01071083|69581222|FG001|Overall Study|Subject Refused to Continue|0|||
37896206|NCT01071083|69581223|FG002|Overall Study|Subject Refused to Continue|0|||
37896207|NCT01071083|69581224|FG003|Overall Study|Subject Refused to Continue|0|||
37896208|NCT01071083|69581225|FG004|Overall Study|Subject Refused to Continue|0|||
37896209|NCT01070771|69581237|FG000|Overall Study|Adverse Event|2|||
37896210|NCT01070771|69581237|FG000|Overall Study|Protocol Violation|1|||
37896211|NCT01070381|69581242|FG000|Period 2, 1 Week of Wear|Handling|0|||
37896212|NCT01070381|69581243|FG001|Period 2, 1 Week of Wear|Handling|1|||
37896213|NCT01070381|69581242|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
37896214|NCT01070381|69581243|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
37896215|NCT01010126|69581264|FG000|Overall Study|Withdrawal by Subject|1|||
37896216|NCT01010126|69581265|FG001|Overall Study|Withdrawal by Subject|0|||
37896217|NCT01010126|69581266|FG002|Overall Study|Withdrawal by Subject|1|||
37896218|NCT01010126|69581267|FG003|Overall Study|Withdrawal by Subject|0|||
37896219|NCT01010126|69581268|FG004|Overall Study|Withdrawal by Subject|3|||
37896220|NCT01010126|69581269|FG005|Overall Study|Withdrawal by Subject|0|||
37896221|NCT01043705|69581286|FG000|Overall Study|Death|28|||
37993340|NCT00316914|69678045|FG001|Overall Study|Adverse Event|7|||
37993341|NCT00316914|69678044|FG000|Overall Study|Other Problems|6|||
37993342|NCT00316914|69678045|FG001|Overall Study|Other Problems|11|||
37993343|NCT00316914|69678044|FG000|Overall Study|Missing end of treatment documentation|14|||
37993344|NCT00316914|69678045|FG001|Overall Study|Missing end of treatment documentation|15|||
37993345|NCT00336284|69678053|FG000|Overall Study|Death|52|||
37993346|NCT00336284|69678054|FG001|Overall Study|Death|26|||
37993347|NCT00336284|69678053|FG000|Overall Study|Lost to Follow-up|82|||
37993348|NCT00336284|69678054|FG001|Overall Study|Lost to Follow-up|61|||
37993349|NCT00336284|69678053|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
37993350|NCT00336284|69678054|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
37993351|NCT00316602|69678062|FG000|Overall Study|Withdrawal by Subject|3|||
37993352|NCT00316602|69678063|FG001|Overall Study|Withdrawal by Subject|2|||
37993353|NCT00316602|69678062|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
37993354|NCT00316602|69678063|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
37993355|NCT00316602|69678062|FG000|Overall Study|Adverse Event|1|||
37993356|NCT00316602|69678063|FG001|Overall Study|Adverse Event|0|||
37993357|NCT00316602|69678062|FG000|Overall Study|Other|3|||
37993358|NCT00316602|69678063|FG001|Overall Study|Other|6|||
37993359|NCT00335972|69678071|FG000|Overall Study|not given treatments|0|||
37993360|NCT00335972|69678072|FG001|Overall Study|not given treatments|3|||
37993361|NCT00346034|69678078|FG000|Overall Study|Adverse Event|34|||
37993362|NCT00346034|69678078|FG000|Overall Study|Lack of Efficacy|8|||
37993363|NCT00346034|69678078|FG000|Overall Study|Withdrawal by Subject|13|||
37993364|NCT00346034|69678078|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
37993365|NCT00346034|69678078|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
37993366|NCT00345878|69678084|FG000|Overall Study|Adverse Event|1|||
37993367|NCT00345878|69678085|FG001|Overall Study|Adverse Event|0|||
37993368|NCT00345878|69678084|FG000|Overall Study|Lost to Follow-up|2|||
37993369|NCT00345878|69678085|FG001|Overall Study|Lost to Follow-up|1|||
37993370|NCT00345878|69678084|FG000|Overall Study|Other|1|||
37993371|NCT00345878|69678085|FG001|Overall Study|Other|0|||
37993372|NCT00335738|69678093|FG000|Overall Study|Physician Decision|6|||
37993373|NCT00335738|69678094|FG001|Overall Study|Physician Decision|0|||
37993374|NCT00335738|69678093|FG000|Overall Study|Withdrawal by Subject|2|||
37993375|NCT00335738|69678094|FG001|Overall Study|Withdrawal by Subject|0|||
37993376|NCT00335738|69678093|FG000|Overall Study|Ineligible|3|||
37696258|NCT01644175|69172390|FG001|Overall Study|Death|2|||
37896222|NCT01043705|69581287|FG001|Overall Study|Death|60|||
37993377|NCT00335738|69678094|FG001|Overall Study|Ineligible|4|||
37993378|NCT00334958|69678112|FG000|Overall Study|Medication Noncompliance|0|||
37993379|NCT00334958|69678113|FG001|Overall Study|Medication Noncompliance|3|||
37993380|NCT00334958|69678112|FG000|Overall Study|Protocol Violation|2|||
37993381|NCT00334958|69678113|FG001|Overall Study|Protocol Violation|2|||
37993382|NCT00334958|69678112|FG000|Overall Study|Request of the investigator or sponsor|0|||
37896223|NCT01043705|69581288|FG002|Overall Study|Death|26|||
37896224|NCT01043705|69581286|FG000|Overall Study|Lost to Follow-up|27|||
37896225|NCT01043705|69581287|FG001|Overall Study|Lost to Follow-up|12|||
37993383|NCT00334958|69678113|FG001|Overall Study|Request of the investigator or sponsor|1|||
37993384|NCT00334958|69678112|FG000|Overall Study|Withdrawal by Subject|7|||
37993385|NCT00334958|69678113|FG001|Overall Study|Withdrawal by Subject|4|||
37993386|NCT00334958|69678112|FG000|Overall Study|Adverse Event|27|||
37993387|NCT00334958|69678113|FG001|Overall Study|Adverse Event|12|||
37993388|NCT00334958|69678112|FG000|Overall Study|Other|1|||
37993389|NCT00334958|69678113|FG001|Overall Study|Other|2|||
37993390|NCT00326898|69678122|FG000|Overall Study|Disease progression|52|||
37993391|NCT00326898|69678123|FG001|Overall Study|Disease progression|54|||
37993392|NCT00326898|69678124|FG002|Overall Study|Disease progression|102|||
37993393|NCT00326898|69678122|FG000|Overall Study|Adverse Event|124|||
37993394|NCT00326898|69678123|FG001|Overall Study|Adverse Event|128|||
37993395|NCT00326898|69678124|FG002|Overall Study|Adverse Event|33|||
37993396|NCT00326898|69678122|FG000|Overall Study|Death|2|||
37993397|NCT00326898|69678123|FG001|Overall Study|Death|0|||
37993398|NCT00326898|69678124|FG002|Overall Study|Death|0|||
37993399|NCT00326898|69678122|FG000|Overall Study|Withdrawal by Subject|134|||
37696259|NCT01644175|69172389|FG000|Overall Study|Poor compliance to protocol|9|||
37696260|NCT01644175|69172390|FG001|Overall Study|Poor compliance to protocol|10|||
37696261|NCT01644175|69172389|FG000|Overall Study|Physician Decision|1|||
37696262|NCT01644175|69172390|FG001|Overall Study|Physician Decision|2|||
37696263|NCT01644175|69172389|FG000|Overall Study|Participant Moved|1|||
37696264|NCT01644175|69172390|FG001|Overall Study|Participant Moved|2|||
37696265|NCT01644175|69172389|FG000|Overall Study|Consent withdrawn by participant|3|||
37696266|NCT01644175|69172390|FG001|Overall Study|Consent withdrawn by participant|4|||
37696267|NCT01644175|69172389|FG000|Overall Study|Related to Autoinjector Administration|2|||
37696268|NCT01644175|69172390|FG001|Overall Study|Related to Autoinjector Administration|1|||
37696269|NCT01644175|69172389|FG000|Overall Study|Last visit outside protocol visit window|4|||
37696270|NCT01644175|69172390|FG001|Overall Study|Last visit outside protocol visit window|11|||
37696271|NCT01644175|69172389|FG000|Overall Study|Selection criteria finally not met|0|||
37696272|NCT01644175|69172390|FG001|Overall Study|Selection criteria finally not met|1|||
37696273|NCT01644175|69172389|FG000|Overall Study|Site closure|2|||
37696274|NCT01644175|69172390|FG001|Overall Study|Site closure|2|||
37696275|NCT01644175|69172389|FG000|Overall Study|Lost to Follow-up|1|||
37696276|NCT01644175|69172390|FG001|Overall Study|Lost to Follow-up|0|||
37696277|NCT01644175|69172389|FG000|Overall Study|Other than specified above|0|||
37696278|NCT01644175|69172390|FG001|Overall Study|Other than specified above|3|||
37696279|NCT02357420|69172400|FG000|Overall Study|Adverse Event|3|||
37696280|NCT02357420|69172401|FG001|Overall Study|Adverse Event|3|||
37696281|NCT02357420|69172402|FG002|Overall Study|Adverse Event|8|||
37696282|NCT02357420|69172403|FG003|Overall Study|Adverse Event|9|||
37696283|NCT02357420|69172400|FG000|Overall Study|Investigator Decision|1|||
37696284|NCT02357420|69172401|FG001|Overall Study|Investigator Decision|0|||
37696285|NCT02357420|69172402|FG002|Overall Study|Investigator Decision|0|||
37696286|NCT02357420|69172403|FG003|Overall Study|Investigator Decision|0|||
37696287|NCT02357420|69172400|FG000|Overall Study|Prohibited Medication|1|||
37896226|NCT01043705|69581288|FG002|Overall Study|Lost to Follow-up|0|||
37896227|NCT01043705|69581286|FG000|Overall Study|Multiple Reasons|4|||
37896228|NCT01043705|69581287|FG001|Overall Study|Multiple Reasons|7|||
37896229|NCT01043705|69581288|FG002|Overall Study|Multiple Reasons|0|||
37896230|NCT01043705|69581286|FG000|Overall Study|Protocol Violation|2|||
37896231|NCT01043705|69581287|FG001|Overall Study|Protocol Violation|1|||
37896232|NCT01043705|69581288|FG002|Overall Study|Protocol Violation|0|||
37896233|NCT01043705|69581286|FG000|Overall Study|Withdrawal by Subject|8|||
37896234|NCT01043705|69581287|FG001|Overall Study|Withdrawal by Subject|6|||
37993400|NCT00326898|69678123|FG001|Overall Study|Withdrawal by Subject|128|||
37696288|NCT02357420|69172401|FG001|Overall Study|Prohibited Medication|1|||
37696289|NCT02357420|69172402|FG002|Overall Study|Prohibited Medication|0|||
37993401|NCT00326898|69678124|FG002|Overall Study|Withdrawal by Subject|32|||
37696290|NCT02357420|69172403|FG003|Overall Study|Prohibited Medication|0|||
37696291|NCT02357420|69172400|FG000|Overall Study|Protocol Non-compliance|0|||
37696292|NCT02357420|69172401|FG001|Overall Study|Protocol Non-compliance|0|||
37696293|NCT02357420|69172402|FG002|Overall Study|Protocol Non-compliance|0|||
37696294|NCT02357420|69172403|FG003|Overall Study|Protocol Non-compliance|1|||
37896235|NCT01043705|69581288|FG002|Overall Study|Withdrawal by Subject|0|||
37896236|NCT01043705|69581286|FG000|Overall Study|Site Closure|8|||
37993402|NCT00326898|69678122|FG000|Overall Study|Alternative therapy|1|||
37993403|NCT00326898|69678123|FG001|Overall Study|Alternative therapy|0|||
37993404|NCT00326898|69678124|FG002|Overall Study|Alternative therapy|0|||
37993405|NCT00326898|69678122|FG000|Overall Study|Other complicating disease|5|||
37993406|NCT00326898|69678123|FG001|Overall Study|Other complicating disease|5|||
37993407|NCT00326898|69678124|FG002|Overall Study|Other complicating disease|4|||
37696295|NCT02357420|69172400|FG000|Overall Study|Withdrawn Consent|4|||
37696296|NCT02357420|69172401|FG001|Overall Study|Withdrawn Consent|8|||
37696297|NCT02357420|69172402|FG002|Overall Study|Withdrawn Consent|6|||
37696298|NCT02357420|69172403|FG003|Overall Study|Withdrawn Consent|6|||
37696299|NCT02357420|69172400|FG000|Overall Study|Lost to Follow-up|3|||
37696300|NCT02357420|69172401|FG001|Overall Study|Lost to Follow-up|0|||
37696301|NCT02357420|69172402|FG002|Overall Study|Lost to Follow-up|2|||
37696302|NCT02357420|69172403|FG003|Overall Study|Lost to Follow-up|3|||
37696303|NCT01832038|69172413|FG000|Overall Study|Death|5|||
37696304|NCT01832038|69172413|FG000|Overall Study|Adverse Event|50|||
37696305|NCT01832038|69172413|FG000|Overall Study|Lack of Efficacy|81|||
37696306|NCT01832038|69172413|FG000|Overall Study|Protocol Violation|7|||
37993408|NCT00326898|69678122|FG000|Overall Study|Other/Missing/Unknown|33|||
37993409|NCT00326898|69678123|FG001|Overall Study|Other/Missing/Unknown|28|||
37993410|NCT00326898|69678124|FG002|Overall Study|Other/Missing/Unknown|32|||
37993411|NCT00326118|69678134|FG000|Active Phase|Withdrawal by Subject|4|||
37993412|NCT00326118|69678135|FG001|Active Phase|Withdrawal by Subject|1|||
37993413|NCT00334802|69678144|FG000|Overall Study|Progressive Disease|2|||
37993414|NCT00334802|69678145|FG001|Overall Study|Progressive Disease|24|||
37993415|NCT00334802|69678144|FG000|Overall Study|Toxicity|1|||
37993416|NCT00334802|69678145|FG001|Overall Study|Toxicity|5|||
37993417|NCT00334802|69678144|FG000|Overall Study|Lack of Efficacy|1|||
37993418|NCT00334802|69678145|FG001|Overall Study|Lack of Efficacy|3|||
37696307|NCT01832038|69172413|FG000|Overall Study|Lost to Follow-up|10|||
37696308|NCT01832038|69172413|FG000|Overall Study|Withdrawal by Subject|49|||
37993419|NCT00334802|69678144|FG000|Overall Study|Patient Condition Aggrevated|1|||
37993420|NCT00334802|69678145|FG001|Overall Study|Patient Condition Aggrevated|0|||
37993421|NCT00334802|69678144|FG000|Overall Study|Physician Decision|1|||
37993422|NCT00334802|69678145|FG001|Overall Study|Physician Decision|0|||
37993423|NCT00334802|69678144|FG000|Overall Study|Withdrawal by Subject|0|||
37993424|NCT00334802|69678145|FG001|Overall Study|Withdrawal by Subject|4|||
37993425|NCT00334802|69678144|FG000|Overall Study|Adverse Event|0|||
37993426|NCT00334802|69678145|FG001|Overall Study|Adverse Event|3|||
37993427|NCT00334802|69678144|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
37993428|NCT00334802|69678145|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
37993429|NCT00307164|69678156|FG000|Overall Study|Death|1|||
37993430|NCT00307164|69678157|FG001|Overall Study|Death|0|||
37993431|NCT00307164|69678156|FG000|Overall Study|Severe debilitation, unable to continue|1|||
37993432|NCT00307164|69678157|FG001|Overall Study|Severe debilitation, unable to continue|0|||
37993433|NCT00307164|69678156|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
37993434|NCT00307164|69678157|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
37993435|NCT00307164|69678156|FG000|Overall Study|Withdrawal by Subject|1|||
37696309|NCT01832038|69172413|FG000|Overall Study|Visit non-compliance|2|||
37696310|NCT01832038|69172413|FG000|Overall Study|Subject refused to return visit|2|||
37825413|NCT01244425|69507477|FG001|Overall Study|Withdrawal by Subject|2|||
37825414|NCT01244425|69507476|FG000|Overall Study|Adverse Event|1|||
37825415|NCT01244425|69507477|FG001|Overall Study|Adverse Event|1|||
37825416|NCT01244191|69507493|FG000|Overall Study|Progressive disease|295|||
37825417|NCT01244191|69507494|FG001|Overall Study|Progressive disease|350|||
37825418|NCT01244191|69507493|FG000|Overall Study|Clinical disease progression|54|||
37825419|NCT01244191|69507494|FG001|Overall Study|Clinical disease progression|36|||
37825420|NCT01244191|69507493|FG000|Overall Study|Adverse Event|65|||
37825421|NCT01244191|69507494|FG001|Overall Study|Adverse Event|48|||
37825422|NCT01244191|69507493|FG000|Overall Study|Death|22|||
37825423|NCT01244191|69507494|FG001|Overall Study|Death|29|||
37825424|NCT01244191|69507493|FG000|Overall Study|Lost to Follow-up|0|||
37825425|NCT01244191|69507494|FG001|Overall Study|Lost to Follow-up|2|||
37825426|NCT01244191|69507493|FG000|Overall Study|Protocol Violation|1|||
37993436|NCT00307164|69678157|FG001|Overall Study|Withdrawal by Subject|8|||
37993437|NCT00307164|69678156|FG000|Overall Study|Not compliant with requirements|4|||
37993438|NCT00307164|69678157|FG001|Overall Study|Not compliant with requirements|4|||
37993439|NCT00307164|69678156|FG000|Overall Study|Lost to Follow-up|6|||
37993440|NCT00307164|69678157|FG001|Overall Study|Lost to Follow-up|1|||
37825427|NCT01244191|69507494|FG001|Overall Study|Protocol Violation|2|||
37993441|NCT03827564|69678165|FG000|Overall Study|Discontinued due to Study Termination|1|||
37696311|NCT01832038|69172413|FG000|Overall Study|Not convenient to come back to site|2|||
37696312|NCT01832038|69172413|FG000|Overall Study|Participant was asked to quit|5|||
37825428|NCT01244191|69507493|FG000|Overall Study|Withdrawal by Subject|31|||
37825429|NCT01244191|69507494|FG001|Overall Study|Withdrawal by Subject|23|||
37993442|NCT03827564|69678166|FG001|Overall Study|Discontinued due to Study Termination|0|||
37696313|NCT01832038|69172413|FG000|Overall Study|Back home|1|||
37696314|NCT01832038|69172413|FG000|Overall Study|Pregnancy|1|||
37825430|NCT01244191|69507493|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
37993443|NCT00307086|69678172|FG000|Overall Study|ineligible|5|||
37993444|NCT00325416|69678178|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
37993445|NCT00325416|69678179|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
37993446|NCT00325416|69678178|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
37993447|NCT00325416|69678179|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
37993448|NCT00325416|69678178|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
37993449|NCT00325416|69678179|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
37993450|NCT00325416|69678178|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
37993451|NCT00325416|69678179|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
37993452|NCT00325416|69678178|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
37993453|NCT00325416|69678179|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
37993454|NCT00325416|69678178|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
37993455|NCT00325416|69678179|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
37993456|NCT00314808|69678185|FG000|Overall Study|Disease Progression without AE|4|||
37993457|NCT00314808|69678185|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
37993458|NCT00314574|69678191|FG000|Overall Study|Death|3|||
37993459|NCT00314574|69678192|FG001|Overall Study|Death|0|||
37993460|NCT00314574|69678191|FG000|Overall Study|Adverse Event|11|||
37993461|NCT00314574|69678192|FG001|Overall Study|Adverse Event|16|||
37993462|NCT00314574|69678191|FG000|Overall Study|Lost to Follow-up|19|||
37993463|NCT00314574|69678192|FG001|Overall Study|Lost to Follow-up|25|||
37993464|NCT00314574|69678191|FG000|Overall Study|Withdrawal by Subject|33|||
37993465|NCT00314574|69678192|FG001|Overall Study|Withdrawal by Subject|22|||
37993466|NCT00314574|69678191|FG000|Overall Study|Physician Decision|22|||
37993467|NCT00314574|69678192|FG001|Overall Study|Physician Decision|15|||
37993468|NCT00314574|69678191|FG000|Overall Study|Pregnancy|6|||
37993469|NCT00314574|69678192|FG001|Overall Study|Pregnancy|4|||
37993470|NCT00314574|69678191|FG000|Overall Study|Data unknown at database lock|0|||
37993471|NCT00314574|69678192|FG001|Overall Study|Data unknown at database lock|1|||
37993472|NCT00314340|69678198|FG000|Overall Study|lost interest|1|||
37993473|NCT00306852|69678206|FG000|Overall Study|Death|14|||
37993474|NCT00306852|69678207|FG001|Overall Study|Death|14|||
37993475|NCT00306852|69678206|FG000|Overall Study|Lost to Follow-up|15|||
37993476|NCT00306852|69678207|FG001|Overall Study|Lost to Follow-up|24|||
37993477|NCT00314262|69678213|FG000|Overall Study|Adverse Event|2|||
37993478|NCT00314262|69678213|FG000|Overall Study|Withdrawal by Subject|2|||
37993479|NCT00314262|69678213|FG000|Overall Study|Physician Decision|1|||
37896237|NCT01043705|69581287|FG001|Overall Study|Site Closure|0|||
37896238|NCT01043705|69581288|FG002|Overall Study|Site Closure|0|||
37896239|NCT01043705|69581286|FG000|Overall Study|Subsequent Procedure|9|||
37993480|NCT00333866|69678221|FG000|Overall Study|Adverse Event|23|||
37993481|NCT00333866|69678222|FG001|Overall Study|Adverse Event|37|||
37993482|NCT00333866|69678223|FG002|Overall Study|Adverse Event|38|||
37993483|NCT00333866|69678224|FG003|Overall Study|Adverse Event|47|||
37993484|NCT00333866|69678221|FG000|Overall Study|Other|3|||
37993485|NCT00333866|69678222|FG001|Overall Study|Other|2|||
37993486|NCT00333866|69678223|FG002|Overall Study|Other|2|||
37993487|NCT00333866|69678224|FG003|Overall Study|Other|2|||
37993488|NCT00333866|69678221|FG000|Overall Study|Lack of Efficacy|8|||
37993489|NCT00333866|69678222|FG001|Overall Study|Lack of Efficacy|6|||
37993490|NCT00333866|69678223|FG002|Overall Study|Lack of Efficacy|3|||
37993491|NCT00333866|69678224|FG003|Overall Study|Lack of Efficacy|5|||
37896240|NCT01043705|69581287|FG001|Overall Study|Subsequent Procedure|24|||
37896241|NCT01043705|69581288|FG002|Overall Study|Subsequent Procedure|29|||
37896242|NCT01043705|69581286|FG000|Overall Study|Adverse Event|0|||
37896243|NCT01043705|69581287|FG001|Overall Study|Adverse Event|2|||
37896244|NCT01043705|69581288|FG002|Overall Study|Adverse Event|0|||
37896245|NCT01043705|69581286|FG000|Overall Study|Screen Fail|21|||
37896246|NCT01043705|69581287|FG001|Overall Study|Screen Fail|0|||
37993492|NCT00333866|69678221|FG000|Overall Study|Lost to Follow-up|1|||
37993493|NCT00333866|69678222|FG001|Overall Study|Lost to Follow-up|2|||
37993494|NCT00333866|69678223|FG002|Overall Study|Lost to Follow-up|2|||
37993495|NCT00333866|69678224|FG003|Overall Study|Lost to Follow-up|2|||
37993496|NCT00333866|69678221|FG000|Overall Study|Withdrawal by Subject|8|||
37993497|NCT00333866|69678222|FG001|Overall Study|Withdrawal by Subject|14|||
37993498|NCT00333866|69678223|FG002|Overall Study|Withdrawal by Subject|4|||
37993499|NCT00333866|69678224|FG003|Overall Study|Withdrawal by Subject|9|||
37993500|NCT00333866|69678221|FG000|Overall Study|Randomized but not Treated|5|||
37993501|NCT00333866|69678222|FG001|Overall Study|Randomized but not Treated|3|||
37993502|NCT00333866|69678223|FG002|Overall Study|Randomized but not Treated|2|||
37993503|NCT00333866|69678224|FG003|Overall Study|Randomized but not Treated|1|||
37993504|NCT00324740|69678234|FG000|Overall Study|Withdrawal by Subject|1|||
37993505|NCT00324740|69678235|FG001|Overall Study|Withdrawal by Subject|0|||
37896247|NCT01043705|69581288|FG002|Overall Study|Screen Fail|0|||
37896248|NCT01043705|69581286|FG000|Overall Study|Other|0|||
37993506|NCT00324740|69678236|FG002|Overall Study|Withdrawal by Subject|1|||
37993507|NCT00333788|69678243|FG000|Overall Study|Adverse Event|44|||
37993508|NCT00333788|69678243|FG000|Overall Study|Lack of Efficacy|80|||
37993509|NCT00333788|69678243|FG000|Overall Study|Lost to Follow-up|2|||
37993510|NCT00333788|69678243|FG000|Overall Study|Withdrawal by Subject|24|||
37993511|NCT00333788|69678243|FG000|Overall Study|Other: Non-compliance|2|||
37993512|NCT00333788|69678243|FG000|Overall Study|Other: Moved|2|||
37993513|NCT00333788|69678243|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
37993514|NCT00333788|69678243|FG000|Overall Study|Other: Investigator decision|1|||
37993515|NCT00333788|69678243|FG000|Overall Study|Other: Quality of life concern|1|||
37896249|NCT01043705|69581287|FG001|Overall Study|Other|19|||
37896250|NCT01043705|69581288|FG002|Overall Study|Other|25|||
37896251|NCT01070303|69581307|FG000|Overall Study|Adverse Event|39|||
37896252|NCT01070303|69581307|FG000|Overall Study|Withdrawal by Subject|20|||
37896253|NCT01070303|69581307|FG000|Overall Study|Lost to Follow-up|9|||
37896254|NCT01070303|69581307|FG000|Overall Study|Protocol Violation|0|||
37896255|NCT01070303|69581307|FG000|Overall Study|Lack of Efficacy|2|||
37896256|NCT01070303|69581307|FG000|Overall Study|Administrative Reason|1|||
37993516|NCT00333788|69678243|FG000|Overall Study|Other: Sponsor decision|1|||
37993517|NCT00333788|69678243|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
37993518|NCT00333788|69678243|FG000|Overall Study|Other: Medical monitor decision|1|||
37993519|NCT00333788|69678243|FG000|Overall Study|Other: Physician decision|1|||
37993520|NCT00333788|69678243|FG000|Overall Study|Other: Signed consent for another study|1|||
37993521|NCT00324116|69678247|FG000|Overall Study|Adverse Event|5|||
37993522|NCT00324116|69678247|FG000|Overall Study|Lack of Efficacy|17|||
37993523|NCT00324116|69678247|FG000|Overall Study|Withdrawal by Subject|5|||
37993524|NCT00324116|69678247|FG000|Overall Study|Other|5|||
37993525|NCT00332696|69678253|FG000|Overall Study|Death|24|||
37993526|NCT00332696|69678254|FG001|Overall Study|Death|14|||
37993527|NCT00332696|69678253|FG000|Overall Study|Insufficient therapeutic effect|4|||
37993528|NCT00332696|69678254|FG001|Overall Study|Insufficient therapeutic effect|11|||
37993529|NCT00332696|69678253|FG000|Overall Study|Adverse Event|1|||
37993530|NCT00332696|69678254|FG001|Overall Study|Adverse Event|2|||
37993531|NCT00332696|69678253|FG000|Overall Study|Condition does not justify treatment|0|||
37993532|NCT00332696|69678254|FG001|Overall Study|Condition does not justify treatment|2|||
37993533|NCT00332696|69678253|FG000|Overall Study|Lost to Follow-up|0|||
37993534|NCT00332696|69678254|FG001|Overall Study|Lost to Follow-up|1|||
37993535|NCT00332696|69678253|FG000|Overall Study|Withdrawal by Subject|1|||
37993536|NCT00332696|69678254|FG001|Overall Study|Withdrawal by Subject|0|||
37993537|NCT00313716|69678266|FG000|Overall Study|Death|3|||
37993538|NCT00313716|69678267|FG001|Overall Study|Death|2|||
37993539|NCT00313716|69678268|FG002|Overall Study|Death|9|||
37993540|NCT00313716|69678269|FG003|Overall Study|Death|3|||
37993541|NCT00313716|69678270|FG004|Overall Study|Death|5|||
37993542|NCT00313716|69678271|FG005|Overall Study|Death|9|||
37993543|NCT00313716|69678266|FG000|Overall Study|Lost to Follow-up|2|||
37993544|NCT00313716|69678267|FG001|Overall Study|Lost to Follow-up|5|||
37993545|NCT00313716|69678268|FG002|Overall Study|Lost to Follow-up|2|||
37993546|NCT00313716|69678269|FG003|Overall Study|Lost to Follow-up|1|||
37993547|NCT00313716|69678270|FG004|Overall Study|Lost to Follow-up|0|||
37993548|NCT00313716|69678271|FG005|Overall Study|Lost to Follow-up|4|||
37993549|NCT00313716|69678266|FG000|Overall Study|Withdrawal by Subject|0|||
37993550|NCT00313716|69678267|FG001|Overall Study|Withdrawal by Subject|1|||
37993551|NCT00313716|69678268|FG002|Overall Study|Withdrawal by Subject|1|||
37993552|NCT00313716|69678269|FG003|Overall Study|Withdrawal by Subject|0|||
37993553|NCT00313716|69678270|FG004|Overall Study|Withdrawal by Subject|1|||
37993554|NCT00313716|69678271|FG005|Overall Study|Withdrawal by Subject|0|||
37993555|NCT00313170|69678292|FG000|Overall Study|Death|2|||
37993556|NCT00313170|69678293|FG001|Overall Study|Death|4|||
37696315|NCT01832038|69172413|FG000|Overall Study|Low compliance|3|||
37896257|NCT01070303|69581307|FG000|Overall Study|Other|18|||
37896258|NCT01009814|69581322|FG000|Overall Study|No longer met study criteria|1|||
37896259|NCT01009814|69581323|FG001|Overall Study|No longer met study criteria|1|||
37896260|NCT01009814|69581324|FG002|Overall Study|No longer met study criteria|0|||
37993557|NCT00313170|69678294|FG002|Overall Study|Death|2|||
37993558|NCT00313170|69678292|FG000|Overall Study|Adverse Event|1|||
37993559|NCT00313170|69678293|FG001|Overall Study|Adverse Event|2|||
37993560|NCT00313170|69678294|FG002|Overall Study|Adverse Event|0|||
37993561|NCT00313170|69678292|FG000|Overall Study|Disease progression|31|||
37993562|NCT00313170|69678293|FG001|Overall Study|Disease progression|26|||
37993563|NCT00313170|69678294|FG002|Overall Study|Disease progression|27|||
37993564|NCT00313170|69678292|FG000|Overall Study|Withdrawal by Subject|1|||
37993565|NCT00313170|69678293|FG001|Overall Study|Withdrawal by Subject|0|||
37993566|NCT00313170|69678294|FG002|Overall Study|Withdrawal by Subject|1|||
37993567|NCT00313170|69678292|FG000|Overall Study|Incorrect enrollment|0|||
37993568|NCT00313170|69678293|FG001|Overall Study|Incorrect enrollment|2|||
37993569|NCT00313170|69678294|FG002|Overall Study|Incorrect enrollment|1|||
37993570|NCT00313170|69678292|FG000|Overall Study|Lost to Follow-up|0|||
37993571|NCT00313170|69678293|FG001|Overall Study|Lost to Follow-up|0|||
37993572|NCT00313170|69678294|FG002|Overall Study|Lost to Follow-up|1|||
37993573|NCT00313170|69678292|FG000|Overall Study|Progression (investigators opinion)|1|||
37993574|NCT00313170|69678293|FG001|Overall Study|Progression (investigators opinion)|0|||
37993575|NCT00313170|69678294|FG002|Overall Study|Progression (investigators opinion)|0|||
37993576|NCT00332462|69678303|FG000|Overall Study|Adverse Event|5|||
37993577|NCT00332462|69678303|FG000|Overall Study|Abnormal Lab Value|1|||
37993578|NCT00332462|69678303|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
37993579|NCT00332462|69678303|FG000|Overall Study|no longer requires study drug|1|||
37993580|NCT00332462|69678303|FG000|Overall Study|Death|3|||
37993581|NCT00332462|69678303|FG000|Overall Study|Graft Loss|2|||
37993582|NCT00324038|69678312|FG000|Overall Study|Adverse Event|38|||
37993583|NCT00324038|69678313|FG001|Overall Study|Adverse Event|23|||
37993584|NCT00324038|69678312|FG000|Overall Study|Lack of Efficacy|5|||
37993585|NCT00324038|69678313|FG001|Overall Study|Lack of Efficacy|13|||
37993586|NCT00324038|69678312|FG000|Overall Study|Lost to Follow-up|0|||
37993587|NCT00324038|69678313|FG001|Overall Study|Lost to Follow-up|2|||
37896261|NCT01009814|69581325|FG003|Overall Study|No longer met study criteria|0|||
37896262|NCT01009814|69581326|FG004|Overall Study|No longer met study criteria|0|||
37896263|NCT03824587|69581344|FG000|Run-in Period|Screen Failure|0|||
37896264|NCT03824587|69581345|FG001|Run-in Period|Screen Failure|275|||
37896265|NCT03824587|69581344|FG000|Treatment Period|Adverse Event|4|||
37896266|NCT03824587|69581345|FG001|Treatment Period|Adverse Event|1|||
37896267|NCT03824587|69581344|FG000|Treatment Period|Withdrawal by Subject|0|||
37896268|NCT03824587|69581345|FG001|Treatment Period|Withdrawal by Subject|1|||
37896269|NCT03824587|69581344|FG000|Treatment Period|Kidney Transplant|1|||
37896270|NCT03824587|69581345|FG001|Treatment Period|Kidney Transplant|1|||
37896271|NCT00773734|69581355|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
37896272|NCT00773734|69581356|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
37896273|NCT00773734|69581357|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
37896274|NCT00773734|69581358|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
37896275|NCT00773734|69581359|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
37896276|NCT00773734|69581360|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
37896277|NCT00773734|69581355|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
37896278|NCT00773734|69581356|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
37993588|NCT00324038|69678312|FG000|Overall Study|Other|6|||
37993589|NCT00324038|69678313|FG001|Overall Study|Other|13|||
37993590|NCT00159861|69678321|FG000|Core Study - 16 Weeks|Death|3|||
37993591|NCT00159861|69678322|FG001|Core Study - 16 Weeks|Death|0|||
37993592|NCT00159861|69678321|FG000|Core Study - 16 Weeks|Adverse Event|12|||
37993593|NCT00159861|69678322|FG001|Core Study - 16 Weeks|Adverse Event|6|||
37993594|NCT00159861|69678321|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
37896279|NCT00773734|69581357|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
37896280|NCT00773734|69581358|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
37896281|NCT00773734|69581359|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
37896282|NCT00773734|69581360|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
37896283|NCT00773734|69581355|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
37896284|NCT00773734|69581356|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
37896285|NCT00773734|69581357|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
37896286|NCT00773734|69581358|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
37896287|NCT00773734|69581359|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
37896288|NCT00773734|69581360|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
37896289|NCT00773734|69581355|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
37896290|NCT00773734|69581356|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
37896291|NCT00773734|69581357|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
37896292|NCT00773734|69581358|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
37896293|NCT00773734|69581359|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
37896294|NCT00773734|69581360|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
37896295|NCT00773734|69581355|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
37896296|NCT00773734|69581356|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
37993595|NCT00159861|69678322|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
37993596|NCT00159861|69678321|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
37993597|NCT00159861|69678322|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
37993598|NCT00159861|69678321|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
37993599|NCT00159861|69678322|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
37993600|NCT00159861|69678321|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
37993601|NCT00159861|69678322|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
37993602|NCT00159861|69678321|FG000|Extension Study - up to 3 Years|Death|24|||
37993603|NCT00159861|69678322|FG001|Extension Study - up to 3 Years|Death|28|||
37993604|NCT00159861|69678321|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
37993605|NCT00159861|69678322|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
37896297|NCT00773734|69581357|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
37896298|NCT00773734|69581358|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
37896299|NCT00773734|69581359|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
37896300|NCT00773734|69581360|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
37896301|NCT00773734|69581355|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
37896302|NCT00773734|69581356|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
37896303|NCT00773734|69581357|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
37993606|NCT00159861|69678321|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
37993607|NCT00159861|69678322|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
37993608|NCT00159861|69678321|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
37993609|NCT00159861|69678322|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
37993610|NCT00159861|69678321|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
37993611|NCT00159861|69678322|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
37993612|NCT00331760|69678335|FG000|Overall Study|Ineligible / no protocol treatment|15|||
37993613|NCT00331760|69678336|FG001|Overall Study|Ineligible / no protocol treatment|8|||
37993614|NCT00225147|69678347|FG000|Open-label Phase|Lost to Follow-up|0|||
37993615|NCT00225147|69678348|FG001|Open-label Phase|Lost to Follow-up|0|||
37993616|NCT00225147|69678349|FG002|Open-label Phase|Lost to Follow-up|0|||
37993617|NCT00225147|69678350|FG003|Open-label Phase|Lost to Follow-up|4|||
37993618|NCT00225147|69678347|FG000|Open-label Phase|Withdrawal by Subject|0|||
37993619|NCT00225147|69678348|FG001|Open-label Phase|Withdrawal by Subject|0|||
37993620|NCT00225147|69678349|FG002|Open-label Phase|Withdrawal by Subject|0|||
37993621|NCT00225147|69678350|FG003|Open-label Phase|Withdrawal by Subject|6|||
37993622|NCT00313014|69678365|FG000|Overall Study|Withdrawal by Subject|11|||
37993623|NCT00313014|69678366|FG001|Overall Study|Withdrawal by Subject|7|||
37993624|NCT00313014|69678367|FG002|Overall Study|Withdrawal by Subject|5|||
37993625|NCT00313014|69678365|FG000|Overall Study|Adverse Event|14|||
37993626|NCT00313014|69678366|FG001|Overall Study|Adverse Event|29|||
37993627|NCT00313014|69678367|FG002|Overall Study|Adverse Event|16|||
37993628|NCT00313014|69678365|FG000|Overall Study|Lost to Follow-up|7|||
37993629|NCT00313014|69678366|FG001|Overall Study|Lost to Follow-up|6|||
37993630|NCT00313014|69678367|FG002|Overall Study|Lost to Follow-up|10|||
37993631|NCT00313014|69678365|FG000|Overall Study|Administrative|9|||
37993632|NCT00313014|69678366|FG001|Overall Study|Administrative|6|||
37993633|NCT00313014|69678367|FG002|Overall Study|Administrative|14|||
37993634|NCT00313014|69678365|FG000|Overall Study|Lack of Efficacy|52|||
37993635|NCT00313014|69678366|FG001|Overall Study|Lack of Efficacy|25|||
37825431|NCT01244191|69507494|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
37825432|NCT01244035|69507500|FG000|Part 1: Period 1|Adverse Event|0|||
37896304|NCT00773734|69581358|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
37896305|NCT00773734|69581359|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
37896306|NCT00773734|69581360|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
37896307|NCT00773734|69581355|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
37896308|NCT00773734|69581356|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
37896309|NCT00773734|69581357|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
37896310|NCT00773734|69581358|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
37896311|NCT00773734|69581359|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
37896312|NCT00773734|69581360|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
37896313|NCT00773734|69581355|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
37896314|NCT00773734|69581356|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
37896315|NCT00773734|69581357|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
37896316|NCT00773734|69581358|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
37896317|NCT00773734|69581359|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
37896318|NCT00773734|69581360|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
37825433|NCT01244035|69507501|FG001|Part 1: Period 1|Adverse Event|0|||
37825434|NCT01244035|69507502|FG002|Part 1: Period 1|Adverse Event|0|||
37825435|NCT01244035|69507503|FG003|Part 1: Period 1|Adverse Event|0|||
37825436|NCT01244035|69507504|FG004|Part 1: Period 1|Adverse Event|0|||
37825437|NCT01244035|69507505|FG005|Part 1: Period 1|Adverse Event|1|||
37825438|NCT01244035|69507500|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
37896319|NCT00773734|69581355|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
37993636|NCT00313014|69678367|FG002|Overall Study|Lack of Efficacy|16|||
37993637|NCT00157209|69678378|FG000|Overall Study|Ongoing at data cut-off|10|||
37993638|NCT00157209|69678379|FG001|Overall Study|Ongoing at data cut-off|0|||
37993639|NCT00312858|69678387|FG000|Overall Study|Adverse Event|0|||
37993640|NCT00312858|69678388|FG001|Overall Study|Adverse Event|1|||
37993641|NCT00312858|69678387|FG000|Overall Study|Lost to Follow-up|25|||
37825439|NCT01244035|69507501|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
37825440|NCT01244035|69507502|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
37825441|NCT01244035|69507503|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
37825442|NCT01244035|69507504|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
37993642|NCT00312858|69678388|FG001|Overall Study|Lost to Follow-up|42|||
37993643|NCT00312858|69678387|FG000|Overall Study|Protocol Violation|3|||
37993644|NCT00312858|69678388|FG001|Overall Study|Protocol Violation|8|||
37993645|NCT00312858|69678387|FG000|Overall Study|Withdraw by Participant|20|||
37993646|NCT00312858|69678388|FG001|Overall Study|Withdraw by Participant|20|||
37993647|NCT00312858|69678387|FG000|Overall Study|Participant Moved|11|||
37993648|NCT00312858|69678388|FG001|Overall Study|Participant Moved|10|||
37993649|NCT00312858|69678387|FG000|Overall Study|Other|9|||
37993650|NCT00312858|69678388|FG001|Overall Study|Other|12|||
37993651|NCT00312702|69678397|FG000|Immunization Phase|Lost to Follow-up|0|||
37993652|NCT00312702|69678398|FG001|Immunization Phase|Lost to Follow-up|1|||
37993653|NCT00312702|69678399|FG002|Immunization Phase|Lost to Follow-up|0|||
37993654|NCT00156819|69678410|FG000|Overall Study|Lost to Follow-up|1|||
37993655|NCT00156819|69678411|FG001|Overall Study|Lost to Follow-up|1|||
37993656|NCT00156819|69678412|FG002|Overall Study|Lost to Follow-up|3|||
37993657|NCT03825042|69678422|FG000|Overall Study|Adverse Event|1|||
37993658|NCT03825042|69678423|FG001|Overall Study|Adverse Event|0|||
37993659|NCT03825042|69678422|FG000|Overall Study|Withdrawal by Subject|1|||
37993660|NCT03825042|69678423|FG001|Overall Study|Withdrawal by Subject|0|||
37993661|NCT00129987|69678431|FG000|1st Educational Session|Withdrawal by Subject|141|||
37993662|NCT00129987|69678432|FG001|1st Educational Session|Withdrawal by Subject|109|||
37993663|NCT00129987|69678431|FG000|1 Year|Withdrawal by Subject|32|||
37993664|NCT00129987|69678432|FG001|1 Year|Withdrawal by Subject|21|||
37993665|NCT00224133|69678438|FG000|Overall Study|Adverse Event|93|||
37993666|NCT00224133|69678438|FG000|Overall Study|Protocol Violation|6|||
37993667|NCT00224133|69678438|FG000|Overall Study|Withdrawal by Subject|33|||
37993668|NCT00224133|69678438|FG000|Overall Study|Lack of Efficacy|58|||
37896320|NCT00773734|69581356|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
37896321|NCT00773734|69581357|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
37896322|NCT00773734|69581358|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
37896323|NCT00773734|69581359|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
37896324|NCT00773734|69581360|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
37896325|NCT00773734|69581355|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
37993669|NCT00224133|69678438|FG000|Overall Study|Lost to Follow-up|21|||
37993670|NCT00224133|69678438|FG000|Overall Study|Physician Decision|1|||
37993671|NCT00224133|69678438|FG000|Overall Study|Other|14|||
37993672|NCT00224055|69678444|FG000|Overall Study|Adverse Event|9|||
37993673|NCT00224055|69678445|FG001|Overall Study|Adverse Event|3|||
37993674|NCT00224055|69678444|FG000|Overall Study|Lost to Follow-up|1|||
37993675|NCT00224055|69678445|FG001|Overall Study|Lost to Follow-up|2|||
37993676|NCT00224055|69678444|FG000|Overall Study|Protocol Violation|1|||
37993677|NCT00224055|69678445|FG001|Overall Study|Protocol Violation|1|||
37993678|NCT00224055|69678444|FG000|Overall Study|Inclusion Violation|3|||
37993679|NCT00224055|69678445|FG001|Overall Study|Inclusion Violation|6|||
37993680|NCT00224055|69678444|FG000|Overall Study|Withdrawal by Subject|0|||
37993681|NCT00224055|69678445|FG001|Overall Study|Withdrawal by Subject|2|||
37993682|NCT00224055|69678444|FG000|Overall Study|Other|1|||
37993683|NCT00224055|69678445|FG001|Overall Study|Other|0|||
37993684|NCT00150969|69678453|FG000|24 Month Main Study|Adverse Event|3|||
37993685|NCT00150969|69678454|FG001|24 Month Main Study|Adverse Event|4|||
37993686|NCT00150969|69678453|FG000|24 Month Main Study|Death|1|||
37993687|NCT00150969|69678454|FG001|24 Month Main Study|Death|1|||
37993688|NCT00150969|69678453|FG000|24 Month Main Study|Lack of Efficacy|1|||
37993689|NCT00150969|69678454|FG001|24 Month Main Study|Lack of Efficacy|8|||
37993690|NCT00150969|69678453|FG000|24 Month Main Study|Lost to Follow-up|3|||
37993691|NCT00150969|69678454|FG001|24 Month Main Study|Lost to Follow-up|2|||
37993692|NCT00150969|69678453|FG000|24 Month Main Study|Protocol Violation|4|||
37993693|NCT00150969|69678454|FG001|24 Month Main Study|Protocol Violation|2|||
37993694|NCT00150969|69678453|FG000|24 Month Main Study|Withdrawal by Subject|7|||
37993695|NCT00150969|69678454|FG001|24 Month Main Study|Withdrawal by Subject|4|||
37993696|NCT00150969|69678453|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
37993697|NCT00150969|69678454|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
37993698|NCT00150969|69678453|FG000|24-48 Month Extension|Lack of Efficacy|0|||
37993699|NCT00150969|69678454|FG001|24-48 Month Extension|Lack of Efficacy|1|||
37993700|NCT00150969|69678453|FG000|24-48 Month Extension|Adverse Event|1|||
37993701|NCT00150969|69678454|FG001|24-48 Month Extension|Adverse Event|3|||
37993702|NCT00150969|69678453|FG000|24-48 Month Extension|Other Reason|81|||
37993703|NCT00150969|69678454|FG001|24-48 Month Extension|Other Reason|91|||
37993704|NCT00150345|69678463|FG000|Overall Study|Death|5|||
37993705|NCT00150345|69678464|FG001|Overall Study|Death|2|||
37993706|NCT00150345|69678463|FG000|Overall Study|Adverse Event|8|||
37993707|NCT00150345|69678464|FG001|Overall Study|Adverse Event|6|||
37993708|NCT00150345|69678463|FG000|Overall Study|Lack of Efficacy|5|||
37993709|NCT00150345|69678464|FG001|Overall Study|Lack of Efficacy|4|||
37993710|NCT00150345|69678463|FG000|Overall Study|Withdrawal by Subject|3|||
37993711|NCT00150345|69678464|FG001|Overall Study|Withdrawal by Subject|4|||
37993712|NCT00150345|69678463|FG000|Overall Study|Laboratory abnormality|1|||
37993713|NCT00150345|69678464|FG001|Overall Study|Laboratory abnormality|2|||
37993714|NCT00150345|69678463|FG000|Overall Study|Other|12|||
37993715|NCT00150345|69678464|FG001|Overall Study|Other|14|||
37993716|NCT00223977|69678474|FG000|Overall Study|Adverse Event|7|||
37993717|NCT00223977|69678475|FG001|Overall Study|Adverse Event|10|||
37993718|NCT00223977|69678476|FG002|Overall Study|Adverse Event|0|||
37993719|NCT00223977|69678474|FG000|Overall Study|Protocol Violation|0|||
37993720|NCT00223977|69678475|FG001|Overall Study|Protocol Violation|0|||
37993721|NCT00223977|69678476|FG002|Overall Study|Protocol Violation|1|||
37993722|NCT00223977|69678474|FG000|Overall Study|Withdrawal by Subject|1|||
37993723|NCT00223977|69678475|FG001|Overall Study|Withdrawal by Subject|1|||
37993724|NCT00223977|69678476|FG002|Overall Study|Withdrawal by Subject|2|||
37993725|NCT00223977|69678474|FG000|Overall Study|Other|1|||
37993726|NCT00223977|69678475|FG001|Overall Study|Other|0|||
37993727|NCT00223977|69678476|FG002|Overall Study|Other|0|||
37993728|NCT00148941|69678488|FG000|Overall Study|Lost to Follow-up|17|||
37993729|NCT00148941|69678489|FG001|Overall Study|Lost to Follow-up|24|||
37993730|NCT00148941|69678490|FG002|Overall Study|Lost to Follow-up|18|||
37993731|NCT00148941|69678491|FG003|Overall Study|Lost to Follow-up|22|||
37993732|NCT00148941|69678488|FG000|Overall Study|Withdrawal by Subject|1|||
37993733|NCT00148941|69678489|FG001|Overall Study|Withdrawal by Subject|0|||
37993734|NCT00148941|69678490|FG002|Overall Study|Withdrawal by Subject|1|||
37993735|NCT00148941|69678491|FG003|Overall Study|Withdrawal by Subject|0|||
37993736|NCT00148941|69678488|FG000|Overall Study|Other|0|||
37993737|NCT00148941|69678489|FG001|Overall Study|Other|0|||
37993738|NCT00148941|69678490|FG002|Overall Study|Other|1|||
37993739|NCT00148941|69678491|FG003|Overall Study|Other|2|||
37993740|NCT00148317|69678501|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
37993741|NCT00148317|69678501|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
37993742|NCT00148317|69678501|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
37993743|NCT00323882|69678513|FG000|Overall Study|Adverse Event|2|||
37993744|NCT00323882|69678514|FG001|Overall Study|Adverse Event|1|||
37993745|NCT00323882|69678515|FG002|Overall Study|Adverse Event|1|||
37993746|NCT00323882|69678516|FG003|Overall Study|Adverse Event|1|||
37993747|NCT00323882|69678517|FG004|Overall Study|Adverse Event|3|||
37993748|NCT00323882|69678513|FG000|Overall Study|Disease Progression|6|||
37993749|NCT00323882|69678514|FG001|Overall Study|Disease Progression|4|||
37993750|NCT00323882|69678515|FG002|Overall Study|Disease Progression|10|||
37993751|NCT00323882|69678516|FG003|Overall Study|Disease Progression|5|||
37993752|NCT00323882|69678517|FG004|Overall Study|Disease Progression|22|||
37993753|NCT00323882|69678513|FG000|Overall Study|Death|0|||
37993754|NCT00323882|69678514|FG001|Overall Study|Death|1|||
37993755|NCT00323882|69678515|FG002|Overall Study|Death|1|||
37993756|NCT00323882|69678516|FG003|Overall Study|Death|0|||
37993757|NCT00323882|69678517|FG004|Overall Study|Death|5|||
37993758|NCT00323882|69678513|FG000|Overall Study|Lost to Follow-up|0|||
37993759|NCT00323882|69678514|FG001|Overall Study|Lost to Follow-up|0|||
37993760|NCT00323882|69678515|FG002|Overall Study|Lost to Follow-up|1|||
37993761|NCT00323882|69678516|FG003|Overall Study|Lost to Follow-up|0|||
37993762|NCT00323882|69678517|FG004|Overall Study|Lost to Follow-up|1|||
37993763|NCT00323882|69678513|FG000|Overall Study|Other|0|||
37993764|NCT00323882|69678514|FG001|Overall Study|Other|0|||
37993765|NCT00323882|69678515|FG002|Overall Study|Other|0|||
37993766|NCT00323882|69678516|FG003|Overall Study|Other|1|||
37993767|NCT00323882|69678517|FG004|Overall Study|Other|1|||
37993768|NCT00331682|69678538|FG000|Overall Study|Adverse Event|1|||
37993769|NCT00323492|69678544|FG000|Study Phase 1|Adverse Event|2|||
37993770|NCT00323492|69678545|FG001|Study Phase 1|Adverse Event|0|||
37993771|NCT00323492|69678546|FG002|Study Phase 1|Adverse Event|0|||
37993772|NCT00323492|69678544|FG000|Study Phase 2|Adverse Event|1|||
37993773|NCT00323492|69678545|FG001|Study Phase 2|Adverse Event|0|||
37993774|NCT00323492|69678546|FG002|Study Phase 2|Adverse Event|0|||
37825443|NCT01244035|69507505|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
37825444|NCT01244035|69507500|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
37993775|NCT00323492|69678544|FG000|Study Phase 2|Physician Decision|1|||
37993776|NCT00323492|69678545|FG001|Study Phase 2|Physician Decision|0|||
37825445|NCT01244035|69507501|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
37825446|NCT01244035|69507502|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
37993777|NCT00323492|69678546|FG002|Study Phase 2|Physician Decision|0|||
37993778|NCT00323492|69678544|FG000|Study Phase 2|Lost to Follow-up|1|||
37993779|NCT00323492|69678545|FG001|Study Phase 2|Lost to Follow-up|0|||
37993780|NCT00323492|69678546|FG002|Study Phase 2|Lost to Follow-up|0|||
37993781|NCT00323492|69678544|FG000|Study Phase 2|Withdrawal by Subject|0|||
37993782|NCT00323492|69678545|FG001|Study Phase 2|Withdrawal by Subject|1|||
37993783|NCT00323492|69678546|FG002|Study Phase 2|Withdrawal by Subject|0|||
37993784|NCT00323492|69678544|FG000|Study Phase 2|Noncompliance with study schedule|0|||
37993785|NCT00323492|69678545|FG001|Study Phase 2|Noncompliance with study schedule|0|||
37993786|NCT00323492|69678546|FG002|Study Phase 2|Noncompliance with study schedule|1|||
37993787|NCT00323492|69678544|FG000|Study Phase 2|Protocol Violation|1|||
37993788|NCT00323492|69678545|FG001|Study Phase 2|Protocol Violation|0|||
37993789|NCT00323492|69678546|FG002|Study Phase 2|Protocol Violation|0|||
37993790|NCT00331136|69678557|FG000|Overall Study|Adverse Event|3|||
37993791|NCT00331136|69678558|FG001|Overall Study|Adverse Event|5|||
37993792|NCT00331136|69678559|FG002|Overall Study|Adverse Event|0|||
37993793|NCT00331136|69678560|FG003|Overall Study|Adverse Event|1|||
37993794|NCT00331136|69678557|FG000|Overall Study|Withdrawal by Subject|0|||
37993795|NCT00331136|69678558|FG001|Overall Study|Withdrawal by Subject|1|||
37993796|NCT00331136|69678559|FG002|Overall Study|Withdrawal by Subject|0|||
37993797|NCT00331136|69678560|FG003|Overall Study|Withdrawal by Subject|0|||
37993798|NCT00331136|69678557|FG000|Overall Study|Lost to Follow-up|0|||
37993799|NCT00331136|69678558|FG001|Overall Study|Lost to Follow-up|1|||
37993800|NCT00331136|69678559|FG002|Overall Study|Lost to Follow-up|0|||
37993801|NCT00331136|69678560|FG003|Overall Study|Lost to Follow-up|0|||
37993802|NCT00331136|69678557|FG000|Overall Study|Protocol Violation|1|||
37993803|NCT00331136|69678558|FG001|Overall Study|Protocol Violation|0|||
37993804|NCT00331136|69678559|FG002|Overall Study|Protocol Violation|0|||
37993805|NCT00331136|69678560|FG003|Overall Study|Protocol Violation|0|||
37993806|NCT00331136|69678557|FG000|Overall Study|Not treated|1|||
37993807|NCT00331136|69678558|FG001|Overall Study|Not treated|0|||
37993808|NCT00331136|69678559|FG002|Overall Study|Not treated|0|||
37993809|NCT00331136|69678560|FG003|Overall Study|Not treated|0|||
37993810|NCT00323414|69678572|FG000|Overall Study|Withdrawal by Subject|0|||
37993811|NCT00323414|69678573|FG001|Overall Study|Withdrawal by Subject|1|||
37825447|NCT01244035|69507503|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
37825448|NCT01244035|69507504|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
37825449|NCT01244035|69507505|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
37825450|NCT01244035|69507500|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
37825451|NCT01244035|69507501|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
37825452|NCT01244035|69507502|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
37825453|NCT01244035|69507503|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
37825454|NCT01244035|69507504|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
37825455|NCT01244035|69507505|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
37896326|NCT00773734|69581356|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
37896327|NCT00773734|69581357|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
37896328|NCT00773734|69581358|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
37896329|NCT00773734|69581359|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
37896330|NCT00773734|69581360|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
37896331|NCT00773734|69581355|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
37896332|NCT00773734|69581356|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
37896333|NCT00773734|69581357|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
37896334|NCT00773734|69581358|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
37896335|NCT00773734|69581359|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
37896336|NCT00773734|69581360|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
37896337|NCT00773734|69581355|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
37896338|NCT00773734|69581356|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
37896339|NCT00773734|69581357|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
37896340|NCT00773734|69581358|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
37825456|NCT01244035|69507500|FG000|Part 1: Period 3|Adverse Event|0|||
37825457|NCT01244035|69507501|FG001|Part 1: Period 3|Adverse Event|0|||
37993812|NCT00330668|69678579|FG000|BID Dosing Period|Adverse Event|1|||
37993813|NCT00330668|69678579|FG000|BID Dosing Period|Lost to Follow-up|7|||
37993814|NCT00330668|69678579|FG000|BID Dosing Period|Non-Compliance|5|||
37993815|NCT00330668|69678579|FG000|BID Dosing Period|Withdrawal by Subject|19|||
37993816|NCT00330668|69678579|FG000|BID Dosing Period|Sponsor's decision|1|||
37993817|NCT00330668|69678579|FG000|BID Dosing Period|Other|3|||
37696316|NCT01832038|69172413|FG000|Overall Study|Prohibit procedure|2|||
37993818|NCT00330668|69678579|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
37993819|NCT00330668|69678579|FG000|QD Dosing Period|Other|1|||
37993820|NCT00330668|69678579|FG000|QD Dosing Period|Withdrawal by Subject|1|||
37993821|NCT00330668|69678579|FG000|QD Dosing Period|Lost to Follow-up|2|||
37993822|NCT00306384|69678586|FG000|Overall Study|Adverse Event|103|||
37993823|NCT00306384|69678587|FG001|Overall Study|Adverse Event|87|||
37993824|NCT00306384|69678588|FG002|Overall Study|Adverse Event|40|||
37896341|NCT00773734|69581359|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
37993825|NCT00306384|69678586|FG000|Overall Study|Major protocol deviation|43|||
37993826|NCT00306384|69678587|FG001|Overall Study|Major protocol deviation|51|||
37993827|NCT00306384|69678588|FG002|Overall Study|Major protocol deviation|18|||
37993828|NCT00306384|69678586|FG000|Overall Study|Lost to Follow-up|57|||
37993829|NCT00306384|69678587|FG001|Overall Study|Lost to Follow-up|41|||
37993830|NCT00306384|69678588|FG002|Overall Study|Lost to Follow-up|35|||
37993831|NCT00306384|69678586|FG000|Overall Study|Voluntary withdrawal|199|||
37993832|NCT00306384|69678587|FG001|Overall Study|Voluntary withdrawal|187|||
37993833|NCT00306384|69678588|FG002|Overall Study|Voluntary withdrawal|91|||
37993834|NCT00306384|69678586|FG000|Overall Study|Study termination|1|||
37993835|NCT00306384|69678587|FG001|Overall Study|Study termination|0|||
37993836|NCT00306384|69678588|FG002|Overall Study|Study termination|1|||
37993837|NCT00306384|69678586|FG000|Overall Study|Pregnancy|3|||
37896342|NCT00773734|69581360|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
37896343|NCT00773734|69581355|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
37896344|NCT00773734|69581356|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
37896345|NCT00773734|69581357|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
37896346|NCT00773734|69581358|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
37896347|NCT00773734|69581359|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
37896348|NCT00773734|69581360|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
37896349|NCT00773734|69581355|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
37896350|NCT00773734|69581356|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
37896351|NCT00773734|69581357|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
37896352|NCT00773734|69581358|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
37896353|NCT00773734|69581359|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
37896354|NCT00773734|69581360|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
37896355|NCT00773734|69581355|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
37896356|NCT00773734|69581356|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
37896357|NCT00773734|69581357|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
37896358|NCT00773734|69581358|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
37896359|NCT00773734|69581359|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
37896360|NCT00773734|69581360|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
37896361|NCT00773734|69581355|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
37896362|NCT00773734|69581356|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
37896363|NCT00773734|69581357|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
37896364|NCT00773734|69581358|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
37896365|NCT00773734|69581359|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
37993838|NCT00306384|69678587|FG001|Overall Study|Pregnancy|1|||
37993839|NCT00306384|69678588|FG002|Overall Study|Pregnancy|1|||
37993840|NCT00306384|69678586|FG000|Overall Study|Lack of Efficacy|26|||
37993841|NCT00306384|69678587|FG001|Overall Study|Lack of Efficacy|40|||
37896366|NCT00773734|69581360|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
37896367|NCT00773734|69581355|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
37896368|NCT00773734|69581356|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
37896369|NCT00773734|69581357|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
37896370|NCT00773734|69581358|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
37896371|NCT00773734|69581359|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
37896372|NCT00773734|69581360|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
37896373|NCT00773734|69581355|FG000|Extension: Active Treatment Week 24-52|Other|0|||
37896374|NCT00773734|69581356|FG001|Extension: Active Treatment Week 24-52|Other|0|||
37896375|NCT00773734|69581357|FG002|Extension: Active Treatment Week 24-52|Other|1|||
37696317|NCT01832038|69172413|FG000|Overall Study|Not possible to visit the hospital|1|||
37896376|NCT00773734|69581358|FG003|Extension: Active Treatment Week 24-52|Other|2|||
37896377|NCT00773734|69581359|FG004|Extension: Active Treatment Week 24-52|Other|0|||
37896378|NCT00773734|69581360|FG005|Extension: Active Treatment Week 24-52|Other|1|||
37896379|NCT00773734|69581355|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
37696318|NCT01832038|69172413|FG000|Overall Study|Changes of implementation system|3|||
37896380|NCT00773734|69581356|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
37993842|NCT00306384|69678588|FG002|Overall Study|Lack of Efficacy|38|||
37993843|NCT00306384|69678586|FG000|Overall Study|Investigator discretion|28|||
37993844|NCT00306384|69678587|FG001|Overall Study|Investigator discretion|31|||
37993845|NCT00306384|69678588|FG002|Overall Study|Investigator discretion|21|||
37993846|NCT00306384|69678586|FG000|Overall Study|Other|80|||
37993847|NCT00306384|69678587|FG001|Overall Study|Other|70|||
37993848|NCT00306384|69678588|FG002|Overall Study|Other|32|||
37993849|NCT00306384|69678586|FG000|Overall Study|Site closure|2|||
37993850|NCT00306384|69678587|FG001|Overall Study|Site closure|0|||
37993851|NCT00306384|69678588|FG002|Overall Study|Site closure|0|||
37993852|NCT00305604|69678598|FG000|Overall Study|Adverse Event|6|||
37993853|NCT00305604|69678599|FG001|Overall Study|Adverse Event|3|||
37993854|NCT00305604|69678598|FG000|Overall Study|Lack of Efficacy|11|||
37993855|NCT00305604|69678599|FG001|Overall Study|Lack of Efficacy|18|||
37993856|NCT00305604|69678598|FG000|Overall Study|Lost to Follow-up|0|||
37993857|NCT00305604|69678599|FG001|Overall Study|Lost to Follow-up|4|||
37993858|NCT00305604|69678598|FG000|Overall Study|Protocol Violation|2|||
37993859|NCT00305604|69678599|FG001|Overall Study|Protocol Violation|1|||
37993860|NCT00305604|69678598|FG000|Overall Study|Withdrawal by Subject|12|||
37993861|NCT00305604|69678599|FG001|Overall Study|Withdrawal by Subject|21|||
37993862|NCT00305604|69678598|FG000|Overall Study|Patient moved|1|||
37993863|NCT00305604|69678599|FG001|Overall Study|Patient moved|0|||
37993864|NCT00501059|69678607|FG000|Overall Study|Protocol Violation|80|||
37993865|NCT00501059|69678608|FG001|Overall Study|Protocol Violation|69|||
37993866|NCT00501059|69678607|FG000|Overall Study|Death|140|||
37993867|NCT00501059|69678608|FG001|Overall Study|Death|137|||
37993868|NCT00501059|69678607|FG000|Overall Study|Other|236|||
37993869|NCT00501059|69678608|FG001|Overall Study|Other|239|||
37993870|NCT00501059|69678607|FG000|Overall Study|Missing end-of-study page|91|||
37993871|NCT00501059|69678608|FG001|Overall Study|Missing end-of-study page|92|||
37993872|NCT00501059|69678607|FG000|Overall Study|Clinical endpoint reached|110|||
37993873|NCT00501059|69678608|FG001|Overall Study|Clinical endpoint reached|123|||
37993874|NCT00501059|69678607|FG000|Overall Study|Insufficient therapeutic effect|4|||
37993875|NCT00501059|69678608|FG001|Overall Study|Insufficient therapeutic effect|5|||
37993876|NCT00501059|69678607|FG000|Overall Study|Consent withdrawn by subject|817|||
37993877|NCT00501059|69678608|FG001|Overall Study|Consent withdrawn by subject|873|||
37993878|NCT00501059|69678607|FG000|Overall Study|Non-compliant with study treatment|23|||
37993879|NCT00501059|69678608|FG001|Overall Study|Non-compliant with study treatment|16|||
37993880|NCT00501059|69678607|FG000|Overall Study|Reason not given|3|||
37993881|NCT00501059|69678608|FG001|Overall Study|Reason not given|1|||
37896381|NCT00773734|69581357|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
37896382|NCT00773734|69581358|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
37896383|NCT00773734|69581359|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
37896384|NCT00773734|69581360|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
37896385|NCT00773734|69581355|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
37896386|NCT00773734|69581356|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
37896387|NCT00773734|69581357|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
37896388|NCT00773734|69581358|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
37896389|NCT00773734|69581359|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
37896390|NCT00773734|69581360|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
37896391|NCT00773734|69581355|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
37896392|NCT00773734|69581356|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
37896393|NCT00773734|69581357|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
37896394|NCT00773734|69581358|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
37896395|NCT00773734|69581359|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
37896396|NCT00773734|69581360|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
37896397|NCT00773734|69581355|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
37896398|NCT00773734|69581356|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
37896399|NCT00773734|69581357|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
37896400|NCT00773734|69581358|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
37896401|NCT00773734|69581359|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
37896402|NCT00773734|69581360|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
37896403|NCT01009580|69581419|FG000|Overall Study|Adverse Event|4|||
37896404|NCT01009580|69581420|FG001|Overall Study|Adverse Event|4|||
37896405|NCT01009580|69581419|FG000|Overall Study|Lack of Efficacy|0|||
37993882|NCT00501059|69678607|FG000|Overall Study|Adverse Event|129|||
37993883|NCT00501059|69678608|FG001|Overall Study|Adverse Event|122|||
37993884|NCT00501059|69678607|FG000|Overall Study|Lost to Follow-up|210|||
37993885|NCT00501059|69678608|FG001|Overall Study|Lost to Follow-up|198|||
37993886|NCT00501059|69678607|FG000|Overall Study|Not treated|25|||
37993887|NCT00501059|69678608|FG001|Overall Study|Not treated|17|||
37993888|NCT00344318|69678620|FG000|Overall Study|Adverse Event|0|||
37993889|NCT00344318|69678621|FG001|Overall Study|Adverse Event|3|||
37993890|NCT00344318|69678622|FG002|Overall Study|Adverse Event|0|||
37993891|NCT00344318|69678623|FG003|Overall Study|Adverse Event|1|||
37993892|NCT00344318|69678620|FG000|Overall Study|Withdrawal by Subject|2|||
37993893|NCT00344318|69678621|FG001|Overall Study|Withdrawal by Subject|2|||
37993894|NCT00344318|69678622|FG002|Overall Study|Withdrawal by Subject|0|||
37993895|NCT00344318|69678623|FG003|Overall Study|Withdrawal by Subject|2|||
37993896|NCT00344318|69678620|FG000|Overall Study|Lost to Follow-up|2|||
37993897|NCT00344318|69678621|FG001|Overall Study|Lost to Follow-up|0|||
37993898|NCT00344318|69678622|FG002|Overall Study|Lost to Follow-up|1|||
37993899|NCT00344318|69678623|FG003|Overall Study|Lost to Follow-up|0|||
37993900|NCT00323258|69678637|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
37993901|NCT00323258|69678638|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
37993902|NCT00323258|69678637|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
37993903|NCT00323258|69678638|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
37993904|NCT00323258|69678637|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
37993905|NCT00323258|69678638|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
37993906|NCT00323258|69678637|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
37993907|NCT00323258|69678638|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
37993908|NCT00323258|69678637|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
37993909|NCT00323258|69678638|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
37993910|NCT00323258|69678637|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
37993911|NCT00323258|69678638|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
37993912|NCT00323258|69678637|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
37993913|NCT00323258|69678638|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
37993914|NCT00322868|69678644|FG000|Overall Study|disease progression|1|||
37993915|NCT00322712|69678649|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
37993916|NCT00343382|69678656|FG000|Overall Study|Adverse Event|2|||
37993917|NCT00343382|69678657|FG001|Overall Study|Adverse Event|10|||
37993918|NCT00343382|69678658|FG002|Overall Study|Adverse Event|7|||
37993919|NCT00343382|69678656|FG000|Overall Study|Withdrawal by Subject|1|||
37993920|NCT00343382|69678657|FG001|Overall Study|Withdrawal by Subject|2|||
37993921|NCT00343382|69678658|FG002|Overall Study|Withdrawal by Subject|6|||
37993922|NCT00343382|69678656|FG000|Overall Study|Other Reason Not Specified|1|||
37993923|NCT00343382|69678657|FG001|Overall Study|Other Reason Not Specified|2|||
37993924|NCT00343382|69678658|FG002|Overall Study|Other Reason Not Specified|4|||
37993925|NCT00481871|69678671|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
37993926|NCT00481871|69678672|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
37993927|NCT00481871|69678673|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
37993928|NCT00481871|69678674|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
37993929|NCT00481871|69678675|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
37993930|NCT00329420|69678686|FG000|Re-induction Phase|Lack of Efficacy|0|||
37993931|NCT00329420|69678687|FG001|Re-induction Phase|Lack of Efficacy|1|||
37993932|NCT00329420|69678688|FG002|Re-induction Phase|Lack of Efficacy|0|||
37993933|NCT00329420|69678686|FG000|Re-induction Phase|Withdrawal of Consent|0|||
37993934|NCT00329420|69678687|FG001|Re-induction Phase|Withdrawal of Consent|0|||
37993935|NCT00329420|69678688|FG002|Re-induction Phase|Withdrawal of Consent|1|||
37993936|NCT00329420|69678686|FG000|Re-induction Phase|Did not respond to re-induction|6|||
37993937|NCT00329420|69678687|FG001|Re-induction Phase|Did not respond to re-induction|5|||
37993938|NCT00329420|69678688|FG002|Re-induction Phase|Did not respond to re-induction|7|||
37993939|NCT00329420|69678686|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
37993940|NCT00329420|69678687|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
37993941|NCT00329420|69678688|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
37993942|NCT00329420|69678686|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
37993943|NCT00329420|69678687|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
37993944|NCT00329420|69678688|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
37993945|NCT00329420|69678686|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
37993946|NCT00329420|69678687|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
37993947|NCT00329420|69678688|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
37993948|NCT00329108|69678700|FG000|Overall Study|Adverse Event|2|||
37993949|NCT00329108|69678701|FG001|Overall Study|Adverse Event|2|||
37993950|NCT00329108|69678700|FG000|Overall Study|Lack of Efficacy|3|||
37993951|NCT00329108|69678701|FG001|Overall Study|Lack of Efficacy|3|||
37993952|NCT00329108|69678700|FG000|Overall Study|Withdrawal by Subject|0|||
37993953|NCT00329108|69678701|FG001|Overall Study|Withdrawal by Subject|2|||
37993954|NCT00329108|69678700|FG000|Overall Study|symptomatic deterioration|1|||
37993955|NCT00329108|69678701|FG001|Overall Study|symptomatic deterioration|1|||
37993956|NCT00329108|69678700|FG000|Overall Study|Subject no longer willing to participate|2|||
37993957|NCT00329108|69678701|FG001|Overall Study|Subject no longer willing to participate|2|||
37993958|NCT00329108|69678700|FG000|Overall Study|study terminated by sponsor|1|||
37993959|NCT00329108|69678701|FG001|Overall Study|study terminated by sponsor|0|||
37993960|NCT00329108|69678700|FG000|Overall Study|withdrew patient after SAE resolved|1|||
37993961|NCT00329108|69678701|FG001|Overall Study|withdrew patient after SAE resolved|0|||
37993962|NCT00329108|69678700|FG000|Overall Study|Protocol Violation|0|||
37993963|NCT00329108|69678701|FG001|Overall Study|Protocol Violation|2|||
37993964|NCT00329030|69678709|FG000|Overall Study|Withdrawal by Subject|1|||
37993965|NCT00329030|69678710|FG001|Overall Study|Withdrawal by Subject|3|||
37993966|NCT00329030|69678709|FG000|Overall Study|Progressive Disease|6|||
37993967|NCT00329030|69678710|FG001|Overall Study|Progressive Disease|2|||
37993968|NCT00329030|69678709|FG000|Overall Study|Ineligible Pathology|1|||
37993969|NCT00329030|69678710|FG001|Overall Study|Ineligible Pathology|1|||
37993970|NCT00328562|69678716|FG000|Overall Study|Disease progression|1|||
37993971|NCT00328172|69678725|FG000|Overall Study|Adverse Event|3|||
37993972|NCT00328172|69678726|FG001|Overall Study|Adverse Event|2|||
37993973|NCT00328172|69678727|FG002|Overall Study|Adverse Event|1|||
37993974|NCT00328172|69678728|FG003|Overall Study|Adverse Event|2|||
37993975|NCT00328172|69678729|FG004|Overall Study|Adverse Event|1|||
37993976|NCT00328172|69678725|FG000|Overall Study|Protocol Violation|0|||
37993977|NCT00328172|69678726|FG001|Overall Study|Protocol Violation|1|||
37993978|NCT00328172|69678727|FG002|Overall Study|Protocol Violation|1|||
37696319|NCT01832038|69172413|FG000|Overall Study|Plan to pregnancy|7|||
37696320|NCT01832038|69172413|FG000|Overall Study|Bad mood and has suicidal thought|1|||
37696321|NCT01832038|69172413|FG000|Overall Study|Prohibited concomitant medication|1|||
37696322|NCT01832038|69172413|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
37696323|NCT01832038|69172413|FG000|Overall Study|Subject considered the efficacy was poor|1|||
37696324|NCT01849588|69172418|FG000|Overall Study|Lack of Efficacy|3|||
37993979|NCT00328172|69678728|FG003|Overall Study|Protocol Violation|0|||
37993980|NCT00328172|69678729|FG004|Overall Study|Protocol Violation|0|||
37993981|NCT00328172|69678725|FG000|Overall Study|Lost to Follow-up|1|||
37993982|NCT00328172|69678726|FG001|Overall Study|Lost to Follow-up|1|||
37993983|NCT00328172|69678727|FG002|Overall Study|Lost to Follow-up|2|||
37993984|NCT00328172|69678728|FG003|Overall Study|Lost to Follow-up|1|||
37993985|NCT00328172|69678729|FG004|Overall Study|Lost to Follow-up|1|||
37993986|NCT00328172|69678725|FG000|Overall Study|Withdrawal by Subject|1|||
37993987|NCT00328172|69678726|FG001|Overall Study|Withdrawal by Subject|1|||
37993988|NCT00328172|69678727|FG002|Overall Study|Withdrawal by Subject|1|||
37993989|NCT00328172|69678728|FG003|Overall Study|Withdrawal by Subject|6|||
37993990|NCT00328172|69678729|FG004|Overall Study|Withdrawal by Subject|0|||
37993991|NCT00328172|69678725|FG000|Overall Study|Lack of Efficacy|14|||
37993992|NCT00328172|69678726|FG001|Overall Study|Lack of Efficacy|9|||
37993993|NCT00328172|69678727|FG002|Overall Study|Lack of Efficacy|4|||
37993994|NCT00328172|69678728|FG003|Overall Study|Lack of Efficacy|4|||
37993995|NCT00328172|69678729|FG004|Overall Study|Lack of Efficacy|3|||
37993996|NCT00328172|69678725|FG000|Overall Study|Other reason (not specified)|3|||
37993997|NCT00328172|69678726|FG001|Overall Study|Other reason (not specified)|0|||
37993998|NCT00328172|69678727|FG002|Overall Study|Other reason (not specified)|1|||
37993999|NCT00328172|69678728|FG003|Overall Study|Other reason (not specified)|0|||
37994000|NCT00328172|69678729|FG004|Overall Study|Other reason (not specified)|0|||
37994001|NCT00328094|69678743|FG000|Overall Study|Physician Decision|3|||
37994002|NCT00328094|69678744|FG001|Overall Study|Physician Decision|3|||
37994003|NCT00500903|69678753|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
37994004|NCT00500903|69678754|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
37994005|NCT00500903|69678755|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
37994006|NCT00500903|69678753|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
37994007|NCT00500903|69678754|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
37994008|NCT00500903|69678755|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
37994009|NCT00500903|69678753|FG000|Overall Study|Progressive Disease|41|||
37994010|NCT00500903|69678754|FG001|Overall Study|Progressive Disease|2|||
37994011|NCT00500903|69678755|FG002|Overall Study|Progressive Disease|15|||
37994012|NCT00500903|69678753|FG000|Overall Study|Patient Declined Further Treatment|0|||
37994013|NCT00500903|69678754|FG001|Overall Study|Patient Declined Further Treatment|0|||
37994014|NCT00500903|69678755|FG002|Overall Study|Patient Declined Further Treatment|3|||
37994015|NCT00500903|69678753|FG000|Overall Study|Symptomatic Deterioration|2|||
37994016|NCT00500903|69678754|FG001|Overall Study|Symptomatic Deterioration|0|||
37994017|NCT00500903|69678755|FG002|Overall Study|Symptomatic Deterioration|0|||
37994018|NCT00500903|69678753|FG000|Overall Study|Reason Not Specified|10|||
37696325|NCT02357342|69172424|FG000|First 6 Months|Death|2|||
37696326|NCT02357342|69172425|FG001|First 6 Months|Death|0|||
37994019|NCT00500903|69678754|FG001|Overall Study|Reason Not Specified|0|||
37994020|NCT00500903|69678755|FG002|Overall Study|Reason Not Specified|2|||
37994021|NCT00295932|69678804|FG000|Overall Study|Not Treated|0|||
37994022|NCT00295932|69678805|FG001|Overall Study|Not Treated|0|||
37994023|NCT00295932|69678806|FG002|Overall Study|Not Treated|0|||
37994024|NCT00295932|69678807|FG003|Overall Study|Not Treated|0|||
37696327|NCT02271529|69172431|FG000|Overall Study|Withdrawal by Subject|1|||
37696328|NCT02325518|69172437|FG000|Overall Study|Adverse Event|4|||
37994025|NCT00295932|69678808|FG004|Overall Study|Not Treated|0|||
37994026|NCT00295932|69678809|FG005|Overall Study|Not Treated|0|||
37994027|NCT00295932|69678810|FG006|Overall Study|Not Treated|0|||
37994028|NCT00295932|69678811|FG007|Overall Study|Not Treated|0|||
37994029|NCT00295932|69678812|FG008|Overall Study|Not Treated|0|||
37994030|NCT00295932|69678813|FG009|Overall Study|Not Treated|0|||
37994031|NCT00295932|69678814|FG010|Overall Study|Not Treated|1|||
37994032|NCT00305448|69678843|FG000|Overall Study|Protocol Violation|0|||
37994033|NCT00305448|69678844|FG001|Overall Study|Protocol Violation|1|||
37994034|NCT00305448|69678845|FG002|Overall Study|Protocol Violation|0|||
37994035|NCT00305448|69678843|FG000|Overall Study|Withdrawal by Subject|2|||
37994036|NCT00305448|69678844|FG001|Overall Study|Withdrawal by Subject|0|||
37994037|NCT00305448|69678845|FG002|Overall Study|Withdrawal by Subject|1|||
37994038|NCT00305448|69678843|FG000|Overall Study|Adverse Event|1|||
37896406|NCT01009580|69581420|FG001|Overall Study|Lack of Efficacy|1|||
37896407|NCT01009580|69581419|FG000|Overall Study|Protocol Violation|2|||
37896408|NCT01009580|69581420|FG001|Overall Study|Protocol Violation|3|||
37896409|NCT01009580|69581419|FG000|Overall Study|Withdrawal Criteria|4|||
37896410|NCT01009580|69581420|FG001|Overall Study|Withdrawal Criteria|6|||
37896411|NCT01009580|69581419|FG000|Overall Study|Unclassified|17|||
37896412|NCT01009580|69581420|FG001|Overall Study|Unclassified|21|||
37896413|NCT01009346|69581426|FG000|Overall Study|Adverse Event|4|||
37896414|NCT01001702|69581431|FG000|Overall Study|Lost to Follow-up|7|||
37896415|NCT01001702|69581431|FG000|Overall Study|Adverse Event|7|||
37896416|NCT01001702|69581431|FG000|Overall Study|Sponsor Discontinued Study|4|||
37896417|NCT01001702|69581431|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
37896418|NCT01001702|69581431|FG000|Overall Study|Investigator withdrew Subject|10|||
37896419|NCT01001702|69581431|FG000|Overall Study|Withdrawal by Subject|19|||
37896420|NCT01001702|69581431|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
37994039|NCT00305448|69678844|FG001|Overall Study|Adverse Event|0|||
37994040|NCT00305448|69678845|FG002|Overall Study|Adverse Event|1|||
37994041|NCT00305448|69678843|FG000|Overall Study|Disease Progression|27|||
37994042|NCT00305448|69678844|FG001|Overall Study|Disease Progression|31|||
37994043|NCT00305448|69678845|FG002|Overall Study|Disease Progression|28|||
37994044|NCT00305448|69678843|FG000|Overall Study|Subjective Disease Progression|1|||
37994045|NCT00305448|69678844|FG001|Overall Study|Subjective Disease Progression|2|||
37994046|NCT00305448|69678845|FG002|Overall Study|Subjective Disease Progression|2|||
37994047|NCT00305448|69678843|FG000|Overall Study|Tumor Marker Elevation|0|||
37994048|NCT00305448|69678844|FG001|Overall Study|Tumor Marker Elevation|0|||
37994049|NCT00305448|69678845|FG002|Overall Study|Tumor Marker Elevation|1|||
37994050|NCT00305058|69678856|FG000|Overall Study|Participant too young|1|||
37994051|NCT00305058|69678857|FG001|Overall Study|Participant too young|0|||
37994052|NCT00305058|69678856|FG000|Overall Study|Missing data collection instrument|3|||
37994053|NCT00305058|69678857|FG001|Overall Study|Missing data collection instrument|2|||
37994054|NCT00305058|69678856|FG000|Overall Study|Missing outcome data|3|||
37994055|NCT00305058|69678857|FG001|Overall Study|Missing outcome data|2|||
37994056|NCT00295854|69678866|FG000|Overall Study|Adverse Event|7|||
37994057|NCT00295854|69678867|FG001|Overall Study|Adverse Event|7|||
37994058|NCT00295854|69678868|FG002|Overall Study|Adverse Event|6|||
37994059|NCT00295854|69678866|FG000|Overall Study|Protocol Violation|1|||
37994060|NCT00295854|69678867|FG001|Overall Study|Protocol Violation|1|||
37994061|NCT00295854|69678868|FG002|Overall Study|Protocol Violation|1|||
37994062|NCT00295854|69678866|FG000|Overall Study|Lost to Follow-up|2|||
37994063|NCT00295854|69678867|FG001|Overall Study|Lost to Follow-up|0|||
37994064|NCT00295854|69678868|FG002|Overall Study|Lost to Follow-up|1|||
37994065|NCT00295854|69678866|FG000|Overall Study|Withdrawal by Subject|3|||
37994066|NCT00295854|69678867|FG001|Overall Study|Withdrawal by Subject|7|||
37994067|NCT00295854|69678868|FG002|Overall Study|Withdrawal by Subject|4|||
37994068|NCT00295854|69678866|FG000|Overall Study|did not continue to meet criteria|1|||
37994069|NCT00295854|69678867|FG001|Overall Study|did not continue to meet criteria|1|||
37994070|NCT00295854|69678868|FG002|Overall Study|did not continue to meet criteria|2|||
37994071|NCT00295854|69678866|FG000|Overall Study|required a prohibited medication|1|||
37994072|NCT00295854|69678867|FG001|Overall Study|required a prohibited medication|0|||
37994073|NCT00295854|69678868|FG002|Overall Study|required a prohibited medication|0|||
37994074|NCT00295854|69678866|FG000|Overall Study|Other|3|||
37994075|NCT00295854|69678867|FG001|Overall Study|Other|5|||
37994076|NCT00295854|69678868|FG002|Overall Study|Other|1|||
37994077|NCT00327470|69678878|FG000|Overall Study|Randomized, but not treated|0|||
37994078|NCT00327470|69678879|FG001|Overall Study|Randomized, but not treated|2|||
37994079|NCT00327470|69678878|FG000|Overall Study|Adverse Event|9|||
37994080|NCT00327470|69678879|FG001|Overall Study|Adverse Event|14|||
37994081|NCT00327470|69678878|FG000|Overall Study|Lack of Efficacy|7|||
37896421|NCT01070069|69581440|FG000|Overall Study|Death|1|||
37896422|NCT01070069|69581441|FG001|Overall Study|Death|0|||
37896423|NCT01070069|69581442|FG002|Overall Study|Death|2|||
37994082|NCT00327470|69678879|FG001|Overall Study|Lack of Efficacy|19|||
37994083|NCT00327470|69678878|FG000|Overall Study|Other|5|||
37696329|NCT02325518|69172438|FG001|Overall Study|Adverse Event|1|||
37994084|NCT00327470|69678879|FG001|Overall Study|Other|9|||
37994085|NCT00327470|69678878|FG000|Overall Study|Lost to Follow-up|1|||
37994086|NCT00327470|69678879|FG001|Overall Study|Lost to Follow-up|3|||
37994087|NCT00327470|69678878|FG000|Overall Study|Withdrawal by Subject|6|||
37994088|NCT00327470|69678879|FG001|Overall Study|Withdrawal by Subject|12|||
37994089|NCT00327470|69678878|FG000|Overall Study|Death|1|||
37994090|NCT00327470|69678879|FG001|Overall Study|Death|4|||
37994091|NCT00322556|69678885|FG000|Overall Study|Adverse Event|1|||
37994092|NCT00322556|69678885|FG000|Overall Study|Withdrawal by Subject|1|||
37994093|NCT00322556|69678885|FG000|Overall Study|Lost to Follow-up|3|||
37994094|NCT00322556|69678885|FG000|Overall Study|Other Reason|7|||
37994095|NCT00321932|69678894|FG000|Overall Study|Death|3|||
37994096|NCT00321932|69678895|FG001|Overall Study|Death|6|||
37994097|NCT00321932|69678894|FG000|Overall Study|Withdrawal by Subject|3|||
37994098|NCT00321932|69678895|FG001|Overall Study|Withdrawal by Subject|6|||
37994099|NCT00321932|69678894|FG000|Overall Study|Early relapse|2|||
37994100|NCT00321932|69678895|FG001|Overall Study|Early relapse|8|||
37994101|NCT00321932|69678894|FG000|Overall Study|Missing data|2|||
37994102|NCT00321932|69678895|FG001|Overall Study|Missing data|1|||
37994103|NCT00326612|69678904|FG000|Overall Study|They did not have a seizure requiring tx|129|||
37994104|NCT00326612|69678905|FG001|Overall Study|They did not have a seizure requiring tx|137|||
37994105|NCT00325130|69678917|FG000|Overall Study|Lost to Follow-up|6|||
37994106|NCT00325130|69678918|FG001|Overall Study|Lost to Follow-up|14|||
37994107|NCT00325130|69678917|FG000|Overall Study|Withdrawal by Subject|12|||
37994108|NCT00325130|69678918|FG001|Overall Study|Withdrawal by Subject|14|||
37994109|NCT00325130|69678917|FG000|Overall Study|Protocol Deviation|0|||
37994110|NCT00325130|69678918|FG001|Overall Study|Protocol Deviation|1|||
37994111|NCT00325130|69678917|FG000|Overall Study|Moved|0|||
37994112|NCT00325130|69678918|FG001|Overall Study|Moved|1|||
37994113|NCT00325130|69678917|FG000|Overall Study|Patient Discontinued for Other|1|||
37994114|NCT00325130|69678918|FG001|Overall Study|Patient Discontinued for Other|0|||
37994115|NCT00321854|69678926|FG000|Overall Study|Adverse Event|41|||
37994116|NCT00321854|69678927|FG001|Overall Study|Adverse Event|43|||
37994117|NCT00321854|69678926|FG000|Overall Study|Lack of Efficacy|9|||
37994118|NCT00321854|69678927|FG001|Overall Study|Lack of Efficacy|14|||
37994119|NCT00321854|69678926|FG000|Overall Study|Protocol Violation|6|||
37994120|NCT00321854|69678927|FG001|Overall Study|Protocol Violation|5|||
37994121|NCT00321854|69678926|FG000|Overall Study|Lost to Follow-up|0|||
37994122|NCT00321854|69678927|FG001|Overall Study|Lost to Follow-up|2|||
37994123|NCT00321854|69678926|FG000|Overall Study|Withdrawal by Subject|6|||
37994124|NCT00321854|69678927|FG001|Overall Study|Withdrawal by Subject|17|||
37994125|NCT00321854|69678926|FG000|Overall Study|Other|1|||
37994126|NCT00321854|69678927|FG001|Overall Study|Other|1|||
37994127|NCT00310388|69678935|FG000|Primary Reporting Phase|Adverse Event|101|||
37994128|NCT00310388|69678936|FG001|Primary Reporting Phase|Adverse Event|0|||
37994129|NCT00310388|69678935|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
37994130|NCT00310388|69678936|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
37994131|NCT00310388|69678935|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
37994132|NCT00310388|69678936|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
37994133|NCT00310388|69678935|FG000|Primary Reporting Phase|Protocol Violation|10|||
37994134|NCT00310388|69678936|FG001|Primary Reporting Phase|Protocol Violation|0|||
37994135|NCT00310388|69678935|FG000|Primary Reporting Phase|Pregnancy|3|||
37994136|NCT00310388|69678936|FG001|Primary Reporting Phase|Pregnancy|0|||
37994137|NCT00310388|69678935|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
37994138|NCT00310388|69678936|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
37994139|NCT00310388|69678935|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
37994140|NCT00310388|69678936|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
37994141|NCT00310388|69678935|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
37994142|NCT00310388|69678936|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
37994143|NCT00310388|69678935|FG000|Primary Reporting Phase|Physician Decision|2|||
37994144|NCT00310388|69678936|FG001|Primary Reporting Phase|Physician Decision|0|||
37994145|NCT00310388|69678935|FG000|Primary Reporting Phase|Request of the sponsor|19|||
37994146|NCT00310388|69678936|FG001|Primary Reporting Phase|Request of the sponsor|0|||
37825458|NCT01244035|69507502|FG002|Part 1: Period 3|Adverse Event|0|||
37825459|NCT01244035|69507503|FG003|Part 1: Period 3|Adverse Event|0|||
37825460|NCT01244035|69507504|FG004|Part 1: Period 3|Adverse Event|0|||
37825461|NCT01244035|69507505|FG005|Part 1: Period 3|Adverse Event|1|||
37825462|NCT01244035|69507500|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
37825463|NCT01244035|69507501|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
37825464|NCT01244035|69507502|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
37994147|NCT00310388|69678935|FG000|Primary Reporting Phase|Failed to return|8|||
37994148|NCT00310388|69678936|FG001|Primary Reporting Phase|Failed to return|0|||
37994149|NCT00310388|69678935|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
37994150|NCT00310388|69678936|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
37994151|NCT00310388|69678935|FG000|Primary Reporting Phase|Participant request|2|||
37994152|NCT00310388|69678936|FG001|Primary Reporting Phase|Participant request|0|||
37994153|NCT00310388|69678935|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
37994154|NCT00310388|69678936|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
37994155|NCT00310388|69678935|FG000|Primary Reporting Phase|Discontinuation of study|1|||
37994156|NCT00310388|69678936|FG001|Primary Reporting Phase|Discontinuation of study|0|||
37994157|NCT00310388|69678935|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
37994158|NCT00310388|69678936|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
37994159|NCT00310388|69678935|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
37994160|NCT00310388|69678936|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
37994161|NCT00310388|69678935|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
37994162|NCT00310388|69678936|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
37994163|NCT00310388|69678935|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
37994164|NCT00310388|69678936|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
37994165|NCT00310388|69678935|FG000|Primary Reporting Phase|Participant passed away|1|||
37994166|NCT00310388|69678936|FG001|Primary Reporting Phase|Participant passed away|0|||
37994167|NCT00310388|69678935|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
37994168|NCT00310388|69678936|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
37994169|NCT00310388|69678935|FG000|Primary Reporting Phase|Missing|1|||
37994170|NCT00310388|69678936|FG001|Primary Reporting Phase|Missing|0|||
37994171|NCT00310388|69678935|FG000|Primary Reporting Phase|Other|1|||
37994172|NCT00310388|69678936|FG001|Primary Reporting Phase|Other|0|||
37994173|NCT00310388|69678935|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
37994174|NCT00310388|69678936|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
37994175|NCT00310388|69678935|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
37994176|NCT00310388|69678936|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
37994177|NCT00310388|69678935|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
37994178|NCT00310388|69678936|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
37994179|NCT00310388|69678935|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
37994180|NCT00310388|69678936|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
37994181|NCT00500357|69678941|FG000|Overall Study|Death|1|||
37994182|NCT00309842|69678956|FG000|Overall Study|Lost to Follow-up|1|||
37994183|NCT00325754|69678962|FG000|Overall Study|Adverse Event|4|||
37994184|NCT00325754|69678963|FG001|Overall Study|Adverse Event|1|||
37994185|NCT00499889|69678969|FG000|Overall Study|Infection prior to treatment|1|||
37994186|NCT00309608|69678978|FG000|Overall Study|Adverse Event|1|||
37994187|NCT00309608|69678979|FG001|Overall Study|Adverse Event|5|||
37896424|NCT01070069|69581443|FG003|Overall Study|Death|0|||
37896425|NCT01070069|69581444|FG004|Overall Study|Death|1|||
37896426|NCT01070069|69581440|FG000|Overall Study|Withdrawal by Subject|1|||
37896427|NCT01070069|69581441|FG001|Overall Study|Withdrawal by Subject|1|||
37896428|NCT01070069|69581442|FG002|Overall Study|Withdrawal by Subject|4|||
37896429|NCT01070069|69581443|FG003|Overall Study|Withdrawal by Subject|0|||
37896430|NCT01070069|69581444|FG004|Overall Study|Withdrawal by Subject|0|||
37896431|NCT01070069|69581440|FG000|Overall Study|Lost to Follow-up|4|||
37896432|NCT01070069|69581441|FG001|Overall Study|Lost to Follow-up|1|||
37896433|NCT01070069|69581442|FG002|Overall Study|Lost to Follow-up|0|||
37896434|NCT01070069|69581443|FG003|Overall Study|Lost to Follow-up|0|||
37896435|NCT01070069|69581444|FG004|Overall Study|Lost to Follow-up|3|||
37896436|NCT01068665|69581461|FG000|Overall Study|Adverse Event|5|||
37896437|NCT01068665|69581462|FG001|Overall Study|Adverse Event|4|||
37896438|NCT01068665|69581461|FG000|Overall Study|Lack of Efficacy|0|||
37896439|NCT01068665|69581462|FG001|Overall Study|Lack of Efficacy|2|||
37896440|NCT01068665|69581461|FG000|Overall Study|Protocol Violation|5|||
37896441|NCT01068665|69581462|FG001|Overall Study|Protocol Violation|2|||
37896442|NCT01068665|69581461|FG000|Overall Study|Withdrawal Criteria|3|||
37896443|NCT01068665|69581462|FG001|Overall Study|Withdrawal Criteria|9|||
37896444|NCT01068665|69581461|FG000|Overall Study|Other|17|||
37896445|NCT01068665|69581462|FG001|Overall Study|Other|12|||
37896446|NCT01001390|69581468|FG000|Overall Study|Failure to wear AFO device|2|||
37994188|NCT00309608|69678980|FG002|Overall Study|Adverse Event|3|||
37994189|NCT00309608|69678981|FG003|Overall Study|Adverse Event|2|||
37994190|NCT00309608|69678982|FG004|Overall Study|Adverse Event|3|||
37994191|NCT00309608|69678978|FG000|Overall Study|Protocol Violation|2|||
37896447|NCT01001390|69581469|FG001|Overall Study|Failure to wear AFO device|0|||
37896448|NCT00772954|69581477|FG000|Overall Study|Adverse Event|0|||
37896449|NCT00772954|69581478|FG001|Overall Study|Adverse Event|0|||
37896450|NCT00772954|69581479|FG002|Overall Study|Adverse Event|1|||
37994192|NCT00309608|69678979|FG001|Overall Study|Protocol Violation|0|||
37994193|NCT00309608|69678980|FG002|Overall Study|Protocol Violation|0|||
37994194|NCT00309608|69678981|FG003|Overall Study|Protocol Violation|0|||
37994195|NCT00309608|69678982|FG004|Overall Study|Protocol Violation|0|||
37994196|NCT00309608|69678978|FG000|Overall Study|Lost to Follow-up|0|||
37994197|NCT00309608|69678979|FG001|Overall Study|Lost to Follow-up|0|||
37994198|NCT00309608|69678980|FG002|Overall Study|Lost to Follow-up|2|||
37994199|NCT00309608|69678981|FG003|Overall Study|Lost to Follow-up|0|||
37994200|NCT00309608|69678982|FG004|Overall Study|Lost to Follow-up|1|||
37994201|NCT00309608|69678978|FG000|Overall Study|Withdrawal by Subject|1|||
37994202|NCT00309608|69678979|FG001|Overall Study|Withdrawal by Subject|4|||
37994203|NCT00309608|69678980|FG002|Overall Study|Withdrawal by Subject|2|||
37994204|NCT00309608|69678981|FG003|Overall Study|Withdrawal by Subject|0|||
37994205|NCT00309608|69678982|FG004|Overall Study|Withdrawal by Subject|0|||
37994206|NCT00309608|69678978|FG000|Overall Study|Other incl. Lack of efficacy|10|||
37994207|NCT00309608|69678979|FG001|Overall Study|Other incl. Lack of efficacy|4|||
37994208|NCT00309608|69678980|FG002|Overall Study|Other incl. Lack of efficacy|3|||
37994209|NCT00309608|69678981|FG003|Overall Study|Other incl. Lack of efficacy|4|||
37994210|NCT00309608|69678982|FG004|Overall Study|Other incl. Lack of efficacy|0|||
37994211|NCT00309452|69678996|FG000|Overall Study|Withdrawal by Subject|3|||
37994212|NCT00309452|69678997|FG001|Overall Study|Withdrawal by Subject|0|||
37994213|NCT00308750|69679006|FG000|Overall Study|Adverse Event|9|||
37994214|NCT00308750|69679007|FG001|Overall Study|Adverse Event|9|||
37994215|NCT00308750|69679008|FG002|Overall Study|Adverse Event|13|||
37994216|NCT00308750|69679006|FG000|Overall Study|Withdrawal by Subject|6|||
37994217|NCT00308750|69679007|FG001|Overall Study|Withdrawal by Subject|2|||
37994218|NCT00308750|69679008|FG002|Overall Study|Withdrawal by Subject|3|||
37994219|NCT00308750|69679006|FG000|Overall Study|Physician Decision|3|||
37994220|NCT00308750|69679007|FG001|Overall Study|Physician Decision|4|||
37994221|NCT00308750|69679008|FG002|Overall Study|Physician Decision|3|||
37896451|NCT00781768|69581493|FG000|Overall Study|Not transplanted.|0|||
37994222|NCT00308750|69679006|FG000|Overall Study|Sponsor Decision|1|||
37994223|NCT00308750|69679007|FG001|Overall Study|Sponsor Decision|0|||
37994224|NCT00308750|69679008|FG002|Overall Study|Sponsor Decision|0|||
37994225|NCT00308750|69679006|FG000|Overall Study|Disease Progression|47|||
37994226|NCT00308750|69679007|FG001|Overall Study|Disease Progression|24|||
37994227|NCT00308750|69679008|FG002|Overall Study|Disease Progression|28|||
37994228|NCT00308750|69679006|FG000|Overall Study|Unrelated Complication|3|||
37994229|NCT00308750|69679007|FG001|Overall Study|Unrelated Complication|0|||
37994230|NCT00308750|69679008|FG002|Overall Study|Unrelated Complication|1|||
37994231|NCT00308750|69679006|FG000|Overall Study|Death|1|||
37994232|NCT00308750|69679007|FG001|Overall Study|Death|0|||
37994233|NCT00308750|69679008|FG002|Overall Study|Death|1|||
37994234|NCT00308750|69679006|FG000|Overall Study|Protocol Violation|1|||
37994235|NCT00308750|69679007|FG001|Overall Study|Protocol Violation|0|||
37994236|NCT00308750|69679008|FG002|Overall Study|Protocol Violation|0|||
37994237|NCT00308750|69679006|FG000|Overall Study|New Primary Disease Identified|1|||
37994238|NCT00308750|69679007|FG001|Overall Study|New Primary Disease Identified|1|||
37994239|NCT00308750|69679008|FG002|Overall Study|New Primary Disease Identified|0|||
37994240|NCT00489359|69679019|FG000|Overall Study|Death|0|||
37994241|NCT00489359|69679020|FG001|Overall Study|Death|2|||
37994242|NCT00489359|69679019|FG000|Overall Study|Progressive Disease|5|||
37825465|NCT01244035|69507503|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
37825466|NCT01244035|69507504|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
37825467|NCT01244035|69507505|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
37825468|NCT01244035|69507500|FG000|Part 1: Period 3|Protocol Deviation|0|||
37825469|NCT01244035|69507501|FG001|Part 1: Period 3|Protocol Deviation|1|||
37825470|NCT01244035|69507502|FG002|Part 1: Period 3|Protocol Deviation|0|||
37825471|NCT01244035|69507503|FG003|Part 1: Period 3|Protocol Deviation|0|||
37825472|NCT01244035|69507504|FG004|Part 1: Period 3|Protocol Deviation|0|||
37825473|NCT01244035|69507505|FG005|Part 1: Period 3|Protocol Deviation|0|||
37825474|NCT01243762|69507541|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
37825475|NCT01243762|69507542|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
37825476|NCT01243762|69507543|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
37825477|NCT01243762|69507544|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
37825478|NCT01243762|69507545|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
37825479|NCT01243762|69507546|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
37825480|NCT01243762|69507547|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
37825481|NCT01243762|69507541|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
37994243|NCT00489359|69679020|FG001|Overall Study|Progressive Disease|6|||
37994244|NCT00489359|69679019|FG000|Overall Study|Lost to Follow-up|1|||
37994245|NCT00489359|69679020|FG001|Overall Study|Lost to Follow-up|0|||
37994246|NCT00489359|69679019|FG000|Overall Study|Withdrawal by Subject|1|||
37994247|NCT00489359|69679020|FG001|Overall Study|Withdrawal by Subject|5|||
37994248|NCT00489359|69679019|FG000|Overall Study|Adverse Event|0|||
37994249|NCT00489359|69679020|FG001|Overall Study|Adverse Event|16|||
37994250|NCT00481247|69679033|FG000|Overall Study|Death|0|||
37994251|NCT00481247|69679034|FG001|Overall Study|Death|1|||
37994252|NCT00481247|69679033|FG000|Overall Study|Disease progression|18|||
37994253|NCT00481247|69679034|FG001|Overall Study|Disease progression|22|||
37994254|NCT00481247|69679033|FG000|Overall Study|Intolerance|42|||
37994255|NCT00481247|69679034|FG001|Overall Study|Intolerance|17|||
37994256|NCT00481247|69679033|FG000|Overall Study|Treatment failure|10|||
37994257|NCT00481247|69679034|FG001|Overall Study|Treatment failure|14|||
37994258|NCT00481247|69679033|FG000|Overall Study|AE unrelated to study drug|13|||
37994259|NCT00481247|69679034|FG001|Overall Study|AE unrelated to study drug|4|||
37994260|NCT00481247|69679033|FG000|Overall Study|Withdrawal by Subject|8|||
37994261|NCT00481247|69679034|FG001|Overall Study|Withdrawal by Subject|13|||
37994262|NCT00481247|69679033|FG000|Overall Study|Pregnancy|2|||
37994263|NCT00481247|69679034|FG001|Overall Study|Pregnancy|1|||
37994264|NCT00481247|69679033|FG000|Overall Study|Lost to Follow-up|1|||
37994265|NCT00481247|69679034|FG001|Overall Study|Lost to Follow-up|2|||
37994266|NCT00481247|69679033|FG000|Overall Study|Poor compliance/noncompliance|1|||
37994267|NCT00481247|69679034|FG001|Overall Study|Poor compliance/noncompliance|7|||
37994268|NCT00481247|69679033|FG000|Overall Study|Administrative reason by sponsor|157|||
37994269|NCT00481247|69679034|FG001|Overall Study|Administrative reason by sponsor|162|||
37994270|NCT00481247|69679033|FG000|Overall Study|Varied|6|||
37994271|NCT00481247|69679034|FG001|Overall Study|Varied|15|||
37994272|NCT00481247|69679033|FG000|Overall Study|Did not receive treatment|1|||
37994273|NCT00481247|69679034|FG001|Overall Study|Did not receive treatment|2|||
37994274|NCT00480857|69679040|FG000|Overall Study|Lack of Efficacy|2|||
37994275|NCT00480779|69679046|FG000|Overall Study|Other|2|||
37994276|NCT00480779|69679047|FG001|Overall Study|Other|0|||
37994277|NCT00480779|69679046|FG000|Overall Study|Job and Health-related|0|||
37994278|NCT00480779|69679047|FG001|Overall Study|Job and Health-related|3|||
37994279|NCT00499031|69679053|FG000|Overall Study|Improper pre-protocol treatment|1|||
37994280|NCT00499031|69679053|FG000|Overall Study|Required test not done|1|||
37994281|NCT00499031|69679053|FG000|Overall Study|Never treated|1|||
37994282|NCT00498797|69679059|FG000|Overall Study|Withdrawal by Subject|4|||
37994283|NCT00498797|69679060|FG001|Overall Study|Withdrawal by Subject|2|||
37994284|NCT00498797|69679059|FG000|Overall Study|Adverse Event|12|||
37994285|NCT00498797|69679060|FG001|Overall Study|Adverse Event|5|||
37994286|NCT00498797|69679059|FG000|Overall Study|Condition under investigation worsened|19|||
37994287|NCT00498797|69679060|FG001|Overall Study|Condition under investigation worsened|21|||
37994288|NCT00498797|69679059|FG000|Overall Study|Other|3|||
37994289|NCT00498797|69679060|FG001|Overall Study|Other|1|||
37994290|NCT00498485|69679068|FG000|Overall Study|Adverse Event|1|||
37896452|NCT00781768|69581494|FG001|Overall Study|Not transplanted.|2|||
37896453|NCT01005680|69581502|FG000|Overall Study|Lost to Follow-up|4|||
37896454|NCT01005680|69581503|FG001|Overall Study|Lost to Follow-up|6|||
37896455|NCT01005680|69581502|FG000|Overall Study|Withdrawal by Subject|1|||
37896456|NCT01005680|69581503|FG001|Overall Study|Withdrawal by Subject|4|||
37896457|NCT01005680|69581502|FG000|Overall Study|Physician Decision|1|||
37896458|NCT01005680|69581503|FG001|Overall Study|Physician Decision|1|||
37896459|NCT01005602|69581512|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
37896460|NCT01005602|69581513|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
37896461|NCT01068509|69581529|FG000|Overall Study|Death|0|||
37896462|NCT01068509|69581530|FG001|Overall Study|Death|0|||
37896463|NCT01068509|69581531|FG002|Overall Study|Death|1|||
37896464|NCT01068509|69581529|FG000|Overall Study|Disease Progression|5|||
37896465|NCT01068509|69581530|FG001|Overall Study|Disease Progression|20|||
37896466|NCT01068509|69581531|FG002|Overall Study|Disease Progression|18|||
37896467|NCT01068509|69581529|FG000|Overall Study|Lost to Follow-up|1|||
37994291|NCT00498485|69679069|FG001|Overall Study|Adverse Event|5|||
37994292|NCT00480077|69679079|FG000|Overall Study|Death|19|||
37994293|NCT00480077|69679080|FG001|Overall Study|Death|15|||
37994294|NCT00480077|69679079|FG000|Overall Study|early exit|12|||
37994295|NCT00480077|69679080|FG001|Overall Study|early exit|11|||
37994296|NCT00498173|69679088|FG000|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2|||
37994297|NCT00498173|69679089|FG001|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1|||
37994298|NCT00498173|69679090|FG002|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0|||
37994299|NCT00295620|69679100|FG000|Overall Study|Lost to Follow-up|9|||
37994300|NCT00295620|69679101|FG001|Overall Study|Lost to Follow-up|5|||
37994301|NCT00295620|69679100|FG000|Overall Study|Withdrawal by Subject|37|||
37994302|NCT00295620|69679101|FG001|Overall Study|Withdrawal by Subject|50|||
37994303|NCT00295620|69679100|FG000|Overall Study|Death|206|||
37994304|NCT00295620|69679101|FG001|Overall Study|Death|207|||
37994305|NCT00295620|69679100|FG000|Overall Study|Other reasons|10|||
37994306|NCT00295620|69679101|FG001|Overall Study|Other reasons|9|||
37994307|NCT00295620|69679100|FG000|Overall Study|Discontinuation by sponsor|580|||
37994308|NCT00295620|69679101|FG001|Overall Study|Discontinuation by sponsor|593|||
37994309|NCT00295620|69679100|FG000|Overall Study|Protocol Violation|30|||
37994310|NCT00295620|69679101|FG001|Overall Study|Protocol Violation|32|||
37994311|NCT00310440|69679109|FG000|Overall Study|Lost to Follow-up|17|||
37994312|NCT00310440|69679110|FG001|Overall Study|Lost to Follow-up|8|||
37994313|NCT00310440|69679109|FG000|Overall Study|Withdrawal by Subject|2|||
37994314|NCT00310440|69679110|FG001|Overall Study|Withdrawal by Subject|1|||
37994315|NCT00310440|69679109|FG000|Overall Study|Missed 12 Month Visit|7|||
37994316|NCT00310440|69679110|FG001|Overall Study|Missed 12 Month Visit|4|||
37994317|NCT00304356|69679116|FG000|Nitazoxanide|Physician Decision|5|||
37994318|NCT00304356|69679116|FG000|Nitazoxanide|Physician Decision|1|||
37994319|NCT00304356|69679116|FG000|Nitazoxanide|number is 0|1|||
37994320|NCT00304356|69679116|FG000|Nitazoxanide|Physician Decision|1|||
37994321|NCT00304356|69679116|FG000|Nitazoxanide|Physician Decision|1|||
37994322|NCT00304356|69679116|FG000|Nitazoxanide|Physician Decision|1|||
37994323|NCT00321620|69679122|FG000|Overall Study|Death|269|||
37825482|NCT01243762|69507542|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
37825483|NCT01243762|69507543|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
37825484|NCT01243762|69507544|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
37825485|NCT01243762|69507545|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
37825486|NCT01243762|69507546|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
37825487|NCT01243762|69507547|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
37825488|NCT01243762|69507541|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
37825489|NCT01243762|69507542|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
37825490|NCT01243762|69507543|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
37825491|NCT01243762|69507544|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
37825492|NCT01243762|69507545|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
37825493|NCT01243762|69507546|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
37825494|NCT01243762|69507547|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
37896468|NCT01068509|69581530|FG001|Overall Study|Lost to Follow-up|0|||
37896469|NCT01068509|69581531|FG002|Overall Study|Lost to Follow-up|0|||
37896470|NCT01068509|69581529|FG000|Overall Study|Withdrew Consent|0|||
37896471|NCT01068509|69581530|FG001|Overall Study|Withdrew Consent|1|||
37896472|NCT01068509|69581531|FG002|Overall Study|Withdrew Consent|2|||
37896473|NCT01068509|69581529|FG000|Overall Study|Reason Not Specified|0|||
37896474|NCT01068509|69581530|FG001|Overall Study|Reason Not Specified|1|||
37896475|NCT01068509|69581531|FG002|Overall Study|Reason Not Specified|0|||
37896476|NCT01009034|69581538|FG000|Overall Study|Lost to Follow-up|2|||
37896477|NCT01009034|69581538|FG000|Overall Study|Withdrawal by Subject|2|||
37896478|NCT00768430|69581544|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
37896479|NCT00768430|69581545|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
37896480|NCT01064297|69581554|FG000|Overall Study|Lost to Follow-up|791|||
37896481|NCT01064297|69581555|FG001|Overall Study|Lost to Follow-up|48|||
37896482|NCT01064297|69581556|FG002|Overall Study|Lost to Follow-up|133|||
37896483|NCT00781456|69581573|FG000|Overall Study|Adverse Event|3|||
37896484|NCT00781456|69581574|FG001|Overall Study|Adverse Event|3|||
37896485|NCT00781456|69581573|FG000|Overall Study|Withdrawal by Subject|3|||
37896486|NCT00781456|69581574|FG001|Overall Study|Withdrawal by Subject|5|||
37896487|NCT00781456|69581573|FG000|Overall Study|Protocol Violation|4|||
37896488|NCT00781456|69581574|FG001|Overall Study|Protocol Violation|1|||
37896489|NCT00781456|69581573|FG000|Overall Study|Noncompliance With Protocol|1|||
37896490|NCT00781456|69581574|FG001|Overall Study|Noncompliance With Protocol|1|||
37896491|NCT00781456|69581573|FG000|Overall Study|Lost to Follow-up|10|||
37896492|NCT00781456|69581574|FG001|Overall Study|Lost to Follow-up|5|||
37896493|NCT00781456|69581573|FG000|Overall Study|Other Reason, Unknown|0|||
37896494|NCT00781456|69581574|FG001|Overall Study|Other Reason, Unknown|1|||
37896495|NCT00587158|69581582|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
37896496|NCT00587158|69581583|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
37896497|NCT00587158|69581582|FG000|Overall Study|Physician Decision|0|||
37896498|NCT00587158|69581583|FG001|Overall Study|Physician Decision|1|||
37896499|NCT00587158|69581582|FG000|Overall Study|Lost to Follow-up|1|||
37896500|NCT00587158|69581583|FG001|Overall Study|Lost to Follow-up|2|||
37896501|NCT00587158|69581582|FG000|Overall Study|Death|0|||
37896502|NCT00587158|69581583|FG001|Overall Study|Death|1|||
37896503|NCT00587158|69581582|FG000|Overall Study|Subject did not want to take study med|0|||
37896504|NCT00587158|69581583|FG001|Overall Study|Subject did not want to take study med|1|||
37896505|NCT00582907|69581589|FG000|1st Course|Withdrawal by Subject|1|||
37896506|NCT00582907|69581590|FG001|1st Course|Withdrawal by Subject|0|||
37896507|NCT00582907|69581591|FG002|1st Course|Withdrawal by Subject|0|||
37994324|NCT00321620|69679123|FG001|Overall Study|Death|294|||
37896508|NCT00582907|69581592|FG003|1st Course|Withdrawal by Subject|0|||
37896509|NCT00582907|69581589|FG000|1st Course|Lost to Follow-up|0|||
37896510|NCT00582907|69581590|FG001|1st Course|Lost to Follow-up|0|||
37825495|NCT01243762|69507541|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
37825496|NCT01243762|69507542|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
37896511|NCT00582907|69581591|FG002|1st Course|Lost to Follow-up|0|||
37896512|NCT00582907|69581592|FG003|1st Course|Lost to Follow-up|1|||
37896513|NCT00582907|69581589|FG000|2nd Course|Lack of Efficacy|1|||
37994325|NCT00321620|69679122|FG000|Overall Study|Withdrawal by Subject|164|||
37994326|NCT00321620|69679123|FG001|Overall Study|Withdrawal by Subject|147|||
37994327|NCT00321620|69679122|FG000|Overall Study|Disease progression|113|||
37994328|NCT00321620|69679123|FG001|Overall Study|Disease progression|117|||
37994329|NCT00321620|69679122|FG000|Overall Study|Adverse Event|43|||
37994330|NCT00321620|69679123|FG001|Overall Study|Adverse Event|56|||
37994331|NCT00321620|69679122|FG000|Overall Study|Lost to Follow-up|13|||
37994332|NCT00321620|69679123|FG001|Overall Study|Lost to Follow-up|9|||
37994333|NCT00321620|69679122|FG000|Overall Study|Physician Decision|4|||
37994334|NCT00321620|69679123|FG001|Overall Study|Physician Decision|1|||
37994335|NCT00321620|69679122|FG000|Overall Study|Noncompliance|14|||
37994336|NCT00321620|69679123|FG001|Overall Study|Noncompliance|7|||
37994337|NCT00321620|69679122|FG000|Overall Study|Protocol deviation|4|||
37994338|NCT00321620|69679123|FG001|Overall Study|Protocol deviation|3|||
37994339|NCT00321620|69679122|FG000|Overall Study|Ineligibility determined|2|||
37994340|NCT00321620|69679123|FG001|Overall Study|Ineligibility determined|3|||
37994341|NCT00321620|69679122|FG000|Overall Study|Participant request|75|||
37994342|NCT00321620|69679123|FG001|Overall Study|Participant request|52|||
37994343|NCT00321620|69679122|FG000|Overall Study|Other|42|||
37994344|NCT00321620|69679123|FG001|Overall Study|Other|33|||
37994345|NCT00304278|69679129|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
37994346|NCT00304278|69679129|FG000|Overall Study|PT had medical condition preventing TX|1|||
37994347|NCT00291018|69679136|FG000|Overall Study|Not Consented or Declined PAS|12|||
37994348|NCT00291018|69679137|FG001|Overall Study|Not Consented or Declined PAS|15|||
37994349|NCT00291018|69679138|FG002|Overall Study|Not Consented or Declined PAS|15|||
37994350|NCT00291018|69679136|FG000|Overall Study|Death|3|||
37994351|NCT00291018|69679137|FG001|Overall Study|Death|3|||
37994352|NCT00291018|69679138|FG002|Overall Study|Death|4|||
37994353|NCT00291018|69679136|FG000|Overall Study|Withdrawal by Subject|2|||
37994354|NCT00291018|69679137|FG001|Overall Study|Withdrawal by Subject|8|||
37994355|NCT00291018|69679138|FG002|Overall Study|Withdrawal by Subject|1|||
37994356|NCT00291018|69679136|FG000|Overall Study|Failures|5|||
37994357|NCT00291018|69679137|FG001|Overall Study|Failures|12|||
37994358|NCT00291018|69679138|FG002|Overall Study|Failures|5|||
37994359|NCT00291018|69679136|FG000|Overall Study|Lost to Follow-up|3|||
37994360|NCT00291018|69679137|FG001|Overall Study|Lost to Follow-up|4|||
37994361|NCT00291018|69679138|FG002|Overall Study|Lost to Follow-up|18|||
37994362|NCT00320606|69679149|FG000|Overall Study|Adverse Event|1|||
37994363|NCT00320606|69679149|FG000|Overall Study|Protocol Violation|1|||
37994364|NCT00320606|69679149|FG000|Overall Study|Withdrawal by Subject|1|||
37994365|NCT00307736|69679154|FG000|Overall Study|Adverse Event|0|||
37994366|NCT00307736|69679155|FG001|Overall Study|Adverse Event|0|||
37994367|NCT00307736|69679156|FG002|Overall Study|Adverse Event|1|||
37994368|NCT00307736|69679157|FG003|Overall Study|Adverse Event|3|||
37994369|NCT00307736|69679154|FG000|Overall Study|Withdrawal by Subject|0|||
37994370|NCT00307736|69679155|FG001|Overall Study|Withdrawal by Subject|0|||
37994371|NCT00307736|69679156|FG002|Overall Study|Withdrawal by Subject|2|||
37994372|NCT00307736|69679157|FG003|Overall Study|Withdrawal by Subject|0|||
37994373|NCT00320528|69679171|FG000|Study Period II|Adverse Event|3|||
37994374|NCT00320528|69679172|FG001|Study Period II|Adverse Event|4|||
37994375|NCT00320528|69679173|FG002|Study Period II|Adverse Event|8|||
37994376|NCT00320528|69679171|FG000|Study Period II|Parent/Caregiver Decision|8|||
37994377|NCT00320528|69679172|FG001|Study Period II|Parent/Caregiver Decision|3|||
37994378|NCT00320528|69679173|FG002|Study Period II|Parent/Caregiver Decision|11|||
37994379|NCT00320528|69679171|FG000|Study Period II|Withdrawal by Subject|0|||
37825497|NCT01243762|69507543|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
37825498|NCT01243762|69507544|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
37825499|NCT01243762|69507545|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
37825500|NCT01243762|69507546|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
37825501|NCT01243762|69507547|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
37825502|NCT01243762|69507541|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
37825503|NCT01243762|69507542|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
37825504|NCT01243762|69507543|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
37825505|NCT01243762|69507544|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
37825506|NCT01243762|69507545|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
37825507|NCT01243762|69507546|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
37825508|NCT01243762|69507547|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
37825509|NCT01243762|69507541|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
37825510|NCT01243762|69507542|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
37994380|NCT00320528|69679172|FG001|Study Period II|Withdrawal by Subject|1|||
37994381|NCT00320528|69679173|FG002|Study Period II|Withdrawal by Subject|1|||
37994382|NCT00320528|69679171|FG000|Study Period II|Entry Criteria Exclusion|0|||
37994383|NCT00320528|69679172|FG001|Study Period II|Entry Criteria Exclusion|2|||
37994384|NCT00320528|69679173|FG002|Study Period II|Entry Criteria Exclusion|2|||
37994385|NCT00320528|69679171|FG000|Study Period III|Adverse Event|1|||
37994386|NCT00320528|69679172|FG001|Study Period III|Adverse Event|0|||
37994387|NCT00320528|69679173|FG002|Study Period III|Adverse Event|0|||
37994388|NCT00320528|69679171|FG000|Study Period III|Lost to Follow-up|1|||
37994389|NCT00320528|69679172|FG001|Study Period III|Lost to Follow-up|0|||
37825511|NCT01243762|69507543|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
37825512|NCT01243762|69507544|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
37825513|NCT01243762|69507545|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
37825514|NCT01243762|69507546|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
37825515|NCT01243762|69507547|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
37825516|NCT01243762|69507541|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
37825517|NCT01243762|69507542|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
37825518|NCT01243762|69507543|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
37825519|NCT01243762|69507544|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
37825520|NCT01243762|69507545|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
37825521|NCT01243762|69507546|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
37825522|NCT01243762|69507547|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
37825523|NCT01243762|69507541|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
37825524|NCT01243762|69507542|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
37825525|NCT01243762|69507543|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
37825526|NCT01243762|69507544|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
37825527|NCT01243762|69507545|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
37825528|NCT01243762|69507546|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
37825529|NCT01243762|69507547|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
37825530|NCT01243411|69507566|FG000|Overall Study|Withdrawal by Subject|18|||
37825531|NCT01243411|69507566|FG000|Overall Study|Lost to Follow-up|10|||
37825532|NCT01243411|69507566|FG000|Overall Study|Adverse Event|5|||
37825533|NCT01243411|69507566|FG000|Overall Study|Other|8|||
37825534|NCT01243177|69507572|FG000|Overall Study|Lack of Efficacy|47|||
37825535|NCT01243177|69507573|FG001|Overall Study|Lack of Efficacy|31|||
37825536|NCT01243177|69507572|FG000|Overall Study|Protocol Violation|11|||
37825537|NCT01243177|69507573|FG001|Overall Study|Protocol Violation|10|||
37825538|NCT01243177|69507572|FG000|Overall Study|Lost to Follow-up|15|||
37825539|NCT01243177|69507573|FG001|Overall Study|Lost to Follow-up|18|||
37896514|NCT00582907|69581590|FG001|2nd Course|Lack of Efficacy|0|||
37896515|NCT00582907|69581591|FG002|2nd Course|Lack of Efficacy|0|||
37896516|NCT00582907|69581592|FG003|2nd Course|Lack of Efficacy|0|||
37896517|NCT01062113|69581601|FG000|Overall Study|Adverse Event|1|||
37896518|NCT01062113|69581602|FG001|Overall Study|Adverse Event|0|||
37896519|NCT01062113|69581603|FG002|Overall Study|Adverse Event|0|||
37896520|NCT01062113|69581601|FG000|Overall Study|Lack of Efficacy|38|||
37896521|NCT01062113|69581602|FG001|Overall Study|Lack of Efficacy|22|||
37896522|NCT01062113|69581603|FG002|Overall Study|Lack of Efficacy|31|||
37896523|NCT01062113|69581601|FG000|Overall Study|Withdrawal by Subject|1|||
37896524|NCT01062113|69581602|FG001|Overall Study|Withdrawal by Subject|0|||
37896525|NCT01062113|69581603|FG002|Overall Study|Withdrawal by Subject|0|||
37896526|NCT00772330|69581611|FG000|Overall Study|Lost to Follow-up|3|||
37896527|NCT01038869|69581618|FG000|Overall Study|Withdrawal by Subject|1|||
37896528|NCT01038869|69581618|FG000|Overall Study|Lost to Follow-up|6|||
37896529|NCT01038713|69581629|FG000|Overall Study|Patient to hospice|1|||
37896530|NCT01038713|69581630|FG001|Overall Study|Patient to hospice|1|||
37896531|NCT01038713|69581631|FG002|Overall Study|Patient to hospice|1|||
37896532|NCT01038713|69581629|FG000|Overall Study|Lost to Follow-up|3|||
37896533|NCT01038713|69581630|FG001|Overall Study|Lost to Follow-up|0|||
37896534|NCT01038713|69581631|FG002|Overall Study|Lost to Follow-up|0|||
37896535|NCT01038713|69581629|FG000|Overall Study|Neuroendocrine Tumor|0|||
37896536|NCT01038713|69581630|FG001|Overall Study|Neuroendocrine Tumor|1|||
37896537|NCT01038713|69581631|FG002|Overall Study|Neuroendocrine Tumor|0|||
37896538|NCT01038713|69581629|FG000|Overall Study|died from PEP|0|||
37896539|NCT01038713|69581630|FG001|Overall Study|died from PEP|1|||
37896540|NCT01038713|69581631|FG002|Overall Study|died from PEP|0|||
37896541|NCT01038713|69581629|FG000|Overall Study|Autoimmune Pancreatitis|1|||
37896542|NCT01038713|69581630|FG001|Overall Study|Autoimmune Pancreatitis|0|||
37896543|NCT01038713|69581631|FG002|Overall Study|Autoimmune Pancreatitis|0|||
37896544|NCT00768040|69581641|FG000|Overall Study|Adverse Event|3|||
37896545|NCT00768040|69581642|FG001|Overall Study|Adverse Event|2|||
37896546|NCT00768040|69581641|FG000|Overall Study|Abnormal laboratory value|1|||
37896547|NCT00768040|69581642|FG001|Overall Study|Abnormal laboratory value|1|||
37896548|NCT00767806|69581650|FG000|Overall Study|Adverse Event|30|||
37896549|NCT00767806|69581651|FG001|Overall Study|Adverse Event|11|||
37896550|NCT00767806|69581650|FG000|Overall Study|Withdrawal by Subject|8|||
37896551|NCT00767806|69581651|FG001|Overall Study|Withdrawal by Subject|13|||
37825540|NCT01243177|69507572|FG000|Overall Study|Withdrawal by Subject|46|||
37825541|NCT01243177|69507573|FG001|Overall Study|Withdrawal by Subject|38|||
37825542|NCT01243177|69507572|FG000|Overall Study|AE, serious fatal|0|||
37896552|NCT00767806|69581650|FG000|Overall Study|Protocol Violation|6|||
37896553|NCT00767806|69581651|FG001|Overall Study|Protocol Violation|5|||
37896554|NCT00767806|69581650|FG000|Overall Study|Lack of Efficacy|1|||
37994390|NCT00320528|69679173|FG002|Study Period III|Lost to Follow-up|0|||
37994391|NCT00320528|69679171|FG000|Study Period III|Withdrawal by Subject|1|||
37994392|NCT00320528|69679172|FG001|Study Period III|Withdrawal by Subject|1|||
37994393|NCT00320528|69679173|FG002|Study Period III|Withdrawal by Subject|2|||
37994394|NCT00320528|69679171|FG000|Study Period III|Lack of Efficacy|2|||
37994395|NCT00320528|69679172|FG001|Study Period III|Lack of Efficacy|0|||
37994396|NCT00320528|69679173|FG002|Study Period III|Lack of Efficacy|0|||
37994397|NCT00320528|69679171|FG000|Study Period III|Parent/Caregiver Decision|14|||
37994398|NCT00320528|69679172|FG001|Study Period III|Parent/Caregiver Decision|3|||
37994399|NCT00320528|69679173|FG002|Study Period III|Parent/Caregiver Decision|11|||
37994400|NCT00320528|69679171|FG000|Study Period III|Protocol Violation|0|||
37994401|NCT00320528|69679172|FG001|Study Period III|Protocol Violation|1|||
37994402|NCT00320528|69679173|FG002|Study Period III|Protocol Violation|0|||
37994403|NCT00320528|69679171|FG000|Study Period III|Physician Decision|0|||
37994404|NCT00320528|69679172|FG001|Study Period III|Physician Decision|1|||
37994405|NCT00320528|69679173|FG002|Study Period III|Physician Decision|2|||
37994406|NCT00320528|69679171|FG000|Study Period III|Sponsor Decision|0|||
37994407|NCT00320528|69679172|FG001|Study Period III|Sponsor Decision|0|||
37994408|NCT00320528|69679173|FG002|Study Period III|Sponsor Decision|1|||
37994409|NCT00320528|69679171|FG000|Study Period III|Atomoxetine Commercially Available|68|||
37994410|NCT00320528|69679172|FG001|Study Period III|Atomoxetine Commercially Available|25|||
37994411|NCT00320528|69679173|FG002|Study Period III|Atomoxetine Commercially Available|90|||
37994412|NCT00320372|69679184|FG000|Overall Study|Physician Decision|4|||
37994413|NCT00320372|69679185|FG001|Overall Study|Physician Decision|7|||
37994414|NCT00320372|69679184|FG000|Overall Study|Death|7|||
37994415|NCT00320372|69679185|FG001|Overall Study|Death|8|||
37994416|NCT00320372|69679184|FG000|Overall Study|Withdrawal by Subject|55|||
37994417|NCT00320372|69679185|FG001|Overall Study|Withdrawal by Subject|37|||
37994418|NCT00320372|69679184|FG000|Overall Study|Non-Compliance|40|||
37994419|NCT00320372|69679185|FG001|Overall Study|Non-Compliance|39|||
37994420|NCT00320372|69679184|FG000|Overall Study|Did not Meet (I/E)|3|||
37994421|NCT00320372|69679185|FG001|Overall Study|Did not Meet (I/E)|1|||
37994422|NCT00320372|69679184|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
37994423|NCT00320372|69679185|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
37994424|NCT00294762|69679201|FG000|Overall Study|Did not receive study treatment|3|||
37994425|NCT00294762|69679202|FG001|Overall Study|Did not receive study treatment|3|||
37994426|NCT00294684|69679210|FG000|Overall Study|Lost to Follow-up|5|||
37994427|NCT00294684|69679211|FG001|Overall Study|Lost to Follow-up|8|||
37994428|NCT00307034|69679219|FG000|Overall Study|Adverse Event|1|||
37994429|NCT00307034|69679220|FG001|Overall Study|Adverse Event|2|||
37994430|NCT00307034|69679219|FG000|Overall Study|Withdrawal by Subject|1|||
37994431|NCT00307034|69679220|FG001|Overall Study|Withdrawal by Subject|2|||
37994432|NCT00307034|69679219|FG000|Overall Study|Lost to Follow-up|0|||
37994433|NCT00307034|69679220|FG001|Overall Study|Lost to Follow-up|3|||
37994434|NCT00320216|69679231|FG000|Overall Study|Adverse Event|0|||
37994435|NCT00320216|69679232|FG001|Overall Study|Adverse Event|6|||
37994436|NCT00320216|69679233|FG002|Overall Study|Adverse Event|0|||
37696330|NCT02325518|69172437|FG000|Overall Study|Physician Decision|0|||
37696331|NCT02325518|69172438|FG001|Overall Study|Physician Decision|1|||
37696332|NCT02325518|69172437|FG000|Overall Study|Withdrawal by Subject|0|||
37696333|NCT02325518|69172438|FG001|Overall Study|Withdrawal by Subject|1|||
37696334|NCT02270983|69172448|FG000|Overall Study|Adverse Event|3|||
37696335|NCT02270983|69172449|FG001|Overall Study|Adverse Event|2|||
37696336|NCT02270983|69172450|FG002|Overall Study|Adverse Event|6|||
37696337|NCT02270983|69172448|FG000|Overall Study|Lack of Efficacy|2|||
37825543|NCT01243177|69507573|FG001|Overall Study|AE, serious fatal|1|||
37825544|NCT01243177|69507572|FG000|Overall Study|SAE, non-fatal|7|||
37825545|NCT01243177|69507573|FG001|Overall Study|SAE, non-fatal|9|||
37825546|NCT01243177|69507572|FG000|Overall Study|AE, non-serious non-fatal|40|||
37825547|NCT01243177|69507573|FG001|Overall Study|AE, non-serious non-fatal|58|||
37825548|NCT01243177|69507572|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
37825549|NCT01243177|69507573|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
37825550|NCT01243177|69507572|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
37825551|NCT01243177|69507573|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
37825552|NCT01243177|69507572|FG000|Overall Study|Other Reason|11|||
37825553|NCT01243177|69507573|FG001|Overall Study|Other Reason|12|||
37994437|NCT00320216|69679234|FG003|Overall Study|Adverse Event|2|||
37994438|NCT00320216|69679235|FG004|Overall Study|Adverse Event|2|||
37994439|NCT00320216|69679231|FG000|Overall Study|Lack of Efficacy|6|||
37994440|NCT00320216|69679232|FG001|Overall Study|Lack of Efficacy|2|||
37994441|NCT00320216|69679233|FG002|Overall Study|Lack of Efficacy|1|||
37994442|NCT00320216|69679234|FG003|Overall Study|Lack of Efficacy|0|||
37994443|NCT00320216|69679235|FG004|Overall Study|Lack of Efficacy|1|||
37994444|NCT00320216|69679231|FG000|Overall Study|Lost to Follow-up|3|||
37696338|NCT02270983|69172449|FG001|Overall Study|Lack of Efficacy|1|||
37994445|NCT00320216|69679232|FG001|Overall Study|Lost to Follow-up|0|||
37994446|NCT00320216|69679233|FG002|Overall Study|Lost to Follow-up|0|||
37994447|NCT00320216|69679234|FG003|Overall Study|Lost to Follow-up|0|||
37994448|NCT00320216|69679235|FG004|Overall Study|Lost to Follow-up|0|||
37994449|NCT00320216|69679231|FG000|Overall Study|Other|7|||
37994450|NCT00320216|69679232|FG001|Overall Study|Other|2|||
37994451|NCT00320216|69679233|FG002|Overall Study|Other|5|||
37994452|NCT00320216|69679234|FG003|Overall Study|Other|1|||
37994453|NCT00320216|69679235|FG004|Overall Study|Other|3|||
37994454|NCT00290706|69679256|FG000|Overall Study|Withdrawal by Subject|2|||
37994455|NCT00290706|69679257|FG001|Overall Study|Withdrawal by Subject|0|||
37994456|NCT00290706|69679258|FG002|Overall Study|Withdrawal by Subject|0|||
37994457|NCT00290706|69679259|FG003|Overall Study|Withdrawal by Subject|0|||
37994458|NCT00290706|69679256|FG000|Overall Study|Progressive Disease|3|||
37994459|NCT00290706|69679257|FG001|Overall Study|Progressive Disease|5|||
37994460|NCT00290706|69679258|FG002|Overall Study|Progressive Disease|4|||
37994461|NCT00290706|69679259|FG003|Overall Study|Progressive Disease|10|||
37994462|NCT00290706|69679256|FG000|Overall Study|Adverse Event|0|||
37994463|NCT00290706|69679257|FG001|Overall Study|Adverse Event|1|||
37994464|NCT00290706|69679258|FG002|Overall Study|Adverse Event|2|||
37994465|NCT00290706|69679259|FG003|Overall Study|Adverse Event|0|||
37994466|NCT00290706|69679256|FG000|Overall Study|Receive auto transplant or radiation|0|||
37994467|NCT00290706|69679257|FG001|Overall Study|Receive auto transplant or radiation|0|||
37994468|NCT00290706|69679258|FG002|Overall Study|Receive auto transplant or radiation|0|||
37994469|NCT00290706|69679259|FG003|Overall Study|Receive auto transplant or radiation|1|||
37994470|NCT00290706|69679256|FG000|Overall Study|Physician Decision|0|||
37994471|NCT00290706|69679257|FG001|Overall Study|Physician Decision|0|||
37994472|NCT00290706|69679258|FG002|Overall Study|Physician Decision|0|||
37994473|NCT00290706|69679259|FG003|Overall Study|Physician Decision|1|||
37994474|NCT00303186|69679270|FG000|Overall Study|Other|52|||
37994475|NCT00294060|69679274|FG000|Overall Study|Death|225|||
37896555|NCT00767806|69581651|FG001|Overall Study|Lack of Efficacy|9|||
37896556|NCT00767806|69581650|FG000|Overall Study|Physician Decision|4|||
37994476|NCT00294060|69679274|FG000|Overall Study|Other|59|||
37994477|NCT00294060|69679274|FG000|Overall Study|Lost to Follow-up|55|||
37994478|NCT00294060|69679274|FG000|Overall Study|Withdrawal by Subject|11|||
37896557|NCT00767806|69581651|FG001|Overall Study|Physician Decision|3|||
37896558|NCT00767806|69581650|FG000|Overall Study|Lost to Follow-up|1|||
37896559|NCT00767806|69581651|FG001|Overall Study|Lost to Follow-up|4|||
37896560|NCT00767806|69581650|FG000|Overall Study|Entry Criteria Not Met|1|||
37896561|NCT00767806|69581651|FG001|Overall Study|Entry Criteria Not Met|1|||
37896562|NCT00767806|69581650|FG000|Overall Study|Sponsor Decision|0|||
37896563|NCT00767806|69581651|FG001|Overall Study|Sponsor Decision|1|||
37896564|NCT00780910|69581657|FG000|Overall Study|Adverse Event|2|||
37896565|NCT00767104|69581663|FG000|Overall Study|Lost to Follow-up|1|||
37896566|NCT00767104|69581664|FG001|Overall Study|Lost to Follow-up|2|||
37896567|NCT00771472|69581672|FG000|Overall Study|Physician Decision|2|||
37896568|NCT00771472|69581673|FG001|Overall Study|Physician Decision|3|||
37896569|NCT00771472|69581672|FG000|Overall Study|Progressive Disease|3|||
37896570|NCT00771472|69581673|FG001|Overall Study|Progressive Disease|1|||
37896571|NCT00771472|69581672|FG000|Overall Study|Protocol Violation|1|||
37896572|NCT00771472|69581673|FG001|Overall Study|Protocol Violation|0|||
37896573|NCT00771316|69581680|FG000|Overall Study|Adverse Event|0|||
37896574|NCT00771316|69581681|FG001|Overall Study|Adverse Event|1|||
37896575|NCT00771316|69581680|FG000|Overall Study|Patient withdrew consent|1|||
37896576|NCT00771316|69581681|FG001|Overall Study|Patient withdrew consent|0|||
37896577|NCT00771316|69581680|FG000|Overall Study|Discontinued due to early termination|1|||
37896578|NCT00771316|69581681|FG001|Overall Study|Discontinued due to early termination|0|||
37896579|NCT00770770|69581689|FG000|Overall Study|Lost to Follow-up|1|||
37896580|NCT00770770|69581690|FG001|Overall Study|Lost to Follow-up|0|||
37896581|NCT00770770|69581689|FG000|Overall Study|Withdrawal by Subject|1|||
37896582|NCT00770770|69581690|FG001|Overall Study|Withdrawal by Subject|0|||
37896583|NCT00770770|69581689|FG000|Overall Study|Death|0|||
37896584|NCT00770770|69581690|FG001|Overall Study|Death|1|||
37896585|NCT00770770|69581689|FG000|Overall Study|Study Terminated|8|||
37896586|NCT00770770|69581690|FG001|Overall Study|Study Terminated|0|||
37994479|NCT00294060|69679274|FG000|Overall Study|Physician Decision|797|||
37994480|NCT00294060|69679274|FG000|Overall Study|Medical condition|3|||
37994481|NCT00294060|69679274|FG000|Overall Study|Device explanted/not replaced|23|||
37994482|NCT00303108|69679281|FG000|Overall Study|Adverse Event|5|||
37994483|NCT00303108|69679282|FG001|Overall Study|Adverse Event|6|||
37896587|NCT00766636|69581698|FG000|Overall Study|Withdrawal by Subject|1|||
37896588|NCT00766636|69581699|FG001|Overall Study|Withdrawal by Subject|1|||
37896589|NCT00766636|69581698|FG000|Overall Study|Incomplete Treatment|0|||
37896590|NCT00766636|69581699|FG001|Overall Study|Incomplete Treatment|1|||
37896591|NCT00766636|69581698|FG000|Overall Study|Adverse Event|1|||
37994484|NCT00303108|69679283|FG002|Overall Study|Adverse Event|7|||
37994485|NCT00303108|69679281|FG000|Overall Study|Patient Request|4|||
37994486|NCT00303108|69679282|FG001|Overall Study|Patient Request|2|||
37994487|NCT00303108|69679283|FG002|Overall Study|Patient Request|8|||
37994488|NCT00303108|69679281|FG000|Overall Study|Failed Entry|1|||
37994489|NCT00303108|69679282|FG001|Overall Study|Failed Entry|0|||
37994490|NCT00303108|69679283|FG002|Overall Study|Failed Entry|1|||
37994491|NCT00303108|69679281|FG000|Overall Study|ineligible|2|||
37994492|NCT00303108|69679282|FG001|Overall Study|ineligible|1|||
37994493|NCT00303108|69679283|FG002|Overall Study|ineligible|0|||
37994494|NCT00302952|69679292|FG000|Overall Study|Physician Decision|1|||
37994495|NCT00302952|69679293|FG001|Overall Study|Physician Decision|1|||
37994496|NCT00302952|69679292|FG000|Overall Study|Withdrawal by Subject|2|||
37994497|NCT00302952|69679293|FG001|Overall Study|Withdrawal by Subject|3|||
37994498|NCT00302952|69679292|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
37994499|NCT00302952|69679293|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
37994500|NCT00302718|69679303|FG000|Overall Study|Participant left the hospital|1|||
37994501|NCT00302718|69679304|FG001|Overall Study|Participant left the hospital|0|||
37994502|NCT00302718|69679305|FG002|Overall Study|Participant left the hospital|0|||
37994503|NCT00302718|69679306|FG003|Overall Study|Participant left the hospital|1|||
37994504|NCT00302718|69679303|FG000|Overall Study|Withdrawal by Subject|0|||
37994505|NCT00302718|69679304|FG001|Overall Study|Withdrawal by Subject|1|||
37994506|NCT00302718|69679305|FG002|Overall Study|Withdrawal by Subject|0|||
37994507|NCT00302718|69679306|FG003|Overall Study|Withdrawal by Subject|0|||
37994508|NCT00302718|69679303|FG000|Overall Study|Participant left primary care setting|0|||
37994509|NCT00302718|69679304|FG001|Overall Study|Participant left primary care setting|0|||
37994510|NCT00302718|69679305|FG002|Overall Study|Participant left primary care setting|2|||
37994511|NCT00302718|69679306|FG003|Overall Study|Participant left primary care setting|1|||
37994512|NCT00302328|69679324|FG000|Overall Study|Physician Decision|0|||
37994513|NCT00302328|69679325|FG001|Overall Study|Physician Decision|1|||
37994514|NCT00302328|69679326|FG002|Overall Study|Physician Decision|0|||
37994515|NCT00301080|69679337|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
37994516|NCT00301080|69679338|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
37994517|NCT00301080|69679339|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
37994518|NCT00301080|69679340|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
37994519|NCT00301080|69679341|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
37994520|NCT00290238|69679352|FG000|Overall Study|Study terminated|27|||
37994521|NCT00290238|69679353|FG001|Overall Study|Study terminated|27|||
37994522|NCT00290238|69679352|FG000|Overall Study|Lost to Follow-up|0|||
37994523|NCT00290238|69679353|FG001|Overall Study|Lost to Follow-up|1|||
37994524|NCT00290238|69679352|FG000|Overall Study|Withdrawal by Subject|15|||
37994525|NCT00290238|69679353|FG001|Overall Study|Withdrawal by Subject|13|||
37994526|NCT00289848|69679361|FG000|Overall Study|Adverse Event|6|||
37994527|NCT00289848|69679362|FG001|Overall Study|Adverse Event|4|||
37994528|NCT00289848|69679361|FG000|Overall Study|Death|1|||
37994529|NCT00289848|69679362|FG001|Overall Study|Death|0|||
37994530|NCT00289848|69679361|FG000|Overall Study|Lack of Efficacy|20|||
37994531|NCT00289848|69679362|FG001|Overall Study|Lack of Efficacy|24|||
37994532|NCT00289848|69679361|FG000|Overall Study|Lost to Follow-up|3|||
37994533|NCT00289848|69679362|FG001|Overall Study|Lost to Follow-up|1|||
37994534|NCT00289848|69679361|FG000|Overall Study|Protocol Violation|5|||
37994535|NCT00289848|69679362|FG001|Overall Study|Protocol Violation|2|||
37994536|NCT00289848|69679361|FG000|Overall Study|Withdrawal by Subject|5|||
37994537|NCT00289848|69679362|FG001|Overall Study|Withdrawal by Subject|11|||
37994538|NCT00289848|69679361|FG000|Overall Study|Patient Moved|6|||
37994539|NCT00289848|69679362|FG001|Overall Study|Patient Moved|2|||
37994540|NCT00289848|69679361|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
37994541|NCT00289848|69679362|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
37994542|NCT00289770|69679368|FG000|Year 15|Withdrawal by Subject|1|||
37994543|NCT00289536|69679372|FG000|Period 3|Lost to Follow-up|0|||
37994544|NCT00289536|69679373|FG001|Period 3|Lost to Follow-up|0|||
37994545|NCT00289536|69679374|FG002|Period 3|Lost to Follow-up|1|||
37994546|NCT00289458|69679383|FG000|Overall Study|Death|1|||
37994547|NCT00289458|69679384|FG001|Overall Study|Death|0|||
37994548|NCT00289458|69679385|FG002|Overall Study|Death|0|||
37994549|NCT00289458|69679383|FG000|Overall Study|Physician Decision|3|||
37994550|NCT00289458|69679384|FG001|Overall Study|Physician Decision|4|||
37994551|NCT00289458|69679385|FG002|Overall Study|Physician Decision|2|||
37994552|NCT00289458|69679383|FG000|Overall Study|Withdrawal by Subject|2|||
37994553|NCT00289458|69679384|FG001|Overall Study|Withdrawal by Subject|2|||
37994554|NCT00289458|69679385|FG002|Overall Study|Withdrawal by Subject|4|||
37994555|NCT00288912|69679396|FG000|Overall Study|Developed exclusion criterion|4|||
37994556|NCT00288912|69679397|FG001|Overall Study|Developed exclusion criterion|6|||
37994557|NCT00288912|69679398|FG002|Overall Study|Developed exclusion criterion|7|||
37994558|NCT00288912|69679396|FG000|Overall Study|Lost to Follow-up|9|||
37994559|NCT00288912|69679397|FG001|Overall Study|Lost to Follow-up|6|||
37994560|NCT00288912|69679398|FG002|Overall Study|Lost to Follow-up|9|||
37994561|NCT00288912|69679396|FG000|Overall Study|Withdrawal by Subject|4|||
37994562|NCT00288912|69679397|FG001|Overall Study|Withdrawal by Subject|5|||
37994563|NCT00288912|69679398|FG002|Overall Study|Withdrawal by Subject|12|||
37994564|NCT00305864|69679410|FG000|Overall Study|Ineligible / No protocol treatment|0|||
37994565|NCT00305864|69679411|FG001|Overall Study|Ineligible / No protocol treatment|1|||
37994566|NCT00305864|69679412|FG002|Overall Study|Ineligible / No protocol treatment|1|||
37994567|NCT00305864|69679413|FG003|Overall Study|Ineligible / No protocol treatment|13|||
37994568|NCT00295880|69679423|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
37994569|NCT00295880|69679423|FG000|Overall Study|Unit randomization did not occur|1|||
37994570|NCT00319982|69679429|FG000|Overall Study|Withdrawal by Subject|1|||
37994571|NCT00319982|69679430|FG001|Overall Study|Withdrawal by Subject|0|||
37994572|NCT00319592|69679438|FG000|Overall Study|Protocol Violation|1|||
37994573|NCT00319592|69679439|FG001|Overall Study|Protocol Violation|0|||
37994574|NCT00319592|69679438|FG000|Overall Study|Physician Decision|0|||
37994575|NCT00319592|69679439|FG001|Overall Study|Physician Decision|1|||
37994576|NCT00295490|69679449|FG000|Overall Study|Protocol Violation|0|||
37994577|NCT00295490|69679450|FG001|Overall Study|Protocol Violation|0|||
37994578|NCT00295490|69679451|FG002|Overall Study|Protocol Violation|3|||
37994579|NCT00295490|69679452|FG003|Overall Study|Protocol Violation|3|||
37994580|NCT00295490|69679449|FG000|Overall Study|Withdrawal by Subject|0|||
37994581|NCT00295490|69679450|FG001|Overall Study|Withdrawal by Subject|2|||
37994582|NCT00295490|69679451|FG002|Overall Study|Withdrawal by Subject|0|||
37994583|NCT00295490|69679452|FG003|Overall Study|Withdrawal by Subject|1|||
37994584|NCT00295490|69679449|FG000|Overall Study|Lost to Follow-up|0|||
37994585|NCT00295490|69679450|FG001|Overall Study|Lost to Follow-up|0|||
37994586|NCT00295490|69679451|FG002|Overall Study|Lost to Follow-up|1|||
37994587|NCT00295490|69679452|FG003|Overall Study|Lost to Follow-up|0|||
37994588|NCT00295490|69679449|FG000|Overall Study|Adverse Event|1|||
37994589|NCT00295490|69679450|FG001|Overall Study|Adverse Event|0|||
37994590|NCT00295490|69679451|FG002|Overall Study|Adverse Event|0|||
37994591|NCT00295490|69679452|FG003|Overall Study|Adverse Event|0|||
37994592|NCT00295490|69679449|FG000|Overall Study|Other|0|||
37994593|NCT00295490|69679450|FG001|Overall Study|Other|2|||
37994594|NCT00295490|69679451|FG002|Overall Study|Other|0|||
37994595|NCT00295490|69679452|FG003|Overall Study|Other|1|||
37994596|NCT00305006|69679464|FG000|Overall Study|Withdrawal by Subject|1|||
37994597|NCT00305006|69679465|FG001|Overall Study|Withdrawal by Subject|0|||
37994598|NCT00305006|69679464|FG000|Overall Study|Failure to complete pretest|0|||
37994599|NCT00305006|69679465|FG001|Overall Study|Failure to complete pretest|1|||
37994600|NCT00319436|69679473|FG000|Overall Study|Withdrawal by Subject|6|||
37994601|NCT00319436|69679474|FG001|Overall Study|Withdrawal by Subject|7|||
37994602|NCT00319046|69679480|FG000|Overall Study|withdrawal of subject's consent|7|||
37994603|NCT00319046|69679480|FG000|Overall Study|administrative reason|1|||
37994604|NCT00303602|69679486|FG000|Overall Study|Adverse Event|2|||
37994605|NCT00303602|69679487|FG001|Overall Study|Adverse Event|2|||
37994606|NCT00303602|69679486|FG000|Overall Study|Withdrawal by Subject|5|||
37994607|NCT00303602|69679487|FG001|Overall Study|Withdrawal by Subject|6|||
37994608|NCT00303602|69679486|FG000|Overall Study|Lost to Follow-up|5|||
37994609|NCT00303602|69679487|FG001|Overall Study|Lost to Follow-up|2|||
37994610|NCT00303602|69679486|FG000|Overall Study|Protocol entry criteria not met|2|||
37994611|NCT00303602|69679487|FG001|Overall Study|Protocol entry criteria not met|2|||
37994612|NCT00303602|69679486|FG000|Overall Study|Physician Decision|2|||
37994613|NCT00303602|69679487|FG001|Overall Study|Physician Decision|1|||
37994614|NCT00303602|69679486|FG000|Overall Study|Noncompliance|2|||
37994615|NCT00303602|69679487|FG001|Overall Study|Noncompliance|2|||
37994616|NCT00303602|69679486|FG000|Overall Study|Protocol Violation|1|||
37994617|NCT00303602|69679487|FG001|Overall Study|Protocol Violation|0|||
37994618|NCT00299130|69679496|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
37994619|NCT00299130|69679497|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
37994620|NCT00299130|69679498|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
37994621|NCT00299130|69679496|FG000|Treatment Period (up to 5 Years)|Death|1|||
37994622|NCT00299130|69679497|FG001|Treatment Period (up to 5 Years)|Death|3|||
37994623|NCT00299130|69679498|FG002|Treatment Period (up to 5 Years)|Death|1|||
37994624|NCT00299130|69679496|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
37994625|NCT00299130|69679497|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
37994626|NCT00299130|69679498|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
37994627|NCT00299130|69679496|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
37994628|NCT00299130|69679497|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
37994629|NCT00299130|69679498|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
37994630|NCT00299130|69679496|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
37994631|NCT00299130|69679497|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
37994632|NCT00299130|69679498|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
37994633|NCT00299130|69679496|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
37994634|NCT00299130|69679497|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
37994635|NCT00299130|69679498|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
37994636|NCT00299130|69679496|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
37994637|NCT00299130|69679497|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
37994638|NCT00299130|69679498|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
37994639|NCT00299130|69679496|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
37994640|NCT00299130|69679497|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
37994641|NCT00299130|69679498|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
37994642|NCT00299130|69679496|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
37994643|NCT00299130|69679497|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
37994644|NCT00299130|69679498|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
37994645|NCT00299130|69679496|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
37994646|NCT00299130|69679497|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
37994647|NCT00299130|69679498|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
37994648|NCT00299130|69679496|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
37994649|NCT00299130|69679497|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
37994650|NCT00299130|69679498|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
37994651|NCT00299130|69679496|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
37994652|NCT00299130|69679497|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
37994653|NCT00299130|69679498|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
37994654|NCT00299130|69679496|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
37994655|NCT00299130|69679497|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
37994656|NCT00299130|69679498|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
37994657|NCT00299130|69679496|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
37994658|NCT00299130|69679497|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
37994659|NCT00299130|69679498|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
37994660|NCT00299130|69679496|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
37994661|NCT00299130|69679497|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
37994662|NCT00299130|69679498|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
37994663|NCT00299130|69679496|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
37994664|NCT00299130|69679497|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
37994665|NCT00299130|69679498|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
37994666|NCT00299130|69679496|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
37994667|NCT00299130|69679497|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
37994668|NCT00299130|69679498|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
37994669|NCT00288054|69679513|FG000|Overall Study|Protocol Violation|2|||
37994670|NCT00288054|69679513|FG000|Overall Study|Lack of Efficacy|16|||
37994671|NCT00288054|69679513|FG000|Overall Study|Adverse Event|3|||
37994672|NCT00288054|69679513|FG000|Overall Study|Withdrawal by Subject|1|||
37994673|NCT00288054|69679513|FG000|Overall Study|Not protocol specified|2|||
37994674|NCT00287586|69679521|FG000|Overall Study|Withdrew Consent|19|||
37994675|NCT00287586|69679522|FG001|Overall Study|Withdrew Consent|30|||
37994676|NCT00287586|69679521|FG000|Overall Study|Lost to Follow-up|5|||
37994677|NCT00287586|69679522|FG001|Overall Study|Lost to Follow-up|4|||
37994678|NCT00287586|69679521|FG000|Overall Study|Death|2|||
37994679|NCT00287586|69679522|FG001|Overall Study|Death|3|||
37994680|NCT00287586|69679521|FG000|Overall Study|Elevated Hematocrit|3|||
37994681|NCT00287586|69679522|FG001|Overall Study|Elevated Hematocrit|0|||
37994682|NCT00287586|69679521|FG000|Overall Study|Rash|3|||
37994683|NCT00287586|69679522|FG001|Overall Study|Rash|0|||
37994684|NCT00287586|69679521|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
37994685|NCT00287586|69679522|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
37994686|NCT00287586|69679521|FG000|Overall Study|Stroke|2|||
37696339|NCT02270983|69172450|FG002|Overall Study|Lack of Efficacy|1|||
37825554|NCT01242748|69507581|FG000|Overall Study|Adverse Event|10|||
37994687|NCT00287586|69679522|FG001|Overall Study|Stroke|0|||
37994688|NCT00287586|69679521|FG000|Overall Study|Myocardial Infarction|1|||
37994689|NCT00287586|69679522|FG001|Overall Study|Myocardial Infarction|0|||
37994690|NCT00287586|69679521|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
37994691|NCT00287586|69679522|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
37994692|NCT00287586|69679521|FG000|Overall Study|Cognitive Impairment|1|||
37994693|NCT00287586|69679522|FG001|Overall Study|Cognitive Impairment|0|||
37994694|NCT00287586|69679521|FG000|Overall Study|Pancreatic Cancer|1|||
37994695|NCT00287586|69679522|FG001|Overall Study|Pancreatic Cancer|3|||
37994696|NCT00287586|69679521|FG000|Overall Study|Sleep Apnea|1|||
37994697|NCT00287586|69679522|FG001|Overall Study|Sleep Apnea|0|||
37994698|NCT00287586|69679521|FG000|Overall Study|Shoulder Pain|1|||
37994699|NCT00287586|69679522|FG001|Overall Study|Shoulder Pain|0|||
37994700|NCT00287586|69679521|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
37994701|NCT00287586|69679522|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
37994702|NCT00287586|69679521|FG000|Overall Study|Nonadherence|1|||
37994703|NCT00287586|69679522|FG001|Overall Study|Nonadherence|1|||
37994704|NCT00287586|69679521|FG000|Overall Study|Enrolled in Another Study|1|||
37994705|NCT00287586|69679522|FG001|Overall Study|Enrolled in Another Study|0|||
37994706|NCT00287586|69679521|FG000|Overall Study|Major Depression|0|||
37994707|NCT00287586|69679522|FG001|Overall Study|Major Depression|2|||
37994708|NCT00287586|69679521|FG000|Overall Study|Lung Cancer|0|||
37994709|NCT00287586|69679522|FG001|Overall Study|Lung Cancer|2|||
37994710|NCT00287586|69679521|FG000|Overall Study|Elevated IPSS Score|0|||
37994711|NCT00287586|69679522|FG001|Overall Study|Elevated IPSS Score|1|||
37994712|NCT00287586|69679521|FG000|Overall Study|Retroperitoneal Cancer|0|||
37994713|NCT00287586|69679522|FG001|Overall Study|Retroperitoneal Cancer|1|||
37994714|NCT00287586|69679521|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
37994715|NCT00287586|69679522|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
37994716|NCT00287586|69679521|FG000|Overall Study|Mood Swings and Irritability|0|||
37994717|NCT00287586|69679522|FG001|Overall Study|Mood Swings and Irritability|1|||
37994718|NCT00287586|69679521|FG000|Overall Study|Bradycardia|0|||
37994719|NCT00287586|69679522|FG001|Overall Study|Bradycardia|1|||
37994720|NCT00287586|69679521|FG000|Overall Study|Itchy Swollen Eyes|0|||
37994721|NCT00287586|69679522|FG001|Overall Study|Itchy Swollen Eyes|1|||
37994722|NCT00287586|69679521|FG000|Overall Study|Recurrent Melanoma|0|||
37994723|NCT00287586|69679522|FG001|Overall Study|Recurrent Melanoma|1|||
37994724|NCT00287118|69679528|FG000|Overall Study|Adverse Event|30|||
37994725|NCT00287118|69679528|FG000|Overall Study|Death|1|||
37994726|NCT00287118|69679528|FG000|Overall Study|Lack of Efficacy|11|||
37994727|NCT00287118|69679528|FG000|Overall Study|Lost to Follow-up|1|||
37994728|NCT00287118|69679528|FG000|Overall Study|Protocol Violation|2|||
37994729|NCT00287118|69679528|FG000|Overall Study|Other|7|||
37994730|NCT00293202|69679534|FG000|Overall Study|Withdrawal by Subject|1|||
37994731|NCT00293202|69679535|FG001|Overall Study|Withdrawal by Subject|2|||
37994732|NCT00293202|69679534|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
37994733|NCT00293202|69679535|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
37994734|NCT00293202|69679534|FG000|Overall Study|on-hold due to fistula maturation time|1|||
37994735|NCT00293202|69679535|FG001|Overall Study|on-hold due to fistula maturation time|0|||
37994736|NCT00298896|69679545|FG000|Overall Study|Death|3|||
37994737|NCT00298896|69679545|FG000|Overall Study|Physician Decision|2|||
37994738|NCT00298896|69679545|FG000|Overall Study|Intercurrent Illness|1|||
37994739|NCT00298896|69679545|FG000|Overall Study|Disease Progression|41|||
37994740|NCT00298896|69679545|FG000|Overall Study|Withdrawal by Subject|2|||
37994741|NCT00298896|69679545|FG000|Overall Study|Assigned to treatment in error|1|||
37994742|NCT00286494|69679552|FG000|Overall Study|Hyperglycemic rescue|12|||
37994743|NCT00286494|69679553|FG001|Overall Study|Hyperglycemic rescue|19|||
37994744|NCT00286494|69679554|FG002|Overall Study|Hyperglycemic rescue|18|||
37994745|NCT00286494|69679552|FG000|Overall Study|Withdrawal by Subject|2|||
37994746|NCT00286494|69679553|FG001|Overall Study|Withdrawal by Subject|10|||
37994747|NCT00286494|69679554|FG002|Overall Study|Withdrawal by Subject|9|||
37994748|NCT00286494|69679552|FG000|Overall Study|Adverse Event|3|||
37994749|NCT00286494|69679553|FG001|Overall Study|Adverse Event|8|||
37994750|NCT00286494|69679554|FG002|Overall Study|Adverse Event|6|||
37825555|NCT01242748|69507582|FG001|Overall Study|Adverse Event|5|||
37994751|NCT00286494|69679552|FG000|Overall Study|Physician Decision|5|||
37994752|NCT00286494|69679553|FG001|Overall Study|Physician Decision|5|||
37994753|NCT00286494|69679554|FG002|Overall Study|Physician Decision|1|||
37994754|NCT00286494|69679552|FG000|Overall Study|Lost to Follow-up|3|||
37994755|NCT00286494|69679553|FG001|Overall Study|Lost to Follow-up|1|||
37994756|NCT00286494|69679554|FG002|Overall Study|Lost to Follow-up|3|||
37994757|NCT00286494|69679552|FG000|Overall Study|Protocol Violation|1|||
37994758|NCT00286494|69679553|FG001|Overall Study|Protocol Violation|1|||
37994759|NCT00286494|69679554|FG002|Overall Study|Protocol Violation|2|||
37994760|NCT00298740|69679562|FG000|Overall Study|Lack of Efficacy|6|||
37994761|NCT00298740|69679562|FG000|Overall Study|Withdrawal by Subject|3|||
37994762|NCT00285012|69679568|FG000|Assigned to Study Treatment (Tx)|Other|2|||
37994763|NCT00285012|69679569|FG001|Assigned to Study Treatment (Tx)|Other|3|||
37994764|NCT00285012|69679568|FG000|Received Study Tx|Death|2|||
37994765|NCT00285012|69679569|FG001|Received Study Tx|Death|1|||
37896592|NCT00766636|69581699|FG001|Overall Study|Adverse Event|0|||
37896593|NCT00766636|69581698|FG000|Overall Study|Disease Progression|1|||
37896594|NCT00766636|69581699|FG001|Overall Study|Disease Progression|0|||
37896595|NCT00770692|69581709|FG000|Overall Study|Withdrawal by Subject|7|||
37896596|NCT00770692|69581710|FG001|Overall Study|Withdrawal by Subject|9|||
37896597|NCT00770692|69581711|FG002|Overall Study|Withdrawal by Subject|9|||
37994766|NCT00285012|69679568|FG000|Received Study Tx|Adverse Event|5|||
37994767|NCT00285012|69679569|FG001|Received Study Tx|Adverse Event|11|||
37994768|NCT00285012|69679568|FG000|Received Study Tx|Lack of Efficacy|0|||
37994769|NCT00285012|69679569|FG001|Received Study Tx|Lack of Efficacy|3|||
37994770|NCT00285012|69679568|FG000|Received Study Tx|Lost to Follow-up|29|||
37994771|NCT00285012|69679569|FG001|Received Study Tx|Lost to Follow-up|31|||
37994772|NCT00285012|69679568|FG000|Received Study Tx|Withdrawal by Subject|31|||
37994773|NCT00285012|69679569|FG001|Received Study Tx|Withdrawal by Subject|43|||
37994774|NCT00285012|69679568|FG000|Received Study Tx|Other|5|||
37994775|NCT00285012|69679569|FG001|Received Study Tx|Other|5|||
37994776|NCT00284934|69679577|FG000|Overall Study|Adverse Event|1|||
37994777|NCT00284934|69679578|FG001|Overall Study|Adverse Event|2|||
37994778|NCT00284934|69679577|FG000|Overall Study|Other reasons|3|||
37994779|NCT00284934|69679578|FG001|Overall Study|Other reasons|1|||
37994780|NCT00284856|69679587|FG000|Overall Study|Adverse Event|3|||
37994781|NCT00284856|69679588|FG001|Overall Study|Adverse Event|3|||
37994782|NCT00284856|69679589|FG002|Overall Study|Adverse Event|3|||
37994783|NCT00284856|69679587|FG000|Overall Study|Lack of Efficacy|2|||
37994784|NCT00284856|69679588|FG001|Overall Study|Lack of Efficacy|1|||
37994785|NCT00284856|69679589|FG002|Overall Study|Lack of Efficacy|8|||
37994786|NCT00284856|69679587|FG000|Overall Study|Lost to Follow-up|25|||
37994787|NCT00284856|69679588|FG001|Overall Study|Lost to Follow-up|21|||
37994788|NCT00284856|69679589|FG002|Overall Study|Lost to Follow-up|22|||
37994789|NCT00284856|69679587|FG000|Overall Study|Protocol Violation|5|||
37994790|NCT00284856|69679588|FG001|Overall Study|Protocol Violation|4|||
37994791|NCT00284856|69679589|FG002|Overall Study|Protocol Violation|5|||
37994792|NCT00284856|69679587|FG000|Overall Study|Withdrawal by Subject|12|||
37994793|NCT00284856|69679588|FG001|Overall Study|Withdrawal by Subject|16|||
37994794|NCT00284856|69679589|FG002|Overall Study|Withdrawal by Subject|18|||
37994795|NCT00284856|69679587|FG000|Overall Study|Other|4|||
37994796|NCT00284856|69679588|FG001|Overall Study|Other|5|||
37994797|NCT00284856|69679589|FG002|Overall Study|Other|4|||
37994798|NCT00298272|69679599|FG000|Double-blind Phase|Adverse Event|2|||
37994799|NCT00298272|69679600|FG001|Double-blind Phase|Adverse Event|0|||
37994800|NCT00298272|69679599|FG000|Double-blind Phase|Failure to Return|2|||
37994801|NCT00298272|69679600|FG001|Double-blind Phase|Failure to Return|0|||
37994802|NCT00298272|69679599|FG000|Double-blind Phase|Protocol Violation|2|||
37994803|NCT00298272|69679600|FG001|Double-blind Phase|Protocol Violation|0|||
37994804|NCT00298272|69679599|FG000|Double-blind Phase|Withdrawal by Subject|2|||
37994805|NCT00298272|69679600|FG001|Double-blind Phase|Withdrawal by Subject|0|||
37896598|NCT00770692|69581712|FG003|Overall Study|Withdrawal by Subject|6|||
37994806|NCT00298272|69679599|FG000|Open Label Retreatment Phase|Adverse Event|1|||
37994807|NCT00298272|69679600|FG001|Open Label Retreatment Phase|Adverse Event|2|||
37994808|NCT00298272|69679599|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
37994809|NCT00298272|69679600|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
37994810|NCT00298272|69679599|FG000|Open Label Retreatment Phase|Failure to Return|1|||
37994811|NCT00298272|69679600|FG001|Open Label Retreatment Phase|Failure to Return|0|||
37825556|NCT01242748|69507581|FG000|Overall Study|Lost to Follow-up|6|||
37825557|NCT01242748|69507582|FG001|Overall Study|Lost to Follow-up|2|||
37825558|NCT01242748|69507581|FG000|Overall Study|Physician Decision|3|||
37825559|NCT01242748|69507582|FG001|Overall Study|Physician Decision|2|||
37825560|NCT01242748|69507581|FG000|Overall Study|Protocol Violation|1|||
37825561|NCT01242748|69507582|FG001|Overall Study|Protocol Violation|0|||
37825562|NCT01242748|69507581|FG000|Overall Study|Withdrawal by Subject|10|||
37825563|NCT01242748|69507582|FG001|Overall Study|Withdrawal by Subject|2|||
37825564|NCT01242748|69507581|FG000|Overall Study|Miscellaneous reasons|8|||
37896599|NCT00770692|69581709|FG000|Overall Study|Adverse Event|3|||
37896600|NCT00770692|69581710|FG001|Overall Study|Adverse Event|0|||
37994812|NCT00298272|69679599|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
37825565|NCT01242748|69507582|FG001|Overall Study|Miscellaneous reasons|3|||
37825566|NCT01242514|69507591|FG000|Overall Study|e.g., project closure|1042|||
37994813|NCT00298272|69679600|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
37896601|NCT00770692|69581711|FG002|Overall Study|Adverse Event|4|||
37896602|NCT00770692|69581712|FG003|Overall Study|Adverse Event|4|||
37896603|NCT00770692|69581709|FG000|Overall Study|Investigator judgment|2|||
37994814|NCT00298272|69679599|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
37994815|NCT00298272|69679600|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
37994816|NCT00298272|69679599|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
37994817|NCT00298272|69679600|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
37994818|NCT00298272|69679599|FG000|Safety Follow-up Phase|Failure to Return|1|||
37994819|NCT00298272|69679600|FG001|Safety Follow-up Phase|Failure to Return|1|||
37994820|NCT00298272|69679599|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
37994821|NCT00298272|69679600|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
37994822|NCT00298272|69679599|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
37994823|NCT00298272|69679600|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
37994824|NCT00283842|69679614|FG000|Overall Study|Adverse Event|8|||
37994825|NCT00283842|69679615|FG001|Overall Study|Adverse Event|7|||
37994826|NCT00283842|69679616|FG002|Overall Study|Adverse Event|21|||
37994827|NCT00283842|69679617|FG003|Overall Study|Adverse Event|21|||
37994828|NCT00283842|69679618|FG004|Overall Study|Adverse Event|5|||
37994829|NCT00283842|69679614|FG000|Overall Study|Protocol Violation|1|||
37994830|NCT00283842|69679615|FG001|Overall Study|Protocol Violation|5|||
37994831|NCT00283842|69679616|FG002|Overall Study|Protocol Violation|4|||
37994832|NCT00283842|69679617|FG003|Overall Study|Protocol Violation|0|||
37994833|NCT00283842|69679618|FG004|Overall Study|Protocol Violation|0|||
37994834|NCT00283842|69679614|FG000|Overall Study|Protocol deviation|0|||
37994835|NCT00283842|69679615|FG001|Overall Study|Protocol deviation|0|||
37994836|NCT00283842|69679616|FG002|Overall Study|Protocol deviation|0|||
37994837|NCT00283842|69679617|FG003|Overall Study|Protocol deviation|0|||
37994838|NCT00283842|69679618|FG004|Overall Study|Protocol deviation|2|||
37994839|NCT00283842|69679614|FG000|Overall Study|Withdrawal by Subject|2|||
37994840|NCT00283842|69679615|FG001|Overall Study|Withdrawal by Subject|1|||
37994841|NCT00283842|69679616|FG002|Overall Study|Withdrawal by Subject|1|||
37994842|NCT00283842|69679617|FG003|Overall Study|Withdrawal by Subject|5|||
37994843|NCT00283842|69679618|FG004|Overall Study|Withdrawal by Subject|4|||
37994844|NCT00283842|69679614|FG000|Overall Study|Lack of Efficacy|1|||
37994845|NCT00283842|69679615|FG001|Overall Study|Lack of Efficacy|3|||
37994846|NCT00283842|69679616|FG002|Overall Study|Lack of Efficacy|1|||
37994847|NCT00283842|69679617|FG003|Overall Study|Lack of Efficacy|0|||
37994848|NCT00283842|69679618|FG004|Overall Study|Lack of Efficacy|3|||
37994849|NCT00283842|69679614|FG000|Overall Study|Lost to Follow-up|0|||
37994850|NCT00283842|69679615|FG001|Overall Study|Lost to Follow-up|2|||
37994851|NCT00283842|69679616|FG002|Overall Study|Lost to Follow-up|4|||
37994852|NCT00283842|69679617|FG003|Overall Study|Lost to Follow-up|1|||
37994853|NCT00283842|69679618|FG004|Overall Study|Lost to Follow-up|1|||
37994854|NCT00298038|69679632|FG000|Overall Study|Lost to Follow-up|0|||
37994855|NCT00298038|69679633|FG001|Overall Study|Lost to Follow-up|1|||
37994856|NCT00298038|69679632|FG000|Overall Study|Liver Transplant|0|||
37994857|NCT00298038|69679633|FG001|Overall Study|Liver Transplant|1|||
37994858|NCT00298038|69679632|FG000|Overall Study|Protocol Violation|1|||
37994859|NCT00298038|69679633|FG001|Overall Study|Protocol Violation|3|||
37994860|NCT00298038|69679632|FG000|Overall Study|Death|6|||
37994861|NCT00298038|69679633|FG001|Overall Study|Death|3|||
37994862|NCT00298038|69679632|FG000|Overall Study|Withdrawal by Subject|6|||
37994863|NCT00298038|69679633|FG001|Overall Study|Withdrawal by Subject|9|||
37994864|NCT00298038|69679632|FG000|Overall Study|Adverse Event|8|||
37994865|NCT00298038|69679633|FG001|Overall Study|Adverse Event|7|||
37994866|NCT00298038|69679632|FG000|Overall Study|Breakthrough overt HE episode|28|||
37994867|NCT00298038|69679633|FG001|Overall Study|Breakthrough overt HE episode|69|||
37994868|NCT00298038|69679632|FG000|Overall Study|Noncompliance|1|||
37994869|NCT00298038|69679633|FG001|Overall Study|Noncompliance|0|||
37994870|NCT00298038|69679632|FG000|Overall Study|Cocaine Abuse|1|||
37994871|NCT00298038|69679633|FG001|Overall Study|Cocaine Abuse|0|||
37994872|NCT00298038|69679632|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
37994873|NCT00298038|69679633|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
37994874|NCT00283686|69679643|FG000|Overall Study|Death|1|||
37994875|NCT00283686|69679644|FG001|Overall Study|Death|1|||
37994876|NCT00283686|69679645|FG002|Overall Study|Death|1|||
37994877|NCT00283686|69679646|FG003|Overall Study|Death|0|||
37994878|NCT00283686|69679643|FG000|Overall Study|Lost to Follow-up|21|||
37994879|NCT00283686|69679644|FG001|Overall Study|Lost to Follow-up|31|||
37994880|NCT00283686|69679645|FG002|Overall Study|Lost to Follow-up|26|||
37994881|NCT00283686|69679646|FG003|Overall Study|Lost to Follow-up|20|||
37994882|NCT00283686|69679643|FG000|Overall Study|Less than full participation|7|||
37994883|NCT00283686|69679644|FG001|Overall Study|Less than full participation|9|||
37994884|NCT00283686|69679645|FG002|Overall Study|Less than full participation|6|||
37825567|NCT01242514|69507592|FG001|Overall Study|e.g., project closure|305|||
37825568|NCT01242514|69507593|FG002|Overall Study|e.g., project closure|171|||
37825569|NCT01242514|69507591|FG000|Overall Study|Subject decision|33|||
37825570|NCT01242514|69507592|FG001|Overall Study|Subject decision|8|||
37825571|NCT01242514|69507593|FG002|Overall Study|Subject decision|2|||
37825572|NCT01242514|69507591|FG000|Overall Study|Severe non-compliance to protocol|5|||
37825573|NCT01242514|69507592|FG001|Overall Study|Severe non-compliance to protocol|2|||
37896604|NCT00770692|69581710|FG001|Overall Study|Investigator judgment|0|||
37896605|NCT00770692|69581711|FG002|Overall Study|Investigator judgment|1|||
37896606|NCT00770692|69581712|FG003|Overall Study|Investigator judgment|1|||
37896607|NCT02743819|69581726|FG000|Overall Study|Lack of Efficacy|5|||
37896608|NCT02743819|69581726|FG000|Overall Study|Death|2|||
37896609|NCT02743819|69581726|FG000|Overall Study|Adverse Event|1|||
37896610|NCT01004822|69581738|FG000|Overall Study|Objective progression or relapse|3|||
37896611|NCT01004822|69581739|FG001|Overall Study|Objective progression or relapse|3|||
37896612|NCT01004822|69581740|FG002|Overall Study|Objective progression or relapse|0|||
37994885|NCT00283686|69679646|FG003|Overall Study|Less than full participation|12|||
37994886|NCT00297882|69679658|FG000|Day 14|Lack of Efficacy|12|||
37994887|NCT00297882|69679659|FG001|Day 14|Lack of Efficacy|49|||
37994888|NCT00297882|69679658|FG000|Day 28|Lost to Follow-up|13|||
37994889|NCT00297882|69679659|FG001|Day 28|Lost to Follow-up|23|||
37994890|NCT00297882|69679658|FG000|Day 28|Lack of Efficacy|3|||
37994891|NCT00297882|69679659|FG001|Day 28|Lack of Efficacy|0|||
37994892|NCT00297648|69679667|FG000|Overall Study|Adverse Event|13|||
37994893|NCT00297648|69679667|FG000|Overall Study|Lack of Efficacy|18|||
37994894|NCT00297648|69679667|FG000|Overall Study|Lost to Follow-up|1|||
37994895|NCT00297648|69679667|FG000|Overall Study|Withdrawal by Subject|3|||
37994896|NCT00297648|69679667|FG000|Overall Study|Other: Incompliance|1|||
37994897|NCT00283296|69679671|FG000|Overall Study|in-home trial not completed|5|||
37994898|NCT00297492|69679679|FG000|Set Quit Date|Lost to Follow-up|7|||
37896613|NCT01004822|69581741|FG003|Overall Study|Objective progression or relapse|1|||
37896614|NCT01004822|69581742|FG004|Overall Study|Objective progression or relapse|2|||
37994899|NCT00297492|69679680|FG001|Set Quit Date|Lost to Follow-up|13|||
37994900|NCT00297492|69679681|FG002|Set Quit Date|Lost to Follow-up|5|||
37994901|NCT00297492|69679679|FG000|6 Month Follow-up|Lost to Follow-up|63|||
37994902|NCT00297492|69679680|FG001|6 Month Follow-up|Lost to Follow-up|49|||
37994903|NCT00297492|69679681|FG002|6 Month Follow-up|Lost to Follow-up|27|||
37994904|NCT00297258|69679689|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
37994905|NCT00297258|69679689|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
37994906|NCT00297258|69679689|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
37994907|NCT00297258|69679689|FG000|Overall Study|Intercurrent Illness|3|||
37994908|NCT00297258|69679689|FG000|Overall Study|Intercurrent Death|2|||
37994909|NCT00297258|69679689|FG000|Overall Study|Deteriorization of General Condition|1|||
37994910|NCT00297258|69679689|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
37994911|NCT00297258|69679689|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
37994912|NCT00297258|69679689|FG000|Overall Study|Switch to Commercial Treatment|1|||
37994913|NCT00297258|69679689|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
37994914|NCT00496769|69679698|FG000|Double Blind|>=1 reason assigned per patient|558|||
37994915|NCT00496769|69679699|FG001|Double Blind|>=1 reason assigned per patient|649|||
37994916|NCT00496769|69679700|FG002|Double Blind|>=1 reason assigned per patient|0|||
37825574|NCT01242514|69507593|FG002|Overall Study|Severe non-compliance to protocol|1|||
37825575|NCT01242514|69507591|FG000|Overall Study|Lack of therapeutic response|99|||
37994917|NCT00496769|69679698|FG000|Open Label|>=1 reason assigned per patient|0|||
37994918|NCT00496769|69679699|FG001|Open Label|>=1 reason assigned per patient|0|||
37994919|NCT00496769|69679700|FG002|Open Label|>=1 reason assigned per patient|1011|||
37994920|NCT00478673|69679709|FG000|30-Days Post-Procedure|Death|2|||
37994921|NCT00478673|69679709|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
37994922|NCT00478673|69679709|FG000|30-Days Post-Procedure|Missed Visit|7|||
37994923|NCT00478673|69679709|FG000|12-Months Post-Procedure|Death|23|||
37994924|NCT00478673|69679709|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
37994925|NCT00478673|69679709|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
37994926|NCT00478673|69679709|FG000|12-Months Post-Procedure|Missed Visit|25|||
37994927|NCT00478673|69679709|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
37994928|NCT00488345|69679716|FG000|Overall Study|Adverse Event|0|||
37994929|NCT00488345|69679717|FG001|Overall Study|Adverse Event|1|||
37994930|NCT00488345|69679718|FG002|Overall Study|Adverse Event|1|||
37994931|NCT00488345|69679716|FG000|Overall Study|Unable to administer antibiotics at home|0|||
37994932|NCT00488345|69679717|FG001|Overall Study|Unable to administer antibiotics at home|1|||
37994933|NCT00488345|69679718|FG002|Overall Study|Unable to administer antibiotics at home|0|||
37994934|NCT00488345|69679716|FG000|Overall Study|Institutional Review Board review|0|||
37994935|NCT00488345|69679717|FG001|Overall Study|Institutional Review Board review|0|||
37994936|NCT00488345|69679718|FG002|Overall Study|Institutional Review Board review|1|||
37994937|NCT00488345|69679716|FG000|Overall Study|Surgical team recommendation|0|||
37994938|NCT00488345|69679717|FG001|Overall Study|Surgical team recommendation|1|||
37994939|NCT00488345|69679718|FG002|Overall Study|Surgical team recommendation|0|||
37994940|NCT00488345|69679716|FG000|Overall Study|Parent/legal guardian request|0|||
37994941|NCT00488345|69679717|FG001|Overall Study|Parent/legal guardian request|1|||
37994942|NCT00488345|69679718|FG002|Overall Study|Parent/legal guardian request|1|||
37994943|NCT00283062|69679731|FG000|Overall Study|Did not receive any study medication|5|||
37994944|NCT00283062|69679732|FG001|Overall Study|Did not receive any study medication|4|||
37994945|NCT00283062|69679733|FG002|Overall Study|Did not receive any study medication|36|||
37994946|NCT00283062|69679734|FG003|Overall Study|Did not receive any study medication|45|||
37994947|NCT00283062|69679731|FG000|Overall Study|Adverse Event|2|||
37994948|NCT00283062|69679732|FG001|Overall Study|Adverse Event|0|||
37994949|NCT00283062|69679733|FG002|Overall Study|Adverse Event|1|||
37994950|NCT00283062|69679734|FG003|Overall Study|Adverse Event|0|||
37994951|NCT00283062|69679731|FG000|Overall Study|Lost to Follow-up|1|||
37994952|NCT00283062|69679732|FG001|Overall Study|Lost to Follow-up|0|||
37994953|NCT00283062|69679733|FG002|Overall Study|Lost to Follow-up|1|||
37994954|NCT00283062|69679734|FG003|Overall Study|Lost to Follow-up|0|||
37994955|NCT00283062|69679731|FG000|Overall Study|Progressive disease|0|||
37994956|NCT00283062|69679732|FG001|Overall Study|Progressive disease|0|||
37994957|NCT00283062|69679733|FG002|Overall Study|Progressive disease|1|||
37994958|NCT00283062|69679734|FG003|Overall Study|Progressive disease|0|||
37994959|NCT00283062|69679731|FG000|Overall Study|Participant did not wish to continue|3|||
37994960|NCT00283062|69679732|FG001|Overall Study|Participant did not wish to continue|2|||
37994961|NCT00283062|69679733|FG002|Overall Study|Participant did not wish to continue|1|||
37994962|NCT00283062|69679734|FG003|Overall Study|Participant did not wish to continue|0|||
37994963|NCT00283062|69679731|FG000|Overall Study|Undefined|0|||
37994964|NCT00283062|69679732|FG001|Overall Study|Undefined|1|||
37994965|NCT00283062|69679733|FG002|Overall Study|Undefined|1|||
37994966|NCT00283062|69679734|FG003|Overall Study|Undefined|4|||
37994967|NCT00283062|69679731|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
37994968|NCT00283062|69679732|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
37994969|NCT00283062|69679733|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
37994970|NCT00283062|69679734|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
37994971|NCT00282984|69679746|FG000|Overall Study|Death|2|||
37994972|NCT00282984|69679747|FG001|Overall Study|Death|5|||
37994973|NCT00282984|69679746|FG000|Overall Study|Adverse Event|8|||
37994974|NCT00282984|69679747|FG001|Overall Study|Adverse Event|5|||
37994975|NCT00282984|69679746|FG000|Overall Study|Lack of Efficacy|0|||
37994976|NCT00282984|69679747|FG001|Overall Study|Lack of Efficacy|2|||
37994977|NCT00282984|69679746|FG000|Overall Study|Lost to Follow-up|14|||
37994978|NCT00282984|69679747|FG001|Overall Study|Lost to Follow-up|10|||
37994979|NCT00282984|69679746|FG000|Overall Study|Withdrawal by Participant|22|||
37994980|NCT00282984|69679747|FG001|Overall Study|Withdrawal by Participant|34|||
37994981|NCT00282984|69679746|FG000|Overall Study|Participant stopped study medication|2|||
37994982|NCT00282984|69679747|FG001|Overall Study|Participant stopped study medication|2|||
37994983|NCT00282984|69679746|FG000|Overall Study|Participant only allowed phone follow-up|0|||
37994984|NCT00282984|69679747|FG001|Overall Study|Participant only allowed phone follow-up|1|||
37994985|NCT00282984|69679746|FG000|Overall Study|Participant used antipsychosis meds|0|||
37994986|NCT00282984|69679747|FG001|Overall Study|Participant used antipsychosis meds|1|||
37994987|NCT00282984|69679746|FG000|Overall Study|lack of motivation|1|||
37994988|NCT00282984|69679747|FG001|Overall Study|lack of motivation|0|||
37994989|NCT00282984|69679746|FG000|Overall Study|in prison|0|||
37994990|NCT00282984|69679747|FG001|Overall Study|in prison|1|||
37994991|NCT00282984|69679746|FG000|Overall Study|Protocol Violation|2|||
37994992|NCT00282984|69679747|FG001|Overall Study|Protocol Violation|0|||
37994993|NCT00282438|69679755|FG000|Overall Study|Lack of Efficacy|1|||
37994994|NCT00282438|69679756|FG001|Overall Study|Lack of Efficacy|0|||
37994995|NCT00282438|69679755|FG000|Overall Study|Death|0|||
37994996|NCT00282438|69679756|FG001|Overall Study|Death|1|||
37994997|NCT00296400|69679765|FG000|Overall Study|Adverse Event|7|||
37994998|NCT00296400|69679766|FG001|Overall Study|Adverse Event|7|||
37994999|NCT00296400|69679767|FG002|Overall Study|Adverse Event|7|||
37995000|NCT00296400|69679765|FG000|Overall Study|Withdrawal by Subject|5|||
37995001|NCT00296400|69679766|FG001|Overall Study|Withdrawal by Subject|6|||
37995002|NCT00296400|69679767|FG002|Overall Study|Withdrawal by Subject|2|||
37995003|NCT00296400|69679765|FG000|Overall Study|Incorrect enrollment|2|||
37995004|NCT00296400|69679766|FG001|Overall Study|Incorrect enrollment|0|||
37995005|NCT00296400|69679767|FG002|Overall Study|Incorrect enrollment|0|||
37995006|NCT00296400|69679765|FG000|Overall Study|Protocol Violation|1|||
37995007|NCT00296400|69679766|FG001|Overall Study|Protocol Violation|1|||
37995008|NCT00296400|69679767|FG002|Overall Study|Protocol Violation|1|||
37995009|NCT00296400|69679765|FG000|Overall Study|Lost to Follow-up|1|||
37995010|NCT00296400|69679766|FG001|Overall Study|Lost to Follow-up|1|||
37995011|NCT00296400|69679767|FG002|Overall Study|Lost to Follow-up|2|||
37995012|NCT00296400|69679765|FG000|Overall Study|Study specific discontinuation criteria|0|||
37995013|NCT00296400|69679766|FG001|Overall Study|Study specific discontinuation criteria|0|||
37995014|NCT00296400|69679767|FG002|Overall Study|Study specific discontinuation criteria|1|||
37995015|NCT00296400|69679765|FG000|Overall Study|Visit 10 was performed earlier|0|||
37995016|NCT00296400|69679766|FG001|Overall Study|Visit 10 was performed earlier|1|||
37995017|NCT00296400|69679767|FG002|Overall Study|Visit 10 was performed earlier|0|||
37995018|NCT00296400|69679765|FG000|Overall Study|Pregnancy|1|||
37995019|NCT00296400|69679766|FG001|Overall Study|Pregnancy|2|||
37995020|NCT00296400|69679767|FG002|Overall Study|Pregnancy|0|||
37995021|NCT00296244|69679780|FG000|Overall Study|Underwent retransplant|0|||
37995022|NCT00296244|69679781|FG001|Overall Study|Underwent retransplant|1|||
37995023|NCT00274716|69679798|FG000|Phase A|Other non-reported reason|4|||
37995024|NCT00274716|69679799|FG001|Phase A|Other non-reported reason|2|||
37995025|NCT00274716|69679800|FG002|Phase A|Other non-reported reason|1|||
37995026|NCT00274716|69679801|FG003|Phase A|Other non-reported reason|2|||
37995027|NCT00274716|69679802|FG004|Phase A|Other non-reported reason|0|||
37995028|NCT00274716|69679803|FG005|Phase A|Other non-reported reason|1|||
37995029|NCT00274716|69679798|FG000|Phase A|Participant moved|0|||
37995030|NCT00274716|69679799|FG001|Phase A|Participant moved|0|||
37995031|NCT00274716|69679800|FG002|Phase A|Participant moved|1|||
37995032|NCT00274716|69679801|FG003|Phase A|Participant moved|0|||
37995033|NCT00274716|69679802|FG004|Phase A|Participant moved|0|||
37995034|NCT00274716|69679803|FG005|Phase A|Participant moved|1|||
37995035|NCT00274716|69679798|FG000|Phase A|Site Terminated|0|||
37995036|NCT00274716|69679799|FG001|Phase A|Site Terminated|0|||
37995037|NCT00274716|69679800|FG002|Phase A|Site Terminated|0|||
37995038|NCT00274716|69679801|FG003|Phase A|Site Terminated|1|||
37995039|NCT00274716|69679802|FG004|Phase A|Site Terminated|0|||
37995040|NCT00274716|69679803|FG005|Phase A|Site Terminated|0|||
37995041|NCT00274716|69679798|FG000|Phase A|Protocol Violation|1|||
37995042|NCT00274716|69679799|FG001|Phase A|Protocol Violation|0|||
37995043|NCT00274716|69679800|FG002|Phase A|Protocol Violation|0|||
37995044|NCT00274716|69679801|FG003|Phase A|Protocol Violation|1|||
37995045|NCT00274716|69679802|FG004|Phase A|Protocol Violation|0|||
37995046|NCT00274716|69679803|FG005|Phase A|Protocol Violation|0|||
37995047|NCT00274716|69679798|FG000|Phase A|Met criteria for discontinuation|1|||
37995048|NCT00274716|69679799|FG001|Phase A|Met criteria for discontinuation|1|||
37995049|NCT00274716|69679800|FG002|Phase A|Met criteria for discontinuation|0|||
37995050|NCT00274716|69679801|FG003|Phase A|Met criteria for discontinuation|0|||
37995051|NCT00274716|69679802|FG004|Phase A|Met criteria for discontinuation|0|||
37995052|NCT00274716|69679803|FG005|Phase A|Met criteria for discontinuation|0|||
37995053|NCT00274716|69679798|FG000|Phase A|Withdrawal by Subject|2|||
37995054|NCT00274716|69679799|FG001|Phase A|Withdrawal by Subject|2|||
37995055|NCT00274716|69679800|FG002|Phase A|Withdrawal by Subject|1|||
37896615|NCT01004822|69581743|FG005|Overall Study|Objective progression or relapse|2|||
37896616|NCT01004822|69581744|FG006|Overall Study|Objective progression or relapse|1|||
37995056|NCT00274716|69679801|FG003|Phase A|Withdrawal by Subject|3|||
37995057|NCT00274716|69679802|FG004|Phase A|Withdrawal by Subject|0|||
37995058|NCT00274716|69679803|FG005|Phase A|Withdrawal by Subject|1|||
37995059|NCT00274716|69679798|FG000|Phase A|Adverse Event|2|||
37995060|NCT00274716|69679799|FG001|Phase A|Adverse Event|3|||
37995061|NCT00274716|69679800|FG002|Phase A|Adverse Event|3|||
37995062|NCT00274716|69679801|FG003|Phase A|Adverse Event|0|||
37995063|NCT00274716|69679802|FG004|Phase A|Adverse Event|2|||
37995064|NCT00274716|69679803|FG005|Phase A|Adverse Event|0|||
37995065|NCT00274716|69679798|FG000|Phase A|Completed but did not enter Phase B|1|||
37995066|NCT00274716|69679799|FG001|Phase A|Completed but did not enter Phase B|2|||
37995067|NCT00274716|69679800|FG002|Phase A|Completed but did not enter Phase B|2|||
37995068|NCT00274716|69679801|FG003|Phase A|Completed but did not enter Phase B|2|||
37995069|NCT00274716|69679802|FG004|Phase A|Completed but did not enter Phase B|1|||
37995070|NCT00274716|69679803|FG005|Phase A|Completed but did not enter Phase B|1|||
37995071|NCT00274716|69679798|FG000|Phase B|Adverse Event|0|||
37995072|NCT00274716|69679799|FG001|Phase B|Adverse Event|0|||
37995073|NCT00274716|69679800|FG002|Phase B|Adverse Event|2|||
37995074|NCT00274716|69679801|FG003|Phase B|Adverse Event|0|||
37995075|NCT00274716|69679802|FG004|Phase B|Adverse Event|0|||
37995076|NCT00274716|69679803|FG005|Phase B|Adverse Event|1|||
37995077|NCT00274716|69679798|FG000|Phase B|Protocol Violation|0|||
37995078|NCT00274716|69679799|FG001|Phase B|Protocol Violation|2|||
37995079|NCT00274716|69679800|FG002|Phase B|Protocol Violation|0|||
37995080|NCT00274716|69679801|FG003|Phase B|Protocol Violation|0|||
37995081|NCT00274716|69679802|FG004|Phase B|Protocol Violation|0|||
37995082|NCT00274716|69679803|FG005|Phase B|Protocol Violation|0|||
37995083|NCT00274716|69679798|FG000|Phase B|Withdrawal by Subject|0|||
37995084|NCT00274716|69679799|FG001|Phase B|Withdrawal by Subject|1|||
37995085|NCT00274716|69679800|FG002|Phase B|Withdrawal by Subject|0|||
37995086|NCT00274716|69679801|FG003|Phase B|Withdrawal by Subject|0|||
37995087|NCT00274716|69679802|FG004|Phase B|Withdrawal by Subject|0|||
37995088|NCT00274716|69679803|FG005|Phase B|Withdrawal by Subject|0|||
37995089|NCT00274716|69679798|FG000|Phase B|Participant moved|1|||
37995090|NCT00274716|69679799|FG001|Phase B|Participant moved|0|||
37995091|NCT00274716|69679800|FG002|Phase B|Participant moved|0|||
37995092|NCT00274716|69679801|FG003|Phase B|Participant moved|0|||
37995093|NCT00274716|69679802|FG004|Phase B|Participant moved|0|||
37995094|NCT00274716|69679803|FG005|Phase B|Participant moved|0|||
37995095|NCT00274716|69679798|FG000|Phase B|Other non-reported reason|0|||
37995096|NCT00274716|69679799|FG001|Phase B|Other non-reported reason|0|||
37995097|NCT00274716|69679800|FG002|Phase B|Other non-reported reason|1|||
37995098|NCT00274716|69679801|FG003|Phase B|Other non-reported reason|1|||
37995099|NCT00274716|69679802|FG004|Phase B|Other non-reported reason|0|||
37995100|NCT00274716|69679803|FG005|Phase B|Other non-reported reason|0|||
37995101|NCT00274716|69679798|FG000|Phase B|Lost to Follow-up|0|||
37995102|NCT00274716|69679799|FG001|Phase B|Lost to Follow-up|1|||
37995103|NCT00274716|69679800|FG002|Phase B|Lost to Follow-up|0|||
37995104|NCT00274716|69679801|FG003|Phase B|Lost to Follow-up|0|||
37995105|NCT00274716|69679802|FG004|Phase B|Lost to Follow-up|0|||
37995106|NCT00274716|69679803|FG005|Phase B|Lost to Follow-up|0|||
37995107|NCT00282048|69679821|FG000|Overall Study|Lack of Efficacy|30|||
37995108|NCT00282048|69679821|FG000|Overall Study|Adverse Event|22|||
37995109|NCT00282048|69679821|FG000|Overall Study|Withdrawal by Subject|1|||
37995110|NCT00282048|69679821|FG000|Overall Study|Other|8|||
37995111|NCT00282048|69679821|FG000|Overall Study|Ongoing|1|||
37995112|NCT00474539|69679827|FG000|Infant Series|Withdrawal by Subject|3|||
37995113|NCT00474539|69679828|FG001|Infant Series|Withdrawal by Subject|4|||
37995114|NCT00474539|69679827|FG000|Infant Series|Randomization error|5|||
37995115|NCT00474539|69679828|FG001|Infant Series|Randomization error|0|||
37995116|NCT00474539|69679827|FG000|Infant Series|Lost to Follow-up|2|||
37995117|NCT00474539|69679828|FG001|Infant Series|Lost to Follow-up|1|||
37995118|NCT00474539|69679827|FG000|Infant Series|Protocol Violation|0|||
37995119|NCT00474539|69679828|FG001|Infant Series|Protocol Violation|1|||
37995120|NCT00474539|69679827|FG000|After Infant Series|Lost to Follow-up|3|||
37995121|NCT00474539|69679828|FG001|After Infant Series|Lost to Follow-up|0|||
37995122|NCT00474539|69679827|FG000|After Infant Series|Withdrawal by Subject|1|||
37995123|NCT00474539|69679828|FG001|After Infant Series|Withdrawal by Subject|0|||
37995124|NCT00474539|69679827|FG000|Toddler Dose|Protocol Violation|1|||
37995125|NCT00474539|69679828|FG001|Toddler Dose|Protocol Violation|0|||
37995126|NCT00281580|69679875|FG000|Overall Study|Adverse Event|2|||
37995127|NCT00281580|69679876|FG001|Overall Study|Adverse Event|0|||
37995128|NCT00281580|69679877|FG002|Overall Study|Adverse Event|2|||
37995129|NCT00281580|69679878|FG003|Overall Study|Adverse Event|4|||
37995130|NCT00281580|69679879|FG004|Overall Study|Adverse Event|1|||
37825576|NCT01242514|69507592|FG001|Overall Study|Lack of therapeutic response|16|||
37825577|NCT01242514|69507593|FG002|Overall Study|Lack of therapeutic response|10|||
37995131|NCT00281580|69679880|FG005|Overall Study|Adverse Event|0|||
37995132|NCT00281580|69679881|FG006|Overall Study|Adverse Event|1|||
37995133|NCT00281580|69679882|FG007|Overall Study|Adverse Event|0|||
37825578|NCT01242514|69507591|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
37995134|NCT00281580|69679883|FG008|Overall Study|Adverse Event|1|||
37995135|NCT00281580|69679884|FG009|Overall Study|Adverse Event|6|||
37995136|NCT00281580|69679885|FG010|Overall Study|Adverse Event|0|||
37995137|NCT00281580|69679886|FG011|Overall Study|Adverse Event|5|||
37995138|NCT00281580|69679887|FG012|Overall Study|Adverse Event|8|||
37995139|NCT00281580|69679888|FG013|Overall Study|Adverse Event|2|||
37995140|NCT00281580|69679889|FG014|Overall Study|Adverse Event|3|||
37995141|NCT00281580|69679890|FG015|Overall Study|Adverse Event|3|||
37995142|NCT00281580|69679875|FG000|Overall Study|Protocol Violation|0|||
37995143|NCT00281580|69679876|FG001|Overall Study|Protocol Violation|0|||
37995144|NCT00281580|69679877|FG002|Overall Study|Protocol Violation|1|||
37995145|NCT00281580|69679878|FG003|Overall Study|Protocol Violation|1|||
37995146|NCT00281580|69679879|FG004|Overall Study|Protocol Violation|0|||
37995147|NCT00281580|69679880|FG005|Overall Study|Protocol Violation|0|||
37995148|NCT00281580|69679881|FG006|Overall Study|Protocol Violation|1|||
37995149|NCT00281580|69679882|FG007|Overall Study|Protocol Violation|0|||
37995150|NCT00281580|69679883|FG008|Overall Study|Protocol Violation|2|||
37995151|NCT00281580|69679884|FG009|Overall Study|Protocol Violation|0|||
37995152|NCT00281580|69679885|FG010|Overall Study|Protocol Violation|1|||
37995153|NCT00281580|69679886|FG011|Overall Study|Protocol Violation|2|||
37995154|NCT00281580|69679887|FG012|Overall Study|Protocol Violation|0|||
37995155|NCT00281580|69679888|FG013|Overall Study|Protocol Violation|1|||
37995156|NCT00281580|69679889|FG014|Overall Study|Protocol Violation|1|||
37995157|NCT00281580|69679890|FG015|Overall Study|Protocol Violation|3|||
37995158|NCT00281580|69679875|FG000|Overall Study|Withdrawal by Subject|3|||
37995159|NCT00281580|69679876|FG001|Overall Study|Withdrawal by Subject|0|||
37995160|NCT00281580|69679877|FG002|Overall Study|Withdrawal by Subject|1|||
37995161|NCT00281580|69679878|FG003|Overall Study|Withdrawal by Subject|1|||
37995162|NCT00281580|69679879|FG004|Overall Study|Withdrawal by Subject|1|||
37995163|NCT00281580|69679880|FG005|Overall Study|Withdrawal by Subject|2|||
37995164|NCT00281580|69679881|FG006|Overall Study|Withdrawal by Subject|2|||
37995165|NCT00281580|69679882|FG007|Overall Study|Withdrawal by Subject|0|||
37995166|NCT00281580|69679883|FG008|Overall Study|Withdrawal by Subject|1|||
37995167|NCT00281580|69679884|FG009|Overall Study|Withdrawal by Subject|4|||
37995168|NCT00281580|69679885|FG010|Overall Study|Withdrawal by Subject|1|||
37995169|NCT00281580|69679886|FG011|Overall Study|Withdrawal by Subject|1|||
37995170|NCT00281580|69679887|FG012|Overall Study|Withdrawal by Subject|2|||
37995171|NCT00281580|69679888|FG013|Overall Study|Withdrawal by Subject|2|||
37995172|NCT00281580|69679889|FG014|Overall Study|Withdrawal by Subject|1|||
37995173|NCT00281580|69679890|FG015|Overall Study|Withdrawal by Subject|5|||
37995174|NCT00281580|69679875|FG000|Overall Study|Lack of Efficacy|2|||
37995175|NCT00281580|69679876|FG001|Overall Study|Lack of Efficacy|1|||
37995176|NCT00281580|69679877|FG002|Overall Study|Lack of Efficacy|1|||
37995177|NCT00281580|69679878|FG003|Overall Study|Lack of Efficacy|6|||
37896617|NCT01004822|69581745|FG007|Overall Study|Objective progression or relapse|4|||
37896618|NCT01004822|69581738|FG000|Overall Study|Global deterioration of health status|0|||
37896619|NCT01004822|69581739|FG001|Overall Study|Global deterioration of health status|0|||
37896620|NCT01004822|69581740|FG002|Overall Study|Global deterioration of health status|0|||
37896621|NCT01004822|69581741|FG003|Overall Study|Global deterioration of health status|1|||
37896622|NCT01004822|69581742|FG004|Overall Study|Global deterioration of health status|0|||
37896623|NCT01004822|69581743|FG005|Overall Study|Global deterioration of health status|0|||
37896624|NCT01004822|69581744|FG006|Overall Study|Global deterioration of health status|1|||
37896625|NCT01004822|69581745|FG007|Overall Study|Global deterioration of health status|0|||
37896626|NCT01004822|69581738|FG000|Overall Study|No longer willing to continue|0|||
37896627|NCT01004822|69581739|FG001|Overall Study|No longer willing to continue|0|||
37896628|NCT01004822|69581740|FG002|Overall Study|No longer willing to continue|0|||
37896629|NCT01004822|69581741|FG003|Overall Study|No longer willing to continue|1|||
37896630|NCT01004822|69581742|FG004|Overall Study|No longer willing to continue|2|||
37896631|NCT01004822|69581743|FG005|Overall Study|No longer willing to continue|1|||
37896632|NCT01004822|69581744|FG006|Overall Study|No longer willing to continue|1|||
37896633|NCT01004822|69581745|FG007|Overall Study|No longer willing to continue|0|||
37896634|NCT01004822|69581738|FG000|Overall Study|Adverse Event|0|||
37896635|NCT01004822|69581739|FG001|Overall Study|Adverse Event|0|||
37896636|NCT01004822|69581740|FG002|Overall Study|Adverse Event|0|||
37896637|NCT01004822|69581741|FG003|Overall Study|Adverse Event|0|||
37896638|NCT01004822|69581742|FG004|Overall Study|Adverse Event|0|||
37896639|NCT01004822|69581743|FG005|Overall Study|Adverse Event|0|||
37896640|NCT01004822|69581744|FG006|Overall Study|Adverse Event|1|||
37896641|NCT01004822|69581745|FG007|Overall Study|Adverse Event|1|||
37896642|NCT01004822|69581738|FG000|Overall Study|Other|0|||
37896643|NCT01004822|69581739|FG001|Overall Study|Other|0|||
37896644|NCT01004822|69581740|FG002|Overall Study|Other|4|||
37896645|NCT01004822|69581741|FG003|Overall Study|Other|1|||
37896646|NCT01004822|69581742|FG004|Overall Study|Other|0|||
37896647|NCT01004822|69581743|FG005|Overall Study|Other|1|||
37896648|NCT01004822|69581744|FG006|Overall Study|Other|0|||
37896649|NCT01004822|69581745|FG007|Overall Study|Other|0|||
37896650|NCT01001234|69581770|FG000|Overall Study|Withdrawal by Subject|2|||
37896651|NCT01001234|69581771|FG001|Overall Study|Withdrawal by Subject|0|||
37995178|NCT00281580|69679879|FG004|Overall Study|Lack of Efficacy|2|||
37995179|NCT00281580|69679880|FG005|Overall Study|Lack of Efficacy|0|||
37995180|NCT00281580|69679881|FG006|Overall Study|Lack of Efficacy|0|||
37995181|NCT00281580|69679882|FG007|Overall Study|Lack of Efficacy|0|||
37995182|NCT00281580|69679883|FG008|Overall Study|Lack of Efficacy|0|||
37995183|NCT00281580|69679884|FG009|Overall Study|Lack of Efficacy|0|||
37896652|NCT01001234|69581772|FG002|Overall Study|Withdrawal by Subject|3|||
37896653|NCT01001234|69581773|FG003|Overall Study|Withdrawal by Subject|0|||
37896654|NCT01001234|69581774|FG004|Overall Study|Withdrawal by Subject|0|||
37896655|NCT01001234|69581770|FG000|Overall Study|Protocol Violation|34|||
37995184|NCT00281580|69679885|FG010|Overall Study|Lack of Efficacy|0|||
37995185|NCT00281580|69679886|FG011|Overall Study|Lack of Efficacy|1|||
37995186|NCT00281580|69679887|FG012|Overall Study|Lack of Efficacy|0|||
37995187|NCT00281580|69679888|FG013|Overall Study|Lack of Efficacy|2|||
37995188|NCT00281580|69679889|FG014|Overall Study|Lack of Efficacy|1|||
37995189|NCT00281580|69679890|FG015|Overall Study|Lack of Efficacy|0|||
37995190|NCT00281580|69679875|FG000|Overall Study|Lost to Follow-up|0|||
37995191|NCT00281580|69679876|FG001|Overall Study|Lost to Follow-up|0|||
37995192|NCT00281580|69679877|FG002|Overall Study|Lost to Follow-up|0|||
37995193|NCT00281580|69679878|FG003|Overall Study|Lost to Follow-up|3|||
37995194|NCT00281580|69679879|FG004|Overall Study|Lost to Follow-up|0|||
37995195|NCT00281580|69679880|FG005|Overall Study|Lost to Follow-up|1|||
37995196|NCT00281580|69679881|FG006|Overall Study|Lost to Follow-up|0|||
37995197|NCT00281580|69679882|FG007|Overall Study|Lost to Follow-up|1|||
37995198|NCT00281580|69679883|FG008|Overall Study|Lost to Follow-up|2|||
37995199|NCT00281580|69679884|FG009|Overall Study|Lost to Follow-up|1|||
37995200|NCT00281580|69679885|FG010|Overall Study|Lost to Follow-up|1|||
37995201|NCT00281580|69679886|FG011|Overall Study|Lost to Follow-up|0|||
37995202|NCT00281580|69679887|FG012|Overall Study|Lost to Follow-up|1|||
37995203|NCT00281580|69679888|FG013|Overall Study|Lost to Follow-up|0|||
37995204|NCT00281580|69679889|FG014|Overall Study|Lost to Follow-up|0|||
37995205|NCT00281580|69679890|FG015|Overall Study|Lost to Follow-up|0|||
37995206|NCT00281580|69679875|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
37995207|NCT00281580|69679876|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
37995208|NCT00281580|69679877|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
37995209|NCT00281580|69679878|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
37995210|NCT00281580|69679879|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
37995211|NCT00281580|69679880|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
37995212|NCT00281580|69679881|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
37995213|NCT00281580|69679882|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
37995214|NCT00281580|69679883|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
37995215|NCT00281580|69679884|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
37995216|NCT00281580|69679885|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
37995217|NCT00281580|69679886|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
37995218|NCT00281580|69679887|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
37995219|NCT00281580|69679888|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
37995220|NCT00281580|69679889|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
37995221|NCT00281580|69679890|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
37995222|NCT00495755|69679959|FG000|Overall Study|Adverse Event|3|||
37995223|NCT00495677|69679971|FG000|Stage 1 (25 Days)|Adverse Event|0|||
37995224|NCT00495677|69679972|FG001|Stage 1 (25 Days)|Adverse Event|0|||
37995225|NCT00495677|69679973|FG002|Stage 1 (25 Days)|Adverse Event|1|||
37995226|NCT00495677|69679974|FG003|Stage 1 (25 Days)|Adverse Event|0|||
37995227|NCT00495677|69679975|FG004|Stage 1 (25 Days)|Adverse Event|0|||
37995228|NCT00495677|69679976|FG005|Stage 1 (25 Days)|Adverse Event|0|||
37995229|NCT00495677|69679977|FG006|Stage 1 (25 Days)|Adverse Event|0|||
37995230|NCT00495521|69679995|FG000|Overall Study|Physician Decision|0|||
37995231|NCT00495521|69679996|FG001|Overall Study|Physician Decision|1|||
37995232|NCT00273858|69680002|FG000|Overall Study|Not completed 24 month observation time|334|||
37995233|NCT00273858|69680002|FG000|Overall Study|Lost to Follow-up|101|||
37995234|NCT00273858|69680002|FG000|Overall Study|Withdrawal by Subject|21|||
37995235|NCT00273858|69680002|FG000|Overall Study|Adverse Event|81|||
37995236|NCT00494507|69680010|FG000|Double-Blind Phase|Adverse Event|2|||
37995237|NCT00494507|69680011|FG001|Double-Blind Phase|Adverse Event|0|||
37995238|NCT00494507|69680012|FG002|Double-Blind Phase|Adverse Event|1|||
37995239|NCT00494507|69680013|FG003|Double-Blind Phase|Adverse Event|0|||
37995240|NCT00494507|69680010|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
37995241|NCT00494507|69680011|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
37995242|NCT00494507|69680012|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
37995243|NCT00494507|69680013|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
37995244|NCT00494507|69680010|FG000|Double-Blind Phase|Subject Non-compliance|0|||
37995245|NCT00494507|69680011|FG001|Double-Blind Phase|Subject Non-compliance|0|||
37995246|NCT00494507|69680012|FG002|Double-Blind Phase|Subject Non-compliance|1|||
37995247|NCT00494507|69680013|FG003|Double-Blind Phase|Subject Non-compliance|0|||
37995248|NCT00494507|69680010|FG000|Double-Blind Phase|Negative DNA test|0|||
37995249|NCT00494507|69680011|FG001|Double-Blind Phase|Negative DNA test|0|||
37995250|NCT00494507|69680012|FG002|Double-Blind Phase|Negative DNA test|0|||
37995251|NCT00494507|69680013|FG003|Double-Blind Phase|Negative DNA test|1|||
37995252|NCT00494507|69680010|FG000|Open-Label Phase|Adverse Event|0|||
37995253|NCT00494507|69680011|FG001|Open-Label Phase|Adverse Event|1|||
37995254|NCT00494507|69680012|FG002|Open-Label Phase|Adverse Event|5|||
37995255|NCT00494507|69680013|FG003|Open-Label Phase|Adverse Event|3|||
37995256|NCT00494507|69680010|FG000|Open-Label Phase|Worsening Disease|0|||
37995257|NCT00494507|69680011|FG001|Open-Label Phase|Worsening Disease|0|||
37995258|NCT00494507|69680012|FG002|Open-Label Phase|Worsening Disease|0|||
37995259|NCT00494507|69680013|FG003|Open-Label Phase|Worsening Disease|2|||
37995260|NCT00292188|69680035|FG000|Single-Blind|Adverse Event|14|||
37995261|NCT00292188|69680036|FG001|Single-Blind|Adverse Event|0|||
37995262|NCT00292188|69680037|FG002|Single-Blind|Adverse Event|0|||
37995263|NCT00292188|69680035|FG000|Single-Blind|Lack of Efficacy|2|||
37995264|NCT00292188|69680036|FG001|Single-Blind|Lack of Efficacy|0|||
37995265|NCT00292188|69680037|FG002|Single-Blind|Lack of Efficacy|0|||
37995266|NCT00292188|69680035|FG000|Single-Blind|Laboratory Abnormality|5|||
37995267|NCT00292188|69680036|FG001|Single-Blind|Laboratory Abnormality|0|||
37995268|NCT00292188|69680037|FG002|Single-Blind|Laboratory Abnormality|0|||
37995269|NCT00292188|69680035|FG000|Single-Blind|Lost to Follow-up|3|||
37995270|NCT00292188|69680036|FG001|Single-Blind|Lost to Follow-up|0|||
37995271|NCT00292188|69680037|FG002|Single-Blind|Lost to Follow-up|0|||
37995272|NCT00292188|69680035|FG000|Single-Blind|Other|77|||
37995273|NCT00292188|69680036|FG001|Single-Blind|Other|0|||
37995274|NCT00292188|69680037|FG002|Single-Blind|Other|0|||
37995275|NCT00292188|69680035|FG000|Single-Blind|Withdrawal by Subject|12|||
37995276|NCT00292188|69680036|FG001|Single-Blind|Withdrawal by Subject|0|||
37995277|NCT00292188|69680037|FG002|Single-Blind|Withdrawal by Subject|0|||
37995278|NCT00292188|69680035|FG000|Single-Blind|Did not receive treatment|1|||
37995279|NCT00292188|69680036|FG001|Single-Blind|Did not receive treatment|0|||
37995280|NCT00292188|69680037|FG002|Single-Blind|Did not receive treatment|0|||
37995281|NCT00292188|69680035|FG000|Double-Blind|Adverse Event|0|||
37995282|NCT00292188|69680036|FG001|Double-Blind|Adverse Event|25|||
37995283|NCT00292188|69680037|FG002|Double-Blind|Adverse Event|9|||
37995284|NCT00292188|69680035|FG000|Double-Blind|Lack of Efficacy|0|||
37995285|NCT00292188|69680036|FG001|Double-Blind|Lack of Efficacy|2|||
37995286|NCT00292188|69680037|FG002|Double-Blind|Lack of Efficacy|12|||
37995287|NCT00292188|69680035|FG000|Double-Blind|Lost to Follow-up|0|||
37995288|NCT00292188|69680036|FG001|Double-Blind|Lost to Follow-up|1|||
37995289|NCT00292188|69680037|FG002|Double-Blind|Lost to Follow-up|0|||
37995290|NCT00292188|69680035|FG000|Double-Blind|Other|0|||
37995291|NCT00292188|69680036|FG001|Double-Blind|Other|3|||
37995292|NCT00292188|69680037|FG002|Double-Blind|Other|4|||
37995293|NCT00292188|69680035|FG000|Double-Blind|Withdrawal by Subject|0|||
37995294|NCT00292188|69680036|FG001|Double-Blind|Withdrawal by Subject|0|||
37995295|NCT00292188|69680037|FG002|Double-Blind|Withdrawal by Subject|3|||
37995296|NCT00292188|69680035|FG000|Double-Blind|Laboratory Abnormality|0|||
37995297|NCT00292188|69680036|FG001|Double-Blind|Laboratory Abnormality|0|||
37995298|NCT00292188|69680037|FG002|Double-Blind|Laboratory Abnormality|1|||
37995299|NCT00272844|69680044|FG000|Overall Study|Withdrawal by Subject|5|||
37995300|NCT00271596|69680050|FG000|Overall Study|Protocol Violation|1|||
37995301|NCT00271596|69680051|FG001|Overall Study|Protocol Violation|0|||
37995302|NCT00271596|69680050|FG000|Overall Study|Withdrawal by Subject|0|||
37995303|NCT00271596|69680051|FG001|Overall Study|Withdrawal by Subject|1|||
37995304|NCT00291642|69680062|FG000|Overall Study|Adverse Event|1|||
37995305|NCT00291642|69680063|FG001|Overall Study|Adverse Event|0|||
37995306|NCT00291642|69680064|FG002|Overall Study|Adverse Event|1|||
37995307|NCT00291642|69680065|FG003|Overall Study|Adverse Event|0|||
37995308|NCT00291642|69680066|FG004|Overall Study|Adverse Event|1|||
37995309|NCT00291642|69680062|FG000|Overall Study|Patient missed visit|0|||
37995310|NCT00291642|69680063|FG001|Overall Study|Patient missed visit|0|||
37995311|NCT00291642|69680064|FG002|Overall Study|Patient missed visit|1|||
37995312|NCT00291642|69680065|FG003|Overall Study|Patient missed visit|0|||
37995313|NCT00291642|69680066|FG004|Overall Study|Patient missed visit|0|||
37995314|NCT00291642|69680062|FG000|Overall Study|Intake of prohibited medication|1|||
37995315|NCT00291642|69680063|FG001|Overall Study|Intake of prohibited medication|0|||
37995316|NCT00291642|69680064|FG002|Overall Study|Intake of prohibited medication|0|||
37995317|NCT00291642|69680065|FG003|Overall Study|Intake of prohibited medication|0|||
37995318|NCT00291642|69680066|FG004|Overall Study|Intake of prohibited medication|0|||
37995319|NCT00280566|69680080|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
37995320|NCT00280566|69680081|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
37995321|NCT00280566|69680082|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
37995322|NCT00280566|69680080|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
37995323|NCT00280566|69680081|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
37995324|NCT00280566|69680082|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
37995325|NCT00280566|69680080|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
37995326|NCT00280566|69680081|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
37995327|NCT00280566|69680082|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
37995328|NCT00280566|69680080|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
37995329|NCT00280566|69680081|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
37995330|NCT00280566|69680082|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
37995331|NCT00280566|69680080|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
37995332|NCT00280566|69680081|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
37995333|NCT00280566|69680082|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
37995334|NCT00280566|69680080|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
37995335|NCT00280566|69680081|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
37995336|NCT00280566|69680082|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
37896656|NCT01001234|69581771|FG001|Overall Study|Protocol Violation|3|||
37995337|NCT00280566|69680080|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
37995338|NCT00280566|69680081|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
37995339|NCT00280566|69680082|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
37995340|NCT00280566|69680080|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
37995341|NCT00280566|69680081|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
37995342|NCT00280566|69680082|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
37995343|NCT00280566|69680080|FG000|Period 2 Double Blind|Adverse Event|0|||
37995344|NCT00280566|69680081|FG001|Period 2 Double Blind|Adverse Event|11|||
37995345|NCT00280566|69680082|FG002|Period 2 Double Blind|Adverse Event|15|||
37995346|NCT00280566|69680080|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
37995347|NCT00280566|69680081|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
37995348|NCT00280566|69680082|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
37995349|NCT00280566|69680080|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
37995350|NCT00280566|69680081|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
37995351|NCT00280566|69680082|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
37995352|NCT00280566|69680080|FG000|Period 2 Double Blind|miscellaneous|0|||
37995353|NCT00280566|69680081|FG001|Period 2 Double Blind|miscellaneous|10|||
37995354|NCT00280566|69680082|FG002|Period 2 Double Blind|miscellaneous|5|||
37995355|NCT00270894|69680089|FG000|Overall Study|Adverse Event|1|||
37995356|NCT00270894|69680089|FG000|Overall Study|Withdrawal by Subject|1|||
37995357|NCT00317642|69680095|FG000|Overall Study|Not Received Either Study Drug|1|||
37995358|NCT00317642|69680096|FG001|Overall Study|Not Received Either Study Drug|3|||
37995359|NCT00317642|69680095|FG000|Overall Study|Physician Decision|15|||
37995360|NCT00317642|69680096|FG001|Overall Study|Physician Decision|7|||
37995361|NCT00317642|69680095|FG000|Overall Study|Participant declined treatment|14|||
37995362|NCT00317642|69680096|FG001|Overall Study|Participant declined treatment|3|||
37995363|NCT00317642|69680095|FG000|Overall Study|Adverse Event|17|||
37995364|NCT00317642|69680096|FG001|Overall Study|Adverse Event|5|||
37995365|NCT00317642|69680095|FG000|Overall Study|Treatment Failure|56|||
37995366|NCT00317642|69680096|FG001|Overall Study|Treatment Failure|102|||
37995367|NCT00317642|69680095|FG000|Overall Study|Disease Recurrence|1|||
37995368|NCT00317642|69680096|FG001|Overall Study|Disease Recurrence|2|||
37995369|NCT00317642|69680095|FG000|Overall Study|Death|14|||
37995370|NCT00317642|69680096|FG001|Overall Study|Death|7|||
37995371|NCT00317642|69680095|FG000|Overall Study|Not Continue to Consolidation|2|||
37995372|NCT00317642|69680096|FG001|Overall Study|Not Continue to Consolidation|0|||
37995373|NCT00317642|69680095|FG000|Overall Study|Withdrawal by Subject|0|||
37995374|NCT00317642|69680096|FG001|Overall Study|Withdrawal by Subject|1|||
37995375|NCT00317642|69680095|FG000|Overall Study|Referred For Transplantation|1|||
37995376|NCT00317642|69680096|FG001|Overall Study|Referred For Transplantation|0|||
37995377|NCT00317642|69680095|FG000|Overall Study|AML Not Centrally Confirmed|1|||
37995378|NCT00317642|69680096|FG001|Overall Study|AML Not Centrally Confirmed|5|||
37995379|NCT00295022|69680112|FG000|Overall Study|Adverse Event|1|||
37995380|NCT00295022|69680113|FG001|Overall Study|Adverse Event|1|||
37995381|NCT00295022|69680114|FG002|Overall Study|Adverse Event|2|||
37995382|NCT00295022|69680112|FG000|Overall Study|Lost to Follow-up|0|||
37995383|NCT00295022|69680113|FG001|Overall Study|Lost to Follow-up|0|||
37995384|NCT00295022|69680114|FG002|Overall Study|Lost to Follow-up|1|||
37995385|NCT00295022|69680112|FG000|Overall Study|Withdrawal by Subject|0|||
37995386|NCT00295022|69680113|FG001|Overall Study|Withdrawal by Subject|0|||
37995387|NCT00295022|69680114|FG002|Overall Study|Withdrawal by Subject|2|||
37995388|NCT00303446|69680126|FG000|Overall Study|Withdrawal by Subject|2|||
37995389|NCT00303446|69680127|FG001|Overall Study|Withdrawal by Subject|2|||
37995390|NCT00303446|69680126|FG000|Overall Study|Death|0|||
37995391|NCT00303446|69680127|FG001|Overall Study|Death|1|||
37995392|NCT00303446|69680126|FG000|Overall Study|Physician Decision|0|||
37995393|NCT00303446|69680127|FG001|Overall Study|Physician Decision|1|||
37995394|NCT00316706|69680135|FG000|Overall Study|Lost to Follow-up|38|||
37995395|NCT00316706|69680136|FG001|Overall Study|Lost to Follow-up|48|||
37995396|NCT00291486|69680147|FG000|Overall Study|Adverse Event|0|||
37995397|NCT00291486|69680148|FG001|Overall Study|Adverse Event|3|||
37995398|NCT00291486|69680149|FG002|Overall Study|Adverse Event|0|||
37995399|NCT00291486|69680150|FG003|Overall Study|Adverse Event|1|||
37825579|NCT01242514|69507592|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
37825580|NCT01242514|69507593|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
37995400|NCT00291486|69680151|FG004|Overall Study|Adverse Event|0|||
37825581|NCT01242514|69507591|FG000|Overall Study|Lost to Follow-up|14|||
37825582|NCT01242514|69507592|FG001|Overall Study|Lost to Follow-up|5|||
37825583|NCT01242514|69507593|FG002|Overall Study|Lost to Follow-up|4|||
37825584|NCT01242514|69507591|FG000|Overall Study|Adverse Event|129|||
37825585|NCT01242514|69507592|FG001|Overall Study|Adverse Event|18|||
37995401|NCT00291486|69680147|FG000|Overall Study|Withdrawal by Subject|0|||
37995402|NCT00291486|69680148|FG001|Overall Study|Withdrawal by Subject|0|||
37995403|NCT00291486|69680149|FG002|Overall Study|Withdrawal by Subject|0|||
37995404|NCT00291486|69680150|FG003|Overall Study|Withdrawal by Subject|0|||
37995405|NCT00291486|69680151|FG004|Overall Study|Withdrawal by Subject|1|||
37995406|NCT00291486|69680147|FG000|Overall Study|Disease progression|1|||
37995407|NCT00291486|69680148|FG001|Overall Study|Disease progression|0|||
37995408|NCT00291486|69680149|FG002|Overall Study|Disease progression|1|||
37995409|NCT00291486|69680150|FG003|Overall Study|Disease progression|0|||
37995410|NCT00291486|69680151|FG004|Overall Study|Disease progression|0|||
37995411|NCT00301964|69680172|FG000|Overall Study|Second primary|2|||
37995412|NCT00301964|69680172|FG000|Overall Study|Wrong primary|1|||
37995413|NCT00301964|69680172|FG000|Overall Study|Inadequate pathology|1|||
37995414|NCT00268242|69680182|FG000|Overall Study|Death|1|||
37995415|NCT00294554|69680188|FG000|Overall Study|Lack of Efficacy|0|||
37995416|NCT00294554|69680189|FG001|Overall Study|Lack of Efficacy|1|||
37995417|NCT00294554|69680188|FG000|Overall Study|Physician Decision|0|||
37995418|NCT00294554|69680189|FG001|Overall Study|Physician Decision|1|||
37995419|NCT00294398|69680197|FG000|Overall Study|Lost to Follow-up|21|||
37995420|NCT00294398|69680198|FG001|Overall Study|Lost to Follow-up|26|||
37995421|NCT00279708|69680206|FG000|Overall Study|Withdrawal by Subject|2|||
37995422|NCT00279708|69680207|FG001|Overall Study|Withdrawal by Subject|3|||
37995423|NCT00279708|69680206|FG000|Overall Study|Adverse Event|1|||
37995424|NCT00279708|69680207|FG001|Overall Study|Adverse Event|1|||
37995425|NCT00299702|69680215|FG000|Overall Study|Death|1|||
37995426|NCT00299702|69680216|FG001|Overall Study|Death|0|||
37995427|NCT00299702|69680215|FG000|Overall Study|Adverse Event|0|||
37995428|NCT00299702|69680216|FG001|Overall Study|Adverse Event|4|||
37995429|NCT00299702|69680215|FG000|Overall Study|Lost to Follow-up|18|||
37995430|NCT00299702|69680216|FG001|Overall Study|Lost to Follow-up|10|||
37995431|NCT00299702|69680215|FG000|Overall Study|Withdrawal by Subject|25|||
37995432|NCT00299702|69680216|FG001|Overall Study|Withdrawal by Subject|23|||
37995433|NCT00299702|69680215|FG000|Overall Study|Pregnancy|0|||
37995434|NCT00299702|69680216|FG001|Overall Study|Pregnancy|1|||
37995435|NCT00299702|69680215|FG000|Overall Study|Insufficient Response|4|||
37995436|NCT00299702|69680216|FG001|Overall Study|Insufficient Response|3|||
37995437|NCT00299702|69680215|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
37995438|NCT00299702|69680216|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
37995439|NCT00291330|69680224|FG000|Overall Study|Adverse Event|47|||
37995440|NCT00291330|69680225|FG001|Overall Study|Adverse Event|40|||
37995441|NCT00291330|69680224|FG000|Overall Study|Protocol Violation|13|||
37995442|NCT00291330|69680225|FG001|Overall Study|Protocol Violation|20|||
37995443|NCT00291330|69680224|FG000|Overall Study|Lost to Follow-up|16|||
37995444|NCT00291330|69680225|FG001|Overall Study|Lost to Follow-up|11|||
37995445|NCT00291330|69680224|FG000|Overall Study|Withdrawal by Subject|22|||
37995446|NCT00291330|69680225|FG001|Overall Study|Withdrawal by Subject|25|||
37995447|NCT00291330|69680224|FG000|Overall Study|Other|3|||
37995448|NCT00291330|69680225|FG001|Overall Study|Other|1|||
37995449|NCT00267150|69680231|FG000|Overall Study|Adverse Event|1|||
37995450|NCT00278148|69680235|FG000|Phase II - Expansion Phase|Disease progression|0|||
37995451|NCT00278148|69680236|FG001|Phase II - Expansion Phase|Disease progression|0|||
37995452|NCT00278148|69680237|FG002|Phase II - Expansion Phase|Disease progression|4|||
37995453|NCT00278148|69680235|FG000|Phase II - Expansion Phase|Adverse Event|0|||
37995454|NCT00278148|69680236|FG001|Phase II - Expansion Phase|Adverse Event|0|||
37995455|NCT00278148|69680237|FG002|Phase II - Expansion Phase|Adverse Event|2|||
37995456|NCT00299546|69680247|FG000|Overall Study|Death|3|||
37995457|NCT00299546|69680248|FG001|Overall Study|Death|2|||
37696340|NCT02270983|69172448|FG000|Overall Study|Withdrawal by Subject|1|||
37696341|NCT02270983|69172449|FG001|Overall Study|Withdrawal by Subject|0|||
37696342|NCT02270983|69172450|FG002|Overall Study|Withdrawal by Subject|2|||
37696343|NCT02270983|69172448|FG000|Overall Study|Lost to Follow-up|1|||
37696344|NCT02270983|69172449|FG001|Overall Study|Lost to Follow-up|1|||
37696345|NCT02270983|69172450|FG002|Overall Study|Lost to Follow-up|2|||
37696346|NCT02270983|69172448|FG000|Overall Study|Protocol Violation|1|||
37696347|NCT02270983|69172449|FG001|Overall Study|Protocol Violation|1|||
37995458|NCT00299546|69680249|FG002|Overall Study|Death|0|||
37995459|NCT00299546|69680247|FG000|Overall Study|Lost to Follow-up|2|||
37995460|NCT00299546|69680248|FG001|Overall Study|Lost to Follow-up|2|||
37995461|NCT00299546|69680249|FG002|Overall Study|Lost to Follow-up|5|||
37995462|NCT00299546|69680247|FG000|Overall Study|Adverse Event|37|||
37995463|NCT00299546|69680248|FG001|Overall Study|Adverse Event|22|||
37995464|NCT00299546|69680249|FG002|Overall Study|Adverse Event|27|||
37995465|NCT00299546|69680247|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
37995466|NCT00299546|69680248|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
37995467|NCT00299546|69680249|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
37995468|NCT00299546|69680247|FG000|Overall Study|Other|24|||
37995469|NCT00299546|69680248|FG001|Overall Study|Other|26|||
37995470|NCT00299546|69680249|FG002|Overall Study|Other|19|||
37995471|NCT00299546|69680247|FG000|Overall Study|Not treated|0|||
37995472|NCT00299546|69680248|FG001|Overall Study|Not treated|1|||
37995473|NCT00299546|69680249|FG002|Overall Study|Not treated|1|||
37995474|NCT00299156|69680261|FG000|Period 2 (Randomized)|Screen Failure|0|||
37995475|NCT00299156|69680262|FG001|Period 2 (Randomized)|Screen Failure|1|||
37995476|NCT00299156|69680263|FG002|Period 2 (Randomized)|Screen Failure|0|||
37995477|NCT00277212|69680271|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
37995478|NCT00277212|69680272|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
37995479|NCT00277212|69680273|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
37995480|NCT00277212|69680271|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
37995481|NCT00277212|69680272|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
37995482|NCT00277212|69680273|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
37995483|NCT00277212|69680271|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
37995484|NCT00277212|69680272|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
37995485|NCT00277212|69680273|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
37995486|NCT00277212|69680271|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
37995487|NCT00277212|69680272|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
37995488|NCT00277212|69680273|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
37995489|NCT00277212|69680271|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
37995490|NCT00277212|69680272|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
37995491|NCT00277212|69680273|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
37995492|NCT00277212|69680271|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
37995493|NCT00277212|69680272|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
37995494|NCT00277212|69680273|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
37995495|NCT00277212|69680271|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
37995496|NCT00277212|69680272|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
37995497|NCT00277212|69680273|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
37995498|NCT00277212|69680271|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
37995499|NCT00277212|69680272|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
37995500|NCT00277212|69680273|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
37995501|NCT00277212|69680271|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
37995502|NCT00277212|69680272|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
37995503|NCT00277212|69680273|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
37995504|NCT00277212|69680271|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
37995505|NCT00277212|69680272|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
37995506|NCT00277212|69680273|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
37995507|NCT00277212|69680271|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
37995508|NCT00277212|69680272|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
37995509|NCT00277212|69680273|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
37995510|NCT00277212|69680271|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
37995511|NCT00277212|69680272|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
37995512|NCT00277212|69680273|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
37995513|NCT00277212|69680271|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
37995514|NCT00277212|69680272|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
37995515|NCT00277212|69680273|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
37995516|NCT00277212|69680271|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
37995517|NCT00277212|69680272|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
37995518|NCT00277212|69680273|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
37995519|NCT00277212|69680271|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
37995520|NCT00277212|69680272|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
37995521|NCT00277212|69680273|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
37995522|NCT00277212|69680271|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
37995523|NCT00277212|69680272|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
37995524|NCT00277212|69680273|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
37995525|NCT00277212|69680271|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
37995526|NCT00277212|69680272|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
37995527|NCT00277212|69680273|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
37995528|NCT00277212|69680271|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
37995529|NCT00277212|69680272|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
37995530|NCT00277212|69680273|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
37995531|NCT00276744|69680281|FG000|PART A|Reason unknown|98|||
37995532|NCT00251316|69680287|FG000|Overall Study|Physician Decision|2|||
37995533|NCT00251316|69680288|FG001|Overall Study|Physician Decision|3|||
37995534|NCT00293462|69680297|FG000|Overall Study|Withdrawal by Subject|4|||
37995535|NCT00293462|69680298|FG001|Overall Study|Withdrawal by Subject|3|||
37896657|NCT01001234|69581772|FG002|Overall Study|Protocol Violation|19|||
37896658|NCT01001234|69581773|FG003|Overall Study|Protocol Violation|18|||
37995536|NCT00293462|69680299|FG002|Overall Study|Withdrawal by Subject|8|||
37995537|NCT00293462|69680297|FG000|Overall Study|Death|1|||
37995538|NCT00293462|69680298|FG001|Overall Study|Death|0|||
37995539|NCT00293462|69680299|FG002|Overall Study|Death|0|||
37995540|NCT00293462|69680297|FG000|Overall Study|Lost to Follow-up|0|||
37995541|NCT00293462|69680298|FG001|Overall Study|Lost to Follow-up|1|||
37995542|NCT00293462|69680299|FG002|Overall Study|Lost to Follow-up|0|||
37995543|NCT00293462|69680297|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
37995544|NCT00293462|69680298|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
37995545|NCT00293462|69680299|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
37995546|NCT00293462|69680297|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
37995547|NCT00293462|69680298|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
37995548|NCT00293462|69680299|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
37995549|NCT00293462|69680297|FG000|Overall Study|Refuse Radiation Treatment|1|||
37995550|NCT00293462|69680298|FG001|Overall Study|Refuse Radiation Treatment|0|||
37995551|NCT00293462|69680299|FG002|Overall Study|Refuse Radiation Treatment|0|||
37995552|NCT00293462|69680297|FG000|Overall Study|No Show|0|||
37995553|NCT00293462|69680298|FG001|Overall Study|No Show|0|||
37995554|NCT00293462|69680299|FG002|Overall Study|No Show|1|||
37995555|NCT00293462|69680297|FG000|Overall Study|Went back to his home country|0|||
37995556|NCT00293462|69680298|FG001|Overall Study|Went back to his home country|0|||
37995557|NCT00293462|69680299|FG002|Overall Study|Went back to his home country|1|||
37995558|NCT00293462|69680297|FG000|Overall Study|Blood clot after chemotherapy|0|||
37995559|NCT00293462|69680298|FG001|Overall Study|Blood clot after chemotherapy|0|||
37995560|NCT00293462|69680299|FG002|Overall Study|Blood clot after chemotherapy|1|||
37995561|NCT00293462|69680297|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
37995562|NCT00293462|69680298|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
37995563|NCT00293462|69680299|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
37995564|NCT00293462|69680297|FG000|Overall Study|Possible Tracheostomy leakage|0|||
37995565|NCT00293462|69680298|FG001|Overall Study|Possible Tracheostomy leakage|1|||
37995566|NCT00293462|69680299|FG002|Overall Study|Possible Tracheostomy leakage|0|||
37995567|NCT00293462|69680297|FG000|Overall Study|Low radiation dose in oral cavity|0|||
37995568|NCT00293462|69680298|FG001|Overall Study|Low radiation dose in oral cavity|1|||
37995569|NCT00293462|69680299|FG002|Overall Study|Low radiation dose in oral cavity|0|||
37995570|NCT00293462|69680297|FG000|Overall Study|Physician Decision|0|||
37995571|NCT00293462|69680298|FG001|Overall Study|Physician Decision|1|||
37995572|NCT00293462|69680299|FG002|Overall Study|Physician Decision|0|||
37995573|NCT00316082|69680312|FG000|Overall Study|Lack of Efficacy|2|||
37995574|NCT00316082|69680313|FG001|Overall Study|Lack of Efficacy|3|||
37995575|NCT00316082|69680314|FG002|Overall Study|Lack of Efficacy|3|||
37995576|NCT00316082|69680315|FG003|Overall Study|Lack of Efficacy|4|||
37995577|NCT00316082|69680316|FG004|Overall Study|Lack of Efficacy|6|||
37995578|NCT00316082|69680312|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
37995579|NCT00316082|69680313|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
37995580|NCT00316082|69680314|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
37995581|NCT00316082|69680315|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
37995582|NCT00316082|69680316|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
37995583|NCT00316082|69680312|FG000|Overall Study|Lost to Follow-up|7|||
37995584|NCT00316082|69680313|FG001|Overall Study|Lost to Follow-up|6|||
37995585|NCT00316082|69680314|FG002|Overall Study|Lost to Follow-up|7|||
37995586|NCT00316082|69680315|FG003|Overall Study|Lost to Follow-up|8|||
37995587|NCT00316082|69680316|FG004|Overall Study|Lost to Follow-up|6|||
37995588|NCT00316082|69680312|FG000|Overall Study|Poor/noncompliance|6|||
37995589|NCT00316082|69680313|FG001|Overall Study|Poor/noncompliance|1|||
37995590|NCT00316082|69680314|FG002|Overall Study|Poor/noncompliance|4|||
37995591|NCT00316082|69680315|FG003|Overall Study|Poor/noncompliance|1|||
37896659|NCT01001234|69581774|FG004|Overall Study|Protocol Violation|0|||
37896660|NCT01001234|69581770|FG000|Overall Study|Lost to Follow-up|0|||
37896661|NCT01001234|69581771|FG001|Overall Study|Lost to Follow-up|0|||
37896662|NCT01001234|69581772|FG002|Overall Study|Lost to Follow-up|1|||
37896663|NCT01001234|69581773|FG003|Overall Study|Lost to Follow-up|2|||
37896664|NCT01001234|69581774|FG004|Overall Study|Lost to Follow-up|0|||
37896665|NCT01001234|69581770|FG000|Overall Study|Physician Decision|1|||
37896666|NCT01001234|69581771|FG001|Overall Study|Physician Decision|0|||
37896667|NCT01001234|69581772|FG002|Overall Study|Physician Decision|0|||
37995592|NCT00316082|69680316|FG004|Overall Study|Poor/noncompliance|4|||
37995593|NCT00316082|69680312|FG000|Overall Study|Adverse Event|4|||
37995594|NCT00316082|69680313|FG001|Overall Study|Adverse Event|2|||
37995595|NCT00316082|69680314|FG002|Overall Study|Adverse Event|5|||
37995596|NCT00316082|69680315|FG003|Overall Study|Adverse Event|1|||
37896668|NCT01001234|69581773|FG003|Overall Study|Physician Decision|0|||
37896669|NCT01001234|69581774|FG004|Overall Study|Physician Decision|0|||
37896670|NCT01001234|69581770|FG000|Overall Study|Not Treated: Adverse Event|1|||
37995597|NCT00316082|69680316|FG004|Overall Study|Adverse Event|3|||
37995598|NCT00316082|69680312|FG000|Overall Study|Subject no longer meets study criteria|3|||
37896671|NCT01001234|69581771|FG001|Overall Study|Not Treated: Adverse Event|0|||
37995599|NCT00316082|69680313|FG001|Overall Study|Subject no longer meets study criteria|1|||
37995600|NCT00316082|69680314|FG002|Overall Study|Subject no longer meets study criteria|2|||
37995601|NCT00316082|69680315|FG003|Overall Study|Subject no longer meets study criteria|2|||
37995602|NCT00316082|69680316|FG004|Overall Study|Subject no longer meets study criteria|1|||
37995603|NCT00316082|69680312|FG000|Overall Study|Physician Decision|1|||
37995604|NCT00316082|69680313|FG001|Overall Study|Physician Decision|1|||
37995605|NCT00316082|69680314|FG002|Overall Study|Physician Decision|2|||
37995606|NCT00316082|69680315|FG003|Overall Study|Physician Decision|1|||
37995607|NCT00316082|69680316|FG004|Overall Study|Physician Decision|1|||
37995608|NCT00316082|69680312|FG000|Overall Study|Death|0|||
37995609|NCT00316082|69680313|FG001|Overall Study|Death|0|||
37995610|NCT00316082|69680314|FG002|Overall Study|Death|1|||
37995611|NCT00316082|69680315|FG003|Overall Study|Death|0|||
37995612|NCT00316082|69680316|FG004|Overall Study|Death|0|||
37995613|NCT00316082|69680312|FG000|Overall Study|Administrative reason by sponsor|0|||
37995614|NCT00316082|69680313|FG001|Overall Study|Administrative reason by sponsor|0|||
37995615|NCT00316082|69680314|FG002|Overall Study|Administrative reason by sponsor|1|||
37995616|NCT00316082|69680315|FG003|Overall Study|Administrative reason by sponsor|0|||
37995617|NCT00316082|69680316|FG004|Overall Study|Administrative reason by sponsor|0|||
37995618|NCT00316004|69680335|FG000|Overall Study|Subject was not given study fluid.|14|||
37995619|NCT00316004|69680336|FG001|Overall Study|Subject was not given study fluid.|14|||
37995620|NCT00316004|69680337|FG002|Overall Study|Subject was not given study fluid.|21|||
37995621|NCT00298766|69680345|FG000|Overall Study|Adverse Event|18|||
37995622|NCT00298766|69680345|FG000|Overall Study|Death|2|||
37995623|NCT00298766|69680345|FG000|Overall Study|Withdrawal by Subject|9|||
37995624|NCT00298766|69680345|FG000|Overall Study|Treatment ongoing|4|||
37995625|NCT00298766|69680345|FG000|Overall Study|Progression of amyloid markers|4|||
37995626|NCT00298766|69680345|FG000|Overall Study|Deterioration in KPS and organ function|1|||
37995627|NCT00298766|69680345|FG000|Overall Study|Subjects overall condition deterioration|4|||
37995628|NCT00298766|69680345|FG000|Overall Study|Other|4|||
37995629|NCT00315458|69680351|FG000|Overall Study|Administrative|0|||
37995630|NCT00315458|69680352|FG001|Overall Study|Administrative|3|||
37995631|NCT00315458|69680353|FG002|Overall Study|Administrative|8|||
37995632|NCT00315458|69680354|FG003|Overall Study|Administrative|21|||
37995633|NCT00315458|69680351|FG000|Overall Study|Adverse Event|2|||
37995634|NCT00315458|69680352|FG001|Overall Study|Adverse Event|4|||
37995635|NCT00315458|69680353|FG002|Overall Study|Adverse Event|23|||
37995636|NCT00315458|69680354|FG003|Overall Study|Adverse Event|3|||
37995637|NCT00315458|69680351|FG000|Overall Study|Lost to Follow-up|1|||
37995638|NCT00315458|69680352|FG001|Overall Study|Lost to Follow-up|2|||
37995639|NCT00315458|69680353|FG002|Overall Study|Lost to Follow-up|0|||
37995640|NCT00315458|69680354|FG003|Overall Study|Lost to Follow-up|2|||
37896672|NCT01001234|69581772|FG002|Overall Study|Not Treated: Adverse Event|0|||
37896673|NCT01001234|69581773|FG003|Overall Study|Not Treated: Adverse Event|0|||
37896674|NCT01001234|69581774|FG004|Overall Study|Not Treated: Adverse Event|0|||
37896675|NCT01001234|69581770|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
37896676|NCT01001234|69581771|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
37896677|NCT01001234|69581772|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
37896678|NCT01001234|69581773|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
37896679|NCT01001234|69581774|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
37896680|NCT01001234|69581770|FG000|Overall Study|Not Treated: Protocol Violation|3|||
37896681|NCT01001234|69581771|FG001|Overall Study|Not Treated: Protocol Violation|0|||
37896682|NCT01001234|69581772|FG002|Overall Study|Not Treated: Protocol Violation|0|||
37896683|NCT01001234|69581773|FG003|Overall Study|Not Treated: Protocol Violation|0|||
37896684|NCT01001234|69581774|FG004|Overall Study|Not Treated: Protocol Violation|0|||
37896685|NCT01001234|69581770|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
37896686|NCT01001234|69581771|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
37896687|NCT01001234|69581772|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
37896688|NCT01001234|69581773|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
37896689|NCT01001234|69581774|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
37896690|NCT01001234|69581770|FG000|Overall Study|Not Treated: Pregnancy|3|||
37896691|NCT01001234|69581771|FG001|Overall Study|Not Treated: Pregnancy|0|||
37896692|NCT01001234|69581772|FG002|Overall Study|Not Treated: Pregnancy|0|||
37995641|NCT00315458|69680351|FG000|Overall Study|Withdrawal by Subject|0|||
37995642|NCT00315458|69680352|FG001|Overall Study|Withdrawal by Subject|3|||
37995643|NCT00315458|69680353|FG002|Overall Study|Withdrawal by Subject|0|||
37995644|NCT00315458|69680354|FG003|Overall Study|Withdrawal by Subject|2|||
37995645|NCT00315458|69680351|FG000|Overall Study|Lack of Efficacy|0|||
37995646|NCT00315458|69680352|FG001|Overall Study|Lack of Efficacy|0|||
37995647|NCT00315458|69680353|FG002|Overall Study|Lack of Efficacy|20|||
37995648|NCT00315458|69680354|FG003|Overall Study|Lack of Efficacy|1|||
37995649|NCT00315458|69680351|FG000|Overall Study|Did not qualify|0|||
37995650|NCT00315458|69680352|FG001|Overall Study|Did not qualify|0|||
37995651|NCT00315458|69680353|FG002|Overall Study|Did not qualify|1|||
37995652|NCT00315458|69680354|FG003|Overall Study|Did not qualify|0|||
37995653|NCT00293384|69680364|FG000|Overall Study|Non-compliance|2|||
37995654|NCT00293384|69680364|FG000|Overall Study|Missed dosage/study drug|1|||
37995655|NCT00293384|69680364|FG000|Overall Study|Ineligible|2|||
37995656|NCT00297830|69680371|FG000|6 Month Visit|Death|1|||
37995657|NCT00297830|69680372|FG001|6 Month Visit|Death|0|||
37995658|NCT00297830|69680373|FG002|6 Month Visit|Death|2|||
37995659|NCT00297830|69680371|FG000|6 Month Visit|Withdrawal by Subject|2|||
37995660|NCT00297830|69680372|FG001|6 Month Visit|Withdrawal by Subject|1|||
37995661|NCT00297830|69680373|FG002|6 Month Visit|Withdrawal by Subject|1|||
37995662|NCT00297830|69680371|FG000|6 Month Visit|Adverse Event|0|||
37995663|NCT00297830|69680372|FG001|6 Month Visit|Adverse Event|1|||
37995664|NCT00297830|69680373|FG002|6 Month Visit|Adverse Event|0|||
37995665|NCT00297830|69680371|FG000|12 Month Visit|Lost to Follow-up|1|||
37995666|NCT00297830|69680372|FG001|12 Month Visit|Lost to Follow-up|0|||
37995667|NCT00297830|69680373|FG002|12 Month Visit|Lost to Follow-up|0|||
37995668|NCT00297830|69680371|FG000|12 Month Visit|Adverse Event|0|||
37995669|NCT00297830|69680372|FG001|12 Month Visit|Adverse Event|3|||
37995670|NCT00297830|69680373|FG002|12 Month Visit|Adverse Event|0|||
37995671|NCT00297830|69680371|FG000|12 Month Visit|Withdrawal by Subject|0|||
37995672|NCT00297830|69680372|FG001|12 Month Visit|Withdrawal by Subject|3|||
37995673|NCT00297830|69680373|FG002|12 Month Visit|Withdrawal by Subject|0|||
37995674|NCT00296816|69680383|FG000|Overall Study|Disease Progression|37|||
37995675|NCT00296816|69680383|FG000|Overall Study|Adverse Event|18|||
37995676|NCT00296816|69680383|FG000|Overall Study|Investigator/Participant request|5|||
37995677|NCT00296816|69680383|FG000|Overall Study|Non-compliance|1|||
37995678|NCT00296816|69680383|FG000|Overall Study|Missing for end of treatment|4|||
37995679|NCT00296816|69680383|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
37995680|NCT00296816|69680383|FG000|Overall Study|Poor performance status|1|||
37995681|NCT00296816|69680383|FG000|Overall Study|Relocation to Florida|1|||
37995682|NCT00296816|69680383|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
37995683|NCT00296816|69680383|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
37995684|NCT00296816|69680383|FG000|Overall Study|Neuropathy/patient preference|1|||
37995685|NCT00296816|69680383|FG000|Overall Study|Proteinuria|1|||
37995686|NCT00296816|69680383|FG000|Overall Study|ineligibility due to radiation treatment|1|||
37995687|NCT00314132|69680389|FG000|Overall Study|Lost to Follow-up|3|||
37995688|NCT00314132|69680390|FG001|Overall Study|Lost to Follow-up|13|||
37995689|NCT00314132|69680389|FG000|Overall Study|Withdrawal by Subject|3|||
37995690|NCT00314132|69680390|FG001|Overall Study|Withdrawal by Subject|5|||
37995691|NCT00314132|69680389|FG000|Overall Study|Adverse Event|1|||
37995692|NCT00314132|69680390|FG001|Overall Study|Adverse Event|0|||
37995693|NCT00314132|69680389|FG000|Overall Study|Physician Decision|1|||
37995694|NCT00314132|69680390|FG001|Overall Study|Physician Decision|0|||
37995695|NCT00117988|69680398|FG000|Overall Study|Death|3|||
37995696|NCT00117988|69680398|FG000|Overall Study|Adverse Event|1|||
37995697|NCT00117676|69680404|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
37995698|NCT00117676|69680405|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
37995699|NCT00117676|69680404|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
37995700|NCT00117676|69680405|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
37995701|NCT00117676|69680404|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
37995702|NCT00117676|69680405|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
37995703|NCT00117676|69680404|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
37896693|NCT01001234|69581773|FG003|Overall Study|Not Treated: Pregnancy|0|||
37896694|NCT01001234|69581774|FG004|Overall Study|Not Treated: Pregnancy|0|||
37896695|NCT01001234|69581770|FG000|Overall Study|Not Treated: Physician Decision|37|||
37896696|NCT01001234|69581771|FG001|Overall Study|Not Treated: Physician Decision|4|||
37896697|NCT01001234|69581772|FG002|Overall Study|Not Treated: Physician Decision|0|||
37995704|NCT00117676|69680405|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
37995705|NCT00117676|69680404|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
37995706|NCT00117676|69680405|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
37995707|NCT00117676|69680404|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
37995708|NCT00117676|69680405|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
37995709|NCT00117676|69680404|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
37995710|NCT00117676|69680405|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
37995711|NCT00117676|69680404|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
37896698|NCT01001234|69581773|FG003|Overall Study|Not Treated: Physician Decision|0|||
37995712|NCT00117676|69680405|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
37995713|NCT00117676|69680404|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
37995714|NCT00117676|69680405|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
37995715|NCT00117676|69680404|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
37995716|NCT00117676|69680405|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
37995717|NCT00117676|69680404|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
37896699|NCT01001234|69581774|FG004|Overall Study|Not Treated: Physician Decision|0|||
37896700|NCT01001234|69581770|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
37896701|NCT01001234|69581771|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
37896702|NCT01001234|69581772|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
37896703|NCT01001234|69581773|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
37896704|NCT01001234|69581774|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
37896705|NCT01004510|69581780|FG000|Overall Study|Adverse Event|1|||
37896706|NCT01004432|69581784|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
37896707|NCT01004432|69581785|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
37896708|NCT01004432|69581786|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
37896709|NCT01004432|69581787|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
37995718|NCT00117676|69680405|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
37995719|NCT00117676|69680404|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
37995720|NCT00117676|69680405|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
37995721|NCT00117676|69680404|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
37995722|NCT00117676|69680405|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
37995723|NCT00117676|69680404|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
37995724|NCT00117676|69680405|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
37995725|NCT00117676|69680404|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
37995726|NCT00117676|69680405|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
37995727|NCT00117676|69680404|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
37995728|NCT00117676|69680405|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
37995729|NCT00117676|69680404|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
37995730|NCT00117676|69680405|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
37995731|NCT00117676|69680404|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
37995732|NCT00117676|69680405|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
37995733|NCT00117676|69680404|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
37995734|NCT00117676|69680405|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
37995735|NCT00117676|69680404|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
37995736|NCT00117676|69680405|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
37995737|NCT00117676|69680404|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
37995738|NCT00117676|69680405|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
37995739|NCT00117676|69680404|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
37995740|NCT00117676|69680405|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
37995741|NCT00117676|69680404|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
37995742|NCT00117676|69680405|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
37995743|NCT00117676|69680404|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
37995744|NCT00117676|69680405|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
37995745|NCT00117676|69680404|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
37995746|NCT00117676|69680405|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
37995747|NCT00117676|69680404|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
37995748|NCT00117676|69680405|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
37896710|NCT01004432|69581788|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
37896711|NCT01004432|69581784|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
37896712|NCT01004432|69581785|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
37896713|NCT01004432|69581786|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
37896714|NCT01004432|69581787|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
37896715|NCT01004432|69581788|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
37896716|NCT01004432|69581784|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
37896717|NCT01004432|69581785|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
37896718|NCT01004432|69581786|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
37896719|NCT01004432|69581787|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
37896720|NCT01004432|69581788|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
37896721|NCT01004432|69581784|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
37896722|NCT01004432|69581785|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
37896723|NCT01004432|69581786|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
37896724|NCT01004432|69581787|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
37896725|NCT01004432|69581788|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
37896726|NCT01004432|69581784|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
37896727|NCT01004432|69581785|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
37896728|NCT01004432|69581786|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
37896729|NCT01004432|69581787|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
37896730|NCT01004432|69581788|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
37696348|NCT02270983|69172450|FG002|Overall Study|Protocol Violation|1|||
37696349|NCT02270983|69172448|FG000|Overall Study|family emergency|0|||
37696350|NCT02270983|69172449|FG001|Overall Study|family emergency|1|||
37696351|NCT02270983|69172450|FG002|Overall Study|family emergency|0|||
37696352|NCT02270983|69172448|FG000|Overall Study|study procedure non-compliance|1|||
37696353|NCT02270983|69172449|FG001|Overall Study|study procedure non-compliance|0|||
37696354|NCT02270983|69172450|FG002|Overall Study|study procedure non-compliance|0|||
37896731|NCT01004432|69581784|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
37896732|NCT01004432|69581785|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
37896733|NCT01004432|69581786|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
37896734|NCT01004432|69581787|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
37696355|NCT02270983|69172448|FG000|Overall Study|moved away from study site|0|||
37696356|NCT02270983|69172449|FG001|Overall Study|moved away from study site|1|||
37696357|NCT02270983|69172450|FG002|Overall Study|moved away from study site|0|||
37696358|NCT02449889|69172461|FG000|Overall Study|Adverse Event|1|||
37696359|NCT02449889|69172462|FG001|Overall Study|Adverse Event|2|||
37696360|NCT02449889|69172463|FG002|Overall Study|Adverse Event|0|||
37696361|NCT02449889|69172461|FG000|Overall Study|Protocol Violation|0|||
37696362|NCT02449889|69172462|FG001|Overall Study|Protocol Violation|4|||
37696363|NCT02449889|69172463|FG002|Overall Study|Protocol Violation|1|||
37696364|NCT01831804|69172480|FG000|Overall Study|Adverse Event|0|||
37896735|NCT01004432|69581788|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
37896736|NCT01004432|69581784|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
37896737|NCT01004432|69581785|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
37896738|NCT01004432|69581786|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
37896739|NCT01004432|69581787|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
37896740|NCT01004432|69581788|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
37896741|NCT01004432|69581784|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
37896742|NCT01004432|69581785|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
37896743|NCT01004432|69581786|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
37896744|NCT01004432|69581787|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
37896745|NCT01004432|69581788|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
37896746|NCT01004432|69581784|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
37896747|NCT01004432|69581785|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
37896748|NCT01004432|69581786|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
37696365|NCT01831804|69172481|FG001|Overall Study|Adverse Event|0|||
37696366|NCT01831804|69172482|FG002|Overall Study|Adverse Event|0|||
37696367|NCT01831804|69172483|FG003|Overall Study|Adverse Event|0|||
37696368|NCT01831804|69172484|FG004|Overall Study|Adverse Event|0|||
37696369|NCT01831804|69172485|FG005|Overall Study|Adverse Event|0|||
37696370|NCT01831804|69172486|FG006|Overall Study|Adverse Event|1|||
37696371|NCT01831804|69172487|FG007|Overall Study|Adverse Event|0|||
37696372|NCT01831804|69172488|FG008|Overall Study|Adverse Event|1|||
37696373|NCT01831804|69172480|FG000|Overall Study|Protocol Violation|0|||
37696374|NCT01831804|69172481|FG001|Overall Study|Protocol Violation|0|||
37696375|NCT01831804|69172482|FG002|Overall Study|Protocol Violation|2|||
37696376|NCT01831804|69172483|FG003|Overall Study|Protocol Violation|0|||
37696377|NCT01831804|69172484|FG004|Overall Study|Protocol Violation|0|||
37696378|NCT01831804|69172485|FG005|Overall Study|Protocol Violation|0|||
37896749|NCT01004432|69581787|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
37896750|NCT01004432|69581788|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
37896751|NCT01004432|69581784|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
37896752|NCT01004432|69581785|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
37896753|NCT01004432|69581786|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
37896754|NCT01004432|69581787|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
37896755|NCT01004432|69581788|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
37896756|NCT01004432|69581784|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
37896757|NCT01004432|69581785|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
37896758|NCT01004432|69581786|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
37896759|NCT01004432|69581787|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
37896760|NCT01004432|69581788|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
37896761|NCT01004432|69581784|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
37696379|NCT01831804|69172486|FG006|Overall Study|Protocol Violation|0|||
37696380|NCT01831804|69172487|FG007|Overall Study|Protocol Violation|0|||
37896762|NCT01004432|69581785|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
37896763|NCT01004432|69581786|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
37896764|NCT01004432|69581787|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
37896765|NCT01004432|69581788|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
37696381|NCT01831804|69172488|FG008|Overall Study|Protocol Violation|0|||
37696382|NCT01831804|69172480|FG000|Overall Study|Protocol defined stopping criteria|1|||
37696383|NCT01831804|69172481|FG001|Overall Study|Protocol defined stopping criteria|1|||
37696384|NCT01831804|69172482|FG002|Overall Study|Protocol defined stopping criteria|3|||
37696385|NCT01831804|69172483|FG003|Overall Study|Protocol defined stopping criteria|0|||
37696386|NCT01831804|69172484|FG004|Overall Study|Protocol defined stopping criteria|1|||
37696387|NCT01831804|69172485|FG005|Overall Study|Protocol defined stopping criteria|0|||
37696388|NCT01831804|69172486|FG006|Overall Study|Protocol defined stopping criteria|0|||
37696389|NCT01831804|69172487|FG007|Overall Study|Protocol defined stopping criteria|0|||
37696390|NCT01831804|69172488|FG008|Overall Study|Protocol defined stopping criteria|0|||
37696391|NCT01831804|69172480|FG000|Overall Study|Lost to Follow-up|0|||
37696392|NCT01831804|69172481|FG001|Overall Study|Lost to Follow-up|0|||
37696393|NCT01831804|69172482|FG002|Overall Study|Lost to Follow-up|1|||
37696394|NCT01831804|69172483|FG003|Overall Study|Lost to Follow-up|0|||
37696395|NCT01831804|69172484|FG004|Overall Study|Lost to Follow-up|0|||
37696396|NCT01831804|69172485|FG005|Overall Study|Lost to Follow-up|0|||
37696397|NCT01831804|69172486|FG006|Overall Study|Lost to Follow-up|0|||
37696398|NCT01831804|69172487|FG007|Overall Study|Lost to Follow-up|0|||
37696399|NCT01831804|69172488|FG008|Overall Study|Lost to Follow-up|1|||
37696400|NCT01831804|69172480|FG000|Overall Study|Investigator discretion|0|||
37696401|NCT01831804|69172481|FG001|Overall Study|Investigator discretion|0|||
37696402|NCT01831804|69172482|FG002|Overall Study|Investigator discretion|0|||
37696403|NCT01831804|69172483|FG003|Overall Study|Investigator discretion|0|||
37696404|NCT01831804|69172484|FG004|Overall Study|Investigator discretion|1|||
37696405|NCT01831804|69172485|FG005|Overall Study|Investigator discretion|0|||
37696406|NCT01831804|69172486|FG006|Overall Study|Investigator discretion|0|||
37696407|NCT01831804|69172487|FG007|Overall Study|Investigator discretion|1|||
37696408|NCT01831804|69172488|FG008|Overall Study|Investigator discretion|0|||
37696409|NCT01831804|69172480|FG000|Overall Study|Withdrew Consent|0|||
37696410|NCT01831804|69172481|FG001|Overall Study|Withdrew Consent|1|||
37696411|NCT01831804|69172482|FG002|Overall Study|Withdrew Consent|0|||
37696412|NCT01831804|69172483|FG003|Overall Study|Withdrew Consent|0|||
37696413|NCT01831804|69172484|FG004|Overall Study|Withdrew Consent|0|||
37696414|NCT01831804|69172485|FG005|Overall Study|Withdrew Consent|0|||
37696415|NCT01831804|69172486|FG006|Overall Study|Withdrew Consent|0|||
37696416|NCT01831804|69172487|FG007|Overall Study|Withdrew Consent|2|||
37696417|NCT01831804|69172488|FG008|Overall Study|Withdrew Consent|0|||
37696418|NCT02270671|69172519|FG000|Overall Study|Withdrawal by Subject|1|||
37696419|NCT02270671|69172520|FG001|Overall Study|Withdrawal by Subject|1|||
37696420|NCT02270671|69172519|FG000|Overall Study|Protocol Violation|0|||
37696421|NCT02270671|69172520|FG001|Overall Study|Protocol Violation|1|||
37696422|NCT02270671|69172519|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
37696423|NCT02270671|69172520|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
37696424|NCT02270671|69172519|FG000|Overall Study|Lost to Follow-up|2|||
37696425|NCT02270671|69172520|FG001|Overall Study|Lost to Follow-up|1|||
37696426|NCT02324270|69172529|FG000|Overall Study|Withdrawal by Subject|0|||
37696427|NCT02324270|69172530|FG001|Overall Study|Withdrawal by Subject|1|||
37696428|NCT02324270|69172531|FG002|Overall Study|Withdrawal by Subject|0|||
37696429|NCT02324270|69172529|FG000|Overall Study|Lost to Follow-up|4|||
37696430|NCT02324270|69172530|FG001|Overall Study|Lost to Follow-up|3|||
37696431|NCT02324270|69172531|FG002|Overall Study|Lost to Follow-up|4|||
37696432|NCT02324270|69172529|FG000|Overall Study|Protocol Violation|0|||
37696433|NCT02324270|69172530|FG001|Overall Study|Protocol Violation|1|||
37696434|NCT02324270|69172531|FG002|Overall Study|Protocol Violation|1|||
37696435|NCT02324270|69172529|FG000|Overall Study|Non Compliance with Study Drug|1|||
37696436|NCT02324270|69172530|FG001|Overall Study|Non Compliance with Study Drug|2|||
37696437|NCT02324270|69172531|FG002|Overall Study|Non Compliance with Study Drug|0|||
37696438|NCT02270515|69172539|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
37696439|NCT02270515|69172539|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
37696440|NCT02270515|69172539|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
37696441|NCT02270515|69172539|FG000|Intervention Period 1: 0-6 Months|Death|7|||
37696442|NCT02270515|69172539|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
37696443|NCT02270515|69172539|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
37696444|NCT02270515|69172539|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
37696445|NCT02270515|69172539|FG000|Intervention Period 2: 6-12 Months|Death|5|||
37696446|NCT02270515|69172539|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
37696447|NCT02270515|69172539|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
37696448|NCT02270515|69172539|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
37696449|NCT02270515|69172539|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
37696450|NCT02270515|69172539|FG000|Intervention Period 3: 12-18 Months|Death|3|||
37696451|NCT02270515|69172539|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
37696452|NCT02448875|69172553|FG000|Overall Study|Adverse Event|2|||
37995749|NCT00117676|69680404|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
37696453|NCT02448875|69172554|FG001|Overall Study|Adverse Event|1|||
37696454|NCT02448875|69172555|FG002|Overall Study|Adverse Event|0|||
37696455|NCT02448875|69172553|FG000|Overall Study|Lost to Follow-up|1|||
37696456|NCT02448875|69172554|FG001|Overall Study|Lost to Follow-up|0|||
37696457|NCT02448875|69172555|FG002|Overall Study|Lost to Follow-up|0|||
37995750|NCT00117676|69680405|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
37995751|NCT00117676|69680404|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
37995752|NCT00117676|69680405|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
37995753|NCT00117676|69680404|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
37995754|NCT00117676|69680405|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
37995755|NCT00117676|69680404|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
37995756|NCT00117676|69680405|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
37995757|NCT00117676|69680404|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
37995758|NCT00117676|69680405|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
37995759|NCT00117676|69680404|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
37995760|NCT00117676|69680405|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
37995761|NCT00117676|69680404|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
37995762|NCT00117676|69680405|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
37995763|NCT00117676|69680404|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
37995764|NCT00117676|69680405|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
37995765|NCT00117676|69680404|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
37995766|NCT00117676|69680405|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
37995767|NCT00251004|69680419|FG000|Overall Study|Withdrawal by Subject|23|||
37995768|NCT00251004|69680420|FG001|Overall Study|Withdrawal by Subject|16|||
37995769|NCT00251004|69680421|FG002|Overall Study|Withdrawal by Subject|14|||
37995770|NCT00251004|69680419|FG000|Overall Study|Death|9|||
37995771|NCT00251004|69680420|FG001|Overall Study|Death|10|||
37995772|NCT00251004|69680421|FG002|Overall Study|Death|8|||
37995773|NCT00251004|69680419|FG000|Overall Study|Lost to Follow-up|1|||
37995774|NCT00251004|69680420|FG001|Overall Study|Lost to Follow-up|2|||
37995775|NCT00251004|69680421|FG002|Overall Study|Lost to Follow-up|1|||
37995776|NCT00251004|69680419|FG000|Overall Study|Graft Loss|12|||
37995777|NCT00251004|69680420|FG001|Overall Study|Graft Loss|13|||
37995778|NCT00251004|69680421|FG002|Overall Study|Graft Loss|8|||
37995779|NCT00275340|69680431|FG000|Overall Study|Lost to Follow-up|2|||
37995780|NCT00275340|69680432|FG001|Overall Study|Lost to Follow-up|4|||
37995781|NCT00275262|69680438|FG000|Overall Study|Adverse Event|2|||
37995782|NCT00275262|69680439|FG001|Overall Study|Adverse Event|0|||
37995783|NCT00275262|69680438|FG000|Overall Study|Disease progression|2|||
37995784|NCT00275262|69680439|FG001|Overall Study|Disease progression|5|||
37825586|NCT01242514|69507593|FG002|Overall Study|Adverse Event|19|||
37825587|NCT01242085|69507604|FG000|Overall Study|Withdrawal by Subject|4|||
37825588|NCT01242085|69507605|FG001|Overall Study|Withdrawal by Subject|2|||
37825589|NCT01242085|69507606|FG002|Overall Study|Withdrawal by Subject|0|||
37825590|NCT01242085|69507604|FG000|Overall Study|medically unable to have surgery|4|||
37825591|NCT01242085|69507605|FG001|Overall Study|medically unable to have surgery|5|||
37825592|NCT01242085|69507606|FG002|Overall Study|medically unable to have surgery|0|||
37825593|NCT01241461|69507614|FG000|Overall Study|Progressive Disease|3|||
37825594|NCT01241461|69507615|FG001|Overall Study|Progressive Disease|6|||
37825595|NCT01240135|69507627|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
37825596|NCT01240135|69507628|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
37825597|NCT01240135|69507627|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
37825598|NCT01240135|69507628|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
37825599|NCT01247701|69507634|FG000|Overall Study|Death|2|||
37825600|NCT01247701|69507634|FG000|Overall Study|Relapsed|8|||
37825601|NCT01248247|69507642|FG000|Overall Study|Adverse Event|2|||
37825602|NCT01248247|69507643|FG001|Overall Study|Adverse Event|4|||
37825603|NCT01248247|69507644|FG002|Overall Study|Adverse Event|4|||
37825604|NCT01248247|69507645|FG003|Overall Study|Adverse Event|2|||
37825605|NCT01248247|69507642|FG000|Overall Study|Death|0|||
37825606|NCT01248247|69507643|FG001|Overall Study|Death|1|||
37825607|NCT01248247|69507644|FG002|Overall Study|Death|4|||
37825608|NCT01248247|69507645|FG003|Overall Study|Death|7|||
37825609|NCT01248247|69507642|FG000|Overall Study|Lost to Follow-up|0|||
37825610|NCT01248247|69507643|FG001|Overall Study|Lost to Follow-up|1|||
37825611|NCT01248247|69507644|FG002|Overall Study|Lost to Follow-up|1|||
37825612|NCT01248247|69507645|FG003|Overall Study|Lost to Follow-up|0|||
37825613|NCT01248247|69507642|FG000|Overall Study|Alternative treatment|0|||
37825614|NCT01248247|69507643|FG001|Overall Study|Alternative treatment|1|||
37825615|NCT01248247|69507644|FG002|Overall Study|Alternative treatment|0|||
37825616|NCT01248247|69507645|FG003|Overall Study|Alternative treatment|0|||
37825617|NCT01248247|69507642|FG000|Overall Study|Other|2|||
37825618|NCT01248247|69507643|FG001|Overall Study|Other|8|||
37825619|NCT01248247|69507644|FG002|Overall Study|Other|8|||
37995785|NCT00275262|69680438|FG000|Overall Study|Lost to Follow-up|0|||
37995786|NCT00275262|69680439|FG001|Overall Study|Lost to Follow-up|2|||
37995787|NCT00275262|69680438|FG000|Overall Study|Protocol Violation|0|||
37995788|NCT00275262|69680439|FG001|Overall Study|Protocol Violation|2|||
37995789|NCT00275262|69680438|FG000|Overall Study|Death|1|||
37995790|NCT00275262|69680439|FG001|Overall Study|Death|0|||
37995791|NCT00275262|69680438|FG000|Overall Study|Started Chemotherapy|1|||
37995792|NCT00275262|69680439|FG001|Overall Study|Started Chemotherapy|0|||
37995793|NCT00275028|69680445|FG000|Overall Study|Withdrew consent before treatment began|1|||
37995794|NCT00275028|69680445|FG000|Overall Study|Withdrawal by Subject|5|||
37995795|NCT00275028|69680445|FG000|Overall Study|Adverse Event|9|||
37995796|NCT00275028|69680445|FG000|Overall Study|Progressive Disease|30|||
37995797|NCT00275028|69680445|FG000|Overall Study|Physician Decision|2|||
37995798|NCT00471497|69680452|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
37995799|NCT00471497|69680453|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
37995800|NCT00471497|69680454|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
37995801|NCT00471497|69680452|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
37995802|NCT00471497|69680453|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
37995803|NCT00471497|69680454|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
37995804|NCT00471497|69680452|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
37995805|NCT00471497|69680453|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
37995806|NCT00471497|69680454|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
37995807|NCT00471497|69680452|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
37995808|NCT00471497|69680453|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
37995809|NCT00471497|69680454|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
37995810|NCT00471497|69680452|FG000|Core Treatment Phase|Lost to Follow-up|6|||
37995811|NCT00471497|69680453|FG001|Core Treatment Phase|Lost to Follow-up|6|||
37995812|NCT00471497|69680454|FG002|Core Treatment Phase|Lost to Follow-up|3|||
37995813|NCT00471497|69680452|FG000|Core Treatment Phase|Death|3|||
37995814|NCT00471497|69680453|FG001|Core Treatment Phase|Death|9|||
37995815|NCT00471497|69680454|FG002|Core Treatment Phase|Death|3|||
37995816|NCT00471497|69680452|FG000|Core Treatment Phase|Disease Progression|10|||
37995817|NCT00471497|69680453|FG001|Core Treatment Phase|Disease Progression|2|||
37995818|NCT00471497|69680454|FG002|Core Treatment Phase|Disease Progression|4|||
37995819|NCT00471497|69680452|FG000|Core Treatment Phase|Protocol Violation|6|||
37995820|NCT00471497|69680453|FG001|Core Treatment Phase|Protocol Violation|15|||
37995821|NCT00471497|69680454|FG002|Core Treatment Phase|Protocol Violation|11|||
37995822|NCT00471497|69680452|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
37995823|NCT00471497|69680453|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
37995824|NCT00471497|69680454|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
37995825|NCT00471497|69680452|FG000|Core Treatment Phase|Administrative problems|14|||
37995826|NCT00471497|69680453|FG001|Core Treatment Phase|Administrative problems|14|||
37995827|NCT00471497|69680454|FG002|Core Treatment Phase|Administrative problems|12|||
37896766|NCT01004432|69581784|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
37896767|NCT01004432|69581785|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
37995828|NCT00471497|69680452|FG000|Core Treatment Phase|Adverse Event|43|||
37995829|NCT00471497|69680453|FG001|Core Treatment Phase|Adverse Event|53|||
37995830|NCT00471497|69680454|FG002|Core Treatment Phase|Adverse Event|89|||
37995831|NCT00471497|69680452|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
37995832|NCT00471497|69680453|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
37995833|NCT00471497|69680454|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
37995834|NCT00471497|69680452|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
37995835|NCT00471497|69680453|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
37825620|NCT01248247|69507645|FG003|Overall Study|Other|5|||
37825621|NCT01248247|69507642|FG000|Overall Study|Progression|18|||
37825622|NCT01248247|69507643|FG001|Overall Study|Progression|27|||
37825623|NCT01248247|69507644|FG002|Overall Study|Progression|56|||
37825624|NCT01248247|69507645|FG003|Overall Study|Progression|44|||
37825625|NCT01248247|69507642|FG000|Overall Study|Refuse further treatment|0|||
37825626|NCT01248247|69507643|FG001|Overall Study|Refuse further treatment|0|||
37825627|NCT01248247|69507644|FG002|Overall Study|Refuse further treatment|1|||
37825628|NCT01248247|69507645|FG003|Overall Study|Refuse further treatment|2|||
37825629|NCT01248247|69507642|FG000|Overall Study|Complicating disease|0|||
37825630|NCT01248247|69507643|FG001|Overall Study|Complicating disease|0|||
37825631|NCT01248247|69507644|FG002|Overall Study|Complicating disease|1|||
37825632|NCT01248247|69507645|FG003|Overall Study|Complicating disease|1|||
37825633|NCT02598583|69507657|FG000|Extension Period|Withdrawal by Subject|1|||
37825634|NCT02598583|69507658|FG001|Extension Period|Withdrawal by Subject|0|||
37825635|NCT04831736|69507675|FG000|Overall Study|Withdrawal by Subject|0|||
37825636|NCT04831736|69507676|FG001|Overall Study|Withdrawal by Subject|1|||
37825637|NCT04583956|69507691|FG000|Overall Study|Death|9|||
37896768|NCT01004432|69581786|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
37995836|NCT00471497|69680454|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
37995837|NCT00471497|69680452|FG000|Extension Phase|Adverse Event|9|||
37995838|NCT00471497|69680453|FG001|Extension Phase|Adverse Event|5|||
37995839|NCT00471497|69680454|FG002|Extension Phase|Adverse Event|1|||
37995840|NCT00471497|69680452|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
37995841|NCT00471497|69680453|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
37995842|NCT00471497|69680454|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
37995843|NCT00471497|69680452|FG000|Extension Phase|Withdrawal by Subject|3|||
37995844|NCT00471497|69680453|FG001|Extension Phase|Withdrawal by Subject|1|||
37995845|NCT00471497|69680454|FG002|Extension Phase|Withdrawal by Subject|0|||
37995846|NCT00471497|69680452|FG000|Extension Phase|Lost to Follow-up|2|||
37995847|NCT00471497|69680453|FG001|Extension Phase|Lost to Follow-up|0|||
37995848|NCT00471497|69680454|FG002|Extension Phase|Lost to Follow-up|0|||
37995849|NCT00471497|69680452|FG000|Extension Phase|Death|1|||
37995850|NCT00471497|69680453|FG001|Extension Phase|Death|0|||
37995851|NCT00471497|69680454|FG002|Extension Phase|Death|0|||
37995852|NCT00471497|69680452|FG000|Extension Phase|Disease progression|2|||
37995853|NCT00471497|69680453|FG001|Extension Phase|Disease progression|0|||
37995854|NCT00471497|69680454|FG002|Extension Phase|Disease progression|0|||
37995855|NCT00471497|69680452|FG000|Extension Phase|Protocol Violation|2|||
37995856|NCT00471497|69680453|FG001|Extension Phase|Protocol Violation|2|||
37896769|NCT01004432|69581787|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
37896770|NCT01004432|69581788|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
37896771|NCT01004432|69581784|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
37896772|NCT01004432|69581785|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
37995857|NCT00471497|69680454|FG002|Extension Phase|Protocol Violation|0|||
37995858|NCT00493649|69680465|FG000|Overall Study|Adverse Event|44|||
37995859|NCT00493649|69680465|FG000|Overall Study|Patient Request|21|||
37995860|NCT00493649|69680465|FG000|Overall Study|Investigator Request|2|||
37995861|NCT00493649|69680465|FG000|Overall Study|Disease Progression|1|||
37995862|NCT00493649|69680465|FG000|Overall Study|Lost to Follow-up|1|||
37995863|NCT00493649|69680465|FG000|Overall Study|Other|13|||
37995864|NCT00471107|69680475|FG000|Overall Study|Technical problems/data loss|3|||
37995865|NCT00471107|69680476|FG001|Overall Study|Technical problems/data loss|1|||
37995866|NCT00471107|69680477|FG002|Overall Study|Technical problems/data loss|3|||
37995867|NCT00488033|69680487|FG000|Overall Study|Withdrawal by Subject|1|||
37995868|NCT00488033|69680488|FG001|Overall Study|Withdrawal by Subject|0|||
37995869|NCT00117598|69680497|FG000|Prior to Treatment Cross Over|Death|40|||
37995870|NCT00117598|69680498|FG001|Prior to Treatment Cross Over|Death|41|||
37995871|NCT00117598|69680499|FG002|Prior to Treatment Cross Over|Death|37|||
37995872|NCT00117598|69680500|FG003|Prior to Treatment Cross Over|Death|0|||
37995873|NCT00117598|69680501|FG004|Prior to Treatment Cross Over|Death|0|||
37995874|NCT00117598|69680497|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
37995875|NCT00117598|69680498|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
37995876|NCT00117598|69680499|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
37995877|NCT00117598|69680500|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
37896773|NCT01004432|69581786|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
37896774|NCT01004432|69581787|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
37896775|NCT01004432|69581788|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
37896776|NCT01004432|69581784|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
37896777|NCT01004432|69581785|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
37896778|NCT01004432|69581786|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
37896779|NCT01004432|69581787|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
37896780|NCT01004432|69581788|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
37896781|NCT01000610|69581802|FG000|Overall Study|Adverse Event|1|||
37896782|NCT01000610|69581802|FG000|Overall Study|Lost to Follow-up|4|||
37995878|NCT00117598|69680501|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
37995879|NCT00117598|69680497|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
37696458|NCT02448875|69172553|FG000|Overall Study|Investigator Decision|3|||
37696459|NCT02448875|69172554|FG001|Overall Study|Investigator Decision|0|||
37696460|NCT02448875|69172555|FG002|Overall Study|Investigator Decision|1|||
37696461|NCT02448875|69172553|FG000|Overall Study|Withdrawal by Subject|1|||
37696462|NCT02448875|69172554|FG001|Overall Study|Withdrawal by Subject|0|||
37696463|NCT02448875|69172555|FG002|Overall Study|Withdrawal by Subject|0|||
37825638|NCT04583956|69507692|FG001|Overall Study|Death|11|||
37825639|NCT04583956|69507691|FG000|Overall Study|Lost to Follow-up|7|||
37825640|NCT04583956|69507692|FG001|Overall Study|Lost to Follow-up|9|||
37825641|NCT04583956|69507691|FG000|Overall Study|Protocol Violation|2|||
37825642|NCT04583956|69507692|FG001|Overall Study|Protocol Violation|0|||
37825643|NCT04583956|69507691|FG000|Overall Study|Withdrawal by Subject|0|||
37825644|NCT04583956|69507692|FG001|Overall Study|Withdrawal by Subject|2|||
37825645|NCT04583956|69507691|FG000|Overall Study|Randomized but not dosed|2|||
37825646|NCT04583956|69507692|FG001|Overall Study|Randomized but not dosed|3|||
37995880|NCT00117598|69680498|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
37696464|NCT01831726|69172566|FG000|Overall Study|Adverse Event|16|||
37825647|NCT04583956|69507691|FG000|Overall Study|Withdrawal of consent before product administration|1|||
37825648|NCT04583956|69507692|FG001|Overall Study|Withdrawal of consent before product administration|0|||
37995881|NCT00117598|69680499|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
37995882|NCT00117598|69680500|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
37995883|NCT00117598|69680501|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
37995884|NCT00117598|69680497|FG000|Prior to Treatment Cross Over|Other|15|||
37995885|NCT00117598|69680498|FG001|Prior to Treatment Cross Over|Other|9|||
37995886|NCT00117598|69680499|FG002|Prior to Treatment Cross Over|Other|9|||
37995887|NCT00117598|69680500|FG003|Prior to Treatment Cross Over|Other|0|||
37995888|NCT00117598|69680501|FG004|Prior to Treatment Cross Over|Other|0|||
37995889|NCT00117598|69680497|FG000|After Treament Cross Over|Death|0|||
37995890|NCT00117598|69680498|FG001|After Treament Cross Over|Death|0|||
37995891|NCT00117598|69680499|FG002|After Treament Cross Over|Death|0|||
37995892|NCT00117598|69680500|FG003|After Treament Cross Over|Death|1|||
37995893|NCT00117598|69680501|FG004|After Treament Cross Over|Death|2|||
37995894|NCT00117598|69680497|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
37995895|NCT00117598|69680498|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
37995896|NCT00117598|69680499|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
37995897|NCT00117598|69680500|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
37696465|NCT01831726|69172566|FG000|Overall Study|Death|7|||
37696466|NCT01831726|69172566|FG000|Overall Study|Disease Progression|49|||
37696467|NCT01831726|69172566|FG000|Overall Study|Physician Decision|1|||
37696468|NCT01831726|69172566|FG000|Overall Study|Subject/guardian decision|7|||
37825649|NCT04463680|69507708|FG000|Overall Study|Not eligible due to laboratory criteria|5|||
37825650|NCT04463680|69507708|FG000|Overall Study|Not eligible due to implant duration of use|1|||
37825651|NCT04463680|69507708|FG000|Overall Study|Withdrawal by Subject|3|||
37825652|NCT04449029|69507720|FG000|Overall Study|Adverse Event|0|||
37825653|NCT04449029|69507721|FG001|Overall Study|Adverse Event|1|||
37825654|NCT04449029|69507722|FG002|Overall Study|Adverse Event|1|||
37825655|NCT04449029|69507723|FG003|Overall Study|Adverse Event|0|||
37896783|NCT01000610|69581802|FG000|Overall Study|Treatment failure|1|||
37896784|NCT01877655|69581808|FG000|Overall Study|Death|57|||
37896785|NCT01877655|69581809|FG001|Overall Study|Death|52|||
37896786|NCT01877655|69581808|FG000|Overall Study|Withdrawal by Subject|18|||
37896787|NCT01877655|69581809|FG001|Overall Study|Withdrawal by Subject|26|||
37896788|NCT01877655|69581808|FG000|Overall Study|Physician Decision|11|||
37896789|NCT01877655|69581809|FG001|Overall Study|Physician Decision|10|||
37896790|NCT01877655|69581808|FG000|Overall Study|Miscellaneous|4|||
37896791|NCT01877655|69581809|FG001|Overall Study|Miscellaneous|4|||
37896792|NCT01877655|69581808|FG000|Overall Study|Randomized but Never Received Drug|8|||
37896793|NCT01877655|69581809|FG001|Overall Study|Randomized but Never Received Drug|5|||
37896794|NCT00586924|69581821|FG000|Overall Study|Adverse event/serious adverse event|0|||
37896795|NCT00586924|69581822|FG001|Overall Study|Adverse event/serious adverse event|0|||
37896796|NCT00586924|69581823|FG002|Overall Study|Adverse event/serious adverse event|0|||
37896797|NCT00586924|69581824|FG003|Overall Study|Adverse event/serious adverse event|1|||
37896798|NCT00586924|69581825|FG004|Overall Study|Adverse event/serious adverse event|0|||
37995898|NCT00117598|69680501|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
37995899|NCT00117598|69680497|FG000|After Treament Cross Over|Other|0|||
37995900|NCT00117598|69680498|FG001|After Treament Cross Over|Other|0|||
37696469|NCT01831258|69172570|FG000|Overall Study|Withdrawal by Subject|2|||
37825656|NCT04449029|69507724|FG004|Overall Study|Adverse Event|1|||
37825657|NCT04449029|69507725|FG005|Overall Study|Adverse Event|0|||
37896799|NCT00586924|69581826|FG005|Overall Study|Adverse event/serious adverse event|2|||
37825658|NCT04449029|69507726|FG006|Overall Study|Adverse Event|1|||
37995901|NCT00117598|69680499|FG002|After Treament Cross Over|Other|0|||
37995902|NCT00117598|69680500|FG003|After Treament Cross Over|Other|1|||
37995903|NCT00117598|69680501|FG004|After Treament Cross Over|Other|2|||
37995904|NCT00469859|69680513|FG000|Overall Study|Inevaluable|0|||
37995905|NCT00469859|69680514|FG001|Overall Study|Inevaluable|2|||
37995906|NCT00093808|69680520|FG000|Overall Study|Cancel participation before receiving tx|1|||
37995907|NCT00093808|69680520|FG000|Overall Study|Protocol Violation|1|||
37995908|NCT00469079|69680527|FG000|Overall Study|Lack of Efficacy|3|||
37995909|NCT00469079|69680528|FG001|Overall Study|Lack of Efficacy|8|||
37995910|NCT00469079|69680529|FG002|Overall Study|Lack of Efficacy|5|||
37995911|NCT00469079|69680527|FG000|Overall Study|Adverse Event|1|||
37995912|NCT00469079|69680528|FG001|Overall Study|Adverse Event|3|||
37995913|NCT00469079|69680529|FG002|Overall Study|Adverse Event|2|||
37995914|NCT00469079|69680527|FG000|Overall Study|Lost to Follow-up|4|||
37995915|NCT00469079|69680528|FG001|Overall Study|Lost to Follow-up|8|||
37995916|NCT00469079|69680529|FG002|Overall Study|Lost to Follow-up|10|||
37995917|NCT00469079|69680527|FG000|Overall Study|Withdrawal by Subject|1|||
37995918|NCT00469079|69680528|FG001|Overall Study|Withdrawal by Subject|2|||
37995919|NCT00469079|69680529|FG002|Overall Study|Withdrawal by Subject|2|||
37995920|NCT00469079|69680527|FG000|Overall Study|Ineligible|0|||
37995921|NCT00469079|69680528|FG001|Overall Study|Ineligible|1|||
37995922|NCT00469079|69680529|FG002|Overall Study|Ineligible|0|||
37995923|NCT00093496|69680545|FG000|Overall Study|Protocol Violation|1|||
37995924|NCT00093496|69680546|FG001|Overall Study|Protocol Violation|3|||
37995925|NCT00117286|69680553|FG000|Overall Study|Adverse Event|12|||
37995926|NCT00117286|69680554|FG001|Overall Study|Adverse Event|6|||
37995927|NCT00117286|69680553|FG000|Overall Study|Lost to Follow-up|2|||
37995928|NCT00117286|69680554|FG001|Overall Study|Lost to Follow-up|0|||
37995929|NCT00117286|69680553|FG000|Overall Study|Protocol Violation|3|||
37995930|NCT00117286|69680554|FG001|Overall Study|Protocol Violation|3|||
37995931|NCT00117286|69680553|FG000|Overall Study|Withdrawal by Subject|6|||
37995932|NCT00117286|69680554|FG001|Overall Study|Withdrawal by Subject|2|||
37995933|NCT00117286|69680553|FG000|Overall Study|Physician Decision|3|||
37995934|NCT00117286|69680554|FG001|Overall Study|Physician Decision|7|||
37995935|NCT00117286|69680553|FG000|Overall Study|Lack of Efficacy|2|||
37995936|NCT00117286|69680554|FG001|Overall Study|Lack of Efficacy|1|||
37995937|NCT00117286|69680553|FG000|Overall Study|Research site closing|0|||
37995938|NCT00117286|69680554|FG001|Overall Study|Research site closing|2|||
37995939|NCT00265122|69680566|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
37995940|NCT00265122|69680567|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
37995941|NCT00265122|69680568|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
37995942|NCT00265122|69680569|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
37995943|NCT00265122|69680570|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
37995944|NCT00265122|69680571|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
37995945|NCT00265122|69680566|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
37995946|NCT00265122|69680567|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
37995947|NCT00265122|69680568|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
37896800|NCT00586924|69581821|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
37896801|NCT00586924|69581822|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
37896802|NCT00586924|69581823|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
37896803|NCT00586924|69581824|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
37896804|NCT00586924|69581825|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
37896805|NCT00586924|69581826|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
37896806|NCT00586924|69581821|FG000|Overall Study|Disease progression|0|||
37995948|NCT00265122|69680569|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
37995949|NCT00265122|69680570|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
37995950|NCT00265122|69680571|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
37995951|NCT00265122|69680566|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
37995952|NCT00265122|69680567|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
37995953|NCT00265122|69680568|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
37995954|NCT00265122|69680569|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
37995955|NCT00265122|69680570|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
37995956|NCT00265122|69680571|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
37995957|NCT00265122|69680566|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
37995958|NCT00265122|69680567|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
37995959|NCT00265122|69680568|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
37995960|NCT00265122|69680569|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
37995961|NCT00265122|69680570|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
37995962|NCT00265122|69680571|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
37696470|NCT01831258|69172571|FG001|Overall Study|Withdrawal by Subject|1|||
37696471|NCT01831258|69172570|FG000|Overall Study|Lost to Follow-up|3|||
37696472|NCT01831258|69172571|FG001|Overall Study|Lost to Follow-up|2|||
37696473|NCT01849276|69172579|FG000|Followed for Survival for 5 Years|Death|1|||
37825659|NCT04449029|69507727|FG007|Overall Study|Adverse Event|0|||
37825660|NCT04449029|69507720|FG000|Overall Study|Lost to Follow-up|0|||
37825661|NCT04449029|69507721|FG001|Overall Study|Lost to Follow-up|1|||
37825662|NCT04449029|69507722|FG002|Overall Study|Lost to Follow-up|0|||
37825663|NCT04449029|69507723|FG003|Overall Study|Lost to Follow-up|0|||
37825664|NCT04449029|69507724|FG004|Overall Study|Lost to Follow-up|0|||
37825665|NCT04449029|69507725|FG005|Overall Study|Lost to Follow-up|0|||
37825666|NCT04449029|69507726|FG006|Overall Study|Lost to Follow-up|0|||
37825667|NCT04449029|69507727|FG007|Overall Study|Lost to Follow-up|0|||
37825668|NCT04449029|69507720|FG000|Overall Study|Protocol Violation|0|||
37896807|NCT00586924|69581822|FG001|Overall Study|Disease progression|0|||
37896808|NCT00586924|69581823|FG002|Overall Study|Disease progression|0|||
37896809|NCT00586924|69581824|FG003|Overall Study|Disease progression|1|||
37896810|NCT00586924|69581825|FG004|Overall Study|Disease progression|1|||
37896811|NCT00586924|69581826|FG005|Overall Study|Disease progression|0|||
37896812|NCT00586924|69581821|FG000|Overall Study|Development of neutralizing antibodies|2|||
37896813|NCT00586924|69581822|FG001|Overall Study|Development of neutralizing antibodies|2|||
37896814|NCT00586924|69581823|FG002|Overall Study|Development of neutralizing antibodies|2|||
37896815|NCT00586924|69581824|FG003|Overall Study|Development of neutralizing antibodies|0|||
37995963|NCT00265122|69680566|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
37825669|NCT04449029|69507721|FG001|Overall Study|Protocol Violation|1|||
37825670|NCT04449029|69507722|FG002|Overall Study|Protocol Violation|0|||
37825671|NCT04449029|69507723|FG003|Overall Study|Protocol Violation|0|||
37825672|NCT04449029|69507724|FG004|Overall Study|Protocol Violation|0|||
37825673|NCT04449029|69507725|FG005|Overall Study|Protocol Violation|0|||
37825674|NCT04449029|69507726|FG006|Overall Study|Protocol Violation|0|||
37825675|NCT04449029|69507727|FG007|Overall Study|Protocol Violation|0|||
37825676|NCT04449029|69507720|FG000|Overall Study|Physician Decision|0|||
37825677|NCT04449029|69507721|FG001|Overall Study|Physician Decision|0|||
37825678|NCT04449029|69507722|FG002|Overall Study|Physician Decision|0|||
37825679|NCT04449029|69507723|FG003|Overall Study|Physician Decision|0|||
37825680|NCT04449029|69507724|FG004|Overall Study|Physician Decision|0|||
37825681|NCT04449029|69507725|FG005|Overall Study|Physician Decision|1|||
37825682|NCT04449029|69507726|FG006|Overall Study|Physician Decision|0|||
37825683|NCT04449029|69507727|FG007|Overall Study|Physician Decision|0|||
37825684|NCT04449029|69507720|FG000|Overall Study|Withdrawal by Subject|3|||
37825685|NCT04449029|69507721|FG001|Overall Study|Withdrawal by Subject|0|||
37825686|NCT04449029|69507722|FG002|Overall Study|Withdrawal by Subject|1|||
37696474|NCT01849276|69172579|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
37825687|NCT04449029|69507723|FG003|Overall Study|Withdrawal by Subject|1|||
37825688|NCT04449029|69507724|FG004|Overall Study|Withdrawal by Subject|5|||
37825689|NCT04449029|69507725|FG005|Overall Study|Withdrawal by Subject|1|||
37825690|NCT04449029|69507726|FG006|Overall Study|Withdrawal by Subject|4|||
37896816|NCT00586924|69581825|FG004|Overall Study|Development of neutralizing antibodies|0|||
37995964|NCT00265122|69680567|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
37696475|NCT02465489|69172583|FG000|Overall Study|Adverse Event|5|||
37825691|NCT04449029|69507727|FG007|Overall Study|Withdrawal by Subject|0|||
37825692|NCT04193202|69507757|FG000|Overall Study|Adverse Event|2|||
37825693|NCT04193202|69507758|FG001|Overall Study|Adverse Event|1|||
37825694|NCT04193202|69507757|FG000|Overall Study|Death|0|||
37825695|NCT04193202|69507758|FG001|Overall Study|Death|1|||
37825696|NCT04193202|69507757|FG000|Overall Study|Physician Decision|1|||
37825697|NCT04193202|69507758|FG001|Overall Study|Physician Decision|1|||
37696476|NCT01829464|69172598|FG000|Overall Study|Adverse Event|1|||
37696477|NCT01829464|69172599|FG001|Overall Study|Adverse Event|0|||
37825698|NCT04193202|69507757|FG000|Overall Study|Protocol Violation|2|||
37825699|NCT04193202|69507758|FG001|Overall Study|Protocol Violation|2|||
37825700|NCT04193202|69507757|FG000|Overall Study|Withdrawal by Subject|11|||
37995965|NCT00265122|69680568|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
37995966|NCT00265122|69680569|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
37995967|NCT00265122|69680570|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
37995968|NCT00265122|69680571|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
37995969|NCT00265122|69680566|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
37995970|NCT00265122|69680567|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
37995971|NCT00265122|69680568|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
37995972|NCT00265122|69680569|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
37995973|NCT00265122|69680570|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
37995974|NCT00265122|69680571|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
37995975|NCT00116584|69680592|FG000|Overall Study|Withdrawal by Subject|1|||
37995976|NCT00116584|69680593|FG001|Overall Study|Withdrawal by Subject|0|||
37995977|NCT00116584|69680592|FG000|Overall Study|Protocol Violation|1|||
37995978|NCT00116584|69680593|FG001|Overall Study|Protocol Violation|1|||
37995979|NCT00096538|69680599|FG000|Overall Study|Withdrawal by Subject|1|||
37995980|NCT00239928|69680603|FG000|Overall Study|Lack of Efficacy|1|||
37995981|NCT00239928|69680603|FG000|Overall Study|Adverse Event|4|||
37995982|NCT00239928|69680603|FG000|Overall Study|Not need to continue study|3|||
37995983|NCT00239928|69680603|FG000|Overall Study|Withdrawal by Subject|2|||
37995984|NCT00116428|69680609|FG000|Overall Study|Withdrawal by Subject|2|||
37995985|NCT00116428|69680610|FG001|Overall Study|Withdrawal by Subject|5|||
37995986|NCT00116428|69680609|FG000|Overall Study|Did not meet inclusion criteria|1|||
37995987|NCT00116428|69680610|FG001|Overall Study|Did not meet inclusion criteria|0|||
37995988|NCT00468845|69680622|FG000|Overall Study|Adverse Event|9|||
37995989|NCT00468845|69680623|FG001|Overall Study|Adverse Event|14|||
37995990|NCT00468845|69680624|FG002|Overall Study|Adverse Event|11|||
37995991|NCT00468845|69680622|FG000|Overall Study|Lost to Follow-up|2|||
37995992|NCT00468845|69680623|FG001|Overall Study|Lost to Follow-up|1|||
37995993|NCT00468845|69680624|FG002|Overall Study|Lost to Follow-up|2|||
37995994|NCT00468845|69680622|FG000|Overall Study|Other|4|||
37995995|NCT00468845|69680623|FG001|Overall Study|Other|9|||
37995996|NCT00468845|69680624|FG002|Overall Study|Other|5|||
37995997|NCT00468845|69680622|FG000|Overall Study|No longer willing to participate|5|||
37995998|NCT00468845|69680623|FG001|Overall Study|No longer willing to participate|6|||
37995999|NCT00468845|69680624|FG002|Overall Study|No longer willing to participate|10|||
37996000|NCT00468845|69680622|FG000|Overall Study|Randomized, not treated|1|||
37996001|NCT00468845|69680623|FG001|Overall Study|Randomized, not treated|4|||
37996002|NCT00468845|69680624|FG002|Overall Study|Randomized, not treated|2|||
37996003|NCT00468299|69680634|FG000|Overall Study|Withdrawal by Subject|0|||
37996004|NCT00468299|69680635|FG001|Overall Study|Withdrawal by Subject|1|||
37996005|NCT00468143|69680643|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
37996006|NCT00468143|69680644|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
37996007|NCT00468143|69680643|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
37996008|NCT00468143|69680644|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
37825701|NCT04193202|69507758|FG001|Overall Study|Withdrawal by Subject|5|||
37825702|NCT04159935|69507766|FG000|Overall Study|Study terminated due to COVID-19|1|||
37825703|NCT04159935|69507767|FG001|Overall Study|Study terminated due to COVID-19|3|||
37825704|NCT03871543|69507791|FG000|Period 1|Unsatisfactory Lens Fitting due Test Article|10|||
37825705|NCT03871543|69507791|FG000|Period 1|Investigator Error|1|||
37996009|NCT00467831|69680650|FG000|Overall Study|Death|2|||
37996010|NCT00467831|69680650|FG000|Overall Study|Withdrawal by Subject|1|||
37996011|NCT00467753|69680656|FG000|Overall Study|Lost to Follow-up|1|||
37996012|NCT00467753|69680657|FG001|Overall Study|Lost to Follow-up|2|||
37996013|NCT00467753|69680656|FG000|Overall Study|Adverse Event|2|||
37996014|NCT00467753|69680657|FG001|Overall Study|Adverse Event|0|||
37996015|NCT00467597|69680671|FG000|Overall Study|Withdrawal by Subject|2|||
37996016|NCT00467597|69680672|FG001|Overall Study|Withdrawal by Subject|0|||
37996017|NCT00115804|69680682|FG000|Overall Study|Adverse Event|2|||
37825706|NCT03871543|69507791|FG000|Period 1|Protocol Violation|2|||
37896817|NCT00586924|69581826|FG005|Overall Study|Development of neutralizing antibodies|22|||
37896818|NCT00586924|69581821|FG000|Overall Study|Complete response|0|||
37896819|NCT00586924|69581822|FG001|Overall Study|Complete response|1|||
37896820|NCT00586924|69581823|FG002|Overall Study|Complete response|0|||
37896821|NCT00586924|69581824|FG003|Overall Study|Complete response|0|||
37896822|NCT00586924|69581825|FG004|Overall Study|Complete response|2|||
37896823|NCT00586924|69581826|FG005|Overall Study|Complete response|2|||
37896824|NCT00586924|69581821|FG000|Overall Study|Other|1|||
37896825|NCT00586924|69581822|FG001|Overall Study|Other|0|||
37896826|NCT00586924|69581823|FG002|Overall Study|Other|1|||
37896827|NCT00586924|69581824|FG003|Overall Study|Other|1|||
37896828|NCT00586924|69581825|FG004|Overall Study|Other|1|||
37896829|NCT00586924|69581826|FG005|Overall Study|Other|6|||
37896830|NCT01000376|69581842|FG000|Cycle 1 Day 1|Adverse Event|1|||
37896831|NCT01000376|69581843|FG001|Cycle 1 Day 1|Adverse Event|0|||
37896832|NCT01000376|69581842|FG000|Cycle 1 Day 1|Progressive Disease|1|||
37896833|NCT01000376|69581843|FG001|Cycle 1 Day 1|Progressive Disease|0|||
37896834|NCT01038635|69581858|FG000|Overall Study|Disease Progression|2|||
37896835|NCT01038635|69581859|FG001|Overall Study|Disease Progression|0|||
37896836|NCT01038635|69581860|FG002|Overall Study|Disease Progression|0|||
37896837|NCT01038635|69581861|FG003|Overall Study|Disease Progression|0|||
37896838|NCT01038635|69581862|FG004|Overall Study|Disease Progression|0|||
37896839|NCT01038635|69581863|FG005|Overall Study|Disease Progression|0|||
37896840|NCT01038635|69581864|FG006|Overall Study|Disease Progression|1|||
37896841|NCT01038635|69581865|FG007|Overall Study|Disease Progression|4|||
37896842|NCT01038635|69581866|FG008|Overall Study|Disease Progression|0|||
37896843|NCT01038635|69581858|FG000|Overall Study|Death|0|||
37896844|NCT01038635|69581859|FG001|Overall Study|Death|0|||
37896845|NCT01038635|69581860|FG002|Overall Study|Death|0|||
37896846|NCT01038635|69581861|FG003|Overall Study|Death|0|||
37896847|NCT01038635|69581862|FG004|Overall Study|Death|1|||
37896848|NCT01038635|69581863|FG005|Overall Study|Death|0|||
37896849|NCT01038635|69581864|FG006|Overall Study|Death|1|||
37896850|NCT01038635|69581865|FG007|Overall Study|Death|1|||
37896851|NCT01038635|69581866|FG008|Overall Study|Death|2|||
37896852|NCT01000064|69581887|FG000|Overall Study|Withdrawal by Subject|1|||
37896853|NCT01000064|69581888|FG001|Overall Study|Withdrawal by Subject|1|||
37896854|NCT00766090|69581899|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
37896855|NCT00766090|69581900|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
37696478|NCT01829464|69172600|FG002|Overall Study|Adverse Event|0|||
37696479|NCT01829464|69172598|FG000|Overall Study|Lost to Follow-up|0|||
37896856|NCT00766090|69581901|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
37896857|NCT00766090|69581902|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
37896858|NCT00766090|69581903|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
37896859|NCT00766090|69581904|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
37896860|NCT00766090|69581905|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
37896861|NCT00766090|69581906|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
37896862|NCT00766090|69581907|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
37896863|NCT00766090|69581908|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
37896864|NCT00766090|69581909|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
37896865|NCT00766090|69581910|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
37896866|NCT00766090|69581899|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
37896867|NCT00766090|69581900|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
37896868|NCT00766090|69581901|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
37896869|NCT00766090|69581902|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
37896870|NCT00766090|69581903|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
37896871|NCT00766090|69581904|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
37896872|NCT00766090|69581905|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
37896873|NCT00766090|69581906|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
37896874|NCT00766090|69581907|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
37896875|NCT00766090|69581908|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
37896876|NCT00766090|69581909|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
37896877|NCT00766090|69581910|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
37896878|NCT00766090|69581899|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
37896879|NCT00766090|69581900|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
37896880|NCT00766090|69581901|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
37896881|NCT00766090|69581902|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
37896882|NCT00766090|69581903|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
37896883|NCT00766090|69581904|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
37896884|NCT00766090|69581905|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
37896885|NCT00766090|69581906|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
37896886|NCT00766090|69581907|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
37896887|NCT00766090|69581908|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
37896888|NCT00766090|69581909|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
37896889|NCT00766090|69581910|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
37896890|NCT00766090|69581899|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
37896891|NCT00766090|69581900|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
37896892|NCT00766090|69581901|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
37896893|NCT00766090|69581902|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
37896894|NCT00766090|69581903|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
37896895|NCT00766090|69581904|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
37896896|NCT00766090|69581905|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
37896897|NCT00766090|69581906|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
37896898|NCT00766090|69581907|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
37896899|NCT00766090|69581908|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
37896900|NCT00766090|69581909|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
37825707|NCT03871543|69507791|FG000|Period 1|COVID-19 Related|1|||
37825708|NCT03871543|69507791|FG000|Period 1|Subject No Longer meets Eligibility Criteria|112|||
37825709|NCT03871543|69507791|FG000|Period 1|Withdrawal by Subject|10|||
37825710|NCT03871543|69507791|FG000|Period 2|Adverse Event|1|||
37825711|NCT03871543|69507791|FG000|Period 2|Withdrawal by Subject|1|||
37825712|NCT03843125|69507803|FG000|Overall Study|Adverse Event|17|||
37896901|NCT00766090|69581910|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
37896902|NCT00766090|69581899|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
37896903|NCT00766090|69581900|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
37896904|NCT00766090|69581901|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
37896905|NCT00766090|69581902|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
37896906|NCT00766090|69581903|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
37896907|NCT00766090|69581904|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
37896908|NCT00766090|69581905|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
37896909|NCT00766090|69581906|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
37896910|NCT00766090|69581907|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
37896911|NCT00766090|69581908|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
37896912|NCT00766090|69581909|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
37896913|NCT00766090|69581910|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
37896914|NCT00766090|69581899|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
37896915|NCT00766090|69581900|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
37896916|NCT00766090|69581901|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
37896917|NCT00766090|69581902|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
37896918|NCT00766090|69581903|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
37896919|NCT00766090|69581904|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
37825713|NCT03843125|69507804|FG001|Overall Study|Adverse Event|13|||
37825714|NCT03843125|69507805|FG002|Overall Study|Adverse Event|5|||
37825715|NCT03843125|69507806|FG003|Overall Study|Adverse Event|9|||
37825716|NCT03843125|69507803|FG000|Overall Study|Death|0|||
37825717|NCT03843125|69507804|FG001|Overall Study|Death|6|||
37825718|NCT03843125|69507805|FG002|Overall Study|Death|2|||
37825719|NCT03843125|69507806|FG003|Overall Study|Death|0|||
37825720|NCT03843125|69507803|FG000|Overall Study|Lack of Efficacy|14|||
37825721|NCT03843125|69507804|FG001|Overall Study|Lack of Efficacy|11|||
37825722|NCT03843125|69507805|FG002|Overall Study|Lack of Efficacy|9|||
37825723|NCT03843125|69507806|FG003|Overall Study|Lack of Efficacy|4|||
37825724|NCT03843125|69507803|FG000|Overall Study|Lost to Follow-up|3|||
37825725|NCT03843125|69507804|FG001|Overall Study|Lost to Follow-up|4|||
37825726|NCT03843125|69507805|FG002|Overall Study|Lost to Follow-up|0|||
37825727|NCT03843125|69507806|FG003|Overall Study|Lost to Follow-up|2|||
37896920|NCT00766090|69581905|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
37896921|NCT00766090|69581906|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
37825728|NCT03843125|69507803|FG000|Overall Study|Other|12|||
37825729|NCT03843125|69507804|FG001|Overall Study|Other|14|||
37825730|NCT03843125|69507805|FG002|Overall Study|Other|3|||
37825731|NCT03843125|69507806|FG003|Overall Study|Other|4|||
37825732|NCT03843125|69507803|FG000|Overall Study|Due to Epidemic/Pandemic|1|||
37825733|NCT03843125|69507804|FG001|Overall Study|Due to Epidemic/Pandemic|0|||
37825734|NCT03843125|69507805|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
37825735|NCT03843125|69507806|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
37825736|NCT03843125|69507803|FG000|Overall Study|Study Terminated by Sponsor|318|||
37825737|NCT03843125|69507804|FG001|Overall Study|Study Terminated by Sponsor|318|||
37825738|NCT03843125|69507805|FG002|Overall Study|Study Terminated by Sponsor|163|||
37825739|NCT03843125|69507806|FG003|Overall Study|Study Terminated by Sponsor|163|||
37825740|NCT03843125|69507803|FG000|Overall Study|Withdrawal by Subject|23|||
37825741|NCT03843125|69507804|FG001|Overall Study|Withdrawal by Subject|12|||
37825742|NCT03843125|69507805|FG002|Overall Study|Withdrawal by Subject|6|||
37825743|NCT03843125|69507806|FG003|Overall Study|Withdrawal by Subject|9|||
37825744|NCT03843125|69507803|FG000|Overall Study|Missing data|0|||
37825745|NCT03843125|69507804|FG001|Overall Study|Missing data|1|||
37996018|NCT00467519|69680690|FG000|Overall Study|Protocol Violation|8|||
37825746|NCT03843125|69507805|FG002|Overall Study|Missing data|1|||
37825747|NCT03843125|69507806|FG003|Overall Study|Missing data|0|||
37825748|NCT03695237|69507819|FG000|Overall Study|Discontinued to Restart Puberty|1|||
37825749|NCT03695237|69507820|FG001|Overall Study|Discontinued to Restart Puberty|0|||
37825750|NCT03603509|69507829|FG000|Overall Study|Lost to Follow-up|3|||
37825751|NCT03603509|69507830|FG001|Overall Study|Lost to Follow-up|4|||
37825752|NCT03066258|69507854|FG000|Overall Study|Death|1|||
37825753|NCT03066258|69507855|FG001|Overall Study|Death|0|||
37825754|NCT03066258|69507856|FG002|Overall Study|Death|0|||
37825755|NCT03066258|69507857|FG003|Overall Study|Death|0|||
37825756|NCT03066258|69507858|FG004|Overall Study|Death|1|||
37825757|NCT03024255|69507874|FG000|Overall Study|Adverse Event|1|||
37825758|NCT03024255|69507875|FG001|Overall Study|Adverse Event|4|||
37825759|NCT03024255|69507876|FG002|Overall Study|Adverse Event|8|||
37825760|NCT03024255|69507877|FG003|Overall Study|Adverse Event|0|||
37825761|NCT03024255|69507874|FG000|Overall Study|Withdrawal by Subject|3|||
37825762|NCT03024255|69507875|FG001|Overall Study|Withdrawal by Subject|1|||
37825763|NCT03024255|69507876|FG002|Overall Study|Withdrawal by Subject|0|||
37825764|NCT03024255|69507877|FG003|Overall Study|Withdrawal by Subject|3|||
37825765|NCT03024255|69507874|FG000|Overall Study|Protocol Violation|0|||
37825766|NCT03024255|69507875|FG001|Overall Study|Protocol Violation|0|||
37896922|NCT00766090|69581907|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
37896923|NCT00766090|69581908|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
37896924|NCT00766090|69581909|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
37896925|NCT00766090|69581910|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
37896926|NCT00766090|69581899|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
37896927|NCT00766090|69581900|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
37896928|NCT00766090|69581901|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
37896929|NCT00766090|69581902|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
37896930|NCT00766090|69581903|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
37896931|NCT00766090|69581904|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
37896932|NCT00766090|69581905|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
37896933|NCT00766090|69581906|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
37696480|NCT01829464|69172599|FG001|Overall Study|Lost to Follow-up|0|||
37825767|NCT03024255|69507876|FG002|Overall Study|Protocol Violation|2|||
37825768|NCT03024255|69507877|FG003|Overall Study|Protocol Violation|0|||
37825769|NCT03024255|69507874|FG000|Overall Study|Lost to Follow-up|1|||
37825770|NCT03024255|69507875|FG001|Overall Study|Lost to Follow-up|2|||
37825771|NCT03024255|69507876|FG002|Overall Study|Lost to Follow-up|1|||
37825772|NCT03024255|69507877|FG003|Overall Study|Lost to Follow-up|1|||
37996019|NCT00467519|69680691|FG001|Overall Study|Protocol Violation|4|||
37996020|NCT00467519|69680690|FG000|Overall Study|Lost to Follow-up|2|||
37996021|NCT00467519|69680691|FG001|Overall Study|Lost to Follow-up|9|||
37996022|NCT00467519|69680690|FG000|Overall Study|Withdrawal by Subject|4|||
37996023|NCT00467519|69680691|FG001|Overall Study|Withdrawal by Subject|10|||
37996024|NCT00264810|69680699|FG000|Baseline|Withdrawal by Subject|10|||
37996025|NCT00264810|69680700|FG001|Baseline|Withdrawal by Subject|10|||
37996026|NCT00264810|69680699|FG000|Baseline|Physician Decision|7|||
37996027|NCT00264810|69680700|FG001|Baseline|Physician Decision|8|||
37996028|NCT00264810|69680699|FG000|Baseline|Subject Compliance Failure|3|||
37996029|NCT00264810|69680700|FG001|Baseline|Subject Compliance Failure|3|||
37996030|NCT00264810|69680699|FG000|Baseline|Insufficient Seizure Frequency|2|||
37996031|NCT00264810|69680700|FG001|Baseline|Insufficient Seizure Frequency|2|||
37996032|NCT00264810|69680699|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
37896934|NCT00766090|69581907|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
37896935|NCT00766090|69581908|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
37896936|NCT00766090|69581909|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
37896937|NCT00766090|69581910|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
37896938|NCT00766090|69581899|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
37896939|NCT00766090|69581900|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
37896940|NCT00766090|69581901|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
37896941|NCT00766090|69581902|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
37896942|NCT00766090|69581903|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
37896943|NCT00766090|69581904|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
37896944|NCT00766090|69581905|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
37896945|NCT00766090|69581906|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
37896946|NCT00766090|69581907|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
37896947|NCT00766090|69581908|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
37896948|NCT00766090|69581909|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
37896949|NCT00766090|69581910|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
37896950|NCT00766090|69581899|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
37896951|NCT00766090|69581900|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
37896952|NCT00766090|69581901|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
37896953|NCT00766090|69581902|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
37896954|NCT00766090|69581903|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
37896955|NCT00766090|69581904|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
37896956|NCT00766090|69581905|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
37896957|NCT00766090|69581906|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
37896958|NCT00766090|69581907|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
37896959|NCT00766090|69581908|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
37825773|NCT03024255|69507874|FG000|Overall Study|Lack of Efficacy|1|||
37825774|NCT03024255|69507875|FG001|Overall Study|Lack of Efficacy|0|||
37825775|NCT03024255|69507876|FG002|Overall Study|Lack of Efficacy|0|||
37825776|NCT03024255|69507877|FG003|Overall Study|Lack of Efficacy|0|||
37825777|NCT03024255|69507874|FG000|Overall Study|Protocol Noncompliance|1|||
37825778|NCT03024255|69507875|FG001|Overall Study|Protocol Noncompliance|1|||
37825779|NCT03024255|69507876|FG002|Overall Study|Protocol Noncompliance|0|||
37825780|NCT03024255|69507877|FG003|Overall Study|Protocol Noncompliance|1|||
37825781|NCT02636582|69507896|FG000|Overall Study|Surgical Pathology|1|||
37825782|NCT02636582|69507897|FG001|Overall Study|Surgical Pathology|0|||
37825783|NCT01252953|69507909|FG000|Overall Study|Withdrawal by Subject|16|||
37825784|NCT01252953|69507910|FG001|Overall Study|Withdrawal by Subject|17|||
37825785|NCT01252953|69507909|FG000|Overall Study|Lost to Follow-up|22|||
37825786|NCT01252953|69507910|FG001|Overall Study|Lost to Follow-up|21|||
37825787|NCT01234480|69507917|FG000|Overall Study|Pregnancy|88|||
37825788|NCT01234480|69507917|FG000|Overall Study|>36/Normal History|50|||
37825789|NCT01234480|69507917|FG000|Overall Study|Age|3|||
37825790|NCT01234480|69507917|FG000|Overall Study|HPV Vaccine History|28|||
37825791|NCT01234480|69507917|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
37825792|NCT01234480|69507917|FG000|Overall Study|Hysterectomy|2|||
37825793|NCT01234480|69507917|FG000|Overall Study|Hysterectomy post enrollment|1|||
37825794|NCT01234480|69507917|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
37825795|NCT01234480|69507917|FG000|Overall Study|Informed Consent Form Violation|30|||
37825796|NCT01234480|69507917|FG000|Overall Study|Incorrect Visit|3|||
37825797|NCT01234480|69507917|FG000|Overall Study|No Florida Lab License|20|||
37825798|NCT01234480|69507917|FG000|Overall Study|Out of Window|42|||
37825799|NCT01234480|69507917|FG000|Overall Study|Sample Processing/Storage|92|||
37825800|NCT01234480|69507917|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
37825801|NCT01234480|69507917|FG000|Overall Study|Site/Subject non-compliance|44|||
37825802|NCT01234480|69507917|FG000|Overall Study|Missing Sample|9|||
37825803|NCT00877851|69507926|FG000|Overall Study|Lost to Follow-up|5|||
37825804|NCT00877851|69507927|FG001|Overall Study|Lost to Follow-up|5|||
37825805|NCT00877851|69507926|FG000|Overall Study|computer problem|3|||
37825806|NCT00877851|69507927|FG001|Overall Study|computer problem|0|||
37825807|NCT00877851|69507926|FG000|Overall Study|no longer interested in participating|1|||
37825808|NCT00877851|69507927|FG001|Overall Study|no longer interested in participating|0|||
37825809|NCT00837616|69507935|FG000|Overall Study|Withdrawal by Subject|0|||
37825810|NCT00837616|69507936|FG001|Overall Study|Withdrawal by Subject|1|||
37896960|NCT00766090|69581909|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
37896961|NCT00766090|69581910|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
37896962|NCT00766090|69581899|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
37896963|NCT00766090|69581900|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
37896964|NCT00766090|69581901|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
37896965|NCT00766090|69581902|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
37896966|NCT00766090|69581903|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
37896967|NCT00766090|69581904|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
37896968|NCT00766090|69581905|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
37896969|NCT00766090|69581906|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
37896970|NCT00766090|69581907|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
37896971|NCT00766090|69581908|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
37896972|NCT00766090|69581909|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
37896973|NCT00766090|69581910|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
37896974|NCT00580801|69581927|FG000|Overall Study|Physician Decision|1|||
37896975|NCT00580801|69581928|FG001|Overall Study|Physician Decision|0|||
37896976|NCT00580801|69581929|FG002|Overall Study|Physician Decision|0|||
37896977|NCT00580801|69581927|FG000|Overall Study|Adverse Event|2|||
37896978|NCT00580801|69581928|FG001|Overall Study|Adverse Event|0|||
37896979|NCT00580801|69581929|FG002|Overall Study|Adverse Event|0|||
37896980|NCT00580801|69581927|FG000|Overall Study|Lost to Follow-up|2|||
37896981|NCT00580801|69581928|FG001|Overall Study|Lost to Follow-up|0|||
37896982|NCT00580801|69581929|FG002|Overall Study|Lost to Follow-up|0|||
37896983|NCT00580801|69581927|FG000|Overall Study|Reached a virologic endpoint|0|||
37896984|NCT00580801|69581928|FG001|Overall Study|Reached a virologic endpoint|1|||
37896985|NCT00580801|69581929|FG002|Overall Study|Reached a virologic endpoint|2|||
37896986|NCT00580801|69581927|FG000|Overall Study|Participant non-compliant|0|||
37896987|NCT00580801|69581928|FG001|Overall Study|Participant non-compliant|0|||
37896988|NCT00580801|69581929|FG002|Overall Study|Participant non-compliant|1|||
37896989|NCT00580801|69581927|FG000|Overall Study|Travel|1|||
37896990|NCT00580801|69581928|FG001|Overall Study|Travel|0|||
37896991|NCT00580801|69581929|FG002|Overall Study|Travel|0|||
37696481|NCT01829464|69172600|FG002|Overall Study|Lost to Follow-up|1|||
37896992|NCT01059539|69581937|FG000|Overall Study|Adverse Event|66|||
37896993|NCT01059539|69581937|FG000|Overall Study|Insufficient Therapeutic Response|26|||
37896994|NCT01059539|69581937|FG000|Overall Study|Protocol Violation|55|||
37896995|NCT01059539|69581937|FG000|Overall Study|Withdrawal of Consent|80|||
37896996|NCT01059539|69581937|FG000|Overall Study|Lost to Follow-up|42|||
37896997|NCT01059539|69581937|FG000|Overall Study|Reason Not Specified|2|||
37896998|NCT00999908|69581941|FG000|Treatment Period 1|Subject withdrew consent|2|||
37896999|NCT00999908|69581942|FG001|Treatment Period 1|Subject withdrew consent|0|||
37897000|NCT00999908|69581943|FG002|Treatment Period 1|Subject withdrew consent|0|||
37897001|NCT00999908|69581941|FG000|Treatment Period 2|Protocol Violation|1|||
37897002|NCT00999908|69581942|FG001|Treatment Period 2|Protocol Violation|0|||
37897003|NCT00999908|69581943|FG002|Treatment Period 2|Protocol Violation|0|||
37897004|NCT00580723|69581951|FG000|Overall Study|Did not want to participate in extension|3|||
37897005|NCT00580723|69581951|FG000|Overall Study|Lost to Follow-up|5|||
37897006|NCT00999596|69581955|FG000|Overall Study|Statistical population not required|101|||
37996033|NCT00264810|69680700|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
37696482|NCT01829464|69172598|FG000|Overall Study|Withdrawal by Subject|2|||
37897007|NCT04676867|69581964|FG000|Overall Study|Screen failure|0|||
37897008|NCT04676867|69581965|FG001|Overall Study|Screen failure|0|||
37897009|NCT04676867|69581966|FG002|Overall Study|Screen failure|6|||
37897010|NCT04676867|69581967|FG003|Overall Study|Screen failure|2|||
37996034|NCT00264810|69680699|FG000|Baseline|Other|0|||
37696483|NCT01829464|69172599|FG001|Overall Study|Withdrawal by Subject|0|||
37825811|NCT00176254|69507942|FG000|Overall Study|Lost to Follow-up|1|||
37825812|NCT03083873|69507955|FG000|Overall Study|Death|6|||
37825813|NCT03083873|69507956|FG001|Overall Study|Death|15|||
37825814|NCT03083873|69507957|FG002|Overall Study|Death|13|||
37825815|NCT03083873|69507958|FG003|Overall Study|Death|9|||
37825816|NCT03083873|69507959|FG004|Overall Study|Death|0|||
37825817|NCT03083873|69507955|FG000|Overall Study|Sponsor Terminated Study|0|||
37825818|NCT03083873|69507956|FG001|Overall Study|Sponsor Terminated Study|1|||
37825819|NCT03083873|69507957|FG002|Overall Study|Sponsor Terminated Study|2|||
37825820|NCT03083873|69507958|FG003|Overall Study|Sponsor Terminated Study|3|||
37825821|NCT03083873|69507959|FG004|Overall Study|Sponsor Terminated Study|0|||
37825822|NCT03083873|69507955|FG000|Overall Study|Lost to Follow-up|0|||
37825823|NCT03083873|69507956|FG001|Overall Study|Lost to Follow-up|1|||
37825824|NCT03083873|69507957|FG002|Overall Study|Lost to Follow-up|1|||
37825825|NCT03083873|69507958|FG003|Overall Study|Lost to Follow-up|0|||
37825826|NCT03083873|69507959|FG004|Overall Study|Lost to Follow-up|0|||
37825827|NCT03083873|69507955|FG000|Overall Study|Withdrawal by Subject|2|||
37825828|NCT03083873|69507956|FG001|Overall Study|Withdrawal by Subject|0|||
37825829|NCT03083873|69507957|FG002|Overall Study|Withdrawal by Subject|0|||
37825830|NCT03083873|69507958|FG003|Overall Study|Withdrawal by Subject|0|||
37825831|NCT03083873|69507959|FG004|Overall Study|Withdrawal by Subject|0|||
37825832|NCT03083873|69507955|FG000|Overall Study|Did Not Receive TIL|2|||
37825833|NCT03083873|69507956|FG001|Overall Study|Did Not Receive TIL|5|||
37825834|NCT03083873|69507957|FG002|Overall Study|Did Not Receive TIL|3|||
37825835|NCT03083873|69507958|FG003|Overall Study|Did Not Receive TIL|1|||
37825836|NCT03083873|69507959|FG004|Overall Study|Did Not Receive TIL|0|||
37825837|NCT04834726|69507993|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
37825838|NCT04834726|69507994|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
37825839|NCT04834726|69507995|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
37825840|NCT04834726|69507996|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
37825841|NCT04834726|69507997|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
37825842|NCT04834726|69507998|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
37825843|NCT04834726|69507999|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
37825844|NCT04834726|69508000|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
37825845|NCT04834726|69508001|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
37825846|NCT04732949|69508017|FG000|Overall Study|Withdrawal by Subject|23|||
37825847|NCT04732949|69508018|FG001|Overall Study|Withdrawal by Subject|27|||
37825848|NCT04732949|69508017|FG000|Overall Study|Protocol Violation|0|||
37825849|NCT04732949|69508018|FG001|Overall Study|Protocol Violation|1|||
37825850|NCT04732949|69508017|FG000|Overall Study|Non-compliance|0|||
37825851|NCT04732949|69508018|FG001|Overall Study|Non-compliance|2|||
37825852|NCT04732949|69508017|FG000|Overall Study|Physician Decision|2|||
37825853|NCT04732949|69508018|FG001|Overall Study|Physician Decision|1|||
37825854|NCT04732949|69508017|FG000|Overall Study|Serious adverse event (Fatal)|16|||
37825855|NCT04732949|69508018|FG001|Overall Study|Serious adverse event (Fatal)|18|||
37825856|NCT04732949|69508017|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
37825857|NCT04732949|69508018|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
37825858|NCT04732949|69508017|FG000|Overall Study|Non-serious adverse event|1|||
37825859|NCT04732949|69508018|FG001|Overall Study|Non-serious adverse event|3|||
37825860|NCT04732949|69508017|FG000|Overall Study|Lost to Follow-up|26|||
37825861|NCT04732949|69508018|FG001|Overall Study|Lost to Follow-up|27|||
37825862|NCT04732949|69508017|FG000|Overall Study|Other|6|||
37825863|NCT04732949|69508018|FG001|Overall Study|Other|3|||
37825864|NCT04235504|69508073|FG000|Study Phase|Withdrawal by Subject|5|||
37825865|NCT04235504|69508074|FG001|Study Phase|Withdrawal by Subject|2|||
37825866|NCT04235504|69508075|FG002|Study Phase|Withdrawal by Subject|0|||
37825867|NCT04235504|69508076|FG003|Study Phase|Withdrawal by Subject|0|||
37825868|NCT04235504|69508073|FG000|Continuation Phase|Withdrawal by Subject|0|||
37825869|NCT04235504|69508074|FG001|Continuation Phase|Withdrawal by Subject|4|||
37825870|NCT04235504|69508075|FG002|Continuation Phase|Withdrawal by Subject|0|||
37825871|NCT04235504|69508076|FG003|Continuation Phase|Withdrawal by Subject|0|||
37825872|NCT04235504|69508073|FG000|Continuation Phase|Adverse Event|0|||
37825873|NCT04235504|69508074|FG001|Continuation Phase|Adverse Event|1|||
37825874|NCT04235504|69508075|FG002|Continuation Phase|Adverse Event|0|||
37825875|NCT04235504|69508076|FG003|Continuation Phase|Adverse Event|0|||
37825876|NCT04235504|69508073|FG000|Continuation Phase|Physician Decision|1|||
37825877|NCT04235504|69508074|FG001|Continuation Phase|Physician Decision|2|||
37825878|NCT04235504|69508075|FG002|Continuation Phase|Physician Decision|1|||
37825879|NCT04235504|69508076|FG003|Continuation Phase|Physician Decision|0|||
37825880|NCT04172987|69508091|FG000|Lead In Period|Adverse Event|1|||
37825881|NCT04172987|69508091|FG000|Lead In Period|Protocol Violation|1|||
37825882|NCT04172987|69508091|FG000|Period 1|Physician Decision|1|||
37825883|NCT04172987|69508091|FG000|Period 2|Adverse Event|5|||
37825884|NCT04172987|69508091|FG000|Period 2|Dosing Termination by Sponsor|4|||
37825885|NCT03705832|69508100|FG000|Overall Study|Physician Decision|0|||
37825886|NCT03705832|69508101|FG001|Overall Study|Physician Decision|1|||
37825887|NCT03705832|69508100|FG000|Overall Study|Withdrawal by Subject|1|||
37825888|NCT03705832|69508101|FG001|Overall Study|Withdrawal by Subject|0|||
37825889|NCT03447743|69508107|FG000|Overall Study|Withdrawal by Subject|2|||
37897011|NCT04676867|69581964|FG000|Overall Study|Death|0|||
37897012|NCT04676867|69581965|FG001|Overall Study|Death|0|||
37897013|NCT04676867|69581966|FG002|Overall Study|Death|1|||
37897014|NCT04676867|69581967|FG003|Overall Study|Death|0|||
37897015|NCT04676867|69581964|FG000|Overall Study|Withdrawal by Subject|2|||
37897016|NCT04676867|69581965|FG001|Overall Study|Withdrawal by Subject|2|||
37897017|NCT04676867|69581966|FG002|Overall Study|Withdrawal by Subject|4|||
37897018|NCT04676867|69581967|FG003|Overall Study|Withdrawal by Subject|4|||
37897019|NCT04676867|69581964|FG000|Overall Study|Lost to Follow-up|1|||
37897020|NCT04676867|69581965|FG001|Overall Study|Lost to Follow-up|0|||
37897021|NCT04676867|69581966|FG002|Overall Study|Lost to Follow-up|0|||
37897022|NCT04676867|69581967|FG003|Overall Study|Lost to Follow-up|0|||
37897023|NCT00770224|69581977|FG000|Step 1: Induction|Adverse Event|3|||
37897024|NCT00770224|69581978|FG001|Step 1: Induction|Adverse Event|0|||
37897025|NCT00770224|69581977|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
37897026|NCT00770224|69581978|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
37897027|NCT00770224|69581977|FG000|Step 1: Induction|Other reason not protocol specified|2|||
37897028|NCT00770224|69581978|FG001|Step 1: Induction|Other reason not protocol specified|0|||
37897029|NCT00770224|69581977|FG000|Step 1: Induction|Ineligible|2|||
37897030|NCT00770224|69581978|FG001|Step 1: Induction|Ineligible|0|||
37897031|NCT00770224|69581977|FG000|Step 1: Induction|No protocol treatment given|1|||
37897032|NCT00770224|69581978|FG001|Step 1: Induction|No protocol treatment given|0|||
37897033|NCT00770224|69581977|FG000|Step 2: Maintenance|Adverse Event|0|||
37897034|NCT00770224|69581978|FG001|Step 2: Maintenance|Adverse Event|10|||
37897035|NCT00770224|69581977|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
37897036|NCT00770224|69581978|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
37897037|NCT00770224|69581977|FG000|Step 2: Maintenance|Progression/relapse|0|||
37897038|NCT00770224|69581978|FG001|Step 2: Maintenance|Progression/relapse|1|||
37897039|NCT00770224|69581977|FG000|Step 2: Maintenance|Death|0|||
37897040|NCT00770224|69581978|FG001|Step 2: Maintenance|Death|2|||
37897041|NCT00770224|69581977|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
37897042|NCT00770224|69581978|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
37825890|NCT03447743|69508107|FG000|Overall Study|Lost to Follow-up|3|||
37825891|NCT03447743|69508107|FG000|Overall Study|Adverse Event|1|||
37825892|NCT03447743|69508107|FG000|Overall Study|Did not meet criteria to continue|1|||
37825893|NCT03433755|69508115|FG000|Overall Study|Lost to Follow-up|1|||
37897043|NCT00770224|69581977|FG000|Step 2: Maintenance|Ineligible|0|||
37696484|NCT01829464|69172600|FG002|Overall Study|Withdrawal by Subject|0|||
37825894|NCT03433755|69508116|FG001|Overall Study|Lost to Follow-up|0|||
37825895|NCT03433755|69508117|FG002|Overall Study|Lost to Follow-up|0|||
37897044|NCT00770224|69581978|FG001|Step 2: Maintenance|Ineligible|2|||
37897045|NCT02399215|69581985|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
37897046|NCT02399215|69581985|FG000|Overall Study|Withdrawal by Subject|1|||
37897047|NCT02389465|69581993|FG000|Overall Study|Lost to Follow-up|1|||
37897048|NCT02389465|69581994|FG001|Overall Study|Lost to Follow-up|3|||
37897049|NCT02389465|69581995|FG002|Overall Study|Lost to Follow-up|3|||
37897050|NCT02389465|69581996|FG003|Overall Study|Lost to Follow-up|0|||
37897051|NCT02389465|69581993|FG000|Overall Study|Physician Decision|0|||
37897052|NCT02389465|69581994|FG001|Overall Study|Physician Decision|0|||
37897053|NCT02389465|69581995|FG002|Overall Study|Physician Decision|0|||
37897054|NCT02389465|69581996|FG003|Overall Study|Physician Decision|1|||
37897055|NCT02389465|69581993|FG000|Overall Study|Withdrawal by Subject|0|||
37897056|NCT02389465|69581994|FG001|Overall Study|Withdrawal by Subject|1|||
37897057|NCT02389465|69581995|FG002|Overall Study|Withdrawal by Subject|2|||
37897058|NCT02389465|69581996|FG003|Overall Study|Withdrawal by Subject|2|||
37897059|NCT01057589|69582006|FG000|Overall Study|Disease Progression|35|||
37897060|NCT01057589|69582006|FG000|Overall Study|Adverse Event|10|||
37897061|NCT01057589|69582006|FG000|Overall Study|Physician Decision|8|||
37897062|NCT01057589|69582006|FG000|Overall Study|Withdrawal by Subject|3|||
37897063|NCT01057589|69582006|FG000|Overall Study|Sponsor Decision|1|||
37897064|NCT01057589|69582006|FG000|Overall Study|Death|8|||
37825896|NCT03433755|69508118|FG003|Overall Study|Lost to Follow-up|0|||
37897065|NCT01057589|69582006|FG000|Overall Study|Lost to Follow-up|1|||
37897066|NCT01716117|69582012|FG000|Overall Study|Death|5|||
37897067|NCT01716117|69582013|FG001|Overall Study|Death|2|||
37825897|NCT03433755|69508115|FG000|Overall Study|Decision by Sponsor|1|||
37825898|NCT03433755|69508116|FG001|Overall Study|Decision by Sponsor|0|||
37825899|NCT03433755|69508117|FG002|Overall Study|Decision by Sponsor|0|||
37825900|NCT03433755|69508118|FG003|Overall Study|Decision by Sponsor|0|||
37825901|NCT03406507|69508141|FG000|Extension Period|Lack of Efficacy|0|||
37825902|NCT03406507|69508142|FG001|Extension Period|Lack of Efficacy|1|||
37825903|NCT03283150|69508151|FG000|Overall Study|Withdrawal by Subject|6|||
37825904|NCT03283150|69508152|FG001|Overall Study|Withdrawal by Subject|0|||
37825905|NCT03283150|69508153|FG002|Overall Study|Withdrawal by Subject|0|||
37825906|NCT03218917|69508164|FG000|Overall Study|Adverse Event|3|||
37825907|NCT03218917|69508165|FG001|Overall Study|Adverse Event|3|||
37825908|NCT03218917|69508166|FG002|Overall Study|Adverse Event|2|||
37825909|NCT03218917|69508164|FG000|Overall Study|Subject withdrew consent|2|||
37825910|NCT03218917|69508165|FG001|Overall Study|Subject withdrew consent|4|||
37825911|NCT03218917|69508166|FG002|Overall Study|Subject withdrew consent|10|||
37825912|NCT03218917|69508164|FG000|Overall Study|Physician Decision|0|||
37825913|NCT03218917|69508165|FG001|Overall Study|Physician Decision|1|||
37825914|NCT03218917|69508166|FG002|Overall Study|Physician Decision|1|||
37825915|NCT03218917|69508164|FG000|Overall Study|Lost to Follow-up|1|||
37825916|NCT03218917|69508165|FG001|Overall Study|Lost to Follow-up|0|||
37825917|NCT03218917|69508166|FG002|Overall Study|Lost to Follow-up|0|||
37825918|NCT03218917|69508164|FG000|Overall Study|Reason Missing|0|||
37825919|NCT03218917|69508165|FG001|Overall Study|Reason Missing|2|||
37825920|NCT03218917|69508166|FG002|Overall Study|Reason Missing|0|||
37825921|NCT03218917|69508164|FG000|Overall Study|Death|0|||
37825922|NCT03218917|69508165|FG001|Overall Study|Death|1|||
37825923|NCT03218917|69508166|FG002|Overall Study|Death|0|||
37825924|NCT03218917|69508164|FG000|Overall Study|Non-Compliance with Study Drug|0|||
37825925|NCT03218917|69508165|FG001|Overall Study|Non-Compliance with Study Drug|1|||
37825926|NCT03218917|69508166|FG002|Overall Study|Non-Compliance with Study Drug|0|||
37825927|NCT03056040|69508177|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
37825928|NCT03056040|69508178|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
37825929|NCT03056040|69508177|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
37825930|NCT03056040|69508178|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
37825931|NCT03056040|69508177|FG000|Primary Evaluation Period|Pregnancy|0|||
37825932|NCT03056040|69508178|FG001|Primary Evaluation Period|Pregnancy|1|||
37825933|NCT03056040|69508177|FG000|Extension Period|Physician Decision|3|||
37825934|NCT03056040|69508178|FG001|Extension Period|Physician Decision|3|||
37825935|NCT03056040|69508177|FG000|Extension Period|Lost to Follow-up|0|||
37825936|NCT03056040|69508178|FG001|Extension Period|Lost to Follow-up|1|||
37825937|NCT03056040|69508177|FG000|Extension Period|Death|0|||
37825938|NCT03056040|69508178|FG001|Extension Period|Death|3|||
37825939|NCT03056040|69508177|FG000|Extension Period|Withdrawal by Subject|1|||
37897068|NCT01716117|69582012|FG000|Overall Study|Withdrawal by Subject|2|||
37897069|NCT01716117|69582013|FG001|Overall Study|Withdrawal by Subject|0|||
37897070|NCT00579553|69582029|FG000|Overall Study|Lost to Follow-up|16|||
37897071|NCT00579553|69582030|FG001|Overall Study|Lost to Follow-up|13|||
37825940|NCT03056040|69508178|FG001|Extension Period|Withdrawal by Subject|0|||
37825941|NCT03021499|69508189|FG000|Overall Study|Adverse Event|1|||
37825942|NCT03021499|69508190|FG001|Overall Study|Adverse Event|0|||
37696485|NCT01829464|69172598|FG000|Overall Study|Study terminated by sponsor|25|||
37696486|NCT01829464|69172599|FG001|Overall Study|Study terminated by sponsor|28|||
37696487|NCT01829464|69172600|FG002|Overall Study|Study terminated by sponsor|25|||
37696488|NCT01829464|69172598|FG000|Overall Study|Lack of Efficacy|0|||
37696489|NCT01829464|69172599|FG001|Overall Study|Lack of Efficacy|1|||
37825943|NCT03021499|69508189|FG000|Overall Study|Death|1|||
37825944|NCT03021499|69508190|FG001|Overall Study|Death|5|||
37825945|NCT03021499|69508189|FG000|Overall Study|Lack of Efficacy|0|||
37825946|NCT03021499|69508190|FG001|Overall Study|Lack of Efficacy|1|||
37825947|NCT03021499|69508189|FG000|Overall Study|Lost to Follow-up|1|||
37825948|NCT03021499|69508190|FG001|Overall Study|Lost to Follow-up|3|||
37825949|NCT03021499|69508189|FG000|Overall Study|Physician Decision|2|||
37825950|NCT03021499|69508190|FG001|Overall Study|Physician Decision|3|||
37825951|NCT03021499|69508189|FG000|Overall Study|Pregnancy|1|||
37825952|NCT03021499|69508190|FG001|Overall Study|Pregnancy|0|||
37825953|NCT03021499|69508189|FG000|Overall Study|Withdrawal by Subject|7|||
37825954|NCT03021499|69508190|FG001|Overall Study|Withdrawal by Subject|14|||
37825955|NCT03021499|69508189|FG000|Overall Study|Prohibited medication required|1|||
37825956|NCT03021499|69508190|FG001|Overall Study|Prohibited medication required|0|||
37825957|NCT03021499|69508189|FG000|Overall Study|Protocol non-compliance|1|||
37897072|NCT01650831|69582036|FG000|Overall Study|Screen failure|1|||
37897073|NCT00581893|69582044|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
37897074|NCT00581893|69582045|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
37897075|NCT00770146|69582053|FG000|Treatment Period|Withdrawal by Subject|6|||
37897076|NCT00770146|69582054|FG001|Treatment Period|Withdrawal by Subject|13|||
37897077|NCT00770146|69582053|FG000|Treatment Period|Adverse Event|2|||
37897078|NCT00770146|69582054|FG001|Treatment Period|Adverse Event|26|||
37897079|NCT00770146|69582053|FG000|Treatment Period|Other|1|||
37897080|NCT00770146|69582054|FG001|Treatment Period|Other|5|||
37897081|NCT00770146|69582053|FG000|Treatment Period|Protocol non-compliance|0|||
37825958|NCT03021499|69508190|FG001|Overall Study|Protocol non-compliance|1|||
37825959|NCT03021499|69508189|FG000|Overall Study|None of the above|0|||
37825960|NCT03021499|69508190|FG001|Overall Study|None of the above|4|||
37825961|NCT03021499|69508189|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
37825962|NCT03021499|69508190|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
37825963|NCT02726581|69508219|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
37825964|NCT02726581|69508220|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
37897082|NCT00770146|69582054|FG001|Treatment Period|Protocol non-compliance|1|||
37897083|NCT00770146|69582053|FG000|Follow-up Period|Withdrawal by Subject|7|||
37897084|NCT00770146|69582054|FG001|Follow-up Period|Withdrawal by Subject|13|||
37897085|NCT00770146|69582053|FG000|Follow-up Period|Adverse Event|0|||
37897086|NCT00770146|69582054|FG001|Follow-up Period|Adverse Event|2|||
37897087|NCT00770146|69582053|FG000|Follow-up Period|Other|4|||
37897088|NCT00770146|69582054|FG001|Follow-up Period|Other|5|||
37897089|NCT01056341|69582065|FG000|Overall Study|Treatment Intolerance|0|||
37897090|NCT01056341|69582066|FG001|Overall Study|Treatment Intolerance|2|||
37897091|NCT01056341|69582067|FG002|Overall Study|Treatment Intolerance|0|||
37897092|NCT01056341|69582068|FG003|Overall Study|Treatment Intolerance|2|||
37696490|NCT01829464|69172600|FG002|Overall Study|Lack of Efficacy|0|||
37696491|NCT01847092|69172610|FG000|Overall Study|Adverse Event|12|||
37696492|NCT01847092|69172611|FG001|Overall Study|Adverse Event|3|||
37825965|NCT02726581|69508221|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
37825966|NCT02726581|69508219|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
37825967|NCT02726581|69508220|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
37825968|NCT02726581|69508221|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
37897093|NCT01056341|69582069|FG004|Overall Study|Treatment Intolerance|0|||
37897094|NCT01056341|69582065|FG000|Overall Study|Lack of Efficacy|32|||
37897095|NCT01056341|69582066|FG001|Overall Study|Lack of Efficacy|30|||
37897096|NCT01056341|69582067|FG002|Overall Study|Lack of Efficacy|7|||
37696493|NCT01847092|69172610|FG000|Overall Study|Withdrawal by Subject|5|||
37696494|NCT01847092|69172611|FG001|Overall Study|Withdrawal by Subject|5|||
37897097|NCT01056341|69582068|FG003|Overall Study|Lack of Efficacy|25|||
37897098|NCT01056341|69582069|FG004|Overall Study|Lack of Efficacy|9|||
37897099|NCT01056341|69582065|FG000|Overall Study|Other reasons|4|||
37897100|NCT01056341|69582066|FG001|Overall Study|Other reasons|4|||
37897101|NCT01056341|69582067|FG002|Overall Study|Other reasons|8|||
37897102|NCT01056341|69582068|FG003|Overall Study|Other reasons|9|||
37897103|NCT01056341|69582069|FG004|Overall Study|Other reasons|5|||
37897104|NCT00999518|69582092|FG000|Overall Study|Adverse Event|1|||
37897105|NCT00999518|69582093|FG001|Overall Study|Adverse Event|6|||
37897106|NCT00999518|69582094|FG002|Overall Study|Adverse Event|3|||
37897107|NCT00999518|69582095|FG003|Overall Study|Adverse Event|1|||
37897108|NCT00999518|69582096|FG004|Overall Study|Adverse Event|2|||
37897109|NCT00999518|69582092|FG000|Overall Study|Lack of Efficacy|2|||
37897110|NCT00999518|69582093|FG001|Overall Study|Lack of Efficacy|0|||
37897111|NCT00999518|69582094|FG002|Overall Study|Lack of Efficacy|0|||
37897112|NCT00999518|69582095|FG003|Overall Study|Lack of Efficacy|2|||
37897113|NCT00999518|69582096|FG004|Overall Study|Lack of Efficacy|2|||
37897114|NCT00999518|69582092|FG000|Overall Study|Lost to Follow-up|0|||
37897115|NCT00999518|69582093|FG001|Overall Study|Lost to Follow-up|0|||
37897116|NCT00999518|69582094|FG002|Overall Study|Lost to Follow-up|0|||
37897117|NCT00999518|69582095|FG003|Overall Study|Lost to Follow-up|4|||
37897118|NCT00999518|69582096|FG004|Overall Study|Lost to Follow-up|1|||
37897119|NCT00999518|69582092|FG000|Overall Study|Did not meet entrance criteria|0|||
37897120|NCT00999518|69582093|FG001|Overall Study|Did not meet entrance criteria|0|||
37897121|NCT00999518|69582094|FG002|Overall Study|Did not meet entrance criteria|0|||
37897122|NCT00999518|69582095|FG003|Overall Study|Did not meet entrance criteria|0|||
37897123|NCT00999518|69582096|FG004|Overall Study|Did not meet entrance criteria|1|||
37897124|NCT00999518|69582092|FG000|Overall Study|Study terminated by sponsor|10|||
37897125|NCT00999518|69582093|FG001|Overall Study|Study terminated by sponsor|6|||
37897126|NCT00999518|69582094|FG002|Overall Study|Study terminated by sponsor|5|||
37897127|NCT00999518|69582095|FG003|Overall Study|Study terminated by sponsor|5|||
37897128|NCT00999518|69582096|FG004|Overall Study|Study terminated by sponsor|9|||
37897129|NCT00999518|69582092|FG000|Overall Study|Pregnancy|0|||
37897130|NCT00999518|69582093|FG001|Overall Study|Pregnancy|0|||
37897131|NCT00999518|69582094|FG002|Overall Study|Pregnancy|1|||
37897132|NCT00999518|69582095|FG003|Overall Study|Pregnancy|0|||
37897133|NCT00999518|69582096|FG004|Overall Study|Pregnancy|0|||
37897134|NCT00999518|69582092|FG000|Overall Study|Protocol Violation|0|||
37897135|NCT00999518|69582093|FG001|Overall Study|Protocol Violation|1|||
37897136|NCT00999518|69582094|FG002|Overall Study|Protocol Violation|0|||
37897137|NCT00999518|69582095|FG003|Overall Study|Protocol Violation|0|||
37897138|NCT00999518|69582096|FG004|Overall Study|Protocol Violation|2|||
37897139|NCT00999518|69582092|FG000|Overall Study|Withdrawal by Subject|5|||
37897140|NCT00999518|69582093|FG001|Overall Study|Withdrawal by Subject|4|||
37897141|NCT00999518|69582094|FG002|Overall Study|Withdrawal by Subject|10|||
37897142|NCT00999518|69582095|FG003|Overall Study|Withdrawal by Subject|6|||
37897143|NCT00999518|69582096|FG004|Overall Study|Withdrawal by Subject|1|||
37897144|NCT00999518|69582092|FG000|Overall Study|Other|5|||
37897145|NCT00999518|69582093|FG001|Overall Study|Other|7|||
37897146|NCT00999518|69582094|FG002|Overall Study|Other|1|||
37897147|NCT00999518|69582095|FG003|Overall Study|Other|4|||
37897148|NCT00999518|69582096|FG004|Overall Study|Other|5|||
37897149|NCT00999518|69582092|FG000|Overall Study|Randomized but not Treated|1|||
37897150|NCT00999518|69582093|FG001|Overall Study|Randomized but not Treated|1|||
37897151|NCT00999518|69582094|FG002|Overall Study|Randomized but not Treated|2|||
37897152|NCT00999518|69582095|FG003|Overall Study|Randomized but not Treated|0|||
37897153|NCT00999518|69582096|FG004|Overall Study|Randomized but not Treated|1|||
37897154|NCT01056263|69582112|FG000|Overall Study|Adverse Event|12|||
37897155|NCT01056263|69582112|FG000|Overall Study|Death|1|||
37897156|NCT01056263|69582112|FG000|Overall Study|Withdrawal by Subject|1|||
37897157|NCT01056263|69582112|FG000|Overall Study|Lack of Efficacy|29|||
37897158|NCT01056263|69582112|FG000|Overall Study|Progressive disease|2|||
37897159|NCT01056263|69582112|FG000|Overall Study|Neoplasm progression|1|||
37897160|NCT01056263|69582112|FG000|Overall Study|Objective progression or relapse|1|||
37897161|NCT01056263|69582112|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
37897162|NCT01056107|69582120|FG000|Overall Study|Withdrawal by Subject|0|||
37897163|NCT01056107|69582121|FG001|Overall Study|Withdrawal by Subject|1|||
37897164|NCT01056107|69582122|FG002|Overall Study|Withdrawal by Subject|3|||
37897165|NCT01056107|69582123|FG003|Overall Study|Withdrawal by Subject|0|||
37897166|NCT01003886|69582133|FG000|Overall Study|Lack of Efficacy|5|||
37897167|NCT01003886|69582133|FG000|Overall Study|Lost to Follow-up|169|||
37897168|NCT01003886|69582133|FG000|Overall Study|Withdrawal by Subject|39|||
37897169|NCT01003886|69582133|FG000|Overall Study|Other|14|||
37897170|NCT01003886|69582133|FG000|Overall Study|Adverse Event|3|||
37897171|NCT01003184|69582139|FG000|Overall Study|Adverse Event|12|||
37897172|NCT01003184|69582140|FG001|Overall Study|Adverse Event|5|||
37897173|NCT01003184|69582139|FG000|Overall Study|Lost to Follow-up|1|||
37825969|NCT02726581|69508219|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
37825970|NCT02726581|69508220|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
37825971|NCT02726581|69508221|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
37897174|NCT01003184|69582140|FG001|Overall Study|Lost to Follow-up|0|||
37897175|NCT01003184|69582139|FG000|Overall Study|Loss of glucose control|1|||
37897176|NCT01003184|69582140|FG001|Overall Study|Loss of glucose control|1|||
37897177|NCT01003184|69582139|FG000|Overall Study|Protocol Violation|3|||
37897178|NCT01003184|69582140|FG001|Overall Study|Protocol Violation|0|||
37897179|NCT01003184|69582139|FG000|Overall Study|Withdrawal by Subject|1|||
37897180|NCT01003184|69582140|FG001|Overall Study|Withdrawal by Subject|6|||
37897181|NCT01003184|69582139|FG000|Overall Study|Physician Decision|1|||
37897182|NCT01003184|69582140|FG001|Overall Study|Physician Decision|0|||
37696495|NCT01847092|69172610|FG000|Overall Study|Protocol Specified|8|||
37825972|NCT02726581|69508219|FG000|Treatment Period|Disease progression|47|||
37996035|NCT00264810|69680700|FG001|Baseline|Other|1|||
37996036|NCT00264810|69680699|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
37996037|NCT00264810|69680700|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
37996038|NCT00264810|69680699|FG000|Stimulation Optimization Period|Death|0|||
37996039|NCT00264810|69680700|FG001|Stimulation Optimization Period|Death|1|||
37996040|NCT00264810|69680699|FG000|Blinded Evaluation Period|Explant due to infection|1|||
37996041|NCT00264810|69680700|FG001|Blinded Evaluation Period|Explant due to infection|1|||
37996042|NCT00264810|69680699|FG000|Open Label Evaluation Period|Explant due to infection|1|||
37996043|NCT00264810|69680700|FG001|Open Label Evaluation Period|Explant due to infection|1|||
37996044|NCT00264810|69680699|FG000|Open Label Evaluation Period|Death|3|||
37996045|NCT00264810|69680700|FG001|Open Label Evaluation Period|Death|2|||
37825973|NCT02726581|69508220|FG001|Treatment Period|Disease progression|50|||
37825974|NCT02726581|69508221|FG002|Treatment Period|Disease progression|16|||
37825975|NCT02726581|69508219|FG000|Treatment Period|Other reasons|9|||
37825976|NCT02726581|69508220|FG001|Treatment Period|Other reasons|8|||
37825977|NCT02726581|69508221|FG002|Treatment Period|Other reasons|2|||
37825978|NCT02726581|69508219|FG000|Treatment Period|Study drug toxicity|6|||
37825979|NCT02726581|69508220|FG001|Treatment Period|Study drug toxicity|3|||
37825980|NCT02726581|69508221|FG002|Treatment Period|Study drug toxicity|2|||
37825981|NCT02726581|69508219|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
37825982|NCT02726581|69508220|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
37825983|NCT02726581|69508221|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
37825984|NCT02726581|69508219|FG000|Treatment Period|Participant withdrew consent|3|||
37825985|NCT02726581|69508220|FG001|Treatment Period|Participant withdrew consent|1|||
37897183|NCT01029353|69582150|FG000|Overall Study|Lost to Follow-up|4|||
37897184|NCT01029353|69582151|FG001|Overall Study|Lost to Follow-up|5|||
37825986|NCT02726581|69508221|FG002|Treatment Period|Participant withdrew consent|1|||
37825987|NCT02726581|69508219|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
37825988|NCT02726581|69508220|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
37825989|NCT02726581|69508221|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
37897185|NCT01029353|69582152|FG002|Overall Study|Lost to Follow-up|5|||
37897186|NCT01029353|69582153|FG003|Overall Study|Lost to Follow-up|4|||
37897187|NCT01029353|69582150|FG000|Overall Study|Consent Withdrawn|2|||
37897188|NCT01029353|69582151|FG001|Overall Study|Consent Withdrawn|0|||
37897189|NCT01029353|69582152|FG002|Overall Study|Consent Withdrawn|0|||
37897190|NCT01029353|69582153|FG003|Overall Study|Consent Withdrawn|0|||
37897191|NCT01029353|69582150|FG000|Overall Study|Primary Outcome Indeterminate|1|||
37897192|NCT01029353|69582151|FG001|Overall Study|Primary Outcome Indeterminate|3|||
37996046|NCT00264810|69680699|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
37996047|NCT00264810|69680700|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
37996048|NCT00467363|69680710|FG000|Overall Study|Lost to Follow-up|80|||
37996049|NCT00467363|69680711|FG001|Overall Study|Lost to Follow-up|70|||
37996050|NCT00091390|69680717|FG000|Overall Study|Protocol Violation|1|||
37825990|NCT02726581|69508219|FG000|Treatment Period|Maximum clinical benefit|0|||
37897193|NCT01029353|69582152|FG002|Overall Study|Primary Outcome Indeterminate|2|||
37897194|NCT01029353|69582153|FG003|Overall Study|Primary Outcome Indeterminate|0|||
37897195|NCT01008410|69582165|FG000|Overall Study|Adverse Event|13|||
37825991|NCT02726581|69508220|FG001|Treatment Period|Maximum clinical benefit|2|||
37897196|NCT01008410|69582166|FG001|Overall Study|Adverse Event|7|||
37897197|NCT01008410|69582165|FG000|Overall Study|Withdrawal by Subject|6|||
37897198|NCT01008410|69582166|FG001|Overall Study|Withdrawal by Subject|2|||
37897199|NCT01008410|69582165|FG000|Overall Study|Lost to Follow-up|1|||
37897200|NCT01008410|69582166|FG001|Overall Study|Lost to Follow-up|0|||
37897201|NCT01008410|69582165|FG000|Overall Study|Noncompliance|1|||
37897202|NCT01008410|69582166|FG001|Overall Study|Noncompliance|0|||
37897203|NCT01008410|69582165|FG000|Overall Study|Low Cortisol|2|||
37897204|NCT01008410|69582166|FG001|Overall Study|Low Cortisol|0|||
37897205|NCT01008410|69582165|FG000|Overall Study|Lack of Efficacy|2|||
37897206|NCT01008410|69582166|FG001|Overall Study|Lack of Efficacy|6|||
37897207|NCT01008410|69582165|FG000|Overall Study|Met Exclusion Criterion|0|||
37897208|NCT01008410|69582166|FG001|Overall Study|Met Exclusion Criterion|1|||
37897209|NCT01023269|69582172|FG000|Overall Study|early termination of the study|2|||
37897210|NCT01023269|69582173|FG001|Overall Study|early termination of the study|0|||
37897211|NCT01007942|69582205|FG000|Overall Study|Adverse Event|29|||
37897212|NCT01007942|69582206|FG001|Overall Study|Adverse Event|14|||
37897213|NCT01007942|69582205|FG000|Overall Study|Abnormal test procedure|0|||
37897214|NCT01007942|69582206|FG001|Overall Study|Abnormal test procedure|1|||
37897215|NCT01007942|69582205|FG000|Overall Study|Disease progression|217|||
37897216|NCT01007942|69582206|FG001|Overall Study|Disease progression|242|||
37897217|NCT01007942|69582205|FG000|Overall Study|New cancer therapy|5|||
37897218|NCT01007942|69582206|FG001|Overall Study|New cancer therapy|1|||
37897219|NCT01007942|69582205|FG000|Overall Study|Protocol Violation|1|||
37996051|NCT00091390|69680717|FG000|Overall Study|No protocol treatment|3|||
37897220|NCT01007942|69582206|FG001|Overall Study|Protocol Violation|1|||
37897221|NCT01007942|69582205|FG000|Overall Study|Withdrawal by Subject|19|||
37897222|NCT01007942|69582206|FG001|Overall Study|Withdrawal by Subject|14|||
37897223|NCT01007942|69582205|FG000|Overall Study|Lost to Follow-up|1|||
37897224|NCT01007942|69582206|FG001|Overall Study|Lost to Follow-up|0|||
37825992|NCT02726581|69508221|FG002|Treatment Period|Maximum clinical benefit|0|||
37996052|NCT00239226|69680725|FG000|Overall Study|permAF during stabilization period|0|||
37996053|NCT00239226|69680726|FG001|Overall Study|permAF during stabilization period|0|||
37825993|NCT02726581|69508219|FG000|Treatment Period|Death|1|||
37825994|NCT02726581|69508220|FG001|Treatment Period|Death|0|||
37825995|NCT02726581|69508221|FG002|Treatment Period|Death|0|||
37825996|NCT02726581|69508219|FG000|Treatment Period|Poor/non-compliance|1|||
37825997|NCT02726581|69508220|FG001|Treatment Period|Poor/non-compliance|0|||
37825998|NCT02726581|69508221|FG002|Treatment Period|Poor/non-compliance|0|||
37825999|NCT02726581|69508219|FG000|Treatment Period|Participant no longer meets study criteria|0|||
37826000|NCT02726581|69508220|FG001|Treatment Period|Participant no longer meets study criteria|1|||
37826001|NCT02726581|69508221|FG002|Treatment Period|Participant no longer meets study criteria|0|||
37897225|NCT01007942|69582205|FG000|Overall Study|Administrative problems|2|||
37897226|NCT01007942|69582206|FG001|Overall Study|Administrative problems|0|||
37897227|NCT01007942|69582205|FG000|Overall Study|Death|3|||
37897228|NCT01007942|69582206|FG001|Overall Study|Death|2|||
37897229|NCT01007942|69582205|FG000|Overall Study|Patients untreated|4|||
37897230|NCT01007942|69582206|FG001|Overall Study|Patients untreated|3|||
37897231|NCT01023035|69582219|FG000|Treatment Period|Adverse Event|27|||
37897232|NCT01023035|69582220|FG001|Treatment Period|Adverse Event|32|||
37897233|NCT01023035|69582221|FG002|Treatment Period|Adverse Event|50|||
37897234|NCT01023035|69582219|FG000|Treatment Period|Non-Medical Reasons|19|||
37897235|NCT01023035|69582220|FG001|Treatment Period|Non-Medical Reasons|22|||
37996054|NCT00239226|69680727|FG002|Overall Study|permAF during stabilization period|0|||
37996055|NCT00239226|69680728|FG003|Overall Study|permAF during stabilization period|3|||
37996056|NCT00239226|69680725|FG000|Overall Study|Lost to Follow-up|1|||
37996057|NCT00239226|69680726|FG001|Overall Study|Lost to Follow-up|0|||
37996058|NCT00239226|69680727|FG002|Overall Study|Lost to Follow-up|1|||
37996059|NCT00239226|69680728|FG003|Overall Study|Lost to Follow-up|0|||
37996060|NCT00467285|69680740|FG000|Overall Study|Lost to Follow-up|4|||
37996061|NCT00467285|69680741|FG001|Overall Study|Lost to Follow-up|4|||
37996062|NCT00264576|69680751|FG000|Overall Study|Lost to Follow-up|1|||
37826002|NCT02700048|69508231|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
37826003|NCT02700048|69508232|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
37826004|NCT02425904|69508249|FG000|Overall Study|Lost to Follow-up|1|||
37826005|NCT02425904|69508250|FG001|Overall Study|Lost to Follow-up|0|||
37826006|NCT02425904|69508249|FG000|Overall Study|Withdrawal by Subject|2|||
37826007|NCT02425904|69508250|FG001|Overall Study|Withdrawal by Subject|0|||
37826008|NCT02425904|69508249|FG000|Overall Study|Death|0|||
37826009|NCT02425904|69508250|FG001|Overall Study|Death|3|||
37826010|NCT01964989|69508272|FG000|Overall Study|Protocol Violation|3|||
37826011|NCT01964989|69508273|FG001|Overall Study|Protocol Violation|4|||
37826012|NCT01964989|69508272|FG000|Overall Study|Administrative Reason|103|||
37826013|NCT01964989|69508273|FG001|Overall Study|Administrative Reason|95|||
37826014|NCT01964989|69508272|FG000|Overall Study|Adverse Event|0|||
37826015|NCT01964989|69508273|FG001|Overall Study|Adverse Event|1|||
37826016|NCT01964989|69508272|FG000|Overall Study|Death|1|||
37826017|NCT01964989|69508273|FG001|Overall Study|Death|3|||
37826018|NCT01964989|69508272|FG000|Overall Study|Withdrawal by Subject|156|||
37826019|NCT01964989|69508273|FG001|Overall Study|Withdrawal by Subject|160|||
37826020|NCT01964989|69508272|FG000|Overall Study|Lost to Follow-up|254|||
37826021|NCT01964989|69508273|FG001|Overall Study|Lost to Follow-up|232|||
37826022|NCT01964989|69508272|FG000|Overall Study|Other|267|||
37826023|NCT01964989|69508273|FG001|Overall Study|Other|252|||
37826024|NCT01575860|69508301|FG000|Overall Study|Withdrawal by Subject|1|||
37826025|NCT01575860|69508301|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
37826026|NCT01416831|69508308|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
37826027|NCT01416831|69508309|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
37897236|NCT01023035|69582221|FG002|Treatment Period|Non-Medical Reasons|44|||
37897237|NCT01023035|69582219|FG000|Treatment Period|Treatment Failure|26|||
37996063|NCT00264576|69680752|FG001|Overall Study|Lost to Follow-up|1|||
37696496|NCT01847092|69172611|FG001|Overall Study|Protocol Specified|0|||
37996064|NCT00466505|69680759|FG000|Overall Study|disease progression|13|||
37996065|NCT00466505|69680759|FG000|Overall Study|Adverse Event|4|||
37996066|NCT00467051|69680763|FG000|Overall Study|Adverse Event|2|||
37696497|NCT01847092|69172610|FG000|Overall Study|Physician Decision|1|||
37826028|NCT00382070|69508330|FG000|Overall Study|No follow up data mapped to Other|17|||
37826029|NCT00382070|69508331|FG001|Overall Study|No follow up data mapped to Other|19|||
37826030|NCT00382070|69508330|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
37826031|NCT00382070|69508331|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
37897238|NCT01023035|69582220|FG001|Treatment Period|Treatment Failure|31|||
37897239|NCT01023035|69582221|FG002|Treatment Period|Treatment Failure|24|||
37996067|NCT00264498|69680770|FG000|Randomized Treatment|Death|0|||
37996068|NCT00264498|69680771|FG001|Randomized Treatment|Death|3|||
37696498|NCT01847092|69172611|FG001|Overall Study|Physician Decision|1|||
37696499|NCT01847092|69172610|FG000|Overall Study|Protocol Violation|0|||
37696500|NCT01847092|69172611|FG001|Overall Study|Protocol Violation|2|||
37696501|NCT01601821|69172619|FG000|Overall Study|Death|2|||
37696502|NCT01601821|69172620|FG001|Overall Study|Death|5|||
37696503|NCT01601821|69172619|FG000|Overall Study|Protocol Violation|2|||
37696504|NCT01601821|69172620|FG001|Overall Study|Protocol Violation|2|||
37696505|NCT01601821|69172619|FG000|Overall Study|Lost to Follow-up|6|||
37696506|NCT01601821|69172620|FG001|Overall Study|Lost to Follow-up|14|||
37696507|NCT01601821|69172619|FG000|Overall Study|Withdrawal by Subject|1|||
37696508|NCT01601821|69172620|FG001|Overall Study|Withdrawal by Subject|0|||
37696509|NCT01601821|69172619|FG000|Overall Study|Graft Loss|6|||
37696510|NCT01601821|69172620|FG001|Overall Study|Graft Loss|6|||
37696511|NCT01601821|69172619|FG000|Overall Study|Study Events|7|||
37696512|NCT01601821|69172620|FG001|Overall Study|Study Events|1|||
37696513|NCT01601821|69172619|FG000|Overall Study|Other|5|||
37696514|NCT01601821|69172620|FG001|Overall Study|Other|1|||
37696515|NCT02323646|69172629|FG000|Treatment Course 1|Adverse Event|1|||
37696516|NCT02323646|69172630|FG001|Treatment Course 1|Adverse Event|0|||
37696517|NCT02323646|69172631|FG002|Treatment Course 1|Adverse Event|1|||
37826032|NCT00382070|69508330|FG000|Overall Study|No clinical assessment|9|||
37826033|NCT00382070|69508331|FG001|Overall Study|No clinical assessment|11|||
37826034|NCT02921269|69508362|FG000|Overall Study|Did not complete DLT period|1|||
37826035|NCT04303559|69508401|FG000|Overall Study|Study closed due to poor enrollment.|1|||
37826036|NCT03784820|69508407|FG000|Overall Study|Lost to Follow-up|5|||
37826037|NCT03784820|69508408|FG001|Overall Study|Lost to Follow-up|5|||
37826038|NCT03784820|69508409|FG002|Overall Study|Lost to Follow-up|3|||
37826039|NCT03784820|69508410|FG003|Overall Study|Lost to Follow-up|3|||
37826040|NCT03769675|69508418|FG000|Overall Study|Lost to Follow-up|1|||
37826041|NCT03729245|69508424|FG000|Overall Study|Lost to Follow-up|5|||
37826042|NCT03729245|69508425|FG001|Overall Study|Lost to Follow-up|6|||
37826043|NCT03729245|69508424|FG000|Overall Study|Withdrawal by Subject|16|||
37826044|NCT03729245|69508425|FG001|Overall Study|Withdrawal by Subject|19|||
37826045|NCT03729245|69508424|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
37826046|NCT03729245|69508425|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
37826047|NCT03311711|69508445|FG000|Overall Study|Death|1|||
37826048|NCT03311711|69508446|FG001|Overall Study|Death|0|||
37826049|NCT03311711|69508447|FG002|Overall Study|Death|0|||
37826050|NCT03311711|69508448|FG003|Overall Study|Death|0|||
37826051|NCT03311711|69508449|FG004|Overall Study|Death|0|||
37826052|NCT03311711|69508450|FG005|Overall Study|Death|0|||
37826053|NCT03311711|69508451|FG006|Overall Study|Death|1|||
37826054|NCT03311711|69508452|FG007|Overall Study|Death|0|||
37826055|NCT03311711|69508453|FG008|Overall Study|Death|1|||
37826056|NCT03311711|69508454|FG009|Overall Study|Death|0|||
37826057|NCT03311711|69508445|FG000|Overall Study|Death of dyad partner|0|||
37826058|NCT03311711|69508446|FG001|Overall Study|Death of dyad partner|1|||
37696518|NCT02323646|69172629|FG000|Treatment Course 1|Heavy Bleeding|1|||
37696519|NCT02323646|69172630|FG001|Treatment Course 1|Heavy Bleeding|1|||
37696520|NCT02323646|69172631|FG002|Treatment Course 1|Heavy Bleeding|0|||
37696521|NCT02323646|69172629|FG000|Treatment Course 1|Lost to Follow-up|1|||
37696522|NCT02323646|69172630|FG001|Treatment Course 1|Lost to Follow-up|0|||
37897240|NCT01023035|69582219|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
37897241|NCT01023035|69582220|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
37897242|NCT01023035|69582221|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
37897243|NCT01023035|69582219|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
37897244|NCT01023035|69582220|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
37897245|NCT01023035|69582221|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
37897246|NCT01028651|69582231|FG000|Overall Study|Death|2|||
37897247|NCT01028651|69582231|FG000|Overall Study|Adverse Event|1|||
37897248|NCT01028027|69582239|FG000|Overall Study|Lost to Follow-up|4|||
37897249|NCT01028027|69582240|FG001|Overall Study|Lost to Follow-up|1|||
37897250|NCT01028027|69582239|FG000|Overall Study|Withdrawal by Subject|5|||
37897251|NCT01028027|69582240|FG001|Overall Study|Withdrawal by Subject|3|||
37897252|NCT01028027|69582239|FG000|Overall Study|Adverse Event|4|||
37897253|NCT01028027|69582240|FG001|Overall Study|Adverse Event|7|||
37897254|NCT01028027|69582239|FG000|Overall Study|Protocol Violation|3|||
37897255|NCT01028027|69582240|FG001|Overall Study|Protocol Violation|1|||
37897256|NCT01028027|69582239|FG000|Overall Study|Lack of Efficacy|0|||
37897257|NCT01028027|69582240|FG001|Overall Study|Lack of Efficacy|1|||
37897258|NCT01007552|69582246|FG000|Overall Study|Withdrawal by Subject|1|||
37897259|NCT01007396|69582250|FG000|Overall Study|Lost to Follow-up|47|||
37897260|NCT00998738|69582254|FG000|Overall Study|Uknown|1|||
37897261|NCT00997334|69582258|FG000|Overall Study|still on therapy|12|||
37897262|NCT00997334|69582258|FG000|Overall Study|Adverse Event|3|||
37897263|NCT00997334|69582258|FG000|Overall Study|Patient non-compliance|1|||
37897264|NCT00997334|69582258|FG000|Overall Study|Withdrawal by Subject|3|||
37897265|NCT00997334|69582258|FG000|Overall Study|Death|2|||
37897266|NCT00997334|69582258|FG000|Overall Study|Urgent Palliative Care|2|||
37897267|NCT00997334|69582258|FG000|Overall Study|No lesion amenable|1|||
37897268|NCT00997334|69582258|FG000|Overall Study|Ineligible|1|||
37897269|NCT00996944|69582264|FG000|Double-blind Treatment Period|Adverse Event|2|||
37897270|NCT00996944|69582265|FG001|Double-blind Treatment Period|Adverse Event|1|||
37897271|NCT00996944|69582264|FG000|Double-blind Treatment Period|Protocol Violation|1|||
37897272|NCT00996944|69582265|FG001|Double-blind Treatment Period|Protocol Violation|0|||
37897273|NCT00996944|69582264|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
37826059|NCT03311711|69508447|FG002|Overall Study|Death of dyad partner|0|||
37826060|NCT03311711|69508448|FG003|Overall Study|Death of dyad partner|0|||
37826061|NCT03311711|69508449|FG004|Overall Study|Death of dyad partner|0|||
37826062|NCT03311711|69508450|FG005|Overall Study|Death of dyad partner|0|||
37826063|NCT03311711|69508451|FG006|Overall Study|Death of dyad partner|0|||
37826064|NCT03311711|69508452|FG007|Overall Study|Death of dyad partner|1|||
37826065|NCT03311711|69508453|FG008|Overall Study|Death of dyad partner|0|||
37826066|NCT03311711|69508454|FG009|Overall Study|Death of dyad partner|1|||
37826067|NCT03311711|69508445|FG000|Overall Study|Lost to Follow-up|2|||
37826068|NCT03311711|69508446|FG001|Overall Study|Lost to Follow-up|2|||
37826069|NCT03311711|69508447|FG002|Overall Study|Lost to Follow-up|0|||
37826070|NCT03311711|69508448|FG003|Overall Study|Lost to Follow-up|0|||
37826071|NCT03311711|69508449|FG004|Overall Study|Lost to Follow-up|0|||
37826072|NCT03311711|69508450|FG005|Overall Study|Lost to Follow-up|0|||
37826073|NCT03311711|69508451|FG006|Overall Study|Lost to Follow-up|1|||
37826074|NCT03311711|69508452|FG007|Overall Study|Lost to Follow-up|1|||
37826075|NCT03311711|69508453|FG008|Overall Study|Lost to Follow-up|0|||
37826076|NCT03311711|69508454|FG009|Overall Study|Lost to Follow-up|0|||
37826077|NCT03311711|69508445|FG000|Overall Study|Withdrawal by Subject|1|||
37826078|NCT03311711|69508446|FG001|Overall Study|Withdrawal by Subject|1|||
37826079|NCT03311711|69508447|FG002|Overall Study|Withdrawal by Subject|0|||
37826080|NCT03311711|69508448|FG003|Overall Study|Withdrawal by Subject|0|||
37826081|NCT03311711|69508449|FG004|Overall Study|Withdrawal by Subject|0|||
37897274|NCT00996944|69582265|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
37826082|NCT03311711|69508450|FG005|Overall Study|Withdrawal by Subject|0|||
37826083|NCT03311711|69508451|FG006|Overall Study|Withdrawal by Subject|3|||
37897275|NCT00996944|69582264|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
37897276|NCT00996944|69582265|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
37826084|NCT03311711|69508452|FG007|Overall Study|Withdrawal by Subject|3|||
37826085|NCT03311711|69508453|FG008|Overall Study|Withdrawal by Subject|0|||
37826086|NCT03311711|69508454|FG009|Overall Study|Withdrawal by Subject|0|||
37826087|NCT03270891|69508484|FG000|Overall Study|Lost to Follow-up|3|||
37826088|NCT03270891|69508485|FG001|Overall Study|Lost to Follow-up|6|||
37826089|NCT03270891|69508486|FG002|Overall Study|Lost to Follow-up|0|||
37826090|NCT03270891|69508484|FG000|Overall Study|Withdrawal by Subject|1|||
37826091|NCT03270891|69508485|FG001|Overall Study|Withdrawal by Subject|0|||
37826092|NCT03270891|69508486|FG002|Overall Study|Withdrawal by Subject|0|||
37897277|NCT00996944|69582264|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
37897278|NCT00996944|69582265|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
37897279|NCT01002482|69582275|FG000|Overall Study|Withdrawal by Subject|14|||
37826093|NCT03270891|69508484|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
37826094|NCT03270891|69508485|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
37826095|NCT03270891|69508486|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
37826096|NCT02992743|69508494|FG000|Overall Study|Withdrawal by Subject|1|||
37826097|NCT02992743|69508495|FG001|Overall Study|Withdrawal by Subject|1|||
37826098|NCT02992743|69508494|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
37826099|NCT02992743|69508495|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
37826100|NCT02992743|69508494|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
37826101|NCT02992743|69508495|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
37826102|NCT02992743|69508494|FG000|Overall Study|No measurable disease|1|||
37826103|NCT02992743|69508495|FG001|Overall Study|No measurable disease|0|||
37826104|NCT02992743|69508494|FG000|Overall Study|Lost to Follow-up|0|||
37826105|NCT02992743|69508495|FG001|Overall Study|Lost to Follow-up|1|||
37826106|NCT02853344|69508503|FG000|Overall Study|Lost to Follow-up|1|||
37897280|NCT01002482|69582276|FG001|Overall Study|Withdrawal by Subject|21|||
37897281|NCT01002482|69582275|FG000|Overall Study|Included twice|1|||
37897282|NCT01002482|69582276|FG001|Overall Study|Included twice|0|||
37897283|NCT01027949|69582282|FG000|Overall Study|Death|174|||
37826107|NCT02853344|69508504|FG001|Overall Study|Lost to Follow-up|1|||
37826108|NCT02853344|69508503|FG000|Overall Study|Withdrawal by Subject|2|||
37826109|NCT02853344|69508504|FG001|Overall Study|Withdrawal by Subject|4|||
37826110|NCT02853344|69508503|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
37826111|NCT02853344|69508504|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
37826112|NCT02853344|69508503|FG000|Overall Study|Death|70|||
37826113|NCT02853344|69508504|FG001|Overall Study|Death|112|||
37826114|NCT02739620|69508515|FG000|Overall Study|Lost to Follow-up|3|||
37826115|NCT02739620|69508516|FG001|Overall Study|Lost to Follow-up|1|||
37826116|NCT02739620|69508515|FG000|Overall Study|Adverse Event|0|||
37826117|NCT02739620|69508516|FG001|Overall Study|Adverse Event|1|||
37826118|NCT02675426|69508525|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
37897284|NCT01027949|69582282|FG000|Overall Study|Progressive Disease|163|||
37897285|NCT01027949|69582282|FG000|Overall Study|Adverse Event|172|||
37996069|NCT00264498|69680770|FG000|Randomized Treatment|Withdrawal by Subject|0|||
37996070|NCT00264498|69680771|FG001|Randomized Treatment|Withdrawal by Subject|1|||
37996071|NCT00264498|69680770|FG000|Randomized Treatment|Objective disease Progression|13|||
37996072|NCT00264498|69680771|FG001|Randomized Treatment|Objective disease Progression|14|||
37996073|NCT00264498|69680770|FG000|Randomized Treatment|Physician Decision|1|||
37996074|NCT00264498|69680771|FG001|Randomized Treatment|Physician Decision|0|||
37996075|NCT00264498|69680770|FG000|Randomized Treatment|Incorrectly randomized|1|||
37996076|NCT00264498|69680771|FG001|Randomized Treatment|Incorrectly randomized|0|||
37996077|NCT00264498|69680770|FG000|Randomized Treatment|Study Closure|1|||
37996078|NCT00264498|69680771|FG001|Randomized Treatment|Study Closure|0|||
37996079|NCT00264498|69680770|FG000|Randomized Treatment|Protocol Violation|1|||
37996080|NCT00264498|69680771|FG001|Randomized Treatment|Protocol Violation|0|||
37996081|NCT00264498|69680770|FG000|Crossover Treatment|Death|1|||
37996082|NCT00264498|69680771|FG001|Crossover Treatment|Death|3|||
37897286|NCT01027949|69582282|FG000|Overall Study|Withdrawal by Subject|113|||
37897287|NCT01027949|69582282|FG000|Overall Study|Lost to Follow-up|17|||
37897288|NCT01027949|69582282|FG000|Overall Study|Protocol Violation|13|||
37897289|NCT01027949|69582282|FG000|Overall Study|PI Decision|8|||
37897290|NCT01027949|69582282|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
37897291|NCT01027949|69582282|FG000|Overall Study|Non-compliance with Study Procedures|7|||
37897292|NCT01027949|69582282|FG000|Overall Study|Lung Transplant|5|||
37897293|NCT01027949|69582282|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
37897294|NCT01027949|69582282|FG000|Overall Study|Use of Excluded Medication|2|||
37897295|NCT01027949|69582282|FG000|Overall Study|Patient Self-discontinuation|1|||
37897296|NCT01027949|69582282|FG000|Overall Study|Pregnancy|1|||
37897297|NCT01027949|69582282|FG000|Overall Study|Surgery|1|||
37897298|NCT01038323|69582289|FG000|Overall Study|Withdrawal by Subject|3|||
37897299|NCT01038323|69582290|FG001|Overall Study|Withdrawal by Subject|2|||
37897300|NCT01038323|69582291|FG002|Overall Study|Withdrawal by Subject|4|||
37826119|NCT02675426|69508526|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
37826120|NCT02675426|69508527|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
37826121|NCT02675426|69508528|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
37826122|NCT02675426|69508525|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
37826123|NCT02675426|69508526|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
37826124|NCT02675426|69508527|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
37897301|NCT01027871|69582302|FG000|Overall Study|Physician Decision|1|||
37996083|NCT00264498|69680770|FG000|Crossover Treatment|Objective disease progression|4|||
37996084|NCT00264498|69680771|FG001|Crossover Treatment|Objective disease progression|5|||
37996085|NCT00264498|69680770|FG000|Crossover Treatment|Study closure|0|||
37897302|NCT01027871|69582303|FG001|Overall Study|Physician Decision|5|||
37897303|NCT01027871|69582304|FG002|Overall Study|Physician Decision|0|||
37996086|NCT00264498|69680771|FG001|Crossover Treatment|Study closure|1|||
37897304|NCT01027871|69582302|FG000|Overall Study|Protocol Violation|0|||
37897305|NCT01027871|69582303|FG001|Overall Study|Protocol Violation|2|||
37897306|NCT01027871|69582304|FG002|Overall Study|Protocol Violation|2|||
37897307|NCT01027871|69582302|FG000|Overall Study|Withdrawal by Subject|1|||
37897308|NCT01027871|69582303|FG001|Overall Study|Withdrawal by Subject|2|||
37897309|NCT01027871|69582304|FG002|Overall Study|Withdrawal by Subject|2|||
37696523|NCT02323646|69172631|FG002|Treatment Course 1|Lost to Follow-up|2|||
37696524|NCT02323646|69172629|FG000|Treatment Course 1|Withdrawal by Subject|0|||
37696525|NCT02323646|69172630|FG001|Treatment Course 1|Withdrawal by Subject|2|||
37696526|NCT02323646|69172631|FG002|Treatment Course 1|Withdrawal by Subject|0|||
37696527|NCT02323646|69172629|FG000|Treatment Course 2|Adverse Event|1|||
37696528|NCT02323646|69172630|FG001|Treatment Course 2|Adverse Event|0|||
37696529|NCT02323646|69172631|FG002|Treatment Course 2|Adverse Event|1|||
37897310|NCT01027871|69582302|FG000|Overall Study|Adverse Event|0|||
37897311|NCT01027871|69582303|FG001|Overall Study|Adverse Event|2|||
37897312|NCT01027871|69582304|FG002|Overall Study|Adverse Event|2|||
37897313|NCT01027871|69582302|FG000|Overall Study|Sponsor Decision|0|||
37897314|NCT01027871|69582303|FG001|Overall Study|Sponsor Decision|2|||
37897315|NCT01027871|69582304|FG002|Overall Study|Sponsor Decision|0|||
37897316|NCT01027871|69582302|FG000|Overall Study|Discontinued Prior to Treatment|0|||
37897317|NCT01027871|69582303|FG001|Overall Study|Discontinued Prior to Treatment|0|||
37897318|NCT01027871|69582304|FG002|Overall Study|Discontinued Prior to Treatment|1|||
37897319|NCT01021553|69582320|FG000|Overall Study|Adverse Event|1|||
37897320|NCT01021553|69582321|FG001|Overall Study|Adverse Event|0|||
37897321|NCT01021553|69582322|FG002|Overall Study|Adverse Event|0|||
37897322|NCT01021553|69582320|FG000|Overall Study|Lack of Efficacy|2|||
37897323|NCT01021553|69582321|FG001|Overall Study|Lack of Efficacy|2|||
37897324|NCT01021553|69582322|FG002|Overall Study|Lack of Efficacy|0|||
37897325|NCT01021553|69582320|FG000|Overall Study|Protocol Violation|0|||
37897326|NCT01021553|69582321|FG001|Overall Study|Protocol Violation|2|||
37897327|NCT01021553|69582322|FG002|Overall Study|Protocol Violation|2|||
37897328|NCT01021553|69582320|FG000|Overall Study|Lost to Follow-up|0|||
37897329|NCT01021553|69582321|FG001|Overall Study|Lost to Follow-up|0|||
37897330|NCT01021553|69582322|FG002|Overall Study|Lost to Follow-up|1|||
37897331|NCT01021553|69582320|FG000|Overall Study|Withdrawal by Subject|1|||
37897332|NCT01021553|69582321|FG001|Overall Study|Withdrawal by Subject|1|||
37897333|NCT01021553|69582322|FG002|Overall Study|Withdrawal by Subject|0|||
37897334|NCT01026389|69582337|FG000|Overall Study|Withdrawal by Subject|1|||
37897335|NCT01026389|69582338|FG001|Overall Study|Withdrawal by Subject|3|||
37897336|NCT01026389|69582337|FG000|Overall Study|change of treatment, patient moved|4|||
37897337|NCT01026389|69582338|FG001|Overall Study|change of treatment, patient moved|2|||
37897338|NCT01006616|69582348|FG000|Period 1 (6 Months)|Adverse Event|10|||
37897339|NCT01006616|69582349|FG001|Period 1 (6 Months)|Adverse Event|31|||
37897340|NCT01006616|69582350|FG002|Period 1 (6 Months)|Adverse Event|37|||
37897341|NCT01006616|69582351|FG003|Period 1 (6 Months)|Adverse Event|9|||
37897342|NCT01006616|69582348|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
37897343|NCT01006616|69582349|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
37897344|NCT01006616|69582350|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
37897345|NCT01006616|69582351|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
37897346|NCT01006616|69582348|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
37897347|NCT01006616|69582349|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
37897348|NCT01006616|69582350|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
37897349|NCT01006616|69582351|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
37897350|NCT01006616|69582348|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
37897351|NCT01006616|69582349|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
37897352|NCT01006616|69582350|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
37897353|NCT01006616|69582351|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
37897354|NCT01006616|69582348|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
37897355|NCT01006616|69582349|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
37897356|NCT01006616|69582350|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
37897357|NCT01006616|69582351|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
37897358|NCT01006616|69582348|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
37897359|NCT01006616|69582349|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
37897360|NCT01006616|69582350|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
37897361|NCT01006616|69582351|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
37897362|NCT01006616|69582348|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
37897363|NCT01006616|69582349|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
37897364|NCT01006616|69582350|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
37897365|NCT01006616|69582351|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
37897366|NCT01006616|69582348|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
37897367|NCT01006616|69582349|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
37696530|NCT02323646|69172629|FG000|Treatment Course 2|Lost to Follow-up|0|||
37696531|NCT02323646|69172630|FG001|Treatment Course 2|Lost to Follow-up|0|||
37897368|NCT01006616|69582350|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
37897369|NCT01006616|69582351|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
37897370|NCT01006616|69582348|FG000|Period 1 (6 Months)|Not Treated|0|||
37897371|NCT01006616|69582349|FG001|Period 1 (6 Months)|Not Treated|0|||
37897372|NCT01006616|69582350|FG002|Period 1 (6 Months)|Not Treated|1|||
37897373|NCT01006616|69582351|FG003|Period 1 (6 Months)|Not Treated|1|||
37897374|NCT01006616|69582348|FG000|Period 2 (18 Months)|Adverse Event|6|||
37696532|NCT02323646|69172631|FG002|Treatment Course 2|Lost to Follow-up|1|||
37696533|NCT02323646|69172629|FG000|Treatment Course 2|Non-compliance|0|||
37696534|NCT02323646|69172630|FG001|Treatment Course 2|Non-compliance|1|||
37696535|NCT02323646|69172631|FG002|Treatment Course 2|Non-compliance|1|||
37826125|NCT02675426|69508528|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
37826126|NCT02675426|69508525|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
37996087|NCT00264498|69680770|FG000|Crossover Treatment|Withdrawal by Subject|1|||
37996088|NCT00264498|69680771|FG001|Crossover Treatment|Withdrawal by Subject|0|||
37996089|NCT00466193|69680779|FG000|Overall Study|Adverse Event|0|||
37996090|NCT00466193|69680780|FG001|Overall Study|Adverse Event|1|||
37996091|NCT00466193|69680779|FG000|Overall Study|Lost to Follow-up|2|||
37996092|NCT00466193|69680780|FG001|Overall Study|Lost to Follow-up|4|||
37996093|NCT00466193|69680779|FG000|Overall Study|Physician Decision|1|||
37996094|NCT00466193|69680780|FG001|Overall Study|Physician Decision|0|||
37996095|NCT00466193|69680779|FG000|Overall Study|Protocol Violation|1|||
37996096|NCT00466193|69680780|FG001|Overall Study|Protocol Violation|1|||
37996097|NCT00466193|69680779|FG000|Overall Study|Withdrawal by Subject|7|||
37996098|NCT00466193|69680780|FG001|Overall Study|Withdrawal by Subject|2|||
37996099|NCT00466193|69680779|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
37996100|NCT00466193|69680780|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
37996101|NCT00263562|69680788|FG000|Overall Study|Protocol Violation|3|||
37996102|NCT00263562|69680789|FG001|Overall Study|Protocol Violation|0|||
37996103|NCT00454181|69680799|FG000|Overall Study|Adverse Event|1|||
37996104|NCT00454181|69680800|FG001|Overall Study|Adverse Event|1|||
37996105|NCT00454181|69680799|FG000|Overall Study|Lost to Follow-up|11|||
37996106|NCT00454181|69680800|FG001|Overall Study|Lost to Follow-up|1|||
37996107|NCT00454181|69680799|FG000|Overall Study|Protocol Violation|1|||
37996108|NCT00454181|69680800|FG001|Overall Study|Protocol Violation|1|||
37996109|NCT00454181|69680799|FG000|Overall Study|Withdrawal by Subject|2|||
37996110|NCT00454181|69680800|FG001|Overall Study|Withdrawal by Subject|0|||
37996111|NCT00237744|69680809|FG000|Overall Study|Withdrawal by Subject|3|||
37996112|NCT00237744|69680810|FG001|Overall Study|Withdrawal by Subject|1|||
37996113|NCT00237744|69680811|FG002|Overall Study|Withdrawal by Subject|0|||
37996114|NCT00237042|69680825|FG000|Treatment|Became ineligible post-randomization|0|||
37996115|NCT00237042|69680826|FG001|Treatment|Became ineligible post-randomization|1|||
37996116|NCT00237042|69680827|FG002|Treatment|Became ineligible post-randomization|16|||
37996117|NCT00237042|69680825|FG000|Treatment|Moved out of state|1|||
37996118|NCT00237042|69680826|FG001|Treatment|Moved out of state|1|||
37996119|NCT00237042|69680827|FG002|Treatment|Moved out of state|1|||
37996120|NCT00237042|69680825|FG000|Treatment|Completed no treatment|5|||
37826127|NCT02675426|69508526|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
37826128|NCT02675426|69508527|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
37826129|NCT02675426|69508528|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
37826130|NCT02675426|69508525|FG000|Period 1: Week 1 to Week 12|Other|2|||
37826131|NCT02675426|69508526|FG001|Period 1: Week 1 to Week 12|Other|1|||
37826132|NCT02675426|69508527|FG002|Period 1: Week 1 to Week 12|Other|0|||
37826133|NCT02675426|69508528|FG003|Period 1: Week 1 to Week 12|Other|2|||
37826134|NCT02675426|69508525|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
37826135|NCT02675426|69508526|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
37826136|NCT02675426|69508527|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
37826137|NCT02675426|69508528|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
37826138|NCT02675426|69508525|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
37826139|NCT02675426|69508526|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
37826140|NCT02675426|69508527|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
37826141|NCT02675426|69508528|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
37826142|NCT02675426|69508525|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
37897375|NCT01006616|69582349|FG001|Period 2 (18 Months)|Adverse Event|6|||
37897376|NCT01006616|69582350|FG002|Period 2 (18 Months)|Adverse Event|6|||
37897377|NCT01006616|69582351|FG003|Period 2 (18 Months)|Adverse Event|4|||
37897378|NCT01006616|69582348|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
37897379|NCT01006616|69582349|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
37996121|NCT00237042|69680826|FG001|Treatment|Completed no treatment|5|||
37996122|NCT00237042|69680827|FG002|Treatment|Completed no treatment|21|||
37996123|NCT00237042|69680825|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
37996124|NCT00237042|69680826|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
37696536|NCT01846624|69172639|FG000|Overall Study|Died during induction, no midostaurin|1|||
37696537|NCT01829230|69172645|FG000|Overall Study|Protocol Violation|0|||
37996125|NCT00237042|69680827|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
37996126|NCT00237042|69680825|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
37897380|NCT01006616|69582350|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
37897381|NCT01006616|69582351|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
37897382|NCT01006616|69582348|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
37897383|NCT01006616|69582349|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
37996127|NCT00237042|69680826|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
37996128|NCT00237042|69680827|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
37996129|NCT00465647|69680839|FG000|Overall Study|Administrative|2|||
37996130|NCT00465647|69680840|FG001|Overall Study|Administrative|2|||
37897384|NCT01006616|69582350|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
37897385|NCT01006616|69582351|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
37897386|NCT01006616|69582348|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
37696538|NCT01829230|69172646|FG001|Overall Study|Protocol Violation|2|||
37826143|NCT02675426|69508526|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
37826144|NCT02675426|69508527|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
37826145|NCT02675426|69508528|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
37826146|NCT02675426|69508525|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
37826147|NCT02675426|69508526|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
37826148|NCT02675426|69508527|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
37826149|NCT02675426|69508528|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
37826150|NCT02675426|69508525|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
37826151|NCT02675426|69508526|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
37826152|NCT02675426|69508527|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
37826153|NCT02675426|69508528|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
37826154|NCT02675426|69508525|FG000|Period 2: Week 12 to Week 260|Other|8|||
37826155|NCT02675426|69508526|FG001|Period 2: Week 12 to Week 260|Other|12|||
37826156|NCT02675426|69508527|FG002|Period 2: Week 12 to Week 260|Other|23|||
37897387|NCT01006616|69582349|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
37897388|NCT01006616|69582350|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
37897389|NCT01006616|69582351|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
37897390|NCT01006616|69582348|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
37897391|NCT01006616|69582349|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
37897392|NCT01006616|69582350|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
37897393|NCT01006616|69582351|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
37897394|NCT01006616|69582348|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
37897395|NCT01006616|69582349|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
37897396|NCT01006616|69582350|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
37897397|NCT01006616|69582351|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
37897398|NCT01006616|69582348|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
37897399|NCT01006616|69582349|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
37897400|NCT01006616|69582350|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
37897401|NCT01006616|69582351|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
37897402|NCT01006616|69582348|FG000|Period 2 (18 Months)|Study Terminated|63|||
37897403|NCT01006616|69582349|FG001|Period 2 (18 Months)|Study Terminated|46|||
37897404|NCT01006616|69582350|FG002|Period 2 (18 Months)|Study Terminated|44|||
37897405|NCT01006616|69582351|FG003|Period 2 (18 Months)|Study Terminated|70|||
37897406|NCT00996632|69582363|FG000|Overall Study|Physician Decision|0|||
37897407|NCT00996632|69582364|FG001|Overall Study|Physician Decision|0|||
37897408|NCT01025843|69582380|FG000|Washout 4|Withdrawal by Subject|0|||
37897409|NCT01025843|69582381|FG001|Washout 4|Withdrawal by Subject|0|||
37897410|NCT01025843|69582382|FG002|Washout 4|Withdrawal by Subject|1|||
37897411|NCT01025843|69582383|FG003|Washout 4|Withdrawal by Subject|1|||
37897412|NCT01025843|69582384|FG004|Washout 4|Withdrawal by Subject|0|||
37897413|NCT01025843|69582385|FG005|Washout 4|Withdrawal by Subject|0|||
37897414|NCT01025843|69582386|FG006|Washout 4|Withdrawal by Subject|0|||
37897415|NCT01025843|69582387|FG007|Washout 4|Withdrawal by Subject|0|||
37897416|NCT01025843|69582388|FG008|Washout 4|Withdrawal by Subject|0|||
37897417|NCT01025843|69582389|FG009|Washout 4|Withdrawal by Subject|0|||
37897418|NCT01036763|69582417|FG000|Overall Study|Adverse Event|25|||
37897419|NCT01036763|69582417|FG000|Overall Study|Lost to Follow-up|28|||
37897420|NCT01036763|69582417|FG000|Overall Study|Other reason (not specified)|40|||
37897421|NCT01021007|69582423|FG000|Overall Study|Lost to Follow-up|1|||
37897422|NCT01021007|69582424|FG001|Overall Study|Lost to Follow-up|1|||
37897423|NCT01021007|69582423|FG000|Overall Study|Adverse Event|1|||
37897424|NCT01021007|69582424|FG001|Overall Study|Adverse Event|3|||
37897425|NCT01020773|69582432|FG000|Overall Study|Withdrawal by Subject|4|||
37897426|NCT01020773|69582433|FG001|Overall Study|Withdrawal by Subject|3|||
37897427|NCT01020305|69582439|FG000|Overall Study|Adverse Event|2|||
37897428|NCT01036529|69582445|FG000|Overall Study|Adverse Event|0|||
37897429|NCT01036529|69582446|FG001|Overall Study|Adverse Event|1|||
37996131|NCT00465647|69680841|FG002|Overall Study|Administrative|3|||
37897430|NCT01036529|69582445|FG000|Overall Study|Lost to Follow-up|0|||
37897431|NCT01036529|69582446|FG001|Overall Study|Lost to Follow-up|1|||
37897432|NCT01036529|69582445|FG000|Overall Study|Physician Decision|1|||
37897433|NCT01036529|69582446|FG001|Overall Study|Physician Decision|0|||
37897434|NCT01036529|69582445|FG000|Overall Study|Withdrawal by Subject|1|||
37897435|NCT01036529|69582446|FG001|Overall Study|Withdrawal by Subject|1|||
37897436|NCT01036529|69582445|FG000|Overall Study|Sponsor study termination|11|||
37897437|NCT01036529|69582446|FG001|Overall Study|Sponsor study termination|12|||
37897438|NCT01024751|69582454|FG000|Enrolled Participants|Ineligible at baseline|3|||
37897439|NCT01024751|69582455|FG001|Enrolled Participants|Ineligible at baseline|4|||
37897440|NCT01024751|69582454|FG000|Eligible Participants|Withdrawal by Subject|0|||
37897441|NCT01024751|69582455|FG001|Eligible Participants|Withdrawal by Subject|1|||
37897442|NCT01024751|69582454|FG000|Eligible Participants|Lost to Follow-up|0|||
37897443|NCT01024751|69582455|FG001|Eligible Participants|Lost to Follow-up|1|||
37897444|NCT01024751|69582454|FG000|Eligible Participants|Ineligible|0|||
37897445|NCT01024751|69582455|FG001|Eligible Participants|Ineligible|1|||
37897446|NCT01019369|69582463|FG000|Overall Study|Lost to Follow-up|10|||
37897447|NCT01019369|69582464|FG001|Overall Study|Lost to Follow-up|6|||
37897448|NCT01019369|69582463|FG000|Overall Study|Withdrawal by Subject|0|||
37897449|NCT01019369|69582464|FG001|Overall Study|Withdrawal by Subject|1|||
37897450|NCT01019135|69582474|FG000|Overall Study|Did not receive allocated intervention|12|||
37897451|NCT01019135|69582475|FG001|Overall Study|Did not receive allocated intervention|6|||
37897452|NCT01019135|69582476|FG002|Overall Study|Did not receive allocated intervention|25|||
37897453|NCT01019135|69582474|FG000|Overall Study|Did not attend CR|8|||
37897454|NCT01019135|69582475|FG001|Overall Study|Did not attend CR|13|||
37897455|NCT01019135|69582476|FG002|Overall Study|Did not attend CR|6|||
37897456|NCT01018979|69582486|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
37897457|NCT01018979|69582487|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
37897458|NCT01018979|69582486|FG000|Overall Study|Not received at least one dose|0|||
37897459|NCT01018979|69582487|FG001|Overall Study|Not received at least one dose|1|||
37897460|NCT01572493|69582505|FG000|Overall Study|Physician Decision|1|||
37897461|NCT01572493|69582506|FG001|Overall Study|Physician Decision|0|||
37897462|NCT01572493|69582507|FG002|Overall Study|Physician Decision|0|||
37897463|NCT01572493|69582508|FG003|Overall Study|Physician Decision|0|||
37897464|NCT01572493|69582509|FG004|Overall Study|Physician Decision|0|||
37897465|NCT01572493|69582510|FG005|Overall Study|Physician Decision|0|||
37897466|NCT01572493|69582511|FG006|Overall Study|Physician Decision|0|||
37897467|NCT01572493|69582512|FG007|Overall Study|Physician Decision|0|||
37897468|NCT01572493|69582513|FG008|Overall Study|Physician Decision|0|||
37897469|NCT01572493|69582505|FG000|Overall Study|Switched to alternative treatment|0|||
37897470|NCT01572493|69582506|FG001|Overall Study|Switched to alternative treatment|1|||
37897471|NCT01572493|69582507|FG002|Overall Study|Switched to alternative treatment|2|||
37897472|NCT01572493|69582508|FG003|Overall Study|Switched to alternative treatment|1|||
37897473|NCT01572493|69582509|FG004|Overall Study|Switched to alternative treatment|2|||
37897474|NCT01572493|69582510|FG005|Overall Study|Switched to alternative treatment|0|||
37897475|NCT01572493|69582511|FG006|Overall Study|Switched to alternative treatment|2|||
37897476|NCT01572493|69582512|FG007|Overall Study|Switched to alternative treatment|0|||
37897477|NCT01572493|69582513|FG008|Overall Study|Switched to alternative treatment|2|||
37897478|NCT01572493|69582505|FG000|Overall Study|Death|0|||
37897479|NCT01572493|69582506|FG001|Overall Study|Death|0|||
37897480|NCT01572493|69582507|FG002|Overall Study|Death|0|||
37897481|NCT01572493|69582508|FG003|Overall Study|Death|1|||
37897482|NCT01572493|69582509|FG004|Overall Study|Death|0|||
37897483|NCT01572493|69582510|FG005|Overall Study|Death|1|||
37897484|NCT01572493|69582511|FG006|Overall Study|Death|0|||
37897485|NCT01572493|69582512|FG007|Overall Study|Death|0|||
37897486|NCT01572493|69582513|FG008|Overall Study|Death|0|||
37897487|NCT01572493|69582505|FG000|Overall Study|Adverse Event|0|||
37996132|NCT00465647|69680842|FG003|Overall Study|Administrative|2|||
37996133|NCT00465647|69680839|FG000|Overall Study|Adverse Event|2|||
37996134|NCT00465647|69680840|FG001|Overall Study|Adverse Event|0|||
37996135|NCT00465647|69680841|FG002|Overall Study|Adverse Event|3|||
37996136|NCT00465647|69680842|FG003|Overall Study|Adverse Event|2|||
37996137|NCT00465647|69680839|FG000|Overall Study|Withdrawal by Subject|1|||
37826157|NCT02675426|69508528|FG003|Period 2: Week 12 to Week 260|Other|15|||
37826158|NCT02060721|69508569|FG000|Overall Study|Lost to Follow-up|1|||
37826159|NCT02060721|69508569|FG000|Overall Study|Physician Decision|2|||
37826160|NCT02060721|69508569|FG000|Overall Study|Death|14|||
37826161|NCT02060721|69508569|FG000|Overall Study|Withdrawal by Subject|2|||
37826162|NCT02060721|69508569|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
37826163|NCT01527149|69508573|FG000|Overall Study|Death|2|||
37826164|NCT01359956|69508581|FG000|Overall Study|Death|58|||
37826165|NCT01359956|69508582|FG001|Overall Study|Death|60|||
37826166|NCT01359956|69508583|FG002|Overall Study|Death|66|||
37897488|NCT01572493|69582506|FG001|Overall Study|Adverse Event|0|||
37826167|NCT01359956|69508584|FG003|Overall Study|Death|57|||
37826168|NCT01359956|69508581|FG000|Overall Study|Lost to Follow-up|3|||
37996138|NCT00465647|69680840|FG001|Overall Study|Withdrawal by Subject|2|||
37897489|NCT01572493|69582507|FG002|Overall Study|Adverse Event|0|||
37897490|NCT01572493|69582508|FG003|Overall Study|Adverse Event|0|||
37897491|NCT01572493|69582509|FG004|Overall Study|Adverse Event|0|||
37897492|NCT01572493|69582510|FG005|Overall Study|Adverse Event|0|||
37826169|NCT01359956|69508582|FG001|Overall Study|Lost to Follow-up|4|||
37826170|NCT01359956|69508583|FG002|Overall Study|Lost to Follow-up|1|||
37897493|NCT01572493|69582511|FG006|Overall Study|Adverse Event|1|||
37897494|NCT01572493|69582512|FG007|Overall Study|Adverse Event|0|||
37897495|NCT01572493|69582513|FG008|Overall Study|Adverse Event|0|||
37897496|NCT01018511|69582540|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
37897497|NCT01018511|69582541|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
37897498|NCT01018511|69582542|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
37897499|NCT01018511|69582543|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
37897500|NCT01018511|69582540|FG000|Overall Study|Adverse Event|5|||
37897501|NCT01018511|69582541|FG001|Overall Study|Adverse Event|9|||
37897502|NCT01018511|69582542|FG002|Overall Study|Adverse Event|13|||
37897503|NCT01018511|69582543|FG003|Overall Study|Adverse Event|10|||
37897504|NCT01018511|69582540|FG000|Overall Study|Lack of Efficacy|4|||
37897505|NCT01018511|69582541|FG001|Overall Study|Lack of Efficacy|1|||
37897506|NCT01018511|69582542|FG002|Overall Study|Lack of Efficacy|1|||
37897507|NCT01018511|69582543|FG003|Overall Study|Lack of Efficacy|2|||
37897508|NCT01018511|69582540|FG000|Overall Study|Withdrawal by Subject|6|||
37897509|NCT01018511|69582541|FG001|Overall Study|Withdrawal by Subject|5|||
37897510|NCT01018511|69582542|FG002|Overall Study|Withdrawal by Subject|11|||
37897511|NCT01018511|69582543|FG003|Overall Study|Withdrawal by Subject|9|||
37897512|NCT01018511|69582540|FG000|Overall Study|Lost to Follow-up|0|||
37897513|NCT01018511|69582541|FG001|Overall Study|Lost to Follow-up|0|||
37897514|NCT01018511|69582542|FG002|Overall Study|Lost to Follow-up|1|||
37897515|NCT01018511|69582543|FG003|Overall Study|Lost to Follow-up|0|||
37897516|NCT01018511|69582540|FG000|Overall Study|Protocol Violation|5|||
37897517|NCT01018511|69582541|FG001|Overall Study|Protocol Violation|8|||
37826171|NCT01359956|69508584|FG003|Overall Study|Lost to Follow-up|1|||
37826172|NCT01306045|69508597|FG000|Met General Eligibility Criteria|Screen failures|193|||
37826173|NCT01306045|69508598|FG001|Met General Eligibility Criteria|Screen failures|11|||
37826174|NCT01306045|69508599|FG002|Met General Eligibility Criteria|Screen failures|8|||
37826175|NCT05121480|69508648|FG000|Overall Study|Lack of Efficacy|2|||
37826176|NCT05121480|69508649|FG001|Overall Study|Lack of Efficacy|2|||
37826177|NCT05121480|69508650|FG002|Overall Study|Lack of Efficacy|1|||
37826178|NCT05121480|69508651|FG003|Overall Study|Lack of Efficacy|4|||
37826179|NCT05121480|69508652|FG004|Overall Study|Lack of Efficacy|0|||
37826180|NCT05121480|69508653|FG005|Overall Study|Lack of Efficacy|1|||
37996139|NCT00465647|69680841|FG002|Overall Study|Withdrawal by Subject|2|||
37996140|NCT00465647|69680842|FG003|Overall Study|Withdrawal by Subject|7|||
37996141|NCT00465647|69680839|FG000|Overall Study|"The other reasons included loss of IV"|8|||
37826181|NCT05121480|69508654|FG006|Overall Study|Lack of Efficacy|0|||
37826182|NCT05121480|69508655|FG007|Overall Study|Lack of Efficacy|2|||
37826183|NCT05121480|69508648|FG000|Overall Study|Treatment Failure|0|||
37897518|NCT01018511|69582542|FG002|Overall Study|Protocol Violation|7|||
37826184|NCT05121480|69508649|FG001|Overall Study|Treatment Failure|2|||
37826185|NCT05121480|69508650|FG002|Overall Study|Treatment Failure|0|||
37897519|NCT01018511|69582543|FG003|Overall Study|Protocol Violation|9|||
37897520|NCT01018511|69582540|FG000|Overall Study|Miscellaneous|0|||
37826186|NCT05121480|69508651|FG003|Overall Study|Treatment Failure|1|||
37826187|NCT05121480|69508652|FG004|Overall Study|Treatment Failure|0|||
37826188|NCT05121480|69508653|FG005|Overall Study|Treatment Failure|0|||
37826189|NCT05121480|69508654|FG006|Overall Study|Treatment Failure|0|||
37826190|NCT05121480|69508655|FG007|Overall Study|Treatment Failure|0|||
37826191|NCT05121480|69508648|FG000|Overall Study|Adverse Event|0|||
37996142|NCT00465647|69680840|FG001|Overall Study|"The other reasons included loss of IV"|4|||
37996143|NCT00465647|69680841|FG002|Overall Study|"The other reasons included loss of IV"|3|||
37996144|NCT00465647|69680842|FG003|Overall Study|"The other reasons included loss of IV"|2|||
37826192|NCT05121480|69508649|FG001|Overall Study|Adverse Event|1|||
37826193|NCT05121480|69508650|FG002|Overall Study|Adverse Event|0|||
37826194|NCT05121480|69508651|FG003|Overall Study|Adverse Event|5|||
37826195|NCT05121480|69508652|FG004|Overall Study|Adverse Event|3|||
37826196|NCT05121480|69508653|FG005|Overall Study|Adverse Event|2|||
37826197|NCT05121480|69508654|FG006|Overall Study|Adverse Event|0|||
37826198|NCT05121480|69508655|FG007|Overall Study|Adverse Event|4|||
37826199|NCT05121480|69508648|FG000|Overall Study|Withdrawal by Subject|4|||
37826200|NCT05121480|69508649|FG001|Overall Study|Withdrawal by Subject|9|||
37826201|NCT05121480|69508650|FG002|Overall Study|Withdrawal by Subject|1|||
37826202|NCT05121480|69508651|FG003|Overall Study|Withdrawal by Subject|8|||
37826203|NCT05121480|69508652|FG004|Overall Study|Withdrawal by Subject|0|||
37826204|NCT05121480|69508653|FG005|Overall Study|Withdrawal by Subject|9|||
37826205|NCT05121480|69508654|FG006|Overall Study|Withdrawal by Subject|0|||
37826206|NCT05121480|69508655|FG007|Overall Study|Withdrawal by Subject|4|||
37826207|NCT05121480|69508648|FG000|Overall Study|Non-compliance with the protocol|0|||
37826208|NCT05121480|69508649|FG001|Overall Study|Non-compliance with the protocol|0|||
37826209|NCT05121480|69508650|FG002|Overall Study|Non-compliance with the protocol|0|||
37826210|NCT05121480|69508651|FG003|Overall Study|Non-compliance with the protocol|0|||
37826211|NCT05121480|69508652|FG004|Overall Study|Non-compliance with the protocol|1|||
37826212|NCT05121480|69508653|FG005|Overall Study|Non-compliance with the protocol|6|||
37826213|NCT05121480|69508654|FG006|Overall Study|Non-compliance with the protocol|0|||
37826214|NCT05121480|69508655|FG007|Overall Study|Non-compliance with the protocol|1|||
37826215|NCT05121480|69508648|FG000|Overall Study|Lost to Follow-up|0|||
37826216|NCT05121480|69508649|FG001|Overall Study|Lost to Follow-up|4|||
37826217|NCT05121480|69508650|FG002|Overall Study|Lost to Follow-up|1|||
37826218|NCT05121480|69508651|FG003|Overall Study|Lost to Follow-up|3|||
37826219|NCT05121480|69508652|FG004|Overall Study|Lost to Follow-up|1|||
37826220|NCT05121480|69508653|FG005|Overall Study|Lost to Follow-up|1|||
37826221|NCT05121480|69508654|FG006|Overall Study|Lost to Follow-up|1|||
37826222|NCT05121480|69508655|FG007|Overall Study|Lost to Follow-up|4|||
37826223|NCT05121480|69508648|FG000|Overall Study|Physician Decision|0|||
37826224|NCT05121480|69508649|FG001|Overall Study|Physician Decision|0|||
37826225|NCT05121480|69508650|FG002|Overall Study|Physician Decision|0|||
37826226|NCT05121480|69508651|FG003|Overall Study|Physician Decision|0|||
37826227|NCT05121480|69508652|FG004|Overall Study|Physician Decision|0|||
37826228|NCT05121480|69508653|FG005|Overall Study|Physician Decision|1|||
37826229|NCT05121480|69508654|FG006|Overall Study|Physician Decision|0|||
37826230|NCT05121480|69508655|FG007|Overall Study|Physician Decision|1|||
37826231|NCT05121480|69508648|FG000|Overall Study|Other Reason|0|||
37826232|NCT05121480|69508649|FG001|Overall Study|Other Reason|0|||
37826233|NCT05121480|69508650|FG002|Overall Study|Other Reason|0|||
37826234|NCT05121480|69508651|FG003|Overall Study|Other Reason|0|||
37826235|NCT05121480|69508652|FG004|Overall Study|Other Reason|0|||
37826236|NCT05121480|69508653|FG005|Overall Study|Other Reason|1|||
37826237|NCT05121480|69508654|FG006|Overall Study|Other Reason|1|||
37826238|NCT05121480|69508655|FG007|Overall Study|Other Reason|1|||
37826239|NCT04772755|69508681|FG000|Overall Study|Withdrawal by Subject|1|||
37826240|NCT04772755|69508682|FG001|Overall Study|Withdrawal by Subject|0|||
37826241|NCT04772755|69508681|FG000|Overall Study|Randomized and subsequently determined to be ineligible|2|||
37826242|NCT04772755|69508682|FG001|Overall Study|Randomized and subsequently determined to be ineligible|3|||
37826243|NCT04590040|69508692|FG000|Treatment Period|Lost to Follow-up|2|||
37826244|NCT04590040|69508693|FG001|Treatment Period|Lost to Follow-up|5|||
37826245|NCT04590040|69508694|FG002|Treatment Period|Lost to Follow-up|0|||
37826246|NCT04590040|69508692|FG000|Treatment Period|Physician Decision|0|||
37826247|NCT04590040|69508693|FG001|Treatment Period|Physician Decision|0|||
37826248|NCT04590040|69508694|FG002|Treatment Period|Physician Decision|2|||
37826249|NCT04430335|69508712|FG000|Overall Study|Withdrawal by Subject|1|||
37826250|NCT03690427|69508725|FG000|Overall Study|Requested by subject not to complete traditional hookah|0|||
37826251|NCT03690427|69508726|FG001|Overall Study|Requested by subject not to complete traditional hookah|2|||
37826252|NCT03658668|69508735|FG000|Overall Study|Time Commitment|1|||
37826253|NCT03658668|69508736|FG001|Overall Study|Time Commitment|1|||
37826254|NCT03469934|69508744|FG000|Overall Study|Withdrawal by Subject|0|||
37826255|NCT03469934|69508745|FG001|Overall Study|Withdrawal by Subject|1|||
37826256|NCT03004404|69508762|FG000|Period 2|Adverse Event|0|||
37826257|NCT03004404|69508763|FG001|Period 2|Adverse Event|0|||
37826258|NCT03004404|69508764|FG002|Period 2|Adverse Event|0|||
37897521|NCT01018511|69582541|FG001|Overall Study|Miscellaneous|2|||
37897522|NCT01018511|69582542|FG002|Overall Study|Miscellaneous|0|||
37897523|NCT01018511|69582543|FG003|Overall Study|Miscellaneous|0|||
37897524|NCT00996476|69582564|FG000|Overall Study|Withdrawal by Subject|1|||
37897525|NCT00996476|69582565|FG001|Overall Study|Withdrawal by Subject|2|||
37897526|NCT00996476|69582566|FG002|Overall Study|Withdrawal by Subject|1|||
37897527|NCT00996476|69582567|FG003|Overall Study|Withdrawal by Subject|0|||
37897528|NCT00996476|69582568|FG004|Overall Study|Withdrawal by Subject|1|||
37897529|NCT00996476|69582564|FG000|Overall Study|Adverse Event|0|||
37897530|NCT00996476|69582565|FG001|Overall Study|Adverse Event|1|||
37897531|NCT00996476|69582566|FG002|Overall Study|Adverse Event|0|||
37897532|NCT00996476|69582567|FG003|Overall Study|Adverse Event|0|||
37897533|NCT00996476|69582568|FG004|Overall Study|Adverse Event|1|||
37897534|NCT02269267|69582585|FG000|Overall Study|Death|5|||
37897535|NCT01017731|69582589|FG000|Overall Study|Lost to Follow-up|2|||
37897536|NCT01017731|69582589|FG000|Overall Study|Withdrawal by Subject|3|||
37897537|NCT01017731|69582589|FG000|Overall Study|Physician Decision|2|||
37897538|NCT01017731|69582589|FG000|Overall Study|Adverse Event|1|||
37897539|NCT01035905|69582596|FG000|Overall Study|Lack of Efficacy|1|||
37897540|NCT01035905|69582597|FG001|Overall Study|Lack of Efficacy|1|||
37897541|NCT00779584|69582621|FG000|Overall Study|Protocol Violation|0|||
37897542|NCT00779584|69582622|FG001|Overall Study|Protocol Violation|0|||
37897543|NCT00779584|69582623|FG002|Overall Study|Protocol Violation|0|||
37897544|NCT00779584|69582624|FG003|Overall Study|Protocol Violation|0|||
37897545|NCT00779584|69582625|FG004|Overall Study|Protocol Violation|0|||
37897546|NCT00779584|69582626|FG005|Overall Study|Protocol Violation|1|||
37897547|NCT00779584|69582627|FG006|Overall Study|Protocol Violation|0|||
37897548|NCT00779584|69582628|FG007|Overall Study|Protocol Violation|0|||
37897549|NCT00779584|69582629|FG008|Overall Study|Protocol Violation|0|||
37897550|NCT00779584|69582621|FG000|Overall Study|Withdrawal by Subject|1|||
37897551|NCT00779584|69582622|FG001|Overall Study|Withdrawal by Subject|1|||
37897552|NCT00779584|69582623|FG002|Overall Study|Withdrawal by Subject|2|||
37897553|NCT00779584|69582624|FG003|Overall Study|Withdrawal by Subject|0|||
37897554|NCT00779584|69582625|FG004|Overall Study|Withdrawal by Subject|0|||
37897555|NCT00779584|69582626|FG005|Overall Study|Withdrawal by Subject|2|||
37897556|NCT00779584|69582627|FG006|Overall Study|Withdrawal by Subject|1|||
37897557|NCT00779584|69582628|FG007|Overall Study|Withdrawal by Subject|0|||
37897558|NCT00779584|69582629|FG008|Overall Study|Withdrawal by Subject|0|||
37897559|NCT00779584|69582621|FG000|Overall Study|Lost to Follow-up|0|||
37897560|NCT00779584|69582622|FG001|Overall Study|Lost to Follow-up|0|||
37897561|NCT00779584|69582623|FG002|Overall Study|Lost to Follow-up|0|||
37897562|NCT00779584|69582624|FG003|Overall Study|Lost to Follow-up|0|||
37897563|NCT00779584|69582625|FG004|Overall Study|Lost to Follow-up|1|||
37897564|NCT00779584|69582626|FG005|Overall Study|Lost to Follow-up|0|||
37826259|NCT03004404|69508765|FG003|Period 2|Adverse Event|0|||
37826260|NCT03004404|69508766|FG004|Period 2|Adverse Event|0|||
37826261|NCT03004404|69508767|FG005|Period 2|Adverse Event|0|||
37826262|NCT03004404|69508768|FG006|Period 2|Adverse Event|0|||
37826263|NCT03004404|69508769|FG007|Period 2|Adverse Event|0|||
37826264|NCT03004404|69508770|FG008|Period 2|Adverse Event|1|||
37826265|NCT03004404|69508771|FG009|Period 2|Adverse Event|0|||
37826266|NCT03004404|69508772|FG010|Period 2|Adverse Event|0|||
37826267|NCT03004404|69508773|FG011|Period 2|Adverse Event|0|||
37826268|NCT03004404|69508774|FG012|Period 2|Adverse Event|0|||
37826269|NCT03004404|69508775|FG013|Period 2|Adverse Event|0|||
37826270|NCT03004404|69508776|FG014|Period 2|Adverse Event|0|||
37826271|NCT03004404|69508777|FG015|Period 2|Adverse Event|1|||
37826272|NCT02512965|69508844|FG000|Overall Study|Withdrawal by Subject|0|||
37897565|NCT00779584|69582627|FG006|Overall Study|Lost to Follow-up|0|||
37897566|NCT00779584|69582628|FG007|Overall Study|Lost to Follow-up|0|||
37897567|NCT00779584|69582629|FG008|Overall Study|Lost to Follow-up|0|||
37897568|NCT00779584|69582621|FG000|Overall Study|Progression of Disease|0|||
37897569|NCT00779584|69582622|FG001|Overall Study|Progression of Disease|1|||
37897570|NCT00779584|69582623|FG002|Overall Study|Progression of Disease|2|||
37897571|NCT00779584|69582624|FG003|Overall Study|Progression of Disease|6|||
37826273|NCT02512965|69508845|FG001|Overall Study|Withdrawal by Subject|4|||
37826274|NCT02335268|69508853|FG000|Overall Study|Physician Decision|5|||
37826275|NCT02335268|69508854|FG001|Overall Study|Physician Decision|1|||
37897572|NCT00779584|69582625|FG004|Overall Study|Progression of Disease|5|||
37897573|NCT00779584|69582626|FG005|Overall Study|Progression of Disease|1|||
37897574|NCT00779584|69582627|FG006|Overall Study|Progression of Disease|4|||
37826276|NCT02335268|69508853|FG000|Overall Study|Lack of Efficacy|2|||
37826277|NCT02335268|69508854|FG001|Overall Study|Lack of Efficacy|1|||
37826278|NCT02335268|69508853|FG000|Overall Study|Adverse Event|5|||
37897575|NCT00779584|69582628|FG007|Overall Study|Progression of Disease|2|||
37897576|NCT00779584|69582629|FG008|Overall Study|Progression of Disease|1|||
37826279|NCT02335268|69508854|FG001|Overall Study|Adverse Event|2|||
37826280|NCT02335268|69508853|FG000|Overall Study|increase blasts|2|||
37897577|NCT00779584|69582621|FG000|Overall Study|Adverse Event|1|||
37897578|NCT00779584|69582622|FG001|Overall Study|Adverse Event|0|||
37826281|NCT02335268|69508854|FG001|Overall Study|increase blasts|0|||
37826282|NCT02335268|69508853|FG000|Overall Study|Withdrawal by Subject|3|||
37826283|NCT02335268|69508854|FG001|Overall Study|Withdrawal by Subject|2|||
37826284|NCT01029002|69508876|FG000|Overall Study|Lost to Follow-up|2|||
37826285|NCT01029002|69508877|FG001|Overall Study|Lost to Follow-up|4|||
37826286|NCT01011478|69508885|FG000|Overall Study|No follow up data|12|||
37826287|NCT01011478|69508886|FG001|Overall Study|No follow up data|7|||
37826288|NCT00546260|69508894|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
37826289|NCT00546260|69508895|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
37897579|NCT00779584|69582623|FG002|Overall Study|Adverse Event|2|||
37897580|NCT00779584|69582624|FG003|Overall Study|Adverse Event|0|||
37897581|NCT00779584|69582625|FG004|Overall Study|Adverse Event|0|||
37897582|NCT00779584|69582626|FG005|Overall Study|Adverse Event|0|||
37897583|NCT00779584|69582627|FG006|Overall Study|Adverse Event|2|||
37897584|NCT00779584|69582628|FG007|Overall Study|Adverse Event|1|||
37897585|NCT00779584|69582629|FG008|Overall Study|Adverse Event|1|||
37897586|NCT00779584|69582621|FG000|Overall Study|Symptomatic Deterioration|1|||
37897587|NCT00779584|69582622|FG001|Overall Study|Symptomatic Deterioration|1|||
37897588|NCT00779584|69582623|FG002|Overall Study|Symptomatic Deterioration|1|||
37897589|NCT00779584|69582624|FG003|Overall Study|Symptomatic Deterioration|0|||
37897590|NCT00779584|69582625|FG004|Overall Study|Symptomatic Deterioration|0|||
37897591|NCT00779584|69582626|FG005|Overall Study|Symptomatic Deterioration|1|||
37897592|NCT00779584|69582627|FG006|Overall Study|Symptomatic Deterioration|1|||
37897593|NCT00779584|69582628|FG007|Overall Study|Symptomatic Deterioration|0|||
37897594|NCT00779584|69582629|FG008|Overall Study|Symptomatic Deterioration|0|||
37897595|NCT00779584|69582621|FG000|Overall Study|Ongoing in Study|0|||
37897596|NCT00779584|69582622|FG001|Overall Study|Ongoing in Study|0|||
37897597|NCT00779584|69582623|FG002|Overall Study|Ongoing in Study|0|||
37897598|NCT00779584|69582624|FG003|Overall Study|Ongoing in Study|0|||
37897599|NCT00779584|69582625|FG004|Overall Study|Ongoing in Study|1|||
37897600|NCT00779584|69582626|FG005|Overall Study|Ongoing in Study|1|||
37897601|NCT00779584|69582627|FG006|Overall Study|Ongoing in Study|0|||
37897602|NCT00779584|69582628|FG007|Overall Study|Ongoing in Study|0|||
37897603|NCT00779584|69582629|FG008|Overall Study|Ongoing in Study|0|||
37897604|NCT00995930|69582651|FG000|Overall Study|Protocol deviation|2|||
37826290|NCT02896192|69508918|FG000|Open-Label Period (10 Weeks)|Lack of Efficacy|1|||
37826291|NCT02896192|69508918|FG000|Open-Label Period (10 Weeks)|Protocol Violation|1|||
37897605|NCT00995930|69582652|FG001|Overall Study|Protocol deviation|5|||
37826292|NCT02896192|69508918|FG000|Open-Label Period (32 Weeks)|Lost to Follow-up|1|||
37897606|NCT00995930|69582651|FG000|Overall Study|Death|0|||
37897607|NCT00995930|69582652|FG001|Overall Study|Death|1|||
37897608|NCT00995930|69582651|FG000|Overall Study|Administrative problems|4|||
37897609|NCT00995930|69582652|FG001|Overall Study|Administrative problems|2|||
37897610|NCT00995930|69582651|FG000|Overall Study|Lost to Follow-up|1|||
37897611|NCT00995930|69582652|FG001|Overall Study|Lost to Follow-up|2|||
37897612|NCT00995930|69582651|FG000|Overall Study|Withdrawal by Subject|3|||
37897613|NCT00995930|69582652|FG001|Overall Study|Withdrawal by Subject|4|||
37897614|NCT00995930|69582651|FG000|Overall Study|Adverse Event|11|||
37897615|NCT00995930|69582652|FG001|Overall Study|Adverse Event|14|||
37897616|NCT00779506|69582659|FG000|Overall Study|Screening Failed|2|||
37897617|NCT00779506|69582659|FG000|Overall Study|Adverse Event|4|||
37897618|NCT00779506|69582659|FG000|Overall Study|Lack of Efficacy|11|||
37897619|NCT00779506|69582659|FG000|Overall Study|Protocol Violation|5|||
37897620|NCT00779506|69582659|FG000|Overall Study|Withdrawal by Subject|6|||
37897621|NCT00779506|69582659|FG000|Overall Study|Lost to Follow-up|1|||
37897622|NCT00995774|69582665|FG000|Training Period 2|Withdrawal by Subject|2|||
37897623|NCT00995774|69582666|FG001|Training Period 2|Withdrawal by Subject|0|||
37897624|NCT00765388|69582672|FG000|Period 1|Lack of Efficacy|1|||
37897625|NCT00765388|69582673|FG001|Period 1|Lack of Efficacy|2|||
37897626|NCT00765388|69582672|FG000|Period 1|Lost to Follow-up|0|||
37897627|NCT00765388|69582673|FG001|Period 1|Lost to Follow-up|1|||
37897628|NCT00765388|69582672|FG000|Period 1|Herpes Zoster|0|||
37897629|NCT00765388|69582673|FG001|Period 1|Herpes Zoster|1|||
37826293|NCT01356940|69508934|FG000|First Intervention (28 Days)|Adverse Event|1|||
37897630|NCT00765388|69582672|FG000|Period 1|Hip operation|0|||
37897631|NCT00765388|69582673|FG001|Period 1|Hip operation|1|||
37897632|NCT00769132|69582688|FG000|Period 1|Adverse Event|1|||
37897633|NCT00769132|69582689|FG001|Period 1|Adverse Event|0|||
37897634|NCT00769132|69582690|FG002|Period 1|Adverse Event|0|||
37897635|NCT00769132|69582691|FG003|Period 1|Adverse Event|1|||
37897636|NCT00769132|69582688|FG000|Period 2|Withdrawal by Subject|0|||
37897637|NCT00769132|69582689|FG001|Period 2|Withdrawal by Subject|0|||
37897638|NCT00769132|69582690|FG002|Period 2|Withdrawal by Subject|0|||
37897639|NCT00769132|69582691|FG003|Period 2|Withdrawal by Subject|1|||
37897640|NCT00769132|69582688|FG000|Period 3|Withdrawal by Subject|1|||
37826294|NCT01356940|69508935|FG001|First Intervention (28 Days)|Adverse Event|0|||
37826295|NCT01356940|69508934|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
37826296|NCT01356940|69508935|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
37826297|NCT01330030|69508954|FG000|Overall Study|Lost to Follow-up|16|||
37826298|NCT01330030|69508955|FG001|Overall Study|Lost to Follow-up|17|||
37826299|NCT00477295|69509070|FG000|Overall Study|Adverse Event|31|||
37826300|NCT00477295|69509071|FG001|Overall Study|Adverse Event|35|||
37826301|NCT00477295|69509070|FG000|Overall Study|Withdrawal by Subject|35|||
37826302|NCT00477295|69509071|FG001|Overall Study|Withdrawal by Subject|24|||
37826303|NCT00477295|69509070|FG000|Overall Study|Lack of Efficacy|23|||
37826304|NCT00477295|69509071|FG001|Overall Study|Lack of Efficacy|23|||
37826305|NCT00477295|69509070|FG000|Overall Study|Protocol Violation|3|||
37826306|NCT00477295|69509071|FG001|Overall Study|Protocol Violation|8|||
37826307|NCT00477295|69509070|FG000|Overall Study|Physician Decision|4|||
37897641|NCT00769132|69582689|FG001|Period 3|Withdrawal by Subject|0|||
37897642|NCT00769132|69582690|FG002|Period 3|Withdrawal by Subject|0|||
37897643|NCT00769132|69582691|FG003|Period 3|Withdrawal by Subject|0|||
37897644|NCT00769132|69582688|FG000|Period 4|Withdrawal by Subject|0|||
37897645|NCT00769132|69582689|FG001|Period 4|Withdrawal by Subject|1|||
37897646|NCT00769132|69582690|FG002|Period 4|Withdrawal by Subject|0|||
37897647|NCT00769132|69582691|FG003|Period 4|Withdrawal by Subject|0|||
37897648|NCT00991952|69582703|FG000|Overall Study|Adverse Event|0|||
37897649|NCT00991952|69582704|FG001|Overall Study|Adverse Event|1|||
37897650|NCT00779038|69582710|FG000|Overall Study|Study Prematurely Terminated|13|||
37897651|NCT00765076|69582717|FG000|Overall Study|Adverse Event|1|||
37897652|NCT00765076|69582718|FG001|Overall Study|Adverse Event|0|||
37897653|NCT00765076|69582719|FG002|Overall Study|Adverse Event|0|||
37897654|NCT00765076|69582717|FG000|Overall Study|Withdrawal by Subject|0|||
37897655|NCT00765076|69582718|FG001|Overall Study|Withdrawal by Subject|0|||
37897656|NCT00765076|69582719|FG002|Overall Study|Withdrawal by Subject|1|||
37897657|NCT00994682|69582729|FG000|Double Bilnd|Withdrawal by Subject|5|||
37897658|NCT00994682|69582730|FG001|Double Bilnd|Withdrawal by Subject|6|||
37897659|NCT00994682|69582729|FG000|Double Bilnd|Lost to Follow-up|3|||
37897660|NCT00994682|69582730|FG001|Double Bilnd|Lost to Follow-up|3|||
37897661|NCT00994682|69582729|FG000|Double Bilnd|Adverse Event|1|||
37897662|NCT00994682|69582730|FG001|Double Bilnd|Adverse Event|0|||
37897663|NCT00994682|69582729|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
37897664|NCT00994682|69582730|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
37897665|NCT00994682|69582729|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
37897666|NCT00994682|69582730|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
37897667|NCT00994682|69582729|FG000|Pioglitazone Open Label|Physician Decision|6|||
37897668|NCT00994682|69582730|FG001|Pioglitazone Open Label|Physician Decision|1|||
37897669|NCT00768898|69582740|FG000|Overall Study|Unrelated injury|1|||
37897670|NCT00768898|69582740|FG000|Overall Study|Headache|1|||
37897671|NCT00994448|69582751|FG000|Overall Study|Adverse Event|1|||
37897672|NCT00994448|69582752|FG001|Overall Study|Adverse Event|0|||
37897673|NCT00994448|69582751|FG000|Overall Study|Lost to Follow-up|5|||
37897674|NCT00994448|69582752|FG001|Overall Study|Lost to Follow-up|1|||
37897675|NCT00994448|69582751|FG000|Overall Study|Withdrawal by Subject|1|||
37996145|NCT00465569|69680864|FG000|Overall Study|persistent eczema during dose escalation|1|||
37996146|NCT00465569|69680865|FG001|Overall Study|persistent eczema during dose escalation|0|||
37996147|NCT00090766|69680874|FG000|Overall Study|Nephrectomy Planned|0|||
37996148|NCT00090766|69680875|FG001|Overall Study|Nephrectomy Planned|0|||
37996149|NCT00090766|69680876|FG002|Overall Study|Nephrectomy Planned|1|||
37996150|NCT00090766|69680874|FG000|Overall Study|Death|1|||
37826308|NCT00477295|69509071|FG001|Overall Study|Physician Decision|5|||
37826309|NCT00477295|69509070|FG000|Overall Study|Lost to Follow-up|21|||
37826310|NCT00477295|69509071|FG001|Overall Study|Lost to Follow-up|11|||
37897676|NCT00994448|69582752|FG001|Overall Study|Withdrawal by Subject|1|||
37826311|NCT00477295|69509070|FG000|Overall Study|Other|4|||
37897677|NCT00994448|69582751|FG000|Overall Study|Physician Decision|1|||
37897678|NCT00994448|69582752|FG001|Overall Study|Physician Decision|0|||
37897679|NCT00991406|69582758|FG000|Overall Study|One participant did not respond to FES.|1|||
37996151|NCT00090766|69680875|FG001|Overall Study|Death|0|||
37897680|NCT01017575|69582767|FG000|Overall Study|Lack of Efficacy|0|||
37897681|NCT01017575|69582768|FG001|Overall Study|Lack of Efficacy|1|||
37897682|NCT01017575|69582769|FG002|Overall Study|Lack of Efficacy|0|||
37897683|NCT01017575|69582770|FG003|Overall Study|Lack of Efficacy|1|||
37897684|NCT01017575|69582771|FG004|Overall Study|Lack of Efficacy|1|||
37897685|NCT01017575|69582767|FG000|Overall Study|Adverse Event|0|||
37897686|NCT01017575|69582768|FG001|Overall Study|Adverse Event|1|||
37897687|NCT01017575|69582769|FG002|Overall Study|Adverse Event|0|||
37897688|NCT01017575|69582770|FG003|Overall Study|Adverse Event|0|||
37897689|NCT01017575|69582771|FG004|Overall Study|Adverse Event|2|||
37897690|NCT01017575|69582767|FG000|Overall Study|Withdrawal by Subject|1|||
37897691|NCT01017575|69582768|FG001|Overall Study|Withdrawal by Subject|0|||
37897692|NCT01017575|69582769|FG002|Overall Study|Withdrawal by Subject|0|||
37897693|NCT01017575|69582770|FG003|Overall Study|Withdrawal by Subject|0|||
37897694|NCT01017575|69582771|FG004|Overall Study|Withdrawal by Subject|0|||
37897695|NCT01017263|69582783|FG000|Overall Study|not eligible|12|||
37897696|NCT00768664|69582787|FG000|Overall Study|Death|57|||
37897697|NCT00768664|69582787|FG000|Overall Study|Lost to Follow-up|2|||
37897698|NCT00768664|69582787|FG000|Overall Study|Other|9|||
37897699|NCT00768664|69582787|FG000|Overall Study|Participant refused|1|||
37897700|NCT00778336|69582795|FG000|Index Procedure-Discharge|Death|6|||
37897701|NCT00778336|69582796|FG001|Index Procedure-Discharge|Death|3|||
37897702|NCT00778336|69582797|FG002|Index Procedure-Discharge|Death|2|||
37897703|NCT00778336|69582798|FG003|Index Procedure-Discharge|Death|0|||
37897704|NCT00778336|69582795|FG000|3 Month Follow Up|Lost to Follow-up|15|||
37897705|NCT00778336|69582796|FG001|3 Month Follow Up|Lost to Follow-up|20|||
37897706|NCT00778336|69582797|FG002|3 Month Follow Up|Lost to Follow-up|3|||
37897707|NCT00778336|69582798|FG003|3 Month Follow Up|Lost to Follow-up|0|||
37897708|NCT00778336|69582795|FG000|3 Month Follow Up|Death|8|||
37897709|NCT00778336|69582796|FG001|3 Month Follow Up|Death|3|||
37897710|NCT00778336|69582797|FG002|3 Month Follow Up|Death|2|||
37897711|NCT00778336|69582798|FG003|3 Month Follow Up|Death|0|||
37897712|NCT01253161|69582808|FG000|Overall Study|Adverse Event|1|||
37897713|NCT00581113|69582814|FG000|Overall Study|Withdrawal by Subject|0|||
37897714|NCT00581113|69582815|FG001|Overall Study|Withdrawal by Subject|1|||
37897715|NCT01016015|69582821|FG000|Overall Study|Not Treated|3|||
37897716|NCT01016015|69582821|FG000|Overall Study|Withdrawal by Subject|1|||
37897717|NCT01016015|69582821|FG000|Overall Study|Adverse Event|15|||
37897718|NCT01015703|69582830|FG000|Overall Study|Withdrawal by Subject|0|||
37897719|NCT01015703|69582831|FG001|Overall Study|Withdrawal by Subject|1|||
37897720|NCT01015703|69582832|FG002|Overall Study|Withdrawal by Subject|0|||
37897721|NCT01015703|69582833|FG003|Overall Study|Withdrawal by Subject|0|||
37897722|NCT01015703|69582834|FG004|Overall Study|Withdrawal by Subject|0|||
37897723|NCT01015703|69582830|FG000|Overall Study|Adverse Event|1|||
37897724|NCT01015703|69582831|FG001|Overall Study|Adverse Event|0|||
37897725|NCT01015703|69582832|FG002|Overall Study|Adverse Event|0|||
37897726|NCT01015703|69582833|FG003|Overall Study|Adverse Event|0|||
37897727|NCT01015703|69582834|FG004|Overall Study|Adverse Event|0|||
37897728|NCT01015703|69582830|FG000|Overall Study|Protocol Violation|1|||
37897729|NCT01015703|69582831|FG001|Overall Study|Protocol Violation|0|||
37897730|NCT01015703|69582832|FG002|Overall Study|Protocol Violation|0|||
37897731|NCT01015703|69582833|FG003|Overall Study|Protocol Violation|0|||
37897732|NCT01015703|69582834|FG004|Overall Study|Protocol Violation|0|||
37897733|NCT04439071|69582848|FG000|Overall Study|Lost to Follow-up|0|||
37996152|NCT00090766|69680876|FG002|Overall Study|Death|0|||
37996153|NCT00090766|69680874|FG000|Overall Study|Admin|0|||
37996154|NCT00090766|69680875|FG001|Overall Study|Admin|2|||
37996155|NCT00090766|69680876|FG002|Overall Study|Admin|0|||
37897734|NCT04439071|69582849|FG001|Overall Study|Lost to Follow-up|3|||
37996156|NCT00090766|69680874|FG000|Overall Study|Lost to Follow-up|2|||
37996157|NCT00090766|69680875|FG001|Overall Study|Lost to Follow-up|0|||
37996158|NCT00090766|69680876|FG002|Overall Study|Lost to Follow-up|2|||
37996159|NCT00465179|69680886|FG000|Overall Study|Adverse Event|4|||
37996160|NCT00465179|69680886|FG000|Overall Study|Withdrawal by Subject|2|||
37897735|NCT04439071|69582848|FG000|Overall Study|Withdrawal by Subject|3|||
37897736|NCT04439071|69582849|FG001|Overall Study|Withdrawal by Subject|8|||
37897737|NCT04439071|69582848|FG000|Overall Study|Death|6|||
37897738|NCT04439071|69582849|FG001|Overall Study|Death|4|||
37897739|NCT04439071|69582848|FG000|Overall Study|Other than specified|3|||
37897740|NCT04439071|69582849|FG001|Overall Study|Other than specified|3|||
37897741|NCT04439071|69582848|FG000|Overall Study|Randomized but not treated|2|||
37897742|NCT04439071|69582849|FG001|Overall Study|Randomized but not treated|0|||
37897743|NCT01017029|69582857|FG000|Overall Study|Lost to Follow-up|1|||
37897744|NCT01017029|69582858|FG001|Overall Study|Lost to Follow-up|0|||
37897745|NCT01017029|69582857|FG000|Overall Study|Administrative problem|0|||
37897746|NCT01017029|69582858|FG001|Overall Study|Administrative problem|1|||
37897747|NCT01017029|69582857|FG000|Overall Study|Death|3|||
37897748|NCT01017029|69582858|FG001|Overall Study|Death|1|||
37897749|NCT00994214|69582868|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
37996161|NCT00465179|69680886|FG000|Overall Study|Progression of Disease|47|||
37897750|NCT00994214|69582869|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
37897751|NCT00994214|69582870|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
37897752|NCT00994214|69582871|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
37897753|NCT00994214|69582868|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
37897754|NCT00994214|69582869|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
37897755|NCT00994214|69582870|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
37897756|NCT00994214|69582871|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
37897757|NCT00994214|69582868|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
37897758|NCT00994214|69582869|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
37897759|NCT00994214|69582870|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
37897760|NCT00994214|69582871|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
37897761|NCT00994214|69582868|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
37897762|NCT00994214|69582869|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
37897763|NCT00994214|69582870|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
37897764|NCT00994214|69582871|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
37897765|NCT00994214|69582868|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
37897766|NCT00994214|69582869|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
37897767|NCT00994214|69582870|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
37897768|NCT00994214|69582871|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
37897769|NCT00994214|69582868|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
37897770|NCT00994214|69582869|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
37897771|NCT00994214|69582870|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
37897772|NCT00994214|69582871|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
37897773|NCT01034657|69582899|FG000|Core Phase|Withdrawal by Subject|1|||
37897774|NCT01034657|69582900|FG001|Core Phase|Withdrawal by Subject|0|||
37897775|NCT01034657|69582901|FG002|Core Phase|Withdrawal by Subject|0|||
37897776|NCT01034657|69582899|FG000|Core Phase|Lack of Efficacy|2|||
37897777|NCT01034657|69582900|FG001|Core Phase|Lack of Efficacy|0|||
37897778|NCT01034657|69582901|FG002|Core Phase|Lack of Efficacy|0|||
37897779|NCT01034657|69582899|FG000|Core Phase|Abnormal laboratory value|1|||
37897780|NCT01034657|69582900|FG001|Core Phase|Abnormal laboratory value|0|||
37897781|NCT01034657|69582901|FG002|Core Phase|Abnormal laboratory value|0|||
37826312|NCT00477295|69509071|FG001|Overall Study|Other|3|||
37826313|NCT00476593|69509083|FG000|Overall Study|Lost to Follow-up|10|||
37826314|NCT00476593|69509084|FG001|Overall Study|Lost to Follow-up|2|||
37826315|NCT00476593|69509085|FG002|Overall Study|Lost to Follow-up|8|||
37897782|NCT01034657|69582899|FG000|Core Phase|Adverse Event|8|||
37897783|NCT01034657|69582900|FG001|Core Phase|Adverse Event|0|||
37897784|NCT01034657|69582901|FG002|Core Phase|Adverse Event|0|||
37897785|NCT01034657|69582899|FG000|Core Phase|Protocol Violation|2|||
37897786|NCT01034657|69582900|FG001|Core Phase|Protocol Violation|0|||
37897787|NCT01034657|69582901|FG002|Core Phase|Protocol Violation|0|||
37897788|NCT01034657|69582899|FG000|Randomized Phase|Withdrawal by Subject|0|||
37897789|NCT01034657|69582900|FG001|Randomized Phase|Withdrawal by Subject|2|||
37897790|NCT01034657|69582901|FG002|Randomized Phase|Withdrawal by Subject|0|||
37897791|NCT01034657|69582899|FG000|Randomized Phase|Lack of Efficacy|5|||
37897792|NCT01034657|69582900|FG001|Randomized Phase|Lack of Efficacy|1|||
37897793|NCT01034657|69582901|FG002|Randomized Phase|Lack of Efficacy|0|||
37897794|NCT01034657|69582899|FG000|Randomized Phase|Abnormal laboratory value|0|||
37897795|NCT01034657|69582900|FG001|Randomized Phase|Abnormal laboratory value|1|||
37897796|NCT01034657|69582901|FG002|Randomized Phase|Abnormal laboratory value|0|||
37696539|NCT01829230|69172645|FG000|Overall Study|Withdrawal by Subject|0|||
37826316|NCT00476593|69509086|FG003|Overall Study|Lost to Follow-up|22|||
37826317|NCT00476476|69509098|FG000|Overall Study|Adverse Event|2|||
37826318|NCT00476476|69509099|FG001|Overall Study|Adverse Event|7|||
37826319|NCT00476476|69509098|FG000|Overall Study|Progressive Disease|0|||
37826320|NCT00476476|69509099|FG001|Overall Study|Progressive Disease|17|||
37826321|NCT00476086|69509104|FG000|Overall Study|Alternative therapy|1|||
37897797|NCT01034657|69582899|FG000|Randomized Phase|Adverse Event|0|||
37897798|NCT01034657|69582900|FG001|Randomized Phase|Adverse Event|2|||
37897799|NCT01034657|69582901|FG002|Randomized Phase|Adverse Event|1|||
37897800|NCT01014767|69582915|FG000|Overall Study|PI left institution, data unavailable|12|||
37897801|NCT01014767|69582916|FG001|Overall Study|PI left institution, data unavailable|1|||
37826322|NCT00476086|69509104|FG000|Overall Study|Progressive Disease|4|||
37826323|NCT00476047|69509110|FG000|Overall Study|Lost to Follow-up|1|||
37826324|NCT00476008|69509118|FG000|Overall Study|Adverse Event|4|||
37826325|NCT00476008|69509119|FG001|Overall Study|Adverse Event|4|||
37897802|NCT01014767|69582917|FG002|Overall Study|PI left institution, data unavailable|4|||
37897803|NCT01014767|69582918|FG003|Overall Study|PI left institution, data unavailable|1|||
37826326|NCT00476008|69509118|FG000|Overall Study|Placebo concerns|2|||
37826327|NCT00476008|69509119|FG001|Overall Study|Placebo concerns|2|||
37897804|NCT02016781|69582930|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
37897805|NCT02016781|69582931|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
37897806|NCT02016781|69582930|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
37897807|NCT02016781|69582931|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
37897808|NCT02016781|69582930|FG000|Final Database Lock|Withdrawal by Subject|2|||
37897809|NCT02016781|69582931|FG001|Final Database Lock|Withdrawal by Subject|1|||
37897810|NCT02016781|69582930|FG000|Final Database Lock|Lost to Follow-up|11|||
37897811|NCT02016781|69582931|FG001|Final Database Lock|Lost to Follow-up|4|||
37826328|NCT00476008|69509118|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
37826329|NCT00476008|69509119|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
37996162|NCT00465101|69680890|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
37996163|NCT00465101|69680890|FG000|Overall Study|Change in health precluded follow up|4|||
37996164|NCT00465101|69680890|FG000|Overall Study|Did not meet study criteria|4|||
37996165|NCT00465101|69680890|FG000|Overall Study|Lost to Follow-up|5|||
37996166|NCT00465101|69680890|FG000|Overall Study|Other|6|||
37996167|NCT00465101|69680890|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
37996168|NCT00465101|69680890|FG000|Overall Study|Patient postponed procedure|1|||
37996169|NCT00465101|69680890|FG000|Overall Study|Site closed due to IRB expiration|1|||
37996170|NCT00465101|69680890|FG000|Overall Study|Unable to obtain IRB approval|1|||
37996171|NCT00465101|69680890|FG000|Overall Study|Death|3|||
37996172|NCT00465101|69680890|FG000|Overall Study|Withdrawal by Subject|25|||
37996173|NCT00465101|69680890|FG000|Overall Study|Physician Decision|1|||
37996174|NCT00465101|69680890|FG000|Overall Study|Withdrew consent prior to procedure|3|||
37996175|NCT00084136|69680919|FG000|PI Comparison|Death|10|||
37996176|NCT00084136|69680920|FG001|PI Comparison|Death|9|||
37996177|NCT00084136|69680921|FG002|PI Comparison|Death|0|||
37996178|NCT00084136|69680919|FG000|PI Comparison|Lost to Follow-up|11|||
37996179|NCT00084136|69680920|FG001|PI Comparison|Lost to Follow-up|8|||
37826330|NCT00476008|69509118|FG000|Overall Study|Withdrawal by Subject|0|||
37826331|NCT00476008|69509119|FG001|Overall Study|Withdrawal by Subject|1|||
37826332|NCT00476008|69509118|FG000|Overall Study|Death|1|||
37826333|NCT00476008|69509119|FG001|Overall Study|Death|0|||
37826334|NCT00475735|69509135|FG000|Treatment Period 1|Adverse Event|2|||
37826335|NCT00475735|69509136|FG001|Treatment Period 1|Adverse Event|0|||
37897812|NCT02016781|69582930|FG000|Final Database Lock|Missing data|0|||
37897813|NCT02016781|69582931|FG001|Final Database Lock|Missing data|3|||
37897814|NCT01014689|69582939|FG000|Overall Study|Lack of Efficacy|0|||
37897815|NCT01014689|69582940|FG001|Overall Study|Lack of Efficacy|1|||
37897816|NCT01014689|69582939|FG000|Overall Study|Adverse Event|3|||
37826336|NCT00475735|69509137|FG002|Treatment Period 1|Adverse Event|0|||
37826337|NCT00475735|69509138|FG003|Treatment Period 1|Adverse Event|0|||
37996180|NCT00084136|69680921|FG002|PI Comparison|Lost to Follow-up|0|||
37826338|NCT00475735|69509139|FG004|Treatment Period 1|Adverse Event|0|||
37897817|NCT01014689|69582940|FG001|Overall Study|Adverse Event|0|||
37897818|NCT01014689|69582939|FG000|Overall Study|Withdrawal by Subject|5|||
37996181|NCT00084136|69680919|FG000|PI Comparison|Withdrawal by Subject|33|||
37996182|NCT00084136|69680920|FG001|PI Comparison|Withdrawal by Subject|30|||
37996183|NCT00084136|69680921|FG002|PI Comparison|Withdrawal by Subject|0|||
37996184|NCT00084136|69680919|FG000|PI Comparison|Clinic site closed|1|||
37996185|NCT00084136|69680920|FG001|PI Comparison|Clinic site closed|0|||
37996186|NCT00084136|69680921|FG002|PI Comparison|Clinic site closed|0|||
37996187|NCT00084136|69680919|FG000|NRTI Comparison|Death|20|||
37996188|NCT00084136|69680920|FG001|NRTI Comparison|Death|0|||
37996189|NCT00084136|69680921|FG002|NRTI Comparison|Death|18|||
37996190|NCT00084136|69680919|FG000|NRTI Comparison|Lost to Follow-up|14|||
37996191|NCT00084136|69680920|FG001|NRTI Comparison|Lost to Follow-up|0|||
37996192|NCT00084136|69680921|FG002|NRTI Comparison|Lost to Follow-up|12|||
37996193|NCT00084136|69680919|FG000|NRTI Comparison|Withdrawal by Subject|54|||
37996194|NCT00084136|69680920|FG001|NRTI Comparison|Withdrawal by Subject|0|||
37996195|NCT00084136|69680921|FG002|NRTI Comparison|Withdrawal by Subject|38|||
37996196|NCT00084136|69680919|FG000|NRTI Comparison|Clinic site closed|12|||
37826339|NCT00475735|69509140|FG005|Treatment Period 1|Adverse Event|0|||
37826340|NCT00475735|69509135|FG000|Treatment Period 1|Lack of Efficacy|1|||
37897819|NCT01014689|69582940|FG001|Overall Study|Withdrawal by Subject|4|||
37897820|NCT01014689|69582939|FG000|Overall Study|Protocol Violation|1|||
37996197|NCT00084136|69680920|FG001|NRTI Comparison|Clinic site closed|0|||
37996198|NCT00084136|69680921|FG002|NRTI Comparison|Clinic site closed|14|||
37996199|NCT00084136|69680919|FG000|NRTI Comparison|Not reason above|1|||
37996200|NCT00084136|69680920|FG001|NRTI Comparison|Not reason above|0|||
37996201|NCT00084136|69680921|FG002|NRTI Comparison|Not reason above|0|||
37996202|NCT03812380|69680932|FG000|Overall Study|Protocol Violation|3|||
37897821|NCT01014689|69582940|FG001|Overall Study|Protocol Violation|1|||
37897822|NCT01014689|69582939|FG000|Overall Study|Lost to Follow-up|3|||
37897823|NCT01014689|69582940|FG001|Overall Study|Lost to Follow-up|7|||
37897824|NCT01014689|69582939|FG000|Overall Study|Pregnancy|1|||
37897825|NCT01014689|69582940|FG001|Overall Study|Pregnancy|0|||
37897826|NCT01014533|69582948|FG000|Overall Study|Protocol Violation|3|||
37897827|NCT01014533|69582949|FG001|Overall Study|Protocol Violation|2|||
37897828|NCT01014533|69582948|FG000|Overall Study|Withdrawal by Subject|2|||
37897829|NCT01014533|69582949|FG001|Overall Study|Withdrawal by Subject|0|||
37897830|NCT01014533|69582948|FG000|Overall Study|unable to come to appointment|0|||
37897831|NCT01014533|69582949|FG001|Overall Study|unable to come to appointment|3|||
37897832|NCT01014143|69582972|FG000|Second Intervention|Lost to Follow-up|2|||
37897833|NCT01014143|69582973|FG001|Second Intervention|Lost to Follow-up|0|||
37897834|NCT01014143|69582974|FG002|Second Intervention|Lost to Follow-up|0|||
37897835|NCT01013753|69582982|FG000|Overall Study|Adverse Event|8|||
37897836|NCT01013753|69582982|FG000|Overall Study|Protocol Violation|3|||
37897837|NCT01013753|69582982|FG000|Overall Study|Lost to Follow-up|1|||
37897838|NCT01013753|69582982|FG000|Overall Study|Withdrawal by Subject|2|||
37897839|NCT01013753|69582982|FG000|Overall Study|Other|2|||
37897840|NCT00757042|69583007|FG000|Overall Study|Lost to Follow-up|0|||
37897841|NCT00757042|69583008|FG001|Overall Study|Lost to Follow-up|0|||
37897842|NCT00757042|69583009|FG002|Overall Study|Lost to Follow-up|0|||
37897843|NCT00757042|69583010|FG003|Overall Study|Lost to Follow-up|0|||
37897844|NCT00757042|69583011|FG004|Overall Study|Lost to Follow-up|0|||
37897845|NCT00757042|69583012|FG005|Overall Study|Lost to Follow-up|0|||
37897846|NCT00757042|69583013|FG006|Overall Study|Lost to Follow-up|0|||
37897847|NCT00757042|69583014|FG007|Overall Study|Lost to Follow-up|0|||
37897848|NCT00757042|69583015|FG008|Overall Study|Lost to Follow-up|1|||
37897849|NCT00757042|69583016|FG009|Overall Study|Lost to Follow-up|0|||
37897850|NCT00757042|69583017|FG010|Overall Study|Lost to Follow-up|0|||
37897851|NCT00757042|69583007|FG000|Overall Study|Ineligibility Determined|0|||
37897852|NCT00757042|69583008|FG001|Overall Study|Ineligibility Determined|0|||
37897853|NCT00757042|69583009|FG002|Overall Study|Ineligibility Determined|0|||
37897854|NCT00757042|69583010|FG003|Overall Study|Ineligibility Determined|0|||
37897855|NCT00757042|69583011|FG004|Overall Study|Ineligibility Determined|0|||
37897856|NCT00757042|69583012|FG005|Overall Study|Ineligibility Determined|0|||
37897857|NCT00757042|69583013|FG006|Overall Study|Ineligibility Determined|0|||
37897858|NCT00757042|69583014|FG007|Overall Study|Ineligibility Determined|0|||
37897859|NCT00757042|69583015|FG008|Overall Study|Ineligibility Determined|0|||
37897860|NCT00757042|69583016|FG009|Overall Study|Ineligibility Determined|0|||
37897861|NCT00757042|69583017|FG010|Overall Study|Ineligibility Determined|1|||
37897862|NCT00757042|69583007|FG000|Overall Study|Withdrawal by Subject|0|||
37897863|NCT00757042|69583008|FG001|Overall Study|Withdrawal by Subject|0|||
37897864|NCT00757042|69583009|FG002|Overall Study|Withdrawal by Subject|0|||
37897865|NCT00757042|69583010|FG003|Overall Study|Withdrawal by Subject|0|||
37996203|NCT03812380|69680933|FG001|Overall Study|Protocol Violation|3|||
37826341|NCT00475735|69509136|FG001|Treatment Period 1|Lack of Efficacy|0|||
37826342|NCT00475735|69509137|FG002|Treatment Period 1|Lack of Efficacy|0|||
37826343|NCT00475735|69509138|FG003|Treatment Period 1|Lack of Efficacy|0|||
37826344|NCT00475735|69509139|FG004|Treatment Period 1|Lack of Efficacy|0|||
37826345|NCT00475735|69509140|FG005|Treatment Period 1|Lack of Efficacy|0|||
37826346|NCT00475735|69509135|FG000|Treatment Period 1|Lost to Follow-up|0|||
37826347|NCT00475735|69509136|FG001|Treatment Period 1|Lost to Follow-up|0|||
37826348|NCT00475735|69509137|FG002|Treatment Period 1|Lost to Follow-up|0|||
37897866|NCT00757042|69583011|FG004|Overall Study|Withdrawal by Subject|0|||
37996204|NCT03812380|69680932|FG000|Overall Study|Withdrawal by Subject|5|||
37826349|NCT00475735|69509138|FG003|Treatment Period 1|Lost to Follow-up|0|||
37826350|NCT00475735|69509139|FG004|Treatment Period 1|Lost to Follow-up|0|||
37897867|NCT00757042|69583012|FG005|Overall Study|Withdrawal by Subject|0|||
37897868|NCT00757042|69583013|FG006|Overall Study|Withdrawal by Subject|0|||
37897869|NCT00757042|69583014|FG007|Overall Study|Withdrawal by Subject|0|||
37897870|NCT00757042|69583015|FG008|Overall Study|Withdrawal by Subject|0|||
37897871|NCT00757042|69583016|FG009|Overall Study|Withdrawal by Subject|1|||
37897872|NCT00757042|69583017|FG010|Overall Study|Withdrawal by Subject|0|||
37897873|NCT01013597|69583048|FG000|Overall Study|Withdrawal by Subject|1|||
37897874|NCT01013285|69583067|FG000|Overall Study|Death|48|||
37897875|NCT01013285|69583068|FG001|Overall Study|Death|89|||
37897876|NCT01033643|69583078|FG000|Overall Study|Withdrew Consent|0|||
37996205|NCT03812380|69680933|FG001|Overall Study|Withdrawal by Subject|4|||
37897877|NCT01033643|69583079|FG001|Overall Study|Withdrew Consent|3|||
37897878|NCT01033643|69583080|FG002|Overall Study|Withdrew Consent|0|||
37897879|NCT01033643|69583081|FG003|Overall Study|Withdrew Consent|0|||
37897880|NCT01033643|69583082|FG004|Overall Study|Withdrew Consent|0|||
37897881|NCT01033643|69583083|FG005|Overall Study|Withdrew Consent|1|||
37897882|NCT01013207|69583097|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
37897883|NCT01033487|69583101|FG000|Fourth Intervention Period|Adverse Event|0|||
37996206|NCT03812380|69680932|FG000|Overall Study|Early termination of study|14|||
37996207|NCT03812380|69680933|FG001|Overall Study|Early termination of study|14|||
37996208|NCT00464945|69680941|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
37996209|NCT00464945|69680942|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
37996210|NCT00464945|69680941|FG000|Infant Series|Protocol Violation|1|||
37996211|NCT00464945|69680942|FG001|Infant Series|Protocol Violation|0|||
37897884|NCT01033487|69583102|FG001|Fourth Intervention Period|Adverse Event|0|||
37897885|NCT01033487|69583103|FG002|Fourth Intervention Period|Adverse Event|0|||
37897886|NCT01033487|69583104|FG003|Fourth Intervention Period|Adverse Event|0|||
37897887|NCT01033487|69583105|FG004|Fourth Intervention Period|Adverse Event|0|||
37897888|NCT01033487|69583106|FG005|Fourth Intervention Period|Adverse Event|0|||
37897889|NCT01033487|69583107|FG006|Fourth Intervention Period|Adverse Event|0|||
37897890|NCT01033487|69583108|FG007|Fourth Intervention Period|Adverse Event|0|||
37897891|NCT01033487|69583109|FG008|Fourth Intervention Period|Adverse Event|1|||
37897892|NCT01033487|69583110|FG009|Fourth Intervention Period|Adverse Event|0|||
37897893|NCT01033019|69583126|FG000|Overall Study|Withdrawal by Subject|1|||
37897894|NCT01033019|69583127|FG001|Overall Study|Withdrawal by Subject|0|||
37897895|NCT00603447|69583141|FG000|Overall Study|Adverse Event|0|||
37897896|NCT00603447|69583142|FG001|Overall Study|Adverse Event|1|||
37897897|NCT00603447|69583143|FG002|Overall Study|Adverse Event|1|||
37897898|NCT00603447|69583144|FG003|Overall Study|Adverse Event|2|||
37897899|NCT00603447|69583145|FG004|Overall Study|Adverse Event|1|||
37996212|NCT00464945|69680941|FG000|Infant Series|Lost to Follow-up|1|||
37897900|NCT00603447|69583146|FG005|Overall Study|Adverse Event|2|||
37897901|NCT00603447|69583147|FG006|Overall Study|Adverse Event|10|||
37897902|NCT00603447|69583141|FG000|Overall Study|Other|0|||
37897903|NCT00603447|69583142|FG001|Overall Study|Other|0|||
37897904|NCT00603447|69583143|FG002|Overall Study|Other|1|||
37897905|NCT00603447|69583144|FG003|Overall Study|Other|0|||
37897906|NCT00603447|69583145|FG004|Overall Study|Other|3|||
37897907|NCT00603447|69583146|FG005|Overall Study|Other|0|||
37996213|NCT00464945|69680942|FG001|Infant Series|Lost to Follow-up|0|||
37996214|NCT00464945|69680941|FG000|After Infant Series|Withdrawal by Subject|0|||
37996215|NCT00464945|69680942|FG001|After Infant Series|Withdrawal by Subject|2|||
37996216|NCT00464945|69680941|FG000|Toddler Dose|Lost to Follow-up|0|||
37996217|NCT00464945|69680942|FG001|Toddler Dose|Lost to Follow-up|1|||
37996218|NCT00464087|69680967|FG000|Overall Study|No PCI per inclusion criteria|0|||
37996219|NCT00464087|69680968|FG001|Overall Study|No PCI per inclusion criteria|0|||
37826351|NCT00475735|69509140|FG005|Treatment Period 1|Lost to Follow-up|1|||
37826352|NCT00475735|69509135|FG000|Treatment Period 1|Protocol Violation|0|||
37826353|NCT00475735|69509136|FG001|Treatment Period 1|Protocol Violation|0|||
37826354|NCT00475735|69509137|FG002|Treatment Period 1|Protocol Violation|0|||
37826355|NCT00475735|69509138|FG003|Treatment Period 1|Protocol Violation|1|||
37897908|NCT00603447|69583147|FG006|Overall Study|Other|13|||
37897909|NCT00603447|69583141|FG000|Overall Study|Withdrew Consent|0|||
37897910|NCT00603447|69583142|FG001|Overall Study|Withdrew Consent|2|||
37897911|NCT00603447|69583143|FG002|Overall Study|Withdrew Consent|0|||
37897912|NCT00603447|69583144|FG003|Overall Study|Withdrew Consent|0|||
37897913|NCT00603447|69583145|FG004|Overall Study|Withdrew Consent|1|||
37826356|NCT00475735|69509139|FG004|Treatment Period 1|Protocol Violation|0|||
37826357|NCT00475735|69509140|FG005|Treatment Period 1|Protocol Violation|0|||
37826358|NCT00475735|69509135|FG000|Treatment Period 1|Withdrawal by Subject|1|||
37897914|NCT00603447|69583146|FG005|Overall Study|Withdrew Consent|0|||
37897915|NCT00603447|69583147|FG006|Overall Study|Withdrew Consent|1|||
37897916|NCT00778258|69583172|FG000|Overall Study|Adverse Event|1|||
37996220|NCT00464087|69680969|FG002|Overall Study|No PCI per inclusion criteria|29|||
37996221|NCT00452699|69680979|FG000|Overall Study|Adverse Event|10|||
37996222|NCT00452699|69680980|FG001|Overall Study|Adverse Event|3|||
37996223|NCT00452699|69680979|FG000|Overall Study|Lack of Efficacy|6|||
37996224|NCT00452699|69680980|FG001|Overall Study|Lack of Efficacy|4|||
37826359|NCT00475735|69509136|FG001|Treatment Period 1|Withdrawal by Subject|1|||
37826360|NCT00475735|69509137|FG002|Treatment Period 1|Withdrawal by Subject|0|||
37897917|NCT00778258|69583173|FG001|Overall Study|Adverse Event|0|||
37897918|NCT00778258|69583174|FG002|Overall Study|Adverse Event|0|||
37897919|NCT00778258|69583175|FG003|Overall Study|Adverse Event|0|||
37897920|NCT00778258|69583176|FG004|Overall Study|Adverse Event|0|||
37897921|NCT00778258|69583177|FG005|Overall Study|Adverse Event|1|||
37897922|NCT00778258|69583178|FG006|Overall Study|Adverse Event|0|||
37897923|NCT00778258|69583179|FG007|Overall Study|Adverse Event|0|||
37897924|NCT00778258|69583180|FG008|Overall Study|Adverse Event|0|||
37897925|NCT00778258|69583172|FG000|Overall Study|Lost to Follow-up|0|||
37897926|NCT00778258|69583173|FG001|Overall Study|Lost to Follow-up|0|||
37897927|NCT00778258|69583174|FG002|Overall Study|Lost to Follow-up|2|||
37897928|NCT00778258|69583175|FG003|Overall Study|Lost to Follow-up|0|||
37897929|NCT00778258|69583176|FG004|Overall Study|Lost to Follow-up|0|||
37897930|NCT00778258|69583177|FG005|Overall Study|Lost to Follow-up|3|||
37897931|NCT00778258|69583178|FG006|Overall Study|Lost to Follow-up|2|||
37897932|NCT00778258|69583179|FG007|Overall Study|Lost to Follow-up|2|||
37897933|NCT00778258|69583180|FG008|Overall Study|Lost to Follow-up|0|||
37897934|NCT00778258|69583172|FG000|Overall Study|Withdrawal by Subject|6|||
37897935|NCT00778258|69583173|FG001|Overall Study|Withdrawal by Subject|2|||
37897936|NCT00778258|69583174|FG002|Overall Study|Withdrawal by Subject|8|||
37897937|NCT00778258|69583175|FG003|Overall Study|Withdrawal by Subject|2|||
37897938|NCT00778258|69583176|FG004|Overall Study|Withdrawal by Subject|0|||
37897939|NCT00778258|69583177|FG005|Overall Study|Withdrawal by Subject|6|||
37897940|NCT00778258|69583178|FG006|Overall Study|Withdrawal by Subject|12|||
37897941|NCT00778258|69583179|FG007|Overall Study|Withdrawal by Subject|12|||
37897942|NCT00778258|69583180|FG008|Overall Study|Withdrawal by Subject|4|||
37897943|NCT00778258|69583172|FG000|Overall Study|New Contraindication|0|||
37996225|NCT00452699|69680979|FG000|Overall Study|Lost to Follow-up|6|||
37996226|NCT00452699|69680980|FG001|Overall Study|Lost to Follow-up|9|||
37996227|NCT00452699|69680979|FG000|Overall Study|Protocol Violation|21|||
37826361|NCT00475735|69509138|FG003|Treatment Period 1|Withdrawal by Subject|0|||
37826362|NCT00475735|69509139|FG004|Treatment Period 1|Withdrawal by Subject|0|||
37826363|NCT00475735|69509140|FG005|Treatment Period 1|Withdrawal by Subject|0|||
37826364|NCT00475735|69509135|FG000|Treatment Period 1|DC due to AE but continuing|0|||
37826365|NCT00475735|69509136|FG001|Treatment Period 1|DC due to AE but continuing|0|||
37826366|NCT00475735|69509137|FG002|Treatment Period 1|DC due to AE but continuing|0|||
37826367|NCT00475735|69509138|FG003|Treatment Period 1|DC due to AE but continuing|1|||
37826368|NCT00475735|69509139|FG004|Treatment Period 1|DC due to AE but continuing|2|||
37826369|NCT00475735|69509140|FG005|Treatment Period 1|DC due to AE but continuing|2|||
37826370|NCT00475735|69509135|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
37826371|NCT00475735|69509136|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
37826372|NCT00475735|69509137|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
37826373|NCT00475735|69509138|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
37826374|NCT00475735|69509139|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
37826375|NCT00475735|69509140|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
37826376|NCT00475735|69509135|FG000|Treatment Washout|Lost to Follow-up|0|||
37826377|NCT00475735|69509136|FG001|Treatment Washout|Lost to Follow-up|1|||
37826378|NCT00475735|69509137|FG002|Treatment Washout|Lost to Follow-up|0|||
37826379|NCT00475735|69509138|FG003|Treatment Washout|Lost to Follow-up|0|||
37826380|NCT00475735|69509139|FG004|Treatment Washout|Lost to Follow-up|0|||
37897944|NCT00778258|69583173|FG001|Overall Study|New Contraindication|0|||
37897945|NCT00778258|69583174|FG002|Overall Study|New Contraindication|0|||
37897946|NCT00778258|69583175|FG003|Overall Study|New Contraindication|0|||
37897947|NCT00778258|69583176|FG004|Overall Study|New Contraindication|0|||
37897948|NCT00778258|69583177|FG005|Overall Study|New Contraindication|0|||
37897949|NCT00778258|69583178|FG006|Overall Study|New Contraindication|0|||
37897950|NCT00778258|69583179|FG007|Overall Study|New Contraindication|1|||
37897951|NCT00778258|69583180|FG008|Overall Study|New Contraindication|0|||
37897952|NCT00778258|69583172|FG000|Overall Study|Non-compliance|0|||
37897953|NCT00778258|69583173|FG001|Overall Study|Non-compliance|0|||
37897954|NCT00778258|69583174|FG002|Overall Study|Non-compliance|0|||
37897955|NCT00778258|69583175|FG003|Overall Study|Non-compliance|1|||
37897956|NCT00778258|69583176|FG004|Overall Study|Non-compliance|0|||
37897957|NCT00778258|69583177|FG005|Overall Study|Non-compliance|0|||
37897958|NCT00778258|69583178|FG006|Overall Study|Non-compliance|0|||
37897959|NCT00778258|69583179|FG007|Overall Study|Non-compliance|0|||
37897960|NCT00778258|69583180|FG008|Overall Study|Non-compliance|0|||
37897961|NCT00778258|69583172|FG000|Overall Study|Other|0|||
37897962|NCT00778258|69583173|FG001|Overall Study|Other|0|||
37897963|NCT00778258|69583174|FG002|Overall Study|Other|0|||
37996228|NCT00452699|69680980|FG001|Overall Study|Protocol Violation|25|||
37996229|NCT00452699|69680979|FG000|Overall Study|Withdrawal by Subject|26|||
37826381|NCT00475735|69509140|FG005|Treatment Washout|Lost to Follow-up|0|||
37826382|NCT00475735|69509135|FG000|Treatment Washout|Protocol Violation|0|||
37826383|NCT00475735|69509136|FG001|Treatment Washout|Protocol Violation|1|||
37826384|NCT00475735|69509137|FG002|Treatment Washout|Protocol Violation|0|||
37826385|NCT00475735|69509138|FG003|Treatment Washout|Protocol Violation|0|||
37897964|NCT00778258|69583175|FG003|Overall Study|Other|0|||
37897965|NCT00778258|69583176|FG004|Overall Study|Other|0|||
37897966|NCT00778258|69583177|FG005|Overall Study|Other|0|||
37897967|NCT00778258|69583178|FG006|Overall Study|Other|1|||
37897968|NCT00778258|69583179|FG007|Overall Study|Other|0|||
37897969|NCT00778258|69583180|FG008|Overall Study|Other|0|||
37897970|NCT00988208|69583208|FG000|Overall Study|Adverse Event|71|||
37897971|NCT00988208|69583209|FG001|Overall Study|Adverse Event|122|||
37897972|NCT00988208|69583208|FG000|Overall Study|Disease Progression|103|||
37897973|NCT00988208|69583209|FG001|Overall Study|Disease Progression|89|||
37996230|NCT00452699|69680980|FG001|Overall Study|Withdrawal by Subject|25|||
37996231|NCT00452699|69680979|FG000|Overall Study|Other|12|||
37996232|NCT00452699|69680980|FG001|Overall Study|Other|7|||
37996233|NCT00069784|69680988|FG000|Overall Study|Adverse Event|105|||
37996234|NCT00069784|69680989|FG001|Overall Study|Adverse Event|0|||
37996235|NCT00069784|69680988|FG000|Overall Study|Withdrawal by Subject|1090|||
37996236|NCT00069784|69680989|FG001|Overall Study|Withdrawal by Subject|0|||
37996237|NCT00069784|69680988|FG000|Overall Study|Other|17|||
37996238|NCT00069784|69680989|FG001|Overall Study|Other|0|||
37996239|NCT03811834|69680995|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
37996240|NCT00090610|69681010|FG000|Overall Study|Withdrawal by Subject|1|||
37996241|NCT00090610|69681011|FG001|Overall Study|Withdrawal by Subject|1|||
37996242|NCT00463385|69681021|FG000|Overall Study|Other|4|||
37996243|NCT00463385|69681022|FG001|Overall Study|Other|3|||
37996244|NCT00463385|69681023|FG002|Overall Study|Other|6|||
37996245|NCT00463385|69681024|FG003|Overall Study|Other|4|||
37996246|NCT00463385|69681021|FG000|Overall Study|Adverse Event|5|||
37996247|NCT00463385|69681022|FG001|Overall Study|Adverse Event|8|||
37996248|NCT00463385|69681023|FG002|Overall Study|Adverse Event|4|||
37996249|NCT00463385|69681024|FG003|Overall Study|Adverse Event|2|||
37996250|NCT00463385|69681021|FG000|Overall Study|Lack of Efficacy|6|||
37996251|NCT00463385|69681022|FG001|Overall Study|Lack of Efficacy|6|||
37996252|NCT00463385|69681023|FG002|Overall Study|Lack of Efficacy|7|||
37996253|NCT00463385|69681024|FG003|Overall Study|Lack of Efficacy|9|||
37996254|NCT00463385|69681021|FG000|Overall Study|Withdrawal by Subject|3|||
37996255|NCT00463385|69681022|FG001|Overall Study|Withdrawal by Subject|3|||
37996256|NCT00463385|69681023|FG002|Overall Study|Withdrawal by Subject|3|||
37996257|NCT00463385|69681024|FG003|Overall Study|Withdrawal by Subject|4|||
37996258|NCT00463385|69681021|FG000|Overall Study|Lost to Follow-up|0|||
37996259|NCT00463385|69681022|FG001|Overall Study|Lost to Follow-up|0|||
37996260|NCT00463385|69681023|FG002|Overall Study|Lost to Follow-up|0|||
37996261|NCT00463385|69681024|FG003|Overall Study|Lost to Follow-up|1|||
37996262|NCT00463385|69681021|FG000|Overall Study|Death|2|||
37996263|NCT00463385|69681022|FG001|Overall Study|Death|1|||
37996264|NCT00463385|69681023|FG002|Overall Study|Death|2|||
37996265|NCT00463385|69681024|FG003|Overall Study|Death|0|||
37996266|NCT00463385|69681021|FG000|Overall Study|Missing|2|||
37996267|NCT00463385|69681022|FG001|Overall Study|Missing|0|||
37996268|NCT00463385|69681023|FG002|Overall Study|Missing|0|||
37996269|NCT00463385|69681024|FG003|Overall Study|Missing|2|||
37996270|NCT00463385|69681021|FG000|Overall Study|1 participant received commercial drug|0|||
37996271|NCT00463385|69681022|FG001|Overall Study|1 participant received commercial drug|1|||
37996272|NCT00463385|69681023|FG002|Overall Study|1 participant received commercial drug|0|||
37996273|NCT00463385|69681024|FG003|Overall Study|1 participant received commercial drug|0|||
37996274|NCT00463229|69681044|FG000|Overall Study|Lost to Follow-up|5|||
37996275|NCT00463229|69681045|FG001|Overall Study|Lost to Follow-up|7|||
37996276|NCT00463229|69681044|FG000|Overall Study|Death|4|||
37996277|NCT00463229|69681045|FG001|Overall Study|Death|3|||
37996278|NCT03839693|69681055|FG000|Overall Study|Lost to Follow-up|0|||
37996279|NCT03839693|69681056|FG001|Overall Study|Lost to Follow-up|2|||
37826386|NCT00475735|69509139|FG004|Treatment Washout|Protocol Violation|0|||
37826387|NCT00475735|69509140|FG005|Treatment Washout|Protocol Violation|0|||
37826388|NCT00475735|69509135|FG000|Treatment Period 2|Adverse Event|0|||
37826389|NCT00475735|69509136|FG001|Treatment Period 2|Adverse Event|1|||
37826390|NCT00475735|69509137|FG002|Treatment Period 2|Adverse Event|0|||
37826391|NCT00475735|69509138|FG003|Treatment Period 2|Adverse Event|2|||
37826392|NCT00475735|69509139|FG004|Treatment Period 2|Adverse Event|0|||
37826393|NCT00475735|69509140|FG005|Treatment Period 2|Adverse Event|0|||
37826394|NCT00475735|69509135|FG000|Treatment Period 2|Lack of Efficacy|0|||
37826395|NCT00475735|69509136|FG001|Treatment Period 2|Lack of Efficacy|0|||
37826396|NCT00475735|69509137|FG002|Treatment Period 2|Lack of Efficacy|0|||
37826397|NCT00475735|69509138|FG003|Treatment Period 2|Lack of Efficacy|0|||
37826398|NCT00475735|69509139|FG004|Treatment Period 2|Lack of Efficacy|0|||
37826399|NCT00475735|69509140|FG005|Treatment Period 2|Lack of Efficacy|1|||
37897974|NCT00988208|69583208|FG000|Overall Study|Withdrawal by Subject|50|||
37996280|NCT03839693|69681057|FG002|Overall Study|Lost to Follow-up|2|||
37996281|NCT03839693|69681055|FG000|Overall Study|Withdrawal by Subject|1|||
37996282|NCT03839693|69681056|FG001|Overall Study|Withdrawal by Subject|0|||
37996283|NCT03839693|69681057|FG002|Overall Study|Withdrawal by Subject|2|||
37996284|NCT03839693|69681055|FG000|Overall Study|subject moved out of the area|1|||
37996285|NCT03839693|69681056|FG001|Overall Study|subject moved out of the area|0|||
37826400|NCT00475735|69509135|FG000|Treatment Period 2|Withdrawal by Subject|0|||
37826401|NCT00475735|69509136|FG001|Treatment Period 2|Withdrawal by Subject|0|||
37826402|NCT00475735|69509137|FG002|Treatment Period 2|Withdrawal by Subject|0|||
37996286|NCT03839693|69681057|FG002|Overall Study|subject moved out of the area|0|||
37996287|NCT00068692|69681070|FG000|Step 1: Registration|Disese progression/relapse|5|||
37996288|NCT00068692|69681071|FG001|Step 1: Registration|Disese progression/relapse|0|||
37897975|NCT00988208|69583209|FG001|Overall Study|Withdrawal by Subject|57|||
37897976|NCT00988208|69583208|FG000|Overall Study|Death|9|||
37897977|NCT00988208|69583209|FG001|Overall Study|Death|15|||
37897978|NCT00988208|69583208|FG000|Overall Study|Lost to Follow-up|2|||
37897979|NCT00988208|69583209|FG001|Overall Study|Lost to Follow-up|3|||
37897980|NCT00988208|69583208|FG000|Overall Study|Protocol Violation|9|||
37897981|NCT00988208|69583209|FG001|Overall Study|Protocol Violation|2|||
37897982|NCT00988208|69583208|FG000|Overall Study|Sponsor Decision|102|||
37897983|NCT00988208|69583209|FG001|Overall Study|Sponsor Decision|78|||
37897984|NCT00988208|69583208|FG000|Overall Study|Clinical Progression|17|||
37897985|NCT00988208|69583209|FG001|Overall Study|Clinical Progression|16|||
37897986|NCT00988208|69583208|FG000|Overall Study|Biochemical Progression|21|||
37996289|NCT00068692|69681072|FG002|Step 1: Registration|Disese progression/relapse|0|||
37996290|NCT00068692|69681073|FG003|Step 1: Registration|Disese progression/relapse|0|||
37826403|NCT00475735|69509138|FG003|Treatment Period 2|Withdrawal by Subject|0|||
37826404|NCT00475735|69509139|FG004|Treatment Period 2|Withdrawal by Subject|1|||
37826405|NCT00475735|69509140|FG005|Treatment Period 2|Withdrawal by Subject|0|||
37826406|NCT00475657|69509148|FG000|Overall Study|Death|1|||
37826407|NCT00475657|69509148|FG000|Overall Study|Sponsor's Decision|3|||
37826408|NCT00475423|69509152|FG000|Overall Study|Protocol Violation|5|||
37826409|NCT00475423|69509152|FG000|Overall Study|Adverse Event|4|||
37826410|NCT00475423|69509152|FG000|Overall Study|Withdrawal by Subject|6|||
37826411|NCT00475423|69509152|FG000|Overall Study|Lack of Efficacy|8|||
37826412|NCT00475423|69509152|FG000|Overall Study|Death|1|||
37826413|NCT00475423|69509152|FG000|Overall Study|Reason not specified|1|||
37826414|NCT00475423|69509152|FG000|Overall Study|Lost to Follow-up|7|||
37826415|NCT00475306|69509160|FG000|Overall Study|Protocol Violation|1|||
37826416|NCT00475306|69509161|FG001|Overall Study|Protocol Violation|1|||
37826417|NCT00475306|69509162|FG002|Overall Study|Protocol Violation|0|||
37826418|NCT00475306|69509163|FG003|Overall Study|Protocol Violation|1|||
37826419|NCT00475228|69509175|FG000|Overall Study|Lost to Follow-up|17|||
37826420|NCT00475228|69509176|FG001|Overall Study|Lost to Follow-up|17|||
37826421|NCT05186311|69509204|FG000|Part A: Serum|Withdrawal by Subject|1|||
37826422|NCT04854434|69509212|FG000|Overall Study|Death|1|||
37826423|NCT04854434|69509213|FG001|Overall Study|Death|3|||
37826424|NCT04854434|69509214|FG002|Overall Study|Death|4|||
37826425|NCT04854434|69509212|FG000|Overall Study|Study Terminated by Sponsor|2|||
37826426|NCT04854434|69509213|FG001|Overall Study|Study Terminated by Sponsor|0|||
37826427|NCT04854434|69509214|FG002|Overall Study|Study Terminated by Sponsor|0|||
37826428|NCT04854434|69509212|FG000|Overall Study|Other|1|||
37826429|NCT04854434|69509213|FG001|Overall Study|Other|1|||
37826430|NCT04854434|69509214|FG002|Overall Study|Other|0|||
37826431|NCT03797014|69509249|FG000|Overall Study|Withdrawal by Subject|1|||
37826432|NCT03797014|69509249|FG000|Overall Study|Lost to Follow-up|1|||
37826433|NCT03797014|69509249|FG000|Overall Study|Protocol Violation|1|||
37826434|NCT03596450|69509255|FG000|Overall Study|Death|4|||
37826435|NCT03596450|69509256|FG001|Overall Study|Death|4|||
37826436|NCT03596450|69509255|FG000|Overall Study|Protocol Violation|7|||
37826437|NCT03596450|69509256|FG001|Overall Study|Protocol Violation|12|||
37826438|NCT03596450|69509255|FG000|Overall Study|Lost to Follow-up|7|||
37826439|NCT03596450|69509256|FG001|Overall Study|Lost to Follow-up|6|||
37826440|NCT03596450|69509255|FG000|Overall Study|Adverse Event|9|||
37826441|NCT03596450|69509256|FG001|Overall Study|Adverse Event|6|||
37826442|NCT03596450|69509255|FG000|Overall Study|Withdrawal by Subject|16|||
37826443|NCT03596450|69509256|FG001|Overall Study|Withdrawal by Subject|9|||
37826444|NCT03596450|69509255|FG000|Overall Study|Accidentally Randomized|2|||
37826445|NCT03596450|69509256|FG001|Overall Study|Accidentally Randomized|0|||
37826446|NCT03596450|69509255|FG000|Overall Study|Other reasons|21|||
37826447|NCT03596450|69509256|FG001|Overall Study|Other reasons|22|||
37996291|NCT00068692|69681074|FG004|Step 1: Registration|Disese progression/relapse|0|||
37996292|NCT00068692|69681075|FG005|Step 1: Registration|Disese progression/relapse|0|||
37826448|NCT03596450|69509255|FG000|Overall Study|Missed the Year 1 study visit|56|||
37826449|NCT03596450|69509256|FG001|Overall Study|Missed the Year 1 study visit|50|||
37826450|NCT03300817|69509271|FG000|Overall Study|Withdrawal by Subject|1|||
37826451|NCT03300817|69509271|FG000|Overall Study|Adverse Event|1|||
37826452|NCT03300817|69509271|FG000|Overall Study|Subject Found to be Ineligible|2|||
37826453|NCT02948842|69509301|FG000|Overall Study|Withdrawal by Subject|4|||
37826454|NCT02782468|69509309|FG000|Overall Study|Progressive Disease|2|||
37826455|NCT02782468|69509310|FG001|Overall Study|Progressive Disease|5|||
37826456|NCT02782468|69509311|FG002|Overall Study|Progressive Disease|0|||
37826457|NCT02782468|69509312|FG003|Overall Study|Progressive Disease|4|||
37897987|NCT00988208|69583209|FG001|Overall Study|Biochemical Progression|7|||
37897988|NCT00988208|69583208|FG000|Overall Study|Clinical Deterioration|7|||
37897989|NCT00988208|69583209|FG001|Overall Study|Clinical Deterioration|14|||
37897990|NCT00988208|69583208|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
37897991|NCT00988208|69583209|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
37826458|NCT02782468|69509309|FG000|Overall Study|Adverse Event|0|||
37826459|NCT02782468|69509310|FG001|Overall Study|Adverse Event|2|||
37826460|NCT02782468|69509311|FG002|Overall Study|Adverse Event|2|||
37826461|NCT02782468|69509312|FG003|Overall Study|Adverse Event|3|||
37826462|NCT02782468|69509309|FG000|Overall Study|Other|0|||
37826463|NCT02782468|69509310|FG001|Overall Study|Other|0|||
37826464|NCT02782468|69509311|FG002|Overall Study|Other|1|||
37826465|NCT02782468|69509312|FG003|Overall Study|Other|1|||
37826466|NCT02782468|69509309|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
37826467|NCT02782468|69509310|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
37826468|NCT02782468|69509311|FG002|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
37826469|NCT02782468|69509312|FG003|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|1|||
37826470|NCT02782468|69509309|FG000|Overall Study|Symptomatic Deterioration|0|||
37826471|NCT02782468|69509310|FG001|Overall Study|Symptomatic Deterioration|0|||
37826472|NCT02782468|69509311|FG002|Overall Study|Symptomatic Deterioration|0|||
37826473|NCT02782468|69509312|FG003|Overall Study|Symptomatic Deterioration|1|||
37826474|NCT02782468|69509309|FG000|Overall Study|Withdrawal by Subject|1|||
37826475|NCT02782468|69509310|FG001|Overall Study|Withdrawal by Subject|0|||
37826476|NCT02782468|69509311|FG002|Overall Study|Withdrawal by Subject|0|||
37826477|NCT02782468|69509312|FG003|Overall Study|Withdrawal by Subject|0|||
37826478|NCT02563769|69509334|FG000|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
37826479|NCT02563769|69509335|FG001|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
37826480|NCT02563769|69509336|FG002|Added 750mg Dose of CLAV (Day 5)|Physician Decision|1|||
37826481|NCT02420717|69509372|FG000|Overall Study|Did not receive all study medication|2|||
37826482|NCT02420717|69509373|FG001|Overall Study|Did not receive all study medication|0|||
37826483|NCT02420717|69509374|FG002|Overall Study|Did not receive all study medication|0|||
37996293|NCT00068692|69681076|FG006|Step 1: Registration|Disese progression/relapse|0|||
37996294|NCT00068692|69681077|FG007|Step 1: Registration|Disese progression/relapse|0|||
37996295|NCT00068692|69681070|FG000|Step 1: Registration|Adverse Event|7|||
37996296|NCT00068692|69681071|FG001|Step 1: Registration|Adverse Event|0|||
37996297|NCT00068692|69681072|FG002|Step 1: Registration|Adverse Event|0|||
37996298|NCT00068692|69681073|FG003|Step 1: Registration|Adverse Event|0|||
37996299|NCT00068692|69681074|FG004|Step 1: Registration|Adverse Event|0|||
37996300|NCT00068692|69681075|FG005|Step 1: Registration|Adverse Event|0|||
37996301|NCT00068692|69681076|FG006|Step 1: Registration|Adverse Event|0|||
37897992|NCT00988208|69583208|FG000|Overall Study|Other|8|||
37897993|NCT00988208|69583209|FG001|Overall Study|Other|3|||
37897994|NCT00990704|69583217|FG000|Overall Study|Adverse Event|1|||
37996302|NCT00068692|69681077|FG007|Step 1: Registration|Adverse Event|0|||
37996303|NCT00068692|69681070|FG000|Step 1: Registration|Death|1|||
37897995|NCT00990704|69583218|FG001|Overall Study|Adverse Event|1|||
37897996|NCT00990704|69583217|FG000|Overall Study|Physician Decision|0|||
37897997|NCT00990704|69583218|FG001|Overall Study|Physician Decision|1|||
37897998|NCT04089553|69583226|FG000|Overall Study|Death|12|||
37897999|NCT04089553|69583227|FG001|Overall Study|Death|11|||
37898000|NCT04089553|69583226|FG000|Overall Study|Lost to Follow-up|2|||
37898001|NCT04089553|69583227|FG001|Overall Study|Lost to Follow-up|2|||
37898002|NCT04089553|69583226|FG000|Overall Study|Progressive disease|0|||
37898003|NCT04089553|69583227|FG001|Overall Study|Progressive disease|1|||
37898004|NCT04089553|69583226|FG000|Overall Study|Withdrawal by Subject|5|||
37898005|NCT04089553|69583227|FG001|Overall Study|Withdrawal by Subject|2|||
37898006|NCT04089553|69583226|FG000|Overall Study|Other|6|||
37898007|NCT04089553|69583227|FG001|Overall Study|Other|2|||
37898008|NCT00993668|69583236|FG000|Single-Blind Period|Adverse Event|1|||
37898009|NCT00993668|69583237|FG001|Single-Blind Period|Adverse Event|1|||
37898010|NCT00993668|69583236|FG000|Single-Blind Period|Lack of Efficacy|0|||
37898011|NCT00993668|69583237|FG001|Single-Blind Period|Lack of Efficacy|1|||
37898012|NCT00993668|69583236|FG000|Single-Blind Period|Lost to Follow-up|3|||
37898013|NCT00993668|69583237|FG001|Single-Blind Period|Lost to Follow-up|1|||
37898014|NCT00993668|69583236|FG000|Open-Label Period|Adverse Event|9|||
37996304|NCT00068692|69681071|FG001|Step 1: Registration|Death|0|||
37996305|NCT00068692|69681072|FG002|Step 1: Registration|Death|0|||
37996306|NCT00068692|69681073|FG003|Step 1: Registration|Death|0|||
37996307|NCT00068692|69681074|FG004|Step 1: Registration|Death|0|||
37996308|NCT00068692|69681075|FG005|Step 1: Registration|Death|0|||
37898015|NCT00993668|69583237|FG001|Open-Label Period|Adverse Event|8|||
37898016|NCT00993668|69583236|FG000|Open-Label Period|Lack of Efficacy|4|||
37898017|NCT00993668|69583237|FG001|Open-Label Period|Lack of Efficacy|3|||
37898018|NCT00993668|69583236|FG000|Open-Label Period|Withdrawal by Subject|4|||
37898019|NCT00993668|69583237|FG001|Open-Label Period|Withdrawal by Subject|3|||
37898020|NCT00993668|69583236|FG000|Open-Label Period|Lost to Follow-up|6|||
37898021|NCT00993668|69583237|FG001|Open-Label Period|Lost to Follow-up|1|||
37996309|NCT00068692|69681076|FG006|Step 1: Registration|Death|0|||
37996310|NCT00068692|69681077|FG007|Step 1: Registration|Death|0|||
37996311|NCT00068692|69681070|FG000|Step 1: Registration|Withdrawal by Subject|11|||
37996312|NCT00068692|69681071|FG001|Step 1: Registration|Withdrawal by Subject|0|||
37898022|NCT00778102|69583246|FG000|Overall Study|Adverse Event|8|||
37898023|NCT00778102|69583247|FG001|Overall Study|Adverse Event|5|||
37898024|NCT00778102|69583246|FG000|Overall Study|Death|1|||
37898025|NCT00778102|69583247|FG001|Overall Study|Death|1|||
37898026|NCT00778102|69583246|FG000|Overall Study|Lost to Follow-up|1|||
37898027|NCT00778102|69583247|FG001|Overall Study|Lost to Follow-up|0|||
37898028|NCT00778102|69583246|FG000|Overall Study|Violation of Selection Criteria|1|||
37898029|NCT00778102|69583247|FG001|Overall Study|Violation of Selection Criteria|1|||
37696540|NCT01829230|69172646|FG001|Overall Study|Withdrawal by Subject|1|||
37696541|NCT01829230|69172645|FG000|Overall Study|Lost to Follow-up|1|||
37696542|NCT01829230|69172646|FG001|Overall Study|Lost to Follow-up|1|||
37696543|NCT02269657|69172652|FG000|Overall Study|Protocol Violation|3|||
37996313|NCT00068692|69681072|FG002|Step 1: Registration|Withdrawal by Subject|0|||
37996314|NCT00068692|69681073|FG003|Step 1: Registration|Withdrawal by Subject|0|||
37996315|NCT00068692|69681074|FG004|Step 1: Registration|Withdrawal by Subject|0|||
37996316|NCT00068692|69681075|FG005|Step 1: Registration|Withdrawal by Subject|0|||
37996317|NCT00068692|69681076|FG006|Step 1: Registration|Withdrawal by Subject|0|||
37996318|NCT00068692|69681077|FG007|Step 1: Registration|Withdrawal by Subject|0|||
37996319|NCT00068692|69681070|FG000|Step 1: Registration|Alternative therapy|2|||
37996320|NCT00068692|69681071|FG001|Step 1: Registration|Alternative therapy|0|||
37996321|NCT00068692|69681072|FG002|Step 1: Registration|Alternative therapy|0|||
37996322|NCT00068692|69681073|FG003|Step 1: Registration|Alternative therapy|0|||
37996323|NCT00068692|69681074|FG004|Step 1: Registration|Alternative therapy|0|||
37996324|NCT00068692|69681075|FG005|Step 1: Registration|Alternative therapy|0|||
37996325|NCT00068692|69681076|FG006|Step 1: Registration|Alternative therapy|0|||
37996326|NCT00068692|69681077|FG007|Step 1: Registration|Alternative therapy|0|||
37996327|NCT00068692|69681070|FG000|Step 1: Registration|Complicating disease|2|||
37996328|NCT00068692|69681071|FG001|Step 1: Registration|Complicating disease|0|||
37996329|NCT00068692|69681072|FG002|Step 1: Registration|Complicating disease|0|||
37826514|NCT02126579|69509416|FG000|Overall Study|disease progression|0|||
37826515|NCT02126579|69509417|FG001|Overall Study|disease progression|0|||
37826516|NCT02126579|69509418|FG002|Overall Study|disease progression|0|||
37826517|NCT02126579|69509419|FG003|Overall Study|disease progression|1|||
37826518|NCT02126579|69509420|FG004|Overall Study|disease progression|0|||
37826519|NCT02126579|69509421|FG005|Overall Study|disease progression|0|||
37826520|NCT02126579|69509422|FG006|Overall Study|disease progression|1|||
37826521|NCT01970306|69509440|FG000|Overall Study|Not eligible|3|||
37826522|NCT01970306|69509440|FG000|Overall Study|Not able to be treated|9|||
37826523|NCT01574274|69509446|FG000|Overall Study|Ineligible|0|||
37826524|NCT01574274|69509447|FG001|Overall Study|Ineligible|1|||
37826525|NCT01574274|69509446|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
37826526|NCT01574274|69509447|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
37826527|NCT01574274|69509446|FG000|Overall Study|Ph+ B-ALL|3|||
37826528|NCT01574274|69509447|FG001|Overall Study|Ph+ B-ALL|4|||
37826529|NCT01574274|69509446|FG000|Overall Study|Induction Death|2|||
37826530|NCT01574274|69509447|FG001|Overall Study|Induction Death|0|||
37826531|NCT01574274|69509446|FG000|Overall Study|Induction Failure|4|||
37826532|NCT01574274|69509447|FG001|Overall Study|Induction Failure|1|||
37826533|NCT01574274|69509446|FG000|Overall Study|Adverse Event|16|||
37826534|NCT01574274|69509447|FG001|Overall Study|Adverse Event|13|||
37826535|NCT01574274|69509446|FG000|Overall Study|Remission Death|1|||
37826536|NCT01574274|69509447|FG001|Overall Study|Remission Death|0|||
37898030|NCT00778102|69583246|FG000|Overall Study|Protocol Violation|0|||
37898031|NCT00778102|69583247|FG001|Overall Study|Protocol Violation|1|||
37696544|NCT02269423|69172662|FG000|Overall Study|Discontinued due to change in residence|0|||
37696545|NCT02269423|69172663|FG001|Overall Study|Discontinued due to change in residence|1|||
37696546|NCT02269423|69172664|FG002|Overall Study|Discontinued due to change in residence|0|||
37696547|NCT02269423|69172665|FG003|Overall Study|Discontinued due to change in residence|1|||
37696548|NCT01827670|69172677|FG000|Overall Study|Withdrawal of Consent|3|||
37696549|NCT01827670|69172678|FG001|Overall Study|Withdrawal of Consent|2|||
37696550|NCT01827670|69172677|FG000|Overall Study|Lost to Follow-up|0|||
37826537|NCT01574274|69509446|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
37826538|NCT01574274|69509447|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
37826539|NCT01574274|69509446|FG000|Overall Study|Other, unknown|3|||
37826540|NCT01574274|69509447|FG001|Overall Study|Other, unknown|2|||
37826541|NCT01268514|69509457|FG000|Overall Study|Adverse Event|20|||
37826542|NCT01268514|69509457|FG000|Overall Study|Death|8|||
37826543|NCT01268514|69509457|FG000|Overall Study|Lost to Follow-up|5|||
37826544|NCT01268514|69509457|FG000|Overall Study|Withdrawal by Subject|3|||
37826545|NCT01268514|69509457|FG000|Overall Study|Withdrawal by Surgeon|5|||
37898032|NCT00778102|69583246|FG000|Overall Study|Refused Treatment|2|||
37898033|NCT00778102|69583247|FG001|Overall Study|Refused Treatment|3|||
37996330|NCT00068692|69681073|FG003|Step 1: Registration|Complicating disease|0|||
37996331|NCT00068692|69681074|FG004|Step 1: Registration|Complicating disease|0|||
37996332|NCT00068692|69681075|FG005|Step 1: Registration|Complicating disease|0|||
37696551|NCT01827670|69172678|FG001|Overall Study|Lost to Follow-up|1|||
37696552|NCT02267317|69172692|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
37696553|NCT02267317|69172693|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
37696554|NCT02267317|69172694|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
37696555|NCT02267317|69172695|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
37696556|NCT02267317|69172696|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
37696557|NCT02267317|69172697|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
37696558|NCT02267317|69172692|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
37696559|NCT02267317|69172693|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
37696560|NCT02267317|69172694|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
37696561|NCT02267317|69172695|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
37696562|NCT02267317|69172696|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
37696563|NCT02267317|69172697|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
37696564|NCT01844830|69172713|FG000|Overall Study|Withdrawal by Subject|1|||
37898034|NCT00778102|69583246|FG000|Overall Study|Withdrawal by Subject|1|||
37898035|NCT00778102|69583247|FG001|Overall Study|Withdrawal by Subject|1|||
37898036|NCT00778102|69583246|FG000|Overall Study|Administrative Reason|7|||
37898037|NCT00778102|69583247|FG001|Overall Study|Administrative Reason|10|||
37898038|NCT00756886|69583255|FG000|Overall Study|Lost to Follow-up|1|||
37898039|NCT00756886|69583256|FG001|Overall Study|Lost to Follow-up|0|||
37898040|NCT00756886|69583255|FG000|Overall Study|Adverse Event|0|||
37898041|NCT00756886|69583256|FG001|Overall Study|Adverse Event|3|||
37898042|NCT00756886|69583255|FG000|Overall Study|Lack of Efficacy|1|||
37898043|NCT00756886|69583256|FG001|Overall Study|Lack of Efficacy|0|||
37696565|NCT01844830|69172714|FG001|Overall Study|Withdrawal by Subject|0|||
37696566|NCT01827592|69172723|FG000|Overall Study|Adverse Event|11|||
37898044|NCT00756886|69583255|FG000|Overall Study|Ineligible|9|||
37898045|NCT00756886|69583256|FG001|Overall Study|Ineligible|4|||
37898046|NCT00756730|69583264|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
37898047|NCT00756730|69583265|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
37898048|NCT00756730|69583264|FG000|Overall Study|persistent low-level viremmia|0|||
37898049|NCT00756730|69583265|FG001|Overall Study|persistent low-level viremmia|1|||
37898050|NCT00984620|69583273|FG000|Overall Study|Adverse Event|5|||
37898051|NCT00984620|69583274|FG001|Overall Study|Adverse Event|5|||
37898052|NCT00984620|69583273|FG000|Overall Study|Lost to Follow-up|1|||
37898053|NCT00984620|69583274|FG001|Overall Study|Lost to Follow-up|1|||
37898054|NCT00984620|69583273|FG000|Overall Study|Withdrawal by Subject|0|||
37898055|NCT00984620|69583274|FG001|Overall Study|Withdrawal by Subject|2|||
37996333|NCT00068692|69681076|FG006|Step 1: Registration|Complicating disease|0|||
37996334|NCT00068692|69681077|FG007|Step 1: Registration|Complicating disease|0|||
37996335|NCT00068692|69681070|FG000|Step 1: Registration|Protocol Violation|1|||
37996336|NCT00068692|69681071|FG001|Step 1: Registration|Protocol Violation|0|||
37996337|NCT00068692|69681072|FG002|Step 1: Registration|Protocol Violation|0|||
37996338|NCT00068692|69681073|FG003|Step 1: Registration|Protocol Violation|0|||
37996339|NCT00068692|69681074|FG004|Step 1: Registration|Protocol Violation|0|||
37996340|NCT00068692|69681075|FG005|Step 1: Registration|Protocol Violation|0|||
37996341|NCT00068692|69681076|FG006|Step 1: Registration|Protocol Violation|0|||
37996342|NCT00068692|69681077|FG007|Step 1: Registration|Protocol Violation|0|||
37996343|NCT00068692|69681070|FG000|Step 1: Registration|Not eligible|6|||
37696567|NCT01827592|69172724|FG001|Overall Study|Adverse Event|9|||
37696568|NCT01827592|69172725|FG002|Overall Study|Adverse Event|2|||
37696569|NCT01827592|69172723|FG000|Overall Study|Physician Decision|0|||
37696570|NCT01827592|69172724|FG001|Overall Study|Physician Decision|2|||
37696571|NCT01827592|69172725|FG002|Overall Study|Physician Decision|1|||
37996344|NCT00068692|69681071|FG001|Step 1: Registration|Not eligible|0|||
37996345|NCT00068692|69681072|FG002|Step 1: Registration|Not eligible|0|||
37996346|NCT00068692|69681073|FG003|Step 1: Registration|Not eligible|0|||
37996347|NCT00068692|69681074|FG004|Step 1: Registration|Not eligible|0|||
37696572|NCT01827592|69172723|FG000|Overall Study|Protocol Violation|2|||
37898056|NCT00984620|69583273|FG000|Overall Study|reason other than listed above|0|||
37696573|NCT01827592|69172724|FG001|Overall Study|Protocol Violation|1|||
37696574|NCT01827592|69172725|FG002|Overall Study|Protocol Violation|0|||
37898057|NCT00984620|69583274|FG001|Overall Study|reason other than listed above|4|||
37826552|NCT00625586|69509481|FG000|Overall Study|Adverse Event|1|||
37826553|NCT00625586|69509481|FG000|Overall Study|Progressive disease|1|||
37826554|NCT00400946|69509490|FG000|Overall Study|Ineligible|0|||
37826555|NCT00400946|69509491|FG001|Overall Study|Ineligible|0|||
37826556|NCT00400946|69509492|FG002|Overall Study|Ineligible|0|||
37826557|NCT00400946|69509493|FG003|Overall Study|Ineligible|5|||
37826558|NCT00400946|69509494|FG004|Overall Study|Ineligible|1|||
37826559|NCT00400946|69509490|FG000|Overall Study|Induction Failure|0|||
37826560|NCT00400946|69509491|FG001|Overall Study|Induction Failure|0|||
37826561|NCT00400946|69509492|FG002|Overall Study|Induction Failure|0|||
37826562|NCT00400946|69509493|FG003|Overall Study|Induction Failure|11|||
37826563|NCT00400946|69509494|FG004|Overall Study|Induction Failure|8|||
37826564|NCT00400946|69509490|FG000|Overall Study|Induction Death|0|||
37826565|NCT00400946|69509491|FG001|Overall Study|Induction Death|0|||
37826566|NCT00400946|69509492|FG002|Overall Study|Induction Death|0|||
37826567|NCT00400946|69509493|FG003|Overall Study|Induction Death|13|||
37826568|NCT00400946|69509494|FG004|Overall Study|Induction Death|3|||
37826569|NCT00400946|69509490|FG000|Overall Study|Lost to Follow-up|1|||
37826570|NCT00400946|69509491|FG001|Overall Study|Lost to Follow-up|1|||
37826571|NCT00400946|69509492|FG002|Overall Study|Lost to Follow-up|0|||
37826572|NCT00400946|69509493|FG003|Overall Study|Lost to Follow-up|0|||
37826573|NCT00400946|69509494|FG004|Overall Study|Lost to Follow-up|1|||
37898058|NCT00777946|69583285|FG000|Overall Study|Adverse Event|11|||
37898059|NCT00777946|69583286|FG001|Overall Study|Adverse Event|1|||
37898060|NCT00777946|69583287|FG002|Overall Study|Adverse Event|3|||
37898061|NCT00777946|69583285|FG000|Overall Study|Lack of Efficacy|0|||
37898062|NCT00777946|69583286|FG001|Overall Study|Lack of Efficacy|0|||
37898063|NCT00777946|69583287|FG002|Overall Study|Lack of Efficacy|9|||
37898064|NCT00777946|69583285|FG000|Overall Study|Condition no longer required study drug|1|||
37898065|NCT00777946|69583286|FG001|Overall Study|Condition no longer required study drug|0|||
37898066|NCT00777946|69583287|FG002|Overall Study|Condition no longer required study drug|0|||
37898067|NCT00777946|69583285|FG000|Overall Study|Patient withdrew consent|3|||
37898068|NCT00777946|69583286|FG001|Overall Study|Patient withdrew consent|2|||
37898069|NCT00777946|69583287|FG002|Overall Study|Patient withdrew consent|3|||
37898070|NCT00777946|69583285|FG000|Overall Study|Lost to Follow-up|3|||
37898071|NCT00777946|69583286|FG001|Overall Study|Lost to Follow-up|1|||
37898072|NCT00777946|69583287|FG002|Overall Study|Lost to Follow-up|0|||
37898073|NCT00777946|69583285|FG000|Overall Study|Protocol deviation|2|||
37898074|NCT00777946|69583286|FG001|Overall Study|Protocol deviation|1|||
37898075|NCT00777946|69583287|FG002|Overall Study|Protocol deviation|1|||
37898076|NCT00777946|69583285|FG000|Overall Study|Randomized in error|1|||
37898077|NCT00777946|69583286|FG001|Overall Study|Randomized in error|1|||
37898078|NCT00777946|69583287|FG002|Overall Study|Randomized in error|0|||
37898079|NCT00990314|69583295|FG000|Overall Study|Death|2|||
37898080|NCT00990314|69583295|FG000|Overall Study|Adverse Event|2|||
37898081|NCT00990314|69583295|FG000|Overall Study|Withdrawal by Subject|3|||
37898082|NCT00990314|69583295|FG000|Overall Study|Non-Compliance|1|||
37898083|NCT00990314|69583295|FG000|Overall Study|Physician Decision|3|||
37898084|NCT00990314|69583295|FG000|Overall Study|Lack of Efficacy|1|||
37826574|NCT00400946|69509490|FG000|Overall Study|Remission Death|1|||
37826575|NCT00400946|69509491|FG001|Overall Study|Remission Death|1|||
37826576|NCT00400946|69509492|FG002|Overall Study|Remission Death|0|||
37826577|NCT00400946|69509493|FG003|Overall Study|Remission Death|0|||
37826578|NCT00400946|69509494|FG004|Overall Study|Remission Death|1|||
37826579|NCT00400946|69509490|FG000|Overall Study|Relapse|9|||
37826580|NCT00400946|69509491|FG001|Overall Study|Relapse|2|||
37826581|NCT00400946|69509492|FG002|Overall Study|Relapse|1|||
37826582|NCT00400946|69509493|FG003|Overall Study|Relapse|1|||
37826583|NCT00400946|69509494|FG004|Overall Study|Relapse|5|||
37826584|NCT00400946|69509490|FG000|Overall Study|Transplant in CR1|0|||
37826585|NCT00400946|69509491|FG001|Overall Study|Transplant in CR1|0|||
37826586|NCT00400946|69509492|FG002|Overall Study|Transplant in CR1|0|||
37826587|NCT00400946|69509493|FG003|Overall Study|Transplant in CR1|10|||
37826588|NCT00400946|69509494|FG004|Overall Study|Transplant in CR1|1|||
37826589|NCT00400946|69509490|FG000|Overall Study|Withdrawal by Subject|2|||
37826590|NCT00400946|69509491|FG001|Overall Study|Withdrawal by Subject|5|||
37826591|NCT00400946|69509492|FG002|Overall Study|Withdrawal by Subject|1|||
37826592|NCT00400946|69509493|FG003|Overall Study|Withdrawal by Subject|5|||
37826593|NCT00400946|69509494|FG004|Overall Study|Withdrawal by Subject|8|||
37826594|NCT00400946|69509490|FG000|Overall Study|Clinical|1|||
37826595|NCT00400946|69509491|FG001|Overall Study|Clinical|2|||
37826596|NCT00400946|69509492|FG002|Overall Study|Clinical|0|||
37826597|NCT00400946|69509493|FG003|Overall Study|Clinical|2|||
37826598|NCT00400946|69509494|FG004|Overall Study|Clinical|9|||
37826599|NCT00400946|69509490|FG000|Overall Study|Other|0|||
37826600|NCT00400946|69509491|FG001|Overall Study|Other|0|||
37826601|NCT00400946|69509492|FG002|Overall Study|Other|0|||
37826602|NCT00400946|69509493|FG003|Overall Study|Other|0|||
37826603|NCT00400946|69509494|FG004|Overall Study|Other|1|||
37826604|NCT00475033|69509514|FG000|Infant Series|Failed to return|3|||
37826605|NCT00475033|69509515|FG001|Infant Series|Failed to return|4|||
37826606|NCT00475033|69509514|FG000|Infant Series|Parent or legal guardian request|1|||
37826607|NCT00475033|69509515|FG001|Infant Series|Parent or legal guardian request|5|||
37898085|NCT00756652|69583301|FG000|Original Phase|Withdrawal by Subject|864|||
37898086|NCT00756652|69583302|FG001|Original Phase|Withdrawal by Subject|23|||
37898087|NCT00756652|69583301|FG000|Original Phase|Lost to Follow-up|601|||
37898088|NCT00756652|69583302|FG001|Original Phase|Lost to Follow-up|0|||
37898089|NCT00756652|69583301|FG000|Original Phase|Other Discontinuation|797|||
37826608|NCT00475033|69509514|FG000|Infant Series|Protocol Violation|1|||
37826609|NCT00475033|69509515|FG001|Infant Series|Protocol Violation|2|||
37826610|NCT00475033|69509514|FG000|Infant Series|Lost to Follow-up|2|||
37826611|NCT00475033|69509515|FG001|Infant Series|Lost to Follow-up|0|||
37826612|NCT00475033|69509514|FG000|Infant Series|Adverse Event|0|||
37826613|NCT00475033|69509515|FG001|Infant Series|Adverse Event|2|||
37898090|NCT00756652|69583302|FG001|Original Phase|Other Discontinuation|5|||
37898091|NCT00756652|69583301|FG000|Original Phase|Participant Noncompliance|18622|||
37898092|NCT00756652|69583302|FG001|Original Phase|Participant Noncompliance|424|||
37826614|NCT00475033|69509514|FG000|After the Infant Series|Adverse Event|0|||
37826615|NCT00475033|69509515|FG001|After the Infant Series|Adverse Event|4|||
37826616|NCT00475033|69509514|FG000|After the Infant Series|Parent or legal guardian request|2|||
37898093|NCT00756652|69583301|FG000|Original Phase|Unknown Discontinuation Reason|2|||
37898094|NCT00756652|69583302|FG001|Original Phase|Unknown Discontinuation Reason|0|||
37898095|NCT00756652|69583301|FG000|Original Phase|Participants without data|3259|||
37898096|NCT00756652|69583302|FG001|Original Phase|Participants without data|466|||
37898097|NCT00756652|69583301|FG000|Original Phase|Death|168|||
37826617|NCT00475033|69509515|FG001|After the Infant Series|Parent or legal guardian request|2|||
37826618|NCT00475033|69509514|FG000|After the Infant Series|Failed to return|2|||
37826619|NCT00475033|69509515|FG001|After the Infant Series|Failed to return|1|||
37898098|NCT00756652|69583302|FG001|Original Phase|Death|1|||
37898099|NCT00756652|69583301|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
37898100|NCT00756652|69583302|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
37898101|NCT00756652|69583301|FG000|Re-Op Phase|Withdrawal by Subject|62|||
37898102|NCT00756652|69583302|FG001|Re-Op Phase|Withdrawal by Subject|0|||
37898103|NCT00756652|69583301|FG000|Re-Op Phase|Death|6|||
37898104|NCT00756652|69583302|FG001|Re-Op Phase|Death|0|||
37898105|NCT00756652|69583301|FG000|Re-Op Phase|Lost to Follow-up|340|||
37898106|NCT00756652|69583302|FG001|Re-Op Phase|Lost to Follow-up|0|||
37898107|NCT00756652|69583301|FG000|Re-Op Phase|Site Closed|2454|||
37898108|NCT00756652|69583302|FG001|Re-Op Phase|Site Closed|0|||
37898109|NCT00756652|69583301|FG000|Re-Op Phase|Withdrawn after explant|14|||
37898110|NCT00756652|69583302|FG001|Re-Op Phase|Withdrawn after explant|0|||
37826620|NCT00475033|69509514|FG000|After the Infant Series|Protocol Violation|1|||
37826621|NCT00475033|69509515|FG001|After the Infant Series|Protocol Violation|0|||
37826622|NCT00475033|69509514|FG000|After the Infant Series|Lost to Follow-up|1|||
37826623|NCT00475033|69509515|FG001|After the Infant Series|Lost to Follow-up|0|||
37826624|NCT00475033|69509514|FG000|After the Infant Series|Other|0|||
37826625|NCT00475033|69509515|FG001|After the Infant Series|Other|1|||
37826626|NCT00475033|69509514|FG000|Toddler Dose|Parent or legal guardian request|2|||
37826627|NCT00475033|69509515|FG001|Toddler Dose|Parent or legal guardian request|0|||
37898111|NCT00777556|69583306|FG000|Overall Study|Inappropriate self-selection|34|||
37898112|NCT00777556|69583306|FG000|Overall Study|Dispensed but did not use product|12|||
37898113|NCT00777556|69583306|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
37898114|NCT00602979|69583315|FG000|Overall Study|Lost to Follow-up|3|||
37898115|NCT00602979|69583316|FG001|Overall Study|Lost to Follow-up|2|||
37898116|NCT00602979|69583317|FG002|Overall Study|Lost to Follow-up|3|||
37898117|NCT00602979|69583318|FG003|Overall Study|Lost to Follow-up|2|||
37898118|NCT00602979|69583319|FG004|Overall Study|Lost to Follow-up|3|||
37898119|NCT00602979|69583315|FG000|Overall Study|Failed Intubation|0|||
37898120|NCT00602979|69583316|FG001|Overall Study|Failed Intubation|1|||
37898121|NCT00602979|69583317|FG002|Overall Study|Failed Intubation|0|||
37898122|NCT00602979|69583318|FG003|Overall Study|Failed Intubation|1|||
37898123|NCT00602979|69583319|FG004|Overall Study|Failed Intubation|0|||
37898124|NCT04081363|69583333|FG000|Overall Study|Withdrawal by Subject|1|||
37898125|NCT04081363|69583334|FG001|Overall Study|Withdrawal by Subject|0|||
37898126|NCT00777088|69583349|FG000|Overall Study|PED Treatment not attempted|1|||
37898127|NCT00763282|69583365|FG000|Overall Study|Withdrawal by Subject|6|||
37898128|NCT00763282|69583366|FG001|Overall Study|Withdrawal by Subject|5|||
37898129|NCT00763282|69583365|FG000|Overall Study|Death|4|||
37898130|NCT00763282|69583366|FG001|Overall Study|Death|3|||
37898131|NCT00763282|69583365|FG000|Overall Study|Lost to Follow-up|22|||
37898132|NCT00763282|69583366|FG001|Overall Study|Lost to Follow-up|26|||
37898133|NCT00988598|69583376|FG000|Overall Study|Withdrawal by Subject|2|||
37898134|NCT00988598|69583377|FG001|Overall Study|Withdrawal by Subject|0|||
37898135|NCT00979628|69583386|FG000|Overall Study|received regimen < 24 hours|7|||
37898136|NCT00979628|69583387|FG001|Overall Study|received regimen < 24 hours|6|||
37898137|NCT00979628|69583388|FG002|Overall Study|received regimen < 24 hours|5|||
37898138|NCT00979628|69583386|FG000|Overall Study|received steroids|1|||
37898139|NCT00979628|69583387|FG001|Overall Study|received steroids|1|||
37898140|NCT00979628|69583388|FG002|Overall Study|received steroids|0|||
37898141|NCT00979628|69583386|FG000|Overall Study|transferred to ICU|1|||
37898142|NCT00979628|69583387|FG001|Overall Study|transferred to ICU|2|||
37898143|NCT00979628|69583388|FG002|Overall Study|transferred to ICU|1|||
37898144|NCT00762970|69583402|FG000|Overall Study|Withdrawal by Subject|7|||
37898145|NCT00762970|69583403|FG001|Overall Study|Withdrawal by Subject|4|||
37898146|NCT00762970|69583404|FG002|Overall Study|Withdrawal by Subject|0|||
37898147|NCT00762970|69583402|FG000|Overall Study|Protocol Violation|3|||
37898148|NCT00762970|69583403|FG001|Overall Study|Protocol Violation|1|||
37898149|NCT00762970|69583404|FG002|Overall Study|Protocol Violation|1|||
37898150|NCT00762970|69583402|FG000|Overall Study|Lost to Follow-up|1|||
37898151|NCT00762970|69583403|FG001|Overall Study|Lost to Follow-up|2|||
37898152|NCT00762970|69583404|FG002|Overall Study|Lost to Follow-up|0|||
37898153|NCT00762970|69583402|FG000|Overall Study|Difficulty of handling lens|1|||
37898154|NCT00762970|69583403|FG001|Overall Study|Difficulty of handling lens|2|||
37898155|NCT00762970|69583404|FG002|Overall Study|Difficulty of handling lens|0|||
37898156|NCT00988442|69583414|FG000|Overall Study|Death|1|||
37898157|NCT00988442|69583415|FG001|Overall Study|Death|2|||
37898158|NCT00988442|69583414|FG000|Overall Study|Lost to Follow-up|0|||
37898159|NCT00988442|69583415|FG001|Overall Study|Lost to Follow-up|1|||
37898160|NCT00988442|69583414|FG000|Overall Study|Early Study Closure|29|||
37898161|NCT00988442|69583415|FG001|Overall Study|Early Study Closure|25|||
37898162|NCT03258723|69583424|FG000|Overall Study|COVID Interruption of study|54|||
37898163|NCT03258723|69583424|FG000|Overall Study|Lost to Follow-up|8|||
37898164|NCT00992186|69583428|FG000|Overall Study|Withdrawal by Subject|2|||
37898165|NCT00992186|69583428|FG000|Overall Study|Protocol Violation|1|||
37898166|NCT00992186|69583428|FG000|Overall Study|Physician Decision|1|||
37898167|NCT00992186|69583428|FG000|Overall Study|Adverse Event|9|||
37898168|NCT00992186|69583428|FG000|Overall Study|Progressive Disease|30|||
37898169|NCT00992186|69583428|FG000|Overall Study|Refusal To Receive Study Agent|3|||
37898170|NCT00992108|69583435|FG000|Overall Study|Lost to Follow-up|0|||
37898171|NCT00992108|69583436|FG001|Overall Study|Lost to Follow-up|1|||
37898172|NCT00752986|69583445|FG000|Overall Study|Withdrawal by Subject|2|||
37898173|NCT00752986|69583446|FG001|Overall Study|Withdrawal by Subject|1|||
37898174|NCT00752986|69583447|FG002|Overall Study|Withdrawal by Subject|2|||
37898175|NCT00752986|69583445|FG000|Overall Study|Protocol Violation|3|||
37898176|NCT00752986|69583446|FG001|Overall Study|Protocol Violation|0|||
37898177|NCT00752986|69583447|FG002|Overall Study|Protocol Violation|0|||
37898178|NCT03483103|69583455|FG000|Pre-Treatment Phase|Other reasons|1|||
37898179|NCT03483103|69583455|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
37898180|NCT03483103|69583455|FG000|Pre-Treatment Phase|Disease-related complications|1|||
37898181|NCT03483103|69583455|FG000|Pre-Treatment Phase|Death|5|||
37898182|NCT03483103|69583455|FG000|Treatment Phase|Withdrawal by Subject|6|||
37898183|NCT03483103|69583455|FG000|Treatment Phase|Other reasons|2|||
37898184|NCT03483103|69583455|FG000|Treatment Phase|Death|20|||
37898185|NCT03483103|69583455|FG000|Treatment Phase|Ongoing in study|26|||
37898186|NCT03483103|69583455|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
37898187|NCT03483103|69583455|FG000|Treatment Phase|Received nonconforming product|1|||
37898188|NCT00762892|69583461|FG000|Overall Study|Lost to Follow-up|2|||
37898189|NCT00762892|69583462|FG001|Overall Study|Lost to Follow-up|5|||
37898190|NCT00762892|69583461|FG000|Overall Study|Withdrawal by Subject|0|||
37898191|NCT00762892|69583462|FG001|Overall Study|Withdrawal by Subject|1|||
37898192|NCT00762892|69583461|FG000|Overall Study|Death|1|||
37898193|NCT00762892|69583462|FG001|Overall Study|Death|0|||
37898194|NCT00762892|69583461|FG000|Overall Study|Pregnancy|1|||
37898195|NCT00762892|69583462|FG001|Overall Study|Pregnancy|0|||
37898196|NCT00762892|69583461|FG000|Overall Study|Incarceration|1|||
37696575|NCT01827592|69172723|FG000|Overall Study|Lost to Follow-up|1|||
37696576|NCT01827592|69172724|FG001|Overall Study|Lost to Follow-up|2|||
37696577|NCT01827592|69172725|FG002|Overall Study|Lost to Follow-up|2|||
37696578|NCT01827592|69172723|FG000|Overall Study|Withdrawal by Subject|12|||
37696579|NCT01827592|69172724|FG001|Overall Study|Withdrawal by Subject|11|||
37696580|NCT01827592|69172725|FG002|Overall Study|Withdrawal by Subject|11|||
37696581|NCT01827592|69172723|FG000|Overall Study|Patient's substantial non-compliance|1|||
37696582|NCT01827592|69172724|FG001|Overall Study|Patient's substantial non-compliance|1|||
37696583|NCT01827592|69172725|FG002|Overall Study|Patient's substantial non-compliance|6|||
37996348|NCT00068692|69681075|FG005|Step 1: Registration|Not eligible|0|||
37996349|NCT00068692|69681076|FG006|Step 1: Registration|Not eligible|0|||
37996350|NCT00068692|69681077|FG007|Step 1: Registration|Not eligible|0|||
37996351|NCT00068692|69681070|FG000|Step 1: Registration|Other|2|||
37996352|NCT00068692|69681071|FG001|Step 1: Registration|Other|0|||
37696584|NCT01827592|69172723|FG000|Overall Study|Trial terminated by Sponsor|47|||
37826628|NCT00475033|69509514|FG000|Toddler Dose|Failed to return|1|||
37826629|NCT00475033|69509515|FG001|Toddler Dose|Failed to return|0|||
37826630|NCT00475033|69509514|FG000|Toddler Dose|Lost to Follow-up|1|||
37826631|NCT00475033|69509515|FG001|Toddler Dose|Lost to Follow-up|0|||
37826632|NCT00474994|69509528|FG000|Overall Study|Patient Not treated|1|||
37826633|NCT00474994|69509528|FG000|Overall Study|Patient evaluable for toxicity only|3|||
37826634|NCT00474994|69509528|FG000|Overall Study|Patient found to be ineligible|1|||
37826635|NCT00474955|69509532|FG000|Overall Study|Adverse Event|2|||
37898197|NCT00762892|69583462|FG001|Overall Study|Incarceration|0|||
37898198|NCT00755716|69583471|FG000|Overall Study|Adverse Event|1|||
37898199|NCT00755716|69583472|FG001|Overall Study|Adverse Event|4|||
37898200|NCT00755716|69583473|FG002|Overall Study|Adverse Event|1|||
37898201|NCT00755716|69583471|FG000|Overall Study|Lack of Efficacy|2|||
37898202|NCT00755716|69583472|FG001|Overall Study|Lack of Efficacy|0|||
37898203|NCT00755716|69583473|FG002|Overall Study|Lack of Efficacy|0|||
37898204|NCT00755716|69583471|FG000|Overall Study|Lost to Follow-up|5|||
37898205|NCT00755716|69583472|FG001|Overall Study|Lost to Follow-up|3|||
37898206|NCT00755716|69583473|FG002|Overall Study|Lost to Follow-up|1|||
37898207|NCT00755716|69583471|FG000|Overall Study|work schedule issues|0|||
37898208|NCT00755716|69583472|FG001|Overall Study|work schedule issues|1|||
37898209|NCT00755716|69583473|FG002|Overall Study|work schedule issues|1|||
37898210|NCT00755326|69583483|FG000|Overall Study|Lost to Follow-up|2|||
37898211|NCT00755326|69583484|FG001|Overall Study|Lost to Follow-up|3|||
37898212|NCT03084471|69583491|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
37898213|NCT03084471|69583491|FG000|Overall Study|Condition under investigation worsened|84|||
37898214|NCT03084471|69583491|FG000|Overall Study|Lack of therapeutic response|2|||
37898215|NCT03084471|69583491|FG000|Overall Study|Protocol Violation|1|||
37898216|NCT03084471|69583491|FG000|Overall Study|Adverse Event|73|||
37898217|NCT03084471|69583491|FG000|Overall Study|Withdrawal by Subject|12|||
37898218|NCT03084471|69583491|FG000|Overall Study|Disease relapse|181|||
37898219|NCT03084471|69583491|FG000|Overall Study|Subjective disease progression|359|||
37898220|NCT03084471|69583491|FG000|Overall Study|Other (as recorded)|33|||
37898221|NCT03084471|69583491|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
37898222|NCT00754936|69583498|FG000|Overall Study|Lost to Follow-up|3|||
37898223|NCT00754936|69583498|FG000|Overall Study|Physician Decision|1|||
37898224|NCT00754936|69583498|FG000|Overall Study|Withdrawal by Subject|2|||
37898225|NCT00754936|69583498|FG000|Overall Study|Side Effects|3|||
37898226|NCT00754936|69583498|FG000|Overall Study|Inter-current medical events|3|||
37898227|NCT00762502|69583505|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
37996353|NCT00068692|69681072|FG002|Step 1: Registration|Other|0|||
37826636|NCT00474955|69509532|FG000|Overall Study|Drug unavailability|1|||
37898228|NCT00762502|69583506|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
37898229|NCT00762502|69583507|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
37696585|NCT01827592|69172724|FG001|Overall Study|Trial terminated by Sponsor|53|||
37826637|NCT00474955|69509532|FG000|Overall Study|Personal reasons|5|||
37898230|NCT00762502|69583505|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
37898231|NCT00762502|69583506|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
37898232|NCT00762502|69583507|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
37898233|NCT00762502|69583505|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
37898234|NCT00762502|69583506|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
37898235|NCT00762502|69583507|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
37898236|NCT00762268|69583515|FG000|Overall Study|Withdrawal by Subject|3|||
37898237|NCT00762268|69583516|FG001|Overall Study|Withdrawal by Subject|3|||
37996354|NCT00068692|69681073|FG003|Step 1: Registration|Other|0|||
37996355|NCT00068692|69681074|FG004|Step 1: Registration|Other|0|||
37996356|NCT00068692|69681075|FG005|Step 1: Registration|Other|0|||
37996357|NCT00068692|69681076|FG006|Step 1: Registration|Other|0|||
37898238|NCT00975884|69583524|FG000|Overall Study|Adverse Event|1|||
37898239|NCT00975884|69583525|FG001|Overall Study|Adverse Event|0|||
37898240|NCT00975884|69583524|FG000|Overall Study|Lost to Follow-up|5|||
37898241|NCT00975884|69583525|FG001|Overall Study|Lost to Follow-up|3|||
37898242|NCT00975884|69583524|FG000|Overall Study|Withdrawal by Subject|9|||
37898243|NCT00975884|69583525|FG001|Overall Study|Withdrawal by Subject|9|||
37898244|NCT00975884|69583524|FG000|Overall Study|Other|1|||
37898245|NCT00975884|69583525|FG001|Overall Study|Other|3|||
37898246|NCT00578227|69583544|FG000|Overall Study|Lost to Follow-up|0|||
37898247|NCT00578227|69583545|FG001|Overall Study|Lost to Follow-up|1|||
37898248|NCT00578227|69583546|FG002|Overall Study|Lost to Follow-up|1|||
37898249|NCT00578227|69583544|FG000|Overall Study|Withdrawal by Subject|5|||
37898250|NCT00578227|69583545|FG001|Overall Study|Withdrawal by Subject|1|||
37898251|NCT00578227|69583546|FG002|Overall Study|Withdrawal by Subject|3|||
37898252|NCT00978380|69583556|FG000|Overall Study|Protocol Violation|2|||
37898253|NCT00978380|69583556|FG000|Overall Study|Withdrawal criteria|9|||
37898254|NCT00978380|69583556|FG000|Overall Study|Unclassified|8|||
37898255|NCT00577993|69583564|FG000|Overall Study|Adverse Event|1|||
37898256|NCT00577993|69583565|FG001|Overall Study|Adverse Event|0|||
37898257|NCT00577993|69583566|FG002|Overall Study|Adverse Event|0|||
37898258|NCT00577993|69583564|FG000|Overall Study|Death|0|||
37898259|NCT00577993|69583565|FG001|Overall Study|Death|1|||
37898260|NCT00577993|69583566|FG002|Overall Study|Death|1|||
37898261|NCT00577993|69583564|FG000|Overall Study|Lack of Efficacy|0|||
37898262|NCT00577993|69583565|FG001|Overall Study|Lack of Efficacy|1|||
37898263|NCT00577993|69583566|FG002|Overall Study|Lack of Efficacy|0|||
37996358|NCT00068692|69681077|FG007|Step 1: Registration|Other|0|||
37996359|NCT00068692|69681070|FG000|Step 1: Registration|Not start protocol therapy|3|||
37996360|NCT00068692|69681071|FG001|Step 1: Registration|Not start protocol therapy|0|||
37996361|NCT00068692|69681072|FG002|Step 1: Registration|Not start protocol therapy|0|||
37996362|NCT00068692|69681073|FG003|Step 1: Registration|Not start protocol therapy|0|||
37996363|NCT00068692|69681074|FG004|Step 1: Registration|Not start protocol therapy|0|||
37996364|NCT00068692|69681075|FG005|Step 1: Registration|Not start protocol therapy|0|||
37996365|NCT00068692|69681076|FG006|Step 1: Registration|Not start protocol therapy|0|||
37826638|NCT00474487|69509540|FG000|Overall Study|Withdrawal by Subject|6|||
37826639|NCT00474487|69509541|FG001|Overall Study|Withdrawal by Subject|0|||
37826640|NCT00474487|69509542|FG002|Overall Study|Withdrawal by Subject|0|||
37826641|NCT00474487|69509543|FG003|Overall Study|Withdrawal by Subject|0|||
37826642|NCT00474487|69509540|FG000|Overall Study|Lost to Follow-up|20|||
37826643|NCT00474487|69509541|FG001|Overall Study|Lost to Follow-up|1|||
37826644|NCT00474487|69509542|FG002|Overall Study|Lost to Follow-up|7|||
37826645|NCT00474487|69509543|FG003|Overall Study|Lost to Follow-up|0|||
37826646|NCT00474487|69509540|FG000|Overall Study|Inappropriate enrollment|4|||
37826647|NCT00474487|69509541|FG001|Overall Study|Inappropriate enrollment|0|||
37826648|NCT00474487|69509542|FG002|Overall Study|Inappropriate enrollment|7|||
37826649|NCT00474487|69509543|FG003|Overall Study|Inappropriate enrollment|0|||
37826650|NCT00474487|69509540|FG000|Overall Study|Death|0|||
37826651|NCT00474487|69509541|FG001|Overall Study|Death|1|||
37826652|NCT00474487|69509542|FG002|Overall Study|Death|0|||
37826653|NCT00474487|69509543|FG003|Overall Study|Death|0|||
37826654|NCT00474253|69509555|FG000|Overall Study|Withdrew consent|2|||
37826655|NCT00474253|69509556|FG001|Overall Study|Withdrew consent|0|||
37826656|NCT00474253|69509555|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
37826657|NCT00474253|69509556|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
37898264|NCT00577993|69583564|FG000|Overall Study|Protocol Violation|2|||
37898265|NCT00577993|69583565|FG001|Overall Study|Protocol Violation|3|||
37898266|NCT00577993|69583566|FG002|Overall Study|Protocol Violation|0|||
37898267|NCT00577993|69583564|FG000|Overall Study|Withdrawal by Subject|1|||
37898268|NCT00577993|69583565|FG001|Overall Study|Withdrawal by Subject|0|||
37898269|NCT00577993|69583566|FG002|Overall Study|Withdrawal by Subject|2|||
37898270|NCT00577993|69583564|FG000|Overall Study|Conversion|2|||
37996366|NCT00068692|69681077|FG007|Step 1: Registration|Not start protocol therapy|0|||
37996367|NCT00068692|69681070|FG000|Step 1: Registration|Registered but not randomized|0|||
37826658|NCT00474253|69509555|FG000|Overall Study|Lost to Follow-up|1|||
37826659|NCT00474253|69509556|FG001|Overall Study|Lost to Follow-up|0|||
37826660|NCT00474253|69509555|FG000|Overall Study|Discharged prior to study completion|0|||
37898271|NCT00577993|69583565|FG001|Overall Study|Conversion|5|||
37898272|NCT00577993|69583566|FG002|Overall Study|Conversion|0|||
37826661|NCT00474253|69509556|FG001|Overall Study|Discharged prior to study completion|1|||
37826662|NCT00474058|69509564|FG000|Overall Study|Adverse Event|11|||
37826663|NCT00474058|69509565|FG001|Overall Study|Adverse Event|6|||
37826664|NCT00474058|69509564|FG000|Overall Study|Lack of Efficacy|0|||
37826665|NCT00474058|69509565|FG001|Overall Study|Lack of Efficacy|4|||
37826666|NCT00474058|69509564|FG000|Overall Study|Withdrawal by Subject|11|||
37826667|NCT00474058|69509565|FG001|Overall Study|Withdrawal by Subject|7|||
37826668|NCT00474058|69509564|FG000|Overall Study|Other|2|||
37826669|NCT00474058|69509565|FG001|Overall Study|Other|0|||
37826670|NCT00473824|69509573|FG000|Overall Study|Virologic Breakthrough|1|||
37826671|NCT00473824|69509574|FG001|Overall Study|Virologic Breakthrough|0|||
37898273|NCT00577993|69583564|FG000|Overall Study|Uninsured|1|||
37898274|NCT00577993|69583565|FG001|Overall Study|Uninsured|0|||
37898275|NCT00577993|69583566|FG002|Overall Study|Uninsured|0|||
37898276|NCT00975806|69583575|FG000|Overall Study|Adverse Event|2|||
37996368|NCT00068692|69681071|FG001|Step 1: Registration|Registered but not randomized|1|||
37996369|NCT00068692|69681072|FG002|Step 1: Registration|Registered but not randomized|0|||
37898277|NCT00975806|69583576|FG001|Overall Study|Adverse Event|1|||
37898278|NCT00975806|69583577|FG002|Overall Study|Adverse Event|2|||
37898279|NCT00975806|69583575|FG000|Overall Study|Disease Progression|1|||
37898280|NCT00975806|69583576|FG001|Overall Study|Disease Progression|5|||
37898281|NCT00975806|69583577|FG002|Overall Study|Disease Progression|1|||
37898282|NCT00975806|69583575|FG000|Overall Study|Withdrawal by Subject|1|||
37898283|NCT00975806|69583576|FG001|Overall Study|Withdrawal by Subject|0|||
37898284|NCT00975806|69583577|FG002|Overall Study|Withdrawal by Subject|0|||
37898285|NCT00975806|69583575|FG000|Overall Study|Death|0|||
37898286|NCT00975806|69583576|FG001|Overall Study|Death|1|||
37898287|NCT00975806|69583577|FG002|Overall Study|Death|0|||
37898288|NCT00975806|69583575|FG000|Overall Study|Physician decision and disease related|1|||
37898289|NCT00975806|69583576|FG001|Overall Study|Physician decision and disease related|0|||
37898290|NCT00975806|69583577|FG002|Overall Study|Physician decision and disease related|1|||
37898291|NCT00978068|69583589|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
37898292|NCT00978068|69583590|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
37898293|NCT00978068|69583589|FG000|Overall Study|Death|1|||
37898294|NCT00978068|69583590|FG001|Overall Study|Death|2|||
37898295|NCT00978068|69583589|FG000|Overall Study|Lost to Follow-up|1|||
37898296|NCT00978068|69583590|FG001|Overall Study|Lost to Follow-up|2|||
37898297|NCT00978068|69583589|FG000|Overall Study|Physician Decision|0|||
37898298|NCT00978068|69583590|FG001|Overall Study|Physician Decision|1|||
37898299|NCT00978068|69583589|FG000|Overall Study|Unable to Comply with Study|0|||
37898300|NCT00978068|69583590|FG001|Overall Study|Unable to Comply with Study|2|||
37898301|NCT00603525|69583602|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
37898302|NCT00603525|69583603|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
37898303|NCT00603525|69583604|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
37898304|NCT00603525|69583602|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
37996370|NCT00068692|69681073|FG003|Step 1: Registration|Registered but not randomized|0|||
37996371|NCT00068692|69681074|FG004|Step 1: Registration|Registered but not randomized|0|||
37996372|NCT00068692|69681075|FG005|Step 1: Registration|Registered but not randomized|0|||
37996373|NCT00068692|69681076|FG006|Step 1: Registration|Registered but not randomized|0|||
37996374|NCT00068692|69681077|FG007|Step 1: Registration|Registered but not randomized|0|||
37996375|NCT00068692|69681070|FG000|Step 2: Randomization|Disesae progression/replase|0|||
37996376|NCT00068692|69681071|FG001|Step 2: Randomization|Disesae progression/replase|0|||
37996377|NCT00068692|69681072|FG002|Step 2: Randomization|Disesae progression/replase|1|||
37996378|NCT00068692|69681073|FG003|Step 2: Randomization|Disesae progression/replase|1|||
37996379|NCT00068692|69681074|FG004|Step 2: Randomization|Disesae progression/replase|0|||
37996380|NCT00068692|69681075|FG005|Step 2: Randomization|Disesae progression/replase|0|||
37996381|NCT00068692|69681076|FG006|Step 2: Randomization|Disesae progression/replase|0|||
37996382|NCT00068692|69681077|FG007|Step 2: Randomization|Disesae progression/replase|0|||
37996383|NCT00068692|69681070|FG000|Step 2: Randomization|Adverse Event|0|||
37996384|NCT00068692|69681071|FG001|Step 2: Randomization|Adverse Event|0|||
37898305|NCT00603525|69583603|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
37898306|NCT00603525|69583604|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
37898307|NCT00603525|69583602|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
37898308|NCT00603525|69583603|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
37898309|NCT00603525|69583604|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
37898310|NCT00603525|69583602|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
37898311|NCT00603525|69583603|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
37826672|NCT00473824|69509573|FG000|Overall Study|Adverse Event|1|||
37826673|NCT00473824|69509574|FG001|Overall Study|Adverse Event|0|||
37996385|NCT00068692|69681072|FG002|Step 2: Randomization|Adverse Event|4|||
37996386|NCT00068692|69681073|FG003|Step 2: Randomization|Adverse Event|2|||
37996387|NCT00068692|69681074|FG004|Step 2: Randomization|Adverse Event|2|||
37996388|NCT00068692|69681075|FG005|Step 2: Randomization|Adverse Event|3|||
37996389|NCT00068692|69681076|FG006|Step 2: Randomization|Adverse Event|4|||
37996390|NCT00068692|69681077|FG007|Step 2: Randomization|Adverse Event|4|||
37996391|NCT00068692|69681070|FG000|Step 2: Randomization|Death|0|||
37996392|NCT00068692|69681071|FG001|Step 2: Randomization|Death|0|||
37996393|NCT00068692|69681072|FG002|Step 2: Randomization|Death|0|||
37996394|NCT00068692|69681073|FG003|Step 2: Randomization|Death|0|||
37996395|NCT00068692|69681074|FG004|Step 2: Randomization|Death|1|||
37898312|NCT00603525|69583604|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
37898313|NCT00603525|69583602|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
37898314|NCT00603525|69583603|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
37898315|NCT00603525|69583604|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
37898316|NCT00603525|69583602|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
37898317|NCT00603525|69583603|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
37898318|NCT00603525|69583604|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
37898319|NCT00603525|69583602|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
37898320|NCT00603525|69583603|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
37898321|NCT00603525|69583604|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
37898322|NCT00603525|69583602|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
37898323|NCT00603525|69583603|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
37898324|NCT00603525|69583604|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
37898325|NCT00603525|69583602|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
37898326|NCT00603525|69583603|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
37898327|NCT00603525|69583604|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
37898328|NCT00603525|69583602|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
37898329|NCT00603525|69583603|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
37898330|NCT00603525|69583604|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
37898331|NCT00603525|69583602|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
37898332|NCT00603525|69583603|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
37898333|NCT00603525|69583604|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
37898334|NCT00603525|69583602|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
37898335|NCT00603525|69583603|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
37898336|NCT00603525|69583604|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
37898337|NCT00603525|69583602|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
37898338|NCT00603525|69583603|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
37898339|NCT00603525|69583604|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
37898340|NCT00603525|69583602|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
37898341|NCT00603525|69583603|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
37898342|NCT00603525|69583604|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
37898343|NCT00603525|69583602|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
37898344|NCT00603525|69583603|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
37898345|NCT00603525|69583604|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
37898346|NCT00762034|69583617|FG000|Induction Period|Protocol Violation|1|||
37898347|NCT00762034|69583618|FG001|Induction Period|Protocol Violation|2|||
37898348|NCT00762034|69583617|FG000|Induction Period|Entry Criterion Not Met|12|||
37898349|NCT00762034|69583618|FG001|Induction Period|Entry Criterion Not Met|11|||
37898350|NCT00762034|69583617|FG000|Induction Period|Adverse Event|27|||
37898351|NCT00762034|69583618|FG001|Induction Period|Adverse Event|38|||
37898352|NCT00762034|69583617|FG000|Induction Period|Lost to Follow-up|1|||
37898353|NCT00762034|69583618|FG001|Induction Period|Lost to Follow-up|1|||
37898354|NCT00762034|69583617|FG000|Induction Period|Progressive Disease|73|||
37898355|NCT00762034|69583618|FG001|Induction Period|Progressive Disease|55|||
37898356|NCT00762034|69583617|FG000|Induction Period|Physician Decision|21|||
37996396|NCT00068692|69681075|FG005|Step 2: Randomization|Death|0|||
37996397|NCT00068692|69681076|FG006|Step 2: Randomization|Death|0|||
37898357|NCT00762034|69583618|FG001|Induction Period|Physician Decision|20|||
37898358|NCT00762034|69583617|FG000|Induction Period|Withdrawal by Subject|15|||
37898359|NCT00762034|69583618|FG001|Induction Period|Withdrawal by Subject|19|||
37898360|NCT00762034|69583617|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
37898361|NCT00762034|69583618|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
37898362|NCT00762034|69583617|FG000|Induction Period|Deaths Due to Study Disease|9|||
37898363|NCT00762034|69583618|FG001|Induction Period|Deaths Due to Study Disease|9|||
37898364|NCT00762034|69583617|FG000|Maintenance Period|Protocol Violation|1|||
37898365|NCT00762034|69583618|FG001|Maintenance Period|Protocol Violation|3|||
37898366|NCT00762034|69583617|FG000|Maintenance Period|Entry Criterion Not Met|0|||
37898367|NCT00762034|69583618|FG001|Maintenance Period|Entry Criterion Not Met|2|||
37898368|NCT00762034|69583617|FG000|Maintenance Period|Adverse Event|42|||
37898369|NCT00762034|69583618|FG001|Maintenance Period|Adverse Event|26|||
37898370|NCT00762034|69583617|FG000|Maintenance Period|Progressive Disease|186|||
37898371|NCT00762034|69583618|FG001|Maintenance Period|Progressive Disease|224|||
37898372|NCT00762034|69583617|FG000|Maintenance Period|Physician Decision|25|||
37898373|NCT00762034|69583618|FG001|Maintenance Period|Physician Decision|20|||
37898374|NCT00762034|69583617|FG000|Maintenance Period|Withdrawal by Subject|34|||
37898375|NCT00762034|69583618|FG001|Maintenance Period|Withdrawal by Subject|14|||
37898376|NCT00762034|69583617|FG000|Maintenance Period|Death not due to study disease|2|||
37898377|NCT00762034|69583618|FG001|Maintenance Period|Death not due to study disease|5|||
37898378|NCT00762034|69583617|FG000|Maintenance Period|Death due to study disease|3|||
37898379|NCT00762034|69583618|FG001|Maintenance Period|Death due to study disease|3|||
37696586|NCT01827592|69172725|FG002|Overall Study|Trial terminated by Sponsor|51|||
37696587|NCT01827592|69172723|FG000|Overall Study|Others|0|||
37696588|NCT01827592|69172724|FG001|Overall Study|Others|1|||
37826674|NCT00473824|69509573|FG000|Overall Study|Death|1|||
37696589|NCT01827592|69172725|FG002|Overall Study|Others|3|||
37696590|NCT02323334|69172743|FG000|Period 3|Lost to Follow-up|0|||
37696591|NCT02323334|69172744|FG001|Period 3|Lost to Follow-up|0|||
37696592|NCT02323334|69172745|FG002|Period 3|Lost to Follow-up|1|||
37696593|NCT02323334|69172746|FG003|Period 3|Lost to Follow-up|0|||
37696594|NCT02323334|69172747|FG004|Period 3|Lost to Follow-up|0|||
37696595|NCT02323334|69172748|FG005|Period 3|Lost to Follow-up|0|||
37696596|NCT02323334|69172749|FG006|Period 3|Lost to Follow-up|0|||
37696597|NCT02323334|69172750|FG007|Period 3|Lost to Follow-up|0|||
37826675|NCT00473824|69509574|FG001|Overall Study|Death|0|||
37826676|NCT00473824|69509573|FG000|Overall Study|Lost to Follow-up|1|||
37898380|NCT00762034|69583617|FG000|Maintenance Period|Other|1|||
37898381|NCT00762034|69583618|FG001|Maintenance Period|Other|1|||
37898382|NCT00761956|69583650|FG000|Overall Study|Lost to Follow-up|6|||
37898383|NCT00761956|69583651|FG001|Overall Study|Lost to Follow-up|11|||
37898384|NCT00761956|69583650|FG000|Overall Study|Withdrawal by Subject|3|||
37898385|NCT00761956|69583651|FG001|Overall Study|Withdrawal by Subject|8|||
37898386|NCT00761956|69583650|FG000|Overall Study|Death|0|||
37898387|NCT00761956|69583651|FG001|Overall Study|Death|1|||
37898388|NCT00761956|69583650|FG000|Overall Study|Adverse Event|26|||
37898389|NCT00761956|69583651|FG001|Overall Study|Adverse Event|34|||
37898390|NCT00754624|69583657|FG000|Overall Study|Adverse Event|16|||
37898391|NCT00754624|69583657|FG000|Overall Study|Death|1|||
37898392|NCT00754624|69583657|FG000|Overall Study|Physician Decision|8|||
37898393|NCT00754624|69583657|FG000|Overall Study|Protocol Violation|1|||
37898394|NCT00754624|69583657|FG000|Overall Study|Withdrawal by Subject|28|||
37898395|NCT00754624|69583657|FG000|Overall Study|Various|12|||
37898396|NCT00754624|69583657|FG000|Overall Study|Lost to Follow-up|3|||
37898397|NCT00586846|69583670|FG000|Overall Study|Physician Decision|1|||
37898398|NCT00586846|69583670|FG000|Overall Study|Death|1|||
37898399|NCT00586846|69583670|FG000|Overall Study|Evaluable for Toxicity Only|4|||
37898400|NCT00973700|69583679|FG000|Overall Study|Withdrawal by Subject|2|||
37826677|NCT00473824|69509574|FG001|Overall Study|Lost to Follow-up|0|||
37826678|NCT00473824|69509573|FG000|Overall Study|Withdrawal by physician|1|||
37826679|NCT00473824|69509574|FG001|Overall Study|Withdrawal by physician|0|||
37826680|NCT00473746|69509585|FG000|Period 1 (Phase 1)|Adverse Event|1|||
37826681|NCT00473746|69509586|FG001|Period 1 (Phase 1)|Adverse Event|0|||
37826682|NCT00473746|69509587|FG002|Period 1 (Phase 1)|Adverse Event|0|||
37898401|NCT00973700|69583680|FG001|Overall Study|Withdrawal by Subject|2|||
37898402|NCT00973700|69583681|FG002|Overall Study|Withdrawal by Subject|8|||
37898403|NCT00973700|69583682|FG003|Overall Study|Withdrawal by Subject|4|||
37898404|NCT00973700|69583683|FG004|Overall Study|Withdrawal by Subject|4|||
37898405|NCT00973700|69583679|FG000|Overall Study|Lost to Follow-up|5|||
37898406|NCT00973700|69583680|FG001|Overall Study|Lost to Follow-up|0|||
37898407|NCT00973700|69583681|FG002|Overall Study|Lost to Follow-up|1|||
37898408|NCT00973700|69583682|FG003|Overall Study|Lost to Follow-up|8|||
37898409|NCT00973700|69583683|FG004|Overall Study|Lost to Follow-up|5|||
37996398|NCT00068692|69681077|FG007|Step 2: Randomization|Death|1|||
37696598|NCT02323334|69172751|FG008|Period 3|Lost to Follow-up|0|||
37826683|NCT00473746|69509588|FG003|Period 1 (Phase 1)|Adverse Event|0|||
37826684|NCT00473746|69509589|FG004|Period 1 (Phase 1)|Adverse Event|0|||
37826685|NCT00473746|69509585|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
37826686|NCT00473746|69509586|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
37696599|NCT02323334|69172752|FG009|Period 3|Lost to Follow-up|0|||
37696600|NCT02323334|69172753|FG010|Period 3|Lost to Follow-up|0|||
37898410|NCT00973700|69583679|FG000|Overall Study|Inappropriate enrolment|0|||
37898411|NCT00973700|69583680|FG001|Overall Study|Inappropriate enrolment|0|||
37898412|NCT00973700|69583681|FG002|Overall Study|Inappropriate enrolment|0|||
37898413|NCT00973700|69583682|FG003|Overall Study|Inappropriate enrolment|4|||
37898414|NCT00973700|69583683|FG004|Overall Study|Inappropriate enrolment|0|||
37898415|NCT00973700|69583679|FG000|Overall Study|Unable to Classify|0|||
37898416|NCT00973700|69583680|FG001|Overall Study|Unable to Classify|0|||
37898417|NCT00973700|69583681|FG002|Overall Study|Unable to Classify|1|||
37898418|NCT00973700|69583682|FG003|Overall Study|Unable to Classify|2|||
37898419|NCT00973700|69583683|FG004|Overall Study|Unable to Classify|1|||
37898420|NCT00754390|69583710|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
37898421|NCT00754390|69583710|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
37898422|NCT00754390|69583710|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
37898423|NCT00754390|69583710|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
37898424|NCT00754234|69583717|FG000|Overall Study|Withdrawal by Subject|3|||
37898425|NCT00753922|69583725|FG000|Overall Study|Lost to Follow-up|155|||
37898426|NCT00753922|69583726|FG001|Overall Study|Lost to Follow-up|24|||
37898427|NCT00753922|69583727|FG002|Overall Study|Lost to Follow-up|28|||
37898428|NCT00753922|69583728|FG003|Overall Study|Lost to Follow-up|5|||
37898429|NCT00753922|69583725|FG000|Overall Study|Withdrawal by Subject|9|||
37898430|NCT00753922|69583726|FG001|Overall Study|Withdrawal by Subject|11|||
37898431|NCT00753922|69583727|FG002|Overall Study|Withdrawal by Subject|4|||
37898432|NCT00753922|69583728|FG003|Overall Study|Withdrawal by Subject|2|||
37898433|NCT00753922|69583725|FG000|Overall Study|Patient Non-compliance|55|||
37898434|NCT00753922|69583726|FG001|Overall Study|Patient Non-compliance|22|||
37898435|NCT00753922|69583727|FG002|Overall Study|Patient Non-compliance|14|||
37898436|NCT00753922|69583728|FG003|Overall Study|Patient Non-compliance|11|||
37898437|NCT00753922|69583725|FG000|Overall Study|Patients Not Completing Visit|11|||
37898438|NCT00753922|69583726|FG001|Overall Study|Patients Not Completing Visit|0|||
37898439|NCT00753922|69583727|FG002|Overall Study|Patients Not Completing Visit|1|||
37898440|NCT00753922|69583728|FG003|Overall Study|Patients Not Completing Visit|0|||
37898441|NCT00753922|69583725|FG000|Overall Study|Death|2|||
37898442|NCT00753922|69583726|FG001|Overall Study|Death|23|||
37898443|NCT00753922|69583727|FG002|Overall Study|Death|2|||
37898444|NCT00753922|69583728|FG003|Overall Study|Death|1|||
37898445|NCT00753922|69583725|FG000|Overall Study|Discontinuation Due to Explantation|14|||
37898446|NCT00753922|69583726|FG001|Overall Study|Discontinuation Due to Explantation|14|||
37898447|NCT00753922|69583727|FG002|Overall Study|Discontinuation Due to Explantation|14|||
37898448|NCT00753922|69583728|FG003|Overall Study|Discontinuation Due to Explantation|4|||
37898449|NCT00761176|69583740|FG000|Overall Study|Death|1|||
37898450|NCT00761176|69583741|FG001|Overall Study|Death|0|||
37898451|NCT00761176|69583740|FG000|Overall Study|Withdrawal by Subject|1|||
37898452|NCT00761176|69583741|FG001|Overall Study|Withdrawal by Subject|1|||
37898453|NCT00760552|69583749|FG000|Overall Study|Death|2|||
37898454|NCT00760552|69583750|FG001|Overall Study|Death|0|||
37898455|NCT00760552|69583749|FG000|Overall Study|Lost to Follow-up|11|||
37996399|NCT00068692|69681070|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
37996400|NCT00068692|69681071|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
37996401|NCT00068692|69681072|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
37996402|NCT00068692|69681073|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
37996403|NCT00068692|69681074|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
37996404|NCT00068692|69681075|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
37996405|NCT00068692|69681076|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
37996406|NCT00068692|69681077|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
37996407|NCT00068692|69681070|FG000|Step 2: Randomization|alternative therapy|0|||
37996408|NCT00068692|69681071|FG001|Step 2: Randomization|alternative therapy|0|||
37996409|NCT00068692|69681072|FG002|Step 2: Randomization|alternative therapy|0|||
37996410|NCT00068692|69681073|FG003|Step 2: Randomization|alternative therapy|1|||
37898456|NCT00760552|69583750|FG001|Overall Study|Lost to Follow-up|10|||
37898457|NCT00753766|69583758|FG000|Overall Study|Physician Decision|1|||
37898458|NCT00753766|69583759|FG001|Overall Study|Physician Decision|0|||
37898459|NCT00976898|69583766|FG000|Overall Study|Protocol Violation|1|||
37898460|NCT00976898|69583766|FG000|Overall Study|Adverse Event|1|||
37898461|NCT00976898|69583766|FG000|Overall Study|Physician Decision|1|||
37898462|NCT00976898|69583766|FG000|Overall Study|Liver Transplant|1|||
37898463|NCT00976898|69583766|FG000|Overall Study|Progressive Disease|1|||
37898464|NCT02620579|69583778|FG000|Overall Study|Physician Decision|0|||
37898465|NCT02620579|69583779|FG001|Overall Study|Physician Decision|0|||
37898466|NCT02620579|69583780|FG002|Overall Study|Physician Decision|0|||
37898467|NCT02620579|69583781|FG003|Overall Study|Physician Decision|1|||
37898468|NCT02620579|69583778|FG000|Overall Study|Withdrawal by Subject|0|||
37898469|NCT02620579|69583779|FG001|Overall Study|Withdrawal by Subject|1|||
37996411|NCT00068692|69681074|FG004|Step 2: Randomization|alternative therapy|1|||
37996412|NCT00068692|69681075|FG005|Step 2: Randomization|alternative therapy|0|||
37996413|NCT00068692|69681076|FG006|Step 2: Randomization|alternative therapy|0|||
37996414|NCT00068692|69681077|FG007|Step 2: Randomization|alternative therapy|0|||
37996415|NCT00068692|69681070|FG000|Step 2: Randomization|Physician Decision|0|||
37996416|NCT00068692|69681071|FG001|Step 2: Randomization|Physician Decision|0|||
37996417|NCT00068692|69681072|FG002|Step 2: Randomization|Physician Decision|0|||
37996418|NCT00068692|69681073|FG003|Step 2: Randomization|Physician Decision|1|||
37996419|NCT00068692|69681074|FG004|Step 2: Randomization|Physician Decision|1|||
37996420|NCT00068692|69681075|FG005|Step 2: Randomization|Physician Decision|0|||
37996421|NCT00068692|69681076|FG006|Step 2: Randomization|Physician Decision|0|||
37996422|NCT00068692|69681077|FG007|Step 2: Randomization|Physician Decision|0|||
37996423|NCT00068692|69681070|FG000|Step 2: Randomization|Other|0|||
37996424|NCT00068692|69681071|FG001|Step 2: Randomization|Other|0|||
37996425|NCT00068692|69681072|FG002|Step 2: Randomization|Other|0|||
37996426|NCT00068692|69681073|FG003|Step 2: Randomization|Other|1|||
37996427|NCT00068692|69681074|FG004|Step 2: Randomization|Other|0|||
37898470|NCT02620579|69583780|FG002|Overall Study|Withdrawal by Subject|1|||
37898471|NCT02620579|69583781|FG003|Overall Study|Withdrawal by Subject|0|||
37898472|NCT00753688|69583797|FG000|Overall Study|Death|102|||
37898473|NCT00753688|69583798|FG001|Overall Study|Death|203|||
37898474|NCT00753688|69583797|FG000|Overall Study|Missing|4|||
37898475|NCT00753688|69583798|FG001|Overall Study|Missing|9|||
37898476|NCT00753688|69583797|FG000|Overall Study|Participant Withdrew Consent|2|||
37898477|NCT00753688|69583798|FG001|Overall Study|Participant Withdrew Consent|2|||
37898478|NCT00753688|69583797|FG000|Overall Study|Ongoing - in Follow-up|15|||
37898479|NCT00753688|69583798|FG001|Overall Study|Ongoing - in Follow-up|31|||
37898480|NCT00753688|69583797|FG000|Overall Study|Adverse Event|0|||
37898481|NCT00753688|69583798|FG001|Overall Study|Adverse Event|1|||
37898482|NCT00586612|69583806|FG000|Primary Phase|Protocol Violation|1|||
37898483|NCT00586612|69583807|FG001|Primary Phase|Protocol Violation|0|||
37898484|NCT00586612|69583806|FG000|Primary Phase|Lost to Follow-up|0|||
37898485|NCT00586612|69583807|FG001|Primary Phase|Lost to Follow-up|1|||
37898486|NCT00586612|69583806|FG000|Primary Phase|Withdrawal by Subject|0|||
37898487|NCT00586612|69583807|FG001|Primary Phase|Withdrawal by Subject|2|||
37898488|NCT00586612|69583806|FG000|Booster Phase|Lost to Follow-up|3|||
37898489|NCT00586612|69583807|FG001|Booster Phase|Lost to Follow-up|1|||
37898490|NCT00586690|69583815|FG000|Overall Study|Death|2|||
37898491|NCT00586690|69583816|FG001|Overall Study|Death|0|||
37898492|NCT00586690|69583815|FG000|Overall Study|Disease Progression|10|||
37898493|NCT00586690|69583816|FG001|Overall Study|Disease Progression|0|||
37898494|NCT00586690|69583815|FG000|Overall Study|Adverse Event|1|||
37898495|NCT00586690|69583816|FG001|Overall Study|Adverse Event|0|||
37898496|NCT00586690|69583815|FG000|Overall Study|Lack of Efficacy|2|||
37898497|NCT00586690|69583816|FG001|Overall Study|Lack of Efficacy|0|||
37898498|NCT00586690|69583815|FG000|Overall Study|Lab can't accommodate|1|||
37898499|NCT00586690|69583816|FG001|Overall Study|Lab can't accommodate|0|||
37898500|NCT00976820|69583825|FG000|Overall Study|Lost to Follow-up|5|||
37898501|NCT00976820|69583826|FG001|Overall Study|Lost to Follow-up|16|||
37898502|NCT00976820|69583827|FG002|Overall Study|Lost to Follow-up|2|||
37898503|NCT00976820|69583828|FG003|Overall Study|Lost to Follow-up|3|||
37898504|NCT00976820|69583825|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
37898505|NCT00976820|69583826|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
37898506|NCT00976820|69583827|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
37898507|NCT00976820|69583828|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
37898508|NCT00976820|69583825|FG000|Overall Study|Withdrawal by Subject|2|||
37898509|NCT00976820|69583826|FG001|Overall Study|Withdrawal by Subject|4|||
37898510|NCT00976820|69583827|FG002|Overall Study|Withdrawal by Subject|1|||
37898511|NCT00976820|69583828|FG003|Overall Study|Withdrawal by Subject|4|||
37898512|NCT00760474|69583879|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
37898513|NCT00760474|69583880|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
37898514|NCT00760474|69583879|FG000|Placebo Washout Period|Other|0|||
37898515|NCT00760474|69583880|FG001|Placebo Washout Period|Other|1|||
37996428|NCT00068692|69681075|FG005|Step 2: Randomization|Other|1|||
37898516|NCT00760474|69583879|FG000|Period 2 (P2)|Lost to Follow-up|1|||
37996429|NCT00068692|69681076|FG006|Step 2: Randomization|Other|0|||
37996430|NCT00068692|69681077|FG007|Step 2: Randomization|Other|0|||
37996431|NCT00068692|69681070|FG000|Step 2: Randomization|never start protocol therapy|0|||
37898517|NCT00760474|69583880|FG001|Period 2 (P2)|Lost to Follow-up|0|||
37898518|NCT00760474|69583879|FG000|Period 2 (P2)|Adverse Event|0|||
37898519|NCT00760474|69583880|FG001|Period 2 (P2)|Adverse Event|1|||
37898520|NCT00975416|69583889|FG000|Overall Study|early discharge from tx|3|||
37898521|NCT00975416|69583890|FG001|Overall Study|early discharge from tx|5|||
37898522|NCT00760084|69583897|FG000|Overall Study|Physician Decision|5|||
37898523|NCT00760084|69583897|FG000|Overall Study|Withdrawal by Subject|2|||
37898524|NCT00760084|69583897|FG000|Overall Study|Progressive Disease|3|||
37898525|NCT00752206|69583903|FG000|Overall Study|Disease progression|8|||
37898526|NCT00752206|69583904|FG001|Overall Study|Disease progression|11|||
37898527|NCT00752206|69583903|FG000|Overall Study|Pregnancy|1|||
37898528|NCT00752206|69583904|FG001|Overall Study|Pregnancy|0|||
37898529|NCT00752128|69583910|FG000|Overall Study|Withdrawal by Subject|4|||
37898530|NCT00976508|69583917|FG000|Overall Study|Death|7|||
37898531|NCT00976508|69583918|FG001|Overall Study|Death|1|||
37898532|NCT00976508|69583917|FG000|Overall Study|Lost to Follow-up|1|||
37898533|NCT00976508|69583918|FG001|Overall Study|Lost to Follow-up|0|||
37898534|NCT00976508|69583917|FG000|Overall Study|Withdrawal by Subject|1|||
37898535|NCT00976508|69583918|FG001|Overall Study|Withdrawal by Subject|0|||
37898536|NCT00976508|69583917|FG000|Overall Study|Disease Progression|4|||
37898537|NCT00976508|69583918|FG001|Overall Study|Disease Progression|4|||
37898538|NCT00976508|69583917|FG000|Overall Study|Subject Enrolled in Hospice|1|||
37898539|NCT00976508|69583918|FG001|Overall Study|Subject Enrolled in Hospice|0|||
37898540|NCT00976508|69583917|FG000|Overall Study|Terminated by the Sponsor|0|||
37898541|NCT00976508|69583918|FG001|Overall Study|Terminated by the Sponsor|1|||
37898542|NCT00973622|69583929|FG000|Overall Study|did not attend MRI|14|||
37898543|NCT00973622|69583930|FG001|Overall Study|did not attend MRI|3|||
37898544|NCT00973622|69583929|FG000|Overall Study|did not pass MRI screen|6|||
37898545|NCT00973622|69583930|FG001|Overall Study|did not pass MRI screen|0|||
37898546|NCT00973622|69583929|FG000|Overall Study|did not complete rTMS sessions|11|||
37898547|NCT00973622|69583930|FG001|Overall Study|did not complete rTMS sessions|2|||
37898548|NCT04044716|69583938|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
37898549|NCT04044716|69583939|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
37898550|NCT04044716|69583940|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
37898551|NCT04044716|69583938|FG000|Overall Study|Lost to Follow-up|2|||
37898552|NCT04044716|69583939|FG001|Overall Study|Lost to Follow-up|3|||
37898553|NCT04044716|69583940|FG002|Overall Study|Lost to Follow-up|0|||
37898554|NCT04041284|69583949|FG000|DB Phase (12 Weeks)|Adverse Event|0|||
37898555|NCT04041284|69583950|FG001|DB Phase (12 Weeks)|Adverse Event|3|||
37898556|NCT04041284|69583949|FG000|DB Phase (12 Weeks)|Withdrawal by Subject|6|||
37898557|NCT04041284|69583950|FG001|DB Phase (12 Weeks)|Withdrawal by Subject|4|||
37898558|NCT04041284|69583949|FG000|DB Phase (12 Weeks)|Protocol deviation|3|||
37996432|NCT00068692|69681071|FG001|Step 2: Randomization|never start protocol therapy|0|||
37996433|NCT00068692|69681072|FG002|Step 2: Randomization|never start protocol therapy|1|||
37898559|NCT04041284|69583950|FG001|DB Phase (12 Weeks)|Protocol deviation|3|||
37898560|NCT04041284|69583949|FG000|DB Phase (12 Weeks)|Lost to Follow-up|1|||
37898561|NCT04041284|69583950|FG001|DB Phase (12 Weeks)|Lost to Follow-up|0|||
37898562|NCT04041284|69583949|FG000|DB Phase (12 Weeks)|Lack of Efficacy|1|||
37898563|NCT04041284|69583950|FG001|DB Phase (12 Weeks)|Lack of Efficacy|1|||
37898564|NCT04041284|69583949|FG000|DB Phase (12 Weeks)|Other than specified|1|||
37898565|NCT04041284|69583950|FG001|DB Phase (12 Weeks)|Other than specified|0|||
37898566|NCT04041284|69583949|FG000|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
37898567|NCT04041284|69583950|FG001|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
37898568|NCT04041284|69583949|FG000|OL Phase (12 Weeks)|Protocol deviation|0|||
37898569|NCT04041284|69583950|FG001|OL Phase (12 Weeks)|Protocol deviation|1|||
37898570|NCT04041284|69583949|FG000|OL Phase (12 Weeks)|Pregnancy|1|||
37898571|NCT04041284|69583950|FG001|OL Phase (12 Weeks)|Pregnancy|1|||
37898572|NCT04041284|69583949|FG000|OL Phase (12 Weeks)|Other than specified|6|||
37898573|NCT04041284|69583950|FG001|OL Phase (12 Weeks)|Other than specified|2|||
37898574|NCT00753454|69583960|FG000|Overall Study|Adverse Event|4|||
37898575|NCT00753454|69583960|FG000|Overall Study|Lack of Efficacy|1|||
37898576|NCT00753454|69583960|FG000|Overall Study|Lost to Follow-up|3|||
37898577|NCT00753454|69583960|FG000|Overall Study|Withdrawal by Subject|5|||
37898578|NCT00753454|69583960|FG000|Overall Study|Investigator Decision|1|||
37898579|NCT00976274|69583966|FG000|Overall Study|Lost to Follow-up|5|||
37898580|NCT00976274|69583967|FG001|Overall Study|Lost to Follow-up|5|||
37898581|NCT00976274|69583966|FG000|Overall Study|Withdrawal by Subject|1|||
37898582|NCT00976274|69583967|FG001|Overall Study|Withdrawal by Subject|1|||
37996434|NCT00068692|69681073|FG003|Step 2: Randomization|never start protocol therapy|0|||
37996435|NCT00068692|69681074|FG004|Step 2: Randomization|never start protocol therapy|1|||
37996436|NCT00068692|69681075|FG005|Step 2: Randomization|never start protocol therapy|0|||
37696601|NCT02323334|69172754|FG011|Period 3|Lost to Follow-up|0|||
37898583|NCT00976274|69583966|FG000|Overall Study|Physician Decision|1|||
37898584|NCT00976274|69583967|FG001|Overall Study|Physician Decision|2|||
37898585|NCT00759148|69583975|FG000|Overall Study|Adverse Event|1|||
37898586|NCT00759148|69583976|FG001|Overall Study|Adverse Event|6|||
37898587|NCT00759148|69583975|FG000|Overall Study|Withdrawal by Subject|3|||
37898588|NCT00759148|69583976|FG001|Overall Study|Withdrawal by Subject|7|||
37898589|NCT00759148|69583975|FG000|Overall Study|Lost to Follow-up|3|||
37898590|NCT00759148|69583976|FG001|Overall Study|Lost to Follow-up|9|||
37898591|NCT00759148|69583975|FG000|Overall Study|Treatment Failure|6|||
37898592|NCT00759148|69583976|FG001|Overall Study|Treatment Failure|10|||
37898593|NCT00759148|69583975|FG000|Overall Study|Reason not given|1|||
37898594|NCT00759148|69583976|FG001|Overall Study|Reason not given|0|||
37898595|NCT02794285|69583986|FG000|Overall Study|Adverse Event|11|||
37898596|NCT02794285|69583987|FG001|Overall Study|Adverse Event|4|||
37898597|NCT02794285|69583988|FG002|Overall Study|Adverse Event|5|||
37898598|NCT02794285|69583989|FG003|Overall Study|Adverse Event|8|||
37898599|NCT02794285|69583986|FG000|Overall Study|Condition Under Investigation Improved|1|||
37898600|NCT02794285|69583987|FG001|Overall Study|Condition Under Investigation Improved|0|||
37898601|NCT02794285|69583988|FG002|Overall Study|Condition Under Investigation Improved|0|||
37898602|NCT02794285|69583989|FG003|Overall Study|Condition Under Investigation Improved|0|||
37898603|NCT02794285|69583986|FG000|Overall Study|Condition Under Investigation Worsened|0|||
37898604|NCT02794285|69583987|FG001|Overall Study|Condition Under Investigation Worsened|2|||
37898605|NCT02794285|69583988|FG002|Overall Study|Condition Under Investigation Worsened|1|||
37898606|NCT02794285|69583989|FG003|Overall Study|Condition Under Investigation Worsened|0|||
37898607|NCT02794285|69583986|FG000|Overall Study|Death|2|||
37898608|NCT02794285|69583987|FG001|Overall Study|Death|1|||
37898609|NCT02794285|69583988|FG002|Overall Study|Death|2|||
37898610|NCT02794285|69583989|FG003|Overall Study|Death|0|||
37898611|NCT02794285|69583986|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
37898612|NCT02794285|69583987|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
37898613|NCT02794285|69583988|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
37898614|NCT02794285|69583989|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
37898615|NCT02794285|69583986|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
37898616|NCT02794285|69583987|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
37898617|NCT02794285|69583988|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
37898618|NCT02794285|69583989|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
37898619|NCT02794285|69583986|FG000|Overall Study|Lack of Efficacy|10|||
37898620|NCT02794285|69583987|FG001|Overall Study|Lack of Efficacy|6|||
37898621|NCT02794285|69583988|FG002|Overall Study|Lack of Efficacy|3|||
37898622|NCT02794285|69583989|FG003|Overall Study|Lack of Efficacy|3|||
37898623|NCT02794285|69583986|FG000|Overall Study|Lost to Follow-up|5|||
37898624|NCT02794285|69583987|FG001|Overall Study|Lost to Follow-up|6|||
37898625|NCT02794285|69583988|FG002|Overall Study|Lost to Follow-up|3|||
37898626|NCT02794285|69583989|FG003|Overall Study|Lost to Follow-up|1|||
37898627|NCT02794285|69583986|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
37898628|NCT02794285|69583987|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
37898629|NCT02794285|69583988|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
37898630|NCT02794285|69583989|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
37898631|NCT02794285|69583986|FG000|Overall Study|Withdrawal by Subject|38|||
37898632|NCT02794285|69583987|FG001|Overall Study|Withdrawal by Subject|29|||
37898633|NCT02794285|69583988|FG002|Overall Study|Withdrawal by Subject|20|||
37898634|NCT02794285|69583989|FG003|Overall Study|Withdrawal by Subject|12|||
37898635|NCT02794285|69583986|FG000|Overall Study|Missing|1|||
37898636|NCT02794285|69583987|FG001|Overall Study|Missing|0|||
37898637|NCT02794285|69583988|FG002|Overall Study|Missing|0|||
37898638|NCT02794285|69583989|FG003|Overall Study|Missing|0|||
37898639|NCT02794285|69583986|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
37898640|NCT02794285|69583987|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
37898641|NCT02794285|69583988|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
37898642|NCT02794285|69583989|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
37898643|NCT02794285|69583986|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
37826687|NCT00473746|69509587|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
37826688|NCT00473746|69509588|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
37826689|NCT00473746|69509589|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
37826690|NCT00473746|69509585|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
37826691|NCT00473746|69509586|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
37826692|NCT00473746|69509587|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
37826693|NCT00473746|69509588|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
37826694|NCT00473746|69509589|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
37898644|NCT02794285|69583987|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
37898645|NCT02794285|69583988|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
37898646|NCT02794285|69583989|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
37898647|NCT00970268|69584001|FG000|Overall Study|Withdrawal by Subject|12|||
37898648|NCT00970268|69584002|FG001|Overall Study|Withdrawal by Subject|19|||
37898649|NCT00970268|69584001|FG000|Overall Study|Adverse Event|15|||
37898650|NCT00970268|69584002|FG001|Overall Study|Adverse Event|12|||
37898651|NCT00970268|69584001|FG000|Overall Study|Lack of Efficacy|3|||
37898652|NCT00970268|69584002|FG001|Overall Study|Lack of Efficacy|6|||
37898653|NCT00970268|69584001|FG000|Overall Study|Protocol Violation|4|||
37826695|NCT00473746|69509585|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
37826696|NCT00473746|69509586|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
37826697|NCT00473746|69509587|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
37696602|NCT02323334|69172755|FG012|Period 3|Lost to Follow-up|0|||
37898654|NCT00970268|69584002|FG001|Overall Study|Protocol Violation|7|||
37898655|NCT00970268|69584001|FG000|Overall Study|Other Reason|3|||
37898656|NCT00970268|69584002|FG001|Overall Study|Other Reason|1|||
37898657|NCT00970268|69584001|FG000|Overall Study|COPD Exacerbation|4|||
37898658|NCT00970268|69584002|FG001|Overall Study|COPD Exacerbation|2|||
37826698|NCT00473746|69509588|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
37826699|NCT00473746|69509589|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
37826700|NCT00473746|69509585|FG000|Period 1 (Phase 1)|Reason not specified|0|||
37826701|NCT00473746|69509586|FG001|Period 1 (Phase 1)|Reason not specified|1|||
37826702|NCT00473746|69509587|FG002|Period 1 (Phase 1)|Reason not specified|0|||
37826703|NCT00473746|69509588|FG003|Period 1 (Phase 1)|Reason not specified|0|||
37826704|NCT00473746|69509589|FG004|Period 1 (Phase 1)|Reason not specified|0|||
37996437|NCT00068692|69681076|FG006|Step 2: Randomization|never start protocol therapy|0|||
37826705|NCT00473746|69509585|FG000|Period 2 (Phase 2)|Adverse Event|0|||
37826706|NCT00473746|69509586|FG001|Period 2 (Phase 2)|Adverse Event|0|||
37826707|NCT00473746|69509587|FG002|Period 2 (Phase 2)|Adverse Event|0|||
37826708|NCT00473746|69509588|FG003|Period 2 (Phase 2)|Adverse Event|0|||
37826709|NCT00473746|69509589|FG004|Period 2 (Phase 2)|Adverse Event|3|||
37826710|NCT00473746|69509585|FG000|Period 2 (Phase 2)|Death|0|||
37826711|NCT00473746|69509586|FG001|Period 2 (Phase 2)|Death|0|||
37826712|NCT00473746|69509587|FG002|Period 2 (Phase 2)|Death|0|||
37826713|NCT00473746|69509588|FG003|Period 2 (Phase 2)|Death|0|||
37826714|NCT00473746|69509589|FG004|Period 2 (Phase 2)|Death|1|||
37826715|NCT00473746|69509585|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
37826716|NCT00473746|69509586|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
37826717|NCT00473746|69509587|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
37826718|NCT00473746|69509588|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
37826719|NCT00473746|69509589|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
37826720|NCT00473746|69509585|FG000|Period 2 (Phase 2)|Reason not specified|0|||
37826721|NCT00473746|69509586|FG001|Period 2 (Phase 2)|Reason not specified|0|||
37996438|NCT00068692|69681077|FG007|Step 2: Randomization|never start protocol therapy|0|||
37996439|NCT00463151|69681094|FG000|Overall Study|Adverse Event|0|||
37996440|NCT00463151|69681095|FG001|Overall Study|Adverse Event|0|||
37996441|NCT00463151|69681096|FG002|Overall Study|Adverse Event|1|||
37996442|NCT00463151|69681097|FG003|Overall Study|Adverse Event|0|||
37996443|NCT00463151|69681094|FG000|Overall Study|Lack of Efficacy|2|||
37826722|NCT00473746|69509587|FG002|Period 2 (Phase 2)|Reason not specified|0|||
37826723|NCT00473746|69509588|FG003|Period 2 (Phase 2)|Reason not specified|0|||
37826724|NCT00473746|69509589|FG004|Period 2 (Phase 2)|Reason not specified|3|||
37826725|NCT00473668|69509606|FG000|Overall Study|Withdrawal by Subject|0|||
37826726|NCT00473668|69509607|FG001|Overall Study|Withdrawal by Subject|2|||
37826727|NCT00473668|69509608|FG002|Overall Study|Withdrawal by Subject|0|||
37826728|NCT00473668|69509606|FG000|Overall Study|Migrated/moved from study area|3|||
37826729|NCT00473668|69509607|FG001|Overall Study|Migrated/moved from study area|2|||
37826730|NCT00473668|69509608|FG002|Overall Study|Migrated/moved from study area|0|||
37826731|NCT00473668|69509606|FG000|Overall Study|Lost to Follow-up|0|||
37826732|NCT00473668|69509607|FG001|Overall Study|Lost to Follow-up|4|||
37826733|NCT00473668|69509608|FG002|Overall Study|Lost to Follow-up|6|||
37826734|NCT00473668|69509606|FG000|Overall Study|Other|2|||
37898659|NCT00970268|69584001|FG000|Overall Study|Lost to Follow-up|1|||
37898660|NCT00970268|69584002|FG001|Overall Study|Lost to Follow-up|2|||
37898661|NCT00970268|69584001|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
37898662|NCT00970268|69584002|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
37898663|NCT00969332|69584014|FG000|Overall Study|Physician Decision|8|||
37898664|NCT00969332|69584014|FG000|Overall Study|Withdrawal by Subject|3|||
37898665|NCT00968864|69584019|FG000|Overall Study|Protocol exception/ not evaluable|1|||
37898666|NCT00758680|69584028|FG000|Overall Study|Adverse Event|0|||
37898667|NCT00758680|69584029|FG001|Overall Study|Adverse Event|0|||
37898668|NCT00758680|69584030|FG002|Overall Study|Adverse Event|0|||
37898669|NCT00758680|69584031|FG003|Overall Study|Adverse Event|0|||
37898670|NCT00758680|69584032|FG004|Overall Study|Adverse Event|0|||
37898671|NCT00758680|69584033|FG005|Overall Study|Adverse Event|0|||
37898672|NCT00758680|69584034|FG006|Overall Study|Adverse Event|0|||
37898673|NCT00758680|69584035|FG007|Overall Study|Adverse Event|1|||
37898674|NCT00758680|69584036|FG008|Overall Study|Adverse Event|0|||
37898675|NCT00758680|69584037|FG009|Overall Study|Adverse Event|1|||
37898676|NCT00758680|69584028|FG000|Overall Study|Laboratory Adverse Event|0|||
37898677|NCT00758680|69584029|FG001|Overall Study|Laboratory Adverse Event|0|||
37898678|NCT00758680|69584030|FG002|Overall Study|Laboratory Adverse Event|0|||
37996444|NCT00463151|69681095|FG001|Overall Study|Lack of Efficacy|5|||
37996445|NCT00463151|69681096|FG002|Overall Study|Lack of Efficacy|2|||
37826735|NCT00473668|69509607|FG001|Overall Study|Other|3|||
37826736|NCT00473668|69509608|FG002|Overall Study|Other|4|||
37826737|NCT00473590|69509618|FG000|Overall Study|Adverse Event|3|||
37826738|NCT00473590|69509619|FG001|Overall Study|Adverse Event|3|||
37826739|NCT00473590|69509618|FG000|Overall Study|Death|4|||
37996446|NCT00463151|69681097|FG003|Overall Study|Lack of Efficacy|5|||
37996447|NCT00463151|69681094|FG000|Overall Study|Protocol Violation|0|||
37996448|NCT00463151|69681095|FG001|Overall Study|Protocol Violation|0|||
37996449|NCT00463151|69681096|FG002|Overall Study|Protocol Violation|0|||
37826740|NCT00473590|69509619|FG001|Overall Study|Death|2|||
37826741|NCT00473590|69509618|FG000|Overall Study|Progression not resulting in death|24|||
37826742|NCT00473590|69509619|FG001|Overall Study|Progression not resulting in death|20|||
37826743|NCT00473590|69509618|FG000|Overall Study|Non-protocol-specified therapy|7|||
37826744|NCT00473590|69509619|FG001|Overall Study|Non-protocol-specified therapy|5|||
37826745|NCT00473590|69509618|FG000|Overall Study|Physician Decision|2|||
37826746|NCT00473590|69509619|FG001|Overall Study|Physician Decision|4|||
37826747|NCT00473590|69509618|FG000|Overall Study|Withdrawal by Subject|5|||
37826748|NCT00473590|69509619|FG001|Overall Study|Withdrawal by Subject|3|||
37826749|NCT00473590|69509618|FG000|Overall Study|Other|0|||
37826750|NCT00473590|69509619|FG001|Overall Study|Other|1|||
37826751|NCT00473512|69509630|FG000|Period 1 (Phase 1)|Adverse Event|0|||
37826752|NCT00473512|69509631|FG001|Period 1 (Phase 1)|Adverse Event|0|||
37826753|NCT00473512|69509632|FG002|Period 1 (Phase 1)|Adverse Event|0|||
37826754|NCT00473512|69509633|FG003|Period 1 (Phase 1)|Adverse Event|5|||
37898679|NCT00758680|69584031|FG003|Overall Study|Laboratory Adverse Event|0|||
37898680|NCT00758680|69584032|FG004|Overall Study|Laboratory Adverse Event|0|||
37898681|NCT00758680|69584033|FG005|Overall Study|Laboratory Adverse Event|0|||
37898682|NCT00758680|69584034|FG006|Overall Study|Laboratory Adverse Event|0|||
37996450|NCT00463151|69681097|FG003|Overall Study|Protocol Violation|1|||
37996451|NCT00463151|69681094|FG000|Overall Study|Withdrawal by Subject|0|||
37996452|NCT00463151|69681095|FG001|Overall Study|Withdrawal by Subject|0|||
37996453|NCT00463151|69681096|FG002|Overall Study|Withdrawal by Subject|0|||
37996454|NCT00463151|69681097|FG003|Overall Study|Withdrawal by Subject|1|||
37826755|NCT00473512|69509634|FG004|Period 1 (Phase 1)|Adverse Event|0|||
37826756|NCT00473512|69509630|FG000|Period 1 (Phase 1)|Death|0|||
37898683|NCT00758680|69584035|FG007|Overall Study|Laboratory Adverse Event|0|||
37898684|NCT00758680|69584036|FG008|Overall Study|Laboratory Adverse Event|1|||
37898685|NCT00758680|69584037|FG009|Overall Study|Laboratory Adverse Event|0|||
37898686|NCT00758680|69584028|FG000|Overall Study|Withdrawal by Subject|0|||
37898687|NCT00758680|69584029|FG001|Overall Study|Withdrawal by Subject|0|||
37898688|NCT00758680|69584030|FG002|Overall Study|Withdrawal by Subject|0|||
37898689|NCT00758680|69584031|FG003|Overall Study|Withdrawal by Subject|0|||
37898690|NCT00758680|69584032|FG004|Overall Study|Withdrawal by Subject|0|||
37898691|NCT00758680|69584033|FG005|Overall Study|Withdrawal by Subject|0|||
37826757|NCT00473512|69509631|FG001|Period 1 (Phase 1)|Death|0|||
37826758|NCT00473512|69509632|FG002|Period 1 (Phase 1)|Death|0|||
37898692|NCT00758680|69584034|FG006|Overall Study|Withdrawal by Subject|1|||
37898693|NCT00758680|69584035|FG007|Overall Study|Withdrawal by Subject|0|||
37898694|NCT00758680|69584036|FG008|Overall Study|Withdrawal by Subject|1|||
37898695|NCT00758680|69584037|FG009|Overall Study|Withdrawal by Subject|0|||
37898696|NCT00758602|69584062|FG000|Overall Study|Adverse Event|11|||
37898697|NCT00758602|69584063|FG001|Overall Study|Adverse Event|10|||
37898698|NCT00758602|69584062|FG000|Overall Study|Lost to Follow-up|4|||
37898699|NCT00758602|69584063|FG001|Overall Study|Lost to Follow-up|3|||
37898700|NCT00758602|69584062|FG000|Overall Study|Withdrawal by Subject|1|||
37898701|NCT00758602|69584063|FG001|Overall Study|Withdrawal by Subject|3|||
37898702|NCT00758602|69584062|FG000|Overall Study|Protocol Violation|0|||
37898703|NCT00758602|69584063|FG001|Overall Study|Protocol Violation|2|||
37898704|NCT00758602|69584062|FG000|Overall Study|Death|0|||
37898705|NCT00758602|69584063|FG001|Overall Study|Death|1|||
37898706|NCT00758602|69584062|FG000|Overall Study|Reason not specified|3|||
37898707|NCT00758602|69584063|FG001|Overall Study|Reason not specified|3|||
37898708|NCT00711529|69584072|FG000|Overall Study|Protocol Violation|2|||
37898709|NCT00711529|69584073|FG001|Overall Study|Protocol Violation|0|||
37898710|NCT00711529|69584072|FG000|Overall Study|Withdrawal by Subject|2|||
37898711|NCT00711529|69584073|FG001|Overall Study|Withdrawal by Subject|6|||
37898712|NCT00601419|69584079|FG000|Overall Study|Lost to Follow-up|3|||
37898713|NCT00601419|69584079|FG000|Overall Study|Missed Visits|1|||
37898714|NCT00712933|69584099|FG000|Overall Study|Adverse Event|69|||
37898715|NCT00712933|69584099|FG000|Overall Study|Lack of Efficacy|6|||
37898716|NCT00712933|69584099|FG000|Overall Study|Lost to Follow-up|22|||
37898717|NCT00712933|69584099|FG000|Overall Study|Non-compliance with study drug|13|||
37898718|NCT00712933|69584099|FG000|Overall Study|Other Pregnancy|37|||
37898719|NCT00712933|69584099|FG000|Overall Study|Sponsor decision|14|||
37898720|NCT00712933|69584099|FG000|Overall Study|Withdrew consent|4|||
37898721|NCT00712933|69584099|FG000|Overall Study|Hip replacement surgery|1|||
37898722|NCT00712933|69584099|FG000|Overall Study|Involved in Clinical research|3|||
37898723|NCT00712933|69584099|FG000|Overall Study|Participant hospitalized|1|||
37898724|NCT00712933|69584099|FG000|Overall Study|Participant travelled overseas|2|||
37898725|NCT00712933|69584099|FG000|Overall Study|Death of patient|1|||
37898726|NCT00712933|69584099|FG000|Overall Study|Other Physician decision|1|||
37996455|NCT00068380|69681107|FG000|Overall Study|Withdrawal by Subject|3|||
37826759|NCT00473512|69509633|FG003|Period 1 (Phase 1)|Death|1|||
37898727|NCT00712933|69584099|FG000|Overall Study|Not committed to contraception|1|||
37898728|NCT00712933|69584099|FG000|Overall Study|Participant received medication|1|||
37898729|NCT00712933|69584099|FG000|Overall Study|Physician Decision|36|||
37898730|NCT00712933|69584099|FG000|Overall Study|Protocol Violation|4|||
37898731|NCT00712933|69584099|FG000|Overall Study|Withdrawal by Subject|151|||
37898732|NCT00712543|69584109|FG000|Day 8-14|Lost to Follow-up|0|||
37898733|NCT00712543|69584110|FG001|Day 8-14|Lost to Follow-up|2|||
37898734|NCT00709111|69584116|FG000|Overall Study|Withdrawal by Subject|1|||
37898735|NCT00709111|69584116|FG000|Overall Study|Unable to attend clinic visits|1|||
37898736|NCT00710749|69584120|FG000|First Intervention|Withdrawal by Subject|1|||
37898737|NCT00710749|69584121|FG001|First Intervention|Withdrawal by Subject|0|||
37898738|NCT00699907|69584141|FG000|Overall Study|Withdrawal by Subject|2|||
37898739|NCT00699907|69584142|FG001|Overall Study|Withdrawal by Subject|1|||
37898740|NCT00699907|69584143|FG002|Overall Study|Withdrawal by Subject|0|||
37898741|NCT00699907|69584141|FG000|Overall Study|No usable sample|0|||
37898742|NCT00699907|69584142|FG001|Overall Study|No usable sample|9|||
37898743|NCT00699907|69584143|FG002|Overall Study|No usable sample|8|||
37898744|NCT00710593|69584153|FG000|Overall Study|Incarceration|1|||
37898745|NCT00710593|69584154|FG001|Overall Study|Incarceration|0|||
37898746|NCT00710593|69584153|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
37898747|NCT00710593|69584154|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
37898748|NCT00710593|69584153|FG000|Overall Study|Lost to Follow-up|3|||
37898749|NCT00710593|69584154|FG001|Overall Study|Lost to Follow-up|1|||
37898750|NCT00710593|69584153|FG000|Overall Study|Moved out of area|1|||
37898751|NCT00710593|69584154|FG001|Overall Study|Moved out of area|0|||
37898752|NCT00710593|69584153|FG000|Overall Study|Failure to adhere or complete study eval|1|||
37898753|NCT00710593|69584154|FG001|Overall Study|Failure to adhere or complete study eval|1|||
37898754|NCT00710593|69584153|FG000|Overall Study|Protocol Violation|1|||
37898755|NCT00710593|69584154|FG001|Overall Study|Protocol Violation|1|||
37898756|NCT00710593|69584153|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
37898757|NCT00710593|69584154|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
37898758|NCT00599313|69584176|FG000|Overall Study|Adverse Event|19|||
37898759|NCT00599313|69584176|FG000|Overall Study|Disease Progression|12|||
37898760|NCT00599313|69584176|FG000|Overall Study|Patient Request|4|||
37898761|NCT00599313|69584176|FG000|Overall Study|Ineligible|1|||
37898762|NCT00708175|69584182|FG000|Overall Study|Adverse Event|4|||
37898763|NCT00708175|69584183|FG001|Overall Study|Adverse Event|5|||
37898764|NCT00708175|69584182|FG000|Overall Study|Protocol Violation|2|||
37898765|NCT00708175|69584183|FG001|Overall Study|Protocol Violation|3|||
37898766|NCT00708175|69584182|FG000|Overall Study|Lost to Follow-up|5|||
37898767|NCT00708175|69584183|FG001|Overall Study|Lost to Follow-up|3|||
37898768|NCT00708175|69584182|FG000|Overall Study|Withdrawal by Subject|5|||
37898769|NCT00708175|69584183|FG001|Overall Study|Withdrawal by Subject|7|||
37898770|NCT00708175|69584182|FG000|Overall Study|BMD loss >7%|2|||
37898771|NCT00708175|69584183|FG001|Overall Study|BMD loss >7%|3|||
37898772|NCT00707239|69584192|FG000|Overall Study|Adverse Event|5|||
37898773|NCT00707239|69584193|FG001|Overall Study|Adverse Event|3|||
37898774|NCT00707239|69584194|FG002|Overall Study|Adverse Event|2|||
37898775|NCT00707239|69584192|FG000|Overall Study|Death|3|||
37898776|NCT00707239|69584193|FG001|Overall Study|Death|1|||
37898777|NCT00707239|69584194|FG002|Overall Study|Death|3|||
37898778|NCT00707239|69584192|FG000|Overall Study|Physician Decision|1|||
37898779|NCT00707239|69584193|FG001|Overall Study|Physician Decision|1|||
37898780|NCT00707239|69584194|FG002|Overall Study|Physician Decision|2|||
37898781|NCT00707239|69584192|FG000|Overall Study|Protocol Violation|0|||
37898782|NCT00707239|69584193|FG001|Overall Study|Protocol Violation|0|||
37898783|NCT00707239|69584194|FG002|Overall Study|Protocol Violation|1|||
37898784|NCT00707239|69584192|FG000|Overall Study|Lack of Efficacy|1|||
37898785|NCT00707239|69584193|FG001|Overall Study|Lack of Efficacy|2|||
37898786|NCT00707239|69584194|FG002|Overall Study|Lack of Efficacy|0|||
37898787|NCT00707239|69584192|FG000|Overall Study|Randomized, but not treated|1|||
37898788|NCT00707239|69584193|FG001|Overall Study|Randomized, but not treated|1|||
37898789|NCT00707239|69584194|FG002|Overall Study|Randomized, but not treated|1|||
37898790|NCT00707239|69584192|FG000|Overall Study|Other|8|||
37898791|NCT00707239|69584193|FG001|Overall Study|Other|3|||
37898792|NCT00707239|69584194|FG002|Overall Study|Other|5|||
37898793|NCT00968708|69584207|FG000|Overall Study|Adverse Event|169|||
37898794|NCT00968708|69584208|FG001|Overall Study|Adverse Event|150|||
37898795|NCT00968708|69584207|FG000|Overall Study|Major Protocol Deviation|0|||
37898796|NCT00968708|69584208|FG001|Overall Study|Major Protocol Deviation|1|||
37898797|NCT00968708|69584207|FG000|Overall Study|Lost to Follow-up|19|||
37898798|NCT00968708|69584208|FG001|Overall Study|Lost to Follow-up|11|||
37898799|NCT00968708|69584207|FG000|Overall Study|Voluntary Withdrawal|104|||
37898800|NCT00968708|69584208|FG001|Overall Study|Voluntary Withdrawal|101|||
37898801|NCT00968708|69584207|FG000|Overall Study|Investigator Discretion|0|||
37898802|NCT00968708|69584208|FG001|Overall Study|Investigator Discretion|1|||
37898803|NCT00968708|69584207|FG000|Overall Study|Other|26|||
37898804|NCT00968708|69584208|FG001|Overall Study|Other|34|||
37996456|NCT00068380|69681107|FG000|Overall Study|Adverse Event|2|||
37898805|NCT00967694|69584214|FG000|Overall Study|Withdrawal by Subject|6|||
37898806|NCT00967616|69584220|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
37898807|NCT00967616|69584221|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
37898808|NCT00967616|69584220|FG000|Overall Study|Death|0|||
37898809|NCT00967616|69584221|FG001|Overall Study|Death|3|||
37898810|NCT00967616|69584220|FG000|Overall Study|Withdrawal by Subject|8|||
37898811|NCT00967616|69584221|FG001|Overall Study|Withdrawal by Subject|4|||
37898812|NCT00967616|69584220|FG000|Overall Study|Progressive Disease|31|||
37898813|NCT00967616|69584221|FG001|Overall Study|Progressive Disease|18|||
37898814|NCT00967616|69584220|FG000|Overall Study|Other|8|||
37898815|NCT00967616|69584221|FG001|Overall Study|Other|8|||
37898816|NCT00967616|69584220|FG000|Overall Study|Protocol Violation|1|||
37898817|NCT00967616|69584221|FG001|Overall Study|Protocol Violation|0|||
37898818|NCT00971204|69584231|FG000|Overall Study|Did not meet all criteria-not treated|14|||
37898819|NCT00971204|69584231|FG000|Overall Study|Lost to Follow-up|10|||
37898820|NCT00974090|69584237|FG000|Period 1: Double Blind Period|Adverse Event|2|||
37898821|NCT00974090|69584238|FG001|Period 1: Double Blind Period|Adverse Event|1|||
37898822|NCT00974090|69584237|FG000|Period 1: Double Blind Period|Physician Decision|1|||
37898823|NCT00974090|69584238|FG001|Period 1: Double Blind Period|Physician Decision|0|||
37898824|NCT00974090|69584237|FG000|Period 2: Open-label Period|Adverse Event|4|||
37898825|NCT00974090|69584238|FG001|Period 2: Open-label Period|Adverse Event|6|||
37898826|NCT00974090|69584237|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
37898827|NCT00974090|69584238|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
37898828|NCT00974090|69584237|FG000|Period 2: Open-label Period|Physician Decision|0|||
37898829|NCT00974090|69584238|FG001|Period 2: Open-label Period|Physician Decision|3|||
37898830|NCT00974090|69584237|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
37898831|NCT00974090|69584238|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
37898832|NCT00971048|69584250|FG000|Overall Study|Protocol Violation|1|||
37898833|NCT00971048|69584251|FG001|Overall Study|Protocol Violation|2|||
37898834|NCT00971048|69584252|FG002|Overall Study|Protocol Violation|0|||
37898835|NCT00971048|69584253|FG003|Overall Study|Protocol Violation|1|||
37898836|NCT00971048|69584250|FG000|Overall Study|Adverse Event|0|||
37898837|NCT00971048|69584251|FG001|Overall Study|Adverse Event|0|||
37898838|NCT00971048|69584252|FG002|Overall Study|Adverse Event|1|||
37898839|NCT00971048|69584253|FG003|Overall Study|Adverse Event|0|||
37898840|NCT00971048|69584250|FG000|Overall Study|Physician Decision|0|||
37898841|NCT00971048|69584251|FG001|Overall Study|Physician Decision|0|||
37898842|NCT00971048|69584252|FG002|Overall Study|Physician Decision|0|||
37898843|NCT00971048|69584253|FG003|Overall Study|Physician Decision|1|||
37898844|NCT00699751|69584267|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
37898845|NCT00699751|69584268|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
37898846|NCT00699751|69584267|FG000|Period 1: Without/Before Drug Switch|Death|28|||
37898847|NCT00699751|69584268|FG001|Period 1: Without/Before Drug Switch|Death|29|||
37898848|NCT00699751|69584267|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
37898849|NCT00699751|69584268|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
37898850|NCT00699751|69584267|FG000|Period 1: Without/Before Drug Switch|Other|30|||
37898851|NCT00699751|69584268|FG001|Period 1: Without/Before Drug Switch|Other|20|||
37898852|NCT00699751|69584267|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
37898853|NCT00699751|69584268|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
37898854|NCT00699751|69584267|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
37898855|NCT00699751|69584268|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
37898856|NCT00699751|69584267|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
37898857|NCT00699751|69584268|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
37898858|NCT00699751|69584267|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
37898859|NCT00699751|69584268|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
37898860|NCT00970502|69584275|FG000|Overall Study|Withdrawal by Subject|1|||
37898861|NCT00967226|69584285|FG000|Overall Study|Adverse Event|0|||
37898862|NCT00967226|69584286|FG001|Overall Study|Adverse Event|5|||
37898863|NCT00967226|69584285|FG000|Overall Study|Protocol Violation|2|||
37898864|NCT00967226|69584286|FG001|Overall Study|Protocol Violation|0|||
37898865|NCT00967226|69584285|FG000|Overall Study|Physician Decision|0|||
37898866|NCT00967226|69584286|FG001|Overall Study|Physician Decision|1|||
37898867|NCT00706381|69584320|FG000|Overall Study|Lost to Follow-up|0|||
37898868|NCT00706381|69584321|FG001|Overall Study|Lost to Follow-up|1|||
37898869|NCT00706381|69584322|FG002|Overall Study|Lost to Follow-up|1|||
37898870|NCT00706381|69584323|FG003|Overall Study|Lost to Follow-up|0|||
37898871|NCT00964886|69584340|FG000|Overall Study|Lost to Follow-up|2|||
37898872|NCT00964886|69584341|FG001|Overall Study|Lost to Follow-up|2|||
37898873|NCT00964886|69584342|FG002|Overall Study|Lost to Follow-up|6|||
37898874|NCT00964886|69584343|FG003|Overall Study|Lost to Follow-up|4|||
37898875|NCT00964886|69584340|FG000|Overall Study|Withdrawal by Subject|6|||
37898876|NCT00964886|69584341|FG001|Overall Study|Withdrawal by Subject|2|||
37898877|NCT00964886|69584342|FG002|Overall Study|Withdrawal by Subject|5|||
37898878|NCT00964886|69584343|FG003|Overall Study|Withdrawal by Subject|3|||
37898879|NCT00964886|69584340|FG000|Overall Study|Adverse Event|3|||
37898880|NCT00964886|69584341|FG001|Overall Study|Adverse Event|1|||
37898881|NCT00964886|69584342|FG002|Overall Study|Adverse Event|5|||
37898882|NCT00964886|69584343|FG003|Overall Study|Adverse Event|2|||
37898883|NCT00964886|69584340|FG000|Overall Study|Protocol Violation|0|||
37898884|NCT00964886|69584341|FG001|Overall Study|Protocol Violation|2|||
37898885|NCT00964886|69584342|FG002|Overall Study|Protocol Violation|0|||
37898886|NCT00964886|69584343|FG003|Overall Study|Protocol Violation|0|||
37898887|NCT00705757|69584360|FG000|Overall Study|Lack of Efficacy|5|||
37898888|NCT00705757|69584361|FG001|Overall Study|Lack of Efficacy|1|||
37898889|NCT00705757|69584362|FG002|Overall Study|Lack of Efficacy|3|||
37996457|NCT00067990|69681113|FG000|Overall Study|Death|5|||
37996458|NCT00067990|69681114|FG001|Overall Study|Death|7|||
37996459|NCT00067990|69681113|FG000|Overall Study|ESRD, Non IF/TA|1|||
37996460|NCT00067990|69681114|FG001|Overall Study|ESRD, Non IF/TA|3|||
37996461|NCT00067990|69681113|FG000|Overall Study|Withdrawal by Subject|4|||
37996462|NCT00067990|69681114|FG001|Overall Study|Withdrawal by Subject|12|||
37996463|NCT00090220|69681122|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
37996464|NCT00090220|69681123|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
37996465|NCT00090220|69681124|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
37996466|NCT00090220|69681125|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
37996467|NCT00090220|69681126|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
37996468|NCT00090220|69681127|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
37996469|NCT00090220|69681122|FG000|Base Study Vaccination Period|Adverse Event|6|||
37996470|NCT00090220|69681123|FG001|Base Study Vaccination Period|Adverse Event|1|||
37996471|NCT00090220|69681124|FG002|Base Study Vaccination Period|Adverse Event|0|||
37996472|NCT00090220|69681125|FG003|Base Study Vaccination Period|Adverse Event|0|||
37996473|NCT00090220|69681126|FG004|Base Study Vaccination Period|Adverse Event|0|||
37996474|NCT00090220|69681127|FG005|Base Study Vaccination Period|Adverse Event|0|||
37996475|NCT00090220|69681122|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
37996476|NCT00090220|69681123|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
37996477|NCT00090220|69681124|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
37996478|NCT00090220|69681125|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
37996479|NCT00090220|69681126|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
37996480|NCT00090220|69681127|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
37996481|NCT00090220|69681122|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
37996482|NCT00090220|69681123|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
37996483|NCT00090220|69681124|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
37996484|NCT00090220|69681125|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
37996485|NCT00090220|69681126|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
37996486|NCT00090220|69681127|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
37996487|NCT00090220|69681122|FG000|Base Study Vaccination Period|Patient Moved|6|||
37996488|NCT00090220|69681123|FG001|Base Study Vaccination Period|Patient Moved|2|||
37996489|NCT00090220|69681124|FG002|Base Study Vaccination Period|Patient Moved|0|||
37996490|NCT00090220|69681125|FG003|Base Study Vaccination Period|Patient Moved|0|||
37996491|NCT00090220|69681126|FG004|Base Study Vaccination Period|Patient Moved|0|||
37996492|NCT00090220|69681127|FG005|Base Study Vaccination Period|Patient Moved|0|||
37996493|NCT00090220|69681122|FG000|Base Study Vaccination Period|Other|4|||
37996494|NCT00090220|69681123|FG001|Base Study Vaccination Period|Other|4|||
37996495|NCT00090220|69681124|FG002|Base Study Vaccination Period|Other|0|||
37996496|NCT00090220|69681125|FG003|Base Study Vaccination Period|Other|0|||
37826760|NCT00473512|69509634|FG004|Period 1 (Phase 1)|Death|0|||
37826761|NCT00473512|69509630|FG000|Period 1 (Phase 1)|Disease Progression|1|||
37826762|NCT00473512|69509631|FG001|Period 1 (Phase 1)|Disease Progression|1|||
37826763|NCT00473512|69509632|FG002|Period 1 (Phase 1)|Disease Progression|0|||
37826764|NCT00473512|69509633|FG003|Period 1 (Phase 1)|Disease Progression|10|||
37826765|NCT00473512|69509634|FG004|Period 1 (Phase 1)|Disease Progression|1|||
37826766|NCT00473512|69509630|FG000|Period 1 (Phase 1)|Other|0|||
37826767|NCT00473512|69509631|FG001|Period 1 (Phase 1)|Other|0|||
37826768|NCT00473512|69509632|FG002|Period 1 (Phase 1)|Other|0|||
37826769|NCT00473512|69509633|FG003|Period 1 (Phase 1)|Other|1|||
37996497|NCT00090220|69681126|FG004|Base Study Vaccination Period|Other|0|||
37996498|NCT00090220|69681127|FG005|Base Study Vaccination Period|Other|0|||
37996499|NCT00090220|69681122|FG000|Base Study Follow-up Period|Adverse Event|6|||
37826770|NCT00473512|69509634|FG004|Period 1 (Phase 1)|Other|0|||
37826771|NCT00473512|69509630|FG000|Period 2 (Phase 2)|Adverse Event|0|||
37898890|NCT00705757|69584360|FG000|Overall Study|Lost to Follow-up|7|||
37898891|NCT00705757|69584361|FG001|Overall Study|Lost to Follow-up|6|||
37898892|NCT00705757|69584362|FG002|Overall Study|Lost to Follow-up|6|||
37996500|NCT00090220|69681123|FG001|Base Study Follow-up Period|Adverse Event|1|||
37996501|NCT00090220|69681124|FG002|Base Study Follow-up Period|Adverse Event|0|||
37996502|NCT00090220|69681125|FG003|Base Study Follow-up Period|Adverse Event|0|||
37996503|NCT00090220|69681126|FG004|Base Study Follow-up Period|Adverse Event|0|||
37826772|NCT00473512|69509631|FG001|Period 2 (Phase 2)|Adverse Event|0|||
37898893|NCT00705757|69584360|FG000|Overall Study|Withdrawal by Subject|1|||
37996504|NCT00090220|69681127|FG005|Base Study Follow-up Period|Adverse Event|0|||
37996505|NCT00090220|69681122|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
37996506|NCT00090220|69681123|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
37996507|NCT00090220|69681124|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
37996508|NCT00090220|69681125|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
37996509|NCT00090220|69681126|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
37996510|NCT00090220|69681127|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
37996511|NCT00090220|69681122|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
37996512|NCT00090220|69681123|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
37996513|NCT00090220|69681124|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
37996514|NCT00090220|69681125|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
37996515|NCT00090220|69681126|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
37996516|NCT00090220|69681127|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
37996517|NCT00090220|69681122|FG000|Base Study Follow-up Period|Patient Moved|20|||
37996518|NCT00090220|69681123|FG001|Base Study Follow-up Period|Patient Moved|28|||
37996519|NCT00090220|69681124|FG002|Base Study Follow-up Period|Patient Moved|0|||
37996520|NCT00090220|69681125|FG003|Base Study Follow-up Period|Patient Moved|0|||
37898894|NCT00705757|69584361|FG001|Overall Study|Withdrawal by Subject|1|||
37898895|NCT00705757|69584362|FG002|Overall Study|Withdrawal by Subject|2|||
37898896|NCT00960752|69584390|FG000|Overall Study|Adverse Event|0|||
37898897|NCT00960752|69584391|FG001|Overall Study|Adverse Event|0|||
37898898|NCT00960752|69584392|FG002|Overall Study|Adverse Event|1|||
37898899|NCT00960752|69584390|FG000|Overall Study|Progression|0|||
37898900|NCT00960752|69584391|FG001|Overall Study|Progression|0|||
37898901|NCT00960752|69584392|FG002|Overall Study|Progression|1|||
37898902|NCT00758524|69584406|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
37898903|NCT00758524|69584407|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
37898904|NCT00758524|69584408|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
37898905|NCT00758524|69584409|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
37898906|NCT00758524|69584410|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
37898907|NCT00758524|69584411|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
37898908|NCT00758524|69584412|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
37898909|NCT00758524|69584413|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
37898910|NCT00758524|69584414|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
37898911|NCT00758524|69584415|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
37898912|NCT00758524|69584416|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
37898913|NCT00758524|69584417|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
37898914|NCT00758524|69584418|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
37898915|NCT00758524|69584419|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
37898916|NCT00758524|69584420|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
37898917|NCT00758524|69584421|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
37898918|NCT00758524|69584422|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
37898919|NCT00758524|69584406|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
37898920|NCT00758524|69584407|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
37898921|NCT00758524|69584408|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
37898922|NCT00758524|69584409|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
37996521|NCT00090220|69681126|FG004|Base Study Follow-up Period|Patient Moved|0|||
37996522|NCT00090220|69681127|FG005|Base Study Follow-up Period|Patient Moved|0|||
37996523|NCT00090220|69681122|FG000|Base Study Follow-up Period|Other|19|||
37996524|NCT00090220|69681123|FG001|Base Study Follow-up Period|Other|21|||
37826773|NCT00473512|69509632|FG002|Period 2 (Phase 2)|Adverse Event|0|||
37826774|NCT00473512|69509633|FG003|Period 2 (Phase 2)|Adverse Event|1|||
37826775|NCT00473512|69509634|FG004|Period 2 (Phase 2)|Adverse Event|0|||
37826776|NCT00473512|69509630|FG000|Period 2 (Phase 2)|Death|0|||
37826777|NCT00473512|69509631|FG001|Period 2 (Phase 2)|Death|0|||
37826778|NCT00473512|69509632|FG002|Period 2 (Phase 2)|Death|0|||
37826779|NCT00473512|69509633|FG003|Period 2 (Phase 2)|Death|1|||
37826780|NCT00473512|69509634|FG004|Period 2 (Phase 2)|Death|1|||
37826781|NCT00473512|69509630|FG000|Period 2 (Phase 2)|Disease Progression|0|||
37826782|NCT00473512|69509631|FG001|Period 2 (Phase 2)|Disease Progression|2|||
37826783|NCT00473512|69509632|FG002|Period 2 (Phase 2)|Disease Progression|2|||
37826784|NCT00473512|69509633|FG003|Period 2 (Phase 2)|Disease Progression|17|||
37898923|NCT00758524|69584410|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
37898924|NCT00758524|69584411|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
37996525|NCT00090220|69681124|FG002|Base Study Follow-up Period|Other|0|||
37996526|NCT00090220|69681125|FG003|Base Study Follow-up Period|Other|0|||
37996527|NCT00090220|69681126|FG004|Base Study Follow-up Period|Other|0|||
37996528|NCT00090220|69681127|FG005|Base Study Follow-up Period|Other|0|||
37996529|NCT00090220|69681122|FG000|Extension 1 (EXT1)|Adverse Event|0|||
37996530|NCT00090220|69681123|FG001|Extension 1 (EXT1)|Adverse Event|0|||
37898925|NCT00758524|69584412|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
37996531|NCT00090220|69681124|FG002|Extension 1 (EXT1)|Adverse Event|4|||
37826785|NCT00473512|69509634|FG004|Period 2 (Phase 2)|Disease Progression|1|||
37996532|NCT00090220|69681125|FG003|Extension 1 (EXT1)|Adverse Event|0|||
37898926|NCT00758524|69584413|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
37898927|NCT00758524|69584414|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
37898928|NCT00758524|69584415|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
37898929|NCT00758524|69584416|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
37898930|NCT00758524|69584417|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
37898931|NCT00758524|69584418|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
37898932|NCT00758524|69584419|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
37898933|NCT00758524|69584420|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
37898934|NCT00758524|69584421|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
37898935|NCT00758524|69584422|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
37898936|NCT00758524|69584406|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
37898937|NCT00758524|69584407|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
37898938|NCT00758524|69584408|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
37898939|NCT00758524|69584409|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
37898940|NCT00758524|69584410|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
37898941|NCT00758524|69584411|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
37898942|NCT00758524|69584412|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
37898943|NCT00758524|69584413|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
37898944|NCT00758524|69584414|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
37898945|NCT00758524|69584415|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
37898946|NCT00758524|69584416|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
37898947|NCT00758524|69584417|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
37898948|NCT00758524|69584418|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
37898949|NCT00758524|69584419|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
37898950|NCT00758524|69584420|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
37898951|NCT00758524|69584421|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
37898952|NCT00758524|69584422|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
37898953|NCT00758524|69584406|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
37898954|NCT00758524|69584407|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
37898955|NCT00758524|69584408|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
37898956|NCT00758524|69584409|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
37898957|NCT00758524|69584410|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
37898958|NCT00758524|69584411|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
37898959|NCT00758524|69584412|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
37898960|NCT00758524|69584413|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
37898961|NCT00758524|69584414|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
37898962|NCT00758524|69584415|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
37898963|NCT00758524|69584416|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
37898964|NCT00758524|69584417|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
37898965|NCT00758524|69584418|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
37898966|NCT00758524|69584419|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
37898967|NCT00758524|69584420|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
37898968|NCT00758524|69584421|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
37898969|NCT00758524|69584422|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
37898970|NCT00758524|69584406|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
37898971|NCT00758524|69584407|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
37898972|NCT00758524|69584408|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
37898973|NCT00758524|69584409|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
37898974|NCT00758524|69584410|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
37898975|NCT00758524|69584411|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
37898976|NCT00758524|69584412|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
37898977|NCT00758524|69584413|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
37898978|NCT00758524|69584414|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
37898979|NCT00758524|69584415|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
37898980|NCT00758524|69584416|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
37898981|NCT00758524|69584417|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
37898982|NCT00758524|69584418|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
37898983|NCT00758524|69584419|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
37898984|NCT00758524|69584420|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
37898985|NCT00758524|69584421|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
37898986|NCT00758524|69584422|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
37898987|NCT00758524|69584406|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
37898988|NCT00758524|69584407|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
37898989|NCT00758524|69584408|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
37898990|NCT00758524|69584409|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
37996533|NCT00090220|69681126|FG004|Extension 1 (EXT1)|Adverse Event|0|||
37898991|NCT00758524|69584410|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
37898992|NCT00758524|69584411|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
37898993|NCT00758524|69584412|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
37898994|NCT00758524|69584413|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
37898995|NCT00758524|69584414|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
37898996|NCT00758524|69584415|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
37898997|NCT00758524|69584416|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
37898998|NCT00758524|69584417|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
37898999|NCT00758524|69584418|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
37899000|NCT00758524|69584419|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
37899001|NCT00758524|69584420|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
37899002|NCT00758524|69584421|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
37996534|NCT00090220|69681127|FG005|Extension 1 (EXT1)|Adverse Event|0|||
37996535|NCT00090220|69681122|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
37996536|NCT00090220|69681123|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
37996537|NCT00090220|69681124|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
37996538|NCT00090220|69681125|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
37996539|NCT00090220|69681126|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
37996540|NCT00090220|69681127|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
37996541|NCT00090220|69681122|FG000|Extension 1 (EXT1)|Moved|0|||
37899003|NCT00758524|69584422|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
37899004|NCT00758524|69584406|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
37899005|NCT00758524|69584407|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
37899006|NCT00758524|69584408|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
37899007|NCT00758524|69584409|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
37899008|NCT00758524|69584410|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
37899009|NCT00758524|69584411|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
37899010|NCT00758524|69584412|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
37899011|NCT00758524|69584413|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
37899012|NCT00758524|69584414|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
37899013|NCT00758524|69584415|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
37899014|NCT00758524|69584416|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
37899015|NCT00758524|69584417|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
37899016|NCT00758524|69584418|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
37899017|NCT00758524|69584419|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
37899018|NCT00758524|69584420|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
37899019|NCT00758524|69584421|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
37899020|NCT00758524|69584422|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
37899021|NCT00758524|69584406|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
37899022|NCT00758524|69584407|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
37899023|NCT00758524|69584408|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
37899024|NCT00758524|69584409|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
37899025|NCT00758524|69584410|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
37899026|NCT00758524|69584411|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
37899027|NCT00758524|69584412|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
37899028|NCT00758524|69584413|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
37899029|NCT00758524|69584414|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
37899030|NCT00758524|69584415|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
37899031|NCT00758524|69584416|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
37899032|NCT00758524|69584417|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
37899033|NCT00758524|69584418|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
37899034|NCT00758524|69584419|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
37899035|NCT00758524|69584420|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
37899036|NCT00758524|69584421|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
37899037|NCT00758524|69584422|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
37899038|NCT00758524|69584406|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
37899039|NCT00758524|69584407|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
37899040|NCT00758524|69584408|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
37899041|NCT00758524|69584409|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
37899042|NCT00758524|69584410|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
37899043|NCT00758524|69584411|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
37996542|NCT00090220|69681123|FG001|Extension 1 (EXT1)|Moved|0|||
37996543|NCT00090220|69681124|FG002|Extension 1 (EXT1)|Moved|2|||
37996544|NCT00090220|69681125|FG003|Extension 1 (EXT1)|Moved|1|||
37996545|NCT00090220|69681126|FG004|Extension 1 (EXT1)|Moved|0|||
37996546|NCT00090220|69681127|FG005|Extension 1 (EXT1)|Moved|0|||
37996547|NCT00090220|69681122|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
37996548|NCT00090220|69681123|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
37996549|NCT00090220|69681124|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
37996550|NCT00090220|69681125|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
37996551|NCT00090220|69681126|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
37996552|NCT00090220|69681127|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
37996553|NCT00090220|69681122|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
37996554|NCT00090220|69681123|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
37996555|NCT00090220|69681124|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
37996556|NCT00090220|69681125|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
37996557|NCT00090220|69681126|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
37996558|NCT00090220|69681127|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
37996559|NCT00090220|69681122|FG000|Extension 1 (EXT1)|Other reason|0|||
37996560|NCT00090220|69681123|FG001|Extension 1 (EXT1)|Other reason|0|||
37996561|NCT00090220|69681124|FG002|Extension 1 (EXT1)|Other reason|2|||
37996562|NCT00090220|69681125|FG003|Extension 1 (EXT1)|Other reason|0|||
37996563|NCT00090220|69681126|FG004|Extension 1 (EXT1)|Other reason|0|||
37996564|NCT00090220|69681127|FG005|Extension 1 (EXT1)|Other reason|0|||
37996565|NCT00090220|69681122|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
37996566|NCT00090220|69681123|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
37996567|NCT00090220|69681124|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
37996568|NCT00090220|69681125|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
37996569|NCT00090220|69681126|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
37996570|NCT00090220|69681127|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
37996571|NCT00090220|69681122|FG000|Long-term Follow-up (EXT2)|Death|0|||
37996572|NCT00090220|69681123|FG001|Long-term Follow-up (EXT2)|Death|0|||
37996573|NCT00090220|69681124|FG002|Long-term Follow-up (EXT2)|Death|0|||
37996574|NCT00090220|69681125|FG003|Long-term Follow-up (EXT2)|Death|0|||
37996575|NCT00090220|69681126|FG004|Long-term Follow-up (EXT2)|Death|1|||
37996576|NCT00090220|69681127|FG005|Long-term Follow-up (EXT2)|Death|1|||
37996577|NCT00090220|69681122|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
37996578|NCT00090220|69681123|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
37996579|NCT00090220|69681124|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
37996580|NCT00090220|69681125|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
37996581|NCT00090220|69681126|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
37996582|NCT00090220|69681127|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
37996583|NCT00090220|69681122|FG000|Long-term Follow-up (EXT2)|Other|0|||
37996584|NCT00090220|69681123|FG001|Long-term Follow-up (EXT2)|Other|0|||
37996585|NCT00090220|69681124|FG002|Long-term Follow-up (EXT2)|Other|0|||
37996586|NCT00090220|69681125|FG003|Long-term Follow-up (EXT2)|Other|0|||
37696603|NCT02323334|69172756|FG013|Period 3|Lost to Follow-up|0|||
37696604|NCT02323334|69172757|FG014|Period 3|Lost to Follow-up|0|||
37696605|NCT02323334|69172758|FG015|Period 3|Lost to Follow-up|0|||
37696606|NCT02323334|69172759|FG016|Period 3|Lost to Follow-up|0|||
37696607|NCT02323334|69172743|FG000|Period 3|Withdrawal by Subject|1|||
37696608|NCT02323334|69172744|FG001|Period 3|Withdrawal by Subject|0|||
37696609|NCT02323334|69172745|FG002|Period 3|Withdrawal by Subject|0|||
37696610|NCT02323334|69172746|FG003|Period 3|Withdrawal by Subject|0|||
37696611|NCT02323334|69172747|FG004|Period 3|Withdrawal by Subject|0|||
37696612|NCT02323334|69172748|FG005|Period 3|Withdrawal by Subject|0|||
37696613|NCT02323334|69172749|FG006|Period 3|Withdrawal by Subject|0|||
37696614|NCT02323334|69172750|FG007|Period 3|Withdrawal by Subject|0|||
37696615|NCT02323334|69172751|FG008|Period 3|Withdrawal by Subject|0|||
37826786|NCT00473512|69509630|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
37826787|NCT00473512|69509631|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
37996587|NCT00090220|69681126|FG004|Long-term Follow-up (EXT2)|Other|1|||
37996588|NCT00090220|69681127|FG005|Long-term Follow-up (EXT2)|Other|0|||
37996589|NCT00263328|69681147|FG000|Overall Study|Death|0|||
37996590|NCT00263328|69681148|FG001|Overall Study|Death|0|||
37696616|NCT02323334|69172752|FG009|Period 3|Withdrawal by Subject|0|||
37696617|NCT02323334|69172753|FG010|Period 3|Withdrawal by Subject|0|||
37996591|NCT00263328|69681149|FG002|Overall Study|Death|1|||
37996592|NCT00263328|69681147|FG000|Overall Study|Lost to Follow-up|1|||
37996593|NCT00263328|69681148|FG001|Overall Study|Lost to Follow-up|1|||
37996594|NCT00263328|69681149|FG002|Overall Study|Lost to Follow-up|0|||
37996595|NCT00263328|69681147|FG000|Overall Study|Withdrawal by Subject|3|||
37696618|NCT02323334|69172754|FG011|Period 3|Withdrawal by Subject|0|||
37826788|NCT00473512|69509632|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
37696619|NCT02323334|69172755|FG012|Period 3|Withdrawal by Subject|0|||
37696620|NCT02323334|69172756|FG013|Period 3|Withdrawal by Subject|0|||
37696621|NCT02323334|69172757|FG014|Period 3|Withdrawal by Subject|0|||
37899044|NCT00758524|69584412|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
37899045|NCT00758524|69584413|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
37899046|NCT00758524|69584414|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
37899047|NCT00758524|69584415|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
37899048|NCT00758524|69584416|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
37899049|NCT00758524|69584417|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
37899050|NCT00758524|69584418|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
37899051|NCT00758524|69584419|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
37899052|NCT00758524|69584420|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
37899053|NCT00758524|69584421|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
37899054|NCT00758524|69584422|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
37899055|NCT00758524|69584406|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
37899056|NCT00758524|69584407|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
37899057|NCT00758524|69584408|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
37899058|NCT00758524|69584409|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
37899059|NCT00758524|69584410|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
37899060|NCT00758524|69584411|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
37899061|NCT00758524|69584412|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
37899062|NCT00758524|69584413|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
37899063|NCT00758524|69584414|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
37899064|NCT00758524|69584415|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
37899065|NCT00758524|69584416|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
37899066|NCT00758524|69584417|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
37899067|NCT00758524|69584418|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
37899068|NCT00758524|69584419|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
37899069|NCT00758524|69584420|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
37899070|NCT00758524|69584421|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
37899071|NCT00758524|69584422|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
37899072|NCT00757588|69584462|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
37899073|NCT00757588|69584463|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
37899074|NCT00757588|69584462|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
37899075|NCT00757588|69584463|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
37899076|NCT00757588|69584462|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
37899077|NCT00757588|69584463|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
37899078|NCT00757588|69584462|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
37899079|NCT00757588|69584463|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
37696622|NCT02323334|69172758|FG015|Period 3|Withdrawal by Subject|0|||
37696623|NCT02323334|69172759|FG016|Period 3|Withdrawal by Subject|0|||
37696624|NCT02448719|69172832|FG000|Overall Study|Withdrawal by Subject|0|||
37696625|NCT02448719|69172833|FG001|Overall Study|Withdrawal by Subject|0|||
37696626|NCT02448719|69172834|FG002|Overall Study|Withdrawal by Subject|0|||
37696627|NCT02448719|69172835|FG003|Overall Study|Withdrawal by Subject|0|||
37696628|NCT02448719|69172836|FG004|Overall Study|Withdrawal by Subject|1|||
37696629|NCT02448719|69172837|FG005|Overall Study|Withdrawal by Subject|0|||
37899080|NCT00757588|69584462|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
37899081|NCT00757588|69584463|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
37899082|NCT00757588|69584462|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
37899083|NCT00757588|69584463|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
37899084|NCT00757588|69584462|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
37899085|NCT00757588|69584463|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
37899086|NCT00757588|69584462|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
37899087|NCT00757588|69584463|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
37899088|NCT00757588|69584462|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
37899089|NCT00757588|69584463|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
37899090|NCT00757588|69584462|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
37899091|NCT00757588|69584463|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
37996596|NCT00263328|69681148|FG001|Overall Study|Withdrawal by Subject|0|||
37996597|NCT00263328|69681149|FG002|Overall Study|Withdrawal by Subject|1|||
37696630|NCT02448719|69172838|FG006|Overall Study|Withdrawal by Subject|0|||
37696631|NCT02448719|69172839|FG007|Overall Study|Withdrawal by Subject|0|||
37899092|NCT00757588|69584462|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
37899093|NCT00757588|69584463|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
37899094|NCT00757588|69584462|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
37899095|NCT00757588|69584463|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
37899096|NCT00757588|69584462|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
37899097|NCT00757588|69584463|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
37899098|NCT00757588|69584462|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
37899099|NCT00757588|69584463|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
37899100|NCT00757588|69584462|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
37899101|NCT00757588|69584463|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
37899102|NCT00757588|69584462|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
37899103|NCT00757588|69584463|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
37899104|NCT00744796|69584469|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
37899105|NCT00705679|69584478|FG000|Overall Study|Adverse Event|1|||
37899106|NCT00705679|69584479|FG001|Overall Study|Adverse Event|1|||
37899107|NCT00705679|69584480|FG002|Overall Study|Adverse Event|0|||
37899108|NCT00705679|69584481|FG003|Overall Study|Adverse Event|0|||
37899109|NCT00705679|69584482|FG004|Overall Study|Adverse Event|0|||
37899110|NCT00705679|69584478|FG000|Overall Study|Death|0|||
37899111|NCT00705679|69584479|FG001|Overall Study|Death|0|||
37696632|NCT02448719|69172840|FG008|Overall Study|Withdrawal by Subject|0|||
37696633|NCT02448719|69172841|FG009|Overall Study|Withdrawal by Subject|0|||
37696634|NCT02448719|69172842|FG010|Overall Study|Withdrawal by Subject|0|||
37696635|NCT02322866|69172905|FG000|Overall Study|Adverse Event|6|||
37696636|NCT02322866|69172906|FG001|Overall Study|Adverse Event|11|||
37696637|NCT02322866|69172905|FG000|Overall Study|Withdrawal of Consent|16|||
37696638|NCT02322866|69172906|FG001|Overall Study|Withdrawal of Consent|25|||
37696639|NCT02322866|69172905|FG000|Overall Study|Lost to Follow-up|36|||
37696640|NCT02322866|69172906|FG001|Overall Study|Lost to Follow-up|39|||
37696641|NCT02322866|69172905|FG000|Overall Study|Protocol Violation|1|||
37696642|NCT02322866|69172906|FG001|Overall Study|Protocol Violation|0|||
37899112|NCT00705679|69584480|FG002|Overall Study|Death|3|||
37899113|NCT00705679|69584481|FG003|Overall Study|Death|2|||
37899114|NCT00705679|69584482|FG004|Overall Study|Death|1|||
37899115|NCT00705679|69584478|FG000|Overall Study|Lost to Follow-up|32|||
37899116|NCT00705679|69584479|FG001|Overall Study|Lost to Follow-up|60|||
37899117|NCT00705679|69584480|FG002|Overall Study|Lost to Follow-up|44|||
37899118|NCT00705679|69584481|FG003|Overall Study|Lost to Follow-up|30|||
37899119|NCT00705679|69584482|FG004|Overall Study|Lost to Follow-up|35|||
37899120|NCT00705679|69584478|FG000|Overall Study|Physician Decision|0|||
37899121|NCT00705679|69584479|FG001|Overall Study|Physician Decision|1|||
37899122|NCT00705679|69584480|FG002|Overall Study|Physician Decision|0|||
37899123|NCT00705679|69584481|FG003|Overall Study|Physician Decision|1|||
37899124|NCT00705679|69584482|FG004|Overall Study|Physician Decision|0|||
37899125|NCT00705679|69584478|FG000|Overall Study|Withdrawal by Subject|32|||
37899126|NCT00705679|69584479|FG001|Overall Study|Withdrawal by Subject|77|||
37899127|NCT00705679|69584480|FG002|Overall Study|Withdrawal by Subject|68|||
37899128|NCT00705679|69584481|FG003|Overall Study|Withdrawal by Subject|47|||
37899129|NCT00705679|69584482|FG004|Overall Study|Withdrawal by Subject|33|||
37899130|NCT00751348|69584505|FG000|Overall Study|Withdrawal by Subject|5|||
37899131|NCT00751348|69584506|FG001|Overall Study|Withdrawal by Subject|2|||
37899132|NCT00751348|69584505|FG000|Overall Study|Migration from study area|1|||
37899133|NCT00751348|69584506|FG001|Overall Study|Migration from study area|0|||
37899134|NCT00751114|69584514|FG000|Overall Study|Adverse Event|2|||
37899135|NCT00751114|69584515|FG001|Overall Study|Adverse Event|4|||
37899136|NCT00751114|69584514|FG000|Overall Study|Protocol Violation|8|||
37899137|NCT00751114|69584515|FG001|Overall Study|Protocol Violation|9|||
37899138|NCT00751114|69584514|FG000|Overall Study|Withdrawal by Subject|9|||
37899139|NCT00751114|69584515|FG001|Overall Study|Withdrawal by Subject|4|||
37899140|NCT00751114|69584514|FG000|Overall Study|Lost to Follow-up|4|||
37899141|NCT00751114|69584515|FG001|Overall Study|Lost to Follow-up|7|||
37899142|NCT00751114|69584514|FG000|Overall Study|Lack of Efficacy|0|||
37899143|NCT00751114|69584515|FG001|Overall Study|Lack of Efficacy|7|||
37899144|NCT00751114|69584514|FG000|Overall Study|Not Treated|13|||
37899145|NCT00751114|69584515|FG001|Overall Study|Not Treated|1|||
37899146|NCT00751114|69584514|FG000|Overall Study|Out of country for 2 months|1|||
37899147|NCT00751114|69584515|FG001|Overall Study|Out of country for 2 months|0|||
37899148|NCT00751114|69584514|FG000|Overall Study|Move to another city|1|||
37899149|NCT00751114|69584515|FG001|Overall Study|Move to another city|0|||
37899150|NCT00960440|69584525|FG000|Overall Study|Death|0|||
37899151|NCT00960440|69584526|FG001|Overall Study|Death|0|||
37899152|NCT00960440|69584527|FG002|Overall Study|Death|0|||
37899153|NCT00960440|69584528|FG003|Overall Study|Death|1|||
37996598|NCT00263328|69681147|FG000|Overall Study|Other|3|||
37696643|NCT02322866|69172905|FG000|Overall Study|Noncompliance with Treatment|3|||
37899154|NCT00960440|69584525|FG000|Overall Study|Adverse Event|12|||
37899155|NCT00960440|69584526|FG001|Overall Study|Adverse Event|12|||
37899156|NCT00960440|69584527|FG002|Overall Study|Adverse Event|4|||
37899157|NCT00960440|69584528|FG003|Overall Study|Adverse Event|4|||
37899158|NCT00960440|69584525|FG000|Overall Study|Lack of Efficacy|2|||
37899159|NCT00960440|69584526|FG001|Overall Study|Lack of Efficacy|5|||
37899160|NCT00960440|69584527|FG002|Overall Study|Lack of Efficacy|3|||
37899161|NCT00960440|69584528|FG003|Overall Study|Lack of Efficacy|8|||
37899162|NCT00960440|69584525|FG000|Overall Study|Protocol Violation|2|||
37899163|NCT00960440|69584526|FG001|Overall Study|Protocol Violation|8|||
37899164|NCT00960440|69584527|FG002|Overall Study|Protocol Violation|3|||
37899165|NCT00960440|69584528|FG003|Overall Study|Protocol Violation|4|||
37899166|NCT00960440|69584525|FG000|Overall Study|Withdrawal by Subject|9|||
37899167|NCT00960440|69584526|FG001|Overall Study|Withdrawal by Subject|5|||
37899168|NCT00960440|69584527|FG002|Overall Study|Withdrawal by Subject|2|||
37899169|NCT00960440|69584528|FG003|Overall Study|Withdrawal by Subject|1|||
37899170|NCT00960440|69584525|FG000|Overall Study|Other|1|||
37899171|NCT00960440|69584526|FG001|Overall Study|Other|1|||
37899172|NCT00960440|69584527|FG002|Overall Study|Other|1|||
37899173|NCT00960440|69584528|FG003|Overall Study|Other|0|||
37899174|NCT04909853|69584572|FG000|Part 1|Assigned but not treated|0|||
37899175|NCT04909853|69584573|FG001|Part 1|Assigned but not treated|0|||
37899176|NCT04909853|69584574|FG002|Part 1|Assigned but not treated|1|||
37899177|NCT04909853|69584575|FG003|Part 1|Assigned but not treated|0|||
37899178|NCT04909853|69584572|FG000|Part 2|Adverse Event|0|||
37899179|NCT04909853|69584573|FG001|Part 2|Adverse Event|0|||
37899180|NCT04909853|69584574|FG002|Part 2|Adverse Event|0|||
37899181|NCT04909853|69584575|FG003|Part 2|Adverse Event|1|||
37899182|NCT04811664|69584588|FG000|Overall Study|Lost to Follow-up|78|||
37899183|NCT04811664|69584589|FG001|Overall Study|Lost to Follow-up|125|||
37899184|NCT04811664|69584590|FG002|Overall Study|Lost to Follow-up|46|||
37899185|NCT04811664|69584588|FG000|Overall Study|Withdrawal by Subject|39|||
37899186|NCT04811664|69584589|FG001|Overall Study|Withdrawal by Subject|76|||
37899187|NCT04811664|69584590|FG002|Overall Study|Withdrawal by Subject|12|||
37899188|NCT04811664|69584588|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
37899189|NCT04811664|69584589|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
37899190|NCT04811664|69584590|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|17|||
37899191|NCT04811664|69584588|FG000|Overall Study|Participant is unwilling or unable to comply with required study|24|||
37899192|NCT04811664|69584589|FG001|Overall Study|Participant is unwilling or unable to comply with required study|47|||
37899193|NCT04811664|69584590|FG002|Overall Study|Participant is unwilling or unable to comply with required study|16|||
37899194|NCT04811664|69584588|FG000|Overall Study|Protocol Violation|0|||
37899195|NCT04811664|69584589|FG001|Overall Study|Protocol Violation|5|||
37899196|NCT04811664|69584590|FG002|Overall Study|Protocol Violation|11|||
37899197|NCT04811664|69584588|FG000|Overall Study|Study Terminated by Sponsor|4|||
37899198|NCT04811664|69584589|FG001|Overall Study|Study Terminated by Sponsor|3|||
37899199|NCT04811664|69584590|FG002|Overall Study|Study Terminated by Sponsor|34|||
37899200|NCT04811664|69584588|FG000|Overall Study|Early Study Closure|3|||
37899201|NCT04811664|69584589|FG001|Overall Study|Early Study Closure|7|||
37899202|NCT04811664|69584590|FG002|Overall Study|Early Study Closure|79|||
37899203|NCT04811664|69584588|FG000|Overall Study|Other (Unable to receive payment visa status)|0|||
37899204|NCT04811664|69584589|FG001|Overall Study|Other (Unable to receive payment visa status)|2|||
37899205|NCT04811664|69584590|FG002|Overall Study|Other (Unable to receive payment visa status)|0|||
37899206|NCT04119414|69584607|FG000|Overall Study|300 couples did not have a male child, and 4 clinics were only observed|300|||
37899207|NCT03762265|69584636|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
37899208|NCT03762265|69584637|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
37899209|NCT03762265|69584636|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
37899210|NCT03762265|69584637|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
37899211|NCT03762265|69584636|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
37899212|NCT03762265|69584637|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
37899213|NCT03762265|69584636|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
37899214|NCT03762265|69584637|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
37996599|NCT00263328|69681148|FG001|Overall Study|Other|0|||
37996600|NCT00263328|69681149|FG002|Overall Study|Other|1|||
37996601|NCT00263328|69681147|FG000|Overall Study|Adverse Event|1|||
37996602|NCT00263328|69681148|FG001|Overall Study|Adverse Event|1|||
37696644|NCT02322866|69172906|FG001|Overall Study|Noncompliance with Treatment|4|||
37696645|NCT02322866|69172905|FG000|Overall Study|Lack of Efficacy|3|||
37899215|NCT03762265|69584636|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
37899216|NCT03762265|69584637|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
37899217|NCT03762265|69584636|FG000|BT Period: Weeks 1 to 37|Other|0|||
37899218|NCT03762265|69584637|FG001|BT Period: Weeks 1 to 37|Other|1|||
37899219|NCT03762265|69584636|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
37899220|NCT03762265|69584637|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
37899221|NCT03762265|69584636|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
37996603|NCT00263328|69681149|FG002|Overall Study|Adverse Event|4|||
37696646|NCT02322866|69172906|FG001|Overall Study|Lack of Efficacy|1|||
37899222|NCT03762265|69584637|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
37899223|NCT03762265|69584636|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
37996604|NCT00262860|69681159|FG000|Overall Study|Adverse Event|2|||
37899224|NCT03762265|69584637|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
37899225|NCT03762265|69584636|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
37899226|NCT03762265|69584637|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
37899227|NCT03762265|69584636|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
37899228|NCT03762265|69584637|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
37899229|NCT03762265|69584636|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
37899230|NCT03762265|69584637|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
37899231|NCT03762265|69584636|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
37899232|NCT03762265|69584637|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
37899233|NCT03762265|69584636|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
37899234|NCT03762265|69584637|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
37899235|NCT03762265|69584636|FG000|LTE Period: Weeks 61 to 109|Other|1|||
37899236|NCT03762265|69584637|FG001|LTE Period: Weeks 61 to 109|Other|0|||
37899237|NCT03704051|69584670|FG000|Overall Study|Withdrawal by Subject|4|||
37899238|NCT03704051|69584671|FG001|Overall Study|Withdrawal by Subject|0|||
37899239|NCT03642938|69584687|FG000|Overall Study|Withdrawal by Subject|0|||
37899240|NCT03642938|69584688|FG001|Overall Study|Withdrawal by Subject|0|||
37899241|NCT03642938|69584689|FG002|Overall Study|Withdrawal by Subject|0|||
37899242|NCT03642938|69584690|FG003|Overall Study|Withdrawal by Subject|1|||
37899243|NCT03562767|69584703|FG000|Overall Study|Physician Decision|2|||
37899244|NCT03562767|69584704|FG001|Overall Study|Physician Decision|0|||
37696647|NCT02322866|69172905|FG000|Overall Study|Other Miscellaneous Reasons|6|||
37696648|NCT02322866|69172906|FG001|Overall Study|Other Miscellaneous Reasons|6|||
37696649|NCT01640353|69172912|FG000|Overall Study|Withdrew prior to treatment|10|||
37696650|NCT01640353|69172912|FG000|Overall Study|Withdrawn from analysis at term site|12|||
37696651|NCT01640353|69172912|FG000|Overall Study|Withdrawal by Subject|5|||
37696652|NCT01640353|69172912|FG000|Overall Study|Death|2|||
37696653|NCT01640353|69172912|FG000|Overall Study|Early site termination|3|||
37696654|NCT01640353|69172912|FG000|Overall Study|Lost to Follow-up|12|||
37696655|NCT01640353|69172912|FG000|Overall Study|Physician Decision|1|||
37696656|NCT02463071|69172919|FG000|Overall Study|Adverse Event|3|||
37696657|NCT02463071|69172920|FG001|Overall Study|Adverse Event|5|||
37696658|NCT02463071|69172921|FG002|Overall Study|Adverse Event|1|||
37696659|NCT02463071|69172919|FG000|Overall Study|Death|1|||
37826789|NCT00473512|69509633|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
37826790|NCT00473512|69509634|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
37826791|NCT00473512|69509630|FG000|Period 2 (Phase 2)|Other|1|||
37826792|NCT00473512|69509631|FG001|Period 2 (Phase 2)|Other|0|||
37826793|NCT00473512|69509632|FG002|Period 2 (Phase 2)|Other|0|||
37826794|NCT00473512|69509633|FG003|Period 2 (Phase 2)|Other|3|||
37826795|NCT00473512|69509634|FG004|Period 2 (Phase 2)|Other|0|||
37826796|NCT00473434|69509654|FG000|Overall Study|Physician Decision|3|||
37826797|NCT00473434|69509654|FG000|Overall Study|Withdrawal by Subject|9|||
37826798|NCT00473434|69509654|FG000|Overall Study|Compliance|3|||
37826799|NCT00473434|69509654|FG000|Overall Study|Lack of Efficacy|3|||
37826800|NCT00473434|69509654|FG000|Overall Study|Adverse Event|3|||
37826801|NCT00473434|69509654|FG000|Overall Study|Patient was selling medication to others|1|||
37826802|NCT00473434|69509654|FG000|Overall Study|Safety evaluation|1|||
37826803|NCT00473434|69509654|FG000|Overall Study|Reason not specified|6|||
37826804|NCT00473434|69509654|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
37826805|NCT00473434|69509654|FG000|Overall Study|Switching to trial medication|1|||
37826806|NCT00473434|69509654|FG000|Overall Study|No longer required|1|||
37826807|NCT00473083|69509674|FG000|Overall Study|Adverse Event|1|||
37826808|NCT00473083|69509675|FG001|Overall Study|Adverse Event|0|||
37826809|NCT00473083|69509676|FG002|Overall Study|Adverse Event|0|||
37826810|NCT00472420|69509687|FG000|Induction Treatment Period|Physician Decision|9|||
37899245|NCT03562767|69584705|FG002|Overall Study|Physician Decision|0|||
37899246|NCT03562767|69584703|FG000|Overall Study|Logistic Reason|1|||
37899247|NCT03562767|69584704|FG001|Overall Study|Logistic Reason|3|||
37899248|NCT03562767|69584705|FG002|Overall Study|Logistic Reason|0|||
37899249|NCT03406156|69584719|FG000|Overall Study|Death|6|||
37696660|NCT02463071|69172920|FG001|Overall Study|Death|0|||
37899250|NCT03406156|69584720|FG001|Overall Study|Death|2|||
37696661|NCT02463071|69172921|FG002|Overall Study|Death|0|||
37696662|NCT02463071|69172919|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
37826811|NCT00472420|69509687|FG000|Induction Treatment Period|Adverse Event|3|||
37826812|NCT00472420|69509687|FG000|Induction Treatment Period|Non-compliance|1|||
37826813|NCT00472420|69509687|FG000|Induction Treatment Period|Death|3|||
37826814|NCT00472420|69509687|FG000|Follow-up Period|Death|5|||
37696663|NCT02463071|69172920|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
37696664|NCT02463071|69172921|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
37696665|NCT02463071|69172919|FG000|Overall Study|Reason not specified|7|||
37696666|NCT02463071|69172920|FG001|Overall Study|Reason not specified|9|||
37696667|NCT02463071|69172921|FG002|Overall Study|Reason not specified|4|||
37696668|NCT02463071|69172919|FG000|Overall Study|Protocol Violation|0|||
37696669|NCT02463071|69172920|FG001|Overall Study|Protocol Violation|2|||
37899251|NCT03406156|69584719|FG000|Overall Study|Withdrawal by Subject|0|||
37899252|NCT03406156|69584720|FG001|Overall Study|Withdrawal by Subject|2|||
37899253|NCT03406156|69584719|FG000|Overall Study|COVID-19 infection|1|||
37899254|NCT03406156|69584720|FG001|Overall Study|COVID-19 infection|0|||
37899255|NCT03406156|69584719|FG000|Overall Study|Non-compliance with study procedures|0|||
37899256|NCT03406156|69584720|FG001|Overall Study|Non-compliance with study procedures|1|||
37899257|NCT03406156|69584719|FG000|Overall Study|Other, not specified|0|||
37899258|NCT03406156|69584720|FG001|Overall Study|Other, not specified|1|||
37899259|NCT03358472|69584731|FG000|Overall Study|Death|6|||
37899260|NCT03358472|69584732|FG001|Overall Study|Death|3|||
37899261|NCT03358472|69584733|FG002|Overall Study|Death|10|||
37899262|NCT03358472|69584731|FG000|Overall Study|Physician Decision|0|||
37899263|NCT03358472|69584732|FG001|Overall Study|Physician Decision|1|||
37899264|NCT03358472|69584733|FG002|Overall Study|Physician Decision|0|||
37899265|NCT03358472|69584731|FG000|Overall Study|Withdrawal by Subject|0|||
37899266|NCT03358472|69584732|FG001|Overall Study|Withdrawal by Subject|0|||
37899267|NCT03358472|69584733|FG002|Overall Study|Withdrawal by Subject|1|||
37899268|NCT03358472|69584731|FG000|Overall Study|On-going at clinical cut off date|9|||
37899269|NCT03358472|69584732|FG001|Overall Study|On-going at clinical cut off date|6|||
37899270|NCT03358472|69584733|FG002|Overall Study|On-going at clinical cut off date|5|||
37899271|NCT03333941|69584741|FG000|Overall Study|Lost to Follow-up|10|||
37899272|NCT03333941|69584741|FG000|Overall Study|Death|2|||
37899273|NCT03333941|69584741|FG000|Overall Study|Adverse Event|1|||
37899274|NCT03315754|69584745|FG000|Overall Study|COVID-19 complications leading to death|1|||
37899275|NCT03315754|69584745|FG000|Overall Study|insurance coverage issue|1|||
37899276|NCT02440711|69584764|FG000|Second Intervention|Lost to Follow-up|1|||
37899277|NCT02440711|69584765|FG001|Second Intervention|Lost to Follow-up|0|||
37899278|NCT02358031|69584776|FG000|Overall Study|Death|226|||
37899279|NCT02358031|69584777|FG001|Overall Study|Death|204|||
37899280|NCT02358031|69584778|FG002|Overall Study|Death|249|||
37899281|NCT02358031|69584776|FG000|Overall Study|Lost to Follow-up|0|||
37899282|NCT02358031|69584777|FG001|Overall Study|Lost to Follow-up|1|||
37899283|NCT02358031|69584778|FG002|Overall Study|Lost to Follow-up|1|||
37899284|NCT02358031|69584776|FG000|Overall Study|Withdrawal by Subject|14|||
37899285|NCT02358031|69584777|FG001|Overall Study|Withdrawal by Subject|12|||
37899286|NCT02358031|69584778|FG002|Overall Study|Withdrawal by Subject|17|||
37899287|NCT02358031|69584776|FG000|Overall Study|Ongoing in Study|61|||
37899288|NCT02358031|69584777|FG001|Overall Study|Ongoing in Study|64|||
37899289|NCT02358031|69584778|FG002|Overall Study|Ongoing in Study|33|||
37899290|NCT02223767|69584788|FG000|Overall Study|Withdrawal by Subject|4|||
37899291|NCT02223767|69584789|FG001|Overall Study|Withdrawal by Subject|4|||
37899292|NCT01956773|69584808|FG000|Overall Study|Lost to Follow-up|628|||
37899293|NCT01956773|69584809|FG001|Overall Study|Lost to Follow-up|1|||
37899294|NCT01946529|69584818|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
37899295|NCT01946529|69584819|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
37899296|NCT01946529|69584820|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
37899297|NCT01946529|69584818|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
37899298|NCT01946529|69584819|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
37899299|NCT01946529|69584820|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
37899300|NCT01666808|69584842|FG000|Overall Study|Lost to Follow-up|9|||
37899301|NCT01666808|69584843|FG001|Overall Study|Lost to Follow-up|15|||
37899302|NCT01666808|69584842|FG000|Overall Study|Withdrawal by Subject|3|||
37899303|NCT01666808|69584843|FG001|Overall Study|Withdrawal by Subject|1|||
37899304|NCT01666808|69584842|FG000|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|4|||
37996605|NCT00236184|69681165|FG000|Overall Study|Adverse Event|5|||
37696670|NCT02463071|69172921|FG002|Overall Study|Protocol Violation|0|||
37696671|NCT02463071|69172919|FG000|Overall Study|Lost to Follow-up|0|||
37696672|NCT02463071|69172920|FG001|Overall Study|Lost to Follow-up|0|||
37899305|NCT01666808|69584843|FG001|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|0|||
37899306|NCT00964028|69584860|FG000|Overall Study|Withdrawal by Subject|0|||
37899307|NCT00964028|69584861|FG001|Overall Study|Withdrawal by Subject|1|||
37899308|NCT00960206|69584870|FG000|Overall Study|Death|7|||
37899309|NCT00960206|69584871|FG001|Overall Study|Death|4|||
37899310|NCT00960206|69584872|FG002|Overall Study|Death|1|||
37899311|NCT00960206|69584870|FG000|Overall Study|Unwilling/Unable to return|1|||
37899312|NCT00960206|69584871|FG001|Overall Study|Unwilling/Unable to return|2|||
37899313|NCT00960206|69584872|FG002|Overall Study|Unwilling/Unable to return|0|||
37899314|NCT00960206|69584870|FG000|Overall Study|Lost to Follow-up|8|||
37899315|NCT00960206|69584871|FG001|Overall Study|Lost to Follow-up|14|||
37899316|NCT00960206|69584872|FG002|Overall Study|Lost to Follow-up|8|||
37899317|NCT00960206|69584870|FG000|Overall Study|Withdrawal by Subject|2|||
37899318|NCT00960206|69584871|FG001|Overall Study|Withdrawal by Subject|4|||
37899319|NCT00960206|69584872|FG002|Overall Study|Withdrawal by Subject|0|||
37899320|NCT00960206|69584870|FG000|Overall Study|Revision of study component|2|||
37899321|NCT00960206|69584871|FG001|Overall Study|Revision of study component|2|||
37899322|NCT00960206|69584872|FG002|Overall Study|Revision of study component|2|||
37899323|NCT00960206|69584870|FG000|Overall Study|Missing 10 year data|20|||
37899324|NCT00960206|69584871|FG001|Overall Study|Missing 10 year data|1|||
37899325|NCT00960206|69584872|FG002|Overall Study|Missing 10 year data|1|||
37899326|NCT00751036|69584883|FG000|Overall Study|Disease Progression|28|||
37899327|NCT00751036|69584884|FG001|Overall Study|Disease Progression|29|||
37899328|NCT00751036|69584883|FG000|Overall Study|Adverse Event|6|||
37899329|NCT00751036|69584884|FG001|Overall Study|Adverse Event|4|||
37899330|NCT00751036|69584883|FG000|Overall Study|Administrative Problems|3|||
37899331|NCT00751036|69584884|FG001|Overall Study|Administrative Problems|4|||
37899332|NCT00751036|69584883|FG000|Overall Study|Withdrawal by Subject|5|||
37899333|NCT00751036|69584884|FG001|Overall Study|Withdrawal by Subject|2|||
37899334|NCT00751036|69584883|FG000|Overall Study|Death|3|||
37899335|NCT00751036|69584884|FG001|Overall Study|Death|3|||
37899336|NCT00751036|69584883|FG000|Overall Study|Lost to Follow-up|0|||
37899337|NCT00751036|69584884|FG001|Overall Study|Lost to Follow-up|1|||
37899338|NCT00751036|69584883|FG000|Overall Study|Protocol Violation|1|||
37899339|NCT00751036|69584884|FG001|Overall Study|Protocol Violation|0|||
37899340|NCT00751036|69584883|FG000|Overall Study|Missing end of Treatment Page|2|||
37899341|NCT00751036|69584884|FG001|Overall Study|Missing end of Treatment Page|3|||
37899342|NCT00961298|69584890|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
37899343|NCT00961298|69584890|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
37899344|NCT00961298|69584890|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
37899345|NCT00744328|69584897|FG000|Overall Study|Lost to Follow-up|2|||
37899346|NCT00744328|69584898|FG001|Overall Study|Lost to Follow-up|5|||
37899347|NCT00744328|69584899|FG002|Overall Study|Lost to Follow-up|3|||
37899348|NCT00744328|69584897|FG000|Overall Study|Withdrawal by Subject|5|||
37899349|NCT00744328|69584898|FG001|Overall Study|Withdrawal by Subject|3|||
37899350|NCT00744328|69584899|FG002|Overall Study|Withdrawal by Subject|4|||
37899351|NCT00744328|69584897|FG000|Overall Study|Found ineligible after randomization|0|||
37899352|NCT00744328|69584898|FG001|Overall Study|Found ineligible after randomization|0|||
37899353|NCT00744328|69584899|FG002|Overall Study|Found ineligible after randomization|1|||
37899354|NCT03245840|69584909|FG000|Overall Study|Adverse Event|6|||
37899355|NCT03245840|69584910|FG001|Overall Study|Adverse Event|0|||
37899356|NCT03245840|69584909|FG000|Overall Study|Death|2|||
37899357|NCT03245840|69584910|FG001|Overall Study|Death|0|||
37899358|NCT03245840|69584909|FG000|Overall Study|Withdrawal by Subject|31|||
37899359|NCT03245840|69584910|FG001|Overall Study|Withdrawal by Subject|1|||
37899360|NCT03245840|69584909|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
37899361|NCT03245840|69584910|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
37899362|NCT03245840|69584909|FG000|Overall Study|Physician Decision|4|||
37899363|NCT03245840|69584910|FG001|Overall Study|Physician Decision|1|||
37899364|NCT03245840|69584909|FG000|Overall Study|Study Terminated by Sponsor|56|||
37899365|NCT03245840|69584910|FG001|Overall Study|Study Terminated by Sponsor|6|||
37899366|NCT03245840|69584909|FG000|Overall Study|Site Terminated by Sponsor|4|||
37899367|NCT03245840|69584910|FG001|Overall Study|Site Terminated by Sponsor|0|||
37899368|NCT03245840|69584909|FG000|Overall Study|Lost to Follow-up|12|||
37899369|NCT03245840|69584910|FG001|Overall Study|Lost to Follow-up|2|||
37899370|NCT03245840|69584909|FG000|Overall Study|Pregnancy|2|||
37899371|NCT03245840|69584910|FG001|Overall Study|Pregnancy|0|||
37899372|NCT03245840|69584909|FG000|Overall Study|Non-Compliance with Study Drug|2|||
37899373|NCT03245840|69584910|FG001|Overall Study|Non-Compliance with Study Drug|0|||
37899374|NCT03245840|69584909|FG000|Overall Study|Not treated|1|||
37899375|NCT03245840|69584910|FG001|Overall Study|Not treated|1|||
37899376|NCT00959894|69584916|FG000|Overall Study|Lost to Follow-up|10|||
37899377|NCT00959894|69584916|FG000|Overall Study|Adverse Event|3|||
37899378|NCT00959894|69584916|FG000|Overall Study|Withdrawal by Subject|1|||
37899379|NCT00959894|69584916|FG000|Overall Study|Need for contraindicated medication|1|||
37899380|NCT00959894|69584916|FG000|Overall Study|Subject moved out of town|1|||
37899381|NCT00750880|69584921|FG000|Overall Study|Adverse Event|76|||
37899382|NCT00750880|69584921|FG000|Overall Study|Death|4|||
37899383|NCT00750880|69584921|FG000|Overall Study|Lack of Efficacy|46|||
37899384|NCT00750880|69584921|FG000|Overall Study|Lost to Follow-up|10|||
37899385|NCT00750880|69584921|FG000|Overall Study|Protocol Violation|15|||
37899386|NCT00750880|69584921|FG000|Overall Study|Withdrawal by Subject|33|||
37899387|NCT00750880|69584921|FG000|Overall Study|Physician Decision|20|||
37899388|NCT00750880|69584921|FG000|Overall Study|Administrative|11|||
37899389|NCT00746590|69584926|FG000|Overall Study|Death|1|||
37899390|NCT01032629|69584933|FG000|Overall Study|Closed Site|21|||
37899391|NCT01032629|69584934|FG001|Overall Study|Closed Site|18|||
37899392|NCT01032629|69584935|FG002|Overall Study|Closed Site|16|||
37899393|NCT01032629|69584933|FG000|Overall Study|Withdrawal by Subject|50|||
37899394|NCT01032629|69584934|FG001|Overall Study|Withdrawal by Subject|36|||
37899395|NCT01032629|69584935|FG002|Overall Study|Withdrawal by Subject|35|||
37899396|NCT01032629|69584933|FG000|Overall Study|Lost to Follow-up|74|||
37899397|NCT01032629|69584934|FG001|Overall Study|Lost to Follow-up|47|||
37899398|NCT01032629|69584935|FG002|Overall Study|Lost to Follow-up|37|||
37899399|NCT00749944|69584946|FG000|Overall Study|Lost to Follow-up|2|||
37899400|NCT00749944|69584947|FG001|Overall Study|Lost to Follow-up|1|||
37899401|NCT00749944|69584946|FG000|Overall Study|Other|1|||
37899402|NCT00749944|69584947|FG001|Overall Study|Other|0|||
37899403|NCT00749944|69584946|FG000|Overall Study|Withdrawal by Subject|2|||
37899404|NCT00749944|69584947|FG001|Overall Study|Withdrawal by Subject|0|||
37899405|NCT00749398|69584953|FG000|Overall Study|Lack of Efficacy|7|||
37899406|NCT00749398|69584953|FG000|Overall Study|Adverse Event|4|||
37899407|NCT00749398|69584953|FG000|Overall Study|Serious adverse event|11|||
37899408|NCT00749398|69584953|FG000|Overall Study|Withdrawal by Subject|17|||
37899409|NCT00749398|69584953|FG000|Overall Study|Lost to Follow-up|11|||
37899410|NCT00749398|69584953|FG000|Overall Study|Reason not specified|2|||
37899411|NCT00749398|69584953|FG000|Overall Study|Unknown reason|1|||
37899412|NCT00746356|69584957|FG000|Overall Study|Withdrawal by Subject|2|||
37899413|NCT00746356|69584958|FG001|Overall Study|Withdrawal by Subject|3|||
37899414|NCT00746356|69584957|FG000|Overall Study|Death|7|||
37899415|NCT00746356|69584958|FG001|Overall Study|Death|3|||
37899416|NCT00746356|69584957|FG000|Overall Study|Lost to Follow-up|1|||
37899417|NCT00746356|69584958|FG001|Overall Study|Lost to Follow-up|0|||
37899418|NCT00746356|69584957|FG000|Overall Study|Removal of Device|0|||
37899419|NCT00746356|69584958|FG001|Overall Study|Removal of Device|1|||
37899420|NCT00746356|69584957|FG000|Overall Study|Patient relocated|1|||
37899421|NCT00746356|69584958|FG001|Overall Study|Patient relocated|0|||
37899422|NCT01012973|69584968|FG000|Overall Study|Adverse Event|5|||
37899423|NCT01012973|69584969|FG001|Overall Study|Adverse Event|5|||
37899424|NCT01012973|69584968|FG000|Overall Study|Lack of Efficacy|0|||
37899425|NCT01012973|69584969|FG001|Overall Study|Lack of Efficacy|5|||
37899426|NCT01012973|69584968|FG000|Overall Study|Lost to Follow-up|1|||
37899427|NCT01012973|69584969|FG001|Overall Study|Lost to Follow-up|0|||
37899428|NCT01012973|69584968|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
37899429|NCT01012973|69584969|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
37899430|NCT01012973|69584968|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
37899431|NCT01012973|69584969|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
37899432|NCT01012973|69584968|FG000|Overall Study|Protocol Violation|5|||
37899433|NCT01012973|69584969|FG001|Overall Study|Protocol Violation|2|||
37899434|NCT01012973|69584968|FG000|Overall Study|Withdrawal by Subject|4|||
37899435|NCT01012973|69584969|FG001|Overall Study|Withdrawal by Subject|6|||
37899436|NCT00748540|69584979|FG000|Overall Study|Physician Decision|1|||
37899437|NCT01012739|69584983|FG000|Treatment Period 1|Adverse Event|0|||
37899438|NCT01012739|69584984|FG001|Treatment Period 1|Adverse Event|0|||
37899439|NCT01012739|69584985|FG002|Treatment Period 1|Adverse Event|0|||
37899440|NCT01012739|69584986|FG003|Treatment Period 1|Adverse Event|1|||
37899441|NCT01012739|69584983|FG000|Treatment Period 2|Abnormal test procedure results|0|||
37899442|NCT01012739|69584984|FG001|Treatment Period 2|Abnormal test procedure results|0|||
37899443|NCT01012739|69584985|FG002|Treatment Period 2|Abnormal test procedure results|0|||
37899444|NCT01012739|69584986|FG003|Treatment Period 2|Abnormal test procedure results|1|||
37899445|NCT00742924|69585001|FG000|Overall Study|Adverse Event|0|||
37899446|NCT00742924|69585002|FG001|Overall Study|Adverse Event|0|||
37899447|NCT00742924|69585003|FG002|Overall Study|Adverse Event|1|||
37899448|NCT00742924|69585004|FG003|Overall Study|Adverse Event|1|||
37899449|NCT00742924|69585001|FG000|Overall Study|Lack of Efficacy|5|||
37899450|NCT00742924|69585002|FG001|Overall Study|Lack of Efficacy|1|||
37899451|NCT00742924|69585003|FG002|Overall Study|Lack of Efficacy|2|||
37899452|NCT00742924|69585004|FG003|Overall Study|Lack of Efficacy|4|||
37899453|NCT00742924|69585001|FG000|Overall Study|Physician Decision|0|||
37899454|NCT00742924|69585002|FG001|Overall Study|Physician Decision|0|||
37899455|NCT00742924|69585003|FG002|Overall Study|Physician Decision|0|||
37899456|NCT00742924|69585004|FG003|Overall Study|Physician Decision|1|||
37899457|NCT00742924|69585001|FG000|Overall Study|Withdrawal by Subject|0|||
37899458|NCT00742924|69585002|FG001|Overall Study|Withdrawal by Subject|1|||
37899459|NCT00742924|69585003|FG002|Overall Study|Withdrawal by Subject|1|||
37899460|NCT00742924|69585004|FG003|Overall Study|Withdrawal by Subject|0|||
37996606|NCT00236184|69681166|FG001|Overall Study|Adverse Event|2|||
37996607|NCT00236184|69681165|FG000|Overall Study|Lack of Efficacy|0|||
37899461|NCT00698815|69585017|FG000|Overall Study|Death|1|||
37899462|NCT00698815|69585018|FG001|Overall Study|Death|2|||
37899463|NCT00698815|69585019|FG002|Overall Study|Death|4|||
37899464|NCT00698815|69585017|FG000|Overall Study|Withdrawal by Subject|6|||
37899465|NCT00698815|69585018|FG001|Overall Study|Withdrawal by Subject|3|||
37899466|NCT00698815|69585019|FG002|Overall Study|Withdrawal by Subject|2|||
37899467|NCT00698815|69585017|FG000|Overall Study|MD discretion|2|||
37899468|NCT00698815|69585018|FG001|Overall Study|MD discretion|7|||
37899469|NCT00698815|69585019|FG002|Overall Study|MD discretion|2|||
37899470|NCT00698815|69585017|FG000|Overall Study|Did not receive protocol treatment|1|||
37899471|NCT00698815|69585018|FG001|Overall Study|Did not receive protocol treatment|2|||
37899472|NCT00698815|69585019|FG002|Overall Study|Did not receive protocol treatment|2|||
37899473|NCT00745498|69585030|FG000|Overall Study|Lost to Follow-up|1|||
37899474|NCT00745498|69585031|FG001|Overall Study|Lost to Follow-up|1|||
37996608|NCT00236184|69681166|FG001|Overall Study|Lack of Efficacy|1|||
37696673|NCT02463071|69172921|FG002|Overall Study|Lost to Follow-up|1|||
37899475|NCT00745498|69585032|FG002|Overall Study|Lost to Follow-up|3|||
37899476|NCT00745498|69585030|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
37899477|NCT00745498|69585031|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
37899478|NCT00745498|69585032|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
37899479|NCT00745498|69585030|FG000|Overall Study|Non-PDR related VH|0|||
37899480|NCT00745498|69585031|FG001|Overall Study|Non-PDR related VH|1|||
37899481|NCT00745498|69585032|FG002|Overall Study|Non-PDR related VH|1|||
37899482|NCT00745498|69585030|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
37899483|NCT00745498|69585031|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
37899484|NCT00745498|69585032|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
37899485|NCT00744874|69585040|FG000|Overall Study|Lost to Follow-up|1|||
37899486|NCT00744874|69585040|FG000|Overall Study|Withdrawal by Subject|1|||
37899487|NCT00744874|69585040|FG000|Overall Study|Study Device not available at procedure|1|||
37899488|NCT00744874|69585040|FG000|Overall Study|Unable to accomodate schedule|1|||
37899489|NCT00576901|69585051|FG000|Overall Study|Withdrawal by Subject|1|||
37899490|NCT00576901|69585051|FG000|Overall Study|Disease course|1|||
37899491|NCT00576901|69585051|FG000|Overall Study|Protocol Violation|1|||
37899492|NCT00699283|69585057|FG000|Overall Study|Lack of Efficacy|15|||
37899493|NCT00699283|69585058|FG001|Overall Study|Lack of Efficacy|5|||
37899494|NCT00699283|69585057|FG000|Overall Study|Lost to Follow-up|2|||
37899495|NCT00699283|69585058|FG001|Overall Study|Lost to Follow-up|0|||
37899496|NCT00699283|69585057|FG000|Overall Study|Withdrawal by Subject|1|||
37899497|NCT00699283|69585058|FG001|Overall Study|Withdrawal by Subject|0|||
37899498|NCT00699283|69585057|FG000|Overall Study|Other Reason|5|||
37899499|NCT00699283|69585058|FG001|Overall Study|Other Reason|1|||
37899500|NCT00699283|69585057|FG000|Overall Study|SAE, non-fatal|1|||
37899501|NCT00699283|69585058|FG001|Overall Study|SAE, non-fatal|1|||
37899502|NCT00699283|69585057|FG000|Overall Study|AE, non-serious non-fatal|8|||
37899503|NCT00699283|69585058|FG001|Overall Study|AE, non-serious non-fatal|1|||
37899504|NCT00699283|69585057|FG000|Overall Study|AE of unknown type|1|||
37899505|NCT00699283|69585058|FG001|Overall Study|AE of unknown type|0|||
37899506|NCT00740584|69585063|FG000|Overall Study|Withdrawal by Subject|1|||
37899507|NCT01023815|69585072|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
37899508|NCT01023815|69585073|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
37899509|NCT01023815|69585074|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
37899510|NCT01023815|69585075|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
37899511|NCT01023815|69585072|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
37899512|NCT01023815|69585073|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
37899513|NCT01023815|69585074|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
37899514|NCT01023815|69585075|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
37899515|NCT01023815|69585072|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
37899516|NCT01023815|69585073|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
37899517|NCT01023815|69585074|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
37899518|NCT01023815|69585075|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
37899519|NCT01023815|69585072|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
37899520|NCT01023815|69585073|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
37899521|NCT01023815|69585074|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
37899522|NCT01023815|69585075|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
37899523|NCT01023815|69585072|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
37899524|NCT01023815|69585073|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
37899525|NCT01023815|69585074|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
37899526|NCT01023815|69585075|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
37899527|NCT01023659|69585089|FG000|Overall Study|Lost to Follow-up|73|||
37899528|NCT01023659|69585090|FG001|Overall Study|Lost to Follow-up|228|||
37899529|NCT01023659|69585091|FG002|Overall Study|Lost to Follow-up|99|||
37899530|NCT00740116|69585102|FG000|Overall Study|Withdrawal by Subject|1|||
37696674|NCT02266381|69172932|FG000|Overall Study|Physician Decision|3|||
37696675|NCT02266381|69172933|FG001|Overall Study|Physician Decision|5|||
37899531|NCT00740116|69585103|FG001|Overall Study|Withdrawal by Subject|1|||
37899532|NCT00740116|69585102|FG000|Overall Study|Protocol Violation|1|||
37899533|NCT00740116|69585103|FG001|Overall Study|Protocol Violation|4|||
37899534|NCT00698581|69585113|FG000|Overall Study|Lack of Efficacy|23|||
37899535|NCT00698581|69585114|FG001|Overall Study|Lack of Efficacy|11|||
37696676|NCT02266381|69172934|FG002|Overall Study|Physician Decision|4|||
37899536|NCT00698581|69585113|FG000|Overall Study|Withdrawal by Subject|6|||
37899537|NCT00698581|69585114|FG001|Overall Study|Withdrawal by Subject|0|||
37899538|NCT00698581|69585113|FG000|Overall Study|Other reason|9|||
37899539|NCT00698581|69585114|FG001|Overall Study|Other reason|1|||
37899540|NCT00698581|69585113|FG000|Overall Study|SAE, non-fatal|1|||
37899541|NCT00698581|69585114|FG001|Overall Study|SAE, non-fatal|0|||
37899542|NCT00698581|69585113|FG000|Overall Study|AE, non-serious non-fatal|4|||
37899543|NCT00698581|69585114|FG001|Overall Study|AE, non-serious non-fatal|0|||
37899544|NCT00698581|69585113|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
37899545|NCT00698581|69585114|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
37899546|NCT00698581|69585113|FG000|Overall Study|AE of unknown type|1|||
37899547|NCT00698581|69585114|FG001|Overall Study|AE of unknown type|0|||
37899548|NCT01023581|69585128|FG000|Overall Study|Adverse Event|4|||
37899549|NCT01023581|69585129|FG001|Overall Study|Adverse Event|4|||
37899550|NCT01023581|69585130|FG002|Overall Study|Adverse Event|7|||
37899551|NCT01023581|69585131|FG003|Overall Study|Adverse Event|3|||
37899552|NCT01023581|69585132|FG004|Overall Study|Adverse Event|2|||
37899553|NCT01023581|69585133|FG005|Overall Study|Adverse Event|5|||
37899554|NCT01023581|69585134|FG006|Overall Study|Adverse Event|11|||
37899555|NCT01023581|69585128|FG000|Overall Study|Major protocol deviation|2|||
37899556|NCT01023581|69585129|FG001|Overall Study|Major protocol deviation|0|||
37899557|NCT01023581|69585130|FG002|Overall Study|Major protocol deviation|3|||
37899558|NCT01023581|69585131|FG003|Overall Study|Major protocol deviation|0|||
37899559|NCT01023581|69585132|FG004|Overall Study|Major protocol deviation|0|||
37899560|NCT01023581|69585133|FG005|Overall Study|Major protocol deviation|0|||
37899561|NCT01023581|69585134|FG006|Overall Study|Major protocol deviation|0|||
37899562|NCT01023581|69585128|FG000|Overall Study|Lost to Follow-up|4|||
37899563|NCT01023581|69585129|FG001|Overall Study|Lost to Follow-up|8|||
37899564|NCT01023581|69585130|FG002|Overall Study|Lost to Follow-up|7|||
37899565|NCT01023581|69585131|FG003|Overall Study|Lost to Follow-up|2|||
37899566|NCT01023581|69585132|FG004|Overall Study|Lost to Follow-up|5|||
37899567|NCT01023581|69585133|FG005|Overall Study|Lost to Follow-up|2|||
37996609|NCT00236184|69681165|FG000|Overall Study|Lost to Follow-up|3|||
37996610|NCT00236184|69681166|FG001|Overall Study|Lost to Follow-up|4|||
37996611|NCT00236184|69681165|FG000|Overall Study|Physician Decision|1|||
37996612|NCT00236184|69681166|FG001|Overall Study|Physician Decision|1|||
37996613|NCT00236184|69681165|FG000|Overall Study|Withdrawal by Subject|3|||
37996614|NCT00236184|69681166|FG001|Overall Study|Withdrawal by Subject|0|||
37996615|NCT00236184|69681165|FG000|Overall Study|Protocol Violation|3|||
37996616|NCT00236184|69681166|FG001|Overall Study|Protocol Violation|0|||
37996617|NCT00236184|69681165|FG000|Overall Study|non-compliance with study drug|2|||
37899568|NCT01023581|69585134|FG006|Overall Study|Lost to Follow-up|2|||
37899569|NCT01023581|69585128|FG000|Overall Study|Withdrawal by Subject|13|||
37899570|NCT01023581|69585129|FG001|Overall Study|Withdrawal by Subject|8|||
37899571|NCT01023581|69585130|FG002|Overall Study|Withdrawal by Subject|16|||
37899572|NCT01023581|69585131|FG003|Overall Study|Withdrawal by Subject|10|||
37899573|NCT01023581|69585132|FG004|Overall Study|Withdrawal by Subject|6|||
37899574|NCT01023581|69585133|FG005|Overall Study|Withdrawal by Subject|8|||
37899575|NCT01023581|69585134|FG006|Overall Study|Withdrawal by Subject|5|||
37899576|NCT01023581|69585128|FG000|Overall Study|Pregnancy|0|||
37899577|NCT01023581|69585129|FG001|Overall Study|Pregnancy|0|||
37899578|NCT01023581|69585130|FG002|Overall Study|Pregnancy|0|||
37899579|NCT01023581|69585131|FG003|Overall Study|Pregnancy|2|||
37899580|NCT01023581|69585132|FG004|Overall Study|Pregnancy|0|||
37899581|NCT01023581|69585133|FG005|Overall Study|Pregnancy|1|||
37899582|NCT01023581|69585134|FG006|Overall Study|Pregnancy|0|||
37899583|NCT01023581|69585128|FG000|Overall Study|Lack of Efficacy|9|||
37899584|NCT01023581|69585129|FG001|Overall Study|Lack of Efficacy|3|||
37899585|NCT01023581|69585130|FG002|Overall Study|Lack of Efficacy|6|||
37899586|NCT01023581|69585131|FG003|Overall Study|Lack of Efficacy|2|||
37899587|NCT01023581|69585132|FG004|Overall Study|Lack of Efficacy|1|||
37899588|NCT01023581|69585133|FG005|Overall Study|Lack of Efficacy|2|||
37996618|NCT00236184|69681166|FG001|Overall Study|non-compliance with study drug|1|||
37996619|NCT00236184|69681165|FG000|Overall Study|other|1|||
37899589|NCT01023581|69585134|FG006|Overall Study|Lack of Efficacy|1|||
37899590|NCT01023581|69585128|FG000|Overall Study|Physician Decision|2|||
37899591|NCT01023581|69585129|FG001|Overall Study|Physician Decision|0|||
37899592|NCT01023581|69585130|FG002|Overall Study|Physician Decision|2|||
37899593|NCT01023581|69585131|FG003|Overall Study|Physician Decision|1|||
37899594|NCT01023581|69585132|FG004|Overall Study|Physician Decision|1|||
37899595|NCT01023581|69585133|FG005|Overall Study|Physician Decision|1|||
37899596|NCT01023581|69585134|FG006|Overall Study|Physician Decision|1|||
37899597|NCT01023581|69585128|FG000|Overall Study|Other|1|||
37996620|NCT00236184|69681166|FG001|Overall Study|other|2|||
37899598|NCT01023581|69585129|FG001|Overall Study|Other|0|||
37899599|NCT01023581|69585130|FG002|Overall Study|Other|1|||
37899600|NCT01023581|69585131|FG003|Overall Study|Other|0|||
37899601|NCT01023581|69585132|FG004|Overall Study|Other|1|||
37899602|NCT01023581|69585133|FG005|Overall Study|Other|0|||
37899603|NCT01023581|69585134|FG006|Overall Study|Other|0|||
37826815|NCT00472420|69509687|FG000|Follow-up Period|Physician Decision|9|||
37826816|NCT00472420|69509687|FG000|Follow-up Period|Lost to Follow-up|2|||
37826817|NCT00472420|69509687|FG000|Follow-up Period|Protocol Violation|1|||
37826818|NCT00472303|69509693|FG000|Titration Phase|Adverse Event|22|||
37826819|NCT00472303|69509694|FG001|Titration Phase|Adverse Event|12|||
37826820|NCT00472303|69509695|FG002|Titration Phase|Adverse Event|0|||
37826821|NCT00472303|69509693|FG000|Titration Phase|Death|4|||
37826822|NCT00472303|69509694|FG001|Titration Phase|Death|2|||
37826823|NCT00472303|69509695|FG002|Titration Phase|Death|0|||
37826824|NCT00472303|69509693|FG000|Titration Phase|Lack of Efficacy|10|||
37826825|NCT00472303|69509694|FG001|Titration Phase|Lack of Efficacy|0|||
37826826|NCT00472303|69509695|FG002|Titration Phase|Lack of Efficacy|0|||
37996621|NCT00296504|69681180|FG000|Interim Analysis|Withdrawal by Subject|8|||
37996622|NCT00296504|69681181|FG001|Interim Analysis|Withdrawal by Subject|0|||
37996623|NCT00296504|69681182|FG002|Interim Analysis|Withdrawal by Subject|12|||
37996624|NCT00296504|69681183|FG003|Interim Analysis|Withdrawal by Subject|0|||
37996625|NCT00296504|69681184|FG004|Interim Analysis|Withdrawal by Subject|5|||
37996626|NCT00296504|69681185|FG005|Interim Analysis|Withdrawal by Subject|5|||
37996627|NCT00296504|69681186|FG006|Interim Analysis|Withdrawal by Subject|9|||
37996628|NCT00296504|69681187|FG007|Interim Analysis|Withdrawal by Subject|3|||
37996629|NCT00296504|69681188|FG008|Interim Analysis|Withdrawal by Subject|0|||
37996630|NCT00296504|69681180|FG000|Interim Analysis|Lost to Follow-up|13|||
37996631|NCT00296504|69681181|FG001|Interim Analysis|Lost to Follow-up|3|||
37996632|NCT00296504|69681182|FG002|Interim Analysis|Lost to Follow-up|26|||
37996633|NCT00296504|69681183|FG003|Interim Analysis|Lost to Follow-up|8|||
37996634|NCT00296504|69681184|FG004|Interim Analysis|Lost to Follow-up|14|||
37996635|NCT00296504|69681185|FG005|Interim Analysis|Lost to Follow-up|4|||
37996636|NCT00296504|69681186|FG006|Interim Analysis|Lost to Follow-up|11|||
37996637|NCT00296504|69681187|FG007|Interim Analysis|Lost to Follow-up|4|||
37996638|NCT00296504|69681188|FG008|Interim Analysis|Lost to Follow-up|0|||
37996639|NCT00296504|69681180|FG000|Interim Analysis|Clinical Progression|1|||
37996640|NCT00296504|69681181|FG001|Interim Analysis|Clinical Progression|0|||
37996641|NCT00296504|69681182|FG002|Interim Analysis|Clinical Progression|1|||
37996642|NCT00296504|69681183|FG003|Interim Analysis|Clinical Progression|1|||
37996643|NCT00296504|69681184|FG004|Interim Analysis|Clinical Progression|0|||
37996644|NCT00296504|69681185|FG005|Interim Analysis|Clinical Progression|2|||
37996645|NCT00296504|69681186|FG006|Interim Analysis|Clinical Progression|1|||
37996646|NCT00296504|69681187|FG007|Interim Analysis|Clinical Progression|2|||
37996647|NCT00296504|69681188|FG008|Interim Analysis|Clinical Progression|0|||
37996648|NCT00296504|69681180|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
37996649|NCT00296504|69681181|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
37996650|NCT00296504|69681182|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
37996651|NCT00296504|69681183|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
37996652|NCT00296504|69681184|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
37996653|NCT00296504|69681185|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
37996654|NCT00296504|69681186|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
37996655|NCT00296504|69681187|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
37996656|NCT00296504|69681188|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
37996657|NCT00296504|69681180|FG000|Interim Analysis|Adverse Event|0|||
37996658|NCT00296504|69681181|FG001|Interim Analysis|Adverse Event|0|||
37996659|NCT00296504|69681182|FG002|Interim Analysis|Adverse Event|13|||
37996660|NCT00296504|69681183|FG003|Interim Analysis|Adverse Event|4|||
37996661|NCT00296504|69681184|FG004|Interim Analysis|Adverse Event|6|||
37996662|NCT00296504|69681185|FG005|Interim Analysis|Adverse Event|3|||
37996663|NCT00296504|69681186|FG006|Interim Analysis|Adverse Event|4|||
37696677|NCT01827046|69172946|FG000|Overall Study|Lost to Follow-up|1|||
37826827|NCT00472303|69509693|FG000|Titration Phase|Withdrawal by Subject|16|||
37826828|NCT00472303|69509694|FG001|Titration Phase|Withdrawal by Subject|13|||
37826829|NCT00472303|69509695|FG002|Titration Phase|Withdrawal by Subject|0|||
37826830|NCT00472303|69509693|FG000|Titration Phase|Trial Medication non-compliant|4|||
37826831|NCT00472303|69509694|FG001|Titration Phase|Trial Medication non-compliant|1|||
37826832|NCT00472303|69509695|FG002|Titration Phase|Trial Medication non-compliant|0|||
37826833|NCT00472303|69509693|FG000|Titration Phase|Other|3|||
37996664|NCT00296504|69681187|FG007|Interim Analysis|Adverse Event|5|||
37996665|NCT00296504|69681188|FG008|Interim Analysis|Adverse Event|0|||
37996666|NCT00296504|69681180|FG000|Interim Analysis|Protocol Violation|0|||
37996667|NCT00296504|69681181|FG001|Interim Analysis|Protocol Violation|0|||
37996668|NCT00296504|69681182|FG002|Interim Analysis|Protocol Violation|2|||
37996669|NCT00296504|69681183|FG003|Interim Analysis|Protocol Violation|0|||
37996670|NCT00296504|69681184|FG004|Interim Analysis|Protocol Violation|1|||
37996671|NCT00296504|69681185|FG005|Interim Analysis|Protocol Violation|0|||
37996672|NCT00296504|69681186|FG006|Interim Analysis|Protocol Violation|0|||
37996673|NCT00296504|69681187|FG007|Interim Analysis|Protocol Violation|1|||
37826834|NCT00472303|69509694|FG001|Titration Phase|Other|1|||
37826835|NCT00472303|69509695|FG002|Titration Phase|Other|0|||
37899604|NCT00962780|69585152|FG000|Overall Study|Death|0|||
37696678|NCT01827046|69172947|FG001|Overall Study|Lost to Follow-up|5|||
37826836|NCT00472303|69509693|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
37826837|NCT00472303|69509694|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
37696679|NCT01827046|69172946|FG000|Overall Study|Withdrawal by Subject|0|||
37696680|NCT01827046|69172947|FG001|Overall Study|Withdrawal by Subject|4|||
37696681|NCT02356562|69172955|FG000|Overall Study|Withdrawal by Subject|0|||
37826838|NCT00472303|69509695|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
37826839|NCT00472303|69509693|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
37826840|NCT00472303|69509694|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
37826841|NCT00472303|69509695|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
37826842|NCT00472303|69509693|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
37826843|NCT00472303|69509694|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
37826844|NCT00472303|69509695|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
37826845|NCT00472303|69509693|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
37826846|NCT00472303|69509694|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
37826847|NCT00472303|69509695|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
37826848|NCT00472303|69509693|FG000|Discontinuations After Titration Phase|Other|5|||
37826849|NCT00472303|69509694|FG001|Discontinuations After Titration Phase|Other|0|||
37826850|NCT00472303|69509695|FG002|Discontinuations After Titration Phase|Other|0|||
37826851|NCT00472303|69509693|FG000|Maintenance Phase|Adverse Event|5|||
37826852|NCT00472303|69509694|FG001|Maintenance Phase|Adverse Event|6|||
37826853|NCT00472303|69509695|FG002|Maintenance Phase|Adverse Event|6|||
37826854|NCT00472303|69509693|FG000|Maintenance Phase|Death|3|||
37826855|NCT00472303|69509694|FG001|Maintenance Phase|Death|0|||
37826856|NCT00472303|69509695|FG002|Maintenance Phase|Death|2|||
37826857|NCT00472303|69509693|FG000|Maintenance Phase|Lack of Efficacy|2|||
37826858|NCT00472303|69509694|FG001|Maintenance Phase|Lack of Efficacy|2|||
37826859|NCT00472303|69509695|FG002|Maintenance Phase|Lack of Efficacy|4|||
37826860|NCT00472303|69509693|FG000|Maintenance Phase|Withdrawal by Subject|6|||
37826861|NCT00472303|69509694|FG001|Maintenance Phase|Withdrawal by Subject|7|||
37826862|NCT00472303|69509695|FG002|Maintenance Phase|Withdrawal by Subject|3|||
37826863|NCT00472303|69509693|FG000|Maintenance Phase|Trial medication non-compliant|0|||
37826864|NCT00472303|69509694|FG001|Maintenance Phase|Trial medication non-compliant|0|||
37826865|NCT00472303|69509695|FG002|Maintenance Phase|Trial medication non-compliant|1|||
37826866|NCT00472303|69509693|FG000|Maintenance Phase|Resolution of pain|0|||
37826867|NCT00472303|69509694|FG001|Maintenance Phase|Resolution of pain|0|||
37826868|NCT00472303|69509695|FG002|Maintenance Phase|Resolution of pain|1|||
37826869|NCT00472303|69509693|FG000|Maintenance Phase|Other|1|||
37826870|NCT00472303|69509694|FG001|Maintenance Phase|Other|1|||
37826871|NCT00472303|69509695|FG002|Maintenance Phase|Other|0|||
37826872|NCT00471718|69509723|FG000|Overall Study|Adverse Event|3|||
37826873|NCT00471718|69509723|FG000|Overall Study|other complicating disease|1|||
37826874|NCT00471718|69509723|FG000|Overall Study|disease progression|22|||
37826875|NCT00471718|69509723|FG000|Overall Study|Withdrawal by Subject|1|||
37826876|NCT00471445|69509733|FG000|Overall Study|Withdrawal by Subject|1|||
37826877|NCT00471445|69509734|FG001|Overall Study|Withdrawal by Subject|1|||
37826878|NCT00471445|69509733|FG000|Overall Study|Ineligible|1|||
37826879|NCT00471445|69509734|FG001|Overall Study|Ineligible|0|||
37826880|NCT00471445|69509733|FG000|Overall Study|Protocol Violation|0|||
37826881|NCT00471445|69509734|FG001|Overall Study|Protocol Violation|1|||
37899605|NCT00962780|69585153|FG001|Overall Study|Death|1|||
37899606|NCT00962780|69585152|FG000|Overall Study|Protocol Violation|9|||
37899607|NCT00962780|69585153|FG001|Overall Study|Protocol Violation|4|||
37899608|NCT00962780|69585152|FG000|Overall Study|Withdrawal by Subject|1|||
37899609|NCT00962780|69585153|FG001|Overall Study|Withdrawal by Subject|8|||
37899610|NCT00962780|69585152|FG000|Overall Study|Other|0|||
37899611|NCT00962780|69585153|FG001|Overall Study|Other|1|||
37899612|NCT00739882|69585167|FG000|Double-blind Period|Adverse Event|1|||
37899613|NCT00739882|69585168|FG001|Double-blind Period|Adverse Event|2|||
37899614|NCT00739882|69585167|FG000|Double-blind Period|Protocol Violation|1|||
37899615|NCT00739882|69585168|FG001|Double-blind Period|Protocol Violation|0|||
37899616|NCT00739882|69585167|FG000|Double-blind Period|Lack of Efficacy|1|||
37899617|NCT00739882|69585168|FG001|Double-blind Period|Lack of Efficacy|1|||
37899618|NCT00739882|69585167|FG000|Double-blind Period|Other|16|||
37899619|NCT00739882|69585168|FG001|Double-blind Period|Other|8|||
37899620|NCT00739882|69585167|FG000|Open-label Period|Adverse Event|1|||
37899621|NCT00739882|69585168|FG001|Open-label Period|Adverse Event|0|||
37899622|NCT00739882|69585167|FG000|Open-label Period|Other|9|||
37899623|NCT00739882|69585168|FG001|Open-label Period|Other|5|||
37899624|NCT00961220|69585176|FG000|Overall Study|Adverse Event|3|||
37899625|NCT00961220|69585176|FG000|Overall Study|Lack of Efficacy|1|||
37899626|NCT00961220|69585176|FG000|Overall Study|No IV access for O6BG|1|||
37899627|NCT00961220|69585176|FG000|Overall Study|O6BG no longer supplied|1|||
37899628|NCT00961220|69585176|FG000|Overall Study|Complete Response prior to 12 courses|1|||
37696682|NCT02356562|69172956|FG001|Overall Study|Withdrawal by Subject|1|||
37826882|NCT00471328|69509742|FG000|Core Phase|Adverse Event|18|||
37826883|NCT00471328|69509743|FG001|Core Phase|Adverse Event|6|||
37826884|NCT00471328|69509742|FG000|Core Phase|Death|8|||
37826885|NCT00471328|69509743|FG001|Core Phase|Death|4|||
37826886|NCT00471328|69509742|FG000|Core Phase|Withdrawal by Subject|2|||
37826887|NCT00471328|69509743|FG001|Core Phase|Withdrawal by Subject|2|||
37826888|NCT00471328|69509742|FG000|Core Phase|Abnormal laboratory value|1|||
37826889|NCT00471328|69509743|FG001|Core Phase|Abnormal laboratory value|0|||
37826890|NCT00471328|69509742|FG000|Core Phase|Disease Progression|78|||
37826891|NCT00471328|69509743|FG001|Core Phase|Disease Progression|53|||
37826892|NCT00471328|69509742|FG000|Core Phase|Administrative Problem|0|||
37826893|NCT00471328|69509743|FG001|Core Phase|Administrative Problem|1|||
37826894|NCT00471328|69509742|FG000|Core Phase|Protocol Deviation|0|||
37826895|NCT00471328|69509743|FG001|Core Phase|Protocol Deviation|1|||
37826896|NCT00471328|69509742|FG000|Extension Phase|Adverse Event|3|||
37826897|NCT00471328|69509743|FG001|Extension Phase|Adverse Event|12|||
37826898|NCT00471328|69509742|FG000|Extension Phase|Withdrawal by Subject|0|||
37826899|NCT00471328|69509743|FG001|Extension Phase|Withdrawal by Subject|2|||
37826900|NCT00471328|69509742|FG000|Extension Phase|Death|1|||
37826901|NCT00471328|69509743|FG001|Extension Phase|Death|7|||
37826902|NCT00471328|69509742|FG000|Extension Phase|Protocol Deviation|3|||
37826903|NCT00471328|69509743|FG001|Extension Phase|Protocol Deviation|1|||
37826904|NCT00471328|69509742|FG000|Extension Phase|Treatment duration as per protocol|0|||
37826905|NCT00471328|69509743|FG001|Extension Phase|Treatment duration as per protocol|1|||
37826906|NCT00471328|69509742|FG000|Extension Phase|Disease Progression|32|||
37826907|NCT00471328|69509743|FG001|Extension Phase|Disease Progression|44|||
37826908|NCT00471328|69509742|FG000|Extension Phase|New cancer Therapy|1|||
37826909|NCT00471328|69509743|FG001|Extension Phase|New cancer Therapy|0|||
37826910|NCT00471328|69509742|FG000|Extension Phase|Administrative Problem|1|||
37826911|NCT00471328|69509743|FG001|Extension Phase|Administrative Problem|0|||
37826912|NCT00470470|69509751|FG000|Overall Study|Adverse Event|2|||
37826913|NCT00470470|69509751|FG000|Overall Study|Death|2|||
37826914|NCT00470470|69509751|FG000|Overall Study|Not treated|1|||
37826915|NCT00470275|69509755|FG000|Overall Study|Death|1|||
37826916|NCT00470275|69509755|FG000|Overall Study|Lack of Efficacy|7|||
37826917|NCT00470275|69509755|FG000|Overall Study|Withdrawal by Subject|2|||
37826918|NCT00470158|69509764|FG000|Overall Study|Death|0|||
37826919|NCT00470158|69509765|FG001|Overall Study|Death|0|||
37826920|NCT00470158|69509766|FG002|Overall Study|Death|0|||
37826921|NCT00470158|69509767|FG003|Overall Study|Death|0|||
37826922|NCT00470158|69509768|FG004|Overall Study|Death|2|||
37826923|NCT00470158|69509764|FG000|Overall Study|Lost to Follow-up|7|||
37826924|NCT00470158|69509765|FG001|Overall Study|Lost to Follow-up|8|||
37826925|NCT00470158|69509766|FG002|Overall Study|Lost to Follow-up|8|||
37826926|NCT00470158|69509767|FG003|Overall Study|Lost to Follow-up|5|||
37826927|NCT00470158|69509768|FG004|Overall Study|Lost to Follow-up|4|||
37996674|NCT00296504|69681188|FG008|Interim Analysis|Protocol Violation|0|||
37826928|NCT00470158|69509764|FG000|Overall Study|Protocol Violation|1|||
37826929|NCT00470158|69509765|FG001|Overall Study|Protocol Violation|0|||
37826930|NCT00470158|69509766|FG002|Overall Study|Protocol Violation|0|||
37826931|NCT00470158|69509767|FG003|Overall Study|Protocol Violation|0|||
37826932|NCT00470158|69509768|FG004|Overall Study|Protocol Violation|0|||
37826933|NCT00475540|69509782|FG000|36 Months|Lost to Follow-up|4|||
37826934|NCT00475540|69509783|FG001|36 Months|Lost to Follow-up|4|||
37826935|NCT00475540|69509782|FG000|36 Months|Death|1|||
37826936|NCT00475540|69509783|FG001|36 Months|Death|2|||
37826937|NCT00475540|69509782|FG000|36 Months|Censored due to reoperation|3|||
37826938|NCT00475540|69509783|FG001|36 Months|Censored due to reoperation|0|||
37826939|NCT00472186|69509791|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
37826940|NCT00472186|69509792|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
37826941|NCT00479713|69509802|FG000|Overall Study|Adverse Event|8|||
37826942|NCT00479713|69509803|FG001|Overall Study|Adverse Event|6|||
37826943|NCT00479713|69509802|FG000|Overall Study|Death|1|||
37826944|NCT00479713|69509803|FG001|Overall Study|Death|0|||
37826945|NCT00479713|69509802|FG000|Overall Study|Lost to Follow-up|0|||
37826946|NCT00479713|69509803|FG001|Overall Study|Lost to Follow-up|1|||
37826947|NCT00479713|69509802|FG000|Overall Study|Protocol Violation|0|||
37826948|NCT00479713|69509803|FG001|Overall Study|Protocol Violation|1|||
37826949|NCT00479713|69509802|FG000|Overall Study|Withdrawal by Subject|4|||
37826950|NCT00479713|69509803|FG001|Overall Study|Withdrawal by Subject|1|||
37826951|NCT00474526|69509835|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
37826952|NCT00474526|69509836|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
37826953|NCT00474526|69509837|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
37826954|NCT00474526|69509838|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
37826955|NCT00474526|69509839|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
37826956|NCT00474526|69509840|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
37826957|NCT00474526|69509841|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
37826958|NCT00474526|69509842|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
37826959|NCT00474526|69509843|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
37826960|NCT00474526|69509844|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
37826961|NCT00474526|69509845|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
37826962|NCT00474526|69509846|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
37826963|NCT00474526|69509847|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
37826964|NCT00474526|69509848|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
37826965|NCT00474526|69509849|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
37826966|NCT00474526|69509850|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
37826967|NCT00474526|69509851|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
37826968|NCT00474526|69509835|FG000|Overall Study|Adverse Event|2|||
37826969|NCT00474526|69509836|FG001|Overall Study|Adverse Event|0|||
37826970|NCT00474526|69509837|FG002|Overall Study|Adverse Event|2|||
37826971|NCT00474526|69509838|FG003|Overall Study|Adverse Event|4|||
37826972|NCT00474526|69509839|FG004|Overall Study|Adverse Event|2|||
37826973|NCT00474526|69509840|FG005|Overall Study|Adverse Event|1|||
37826974|NCT00474526|69509841|FG006|Overall Study|Adverse Event|1|||
37826975|NCT00474526|69509842|FG007|Overall Study|Adverse Event|0|||
37826976|NCT00474526|69509843|FG008|Overall Study|Adverse Event|0|||
37826977|NCT00474526|69509844|FG009|Overall Study|Adverse Event|0|||
37826978|NCT00474526|69509845|FG010|Overall Study|Adverse Event|0|||
37899629|NCT00734656|69585182|FG000|Lab Session 1|Withdrawal by Subject|2|||
37899630|NCT00734656|69585183|FG001|Lab Session 1|Withdrawal by Subject|0|||
37899631|NCT00734656|69585184|FG002|Lab Session 1|Withdrawal by Subject|0|||
37899632|NCT00734656|69585185|FG003|Lab Session 1|Withdrawal by Subject|0|||
37899633|NCT00734656|69585182|FG000|Washout 1|Withdrawal by Subject|1|||
37899634|NCT00734656|69585183|FG001|Washout 1|Withdrawal by Subject|5|||
37899635|NCT00734656|69585184|FG002|Washout 1|Withdrawal by Subject|2|||
37899636|NCT00734656|69585185|FG003|Washout 1|Withdrawal by Subject|3|||
37899637|NCT00734656|69585182|FG000|Lab Session 2|Withdrawal by Subject|1|||
37899638|NCT00734656|69585183|FG001|Lab Session 2|Withdrawal by Subject|0|||
37899639|NCT00734656|69585184|FG002|Lab Session 2|Withdrawal by Subject|0|||
37899640|NCT00734656|69585185|FG003|Lab Session 2|Withdrawal by Subject|1|||
37899641|NCT00734656|69585182|FG000|Washout 2|Withdrawal by Subject|1|||
37899642|NCT00734656|69585183|FG001|Washout 2|Withdrawal by Subject|1|||
37899643|NCT00734656|69585184|FG002|Washout 2|Withdrawal by Subject|1|||
37899644|NCT00734656|69585185|FG003|Washout 2|Withdrawal by Subject|0|||
37899645|NCT00734656|69585182|FG000|Washout 3|Withdrawal by Subject|1|||
37899646|NCT00734656|69585183|FG001|Washout 3|Withdrawal by Subject|0|||
37899647|NCT00734656|69585184|FG002|Washout 3|Withdrawal by Subject|0|||
37899648|NCT00734656|69585185|FG003|Washout 3|Withdrawal by Subject|1|||
37899649|NCT00734656|69585182|FG000|Lab Session 4|Withdrawal by Subject|0|||
37899650|NCT00734656|69585183|FG001|Lab Session 4|Withdrawal by Subject|0|||
37899651|NCT00734656|69585184|FG002|Lab Session 4|Withdrawal by Subject|0|||
37899652|NCT00734656|69585185|FG003|Lab Session 4|Withdrawal by Subject|1|||
37899653|NCT00739648|69585197|FG000|Overall Study|Adverse Event|3|||
37899654|NCT00739648|69585198|FG001|Overall Study|Adverse Event|15|||
37899655|NCT00739648|69585197|FG000|Overall Study|Withdrawal by Subject|13|||
37826979|NCT00474526|69509846|FG011|Overall Study|Adverse Event|0|||
37826980|NCT00474526|69509847|FG012|Overall Study|Adverse Event|0|||
37826981|NCT00474526|69509848|FG013|Overall Study|Adverse Event|0|||
37826982|NCT00474526|69509849|FG014|Overall Study|Adverse Event|1|||
37826983|NCT00474526|69509850|FG015|Overall Study|Adverse Event|1|||
37826984|NCT00474526|69509851|FG016|Overall Study|Adverse Event|0|||
37826985|NCT00474526|69509835|FG000|Overall Study|Death|0|||
37826986|NCT00474526|69509836|FG001|Overall Study|Death|0|||
37826987|NCT00474526|69509837|FG002|Overall Study|Death|0|||
37899656|NCT00739648|69585198|FG001|Overall Study|Withdrawal by Subject|25|||
37826988|NCT00474526|69509838|FG003|Overall Study|Death|0|||
37826989|NCT00474526|69509839|FG004|Overall Study|Death|0|||
37826990|NCT00474526|69509840|FG005|Overall Study|Death|0|||
37826991|NCT00474526|69509841|FG006|Overall Study|Death|0|||
37826992|NCT00474526|69509842|FG007|Overall Study|Death|0|||
37826993|NCT00474526|69509843|FG008|Overall Study|Death|0|||
37899657|NCT00739648|69585197|FG000|Overall Study|Lost to Follow-up|4|||
37899658|NCT00739648|69585198|FG001|Overall Study|Lost to Follow-up|7|||
37899659|NCT00739648|69585197|FG000|Overall Study|Death|2|||
37899660|NCT00739648|69585198|FG001|Overall Study|Death|0|||
37899661|NCT00739648|69585197|FG000|Overall Study|Do not know|4|||
37899662|NCT00739648|69585198|FG001|Overall Study|Do not know|6|||
37996675|NCT00296504|69681180|FG000|Interim Analysis|Insufficient CD4 Response|0|||
37996676|NCT00296504|69681181|FG001|Interim Analysis|Insufficient CD4 Response|0|||
37996677|NCT00296504|69681182|FG002|Interim Analysis|Insufficient CD4 Response|0|||
37996678|NCT00296504|69681183|FG003|Interim Analysis|Insufficient CD4 Response|0|||
37996679|NCT00296504|69681184|FG004|Interim Analysis|Insufficient CD4 Response|1|||
37996680|NCT00296504|69681185|FG005|Interim Analysis|Insufficient CD4 Response|1|||
37996681|NCT00296504|69681186|FG006|Interim Analysis|Insufficient CD4 Response|0|||
37996682|NCT00296504|69681187|FG007|Interim Analysis|Insufficient CD4 Response|0|||
37996683|NCT00296504|69681188|FG008|Interim Analysis|Insufficient CD4 Response|0|||
37996684|NCT00296504|69681180|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
37996685|NCT00296504|69681181|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
37996686|NCT00296504|69681182|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
37996687|NCT00296504|69681183|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
37996688|NCT00296504|69681184|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
37996689|NCT00296504|69681185|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
37996690|NCT00296504|69681186|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
37996691|NCT00296504|69681187|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
37996692|NCT00296504|69681188|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
37996693|NCT00296504|69681180|FG000|Interim Analysis|Pregnancy|4|||
37996694|NCT00296504|69681181|FG001|Interim Analysis|Pregnancy|1|||
37996695|NCT00296504|69681182|FG002|Interim Analysis|Pregnancy|4|||
37996696|NCT00296504|69681183|FG003|Interim Analysis|Pregnancy|2|||
37996697|NCT00296504|69681184|FG004|Interim Analysis|Pregnancy|0|||
37996698|NCT00296504|69681185|FG005|Interim Analysis|Pregnancy|1|||
37996699|NCT00296504|69681186|FG006|Interim Analysis|Pregnancy|1|||
37996700|NCT00296504|69681187|FG007|Interim Analysis|Pregnancy|1|||
37996701|NCT00296504|69681188|FG008|Interim Analysis|Pregnancy|0|||
37899663|NCT01032239|69585210|FG000|Overall Study|Lost to Follow-up|3|||
37899664|NCT01032239|69585211|FG001|Overall Study|Lost to Follow-up|2|||
37899665|NCT01032239|69585210|FG000|Overall Study|Withdrawal by Subject|2|||
37899666|NCT01032239|69585211|FG001|Overall Study|Withdrawal by Subject|3|||
37899667|NCT01032239|69585210|FG000|Overall Study|Death|1|||
37899668|NCT01032239|69585211|FG001|Overall Study|Death|0|||
37899669|NCT01032239|69585210|FG000|Overall Study|Protocol Violation|1|||
37899670|NCT01032239|69585211|FG001|Overall Study|Protocol Violation|0|||
37899671|NCT00734578|69585220|FG000|Overall Study|Adverse Event|4|||
37899672|NCT00734578|69585221|FG001|Overall Study|Adverse Event|6|||
37899673|NCT00734578|69585222|FG002|Overall Study|Adverse Event|1|||
37899674|NCT00734578|69585220|FG000|Overall Study|Protocol Violation|8|||
37899675|NCT00734578|69585221|FG001|Overall Study|Protocol Violation|6|||
37899676|NCT00734578|69585222|FG002|Overall Study|Protocol Violation|3|||
37899677|NCT00734578|69585220|FG000|Overall Study|Withdrawal by Subject|7|||
37899678|NCT00734578|69585221|FG001|Overall Study|Withdrawal by Subject|8|||
37899679|NCT00734578|69585222|FG002|Overall Study|Withdrawal by Subject|11|||
37899680|NCT00734578|69585220|FG000|Overall Study|Lost to Follow-up|9|||
37899681|NCT00734578|69585221|FG001|Overall Study|Lost to Follow-up|3|||
37899682|NCT00734578|69585222|FG002|Overall Study|Lost to Follow-up|5|||
37899683|NCT00734578|69585220|FG000|Overall Study|Lack of Efficacy|3|||
37899684|NCT00734578|69585221|FG001|Overall Study|Lack of Efficacy|2|||
37899685|NCT00734578|69585222|FG002|Overall Study|Lack of Efficacy|5|||
37899686|NCT00734578|69585220|FG000|Overall Study|Randomized in error|1|||
37899687|NCT00734578|69585221|FG001|Overall Study|Randomized in error|0|||
37899688|NCT00734578|69585222|FG002|Overall Study|Randomized in error|0|||
37899689|NCT00734578|69585220|FG000|Overall Study|Exclusion criteria|1|||
37899690|NCT00734578|69585221|FG001|Overall Study|Exclusion criteria|0|||
37899691|NCT00734578|69585222|FG002|Overall Study|Exclusion criteria|0|||
37899692|NCT00739102|69585230|FG000|Overall Study|Death|5|||
37899693|NCT00739102|69585230|FG000|Overall Study|Withdrawal by Subject|10|||
37899694|NCT00959192|69585238|FG000|Overall Study|Adverse Event|1|||
37899695|NCT00959192|69585239|FG001|Overall Study|Adverse Event|1|||
37899696|NCT00959192|69585240|FG002|Overall Study|Adverse Event|1|||
37899697|NCT00959192|69585241|FG003|Overall Study|Adverse Event|0|||
37899698|NCT00959192|69585238|FG000|Overall Study|Investigator Request|1|||
37899699|NCT00959192|69585239|FG001|Overall Study|Investigator Request|0|||
37899700|NCT00959192|69585240|FG002|Overall Study|Investigator Request|0|||
37996702|NCT00296504|69681180|FG000|Interim Analysis|Death|1|||
37996703|NCT00296504|69681181|FG001|Interim Analysis|Death|0|||
37899701|NCT00959192|69585241|FG003|Overall Study|Investigator Request|0|||
37899702|NCT00959192|69585238|FG000|Overall Study|Caregiver Request|0|||
37899703|NCT00959192|69585239|FG001|Overall Study|Caregiver Request|0|||
37996704|NCT00296504|69681182|FG002|Interim Analysis|Death|3|||
37996705|NCT00296504|69681183|FG003|Interim Analysis|Death|0|||
37996706|NCT00296504|69681184|FG004|Interim Analysis|Death|0|||
37996707|NCT00296504|69681185|FG005|Interim Analysis|Death|0|||
37899704|NCT00959192|69585240|FG002|Overall Study|Caregiver Request|2|||
37899705|NCT00959192|69585241|FG003|Overall Study|Caregiver Request|1|||
37899706|NCT00696787|69585255|FG000|Overall Study|Adverse Event|1|||
37899707|NCT00696787|69585256|FG001|Overall Study|Adverse Event|0|||
37899708|NCT00696787|69585257|FG002|Overall Study|Adverse Event|6|||
37899709|NCT00696787|69585255|FG000|Overall Study|Discontinuation by Sponsor|9|||
37899710|NCT00696787|69585256|FG001|Overall Study|Discontinuation by Sponsor|13|||
37899711|NCT00696787|69585257|FG002|Overall Study|Discontinuation by Sponsor|14|||
37899712|NCT00696787|69585255|FG000|Overall Study|Lack of Efficacy|0|||
37899713|NCT00696787|69585256|FG001|Overall Study|Lack of Efficacy|1|||
37899714|NCT00696787|69585257|FG002|Overall Study|Lack of Efficacy|0|||
37899715|NCT00696787|69585255|FG000|Overall Study|Lost to Follow-up|4|||
37899716|NCT00696787|69585256|FG001|Overall Study|Lost to Follow-up|0|||
37899717|NCT00696787|69585257|FG002|Overall Study|Lost to Follow-up|3|||
37899718|NCT00696787|69585255|FG000|Overall Study|Withdrawal by Subject|0|||
37899719|NCT00696787|69585256|FG001|Overall Study|Withdrawal by Subject|3|||
37899720|NCT00696787|69585257|FG002|Overall Study|Withdrawal by Subject|2|||
37899721|NCT00696787|69585255|FG000|Overall Study|Failed to return|1|||
37899722|NCT00696787|69585256|FG001|Overall Study|Failed to return|3|||
37899723|NCT00696787|69585257|FG002|Overall Study|Failed to return|1|||
37899724|NCT01012037|69585268|FG000|Overall Study|Adverse Event|0|||
37899725|NCT01012037|69585269|FG001|Overall Study|Adverse Event|8|||
37899726|NCT01012037|69585270|FG002|Overall Study|Adverse Event|3|||
37899727|NCT01012037|69585268|FG000|Overall Study|Protocol Violation|0|||
37899728|NCT01012037|69585269|FG001|Overall Study|Protocol Violation|3|||
37899729|NCT01012037|69585270|FG002|Overall Study|Protocol Violation|5|||
37899730|NCT01012037|69585268|FG000|Overall Study|Withdrawal by Subject|0|||
37899731|NCT01012037|69585269|FG001|Overall Study|Withdrawal by Subject|4|||
37899732|NCT01012037|69585270|FG002|Overall Study|Withdrawal by Subject|1|||
37899733|NCT01012037|69585268|FG000|Overall Study|Other reason (not specified)|1|||
37899734|NCT01012037|69585269|FG001|Overall Study|Other reason (not specified)|1|||
37899735|NCT01012037|69585270|FG002|Overall Study|Other reason (not specified)|1|||
37899736|NCT00734032|69585282|FG000|Overall Study|Adverse Event|0|||
37899737|NCT00734032|69585283|FG001|Overall Study|Adverse Event|1|||
37899738|NCT00734032|69585284|FG002|Overall Study|Adverse Event|0|||
37899739|NCT00734032|69585285|FG003|Overall Study|Adverse Event|0|||
37899740|NCT01010633|69585297|FG000|Overall Study|Adverse Event|1|||
37899741|NCT01010633|69585298|FG001|Overall Study|Adverse Event|1|||
37899742|NCT01010633|69585297|FG000|Overall Study|Protocol Violation|1|||
37899743|NCT01010633|69585298|FG001|Overall Study|Protocol Violation|2|||
37899744|NCT01010633|69585297|FG000|Overall Study|Withdrawal by Subject|2|||
37899745|NCT01010633|69585298|FG001|Overall Study|Withdrawal by Subject|1|||
37899746|NCT01010633|69585297|FG000|Overall Study|Investigator decision|0|||
37899747|NCT01010633|69585298|FG001|Overall Study|Investigator decision|1|||
37899748|NCT00733954|69585306|FG000|Overall Study|Lost to Follow-up|5|||
37899749|NCT00733954|69585307|FG001|Overall Study|Lost to Follow-up|2|||
37899750|NCT00733954|69585306|FG000|Overall Study|Protocol Violation|1|||
37899751|NCT00733954|69585307|FG001|Overall Study|Protocol Violation|0|||
37899752|NCT00733954|69585306|FG000|Overall Study|Withdrawal by Subject|2|||
37899753|NCT00733954|69585307|FG001|Overall Study|Withdrawal by Subject|0|||
37899754|NCT00733408|69585313|FG000|Overall Study|Adverse Event|4|||
37826994|NCT00474526|69509844|FG009|Overall Study|Death|0|||
37826995|NCT00474526|69509845|FG010|Overall Study|Death|0|||
37826996|NCT00474526|69509846|FG011|Overall Study|Death|0|||
37826997|NCT00474526|69509847|FG012|Overall Study|Death|0|||
37826998|NCT00474526|69509848|FG013|Overall Study|Death|3|||
37826999|NCT00474526|69509849|FG014|Overall Study|Death|0|||
37827000|NCT00474526|69509850|FG015|Overall Study|Death|0|||
37827001|NCT00474526|69509851|FG016|Overall Study|Death|0|||
37827002|NCT00474526|69509835|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
37827003|NCT00474526|69509836|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
37827004|NCT00474526|69509837|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
37827005|NCT00474526|69509838|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
37827006|NCT00474526|69509839|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
37827007|NCT00474526|69509840|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
37827008|NCT00474526|69509841|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
37827009|NCT00474526|69509842|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
37899755|NCT01010867|69585317|FG000|Overall Study|< 50% adherence to probiotic|1|||
37899756|NCT00576823|69585324|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
37899757|NCT00576823|69585325|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
37899758|NCT00576823|69585326|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
37899759|NCT00576823|69585324|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
37899760|NCT00576823|69585325|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
37899761|NCT00576823|69585326|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
37899762|NCT00732940|69585339|FG000|Overall Study|Withdrawal by Subject|1|||
37899763|NCT00732940|69585340|FG001|Overall Study|Withdrawal by Subject|2|||
37827010|NCT00474526|69509843|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
37827011|NCT00474526|69509844|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
37827012|NCT00474526|69509845|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
37827013|NCT00474526|69509846|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
37899764|NCT00732940|69585339|FG000|Overall Study|Adverse Event|0|||
37899765|NCT00732940|69585340|FG001|Overall Study|Adverse Event|1|||
37899766|NCT00732940|69585339|FG000|Overall Study|Lost to Follow-up|1|||
37899767|NCT00732940|69585340|FG001|Overall Study|Lost to Follow-up|0|||
37899768|NCT00962390|69585350|FG000|Overall Study|Adverse Event|0|||
37899769|NCT00962390|69585351|FG001|Overall Study|Adverse Event|0|||
37899770|NCT00962390|69585352|FG002|Overall Study|Adverse Event|3|||
37899771|NCT00962390|69585353|FG003|Overall Study|Adverse Event|1|||
37899772|NCT00962390|69585350|FG000|Overall Study|Lost to Follow-up|2|||
37899773|NCT00962390|69585351|FG001|Overall Study|Lost to Follow-up|2|||
37899774|NCT00962390|69585352|FG002|Overall Study|Lost to Follow-up|0|||
37899775|NCT00962390|69585353|FG003|Overall Study|Lost to Follow-up|0|||
37899776|NCT00962390|69585350|FG000|Overall Study|Protocol Violation|1|||
37899777|NCT00962390|69585351|FG001|Overall Study|Protocol Violation|0|||
37899778|NCT00962390|69585352|FG002|Overall Study|Protocol Violation|0|||
37899779|NCT00962390|69585353|FG003|Overall Study|Protocol Violation|0|||
37899780|NCT00962390|69585350|FG000|Overall Study|Withdrawal by Subject|1|||
37899781|NCT00962390|69585351|FG001|Overall Study|Withdrawal by Subject|1|||
37899782|NCT00962390|69585352|FG002|Overall Study|Withdrawal by Subject|1|||
37899783|NCT00962390|69585353|FG003|Overall Study|Withdrawal by Subject|0|||
37899784|NCT00732472|69585367|FG000|Overall Study|Adverse Event|0|||
37899785|NCT00732472|69585368|FG001|Overall Study|Adverse Event|1|||
37899786|NCT00732472|69585369|FG002|Overall Study|Adverse Event|1|||
37899787|NCT00732472|69585370|FG003|Overall Study|Adverse Event|1|||
37899788|NCT00732472|69585367|FG000|Overall Study|Protocol Violation|0|||
37899789|NCT00732472|69585368|FG001|Overall Study|Protocol Violation|0|||
37899790|NCT00732472|69585369|FG002|Overall Study|Protocol Violation|0|||
37899791|NCT00732472|69585370|FG003|Overall Study|Protocol Violation|1|||
37899792|NCT00732472|69585367|FG000|Overall Study|Withdrawal by Subject|0|||
37899793|NCT00732472|69585368|FG001|Overall Study|Withdrawal by Subject|2|||
37899794|NCT00732472|69585369|FG002|Overall Study|Withdrawal by Subject|0|||
37899795|NCT00732472|69585370|FG003|Overall Study|Withdrawal by Subject|1|||
37899796|NCT00960986|69585385|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
37899797|NCT00960986|69585386|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
37899798|NCT00960986|69585387|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
37899799|NCT00960986|69585388|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
37899800|NCT00960986|69585385|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
37899801|NCT00960986|69585386|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
37899802|NCT00960986|69585387|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
37899803|NCT00960986|69585388|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
37899804|NCT00960986|69585385|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
37899805|NCT00960986|69585386|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
37899806|NCT00960986|69585387|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
37899807|NCT00960986|69585388|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
37899808|NCT00960986|69585385|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
37899809|NCT00960986|69585386|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
37899810|NCT00960986|69585387|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
37899811|NCT00960986|69585388|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
37899812|NCT00960986|69585385|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
37899813|NCT00960986|69585386|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
37899814|NCT00960986|69585387|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
37899815|NCT00960986|69585388|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
37899816|NCT00960986|69585385|FG000|Period 3 (7-week Therapy Period)|Death|0|||
37899817|NCT00960986|69585386|FG001|Period 3 (7-week Therapy Period)|Death|0|||
37899818|NCT00960986|69585387|FG002|Period 3 (7-week Therapy Period)|Death|1|||
37899819|NCT00960986|69585388|FG003|Period 3 (7-week Therapy Period)|Death|0|||
37899820|NCT00960986|69585385|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
37899821|NCT00960986|69585386|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
37899822|NCT00960986|69585387|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
37899823|NCT00960986|69585388|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
37899824|NCT00960986|69585385|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
37899825|NCT00960986|69585386|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
37899826|NCT00960986|69585387|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
37899827|NCT00960986|69585388|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
37899828|NCT00960986|69585385|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
37899829|NCT00960986|69585386|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
37899830|NCT00960986|69585387|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
37996708|NCT00296504|69681186|FG006|Interim Analysis|Death|0|||
37899831|NCT00960986|69585388|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
37899832|NCT00960986|69585385|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
37899833|NCT00960986|69585386|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
37899834|NCT00960986|69585387|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
37899835|NCT00960986|69585388|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
37899836|NCT00732238|69585400|FG000|Overall Study|Bacteremia|4|||
37899837|NCT00732238|69585401|FG001|Overall Study|Bacteremia|1|||
37899838|NCT00732238|69585400|FG000|Overall Study|Asymptomatic bacteriuria|1|||
37696683|NCT02356562|69172955|FG000|Overall Study|Re-entered treatment in a previous study|1|||
37696684|NCT02356562|69172956|FG001|Overall Study|Re-entered treatment in a previous study|0|||
37827014|NCT00474526|69509847|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
37827015|NCT00474526|69509848|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
37827016|NCT00474526|69509849|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
37827017|NCT00474526|69509850|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
37827018|NCT00474526|69509851|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
37827019|NCT00474526|69509835|FG000|Overall Study|Lost to Follow-up|8|||
37827020|NCT00474526|69509836|FG001|Overall Study|Lost to Follow-up|6|||
37827021|NCT00474526|69509837|FG002|Overall Study|Lost to Follow-up|13|||
37827022|NCT00474526|69509838|FG003|Overall Study|Lost to Follow-up|29|||
37827023|NCT00474526|69509839|FG004|Overall Study|Lost to Follow-up|11|||
37827024|NCT00474526|69509840|FG005|Overall Study|Lost to Follow-up|5|||
37827025|NCT00474526|69509841|FG006|Overall Study|Lost to Follow-up|8|||
37827026|NCT00474526|69509842|FG007|Overall Study|Lost to Follow-up|1|||
37827027|NCT00474526|69509843|FG008|Overall Study|Lost to Follow-up|0|||
37827028|NCT00474526|69509844|FG009|Overall Study|Lost to Follow-up|6|||
37827029|NCT00474526|69509845|FG010|Overall Study|Lost to Follow-up|2|||
37827030|NCT00474526|69509846|FG011|Overall Study|Lost to Follow-up|4|||
37827031|NCT00474526|69509847|FG012|Overall Study|Lost to Follow-up|6|||
37827032|NCT00474526|69509848|FG013|Overall Study|Lost to Follow-up|74|||
37827033|NCT00474526|69509849|FG014|Overall Study|Lost to Follow-up|29|||
37827034|NCT00474526|69509850|FG015|Overall Study|Lost to Follow-up|4|||
37827035|NCT00474526|69509851|FG016|Overall Study|Lost to Follow-up|5|||
37827036|NCT00474526|69509835|FG000|Overall Study|Protocol Violation|2|||
37827037|NCT00474526|69509836|FG001|Overall Study|Protocol Violation|6|||
37827038|NCT00474526|69509837|FG002|Overall Study|Protocol Violation|4|||
37827039|NCT00474526|69509838|FG003|Overall Study|Protocol Violation|12|||
37827040|NCT00474526|69509839|FG004|Overall Study|Protocol Violation|3|||
37827041|NCT00474526|69509840|FG005|Overall Study|Protocol Violation|1|||
37827042|NCT00474526|69509841|FG006|Overall Study|Protocol Violation|3|||
37827043|NCT00474526|69509842|FG007|Overall Study|Protocol Violation|0|||
37827044|NCT00474526|69509843|FG008|Overall Study|Protocol Violation|0|||
37827045|NCT00474526|69509844|FG009|Overall Study|Protocol Violation|4|||
37827046|NCT00474526|69509845|FG010|Overall Study|Protocol Violation|2|||
37827047|NCT00474526|69509846|FG011|Overall Study|Protocol Violation|2|||
37827048|NCT00474526|69509847|FG012|Overall Study|Protocol Violation|4|||
37827049|NCT00474526|69509848|FG013|Overall Study|Protocol Violation|19|||
37827050|NCT00474526|69509849|FG014|Overall Study|Protocol Violation|9|||
37827051|NCT00474526|69509850|FG015|Overall Study|Protocol Violation|6|||
37827052|NCT00474526|69509851|FG016|Overall Study|Protocol Violation|2|||
37827053|NCT00474526|69509835|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
37827054|NCT00474526|69509836|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
37827055|NCT00474526|69509837|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
37827056|NCT00474526|69509838|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
37827057|NCT00474526|69509839|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
37827058|NCT00474526|69509840|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
37827059|NCT00474526|69509841|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
37827060|NCT00474526|69509842|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
37827061|NCT00474526|69509843|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
37827062|NCT00474526|69509844|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
37899839|NCT00732238|69585401|FG001|Overall Study|Asymptomatic bacteriuria|0|||
37899840|NCT00958880|69585411|FG000|Overall Study|Lost to Follow-up|2|||
37899841|NCT00958880|69585412|FG001|Overall Study|Lost to Follow-up|2|||
37899842|NCT00732160|69585422|FG000|Overall Study|Adverse Event|1|||
37827063|NCT00474526|69509845|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
37827064|NCT00474526|69509846|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
37899843|NCT00732160|69585423|FG001|Overall Study|Adverse Event|0|||
37899844|NCT00732160|69585424|FG002|Overall Study|Adverse Event|1|||
37827065|NCT00474526|69509847|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
37827066|NCT00474526|69509848|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
37827067|NCT00474526|69509849|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
37827068|NCT00474526|69509850|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
37827069|NCT00474526|69509851|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
37827070|NCT00474526|69509835|FG000|Overall Study|Withdrawal by Subject|9|||
37827071|NCT00474526|69509836|FG001|Overall Study|Withdrawal by Subject|24|||
37827072|NCT00474526|69509837|FG002|Overall Study|Withdrawal by Subject|21|||
37827073|NCT00474526|69509838|FG003|Overall Study|Withdrawal by Subject|52|||
37827074|NCT00474526|69509839|FG004|Overall Study|Withdrawal by Subject|38|||
37899845|NCT00732160|69585425|FG003|Overall Study|Adverse Event|1|||
37899846|NCT00732160|69585422|FG000|Overall Study|scheduling|4|||
37899847|NCT00732160|69585423|FG001|Overall Study|scheduling|4|||
37899848|NCT00732160|69585424|FG002|Overall Study|scheduling|2|||
37899849|NCT00732160|69585425|FG003|Overall Study|scheduling|1|||
37899850|NCT00958724|69585435|FG000|Overall Study|Disease Progression|6|||
37899851|NCT00738400|69585441|FG000|Overall Study|Adverse Event|3|||
37899852|NCT00738400|69585442|FG001|Overall Study|Adverse Event|1|||
37899853|NCT00738400|69585441|FG000|Overall Study|Withdrawal by Subject|0|||
37899854|NCT00738400|69585442|FG001|Overall Study|Withdrawal by Subject|1|||
37899855|NCT00738400|69585441|FG000|Overall Study|Lack of Efficacy|0|||
37899856|NCT00738400|69585442|FG001|Overall Study|Lack of Efficacy|1|||
37899857|NCT00738400|69585441|FG000|Overall Study|Lost to Follow-up|0|||
37899858|NCT00738400|69585442|FG001|Overall Study|Lost to Follow-up|3|||
37899859|NCT00738400|69585441|FG000|Overall Study|Protocol Violation|1|||
37899860|NCT00738400|69585442|FG001|Overall Study|Protocol Violation|0|||
37899861|NCT00738400|69585441|FG000|Overall Study|Non-compliant with study medication|0|||
37899862|NCT00738400|69585442|FG001|Overall Study|Non-compliant with study medication|1|||
37899863|NCT01009463|69585452|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
37899864|NCT01009463|69585453|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
37899865|NCT01009463|69585454|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
37899866|NCT01009463|69585455|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
37899867|NCT01009463|69585456|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
37899868|NCT01009463|69585452|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
37899869|NCT01009463|69585453|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
37899870|NCT01009463|69585454|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
37899871|NCT01009463|69585455|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
37899872|NCT01009463|69585456|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
37899873|NCT01009463|69585452|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
37899874|NCT01009463|69585453|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
37899875|NCT01009463|69585454|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
37899876|NCT01009463|69585455|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
37899877|NCT01009463|69585456|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
37899878|NCT01009463|69585452|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
37899879|NCT01009463|69585453|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
37899880|NCT01009463|69585454|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
37899881|NCT01009463|69585455|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
37899882|NCT01009463|69585456|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
37899883|NCT01009463|69585452|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
37899884|NCT01009463|69585453|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
37899885|NCT01009463|69585454|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
37899886|NCT01009463|69585455|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
37899887|NCT01009463|69585456|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
37899888|NCT01009463|69585452|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
37899889|NCT01009463|69585453|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
37899890|NCT01009463|69585454|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
37899891|NCT01009463|69585455|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
37996709|NCT00296504|69681187|FG007|Interim Analysis|Death|0|||
37996710|NCT00296504|69681188|FG008|Interim Analysis|Death|0|||
37996711|NCT00296504|69681180|FG000|Interim Analysis|Participant Non-compliant|0|||
37996712|NCT00296504|69681181|FG001|Interim Analysis|Participant Non-compliant|1|||
37996713|NCT00296504|69681182|FG002|Interim Analysis|Participant Non-compliant|2|||
37996714|NCT00296504|69681183|FG003|Interim Analysis|Participant Non-compliant|1|||
37996715|NCT00296504|69681184|FG004|Interim Analysis|Participant Non-compliant|1|||
37996716|NCT00296504|69681185|FG005|Interim Analysis|Participant Non-compliant|3|||
37996717|NCT00296504|69681186|FG006|Interim Analysis|Participant Non-compliant|6|||
37996718|NCT00296504|69681187|FG007|Interim Analysis|Participant Non-compliant|2|||
37996719|NCT00296504|69681188|FG008|Interim Analysis|Participant Non-compliant|0|||
37996720|NCT00296504|69681180|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
37996721|NCT00296504|69681181|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
37996722|NCT00296504|69681182|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
37996723|NCT00296504|69681183|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
37996724|NCT00296504|69681184|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
37996725|NCT00296504|69681185|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
37899892|NCT01009463|69585456|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
37899893|NCT01009463|69585452|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
37899894|NCT01009463|69585453|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
37899895|NCT01009463|69585454|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
37899896|NCT01009463|69585455|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
37899897|NCT01009463|69585456|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
37899898|NCT01009463|69585452|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
37899899|NCT01009463|69585453|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
37899900|NCT01009463|69585454|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
37899901|NCT01009463|69585455|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
37899902|NCT01009463|69585456|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
37899903|NCT01009463|69585452|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
37899904|NCT01009463|69585453|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
37899905|NCT01009463|69585454|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
37899906|NCT01009463|69585455|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
37899907|NCT01009463|69585456|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
37899908|NCT01009463|69585452|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
37899909|NCT01009463|69585453|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
37899910|NCT01009463|69585454|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
37899911|NCT01009463|69585455|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
37899912|NCT01009463|69585456|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
37899913|NCT01009463|69585452|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
37899914|NCT01009463|69585453|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
37899915|NCT01009463|69585454|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
37899916|NCT01009463|69585455|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
37899917|NCT01009463|69585456|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
37899918|NCT01009463|69585452|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
37899919|NCT01009463|69585453|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
37899920|NCT01009463|69585454|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
37899921|NCT01009463|69585455|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
37899922|NCT01009463|69585456|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
37899923|NCT01009463|69585452|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
37899924|NCT01009463|69585453|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
37899925|NCT01009463|69585454|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
37899926|NCT01009463|69585455|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
37899927|NCT01009463|69585456|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
37899928|NCT00958568|69585467|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
37899929|NCT00958568|69585468|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
37899930|NCT00958568|69585469|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
37899931|NCT00958568|69585470|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
37899932|NCT00958568|69585467|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
37899933|NCT00958568|69585468|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
37899934|NCT00958568|69585469|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
37899935|NCT00958568|69585470|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
37899936|NCT00958568|69585467|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
37899937|NCT00958568|69585468|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
37899938|NCT00958568|69585469|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
37899939|NCT00958568|69585470|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
37899940|NCT00958568|69585467|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
37899941|NCT00958568|69585468|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
37899942|NCT00958568|69585469|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
37899943|NCT00958568|69585470|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
37899944|NCT00958568|69585467|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
37899945|NCT00958568|69585468|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
37899946|NCT00958568|69585469|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
37899947|NCT00958568|69585470|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
37899948|NCT00958568|69585467|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
37899949|NCT00958568|69585468|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
37899950|NCT00958568|69585469|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
37899951|NCT00958568|69585470|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
37899952|NCT00958568|69585467|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
37899953|NCT00958568|69585468|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
37899954|NCT00958568|69585469|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
37899955|NCT00958568|69585470|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
37899956|NCT00958568|69585467|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
37899957|NCT00958568|69585468|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
37996726|NCT00296504|69681186|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
37696685|NCT02356562|69172955|FG000|Overall Study|site closure|1|||
37696686|NCT02356562|69172956|FG001|Overall Study|site closure|0|||
37696687|NCT02448563|69172967|FG000|Overall Study|Lost to Follow-up|16|||
37899958|NCT00958568|69585469|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
37899959|NCT00958568|69585470|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
37899960|NCT00958568|69585467|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
37899961|NCT00958568|69585468|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
37899962|NCT00958568|69585469|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
37899963|NCT00958568|69585470|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
37899964|NCT00958568|69585467|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
37899965|NCT00958568|69585468|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
37899966|NCT00958568|69585469|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
37899967|NCT00958568|69585470|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
37899968|NCT00958568|69585467|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
37899969|NCT00958568|69585468|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
37899970|NCT00958568|69585469|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
37899971|NCT00958568|69585470|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
37899972|NCT00958568|69585467|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
37899973|NCT00958568|69585468|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
37899974|NCT00958568|69585469|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
37899975|NCT00958568|69585470|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
37899976|NCT00958568|69585467|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
37899977|NCT00958568|69585468|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
37899978|NCT00958568|69585469|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
37899979|NCT00958568|69585470|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
37899980|NCT00958568|69585467|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
37899981|NCT00958568|69585468|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
37899982|NCT00958568|69585469|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
37899983|NCT00958568|69585470|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
37899984|NCT00958568|69585467|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
37899985|NCT00958568|69585468|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
37899986|NCT00958568|69585469|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
37899987|NCT00958568|69585470|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
37899988|NCT00958568|69585467|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
37899989|NCT00958568|69585468|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
37899990|NCT00958568|69585469|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
37899991|NCT00958568|69585470|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
37899992|NCT00958568|69585467|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
37899993|NCT00958568|69585468|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
37899994|NCT00958568|69585469|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
37899995|NCT00958568|69585470|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
37899996|NCT00958568|69585467|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
37899997|NCT00958568|69585468|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
37899998|NCT00958568|69585469|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
37899999|NCT00958568|69585470|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
37900000|NCT00958568|69585467|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
37996727|NCT00296504|69681187|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
37827075|NCT00474526|69509840|FG005|Overall Study|Withdrawal by Subject|6|||
37827076|NCT00474526|69509841|FG006|Overall Study|Withdrawal by Subject|12|||
37827077|NCT00474526|69509842|FG007|Overall Study|Withdrawal by Subject|4|||
37996728|NCT00296504|69681188|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
37996729|NCT00296504|69681180|FG000|Interim Analysis|To Simplify Treatment|0|||
37996730|NCT00296504|69681181|FG001|Interim Analysis|To Simplify Treatment|0|||
37827078|NCT00474526|69509843|FG008|Overall Study|Withdrawal by Subject|4|||
37827079|NCT00474526|69509844|FG009|Overall Study|Withdrawal by Subject|13|||
37827080|NCT00474526|69509845|FG010|Overall Study|Withdrawal by Subject|5|||
37827081|NCT00474526|69509846|FG011|Overall Study|Withdrawal by Subject|4|||
37827082|NCT00474526|69509847|FG012|Overall Study|Withdrawal by Subject|4|||
37827083|NCT00474526|69509848|FG013|Overall Study|Withdrawal by Subject|37|||
37827084|NCT00474526|69509849|FG014|Overall Study|Withdrawal by Subject|22|||
37827085|NCT00474526|69509850|FG015|Overall Study|Withdrawal by Subject|1|||
37827086|NCT00474526|69509851|FG016|Overall Study|Withdrawal by Subject|1|||
37827087|NCT00478426|69509937|FG000|Overall Study|Withdrawal by Subject|1|||
37827088|NCT00477412|69509945|FG000|Overall Study|Death|0|||
37827089|NCT00477412|69509946|FG001|Overall Study|Death|0|||
37827090|NCT00477412|69509947|FG002|Overall Study|Death|0|||
37827091|NCT00477412|69509948|FG003|Overall Study|Death|4|||
37827092|NCT00477412|69509945|FG000|Overall Study|Lost to Follow-up|0|||
37900001|NCT00958568|69585468|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
37900002|NCT00958568|69585469|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
37900003|NCT00958568|69585470|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
37900004|NCT00958568|69585467|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
37900005|NCT00958568|69585468|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
37900006|NCT00958568|69585469|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
37900007|NCT00958568|69585470|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
37900008|NCT00958568|69585467|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
37900009|NCT00958568|69585468|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
37900010|NCT00958568|69585469|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
37900011|NCT00958568|69585470|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
37900012|NCT00958568|69585467|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
37900013|NCT00958568|69585468|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
37900014|NCT00958568|69585469|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
37900015|NCT00958568|69585470|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
37900016|NCT00958568|69585467|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
37900017|NCT00958568|69585468|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
37900018|NCT00958568|69585469|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
37900019|NCT00958568|69585470|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
37900020|NCT00958568|69585467|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
37900021|NCT00958568|69585468|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
37900022|NCT00958568|69585469|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
37900023|NCT00958568|69585470|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
37900024|NCT00958568|69585467|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
37900025|NCT00958568|69585468|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
37900026|NCT00958568|69585469|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
37900027|NCT00958568|69585470|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
37900028|NCT00958568|69585467|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
37900029|NCT00958568|69585468|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
37900030|NCT00958568|69585469|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
37900031|NCT00958568|69585470|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
37900032|NCT00958568|69585467|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
37900033|NCT00958568|69585468|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
37900034|NCT00958568|69585469|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
37900035|NCT00958568|69585470|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
37900036|NCT00958568|69585467|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
37900037|NCT00958568|69585468|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
37900038|NCT00958568|69585469|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
37900039|NCT00958568|69585470|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
37900040|NCT00958568|69585467|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
37900041|NCT00958568|69585468|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
37900042|NCT00958568|69585469|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
37900043|NCT00958568|69585470|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
37900044|NCT00958412|69585481|FG000|Overall Study|Study prematurely terminated|18|||
37900045|NCT00958256|69585485|FG000|Overall Study|Adverse Event|3|||
37996731|NCT00296504|69681182|FG002|Interim Analysis|To Simplify Treatment|1|||
37996732|NCT00296504|69681183|FG003|Interim Analysis|To Simplify Treatment|0|||
37996733|NCT00296504|69681184|FG004|Interim Analysis|To Simplify Treatment|0|||
37996734|NCT00296504|69681185|FG005|Interim Analysis|To Simplify Treatment|0|||
37996735|NCT00296504|69681186|FG006|Interim Analysis|To Simplify Treatment|2|||
37996736|NCT00296504|69681187|FG007|Interim Analysis|To Simplify Treatment|0|||
37996737|NCT00296504|69681188|FG008|Interim Analysis|To Simplify Treatment|0|||
37996738|NCT00296504|69681180|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
37996739|NCT00296504|69681181|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
37996740|NCT00296504|69681182|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
37996741|NCT00296504|69681183|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
37996742|NCT00296504|69681184|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
37996743|NCT00296504|69681185|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
37900046|NCT00696709|69585494|FG000|Overall Study|Withdrawal by Subject|1|||
37996744|NCT00296504|69681186|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
37900047|NCT00696709|69585495|FG001|Overall Study|Withdrawal by Subject|2|||
37996745|NCT00296504|69681187|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
37996746|NCT00296504|69681188|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
37827093|NCT00477412|69509946|FG001|Overall Study|Lost to Follow-up|0|||
37900048|NCT00696709|69585496|FG002|Overall Study|Withdrawal by Subject|1|||
37900049|NCT00696709|69585497|FG003|Overall Study|Withdrawal by Subject|4|||
37900050|NCT00696709|69585498|FG004|Overall Study|Withdrawal by Subject|3|||
37900051|NCT00696709|69585494|FG000|Overall Study|Protocol Violation|1|||
37900052|NCT00696709|69585495|FG001|Overall Study|Protocol Violation|0|||
37900053|NCT00696709|69585496|FG002|Overall Study|Protocol Violation|0|||
37900054|NCT00696709|69585497|FG003|Overall Study|Protocol Violation|0|||
37900055|NCT00696709|69585498|FG004|Overall Study|Protocol Violation|0|||
37996747|NCT00296504|69681180|FG000|Interim Analysis|Participant Moved|1|||
37996748|NCT00296504|69681181|FG001|Interim Analysis|Participant Moved|0|||
37996749|NCT00296504|69681182|FG002|Interim Analysis|Participant Moved|1|||
37996750|NCT00296504|69681183|FG003|Interim Analysis|Participant Moved|0|||
37996751|NCT00296504|69681184|FG004|Interim Analysis|Participant Moved|0|||
37996752|NCT00296504|69681185|FG005|Interim Analysis|Participant Moved|1|||
37996753|NCT00296504|69681186|FG006|Interim Analysis|Participant Moved|1|||
37996754|NCT00296504|69681187|FG007|Interim Analysis|Participant Moved|0|||
37996755|NCT00296504|69681188|FG008|Interim Analysis|Participant Moved|0|||
37996756|NCT00296504|69681180|FG000|Interim Analysis|Participant Was Incarcerated|2|||
37996757|NCT00296504|69681181|FG001|Interim Analysis|Participant Was Incarcerated|0|||
37996758|NCT00296504|69681182|FG002|Interim Analysis|Participant Was Incarcerated|1|||
37827094|NCT00477412|69509947|FG002|Overall Study|Lost to Follow-up|0|||
37827095|NCT00477412|69509948|FG003|Overall Study|Lost to Follow-up|1|||
37827096|NCT00477412|69509945|FG000|Overall Study|Withdrawal by Subject|0|||
37900056|NCT00696709|69585494|FG000|Overall Study|Lost to Follow-up|1|||
37900057|NCT00696709|69585495|FG001|Overall Study|Lost to Follow-up|1|||
37900058|NCT00696709|69585496|FG002|Overall Study|Lost to Follow-up|0|||
37900059|NCT00696709|69585497|FG003|Overall Study|Lost to Follow-up|0|||
37900060|NCT00696709|69585498|FG004|Overall Study|Lost to Follow-up|0|||
37900061|NCT00696709|69585494|FG000|Overall Study|Adverse Event|0|||
37900062|NCT00696709|69585495|FG001|Overall Study|Adverse Event|0|||
37900063|NCT00696709|69585496|FG002|Overall Study|Adverse Event|0|||
37900064|NCT00696709|69585497|FG003|Overall Study|Adverse Event|1|||
37900065|NCT00696709|69585498|FG004|Overall Study|Adverse Event|0|||
37900066|NCT01006265|69585518|FG000|Overall Study|Lost to Follow-up|1|||
37900067|NCT01006265|69585519|FG001|Overall Study|Lost to Follow-up|0|||
37900068|NCT01006265|69585520|FG002|Overall Study|Lost to Follow-up|1|||
37900069|NCT01006265|69585521|FG003|Overall Study|Lost to Follow-up|0|||
37900070|NCT01006265|69585518|FG000|Overall Study|Withdrawal by Subject|4|||
37900071|NCT01006265|69585519|FG001|Overall Study|Withdrawal by Subject|7|||
37900072|NCT01006265|69585520|FG002|Overall Study|Withdrawal by Subject|5|||
37900073|NCT01006265|69585521|FG003|Overall Study|Withdrawal by Subject|5|||
37900074|NCT01006265|69585518|FG000|Overall Study|Administrative reason|1|||
37900075|NCT01006265|69585519|FG001|Overall Study|Administrative reason|2|||
37996759|NCT00296504|69681183|FG003|Interim Analysis|Participant Was Incarcerated|0|||
37996760|NCT00296504|69681184|FG004|Interim Analysis|Participant Was Incarcerated|0|||
37827097|NCT00477412|69509946|FG001|Overall Study|Withdrawal by Subject|0|||
37827098|NCT00477412|69509947|FG002|Overall Study|Withdrawal by Subject|0|||
37827099|NCT00477412|69509948|FG003|Overall Study|Withdrawal by Subject|2|||
37827100|NCT00477412|69509945|FG000|Overall Study|Second Malignancy|0|||
37827101|NCT00477412|69509946|FG001|Overall Study|Second Malignancy|0|||
37827102|NCT00477412|69509947|FG002|Overall Study|Second Malignancy|0|||
37827103|NCT00477412|69509948|FG003|Overall Study|Second Malignancy|1|||
37827104|NCT00477412|69509945|FG000|Overall Study|Adverse Event|1|||
37827105|NCT00477412|69509946|FG001|Overall Study|Adverse Event|0|||
37827106|NCT00477412|69509947|FG002|Overall Study|Adverse Event|1|||
37827107|NCT00477412|69509948|FG003|Overall Study|Adverse Event|0|||
37827108|NCT01089556|69509958|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
37827109|NCT01089556|69509959|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
37827110|NCT01089556|69509960|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
37900076|NCT01006265|69585520|FG002|Overall Study|Administrative reason|3|||
37900077|NCT01006265|69585521|FG003|Overall Study|Administrative reason|0|||
37900078|NCT01008995|69585533|FG000|Controlled Period|Adverse Event|1|||
37900079|NCT01008995|69585534|FG001|Controlled Period|Adverse Event|2|||
37900080|NCT01008995|69585535|FG002|Controlled Period|Adverse Event|0|||
37996761|NCT00296504|69681185|FG005|Interim Analysis|Participant Was Incarcerated|0|||
37827111|NCT01089556|69509961|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
37827112|NCT01089556|69509962|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
37827113|NCT01089556|69509963|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
37827114|NCT01089556|69509958|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
37900081|NCT01008995|69585536|FG003|Controlled Period|Adverse Event|0|||
37900082|NCT01008995|69585533|FG000|Controlled Period|Other|2|||
37900083|NCT01008995|69585534|FG001|Controlled Period|Other|1|||
37900084|NCT01008995|69585535|FG002|Controlled Period|Other|0|||
37900085|NCT01008995|69585536|FG003|Controlled Period|Other|0|||
37996762|NCT00296504|69681186|FG006|Interim Analysis|Participant Was Incarcerated|0|||
37996763|NCT00296504|69681187|FG007|Interim Analysis|Participant Was Incarcerated|0|||
37900086|NCT01008995|69585533|FG000|After Controlled Period|Adverse Event|0|||
37900087|NCT01008995|69585534|FG001|After Controlled Period|Adverse Event|0|||
37900088|NCT01008995|69585535|FG002|After Controlled Period|Adverse Event|1|||
37900089|NCT01008995|69585536|FG003|After Controlled Period|Adverse Event|1|||
37900090|NCT01008995|69585533|FG000|After Controlled Period|Other|0|||
37900091|NCT01008995|69585534|FG001|After Controlled Period|Other|0|||
37900092|NCT01008995|69585535|FG002|After Controlled Period|Other|1|||
37900093|NCT01008995|69585536|FG003|After Controlled Period|Other|0|||
37996764|NCT00296504|69681188|FG008|Interim Analysis|Participant Was Incarcerated|0|||
37996765|NCT00296504|69681180|FG000|Interim Analysis|Resistance to FPV|0|||
37996766|NCT00296504|69681181|FG001|Interim Analysis|Resistance to FPV|0|||
37996767|NCT00296504|69681182|FG002|Interim Analysis|Resistance to FPV|1|||
37996768|NCT00296504|69681183|FG003|Interim Analysis|Resistance to FPV|0|||
37996769|NCT00296504|69681184|FG004|Interim Analysis|Resistance to FPV|0|||
37996770|NCT00296504|69681185|FG005|Interim Analysis|Resistance to FPV|0|||
37996771|NCT00296504|69681186|FG006|Interim Analysis|Resistance to FPV|0|||
37900094|NCT00957944|69585546|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
37900095|NCT00957944|69585547|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
37900096|NCT01005875|69585553|FG000|Overall Study|Death|3|||
37900097|NCT01005719|69585557|FG000|Period 1|Adverse Event|0|||
37900098|NCT01005719|69585558|FG001|Period 1|Adverse Event|0|||
37900099|NCT01005719|69585559|FG002|Period 1|Adverse Event|0|||
37900100|NCT01005719|69585560|FG003|Period 1|Adverse Event|1|||
37900101|NCT01005719|69585561|FG004|Period 1|Adverse Event|0|||
37900102|NCT01005719|69585562|FG005|Period 1|Adverse Event|0|||
37900103|NCT01005719|69585557|FG000|Period 1|Delay in completing study procedures|0|||
37900104|NCT01005719|69585558|FG001|Period 1|Delay in completing study procedures|0|||
37900105|NCT01005719|69585559|FG002|Period 1|Delay in completing study procedures|0|||
37900106|NCT01005719|69585560|FG003|Period 1|Delay in completing study procedures|0|||
37900107|NCT01005719|69585561|FG004|Period 1|Delay in completing study procedures|0|||
37900108|NCT01005719|69585562|FG005|Period 1|Delay in completing study procedures|1|||
37900109|NCT01005719|69585557|FG000|Period 2|Adverse Event|0|||
37900110|NCT01005719|69585558|FG001|Period 2|Adverse Event|0|||
37900111|NCT01005719|69585559|FG002|Period 2|Adverse Event|0|||
37900112|NCT01005719|69585560|FG003|Period 2|Adverse Event|0|||
37900113|NCT01005719|69585561|FG004|Period 2|Adverse Event|1|||
37900114|NCT01005719|69585562|FG005|Period 2|Adverse Event|1|||
37900115|NCT00953576|69585573|FG000|Overall Study|Adverse Event|0|||
37900116|NCT00953576|69585574|FG001|Overall Study|Adverse Event|1|||
37900117|NCT00953576|69585573|FG000|Overall Study|Ineligible after Consent|2|||
37900118|NCT00953576|69585574|FG001|Overall Study|Ineligible after Consent|0|||
37900119|NCT01005329|69585589|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
37900120|NCT01005251|69585599|FG000|Overall Study|Withdrawal by Subject|2|||
37900121|NCT01005251|69585600|FG001|Overall Study|Withdrawal by Subject|5|||
37900122|NCT01005251|69585601|FG002|Overall Study|Withdrawal by Subject|3|||
37900123|NCT01005251|69585602|FG003|Overall Study|Withdrawal by Subject|4|||
37900124|NCT01005251|69585603|FG004|Overall Study|Withdrawal by Subject|9|||
37900125|NCT01005251|69585599|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
37900126|NCT01005251|69585600|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
37900127|NCT01005251|69585601|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
37900128|NCT01005251|69585602|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
37900129|NCT01005251|69585603|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
37900130|NCT01005251|69585599|FG000|Overall Study|Adverse Event|2|||
37900131|NCT01005251|69585600|FG001|Overall Study|Adverse Event|6|||
37900132|NCT01005251|69585601|FG002|Overall Study|Adverse Event|8|||
37900133|NCT01005251|69585602|FG003|Overall Study|Adverse Event|5|||
37900134|NCT01005251|69585603|FG004|Overall Study|Adverse Event|4|||
37900135|NCT01005251|69585599|FG000|Overall Study|Protocol Violation|1|||
37900136|NCT01005251|69585600|FG001|Overall Study|Protocol Violation|0|||
37900137|NCT01005251|69585601|FG002|Overall Study|Protocol Violation|0|||
37900138|NCT01005251|69585602|FG003|Overall Study|Protocol Violation|0|||
37900139|NCT01005251|69585603|FG004|Overall Study|Protocol Violation|2|||
37996772|NCT00296504|69681187|FG007|Interim Analysis|Resistance to FPV|0|||
37996773|NCT00296504|69681188|FG008|Interim Analysis|Resistance to FPV|0|||
37996774|NCT00296504|69681180|FG000|Interim Analysis|Physician Decision|0|||
37900140|NCT01005251|69585599|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
37900141|NCT01005251|69585600|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
37900142|NCT01005251|69585601|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
37900143|NCT01005251|69585602|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
37900144|NCT01005251|69585603|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
37900145|NCT01005251|69585599|FG000|Overall Study|Lost to Follow-up|1|||
37900146|NCT01005251|69585600|FG001|Overall Study|Lost to Follow-up|4|||
37996775|NCT00296504|69681181|FG001|Interim Analysis|Physician Decision|0|||
37996776|NCT00296504|69681182|FG002|Interim Analysis|Physician Decision|1|||
37996777|NCT00296504|69681183|FG003|Interim Analysis|Physician Decision|0|||
37900147|NCT01005251|69585601|FG002|Overall Study|Lost to Follow-up|2|||
37900148|NCT01005251|69585602|FG003|Overall Study|Lost to Follow-up|0|||
37900149|NCT01005251|69585603|FG004|Overall Study|Lost to Follow-up|0|||
37900150|NCT01005251|69585599|FG000|Overall Study|Physician Decision|0|||
37900151|NCT01005251|69585600|FG001|Overall Study|Physician Decision|0|||
37900152|NCT01005251|69585601|FG002|Overall Study|Physician Decision|0|||
37900153|NCT01005251|69585602|FG003|Overall Study|Physician Decision|0|||
37900154|NCT01005251|69585603|FG004|Overall Study|Physician Decision|2|||
37900155|NCT01005251|69585599|FG000|Overall Study|Patient moved|1|||
37900156|NCT01005251|69585600|FG001|Overall Study|Patient moved|0|||
37900157|NCT01005251|69585601|FG002|Overall Study|Patient moved|0|||
37900158|NCT01005251|69585602|FG003|Overall Study|Patient moved|0|||
37900159|NCT01005251|69585603|FG004|Overall Study|Patient moved|0|||
37900160|NCT01005251|69585599|FG000|Overall Study|Wrong drug dispensed|0|||
37900161|NCT01005251|69585600|FG001|Overall Study|Wrong drug dispensed|1|||
37900162|NCT01005251|69585601|FG002|Overall Study|Wrong drug dispensed|0|||
37900163|NCT01005251|69585602|FG003|Overall Study|Wrong drug dispensed|0|||
37900164|NCT01005251|69585603|FG004|Overall Study|Wrong drug dispensed|0|||
37900165|NCT01005251|69585599|FG000|Overall Study|Randomized in error|0|||
37900166|NCT01005251|69585600|FG001|Overall Study|Randomized in error|0|||
37900167|NCT01005251|69585601|FG002|Overall Study|Randomized in error|1|||
37900168|NCT01005251|69585602|FG003|Overall Study|Randomized in error|1|||
37900169|NCT01005251|69585603|FG004|Overall Study|Randomized in error|0|||
37900170|NCT01005251|69585599|FG000|Overall Study|Lack of Efficacy|0|||
37900171|NCT01005251|69585600|FG001|Overall Study|Lack of Efficacy|0|||
37900172|NCT01005251|69585601|FG002|Overall Study|Lack of Efficacy|1|||
37900173|NCT01005251|69585602|FG003|Overall Study|Lack of Efficacy|1|||
37900174|NCT01005251|69585603|FG004|Overall Study|Lack of Efficacy|0|||
37900175|NCT03048578|69585617|FG000|Overall Study|Withdrawal by Subject|5|||
37900176|NCT03048578|69585618|FG001|Overall Study|Withdrawal by Subject|6|||
37900177|NCT03048578|69585617|FG000|Overall Study|Lost to Follow-up|22|||
37900178|NCT03048578|69585618|FG001|Overall Study|Lost to Follow-up|10|||
37900179|NCT03048578|69585617|FG000|Overall Study|Adverse Event|1|||
37900180|NCT03048578|69585618|FG001|Overall Study|Adverse Event|2|||
37900181|NCT03048578|69585617|FG000|Overall Study|Terminated|3|||
37900182|NCT03048578|69585618|FG001|Overall Study|Terminated|2|||
37900183|NCT01008449|69585626|FG000|Overall Study|Lost to Follow-up|29|||
37900184|NCT01008449|69585627|FG001|Overall Study|Lost to Follow-up|19|||
37900185|NCT00696241|69585638|FG000|Overall Study|Adverse Event|11|||
37900186|NCT00696241|69585639|FG001|Overall Study|Adverse Event|3|||
37900187|NCT00696241|69585640|FG002|Overall Study|Adverse Event|6|||
37900188|NCT00696241|69585641|FG003|Overall Study|Adverse Event|4|||
37900189|NCT00696241|69585642|FG004|Overall Study|Adverse Event|5|||
37900190|NCT00696241|69585638|FG000|Overall Study|Protocol Violation|1|||
37900191|NCT00696241|69585639|FG001|Overall Study|Protocol Violation|1|||
37900192|NCT00696241|69585640|FG002|Overall Study|Protocol Violation|2|||
37900193|NCT00696241|69585641|FG003|Overall Study|Protocol Violation|0|||
37900194|NCT00696241|69585642|FG004|Overall Study|Protocol Violation|3|||
37900195|NCT00696241|69585638|FG000|Overall Study|Lost to Follow-up|1|||
37900196|NCT00696241|69585639|FG001|Overall Study|Lost to Follow-up|4|||
37900197|NCT00696241|69585640|FG002|Overall Study|Lost to Follow-up|1|||
37900198|NCT00696241|69585641|FG003|Overall Study|Lost to Follow-up|2|||
37900199|NCT00696241|69585642|FG004|Overall Study|Lost to Follow-up|0|||
37900200|NCT00696241|69585638|FG000|Overall Study|Withdrawal by Subject|4|||
37900201|NCT00696241|69585639|FG001|Overall Study|Withdrawal by Subject|8|||
37900202|NCT00696241|69585640|FG002|Overall Study|Withdrawal by Subject|6|||
37900203|NCT00696241|69585641|FG003|Overall Study|Withdrawal by Subject|1|||
37900204|NCT00696241|69585642|FG004|Overall Study|Withdrawal by Subject|0|||
37900205|NCT00696241|69585638|FG000|Overall Study|Lack of Efficacy|1|||
37900206|NCT00696241|69585639|FG001|Overall Study|Lack of Efficacy|5|||
37900207|NCT00696241|69585640|FG002|Overall Study|Lack of Efficacy|4|||
37900208|NCT00696241|69585641|FG003|Overall Study|Lack of Efficacy|5|||
37900209|NCT00696241|69585642|FG004|Overall Study|Lack of Efficacy|3|||
37900210|NCT00696241|69585638|FG000|Overall Study|Other|6|||
37900211|NCT00696241|69585639|FG001|Overall Study|Other|1|||
37900212|NCT00696241|69585640|FG002|Overall Study|Other|5|||
37900213|NCT00696241|69585641|FG003|Overall Study|Other|2|||
37900214|NCT00696241|69585642|FG004|Overall Study|Other|1|||
37900215|NCT00957008|69585658|FG000|Overall Study|Withdrawal by Subject|13|||
37900216|NCT00957008|69585659|FG001|Overall Study|Withdrawal by Subject|10|||
37900217|NCT00957008|69585660|FG002|Overall Study|Withdrawal by Subject|12|||
37900218|NCT00957008|69585661|FG003|Overall Study|Withdrawal by Subject|16|||
37900219|NCT00957008|69585658|FG000|Overall Study|Lost to Follow-up|3|||
37900220|NCT00957008|69585659|FG001|Overall Study|Lost to Follow-up|1|||
37900221|NCT00957008|69585660|FG002|Overall Study|Lost to Follow-up|3|||
37996778|NCT00296504|69681184|FG004|Interim Analysis|Physician Decision|0|||
37900222|NCT00957008|69585661|FG003|Overall Study|Lost to Follow-up|4|||
37900223|NCT00957008|69585658|FG000|Overall Study|Physician Decision|1|||
37900224|NCT00957008|69585659|FG001|Overall Study|Physician Decision|0|||
37900225|NCT00957008|69585660|FG002|Overall Study|Physician Decision|1|||
37900226|NCT00957008|69585661|FG003|Overall Study|Physician Decision|1|||
37900227|NCT00957008|69585658|FG000|Overall Study|Relocated; Family conflict|4|||
37827115|NCT01089556|69509959|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
37827116|NCT01089556|69509960|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
37900228|NCT00957008|69585659|FG001|Overall Study|Relocated; Family conflict|1|||
37900229|NCT00957008|69585660|FG002|Overall Study|Relocated; Family conflict|1|||
37900230|NCT00957008|69585661|FG003|Overall Study|Relocated; Family conflict|3|||
37900231|NCT00952484|69585678|FG000|Overall Study|Withdrawal by Subject|0|||
37900232|NCT00952484|69585679|FG001|Overall Study|Withdrawal by Subject|1|||
37900233|NCT00952484|69585680|FG002|Overall Study|Withdrawal by Subject|0|||
37900234|NCT00689611|69585691|FG000|Overall Study|Death|6|||
37900235|NCT00689611|69585692|FG001|Overall Study|Death|9|||
37900236|NCT00689611|69585691|FG000|Overall Study|Withdrawal by Subject|8|||
37900237|NCT00689611|69585692|FG001|Overall Study|Withdrawal by Subject|9|||
37900238|NCT00689611|69585691|FG000|Overall Study|Lost to Follow-up|27|||
37900239|NCT00689611|69585692|FG001|Overall Study|Lost to Follow-up|28|||
37900240|NCT00689299|69585701|FG000|Overall Study|Adverse Event|2|||
37900241|NCT00689299|69585702|FG001|Overall Study|Adverse Event|1|||
37900242|NCT00689299|69585703|FG002|Overall Study|Adverse Event|1|||
37900243|NCT00689299|69585701|FG000|Overall Study|Lost to Follow-up|0|||
37900244|NCT00689299|69585702|FG001|Overall Study|Lost to Follow-up|1|||
37900245|NCT00689299|69585703|FG002|Overall Study|Lost to Follow-up|1|||
37900246|NCT00689299|69585701|FG000|Overall Study|Withdrawal by Subject|4|||
37900247|NCT00689299|69585702|FG001|Overall Study|Withdrawal by Subject|1|||
37900248|NCT00689299|69585703|FG002|Overall Study|Withdrawal by Subject|3|||
37900249|NCT00689299|69585701|FG000|Overall Study|Protocol Violation|1|||
37900250|NCT00689299|69585702|FG001|Overall Study|Protocol Violation|0|||
37900251|NCT00689299|69585703|FG002|Overall Study|Protocol Violation|0|||
37900252|NCT02506244|69585714|FG000|Overall Study|Did not undergo active monitoring|458|||
37900253|NCT02506244|69585715|FG001|Overall Study|Did not undergo active monitoring|459|||
37900254|NCT02506244|69585716|FG002|Overall Study|Did not undergo active monitoring|0|||
37900255|NCT00948974|69585726|FG000|Overall Study|Lost to Follow-up|23|||
37900256|NCT00948974|69585727|FG001|Overall Study|Lost to Follow-up|20|||
37900257|NCT01007435|69585737|FG000|Overall Study|Adverse Event|16|||
37900258|NCT01007435|69585738|FG001|Overall Study|Adverse Event|25|||
37900259|NCT01007435|69585739|FG002|Overall Study|Adverse Event|47|||
37827117|NCT01089556|69509961|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
37827118|NCT01089556|69509962|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
37827119|NCT01089556|69509963|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
37827120|NCT01089556|69509958|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
37827121|NCT01089556|69509959|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
37827122|NCT01089556|69509960|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
37827123|NCT01089556|69509961|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
37827124|NCT01089556|69509962|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
37827125|NCT01089556|69509963|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
37827126|NCT01089556|69509958|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
37827127|NCT01089556|69509959|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
37827128|NCT01089556|69509960|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
37827129|NCT01089556|69509961|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
37827130|NCT01089556|69509962|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
37900260|NCT01007435|69585740|FG003|Overall Study|Adverse Event|31|||
37900261|NCT01007435|69585737|FG000|Overall Study|Death|2|||
37900262|NCT01007435|69585738|FG001|Overall Study|Death|4|||
37900263|NCT01007435|69585739|FG002|Overall Study|Death|2|||
37900264|NCT01007435|69585740|FG003|Overall Study|Death|1|||
37900265|NCT01007435|69585737|FG000|Overall Study|Insufficient Therapeutic Response|21|||
37827131|NCT01089556|69509963|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
37900266|NCT01007435|69585738|FG001|Overall Study|Insufficient Therapeutic Response|7|||
37900267|NCT01007435|69585739|FG002|Overall Study|Insufficient Therapeutic Response|2|||
37900268|NCT01007435|69585740|FG003|Overall Study|Insufficient Therapeutic Response|9|||
37996779|NCT00296504|69681185|FG005|Interim Analysis|Physician Decision|0|||
37996780|NCT00296504|69681186|FG006|Interim Analysis|Physician Decision|0|||
37827132|NCT01089556|69509958|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
37827133|NCT01089556|69509959|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
37900269|NCT01007435|69585737|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
37900270|NCT01007435|69585738|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
37900271|NCT01007435|69585739|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
37900272|NCT01007435|69585740|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
37900273|NCT01007435|69585737|FG000|Overall Study|Other Protocol Violation|2|||
37900274|NCT01007435|69585738|FG001|Overall Study|Other Protocol Violation|0|||
37900275|NCT01007435|69585739|FG002|Overall Study|Other Protocol Violation|1|||
37900276|NCT01007435|69585740|FG003|Overall Study|Other Protocol Violation|0|||
37900277|NCT01007435|69585737|FG000|Overall Study|Refused Treatment|13|||
37900278|NCT01007435|69585738|FG001|Overall Study|Refused Treatment|13|||
37900279|NCT01007435|69585739|FG002|Overall Study|Refused Treatment|5|||
37900280|NCT01007435|69585740|FG003|Overall Study|Refused Treatment|8|||
37900281|NCT01007435|69585737|FG000|Overall Study|Failure to Return|5|||
37900282|NCT01007435|69585738|FG001|Overall Study|Failure to Return|4|||
37900283|NCT01007435|69585739|FG002|Overall Study|Failure to Return|3|||
37900284|NCT01007435|69585740|FG003|Overall Study|Failure to Return|6|||
37900285|NCT01007435|69585737|FG000|Overall Study|Reason not Specified|1|||
37900286|NCT01007435|69585738|FG001|Overall Study|Reason not Specified|1|||
37900287|NCT01007435|69585739|FG002|Overall Study|Reason not Specified|2|||
37900288|NCT01007435|69585740|FG003|Overall Study|Reason not Specified|1|||
37900289|NCT00948896|69585758|FG000|Randomization to 24 Months of Age|Death|1|||
37900290|NCT00948896|69585759|FG001|Randomization to 24 Months of Age|Death|0|||
37900291|NCT00948896|69585760|FG002|Randomization to 24 Months of Age|Death|0|||
37900292|NCT00948896|69585761|FG003|Randomization to 24 Months of Age|Death|0|||
37900293|NCT00948896|69585762|FG004|Randomization to 24 Months of Age|Death|2|||
37900294|NCT00948896|69585763|FG005|Randomization to 24 Months of Age|Death|1|||
37900295|NCT00948896|69585764|FG006|Randomization to 24 Months of Age|Death|2|||
37900296|NCT00948896|69585765|FG007|Randomization to 24 Months of Age|Death|1|||
37900297|NCT00948896|69585758|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
37900298|NCT00948896|69585759|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
37900299|NCT00948896|69585760|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
37900300|NCT00948896|69585761|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
37900301|NCT00948896|69585762|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
37900302|NCT00948896|69585763|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
37900303|NCT00948896|69585764|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
37900304|NCT00948896|69585765|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
37900305|NCT00948896|69585758|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
37900306|NCT00948896|69585759|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
37900307|NCT00948896|69585760|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
37900308|NCT00948896|69585761|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
37900309|NCT00948896|69585762|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
37900310|NCT00948896|69585763|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
37900311|NCT00948896|69585764|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
37900312|NCT00948896|69585765|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
37900313|NCT00948896|69585758|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
37900314|NCT00948896|69585759|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
37900315|NCT00948896|69585760|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
37900316|NCT00948896|69585761|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
37900317|NCT00948896|69585762|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
37900318|NCT00948896|69585763|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
37900319|NCT00948896|69585764|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
37900320|NCT00948896|69585765|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
37900321|NCT00948896|69585758|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
37900322|NCT00948896|69585759|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
37900323|NCT00948896|69585760|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
37900324|NCT00948896|69585761|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
37900325|NCT00948896|69585762|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
37900326|NCT00948896|69585763|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
37900327|NCT00948896|69585764|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
37900328|NCT00948896|69585765|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
37900329|NCT00948896|69585758|FG000|24 Months of Age to 36 Months of Age|Death|0|||
37900330|NCT00948896|69585759|FG001|24 Months of Age to 36 Months of Age|Death|2|||
37900331|NCT00948896|69585760|FG002|24 Months of Age to 36 Months of Age|Death|2|||
37900332|NCT00948896|69585761|FG003|24 Months of Age to 36 Months of Age|Death|0|||
37900333|NCT00948896|69585762|FG004|24 Months of Age to 36 Months of Age|Death|0|||
37900334|NCT00948896|69585763|FG005|24 Months of Age to 36 Months of Age|Death|1|||
37900335|NCT00948896|69585764|FG006|24 Months of Age to 36 Months of Age|Death|0|||
37900336|NCT00948896|69585765|FG007|24 Months of Age to 36 Months of Age|Death|0|||
37900337|NCT00948896|69585758|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
37900338|NCT00948896|69585759|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
37900339|NCT00948896|69585760|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
37900340|NCT00948896|69585761|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
37900341|NCT00948896|69585762|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
37996781|NCT00296504|69681187|FG007|Interim Analysis|Physician Decision|0|||
37996782|NCT00296504|69681188|FG008|Interim Analysis|Physician Decision|0|||
37996783|NCT00296504|69681180|FG000|Interim Analysis|Principle Investigator Discretion|2|||
37996784|NCT00296504|69681181|FG001|Interim Analysis|Principle Investigator Discretion|0|||
37996785|NCT00296504|69681182|FG002|Interim Analysis|Principle Investigator Discretion|1|||
37996786|NCT00296504|69681183|FG003|Interim Analysis|Principle Investigator Discretion|1|||
37996787|NCT00296504|69681184|FG004|Interim Analysis|Principle Investigator Discretion|0|||
37996788|NCT00296504|69681185|FG005|Interim Analysis|Principle Investigator Discretion|0|||
37996789|NCT00296504|69681186|FG006|Interim Analysis|Principle Investigator Discretion|0|||
37996790|NCT00296504|69681187|FG007|Interim Analysis|Principle Investigator Discretion|0|||
37996791|NCT00296504|69681188|FG008|Interim Analysis|Principle Investigator Discretion|0|||
37996792|NCT00296504|69681180|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
37996793|NCT00296504|69681181|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
37996794|NCT00296504|69681182|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
37996795|NCT00296504|69681183|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
37996796|NCT00296504|69681184|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
37827134|NCT01089556|69509960|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
37827135|NCT01089556|69509961|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
37827136|NCT01089556|69509962|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
37827137|NCT01089556|69509963|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
37827138|NCT01089556|69509958|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
37827139|NCT01089556|69509959|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
37827140|NCT01089556|69509960|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
37827141|NCT01089556|69509961|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
37827142|NCT01089556|69509962|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
37827143|NCT01089556|69509963|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
37827144|NCT01089556|69509958|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
37827145|NCT01089556|69509959|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
37827146|NCT01089556|69509960|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
37827147|NCT01089556|69509961|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
37827148|NCT01089556|69509962|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
37827149|NCT01089556|69509963|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
37827150|NCT01089556|69509958|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
37827151|NCT01089556|69509959|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
37827152|NCT01089556|69509960|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
37827153|NCT01089556|69509961|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
37827154|NCT01089556|69509962|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
37827155|NCT01089556|69509963|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
37827156|NCT01089556|69509958|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
37827157|NCT01089556|69509959|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
37827158|NCT01089556|69509960|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
37827159|NCT01089556|69509961|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
37827160|NCT01089556|69509962|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
37827161|NCT01089556|69509963|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
37827162|NCT01089556|69509958|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
37827163|NCT01089556|69509959|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
37827164|NCT01089556|69509960|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
37827165|NCT01089556|69509961|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
37827166|NCT01089556|69509962|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
37827167|NCT01089556|69509963|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
37827168|NCT01089556|69509958|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
37827169|NCT01089556|69509959|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
37827170|NCT01089556|69509960|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
37827171|NCT01089556|69509961|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
37827172|NCT01089556|69509962|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
37827173|NCT01089556|69509963|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
37827174|NCT01089556|69509958|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
37827175|NCT01089556|69509959|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
37827176|NCT01089556|69509960|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
37827177|NCT01089556|69509961|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
37827178|NCT01089556|69509962|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
37996797|NCT00296504|69681185|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
37900342|NCT00948896|69585763|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
37900343|NCT00948896|69585764|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
37900344|NCT00948896|69585765|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
37900345|NCT00948896|69585758|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
37900346|NCT00948896|69585759|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
37900347|NCT00948896|69585760|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
37900348|NCT00948896|69585761|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
37900349|NCT00948896|69585762|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
37900350|NCT00948896|69585763|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
37900351|NCT00948896|69585764|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
37900352|NCT00948896|69585765|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
37996798|NCT00296504|69681186|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
37996799|NCT00296504|69681187|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
37996800|NCT00296504|69681188|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
37996801|NCT00296504|69681180|FG000|Interim Analysis|Non-adherence|2|||
37996802|NCT00296504|69681181|FG001|Interim Analysis|Non-adherence|0|||
37996803|NCT00296504|69681182|FG002|Interim Analysis|Non-adherence|0|||
37996804|NCT00296504|69681183|FG003|Interim Analysis|Non-adherence|0|||
37996805|NCT00296504|69681184|FG004|Interim Analysis|Non-adherence|1|||
37996806|NCT00296504|69681185|FG005|Interim Analysis|Non-adherence|0|||
37827179|NCT01089556|69509963|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
37827180|NCT01089556|69509958|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
37827181|NCT01089556|69509959|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
37827182|NCT01089556|69509960|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
37827183|NCT01089556|69509961|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
37827184|NCT01089556|69509962|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
37827185|NCT01089556|69509963|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
37827186|NCT01089556|69509958|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
37827187|NCT01089556|69509959|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
37827188|NCT01089556|69509960|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
37827189|NCT01089556|69509961|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
37827190|NCT01089556|69509962|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
37827191|NCT01089556|69509963|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
37827192|NCT01089556|69509958|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
37827193|NCT01089556|69509959|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
37827194|NCT01089556|69509960|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
37827195|NCT01089556|69509961|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
37827196|NCT01089556|69509962|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
37827197|NCT01089556|69509963|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
37827198|NCT01089127|69509981|FG000|Overall Study|Adverse Event|5|||
37827199|NCT01089127|69509982|FG001|Overall Study|Adverse Event|1|||
37827200|NCT01089127|69509983|FG002|Overall Study|Adverse Event|1|||
37827201|NCT01089127|69509984|FG003|Overall Study|Adverse Event|0|||
37827202|NCT01089127|69509985|FG004|Overall Study|Adverse Event|0|||
37827203|NCT01089127|69509986|FG005|Overall Study|Adverse Event|1|||
37827204|NCT01089127|69509981|FG000|Overall Study|Subject withdrew consent|0|||
37827205|NCT01089127|69509982|FG001|Overall Study|Subject withdrew consent|1|||
37827206|NCT01089127|69509983|FG002|Overall Study|Subject withdrew consent|1|||
37827207|NCT01089127|69509984|FG003|Overall Study|Subject withdrew consent|1|||
37827208|NCT01089127|69509985|FG004|Overall Study|Subject withdrew consent|0|||
37827209|NCT01089127|69509986|FG005|Overall Study|Subject withdrew consent|2|||
37827210|NCT01089127|69509981|FG000|Overall Study|Abnormal test procedure result(s)|2|||
37827211|NCT01089127|69509982|FG001|Overall Study|Abnormal test procedure result(s)|1|||
37827212|NCT01089127|69509983|FG002|Overall Study|Abnormal test procedure result(s)|0|||
37827213|NCT01089127|69509984|FG003|Overall Study|Abnormal test procedure result(s)|0|||
37827214|NCT01089127|69509985|FG004|Overall Study|Abnormal test procedure result(s)|0|||
37827215|NCT01089127|69509986|FG005|Overall Study|Abnormal test procedure result(s)|0|||
37827216|NCT01089127|69509981|FG000|Overall Study|Lost to Follow-up|1|||
37827217|NCT01089127|69509982|FG001|Overall Study|Lost to Follow-up|1|||
37827218|NCT01089127|69509983|FG002|Overall Study|Lost to Follow-up|0|||
37827219|NCT01089127|69509984|FG003|Overall Study|Lost to Follow-up|0|||
37827220|NCT01089127|69509985|FG004|Overall Study|Lost to Follow-up|1|||
37900353|NCT00948896|69585758|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
37996807|NCT00296504|69681186|FG006|Interim Analysis|Non-adherence|0|||
37996808|NCT00296504|69681187|FG007|Interim Analysis|Non-adherence|1|||
37827221|NCT01089127|69509986|FG005|Overall Study|Lost to Follow-up|0|||
37827222|NCT01089127|69509981|FG000|Overall Study|Protocol deviation|0|||
37827223|NCT01089127|69509982|FG001|Overall Study|Protocol deviation|1|||
37827224|NCT01089127|69509983|FG002|Overall Study|Protocol deviation|0|||
37996809|NCT00296504|69681188|FG008|Interim Analysis|Non-adherence|0|||
37996810|NCT00296504|69681180|FG000|Interim Analysis|Site Closing|1|||
37996811|NCT00296504|69681181|FG001|Interim Analysis|Site Closing|0|||
37996812|NCT00296504|69681182|FG002|Interim Analysis|Site Closing|0|||
37996813|NCT00296504|69681183|FG003|Interim Analysis|Site Closing|0|||
37996814|NCT00296504|69681184|FG004|Interim Analysis|Site Closing|0|||
37996815|NCT00296504|69681185|FG005|Interim Analysis|Site Closing|1|||
37996816|NCT00296504|69681186|FG006|Interim Analysis|Site Closing|2|||
37996817|NCT00296504|69681187|FG007|Interim Analysis|Site Closing|0|||
37996818|NCT00296504|69681188|FG008|Interim Analysis|Site Closing|0|||
37996819|NCT00296504|69681180|FG000|Interim Analysis|Lack of Personnel at Site|1|||
37996820|NCT00296504|69681181|FG001|Interim Analysis|Lack of Personnel at Site|0|||
37996821|NCT00296504|69681182|FG002|Interim Analysis|Lack of Personnel at Site|0|||
37996822|NCT00296504|69681183|FG003|Interim Analysis|Lack of Personnel at Site|0|||
37996823|NCT00296504|69681184|FG004|Interim Analysis|Lack of Personnel at Site|0|||
37996824|NCT00296504|69681185|FG005|Interim Analysis|Lack of Personnel at Site|0|||
37996825|NCT00296504|69681186|FG006|Interim Analysis|Lack of Personnel at Site|0|||
37996826|NCT00296504|69681187|FG007|Interim Analysis|Lack of Personnel at Site|0|||
37996827|NCT00296504|69681188|FG008|Interim Analysis|Lack of Personnel at Site|0|||
37996828|NCT00296504|69681180|FG000|Interim Analysis|Missed Schedule Date|1|||
37996829|NCT00296504|69681181|FG001|Interim Analysis|Missed Schedule Date|0|||
37996830|NCT00296504|69681182|FG002|Interim Analysis|Missed Schedule Date|0|||
37996831|NCT00296504|69681183|FG003|Interim Analysis|Missed Schedule Date|0|||
37996832|NCT00296504|69681184|FG004|Interim Analysis|Missed Schedule Date|0|||
37996833|NCT00296504|69681185|FG005|Interim Analysis|Missed Schedule Date|0|||
37996834|NCT00296504|69681186|FG006|Interim Analysis|Missed Schedule Date|0|||
37996835|NCT00296504|69681187|FG007|Interim Analysis|Missed Schedule Date|0|||
37996836|NCT00296504|69681188|FG008|Interim Analysis|Missed Schedule Date|0|||
37996837|NCT00296504|69681180|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
37996838|NCT00296504|69681181|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
37996839|NCT00296504|69681182|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
37996840|NCT00296504|69681183|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
37996841|NCT00296504|69681184|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
37996842|NCT00296504|69681185|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
37996843|NCT00296504|69681186|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
37996844|NCT00296504|69681187|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
37996845|NCT00296504|69681188|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
37996846|NCT00296504|69681180|FG000|Interim Analysis|Participant Stopped|0|||
37996847|NCT00296504|69681181|FG001|Interim Analysis|Participant Stopped|0|||
37996848|NCT00296504|69681182|FG002|Interim Analysis|Participant Stopped|0|||
37996849|NCT00296504|69681183|FG003|Interim Analysis|Participant Stopped|0|||
37996850|NCT00296504|69681184|FG004|Interim Analysis|Participant Stopped|1|||
37996851|NCT00296504|69681185|FG005|Interim Analysis|Participant Stopped|0|||
37996852|NCT00296504|69681186|FG006|Interim Analysis|Participant Stopped|0|||
37996853|NCT00296504|69681187|FG007|Interim Analysis|Participant Stopped|0|||
37996854|NCT00296504|69681188|FG008|Interim Analysis|Participant Stopped|0|||
37996855|NCT00296504|69681180|FG000|Interim Analysis|Physician and Participant Decision|0|||
37996856|NCT00296504|69681181|FG001|Interim Analysis|Physician and Participant Decision|0|||
37996857|NCT00296504|69681182|FG002|Interim Analysis|Physician and Participant Decision|0|||
37996858|NCT00296504|69681183|FG003|Interim Analysis|Physician and Participant Decision|0|||
37996859|NCT00296504|69681184|FG004|Interim Analysis|Physician and Participant Decision|0|||
37996860|NCT00296504|69681185|FG005|Interim Analysis|Physician and Participant Decision|1|||
37996861|NCT00296504|69681186|FG006|Interim Analysis|Physician and Participant Decision|0|||
37996862|NCT00296504|69681187|FG007|Interim Analysis|Physician and Participant Decision|0|||
37996863|NCT00296504|69681188|FG008|Interim Analysis|Physician and Participant Decision|0|||
37996864|NCT00296504|69681180|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
37996865|NCT00296504|69681181|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
37996866|NCT00296504|69681182|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
37827225|NCT01089127|69509984|FG003|Overall Study|Protocol deviation|0|||
37827226|NCT01089127|69509985|FG004|Overall Study|Protocol deviation|1|||
37827227|NCT01089127|69509986|FG005|Overall Study|Protocol deviation|0|||
37827228|NCT01087957|69510002|FG000|Overall Study|Death|2|||
37827229|NCT01087957|69510003|FG001|Overall Study|Death|2|||
37996867|NCT00296504|69681183|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
37996868|NCT00296504|69681184|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
37827230|NCT01087957|69510002|FG000|Overall Study|Lost to Follow-up|3|||
37827231|NCT01087957|69510003|FG001|Overall Study|Lost to Follow-up|4|||
37827232|NCT01087957|69510002|FG000|Overall Study|Protocol Violation|13|||
37996869|NCT00296504|69681185|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
37996870|NCT00296504|69681186|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
37996871|NCT00296504|69681187|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
37827233|NCT01087957|69510003|FG001|Overall Study|Protocol Violation|25|||
37827234|NCT01087957|69510002|FG000|Overall Study|Withdrawal by Subject|18|||
37996872|NCT00296504|69681188|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
37996873|NCT00296504|69681180|FG000|Interim Analysis|Study Ended|0|||
37996874|NCT00296504|69681181|FG001|Interim Analysis|Study Ended|0|||
37996875|NCT00296504|69681182|FG002|Interim Analysis|Study Ended|0|||
37996876|NCT00296504|69681183|FG003|Interim Analysis|Study Ended|0|||
37996877|NCT00296504|69681184|FG004|Interim Analysis|Study Ended|0|||
37996878|NCT00296504|69681185|FG005|Interim Analysis|Study Ended|0|||
37996879|NCT00296504|69681186|FG006|Interim Analysis|Study Ended|1|||
37996880|NCT00296504|69681187|FG007|Interim Analysis|Study Ended|0|||
37996881|NCT00296504|69681188|FG008|Interim Analysis|Study Ended|0|||
37996882|NCT00296504|69681180|FG000|Interim Analysis|Participant Needed Interferon|0|||
37996883|NCT00296504|69681181|FG001|Interim Analysis|Participant Needed Interferon|0|||
37996884|NCT00296504|69681182|FG002|Interim Analysis|Participant Needed Interferon|0|||
37900354|NCT00948896|69585759|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
37900355|NCT00948896|69585760|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
37900356|NCT00948896|69585761|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
37900357|NCT00948896|69585762|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
37900358|NCT00948896|69585763|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
37900359|NCT00948896|69585764|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
37996885|NCT00296504|69681183|FG003|Interim Analysis|Participant Needed Interferon|0|||
37996886|NCT00296504|69681184|FG004|Interim Analysis|Participant Needed Interferon|0|||
37996887|NCT00296504|69681185|FG005|Interim Analysis|Participant Needed Interferon|0|||
37996888|NCT00296504|69681186|FG006|Interim Analysis|Participant Needed Interferon|0|||
37996889|NCT00296504|69681187|FG007|Interim Analysis|Participant Needed Interferon|1|||
37996890|NCT00296504|69681188|FG008|Interim Analysis|Participant Needed Interferon|0|||
37996891|NCT00296504|69681180|FG000|Interim Analysis|Ongoing|32|||
37996892|NCT00296504|69681181|FG001|Interim Analysis|Ongoing|12|||
37996893|NCT00296504|69681182|FG002|Interim Analysis|Ongoing|16|||
37996894|NCT00296504|69681183|FG003|Interim Analysis|Ongoing|22|||
37996895|NCT00296504|69681184|FG004|Interim Analysis|Ongoing|0|||
37996896|NCT00296504|69681185|FG005|Interim Analysis|Ongoing|0|||
37996897|NCT00296504|69681186|FG006|Interim Analysis|Ongoing|30|||
37996898|NCT00296504|69681187|FG007|Interim Analysis|Ongoing|1|||
37996899|NCT00296504|69681188|FG008|Interim Analysis|Ongoing|0|||
37996900|NCT00296504|69681180|FG000|Final Analysis|Withdrawal by Subject|0|||
37996901|NCT00296504|69681181|FG001|Final Analysis|Withdrawal by Subject|0|||
37996902|NCT00296504|69681182|FG002|Final Analysis|Withdrawal by Subject|0|||
37996903|NCT00296504|69681183|FG003|Final Analysis|Withdrawal by Subject|0|||
37996904|NCT00296504|69681184|FG004|Final Analysis|Withdrawal by Subject|0|||
37996905|NCT00296504|69681185|FG005|Final Analysis|Withdrawal by Subject|0|||
37996906|NCT00296504|69681186|FG006|Final Analysis|Withdrawal by Subject|0|||
37996907|NCT00296504|69681187|FG007|Final Analysis|Withdrawal by Subject|0|||
37996908|NCT00296504|69681188|FG008|Final Analysis|Withdrawal by Subject|1|||
37996909|NCT00296504|69681180|FG000|Final Analysis|Lost to Follow-up|0|||
37996910|NCT00296504|69681181|FG001|Final Analysis|Lost to Follow-up|0|||
37996911|NCT00296504|69681182|FG002|Final Analysis|Lost to Follow-up|0|||
37996912|NCT00296504|69681183|FG003|Final Analysis|Lost to Follow-up|0|||
37996913|NCT00296504|69681184|FG004|Final Analysis|Lost to Follow-up|0|||
37996914|NCT00296504|69681185|FG005|Final Analysis|Lost to Follow-up|0|||
37996915|NCT00296504|69681186|FG006|Final Analysis|Lost to Follow-up|0|||
37996916|NCT00296504|69681187|FG007|Final Analysis|Lost to Follow-up|0|||
37996917|NCT00296504|69681188|FG008|Final Analysis|Lost to Follow-up|5|||
37996918|NCT00296504|69681180|FG000|Final Analysis|Insufficient Viral Load Response|0|||
37996919|NCT00296504|69681181|FG001|Final Analysis|Insufficient Viral Load Response|0|||
37996920|NCT00296504|69681182|FG002|Final Analysis|Insufficient Viral Load Response|0|||
37996921|NCT00296504|69681183|FG003|Final Analysis|Insufficient Viral Load Response|0|||
37996922|NCT00296504|69681184|FG004|Final Analysis|Insufficient Viral Load Response|0|||
37996923|NCT00296504|69681185|FG005|Final Analysis|Insufficient Viral Load Response|0|||
37996924|NCT00296504|69681186|FG006|Final Analysis|Insufficient Viral Load Response|0|||
37996925|NCT00296504|69681187|FG007|Final Analysis|Insufficient Viral Load Response|0|||
37996926|NCT00296504|69681188|FG008|Final Analysis|Insufficient Viral Load Response|6|||
37996927|NCT00296504|69681180|FG000|Final Analysis|Adverse Event|0|||
37996928|NCT00296504|69681181|FG001|Final Analysis|Adverse Event|0|||
37996929|NCT00296504|69681182|FG002|Final Analysis|Adverse Event|0|||
37996930|NCT00296504|69681183|FG003|Final Analysis|Adverse Event|0|||
37996931|NCT00296504|69681184|FG004|Final Analysis|Adverse Event|0|||
37996932|NCT00296504|69681185|FG005|Final Analysis|Adverse Event|0|||
37996933|NCT00296504|69681186|FG006|Final Analysis|Adverse Event|0|||
37996934|NCT00296504|69681187|FG007|Final Analysis|Adverse Event|0|||
37996935|NCT00296504|69681188|FG008|Final Analysis|Adverse Event|2|||
37996936|NCT00296504|69681180|FG000|Final Analysis|Pregnancy|0|||
37996937|NCT00296504|69681181|FG001|Final Analysis|Pregnancy|0|||
37996938|NCT00296504|69681182|FG002|Final Analysis|Pregnancy|0|||
37996939|NCT00296504|69681183|FG003|Final Analysis|Pregnancy|0|||
37996940|NCT00296504|69681184|FG004|Final Analysis|Pregnancy|0|||
37996941|NCT00296504|69681185|FG005|Final Analysis|Pregnancy|0|||
37996942|NCT00296504|69681186|FG006|Final Analysis|Pregnancy|0|||
37996943|NCT00296504|69681187|FG007|Final Analysis|Pregnancy|0|||
37996944|NCT00296504|69681188|FG008|Final Analysis|Pregnancy|4|||
37900360|NCT00948896|69585765|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
37900361|NCT00948896|69585758|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
37900362|NCT00948896|69585759|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
37900363|NCT00948896|69585760|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
37900364|NCT00948896|69585761|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
37900365|NCT00948896|69585762|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
37900366|NCT00948896|69585763|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
37900367|NCT00948896|69585764|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
37900368|NCT00948896|69585765|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
37900369|NCT01004159|69585787|FG000|Overall Study|Adverse Event|2|||
37900370|NCT01004159|69585787|FG000|Overall Study|Disease Progression|18|||
37900371|NCT00948818|69585793|FG000|Overall Study|Adverse Event|10|||
37900372|NCT00948818|69585794|FG001|Overall Study|Adverse Event|32|||
37900373|NCT00948818|69585793|FG000|Overall Study|Protocol Violation|9|||
37900374|NCT00948818|69585794|FG001|Overall Study|Protocol Violation|10|||
37900375|NCT00948818|69585793|FG000|Overall Study|Withdrawal by Subject|25|||
37900376|NCT00948818|69585794|FG001|Overall Study|Withdrawal by Subject|25|||
37900377|NCT00948818|69585793|FG000|Overall Study|Lost to Follow-up|10|||
37900378|NCT00948818|69585794|FG001|Overall Study|Lost to Follow-up|17|||
37900379|NCT00948818|69585793|FG000|Overall Study|Lack of Efficacy|4|||
37900380|NCT00948818|69585794|FG001|Overall Study|Lack of Efficacy|5|||
37900381|NCT00948818|69585793|FG000|Overall Study|Other Reason|4|||
37696688|NCT02448563|69172968|FG001|Overall Study|Lost to Follow-up|10|||
37900382|NCT00948818|69585794|FG001|Overall Study|Other Reason|5|||
37900383|NCT00948506|69585805|FG000|Overall Study|Withdrawal by Subject|3|||
37996945|NCT00296504|69681180|FG000|Final Analysis|Tuberculosis|0|||
37996946|NCT00296504|69681181|FG001|Final Analysis|Tuberculosis|0|||
37996947|NCT00296504|69681182|FG002|Final Analysis|Tuberculosis|0|||
37996948|NCT00296504|69681183|FG003|Final Analysis|Tuberculosis|0|||
37996949|NCT00296504|69681184|FG004|Final Analysis|Tuberculosis|0|||
37900384|NCT00948506|69585806|FG001|Overall Study|Withdrawal by Subject|1|||
37900385|NCT00955682|69585817|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
37900386|NCT00955682|69585818|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
37900387|NCT00689221|69585834|FG000|Overall Study|Ongoing at cut-off date|39|||
37900388|NCT00689221|69585835|FG001|Overall Study|Ongoing at cut-off date|36|||
37900389|NCT01875445|69585843|FG000|Overall Study|Lost to Follow-up|5|||
37996950|NCT00296504|69681185|FG005|Final Analysis|Tuberculosis|0|||
37996951|NCT00296504|69681186|FG006|Final Analysis|Tuberculosis|0|||
37996952|NCT00296504|69681187|FG007|Final Analysis|Tuberculosis|0|||
37996953|NCT00296504|69681188|FG008|Final Analysis|Tuberculosis|1|||
37996954|NCT00296504|69681180|FG000|Final Analysis|Participant Moved to Another Country|0|||
37996955|NCT00296504|69681181|FG001|Final Analysis|Participant Moved to Another Country|0|||
37996956|NCT00296504|69681182|FG002|Final Analysis|Participant Moved to Another Country|0|||
37996957|NCT00296504|69681183|FG003|Final Analysis|Participant Moved to Another Country|0|||
37996958|NCT00296504|69681184|FG004|Final Analysis|Participant Moved to Another Country|0|||
37996959|NCT00296504|69681185|FG005|Final Analysis|Participant Moved to Another Country|0|||
37996960|NCT00296504|69681186|FG006|Final Analysis|Participant Moved to Another Country|0|||
37996961|NCT00296504|69681187|FG007|Final Analysis|Participant Moved to Another Country|0|||
37996962|NCT00296504|69681188|FG008|Final Analysis|Participant Moved to Another Country|1|||
37996963|NCT00296504|69681180|FG000|Final Analysis|Poor Adherence|0|||
37996964|NCT00296504|69681181|FG001|Final Analysis|Poor Adherence|0|||
37996965|NCT00296504|69681182|FG002|Final Analysis|Poor Adherence|0|||
37996966|NCT00296504|69681183|FG003|Final Analysis|Poor Adherence|0|||
37996967|NCT00296504|69681184|FG004|Final Analysis|Poor Adherence|0|||
37996968|NCT00296504|69681185|FG005|Final Analysis|Poor Adherence|0|||
37996969|NCT00296504|69681186|FG006|Final Analysis|Poor Adherence|0|||
37996970|NCT00296504|69681187|FG007|Final Analysis|Poor Adherence|0|||
37996971|NCT00296504|69681188|FG008|Final Analysis|Poor Adherence|1|||
37827235|NCT01087957|69510003|FG001|Overall Study|Withdrawal by Subject|15|||
37827236|NCT01087957|69510002|FG000|Overall Study|Physician Decision|5|||
37827237|NCT01087957|69510003|FG001|Overall Study|Physician Decision|9|||
37827238|NCT01087723|69510011|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
37827239|NCT01087723|69510012|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
37827240|NCT01087723|69510011|FG000|Overall Study|Withdrawal by Subject|10|||
37900390|NCT01875445|69585844|FG001|Overall Study|Lost to Follow-up|0|||
37900391|NCT01875445|69585843|FG000|Overall Study|Withdrawal by Subject|2|||
37827241|NCT01087723|69510012|FG001|Overall Study|Withdrawal by Subject|13|||
37827242|NCT01087723|69510011|FG000|Overall Study|Physician Decision|2|||
37996972|NCT00313820|69681215|FG000|Assigned to Treatment|Other|1|||
37996973|NCT00313820|69681216|FG001|Assigned to Treatment|Other|0|||
37900392|NCT01875445|69585844|FG001|Overall Study|Withdrawal by Subject|0|||
37900393|NCT00688909|69585850|FG000|Overall Study|Adverse Event|28|||
37900394|NCT00688909|69585850|FG000|Overall Study|Patient withdrew consent|2|||
37900395|NCT00688909|69585850|FG000|Overall Study|Administrative problems|1|||
37900396|NCT00688909|69585850|FG000|Overall Study|Protocol Violation|2|||
37900397|NCT00948428|69585858|FG000|Overall Study|Withdrawal by Subject|6|||
37900398|NCT00948428|69585859|FG001|Overall Study|Withdrawal by Subject|12|||
37900399|NCT00948428|69585860|FG002|Overall Study|Withdrawal by Subject|7|||
37900400|NCT00948428|69585858|FG000|Overall Study|Adverse Event|6|||
37900401|NCT00948428|69585859|FG001|Overall Study|Adverse Event|3|||
37900402|NCT00948428|69585860|FG002|Overall Study|Adverse Event|0|||
37900403|NCT00948428|69585858|FG000|Overall Study|Lost to Follow-up|2|||
37900404|NCT00948428|69585859|FG001|Overall Study|Lost to Follow-up|1|||
37900405|NCT00948428|69585860|FG002|Overall Study|Lost to Follow-up|1|||
37900406|NCT00948428|69585858|FG000|Overall Study|Death|2|||
37900407|NCT00948428|69585859|FG001|Overall Study|Death|0|||
37900408|NCT00948428|69585860|FG002|Overall Study|Death|0|||
37900409|NCT00948428|69585858|FG000|Overall Study|Intercurrent Illness|1|||
37900410|NCT00948428|69585859|FG001|Overall Study|Intercurrent Illness|0|||
37900411|NCT00948428|69585860|FG002|Overall Study|Intercurrent Illness|0|||
37900412|NCT00948428|69585858|FG000|Overall Study|Non-compliance|1|||
37900413|NCT00948428|69585859|FG001|Overall Study|Non-compliance|2|||
37900414|NCT00948428|69585860|FG002|Overall Study|Non-compliance|0|||
37900415|NCT00948194|69585870|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
37900416|NCT00948194|69585871|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
37900417|NCT00691483|69585879|FG000|Overall Study|Adverse Event|14|||
37900418|NCT00691483|69585880|FG001|Overall Study|Adverse Event|6|||
37900419|NCT00691483|69585879|FG000|Overall Study|Lost to Follow-up|17|||
37900420|NCT00691483|69585880|FG001|Overall Study|Lost to Follow-up|10|||
37900421|NCT00691483|69585879|FG000|Overall Study|Withdrawal by Subject|24|||
37900422|NCT00691483|69585880|FG001|Overall Study|Withdrawal by Subject|7|||
37900423|NCT00691483|69585879|FG000|Overall Study|Other known cause|6|||
37900424|NCT00691483|69585880|FG001|Overall Study|Other known cause|1|||
37900425|NCT00691483|69585879|FG000|Overall Study|Randomized by not treated|7|||
37900426|NCT00691483|69585880|FG001|Overall Study|Randomized by not treated|1|||
37900427|NCT00691093|69585886|FG000|Overall Study|Adverse Event|1|||
37900428|NCT00691093|69585886|FG000|Overall Study|Lost to Follow-up|1|||
37900429|NCT00691093|69585886|FG000|Overall Study|Lack of Efficacy|1|||
37900430|NCT00691093|69585886|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
37900431|NCT00947882|69585899|FG000|Overall Study|Adverse Event|0|||
37900432|NCT00947882|69585900|FG001|Overall Study|Adverse Event|1|||
37900433|NCT00947882|69585901|FG002|Overall Study|Adverse Event|4|||
37900434|NCT00947882|69585902|FG003|Overall Study|Adverse Event|4|||
37900435|NCT00947882|69585899|FG000|Overall Study|Withdrawal by Subject|2|||
37900436|NCT00947882|69585900|FG001|Overall Study|Withdrawal by Subject|0|||
37900437|NCT00947882|69585901|FG002|Overall Study|Withdrawal by Subject|8|||
37900438|NCT00947882|69585902|FG003|Overall Study|Withdrawal by Subject|2|||
37900439|NCT00947882|69585899|FG000|Overall Study|Protocol Violation|0|||
37900440|NCT00947882|69585900|FG001|Overall Study|Protocol Violation|0|||
37900441|NCT00947882|69585901|FG002|Overall Study|Protocol Violation|1|||
37900442|NCT00947882|69585902|FG003|Overall Study|Protocol Violation|0|||
37827243|NCT01087723|69510012|FG001|Overall Study|Physician Decision|0|||
37827244|NCT01087723|69510011|FG000|Overall Study|Lost to Follow-up|1|||
37827245|NCT01087723|69510012|FG001|Overall Study|Lost to Follow-up|4|||
37827246|NCT01087723|69510011|FG000|Overall Study|Reason Not Specified|1|||
37827247|NCT01087723|69510012|FG001|Overall Study|Reason Not Specified|2|||
37827248|NCT01087528|69510018|FG000|Overall Study|Withdrawal by Subject|1|||
37827249|NCT01087528|69510018|FG000|Overall Study|Incomplete CE procedure|6|||
37827250|NCT01085812|69510024|FG000|Open-Label Period|Adverse Event|0|||
37900443|NCT00947882|69585899|FG000|Overall Study|Lost to Follow-up|0|||
37900444|NCT00947882|69585900|FG001|Overall Study|Lost to Follow-up|2|||
37996974|NCT00313820|69681215|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
37996975|NCT00313820|69681216|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
37996976|NCT00313820|69681215|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
37996977|NCT00313820|69681216|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
37996978|NCT00313820|69681215|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
37996979|NCT00313820|69681216|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
37900445|NCT00947882|69585901|FG002|Overall Study|Lost to Follow-up|1|||
37900446|NCT00947882|69585902|FG003|Overall Study|Lost to Follow-up|0|||
37900447|NCT00947882|69585899|FG000|Overall Study|Other/Unknown|10|||
37900448|NCT00947882|69585900|FG001|Overall Study|Other/Unknown|13|||
37900449|NCT00947882|69585901|FG002|Overall Study|Other/Unknown|3|||
37900450|NCT00947882|69585902|FG003|Overall Study|Other/Unknown|6|||
37827251|NCT01085812|69510025|FG001|Open-Label Period|Adverse Event|80|||
37827252|NCT01085812|69510024|FG000|Open-Label Period|Lack of Efficacy|0|||
37900451|NCT00947882|69585899|FG000|Overall Study|Trial Terminated by Sponsor|62|||
37996980|NCT00313820|69681215|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
37996981|NCT00313820|69681216|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
37996982|NCT00313820|69681215|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
37996983|NCT00313820|69681216|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
37996984|NCT00462761|69681222|FG000|Overall Study|Adverse Event|6|||
37996985|NCT00462761|69681222|FG000|Overall Study|Withdrawal by Subject|9|||
37996986|NCT00462761|69681222|FG000|Overall Study|Physician Decision|5|||
37996987|NCT00462761|69681222|FG000|Overall Study|Disease progression|43|||
37996988|NCT00462761|69681222|FG000|Overall Study|Death|12|||
37996989|NCT00462761|69681222|FG000|Overall Study|Other|1|||
37900452|NCT00947882|69585900|FG001|Overall Study|Trial Terminated by Sponsor|61|||
37900453|NCT00947882|69585901|FG002|Overall Study|Trial Terminated by Sponsor|62|||
37900454|NCT00947882|69585902|FG003|Overall Study|Trial Terminated by Sponsor|70|||
37900455|NCT00688753|69585913|FG000|Overall Study|Disease progression|55|||
37900456|NCT00688753|69585913|FG000|Overall Study|Missing|1|||
37900457|NCT00688753|69585913|FG000|Overall Study|Death|9|||
37900458|NCT00688753|69585913|FG000|Overall Study|Withdrawal by Subject|3|||
37996990|NCT00235872|69681254|FG000|Overall Study|Adverse Event|34|||
37996991|NCT00235872|69681254|FG000|Overall Study|Death|1|||
37827253|NCT01085812|69510025|FG001|Open-Label Period|Lack of Efficacy|26|||
37827254|NCT01085812|69510024|FG000|Open-Label Period|Protocol Violation|0|||
37827255|NCT01085812|69510025|FG001|Open-Label Period|Protocol Violation|39|||
37827256|NCT01085812|69510024|FG000|Open-Label Period|Withdrawal by Subject|0|||
37827257|NCT01085812|69510025|FG001|Open-Label Period|Withdrawal by Subject|53|||
37827258|NCT01085812|69510024|FG000|Open-Label Period|Lost to Follow-up|0|||
37827259|NCT01085812|69510025|FG001|Open-Label Period|Lost to Follow-up|42|||
37827260|NCT01085812|69510024|FG000|Double-Blind Period|Adverse Event|3|||
37827261|NCT01085812|69510025|FG001|Double-Blind Period|Adverse Event|8|||
37827262|NCT01085812|69510024|FG000|Double-Blind Period|Protocol Violation|2|||
37827263|NCT01085812|69510025|FG001|Double-Blind Period|Protocol Violation|7|||
37827264|NCT01085812|69510024|FG000|Double-Blind Period|Withdrawal by Subject|11|||
37827265|NCT01085812|69510025|FG001|Double-Blind Period|Withdrawal by Subject|24|||
37827266|NCT01085812|69510024|FG000|Double-Blind Period|Lost to Follow-up|5|||
37827267|NCT01085812|69510025|FG001|Double-Blind Period|Lost to Follow-up|17|||
37827268|NCT01085812|69510024|FG000|Double-Blind Period|Other Reasons|0|||
37827269|NCT01085812|69510025|FG001|Double-Blind Period|Other Reasons|2|||
37827270|NCT01085812|69510024|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
37827271|NCT01085812|69510025|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
37827272|NCT01085812|69510024|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
37827273|NCT01085812|69510025|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
37827274|NCT01085812|69510024|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
37827275|NCT01085812|69510025|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
37827276|NCT01085812|69510024|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
37827277|NCT01085812|69510025|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
37900459|NCT00688753|69585913|FG000|Overall Study|Adverse Event|20|||
37900460|NCT00688753|69585913|FG000|Overall Study|Protocol Violation|1|||
37900461|NCT00688753|69585913|FG000|Overall Study|Lost to Follow-up|3|||
37900462|NCT00951080|69585919|FG000|Overall Study|Adverse Event|3|||
37996992|NCT00235872|69681254|FG000|Overall Study|Lost to Follow-up|1|||
37996993|NCT00235872|69681254|FG000|Overall Study|Withdrawal by Subject|50|||
37996994|NCT00235872|69681254|FG000|Overall Study|Administrative reason|61|||
37996995|NCT00461981|69681260|FG000|Overall Study|Lost to Follow-up|9|||
37996996|NCT00461981|69681261|FG001|Overall Study|Lost to Follow-up|6|||
37996997|NCT00461981|69681260|FG000|Overall Study|Withdrawal by Subject|2|||
37996998|NCT00461981|69681261|FG001|Overall Study|Withdrawal by Subject|3|||
37996999|NCT00296036|69681269|FG000|Overall Study|Withdrawal by Subject|1|||
37827278|NCT01085812|69510024|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
37827279|NCT01085812|69510025|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
37827280|NCT01085734|69510034|FG000|Overall Study|Adverse Event|0|||
37827281|NCT01085734|69510035|FG001|Overall Study|Adverse Event|2|||
37827282|NCT01085734|69510034|FG000|Overall Study|Death|1|||
37827283|NCT01085734|69510035|FG001|Overall Study|Death|0|||
37900463|NCT00951080|69585920|FG001|Overall Study|Adverse Event|3|||
37900464|NCT00951080|69585919|FG000|Overall Study|Lost to Follow-up|0|||
37997000|NCT00296036|69681270|FG001|Overall Study|Withdrawal by Subject|0|||
37900465|NCT00951080|69585920|FG001|Overall Study|Lost to Follow-up|1|||
37900466|NCT00951080|69585919|FG000|Overall Study|Physician Decision|4|||
37900467|NCT00951080|69585920|FG001|Overall Study|Physician Decision|1|||
37900468|NCT00951080|69585919|FG000|Overall Study|Other|19|||
37900469|NCT00951080|69585920|FG001|Overall Study|Other|22|||
37900470|NCT00946322|69585926|FG000|Pre-treatment|participant failure to follow up|1|||
37900471|NCT00946322|69585926|FG000|Post-treatment|participant failure to follow up|2|||
37900472|NCT00950690|69585930|FG000|Overall Study|Death|4|||
37900473|NCT00950690|69585930|FG000|Overall Study|Adverse Event|15|||
37900474|NCT00950690|69585930|FG000|Overall Study|Lack of Efficacy|22|||
37900475|NCT00950690|69585930|FG000|Overall Study|Lost to Follow-up|40|||
37900476|NCT00950690|69585930|FG000|Overall Study|Other|163|||
37900477|NCT00694369|69585939|FG000|Overall Study|Adverse Event|0|||
37900478|NCT00694369|69585940|FG001|Overall Study|Adverse Event|1|||
37900479|NCT00694369|69585941|FG002|Overall Study|Adverse Event|0|||
37900480|NCT00694369|69585942|FG003|Overall Study|Adverse Event|1|||
37900481|NCT00694369|69585943|FG004|Overall Study|Adverse Event|3|||
37900482|NCT00694369|69585939|FG000|Overall Study|Lost to Follow-up|0|||
37900483|NCT00694369|69585940|FG001|Overall Study|Lost to Follow-up|0|||
37900484|NCT00694369|69585941|FG002|Overall Study|Lost to Follow-up|1|||
37900485|NCT00694369|69585942|FG003|Overall Study|Lost to Follow-up|1|||
37900486|NCT00694369|69585943|FG004|Overall Study|Lost to Follow-up|0|||
37900487|NCT00694369|69585939|FG000|Overall Study|Physician Decision|0|||
37900488|NCT00694369|69585940|FG001|Overall Study|Physician Decision|0|||
37900489|NCT00694369|69585941|FG002|Overall Study|Physician Decision|0|||
37900490|NCT00694369|69585942|FG003|Overall Study|Physician Decision|0|||
37900491|NCT00694369|69585943|FG004|Overall Study|Physician Decision|1|||
37900492|NCT00694369|69585939|FG000|Overall Study|Protocol Violation|0|||
37900493|NCT00694369|69585940|FG001|Overall Study|Protocol Violation|1|||
37900494|NCT00694369|69585941|FG002|Overall Study|Protocol Violation|0|||
37900495|NCT00694369|69585942|FG003|Overall Study|Protocol Violation|0|||
37900496|NCT00694369|69585943|FG004|Overall Study|Protocol Violation|0|||
37900497|NCT00694369|69585939|FG000|Overall Study|Withdrawal by Subject|1|||
37900498|NCT00694369|69585940|FG001|Overall Study|Withdrawal by Subject|1|||
37900499|NCT00694369|69585941|FG002|Overall Study|Withdrawal by Subject|1|||
37900500|NCT00694369|69585942|FG003|Overall Study|Withdrawal by Subject|1|||
37900501|NCT00694369|69585943|FG004|Overall Study|Withdrawal by Subject|2|||
37900502|NCT03412747|69585958|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
37900503|NCT03412747|69585959|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
37900504|NCT03412747|69585960|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
37900505|NCT03412747|69585958|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
37900506|NCT03412747|69585959|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
37900507|NCT03412747|69585960|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
37900508|NCT03412747|69585958|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
37900509|NCT03412747|69585959|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
37900510|NCT03412747|69585960|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
37900511|NCT03412747|69585958|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
37900512|NCT03412747|69585959|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
37900513|NCT03412747|69585960|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
37900514|NCT03412747|69585958|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
37900515|NCT03412747|69585959|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
37900516|NCT03412747|69585960|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
37900517|NCT03412747|69585958|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
37900518|NCT03412747|69585959|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
37900519|NCT03412747|69585960|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
37900520|NCT03412747|69585958|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
37900521|NCT03412747|69585959|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
37900522|NCT03412747|69585960|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
37900523|NCT03412747|69585958|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
37900524|NCT03412747|69585959|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
37900525|NCT03412747|69585960|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
37900526|NCT03412747|69585958|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
37900527|NCT03412747|69585959|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
37900528|NCT03412747|69585960|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
37900529|NCT03412747|69585958|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
37900530|NCT03412747|69585959|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
37900531|NCT03412747|69585960|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
37900532|NCT03412747|69585958|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
37900533|NCT03412747|69585959|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
37900534|NCT03412747|69585960|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
37900535|NCT03412747|69585958|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
37900536|NCT03412747|69585959|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
37900537|NCT03412747|69585960|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
37900538|NCT03412747|69585958|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
37900539|NCT03412747|69585959|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
37900540|NCT03412747|69585960|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
37900541|NCT03412747|69585958|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
37900542|NCT03412747|69585959|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
37900543|NCT03412747|69585960|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
37900544|NCT03412747|69585958|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
37900545|NCT03412747|69585959|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
37900546|NCT03412747|69585960|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
37900547|NCT03412747|69585958|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
37900548|NCT03412747|69585959|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
37900549|NCT03412747|69585960|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
37900550|NCT00513019|69585980|FG000|Overall Study|Adverse Event|1|||
37900551|NCT00513019|69585981|FG001|Overall Study|Adverse Event|0|||
37900552|NCT00513019|69585980|FG000|Overall Study|Withdrawal by Subject|4|||
37900553|NCT00513019|69585981|FG001|Overall Study|Withdrawal by Subject|5|||
37900554|NCT00954512|69586002|FG000|Overall Study|Withdrawal by Subject|0|||
37900555|NCT00954512|69586003|FG001|Overall Study|Withdrawal by Subject|0|||
37900556|NCT00954512|69586004|FG002|Overall Study|Withdrawal by Subject|0|||
37900557|NCT00954512|69586005|FG003|Overall Study|Withdrawal by Subject|0|||
37900558|NCT00954512|69586006|FG004|Overall Study|Withdrawal by Subject|0|||
37900559|NCT00954512|69586007|FG005|Overall Study|Withdrawal by Subject|1|||
37900560|NCT00954512|69586002|FG000|Overall Study|Adverse Event|0|||
37900561|NCT00954512|69586003|FG001|Overall Study|Adverse Event|0|||
37900562|NCT00954512|69586004|FG002|Overall Study|Adverse Event|0|||
37900563|NCT00954512|69586005|FG003|Overall Study|Adverse Event|0|||
37900564|NCT00954512|69586006|FG004|Overall Study|Adverse Event|1|||
37900565|NCT00954512|69586007|FG005|Overall Study|Adverse Event|2|||
37900566|NCT00954512|69586002|FG000|Overall Study|Physician Decision|0|||
37900567|NCT00954512|69586003|FG001|Overall Study|Physician Decision|1|||
37900568|NCT00954512|69586004|FG002|Overall Study|Physician Decision|0|||
37900569|NCT00954512|69586005|FG003|Overall Study|Physician Decision|1|||
37900570|NCT00954512|69586006|FG004|Overall Study|Physician Decision|0|||
37900571|NCT00954512|69586007|FG005|Overall Study|Physician Decision|0|||
37900572|NCT00954512|69586002|FG000|Overall Study|Symptomatic Deterioration|0|||
37900573|NCT00954512|69586003|FG001|Overall Study|Symptomatic Deterioration|1|||
37900574|NCT00954512|69586004|FG002|Overall Study|Symptomatic Deterioration|0|||
37900575|NCT00954512|69586005|FG003|Overall Study|Symptomatic Deterioration|0|||
37900576|NCT00954512|69586006|FG004|Overall Study|Symptomatic Deterioration|2|||
37900577|NCT00954512|69586007|FG005|Overall Study|Symptomatic Deterioration|0|||
37900578|NCT00954512|69586002|FG000|Overall Study|Progression of Disease|2|||
37900579|NCT00954512|69586003|FG001|Overall Study|Progression of Disease|1|||
37827284|NCT01085734|69510034|FG000|Overall Study|Lost to Follow-up|0|||
37827285|NCT01085734|69510035|FG001|Overall Study|Lost to Follow-up|1|||
37827286|NCT01085734|69510034|FG000|Overall Study|Withdrawal by Subject|0|||
37827287|NCT01085734|69510035|FG001|Overall Study|Withdrawal by Subject|1|||
37827288|NCT01084603|69510042|FG000|Baseline|Withdrawal by Subject|2|||
37827289|NCT01084603|69510042|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
37827290|NCT01084603|69510042|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
37827291|NCT01084603|69510042|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
37827292|NCT01084603|69510042|FG000|Washout Period 4|Adverse Event|1|||
37827293|NCT01084174|69510057|FG000|Overall Study|gastrointestinal symptoms|1|||
37827294|NCT01084174|69510058|FG001|Overall Study|gastrointestinal symptoms|1|||
37900580|NCT00954512|69586004|FG002|Overall Study|Progression of Disease|0|||
37900581|NCT00954512|69586005|FG003|Overall Study|Progression of Disease|1|||
37900582|NCT00954512|69586006|FG004|Overall Study|Progression of Disease|1|||
37900583|NCT00954512|69586007|FG005|Overall Study|Progression of Disease|1|||
37900584|NCT00691015|69586020|FG000|Overall Study|Refused further treatment|1|||
37900585|NCT00950300|69586026|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
37900586|NCT00950300|69586027|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
37900587|NCT00950300|69586026|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
37900588|NCT00950300|69586027|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
37900589|NCT00950300|69586026|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
37900590|NCT00950300|69586027|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
37900591|NCT00950300|69586026|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
37900592|NCT00950300|69586027|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
37900593|NCT00950300|69586026|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
37900594|NCT00950300|69586027|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
37900595|NCT00950300|69586026|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
37900596|NCT00950300|69586027|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
37900597|NCT00950300|69586026|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
37900598|NCT00950300|69586027|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
37900599|NCT00950300|69586026|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
37900600|NCT00950300|69586027|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
37900601|NCT00950300|69586026|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
37997001|NCT00296036|69681271|FG002|Overall Study|Withdrawal by Subject|2|||
37997002|NCT00296036|69681272|FG003|Overall Study|Withdrawal by Subject|1|||
37997003|NCT00296036|69681273|FG004|Overall Study|Withdrawal by Subject|2|||
37997004|NCT00296036|69681274|FG005|Overall Study|Withdrawal by Subject|1|||
37997005|NCT00296036|69681269|FG000|Overall Study|Protocol Violation|0|||
37900602|NCT00950300|69586027|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
37900603|NCT00950300|69586026|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
37900604|NCT00950300|69586027|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
37900605|NCT00950300|69586026|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
37900606|NCT00950300|69586027|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
37900607|NCT00950300|69586026|FG000|TFFU Period|Death|4|||
37900608|NCT00950300|69586027|FG001|TFFU Period|Death|1|||
37900609|NCT00950300|69586026|FG000|TFFU Period|Refused Treatment|10|||
37900610|NCT00950300|69586027|FG001|TFFU Period|Refused Treatment|11|||
37900611|NCT00950300|69586026|FG000|TFFU Period|Failure to Return|16|||
37900612|NCT00950300|69586027|FG001|TFFU Period|Failure to Return|16|||
37900613|NCT00950300|69586026|FG000|TFFU Period|Recurrence of Disease|63|||
37900614|NCT00950300|69586027|FG001|TFFU Period|Recurrence of Disease|72|||
37900615|NCT00950300|69586026|FG000|TFFU Period|Other|4|||
37900616|NCT00950300|69586027|FG001|TFFU Period|Other|3|||
37900617|NCT00950300|69586026|FG000|SFU Period|Death|44|||
37900618|NCT00950300|69586027|FG001|SFU Period|Death|42|||
37900619|NCT00950300|69586026|FG000|SFU Period|Lost to Follow-up|30|||
37900620|NCT00950300|69586027|FG001|SFU Period|Lost to Follow-up|28|||
37900621|NCT00950300|69586026|FG000|SFU Period|Withdrawal by Subject|4|||
37900622|NCT00950300|69586027|FG001|SFU Period|Withdrawal by Subject|8|||
37900623|NCT00949988|69586034|FG000|Overall Study|Withdrawal by Subject|3|||
37900624|NCT00731692|69586041|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
37900625|NCT00731692|69586042|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
37900626|NCT00731692|69586043|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
37900627|NCT00731692|69586041|FG000|Core Study (36 Months)|Physician Decision|1|||
37900628|NCT00731692|69586042|FG001|Core Study (36 Months)|Physician Decision|0|||
37900629|NCT00731692|69586043|FG002|Core Study (36 Months)|Physician Decision|2|||
37900630|NCT00731692|69586041|FG000|Core Study (36 Months)|Death|2|||
37900631|NCT00731692|69586042|FG001|Core Study (36 Months)|Death|1|||
37900632|NCT00731692|69586043|FG002|Core Study (36 Months)|Death|2|||
37900633|NCT00731692|69586041|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
37900634|NCT00731692|69586042|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
37900635|NCT00731692|69586043|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
37900636|NCT00731692|69586041|FG000|Core Study (36 Months)|Administrative|2|||
37997006|NCT00296036|69681270|FG001|Overall Study|Protocol Violation|0|||
37997007|NCT00296036|69681271|FG002|Overall Study|Protocol Violation|0|||
37997008|NCT00296036|69681272|FG003|Overall Study|Protocol Violation|0|||
37900637|NCT00731692|69586042|FG001|Core Study (36 Months)|Administrative|2|||
37997009|NCT00296036|69681273|FG004|Overall Study|Protocol Violation|0|||
37900638|NCT00731692|69586043|FG002|Core Study (36 Months)|Administrative|6|||
37997010|NCT00296036|69681274|FG005|Overall Study|Protocol Violation|3|||
37900639|NCT00731692|69586041|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
37900640|NCT00731692|69586042|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
37997011|NCT00089674|69681293|FG000|Overall Study|Physician Decision|4|||
37997012|NCT00089674|69681294|FG001|Overall Study|Physician Decision|2|||
37900641|NCT00731692|69586043|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
37900642|NCT00731692|69586041|FG000|Core Study (36 Months)|Protocol Violation|4|||
37997013|NCT00089674|69681293|FG000|Overall Study|Adverse Event|23|||
37997014|NCT00089674|69681294|FG001|Overall Study|Adverse Event|29|||
37900643|NCT00731692|69586042|FG001|Core Study (36 Months)|Protocol Violation|5|||
37900644|NCT00731692|69586043|FG002|Core Study (36 Months)|Protocol Violation|8|||
37900645|NCT00731692|69586041|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
37900646|NCT00731692|69586042|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
37900647|NCT00731692|69586043|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
37900648|NCT00731692|69586041|FG000|Core Study (36 Months)|Adverse Event|25|||
37900649|NCT00731692|69586042|FG001|Core Study (36 Months)|Adverse Event|28|||
37900650|NCT00731692|69586043|FG002|Core Study (36 Months)|Adverse Event|29|||
37900651|NCT00731692|69586041|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
37900652|NCT00731692|69586042|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
37900653|NCT00731692|69586043|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
37900654|NCT00731692|69586041|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
37900655|NCT00731692|69586042|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
37900656|NCT00731692|69586043|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
37900657|NCT00731692|69586041|FG000|Extension Phase|Abnormal test procedure|0|||
37900658|NCT00731692|69586042|FG001|Extension Phase|Abnormal test procedure|0|||
37997015|NCT00089674|69681293|FG000|Overall Study|Withdrawal by Subject|143|||
37997016|NCT00089674|69681294|FG001|Overall Study|Withdrawal by Subject|127|||
37997017|NCT00089674|69681293|FG000|Overall Study|Death|43|||
37997018|NCT00089674|69681294|FG001|Overall Study|Death|43|||
37997019|NCT00089674|69681293|FG000|Overall Study|Disease progression|21|||
37997020|NCT00089674|69681294|FG001|Overall Study|Disease progression|23|||
37997021|NCT00089674|69681293|FG000|Overall Study|Ineligibility determined|8|||
37900659|NCT00731692|69586043|FG002|Extension Phase|Abnormal test procedure|1|||
37900660|NCT00731692|69586041|FG000|Extension Phase|Abnormal lab values|0|||
37900661|NCT00731692|69586042|FG001|Extension Phase|Abnormal lab values|0|||
37900662|NCT00731692|69586043|FG002|Extension Phase|Abnormal lab values|1|||
37900663|NCT00731692|69586041|FG000|Extension Phase|Lost to Follow-up|0|||
37900664|NCT00731692|69586042|FG001|Extension Phase|Lost to Follow-up|1|||
37900665|NCT00731692|69586043|FG002|Extension Phase|Lost to Follow-up|4|||
37900666|NCT00731692|69586041|FG000|Extension Phase|Withdrawal by Subject|4|||
37900667|NCT00731692|69586042|FG001|Extension Phase|Withdrawal by Subject|5|||
37900668|NCT00731692|69586043|FG002|Extension Phase|Withdrawal by Subject|3|||
37900669|NCT00731692|69586041|FG000|Extension Phase|Adverse Event|1|||
37900670|NCT00731692|69586042|FG001|Extension Phase|Adverse Event|1|||
37900671|NCT00731692|69586043|FG002|Extension Phase|Adverse Event|15|||
37900672|NCT00687193|69586065|FG000|Overall Study|Adverse Event|0|||
37900673|NCT00687193|69586066|FG001|Overall Study|Adverse Event|1|||
37900674|NCT00687193|69586067|FG002|Overall Study|Adverse Event|2|||
37997022|NCT00089674|69681294|FG001|Overall Study|Ineligibility determined|10|||
37997023|NCT00089674|69681293|FG000|Overall Study|Lost to Follow-up|21|||
37997024|NCT00089674|69681294|FG001|Overall Study|Lost to Follow-up|17|||
37997025|NCT00089674|69681293|FG000|Overall Study|Noncompliance|7|||
37900675|NCT00687193|69586068|FG003|Overall Study|Adverse Event|3|||
37900676|NCT00687193|69586069|FG004|Overall Study|Adverse Event|0|||
37997026|NCT00089674|69681294|FG001|Overall Study|Noncompliance|3|||
37997027|NCT00089674|69681293|FG000|Overall Study|Other|5|||
37997028|NCT00089674|69681294|FG001|Overall Study|Other|9|||
37997029|NCT00089674|69681293|FG000|Overall Study|Requirement for alternative therapy|14|||
37997030|NCT00089674|69681294|FG001|Overall Study|Requirement for alternative therapy|4|||
37997031|NCT00313586|69681304|FG000|Overall Study|Disease progression|14|||
37997032|NCT00313586|69681305|FG001|Overall Study|Disease progression|19|||
37997033|NCT00313586|69681306|FG002|Overall Study|Disease progression|10|||
37997034|NCT00313586|69681307|FG003|Overall Study|Disease progression|3|||
37997035|NCT00313586|69681304|FG000|Overall Study|Adverse Event|12|||
37997036|NCT00313586|69681305|FG001|Overall Study|Adverse Event|18|||
37997037|NCT00313586|69681306|FG002|Overall Study|Adverse Event|3|||
37997038|NCT00313586|69681307|FG003|Overall Study|Adverse Event|10|||
37997039|NCT00313586|69681304|FG000|Overall Study|Death|11|||
37997040|NCT00313586|69681305|FG001|Overall Study|Death|8|||
37997041|NCT00313586|69681306|FG002|Overall Study|Death|1|||
37997042|NCT00313586|69681307|FG003|Overall Study|Death|7|||
37997043|NCT00313586|69681304|FG000|Overall Study|Withdrawal by Subject|13|||
37997044|NCT00313586|69681305|FG001|Overall Study|Withdrawal by Subject|6|||
37997045|NCT00313586|69681306|FG002|Overall Study|Withdrawal by Subject|6|||
37997046|NCT00313586|69681307|FG003|Overall Study|Withdrawal by Subject|2|||
37997047|NCT00313586|69681304|FG000|Overall Study|Alternative therapy|3|||
37997048|NCT00313586|69681305|FG001|Overall Study|Alternative therapy|6|||
37997049|NCT00313586|69681306|FG002|Overall Study|Alternative therapy|2|||
37900677|NCT00687193|69586070|FG005|Overall Study|Adverse Event|2|||
37900678|NCT00687193|69586065|FG000|Overall Study|Lack of Efficacy|1|||
37900679|NCT00687193|69586066|FG001|Overall Study|Lack of Efficacy|1|||
37900680|NCT00687193|69586067|FG002|Overall Study|Lack of Efficacy|0|||
37900681|NCT00687193|69586068|FG003|Overall Study|Lack of Efficacy|0|||
37900682|NCT00687193|69586069|FG004|Overall Study|Lack of Efficacy|0|||
37997050|NCT00313586|69681307|FG003|Overall Study|Alternative therapy|0|||
37997051|NCT00313586|69681304|FG000|Overall Study|Other complicating disease|2|||
37997052|NCT00313586|69681305|FG001|Overall Study|Other complicating disease|2|||
37900683|NCT00687193|69586070|FG005|Overall Study|Lack of Efficacy|2|||
37900684|NCT00687193|69586065|FG000|Overall Study|Protocol Violation|1|||
37900685|NCT00687193|69586066|FG001|Overall Study|Protocol Violation|2|||
37900686|NCT00687193|69586067|FG002|Overall Study|Protocol Violation|0|||
37900687|NCT00687193|69586068|FG003|Overall Study|Protocol Violation|1|||
37900688|NCT00687193|69586069|FG004|Overall Study|Protocol Violation|2|||
37997053|NCT00313586|69681306|FG002|Overall Study|Other complicating disease|0|||
37997054|NCT00313586|69681307|FG003|Overall Study|Other complicating disease|0|||
37900689|NCT00687193|69586070|FG005|Overall Study|Protocol Violation|0|||
37900690|NCT00730912|69586090|FG000|Overall Study|Discontinued|0|||
37900691|NCT00730912|69586091|FG001|Overall Study|Discontinued|0|||
37900692|NCT00730912|69586092|FG002|Overall Study|Discontinued|1|||
37997055|NCT00313586|69681304|FG000|Overall Study|Did not achieve HI-major/better response|10|||
37997056|NCT00313586|69681305|FG001|Overall Study|Did not achieve HI-major/better response|7|||
37997057|NCT00313586|69681306|FG002|Overall Study|Did not achieve HI-major/better response|2|||
37997058|NCT00313586|69681307|FG003|Overall Study|Did not achieve HI-major/better response|1|||
37900693|NCT00730756|69586102|FG000|Overall Study|Adverse Event|2|||
37900694|NCT00730756|69586103|FG001|Overall Study|Adverse Event|0|||
37900695|NCT00730756|69586102|FG000|Overall Study|Lack of Efficacy|1|||
37900696|NCT00730756|69586103|FG001|Overall Study|Lack of Efficacy|1|||
37900697|NCT00730756|69586102|FG000|Overall Study|Protocol Deviation|1|||
37900698|NCT00730756|69586103|FG001|Overall Study|Protocol Deviation|2|||
37900699|NCT00730756|69586102|FG000|Overall Study|Lost to Follow-up|0|||
37900700|NCT00730756|69586103|FG001|Overall Study|Lost to Follow-up|1|||
37900701|NCT00730756|69586102|FG000|Overall Study|Withdrew Consent|0|||
37900702|NCT00730756|69586103|FG001|Overall Study|Withdrew Consent|1|||
37900703|NCT00730132|69586109|FG000|Overall Study|Protocol Violation|154|||
37900704|NCT00730132|69586109|FG000|Overall Study|Death|1|||
37900705|NCT00737464|69586116|FG000|Overall Study|Adverse Event|1|||
37900706|NCT00737464|69586116|FG000|Overall Study|Death|6|||
37900707|NCT00737464|69586116|FG000|Overall Study|Other - Failure to Return|1|||
37900708|NCT00737464|69586116|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
37900709|NCT00737464|69586116|FG000|Overall Study|Other reasons|4|||
37900710|NCT00729586|69586122|FG000|Overall Study|Ineligible|0|||
37900711|NCT00729586|69586123|FG001|Overall Study|Ineligible|1|||
37900712|NCT00729586|69586122|FG000|Overall Study|never treated|1|||
37900713|NCT00729586|69586123|FG001|Overall Study|never treated|0|||
37900714|NCT00949910|69586130|FG000|Overall Study|Progressive Disease|3750|||
37997059|NCT00313586|69681304|FG000|Overall Study|Physician Decision|2|||
37900715|NCT00949910|69586130|FG000|Overall Study|Symptomatic Deterioration|1088|||
37997060|NCT00313586|69681305|FG001|Overall Study|Physician Decision|1|||
37997061|NCT00313586|69681306|FG002|Overall Study|Physician Decision|0|||
37997062|NCT00313586|69681307|FG003|Overall Study|Physician Decision|0|||
37997063|NCT00313586|69681304|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
37997064|NCT00313586|69681305|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
37997065|NCT00313586|69681306|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
37997066|NCT00313586|69681307|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
37997067|NCT00313586|69681304|FG000|Overall Study|Lost insurance|0|||
37997068|NCT00313586|69681305|FG001|Overall Study|Lost insurance|1|||
37997069|NCT00313586|69681306|FG002|Overall Study|Lost insurance|0|||
37997070|NCT00313586|69681307|FG003|Overall Study|Lost insurance|0|||
37997071|NCT00313586|69681304|FG000|Overall Study|Moved|0|||
37997072|NCT00313586|69681305|FG001|Overall Study|Moved|1|||
37997073|NCT00313586|69681306|FG002|Overall Study|Moved|0|||
37997074|NCT00313586|69681307|FG003|Overall Study|Moved|0|||
37997075|NCT00313586|69681304|FG000|Overall Study|Death before starting treatment|1|||
37997076|NCT00313586|69681305|FG001|Overall Study|Death before starting treatment|0|||
37997077|NCT00313586|69681306|FG002|Overall Study|Death before starting treatment|0|||
37997078|NCT00313586|69681307|FG003|Overall Study|Death before starting treatment|0|||
37997079|NCT00312572|69681317|FG000|Overall Study|Adverse Event|10|||
37696689|NCT02448563|69172967|FG000|Overall Study|Withdrawal by Subject|0|||
37696690|NCT02448563|69172968|FG001|Overall Study|Withdrawal by Subject|1|||
37696691|NCT02266225|69172978|FG000|Overall Study|Lost to Follow-up|2|||
37696692|NCT02266225|69172978|FG000|Overall Study|Death|1|||
37997080|NCT00312572|69681318|FG001|Overall Study|Adverse Event|16|||
37997081|NCT00312572|69681317|FG000|Overall Study|Lost to Follow-up|1|||
37997082|NCT00312572|69681318|FG001|Overall Study|Lost to Follow-up|1|||
37997083|NCT00312572|69681317|FG000|Overall Study|Administrative|4|||
37997084|NCT00312572|69681318|FG001|Overall Study|Administrative|2|||
37900716|NCT00949910|69586130|FG000|Overall Study|Lost to Follow-up|100|||
37900717|NCT00949910|69586130|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
37900718|NCT00949910|69586130|FG000|Overall Study|Participant Refusal|390|||
37900719|NCT00949910|69586130|FG000|Overall Study|Death Due to Malignant Disease|456|||
37900720|NCT00949910|69586130|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
37900721|NCT00949910|69586130|FG000|Overall Study|Death Due to Adverse Event|115|||
37696693|NCT02266225|69172978|FG000|Overall Study|Withdrawal by Subject|13|||
37900722|NCT00949910|69586130|FG000|Overall Study|Death Due to Toxicity|3|||
37900723|NCT00949910|69586130|FG000|Overall Study|Death from Unknown Cause|5|||
37900724|NCT00949910|69586130|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
37900725|NCT00949910|69586130|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
37900726|NCT00949910|69586130|FG000|Overall Study|Switched to Commercial Treatment|4|||
37900727|NCT00949910|69586130|FG000|Overall Study|Violation of Eligibility|23|||
37900728|NCT00949910|69586130|FG000|Overall Study|Logistical Reasons|13|||
37900729|NCT00949910|69586130|FG000|Overall Study|Non-Compliance|10|||
37900730|NCT00949910|69586130|FG000|Overall Study|Prolonged Dosing Interruption|4|||
37900731|NCT00949910|69586130|FG000|Overall Study|Adverse Event|83|||
37900732|NCT00949910|69586130|FG000|Overall Study|Serious Adverse Event|6|||
37900733|NCT00949910|69586130|FG000|Overall Study|Physician/Participant Decision|7|||
37900734|NCT00949910|69586130|FG000|Overall Study|Other|4|||
37900735|NCT00949910|69586130|FG000|Overall Study|No Data|9|||
37900736|NCT00686959|69586136|FG000|Overall Study|Participants censored (no death events)|124|||
37900737|NCT00686959|69586137|FG001|Overall Study|Participants censored (no death events)|117|||
37900738|NCT00946088|69586145|FG000|Overall Study|Withdrawal by Subject|0|||
37900739|NCT00946088|69586146|FG001|Overall Study|Withdrawal by Subject|1|||
37900740|NCT00736996|69586157|FG000|Overall Study|Lost to Follow-up|1|||
37900741|NCT00736996|69586158|FG001|Overall Study|Lost to Follow-up|9|||
37900742|NCT00736996|69586159|FG002|Overall Study|Lost to Follow-up|2|||
37900743|NCT00728962|69586173|FG000|Implant Placement Surgery|Adverse Event|8|||
37900744|NCT00728962|69586173|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
37900745|NCT00728962|69586173|FG000|Implant Placement Surgery|Protocol Violation|1|||
37900746|NCT00728962|69586173|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
37900747|NCT00728962|69586173|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
37900748|NCT00954122|69586177|FG000|Overall Study|Withdrawal by Subject|5|||
37900749|NCT00954122|69586177|FG000|Overall Study|Adverse Event|1|||
37900750|NCT00954122|69586177|FG000|Overall Study|Safety Reason|1|||
37900751|NCT00586066|69586184|FG000|Overall Study|Lost to Follow-up|6|||
37997085|NCT00312572|69681317|FG000|Overall Study|Lack of Efficacy|1|||
37997086|NCT00312572|69681318|FG001|Overall Study|Lack of Efficacy|2|||
37997087|NCT00290888|69681328|FG000|Overall Study|Physician Decision|3|||
37997088|NCT00290888|69681329|FG001|Overall Study|Physician Decision|1|||
37997089|NCT00290732|69681338|FG000|Overall Study|Inability to instill drug intraductally.|0|||
37997090|NCT00290732|69681339|FG001|Overall Study|Inability to instill drug intraductally.|1|||
37997091|NCT00290732|69681340|FG002|Overall Study|Inability to instill drug intraductally.|1|||
37997092|NCT00290732|69681341|FG003|Overall Study|Inability to instill drug intraductally.|0|||
37997093|NCT00290732|69681342|FG004|Overall Study|Inability to instill drug intraductally.|0|||
37997094|NCT00312494|69681358|FG000|Overall Study|Randomized; not treated with study drug|9|||
37997095|NCT00312494|69681359|FG001|Overall Study|Randomized; not treated with study drug|10|||
37997096|NCT00312494|69681360|FG002|Overall Study|Randomized; not treated with study drug|5|||
37900752|NCT00586066|69586185|FG001|Overall Study|Lost to Follow-up|3|||
37900753|NCT00586066|69586184|FG000|Overall Study|Lack of Efficacy|5|||
37900754|NCT00586066|69586185|FG001|Overall Study|Lack of Efficacy|3|||
37900755|NCT00586066|69586184|FG000|Overall Study|Adverse Event|2|||
37900756|NCT00586066|69586185|FG001|Overall Study|Adverse Event|2|||
37900757|NCT00586066|69586184|FG000|Overall Study|Physician Decision|1|||
37900758|NCT00586066|69586185|FG001|Overall Study|Physician Decision|0|||
37900759|NCT00586066|69586184|FG000|Overall Study|Withdrawal of consent|4|||
37997097|NCT00312494|69681358|FG000|Overall Study|Adverse Event|33|||
37997098|NCT00312494|69681359|FG001|Overall Study|Adverse Event|15|||
37997099|NCT00312494|69681360|FG002|Overall Study|Adverse Event|11|||
37900760|NCT00586066|69586185|FG001|Overall Study|Withdrawal of consent|2|||
37900761|NCT00728884|69586191|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
37900762|NCT00728884|69586191|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
37900763|NCT00728494|69586197|FG000|Overall Study|Adverse Event|7|||
37900764|NCT00728494|69586198|FG001|Overall Study|Adverse Event|0|||
37900765|NCT00728494|69586197|FG000|Overall Study|Withdrawal by Subject|0|||
37997100|NCT00312494|69681358|FG000|Overall Study|Lack of Efficacy|4|||
37997101|NCT00312494|69681359|FG001|Overall Study|Lack of Efficacy|6|||
37900766|NCT00728494|69586198|FG001|Overall Study|Withdrawal by Subject|2|||
37900767|NCT00728494|69586197|FG000|Overall Study|Lack of Efficacy|2|||
37900768|NCT00728494|69586198|FG001|Overall Study|Lack of Efficacy|4|||
37900769|NCT00728494|69586197|FG000|Overall Study|No data available|0|||
37900770|NCT00728494|69586198|FG001|Overall Study|No data available|1|||
37900771|NCT00728416|69586206|FG000|Overall Study|Adverse Event|1|||
37900772|NCT00728416|69586207|FG001|Overall Study|Adverse Event|1|||
37900773|NCT00728416|69586206|FG000|Overall Study|Treatment Failure|0|||
37900774|NCT00728416|69586207|FG001|Overall Study|Treatment Failure|1|||
37900775|NCT00728416|69586206|FG000|Overall Study|Withdrawal by Subject|1|||
37900776|NCT00728416|69586207|FG001|Overall Study|Withdrawal by Subject|0|||
37900777|NCT00728182|69586215|FG000|Overall Study|Adverse Event|1|||
37900778|NCT00728182|69586216|FG001|Overall Study|Adverse Event|0|||
37900779|NCT00728182|69586215|FG000|Overall Study|Lost to Follow-up|2|||
37900780|NCT00728182|69586216|FG001|Overall Study|Lost to Follow-up|0|||
37900781|NCT00728182|69586215|FG000|Overall Study|Death|0|||
37900782|NCT00728182|69586216|FG001|Overall Study|Death|2|||
37900783|NCT00728182|69586215|FG000|Overall Study|Protocol Noncompliance|0|||
37900784|NCT00728182|69586216|FG001|Overall Study|Protocol Noncompliance|1|||
37696694|NCT02354690|69172983|FG000|Overall Study|Physician Decision|1|||
37696695|NCT02354222|69172989|FG000|Overall Study|Adverse Event|0|||
37696696|NCT02354222|69172990|FG001|Overall Study|Adverse Event|3|||
37696697|NCT02354222|69172989|FG000|Overall Study|Physician Decision|1|||
37696698|NCT02354222|69172990|FG001|Overall Study|Physician Decision|1|||
37696699|NCT02354222|69172989|FG000|Overall Study|Pregnancy|1|||
37900785|NCT00941330|69586226|FG000|Overall Study|Other|1|||
37900786|NCT00941330|69586227|FG001|Overall Study|Other|0|||
37900787|NCT00941330|69586226|FG000|Overall Study|Physician Decision|0|||
37900788|NCT00941330|69586227|FG001|Overall Study|Physician Decision|2|||
37900789|NCT00686881|69586235|FG000|Overall Study|Withdrawal by Subject|11|||
37900790|NCT00686881|69586236|FG001|Overall Study|Withdrawal by Subject|18|||
37900791|NCT00686881|69586235|FG000|Overall Study|Lost to Follow-up|0|||
37900792|NCT00686881|69586236|FG001|Overall Study|Lost to Follow-up|1|||
37900793|NCT00686881|69586235|FG000|Overall Study|Treatment-related adverse event|10|||
37900794|NCT00686881|69586236|FG001|Overall Study|Treatment-related adverse event|9|||
37900795|NCT00686881|69586235|FG000|Overall Study|Met discontinuation criteria|5|||
37900796|NCT00686881|69586236|FG001|Overall Study|Met discontinuation criteria|0|||
37900797|NCT00686881|69586235|FG000|Overall Study|Onset of malignant tumor|11|||
37900798|NCT00686881|69586236|FG001|Overall Study|Onset of malignant tumor|11|||
37900799|NCT00686881|69586235|FG000|Overall Study|Lack of Efficacy|4|||
37900800|NCT00686881|69586236|FG001|Overall Study|Lack of Efficacy|3|||
37900801|NCT00686881|69586235|FG000|Overall Study|Physician Decision|1|||
37900802|NCT00686881|69586236|FG001|Overall Study|Physician Decision|0|||
37900803|NCT00686881|69586235|FG000|Overall Study|Circumstances of site|1|||
37900804|NCT00686881|69586236|FG001|Overall Study|Circumstances of site|1|||
37900805|NCT00686881|69586235|FG000|Overall Study|Did not meet protocol eligibility|1|||
37900806|NCT00686881|69586236|FG001|Overall Study|Did not meet protocol eligibility|0|||
37900807|NCT00686881|69586235|FG000|Overall Study|Irregular visits|1|||
37900808|NCT00686881|69586236|FG001|Overall Study|Irregular visits|0|||
37900809|NCT00686881|69586235|FG000|Overall Study|Study discontinuation|35|||
37900810|NCT00686881|69586236|FG001|Overall Study|Study discontinuation|32|||
37900811|NCT00686881|69586235|FG000|Overall Study|Never received study drug|2|||
37900812|NCT00686881|69586236|FG001|Overall Study|Never received study drug|6|||
37900813|NCT00727714|69586244|FG000|Overall Study|Lost to Follow-up|2|||
37900814|NCT00727558|69586250|FG000|Overall Study|Lens issue|0|||
37900815|NCT00727558|69586251|FG001|Overall Study|Lens issue|1|||
37997102|NCT00312494|69681360|FG002|Overall Study|Lack of Efficacy|8|||
37900816|NCT00727558|69586250|FG000|Overall Study|Adverse Event|0|||
37900817|NCT00727558|69586251|FG001|Overall Study|Adverse Event|1|||
37900818|NCT00727558|69586250|FG000|Overall Study|Subject unable to return for follow-up|1|||
37900819|NCT00727558|69586251|FG001|Overall Study|Subject unable to return for follow-up|1|||
37900820|NCT00727558|69586250|FG000|Overall Study|Lost to Follow-up|1|||
37900821|NCT00727558|69586251|FG001|Overall Study|Lost to Follow-up|0|||
37997103|NCT00312494|69681358|FG000|Overall Study|Laboratory abnormality|1|||
37696700|NCT02354222|69172990|FG001|Overall Study|Pregnancy|0|||
37696701|NCT02354222|69172989|FG000|Overall Study|Withdrawal by Subject|2|||
37900822|NCT00688597|69586260|FG000|Overall Study|Adverse Event|2|||
37900823|NCT00688597|69586261|FG001|Overall Study|Adverse Event|0|||
37900824|NCT00688597|69586262|FG002|Overall Study|Adverse Event|0|||
37900825|NCT00688597|69586260|FG000|Overall Study|Physician Decision|1|||
37900826|NCT00688597|69586261|FG001|Overall Study|Physician Decision|0|||
37900827|NCT00688597|69586262|FG002|Overall Study|Physician Decision|0|||
37900828|NCT00735904|69586270|FG000|Overall Study|Adverse Event|3|||
37997104|NCT00312494|69681359|FG001|Overall Study|Laboratory abnormality|0|||
37900829|NCT00735904|69586270|FG000|Overall Study|Death|20|||
37900830|NCT00735904|69586270|FG000|Overall Study|Protocol Violation|1|||
37997105|NCT00312494|69681360|FG002|Overall Study|Laboratory abnormality|0|||
37900831|NCT00735904|69586270|FG000|Overall Study|Withdrawal by Subject|1|||
37997106|NCT00312494|69681358|FG000|Overall Study|Lost to Follow-up|8|||
37696702|NCT02354222|69172990|FG001|Overall Study|Withdrawal by Subject|3|||
37696703|NCT02354222|69172989|FG000|Overall Study|Conflict with the stopping criteria|0|||
37696704|NCT02354222|69172990|FG001|Overall Study|Conflict with the stopping criteria|4|||
37696705|NCT02353442|69172998|FG000|Overall Study|Withdrawal by Subject|3|||
37696706|NCT02353442|69172999|FG001|Overall Study|Withdrawal by Subject|4|||
37696707|NCT02351960|69173007|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
37696708|NCT02351960|69173008|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
37696709|NCT02351960|69173007|FG000|Overall Study|Voluntary Withdrawal|5|||
37696710|NCT02351960|69173008|FG001|Overall Study|Voluntary Withdrawal|4|||
37696711|NCT02351960|69173007|FG000|Overall Study|Significant Protocol Deviation|0|||
37696712|NCT02351960|69173008|FG001|Overall Study|Significant Protocol Deviation|5|||
37696713|NCT02351180|69173017|FG000|Overall Study|Withdrawal by Subject|1|||
37696714|NCT02351180|69173018|FG001|Overall Study|Withdrawal by Subject|0|||
37696715|NCT02350478|69173026|FG000|Overall Study|Lost to Follow-up|5|||
37696716|NCT02350478|69173027|FG001|Overall Study|Lost to Follow-up|1|||
37696717|NCT02349542|69173033|FG000|Overall Study|Withdrawal by Subject|5|||
37696718|NCT02321930|69173037|FG000|Overall Study|Lost to Follow-up|1|||
37696719|NCT01647542|69173044|FG000|Overall Study|Major Protocol Deviation|1|||
37696720|NCT01647542|69173045|FG001|Overall Study|Major Protocol Deviation|0|||
37696721|NCT01647542|69173046|FG002|Overall Study|Major Protocol Deviation|0|||
37696722|NCT01647542|69173044|FG000|Overall Study|Adverse Event|4|||
37696723|NCT01647542|69173045|FG001|Overall Study|Adverse Event|5|||
37696724|NCT01647542|69173046|FG002|Overall Study|Adverse Event|4|||
37696725|NCT01647542|69173044|FG000|Overall Study|Lost to Follow-up|0|||
37696726|NCT01647542|69173045|FG001|Overall Study|Lost to Follow-up|2|||
37696727|NCT01647542|69173046|FG002|Overall Study|Lost to Follow-up|2|||
37696728|NCT01647542|69173044|FG000|Overall Study|Withdrawal by Subject|6|||
37696729|NCT01647542|69173045|FG001|Overall Study|Withdrawal by Subject|4|||
37696730|NCT01647542|69173046|FG002|Overall Study|Withdrawal by Subject|0|||
37696731|NCT01647542|69173044|FG000|Overall Study|Study Termination|64|||
37696732|NCT01647542|69173045|FG001|Overall Study|Study Termination|61|||
37696733|NCT01647542|69173046|FG002|Overall Study|Study Termination|65|||
37827295|NCT01084174|69510057|FG000|Overall Study|Eosinophilic esophagitis|0|||
37827296|NCT01084174|69510058|FG001|Overall Study|Eosinophilic esophagitis|1|||
37827297|NCT01084174|69510057|FG000|Overall Study|Anaphylaxis|0|||
37827298|NCT01084174|69510058|FG001|Overall Study|Anaphylaxis|1|||
37827299|NCT01084174|69510057|FG000|Overall Study|Participant noncompliance|0|||
37827300|NCT01084174|69510058|FG001|Overall Study|Participant noncompliance|1|||
37827301|NCT01084135|69510068|FG000|20 Week|Physician Decision|0|||
37827302|NCT01084135|69510069|FG001|20 Week|Physician Decision|1|||
37827303|NCT01083316|69510077|FG000|Overall Study|Adverse Event|2|||
37827304|NCT01083316|69510077|FG000|Overall Study|Withdrawal by Subject|1|||
37827305|NCT01083160|69510082|FG000|Overall Study|Adverse Event|1|||
37827306|NCT01083121|69510086|FG000|Overall Study|Use of Humira outside the approved label|81|||
37827307|NCT01082614|69510096|FG000|Overall Study|Adverse Event|1|||
37900832|NCT00735904|69586270|FG000|Overall Study|Study Terminated by Sponsor|5|||
37900833|NCT00735904|69586270|FG000|Overall Study|Other|8|||
37900834|NCT00688519|69586276|FG000|Overall Study|Adverse Event|2|||
37900835|NCT00688519|69586277|FG001|Overall Study|Adverse Event|3|||
37900836|NCT00688519|69586276|FG000|Overall Study|Lost to Follow-up|3|||
37900837|NCT00688519|69586277|FG001|Overall Study|Lost to Follow-up|3|||
37900838|NCT00688519|69586276|FG000|Overall Study|Lack of Efficacy|3|||
37900839|NCT00688519|69586277|FG001|Overall Study|Lack of Efficacy|1|||
37696734|NCT01647542|69173044|FG000|Overall Study|Lack of Efficacy|1|||
37696735|NCT01647542|69173045|FG001|Overall Study|Lack of Efficacy|1|||
37696736|NCT01647542|69173046|FG002|Overall Study|Lack of Efficacy|0|||
37696737|NCT01647542|69173044|FG000|Overall Study|Death|0|||
37696738|NCT01647542|69173045|FG001|Overall Study|Death|0|||
37827308|NCT01082614|69510097|FG001|Overall Study|Adverse Event|4|||
37900840|NCT00688519|69586276|FG000|Overall Study|Withdrawal by Subject|7|||
37900841|NCT00688519|69586277|FG001|Overall Study|Withdrawal by Subject|6|||
37696739|NCT01647542|69173046|FG002|Overall Study|Death|1|||
37696740|NCT02321462|69173056|FG000|Overall Study|Withdrawal by Subject|5|||
37696741|NCT02321462|69173057|FG001|Overall Study|Withdrawal by Subject|2|||
37696742|NCT02321462|69173056|FG000|Overall Study|Subject withdrawn before any treatment|1|||
37696743|NCT02321462|69173057|FG001|Overall Study|Subject withdrawn before any treatment|1|||
37696744|NCT02391584|69173066|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
37696745|NCT02391584|69173067|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
37696746|NCT02391584|69173066|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
37696747|NCT02391584|69173067|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
37696748|NCT02391584|69173066|FG000|3 Month|Lost to Follow-up|1|||
37696749|NCT02391584|69173067|FG001|3 Month|Lost to Follow-up|0|||
37696750|NCT02391584|69173066|FG000|6 Month|Withdrawal by Subject|1|||
37696751|NCT02391584|69173067|FG001|6 Month|Withdrawal by Subject|0|||
37696752|NCT02391584|69173066|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
37696753|NCT02391584|69173067|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
37696754|NCT02266147|69173080|FG000|PART 1: Dose Escalation|Physician Decision|0|||
37696755|NCT02266147|69173081|FG001|PART 1: Dose Escalation|Physician Decision|0|||
37696756|NCT02266147|69173082|FG002|PART 1: Dose Escalation|Physician Decision|1|||
37696757|NCT02266147|69173083|FG003|PART 1: Dose Escalation|Physician Decision|0|||
37696758|NCT02266147|69173080|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
37696759|NCT02266147|69173081|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
37696760|NCT02266147|69173082|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
37696761|NCT02266147|69173083|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
37696762|NCT02266147|69173080|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
37696763|NCT02266147|69173081|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
37696764|NCT02266147|69173082|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
37696765|NCT02266147|69173083|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
37696766|NCT02266147|69173080|FG000|PART 1: Dose Escalation|Other|1|||
37696767|NCT02266147|69173081|FG001|PART 1: Dose Escalation|Other|1|||
37696768|NCT02266147|69173082|FG002|PART 1: Dose Escalation|Other|0|||
37696769|NCT02266147|69173083|FG003|PART 1: Dose Escalation|Other|0|||
37696770|NCT02266147|69173080|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
37696771|NCT02266147|69173081|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
37696772|NCT02266147|69173082|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
37696773|NCT02266147|69173083|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
37696774|NCT02266147|69173080|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
37696775|NCT02266147|69173081|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
37696776|NCT02266147|69173082|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
37696777|NCT02266147|69173083|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
37696778|NCT02264977|69173095|FG000|Overall Study|Death|3|||
37696779|NCT02264977|69173095|FG000|Overall Study|Physician Decision|1|||
37696780|NCT02264977|69173095|FG000|Overall Study|Refuse to return|1|||
37696781|NCT02264821|69173102|FG000|Overall Study|Protocol Violation|1|||
37827309|NCT01082614|69510096|FG000|Overall Study|Equipment Malfunction|0|||
37827310|NCT01082614|69510097|FG001|Overall Study|Equipment Malfunction|1|||
37900842|NCT00688519|69586276|FG000|Overall Study|Prohibited medication|1|||
37696782|NCT02264821|69173103|FG001|Overall Study|Protocol Violation|3|||
37696783|NCT02264821|69173104|FG002|Overall Study|Protocol Violation|6|||
37696784|NCT02261467|69173114|FG000|Overall Study|Enrolled in Error|1|||
37827311|NCT01082614|69510096|FG000|Overall Study|Physician Decision|2|||
37827312|NCT01082614|69510097|FG001|Overall Study|Physician Decision|0|||
37827313|NCT01081873|69510103|FG000|Overall Study|Death|86|||
37827314|NCT01081873|69510103|FG000|Overall Study|Withdrawal by Subject|10|||
37827315|NCT01081873|69510103|FG000|Overall Study|Lost to Follow-up|142|||
37827316|NCT01081873|69510103|FG000|Overall Study|Progression of prostate cancer|13|||
37827317|NCT01081873|69510103|FG000|Overall Study|Other|47|||
37827318|NCT01081795|69510135|FG000|Overall Study|Adverse Event|18|||
37827319|NCT01081795|69510136|FG001|Overall Study|Adverse Event|23|||
37827320|NCT01081795|69510137|FG002|Overall Study|Adverse Event|6|||
37827321|NCT01081795|69510135|FG000|Overall Study|Lack of Efficacy|7|||
37827322|NCT01081795|69510136|FG001|Overall Study|Lack of Efficacy|5|||
37827323|NCT01081795|69510137|FG002|Overall Study|Lack of Efficacy|19|||
37827324|NCT01081795|69510135|FG000|Overall Study|Subject's schedule|1|||
37827325|NCT01081795|69510136|FG001|Overall Study|Subject's schedule|1|||
37827326|NCT01081795|69510137|FG002|Overall Study|Subject's schedule|2|||
37827327|NCT01081795|69510135|FG000|Overall Study|Revocation of informed consent|2|||
37696785|NCT02261467|69173115|FG001|Overall Study|Enrolled in Error|0|||
37696786|NCT02261467|69173114|FG000|Overall Study|Protocol Violation|0|||
37827328|NCT01081795|69510136|FG001|Overall Study|Revocation of informed consent|0|||
37827329|NCT01081795|69510137|FG002|Overall Study|Revocation of informed consent|0|||
37900843|NCT00688519|69586277|FG001|Overall Study|Prohibited medication|0|||
37900844|NCT00688519|69586276|FG000|Overall Study|Non-compliance|0|||
37696787|NCT02261467|69173115|FG001|Overall Study|Protocol Violation|1|||
37696788|NCT02261467|69173114|FG000|Overall Study|Personal Reasons|17|||
37827330|NCT01081795|69510135|FG000|Overall Study|Ineligible for participation|1|||
37900845|NCT00688519|69586277|FG001|Overall Study|Non-compliance|1|||
37696789|NCT02261467|69173115|FG001|Overall Study|Personal Reasons|22|||
37696790|NCT02261467|69173114|FG000|Overall Study|Lost to Follow-up|2|||
37696791|NCT02261467|69173115|FG001|Overall Study|Lost to Follow-up|13|||
37696792|NCT02261467|69173114|FG000|Overall Study|Adverse Event|1|||
37696793|NCT02261467|69173115|FG001|Overall Study|Adverse Event|1|||
37696794|NCT01643473|69173123|FG000|Overall Study|Lost to Follow-up|1|||
37696795|NCT01643473|69173124|FG001|Overall Study|Lost to Follow-up|0|||
37696796|NCT02320058|69173132|FG000|Overall Study|Death|25|||
37696797|NCT02320058|69173133|FG001|Overall Study|Death|10|||
37696798|NCT02320058|69173132|FG000|Overall Study|Lost to Follow-up|4|||
37696799|NCT02320058|69173133|FG001|Overall Study|Lost to Follow-up|0|||
37696800|NCT02320058|69173132|FG000|Overall Study|Other reasons|4|||
37696801|NCT02320058|69173133|FG001|Overall Study|Other reasons|1|||
37696802|NCT02320058|69173132|FG000|Overall Study|Withdrawal by Subject|8|||
37696803|NCT02320058|69173133|FG001|Overall Study|Withdrawal by Subject|2|||
37696804|NCT02320058|69173132|FG000|Overall Study|Not reported|1|||
37696805|NCT02320058|69173133|FG001|Overall Study|Not reported|0|||
37696806|NCT02319668|69173141|FG000|Overall Study|Other (Not specified)|0|||
37696807|NCT02319668|69173142|FG001|Overall Study|Other (Not specified)|2|||
37696808|NCT02092467|69173154|FG000|Overall Study|Death|49|||
37696809|NCT02092467|69173155|FG001|Overall Study|Death|66|||
37696810|NCT02092467|69173156|FG002|Overall Study|Death|38|||
37696811|NCT02092467|69173154|FG000|Overall Study|Lost to Follow-up|38|||
37696812|NCT02092467|69173155|FG001|Overall Study|Lost to Follow-up|35|||
37696813|NCT02092467|69173156|FG002|Overall Study|Lost to Follow-up|40|||
37696814|NCT02092467|69173154|FG000|Overall Study|Global Deterioration of Health Status|1|||
37696815|NCT02092467|69173155|FG001|Overall Study|Global Deterioration of Health Status|0|||
37696816|NCT02092467|69173156|FG002|Overall Study|Global Deterioration of Health Status|0|||
37696817|NCT02092467|69173154|FG000|Overall Study|Other|32|||
37696818|NCT02092467|69173155|FG001|Overall Study|Other|30|||
37696819|NCT02092467|69173156|FG002|Overall Study|Other|24|||
37696820|NCT02092467|69173154|FG000|Overall Study|Withdrawal by Subject|282|||
37696821|NCT02092467|69173155|FG001|Overall Study|Withdrawal by Subject|327|||
37696822|NCT02092467|69173156|FG002|Overall Study|Withdrawal by Subject|289|||
37696823|NCT02092467|69173154|FG000|Overall Study|Randomized but not treated|2|||
37696824|NCT02092467|69173155|FG001|Overall Study|Randomized but not treated|1|||
37696825|NCT02092467|69173156|FG002|Overall Study|Randomized but not treated|7|||
37696826|NCT02462759|69173168|FG000|Part 1: Double Blind|Death|1|||
37696827|NCT02462759|69173169|FG001|Part 1: Double Blind|Death|0|||
37696828|NCT02462759|69173170|FG002|Part 1: Double Blind|Death|0|||
37696829|NCT02349386|69173185|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
37696830|NCT02349386|69173186|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
37696831|NCT02349386|69173187|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
37696832|NCT02349386|69173188|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
37696833|NCT02349386|69173185|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
37696834|NCT02349386|69173186|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
37696835|NCT02349386|69173187|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
37696836|NCT02349386|69173188|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
37696837|NCT02349386|69173185|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
37696838|NCT02349386|69173186|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
37696839|NCT02349386|69173187|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
37696840|NCT02349386|69173188|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
37696841|NCT02349386|69173185|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
37696842|NCT02349386|69173186|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
37696843|NCT02349386|69173187|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
37696844|NCT02349386|69173188|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
37696845|NCT02349386|69173185|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
37696846|NCT02349386|69173186|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
37696847|NCT02349386|69173187|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
37696848|NCT02349386|69173188|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
37696849|NCT02349386|69173185|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
37696850|NCT02349386|69173186|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
37696851|NCT02349386|69173187|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
37696852|NCT02349386|69173188|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
37696853|NCT02036775|69173198|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
37696854|NCT02036775|69173199|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
37696855|NCT02036775|69173200|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
37696856|NCT02036775|69173201|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
37696857|NCT02036775|69173202|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
37900846|NCT00688519|69586276|FG000|Overall Study|Subject moved out of state|1|||
37997107|NCT00312494|69681359|FG001|Overall Study|Lost to Follow-up|8|||
37997108|NCT00312494|69681360|FG002|Overall Study|Lost to Follow-up|8|||
37696858|NCT02036775|69173203|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
37696859|NCT02092389|69173211|FG000|Overall Study|Adverse Event|1|||
37696860|NCT02092389|69173211|FG000|Overall Study|Other|5|||
37696861|NCT02034591|69173215|FG000|Overall Study|Withdrawal by Subject|0|||
37696862|NCT02034591|69173216|FG001|Overall Study|Withdrawal by Subject|0|||
37696863|NCT02034591|69173217|FG002|Overall Study|Withdrawal by Subject|0|||
37696864|NCT02034591|69173218|FG003|Overall Study|Withdrawal by Subject|0|||
37696865|NCT02034591|69173219|FG004|Overall Study|Withdrawal by Subject|1|||
37696866|NCT02034591|69173220|FG005|Overall Study|Withdrawal by Subject|0|||
37696867|NCT02391116|69173229|FG000|Treatment|Withdrawal by Subject|1|||
37696868|NCT02391116|69173229|FG000|Treatment|Protocol Violation|1|||
37696869|NCT02391116|69173229|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
37696870|NCT02391116|69173229|FG000|Treatment|AE with Clinical PD|3|||
37696871|NCT02391116|69173229|FG000|Safety Follow-up|Adverse Event|1|||
37696872|NCT02391116|69173229|FG000|Safety Follow-up|Withdrawal by Subject|4|||
37696873|NCT02391116|69173229|FG000|Safety Follow-up|Switching to Other Therapy|4|||
37696874|NCT02391116|69173229|FG000|Safety Follow-up|No Follow Up|1|||
37696875|NCT02391116|69173229|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
37696876|NCT02391116|69173229|FG000|Active Follow-up|Withdrawal by Subject|1|||
37696877|NCT02391116|69173229|FG000|Active Follow-up|Switching to Other Therapy|2|||
37696878|NCT02391116|69173229|FG000|Survival Follow-up|Withdrawal by Subject|3|||
37696879|NCT02391116|69173229|FG000|Survival Follow-up|Switching to Other Therapy|1|||
37696880|NCT02091921|69173240|FG000|Overall Study|Adverse Event|3|||
37696881|NCT02447081|69173247|FG000|Overall Study|Death|161|||
37696882|NCT02447081|69173247|FG000|Overall Study|Lost to Follow-up|36|||
37696883|NCT02447081|69173247|FG000|Overall Study|Visit not completed|17|||
37696884|NCT02447081|69173247|FG000|Overall Study|unsuccessful implant procedure|10|||
37696885|NCT02391038|69173251|FG000|Overall Study|Progressive disease|3|||
37696886|NCT02391038|69173252|FG001|Overall Study|Progressive disease|3|||
37696887|NCT02391038|69173253|FG002|Overall Study|Progressive disease|6|||
37696888|NCT02260921|69173264|FG000|Overall Study|Adverse Event|1|||
37696889|NCT02260921|69173265|FG001|Overall Study|Adverse Event|0|||
37696890|NCT02260921|69173264|FG000|Overall Study|Lost to Follow-up|4|||
37696891|NCT02260921|69173265|FG001|Overall Study|Lost to Follow-up|3|||
37696892|NCT02260921|69173264|FG000|Overall Study|Withdraw Consent|4|||
37696893|NCT02260921|69173265|FG001|Overall Study|Withdraw Consent|1|||
37696894|NCT02260921|69173264|FG000|Overall Study|Death|1|||
37696895|NCT02260921|69173265|FG001|Overall Study|Death|0|||
37696896|NCT02260921|69173264|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
37696897|NCT02260921|69173265|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
37696898|NCT02462603|69173271|FG000|Overall Study|Investigator Decision|1|||
37696899|NCT02462603|69173271|FG000|Overall Study|Non-Compliance|1|||
37696900|NCT02462603|69173271|FG000|Overall Study|Withdrawal by Subject|2|||
37696901|NCT02034513|69173277|FG000|Overall Study|Adverse Event|11|||
37696902|NCT02034513|69173278|FG001|Overall Study|Adverse Event|10|||
37696903|NCT02034513|69173277|FG000|Overall Study|Lack of Efficacy|0|||
37696904|NCT02034513|69173278|FG001|Overall Study|Lack of Efficacy|1|||
37696905|NCT02034513|69173277|FG000|Overall Study|Lost to Follow-up|6|||
37696906|NCT02034513|69173278|FG001|Overall Study|Lost to Follow-up|7|||
37696907|NCT02034513|69173277|FG000|Overall Study|Pregnancy|0|||
37696908|NCT02034513|69173278|FG001|Overall Study|Pregnancy|3|||
37696909|NCT02034513|69173277|FG000|Overall Study|Protocol Violation|7|||
37696910|NCT02034513|69173278|FG001|Overall Study|Protocol Violation|10|||
37696911|NCT02034513|69173277|FG000|Overall Study|Withdrawal by Subject|25|||
37696912|NCT02034513|69173278|FG001|Overall Study|Withdrawal by Subject|25|||
37696913|NCT02034513|69173277|FG000|Overall Study|Unclassified|0|||
37696914|NCT02034513|69173278|FG001|Overall Study|Unclassified|1|||
37696915|NCT02348840|69173290|FG000|Overall Study|Withdrawal by Subject|2|||
37696916|NCT02348840|69173291|FG001|Overall Study|Withdrawal by Subject|1|||
37696917|NCT02348840|69173292|FG002|Overall Study|Withdrawal by Subject|0|||
37696918|NCT02348840|69173293|FG003|Overall Study|Withdrawal by Subject|0|||
37696919|NCT02462057|69173308|FG000|Overall Study|Left Vitality|32|||
37827331|NCT01081795|69510136|FG001|Overall Study|Ineligible for participation|0|||
37827332|NCT01081795|69510137|FG002|Overall Study|Ineligible for participation|0|||
37827333|NCT01081795|69510135|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
37696920|NCT02462057|69173309|FG001|Overall Study|Left Vitality|27|||
37696921|NCT02462057|69173310|FG002|Overall Study|Left Vitality|23|||
37696922|NCT02462057|69173311|FG003|Overall Study|Left Vitality|35|||
37696923|NCT02462057|69173312|FG004|Overall Study|Left Vitality|33|||
37696924|NCT02462057|69173308|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
37696925|NCT02462057|69173309|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
37696926|NCT02462057|69173310|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
37696927|NCT02462057|69173311|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
37696928|NCT02462057|69173312|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
37696929|NCT02461745|69173326|FG000|Overall Study|Lack of Efficacy|9|||
37827334|NCT01081795|69510136|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
37696930|NCT02461745|69173327|FG001|Overall Study|Lack of Efficacy|1|||
37696931|NCT02461745|69173326|FG000|Overall Study|Lost to Follow-up|2|||
37696932|NCT02461745|69173327|FG001|Overall Study|Lost to Follow-up|2|||
37696933|NCT02461745|69173326|FG000|Overall Study|Withdrawal by Subject|3|||
37696934|NCT02461745|69173327|FG001|Overall Study|Withdrawal by Subject|1|||
37696935|NCT02034435|69173337|FG000|Overall Study|Withdrawal by Subject|1|||
37696936|NCT02034435|69173338|FG001|Overall Study|Withdrawal by Subject|0|||
37696937|NCT02034435|69173339|FG002|Overall Study|Withdrawal by Subject|0|||
37696938|NCT02034435|69173340|FG003|Overall Study|Withdrawal by Subject|0|||
37696939|NCT02034435|69173337|FG000|Overall Study|Illness|0|||
37696940|NCT02034435|69173338|FG001|Overall Study|Illness|2|||
37696941|NCT02034435|69173339|FG002|Overall Study|Illness|0|||
37696942|NCT02034435|69173340|FG003|Overall Study|Illness|0|||
37696943|NCT02034435|69173337|FG000|Overall Study|Inadequate IV access|1|||
37696944|NCT02034435|69173338|FG001|Overall Study|Inadequate IV access|0|||
37696945|NCT02034435|69173339|FG002|Overall Study|Inadequate IV access|0|||
37696946|NCT02034435|69173340|FG003|Overall Study|Inadequate IV access|1|||
37696947|NCT02033889|69173353|FG000|Overall Study|Adverse Event|3|||
37696948|NCT02033889|69173354|FG001|Overall Study|Adverse Event|1|||
37696949|NCT02033889|69173355|FG002|Overall Study|Adverse Event|3|||
37696950|NCT02033889|69173353|FG000|Overall Study|Death|3|||
37696951|NCT02033889|69173354|FG001|Overall Study|Death|1|||
37696952|NCT02033889|69173355|FG002|Overall Study|Death|2|||
37696953|NCT02033889|69173353|FG000|Overall Study|Excluded Medication|1|||
37696954|NCT02033889|69173354|FG001|Overall Study|Excluded Medication|1|||
37696955|NCT02033889|69173355|FG002|Overall Study|Excluded Medication|0|||
37696956|NCT02033889|69173353|FG000|Overall Study|Lost to Follow-up|8|||
37696957|NCT02033889|69173354|FG001|Overall Study|Lost to Follow-up|5|||
37696958|NCT02033889|69173355|FG002|Overall Study|Lost to Follow-up|6|||
37696959|NCT02033889|69173353|FG000|Overall Study|Non-Compliance With Study Drug|1|||
37696960|NCT02033889|69173354|FG001|Overall Study|Non-Compliance With Study Drug|0|||
37696961|NCT02033889|69173355|FG002|Overall Study|Non-Compliance With Study Drug|0|||
37696962|NCT02033889|69173353|FG000|Overall Study|Physician Decision|0|||
37696963|NCT02033889|69173354|FG001|Overall Study|Physician Decision|1|||
37696964|NCT02033889|69173355|FG002|Overall Study|Physician Decision|1|||
37696965|NCT02033889|69173353|FG000|Overall Study|Participant moved|0|||
37696966|NCT02033889|69173354|FG001|Overall Study|Participant moved|1|||
37696967|NCT02033889|69173355|FG002|Overall Study|Participant moved|0|||
37696968|NCT02033889|69173353|FG000|Overall Study|Withdrawal by Subject|18|||
37696969|NCT02033889|69173354|FG001|Overall Study|Withdrawal by Subject|10|||
37696970|NCT02033889|69173355|FG002|Overall Study|Withdrawal by Subject|13|||
37696971|NCT02447003|69173365|FG000|Overall Study|Other|0|||
37696972|NCT02447003|69173366|FG001|Overall Study|Other|4|||
37696973|NCT02447003|69173365|FG000|Overall Study|Site discontinued|0|||
37696974|NCT02447003|69173366|FG001|Overall Study|Site discontinued|2|||
37696975|NCT02447003|69173365|FG000|Overall Study|Physician Decision|0|||
37827335|NCT01081795|69510137|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
37827336|NCT01081795|69510135|FG000|Overall Study|Using drug with restricted days of use|2|||
37827337|NCT01081795|69510136|FG001|Overall Study|Using drug with restricted days of use|3|||
37827338|NCT01081795|69510137|FG002|Overall Study|Using drug with restricted days of use|2|||
37827339|NCT01081795|69510135|FG000|Overall Study|Other|1|||
37827340|NCT01081795|69510136|FG001|Overall Study|Other|2|||
37827341|NCT01081795|69510137|FG002|Overall Study|Other|0|||
37827342|NCT01081678|69510149|FG000|Overall Study|Ineligibility Determined|0|||
37827343|NCT01081678|69510150|FG001|Overall Study|Ineligibility Determined|0|||
37827344|NCT01081678|69510151|FG002|Overall Study|Ineligibility Determined|1|||
37696976|NCT02447003|69173366|FG001|Overall Study|Physician Decision|1|||
37696977|NCT02447003|69173365|FG000|Overall Study|Withdrawal by Subject|4|||
37696978|NCT02447003|69173366|FG001|Overall Study|Withdrawal by Subject|3|||
37696979|NCT02447003|69173365|FG000|Overall Study|Sponsor Decision|6|||
37696980|NCT02447003|69173366|FG001|Overall Study|Sponsor Decision|11|||
37696981|NCT02447003|69173365|FG000|Overall Study|Progressive Disease|1|||
37696982|NCT02447003|69173366|FG001|Overall Study|Progressive Disease|0|||
37696983|NCT02447003|69173365|FG000|Overall Study|Lost to Follow-up|5|||
37696984|NCT02447003|69173366|FG001|Overall Study|Lost to Follow-up|0|||
37696985|NCT02447003|69173365|FG000|Overall Study|Death|154|||
37696986|NCT02447003|69173366|FG001|Overall Study|Death|63|||
37696987|NCT01844284|69173376|FG000|Overall Study|Lost to Follow-up|12|||
37827345|NCT01081678|69510152|FG003|Overall Study|Ineligibility Determined|1|||
37696988|NCT01844284|69173377|FG001|Overall Study|Lost to Follow-up|7|||
37696989|NCT02054715|69173385|FG000|Baseline/Follow-up 1|Refused|1|||
37696990|NCT02054715|69173386|FG001|Baseline/Follow-up 1|Refused|3|||
37696991|NCT02054715|69173385|FG000|Baseline/Follow-up 1|Medical|0|||
37696992|NCT02054715|69173386|FG001|Baseline/Follow-up 1|Medical|1|||
37696993|NCT02054715|69173385|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
37696994|NCT02054715|69173386|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
37696995|NCT02054715|69173385|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
37696996|NCT02054715|69173386|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
37696997|NCT02054715|69173385|FG000|Baseline/Follow-up 1|No Reason|0|||
37827346|NCT01081678|69510149|FG000|Overall Study|Noncompliance|3|||
37827347|NCT01081678|69510150|FG001|Overall Study|Noncompliance|4|||
37827348|NCT01081678|69510151|FG002|Overall Study|Noncompliance|5|||
37827349|NCT01081678|69510152|FG003|Overall Study|Noncompliance|2|||
37827350|NCT01081678|69510149|FG000|Overall Study|Adverse Event|2|||
37900847|NCT00688519|69586277|FG001|Overall Study|Subject moved out of state|0|||
37900848|NCT00688519|69586276|FG000|Overall Study|Investigator decision|1|||
37900849|NCT00688519|69586277|FG001|Overall Study|Investigator decision|0|||
37900850|NCT00688519|69586276|FG000|Overall Study|Subject moved out of area|1|||
37900851|NCT00688519|69586277|FG001|Overall Study|Subject moved out of area|0|||
37900852|NCT00688519|69586276|FG000|Overall Study|Pregnancy|0|||
37900853|NCT00688519|69586277|FG001|Overall Study|Pregnancy|1|||
37900854|NCT00721630|69586283|FG000|Overall Study|Participant found to be ineligible|1|||
37900855|NCT00686725|69586289|FG000|Overall Study|Adverse Event|1|||
37900856|NCT00686725|69586290|FG001|Overall Study|Adverse Event|1|||
37997109|NCT00312494|69681358|FG000|Overall Study|Withdrawal by Subject|6|||
37997110|NCT00312494|69681359|FG001|Overall Study|Withdrawal by Subject|9|||
37997111|NCT00312494|69681360|FG002|Overall Study|Withdrawal by Subject|10|||
37997112|NCT00312494|69681358|FG000|Overall Study|Other|10|||
37997113|NCT00312494|69681359|FG001|Overall Study|Other|10|||
37997114|NCT00312494|69681360|FG002|Overall Study|Other|1|||
37997115|NCT00312338|69681370|FG000|Overall Study|Adverse Event|7|||
37827351|NCT01081678|69510150|FG001|Overall Study|Adverse Event|1|||
37997116|NCT00312338|69681371|FG001|Overall Study|Adverse Event|2|||
37997117|NCT00312338|69681370|FG000|Overall Study|Lost to Follow-up|9|||
37997118|NCT00312338|69681371|FG001|Overall Study|Lost to Follow-up|1|||
37997119|NCT00312338|69681370|FG000|Overall Study|Withdrawal by Subject|4|||
37997120|NCT00312338|69681371|FG001|Overall Study|Withdrawal by Subject|0|||
37997121|NCT00312338|69681370|FG000|Overall Study|Subsequent infection|2|||
37997122|NCT00312338|69681371|FG001|Overall Study|Subsequent infection|0|||
37997123|NCT00290498|69681379|FG000|Overall Study|Death|2|||
37997124|NCT00290498|69681380|FG001|Overall Study|Death|0|||
37997125|NCT00290498|69681379|FG000|Overall Study|Physician Decision|1|||
37997126|NCT00290498|69681380|FG001|Overall Study|Physician Decision|0|||
37997127|NCT00290498|69681379|FG000|Overall Study|Withdrawal by Subject|1|||
37997128|NCT00290498|69681380|FG001|Overall Study|Withdrawal by Subject|0|||
37827352|NCT01081678|69510151|FG002|Overall Study|Adverse Event|2|||
37827353|NCT01081678|69510152|FG003|Overall Study|Adverse Event|2|||
37827354|NCT01081678|69510149|FG000|Overall Study|Withdrawal by Subject|15|||
37827355|NCT01081678|69510150|FG001|Overall Study|Withdrawal by Subject|7|||
37827356|NCT01081678|69510151|FG002|Overall Study|Withdrawal by Subject|17|||
37900857|NCT00686725|69586289|FG000|Overall Study|Progressive Disease|17|||
37900858|NCT00686725|69586290|FG001|Overall Study|Progressive Disease|23|||
37900859|NCT00686725|69586289|FG000|Overall Study|Lost to Follow-up|7|||
37900860|NCT00686725|69586290|FG001|Overall Study|Lost to Follow-up|5|||
37900861|NCT00686725|69586289|FG000|Overall Study|Death|6|||
37997129|NCT00290498|69681379|FG000|Overall Study|Ineligible|3|||
37997130|NCT00290498|69681380|FG001|Overall Study|Ineligible|0|||
37827357|NCT01081678|69510152|FG003|Overall Study|Withdrawal by Subject|14|||
37827358|NCT01081678|69510149|FG000|Overall Study|Administrative Decision|1|||
37827359|NCT01081678|69510150|FG001|Overall Study|Administrative Decision|0|||
37997131|NCT00290498|69681379|FG000|Overall Study|Non-Compliance|1|||
37997132|NCT00290498|69681380|FG001|Overall Study|Non-Compliance|0|||
37997133|NCT00451451|69681391|FG000|Overall Study|Adverse Event|11|||
37696998|NCT02054715|69173386|FG001|Baseline/Follow-up 1|No Reason|1|||
37827360|NCT01081678|69510151|FG002|Overall Study|Administrative Decision|0|||
37696999|NCT02054715|69173385|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
37900862|NCT00686725|69586290|FG001|Overall Study|Death|3|||
37997134|NCT00451451|69681392|FG001|Overall Study|Adverse Event|21|||
37997135|NCT00451451|69681393|FG002|Overall Study|Adverse Event|26|||
37997136|NCT00451451|69681394|FG003|Overall Study|Adverse Event|10|||
37900863|NCT00686725|69586289|FG000|Overall Study|Withdrawal by Subject|13|||
37900864|NCT00686725|69586290|FG001|Overall Study|Withdrawal by Subject|4|||
37900865|NCT00686725|69586289|FG000|Overall Study|Protocol Violation|1|||
37900866|NCT00686725|69586290|FG001|Overall Study|Protocol Violation|3|||
37900867|NCT00686725|69586289|FG000|Overall Study|Other|1|||
37900868|NCT00686725|69586290|FG001|Overall Study|Other|3|||
37900869|NCT00727402|69586296|FG000|Overall Study|Physician Decision|116|||
37900870|NCT00727246|69586304|FG000|Overall Study|could not complete MRI|0|||
37900871|NCT00727246|69586305|FG001|Overall Study|could not complete MRI|1|||
37900872|NCT00727246|69586306|FG002|Overall Study|could not complete MRI|0|||
37900873|NCT00727246|69586307|FG003|Overall Study|could not complete MRI|1|||
37900874|NCT00727246|69586304|FG000|Overall Study|incidental finding|0|||
37900875|NCT00727246|69586305|FG001|Overall Study|incidental finding|0|||
37900876|NCT00727246|69586306|FG002|Overall Study|incidental finding|0|||
37900877|NCT00727246|69586307|FG003|Overall Study|incidental finding|1|||
37900878|NCT00727246|69586304|FG000|Overall Study|withdrawn|0|||
37900879|NCT00727246|69586305|FG001|Overall Study|withdrawn|0|||
37900880|NCT00727246|69586306|FG002|Overall Study|withdrawn|1|||
37900881|NCT00727246|69586307|FG003|Overall Study|withdrawn|0|||
37900882|NCT00686647|69586317|FG000|Overall Study|Lost to Follow-up|1|||
37900883|NCT00686647|69586317|FG000|Overall Study|Death|1|||
37900884|NCT00687973|69586324|FG000|Overall Study|Adverse Event|18|||
37900885|NCT00687973|69586325|FG001|Overall Study|Adverse Event|28|||
37900886|NCT00687973|69586324|FG000|Overall Study|Lack of Efficacy|2|||
37900887|NCT00687973|69586325|FG001|Overall Study|Lack of Efficacy|3|||
37997137|NCT00451451|69681391|FG000|Overall Study|Lost to Follow-up|11|||
37997138|NCT00451451|69681392|FG001|Overall Study|Lost to Follow-up|9|||
37997139|NCT00451451|69681393|FG002|Overall Study|Lost to Follow-up|8|||
37997140|NCT00451451|69681394|FG003|Overall Study|Lost to Follow-up|11|||
37997141|NCT00451451|69681391|FG000|Overall Study|Consent Withdrawn|14|||
37997142|NCT00451451|69681392|FG001|Overall Study|Consent Withdrawn|9|||
37997143|NCT00451451|69681393|FG002|Overall Study|Consent Withdrawn|17|||
37997144|NCT00451451|69681394|FG003|Overall Study|Consent Withdrawn|17|||
37997145|NCT00451451|69681391|FG000|Overall Study|Investigator Decision|6|||
37997146|NCT00451451|69681392|FG001|Overall Study|Investigator Decision|2|||
37997147|NCT00451451|69681393|FG002|Overall Study|Investigator Decision|1|||
37997148|NCT00451451|69681394|FG003|Overall Study|Investigator Decision|2|||
37997149|NCT00451451|69681391|FG000|Overall Study|Subject Non-Compliance|8|||
37997150|NCT00451451|69681392|FG001|Overall Study|Subject Non-Compliance|4|||
37827361|NCT01081678|69510152|FG003|Overall Study|Administrative Decision|1|||
37827362|NCT01081678|69510149|FG000|Overall Study|Lost to Follow-up|4|||
37827363|NCT01081678|69510150|FG001|Overall Study|Lost to Follow-up|1|||
37827364|NCT01081678|69510151|FG002|Overall Study|Lost to Follow-up|4|||
37827365|NCT01081678|69510152|FG003|Overall Study|Lost to Follow-up|3|||
37827366|NCT01081678|69510149|FG000|Overall Study|Death|2|||
37827367|NCT01081678|69510150|FG001|Overall Study|Death|2|||
37827368|NCT01081678|69510151|FG002|Overall Study|Death|2|||
37827369|NCT01081678|69510152|FG003|Overall Study|Death|6|||
37827370|NCT01081678|69510149|FG000|Overall Study|Other|0|||
37827371|NCT01081678|69510150|FG001|Overall Study|Other|1|||
37900888|NCT00687973|69586324|FG000|Overall Study|Protocol Violation|1|||
37900889|NCT00687973|69586325|FG001|Overall Study|Protocol Violation|2|||
37900890|NCT00687973|69586324|FG000|Overall Study|Administrative Reasons|0|||
37900891|NCT00687973|69586325|FG001|Overall Study|Administrative Reasons|2|||
37900892|NCT00687973|69586324|FG000|Overall Study|Withdrawal by Subject|3|||
37900893|NCT00687973|69586325|FG001|Overall Study|Withdrawal by Subject|3|||
37900894|NCT00721396|69586336|FG000|Overall Study|Adverse Event|4|||
37900895|NCT00721396|69586337|FG001|Overall Study|Adverse Event|7|||
37900896|NCT00721396|69586338|FG002|Overall Study|Adverse Event|2|||
37900897|NCT00721396|69586339|FG003|Overall Study|Adverse Event|0|||
37900898|NCT00721396|69586336|FG000|Overall Study|Withdrawal by Subject|12|||
37900899|NCT00721396|69586337|FG001|Overall Study|Withdrawal by Subject|15|||
37900900|NCT00721396|69586338|FG002|Overall Study|Withdrawal by Subject|3|||
37900901|NCT00721396|69586339|FG003|Overall Study|Withdrawal by Subject|7|||
37900902|NCT00721396|69586336|FG000|Overall Study|Lost to Follow-up|7|||
37900903|NCT00721396|69586337|FG001|Overall Study|Lost to Follow-up|9|||
37900904|NCT00721396|69586338|FG002|Overall Study|Lost to Follow-up|3|||
37900905|NCT00721396|69586339|FG003|Overall Study|Lost to Follow-up|3|||
37900906|NCT00721396|69586336|FG000|Overall Study|Protocol Violation|4|||
37997151|NCT00451451|69681393|FG002|Overall Study|Subject Non-Compliance|3|||
37997152|NCT00451451|69681394|FG003|Overall Study|Subject Non-Compliance|3|||
37900907|NCT00721396|69586337|FG001|Overall Study|Protocol Violation|3|||
37900908|NCT00721396|69586338|FG002|Overall Study|Protocol Violation|1|||
37900909|NCT00721396|69586339|FG003|Overall Study|Protocol Violation|0|||
37900910|NCT00721396|69586336|FG000|Overall Study|Inappropriate enrollment|0|||
37900911|NCT00721396|69586337|FG001|Overall Study|Inappropriate enrollment|2|||
37900912|NCT00721396|69586338|FG002|Overall Study|Inappropriate enrollment|0|||
37900913|NCT00721396|69586339|FG003|Overall Study|Inappropriate enrollment|0|||
37900914|NCT00721396|69586336|FG000|Overall Study|Administrative reason|3|||
37900915|NCT00721396|69586337|FG001|Overall Study|Administrative reason|0|||
37900916|NCT00721396|69586338|FG002|Overall Study|Administrative reason|1|||
37900917|NCT00721396|69586339|FG003|Overall Study|Administrative reason|0|||
37900918|NCT00943826|69586356|FG000|Concurrent Phase|Adverse Event|50|||
37900919|NCT00943826|69586357|FG001|Concurrent Phase|Adverse Event|27|||
37900920|NCT00943826|69586356|FG000|Concurrent Phase|Withdrew consent|3|||
37900921|NCT00943826|69586357|FG001|Concurrent Phase|Withdrew consent|7|||
37900922|NCT00943826|69586356|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
37900923|NCT00943826|69586357|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
37900924|NCT00943826|69586356|FG000|Concurrent Phase|Administrative reasons|2|||
37900925|NCT00943826|69586357|FG001|Concurrent Phase|Administrative reasons|1|||
37900926|NCT00943826|69586356|FG000|Concurrent Phase|Protocol Violation|1|||
37900927|NCT00943826|69586357|FG001|Concurrent Phase|Protocol Violation|0|||
37900928|NCT00943826|69586356|FG000|Maintenance Phase|Adverse Event|31|||
37900929|NCT00943826|69586357|FG001|Maintenance Phase|Adverse Event|30|||
37900930|NCT00943826|69586356|FG000|Maintenance Phase|Withdrew consent|2|||
37997153|NCT00451451|69681391|FG000|Overall Study|Death|1|||
37997154|NCT00451451|69681392|FG001|Overall Study|Death|0|||
37997155|NCT00451451|69681393|FG002|Overall Study|Death|0|||
37997156|NCT00451451|69681394|FG003|Overall Study|Death|1|||
37997157|NCT00451451|69681391|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
37827372|NCT01081678|69510151|FG002|Overall Study|Other|0|||
37827373|NCT01081678|69510152|FG003|Overall Study|Other|0|||
37827374|NCT01081249|69510162|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
37827375|NCT01081249|69510163|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
37827376|NCT01081132|69510171|FG000|Overall Study|Lack of Efficacy|25|||
37827377|NCT01081132|69510172|FG001|Overall Study|Lack of Efficacy|9|||
37827378|NCT01081132|69510171|FG000|Overall Study|Withdrawal by Subject|13|||
37827379|NCT01081132|69510172|FG001|Overall Study|Withdrawal by Subject|16|||
37827380|NCT01081132|69510171|FG000|Overall Study|Lost to Follow-up|4|||
37827381|NCT01081132|69510172|FG001|Overall Study|Lost to Follow-up|11|||
37827382|NCT01081132|69510171|FG000|Overall Study|Adverse Event|3|||
37827383|NCT01081132|69510172|FG001|Overall Study|Adverse Event|9|||
37827384|NCT01081132|69510171|FG000|Overall Study|Non Compliance|4|||
37827385|NCT01081132|69510172|FG001|Overall Study|Non Compliance|2|||
37827386|NCT01081132|69510171|FG000|Overall Study|Lack Of Compliance|0|||
37827387|NCT01081132|69510172|FG001|Overall Study|Lack Of Compliance|1|||
37827388|NCT01081132|69510171|FG000|Overall Study|Missed Visits|1|||
37827389|NCT01081132|69510172|FG001|Overall Study|Missed Visits|1|||
37827390|NCT01081132|69510171|FG000|Overall Study|Stopped Taking Meds|2|||
37827391|NCT01081132|69510172|FG001|Overall Study|Stopped Taking Meds|0|||
37827392|NCT01081132|69510171|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
37827393|NCT01081132|69510172|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
37827394|NCT01081132|69510171|FG000|Overall Study|Declined Taper Phase|0|||
37827395|NCT01081132|69510172|FG001|Overall Study|Declined Taper Phase|1|||
37827396|NCT01081132|69510171|FG000|Overall Study|Protocol Violation|3|||
37827397|NCT01081132|69510172|FG001|Overall Study|Protocol Violation|1|||
37827398|NCT01080625|69510181|FG000|Overall Study|Physician Decision|0|||
37827399|NCT01080625|69510182|FG001|Overall Study|Physician Decision|2|||
37827400|NCT01080625|69510183|FG002|Overall Study|Physician Decision|1|||
37827401|NCT01059903|69510193|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
37827402|NCT01059903|69510194|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
37827403|NCT00199888|69510250|FG000|Overall Study|Lost to Follow-up|1|||
37827404|NCT00199849|69510257|FG000|Overall Study|Unrelated illness or complication|0|||
37827405|NCT00199849|69510258|FG001|Overall Study|Unrelated illness or complication|1|||
37827406|NCT00199849|69510259|FG002|Overall Study|Unrelated illness or complication|0|||
37827407|NCT00199849|69510257|FG000|Overall Study|Progressive disease requiring intervention|0|||
37827408|NCT00199849|69510258|FG001|Overall Study|Progressive disease requiring intervention|0|||
37900931|NCT00943826|69586357|FG001|Maintenance Phase|Withdrew consent|4|||
37900932|NCT00943826|69586356|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
37900933|NCT00943826|69586357|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
37900934|NCT00943826|69586356|FG000|Maintenance Phase|Administrative reasons|4|||
37900935|NCT00943826|69586357|FG001|Maintenance Phase|Administrative reasons|1|||
37900936|NCT00943826|69586356|FG000|Maintenance Phase|Failure to return|0|||
37900937|NCT00943826|69586357|FG001|Maintenance Phase|Failure to return|1|||
37827409|NCT00199849|69510259|FG002|Overall Study|Progressive disease requiring intervention|1|||
37827410|NCT00199849|69510257|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
37997158|NCT00451451|69681392|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
37997159|NCT00451451|69681393|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
37997160|NCT00451451|69681394|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
37997161|NCT03824912|69681409|FG000|Overall Study|Lost to Follow-up|18|||
37997162|NCT03824912|69681410|FG001|Overall Study|Lost to Follow-up|15|||
37997163|NCT03824912|69681411|FG002|Overall Study|Lost to Follow-up|8|||
37997164|NCT03824912|69681409|FG000|Overall Study|Negative Baseline Culture Result|118|||
37997165|NCT03824912|69681410|FG001|Overall Study|Negative Baseline Culture Result|112|||
37997166|NCT03824912|69681411|FG002|Overall Study|Negative Baseline Culture Result|57|||
37997167|NCT03824912|69681409|FG000|Overall Study|Non-Compliance with Study Drug|0|||
37997168|NCT03824912|69681410|FG001|Overall Study|Non-Compliance with Study Drug|0|||
37997169|NCT03824912|69681411|FG002|Overall Study|Non-Compliance with Study Drug|1|||
37900938|NCT00943826|69586356|FG000|Monotherapy Phase|Adverse Event|42|||
37900939|NCT00943826|69586357|FG001|Monotherapy Phase|Adverse Event|5|||
37900940|NCT00943826|69586356|FG000|Monotherapy Phase|Administrative reasons|11|||
37900941|NCT00943826|69586357|FG001|Monotherapy Phase|Administrative reasons|5|||
37900942|NCT00943826|69586356|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
37900943|NCT00943826|69586357|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
37900944|NCT00943826|69586356|FG000|Monotherapy Phase|Withdrew Consent|2|||
37900945|NCT00943826|69586357|FG001|Monotherapy Phase|Withdrew Consent|3|||
37900946|NCT00943826|69586356|FG000|Monotherapy Phase|Failure to return|2|||
37900947|NCT00943826|69586357|FG001|Monotherapy Phase|Failure to return|1|||
37900948|NCT00943826|69586356|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
37900949|NCT00943826|69586357|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
37900950|NCT00943826|69586356|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
37900951|NCT00943826|69586357|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
37900952|NCT00943826|69586356|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
37900953|NCT00943826|69586357|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
37900954|NCT00943826|69586356|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
37900955|NCT00943826|69586357|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
37900956|NCT01004003|69586373|FG000|Overall Study|Progressive disease|2|||
37900957|NCT01004003|69586374|FG001|Overall Study|Progressive disease|1|||
37900958|NCT01004003|69586375|FG002|Overall Study|Progressive disease|1|||
37900959|NCT01004003|69586376|FG003|Overall Study|Progressive disease|0|||
37900960|NCT01004003|69586377|FG004|Overall Study|Progressive disease|2|||
37900961|NCT01004003|69586378|FG005|Overall Study|Progressive disease|1|||
37900962|NCT01004003|69586379|FG006|Overall Study|Progressive disease|1|||
37900963|NCT01004003|69586380|FG007|Overall Study|Progressive disease|39|||
37900964|NCT01004003|69586381|FG008|Overall Study|Progressive disease|22|||
37900965|NCT01004003|69586373|FG000|Overall Study|Adverse Event|4|||
37900966|NCT01004003|69586374|FG001|Overall Study|Adverse Event|2|||
37900967|NCT01004003|69586375|FG002|Overall Study|Adverse Event|3|||
37900968|NCT01004003|69586376|FG003|Overall Study|Adverse Event|3|||
37900969|NCT01004003|69586377|FG004|Overall Study|Adverse Event|2|||
37997170|NCT03824912|69681409|FG000|Overall Study|Protocol Violation|1|||
37997171|NCT03824912|69681410|FG001|Overall Study|Protocol Violation|4|||
37997172|NCT03824912|69681411|FG002|Overall Study|Protocol Violation|1|||
37997173|NCT03824912|69681409|FG000|Overall Study|Withdrawal by Subject|3|||
37900970|NCT01004003|69586378|FG005|Overall Study|Adverse Event|2|||
37900971|NCT01004003|69586379|FG006|Overall Study|Adverse Event|7|||
37900972|NCT01004003|69586380|FG007|Overall Study|Adverse Event|21|||
37900973|NCT01004003|69586381|FG008|Overall Study|Adverse Event|6|||
37900974|NCT01004003|69586373|FG000|Overall Study|Refused to continue taking trial med.|0|||
37900975|NCT01004003|69586374|FG001|Overall Study|Refused to continue taking trial med.|0|||
37900976|NCT01004003|69586375|FG002|Overall Study|Refused to continue taking trial med.|0|||
37900977|NCT01004003|69586376|FG003|Overall Study|Refused to continue taking trial med.|0|||
37900978|NCT01004003|69586377|FG004|Overall Study|Refused to continue taking trial med.|0|||
37900979|NCT01004003|69586378|FG005|Overall Study|Refused to continue taking trial med.|0|||
37900980|NCT01004003|69586379|FG006|Overall Study|Refused to continue taking trial med.|0|||
37900981|NCT01004003|69586380|FG007|Overall Study|Refused to continue taking trial med.|0|||
37900982|NCT01004003|69586381|FG008|Overall Study|Refused to continue taking trial med.|2|||
37900983|NCT01004003|69586373|FG000|Overall Study|Other|0|||
37900984|NCT01004003|69586374|FG001|Overall Study|Other|0|||
37900985|NCT01004003|69586375|FG002|Overall Study|Other|0|||
37900986|NCT01004003|69586376|FG003|Overall Study|Other|0|||
37900987|NCT01004003|69586377|FG004|Overall Study|Other|0|||
37900988|NCT01004003|69586378|FG005|Overall Study|Other|1|||
37900989|NCT01004003|69586379|FG006|Overall Study|Other|0|||
37900990|NCT01004003|69586380|FG007|Overall Study|Other|0|||
37900991|NCT01004003|69586381|FG008|Overall Study|Other|0|||
37997174|NCT03824912|69681410|FG001|Overall Study|Withdrawal by Subject|2|||
37997175|NCT03824912|69681411|FG002|Overall Study|Withdrawal by Subject|1|||
37997176|NCT03824912|69681409|FG000|Overall Study|Participation in another study|0|||
37997177|NCT03824912|69681410|FG001|Overall Study|Participation in another study|1|||
37997178|NCT03824912|69681411|FG002|Overall Study|Participation in another study|0|||
37997179|NCT00461123|69681421|FG000|Overall Study|Adverse Event|1|||
37997180|NCT00461123|69681422|FG001|Overall Study|Adverse Event|0|||
37997181|NCT00461123|69681421|FG000|Overall Study|Lost to Follow-up|1|||
37997182|NCT00461123|69681422|FG001|Overall Study|Lost to Follow-up|1|||
37997183|NCT00461123|69681421|FG000|Overall Study|Protocol Violation|3|||
37997184|NCT00461123|69681422|FG001|Overall Study|Protocol Violation|2|||
37997185|NCT00461123|69681421|FG000|Overall Study|Withdrawal by Subject|1|||
37997186|NCT00461123|69681422|FG001|Overall Study|Withdrawal by Subject|3|||
37997187|NCT00290342|69681430|FG000|Overall Study|Other|0|||
37997188|NCT00290342|69681431|FG001|Overall Study|Other|1|||
37997189|NCT00290342|69681430|FG000|Overall Study|Withdrawal by Subject|6|||
37997190|NCT00290342|69681431|FG001|Overall Study|Withdrawal by Subject|4|||
37900992|NCT00943670|69586403|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
37900993|NCT00943670|69586403|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
37900994|NCT00943670|69586403|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
37900995|NCT00943670|69586403|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
37900996|NCT00943670|69586403|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
37900997|NCT00943670|69586403|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
37900998|NCT00943670|69586403|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
37900999|NCT00943670|69586403|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
37901000|NCT00943670|69586403|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
37901001|NCT00943670|69586403|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
37901002|NCT00938366|69586420|FG000|Overall Study|Withdrawal by Subject|1|||
37901003|NCT00938366|69586421|FG001|Overall Study|Withdrawal by Subject|0|||
37901004|NCT00943592|69586427|FG000|Overall Study|Death|3|||
37827411|NCT00199849|69510258|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
37997191|NCT00290342|69681430|FG000|Overall Study|Lost to Follow-up|1|||
37997192|NCT00290342|69681431|FG001|Overall Study|Lost to Follow-up|0|||
37997193|NCT00460811|69681442|FG000|Overall Study|Adverse Event|4|||
37997194|NCT00460811|69681443|FG001|Overall Study|Adverse Event|6|||
37997195|NCT00460811|69681444|FG002|Overall Study|Adverse Event|3|||
37997196|NCT00460811|69681445|FG003|Overall Study|Adverse Event|10|||
37997197|NCT00460811|69681446|FG004|Overall Study|Adverse Event|2|||
37997198|NCT00460811|69681442|FG000|Overall Study|Noncompliance|1|||
37997199|NCT00460811|69681443|FG001|Overall Study|Noncompliance|0|||
37997200|NCT00460811|69681444|FG002|Overall Study|Noncompliance|0|||
37997201|NCT00460811|69681445|FG003|Overall Study|Noncompliance|2|||
37997202|NCT00460811|69681446|FG004|Overall Study|Noncompliance|1|||
37901005|NCT00943124|69586431|FG000|Period 1|Withdrawal by Subject|1|||
37901006|NCT00943124|69586432|FG001|Period 1|Withdrawal by Subject|1|||
37901007|NCT00943124|69586431|FG000|Period 1|Did Not Follow Study Procedures|1|||
37901008|NCT00943124|69586432|FG001|Period 1|Did Not Follow Study Procedures|0|||
37997203|NCT00460811|69681442|FG000|Overall Study|Withdrawal by Subject|7|||
37997204|NCT00460811|69681443|FG001|Overall Study|Withdrawal by Subject|7|||
37997205|NCT00460811|69681444|FG002|Overall Study|Withdrawal by Subject|6|||
37827412|NCT00199849|69510259|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
37827413|NCT00199381|69510267|FG000|Overall Study|Withdrawal by Subject|38|||
37827414|NCT00199381|69510267|FG000|Overall Study|Adverse Event|73|||
37827415|NCT00199381|69510267|FG000|Overall Study|Protocol Violation|6|||
37827416|NCT00199381|69510267|FG000|Overall Study|Lack of Efficacy|27|||
37827417|NCT00199381|69510267|FG000|Overall Study|Not including due to early termination|37|||
37827418|NCT00199381|69510267|FG000|Overall Study|Study termination by Sponsor|323|||
37827419|NCT00198133|69510273|FG000|Overall Study|Disease progression|2|||
37827420|NCT00198133|69510274|FG001|Overall Study|Disease progression|5|||
37827421|NCT00198133|69510273|FG000|Overall Study|Adverse Event|1|||
37827422|NCT00198133|69510274|FG001|Overall Study|Adverse Event|3|||
37901009|NCT00943124|69586431|FG000|Period 1|Personal Reasons|0|||
37901010|NCT00943124|69586432|FG001|Period 1|Personal Reasons|1|||
37901011|NCT00726622|69586440|FG000|Overall Study|Withdrawal by Subject|16|||
37901012|NCT00726622|69586441|FG001|Overall Study|Withdrawal by Subject|2|||
37901013|NCT00726622|69586440|FG000|Overall Study|Physician Decision|0|||
37997206|NCT00460811|69681445|FG003|Overall Study|Withdrawal by Subject|3|||
37997207|NCT00460811|69681446|FG004|Overall Study|Withdrawal by Subject|11|||
37997208|NCT00460811|69681442|FG000|Overall Study|Physician Decision|1|||
37997209|NCT00460811|69681443|FG001|Overall Study|Physician Decision|0|||
37827423|NCT00198133|69510273|FG000|Overall Study|Withdrawal by Subject|1|||
37827424|NCT00198133|69510274|FG001|Overall Study|Withdrawal by Subject|0|||
37901014|NCT00726622|69586441|FG001|Overall Study|Physician Decision|1|||
37901015|NCT00726622|69586440|FG000|Overall Study|Metastasis|2|||
37901016|NCT00726622|69586441|FG001|Overall Study|Metastasis|0|||
37901017|NCT00940316|69586450|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
37901018|NCT00940316|69586451|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
37901019|NCT00940316|69586452|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
37901020|NCT00940316|69586450|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
37901021|NCT00940316|69586451|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
37901022|NCT00940316|69586452|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
37901023|NCT00940316|69586450|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
37901024|NCT00940316|69586451|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
37901025|NCT00940316|69586452|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
37901026|NCT00940316|69586450|FG000|Treated After Cycle 5|Adverse Event|0|||
37901027|NCT00940316|69586451|FG001|Treated After Cycle 5|Adverse Event|0|||
37901028|NCT00940316|69586452|FG002|Treated After Cycle 5|Adverse Event|1|||
37901029|NCT00940316|69586450|FG000|Treated After Cycle 5|Progressive disease|0|||
37901030|NCT00940316|69586451|FG001|Treated After Cycle 5|Progressive disease|1|||
37901031|NCT00940316|69586452|FG002|Treated After Cycle 5|Progressive disease|0|||
37901032|NCT00726388|69586468|FG000|Overall Study|Withdrawal by Subject|5|||
37901033|NCT00726388|69586468|FG000|Overall Study|Adverse Event|3|||
37901034|NCT00726388|69586468|FG000|Overall Study|Lost to Follow-up|10|||
37901035|NCT00726388|69586468|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
37901036|NCT00726388|69586468|FG000|Overall Study|Other|5|||
37901037|NCT00726388|69586468|FG000|Overall Study|Enrolled, Not Treated|79|||
37901038|NCT00572455|69586486|FG000|Stage I (14 Days)|Adverse Event|0|||
37901039|NCT00572455|69586487|FG001|Stage I (14 Days)|Adverse Event|0|||
37997210|NCT00460811|69681444|FG002|Overall Study|Physician Decision|0|||
37827425|NCT00198133|69510273|FG000|Overall Study|Physician Decision|1|||
37827426|NCT00198133|69510274|FG001|Overall Study|Physician Decision|0|||
37827427|NCT00197236|69510283|FG000|Overall Study|Adverse Event|1|||
37827428|NCT00197236|69510284|FG001|Overall Study|Adverse Event|0|||
37827429|NCT00197236|69510285|FG002|Overall Study|Adverse Event|1|||
37827430|NCT00197236|69510283|FG000|Overall Study|Lost to Follow-up|5|||
37827431|NCT00197236|69510284|FG001|Overall Study|Lost to Follow-up|14|||
37827432|NCT00197236|69510285|FG002|Overall Study|Lost to Follow-up|6|||
37827433|NCT00197236|69510283|FG000|Overall Study|Protocol Violation|0|||
37827434|NCT00197236|69510284|FG001|Overall Study|Protocol Violation|0|||
37827435|NCT00197236|69510285|FG002|Overall Study|Protocol Violation|1|||
37827436|NCT00197236|69510283|FG000|Overall Study|Withdrawal by Subject|7|||
37827437|NCT00197236|69510284|FG001|Overall Study|Withdrawal by Subject|3|||
37827438|NCT00197236|69510285|FG002|Overall Study|Withdrawal by Subject|11|||
37827439|NCT00197236|69510283|FG000|Overall Study|Study drug/medication expiration|1|||
37827440|NCT00197236|69510284|FG001|Overall Study|Study drug/medication expiration|0|||
37827441|NCT00197236|69510285|FG002|Overall Study|Study drug/medication expiration|3|||
37827442|NCT00197236|69510283|FG000|Overall Study|Returned out of specified time window|0|||
37827443|NCT00197236|69510284|FG001|Overall Study|Returned out of specified time window|0|||
37827444|NCT00197236|69510285|FG002|Overall Study|Returned out of specified time window|1|||
37827445|NCT00197002|69510299|FG000|Overall Study|Adverse Event|0|||
37827446|NCT00197002|69510300|FG001|Overall Study|Adverse Event|1|||
37827447|NCT00197002|69510301|FG002|Overall Study|Adverse Event|0|||
37827448|NCT00197002|69510299|FG000|Overall Study|Protocol Violation|1|||
37827449|NCT00197002|69510300|FG001|Overall Study|Protocol Violation|0|||
37827450|NCT00197002|69510301|FG002|Overall Study|Protocol Violation|2|||
37827451|NCT00197002|69510299|FG000|Overall Study|Withdrawal by Subject|9|||
37901040|NCT00572455|69586488|FG002|Stage I (14 Days)|Adverse Event|0|||
37901041|NCT00572455|69586489|FG003|Stage I (14 Days)|Adverse Event|0|||
37901042|NCT00572455|69586490|FG004|Stage I (14 Days)|Adverse Event|0|||
37901043|NCT00572455|69586491|FG005|Stage I (14 Days)|Adverse Event|3|||
37901044|NCT00572455|69586492|FG006|Stage I (14 Days)|Adverse Event|0|||
37901045|NCT00572455|69586493|FG007|Stage I (14 Days)|Adverse Event|0|||
37901046|NCT00572455|69586494|FG008|Stage I (14 Days)|Adverse Event|0|||
37901047|NCT00572455|69586495|FG009|Stage I (14 Days)|Adverse Event|0|||
37901048|NCT00572455|69586496|FG010|Stage I (14 Days)|Adverse Event|0|||
37901049|NCT00572455|69586497|FG011|Stage I (14 Days)|Adverse Event|0|||
37901050|NCT00572455|69586498|FG012|Stage I (14 Days)|Adverse Event|0|||
37901051|NCT00572455|69586499|FG013|Stage I (14 Days)|Adverse Event|0|||
37901052|NCT00572455|69586486|FG000|Stage I (14 Days)|Other|0|||
37901053|NCT00572455|69586487|FG001|Stage I (14 Days)|Other|0|||
37901054|NCT00572455|69586488|FG002|Stage I (14 Days)|Other|0|||
37901055|NCT00572455|69586489|FG003|Stage I (14 Days)|Other|0|||
37901056|NCT00572455|69586490|FG004|Stage I (14 Days)|Other|1|||
37901057|NCT00572455|69586491|FG005|Stage I (14 Days)|Other|0|||
37901058|NCT00572455|69586492|FG006|Stage I (14 Days)|Other|0|||
37901059|NCT00572455|69586493|FG007|Stage I (14 Days)|Other|0|||
37901060|NCT00572455|69586494|FG008|Stage I (14 Days)|Other|0|||
37901061|NCT00572455|69586495|FG009|Stage I (14 Days)|Other|0|||
37901062|NCT00572455|69586496|FG010|Stage I (14 Days)|Other|0|||
37901063|NCT00572455|69586497|FG011|Stage I (14 Days)|Other|0|||
37901064|NCT00572455|69586498|FG012|Stage I (14 Days)|Other|0|||
37901065|NCT00572455|69586499|FG013|Stage I (14 Days)|Other|0|||
37901066|NCT00572455|69586486|FG000|Stage II (28 Days)|Adverse Event|0|||
37901067|NCT00572455|69586487|FG001|Stage II (28 Days)|Adverse Event|0|||
37901068|NCT00572455|69586488|FG002|Stage II (28 Days)|Adverse Event|0|||
37901069|NCT00572455|69586489|FG003|Stage II (28 Days)|Adverse Event|0|||
37901070|NCT00572455|69586490|FG004|Stage II (28 Days)|Adverse Event|0|||
37901071|NCT00572455|69586491|FG005|Stage II (28 Days)|Adverse Event|0|||
37901072|NCT00572455|69586492|FG006|Stage II (28 Days)|Adverse Event|0|||
37901073|NCT00572455|69586493|FG007|Stage II (28 Days)|Adverse Event|0|||
37901074|NCT00572455|69586494|FG008|Stage II (28 Days)|Adverse Event|1|||
37901075|NCT00572455|69586495|FG009|Stage II (28 Days)|Adverse Event|3|||
37901076|NCT00572455|69586496|FG010|Stage II (28 Days)|Adverse Event|3|||
37901077|NCT00572455|69586497|FG011|Stage II (28 Days)|Adverse Event|4|||
37901078|NCT00572455|69586498|FG012|Stage II (28 Days)|Adverse Event|5|||
37901079|NCT00572455|69586499|FG013|Stage II (28 Days)|Adverse Event|1|||
37901080|NCT00572455|69586486|FG000|Stage II (28 Days)|Death|0|||
37901081|NCT00572455|69586487|FG001|Stage II (28 Days)|Death|0|||
37901082|NCT00572455|69586488|FG002|Stage II (28 Days)|Death|0|||
37901083|NCT00572455|69586489|FG003|Stage II (28 Days)|Death|0|||
37901084|NCT00572455|69586490|FG004|Stage II (28 Days)|Death|0|||
37901085|NCT00572455|69586491|FG005|Stage II (28 Days)|Death|0|||
37901086|NCT00572455|69586492|FG006|Stage II (28 Days)|Death|0|||
37901087|NCT00572455|69586493|FG007|Stage II (28 Days)|Death|0|||
37901088|NCT00572455|69586494|FG008|Stage II (28 Days)|Death|1|||
37901089|NCT00572455|69586495|FG009|Stage II (28 Days)|Death|0|||
37901090|NCT00572455|69586496|FG010|Stage II (28 Days)|Death|0|||
37901091|NCT00572455|69586497|FG011|Stage II (28 Days)|Death|0|||
37901092|NCT00572455|69586498|FG012|Stage II (28 Days)|Death|0|||
37901093|NCT00572455|69586499|FG013|Stage II (28 Days)|Death|0|||
37901094|NCT00572455|69586486|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
37901095|NCT00572455|69586487|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
37901096|NCT00572455|69586488|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
37901097|NCT00572455|69586489|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
37901098|NCT00572455|69586490|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
37901099|NCT00572455|69586491|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
37901100|NCT00572455|69586492|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
37901101|NCT00572455|69586493|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
37901102|NCT00572455|69586494|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
37901103|NCT00572455|69586495|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
37901104|NCT00572455|69586496|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
37901105|NCT00572455|69586497|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
37901106|NCT00572455|69586498|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
37901107|NCT00572455|69586499|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
37901108|NCT00572455|69586486|FG000|Stage II (28 Days)|Other|0|||
37901109|NCT00572455|69586487|FG001|Stage II (28 Days)|Other|0|||
37901110|NCT00572455|69586488|FG002|Stage II (28 Days)|Other|0|||
37901111|NCT00572455|69586489|FG003|Stage II (28 Days)|Other|0|||
37901112|NCT00572455|69586490|FG004|Stage II (28 Days)|Other|0|||
37901113|NCT00572455|69586491|FG005|Stage II (28 Days)|Other|0|||
37901114|NCT00572455|69586492|FG006|Stage II (28 Days)|Other|0|||
37901115|NCT00572455|69586493|FG007|Stage II (28 Days)|Other|0|||
37901116|NCT00572455|69586494|FG008|Stage II (28 Days)|Other|1|||
37901117|NCT00572455|69586495|FG009|Stage II (28 Days)|Other|0|||
37901118|NCT00572455|69586496|FG010|Stage II (28 Days)|Other|0|||
37901119|NCT00572455|69586497|FG011|Stage II (28 Days)|Other|0|||
37901120|NCT00572455|69586498|FG012|Stage II (28 Days)|Other|0|||
37901121|NCT00572455|69586499|FG013|Stage II (28 Days)|Other|0|||
37901122|NCT00572455|69586486|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
37901123|NCT00572455|69586487|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
37901124|NCT00572455|69586488|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
37901125|NCT00572455|69586489|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
37901126|NCT00572455|69586490|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
37901127|NCT00572455|69586491|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
37901128|NCT00572455|69586492|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
37901129|NCT00572455|69586493|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
37901130|NCT00572455|69586494|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
37901131|NCT00572455|69586495|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
37901132|NCT00572455|69586496|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
37901133|NCT00572455|69586497|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
37901134|NCT00572455|69586498|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
37901135|NCT00572455|69586499|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
37901136|NCT01003691|69586533|FG000|Overall Study|Adverse Event|0|||
37901137|NCT01003691|69586534|FG001|Overall Study|Adverse Event|0|||
37901138|NCT01003691|69586535|FG002|Overall Study|Adverse Event|0|||
37901139|NCT01003691|69586536|FG003|Overall Study|Adverse Event|1|||
37901140|NCT00686335|69586547|FG000|Run-in Period|Adverse Event|1|||
37901141|NCT00686335|69586547|FG000|Run-in Period|asthma exacerbation|1|||
37901142|NCT00686335|69586547|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
37901143|NCT01002989|69586553|FG000|Overall Study|exclusion criteria, no consent|5|||
37901144|NCT00685945|69586557|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
37901145|NCT01007123|69586571|FG000|Overall Study|Adverse Event|3|||
37901146|NCT01007123|69586572|FG001|Overall Study|Adverse Event|4|||
37901147|NCT01007123|69586573|FG002|Overall Study|Adverse Event|7|||
37697000|NCT02054715|69173386|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
37901148|NCT01007123|69586574|FG003|Overall Study|Adverse Event|1|||
37901149|NCT01007123|69586571|FG000|Overall Study|Lack of Efficacy|1|||
37901150|NCT01007123|69586572|FG001|Overall Study|Lack of Efficacy|0|||
37901151|NCT01007123|69586573|FG002|Overall Study|Lack of Efficacy|1|||
37901152|NCT01007123|69586574|FG003|Overall Study|Lack of Efficacy|4|||
37901153|NCT01007123|69586571|FG000|Overall Study|Protocol Violation|1|||
37901154|NCT01007123|69586572|FG001|Overall Study|Protocol Violation|1|||
37901155|NCT01007123|69586573|FG002|Overall Study|Protocol Violation|2|||
37901156|NCT01007123|69586574|FG003|Overall Study|Protocol Violation|1|||
37901157|NCT01007123|69586571|FG000|Overall Study|Withdrawal by Subject|1|||
37901158|NCT01007123|69586572|FG001|Overall Study|Withdrawal by Subject|0|||
37901159|NCT01007123|69586573|FG002|Overall Study|Withdrawal by Subject|1|||
37901160|NCT01007123|69586574|FG003|Overall Study|Withdrawal by Subject|0|||
37901161|NCT01007123|69586571|FG000|Overall Study|Lost to Follow-up|0|||
37901162|NCT01007123|69586572|FG001|Overall Study|Lost to Follow-up|1|||
37901163|NCT01007123|69586573|FG002|Overall Study|Lost to Follow-up|0|||
37901164|NCT01007123|69586574|FG003|Overall Study|Lost to Follow-up|0|||
37901165|NCT00687739|69586589|FG000|Overall Study|Lost to Follow-up|2|||
37901166|NCT00687739|69586590|FG001|Overall Study|Lost to Follow-up|2|||
37901167|NCT00687739|69586591|FG002|Overall Study|Lost to Follow-up|1|||
37697001|NCT02054715|69173385|FG000|Baseline/Follow-up 1|Ineligible|3|||
37901168|NCT00687739|69586592|FG003|Overall Study|Lost to Follow-up|2|||
37901169|NCT00687739|69586589|FG000|Overall Study|Adverse Event|0|||
37997211|NCT00460811|69681445|FG003|Overall Study|Physician Decision|0|||
37997212|NCT00460811|69681446|FG004|Overall Study|Physician Decision|0|||
37901170|NCT00687739|69586590|FG001|Overall Study|Adverse Event|1|||
37901171|NCT00687739|69586591|FG002|Overall Study|Adverse Event|1|||
37901172|NCT00687739|69586592|FG003|Overall Study|Adverse Event|0|||
37901173|NCT01006889|69586604|FG000|Overall Study|Withdrawal by Subject|3|||
37997213|NCT00460811|69681442|FG000|Overall Study|Lost to Follow-up|3|||
37997214|NCT00460811|69681443|FG001|Overall Study|Lost to Follow-up|2|||
37997215|NCT00460811|69681444|FG002|Overall Study|Lost to Follow-up|5|||
37997216|NCT00460811|69681445|FG003|Overall Study|Lost to Follow-up|3|||
37997217|NCT00460811|69681446|FG004|Overall Study|Lost to Follow-up|6|||
37997218|NCT00290186|69681465|FG000|Overall Study|Adverse Event|1|||
37901174|NCT01001429|69586611|FG000|Overall Study|surgery cancelled|0|||
37901175|NCT01001429|69586612|FG001|Overall Study|surgery cancelled|1|||
37997219|NCT00290186|69681466|FG001|Overall Study|Adverse Event|1|||
37997220|NCT00290186|69681465|FG000|Overall Study|Lost to Follow-up|3|||
37997221|NCT00290186|69681466|FG001|Overall Study|Lost to Follow-up|2|||
37997222|NCT00290186|69681465|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
37997223|NCT00290186|69681466|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
37997224|NCT00290186|69681465|FG000|Overall Study|Withdrawal by Subject|0|||
37997225|NCT00290186|69681466|FG001|Overall Study|Withdrawal by Subject|1|||
37997226|NCT00460655|69681476|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
37997227|NCT00460655|69681477|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
37997228|NCT00460655|69681478|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
37997229|NCT00460655|69681479|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
37997230|NCT00460655|69681476|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
37997231|NCT00460655|69681477|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
37997232|NCT00460655|69681478|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
37997233|NCT00460655|69681479|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
37997234|NCT00460655|69681476|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
37997235|NCT00460655|69681477|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
37997236|NCT00460655|69681478|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
37997237|NCT00460655|69681479|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
37997238|NCT00460655|69681476|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
37997239|NCT00460655|69681477|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
37901176|NCT01000961|69586642|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
37901177|NCT01000961|69586643|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
37901178|NCT01000961|69586642|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
37901179|NCT01000961|69586643|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
37901180|NCT01000805|69586653|FG000|Overall Study|Adverse Event|21|||
37901181|NCT01000805|69586654|FG001|Overall Study|Adverse Event|9|||
37901182|NCT01000805|69586653|FG000|Overall Study|Lack of Efficacy|5|||
37901183|NCT01000805|69586654|FG001|Overall Study|Lack of Efficacy|16|||
37901184|NCT01000805|69586653|FG000|Overall Study|Lost to Follow-up|16|||
37901185|NCT01000805|69586654|FG001|Overall Study|Lost to Follow-up|21|||
37901186|NCT01000805|69586653|FG000|Overall Study|Physician Decision|0|||
37901187|NCT01000805|69586654|FG001|Overall Study|Physician Decision|1|||
37901188|NCT01000805|69586653|FG000|Overall Study|Protocol Violation|12|||
37901189|NCT01000805|69586654|FG001|Overall Study|Protocol Violation|8|||
37901190|NCT01000805|69586653|FG000|Overall Study|Withdrawal by Subject|16|||
37901191|NCT01000805|69586654|FG001|Overall Study|Withdrawal by Subject|6|||
37901192|NCT01000805|69586653|FG000|Overall Study|Sponsor Decision|0|||
37901193|NCT01000805|69586654|FG001|Overall Study|Sponsor Decision|1|||
37901194|NCT00684307|69586666|FG000|Overall Study|Adverse Event|11|||
37901195|NCT00684307|69586667|FG001|Overall Study|Adverse Event|6|||
37901196|NCT00684307|69586668|FG002|Overall Study|Adverse Event|15|||
37997240|NCT00460655|69681478|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
37997241|NCT00460655|69681479|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
37997242|NCT00460655|69681476|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
37997243|NCT00460655|69681477|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
37997244|NCT00460655|69681478|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
37997245|NCT00460655|69681479|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
37997246|NCT00460655|69681476|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
37901197|NCT00684307|69586669|FG003|Overall Study|Adverse Event|16|||
37901198|NCT00684307|69586670|FG004|Overall Study|Adverse Event|8|||
37697002|NCT02054715|69173386|FG001|Baseline/Follow-up 1|Ineligible|0|||
37901199|NCT00684307|69586666|FG000|Overall Study|Development of increasing Liver Function|0|||
37901200|NCT00684307|69586667|FG001|Overall Study|Development of increasing Liver Function|2|||
37997247|NCT00460655|69681477|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
37997248|NCT00460655|69681478|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
37997249|NCT00460655|69681479|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
37697003|NCT02054715|69173385|FG000|Baseline/Follow-up 1|Hospitalization|1|||
37901201|NCT00684307|69586668|FG002|Overall Study|Development of increasing Liver Function|0|||
37901202|NCT00684307|69586669|FG003|Overall Study|Development of increasing Liver Function|1|||
37997250|NCT00460577|69681491|FG000|Overall Study|Protocol Violation|2|||
37997251|NCT00460577|69681492|FG001|Overall Study|Protocol Violation|6|||
37997252|NCT00289016|69681498|FG000|Overall Study|Disease Progression|29|||
37997253|NCT00289016|69681498|FG000|Overall Study|Death|2|||
37997254|NCT00289016|69681498|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
37901203|NCT00684307|69586670|FG004|Overall Study|Development of increasing Liver Function|0|||
37901204|NCT00684307|69586666|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
37901205|NCT00684307|69586667|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
37901206|NCT00684307|69586668|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
37901207|NCT00684307|69586669|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
37901208|NCT00684307|69586670|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
37901209|NCT00684307|69586666|FG000|Overall Study|Incorrect enrolment or randomization|4|||
37901210|NCT00684307|69586667|FG001|Overall Study|Incorrect enrolment or randomization|0|||
37901211|NCT00684307|69586668|FG002|Overall Study|Incorrect enrolment or randomization|0|||
37901212|NCT00684307|69586669|FG003|Overall Study|Incorrect enrolment or randomization|0|||
37901213|NCT00684307|69586670|FG004|Overall Study|Incorrect enrolment or randomization|0|||
37901214|NCT00684307|69586666|FG000|Overall Study|Interupted IP for more than 7 days|0|||
37997255|NCT00289016|69681498|FG000|Overall Study|Withdrawal by Subject|2|||
37997256|NCT00289016|69681498|FG000|Overall Study|Adverse Event|1|||
37997257|NCT00289016|69681498|FG000|Overall Study|Other|1|||
37997258|NCT00288860|69681504|FG000|Overall Study|Did not complete intake|4|||
37997259|NCT00288860|69681505|FG001|Overall Study|Did not complete intake|8|||
37997260|NCT00288860|69681504|FG000|Overall Study|Death|4|||
37997261|NCT00288860|69681505|FG001|Overall Study|Death|3|||
37997262|NCT00288860|69681504|FG000|Overall Study|Withdrawal by Subject|20|||
37997263|NCT00288860|69681505|FG001|Overall Study|Withdrawal by Subject|15|||
37901215|NCT00684307|69586667|FG001|Overall Study|Interupted IP for more than 7 days|4|||
37901216|NCT00684307|69586668|FG002|Overall Study|Interupted IP for more than 7 days|1|||
37901217|NCT00684307|69586669|FG003|Overall Study|Interupted IP for more than 7 days|3|||
37901218|NCT00684307|69586670|FG004|Overall Study|Interupted IP for more than 7 days|3|||
37901219|NCT00684307|69586666|FG000|Overall Study|Severe non compliance to protocol|1|||
37901220|NCT00684307|69586667|FG001|Overall Study|Severe non compliance to protocol|0|||
37901221|NCT00684307|69586668|FG002|Overall Study|Severe non compliance to protocol|0|||
37901222|NCT00684307|69586669|FG003|Overall Study|Severe non compliance to protocol|1|||
37901223|NCT00684307|69586670|FG004|Overall Study|Severe non compliance to protocol|2|||
37901224|NCT00684307|69586666|FG000|Overall Study|Participant not willing to continue|7|||
37901225|NCT00684307|69586667|FG001|Overall Study|Participant not willing to continue|10|||
37901226|NCT00684307|69586668|FG002|Overall Study|Participant not willing to continue|11|||
37901227|NCT00684307|69586669|FG003|Overall Study|Participant not willing to continue|5|||
37901228|NCT00684307|69586670|FG004|Overall Study|Participant not willing to continue|8|||
37901229|NCT00684307|69586666|FG000|Overall Study|Criteria from the CSR|0|||
37901230|NCT00684307|69586667|FG001|Overall Study|Criteria from the CSR|0|||
37901231|NCT00684307|69586668|FG002|Overall Study|Criteria from the CSR|1|||
37901232|NCT00684307|69586669|FG003|Overall Study|Criteria from the CSR|3|||
37901233|NCT00684307|69586670|FG004|Overall Study|Criteria from the CSR|3|||
37901234|NCT00683917|69586685|FG000|Overall Study|Study prematurely terminated|10|||
37901235|NCT00687271|69586697|FG000|Overall Study|Adverse Event|1|||
37901236|NCT00687271|69586698|FG001|Overall Study|Adverse Event|3|||
37901237|NCT00687271|69586699|FG002|Overall Study|Adverse Event|1|||
37901238|NCT00687271|69586700|FG003|Overall Study|Adverse Event|0|||
37901239|NCT00687271|69586697|FG000|Overall Study|Lost to Follow-up|0|||
37901240|NCT00687271|69586698|FG001|Overall Study|Lost to Follow-up|1|||
37901241|NCT00687271|69586699|FG002|Overall Study|Lost to Follow-up|0|||
37901242|NCT00687271|69586700|FG003|Overall Study|Lost to Follow-up|0|||
37901243|NCT00687271|69586697|FG000|Overall Study|Protocol Violation|2|||
37901244|NCT00687271|69586698|FG001|Overall Study|Protocol Violation|1|||
37901245|NCT00687271|69586699|FG002|Overall Study|Protocol Violation|1|||
37901246|NCT00687271|69586700|FG003|Overall Study|Protocol Violation|0|||
37901247|NCT00687271|69586697|FG000|Overall Study|Withdrawal by Subject|0|||
37901248|NCT00687271|69586698|FG001|Overall Study|Withdrawal by Subject|1|||
37901249|NCT00687271|69586699|FG002|Overall Study|Withdrawal by Subject|3|||
37901250|NCT00687271|69586700|FG003|Overall Study|Withdrawal by Subject|0|||
37901251|NCT04617275|69586718|FG000|Treatment Period|Adverse Event|1|||
37901252|NCT04617275|69586719|FG001|Treatment Period|Adverse Event|6|||
37901253|NCT04617275|69586720|FG002|Treatment Period|Adverse Event|4|||
37901254|NCT04617275|69586721|FG003|Treatment Period|Adverse Event|6|||
37901255|NCT04617275|69586722|FG004|Treatment Period|Adverse Event|7|||
37901256|NCT04617275|69586723|FG005|Treatment Period|Adverse Event|8|||
37901257|NCT04617275|69586724|FG006|Treatment Period|Adverse Event|0|||
37997264|NCT00288860|69681504|FG000|Overall Study|Lost to Follow-up|74|||
37997265|NCT00288860|69681505|FG001|Overall Study|Lost to Follow-up|71|||
37997266|NCT00288704|69681517|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
37997267|NCT00288704|69681518|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
37997268|NCT00288704|69681519|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
37901258|NCT04617275|69586725|FG007|Treatment Period|Adverse Event|12|||
37901259|NCT04617275|69586718|FG000|Treatment Period|Lost to Follow-up|0|||
37901260|NCT04617275|69586719|FG001|Treatment Period|Lost to Follow-up|0|||
37901261|NCT04617275|69586720|FG002|Treatment Period|Lost to Follow-up|2|||
37901262|NCT04617275|69586721|FG003|Treatment Period|Lost to Follow-up|0|||
37901263|NCT04617275|69586722|FG004|Treatment Period|Lost to Follow-up|0|||
37901264|NCT04617275|69586723|FG005|Treatment Period|Lost to Follow-up|3|||
37901265|NCT04617275|69586724|FG006|Treatment Period|Lost to Follow-up|0|||
37901266|NCT04617275|69586725|FG007|Treatment Period|Lost to Follow-up|2|||
37901267|NCT04617275|69586718|FG000|Treatment Period|No longer meets eligibility criteria|0|||
37901268|NCT04617275|69586719|FG001|Treatment Period|No longer meets eligibility criteria|0|||
37901269|NCT04617275|69586720|FG002|Treatment Period|No longer meets eligibility criteria|0|||
37901270|NCT04617275|69586721|FG003|Treatment Period|No longer meets eligibility criteria|1|||
37901271|NCT04617275|69586722|FG004|Treatment Period|No longer meets eligibility criteria|0|||
37901272|NCT04617275|69586723|FG005|Treatment Period|No longer meets eligibility criteria|0|||
37901273|NCT04617275|69586724|FG006|Treatment Period|No longer meets eligibility criteria|0|||
37901274|NCT04617275|69586725|FG007|Treatment Period|No longer meets eligibility criteria|0|||
37901275|NCT04617275|69586718|FG000|Treatment Period|Other|0|||
37901276|NCT04617275|69586719|FG001|Treatment Period|Other|1|||
37901277|NCT04617275|69586720|FG002|Treatment Period|Other|0|||
37901278|NCT04617275|69586721|FG003|Treatment Period|Other|0|||
37901279|NCT04617275|69586722|FG004|Treatment Period|Other|0|||
37901280|NCT04617275|69586723|FG005|Treatment Period|Other|0|||
37901281|NCT04617275|69586724|FG006|Treatment Period|Other|0|||
37901282|NCT04617275|69586725|FG007|Treatment Period|Other|0|||
37901283|NCT04617275|69586718|FG000|Treatment Period|Withdrawal by Subject|2|||
37901284|NCT04617275|69586719|FG001|Treatment Period|Withdrawal by Subject|0|||
37901285|NCT04617275|69586720|FG002|Treatment Period|Withdrawal by Subject|0|||
37901286|NCT04617275|69586721|FG003|Treatment Period|Withdrawal by Subject|2|||
37997269|NCT00288704|69681517|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
37997270|NCT00288704|69681518|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
37997271|NCT00288704|69681519|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
37997272|NCT00288704|69681517|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
37997273|NCT00288704|69681518|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
37997274|NCT00288704|69681519|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
37997275|NCT00288704|69681517|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
37997276|NCT00288704|69681518|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
37997277|NCT00288704|69681519|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
37997278|NCT00288704|69681517|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
37997279|NCT00288704|69681518|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
37997280|NCT00288704|69681519|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
37997281|NCT00288704|69681517|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
37997282|NCT00288704|69681518|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
37997283|NCT00288704|69681519|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
37997284|NCT00288704|69681517|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
37997285|NCT00288704|69681518|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
37997286|NCT00288704|69681519|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
37997287|NCT00288626|69681526|FG000|Overall Study|Death|3|||
37997288|NCT00288626|69681526|FG000|Overall Study|Withdrawal by Subject|4|||
37997289|NCT00087490|69681534|FG000|Overall Study|Death|6|||
37997290|NCT00087490|69681535|FG001|Overall Study|Death|4|||
37997291|NCT00087490|69681534|FG000|Overall Study|Adverse Event|3|||
37997292|NCT00087490|69681535|FG001|Overall Study|Adverse Event|8|||
37997293|NCT00087490|69681534|FG000|Overall Study|Lack of Efficacy|0|||
37997294|NCT00087490|69681535|FG001|Overall Study|Lack of Efficacy|2|||
37997295|NCT00087490|69681534|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
37901287|NCT04617275|69586722|FG004|Treatment Period|Withdrawal by Subject|2|||
37901288|NCT04617275|69586723|FG005|Treatment Period|Withdrawal by Subject|0|||
37901289|NCT04617275|69586724|FG006|Treatment Period|Withdrawal by Subject|1|||
37901290|NCT04617275|69586725|FG007|Treatment Period|Withdrawal by Subject|2|||
37901291|NCT04617275|69586718|FG000|Follow-up Period|Adverse Event|1|||
37901292|NCT04617275|69586719|FG001|Follow-up Period|Adverse Event|1|||
37997296|NCT00087490|69681535|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
37997297|NCT00087490|69681534|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
37997298|NCT00087490|69681535|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
37901293|NCT04617275|69586720|FG002|Follow-up Period|Adverse Event|2|||
37901294|NCT04617275|69586721|FG003|Follow-up Period|Adverse Event|3|||
37901295|NCT04617275|69586722|FG004|Follow-up Period|Adverse Event|4|||
37901296|NCT04617275|69586723|FG005|Follow-up Period|Adverse Event|3|||
37901297|NCT04617275|69586724|FG006|Follow-up Period|Adverse Event|0|||
37901298|NCT04617275|69586725|FG007|Follow-up Period|Adverse Event|3|||
37901299|NCT04617275|69586718|FG000|Follow-up Period|Lost to Follow-up|0|||
37901300|NCT04617275|69586719|FG001|Follow-up Period|Lost to Follow-up|1|||
37901301|NCT04617275|69586720|FG002|Follow-up Period|Lost to Follow-up|2|||
37901302|NCT04617275|69586721|FG003|Follow-up Period|Lost to Follow-up|0|||
37901303|NCT04617275|69586722|FG004|Follow-up Period|Lost to Follow-up|0|||
37901304|NCT04617275|69586723|FG005|Follow-up Period|Lost to Follow-up|4|||
37901305|NCT04617275|69586724|FG006|Follow-up Period|Lost to Follow-up|0|||
37901306|NCT04617275|69586725|FG007|Follow-up Period|Lost to Follow-up|3|||
37901307|NCT04617275|69586718|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
37901308|NCT04617275|69586719|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
37697004|NCT02054715|69173386|FG001|Baseline/Follow-up 1|Hospitalization|0|||
37827452|NCT00197002|69510300|FG001|Overall Study|Withdrawal by Subject|5|||
37827453|NCT00197002|69510301|FG002|Overall Study|Withdrawal by Subject|7|||
37827454|NCT00197002|69510299|FG000|Overall Study|Migrated/moved from study area|3|||
37827455|NCT00197002|69510300|FG001|Overall Study|Migrated/moved from study area|5|||
37827456|NCT00197002|69510301|FG002|Overall Study|Migrated/moved from study area|1|||
37827457|NCT00197002|69510299|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
37827458|NCT00197002|69510300|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
37827459|NCT00197002|69510301|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
37827460|NCT00197002|69510299|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
37827461|NCT00197002|69510300|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
37827462|NCT00197002|69510301|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
37827463|NCT00197002|69510299|FG000|Overall Study|Others|3|||
37901309|NCT04617275|69586720|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
37901310|NCT04617275|69586721|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
37901311|NCT04617275|69586722|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
37901312|NCT04617275|69586723|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
37901313|NCT04617275|69586724|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
37901314|NCT04617275|69586725|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
37901315|NCT04617275|69586718|FG000|Follow-up Period|Other|0|||
37901316|NCT04617275|69586719|FG001|Follow-up Period|Other|1|||
37901317|NCT04617275|69586720|FG002|Follow-up Period|Other|0|||
37901318|NCT04617275|69586721|FG003|Follow-up Period|Other|0|||
37901319|NCT04617275|69586722|FG004|Follow-up Period|Other|0|||
37901320|NCT04617275|69586723|FG005|Follow-up Period|Other|0|||
37901321|NCT04617275|69586724|FG006|Follow-up Period|Other|0|||
37901322|NCT04617275|69586725|FG007|Follow-up Period|Other|0|||
37901323|NCT04617275|69586718|FG000|Follow-up Period|Withdrawal by Subject|2|||
37901324|NCT04617275|69586719|FG001|Follow-up Period|Withdrawal by Subject|0|||
37901325|NCT04617275|69586720|FG002|Follow-up Period|Withdrawal by Subject|0|||
37901326|NCT04617275|69586721|FG003|Follow-up Period|Withdrawal by Subject|2|||
37901327|NCT04617275|69586722|FG004|Follow-up Period|Withdrawal by Subject|2|||
37901328|NCT04617275|69586723|FG005|Follow-up Period|Withdrawal by Subject|0|||
37901329|NCT04617275|69586724|FG006|Follow-up Period|Withdrawal by Subject|1|||
37901330|NCT04617275|69586725|FG007|Follow-up Period|Withdrawal by Subject|2|||
37901331|NCT01031537|69586760|FG000|Overall Study|medical reasons not related to study|3|||
37901332|NCT01031537|69586760|FG000|Overall Study|Lack of Efficacy|1|||
37901333|NCT01031537|69586760|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
37901334|NCT01031537|69586760|FG000|Overall Study|moved, met exclusion criteria|10|||
37901335|NCT01031537|69586760|FG000|Overall Study|Withdrawal by Subject|5|||
37901336|NCT01031537|69586760|FG000|Overall Study|PI removal, no longer met eligibility|12|||
37901337|NCT01031381|69586764|FG000|Overall Study|Physician Decision|3|||
37901338|NCT01031381|69586764|FG000|Overall Study|Withdrawal by Subject|6|||
37901339|NCT00685399|69586776|FG000|Treatment Period 1|Withdrawal by Subject|2|||
37901340|NCT00685399|69586777|FG001|Treatment Period 1|Withdrawal by Subject|0|||
37901341|NCT00685399|69586778|FG002|Treatment Period 1|Withdrawal by Subject|0|||
37697005|NCT02054715|69173385|FG000|Baseline/Follow-up 1|Changed Mind|1|||
37901342|NCT00685399|69586779|FG003|Treatment Period 1|Withdrawal by Subject|0|||
37901343|NCT00685399|69586780|FG004|Treatment Period 1|Withdrawal by Subject|0|||
37901344|NCT00685399|69586781|FG005|Treatment Period 1|Withdrawal by Subject|0|||
37901345|NCT00685399|69586782|FG006|Treatment Period 1|Withdrawal by Subject|0|||
37901346|NCT00685399|69586783|FG007|Treatment Period 1|Withdrawal by Subject|0|||
37901347|NCT00685399|69586776|FG000|Treatment Period 1|Protocol Violation|1|||
37901348|NCT00685399|69586777|FG001|Treatment Period 1|Protocol Violation|0|||
37901349|NCT00685399|69586778|FG002|Treatment Period 1|Protocol Violation|0|||
37901350|NCT00685399|69586779|FG003|Treatment Period 1|Protocol Violation|0|||
37901351|NCT00685399|69586780|FG004|Treatment Period 1|Protocol Violation|0|||
37901352|NCT00685399|69586781|FG005|Treatment Period 1|Protocol Violation|0|||
37901353|NCT00685399|69586782|FG006|Treatment Period 1|Protocol Violation|0|||
37901354|NCT00685399|69586783|FG007|Treatment Period 1|Protocol Violation|0|||
37901355|NCT00685399|69586776|FG000|Treatment Period 1|Administrative|2|||
37827464|NCT00197002|69510300|FG001|Overall Study|Others|1|||
37827465|NCT00197002|69510301|FG002|Overall Study|Others|1|||
37827466|NCT00196105|69510315|FG000|Overall Study|Lost to Follow-up|4|||
37827467|NCT00196105|69510316|FG001|Overall Study|Lost to Follow-up|5|||
37827468|NCT00196105|69510317|FG002|Overall Study|Lost to Follow-up|7|||
37827469|NCT00195715|69510325|FG000|Overall Study|Adverse Event|122|||
37901356|NCT00685399|69586777|FG001|Treatment Period 1|Administrative|0|||
37901357|NCT00685399|69586778|FG002|Treatment Period 1|Administrative|0|||
37901358|NCT00685399|69586779|FG003|Treatment Period 1|Administrative|0|||
37827470|NCT00195715|69510325|FG000|Overall Study|Withdrawal by Subject|58|||
37827471|NCT00195715|69510325|FG000|Overall Study|Lost to Follow-up|27|||
37827472|NCT00195715|69510325|FG000|Overall Study|Protocol Violation|13|||
37827473|NCT00195715|69510325|FG000|Overall Study|Lack of Efficacy|93|||
37827474|NCT00195715|69510325|FG000|Overall Study|Pregnancy|14|||
37827475|NCT00195715|69510325|FG000|Overall Study|Investigative site closure|8|||
37827476|NCT00195715|69510325|FG000|Overall Study|Subject moved/relocated|7|||
37827477|NCT00195715|69510325|FG000|Overall Study|Subject non-compliance|6|||
37827478|NCT00195715|69510325|FG000|Overall Study|Subject started commercial Humira|5|||
37827479|NCT00195715|69510325|FG000|Overall Study|Subject choice|3|||
37827480|NCT00195715|69510325|FG000|Overall Study|Loss of response/no improvement|3|||
37827481|NCT00195715|69510325|FG000|Overall Study|Sponsor stopped study|1|||
37827482|NCT00195715|69510325|FG000|Overall Study|Administrative reasons|2|||
37827483|NCT00195715|69510325|FG000|Overall Study|Investigator's decision|2|||
37827484|NCT00195715|69510325|FG000|Overall Study|Subject wants to get pregnant|4|||
37901359|NCT00685399|69586780|FG004|Treatment Period 1|Administrative|0|||
37901360|NCT00685399|69586781|FG005|Treatment Period 1|Administrative|0|||
37901361|NCT00685399|69586782|FG006|Treatment Period 1|Administrative|0|||
37901362|NCT00685399|69586783|FG007|Treatment Period 1|Administrative|0|||
37827485|NCT00195715|69510325|FG000|Overall Study|Use of prohibited medication|2|||
37827486|NCT00195715|69510325|FG000|Overall Study|Planned surgery|2|||
37827487|NCT00195715|69510325|FG000|Overall Study|Increased infection rate|1|||
37901363|NCT00685399|69586776|FG000|Treatment Period 1|Lack of Efficacy|1|||
37901364|NCT00685399|69586777|FG001|Treatment Period 1|Lack of Efficacy|0|||
37901365|NCT00685399|69586778|FG002|Treatment Period 1|Lack of Efficacy|0|||
37901366|NCT00685399|69586779|FG003|Treatment Period 1|Lack of Efficacy|0|||
37901367|NCT00685399|69586780|FG004|Treatment Period 1|Lack of Efficacy|0|||
37901368|NCT00685399|69586781|FG005|Treatment Period 1|Lack of Efficacy|0|||
37901369|NCT00685399|69586782|FG006|Treatment Period 1|Lack of Efficacy|0|||
37901370|NCT00685399|69586783|FG007|Treatment Period 1|Lack of Efficacy|0|||
37901371|NCT00685399|69586776|FG000|Treatment Period 2|Administrative Problems|0|||
37901372|NCT00685399|69586777|FG001|Treatment Period 2|Administrative Problems|2|||
37901373|NCT00685399|69586778|FG002|Treatment Period 2|Administrative Problems|1|||
37901374|NCT00685399|69586779|FG003|Treatment Period 2|Administrative Problems|0|||
37901375|NCT00685399|69586780|FG004|Treatment Period 2|Administrative Problems|0|||
37901376|NCT00685399|69586781|FG005|Treatment Period 2|Administrative Problems|0|||
37901377|NCT00685399|69586782|FG006|Treatment Period 2|Administrative Problems|0|||
37901378|NCT00685399|69586783|FG007|Treatment Period 2|Administrative Problems|0|||
37901379|NCT00685399|69586776|FG000|Treatment Period 2|Withdrawal by Subject|0|||
37901380|NCT00685399|69586777|FG001|Treatment Period 2|Withdrawal by Subject|0|||
37997299|NCT00087490|69681534|FG000|Overall Study|Randomized but not treated|7|||
37997300|NCT00087490|69681535|FG001|Overall Study|Randomized but not treated|18|||
37997301|NCT00087178|69681543|FG000|Overall Study|No follow up data|5|||
37901381|NCT00685399|69586778|FG002|Treatment Period 2|Withdrawal by Subject|0|||
37827488|NCT00195715|69510325|FG000|Overall Study|Ineligible|1|||
37997302|NCT00087178|69681544|FG001|Overall Study|No follow up data|15|||
37827489|NCT00195715|69510325|FG000|Overall Study|Colonic stricture|1|||
37997303|NCT00087178|69681543|FG000|Overall Study|No clinical assessment|1|||
37827490|NCT00195715|69510325|FG000|Overall Study|Sponsor discontinued trial|1|||
37827491|NCT00195715|69510325|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
37827492|NCT00195676|69510329|FG000|Period O - Open-label Treatment|Adverse Event|82|||
37827493|NCT00195676|69510329|FG000|Period O - Open-label Treatment|Death|6|||
37901382|NCT00685399|69586779|FG003|Treatment Period 2|Withdrawal by Subject|0|||
37901383|NCT00685399|69586780|FG004|Treatment Period 2|Withdrawal by Subject|0|||
37901384|NCT00685399|69586781|FG005|Treatment Period 2|Withdrawal by Subject|0|||
37997304|NCT00087178|69681544|FG001|Overall Study|No clinical assessment|2|||
37901385|NCT00685399|69586782|FG006|Treatment Period 2|Withdrawal by Subject|0|||
37901386|NCT00685399|69586783|FG007|Treatment Period 2|Withdrawal by Subject|2|||
37901387|NCT00685399|69586776|FG000|Treatment Period 2|Adverse Event|0|||
37901388|NCT00685399|69586777|FG001|Treatment Period 2|Adverse Event|0|||
37901389|NCT00685399|69586778|FG002|Treatment Period 2|Adverse Event|0|||
37901390|NCT00685399|69586779|FG003|Treatment Period 2|Adverse Event|0|||
37901391|NCT00685399|69586780|FG004|Treatment Period 2|Adverse Event|0|||
37901392|NCT00685399|69586781|FG005|Treatment Period 2|Adverse Event|1|||
37901393|NCT00685399|69586782|FG006|Treatment Period 2|Adverse Event|0|||
37827494|NCT00195676|69510329|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
37827495|NCT00195676|69510329|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
37827496|NCT00195676|69510329|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
37827497|NCT00195676|69510329|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
37827498|NCT00195676|69510329|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
37827499|NCT00195676|69510329|FG000|Period O - Open-label Treatment|Other reasons|68|||
37827500|NCT00195676|69510329|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
37827501|NCT00195676|69510329|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
37827502|NCT00195676|69510329|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
37827503|NCT00195676|69510329|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
37827504|NCT00195676|69510329|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
37827505|NCT00195676|69510329|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
37827506|NCT00195676|69510329|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
37827507|NCT00195676|69510329|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
37827508|NCT00195676|69510329|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
37827509|NCT00195676|69510329|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
37827510|NCT00195676|69510329|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
37827511|NCT00195676|69510329|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
37827512|NCT00195676|69510329|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
37827513|NCT00194077|69510339|FG000|Overall Study|Lack of Efficacy|22|||
37827514|NCT00194077|69510340|FG001|Overall Study|Lack of Efficacy|29|||
37827515|NCT00194077|69510339|FG000|Overall Study|Study nonadherence|1|||
37827516|NCT00194077|69510340|FG001|Overall Study|Study nonadherence|0|||
37827517|NCT00194077|69510339|FG000|Overall Study|Withdrawal by Subject|1|||
37827518|NCT00194077|69510340|FG001|Overall Study|Withdrawal by Subject|1|||
37997305|NCT00087178|69681543|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
37997306|NCT00087178|69681544|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
37997307|NCT00288080|69681552|FG000|Overall Study|Withdrawal by Subject|1|||
37997308|NCT00288080|69681553|FG001|Overall Study|Withdrawal by Subject|3|||
37997309|NCT00288080|69681552|FG000|Overall Study|Protocol Violation|25|||
37997310|NCT00288080|69681553|FG001|Overall Study|Protocol Violation|20|||
37997311|NCT00287690|69681561|FG000|Overall Study|Protocol Violation|20|||
37997312|NCT00287690|69681562|FG001|Overall Study|Protocol Violation|26|||
37997313|NCT00286754|69681571|FG000|Overall Study|Adverse Event|2|||
37997314|NCT00286754|69681572|FG001|Overall Study|Adverse Event|2|||
37997315|NCT00286754|69681573|FG002|Overall Study|Adverse Event|3|||
37901394|NCT00685399|69586783|FG007|Treatment Period 2|Adverse Event|0|||
37901395|NCT00685399|69586776|FG000|Treatment Period 2|Lack of Efficacy|0|||
37901396|NCT00685399|69586777|FG001|Treatment Period 2|Lack of Efficacy|10|||
37901397|NCT00685399|69586778|FG002|Treatment Period 2|Lack of Efficacy|2|||
37901398|NCT00685399|69586779|FG003|Treatment Period 2|Lack of Efficacy|0|||
37901399|NCT00685399|69586780|FG004|Treatment Period 2|Lack of Efficacy|0|||
37997316|NCT00286754|69681571|FG000|Overall Study|Withdrawal by Subject|6|||
37997317|NCT00286754|69681572|FG001|Overall Study|Withdrawal by Subject|2|||
37997318|NCT00286754|69681573|FG002|Overall Study|Withdrawal by Subject|0|||
37697006|NCT02054715|69173386|FG001|Baseline/Follow-up 1|Changed Mind|0|||
37827519|NCT00193609|69510346|FG000|Overall Study|Lack of Efficacy|2|||
37827520|NCT00193609|69510346|FG000|Overall Study|Adverse Event|2|||
37827521|NCT00193180|69510350|FG000|Overall Study|Lack of Efficacy|1|||
37827522|NCT00193180|69510350|FG000|Overall Study|Adverse Event|8|||
37827523|NCT00193180|69510350|FG000|Overall Study|Protocol Violation|1|||
37827524|NCT00193063|69510355|FG000|Overall Study|Lack of Efficacy|3|||
37901400|NCT00685399|69586781|FG005|Treatment Period 2|Lack of Efficacy|1|||
37901401|NCT00685399|69586782|FG006|Treatment Period 2|Lack of Efficacy|0|||
37901402|NCT00685399|69586783|FG007|Treatment Period 2|Lack of Efficacy|0|||
37827525|NCT00193063|69510355|FG000|Overall Study|Adverse Event|1|||
37827526|NCT00191854|69510362|FG000|Overall Study|Death|26|||
37827527|NCT00191854|69510363|FG001|Overall Study|Death|23|||
37997319|NCT00286754|69681571|FG000|Overall Study|Lost to Follow-up|12|||
37901403|NCT00685399|69586776|FG000|Extension|Administrative Issues|0|||
37901404|NCT00685399|69586777|FG001|Extension|Administrative Issues|0|||
37901405|NCT00685399|69586778|FG002|Extension|Administrative Issues|0|||
37901406|NCT00685399|69586779|FG003|Extension|Administrative Issues|1|||
37997320|NCT00286754|69681572|FG001|Overall Study|Lost to Follow-up|14|||
37997321|NCT00286754|69681573|FG002|Overall Study|Lost to Follow-up|6|||
37901407|NCT00685399|69586780|FG004|Extension|Administrative Issues|0|||
37901408|NCT00685399|69586781|FG005|Extension|Administrative Issues|0|||
37901409|NCT00685399|69586782|FG006|Extension|Administrative Issues|0|||
37901410|NCT00685399|69586783|FG007|Extension|Administrative Issues|0|||
37901411|NCT00685399|69586776|FG000|Extension|Withdrawal by Subject|0|||
37901412|NCT00685399|69586777|FG001|Extension|Withdrawal by Subject|0|||
37901413|NCT00685399|69586778|FG002|Extension|Withdrawal by Subject|0|||
37901414|NCT00685399|69586779|FG003|Extension|Withdrawal by Subject|1|||
37901415|NCT00685399|69586780|FG004|Extension|Withdrawal by Subject|0|||
37901416|NCT00685399|69586781|FG005|Extension|Withdrawal by Subject|0|||
37901417|NCT00685399|69586782|FG006|Extension|Withdrawal by Subject|0|||
37901418|NCT00685399|69586783|FG007|Extension|Withdrawal by Subject|0|||
37901419|NCT00685399|69586776|FG000|Extension|Protocol Violation|0|||
37901420|NCT00685399|69586777|FG001|Extension|Protocol Violation|0|||
37901421|NCT00685399|69586778|FG002|Extension|Protocol Violation|0|||
37901422|NCT00685399|69586779|FG003|Extension|Protocol Violation|1|||
37901423|NCT00685399|69586780|FG004|Extension|Protocol Violation|0|||
37901424|NCT00685399|69586781|FG005|Extension|Protocol Violation|0|||
37901425|NCT00685399|69586782|FG006|Extension|Protocol Violation|0|||
37901426|NCT00685399|69586783|FG007|Extension|Protocol Violation|0|||
37901427|NCT00685399|69586776|FG000|Extension|Lack of Efficacy|0|||
37901428|NCT00685399|69586777|FG001|Extension|Lack of Efficacy|0|||
37901429|NCT00685399|69586778|FG002|Extension|Lack of Efficacy|0|||
37901430|NCT00685399|69586779|FG003|Extension|Lack of Efficacy|2|||
37901431|NCT00685399|69586780|FG004|Extension|Lack of Efficacy|0|||
37901432|NCT00685399|69586781|FG005|Extension|Lack of Efficacy|0|||
37901433|NCT00685399|69586782|FG006|Extension|Lack of Efficacy|0|||
37901434|NCT00685399|69586783|FG007|Extension|Lack of Efficacy|0|||
37901435|NCT00685399|69586776|FG000|Extension|Adverse Event|0|||
37901436|NCT00685399|69586777|FG001|Extension|Adverse Event|0|||
37901437|NCT00685399|69586778|FG002|Extension|Adverse Event|0|||
37901438|NCT00685399|69586779|FG003|Extension|Adverse Event|2|||
37901439|NCT00685399|69586780|FG004|Extension|Adverse Event|0|||
37901440|NCT00685399|69586781|FG005|Extension|Adverse Event|0|||
37901441|NCT00685399|69586782|FG006|Extension|Adverse Event|0|||
37901442|NCT00685399|69586783|FG007|Extension|Adverse Event|0|||
37901443|NCT00685165|69586810|FG000|Washout Period of 14 Days|Adverse Event|1|||
37997322|NCT00286754|69681571|FG000|Overall Study|Moved out of state|0|||
37997323|NCT00286754|69681572|FG001|Overall Study|Moved out of state|0|||
37997324|NCT00286754|69681573|FG002|Overall Study|Moved out of state|1|||
37997325|NCT00066742|69681587|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
37997326|NCT00066742|69681587|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
37997327|NCT00066742|69681587|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
37997328|NCT00066742|69681587|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
37827528|NCT00191854|69510364|FG002|Overall Study|Death|29|||
37827529|NCT00191854|69510362|FG000|Overall Study|Lost to Follow-up|7|||
37901444|NCT00685165|69586811|FG001|Washout Period of 14 Days|Adverse Event|0|||
37901445|NCT00683449|69586822|FG000|Overall Study|Lost to Follow-up|0|||
37901446|NCT00683449|69586823|FG001|Overall Study|Lost to Follow-up|1|||
37901447|NCT00683449|69586824|FG002|Overall Study|Lost to Follow-up|0|||
37901448|NCT00683449|69586825|FG003|Overall Study|Lost to Follow-up|0|||
37901449|NCT00683449|69586826|FG004|Overall Study|Lost to Follow-up|0|||
37901450|NCT00683293|69586845|FG000|Overall Study|Withdrawal by Subject|2|||
37901451|NCT00683293|69586846|FG001|Overall Study|Withdrawal by Subject|3|||
37901452|NCT00726232|69586858|FG000|Initial Phase (Dose-finding)|Death|0|||
37997329|NCT00066742|69681587|FG000|Induction Chemoradiotherapy|Ineligible|3|||
37997330|NCT00066742|69681587|FG000|Consolidation Chemotherapy|not protocol specified|1|||
37827530|NCT00191854|69510363|FG001|Overall Study|Lost to Follow-up|5|||
37827531|NCT00191854|69510364|FG002|Overall Study|Lost to Follow-up|5|||
37827532|NCT00191854|69510362|FG000|Overall Study|Withdrawal by Subject|4|||
37827533|NCT00191854|69510363|FG001|Overall Study|Withdrawal by Subject|2|||
37827534|NCT00191854|69510364|FG002|Overall Study|Withdrawal by Subject|3|||
37827535|NCT00191854|69510362|FG000|Overall Study|Sponsor Decision|0|||
37827536|NCT00191854|69510363|FG001|Overall Study|Sponsor Decision|0|||
37827537|NCT00191854|69510364|FG002|Overall Study|Sponsor Decision|1|||
37901453|NCT00726232|69586859|FG001|Initial Phase (Dose-finding)|Death|0|||
37997331|NCT00066742|69681587|FG000|Consolidation Chemotherapy|Ineligible|2|||
37997332|NCT00460265|69681595|FG000|Overall Study|Lost to Follow-up|14|||
37997333|NCT00460265|69681596|FG001|Overall Study|Lost to Follow-up|15|||
37827538|NCT00191854|69510362|FG000|Overall Study|Screen Failure|0|||
37901454|NCT00726232|69586860|FG002|Initial Phase (Dose-finding)|Death|0|||
37901455|NCT00726232|69586861|FG003|Initial Phase (Dose-finding)|Death|0|||
37901456|NCT00726232|69586862|FG004|Initial Phase (Dose-finding)|Death|1|||
37901457|NCT00726232|69586863|FG005|Initial Phase (Dose-finding)|Death|0|||
37901458|NCT00726232|69586864|FG006|Initial Phase (Dose-finding)|Death|0|||
37901459|NCT00726232|69586865|FG007|Initial Phase (Dose-finding)|Death|0|||
37901460|NCT00726232|69586858|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
37901461|NCT00726232|69586859|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
37901462|NCT00726232|69586860|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
37901463|NCT00726232|69586861|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
37901464|NCT00726232|69586862|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
37901465|NCT00726232|69586863|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
37901466|NCT00726232|69586864|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
37901467|NCT00726232|69586865|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
37901468|NCT00726232|69586858|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
37901469|NCT00726232|69586859|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
37901470|NCT00726232|69586860|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
37901471|NCT00726232|69586861|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
37901472|NCT00726232|69586862|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
37901473|NCT00726232|69586863|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
37901474|NCT00726232|69586864|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
37901475|NCT00726232|69586865|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
37901476|NCT00726232|69586858|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
37901477|NCT00726232|69586859|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
37901478|NCT00726232|69586860|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
37901479|NCT00726232|69586861|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
37901480|NCT00726232|69586862|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
37901481|NCT00726232|69586863|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
37901482|NCT00726232|69586864|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
37901483|NCT00726232|69586865|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
37901484|NCT00726232|69586858|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
37901485|NCT00726232|69586859|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
37901486|NCT00726232|69586860|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
37901487|NCT00726232|69586861|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
37901488|NCT00726232|69586862|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
37901489|NCT00726232|69586863|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
37901490|NCT00726232|69586864|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
37901491|NCT00726232|69586865|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
37901492|NCT00726232|69586858|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
37901493|NCT00726232|69586859|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
37901494|NCT00726232|69586860|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
37901495|NCT00726232|69586861|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
37997334|NCT00460265|69681595|FG000|Overall Study|Physician Decision|1|||
37901496|NCT00726232|69586862|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
37901497|NCT00726232|69586863|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
37901498|NCT00726232|69586864|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
37901499|NCT00726232|69586865|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
37901500|NCT00726232|69586858|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
37901501|NCT00726232|69586859|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
37901502|NCT00726232|69586860|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
37901503|NCT00726232|69586861|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
37901504|NCT00726232|69586862|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
37997335|NCT00460265|69681596|FG001|Overall Study|Physician Decision|2|||
37901505|NCT00726232|69586863|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
37901506|NCT00726232|69586864|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
37901507|NCT00726232|69586865|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
37901508|NCT00726232|69586858|FG000|Expansion Phase|Death|0|||
37901509|NCT00726232|69586859|FG001|Expansion Phase|Death|0|||
37901510|NCT00726232|69586860|FG002|Expansion Phase|Death|0|||
37901511|NCT00726232|69586861|FG003|Expansion Phase|Death|0|||
37901512|NCT00726232|69586862|FG004|Expansion Phase|Death|0|||
37901513|NCT00726232|69586863|FG005|Expansion Phase|Death|0|||
37901514|NCT00726232|69586864|FG006|Expansion Phase|Death|0|||
37901515|NCT00726232|69586865|FG007|Expansion Phase|Death|1|||
37901516|NCT00726232|69586858|FG000|Expansion Phase|Adverse Event|0|||
37997336|NCT00460265|69681595|FG000|Overall Study|Withdrawal by Subject|10|||
37697007|NCT02054715|69173385|FG000|Follow-up 2|Lost to Followup|3|||
37827539|NCT00191854|69510363|FG001|Overall Study|Screen Failure|0|||
37827540|NCT00191854|69510364|FG002|Overall Study|Screen Failure|1|||
37827541|NCT00191815|69510372|FG000|Overall Study|Adverse Event|2|||
37827542|NCT00191815|69510372|FG000|Overall Study|Disease progression or relapse|24|||
37827543|NCT00191815|69510372|FG000|Overall Study|Death|2|||
37827544|NCT00191815|69510372|FG000|Overall Study|Protocol Violation|3|||
37827545|NCT00191815|69510372|FG000|Overall Study|Physician Decision|2|||
37827546|NCT00191815|69510372|FG000|Overall Study|Withdrawal by Subject|7|||
37827547|NCT00191386|69510376|FG000|Overall Study|Adverse Event|16|||
37827548|NCT00191386|69510376|FG000|Overall Study|Lost to Follow-up|1|||
37827549|NCT00191386|69510376|FG000|Overall Study|Entry Criteria Exclusion|3|||
37827550|NCT00191386|69510376|FG000|Overall Study|Protocol Violation|18|||
37901517|NCT00726232|69586859|FG001|Expansion Phase|Adverse Event|0|||
37901518|NCT00726232|69586860|FG002|Expansion Phase|Adverse Event|0|||
37901519|NCT00726232|69586861|FG003|Expansion Phase|Adverse Event|0|||
37901520|NCT00726232|69586862|FG004|Expansion Phase|Adverse Event|0|||
37901521|NCT00726232|69586863|FG005|Expansion Phase|Adverse Event|0|||
37901522|NCT00726232|69586864|FG006|Expansion Phase|Adverse Event|6|||
37901523|NCT00726232|69586865|FG007|Expansion Phase|Adverse Event|11|||
37901524|NCT00726232|69586858|FG000|Expansion Phase|Withdrawal by Subject|0|||
37901525|NCT00726232|69586859|FG001|Expansion Phase|Withdrawal by Subject|0|||
37901526|NCT00726232|69586860|FG002|Expansion Phase|Withdrawal by Subject|0|||
37901527|NCT00726232|69586861|FG003|Expansion Phase|Withdrawal by Subject|0|||
37901528|NCT00726232|69586862|FG004|Expansion Phase|Withdrawal by Subject|0|||
37901529|NCT00726232|69586863|FG005|Expansion Phase|Withdrawal by Subject|0|||
37901530|NCT00726232|69586864|FG006|Expansion Phase|Withdrawal by Subject|2|||
37901531|NCT00726232|69586865|FG007|Expansion Phase|Withdrawal by Subject|3|||
37901532|NCT00726232|69586858|FG000|Expansion Phase|Disease progression|0|||
37901533|NCT00726232|69586859|FG001|Expansion Phase|Disease progression|0|||
37901534|NCT00726232|69586860|FG002|Expansion Phase|Disease progression|0|||
37901535|NCT00726232|69586861|FG003|Expansion Phase|Disease progression|0|||
37901536|NCT00726232|69586862|FG004|Expansion Phase|Disease progression|0|||
37901537|NCT00726232|69586863|FG005|Expansion Phase|Disease progression|0|||
37997337|NCT00460265|69681596|FG001|Overall Study|Withdrawal by Subject|25|||
37997338|NCT00460265|69681595|FG000|Overall Study|Ongoing|60|||
37901538|NCT00726232|69586864|FG006|Expansion Phase|Disease progression|4|||
37901539|NCT00726232|69586865|FG007|Expansion Phase|Disease progression|0|||
37901540|NCT00726232|69586858|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
37901541|NCT00726232|69586859|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
37901542|NCT00726232|69586860|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
37901543|NCT00726232|69586861|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
37901544|NCT00726232|69586862|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
37901545|NCT00726232|69586863|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
37997339|NCT00460265|69681596|FG001|Overall Study|Ongoing|47|||
37997340|NCT00460109|69681602|FG000|Overall Study|Death|1|||
37997341|NCT00065260|69681608|FG000|Overall Study|Death|0|||
37997342|NCT00065260|69681609|FG001|Overall Study|Death|1|||
37997343|NCT00460031|69681615|FG000|Overall Study|Adverse Event|5|||
37997344|NCT00460031|69681615|FG000|Overall Study|Withdrawal by Subject|5|||
37997345|NCT00460031|69681615|FG000|Overall Study|Death|1|||
37997346|NCT00451217|69681623|FG000|Overall Study|Lost to Follow-up|0|||
37997347|NCT00451217|69681624|FG001|Overall Study|Lost to Follow-up|1|||
37997348|NCT00451217|69681625|FG002|Overall Study|Lost to Follow-up|1|||
37997349|NCT00451217|69681626|FG003|Overall Study|Lost to Follow-up|1|||
37997350|NCT00451217|69681623|FG000|Overall Study|Withdrawal by Subject|1|||
37997351|NCT00451217|69681624|FG001|Overall Study|Withdrawal by Subject|0|||
37997352|NCT00451217|69681625|FG002|Overall Study|Withdrawal by Subject|0|||
37997353|NCT00451217|69681626|FG003|Overall Study|Withdrawal by Subject|0|||
37997354|NCT00451217|69681623|FG000|Overall Study|Not Treated|1|||
37901546|NCT00726232|69586864|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
37901547|NCT00726232|69586865|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
37901548|NCT00726232|69586858|FG000|Expansion Phase|Per Investigator: lack of response|0|||
37901549|NCT00726232|69586859|FG001|Expansion Phase|Per Investigator: lack of response|0|||
37901550|NCT00726232|69586860|FG002|Expansion Phase|Per Investigator: lack of response|0|||
37997355|NCT00451217|69681624|FG001|Overall Study|Not Treated|1|||
37901551|NCT00726232|69586861|FG003|Expansion Phase|Per Investigator: lack of response|0|||
37901552|NCT00726232|69586862|FG004|Expansion Phase|Per Investigator: lack of response|0|||
37901553|NCT00726232|69586863|FG005|Expansion Phase|Per Investigator: lack of response|0|||
37901554|NCT00726232|69586864|FG006|Expansion Phase|Per Investigator: lack of response|1|||
37901555|NCT00726232|69586865|FG007|Expansion Phase|Per Investigator: lack of response|7|||
37901556|NCT00726232|69586858|FG000|Expansion Phase|Unspecified reason|0|||
37901557|NCT00726232|69586859|FG001|Expansion Phase|Unspecified reason|0|||
37901558|NCT00726232|69586860|FG002|Expansion Phase|Unspecified reason|0|||
37997356|NCT00451217|69681625|FG002|Overall Study|Not Treated|3|||
37997357|NCT00451217|69681626|FG003|Overall Study|Not Treated|4|||
37997358|NCT00459953|69681638|FG000|Overall Study|not analyzed-household member in study|1|||
37901559|NCT00726232|69586861|FG003|Expansion Phase|Unspecified reason|0|||
37901560|NCT00726232|69586862|FG004|Expansion Phase|Unspecified reason|0|||
37997359|NCT00459953|69681639|FG001|Overall Study|not analyzed-household member in study|1|||
37901561|NCT00726232|69586863|FG005|Expansion Phase|Unspecified reason|0|||
37997360|NCT00459875|69681645|FG000|Overall Study|Ineligible participant|1|||
37997361|NCT00459875|69681645|FG000|Overall Study|Adverse Event|2|||
37997362|NCT00311402|69681651|FG000|Overall Study|Adverse Event|118|||
37997363|NCT00311402|69681652|FG001|Overall Study|Adverse Event|105|||
37997364|NCT00311402|69681651|FG000|Overall Study|Lost to Follow-up|0|||
37997365|NCT00311402|69681652|FG001|Overall Study|Lost to Follow-up|3|||
37997366|NCT00311402|69681651|FG000|Overall Study|Withdrawal by Subject|17|||
37997367|NCT00311402|69681652|FG001|Overall Study|Withdrawal by Subject|18|||
37901562|NCT00726232|69586864|FG006|Expansion Phase|Unspecified reason|1|||
37901563|NCT00726232|69586865|FG007|Expansion Phase|Unspecified reason|0|||
37901564|NCT00720382|69586886|FG000|Overall Study|Adverse Event|54|||
37901565|NCT00720382|69586887|FG001|Overall Study|Adverse Event|17|||
37901566|NCT00720382|69586886|FG000|Overall Study|Lack of Efficacy|18|||
37901567|NCT00720382|69586887|FG001|Overall Study|Lack of Efficacy|7|||
37901568|NCT00720382|69586886|FG000|Overall Study|Non-Compliance|15|||
37901569|NCT00720382|69586887|FG001|Overall Study|Non-Compliance|5|||
37901570|NCT00720382|69586886|FG000|Overall Study|Withdrawal by Subject|47|||
37901571|NCT00720382|69586887|FG001|Overall Study|Withdrawal by Subject|11|||
37901572|NCT00720382|69586886|FG000|Overall Study|Lost to Follow-up|28|||
37901573|NCT00720382|69586887|FG001|Overall Study|Lost to Follow-up|14|||
37901574|NCT00720382|69586886|FG000|Overall Study|administrative|14|||
37827551|NCT00191386|69510376|FG000|Overall Study|Withdrawal by Subject|96|||
37901575|NCT00720382|69586887|FG001|Overall Study|administrative|5|||
37901576|NCT00720226|69586895|FG000|Overall Study|Withdrawal by Subject|7|||
37901577|NCT00720226|69586896|FG001|Overall Study|Withdrawal by Subject|4|||
37901578|NCT00725920|69586904|FG000|Overall Study|Lack of Efficacy|3|||
37901579|NCT00725920|69586905|FG001|Overall Study|Lack of Efficacy|6|||
37901580|NCT00725842|69586911|FG000|Overall Study|Lost to Follow-up|19|||
37901581|NCT00725842|69586911|FG000|Overall Study|Death|1|||
37901582|NCT00725842|69586911|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
37901583|NCT00725842|69586911|FG000|Overall Study|Consent date prior to study start date|5|||
37901584|NCT00725842|69586911|FG000|Overall Study|Inclusion criterion not met|1|||
37901585|NCT00725842|69586911|FG000|Overall Study|No Visit 1 data|1|||
37901586|NCT00725764|69586915|FG000|Overall Study|Withdrawal by Subject|2|||
37901587|NCT00725764|69586915|FG000|Overall Study|Physician Decision|1|||
37901588|NCT00725764|69586915|FG000|Overall Study|Progressive Disease|7|||
37901589|NCT00725764|69586915|FG000|Overall Study|Lost to Follow-up|1|||
37901590|NCT00725764|69586915|FG000|Overall Study|Death|1|||
37901591|NCT00725764|69586915|FG000|Overall Study|Participant non compliant with protocol|1|||
37901592|NCT00725764|69586915|FG000|Overall Study|Decline in performance status|1|||
37901593|NCT00725608|69586920|FG000|Overall Study|Lost to Follow-up|60|||
37901594|NCT00725608|69586920|FG000|Overall Study|Adverse Event|14|||
37901595|NCT00725608|69586920|FG000|Overall Study|Individual reasons|86|||
37901596|NCT00725608|69586920|FG000|Overall Study|Other|7|||
37901597|NCT00725452|69586924|FG000|Overall Study|Adverse Event|3|||
37901598|NCT00725452|69586924|FG000|Overall Study|Lack of Efficacy|2|||
37901599|NCT00725452|69586924|FG000|Overall Study|Reason not specified|1|||
37901600|NCT00725452|69586924|FG000|Overall Study|Physician Decision|1|||
37901601|NCT00725452|69586924|FG000|Overall Study|Withdrawal by Subject|3|||
37901602|NCT00725452|69586924|FG000|Overall Study|Lost to Follow-up|1|||
37901603|NCT00725296|69586928|FG000|Overall Study|Adverse Event|11|||
37901604|NCT00725296|69586928|FG000|Overall Study|Lack of Efficacy|7|||
37997368|NCT00311402|69681651|FG000|Overall Study|Lack of Efficacy|58|||
37997369|NCT00311402|69681652|FG001|Overall Study|Lack of Efficacy|42|||
37901605|NCT00725296|69586928|FG000|Overall Study|Withdrawal by Subject|3|||
37901606|NCT00725296|69586928|FG000|Overall Study|Non-Compliance|2|||
37901607|NCT00725296|69586928|FG000|Overall Study|Lost to Follow-up|1|||
37901608|NCT00725296|69586928|FG000|Overall Study|Other|38|||
37901609|NCT00719680|69586933|FG000|Overall Study|Adverse Event|1|||
37901610|NCT00719680|69586933|FG000|Overall Study|Lost to Follow-up|1|||
37901611|NCT00719680|69586933|FG000|Overall Study|Withdrawal by Subject|3|||
37997370|NCT00311402|69681651|FG000|Overall Study|Protocol Violation|7|||
37827552|NCT00191386|69510376|FG000|Overall Study|Physician Decision|11|||
37827553|NCT00191386|69510376|FG000|Overall Study|Lack of Efficacy|15|||
37827554|NCT00191308|69510380|FG000|Overall Study|Adverse Event|1|||
37827555|NCT00191269|69510386|FG000|Overall Study|Protocol Violation|0|||
37827556|NCT00191269|69510387|FG001|Overall Study|Protocol Violation|2|||
37827557|NCT00191269|69510386|FG000|Overall Study|Adverse Event|1|||
37827558|NCT00191269|69510387|FG001|Overall Study|Adverse Event|4|||
37827559|NCT00191269|69510386|FG000|Overall Study|Progression of Disease|4|||
37827560|NCT00191269|69510387|FG001|Overall Study|Progression of Disease|42|||
37827561|NCT00191269|69510386|FG000|Overall Study|Lack of Efficacy|1|||
37827562|NCT00191269|69510387|FG001|Overall Study|Lack of Efficacy|5|||
37827563|NCT00191269|69510386|FG000|Overall Study|Withdrawal by Subject|0|||
37827564|NCT00191269|69510387|FG001|Overall Study|Withdrawal by Subject|1|||
37827565|NCT00191269|69510386|FG000|Overall Study|Pathologic Aggrevation|0|||
37901612|NCT00719212|69586937|FG000|Overall Study|Death|41|||
37901613|NCT00719212|69586937|FG000|Overall Study|Lost to Follow-up|2|||
37997371|NCT00311402|69681652|FG001|Overall Study|Protocol Violation|6|||
37997372|NCT00311402|69681651|FG000|Overall Study|IRB's rejection etc.|10|||
37827566|NCT00191269|69510387|FG001|Overall Study|Pathologic Aggrevation|1|||
37901614|NCT00719212|69586937|FG000|Overall Study|Withdrawal by Subject|1|||
37827567|NCT00191269|69510386|FG000|Overall Study|Physician Decision|0|||
37901615|NCT00585052|69586941|FG000|Overall Study|Withdrawal by Subject|1|||
37901616|NCT00724282|69586945|FG000|Overall Study|Withdrawal by Subject|3|||
37901617|NCT00724282|69586945|FG000|Overall Study|Physician Decision|1|||
37901618|NCT00724126|69586951|FG000|Overall Study|Adverse Event|2|||
37901619|NCT00724126|69586952|FG001|Overall Study|Adverse Event|0|||
37901620|NCT00724126|69586951|FG000|Overall Study|Withdrawal by Subject|8|||
37901621|NCT00724126|69586952|FG001|Overall Study|Withdrawal by Subject|6|||
37901622|NCT00724126|69586951|FG000|Overall Study|Lost to Follow-up|6|||
37901623|NCT00724126|69586952|FG001|Overall Study|Lost to Follow-up|6|||
37901624|NCT00724126|69586951|FG000|Overall Study|Noncompliance|2|||
37901625|NCT00724126|69586952|FG001|Overall Study|Noncompliance|1|||
37901626|NCT00724126|69586951|FG000|Overall Study|Subject randomized although ineligible|1|||
37901627|NCT00724126|69586952|FG001|Overall Study|Subject randomized although ineligible|1|||
37901628|NCT00724126|69586951|FG000|Overall Study|Subject had to leave vicinity of site|0|||
37901629|NCT00724126|69586952|FG001|Overall Study|Subject had to leave vicinity of site|1|||
37901630|NCT00723892|69586960|FG000|Overall Study|Participant not tracked|33|||
37901631|NCT00723892|69586961|FG001|Overall Study|Participant not tracked|35|||
37901632|NCT00723892|69586960|FG000|Overall Study|Virological criterion|24|||
37901633|NCT00723892|69586961|FG001|Overall Study|Virological criterion|9|||
37901634|NCT00723892|69586960|FG000|Overall Study|Withdrawal by Subject|6|||
37901635|NCT00723892|69586961|FG001|Overall Study|Withdrawal by Subject|9|||
37901636|NCT00723892|69586960|FG000|Overall Study|End planned|11|||
37901637|NCT00723892|69586961|FG001|Overall Study|End planned|7|||
37901638|NCT00723892|69586960|FG000|Overall Study|Bad tolerance|5|||
37901639|NCT00723892|69586961|FG001|Overall Study|Bad tolerance|5|||
37901640|NCT00723892|69586960|FG000|Overall Study|Multiple reasons|17|||
37901641|NCT00723892|69586961|FG001|Overall Study|Multiple reasons|12|||
37901642|NCT00723892|69586960|FG000|Overall Study|Other|6|||
37901643|NCT00723892|69586961|FG001|Overall Study|Other|3|||
37901644|NCT00723892|69586960|FG000|Overall Study|Study end|1|||
37901645|NCT00723892|69586961|FG001|Overall Study|Study end|3|||
37901646|NCT00723892|69586960|FG000|Overall Study|Weight loss|1|||
37901647|NCT00723892|69586961|FG001|Overall Study|Weight loss|3|||
37901648|NCT00723892|69586960|FG000|Overall Study|Alcohol abuse|0|||
37901649|NCT00723892|69586961|FG001|Overall Study|Alcohol abuse|1|||
37901650|NCT00723892|69586960|FG000|Overall Study|Intercurrent infection|2|||
37901651|NCT00723892|69586961|FG001|Overall Study|Intercurrent infection|0|||
37997373|NCT00311402|69681652|FG001|Overall Study|IRB's rejection etc.|3|||
37997374|NCT00450749|69681661|FG000|Overall Study|Withdrawal by Subject|0|||
37997375|NCT00450749|69681662|FG001|Overall Study|Withdrawal by Subject|0|||
37997376|NCT00450749|69681663|FG002|Overall Study|Withdrawal by Subject|2|||
37997377|NCT00450749|69681661|FG000|Overall Study|Noncompliant|0|||
37901652|NCT00723892|69586960|FG000|Overall Study|Drug addiction|1|||
37901653|NCT00723892|69586961|FG001|Overall Study|Drug addiction|0|||
37901654|NCT00718666|69586970|FG000|Booster Phase Year 5|No active participation request|0|||
37901655|NCT00718666|69586971|FG001|Booster Phase Year 5|No active participation request|0|||
37901656|NCT00718666|69586972|FG002|Booster Phase Year 5|No active participation request|1|||
37901657|NCT00718666|69586970|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
37901658|NCT00718666|69586971|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
37901659|NCT00718666|69586972|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
37901660|NCT00718666|69586970|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
37901661|NCT00718666|69586971|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
37901662|NCT00718666|69586972|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
37901663|NCT00718666|69586970|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
37901664|NCT00718666|69586971|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
37901665|NCT00718666|69586972|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
37901666|NCT03950440|69586993|FG000|Overall Study|Death|8|||
37901667|NCT03950440|69586994|FG001|Overall Study|Death|2|||
37901668|NCT03950440|69586995|FG002|Overall Study|Death|1|||
37901669|NCT00718510|69587005|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
37997378|NCT00450749|69681662|FG001|Overall Study|Noncompliant|1|||
37997379|NCT00450749|69681663|FG002|Overall Study|Noncompliant|0|||
37997380|NCT00292370|69681674|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
37997381|NCT00292370|69681675|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
37997382|NCT00292370|69681676|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
37827568|NCT00191269|69510387|FG001|Overall Study|Physician Decision|3|||
37827569|NCT00191191|69510396|FG000|Overall Study|Entry Criteria Exclusion|2|||
37827570|NCT00191191|69510397|FG001|Overall Study|Entry Criteria Exclusion|0|||
37827571|NCT00191191|69510396|FG000|Overall Study|Treated with Another Systemic Agent|1|||
37827572|NCT00191191|69510397|FG001|Overall Study|Treated with Another Systemic Agent|1|||
37827573|NCT00191191|69510396|FG000|Overall Study|Adverse Event|11|||
37827574|NCT00191191|69510397|FG001|Overall Study|Adverse Event|21|||
37827575|NCT00191191|69510396|FG000|Overall Study|Progressive Disease|84|||
37901670|NCT00718510|69587006|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
37827576|NCT00191191|69510397|FG001|Overall Study|Progressive Disease|72|||
37901671|NCT00718510|69587005|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
37901672|NCT00718510|69587006|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
37901673|NCT00585286|69587012|FG000|Overall Study|Lost to Follow-up|1|||
37901674|NCT00723190|69587016|FG000|Overall Study|Withdrawal by Subject|45|||
37901675|NCT00723190|69587016|FG000|Overall Study|Lost to Follow-up|37|||
37901676|NCT00723190|69587016|FG000|Overall Study|Adverse Event|18|||
37901677|NCT00723190|69587016|FG000|Overall Study|Lack of Efficacy|16|||
37901678|NCT00723190|69587016|FG000|Overall Study|Protocol Violation|15|||
37901679|NCT00723190|69587016|FG000|Overall Study|Other-Premature Discontinuation|9|||
37901680|NCT00723190|69587016|FG000|Overall Study|Other-Not included in safety population|2|||
37997383|NCT00292370|69681674|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
37997384|NCT00292370|69681675|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
37997385|NCT00292370|69681676|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
37997386|NCT00292370|69681674|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
37997387|NCT00292370|69681675|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
37997388|NCT00292370|69681676|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
37997389|NCT00292370|69681674|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
37997390|NCT00292370|69681675|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
37997391|NCT00292370|69681676|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
37997392|NCT00292370|69681674|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
37997393|NCT00292370|69681675|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
37997394|NCT00292370|69681676|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
37997395|NCT00292370|69681674|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
37997396|NCT00292370|69681675|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
37997397|NCT00292370|69681676|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
37997398|NCT00065182|69681685|FG000|Overall Study|Adverse Event|24|||
37997399|NCT00065182|69681686|FG001|Overall Study|Adverse Event|17|||
37997400|NCT00065182|69681685|FG000|Overall Study|Lost to Follow-up|0|||
37997401|NCT00065182|69681686|FG001|Overall Study|Lost to Follow-up|4|||
37997402|NCT00065182|69681685|FG000|Overall Study|Protocol Violation|3|||
37997403|NCT00065182|69681686|FG001|Overall Study|Protocol Violation|4|||
37997404|NCT00065182|69681685|FG000|Overall Study|Serious adverse events (SAE)|1|||
37997405|NCT00065182|69681686|FG001|Overall Study|Serious adverse events (SAE)|0|||
37997406|NCT00065182|69681685|FG000|Overall Study|Sponsor Decision|11|||
37997407|NCT00065182|69681686|FG001|Overall Study|Sponsor Decision|7|||
37997408|NCT00065182|69681685|FG000|Overall Study|Withdrawal by Subject|8|||
37997409|NCT00065182|69681686|FG001|Overall Study|Withdrawal by Subject|3|||
37997410|NCT00065182|69681685|FG000|Overall Study|No clinical benefit|1|||
37997411|NCT00065182|69681686|FG001|Overall Study|No clinical benefit|0|||
37997412|NCT00065182|69681685|FG000|Overall Study|Death|0|||
37997413|NCT00065182|69681686|FG001|Overall Study|Death|1|||
37827577|NCT00191191|69510396|FG000|Overall Study|Toxicity After Dose Reduction|7|||
37827578|NCT00191191|69510397|FG001|Overall Study|Toxicity After Dose Reduction|8|||
37827579|NCT00191191|69510396|FG000|Overall Study|Family/Caregiver Decision|5|||
37827580|NCT00191191|69510397|FG001|Overall Study|Family/Caregiver Decision|7|||
37997414|NCT00065182|69681685|FG000|Overall Study|Decline in Status|0|||
37997415|NCT00065182|69681686|FG001|Overall Study|Decline in Status|1|||
37827581|NCT00191191|69510396|FG000|Overall Study|Lost to Follow-up|1|||
37827582|NCT00191191|69510397|FG001|Overall Study|Lost to Follow-up|0|||
37827583|NCT00191191|69510396|FG000|Overall Study|Physician Decision|3|||
37827584|NCT00191191|69510397|FG001|Overall Study|Physician Decision|2|||
37827585|NCT00191191|69510396|FG000|Overall Study|Good Clinical Practice Violation|0|||
37827586|NCT00191191|69510397|FG001|Overall Study|Good Clinical Practice Violation|1|||
37827587|NCT00191152|69510405|FG000|Initial Treatment|Adverse Event|43|||
37827588|NCT00191152|69510406|FG001|Initial Treatment|Adverse Event|67|||
37827589|NCT00191152|69510405|FG000|Initial Treatment|Physician Decision|40|||
37827590|NCT00191152|69510406|FG001|Initial Treatment|Physician Decision|31|||
37827591|NCT00191152|69510405|FG000|Initial Treatment|Withdrawal by Subject|40|||
37827592|NCT00191152|69510406|FG001|Initial Treatment|Withdrawal by Subject|28|||
37827593|NCT00191152|69510405|FG000|Initial Treatment|Lost to Follow-up|0|||
37827594|NCT00191152|69510406|FG001|Initial Treatment|Lost to Follow-up|6|||
37827595|NCT00191152|69510405|FG000|Initial Treatment|Other|18|||
37827596|NCT00191152|69510406|FG001|Initial Treatment|Other|21|||
37997416|NCT00064792|69681694|FG000|Overall Study|Withdrawal by Subject|2|||
37997417|NCT00064792|69681695|FG001|Overall Study|Withdrawal by Subject|0|||
37997418|NCT00064792|69681694|FG000|Overall Study|Adverse Event|3|||
37997419|NCT00064792|69681695|FG001|Overall Study|Adverse Event|0|||
37827597|NCT00191152|69510405|FG000|Crossover Treatment|Adverse Event|8|||
37827598|NCT00191152|69510406|FG001|Crossover Treatment|Adverse Event|8|||
37827599|NCT00191152|69510405|FG000|Crossover Treatment|Physician Decision|7|||
37827600|NCT00191152|69510406|FG001|Crossover Treatment|Physician Decision|7|||
37827601|NCT00191152|69510405|FG000|Crossover Treatment|Withdrawal by Subject|6|||
37827602|NCT00191152|69510406|FG001|Crossover Treatment|Withdrawal by Subject|9|||
37827603|NCT00191152|69510405|FG000|Crossover Treatment|Lost to Follow-up|2|||
37827604|NCT00191152|69510406|FG001|Crossover Treatment|Lost to Follow-up|1|||
37827605|NCT00191152|69510405|FG000|Crossover Treatment|Other|4|||
37827606|NCT00191152|69510406|FG001|Crossover Treatment|Other|3|||
37901681|NCT00722800|69587022|FG000|Overall Study|Withdrawal by Subject|1|||
37901682|NCT00722800|69587023|FG001|Overall Study|Withdrawal by Subject|0|||
37901683|NCT00722800|69587022|FG000|Overall Study|Physician Decision|1|||
37901684|NCT00722800|69587023|FG001|Overall Study|Physician Decision|0|||
37901685|NCT00718042|69587035|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
37901686|NCT00718042|69587036|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
37901687|NCT00718042|69587037|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
37901688|NCT00718042|69587038|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
37901689|NCT00718042|69587039|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
37901690|NCT00718042|69587040|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
37901691|NCT00718042|69587035|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
37901692|NCT00718042|69587036|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
37901693|NCT00718042|69587037|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
37901694|NCT00718042|69587038|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
37901695|NCT00718042|69587039|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
37901696|NCT00718042|69587040|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
37901697|NCT00718042|69587035|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
37901698|NCT00718042|69587036|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
37901699|NCT00718042|69587037|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
37901700|NCT00718042|69587038|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
37901701|NCT00718042|69587039|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
37901702|NCT00718042|69587040|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
37901703|NCT00718042|69587035|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
37901704|NCT00718042|69587036|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
37901705|NCT00718042|69587037|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
37901706|NCT00718042|69587038|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
37901707|NCT00718042|69587039|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
37901708|NCT00718042|69587040|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
37901709|NCT00718042|69587035|FG000|Donor Follow-up|Lost to Follow-up|13|||
37901710|NCT00718042|69587036|FG001|Donor Follow-up|Lost to Follow-up|0|||
37901711|NCT00718042|69587037|FG002|Donor Follow-up|Lost to Follow-up|0|||
37901712|NCT00718042|69587038|FG003|Donor Follow-up|Lost to Follow-up|0|||
37901713|NCT00718042|69587039|FG004|Donor Follow-up|Lost to Follow-up|19|||
37901714|NCT00718042|69587040|FG005|Donor Follow-up|Lost to Follow-up|0|||
37901715|NCT00741598|69587054|FG000|Overall Study|Lost to Follow-up|3|||
37901716|NCT00741598|69587055|FG001|Overall Study|Lost to Follow-up|4|||
37697008|NCT02054715|69173386|FG001|Follow-up 2|Lost to Followup|1|||
37697009|NCT02054715|69173385|FG000|Follow-up 2|Refused|3|||
37697010|NCT02054715|69173386|FG001|Follow-up 2|Refused|2|||
37697011|NCT02054715|69173385|FG000|Follow-up 2|Followup Not Completed|3|||
37827607|NCT00190684|69510424|FG000|Overall Study|Adverse Event|86|||
37827608|NCT00190684|69510424|FG000|Overall Study|Satisfactory response|80|||
37827609|NCT00190684|69510424|FG000|Overall Study|Lack of efficacy|204|||
37827610|NCT00190684|69510424|FG000|Overall Study|Lost to Follow-up|232|||
37827611|NCT00190684|69510424|FG000|Overall Study|Patient moved|60|||
37827612|NCT00190684|69510424|FG000|Overall Study|Patient Decision|432|||
37827613|NCT00190684|69510424|FG000|Overall Study|Clinical relapse|67|||
37827614|NCT00190684|69510424|FG000|Overall Study|Sponsor's decision|17|||
37827615|NCT00190684|69510424|FG000|Overall Study|Physician Decision|84|||
37827616|NCT00190684|69510424|FG000|Overall Study|Protocol Violation|123|||
37827617|NCT00190684|69510424|FG000|Overall Study|Study Period III Completed|103|||
37827618|NCT00190684|69510424|FG000|Overall Study|Study Period V Completed|1|||
37827619|NCT00179959|69510435|FG000|Overall Study|Lost to Follow-up|3|||
37827620|NCT00179959|69510436|FG001|Overall Study|Lost to Follow-up|1|||
37827621|NCT00179959|69510435|FG000|Overall Study|Withdrawal by Subject|3|||
37827622|NCT00179959|69510436|FG001|Overall Study|Withdrawal by Subject|2|||
37827623|NCT00179647|69510442|FG000|Overall Study|Adverse Event|294|||
37827624|NCT00179647|69510442|FG000|Overall Study|Lack of Efficacy|478|||
37827625|NCT00179647|69510442|FG000|Overall Study|Withdrawal by Subject|83|||
37827626|NCT00179647|69510442|FG000|Overall Study|Lost to Follow-up|4|||
37827627|NCT00179647|69510442|FG000|Overall Study|Death|94|||
37827628|NCT00179647|69510442|FG000|Overall Study|Other|960|||
37827629|NCT00179413|69510448|FG000|Overall Study|Adverse Event|38|||
37827630|NCT00179413|69510449|FG001|Overall Study|Adverse Event|20|||
37827631|NCT00179413|69510448|FG000|Overall Study|Withdrawal by Subject|87|||
37827632|NCT00179413|69510449|FG001|Overall Study|Withdrawal by Subject|95|||
37827633|NCT00178633|69510455|FG000|Overall Study|Lost to Follow-up|6|||
37827634|NCT00178399|69510460|FG000|Overall Study|Physician Decision|4|||
37827635|NCT00178399|69510460|FG000|Overall Study|Withdrawal by Subject|8|||
37827636|NCT00178399|69510460|FG000|Overall Study|Lost to Follow-up|1|||
37827637|NCT00178126|69510467|FG000|Overall Study|Lost to Follow-up|21|||
37901717|NCT00741598|69587054|FG000|Overall Study|Lack of Efficacy|1|||
37901718|NCT00741598|69587055|FG001|Overall Study|Lack of Efficacy|2|||
37901719|NCT00741598|69587054|FG000|Overall Study|Physician Decision|1|||
37901720|NCT00741598|69587055|FG001|Overall Study|Physician Decision|1|||
37901721|NCT00741598|69587054|FG000|Overall Study|Pregnancy|1|||
37827638|NCT00178126|69510468|FG001|Overall Study|Lost to Follow-up|21|||
37827639|NCT00178126|69510467|FG000|Overall Study|did not receive intervention|4|||
37997420|NCT00450437|69681703|FG000|Overall Study|Withdrawal by Subject|10|||
37997421|NCT00450437|69681704|FG001|Overall Study|Withdrawal by Subject|2|||
37997422|NCT00450437|69681705|FG002|Overall Study|Withdrawal by Subject|0|||
37997423|NCT00450437|69681706|FG003|Overall Study|Withdrawal by Subject|1|||
37997424|NCT00450437|69681703|FG000|Overall Study|Lost to Follow-up|31|||
37997425|NCT00450437|69681704|FG001|Overall Study|Lost to Follow-up|12|||
37901722|NCT00741598|69587055|FG001|Overall Study|Pregnancy|0|||
37901723|NCT00741598|69587054|FG000|Overall Study|Withdrawal by Subject|3|||
37901724|NCT00741598|69587055|FG001|Overall Study|Withdrawal by Subject|2|||
37901725|NCT00717886|69587062|FG000|Overall Study|Withdrawal by Subject|3|||
37901726|NCT00717886|69587062|FG000|Overall Study|Treatment Failure|1|||
37901727|NCT00741286|69587068|FG000|Overall Study|Lost to Follow-up|15|||
37901728|NCT00741286|69587069|FG001|Overall Study|Lost to Follow-up|10|||
37901729|NCT00741286|69587068|FG000|Overall Study|Adverse Event|1|||
37901730|NCT00741286|69587069|FG001|Overall Study|Adverse Event|6|||
37901731|NCT00741286|69587068|FG000|Overall Study|Protocol Violation|3|||
37901732|NCT00741286|69587069|FG001|Overall Study|Protocol Violation|2|||
37901733|NCT00741286|69587068|FG000|Overall Study|Primary Outcome|1|||
37901734|NCT00741286|69587069|FG001|Overall Study|Primary Outcome|1|||
37901735|NCT00716482|69587075|FG000|Overall Study|Lost to Follow-up|6|||
37901736|NCT00716482|69587075|FG000|Overall Study|Inadequate acquisition or analysis|50|||
37901737|NCT00716482|69587075|FG000|Overall Study|no pathology obtained|10|||
37901738|NCT00716482|69587075|FG000|Overall Study|technical/machine error|28|||
37901739|NCT00716482|69587075|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
37901740|NCT00716092|69587088|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
37901741|NCT00716092|69587089|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
37901742|NCT00716092|69587090|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
37901743|NCT00715624|69587100|FG000|Overall Study|Adverse Event|12|||
37901744|NCT00715624|69587101|FG001|Overall Study|Adverse Event|37|||
37997426|NCT00450437|69681705|FG002|Overall Study|Lost to Follow-up|19|||
37997427|NCT00450437|69681706|FG003|Overall Study|Lost to Follow-up|9|||
37997428|NCT00450437|69681703|FG000|Overall Study|Protocol Violation|0|||
37997429|NCT00450437|69681704|FG001|Overall Study|Protocol Violation|1|||
37997430|NCT00450437|69681705|FG002|Overall Study|Protocol Violation|0|||
37997431|NCT00450437|69681706|FG003|Overall Study|Protocol Violation|1|||
37997432|NCT00450437|69681703|FG000|Overall Study|Inappropriate enrollment|4|||
37997433|NCT00450437|69681704|FG001|Overall Study|Inappropriate enrollment|1|||
37997434|NCT00450437|69681705|FG002|Overall Study|Inappropriate enrollment|3|||
37997435|NCT00450437|69681706|FG003|Overall Study|Inappropriate enrollment|0|||
37997436|NCT00450437|69681703|FG000|Overall Study|Administrative reason|0|||
37997437|NCT00450437|69681704|FG001|Overall Study|Administrative reason|0|||
37997438|NCT00450437|69681705|FG002|Overall Study|Administrative reason|1|||
37997439|NCT00450437|69681706|FG003|Overall Study|Administrative reason|0|||
37997440|NCT00450437|69681703|FG000|Overall Study|Unable to Classify|1|||
37827640|NCT00178126|69510468|FG001|Overall Study|did not receive intervention|6|||
37827641|NCT00177307|69510474|FG000|Overall Study|Withdrawal by Subject|1|||
37901745|NCT00715624|69587100|FG000|Overall Study|Lack of Efficacy|11|||
37901746|NCT00715624|69587101|FG001|Overall Study|Lack of Efficacy|11|||
37901747|NCT00715624|69587100|FG000|Overall Study|Lost to Follow-up|1|||
37901748|NCT00715624|69587101|FG001|Overall Study|Lost to Follow-up|2|||
37901749|NCT00715624|69587100|FG000|Overall Study|Protocol Violation|1|||
37901750|NCT00715624|69587101|FG001|Overall Study|Protocol Violation|0|||
37901751|NCT00715624|69587100|FG000|Overall Study|Withdrawal by Subject|11|||
37901752|NCT00715624|69587101|FG001|Overall Study|Withdrawal by Subject|25|||
37901753|NCT00715624|69587100|FG000|Overall Study|Familial and personal reasons|10|||
37997441|NCT00450437|69681704|FG001|Overall Study|Unable to Classify|0|||
37997442|NCT00450437|69681705|FG002|Overall Study|Unable to Classify|1|||
37827642|NCT00176605|69510482|FG000|Overall Study|Withdrawal by Subject|2|||
37827643|NCT00176488|69510486|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
37827644|NCT00175825|69510494|FG000|Overall Study|Adverse Event|3|||
37827645|NCT00175825|69510495|FG001|Overall Study|Adverse Event|2|||
37827646|NCT00175825|69510496|FG002|Overall Study|Adverse Event|1|||
37827647|NCT00175825|69510497|FG003|Overall Study|Adverse Event|1|||
37827648|NCT00175825|69510494|FG000|Overall Study|Lost to Follow-up|1|||
37827649|NCT00175825|69510495|FG001|Overall Study|Lost to Follow-up|2|||
37827650|NCT00175825|69510496|FG002|Overall Study|Lost to Follow-up|0|||
37827651|NCT00175825|69510497|FG003|Overall Study|Lost to Follow-up|0|||
37901754|NCT00715624|69587101|FG001|Overall Study|Familial and personal reasons|22|||
37901755|NCT00715624|69587100|FG000|Overall Study|Poor compliance|6|||
37901756|NCT00715624|69587101|FG001|Overall Study|Poor compliance|13|||
37901757|NCT00715624|69587100|FG000|Overall Study|Sponsor decision|0|||
37901758|NCT00715624|69587101|FG001|Overall Study|Sponsor decision|4|||
37901759|NCT00715624|69587100|FG000|Overall Study|Incorrect randomization (not treated)|0|||
37901760|NCT00715624|69587101|FG001|Overall Study|Incorrect randomization (not treated)|1|||
37997443|NCT00450437|69681706|FG003|Overall Study|Unable to Classify|0|||
37997444|NCT00286442|69681723|FG000|Overall Study|Hyperglycemic Rescue|19|||
37901761|NCT00715624|69587100|FG000|Overall Study|Other|0|||
37901762|NCT00715624|69587101|FG001|Overall Study|Other|1|||
37901763|NCT00576199|69587107|FG000|Overall Study|Adverse Event|12|||
37901764|NCT00576199|69587107|FG000|Overall Study|Insufficient Therapeutic Response|14|||
37901765|NCT00576199|69587107|FG000|Overall Study|Refused Treatment|2|||
37901766|NCT00576199|69587107|FG000|Overall Study|Reason Unspecified|2|||
37901767|NCT00715078|69587114|FG000|Overall Study|Death|29|||
37901768|NCT00715078|69587115|FG001|Overall Study|Death|36|||
37901769|NCT00715078|69587116|FG002|Overall Study|Death|36|||
37901770|NCT00715078|69587114|FG000|Overall Study|Withdrawal by Subject|1|||
37901771|NCT00715078|69587115|FG001|Overall Study|Withdrawal by Subject|0|||
37901772|NCT00715078|69587116|FG002|Overall Study|Withdrawal by Subject|1|||
37901773|NCT00715078|69587114|FG000|Overall Study|Unable to start due to disease prog.|0|||
37901774|NCT00715078|69587115|FG001|Overall Study|Unable to start due to disease prog.|0|||
37901775|NCT00715078|69587116|FG002|Overall Study|Unable to start due to disease prog.|1|||
37901776|NCT00679627|69587126|FG000|Overall Study|Death|41|||
37901777|NCT00679627|69587127|FG001|Overall Study|Death|29|||
37901778|NCT00679627|69587126|FG000|Overall Study|Adverse Event|43|||
37901779|NCT00679627|69587127|FG001|Overall Study|Adverse Event|53|||
37901780|NCT00679627|69587126|FG000|Overall Study|Withdrawal by Subject|168|||
37901781|NCT00679627|69587127|FG001|Overall Study|Withdrawal by Subject|172|||
37901782|NCT00679627|69587126|FG000|Overall Study|Lost to Follow-up|22|||
37901783|NCT00679627|69587127|FG001|Overall Study|Lost to Follow-up|26|||
37901784|NCT00679627|69587126|FG000|Overall Study|Early Study Closure|425|||
37901785|NCT00679627|69587127|FG001|Overall Study|Early Study Closure|405|||
37901786|NCT00714688|69587136|FG000|Overall Study|Lack of Efficacy|14|||
37901787|NCT00714688|69587137|FG001|Overall Study|Lack of Efficacy|1|||
37901788|NCT00714688|69587138|FG002|Overall Study|Lack of Efficacy|4|||
37901789|NCT00714688|69587136|FG000|Overall Study|Withdrawal by Subject|4|||
37901790|NCT00714688|69587137|FG001|Overall Study|Withdrawal by Subject|3|||
37901791|NCT00714688|69587138|FG002|Overall Study|Withdrawal by Subject|3|||
37901792|NCT00714688|69587136|FG000|Overall Study|Lost to Follow-up|5|||
37901793|NCT00714688|69587137|FG001|Overall Study|Lost to Follow-up|2|||
37901794|NCT00714688|69587138|FG002|Overall Study|Lost to Follow-up|0|||
37901795|NCT00714688|69587136|FG000|Overall Study|Adverse Event|2|||
37901796|NCT00714688|69587137|FG001|Overall Study|Adverse Event|15|||
37901797|NCT00714688|69587138|FG002|Overall Study|Adverse Event|19|||
37901798|NCT00714688|69587136|FG000|Overall Study|Subject Non-compliant|3|||
37901799|NCT00714688|69587137|FG001|Overall Study|Subject Non-compliant|5|||
37901800|NCT00714688|69587138|FG002|Overall Study|Subject Non-compliant|5|||
37901801|NCT00714688|69587136|FG000|Overall Study|Ineligible to Continue the Study|0|||
37901802|NCT00714688|69587137|FG001|Overall Study|Ineligible to Continue the Study|1|||
37901803|NCT00714688|69587138|FG002|Overall Study|Ineligible to Continue the Study|1|||
37901804|NCT00714688|69587136|FG000|Overall Study|Sponsor's Decision|0|||
37901805|NCT00714688|69587137|FG001|Overall Study|Sponsor's Decision|2|||
37901806|NCT00714688|69587138|FG002|Overall Study|Sponsor's Decision|0|||
37901807|NCT00714688|69587136|FG000|Overall Study|Other|1|||
37901808|NCT00714688|69587137|FG001|Overall Study|Other|6|||
37901809|NCT00714688|69587138|FG002|Overall Study|Other|5|||
37901810|NCT00679549|69587148|FG000|Overall Study|dropout|2|||
37901811|NCT00679549|69587149|FG001|Overall Study|dropout|4|||
37901812|NCT00679549|69587148|FG000|Overall Study|missing outcome echocardiograms|4|||
37901813|NCT00679549|69587149|FG001|Overall Study|missing outcome echocardiograms|5|||
37901814|NCT01031069|69587159|FG000|Overall Study|Serious Adverse Event|0|||
37901815|NCT01031069|69587160|FG001|Overall Study|Serious Adverse Event|1|||
37901816|NCT01031069|69587161|FG002|Overall Study|Serious Adverse Event|0|||
37901817|NCT01031069|69587162|FG003|Overall Study|Serious Adverse Event|0|||
37901818|NCT01031069|69587159|FG000|Overall Study|Withdrawal by Subject|2|||
37901819|NCT01031069|69587160|FG001|Overall Study|Withdrawal by Subject|3|||
37901820|NCT01031069|69587161|FG002|Overall Study|Withdrawal by Subject|18|||
37901821|NCT01031069|69587162|FG003|Overall Study|Withdrawal by Subject|18|||
37901822|NCT01031069|69587159|FG000|Overall Study|Migrated/moved from study area|1|||
37901823|NCT01031069|69587160|FG001|Overall Study|Migrated/moved from study area|2|||
37901824|NCT01031069|69587161|FG002|Overall Study|Migrated/moved from study area|1|||
37901825|NCT01031069|69587162|FG003|Overall Study|Migrated/moved from study area|1|||
37901826|NCT01031069|69587159|FG000|Overall Study|Lost to Follow-up|9|||
37901827|NCT01031069|69587160|FG001|Overall Study|Lost to Follow-up|5|||
37901828|NCT01031069|69587161|FG002|Overall Study|Lost to Follow-up|21|||
37901829|NCT01031069|69587162|FG003|Overall Study|Lost to Follow-up|15|||
37901830|NCT01031069|69587159|FG000|Overall Study|Other|0|||
37901831|NCT01031069|69587160|FG001|Overall Study|Other|0|||
37901832|NCT01031069|69587161|FG002|Overall Study|Other|1|||
37901833|NCT01031069|69587162|FG003|Overall Study|Other|0|||
37901834|NCT00679081|69587174|FG000|Overall Study|Lost to Follow-up|1|||
37901835|NCT00682435|69587182|FG000|Overall Study|Insufficient data|5|||
37901836|NCT00682435|69587182|FG000|Overall Study|Erroneously enrolled twice|2|||
37901837|NCT00713830|69587188|FG000|Overall Study|Adverse Event|23|||
37997445|NCT00286442|69681724|FG001|Overall Study|Hyperglycemic Rescue|17|||
37997446|NCT00286442|69681725|FG002|Overall Study|Hyperglycemic Rescue|25|||
37997447|NCT00286442|69681723|FG000|Overall Study|Adverse Event|7|||
37997448|NCT00286442|69681724|FG001|Overall Study|Adverse Event|6|||
37997449|NCT00286442|69681725|FG002|Overall Study|Adverse Event|1|||
37997450|NCT00286442|69681723|FG000|Overall Study|Protocol Violation|2|||
37997451|NCT00286442|69681724|FG001|Overall Study|Protocol Violation|4|||
37997452|NCT00286442|69681725|FG002|Overall Study|Protocol Violation|2|||
37997453|NCT00286442|69681723|FG000|Overall Study|Lost to Follow-up|5|||
37997454|NCT00286442|69681724|FG001|Overall Study|Lost to Follow-up|2|||
37997455|NCT00286442|69681725|FG002|Overall Study|Lost to Follow-up|1|||
37997456|NCT00286442|69681723|FG000|Overall Study|Physician Decision|1|||
37997457|NCT00286442|69681724|FG001|Overall Study|Physician Decision|1|||
37997458|NCT00286442|69681725|FG002|Overall Study|Physician Decision|1|||
37997459|NCT00286442|69681723|FG000|Overall Study|Administrative Error|1|||
37997460|NCT00286442|69681724|FG001|Overall Study|Administrative Error|1|||
37997461|NCT00286442|69681725|FG002|Overall Study|Administrative Error|0|||
37997462|NCT00286442|69681723|FG000|Overall Study|Withdrawal by Subject|2|||
37997463|NCT00286442|69681724|FG001|Overall Study|Withdrawal by Subject|14|||
37997464|NCT00286442|69681725|FG002|Overall Study|Withdrawal by Subject|2|||
37997465|NCT00063934|69681733|FG000|Overall Study|Ineligible|1|||
37997466|NCT00458783|69681739|FG000|Overall Study|Protocol Violation|1228|||
37997467|NCT00458783|69681740|FG001|Overall Study|Protocol Violation|1220|||
37997468|NCT00063154|69681746|FG000|Overall Study|Disease progression|27|||
37997469|NCT00063154|69681746|FG000|Overall Study|Adverse Event|2|||
37997470|NCT00063154|69681746|FG000|Overall Study|Physician Decision|10|||
37997471|NCT00063154|69681746|FG000|Overall Study|Death|3|||
37997472|NCT00063154|69681746|FG000|Overall Study|Reason unspecified|1|||
37997473|NCT00063154|69681746|FG000|Overall Study|Did not receive treatment|8|||
37997474|NCT00311168|69681752|FG000|First Intervention|Withdrawal by Subject|2|||
37997475|NCT00311168|69681753|FG001|First Intervention|Withdrawal by Subject|2|||
37997476|NCT00311168|69681752|FG000|First Intervention|Lost to Follow-up|1|||
37997477|NCT00311168|69681753|FG001|First Intervention|Lost to Follow-up|1|||
37997478|NCT00311168|69681752|FG000|First Intervention|Protocol Violation|1|||
37997479|NCT00311168|69681753|FG001|First Intervention|Protocol Violation|1|||
37997480|NCT00311168|69681752|FG000|First Intervention|Adverse Event|1|||
37997481|NCT00311168|69681753|FG001|First Intervention|Adverse Event|0|||
37997482|NCT00311168|69681752|FG000|First Intervention|Other|2|||
37997483|NCT00311168|69681753|FG001|First Intervention|Other|2|||
37997484|NCT00311168|69681752|FG000|Second Intervention|Lost to Follow-up|9|||
37997485|NCT00311168|69681753|FG001|Second Intervention|Lost to Follow-up|2|||
37997486|NCT00311168|69681752|FG000|Second Intervention|Withdrawal by Subject|0|||
37997487|NCT00311168|69681753|FG001|Second Intervention|Withdrawal by Subject|1|||
37997488|NCT00311168|69681752|FG000|Second Intervention|Other|1|||
37997489|NCT00311168|69681753|FG001|Second Intervention|Other|1|||
37997490|NCT00458705|69681761|FG000|Overall Study|Adverse Event|4|||
37997491|NCT00458705|69681761|FG000|Overall Study|Not Treated|1|||
37997492|NCT00062374|69681765|FG000|Overall Study|Not treated|12|||
37997493|NCT00285818|69681771|FG000|Overall Study|Withdrawal by Subject|3|||
37997494|NCT00285818|69681772|FG001|Overall Study|Withdrawal by Subject|2|||
37997495|NCT00285818|69681771|FG000|Overall Study|Lost to Follow-up|1|||
37997496|NCT00285818|69681772|FG001|Overall Study|Lost to Follow-up|0|||
37997497|NCT00285584|69681780|FG000|Month 3|Lost to Follow-up|3|||
37997498|NCT00285584|69681781|FG001|Month 3|Lost to Follow-up|3|||
37997499|NCT00285584|69681780|FG000|Month 3|Withdrawal by Subject|1|||
37697012|NCT02054715|69173386|FG001|Follow-up 2|Followup Not Completed|4|||
37827652|NCT00175825|69510494|FG000|Overall Study|Withdrawal by Subject|1|||
37827653|NCT00175825|69510495|FG001|Overall Study|Withdrawal by Subject|0|||
37827654|NCT00175825|69510496|FG002|Overall Study|Withdrawal by Subject|0|||
37827655|NCT00175825|69510497|FG003|Overall Study|Withdrawal by Subject|0|||
37827656|NCT00174967|69510511|FG000|Overall Study|Adverse Event|1|||
37827657|NCT00174967|69510512|FG001|Overall Study|Adverse Event|2|||
37827658|NCT00174967|69510513|FG002|Overall Study|Adverse Event|2|||
37827659|NCT00174967|69510514|FG003|Overall Study|Adverse Event|1|||
37827660|NCT00174967|69510511|FG000|Overall Study|Gout Flare|0|||
37827661|NCT00174967|69510512|FG001|Overall Study|Gout Flare|0|||
37997500|NCT00285584|69681781|FG001|Month 3|Withdrawal by Subject|0|||
37997501|NCT00285584|69681780|FG000|Month 6|Lost to Follow-up|0|||
37997502|NCT00285584|69681781|FG001|Month 6|Lost to Follow-up|1|||
37997503|NCT03807700|69681793|FG000|Overall Study|Withdrawal by Subject|2|||
37997504|NCT03807700|69681794|FG001|Overall Study|Withdrawal by Subject|1|||
37997505|NCT00291668|69681804|FG000|Overall Study|Lack of Efficacy|1|||
37997506|NCT00291668|69681805|FG001|Overall Study|Lack of Efficacy|0|||
37997507|NCT00291668|69681806|FG002|Overall Study|Lack of Efficacy|0|||
37997508|NCT00291668|69681804|FG000|Overall Study|SAE, non-fatal|1|||
37827662|NCT00174967|69510513|FG002|Overall Study|Gout Flare|0|||
37697013|NCT02054715|69173385|FG000|Follow-up 2|Ineligible|4|||
37697014|NCT02054715|69173386|FG001|Follow-up 2|Ineligible|5|||
37997509|NCT00291668|69681805|FG001|Overall Study|SAE, non-fatal|1|||
37997510|NCT00291668|69681806|FG002|Overall Study|SAE, non-fatal|1|||
37997511|NCT00291668|69681804|FG000|Overall Study|AE, non-serious non-fatal|1|||
37997512|NCT00291668|69681805|FG001|Overall Study|AE, non-serious non-fatal|0|||
37997513|NCT00291668|69681806|FG002|Overall Study|AE, non-serious non-fatal|0|||
37997514|NCT00291668|69681804|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
37997515|NCT00291668|69681805|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
37997516|NCT00291668|69681806|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
37997517|NCT00458393|69681816|FG000|Overall Study|Withdrawal by Subject|67|||
37997518|NCT00458393|69681817|FG001|Overall Study|Withdrawal by Subject|80|||
37997519|NCT00458393|69681816|FG000|Overall Study|Physician Decision|31|||
37997520|NCT00458393|69681817|FG001|Overall Study|Physician Decision|22|||
37901838|NCT00713830|69587189|FG001|Overall Study|Adverse Event|71|||
37901839|NCT00713830|69587188|FG000|Overall Study|Lack of Efficacy|24|||
37901840|NCT00713830|69587189|FG001|Overall Study|Lack of Efficacy|16|||
37901841|NCT00713830|69587188|FG000|Overall Study|Lost to Follow-up|2|||
37901842|NCT00713830|69587189|FG001|Overall Study|Lost to Follow-up|9|||
37901843|NCT00713830|69587188|FG000|Overall Study|Withdrawal by Subject|13|||
37901844|NCT00713830|69587189|FG001|Overall Study|Withdrawal by Subject|23|||
37901845|NCT00713830|69587188|FG000|Overall Study|Poor Compliance to Protocol|7|||
37901846|NCT00713830|69587189|FG001|Overall Study|Poor Compliance to Protocol|14|||
37901847|NCT00713830|69587188|FG000|Overall Study|Familial and Personal Reasons|9|||
37901848|NCT00713830|69587189|FG001|Overall Study|Familial and Personal Reasons|34|||
37901849|NCT00713830|69587188|FG000|Overall Study|Sponsor Decision|4|||
37901850|NCT00713830|69587189|FG001|Overall Study|Sponsor Decision|10|||
37901851|NCT00681811|69587197|FG000|Overall Study|Adverse Event|1|||
37901852|NCT00681811|69587198|FG001|Overall Study|Adverse Event|1|||
37901853|NCT00681811|69587197|FG000|Overall Study|Withdrawal by Subject|2|||
37901854|NCT00681811|69587198|FG001|Overall Study|Withdrawal by Subject|2|||
37901855|NCT00681811|69587197|FG000|Overall Study|Non-compliance|0|||
37901856|NCT00681811|69587198|FG001|Overall Study|Non-compliance|1|||
37997521|NCT00458393|69681816|FG000|Overall Study|Relocated|77|||
37997522|NCT00458393|69681817|FG001|Overall Study|Relocated|81|||
37997523|NCT00458393|69681816|FG000|Overall Study|Lost to Follow-up|115|||
37997524|NCT00458393|69681817|FG001|Overall Study|Lost to Follow-up|92|||
37997525|NCT00458393|69681816|FG000|Overall Study|Sites marked other on the form.|19|||
37997526|NCT00458393|69681817|FG001|Overall Study|Sites marked other on the form.|20|||
37997527|NCT00310856|69681828|FG000|Overall Study|Withdrawal by Subject|2|||
37997528|NCT00310856|69681829|FG001|Overall Study|Withdrawal by Subject|2|||
37997529|NCT00310856|69681830|FG002|Overall Study|Withdrawal by Subject|2|||
37827663|NCT00174967|69510514|FG003|Overall Study|Gout Flare|1|||
37827664|NCT00174967|69510511|FG000|Overall Study|Other|0|||
37827665|NCT00174967|69510512|FG001|Overall Study|Other|1|||
37827666|NCT00174967|69510513|FG002|Overall Study|Other|0|||
37827667|NCT00174967|69510514|FG003|Overall Study|Other|0|||
37827668|NCT00174265|69510526|FG000|Overall Study|Adverse Event|7|||
37827669|NCT00174265|69510527|FG001|Overall Study|Adverse Event|4|||
37827670|NCT00174265|69510526|FG000|Overall Study|Lack of Efficacy|2|||
37827671|NCT00174265|69510527|FG001|Overall Study|Lack of Efficacy|2|||
37827672|NCT00174265|69510526|FG000|Overall Study|Withdrawal by Subject|3|||
37827673|NCT00174265|69510527|FG001|Overall Study|Withdrawal by Subject|5|||
37827674|NCT00174265|69510526|FG000|Overall Study|Lost to Follow-up|1|||
37827675|NCT00174265|69510527|FG001|Overall Study|Lost to Follow-up|0|||
37827676|NCT00174265|69510526|FG000|Overall Study|Other (Not specified)|16|||
37827677|NCT00174265|69510527|FG001|Overall Study|Other (Not specified)|10|||
37827678|NCT00172042|69510535|FG000|Overall Study|Adverse Event|27|||
37827679|NCT00172042|69510536|FG001|Overall Study|Adverse Event|13|||
37827680|NCT00172042|69510535|FG000|Overall Study|Abnormal laboratory value(s)|5|||
37827681|NCT00172042|69510536|FG001|Overall Study|Abnormal laboratory value(s)|1|||
37827682|NCT00172042|69510535|FG000|Overall Study|Abnormal test procedure(s)|0|||
37997530|NCT00310856|69681828|FG000|Overall Study|Lost to Follow-up|1|||
37997531|NCT00310856|69681829|FG001|Overall Study|Lost to Follow-up|2|||
37997532|NCT00310856|69681830|FG002|Overall Study|Lost to Follow-up|6|||
37997533|NCT00310856|69681828|FG000|Overall Study|Inappropriate enrollment|1|||
37997534|NCT00310856|69681829|FG001|Overall Study|Inappropriate enrollment|1|||
37997535|NCT00310856|69681830|FG002|Overall Study|Inappropriate enrollment|0|||
37827683|NCT00172042|69510536|FG001|Overall Study|Abnormal test procedure(s)|3|||
37827684|NCT00172042|69510535|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
37997536|NCT00310856|69681828|FG000|Overall Study|Unable to classify|1|||
37827685|NCT00172042|69510536|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
37827686|NCT00172042|69510535|FG000|Overall Study|Patient no longer requires study drug|10|||
37997537|NCT00310856|69681829|FG001|Overall Study|Unable to classify|0|||
37827687|NCT00172042|69510536|FG001|Overall Study|Patient no longer requires study drug|8|||
37901857|NCT00681187|69587217|FG000|Overall Study|Withdrawal by Subject|1|||
37901858|NCT00681187|69587218|FG001|Overall Study|Withdrawal by Subject|0|||
37901859|NCT00681187|69587217|FG000|Overall Study|Death|0|||
37901860|NCT00681187|69587218|FG001|Overall Study|Death|1|||
37901861|NCT00681187|69587217|FG000|Overall Study|Adverse Event|0|||
37901862|NCT00681187|69587218|FG001|Overall Study|Adverse Event|1|||
37901863|NCT00681109|69587240|FG000|Overall Study|Lost to Follow-up|2|||
37901864|NCT00681109|69587241|FG001|Overall Study|Lost to Follow-up|6|||
37901865|NCT00681109|69587242|FG002|Overall Study|Lost to Follow-up|0|||
37901866|NCT02588950|69587253|FG000|Period 2 (Part A)|Withdrawal by Subject|0|||
37901867|NCT02588950|69587254|FG001|Period 2 (Part A)|Withdrawal by Subject|0|||
37901868|NCT02588950|69587255|FG002|Period 2 (Part A)|Withdrawal by Subject|1|||
37901869|NCT02588950|69587256|FG003|Period 2 (Part A)|Withdrawal by Subject|0|||
37901870|NCT02588950|69587253|FG000|Period 3 (Part B)|Withdrawal by Subject|0|||
37901871|NCT02588950|69587254|FG001|Period 3 (Part B)|Withdrawal by Subject|0|||
37901872|NCT02588950|69587255|FG002|Period 3 (Part B)|Withdrawal by Subject|0|||
37997538|NCT00310856|69681830|FG002|Overall Study|Unable to classify|0|||
37997539|NCT00283712|69681841|FG000|Overall Study|Death|0|||
37997540|NCT00283712|69681842|FG001|Overall Study|Death|1|||
37997541|NCT00048724|69681850|FG000|Overall Study|Adverse Event|53|||
37997542|NCT00048724|69681851|FG001|Overall Study|Adverse Event|12|||
37997543|NCT00048724|69681850|FG000|Overall Study|Withdrawal by Subject|34|||
37901873|NCT02588950|69587256|FG003|Period 3 (Part B)|Withdrawal by Subject|1|||
37901874|NCT00680407|69587269|FG000|Overall Study|Lost to Follow-up|3|||
37901875|NCT00680407|69587270|FG001|Overall Study|Lost to Follow-up|3|||
37901876|NCT00680407|69587271|FG002|Overall Study|Lost to Follow-up|1|||
37901877|NCT00680407|69587269|FG000|Overall Study|Withdrawal by Subject|5|||
37901878|NCT00680407|69587270|FG001|Overall Study|Withdrawal by Subject|2|||
37901879|NCT00680407|69587271|FG002|Overall Study|Withdrawal by Subject|2|||
37901880|NCT00677365|69587283|FG000|Overall Study|Adverse Event|2|||
37901881|NCT00677365|69587284|FG001|Overall Study|Adverse Event|1|||
37901882|NCT00677365|69587285|FG002|Overall Study|Adverse Event|1|||
37901883|NCT00677365|69587286|FG003|Overall Study|Adverse Event|2|||
37901884|NCT00677365|69587283|FG000|Overall Study|Withdrawal by Subject|0|||
37901885|NCT00677365|69587284|FG001|Overall Study|Withdrawal by Subject|0|||
37901886|NCT00677365|69587285|FG002|Overall Study|Withdrawal by Subject|1|||
37901887|NCT00677365|69587286|FG003|Overall Study|Withdrawal by Subject|0|||
37901888|NCT00677365|69587283|FG000|Overall Study|Other reason|0|||
37901889|NCT00677365|69587284|FG001|Overall Study|Other reason|0|||
37901890|NCT00677365|69587285|FG002|Overall Study|Other reason|0|||
37901891|NCT00677365|69587286|FG003|Overall Study|Other reason|1|||
37827688|NCT00172042|69510535|FG000|Overall Study|Protocol Violation|8|||
37827689|NCT00172042|69510536|FG001|Overall Study|Protocol Violation|7|||
37901892|NCT00680017|69587298|FG000|Overall Study|Adverse Event|13|||
37997544|NCT00048724|69681851|FG001|Overall Study|Withdrawal by Subject|54|||
37997545|NCT00048724|69681850|FG000|Overall Study|Lost to Follow-up|5|||
37997546|NCT00048724|69681851|FG001|Overall Study|Lost to Follow-up|5|||
37997547|NCT00048724|69681850|FG000|Overall Study|Protocol-defined Clinical Event|17|||
37997548|NCT00048724|69681851|FG001|Overall Study|Protocol-defined Clinical Event|32|||
37997549|NCT00048724|69681850|FG000|Overall Study|Noncompliance With Protocol|4|||
37997550|NCT00048724|69681851|FG001|Overall Study|Noncompliance With Protocol|12|||
37997551|NCT00048724|69681850|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
37997552|NCT00048724|69681851|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
37827690|NCT00172042|69510535|FG000|Overall Study|Withdrawal by Subject|37|||
37827691|NCT00172042|69510536|FG001|Overall Study|Withdrawal by Subject|25|||
37827692|NCT00172042|69510535|FG000|Overall Study|Lost to Follow-up|3|||
37827693|NCT00172042|69510536|FG001|Overall Study|Lost to Follow-up|5|||
37827694|NCT00172042|69510535|FG000|Overall Study|Administrative problems|13|||
37827695|NCT00172042|69510536|FG001|Overall Study|Administrative problems|10|||
37827696|NCT00172042|69510535|FG000|Overall Study|Death|42|||
37901893|NCT00680017|69587299|FG001|Overall Study|Adverse Event|7|||
37901894|NCT00680017|69587298|FG000|Overall Study|Withdrawal by Subject|2|||
37901895|NCT00680017|69587299|FG001|Overall Study|Withdrawal by Subject|5|||
37901896|NCT00680017|69587298|FG000|Overall Study|Lost to Follow-up|2|||
37901897|NCT00680017|69587299|FG001|Overall Study|Lost to Follow-up|0|||
37901898|NCT00676663|69587307|FG000|Overall Study|Death|43|||
37901899|NCT00676663|69587308|FG001|Overall Study|Death|27|||
37901900|NCT00676663|69587307|FG000|Overall Study|Withdrew Consent|1|||
37901901|NCT00676663|69587308|FG001|Overall Study|Withdrew Consent|8|||
37901902|NCT00676663|69587307|FG000|Overall Study|Lost to Follow-up|1|||
37901903|NCT00676663|69587308|FG001|Overall Study|Lost to Follow-up|3|||
37901904|NCT00678691|69587318|FG000|Overall Study|Adverse Event|6|||
37901905|NCT00678691|69587319|FG001|Overall Study|Adverse Event|4|||
37901906|NCT00679939|69587327|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
37901907|NCT00679939|69587328|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
37901908|NCT00679939|69587327|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
37901909|NCT00679939|69587328|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
37901910|NCT00679939|69587327|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
37901911|NCT00679939|69587328|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
37901912|NCT00679939|69587327|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
37901913|NCT00679939|69587328|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
37901914|NCT00679939|69587327|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
37901915|NCT00679939|69587328|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
37901916|NCT00679939|69587327|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
37901917|NCT00679939|69587328|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
37901918|NCT00679939|69587327|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
37901919|NCT00679939|69587328|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
37901920|NCT00679939|69587327|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
37901921|NCT00679939|69587328|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
37901922|NCT00679939|69587327|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
37901923|NCT00679939|69587328|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
37901924|NCT00679939|69587327|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
37901925|NCT00679939|69587328|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
37901926|NCT00673933|69587338|FG000|Overall Study|Withdrawal by Subject|2|||
37901927|NCT00673933|69587338|FG000|Overall Study|Lost to Follow-up|1|||
37901928|NCT00571519|69587351|FG000|Overall Study|Subject withdrew consent|0|||
37901929|NCT00571519|69587352|FG001|Overall Study|Subject withdrew consent|1|||
37901930|NCT00571519|69587353|FG002|Overall Study|Subject withdrew consent|0|||
37901931|NCT00571519|69587354|FG003|Overall Study|Subject withdrew consent|2|||
37901932|NCT00571519|69587355|FG004|Overall Study|Subject withdrew consent|1|||
37901933|NCT00571519|69587356|FG005|Overall Study|Subject withdrew consent|1|||
37901934|NCT00571519|69587357|FG006|Overall Study|Subject withdrew consent|2|||
37901935|NCT00571519|69587351|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
37901936|NCT00571519|69587352|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
37901937|NCT00571519|69587353|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
37901938|NCT00571519|69587354|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
37901939|NCT00571519|69587355|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
37901940|NCT00571519|69587356|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
37901941|NCT00571519|69587357|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
37901942|NCT00571519|69587351|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
37901943|NCT00571519|69587352|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
37901944|NCT00571519|69587353|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
37901945|NCT00571519|69587354|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
37901946|NCT00571519|69587355|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
37901947|NCT00571519|69587356|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
37901948|NCT00571519|69587357|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
37901949|NCT00571519|69587351|FG000|Overall Study|Termination of study by Sponsor|2|||
37901950|NCT00571519|69587352|FG001|Overall Study|Termination of study by Sponsor|7|||
37901951|NCT00571519|69587353|FG002|Overall Study|Termination of study by Sponsor|10|||
37901952|NCT00571519|69587354|FG003|Overall Study|Termination of study by Sponsor|24|||
37901953|NCT00571519|69587355|FG004|Overall Study|Termination of study by Sponsor|8|||
37901954|NCT00571519|69587356|FG005|Overall Study|Termination of study by Sponsor|9|||
37901955|NCT00571519|69587357|FG006|Overall Study|Termination of study by Sponsor|22|||
37901956|NCT00571519|69587351|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
37901957|NCT00571519|69587352|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
37901958|NCT00571519|69587353|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
37901959|NCT00571519|69587354|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
37901960|NCT00571519|69587355|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
37901961|NCT00571519|69587356|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
37901962|NCT00571519|69587357|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
37901963|NCT00676195|69587373|FG000|Overall Study|Lost to Follow-up|1|||
37901964|NCT00676195|69587373|FG000|Overall Study|Adverse Event|1|||
37901965|NCT00676195|69587373|FG000|Overall Study|Physician Decision|1|||
37901966|NCT00675103|69587378|FG000|Overall Study|Lack of Efficacy|2|||
37901967|NCT00675103|69587378|FG000|Overall Study|Adverse Event|1|||
37901968|NCT00675025|69587384|FG000|Overall Study|Study Terminated by Sponsor|38|||
37901969|NCT00675025|69587385|FG001|Overall Study|Study Terminated by Sponsor|42|||
37997553|NCT00048724|69681850|FG000|Overall Study|Administrative|1|||
37901970|NCT00675025|69587384|FG000|Overall Study|Adverse Event|6|||
37901971|NCT00675025|69587385|FG001|Overall Study|Adverse Event|11|||
37901972|NCT00675025|69587384|FG000|Overall Study|Lost to Follow-up|6|||
37901973|NCT00675025|69587385|FG001|Overall Study|Lost to Follow-up|4|||
37901974|NCT00675025|69587384|FG000|Overall Study|Withdrawal by Subject|4|||
37901975|NCT00675025|69587385|FG001|Overall Study|Withdrawal by Subject|6|||
37901976|NCT00678379|69587403|FG000|Overall Study|Injection performed after tonsillectomy|2|||
37901977|NCT00678379|69587404|FG001|Overall Study|Injection performed after tonsillectomy|0|||
37901978|NCT00678379|69587405|FG002|Overall Study|Injection performed after tonsillectomy|1|||
37901979|NCT00678379|69587403|FG000|Overall Study|Incomplete Data|4|||
37901980|NCT00678379|69587404|FG001|Overall Study|Incomplete Data|3|||
37901981|NCT00678379|69587405|FG002|Overall Study|Incomplete Data|3|||
37901982|NCT00674323|69587416|FG000|Overall Study|Adverse Event|0|||
37901983|NCT00674323|69587417|FG001|Overall Study|Adverse Event|1|||
37827697|NCT00172042|69510536|FG001|Overall Study|Death|42|||
37901984|NCT00674323|69587418|FG002|Overall Study|Adverse Event|0|||
37901985|NCT00674323|69587416|FG000|Overall Study|Protocol Violation|1|||
37901986|NCT00674323|69587417|FG001|Overall Study|Protocol Violation|0|||
37901987|NCT00674323|69587418|FG002|Overall Study|Protocol Violation|0|||
37901988|NCT00678301|69587428|FG000|Overall Study|Non-compliance with study procedures|0|||
37901989|NCT00678301|69587429|FG001|Overall Study|Non-compliance with study procedures|1|||
37901990|NCT00678301|69587428|FG000|Overall Study|Adverse Event|1|||
37901991|NCT00678301|69587429|FG001|Overall Study|Adverse Event|0|||
37901992|NCT00678301|69587428|FG000|Overall Study|Withdrawal by Subject|4|||
37901993|NCT00678301|69587429|FG001|Overall Study|Withdrawal by Subject|0|||
37901994|NCT00678301|69587428|FG000|Overall Study|Lost to Follow-up|3|||
37901995|NCT00678301|69587429|FG001|Overall Study|Lost to Follow-up|1|||
37901996|NCT00939770|69587443|FG000|Overall Study|Adverse Event|1|||
37901997|NCT00939770|69587444|FG001|Overall Study|Adverse Event|1|||
37901998|NCT00939770|69587445|FG002|Overall Study|Adverse Event|0|||
37901999|NCT00939770|69587446|FG003|Overall Study|Adverse Event|0|||
37902000|NCT00939770|69587447|FG004|Overall Study|Adverse Event|6|||
37902001|NCT00939770|69587448|FG005|Overall Study|Adverse Event|2|||
37827698|NCT00171925|69510544|FG000|Overall Study|Adverse Event|10|||
37827699|NCT00171925|69510545|FG001|Overall Study|Adverse Event|6|||
37902002|NCT00939770|69587449|FG006|Overall Study|Adverse Event|1|||
37902003|NCT00939770|69587450|FG007|Overall Study|Adverse Event|1|||
37902004|NCT00939770|69587443|FG000|Overall Study|Lack of Efficacy|4|||
37902005|NCT00939770|69587444|FG001|Overall Study|Lack of Efficacy|6|||
37902006|NCT00939770|69587445|FG002|Overall Study|Lack of Efficacy|13|||
37902007|NCT00939770|69587446|FG003|Overall Study|Lack of Efficacy|9|||
37902008|NCT00939770|69587447|FG004|Overall Study|Lack of Efficacy|16|||
37902009|NCT00939770|69587448|FG005|Overall Study|Lack of Efficacy|8|||
37902010|NCT00939770|69587449|FG006|Overall Study|Lack of Efficacy|11|||
37902011|NCT00939770|69587450|FG007|Overall Study|Lack of Efficacy|1|||
37902012|NCT00939770|69587443|FG000|Overall Study|Lost to Follow-up|0|||
37902013|NCT00939770|69587444|FG001|Overall Study|Lost to Follow-up|0|||
37902014|NCT00939770|69587445|FG002|Overall Study|Lost to Follow-up|0|||
37902015|NCT00939770|69587446|FG003|Overall Study|Lost to Follow-up|0|||
37902016|NCT00939770|69587447|FG004|Overall Study|Lost to Follow-up|1|||
37902017|NCT00939770|69587448|FG005|Overall Study|Lost to Follow-up|0|||
37902018|NCT00939770|69587449|FG006|Overall Study|Lost to Follow-up|0|||
37902019|NCT00939770|69587450|FG007|Overall Study|Lost to Follow-up|0|||
37902020|NCT00939770|69587443|FG000|Overall Study|Physician Decision|0|||
37902021|NCT00939770|69587444|FG001|Overall Study|Physician Decision|0|||
37902022|NCT00939770|69587445|FG002|Overall Study|Physician Decision|2|||
37902023|NCT00939770|69587446|FG003|Overall Study|Physician Decision|0|||
37902024|NCT00939770|69587447|FG004|Overall Study|Physician Decision|7|||
37902025|NCT00939770|69587448|FG005|Overall Study|Physician Decision|1|||
37902026|NCT00939770|69587449|FG006|Overall Study|Physician Decision|0|||
37902027|NCT00939770|69587450|FG007|Overall Study|Physician Decision|6|||
37697015|NCT02054715|69173385|FG000|Follow-up 2|Death|3|||
37827700|NCT00171925|69510544|FG000|Overall Study|Protocol Violation|1|||
37827701|NCT00171925|69510545|FG001|Overall Study|Protocol Violation|1|||
37827702|NCT00171925|69510544|FG000|Overall Study|Withdrawal by Subject|6|||
37827703|NCT00171925|69510545|FG001|Overall Study|Withdrawal by Subject|9|||
37827704|NCT00171925|69510544|FG000|Overall Study|Lost to Follow-up|2|||
37827705|NCT00171925|69510545|FG001|Overall Study|Lost to Follow-up|2|||
37827706|NCT00171925|69510544|FG000|Overall Study|Administrative problems|10|||
37827707|NCT00171925|69510545|FG001|Overall Study|Administrative problems|11|||
37827708|NCT00171925|69510544|FG000|Overall Study|Death|1|||
37827709|NCT00171925|69510545|FG001|Overall Study|Death|2|||
37827710|NCT00171340|69510553|FG000|Overall Study|Adverse Event|46|||
37827711|NCT00171340|69510554|FG001|Overall Study|Adverse Event|42|||
37827712|NCT00171340|69510553|FG000|Overall Study|Lack of Efficacy|29|||
37827713|NCT00171340|69510554|FG001|Overall Study|Lack of Efficacy|41|||
37827714|NCT00171340|69510553|FG000|Overall Study|Protocol Violation|7|||
37997554|NCT00048724|69681851|FG001|Overall Study|Administrative|1|||
37902028|NCT00939770|69587443|FG000|Overall Study|Protocol Violation|0|||
37902029|NCT00939770|69587444|FG001|Overall Study|Protocol Violation|0|||
37902030|NCT00939770|69587445|FG002|Overall Study|Protocol Violation|0|||
37902031|NCT00939770|69587446|FG003|Overall Study|Protocol Violation|0|||
37902032|NCT00939770|69587447|FG004|Overall Study|Protocol Violation|1|||
37997555|NCT00449033|69681859|FG000|Treatment Period|Adverse Event|117|||
37827715|NCT00171340|69510554|FG001|Overall Study|Protocol Violation|8|||
37827716|NCT00171340|69510553|FG000|Overall Study|Withdrawal by Subject|22|||
37902033|NCT00939770|69587448|FG005|Overall Study|Protocol Violation|0|||
37902034|NCT00939770|69587449|FG006|Overall Study|Protocol Violation|0|||
37902035|NCT00939770|69587450|FG007|Overall Study|Protocol Violation|0|||
37902036|NCT00939770|69587443|FG000|Overall Study|Withdrawal by Subject|0|||
37902037|NCT00939770|69587444|FG001|Overall Study|Withdrawal by Subject|1|||
37902038|NCT00939770|69587445|FG002|Overall Study|Withdrawal by Subject|5|||
37902039|NCT00939770|69587446|FG003|Overall Study|Withdrawal by Subject|2|||
37902040|NCT00939770|69587447|FG004|Overall Study|Withdrawal by Subject|6|||
37697016|NCT02054715|69173386|FG001|Follow-up 2|Death|3|||
37997556|NCT00449033|69681860|FG001|Treatment Period|Adverse Event|83|||
37997557|NCT00449033|69681859|FG000|Treatment Period|Death|21|||
37902041|NCT00939770|69587448|FG005|Overall Study|Withdrawal by Subject|0|||
37902042|NCT00939770|69587449|FG006|Overall Study|Withdrawal by Subject|2|||
37902043|NCT00939770|69587450|FG007|Overall Study|Withdrawal by Subject|2|||
37997558|NCT00449033|69681860|FG001|Treatment Period|Death|12|||
37997559|NCT00449033|69681859|FG000|Treatment Period|Lost to Follow-up|0|||
37997560|NCT00449033|69681860|FG001|Treatment Period|Lost to Follow-up|2|||
37997561|NCT00449033|69681859|FG000|Treatment Period|Physician Decision|4|||
37997562|NCT00449033|69681860|FG001|Treatment Period|Physician Decision|5|||
37997563|NCT00449033|69681859|FG000|Treatment Period|Protocol Violation|8|||
37997564|NCT00449033|69681860|FG001|Treatment Period|Protocol Violation|7|||
37997565|NCT00449033|69681859|FG000|Treatment Period|Disease Progression|231|||
37997566|NCT00449033|69681860|FG001|Treatment Period|Disease Progression|288|||
37997567|NCT00449033|69681859|FG000|Treatment Period|Consent Withdrawn|36|||
37997568|NCT00449033|69681860|FG001|Treatment Period|Consent Withdrawn|20|||
37997569|NCT00449033|69681859|FG000|Treatment Period|Amended Protocol Criteria|22|||
37997570|NCT00449033|69681860|FG001|Treatment Period|Amended Protocol Criteria|18|||
37997571|NCT00449033|69681859|FG000|Treatment Period|Non-compliance|7|||
37997572|NCT00449033|69681860|FG001|Treatment Period|Non-compliance|8|||
37997573|NCT00449033|69681859|FG000|Treatment Period|Second Malignancy|0|||
37997574|NCT00449033|69681860|FG001|Treatment Period|Second Malignancy|1|||
37997575|NCT00449033|69681859|FG000|Treatment Period|Reason Missing|0|||
37997576|NCT00449033|69681860|FG001|Treatment Period|Reason Missing|4|||
37997577|NCT00449033|69681859|FG000|Treatment Period|Treatment Ongoing|6|||
37997578|NCT00449033|69681860|FG001|Treatment Period|Treatment Ongoing|4|||
37997579|NCT00449033|69681859|FG000|Follow-up Period|Death|299|||
37997580|NCT00449033|69681860|FG001|Follow-up Period|Death|311|||
37997581|NCT00449033|69681859|FG000|Follow-up Period|Lost to Follow-up|6|||
37997582|NCT00449033|69681860|FG001|Follow-up Period|Lost to Follow-up|10|||
37997583|NCT00449033|69681859|FG000|Follow-up Period|Reason Missing|120|||
37997584|NCT00449033|69681860|FG001|Follow-up Period|Reason Missing|113|||
37902044|NCT00939692|69587483|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
37902045|NCT00939692|69587484|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
37902046|NCT00939692|69587483|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
37902047|NCT00939692|69587484|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
37902048|NCT04672252|69587492|FG000|Overall Study|Protocol Violation|1|||
37902049|NCT04672252|69587493|FG001|Overall Study|Protocol Violation|0|||
37902050|NCT00584740|69587501|FG000|Overall Study|Adverse Event|1|||
37902051|NCT00584740|69587502|FG001|Overall Study|Adverse Event|1|||
37902052|NCT00584740|69587501|FG000|Overall Study|Lack of Efficacy|8|||
37902053|NCT00584740|69587502|FG001|Overall Study|Lack of Efficacy|2|||
37902054|NCT00584740|69587501|FG000|Overall Study|Withdrawal by Subject|3|||
37902055|NCT00584740|69587502|FG001|Overall Study|Withdrawal by Subject|2|||
37902056|NCT00584740|69587501|FG000|Overall Study|Lost to Follow-up|0|||
37902057|NCT00584740|69587502|FG001|Overall Study|Lost to Follow-up|1|||
37902058|NCT00942968|69587508|FG000|Overall Study|Adverse Event|60|||
37902059|NCT00942968|69587508|FG000|Overall Study|Death|76|||
37902060|NCT00942968|69587508|FG000|Overall Study|Protocol Violation|9|||
37902061|NCT00942968|69587508|FG000|Overall Study|Lost to Follow-up|4|||
37902062|NCT00942968|69587508|FG000|Overall Study|Withdrawal by Subject|44|||
37997585|NCT00448019|69681866|FG000|Overall Study|Withdrawal by Subject|3|||
37997586|NCT00448019|69681866|FG000|Overall Study|Disease progression|1|||
37997587|NCT00448019|69681866|FG000|Overall Study|Death|2|||
37997588|NCT00448019|69681866|FG000|Overall Study|Insurance Issues|1|||
37827717|NCT00171340|69510554|FG001|Overall Study|Withdrawal by Subject|19|||
37827718|NCT00171340|69510553|FG000|Overall Study|Lost to Follow-up|0|||
37827719|NCT00171340|69510554|FG001|Overall Study|Lost to Follow-up|5|||
37827720|NCT00171340|69510553|FG000|Overall Study|Abnormal Laboratory Results|2|||
37827721|NCT00171340|69510554|FG001|Overall Study|Abnormal Laboratory Results|0|||
37827722|NCT00171340|69510553|FG000|Overall Study|Abnormal Test Procedure Results|6|||
37827723|NCT00171340|69510554|FG001|Overall Study|Abnormal Test Procedure Results|11|||
37827724|NCT00171340|69510553|FG000|Overall Study|No Longer Required Study Drug|1|||
37827725|NCT00171340|69510554|FG001|Overall Study|No Longer Required Study Drug|1|||
37827726|NCT00171340|69510553|FG000|Overall Study|Administrative Problems|5|||
37827727|NCT00171340|69510554|FG001|Overall Study|Administrative Problems|2|||
37827728|NCT00171340|69510553|FG000|Overall Study|Death|6|||
37827729|NCT00171340|69510554|FG001|Overall Study|Death|6|||
37902063|NCT00942968|69587508|FG000|Overall Study|Sponsor request|5|||
37902064|NCT00942968|69587508|FG000|Overall Study|Physician Decision|11|||
37997589|NCT00457691|69681872|FG000|Overall Study|Adverse Event|4|||
37997590|NCT00457691|69681873|FG001|Overall Study|Adverse Event|1|||
37997591|NCT00457691|69681872|FG000|Overall Study|Death|163|||
37997592|NCT00457691|69681873|FG001|Overall Study|Death|148|||
37997593|NCT00457691|69681872|FG000|Overall Study|Protocol Violation|1|||
37997594|NCT00457691|69681873|FG001|Overall Study|Protocol Violation|3|||
37997595|NCT00457691|69681872|FG000|Overall Study|Lost to Follow-up|23|||
37902065|NCT00942968|69587508|FG000|Overall Study|Progression of disease|12|||
37902066|NCT00942968|69587508|FG000|Overall Study|Inferior vena cava filter placement|4|||
37902067|NCT00942968|69587508|FG000|Overall Study|Pulmonary embolism (PE)|1|||
37902068|NCT00942968|69587508|FG000|Overall Study|Participant required pancreatic biopsy|1|||
37902069|NCT00942968|69587508|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
37902070|NCT00942734|69587512|FG000|Overall Study|Adverse Event|2|||
37902071|NCT00942734|69587512|FG000|Overall Study|Protocol Violation|3|||
37902072|NCT00942734|69587512|FG000|Overall Study|Disease Progression|2|||
37902073|NCT00942734|69587512|FG000|Overall Study|Physician Decision|1|||
37902074|NCT00584194|69587516|FG000|Overall Study|Other|135|||
37902075|NCT00942422|69587520|FG000|Overall Study|Withdrawal by Subject|1|||
37902076|NCT00942422|69587520|FG000|Overall Study|Death|1|||
37997596|NCT00457691|69681873|FG001|Overall Study|Lost to Follow-up|14|||
37997597|NCT00457691|69681872|FG000|Overall Study|Study terminated by Sponsor|1|||
37997598|NCT00457691|69681873|FG001|Overall Study|Study terminated by Sponsor|1|||
37997599|NCT00457691|69681872|FG000|Overall Study|Subject refused (reason other than AE)|14|||
37997600|NCT00457691|69681873|FG001|Overall Study|Subject refused (reason other than AE)|19|||
37997601|NCT00457691|69681872|FG000|Overall Study|Disease progression, study terminated|180|||
37997602|NCT00457691|69681873|FG001|Overall Study|Disease progression, study terminated|196|||
37997603|NCT00457301|69681881|FG000|Overall Study|Withdrawal by Subject|3|||
37997604|NCT00457301|69681882|FG001|Overall Study|Withdrawal by Subject|3|||
37997605|NCT00457301|69681881|FG000|Overall Study|Censored out of the study|15|||
37997606|NCT00457301|69681882|FG001|Overall Study|Censored out of the study|14|||
37997607|NCT00457301|69681881|FG000|Overall Study|Death|5|||
37997608|NCT00457301|69681882|FG001|Overall Study|Death|7|||
37997609|NCT00456755|69681890|FG000|Overall Study|Lost to Follow-up|2|||
37997610|NCT00456755|69681891|FG001|Overall Study|Lost to Follow-up|1|||
37997611|NCT00447005|69681897|FG000|Overall Study|Adverse Event|1|||
37997612|NCT00447005|69681897|FG000|Overall Study|Lack of Efficacy|11|||
37997613|NCT00446849|69681901|FG000|Acute Phase|Lack of Efficacy|64|||
37997614|NCT00446849|69681901|FG000|Acute Phase|Protocol Violation|10|||
37997615|NCT00446849|69681901|FG000|Acute Phase|Consent withdrawn|4|||
37997616|NCT00446849|69681901|FG000|Acute Phase|Lost to Follow-up|2|||
37997617|NCT00446849|69681901|FG000|Acute Phase|Physician Decision|1|||
37997618|NCT00446849|69681901|FG000|Acute Phase|noncompliance|1|||
37997619|NCT00446849|69681901|FG000|Maintenance Phase|Lack of Efficacy|40|||
37997620|NCT00446849|69681901|FG000|Maintenance Phase|Protocol Violation|7|||
37997621|NCT00446849|69681901|FG000|Maintenance Phase|Adverse Event|6|||
37997622|NCT00446849|69681901|FG000|Maintenance Phase|Consent withdrawn|5|||
37902077|NCT00942422|69587520|FG000|Overall Study|Progressive diease|1|||
37902078|NCT00677833|69587528|FG000|Overall Study|Withdrawal by Subject|4|||
37902079|NCT00677833|69587529|FG001|Overall Study|Withdrawal by Subject|0|||
37902080|NCT00677833|69587530|FG002|Overall Study|Withdrawal by Subject|1|||
37902081|NCT00677833|69587531|FG003|Overall Study|Withdrawal by Subject|3|||
37902082|NCT00677833|69587528|FG000|Overall Study|Lost to Follow-up|0|||
37902083|NCT00677833|69587529|FG001|Overall Study|Lost to Follow-up|0|||
37902084|NCT00677833|69587530|FG002|Overall Study|Lost to Follow-up|1|||
37902085|NCT00677833|69587531|FG003|Overall Study|Lost to Follow-up|0|||
37902086|NCT00942266|69587541|FG000|Overall Study|Withdrawal by Subject|1|||
37902087|NCT00942266|69587542|FG001|Overall Study|Withdrawal by Subject|0|||
37902088|NCT00942266|69587541|FG000|Overall Study|Adverse Event|2|||
37902089|NCT00942266|69587542|FG001|Overall Study|Adverse Event|1|||
37902090|NCT00942266|69587541|FG000|Overall Study|Disease Progression|38|||
37902091|NCT00942266|69587542|FG001|Overall Study|Disease Progression|11|||
37902092|NCT00942266|69587541|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
37902093|NCT00942266|69587542|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
37902094|NCT00942266|69587541|FG000|Overall Study|Intercurrent illness|0|||
37902095|NCT00942266|69587542|FG001|Overall Study|Intercurrent illness|1|||
37902096|NCT00942266|69587541|FG000|Overall Study|Physician Decision|2|||
37997623|NCT00446849|69681901|FG000|Maintenance Phase|Lost to Follow-up|3|||
37997624|NCT00446849|69681901|FG000|Maintenance Phase|Pregnancy|1|||
37997625|NCT00446849|69681901|FG000|Maintenance Phase|noncompliance|2|||
37997626|NCT00446849|69681901|FG000|Maintenance Phase|prohibited medication use|2|||
37697017|NCT02054715|69173385|FG000|Follow-up 2|Hospitalization|0|||
37902097|NCT00942266|69587542|FG001|Overall Study|Physician Decision|0|||
37902098|NCT00942266|69587541|FG000|Overall Study|medical deterioration (pneumonia)|0|||
37902099|NCT00942266|69587542|FG001|Overall Study|medical deterioration (pneumonia)|1|||
37997627|NCT00446849|69681901|FG000|Maintenance Phase|antibiotic use|1|||
37997628|NCT00446849|69681901|FG000|Maintenance Phase|study closure|1|||
37997629|NCT00446849|69681901|FG000|Maintenance Phase|hydrocodone use|1|||
37997630|NCT00446849|69681901|FG000|Maintenance Phase|concomitant medication use|1|||
37902100|NCT00942188|69587552|FG000|Overall Study|Adverse Event|0|||
37902101|NCT00942188|69587553|FG001|Overall Study|Adverse Event|3|||
37902102|NCT00942188|69587554|FG002|Overall Study|Adverse Event|2|||
37902103|NCT00942188|69587555|FG003|Overall Study|Adverse Event|0|||
37902104|NCT00942188|69587552|FG000|Overall Study|Lack of Efficacy|0|||
37902105|NCT00942188|69587553|FG001|Overall Study|Lack of Efficacy|0|||
37997631|NCT00446459|69681906|FG000|8 Months|Protocol Violation|12|||
37997632|NCT00446459|69681906|FG000|12 Months|Protocol Violation|4|||
37997633|NCT00446459|69681906|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
37997634|NCT00456599|69681910|FG000|Overall Study|Non-compliance|1|||
37997635|NCT00456599|69681910|FG000|Overall Study|Withdrawal by Subject|2|||
37997636|NCT00456521|69681916|FG000|Overall Study|Adverse Event|150|||
37997637|NCT00456521|69681917|FG001|Overall Study|Adverse Event|25|||
37997638|NCT00456521|69681916|FG000|Overall Study|Withdrawal by Subject|43|||
37997639|NCT00456521|69681917|FG001|Overall Study|Withdrawal by Subject|24|||
37997640|NCT00456521|69681916|FG000|Overall Study|Lost to Follow-up|22|||
37997641|NCT00456521|69681917|FG001|Overall Study|Lost to Follow-up|17|||
37997642|NCT00456521|69681916|FG000|Overall Study|Lack of Efficacy|3|||
37997643|NCT00456521|69681917|FG001|Overall Study|Lack of Efficacy|6|||
37997644|NCT00456521|69681916|FG000|Overall Study|Protocol Violation|4|||
37997645|NCT00456521|69681917|FG001|Overall Study|Protocol Violation|0|||
37997646|NCT00456521|69681916|FG000|Overall Study|Pregnancy|1|||
37997647|NCT00456521|69681917|FG001|Overall Study|Pregnancy|1|||
37997648|NCT00456521|69681916|FG000|Overall Study|Drug non-compliance, moved, other|26|||
37997649|NCT00456521|69681917|FG001|Overall Study|Drug non-compliance, moved, other|11|||
37997650|NCT00456365|69681926|FG000|Overall Study|Lost to Follow-up|1|||
37902106|NCT00942188|69587554|FG002|Overall Study|Lack of Efficacy|0|||
37902107|NCT00942188|69587555|FG003|Overall Study|Lack of Efficacy|1|||
37902108|NCT00942188|69587552|FG000|Overall Study|Protocol Violation|1|||
37902109|NCT00942188|69587553|FG001|Overall Study|Protocol Violation|1|||
37902110|NCT00942188|69587554|FG002|Overall Study|Protocol Violation|0|||
37902111|NCT00942188|69587555|FG003|Overall Study|Protocol Violation|0|||
37902112|NCT00942188|69587552|FG000|Overall Study|Lost to Follow-up|2|||
37902113|NCT00942188|69587553|FG001|Overall Study|Lost to Follow-up|1|||
37902114|NCT00942188|69587554|FG002|Overall Study|Lost to Follow-up|2|||
37997651|NCT00456365|69681927|FG001|Overall Study|Lost to Follow-up|3|||
37997652|NCT00456365|69681926|FG000|Overall Study|Withdrawal by Subject|4|||
37997653|NCT00456365|69681927|FG001|Overall Study|Withdrawal by Subject|7|||
37997654|NCT00456365|69681926|FG000|Overall Study|Pregnancy|1|||
37997655|NCT00456365|69681927|FG001|Overall Study|Pregnancy|1|||
37997656|NCT00456365|69681926|FG000|Overall Study|oncologic diagnosis|1|||
37997657|NCT00456365|69681927|FG001|Overall Study|oncologic diagnosis|1|||
37997658|NCT00455741|69681937|FG000|Overall Study|Physician Decision|0|||
37997659|NCT00455741|69681938|FG001|Overall Study|Physician Decision|1|||
37997660|NCT00445679|69681958|FG000|Overall Study|Adverse Event|22|||
37997661|NCT00445679|69681959|FG001|Overall Study|Adverse Event|12|||
37997662|NCT00445679|69681960|FG002|Overall Study|Adverse Event|30|||
37997663|NCT00445679|69681961|FG003|Overall Study|Adverse Event|19|||
37997664|NCT00445679|69681958|FG000|Overall Study|Failed to return|1|||
37997665|NCT00445679|69681959|FG001|Overall Study|Failed to return|3|||
37997666|NCT00445679|69681960|FG002|Overall Study|Failed to return|2|||
37997667|NCT00445679|69681961|FG003|Overall Study|Failed to return|2|||
37997668|NCT00445679|69681958|FG000|Overall Study|Physician Decision|0|||
37827730|NCT00171301|69510564|FG000|Overall Study|Death|1|||
37827731|NCT00171301|69510565|FG001|Overall Study|Death|2|||
37827732|NCT00171301|69510564|FG000|Overall Study|Adverse Event|1|||
37827733|NCT00171301|69510565|FG001|Overall Study|Adverse Event|2|||
37827734|NCT00171301|69510564|FG000|Overall Study|Lost to Follow-up|6|||
37827735|NCT00171301|69510565|FG001|Overall Study|Lost to Follow-up|2|||
37827736|NCT00171301|69510564|FG000|Overall Study|Protocol Violation|0|||
37827737|NCT00171301|69510565|FG001|Overall Study|Protocol Violation|2|||
37827738|NCT00171301|69510564|FG000|Overall Study|Withdrawal by Subject|0|||
37827739|NCT00171301|69510565|FG001|Overall Study|Withdrawal by Subject|1|||
37827740|NCT00171223|69510575|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
37827741|NCT00171223|69510576|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
37902115|NCT00942188|69587555|FG003|Overall Study|Lost to Follow-up|0|||
37902116|NCT00942188|69587552|FG000|Overall Study|Withdrawal by Subject|1|||
37827742|NCT00171223|69510577|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
37902117|NCT00942188|69587553|FG001|Overall Study|Withdrawal by Subject|3|||
37902118|NCT00942188|69587554|FG002|Overall Study|Withdrawal by Subject|4|||
37902119|NCT00942188|69587555|FG003|Overall Study|Withdrawal by Subject|2|||
37902120|NCT00942188|69587552|FG000|Overall Study|Physician Decision|0|||
37902121|NCT00942188|69587553|FG001|Overall Study|Physician Decision|0|||
37997669|NCT00445679|69681959|FG001|Overall Study|Physician Decision|0|||
37997670|NCT00445679|69681960|FG002|Overall Study|Physician Decision|1|||
37997671|NCT00445679|69681961|FG003|Overall Study|Physician Decision|0|||
37997672|NCT00445679|69681958|FG000|Overall Study|Lost to Follow-up|10|||
37997673|NCT00445679|69681959|FG001|Overall Study|Lost to Follow-up|6|||
37997674|NCT00445679|69681960|FG002|Overall Study|Lost to Follow-up|6|||
37997675|NCT00445679|69681961|FG003|Overall Study|Lost to Follow-up|5|||
37827743|NCT00171223|69510575|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
37902122|NCT00942188|69587554|FG002|Overall Study|Physician Decision|1|||
37997676|NCT00445679|69681958|FG000|Overall Study|Compliance|3|||
37902123|NCT00942188|69587555|FG003|Overall Study|Physician Decision|0|||
37997677|NCT00445679|69681959|FG001|Overall Study|Compliance|2|||
37997678|NCT00445679|69681960|FG002|Overall Study|Compliance|1|||
37902124|NCT00942188|69587552|FG000|Overall Study|Sponsor Decision|0|||
37902125|NCT00942188|69587553|FG001|Overall Study|Sponsor Decision|2|||
37902126|NCT00942188|69587554|FG002|Overall Study|Sponsor Decision|0|||
37902127|NCT00942188|69587555|FG003|Overall Study|Sponsor Decision|1|||
37902128|NCT00673231|69587569|FG000|Overall Study|Withdrawal by Subject|14|||
37902129|NCT00673231|69587570|FG001|Overall Study|Withdrawal by Subject|10|||
37902130|NCT00673231|69587571|FG002|Overall Study|Withdrawal by Subject|8|||
37902131|NCT00673231|69587572|FG003|Overall Study|Withdrawal by Subject|6|||
37902132|NCT00673231|69587569|FG000|Overall Study|Adverse Event|6|||
37902133|NCT00673231|69587570|FG001|Overall Study|Adverse Event|5|||
37902134|NCT00673231|69587571|FG002|Overall Study|Adverse Event|9|||
37902135|NCT00673231|69587572|FG003|Overall Study|Adverse Event|6|||
37902136|NCT00673231|69587569|FG000|Overall Study|Lost to Follow-up|1|||
37902137|NCT00673231|69587570|FG001|Overall Study|Lost to Follow-up|2|||
37902138|NCT00673231|69587571|FG002|Overall Study|Lost to Follow-up|1|||
37902139|NCT00673231|69587572|FG003|Overall Study|Lost to Follow-up|2|||
37902140|NCT00673231|69587569|FG000|Overall Study|Death|0|||
37902141|NCT00673231|69587570|FG001|Overall Study|Death|0|||
37902142|NCT00673231|69587571|FG002|Overall Study|Death|1|||
37902143|NCT00673231|69587572|FG003|Overall Study|Death|0|||
37902144|NCT00673231|69587569|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
37902145|NCT00673231|69587570|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
37902146|NCT00673231|69587571|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
37902147|NCT00673231|69587572|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
37902148|NCT00672841|69587584|FG000|Overall Study|Comfort care|1|||
37902149|NCT00672841|69587585|FG001|Overall Study|Comfort care|4|||
37902150|NCT00672841|69587584|FG000|Overall Study|icteric specimens|0|||
37902151|NCT00672841|69587585|FG001|Overall Study|icteric specimens|3|||
37902152|NCT00672841|69587584|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
37902153|NCT00672841|69587585|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
37902154|NCT00672841|69587584|FG000|Overall Study|Adverse Event|0|||
37902155|NCT00672841|69587585|FG001|Overall Study|Adverse Event|3|||
37902156|NCT00672841|69587584|FG000|Overall Study|Pregnancy|0|||
37902157|NCT00672841|69587585|FG001|Overall Study|Pregnancy|1|||
37902158|NCT00673465|69587594|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
37902159|NCT00673465|69587595|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
37902160|NCT00673465|69587596|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
37902161|NCT00673465|69587597|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
37902162|NCT00673465|69587598|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
37902163|NCT00673465|69587599|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
37902164|NCT00673465|69587600|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
37902165|NCT00673465|69587601|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
37902166|NCT00673465|69587602|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
37902167|NCT00673465|69587603|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
37902168|NCT00673465|69587604|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
37902169|NCT00673465|69587605|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
37902170|NCT00673465|69587594|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
37902171|NCT00673465|69587595|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
37902172|NCT00673465|69587596|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
37902173|NCT00673465|69587597|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
37902174|NCT00673465|69587598|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
37902175|NCT00673465|69587599|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
37902176|NCT00673465|69587600|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
37902177|NCT00673465|69587601|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
37902178|NCT00673465|69587602|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
37902179|NCT00673465|69587603|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
37902180|NCT00673465|69587604|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
37902181|NCT00673465|69587605|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
37902182|NCT00941798|69587615|FG000|Overall Study|Withdrawal by Subject|72|||
37902183|NCT00941798|69587616|FG001|Overall Study|Withdrawal by Subject|74|||
37902184|NCT00941798|69587615|FG000|Overall Study|Adverse Event|43|||
37902185|NCT00941798|69587616|FG001|Overall Study|Adverse Event|23|||
37902186|NCT00941798|69587615|FG000|Overall Study|Lost to Follow-up|29|||
37902187|NCT00941798|69587616|FG001|Overall Study|Lost to Follow-up|23|||
37902188|NCT00941798|69587615|FG000|Overall Study|Protocol Violation|17|||
37902189|NCT00941798|69587616|FG001|Overall Study|Protocol Violation|20|||
37902190|NCT00941798|69587615|FG000|Overall Study|Administrative problems|13|||
37902191|NCT00941798|69587616|FG001|Overall Study|Administrative problems|23|||
37902192|NCT00941798|69587615|FG000|Overall Study|Lack of Efficacy|10|||
37902193|NCT00941798|69587616|FG001|Overall Study|Lack of Efficacy|17|||
37902194|NCT00941798|69587615|FG000|Overall Study|Patient's inability to use device|6|||
37902195|NCT00941798|69587616|FG001|Overall Study|Patient's inability to use device|1|||
37902196|NCT00941798|69587615|FG000|Overall Study|Abnormal test procedure results|3|||
37997679|NCT00445679|69681961|FG003|Overall Study|Compliance|2|||
37902197|NCT00941798|69587616|FG001|Overall Study|Abnormal test procedure results|1|||
37902198|NCT00941798|69587615|FG000|Overall Study|Abnormal laboratory values|1|||
37902199|NCT00941798|69587616|FG001|Overall Study|Abnormal laboratory values|2|||
37902200|NCT00941798|69587615|FG000|Overall Study|Death|0|||
37902201|NCT00941798|69587616|FG001|Overall Study|Death|1|||
37902202|NCT00583102|69587622|FG000|Overall Study|Adverse Event|3|||
37902203|NCT05208866|69587630|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
37902204|NCT04745351|69587645|FG000|Overall Study|Death|51|||
37902205|NCT04745351|69587646|FG001|Overall Study|Death|25|||
37902206|NCT04745351|69587645|FG000|Overall Study|Lost to Follow-up|9|||
37902207|NCT04745351|69587646|FG001|Overall Study|Lost to Follow-up|3|||
37902208|NCT04745351|69587645|FG000|Overall Study|Randomized but Never Treated|3|||
37902209|NCT04745351|69587646|FG001|Overall Study|Randomized but Never Treated|3|||
37902210|NCT04745351|69587645|FG000|Overall Study|Adverse Event|4|||
37902211|NCT04745351|69587646|FG001|Overall Study|Adverse Event|0|||
37902212|NCT04745351|69587645|FG000|Overall Study|Withdrew Consent|1|||
37902213|NCT04745351|69587646|FG001|Overall Study|Withdrew Consent|2|||
37902214|NCT04745351|69587645|FG000|Overall Study|Investigator's Discretion|2|||
37902215|NCT04745351|69587646|FG001|Overall Study|Investigator's Discretion|0|||
37902216|NCT04745351|69587645|FG000|Overall Study|Protocol Violation|1|||
37902217|NCT04745351|69587646|FG001|Overall Study|Protocol Violation|0|||
37902218|NCT04427501|69587671|FG000|Overall Study|Death|0|||
37902219|NCT04427501|69587672|FG001|Overall Study|Death|0|||
37902220|NCT04427501|69587673|FG002|Overall Study|Death|0|||
37902221|NCT04427501|69587674|FG003|Overall Study|Death|0|||
37902222|NCT04427501|69587675|FG004|Overall Study|Death|0|||
37902223|NCT04427501|69587676|FG005|Overall Study|Death|15|||
37902224|NCT04427501|69587677|FG006|Overall Study|Death|0|||
37997680|NCT00445679|69681958|FG000|Overall Study|Withdrawal of Informed Consent|0|||
37997681|NCT00445679|69681959|FG001|Overall Study|Withdrawal of Informed Consent|0|||
37997682|NCT00445679|69681960|FG002|Overall Study|Withdrawal of Informed Consent|1|||
37997683|NCT00445679|69681961|FG003|Overall Study|Withdrawal of Informed Consent|0|||
37997684|NCT00445679|69681958|FG000|Overall Study|Protocol Violation|2|||
37997685|NCT00445679|69681959|FG001|Overall Study|Protocol Violation|3|||
37997686|NCT00445679|69681960|FG002|Overall Study|Protocol Violation|3|||
37997687|NCT00445679|69681961|FG003|Overall Study|Protocol Violation|1|||
37997688|NCT00445679|69681958|FG000|Overall Study|Withdrawal by Subject|8|||
37997689|NCT00445679|69681959|FG001|Overall Study|Withdrawal by Subject|14|||
37997690|NCT00445679|69681960|FG002|Overall Study|Withdrawal by Subject|20|||
37997691|NCT00445679|69681961|FG003|Overall Study|Withdrawal by Subject|18|||
37997692|NCT00445679|69681958|FG000|Overall Study|Lack of Efficacy|2|||
37997693|NCT00445679|69681959|FG001|Overall Study|Lack of Efficacy|6|||
37997694|NCT00445679|69681960|FG002|Overall Study|Lack of Efficacy|2|||
37997695|NCT00445679|69681961|FG003|Overall Study|Lack of Efficacy|0|||
37997696|NCT00455429|69681975|FG000|Overall Study|Study Terminated by Sponsor|0|||
37997697|NCT00455429|69681976|FG001|Overall Study|Study Terminated by Sponsor|0|||
37997698|NCT00455429|69681977|FG002|Overall Study|Study Terminated by Sponsor|0|||
37997699|NCT00455429|69681978|FG003|Overall Study|Study Terminated by Sponsor|3|||
37997700|NCT00455429|69681975|FG000|Overall Study|Lost to Follow-up|1|||
37997701|NCT00455429|69681976|FG001|Overall Study|Lost to Follow-up|0|||
37997702|NCT00455429|69681977|FG002|Overall Study|Lost to Follow-up|0|||
37997703|NCT00455429|69681978|FG003|Overall Study|Lost to Follow-up|3|||
37997704|NCT00455429|69681975|FG000|Overall Study|Withdrawal by Subject|0|||
37902225|NCT04427501|69587678|FG007|Overall Study|Death|0|||
37902226|NCT04427501|69587679|FG008|Overall Study|Death|0|||
37997705|NCT00455429|69681976|FG001|Overall Study|Withdrawal by Subject|1|||
37997706|NCT00455429|69681977|FG002|Overall Study|Withdrawal by Subject|1|||
37997707|NCT00455429|69681978|FG003|Overall Study|Withdrawal by Subject|0|||
37997708|NCT00455429|69681975|FG000|Overall Study|Lack of Efficacy|0|||
37997709|NCT00455429|69681976|FG001|Overall Study|Lack of Efficacy|1|||
37997710|NCT00455429|69681977|FG002|Overall Study|Lack of Efficacy|0|||
37697018|NCT02054715|69173386|FG001|Follow-up 2|Hospitalization|2|||
37902227|NCT04427501|69587680|FG009|Overall Study|Death|0|||
37902228|NCT04427501|69587671|FG000|Overall Study|Lost to Follow-up|5|||
37902229|NCT04427501|69587672|FG001|Overall Study|Lost to Follow-up|1|||
37902230|NCT04427501|69587673|FG002|Overall Study|Lost to Follow-up|2|||
37902231|NCT04427501|69587674|FG003|Overall Study|Lost to Follow-up|0|||
37902232|NCT04427501|69587675|FG004|Overall Study|Lost to Follow-up|2|||
37902233|NCT04427501|69587676|FG005|Overall Study|Lost to Follow-up|11|||
37902234|NCT04427501|69587677|FG006|Overall Study|Lost to Follow-up|10|||
37902235|NCT04427501|69587678|FG007|Overall Study|Lost to Follow-up|10|||
37902236|NCT04427501|69587679|FG008|Overall Study|Lost to Follow-up|2|||
37997711|NCT00455429|69681978|FG003|Overall Study|Lack of Efficacy|1|||
37997712|NCT00455429|69681975|FG000|Overall Study|Adverse Event|0|||
37902237|NCT04427501|69587680|FG009|Overall Study|Lost to Follow-up|5|||
37902238|NCT04427501|69587671|FG000|Overall Study|Physician Decision|0|||
37902239|NCT04427501|69587672|FG001|Overall Study|Physician Decision|3|||
37902240|NCT04427501|69587673|FG002|Overall Study|Physician Decision|0|||
37997713|NCT00455429|69681976|FG001|Overall Study|Adverse Event|1|||
37997714|NCT00455429|69681977|FG002|Overall Study|Adverse Event|0|||
37902241|NCT04427501|69587674|FG003|Overall Study|Physician Decision|0|||
37997715|NCT00455429|69681978|FG003|Overall Study|Adverse Event|3|||
37997716|NCT00455429|69681975|FG000|Overall Study|Randomly assigned but not treated|0|||
37997717|NCT00455429|69681976|FG001|Overall Study|Randomly assigned but not treated|0|||
37997718|NCT00455429|69681977|FG002|Overall Study|Randomly assigned but not treated|0|||
37997719|NCT00455429|69681978|FG003|Overall Study|Randomly assigned but not treated|2|||
37997720|NCT00455429|69681975|FG000|Overall Study|Personal Reason|1|||
37997721|NCT00455429|69681976|FG001|Overall Study|Personal Reason|0|||
37997722|NCT00455429|69681977|FG002|Overall Study|Personal Reason|0|||
37997723|NCT00455429|69681978|FG003|Overall Study|Personal Reason|0|||
37997724|NCT00455429|69681975|FG000|Overall Study|Non-compliance|0|||
37997725|NCT00455429|69681976|FG001|Overall Study|Non-compliance|0|||
37997726|NCT00455429|69681977|FG002|Overall Study|Non-compliance|0|||
37997727|NCT00455429|69681978|FG003|Overall Study|Non-compliance|1|||
37997728|NCT00455429|69681975|FG000|Overall Study|Other|0|||
37997729|NCT00455429|69681976|FG001|Overall Study|Other|2|||
37997730|NCT00455429|69681977|FG002|Overall Study|Other|0|||
37997731|NCT00455429|69681978|FG003|Overall Study|Other|1|||
37997732|NCT00445601|69681993|FG000|Overall Study|Withdrawal by Subject|11|||
37997733|NCT00445601|69681994|FG001|Overall Study|Withdrawal by Subject|11|||
37997734|NCT00445601|69681993|FG000|Overall Study|TURBT Complication|12|||
37997735|NCT00445601|69681994|FG001|Overall Study|TURBT Complication|8|||
37997736|NCT00445601|69681993|FG000|Overall Study|Incorrect Disease Status|6|||
37997737|NCT00445601|69681994|FG001|Overall Study|Incorrect Disease Status|6|||
37997738|NCT00445601|69681993|FG000|Overall Study|Drug Delivery Issue|2|||
37997739|NCT00445601|69681994|FG001|Overall Study|Drug Delivery Issue|2|||
37997740|NCT00445601|69681993|FG000|Overall Study|Adverse Event|2|||
37997741|NCT00445601|69681994|FG001|Overall Study|Adverse Event|0|||
37997742|NCT00445601|69681993|FG000|Overall Study|Death prior to TURBT|0|||
37997743|NCT00445601|69681994|FG001|Overall Study|Death prior to TURBT|1|||
37902242|NCT04427501|69587675|FG004|Overall Study|Physician Decision|0|||
37902243|NCT04427501|69587676|FG005|Overall Study|Physician Decision|0|||
37902244|NCT04427501|69587677|FG006|Overall Study|Physician Decision|2|||
37997744|NCT00444587|69682006|FG000|Overall Study|Death|2|||
37997745|NCT00444587|69682007|FG001|Overall Study|Death|1|||
37997746|NCT00444587|69682006|FG000|Overall Study|Progression of the disease|73|||
37997747|NCT00444587|69682007|FG001|Overall Study|Progression of the disease|8|||
37997748|NCT00444587|69682006|FG000|Overall Study|Refused treatment/did not cooperate|4|||
37997749|NCT00444587|69682007|FG001|Overall Study|Refused treatment/did not cooperate|1|||
37997750|NCT00444587|69682006|FG000|Overall Study|Investigator decision|3|||
37997751|NCT00444587|69682007|FG001|Overall Study|Investigator decision|0|||
37997752|NCT00444587|69682006|FG000|Overall Study|Protocol Violation|1|||
37997753|NCT00444587|69682007|FG001|Overall Study|Protocol Violation|0|||
37997754|NCT00444587|69682006|FG000|Overall Study|Missing|0|||
37997755|NCT00444587|69682007|FG001|Overall Study|Missing|5|||
37997756|NCT00455195|69682017|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
37997757|NCT00455195|69682018|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
37997758|NCT00455195|69682017|FG000|Double-blind Study AGLU02704|Death|1|||
37997759|NCT00455195|69682018|FG001|Double-blind Study AGLU02704|Death|0|||
37997760|NCT00455195|69682017|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
37902245|NCT04427501|69587678|FG007|Overall Study|Physician Decision|0|||
37902246|NCT04427501|69587679|FG008|Overall Study|Physician Decision|0|||
37902247|NCT04427501|69587680|FG009|Overall Study|Physician Decision|0|||
37902248|NCT04427501|69587671|FG000|Overall Study|Withdrawal by Subject|9|||
37902249|NCT04427501|69587672|FG001|Overall Study|Withdrawal by Subject|2|||
37902250|NCT04427501|69587673|FG002|Overall Study|Withdrawal by Subject|2|||
37902251|NCT04427501|69587674|FG003|Overall Study|Withdrawal by Subject|3|||
37902252|NCT04427501|69587675|FG004|Overall Study|Withdrawal by Subject|7|||
37902253|NCT04427501|69587676|FG005|Overall Study|Withdrawal by Subject|25|||
37902254|NCT04427501|69587677|FG006|Overall Study|Withdrawal by Subject|15|||
37997761|NCT00455195|69682018|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
37997762|NCT00455195|69682017|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
37997763|NCT00455195|69682018|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
37902255|NCT04427501|69587678|FG007|Overall Study|Withdrawal by Subject|7|||
37902256|NCT04427501|69587679|FG008|Overall Study|Withdrawal by Subject|4|||
37902257|NCT04427501|69587680|FG009|Overall Study|Withdrawal by Subject|1|||
37997764|NCT00235716|69682028|FG000|Overall Study|Death|26|||
37997765|NCT00235716|69682029|FG001|Overall Study|Death|39|||
37997766|NCT00235716|69682030|FG002|Overall Study|Death|32|||
37997767|NCT00235716|69682031|FG003|Overall Study|Death|31|||
37997768|NCT00235716|69682028|FG000|Overall Study|Withdrawal by Subject|23|||
37997769|NCT00235716|69682029|FG001|Overall Study|Withdrawal by Subject|19|||
37997770|NCT00235716|69682030|FG002|Overall Study|Withdrawal by Subject|17|||
37997771|NCT00235716|69682031|FG003|Overall Study|Withdrawal by Subject|18|||
37997772|NCT00235716|69682028|FG000|Overall Study|Lost to Follow-up|12|||
37997773|NCT00235716|69682029|FG001|Overall Study|Lost to Follow-up|7|||
37997774|NCT00235716|69682030|FG002|Overall Study|Lost to Follow-up|14|||
37997775|NCT00235716|69682031|FG003|Overall Study|Lost to Follow-up|10|||
37902258|NCT04427501|69587671|FG000|Overall Study|Other - as reported by the investigator|1|||
37902259|NCT04427501|69587672|FG001|Overall Study|Other - as reported by the investigator|0|||
37997776|NCT00235716|69682028|FG000|Overall Study|Adverse Event|1|||
37997777|NCT00235716|69682029|FG001|Overall Study|Adverse Event|1|||
37997778|NCT00235716|69682030|FG002|Overall Study|Adverse Event|1|||
37997779|NCT00235716|69682031|FG003|Overall Study|Adverse Event|0|||
37997780|NCT00235716|69682028|FG000|Overall Study|Physician Decision|0|||
37997781|NCT00235716|69682029|FG001|Overall Study|Physician Decision|1|||
37997782|NCT00235716|69682030|FG002|Overall Study|Physician Decision|1|||
37997783|NCT00235716|69682031|FG003|Overall Study|Physician Decision|3|||
37997784|NCT00274742|69682047|FG000|Overall Study|Adverse Event|0|||
37997785|NCT00274742|69682048|FG001|Overall Study|Adverse Event|4|||
37997786|NCT00274742|69682049|FG002|Overall Study|Adverse Event|1|||
37997787|NCT00274742|69682050|FG003|Overall Study|Adverse Event|4|||
37997788|NCT00274742|69682051|FG004|Overall Study|Adverse Event|12|||
37997789|NCT00274742|69682052|FG005|Overall Study|Adverse Event|3|||
37997790|NCT00274742|69682047|FG000|Overall Study|Lost to Follow-up|0|||
37997791|NCT00274742|69682048|FG001|Overall Study|Lost to Follow-up|0|||
37997792|NCT00274742|69682049|FG002|Overall Study|Lost to Follow-up|0|||
37997793|NCT00274742|69682050|FG003|Overall Study|Lost to Follow-up|0|||
37997794|NCT00274742|69682051|FG004|Overall Study|Lost to Follow-up|1|||
37997795|NCT00274742|69682052|FG005|Overall Study|Lost to Follow-up|0|||
37997796|NCT00274742|69682047|FG000|Overall Study|End of Study|0|||
37997797|NCT00274742|69682048|FG001|Overall Study|End of Study|0|||
37997798|NCT00274742|69682049|FG002|Overall Study|End of Study|0|||
37997799|NCT00274742|69682050|FG003|Overall Study|End of Study|1|||
37997800|NCT00274742|69682051|FG004|Overall Study|End of Study|0|||
37997801|NCT00274742|69682052|FG005|Overall Study|End of Study|0|||
37997802|NCT00274742|69682047|FG000|Overall Study|Disease Progression|0|||
37697019|NCT02054715|69173385|FG000|Follow-up 2|Changed MD/Facility|0|||
37902260|NCT04427501|69587673|FG002|Overall Study|Other - as reported by the investigator|0|||
37902261|NCT04427501|69587674|FG003|Overall Study|Other - as reported by the investigator|0|||
37902262|NCT04427501|69587675|FG004|Overall Study|Other - as reported by the investigator|0|||
37902263|NCT04427501|69587676|FG005|Overall Study|Other - as reported by the investigator|6|||
37902264|NCT04427501|69587677|FG006|Overall Study|Other - as reported by the investigator|6|||
37902265|NCT04427501|69587678|FG007|Overall Study|Other - as reported by the investigator|0|||
37902266|NCT04427501|69587679|FG008|Overall Study|Other - as reported by the investigator|0|||
37902267|NCT04427501|69587680|FG009|Overall Study|Other - as reported by the investigator|0|||
37902268|NCT03439124|69587732|FG000|Overall Study|Adverse Event|2|||
37902269|NCT03439124|69587733|FG001|Overall Study|Adverse Event|0|||
37902270|NCT03439124|69587732|FG000|Overall Study|Lost to Follow-up|1|||
37902271|NCT03439124|69587733|FG001|Overall Study|Lost to Follow-up|0|||
37902272|NCT03439124|69587732|FG000|Overall Study|Other reasons|1|||
37902273|NCT03439124|69587733|FG001|Overall Study|Other reasons|0|||
37902274|NCT03212989|69587752|FG000|Overall Study|Physician Decision|8|||
37902275|NCT03200548|69587760|FG000|Overall Study|Withdrawal by Subject|5|||
37902276|NCT03200548|69587761|FG001|Overall Study|Withdrawal by Subject|11|||
37902277|NCT03200548|69587762|FG002|Overall Study|Withdrawal by Subject|7|||
37902278|NCT03200548|69587763|FG003|Overall Study|Withdrawal by Subject|6|||
37902279|NCT03158688|69587775|FG000|Overall Study|Withdrawal by Subject|14|||
37902280|NCT03158688|69587776|FG001|Overall Study|Withdrawal by Subject|28|||
37902281|NCT03158688|69587775|FG000|Overall Study|Decision by sponsor|13|||
37902282|NCT03158688|69587776|FG001|Overall Study|Decision by sponsor|37|||
37902283|NCT03158688|69587775|FG000|Overall Study|Lost to Follow-up|4|||
37902284|NCT03158688|69587776|FG001|Overall Study|Lost to Follow-up|3|||
37902285|NCT03158688|69587775|FG000|Overall Study|Death|74|||
37902286|NCT03158688|69587776|FG001|Overall Study|Death|142|||
37902287|NCT03137173|69587784|FG000|Overall Study|Withdrawal by Subject|8|||
37997803|NCT00274742|69682048|FG001|Overall Study|Disease Progression|1|||
37997804|NCT00274742|69682049|FG002|Overall Study|Disease Progression|1|||
37997805|NCT00274742|69682050|FG003|Overall Study|Disease Progression|0|||
37997806|NCT00274742|69682051|FG004|Overall Study|Disease Progression|1|||
37902288|NCT03137173|69587785|FG001|Overall Study|Withdrawal by Subject|13|||
37902289|NCT03137173|69587784|FG000|Overall Study|Death|1|||
37902290|NCT03137173|69587785|FG001|Overall Study|Death|3|||
37902291|NCT03137173|69587784|FG000|Overall Study|Physician Decision|1|||
37902292|NCT03137173|69587785|FG001|Overall Study|Physician Decision|0|||
37902293|NCT03137173|69587784|FG000|Overall Study|Lost to Follow-up|13|||
37902294|NCT03137173|69587785|FG001|Overall Study|Lost to Follow-up|18|||
37997807|NCT00274742|69682052|FG005|Overall Study|Disease Progression|0|||
37997808|NCT00274742|69682047|FG000|Overall Study|Other|0|||
37997809|NCT00274742|69682048|FG001|Overall Study|Other|3|||
37997810|NCT00274742|69682049|FG002|Overall Study|Other|0|||
37902295|NCT03137173|69587784|FG000|Overall Study|Other reasons|3|||
37902296|NCT03137173|69587785|FG001|Overall Study|Other reasons|2|||
37997811|NCT00274742|69682050|FG003|Overall Study|Other|0|||
37997812|NCT00274742|69682051|FG004|Overall Study|Other|2|||
37997813|NCT00274742|69682052|FG005|Overall Study|Other|0|||
37997814|NCT00262314|69682072|FG000|Overall Study|Changing physicians|38|||
37997815|NCT00262314|69682072|FG000|Overall Study|Death|12|||
37997816|NCT00262314|69682072|FG000|Overall Study|Patient's decision|92|||
37997817|NCT00262314|69682072|FG000|Overall Study|Other|95|||
37997818|NCT00262314|69682072|FG000|Overall Study|Lost to Follow-up|70|||
37997819|NCT00262314|69682072|FG000|Overall Study|Administrative withdrawal|30|||
37997820|NCT00283400|69682080|FG000|Overall Study|Withdrawal by Subject|1|||
37997821|NCT00283400|69682081|FG001|Overall Study|Withdrawal by Subject|1|||
37997822|NCT00283400|69682082|FG002|Overall Study|Withdrawal by Subject|0|||
37997823|NCT00283400|69682083|FG003|Overall Study|Withdrawal by Subject|0|||
37997824|NCT00283400|69682080|FG000|Overall Study|Death|1|||
37997825|NCT00283400|69682081|FG001|Overall Study|Death|0|||
37997826|NCT00283400|69682082|FG002|Overall Study|Death|1|||
37997827|NCT00283400|69682083|FG003|Overall Study|Death|0|||
37997828|NCT00444275|69682096|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
37997829|NCT00444275|69682097|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
37997830|NCT00444275|69682098|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
37997831|NCT00444275|69682099|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
37997832|NCT00444275|69682100|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
37997833|NCT00444275|69682096|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
37997834|NCT00444275|69682097|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
37997835|NCT00444275|69682098|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
37997836|NCT00444275|69682099|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
37997837|NCT00444275|69682100|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
37997838|NCT00444275|69682096|FG000|Maintenance Treatment Phase|Adverse Event|0|||
37997839|NCT00444275|69682097|FG001|Maintenance Treatment Phase|Adverse Event|0|||
37997840|NCT00444275|69682098|FG002|Maintenance Treatment Phase|Adverse Event|3|||
37997841|NCT00444275|69682099|FG003|Maintenance Treatment Phase|Adverse Event|2|||
37997842|NCT00444275|69682100|FG004|Maintenance Treatment Phase|Adverse Event|13|||
37997843|NCT00444275|69682096|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
37997844|NCT00444275|69682097|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
37997845|NCT00444275|69682098|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
37997846|NCT00444275|69682099|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
37997847|NCT00444275|69682100|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
37997848|NCT00444275|69682096|FG000|Maintenance Treatment Phase|Patient's wish|0|||
37997849|NCT00444275|69682097|FG001|Maintenance Treatment Phase|Patient's wish|0|||
37997850|NCT00444275|69682098|FG002|Maintenance Treatment Phase|Patient's wish|19|||
37997851|NCT00444275|69682099|FG003|Maintenance Treatment Phase|Patient's wish|9|||
37997852|NCT00444275|69682100|FG004|Maintenance Treatment Phase|Patient's wish|20|||
37997853|NCT00444275|69682096|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
37902297|NCT01575808|69587832|FG000|Overall Study|Death|2|||
37902298|NCT01575808|69587833|FG001|Overall Study|Death|0|||
37902299|NCT01575808|69587832|FG000|Overall Study|Withdrawal by Subject|1|||
37902300|NCT01575808|69587833|FG001|Overall Study|Withdrawal by Subject|0|||
37902301|NCT01546753|69587843|FG000|Overall Study|anxiety|1|||
37902302|NCT01546753|69587844|FG001|Overall Study|anxiety|1|||
37902303|NCT01546753|69587843|FG000|Overall Study|diagnosis of ulcerative colitis|1|||
37902304|NCT01546753|69587844|FG001|Overall Study|diagnosis of ulcerative colitis|0|||
37902305|NCT00941720|69587857|FG000|Overall Study|Withdrawal by Subject|1|||
37902306|NCT00941720|69587857|FG000|Overall Study|Insurance denied participation|11|||
37902307|NCT00941720|69587857|FG000|Overall Study|ineligible|2|||
37902308|NCT00933686|69587863|FG000|Overall Study|Protocol Violation|0|||
37902309|NCT00933686|69587864|FG001|Overall Study|Protocol Violation|1|||
37902310|NCT00933686|69587863|FG000|Overall Study|Lost to Follow-up|2|||
37902311|NCT00933686|69587864|FG001|Overall Study|Lost to Follow-up|2|||
37902312|NCT00933686|69587863|FG000|Overall Study|Withdrawal by Subject|6|||
37902313|NCT00933686|69587864|FG001|Overall Study|Withdrawal by Subject|5|||
37902314|NCT00933686|69587863|FG000|Overall Study|Adverse Event|1|||
37902315|NCT00933686|69587864|FG001|Overall Study|Adverse Event|1|||
37902316|NCT00933686|69587863|FG000|Overall Study|Physician Decision|1|||
37902317|NCT00933686|69587864|FG001|Overall Study|Physician Decision|0|||
37902318|NCT00933686|69587863|FG000|Overall Study|Failure to show up at endpoint visits|0|||
37997854|NCT00444275|69682097|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
37997855|NCT00444275|69682098|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
37902319|NCT00933686|69587864|FG001|Overall Study|Failure to show up at endpoint visits|2|||
37997856|NCT00444275|69682099|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
37997857|NCT00444275|69682100|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
37997858|NCT00444275|69682096|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
37997859|NCT00444275|69682097|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
37902320|NCT00937040|69587872|FG000|Overall Study|Adverse Event|5|||
37902321|NCT00937040|69587873|FG001|Overall Study|Adverse Event|8|||
37902322|NCT00937040|69587872|FG000|Overall Study|Lost to Follow-up|12|||
37997860|NCT00444275|69682098|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
37902323|NCT00937040|69587873|FG001|Overall Study|Lost to Follow-up|12|||
37902324|NCT00937040|69587872|FG000|Overall Study|Protocol Violation|3|||
37902325|NCT00937040|69587873|FG001|Overall Study|Protocol Violation|0|||
37902326|NCT00937040|69587872|FG000|Overall Study|Withdrawal by Subject|13|||
37902327|NCT00937040|69587873|FG001|Overall Study|Withdrawal by Subject|7|||
37902328|NCT00937040|69587872|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
37902329|NCT00937040|69587873|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
37902330|NCT00937040|69587872|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
37902331|NCT00937040|69587873|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
37902332|NCT00673387|69587887|FG000|Overall Study|Withdrawal by Subject|15|||
37902333|NCT00673387|69587888|FG001|Overall Study|Withdrawal by Subject|16|||
37902334|NCT00673387|69587889|FG002|Overall Study|Withdrawal by Subject|20|||
37902335|NCT00673387|69587890|FG003|Overall Study|Withdrawal by Subject|16|||
37902336|NCT00673387|69587891|FG004|Overall Study|Withdrawal by Subject|18|||
37902337|NCT00673387|69587892|FG005|Overall Study|Withdrawal by Subject|21|||
37902338|NCT00673387|69587893|FG006|Overall Study|Withdrawal by Subject|15|||
37997861|NCT00444275|69682099|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
37997862|NCT00444275|69682100|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
37997863|NCT00454805|69682117|FG000|Overall Study|Withdrawal by Subject|9|||
37997864|NCT00454805|69682118|FG001|Overall Study|Withdrawal by Subject|2|||
37997865|NCT00454805|69682117|FG000|Overall Study|Death|0|||
37997866|NCT00454805|69682118|FG001|Overall Study|Death|2|||
37997867|NCT00454805|69682117|FG000|Overall Study|Disease progression|16|||
37997868|NCT00454805|69682118|FG001|Overall Study|Disease progression|19|||
37997869|NCT00454805|69682117|FG000|Overall Study|In order to begin radiotherapy|1|||
37902339|NCT00673387|69587894|FG007|Overall Study|Withdrawal by Subject|21|||
37902340|NCT00673387|69587887|FG000|Overall Study|Adverse Event|3|||
37902341|NCT00673387|69587888|FG001|Overall Study|Adverse Event|1|||
37902342|NCT00673387|69587889|FG002|Overall Study|Adverse Event|5|||
37902343|NCT00673387|69587890|FG003|Overall Study|Adverse Event|2|||
37902344|NCT00673387|69587891|FG004|Overall Study|Adverse Event|6|||
37902345|NCT00673387|69587892|FG005|Overall Study|Adverse Event|2|||
37902346|NCT00673387|69587893|FG006|Overall Study|Adverse Event|5|||
37902347|NCT00673387|69587894|FG007|Overall Study|Adverse Event|5|||
37902348|NCT00673387|69587887|FG000|Overall Study|Physician Decision|0|||
37902349|NCT00673387|69587888|FG001|Overall Study|Physician Decision|0|||
37902350|NCT00673387|69587889|FG002|Overall Study|Physician Decision|0|||
37902351|NCT00673387|69587890|FG003|Overall Study|Physician Decision|0|||
37902352|NCT00673387|69587891|FG004|Overall Study|Physician Decision|0|||
37902353|NCT00673387|69587892|FG005|Overall Study|Physician Decision|5|||
37902354|NCT00673387|69587893|FG006|Overall Study|Physician Decision|1|||
37902355|NCT00673387|69587894|FG007|Overall Study|Physician Decision|1|||
37902356|NCT00673387|69587887|FG000|Overall Study|Protocol Violation|3|||
37902357|NCT00673387|69587888|FG001|Overall Study|Protocol Violation|0|||
37902358|NCT00673387|69587889|FG002|Overall Study|Protocol Violation|1|||
37902359|NCT00673387|69587890|FG003|Overall Study|Protocol Violation|2|||
37902360|NCT00673387|69587891|FG004|Overall Study|Protocol Violation|0|||
37902361|NCT00673387|69587892|FG005|Overall Study|Protocol Violation|1|||
37902362|NCT00673387|69587893|FG006|Overall Study|Protocol Violation|1|||
37902363|NCT00673387|69587894|FG007|Overall Study|Protocol Violation|3|||
37902364|NCT00673387|69587887|FG000|Overall Study|Lost to Follow-up|8|||
37902365|NCT00673387|69587888|FG001|Overall Study|Lost to Follow-up|6|||
37997870|NCT00454805|69682118|FG001|Overall Study|In order to begin radiotherapy|0|||
37997871|NCT00283244|69682127|FG000|Overall Study|Adverse Event|0|||
37827744|NCT00171223|69510576|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
37827745|NCT00171223|69510577|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
37827746|NCT00171223|69510575|FG000|Overall Study|Abnormal Procedure|1|||
37827747|NCT00171223|69510576|FG001|Overall Study|Abnormal Procedure|0|||
37827748|NCT00171223|69510577|FG002|Overall Study|Abnormal Procedure|0|||
37827749|NCT00171223|69510575|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
37997872|NCT00283244|69682128|FG001|Overall Study|Adverse Event|8|||
37997873|NCT00283244|69682129|FG002|Overall Study|Adverse Event|11|||
37827750|NCT00171223|69510576|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
37827751|NCT00171223|69510577|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
37827752|NCT00171223|69510575|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
37827753|NCT00171223|69510576|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
37997874|NCT00283244|69682127|FG000|Overall Study|Death|4|||
37997875|NCT00283244|69682128|FG001|Overall Study|Death|3|||
37997876|NCT00283244|69682129|FG002|Overall Study|Death|2|||
37902366|NCT00673387|69587889|FG002|Overall Study|Lost to Follow-up|5|||
37902367|NCT00673387|69587890|FG003|Overall Study|Lost to Follow-up|6|||
37902368|NCT00673387|69587891|FG004|Overall Study|Lost to Follow-up|6|||
37902369|NCT00673387|69587892|FG005|Overall Study|Lost to Follow-up|5|||
37902370|NCT00673387|69587893|FG006|Overall Study|Lost to Follow-up|8|||
37902371|NCT00673387|69587894|FG007|Overall Study|Lost to Follow-up|5|||
37902372|NCT00933608|69587924|FG000|Overall Study|Adverse Event|4|||
37902373|NCT00933608|69587925|FG001|Overall Study|Adverse Event|2|||
37997877|NCT00283244|69682127|FG000|Overall Study|Lack of Efficacy|8|||
37997878|NCT00283244|69682128|FG001|Overall Study|Lack of Efficacy|32|||
37997879|NCT00283244|69682129|FG002|Overall Study|Lack of Efficacy|26|||
37997880|NCT00283244|69682127|FG000|Overall Study|Withdrawal by Subject|1|||
37997881|NCT00283244|69682128|FG001|Overall Study|Withdrawal by Subject|2|||
37997882|NCT00283244|69682129|FG002|Overall Study|Withdrawal by Subject|2|||
37997883|NCT00283244|69682127|FG000|Overall Study|Physician Decision|0|||
37997884|NCT00283244|69682128|FG001|Overall Study|Physician Decision|0|||
37997885|NCT00283244|69682129|FG002|Overall Study|Physician Decision|1|||
37997886|NCT00283244|69682127|FG000|Overall Study|Medical illness (other complicating dz)|4|||
37997887|NCT00283244|69682128|FG001|Overall Study|Medical illness (other complicating dz)|3|||
37997888|NCT00283244|69682129|FG002|Overall Study|Medical illness (other complicating dz)|6|||
37997889|NCT00283244|69682127|FG000|Overall Study|Clinical deterioration|1|||
37997890|NCT00283244|69682128|FG001|Overall Study|Clinical deterioration|3|||
37997891|NCT00283244|69682129|FG002|Overall Study|Clinical deterioration|3|||
37997892|NCT00282464|69682140|FG000|Overall Study|Adverse Event|26|||
37997893|NCT00282464|69682141|FG001|Overall Study|Adverse Event|20|||
37997894|NCT00282464|69682140|FG000|Overall Study|Lack of Efficacy|8|||
37997895|NCT00282464|69682141|FG001|Overall Study|Lack of Efficacy|8|||
37997896|NCT00282464|69682140|FG000|Overall Study|Lost to Follow-up|10|||
37997897|NCT00282464|69682141|FG001|Overall Study|Lost to Follow-up|10|||
37997898|NCT00282464|69682140|FG000|Overall Study|Withdrawal by Subject|24|||
37997899|NCT00282464|69682141|FG001|Overall Study|Withdrawal by Subject|10|||
37997900|NCT00282464|69682140|FG000|Overall Study|laboratory abnormality|1|||
37997901|NCT00282464|69682141|FG001|Overall Study|laboratory abnormality|2|||
37997902|NCT00282464|69682140|FG000|Overall Study|Protocol Violation|0|||
37997903|NCT00282464|69682141|FG001|Overall Study|Protocol Violation|7|||
37997904|NCT00282464|69682140|FG000|Overall Study|Patient moved|1|||
37997905|NCT00282464|69682141|FG001|Overall Study|Patient moved|0|||
37997906|NCT00282464|69682140|FG000|Overall Study|patient non-compliant|3|||
37997907|NCT00282464|69682141|FG001|Overall Study|patient non-compliant|0|||
37997908|NCT00282464|69682140|FG000|Overall Study|patient no show|0|||
37997909|NCT00282464|69682141|FG001|Overall Study|patient no show|1|||
37997910|NCT00282464|69682140|FG000|Overall Study|patient incarcerated|0|||
37997911|NCT00282464|69682141|FG001|Overall Study|patient incarcerated|1|||
37997912|NCT00282464|69682140|FG000|Overall Study|family crisis|0|||
37997913|NCT00282464|69682141|FG001|Overall Study|family crisis|1|||
37997914|NCT00282464|69682140|FG000|Overall Study|dispensed wrong kit|0|||
37997915|NCT00282464|69682141|FG001|Overall Study|dispensed wrong kit|1|||
37997916|NCT00282464|69682140|FG000|Overall Study|dropped due to missed visits|0|||
37997917|NCT00282464|69682141|FG001|Overall Study|dropped due to missed visits|1|||
37997918|NCT00273182|69682147|FG000|Overall Study|Death|450|||
37997919|NCT00273182|69682147|FG000|Overall Study|Lost to Follow-up|88|||
37997920|NCT00273182|69682147|FG000|Overall Study|Withdrawal by Subject|257|||
37997921|NCT00273182|69682147|FG000|Overall Study|Device/System Explant|154|||
37997922|NCT00273182|69682147|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
37997923|NCT00209274|69682154|FG000|Overall Study|Missed visit|3|||
37997924|NCT00209274|69682155|FG001|Overall Study|Missed visit|2|||
37997925|NCT00209274|69682154|FG000|Overall Study|Death|32|||
37997926|NCT00209274|69682155|FG001|Overall Study|Death|15|||
37997927|NCT00209274|69682154|FG000|Overall Study|Withdrawal by Subject|30|||
37827754|NCT00171223|69510577|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
37827755|NCT00171223|69510575|FG000|Overall Study|Protocol Violation|2|||
37827756|NCT00171223|69510576|FG001|Overall Study|Protocol Violation|2|||
37827757|NCT00171223|69510577|FG002|Overall Study|Protocol Violation|3|||
37827758|NCT00171223|69510575|FG000|Overall Study|Participant Withdrew Consent|12|||
37827759|NCT00171223|69510576|FG001|Overall Study|Participant Withdrew Consent|21|||
37827760|NCT00171223|69510577|FG002|Overall Study|Participant Withdrew Consent|15|||
37827761|NCT00171223|69510575|FG000|Overall Study|Lost to Follow-up|5|||
37827762|NCT00171223|69510576|FG001|Overall Study|Lost to Follow-up|2|||
37827763|NCT00171223|69510577|FG002|Overall Study|Lost to Follow-up|3|||
37827764|NCT00171223|69510575|FG000|Overall Study|Administrative Problems|4|||
37827765|NCT00171223|69510576|FG001|Overall Study|Administrative Problems|7|||
37997928|NCT00209274|69682155|FG001|Overall Study|Withdrawal by Subject|15|||
37997929|NCT00209274|69682154|FG000|Overall Study|Randomized not treated (RNT)|6|||
37997930|NCT00209274|69682155|FG001|Overall Study|Randomized not treated (RNT)|15|||
37997931|NCT03841331|69682163|FG000|Overall Study|Withdrawal by Subject|4|||
37997932|NCT03841331|69682164|FG001|Overall Study|Withdrawal by Subject|9|||
37997933|NCT03841331|69682163|FG000|Overall Study|Lost to Follow-up|5|||
37827766|NCT00171223|69510577|FG002|Overall Study|Administrative Problems|6|||
37997934|NCT03841331|69682164|FG001|Overall Study|Lost to Follow-up|1|||
37997935|NCT00262080|69682173|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
37997936|NCT00262080|69682174|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
37997937|NCT00262080|69682175|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
37997938|NCT00262080|69682173|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
37997939|NCT00262080|69682174|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
37997940|NCT00262080|69682175|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
37997941|NCT00262080|69682173|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
37997942|NCT00262080|69682174|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
37997943|NCT00262080|69682175|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
37997944|NCT00262080|69682173|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
37997945|NCT00262080|69682174|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
37997946|NCT00262080|69682175|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
37997947|NCT00262080|69682173|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
37997948|NCT00262080|69682174|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
37997949|NCT00262080|69682175|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
37997950|NCT00262080|69682173|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
37997951|NCT00262080|69682174|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
37997952|NCT00262080|69682175|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
37997953|NCT00282308|69682185|FG000|Treatment Period|Lost to Follow-up|1|||
37997954|NCT00282308|69682186|FG001|Treatment Period|Lost to Follow-up|0|||
37997955|NCT00282308|69682187|FG002|Treatment Period|Lost to Follow-up|0|||
37997956|NCT00282308|69682185|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
37997957|NCT00282308|69682186|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
37997958|NCT00282308|69682187|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
37997959|NCT00282308|69682185|FG000|Treatment Period|Adverse Event|0|||
37997960|NCT00282308|69682186|FG001|Treatment Period|Adverse Event|2|||
37997961|NCT00282308|69682187|FG002|Treatment Period|Adverse Event|0|||
37997962|NCT00282308|69682185|FG000|Treatment Period|Not Treated with Study Drug|1|||
37997963|NCT00282308|69682186|FG001|Treatment Period|Not Treated with Study Drug|0|||
37997964|NCT00282308|69682187|FG002|Treatment Period|Not Treated with Study Drug|0|||
37997965|NCT00282308|69682185|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
37997966|NCT00282308|69682186|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
37997967|NCT00282308|69682187|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
37997968|NCT00282308|69682185|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
37997969|NCT00282308|69682186|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
37997970|NCT00282308|69682187|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
37997971|NCT00282308|69682185|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
37827767|NCT00171223|69510575|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
37827768|NCT00171223|69510576|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
37827769|NCT00171223|69510577|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
37827770|NCT00171223|69510575|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
37827771|NCT00171223|69510576|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
37827772|NCT00171223|69510577|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
37827773|NCT00479674|69510583|FG000|Overall Study|Adverse Event|18|||
37902374|NCT00933608|69587924|FG000|Overall Study|Physician Decision|1|||
37902375|NCT00933608|69587925|FG001|Overall Study|Physician Decision|0|||
37902376|NCT00574951|69587931|FG000|Overall Study|Ineligible - improper prior treatment|1|||
37902377|NCT01557751|69587935|FG000|Overall Study|Physician Decision|3|||
37902378|NCT00936884|69587941|FG000|Double-blind|Withdrawal by Subject|6|||
37902379|NCT00936884|69587942|FG001|Double-blind|Withdrawal by Subject|4|||
37902380|NCT00936884|69587943|FG002|Double-blind|Withdrawal by Subject|0|||
37902381|NCT00936884|69587941|FG000|Double-blind|Death|2|||
37902382|NCT00936884|69587942|FG001|Double-blind|Death|1|||
37902383|NCT00936884|69587943|FG002|Double-blind|Death|0|||
37902384|NCT00936884|69587941|FG000|Double-blind|Lack of Efficacy|1|||
37902385|NCT00936884|69587942|FG001|Double-blind|Lack of Efficacy|1|||
37902386|NCT00936884|69587943|FG002|Double-blind|Lack of Efficacy|0|||
37902387|NCT00936884|69587941|FG000|Double-blind|Adverse Event|1|||
37902388|NCT00936884|69587942|FG001|Double-blind|Adverse Event|0|||
37902389|NCT00936884|69587943|FG002|Double-blind|Adverse Event|0|||
37902390|NCT00936884|69587941|FG000|Double-blind|Physician Decision|1|||
37997972|NCT00282308|69682186|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
37997973|NCT00282308|69682187|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
37997974|NCT00282308|69682185|FG000|Safety Follow-up Period|Adverse Event|0|||
37997975|NCT00282308|69682186|FG001|Safety Follow-up Period|Adverse Event|0|||
37997976|NCT00282308|69682187|FG002|Safety Follow-up Period|Adverse Event|1|||
37997977|NCT00282308|69682185|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
37997978|NCT00282308|69682186|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
37827774|NCT00479674|69510583|FG000|Overall Study|Withdrawal by Subject|6|||
37827775|NCT00479674|69510583|FG000|Overall Study|Physician Decision|14|||
37827776|NCT00479674|69510583|FG000|Overall Study|none provided|3|||
37827777|NCT00479401|69510590|FG000|Overall Study|Adverse Event|24|||
37827778|NCT00479401|69510591|FG001|Overall Study|Adverse Event|20|||
37827779|NCT00479401|69510592|FG002|Overall Study|Adverse Event|4|||
37827780|NCT00479401|69510590|FG000|Overall Study|Lack of Efficacy|2|||
37827781|NCT00479401|69510591|FG001|Overall Study|Lack of Efficacy|2|||
37827782|NCT00479401|69510592|FG002|Overall Study|Lack of Efficacy|4|||
37997979|NCT00282308|69682187|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
37997980|NCT00282308|69682185|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
37997981|NCT00282308|69682186|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
37997982|NCT00282308|69682187|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
37997983|NCT00282308|69682185|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
37997984|NCT00282308|69682186|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
37997985|NCT00282308|69682187|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
37997986|NCT00282152|69682199|FG000|Overall Study|Withdrawal by Subject|1|||
37997987|NCT00282152|69682200|FG001|Overall Study|Withdrawal by Subject|0|||
37997988|NCT00281840|69682207|FG000|Overall Study|Adverse Event|12|||
37997989|NCT00281840|69682207|FG000|Overall Study|Physician Decision|6|||
37997990|NCT00281840|69682207|FG000|Overall Study|Withdrawal by Subject|3|||
37997991|NCT00281840|69682207|FG000|Overall Study|Disease Progression|2|||
37997992|NCT00281840|69682207|FG000|Overall Study|exceed maximum delay in treatment|1|||
37997993|NCT00281840|69682207|FG000|Overall Study|Complicating Disease|1|||
37997994|NCT00281684|69682216|FG000|Overall Study|Lost to Follow-up|0|||
37997995|NCT00281684|69682217|FG001|Overall Study|Lost to Follow-up|0|||
37997996|NCT00281684|69682218|FG002|Overall Study|Lost to Follow-up|1|||
37997997|NCT00281684|69682219|FG003|Overall Study|Lost to Follow-up|0|||
37997998|NCT00281684|69682216|FG000|Overall Study|Withdrawal by Subject|1|||
37997999|NCT00281684|69682217|FG001|Overall Study|Withdrawal by Subject|0|||
37998000|NCT00281684|69682218|FG002|Overall Study|Withdrawal by Subject|0|||
37998001|NCT00281684|69682219|FG003|Overall Study|Withdrawal by Subject|0|||
37998002|NCT00272792|69682233|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
37998003|NCT00272792|69682234|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
37998004|NCT00272792|69682233|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
37998005|NCT00272792|69682234|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
37998006|NCT00272792|69682233|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
37998007|NCT00272792|69682234|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
37998008|NCT00272792|69682233|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
37998009|NCT00272792|69682234|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
37998010|NCT00048568|69682242|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
37998011|NCT00048568|69682243|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
37998012|NCT00048568|69682244|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
37998013|NCT00048568|69682242|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
37998014|NCT00048568|69682243|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
37998015|NCT00048568|69682244|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
37998016|NCT00048568|69682242|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
37998017|NCT00048568|69682243|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
37998018|NCT00048568|69682244|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
37998019|NCT00048568|69682242|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
37998020|NCT00048568|69682243|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
37998021|NCT00048568|69682244|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
37998022|NCT00048568|69682242|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
37998023|NCT00048568|69682243|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
37998024|NCT00048568|69682244|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
37998025|NCT00048568|69682242|FG000|Double-Blind Period Days 170 to 365|Death|1|||
37998026|NCT00048568|69682243|FG001|Double-Blind Period Days 170 to 365|Death|1|||
37998027|NCT00048568|69682244|FG002|Double-Blind Period Days 170 to 365|Death|0|||
37998028|NCT00048568|69682242|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
37998029|NCT00048568|69682243|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
37998030|NCT00048568|69682244|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
37998031|NCT00048568|69682242|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
37998032|NCT00048568|69682243|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
37998033|NCT00048568|69682244|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
37998034|NCT00048568|69682242|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
37998035|NCT00048568|69682243|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
37998036|NCT00048568|69682244|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
37998037|NCT00048568|69682242|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
37998038|NCT00048568|69682243|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
37998039|NCT00048568|69682244|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
37998040|NCT00048568|69682242|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
37998041|NCT00048568|69682243|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
37998042|NCT00048568|69682244|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
37998043|NCT00048568|69682242|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
37998044|NCT00048568|69682243|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
37998045|NCT00048568|69682244|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
37998046|NCT00048568|69682242|FG000|Open-Label Period|Death|0|||
37998047|NCT00048568|69682243|FG001|Open-Label Period|Death|0|||
37998048|NCT00048568|69682244|FG002|Open-Label Period|Death|13|||
37998049|NCT00048568|69682242|FG000|Open-Label Period|Adverse Event|0|||
37998050|NCT00048568|69682243|FG001|Open-Label Period|Adverse Event|0|||
37998051|NCT00048568|69682244|FG002|Open-Label Period|Adverse Event|49|||
37998052|NCT00048568|69682242|FG000|Open-Label Period|Lack of Efficacy|0|||
37998053|NCT00048568|69682243|FG001|Open-Label Period|Lack of Efficacy|0|||
37998054|NCT00048568|69682244|FG002|Open-Label Period|Lack of Efficacy|32|||
37998055|NCT00048568|69682242|FG000|Open-Label Period|Withdrawal by Subject|0|||
37827783|NCT00479401|69510590|FG000|Overall Study|Protocol Violation|2|||
37827784|NCT00479401|69510591|FG001|Overall Study|Protocol Violation|1|||
37827785|NCT00479401|69510592|FG002|Overall Study|Protocol Violation|1|||
37827786|NCT00479401|69510590|FG000|Overall Study|Lost to Follow-up|1|||
37827787|NCT00479401|69510591|FG001|Overall Study|Lost to Follow-up|1|||
37827788|NCT00479401|69510592|FG002|Overall Study|Lost to Follow-up|1|||
37827789|NCT00479401|69510590|FG000|Overall Study|Withdrawal by Subject|16|||
37827790|NCT00479401|69510591|FG001|Overall Study|Withdrawal by Subject|10|||
37827791|NCT00479401|69510592|FG002|Overall Study|Withdrawal by Subject|2|||
37827792|NCT00479401|69510590|FG000|Overall Study|Exclusion criteria, relocation|4|||
37827793|NCT00479401|69510591|FG001|Overall Study|Exclusion criteria, relocation|3|||
37827794|NCT00479401|69510592|FG002|Overall Study|Exclusion criteria, relocation|0|||
37827795|NCT00478777|69510600|FG000|Overall Study|Adverse Event|29|||
37827796|NCT00478777|69510600|FG000|Overall Study|Lack of Efficacy|23|||
37827797|NCT00478777|69510600|FG000|Overall Study|Withdrawal by Subject|4|||
37827798|NCT00478777|69510600|FG000|Overall Study|Death|3|||
37827799|NCT00478777|69510600|FG000|Overall Study|Protocol Violation|3|||
37827800|NCT00478777|69510600|FG000|Overall Study|Lost to Follow-up|3|||
37902391|NCT00936884|69587942|FG001|Double-blind|Physician Decision|0|||
37902392|NCT00936884|69587943|FG002|Double-blind|Physician Decision|0|||
37902393|NCT00936884|69587941|FG000|Double-blind|No post baseline diary entry|1|||
37902394|NCT00936884|69587942|FG001|Double-blind|No post baseline diary entry|0|||
37902395|NCT00936884|69587943|FG002|Double-blind|No post baseline diary entry|0|||
37902396|NCT00936884|69587941|FG000|Double-blind|Did not receive study drug|0|||
37902397|NCT00936884|69587942|FG001|Double-blind|Did not receive study drug|1|||
37902398|NCT00936884|69587943|FG002|Double-blind|Did not receive study drug|0|||
37902399|NCT00668863|69587959|FG000|Overall Study|Objective Progression or Relapse|42|||
37902400|NCT00668863|69587959|FG000|Overall Study|Adverse Event|13|||
37902401|NCT00668863|69587959|FG000|Overall Study|Study Terminated by Sponsor|8|||
37902402|NCT00668863|69587959|FG000|Overall Study|Global Deterioration of Health Status|4|||
37902403|NCT00668863|69587959|FG000|Overall Study|Withdrawal by Subject|1|||
37902404|NCT00668863|69587959|FG000|Overall Study|Surgery|1|||
37902405|NCT00668863|69587959|FG000|Overall Study|Subject's work scheduling problem|1|||
37902406|NCT00668863|69587959|FG000|Overall Study|Physician Decision|1|||
37902407|NCT00935012|69587963|FG000|Overall Study|Death|19|||
37902408|NCT00935012|69587963|FG000|Overall Study|Withdrawal by Subject|3|||
37902409|NCT00935012|69587963|FG000|Overall Study|Other|5|||
37902410|NCT00935012|69587963|FG000|Overall Study|Adverse Event|2|||
37902411|NCT00932360|69587967|FG000|Washout (One Week)|Withdrawal by Subject|0|||
37902412|NCT00932360|69587968|FG001|Washout (One Week)|Withdrawal by Subject|0|||
37902413|NCT00932360|69587969|FG002|Washout (One Week)|Withdrawal by Subject|0|||
37902414|NCT00932360|69587970|FG003|Washout (One Week)|Withdrawal by Subject|0|||
37902415|NCT00932360|69587971|FG004|Washout (One Week)|Withdrawal by Subject|2|||
37902416|NCT00932360|69587972|FG005|Washout (One Week)|Withdrawal by Subject|0|||
37902417|NCT00668707|69587988|FG000|Overall Study|Cancer Recurrence|58|||
37902418|NCT00668707|69587989|FG001|Overall Study|Cancer Recurrence|58|||
37902419|NCT00668707|69587988|FG000|Overall Study|Withdrawal by Subject|117|||
37902420|NCT00668707|69587989|FG001|Overall Study|Withdrawal by Subject|100|||
37902421|NCT00668707|69587988|FG000|Overall Study|Lost to Follow-up|3|||
37902422|NCT00668707|69587989|FG001|Overall Study|Lost to Follow-up|6|||
37902423|NCT00668707|69587988|FG000|Overall Study|Protocol Violation|10|||
37902424|NCT00668707|69587989|FG001|Overall Study|Protocol Violation|12|||
37998056|NCT00048568|69682243|FG001|Open-Label Period|Withdrawal by Subject|0|||
37827801|NCT00478777|69510600|FG000|Overall Study|Physician Decision|1|||
37827802|NCT00478777|69510600|FG000|Overall Study|Intolerance of therapy|1|||
37827803|NCT00478777|69510600|FG000|Overall Study|Lack of compliance|1|||
37902425|NCT00668707|69587988|FG000|Overall Study|Death|11|||
37902426|NCT00668707|69587989|FG001|Overall Study|Death|4|||
37902427|NCT00668395|69588003|FG000|Overall Study|Withdrawal by Subject|4|||
37902428|NCT00668395|69588004|FG001|Overall Study|Withdrawal by Subject|4|||
37998057|NCT00048568|69682244|FG002|Open-Label Period|Withdrawal by Subject|26|||
37827804|NCT00478777|69510600|FG000|Overall Study|Lymphocytes infusion|1|||
37827805|NCT00478777|69510600|FG000|Overall Study|End of therapy|2|||
37827806|NCT00478777|69510600|FG000|Overall Study|Not treated with lenalidomide|6|||
37902429|NCT00668395|69588005|FG002|Overall Study|Withdrawal by Subject|1|||
37902430|NCT00668395|69588003|FG000|Overall Study|Adverse Event|1|||
37902431|NCT00668395|69588004|FG001|Overall Study|Adverse Event|1|||
37902432|NCT00668395|69588005|FG002|Overall Study|Adverse Event|0|||
37902433|NCT00668395|69588003|FG000|Overall Study|Physician Decision|1|||
37902434|NCT00668395|69588004|FG001|Overall Study|Physician Decision|1|||
37902435|NCT00668395|69588005|FG002|Overall Study|Physician Decision|0|||
37998058|NCT00048568|69682242|FG000|Open-Label Period|Pregnancy|0|||
37998059|NCT00048568|69682243|FG001|Open-Label Period|Pregnancy|0|||
37998060|NCT00048568|69682244|FG002|Open-Label Period|Pregnancy|5|||
37998061|NCT00048568|69682242|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
37998062|NCT00048568|69682243|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
37902436|NCT00668317|69588013|FG000|Overall Study|Adverse Event|2|||
37902437|NCT00670111|69588034|FG000|Enrollment to One Month|Testing Failure|0|||
37902438|NCT00670111|69588035|FG001|Enrollment to One Month|Testing Failure|0|||
37902439|NCT00670111|69588036|FG002|Enrollment to One Month|Testing Failure|13|||
37902440|NCT00670111|69588034|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
37902441|NCT00670111|69588035|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
37998063|NCT00048568|69682244|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
37998064|NCT00048568|69682242|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
37998065|NCT00048568|69682243|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
37998066|NCT00048568|69682244|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
37998067|NCT00048568|69682242|FG000|Open-Label Period|Unknown Reasons|0|||
37998068|NCT00048568|69682243|FG001|Open-Label Period|Unknown Reasons|0|||
37998069|NCT00048568|69682244|FG002|Open-Label Period|Unknown Reasons|25|||
37998070|NCT00048568|69682242|FG000|Open-Label Period|Lost to Follow-up|0|||
37998071|NCT00048568|69682243|FG001|Open-Label Period|Lost to Follow-up|0|||
37998072|NCT00048568|69682244|FG002|Open-Label Period|Lost to Follow-up|7|||
37827807|NCT00477607|69510606|FG000|Overall Study|Lost to Follow-up|7|||
37827808|NCT00477607|69510607|FG001|Overall Study|Lost to Follow-up|7|||
37827809|NCT00477490|69510618|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
37827810|NCT00477490|69510619|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
37827811|NCT00477490|69510620|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
37827812|NCT00477490|69510621|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
37827813|NCT00477490|69510622|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
37827814|NCT00477490|69510623|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
37902442|NCT00670111|69588036|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
37827815|NCT00477490|69510624|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
37827816|NCT00477490|69510625|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
37827817|NCT00477490|69510626|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
37827818|NCT00477490|69510618|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
37827819|NCT00477490|69510619|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
37827820|NCT00477490|69510620|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
37827821|NCT00477490|69510621|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
37827822|NCT00477490|69510622|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
37827823|NCT00477490|69510623|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
37827824|NCT00477490|69510624|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
37827825|NCT00477490|69510625|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
37827826|NCT00477490|69510626|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
37827827|NCT00477490|69510618|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
37827828|NCT00477490|69510619|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
37902443|NCT00670111|69588034|FG000|Enrollment to One Month|Physician Decision|1|||
37902444|NCT00670111|69588035|FG001|Enrollment to One Month|Physician Decision|0|||
37902445|NCT00670111|69588036|FG002|Enrollment to One Month|Physician Decision|0|||
37902446|NCT00672139|69588046|FG000|Overall Study|Death|14|||
37902447|NCT00672139|69588047|FG001|Overall Study|Death|23|||
37902448|NCT00672139|69588046|FG000|Overall Study|Withdrawal by Subject|2|||
37902449|NCT00672139|69588047|FG001|Overall Study|Withdrawal by Subject|11|||
37902450|NCT00672139|69588046|FG000|Overall Study|Adverse Event|4|||
37902451|NCT00672139|69588047|FG001|Overall Study|Adverse Event|7|||
37902452|NCT00672139|69588046|FG000|Overall Study|Physician Decision|2|||
37902453|NCT00672139|69588047|FG001|Overall Study|Physician Decision|0|||
37902454|NCT00672139|69588046|FG000|Overall Study|Lack of Efficacy|4|||
37902455|NCT00672139|69588047|FG001|Overall Study|Lack of Efficacy|1|||
37902456|NCT00672139|69588046|FG000|Overall Study|Protocol Violation|1|||
37902457|NCT00672139|69588047|FG001|Overall Study|Protocol Violation|1|||
37902458|NCT00672139|69588046|FG000|Overall Study|hospice discharge, caregiver requests|3|||
37902459|NCT00672139|69588047|FG001|Overall Study|hospice discharge, caregiver requests|2|||
37902460|NCT00570739|69588057|FG000|Overall Study|Adverse Event|8|||
37902461|NCT00570739|69588058|FG001|Overall Study|Adverse Event|6|||
37902462|NCT00570739|69588059|FG002|Overall Study|Adverse Event|2|||
37902463|NCT00570739|69588060|FG003|Overall Study|Adverse Event|2|||
37902464|NCT00570739|69588057|FG000|Overall Study|Lost to Follow-up|4|||
37902465|NCT00570739|69588058|FG001|Overall Study|Lost to Follow-up|5|||
37998073|NCT00262002|69682272|FG000|Overall Study|Adverse Event|2|||
37827829|NCT00477490|69510620|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
37902466|NCT00570739|69588059|FG002|Overall Study|Lost to Follow-up|4|||
37902467|NCT00570739|69588060|FG003|Overall Study|Lost to Follow-up|1|||
37902468|NCT00570739|69588057|FG000|Overall Study|Physician Decision|1|||
37902469|NCT00570739|69588058|FG001|Overall Study|Physician Decision|1|||
37902470|NCT00570739|69588059|FG002|Overall Study|Physician Decision|0|||
37827830|NCT00477490|69510621|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
37998074|NCT00262002|69682273|FG001|Overall Study|Adverse Event|1|||
37998075|NCT00262002|69682274|FG002|Overall Study|Adverse Event|0|||
37998076|NCT00262002|69682275|FG003|Overall Study|Adverse Event|0|||
37998077|NCT00262002|69682276|FG004|Overall Study|Adverse Event|0|||
37998078|NCT00262002|69682277|FG005|Overall Study|Adverse Event|1|||
37998079|NCT00262002|69682278|FG006|Overall Study|Adverse Event|0|||
37998080|NCT00262002|69682272|FG000|Overall Study|Withdrawal by Subject|4|||
37998081|NCT00262002|69682273|FG001|Overall Study|Withdrawal by Subject|2|||
37998082|NCT00262002|69682274|FG002|Overall Study|Withdrawal by Subject|0|||
37902471|NCT00570739|69588060|FG003|Overall Study|Physician Decision|0|||
37902472|NCT00570739|69588057|FG000|Overall Study|Withdrawal by Subject|7|||
37902473|NCT00570739|69588058|FG001|Overall Study|Withdrawal by Subject|7|||
37902474|NCT00570739|69588059|FG002|Overall Study|Withdrawal by Subject|3|||
37902475|NCT00570739|69588060|FG003|Overall Study|Withdrawal by Subject|5|||
37902476|NCT00570739|69588057|FG000|Overall Study|Required restricted medication|0|||
37902477|NCT00570739|69588058|FG001|Overall Study|Required restricted medication|0|||
37902478|NCT00570739|69588059|FG002|Overall Study|Required restricted medication|1|||
37902479|NCT00570739|69588060|FG003|Overall Study|Required restricted medication|0|||
37902480|NCT00570739|69588057|FG000|Overall Study|Met discontinuation criteria|1|||
37902481|NCT00570739|69588058|FG001|Overall Study|Met discontinuation criteria|0|||
37998083|NCT00262002|69682275|FG003|Overall Study|Withdrawal by Subject|1|||
37902482|NCT00570739|69588059|FG002|Overall Study|Met discontinuation criteria|1|||
37998084|NCT00262002|69682276|FG004|Overall Study|Withdrawal by Subject|2|||
37998085|NCT00262002|69682277|FG005|Overall Study|Withdrawal by Subject|2|||
37998086|NCT00262002|69682278|FG006|Overall Study|Withdrawal by Subject|2|||
37998087|NCT00262002|69682272|FG000|Overall Study|Lost to Follow-up|2|||
37998088|NCT00262002|69682273|FG001|Overall Study|Lost to Follow-up|0|||
37902483|NCT00570739|69588060|FG003|Overall Study|Met discontinuation criteria|1|||
37902484|NCT00570739|69588057|FG000|Overall Study|Other|0|||
37902485|NCT00570739|69588058|FG001|Overall Study|Other|2|||
37902486|NCT00570739|69588059|FG002|Overall Study|Other|5|||
37902487|NCT00570739|69588060|FG003|Overall Study|Other|3|||
37902488|NCT03689530|69588092|FG000|Overall Study|Withdrawal by Subject|53|||
37902489|NCT03689530|69588093|FG001|Overall Study|Withdrawal by Subject|16|||
37902490|NCT04188106|69588099|FG000|Overall Study|Lost to Follow-up|5|||
37902491|NCT04188106|69588099|FG000|Overall Study|Non-Compliance|1|||
37902492|NCT00669955|69588107|FG000|Overall Study|Adverse Event|3|||
37998089|NCT00262002|69682274|FG002|Overall Study|Lost to Follow-up|0|||
37998090|NCT00262002|69682275|FG003|Overall Study|Lost to Follow-up|2|||
37998091|NCT00262002|69682276|FG004|Overall Study|Lost to Follow-up|0|||
37998092|NCT00262002|69682277|FG005|Overall Study|Lost to Follow-up|1|||
37998093|NCT00262002|69682278|FG006|Overall Study|Lost to Follow-up|0|||
37998094|NCT00262002|69682272|FG000|Overall Study|Inapropriate enrollment|0|||
37998095|NCT00262002|69682273|FG001|Overall Study|Inapropriate enrollment|1|||
37998096|NCT00262002|69682274|FG002|Overall Study|Inapropriate enrollment|0|||
37998097|NCT00262002|69682275|FG003|Overall Study|Inapropriate enrollment|0|||
37998098|NCT00262002|69682276|FG004|Overall Study|Inapropriate enrollment|0|||
37998099|NCT00262002|69682277|FG005|Overall Study|Inapropriate enrollment|0|||
37998100|NCT00262002|69682278|FG006|Overall Study|Inapropriate enrollment|0|||
37998101|NCT00262002|69682272|FG000|Overall Study|Protocol Violation|3|||
37998102|NCT00262002|69682273|FG001|Overall Study|Protocol Violation|2|||
37998103|NCT00262002|69682274|FG002|Overall Study|Protocol Violation|0|||
37998104|NCT00262002|69682275|FG003|Overall Study|Protocol Violation|2|||
37998105|NCT00262002|69682276|FG004|Overall Study|Protocol Violation|5|||
37998106|NCT00262002|69682277|FG005|Overall Study|Protocol Violation|3|||
37998107|NCT00262002|69682278|FG006|Overall Study|Protocol Violation|2|||
37998108|NCT00262002|69682272|FG000|Overall Study|Unable to classify|0|||
37902493|NCT00669955|69588108|FG001|Overall Study|Adverse Event|5|||
37902494|NCT00669955|69588107|FG000|Overall Study|Death|0|||
37902495|NCT00669955|69588108|FG001|Overall Study|Death|1|||
37902496|NCT00669955|69588107|FG000|Overall Study|Withdrawal by Subject|2|||
37902497|NCT00669955|69588108|FG001|Overall Study|Withdrawal by Subject|3|||
37902498|NCT00669955|69588107|FG000|Overall Study|Lost to Follow-up|5|||
37902499|NCT00669955|69588108|FG001|Overall Study|Lost to Follow-up|7|||
37902500|NCT00669955|69588107|FG000|Overall Study|Protocol Violation|2|||
37902501|NCT00669955|69588108|FG001|Overall Study|Protocol Violation|7|||
37902502|NCT00669955|69588107|FG000|Overall Study|Investigator Sponsor Judgement|0|||
37998109|NCT00262002|69682273|FG001|Overall Study|Unable to classify|0|||
37998110|NCT00262002|69682274|FG002|Overall Study|Unable to classify|0|||
37998111|NCT00262002|69682275|FG003|Overall Study|Unable to classify|0|||
37998112|NCT00262002|69682276|FG004|Overall Study|Unable to classify|0|||
37998113|NCT00262002|69682277|FG005|Overall Study|Unable to classify|0|||
37998114|NCT00262002|69682278|FG006|Overall Study|Unable to classify|2|||
37902503|NCT00669955|69588108|FG001|Overall Study|Investigator Sponsor Judgement|1|||
37902504|NCT00669955|69588107|FG000|Overall Study|not compliant with study drug/visit|2|||
37902505|NCT00669955|69588108|FG001|Overall Study|not compliant with study drug/visit|3|||
37902506|NCT00671749|69588114|FG000|Overall Study|Adverse Event|2|||
37902507|NCT00671749|69588114|FG000|Overall Study|Withdrawal by Subject|4|||
37902508|NCT00671749|69588114|FG000|Overall Study|Protocol Violation|1|||
37902509|NCT00671749|69588114|FG000|Overall Study|Lost to Follow-up|1|||
37902510|NCT00669877|69588118|FG000|Overall Study|Disease Progression/Death|4|||
37902511|NCT00882999|69588129|FG000|Overall Study|Adverse Event|0|||
37902512|NCT00882999|69588130|FG001|Overall Study|Adverse Event|0|||
37902513|NCT00882999|69588131|FG002|Overall Study|Adverse Event|0|||
37902514|NCT00882999|69588132|FG003|Overall Study|Adverse Event|0|||
37902515|NCT00882999|69588133|FG004|Overall Study|Adverse Event|1|||
37902516|NCT00882999|69588134|FG005|Overall Study|Adverse Event|0|||
37902517|NCT00882999|69588135|FG006|Overall Study|Adverse Event|0|||
37902518|NCT00882999|69588129|FG000|Overall Study|Death|0|||
37902519|NCT00882999|69588130|FG001|Overall Study|Death|1|||
37902520|NCT00882999|69588131|FG002|Overall Study|Death|0|||
37902521|NCT00882999|69588132|FG003|Overall Study|Death|0|||
37902522|NCT00882999|69588133|FG004|Overall Study|Death|0|||
37902523|NCT00882999|69588134|FG005|Overall Study|Death|0|||
37902524|NCT00882999|69588135|FG006|Overall Study|Death|0|||
37902525|NCT00882999|69588129|FG000|Overall Study|Withdrawal by Subject|7|||
37902526|NCT00882999|69588130|FG001|Overall Study|Withdrawal by Subject|6|||
37902527|NCT00882999|69588131|FG002|Overall Study|Withdrawal by Subject|3|||
37902528|NCT00882999|69588132|FG003|Overall Study|Withdrawal by Subject|3|||
37902529|NCT00882999|69588133|FG004|Overall Study|Withdrawal by Subject|6|||
37902530|NCT00882999|69588134|FG005|Overall Study|Withdrawal by Subject|5|||
37902531|NCT00882999|69588135|FG006|Overall Study|Withdrawal by Subject|5|||
37902532|NCT00882999|69588129|FG000|Overall Study|Lost to Follow-up|0|||
37902533|NCT00882999|69588130|FG001|Overall Study|Lost to Follow-up|1|||
37902534|NCT00882999|69588131|FG002|Overall Study|Lost to Follow-up|1|||
37998115|NCT00281528|69682346|FG000|Overall Study|Progressive Disease|28|||
37998116|NCT00281528|69682347|FG001|Overall Study|Progressive Disease|18|||
37998117|NCT00281528|69682348|FG002|Overall Study|Progressive Disease|27|||
37998118|NCT00281528|69682346|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
37827831|NCT00477490|69510622|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
37827832|NCT00477490|69510623|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
37827833|NCT00477490|69510624|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
37827834|NCT00477490|69510625|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
37827835|NCT00477490|69510626|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
37827836|NCT00477490|69510618|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
37827837|NCT00477490|69510619|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
37827838|NCT00477490|69510620|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
37827839|NCT00477490|69510621|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
37827840|NCT00477490|69510622|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
37827841|NCT00477490|69510623|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
37827842|NCT00477490|69510624|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
37827843|NCT00477490|69510625|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
37827844|NCT00477490|69510626|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
37827845|NCT00477490|69510618|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
37827846|NCT00477490|69510619|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
37827847|NCT00477490|69510620|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
37827848|NCT00477490|69510621|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
37827849|NCT00477490|69510622|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
37827850|NCT00477490|69510623|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
37827851|NCT00477490|69510624|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
37827852|NCT00477490|69510625|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
37827853|NCT00477490|69510626|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
37827854|NCT00477490|69510618|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
37902535|NCT00882999|69588132|FG003|Overall Study|Lost to Follow-up|2|||
37902536|NCT00882999|69588133|FG004|Overall Study|Lost to Follow-up|1|||
37902537|NCT00882999|69588134|FG005|Overall Study|Lost to Follow-up|1|||
37827855|NCT00477490|69510619|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
37827856|NCT00477490|69510620|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
37827857|NCT00477490|69510621|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
37827858|NCT00477490|69510622|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
37827859|NCT00477490|69510623|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
37902538|NCT00882999|69588135|FG006|Overall Study|Lost to Follow-up|2|||
37902539|NCT00882999|69588129|FG000|Overall Study|Physician Decision|1|||
37902540|NCT00882999|69588130|FG001|Overall Study|Physician Decision|0|||
37902541|NCT00882999|69588131|FG002|Overall Study|Physician Decision|0|||
37902542|NCT00882999|69588132|FG003|Overall Study|Physician Decision|0|||
37902543|NCT00882999|69588133|FG004|Overall Study|Physician Decision|0|||
37902544|NCT00882999|69588134|FG005|Overall Study|Physician Decision|1|||
37998119|NCT00281528|69682347|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
37998120|NCT00281528|69682348|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
37998121|NCT00281528|69682346|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
37998122|NCT00281528|69682347|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
37998123|NCT00281528|69682348|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
37998124|NCT00281528|69682346|FG000|Overall Study|Physician Decision|11|||
37998125|NCT00281528|69682347|FG001|Overall Study|Physician Decision|4|||
37998126|NCT00281528|69682348|FG002|Overall Study|Physician Decision|5|||
37998127|NCT00281528|69682346|FG000|Overall Study|Protocol Violation|1|||
37998128|NCT00281528|69682347|FG001|Overall Study|Protocol Violation|0|||
37998129|NCT00281528|69682348|FG002|Overall Study|Protocol Violation|1|||
37998130|NCT00281528|69682346|FG000|Overall Study|Withdrawal by Subject|5|||
37998131|NCT00281528|69682347|FG001|Overall Study|Withdrawal by Subject|5|||
37998132|NCT00281528|69682348|FG002|Overall Study|Withdrawal by Subject|7|||
37998133|NCT00281528|69682346|FG000|Overall Study|Other|6|||
37998134|NCT00281528|69682347|FG001|Overall Study|Other|3|||
37998135|NCT00281528|69682348|FG002|Overall Study|Other|5|||
37998136|NCT00280748|69682356|FG000|Overall Study|Decline in performance|3|||
37998137|NCT00280748|69682356|FG000|Overall Study|Extra-cranial disease progression|1|||
37998138|NCT00271856|69682362|FG000|Overall Study|Withdrawal by Subject|1|||
37998139|NCT00271856|69682363|FG001|Overall Study|Withdrawal by Subject|7|||
37998140|NCT00271856|69682362|FG000|Overall Study|Lost to Follow-up|10|||
37998141|NCT00271856|69682363|FG001|Overall Study|Lost to Follow-up|11|||
37998142|NCT00061048|69682369|FG000|Overall Study|Adverse Event|2|||
37998143|NCT00061048|69682369|FG000|Overall Study|disease progression|20|||
37998144|NCT00270998|69682376|FG000|3 Month Follow-up|Adverse Event|1|||
37998145|NCT00270998|69682377|FG001|3 Month Follow-up|Adverse Event|0|||
37998146|NCT00270998|69682378|FG002|3 Month Follow-up|Adverse Event|0|||
37998147|NCT00270998|69682376|FG000|3 Month Follow-up|Lack of Efficacy|1|||
37998148|NCT00270998|69682377|FG001|3 Month Follow-up|Lack of Efficacy|2|||
37998149|NCT00270998|69682378|FG002|3 Month Follow-up|Lack of Efficacy|1|||
37998150|NCT00270998|69682376|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
37998151|NCT00270998|69682377|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
37998152|NCT00270998|69682378|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
37998153|NCT00270998|69682376|FG000|3 Month Follow-up|Pessary did not fit|12|||
37697020|NCT02054715|69173386|FG001|Follow-up 2|Changed MD/Facility|1|||
37827860|NCT00477490|69510624|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
37827861|NCT00477490|69510625|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
37827862|NCT00477490|69510626|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
37827863|NCT00477490|69510618|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
37827864|NCT00477490|69510619|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
37827865|NCT00477490|69510620|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
37827866|NCT00477490|69510621|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
37827867|NCT00477490|69510622|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
37827868|NCT00477490|69510623|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
37827869|NCT00477490|69510624|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
37827870|NCT00477490|69510625|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
37827871|NCT00477490|69510626|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
37827872|NCT00477490|69510618|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
37827873|NCT00477490|69510619|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
37827874|NCT00477490|69510620|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
37827875|NCT00477490|69510621|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
37827876|NCT00477490|69510622|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
37827877|NCT00477490|69510623|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
37827878|NCT00477490|69510624|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
37827879|NCT00477490|69510625|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
37827880|NCT00477490|69510626|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
37827881|NCT00477490|69510618|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
37827882|NCT00477490|69510619|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
37827883|NCT00477490|69510620|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
37827884|NCT00477490|69510621|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
37827885|NCT00477490|69510622|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
37827886|NCT00477490|69510623|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
37827887|NCT00477490|69510624|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
37827888|NCT00477490|69510625|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
37827889|NCT00477490|69510626|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
37827890|NCT00477490|69510618|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
37998154|NCT00270998|69682377|FG001|3 Month Follow-up|Pessary did not fit|0|||
37998155|NCT00270998|69682378|FG002|3 Month Follow-up|Pessary did not fit|0|||
37998156|NCT00270998|69682376|FG000|3 Month Follow-up|Personal/family health|1|||
37998157|NCT00270998|69682377|FG001|3 Month Follow-up|Personal/family health|1|||
37998158|NCT00270998|69682378|FG002|3 Month Follow-up|Personal/family health|0|||
37998159|NCT00270998|69682376|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
37998160|NCT00270998|69682377|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
37998161|NCT00270998|69682378|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
37998162|NCT00270998|69682376|FG000|12 Month Follow-up|Lack of Efficacy|5|||
37998163|NCT00270998|69682377|FG001|12 Month Follow-up|Lack of Efficacy|4|||
37998164|NCT00270998|69682378|FG002|12 Month Follow-up|Lack of Efficacy|3|||
37998165|NCT00270998|69682376|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
37998166|NCT00270998|69682377|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
37998167|NCT00270998|69682378|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
37998168|NCT00270998|69682376|FG000|12 Month Follow-up|Pessary did not fit|1|||
37998169|NCT00270998|69682377|FG001|12 Month Follow-up|Pessary did not fit|0|||
37998170|NCT00270998|69682378|FG002|12 Month Follow-up|Pessary did not fit|0|||
37998171|NCT00270998|69682376|FG000|12 Month Follow-up|Personal/family health|0|||
37998172|NCT00270998|69682377|FG001|12 Month Follow-up|Personal/family health|5|||
37998173|NCT00270998|69682378|FG002|12 Month Follow-up|Personal/family health|1|||
37998174|NCT00270998|69682376|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
37998175|NCT00270998|69682377|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
37998176|NCT00270998|69682378|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
37998177|NCT00279812|69682394|FG000|Overall Study|Protocol Violation|1|||
37998178|NCT00279812|69682395|FG001|Overall Study|Protocol Violation|1|||
37902545|NCT00882999|69588135|FG006|Overall Study|Physician Decision|1|||
37902546|NCT00671437|69588158|FG000|Overall Study|Progressive disease before C1 week 8|8|||
37902547|NCT00671437|69588158|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
37902548|NCT00671437|69588158|FG000|Overall Study|Adverse Event|3|||
37902549|NCT00671437|69588158|FG000|Overall Study|Ineligible post-hoc|1|||
37902550|NCT00882921|69588170|FG000|Overall Study|Death|2|||
37902551|NCT00882921|69588170|FG000|Overall Study|Other|3|||
37902552|NCT00882921|69588170|FG000|Overall Study|Lost to Follow-up|2|||
37902553|NCT00882921|69588170|FG000|Overall Study|Termination By Investigator|3|||
37902554|NCT00882921|69588170|FG000|Overall Study|Withdrawal Of Consent|1|||
37902555|NCT00582712|69588175|FG000|Overall Study|Adverse Event|1|||
37998179|NCT00279812|69682396|FG002|Overall Study|Protocol Violation|0|||
37998180|NCT00279812|69682397|FG003|Overall Study|Protocol Violation|0|||
37998181|NCT00279812|69682398|FG004|Overall Study|Protocol Violation|1|||
37998182|NCT00279812|69682399|FG005|Overall Study|Protocol Violation|0|||
37998183|NCT00279812|69682394|FG000|Overall Study|Withdrawal by Subject|0|||
37998184|NCT00279812|69682395|FG001|Overall Study|Withdrawal by Subject|4|||
37827891|NCT00477490|69510619|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
37827892|NCT00477490|69510620|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
37827893|NCT00477490|69510621|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
37827894|NCT00477490|69510622|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
37827895|NCT00477490|69510623|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
37827896|NCT00477490|69510624|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
37827897|NCT00477490|69510625|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
37827898|NCT00477490|69510626|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
37827899|NCT00477490|69510618|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
37902556|NCT00582712|69588175|FG000|Overall Study|Lack of Efficacy|1|||
37902557|NCT00582712|69588175|FG000|Overall Study|Withdrawal by Subject|1|||
37902558|NCT00582712|69588175|FG000|Overall Study|Complicating disease requiring treatment|1|||
37902559|NCT00582790|69588179|FG000|Overall Study|Rapid progression of disease|1|||
37902560|NCT00881751|69588186|FG000|Overall Study|Physician Decision|0|||
37902561|NCT00881751|69588187|FG001|Overall Study|Physician Decision|1|||
37902562|NCT00881751|69588186|FG000|Overall Study|Adverse Event|0|||
37902563|NCT00881751|69588187|FG001|Overall Study|Adverse Event|2|||
37902564|NCT00881751|69588186|FG000|Overall Study|Withdrawal by Subject|0|||
37902565|NCT00881751|69588187|FG001|Overall Study|Withdrawal by Subject|2|||
37902566|NCT00934856|69588199|FG000|Feasibility Part|Progressive disease|4|||
37902567|NCT00934856|69588200|FG001|Feasibility Part|Progressive disease|4|||
37902568|NCT00934856|69588201|FG002|Feasibility Part|Progressive disease|2|||
37902569|NCT00934856|69588202|FG003|Feasibility Part|Progressive disease|3|||
37902570|NCT00934856|69588203|FG004|Feasibility Part|Progressive disease|0|||
37902571|NCT00934856|69588204|FG005|Feasibility Part|Progressive disease|0|||
37902572|NCT00934856|69588199|FG000|Feasibility Part|Physician Decision|0|||
37902573|NCT00934856|69588200|FG001|Feasibility Part|Physician Decision|0|||
37902574|NCT00934856|69588201|FG002|Feasibility Part|Physician Decision|1|||
37827900|NCT00477490|69510619|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
37902575|NCT00934856|69588202|FG003|Feasibility Part|Physician Decision|0|||
37998185|NCT00279812|69682396|FG002|Overall Study|Withdrawal by Subject|2|||
37998186|NCT00279812|69682397|FG003|Overall Study|Withdrawal by Subject|0|||
37998187|NCT00279812|69682398|FG004|Overall Study|Withdrawal by Subject|0|||
37998188|NCT00279812|69682399|FG005|Overall Study|Withdrawal by Subject|0|||
37998189|NCT00279812|69682394|FG000|Overall Study|Adverse Event|0|||
37998190|NCT00279812|69682395|FG001|Overall Study|Adverse Event|1|||
37998191|NCT00279812|69682396|FG002|Overall Study|Adverse Event|1|||
37998192|NCT00279812|69682397|FG003|Overall Study|Adverse Event|0|||
37998193|NCT00279812|69682398|FG004|Overall Study|Adverse Event|2|||
37998194|NCT00279812|69682399|FG005|Overall Study|Adverse Event|1|||
37998195|NCT00207714|69682418|FG000|Overall Study|Adverse Event|6|||
37998196|NCT00207714|69682419|FG001|Overall Study|Adverse Event|2|||
37998197|NCT00207714|69682420|FG002|Overall Study|Adverse Event|4|||
37998198|NCT00207714|69682421|FG003|Overall Study|Adverse Event|3|||
37998199|NCT00207714|69682422|FG004|Overall Study|Adverse Event|1|||
37998200|NCT00207714|69682418|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
37998201|NCT00207714|69682419|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
37998202|NCT00207714|69682420|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
37902576|NCT00934856|69588203|FG004|Feasibility Part|Physician Decision|0|||
37902577|NCT00934856|69588204|FG005|Feasibility Part|Physician Decision|0|||
37902578|NCT00934856|69588199|FG000|Feasibility Part|Adverse Event|1|||
37902579|NCT00934856|69588200|FG001|Feasibility Part|Adverse Event|1|||
37902580|NCT00934856|69588201|FG002|Feasibility Part|Adverse Event|0|||
37902581|NCT00934856|69588202|FG003|Feasibility Part|Adverse Event|1|||
37902582|NCT00934856|69588203|FG004|Feasibility Part|Adverse Event|0|||
37902583|NCT00934856|69588204|FG005|Feasibility Part|Adverse Event|2|||
37998203|NCT00207714|69682421|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
37998204|NCT00207714|69682422|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
37998205|NCT00207714|69682418|FG000|Overall Study|Other|3|||
37998206|NCT00207714|69682419|FG001|Overall Study|Other|2|||
37998207|NCT00207714|69682420|FG002|Overall Study|Other|5|||
37998208|NCT00207714|69682421|FG003|Overall Study|Other|1|||
37998209|NCT00207714|69682422|FG004|Overall Study|Other|0|||
37998210|NCT00207090|69682441|FG000|Overall Study|Study drug toxicity|3|||
37998211|NCT00207090|69682441|FG000|Overall Study|Chest wall mass larger|1|||
37998212|NCT00207090|69682441|FG000|Overall Study|Disease progression/relapse|2|||
37998213|NCT00207090|69682441|FG000|Overall Study|Physician Decision|1|||
37998214|NCT00059332|69682452|FG000|Overall Study|Withdrawal by Subject|2|||
37998215|NCT00059332|69682453|FG001|Overall Study|Withdrawal by Subject|1|||
37998216|NCT00059332|69682452|FG000|Overall Study|Lost to Follow-up|1|||
37998217|NCT00059332|69682453|FG001|Overall Study|Lost to Follow-up|1|||
37998218|NCT00233454|69682459|FG000|Overall Study|Death|6|||
37998219|NCT00047320|69682463|FG000|Overall Study|Lack of Efficacy|8|||
37998220|NCT00047320|69682463|FG000|Overall Study|Lost to Follow-up|1|||
37998221|NCT00047320|69682463|FG000|Overall Study|Physician Decision|8|||
37998222|NCT00047320|69682463|FG000|Overall Study|Withdrawal by Subject|9|||
37998223|NCT00047320|69682463|FG000|Overall Study|Ineligible|2|||
37998224|NCT00233064|69682469|FG000|Overall Study|Lost to Follow-up|7|||
37998225|NCT00233064|69682470|FG001|Overall Study|Lost to Follow-up|7|||
37998226|NCT00233064|69682469|FG000|Overall Study|Withdrawal by Subject|5|||
37998227|NCT00233064|69682470|FG001|Overall Study|Withdrawal by Subject|3|||
37998228|NCT00233064|69682469|FG000|Overall Study|Death|0|||
37998229|NCT00233064|69682470|FG001|Overall Study|Death|1|||
37998230|NCT00233064|69682469|FG000|Overall Study|Relocation|0|||
37998231|NCT00233064|69682470|FG001|Overall Study|Relocation|1|||
37998232|NCT00233064|69682469|FG000|Overall Study|Protocol Violation|1|||
37998233|NCT00233064|69682470|FG001|Overall Study|Protocol Violation|0|||
37902584|NCT00934856|69588199|FG000|Feasibility Part|Withdrawal by Subject|0|||
37902585|NCT00934856|69588200|FG001|Feasibility Part|Withdrawal by Subject|0|||
37902586|NCT00934856|69588201|FG002|Feasibility Part|Withdrawal by Subject|0|||
37902587|NCT00934856|69588202|FG003|Feasibility Part|Withdrawal by Subject|1|||
37902588|NCT00934856|69588203|FG004|Feasibility Part|Withdrawal by Subject|0|||
37902589|NCT00934856|69588204|FG005|Feasibility Part|Withdrawal by Subject|1|||
37902590|NCT00934856|69588199|FG000|Extension Part|Adverse Event|0|||
37902591|NCT00934856|69588200|FG001|Extension Part|Adverse Event|0|||
37902592|NCT00934856|69588201|FG002|Extension Part|Adverse Event|0|||
37902593|NCT00934856|69588202|FG003|Extension Part|Adverse Event|1|||
37902594|NCT00934856|69588203|FG004|Extension Part|Adverse Event|4|||
37902595|NCT00934856|69588204|FG005|Extension Part|Adverse Event|4|||
37902596|NCT00934856|69588199|FG000|Extension Part|Progressive disease|0|||
37902597|NCT00934856|69588200|FG001|Extension Part|Progressive disease|0|||
37902598|NCT00934856|69588201|FG002|Extension Part|Progressive disease|0|||
37902599|NCT00934856|69588202|FG003|Extension Part|Progressive disease|1|||
37902600|NCT00934856|69588203|FG004|Extension Part|Progressive disease|0|||
37998234|NCT00233064|69682469|FG000|Overall Study|Moved to Dom. Republic|1|||
37998235|NCT00233064|69682470|FG001|Overall Study|Moved to Dom. Republic|0|||
37998236|NCT00268892|69682480|FG000|Overall Study|Adverse Event|14|||
37998237|NCT00268892|69682481|FG001|Overall Study|Adverse Event|17|||
37998238|NCT00268892|69682482|FG002|Overall Study|Adverse Event|20|||
37998239|NCT00268892|69682480|FG000|Overall Study|Lack of Efficacy|1|||
37998240|NCT00268892|69682481|FG001|Overall Study|Lack of Efficacy|3|||
37998241|NCT00268892|69682482|FG002|Overall Study|Lack of Efficacy|0|||
37998242|NCT00268892|69682480|FG000|Overall Study|Withdrawal by Subject|14|||
37998243|NCT00268892|69682481|FG001|Overall Study|Withdrawal by Subject|15|||
37998244|NCT00268892|69682482|FG002|Overall Study|Withdrawal by Subject|13|||
37998245|NCT00268892|69682480|FG000|Overall Study|Physician Decision|0|||
37998246|NCT00268892|69682481|FG001|Overall Study|Physician Decision|1|||
37998247|NCT00268892|69682482|FG002|Overall Study|Physician Decision|0|||
37998248|NCT00268892|69682480|FG000|Overall Study|Lost to Follow-up|5|||
37998249|NCT00268892|69682481|FG001|Overall Study|Lost to Follow-up|2|||
37998250|NCT00268892|69682482|FG002|Overall Study|Lost to Follow-up|4|||
37998251|NCT00268892|69682480|FG000|Overall Study|Protocol Violation|0|||
37998252|NCT00268892|69682481|FG001|Overall Study|Protocol Violation|1|||
37998253|NCT00268892|69682482|FG002|Overall Study|Protocol Violation|0|||
37998254|NCT00268892|69682480|FG000|Overall Study|Disease Progression|1|||
37998255|NCT00268892|69682481|FG001|Overall Study|Disease Progression|1|||
37998256|NCT00268892|69682482|FG002|Overall Study|Disease Progression|0|||
37998257|NCT00268892|69682480|FG000|Overall Study|Trial Site Closed|4|||
37998258|NCT00268892|69682481|FG001|Overall Study|Trial Site Closed|2|||
37998259|NCT00268892|69682482|FG002|Overall Study|Trial Site Closed|2|||
37998260|NCT00206076|69682492|FG000|Overall Study|Physician Decision|2|||
37998261|NCT00206076|69682493|FG001|Overall Study|Physician Decision|0|||
37998262|NCT00206076|69682492|FG000|Overall Study|Withdrawal by Subject|1|||
37998263|NCT00206076|69682493|FG001|Overall Study|Withdrawal by Subject|1|||
37998264|NCT00278954|69682501|FG000|Overall Study|Adverse Event|3|||
37998265|NCT00278954|69682501|FG000|Overall Study|Lost to Follow-up|1|||
37998266|NCT00278954|69682501|FG000|Overall Study|Withdrawal by Subject|1|||
37998267|NCT00278564|69682505|FG000|Overall Study|Lack of Efficacy|4|||
37998268|NCT00268346|69682511|FG000|Overall Study|Adverse Event|0|||
37998269|NCT00268346|69682512|FG001|Overall Study|Adverse Event|1|||
37998270|NCT00268346|69682511|FG000|Overall Study|Death|0|||
37998271|NCT00268346|69682512|FG001|Overall Study|Death|1|||
37998272|NCT00268346|69682511|FG000|Overall Study|Withdrawal by Subject|0|||
37998273|NCT00268346|69682512|FG001|Overall Study|Withdrawal by Subject|1|||
37998274|NCT00203892|69682521|FG000|Overall Study|Physician Decision|1|||
37998275|NCT00203892|69682522|FG001|Overall Study|Physician Decision|2|||
37998276|NCT00203892|69682523|FG002|Overall Study|Physician Decision|0|||
37998277|NCT00203892|69682521|FG000|Overall Study|Death|1|||
37998278|NCT00203892|69682522|FG001|Overall Study|Death|0|||
37998279|NCT00203892|69682523|FG002|Overall Study|Death|0|||
37998280|NCT00250718|69682531|FG000|Overall Study|Death|1|||
37998281|NCT00250718|69682531|FG000|Overall Study|Adverse Event|1|||
37998282|NCT00250718|69682531|FG000|Overall Study|Withdrawal by Subject|1|||
37998283|NCT00276614|69682535|FG000|Overall Study|Progression of disease under study|3|||
37697021|NCT02054715|69173385|FG000|Follow-up 2|Changed Mind|0|||
37697022|NCT02054715|69173386|FG001|Follow-up 2|Changed Mind|1|||
37697023|NCT02054715|69173385|FG000|Follow-up 2|No Reason|2|||
37697024|NCT02054715|69173386|FG001|Follow-up 2|No Reason|0|||
37697025|NCT02054715|69173385|FG000|Follow-up 2|Treatment Change or Delay|1|||
37697026|NCT02054715|69173386|FG001|Follow-up 2|Treatment Change or Delay|0|||
37998284|NCT00276458|69682541|FG000|Overall Study|Adverse Event|0|||
37998285|NCT00276458|69682542|FG001|Overall Study|Adverse Event|2|||
37998286|NCT00276458|69682541|FG000|Overall Study|Lost to Follow-up|2|||
37998287|NCT00276458|69682542|FG001|Overall Study|Lost to Follow-up|2|||
37998288|NCT00276458|69682541|FG000|Overall Study|Protocol Violation|4|||
37998289|NCT00276458|69682542|FG001|Overall Study|Protocol Violation|3|||
37998290|NCT00276380|69682550|FG000|Overall Study|Adverse Event|5|||
37998291|NCT00276380|69682551|FG001|Overall Study|Adverse Event|3|||
37998292|NCT00276380|69682550|FG000|Overall Study|Lost to Follow-up|1|||
37998293|NCT00276380|69682551|FG001|Overall Study|Lost to Follow-up|1|||
37998294|NCT00276380|69682550|FG000|Overall Study|Withdrawal by Subject|3|||
37697027|NCT02446769|69173392|FG000|Screening Period|Screen Failure|11|||
37697028|NCT02446769|69173393|FG001|Screening Period|Screen Failure|0|||
37697029|NCT02446769|69173394|FG002|Screening Period|Screen Failure|0|||
37697030|NCT02446769|69173392|FG000|Study Period|Randomized in Error|0|||
37902601|NCT00934856|69588204|FG005|Extension Part|Progressive disease|0|||
37902602|NCT00934856|69588199|FG000|Extension Part|Non-compliance with drug|0|||
37697031|NCT02446769|69173393|FG001|Study Period|Randomized in Error|2|||
37998295|NCT00276380|69682551|FG001|Overall Study|Withdrawal by Subject|6|||
37998296|NCT00276380|69682550|FG000|Overall Study|Death|5|||
37998297|NCT00276380|69682551|FG001|Overall Study|Death|3|||
37998298|NCT00276380|69682550|FG000|Overall Study|Abnormal aPPT Levels|0|||
37998299|NCT00276380|69682551|FG001|Overall Study|Abnormal aPPT Levels|1|||
37998300|NCT00267956|69682560|FG000|Controlled Period|Adverse Event|4|||
37998301|NCT00267956|69682561|FG001|Controlled Period|Adverse Event|1|||
37998302|NCT00267956|69682562|FG002|Controlled Period|Adverse Event|0|||
37998303|NCT00267956|69682563|FG003|Controlled Period|Adverse Event|0|||
37998304|NCT00267956|69682560|FG000|Controlled Period|Lack of Efficacy|4|||
37998305|NCT00267956|69682561|FG001|Controlled Period|Lack of Efficacy|2|||
37998306|NCT00267956|69682562|FG002|Controlled Period|Lack of Efficacy|0|||
37998307|NCT00267956|69682563|FG003|Controlled Period|Lack of Efficacy|0|||
37998308|NCT00267956|69682560|FG000|Controlled Period|Lost to Follow-up|2|||
37998309|NCT00267956|69682561|FG001|Controlled Period|Lost to Follow-up|0|||
37998310|NCT00267956|69682562|FG002|Controlled Period|Lost to Follow-up|0|||
37998311|NCT00267956|69682563|FG003|Controlled Period|Lost to Follow-up|0|||
37998312|NCT00267956|69682560|FG000|Controlled Period|Withdrew consent|3|||
37998313|NCT00267956|69682561|FG001|Controlled Period|Withdrew consent|1|||
37998314|NCT00267956|69682562|FG002|Controlled Period|Withdrew consent|0|||
37998315|NCT00267956|69682563|FG003|Controlled Period|Withdrew consent|0|||
37998316|NCT00267956|69682560|FG000|After Controlled Period|Adverse Event|0|||
37998317|NCT00267956|69682561|FG001|After Controlled Period|Adverse Event|0|||
37998318|NCT00267956|69682562|FG002|After Controlled Period|Adverse Event|2|||
37998319|NCT00267956|69682563|FG003|After Controlled Period|Adverse Event|1|||
37998320|NCT00267956|69682560|FG000|After Controlled Period|Lack of Efficacy|0|||
37998321|NCT00267956|69682561|FG001|After Controlled Period|Lack of Efficacy|0|||
37998322|NCT00267956|69682562|FG002|After Controlled Period|Lack of Efficacy|1|||
37998323|NCT00267956|69682563|FG003|After Controlled Period|Lack of Efficacy|1|||
37998324|NCT00267956|69682560|FG000|After Controlled Period|Lost to Follow-up|0|||
37998325|NCT00267956|69682561|FG001|After Controlled Period|Lost to Follow-up|0|||
37998326|NCT00267956|69682562|FG002|After Controlled Period|Lost to Follow-up|1|||
37998327|NCT00267956|69682563|FG003|After Controlled Period|Lost to Follow-up|0|||
37998328|NCT00267956|69682560|FG000|After Controlled Period|Withdrew consent|0|||
37998329|NCT00267956|69682561|FG001|After Controlled Period|Withdrew consent|0|||
37998330|NCT00267956|69682562|FG002|After Controlled Period|Withdrew consent|1|||
37998331|NCT00267956|69682563|FG003|After Controlled Period|Withdrew consent|0|||
37998332|NCT00267488|69682571|FG000|Overall Study|Sponsor Terminated Study|9|||
37998333|NCT00267488|69682571|FG000|Overall Study|Protocol Violation|1|||
37998334|NCT00267488|69682571|FG000|Overall Study|Other (Disease Progression)|1|||
37998335|NCT00058552|69682577|FG000|Overall Study|Died prior to receiving treatment|4|||
37998336|NCT00058552|69682578|FG001|Overall Study|Died prior to receiving treatment|2|||
37998337|NCT00058552|69682577|FG000|Overall Study|Disease progression|52|||
37998338|NCT00058552|69682578|FG001|Overall Study|Disease progression|44|||
37998339|NCT00058552|69682577|FG000|Overall Study|Adverse Event|4|||
37998340|NCT00058552|69682578|FG001|Overall Study|Adverse Event|2|||
37998341|NCT00058552|69682577|FG000|Overall Study|Withdrawal by Subject|3|||
37998342|NCT00058552|69682578|FG001|Overall Study|Withdrawal by Subject|5|||
37998343|NCT00058552|69682577|FG000|Overall Study|Physician Decision|2|||
37998344|NCT00058552|69682578|FG001|Overall Study|Physician Decision|5|||
37998345|NCT00058552|69682577|FG000|Overall Study|Clinical disease progression|0|||
37998346|NCT00058552|69682578|FG001|Overall Study|Clinical disease progression|4|||
37998347|NCT00044512|69682586|FG000|Follow Up|Lost to Follow-up|2|||
37998348|NCT03805438|69682590|FG000|Overall Study|Lack of Efficacy|1|||
37998349|NCT03805438|69682590|FG000|Overall Study|Protocol Violation|1|||
37998350|NCT00147537|69682598|FG000|Phase 1b|Death|0|||
37998351|NCT00147537|69682599|FG001|Phase 1b|Death|1|||
37998352|NCT00147537|69682600|FG002|Phase 1b|Death|2|||
37998353|NCT00147537|69682601|FG003|Phase 1b|Death|1|||
37902603|NCT00934856|69588200|FG001|Extension Part|Non-compliance with drug|0|||
37902604|NCT00934856|69588201|FG002|Extension Part|Non-compliance with drug|0|||
37902605|NCT00934856|69588202|FG003|Extension Part|Non-compliance with drug|0|||
37902606|NCT00934856|69588203|FG004|Extension Part|Non-compliance with drug|0|||
37902607|NCT00934856|69588204|FG005|Extension Part|Non-compliance with drug|1|||
37902608|NCT00934700|69588238|FG000|Overall Study|missing scan|5|||
37902609|NCT00934700|69588239|FG001|Overall Study|missing scan|9|||
37902610|NCT00934700|69588238|FG000|Overall Study|Death|8|||
37902611|NCT00934700|69588239|FG001|Overall Study|Death|3|||
37902612|NCT00930176|69588246|FG000|Overall Study|Death|1|||
37902613|NCT00669409|69588256|FG000|Part 2|Withdrawal by Subject|0|||
37902614|NCT00669409|69588257|FG001|Part 2|Withdrawal by Subject|0|||
37902615|NCT00669409|69588258|FG002|Part 2|Withdrawal by Subject|0|||
37902616|NCT00669409|69588259|FG003|Part 2|Withdrawal by Subject|0|||
37902617|NCT00669409|69588260|FG004|Part 2|Withdrawal by Subject|0|||
37902618|NCT00669409|69588261|FG005|Part 2|Withdrawal by Subject|0|||
37902619|NCT00669409|69588262|FG006|Part 2|Withdrawal by Subject|0|||
37902620|NCT00669409|69588263|FG007|Part 2|Withdrawal by Subject|0|||
37902621|NCT00669409|69588264|FG008|Part 2|Withdrawal by Subject|0|||
37902622|NCT00669409|69588265|FG009|Part 2|Withdrawal by Subject|1|||
37902623|NCT00669409|69588266|FG010|Part 2|Withdrawal by Subject|0|||
37902624|NCT00669331|69588295|FG000|Randomisation to First Dose|Adverse Event|1|||
37998354|NCT00147537|69682602|FG004|Phase 1b|Death|2|||
37998355|NCT00147537|69682603|FG005|Phase 1b|Death|2|||
37998356|NCT00147537|69682604|FG006|Phase 1b|Death|1|||
37998357|NCT00147537|69682605|FG007|Phase 1b|Death|3|||
37998358|NCT00147537|69682606|FG008|Phase 1b|Death|9|||
37998359|NCT00147537|69682607|FG009|Phase 1b|Death|0|||
37998360|NCT00147537|69682608|FG010|Phase 1b|Death|0|||
37998361|NCT00147537|69682598|FG000|Phase 1b|Lost to Follow-up|2|||
37998362|NCT00147537|69682599|FG001|Phase 1b|Lost to Follow-up|1|||
37998363|NCT00147537|69682600|FG002|Phase 1b|Lost to Follow-up|0|||
37998364|NCT00147537|69682601|FG003|Phase 1b|Lost to Follow-up|0|||
37998365|NCT00147537|69682602|FG004|Phase 1b|Lost to Follow-up|0|||
37998366|NCT00147537|69682603|FG005|Phase 1b|Lost to Follow-up|0|||
37998367|NCT00147537|69682604|FG006|Phase 1b|Lost to Follow-up|2|||
37998368|NCT00147537|69682605|FG007|Phase 1b|Lost to Follow-up|0|||
37998369|NCT00147537|69682606|FG008|Phase 1b|Lost to Follow-up|1|||
37998370|NCT00147537|69682607|FG009|Phase 1b|Lost to Follow-up|0|||
37998371|NCT00147537|69682608|FG010|Phase 1b|Lost to Follow-up|0|||
37998372|NCT00147537|69682598|FG000|Phase 1b|Other|0|||
37998373|NCT00147537|69682599|FG001|Phase 1b|Other|0|||
37998374|NCT00147537|69682600|FG002|Phase 1b|Other|2|||
37998375|NCT00147537|69682601|FG003|Phase 1b|Other|1|||
37998376|NCT00147537|69682602|FG004|Phase 1b|Other|1|||
37998377|NCT00147537|69682603|FG005|Phase 1b|Other|1|||
37998378|NCT00147537|69682604|FG006|Phase 1b|Other|14|||
37998379|NCT00147537|69682605|FG007|Phase 1b|Other|4|||
37998380|NCT00147537|69682606|FG008|Phase 1b|Other|4|||
37998381|NCT00147537|69682607|FG009|Phase 1b|Other|0|||
37998382|NCT00147537|69682608|FG010|Phase 1b|Other|0|||
37998383|NCT00147537|69682598|FG000|Phase 1b|Withdrawal by Subject|0|||
37998384|NCT00147537|69682599|FG001|Phase 1b|Withdrawal by Subject|0|||
37998385|NCT00147537|69682600|FG002|Phase 1b|Withdrawal by Subject|0|||
37998386|NCT00147537|69682601|FG003|Phase 1b|Withdrawal by Subject|0|||
37998387|NCT00147537|69682602|FG004|Phase 1b|Withdrawal by Subject|0|||
37998388|NCT00147537|69682603|FG005|Phase 1b|Withdrawal by Subject|0|||
37998389|NCT00147537|69682604|FG006|Phase 1b|Withdrawal by Subject|0|||
37998390|NCT00147537|69682605|FG007|Phase 1b|Withdrawal by Subject|0|||
37827901|NCT00477490|69510620|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
37827902|NCT00477490|69510621|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
37827903|NCT00477490|69510622|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
37827904|NCT00477490|69510623|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
37902625|NCT00669331|69588296|FG001|Randomisation to First Dose|Adverse Event|0|||
37902626|NCT00669331|69588295|FG000|Randomisation to First Dose|Protocol Violation|1|||
37902627|NCT00669331|69588296|FG001|Randomisation to First Dose|Protocol Violation|0|||
37902628|NCT00669331|69588295|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
37902629|NCT00669331|69588296|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
37902630|NCT00669331|69588295|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
37902631|NCT00669331|69588296|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
37902632|NCT00669331|69588295|FG000|Randomisation to First Dose|Death|1|||
37902633|NCT00669331|69588296|FG001|Randomisation to First Dose|Death|0|||
37902634|NCT00669331|69588295|FG000|Randomisation to First Dose|Sponsor decision|0|||
37902635|NCT00669331|69588296|FG001|Randomisation to First Dose|Sponsor decision|1|||
37902636|NCT00669331|69588295|FG000|Randomisation to First Dose|Randomised in error|3|||
37902637|NCT00669331|69588296|FG001|Randomisation to First Dose|Randomised in error|10|||
37902638|NCT00669331|69588295|FG000|Blinded Treatment Period|Adverse Event|16|||
37902639|NCT00669331|69588296|FG001|Blinded Treatment Period|Adverse Event|10|||
37902640|NCT00669331|69588295|FG000|Blinded Treatment Period|Protocol Violation|1|||
37902641|NCT00669331|69588296|FG001|Blinded Treatment Period|Protocol Violation|1|||
37998391|NCT00147537|69682606|FG008|Phase 1b|Withdrawal by Subject|2|||
37998392|NCT00147537|69682607|FG009|Phase 1b|Withdrawal by Subject|0|||
37998393|NCT00147537|69682608|FG010|Phase 1b|Withdrawal by Subject|0|||
37827905|NCT00477490|69510624|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
37827906|NCT00477490|69510625|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
37827907|NCT00477490|69510626|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
37827908|NCT00477490|69510618|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
37827909|NCT00477490|69510619|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
37827910|NCT00477490|69510620|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
37827911|NCT00477490|69510621|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
37827912|NCT00477490|69510622|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
37827913|NCT00477490|69510623|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
37902642|NCT00669331|69588295|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
37902643|NCT00669331|69588296|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
37902644|NCT00669331|69588295|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
37697032|NCT02446769|69173394|FG002|Study Period|Randomized in Error|0|||
37697033|NCT02420093|69173403|FG000|Overall Study|Withdrawal by Subject|1|||
37827914|NCT00477490|69510624|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
37998394|NCT00147537|69682598|FG000|Phase 1b|Randomized but not treated|0|||
37998395|NCT00147537|69682599|FG001|Phase 1b|Randomized but not treated|0|||
37998396|NCT00147537|69682600|FG002|Phase 1b|Randomized but not treated|0|||
37998397|NCT00147537|69682601|FG003|Phase 1b|Randomized but not treated|0|||
37998398|NCT00147537|69682602|FG004|Phase 1b|Randomized but not treated|0|||
37998399|NCT00147537|69682603|FG005|Phase 1b|Randomized but not treated|0|||
37998400|NCT00147537|69682604|FG006|Phase 1b|Randomized but not treated|1|||
37998401|NCT00147537|69682605|FG007|Phase 1b|Randomized but not treated|0|||
37998402|NCT00147537|69682606|FG008|Phase 1b|Randomized but not treated|1|||
37827915|NCT00477490|69510625|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
37827916|NCT00477490|69510626|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
37827917|NCT00477490|69510618|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
37827918|NCT00477490|69510619|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
37902645|NCT00669331|69588296|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
37902646|NCT00669331|69588295|FG000|Blinded Treatment Period|Death|0|||
37902647|NCT00669331|69588296|FG001|Blinded Treatment Period|Death|2|||
37902648|NCT00669331|69588295|FG000|Blinded Treatment Period|Physician Decision|3|||
37998403|NCT00147537|69682607|FG009|Phase 1b|Randomized but not treated|0|||
37998404|NCT00147537|69682608|FG010|Phase 1b|Randomized but not treated|0|||
37998405|NCT00147537|69682598|FG000|Phase 2|Death|0|||
37998406|NCT00147537|69682599|FG001|Phase 2|Death|0|||
37998407|NCT00147537|69682600|FG002|Phase 2|Death|0|||
37998408|NCT00147537|69682601|FG003|Phase 2|Death|0|||
37998409|NCT00147537|69682602|FG004|Phase 2|Death|0|||
37998410|NCT00147537|69682603|FG005|Phase 2|Death|0|||
37998411|NCT00147537|69682604|FG006|Phase 2|Death|0|||
37998412|NCT00147537|69682605|FG007|Phase 2|Death|0|||
37998413|NCT00147537|69682606|FG008|Phase 2|Death|0|||
37998414|NCT00147537|69682607|FG009|Phase 2|Death|85|||
37998415|NCT00147537|69682608|FG010|Phase 2|Death|31|||
37998416|NCT00147537|69682598|FG000|Phase 2|Lost to Follow-up|0|||
37998417|NCT00147537|69682599|FG001|Phase 2|Lost to Follow-up|0|||
37998418|NCT00147537|69682600|FG002|Phase 2|Lost to Follow-up|0|||
37998419|NCT00147537|69682601|FG003|Phase 2|Lost to Follow-up|0|||
37998420|NCT00147537|69682602|FG004|Phase 2|Lost to Follow-up|0|||
37998421|NCT00147537|69682603|FG005|Phase 2|Lost to Follow-up|0|||
37998422|NCT00147537|69682604|FG006|Phase 2|Lost to Follow-up|0|||
37998423|NCT00147537|69682605|FG007|Phase 2|Lost to Follow-up|0|||
37998424|NCT00147537|69682606|FG008|Phase 2|Lost to Follow-up|0|||
37998425|NCT00147537|69682607|FG009|Phase 2|Lost to Follow-up|12|||
37998426|NCT00147537|69682608|FG010|Phase 2|Lost to Follow-up|4|||
37998427|NCT00147537|69682598|FG000|Phase 2|Other|0|||
37998428|NCT00147537|69682599|FG001|Phase 2|Other|0|||
37998429|NCT00147537|69682600|FG002|Phase 2|Other|0|||
37998430|NCT00147537|69682601|FG003|Phase 2|Other|0|||
37998431|NCT00147537|69682602|FG004|Phase 2|Other|0|||
37998432|NCT00147537|69682603|FG005|Phase 2|Other|0|||
37998433|NCT00147537|69682604|FG006|Phase 2|Other|0|||
37998434|NCT00147537|69682605|FG007|Phase 2|Other|0|||
37998435|NCT00147537|69682606|FG008|Phase 2|Other|0|||
37998436|NCT00147537|69682607|FG009|Phase 2|Other|47|||
37998437|NCT00147537|69682608|FG010|Phase 2|Other|12|||
37998438|NCT00147537|69682598|FG000|Phase 2|Withdrawal by Subject|0|||
37827919|NCT00477490|69510620|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
37827920|NCT00477490|69510621|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
37902649|NCT00669331|69588296|FG001|Blinded Treatment Period|Physician Decision|3|||
37902650|NCT00669331|69588295|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
37902651|NCT00669331|69588296|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
37902652|NCT00932126|69588304|FG000|Overall Study|Adverse Event|0|||
37902653|NCT00932126|69588305|FG001|Overall Study|Adverse Event|0|||
37902654|NCT00932126|69588306|FG002|Overall Study|Adverse Event|0|||
37902655|NCT00932126|69588307|FG003|Overall Study|Adverse Event|0|||
37902656|NCT00932126|69588308|FG004|Overall Study|Adverse Event|0|||
37902657|NCT00932126|69588309|FG005|Overall Study|Adverse Event|0|||
37902658|NCT00932126|69588310|FG006|Overall Study|Adverse Event|1|||
37902659|NCT00932126|69588311|FG007|Overall Study|Adverse Event|2|||
37902660|NCT00932126|69588304|FG000|Overall Study|Protocol Violation|0|||
37998439|NCT00147537|69682599|FG001|Phase 2|Withdrawal by Subject|0|||
37827921|NCT00477490|69510622|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
37902661|NCT00932126|69588305|FG001|Overall Study|Protocol Violation|0|||
37902662|NCT00932126|69588306|FG002|Overall Study|Protocol Violation|0|||
37902663|NCT00932126|69588307|FG003|Overall Study|Protocol Violation|0|||
37902664|NCT00932126|69588308|FG004|Overall Study|Protocol Violation|1|||
37902665|NCT00932126|69588309|FG005|Overall Study|Protocol Violation|0|||
37902666|NCT00932126|69588310|FG006|Overall Study|Protocol Violation|0|||
37902667|NCT00932126|69588311|FG007|Overall Study|Protocol Violation|0|||
37902668|NCT00932126|69588304|FG000|Overall Study|Withdrawal by Subject|0|||
37998440|NCT00147537|69682600|FG002|Phase 2|Withdrawal by Subject|0|||
37998441|NCT00147537|69682601|FG003|Phase 2|Withdrawal by Subject|0|||
37998442|NCT00147537|69682602|FG004|Phase 2|Withdrawal by Subject|0|||
37998443|NCT00147537|69682603|FG005|Phase 2|Withdrawal by Subject|0|||
37998444|NCT00147537|69682604|FG006|Phase 2|Withdrawal by Subject|0|||
37998445|NCT00147537|69682605|FG007|Phase 2|Withdrawal by Subject|0|||
37998446|NCT00147537|69682606|FG008|Phase 2|Withdrawal by Subject|0|||
37998447|NCT00147537|69682607|FG009|Phase 2|Withdrawal by Subject|16|||
37998448|NCT00147537|69682608|FG010|Phase 2|Withdrawal by Subject|4|||
37998449|NCT00147537|69682598|FG000|Phase 2|Randomized but not treated|0|||
37998450|NCT00147537|69682599|FG001|Phase 2|Randomized but not treated|0|||
37998451|NCT00147537|69682600|FG002|Phase 2|Randomized but not treated|0|||
37998452|NCT00147537|69682601|FG003|Phase 2|Randomized but not treated|0|||
37998453|NCT00147537|69682602|FG004|Phase 2|Randomized but not treated|0|||
37902669|NCT00932126|69588305|FG001|Overall Study|Withdrawal by Subject|0|||
37902670|NCT00932126|69588306|FG002|Overall Study|Withdrawal by Subject|1|||
37902671|NCT00932126|69588307|FG003|Overall Study|Withdrawal by Subject|0|||
37902672|NCT00932126|69588308|FG004|Overall Study|Withdrawal by Subject|0|||
37902673|NCT00932126|69588309|FG005|Overall Study|Withdrawal by Subject|0|||
37902674|NCT00932126|69588310|FG006|Overall Study|Withdrawal by Subject|0|||
37902675|NCT00932126|69588311|FG007|Overall Study|Withdrawal by Subject|1|||
37902676|NCT00932126|69588304|FG000|Overall Study|Objective progression or relapse|3|||
37902677|NCT00932126|69588305|FG001|Overall Study|Objective progression or relapse|3|||
37902678|NCT00932126|69588306|FG002|Overall Study|Objective progression or relapse|2|||
37902679|NCT00932126|69588307|FG003|Overall Study|Objective progression or relapse|3|||
37902680|NCT00932126|69588308|FG004|Overall Study|Objective progression or relapse|3|||
37902681|NCT00932126|69588309|FG005|Overall Study|Objective progression or relapse|3|||
37902682|NCT00932126|69588310|FG006|Overall Study|Objective progression or relapse|3|||
37902683|NCT00932126|69588311|FG007|Overall Study|Objective progression or relapse|5|||
37902684|NCT00932126|69588304|FG000|Overall Study|Other|0|||
37902685|NCT00932126|69588305|FG001|Overall Study|Other|0|||
37902686|NCT00932126|69588306|FG002|Overall Study|Other|0|||
37902687|NCT00932126|69588307|FG003|Overall Study|Other|0|||
37902688|NCT00932126|69588308|FG004|Overall Study|Other|1|||
37902689|NCT00932126|69588309|FG005|Overall Study|Other|0|||
37902690|NCT00932126|69588310|FG006|Overall Study|Other|1|||
37902691|NCT00932126|69588311|FG007|Overall Study|Other|2|||
37902692|NCT00667225|69588333|FG000|Overall Study|Subject had no more lesions to treat.|1|||
37902693|NCT00667225|69588334|FG001|Overall Study|Subject had no more lesions to treat.|0|||
37902694|NCT00667225|69588333|FG000|Overall Study|Lost to Follow-up|0|||
37902695|NCT00667225|69588334|FG001|Overall Study|Lost to Follow-up|1|||
37902696|NCT00929864|69588342|FG000|Overall Study|Death|1|||
37902697|NCT00929864|69588343|FG001|Overall Study|Death|1|||
37902698|NCT00929864|69588342|FG000|Overall Study|Adverse Event|11|||
37902699|NCT00929864|69588343|FG001|Overall Study|Adverse Event|30|||
37902700|NCT00929864|69588342|FG000|Overall Study|Lack of Efficacy|19|||
37902701|NCT00929864|69588343|FG001|Overall Study|Lack of Efficacy|16|||
37902702|NCT00929864|69588342|FG000|Overall Study|Lost to Follow-up|7|||
37902703|NCT00929864|69588343|FG001|Overall Study|Lost to Follow-up|12|||
37902704|NCT00929864|69588342|FG000|Overall Study|Withdrawal by Subject|20|||
37998454|NCT00147537|69682603|FG005|Phase 2|Randomized but not treated|0|||
37998455|NCT00147537|69682604|FG006|Phase 2|Randomized but not treated|0|||
37998456|NCT00147537|69682605|FG007|Phase 2|Randomized but not treated|0|||
37998457|NCT00147537|69682606|FG008|Phase 2|Randomized but not treated|0|||
37998458|NCT00147537|69682607|FG009|Phase 2|Randomized but not treated|1|||
37998459|NCT00147537|69682608|FG010|Phase 2|Randomized but not treated|1|||
37998460|NCT00222729|69682653|FG000|Overall Study|Adverse Event|3|||
37998461|NCT00147225|69682663|FG000|Overall Study|Withdrawal by Subject|1|||
37998462|NCT00147225|69682664|FG001|Overall Study|Withdrawal by Subject|0|||
37998463|NCT00147225|69682665|FG002|Overall Study|Withdrawal by Subject|1|||
37998464|NCT00147225|69682666|FG003|Overall Study|Withdrawal by Subject|0|||
37998465|NCT00147225|69682667|FG004|Overall Study|Withdrawal by Subject|0|||
37998466|NCT00147225|69682668|FG005|Overall Study|Withdrawal by Subject|1|||
37998467|NCT00147225|69682663|FG000|Overall Study|Adverse Event|0|||
37827922|NCT00477490|69510623|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
37827923|NCT00477490|69510624|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
37827924|NCT00477490|69510625|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
37827925|NCT00477490|69510626|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
37827926|NCT00477490|69510618|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
37827927|NCT00477490|69510619|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
37827928|NCT00477490|69510620|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
37827929|NCT00477490|69510621|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
37827930|NCT00477490|69510622|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
37827931|NCT00477490|69510623|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
37827932|NCT00477490|69510624|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
37902705|NCT00929864|69588343|FG001|Overall Study|Withdrawal by Subject|9|||
37902706|NCT00929864|69588342|FG000|Overall Study|No longer met criteria|2|||
37902707|NCT00929864|69588343|FG001|Overall Study|No longer met criteria|1|||
37902708|NCT00929864|69588342|FG000|Overall Study|Poor or non-compliance|3|||
37902709|NCT00929864|69588343|FG001|Overall Study|Poor or non-compliance|3|||
37902710|NCT00929864|69588342|FG000|Overall Study|Pregnancy|0|||
37902711|NCT00929864|69588343|FG001|Overall Study|Pregnancy|3|||
37902712|NCT00929864|69588342|FG000|Overall Study|Administrative reason by Sponsor|1|||
37902713|NCT00929864|69588343|FG001|Overall Study|Administrative reason by Sponsor|1|||
37902714|NCT00929864|69588342|FG000|Overall Study|Non-specified|2|||
37902715|NCT00929864|69588343|FG001|Overall Study|Non-specified|7|||
37998468|NCT00147225|69682664|FG001|Overall Study|Adverse Event|0|||
37998469|NCT00147225|69682665|FG002|Overall Study|Adverse Event|1|||
37998470|NCT00147225|69682666|FG003|Overall Study|Adverse Event|1|||
37998471|NCT00147225|69682667|FG004|Overall Study|Adverse Event|0|||
37998472|NCT00147225|69682668|FG005|Overall Study|Adverse Event|0|||
37902716|NCT00597753|69588351|FG000|Overall Study|Adverse Event|6|||
37902717|NCT00597753|69588352|FG001|Overall Study|Adverse Event|2|||
37902718|NCT00597753|69588351|FG000|Overall Study|Death|55|||
37902719|NCT00597753|69588352|FG001|Overall Study|Death|29|||
37902720|NCT00597753|69588351|FG000|Overall Study|Lack of Efficacy|2|||
37902721|NCT00597753|69588352|FG001|Overall Study|Lack of Efficacy|0|||
37902722|NCT00597753|69588351|FG000|Overall Study|Lost to Follow-up|10|||
37902723|NCT00597753|69588352|FG001|Overall Study|Lost to Follow-up|3|||
37902724|NCT00597753|69588351|FG000|Overall Study|Physician Decision|5|||
37902725|NCT00597753|69588352|FG001|Overall Study|Physician Decision|1|||
37902726|NCT00597753|69588351|FG000|Overall Study|Pregnancy|1|||
37902727|NCT00597753|69588352|FG001|Overall Study|Pregnancy|0|||
37902728|NCT00597753|69588351|FG000|Overall Study|Withdrawal by Subject|35|||
37902729|NCT00597753|69588352|FG001|Overall Study|Withdrawal by Subject|12|||
37902730|NCT00597753|69588351|FG000|Overall Study|Discontinued Dialysis|0|||
37902731|NCT00597753|69588352|FG001|Overall Study|Discontinued Dialysis|1|||
37902732|NCT00597753|69588351|FG000|Overall Study|Never dosed|2|||
37902733|NCT00597753|69588352|FG001|Overall Study|Never dosed|0|||
37902734|NCT00597753|69588351|FG000|Overall Study|Noncompliance|2|||
37902735|NCT00597753|69588352|FG001|Overall Study|Noncompliance|1|||
37902736|NCT00597753|69588351|FG000|Overall Study|Relocation|17|||
37902737|NCT00597753|69588352|FG001|Overall Study|Relocation|6|||
37902738|NCT00597753|69588351|FG000|Overall Study|Renal transplant|10|||
37902739|NCT00597753|69588352|FG001|Overall Study|Renal transplant|3|||
37902740|NCT00597753|69588351|FG000|Overall Study|Site closed by sponsor|19|||
37902741|NCT00597753|69588352|FG001|Overall Study|Site closed by sponsor|7|||
37902742|NCT00597753|69588351|FG000|Overall Study|Site elected to close|2|||
37902743|NCT00597753|69588352|FG001|Overall Study|Site elected to close|4|||
37902744|NCT00665431|69588361|FG000|Overall Study|Adverse Event|16|||
37902745|NCT00665431|69588362|FG001|Overall Study|Adverse Event|22|||
37902746|NCT00665431|69588363|FG002|Overall Study|Adverse Event|6|||
37902747|NCT00665431|69588361|FG000|Overall Study|Withdrawal by Subject|17|||
37902748|NCT00665431|69588362|FG001|Overall Study|Withdrawal by Subject|25|||
37902749|NCT00665431|69588363|FG002|Overall Study|Withdrawal by Subject|15|||
37902750|NCT00665431|69588361|FG000|Overall Study|Lost to Follow-up|3|||
37902751|NCT00665431|69588362|FG001|Overall Study|Lost to Follow-up|3|||
37827933|NCT00477490|69510625|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
37902752|NCT00665431|69588363|FG002|Overall Study|Lost to Follow-up|1|||
37902753|NCT00665431|69588361|FG000|Overall Study|Other|4|||
37902754|NCT00665431|69588362|FG001|Overall Study|Other|7|||
37902755|NCT00665431|69588363|FG002|Overall Study|Other|2|||
37902756|NCT00934622|69588371|FG000|Overall Study|Lost to Follow-up|7|||
37902757|NCT00934622|69588371|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
37902758|NCT00881361|69588377|FG000|Overall Study|Terminated prior to surgery|27|||
37902759|NCT00881361|69588378|FG001|Overall Study|Terminated prior to surgery|7|||
37902760|NCT00881361|69588379|FG002|Overall Study|Terminated prior to surgery|0|||
37902761|NCT00881361|69588377|FG000|Overall Study|Ineligible|17|||
37902762|NCT00881361|69588378|FG001|Overall Study|Ineligible|2|||
37902763|NCT00881361|69588379|FG002|Overall Study|Ineligible|2|||
37902764|NCT01000727|69588390|FG000|Overall Study|Lost to Follow-up|41|||
37902765|NCT01000727|69588391|FG001|Overall Study|Lost to Follow-up|43|||
37902766|NCT01000727|69588390|FG000|Overall Study|Withdrawal by Subject|111|||
37902767|NCT01000727|69588391|FG001|Overall Study|Withdrawal by Subject|109|||
37902768|NCT01000727|69588390|FG000|Overall Study|Study closed/terminated|23|||
37902769|NCT01000727|69588391|FG001|Overall Study|Study closed/terminated|24|||
37902770|NCT00881205|69588401|FG000|Overall Study|Adverse Event|8|||
37902771|NCT00881205|69588402|FG001|Overall Study|Adverse Event|3|||
37902772|NCT00881205|69588401|FG000|Overall Study|Withdrawal by Subject|1|||
37902773|NCT00881205|69588402|FG001|Overall Study|Withdrawal by Subject|2|||
37902774|NCT00881205|69588401|FG000|Overall Study|Lost to Follow-up|0|||
37902775|NCT00881205|69588402|FG001|Overall Study|Lost to Follow-up|1|||
37902776|NCT00881205|69588401|FG000|Overall Study|Administrative problems|1|||
37902777|NCT00881205|69588402|FG001|Overall Study|Administrative problems|1|||
37902778|NCT00881205|69588401|FG000|Overall Study|Condition no longer requires drug|1|||
37902779|NCT00881205|69588402|FG001|Overall Study|Condition no longer requires drug|0|||
37827934|NCT00477490|69510626|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
37827935|NCT00477334|69510656|FG000|Overall Study|Discontinued prior to taking study drug|106|||
37827936|NCT00477334|69510657|FG001|Overall Study|Discontinued prior to taking study drug|53|||
37827937|NCT00477334|69510656|FG000|Overall Study|Adverse Event|1|||
37827938|NCT00477334|69510657|FG001|Overall Study|Adverse Event|2|||
37827939|NCT00477334|69510656|FG000|Overall Study|Withdrawal by Subject|2|||
37827940|NCT00477334|69510657|FG001|Overall Study|Withdrawal by Subject|1|||
37902780|NCT00879879|69588409|FG000|Overall Study|Death|1|||
37902781|NCT00879879|69588409|FG000|Overall Study|Withdrawal by Subject|1|||
37902782|NCT00879879|69588409|FG000|Overall Study|Physician Decision|1|||
37998473|NCT00147225|69682663|FG000|Overall Study|Screen Failure|0|||
37902783|NCT00661999|69588418|FG000|Overall Study|Adverse Event|11|||
37902784|NCT00661999|69588419|FG001|Overall Study|Adverse Event|5|||
37902785|NCT00661999|69588420|FG002|Overall Study|Adverse Event|8|||
37902786|NCT00661999|69588418|FG000|Overall Study|Death|8|||
37902787|NCT00661999|69588419|FG001|Overall Study|Death|6|||
37902788|NCT00661999|69588420|FG002|Overall Study|Death|3|||
37902789|NCT00661999|69588418|FG000|Overall Study|Other Reasons|5|||
37902790|NCT00661999|69588419|FG001|Overall Study|Other Reasons|12|||
37902791|NCT00661999|69588420|FG002|Overall Study|Other Reasons|23|||
37902792|NCT00661999|69588418|FG000|Overall Study|Withdrawal by Subject|30|||
37902793|NCT00661999|69588419|FG001|Overall Study|Withdrawal by Subject|23|||
37902794|NCT00661999|69588420|FG002|Overall Study|Withdrawal by Subject|14|||
37902795|NCT00661999|69588418|FG000|Overall Study|Alternative Treatment|1|||
37902796|NCT00661999|69588419|FG001|Overall Study|Alternative Treatment|0|||
37902797|NCT00661999|69588420|FG002|Overall Study|Alternative Treatment|0|||
37902798|NCT00661999|69588418|FG000|Overall Study|Other Medical Problems|4|||
37902799|NCT00661999|69588419|FG001|Overall Study|Other Medical Problems|4|||
37902800|NCT00661999|69588420|FG002|Overall Study|Other Medical Problems|9|||
37902801|NCT00665353|69588428|FG000|Study Step 1|Adverse Event|1|||
37902802|NCT00665353|69588428|FG000|Study Step 1|Withdrawal by Subject|2|||
37902803|NCT00665353|69588428|FG000|Study Step 2|Lost to Follow-up|2|||
37902804|NCT00665353|69588428|FG000|Study Step 2|Lack of Efficacy|12|||
37902805|NCT00597207|69588434|FG000|Overall Study|Lost to Follow-up|5|||
37902806|NCT00597207|69588435|FG001|Overall Study|Lost to Follow-up|7|||
37998474|NCT00147225|69682664|FG001|Overall Study|Screen Failure|0|||
37998475|NCT00147225|69682665|FG002|Overall Study|Screen Failure|0|||
37998476|NCT00147225|69682666|FG003|Overall Study|Screen Failure|0|||
37998477|NCT00147225|69682667|FG004|Overall Study|Screen Failure|1|||
37998478|NCT00147225|69682668|FG005|Overall Study|Screen Failure|0|||
37902807|NCT00879645|69588445|FG000|Overall Study|Adverse Event|1|||
37902808|NCT00879645|69588446|FG001|Overall Study|Adverse Event|0|||
37902809|NCT00879645|69588447|FG002|Overall Study|Adverse Event|0|||
37902810|NCT00879645|69588448|FG003|Overall Study|Adverse Event|0|||
37902811|NCT00664105|69588458|FG000|Overall Study|Death|3|||
37902812|NCT00664105|69588458|FG000|Overall Study|Withdrawal by Subject|5|||
37902813|NCT00664105|69588458|FG000|Overall Study|Adverse Event|9|||
37998479|NCT00147225|69682663|FG000|Overall Study|Chemotherapy Changed|0|||
37998480|NCT00147225|69682664|FG001|Overall Study|Chemotherapy Changed|0|||
37998481|NCT00147225|69682665|FG002|Overall Study|Chemotherapy Changed|0|||
37998482|NCT00147225|69682666|FG003|Overall Study|Chemotherapy Changed|0|||
37998483|NCT00147225|69682667|FG004|Overall Study|Chemotherapy Changed|0|||
37998484|NCT00147225|69682668|FG005|Overall Study|Chemotherapy Changed|1|||
37998485|NCT00222105|69682682|FG000|Overall Study|Removed due to wrong diagnosis|1|||
37998486|NCT00222105|69682682|FG000|Overall Study|Withdrawal by Subject|1|||
37998487|NCT00222105|69682682|FG000|Overall Study|Adverse Event|8|||
37998488|NCT00222105|69682682|FG000|Overall Study|Treatment delays|2|||
37998489|NCT00222105|69682682|FG000|Overall Study|Death|2|||
37998490|NCT00146757|69682686|FG000|Overall Study|Death|1|||
37902814|NCT00664105|69588458|FG000|Overall Study|Disease progression|7|||
37902815|NCT00661687|69588463|FG000|Overall Study|Study related symptoms and complaints|5|||
37998491|NCT00146757|69682687|FG001|Overall Study|Death|0|||
37998492|NCT00146757|69682686|FG000|Overall Study|Adverse Event|1|||
37902816|NCT00661687|69588463|FG000|Overall Study|Positive slit lamp findings|4|||
37902817|NCT00661687|69588463|FG000|Overall Study|Inability to maintain wearing schedule|3|||
37902818|NCT00661687|69588463|FG000|Overall Study|Physician Decision|1|||
37902819|NCT00661687|69588463|FG000|Overall Study|Adverse Event|2|||
37998493|NCT00146757|69682687|FG001|Overall Study|Adverse Event|0|||
37998494|NCT00267098|69682701|FG000|Overall Study|Death|0|||
37998495|NCT00267098|69682702|FG001|Overall Study|Death|0|||
37998496|NCT00267098|69682703|FG002|Overall Study|Death|57|||
37998497|NCT00267098|69682704|FG003|Overall Study|Death|66|||
37902820|NCT00596817|69588472|FG000|Open-label Period|Adverse Event|0|||
37902821|NCT00596817|69588473|FG001|Open-label Period|Adverse Event|49|||
37902822|NCT00596817|69588472|FG000|Open-label Period|Lack of Efficacy|0|||
37902823|NCT00596817|69588473|FG001|Open-label Period|Lack of Efficacy|33|||
37902824|NCT00596817|69588472|FG000|Open-label Period|Other Reasons|0|||
37998498|NCT00267098|69682705|FG004|Overall Study|Death|14|||
37902825|NCT00596817|69588473|FG001|Open-label Period|Other Reasons|65|||
37902826|NCT00596817|69588472|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
37998499|NCT00267098|69682706|FG005|Overall Study|Death|23|||
37998500|NCT00267098|69682707|FG006|Overall Study|Death|28|||
37998501|NCT00267098|69682708|FG007|Overall Study|Death|9|||
37998502|NCT00267098|69682701|FG000|Overall Study|Lost to Follow-up|0|||
37998503|NCT00267098|69682702|FG001|Overall Study|Lost to Follow-up|0|||
37998504|NCT00267098|69682703|FG002|Overall Study|Lost to Follow-up|6|||
37998505|NCT00267098|69682704|FG003|Overall Study|Lost to Follow-up|5|||
37902827|NCT00596817|69588473|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
37902828|NCT00596817|69588472|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
37998506|NCT00267098|69682705|FG004|Overall Study|Lost to Follow-up|2|||
37998507|NCT00267098|69682706|FG005|Overall Study|Lost to Follow-up|3|||
37998508|NCT00267098|69682707|FG006|Overall Study|Lost to Follow-up|1|||
37998509|NCT00267098|69682708|FG007|Overall Study|Lost to Follow-up|1|||
37998510|NCT00267098|69682701|FG000|Overall Study|Withdrawal by Subject|8|||
37998511|NCT00267098|69682702|FG001|Overall Study|Withdrawal by Subject|0|||
37998512|NCT00267098|69682703|FG002|Overall Study|Withdrawal by Subject|24|||
37998513|NCT00267098|69682704|FG003|Overall Study|Withdrawal by Subject|21|||
37998514|NCT00267098|69682705|FG004|Overall Study|Withdrawal by Subject|12|||
37998515|NCT00267098|69682706|FG005|Overall Study|Withdrawal by Subject|9|||
37998516|NCT00267098|69682707|FG006|Overall Study|Withdrawal by Subject|12|||
37998517|NCT00267098|69682708|FG007|Overall Study|Withdrawal by Subject|5|||
37998518|NCT00267098|69682701|FG000|Overall Study|Physician Decision|5|||
37998519|NCT00267098|69682702|FG001|Overall Study|Physician Decision|0|||
37998520|NCT00267098|69682703|FG002|Overall Study|Physician Decision|7|||
37998521|NCT00267098|69682704|FG003|Overall Study|Physician Decision|11|||
37998522|NCT00267098|69682705|FG004|Overall Study|Physician Decision|5|||
37998523|NCT00267098|69682706|FG005|Overall Study|Physician Decision|4|||
37998524|NCT00267098|69682707|FG006|Overall Study|Physician Decision|3|||
37998525|NCT00267098|69682708|FG007|Overall Study|Physician Decision|0|||
37998526|NCT00267098|69682701|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
37998527|NCT00267098|69682702|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
37998528|NCT00267098|69682703|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
37998529|NCT00267098|69682704|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
37998530|NCT00267098|69682705|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
37998531|NCT00267098|69682706|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
37998532|NCT00267098|69682707|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
37998533|NCT00267098|69682708|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
37998534|NCT00267098|69682701|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
37998535|NCT00267098|69682702|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
37998536|NCT00267098|69682703|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
37902829|NCT00596817|69588473|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
37998537|NCT00267098|69682704|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
37697034|NCT02420093|69173404|FG001|Overall Study|Withdrawal by Subject|1|||
37697035|NCT02419937|69173412|FG000|Overall Study|Lost to Follow-up|1|||
37697036|NCT02419937|69173413|FG001|Overall Study|Lost to Follow-up|0|||
37697037|NCT02054481|69173423|FG000|Overall Study|Adverse Event|1|||
37697038|NCT02054481|69173424|FG001|Overall Study|Adverse Event|1|||
37697039|NCT02054481|69173425|FG002|Overall Study|Adverse Event|0|||
37697040|NCT02054481|69173426|FG003|Overall Study|Adverse Event|1|||
37697041|NCT02054481|69173423|FG000|Overall Study|Lost to Follow-up|1|||
37697042|NCT02054481|69173424|FG001|Overall Study|Lost to Follow-up|0|||
37697043|NCT02054481|69173425|FG002|Overall Study|Lost to Follow-up|0|||
37697044|NCT02054481|69173426|FG003|Overall Study|Lost to Follow-up|0|||
37697045|NCT02054481|69173423|FG000|Overall Study|Other reason|2|||
37697046|NCT02054481|69173424|FG001|Overall Study|Other reason|1|||
37697047|NCT02054481|69173425|FG002|Overall Study|Other reason|2|||
37697048|NCT02054481|69173426|FG003|Overall Study|Other reason|0|||
37697049|NCT01610752|69173440|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
37697050|NCT01610752|69173441|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
37697051|NCT01610752|69173442|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
37697052|NCT02054325|69173452|FG000|Overall Study|Lost to Follow-up|8|||
37697053|NCT02054325|69173453|FG001|Overall Study|Lost to Follow-up|5|||
37827941|NCT00477334|69510656|FG000|Overall Study|Lost to Follow-up|15|||
37998538|NCT00267098|69682705|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
37827942|NCT00477334|69510657|FG001|Overall Study|Lost to Follow-up|4|||
37827943|NCT00477334|69510656|FG000|Overall Study|Administrative Problems|39|||
37827944|NCT00477334|69510657|FG001|Overall Study|Administrative Problems|15|||
37827945|NCT00477334|69510656|FG000|Overall Study|Protocol Violation|7|||
37827946|NCT00477334|69510657|FG001|Overall Study|Protocol Violation|1|||
37827947|NCT04536727|69510736|FG000|Overall Study|Lost to Follow-up|1|||
37827948|NCT04536727|69510737|FG001|Overall Study|Lost to Follow-up|1|||
37827949|NCT04536727|69510736|FG000|Overall Study|Death|0|||
37827950|NCT04536727|69510737|FG001|Overall Study|Death|1|||
37827951|NCT04971967|69510798|FG000|Overall Study|Lost to Follow-up|6|||
37827952|NCT04971967|69510799|FG001|Overall Study|Lost to Follow-up|7|||
37827953|NCT04716881|69510813|FG000|Overall Study|Adverse Event|1|||
37827954|NCT04716881|69510813|FG000|Overall Study|Lost to Follow-up|1|||
37827955|NCT04582266|69510830|FG000|Overall Study|Lost to Follow-up|7|||
37827956|NCT04582266|69510831|FG001|Overall Study|Lost to Follow-up|5|||
37998539|NCT00267098|69682706|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
37998540|NCT00267098|69682707|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
37998541|NCT00267098|69682708|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
37998542|NCT00267098|69682701|FG000|Overall Study|Site closure|0|||
37697054|NCT02446691|69173459|FG000|Overall Study|Withdrawal by Subject|2|||
37697055|NCT02446691|69173459|FG000|Overall Study|Lost to Follow-up|8|||
37697056|NCT02446691|69173459|FG000|Overall Study|Protocol Violation|1|||
37697057|NCT02091375|69173465|FG000|Overall Study|Adverse Event|8|||
37697058|NCT02091375|69173466|FG001|Overall Study|Adverse Event|1|||
37697059|NCT02091375|69173465|FG000|Overall Study|Lost to Follow-up|0|||
37697060|NCT02091375|69173466|FG001|Overall Study|Lost to Follow-up|1|||
37697061|NCT02091375|69173465|FG000|Overall Study|Withdrawal by Subject|0|||
37697062|NCT02091375|69173466|FG001|Overall Study|Withdrawal by Subject|1|||
37697063|NCT02091375|69173465|FG000|Overall Study|Withdrawn by the investigator|1|||
37697064|NCT02091375|69173466|FG001|Overall Study|Withdrawn by the investigator|0|||
37697065|NCT02032875|69173474|FG000|Treatment Period|Adverse Event|1|||
37697066|NCT02032875|69173475|FG001|Treatment Period|Adverse Event|0|||
37697067|NCT02032875|69173474|FG000|Treatment Period|Liver transplant, No extension needed|0|||
37697068|NCT02032875|69173475|FG001|Treatment Period|Liver transplant, No extension needed|1|||
37998543|NCT00267098|69682702|FG001|Overall Study|Site closure|0|||
37998544|NCT00267098|69682703|FG002|Overall Study|Site closure|0|||
37998545|NCT00267098|69682704|FG003|Overall Study|Site closure|1|||
37998546|NCT00267098|69682705|FG004|Overall Study|Site closure|0|||
37998547|NCT00267098|69682706|FG005|Overall Study|Site closure|1|||
37827957|NCT04582266|69510830|FG000|Overall Study|Withdrawal by Subject|1|||
37827958|NCT04582266|69510831|FG001|Overall Study|Withdrawal by Subject|0|||
37827959|NCT04582266|69510830|FG000|Overall Study|Logistical and Personnel Constraints at Time of Infusion|1|||
37827960|NCT04582266|69510831|FG001|Overall Study|Logistical and Personnel Constraints at Time of Infusion|0|||
37827961|NCT04459338|69510841|FG000|Overall Study|Loss of IV during study|1|||
37827962|NCT04459338|69510842|FG001|Overall Study|Loss of IV during study|0|||
37827963|NCT03740048|69510888|FG000|Overall Study|Withdrawal by Subject|1|||
37827964|NCT03740048|69510889|FG001|Overall Study|Withdrawal by Subject|1|||
37827965|NCT03740048|69510888|FG000|Overall Study|Death|1|||
37827966|NCT03740048|69510889|FG001|Overall Study|Death|6|||
37827967|NCT03740048|69510888|FG000|Overall Study|Switched to thrice-weekly HD|2|||
37827968|NCT03740048|69510889|FG001|Overall Study|Switched to thrice-weekly HD|0|||
37827969|NCT03740048|69510888|FG000|Overall Study|Switched to Peritoneal Dialysis|2|||
37827970|NCT03740048|69510889|FG001|Overall Study|Switched to Peritoneal Dialysis|0|||
37998548|NCT00267098|69682707|FG006|Overall Study|Site closure|1|||
37697069|NCT02032875|69173474|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
37998549|NCT00267098|69682708|FG007|Overall Study|Site closure|0|||
37998550|NCT00267098|69682701|FG000|Overall Study|Explanted Medtronic device|0|||
37998551|NCT00267098|69682702|FG001|Overall Study|Explanted Medtronic device|0|||
37998552|NCT00267098|69682703|FG002|Overall Study|Explanted Medtronic device|0|||
37697070|NCT02032875|69173475|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
37697071|NCT02032875|69173474|FG000|Follow-up Period|Death|0|||
37902830|NCT00596817|69588472|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
37902831|NCT00596817|69588473|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
37902832|NCT00596817|69588472|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
37902833|NCT00596817|69588473|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
37697072|NCT02032875|69173475|FG001|Follow-up Period|Death|1|||
37998553|NCT00267098|69682704|FG003|Overall Study|Explanted Medtronic device|1|||
37998554|NCT00267098|69682705|FG004|Overall Study|Explanted Medtronic device|0|||
37697073|NCT02032875|69173474|FG000|Follow-up Period|Virologic Relapse|3|||
37902834|NCT00596817|69588472|FG000|Double-blind Period|Adverse Event|5|||
37902835|NCT00596817|69588473|FG001|Double-blind Period|Adverse Event|16|||
37902836|NCT00596817|69588472|FG000|Double-blind Period|Lack of Efficacy|52|||
37998555|NCT00267098|69682706|FG005|Overall Study|Explanted Medtronic device|0|||
37998556|NCT00267098|69682707|FG006|Overall Study|Explanted Medtronic device|0|||
37998557|NCT00267098|69682708|FG007|Overall Study|Explanted Medtronic device|0|||
37998558|NCT00267098|69682701|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
37998559|NCT00267098|69682702|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
37998560|NCT00267098|69682703|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
37998561|NCT00267098|69682704|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
37998562|NCT00267098|69682705|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
37998563|NCT00267098|69682706|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
37998564|NCT00267098|69682707|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
37998565|NCT00267098|69682708|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
37998566|NCT00267098|69682701|FG000|Overall Study|Subject listed for heart transplant|0|||
37998567|NCT00267098|69682702|FG001|Overall Study|Subject listed for heart transplant|0|||
37998568|NCT00267098|69682703|FG002|Overall Study|Subject listed for heart transplant|0|||
37998569|NCT00267098|69682704|FG003|Overall Study|Subject listed for heart transplant|0|||
37998570|NCT00267098|69682705|FG004|Overall Study|Subject listed for heart transplant|0|||
37998571|NCT00267098|69682706|FG005|Overall Study|Subject listed for heart transplant|0|||
37998572|NCT00267098|69682707|FG006|Overall Study|Subject listed for heart transplant|1|||
37998573|NCT00267098|69682708|FG007|Overall Study|Subject listed for heart transplant|0|||
37998574|NCT00267098|69682701|FG000|Overall Study|Sponsor withdrew subject|0|||
37998575|NCT00267098|69682702|FG001|Overall Study|Sponsor withdrew subject|0|||
37998576|NCT00267098|69682703|FG002|Overall Study|Sponsor withdrew subject|0|||
37998577|NCT00267098|69682704|FG003|Overall Study|Sponsor withdrew subject|1|||
37998578|NCT00267098|69682705|FG004|Overall Study|Sponsor withdrew subject|0|||
37998579|NCT00267098|69682706|FG005|Overall Study|Sponsor withdrew subject|0|||
37998580|NCT00267098|69682707|FG006|Overall Study|Sponsor withdrew subject|0|||
37998581|NCT00267098|69682708|FG007|Overall Study|Sponsor withdrew subject|0|||
37827971|NCT03740048|69510888|FG000|Overall Study|Lost to Follow-up|0|||
37827972|NCT03740048|69510889|FG001|Overall Study|Lost to Follow-up|1|||
37827973|NCT03740048|69510888|FG000|Overall Study|Non-compliance with HD|0|||
37827974|NCT03740048|69510889|FG001|Overall Study|Non-compliance with HD|1|||
37827975|NCT03436862|69510949|FG000|Overall Study|Adverse Event|4|||
37827976|NCT03436862|69510949|FG000|Overall Study|Progressive Disease|2|||
37827977|NCT03373760|69510970|FG000|Overall Study|Adverse Event|8|||
37827978|NCT03373760|69510970|FG000|Overall Study|Disease Progression|46|||
37827979|NCT03373760|69510970|FG000|Overall Study|Death|4|||
37827980|NCT03324880|69510979|FG000|Overall Study|Adverse Event|0|||
37827981|NCT03324880|69510980|FG001|Overall Study|Adverse Event|2|||
37827982|NCT03324880|69510979|FG000|Overall Study|Withdrawal by Subject|2|||
37998582|NCT00247676|69682731|FG000|Overall Study|Death|5|||
37827983|NCT03324880|69510980|FG001|Overall Study|Withdrawal by Subject|2|||
37827984|NCT03324880|69510979|FG000|Overall Study|Lost to Follow-up|0|||
37827985|NCT03324880|69510980|FG001|Overall Study|Lost to Follow-up|1|||
37827986|NCT03324880|69510979|FG000|Overall Study|Product Recall|0|||
37998583|NCT00247676|69682731|FG000|Overall Study|Adverse Event|11|||
37827987|NCT03324880|69510980|FG001|Overall Study|Product Recall|1|||
37998584|NCT00247676|69682731|FG000|Overall Study|Lack of Efficacy|15|||
37998585|NCT00247676|69682731|FG000|Overall Study|Other|3|||
37998586|NCT00247676|69682731|FG000|Overall Study|Withdrawal by Subject|2|||
37998587|NCT00267020|69682737|FG000|Overall Study|Adverse Event|22|||
37998588|NCT00267020|69682738|FG001|Overall Study|Adverse Event|5|||
37998589|NCT00267020|69682737|FG000|Overall Study|Death|2|||
37998590|NCT00267020|69682738|FG001|Overall Study|Death|1|||
37998591|NCT00267020|69682737|FG000|Overall Study|Withdrawal by Subject|17|||
37998592|NCT00267020|69682738|FG001|Overall Study|Withdrawal by Subject|7|||
37998593|NCT00267020|69682737|FG000|Overall Study|Physician Decision|3|||
37998594|NCT00267020|69682738|FG001|Overall Study|Physician Decision|2|||
37998595|NCT00267020|69682737|FG000|Overall Study|Disease Progression|39|||
37998596|NCT00267020|69682738|FG001|Overall Study|Disease Progression|25|||
37998597|NCT00267020|69682737|FG000|Overall Study|Unrelated Complication|1|||
37998598|NCT00267020|69682738|FG001|Overall Study|Unrelated Complication|1|||
37998599|NCT00267020|69682737|FG000|Overall Study|Sponsor Request|1|||
37998600|NCT00267020|69682738|FG001|Overall Study|Sponsor Request|0|||
37998601|NCT00267020|69682737|FG000|Overall Study|Other|1|||
37998602|NCT00267020|69682738|FG001|Overall Study|Other|2|||
37998603|NCT00242216|69682746|FG000|Overall Study|Lost to Follow-up|12|||
37998604|NCT00242216|69682747|FG001|Overall Study|Lost to Follow-up|17|||
37827988|NCT03053440|69510990|FG000|Overall Study|Sponsor's Decision to End the Study|20|||
37827989|NCT03053440|69510991|FG001|Overall Study|Sponsor's Decision to End the Study|13|||
37827990|NCT03053440|69510990|FG000|Overall Study|Death|18|||
37827991|NCT03053440|69510991|FG001|Overall Study|Death|14|||
37827992|NCT03053440|69510990|FG000|Overall Study|Withdrawal by Subject|9|||
37827993|NCT03053440|69510991|FG001|Overall Study|Withdrawal by Subject|8|||
37827994|NCT03053440|69510990|FG000|Overall Study|Lost to Follow-up|1|||
37827995|NCT03053440|69510991|FG001|Overall Study|Lost to Follow-up|0|||
37827996|NCT03053440|69510990|FG000|Overall Study|Enrolled in Long-term Extension Study|48|||
37827997|NCT03053440|69510991|FG001|Overall Study|Enrolled in Long-term Extension Study|66|||
37827998|NCT03053440|69510990|FG000|Overall Study|Physician Decision|2|||
37827999|NCT03053440|69510991|FG001|Overall Study|Physician Decision|1|||
37828000|NCT03053440|69510990|FG000|Overall Study|Participant Randomized but died before dosing|1|||
37828001|NCT03053440|69510991|FG001|Overall Study|Participant Randomized but died before dosing|0|||
37828002|NCT02985684|69510998|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
37828003|NCT02985684|69510998|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
37828004|NCT02985684|69510998|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
37828005|NCT02949934|69511037|FG000|Natural Drinking Period|Adverse Event|1|||
37828006|NCT02949934|69511038|FG001|Natural Drinking Period|Adverse Event|0|||
37828007|NCT02949934|69511039|FG002|Natural Drinking Period|Adverse Event|0|||
37828008|NCT02949934|69511040|FG003|Natural Drinking Period|Adverse Event|1|||
37828009|NCT02949934|69511041|FG004|Natural Drinking Period|Adverse Event|0|||
37828010|NCT02949934|69511042|FG005|Natural Drinking Period|Adverse Event|0|||
37828011|NCT02949934|69511037|FG000|Natural Drinking Period|Lost to Follow-up|0|||
37828012|NCT02949934|69511038|FG001|Natural Drinking Period|Lost to Follow-up|0|||
37828013|NCT02949934|69511039|FG002|Natural Drinking Period|Lost to Follow-up|0|||
37828014|NCT02949934|69511040|FG003|Natural Drinking Period|Lost to Follow-up|0|||
37828015|NCT02949934|69511041|FG004|Natural Drinking Period|Lost to Follow-up|1|||
37828016|NCT02949934|69511042|FG005|Natural Drinking Period|Lost to Follow-up|0|||
37828017|NCT02949934|69511037|FG000|Neuroimaging|Protocol Violation|2|||
37828018|NCT02949934|69511038|FG001|Neuroimaging|Protocol Violation|0|||
37828019|NCT02949934|69511039|FG002|Neuroimaging|Protocol Violation|0|||
37828020|NCT02949934|69511040|FG003|Neuroimaging|Protocol Violation|0|||
37828021|NCT02949934|69511041|FG004|Neuroimaging|Protocol Violation|1|||
37828022|NCT02949934|69511042|FG005|Neuroimaging|Protocol Violation|0|||
37828023|NCT02949934|69511037|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
37998605|NCT00242216|69682746|FG000|Overall Study|Death|4|||
37998606|NCT00242216|69682747|FG001|Overall Study|Death|2|||
37998607|NCT00242216|69682746|FG000|Overall Study|Lack of Efficacy|1|||
37998608|NCT00242216|69682747|FG001|Overall Study|Lack of Efficacy|2|||
37828024|NCT02949934|69511038|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
37828025|NCT02949934|69511039|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
37828026|NCT02949934|69511040|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
37828027|NCT02949934|69511041|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
37828028|NCT02949934|69511042|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
37828029|NCT02949934|69511037|FG000|Neuroimaging|Not scanned|0|||
37828030|NCT02949934|69511038|FG001|Neuroimaging|Not scanned|0|||
37828031|NCT02949934|69511039|FG002|Neuroimaging|Not scanned|1|||
37828032|NCT02949934|69511040|FG003|Neuroimaging|Not scanned|0|||
37828033|NCT02949934|69511041|FG004|Neuroimaging|Not scanned|0|||
37828034|NCT02949934|69511042|FG005|Neuroimaging|Not scanned|2|||
37828035|NCT02949934|69511037|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
37828036|NCT02949934|69511038|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
37828037|NCT02949934|69511039|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
37828038|NCT02949934|69511040|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
37828039|NCT02949934|69511041|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
37828040|NCT02949934|69511042|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
37828041|NCT02949934|69511037|FG000|Bar Laboratory|Adverse Event|1|||
37828042|NCT02949934|69511038|FG001|Bar Laboratory|Adverse Event|0|||
37828043|NCT02949934|69511039|FG002|Bar Laboratory|Adverse Event|2|||
37828044|NCT02949934|69511040|FG003|Bar Laboratory|Adverse Event|0|||
37828045|NCT02949934|69511041|FG004|Bar Laboratory|Adverse Event|1|||
37828046|NCT02949934|69511042|FG005|Bar Laboratory|Adverse Event|0|||
37828047|NCT02949934|69511037|FG000|Bar Laboratory|Protocol Violation|0|||
37828048|NCT02949934|69511038|FG001|Bar Laboratory|Protocol Violation|0|||
37828049|NCT02949934|69511039|FG002|Bar Laboratory|Protocol Violation|0|||
37828050|NCT02949934|69511040|FG003|Bar Laboratory|Protocol Violation|1|||
37828051|NCT02949934|69511041|FG004|Bar Laboratory|Protocol Violation|0|||
37828052|NCT02949934|69511042|FG005|Bar Laboratory|Protocol Violation|0|||
37828053|NCT02935634|69511074|FG000|Randomization|Participant withdrew consent|0|||
37828054|NCT02935634|69511075|FG001|Randomization|Participant withdrew consent|1|||
37828055|NCT02935634|69511076|FG002|Randomization|Participant withdrew consent|0|||
37828056|NCT02935634|69511077|FG003|Randomization|Participant withdrew consent|0|||
37828057|NCT02935634|69511078|FG004|Randomization|Participant withdrew consent|0|||
37828058|NCT02935634|69511079|FG005|Randomization|Participant withdrew consent|0|||
37828059|NCT02935634|69511074|FG000|Randomization|Death|2|||
37828060|NCT02935634|69511075|FG001|Randomization|Death|1|||
37828061|NCT02935634|69511076|FG002|Randomization|Death|1|||
37828062|NCT02935634|69511077|FG003|Randomization|Death|0|||
37828063|NCT02935634|69511078|FG004|Randomization|Death|0|||
37828064|NCT02935634|69511079|FG005|Randomization|Death|0|||
37828065|NCT02935634|69511074|FG000|Randomization|Other reasons|0|||
37828066|NCT02935634|69511075|FG001|Randomization|Other reasons|2|||
37828067|NCT02935634|69511076|FG002|Randomization|Other reasons|2|||
37828068|NCT02935634|69511077|FG003|Randomization|Other reasons|0|||
37828069|NCT02935634|69511078|FG004|Randomization|Other reasons|0|||
37828070|NCT02935634|69511079|FG005|Randomization|Other reasons|0|||
37828071|NCT02935634|69511074|FG000|Treatment: Track 1|Disease progression|15|||
37828072|NCT02935634|69511075|FG001|Treatment: Track 1|Disease progression|17|||
37828073|NCT02935634|69511076|FG002|Treatment: Track 1|Disease progression|28|||
37828074|NCT02935634|69511077|FG003|Treatment: Track 1|Disease progression|4|||
37828075|NCT02935634|69511078|FG004|Treatment: Track 1|Disease progression|6|||
37828076|NCT02935634|69511079|FG005|Treatment: Track 1|Disease progression|2|||
37828077|NCT02935634|69511074|FG000|Treatment: Track 1|Adverse event unrelated to study drug|1|||
37828078|NCT02935634|69511075|FG001|Treatment: Track 1|Adverse event unrelated to study drug|1|||
37828079|NCT02935634|69511076|FG002|Treatment: Track 1|Adverse event unrelated to study drug|2|||
37828080|NCT02935634|69511077|FG003|Treatment: Track 1|Adverse event unrelated to study drug|3|||
37828081|NCT02935634|69511078|FG004|Treatment: Track 1|Adverse event unrelated to study drug|0|||
37828082|NCT02935634|69511079|FG005|Treatment: Track 1|Adverse event unrelated to study drug|3|||
37828083|NCT02935634|69511074|FG000|Treatment: Track 1|Lost to Follow-up|1|||
37828084|NCT02935634|69511075|FG001|Treatment: Track 1|Lost to Follow-up|0|||
37828085|NCT02935634|69511076|FG002|Treatment: Track 1|Lost to Follow-up|0|||
37828086|NCT02935634|69511077|FG003|Treatment: Track 1|Lost to Follow-up|0|||
37828087|NCT02935634|69511078|FG004|Treatment: Track 1|Lost to Follow-up|0|||
37828088|NCT02935634|69511079|FG005|Treatment: Track 1|Lost to Follow-up|0|||
37828089|NCT02935634|69511074|FG000|Treatment: Track 1|Study drug toxicity|2|||
37828090|NCT02935634|69511075|FG001|Treatment: Track 1|Study drug toxicity|1|||
37828091|NCT02935634|69511076|FG002|Treatment: Track 1|Study drug toxicity|3|||
37828092|NCT02935634|69511077|FG003|Treatment: Track 1|Study drug toxicity|0|||
37828093|NCT02935634|69511078|FG004|Treatment: Track 1|Study drug toxicity|0|||
37828094|NCT02935634|69511079|FG005|Treatment: Track 1|Study drug toxicity|1|||
37828095|NCT02935634|69511074|FG000|Treatment: Track 1|Participant request to discontinue treatment|1|||
37828096|NCT02935634|69511075|FG001|Treatment: Track 1|Participant request to discontinue treatment|0|||
37998609|NCT00242216|69682746|FG000|Overall Study|no medicaiton dispensed|1|||
37998610|NCT00242216|69682747|FG001|Overall Study|no medicaiton dispensed|1|||
37998611|NCT00240110|69682755|FG000|Overall Study|Lost to Follow-up|6|||
37998612|NCT00240110|69682756|FG001|Overall Study|Lost to Follow-up|7|||
37998613|NCT00239720|69682766|FG000|Overall Study|Adverse Event|1|||
37998614|NCT00239720|69682767|FG001|Overall Study|Adverse Event|0|||
37998615|NCT00239720|69682766|FG000|Overall Study|Lost to Follow-up|0|||
37998616|NCT00239720|69682767|FG001|Overall Study|Lost to Follow-up|1|||
37998617|NCT00266864|69682775|FG000|Overall Study|Lost to Follow-up|4|||
37998618|NCT00266864|69682776|FG001|Overall Study|Lost to Follow-up|1|||
37998619|NCT00266864|69682775|FG000|Overall Study|Withdrawal by Subject|1|||
37998620|NCT00266864|69682776|FG001|Overall Study|Withdrawal by Subject|1|||
37998621|NCT00266708|69682784|FG000|Overall Study|No renal function|1|||
37828097|NCT02935634|69511076|FG002|Treatment: Track 1|Participant request to discontinue treatment|1|||
37828098|NCT02935634|69511077|FG003|Treatment: Track 1|Participant request to discontinue treatment|0|||
37998622|NCT00266708|69682785|FG001|Overall Study|No renal function|1|||
37998623|NCT00266708|69682784|FG000|Overall Study|Refused biopsy|3|||
37998624|NCT00266708|69682785|FG001|Overall Study|Refused biopsy|6|||
37998625|NCT00266708|69682784|FG000|Overall Study|Asthma|0|||
37828099|NCT02935634|69511078|FG004|Treatment: Track 1|Participant request to discontinue treatment|1|||
37828100|NCT02935634|69511079|FG005|Treatment: Track 1|Participant request to discontinue treatment|0|||
37828101|NCT02935634|69511074|FG000|Treatment: Track 1|Participant withdrew consent|2|||
37828102|NCT02935634|69511075|FG001|Treatment: Track 1|Participant withdrew consent|0|||
37828103|NCT02935634|69511076|FG002|Treatment: Track 1|Participant withdrew consent|1|||
37828104|NCT02935634|69511077|FG003|Treatment: Track 1|Participant withdrew consent|0|||
37828105|NCT02935634|69511078|FG004|Treatment: Track 1|Participant withdrew consent|1|||
37828106|NCT02935634|69511079|FG005|Treatment: Track 1|Participant withdrew consent|0|||
37828107|NCT02935634|69511074|FG000|Treatment: Track 1|Other reasons|0|||
37828108|NCT02935634|69511075|FG001|Treatment: Track 1|Other reasons|0|||
37998626|NCT00266708|69682785|FG001|Overall Study|Asthma|2|||
37998627|NCT00266630|69682793|FG000|Overall Study|Adverse Event|8|||
37697074|NCT02032875|69173475|FG001|Follow-up Period|Virologic Relapse|10|||
37697075|NCT02032407|69173482|FG000|Overall Study|Lost to Follow-up|2|||
37697076|NCT02032407|69173482|FG000|Overall Study|Pregnancy|1|||
37697077|NCT02032407|69173482|FG000|Overall Study|Other Miscellaneous Reasons|2|||
37697078|NCT01843972|69173500|FG000|Overall Study|Withdrawal by Subject|0|||
37697079|NCT01843972|69173501|FG001|Overall Study|Withdrawal by Subject|0|||
37697080|NCT01843972|69173502|FG002|Overall Study|Withdrawal by Subject|0|||
37697081|NCT01843972|69173503|FG003|Overall Study|Withdrawal by Subject|0|||
37697082|NCT01843972|69173504|FG004|Overall Study|Withdrawal by Subject|1|||
37697083|NCT01843972|69173505|FG005|Overall Study|Withdrawal by Subject|0|||
37697084|NCT01843972|69173506|FG006|Overall Study|Withdrawal by Subject|0|||
37697085|NCT01843972|69173507|FG007|Overall Study|Withdrawal by Subject|0|||
37697086|NCT01843972|69173508|FG008|Overall Study|Withdrawal by Subject|0|||
37697087|NCT01843972|69173509|FG009|Overall Study|Withdrawal by Subject|0|||
37697088|NCT01826422|69173547|FG000|Overall Study|Withdrawal by Subject|1|||
37697089|NCT01826422|69173548|FG001|Overall Study|Withdrawal by Subject|3|||
37998628|NCT00266630|69682794|FG001|Overall Study|Adverse Event|6|||
37998629|NCT00266630|69682793|FG000|Overall Study|Lack of Efficacy|1|||
37998630|NCT00266630|69682794|FG001|Overall Study|Lack of Efficacy|4|||
37998631|NCT00266630|69682793|FG000|Overall Study|Entry Criteria not met|1|||
37998632|NCT00266630|69682794|FG001|Overall Study|Entry Criteria not met|0|||
37998633|NCT00266630|69682793|FG000|Overall Study|Protocol Violation|1|||
37998634|NCT00266630|69682794|FG001|Overall Study|Protocol Violation|3|||
37998635|NCT00266630|69682793|FG000|Overall Study|Physician Decision|1|||
37998636|NCT00266630|69682794|FG001|Overall Study|Physician Decision|2|||
37998637|NCT00266630|69682793|FG000|Overall Study|Withdrawal by Subject|10|||
37998638|NCT00266630|69682794|FG001|Overall Study|Withdrawal by Subject|2|||
37998639|NCT00266630|69682793|FG000|Overall Study|Lost to Follow-up|1|||
37998640|NCT00266630|69682794|FG001|Overall Study|Lost to Follow-up|0|||
37998641|NCT00266630|69682793|FG000|Overall Study|Other|19|||
37998642|NCT00266630|69682794|FG001|Overall Study|Other|11|||
37998643|NCT00129129|69682805|FG000|Primary Phase|Adverse Event|2|||
37998644|NCT00129129|69682806|FG001|Primary Phase|Adverse Event|1|||
37998645|NCT00129129|69682807|FG002|Primary Phase|Adverse Event|0|||
37998646|NCT00129129|69682808|FG003|Primary Phase|Adverse Event|0|||
37998647|NCT00129129|69682809|FG004|Primary Phase|Adverse Event|0|||
37998648|NCT00129129|69682805|FG000|Primary Phase|Withdrawal by Subject|12|||
37998649|NCT00129129|69682806|FG001|Primary Phase|Withdrawal by Subject|10|||
37998650|NCT00129129|69682807|FG002|Primary Phase|Withdrawal by Subject|0|||
37697090|NCT01843660|69173554|FG000|Overall Study|Other|30|||
37697091|NCT02090283|69173561|FG000|Overall Study|Withdrawal by Subject|6|||
37697092|NCT02090283|69173562|FG001|Overall Study|Withdrawal by Subject|6|||
37697093|NCT02090283|69173563|FG002|Overall Study|Withdrawal by Subject|6|||
37697094|NCT02090283|69173561|FG000|Overall Study|Sponsor Terminated Study|6|||
37697095|NCT02090283|69173562|FG001|Overall Study|Sponsor Terminated Study|6|||
37998651|NCT00129129|69682808|FG003|Primary Phase|Withdrawal by Subject|0|||
37998652|NCT00129129|69682809|FG004|Primary Phase|Withdrawal by Subject|0|||
37998653|NCT00129129|69682805|FG000|Primary Phase|Migration from study area|1|||
37998654|NCT00129129|69682806|FG001|Primary Phase|Migration from study area|3|||
37998655|NCT00129129|69682807|FG002|Primary Phase|Migration from study area|0|||
37998656|NCT00129129|69682808|FG003|Primary Phase|Migration from study area|0|||
37998657|NCT00129129|69682809|FG004|Primary Phase|Migration from study area|0|||
37998658|NCT00129129|69682805|FG000|Primary Phase|Lost to Follow-up|8|||
37998659|NCT00129129|69682806|FG001|Primary Phase|Lost to Follow-up|6|||
37998660|NCT00129129|69682807|FG002|Primary Phase|Lost to Follow-up|0|||
37998661|NCT00129129|69682808|FG003|Primary Phase|Lost to Follow-up|0|||
37998662|NCT00129129|69682809|FG004|Primary Phase|Lost to Follow-up|0|||
37998663|NCT00129129|69682805|FG000|Primary Phase|Other|2|||
37998664|NCT00129129|69682806|FG001|Primary Phase|Other|5|||
37998665|NCT00129129|69682807|FG002|Primary Phase|Other|0|||
37998666|NCT00129129|69682808|FG003|Primary Phase|Other|0|||
37998667|NCT00129129|69682809|FG004|Primary Phase|Other|0|||
37998668|NCT00129129|69682805|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
37998669|NCT00129129|69682806|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
37998670|NCT00129129|69682807|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
37998671|NCT00129129|69682808|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
37998672|NCT00129129|69682809|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
37998673|NCT00129129|69682805|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
37828109|NCT02935634|69511076|FG002|Treatment: Track 1|Other reasons|2|||
37828110|NCT02935634|69511077|FG003|Treatment: Track 1|Other reasons|0|||
37828111|NCT02935634|69511078|FG004|Treatment: Track 1|Other reasons|0|||
37828112|NCT02935634|69511079|FG005|Treatment: Track 1|Other reasons|0|||
37828113|NCT02935634|69511074|FG000|Treatment: Track 2|Disease progression|13|||
37828114|NCT02935634|69511075|FG001|Treatment: Track 2|Disease progression|26|||
37828115|NCT02935634|69511076|FG002|Treatment: Track 2|Disease progression|20|||
37998674|NCT00129129|69682806|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
37828116|NCT02935634|69511077|FG003|Treatment: Track 2|Disease progression|5|||
37998675|NCT00129129|69682807|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
37998676|NCT00129129|69682808|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
37998677|NCT00129129|69682809|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
37998678|NCT00129129|69682805|FG000|Fourth Dose Phase|Migration from study area|0|||
37998679|NCT00129129|69682806|FG001|Fourth Dose Phase|Migration from study area|0|||
37902837|NCT00596817|69588473|FG001|Double-blind Period|Lack of Efficacy|28|||
37828117|NCT02935634|69511078|FG004|Treatment: Track 2|Disease progression|1|||
37828118|NCT02935634|69511079|FG005|Treatment: Track 2|Disease progression|4|||
37828119|NCT02935634|69511074|FG000|Treatment: Track 2|Adverse event unrelated to study drug|2|||
37828120|NCT02935634|69511075|FG001|Treatment: Track 2|Adverse event unrelated to study drug|2|||
37828121|NCT02935634|69511076|FG002|Treatment: Track 2|Adverse event unrelated to study drug|0|||
37828122|NCT02935634|69511077|FG003|Treatment: Track 2|Adverse event unrelated to study drug|0|||
37828123|NCT02935634|69511078|FG004|Treatment: Track 2|Adverse event unrelated to study drug|0|||
37828124|NCT02935634|69511079|FG005|Treatment: Track 2|Adverse event unrelated to study drug|0|||
37828125|NCT02935634|69511074|FG000|Treatment: Track 2|Study drug toxicity|7|||
37828126|NCT02935634|69511075|FG001|Treatment: Track 2|Study drug toxicity|3|||
37828127|NCT02935634|69511076|FG002|Treatment: Track 2|Study drug toxicity|0|||
37828128|NCT02935634|69511077|FG003|Treatment: Track 2|Study drug toxicity|0|||
37828129|NCT02935634|69511078|FG004|Treatment: Track 2|Study drug toxicity|0|||
37828130|NCT02935634|69511079|FG005|Treatment: Track 2|Study drug toxicity|0|||
37828131|NCT02935634|69511074|FG000|Treatment: Track 2|Participant request to discontinue treatment|0|||
37828132|NCT02935634|69511075|FG001|Treatment: Track 2|Participant request to discontinue treatment|2|||
37902838|NCT00596817|69588472|FG000|Double-blind Period|Non-compliance With Study Product|3|||
37902839|NCT00596817|69588473|FG001|Double-blind Period|Non-compliance With Study Product|4|||
37902840|NCT00596817|69588472|FG000|Double-blind Period|Protocol Violation|11|||
37902841|NCT00596817|69588473|FG001|Double-blind Period|Protocol Violation|8|||
37902842|NCT00596817|69588472|FG000|Double-blind Period|Withdrawal of Consent|7|||
37902843|NCT00596817|69588473|FG001|Double-blind Period|Withdrawal of Consent|3|||
37902844|NCT00596817|69588472|FG000|Double-blind Period|Lost to Follow-up|0|||
37902845|NCT00596817|69588473|FG001|Double-blind Period|Lost to Follow-up|2|||
37902846|NCT00596817|69588472|FG000|Double-blind Period|Other Reasons|10|||
37902847|NCT00596817|69588473|FG001|Double-blind Period|Other Reasons|18|||
37902848|NCT01000649|69588484|FG000|Overall Study|Adverse Event|5|||
37902849|NCT01000649|69588485|FG001|Overall Study|Adverse Event|1|||
37902850|NCT01000649|69588486|FG002|Overall Study|Adverse Event|2|||
37902851|NCT01000649|69588487|FG003|Overall Study|Adverse Event|4|||
37902852|NCT01000649|69588484|FG000|Overall Study|Lost to Follow-up|0|||
37902853|NCT01000649|69588485|FG001|Overall Study|Lost to Follow-up|2|||
37902854|NCT01000649|69588486|FG002|Overall Study|Lost to Follow-up|0|||
37902855|NCT01000649|69588487|FG003|Overall Study|Lost to Follow-up|2|||
37902856|NCT00879411|69588496|FG000|Overall Study|lost to follow-up (non-AE)|162|||
37902857|NCT01000493|69588502|FG000|Overall Study|Adverse Event|3|||
37902858|NCT01000493|69588503|FG001|Overall Study|Adverse Event|6|||
37902859|NCT01000493|69588502|FG000|Overall Study|Lack of Efficacy|1|||
37902860|NCT01000493|69588503|FG001|Overall Study|Lack of Efficacy|1|||
37902861|NCT01000493|69588502|FG000|Overall Study|Protocol Violation|1|||
37902862|NCT01000493|69588503|FG001|Overall Study|Protocol Violation|8|||
37902863|NCT01000493|69588502|FG000|Overall Study|Study closed/terminated|25|||
37902864|NCT01000493|69588503|FG001|Overall Study|Study closed/terminated|23|||
37902865|NCT01000493|69588502|FG000|Overall Study|Lost to Follow-up|5|||
37902866|NCT01000493|69588503|FG001|Overall Study|Lost to Follow-up|9|||
37902867|NCT01000493|69588502|FG000|Overall Study|Physician Decision|1|||
37902868|NCT01000493|69588503|FG001|Overall Study|Physician Decision|1|||
37902869|NCT01000493|69588502|FG000|Overall Study|Withdrawal by Subject|3|||
37902870|NCT01000493|69588503|FG001|Overall Study|Withdrawal by Subject|7|||
37902871|NCT00666757|69588511|FG000|Overall Study|Lost to Follow-up|39|||
37902872|NCT00666757|69588512|FG001|Overall Study|Lost to Follow-up|35|||
37902873|NCT00666757|69588511|FG000|Overall Study|Protocol Violation|23|||
37902874|NCT00666757|69588512|FG001|Overall Study|Protocol Violation|24|||
37902875|NCT00666757|69588511|FG000|Overall Study|Adverse Event|22|||
37902876|NCT00666757|69588512|FG001|Overall Study|Adverse Event|12|||
37902877|NCT00666757|69588511|FG000|Overall Study|Withdrawal by Subject|13|||
37902878|NCT00666757|69588512|FG001|Overall Study|Withdrawal by Subject|17|||
37902879|NCT00666757|69588511|FG000|Overall Study|Lack of Efficacy|3|||
37902880|NCT00666757|69588512|FG001|Overall Study|Lack of Efficacy|6|||
37902881|NCT00666757|69588511|FG000|Overall Study|Physician Decision|0|||
37902882|NCT00666757|69588512|FG001|Overall Study|Physician Decision|2|||
37902883|NCT00666757|69588511|FG000|Overall Study|Sponsor decision|0|||
37902884|NCT00666757|69588512|FG001|Overall Study|Sponsor decision|1|||
37902885|NCT01000337|69588523|FG000|Overall Study|Lost to Follow-up|4|||
37902886|NCT01000337|69588524|FG001|Overall Study|Lost to Follow-up|3|||
37902887|NCT00666679|69588532|FG000|First Intervention|Lost to Follow-up|1|||
37828133|NCT02935634|69511076|FG002|Treatment: Track 2|Participant request to discontinue treatment|1|||
37828134|NCT02935634|69511077|FG003|Treatment: Track 2|Participant request to discontinue treatment|0|||
37828135|NCT02935634|69511078|FG004|Treatment: Track 2|Participant request to discontinue treatment|0|||
37828136|NCT02935634|69511079|FG005|Treatment: Track 2|Participant request to discontinue treatment|0|||
37828137|NCT02935634|69511074|FG000|Treatment: Track 2|Participant withdrew consent|0|||
37828138|NCT02935634|69511075|FG001|Treatment: Track 2|Participant withdrew consent|1|||
37828139|NCT02935634|69511076|FG002|Treatment: Track 2|Participant withdrew consent|1|||
37828140|NCT02935634|69511077|FG003|Treatment: Track 2|Participant withdrew consent|0|||
37828141|NCT02935634|69511078|FG004|Treatment: Track 2|Participant withdrew consent|1|||
37828142|NCT02935634|69511079|FG005|Treatment: Track 2|Participant withdrew consent|0|||
37828143|NCT02864992|69511108|FG000|Overall Study|still on treatment|15|||
37902888|NCT00666679|69588533|FG001|First Intervention|Lost to Follow-up|0|||
37902889|NCT00666679|69588532|FG000|First Intervention|Protocol Violation|1|||
37902890|NCT00666679|69588533|FG001|First Intervention|Protocol Violation|0|||
37902891|NCT00666679|69588532|FG000|First Intervention|Withdrawal by Subject|1|||
37902892|NCT00666679|69588533|FG001|First Intervention|Withdrawal by Subject|0|||
37902893|NCT00666679|69588532|FG000|First Intervention|Randomized did not start treatment|1|||
37902894|NCT00666679|69588533|FG001|First Intervention|Randomized did not start treatment|1|||
37902895|NCT00666679|69588532|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
37902896|NCT00666679|69588533|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
37902897|NCT00666679|69588532|FG000|Washout Period of 1 Week|Protocol Violation|0|||
37902898|NCT00666679|69588533|FG001|Washout Period of 1 Week|Protocol Violation|1|||
37902899|NCT00666679|69588532|FG000|Second Intervention|Adverse Event|1|||
37902900|NCT00666679|69588533|FG001|Second Intervention|Adverse Event|0|||
37902901|NCT00666679|69588532|FG000|Second Intervention|Death|0|||
37902902|NCT00666679|69588533|FG001|Second Intervention|Death|1|||
37902903|NCT00595413|69588543|FG000|Overall Study|Adverse Event|0|||
37902904|NCT00595413|69588544|FG001|Overall Study|Adverse Event|2|||
37902905|NCT00595413|69588545|FG002|Overall Study|Adverse Event|1|||
37902906|NCT00595413|69588546|FG003|Overall Study|Adverse Event|1|||
37902907|NCT00595413|69588543|FG000|Overall Study|Lost to Follow-up|2|||
37902908|NCT00595413|69588544|FG001|Overall Study|Lost to Follow-up|2|||
37902909|NCT00595413|69588545|FG002|Overall Study|Lost to Follow-up|1|||
37902910|NCT00595413|69588546|FG003|Overall Study|Lost to Follow-up|3|||
37902911|NCT00595413|69588543|FG000|Overall Study|Death|0|||
37902912|NCT00595413|69588544|FG001|Overall Study|Death|0|||
37902913|NCT00595413|69588545|FG002|Overall Study|Death|1|||
37902914|NCT00595413|69588546|FG003|Overall Study|Death|0|||
37902915|NCT00595413|69588543|FG000|Overall Study|Other|5|||
37902916|NCT00595413|69588544|FG001|Overall Study|Other|1|||
37902917|NCT00595413|69588545|FG002|Overall Study|Other|5|||
37902918|NCT00595413|69588546|FG003|Overall Study|Other|0|||
37902919|NCT01000025|69588558|FG000|Overall Study|Adverse Event|43|||
37902920|NCT01000025|69588559|FG001|Overall Study|Adverse Event|2|||
37902921|NCT01000025|69588558|FG000|Overall Study|Withdrawal by Subject|13|||
37902922|NCT01000025|69588559|FG001|Overall Study|Withdrawal by Subject|8|||
37902923|NCT01000025|69588558|FG000|Overall Study|Death|23|||
37902924|NCT01000025|69588559|FG001|Overall Study|Death|13|||
37902925|NCT01000025|69588558|FG000|Overall Study|Lack of Efficacy|363|||
37902926|NCT01000025|69588559|FG001|Overall Study|Lack of Efficacy|208|||
37902927|NCT01000025|69588558|FG000|Overall Study|Intercurrent Illness|26|||
37902928|NCT01000025|69588559|FG001|Overall Study|Intercurrent Illness|7|||
37902929|NCT00595335|69588567|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
37902930|NCT00595335|69588568|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
37902931|NCT00595335|69588567|FG000|Baseline to Six Months|Disease Progression|1|||
37902932|NCT00595335|69588568|FG001|Baseline to Six Months|Disease Progression|1|||
37902933|NCT00595335|69588567|FG000|Baseline to Six Months|Adverse Event|1|||
37902934|NCT00595335|69588568|FG001|Baseline to Six Months|Adverse Event|0|||
37902935|NCT00595335|69588567|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
37902936|NCT00595335|69588568|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
37902937|NCT00595335|69588567|FG000|Six Months to Twelve Months|Disease Progression|1|||
37902938|NCT00595335|69588568|FG001|Six Months to Twelve Months|Disease Progression|0|||
37902939|NCT00661609|69588578|FG000|Overall Study|Adverse Event|4|||
37902940|NCT00661609|69588578|FG000|Overall Study|Death|20|||
37902941|NCT00661609|69588578|FG000|Overall Study|Withdrawal by Subject|2|||
37902942|NCT00661609|69588578|FG000|Overall Study|PI Decision|1|||
37902943|NCT00661609|69588578|FG000|Overall Study|Survival follow up stage discontinued|11|||
37902944|NCT00661609|69588578|FG000|Overall Study|Disease progression|3|||
37902945|NCT00661531|69588582|FG000|Overall Study|Withdrawal by Subject|3|||
37902946|NCT00998309|69588586|FG000|Overall Study|Protocol Violation|4|||
37828144|NCT02864992|69511109|FG001|Overall Study|still on treatment|1|||
37828145|NCT02864992|69511110|FG002|Overall Study|still on treatment|33|||
37828146|NCT02684578|69511118|FG000|Overall Study|Withdrawal by Subject|10|||
37828147|NCT02684578|69511119|FG001|Overall Study|Withdrawal by Subject|7|||
37828148|NCT02684578|69511118|FG000|Overall Study|Lost to Follow-up|0|||
37828149|NCT02684578|69511119|FG001|Overall Study|Lost to Follow-up|3|||
37828150|NCT02684578|69511118|FG000|Overall Study|Ineligible after reviewing baseline imaging|1|||
37828151|NCT02684578|69511119|FG001|Overall Study|Ineligible after reviewing baseline imaging|0|||
37828152|NCT02684578|69511118|FG000|Overall Study|Missing follow-up data|0|||
37828153|NCT02684578|69511119|FG001|Overall Study|Missing follow-up data|1|||
37828154|NCT02612129|69511127|FG000|Single Dose Treatment Period|Screening Failure|1|||
37828155|NCT02612129|69511128|FG001|Single Dose Treatment Period|Screening Failure|0|||
37828156|NCT02612129|69511129|FG002|Single Dose Treatment Period|Screening Failure|0|||
37828157|NCT02612129|69511127|FG000|Continuous Treatment Period|Early Escape|0|||
37828158|NCT02612129|69511128|FG001|Continuous Treatment Period|Early Escape|2|||
37828159|NCT02612129|69511129|FG002|Continuous Treatment Period|Early Escape|0|||
37902947|NCT00999713|69588640|FG000|Overall Study|Physician Decision|2|||
37902948|NCT00999713|69588641|FG001|Overall Study|Physician Decision|0|||
37902949|NCT00997373|69588649|FG000|Overall Study|Withdrawal by Subject|5|||
37902950|NCT00997373|69588650|FG001|Overall Study|Withdrawal by Subject|0|||
37902951|NCT00997373|69588649|FG000|Overall Study|wrong tumor type|4|||
37902952|NCT00997373|69588650|FG001|Overall Study|wrong tumor type|0|||
37902953|NCT00997373|69588649|FG000|Overall Study|could not have hysterectomy|6|||
37833618|NCT01262872|69517332|FG005|Step 2|Migrated/moved from study area|6|||
37902954|NCT00997373|69588650|FG001|Overall Study|could not have hysterectomy|0|||
37902955|NCT00663871|69588658|FG000|Overall Study|Lost to Follow-up|5|||
37902956|NCT00663871|69588659|FG001|Overall Study|Lost to Follow-up|5|||
37902957|NCT00663871|69588658|FG000|Overall Study|Withdrawal by Subject|5|||
37902958|NCT00663871|69588659|FG001|Overall Study|Withdrawal by Subject|2|||
37902959|NCT04152447|69588669|FG000|Overall Study|Lost to Follow-up|1|||
37902960|NCT04152447|69588670|FG001|Overall Study|Lost to Follow-up|0|||
37902961|NCT04152447|69588669|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
37902962|NCT04152447|69588670|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
37902963|NCT04152447|69588669|FG000|Overall Study|Withdrawal by Subject|0|||
37902964|NCT04152447|69588670|FG001|Overall Study|Withdrawal by Subject|1|||
37902965|NCT04152447|69588669|FG000|Overall Study|Found ineligible after enrolling|1|||
37902966|NCT04152447|69588670|FG001|Overall Study|Found ineligible after enrolling|1|||
37902967|NCT04152447|69588669|FG000|Overall Study|Did not receive VR headset in time.|0|||
37902968|NCT04152447|69588670|FG001|Overall Study|Did not receive VR headset in time.|2|||
37902969|NCT00996593|69588676|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
37902970|NCT00996593|69588676|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
37902971|NCT00996593|69588676|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
37902972|NCT00996593|69588676|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
37902973|NCT00996593|69588676|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
37902974|NCT00996593|69588676|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
37902975|NCT00996593|69588676|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
37902976|NCT00996593|69588676|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
37902977|NCT00996593|69588676|FG000|Long-Term Follow-Up|Site Closed|1|||
37902978|NCT00570661|69588680|FG000|Overall Study|Disease worsening|5|||
37902979|NCT00570661|69588680|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
37902980|NCT00570661|69588680|FG000|Overall Study|Adverse Event|1|||
37902981|NCT00934544|69588687|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
37902982|NCT00934544|69588688|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
37902983|NCT00934544|69588689|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
37902984|NCT00934544|69588687|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
37902985|NCT00934544|69588688|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
37902986|NCT00934544|69588689|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
37902987|NCT00934544|69588687|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
37902988|NCT00934544|69588688|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
37902989|NCT00934544|69588689|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
37902990|NCT00934544|69588687|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
37828160|NCT02612129|69511127|FG000|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
37828161|NCT02612129|69511128|FG001|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|1|||
37828162|NCT02612129|69511129|FG002|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
37902991|NCT00934544|69588688|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
37902992|NCT00934544|69588689|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
37828163|NCT02612129|69511127|FG000|Continuous Treatment Period|Safety Reasons|0|||
37828164|NCT02612129|69511128|FG001|Continuous Treatment Period|Safety Reasons|3|||
37828165|NCT02612129|69511129|FG002|Continuous Treatment Period|Safety Reasons|0|||
37828166|NCT02612129|69511127|FG000|Continuous Treatment Period|Death|0|||
37828167|NCT02612129|69511128|FG001|Continuous Treatment Period|Death|1|||
37828168|NCT02612129|69511129|FG002|Continuous Treatment Period|Death|0|||
37828169|NCT02612129|69511127|FG000|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
37828170|NCT02612129|69511128|FG001|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
37828171|NCT02612129|69511129|FG002|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|1|||
37828172|NCT02580305|69511139|FG000|Overall Study|Adverse Event|15|||
37902993|NCT00934544|69588687|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
37902994|NCT00934544|69588688|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
37902995|NCT00934544|69588689|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
37902996|NCT00934544|69588687|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
37902997|NCT00934544|69588688|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
37902998|NCT00934544|69588689|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
37902999|NCT00934544|69588687|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
37903000|NCT00934544|69588688|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
37903001|NCT00934544|69588689|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
37903002|NCT00934544|69588687|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
37903003|NCT00934544|69588688|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
37903004|NCT00934544|69588689|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
37903005|NCT00934544|69588687|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
37903006|NCT00934544|69588688|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
37903007|NCT00934544|69588689|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
37903008|NCT00934544|69588687|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
37903009|NCT00934544|69588688|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
37903010|NCT00934544|69588689|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
37903011|NCT00934544|69588687|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
37903012|NCT00934544|69588688|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
37903013|NCT00934544|69588689|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
37903014|NCT00934544|69588687|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
37903015|NCT00934544|69588688|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
37903016|NCT00934544|69588689|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
37903017|NCT00934544|69588687|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
37903018|NCT00934544|69588688|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
37903019|NCT00934544|69588689|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
37903020|NCT00934544|69588687|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
37903021|NCT00934544|69588688|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
37903022|NCT00934544|69588689|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
37903023|NCT00934544|69588687|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
37903024|NCT00934544|69588688|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
37903025|NCT00934544|69588689|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
37903026|NCT00934544|69588687|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
37903027|NCT00934544|69588688|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
37903028|NCT00934544|69588689|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
37903029|NCT00999167|69588708|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
37903030|NCT00999167|69588709|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
37903031|NCT00999167|69588710|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
37903032|NCT00999167|69588708|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
37903033|NCT00999167|69588709|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
37903034|NCT00999167|69588710|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
37903035|NCT00999167|69588708|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
37903036|NCT00999167|69588709|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
37903037|NCT00999167|69588710|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
37828173|NCT02580305|69511140|FG001|Overall Study|Adverse Event|19|||
37903038|NCT00999167|69588708|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
37903039|NCT00999167|69588709|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
37903040|NCT00999167|69588710|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
37903041|NCT00999167|69588708|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
37903042|NCT00999167|69588709|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
37903043|NCT00999167|69588710|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
37903044|NCT00999167|69588708|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
37998680|NCT00129129|69682807|FG002|Fourth Dose Phase|Migration from study area|0|||
37998681|NCT00129129|69682808|FG003|Fourth Dose Phase|Migration from study area|0|||
37998682|NCT00129129|69682809|FG004|Fourth Dose Phase|Migration from study area|2|||
37998683|NCT00129129|69682805|FG000|Fourth Dose Phase|Other|0|||
37998684|NCT00129129|69682806|FG001|Fourth Dose Phase|Other|0|||
37998685|NCT00129129|69682807|FG002|Fourth Dose Phase|Other|0|||
37998686|NCT00129129|69682808|FG003|Fourth Dose Phase|Other|1|||
37998687|NCT00129129|69682809|FG004|Fourth Dose Phase|Other|1|||
37998688|NCT00129129|69682805|FG000|Fourth Dose Phase|Protocol Violation|0|||
37998689|NCT00129129|69682806|FG001|Fourth Dose Phase|Protocol Violation|0|||
37998690|NCT00129129|69682807|FG002|Fourth Dose Phase|Protocol Violation|0|||
37998691|NCT00129129|69682808|FG003|Fourth Dose Phase|Protocol Violation|1|||
37998692|NCT00129129|69682809|FG004|Fourth Dose Phase|Protocol Violation|0|||
37998693|NCT00221403|69682832|FG000|Overall Study|Protocol Violation|1|||
37998694|NCT00221403|69682833|FG001|Overall Study|Protocol Violation|0|||
37998695|NCT00221403|69682834|FG002|Overall Study|Protocol Violation|0|||
37998696|NCT00221403|69682832|FG000|Overall Study|Physician Decision|1|||
37998697|NCT00221403|69682833|FG001|Overall Study|Physician Decision|0|||
37998698|NCT00221403|69682834|FG002|Overall Study|Physician Decision|0|||
37998699|NCT00221403|69682832|FG000|Overall Study|Withdrawal by Subject|0|||
37828174|NCT02580305|69511141|FG002|Overall Study|Adverse Event|10|||
37828175|NCT02580305|69511139|FG000|Overall Study|Lack of Efficacy|5|||
37828176|NCT02580305|69511140|FG001|Overall Study|Lack of Efficacy|0|||
37828177|NCT02580305|69511141|FG002|Overall Study|Lack of Efficacy|2|||
37828178|NCT02580305|69511139|FG000|Overall Study|Protocol Violation|4|||
37828179|NCT02580305|69511140|FG001|Overall Study|Protocol Violation|9|||
37828180|NCT02580305|69511141|FG002|Overall Study|Protocol Violation|6|||
37828181|NCT02580305|69511139|FG000|Overall Study|Lost to Follow-up|4|||
37828182|NCT02580305|69511140|FG001|Overall Study|Lost to Follow-up|4|||
37828183|NCT02580305|69511141|FG002|Overall Study|Lost to Follow-up|2|||
37828184|NCT02580305|69511139|FG000|Overall Study|Withdrawal by Subject|11|||
37828185|NCT02580305|69511140|FG001|Overall Study|Withdrawal by Subject|9|||
37828186|NCT02580305|69511141|FG002|Overall Study|Withdrawal by Subject|7|||
37828187|NCT02580305|69511139|FG000|Overall Study|Randomized in error and never treated|4|||
37903045|NCT00999167|69588709|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
37998700|NCT00221403|69682833|FG001|Overall Study|Withdrawal by Subject|3|||
37998701|NCT00221403|69682834|FG002|Overall Study|Withdrawal by Subject|0|||
37998702|NCT00221403|69682832|FG000|Overall Study|Lack of Efficacy|0|||
37828188|NCT02580305|69511140|FG001|Overall Study|Randomized in error and never treated|8|||
37828189|NCT02580305|69511141|FG002|Overall Study|Randomized in error and never treated|5|||
37998703|NCT00221403|69682833|FG001|Overall Study|Lack of Efficacy|1|||
37998704|NCT00221403|69682834|FG002|Overall Study|Lack of Efficacy|0|||
37828190|NCT02054741|69511160|FG000|Overall Study|Protocol Violation|13|||
37828191|NCT02054741|69511161|FG001|Overall Study|Protocol Violation|2|||
37828192|NCT02054741|69511160|FG000|Overall Study|Withdrawal by Subject|10|||
37828193|NCT02054741|69511161|FG001|Overall Study|Withdrawal by Subject|5|||
37828194|NCT02054741|69511160|FG000|Overall Study|Death|94|||
37828195|NCT02054741|69511161|FG001|Overall Study|Death|90|||
37828196|NCT02054741|69511160|FG000|Overall Study|Subject passively continued participation only with data obtained from their medical records|35|||
37828197|NCT02054741|69511161|FG001|Overall Study|Subject passively continued participation only with data obtained from their medical records|32|||
37828198|NCT01555463|69511169|FG000|Treatment|Adverse Event|6|||
37828199|NCT01555463|69511170|FG001|Treatment|Adverse Event|12|||
37828200|NCT01555463|69511169|FG000|Treatment|Withdrawal by Subject|24|||
37828201|NCT01555463|69511170|FG001|Treatment|Withdrawal by Subject|36|||
37828202|NCT01555463|69511169|FG000|Treatment|Lost to Follow-up|28|||
37828203|NCT01555463|69511170|FG001|Treatment|Lost to Follow-up|23|||
37828204|NCT01555463|69511169|FG000|Treatment|Protocol Violation|4|||
37828205|NCT01555463|69511170|FG001|Treatment|Protocol Violation|5|||
37828206|NCT01555463|69511169|FG000|Treatment|Other reason|2|||
37828207|NCT01555463|69511170|FG001|Treatment|Other reason|3|||
37828208|NCT01555463|69511169|FG000|Follow up|Adverse Event|2|||
37828209|NCT01555463|69511170|FG001|Follow up|Adverse Event|5|||
37828210|NCT01555463|69511169|FG000|Follow up|Death|0|||
37828211|NCT01555463|69511170|FG001|Follow up|Death|1|||
37828212|NCT01555463|69511169|FG000|Follow up|Withdrawal by Subject|22|||
37828213|NCT01555463|69511170|FG001|Follow up|Withdrawal by Subject|22|||
37828214|NCT01555463|69511169|FG000|Follow up|Lost to Follow-up|9|||
37828215|NCT01555463|69511170|FG001|Follow up|Lost to Follow-up|10|||
37828216|NCT01555463|69511169|FG000|Follow up|Protocol Violation|2|||
37828217|NCT01555463|69511170|FG001|Follow up|Protocol Violation|4|||
37828218|NCT01555463|69511169|FG000|Follow up|Other reason|3|||
37828219|NCT01555463|69511170|FG001|Follow up|Other reason|3|||
37828220|NCT02277106|69511246|FG000|Stage 2|Adverse Event|0|||
37828221|NCT02277106|69511247|FG001|Stage 2|Adverse Event|0|||
37828222|NCT02277106|69511248|FG002|Stage 2|Adverse Event|1|||
37828223|NCT02215096|69511271|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
37828224|NCT02215096|69511272|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
37828225|NCT02215096|69511273|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
37697096|NCT02090283|69173563|FG002|Overall Study|Sponsor Terminated Study|1|||
37697097|NCT02090283|69173561|FG000|Overall Study|Lost to Follow-up|2|||
37697098|NCT02090283|69173562|FG001|Overall Study|Lost to Follow-up|2|||
37697099|NCT02090283|69173563|FG002|Overall Study|Lost to Follow-up|3|||
37697100|NCT02090283|69173561|FG000|Overall Study|Adverse Event|1|||
37697101|NCT02090283|69173562|FG001|Overall Study|Adverse Event|1|||
37697102|NCT02090283|69173563|FG002|Overall Study|Adverse Event|0|||
37697103|NCT02090283|69173561|FG000|Overall Study|Protocol Violation|2|||
37828226|NCT02215096|69511274|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
37828227|NCT02215096|69511275|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
37828228|NCT02215096|69511271|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
37828229|NCT02215096|69511272|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
37828230|NCT02215096|69511273|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
37828231|NCT02215096|69511274|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
37828232|NCT02215096|69511275|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
37828233|NCT02215096|69511271|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
37828234|NCT02215096|69511272|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
37828235|NCT02215096|69511273|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
37828236|NCT02215096|69511274|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
37828237|NCT02215096|69511275|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
37828238|NCT02215096|69511271|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
37828239|NCT02215096|69511272|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
37828240|NCT02215096|69511273|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
37828241|NCT02215096|69511274|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
37828242|NCT02215096|69511275|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
37828243|NCT03189862|69511310|FG000|Overall Study|Withdrawal by Subject|1|||
37697104|NCT02090283|69173562|FG001|Overall Study|Protocol Violation|0|||
37697105|NCT02090283|69173563|FG002|Overall Study|Protocol Violation|0|||
37697106|NCT02032173|69173571|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
37828244|NCT03189862|69511311|FG001|Overall Study|Withdrawal by Subject|0|||
37828245|NCT03189862|69511310|FG000|Overall Study|Lost to Follow-up|54|||
37828246|NCT03189862|69511311|FG001|Overall Study|Lost to Follow-up|62|||
37903046|NCT00999167|69588710|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
37903047|NCT00999167|69588708|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
37903048|NCT00999167|69588709|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
37903049|NCT00999167|69588710|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
37903050|NCT00999167|69588708|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
37903051|NCT00999167|69588709|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
37903052|NCT00999167|69588710|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
37903053|NCT00570505|69588720|FG000|Overall Study|Adverse Event|7|||
37903054|NCT00570505|69588720|FG000|Overall Study|Withdrawal by Subject|7|||
37903055|NCT00570505|69588720|FG000|Overall Study|Lost to Follow-up|23|||
37903056|NCT00570505|69588720|FG000|Overall Study|Other loss to follow-up|4|||
37903057|NCT00931892|69588726|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
37903058|NCT00931892|69588727|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
37903059|NCT00666211|69588775|FG000|Overall Study|Withdrawal by Subject|10|||
37903060|NCT00666211|69588776|FG001|Overall Study|Withdrawal by Subject|13|||
37828247|NCT00107614|69511339|FG000|Overall Study|Physician Decision|10|||
37828248|NCT00107614|69511339|FG000|Overall Study|Death|2|||
37828249|NCT00107380|69511343|FG000|Overall Study|Adverse Event|7|||
37828250|NCT00107380|69511343|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
37903061|NCT00666211|69588775|FG000|Overall Study|went off medication, no more pain|1|||
37903062|NCT00666211|69588776|FG001|Overall Study|went off medication, no more pain|0|||
37903063|NCT00666211|69588775|FG000|Overall Study|patient non-compliant|6|||
37998705|NCT00221403|69682832|FG000|Overall Study|Adverse Event|0|||
37828251|NCT00107380|69511343|FG000|Overall Study|Progression/relapse|4|||
37828252|NCT00107380|69511343|FG000|Overall Study|Death|3|||
37828253|NCT00107380|69511343|FG000|Overall Study|Other - not protocol specified|7|||
37828254|NCT00107380|69511343|FG000|Overall Study|Ineligible|2|||
37828255|NCT01340014|69511350|FG000|Period 1, First 7 Days|Adverse Event|1|||
37828256|NCT01340014|69511351|FG001|Period 1, First 7 Days|Adverse Event|0|||
37998706|NCT00221403|69682833|FG001|Overall Study|Adverse Event|1|||
37828257|NCT01340014|69511350|FG000|Period 1, First 7 Days|Personal Reasons|1|||
37998707|NCT00221403|69682834|FG002|Overall Study|Adverse Event|0|||
37998708|NCT00145977|69682844|FG000|Overall Study|Lack of Efficacy|0|||
37998709|NCT00145977|69682845|FG001|Overall Study|Lack of Efficacy|4|||
37998710|NCT00145977|69682844|FG000|Overall Study|Lost to Follow-up|1|||
37998711|NCT00145977|69682845|FG001|Overall Study|Lost to Follow-up|0|||
37998712|NCT00145977|69682844|FG000|Overall Study|Withdrawal by Subject|1|||
37998713|NCT00145977|69682845|FG001|Overall Study|Withdrawal by Subject|0|||
37998714|NCT00238238|69682854|FG000|Overall Study|Withdrawal by Subject|0|||
37998715|NCT00238238|69682855|FG001|Overall Study|Withdrawal by Subject|3|||
37998716|NCT00238238|69682856|FG002|Overall Study|Withdrawal by Subject|0|||
37998717|NCT00128661|69682866|FG000|Overall Study|Adverse Event|14|||
37998718|NCT00128661|69682867|FG001|Overall Study|Adverse Event|11|||
37998719|NCT00128661|69682866|FG000|Overall Study|Lost to Follow-up|10|||
37998720|NCT00128661|69682867|FG001|Overall Study|Lost to Follow-up|7|||
37998721|NCT00128661|69682866|FG000|Overall Study|Withdrawal by Subject|243|||
37998722|NCT00128661|69682867|FG001|Overall Study|Withdrawal by Subject|232|||
37998723|NCT00128661|69682866|FG000|Overall Study|Other|7|||
37998724|NCT00128661|69682867|FG001|Overall Study|Other|8|||
37998725|NCT00145509|69682875|FG000|Overall Study|Adverse Event|10|||
37998726|NCT00145509|69682876|FG001|Overall Study|Adverse Event|3|||
37998727|NCT00145509|69682875|FG000|Overall Study|Lack of Efficacy|3|||
37998728|NCT00145509|69682876|FG001|Overall Study|Lack of Efficacy|1|||
37998729|NCT00145509|69682875|FG000|Overall Study|Lost to Follow-up|5|||
37998730|NCT00145509|69682876|FG001|Overall Study|Lost to Follow-up|9|||
37998731|NCT00145509|69682875|FG000|Overall Study|Withdrew Consent|2|||
37998732|NCT00145509|69682876|FG001|Overall Study|Withdrew Consent|7|||
37998733|NCT00145509|69682875|FG000|Overall Study|Reason not provided|2|||
37998734|NCT00145509|69682876|FG001|Overall Study|Reason not provided|1|||
37998735|NCT00145119|69682882|FG000|Overall Study|Death|45|||
37998736|NCT00220779|69682889|FG000|Overall Study|Adverse Event|1|||
37998737|NCT00220779|69682890|FG001|Overall Study|Adverse Event|0|||
37998738|NCT00220779|69682891|FG002|Overall Study|Adverse Event|0|||
37998739|NCT00220779|69682889|FG000|Overall Study|Withdrawal by Subject|1|||
37998740|NCT00220779|69682890|FG001|Overall Study|Withdrawal by Subject|4|||
37998741|NCT00220779|69682891|FG002|Overall Study|Withdrawal by Subject|1|||
37998742|NCT00220779|69682889|FG000|Overall Study|Non-compliance|1|||
37998743|NCT00220779|69682890|FG001|Overall Study|Non-compliance|0|||
37998744|NCT00220779|69682891|FG002|Overall Study|Non-compliance|0|||
37998745|NCT00220779|69682889|FG000|Overall Study|Too time consuming|1|||
37998746|NCT00220779|69682890|FG001|Overall Study|Too time consuming|0|||
37998747|NCT00220779|69682891|FG002|Overall Study|Too time consuming|0|||
37998748|NCT00220779|69682889|FG000|Overall Study|Pregnancy|0|||
37998749|NCT00220779|69682890|FG001|Overall Study|Pregnancy|0|||
37998750|NCT00220779|69682891|FG002|Overall Study|Pregnancy|2|||
37998751|NCT00220779|69682889|FG000|Overall Study|Lack of Efficacy|3|||
37998752|NCT00220779|69682890|FG001|Overall Study|Lack of Efficacy|0|||
37998753|NCT00220779|69682891|FG002|Overall Study|Lack of Efficacy|1|||
37998754|NCT00207740|69682903|FG000|Overall Study|Adverse Event|4|||
37998755|NCT00207740|69682904|FG001|Overall Study|Adverse Event|14|||
37998756|NCT00207740|69682905|FG002|Overall Study|Adverse Event|14|||
37998757|NCT00207740|69682906|FG003|Overall Study|Adverse Event|11|||
37998758|NCT00207740|69682903|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
37998759|NCT00207740|69682904|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
37998760|NCT00207740|69682905|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
37998761|NCT00207740|69682906|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
37998762|NCT00207740|69682903|FG000|Overall Study|Lost to Follow-up|0|||
37998763|NCT00207740|69682904|FG001|Overall Study|Lost to Follow-up|2|||
37998764|NCT00207740|69682905|FG002|Overall Study|Lost to Follow-up|1|||
37998765|NCT00207740|69682906|FG003|Overall Study|Lost to Follow-up|1|||
37998766|NCT00207740|69682903|FG000|Overall Study|Death|0|||
37998767|NCT00207740|69682904|FG001|Overall Study|Death|0|||
37998768|NCT00207740|69682905|FG002|Overall Study|Death|0|||
37998769|NCT00207740|69682906|FG003|Overall Study|Death|1|||
37998770|NCT00207740|69682903|FG000|Overall Study|Sponsor Directive|22|||
37998771|NCT00207740|69682904|FG001|Overall Study|Sponsor Directive|15|||
37998772|NCT00207740|69682905|FG002|Overall Study|Sponsor Directive|16|||
37998773|NCT00207740|69682906|FG003|Overall Study|Sponsor Directive|21|||
37998774|NCT00207740|69682903|FG000|Overall Study|Other|2|||
37998775|NCT00207740|69682904|FG001|Overall Study|Other|10|||
37998776|NCT00207740|69682905|FG002|Overall Study|Other|7|||
37998777|NCT00207740|69682906|FG003|Overall Study|Other|5|||
37998778|NCT00265382|69682920|FG000|Overall Study|Adverse Event|21|||
37998779|NCT00265382|69682920|FG000|Overall Study|Laboratory Abnormality|1|||
37998780|NCT00265382|69682920|FG000|Overall Study|Lost to Follow-up|3|||
37998781|NCT00265382|69682920|FG000|Overall Study|Lack of Efficacy|6|||
37998782|NCT00265382|69682920|FG000|Overall Study|Miscellaneous|6|||
37998783|NCT00265382|69682920|FG000|Overall Study|Withdrawal by Subject|13|||
37998784|NCT00265382|69682920|FG000|Overall Study|Study terminated by sponsor|94|||
37998785|NCT00265382|69682920|FG000|Overall Study|Death|1|||
37998786|NCT00206726|69682924|FG000|Overall Study|Delayed recovery of blood counts|1|||
37998787|NCT00206726|69682924|FG000|Overall Study|Progressive disease or relapsed disease|18|||
37998788|NCT00206726|69682924|FG000|Overall Study|Placed on new protocol|1|||
37998789|NCT00206726|69682924|FG000|Overall Study|Bone marrow transplant|1|||
37998790|NCT00206726|69682924|FG000|Overall Study|Adverse Event|17|||
37998791|NCT00206726|69682924|FG000|Overall Study|Death|4|||
37998792|NCT00206726|69682924|FG000|Overall Study|Protocol Violation|1|||
37998793|NCT00206726|69682924|FG000|Overall Study|Withdrawal by Subject|8|||
37998794|NCT00237692|69682932|FG000|Overall Study|Lost to Follow-up|9|||
37998795|NCT00237692|69682933|FG001|Overall Study|Lost to Follow-up|3|||
37998796|NCT00237692|69682934|FG002|Overall Study|Lost to Follow-up|5|||
37998797|NCT00237692|69682935|FG003|Overall Study|Lost to Follow-up|3|||
37998798|NCT00237692|69682932|FG000|Overall Study|Death|1|||
37998799|NCT00237692|69682933|FG001|Overall Study|Death|2|||
37998800|NCT00237692|69682934|FG002|Overall Study|Death|2|||
37998801|NCT00237692|69682935|FG003|Overall Study|Death|3|||
37998802|NCT00237692|69682932|FG000|Overall Study|Excluded - did not meet criteria|4|||
37998803|NCT00237692|69682933|FG001|Overall Study|Excluded - did not meet criteria|3|||
37998804|NCT00237692|69682934|FG002|Overall Study|Excluded - did not meet criteria|5|||
37998805|NCT00237692|69682935|FG003|Overall Study|Excluded - did not meet criteria|9|||
37998806|NCT00237692|69682932|FG000|Overall Study|Withdrawal by Subject|4|||
37998807|NCT00237692|69682933|FG001|Overall Study|Withdrawal by Subject|6|||
37998808|NCT00237692|69682934|FG002|Overall Study|Withdrawal by Subject|10|||
37998809|NCT00237692|69682935|FG003|Overall Study|Withdrawal by Subject|4|||
37998810|NCT00237458|69682945|FG000|Overall Study|Lack of Efficacy|1|||
37998811|NCT00237458|69682945|FG000|Overall Study|Adverse Event|1|||
37998812|NCT00237458|69682945|FG000|Overall Study|Withdrawal by Subject|1|||
37998813|NCT00265148|69682951|FG000|Overall Study|Adverse Event|2|||
37998814|NCT00265148|69682952|FG001|Overall Study|Adverse Event|2|||
37998815|NCT00265148|69682951|FG000|Overall Study|Lack of Efficacy|0|||
37998816|NCT00265148|69682952|FG001|Overall Study|Lack of Efficacy|2|||
37998817|NCT00265148|69682951|FG000|Overall Study|Protocol Violation|3|||
37998818|NCT00265148|69682952|FG001|Overall Study|Protocol Violation|2|||
37998819|NCT00265148|69682951|FG000|Overall Study|Lost to Follow-up|0|||
37998820|NCT00265148|69682952|FG001|Overall Study|Lost to Follow-up|1|||
37998821|NCT00265148|69682951|FG000|Overall Study|Withdrawal by Subject|2|||
37998822|NCT00265148|69682952|FG001|Overall Study|Withdrawal by Subject|1|||
37998823|NCT00265148|69682951|FG000|Overall Study|Physician Decision|1|||
37998824|NCT00265148|69682952|FG001|Overall Study|Physician Decision|0|||
37998825|NCT00265148|69682951|FG000|Overall Study|Increasing frailty|0|||
37998826|NCT00265148|69682952|FG001|Overall Study|Increasing frailty|1|||
37998827|NCT00265148|69682951|FG000|Overall Study|Subject chose to change of the dose|1|||
37998828|NCT00265148|69682952|FG001|Overall Study|Subject chose to change of the dose|0|||
37998829|NCT00043186|69682968|FG000|Overall Study|Physician Decision|0|||
37998830|NCT00043186|69682969|FG001|Overall Study|Physician Decision|0|||
37998831|NCT00043186|69682970|FG002|Overall Study|Physician Decision|3|||
37998832|NCT00043186|69682971|FG003|Overall Study|Physician Decision|0|||
37998833|NCT00043186|69682972|FG004|Overall Study|Physician Decision|1|||
37998834|NCT00043186|69682973|FG005|Overall Study|Physician Decision|0|||
37998835|NCT00043186|69682974|FG006|Overall Study|Physician Decision|0|||
37998836|NCT00043186|69682975|FG007|Overall Study|Physician Decision|1|||
37998837|NCT00043186|69682976|FG008|Overall Study|Physician Decision|1|||
37998838|NCT00043186|69682968|FG000|Overall Study|Adverse Event|2|||
37998839|NCT00043186|69682969|FG001|Overall Study|Adverse Event|2|||
37998840|NCT00043186|69682970|FG002|Overall Study|Adverse Event|2|||
37998841|NCT00043186|69682971|FG003|Overall Study|Adverse Event|3|||
37998842|NCT00043186|69682972|FG004|Overall Study|Adverse Event|2|||
37998843|NCT00043186|69682973|FG005|Overall Study|Adverse Event|1|||
37998844|NCT00043186|69682974|FG006|Overall Study|Adverse Event|2|||
37998845|NCT00043186|69682975|FG007|Overall Study|Adverse Event|1|||
37998846|NCT00043186|69682976|FG008|Overall Study|Adverse Event|3|||
37998847|NCT00043186|69682968|FG000|Overall Study|Withdrawal by Subject|11|||
37998848|NCT00043186|69682969|FG001|Overall Study|Withdrawal by Subject|8|||
37998849|NCT00043186|69682970|FG002|Overall Study|Withdrawal by Subject|11|||
37998850|NCT00043186|69682971|FG003|Overall Study|Withdrawal by Subject|13|||
37998851|NCT00043186|69682972|FG004|Overall Study|Withdrawal by Subject|14|||
37828258|NCT01340014|69511351|FG001|Period 1, First 7 Days|Personal Reasons|0|||
37828259|NCT01340014|69511350|FG000|Period 2, Second 7 Days|Adverse Event|0|||
37828260|NCT01340014|69511351|FG001|Period 2, Second 7 Days|Adverse Event|1|||
37828261|NCT01339897|69511361|FG000|Overall Study|Adverse Event|1|||
37828262|NCT01339897|69511362|FG001|Overall Study|Adverse Event|0|||
37828263|NCT01339897|69511363|FG002|Overall Study|Adverse Event|0|||
37828264|NCT01339897|69511364|FG003|Overall Study|Adverse Event|1|||
37828265|NCT01339429|69511376|FG000|Overall Study|Withdrawal by Subject|1|||
37828266|NCT01339429|69511376|FG000|Overall Study|Physician Decision|3|||
37828267|NCT01339390|69511382|FG000|Overall Study|Death|32|||
37828268|NCT01339390|69511383|FG001|Overall Study|Death|29|||
37828269|NCT01339390|69511382|FG000|Overall Study|Lost to Follow-up|125|||
37828270|NCT01339390|69511383|FG001|Overall Study|Lost to Follow-up|127|||
37828271|NCT01339273|69511391|FG000|Overall Study|Lost to Follow-up|8|||
37828272|NCT01339273|69511392|FG001|Overall Study|Lost to Follow-up|8|||
37828273|NCT01334866|69511398|FG000|Overall Study|Withdrawal by Subject|10|||
37828274|NCT01334866|69511398|FG000|Overall Study|Lost to Follow-up|3|||
37828275|NCT01334866|69511398|FG000|Overall Study|Physician Decision|3|||
37828276|NCT01334866|69511398|FG000|Overall Study|medically necessary prior to procedure|2|||
37828277|NCT01334866|69511398|FG000|Overall Study|medically necessary post-procedure|1|||
37828278|NCT01334710|69511404|FG000|Overall Study|Trial was terminated|3|||
37828279|NCT01334554|69511411|FG000|Overall Study|Adverse Event|4|||
37828280|NCT01334554|69511412|FG001|Overall Study|Adverse Event|2|||
37828281|NCT01332799|69511422|FG000|Overall Study|Insufficient funding|10|||
37828282|NCT01332799|69511423|FG001|Overall Study|Insufficient funding|10|||
37828283|NCT01332331|69511431|FG000|Overall Study|Lost to Follow-up|0|||
37828284|NCT01332331|69511432|FG001|Overall Study|Lost to Follow-up|1|||
37998852|NCT00043186|69682973|FG005|Overall Study|Withdrawal by Subject|6|||
37998853|NCT00043186|69682974|FG006|Overall Study|Withdrawal by Subject|12|||
37998854|NCT00043186|69682975|FG007|Overall Study|Withdrawal by Subject|9|||
37998855|NCT00043186|69682976|FG008|Overall Study|Withdrawal by Subject|10|||
37998856|NCT00043186|69682968|FG000|Overall Study|Death|0|||
37998857|NCT00043186|69682969|FG001|Overall Study|Death|0|||
37998858|NCT00043186|69682970|FG002|Overall Study|Death|1|||
37828285|NCT01332331|69511431|FG000|Overall Study|Adverse Event|1|||
37828286|NCT01332331|69511432|FG001|Overall Study|Adverse Event|1|||
37828287|NCT01332331|69511431|FG000|Overall Study|Physician Decision|1|||
37828288|NCT01332331|69511432|FG001|Overall Study|Physician Decision|0|||
37998859|NCT00043186|69682971|FG003|Overall Study|Death|0|||
37998860|NCT00043186|69682972|FG004|Overall Study|Death|0|||
37998861|NCT00043186|69682973|FG005|Overall Study|Death|0|||
37998862|NCT00043186|69682974|FG006|Overall Study|Death|2|||
37998863|NCT00043186|69682975|FG007|Overall Study|Death|0|||
37998864|NCT00043186|69682976|FG008|Overall Study|Death|0|||
37998865|NCT00043186|69682968|FG000|Overall Study|Disease progression|1|||
37998866|NCT00043186|69682969|FG001|Overall Study|Disease progression|0|||
37998867|NCT00043186|69682970|FG002|Overall Study|Disease progression|0|||
37998868|NCT00043186|69682971|FG003|Overall Study|Disease progression|3|||
37998869|NCT00043186|69682972|FG004|Overall Study|Disease progression|0|||
37998870|NCT00043186|69682973|FG005|Overall Study|Disease progression|0|||
37998871|NCT00043186|69682974|FG006|Overall Study|Disease progression|0|||
37998872|NCT00043186|69682975|FG007|Overall Study|Disease progression|4|||
37998873|NCT00043186|69682976|FG008|Overall Study|Disease progression|0|||
37998874|NCT00043186|69682968|FG000|Overall Study|Ineligibility determined|0|||
37998875|NCT00043186|69682969|FG001|Overall Study|Ineligibility determined|0|||
37998876|NCT00043186|69682970|FG002|Overall Study|Ineligibility determined|0|||
37998877|NCT00043186|69682971|FG003|Overall Study|Ineligibility determined|0|||
37998878|NCT00043186|69682972|FG004|Overall Study|Ineligibility determined|0|||
37998879|NCT00043186|69682973|FG005|Overall Study|Ineligibility determined|0|||
37998880|NCT00043186|69682974|FG006|Overall Study|Ineligibility determined|0|||
37998881|NCT00043186|69682975|FG007|Overall Study|Ineligibility determined|0|||
37998882|NCT00043186|69682976|FG008|Overall Study|Ineligibility determined|1|||
37998883|NCT00043186|69682968|FG000|Overall Study|Lost to Follow-up|3|||
37998884|NCT00043186|69682969|FG001|Overall Study|Lost to Follow-up|5|||
37998885|NCT00043186|69682970|FG002|Overall Study|Lost to Follow-up|1|||
37998886|NCT00043186|69682971|FG003|Overall Study|Lost to Follow-up|1|||
37998887|NCT00043186|69682972|FG004|Overall Study|Lost to Follow-up|1|||
37998888|NCT00043186|69682973|FG005|Overall Study|Lost to Follow-up|1|||
37998889|NCT00043186|69682974|FG006|Overall Study|Lost to Follow-up|1|||
37998890|NCT00043186|69682975|FG007|Overall Study|Lost to Follow-up|1|||
37998891|NCT00043186|69682976|FG008|Overall Study|Lost to Follow-up|2|||
37998892|NCT00043186|69682968|FG000|Overall Study|Noncompliance|0|||
37828289|NCT01332292|69511439|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
37828290|NCT01332292|69511440|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
37828291|NCT01332292|69511439|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
37828292|NCT01332292|69511440|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
37828293|NCT01332292|69511439|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
37828294|NCT01332292|69511440|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
37828295|NCT01332019|69511450|FG000|Overall Study|Was Not Dosed|1|||
37998893|NCT00043186|69682969|FG001|Overall Study|Noncompliance|0|||
37998894|NCT00043186|69682970|FG002|Overall Study|Noncompliance|1|||
37998895|NCT00043186|69682971|FG003|Overall Study|Noncompliance|1|||
37998896|NCT00043186|69682972|FG004|Overall Study|Noncompliance|0|||
37998897|NCT00043186|69682973|FG005|Overall Study|Noncompliance|0|||
37828296|NCT01332019|69511451|FG001|Overall Study|Was Not Dosed|0|||
37998898|NCT00043186|69682974|FG006|Overall Study|Noncompliance|0|||
37998899|NCT00043186|69682975|FG007|Overall Study|Noncompliance|0|||
37998900|NCT00043186|69682976|FG008|Overall Study|Noncompliance|0|||
37998901|NCT00043186|69682968|FG000|Overall Study|Other|0|||
37998902|NCT00043186|69682969|FG001|Overall Study|Other|0|||
37998903|NCT00043186|69682970|FG002|Overall Study|Other|1|||
37998904|NCT00043186|69682971|FG003|Overall Study|Other|1|||
37998905|NCT00043186|69682972|FG004|Overall Study|Other|0|||
37998906|NCT00043186|69682973|FG005|Overall Study|Other|0|||
37998907|NCT00043186|69682974|FG006|Overall Study|Other|0|||
37998908|NCT00043186|69682975|FG007|Overall Study|Other|0|||
37998909|NCT00043186|69682976|FG008|Overall Study|Other|0|||
37998910|NCT00041470|69682997|FG000|Overall Study|Loss of Funding|38|||
37998911|NCT00206102|69683003|FG000|Overall Study|Adverse Event|119|||
37998912|NCT00206102|69683004|FG001|Overall Study|Adverse Event|82|||
37998913|NCT00206102|69683003|FG000|Overall Study|Protocol Violation|0|||
37998914|NCT00206102|69683004|FG001|Overall Study|Protocol Violation|2|||
37998915|NCT00206102|69683003|FG000|Overall Study|Lack of therapeutic response|16|||
37998916|NCT00206102|69683004|FG001|Overall Study|Lack of therapeutic response|11|||
37998917|NCT00206102|69683003|FG000|Overall Study|Lost to Follow-up|95|||
37998918|NCT00206102|69683004|FG001|Overall Study|Lost to Follow-up|66|||
37998919|NCT00206102|69683003|FG000|Overall Study|Withdrawal by Subject|118|||
37998920|NCT00206102|69683004|FG001|Overall Study|Withdrawal by Subject|101|||
37998921|NCT00206102|69683003|FG000|Overall Study|Study-specific discontinuation criteria|18|||
37998922|NCT00206102|69683004|FG001|Overall Study|Study-specific discontinuation criteria|17|||
37998923|NCT00206102|69683003|FG000|Overall Study|None of those categories|42|||
37998924|NCT00206102|69683004|FG001|Overall Study|None of those categories|36|||
37998925|NCT00041080|69683012|FG000|Overall Study|Adverse Event|21|||
37998926|NCT00041080|69683013|FG001|Overall Study|Adverse Event|1|||
37998927|NCT00041080|69683012|FG000|Overall Study|Withdrawal by Subject|6|||
37998928|NCT00041080|69683013|FG001|Overall Study|Withdrawal by Subject|6|||
37998929|NCT00041080|69683012|FG000|Overall Study|Concommitant Illness/Other|1|||
37998930|NCT00041080|69683013|FG001|Overall Study|Concommitant Illness/Other|2|||
37998931|NCT00041080|69683012|FG000|Overall Study|Did not start therapy|1|||
37998932|NCT00041080|69683013|FG001|Overall Study|Did not start therapy|1|||
37998933|NCT00041080|69683012|FG000|Overall Study|Ineligible|1|||
37998934|NCT00041080|69683013|FG001|Overall Study|Ineligible|0|||
37998935|NCT00205712|69683021|FG000|Overall Study|Lost to Follow-up|0|||
37998936|NCT00205712|69683022|FG001|Overall Study|Lost to Follow-up|1|||
37998937|NCT00203294|69683032|FG000|Overall Study|Withdrawal by Subject|8|||
37998938|NCT00203294|69683033|FG001|Overall Study|Withdrawal by Subject|13|||
37998939|NCT00264290|69683041|FG000|Intervention (8 Weeks)|Adverse Event|1|||
37998940|NCT00264290|69683042|FG001|Intervention (8 Weeks)|Adverse Event|0|||
37998941|NCT00234494|69683052|FG000|Overall Study|Protocol Violation|2|||
37998942|NCT00234104|69683060|FG000|Overall Study|Adverse Event|4|||
37998943|NCT00234104|69683061|FG001|Overall Study|Adverse Event|0|||
37998944|NCT00234104|69683062|FG002|Overall Study|Adverse Event|3|||
37998945|NCT00234104|69683063|FG003|Overall Study|Adverse Event|5|||
37998946|NCT00234104|69683060|FG000|Overall Study|Protocol Violation|0|||
37998947|NCT00234104|69683061|FG001|Overall Study|Protocol Violation|0|||
37998948|NCT00234104|69683062|FG002|Overall Study|Protocol Violation|0|||
37998949|NCT00234104|69683063|FG003|Overall Study|Protocol Violation|1|||
37998950|NCT00234104|69683060|FG000|Overall Study|Physician Decision|0|||
37998951|NCT00234104|69683061|FG001|Overall Study|Physician Decision|1|||
37998952|NCT00234104|69683062|FG002|Overall Study|Physician Decision|2|||
37998953|NCT00234104|69683063|FG003|Overall Study|Physician Decision|2|||
37998954|NCT00263666|69683075|FG000|Overall Study|Adverse Event|6|||
37998955|NCT00263666|69683076|FG001|Overall Study|Adverse Event|8|||
37998956|NCT00263666|69683075|FG000|Overall Study|Lost to Follow-up|1|||
37998957|NCT00263666|69683076|FG001|Overall Study|Lost to Follow-up|2|||
37998958|NCT00263666|69683075|FG000|Overall Study|Withdrawal by Subject|0|||
37998959|NCT00263666|69683076|FG001|Overall Study|Withdrawal by Subject|1|||
37998960|NCT00195338|69683082|FG000|Overall Study|Lost to Follow-up|2|||
37998961|NCT00195338|69683082|FG000|Overall Study|Adverse Event|5|||
37998962|NCT00195338|69683082|FG000|Overall Study|Lack of Efficacy|1|||
37998963|NCT00195338|69683082|FG000|Overall Study|Early closure of the site|4|||
37998964|NCT00035932|69683089|FG000|Overall Study|Adverse Event|10|||
37998965|NCT00035932|69683090|FG001|Overall Study|Adverse Event|9|||
37998966|NCT00035932|69683091|FG002|Overall Study|Adverse Event|9|||
37998967|NCT00035932|69683089|FG000|Overall Study|Death|0|||
37998968|NCT00035932|69683090|FG001|Overall Study|Death|0|||
37998969|NCT00035932|69683091|FG002|Overall Study|Death|1|||
37998970|NCT00035932|69683089|FG000|Overall Study|Disease Progression / Relapse|1|||
37998971|NCT00035932|69683090|FG001|Overall Study|Disease Progression / Relapse|1|||
37998972|NCT00035932|69683091|FG002|Overall Study|Disease Progression / Relapse|0|||
37998973|NCT00035932|69683089|FG000|Overall Study|Lost to Follow-up|4|||
37998974|NCT00035932|69683090|FG001|Overall Study|Lost to Follow-up|4|||
37998975|NCT00035932|69683091|FG002|Overall Study|Lost to Follow-up|3|||
37998976|NCT00035932|69683089|FG000|Overall Study|Noncompliance|6|||
37998977|NCT00035932|69683090|FG001|Overall Study|Noncompliance|7|||
37998978|NCT00035932|69683091|FG002|Overall Study|Noncompliance|6|||
37998979|NCT00035932|69683089|FG000|Overall Study|Protocol Violation While on Study|0|||
37998980|NCT00035932|69683090|FG001|Overall Study|Protocol Violation While on Study|1|||
37998981|NCT00035932|69683091|FG002|Overall Study|Protocol Violation While on Study|2|||
37998982|NCT00035932|69683089|FG000|Overall Study|Withdrawal by Subject|1|||
37998983|NCT00035932|69683090|FG001|Overall Study|Withdrawal by Subject|5|||
37998984|NCT00035932|69683091|FG002|Overall Study|Withdrawal by Subject|0|||
37998985|NCT00035932|69683089|FG000|Overall Study|Study Termination by Sponsor|1|||
37998986|NCT00035932|69683090|FG001|Overall Study|Study Termination by Sponsor|0|||
37998987|NCT00035932|69683091|FG002|Overall Study|Study Termination by Sponsor|0|||
37998988|NCT00035932|69683089|FG000|Overall Study|Lack of Efficacy|33|||
37998989|NCT00035932|69683090|FG001|Overall Study|Lack of Efficacy|33|||
37998990|NCT00035932|69683091|FG002|Overall Study|Lack of Efficacy|28|||
37998991|NCT00022516|69683106|FG000|Overall Study|Adverse Event|0|||
37998992|NCT00022516|69683107|FG001|Overall Study|Adverse Event|59|||
37998993|NCT00022516|69683106|FG000|Overall Study|Lack of Efficacy|0|||
37998994|NCT00022516|69683107|FG001|Overall Study|Lack of Efficacy|27|||
37998995|NCT00022516|69683106|FG000|Overall Study|Physician Decision|0|||
37998996|NCT00022516|69683107|FG001|Overall Study|Physician Decision|1|||
37828297|NCT01332019|69511450|FG000|Overall Study|Other|16|||
37828298|NCT01332019|69511451|FG001|Overall Study|Other|18|||
37828299|NCT01332019|69511450|FG000|Overall Study|Death|2|||
37828300|NCT01332019|69511451|FG001|Overall Study|Death|1|||
37828301|NCT01332019|69511450|FG000|Overall Study|Physician Decision|4|||
37828302|NCT01332019|69511451|FG001|Overall Study|Physician Decision|3|||
37828303|NCT01332019|69511450|FG000|Overall Study|Withdrawal by Subject|73|||
37828304|NCT01332019|69511451|FG001|Overall Study|Withdrawal by Subject|71|||
37828305|NCT01332019|69511450|FG000|Overall Study|Lost to Follow-up|4|||
37828306|NCT01332019|69511451|FG001|Overall Study|Lost to Follow-up|7|||
37828307|NCT01332019|69511450|FG000|Overall Study|Adverse Event|13|||
37828308|NCT01332019|69511451|FG001|Overall Study|Adverse Event|22|||
37828309|NCT01331239|69511459|FG000|Part II: Core Study|Adverse Event|0|||
37998997|NCT00022516|69683106|FG000|Overall Study|Protocol Violation|1|||
37998998|NCT00022516|69683107|FG001|Overall Study|Protocol Violation|3|||
37998999|NCT00022516|69683106|FG000|Overall Study|Withdrawal by Subject|2|||
37999000|NCT00022516|69683107|FG001|Overall Study|Withdrawal by Subject|113|||
37999001|NCT00022516|69683106|FG000|Overall Study|Incomplete documentation|0|||
37999002|NCT00022516|69683107|FG001|Overall Study|Incomplete documentation|27|||
37999003|NCT00033514|69683115|FG000|Overall Study|Lost to Follow-up|1|||
37999004|NCT00033514|69683116|FG001|Overall Study|Lost to Follow-up|1|||
37999005|NCT00033514|69683115|FG000|Overall Study|Withdrawal by Subject|0|||
37999006|NCT00033514|69683116|FG001|Overall Study|Withdrawal by Subject|3|||
37999007|NCT00006916|69683123|FG000|Overall Study|Device not inserted|4|||
37999008|NCT00006916|69683123|FG000|Overall Study|Complication of device insertion|1|||
37999009|NCT00454649|69683137|FG000|Overall Study|Lack of Efficacy|2|||
37999010|NCT00454649|69683138|FG001|Overall Study|Lack of Efficacy|2|||
37999011|NCT00454649|69683139|FG002|Overall Study|Lack of Efficacy|10|||
37999012|NCT00454649|69683140|FG003|Overall Study|Lack of Efficacy|3|||
37999013|NCT00454649|69683141|FG004|Overall Study|Lack of Efficacy|0|||
37999014|NCT00454649|69683142|FG005|Overall Study|Lack of Efficacy|4|||
37999015|NCT00454649|69683143|FG006|Overall Study|Lack of Efficacy|5|||
37999016|NCT00454649|69683144|FG007|Overall Study|Lack of Efficacy|13|||
37999017|NCT00454649|69683145|FG008|Overall Study|Lack of Efficacy|10|||
37999018|NCT00454649|69683146|FG009|Overall Study|Lack of Efficacy|2|||
37999019|NCT00454649|69683137|FG000|Overall Study|Adverse Event|0|||
37903064|NCT00666211|69588776|FG001|Overall Study|patient non-compliant|6|||
37903065|NCT00666211|69588775|FG000|Overall Study|disease progression|1|||
37903066|NCT00666211|69588776|FG001|Overall Study|disease progression|8|||
37903067|NCT00666211|69588775|FG000|Overall Study|Lost to Follow-up|2|||
37903068|NCT00666211|69588776|FG001|Overall Study|Lost to Follow-up|0|||
37903069|NCT00666211|69588775|FG000|Overall Study|toxicity|0|||
37903070|NCT00666211|69588776|FG001|Overall Study|toxicity|2|||
37903071|NCT00666211|69588775|FG000|Overall Study|hospital admission|0|||
37903072|NCT00666211|69588776|FG001|Overall Study|hospital admission|5|||
37903073|NCT00666211|69588775|FG000|Overall Study|Death|0|||
37903074|NCT00666211|69588776|FG001|Overall Study|Death|2|||
37903075|NCT00666211|69588775|FG000|Overall Study|off tx for other complicating disease|0|||
37903076|NCT00666211|69588776|FG001|Overall Study|off tx for other complicating disease|1|||
37903077|NCT00666211|69588775|FG000|Overall Study|Physician Decision|0|||
37903078|NCT00666211|69588776|FG001|Overall Study|Physician Decision|1|||
37903079|NCT00878709|69588784|FG000|Overall Study|Withdrawal by Subject|197|||
37903080|NCT00878709|69588785|FG001|Overall Study|Withdrawal by Subject|120|||
37903081|NCT00878709|69588784|FG000|Overall Study|Lost to Follow-up|35|||
37999020|NCT00454649|69683138|FG001|Overall Study|Adverse Event|1|||
37999021|NCT00454649|69683139|FG002|Overall Study|Adverse Event|3|||
37999022|NCT00454649|69683140|FG003|Overall Study|Adverse Event|0|||
37999023|NCT00454649|69683141|FG004|Overall Study|Adverse Event|1|||
37999024|NCT00454649|69683142|FG005|Overall Study|Adverse Event|2|||
37999025|NCT00454649|69683143|FG006|Overall Study|Adverse Event|3|||
37828310|NCT01331239|69511460|FG001|Part II: Core Study|Adverse Event|3|||
37828311|NCT01331239|69511461|FG002|Part II: Core Study|Adverse Event|0|||
37828312|NCT01331239|69511459|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
37828313|NCT01331239|69511460|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
37828314|NCT01331239|69511461|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
37828315|NCT01331239|69511459|FG000|Part II: Core Study|Withdrawal by Subject|0|||
37828316|NCT01331239|69511460|FG001|Part II: Core Study|Withdrawal by Subject|2|||
37828317|NCT01331239|69511461|FG002|Part II: Core Study|Withdrawal by Subject|0|||
37828318|NCT01331239|69511459|FG000|Part II: Core Study|Administrative problems|0|||
37903082|NCT00878709|69588785|FG001|Overall Study|Lost to Follow-up|33|||
37999026|NCT00454649|69683144|FG007|Overall Study|Adverse Event|4|||
37999027|NCT00454649|69683145|FG008|Overall Study|Adverse Event|6|||
37999028|NCT00454649|69683146|FG009|Overall Study|Adverse Event|2|||
37999029|NCT00454649|69683137|FG000|Overall Study|Lost to Follow-up|0|||
37999030|NCT00454649|69683138|FG001|Overall Study|Lost to Follow-up|0|||
37999031|NCT00454649|69683139|FG002|Overall Study|Lost to Follow-up|1|||
37999032|NCT00454649|69683140|FG003|Overall Study|Lost to Follow-up|0|||
37999033|NCT00454649|69683141|FG004|Overall Study|Lost to Follow-up|0|||
37999034|NCT00454649|69683142|FG005|Overall Study|Lost to Follow-up|0|||
37903083|NCT00878709|69588784|FG000|Overall Study|Other Reasons|93|||
37903084|NCT00878709|69588785|FG001|Overall Study|Other Reasons|84|||
37903085|NCT00927758|69588792|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
37903086|NCT00927758|69588793|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
37903087|NCT00927758|69588794|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
37999035|NCT00454649|69683143|FG006|Overall Study|Lost to Follow-up|1|||
37999036|NCT00454649|69683144|FG007|Overall Study|Lost to Follow-up|0|||
37999037|NCT00454649|69683145|FG008|Overall Study|Lost to Follow-up|0|||
37999038|NCT00454649|69683146|FG009|Overall Study|Lost to Follow-up|0|||
37999039|NCT00454649|69683137|FG000|Overall Study|Other|1|||
37999040|NCT00454649|69683138|FG001|Overall Study|Other|1|||
37999041|NCT00454649|69683139|FG002|Overall Study|Other|5|||
37999042|NCT00454649|69683140|FG003|Overall Study|Other|3|||
37999043|NCT00454649|69683141|FG004|Overall Study|Other|0|||
37999044|NCT00454649|69683142|FG005|Overall Study|Other|0|||
37999045|NCT00454649|69683143|FG006|Overall Study|Other|0|||
37999046|NCT00454649|69683144|FG007|Overall Study|Other|0|||
37999047|NCT00454649|69683145|FG008|Overall Study|Other|3|||
37999048|NCT00454649|69683146|FG009|Overall Study|Other|1|||
37999049|NCT00454649|69683137|FG000|Overall Study|Withdrawal by Subject|0|||
37999050|NCT00454649|69683138|FG001|Overall Study|Withdrawal by Subject|0|||
37999051|NCT00454649|69683139|FG002|Overall Study|Withdrawal by Subject|0|||
37999052|NCT00454649|69683140|FG003|Overall Study|Withdrawal by Subject|0|||
37999053|NCT00454649|69683141|FG004|Overall Study|Withdrawal by Subject|0|||
37999054|NCT00454649|69683142|FG005|Overall Study|Withdrawal by Subject|1|||
37999055|NCT00454649|69683143|FG006|Overall Study|Withdrawal by Subject|0|||
37999056|NCT00454649|69683144|FG007|Overall Study|Withdrawal by Subject|2|||
37999057|NCT00454649|69683145|FG008|Overall Study|Withdrawal by Subject|1|||
37999058|NCT00454649|69683146|FG009|Overall Study|Withdrawal by Subject|0|||
37999059|NCT00454571|69683189|FG000|Overall Study|Adverse Event|2|||
37999060|NCT00454571|69683190|FG001|Overall Study|Adverse Event|0|||
37999061|NCT00454571|69683189|FG000|Overall Study|Physician Decision|0|||
37999062|NCT00454571|69683190|FG001|Overall Study|Physician Decision|1|||
37999063|NCT00454571|69683189|FG000|Overall Study|Protocol Violation|1|||
37999064|NCT00454571|69683190|FG001|Overall Study|Protocol Violation|0|||
37828319|NCT01331239|69511460|FG001|Part II: Core Study|Administrative problems|1|||
37828320|NCT01331239|69511461|FG002|Part II: Core Study|Administrative problems|0|||
37828321|NCT01331161|69511479|FG000|Overall Study|Physician Decision|1|||
37828322|NCT01331161|69511480|FG001|Overall Study|Physician Decision|0|||
37828323|NCT01331161|69511479|FG000|Overall Study|Lost to Follow-up|0|||
37828324|NCT01331161|69511480|FG001|Overall Study|Lost to Follow-up|1|||
37828325|NCT01331161|69511479|FG000|Overall Study|Pregnancy|0|||
37828326|NCT01331161|69511480|FG001|Overall Study|Pregnancy|1|||
37828327|NCT01331005|69511490|FG000|Overall Study|Lost to Follow-up|2|||
37828328|NCT01331005|69511491|FG001|Overall Study|Lost to Follow-up|1|||
37828329|NCT01331005|69511490|FG000|Overall Study|Withdrawal by Subject|2|||
37828330|NCT01331005|69511491|FG001|Overall Study|Withdrawal by Subject|3|||
37903088|NCT00927758|69588795|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
37903089|NCT00927758|69588796|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
37903090|NCT00927758|69588797|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
37903091|NCT00927758|69588792|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
37903092|NCT00927758|69588793|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
37903093|NCT00927758|69588794|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
37903094|NCT00927758|69588795|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
37903095|NCT00927758|69588796|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
37903096|NCT00927758|69588797|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
37903097|NCT00927368|69588808|FG000|Overall Study|enrollment in another study|1|||
37999065|NCT00454571|69683189|FG000|Overall Study|Withdrawal by Subject|10|||
37999066|NCT00454571|69683190|FG001|Overall Study|Withdrawal by Subject|5|||
37999067|NCT03837743|69683196|FG000|Overall Study|Adverse Event|1|||
37999068|NCT03837743|69683196|FG000|Overall Study|Withdrawal by Subject|2|||
37999069|NCT03836729|69683204|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
37999070|NCT00443729|69683214|FG000|Overall Study|Never Treated|0|||
37999071|NCT00443729|69683215|FG001|Overall Study|Never Treated|1|||
37999072|NCT00443729|69683214|FG000|Overall Study|Lack of Efficacy|4|||
37999073|NCT00443729|69683215|FG001|Overall Study|Lack of Efficacy|2|||
37828331|NCT01330459|69511499|FG000|Overall Study|Physician Decision|0|||
37828332|NCT01330459|69511500|FG001|Overall Study|Physician Decision|2|||
37697107|NCT02031471|69173575|FG000|24 Week Treatment Period|Adverse Event|6|||
37999074|NCT00443729|69683214|FG000|Overall Study|Lost to Follow-up|0|||
37828333|NCT01330381|69511510|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
37828334|NCT01330381|69511511|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
37828335|NCT01330381|69511512|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
37828336|NCT01330381|69511510|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
37828337|NCT01330381|69511511|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
37828338|NCT01330381|69511512|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
37828339|NCT01330381|69511510|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
37828340|NCT01330381|69511511|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
37828341|NCT01330381|69511512|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
37828342|NCT01330381|69511510|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
37828343|NCT01330381|69511511|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
37828344|NCT01330381|69511512|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
37828345|NCT01330381|69511510|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
37828346|NCT01330381|69511511|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
37828347|NCT01330381|69511512|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
37828348|NCT01330381|69511510|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
37828349|NCT01330381|69511511|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
37828350|NCT01330381|69511512|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
37828351|NCT01330381|69511510|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
37828352|NCT01330381|69511511|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
37828353|NCT01330381|69511512|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
37828354|NCT01330381|69511510|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
37828355|NCT01330381|69511511|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
37828356|NCT01330381|69511512|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
37828357|NCT01330381|69511510|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
37828358|NCT01330381|69511511|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
37828359|NCT01330381|69511512|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
37828360|NCT01330381|69511510|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
37828361|NCT01330381|69511511|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
37828362|NCT01330381|69511512|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
37828363|NCT01330303|69511521|FG000|Period 1|Adverse Event|1|||
37828364|NCT01330303|69511522|FG001|Period 1|Adverse Event|0|||
37828365|NCT01330303|69511521|FG000|Period 1|Protocol Violation|0|||
37828366|NCT01330303|69511522|FG001|Period 1|Protocol Violation|1|||
37828367|NCT01330303|69511521|FG000|Period 1|Withdrawal by Subject|0|||
37697108|NCT02031471|69173575|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
37999075|NCT00443729|69683215|FG001|Overall Study|Lost to Follow-up|1|||
37999076|NCT00443729|69683214|FG000|Overall Study|Physician Decision|2|||
37999077|NCT00443729|69683215|FG001|Overall Study|Physician Decision|1|||
37999078|NCT00443729|69683214|FG000|Overall Study|Protocol Violation|1|||
37999079|NCT00443729|69683215|FG001|Overall Study|Protocol Violation|1|||
37999080|NCT00443729|69683214|FG000|Overall Study|Withdrawal by Subject|3|||
37999081|NCT00443729|69683215|FG001|Overall Study|Withdrawal by Subject|1|||
37999082|NCT00443651|69683223|FG000|Overall Study|Death|1|||
37999083|NCT00443651|69683224|FG001|Overall Study|Death|5|||
37999084|NCT00443651|69683223|FG000|Overall Study|Adverse Event|5|||
37999085|NCT00443651|69683224|FG001|Overall Study|Adverse Event|6|||
37999086|NCT00443651|69683223|FG000|Overall Study|Lost to Follow-up|18|||
37999087|NCT00443651|69683224|FG001|Overall Study|Lost to Follow-up|12|||
37999088|NCT00443651|69683223|FG000|Overall Study|Patient's/Guardian's Decision|58|||
37999089|NCT00443651|69683224|FG001|Overall Study|Patient's/Guardian's Decision|30|||
37999090|NCT00443651|69683223|FG000|Overall Study|Physician Decision|13|||
37999091|NCT00443651|69683224|FG001|Overall Study|Physician Decision|4|||
37999092|NCT00443651|69683223|FG000|Overall Study|Pregnancy|0|||
37999093|NCT00443651|69683224|FG001|Overall Study|Pregnancy|1|||
37999094|NCT00443261|69683230|FG000|Overall Study|Death|1|||
37999095|NCT00439517|69683236|FG000|Overall Study|Subject on treatment|1|||
37999096|NCT00439517|69683237|FG001|Overall Study|Subject on treatment|0|||
37999097|NCT00439517|69683236|FG000|Overall Study|Subject in survival follow-up|1|||
37999098|NCT00439517|69683237|FG001|Overall Study|Subject in survival follow-up|0|||
37999099|NCT00438815|69683243|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
37999100|NCT00438815|69683243|FG000|Overall Study|3-month follow-up no longer required|12|||
37999101|NCT00438815|69683243|FG000|Overall Study|Noncompliance with protocol requirements|9|||
37999102|NCT00438815|69683243|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
37999103|NCT00438815|69683243|FG000|Overall Study|Lost to Follow-up|6|||
37999104|NCT00438815|69683243|FG000|Overall Study|Withdrawal by Subject|6|||
37999105|NCT00438815|69683243|FG000|Overall Study|Death|1|||
37999106|NCT00438659|69683249|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
37999107|NCT00438659|69683250|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
37999108|NCT00438659|69683249|FG000|Overall Study|Cancel|5|||
37999109|NCT00438659|69683250|FG001|Overall Study|Cancel|2|||
37999110|NCT00437645|69683259|FG000|Overall Study|Adverse Event|15|||
37999111|NCT00437645|69683260|FG001|Overall Study|Adverse Event|84|||
37999112|NCT00437645|69683259|FG000|Overall Study|Withdrawal by Subject|10|||
37999113|NCT00437645|69683260|FG001|Overall Study|Withdrawal by Subject|22|||
37999114|NCT00437645|69683259|FG000|Overall Study|Protocol Violation|3|||
37828368|NCT01330303|69511522|FG001|Period 1|Withdrawal by Subject|1|||
37828369|NCT01330108|69511529|FG000|Overall Study|Withdrawal by Subject|4|||
37828370|NCT04696055|69511539|FG000|Overall Study|Adverse Event|10|||
37828371|NCT04696055|69511540|FG001|Overall Study|Adverse Event|0|||
37999115|NCT00437645|69683260|FG001|Overall Study|Protocol Violation|3|||
37999116|NCT00437645|69683259|FG000|Overall Study|Lost to Follow-up|2|||
37999117|NCT00437645|69683260|FG001|Overall Study|Lost to Follow-up|3|||
37828372|NCT04696055|69511539|FG000|Overall Study|Death|2|||
37828373|NCT04696055|69511540|FG001|Overall Study|Death|1|||
37828374|NCT04696055|69511539|FG000|Overall Study|Other|4|||
37828375|NCT04696055|69511540|FG001|Overall Study|Other|0|||
37828376|NCT04696055|69511539|FG000|Overall Study|Physician Decision|1|||
37828377|NCT04696055|69511540|FG001|Overall Study|Physician Decision|0|||
37828378|NCT04696055|69511539|FG000|Overall Study|Progressive Disease - Clinical Progression|1|||
37828379|NCT04696055|69511540|FG001|Overall Study|Progressive Disease - Clinical Progression|1|||
37903098|NCT00927368|69588809|FG001|Overall Study|enrollment in another study|1|||
37903099|NCT00927368|69588810|FG002|Overall Study|enrollment in another study|2|||
37903100|NCT00927368|69588808|FG000|Overall Study|Lost to Follow-up|4|||
37903101|NCT00927368|69588809|FG001|Overall Study|Lost to Follow-up|0|||
37903102|NCT00927368|69588810|FG002|Overall Study|Lost to Follow-up|0|||
37903103|NCT00927368|69588808|FG000|Overall Study|equipment failure|1|||
37903104|NCT00927368|69588809|FG001|Overall Study|equipment failure|0|||
37903105|NCT00927368|69588810|FG002|Overall Study|equipment failure|0|||
37903106|NCT00927368|69588808|FG000|Overall Study|ineligible post randomization|0|||
37828380|NCT04696055|69511539|FG000|Overall Study|Progressive Disease - Radiological Progression|36|||
37828381|NCT04696055|69511540|FG001|Overall Study|Progressive Disease - Radiological Progression|13|||
37999118|NCT00437645|69683259|FG000|Overall Study|Administrative problems|2|||
37999119|NCT00437645|69683260|FG001|Overall Study|Administrative problems|1|||
37999120|NCT00437645|69683259|FG000|Overall Study|Lack of Efficacy|2|||
37999121|NCT00437645|69683260|FG001|Overall Study|Lack of Efficacy|1|||
37999122|NCT00437645|69683259|FG000|Overall Study|Condition no longer requires study drug|1|||
37999123|NCT00437645|69683260|FG001|Overall Study|Condition no longer requires study drug|1|||
37903107|NCT00927368|69588809|FG001|Overall Study|ineligible post randomization|3|||
37903108|NCT00927368|69588810|FG002|Overall Study|ineligible post randomization|1|||
37999124|NCT00437489|69683268|FG000|Overall Study|Study terminated by sponsor|23|||
37999125|NCT00437489|69683269|FG001|Overall Study|Study terminated by sponsor|21|||
37999126|NCT00437489|69683268|FG000|Overall Study|Lost to Follow-up|0|||
37999127|NCT00437489|69683269|FG001|Overall Study|Lost to Follow-up|1|||
37999128|NCT00442559|69683277|FG000|Overall Study|Lost to Follow-up|32|||
37999129|NCT00442559|69683278|FG001|Overall Study|Lost to Follow-up|34|||
37999130|NCT00442559|69683277|FG000|Overall Study|Protocol Violation|1|||
37999131|NCT00442559|69683278|FG001|Overall Study|Protocol Violation|1|||
37999132|NCT00442559|69683277|FG000|Overall Study|Withdrawal by Subject|1|||
37999133|NCT00442559|69683278|FG001|Overall Study|Withdrawal by Subject|0|||
37999134|NCT00441701|69683300|FG000|Overall Study|Adverse Event|3|||
37999135|NCT00441701|69683301|FG001|Overall Study|Adverse Event|2|||
37999136|NCT00441701|69683302|FG002|Overall Study|Adverse Event|1|||
37999137|NCT00441701|69683303|FG003|Overall Study|Adverse Event|0|||
37999138|NCT00441701|69683304|FG004|Overall Study|Adverse Event|2|||
37999139|NCT00441701|69683305|FG005|Overall Study|Adverse Event|2|||
37999140|NCT00441701|69683306|FG006|Overall Study|Adverse Event|0|||
37999141|NCT00441701|69683307|FG007|Overall Study|Adverse Event|0|||
37999142|NCT00441701|69683308|FG008|Overall Study|Adverse Event|0|||
37999143|NCT00441701|69683309|FG009|Overall Study|Adverse Event|0|||
37999144|NCT00441701|69683300|FG000|Overall Study|Lack of Efficacy|2|||
37999145|NCT00441701|69683301|FG001|Overall Study|Lack of Efficacy|0|||
37999146|NCT00441701|69683302|FG002|Overall Study|Lack of Efficacy|2|||
37999147|NCT00441701|69683303|FG003|Overall Study|Lack of Efficacy|2|||
37999148|NCT00441701|69683304|FG004|Overall Study|Lack of Efficacy|0|||
37999149|NCT00441701|69683305|FG005|Overall Study|Lack of Efficacy|1|||
37999150|NCT00441701|69683306|FG006|Overall Study|Lack of Efficacy|0|||
37999151|NCT00441701|69683307|FG007|Overall Study|Lack of Efficacy|0|||
37999152|NCT00441701|69683308|FG008|Overall Study|Lack of Efficacy|0|||
37999153|NCT00441701|69683309|FG009|Overall Study|Lack of Efficacy|0|||
37999154|NCT00441701|69683300|FG000|Overall Study|Withdrawal by Subject|0|||
37999155|NCT00441701|69683301|FG001|Overall Study|Withdrawal by Subject|2|||
37999156|NCT00441701|69683302|FG002|Overall Study|Withdrawal by Subject|1|||
37999157|NCT00441701|69683303|FG003|Overall Study|Withdrawal by Subject|1|||
37999158|NCT00441701|69683304|FG004|Overall Study|Withdrawal by Subject|0|||
37999159|NCT00441701|69683305|FG005|Overall Study|Withdrawal by Subject|0|||
37999160|NCT00441701|69683306|FG006|Overall Study|Withdrawal by Subject|0|||
37999161|NCT00441701|69683307|FG007|Overall Study|Withdrawal by Subject|0|||
37999162|NCT00441701|69683308|FG008|Overall Study|Withdrawal by Subject|0|||
37999163|NCT00441701|69683309|FG009|Overall Study|Withdrawal by Subject|0|||
37999164|NCT00441545|69683327|FG000|First Intervention|Adverse Event|6|||
37999165|NCT00441545|69683328|FG001|First Intervention|Adverse Event|5|||
37999166|NCT00441545|69683327|FG000|First Intervention|Protocol Violation|2|||
37999167|NCT00441545|69683328|FG001|First Intervention|Protocol Violation|2|||
37999168|NCT00441545|69683327|FG000|First Intervention|Withdrawal by Subject|3|||
37999169|NCT00441545|69683328|FG001|First Intervention|Withdrawal by Subject|3|||
37999170|NCT00441545|69683327|FG000|First Intervention|Kidney transplant|1|||
37999171|NCT00441545|69683328|FG001|First Intervention|Kidney transplant|1|||
37999172|NCT00441545|69683327|FG000|First Intervention|Lack of Efficacy|2|||
37999173|NCT00441545|69683328|FG001|First Intervention|Lack of Efficacy|0|||
37999174|NCT00441545|69683327|FG000|First Intervention|Subject exceeded safety criteria|0|||
37999175|NCT00441545|69683328|FG001|First Intervention|Subject exceeded safety criteria|1|||
37999176|NCT00441545|69683327|FG000|First Intervention|Subject met an exclusionary criteria|1|||
37999177|NCT00441545|69683328|FG001|First Intervention|Subject met an exclusionary criteria|0|||
37999178|NCT00441545|69683327|FG000|First Intervention|Extended hospitalization|1|||
37999179|NCT00441545|69683328|FG001|First Intervention|Extended hospitalization|0|||
37999180|NCT00441545|69683327|FG000|First Intervention|Site error|1|||
37999181|NCT00441545|69683328|FG001|First Intervention|Site error|0|||
37903109|NCT00927368|69588808|FG000|Overall Study|cancellation of surgery|0|||
37903110|NCT00927368|69588809|FG001|Overall Study|cancellation of surgery|1|||
37903111|NCT00927368|69588810|FG002|Overall Study|cancellation of surgery|2|||
37903112|NCT00662857|69588818|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
37903113|NCT00662857|69588819|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
37903114|NCT00662857|69588818|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
37903115|NCT00662857|69588819|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
37903116|NCT00662857|69588818|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
37999182|NCT00441545|69683327|FG000|First Intervention|Sponsor's request|1|||
37999183|NCT00441545|69683328|FG001|First Intervention|Sponsor's request|0|||
37999184|NCT00441545|69683327|FG000|Second Intervention|Adverse Event|5|||
37999185|NCT00441545|69683328|FG001|Second Intervention|Adverse Event|2|||
37999186|NCT00441545|69683327|FG000|Second Intervention|Protocol Violation|4|||
37999187|NCT00441545|69683328|FG001|Second Intervention|Protocol Violation|1|||
37999188|NCT00441545|69683327|FG000|Second Intervention|Withdrawal by Subject|1|||
37999189|NCT00441545|69683328|FG001|Second Intervention|Withdrawal by Subject|1|||
37999190|NCT00441545|69683327|FG000|Second Intervention|Kidney Transplant|1|||
37999191|NCT00441545|69683328|FG001|Second Intervention|Kidney Transplant|1|||
37999192|NCT00441545|69683327|FG000|Second Intervention|Lack of Efficacy|0|||
37999193|NCT00441545|69683328|FG001|Second Intervention|Lack of Efficacy|1|||
37999194|NCT00441545|69683327|FG000|Second Intervention|Subject exceeded safety criteria|1|||
37999195|NCT00441545|69683328|FG001|Second Intervention|Subject exceeded safety criteria|0|||
37999196|NCT00441545|69683327|FG000|Second Intervention|Subject moved|0|||
37999197|NCT00441545|69683328|FG001|Second Intervention|Subject moved|1|||
37999198|NCT00436553|69683337|FG000|Overall Study|Adverse Event|4|||
37999199|NCT00436553|69683338|FG001|Overall Study|Adverse Event|3|||
37999200|NCT00436553|69683339|FG002|Overall Study|Adverse Event|4|||
37999201|NCT00436553|69683337|FG000|Overall Study|Death|3|||
37999202|NCT00436553|69683338|FG001|Overall Study|Death|1|||
37999203|NCT00436553|69683339|FG002|Overall Study|Death|3|||
37999204|NCT00436553|69683337|FG000|Overall Study|Lost to Follow-up|0|||
37999205|NCT00436553|69683338|FG001|Overall Study|Lost to Follow-up|2|||
37999206|NCT00436553|69683339|FG002|Overall Study|Lost to Follow-up|0|||
37999207|NCT00436553|69683337|FG000|Overall Study|Protocol Violation|1|||
37999208|NCT00436553|69683338|FG001|Overall Study|Protocol Violation|0|||
37999209|NCT00436553|69683339|FG002|Overall Study|Protocol Violation|0|||
37999210|NCT00436553|69683337|FG000|Overall Study|Withdrawal by Subject|5|||
37999211|NCT00436553|69683338|FG001|Overall Study|Withdrawal by Subject|6|||
37999212|NCT00436553|69683339|FG002|Overall Study|Withdrawal by Subject|3|||
37999213|NCT00441467|69683347|FG000|Overall Study|Adverse Event|6|||
37999214|NCT00441467|69683347|FG000|Overall Study|Withdrawal by Subject|3|||
37999215|NCT00441467|69683347|FG000|Overall Study|Progressive disease|9|||
37999216|NCT00436163|69683351|FG000|Overall Study|Lost to Follow-up|2|||
37999217|NCT00436163|69683351|FG000|Overall Study|Adverse Event|1|||
37999218|NCT00006604|69683363|FG000|Overall Study|Met study objective - no further FU|1|||
37999219|NCT00006604|69683364|FG001|Overall Study|Met study objective - no further FU|0|||
37999220|NCT00006604|69683365|FG002|Overall Study|Met study objective - no further FU|0|||
37999221|NCT00006604|69683366|FG003|Overall Study|Met study objective - no further FU|0|||
37999222|NCT00006604|69683367|FG004|Overall Study|Met study objective - no further FU|0|||
37999223|NCT00006604|69683368|FG005|Overall Study|Met study objective - no further FU|0|||
37999224|NCT00006604|69683369|FG006|Overall Study|Met study objective - no further FU|0|||
37999225|NCT00006604|69683370|FG007|Overall Study|Met study objective - no further FU|0|||
37999226|NCT00006604|69683371|FG008|Overall Study|Met study objective - no further FU|0|||
37999227|NCT00006604|69683372|FG009|Overall Study|Met study objective - no further FU|0|||
37999228|NCT00006604|69683373|FG010|Overall Study|Met study objective - no further FU|0|||
37999229|NCT00006604|69683374|FG011|Overall Study|Met study objective - no further FU|0|||
37999230|NCT00006604|69683375|FG012|Overall Study|Met study objective - no further FU|0|||
37999231|NCT00006604|69683376|FG013|Overall Study|Met study objective - no further FU|0|||
37903117|NCT00662857|69588819|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
37903118|NCT00878553|69588832|FG000|Sleep Study|Withdrawal by Subject|2|||
37903119|NCT00878553|69588833|FG001|Sleep Study|Withdrawal by Subject|0|||
37903120|NCT00878553|69588834|FG002|Sleep Study|Withdrawal by Subject|0|||
37903121|NCT00878553|69588835|FG003|Sleep Study|Withdrawal by Subject|0|||
37903122|NCT00878553|69588836|FG004|Sleep Study|Withdrawal by Subject|0|||
37903123|NCT00878553|69588832|FG000|Sleep Study|Lost to Follow-up|1|||
37903124|NCT00878553|69588833|FG001|Sleep Study|Lost to Follow-up|0|||
37999232|NCT00006604|69683377|FG014|Overall Study|Met study objective - no further FU|1|||
37903125|NCT00878553|69588834|FG002|Sleep Study|Lost to Follow-up|0|||
37999233|NCT00006604|69683378|FG015|Overall Study|Met study objective - no further FU|1|||
37999234|NCT00006604|69683379|FG016|Overall Study|Met study objective - no further FU|0|||
37828382|NCT04696055|69511539|FG000|Overall Study|Subject Decision|1|||
37828383|NCT04696055|69511540|FG001|Overall Study|Subject Decision|2|||
37828384|NCT04696055|69511539|FG000|Overall Study|Ongoing with study treatment|13|||
37828385|NCT04696055|69511540|FG001|Overall Study|Ongoing with study treatment|10|||
37828386|NCT04543409|69511552|FG000|Double-Blind Treatment Period|Withdrawal by Subject|1|||
37828387|NCT04543409|69511553|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
37828388|NCT04543409|69511552|FG000|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|1|||
37828389|NCT04543409|69511553|FG001|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|0|||
37828390|NCT04543409|69511552|FG000|Open-Label Treatment Period|Lost to Follow-up|0|||
37828391|NCT04543409|69511553|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
37828392|NCT04543409|69511552|FG000|Open-Label Treatment Period|Study terminated by sponsor|17|||
37903126|NCT00878553|69588835|FG003|Sleep Study|Lost to Follow-up|0|||
37903127|NCT00878553|69588836|FG004|Sleep Study|Lost to Follow-up|0|||
37828393|NCT04543409|69511553|FG001|Open-Label Treatment Period|Study terminated by sponsor|19|||
37828394|NCT04543409|69511552|FG000|Open-Label Treatment Period|Withdrawal by Subject|4|||
37828395|NCT04543409|69511553|FG001|Open-Label Treatment Period|Withdrawal by Subject|3|||
37828396|NCT04543409|69511552|FG000|Open-Label Extension Treatment Period|Adverse Event|0|||
37828397|NCT04543409|69511553|FG001|Open-Label Extension Treatment Period|Adverse Event|1|||
37828398|NCT04543409|69511552|FG000|Open-Label Extension Treatment Period|Lost to Follow-up|1|||
37828399|NCT04543409|69511553|FG001|Open-Label Extension Treatment Period|Lost to Follow-up|0|||
37828400|NCT04543409|69511552|FG000|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
37828401|NCT04543409|69511553|FG001|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
37828402|NCT04543409|69511552|FG000|Open-Label Extension Treatment Period|Withdrawal by Subject|0|||
37828403|NCT04543409|69511553|FG001|Open-Label Extension Treatment Period|Withdrawal by Subject|1|||
37828404|NCT04543409|69511552|FG000|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|0|||
37828405|NCT04543409|69511553|FG001|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|1|||
37828406|NCT04543409|69511552|FG000|Open-Label Extension Treatment Period|No study/treatment discontinuation information|0|||
37828407|NCT04543409|69511553|FG001|Open-Label Extension Treatment Period|No study/treatment discontinuation information|1|||
37828408|NCT04423718|69511563|FG000|Overall Study|Adverse Event|5|||
37828409|NCT04423718|69511564|FG001|Overall Study|Adverse Event|1|||
37828410|NCT04423718|69511565|FG002|Overall Study|Adverse Event|5|||
37828411|NCT04423718|69511563|FG000|Overall Study|Physician Decision|1|||
37828412|NCT04423718|69511564|FG001|Overall Study|Physician Decision|3|||
37903128|NCT00878553|69588832|FG000|Sleep Study|car accident|1|||
37903129|NCT00878553|69588833|FG001|Sleep Study|car accident|0|||
37903130|NCT00878553|69588834|FG002|Sleep Study|car accident|0|||
37903131|NCT00878553|69588835|FG003|Sleep Study|car accident|0|||
37903132|NCT00878553|69588836|FG004|Sleep Study|car accident|0|||
37903133|NCT00878553|69588832|FG000|Sleep Study|family emergency|1|||
37903134|NCT00878553|69588833|FG001|Sleep Study|family emergency|0|||
37903135|NCT00878553|69588834|FG002|Sleep Study|family emergency|0|||
37903136|NCT00878553|69588835|FG003|Sleep Study|family emergency|0|||
37903137|NCT00878553|69588836|FG004|Sleep Study|family emergency|0|||
37903138|NCT00878553|69588832|FG000|PK Study|Withdrawal by Subject|0|||
37903139|NCT00878553|69588833|FG001|PK Study|Withdrawal by Subject|0|||
37903140|NCT00878553|69588834|FG002|PK Study|Withdrawal by Subject|0|||
37903141|NCT00878553|69588835|FG003|PK Study|Withdrawal by Subject|1|||
37903142|NCT00878553|69588836|FG004|PK Study|Withdrawal by Subject|0|||
37903143|NCT00996437|69588855|FG000|Overall Study|Death|1|||
37903144|NCT00996437|69588856|FG001|Overall Study|Death|0|||
37903145|NCT00996437|69588855|FG000|Overall Study|Dropped|2|||
37828413|NCT04423718|69511565|FG002|Overall Study|Physician Decision|2|||
37828414|NCT04423718|69511563|FG000|Overall Study|Protocol Violation|0|||
37903146|NCT00996437|69588856|FG001|Overall Study|Dropped|2|||
37903147|NCT00996437|69588855|FG000|Overall Study|Missed|2|||
37903148|NCT00996437|69588856|FG001|Overall Study|Missed|5|||
37903149|NCT00662311|69588865|FG000|Overall Study|Respiratory Infection|1|||
37903150|NCT00662311|69588866|FG001|Overall Study|Respiratory Infection|0|||
37903151|NCT00662311|69588867|FG002|Overall Study|Respiratory Infection|0|||
37903152|NCT00929708|69588880|FG000|Overall Study|Protocol Violation|2|||
37903153|NCT00929708|69588881|FG001|Overall Study|Protocol Violation|1|||
37999235|NCT00006604|69683363|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
37999236|NCT00006604|69683364|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
37999237|NCT00006604|69683365|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
37999238|NCT00006604|69683366|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
37999239|NCT00006604|69683367|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
37999240|NCT00006604|69683368|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
37999241|NCT00006604|69683369|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
37999242|NCT00006604|69683370|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
37999243|NCT00006604|69683371|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
37999244|NCT00006604|69683372|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
37999245|NCT00006604|69683373|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
37903154|NCT00929708|69588882|FG002|Overall Study|Protocol Violation|1|||
37903155|NCT00929708|69588883|FG003|Overall Study|Protocol Violation|1|||
37903156|NCT00929708|69588884|FG004|Overall Study|Protocol Violation|1|||
37903157|NCT00929708|69588880|FG000|Overall Study|Withdrawal by Subject|2|||
37999246|NCT00006604|69683374|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
37999247|NCT00006604|69683375|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
37999248|NCT00006604|69683376|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
37999249|NCT00006604|69683377|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
37999250|NCT00006604|69683378|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
37999251|NCT00006604|69683379|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
37999252|NCT00006604|69683363|FG000|Overall Study|Death|0|||
37999253|NCT00006604|69683364|FG001|Overall Study|Death|0|||
37999254|NCT00006604|69683365|FG002|Overall Study|Death|0|||
37999255|NCT00006604|69683366|FG003|Overall Study|Death|0|||
37999256|NCT00006604|69683367|FG004|Overall Study|Death|0|||
37999257|NCT00006604|69683368|FG005|Overall Study|Death|0|||
37999258|NCT00006604|69683369|FG006|Overall Study|Death|0|||
37999259|NCT00006604|69683370|FG007|Overall Study|Death|0|||
37999260|NCT00006604|69683371|FG008|Overall Study|Death|0|||
37999261|NCT00006604|69683372|FG009|Overall Study|Death|1|||
37999262|NCT00006604|69683373|FG010|Overall Study|Death|1|||
37999263|NCT00006604|69683374|FG011|Overall Study|Death|1|||
37999264|NCT00006604|69683375|FG012|Overall Study|Death|0|||
37999265|NCT00006604|69683376|FG013|Overall Study|Death|0|||
37999266|NCT00006604|69683377|FG014|Overall Study|Death|0|||
37999267|NCT00006604|69683378|FG015|Overall Study|Death|0|||
37999268|NCT00006604|69683379|FG016|Overall Study|Death|0|||
37999269|NCT00006604|69683363|FG000|Overall Study|Severe debilitation, unable to continue|0|||
37999270|NCT00006604|69683364|FG001|Overall Study|Severe debilitation, unable to continue|0|||
37999271|NCT00006604|69683365|FG002|Overall Study|Severe debilitation, unable to continue|0|||
37999272|NCT00006604|69683366|FG003|Overall Study|Severe debilitation, unable to continue|0|||
37999273|NCT00006604|69683367|FG004|Overall Study|Severe debilitation, unable to continue|0|||
37999274|NCT00006604|69683368|FG005|Overall Study|Severe debilitation, unable to continue|0|||
37828415|NCT04423718|69511564|FG001|Overall Study|Protocol Violation|1|||
37903158|NCT00929708|69588881|FG001|Overall Study|Withdrawal by Subject|0|||
37903159|NCT00929708|69588882|FG002|Overall Study|Withdrawal by Subject|0|||
37903160|NCT00929708|69588883|FG003|Overall Study|Withdrawal by Subject|2|||
37903161|NCT00929708|69588884|FG004|Overall Study|Withdrawal by Subject|1|||
37903162|NCT00929708|69588880|FG000|Overall Study|Adverse Event|0|||
37903163|NCT00929708|69588881|FG001|Overall Study|Adverse Event|0|||
37903164|NCT00929708|69588882|FG002|Overall Study|Adverse Event|0|||
37828416|NCT04423718|69511565|FG002|Overall Study|Protocol Violation|1|||
37828417|NCT04423718|69511563|FG000|Overall Study|Lost to Follow-up|1|||
37828418|NCT04423718|69511564|FG001|Overall Study|Lost to Follow-up|1|||
37828419|NCT04423718|69511565|FG002|Overall Study|Lost to Follow-up|0|||
37828420|NCT04423718|69511563|FG000|Overall Study|Lack of Efficacy|2|||
37828421|NCT04423718|69511564|FG001|Overall Study|Lack of Efficacy|0|||
37828422|NCT04423718|69511565|FG002|Overall Study|Lack of Efficacy|0|||
37828423|NCT04423718|69511563|FG000|Overall Study|Withdrawal by Subject|5|||
37828424|NCT04423718|69511564|FG001|Overall Study|Withdrawal by Subject|5|||
37903165|NCT00929708|69588883|FG003|Overall Study|Adverse Event|0|||
37999275|NCT00006604|69683369|FG006|Overall Study|Severe debilitation, unable to continue|3|||
37999276|NCT00006604|69683370|FG007|Overall Study|Severe debilitation, unable to continue|0|||
37999277|NCT00006604|69683371|FG008|Overall Study|Severe debilitation, unable to continue|0|||
37999278|NCT00006604|69683372|FG009|Overall Study|Severe debilitation, unable to continue|5|||
37999279|NCT00006604|69683373|FG010|Overall Study|Severe debilitation, unable to continue|0|||
37999280|NCT00006604|69683374|FG011|Overall Study|Severe debilitation, unable to continue|2|||
37828425|NCT04423718|69511565|FG002|Overall Study|Withdrawal by Subject|12|||
37999281|NCT00006604|69683375|FG012|Overall Study|Severe debilitation, unable to continue|1|||
37999282|NCT00006604|69683376|FG013|Overall Study|Severe debilitation, unable to continue|0|||
37999283|NCT00006604|69683377|FG014|Overall Study|Severe debilitation, unable to continue|2|||
37999284|NCT00006604|69683378|FG015|Overall Study|Severe debilitation, unable to continue|0|||
37999285|NCT00006604|69683379|FG016|Overall Study|Severe debilitation, unable to continue|0|||
37999286|NCT00006604|69683363|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
37999287|NCT00006604|69683364|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
37999288|NCT00006604|69683365|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
37999289|NCT00006604|69683366|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
37999290|NCT00006604|69683367|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
37999291|NCT00006604|69683368|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
37999292|NCT00006604|69683369|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
37903166|NCT00929708|69588884|FG004|Overall Study|Adverse Event|3|||
37903167|NCT00929708|69588880|FG000|Overall Study|Physician Decision|0|||
37903168|NCT00929708|69588881|FG001|Overall Study|Physician Decision|2|||
37903169|NCT00929708|69588882|FG002|Overall Study|Physician Decision|2|||
37999293|NCT00006604|69683370|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
37999294|NCT00006604|69683371|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
37999295|NCT00006604|69683372|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
37999296|NCT00006604|69683373|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
37999297|NCT00006604|69683374|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
37999298|NCT00006604|69683375|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
37999299|NCT00006604|69683376|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
37999300|NCT00006604|69683377|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
37999301|NCT00006604|69683378|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
37999302|NCT00006604|69683379|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
37999303|NCT00006604|69683363|FG000|Overall Study|Site closing|0|||
37999304|NCT00006604|69683364|FG001|Overall Study|Site closing|0|||
37999305|NCT00006604|69683365|FG002|Overall Study|Site closing|1|||
37999306|NCT00006604|69683366|FG003|Overall Study|Site closing|1|||
37999307|NCT00006604|69683367|FG004|Overall Study|Site closing|0|||
37828426|NCT04423718|69511563|FG000|Overall Study|Death|5|||
37828427|NCT04423718|69511564|FG001|Overall Study|Death|3|||
37828428|NCT04423718|69511565|FG002|Overall Study|Death|1|||
37828429|NCT04423718|69511563|FG000|Overall Study|COVID-19 pandemic|2|||
37828430|NCT04423718|69511564|FG001|Overall Study|COVID-19 pandemic|2|||
37828431|NCT04423718|69511565|FG002|Overall Study|COVID-19 pandemic|2|||
37828432|NCT04423718|69511563|FG000|Overall Study|Other|4|||
37828433|NCT04423718|69511564|FG001|Overall Study|Other|2|||
37828434|NCT04423718|69511565|FG002|Overall Study|Other|2|||
37903170|NCT00929708|69588883|FG003|Overall Study|Physician Decision|2|||
37903171|NCT00929708|69588884|FG004|Overall Study|Physician Decision|1|||
37903172|NCT00929708|69588880|FG000|Overall Study|Lost to Follow-up|0|||
37903173|NCT00929708|69588881|FG001|Overall Study|Lost to Follow-up|0|||
37903174|NCT00929708|69588882|FG002|Overall Study|Lost to Follow-up|0|||
37903175|NCT00929708|69588883|FG003|Overall Study|Lost to Follow-up|1|||
37903176|NCT00929708|69588884|FG004|Overall Study|Lost to Follow-up|0|||
37903177|NCT00996281|69588898|FG000|Overall Study|Adverse Event|75|||
37903178|NCT00996281|69588899|FG001|Overall Study|Adverse Event|37|||
37999308|NCT00006604|69683368|FG005|Overall Study|Site closing|0|||
37999309|NCT00006604|69683369|FG006|Overall Study|Site closing|0|||
37999310|NCT00006604|69683370|FG007|Overall Study|Site closing|1|||
37999311|NCT00006604|69683371|FG008|Overall Study|Site closing|0|||
37828435|NCT04423718|69511563|FG000|Overall Study|Unknown if completed study until Week 48|3|||
37828436|NCT04423718|69511564|FG001|Overall Study|Unknown if completed study until Week 48|2|||
37903179|NCT00996281|69588898|FG000|Overall Study|Major Protocol Deviation|6|||
37903180|NCT00996281|69588899|FG001|Overall Study|Major Protocol Deviation|7|||
37903181|NCT00996281|69588898|FG000|Overall Study|Lost to Follow-up|14|||
37903182|NCT00996281|69588899|FG001|Overall Study|Lost to Follow-up|16|||
37903183|NCT00996281|69588898|FG000|Overall Study|Withdrawal by Subject|31|||
37999312|NCT00006604|69683372|FG009|Overall Study|Site closing|0|||
37828437|NCT04423718|69511565|FG002|Overall Study|Unknown if completed study until Week 48|1|||
37828438|NCT04107935|69511588|FG000|Overall Study|Death|1|||
37828439|NCT04107935|69511589|FG001|Overall Study|Death|0|||
37828440|NCT04076059|69511619|FG000|Double Blind Phase|Progressive disease|22|||
37828441|NCT04076059|69511620|FG001|Double Blind Phase|Progressive disease|26|||
37828442|NCT04076059|69511621|FG002|Double Blind Phase|Progressive disease|0|||
37828443|NCT04076059|69511619|FG000|Double Blind Phase|Withdrawal by Subject|4|||
37828444|NCT04076059|69511620|FG001|Double Blind Phase|Withdrawal by Subject|11|||
37828445|NCT04076059|69511621|FG002|Double Blind Phase|Withdrawal by Subject|0|||
37828446|NCT04076059|69511619|FG000|Double Blind Phase|Death|1|||
37828447|NCT04076059|69511620|FG001|Double Blind Phase|Death|1|||
37828448|NCT04076059|69511621|FG002|Double Blind Phase|Death|0|||
37828449|NCT04076059|69511619|FG000|Double Blind Phase|Lost to Follow-up|1|||
37828450|NCT04076059|69511620|FG001|Double Blind Phase|Lost to Follow-up|0|||
37828451|NCT04076059|69511621|FG002|Double Blind Phase|Lost to Follow-up|0|||
37828452|NCT04076059|69511619|FG000|Double Blind Phase|Adverse Event|5|||
37828453|NCT04076059|69511620|FG001|Double Blind Phase|Adverse Event|1|||
37828454|NCT04076059|69511621|FG002|Double Blind Phase|Adverse Event|0|||
37828455|NCT04076059|69511619|FG000|Double Blind Phase|Ongoing Participants|82|||
37828456|NCT04076059|69511620|FG001|Double Blind Phase|Ongoing Participants|18|||
37828457|NCT04076059|69511621|FG002|Double Blind Phase|Ongoing Participants|0|||
37828458|NCT04076059|69511619|FG000|Double Blind Phase|Miscellaneous|3|||
37828459|NCT04076059|69511620|FG001|Double Blind Phase|Miscellaneous|1|||
37828460|NCT04076059|69511621|FG002|Double Blind Phase|Miscellaneous|0|||
37828461|NCT04076059|69511619|FG000|Double Blind Phase|Protocol Deviation|1|||
37828462|NCT04076059|69511620|FG001|Double Blind Phase|Protocol Deviation|1|||
37828463|NCT04076059|69511621|FG002|Double Blind Phase|Protocol Deviation|0|||
37828464|NCT04076059|69511619|FG000|Double Blind Phase|Did not take study drug|1|||
37828465|NCT04076059|69511620|FG001|Double Blind Phase|Did not take study drug|1|||
37828466|NCT04076059|69511621|FG002|Double Blind Phase|Did not take study drug|0|||
37828467|NCT04076059|69511619|FG000|Open Label Phase|Progressive disease|0|||
37828468|NCT04076059|69511620|FG001|Open Label Phase|Progressive disease|0|||
37828469|NCT04076059|69511621|FG002|Open Label Phase|Progressive disease|7|||
37828470|NCT04076059|69511619|FG000|Open Label Phase|Withdrawal by Subject|0|||
37828471|NCT04076059|69511620|FG001|Open Label Phase|Withdrawal by Subject|0|||
37828472|NCT04076059|69511621|FG002|Open Label Phase|Withdrawal by Subject|3|||
37828473|NCT04076059|69511619|FG000|Open Label Phase|Death|0|||
37828474|NCT04076059|69511620|FG001|Open Label Phase|Death|0|||
37828475|NCT04076059|69511621|FG002|Open Label Phase|Death|2|||
37828476|NCT04076059|69511619|FG000|Open Label Phase|Ongoing Participants|0|||
37828477|NCT04076059|69511620|FG001|Open Label Phase|Ongoing Participants|0|||
37828478|NCT04076059|69511621|FG002|Open Label Phase|Ongoing Participants|11|||
37828479|NCT04030143|69511630|FG000|Overall Study|Adverse Event|5|||
37828480|NCT04030143|69511631|FG001|Overall Study|Adverse Event|10|||
37828481|NCT04030143|69511630|FG000|Overall Study|Lost to Follow-up|3|||
37828482|NCT04030143|69511631|FG001|Overall Study|Lost to Follow-up|7|||
37828483|NCT04030143|69511630|FG000|Overall Study|Protocol Deviation|2|||
37828484|NCT04030143|69511631|FG001|Overall Study|Protocol Deviation|2|||
37828485|NCT04030143|69511630|FG000|Overall Study|Withdrawal by Subject|16|||
37828486|NCT04030143|69511631|FG001|Overall Study|Withdrawal by Subject|18|||
37828487|NCT04030143|69511630|FG000|Overall Study|Physician Decision|1|||
37828488|NCT04030143|69511631|FG001|Overall Study|Physician Decision|1|||
37828489|NCT04030143|69511630|FG000|Overall Study|Due to Covid-19|2|||
37828490|NCT04030143|69511631|FG001|Overall Study|Due to Covid-19|3|||
37828491|NCT04030143|69511630|FG000|Overall Study|Not Due to Covid-19|1|||
37828492|NCT04030143|69511631|FG001|Overall Study|Not Due to Covid-19|1|||
37828493|NCT03934931|69511646|FG000|Overall Study|Excluded as a duplicate enrollment|1|||
37828494|NCT03934931|69511647|FG001|Overall Study|Excluded as a duplicate enrollment|0|||
37828495|NCT03934931|69511648|FG002|Overall Study|Excluded as a duplicate enrollment|0|||
37828496|NCT03927144|69511658|FG000|Core Phase|Adverse Event|9|||
37903184|NCT00996281|69588899|FG001|Overall Study|Withdrawal by Subject|20|||
37903185|NCT00996281|69588898|FG000|Overall Study|Lack of Efficacy|0|||
37903186|NCT00996281|69588899|FG001|Overall Study|Lack of Efficacy|2|||
37903187|NCT00996281|69588898|FG000|Overall Study|Other|5|||
37903188|NCT00996281|69588899|FG001|Overall Study|Other|7|||
37999313|NCT00006604|69683373|FG010|Overall Study|Site closing|0|||
37999314|NCT00006604|69683374|FG011|Overall Study|Site closing|1|||
37828497|NCT03927144|69511659|FG001|Core Phase|Adverse Event|5|||
37828498|NCT03927144|69511658|FG000|Core Phase|Lost to Follow-up|3|||
37828499|NCT03927144|69511659|FG001|Core Phase|Lost to Follow-up|2|||
37828500|NCT03927144|69511658|FG000|Core Phase|New Therapy for Study Indication|0|||
37828501|NCT03927144|69511659|FG001|Core Phase|New Therapy for Study Indication|1|||
37903189|NCT00996203|69588905|FG000|Overall Study|Adverse Event|3|||
37903190|NCT00996203|69588905|FG000|Overall Study|Lost to Follow-up|1|||
37903191|NCT00996203|69588905|FG000|Overall Study|Lack of Efficacy|1|||
37828502|NCT03927144|69511658|FG000|Core Phase|No Longer Clinically Benefiting|4|||
37828503|NCT03927144|69511659|FG001|Core Phase|No Longer Clinically Benefiting|4|||
37828504|NCT03927144|69511658|FG000|Core Phase|Physician Decision|2|||
37828505|NCT03927144|69511659|FG001|Core Phase|Physician Decision|8|||
37828506|NCT03927144|69511658|FG000|Core Phase|Protocol Violation|2|||
37828507|NCT03927144|69511659|FG001|Core Phase|Protocol Violation|2|||
37828508|NCT03927144|69511658|FG000|Core Phase|Withdrawal by Subject|16|||
37828509|NCT03927144|69511659|FG001|Core Phase|Withdrawal by Subject|40|||
37828510|NCT03927144|69511658|FG000|Extension Phase|Adverse Event|2|||
37828511|NCT03927144|69511659|FG001|Extension Phase|Adverse Event|1|||
37828512|NCT03927144|69511658|FG000|Extension Phase|No longer clinically benefiting|4|||
37828513|NCT03927144|69511659|FG001|Extension Phase|No longer clinically benefiting|5|||
37828514|NCT03927144|69511658|FG000|Extension Phase|Pregnancy|1|||
37828515|NCT03927144|69511659|FG001|Extension Phase|Pregnancy|0|||
37828516|NCT03927144|69511658|FG000|Extension Phase|Protocol Violation|0|||
37828517|NCT03927144|69511659|FG001|Extension Phase|Protocol Violation|1|||
37828518|NCT03927144|69511658|FG000|Extension Phase|Withdrawal by Subject|8|||
37828519|NCT03927144|69511659|FG001|Extension Phase|Withdrawal by Subject|3|||
37828520|NCT03859973|69511669|FG000|Overall Study|Other reason than listed|3|||
37828521|NCT03859973|69511670|FG001|Overall Study|Other reason than listed|2|||
37828522|NCT03859973|69511669|FG000|Overall Study|COVID-19 related, not due to AE|3|||
37828523|NCT03859973|69511670|FG001|Overall Study|COVID-19 related, not due to AE|4|||
37828524|NCT03859973|69511669|FG000|Overall Study|Withdrawal by Subject|8|||
37828525|NCT03859973|69511670|FG001|Overall Study|Withdrawal by Subject|9|||
37828526|NCT03859973|69511669|FG000|Overall Study|Lost to Follow-up|2|||
37828527|NCT03859973|69511670|FG001|Overall Study|Lost to Follow-up|3|||
37828528|NCT03859973|69511669|FG000|Overall Study|Protocol Violation|1|||
37828529|NCT03859973|69511670|FG001|Overall Study|Protocol Violation|3|||
37828530|NCT03859973|69511669|FG000|Overall Study|Adverse Event|3|||
37828531|NCT03859973|69511670|FG001|Overall Study|Adverse Event|5|||
37828532|NCT03761394|69511680|FG000|14-day Intervention & Control Period|Lost to Follow-up|0|||
37828533|NCT03761394|69511681|FG001|14-day Intervention & Control Period|Lost to Follow-up|1|||
37828534|NCT03761394|69511682|FG002|14-day Intervention & Control Period|Lost to Follow-up|0|||
37828535|NCT03761394|69511683|FG003|14-day Intervention & Control Period|Lost to Follow-up|0|||
37828536|NCT03761394|69511680|FG000|14-day Intervention & Control Period|Withdrawal by Subject|3|||
37828537|NCT03761394|69511681|FG001|14-day Intervention & Control Period|Withdrawal by Subject|1|||
37999315|NCT00006604|69683375|FG012|Overall Study|Site closing|1|||
37999316|NCT00006604|69683376|FG013|Overall Study|Site closing|1|||
37999317|NCT00006604|69683377|FG014|Overall Study|Site closing|0|||
37828538|NCT03761394|69511682|FG002|14-day Intervention & Control Period|Withdrawal by Subject|0|||
37828539|NCT03761394|69511683|FG003|14-day Intervention & Control Period|Withdrawal by Subject|0|||
37828540|NCT03761394|69511680|FG000|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
37828541|NCT03761394|69511681|FG001|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
37999318|NCT00006604|69683378|FG015|Overall Study|Site closing|0|||
37828542|NCT03761394|69511682|FG002|30-day Period (Extension 44 Days)|Lost to Follow-up|2|||
37999319|NCT00006604|69683379|FG016|Overall Study|Site closing|1|||
37999320|NCT00006604|69683363|FG000|Overall Study|Withdrawal by Subject|1|||
37999321|NCT00006604|69683364|FG001|Overall Study|Withdrawal by Subject|0|||
37999322|NCT00006604|69683365|FG002|Overall Study|Withdrawal by Subject|2|||
37999323|NCT00006604|69683366|FG003|Overall Study|Withdrawal by Subject|0|||
37999324|NCT00006604|69683367|FG004|Overall Study|Withdrawal by Subject|1|||
37999325|NCT00006604|69683368|FG005|Overall Study|Withdrawal by Subject|2|||
37999326|NCT00006604|69683369|FG006|Overall Study|Withdrawal by Subject|2|||
37999327|NCT00006604|69683370|FG007|Overall Study|Withdrawal by Subject|0|||
37828543|NCT03761394|69511683|FG003|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
37828544|NCT03761394|69511680|FG000|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
37828545|NCT03761394|69511681|FG001|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
37828546|NCT03761394|69511682|FG002|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
37828547|NCT03761394|69511683|FG003|30-day Period (Extension 44 Days)|Withdrawal by Subject|3|||
37828548|NCT03699020|69511695|FG000|Overall Study|Withdrawal by Subject|3|||
37828549|NCT03699020|69511696|FG001|Overall Study|Withdrawal by Subject|2|||
37828550|NCT03661723|69511734|FG000|Overall Study|Disease Progression|4|||
37828551|NCT03661723|69511735|FG001|Overall Study|Disease Progression|24|||
37697109|NCT02031471|69173575|FG000|24 Week Treatment Period|Protocol Violation|1|||
37828552|NCT03661723|69511736|FG002|Overall Study|Disease Progression|4|||
37828553|NCT03661723|69511737|FG003|Overall Study|Disease Progression|19|||
37828554|NCT03661723|69511734|FG000|Overall Study|Withdrawal by Subject|1|||
37828555|NCT03661723|69511735|FG001|Overall Study|Withdrawal by Subject|0|||
37828556|NCT03661723|69511736|FG002|Overall Study|Withdrawal by Subject|2|||
37828557|NCT03661723|69511737|FG003|Overall Study|Withdrawal by Subject|4|||
37828558|NCT03661723|69511734|FG000|Overall Study|Physician Decision|1|||
37828559|NCT03661723|69511735|FG001|Overall Study|Physician Decision|0|||
37828560|NCT03661723|69511736|FG002|Overall Study|Physician Decision|0|||
37828561|NCT03661723|69511737|FG003|Overall Study|Physician Decision|0|||
37828562|NCT03661723|69511734|FG000|Overall Study|Clinical Deterioration|0|||
37828563|NCT03661723|69511735|FG001|Overall Study|Clinical Deterioration|0|||
37828564|NCT03661723|69511736|FG002|Overall Study|Clinical Deterioration|0|||
37828565|NCT03661723|69511737|FG003|Overall Study|Clinical Deterioration|1|||
37828566|NCT03414983|69511758|FG000|Pre-Treatment|Other reasons|1|||
37828567|NCT03414983|69511759|FG001|Pre-Treatment|Other reasons|0|||
37828568|NCT03414983|69511758|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
37828569|NCT03414983|69511759|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
37828570|NCT03414983|69511758|FG000|Pre-Treatment|Participant withdrew consent|1|||
37828571|NCT03414983|69511759|FG001|Pre-Treatment|Participant withdrew consent|3|||
37828572|NCT03414983|69511758|FG000|Treatment|Participant withdrew consent|4|||
37828573|NCT03414983|69511759|FG001|Treatment|Participant withdrew consent|3|||
37828574|NCT03414983|69511758|FG000|Treatment|Participant request to discontinue study treatment|8|||
37828575|NCT03414983|69511759|FG001|Treatment|Participant request to discontinue study treatment|10|||
37828576|NCT03414983|69511758|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
37828577|NCT03414983|69511759|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
37828578|NCT03414983|69511758|FG000|Treatment|Death|0|||
37828579|NCT03414983|69511759|FG001|Treatment|Death|1|||
37828580|NCT03414983|69511758|FG000|Treatment|Study Drug Toxicity|10|||
37828581|NCT03414983|69511759|FG001|Treatment|Study Drug Toxicity|5|||
37828582|NCT03414983|69511758|FG000|Treatment|Disease Progression|75|||
37828583|NCT03414983|69511759|FG001|Treatment|Disease Progression|29|||
37828584|NCT03414983|69511758|FG000|Treatment|Not reported|1|||
37828585|NCT03414983|69511759|FG001|Treatment|Not reported|0|||
37828586|NCT03414983|69511758|FG000|Treatment|Other reasons|3|||
37828587|NCT03414983|69511759|FG001|Treatment|Other reasons|2|||
37828588|NCT03414983|69511758|FG000|Treatment|Poor/non-compliance|2|||
37828589|NCT03414983|69511759|FG001|Treatment|Poor/non-compliance|0|||
37828590|NCT03414983|69511758|FG000|Treatment|Maximum clinical benefit|5|||
37828591|NCT03414983|69511759|FG001|Treatment|Maximum clinical benefit|9|||
37828592|NCT03414983|69511758|FG000|Treatment|Lost to Follow-up|0|||
37828593|NCT03414983|69511759|FG001|Treatment|Lost to Follow-up|1|||
37999328|NCT00006604|69683371|FG008|Overall Study|Withdrawal by Subject|1|||
37999329|NCT00006604|69683372|FG009|Overall Study|Withdrawal by Subject|3|||
37999330|NCT00006604|69683373|FG010|Overall Study|Withdrawal by Subject|2|||
37999331|NCT00006604|69683374|FG011|Overall Study|Withdrawal by Subject|0|||
37999332|NCT00006604|69683375|FG012|Overall Study|Withdrawal by Subject|1|||
37999333|NCT00006604|69683376|FG013|Overall Study|Withdrawal by Subject|2|||
37999334|NCT00006604|69683377|FG014|Overall Study|Withdrawal by Subject|1|||
37999335|NCT00006604|69683378|FG015|Overall Study|Withdrawal by Subject|0|||
37999336|NCT00006604|69683379|FG016|Overall Study|Withdrawal by Subject|1|||
37999337|NCT00006604|69683363|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
37999338|NCT00006604|69683364|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
37999339|NCT00006604|69683365|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
37999340|NCT00006604|69683366|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
37999341|NCT00006604|69683367|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
37999342|NCT00006604|69683368|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
37999343|NCT00006604|69683369|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
37999344|NCT00006604|69683370|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
37828594|NCT03414983|69511758|FG000|Treatment|Administrative reasons by sponsor|1|||
37828595|NCT03414983|69511759|FG001|Treatment|Administrative reasons by sponsor|0|||
37828596|NCT02986659|69511793|FG000|First Intervention Period|Adverse Event|3|||
37828597|NCT02986659|69511794|FG001|First Intervention Period|Adverse Event|1|||
37828598|NCT02986659|69511793|FG000|First Intervention Period|Lost to Follow-up|1|||
37828599|NCT02986659|69511794|FG001|First Intervention Period|Lost to Follow-up|0|||
37828600|NCT02986659|69511793|FG000|First Intervention Period|Withdrawal by Subject|0|||
37828601|NCT02986659|69511794|FG001|First Intervention Period|Withdrawal by Subject|1|||
37828602|NCT02986659|69511793|FG000|Second Intervention Period|Adverse Event|0|||
37828603|NCT02986659|69511794|FG001|Second Intervention Period|Adverse Event|6|||
37828604|NCT02933489|69511802|FG000|Overall Study|Ineligible|3|||
37999345|NCT00006604|69683371|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
37999346|NCT00006604|69683372|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
37828605|NCT02933489|69511803|FG001|Overall Study|Ineligible|3|||
37828606|NCT02933489|69511802|FG000|Overall Study|Withdrawal by Subject|27|||
37828607|NCT02933489|69511803|FG001|Overall Study|Withdrawal by Subject|18|||
37828608|NCT02933489|69511802|FG000|Overall Study|Unable to complete exams (other)|14|||
37828609|NCT02933489|69511803|FG001|Overall Study|Unable to complete exams (other)|7|||
37828610|NCT02743806|69511821|FG000|Overall Study|Adverse Event|9|||
37828611|NCT02743806|69511821|FG000|Overall Study|Lost to Follow-up|8|||
37828612|NCT02743806|69511821|FG000|Overall Study|Voluntary Withdrawal|54|||
37828613|NCT02743806|69511821|FG000|Overall Study|Study Termination|65|||
37828614|NCT02743806|69511821|FG000|Overall Study|Pregnancy|6|||
37999347|NCT00006604|69683373|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
37999348|NCT00006604|69683374|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
37828615|NCT02743806|69511821|FG000|Overall Study|No Longer Clinically Benefiting|27|||
37999349|NCT00006604|69683375|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
37999350|NCT00006604|69683376|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
37999351|NCT00006604|69683377|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
37999352|NCT00006604|69683378|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
37999353|NCT00006604|69683379|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
37999354|NCT00006604|69683363|FG000|Overall Study|Lost to Follow-up|0|||
37999355|NCT00006604|69683364|FG001|Overall Study|Lost to Follow-up|0|||
37999356|NCT00006604|69683365|FG002|Overall Study|Lost to Follow-up|0|||
37999357|NCT00006604|69683366|FG003|Overall Study|Lost to Follow-up|0|||
37999358|NCT00006604|69683367|FG004|Overall Study|Lost to Follow-up|0|||
37999359|NCT00006604|69683368|FG005|Overall Study|Lost to Follow-up|0|||
37999360|NCT00006604|69683369|FG006|Overall Study|Lost to Follow-up|0|||
37999361|NCT00006604|69683370|FG007|Overall Study|Lost to Follow-up|1|||
37999362|NCT00006604|69683371|FG008|Overall Study|Lost to Follow-up|0|||
37999363|NCT00006604|69683372|FG009|Overall Study|Lost to Follow-up|2|||
37999364|NCT00006604|69683373|FG010|Overall Study|Lost to Follow-up|0|||
37999365|NCT00006604|69683374|FG011|Overall Study|Lost to Follow-up|0|||
37999366|NCT00006604|69683375|FG012|Overall Study|Lost to Follow-up|0|||
37999367|NCT00006604|69683376|FG013|Overall Study|Lost to Follow-up|0|||
37999368|NCT00006604|69683377|FG014|Overall Study|Lost to Follow-up|0|||
37999369|NCT00006604|69683378|FG015|Overall Study|Lost to Follow-up|1|||
37999370|NCT00006604|69683379|FG016|Overall Study|Lost to Follow-up|3|||
37999371|NCT00006604|69683363|FG000|Overall Study|Other Reason|0|||
37999372|NCT00006604|69683364|FG001|Overall Study|Other Reason|0|||
37999373|NCT00006604|69683365|FG002|Overall Study|Other Reason|0|||
37999374|NCT00006604|69683366|FG003|Overall Study|Other Reason|0|||
37999375|NCT00006604|69683367|FG004|Overall Study|Other Reason|0|||
37999376|NCT00006604|69683368|FG005|Overall Study|Other Reason|1|||
37999377|NCT00006604|69683369|FG006|Overall Study|Other Reason|0|||
37999378|NCT00006604|69683370|FG007|Overall Study|Other Reason|0|||
37999379|NCT00006604|69683371|FG008|Overall Study|Other Reason|0|||
37999380|NCT00006604|69683372|FG009|Overall Study|Other Reason|1|||
37999381|NCT00006604|69683373|FG010|Overall Study|Other Reason|0|||
37999382|NCT00006604|69683374|FG011|Overall Study|Other Reason|0|||
37999383|NCT00006604|69683375|FG012|Overall Study|Other Reason|0|||
37999384|NCT00006604|69683376|FG013|Overall Study|Other Reason|0|||
37999385|NCT00006604|69683377|FG014|Overall Study|Other Reason|0|||
37999386|NCT00006604|69683378|FG015|Overall Study|Other Reason|0|||
37999387|NCT00006604|69683379|FG016|Overall Study|Other Reason|0|||
37999388|NCT00436007|69683405|FG000|Overall Study|Withdrawal by Subject|5|||
37999389|NCT00436007|69683406|FG001|Overall Study|Withdrawal by Subject|3|||
37999390|NCT00436007|69683407|FG002|Overall Study|Withdrawal by Subject|4|||
37999391|NCT00436007|69683405|FG000|Overall Study|Lost to Follow-up|14|||
37828616|NCT02743806|69511821|FG000|Overall Study|Reason Not Specified|12|||
37828617|NCT02677896|69511827|FG000|Double Blind Period (up to 35 Months)|Death|113|||
37828618|NCT02677896|69511828|FG001|Double Blind Period (up to 35 Months)|Death|189|||
37828619|NCT02677896|69511827|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
37828620|NCT02677896|69511828|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
37828621|NCT02677896|69511827|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
37828622|NCT02677896|69511828|FG001|Double Blind Period (up to 35 Months)|Progressive disease|4|||
37828623|NCT02677896|69511827|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
37828624|NCT02677896|69511828|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|69|||
37828625|NCT02677896|69511827|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|9|||
37828626|NCT02677896|69511828|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|14|||
37828627|NCT02677896|69511827|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|365|||
37828628|NCT02677896|69511828|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|180|||
37828629|NCT02677896|69511827|FG000|Double Blind Period (up to 35 Months)|Followed-up for OS|31|||
37828630|NCT02677896|69511828|FG001|Double Blind Period (up to 35 Months)|Followed-up for OS|108|||
37828631|NCT02677896|69511827|FG000|Open-Label Extension (up to 25 Months)|Death|40|||
37828632|NCT02677896|69511828|FG001|Open-Label Extension (up to 25 Months)|Death|14|||
37828633|NCT02677896|69511827|FG000|Open-Label Extension (up to 25 Months)|Lost to Follow-up|2|||
37828634|NCT02677896|69511828|FG001|Open-Label Extension (up to 25 Months)|Lost to Follow-up|1|||
37828635|NCT02677896|69511827|FG000|Open-Label Extension (up to 25 Months)|Progressive disease|3|||
37828636|NCT02677896|69511828|FG001|Open-Label Extension (up to 25 Months)|Progressive disease|1|||
37903192|NCT00996203|69588905|FG000|Overall Study|Protocol Violation|2|||
37999392|NCT00436007|69683406|FG001|Overall Study|Lost to Follow-up|10|||
37999393|NCT00436007|69683407|FG002|Overall Study|Lost to Follow-up|13|||
37999394|NCT00436007|69683405|FG000|Overall Study|Physician Decision|0|||
37999395|NCT00436007|69683406|FG001|Overall Study|Physician Decision|0|||
37999396|NCT00436007|69683407|FG002|Overall Study|Physician Decision|2|||
37999397|NCT00436007|69683405|FG000|Overall Study|Death|0|||
37999398|NCT00436007|69683406|FG001|Overall Study|Death|1|||
37999399|NCT00436007|69683407|FG002|Overall Study|Death|3|||
37999400|NCT00436007|69683405|FG000|Overall Study|Other|0|||
37999401|NCT00436007|69683406|FG001|Overall Study|Other|0|||
37999402|NCT00436007|69683407|FG002|Overall Study|Other|1|||
37999403|NCT00435461|69683423|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
37999404|NCT00435461|69683424|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
37999405|NCT00435461|69683425|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
37999406|NCT00435461|69683423|FG000|Overall Study|Protocol Violation|6|||
37999407|NCT00435461|69683424|FG001|Overall Study|Protocol Violation|9|||
37999408|NCT00435461|69683425|FG002|Overall Study|Protocol Violation|10|||
37999409|NCT00435461|69683423|FG000|Overall Study|Participant randomized(inadequate score)|1|||
37999410|NCT00435461|69683424|FG001|Overall Study|Participant randomized(inadequate score)|0|||
37999411|NCT00435461|69683425|FG002|Overall Study|Participant randomized(inadequate score)|0|||
37999412|NCT00435461|69683423|FG000|Overall Study|Compliance less than 80 percent|1|||
37999413|NCT00435461|69683424|FG001|Overall Study|Compliance less than 80 percent|0|||
37999414|NCT00435461|69683425|FG002|Overall Study|Compliance less than 80 percent|0|||
37999415|NCT00435461|69683423|FG000|Overall Study|In error, two study medications switched|1|||
37999416|NCT00435461|69683424|FG001|Overall Study|In error, two study medications switched|0|||
37999417|NCT00435461|69683425|FG002|Overall Study|In error, two study medications switched|0|||
37999418|NCT00435461|69683423|FG000|Overall Study|Lack of Efficacy|2|||
37999419|NCT00435461|69683424|FG001|Overall Study|Lack of Efficacy|1|||
37999420|NCT00435461|69683425|FG002|Overall Study|Lack of Efficacy|0|||
37999421|NCT00435461|69683423|FG000|Overall Study|Withdrawal by Subject|1|||
37999422|NCT00435461|69683424|FG001|Overall Study|Withdrawal by Subject|0|||
37999423|NCT00435461|69683425|FG002|Overall Study|Withdrawal by Subject|2|||
37999424|NCT00435461|69683423|FG000|Overall Study|Randomized in error|1|||
37999425|NCT00435461|69683424|FG001|Overall Study|Randomized in error|0|||
37999426|NCT00435461|69683425|FG002|Overall Study|Randomized in error|0|||
37999427|NCT00435461|69683423|FG000|Overall Study|Participant could not tolerate symptoms|0|||
37999428|NCT00435461|69683424|FG001|Overall Study|Participant could not tolerate symptoms|0|||
37999429|NCT00435461|69683425|FG002|Overall Study|Participant could not tolerate symptoms|1|||
37999430|NCT00435461|69683423|FG000|Overall Study|Participant could not swallow capsule|0|||
37999431|NCT00435461|69683424|FG001|Overall Study|Participant could not swallow capsule|0|||
37999432|NCT00435461|69683425|FG002|Overall Study|Participant could not swallow capsule|1|||
37999433|NCT00435461|69683423|FG000|Overall Study|Pregnancy|2|||
37999434|NCT00435461|69683424|FG001|Overall Study|Pregnancy|0|||
37999435|NCT00435461|69683425|FG002|Overall Study|Pregnancy|0|||
37999436|NCT00435461|69683423|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
37999437|NCT00435461|69683424|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
37999438|NCT00435461|69683425|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
37999439|NCT00435461|69683423|FG000|Overall Study|Participant ended study one day early|1|||
37999440|NCT00435461|69683424|FG001|Overall Study|Participant ended study one day early|0|||
37999441|NCT00435461|69683425|FG002|Overall Study|Participant ended study one day early|0|||
37999442|NCT00435461|69683423|FG000|Overall Study|Noncompliance with study requirements|1|||
37999443|NCT00435461|69683424|FG001|Overall Study|Noncompliance with study requirements|1|||
37999444|NCT00435461|69683425|FG002|Overall Study|Noncompliance with study requirements|1|||
37999445|NCT00435461|69683423|FG000|Overall Study|Adverse Event|1|||
37828637|NCT02677896|69511827|FG000|Open-Label Extension (up to 25 Months)|Withdrawal by Subject|10|||
37828638|NCT02677896|69511828|FG001|Open-Label Extension (up to 25 Months)|Withdrawal by Subject|9|||
37828639|NCT02677896|69511827|FG000|Open-Label Extension (up to 25 Months)|Miscellaneous|0|||
37828640|NCT02677896|69511828|FG001|Open-Label Extension (up to 25 Months)|Miscellaneous|1|||
37828641|NCT02677896|69511827|FG000|Open-Label Extension (up to 25 Months)|OLE treatment ongoing|261|||
37828642|NCT02677896|69511828|FG001|Open-Label Extension (up to 25 Months)|OLE treatment ongoing|136|||
37828643|NCT02677896|69511827|FG000|Open-Label Extension (up to 25 Months)|Followed up for OS|49|||
37828644|NCT02677896|69511828|FG001|Open-Label Extension (up to 25 Months)|Followed up for OS|18|||
37828645|NCT02668653|69511837|FG000|Overall Study|Refractory disease|41|||
37828646|NCT02668653|69511838|FG001|Overall Study|Refractory disease|70|||
37828647|NCT02668653|69511837|FG000|Overall Study|Relapse|44|||
37999446|NCT00435461|69683424|FG001|Overall Study|Adverse Event|2|||
37999447|NCT00435461|69683425|FG002|Overall Study|Adverse Event|6|||
37999448|NCT00435461|69683423|FG000|Overall Study|Non-Compliance of diary|2|||
37999449|NCT00435461|69683424|FG001|Overall Study|Non-Compliance of diary|0|||
37999450|NCT00435461|69683425|FG002|Overall Study|Non-Compliance of diary|1|||
37999451|NCT00435461|69683423|FG000|Overall Study|Lost to Follow-up|1|||
37999452|NCT00435461|69683424|FG001|Overall Study|Lost to Follow-up|1|||
37999453|NCT00435461|69683425|FG002|Overall Study|Lost to Follow-up|2|||
37999454|NCT00434759|69683435|FG000|Overall Study|Lack of Efficacy|5|||
37999455|NCT00434759|69683436|FG001|Overall Study|Lack of Efficacy|4|||
37999456|NCT00434759|69683435|FG000|Overall Study|Withdrawal by Subject|17|||
37999457|NCT00434759|69683436|FG001|Overall Study|Withdrawal by Subject|1|||
37999458|NCT00434759|69683435|FG000|Overall Study|family affairs|2|||
37999459|NCT00434759|69683436|FG001|Overall Study|family affairs|0|||
37999460|NCT00440999|69683446|FG000|Overall Study|Adverse Event|0|||
37999461|NCT00440999|69683447|FG001|Overall Study|Adverse Event|2|||
37999462|NCT00440999|69683446|FG000|Overall Study|Lack of Efficacy|6|||
37999463|NCT00440999|69683447|FG001|Overall Study|Lack of Efficacy|7|||
37999464|NCT00440999|69683446|FG000|Overall Study|Lost to Follow-up|19|||
37999465|NCT00440999|69683447|FG001|Overall Study|Lost to Follow-up|12|||
37999466|NCT00440999|69683446|FG000|Overall Study|Protocol Violation|1|||
37828648|NCT02668653|69511838|FG001|Overall Study|Relapse|65|||
37999467|NCT00440999|69683447|FG001|Overall Study|Protocol Violation|0|||
37999468|NCT00440999|69683446|FG000|Overall Study|Withdrawal by Subject|2|||
37999469|NCT00440999|69683447|FG001|Overall Study|Withdrawal by Subject|5|||
37828649|NCT02668653|69511837|FG000|Overall Study|Adverse Event|58|||
37999470|NCT00440999|69683446|FG000|Overall Study|Subjets missed the visit|1|||
37999471|NCT00440999|69683447|FG001|Overall Study|Subjets missed the visit|0|||
37828650|NCT02668653|69511838|FG001|Overall Study|Adverse Event|23|||
37903193|NCT00877929|69588912|FG000|Overall Study|Adverse Event|11|||
37903194|NCT00877929|69588913|FG001|Overall Study|Adverse Event|20|||
37903195|NCT00877929|69588912|FG000|Overall Study|Protocol Violation|3|||
37903196|NCT00877929|69588913|FG001|Overall Study|Protocol Violation|3|||
37903197|NCT00877929|69588912|FG000|Overall Study|Lost to Follow-up|0|||
37903198|NCT00877929|69588913|FG001|Overall Study|Lost to Follow-up|1|||
37903199|NCT00877929|69588912|FG000|Overall Study|Withdrawal by Subject|4|||
37903200|NCT00877929|69588913|FG001|Overall Study|Withdrawal by Subject|4|||
37903201|NCT00877929|69588912|FG000|Overall Study|Lack of Efficacy|0|||
37903202|NCT00877929|69588913|FG001|Overall Study|Lack of Efficacy|1|||
37903203|NCT00877929|69588912|FG000|Overall Study|Other reason (not specified)|2|||
37903204|NCT00877929|69588913|FG001|Overall Study|Other reason (not specified)|6|||
37903205|NCT00931268|69588923|FG000|Overall Study|Lost to Follow-up|6|||
37903206|NCT00996125|69588929|FG000|Overall Study|Adverse Event|0|||
37903207|NCT00996125|69588930|FG001|Overall Study|Adverse Event|2|||
37903208|NCT00996125|69588929|FG000|Overall Study|Lost to Follow-up|1|||
37903209|NCT00996125|69588930|FG001|Overall Study|Lost to Follow-up|6|||
37903210|NCT00996125|69588929|FG000|Overall Study|Withdrawal by Subject|4|||
37903211|NCT00996125|69588930|FG001|Overall Study|Withdrawal by Subject|3|||
37903212|NCT04211363|69588938|FG000|Overall Study|Adverse Event|5|||
37903213|NCT04211363|69588939|FG001|Overall Study|Adverse Event|2|||
37903214|NCT04211363|69588938|FG000|Overall Study|Physician Decision|0|||
37903215|NCT04211363|69588939|FG001|Overall Study|Physician Decision|1|||
37903216|NCT04211363|69588938|FG000|Overall Study|Protocol Violation|1|||
37903217|NCT04211363|69588939|FG001|Overall Study|Protocol Violation|0|||
37903218|NCT04211363|69588938|FG000|Overall Study|Pregnancy|1|||
37903219|NCT04211363|69588939|FG001|Overall Study|Pregnancy|0|||
37903220|NCT04211363|69588938|FG000|Overall Study|Lost to Follow-up|12|||
37903221|NCT04211363|69588939|FG001|Overall Study|Lost to Follow-up|4|||
37903222|NCT04211363|69588938|FG000|Overall Study|Withdrawal by Subject|11|||
37903223|NCT04211363|69588939|FG001|Overall Study|Withdrawal by Subject|11|||
37903224|NCT04211363|69588938|FG000|Overall Study|Other|1|||
37903225|NCT04211363|69588939|FG001|Overall Study|Other|2|||
37903226|NCT00995345|69588950|FG000|Overall Study|Withdrawal by Subject|4|||
37903227|NCT00995345|69588951|FG001|Overall Study|Withdrawal by Subject|2|||
37903228|NCT00995345|69588952|FG002|Overall Study|Withdrawal by Subject|1|||
37999472|NCT00440999|69683446|FG000|Overall Study|Mixed infection at entry|1|||
37999473|NCT00440999|69683447|FG001|Overall Study|Mixed infection at entry|0|||
37999474|NCT00440999|69683446|FG000|Overall Study|P. falciparum malaria|5|||
37999475|NCT00440999|69683447|FG001|Overall Study|P. falciparum malaria|14|||
37999476|NCT00440999|69683446|FG000|Overall Study|Subj left hosp without inform staff|0|||
37999477|NCT00440999|69683447|FG001|Overall Study|Subj left hosp without inform staff|1|||
37999478|NCT00434213|69683455|FG000|Overall Study|Adverse Event|12|||
37999479|NCT00434213|69683455|FG000|Overall Study|Lack of Efficacy|9|||
37999480|NCT00434213|69683455|FG000|Overall Study|Lost to Follow-up|14|||
37999481|NCT00434213|69683455|FG000|Overall Study|Withdrawal by Subject|7|||
37697110|NCT02031471|69173575|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
37697111|NCT02031471|69173575|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
37697112|NCT02031471|69173575|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
37697113|NCT02031471|69173575|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
37697114|NCT02461589|69173589|FG000|Overall Study|Withdrawal by Subject|5|||
37697115|NCT02461589|69173590|FG001|Overall Study|Withdrawal by Subject|1|||
37697116|NCT02461589|69173591|FG002|Overall Study|Withdrawal by Subject|3|||
37697117|NCT02461589|69173592|FG003|Overall Study|Withdrawal by Subject|2|||
37697118|NCT02461589|69173593|FG004|Overall Study|Withdrawal by Subject|1|||
37697119|NCT02461589|69173594|FG005|Overall Study|Withdrawal by Subject|2|||
37697120|NCT02461589|69173595|FG006|Overall Study|Withdrawal by Subject|1|||
37697121|NCT02461589|69173596|FG007|Overall Study|Withdrawal by Subject|3|||
37903229|NCT00995345|69588953|FG003|Overall Study|Withdrawal by Subject|3|||
37903230|NCT00995345|69588954|FG004|Overall Study|Withdrawal by Subject|1|||
37903231|NCT00995345|69588950|FG000|Overall Study|Adverse Event|3|||
37903232|NCT00995345|69588951|FG001|Overall Study|Adverse Event|1|||
37903233|NCT00995345|69588952|FG002|Overall Study|Adverse Event|2|||
37903234|NCT00995345|69588953|FG003|Overall Study|Adverse Event|0|||
37903235|NCT00995345|69588954|FG004|Overall Study|Adverse Event|1|||
37903236|NCT00995345|69588950|FG000|Overall Study|Lost to Follow-up|2|||
37903237|NCT00995345|69588951|FG001|Overall Study|Lost to Follow-up|2|||
37903238|NCT00995345|69588952|FG002|Overall Study|Lost to Follow-up|2|||
37903239|NCT00995345|69588953|FG003|Overall Study|Lost to Follow-up|1|||
37903240|NCT00995345|69588954|FG004|Overall Study|Lost to Follow-up|0|||
37999482|NCT00434213|69683455|FG000|Overall Study|Protocol Violation|3|||
37999483|NCT00434213|69683455|FG000|Overall Study|Unable to comply with study visit window|2|||
37999484|NCT00434213|69683455|FG000|Overall Study|Application site reaction|1|||
37999485|NCT00434213|69683455|FG000|Overall Study|Non-compliant to study schedule|1|||
37999486|NCT00006184|69683461|FG000|Overall Study|Death|1|||
37999487|NCT00006184|69683462|FG001|Overall Study|Death|0|||
37903241|NCT00995345|69588950|FG000|Overall Study|all other reasons combined|2|||
37903242|NCT00995345|69588951|FG001|Overall Study|all other reasons combined|2|||
37903243|NCT00995345|69588952|FG002|Overall Study|all other reasons combined|2|||
37903244|NCT00995345|69588953|FG003|Overall Study|all other reasons combined|1|||
37903245|NCT00995345|69588954|FG004|Overall Study|all other reasons combined|3|||
37903246|NCT00660907|69588968|FG000|Overall Study|Incorrect Enrollment|1|||
37903247|NCT00660907|69588969|FG001|Overall Study|Incorrect Enrollment|1|||
37999488|NCT00434057|69683468|FG000|Overall Study|Withdrawal by Subject|1|||
37999489|NCT00433199|69683474|FG000|Double-Blind Period|Adverse Event|0|||
37999490|NCT00433199|69683475|FG001|Double-Blind Period|Adverse Event|25|||
37999491|NCT00433199|69683474|FG000|Double-Blind Period|Lack of Efficacy|0|||
37999492|NCT00433199|69683475|FG001|Double-Blind Period|Lack of Efficacy|2|||
37999493|NCT00433199|69683474|FG000|Double-Blind Period|Lost to Follow-up|2|||
37999494|NCT00433199|69683475|FG001|Double-Blind Period|Lost to Follow-up|5|||
37999495|NCT00433199|69683474|FG000|Double-Blind Period|Withdrawal by Subject|8|||
37999496|NCT00433199|69683475|FG001|Double-Blind Period|Withdrawal by Subject|19|||
37999497|NCT00433199|69683474|FG000|Double-Blind Period|Protocol Violation|1|||
37999498|NCT00433199|69683475|FG001|Double-Blind Period|Protocol Violation|10|||
37999499|NCT00433199|69683474|FG000|Double-Blind Period|Administrative|1|||
37828651|NCT02668653|69511837|FG000|Overall Study|Subject decision to stop study drug|25|||
37903248|NCT00660907|69588968|FG000|Overall Study|Adverse Event|33|||
37903249|NCT00660907|69588969|FG001|Overall Study|Adverse Event|19|||
37903250|NCT00660907|69588968|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
37903251|NCT00660907|69588969|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
37903252|NCT00660907|69588968|FG000|Overall Study|Withdrawal by Subject|23|||
37903253|NCT00660907|69588969|FG001|Overall Study|Withdrawal by Subject|32|||
37903254|NCT00660907|69588968|FG000|Overall Study|Lost to Follow-up|3|||
37903255|NCT00660907|69588969|FG001|Overall Study|Lost to Follow-up|3|||
37903256|NCT00660907|69588968|FG000|Overall Study|Poor/Non-Compliance|5|||
37903257|NCT00660907|69588969|FG001|Overall Study|Poor/Non-Compliance|1|||
37903258|NCT00660907|69588968|FG000|Overall Study|Safety|1|||
37903259|NCT00660907|69588969|FG001|Overall Study|Safety|0|||
37903260|NCT00660907|69588968|FG000|Overall Study|Death|1|||
37903261|NCT00660907|69588969|FG001|Overall Study|Death|3|||
37903262|NCT00660907|69588968|FG000|Overall Study|Various|11|||
37903263|NCT00660907|69588969|FG001|Overall Study|Various|8|||
37903264|NCT00877773|69588975|FG000|Overall Study|Disease Progression|44|||
37903265|NCT00659815|69588981|FG000|Overall Study|Study related symptoms and complaints|2|||
37903266|NCT00659815|69588982|FG001|Overall Study|Study related symptoms and complaints|1|||
37903267|NCT00659815|69588981|FG000|Overall Study|Inability to maintain wearing schedule|1|||
37903268|NCT00659815|69588982|FG001|Overall Study|Inability to maintain wearing schedule|2|||
37903269|NCT00659815|69588981|FG000|Overall Study|Withdrawal by Subject|1|||
37903270|NCT00659815|69588982|FG001|Overall Study|Withdrawal by Subject|1|||
37903271|NCT00994643|69588988|FG000|Overall Study|Withdrawal by Subject|1|||
37903272|NCT00660829|69588994|FG000|Overall Study|Adverse Event|3|||
37903273|NCT00660829|69588995|FG001|Overall Study|Adverse Event|4|||
37903274|NCT00660829|69588994|FG000|Overall Study|Lack of Efficacy|2|||
37999500|NCT00433199|69683475|FG001|Double-Blind Period|Administrative|5|||
37999501|NCT00433199|69683474|FG000|Open-Label Period|Adverse Event|0|||
37999502|NCT00433199|69683475|FG001|Open-Label Period|Adverse Event|19|||
37999503|NCT00433199|69683474|FG000|Open-Label Period|Lack of Efficacy|0|||
37999504|NCT00433199|69683475|FG001|Open-Label Period|Lack of Efficacy|2|||
37999505|NCT00433199|69683474|FG000|Open-Label Period|Lost to Follow-up|0|||
37999506|NCT00433199|69683475|FG001|Open-Label Period|Lost to Follow-up|3|||
37999507|NCT00433199|69683474|FG000|Open-Label Period|Withdrawal by Subject|0|||
37999508|NCT00433199|69683475|FG001|Open-Label Period|Withdrawal by Subject|7|||
37999509|NCT00433199|69683474|FG000|Open-Label Period|Protocol Violation|0|||
37828652|NCT02668653|69511838|FG001|Overall Study|Subject decision to stop study drug|23|||
37828653|NCT02668653|69511837|FG000|Overall Study|Other reasons not specified|16|||
37828654|NCT02668653|69511838|FG001|Overall Study|Other reasons not specified|11|||
37828655|NCT02668653|69511837|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
37828656|NCT02668653|69511838|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
37828657|NCT02668653|69511837|FG000|Overall Study|Investigator decision|10|||
37828658|NCT02668653|69511838|FG001|Overall Study|Investigator decision|7|||
37828659|NCT02668653|69511837|FG000|Overall Study|Failure to meet continuation criteria|5|||
37828660|NCT02668653|69511838|FG001|Overall Study|Failure to meet continuation criteria|12|||
37828661|NCT02668653|69511837|FG000|Overall Study|Lost to Follow-up|1|||
37999510|NCT00433199|69683475|FG001|Open-Label Period|Protocol Violation|2|||
37903275|NCT00660829|69588995|FG001|Overall Study|Lack of Efficacy|3|||
37903276|NCT00660829|69588994|FG000|Overall Study|Non-Compliance|0|||
37903277|NCT00660829|69588995|FG001|Overall Study|Non-Compliance|4|||
37903278|NCT00660829|69588994|FG000|Overall Study|Withdrawal by Subject|1|||
37903279|NCT00660829|69588995|FG001|Overall Study|Withdrawal by Subject|2|||
37903280|NCT00660829|69588994|FG000|Overall Study|Lost to Follow-up|3|||
37903281|NCT00660829|69588995|FG001|Overall Study|Lost to Follow-up|2|||
37903282|NCT00660829|69588994|FG000|Overall Study|Other|9|||
37903283|NCT00660829|69588995|FG001|Overall Study|Other|4|||
37903284|NCT00877383|69589003|FG000|Overall Study|Adverse Event|13|||
37903285|NCT00877383|69589004|FG001|Overall Study|Adverse Event|14|||
37903286|NCT00877383|69589003|FG000|Overall Study|Lost to Follow-up|5|||
37903287|NCT00877383|69589004|FG001|Overall Study|Lost to Follow-up|3|||
37903288|NCT00877383|69589003|FG000|Overall Study|Subject withdrew consent|3|||
37903289|NCT00877383|69589004|FG001|Overall Study|Subject withdrew consent|12|||
37903290|NCT00877383|69589003|FG000|Overall Study|Subject no longer requires study drug|2|||
37903291|NCT00877383|69589004|FG001|Overall Study|Subject no longer requires study drug|0|||
37903292|NCT00877383|69589003|FG000|Overall Study|Administrative problems|2|||
37903293|NCT00877383|69589004|FG001|Overall Study|Administrative problems|0|||
37999511|NCT00433199|69683474|FG000|Open-Label Period|Administrative|0|||
37999512|NCT00433199|69683475|FG001|Open-Label Period|Administrative|1|||
37999513|NCT00005908|69683486|FG000|Overall Study|Withdrawal by Subject|1|||
37999514|NCT00005908|69683487|FG001|Overall Study|Withdrawal by Subject|0|||
37999515|NCT00432965|69683498|FG000|Overall Study|Lost to Follow-up|22|||
37999516|NCT00432965|69683499|FG001|Overall Study|Lost to Follow-up|19|||
37999517|NCT00432965|69683498|FG000|Overall Study|Withdrawal by Subject|13|||
37999518|NCT00432965|69683499|FG001|Overall Study|Withdrawal by Subject|13|||
37999519|NCT00432965|69683498|FG000|Overall Study|Physician Decision|14|||
37999520|NCT00432965|69683499|FG001|Overall Study|Physician Decision|13|||
37903294|NCT00877383|69589003|FG000|Overall Study|Protocol deviation|2|||
37903295|NCT00877383|69589004|FG001|Overall Study|Protocol deviation|6|||
37903296|NCT00877383|69589003|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
37903297|NCT00877383|69589004|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
37903298|NCT00877383|69589003|FG000|Overall Study|Death|1|||
37903299|NCT00877383|69589004|FG001|Overall Study|Death|2|||
37903300|NCT00993473|69589012|FG000|Overall Study|Adverse Event|0|||
37903301|NCT00993473|69589013|FG001|Overall Study|Adverse Event|2|||
37903302|NCT00993473|69589012|FG000|Overall Study|Protocol Violation|1|||
37903303|NCT00993473|69589013|FG001|Overall Study|Protocol Violation|2|||
37903304|NCT00993473|69589012|FG000|Overall Study|Lost to Follow-up|1|||
37903305|NCT00993473|69589013|FG001|Overall Study|Lost to Follow-up|0|||
37903306|NCT00993473|69589012|FG000|Overall Study|Withdrawal by Subject|1|||
37903307|NCT00993473|69589013|FG001|Overall Study|Withdrawal by Subject|5|||
37903308|NCT00993473|69589012|FG000|Overall Study|Technical problem with CGM device|0|||
37903309|NCT00993473|69589013|FG001|Overall Study|Technical problem with CGM device|1|||
37903310|NCT00993473|69589012|FG000|Overall Study|Family event|1|||
37999521|NCT00432965|69683498|FG000|Overall Study|Lack of Efficacy|8|||
37999522|NCT00432965|69683499|FG001|Overall Study|Lack of Efficacy|13|||
37999523|NCT00432965|69683498|FG000|Overall Study|Non-compliance|7|||
37999524|NCT00432965|69683499|FG001|Overall Study|Non-compliance|0|||
37999525|NCT00432965|69683498|FG000|Overall Study|Adverse Event|22|||
37999526|NCT00432965|69683499|FG001|Overall Study|Adverse Event|19|||
37999527|NCT00432965|69683498|FG000|Overall Study|Death|3|||
37999528|NCT00432965|69683499|FG001|Overall Study|Death|4|||
37999529|NCT00432965|69683498|FG000|Overall Study|Exclusionary Methods|1|||
37999530|NCT00432965|69683499|FG001|Overall Study|Exclusionary Methods|2|||
37999531|NCT00432965|69683498|FG000|Overall Study|Incomplete Data|4|||
37903311|NCT00993473|69589013|FG001|Overall Study|Family event|0|||
37903312|NCT00660595|69589021|FG000|Overall Study|Lost to Follow-up|0|||
37903313|NCT00660595|69589022|FG001|Overall Study|Lost to Follow-up|1|||
37903314|NCT00660595|69589021|FG000|Overall Study|Did not consent to participate in study|12|||
37903315|NCT00660595|69589022|FG001|Overall Study|Did not consent to participate in study|8|||
37903316|NCT00660595|69589021|FG000|Overall Study|Participant left hospital|1|||
37903317|NCT00660595|69589022|FG001|Overall Study|Participant left hospital|0|||
37999532|NCT00432965|69683499|FG001|Overall Study|Incomplete Data|3|||
37903318|NCT00660595|69589021|FG000|Overall Study|Non Specified reasons|5|||
37903319|NCT00660595|69589022|FG001|Overall Study|Non Specified reasons|0|||
37903320|NCT00929240|69589028|FG000|Initial Treatment Phase|Adverse Event|31|||
37828662|NCT02668653|69511838|FG001|Overall Study|Lost to Follow-up|0|||
37828663|NCT02668653|69511837|FG000|Overall Study|Pregnancy|0|||
37828664|NCT02668653|69511838|FG001|Overall Study|Pregnancy|1|||
37828665|NCT02668653|69511837|FG000|Overall Study|Death|0|||
37828666|NCT02668653|69511838|FG001|Overall Study|Death|1|||
37828667|NCT02649972|69511844|FG000|Overall Study|Not treated|1|||
37903321|NCT00929240|69589029|FG001|Initial Treatment Phase|Adverse Event|0|||
37903322|NCT00929240|69589030|FG002|Initial Treatment Phase|Adverse Event|0|||
37903323|NCT00929240|69589028|FG000|Initial Treatment Phase|Disease progression|41|||
37903324|NCT00929240|69589029|FG001|Initial Treatment Phase|Disease progression|0|||
37828668|NCT02437318|69511870|FG000|Overall Study|Progressive disease|173|||
37828669|NCT02437318|69511871|FG001|Overall Study|Progressive disease|208|||
37828670|NCT02437318|69511870|FG000|Overall Study|Subject/guardian decision|22|||
37828671|NCT02437318|69511871|FG001|Overall Study|Subject/guardian decision|10|||
37828672|NCT02437318|69511870|FG000|Overall Study|Physician Decision|11|||
37828673|NCT02437318|69511871|FG001|Overall Study|Physician Decision|10|||
37828674|NCT02437318|69511870|FG000|Overall Study|Adverse Event|14|||
37828675|NCT02437318|69511871|FG001|Overall Study|Adverse Event|3|||
37828676|NCT02437318|69511870|FG000|Overall Study|Death|4|||
37828677|NCT02437318|69511871|FG001|Overall Study|Death|4|||
37828678|NCT02437318|69511870|FG000|Overall Study|Protocol Violation|5|||
37828679|NCT02437318|69511871|FG001|Overall Study|Protocol Violation|6|||
37828680|NCT02437318|69511870|FG000|Overall Study|Untreated|0|||
37903325|NCT00929240|69589030|FG002|Initial Treatment Phase|Disease progression|0|||
37903326|NCT00929240|69589028|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
37903327|NCT00929240|69589029|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
37903328|NCT00929240|69589030|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
37903329|NCT00929240|69589028|FG000|Initial Treatment Phase|Protocol Violation|5|||
37828681|NCT02437318|69511871|FG001|Overall Study|Untreated|1|||
37828682|NCT02305238|69511880|FG000|Overall Study|Death|2|||
37903330|NCT00929240|69589029|FG001|Initial Treatment Phase|Protocol Violation|0|||
37903331|NCT00929240|69589030|FG002|Initial Treatment Phase|Protocol Violation|0|||
37903332|NCT00929240|69589028|FG000|Initial Treatment Phase|Death|2|||
37903333|NCT00929240|69589029|FG001|Initial Treatment Phase|Death|0|||
37903334|NCT00929240|69589030|FG002|Initial Treatment Phase|Death|0|||
37903335|NCT00929240|69589028|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
37903336|NCT00929240|69589029|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
37903337|NCT00929240|69589030|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
37903338|NCT00929240|69589028|FG000|Initial Treatment Phase|Physician Decision|4|||
37903339|NCT00929240|69589029|FG001|Initial Treatment Phase|Physician Decision|0|||
37903340|NCT00929240|69589030|FG002|Initial Treatment Phase|Physician Decision|0|||
37903341|NCT00929240|69589028|FG000|Maintenance Phase|Disease progression|0|||
37903342|NCT00929240|69589029|FG001|Maintenance Phase|Disease progression|73|||
37903343|NCT00929240|69589030|FG002|Maintenance Phase|Disease progression|60|||
37903344|NCT00929240|69589028|FG000|Maintenance Phase|Adverse Event|0|||
37903345|NCT00929240|69589029|FG001|Maintenance Phase|Adverse Event|9|||
37903346|NCT00929240|69589030|FG002|Maintenance Phase|Adverse Event|12|||
37999533|NCT00440297|69683507|FG000|Overall Study|Adverse Event|8|||
37999534|NCT00440297|69683508|FG001|Overall Study|Adverse Event|5|||
37999535|NCT00440297|69683507|FG000|Overall Study|Lost to Follow-up|1|||
37999536|NCT00440297|69683508|FG001|Overall Study|Lost to Follow-up|0|||
37999537|NCT00440297|69683507|FG000|Overall Study|Physician Decision|1|||
37999538|NCT00440297|69683508|FG001|Overall Study|Physician Decision|0|||
37828683|NCT02305238|69511881|FG001|Overall Study|Death|1|||
37828684|NCT02305238|69511882|FG002|Overall Study|Death|0|||
37828685|NCT02305238|69511880|FG000|Overall Study|Progressive disease|4|||
37828686|NCT02305238|69511881|FG001|Overall Study|Progressive disease|4|||
37828687|NCT02305238|69511882|FG002|Overall Study|Progressive disease|0|||
37828688|NCT02305238|69511880|FG000|Overall Study|Logistical difficulties|1|||
37828689|NCT02305238|69511881|FG001|Overall Study|Logistical difficulties|3|||
37828690|NCT02305238|69511882|FG002|Overall Study|Logistical difficulties|0|||
37828691|NCT02305238|69511880|FG000|Overall Study|Protocol Violation|0|||
37828692|NCT02305238|69511881|FG001|Overall Study|Protocol Violation|3|||
37828693|NCT02305238|69511882|FG002|Overall Study|Protocol Violation|0|||
37828694|NCT02305238|69511880|FG000|Overall Study|Physician Decision|2|||
37828695|NCT02305238|69511881|FG001|Overall Study|Physician Decision|1|||
37828696|NCT02305238|69511882|FG002|Overall Study|Physician Decision|0|||
37828697|NCT02305238|69511880|FG000|Overall Study|Adverse Event|4|||
37828698|NCT02305238|69511881|FG001|Overall Study|Adverse Event|2|||
37828699|NCT02305238|69511882|FG002|Overall Study|Adverse Event|0|||
37828700|NCT02305238|69511880|FG000|Overall Study|Withdrawal by Subject|3|||
37828701|NCT02305238|69511881|FG001|Overall Study|Withdrawal by Subject|4|||
37828702|NCT02305238|69511882|FG002|Overall Study|Withdrawal by Subject|0|||
37828703|NCT02305238|69511880|FG000|Overall Study|Randomized failure|0|||
37828704|NCT02305238|69511881|FG001|Overall Study|Randomized failure|0|||
37828705|NCT02305238|69511882|FG002|Overall Study|Randomized failure|8|||
37828706|NCT02305238|69511880|FG000|Overall Study|Required procedure failed|0|||
37828707|NCT02305238|69511881|FG001|Overall Study|Required procedure failed|1|||
37828708|NCT02305238|69511882|FG002|Overall Study|Required procedure failed|0|||
37828709|NCT02175004|69511891|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
37903347|NCT00929240|69589028|FG000|Maintenance Phase|Withdrawal by Subject|0|||
37903348|NCT00929240|69589029|FG001|Maintenance Phase|Withdrawal by Subject|2|||
37903349|NCT00929240|69589030|FG002|Maintenance Phase|Withdrawal by Subject|6|||
37903350|NCT00929240|69589028|FG000|Maintenance Phase|Protocol Violation|0|||
37903351|NCT00929240|69589029|FG001|Maintenance Phase|Protocol Violation|1|||
37903352|NCT00929240|69589030|FG002|Maintenance Phase|Protocol Violation|0|||
37903353|NCT00929240|69589028|FG000|Maintenance Phase|Health authority/Study termination|0|||
37903354|NCT00929240|69589029|FG001|Maintenance Phase|Health authority/Study termination|1|||
37903355|NCT00929240|69589030|FG002|Maintenance Phase|Health authority/Study termination|2|||
37903356|NCT00929240|69589028|FG000|Maintenance Phase|Physician Decision|0|||
37903357|NCT00929240|69589029|FG001|Maintenance Phase|Physician Decision|2|||
37903358|NCT00929240|69589030|FG002|Maintenance Phase|Physician Decision|1|||
37903359|NCT00929240|69589028|FG000|Maintenance Phase|Change of treatment|0|||
37903360|NCT00929240|69589029|FG001|Maintenance Phase|Change of treatment|4|||
37903361|NCT00929240|69589030|FG002|Maintenance Phase|Change of treatment|0|||
37903362|NCT00929240|69589028|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
37903363|NCT00929240|69589029|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
37903364|NCT00929240|69589030|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
37903365|NCT00929240|69589028|FG000|Maintenance Phase|Participant not treated|0|||
37903366|NCT00929240|69589029|FG001|Maintenance Phase|Participant not treated|2|||
37903367|NCT00929240|69589030|FG002|Maintenance Phase|Participant not treated|0|||
37903368|NCT00993317|69589041|FG000|Overall Study|Adverse Event|2|||
37903369|NCT00993317|69589042|FG001|Overall Study|Adverse Event|4|||
37903370|NCT00993317|69589041|FG000|Overall Study|Lack of Efficacy|18|||
37903371|NCT00993317|69589042|FG001|Overall Study|Lack of Efficacy|18|||
37903372|NCT00993317|69589041|FG000|Overall Study|Withdrawal by Subject|0|||
37999539|NCT00440297|69683507|FG000|Overall Study|Protocol Violation|11|||
37999540|NCT00440297|69683508|FG001|Overall Study|Protocol Violation|7|||
37999541|NCT00440297|69683507|FG000|Overall Study|Withdrawal by Subject|1|||
37999542|NCT00440297|69683508|FG001|Overall Study|Withdrawal by Subject|6|||
37999543|NCT00440297|69683507|FG000|Overall Study|Randomized by mistake|1|||
37999544|NCT00440297|69683508|FG001|Overall Study|Randomized by mistake|0|||
37828710|NCT02175004|69511892|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
37828711|NCT02175004|69511891|FG000|Overall Study|Investigator Judgment|1|||
37828712|NCT02175004|69511892|FG001|Overall Study|Investigator Judgment|4|||
37828713|NCT02175004|69511891|FG000|Overall Study|Voluntary Withdrawal|6|||
37828714|NCT02175004|69511892|FG001|Overall Study|Voluntary Withdrawal|19|||
37828715|NCT02175004|69511891|FG000|Overall Study|Liver Transplant|1|||
37828716|NCT02175004|69511892|FG001|Overall Study|Liver Transplant|0|||
37828717|NCT02175004|69511891|FG000|Overall Study|Disease Progression|1|||
37828718|NCT02175004|69511892|FG001|Overall Study|Disease Progression|0|||
37828719|NCT02175004|69511891|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
37828720|NCT02175004|69511892|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
37828721|NCT02075840|69511900|FG000|Overall Study|Withdrawal by Subject|13|||
37828722|NCT02075840|69511901|FG001|Overall Study|Withdrawal by Subject|22|||
37828723|NCT02075840|69511900|FG000|Overall Study|Reason not specified|1|||
37828724|NCT02075840|69511901|FG001|Overall Study|Reason not specified|0|||
37903373|NCT00993317|69589042|FG001|Overall Study|Withdrawal by Subject|2|||
37903374|NCT00993317|69589041|FG000|Overall Study|Investigator's opinion|0|||
37903375|NCT00993317|69589042|FG001|Overall Study|Investigator's opinion|1|||
37828725|NCT02075840|69511900|FG000|Overall Study|Adverse Event|0|||
37828726|NCT02075840|69511901|FG001|Overall Study|Adverse Event|2|||
37828727|NCT02075840|69511900|FG000|Overall Study|Death|35|||
37828728|NCT02075840|69511901|FG001|Overall Study|Death|40|||
37828729|NCT02075840|69511900|FG000|Overall Study|Lost to Follow-up|3|||
37828730|NCT02075840|69511901|FG001|Overall Study|Lost to Follow-up|2|||
37828731|NCT02075840|69511900|FG000|Overall Study|Physician Decision|1|||
37828732|NCT02075840|69511901|FG001|Overall Study|Physician Decision|3|||
37828733|NCT02075840|69511900|FG000|Overall Study|Ongoing at CCOD|99|||
37828734|NCT02075840|69511901|FG001|Overall Study|Ongoing at CCOD|82|||
37828735|NCT01059825|69511913|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
37828736|NCT01059825|69511914|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
37903376|NCT00993317|69589041|FG000|Overall Study|Early study termination at the site|1|||
37903377|NCT00993317|69589042|FG001|Overall Study|Early study termination at the site|0|||
37903378|NCT01030133|69589050|FG000|Overall Study|failed to experience pain at level 7/10|2|||
37903379|NCT01030133|69589051|FG001|Overall Study|failed to experience pain at level 7/10|2|||
37903380|NCT00877071|69589061|FG000|Overall Study|disease progression|2|||
37903381|NCT00987389|69589067|FG000|Overall Study|Ineligible|0|||
37903382|NCT00987389|69589068|FG001|Overall Study|Ineligible|3|||
37903383|NCT00987389|69589069|FG002|Overall Study|Ineligible|0|||
37903384|NCT00987389|69589070|FG003|Overall Study|Ineligible|0|||
37903385|NCT00987389|69589067|FG000|Overall Study|Lost to Follow-up|4|||
37903386|NCT00987389|69589068|FG001|Overall Study|Lost to Follow-up|1|||
37903387|NCT00987389|69589069|FG002|Overall Study|Lost to Follow-up|3|||
37903388|NCT00987389|69589070|FG003|Overall Study|Lost to Follow-up|1|||
37903389|NCT00987389|69589067|FG000|Overall Study|Withdrawal by Subject|4|||
37903390|NCT00987389|69589068|FG001|Overall Study|Withdrawal by Subject|3|||
37903391|NCT00987389|69589069|FG002|Overall Study|Withdrawal by Subject|2|||
37903392|NCT00987389|69589070|FG003|Overall Study|Withdrawal by Subject|1|||
37903393|NCT00987389|69589067|FG000|Overall Study|Withdrawn from Treatment|0|||
37903394|NCT00987389|69589068|FG001|Overall Study|Withdrawn from Treatment|1|||
37903395|NCT00987389|69589069|FG002|Overall Study|Withdrawn from Treatment|0|||
37903396|NCT00987389|69589070|FG003|Overall Study|Withdrawn from Treatment|0|||
37903397|NCT00987389|69589067|FG000|Overall Study|Multiple different reasons|1|||
37903398|NCT00987389|69589068|FG001|Overall Study|Multiple different reasons|0|||
37903399|NCT00987389|69589069|FG002|Overall Study|Multiple different reasons|3|||
37903400|NCT00987389|69589070|FG003|Overall Study|Multiple different reasons|1|||
37903401|NCT00929162|69589080|FG000|Overall Study|Adverse Event|8|||
37903402|NCT00929162|69589081|FG001|Overall Study|Adverse Event|5|||
37999545|NCT00432809|69683517|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
37828737|NCT01059825|69511915|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
37828738|NCT01059825|69511916|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
37828739|NCT01059825|69511917|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
37903403|NCT00929162|69589080|FG000|Overall Study|Withdrawal by Subject|3|||
37903404|NCT00929162|69589081|FG001|Overall Study|Withdrawal by Subject|1|||
37903405|NCT00929162|69589080|FG000|Overall Study|Protocol Violation|32|||
37903406|NCT00929162|69589081|FG001|Overall Study|Protocol Violation|30|||
37903407|NCT00929162|69589080|FG000|Overall Study|Other termination reason|5|||
37903408|NCT00929162|69589081|FG001|Overall Study|Other termination reason|6|||
37903409|NCT00992459|69589089|FG000|Overall Study|Withdrawal by Subject|0|||
37903410|NCT00992459|69589090|FG001|Overall Study|Withdrawal by Subject|1|||
37903411|NCT00992459|69589089|FG000|Overall Study|Adverse Event|1|||
37999546|NCT00432809|69683518|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
37999547|NCT00432809|69683519|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
37999548|NCT00432809|69683517|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
37999549|NCT00432809|69683518|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
37999550|NCT00432809|69683519|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
37999551|NCT00431951|69683531|FG000|Overall Study|Inability to follow study procedures|1|||
37999552|NCT00431951|69683532|FG001|Overall Study|Inability to follow study procedures|0|||
37999553|NCT00431951|69683533|FG002|Overall Study|Inability to follow study procedures|1|||
37999554|NCT00431951|69683534|FG003|Overall Study|Inability to follow study procedures|2|||
37999555|NCT00431951|69683531|FG000|Overall Study|Lost to Follow-up|0|||
37999556|NCT00431951|69683532|FG001|Overall Study|Lost to Follow-up|1|||
37999557|NCT00431951|69683533|FG002|Overall Study|Lost to Follow-up|0|||
37999558|NCT00431951|69683534|FG003|Overall Study|Lost to Follow-up|0|||
37999559|NCT00431951|69683531|FG000|Overall Study|Withdrawal by Subject|0|||
37999560|NCT00431951|69683532|FG001|Overall Study|Withdrawal by Subject|1|||
37999561|NCT00431951|69683533|FG002|Overall Study|Withdrawal by Subject|0|||
37999562|NCT00431951|69683534|FG003|Overall Study|Withdrawal by Subject|0|||
37999563|NCT00431951|69683531|FG000|Overall Study|Adverse Event|0|||
37999564|NCT00431951|69683532|FG001|Overall Study|Adverse Event|0|||
37999565|NCT00431951|69683533|FG002|Overall Study|Adverse Event|1|||
37999566|NCT00431951|69683534|FG003|Overall Study|Adverse Event|0|||
37999567|NCT00004978|69683550|FG000|Overall Study|Death|107|||
37999568|NCT00004978|69683551|FG001|Overall Study|Death|116|||
37999569|NCT00004978|69683550|FG000|Overall Study|Lost to Follow-up|101|||
37999570|NCT00004978|69683551|FG001|Overall Study|Lost to Follow-up|108|||
37999571|NCT00004978|69683550|FG000|Overall Study|Withdrawal by Subject|17|||
37999572|NCT00004978|69683551|FG001|Overall Study|Withdrawal by Subject|26|||
37999573|NCT00004978|69683550|FG000|Overall Study|site closure - not in analysis cohort|19|||
37903412|NCT00992459|69589090|FG001|Overall Study|Adverse Event|0|||
37903413|NCT00930722|69589096|FG000|Overall Study|Lost to Follow-up|16|||
37903414|NCT00930722|69589096|FG000|Overall Study|No longer willing to participate|9|||
37903415|NCT00930722|69589096|FG000|Overall Study|Study terminated by sponsor|2|||
37903416|NCT00992225|69589100|FG000|Overall Study|Entry Criteria Not Met|8|||
37903417|NCT00992225|69589100|FG000|Overall Study|Adverse Event|2|||
37903418|NCT00659581|69589104|FG000|Overall Study|Adverse Event|1006|||
37903419|NCT00659581|69589104|FG000|Overall Study|Lack of Efficacy|1183|||
37903420|NCT00659581|69589104|FG000|Overall Study|Other|6393|||
37903421|NCT00991289|69589108|FG000|Overall Study|Adverse Event|1|||
37903422|NCT00991289|69589108|FG000|Overall Study|Physician Decision|2|||
37903423|NCT00991289|69589108|FG000|Overall Study|Withdrawal by Subject|3|||
37999574|NCT00004978|69683551|FG001|Overall Study|site closure - not in analysis cohort|20|||
37999575|NCT00430937|69683559|FG000|Overall Study|Adverse Event|3|||
37999576|NCT00430937|69683560|FG001|Overall Study|Adverse Event|8|||
37999577|NCT00430937|69683559|FG000|Overall Study|Death|0|||
37999578|NCT00430937|69683560|FG001|Overall Study|Death|1|||
37999579|NCT00430937|69683559|FG000|Overall Study|Lost to Follow-up|6|||
37999580|NCT00430937|69683560|FG001|Overall Study|Lost to Follow-up|6|||
37999581|NCT00430937|69683559|FG000|Overall Study|Withdrawal by Subject|5|||
37999582|NCT00430937|69683560|FG001|Overall Study|Withdrawal by Subject|2|||
37999583|NCT00430937|69683559|FG000|Overall Study|Protocol Violation|3|||
37999584|NCT00430937|69683560|FG001|Overall Study|Protocol Violation|2|||
37999585|NCT00430937|69683559|FG000|Overall Study|Lack of Efficacy|6|||
37999586|NCT00430937|69683560|FG001|Overall Study|Lack of Efficacy|5|||
37999587|NCT00430937|69683559|FG000|Overall Study|Inappropriate enrollment|2|||
37999588|NCT00430937|69683560|FG001|Overall Study|Inappropriate enrollment|1|||
37999589|NCT00430937|69683559|FG000|Overall Study|Administrative reasons|1|||
37999590|NCT00430937|69683560|FG001|Overall Study|Administrative reasons|0|||
37999591|NCT00430937|69683559|FG000|Overall Study|Protocol discontinuation criteria met|1|||
37999592|NCT00430937|69683560|FG001|Overall Study|Protocol discontinuation criteria met|2|||
37999593|NCT00430937|69683559|FG000|Overall Study|Unable to classify|0|||
37999594|NCT00430937|69683560|FG001|Overall Study|Unable to classify|1|||
37999595|NCT00004888|69683568|FG000|Overall Study|Adverse Event|5|||
37999596|NCT00004888|69683569|FG001|Overall Study|Adverse Event|10|||
37999597|NCT00004888|69683568|FG000|Overall Study|Withdrawal by Subject|0|||
37999598|NCT00004888|69683569|FG001|Overall Study|Withdrawal by Subject|3|||
37999599|NCT00004888|69683568|FG000|Overall Study|Physician Decision|1|||
37903424|NCT00991289|69589108|FG000|Overall Study|Lost to Follow-up|4|||
37903425|NCT00991289|69589108|FG000|Overall Study|Protocol Violation|2|||
37903426|NCT00930644|69589112|FG000|Overall Study|Withdrawal by Subject|4|||
37999600|NCT00004888|69683569|FG001|Overall Study|Physician Decision|1|||
37999601|NCT00004888|69683568|FG000|Overall Study|Progressive Disease|4|||
37999602|NCT00004888|69683569|FG001|Overall Study|Progressive Disease|9|||
37999603|NCT00004888|69683568|FG000|Overall Study|Death without progressive disease|0|||
37999604|NCT00004888|69683569|FG001|Overall Study|Death without progressive disease|1|||
37999605|NCT00004888|69683568|FG000|Overall Study|Toxic death|1|||
37999606|NCT00004888|69683569|FG001|Overall Study|Toxic death|0|||
37903427|NCT00930644|69589112|FG000|Overall Study|Physician Decision|2|||
37999607|NCT00004732|69683577|FG000|Overall Study|Withdrawal by Subject|36|||
37999608|NCT00004732|69683578|FG001|Overall Study|Withdrawal by Subject|64|||
37999609|NCT00004732|69683577|FG000|Overall Study|Lost to Follow-up|33|||
37999610|NCT00004732|69683578|FG001|Overall Study|Lost to Follow-up|47|||
37999611|NCT00430781|69683589|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
37999612|NCT00430781|69683590|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
37903428|NCT00930644|69589112|FG000|Overall Study|Death|1|||
37903429|NCT00930644|69589112|FG000|Overall Study|Adverse Event|16|||
37903430|NCT00990821|69589133|FG000|Overall Study|Withdrawal by Subject|0|||
37903431|NCT00990821|69589134|FG001|Overall Study|Withdrawal by Subject|2|||
37903432|NCT00990821|69589135|FG002|Overall Study|Withdrawal by Subject|0|||
37697122|NCT02461589|69173597|FG008|Overall Study|Withdrawal by Subject|3|||
37903433|NCT00990821|69589136|FG003|Overall Study|Withdrawal by Subject|0|||
37903434|NCT00990821|69589137|FG004|Overall Study|Withdrawal by Subject|3|||
37903435|NCT00990821|69589138|FG005|Overall Study|Withdrawal by Subject|3|||
37903436|NCT00990821|69589139|FG006|Overall Study|Withdrawal by Subject|1|||
37999613|NCT00430781|69683591|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
37999614|NCT00430781|69683589|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
37999615|NCT00430781|69683590|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
37999616|NCT00430781|69683591|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
37999617|NCT00430781|69683589|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
37999618|NCT00430781|69683590|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
37999619|NCT00430781|69683591|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
37999620|NCT00430781|69683589|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
37903437|NCT00990821|69589140|FG007|Overall Study|Withdrawal by Subject|0|||
37903438|NCT00990821|69589141|FG008|Overall Study|Withdrawal by Subject|0|||
37903439|NCT00990821|69589142|FG009|Overall Study|Withdrawal by Subject|1|||
37903440|NCT00990821|69589143|FG010|Overall Study|Withdrawal by Subject|3|||
37999621|NCT00430781|69683590|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
37999622|NCT00430781|69683591|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
37999623|NCT00430781|69683589|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
37697123|NCT02461589|69173598|FG009|Overall Study|Withdrawal by Subject|1|||
37697124|NCT02461589|69173589|FG000|Overall Study|Lost to Follow-up|0|||
37828740|NCT01059825|69511918|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
37999624|NCT00430781|69683590|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
37828741|NCT01059825|69511919|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
37828742|NCT01059825|69511913|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
37828743|NCT01059825|69511914|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
37828744|NCT01059825|69511915|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
37828745|NCT01059825|69511916|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
37828746|NCT01059825|69511917|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
37828747|NCT01059825|69511918|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
37828748|NCT01059825|69511919|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
37828749|NCT01059825|69511913|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
37828750|NCT01059825|69511914|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
37828751|NCT01059825|69511915|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
37828752|NCT01059825|69511916|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
37828753|NCT01059825|69511917|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
37828754|NCT01059825|69511918|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
37828755|NCT01059825|69511919|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
37903441|NCT00990821|69589144|FG011|Overall Study|Withdrawal by Subject|5|||
37903442|NCT00990821|69589145|FG012|Overall Study|Withdrawal by Subject|2|||
37903443|NCT00990821|69589146|FG013|Overall Study|Withdrawal by Subject|1|||
37999625|NCT00430781|69683591|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
37999626|NCT00430781|69683589|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
37903444|NCT00990665|69589163|FG000|Overall Study|Unsuccessful Implant|8|||
37903445|NCT00990665|69589163|FG000|Overall Study|Death|29|||
37903446|NCT00990665|69589163|FG000|Overall Study|Heart Transplant|1|||
37903447|NCT00990665|69589163|FG000|Overall Study|Withdrawal by Subject|6|||
37903448|NCT00990665|69589163|FG000|Overall Study|Lost to Follow-up|1|||
37903449|NCT00990665|69589163|FG000|Overall Study|System Explant|3|||
37903450|NCT00658567|69589172|FG000|Overall Study|Adverse Event|5|||
37903451|NCT00658567|69589173|FG001|Overall Study|Adverse Event|2|||
37903452|NCT00658567|69589174|FG002|Overall Study|Adverse Event|3|||
37903453|NCT00658567|69589172|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
37903454|NCT00658567|69589173|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
37903455|NCT00658567|69589174|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
37903456|NCT00658567|69589172|FG000|Overall Study|Physician Decision|0|||
37903457|NCT00658567|69589173|FG001|Overall Study|Physician Decision|1|||
37903458|NCT00658567|69589174|FG002|Overall Study|Physician Decision|0|||
37903459|NCT00658567|69589172|FG000|Overall Study|At Discretion of Sponsor|1|||
37903460|NCT00658567|69589173|FG001|Overall Study|At Discretion of Sponsor|1|||
37903461|NCT00658567|69589174|FG002|Overall Study|At Discretion of Sponsor|1|||
37903462|NCT00875433|69589182|FG000|Overall Study|Progressive disease|41|||
37903463|NCT00875433|69589182|FG000|Overall Study|Other Adverse Event|14|||
37903464|NCT00875433|69589182|FG000|Overall Study|Withdrawal by Subject|2|||
37903465|NCT00875433|69589182|FG000|Overall Study|Other|3|||
37903466|NCT00985985|69589190|FG000|Overall Study|Adverse Event|4|||
37903467|NCT00985985|69589191|FG001|Overall Study|Adverse Event|2|||
37903468|NCT00985985|69589192|FG002|Overall Study|Adverse Event|2|||
37999627|NCT00430781|69683590|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
37903469|NCT00985985|69589193|FG003|Overall Study|Adverse Event|2|||
37903470|NCT00985985|69589190|FG000|Overall Study|Lost to Follow-up|4|||
37903471|NCT00985985|69589191|FG001|Overall Study|Lost to Follow-up|11|||
37903472|NCT00985985|69589192|FG002|Overall Study|Lost to Follow-up|2|||
37903473|NCT00985985|69589193|FG003|Overall Study|Lost to Follow-up|3|||
37903474|NCT00985985|69589190|FG000|Overall Study|Protocol Violation|1|||
37903475|NCT00985985|69589191|FG001|Overall Study|Protocol Violation|2|||
37903476|NCT00985985|69589192|FG002|Overall Study|Protocol Violation|0|||
37903477|NCT00985985|69589193|FG003|Overall Study|Protocol Violation|1|||
37903478|NCT00985985|69589190|FG000|Overall Study|Lack of Efficacy|5|||
37903479|NCT00985985|69589191|FG001|Overall Study|Lack of Efficacy|6|||
37999628|NCT00430781|69683591|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
37828756|NCT01059825|69511913|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
37828757|NCT01059825|69511914|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
37828758|NCT01059825|69511915|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
37828759|NCT01059825|69511916|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
37828760|NCT01059825|69511917|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
37828761|NCT01059825|69511918|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
37828762|NCT01059825|69511919|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
37828763|NCT01059825|69511913|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
37828764|NCT01059825|69511914|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
37903480|NCT00985985|69589192|FG002|Overall Study|Lack of Efficacy|1|||
37903481|NCT00985985|69589193|FG003|Overall Study|Lack of Efficacy|3|||
37903482|NCT00985985|69589190|FG000|Overall Study|Withdrawal by Subject|4|||
37903483|NCT00985985|69589191|FG001|Overall Study|Withdrawal by Subject|2|||
37903484|NCT00985985|69589192|FG002|Overall Study|Withdrawal by Subject|2|||
37903485|NCT00985985|69589193|FG003|Overall Study|Withdrawal by Subject|2|||
37903486|NCT00985985|69589190|FG000|Overall Study|Other Reason|6|||
37903487|NCT00985985|69589191|FG001|Overall Study|Other Reason|1|||
37697125|NCT02461589|69173590|FG001|Overall Study|Lost to Follow-up|0|||
37903488|NCT00985985|69589192|FG002|Overall Study|Other Reason|4|||
37697126|NCT02461589|69173591|FG002|Overall Study|Lost to Follow-up|2|||
37828765|NCT01059825|69511915|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
37903489|NCT00985985|69589193|FG003|Overall Study|Other Reason|2|||
37903490|NCT00923936|69589210|FG000|Overall Study|progressive disease on study|2|||
37903491|NCT00923936|69589211|FG001|Overall Study|progressive disease on study|1|||
37903492|NCT00923936|69589210|FG000|Overall Study|Adverse Event|2|||
37903493|NCT00923936|69589211|FG001|Overall Study|Adverse Event|1|||
37903494|NCT00923936|69589210|FG000|Overall Study|Lost to follow up|2|||
37903495|NCT00923936|69589211|FG001|Overall Study|Lost to follow up|0|||
37903496|NCT00923936|69589210|FG000|Overall Study|Continuing in follow up period|2|||
37903497|NCT00923936|69589211|FG001|Overall Study|Continuing in follow up period|1|||
37903498|NCT00924950|69589219|FG000|Overall Study|Lost to Follow-up|2|||
37903499|NCT00988637|69589228|FG000|Overall Study|Lost to Follow-up|2|||
37903500|NCT00988637|69589229|FG001|Overall Study|Lost to Follow-up|1|||
37903501|NCT00988637|69589228|FG000|Overall Study|Withdrawal by Subject|1|||
37697127|NCT02461589|69173592|FG003|Overall Study|Lost to Follow-up|3|||
37697128|NCT02461589|69173593|FG004|Overall Study|Lost to Follow-up|1|||
37697129|NCT02461589|69173594|FG005|Overall Study|Lost to Follow-up|1|||
37697130|NCT02461589|69173595|FG006|Overall Study|Lost to Follow-up|3|||
37697131|NCT02461589|69173596|FG007|Overall Study|Lost to Follow-up|1|||
37697132|NCT02461589|69173597|FG008|Overall Study|Lost to Follow-up|3|||
37697133|NCT02461589|69173598|FG009|Overall Study|Lost to Follow-up|1|||
37697134|NCT02461589|69173589|FG000|Overall Study|Death|0|||
37697135|NCT02461589|69173590|FG001|Overall Study|Death|0|||
37697136|NCT02461589|69173591|FG002|Overall Study|Death|0|||
37697137|NCT02461589|69173592|FG003|Overall Study|Death|0|||
37697138|NCT02461589|69173593|FG004|Overall Study|Death|0|||
37697139|NCT02461589|69173594|FG005|Overall Study|Death|0|||
37697140|NCT02461589|69173595|FG006|Overall Study|Death|0|||
37697141|NCT02461589|69173596|FG007|Overall Study|Death|1|||
37828766|NCT01059825|69511916|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
37828767|NCT01059825|69511917|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
37828768|NCT01059825|69511918|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
37999629|NCT00430781|69683589|FG000|Interim Analysis; 11 February 2008|Death|0|||
37999630|NCT00430781|69683590|FG001|Interim Analysis; 11 February 2008|Death|1|||
37999631|NCT00430781|69683591|FG002|Interim Analysis; 11 February 2008|Death|0|||
37999632|NCT00430781|69683589|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
37999633|NCT00430781|69683590|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
37999634|NCT00430781|69683591|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
37999635|NCT00430781|69683589|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
37999636|NCT00430781|69683590|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
37999637|NCT00430781|69683591|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
37999638|NCT00430781|69683589|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
37999639|NCT00430781|69683590|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
37999640|NCT00430781|69683591|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
37999641|NCT00430781|69683589|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
37999642|NCT00430781|69683590|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
37999643|NCT00430781|69683591|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
37999644|NCT00430781|69683589|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
37999645|NCT00430781|69683590|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
37999646|NCT00430781|69683591|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
37828769|NCT01059825|69511919|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
37828770|NCT01059825|69511913|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
37828771|NCT01059825|69511914|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
37828772|NCT01059825|69511915|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
37828773|NCT01059825|69511916|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
37828774|NCT01059825|69511917|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
37828775|NCT01059825|69511918|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
37828776|NCT01059825|69511919|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
37828777|NCT01059825|69511913|FG000|Treatment Period|Lost to Follow-up|2|||
37828778|NCT01059825|69511914|FG001|Treatment Period|Lost to Follow-up|1|||
37828779|NCT01059825|69511915|FG002|Treatment Period|Lost to Follow-up|0|||
37828780|NCT01059825|69511916|FG003|Treatment Period|Lost to Follow-up|1|||
37828781|NCT01059825|69511917|FG004|Treatment Period|Lost to Follow-up|2|||
37828782|NCT01059825|69511918|FG005|Treatment Period|Lost to Follow-up|0|||
37828783|NCT01059825|69511919|FG006|Treatment Period|Lost to Follow-up|0|||
37828784|NCT01059825|69511913|FG000|Treatment Period|Withdrawal by Subject|3|||
37828785|NCT01059825|69511914|FG001|Treatment Period|Withdrawal by Subject|0|||
37903502|NCT00988637|69589229|FG001|Overall Study|Withdrawal by Subject|1|||
37697142|NCT02461589|69173597|FG008|Overall Study|Death|0|||
37697143|NCT02461589|69173598|FG009|Overall Study|Death|0|||
37697144|NCT02461589|69173589|FG000|Overall Study|Unclassified|0|||
37903503|NCT00988637|69589228|FG000|Overall Study|non-compliance with study drug|0|||
37903504|NCT00988637|69589229|FG001|Overall Study|non-compliance with study drug|1|||
37999647|NCT00430781|69683589|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
37999648|NCT00430781|69683590|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
37999649|NCT00430781|69683591|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
37999650|NCT00430781|69683589|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
37999651|NCT00430781|69683590|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
37999652|NCT00430781|69683591|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
37999653|NCT00430781|69683589|FG000|Final Analysis; 31 July 2008|Other|0|||
37999654|NCT00430781|69683590|FG001|Final Analysis; 31 July 2008|Other|1|||
37999655|NCT00430781|69683591|FG002|Final Analysis; 31 July 2008|Other|0|||
37999656|NCT00430781|69683589|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
37999657|NCT00430781|69683590|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
37903505|NCT00923156|69589238|FG000|Overall Study|Adverse Event|0|||
37903506|NCT00923156|69589239|FG001|Overall Study|Adverse Event|2|||
37903507|NCT00923156|69589240|FG002|Overall Study|Adverse Event|1|||
37828786|NCT01059825|69511915|FG002|Treatment Period|Withdrawal by Subject|1|||
37828787|NCT01059825|69511916|FG003|Treatment Period|Withdrawal by Subject|5|||
37828788|NCT01059825|69511917|FG004|Treatment Period|Withdrawal by Subject|4|||
37828789|NCT01059825|69511918|FG005|Treatment Period|Withdrawal by Subject|1|||
37828790|NCT01059825|69511919|FG006|Treatment Period|Withdrawal by Subject|0|||
37828791|NCT01059825|69511913|FG000|Treatment Period|Other reason not specified|1|||
37903508|NCT00923156|69589238|FG000|Overall Study|Abnormal laboratory values|0|||
37903509|NCT00923156|69589239|FG001|Overall Study|Abnormal laboratory values|0|||
37903510|NCT00923156|69589240|FG002|Overall Study|Abnormal laboratory values|1|||
37903511|NCT00923156|69589238|FG000|Overall Study|Withdrawal by Subject|0|||
37903512|NCT00923156|69589239|FG001|Overall Study|Withdrawal by Subject|1|||
37903513|NCT00923156|69589240|FG002|Overall Study|Withdrawal by Subject|0|||
37903514|NCT00923156|69589238|FG000|Overall Study|Death|0|||
37903515|NCT00923156|69589239|FG001|Overall Study|Death|1|||
37903516|NCT00923156|69589240|FG002|Overall Study|Death|0|||
37903517|NCT00923156|69589238|FG000|Overall Study|Lack of Efficacy|0|||
37903518|NCT00923156|69589239|FG001|Overall Study|Lack of Efficacy|0|||
37903519|NCT00923156|69589240|FG002|Overall Study|Lack of Efficacy|1|||
37903520|NCT00874731|69589248|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
37903521|NCT00874731|69589249|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
37903522|NCT00874731|69589250|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
37903523|NCT00874731|69589248|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
37903524|NCT00874731|69589249|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
37903525|NCT00874731|69589250|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
37903526|NCT00874731|69589248|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
37903527|NCT00874731|69589249|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
37903528|NCT00874731|69589250|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
37903529|NCT00924638|69589260|FG000|Overall Study|Death|3|||
37903530|NCT00924638|69589261|FG001|Overall Study|Death|2|||
37903531|NCT00924638|69589260|FG000|Overall Study|Lost to Follow-up|1|||
37903532|NCT00924638|69589261|FG001|Overall Study|Lost to Follow-up|1|||
37903533|NCT00924638|69589260|FG000|Overall Study|Withdrawal by Subject|5|||
37903534|NCT00924638|69589261|FG001|Overall Study|Withdrawal by Subject|7|||
37903535|NCT00924638|69589260|FG000|Overall Study|Physician Decision|3|||
37903536|NCT00924638|69589261|FG001|Overall Study|Physician Decision|3|||
37903537|NCT00874497|69589269|FG000|Overall Study|Lost to Follow-up|2|||
37903538|NCT00874497|69589270|FG001|Overall Study|Lost to Follow-up|4|||
37903539|NCT00874497|69589269|FG000|Overall Study|Adverse Event|9|||
37903540|NCT00874497|69589270|FG001|Overall Study|Adverse Event|4|||
37903541|NCT00874497|69589269|FG000|Overall Study|Sponsor Discontinued Trial|7|||
37903542|NCT00874497|69589270|FG001|Overall Study|Sponsor Discontinued Trial|3|||
37999658|NCT00430781|69683591|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
37999659|NCT00430781|69683589|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
37999660|NCT00430781|69683590|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
37828792|NCT01059825|69511914|FG001|Treatment Period|Other reason not specified|2|||
37828793|NCT01059825|69511915|FG002|Treatment Period|Other reason not specified|1|||
37828794|NCT01059825|69511916|FG003|Treatment Period|Other reason not specified|2|||
37828795|NCT01059825|69511917|FG004|Treatment Period|Other reason not specified|0|||
37828796|NCT01059825|69511918|FG005|Treatment Period|Other reason not specified|0|||
37828797|NCT01059825|69511919|FG006|Treatment Period|Other reason not specified|0|||
37828798|NCT01059825|69511913|FG000|Treatment Period|Protocol Violation|0|||
37903543|NCT00874497|69589269|FG000|Overall Study|Met Withdrawal Criteria|4|||
37903544|NCT00874497|69589270|FG001|Overall Study|Met Withdrawal Criteria|2|||
37999661|NCT00430781|69683591|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
37999662|NCT00430781|69683589|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
37999663|NCT00430781|69683590|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
37999664|NCT00430781|69683591|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
37828799|NCT01059825|69511914|FG001|Treatment Period|Protocol Violation|0|||
37828800|NCT01059825|69511915|FG002|Treatment Period|Protocol Violation|1|||
37828801|NCT01059825|69511916|FG003|Treatment Period|Protocol Violation|1|||
37828802|NCT01059825|69511917|FG004|Treatment Period|Protocol Violation|1|||
37828803|NCT01059825|69511918|FG005|Treatment Period|Protocol Violation|1|||
37828804|NCT01059825|69511919|FG006|Treatment Period|Protocol Violation|0|||
37828805|NCT01059825|69511913|FG000|Treatment Period|Adverse event related to study drug|1|||
37828806|NCT01059825|69511914|FG001|Treatment Period|Adverse event related to study drug|0|||
37828807|NCT01059825|69511915|FG002|Treatment Period|Adverse event related to study drug|1|||
37828808|NCT01059825|69511916|FG003|Treatment Period|Adverse event related to study drug|1|||
37828809|NCT01059825|69511917|FG004|Treatment Period|Adverse event related to study drug|0|||
37828810|NCT01059825|69511918|FG005|Treatment Period|Adverse event related to study drug|0|||
37828811|NCT01059825|69511919|FG006|Treatment Period|Adverse event related to study drug|0|||
37999665|NCT00430781|69683589|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
37999666|NCT00430781|69683590|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
37828812|NCT01059825|69511913|FG000|Treatment Period|Insufficient clinical response|3|||
37828813|NCT01059825|69511914|FG001|Treatment Period|Insufficient clinical response|0|||
37828814|NCT01059825|69511915|FG002|Treatment Period|Insufficient clinical response|0|||
37828815|NCT01059825|69511916|FG003|Treatment Period|Insufficient clinical response|0|||
37828816|NCT01059825|69511917|FG004|Treatment Period|Insufficient clinical response|0|||
37828817|NCT01059825|69511918|FG005|Treatment Period|Insufficient clinical response|0|||
37999667|NCT00430781|69683591|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
37999668|NCT00430781|69683589|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
37999669|NCT00430781|69683590|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
37999670|NCT00430781|69683591|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
37999671|NCT00430781|69683589|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
37999672|NCT00430781|69683590|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
37999673|NCT00430781|69683591|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
37999674|NCT00430781|69683589|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
37999675|NCT00430781|69683590|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
37999676|NCT00430781|69683591|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
37999677|NCT00429299|69683605|FG000|Overall Study|Disease Progression|1|||
37999678|NCT00429299|69683606|FG001|Overall Study|Disease Progression|1|||
37999679|NCT00429299|69683607|FG002|Overall Study|Disease Progression|0|||
37999680|NCT00429299|69683605|FG000|Overall Study|Adverse Event|2|||
37999681|NCT00429299|69683606|FG001|Overall Study|Adverse Event|5|||
37999682|NCT00429299|69683607|FG002|Overall Study|Adverse Event|1|||
37999683|NCT00429299|69683605|FG000|Overall Study|Protocol Violation|1|||
37999684|NCT00429299|69683606|FG001|Overall Study|Protocol Violation|0|||
37999685|NCT00429299|69683607|FG002|Overall Study|Protocol Violation|0|||
37999686|NCT00429299|69683605|FG000|Overall Study|Withdrawal by Subject|0|||
37903545|NCT00874497|69589269|FG000|Overall Study|Physician Decision|1|||
37903546|NCT00874497|69589270|FG001|Overall Study|Physician Decision|1|||
37903547|NCT00874497|69589269|FG000|Overall Study|Withdrawal by Subject|5|||
37903548|NCT00874497|69589270|FG001|Overall Study|Withdrawal by Subject|4|||
37903549|NCT00924560|69589279|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
37999687|NCT00429299|69683606|FG001|Overall Study|Withdrawal by Subject|1|||
37999688|NCT00429299|69683607|FG002|Overall Study|Withdrawal by Subject|3|||
37999689|NCT00428597|69683617|FG000|Overall Study|Randomized but not treated|3|||
37999690|NCT00428597|69683618|FG001|Overall Study|Randomized but not treated|3|||
37999691|NCT00428597|69683617|FG000|Overall Study|Objective Progression or Relapse|19|||
37999692|NCT00428597|69683618|FG001|Overall Study|Objective Progression or Relapse|47|||
37999693|NCT00428597|69683617|FG000|Overall Study|Study Terminated by Sponsor|41|||
37999694|NCT00428597|69683618|FG001|Overall Study|Study Terminated by Sponsor|16|||
37999695|NCT00428597|69683617|FG000|Overall Study|Adverse Event|15|||
37999696|NCT00428597|69683618|FG001|Overall Study|Adverse Event|7|||
37999697|NCT00428597|69683617|FG000|Overall Study|Global Deterioration of Health Status|1|||
37999698|NCT00428597|69683618|FG001|Overall Study|Global Deterioration of Health Status|5|||
37999699|NCT00428597|69683617|FG000|Overall Study|Protocol Violation|2|||
37999700|NCT00428597|69683618|FG001|Overall Study|Protocol Violation|1|||
37999701|NCT00428597|69683617|FG000|Overall Study|Withdrawal by Subject|2|||
37999702|NCT00428597|69683618|FG001|Overall Study|Withdrawal by Subject|1|||
37999703|NCT00428597|69683617|FG000|Overall Study|Other|1|||
37999704|NCT00428597|69683618|FG001|Overall Study|Other|1|||
37999705|NCT00428597|69683617|FG000|Overall Study|Lost to Follow-up|0|||
37999706|NCT00428597|69683618|FG001|Overall Study|Lost to Follow-up|1|||
37999707|NCT00428597|69683617|FG000|Overall Study|Pregnancy|1|||
37999708|NCT00428597|69683618|FG001|Overall Study|Pregnancy|0|||
37999709|NCT00428597|69683617|FG000|Overall Study|Death|1|||
37999710|NCT00428597|69683618|FG001|Overall Study|Death|3|||
37999711|NCT00428441|69683624|FG000|Overall Study|Lost to Follow-up|1|||
37903550|NCT00924560|69589280|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
37903551|NCT00924560|69589281|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
37999712|NCT00144339|69683630|FG000|Overall Study|Adverse Event|746|||
37697145|NCT02461589|69173590|FG001|Overall Study|Unclassified|0|||
37903552|NCT00924560|69589279|FG000|Overall Study|Non Compliance with the Protocol|20|||
37903553|NCT00924560|69589280|FG001|Overall Study|Non Compliance with the Protocol|15|||
37903554|NCT00924560|69589281|FG002|Overall Study|Non Compliance with the Protocol|4|||
37903555|NCT00924560|69589279|FG000|Overall Study|Physician Decision|2|||
37999713|NCT00144339|69683631|FG001|Overall Study|Adverse Event|627|||
37999714|NCT00144339|69683630|FG000|Overall Study|Protocol Violation|75|||
37999715|NCT00144339|69683631|FG001|Overall Study|Protocol Violation|48|||
37999716|NCT00144339|69683630|FG000|Overall Study|Withdrawal by Subject|403|||
37999717|NCT00144339|69683631|FG001|Overall Study|Withdrawal by Subject|300|||
37999718|NCT00144339|69683630|FG000|Overall Study|Lost to Follow-up|76|||
37999719|NCT00144339|69683631|FG001|Overall Study|Lost to Follow-up|64|||
37999720|NCT00144339|69683630|FG000|Overall Study|Other|58|||
37999721|NCT00144339|69683631|FG001|Overall Study|Other|60|||
37903556|NCT00924560|69589280|FG001|Overall Study|Physician Decision|3|||
37903557|NCT00924560|69589281|FG002|Overall Study|Physician Decision|4|||
37999722|NCT00144027|69683639|FG000|Overall Study|Lost to Follow-up|1|||
37999723|NCT00144027|69683640|FG001|Overall Study|Lost to Follow-up|3|||
37903558|NCT00924560|69589279|FG000|Overall Study|Withdrawal by Subject|50|||
37903559|NCT00924560|69589280|FG001|Overall Study|Withdrawal by Subject|44|||
37903560|NCT00924560|69589281|FG002|Overall Study|Withdrawal by Subject|18|||
37903561|NCT00924560|69589279|FG000|Overall Study|Adverse Event|39|||
37903562|NCT00924560|69589280|FG001|Overall Study|Adverse Event|33|||
37903563|NCT00924560|69589281|FG002|Overall Study|Adverse Event|0|||
37903564|NCT00924560|69589279|FG000|Overall Study|Pregnancy|5|||
37903565|NCT00924560|69589280|FG001|Overall Study|Pregnancy|7|||
37903566|NCT00924560|69589281|FG002|Overall Study|Pregnancy|1|||
37903567|NCT00924560|69589279|FG000|Overall Study|Lost to Follow-up|78|||
37999724|NCT00144027|69683639|FG000|Overall Study|Withdrawal by Subject|2|||
37999725|NCT00144027|69683640|FG001|Overall Study|Withdrawal by Subject|2|||
37999726|NCT00144027|69683639|FG000|Overall Study|did not complete baseline assessment|0|||
37999727|NCT00144027|69683640|FG001|Overall Study|did not complete baseline assessment|6|||
37999728|NCT00127803|69683650|FG000|Overall Study|Adverse Event|2|||
37999729|NCT00127803|69683651|FG001|Overall Study|Adverse Event|0|||
37999730|NCT00127803|69683652|FG002|Overall Study|Adverse Event|0|||
37999731|NCT00127803|69683653|FG003|Overall Study|Adverse Event|0|||
37999732|NCT00127803|69683650|FG000|Overall Study|Withdrawal by Subject|1|||
37999733|NCT00127803|69683651|FG001|Overall Study|Withdrawal by Subject|0|||
37999734|NCT00127803|69683652|FG002|Overall Study|Withdrawal by Subject|0|||
37999735|NCT00127803|69683653|FG003|Overall Study|Withdrawal by Subject|0|||
37999736|NCT00127803|69683650|FG000|Overall Study|Lost to Follow-up|0|||
37999737|NCT00127803|69683651|FG001|Overall Study|Lost to Follow-up|0|||
37999738|NCT00127803|69683652|FG002|Overall Study|Lost to Follow-up|0|||
37999739|NCT00127803|69683653|FG003|Overall Study|Lost to Follow-up|1|||
37999740|NCT00127413|69683667|FG000|Overall Study|Lost to Follow-up|6|||
37999741|NCT00127413|69683668|FG001|Overall Study|Lost to Follow-up|4|||
37697146|NCT02461589|69173591|FG002|Overall Study|Unclassified|0|||
37697147|NCT02461589|69173592|FG003|Overall Study|Unclassified|0|||
37903568|NCT00924560|69589280|FG001|Overall Study|Lost to Follow-up|94|||
37903569|NCT00924560|69589281|FG002|Overall Study|Lost to Follow-up|45|||
37903570|NCT00924560|69589279|FG000|Overall Study|Miscellaneous Reasons|13|||
37903571|NCT00924560|69589280|FG001|Overall Study|Miscellaneous Reasons|10|||
37903572|NCT00924560|69589281|FG002|Overall Study|Miscellaneous Reasons|10|||
37903573|NCT00923078|69589294|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
37903574|NCT00923078|69589295|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
37697148|NCT02461589|69173593|FG004|Overall Study|Unclassified|0|||
37697149|NCT02461589|69173594|FG005|Overall Study|Unclassified|0|||
37828818|NCT01059825|69511919|FG006|Treatment Period|Insufficient clinical response|0|||
37828819|NCT01059825|69511913|FG000|Treatment Period|Adverse event not related to study drug|0|||
37828820|NCT01059825|69511914|FG001|Treatment Period|Adverse event not related to study drug|1|||
37828821|NCT01059825|69511915|FG002|Treatment Period|Adverse event not related to study drug|2|||
37828822|NCT01059825|69511916|FG003|Treatment Period|Adverse event not related to study drug|1|||
37828823|NCT01059825|69511917|FG004|Treatment Period|Adverse event not related to study drug|1|||
37828824|NCT01059825|69511918|FG005|Treatment Period|Adverse event not related to study drug|1|||
37903575|NCT00923078|69589296|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
37903576|NCT00923078|69589294|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
37903577|NCT00923078|69589295|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
37828825|NCT01059825|69511919|FG006|Treatment Period|Adverse event not related to study drug|0|||
37903578|NCT00923078|69589296|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
37903579|NCT00978731|69589307|FG000|Overall Study|Death|4|||
37999742|NCT00127413|69683669|FG002|Overall Study|Lost to Follow-up|8|||
37999743|NCT00127413|69683670|FG003|Overall Study|Lost to Follow-up|2|||
37697150|NCT02461589|69173595|FG006|Overall Study|Unclassified|1|||
37697151|NCT02461589|69173596|FG007|Overall Study|Unclassified|0|||
37697152|NCT02461589|69173597|FG008|Overall Study|Unclassified|0|||
37903580|NCT00978731|69589308|FG001|Overall Study|Death|1|||
37903581|NCT00978731|69589309|FG002|Overall Study|Death|1|||
37903582|NCT00978731|69589310|FG003|Overall Study|Death|0|||
37903583|NCT00978731|69589307|FG000|Overall Study|Lost to Follow-up|0|||
37903584|NCT00978731|69589308|FG001|Overall Study|Lost to Follow-up|0|||
37903585|NCT00978731|69589309|FG002|Overall Study|Lost to Follow-up|0|||
37999744|NCT00143403|69683682|FG000|Overall Study|Adverse Event|3|||
37999745|NCT00143403|69683683|FG001|Overall Study|Adverse Event|8|||
37999746|NCT00143403|69683682|FG000|Overall Study|Death|1|||
37903586|NCT00978731|69589310|FG003|Overall Study|Lost to Follow-up|1|||
37999747|NCT00143403|69683683|FG001|Overall Study|Death|0|||
37999748|NCT00143403|69683682|FG000|Overall Study|Withdrawal by Subject|3|||
37999749|NCT00143403|69683683|FG001|Overall Study|Withdrawal by Subject|12|||
37999750|NCT00143403|69683682|FG000|Overall Study|Relapse|15|||
37999751|NCT00143403|69683683|FG001|Overall Study|Relapse|7|||
37999752|NCT00143403|69683682|FG000|Overall Study|Protocol Violation|2|||
37999753|NCT00143403|69683683|FG001|Overall Study|Protocol Violation|2|||
37999754|NCT00143403|69683682|FG000|Overall Study|specified by site|4|||
37999755|NCT00143403|69683683|FG001|Overall Study|specified by site|9|||
37999756|NCT00143403|69683682|FG000|Overall Study|Randomized Not Treated|7|||
37999757|NCT00143403|69683683|FG001|Overall Study|Randomized Not Treated|8|||
37903587|NCT00978731|69589307|FG000|Overall Study|Adverse Event|5|||
37903588|NCT00978731|69589308|FG001|Overall Study|Adverse Event|2|||
37903589|NCT00978731|69589309|FG002|Overall Study|Adverse Event|0|||
37903590|NCT00978731|69589310|FG003|Overall Study|Adverse Event|0|||
37903591|NCT00978731|69589307|FG000|Overall Study|Participant's request|1|||
37903592|NCT00978731|69589308|FG001|Overall Study|Participant's request|0|||
37903593|NCT00978731|69589309|FG002|Overall Study|Participant's request|0|||
37903594|NCT00978731|69589310|FG003|Overall Study|Participant's request|0|||
37903595|NCT00978731|69589307|FG000|Overall Study|Administrative reason|3|||
37903596|NCT00978731|69589308|FG001|Overall Study|Administrative reason|3|||
37903597|NCT00978731|69589309|FG002|Overall Study|Administrative reason|1|||
37903598|NCT00978731|69589310|FG003|Overall Study|Administrative reason|0|||
37903599|NCT00978731|69589307|FG000|Overall Study|Deterioration without progression|0|||
37903600|NCT00978731|69589308|FG001|Overall Study|Deterioration without progression|1|||
37903601|NCT00978731|69589309|FG002|Overall Study|Deterioration without progression|0|||
37903602|NCT00978731|69589310|FG003|Overall Study|Deterioration without progression|0|||
37903603|NCT00978731|69589307|FG000|Overall Study|Disease progression/relapse|5|||
37903604|NCT00978731|69589308|FG001|Overall Study|Disease progression/relapse|4|||
37903605|NCT00978731|69589309|FG002|Overall Study|Disease progression/relapse|2|||
37903606|NCT00978731|69589310|FG003|Overall Study|Disease progression/relapse|2|||
37903607|NCT00978731|69589307|FG000|Overall Study|Study closure|3|||
37903608|NCT00978731|69589308|FG001|Overall Study|Study closure|4|||
37903609|NCT00978731|69589309|FG002|Overall Study|Study closure|1|||
37903610|NCT00978731|69589310|FG003|Overall Study|Study closure|1|||
37903611|NCT00978731|69589307|FG000|Overall Study|No response|1|||
37903612|NCT00978731|69589308|FG001|Overall Study|No response|0|||
37903613|NCT00978731|69589309|FG002|Overall Study|No response|0|||
37903614|NCT00978731|69589310|FG003|Overall Study|No response|0|||
37903615|NCT05056870|69589324|FG000|Period 1|Site COVID-19 Related|3|||
37903616|NCT05056870|69589325|FG001|Period 1|Site COVID-19 Related|3|||
37903617|NCT05056870|69589324|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
37903618|NCT05056870|69589325|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
37903619|NCT05056870|69589324|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
37903620|NCT05056870|69589325|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
37903621|NCT05056870|69589324|FG000|Period 2|COVID-19 Related|1|||
37903622|NCT05056870|69589325|FG001|Period 2|COVID-19 Related|0|||
37999758|NCT00220701|69683691|FG000|Overall Study|Lost to Follow-up|5|||
37999759|NCT00220701|69683692|FG001|Overall Study|Lost to Follow-up|4|||
37999760|NCT00127101|69683704|FG000|Base Protocol|Adverse Event|0|||
37999761|NCT00127101|69683705|FG001|Base Protocol|Adverse Event|2|||
37999762|NCT00127101|69683706|FG002|Base Protocol|Adverse Event|1|||
37999763|NCT00127101|69683707|FG003|Base Protocol|Adverse Event|0|||
37999764|NCT00127101|69683708|FG004|Base Protocol|Adverse Event|0|||
37999765|NCT00127101|69683709|FG005|Base Protocol|Adverse Event|0|||
37999766|NCT00127101|69683704|FG000|Base Protocol|Lack of Efficacy|1|||
37999767|NCT00127101|69683705|FG001|Base Protocol|Lack of Efficacy|0|||
37999768|NCT00127101|69683706|FG002|Base Protocol|Lack of Efficacy|0|||
37999769|NCT00127101|69683707|FG003|Base Protocol|Lack of Efficacy|0|||
37999770|NCT00127101|69683708|FG004|Base Protocol|Lack of Efficacy|2|||
37999771|NCT00127101|69683709|FG005|Base Protocol|Lack of Efficacy|0|||
37999772|NCT00127101|69683704|FG000|Base Protocol|Withdrawal by Subject|1|||
37999773|NCT00127101|69683705|FG001|Base Protocol|Withdrawal by Subject|2|||
37999774|NCT00127101|69683706|FG002|Base Protocol|Withdrawal by Subject|1|||
37999775|NCT00127101|69683707|FG003|Base Protocol|Withdrawal by Subject|0|||
37999776|NCT00127101|69683708|FG004|Base Protocol|Withdrawal by Subject|0|||
37999777|NCT00127101|69683709|FG005|Base Protocol|Withdrawal by Subject|1|||
37999778|NCT00127101|69683704|FG000|Continuation Phase|Adverse Event|0|||
37999779|NCT00127101|69683705|FG001|Continuation Phase|Adverse Event|0|||
37999780|NCT00127101|69683706|FG002|Continuation Phase|Adverse Event|0|||
37999781|NCT00127101|69683707|FG003|Continuation Phase|Adverse Event|0|||
37999782|NCT00127101|69683708|FG004|Continuation Phase|Adverse Event|1|||
37999783|NCT00127101|69683709|FG005|Continuation Phase|Adverse Event|1|||
37999784|NCT00127101|69683704|FG000|Continuation Phase|Lack of Efficacy|0|||
37999785|NCT00127101|69683705|FG001|Continuation Phase|Lack of Efficacy|0|||
37999786|NCT00127101|69683706|FG002|Continuation Phase|Lack of Efficacy|0|||
37999787|NCT00127101|69683707|FG003|Continuation Phase|Lack of Efficacy|0|||
37999788|NCT00127101|69683708|FG004|Continuation Phase|Lack of Efficacy|0|||
37999789|NCT00127101|69683709|FG005|Continuation Phase|Lack of Efficacy|1|||
37999790|NCT00127101|69683704|FG000|Continuation Phase|Withdrawal by Subject|0|||
37999791|NCT00127101|69683705|FG001|Continuation Phase|Withdrawal by Subject|0|||
37999792|NCT00127101|69683706|FG002|Continuation Phase|Withdrawal by Subject|1|||
37999793|NCT00127101|69683707|FG003|Continuation Phase|Withdrawal by Subject|0|||
37999794|NCT00127101|69683708|FG004|Continuation Phase|Withdrawal by Subject|2|||
37697153|NCT02461589|69173598|FG009|Overall Study|Unclassified|2|||
37697154|NCT02461589|69173589|FG000|Overall Study|Missing follow-up information|1|||
37697155|NCT02461589|69173590|FG001|Overall Study|Missing follow-up information|1|||
37697156|NCT02461589|69173591|FG002|Overall Study|Missing follow-up information|0|||
37697157|NCT02461589|69173592|FG003|Overall Study|Missing follow-up information|0|||
37999795|NCT00127101|69683709|FG005|Continuation Phase|Withdrawal by Subject|1|||
37999796|NCT00126555|69683723|FG000|Overall Study|Withdrawal by Subject|1|||
37999797|NCT00126555|69683723|FG000|Overall Study|Adverse Event|2|||
37999798|NCT00126555|69683723|FG000|Overall Study|Progressive Disease|3|||
37999799|NCT00004228|69683746|FG000|Overall Study|Adverse Event|0|||
37999800|NCT00004228|69683747|FG001|Overall Study|Adverse Event|1|||
37999801|NCT00004228|69683748|FG002|Overall Study|Adverse Event|0|||
37697158|NCT02461589|69173593|FG004|Overall Study|Missing follow-up information|0|||
37697159|NCT02461589|69173594|FG005|Overall Study|Missing follow-up information|0|||
37697160|NCT02461589|69173595|FG006|Overall Study|Missing follow-up information|1|||
37697161|NCT02461589|69173596|FG007|Overall Study|Missing follow-up information|0|||
37999802|NCT00004228|69683749|FG003|Overall Study|Adverse Event|0|||
37999803|NCT00004228|69683750|FG004|Overall Study|Adverse Event|1|||
37999804|NCT00004228|69683751|FG005|Overall Study|Adverse Event|0|||
37828826|NCT01059773|69511978|FG000|Overall Study|Adverse Event|2|||
37828827|NCT01059773|69511979|FG001|Overall Study|Adverse Event|2|||
37828828|NCT01059773|69511978|FG000|Overall Study|Withdrawal by Subject|1|||
37828829|NCT01059773|69511979|FG001|Overall Study|Withdrawal by Subject|5|||
37828830|NCT01059773|69511978|FG000|Overall Study|Lost to Follow-up|1|||
37828831|NCT01059773|69511979|FG001|Overall Study|Lost to Follow-up|1|||
37828832|NCT01059773|69511978|FG000|Overall Study|Pregnancy|1|||
37828833|NCT01059773|69511979|FG001|Overall Study|Pregnancy|1|||
37828834|NCT01059773|69511978|FG000|Overall Study|Protocol Violation|6|||
37828835|NCT01059773|69511979|FG001|Overall Study|Protocol Violation|2|||
37828836|NCT01059773|69511978|FG000|Overall Study|Physician Decision|5|||
37828837|NCT01059773|69511979|FG001|Overall Study|Physician Decision|4|||
37828838|NCT01059773|69511978|FG000|Overall Study|Lack of Efficacy|3|||
37828839|NCT01059773|69511979|FG001|Overall Study|Lack of Efficacy|3|||
37828840|NCT01059773|69511978|FG000|Overall Study|Death|0|||
37828841|NCT01059773|69511979|FG001|Overall Study|Death|1|||
37828842|NCT01059773|69511978|FG000|Overall Study|Malignancy including squamous cell skin|0|||
37903623|NCT05056870|69589324|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
37903624|NCT05056870|69589325|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
37903625|NCT04488822|69589349|FG000|Overall Study|Adverse Event|8|||
37903626|NCT04488822|69589349|FG000|Overall Study|Withdrawal by Subject|1|||
37903627|NCT04396626|69589362|FG000|Overall Study|Premature termination of study|975|||
37903628|NCT04242186|69589366|FG000|Overall Study|Death|5|||
37903629|NCT03934216|69589373|FG000|Randomization|Randomized in Error|1|||
37903630|NCT03934216|69589374|FG001|Randomization|Randomized in Error|1|||
37903631|NCT03934216|69589373|FG000|Treatment Period|Adverse Event|10|||
37903632|NCT03934216|69589374|FG001|Treatment Period|Adverse Event|3|||
37903633|NCT03934216|69589373|FG000|Treatment Period|Withdrawal by Participant|6|||
37903634|NCT03934216|69589374|FG001|Treatment Period|Withdrawal by Participant|2|||
37903635|NCT03934216|69589373|FG000|Treatment Period|Other Reasons|2|||
37903636|NCT03934216|69589374|FG001|Treatment Period|Other Reasons|2|||
37903637|NCT03183128|69589420|FG000|Overall Study|Adverse Event|1|||
37903638|NCT03183128|69589421|FG001|Overall Study|Adverse Event|2|||
37903639|NCT03183128|69589420|FG000|Overall Study|Withdrawal by Subject|1|||
37903640|NCT03183128|69589421|FG001|Overall Study|Withdrawal by Subject|8|||
37903641|NCT03183128|69589420|FG000|Overall Study|Protocol Violation|2|||
37903642|NCT03183128|69589421|FG001|Overall Study|Protocol Violation|0|||
37903643|NCT03183128|69589420|FG000|Overall Study|Lack of Efficacy|4|||
37903644|NCT03183128|69589421|FG001|Overall Study|Lack of Efficacy|27|||
37999805|NCT00004228|69683752|FG006|Overall Study|Adverse Event|0|||
37999806|NCT00004228|69683746|FG000|Overall Study|Death|0|||
37999807|NCT00004228|69683747|FG001|Overall Study|Death|1|||
37999808|NCT00004228|69683748|FG002|Overall Study|Death|2|||
37903645|NCT03183128|69589420|FG000|Overall Study|Lost to Follow-up|1|||
37903646|NCT03183128|69589421|FG001|Overall Study|Lost to Follow-up|0|||
37903647|NCT03183128|69589420|FG000|Overall Study|Death|2|||
37903648|NCT03183128|69589421|FG001|Overall Study|Death|0|||
37903649|NCT03183128|69589420|FG000|Overall Study|Physician Decision|1|||
37903650|NCT03183128|69589421|FG001|Overall Study|Physician Decision|0|||
37903651|NCT02308488|69589454|FG000|Overall Study|Withdrawal by Subject|2|||
37903652|NCT02159950|69589460|FG000|Overall Study|Adverse Event|0|||
37903653|NCT02159950|69589461|FG001|Overall Study|Adverse Event|1|||
37903654|NCT02159950|69589460|FG000|Overall Study|Progression|0|||
37903655|NCT02159950|69589461|FG001|Overall Study|Progression|1|||
37999809|NCT00004228|69683749|FG003|Overall Study|Death|0|||
37999810|NCT00004228|69683750|FG004|Overall Study|Death|1|||
37999811|NCT00004228|69683751|FG005|Overall Study|Death|0|||
37999812|NCT00004228|69683752|FG006|Overall Study|Death|0|||
37999813|NCT00004228|69683746|FG000|Overall Study|Lack of Efficacy|1|||
37999814|NCT00004228|69683747|FG001|Overall Study|Lack of Efficacy|6|||
37999815|NCT00004228|69683748|FG002|Overall Study|Lack of Efficacy|5|||
37999816|NCT00004228|69683749|FG003|Overall Study|Lack of Efficacy|3|||
37999817|NCT00004228|69683750|FG004|Overall Study|Lack of Efficacy|9|||
37999818|NCT00004228|69683751|FG005|Overall Study|Lack of Efficacy|8|||
37999819|NCT00004228|69683752|FG006|Overall Study|Lack of Efficacy|4|||
37828843|NCT01059773|69511979|FG001|Overall Study|Malignancy including squamous cell skin|1|||
37828844|NCT01059773|69511978|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
37828845|NCT01059773|69511979|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
37828846|NCT01059773|69511978|FG000|Overall Study|Other|1|||
37828847|NCT01059773|69511979|FG001|Overall Study|Other|3|||
37828848|NCT01059318|69511990|FG000|Core Study (26 Week)|Adverse Event|3|||
37828849|NCT01059318|69511990|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
37828850|NCT01059318|69511990|FG000|Extension (36 Week)|Adverse Event|3|||
37828851|NCT01058655|69512001|FG000|Overall Study|Withdrawal by Subject|1|||
37828852|NCT01058655|69512002|FG001|Overall Study|Withdrawal by Subject|0|||
37828853|NCT01058655|69512003|FG002|Overall Study|Withdrawal by Subject|3|||
37903656|NCT02152137|69589467|FG000|Overall Study|Withdrawal by Subject|1|||
37903657|NCT02152137|69589467|FG000|Overall Study|Originally assigned to Arm B|3|||
37903658|NCT02007512|69589475|FG000|Double Blind Treatment Period|Adverse Event|4|||
37903659|NCT02007512|69589476|FG001|Double Blind Treatment Period|Adverse Event|2|||
37903660|NCT02007512|69589477|FG002|Double Blind Treatment Period|Adverse Event|6|||
37903661|NCT02007512|69589478|FG003|Double Blind Treatment Period|Adverse Event|2|||
37903662|NCT02007512|69589475|FG000|Double Blind Treatment Period|Death|1|||
37999820|NCT00004228|69683746|FG000|Overall Study|Lost to Follow-up|0|||
37697162|NCT02461589|69173597|FG008|Overall Study|Missing follow-up information|0|||
37697163|NCT02461589|69173598|FG009|Overall Study|Missing follow-up information|0|||
37903663|NCT02007512|69589476|FG001|Double Blind Treatment Period|Death|0|||
37697164|NCT02461589|69173589|FG000|Overall Study|Withdrawal from trial before exposure|0|||
37828854|NCT01058655|69512004|FG003|Overall Study|Withdrawal by Subject|4|||
37828855|NCT01058655|69512001|FG000|Overall Study|Prolonged Treatment Delay|0|||
37903664|NCT02007512|69589477|FG002|Double Blind Treatment Period|Death|0|||
37903665|NCT02007512|69589478|FG003|Double Blind Treatment Period|Death|0|||
37999821|NCT00004228|69683747|FG001|Overall Study|Lost to Follow-up|0|||
37999822|NCT00004228|69683748|FG002|Overall Study|Lost to Follow-up|1|||
37903666|NCT02007512|69589475|FG000|Double Blind Treatment Period|Disease progression|44|||
37903667|NCT02007512|69589476|FG001|Double Blind Treatment Period|Disease progression|49|||
37903668|NCT02007512|69589477|FG002|Double Blind Treatment Period|Disease progression|45|||
37903669|NCT02007512|69589478|FG003|Double Blind Treatment Period|Disease progression|51|||
37903670|NCT02007512|69589475|FG000|Double Blind Treatment Period|Withdrawal by Subject|4|||
37697165|NCT02461589|69173590|FG001|Overall Study|Withdrawal from trial before exposure|0|||
37697166|NCT02461589|69173591|FG002|Overall Study|Withdrawal from trial before exposure|0|||
37697167|NCT02461589|69173592|FG003|Overall Study|Withdrawal from trial before exposure|0|||
37697168|NCT02461589|69173593|FG004|Overall Study|Withdrawal from trial before exposure|0|||
37828856|NCT01058655|69512002|FG001|Overall Study|Prolonged Treatment Delay|0|||
37828857|NCT01058655|69512003|FG002|Overall Study|Prolonged Treatment Delay|0|||
37828858|NCT01058655|69512004|FG003|Overall Study|Prolonged Treatment Delay|2|||
37828859|NCT01058655|69512001|FG000|Overall Study|Symptomatic Deterioration|0|||
37828860|NCT01058655|69512002|FG001|Overall Study|Symptomatic Deterioration|0|||
37828861|NCT01058655|69512003|FG002|Overall Study|Symptomatic Deterioration|0|||
37828862|NCT01058655|69512004|FG003|Overall Study|Symptomatic Deterioration|1|||
37828863|NCT01058655|69512001|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
37828864|NCT01058655|69512002|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
37828865|NCT01058655|69512003|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
37828866|NCT01058655|69512004|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
37828867|NCT01058655|69512001|FG000|Overall Study|Death|0|||
37828868|NCT01058655|69512002|FG001|Overall Study|Death|1|||
37828869|NCT01058655|69512003|FG002|Overall Study|Death|1|||
37828870|NCT01058655|69512004|FG003|Overall Study|Death|0|||
37828871|NCT01058655|69512001|FG000|Overall Study|Disease Progression|1|||
37828872|NCT01058655|69512002|FG001|Overall Study|Disease Progression|2|||
37828873|NCT01058655|69512003|FG002|Overall Study|Disease Progression|4|||
37828874|NCT01058655|69512004|FG003|Overall Study|Disease Progression|24|||
37828875|NCT01058655|69512001|FG000|Overall Study|Other|0|||
37828876|NCT01058655|69512002|FG001|Overall Study|Other|0|||
37828877|NCT01058655|69512003|FG002|Overall Study|Other|0|||
37828878|NCT01058655|69512004|FG003|Overall Study|Other|4|||
37828879|NCT01058421|69512017|FG000|1 Month Outcomes|Death|10|||
37828880|NCT01058421|69512018|FG001|1 Month Outcomes|Death|6|||
37828881|NCT01058421|69512017|FG000|1 Month Outcomes|Lost to Follow-up|8|||
37828882|NCT01058421|69512018|FG001|1 Month Outcomes|Lost to Follow-up|7|||
37697169|NCT02461589|69173594|FG005|Overall Study|Withdrawal from trial before exposure|0|||
37828883|NCT01058421|69512017|FG000|1 Month Outcomes|Remained in Hospital|5|||
37828884|NCT01058421|69512018|FG001|1 Month Outcomes|Remained in Hospital|12|||
37828885|NCT01058421|69512017|FG000|1 Month Outcomes|Remained in Other Facility|16|||
37828886|NCT01058421|69512018|FG001|1 Month Outcomes|Remained in Other Facility|17|||
37828887|NCT01058421|69512017|FG000|3 Month Outcomes|Death|3|||
37828888|NCT01058421|69512018|FG001|3 Month Outcomes|Death|5|||
37828889|NCT01058421|69512017|FG000|3 Month Outcomes|Lost to Follow-up|12|||
37828890|NCT01058421|69512018|FG001|3 Month Outcomes|Lost to Follow-up|11|||
37828891|NCT01058421|69512017|FG000|3 Month Outcomes|Remained in Hospital|0|||
37828892|NCT01058421|69512018|FG001|3 Month Outcomes|Remained in Hospital|2|||
37828893|NCT01058421|69512017|FG000|3 Month Outcomes|Remained in Other Facility|5|||
37828894|NCT01058421|69512018|FG001|3 Month Outcomes|Remained in Other Facility|8|||
37828895|NCT01058421|69512017|FG000|6 Month Outcomes|Death|2|||
37828896|NCT01058421|69512018|FG001|6 Month Outcomes|Death|2|||
37903671|NCT02007512|69589476|FG001|Double Blind Treatment Period|Withdrawal by Subject|2|||
37903672|NCT02007512|69589477|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
37903673|NCT02007512|69589478|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
37903674|NCT02007512|69589475|FG000|Double Blind Treatment Period|Protocol Violation|0|||
37828897|NCT01058421|69512017|FG000|6 Month Outcomes|Lost to Follow-up|16|||
37828898|NCT01058421|69512018|FG001|6 Month Outcomes|Lost to Follow-up|21|||
37903675|NCT02007512|69589476|FG001|Double Blind Treatment Period|Protocol Violation|0|||
37903676|NCT02007512|69589477|FG002|Double Blind Treatment Period|Protocol Violation|0|||
37828899|NCT01058421|69512017|FG000|6 Month Outcomes|Remained in Other Facility|1|||
37828900|NCT01058421|69512018|FG001|6 Month Outcomes|Remained in Other Facility|3|||
37828901|NCT01058304|69512026|FG000|Overall Study|Withdrawal by Subject|8|||
37903677|NCT02007512|69589478|FG003|Double Blind Treatment Period|Protocol Violation|1|||
37828902|NCT01058304|69512027|FG001|Overall Study|Withdrawal by Subject|5|||
37828903|NCT01058304|69512026|FG000|Overall Study|Lost to Follow-up|13|||
37828904|NCT01058304|69512027|FG001|Overall Study|Lost to Follow-up|16|||
37828905|NCT01058304|69512026|FG000|Overall Study|Developed exclusion criterion|6|||
37828906|NCT01058304|69512027|FG001|Overall Study|Developed exclusion criterion|12|||
37828907|NCT01058265|69512035|FG000|Overall Study|Lost to Follow-up|11|||
37828908|NCT01058265|69512036|FG001|Overall Study|Lost to Follow-up|12|||
37828909|NCT01057251|69512044|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
37828910|NCT01057251|69512045|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
37903678|NCT02007512|69589475|FG000|Double Blind Treatment Period|Other|0|||
37903679|NCT02007512|69589476|FG001|Double Blind Treatment Period|Other|0|||
37903680|NCT02007512|69589477|FG002|Double Blind Treatment Period|Other|1|||
37903681|NCT02007512|69589478|FG003|Double Blind Treatment Period|Other|2|||
37903682|NCT02007512|69589475|FG000|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|10|||
37903683|NCT02007512|69589476|FG001|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|11|||
37903684|NCT02007512|69589477|FG002|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|5|||
37903685|NCT02007512|69589478|FG003|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|1|||
37903686|NCT02007512|69589475|FG000|Open Label Treatment Period|Adverse Event|0|||
37903687|NCT02007512|69589476|FG001|Open Label Treatment Period|Adverse Event|1|||
37903688|NCT02007512|69589477|FG002|Open Label Treatment Period|Adverse Event|0|||
37903689|NCT02007512|69589478|FG003|Open Label Treatment Period|Adverse Event|0|||
37903690|NCT02007512|69589475|FG000|Open Label Treatment Period|Other|0|||
37903691|NCT02007512|69589476|FG001|Open Label Treatment Period|Other|0|||
37903692|NCT02007512|69589477|FG002|Open Label Treatment Period|Other|0|||
37903693|NCT02007512|69589478|FG003|Open Label Treatment Period|Other|1|||
37903694|NCT02007512|69589475|FG000|Open Label Treatment Period|Disease progression|0|||
37903695|NCT02007512|69589476|FG001|Open Label Treatment Period|Disease progression|17|||
37903696|NCT02007512|69589477|FG002|Open Label Treatment Period|Disease progression|0|||
37903697|NCT02007512|69589478|FG003|Open Label Treatment Period|Disease progression|11|||
37903698|NCT02007512|69589475|FG000|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
37903699|NCT02007512|69589476|FG001|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|3|||
37903700|NCT02007512|69589477|FG002|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
37903701|NCT02007512|69589478|FG003|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
37903702|NCT01942135|69589493|FG000|Overall Study|Adverse Event|9|||
37903703|NCT01942135|69589494|FG001|Overall Study|Adverse Event|3|||
37903704|NCT01942135|69589493|FG000|Overall Study|Global deterioration of health status|8|||
37903705|NCT01942135|69589494|FG001|Overall Study|Global deterioration of health status|3|||
37903706|NCT01942135|69589493|FG000|Overall Study|Randomized Not Treated|2|||
37903707|NCT01942135|69589494|FG001|Overall Study|Randomized Not Treated|2|||
37903708|NCT01942135|69589493|FG000|Overall Study|Death|0|||
37903709|NCT01942135|69589494|FG001|Overall Study|Death|1|||
37903710|NCT01942135|69589493|FG000|Overall Study|ObjectiveProgression+Progressive Disease|85|||
37903711|NCT01942135|69589494|FG001|Overall Study|ObjectiveProgression+Progressive Disease|87|||
37903712|NCT01942135|69589493|FG000|Overall Study|Participant Refused toContinue Treatment|1|||
37828911|NCT01057251|69512044|FG000|Overall Study|Adverse Event|4|||
37828912|NCT01057251|69512045|FG001|Overall Study|Adverse Event|2|||
37903713|NCT01942135|69589494|FG001|Overall Study|Participant Refused toContinue Treatment|1|||
37903714|NCT01942135|69589493|FG000|Overall Study|Withdrawal by Subject|4|||
37903715|NCT01942135|69589494|FG001|Overall Study|Withdrawal by Subject|2|||
37903716|NCT01942135|69589493|FG000|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|238|||
37999823|NCT00004228|69683749|FG003|Overall Study|Lost to Follow-up|0|||
37828913|NCT01057251|69512044|FG000|Overall Study|Lack of Efficacy|2|||
37903717|NCT01942135|69589494|FG001|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|75|||
37903718|NCT01889238|69589500|FG000|Overall Study|Treatment ongoing|9|||
37903719|NCT01696968|69589523|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
37903720|NCT01696968|69589524|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
37903721|NCT01696968|69589523|FG000|Overall Study|Died Before Randomization|3|||
37903722|NCT01696968|69589524|FG001|Overall Study|Died Before Randomization|8|||
37903723|NCT01696968|69589523|FG000|Overall Study|Died Before ASU (Control)|278|||
37903724|NCT01696968|69589524|FG001|Overall Study|Died Before ASU (Control)|0|||
37903725|NCT01696968|69589523|FG000|Overall Study|Refused ASU (Control)|920|||
37903726|NCT01696968|69589524|FG001|Overall Study|Refused ASU (Control)|0|||
37697170|NCT02461589|69173595|FG006|Overall Study|Withdrawal from trial before exposure|0|||
37697171|NCT02461589|69173596|FG007|Overall Study|Withdrawal from trial before exposure|0|||
37697172|NCT02461589|69173597|FG008|Overall Study|Withdrawal from trial before exposure|0|||
37697173|NCT02461589|69173598|FG009|Overall Study|Withdrawal from trial before exposure|1|||
37697174|NCT02089737|69173620|FG000|Overall Study|Survey form not completed|5|||
37903727|NCT01696968|69589523|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
37903728|NCT01696968|69589524|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
37903729|NCT00978341|69589536|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
37903730|NCT00978341|69589537|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
37903731|NCT00978029|69589547|FG000|Overall Study|Adverse Event|1|||
37903732|NCT00978029|69589548|FG001|Overall Study|Adverse Event|2|||
37999824|NCT00004228|69683750|FG004|Overall Study|Lost to Follow-up|0|||
37999825|NCT00004228|69683751|FG005|Overall Study|Lost to Follow-up|0|||
37999826|NCT00004228|69683752|FG006|Overall Study|Lost to Follow-up|0|||
37999827|NCT00004228|69683746|FG000|Overall Study|Physician Decision|1|||
37999828|NCT00004228|69683747|FG001|Overall Study|Physician Decision|0|||
37999829|NCT00004228|69683748|FG002|Overall Study|Physician Decision|3|||
37903733|NCT00978029|69589549|FG002|Overall Study|Adverse Event|5|||
37903734|NCT00978029|69589547|FG000|Overall Study|Withdrawal by Subject|0|||
37903735|NCT00978029|69589548|FG001|Overall Study|Withdrawal by Subject|0|||
37903736|NCT00978029|69589549|FG002|Overall Study|Withdrawal by Subject|1|||
37903737|NCT00978029|69589547|FG000|Overall Study|Protocol Violation|0|||
37903738|NCT00978029|69589548|FG001|Overall Study|Protocol Violation|1|||
37903739|NCT00978029|69589549|FG002|Overall Study|Protocol Violation|0|||
37903740|NCT00871377|69589557|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
37903741|NCT00871377|69589558|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
37903742|NCT00871377|69589559|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
37903743|NCT00871377|69589560|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
37903744|NCT00871377|69589561|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
37903745|NCT00871377|69589562|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
37903746|NCT00871377|69589557|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
37903747|NCT00871377|69589558|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
37903748|NCT00871377|69589559|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
37903749|NCT00871377|69589560|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
37903750|NCT00871377|69589561|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
37903751|NCT00871377|69589562|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
37903752|NCT00871377|69589557|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
37903753|NCT00871377|69589558|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
37903754|NCT00871377|69589559|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
37903755|NCT00871377|69589560|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
37999830|NCT00004228|69683749|FG003|Overall Study|Physician Decision|2|||
37999831|NCT00004228|69683750|FG004|Overall Study|Physician Decision|1|||
37999832|NCT00004228|69683751|FG005|Overall Study|Physician Decision|1|||
37999833|NCT00004228|69683752|FG006|Overall Study|Physician Decision|1|||
37999834|NCT00004228|69683746|FG000|Overall Study|Protocol Violation|0|||
37999835|NCT00004228|69683747|FG001|Overall Study|Protocol Violation|5|||
37999836|NCT00004228|69683748|FG002|Overall Study|Protocol Violation|2|||
37999837|NCT00004228|69683749|FG003|Overall Study|Protocol Violation|1|||
37903756|NCT00871377|69589561|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
37999838|NCT00004228|69683750|FG004|Overall Study|Protocol Violation|1|||
37999839|NCT00004228|69683751|FG005|Overall Study|Protocol Violation|2|||
37999840|NCT00004228|69683752|FG006|Overall Study|Protocol Violation|0|||
37999841|NCT00004228|69683746|FG000|Overall Study|Withdrawal by Subject|3|||
37999842|NCT00004228|69683747|FG001|Overall Study|Withdrawal by Subject|0|||
37999843|NCT00004228|69683748|FG002|Overall Study|Withdrawal by Subject|1|||
37999844|NCT00004228|69683749|FG003|Overall Study|Withdrawal by Subject|0|||
37999845|NCT00004228|69683750|FG004|Overall Study|Withdrawal by Subject|2|||
37999846|NCT00004228|69683751|FG005|Overall Study|Withdrawal by Subject|1|||
37999847|NCT00004228|69683752|FG006|Overall Study|Withdrawal by Subject|2|||
37999848|NCT00004228|69683746|FG000|Overall Study|Other|0|||
37999849|NCT00004228|69683747|FG001|Overall Study|Other|0|||
37999850|NCT00004228|69683748|FG002|Overall Study|Other|1|||
37903757|NCT00871377|69589562|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
37903758|NCT00871377|69589557|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
37903759|NCT00871377|69589558|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
37903760|NCT00871377|69589559|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
37903761|NCT00871377|69589560|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
37903762|NCT00871377|69589561|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
37903763|NCT00871377|69589562|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
37903764|NCT00871377|69589557|FG000|Third Intervention (10 Weeks)|Death|0|||
37903765|NCT00871377|69589558|FG001|Third Intervention (10 Weeks)|Death|0|||
37903766|NCT00871377|69589559|FG002|Third Intervention (10 Weeks)|Death|0|||
37903767|NCT00871377|69589560|FG003|Third Intervention (10 Weeks)|Death|1|||
37903768|NCT00871377|69589561|FG004|Third Intervention (10 Weeks)|Death|0|||
37903769|NCT00871377|69589562|FG005|Third Intervention (10 Weeks)|Death|0|||
37903770|NCT00977561|69589572|FG000|Overall Study|Death|3|||
37903771|NCT00977561|69589573|FG001|Overall Study|Death|2|||
37903772|NCT00977561|69589572|FG000|Overall Study|Study terminated|0|||
37903773|NCT00977561|69589573|FG001|Overall Study|Study terminated|2|||
37903774|NCT00977561|69589572|FG000|Overall Study|Other|2|||
37903775|NCT00977561|69589573|FG001|Overall Study|Other|0|||
37903776|NCT00594165|69589581|FG000|Overall Study|Major protocol violation|1|||
37903777|NCT00594165|69589581|FG000|Overall Study|Lack of Efficacy|12|||
37903778|NCT00594165|69589581|FG000|Overall Study|Adverse Event|52|||
37903779|NCT00594165|69589581|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
37903780|NCT00594165|69589581|FG000|Overall Study|Subject withdrew consent|27|||
37903781|NCT00594165|69589581|FG000|Overall Study|Study ended per sponsor|102|||
37903782|NCT00594165|69589581|FG000|Overall Study|Lost to Follow-up|4|||
37903783|NCT00594165|69589581|FG000|Overall Study|Other: PI discretion|5|||
37903784|NCT00594165|69589581|FG000|Overall Study|Other: Subject moving|3|||
37903785|NCT00594165|69589581|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
37903786|NCT00594165|69589581|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
37903787|NCT00594165|69589581|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
37903788|NCT00594165|69589581|FG000|Overall Study|Other: Site terminated participation|2|||
37903789|NCT00975923|69589587|FG000|Overall Study|Withdrawal by Subject|0|||
37903790|NCT00975923|69589588|FG001|Overall Study|Withdrawal by Subject|1|||
37903791|NCT00928070|69589597|FG000|Overall Study|Lost to Follow-up|1|||
37903792|NCT00928070|69589598|FG001|Overall Study|Lost to Follow-up|2|||
37903793|NCT00928070|69589597|FG000|Overall Study|Withdrawal by Subject|10|||
37903794|NCT00928070|69589598|FG001|Overall Study|Withdrawal by Subject|3|||
37903795|NCT00928070|69589597|FG000|Overall Study|Adverse Event|14|||
37903796|NCT00928070|69589598|FG001|Overall Study|Adverse Event|26|||
37903797|NCT00928070|69589597|FG000|Overall Study|Lack of Efficacy|9|||
37903798|NCT00928070|69589598|FG001|Overall Study|Lack of Efficacy|5|||
37903799|NCT00928070|69589597|FG000|Overall Study|Did not meet entrance criteria|16|||
37903800|NCT00928070|69589598|FG001|Overall Study|Did not meet entrance criteria|9|||
37903801|NCT00928070|69589597|FG000|Overall Study|Protocol Violation|6|||
37999851|NCT00004228|69683749|FG003|Overall Study|Other|0|||
37903802|NCT00928070|69589598|FG001|Overall Study|Protocol Violation|5|||
37999852|NCT00004228|69683750|FG004|Overall Study|Other|0|||
37903803|NCT00928070|69589597|FG000|Overall Study|Randomized but not treated|2|||
37828914|NCT01057251|69512045|FG001|Overall Study|Lack of Efficacy|11|||
37903804|NCT00928070|69589598|FG001|Overall Study|Randomized but not treated|2|||
37903805|NCT00928070|69589597|FG000|Overall Study|Other|5|||
37903806|NCT00928070|69589598|FG001|Overall Study|Other|5|||
37903807|NCT00924404|69589606|FG000|Overall Study|Lost to Follow-up|6|||
37903808|NCT00924404|69589607|FG001|Overall Study|Lost to Follow-up|4|||
37903809|NCT00976937|69589615|FG000|Overall Study|Adverse Event|4|||
37903810|NCT00976937|69589616|FG001|Overall Study|Adverse Event|5|||
37903811|NCT00976937|69589615|FG000|Overall Study|Lost to Follow-up|2|||
37903812|NCT00976937|69589616|FG001|Overall Study|Lost to Follow-up|1|||
37903813|NCT00976937|69589615|FG000|Overall Study|Withdrawal by Subject|5|||
37903814|NCT00976937|69589616|FG001|Overall Study|Withdrawal by Subject|3|||
37903815|NCT00976937|69589615|FG000|Overall Study|Poor compliance to protocol|3|||
37903816|NCT00976937|69589616|FG001|Overall Study|Poor compliance to protocol|0|||
37903817|NCT00976937|69589615|FG000|Overall Study|Personal and Familial Reason|2|||
37999853|NCT00004228|69683751|FG005|Overall Study|Other|0|||
37999854|NCT00004228|69683752|FG006|Overall Study|Other|0|||
37999855|NCT00004228|69683746|FG000|Overall Study|ineligible|4|||
37999856|NCT00004228|69683747|FG001|Overall Study|ineligible|2|||
37999857|NCT00004228|69683748|FG002|Overall Study|ineligible|4|||
37999858|NCT00004228|69683749|FG003|Overall Study|ineligible|1|||
37999859|NCT00004228|69683750|FG004|Overall Study|ineligible|1|||
37999860|NCT00004228|69683751|FG005|Overall Study|ineligible|2|||
37999861|NCT00004228|69683752|FG006|Overall Study|ineligible|5|||
37999862|NCT00003526|69683769|FG000|Overall Study|Not evaluable|6|||
37999863|NCT00195260|69683775|FG000|Part 1: Dose Escalation|Adverse Event|0|||
37999864|NCT00195260|69683776|FG001|Part 1: Dose Escalation|Adverse Event|1|||
37999865|NCT00195260|69683777|FG002|Part 1: Dose Escalation|Adverse Event|0|||
37999866|NCT00195260|69683778|FG003|Part 1: Dose Escalation|Adverse Event|1|||
37999867|NCT00195260|69683779|FG004|Part 1: Dose Escalation|Adverse Event|1|||
37999868|NCT00195260|69683780|FG005|Part 1: Dose Escalation|Adverse Event|0|||
37999869|NCT00195260|69683781|FG006|Part 1: Dose Escalation|Adverse Event|3|||
37999870|NCT00195260|69683782|FG007|Part 1: Dose Escalation|Adverse Event|0|||
37999871|NCT00195260|69683783|FG008|Part 1: Dose Escalation|Adverse Event|0|||
37999872|NCT00195260|69683784|FG009|Part 1: Dose Escalation|Adverse Event|0|||
37999873|NCT00195260|69683785|FG010|Part 1: Dose Escalation|Adverse Event|0|||
37999874|NCT00195260|69683775|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
37999875|NCT00195260|69683776|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
37999876|NCT00195260|69683777|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
37828915|NCT01057251|69512044|FG000|Overall Study|Protocol Violation|6|||
37828916|NCT01057251|69512045|FG001|Overall Study|Protocol Violation|2|||
37828917|NCT01057251|69512044|FG000|Overall Study|Withdrawal by Subject|4|||
37828918|NCT01057251|69512045|FG001|Overall Study|Withdrawal by Subject|5|||
37828919|NCT01057251|69512044|FG000|Overall Study|Lost to Follow-up|7|||
37828920|NCT01057251|69512045|FG001|Overall Study|Lost to Follow-up|6|||
37828921|NCT01057251|69512044|FG000|Overall Study|Other Reason|1|||
37828922|NCT01057251|69512045|FG001|Overall Study|Other Reason|1|||
37828923|NCT01056822|69512053|FG000|Overall Study|Adverse Event|0|||
37828924|NCT01056822|69512054|FG001|Overall Study|Adverse Event|1|||
37828925|NCT01056822|69512053|FG000|Overall Study|Protocol Violation|6|||
37828926|NCT01056822|69512054|FG001|Overall Study|Protocol Violation|5|||
37828927|NCT01056822|69512053|FG000|Overall Study|Withdrawal by Subject|1|||
37828928|NCT01056822|69512054|FG001|Overall Study|Withdrawal by Subject|1|||
37903818|NCT00976937|69589616|FG001|Overall Study|Personal and Familial Reason|2|||
37903819|NCT00976703|69589624|FG000|Overall Study|Physician Decision|1|||
37903820|NCT00976703|69589625|FG001|Overall Study|Physician Decision|1|||
37903821|NCT00976703|69589624|FG000|Overall Study|ineligible for study|2|||
37828929|NCT01056822|69512053|FG000|Overall Study|Lost to Follow-up|1|||
37903822|NCT00976703|69589625|FG001|Overall Study|ineligible for study|2|||
37903823|NCT00975689|69589633|FG000|Overall Study|Adverse Event|0|||
37999877|NCT00195260|69683778|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
37999878|NCT00195260|69683779|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
37999879|NCT00195260|69683780|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
37999880|NCT00195260|69683781|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
37999881|NCT00195260|69683782|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
37828930|NCT01056822|69512054|FG001|Overall Study|Lost to Follow-up|0|||
37828931|NCT01051791|69512061|FG000|Overall Study|Failed screening|3|||
37828932|NCT01051791|69512061|FG000|Overall Study|Withdrawal by Subject|1|||
37828933|NCT01056510|69512073|FG000|Overall Study|Dropout Before Start of Treatment|1|||
37828934|NCT01056510|69512074|FG001|Overall Study|Dropout Before Start of Treatment|1|||
37828935|NCT01056510|69512073|FG000|Overall Study|Withdrawal by Subject|4|||
37828936|NCT01056510|69512074|FG001|Overall Study|Withdrawal by Subject|2|||
37828937|NCT01056510|69512073|FG000|Overall Study|Death|29|||
37999882|NCT00195260|69683783|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
37999883|NCT00195260|69683784|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
37999884|NCT00195260|69683785|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
37999885|NCT00195260|69683775|FG000|Part 1: Dose Escalation|Death|0|||
37999886|NCT00195260|69683776|FG001|Part 1: Dose Escalation|Death|0|||
37999887|NCT00195260|69683777|FG002|Part 1: Dose Escalation|Death|0|||
37999888|NCT00195260|69683778|FG003|Part 1: Dose Escalation|Death|0|||
37999889|NCT00195260|69683779|FG004|Part 1: Dose Escalation|Death|0|||
37999890|NCT00195260|69683780|FG005|Part 1: Dose Escalation|Death|0|||
37903824|NCT00975689|69589634|FG001|Overall Study|Adverse Event|3|||
37903825|NCT00975689|69589633|FG000|Overall Study|Withdrawal by Subject|1|||
37903826|NCT00975689|69589634|FG001|Overall Study|Withdrawal by Subject|0|||
37903827|NCT00975689|69589633|FG000|Overall Study|Physician Decision|1|||
37903828|NCT00975689|69589634|FG001|Overall Study|Physician Decision|0|||
37903829|NCT00922766|69589640|FG000|Overall Study|Death|3|||
37903830|NCT00922766|69589640|FG000|Overall Study|Withdrawal by Subject|2|||
37903831|NCT00922766|69589640|FG000|Overall Study|Other|1|||
37903832|NCT00922766|69589640|FG000|Overall Study|Adverse Event|1|||
37903833|NCT00917852|69589644|FG000|Overall Study|Death|6|||
37903834|NCT00976391|69589651|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
37903835|NCT00976391|69589652|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
37903836|NCT00976391|69589651|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
37903837|NCT00976391|69589652|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
37903838|NCT00976391|69589651|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
37903839|NCT00976391|69589652|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
37903840|NCT00976391|69589651|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
37903841|NCT00976391|69589652|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
37903842|NCT00976391|69589651|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
37697175|NCT02089737|69173620|FG000|Overall Study|Not treated|1|||
37697176|NCT02460575|69173627|FG000|Overall Study|Lost to Follow-up|1|||
37697177|NCT02460575|69173628|FG001|Overall Study|Lost to Follow-up|0|||
37697178|NCT02089347|69173636|FG000|Overall Study|Protocol Violation|1|||
37697179|NCT02089347|69173637|FG001|Overall Study|Protocol Violation|0|||
37697180|NCT02445755|69173643|FG000|Overall Study|Withdrawal by Subject|2|||
37697181|NCT02445755|69173643|FG000|Overall Study|Protocol Violation|6|||
37697182|NCT02445755|69173643|FG000|Overall Study|Screen Failure|5|||
37697183|NCT02419469|69173650|FG000|Overall Study|Withdrawal by Subject|1|||
37697184|NCT02419313|69173654|FG000|First Intervention|Lost to Follow-up|2|||
37697185|NCT02419313|69173655|FG001|First Intervention|Lost to Follow-up|0|||
37903843|NCT00976391|69589652|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
37903844|NCT00976391|69589651|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
37903845|NCT00976391|69589652|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
37903846|NCT00976391|69589651|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
37903847|NCT00976391|69589652|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
37999891|NCT00195260|69683781|FG006|Part 1: Dose Escalation|Death|0|||
37697186|NCT02419313|69173654|FG000|Second Intervention|Lost to Follow-up|1|||
37828938|NCT01056510|69512074|FG001|Overall Study|Death|34|||
37828939|NCT01056510|69512073|FG000|Overall Study|Noncompliance|1|||
37828940|NCT01056510|69512074|FG001|Overall Study|Noncompliance|3|||
37828941|NCT01056510|69512073|FG000|Overall Study|Physician Decision|4|||
37828942|NCT01056510|69512074|FG001|Overall Study|Physician Decision|5|||
37828943|NCT01056510|69512073|FG000|Overall Study|Lost to Follow-up|5|||
37828944|NCT01056510|69512074|FG001|Overall Study|Lost to Follow-up|6|||
37828945|NCT01056510|69512073|FG000|Overall Study|Other|10|||
37828946|NCT01056510|69512074|FG001|Overall Study|Other|12|||
37828947|NCT01056510|69512073|FG000|Overall Study|Missing|0|||
37828948|NCT01056510|69512074|FG001|Overall Study|Missing|1|||
37828949|NCT01051323|69512082|FG000|Overall Study|Discontinuation of treatment|103|||
37903848|NCT00976391|69589651|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
37903849|NCT00976391|69589652|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
37697187|NCT02419313|69173655|FG001|Second Intervention|Lost to Follow-up|0|||
37697188|NCT02419001|69173663|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
37697189|NCT02419001|69173664|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
37903850|NCT00976391|69589651|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
37999892|NCT00195260|69683782|FG007|Part 1: Dose Escalation|Death|1|||
37999893|NCT00195260|69683783|FG008|Part 1: Dose Escalation|Death|0|||
37697190|NCT02031237|69173672|FG000|Overall Study|Death|1|||
37828950|NCT01051323|69512082|FG000|Overall Study|Transplantation|28|||
37828951|NCT01051323|69512082|FG000|Overall Study|Dialysis dependency|22|||
37828952|NCT01051323|69512082|FG000|Overall Study|Withdrawal by Subject|13|||
37903851|NCT00976391|69589652|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
37999894|NCT00195260|69683784|FG009|Part 1: Dose Escalation|Death|0|||
37999895|NCT00195260|69683785|FG010|Part 1: Dose Escalation|Death|0|||
37999896|NCT00195260|69683775|FG000|Part 1: Dose Escalation|Disease Progression|3|||
37999897|NCT00195260|69683776|FG001|Part 1: Dose Escalation|Disease Progression|2|||
37903852|NCT00976391|69589651|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
37903853|NCT00976391|69589652|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
37903854|NCT00976391|69589651|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
37903855|NCT00976391|69589652|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
37903856|NCT00976391|69589651|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
37903857|NCT00976391|69589652|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
37903858|NCT00976391|69589651|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
37999898|NCT00195260|69683777|FG002|Part 1: Dose Escalation|Disease Progression|5|||
37999899|NCT00195260|69683778|FG003|Part 1: Dose Escalation|Disease Progression|6|||
37999900|NCT00195260|69683779|FG004|Part 1: Dose Escalation|Disease Progression|4|||
37999901|NCT00195260|69683780|FG005|Part 1: Dose Escalation|Disease Progression|6|||
37999902|NCT00195260|69683781|FG006|Part 1: Dose Escalation|Disease Progression|7|||
37999903|NCT00195260|69683782|FG007|Part 1: Dose Escalation|Disease Progression|4|||
37999904|NCT00195260|69683783|FG008|Part 1: Dose Escalation|Disease Progression|0|||
37999905|NCT00195260|69683784|FG009|Part 1: Dose Escalation|Disease Progression|0|||
37999906|NCT00195260|69683785|FG010|Part 1: Dose Escalation|Disease Progression|0|||
37999907|NCT00195260|69683775|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
37999908|NCT00195260|69683776|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
37999909|NCT00195260|69683777|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
37999910|NCT00195260|69683778|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
37999911|NCT00195260|69683779|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
37999912|NCT00195260|69683780|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
37999913|NCT00195260|69683781|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
37999914|NCT00195260|69683782|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
37999915|NCT00195260|69683783|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
37999916|NCT00195260|69683784|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
37999917|NCT00195260|69683785|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
37697191|NCT02031237|69173673|FG001|Overall Study|Death|5|||
37697192|NCT02031237|69173674|FG002|Overall Study|Death|0|||
37828953|NCT01051323|69512082|FG000|Overall Study|Lost to Follow-up|31|||
37828954|NCT01051323|69512082|FG000|Overall Study|Death|129|||
37828955|NCT01051323|69512082|FG000|Overall Study|Hospitalization|28|||
37828956|NCT01051323|69512082|FG000|Overall Study|Other|148|||
37828957|NCT01051323|69512082|FG000|Overall Study|Missing|37|||
37828958|NCT01056276|69512092|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
37828959|NCT01056276|69512093|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
37828960|NCT01056276|69512092|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
37828961|NCT01056276|69512093|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
37903859|NCT00976391|69589652|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
37903860|NCT00976391|69589651|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
37903861|NCT00976391|69589652|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
37903862|NCT00917462|69589658|FG000|Overall Study|Clinical Deterioration|1|||
37903863|NCT00979901|69589666|FG000|Overall Study|Adverse Event|1|||
37903864|NCT00979901|69589667|FG001|Overall Study|Adverse Event|3|||
37903865|NCT00979901|69589668|FG002|Overall Study|Adverse Event|9|||
37903866|NCT00979901|69589669|FG003|Overall Study|Adverse Event|2|||
37903867|NCT00979901|69589666|FG000|Overall Study|Lack of Efficacy|8|||
37903868|NCT00979901|69589667|FG001|Overall Study|Lack of Efficacy|4|||
37903869|NCT00979901|69589668|FG002|Overall Study|Lack of Efficacy|9|||
37903870|NCT00979901|69589669|FG003|Overall Study|Lack of Efficacy|0|||
37903871|NCT00979901|69589666|FG000|Overall Study|Lost to Follow-up|1|||
37903872|NCT00979901|69589667|FG001|Overall Study|Lost to Follow-up|1|||
37903873|NCT00979901|69589668|FG002|Overall Study|Lost to Follow-up|2|||
37903874|NCT00979901|69589669|FG003|Overall Study|Lost to Follow-up|0|||
37903875|NCT00979901|69589666|FG000|Overall Study|Protocol Violation|2|||
37903876|NCT00979901|69589667|FG001|Overall Study|Protocol Violation|2|||
37903877|NCT00979901|69589668|FG002|Overall Study|Protocol Violation|7|||
37999918|NCT00195260|69683775|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
37999919|NCT00195260|69683776|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
37828962|NCT01056276|69512092|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
37999920|NCT00195260|69683777|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
37999921|NCT00195260|69683778|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
37999922|NCT00195260|69683779|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
37999923|NCT00195260|69683780|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
37903878|NCT00979901|69589669|FG003|Overall Study|Protocol Violation|1|||
37903879|NCT00979901|69589666|FG000|Overall Study|Withdrawal by Subject|2|||
37903880|NCT00979901|69589667|FG001|Overall Study|Withdrawal by Subject|1|||
37903881|NCT00979901|69589668|FG002|Overall Study|Withdrawal by Subject|1|||
37903882|NCT00979901|69589669|FG003|Overall Study|Withdrawal by Subject|1|||
37903883|NCT00979901|69589666|FG000|Overall Study|Noncompliance|1|||
37903884|NCT00979901|69589667|FG001|Overall Study|Noncompliance|0|||
37903885|NCT00979901|69589668|FG002|Overall Study|Noncompliance|0|||
37903886|NCT00979901|69589669|FG003|Overall Study|Noncompliance|0|||
37903887|NCT00979901|69589666|FG000|Overall Study|out-of-state|1|||
37903888|NCT00979901|69589667|FG001|Overall Study|out-of-state|0|||
37903889|NCT00979901|69589668|FG002|Overall Study|out-of-state|0|||
37903890|NCT00979901|69589669|FG003|Overall Study|out-of-state|0|||
37903891|NCT00979901|69589666|FG000|Overall Study|vacation|1|||
37903892|NCT00979901|69589667|FG001|Overall Study|vacation|0|||
37903893|NCT00979901|69589668|FG002|Overall Study|vacation|0|||
37903894|NCT00979901|69589669|FG003|Overall Study|vacation|0|||
37903895|NCT00979901|69589666|FG000|Overall Study|elevated lab values pre-randomization|1|||
37903896|NCT00979901|69589667|FG001|Overall Study|elevated lab values pre-randomization|0|||
37903897|NCT00979901|69589668|FG002|Overall Study|elevated lab values pre-randomization|0|||
37903898|NCT00979901|69589669|FG003|Overall Study|elevated lab values pre-randomization|0|||
37903899|NCT00979901|69589666|FG000|Overall Study|Discontinued in Error|0|||
37903900|NCT00979901|69589667|FG001|Overall Study|Discontinued in Error|1|||
37903901|NCT00979901|69589668|FG002|Overall Study|Discontinued in Error|0|||
37903902|NCT00979901|69589669|FG003|Overall Study|Discontinued in Error|0|||
37903903|NCT00979901|69589666|FG000|Overall Study|Left Country|0|||
37903904|NCT00979901|69589667|FG001|Overall Study|Left Country|0|||
37903905|NCT00979901|69589668|FG002|Overall Study|Left Country|1|||
37903906|NCT00979901|69589669|FG003|Overall Study|Left Country|0|||
37903907|NCT00979901|69589666|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
37903908|NCT00979901|69589667|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
37903909|NCT00979901|69589668|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
37903910|NCT00979901|69589669|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
37903911|NCT00975611|69589678|FG000|Overall Study|Screen Fail|16|||
37903912|NCT00975611|69589678|FG000|Overall Study|Physician Decision|1|||
37903913|NCT00970307|69589685|FG000|Overall Study|Serious Adverse Event|1|||
37903914|NCT00970307|69589686|FG001|Overall Study|Serious Adverse Event|0|||
37903915|NCT00970307|69589687|FG002|Overall Study|Serious Adverse Event|0|||
37903916|NCT00970307|69589685|FG000|Overall Study|Withdrawal by Subject|2|||
37903917|NCT00970307|69589686|FG001|Overall Study|Withdrawal by Subject|3|||
37903918|NCT00970307|69589687|FG002|Overall Study|Withdrawal by Subject|2|||
37903919|NCT00917384|69589697|FG000|Overall Study|Lost to Follow-up|4|||
37903920|NCT00917384|69589698|FG001|Overall Study|Lost to Follow-up|2|||
37903921|NCT00917384|69589697|FG000|Overall Study|Withdrawal by Subject|10|||
37903922|NCT00917384|69589698|FG001|Overall Study|Withdrawal by Subject|2|||
37903923|NCT00864513|69589704|FG000|Overall Study|Withdrawal by Subject|3|||
37903924|NCT00917150|69589712|FG000|Overall Study|Adverse Event|12|||
37828963|NCT01056276|69512093|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
37828964|NCT01056276|69512092|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
37828965|NCT01056276|69512093|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
37828966|NCT01056276|69512092|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
37828967|NCT01056276|69512093|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
37828968|NCT01056276|69512092|FG000|Treatment Period-Cycles 1-8|Death|3|||
37828969|NCT01056276|69512093|FG001|Treatment Period-Cycles 1-8|Death|1|||
37828970|NCT01056276|69512092|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
37828971|NCT01056276|69512093|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
37828972|NCT01056276|69512092|FG000|Maintenance Therapy|Toxicity|0|||
37828973|NCT01056276|69512093|FG001|Maintenance Therapy|Toxicity|2|||
37828974|NCT01056276|69512092|FG000|Maintenance Therapy|Progressive Disease|0|||
37828975|NCT01056276|69512093|FG001|Maintenance Therapy|Progressive Disease|9|||
37828976|NCT01056276|69512092|FG000|Maintenance Therapy|Physician Decision|0|||
37828977|NCT01056276|69512093|FG001|Maintenance Therapy|Physician Decision|1|||
37828978|NCT01056276|69512092|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
37828979|NCT01056276|69512093|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
37828980|NCT01056276|69512092|FG000|Maintenance Therapy|Intercurrent Illness|0|||
37828981|NCT01056276|69512093|FG001|Maintenance Therapy|Intercurrent Illness|1|||
37828982|NCT01056276|69512092|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
37828983|NCT01056276|69512093|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
37828984|NCT01055886|69512106|FG000|Overall Study|Withdrawal by Subject|4|||
37828985|NCT01055886|69512107|FG001|Overall Study|Withdrawal by Subject|9|||
37828986|NCT01055886|69512106|FG000|Overall Study|Lost to Follow-up|1|||
37903925|NCT00917150|69589713|FG001|Overall Study|Adverse Event|7|||
37903926|NCT00917150|69589714|FG002|Overall Study|Adverse Event|12|||
37903927|NCT00917150|69589715|FG003|Overall Study|Adverse Event|11|||
37903928|NCT00917150|69589712|FG000|Overall Study|Death|1|||
37903929|NCT00917150|69589713|FG001|Overall Study|Death|4|||
37903930|NCT00917150|69589714|FG002|Overall Study|Death|3|||
37903931|NCT00917150|69589715|FG003|Overall Study|Death|2|||
37903932|NCT00917150|69589712|FG000|Overall Study|Lost to Follow-up|1|||
37903933|NCT00917150|69589713|FG001|Overall Study|Lost to Follow-up|0|||
37903934|NCT00917150|69589714|FG002|Overall Study|Lost to Follow-up|4|||
37903935|NCT00917150|69589715|FG003|Overall Study|Lost to Follow-up|2|||
37903936|NCT00917150|69589712|FG000|Overall Study|Physician Decision|0|||
37903937|NCT00917150|69589713|FG001|Overall Study|Physician Decision|2|||
37903938|NCT00917150|69589714|FG002|Overall Study|Physician Decision|0|||
37903939|NCT00917150|69589715|FG003|Overall Study|Physician Decision|1|||
37903940|NCT00917150|69589712|FG000|Overall Study|Protocol Violation|5|||
37903941|NCT00917150|69589713|FG001|Overall Study|Protocol Violation|5|||
37903942|NCT00917150|69589714|FG002|Overall Study|Protocol Violation|3|||
37903943|NCT00917150|69589715|FG003|Overall Study|Protocol Violation|5|||
37903944|NCT00917150|69589712|FG000|Overall Study|Withdrawal by Subject|15|||
37697193|NCT02031237|69173672|FG000|Overall Study|Physician Decision|0|||
37828987|NCT01055886|69512107|FG001|Overall Study|Lost to Follow-up|1|||
37828988|NCT01055886|69512106|FG000|Overall Study|Withdrawal by PI|0|||
37828989|NCT01055886|69512107|FG001|Overall Study|Withdrawal by PI|1|||
37828990|NCT01055613|69512115|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
37828991|NCT01055613|69512116|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
37828992|NCT01055613|69512115|FG000|Overall Study|Unacceptable lens fit|1|||
37828993|NCT01055613|69512116|FG001|Overall Study|Unacceptable lens fit|0|||
37828994|NCT01055613|69512115|FG000|Overall Study|Discomfort|2|||
37828995|NCT01055613|69512116|FG001|Overall Study|Discomfort|1|||
37828996|NCT01055613|69512115|FG000|Overall Study|Lost to Follow-up|1|||
37903945|NCT00917150|69589713|FG001|Overall Study|Withdrawal by Subject|16|||
37697194|NCT02031237|69173673|FG001|Overall Study|Physician Decision|1|||
37828997|NCT01055613|69512116|FG001|Overall Study|Lost to Follow-up|1|||
37903946|NCT00917150|69589714|FG002|Overall Study|Withdrawal by Subject|18|||
37903947|NCT00917150|69589715|FG003|Overall Study|Withdrawal by Subject|11|||
37903948|NCT00917150|69589712|FG000|Overall Study|Other than specified|3|||
37903949|NCT00917150|69589713|FG001|Overall Study|Other than specified|3|||
37903950|NCT00917150|69589714|FG002|Overall Study|Other than specified|2|||
37903951|NCT00917150|69589715|FG003|Overall Study|Other than specified|2|||
37697195|NCT02031237|69173674|FG002|Overall Study|Physician Decision|0|||
37828998|NCT01055613|69512115|FG000|Overall Study|Protocol Violation|1|||
37828999|NCT01055613|69512116|FG001|Overall Study|Protocol Violation|1|||
37829000|NCT01055613|69512115|FG000|Overall Study|Subject Disinterest|1|||
37829001|NCT01055613|69512116|FG001|Overall Study|Subject Disinterest|1|||
37829002|NCT01055457|69512132|FG000|Overall Study|Lost to Follow-up|0|||
37697196|NCT02031237|69173672|FG000|Overall Study|Withdrawal by Subject|2|||
37829003|NCT01055457|69512133|FG001|Overall Study|Lost to Follow-up|1|||
37829004|NCT01055457|69512134|FG002|Overall Study|Lost to Follow-up|0|||
37829005|NCT01055457|69512135|FG003|Overall Study|Lost to Follow-up|0|||
37829006|NCT01055457|69512136|FG004|Overall Study|Lost to Follow-up|0|||
37829007|NCT01055457|69512137|FG005|Overall Study|Lost to Follow-up|1|||
37829008|NCT01055457|69512138|FG006|Overall Study|Lost to Follow-up|0|||
37829009|NCT01055457|69512139|FG007|Overall Study|Lost to Follow-up|0|||
37829010|NCT01055457|69512140|FG008|Overall Study|Lost to Follow-up|0|||
37829011|NCT01055457|69512141|FG009|Overall Study|Lost to Follow-up|0|||
37829012|NCT01055457|69512132|FG000|Overall Study|Protocol Violation|0|||
37829013|NCT01055457|69512133|FG001|Overall Study|Protocol Violation|0|||
37829014|NCT01055457|69512134|FG002|Overall Study|Protocol Violation|1|||
37829015|NCT01055457|69512135|FG003|Overall Study|Protocol Violation|1|||
37829016|NCT01055457|69512136|FG004|Overall Study|Protocol Violation|1|||
37829017|NCT01055457|69512137|FG005|Overall Study|Protocol Violation|2|||
37903952|NCT00659425|69589735|FG000|Overall Study|Disease progression|1|||
37903953|NCT00659425|69589736|FG001|Overall Study|Disease progression|0|||
37903954|NCT00659425|69589737|FG002|Overall Study|Disease progression|0|||
37903955|NCT00659425|69589738|FG003|Overall Study|Disease progression|1|||
37903956|NCT00659425|69589739|FG004|Overall Study|Disease progression|0|||
37903957|NCT00659425|69589740|FG005|Overall Study|Disease progression|2|||
37829018|NCT01055457|69512138|FG006|Overall Study|Protocol Violation|1|||
37829019|NCT01055457|69512139|FG007|Overall Study|Protocol Violation|0|||
37903958|NCT00659425|69589741|FG006|Overall Study|Disease progression|4|||
37903959|NCT00659425|69589742|FG007|Overall Study|Disease progression|3|||
37903960|NCT00659425|69589743|FG008|Overall Study|Disease progression|5|||
37903961|NCT00659425|69589744|FG009|Overall Study|Disease progression|3|||
37903962|NCT00659425|69589735|FG000|Overall Study|Death|0|||
37903963|NCT00659425|69589736|FG001|Overall Study|Death|0|||
37829020|NCT01055457|69512140|FG008|Overall Study|Protocol Violation|0|||
37829021|NCT01055457|69512141|FG009|Overall Study|Protocol Violation|1|||
37829022|NCT01055457|69512132|FG000|Overall Study|Subject Disinterest|0|||
37829023|NCT01055457|69512133|FG001|Overall Study|Subject Disinterest|0|||
37829024|NCT01055457|69512134|FG002|Overall Study|Subject Disinterest|0|||
37903964|NCT00659425|69589737|FG002|Overall Study|Death|0|||
37903965|NCT00659425|69589738|FG003|Overall Study|Death|1|||
37903966|NCT00659425|69589739|FG004|Overall Study|Death|0|||
37903967|NCT00659425|69589740|FG005|Overall Study|Death|0|||
37903968|NCT00659425|69589741|FG006|Overall Study|Death|1|||
37903969|NCT00659425|69589742|FG007|Overall Study|Death|0|||
37903970|NCT00659425|69589743|FG008|Overall Study|Death|0|||
37903971|NCT00659425|69589744|FG009|Overall Study|Death|0|||
37903972|NCT00659425|69589735|FG000|Overall Study|Adverse Event|0|||
37903973|NCT00659425|69589736|FG001|Overall Study|Adverse Event|0|||
37903974|NCT00659425|69589737|FG002|Overall Study|Adverse Event|0|||
37903975|NCT00659425|69589738|FG003|Overall Study|Adverse Event|0|||
37903976|NCT00659425|69589739|FG004|Overall Study|Adverse Event|0|||
37903977|NCT00659425|69589740|FG005|Overall Study|Adverse Event|1|||
37903978|NCT00659425|69589741|FG006|Overall Study|Adverse Event|0|||
37903979|NCT00659425|69589742|FG007|Overall Study|Adverse Event|3|||
37903980|NCT00659425|69589743|FG008|Overall Study|Adverse Event|1|||
37903981|NCT00659425|69589744|FG009|Overall Study|Adverse Event|4|||
37903982|NCT00659425|69589735|FG000|Overall Study|Investigator Discretion|0|||
37829025|NCT01055457|69512135|FG003|Overall Study|Subject Disinterest|0|||
37903983|NCT00659425|69589736|FG001|Overall Study|Investigator Discretion|0|||
37903984|NCT00659425|69589737|FG002|Overall Study|Investigator Discretion|0|||
37903985|NCT00659425|69589738|FG003|Overall Study|Investigator Discretion|0|||
37903986|NCT00659425|69589739|FG004|Overall Study|Investigator Discretion|0|||
37999924|NCT00195260|69683781|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
37829026|NCT01055457|69512136|FG004|Overall Study|Subject Disinterest|0|||
37829027|NCT01055457|69512137|FG005|Overall Study|Subject Disinterest|0|||
37829028|NCT01055457|69512138|FG006|Overall Study|Subject Disinterest|0|||
37829029|NCT01055457|69512139|FG007|Overall Study|Subject Disinterest|1|||
37829030|NCT01055457|69512140|FG008|Overall Study|Subject Disinterest|0|||
37829031|NCT01055457|69512141|FG009|Overall Study|Subject Disinterest|0|||
37903987|NCT00659425|69589740|FG005|Overall Study|Investigator Discretion|1|||
37903988|NCT00659425|69589741|FG006|Overall Study|Investigator Discretion|0|||
37903989|NCT00659425|69589742|FG007|Overall Study|Investigator Discretion|3|||
37903990|NCT00659425|69589743|FG008|Overall Study|Investigator Discretion|0|||
37903991|NCT00659425|69589744|FG009|Overall Study|Investigator Discretion|0|||
37903992|NCT00659425|69589735|FG000|Overall Study|Other|0|||
37903993|NCT00659425|69589736|FG001|Overall Study|Other|1|||
37697197|NCT02031237|69173673|FG001|Overall Study|Withdrawal by Subject|2|||
37697198|NCT02031237|69173674|FG002|Overall Study|Withdrawal by Subject|0|||
37697199|NCT02031237|69173672|FG000|Overall Study|Protocol Violation|2|||
37697200|NCT02031237|69173673|FG001|Overall Study|Protocol Violation|6|||
37697201|NCT02031237|69173674|FG002|Overall Study|Protocol Violation|0|||
37697202|NCT02031237|69173672|FG000|Overall Study|Alternate Treatment Given|0|||
37697203|NCT02031237|69173673|FG001|Overall Study|Alternate Treatment Given|0|||
37697204|NCT02031237|69173674|FG002|Overall Study|Alternate Treatment Given|3|||
37697205|NCT02088957|69173681|FG000|Overall Study|Lack of Efficacy|1|||
37697206|NCT02088957|69173682|FG001|Overall Study|Lack of Efficacy|0|||
37697207|NCT02418845|69173690|FG000|Overall Study|Lost to Follow-up|7|||
37697208|NCT02418845|69173691|FG001|Overall Study|Lost to Follow-up|2|||
37697209|NCT02418845|69173690|FG000|Overall Study|Lack of Efficacy|0|||
37697210|NCT02418845|69173691|FG001|Overall Study|Lack of Efficacy|3|||
37697211|NCT02418845|69173690|FG000|Overall Study|Physician Decision|5|||
37697212|NCT02418845|69173691|FG001|Overall Study|Physician Decision|5|||
37697213|NCT02418845|69173690|FG000|Overall Study|Protocol Violation|1|||
37697214|NCT02418845|69173691|FG001|Overall Study|Protocol Violation|0|||
37697215|NCT02418845|69173690|FG000|Overall Study|Withdrawal by Subject|3|||
37697216|NCT02418845|69173691|FG001|Overall Study|Withdrawal by Subject|2|||
37697217|NCT02088177|69173697|FG000|Overall Study|Lost to Follow-up|3|||
37697218|NCT02030535|69173701|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
37697219|NCT02029989|69173717|FG000|Overall Study|Withdrawal by Subject|1|||
37697220|NCT02029989|69173718|FG001|Overall Study|Withdrawal by Subject|0|||
37829032|NCT01055457|69512132|FG000|Overall Study|Subject Ineligible|1|||
37697221|NCT02029989|69173717|FG000|Overall Study|Withdrawal: Fear of needles|1|||
37697222|NCT02029989|69173718|FG001|Overall Study|Withdrawal: Fear of needles|0|||
37697223|NCT02029989|69173717|FG000|Overall Study|Change of location|2|||
37697224|NCT02029989|69173718|FG001|Overall Study|Change of location|3|||
37697225|NCT02029989|69173717|FG000|Overall Study|Physician Decision|2|||
37697226|NCT02029989|69173718|FG001|Overall Study|Physician Decision|0|||
37829033|NCT01055457|69512133|FG001|Overall Study|Subject Ineligible|0|||
37697227|NCT02029989|69173717|FG000|Overall Study|Lost to Follow-up|9|||
37697228|NCT02029989|69173718|FG001|Overall Study|Lost to Follow-up|7|||
37697229|NCT02029989|69173717|FG000|Overall Study|Death|0|||
37697230|NCT02029989|69173718|FG001|Overall Study|Death|1|||
37697231|NCT02029989|69173717|FG000|Overall Study|Protocol Violation|1|||
37697232|NCT02029989|69173718|FG001|Overall Study|Protocol Violation|0|||
37697233|NCT02048241|69173726|FG000|Overall Study|Withdrawal by Subject|0|||
37697234|NCT02048241|69173727|FG001|Overall Study|Withdrawal by Subject|1|||
37697235|NCT02087943|69173736|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
37697236|NCT02087943|69173737|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
37697237|NCT02087943|69173738|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
37697238|NCT02087943|69173739|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
37697239|NCT02087943|69173740|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
37829034|NCT01055457|69512134|FG002|Overall Study|Subject Ineligible|1|||
37829035|NCT01055457|69512135|FG003|Overall Study|Subject Ineligible|0|||
37829036|NCT01055457|69512136|FG004|Overall Study|Subject Ineligible|1|||
37829037|NCT01055457|69512137|FG005|Overall Study|Subject Ineligible|0|||
37829038|NCT01055457|69512138|FG006|Overall Study|Subject Ineligible|0|||
37829039|NCT01055457|69512139|FG007|Overall Study|Subject Ineligible|0|||
37829040|NCT01055457|69512140|FG008|Overall Study|Subject Ineligible|0|||
37829041|NCT01055457|69512141|FG009|Overall Study|Subject Ineligible|0|||
37829042|NCT01055457|69512132|FG000|Overall Study|Discomfort|0|||
37829043|NCT01055457|69512133|FG001|Overall Study|Discomfort|0|||
37829044|NCT01055457|69512134|FG002|Overall Study|Discomfort|0|||
37829045|NCT01055457|69512135|FG003|Overall Study|Discomfort|0|||
37829046|NCT01055457|69512136|FG004|Overall Study|Discomfort|1|||
37829047|NCT01055457|69512137|FG005|Overall Study|Discomfort|0|||
37829048|NCT01055457|69512138|FG006|Overall Study|Discomfort|0|||
37829049|NCT01055457|69512139|FG007|Overall Study|Discomfort|0|||
37829050|NCT01055457|69512140|FG008|Overall Study|Discomfort|0|||
37829051|NCT01055457|69512141|FG009|Overall Study|Discomfort|0|||
37829052|NCT01055457|69512132|FG000|Overall Study|Pregnancy|0|||
37829053|NCT01055457|69512133|FG001|Overall Study|Pregnancy|0|||
37829054|NCT01055457|69512134|FG002|Overall Study|Pregnancy|0|||
37829055|NCT01055457|69512135|FG003|Overall Study|Pregnancy|1|||
37829056|NCT01055457|69512136|FG004|Overall Study|Pregnancy|0|||
37829057|NCT01055457|69512137|FG005|Overall Study|Pregnancy|0|||
37829058|NCT01055457|69512138|FG006|Overall Study|Pregnancy|0|||
37829059|NCT01055457|69512139|FG007|Overall Study|Pregnancy|0|||
37829060|NCT01055457|69512140|FG008|Overall Study|Pregnancy|0|||
37829061|NCT01055457|69512141|FG009|Overall Study|Pregnancy|0|||
37829062|NCT01055457|69512132|FG000|Overall Study|Adverse Event|0|||
37829063|NCT01055457|69512133|FG001|Overall Study|Adverse Event|0|||
37829064|NCT01055457|69512134|FG002|Overall Study|Adverse Event|0|||
37829065|NCT01055457|69512135|FG003|Overall Study|Adverse Event|1|||
37829066|NCT01055457|69512136|FG004|Overall Study|Adverse Event|0|||
37829067|NCT01055457|69512137|FG005|Overall Study|Adverse Event|0|||
37829068|NCT01055457|69512138|FG006|Overall Study|Adverse Event|0|||
37829069|NCT01055457|69512139|FG007|Overall Study|Adverse Event|0|||
37829070|NCT01055457|69512140|FG008|Overall Study|Adverse Event|0|||
37829071|NCT01055457|69512141|FG009|Overall Study|Adverse Event|0|||
37829072|NCT01055028|69512165|FG000|Screening|Screen Failure|1|||
37829073|NCT01055028|69512166|FG001|Screening|Screen Failure|1|||
37829074|NCT01055028|69512165|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
37829075|NCT01055028|69512166|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
37829076|NCT01055028|69512165|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
37829077|NCT01055028|69512166|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
37829078|NCT01055028|69512165|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
37829079|NCT01055028|69512166|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
37829080|NCT01050816|69512198|FG000|Overall Study|Lost to Follow-up|2|||
37829081|NCT01050816|69512198|FG000|Overall Study|patient's refusal|2|||
37829082|NCT01054560|69512204|FG000|Overall Study|Death|10|||
37829083|NCT01054560|69512205|FG001|Overall Study|Death|21|||
37829084|NCT01054560|69512204|FG000|Overall Study|Lost to Follow-up|2|||
37829085|NCT01054560|69512205|FG001|Overall Study|Lost to Follow-up|5|||
37697240|NCT02087943|69173736|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
37829086|NCT01054560|69512204|FG000|Overall Study|Withdrawal by Subject|0|||
37829087|NCT01054560|69512205|FG001|Overall Study|Withdrawal by Subject|2|||
37829088|NCT01054560|69512204|FG000|Overall Study|Physician Decision|1|||
37829089|NCT01054560|69512205|FG001|Overall Study|Physician Decision|0|||
37829090|NCT01054443|69512217|FG000|Overall Study|Withdrawal by Subject|0|||
37829091|NCT01054443|69512218|FG001|Overall Study|Withdrawal by Subject|0|||
37697241|NCT02087943|69173737|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
37697242|NCT02087943|69173738|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
37829092|NCT01054443|69512219|FG002|Overall Study|Withdrawal by Subject|0|||
37829093|NCT01054443|69512220|FG003|Overall Study|Withdrawal by Subject|1|||
37829094|NCT01050543|69512235|FG000|Overall Study|Withdrawal by Subject|0|||
37697243|NCT02087943|69173739|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
37697244|NCT02087943|69173740|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
37697245|NCT02087943|69173736|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
37697246|NCT02087943|69173737|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
37829095|NCT01050543|69512236|FG001|Overall Study|Withdrawal by Subject|2|||
37829096|NCT01050543|69512235|FG000|Overall Study|Protocol Violation|0|||
37829097|NCT01050543|69512236|FG001|Overall Study|Protocol Violation|1|||
37903994|NCT00659425|69589737|FG002|Overall Study|Other|1|||
37903995|NCT00659425|69589738|FG003|Overall Study|Other|2|||
37903996|NCT00659425|69589739|FG004|Overall Study|Other|4|||
37903997|NCT00659425|69589740|FG005|Overall Study|Other|0|||
37903998|NCT00659425|69589741|FG006|Overall Study|Other|3|||
37903999|NCT00659425|69589742|FG007|Overall Study|Other|2|||
37904000|NCT00659425|69589743|FG008|Overall Study|Other|0|||
37904001|NCT00659425|69589744|FG009|Overall Study|Other|6|||
37904002|NCT00656851|69589781|FG000|Overall Study|Withdrawal by Subject|0|||
37904003|NCT00656851|69589782|FG001|Overall Study|Withdrawal by Subject|4|||
37904004|NCT00656617|69589788|FG000|Overall Study|Adverse Event|1|||
37904005|NCT00656617|69589788|FG000|Overall Study|Death|2|||
37904006|NCT00656617|69589788|FG000|Overall Study|Insurance Issues|2|||
37904007|NCT00656617|69589788|FG000|Overall Study|Move to different clinical trial|2|||
37904008|NCT00659269|69589795|FG000|Overall Study|Physician Decision|1|||
37904009|NCT00659269|69589796|FG001|Overall Study|Physician Decision|1|||
37904010|NCT00658333|69589813|FG000|Overall Study|Adverse Event|2|||
37904011|NCT00658333|69589814|FG001|Overall Study|Adverse Event|1|||
37904012|NCT00570037|69589822|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
37999925|NCT00195260|69683782|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
37999926|NCT00195260|69683783|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
37829098|NCT01050543|69512235|FG000|Overall Study|Administrative|4|||
37829099|NCT01050543|69512236|FG001|Overall Study|Administrative|1|||
37829100|NCT01051557|69512249|FG000|Overall Study|Physician Decision|1|||
37829101|NCT01051557|69512250|FG001|Overall Study|Physician Decision|0|||
37829102|NCT01051557|69512251|FG002|Overall Study|Physician Decision|0|||
37829103|NCT01051557|69512252|FG003|Overall Study|Physician Decision|0|||
37829104|NCT01051557|69512253|FG004|Overall Study|Physician Decision|0|||
37904013|NCT00570037|69589823|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
37904014|NCT00863655|69589831|FG000|Overall Study|Protocol Violation|4|||
37904015|NCT00863655|69589832|FG001|Overall Study|Protocol Violation|0|||
37904016|NCT00863655|69589831|FG000|Overall Study|Adverse Event|52|||
37829105|NCT01051557|69512254|FG005|Overall Study|Physician Decision|0|||
37904017|NCT00863655|69589832|FG001|Overall Study|Adverse Event|8|||
37904018|NCT00863655|69589831|FG000|Overall Study|Withdrawal by Subject|47|||
37904019|NCT00863655|69589832|FG001|Overall Study|Withdrawal by Subject|7|||
37904020|NCT00863655|69589831|FG000|Overall Study|Administrative problems|1|||
37904021|NCT00863655|69589832|FG001|Overall Study|Administrative problems|0|||
37697247|NCT02087943|69173738|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
37697248|NCT02087943|69173739|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
37697249|NCT02087943|69173740|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
37904022|NCT00863655|69589831|FG000|Overall Study|Death|7|||
37697250|NCT02087943|69173736|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
37697251|NCT02087943|69173737|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
37829106|NCT01051557|69512255|FG006|Overall Study|Physician Decision|0|||
37904023|NCT00863655|69589832|FG001|Overall Study|Death|1|||
37904024|NCT00863655|69589831|FG000|Overall Study|New cancer therapy|5|||
37904025|NCT00863655|69589832|FG001|Overall Study|New cancer therapy|1|||
37904026|NCT00863655|69589831|FG000|Overall Study|Disease progression|364|||
37904027|NCT00863655|69589832|FG001|Overall Study|Disease progression|221|||
37904028|NCT00863655|69589831|FG000|Overall Study|Treatment completed as per protocol|5|||
37904029|NCT00863655|69589832|FG001|Overall Study|Treatment completed as per protocol|1|||
37904030|NCT00658723|69589840|FG000|Overall Study|Lost to Follow-up|0|||
37904031|NCT00658723|69589841|FG001|Overall Study|Lost to Follow-up|2|||
37904032|NCT00658723|69589842|FG002|Overall Study|Lost to Follow-up|2|||
37999927|NCT00195260|69683784|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
37999928|NCT00195260|69683785|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
37999929|NCT00195260|69683775|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
37999930|NCT00195260|69683776|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
37999931|NCT00195260|69683777|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
37999932|NCT00195260|69683778|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
37999933|NCT00195260|69683779|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
37999934|NCT00195260|69683780|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
37829107|NCT01051557|69512249|FG000|Overall Study|disease progression|3|||
37829108|NCT01051557|69512250|FG001|Overall Study|disease progression|3|||
37829109|NCT01051557|69512251|FG002|Overall Study|disease progression|5|||
37829110|NCT01051557|69512252|FG003|Overall Study|disease progression|2|||
37829111|NCT01051557|69512253|FG004|Overall Study|disease progression|4|||
37829112|NCT01051557|69512254|FG005|Overall Study|disease progression|3|||
37829113|NCT01051557|69512255|FG006|Overall Study|disease progression|1|||
37829114|NCT01051557|69512249|FG000|Overall Study|Withdrawal by Subject|0|||
37829115|NCT01051557|69512250|FG001|Overall Study|Withdrawal by Subject|0|||
37829116|NCT01051557|69512251|FG002|Overall Study|Withdrawal by Subject|1|||
37829117|NCT01051557|69512252|FG003|Overall Study|Withdrawal by Subject|0|||
37829118|NCT01051557|69512253|FG004|Overall Study|Withdrawal by Subject|2|||
37829119|NCT01051557|69512254|FG005|Overall Study|Withdrawal by Subject|0|||
37904033|NCT00658723|69589840|FG000|Overall Study|Death|2|||
37904034|NCT00658723|69589841|FG001|Overall Study|Death|1|||
37904035|NCT00658723|69589842|FG002|Overall Study|Death|4|||
37904036|NCT00658723|69589840|FG000|Overall Study|Scheduling Issue|1|||
37904037|NCT00658723|69589841|FG001|Overall Study|Scheduling Issue|1|||
37904038|NCT00658723|69589842|FG002|Overall Study|Scheduling Issue|0|||
37904039|NCT00658723|69589840|FG000|Overall Study|Withdrawal by Subject|1|||
37904040|NCT00658723|69589841|FG001|Overall Study|Withdrawal by Subject|0|||
37999935|NCT00195260|69683781|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
37999936|NCT00195260|69683782|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
37999937|NCT00195260|69683783|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
37999938|NCT00195260|69683784|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
37999939|NCT00195260|69683785|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
37999940|NCT00195260|69683775|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
37999941|NCT00195260|69683776|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
37999942|NCT00195260|69683777|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
37999943|NCT00195260|69683778|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
37999944|NCT00195260|69683779|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
37999945|NCT00195260|69683780|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
37999946|NCT00195260|69683781|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
37999947|NCT00195260|69683782|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
37999948|NCT00195260|69683783|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
37999949|NCT00195260|69683784|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
37999950|NCT00195260|69683785|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
37999951|NCT00195260|69683775|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
37999952|NCT00195260|69683776|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
37999953|NCT00195260|69683777|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
37999954|NCT00195260|69683778|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
37999955|NCT00195260|69683779|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
37999956|NCT00195260|69683780|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
37999957|NCT00195260|69683781|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
37999958|NCT00195260|69683782|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
37999959|NCT00195260|69683783|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
37999960|NCT00195260|69683784|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
37999961|NCT00195260|69683785|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
37999962|NCT00031486|69683815|FG000|Overall Study|Adverse Event|1|||
37999963|NCT00031486|69683816|FG001|Overall Study|Adverse Event|0|||
37999964|NCT00031486|69683815|FG000|Overall Study|Lost to Follow-up|0|||
37999965|NCT00031486|69683816|FG001|Overall Study|Lost to Follow-up|1|||
37999966|NCT00031486|69683815|FG000|Overall Study|Withdrawal by Subject|3|||
37999967|NCT00031486|69683816|FG001|Overall Study|Withdrawal by Subject|2|||
37999968|NCT00031486|69683815|FG000|Overall Study|Death|0|||
37999969|NCT00031486|69683816|FG001|Overall Study|Death|3|||
37999970|NCT00031486|69683815|FG000|Overall Study|Non-compliant|0|||
37999971|NCT00031486|69683816|FG001|Overall Study|Non-compliant|4|||
37999972|NCT00031486|69683815|FG000|Overall Study|Did not meet eligibility requirement|2|||
37999973|NCT00031486|69683816|FG001|Overall Study|Did not meet eligibility requirement|1|||
37999974|NCT00031486|69683815|FG000|Overall Study|Other|1|||
37999975|NCT00031486|69683816|FG001|Overall Study|Other|1|||
37999976|NCT00003508|69683824|FG000|Overall Study|Not evaluable|5|||
37999977|NCT00003472|69683828|FG000|Overall Study|Not evaluable|3|||
37999978|NCT00003298|69683832|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
37999979|NCT00003298|69683832|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
37999980|NCT00003298|69683832|FG000|Surgery|Unresectable at surgery|3|||
37999981|NCT00003298|69683832|FG000|Surgery|Progression before surgery|2|||
37999982|NCT00003298|69683832|FG000|Surgery|Unevaluable and off study|2|||
37697252|NCT02087943|69173738|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
37999983|NCT00003298|69683832|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
37697253|NCT02087943|69173739|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
37829120|NCT01051557|69512255|FG006|Overall Study|Withdrawal by Subject|1|||
37829121|NCT01051557|69512249|FG000|Overall Study|Adverse Event|0|||
37829122|NCT01051557|69512250|FG001|Overall Study|Adverse Event|0|||
37829123|NCT01051557|69512251|FG002|Overall Study|Adverse Event|0|||
37829124|NCT01051557|69512252|FG003|Overall Study|Adverse Event|1|||
37829125|NCT01051557|69512253|FG004|Overall Study|Adverse Event|1|||
37829126|NCT01051557|69512254|FG005|Overall Study|Adverse Event|3|||
37829127|NCT01051557|69512255|FG006|Overall Study|Adverse Event|4|||
37829128|NCT01054170|69512274|FG000|Overall Study|Protocol Violation|1|||
37829129|NCT01054170|69512275|FG001|Overall Study|Protocol Violation|0|||
37829130|NCT01054170|69512274|FG000|Overall Study|Withdrawal by Subject|3|||
37829131|NCT01054170|69512275|FG001|Overall Study|Withdrawal by Subject|2|||
37829132|NCT01054170|69512274|FG000|Overall Study|Adverse Event|0|||
37829133|NCT01054170|69512275|FG001|Overall Study|Adverse Event|4|||
37829134|NCT01053741|69512283|FG000|2nd Study Intervention|Physician Decision|0|||
37829135|NCT01053741|69512284|FG001|2nd Study Intervention|Physician Decision|1|||
37697254|NCT02087943|69173740|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
37697255|NCT02087943|69173736|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
37829136|NCT01052493|69512290|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
37829137|NCT01052493|69512291|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
37829138|NCT01052493|69512292|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
37829139|NCT01052103|69512307|FG000|Overall Study|Adverse Event|10|||
37829140|NCT01052103|69512308|FG001|Overall Study|Adverse Event|6|||
37829141|NCT01052103|69512307|FG000|Overall Study|Entry Criteria Not Met|3|||
37829142|NCT01052103|69512308|FG001|Overall Study|Entry Criteria Not Met|1|||
37829143|NCT01052103|69512307|FG000|Overall Study|Lost to Follow-up|3|||
37904041|NCT00658723|69589842|FG002|Overall Study|Withdrawal by Subject|1|||
37904042|NCT00593385|69589853|FG000|Overall Study|Death|14|||
37904043|NCT00593385|69589853|FG000|Overall Study|Lost to Follow-up|17|||
37829144|NCT01052103|69512308|FG001|Overall Study|Lost to Follow-up|5|||
37829145|NCT01052103|69512307|FG000|Overall Study|Protocol Violation|10|||
37829146|NCT01052103|69512308|FG001|Overall Study|Protocol Violation|4|||
37829147|NCT01052103|69512307|FG000|Overall Study|Scheduling conflict|2|||
37829148|NCT01052103|69512308|FG001|Overall Study|Scheduling conflict|1|||
37829149|NCT01052103|69512307|FG000|Overall Study|Sponsor Decision|2|||
37829150|NCT01052103|69512308|FG001|Overall Study|Sponsor Decision|0|||
37829151|NCT01052103|69512307|FG000|Overall Study|Withdrawal by Subject|3|||
37829152|NCT01052103|69512308|FG001|Overall Study|Withdrawal by Subject|6|||
37829153|NCT01052103|69512307|FG000|Overall Study|Perceived Lack of Efficacy|1|||
37829154|NCT01052103|69512308|FG001|Overall Study|Perceived Lack of Efficacy|0|||
37829155|NCT01051986|69512317|FG000|Overall Study|Death|1|||
37829156|NCT01051986|69512318|FG001|Overall Study|Death|0|||
37829157|NCT01051986|69512317|FG000|Overall Study|Withdrawal by Subject|2|||
37829158|NCT01051986|69512318|FG001|Overall Study|Withdrawal by Subject|1|||
37829159|NCT01051986|69512317|FG000|Overall Study|Protocol Violation|2|||
37829160|NCT01051986|69512318|FG001|Overall Study|Protocol Violation|3|||
37829161|NCT03279978|69512334|FG000|Overall Study|Withdrawal by Subject|0|||
37829162|NCT03279978|69512335|FG001|Overall Study|Withdrawal by Subject|1|||
37829163|NCT03279978|69512336|FG002|Overall Study|Withdrawal by Subject|0|||
37829164|NCT03279978|69512337|FG003|Overall Study|Withdrawal by Subject|0|||
37829165|NCT03279978|69512338|FG004|Overall Study|Withdrawal by Subject|0|||
37829166|NCT03279978|69512339|FG005|Overall Study|Withdrawal by Subject|0|||
37829167|NCT03279978|69512340|FG006|Overall Study|Withdrawal by Subject|0|||
37829168|NCT03279978|69512341|FG007|Overall Study|Withdrawal by Subject|0|||
37829169|NCT03279978|69512342|FG008|Overall Study|Withdrawal by Subject|0|||
37829170|NCT03279978|69512343|FG009|Overall Study|Withdrawal by Subject|1|||
37829171|NCT03279978|69512334|FG000|Overall Study|Lost to Follow-up|1|||
37829172|NCT03279978|69512335|FG001|Overall Study|Lost to Follow-up|0|||
37829173|NCT03279978|69512336|FG002|Overall Study|Lost to Follow-up|1|||
37829174|NCT03279978|69512337|FG003|Overall Study|Lost to Follow-up|0|||
37829175|NCT03279978|69512338|FG004|Overall Study|Lost to Follow-up|0|||
37829176|NCT03279978|69512339|FG005|Overall Study|Lost to Follow-up|0|||
37999984|NCT00003298|69683832|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
37829177|NCT03279978|69512340|FG006|Overall Study|Lost to Follow-up|0|||
37829178|NCT03279978|69512341|FG007|Overall Study|Lost to Follow-up|0|||
37829179|NCT03279978|69512342|FG008|Overall Study|Lost to Follow-up|0|||
37829180|NCT03279978|69512343|FG009|Overall Study|Lost to Follow-up|0|||
37999985|NCT00003298|69683832|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
37999986|NCT00003298|69683832|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
37999987|NCT00003298|69683832|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
37999988|NCT00003298|69683832|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
37999989|NCT00003298|69683832|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
37999990|NCT00003298|69683832|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
37999991|NCT00003298|69683832|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
37999992|NCT00003298|69683832|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
37999993|NCT00002842|69683837|FG000|Overall Study|ineligible for surgical resection|27|||
37999994|NCT00143247|69683841|FG000|Overall Study|Death|8|||
37999995|NCT00143247|69683841|FG000|Overall Study|Adverse Event|19|||
37999996|NCT00143247|69683841|FG000|Overall Study|Lack of Efficacy|3|||
37999997|NCT00143247|69683841|FG000|Overall Study|Withdrawal by Subject|55|||
37999998|NCT00143247|69683841|FG000|Overall Study|Study terminated by sponsor|31|||
37999999|NCT00143247|69683841|FG000|Overall Study|Protocol Violation|15|||
38000000|NCT00143247|69683841|FG000|Overall Study|Lost to Follow-up|12|||
38000001|NCT00143247|69683841|FG000|Overall Study|following inaccurate lab adverse event|1|||
38000002|NCT00143247|69683841|FG000|Overall Study|Other|12|||
38000003|NCT00125853|69683845|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
38000004|NCT00125853|69683846|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
38000005|NCT00219141|69683855|FG000|Overall Study|Adverse Event|4|||
38000006|NCT00219141|69683856|FG001|Overall Study|Adverse Event|10|||
38000007|NCT00219141|69683857|FG002|Overall Study|Adverse Event|5|||
38000008|NCT00219141|69683855|FG000|Overall Study|Lack of Efficacy|3|||
38000009|NCT00219141|69683856|FG001|Overall Study|Lack of Efficacy|2|||
38000010|NCT00219141|69683857|FG002|Overall Study|Lack of Efficacy|0|||
38000011|NCT00219141|69683855|FG000|Overall Study|Administrative problems|0|||
38000012|NCT00219141|69683856|FG001|Overall Study|Administrative problems|1|||
38000013|NCT00219141|69683857|FG002|Overall Study|Administrative problems|0|||
37697256|NCT02087943|69173737|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
37697257|NCT02087943|69173738|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
37697258|NCT02087943|69173739|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
37697259|NCT02087943|69173740|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
37697260|NCT02087943|69173736|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
37697261|NCT02087943|69173737|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
37904044|NCT00593385|69589853|FG000|Overall Study|Withdrawal by Subject|9|||
37904045|NCT00658021|69589862|FG000|28-Week Treatment Period|Adverse Event|3|||
37904046|NCT00658021|69589863|FG001|28-Week Treatment Period|Adverse Event|1|||
37904047|NCT00658021|69589864|FG002|28-Week Treatment Period|Adverse Event|0|||
37904048|NCT00658021|69589862|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
37904049|NCT00658021|69589863|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
37697262|NCT02087943|69173738|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
37697263|NCT02087943|69173739|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
37697264|NCT02087943|69173740|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
37904050|NCT00658021|69589864|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
37904051|NCT00658021|69589862|FG000|28-Week Treatment Period|Protocol Violation|0|||
37904052|NCT00658021|69589863|FG001|28-Week Treatment Period|Protocol Violation|2|||
37904053|NCT00658021|69589864|FG002|28-Week Treatment Period|Protocol Violation|1|||
37904054|NCT00658021|69589862|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
37697265|NCT02087943|69173736|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
37697266|NCT02087943|69173737|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
37697267|NCT02087943|69173738|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
37697268|NCT02087943|69173739|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
37697269|NCT02087943|69173740|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
37697270|NCT02087943|69173736|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
37697271|NCT02087943|69173737|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
37697272|NCT02087943|69173738|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
37904055|NCT00658021|69589863|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
38000014|NCT00219141|69683855|FG000|Overall Study|Lost to Follow-up|2|||
37697273|NCT02087943|69173739|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
37697274|NCT02087943|69173740|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
37697275|NCT02087943|69173736|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
37697276|NCT02087943|69173737|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
37697277|NCT02087943|69173738|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
37829181|NCT03279978|69512334|FG000|Overall Study|Other than stated above|0|||
37829182|NCT03279978|69512335|FG001|Overall Study|Other than stated above|0|||
37829183|NCT03279978|69512336|FG002|Overall Study|Other than stated above|0|||
37829184|NCT03279978|69512337|FG003|Overall Study|Other than stated above|0|||
37829185|NCT03279978|69512338|FG004|Overall Study|Other than stated above|0|||
37829186|NCT03279978|69512339|FG005|Overall Study|Other than stated above|0|||
37829187|NCT03279978|69512340|FG006|Overall Study|Other than stated above|1|||
37829188|NCT03279978|69512341|FG007|Overall Study|Other than stated above|0|||
37829189|NCT03279978|69512342|FG008|Overall Study|Other than stated above|0|||
37829190|NCT03279978|69512343|FG009|Overall Study|Other than stated above|0|||
37829191|NCT00105534|69512376|FG000|Overall Study|Adverse Event|2|||
37829192|NCT00105534|69512377|FG001|Overall Study|Adverse Event|5|||
37829193|NCT00105534|69512376|FG000|Overall Study|Protocol Violation|1|||
37829194|NCT00105534|69512377|FG001|Overall Study|Protocol Violation|4|||
37829195|NCT00105534|69512376|FG000|Overall Study|Withdrawal by Subject|6|||
37829196|NCT00105534|69512377|FG001|Overall Study|Withdrawal by Subject|6|||
37829197|NCT00105534|69512376|FG000|Overall Study|Lost to Follow-up|5|||
37829198|NCT00105534|69512377|FG001|Overall Study|Lost to Follow-up|1|||
37829199|NCT00105534|69512376|FG000|Overall Study|Lack of Efficacy|7|||
37829200|NCT00105534|69512377|FG001|Overall Study|Lack of Efficacy|15|||
37829201|NCT00105534|69512376|FG000|Overall Study|Treatment unmasked|1|||
37829202|NCT00105534|69512377|FG001|Overall Study|Treatment unmasked|0|||
37829203|NCT00105534|69512376|FG000|Overall Study|Other Reason|0|||
37829204|NCT00105534|69512377|FG001|Overall Study|Other Reason|2|||
37829205|NCT00105183|69512386|FG000|Overall Study|Death|19|||
37829206|NCT00105183|69512387|FG001|Overall Study|Death|13|||
37829207|NCT00105183|69512388|FG002|Overall Study|Death|15|||
37829208|NCT00105183|69512386|FG000|Overall Study|Withdrawal by Subject|1|||
37829209|NCT00105183|69512387|FG001|Overall Study|Withdrawal by Subject|1|||
37829210|NCT00105183|69512388|FG002|Overall Study|Withdrawal by Subject|4|||
37829211|NCT00105183|69512386|FG000|Overall Study|Physician Decision|1|||
37829212|NCT00105183|69512387|FG001|Overall Study|Physician Decision|2|||
37829213|NCT00105183|69512388|FG002|Overall Study|Physician Decision|3|||
37829214|NCT00105183|69512386|FG000|Overall Study|Lost to Follow-up|0|||
37829215|NCT00105183|69512387|FG001|Overall Study|Lost to Follow-up|1|||
37829216|NCT00105183|69512388|FG002|Overall Study|Lost to Follow-up|1|||
37829217|NCT00105183|69512386|FG000|Overall Study|Other reason|1|||
37829218|NCT00105183|69512387|FG001|Overall Study|Other reason|2|||
37829219|NCT00105183|69512388|FG002|Overall Study|Other reason|0|||
37829220|NCT01059617|69512400|FG000|Overall Study|Other|7|||
37829221|NCT01059617|69512401|FG001|Overall Study|Other|1|||
37829222|NCT01059617|69512402|FG002|Overall Study|Other|8|||
37829223|NCT01059617|69512403|FG003|Overall Study|Other|6|||
37829224|NCT01059344|69512423|FG000|Overall Study|Adverse Event|12|||
37829225|NCT01059344|69512424|FG001|Overall Study|Adverse Event|30|||
37829226|NCT01059344|69512423|FG000|Overall Study|Withdrawal by Subject|6|||
37829227|NCT01059344|69512424|FG001|Overall Study|Withdrawal by Subject|9|||
37697278|NCT02087943|69173739|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
37829228|NCT01059344|69512423|FG000|Overall Study|Lost to Follow-up|1|||
37829229|NCT01059344|69512424|FG001|Overall Study|Lost to Follow-up|1|||
37829230|NCT01059344|69512423|FG000|Overall Study|Other|3|||
37829231|NCT01059344|69512424|FG001|Overall Study|Other|6|||
37829232|NCT01058369|69512432|FG000|Overall Study|Adverse Event|1|||
37829233|NCT01058369|69512432|FG000|Overall Study|Early termination study|1|||
37829234|NCT01057433|69512436|FG000|Overall Study|Adverse Event|1|||
37829235|NCT01057394|69512440|FG000|Overall Study|Not eligible|0|||
37904056|NCT00658021|69589864|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
37829236|NCT01057394|69512441|FG001|Overall Study|Not eligible|2|||
37829237|NCT01058642|69512449|FG000|Treatment Period 1|Adverse Event|0|||
37829238|NCT01058642|69512450|FG001|Treatment Period 1|Adverse Event|1|||
37904057|NCT00658021|69589862|FG000|28-Week Treatment Period|Physician Decision|1|||
37904058|NCT00658021|69589863|FG001|28-Week Treatment Period|Physician Decision|2|||
37904059|NCT00658021|69589864|FG002|28-Week Treatment Period|Physician Decision|1|||
37697279|NCT02087943|69173740|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
37697280|NCT02087943|69173736|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
37697281|NCT02087943|69173737|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
37697282|NCT02087943|69173738|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
37697283|NCT02087943|69173739|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
37697284|NCT02087943|69173740|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
37697285|NCT02029521|69173754|FG000|Overall Study|Protocol Violation|1|||
37829239|NCT01058642|69512451|FG002|Treatment Period 1|Adverse Event|1|||
37829240|NCT01058642|69512452|FG003|Treatment Period 1|Adverse Event|0|||
37829241|NCT01058642|69512449|FG000|Treatment Period 1|Physician Decision|0|||
37829242|NCT01058642|69512450|FG001|Treatment Period 1|Physician Decision|0|||
37829243|NCT01058642|69512451|FG002|Treatment Period 1|Physician Decision|1|||
37829244|NCT01058642|69512452|FG003|Treatment Period 1|Physician Decision|0|||
37829245|NCT01058642|69512449|FG000|Treatment Period 1|Withdrawal by Subject|1|||
37904060|NCT00658021|69589862|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
37904061|NCT00658021|69589863|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
37904062|NCT00658021|69589864|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
37904063|NCT00658021|69589862|FG000|28-Week Treatment Period|Loss of glucose control|1|||
37904064|NCT00658021|69589863|FG001|28-Week Treatment Period|Loss of glucose control|1|||
37904065|NCT00658021|69589864|FG002|28-Week Treatment Period|Loss of glucose control|10|||
37904066|NCT00658021|69589862|FG000|28-Week Treatment Period|Other|2|||
37904067|NCT00658021|69589863|FG001|28-Week Treatment Period|Other|3|||
37904068|NCT00658021|69589864|FG002|28-Week Treatment Period|Other|1|||
37904069|NCT00658021|69589862|FG000|28-Week Treatment Period|Did not receive treatment|2|||
37904070|NCT00658021|69589863|FG001|28-Week Treatment Period|Did not receive treatment|0|||
37904071|NCT00658021|69589864|FG002|28-Week Treatment Period|Did not receive treatment|0|||
37697286|NCT02029521|69173755|FG001|Overall Study|Protocol Violation|0|||
37829246|NCT01058642|69512450|FG001|Treatment Period 1|Withdrawal by Subject|0|||
37829247|NCT01058642|69512451|FG002|Treatment Period 1|Withdrawal by Subject|0|||
37829248|NCT01058642|69512452|FG003|Treatment Period 1|Withdrawal by Subject|0|||
37829249|NCT01058642|69512449|FG000|Treatment Period 1|Lack of Efficacy|0|||
37904072|NCT00658021|69589862|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
37829250|NCT01058642|69512450|FG001|Treatment Period 1|Lack of Efficacy|0|||
37829251|NCT01058642|69512451|FG002|Treatment Period 1|Lack of Efficacy|0|||
37829252|NCT01058642|69512452|FG003|Treatment Period 1|Lack of Efficacy|1|||
37829253|NCT01058642|69512449|FG000|Treatment Period 1|Protocol Violation|0|||
37829254|NCT01058642|69512450|FG001|Treatment Period 1|Protocol Violation|0|||
37829255|NCT01058642|69512451|FG002|Treatment Period 1|Protocol Violation|0|||
37829256|NCT01058642|69512452|FG003|Treatment Period 1|Protocol Violation|1|||
37829257|NCT01058642|69512449|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
37829258|NCT01058642|69512450|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
37829259|NCT01058642|69512451|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
37829260|NCT01058642|69512452|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
37829261|NCT01056653|69512463|FG000|Overall Study|Lost to Follow-up|0|||
37904073|NCT00658021|69589863|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
37904074|NCT00658021|69589864|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
37904075|NCT00658021|69589862|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
37904076|NCT00658021|69589863|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
37904077|NCT00658021|69589864|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
37904078|NCT00920816|69589878|FG000|Overall Study|Death|116|||
37904079|NCT00920816|69589879|FG001|Overall Study|Death|63|||
37697287|NCT02029521|69173754|FG000|Overall Study|Withdrawal by Subject|1|||
37904080|NCT00920816|69589880|FG002|Overall Study|Death|8|||
37904081|NCT00920816|69589881|FG003|Overall Study|Death|3|||
37904082|NCT00920816|69589878|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
37904083|NCT00920816|69589879|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
37904084|NCT00920816|69589880|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
37904085|NCT00920816|69589881|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
37904086|NCT00920816|69589878|FG000|Overall Study|Global deterioration of health status|2|||
37904087|NCT00920816|69589879|FG001|Overall Study|Global deterioration of health status|0|||
37829262|NCT01056653|69512464|FG001|Overall Study|Lost to Follow-up|0|||
37829263|NCT01056653|69512465|FG002|Overall Study|Lost to Follow-up|2|||
37829264|NCT01056536|69512477|FG000|Overall Study|Lost to Follow-up|202|||
37904088|NCT00920816|69589880|FG002|Overall Study|Global deterioration of health status|0|||
37697288|NCT02029521|69173755|FG001|Overall Study|Withdrawal by Subject|1|||
37697289|NCT02443883|69173776|FG000|Overall Study|Adverse Event|0|||
37697290|NCT02443883|69173777|FG001|Overall Study|Adverse Event|1|||
37697291|NCT02443883|69173778|FG002|Overall Study|Adverse Event|0|||
37697292|NCT02443883|69173779|FG003|Overall Study|Adverse Event|0|||
37697293|NCT02443883|69173776|FG000|Overall Study|Lost to Follow-up|3|||
37697294|NCT02443883|69173777|FG001|Overall Study|Lost to Follow-up|2|||
37697295|NCT02443883|69173778|FG002|Overall Study|Lost to Follow-up|1|||
37697296|NCT02443883|69173779|FG003|Overall Study|Lost to Follow-up|0|||
37697297|NCT02443883|69173776|FG000|Overall Study|Physician Decision|1|||
37697298|NCT02443883|69173777|FG001|Overall Study|Physician Decision|1|||
37697299|NCT02443883|69173778|FG002|Overall Study|Physician Decision|0|||
37697300|NCT02443883|69173779|FG003|Overall Study|Physician Decision|3|||
38000015|NCT00219141|69683856|FG001|Overall Study|Lost to Follow-up|4|||
38000016|NCT00219141|69683857|FG002|Overall Study|Lost to Follow-up|1|||
38000017|NCT00219141|69683855|FG000|Overall Study|Protocol Violation|3|||
38000018|NCT00219141|69683856|FG001|Overall Study|Protocol Violation|1|||
38000019|NCT00219141|69683857|FG002|Overall Study|Protocol Violation|1|||
38000020|NCT00219141|69683855|FG000|Overall Study|Withdrawal by Subject|1|||
38000021|NCT00219141|69683856|FG001|Overall Study|Withdrawal by Subject|3|||
38000022|NCT00219141|69683857|FG002|Overall Study|Withdrawal by Subject|5|||
38000023|NCT00219141|69683855|FG000|Overall Study|Condition no longer requires study drug|1|||
38000024|NCT00219141|69683856|FG001|Overall Study|Condition no longer requires study drug|0|||
38000025|NCT00219141|69683857|FG002|Overall Study|Condition no longer requires study drug|0|||
38000026|NCT00142935|69683868|FG000|Overall Study|Other reason|1|||
38000027|NCT00142935|69683869|FG001|Overall Study|Other reason|1|||
38000028|NCT00142935|69683870|FG002|Overall Study|Other reason|1|||
38000029|NCT00142935|69683868|FG000|Overall Study|Lost to Follow-up|2|||
38000030|NCT00142935|69683869|FG001|Overall Study|Lost to Follow-up|5|||
38000031|NCT00142935|69683870|FG002|Overall Study|Lost to Follow-up|5|||
38000032|NCT00142935|69683868|FG000|Overall Study|Death|0|||
38000033|NCT00142935|69683869|FG001|Overall Study|Death|2|||
38000034|NCT00142935|69683870|FG002|Overall Study|Death|1|||
38000035|NCT00233948|69683884|FG000|Overall Study|Adverse Event|1|||
38000036|NCT00233948|69683885|FG001|Overall Study|Adverse Event|0|||
38000037|NCT00233948|69683886|FG002|Overall Study|Adverse Event|0|||
38000038|NCT00233948|69683887|FG003|Overall Study|Adverse Event|0|||
38000039|NCT00233948|69683888|FG004|Overall Study|Adverse Event|0|||
38000040|NCT00233948|69683889|FG005|Overall Study|Adverse Event|0|||
38000041|NCT00233480|69683906|FG000|Overall Study|Underwent status II heart transplant|0|||
38000042|NCT00233480|69683907|FG001|Overall Study|Underwent status II heart transplant|1|||
38000043|NCT03801928|69683921|FG000|Overall Study|Adverse Event|1|||
38000044|NCT03801928|69683922|FG001|Overall Study|Adverse Event|0|||
38000045|NCT03801928|69683923|FG002|Overall Study|Adverse Event|1|||
38000046|NCT03801928|69683924|FG003|Overall Study|Adverse Event|2|||
38000047|NCT03801928|69683925|FG004|Overall Study|Adverse Event|0|||
38000048|NCT03801928|69683926|FG005|Overall Study|Adverse Event|2|||
38000049|NCT03801928|69683921|FG000|Overall Study|Lack of Efficacy|0|||
38000050|NCT03801928|69683922|FG001|Overall Study|Lack of Efficacy|0|||
38000051|NCT03801928|69683923|FG002|Overall Study|Lack of Efficacy|1|||
38000052|NCT03801928|69683924|FG003|Overall Study|Lack of Efficacy|0|||
38000053|NCT03801928|69683925|FG004|Overall Study|Lack of Efficacy|0|||
38000054|NCT03801928|69683926|FG005|Overall Study|Lack of Efficacy|0|||
38000055|NCT03801928|69683921|FG000|Overall Study|Lost to Follow-up|5|||
38000056|NCT03801928|69683922|FG001|Overall Study|Lost to Follow-up|1|||
38000057|NCT03801928|69683923|FG002|Overall Study|Lost to Follow-up|1|||
38000058|NCT03801928|69683924|FG003|Overall Study|Lost to Follow-up|4|||
38000059|NCT03801928|69683925|FG004|Overall Study|Lost to Follow-up|4|||
38000060|NCT03801928|69683926|FG005|Overall Study|Lost to Follow-up|2|||
38000061|NCT03801928|69683921|FG000|Overall Study|Withdrawal by Subject|0|||
38000062|NCT03801928|69683922|FG001|Overall Study|Withdrawal by Subject|0|||
38000063|NCT03801928|69683923|FG002|Overall Study|Withdrawal by Subject|2|||
38000064|NCT03801928|69683924|FG003|Overall Study|Withdrawal by Subject|1|||
38000065|NCT03801928|69683925|FG004|Overall Study|Withdrawal by Subject|0|||
38000066|NCT03801928|69683926|FG005|Overall Study|Withdrawal by Subject|0|||
37697301|NCT02443883|69173776|FG000|Overall Study|Withdrawal by Subject|1|||
37697302|NCT02443883|69173777|FG001|Overall Study|Withdrawal by Subject|0|||
38000067|NCT03801928|69683921|FG000|Overall Study|Other|0|||
38000068|NCT03801928|69683922|FG001|Overall Study|Other|2|||
38000069|NCT03801928|69683923|FG002|Overall Study|Other|0|||
38000070|NCT03801928|69683924|FG003|Overall Study|Other|1|||
38000071|NCT03801928|69683925|FG004|Overall Study|Other|0|||
38000072|NCT03801928|69683926|FG005|Overall Study|Other|1|||
38000073|NCT00263588|69683945|FG000|Overall Study|Death|54|||
38000074|NCT00263588|69683946|FG001|Overall Study|Death|90|||
38000075|NCT00263588|69683945|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
37904089|NCT00920816|69589881|FG003|Overall Study|Global deterioration of health status|0|||
37904090|NCT00920816|69589878|FG000|Overall Study|Objective progression or relapse|6|||
37904091|NCT00920816|69589879|FG001|Overall Study|Objective progression or relapse|2|||
37904092|NCT00920816|69589880|FG002|Overall Study|Objective progression or relapse|0|||
37904093|NCT00920816|69589881|FG003|Overall Study|Objective progression or relapse|0|||
37904094|NCT00920816|69589878|FG000|Overall Study|Other|26|||
38000076|NCT00263588|69683946|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
38000077|NCT00263588|69683945|FG000|Overall Study|Lost to Follow-up|7|||
38000078|NCT00263588|69683946|FG001|Overall Study|Lost to Follow-up|10|||
38000079|NCT00263588|69683945|FG000|Overall Study|Withdrawal by Subject|3|||
38000080|NCT00263588|69683946|FG001|Overall Study|Withdrawal by Subject|4|||
38000081|NCT00263588|69683945|FG000|Overall Study|Protocol Violation|0|||
38000082|NCT00263588|69683946|FG001|Overall Study|Protocol Violation|1|||
38000083|NCT00263588|69683945|FG000|Overall Study|Investigator decision|7|||
38000084|NCT00263588|69683946|FG001|Overall Study|Investigator decision|15|||
38000085|NCT00263588|69683945|FG000|Overall Study|Sponsor terminated study|0|||
38000086|NCT00263588|69683946|FG001|Overall Study|Sponsor terminated study|1|||
38000087|NCT00213135|69683956|FG000|Overall Study|Adverse Event|9|||
38000088|NCT00213135|69683957|FG001|Overall Study|Adverse Event|5|||
37904095|NCT00920816|69589879|FG001|Overall Study|Other|15|||
37904096|NCT00920816|69589880|FG002|Overall Study|Other|1|||
38000089|NCT00213135|69683958|FG002|Overall Study|Adverse Event|5|||
38000090|NCT00213135|69683956|FG000|Overall Study|Lost to Follow-up|11|||
38000091|NCT00213135|69683957|FG001|Overall Study|Lost to Follow-up|8|||
38000092|NCT00213135|69683958|FG002|Overall Study|Lost to Follow-up|4|||
38000093|NCT00213135|69683956|FG000|Overall Study|Protocol Violation|4|||
38000094|NCT00213135|69683957|FG001|Overall Study|Protocol Violation|4|||
38000095|NCT00213135|69683958|FG002|Overall Study|Protocol Violation|10|||
38000096|NCT00213135|69683956|FG000|Overall Study|Death|1|||
37904097|NCT00920816|69589881|FG003|Overall Study|Other|2|||
37904098|NCT00920816|69589878|FG000|Overall Study|Lost to Follow-up|11|||
37904099|NCT00920816|69589879|FG001|Overall Study|Lost to Follow-up|2|||
37904100|NCT00920816|69589880|FG002|Overall Study|Lost to Follow-up|0|||
37904101|NCT00920816|69589881|FG003|Overall Study|Lost to Follow-up|0|||
37904102|NCT00920816|69589878|FG000|Overall Study|Adverse Event|1|||
37904103|NCT00920816|69589879|FG001|Overall Study|Adverse Event|1|||
38000097|NCT00213135|69683957|FG001|Overall Study|Death|1|||
38000098|NCT00213135|69683958|FG002|Overall Study|Death|2|||
37904104|NCT00920816|69589880|FG002|Overall Study|Adverse Event|1|||
37904105|NCT00920816|69589881|FG003|Overall Study|Adverse Event|0|||
37904106|NCT00920816|69589878|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
37904107|NCT00920816|69589879|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
38000099|NCT00213135|69683956|FG000|Overall Study|Disease progression|4|||
38000100|NCT00213135|69683957|FG001|Overall Study|Disease progression|5|||
38000101|NCT00213135|69683958|FG002|Overall Study|Disease progression|21|||
38000102|NCT00213135|69683956|FG000|Overall Study|Other|21|||
38000103|NCT00213135|69683957|FG001|Overall Study|Other|12|||
38000104|NCT00213135|69683958|FG002|Overall Study|Other|15|||
38000105|NCT00077974|69683966|FG000|Overall Study|Adverse Event|22|||
38000106|NCT00077974|69683966|FG000|Overall Study|Protocol Violation|1|||
37904108|NCT00920816|69589880|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
38000107|NCT00077974|69683966|FG000|Overall Study|Withdrawal by Subject|3|||
38000108|NCT00077974|69683966|FG000|Overall Study|Lack of Efficacy|76|||
38000109|NCT00077974|69683966|FG000|Overall Study|Decision of Sponsor|2|||
38000110|NCT00124917|69683970|FG000|Overall Study|Physician Decision|3|||
38000111|NCT00141921|69683975|FG000|Overall Study|Remain on Study|28|||
38000112|NCT00141921|69683975|FG000|Overall Study|Withdrawal by Subject|42|||
38000113|NCT00141921|69683975|FG000|Overall Study|Lost to Follow-up|19|||
38000114|NCT00141921|69683975|FG000|Overall Study|Noncompliance|17|||
38000115|NCT00141921|69683975|FG000|Overall Study|Disease Progression|7|||
38000116|NCT00141921|69683975|FG000|Overall Study|Protocol Deviation|7|||
38000117|NCT00141921|69683975|FG000|Overall Study|Adverse Event|5|||
38000118|NCT00141921|69683975|FG000|Overall Study|Administrative Decision|2|||
38000119|NCT00141921|69683975|FG000|Overall Study|Pregnancy|4|||
38000120|NCT00141921|69683975|FG000|Overall Study|Ineligibility Determined|2|||
38000121|NCT00141921|69683975|FG000|Overall Study|Other|8|||
38000122|NCT00029146|69683981|FG000|Overall Study|Lost to Follow-up|2|||
38000123|NCT00029146|69683982|FG001|Overall Study|Lost to Follow-up|1|||
38000124|NCT00026494|69683992|FG000|Overall Study|Withdrawal by Subject|1|||
38000125|NCT00026494|69683993|FG001|Overall Study|Withdrawal by Subject|0|||
38000126|NCT00026494|69683994|FG002|Overall Study|Withdrawal by Subject|1|||
38000127|NCT00026494|69683995|FG003|Overall Study|Withdrawal by Subject|0|||
38000128|NCT00026494|69683992|FG000|Overall Study|Patient non-compliance|1|||
38000129|NCT00026494|69683993|FG001|Overall Study|Patient non-compliance|0|||
38000130|NCT00026494|69683994|FG002|Overall Study|Patient non-compliance|0|||
38000131|NCT00026494|69683995|FG003|Overall Study|Patient non-compliance|0|||
38000132|NCT00026494|69683992|FG000|Overall Study|Patient not treated|0|||
38000133|NCT00026494|69683993|FG001|Overall Study|Patient not treated|0|||
38000134|NCT00026494|69683994|FG002|Overall Study|Patient not treated|2|||
38000135|NCT00026494|69683995|FG003|Overall Study|Patient not treated|0|||
38000136|NCT00026494|69683992|FG000|Overall Study|Clinical progression|0|||
38000137|NCT00026494|69683993|FG001|Overall Study|Clinical progression|0|||
38000138|NCT00026494|69683994|FG002|Overall Study|Clinical progression|3|||
38000139|NCT00026494|69683995|FG003|Overall Study|Clinical progression|0|||
38000140|NCT00023764|69684005|FG000|Overall Study|Other|1|||
38000141|NCT00023764|69684005|FG000|Overall Study|Adverse Event|4|||
38000142|NCT00023764|69684005|FG000|Overall Study|Withdrawal by Subject|1|||
38000143|NCT00023764|69684005|FG000|Overall Study|Progression of disease|6|||
38000144|NCT00023764|69684005|FG000|Overall Study|patient received other treatment|1|||
38000145|NCT00023764|69684005|FG000|Overall Study|delay in obtaining staging images|1|||
38000146|NCT00189488|69684012|FG000|Overall Study|Ineligibility determined|1|||
38000147|NCT00189488|69684013|FG001|Overall Study|Ineligibility determined|0|||
38000148|NCT00189488|69684012|FG000|Overall Study|Protocol deviation|2|||
38000149|NCT00189488|69684013|FG001|Overall Study|Protocol deviation|1|||
38000150|NCT00189488|69684012|FG000|Overall Study|Adverse Event|2|||
38000151|NCT00189488|69684013|FG001|Overall Study|Adverse Event|1|||
38000152|NCT00189488|69684012|FG000|Overall Study|Withdrawal by Subject|2|||
38000153|NCT00189488|69684013|FG001|Overall Study|Withdrawal by Subject|6|||
38000154|NCT00189488|69684012|FG000|Overall Study|Disease progression|2|||
38000155|NCT00189488|69684013|FG001|Overall Study|Disease progression|4|||
38000156|NCT00189488|69684012|FG000|Overall Study|Administrative Decision|0|||
38000157|NCT00189488|69684013|FG001|Overall Study|Administrative Decision|2|||
38000158|NCT00189488|69684012|FG000|Overall Study|Death|5|||
38000159|NCT00189488|69684013|FG001|Overall Study|Death|8|||
38000160|NCT00189488|69684012|FG000|Overall Study|Other|1|||
38000161|NCT00189488|69684013|FG001|Overall Study|Other|0|||
37697303|NCT02443883|69173778|FG002|Overall Study|Withdrawal by Subject|0|||
38000162|NCT00233402|69684022|FG000|Overall Study|No pathology data|12|||
38000163|NCT00233402|69684023|FG001|Overall Study|No pathology data|9|||
38000164|NCT00233402|69684022|FG000|Overall Study|No Ta/T1|89|||
38000165|NCT00233402|69684023|FG001|Overall Study|No Ta/T1|94|||
38000166|NCT00233402|69684022|FG000|Overall Study|Lost to follow up etc|3|||
38000167|NCT00233402|69684023|FG001|Overall Study|Lost to follow up etc|21|||
38000168|NCT00233324|69684035|FG000|Main Study|Death|68|||
38000169|NCT00233324|69684036|FG001|Main Study|Death|60|||
38000170|NCT00233324|69684037|FG002|Main Study|Death|62|||
38000171|NCT00233324|69684038|FG003|Main Study|Death|47|||
38000172|NCT00233324|69684035|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
38000173|NCT00233324|69684036|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
38000174|NCT00233324|69684037|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
38000175|NCT00233324|69684038|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
38000176|NCT00233324|69684035|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
38000177|NCT00233324|69684036|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
38000178|NCT00233324|69684037|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
38000179|NCT00233324|69684038|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
38000180|NCT00023452|69684057|FG000|Overall Study|Ineligible for Study|163|||
38000181|NCT00023452|69684058|FG001|Overall Study|Ineligible for Study|159|||
38000182|NCT00023452|69684057|FG000|Overall Study|Out of Window|129|||
38000183|NCT00023452|69684058|FG001|Overall Study|Out of Window|69|||
38000184|NCT00023452|69684057|FG000|Overall Study|Death|2|||
38000185|NCT00023452|69684058|FG001|Overall Study|Death|0|||
38000186|NCT00023452|69684057|FG000|Overall Study|Withdrawal by Subject|66|||
38000187|NCT00023452|69684058|FG001|Overall Study|Withdrawal by Subject|54|||
38000188|NCT00023452|69684057|FG000|Overall Study|Adverse Event|139|||
38000189|NCT00023452|69684058|FG001|Overall Study|Adverse Event|196|||
38000190|NCT00023452|69684057|FG000|Overall Study|Lost to Follow-up|293|||
38000191|NCT00023452|69684058|FG001|Overall Study|Lost to Follow-up|60|||
37904109|NCT00920816|69589881|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
37904110|NCT00920816|69589878|FG000|Overall Study|Randomized but not treated|3|||
38000192|NCT00023452|69684057|FG000|Overall Study|Physician Decision|49|||
38000193|NCT00023452|69684058|FG001|Overall Study|Physician Decision|21|||
38000194|NCT00023452|69684057|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
38000195|NCT00023452|69684058|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
38000196|NCT00023452|69684057|FG000|Overall Study|Pregnant|53|||
38000197|NCT00023452|69684058|FG001|Overall Study|Pregnant|20|||
38000198|NCT00023452|69684057|FG000|Overall Study|Other|204|||
38000199|NCT00023452|69684058|FG001|Overall Study|Other|69|||
38000200|NCT00022672|69684070|FG000|Main Phase: 24 Months|Adverse Event|6|||
38000201|NCT00022672|69684071|FG001|Main Phase: 24 Months|Adverse Event|0|||
37904111|NCT00920816|69589879|FG001|Overall Study|Randomized but not treated|0|||
37904112|NCT00920816|69589880|FG002|Overall Study|Randomized but not treated|0|||
37904113|NCT00920816|69589881|FG003|Overall Study|Randomized but not treated|0|||
37904114|NCT00657709|69589896|FG000|Overall Study|AE or Death|7|||
37904115|NCT00657709|69589897|FG001|Overall Study|AE or Death|7|||
37904116|NCT00657709|69589898|FG002|Overall Study|AE or Death|6|||
37904117|NCT00657709|69589899|FG003|Overall Study|AE or Death|7|||
37904118|NCT00657709|69589900|FG004|Overall Study|AE or Death|1|||
37904119|NCT00657709|69589896|FG000|Overall Study|Withdrawal by Subject|7|||
37904120|NCT00657709|69589897|FG001|Overall Study|Withdrawal by Subject|15|||
38000202|NCT00022672|69684070|FG000|Main Phase: 24 Months|Death|0|||
38000203|NCT00022672|69684071|FG001|Main Phase: 24 Months|Death|3|||
38000204|NCT00022672|69684070|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
38000205|NCT00022672|69684071|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
38000206|NCT00022672|69684070|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
38000207|NCT00022672|69684071|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
37904121|NCT00657709|69589898|FG002|Overall Study|Withdrawal by Subject|15|||
38000208|NCT00022672|69684070|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
38000209|NCT00022672|69684071|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
38000210|NCT00022672|69684070|FG000|Main Phase: 24 Months|Refused Treatment|3|||
38000211|NCT00022672|69684071|FG001|Main Phase: 24 Months|Refused Treatment|4|||
38000212|NCT00022672|69684070|FG000|Main Phase: 24 Months|Failure to Return|1|||
38000213|NCT00022672|69684071|FG001|Main Phase: 24 Months|Failure to Return|1|||
38000214|NCT00022672|69684070|FG000|Main Phase: 24 Months|Other|1|||
38000215|NCT00022672|69684071|FG001|Main Phase: 24 Months|Other|0|||
38000216|NCT00022672|69684070|FG000|Extension Phase|Adverse Event|1|||
38000217|NCT00022672|69684071|FG001|Extension Phase|Adverse Event|3|||
38000218|NCT00022672|69684070|FG000|Extension Phase|Death|0|||
38000219|NCT00022672|69684071|FG001|Extension Phase|Death|1|||
38000220|NCT00022672|69684070|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
38000221|NCT00022672|69684071|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
38000222|NCT00022672|69684070|FG000|Extension Phase|Refused Treatment|0|||
38000223|NCT00022672|69684071|FG001|Extension Phase|Refused Treatment|2|||
38000224|NCT00022672|69684070|FG000|Extension Phase|Other|1|||
38000225|NCT00022672|69684071|FG001|Extension Phase|Other|1|||
38000226|NCT00076804|69684080|FG000|Overall Study|Death|9|||
38000227|NCT00076804|69684081|FG001|Overall Study|Death|20|||
38000228|NCT00076804|69684080|FG000|Overall Study|Lost to Follow-up|9|||
38000229|NCT00076804|69684081|FG001|Overall Study|Lost to Follow-up|9|||
37904122|NCT00657709|69589899|FG003|Overall Study|Withdrawal by Subject|5|||
37904123|NCT00657709|69589900|FG004|Overall Study|Withdrawal by Subject|9|||
37904124|NCT00657709|69589896|FG000|Overall Study|Lost to Follow-up|9|||
37904125|NCT00657709|69589897|FG001|Overall Study|Lost to Follow-up|9|||
38000230|NCT00076804|69684080|FG000|Overall Study|Withdrawal by Subject|10|||
38000231|NCT00076804|69684081|FG001|Overall Study|Withdrawal by Subject|8|||
38000232|NCT00076804|69684080|FG000|Overall Study|Early study Closure|32|||
38000233|NCT00076804|69684081|FG001|Overall Study|Early study Closure|32|||
38000234|NCT00141453|69684089|FG000|Overall Study|Protocol Violation|6|||
38000235|NCT00141453|69684090|FG001|Overall Study|Protocol Violation|5|||
38000236|NCT00076570|69684098|FG000|Overall Study|Drug intolerance|8|||
37904126|NCT00657709|69589898|FG002|Overall Study|Lost to Follow-up|7|||
38000237|NCT00076570|69684099|FG001|Overall Study|Drug intolerance|8|||
38000238|NCT00124449|69684107|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
38000239|NCT00124449|69684108|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
38000240|NCT00124449|69684107|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
38000241|NCT00124449|69684108|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
38000242|NCT00124449|69684107|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
38000243|NCT00124449|69684108|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
38000244|NCT00124449|69684107|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
38000245|NCT00124449|69684108|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
38000246|NCT00124449|69684107|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
38000247|NCT00124449|69684108|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
38000248|NCT00124449|69684107|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
38000249|NCT00124449|69684108|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
38000250|NCT00124449|69684107|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
38000251|NCT00124449|69684108|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
38000252|NCT00124449|69684107|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
38000253|NCT00124449|69684108|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
38000254|NCT00124449|69684107|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
38000255|NCT00124449|69684108|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
38000256|NCT00124449|69684107|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
38000257|NCT00124449|69684108|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
38000258|NCT00124449|69684107|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
38000259|NCT00124449|69684108|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
38000260|NCT00124449|69684107|FG000|18-Month Untreated Observation Period|Relocated|1|||
38000261|NCT00124449|69684108|FG001|18-Month Untreated Observation Period|Relocated|0|||
38000262|NCT00076336|69684117|FG000|Overall Study|Death|13|||
38000263|NCT00076336|69684118|FG001|Overall Study|Death|17|||
38000264|NCT00076336|69684117|FG000|Overall Study|Adverse Event|4|||
38000265|NCT00076336|69684118|FG001|Overall Study|Adverse Event|4|||
38000266|NCT00076336|69684117|FG000|Overall Study|Lost to Follow-up|4|||
38000267|NCT00076336|69684118|FG001|Overall Study|Lost to Follow-up|4|||
38000268|NCT00076336|69684117|FG000|Overall Study|Non-Compliance|2|||
38000269|NCT00076336|69684118|FG001|Overall Study|Non-Compliance|0|||
37904127|NCT00657709|69589899|FG003|Overall Study|Lost to Follow-up|1|||
37904128|NCT00657709|69589900|FG004|Overall Study|Lost to Follow-up|21|||
37904129|NCT00657709|69589896|FG000|Overall Study|Protocol Violation|0|||
37904130|NCT00657709|69589897|FG001|Overall Study|Protocol Violation|2|||
37904131|NCT00657709|69589898|FG002|Overall Study|Protocol Violation|0|||
37904132|NCT00657709|69589899|FG003|Overall Study|Protocol Violation|1|||
37904133|NCT00657709|69589900|FG004|Overall Study|Protocol Violation|2|||
37904134|NCT00915356|69589927|FG000|Overall Study|Withdrawal by Subject|1|||
37904135|NCT00915356|69589928|FG001|Overall Study|Withdrawal by Subject|0|||
37904136|NCT00915356|69589929|FG002|Overall Study|Withdrawal by Subject|0|||
37904137|NCT00915356|69589930|FG003|Overall Study|Withdrawal by Subject|0|||
37904138|NCT00915356|69589931|FG004|Overall Study|Withdrawal by Subject|0|||
37904139|NCT00657553|69589945|FG000|Overall Study|low accrual, no analysis run|5|||
37904140|NCT00657553|69589946|FG001|Overall Study|low accrual, no analysis run|5|||
37904141|NCT00862719|69589956|FG000|Overall Study|Disease Progression|5|||
37904142|NCT00862719|69589957|FG001|Overall Study|Disease Progression|0|||
37904143|NCT00862719|69589958|FG002|Overall Study|Disease Progression|1|||
37904144|NCT00862719|69589959|FG003|Overall Study|Disease Progression|0|||
37904145|NCT00862719|69589956|FG000|Overall Study|Death|5|||
37904146|NCT00862719|69589957|FG001|Overall Study|Death|6|||
37904147|NCT00862719|69589958|FG002|Overall Study|Death|1|||
37904148|NCT00862719|69589959|FG003|Overall Study|Death|1|||
37904149|NCT00862719|69589956|FG000|Overall Study|Engraftment failure|0|||
37904150|NCT00862719|69589957|FG001|Overall Study|Engraftment failure|0|||
37904151|NCT00862719|69589958|FG002|Overall Study|Engraftment failure|1|||
37904152|NCT00862719|69589959|FG003|Overall Study|Engraftment failure|0|||
37904153|NCT00862719|69589956|FG000|Overall Study|Veno-Occlusive Disease|0|||
38000270|NCT00076336|69684117|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
38000271|NCT00076336|69684118|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
38000272|NCT00076336|69684117|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
38000273|NCT00076336|69684118|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
38000274|NCT00076336|69684117|FG000|Overall Study|Liver Transplantation|3|||
37904154|NCT00862719|69589957|FG001|Overall Study|Veno-Occlusive Disease|0|||
37904155|NCT00862719|69589958|FG002|Overall Study|Veno-Occlusive Disease|1|||
37904156|NCT00862719|69589959|FG003|Overall Study|Veno-Occlusive Disease|0|||
37904157|NCT00862641|69589973|FG000|Overall Study|Randomized, but drug not received|1|||
38000275|NCT00076336|69684118|FG001|Overall Study|Liver Transplantation|3|||
38000276|NCT00076336|69684117|FG000|Overall Study|Virologic Breakthrough|14|||
37904158|NCT00862641|69589974|FG001|Overall Study|Randomized, but drug not received|4|||
37904159|NCT00862641|69589975|FG002|Overall Study|Randomized, but drug not received|1|||
37904160|NCT00862641|69589976|FG003|Overall Study|Randomized, but drug not received|4|||
37904161|NCT00861471|69589986|FG000|Overall Study|Withdrawal by Subject|1|||
37829265|NCT01056536|69512478|FG001|Overall Study|Lost to Follow-up|116|||
37829266|NCT01056536|69512479|FG002|Overall Study|Lost to Follow-up|248|||
37829267|NCT01056380|69512489|FG000|Overall Study|Lost to Follow-up|2|||
38000277|NCT00076336|69684118|FG001|Overall Study|Virologic Breakthrough|16|||
38000278|NCT00076336|69684117|FG000|Overall Study|Treatment failure|4|||
38000279|NCT00076336|69684118|FG001|Overall Study|Treatment failure|5|||
38000280|NCT00185588|69684128|FG000|Overall Study|Adverse Event|3|||
38000281|NCT00185588|69684129|FG001|Overall Study|Adverse Event|1|||
38000282|NCT00185588|69684130|FG002|Overall Study|Adverse Event|4|||
38000283|NCT00185588|69684131|FG003|Overall Study|Adverse Event|2|||
38000284|NCT00185588|69684128|FG000|Overall Study|Lost to Follow-up|0|||
37829268|NCT01056380|69512490|FG001|Overall Study|Lost to Follow-up|3|||
37829269|NCT01055834|69512500|FG000|Treatment Period I|Adverse Event|1|||
37829270|NCT01055834|69512501|FG001|Treatment Period I|Adverse Event|0|||
37829271|NCT01055639|69512512|FG000|Overall Study|Adverse Event|0|||
37829272|NCT01055639|69512513|FG001|Overall Study|Adverse Event|1|||
37829273|NCT01055639|69512512|FG000|Overall Study|Lack of Efficacy|0|||
37829274|NCT01055639|69512513|FG001|Overall Study|Lack of Efficacy|1|||
37829275|NCT01055639|69512512|FG000|Overall Study|Lost to Follow-up|8|||
37829276|NCT01055639|69512513|FG001|Overall Study|Lost to Follow-up|11|||
37904162|NCT00861471|69589986|FG000|Overall Study|Adverse Event|2|||
37829277|NCT01055639|69512512|FG000|Overall Study|Protocol Violation|5|||
37829278|NCT01055639|69512513|FG001|Overall Study|Protocol Violation|5|||
38000285|NCT00185588|69684129|FG001|Overall Study|Lost to Follow-up|0|||
38000286|NCT00185588|69684130|FG002|Overall Study|Lost to Follow-up|1|||
38000287|NCT00185588|69684131|FG003|Overall Study|Lost to Follow-up|2|||
38000288|NCT00185588|69684128|FG000|Overall Study|Withdrawal by Subject|0|||
38000289|NCT00185588|69684129|FG001|Overall Study|Withdrawal by Subject|1|||
38000290|NCT00185588|69684130|FG002|Overall Study|Withdrawal by Subject|0|||
38000291|NCT00185588|69684131|FG003|Overall Study|Withdrawal by Subject|0|||
38000292|NCT00185588|69684128|FG000|Overall Study|Physician Decision|0|||
38000293|NCT00185588|69684129|FG001|Overall Study|Physician Decision|0|||
38000294|NCT00185588|69684130|FG002|Overall Study|Physician Decision|1|||
38000295|NCT00185588|69684131|FG003|Overall Study|Physician Decision|0|||
38000296|NCT00232544|69684143|FG000|Overall Study|Lost to Follow-up|20|||
38000297|NCT00232544|69684144|FG001|Overall Study|Lost to Follow-up|15|||
37904163|NCT00861471|69589986|FG000|Overall Study|Lack of Efficacy|3|||
37904164|NCT00861471|69589986|FG000|Overall Study|treatment for lumbar laminectomy|1|||
37904165|NCT00861471|69589986|FG000|Overall Study|Physician Decision|2|||
37904166|NCT00860067|69589993|FG000|Overall Study|Lost to Follow-up|46|||
37904167|NCT00860067|69589994|FG001|Overall Study|Lost to Follow-up|9|||
37904168|NCT00860067|69589995|FG002|Overall Study|Lost to Follow-up|9|||
37904169|NCT00860067|69589993|FG000|Overall Study|Withdrawal by Subject|4|||
38000298|NCT00231842|69684150|FG000|Overall Study|Withdrawal by Subject|3|||
38000299|NCT00231842|69684150|FG000|Overall Study|Did not complete the last 3 cycle|8|||
37904170|NCT00860067|69589994|FG001|Overall Study|Withdrawal by Subject|0|||
38000300|NCT00076102|69684155|FG000|Overall Study|Clinical progression|1|||
38000301|NCT00076102|69684155|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
38000302|NCT00076102|69684155|FG000|Overall Study|plexiform neurofibroma surgery|1|||
37904171|NCT00860067|69589995|FG002|Overall Study|Withdrawal by Subject|0|||
38000303|NCT00076102|69684155|FG000|Overall Study|refusal of further therapy|2|||
37697304|NCT02443883|69173779|FG003|Overall Study|Withdrawal by Subject|2|||
37829279|NCT01055639|69512512|FG000|Overall Study|Withdrawal by Subject|8|||
37829280|NCT01055639|69512513|FG001|Overall Study|Withdrawal by Subject|11|||
37829281|NCT01055132|69512528|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
37829282|NCT01055132|69512529|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
37829283|NCT01055132|69512528|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
37829284|NCT01055132|69512529|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
37829285|NCT01054976|69512539|FG000|Overall Study|Adverse Event|16|||
37829286|NCT01054976|69512539|FG000|Overall Study|Uncooperative participations to study|7|||
37904172|NCT00860067|69589993|FG000|Overall Study|Pregnancy|1|||
37904173|NCT00860067|69589994|FG001|Overall Study|Pregnancy|0|||
37904174|NCT00860067|69589995|FG002|Overall Study|Pregnancy|0|||
37904175|NCT00858117|69590006|FG000|Treatment on Study|Adverse Event|2|||
37904176|NCT00858117|69590006|FG000|Follow up for 5 Years|Death|4|||
37904177|NCT00858117|69590006|FG000|Follow up for 5 Years|No further data collected for study|9|||
37904178|NCT00652951|69590013|FG000|Booster Phase|Adverse event, non-fatal|0|||
38000304|NCT00231062|69684169|FG000|Overall Study|Physician Decision|6|||
38000305|NCT00184028|69684173|FG000|Overall Study|Death|1|||
37829287|NCT01054976|69512539|FG000|Overall Study|Withdrawal by Subject|4|||
37829288|NCT01054976|69512539|FG000|Overall Study|Other|8|||
37904179|NCT00652951|69590014|FG001|Booster Phase|Adverse event, non-fatal|1|||
38000306|NCT00184028|69684173|FG000|Overall Study|Lack of Efficacy|4|||
38000307|NCT00184028|69684173|FG000|Overall Study|Adverse Event|2|||
38000308|NCT00184028|69684173|FG000|Overall Study|Withdrawal by Subject|1|||
38000309|NCT00184028|69684173|FG000|Overall Study|Non-compliance|2|||
38000310|NCT00183872|69684178|FG000|Overall Study|Death|3|||
38000311|NCT00183872|69684178|FG000|Overall Study|Adverse Event|9|||
38000312|NCT00183872|69684178|FG000|Overall Study|Withdrawal by Subject|2|||
38000313|NCT00183872|69684178|FG000|Overall Study|Drug delayed more than 28 days|2|||
38000314|NCT03815175|69684182|FG000|Overall Study|Subject Lost to Follow-up|6|||
38000315|NCT03815175|69684182|FG000|Overall Study|Subject Withdrew Consent|48|||
38000316|NCT03815175|69684182|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
38000317|NCT03815175|69684182|FG000|Overall Study|Death|86|||
38000318|NCT03815175|69684182|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
38000319|NCT03815175|69684182|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
38000320|NCT03815175|69684182|FG000|Overall Study|Other Status Change Reason|1|||
38000321|NCT03815175|69684182|FG000|Overall Study|Missed Visit|12|||
38000322|NCT00262028|69684195|FG000|Overall Study|Withdrawal by Subject|6|||
38000323|NCT00262028|69684196|FG001|Overall Study|Withdrawal by Subject|3|||
38000324|NCT00262028|69684197|FG002|Overall Study|Withdrawal by Subject|6|||
38000325|NCT00262028|69684198|FG003|Overall Study|Withdrawal by Subject|5|||
38000326|NCT00262028|69684199|FG004|Overall Study|Withdrawal by Subject|2|||
38000327|NCT00262028|69684200|FG005|Overall Study|Withdrawal by Subject|3|||
38000328|NCT00262028|69684201|FG006|Overall Study|Withdrawal by Subject|5|||
38000329|NCT00262028|69684202|FG007|Overall Study|Withdrawal by Subject|7|||
38000330|NCT00262028|69684203|FG008|Overall Study|Withdrawal by Subject|2|||
38000331|NCT00262028|69684195|FG000|Overall Study|Lost to Follow-up|7|||
38000332|NCT00262028|69684196|FG001|Overall Study|Lost to Follow-up|7|||
38000333|NCT00262028|69684197|FG002|Overall Study|Lost to Follow-up|5|||
38000334|NCT00262028|69684198|FG003|Overall Study|Lost to Follow-up|5|||
38000335|NCT00262028|69684199|FG004|Overall Study|Lost to Follow-up|4|||
38000336|NCT00262028|69684200|FG005|Overall Study|Lost to Follow-up|3|||
38000337|NCT00262028|69684201|FG006|Overall Study|Lost to Follow-up|3|||
38000338|NCT00262028|69684202|FG007|Overall Study|Lost to Follow-up|5|||
38000339|NCT00262028|69684203|FG008|Overall Study|Lost to Follow-up|6|||
38000340|NCT00262028|69684195|FG000|Overall Study|Administrative Reason|11|||
38000341|NCT00262028|69684196|FG001|Overall Study|Administrative Reason|14|||
38000342|NCT00262028|69684197|FG002|Overall Study|Administrative Reason|9|||
38000343|NCT00262028|69684198|FG003|Overall Study|Administrative Reason|12|||
38000344|NCT00262028|69684199|FG004|Overall Study|Administrative Reason|6|||
38000345|NCT00262028|69684200|FG005|Overall Study|Administrative Reason|7|||
38000346|NCT00262028|69684201|FG006|Overall Study|Administrative Reason|4|||
38000347|NCT00262028|69684202|FG007|Overall Study|Administrative Reason|6|||
38000348|NCT00262028|69684203|FG008|Overall Study|Administrative Reason|10|||
38000349|NCT00262028|69684195|FG000|Overall Study|Protocol Violation|0|||
38000350|NCT00262028|69684196|FG001|Overall Study|Protocol Violation|0|||
38000351|NCT00262028|69684197|FG002|Overall Study|Protocol Violation|0|||
38000352|NCT00262028|69684198|FG003|Overall Study|Protocol Violation|1|||
38000353|NCT00262028|69684199|FG004|Overall Study|Protocol Violation|0|||
38000354|NCT00262028|69684200|FG005|Overall Study|Protocol Violation|0|||
37697305|NCT02443883|69173776|FG000|Overall Study|Randomized, but never treated|1|||
37829289|NCT01053962|69512548|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
37829290|NCT01053962|69512549|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
37829291|NCT01053962|69512550|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
38000355|NCT00262028|69684201|FG006|Overall Study|Protocol Violation|0|||
37829292|NCT01053962|69512551|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
37829293|NCT01053962|69512552|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
37829294|NCT01053962|69512548|FG000|Pretreatment Period|Venipuncture Failure|0|||
37829295|NCT01053962|69512549|FG001|Pretreatment Period|Venipuncture Failure|0|||
37829296|NCT01053962|69512550|FG002|Pretreatment Period|Venipuncture Failure|1|||
37829297|NCT01053962|69512551|FG003|Pretreatment Period|Venipuncture Failure|0|||
37829298|NCT01053962|69512552|FG004|Pretreatment Period|Venipuncture Failure|0|||
37829299|NCT01053962|69512548|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
37829300|NCT01053962|69512549|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
37829301|NCT01053962|69512550|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
38000356|NCT00262028|69684202|FG007|Overall Study|Protocol Violation|0|||
38000357|NCT00262028|69684203|FG008|Overall Study|Protocol Violation|0|||
38000358|NCT00262028|69684195|FG000|Overall Study|Unable to classify|0|||
38000359|NCT00262028|69684196|FG001|Overall Study|Unable to classify|3|||
38000360|NCT00262028|69684197|FG002|Overall Study|Unable to classify|0|||
38000361|NCT00262028|69684198|FG003|Overall Study|Unable to classify|0|||
38000362|NCT00262028|69684199|FG004|Overall Study|Unable to classify|0|||
38000363|NCT00262028|69684200|FG005|Overall Study|Unable to classify|0|||
38000364|NCT00262028|69684201|FG006|Overall Study|Unable to classify|0|||
38000365|NCT00262028|69684202|FG007|Overall Study|Unable to classify|0|||
37697306|NCT02443883|69173777|FG001|Overall Study|Randomized, but never treated|0|||
38000366|NCT00262028|69684203|FG008|Overall Study|Unable to classify|1|||
38000367|NCT00183248|69684247|FG000|Overall Study|Lost to Follow-up|0|||
38000368|NCT00183248|69684248|FG001|Overall Study|Lost to Follow-up|1|||
38000369|NCT00183248|69684247|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
38000370|NCT00183248|69684248|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
38000371|NCT00183170|69684256|FG000|First Intervention|Did not complete study|1|||
37697307|NCT02443883|69173778|FG002|Overall Study|Randomized, but never treated|0|||
37697308|NCT02443883|69173779|FG003|Overall Study|Randomized, but never treated|0|||
37697309|NCT02460263|69173789|FG000|Transition Period|Withdrawal by Subject|1|||
37697310|NCT02460263|69173789|FG000|Transition Period|Death|1|||
37697311|NCT02443805|69173799|FG000|Overall Study|Adverse Event|100|||
37697312|NCT02443805|69173800|FG001|Overall Study|Adverse Event|18|||
37697313|NCT02443805|69173799|FG000|Overall Study|Withdrawal by Subject|73|||
37697314|NCT02443805|69173800|FG001|Overall Study|Withdrawal by Subject|74|||
37697315|NCT02443805|69173799|FG000|Overall Study|Lost to Follow-up|19|||
37697316|NCT02443805|69173800|FG001|Overall Study|Lost to Follow-up|14|||
37697317|NCT02443805|69173799|FG000|Overall Study|Pregnancy|6|||
37697318|NCT02443805|69173800|FG001|Overall Study|Pregnancy|5|||
37697319|NCT02443805|69173799|FG000|Overall Study|Protocol Violation|2|||
37697320|NCT02443805|69173800|FG001|Overall Study|Protocol Violation|4|||
37697321|NCT02443805|69173799|FG000|Overall Study|Lack of Efficacy|1|||
37697322|NCT02443805|69173800|FG001|Overall Study|Lack of Efficacy|1|||
37697323|NCT02443805|69173799|FG000|Overall Study|Non-compliance with study drug|6|||
37697324|NCT02443805|69173800|FG001|Overall Study|Non-compliance with study drug|4|||
37697325|NCT02443805|69173799|FG000|Overall Study|Withdrawal by parent/guardian|3|||
38000372|NCT00183170|69684257|FG001|First Intervention|Did not complete study|0|||
37697326|NCT02443805|69173800|FG001|Overall Study|Withdrawal by parent/guardian|5|||
37697327|NCT02443805|69173799|FG000|Overall Study|Any other reason not above-mentioned|3|||
37697328|NCT02443805|69173800|FG001|Overall Study|Any other reason not above-mentioned|2|||
37697329|NCT01652885|69173806|FG000|Overall Study|Adverse Event|1|||
37697330|NCT02459951|69173810|FG000|Overall Study|Unable to meet holding requirement|1|||
37697331|NCT02087241|69173819|FG000|Overall Study|Death|2|||
37697332|NCT02087241|69173820|FG001|Overall Study|Death|1|||
37697333|NCT02087241|69173821|FG002|Overall Study|Death|1|||
37697334|NCT02087241|69173822|FG003|Overall Study|Death|1|||
37697335|NCT02087241|69173819|FG000|Overall Study|Withdrawal by Subject|1|||
37697336|NCT02087241|69173820|FG001|Overall Study|Withdrawal by Subject|0|||
37697337|NCT02087241|69173821|FG002|Overall Study|Withdrawal by Subject|0|||
37697338|NCT02087241|69173822|FG003|Overall Study|Withdrawal by Subject|1|||
37697339|NCT02087241|69173819|FG000|Overall Study|Progressive Disease|0|||
37697340|NCT02087241|69173820|FG001|Overall Study|Progressive Disease|0|||
37697341|NCT02087241|69173821|FG002|Overall Study|Progressive Disease|0|||
37697342|NCT02087241|69173822|FG003|Overall Study|Progressive Disease|1|||
37697343|NCT02087241|69173819|FG000|Overall Study|Study Terminated by Sponsor|0|||
37697344|NCT02087241|69173820|FG001|Overall Study|Study Terminated by Sponsor|2|||
38000373|NCT00183170|69684256|FG000|First Intervention|Did not meet targeted BrAC|1|||
38000374|NCT00183170|69684257|FG001|First Intervention|Did not meet targeted BrAC|0|||
38000375|NCT00183170|69684256|FG000|Washout 1 Week|Did not complete study|6|||
38000376|NCT00183170|69684257|FG001|Washout 1 Week|Did not complete study|8|||
38000377|NCT00183170|69684256|FG000|Second Intervention|Did not complete study|1|||
38000378|NCT00183170|69684257|FG001|Second Intervention|Did not complete study|0|||
38000379|NCT00183170|69684256|FG000|Second Intervention|Did not meet targeted BrAC|0|||
38000380|NCT00183170|69684257|FG001|Second Intervention|Did not meet targeted BrAC|2|||
38000381|NCT00230282|69684263|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
38000382|NCT00230282|69684263|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
37829302|NCT01053962|69512551|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
37829303|NCT01053962|69512552|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
37829304|NCT01053962|69512548|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
37829305|NCT01053962|69512549|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
37829306|NCT01053962|69512550|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
37829307|NCT01053962|69512551|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
37829308|NCT01053962|69512552|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
37829309|NCT01053962|69512548|FG000|Treatment Period|Lack of Efficacy|0|||
37829310|NCT01053962|69512549|FG001|Treatment Period|Lack of Efficacy|0|||
37829311|NCT01053962|69512550|FG002|Treatment Period|Lack of Efficacy|0|||
37829312|NCT01053962|69512551|FG003|Treatment Period|Lack of Efficacy|0|||
37829313|NCT01053962|69512552|FG004|Treatment Period|Lack of Efficacy|1|||
37829314|NCT01053962|69512548|FG000|Treatment Period|Adverse Event|0|||
37829315|NCT01053962|69512549|FG001|Treatment Period|Adverse Event|0|||
37829316|NCT01053962|69512550|FG002|Treatment Period|Adverse Event|0|||
38000383|NCT00230282|69684263|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
38000384|NCT00230282|69684263|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
38000385|NCT00261950|69684267|FG000|Overall Study|Lost to Follow-up|2|||
38000386|NCT00261950|69684267|FG000|Overall Study|Death|6|||
38000387|NCT00261950|69684267|FG000|Overall Study|Withdrawal by Subject|5|||
38000388|NCT00261950|69684267|FG000|Overall Study|Other|1|||
38000389|NCT00261950|69684267|FG000|Overall Study|Physician Decision|1|||
38000390|NCT00261950|69684267|FG000|Overall Study|Protocol specified Criteria|11|||
38000391|NCT00230048|69684273|FG000|Overall Study|Lost to Follow-up|13|||
38000392|NCT00230048|69684274|FG001|Overall Study|Lost to Follow-up|18|||
38000393|NCT00229658|69684284|FG000|Overall Study|Administrative|2|||
38000394|NCT00229658|69684285|FG001|Overall Study|Administrative|1|||
38000395|NCT00229658|69684284|FG000|Overall Study|Investigator decision|13|||
38000396|NCT00229658|69684285|FG001|Overall Study|Investigator decision|10|||
38000397|NCT00229658|69684284|FG000|Overall Study|Other|80|||
38000398|NCT00229658|69684285|FG001|Overall Study|Other|60|||
38000399|NCT00229658|69684284|FG000|Overall Study|Lost to Follow-up|82|||
38000400|NCT00229658|69684285|FG001|Overall Study|Lost to Follow-up|55|||
38000401|NCT00229658|69684284|FG000|Overall Study|Serious Adverse Event|2|||
38000402|NCT00229658|69684285|FG001|Overall Study|Serious Adverse Event|2|||
38000403|NCT00229658|69684284|FG000|Overall Study|Withdrawal of consent|46|||
38000404|NCT00229658|69684285|FG001|Overall Study|Withdrawal of consent|39|||
38000405|NCT00182078|69684293|FG000|Overall Study|Withdrawal by Subject|1|||
38000406|NCT00182078|69684294|FG001|Overall Study|Withdrawal by Subject|0|||
38000407|NCT00181844|69684300|FG000|Signed Consent|Withdrawal by Subject|5|||
38000408|NCT00181844|69684300|FG000|Signed Consent|Did not meet entrance criteria|7|||
38000409|NCT00181844|69684300|FG000|Exposed to Study Medication|Adverse Event|10|||
38000410|NCT00181844|69684300|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
38000411|NCT00181844|69684300|FG000|Exposed to Study Medication|Non-compliance|2|||
38000412|NCT00181844|69684300|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
38000413|NCT00181844|69684300|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
38000414|NCT00181766|69684304|FG000|Overall Study|Lost to Follow-up|6|||
38000415|NCT00181766|69684304|FG000|Overall Study|Adverse Event|4|||
38000416|NCT00181766|69684304|FG000|Overall Study|non-compliance|2|||
37697345|NCT02087241|69173821|FG002|Overall Study|Study Terminated by Sponsor|0|||
37697346|NCT02087241|69173822|FG003|Overall Study|Study Terminated by Sponsor|4|||
37697347|NCT02087085|69173838|FG000|Overall Study|Adverse Event|10|||
37697348|NCT02087085|69173839|FG001|Overall Study|Adverse Event|14|||
37697349|NCT02087085|69173838|FG000|Overall Study|Lack of Efficacy|4|||
37697350|NCT02087085|69173839|FG001|Overall Study|Lack of Efficacy|3|||
37697351|NCT02087085|69173838|FG000|Overall Study|Lost to Follow-up|6|||
37697352|NCT02087085|69173839|FG001|Overall Study|Lost to Follow-up|4|||
38000417|NCT00180674|69684308|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
37697353|NCT02087085|69173838|FG000|Overall Study|Withdrawal by Subject|9|||
37697354|NCT02087085|69173839|FG001|Overall Study|Withdrawal by Subject|11|||
37697355|NCT02087085|69173838|FG000|Overall Study|Protocol Violation|1|||
37697356|NCT02087085|69173839|FG001|Overall Study|Protocol Violation|0|||
37697357|NCT02087085|69173838|FG000|Overall Study|Study Terminated by Sponsor|87|||
38000418|NCT00180674|69684308|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
38000419|NCT00076024|69684319|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
38000420|NCT00076024|69684320|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
38000421|NCT00076024|69684321|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
38000422|NCT00076024|69684322|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
38000423|NCT00076024|69684319|FG000|Phase 1, Lead-in|Adverse Event|1|||
38000424|NCT00076024|69684320|FG001|Phase 1, Lead-in|Adverse Event|0|||
38000425|NCT00076024|69684321|FG002|Phase 1, Lead-in|Adverse Event|0|||
38000426|NCT00076024|69684322|FG003|Phase 1, Lead-in|Adverse Event|0|||
38000427|NCT00076024|69684319|FG000|Phase 1, Lead-in|Clinical progression|1|||
37697358|NCT02087085|69173839|FG001|Overall Study|Study Terminated by Sponsor|80|||
37697359|NCT02087085|69173838|FG000|Overall Study|Other Miscellaneous Reasons|3|||
37697360|NCT02087085|69173839|FG001|Overall Study|Other Miscellaneous Reasons|4|||
38000428|NCT00076024|69684320|FG001|Phase 1, Lead-in|Clinical progression|0|||
38000429|NCT00076024|69684321|FG002|Phase 1, Lead-in|Clinical progression|0|||
38000430|NCT00076024|69684322|FG003|Phase 1, Lead-in|Clinical progression|0|||
38000431|NCT00076024|69684319|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
38000432|NCT00076024|69684320|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
38000433|NCT00076024|69684321|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
38000434|NCT00076024|69684322|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
38000435|NCT00076024|69684319|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
38000436|NCT00076024|69684320|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
38000437|NCT00076024|69684321|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
38000438|NCT00076024|69684322|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
37697361|NCT02443337|69173847|FG000|Overall Study|Adverse Event|0|||
37697362|NCT02443337|69173848|FG001|Overall Study|Adverse Event|1|||
38000439|NCT00076024|69684319|FG000|Phase 2, Double-blind|Adverse Event|0|||
38000440|NCT00076024|69684320|FG001|Phase 2, Double-blind|Adverse Event|25|||
38000441|NCT00076024|69684321|FG002|Phase 2, Double-blind|Adverse Event|6|||
38000442|NCT00076024|69684322|FG003|Phase 2, Double-blind|Adverse Event|0|||
38000443|NCT00076024|69684319|FG000|Phase 2, Double-blind|Un-specified|0|||
38000444|NCT00076024|69684320|FG001|Phase 2, Double-blind|Un-specified|14|||
38000445|NCT00076024|69684321|FG002|Phase 2, Double-blind|Un-specified|6|||
38000446|NCT00076024|69684322|FG003|Phase 2, Double-blind|Un-specified|0|||
38000447|NCT00076024|69684319|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
38000448|NCT00076024|69684320|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
38000449|NCT00076024|69684321|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
38000450|NCT00076024|69684322|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
38000451|NCT00076024|69684319|FG000|Phase 2, Open-label|Adverse Event|0|||
38000452|NCT00076024|69684320|FG001|Phase 2, Open-label|Adverse Event|0|||
38000453|NCT00076024|69684321|FG002|Phase 2, Open-label|Adverse Event|0|||
38000454|NCT00076024|69684322|FG003|Phase 2, Open-label|Adverse Event|2|||
38000455|NCT00076024|69684319|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
38000456|NCT00076024|69684320|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
38000457|NCT00076024|69684321|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
37829317|NCT01053962|69512551|FG003|Treatment Period|Adverse Event|0|||
38000458|NCT00076024|69684322|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
38000459|NCT00076024|69684319|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
38000460|NCT00076024|69684320|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
38000461|NCT00076024|69684321|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
38000462|NCT00076024|69684322|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
38000463|NCT00076024|69684319|FG000|Phase 2, Open-label|Other|0|||
38000464|NCT00076024|69684320|FG001|Phase 2, Open-label|Other|0|||
37829318|NCT01053962|69512552|FG004|Treatment Period|Adverse Event|1|||
38000465|NCT00076024|69684321|FG002|Phase 2, Open-label|Other|0|||
38000466|NCT00076024|69684322|FG003|Phase 2, Open-label|Other|2|||
38000467|NCT00075478|69684333|FG000|Overall Study|not eligible|1|||
38000468|NCT00075478|69684334|FG001|Overall Study|not eligible|0|||
38000469|NCT00075478|69684333|FG000|Overall Study|Physician Decision|0|||
38000470|NCT00075478|69684334|FG001|Overall Study|Physician Decision|1|||
38000471|NCT00175916|69684340|FG000|Overall Study|Death|19|||
38000472|NCT00175916|69684340|FG000|Overall Study|Adverse Event|81|||
38000473|NCT00175916|69684340|FG000|Overall Study|Lack of Efficacy|354|||
38000474|NCT00175916|69684340|FG000|Overall Study|Lost to Follow-up|17|||
38000475|NCT00175916|69684340|FG000|Overall Study|Subject Choice|98|||
37829319|NCT01053962|69512548|FG000|Treatment Period|Withdrawal by Subject|0|||
38000476|NCT00175916|69684340|FG000|Overall Study|Lack of compliance|8|||
38000477|NCT00175916|69684340|FG000|Overall Study|Patient cannot record seizures|1|||
38000478|NCT00175916|69684340|FG000|Overall Study|Sponsor decision|17|||
38000479|NCT00175916|69684340|FG000|Overall Study|Vigabatrin intake|1|||
38000480|NCT00175916|69684340|FG000|Overall Study|Suicidal behaviour|1|||
38000481|NCT00175916|69684340|FG000|Overall Study|Withdrawal by Subject|1|||
37697363|NCT02443337|69173847|FG000|Overall Study|Clinical Progressive Disease|3|||
37904180|NCT00652951|69590015|FG002|Booster Phase|Adverse event, non-fatal|0|||
38000482|NCT00175916|69684340|FG000|Overall Study|Seizure - free|4|||
38000483|NCT00175916|69684340|FG000|Overall Study|Administrative reason|1|||
38000484|NCT00175916|69684340|FG000|Overall Study|Pregnancy|1|||
38000485|NCT00175916|69684340|FG000|Overall Study|Patient's request|2|||
37904181|NCT00652951|69590013|FG000|Booster Phase|Other|1|||
37904182|NCT00652951|69590014|FG001|Booster Phase|Other|0|||
37904183|NCT00652951|69590015|FG002|Booster Phase|Other|0|||
37904184|NCT00848211|69590027|FG000|Overall Study|Protocol Violation|0|||
37904185|NCT00848211|69590028|FG001|Overall Study|Protocol Violation|1|||
37904186|NCT00848211|69590029|FG002|Overall Study|Protocol Violation|1|||
37904187|NCT00848211|69590030|FG003|Overall Study|Protocol Violation|0|||
37904188|NCT00848211|69590027|FG000|Overall Study|Adverse Event|0|||
38000486|NCT00175916|69684340|FG000|Overall Study|Treating physiciant's choice|1|||
37904189|NCT00848211|69590028|FG001|Overall Study|Adverse Event|0|||
38000487|NCT00175916|69684340|FG000|Overall Study|Moved overseas|1|||
38000488|NCT00175916|69684340|FG000|Overall Study|Loss of job and economic burden|1|||
38000489|NCT00175916|69684340|FG000|Overall Study|Site was closed|9|||
38000490|NCT00175916|69684340|FG000|Overall Study|Patient went to prison|1|||
38000491|NCT00075400|69684345|FG000|Overall Study|Ineligible: wrong primary|1|||
38000492|NCT00075400|69684345|FG000|Overall Study|Never treated|2|||
38000493|NCT00228566|69684354|FG000|Overall Study|Adverse Event|31|||
38000494|NCT00228566|69684354|FG000|Overall Study|Lack of Efficacy|14|||
38000495|NCT00228566|69684354|FG000|Overall Study|Lost to Follow-up|16|||
38000496|NCT00228566|69684354|FG000|Overall Study|Physician Decision|5|||
38000497|NCT00228566|69684354|FG000|Overall Study|Withdrawal by Subject|4|||
38000498|NCT00228566|69684354|FG000|Overall Study|Miscellaneous|1|||
38000499|NCT00074152|69684360|FG000|Overall Study|Death|21|||
38000500|NCT00074152|69684361|FG001|Overall Study|Death|9|||
38000501|NCT00074152|69684360|FG000|Overall Study|Lack of Efficacy|34|||
38000502|NCT00074152|69684361|FG001|Overall Study|Lack of Efficacy|24|||
37697364|NCT02443337|69173848|FG001|Overall Study|Clinical Progressive Disease|0|||
37697365|NCT02443337|69173847|FG000|Overall Study|Withdrawal by Subject|2|||
37697366|NCT02443337|69173848|FG001|Overall Study|Withdrawal by Subject|1|||
38000503|NCT00261846|69684377|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
38000504|NCT00261846|69684378|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
38000505|NCT00261846|69684379|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
37829320|NCT01053962|69512549|FG001|Treatment Period|Withdrawal by Subject|0|||
37829321|NCT01053962|69512550|FG002|Treatment Period|Withdrawal by Subject|0|||
37829322|NCT01053962|69512551|FG003|Treatment Period|Withdrawal by Subject|0|||
37829323|NCT01053962|69512552|FG004|Treatment Period|Withdrawal by Subject|1|||
37829324|NCT01053962|69512548|FG000|Treatment Period|Noncompliance with protocol|1|||
37829325|NCT01053962|69512549|FG001|Treatment Period|Noncompliance with protocol|0|||
37829326|NCT01053962|69512550|FG002|Treatment Period|Noncompliance with protocol|0|||
37829327|NCT01053962|69512551|FG003|Treatment Period|Noncompliance with protocol|0|||
37829328|NCT01053962|69512552|FG004|Treatment Period|Noncompliance with protocol|0|||
38000506|NCT00261846|69684380|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
38000507|NCT00261846|69684381|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
37904190|NCT00848211|69590029|FG002|Overall Study|Adverse Event|0|||
37904191|NCT00848211|69590030|FG003|Overall Study|Adverse Event|0|||
37904192|NCT00592683|69590042|FG000|Overall Study|Found ineligible|0|||
37904193|NCT00592683|69590043|FG001|Overall Study|Found ineligible|1|||
38000508|NCT00261846|69684382|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
38000509|NCT00261846|69684383|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
37829329|NCT01053221|69512571|FG000|Overall Study|The study was closed prematurely|5|||
37904194|NCT00592683|69590042|FG000|Overall Study|Withdrawal by Subject|1|||
37904195|NCT00592683|69590043|FG001|Overall Study|Withdrawal by Subject|0|||
37904196|NCT00592683|69590042|FG000|Overall Study|Adverse Event|0|||
37904197|NCT00592683|69590043|FG001|Overall Study|Adverse Event|2|||
37904198|NCT00592683|69590042|FG000|Overall Study|Protocol Violation|1|||
37904199|NCT00592683|69590043|FG001|Overall Study|Protocol Violation|0|||
37904200|NCT00592683|69590042|FG000|Overall Study|Study drug expired|1|||
37904201|NCT00592683|69590043|FG001|Overall Study|Study drug expired|0|||
37904202|NCT00592683|69590042|FG000|Overall Study|Other|1|||
37904203|NCT00592683|69590043|FG001|Overall Study|Other|0|||
37904204|NCT00592683|69590042|FG000|Overall Study|Lost to Follow-up|0|||
37904205|NCT00592683|69590043|FG001|Overall Study|Lost to Follow-up|1|||
37904206|NCT00847665|69590051|FG000|Overall Study|Withdrawal by Subject|1|||
37904207|NCT00847665|69590052|FG001|Overall Study|Withdrawal by Subject|0|||
37904208|NCT00916370|69590060|FG000|Overall Study|Death|3|||
38000510|NCT00261846|69684384|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
38000511|NCT00261846|69684385|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
37829330|NCT01053221|69512572|FG001|Overall Study|The study was closed prematurely|9|||
37829331|NCT01052012|69512584|FG000|Overall Study|Not treated|2|||
37829332|NCT01052012|69512585|FG001|Overall Study|Not treated|5|||
37829333|NCT01052012|69512586|FG002|Overall Study|Not treated|0|||
37829334|NCT01052012|69512587|FG003|Overall Study|Not treated|0|||
37829335|NCT01052012|69512588|FG004|Overall Study|Not treated|11|||
37829336|NCT01052012|69512589|FG005|Overall Study|Not treated|8|||
37829337|NCT01052012|69512584|FG000|Overall Study|Adverse Event|1|||
37829338|NCT01052012|69512585|FG001|Overall Study|Adverse Event|0|||
37904209|NCT00916370|69590061|FG001|Overall Study|Death|1|||
37904210|NCT00916370|69590060|FG000|Overall Study|Withdrawal by Subject|2|||
37904211|NCT00916370|69590061|FG001|Overall Study|Withdrawal by Subject|0|||
38000512|NCT00261846|69684386|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
38000513|NCT00261846|69684387|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
38000514|NCT00261846|69684388|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
38000515|NCT00261846|69684377|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
38000516|NCT00261846|69684378|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
38000517|NCT00261846|69684379|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
37829339|NCT01052012|69512586|FG002|Overall Study|Adverse Event|0|||
37904212|NCT00916370|69590060|FG000|Overall Study|Physician Decision|0|||
37904213|NCT00916370|69590061|FG001|Overall Study|Physician Decision|1|||
37904214|NCT00847197|69590070|FG000|Overall Study|Adverse Event|21|||
37904215|NCT00847197|69590071|FG001|Overall Study|Adverse Event|3|||
37697367|NCT02443103|69173859|FG000|Overall Study|Adverse Event|2|||
37697368|NCT02443103|69173859|FG000|Overall Study|Noncompliance|1|||
37697369|NCT02022657|69173863|FG000|Overall Study|Withdrawal by Subject|2|||
37697370|NCT02022657|69173864|FG001|Overall Study|Withdrawal by Subject|0|||
38000518|NCT00261846|69684380|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
38000519|NCT00261846|69684381|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
38000520|NCT00261846|69684382|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
38000521|NCT00261846|69684383|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
38000522|NCT00261846|69684384|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
37697371|NCT02022657|69173865|FG002|Overall Study|Withdrawal by Subject|1|||
37697372|NCT02022657|69173866|FG003|Overall Study|Withdrawal by Subject|0|||
37697373|NCT02022657|69173867|FG004|Overall Study|Withdrawal by Subject|0|||
37904216|NCT00847197|69590070|FG000|Overall Study|Protocol Violation|0|||
37904217|NCT00847197|69590071|FG001|Overall Study|Protocol Violation|1|||
37904218|NCT00847197|69590070|FG000|Overall Study|Withdrawal by Subject|3|||
37904219|NCT00847197|69590071|FG001|Overall Study|Withdrawal by Subject|1|||
37904220|NCT00654901|69590081|FG000|Overall Study|Lost to Follow-up|1|||
37904221|NCT00654901|69590082|FG001|Overall Study|Lost to Follow-up|0|||
37904222|NCT00654901|69590083|FG002|Overall Study|Lost to Follow-up|1|||
37904223|NCT00654901|69590084|FG003|Overall Study|Lost to Follow-up|0|||
37904224|NCT00654901|69590081|FG000|Overall Study|Withdrawal by Subject|3|||
37697374|NCT02022657|69173868|FG005|Overall Study|Withdrawal by Subject|0|||
37697375|NCT02022657|69173863|FG000|Overall Study|Physician Decision|0|||
37697376|NCT02022657|69173864|FG001|Overall Study|Physician Decision|0|||
37697377|NCT02022657|69173865|FG002|Overall Study|Physician Decision|0|||
37904225|NCT00654901|69590082|FG001|Overall Study|Withdrawal by Subject|0|||
38000523|NCT00261846|69684385|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
38000524|NCT00261846|69684386|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
38000525|NCT00261846|69684387|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
38000526|NCT00261846|69684388|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
38000527|NCT00261846|69684377|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
38000528|NCT00261846|69684378|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
38000529|NCT00261846|69684379|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
38000530|NCT00261846|69684380|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
38000531|NCT00261846|69684381|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
38000532|NCT00261846|69684382|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
38000533|NCT00261846|69684383|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
38000534|NCT00261846|69684384|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
38000535|NCT00261846|69684385|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
38000536|NCT00261846|69684386|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
38000537|NCT00261846|69684387|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
38000538|NCT00261846|69684388|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
38000539|NCT00261846|69684377|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
38000540|NCT00261846|69684378|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
38000541|NCT00261846|69684379|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
38000542|NCT00261846|69684380|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
38000543|NCT00261846|69684381|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
38000544|NCT00261846|69684382|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
38000545|NCT00261846|69684383|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
38000546|NCT00261846|69684384|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
38000547|NCT00261846|69684385|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
37829340|NCT01052012|69512587|FG003|Overall Study|Adverse Event|1|||
37829341|NCT01052012|69512588|FG004|Overall Study|Adverse Event|0|||
37829342|NCT01052012|69512589|FG005|Overall Study|Adverse Event|0|||
37829343|NCT01052012|69512584|FG000|Overall Study|Lost to Follow-up|0|||
37829344|NCT01052012|69512585|FG001|Overall Study|Lost to Follow-up|0|||
37829345|NCT01052012|69512586|FG002|Overall Study|Lost to Follow-up|0|||
37829346|NCT01052012|69512587|FG003|Overall Study|Lost to Follow-up|0|||
37829347|NCT01052012|69512588|FG004|Overall Study|Lost to Follow-up|1|||
37829348|NCT01052012|69512589|FG005|Overall Study|Lost to Follow-up|0|||
37904226|NCT00654901|69590083|FG002|Overall Study|Withdrawal by Subject|1|||
37904227|NCT00654901|69590084|FG003|Overall Study|Withdrawal by Subject|0|||
37904228|NCT00846807|69590094|FG000|Overall Study|Adverse Event|270|||
37904229|NCT00846807|69590094|FG000|Overall Study|Lost to Follow-up|94|||
37904230|NCT00846807|69590094|FG000|Overall Study|Withdrawal by Subject|56|||
37904231|NCT00846807|69590094|FG000|Overall Study|Non compliant with European label|7|||
37904232|NCT00846807|69590094|FG000|Overall Study|Switch to other anticoagulants|89|||
37904233|NCT00846807|69590094|FG000|Overall Study|No prescription after hospital discharge|56|||
37904234|NCT00846807|69590094|FG000|Overall Study|Other|60|||
37904235|NCT00846495|69590100|FG000|Overall Study|Lost to Follow-up|1|||
37904236|NCT00846495|69590101|FG001|Overall Study|Lost to Follow-up|0|||
37904237|NCT00846495|69590100|FG000|Overall Study|Adverse Event|5|||
38000548|NCT00261846|69684386|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
38000549|NCT00261846|69684387|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
38000550|NCT00261846|69684388|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
38000551|NCT00261846|69684377|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
38000552|NCT00261846|69684378|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
38000553|NCT00261846|69684379|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
38000554|NCT00261846|69684380|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
37904238|NCT00846495|69590101|FG001|Overall Study|Adverse Event|1|||
37904239|NCT00846495|69590100|FG000|Overall Study|Lack of Efficacy|1|||
37904240|NCT00846495|69590101|FG001|Overall Study|Lack of Efficacy|2|||
37829349|NCT01052012|69512584|FG000|Overall Study|Withdrawal by Subject|1|||
37904241|NCT00846495|69590100|FG000|Overall Study|Physician Decision|1|||
37904242|NCT00846495|69590101|FG001|Overall Study|Physician Decision|0|||
38000555|NCT00261846|69684381|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
38000556|NCT00261846|69684382|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
38000557|NCT00261846|69684383|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
38000558|NCT00261846|69684384|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
38000559|NCT00261846|69684385|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
38000560|NCT00261846|69684386|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
38000561|NCT00261846|69684387|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
38000562|NCT00261846|69684388|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
38000563|NCT00261846|69684377|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
38000564|NCT00261846|69684378|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
38000565|NCT00261846|69684379|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
38000566|NCT00261846|69684380|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
38000567|NCT00261846|69684381|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
38000568|NCT00261846|69684382|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
38000569|NCT00261846|69684383|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
38000570|NCT00261846|69684384|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
38000571|NCT00261846|69684385|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
38000572|NCT00261846|69684386|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
38000573|NCT00261846|69684387|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
38000574|NCT00261846|69684388|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
38000575|NCT00261846|69684377|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
38000576|NCT00261846|69684378|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
38000577|NCT00261846|69684379|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
38000578|NCT00261846|69684380|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
38000579|NCT00261846|69684381|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
38000580|NCT00261846|69684382|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
38000581|NCT00261846|69684383|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
38000582|NCT00261846|69684384|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
38000583|NCT00261846|69684385|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
38000584|NCT00261846|69684386|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
38000585|NCT00261846|69684387|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
37904243|NCT00654745|69590107|FG000|Overall Study|Adverse Event|12|||
37904244|NCT00654745|69590107|FG000|Overall Study|Lost to Follow-up|7|||
37904245|NCT00654745|69590107|FG000|Overall Study|Protocol Violation|11|||
37904246|NCT00654745|69590107|FG000|Overall Study|Withdrawal by Subject|10|||
37904247|NCT00654745|69590107|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
37829350|NCT01052012|69512585|FG001|Overall Study|Withdrawal by Subject|1|||
37829351|NCT01052012|69512586|FG002|Overall Study|Withdrawal by Subject|0|||
37829352|NCT01052012|69512587|FG003|Overall Study|Withdrawal by Subject|0|||
37829353|NCT01052012|69512588|FG004|Overall Study|Withdrawal by Subject|3|||
37829354|NCT01052012|69512589|FG005|Overall Study|Withdrawal by Subject|1|||
37829355|NCT01052012|69512584|FG000|Overall Study|Physician Decision|0|||
37829356|NCT01052012|69512585|FG001|Overall Study|Physician Decision|0|||
37829357|NCT01052012|69512586|FG002|Overall Study|Physician Decision|0|||
37829358|NCT01052012|69512587|FG003|Overall Study|Physician Decision|0|||
37829359|NCT01052012|69512588|FG004|Overall Study|Physician Decision|0|||
37829360|NCT01052012|69512589|FG005|Overall Study|Physician Decision|1|||
37829361|NCT01052012|69512584|FG000|Overall Study|Other|0|||
37829362|NCT01052012|69512585|FG001|Overall Study|Other|0|||
37829363|NCT01052012|69512586|FG002|Overall Study|Other|0|||
37829364|NCT01052012|69512587|FG003|Overall Study|Other|0|||
37829365|NCT01052012|69512588|FG004|Overall Study|Other|1|||
37829366|NCT01052012|69512589|FG005|Overall Study|Other|0|||
37829367|NCT01051817|69512605|FG000|Overall Study|Adverse Event|0|||
37829368|NCT01051817|69512606|FG001|Overall Study|Adverse Event|2|||
37829369|NCT01051817|69512605|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
37829370|NCT01051817|69512606|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
37829371|NCT01051817|69512605|FG000|Overall Study|Withdrawal by Subject|3|||
37829372|NCT01051817|69512606|FG001|Overall Study|Withdrawal by Subject|5|||
37904248|NCT00846027|69590117|FG000|Overall Study|Death|3|||
37904249|NCT00846027|69590117|FG000|Overall Study|Disease Progression|30|||
37904250|NCT00846027|69590117|FG000|Overall Study|Toxicity|12|||
38000586|NCT00261846|69684388|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
37904251|NCT00846027|69590117|FG000|Overall Study|Patient Decision|7|||
38000587|NCT00169442|69684433|FG000|Overall Study|Withdrawal by Subject|0|||
38000588|NCT00169442|69684434|FG001|Overall Study|Withdrawal by Subject|0|||
38000589|NCT00169442|69684435|FG002|Overall Study|Withdrawal by Subject|1|||
38000590|NCT00169442|69684436|FG003|Overall Study|Withdrawal by Subject|0|||
38000591|NCT00169442|69684437|FG004|Overall Study|Withdrawal by Subject|0|||
37829373|NCT01051817|69512605|FG000|Overall Study|Protocol Violation|0|||
37829374|NCT01051817|69512606|FG001|Overall Study|Protocol Violation|1|||
37829375|NCT01327846|69512616|FG000|Core Phase|Subject decision (vital status: missing)|1|||
37829376|NCT01327846|69512617|FG001|Core Phase|Subject decision (vital status: missing)|2|||
38000592|NCT00169442|69684438|FG005|Overall Study|Withdrawal by Subject|0|||
38000593|NCT00169442|69684433|FG000|Overall Study|Migrated/moved from study area|0|||
38000594|NCT00169442|69684434|FG001|Overall Study|Migrated/moved from study area|0|||
38000595|NCT00169442|69684435|FG002|Overall Study|Migrated/moved from study area|0|||
38000596|NCT00169442|69684436|FG003|Overall Study|Migrated/moved from study area|0|||
38000597|NCT00169442|69684437|FG004|Overall Study|Migrated/moved from study area|0|||
38000598|NCT00169442|69684438|FG005|Overall Study|Migrated/moved from study area|2|||
38000599|NCT00169442|69684433|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
38000600|NCT00169442|69684434|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
38000601|NCT00169442|69684435|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
38000602|NCT00169442|69684436|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
38000603|NCT00169442|69684437|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
38000604|NCT00169442|69684438|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
38000605|NCT00169442|69684433|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
38000606|NCT00169442|69684434|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
38000607|NCT00169442|69684435|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
38000608|NCT00169442|69684436|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
38000609|NCT00169442|69684437|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
38000610|NCT00169442|69684438|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
37904252|NCT00846027|69590117|FG000|Overall Study|Investigator Discretion|29|||
37904253|NCT00846027|69590117|FG000|Overall Study|Protocol Violation|2|||
37904254|NCT00846027|69590117|FG000|Overall Study|Subject Not Treated|7|||
37904255|NCT00646399|69590123|FG000|Overall Study|Death|63|||
37904256|NCT00646399|69590124|FG001|Overall Study|Death|53|||
37904257|NCT00646399|69590123|FG000|Overall Study|Withdrawal by Subject|9|||
38000611|NCT00261716|69684456|FG000|Overall Study|Withdrawal by Subject|6|||
38000612|NCT00261716|69684457|FG001|Overall Study|Withdrawal by Subject|8|||
37904258|NCT00646399|69590124|FG001|Overall Study|Withdrawal by Subject|10|||
37829377|NCT01327846|69512618|FG002|Core Phase|Subject decision (vital status: missing)|2|||
37829378|NCT01327846|69512619|FG003|Core Phase|Subject decision (vital status: missing)|1|||
37829379|NCT01327846|69512616|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
37829380|NCT01327846|69512617|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
37829381|NCT01327846|69512618|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
37904259|NCT00646399|69590123|FG000|Overall Study|Other Reason|11|||
37904260|NCT00646399|69590124|FG001|Overall Study|Other Reason|11|||
37904261|NCT00652327|69590132|FG000|Overall Study|Adverse Event|0|||
37904262|NCT00652327|69590133|FG001|Overall Study|Adverse Event|2|||
37904263|NCT00652327|69590132|FG000|Overall Study|Lost to Follow-up|0|||
37904264|NCT00652327|69590133|FG001|Overall Study|Lost to Follow-up|3|||
37904265|NCT00645853|69590141|FG000|Overall Study|Adverse Event|18|||
37904266|NCT00645853|69590142|FG001|Overall Study|Adverse Event|7|||
37904267|NCT00645853|69590141|FG000|Overall Study|AZ study closure in Hungary|60|||
37904268|NCT00645853|69590142|FG001|Overall Study|AZ study closure in Hungary|40|||
37904269|NCT00645853|69590141|FG000|Overall Study|Withdrawal by Subject|5|||
37904270|NCT00645853|69590142|FG001|Overall Study|Withdrawal by Subject|2|||
37904271|NCT00645853|69590141|FG000|Overall Study|Protocol Violation|0|||
37904272|NCT00645853|69590142|FG001|Overall Study|Protocol Violation|2|||
37904273|NCT00645853|69590141|FG000|Overall Study|Discontinuation criteria|2|||
37904274|NCT00645853|69590142|FG001|Overall Study|Discontinuation criteria|2|||
37829382|NCT01327846|69512619|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
37829383|NCT01327846|69512616|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
37829384|NCT01327846|69512617|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
37829385|NCT01327846|69512618|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
37829386|NCT01327846|69512619|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
37829387|NCT01327846|69512616|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
37829388|NCT01327846|69512617|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
37829389|NCT01327846|69512618|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
37829390|NCT01327846|69512619|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
37829391|NCT01327846|69512616|FG000|Core Phase|Lost to Follow-up|3|||
37829392|NCT01327846|69512617|FG001|Core Phase|Lost to Follow-up|3|||
37829393|NCT01327846|69512618|FG002|Core Phase|Lost to Follow-up|4|||
37829394|NCT01327846|69512619|FG003|Core Phase|Lost to Follow-up|5|||
37829395|NCT01327846|69512616|FG000|Extension Phase|Study terminated by sponsor|1073|||
37829396|NCT01327846|69512617|FG001|Extension Phase|Study terminated by sponsor|1124|||
37829397|NCT01327846|69512618|FG002|Extension Phase|Study terminated by sponsor|1067|||
37829398|NCT01327846|69512619|FG003|Extension Phase|Study terminated by sponsor|1660|||
37829399|NCT01327846|69512616|FG000|Extension Phase|Withdrawal by Subject|20|||
37829400|NCT01327846|69512617|FG001|Extension Phase|Withdrawal by Subject|13|||
37829401|NCT01327846|69512618|FG002|Extension Phase|Withdrawal by Subject|19|||
37829402|NCT01327846|69512619|FG003|Extension Phase|Withdrawal by Subject|37|||
37829403|NCT01327846|69512616|FG000|Extension Phase|Lost to Follow-up|4|||
37829404|NCT01327846|69512617|FG001|Extension Phase|Lost to Follow-up|3|||
37829405|NCT01327846|69512618|FG002|Extension Phase|Lost to Follow-up|4|||
37829406|NCT01327846|69512619|FG003|Extension Phase|Lost to Follow-up|7|||
37904275|NCT00645853|69590141|FG000|Overall Study|recall of ICF, planned operation, death|7|||
37829407|NCT01327846|69512616|FG000|Extension Phase|Technical Problems|2|||
37829408|NCT01327846|69512617|FG001|Extension Phase|Technical Problems|4|||
37904276|NCT00645853|69590142|FG001|Overall Study|recall of ICF, planned operation, death|4|||
37904277|NCT00652093|69590154|FG000|Overall Study|Withdrawal by Subject|0|||
37829409|NCT01327846|69512618|FG002|Extension Phase|Technical Problems|2|||
37904278|NCT00652093|69590155|FG001|Overall Study|Withdrawal by Subject|0|||
37904279|NCT00652093|69590156|FG002|Overall Study|Withdrawal by Subject|1|||
38000613|NCT00261716|69684456|FG000|Overall Study|Lost to Follow-up|0|||
38000614|NCT00261716|69684457|FG001|Overall Study|Lost to Follow-up|2|||
38000615|NCT03809104|69684467|FG000|Overall Study|Withdrawal by Subject|3|||
38000616|NCT00203502|69684471|FG000|Overall Study|Death|1|||
38000617|NCT03799198|69684477|FG000|Overall Study|Lost to Follow-up|4|||
38000618|NCT03799198|69684478|FG001|Overall Study|Lost to Follow-up|8|||
38000619|NCT03799198|69684477|FG000|Overall Study|Death|0|||
37904280|NCT00652093|69590157|FG003|Overall Study|Withdrawal by Subject|0|||
37904281|NCT00652093|69590158|FG004|Overall Study|Withdrawal by Subject|1|||
37904282|NCT00652093|69590159|FG005|Overall Study|Withdrawal by Subject|0|||
37904283|NCT00652093|69590154|FG000|Overall Study|Physician Decision|0|||
37904284|NCT00652093|69590155|FG001|Overall Study|Physician Decision|0|||
37904285|NCT00652093|69590156|FG002|Overall Study|Physician Decision|0|||
37904286|NCT00652093|69590157|FG003|Overall Study|Physician Decision|0|||
37904287|NCT00652093|69590158|FG004|Overall Study|Physician Decision|1|||
37904288|NCT00652093|69590159|FG005|Overall Study|Physician Decision|0|||
37904289|NCT00651937|69590175|FG000|Overall Study|Withdrawal by Subject|4|||
37904290|NCT00651937|69590176|FG001|Overall Study|Withdrawal by Subject|1|||
37904291|NCT00654355|69590184|FG000|Overall Study|Lost to Follow-up|2|||
37904292|NCT00654355|69590185|FG001|Overall Study|Lost to Follow-up|2|||
37904293|NCT00651313|69590193|FG000|Overall Study|Adverse Event|0|||
37904294|NCT00651313|69590194|FG001|Overall Study|Adverse Event|1|||
37904295|NCT00651313|69590193|FG000|Overall Study|Withdrawal by Subject|3|||
37904296|NCT00651313|69590194|FG001|Overall Study|Withdrawal by Subject|1|||
37904297|NCT00651313|69590193|FG000|Overall Study|Lost to Follow-up|1|||
37904298|NCT00651313|69590194|FG001|Overall Study|Lost to Follow-up|1|||
37904299|NCT00651313|69590193|FG000|Overall Study|Adminstrative Discontinuation|2|||
37904300|NCT00651313|69590194|FG001|Overall Study|Adminstrative Discontinuation|3|||
38000620|NCT03799198|69684478|FG001|Overall Study|Death|1|||
37904301|NCT00969761|69590212|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
37904302|NCT00969761|69590213|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
37904303|NCT00969761|69590214|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
38000621|NCT00232596|69684486|FG000|6-Week Titration Phase|Adverse Event|6|||
37904304|NCT00969761|69590215|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
37904305|NCT00969761|69590216|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
38000622|NCT00232596|69684487|FG001|6-Week Titration Phase|Adverse Event|19|||
38000623|NCT00232596|69684486|FG000|6-Week Titration Phase|Failed to Return|2|||
38000624|NCT00232596|69684487|FG001|6-Week Titration Phase|Failed to Return|1|||
38000625|NCT00232596|69684486|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
38000626|NCT00232596|69684487|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
38000627|NCT00232596|69684486|FG000|6-Week Titration Phase|Protocol Violation|1|||
38000628|NCT00232596|69684487|FG001|6-Week Titration Phase|Protocol Violation|3|||
38000629|NCT00232596|69684486|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
38000630|NCT00232596|69684487|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
38000631|NCT00232596|69684486|FG000|6-Week Titration Phase|Other|3|||
38000632|NCT00232596|69684487|FG001|6-Week Titration Phase|Other|3|||
37829410|NCT01327846|69512619|FG003|Extension Phase|Technical Problems|2|||
37829411|NCT01051739|69512632|FG000|Overall Study|Death|3|||
37829412|NCT01051739|69512633|FG001|Overall Study|Death|3|||
37829413|NCT01051739|69512632|FG000|Overall Study|Withdrawal by Subject|25|||
37829414|NCT01051739|69512633|FG001|Overall Study|Withdrawal by Subject|10|||
37829415|NCT01051661|69512645|FG000|Overall Study|Adverse Event|1|||
37829416|NCT01051661|69512646|FG001|Overall Study|Adverse Event|1|||
38000633|NCT00232596|69684486|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
38000634|NCT00232596|69684487|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
38000635|NCT00232596|69684486|FG000|12-Week Maintenance Phase|Adverse Event|7|||
38000636|NCT00232596|69684487|FG001|12-Week Maintenance Phase|Adverse Event|22|||
38000637|NCT00232596|69684486|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
38000638|NCT00232596|69684487|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
37829417|NCT01051661|69512647|FG002|Overall Study|Adverse Event|1|||
37829418|NCT01051661|69512648|FG003|Overall Study|Adverse Event|1|||
37829419|NCT01051661|69512649|FG004|Overall Study|Adverse Event|0|||
37829420|NCT01051661|69512650|FG005|Overall Study|Adverse Event|0|||
38000639|NCT00232596|69684486|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
37697378|NCT02022657|69173866|FG003|Overall Study|Physician Decision|0|||
37697379|NCT02022657|69173867|FG004|Overall Study|Physician Decision|0|||
37829421|NCT01051661|69512645|FG000|Overall Study|Lost to Follow-up|13|||
37829422|NCT01051661|69512646|FG001|Overall Study|Lost to Follow-up|22|||
37829423|NCT01051661|69512647|FG002|Overall Study|Lost to Follow-up|15|||
37829424|NCT01051661|69512648|FG003|Overall Study|Lost to Follow-up|17|||
37829425|NCT01051661|69512649|FG004|Overall Study|Lost to Follow-up|10|||
37829426|NCT01051661|69512650|FG005|Overall Study|Lost to Follow-up|24|||
37829427|NCT01051661|69512645|FG000|Overall Study|Migrated/moved from study area|1|||
37829428|NCT01051661|69512646|FG001|Overall Study|Migrated/moved from study area|6|||
37829429|NCT01051661|69512647|FG002|Overall Study|Migrated/moved from study area|6|||
37829430|NCT01051661|69512648|FG003|Overall Study|Migrated/moved from study area|8|||
37829431|NCT01051661|69512649|FG004|Overall Study|Migrated/moved from study area|7|||
37829432|NCT01051661|69512650|FG005|Overall Study|Migrated/moved from study area|3|||
37829433|NCT01051661|69512645|FG000|Overall Study|Refused blood sampling|0|||
37829434|NCT01051661|69512646|FG001|Overall Study|Refused blood sampling|0|||
37829435|NCT01051661|69512647|FG002|Overall Study|Refused blood sampling|0|||
37829436|NCT01051661|69512648|FG003|Overall Study|Refused blood sampling|0|||
37904306|NCT00969761|69590217|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
37904307|NCT00969761|69590218|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
37904308|NCT00969761|69590219|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
38000640|NCT00232596|69684487|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
38000641|NCT00232596|69684486|FG000|12-Week Maintenance Phase|Other|1|||
37904309|NCT00969761|69590220|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
37904310|NCT00969761|69590221|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
37904311|NCT00969761|69590222|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
37904312|NCT00969761|69590223|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
37904313|NCT00969761|69590212|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
37904314|NCT00969761|69590213|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
37904315|NCT00969761|69590214|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
37904316|NCT00969761|69590215|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
37904317|NCT00969761|69590216|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
37904318|NCT00969761|69590217|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
37904319|NCT00969761|69590218|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
38000642|NCT00232596|69684487|FG001|12-Week Maintenance Phase|Other|3|||
38000643|NCT00073918|69684505|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
38000644|NCT00073918|69684505|FG000|Overall Study|Rapid disease progression|2|||
37697380|NCT02022657|69173868|FG005|Overall Study|Physician Decision|1|||
37829437|NCT01051661|69512649|FG004|Overall Study|Refused blood sampling|0|||
37829438|NCT01051661|69512650|FG005|Overall Study|Refused blood sampling|1|||
37829439|NCT01051661|69512645|FG000|Overall Study|Data not reliable|1|||
37829440|NCT01051661|69512646|FG001|Overall Study|Data not reliable|0|||
37829441|NCT01051661|69512647|FG002|Overall Study|Data not reliable|0|||
37829442|NCT01051661|69512648|FG003|Overall Study|Data not reliable|0|||
37829443|NCT01051661|69512649|FG004|Overall Study|Data not reliable|0|||
37829444|NCT01051661|69512650|FG005|Overall Study|Data not reliable|1|||
37829445|NCT01051661|69512645|FG000|Overall Study|Unable to attend visit(s)|2|||
37829446|NCT01051661|69512646|FG001|Overall Study|Unable to attend visit(s)|4|||
37829447|NCT01051661|69512647|FG002|Overall Study|Unable to attend visit(s)|2|||
37829448|NCT01051661|69512648|FG003|Overall Study|Unable to attend visit(s)|1|||
37829449|NCT01051661|69512649|FG004|Overall Study|Unable to attend visit(s)|3|||
37829450|NCT01051661|69512650|FG005|Overall Study|Unable to attend visit(s)|2|||
37829451|NCT01051661|69512645|FG000|Overall Study|Consent not received from both parents|0|||
37829452|NCT01051661|69512646|FG001|Overall Study|Consent not received from both parents|0|||
37829453|NCT01051661|69512647|FG002|Overall Study|Consent not received from both parents|0|||
37829454|NCT01051661|69512648|FG003|Overall Study|Consent not received from both parents|0|||
37829455|NCT01051661|69512649|FG004|Overall Study|Consent not received from both parents|0|||
37829456|NCT01051661|69512650|FG005|Overall Study|Consent not received from both parents|1|||
37829457|NCT01051661|69512645|FG000|Overall Study|Failure to comply with protocol|0|||
37829458|NCT01051661|69512646|FG001|Overall Study|Failure to comply with protocol|0|||
37829459|NCT01051661|69512647|FG002|Overall Study|Failure to comply with protocol|2|||
37829460|NCT01051661|69512648|FG003|Overall Study|Failure to comply with protocol|0|||
37829461|NCT01051661|69512649|FG004|Overall Study|Failure to comply with protocol|0|||
37829462|NCT01051661|69512650|FG005|Overall Study|Failure to comply with protocol|0|||
37829463|NCT01051661|69512645|FG000|Overall Study|Subject lost legal representation|0|||
37829464|NCT01051661|69512646|FG001|Overall Study|Subject lost legal representation|0|||
37829465|NCT01051661|69512647|FG002|Overall Study|Subject lost legal representation|0|||
37829466|NCT01051661|69512648|FG003|Overall Study|Subject lost legal representation|0|||
37829467|NCT01051661|69512649|FG004|Overall Study|Subject lost legal representation|1|||
37829468|NCT01051661|69512650|FG005|Overall Study|Subject lost legal representation|0|||
37829469|NCT01051661|69512645|FG000|Overall Study|Protocol Violation|0|||
37829470|NCT01051661|69512646|FG001|Overall Study|Protocol Violation|0|||
37829471|NCT01051661|69512647|FG002|Overall Study|Protocol Violation|0|||
37829472|NCT01051661|69512648|FG003|Overall Study|Protocol Violation|1|||
37829473|NCT01051661|69512649|FG004|Overall Study|Protocol Violation|2|||
37829474|NCT01051661|69512650|FG005|Overall Study|Protocol Violation|1|||
37829475|NCT01051661|69512645|FG000|Overall Study|Withdrawal by Subject|16|||
37829476|NCT01051661|69512646|FG001|Overall Study|Withdrawal by Subject|30|||
37829477|NCT01051661|69512647|FG002|Overall Study|Withdrawal by Subject|13|||
37829478|NCT01051661|69512648|FG003|Overall Study|Withdrawal by Subject|28|||
37829479|NCT01051661|69512649|FG004|Overall Study|Withdrawal by Subject|12|||
37829480|NCT01051661|69512650|FG005|Overall Study|Withdrawal by Subject|34|||
37829481|NCT01051466|69512687|FG000|Overall Study|Adverse Event|1|||
37829482|NCT01051466|69512688|FG001|Overall Study|Adverse Event|0|||
37829483|NCT01051466|69512687|FG000|Overall Study|Lost to Follow-up|1|||
38000645|NCT00073918|69684505|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
38000646|NCT00231894|69684511|FG000|Overall Study|Withdrawal by Subject|1|||
37697381|NCT02418455|69173874|FG000|48-Week Treatment Period|Other- Not Specified|1|||
38000647|NCT00231894|69684512|FG001|Overall Study|Withdrawal by Subject|1|||
38000648|NCT00203424|69684524|FG000|Treatment Period|Withdrawal by Subject|4|||
37697382|NCT02418455|69173874|FG000|Continuation Period|Sponsor Decision|7|||
37697383|NCT02417753|69173880|FG000|Overall Study|Death|1|||
37829484|NCT01051466|69512688|FG001|Overall Study|Lost to Follow-up|1|||
37829485|NCT01051466|69512687|FG000|Overall Study|Withdrawal by Subject|5|||
37829486|NCT01051466|69512688|FG001|Overall Study|Withdrawal by Subject|1|||
37829487|NCT01051466|69512687|FG000|Overall Study|Entry Criteria Not Met|0|||
37829488|NCT01051466|69512688|FG001|Overall Study|Entry Criteria Not Met|3|||
37829489|NCT01051466|69512687|FG000|Overall Study|Physician Decision|1|||
37829490|NCT01051466|69512688|FG001|Overall Study|Physician Decision|0|||
37829491|NCT01051349|69512702|FG000|Overall Study|Adverse Event|88|||
37829492|NCT01051349|69512702|FG000|Overall Study|Consent Withdrawn|54|||
37904320|NCT00969761|69590219|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
37904321|NCT00969761|69590220|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
37904322|NCT00969761|69590221|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
37904323|NCT00969761|69590222|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
37904324|NCT00969761|69590223|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
37904325|NCT00969761|69590212|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
37904326|NCT00969761|69590213|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
37904327|NCT00969761|69590214|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
37904328|NCT00969761|69590215|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
37904329|NCT00969761|69590216|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
37904330|NCT00969761|69590217|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
37904331|NCT00969761|69590218|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
38000649|NCT00203424|69684524|FG000|Treatment Period|Adverse Event|5|||
38000650|NCT00203424|69684524|FG000|Treatment Period|progressive disease|2|||
38000651|NCT00203424|69684524|FG000|Follow-up Period|Withdrawal by Subject|1|||
37829493|NCT01051349|69512702|FG000|Overall Study|Investigator Decision|6|||
37829494|NCT01051349|69512702|FG000|Overall Study|Lost to Follow-up|6|||
38000652|NCT00203424|69684524|FG000|Follow-up Period|progressive disease|4|||
38000653|NCT00203424|69684524|FG000|Follow-up Period|Lost to Follow-up|1|||
37829495|NCT01051349|69512702|FG000|Overall Study|Subject non-compliance|7|||
38000654|NCT00203268|69684528|FG000|Early Treatment|only treated one headache|2|||
38000655|NCT00203268|69684528|FG000|Early Treatment|Lost to Follow-up|1|||
38000656|NCT00203268|69684528|FG000|Early Treatment|Withdrawal by Subject|1|||
38000657|NCT00168818|69684537|FG000|Overall Study|Adverse Event|23|||
38000658|NCT00168818|69684538|FG001|Overall Study|Adverse Event|29|||
38000659|NCT00168818|69684539|FG002|Overall Study|Adverse Event|31|||
37829496|NCT01051349|69512702|FG000|Overall Study|Reason not Specified|12|||
37829497|NCT01050998|69512714|FG000|Overall Study|Adverse Event|1|||
37829498|NCT01050998|69512715|FG001|Overall Study|Adverse Event|0|||
37829499|NCT01050998|69512716|FG002|Overall Study|Adverse Event|1|||
37829500|NCT01050998|69512717|FG003|Overall Study|Adverse Event|0|||
37829501|NCT01050998|69512718|FG004|Overall Study|Adverse Event|2|||
37829502|NCT01050998|69512714|FG000|Overall Study|Withdrawal by Subject|0|||
37829503|NCT01050998|69512715|FG001|Overall Study|Withdrawal by Subject|0|||
37829504|NCT01050998|69512716|FG002|Overall Study|Withdrawal by Subject|0|||
37829505|NCT01050998|69512717|FG003|Overall Study|Withdrawal by Subject|1|||
37829506|NCT01050998|69512718|FG004|Overall Study|Withdrawal by Subject|3|||
37829507|NCT01050998|69512714|FG000|Overall Study|Other|3|||
37829508|NCT01050998|69512715|FG001|Overall Study|Other|2|||
37829509|NCT01050998|69512716|FG002|Overall Study|Other|1|||
37829510|NCT01050998|69512717|FG003|Overall Study|Other|1|||
37829511|NCT01050998|69512718|FG004|Overall Study|Other|5|||
37829512|NCT01050998|69512714|FG000|Overall Study|Data integrity issues|0|||
37829513|NCT01050998|69512715|FG001|Overall Study|Data integrity issues|0|||
37829514|NCT01050998|69512716|FG002|Overall Study|Data integrity issues|1|||
37829515|NCT01050998|69512717|FG003|Overall Study|Data integrity issues|1|||
37829516|NCT01050998|69512718|FG004|Overall Study|Data integrity issues|4|||
37829517|NCT00106028|69512736|FG000|Overall Study|Adverse Event|3|||
37829518|NCT00106028|69512737|FG001|Overall Study|Adverse Event|2|||
37829519|NCT00106028|69512736|FG000|Overall Study|Protocol Violation|1|||
37829520|NCT00106028|69512737|FG001|Overall Study|Protocol Violation|1|||
37829521|NCT00106028|69512736|FG000|Overall Study|Withdrawal by Subject|2|||
37829522|NCT00106028|69512737|FG001|Overall Study|Withdrawal by Subject|8|||
37829523|NCT00106028|69512736|FG000|Overall Study|Lost to Follow-up|0|||
37829524|NCT00106028|69512737|FG001|Overall Study|Lost to Follow-up|1|||
37829525|NCT01050764|69512745|FG000|Overall Study|Death, before HSCT|1|||
37829526|NCT01050764|69512745|FG000|Overall Study|Donor mobilization failure, death|1|||
37829527|NCT01050764|69512745|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
37829528|NCT01050569|69512752|FG000|Overall Study|Lost to Follow-up|20|||
37829529|NCT01050569|69512753|FG001|Overall Study|Lost to Follow-up|14|||
37829530|NCT01050569|69512754|FG002|Overall Study|Lost to Follow-up|16|||
37829531|NCT01050569|69512752|FG000|Overall Study|Withdrawal by Subject|9|||
37829532|NCT01050569|69512753|FG001|Overall Study|Withdrawal by Subject|3|||
37829533|NCT01050569|69512754|FG002|Overall Study|Withdrawal by Subject|11|||
37829534|NCT01050569|69512752|FG000|Overall Study|Lack of Efficacy|5|||
37829535|NCT01050569|69512753|FG001|Overall Study|Lack of Efficacy|4|||
37829536|NCT01050569|69512754|FG002|Overall Study|Lack of Efficacy|3|||
37829537|NCT01050569|69512752|FG000|Overall Study|Adverse Event|1|||
37829538|NCT01050569|69512753|FG001|Overall Study|Adverse Event|0|||
37829539|NCT01050569|69512754|FG002|Overall Study|Adverse Event|0|||
37829540|NCT01050569|69512752|FG000|Overall Study|Physician Decision|3|||
37829541|NCT01050569|69512753|FG001|Overall Study|Physician Decision|3|||
37829542|NCT01050569|69512754|FG002|Overall Study|Physician Decision|3|||
37829543|NCT01050530|69512768|FG000|Overall Study|Adverse Event|6|||
37829544|NCT01050530|69512769|FG001|Overall Study|Adverse Event|3|||
37829545|NCT01050530|69512768|FG000|Overall Study|Lack of Efficacy|1|||
37829546|NCT01050530|69512769|FG001|Overall Study|Lack of Efficacy|4|||
37829547|NCT01050530|69512768|FG000|Overall Study|Withdrawal by Subject|0|||
37829548|NCT01050530|69512769|FG001|Overall Study|Withdrawal by Subject|3|||
38000660|NCT00168818|69684537|FG000|Overall Study|Protocol Violation|16|||
38000661|NCT00168818|69684538|FG001|Overall Study|Protocol Violation|11|||
38000662|NCT00168818|69684539|FG002|Overall Study|Protocol Violation|11|||
38000663|NCT00168818|69684537|FG000|Overall Study|Lost to Follow-up|13|||
38000664|NCT00168818|69684538|FG001|Overall Study|Lost to Follow-up|4|||
38000665|NCT00168818|69684539|FG002|Overall Study|Lost to Follow-up|15|||
38000666|NCT00168818|69684537|FG000|Overall Study|Withdrawal by Subject|43|||
37904332|NCT00969761|69590219|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
37904333|NCT00969761|69590220|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
37904334|NCT00969761|69590221|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
37904335|NCT00969761|69590222|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
37904336|NCT00969761|69590223|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
37904337|NCT00969761|69590212|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
37904338|NCT00969761|69590213|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
37904339|NCT00969761|69590214|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
37904340|NCT00969761|69590215|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
37904341|NCT00969761|69590216|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
37904342|NCT00969761|69590217|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
38000667|NCT00168818|69684538|FG001|Overall Study|Withdrawal by Subject|41|||
37829549|NCT01050530|69512768|FG000|Overall Study|Protocol Violation|1|||
37829550|NCT01050530|69512769|FG001|Overall Study|Protocol Violation|0|||
37829551|NCT01050257|69512778|FG000|Overall Study|Adverse Event|4|||
37829552|NCT01050257|69512779|FG001|Overall Study|Adverse Event|4|||
37829553|NCT01050257|69512780|FG002|Overall Study|Adverse Event|2|||
37829554|NCT01050257|69512778|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
37829555|NCT01050257|69512779|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
37829556|NCT01050257|69512780|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
37829557|NCT01050257|69512778|FG000|Overall Study|Withdrawal by Subject|0|||
37829558|NCT01050257|69512779|FG001|Overall Study|Withdrawal by Subject|3|||
37829559|NCT01050257|69512780|FG002|Overall Study|Withdrawal by Subject|0|||
37829560|NCT01050257|69512778|FG000|Overall Study|No reason specified|0|||
37829561|NCT01050257|69512779|FG001|Overall Study|No reason specified|0|||
37829562|NCT01050257|69512780|FG002|Overall Study|No reason specified|2|||
37829563|NCT01050257|69512778|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
37829564|NCT01050257|69512779|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
37829565|NCT01050257|69512780|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
37829566|NCT01050257|69512778|FG000|Overall Study|Violation criteria|0|||
37829567|NCT01050257|69512779|FG001|Overall Study|Violation criteria|1|||
37829568|NCT01050257|69512780|FG002|Overall Study|Violation criteria|0|||
37829569|NCT01050257|69512778|FG000|Overall Study|Failure to return|0|||
37829570|NCT01050257|69512779|FG001|Overall Study|Failure to return|2|||
37829571|NCT01050257|69512780|FG002|Overall Study|Failure to return|0|||
37829572|NCT01050257|69512778|FG000|Overall Study|Death|0|||
37829573|NCT01050257|69512779|FG001|Overall Study|Death|0|||
37829574|NCT01050257|69512780|FG002|Overall Study|Death|1|||
37829575|NCT01050218|69512788|FG000|Overall Study|Adverse Event|37|||
37829576|NCT01050218|69512788|FG000|Overall Study|Lack of Efficacy|8|||
37829577|NCT01050218|69512788|FG000|Overall Study|Protocol Violation|3|||
37904343|NCT00969761|69590218|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
37904344|NCT00969761|69590219|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
37904345|NCT00969761|69590220|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
37904346|NCT00969761|69590221|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
37904347|NCT00969761|69590222|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
37904348|NCT00969761|69590223|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
37904349|NCT00969761|69590212|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
37904350|NCT00969761|69590213|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
37904351|NCT00969761|69590214|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
37904352|NCT00969761|69590215|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
37904353|NCT00969761|69590216|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
37904354|NCT00969761|69590217|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
37904355|NCT00969761|69590218|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
37904356|NCT00969761|69590219|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
37904357|NCT00969761|69590220|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
37904358|NCT00969761|69590221|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
37904359|NCT00969761|69590222|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
37904360|NCT00969761|69590223|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
37904361|NCT00969761|69590212|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
37904362|NCT00969761|69590213|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
37904363|NCT00969761|69590214|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
37904364|NCT00969761|69590215|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
37904365|NCT00969761|69590216|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
37829578|NCT01050218|69512788|FG000|Overall Study|Withdrawal by Subject|18|||
37829579|NCT01050218|69512788|FG000|Overall Study|Discontinued by sponsor|18|||
37829580|NCT01050218|69512788|FG000|Overall Study|Compliance|2|||
37829581|NCT01050218|69512788|FG000|Overall Study|Failed to return|7|||
37829582|NCT01050218|69512788|FG000|Overall Study|Serious Adverse Event|1|||
37829583|NCT01050218|69512788|FG000|Overall Study|Family emergency|1|||
37829584|NCT01050062|69512794|FG000|Overall Study|Adverse Event|75|||
37829585|NCT01050062|69512795|FG001|Overall Study|Adverse Event|22|||
37829586|NCT01050062|69512794|FG000|Overall Study|Lost to Follow-up|83|||
37829587|NCT01050062|69512795|FG001|Overall Study|Lost to Follow-up|35|||
37829588|NCT01050062|69512794|FG000|Overall Study|Lack of Efficacy|22|||
37829589|NCT01050062|69512795|FG001|Overall Study|Lack of Efficacy|35|||
37829590|NCT01050062|69512794|FG000|Overall Study|Physician Decision|74|||
37829591|NCT01050062|69512795|FG001|Overall Study|Physician Decision|9|||
37829592|NCT01050062|69512794|FG000|Overall Study|Others|17|||
37829593|NCT01050062|69512795|FG001|Overall Study|Others|11|||
37829594|NCT00105989|69512813|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
37829595|NCT00105989|69512814|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
37829596|NCT00105989|69512813|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
37829597|NCT00105989|69512814|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
37829598|NCT00105989|69512813|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
37829599|NCT00105989|69512814|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
37829600|NCT00105989|69512813|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
37829601|NCT00105989|69512814|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
37829602|NCT00105989|69512813|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
37829603|NCT00105989|69512814|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
37829604|NCT00105989|69512813|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
37829605|NCT00105989|69512814|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
37829606|NCT00105989|69512813|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
37829607|NCT00105989|69512814|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
37829608|NCT00105989|69512813|FG000|Acute - Open Label: Week 0-10|Death|1|||
37829609|NCT00105989|69512814|FG001|Acute - Open Label: Week 0-10|Death|0|||
37829610|NCT00105989|69512813|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
37829611|NCT00105989|69512814|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
37829612|NCT00105989|69512813|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
37829613|NCT00105989|69512814|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
37829614|NCT00105989|69512813|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
37829615|NCT00105989|69512814|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
37829616|NCT00105989|69512813|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
37829617|NCT00105989|69512814|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
37829618|NCT00105989|69512813|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
37829619|NCT00105989|69512814|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
37829620|NCT00105989|69512813|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
37829621|NCT00105989|69512814|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
37829622|NCT00105989|69512813|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
37829623|NCT00105989|69512814|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
37829624|NCT00105989|69512813|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
37904366|NCT00969761|69590217|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
37904367|NCT00969761|69590218|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
37904368|NCT00969761|69590219|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
37829625|NCT00105989|69512814|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
37829626|NCT00105989|69512813|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
37904369|NCT00969761|69590220|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
37829627|NCT00105989|69512814|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
37829628|NCT00105989|69512813|FG000|Continuation - Open Label:Week 10-34|Death|0|||
37904370|NCT00969761|69590221|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
38000668|NCT00168818|69684539|FG002|Overall Study|Withdrawal by Subject|37|||
38000669|NCT00168818|69684537|FG000|Overall Study|Other|22|||
38000670|NCT00168818|69684538|FG001|Overall Study|Other|24|||
38000671|NCT00168818|69684539|FG002|Overall Study|Other|30|||
38000672|NCT00168818|69684537|FG000|Treatment|Adverse Event|77|||
38000673|NCT00168818|69684538|FG001|Treatment|Adverse Event|89|||
38000674|NCT00168818|69684539|FG002|Treatment|Adverse Event|68|||
38000675|NCT00168818|69684537|FG000|Treatment|Protocol Violation|8|||
38000676|NCT00168818|69684538|FG001|Treatment|Protocol Violation|11|||
37904371|NCT00969761|69590222|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
37904372|NCT00969761|69590223|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
37904373|NCT00845871|69590249|FG000|Assessment Period|Adverse Event|2|||
37904374|NCT00845871|69590249|FG000|Assessment Period|Abnormal laboratory values|1|||
37904375|NCT00845871|69590249|FG000|Assessment Period|Abnormal test procedure results|1|||
37904376|NCT00845871|69590249|FG000|Assessment Period|Patient withdrew consent|3|||
37904377|NCT00915278|69590279|FG000|Overall Study|Death|1|||
37904378|NCT00915278|69590280|FG001|Overall Study|Death|0|||
37904379|NCT00915278|69590281|FG002|Overall Study|Death|0|||
37904380|NCT00915278|69590282|FG003|Overall Study|Death|0|||
37904381|NCT00915278|69590283|FG004|Overall Study|Death|0|||
37904382|NCT00915278|69590284|FG005|Overall Study|Death|0|||
38000677|NCT00168818|69684539|FG002|Treatment|Protocol Violation|11|||
38000678|NCT00168818|69684537|FG000|Treatment|Lost to Follow-up|0|||
38000679|NCT00168818|69684538|FG001|Treatment|Lost to Follow-up|2|||
38000680|NCT00168818|69684539|FG002|Treatment|Lost to Follow-up|1|||
38000681|NCT00168818|69684537|FG000|Treatment|Withdrawal by Subject|25|||
37904383|NCT00915278|69590279|FG000|Overall Study|Lost to Follow-up|0|||
37904384|NCT00915278|69590280|FG001|Overall Study|Lost to Follow-up|1|||
37904385|NCT00915278|69590281|FG002|Overall Study|Lost to Follow-up|0|||
37904386|NCT00915278|69590282|FG003|Overall Study|Lost to Follow-up|0|||
37904387|NCT00915278|69590283|FG004|Overall Study|Lost to Follow-up|0|||
37904388|NCT00915278|69590284|FG005|Overall Study|Lost to Follow-up|0|||
38000682|NCT00168818|69684538|FG001|Treatment|Withdrawal by Subject|20|||
38000683|NCT00168818|69684539|FG002|Treatment|Withdrawal by Subject|22|||
38000684|NCT00168818|69684537|FG000|Treatment|Other|23|||
38000685|NCT00168818|69684538|FG001|Treatment|Other|29|||
38000686|NCT00168818|69684539|FG002|Treatment|Other|31|||
38000687|NCT00260832|69684549|FG000|Overall Study|Adverse Event|26|||
38000688|NCT00260832|69684550|FG001|Overall Study|Adverse Event|19|||
38000689|NCT00260832|69684549|FG000|Overall Study|Progression|116|||
38000690|NCT00260832|69684550|FG001|Overall Study|Progression|96|||
38000691|NCT00260832|69684549|FG000|Overall Study|Withdrawal by Subject|15|||
38000692|NCT00260832|69684550|FG001|Overall Study|Withdrawal by Subject|17|||
37829629|NCT00105989|69512814|FG001|Continuation - Open Label:Week 10-34|Death|0|||
37829630|NCT00105989|69512813|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
37829631|NCT00105989|69512814|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
37829632|NCT00105989|69512813|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
37829633|NCT00105989|69512814|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
37829634|NCT00105989|69512813|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
37829635|NCT00105989|69512814|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
37829636|NCT00105989|69512813|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
37829637|NCT00105989|69512814|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
37829638|NCT00105989|69512813|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
37829639|NCT00105989|69512814|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
37829640|NCT00105989|69512813|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
37904389|NCT00915278|69590279|FG000|Overall Study|Withdrawal by Subject|0|||
37904390|NCT00915278|69590280|FG001|Overall Study|Withdrawal by Subject|1|||
37904391|NCT00915278|69590281|FG002|Overall Study|Withdrawal by Subject|0|||
37904392|NCT00915278|69590282|FG003|Overall Study|Withdrawal by Subject|0|||
37904393|NCT00915278|69590283|FG004|Overall Study|Withdrawal by Subject|1|||
37904394|NCT00915278|69590284|FG005|Overall Study|Withdrawal by Subject|4|||
37904395|NCT00915278|69590279|FG000|Overall Study|Adverse Event|4|||
37904396|NCT00915278|69590280|FG001|Overall Study|Adverse Event|1|||
37904397|NCT00915278|69590281|FG002|Overall Study|Adverse Event|0|||
37904398|NCT00915278|69590282|FG003|Overall Study|Adverse Event|0|||
37904399|NCT00915278|69590283|FG004|Overall Study|Adverse Event|0|||
37904400|NCT00915278|69590284|FG005|Overall Study|Adverse Event|0|||
37904401|NCT00915278|69590279|FG000|Overall Study|Progressive disease/clinical progression|0|||
37904402|NCT00915278|69590280|FG001|Overall Study|Progressive disease/clinical progression|0|||
37904403|NCT00915278|69590281|FG002|Overall Study|Progressive disease/clinical progression|0|||
37904404|NCT00915278|69590282|FG003|Overall Study|Progressive disease/clinical progression|3|||
37904405|NCT00915278|69590283|FG004|Overall Study|Progressive disease/clinical progression|1|||
37904406|NCT00915278|69590284|FG005|Overall Study|Progressive disease/clinical progression|2|||
37904407|NCT00915278|69590279|FG000|Overall Study|Infusion related AEs|0|||
37904408|NCT00915278|69590280|FG001|Overall Study|Infusion related AEs|0|||
38000693|NCT00260832|69684549|FG000|Overall Study|Physician Decision|15|||
38000694|NCT00260832|69684550|FG001|Overall Study|Physician Decision|9|||
38000695|NCT00260832|69684549|FG000|Overall Study|Death|43|||
38000696|NCT00260832|69684550|FG001|Overall Study|Death|62|||
37904409|NCT00915278|69590281|FG002|Overall Study|Infusion related AEs|0|||
37904410|NCT00915278|69590282|FG003|Overall Study|Infusion related AEs|0|||
37904411|NCT00915278|69590283|FG004|Overall Study|Infusion related AEs|0|||
37904412|NCT00915278|69590284|FG005|Overall Study|Infusion related AEs|2|||
37904413|NCT00915278|69590279|FG000|Overall Study|Admission to hospice|0|||
37904414|NCT00915278|69590280|FG001|Overall Study|Admission to hospice|0|||
37904415|NCT00915278|69590281|FG002|Overall Study|Admission to hospice|1|||
37904416|NCT00915278|69590282|FG003|Overall Study|Admission to hospice|0|||
37904417|NCT00915278|69590283|FG004|Overall Study|Admission to hospice|0|||
37904418|NCT00915278|69590284|FG005|Overall Study|Admission to hospice|0|||
37904419|NCT00844857|69590300|FG000|Overall Study|Adverse Event|24|||
37904420|NCT00844857|69590301|FG001|Overall Study|Adverse Event|5|||
37904421|NCT00844857|69590300|FG000|Overall Study|Sponsor Decision|1|||
37904422|NCT00844857|69590301|FG001|Overall Study|Sponsor Decision|1|||
38000697|NCT00260832|69684549|FG000|Overall Study|Other|10|||
37904423|NCT00844857|69590300|FG000|Overall Study|Physician Decision|2|||
37904424|NCT00844857|69590301|FG001|Overall Study|Physician Decision|0|||
38000698|NCT00260832|69684550|FG001|Overall Study|Other|7|||
38000699|NCT00260832|69684549|FG000|Overall Study|Protocol Violation|3|||
38000700|NCT00260832|69684550|FG001|Overall Study|Protocol Violation|1|||
38000701|NCT00168038|69684556|FG000|Overall Study|Adverse Event|1|||
38000702|NCT00168038|69684556|FG000|Overall Study|Therapy failure|1|||
38000703|NCT00167414|69684560|FG000|Overall Study|Death|10|||
37904425|NCT00844857|69590300|FG000|Overall Study|Parent/Caregiver Decision|6|||
38000704|NCT00166712|69684566|FG000|Overall Study|Death|0|||
38000705|NCT00166712|69684567|FG001|Overall Study|Death|1|||
38000706|NCT00166712|69684566|FG000|Overall Study|Adverse Event|1|||
38000707|NCT00166712|69684567|FG001|Overall Study|Adverse Event|0|||
38000708|NCT00166712|69684566|FG000|Overall Study|Withdrawal by Subject|1|||
38000709|NCT00166712|69684567|FG001|Overall Study|Withdrawal by Subject|2|||
38000710|NCT00166712|69684566|FG000|Overall Study|Physician Decision|0|||
38000711|NCT00166712|69684567|FG001|Overall Study|Physician Decision|2|||
38000712|NCT00073528|69684579|FG000|Overall Study|Death|488|||
38000713|NCT00073528|69684580|FG001|Overall Study|Death|473|||
38000714|NCT00073528|69684579|FG000|Overall Study|Lost to Follow-up|52|||
38000715|NCT00073528|69684580|FG001|Overall Study|Lost to Follow-up|45|||
38000716|NCT00073528|69684579|FG000|Overall Study|Withdrawal by Subject|50|||
38000717|NCT00073528|69684580|FG001|Overall Study|Withdrawal by Subject|45|||
38000718|NCT00073528|69684579|FG000|Overall Study|Study terminated by Sponsor|10|||
38000719|NCT00073528|69684580|FG001|Overall Study|Study terminated by Sponsor|29|||
38000720|NCT00073528|69684579|FG000|Overall Study|Other|18|||
37904426|NCT00844857|69590301|FG001|Overall Study|Parent/Caregiver Decision|2|||
37904427|NCT00844857|69590300|FG000|Overall Study|Withdrawal by Subject|8|||
37904428|NCT00844857|69590301|FG001|Overall Study|Withdrawal by Subject|7|||
38000721|NCT00073528|69684580|FG001|Overall Study|Other|19|||
38000722|NCT00073528|69684579|FG000|Overall Study|Other|9|||
38000723|NCT00073528|69684580|FG001|Overall Study|Other|12|||
38000724|NCT00073528|69684579|FG000|Overall Study|Protocol Violation|3|||
38000725|NCT00073528|69684580|FG001|Overall Study|Protocol Violation|5|||
38000726|NCT03801148|69684590|FG000|Period 1 (2 Days)|Adverse Event|1|||
38000727|NCT03801148|69684591|FG001|Period 1 (2 Days)|Adverse Event|1|||
38000728|NCT03801148|69684592|FG002|Period 1 (2 Days)|Adverse Event|0|||
38000729|NCT03801148|69684593|FG003|Period 1 (2 Days)|Adverse Event|0|||
38000730|NCT03801148|69684590|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
38000731|NCT03801148|69684591|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
38000732|NCT03801148|69684592|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
38000733|NCT03801148|69684593|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
38000734|NCT03801148|69684590|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
38000735|NCT03801148|69684591|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
38000736|NCT03801148|69684592|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
38000737|NCT03801148|69684593|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
38000738|NCT03801148|69684590|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
38000739|NCT03801148|69684591|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
38000740|NCT03801148|69684592|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
38000741|NCT03801148|69684593|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
38000742|NCT00072280|69684605|FG000|Treatment|Found ineligible|1|||
38000743|NCT00072280|69684606|FG001|Treatment|Found ineligible|2|||
38000744|NCT00072280|69684605|FG000|Follow-up|Early termination of study|2|||
38000745|NCT00072280|69684606|FG001|Follow-up|Early termination of study|2|||
38000746|NCT00071812|69684615|FG000|24-Week Double-Blind Period|Adverse Event|2|||
38000747|NCT00071812|69684616|FG001|24-Week Double-Blind Period|Adverse Event|3|||
38000748|NCT00071812|69684617|FG002|24-Week Double-Blind Period|Adverse Event|4|||
38000749|NCT00071812|69684618|FG003|24-Week Double-Blind Period|Adverse Event|4|||
38000750|NCT00071812|69684615|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
38000751|NCT00071812|69684616|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
38000752|NCT00071812|69684617|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
38000753|NCT00071812|69684618|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
38000754|NCT00071812|69684615|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
38000755|NCT00071812|69684616|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
38000756|NCT00071812|69684617|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
38000757|NCT00071812|69684618|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
38000758|NCT00071812|69684615|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
38000759|NCT00071812|69684616|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
38000760|NCT00071812|69684617|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
38000761|NCT00071812|69684618|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
38000762|NCT00071812|69684615|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
38000763|NCT00071812|69684616|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
38000764|NCT00071812|69684617|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
38000765|NCT00071812|69684618|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
38000766|NCT00071812|69684615|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
38000767|NCT00071812|69684616|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
38000768|NCT00071812|69684617|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
38000769|NCT00071812|69684618|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
37829641|NCT00105989|69512814|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
37829642|NCT00105989|69512813|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
37829643|NCT00105989|69512814|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
37829644|NCT00105989|69512813|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
37829645|NCT00105989|69512814|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
37829646|NCT00105989|69512813|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
37829647|NCT00105989|69512814|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
37829648|NCT00105989|69512813|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
37829649|NCT00105989|69512814|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
37829650|NCT00105989|69512813|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
37829651|NCT00105989|69512814|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
37829652|NCT00105989|69512813|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
37829653|NCT00105989|69512814|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
37829654|NCT03277248|69512832|FG000|Overall Study|Adverse Event|3|||
37829655|NCT03277248|69512833|FG001|Overall Study|Adverse Event|1|||
37829656|NCT03277248|69512832|FG000|Overall Study|Subject Withdrawal of Consent|6|||
37829657|NCT03277248|69512833|FG001|Overall Study|Subject Withdrawal of Consent|23|||
37904429|NCT00844857|69590300|FG000|Overall Study|Protocol Violation|6|||
38000770|NCT00071812|69684615|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
38000771|NCT00071812|69684616|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
38000772|NCT00071812|69684617|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
38000773|NCT00071812|69684618|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
38000774|NCT00071812|69684615|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
38000775|NCT00071812|69684616|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
38000776|NCT00071812|69684617|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
38000777|NCT00071812|69684618|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
38000778|NCT00071812|69684615|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
38000779|NCT00071812|69684616|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
38000780|NCT00071812|69684617|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
38000781|NCT00071812|69684618|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
38000782|NCT00071812|69684615|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
38000783|NCT00071812|69684616|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
38000784|NCT00071812|69684617|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
38000785|NCT00071812|69684618|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
38000786|NCT00071110|69684632|FG000|Overall Study|Protocol Violation|0|||
38000787|NCT00071110|69684633|FG001|Overall Study|Protocol Violation|4|||
38000788|NCT00071032|69684641|FG000|Overall Study|Lost to Follow-up|1|||
38000789|NCT00071032|69684642|FG001|Overall Study|Lost to Follow-up|1|||
38000790|NCT00071032|69684641|FG000|Overall Study|Withdrawal by Subject|8|||
38000791|NCT00071032|69684642|FG001|Overall Study|Withdrawal by Subject|6|||
38000792|NCT00071032|69684641|FG000|Overall Study|Missing Primary Outcome|0|||
37697384|NCT02417441|69173886|FG000|Overall Study|Inconclusive due to missing data|52|||
37697385|NCT02417441|69173887|FG001|Overall Study|Inconclusive due to missing data|19|||
37697386|NCT02021643|69173900|FG000|Overall Study|Enrolled but Never Treated|1|||
37829658|NCT03277248|69512832|FG000|Overall Study|Investigator/Sponsor Decision|2|||
37829659|NCT03277248|69512833|FG001|Overall Study|Investigator/Sponsor Decision|2|||
37829660|NCT03277248|69512832|FG000|Overall Study|Pregnancy|4|||
37829661|NCT03277248|69512833|FG001|Overall Study|Pregnancy|1|||
37829662|NCT03277248|69512832|FG000|Overall Study|Lost to Follow-up|0|||
37829663|NCT03277248|69512833|FG001|Overall Study|Lost to Follow-up|2|||
37829664|NCT03277248|69512832|FG000|Overall Study|Lack of Efficacy|0|||
37829665|NCT03277248|69512833|FG001|Overall Study|Lack of Efficacy|2|||
37829666|NCT03277248|69512832|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
37829667|NCT03277248|69512833|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
37829668|NCT03276780|69512841|FG000|Overall Study|Withdrawal by Subject|5|||
37829669|NCT03276780|69512842|FG001|Overall Study|Withdrawal by Subject|3|||
37829670|NCT03276780|69512841|FG000|Overall Study|Lost to Follow-up|3|||
37829671|NCT03276780|69512842|FG001|Overall Study|Lost to Follow-up|5|||
37829672|NCT03276780|69512841|FG000|Overall Study|Moved out of state|1|||
37829673|NCT03276780|69512842|FG001|Overall Study|Moved out of state|1|||
37829674|NCT03276780|69512841|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
37829675|NCT03276780|69512842|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
37829676|NCT03276780|69512841|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
37904430|NCT00844857|69590301|FG001|Overall Study|Protocol Violation|0|||
37904431|NCT00844857|69590300|FG000|Overall Study|Lack of Efficacy|5|||
37904432|NCT00844857|69590301|FG001|Overall Study|Lack of Efficacy|5|||
37904433|NCT00844857|69590300|FG000|Overall Study|Clinical Relapse|0|||
37904434|NCT00844857|69590301|FG001|Overall Study|Clinical Relapse|1|||
37904435|NCT00844857|69590300|FG000|Overall Study|Entry Criteria Not Met|0|||
37904436|NCT00844857|69590301|FG001|Overall Study|Entry Criteria Not Met|1|||
37904437|NCT00844857|69590300|FG000|Overall Study|Lost to Follow-up|2|||
37904438|NCT00844857|69590301|FG001|Overall Study|Lost to Follow-up|3|||
37904439|NCT00844857|69590300|FG000|Overall Study|Did Not Take Study Drug|3|||
37904440|NCT00844857|69590301|FG001|Overall Study|Did Not Take Study Drug|1|||
37904441|NCT00844857|69590300|FG000|Overall Study|Good Clinical Practice Violations|21|||
37904442|NCT00844857|69590301|FG001|Overall Study|Good Clinical Practice Violations|11|||
37904443|NCT00569803|69590318|FG000|Overall Study|Lost to Follow-up|1|||
37833619|NCT01262872|69517333|FG006|Step 2|Migrated/moved from study area|2|||
37904444|NCT00569803|69590319|FG001|Overall Study|Lost to Follow-up|0|||
38000793|NCT00071032|69684642|FG001|Overall Study|Missing Primary Outcome|1|||
38000794|NCT00259610|69684653|FG000|Overall Study|Withdrawal by Subject|33|||
38000795|NCT00259610|69684654|FG001|Overall Study|Withdrawal by Subject|25|||
38000796|NCT00259610|69684655|FG002|Overall Study|Withdrawal by Subject|29|||
38000797|NCT00259610|69684656|FG003|Overall Study|Withdrawal by Subject|19|||
38000798|NCT00259610|69684653|FG000|Overall Study|Lost to Follow-up|19|||
38000799|NCT00259610|69684654|FG001|Overall Study|Lost to Follow-up|8|||
38000800|NCT00259610|69684655|FG002|Overall Study|Lost to Follow-up|18|||
38000801|NCT00259610|69684656|FG003|Overall Study|Lost to Follow-up|15|||
38000802|NCT00259610|69684653|FG000|Overall Study|Physician Decision|6|||
38000803|NCT00259610|69684654|FG001|Overall Study|Physician Decision|4|||
38000804|NCT00259610|69684655|FG002|Overall Study|Physician Decision|7|||
37697387|NCT02021643|69173901|FG001|Overall Study|Enrolled but Never Treated|0|||
38000805|NCT00259610|69684656|FG003|Overall Study|Physician Decision|2|||
38000806|NCT00259610|69684653|FG000|Overall Study|Death|1|||
37697388|NCT02021643|69173902|FG002|Overall Study|Enrolled but Never Treated|0|||
37697389|NCT02021643|69173903|FG003|Overall Study|Enrolled but Never Treated|0|||
37697390|NCT02021643|69173900|FG000|Overall Study|Adverse Event|0|||
37697391|NCT02021643|69173901|FG001|Overall Study|Adverse Event|1|||
37697392|NCT02021643|69173902|FG002|Overall Study|Adverse Event|0|||
37697393|NCT02021643|69173903|FG003|Overall Study|Adverse Event|0|||
38000807|NCT00259610|69684654|FG001|Overall Study|Death|1|||
38000808|NCT00259610|69684655|FG002|Overall Study|Death|2|||
38000809|NCT00259610|69684656|FG003|Overall Study|Death|0|||
38000810|NCT00259610|69684653|FG000|Overall Study|non medical reason|6|||
38000811|NCT00259610|69684654|FG001|Overall Study|non medical reason|2|||
38000812|NCT00259610|69684655|FG002|Overall Study|non medical reason|10|||
38000813|NCT00259610|69684656|FG003|Overall Study|non medical reason|3|||
38000814|NCT00259610|69684653|FG000|Overall Study|Adverse Event|3|||
37697394|NCT02021643|69173900|FG000|Overall Study|Death|0|||
37697395|NCT02021643|69173901|FG001|Overall Study|Death|1|||
37829677|NCT03276780|69512842|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
37829678|NCT03271047|69512858|FG000|Phase 1b: Dose Finding Period|Death|8|||
37829679|NCT03271047|69512859|FG001|Phase 1b: Dose Finding Period|Death|8|||
37829680|NCT03271047|69512860|FG002|Phase 1b: Dose Finding Period|Death|0|||
37829681|NCT03271047|69512861|FG003|Phase 1b: Dose Finding Period|Death|0|||
37829682|NCT03271047|69512858|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
37829683|NCT03271047|69512859|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
37904445|NCT00569803|69590320|FG002|Overall Study|Lost to Follow-up|0|||
37697396|NCT02021643|69173902|FG002|Overall Study|Death|0|||
37904446|NCT00569803|69590321|FG003|Overall Study|Lost to Follow-up|0|||
37904447|NCT00569803|69590322|FG004|Overall Study|Lost to Follow-up|0|||
37904448|NCT00569803|69590323|FG005|Overall Study|Lost to Follow-up|0|||
37829684|NCT03271047|69512860|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
37829685|NCT03271047|69512861|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
37904449|NCT00569803|69590324|FG006|Overall Study|Lost to Follow-up|0|||
38000815|NCT00259610|69684654|FG001|Overall Study|Adverse Event|4|||
38000816|NCT00259610|69684655|FG002|Overall Study|Adverse Event|5|||
38000817|NCT00259610|69684656|FG003|Overall Study|Adverse Event|2|||
38000818|NCT00259610|69684653|FG000|Overall Study|Serious Adverse Event|8|||
38000819|NCT00259610|69684654|FG001|Overall Study|Serious Adverse Event|2|||
38000820|NCT00259610|69684655|FG002|Overall Study|Serious Adverse Event|2|||
38000821|NCT00259610|69684656|FG003|Overall Study|Serious Adverse Event|2|||
38000822|NCT00165776|69684670|FG000|Overall Study|Lack of Efficacy|0|||
38000823|NCT00165776|69684671|FG001|Overall Study|Lack of Efficacy|0|||
38000824|NCT00165776|69684672|FG002|Overall Study|Lack of Efficacy|0|||
38000825|NCT00165776|69684673|FG003|Overall Study|Lack of Efficacy|1|||
38000826|NCT00165776|69684670|FG000|Overall Study|Withdrawal by Subject|4|||
38000827|NCT00165776|69684671|FG001|Overall Study|Withdrawal by Subject|1|||
38000828|NCT00165776|69684672|FG002|Overall Study|Withdrawal by Subject|2|||
38000829|NCT00165776|69684673|FG003|Overall Study|Withdrawal by Subject|0|||
38000830|NCT00165776|69684670|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
38000831|NCT00165776|69684671|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
38000832|NCT00165776|69684672|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
38000833|NCT00165776|69684673|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
37904450|NCT00569803|69590325|FG007|Overall Study|Lost to Follow-up|0|||
38000834|NCT00165698|69684685|FG000|Overall Study|Adverse Event|2|||
38000835|NCT00165698|69684686|FG001|Overall Study|Adverse Event|10|||
38000836|NCT00165698|69684685|FG000|Overall Study|Lost to Follow-up|2|||
38000837|NCT00165698|69684686|FG001|Overall Study|Lost to Follow-up|2|||
38000838|NCT00165698|69684685|FG000|Overall Study|Withdrawal by Subject|2|||
38000839|NCT00165698|69684686|FG001|Overall Study|Withdrawal by Subject|1|||
38000840|NCT00165698|69684685|FG000|Overall Study|Protocol Violation|1|||
38000841|NCT00165698|69684686|FG001|Overall Study|Protocol Violation|0|||
37904451|NCT00569803|69590318|FG000|Overall Study|injection syringe leaked during dosing|0|||
37904452|NCT00569803|69590319|FG001|Overall Study|injection syringe leaked during dosing|0|||
38000842|NCT00165698|69684685|FG000|Overall Study|Not Taken/Lost the medicine|1|||
38000843|NCT00165698|69684686|FG001|Overall Study|Not Taken/Lost the medicine|2|||
38000844|NCT00225758|69684692|FG000|Overall Study|Adverse Event|4|||
38000845|NCT00259298|69684698|FG000|Overall Study|Withdrawal by Subject|1|||
38000846|NCT00259298|69684698|FG000|Overall Study|Physician Decision|2|||
38000847|NCT03789292|69684704|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
38000848|NCT03789292|69684705|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
38000849|NCT03789292|69684706|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
37904453|NCT00569803|69590320|FG002|Overall Study|injection syringe leaked during dosing|0|||
37904454|NCT00569803|69590321|FG003|Overall Study|injection syringe leaked during dosing|1|||
37904455|NCT00569803|69590322|FG004|Overall Study|injection syringe leaked during dosing|0|||
37904456|NCT00569803|69590323|FG005|Overall Study|injection syringe leaked during dosing|0|||
37904457|NCT00569803|69590324|FG006|Overall Study|injection syringe leaked during dosing|0|||
37904458|NCT00569803|69590325|FG007|Overall Study|injection syringe leaked during dosing|0|||
38000850|NCT03789292|69684704|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
38000851|NCT03789292|69684705|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
38000852|NCT03789292|69684706|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
38000853|NCT03789292|69684704|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
38000854|NCT03789292|69684705|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
38000855|NCT03789292|69684706|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
38000856|NCT03789292|69684704|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
38000857|NCT03789292|69684705|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
38000858|NCT03789292|69684706|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
38000859|NCT03789292|69684704|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
38000860|NCT03789292|69684705|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
38000861|NCT03789292|69684706|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
38000862|NCT03789292|69684704|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
38000863|NCT03789292|69684705|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
38000864|NCT03789292|69684706|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
38000865|NCT03789292|69684704|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
38000866|NCT03789292|69684705|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
38000867|NCT03789292|69684706|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
38000868|NCT03789292|69684704|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
38000869|NCT03789292|69684705|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
38000870|NCT03789292|69684706|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
37904459|NCT00569803|69590318|FG000|Overall Study|Withdrawal by Subject|0|||
37904460|NCT00569803|69590319|FG001|Overall Study|Withdrawal by Subject|0|||
37904461|NCT00569803|69590320|FG002|Overall Study|Withdrawal by Subject|0|||
37904462|NCT00569803|69590321|FG003|Overall Study|Withdrawal by Subject|0|||
37904463|NCT00569803|69590322|FG004|Overall Study|Withdrawal by Subject|0|||
38000871|NCT03789292|69684704|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
38000872|NCT03789292|69684705|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
38000873|NCT03789292|69684706|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
38000874|NCT03789292|69684704|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
38000875|NCT03789292|69684705|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
38000876|NCT03789292|69684706|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
38000877|NCT03789292|69684704|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
38000878|NCT03789292|69684705|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
38000879|NCT03789292|69684706|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
38000880|NCT03789292|69684704|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
38000881|NCT03789292|69684705|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
38000882|NCT03789292|69684706|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
38000883|NCT03789292|69684704|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
38000884|NCT03789292|69684705|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
37904464|NCT00569803|69590323|FG005|Overall Study|Withdrawal by Subject|0|||
37904465|NCT00569803|69590324|FG006|Overall Study|Withdrawal by Subject|0|||
37904466|NCT00569803|69590325|FG007|Overall Study|Withdrawal by Subject|1|||
37904467|NCT00920426|69590350|FG000|ITZ111451|Adverse Event|1|||
37904468|NCT00920426|69590351|FG001|ITZ111451|Adverse Event|0|||
37904469|NCT00920426|69590352|FG002|ITZ111451|Adverse Event|0|||
37904470|NCT00920426|69590353|FG003|ITZ111451|Adverse Event|0|||
37904471|NCT00644995|69590367|FG000|Overall Study|Lost to Follow-up|1|||
37904472|NCT00644995|69590368|FG001|Overall Study|Lost to Follow-up|4|||
37904473|NCT00644995|69590367|FG000|Overall Study|Refused|1|||
37904474|NCT00644995|69590368|FG001|Overall Study|Refused|0|||
37904475|NCT00914966|69590376|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
37904476|NCT00914966|69590376|FG000|Step 1: 1500 Units|Physician Decision|1|||
37904477|NCT00914966|69590376|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
37904478|NCT00914810|69590387|FG000|Overall Study|Withdrawal by Subject|1|||
37904479|NCT00914810|69590388|FG001|Overall Study|Withdrawal by Subject|0|||
37904480|NCT00914810|69590387|FG000|Overall Study|Relocated out of state|1|||
37904481|NCT00914810|69590388|FG001|Overall Study|Relocated out of state|0|||
37904482|NCT00914810|69590387|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
37904483|NCT00914810|69590388|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
37904484|NCT00644917|69590394|FG000|Overall Study|Withdrawal by Subject|2|||
37904485|NCT00914732|69590405|FG000|Overall Study|Lost to Follow-up|6|||
37904486|NCT00914732|69590406|FG001|Overall Study|Lost to Follow-up|7|||
37904487|NCT00914732|69590407|FG002|Overall Study|Lost to Follow-up|9|||
37904488|NCT00914732|69590405|FG000|Overall Study|Withdrawal by Subject|3|||
37904489|NCT00914732|69590406|FG001|Overall Study|Withdrawal by Subject|0|||
37904490|NCT00914732|69590407|FG002|Overall Study|Withdrawal by Subject|2|||
37904491|NCT00914732|69590405|FG000|Overall Study|Adverse Event|1|||
37904492|NCT00914732|69590406|FG001|Overall Study|Adverse Event|0|||
37904493|NCT00914732|69590407|FG002|Overall Study|Adverse Event|0|||
37904494|NCT00844545|69590416|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
37829686|NCT03271047|69512858|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
37829687|NCT03271047|69512859|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
37829688|NCT03271047|69512860|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
37829689|NCT03271047|69512861|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
37829690|NCT03271047|69512858|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
37829691|NCT03271047|69512859|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
37829692|NCT03271047|69512860|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
37829693|NCT03271047|69512861|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
37829694|NCT03271047|69512858|FG000|Randomized Phase 2 Period|Other|0|||
37829695|NCT03271047|69512859|FG001|Randomized Phase 2 Period|Other|0|||
37829696|NCT03271047|69512860|FG002|Randomized Phase 2 Period|Other|0|||
37829697|NCT03271047|69512861|FG003|Randomized Phase 2 Period|Other|1|||
37829698|NCT03271047|69512858|FG000|Randomized Phase 2 Period|Death|0|||
37829699|NCT03271047|69512859|FG001|Randomized Phase 2 Period|Death|0|||
37829700|NCT03271047|69512860|FG002|Randomized Phase 2 Period|Death|20|||
37829701|NCT03271047|69512861|FG003|Randomized Phase 2 Period|Death|21|||
37904495|NCT00844545|69590416|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
37904496|NCT00844545|69590416|FG000|Extension Treatment Period|Adverse Event|2|||
37904497|NCT00844545|69590416|FG000|Post Treatment Period|Withdrawal by Subject|1|||
37904498|NCT00651157|69590421|FG000|Overall Study|Death|1|||
37904499|NCT00651157|69590421|FG000|Overall Study|Protocol Violation|1|||
37904500|NCT00843843|69590427|FG000|Overall Study|Physician Decision|1|||
37904501|NCT00843843|69590428|FG001|Overall Study|Physician Decision|1|||
37904502|NCT00843843|69590427|FG000|Overall Study|Protocol Violation|1|||
37904503|NCT00843843|69590428|FG001|Overall Study|Protocol Violation|1|||
37904504|NCT00650845|69590436|FG000|Overall Study|Withdrawal by Subject|5|||
37904505|NCT00650845|69590437|FG001|Overall Study|Withdrawal by Subject|0|||
37829702|NCT03271047|69512858|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
37829703|NCT03271047|69512859|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
37904506|NCT00650845|69590436|FG000|Overall Study|Protocol Violation|0|||
37904507|NCT00650845|69590437|FG001|Overall Study|Protocol Violation|13|||
37904508|NCT00842985|69590444|FG000|Screening|Did not meet entrance requirements|27|||
37904509|NCT00842985|69590444|FG000|First Intervention|Withdrawal by Subject|3|||
37904510|NCT00842985|69590444|FG000|First Intervention|Protocol Violation|3|||
37904511|NCT00842985|69590444|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
37904512|NCT00842985|69590444|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
37904513|NCT00842829|69590453|FG000|Dose Titration Period|Adverse Event|11|||
37904514|NCT00842829|69590454|FG001|Dose Titration Period|Adverse Event|10|||
37904515|NCT00842829|69590455|FG002|Dose Titration Period|Adverse Event|0|||
37904516|NCT00842829|69590453|FG000|Dose Titration Period|Lack of Efficacy|4|||
37904517|NCT00842829|69590454|FG001|Dose Titration Period|Lack of Efficacy|1|||
37904518|NCT00842829|69590455|FG002|Dose Titration Period|Lack of Efficacy|0|||
37904519|NCT00842829|69590453|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
37904520|NCT00842829|69590454|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
37904521|NCT00842829|69590455|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
37904522|NCT00842829|69590453|FG000|Dose Titration Period|Withdrawal by Subject|2|||
37904523|NCT00842829|69590454|FG001|Dose Titration Period|Withdrawal by Subject|6|||
37904524|NCT00842829|69590455|FG002|Dose Titration Period|Withdrawal by Subject|0|||
37904525|NCT00842829|69590453|FG000|Dose Titration Period|Other|5|||
37904526|NCT00842829|69590454|FG001|Dose Titration Period|Other|4|||
37904527|NCT00842829|69590455|FG002|Dose Titration Period|Other|0|||
37904528|NCT00842829|69590453|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
37904529|NCT00842829|69590454|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
37904530|NCT00842829|69590455|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
37904531|NCT00842829|69590453|FG000|Dose Titration Period|Non-compliance to study drug|2|||
37904532|NCT00842829|69590454|FG001|Dose Titration Period|Non-compliance to study drug|1|||
37904533|NCT00842829|69590455|FG002|Dose Titration Period|Non-compliance to study drug|0|||
37904534|NCT00842829|69590453|FG000|Treatment Period|Adverse Event|0|||
37904535|NCT00842829|69590454|FG001|Treatment Period|Adverse Event|0|||
37904536|NCT00842829|69590455|FG002|Treatment Period|Adverse Event|15|||
37904537|NCT00842829|69590453|FG000|Treatment Period|Lack of Efficacy|0|||
37904538|NCT00842829|69590454|FG001|Treatment Period|Lack of Efficacy|0|||
37904539|NCT00842829|69590455|FG002|Treatment Period|Lack of Efficacy|6|||
37904540|NCT00842829|69590453|FG000|Treatment Period|Unstable persistent cancer pain|0|||
38000885|NCT03789292|69684706|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
38000886|NCT03781336|69684722|FG000|Overall Study|Withdrawal by Subject|2|||
38000887|NCT03781336|69684723|FG001|Overall Study|Withdrawal by Subject|2|||
38000888|NCT03780400|69684729|FG000|Overall Study|Lost to Follow-up|5|||
38000889|NCT03780400|69684729|FG000|Overall Study|Withdrawal by Subject|2|||
38000890|NCT03780244|69684735|FG000|Overall Study|Lost to Follow-up|1|||
38000891|NCT03780244|69684736|FG001|Overall Study|Lost to Follow-up|0|||
38000892|NCT03785548|69684744|FG000|Overall Study|age > 80|1|||
38000893|NCT03785548|69684745|FG001|Overall Study|age > 80|0|||
38000894|NCT03785548|69684744|FG000|Overall Study|no Postop queries|1|||
38000895|NCT03785548|69684745|FG001|Overall Study|no Postop queries|0|||
38000896|NCT00141297|69684753|FG000|Overall Study|Adverse Event|0|||
38000897|NCT00141297|69684754|FG001|Overall Study|Adverse Event|0|||
38000898|NCT00141297|69684755|FG002|Overall Study|Adverse Event|1|||
38000899|NCT00141297|69684756|FG003|Overall Study|Adverse Event|0|||
38000900|NCT00141297|69684757|FG004|Overall Study|Adverse Event|1|||
38000901|NCT00141297|69684758|FG005|Overall Study|Adverse Event|1|||
37829704|NCT03271047|69512860|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
37829705|NCT03271047|69512861|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
37829706|NCT03271047|69512858|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
37829707|NCT03271047|69512859|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
37829708|NCT03271047|69512860|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
37829709|NCT03271047|69512861|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
38000902|NCT00141297|69684759|FG006|Overall Study|Adverse Event|0|||
38000903|NCT00141297|69684760|FG007|Overall Study|Adverse Event|1|||
38000904|NCT00141297|69684761|FG008|Overall Study|Adverse Event|1|||
38000905|NCT00141297|69684762|FG009|Overall Study|Adverse Event|0|||
37829710|NCT03271047|69512858|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
37829711|NCT03271047|69512859|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
37904541|NCT00842829|69590454|FG001|Treatment Period|Unstable persistent cancer pain|0|||
37904542|NCT00842829|69590455|FG002|Treatment Period|Unstable persistent cancer pain|5|||
37904543|NCT00842829|69590453|FG000|Treatment Period|Withdrawal by Subject|0|||
37904544|NCT00842829|69590454|FG001|Treatment Period|Withdrawal by Subject|0|||
37904545|NCT00842829|69590455|FG002|Treatment Period|Withdrawal by Subject|11|||
37904546|NCT00842829|69590453|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
37904547|NCT00842829|69590454|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
38000906|NCT00141297|69684753|FG000|Overall Study|Death|1|||
38000907|NCT00141297|69684754|FG001|Overall Study|Death|0|||
38000908|NCT00141297|69684755|FG002|Overall Study|Death|0|||
38000909|NCT00141297|69684756|FG003|Overall Study|Death|0|||
38000910|NCT00141297|69684757|FG004|Overall Study|Death|0|||
38000911|NCT00141297|69684758|FG005|Overall Study|Death|0|||
38000912|NCT00141297|69684759|FG006|Overall Study|Death|0|||
38000913|NCT00141297|69684760|FG007|Overall Study|Death|0|||
38000914|NCT00141297|69684761|FG008|Overall Study|Death|1|||
38000915|NCT00141297|69684762|FG009|Overall Study|Death|0|||
38000916|NCT00141297|69684753|FG000|Overall Study|Withdrawal by Subject|0|||
38000917|NCT00141297|69684754|FG001|Overall Study|Withdrawal by Subject|0|||
38000918|NCT00141297|69684755|FG002|Overall Study|Withdrawal by Subject|0|||
38000919|NCT00141297|69684756|FG003|Overall Study|Withdrawal by Subject|0|||
38000920|NCT00141297|69684757|FG004|Overall Study|Withdrawal by Subject|0|||
38000921|NCT00141297|69684758|FG005|Overall Study|Withdrawal by Subject|0|||
38000922|NCT00141297|69684759|FG006|Overall Study|Withdrawal by Subject|0|||
38000923|NCT00141297|69684760|FG007|Overall Study|Withdrawal by Subject|0|||
38000924|NCT00141297|69684761|FG008|Overall Study|Withdrawal by Subject|1|||
38000925|NCT00141297|69684762|FG009|Overall Study|Withdrawal by Subject|0|||
38000926|NCT00141297|69684753|FG000|Overall Study|Other|0|||
38000927|NCT00141297|69684754|FG001|Overall Study|Other|0|||
37904548|NCT00842829|69590455|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
37904549|NCT00842829|69590453|FG000|Treatment Period|Protocol Violation|0|||
37904550|NCT00842829|69590454|FG001|Treatment Period|Protocol Violation|0|||
37904551|NCT00842829|69590455|FG002|Treatment Period|Protocol Violation|2|||
37904552|NCT00842829|69590453|FG000|Treatment Period|Other|0|||
37904553|NCT00842829|69590454|FG001|Treatment Period|Other|0|||
37904554|NCT00842829|69590455|FG002|Treatment Period|Other|18|||
37904555|NCT00842829|69590453|FG000|Treatment Period|Non-compliance to study procedures|0|||
38000928|NCT00141297|69684755|FG002|Overall Study|Other|0|||
38000929|NCT00141297|69684756|FG003|Overall Study|Other|1|||
38000930|NCT00141297|69684757|FG004|Overall Study|Other|5|||
38000931|NCT00141297|69684758|FG005|Overall Study|Other|0|||
38000932|NCT00141297|69684759|FG006|Overall Study|Other|0|||
38000933|NCT00141297|69684760|FG007|Overall Study|Other|0|||
38000934|NCT00141297|69684761|FG008|Overall Study|Other|2|||
38000935|NCT00141297|69684762|FG009|Overall Study|Other|0|||
38000936|NCT00141297|69684753|FG000|Overall Study|Progressive Disease|2|||
38000937|NCT00141297|69684754|FG001|Overall Study|Progressive Disease|3|||
38000938|NCT00141297|69684755|FG002|Overall Study|Progressive Disease|6|||
37829712|NCT03271047|69512860|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
37829713|NCT03271047|69512861|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
37829714|NCT03276936|69512875|FG000|Overall Study|Adverse Event|4|||
37829715|NCT03276936|69512876|FG001|Overall Study|Adverse Event|2|||
37829716|NCT03276936|69512875|FG000|Overall Study|Lost to Follow-up|16|||
37829717|NCT03276936|69512876|FG001|Overall Study|Lost to Follow-up|13|||
37829718|NCT03276936|69512875|FG000|Overall Study|Withdrawal by Subject|30|||
37829719|NCT03276936|69512876|FG001|Overall Study|Withdrawal by Subject|20|||
37829720|NCT03276936|69512875|FG000|Overall Study|Not mentioned|6|||
37829721|NCT03276936|69512876|FG001|Overall Study|Not mentioned|3|||
37829722|NCT00106002|69512882|FG000|Overall Study|Did not take any study drug|1|||
37829723|NCT00106002|69512882|FG000|Overall Study|Ineligible after Registration|1|||
37829724|NCT00105482|69512900|FG000|Overall Study|Adverse Event|1|||
37829725|NCT00105482|69512901|FG001|Overall Study|Adverse Event|1|||
37829726|NCT00105482|69512900|FG000|Overall Study|Lost to Follow-up|26|||
37829727|NCT00105482|69512901|FG001|Overall Study|Lost to Follow-up|17|||
37829728|NCT00105482|69512900|FG000|Overall Study|Withdrawal by Subject|0|||
37829729|NCT00105482|69512901|FG001|Overall Study|Withdrawal by Subject|1|||
37829730|NCT00105482|69512900|FG000|Overall Study|Lost Interest|29|||
37829731|NCT00105482|69512901|FG001|Overall Study|Lost Interest|32|||
37829732|NCT00105482|69512900|FG000|Overall Study|Scheduling Conflict|2|||
37829733|NCT00105482|69512901|FG001|Overall Study|Scheduling Conflict|3|||
37829734|NCT00105482|69512900|FG000|Overall Study|Withdrawn by PI|1|||
37829735|NCT00105482|69512901|FG001|Overall Study|Withdrawn by PI|1|||
37829736|NCT01327651|69512916|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
37904556|NCT00842829|69590454|FG001|Treatment Period|Non-compliance to study procedures|0|||
37829737|NCT01327651|69512917|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
37829738|NCT01327651|69512918|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
37829739|NCT01327651|69512919|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
37829740|NCT01327651|69512920|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
37904557|NCT00842829|69590455|FG002|Treatment Period|Non-compliance to study procedures|4|||
37904558|NCT00842829|69590453|FG000|Treatment Period|Unclear completion status|0|||
38000939|NCT00141297|69684756|FG003|Overall Study|Progressive Disease|2|||
37829741|NCT01327651|69512921|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
37829742|NCT01327651|69512922|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
37829743|NCT01327651|69512923|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
37829744|NCT01327651|69512924|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
37829745|NCT01327651|69512916|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
37829746|NCT01327651|69512917|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
37829747|NCT01327651|69512918|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
37829748|NCT01327651|69512919|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
37829749|NCT01327651|69512920|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
37829750|NCT01327651|69512921|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
37829751|NCT01327651|69512922|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
37829752|NCT01327651|69512923|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
37829753|NCT01327651|69512924|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
37829754|NCT01327651|69512916|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
37904559|NCT00842829|69590454|FG001|Treatment Period|Unclear completion status|0|||
37904560|NCT00842829|69590455|FG002|Treatment Period|Unclear completion status|1|||
37904561|NCT00842829|69590453|FG000|Continuation Period|Adverse Event|0|||
37904562|NCT00842829|69590454|FG001|Continuation Period|Adverse Event|0|||
37829755|NCT01327651|69512917|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
37829756|NCT01327651|69512918|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
37829757|NCT01327651|69512919|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
37829758|NCT01327651|69512920|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
37829759|NCT01327651|69512921|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
37904563|NCT00842829|69590455|FG002|Continuation Period|Adverse Event|32|||
37904564|NCT00842829|69590453|FG000|Continuation Period|Lack of Efficacy|0|||
37904565|NCT00842829|69590454|FG001|Continuation Period|Lack of Efficacy|0|||
37697397|NCT02021643|69173903|FG003|Overall Study|Death|0|||
37697398|NCT02021643|69173900|FG000|Overall Study|Investigator's Discretion|1|||
37697399|NCT02021643|69173901|FG001|Overall Study|Investigator's Discretion|0|||
37697400|NCT02021643|69173902|FG002|Overall Study|Investigator's Discretion|0|||
37697401|NCT02021643|69173903|FG003|Overall Study|Investigator's Discretion|0|||
37697402|NCT02021643|69173900|FG000|Overall Study|Lack of Efficacy|7|||
37904566|NCT00842829|69590455|FG002|Continuation Period|Lack of Efficacy|6|||
37904567|NCT00842829|69590453|FG000|Continuation Period|Unstable persistent cancer pain|0|||
37904568|NCT00842829|69590454|FG001|Continuation Period|Unstable persistent cancer pain|0|||
37904569|NCT00842829|69590455|FG002|Continuation Period|Unstable persistent cancer pain|3|||
37904570|NCT00842829|69590453|FG000|Continuation Period|Withdrawal by Subject|0|||
37904571|NCT00842829|69590454|FG001|Continuation Period|Withdrawal by Subject|0|||
37904572|NCT00842829|69590455|FG002|Continuation Period|Withdrawal by Subject|10|||
37904573|NCT00842829|69590453|FG000|Continuation Period|Other|0|||
37904574|NCT00842829|69590454|FG001|Continuation Period|Other|0|||
37904575|NCT00842829|69590455|FG002|Continuation Period|Other|7|||
37904576|NCT00842829|69590453|FG000|Continuation Period|Non-compliance to study procedures|0|||
37904577|NCT00842829|69590454|FG001|Continuation Period|Non-compliance to study procedures|0|||
37904578|NCT00842829|69590455|FG002|Continuation Period|Non-compliance to study procedures|2|||
37904579|NCT00842829|69590453|FG000|Continuation Period|Non-compliance to study drug|0|||
37904580|NCT00842829|69590454|FG001|Continuation Period|Non-compliance to study drug|0|||
37904581|NCT00842829|69590455|FG002|Continuation Period|Non-compliance to study drug|1|||
37904582|NCT00653263|69590467|FG000|Overall Study|Withdrawal by Subject|1|||
37904583|NCT00653263|69590467|FG000|Overall Study|Physician Decision|1|||
37904584|NCT00842361|69590473|FG000|Overall Study|Protocol Violation|1|||
37904585|NCT00842361|69590474|FG001|Overall Study|Protocol Violation|0|||
37904586|NCT00842361|69590473|FG000|Overall Study|Unclassified|0|||
37904587|NCT00842361|69590474|FG001|Overall Study|Unclassified|2|||
37904588|NCT00841035|69590480|FG000|Phase 1 Overall Study|Physician Decision|13|||
37904589|NCT00642811|69590491|FG000|Overall Study|Adverse Event|2|||
37904590|NCT00642811|69590492|FG001|Overall Study|Adverse Event|3|||
37904591|NCT00642811|69590493|FG002|Overall Study|Adverse Event|0|||
37904592|NCT00642811|69590494|FG003|Overall Study|Adverse Event|0|||
37904593|NCT00642811|69590495|FG004|Overall Study|Adverse Event|0|||
37904594|NCT00642811|69590496|FG005|Overall Study|Adverse Event|1|||
37904595|NCT00642811|69590491|FG000|Overall Study|Developement of discontinuation criteria|0|||
37904596|NCT00642811|69590492|FG001|Overall Study|Developement of discontinuation criteria|0|||
37904597|NCT00642811|69590493|FG002|Overall Study|Developement of discontinuation criteria|0|||
37904598|NCT00642811|69590494|FG003|Overall Study|Developement of discontinuation criteria|0|||
37904599|NCT00642811|69590495|FG004|Overall Study|Developement of discontinuation criteria|1|||
37904600|NCT00642811|69590496|FG005|Overall Study|Developement of discontinuation criteria|0|||
37904601|NCT00642811|69590491|FG000|Overall Study|Severe Non-compliance to protocol|1|||
37904602|NCT00642811|69590492|FG001|Overall Study|Severe Non-compliance to protocol|0|||
37904603|NCT00642811|69590493|FG002|Overall Study|Severe Non-compliance to protocol|0|||
37904604|NCT00642811|69590494|FG003|Overall Study|Severe Non-compliance to protocol|0|||
37697403|NCT02021643|69173901|FG001|Overall Study|Lack of Efficacy|6|||
37697404|NCT02021643|69173902|FG002|Overall Study|Lack of Efficacy|0|||
37697405|NCT02021643|69173903|FG003|Overall Study|Lack of Efficacy|12|||
37697406|NCT02021643|69173900|FG000|Overall Study|Lost to Follow-up|0|||
37697407|NCT02021643|69173901|FG001|Overall Study|Lost to Follow-up|1|||
37904605|NCT00642811|69590495|FG004|Overall Study|Severe Non-compliance to protocol|0|||
37904606|NCT00642811|69590496|FG005|Overall Study|Severe Non-compliance to protocol|0|||
37697408|NCT02021643|69173902|FG002|Overall Study|Lost to Follow-up|0|||
37697409|NCT02021643|69173903|FG003|Overall Study|Lost to Follow-up|0|||
37697410|NCT02021643|69173900|FG000|Overall Study|Withdrew Consent|0|||
37697411|NCT02021643|69173901|FG001|Overall Study|Withdrew Consent|1|||
37697412|NCT02021643|69173902|FG002|Overall Study|Withdrew Consent|0|||
37697413|NCT02021643|69173903|FG003|Overall Study|Withdrew Consent|0|||
37697414|NCT02415959|69173924|FG000|Overall Study|Adverse Event|0|||
37697415|NCT02415959|69173925|FG001|Overall Study|Adverse Event|1|||
37829760|NCT01327651|69512922|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
38000940|NCT00141297|69684757|FG004|Overall Study|Progressive Disease|15|||
38000941|NCT00141297|69684758|FG005|Overall Study|Progressive Disease|2|||
38000942|NCT00141297|69684759|FG006|Overall Study|Progressive Disease|3|||
38000943|NCT00141297|69684760|FG007|Overall Study|Progressive Disease|3|||
38000944|NCT00141297|69684761|FG008|Overall Study|Progressive Disease|15|||
38000945|NCT00141297|69684762|FG009|Overall Study|Progressive Disease|6|||
38000946|NCT00141297|69684753|FG000|Overall Study|Transitioned|0|||
38000947|NCT00141297|69684754|FG001|Overall Study|Transitioned|0|||
38000948|NCT00141297|69684755|FG002|Overall Study|Transitioned|0|||
38000949|NCT00141297|69684756|FG003|Overall Study|Transitioned|0|||
38000950|NCT00141297|69684757|FG004|Overall Study|Transitioned|1|||
38000951|NCT00141297|69684758|FG005|Overall Study|Transitioned|0|||
38000952|NCT00141297|69684759|FG006|Overall Study|Transitioned|0|||
38000953|NCT00141297|69684760|FG007|Overall Study|Transitioned|0|||
38000954|NCT00141297|69684761|FG008|Overall Study|Transitioned|0|||
38000955|NCT00141297|69684762|FG009|Overall Study|Transitioned|0|||
38000956|NCT00141219|69684797|FG000|Overall Study|Protocol violations|5|||
38000957|NCT00141219|69684798|FG001|Overall Study|Protocol violations|4|||
37829761|NCT01327651|69512923|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
37829762|NCT01327651|69512924|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
37829763|NCT01327651|69512916|FG000|Post Study Follow-up|Lost to Follow-up|0|||
37829764|NCT01327651|69512917|FG001|Post Study Follow-up|Lost to Follow-up|1|||
37829765|NCT01327651|69512918|FG002|Post Study Follow-up|Lost to Follow-up|1|||
37904607|NCT00642811|69590491|FG000|Overall Study|Other|0|||
37904608|NCT00642811|69590492|FG001|Overall Study|Other|1|||
37904609|NCT00642811|69590493|FG002|Overall Study|Other|0|||
37904610|NCT00642811|69590494|FG003|Overall Study|Other|1|||
37904611|NCT00642811|69590495|FG004|Overall Study|Other|0|||
37904612|NCT00642811|69590496|FG005|Overall Study|Other|0|||
37904613|NCT00838929|69590513|FG000|Overall Study|Protocol Violation|0|||
37904614|NCT00838929|69590514|FG001|Overall Study|Protocol Violation|1|||
37904615|NCT00838929|69590515|FG002|Overall Study|Protocol Violation|0|||
37904616|NCT00838929|69590513|FG000|Overall Study|Disease progression|0|||
37904617|NCT00838929|69590514|FG001|Overall Study|Disease progression|2|||
37904618|NCT00838929|69590515|FG002|Overall Study|Disease progression|1|||
37904619|NCT00916058|69590528|FG000|Phase 1|Screen Failure|0|||
37904620|NCT00916058|69590529|FG001|Phase 1|Screen Failure|0|||
37904621|NCT00916058|69590530|FG002|Phase 1|Screen Failure|0|||
37904622|NCT00916058|69590531|FG003|Phase 1|Screen Failure|0|||
37904623|NCT00916058|69590532|FG004|Phase 1|Screen Failure|0|||
37904624|NCT00916058|69590533|FG005|Phase 1|Screen Failure|1|||
37904625|NCT00916058|69590534|FG006|Phase 1|Screen Failure|0|||
37904626|NCT00916058|69590528|FG000|Phase 2|Screen Failure|0|||
37904627|NCT00916058|69590529|FG001|Phase 2|Screen Failure|0|||
37904628|NCT00916058|69590530|FG002|Phase 2|Screen Failure|0|||
37904629|NCT00916058|69590531|FG003|Phase 2|Screen Failure|0|||
37904630|NCT00916058|69590532|FG004|Phase 2|Screen Failure|0|||
37904631|NCT00916058|69590533|FG005|Phase 2|Screen Failure|0|||
37904632|NCT00916058|69590534|FG006|Phase 2|Screen Failure|3|||
37904633|NCT00912782|69590554|FG000|Overall Study|Death|2|||
37904634|NCT00912782|69590555|FG001|Overall Study|Death|1|||
37904635|NCT00912782|69590554|FG000|Overall Study|Lost to Follow-up|0|||
38000958|NCT00141219|69684797|FG000|Overall Study|Adverse Event|8|||
38000959|NCT00141219|69684798|FG001|Overall Study|Adverse Event|6|||
38000960|NCT00141219|69684797|FG000|Overall Study|Lack of Efficacy|5|||
38000961|NCT00141219|69684798|FG001|Overall Study|Lack of Efficacy|4|||
38000962|NCT00141219|69684797|FG000|Overall Study|Withdrawal by Subject|6|||
38000963|NCT00141219|69684798|FG001|Overall Study|Withdrawal by Subject|2|||
37829766|NCT01327651|69512919|FG003|Post Study Follow-up|Lost to Follow-up|0|||
38000964|NCT00162266|69684807|FG000|Double-Blind Period|Adverse Event|5|||
37829767|NCT01327651|69512920|FG004|Post Study Follow-up|Lost to Follow-up|0|||
37904636|NCT00912782|69590555|FG001|Overall Study|Lost to Follow-up|1|||
38000965|NCT00162266|69684808|FG001|Double-Blind Period|Adverse Event|9|||
37697416|NCT02415959|69173926|FG002|Overall Study|Adverse Event|0|||
37697417|NCT02415959|69173927|FG003|Overall Study|Adverse Event|0|||
37904637|NCT00912782|69590554|FG000|Overall Study|Did not receive vascular access type|1|||
37904638|NCT00912782|69590555|FG001|Overall Study|Did not receive vascular access type|2|||
37904639|NCT00912782|69590554|FG000|Overall Study|Relocated before study completion|0|||
37904640|NCT00912782|69590555|FG001|Overall Study|Relocated before study completion|1|||
37904641|NCT03444038|69590561|FG000|Overall Study|Adverse Event|12|||
37904642|NCT03444038|69590561|FG000|Overall Study|Withdrawal by Subject|7|||
38000966|NCT00162266|69684809|FG002|Double-Blind Period|Adverse Event|11|||
38000967|NCT00162266|69684810|FG003|Double-Blind Period|Adverse Event|0|||
38000968|NCT00162266|69684807|FG000|Double-Blind Period|Death|0|||
38000969|NCT00162266|69684808|FG001|Double-Blind Period|Death|1|||
38000970|NCT00162266|69684809|FG002|Double-Blind Period|Death|0|||
38000971|NCT00162266|69684810|FG003|Double-Blind Period|Death|0|||
38000972|NCT00162266|69684807|FG000|Double-Blind Period|Lost to Follow-up|1|||
38000973|NCT00162266|69684808|FG001|Double-Blind Period|Lost to Follow-up|2|||
38000974|NCT00162266|69684809|FG002|Double-Blind Period|Lost to Follow-up|0|||
38000975|NCT00162266|69684810|FG003|Double-Blind Period|Lost to Follow-up|0|||
38000976|NCT00162266|69684807|FG000|Double-Blind Period|Other Reason|1|||
38000977|NCT00162266|69684808|FG001|Double-Blind Period|Other Reason|0|||
38000978|NCT00162266|69684809|FG002|Double-Blind Period|Other Reason|1|||
38000979|NCT00162266|69684810|FG003|Double-Blind Period|Other Reason|0|||
38000980|NCT00162266|69684807|FG000|Double-Blind Period|Lack of Efficacy|13|||
38000981|NCT00162266|69684808|FG001|Double-Blind Period|Lack of Efficacy|17|||
38000982|NCT00162266|69684809|FG002|Double-Blind Period|Lack of Efficacy|30|||
38000983|NCT00162266|69684810|FG003|Double-Blind Period|Lack of Efficacy|0|||
38000984|NCT00162266|69684807|FG000|Double-Blind Period|Withdrawal by Subject|5|||
38000985|NCT00162266|69684808|FG001|Double-Blind Period|Withdrawal by Subject|2|||
38000986|NCT00162266|69684809|FG002|Double-Blind Period|Withdrawal by Subject|6|||
38000987|NCT00162266|69684810|FG003|Double-Blind Period|Withdrawal by Subject|0|||
38000988|NCT00162266|69684807|FG000|Open-Label Period|Death|0|||
38000989|NCT00162266|69684808|FG001|Open-Label Period|Death|0|||
38000990|NCT00162266|69684809|FG002|Open-Label Period|Death|0|||
38000991|NCT00162266|69684810|FG003|Open-Label Period|Death|7|||
38000992|NCT00162266|69684807|FG000|Open-Label Period|Adverse Event|0|||
38000993|NCT00162266|69684808|FG001|Open-Label Period|Adverse Event|0|||
38000994|NCT00162266|69684809|FG002|Open-Label Period|Adverse Event|0|||
38000995|NCT00162266|69684810|FG003|Open-Label Period|Adverse Event|46|||
38000996|NCT00162266|69684807|FG000|Open-Label Period|Lack of Efficacy|0|||
38000997|NCT00162266|69684808|FG001|Open-Label Period|Lack of Efficacy|0|||
38000998|NCT00162266|69684809|FG002|Open-Label Period|Lack of Efficacy|0|||
38000999|NCT00162266|69684810|FG003|Open-Label Period|Lack of Efficacy|26|||
38001000|NCT00162266|69684807|FG000|Open-Label Period|Lost to Follow-up|0|||
38001001|NCT00162266|69684808|FG001|Open-Label Period|Lost to Follow-up|0|||
38001002|NCT00162266|69684809|FG002|Open-Label Period|Lost to Follow-up|0|||
38001003|NCT00162266|69684810|FG003|Open-Label Period|Lost to Follow-up|3|||
38001004|NCT00162266|69684807|FG000|Open-Label Period|Withdrawal by Subject|0|||
38001005|NCT00162266|69684808|FG001|Open-Label Period|Withdrawal by Subject|0|||
38001006|NCT00162266|69684809|FG002|Open-Label Period|Withdrawal by Subject|0|||
38001007|NCT00162266|69684810|FG003|Open-Label Period|Withdrawal by Subject|31|||
38001008|NCT00162266|69684807|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
38001009|NCT00162266|69684808|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
38001010|NCT00162266|69684809|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
38001011|NCT00162266|69684810|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
38001012|NCT00162266|69684807|FG000|Open-Label Period|Other Reasons|0|||
38001013|NCT00162266|69684808|FG001|Open-Label Period|Other Reasons|0|||
38001014|NCT00162266|69684809|FG002|Open-Label Period|Other Reasons|0|||
38001015|NCT00162266|69684810|FG003|Open-Label Period|Other Reasons|15|||
38001016|NCT00225212|69684862|FG000|Overall Study|Disease progression|2|||
38001017|NCT00225212|69684862|FG000|Overall Study|Death|1|||
38001018|NCT00225212|69684862|FG000|Overall Study|Adverse Event|2|||
38001019|NCT00225212|69684862|FG000|Overall Study|Intercurrent illness|1|||
38001020|NCT00162032|69684868|FG000|Overall Study|Lost to Follow-up|4|||
38001021|NCT00162032|69684869|FG001|Overall Study|Lost to Follow-up|2|||
38001022|NCT00162032|69684868|FG000|Overall Study|Reason not specified|1|||
38001023|NCT00162032|69684869|FG001|Overall Study|Reason not specified|0|||
38001024|NCT00258674|69684883|FG000|Overall Study|Death|32|||
38001025|NCT00258674|69684884|FG001|Overall Study|Death|53|||
38001026|NCT00258674|69684885|FG002|Overall Study|Death|34|||
38001027|NCT00258440|69684896|FG000|Overall Study|Withdrawal by Subject|0|||
37904643|NCT03444038|69590561|FG000|Overall Study|Lost to Follow-up|1|||
37904644|NCT03444038|69590561|FG000|Overall Study|Physician Decision|2|||
37904645|NCT03444038|69590561|FG000|Overall Study|Lack of Efficacy|7|||
37904646|NCT00911534|69590567|FG000|Overall Study|Adverse Event|4|||
37904647|NCT00911534|69590568|FG001|Overall Study|Adverse Event|4|||
37904648|NCT00911534|69590567|FG000|Overall Study|Lost to Follow-up|2|||
37904649|NCT00911534|69590568|FG001|Overall Study|Lost to Follow-up|4|||
37904650|NCT00911534|69590567|FG000|Overall Study|Withdrawal by Subject|2|||
37904651|NCT00911534|69590568|FG001|Overall Study|Withdrawal by Subject|1|||
37904652|NCT00911534|69590567|FG000|Overall Study|Lack of Efficacy|4|||
37904653|NCT00911534|69590568|FG001|Overall Study|Lack of Efficacy|1|||
37904654|NCT00911534|69590567|FG000|Overall Study|Withdrawal of consent|1|||
37904655|NCT00911534|69590568|FG001|Overall Study|Withdrawal of consent|4|||
38001028|NCT00258440|69684897|FG001|Overall Study|Withdrawal by Subject|0|||
38001029|NCT00258440|69684898|FG002|Overall Study|Withdrawal by Subject|1|||
37904656|NCT00911534|69590567|FG000|Overall Study|Other|2|||
38001030|NCT00224120|69684908|FG000|Overall Study|Adverse Event|10|||
38001031|NCT00224120|69684909|FG001|Overall Study|Adverse Event|4|||
38001032|NCT00224120|69684908|FG000|Overall Study|Protocol Violation|1|||
38001033|NCT00224120|69684909|FG001|Overall Study|Protocol Violation|0|||
38001034|NCT00224120|69684908|FG000|Overall Study|Withdrawal by Subject|5|||
38001035|NCT00224120|69684909|FG001|Overall Study|Withdrawal by Subject|10|||
38001036|NCT00224120|69684908|FG000|Overall Study|Lack of Efficacy|0|||
38001037|NCT00224120|69684909|FG001|Overall Study|Lack of Efficacy|2|||
38001038|NCT00224120|69684908|FG000|Overall Study|Lost to Follow-up|2|||
38001039|NCT00224120|69684909|FG001|Overall Study|Lost to Follow-up|3|||
38001040|NCT00224120|69684908|FG000|Overall Study|Other|4|||
38001041|NCT00224120|69684909|FG001|Overall Study|Other|5|||
38001042|NCT00257660|69684917|FG000|Overall Study|Lack of Efficacy|5|||
38001043|NCT00257660|69684918|FG001|Overall Study|Lack of Efficacy|23|||
38001044|NCT00257660|69684917|FG000|Overall Study|Withdrawal by Subject|2|||
38001045|NCT00257660|69684918|FG001|Overall Study|Withdrawal by Subject|0|||
38001046|NCT00257660|69684917|FG000|Overall Study|Lost to Follow-up|1|||
38001047|NCT00257660|69684918|FG001|Overall Study|Lost to Follow-up|0|||
38001048|NCT00257660|69684917|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
38001049|NCT00257660|69684918|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
38001050|NCT00257660|69684917|FG000|Overall Study|No longer wanted to do blood draws|1|||
38001051|NCT00257660|69684918|FG001|Overall Study|No longer wanted to do blood draws|0|||
38001052|NCT00224042|69684926|FG000|Overall Study|Adverse Event|2|||
38001053|NCT00224042|69684927|FG001|Overall Study|Adverse Event|1|||
38001054|NCT00224042|69684926|FG000|Overall Study|Protocol Violation|0|||
38001055|NCT00224042|69684927|FG001|Overall Study|Protocol Violation|1|||
38001056|NCT00224042|69684926|FG000|Overall Study|Physician Decision|0|||
38001057|NCT00224042|69684927|FG001|Overall Study|Physician Decision|1|||
38001058|NCT00224042|69684926|FG000|Overall Study|Did not meet lab incusion criteria|2|||
38001059|NCT00224042|69684927|FG001|Overall Study|Did not meet lab incusion criteria|3|||
38001060|NCT00224042|69684926|FG000|Overall Study|Other|2|||
38001061|NCT00224042|69684927|FG001|Overall Study|Other|0|||
38001062|NCT00160706|69684933|FG000|Overall Study|Adverse Event|53|||
38001063|NCT00160706|69684933|FG000|Overall Study|Adverse Event and Other Reason|105|||
38001064|NCT00160706|69684933|FG000|Overall Study|Protocol Violation|3|||
38001065|NCT00160706|69684933|FG000|Overall Study|Withdrawal by Subject|41|||
38001066|NCT00160706|69684933|FG000|Overall Study|Withdrawal by Subject and Other|12|||
38001067|NCT00160706|69684933|FG000|Overall Study|Physician Decision|10|||
38001068|NCT00160706|69684933|FG000|Overall Study|Physician Decision and Other|3|||
38001069|NCT00160706|69684933|FG000|Overall Study|Lost to Follow-up|4|||
38001070|NCT00160706|69684933|FG000|Overall Study|Lost to Follow-up and Other|1|||
38001071|NCT00160706|69684933|FG000|Overall Study|Lack of Efficacy|42|||
37904657|NCT00911534|69590568|FG001|Overall Study|Other|2|||
37904658|NCT00911300|69590576|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
37904659|NCT00911300|69590577|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
37904660|NCT00911300|69590576|FG000|Overall Study|Death|1|||
37904661|NCT00911300|69590577|FG001|Overall Study|Death|0|||
37904662|NCT00911300|69590576|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
37904663|NCT00911300|69590577|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
37904664|NCT00911300|69590576|FG000|Overall Study|Adverse Event|14|||
37904665|NCT00911300|69590577|FG001|Overall Study|Adverse Event|6|||
37904666|NCT00911300|69590576|FG000|Overall Study|Protocol Violation|3|||
37904667|NCT00911300|69590577|FG001|Overall Study|Protocol Violation|2|||
37904668|NCT00911300|69590576|FG000|Overall Study|Consent Withdrawn|4|||
37904669|NCT00911300|69590577|FG001|Overall Study|Consent Withdrawn|12|||
37904670|NCT00911300|69590576|FG000|Overall Study|Coronary Angiography Performed|1|||
37904671|NCT00911300|69590577|FG001|Overall Study|Coronary Angiography Performed|0|||
37904672|NCT00911300|69590576|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
37904673|NCT00911300|69590577|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
37904674|NCT00911300|69590576|FG000|Overall Study|Received Commercial Treatment|1|||
37904675|NCT00911300|69590577|FG001|Overall Study|Received Commercial Treatment|0|||
38001072|NCT00160706|69684933|FG000|Overall Study|Lack of Efficacy and Other|1|||
38001073|NCT00160706|69684933|FG000|Overall Study|Other Reason|11|||
38001074|NCT00257192|69684939|FG000|Overall Study|Adverse Event|21|||
38001075|NCT00257192|69684940|FG001|Overall Study|Adverse Event|10|||
38001076|NCT00257192|69684939|FG000|Overall Study|Laboratory abnormality|1|||
38001077|NCT00257192|69684940|FG001|Overall Study|Laboratory abnormality|1|||
38001078|NCT00257192|69684939|FG000|Overall Study|Lost to Follow-up|3|||
38001079|NCT00257192|69684940|FG001|Overall Study|Lost to Follow-up|3|||
38001080|NCT00257192|69684939|FG000|Overall Study|Insufficient clinical response|18|||
37904676|NCT00911300|69590576|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
37904677|NCT00911300|69590577|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
38001081|NCT00257192|69684940|FG001|Overall Study|Insufficient clinical response|18|||
38001082|NCT00257192|69684939|FG000|Overall Study|Withdrawal by Subject|14|||
38001083|NCT00257192|69684940|FG001|Overall Study|Withdrawal by Subject|2|||
38001084|NCT00257192|69684939|FG000|Overall Study|Randomized but not treated|0|||
38001085|NCT00257192|69684940|FG001|Overall Study|Randomized but not treated|1|||
38001086|NCT00257192|69684939|FG000|Overall Study|Study terminated by sponsor|1|||
38001087|NCT00257192|69684940|FG001|Overall Study|Study terminated by sponsor|0|||
38001088|NCT00257192|69684939|FG000|Overall Study|Miscellaneous|0|||
37904678|NCT00911300|69590576|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
37904679|NCT00911300|69590577|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
37904680|NCT00911300|69590576|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
37904681|NCT00911300|69590577|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
37904682|NCT00911300|69590576|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
37904683|NCT00911300|69590577|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
37904684|NCT00911300|69590576|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
37904685|NCT00911300|69590577|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
37904686|NCT00911300|69590576|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
37904687|NCT00911300|69590577|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
38001089|NCT00257192|69684940|FG001|Overall Study|Miscellaneous|4|||
38001090|NCT00256724|69684948|FG000|Overall Study|Physician Decision|2|||
38001091|NCT00256724|69684949|FG001|Overall Study|Physician Decision|5|||
38001092|NCT00256724|69684948|FG000|Overall Study|Protocol Violation|3|||
38001093|NCT00256724|69684949|FG001|Overall Study|Protocol Violation|3|||
38001094|NCT00157820|69684958|FG000|Randomized|Physician Decision|4|||
38001095|NCT00157820|69684959|FG001|Randomized|Physician Decision|2|||
38001096|NCT00157820|69684960|FG002|Randomized|Physician Decision|3|||
38001097|NCT00157820|69684958|FG000|Randomized|Withdrawal by Subject|1|||
38001098|NCT00157820|69684959|FG001|Randomized|Withdrawal by Subject|2|||
38001099|NCT00157820|69684960|FG002|Randomized|Withdrawal by Subject|3|||
38001100|NCT00157820|69684958|FG000|Randomized|Protocol Violation|2|||
38001101|NCT00157820|69684959|FG001|Randomized|Protocol Violation|1|||
38001102|NCT00157820|69684960|FG002|Randomized|Protocol Violation|2|||
38001103|NCT00157820|69684958|FG000|1st 8 Month|Death|7|||
38001104|NCT00157820|69684959|FG001|1st 8 Month|Death|8|||
38001105|NCT00157820|69684960|FG002|1st 8 Month|Death|3|||
38001106|NCT00157820|69684958|FG000|1st 8 Month|Lost to Follow-up|1|||
38001107|NCT00157820|69684959|FG001|1st 8 Month|Lost to Follow-up|2|||
38001108|NCT00157820|69684960|FG002|1st 8 Month|Lost to Follow-up|1|||
38001109|NCT00157820|69684958|FG000|1st 8 Month|Premature cross-over|0|||
38001110|NCT00157820|69684959|FG001|1st 8 Month|Premature cross-over|2|||
38001111|NCT00157820|69684960|FG002|1st 8 Month|Premature cross-over|2|||
38001112|NCT00157820|69684958|FG000|2nd 8 Months|Death|3|||
38001113|NCT00157820|69684959|FG001|2nd 8 Months|Death|1|||
38001114|NCT00157820|69684960|FG002|2nd 8 Months|Death|3|||
38001115|NCT00157820|69684958|FG000|2nd 8 Months|Lost to Follow-up|1|||
38001116|NCT00157820|69684959|FG001|2nd 8 Months|Lost to Follow-up|5|||
38001117|NCT00157820|69684960|FG002|2nd 8 Months|Lost to Follow-up|2|||
38001118|NCT00157820|69684958|FG000|2nd 8 Months|Premature cross-over|1|||
38001119|NCT00157820|69684959|FG001|2nd 8 Months|Premature cross-over|7|||
38001120|NCT00157820|69684960|FG002|2nd 8 Months|Premature cross-over|9|||
38001121|NCT00223808|69684972|FG000|Overall Study|<5 hrs therapy before discharge|3|||
38001122|NCT00223808|69684973|FG001|Overall Study|<5 hrs therapy before discharge|5|||
38001123|NCT00223808|69684974|FG002|Overall Study|<5 hrs therapy before discharge|5|||
38001124|NCT00154310|69684984|FG000|Overall Study|Adverse Event|19|||
38001125|NCT00154310|69684985|FG001|Overall Study|Adverse Event|9|||
37904688|NCT00911300|69590576|FG000|Overall Study|International Normalized Ratio Too High|0|||
37904689|NCT00911300|69590577|FG001|Overall Study|International Normalized Ratio Too High|1|||
37904690|NCT00911300|69590576|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
37904691|NCT00911300|69590577|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
37904692|NCT00911300|69590576|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
37904693|NCT00911300|69590577|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
37904694|NCT00911300|69590576|FG000|Overall Study|Physician Decision|0|||
37904695|NCT00911300|69590577|FG001|Overall Study|Physician Decision|1|||
37904696|NCT00911300|69590576|FG000|Overall Study|Treatment Stopped by Mistake|0|||
37904697|NCT00911300|69590577|FG001|Overall Study|Treatment Stopped by Mistake|1|||
37904698|NCT00911300|69590576|FG000|Overall Study|Randomized; No Study Medication Received|0|||
37904699|NCT00911300|69590577|FG001|Overall Study|Randomized; No Study Medication Received|2|||
37904700|NCT00911144|69590586|FG000|Overall Study|Withdrawal by Subject|16|||
37904701|NCT00911144|69590587|FG001|Overall Study|Withdrawal by Subject|5|||
38001126|NCT00154310|69684984|FG000|Overall Study|Lack of Efficacy|5|||
38001127|NCT00154310|69684985|FG001|Overall Study|Lack of Efficacy|4|||
38001128|NCT00154310|69684984|FG000|Overall Study|Protocol Violation|4|||
38001129|NCT00154310|69684985|FG001|Overall Study|Protocol Violation|2|||
38001130|NCT00154310|69684984|FG000|Overall Study|Withdrawal by Subject|9|||
38001131|NCT00154310|69684985|FG001|Overall Study|Withdrawal by Subject|3|||
37904702|NCT00910988|69590597|FG000|Overall Study|Lost to Follow-up|2|||
38001132|NCT00154310|69684984|FG000|Overall Study|Lost to Follow-up|0|||
38001133|NCT00154310|69684985|FG001|Overall Study|Lost to Follow-up|8|||
37904703|NCT00910988|69590598|FG001|Overall Study|Lost to Follow-up|4|||
38001134|NCT00154310|69684984|FG000|Overall Study|Administrative problems|0|||
38001135|NCT00154310|69684985|FG001|Overall Study|Administrative problems|1|||
38001136|NCT00154310|69684984|FG000|Overall Study|Death|0|||
38001137|NCT00154310|69684985|FG001|Overall Study|Death|1|||
37904704|NCT00910988|69590599|FG002|Overall Study|Lost to Follow-up|3|||
37904705|NCT00910988|69590600|FG003|Overall Study|Lost to Follow-up|0|||
37904706|NCT00644059|69590629|FG000|Overall Study|Lost to Follow-up|37|||
37904707|NCT00644059|69590630|FG001|Overall Study|Lost to Follow-up|34|||
37904708|NCT00644059|69590631|FG002|Overall Study|Lost to Follow-up|16|||
37904709|NCT00644059|69590629|FG000|Overall Study|Withdrawal by Subject|52|||
38001146|NCT03771352|69685000|FG000|Overall Study|Screen failure|2|||
38001147|NCT03771352|69685000|FG000|Overall Study|Withdrawal by Subject|2|||
38001148|NCT03770728|69685008|FG000|Overall Study|Adverse Event|1|||
38001149|NCT03770728|69685009|FG001|Overall Study|Adverse Event|0|||
38001150|NCT03770728|69685010|FG002|Overall Study|Adverse Event|1|||
38001151|NCT03770728|69685011|FG003|Overall Study|Adverse Event|0|||
38001152|NCT03770728|69685008|FG000|Overall Study|Poor compliance to protocol|0|||
38001153|NCT03770728|69685009|FG001|Overall Study|Poor compliance to protocol|0|||
38001154|NCT03770728|69685010|FG002|Overall Study|Poor compliance to protocol|1|||
38001155|NCT03770728|69685011|FG003|Overall Study|Poor compliance to protocol|0|||
38001156|NCT03770728|69685008|FG000|Overall Study|Withdrawal by Subject|13|||
38001157|NCT03770728|69685009|FG001|Overall Study|Withdrawal by Subject|8|||
38001158|NCT03770728|69685010|FG002|Overall Study|Withdrawal by Subject|9|||
38001159|NCT03770728|69685011|FG003|Overall Study|Withdrawal by Subject|13|||
38001160|NCT03770728|69685008|FG000|Overall Study|Other than specified|24|||
38001161|NCT03770728|69685009|FG001|Overall Study|Other than specified|23|||
38001162|NCT03770728|69685010|FG002|Overall Study|Other than specified|21|||
38001163|NCT03770728|69685011|FG003|Overall Study|Other than specified|22|||
38001164|NCT03769090|69685026|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
38001165|NCT03769090|69685027|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
38001166|NCT03769090|69685028|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
38001167|NCT03769090|69685026|FG000|Overall Study|Withdrawal by Subject|52|||
38001168|NCT03769090|69685027|FG001|Overall Study|Withdrawal by Subject|62|||
38001169|NCT03769090|69685028|FG002|Overall Study|Withdrawal by Subject|74|||
38001170|NCT03769090|69685026|FG000|Overall Study|Death|4|||
38001171|NCT03769090|69685027|FG001|Overall Study|Death|2|||
38001172|NCT03769090|69685028|FG002|Overall Study|Death|2|||
38001173|NCT03769090|69685026|FG000|Overall Study|Adverse Event|7|||
38001174|NCT03769090|69685027|FG001|Overall Study|Adverse Event|7|||
38001175|NCT03769090|69685028|FG002|Overall Study|Adverse Event|8|||
38001176|NCT03769090|69685026|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
38001177|NCT03769090|69685027|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
38001178|NCT03769090|69685028|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
38001179|NCT03769090|69685026|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
38001180|NCT03769090|69685027|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
38001181|NCT03769090|69685028|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
38001182|NCT03769090|69685026|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
38001183|NCT03769090|69685027|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
38001184|NCT03769090|69685028|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
38001185|NCT03769090|69685026|FG000|Overall Study|Protocol Violation|5|||
38001186|NCT03769090|69685027|FG001|Overall Study|Protocol Violation|6|||
38001187|NCT03769090|69685028|FG002|Overall Study|Protocol Violation|8|||
38001188|NCT03769090|69685026|FG000|Overall Study|Pregnancy|1|||
37904710|NCT00644059|69590630|FG001|Overall Study|Withdrawal by Subject|60|||
37904711|NCT00644059|69590631|FG002|Overall Study|Withdrawal by Subject|30|||
37904712|NCT00644059|69590629|FG000|Overall Study|Adverse Event|8|||
38001189|NCT03769090|69685027|FG001|Overall Study|Pregnancy|0|||
38001190|NCT03769090|69685028|FG002|Overall Study|Pregnancy|3|||
38001191|NCT03769090|69685026|FG000|Overall Study|Lost to Follow-up|19|||
38001192|NCT03769090|69685027|FG001|Overall Study|Lost to Follow-up|25|||
38001193|NCT03769090|69685028|FG002|Overall Study|Lost to Follow-up|21|||
38001194|NCT03769090|69685026|FG000|Overall Study|Condition under investigation worsened|2|||
38001195|NCT03769090|69685027|FG001|Overall Study|Condition under investigation worsened|0|||
38001196|NCT03769090|69685028|FG002|Overall Study|Condition under investigation worsened|1|||
38001197|NCT03769090|69685026|FG000|Overall Study|Lack of Efficacy|1|||
38001198|NCT03769090|69685027|FG001|Overall Study|Lack of Efficacy|2|||
38001199|NCT03769090|69685028|FG002|Overall Study|Lack of Efficacy|2|||
38001200|NCT03769090|69685026|FG000|Overall Study|Other reasons|8|||
38001201|NCT03769090|69685027|FG001|Overall Study|Other reasons|12|||
38001202|NCT03769090|69685028|FG002|Overall Study|Other reasons|15|||
37904713|NCT00644059|69590630|FG001|Overall Study|Adverse Event|5|||
38001203|NCT03559270|69685052|FG000|Overall Study|Adverse Event|6|||
38001204|NCT03559270|69685053|FG001|Overall Study|Adverse Event|5|||
38001205|NCT03559270|69685054|FG002|Overall Study|Adverse Event|3|||
38001206|NCT03559270|69685055|FG003|Overall Study|Adverse Event|0|||
38001207|NCT03559270|69685052|FG000|Overall Study|Lack of Efficacy|34|||
38001208|NCT03559270|69685053|FG001|Overall Study|Lack of Efficacy|52|||
38001209|NCT03559270|69685054|FG002|Overall Study|Lack of Efficacy|37|||
38001210|NCT03559270|69685055|FG003|Overall Study|Lack of Efficacy|2|||
38001211|NCT03559270|69685052|FG000|Overall Study|Death|0|||
38001212|NCT03559270|69685053|FG001|Overall Study|Death|2|||
38001213|NCT03559270|69685054|FG002|Overall Study|Death|0|||
38001214|NCT03559270|69685055|FG003|Overall Study|Death|0|||
38001215|NCT03559270|69685052|FG000|Overall Study|Lost to Follow-up|16|||
38001216|NCT03559270|69685053|FG001|Overall Study|Lost to Follow-up|4|||
38001217|NCT03559270|69685054|FG002|Overall Study|Lost to Follow-up|12|||
38001218|NCT03559270|69685055|FG003|Overall Study|Lost to Follow-up|3|||
38001219|NCT03559270|69685052|FG000|Overall Study|Sponsor Decision|38|||
38001220|NCT03559270|69685053|FG001|Overall Study|Sponsor Decision|31|||
38001221|NCT03559270|69685054|FG002|Overall Study|Sponsor Decision|35|||
38001222|NCT03559270|69685055|FG003|Overall Study|Sponsor Decision|18|||
38001223|NCT03559270|69685052|FG000|Overall Study|Withdrawal by Subject|19|||
38001224|NCT03559270|69685053|FG001|Overall Study|Withdrawal by Subject|21|||
38001225|NCT03559270|69685054|FG002|Overall Study|Withdrawal by Subject|18|||
38001226|NCT03559270|69685055|FG003|Overall Study|Withdrawal by Subject|7|||
38001227|NCT03559270|69685052|FG000|Overall Study|Physician Decision|3|||
38001228|NCT03559270|69685053|FG001|Overall Study|Physician Decision|2|||
38001229|NCT03559270|69685054|FG002|Overall Study|Physician Decision|1|||
38001230|NCT03559270|69685055|FG003|Overall Study|Physician Decision|0|||
38001231|NCT03559270|69685052|FG000|Overall Study|Pregnancy|0|||
38001232|NCT03559270|69685053|FG001|Overall Study|Pregnancy|1|||
38001233|NCT03559270|69685054|FG002|Overall Study|Pregnancy|0|||
38001234|NCT03559270|69685055|FG003|Overall Study|Pregnancy|0|||
38001235|NCT03559270|69685052|FG000|Overall Study|Protocol Violation|1|||
38001236|NCT03559270|69685053|FG001|Overall Study|Protocol Violation|0|||
38001237|NCT03559270|69685054|FG002|Overall Study|Protocol Violation|2|||
38001238|NCT03559270|69685055|FG003|Overall Study|Protocol Violation|0|||
38001239|NCT00114777|69685110|FG000|Randomization to Month 36|Death|10|||
38001240|NCT00114777|69685111|FG001|Randomization to Month 36|Death|4|||
38001241|NCT00114777|69685112|FG002|Randomization to Month 36|Death|3|||
38001242|NCT00114777|69685110|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
38001243|NCT00114777|69685111|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
38001244|NCT00114777|69685112|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
38001245|NCT00114777|69685110|FG000|Randomization to Month 36|Lack of Efficacy|19|||
38001246|NCT00114777|69685111|FG001|Randomization to Month 36|Lack of Efficacy|15|||
37697418|NCT02415959|69173928|FG004|Overall Study|Adverse Event|0|||
37904714|NCT00644059|69590631|FG002|Overall Study|Adverse Event|1|||
37904715|NCT00644059|69590629|FG000|Overall Study|Inappropriate Enrollment|1|||
37904716|NCT00644059|69590630|FG001|Overall Study|Inappropriate Enrollment|3|||
37904717|NCT00644059|69590631|FG002|Overall Study|Inappropriate Enrollment|0|||
37904718|NCT00644059|69590629|FG000|Overall Study|Protocol Deviation/violation|20|||
37904719|NCT00644059|69590630|FG001|Overall Study|Protocol Deviation/violation|19|||
37904720|NCT00644059|69590631|FG002|Overall Study|Protocol Deviation/violation|15|||
37904721|NCT00644059|69590629|FG000|Overall Study|Unable to classify|6|||
37904722|NCT00644059|69590630|FG001|Overall Study|Unable to classify|2|||
37904723|NCT00644059|69590631|FG002|Overall Study|Unable to classify|3|||
37904724|NCT00643279|69590682|FG000|Overall Study|Death|13|||
37904725|NCT00643279|69590683|FG001|Overall Study|Death|11|||
37904726|NCT00643279|69590682|FG000|Overall Study|Withdrawal by Subject|3|||
37904727|NCT00643279|69590683|FG001|Overall Study|Withdrawal by Subject|0|||
37904728|NCT00643279|69590682|FG000|Overall Study|Lost to Follow-up|0|||
37904729|NCT00643279|69590683|FG001|Overall Study|Lost to Follow-up|1|||
37904730|NCT00643279|69590682|FG000|Overall Study|Physician Decision|0|||
37904731|NCT00643279|69590683|FG001|Overall Study|Physician Decision|1|||
37904732|NCT00910910|69590693|FG000|Overall Study|Adverse Event|63|||
37904733|NCT00910910|69590694|FG001|Overall Study|Adverse Event|35|||
37904734|NCT00910910|69590693|FG000|Overall Study|PD without histologic change|27|||
37904735|NCT00910910|69590694|FG001|Overall Study|PD without histologic change|23|||
37904736|NCT00910910|69590693|FG000|Overall Study|PD with histologic change|0|||
37904737|NCT00910910|69590694|FG001|Overall Study|PD with histologic change|2|||
37904738|NCT00910910|69590693|FG000|Overall Study|Withdrawal by Subject|7|||
37904739|NCT00910910|69590694|FG001|Overall Study|Withdrawal by Subject|5|||
37904740|NCT00910910|69590693|FG000|Overall Study|Lost to Follow-up|2|||
37904741|NCT00910910|69590694|FG001|Overall Study|Lost to Follow-up|2|||
37904742|NCT00910910|69590693|FG000|Overall Study|Death|9|||
37904743|NCT00910910|69590694|FG001|Overall Study|Death|3|||
37904744|NCT00910910|69590693|FG000|Overall Study|Protocol Violation|2|||
38001247|NCT00114777|69685112|FG002|Randomization to Month 36|Lack of Efficacy|17|||
38001248|NCT00114777|69685110|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
37904745|NCT00910910|69590694|FG001|Overall Study|Protocol Violation|2|||
38001249|NCT00114777|69685111|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
37829768|NCT01327651|69512921|FG005|Post Study Follow-up|Lost to Follow-up|0|||
37829769|NCT01327651|69512922|FG006|Post Study Follow-up|Lost to Follow-up|4|||
37829770|NCT01327651|69512923|FG007|Post Study Follow-up|Lost to Follow-up|1|||
37829771|NCT01327651|69512924|FG008|Post Study Follow-up|Lost to Follow-up|2|||
37829772|NCT00105443|69512965|FG000|Double-Blind Treatment|Adverse Event|1|||
37829773|NCT00105443|69512966|FG001|Double-Blind Treatment|Adverse Event|0|||
37904746|NCT00910910|69590693|FG000|Overall Study|Completed 13 cycles of treatment|0|||
37904747|NCT00910910|69590694|FG001|Overall Study|Completed 13 cycles of treatment|118|||
37904748|NCT00910910|69590693|FG000|Overall Study|Other|114|||
37904749|NCT00910910|69590694|FG001|Overall Study|Other|32|||
37904750|NCT00910910|69590693|FG000|Overall Study|Untreated before cycle 1|1|||
37904751|NCT00910910|69590694|FG001|Overall Study|Untreated before cycle 1|2|||
37904752|NCT00911768|69590702|FG000|Overall Study|Protocol Violation|5|||
37904753|NCT00911768|69590703|FG001|Overall Study|Protocol Violation|4|||
37904754|NCT00911768|69590702|FG000|Overall Study|Withdrawal by Subject|1|||
37904755|NCT00911768|69590703|FG001|Overall Study|Withdrawal by Subject|0|||
37904756|NCT00909038|69590709|FG000|Overall Study|Protocol Violation|187|||
37904757|NCT00909038|69590709|FG000|Overall Study|Non-evaluable Subjects|230|||
37904758|NCT00909428|69590716|FG000|Overall Study|Lost to Follow-up|13|||
37904759|NCT00909428|69590717|FG001|Overall Study|Lost to Follow-up|10|||
37904760|NCT00909428|69590718|FG002|Overall Study|Lost to Follow-up|9|||
37904761|NCT00908960|69590728|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
37904762|NCT00908960|69590729|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
37904763|NCT00908960|69590730|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
37904764|NCT00650767|69590748|FG000|Overall Study|Adverse Event|0|||
37904765|NCT00650767|69590749|FG001|Overall Study|Adverse Event|3|||
37904766|NCT00650767|69590750|FG002|Overall Study|Adverse Event|10|||
37904767|NCT00650767|69590751|FG003|Overall Study|Adverse Event|8|||
37904768|NCT00650767|69590748|FG000|Overall Study|Death|1|||
37904769|NCT00650767|69590749|FG001|Overall Study|Death|0|||
37904770|NCT00650767|69590750|FG002|Overall Study|Death|0|||
37904771|NCT00650767|69590751|FG003|Overall Study|Death|0|||
37904772|NCT00650767|69590748|FG000|Overall Study|Withdrawal by Subject|2|||
37904773|NCT00650767|69590749|FG001|Overall Study|Withdrawal by Subject|4|||
37904774|NCT00650767|69590750|FG002|Overall Study|Withdrawal by Subject|3|||
37904775|NCT00650767|69590751|FG003|Overall Study|Withdrawal by Subject|3|||
37904776|NCT00650767|69590748|FG000|Overall Study|Lost to Follow-up|1|||
37904777|NCT00650767|69590749|FG001|Overall Study|Lost to Follow-up|1|||
37904778|NCT00650767|69590750|FG002|Overall Study|Lost to Follow-up|1|||
37904779|NCT00650767|69590751|FG003|Overall Study|Lost to Follow-up|0|||
37904780|NCT00650767|69590748|FG000|Overall Study|Other|1|||
37904781|NCT00650767|69590749|FG001|Overall Study|Other|1|||
37904782|NCT00650767|69590750|FG002|Overall Study|Other|0|||
37904783|NCT00650767|69590751|FG003|Overall Study|Other|0|||
37904784|NCT00973349|69590777|FG000|Overall Study|Adverse Event|0|||
37904785|NCT00973349|69590778|FG001|Overall Study|Adverse Event|0|||
37904786|NCT00973349|69590779|FG002|Overall Study|Adverse Event|0|||
37904787|NCT00973349|69590780|FG003|Overall Study|Adverse Event|0|||
37904788|NCT00973349|69590781|FG004|Overall Study|Adverse Event|1|||
37904789|NCT00973349|69590782|FG005|Overall Study|Adverse Event|0|||
37904790|NCT00973349|69590783|FG006|Overall Study|Adverse Event|0|||
37904791|NCT00973349|69590784|FG007|Overall Study|Adverse Event|0|||
37904792|NCT00973349|69590785|FG008|Overall Study|Adverse Event|1|||
37904793|NCT00973349|69590786|FG009|Overall Study|Adverse Event|0|||
37904794|NCT00973349|69590787|FG010|Overall Study|Adverse Event|0|||
37904795|NCT00973349|69590788|FG011|Overall Study|Adverse Event|0|||
37904796|NCT00973349|69590789|FG012|Overall Study|Adverse Event|0|||
37904797|NCT00973349|69590790|FG013|Overall Study|Adverse Event|0|||
38001250|NCT00114777|69685112|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
38001251|NCT00114777|69685110|FG000|Randomization to Month 36|Adverse Event|34|||
38001252|NCT00114777|69685111|FG001|Randomization to Month 36|Adverse Event|35|||
37904798|NCT00973349|69590791|FG014|Overall Study|Adverse Event|1|||
37904799|NCT00973349|69590792|FG015|Overall Study|Adverse Event|0|||
37904800|NCT00973349|69590777|FG000|Overall Study|Withdrawal by Subject|1|||
37904801|NCT00973349|69590778|FG001|Overall Study|Withdrawal by Subject|2|||
37904802|NCT00973349|69590779|FG002|Overall Study|Withdrawal by Subject|2|||
37904803|NCT00973349|69590780|FG003|Overall Study|Withdrawal by Subject|3|||
37829774|NCT00105443|69512967|FG002|Double-Blind Treatment|Adverse Event|0|||
37829775|NCT00105443|69512968|FG003|Double-Blind Treatment|Adverse Event|0|||
37829776|NCT00105443|69512965|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
37829777|NCT00105443|69512966|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
37904804|NCT00973349|69590781|FG004|Overall Study|Withdrawal by Subject|2|||
37904805|NCT00973349|69590782|FG005|Overall Study|Withdrawal by Subject|0|||
37904806|NCT00973349|69590783|FG006|Overall Study|Withdrawal by Subject|2|||
37904807|NCT00973349|69590784|FG007|Overall Study|Withdrawal by Subject|2|||
37904808|NCT00973349|69590785|FG008|Overall Study|Withdrawal by Subject|0|||
37829778|NCT00105443|69512967|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
38001253|NCT00114777|69685112|FG002|Randomization to Month 36|Adverse Event|44|||
38001254|NCT00114777|69685110|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
38001255|NCT00114777|69685111|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
38001256|NCT00114777|69685112|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
38001257|NCT00114777|69685110|FG000|Randomization to Month 36|Other|9|||
38001258|NCT00114777|69685111|FG001|Randomization to Month 36|Other|3|||
38001259|NCT00114777|69685112|FG002|Randomization to Month 36|Other|12|||
38001260|NCT00114777|69685110|FG000|Long-Term Extension to Month 84|Death|8|||
38001261|NCT00114777|69685111|FG001|Long-Term Extension to Month 84|Death|13|||
38001262|NCT00114777|69685112|FG002|Long-Term Extension to Month 84|Death|7|||
38001263|NCT00114777|69685110|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
38001264|NCT00114777|69685111|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
38001265|NCT00114777|69685112|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
38001266|NCT00114777|69685110|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
38001267|NCT00114777|69685111|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
38001268|NCT00114777|69685112|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
38001269|NCT00114777|69685110|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
38001270|NCT00114777|69685111|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
38001271|NCT00114777|69685112|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
38001272|NCT00114777|69685110|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
38001273|NCT00114777|69685111|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
38001274|NCT00114777|69685112|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
38001275|NCT00114777|69685110|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
38001276|NCT00114777|69685111|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
38001277|NCT00114777|69685112|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
38001278|NCT00114777|69685110|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
38001279|NCT00114777|69685111|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
38001280|NCT00114777|69685112|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
38001281|NCT00114777|69685110|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
38001282|NCT00114777|69685111|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
38001283|NCT00114777|69685112|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
38001284|NCT00114777|69685110|FG000|Long-Term Extension to Month 84|Other|2|||
38001285|NCT00114777|69685111|FG001|Long-Term Extension to Month 84|Other|0|||
38001286|NCT00114777|69685112|FG002|Long-Term Extension to Month 84|Other|2|||
38001287|NCT00139737|69685121|FG000|Overall Study|Withdrawal by Subject|190|||
38001288|NCT00139737|69685121|FG000|Overall Study|Adverse Event|58|||
38001289|NCT00139737|69685121|FG000|Overall Study|Lack of Efficacy|40|||
38001290|NCT00139737|69685121|FG000|Overall Study|Lost to Follow-up|8|||
38001291|NCT00139737|69685121|FG000|Overall Study|Death|3|||
38001292|NCT00139737|69685121|FG000|Overall Study|Laboratory Abnormality|2|||
38001293|NCT00139737|69685121|FG000|Overall Study|Protocol Violation|18|||
38001294|NCT00139737|69685121|FG000|Overall Study|Withdrew During Screening Phase|8|||
38001295|NCT00139737|69685121|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
38001296|NCT00139737|69685121|FG000|Overall Study|Screened, Not Treated|13|||
38001297|NCT00122187|69685127|FG000|Overall Study|Withdrew because of resource limitations|2|||
38001298|NCT00122187|69685128|FG001|Overall Study|Withdrew because of resource limitations|2|||
38001299|NCT00139659|69685138|FG000|Overall Study|Adverse Event|12|||
38001300|NCT00139659|69685139|FG001|Overall Study|Adverse Event|1|||
38001301|NCT00139659|69685138|FG000|Overall Study|Lack of Efficacy|1|||
38001302|NCT00139659|69685139|FG001|Overall Study|Lack of Efficacy|1|||
38001303|NCT00139659|69685138|FG000|Overall Study|Lost to Follow-up|7|||
38001304|NCT00139659|69685139|FG001|Overall Study|Lost to Follow-up|3|||
38001305|NCT00139659|69685138|FG000|Overall Study|Reason not Specified|6|||
38001306|NCT00139659|69685139|FG001|Overall Study|Reason not Specified|3|||
38001307|NCT00139659|69685138|FG000|Overall Study|Withdrawal by Subject|14|||
38001308|NCT00139659|69685139|FG001|Overall Study|Withdrawal by Subject|10|||
38001309|NCT00137631|69685151|FG000|Overall Study|Lost to Follow-up|37|||
38001310|NCT00137631|69685152|FG001|Overall Study|Lost to Follow-up|41|||
38001311|NCT00114231|69685160|FG000|Overall Study|No consent|2|||
38001312|NCT00114231|69685161|FG001|Overall Study|No consent|0|||
38001313|NCT00114231|69685160|FG000|Overall Study|QARC requirement not met|1|||
38001314|NCT00114231|69685161|FG001|Overall Study|QARC requirement not met|0|||
38001315|NCT00114231|69685160|FG000|Overall Study|Suspected metastatic disease|1|||
38001316|NCT00114231|69685161|FG001|Overall Study|Suspected metastatic disease|0|||
38001317|NCT00114231|69685160|FG000|Overall Study|No adenocarcinoma|1|||
38001318|NCT00114231|69685161|FG001|Overall Study|No adenocarcinoma|0|||
38001319|NCT00114231|69685160|FG000|Overall Study|Low creatinine clearance|0|||
38001320|NCT00114231|69685161|FG001|Overall Study|Low creatinine clearance|1|||
38001321|NCT00114231|69685160|FG000|Overall Study|Tumor size > 4cm|1|||
38001322|NCT00114231|69685161|FG001|Overall Study|Tumor size > 4cm|0|||
38001323|NCT00114231|69685160|FG000|Overall Study|Tumor fixed on digital exam|0|||
38001324|NCT00114231|69685161|FG001|Overall Study|Tumor fixed on digital exam|1|||
38001325|NCT00114231|69685160|FG000|Overall Study|No Absolute Neutrophil Count|2|||
38001326|NCT00114231|69685161|FG001|Overall Study|No Absolute Neutrophil Count|0|||
38001327|NCT00114231|69685160|FG000|Overall Study|Biopsy done after registration|1|||
38001328|NCT00114231|69685161|FG001|Overall Study|Biopsy done after registration|0|||
38001329|NCT00113919|69685166|FG000|Overall Study|Physician Decision|8|||
38001330|NCT00113919|69685166|FG000|Overall Study|Death|6|||
38001331|NCT00113841|69685172|FG000|Overall Study|Disease progression|0|||
38001332|NCT00113841|69685173|FG001|Overall Study|Disease progression|2|||
38001333|NCT00113841|69685172|FG000|Overall Study|Non-compliant|1|||
38001334|NCT00113841|69685173|FG001|Overall Study|Non-compliant|0|||
38001335|NCT00113607|69685181|FG000|Overall Study|Adverse Event|40|||
38001336|NCT00113607|69685182|FG001|Overall Study|Adverse Event|71|||
38001337|NCT00113607|69685181|FG000|Overall Study|Death|8|||
38001338|NCT00113607|69685182|FG001|Overall Study|Death|8|||
38001339|NCT00113607|69685181|FG000|Overall Study|Withdrawal by Subject|50|||
38001340|NCT00113607|69685182|FG001|Overall Study|Withdrawal by Subject|58|||
38001341|NCT00113607|69685181|FG000|Overall Study|Lost to Follow-up|0|||
38001342|NCT00113607|69685182|FG001|Overall Study|Lost to Follow-up|2|||
38001343|NCT00113607|69685181|FG000|Overall Study|Disease Progression|180|||
38001344|NCT00113607|69685182|FG001|Overall Study|Disease Progression|142|||
38001345|NCT00113607|69685181|FG000|Overall Study|Complete Response (Confirmed)|14|||
38001346|NCT00113607|69685182|FG001|Overall Study|Complete Response (Confirmed)|24|||
38001347|NCT00113607|69685181|FG000|Overall Study|Other|43|||
38001348|NCT00113607|69685182|FG001|Overall Study|Other|32|||
38001349|NCT00113529|69685189|FG000|Overall Study|Adverse Event|4|||
38001350|NCT00113529|69685189|FG000|Overall Study|Lack of Efficacy|20|||
38001351|NCT00113529|69685189|FG000|Overall Study|Decision of sponsor|6|||
38001352|NCT00113529|69685189|FG000|Overall Study|Withdrawal by Subject|4|||
38001353|NCT00134901|69685195|FG000|Overall Study|Lost to Follow-up|5|||
38001354|NCT00134901|69685196|FG001|Overall Study|Lost to Follow-up|5|||
38001355|NCT00134901|69685195|FG000|Overall Study|discontinued intervention|12|||
38001356|NCT00134901|69685196|FG001|Overall Study|discontinued intervention|10|||
38001357|NCT00122109|69685206|FG000|Overall Study|Did not meet criteria|6|||
38001358|NCT00122109|69685207|FG001|Overall Study|Did not meet criteria|7|||
38001359|NCT00113373|69685216|FG000|Overall Study|Ineligible: wrong primary|1|||
38001360|NCT00113373|69685216|FG000|Overall Study|Ineligible: second primary|1|||
38001361|NCT00113373|69685216|FG000|Overall Study|Never Treated|1|||
38001362|NCT00113295|69685227|FG000|Overall Study|Adverse Event|4|||
38001363|NCT00113295|69685228|FG001|Overall Study|Adverse Event|1|||
37904809|NCT00973349|69590786|FG009|Overall Study|Withdrawal by Subject|2|||
37904810|NCT00973349|69590787|FG010|Overall Study|Withdrawal by Subject|0|||
37904811|NCT00973349|69590788|FG011|Overall Study|Withdrawal by Subject|1|||
38001364|NCT00113295|69685227|FG000|Overall Study|Unrelated Medical Illness|1|||
38001365|NCT00113295|69685228|FG001|Overall Study|Unrelated Medical Illness|0|||
37904812|NCT00973349|69590789|FG012|Overall Study|Withdrawal by Subject|0|||
37904813|NCT00973349|69590790|FG013|Overall Study|Withdrawal by Subject|0|||
37904814|NCT00973349|69590791|FG014|Overall Study|Withdrawal by Subject|0|||
37904815|NCT00973349|69590792|FG015|Overall Study|Withdrawal by Subject|0|||
38001366|NCT00112905|69685236|FG000|Overall Study|Adverse Event|4|||
38001367|NCT00112905|69685236|FG000|Overall Study|Death|1|||
38001368|NCT00112905|69685236|FG000|Overall Study|Ineligibility|5|||
38001369|NCT00112905|69685236|FG000|Overall Study|Alternative treatment|1|||
37829779|NCT00105443|69512968|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
37829780|NCT00105443|69512965|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
37829781|NCT00105443|69512966|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
37829782|NCT00105443|69512967|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
37829783|NCT00105443|69512968|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
37829784|NCT00105443|69512965|FG000|Double-Blind Treatment|Physician Decision|1|||
37829785|NCT00105443|69512966|FG001|Double-Blind Treatment|Physician Decision|0|||
37829786|NCT00105443|69512967|FG002|Double-Blind Treatment|Physician Decision|2|||
37829787|NCT00105443|69512968|FG003|Double-Blind Treatment|Physician Decision|0|||
37829788|NCT00105443|69512965|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
37829789|NCT00105443|69512966|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
37904816|NCT00973349|69590777|FG000|Overall Study|Lost to Follow-up|3|||
37904817|NCT00973349|69590778|FG001|Overall Study|Lost to Follow-up|1|||
38001370|NCT00112905|69685236|FG000|Overall Study|performance status was deteiorating|1|||
38001371|NCT00427895|69685244|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
38001372|NCT00427895|69685245|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
37829790|NCT00105443|69512967|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
38001373|NCT00427895|69685246|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
38001374|NCT00427895|69685247|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
38001375|NCT00427895|69685248|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
38001376|NCT00427895|69685249|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
38001377|NCT00427895|69685250|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
38001378|NCT00427895|69685251|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
38001379|NCT00427895|69685244|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
38001380|NCT00427895|69685245|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
38001381|NCT00427895|69685246|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
38001382|NCT00427895|69685247|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
38001383|NCT00427895|69685248|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
38001384|NCT00427895|69685249|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
38001385|NCT00427895|69685250|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
38001386|NCT00427895|69685251|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
38001387|NCT00427895|69685244|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
38001388|NCT00427895|69685245|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
38001389|NCT00427895|69685246|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
38001390|NCT00427895|69685247|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
38001391|NCT00427895|69685248|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
38001392|NCT00427895|69685249|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
38001393|NCT00427895|69685250|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
38001394|NCT00427895|69685251|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
38001395|NCT00427895|69685244|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
38001396|NCT00427895|69685245|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
38001397|NCT00427895|69685246|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
38001398|NCT00427895|69685247|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
38001399|NCT00427895|69685248|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
38001400|NCT00427895|69685249|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
38001401|NCT00427895|69685250|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
38001402|NCT00427895|69685251|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
38001403|NCT00427895|69685244|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
38001404|NCT00427895|69685245|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
38001405|NCT00427895|69685246|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
38001406|NCT00427895|69685247|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
38001407|NCT00427895|69685248|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
38001408|NCT00427895|69685249|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
38001409|NCT00427895|69685250|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
38001410|NCT00427895|69685251|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
38001411|NCT00427895|69685244|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
38001412|NCT00427895|69685245|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
38001413|NCT00427895|69685246|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
37829791|NCT00105443|69512968|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
37829792|NCT00105443|69512965|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
37829793|NCT00105443|69512966|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
37829794|NCT00105443|69512967|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
37829795|NCT00105443|69512968|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
37829796|NCT00105443|69512965|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
37829797|NCT00105443|69512966|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
37829798|NCT00105443|69512967|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
37829799|NCT00105443|69512968|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
37829800|NCT00105443|69512965|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
37829801|NCT00105443|69512966|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
37829802|NCT00105443|69512967|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
37904818|NCT00973349|69590779|FG002|Overall Study|Lost to Follow-up|2|||
37904819|NCT00973349|69590780|FG003|Overall Study|Lost to Follow-up|2|||
37904820|NCT00973349|69590781|FG004|Overall Study|Lost to Follow-up|1|||
37904821|NCT00973349|69590782|FG005|Overall Study|Lost to Follow-up|3|||
37904822|NCT00973349|69590783|FG006|Overall Study|Lost to Follow-up|0|||
37904823|NCT00973349|69590784|FG007|Overall Study|Lost to Follow-up|1|||
37904824|NCT00973349|69590785|FG008|Overall Study|Lost to Follow-up|2|||
37904825|NCT00973349|69590786|FG009|Overall Study|Lost to Follow-up|1|||
37904826|NCT00973349|69590787|FG010|Overall Study|Lost to Follow-up|0|||
37904827|NCT00973349|69590788|FG011|Overall Study|Lost to Follow-up|1|||
37904828|NCT00973349|69590789|FG012|Overall Study|Lost to Follow-up|0|||
37829803|NCT00105443|69512968|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
37904829|NCT00973349|69590790|FG013|Overall Study|Lost to Follow-up|0|||
37904830|NCT00973349|69590791|FG014|Overall Study|Lost to Follow-up|0|||
37904831|NCT00973349|69590792|FG015|Overall Study|Lost to Follow-up|1|||
38001414|NCT00427895|69685247|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
38001415|NCT00427895|69685248|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
38001416|NCT00427895|69685249|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
38001417|NCT00427895|69685250|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
38001418|NCT00427895|69685251|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
38001419|NCT00427895|69685244|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
38001420|NCT00427895|69685245|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
37904832|NCT00973349|69590777|FG000|Overall Study|Inappropriate enrolment|0|||
37904833|NCT00973349|69590778|FG001|Overall Study|Inappropriate enrolment|0|||
37904834|NCT00973349|69590779|FG002|Overall Study|Inappropriate enrolment|1|||
38001421|NCT00427895|69685246|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
38001422|NCT00427895|69685247|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
38001423|NCT00427895|69685248|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
38001424|NCT00427895|69685249|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
38001425|NCT00427895|69685250|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
38001426|NCT00427895|69685251|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
38001427|NCT00427895|69685244|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
38001428|NCT00427895|69685245|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
38001429|NCT00427895|69685246|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
38001430|NCT00427895|69685247|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
38001431|NCT00427895|69685248|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
38001432|NCT00427895|69685249|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
38001433|NCT00427895|69685250|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
38001434|NCT00427895|69685251|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
38001435|NCT00427895|69685244|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
38001436|NCT00427895|69685245|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
38001437|NCT00427895|69685246|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
37697419|NCT02415959|69173924|FG000|Overall Study|Protocol Violation|0|||
37697420|NCT02415959|69173925|FG001|Overall Study|Protocol Violation|0|||
37904835|NCT00973349|69590780|FG003|Overall Study|Inappropriate enrolment|0|||
37904836|NCT00973349|69590781|FG004|Overall Study|Inappropriate enrolment|0|||
37904837|NCT00973349|69590782|FG005|Overall Study|Inappropriate enrolment|0|||
37904838|NCT00973349|69590783|FG006|Overall Study|Inappropriate enrolment|0|||
37904839|NCT00973349|69590784|FG007|Overall Study|Inappropriate enrolment|0|||
37904840|NCT00973349|69590785|FG008|Overall Study|Inappropriate enrolment|0|||
37904841|NCT00973349|69590786|FG009|Overall Study|Inappropriate enrolment|2|||
38001438|NCT00427895|69685247|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
38001439|NCT00427895|69685248|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
38001440|NCT00427895|69685249|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
37697421|NCT02415959|69173926|FG002|Overall Study|Protocol Violation|0|||
37697422|NCT02415959|69173927|FG003|Overall Study|Protocol Violation|1|||
37829804|NCT00105443|69512965|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
37829805|NCT00105443|69512966|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
37829806|NCT00105443|69512967|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
37829807|NCT00105443|69512968|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
37829808|NCT00105443|69512965|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
37829809|NCT00105443|69512966|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
37829810|NCT00105443|69512967|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
37829811|NCT00105443|69512968|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
37829812|NCT00105443|69512965|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
37829813|NCT00105443|69512966|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
37829814|NCT00105443|69512967|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
37904842|NCT00973349|69590787|FG010|Overall Study|Inappropriate enrolment|0|||
37904843|NCT00973349|69590788|FG011|Overall Study|Inappropriate enrolment|0|||
37904844|NCT00973349|69590789|FG012|Overall Study|Inappropriate enrolment|1|||
37697423|NCT02415959|69173928|FG004|Overall Study|Protocol Violation|0|||
37829815|NCT00105443|69512968|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
37904845|NCT00973349|69590790|FG013|Overall Study|Inappropriate enrolment|0|||
37904846|NCT00973349|69590791|FG014|Overall Study|Inappropriate enrolment|1|||
37904847|NCT00973349|69590792|FG015|Overall Study|Inappropriate enrolment|1|||
37904848|NCT00973349|69590777|FG000|Overall Study|Protocol Violation|0|||
37904849|NCT00973349|69590778|FG001|Overall Study|Protocol Violation|0|||
37904850|NCT00973349|69590779|FG002|Overall Study|Protocol Violation|0|||
37904851|NCT00973349|69590780|FG003|Overall Study|Protocol Violation|0|||
37904852|NCT00973349|69590781|FG004|Overall Study|Protocol Violation|0|||
37904853|NCT00973349|69590782|FG005|Overall Study|Protocol Violation|0|||
37904854|NCT00973349|69590783|FG006|Overall Study|Protocol Violation|0|||
37904855|NCT00973349|69590784|FG007|Overall Study|Protocol Violation|0|||
37904856|NCT00973349|69590785|FG008|Overall Study|Protocol Violation|1|||
37904857|NCT00973349|69590786|FG009|Overall Study|Protocol Violation|0|||
37904858|NCT00973349|69590787|FG010|Overall Study|Protocol Violation|0|||
37904859|NCT00973349|69590788|FG011|Overall Study|Protocol Violation|0|||
37904860|NCT00973349|69590789|FG012|Overall Study|Protocol Violation|0|||
37904861|NCT00973349|69590790|FG013|Overall Study|Protocol Violation|0|||
37904862|NCT00973349|69590791|FG014|Overall Study|Protocol Violation|0|||
37904863|NCT00973349|69590792|FG015|Overall Study|Protocol Violation|0|||
37904864|NCT00973349|69590777|FG000|Overall Study|Unable to classify|0|||
37904865|NCT00973349|69590778|FG001|Overall Study|Unable to classify|0|||
37904866|NCT00973349|69590779|FG002|Overall Study|Unable to classify|0|||
37904867|NCT00973349|69590780|FG003|Overall Study|Unable to classify|0|||
37904868|NCT00973349|69590781|FG004|Overall Study|Unable to classify|1|||
37904869|NCT00973349|69590782|FG005|Overall Study|Unable to classify|1|||
37904870|NCT00973349|69590783|FG006|Overall Study|Unable to classify|0|||
37904871|NCT00973349|69590784|FG007|Overall Study|Unable to classify|0|||
37904872|NCT00973349|69590785|FG008|Overall Study|Unable to classify|0|||
37904873|NCT00973349|69590786|FG009|Overall Study|Unable to classify|1|||
37904874|NCT00973349|69590787|FG010|Overall Study|Unable to classify|0|||
37904875|NCT00973349|69590788|FG011|Overall Study|Unable to classify|0|||
37904876|NCT00973349|69590789|FG012|Overall Study|Unable to classify|0|||
38001441|NCT00427895|69685250|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
38001442|NCT00427895|69685251|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
38001443|NCT00427895|69685244|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
38001444|NCT00427895|69685245|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
38001445|NCT00427895|69685246|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
38001446|NCT00427895|69685247|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
38001447|NCT00427895|69685248|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
38001448|NCT00427895|69685249|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
38001449|NCT00427895|69685250|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
38001450|NCT00427895|69685251|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
38001451|NCT00427895|69685244|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
38001452|NCT00427895|69685245|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
38001453|NCT00427895|69685246|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
38001454|NCT00427895|69685247|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
38001455|NCT00427895|69685248|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
38001456|NCT00427895|69685249|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
38001457|NCT00427895|69685250|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
37904877|NCT00973349|69590790|FG013|Overall Study|Unable to classify|0|||
38001458|NCT00427895|69685251|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
38001459|NCT00427895|69685244|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
38001460|NCT00427895|69685245|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
38001461|NCT00427895|69685246|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
38001462|NCT00427895|69685247|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
38001463|NCT00427895|69685248|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
38001464|NCT00427895|69685249|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
38001465|NCT00427895|69685250|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
38001466|NCT00427895|69685251|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
38001467|NCT00427895|69685244|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
38001468|NCT00427895|69685245|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
38001469|NCT00427895|69685246|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
38001470|NCT00427895|69685247|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
38001471|NCT00427895|69685248|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
38001472|NCT00427895|69685249|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
38001473|NCT00427895|69685250|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
38001474|NCT00427895|69685251|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
38001475|NCT00427895|69685244|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
38001476|NCT00427895|69685245|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
38001477|NCT00427895|69685246|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
38001478|NCT00427895|69685247|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
38001479|NCT00427895|69685248|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
38001480|NCT00427895|69685249|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
38001481|NCT00427895|69685250|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
38001482|NCT00427895|69685251|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
38001483|NCT00427895|69685244|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
38001484|NCT00427895|69685245|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
38001485|NCT00427895|69685246|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
38001486|NCT00427895|69685247|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
38001487|NCT00427895|69685248|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
38001488|NCT00427895|69685249|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
38001489|NCT00427895|69685250|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
38001490|NCT00427895|69685251|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
38001491|NCT00427895|69685244|FG000|Vax 1/Year 1 Follow-up|Death|1|||
38001492|NCT00427895|69685245|FG001|Vax 1/Year 1 Follow-up|Death|0|||
38001493|NCT00427895|69685246|FG002|Vax 1/Year 1 Follow-up|Death|0|||
37829816|NCT00105443|69512965|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
37829817|NCT00105443|69512966|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
37829818|NCT00105443|69512967|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
37829819|NCT00105443|69512968|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
37829820|NCT00105443|69512965|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
37829821|NCT00105443|69512966|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
37829822|NCT00105443|69512967|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
37829823|NCT00105443|69512968|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
37829824|NCT00105443|69512965|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
37829825|NCT00105443|69512966|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
37829826|NCT00105443|69512967|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
37829827|NCT00105443|69512968|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
37829828|NCT00105443|69512965|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
37829829|NCT00105443|69512966|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
37829830|NCT00105443|69512967|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
37829831|NCT00105443|69512968|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
37904878|NCT00973349|69590791|FG014|Overall Study|Unable to classify|0|||
37904879|NCT00973349|69590792|FG015|Overall Study|Unable to classify|0|||
37904880|NCT00643201|69590820|FG000|Randomized, Completed 6 Months of Study|Death|20|||
37904881|NCT00643201|69590821|FG001|Randomized, Completed 6 Months of Study|Death|26|||
37904882|NCT00643201|69590820|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
37904883|NCT00643201|69590821|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
37904884|NCT00643201|69590820|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
37904885|NCT00643201|69590821|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
38001494|NCT00427895|69685247|FG003|Vax 1/Year 1 Follow-up|Death|0|||
37904886|NCT00643201|69590820|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
37904887|NCT00643201|69590821|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
38001495|NCT00427895|69685248|FG004|Vax 1/Year 1 Follow-up|Death|0|||
38001496|NCT00427895|69685249|FG005|Vax 1/Year 1 Follow-up|Death|0|||
38001497|NCT00427895|69685250|FG006|Vax 1/Year 1 Follow-up|Death|0|||
38001498|NCT00427895|69685251|FG007|Vax 1/Year 1 Follow-up|Death|0|||
38001499|NCT00427895|69685244|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
38001500|NCT00427895|69685245|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
38001501|NCT00427895|69685246|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
38001502|NCT00427895|69685247|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
38001503|NCT00427895|69685248|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
38001504|NCT00427895|69685249|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
38001505|NCT00427895|69685250|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
38001506|NCT00427895|69685251|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
38001507|NCT00427895|69685244|FG000|Vax 1/Year 1 Follow-up|Other|0|||
38001508|NCT00427895|69685245|FG001|Vax 1/Year 1 Follow-up|Other|0|||
38001509|NCT00427895|69685246|FG002|Vax 1/Year 1 Follow-up|Other|0|||
38001510|NCT00427895|69685247|FG003|Vax 1/Year 1 Follow-up|Other|2|||
38001511|NCT00427895|69685248|FG004|Vax 1/Year 1 Follow-up|Other|0|||
38001512|NCT00427895|69685249|FG005|Vax 1/Year 1 Follow-up|Other|0|||
38001513|NCT00427895|69685250|FG006|Vax 1/Year 1 Follow-up|Other|0|||
38001514|NCT00427895|69685251|FG007|Vax 1/Year 1 Follow-up|Other|0|||
38001515|NCT00427895|69685244|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
38001516|NCT00427895|69685245|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
38001517|NCT00427895|69685246|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
38001518|NCT00427895|69685247|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
38001519|NCT00427895|69685248|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
38001520|NCT00427895|69685249|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
38001521|NCT00427895|69685250|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
38001522|NCT00427895|69685251|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
38001523|NCT00425945|69685292|FG000|Overall Study|Concern about Supplement|2|||
38001524|NCT00425945|69685293|FG001|Overall Study|Concern about Supplement|0|||
38001525|NCT00425945|69685292|FG000|Overall Study|Inconvenience|0|||
38001526|NCT00425945|69685293|FG001|Overall Study|Inconvenience|2|||
38001527|NCT00425945|69685292|FG000|Overall Study|Lost to Follow-up|0|||
38001528|NCT00425945|69685293|FG001|Overall Study|Lost to Follow-up|2|||
38001529|NCT00425945|69685292|FG000|Overall Study|Began hypertension medication|1|||
38001530|NCT00425945|69685293|FG001|Overall Study|Began hypertension medication|0|||
38001531|NCT00425945|69685292|FG000|Overall Study|Began cancer treatments|1|||
38001532|NCT00425945|69685293|FG001|Overall Study|Began cancer treatments|0|||
38001533|NCT00425945|69685292|FG000|Overall Study|Moved from area|0|||
38001534|NCT00425945|69685293|FG001|Overall Study|Moved from area|1|||
38001535|NCT00416195|69685303|FG000|Overall Study|Adverse Event|1|||
38001536|NCT00416195|69685304|FG001|Overall Study|Adverse Event|2|||
38001537|NCT00416195|69685303|FG000|Overall Study|Protocol Violation|1|||
38001538|NCT00416195|69685304|FG001|Overall Study|Protocol Violation|1|||
38001539|NCT00416195|69685303|FG000|Overall Study|Other|0|||
38001540|NCT00416195|69685304|FG001|Overall Study|Other|1|||
38001541|NCT00121641|69685314|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
38001542|NCT00121641|69685315|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
38001543|NCT00121641|69685316|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
38001544|NCT00121641|69685317|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
38001545|NCT00121641|69685318|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
38001546|NCT00121641|69685314|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
38001547|NCT00121641|69685315|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
38001548|NCT00121641|69685316|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
38001549|NCT00121641|69685317|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
38001550|NCT00121641|69685318|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
38001551|NCT00121641|69685314|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
38001552|NCT00121641|69685315|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
38001553|NCT00121641|69685316|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
38001554|NCT00121641|69685317|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
38001555|NCT00121641|69685318|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
38001556|NCT00121641|69685314|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
38001557|NCT00121641|69685315|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
38001558|NCT00121641|69685316|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
38001559|NCT00121641|69685317|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
38001560|NCT00121641|69685318|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
38001561|NCT00121641|69685314|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
38001562|NCT00121641|69685315|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
38001563|NCT00121641|69685316|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
38001564|NCT00121641|69685317|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
38001565|NCT00121641|69685318|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
38001566|NCT00121641|69685314|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
38001567|NCT00121641|69685315|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
38001568|NCT00121641|69685316|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
38001569|NCT00121641|69685317|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
38001570|NCT00121641|69685318|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
38001571|NCT00121641|69685314|FG000|24-week Short-term Treatment Period|Other Reason|1|||
38001572|NCT00121641|69685315|FG001|24-week Short-term Treatment Period|Other Reason|0|||
38001573|NCT00121641|69685316|FG002|24-week Short-term Treatment Period|Other Reason|0|||
38001574|NCT00121641|69685317|FG003|24-week Short-term Treatment Period|Other Reason|0|||
37904888|NCT00643201|69590820|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
37904889|NCT00643201|69590821|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
37904890|NCT00643201|69590820|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
37904891|NCT00643201|69590821|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
37904892|NCT00643201|69590820|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
37904893|NCT00643201|69590821|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
37904894|NCT00643201|69590820|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
37904895|NCT00643201|69590821|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
37904896|NCT00643201|69590820|FG000|Randomized, Completed 6 Months of Study|Other|107|||
37904897|NCT00643201|69590821|FG001|Randomized, Completed 6 Months of Study|Other|107|||
37904898|NCT00643201|69590820|FG000|Completed Study Follow Up|Death|28|||
37904899|NCT00643201|69590821|FG001|Completed Study Follow Up|Death|34|||
37904900|NCT00643201|69590820|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
37904901|NCT00643201|69590821|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
37904902|NCT00643201|69590820|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
37904903|NCT00643201|69590821|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
37904904|NCT00643201|69590820|FG000|Completed Study Follow Up|non-specified|1|||
37904905|NCT00643201|69590821|FG001|Completed Study Follow Up|non-specified|0|||
37904906|NCT00643123|69590831|FG000|Overall Study|Lost to Follow-up|4|||
37904907|NCT00643123|69590832|FG001|Overall Study|Lost to Follow-up|0|||
37904908|NCT00643123|69590831|FG000|Overall Study|Withdrawal by Subject|1|||
37904909|NCT00643123|69590832|FG001|Overall Study|Withdrawal by Subject|1|||
37904910|NCT00968981|69590841|FG000|Overall Study|Adverse Event|2|||
37904911|NCT00968981|69590842|FG001|Overall Study|Adverse Event|0|||
37904912|NCT00968981|69590843|FG002|Overall Study|Adverse Event|0|||
37904913|NCT00968981|69590841|FG000|Overall Study|Disease Progression|14|||
37904914|NCT00968981|69590842|FG001|Overall Study|Disease Progression|16|||
37904915|NCT00968981|69590843|FG002|Overall Study|Disease Progression|13|||
37904916|NCT00968981|69590841|FG000|Overall Study|Lost to Follow-up|0|||
37904917|NCT00968981|69590842|FG001|Overall Study|Lost to Follow-up|0|||
37904918|NCT00968981|69590843|FG002|Overall Study|Lost to Follow-up|1|||
37904919|NCT00968981|69590841|FG000|Overall Study|Physician Decision|5|||
37904920|NCT00968981|69590842|FG001|Overall Study|Physician Decision|3|||
37904921|NCT00968981|69590843|FG002|Overall Study|Physician Decision|5|||
37904922|NCT00968981|69590841|FG000|Overall Study|Withdrawal by Subject|1|||
37904923|NCT00968981|69590842|FG001|Overall Study|Withdrawal by Subject|3|||
37904924|NCT00968981|69590843|FG002|Overall Study|Withdrawal by Subject|3|||
37904925|NCT00641719|69590854|FG000|Overall Study|Lack of Efficacy|1|||
37904926|NCT00641719|69590855|FG001|Overall Study|Lack of Efficacy|2|||
37904927|NCT00641719|69590854|FG000|Overall Study|Adverse Event|24|||
37904928|NCT00641719|69590855|FG001|Overall Study|Adverse Event|29|||
37904929|NCT00641719|69590854|FG000|Overall Study|Withdrawal by Subject|4|||
37904930|NCT00641719|69590855|FG001|Overall Study|Withdrawal by Subject|4|||
37904931|NCT00641719|69590854|FG000|Overall Study|Reason Not Specified|1|||
37904932|NCT00641719|69590855|FG001|Overall Study|Reason Not Specified|2|||
37904933|NCT00648895|69590863|FG000|Overall Study|Lack of Efficacy|0|||
37904934|NCT00648895|69590864|FG001|Overall Study|Lack of Efficacy|1|||
37904935|NCT00975221|69590872|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
38001575|NCT00121641|69685318|FG004|24-week Short-term Treatment Period|Other Reason|0|||
38001576|NCT00121641|69685314|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
38001577|NCT00121641|69685315|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
38001578|NCT00121641|69685316|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
38001579|NCT00121641|69685317|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
38001580|NCT00121641|69685318|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
38001581|NCT00121641|69685314|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
38001582|NCT00121641|69685315|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
38001583|NCT00121641|69685316|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
38001584|NCT00121641|69685317|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
38001585|NCT00121641|69685318|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
38001586|NCT00121641|69685314|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
38001587|NCT00121641|69685315|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
38001588|NCT00121641|69685316|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
38001589|NCT00121641|69685317|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
38001590|NCT00121641|69685318|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
38001591|NCT00121641|69685314|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
38001592|NCT00121641|69685315|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
38001593|NCT00121641|69685316|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
38001594|NCT00121641|69685317|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
38001595|NCT00121641|69685318|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
38001596|NCT00121641|69685314|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
38001597|NCT00121641|69685315|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
38001598|NCT00121641|69685316|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
38001599|NCT00121641|69685317|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
38001600|NCT00121641|69685318|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
38001601|NCT00121641|69685314|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
38001602|NCT00121641|69685315|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
38001603|NCT00121641|69685316|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
38001604|NCT00121641|69685317|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
38001605|NCT00121641|69685318|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
38001606|NCT00121641|69685314|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
38001607|NCT00121641|69685315|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
38001608|NCT00121641|69685316|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
38001609|NCT00121641|69685317|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
38001610|NCT00121641|69685318|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
38001611|NCT00121641|69685314|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
38001612|NCT00121641|69685315|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
38001613|NCT00121641|69685316|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
37904936|NCT00975221|69590873|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
37904937|NCT00975221|69590872|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
37904938|NCT00975221|69590873|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
37904939|NCT00975221|69590872|FG000|Titration Phase (Weeks 1-12)|Other|0|||
37904940|NCT00975221|69590873|FG001|Titration Phase (Weeks 1-12)|Other|1|||
37904941|NCT00975221|69590872|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
37904942|NCT00975221|69590873|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
37904943|NCT00975221|69590872|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
37904944|NCT00975221|69590873|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
37904945|NCT00975221|69590872|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
37904946|NCT00975221|69590873|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
37904947|NCT00972179|69590888|FG000|Overall Study|Noncompliance|1|||
37904948|NCT00972179|69590889|FG001|Overall Study|Noncompliance|0|||
37904949|NCT00972179|69590890|FG002|Overall Study|Noncompliance|0|||
37904950|NCT00972179|69590891|FG003|Overall Study|Noncompliance|0|||
37904951|NCT00972179|69590892|FG004|Overall Study|Noncompliance|1|||
37904952|NCT00972179|69590893|FG005|Overall Study|Noncompliance|0|||
37904953|NCT00972179|69590894|FG006|Overall Study|Noncompliance|1|||
37904954|NCT00972179|69590888|FG000|Overall Study|Withdrawal by Subject|0|||
37904955|NCT00972179|69590889|FG001|Overall Study|Withdrawal by Subject|3|||
37904956|NCT00972179|69590890|FG002|Overall Study|Withdrawal by Subject|0|||
37904957|NCT00972179|69590891|FG003|Overall Study|Withdrawal by Subject|1|||
37904958|NCT00972179|69590892|FG004|Overall Study|Withdrawal by Subject|0|||
37904959|NCT00972179|69590893|FG005|Overall Study|Withdrawal by Subject|0|||
37904960|NCT00972179|69590894|FG006|Overall Study|Withdrawal by Subject|2|||
37904961|NCT00972179|69590888|FG000|Overall Study|Administrative Decision|0|||
37904962|NCT00972179|69590889|FG001|Overall Study|Administrative Decision|0|||
37904963|NCT00972179|69590890|FG002|Overall Study|Administrative Decision|0|||
37904964|NCT00972179|69590891|FG003|Overall Study|Administrative Decision|0|||
37904965|NCT00972179|69590892|FG004|Overall Study|Administrative Decision|1|||
37904966|NCT00972179|69590893|FG005|Overall Study|Administrative Decision|0|||
37904967|NCT00972179|69590894|FG006|Overall Study|Administrative Decision|0|||
37904968|NCT00972179|69590888|FG000|Overall Study|Lost to Follow-up|0|||
37904969|NCT00972179|69590889|FG001|Overall Study|Lost to Follow-up|0|||
37904970|NCT00972179|69590890|FG002|Overall Study|Lost to Follow-up|1|||
37904971|NCT00972179|69590891|FG003|Overall Study|Lost to Follow-up|0|||
37904972|NCT00972179|69590892|FG004|Overall Study|Lost to Follow-up|0|||
37904973|NCT00972179|69590893|FG005|Overall Study|Lost to Follow-up|3|||
37904974|NCT00972179|69590894|FG006|Overall Study|Lost to Follow-up|1|||
37904975|NCT00906698|69590920|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
37904976|NCT00906698|69590921|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
37904977|NCT00906698|69590922|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
37904978|NCT00906698|69590923|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
37904979|NCT00906698|69590924|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
37904980|NCT00906698|69590925|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
37904981|NCT00906698|69590920|FG000|Overall Study|Adverse Event|0|||
37904982|NCT00906698|69590921|FG001|Overall Study|Adverse Event|0|||
37904983|NCT00906698|69590922|FG002|Overall Study|Adverse Event|2|||
37904984|NCT00906698|69590923|FG003|Overall Study|Adverse Event|0|||
37904985|NCT00906698|69590924|FG004|Overall Study|Adverse Event|4|||
37904986|NCT00906698|69590925|FG005|Overall Study|Adverse Event|1|||
37904987|NCT00906698|69590920|FG000|Overall Study|Disease progression|3|||
37904988|NCT00906698|69590921|FG001|Overall Study|Disease progression|12|||
37904989|NCT00906698|69590922|FG002|Overall Study|Disease progression|4|||
37904990|NCT00906698|69590923|FG003|Overall Study|Disease progression|4|||
37904991|NCT00906698|69590924|FG004|Overall Study|Disease progression|12|||
37904992|NCT00906698|69590925|FG005|Overall Study|Disease progression|4|||
37904993|NCT00906698|69590920|FG000|Overall Study|Withdrawal by Subject|0|||
37904994|NCT00906698|69590921|FG001|Overall Study|Withdrawal by Subject|0|||
37904995|NCT00906698|69590922|FG002|Overall Study|Withdrawal by Subject|0|||
37904996|NCT00906698|69590923|FG003|Overall Study|Withdrawal by Subject|0|||
37904997|NCT00906698|69590924|FG004|Overall Study|Withdrawal by Subject|1|||
37904998|NCT00906698|69590925|FG005|Overall Study|Withdrawal by Subject|0|||
37904999|NCT00906698|69590920|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
37905000|NCT00906698|69590921|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
37905001|NCT00906698|69590922|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
37905002|NCT00906698|69590923|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
37905003|NCT00906698|69590924|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
37905004|NCT00906698|69590925|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
37905005|NCT00972023|69590957|FG000|Overall Study|Withdrawal by Subject|1|||
37905006|NCT00971945|69590963|FG000|Overall Study|Progressive Disease|3|||
37905007|NCT00971945|69590963|FG000|Overall Study|Change in treatment policy|1|||
37905008|NCT00971945|69590963|FG000|Overall Study|Other reasons|2|||
37905009|NCT00971867|69590967|FG000|Overall Study|Adverse Event|4|||
37905010|NCT00971867|69590967|FG000|Overall Study|Participant Withdrew Consent|1|||
37905011|NCT00971867|69590967|FG000|Overall Study|Disease Progression|6|||
37905012|NCT00971321|69590973|FG000|Up to Month 7|Withdrawal by Subject|1|||
37905013|NCT00971321|69590974|FG001|Up to Month 7|Withdrawal by Subject|0|||
37905014|NCT00971321|69590973|FG000|Up to Month 7|Migrated/moved from study area|3|||
37905015|NCT00971321|69590974|FG001|Up to Month 7|Migrated/moved from study area|2|||
37905016|NCT00971321|69590973|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
37905017|NCT00971321|69590974|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
37905018|NCT00971321|69590973|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
37905019|NCT00971321|69590974|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
37905020|NCT00971321|69590973|FG000|Up to Month 11-12|Lost to Follow-up|1|||
37905021|NCT00971321|69590974|FG001|Up to Month 11-12|Lost to Follow-up|0|||
37905022|NCT00648739|69590980|FG000|Overall Study|Adverse Event|1|||
37905023|NCT00648739|69590981|FG001|Overall Study|Adverse Event|0|||
37905024|NCT00648739|69590982|FG002|Overall Study|Adverse Event|1|||
37905025|NCT00648739|69590983|FG003|Overall Study|Adverse Event|2|||
37905026|NCT00648739|69590984|FG004|Overall Study|Adverse Event|1|||
37905027|NCT00648739|69590985|FG005|Overall Study|Adverse Event|0|||
37905028|NCT00648739|69590986|FG006|Overall Study|Adverse Event|0|||
37905029|NCT00648739|69590980|FG000|Overall Study|Withdrawal by Subject|1|||
37905030|NCT00648739|69590981|FG001|Overall Study|Withdrawal by Subject|0|||
37905031|NCT00648739|69590982|FG002|Overall Study|Withdrawal by Subject|1|||
37905032|NCT00648739|69590983|FG003|Overall Study|Withdrawal by Subject|0|||
37905033|NCT00648739|69590984|FG004|Overall Study|Withdrawal by Subject|0|||
37905034|NCT00648739|69590985|FG005|Overall Study|Withdrawal by Subject|2|||
37905035|NCT00648739|69590986|FG006|Overall Study|Withdrawal by Subject|0|||
38001614|NCT00121641|69685317|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
38001615|NCT00121641|69685318|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
38001616|NCT00121641|69685314|FG000|48-month Short Term + Long Term Period|Death|0|||
38001617|NCT00121641|69685315|FG001|48-month Short Term + Long Term Period|Death|0|||
38001618|NCT00121641|69685316|FG002|48-month Short Term + Long Term Period|Death|0|||
38001619|NCT00121641|69685317|FG003|48-month Short Term + Long Term Period|Death|1|||
38001620|NCT00121641|69685318|FG004|48-month Short Term + Long Term Period|Death|0|||
38001621|NCT00121641|69685314|FG000|48-month Short Term + Long Term Period|Missing|0|||
38001622|NCT00121641|69685315|FG001|48-month Short Term + Long Term Period|Missing|0|||
38001623|NCT00121641|69685316|FG002|48-month Short Term + Long Term Period|Missing|1|||
38001624|NCT00121641|69685317|FG003|48-month Short Term + Long Term Period|Missing|0|||
38001625|NCT00121641|69685318|FG004|48-month Short Term + Long Term Period|Missing|0|||
38001626|NCT00121641|69685314|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
38001627|NCT00121641|69685315|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
38001628|NCT00121641|69685316|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
38001629|NCT00121641|69685317|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
38001630|NCT00121641|69685318|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
38001631|NCT00425555|69685334|FG000|Overall Study|Withdrawal by Subject|11|||
38001632|NCT00425555|69685335|FG001|Overall Study|Withdrawal by Subject|8|||
38001633|NCT00425555|69685334|FG000|Overall Study|Lost to Follow-up|0|||
38001634|NCT00425555|69685335|FG001|Overall Study|Lost to Follow-up|1|||
38001635|NCT00425555|69685334|FG000|Overall Study|Administrative problems|3|||
38001636|NCT00425555|69685335|FG001|Overall Study|Administrative problems|0|||
38001637|NCT00425555|69685334|FG000|Overall Study|Death|1|||
38001638|NCT00425555|69685335|FG001|Overall Study|Death|2|||
38001639|NCT00425555|69685334|FG000|Overall Study|New cancer therapy|2|||
38001640|NCT00425555|69685335|FG001|Overall Study|New cancer therapy|1|||
38001641|NCT00425555|69685334|FG000|Overall Study|Disease progression|36|||
38001642|NCT00425555|69685335|FG001|Overall Study|Disease progression|33|||
38001643|NCT00425555|69685334|FG000|Overall Study|Adverse Event|25|||
38001644|NCT00425555|69685335|FG001|Overall Study|Adverse Event|15|||
38001645|NCT00425555|69685334|FG000|Overall Study|Protocol Violation|1|||
38001646|NCT00425555|69685335|FG001|Overall Study|Protocol Violation|0|||
38001647|NCT00424775|69685344|FG000|Overall Study|Adverse Event|2|||
38001648|NCT00424775|69685345|FG001|Overall Study|Adverse Event|0|||
38001649|NCT00424775|69685344|FG000|Overall Study|Lack of Efficacy|1|||
38001650|NCT00424775|69685345|FG001|Overall Study|Lack of Efficacy|0|||
38021532|NCT03526861|69704649|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
38021533|NCT03526861|69704650|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
38021534|NCT03526861|69704651|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
38021535|NCT03526861|69704652|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
38021536|NCT03526861|69704653|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
38021537|NCT03526861|69704654|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
38021538|NCT03526861|69704655|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
38021539|NCT03526861|69704656|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
38021540|NCT03526861|69704657|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
38021541|NCT03526861|69704649|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
38021542|NCT03526861|69704650|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
38021543|NCT03526861|69704651|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
38021544|NCT03526861|69704652|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
38021545|NCT03526861|69704653|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
38021546|NCT03526861|69704654|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
37905036|NCT00648739|69590980|FG000|Overall Study|Lack of Efficacy|0|||
37905037|NCT00648739|69590981|FG001|Overall Study|Lack of Efficacy|0|||
37905038|NCT00648739|69590982|FG002|Overall Study|Lack of Efficacy|0|||
37905039|NCT00648739|69590983|FG003|Overall Study|Lack of Efficacy|0|||
37905040|NCT00648739|69590984|FG004|Overall Study|Lack of Efficacy|1|||
37905041|NCT00648739|69590985|FG005|Overall Study|Lack of Efficacy|2|||
37905042|NCT00648739|69590986|FG006|Overall Study|Lack of Efficacy|0|||
37905043|NCT00648739|69590980|FG000|Overall Study|Investigator Considered it Advisable|0|||
38021547|NCT03526861|69704655|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
37905044|NCT00648739|69590981|FG001|Overall Study|Investigator Considered it Advisable|0|||
37905045|NCT00648739|69590982|FG002|Overall Study|Investigator Considered it Advisable|0|||
38001651|NCT00121485|69685351|FG000|Overall Study|Not implanted|1|||
38001652|NCT00121485|69685352|FG001|Overall Study|Not implanted|5|||
38001653|NCT00121485|69685351|FG000|Overall Study|Crossover|0|||
38001654|NCT00121485|69685352|FG001|Overall Study|Crossover|2|||
38001655|NCT01763866|69685383|FG000|Overall Study|Withdrawal by Subject|2|||
38001656|NCT01763866|69685384|FG001|Overall Study|Withdrawal by Subject|1|||
38001657|NCT01763866|69685385|FG002|Overall Study|Withdrawal by Subject|4|||
38001658|NCT01763866|69685386|FG003|Overall Study|Withdrawal by Subject|0|||
38001659|NCT01763866|69685387|FG004|Overall Study|Withdrawal by Subject|0|||
38001660|NCT01763866|69685388|FG005|Overall Study|Withdrawal by Subject|3|||
38001661|NCT01763866|69685389|FG006|Overall Study|Withdrawal by Subject|4|||
38001662|NCT01763866|69685390|FG007|Overall Study|Withdrawal by Subject|0|||
38001663|NCT01763866|69685391|FG008|Overall Study|Withdrawal by Subject|1|||
38001664|NCT01763866|69685392|FG009|Overall Study|Withdrawal by Subject|1|||
38001665|NCT01763866|69685393|FG010|Overall Study|Withdrawal by Subject|2|||
38001666|NCT01763866|69685394|FG011|Overall Study|Withdrawal by Subject|2|||
38001667|NCT01763866|69685395|FG012|Overall Study|Withdrawal by Subject|2|||
38001668|NCT01763866|69685396|FG013|Overall Study|Withdrawal by Subject|0|||
38001669|NCT01763866|69685397|FG014|Overall Study|Withdrawal by Subject|6|||
38001670|NCT01763866|69685398|FG015|Overall Study|Withdrawal by Subject|3|||
37697424|NCT02021565|69173942|FG000|Baseline Through Intervention|Death|0|||
37829832|NCT00105443|69512965|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
37829833|NCT00105443|69512966|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
37829834|NCT00105443|69512967|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
37829835|NCT00105443|69512968|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
37905046|NCT00648739|69590983|FG003|Overall Study|Investigator Considered it Advisable|0|||
37905047|NCT00648739|69590984|FG004|Overall Study|Investigator Considered it Advisable|0|||
37905048|NCT00648739|69590985|FG005|Overall Study|Investigator Considered it Advisable|1|||
37905049|NCT00648739|69590986|FG006|Overall Study|Investigator Considered it Advisable|1|||
37905050|NCT00648739|69590980|FG000|Overall Study|Death|0|||
37905051|NCT00648739|69590981|FG001|Overall Study|Death|1|||
37905052|NCT00648739|69590982|FG002|Overall Study|Death|0|||
37905053|NCT00648739|69590983|FG003|Overall Study|Death|0|||
37905054|NCT00648739|69590984|FG004|Overall Study|Death|0|||
37905055|NCT00648739|69590985|FG005|Overall Study|Death|0|||
37905056|NCT00648739|69590986|FG006|Overall Study|Death|0|||
37905057|NCT00648739|69590980|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
37905058|NCT00648739|69590981|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
37905059|NCT00648739|69590982|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
37905060|NCT00648739|69590983|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
37905061|NCT00648739|69590984|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
37905062|NCT00648739|69590985|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
37905063|NCT00648739|69590986|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
37905064|NCT00648739|69590980|FG000|Overall Study|Follow-up Visits Not Completed|0|||
37905065|NCT00648739|69590981|FG001|Overall Study|Follow-up Visits Not Completed|1|||
37905066|NCT00648739|69590982|FG002|Overall Study|Follow-up Visits Not Completed|0|||
37905067|NCT00648739|69590983|FG003|Overall Study|Follow-up Visits Not Completed|0|||
37905068|NCT00648739|69590984|FG004|Overall Study|Follow-up Visits Not Completed|0|||
37905069|NCT00648739|69590985|FG005|Overall Study|Follow-up Visits Not Completed|0|||
37905070|NCT00648739|69590986|FG006|Overall Study|Follow-up Visits Not Completed|0|||
37905071|NCT00648037|69591007|FG000|Overall Study|Not Treated|1|||
37905072|NCT00648037|69591007|FG000|Overall Study|Withdrawal by Subject|1|||
37905073|NCT00648037|69591007|FG000|Overall Study|Adverse Event|11|||
37905074|NCT00648037|69591007|FG000|Overall Study|Relapse|2|||
37905075|NCT00648037|69591007|FG000|Overall Study|Other|1|||
37905076|NCT00627523|69591013|FG000|Overall Study|Lack of Efficacy|1|||
37905077|NCT00627523|69591014|FG001|Overall Study|Lack of Efficacy|0|||
38001671|NCT01763866|69685399|FG016|Overall Study|Withdrawal by Subject|0|||
38001672|NCT01763866|69685400|FG017|Overall Study|Withdrawal by Subject|1|||
38001673|NCT01763866|69685401|FG018|Overall Study|Withdrawal by Subject|1|||
37829836|NCT00105443|69512965|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
37829837|NCT00105443|69512966|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
37829838|NCT00105443|69512967|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
37829839|NCT00105443|69512968|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
37905078|NCT00627523|69591013|FG000|Overall Study|Withdrawal by Subject|0|||
37905079|NCT00627523|69591014|FG001|Overall Study|Withdrawal by Subject|2|||
37697425|NCT02021565|69173943|FG001|Baseline Through Intervention|Death|1|||
37905080|NCT00627523|69591013|FG000|Overall Study|Other|1|||
37905081|NCT00627523|69591014|FG001|Overall Study|Other|0|||
37905082|NCT00640393|69591020|FG000|Part 1|Lost to Follow-up|2|||
37905083|NCT00640393|69591021|FG001|Part 1|Lost to Follow-up|0|||
37905084|NCT00640393|69591022|FG002|Part 1|Lost to Follow-up|0|||
38001674|NCT01763866|69685402|FG019|Overall Study|Withdrawal by Subject|1|||
38001675|NCT01763866|69685403|FG020|Overall Study|Withdrawal by Subject|2|||
38001676|NCT01763866|69685404|FG021|Overall Study|Withdrawal by Subject|1|||
38001677|NCT01763866|69685405|FG022|Overall Study|Withdrawal by Subject|2|||
38001678|NCT01763866|69685406|FG023|Overall Study|Withdrawal by Subject|1|||
38001679|NCT01763866|69685383|FG000|Overall Study|Decision by sponsor|0|||
38001680|NCT01763866|69685384|FG001|Overall Study|Decision by sponsor|0|||
38001681|NCT01763866|69685385|FG002|Overall Study|Decision by sponsor|1|||
38001682|NCT01763866|69685386|FG003|Overall Study|Decision by sponsor|0|||
38001683|NCT01763866|69685387|FG004|Overall Study|Decision by sponsor|2|||
38001684|NCT01763866|69685388|FG005|Overall Study|Decision by sponsor|0|||
37697426|NCT02021565|69173942|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
37697427|NCT02021565|69173943|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
37829840|NCT00105443|69512965|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
37905085|NCT00640393|69591020|FG000|Part 1|Withdrawal by Subject|3|||
37905086|NCT00640393|69591021|FG001|Part 1|Withdrawal by Subject|0|||
37905087|NCT00640393|69591022|FG002|Part 1|Withdrawal by Subject|0|||
37905088|NCT00640393|69591020|FG000|Randomization|Withdrawn per protocol|17|||
37905089|NCT00640393|69591021|FG001|Randomization|Withdrawn per protocol|0|||
37905090|NCT00640393|69591022|FG002|Randomization|Withdrawn per protocol|0|||
37905091|NCT00640393|69591020|FG000|Randomization|Never randomized by site|2|||
37905092|NCT00640393|69591021|FG001|Randomization|Never randomized by site|0|||
37905093|NCT00640393|69591022|FG002|Randomization|Never randomized by site|0|||
37905094|NCT00640393|69591020|FG000|Part 2|Lost to Follow-up|0|||
37905095|NCT00640393|69591021|FG001|Part 2|Lost to Follow-up|2|||
37905096|NCT00640393|69591022|FG002|Part 2|Lost to Follow-up|2|||
37905097|NCT00640393|69591020|FG000|Part 2|Withdrawal by Subject|0|||
37905098|NCT00640393|69591021|FG001|Part 2|Withdrawal by Subject|6|||
37905099|NCT00640393|69591022|FG002|Part 2|Withdrawal by Subject|1|||
37905100|NCT00640393|69591020|FG000|Part 2|Non-adherence|0|||
37905101|NCT00640393|69591021|FG001|Part 2|Non-adherence|1|||
37905102|NCT00640393|69591022|FG002|Part 2|Non-adherence|0|||
37905103|NCT00640393|69591020|FG000|Part 2|Adverse Event|0|||
37905104|NCT00640393|69591021|FG001|Part 2|Adverse Event|1|||
37829841|NCT00105443|69512966|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
37829842|NCT00105443|69512967|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
37829843|NCT00105443|69512968|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
37829844|NCT00105443|69512965|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
37829845|NCT00105443|69512966|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
37829846|NCT00105443|69512967|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
37829847|NCT00105443|69512968|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
37829848|NCT01327612|69512984|FG000|Overall Study|Withdrawal by Subject|0|||
37829849|NCT01327612|69512985|FG001|Overall Study|Withdrawal by Subject|0|||
37829850|NCT01327612|69512986|FG002|Overall Study|Withdrawal by Subject|0|||
37829851|NCT01327612|69512987|FG003|Overall Study|Withdrawal by Subject|0|||
37829852|NCT01327612|69512988|FG004|Overall Study|Withdrawal by Subject|0|||
37829853|NCT01327612|69512989|FG005|Overall Study|Withdrawal by Subject|1|||
37829854|NCT01327612|69512990|FG006|Overall Study|Withdrawal by Subject|0|||
37829855|NCT01327612|69512984|FG000|Overall Study|Disease Progression|1|||
37829856|NCT01327612|69512985|FG001|Overall Study|Disease Progression|1|||
37829857|NCT01327612|69512986|FG002|Overall Study|Disease Progression|1|||
37829858|NCT01327612|69512987|FG003|Overall Study|Disease Progression|0|||
37829859|NCT01327612|69512988|FG004|Overall Study|Disease Progression|1|||
37829860|NCT01327612|69512989|FG005|Overall Study|Disease Progression|2|||
37829861|NCT01327612|69512990|FG006|Overall Study|Disease Progression|2|||
37829862|NCT01327612|69512984|FG000|Overall Study|Administrative Decision|0|||
37829863|NCT01327612|69512985|FG001|Overall Study|Administrative Decision|0|||
37905105|NCT00640393|69591022|FG002|Part 2|Adverse Event|0|||
37905106|NCT00907478|69591033|FG000|Overall Study|Ineligibility determined|0|||
37905107|NCT00907478|69591034|FG001|Overall Study|Ineligibility determined|0|||
37905108|NCT00907478|69591035|FG002|Overall Study|Ineligibility determined|1|||
37905109|NCT00907478|69591033|FG000|Overall Study|Noncompliance|0|||
37905110|NCT00907478|69591034|FG001|Overall Study|Noncompliance|0|||
37905111|NCT00907478|69591035|FG002|Overall Study|Noncompliance|1|||
38001685|NCT01763866|69685389|FG006|Overall Study|Decision by sponsor|2|||
37829864|NCT01327612|69512986|FG002|Overall Study|Administrative Decision|0|||
37829865|NCT01327612|69512987|FG003|Overall Study|Administrative Decision|1|||
37829866|NCT01327612|69512988|FG004|Overall Study|Administrative Decision|0|||
37829867|NCT01327612|69512989|FG005|Overall Study|Administrative Decision|0|||
37905112|NCT00907478|69591033|FG000|Overall Study|Adverse Event|3|||
37905113|NCT00907478|69591034|FG001|Overall Study|Adverse Event|1|||
37905114|NCT00907478|69591035|FG002|Overall Study|Adverse Event|2|||
38001686|NCT01763866|69685390|FG007|Overall Study|Decision by sponsor|0|||
37905115|NCT00907478|69591033|FG000|Overall Study|Withdrawal by Subject|8|||
37905116|NCT00907478|69591034|FG001|Overall Study|Withdrawal by Subject|9|||
37905117|NCT00907478|69591035|FG002|Overall Study|Withdrawal by Subject|6|||
37905118|NCT00907478|69591033|FG000|Overall Study|Requirement for alternative therapy|1|||
38001687|NCT01763866|69685391|FG008|Overall Study|Decision by sponsor|2|||
38001688|NCT01763866|69685392|FG009|Overall Study|Decision by sponsor|0|||
38001689|NCT01763866|69685393|FG010|Overall Study|Decision by sponsor|6|||
38001690|NCT01763866|69685394|FG011|Overall Study|Decision by sponsor|0|||
38001691|NCT01763866|69685395|FG012|Overall Study|Decision by sponsor|1|||
38001692|NCT01763866|69685396|FG013|Overall Study|Decision by sponsor|0|||
38001693|NCT01763866|69685397|FG014|Overall Study|Decision by sponsor|5|||
38001694|NCT01763866|69685398|FG015|Overall Study|Decision by sponsor|0|||
38001695|NCT01763866|69685399|FG016|Overall Study|Decision by sponsor|0|||
38001696|NCT01763866|69685400|FG017|Overall Study|Decision by sponsor|0|||
38001697|NCT01763866|69685401|FG018|Overall Study|Decision by sponsor|4|||
38001698|NCT01763866|69685402|FG019|Overall Study|Decision by sponsor|0|||
38001699|NCT01763866|69685403|FG020|Overall Study|Decision by sponsor|2|||
38001700|NCT01763866|69685404|FG021|Overall Study|Decision by sponsor|0|||
38001701|NCT01763866|69685405|FG022|Overall Study|Decision by sponsor|1|||
38001702|NCT01763866|69685406|FG023|Overall Study|Decision by sponsor|0|||
38001703|NCT01763866|69685383|FG000|Overall Study|Lost to Follow-up|0|||
38001704|NCT01763866|69685384|FG001|Overall Study|Lost to Follow-up|0|||
37905119|NCT00907478|69591034|FG001|Overall Study|Requirement for alternative therapy|2|||
37905120|NCT00907478|69591035|FG002|Overall Study|Requirement for alternative therapy|3|||
37905121|NCT00907478|69591033|FG000|Overall Study|Physician Decision|2|||
38001705|NCT01763866|69685385|FG002|Overall Study|Lost to Follow-up|0|||
38001706|NCT01763866|69685386|FG003|Overall Study|Lost to Follow-up|0|||
38001707|NCT01763866|69685387|FG004|Overall Study|Lost to Follow-up|0|||
38001708|NCT01763866|69685388|FG005|Overall Study|Lost to Follow-up|0|||
38001709|NCT01763866|69685389|FG006|Overall Study|Lost to Follow-up|1|||
38001710|NCT01763866|69685390|FG007|Overall Study|Lost to Follow-up|0|||
38001711|NCT01763866|69685391|FG008|Overall Study|Lost to Follow-up|0|||
38001712|NCT01763866|69685392|FG009|Overall Study|Lost to Follow-up|0|||
38001713|NCT01763866|69685393|FG010|Overall Study|Lost to Follow-up|0|||
38001714|NCT01763866|69685394|FG011|Overall Study|Lost to Follow-up|0|||
38001715|NCT01763866|69685395|FG012|Overall Study|Lost to Follow-up|1|||
38001716|NCT01763866|69685396|FG013|Overall Study|Lost to Follow-up|0|||
38001717|NCT01763866|69685397|FG014|Overall Study|Lost to Follow-up|1|||
38001718|NCT01763866|69685398|FG015|Overall Study|Lost to Follow-up|0|||
38001719|NCT01763866|69685399|FG016|Overall Study|Lost to Follow-up|0|||
38001720|NCT01763866|69685400|FG017|Overall Study|Lost to Follow-up|0|||
38001721|NCT01763866|69685401|FG018|Overall Study|Lost to Follow-up|1|||
38001722|NCT01763866|69685402|FG019|Overall Study|Lost to Follow-up|1|||
38001723|NCT01763866|69685403|FG020|Overall Study|Lost to Follow-up|0|||
38001724|NCT01763866|69685404|FG021|Overall Study|Lost to Follow-up|0|||
38001725|NCT01763866|69685405|FG022|Overall Study|Lost to Follow-up|0|||
38001726|NCT01763866|69685406|FG023|Overall Study|Lost to Follow-up|1|||
38001727|NCT01763866|69685383|FG000|Overall Study|Death|0|||
38001728|NCT01763866|69685384|FG001|Overall Study|Death|0|||
38001729|NCT01763866|69685385|FG002|Overall Study|Death|0|||
38001730|NCT01763866|69685386|FG003|Overall Study|Death|0|||
38001731|NCT01763866|69685387|FG004|Overall Study|Death|0|||
38001732|NCT01763866|69685388|FG005|Overall Study|Death|0|||
38001733|NCT01763866|69685389|FG006|Overall Study|Death|0|||
38001734|NCT01763866|69685390|FG007|Overall Study|Death|0|||
37829868|NCT01327612|69512990|FG006|Overall Study|Administrative Decision|0|||
37829869|NCT01327612|69512984|FG000|Overall Study|Death|0|||
37829870|NCT01327612|69512985|FG001|Overall Study|Death|0|||
37829871|NCT01327612|69512986|FG002|Overall Study|Death|0|||
37829872|NCT01327612|69512987|FG003|Overall Study|Death|0|||
37829873|NCT01327612|69512988|FG004|Overall Study|Death|1|||
37829874|NCT01327612|69512989|FG005|Overall Study|Death|0|||
37829875|NCT01327612|69512990|FG006|Overall Study|Death|0|||
37905122|NCT00907478|69591034|FG001|Overall Study|Physician Decision|0|||
37905123|NCT00907478|69591035|FG002|Overall Study|Physician Decision|3|||
37829876|NCT01327573|69513009|FG000|Overall Study|Physician Decision|3|||
37905124|NCT00907478|69591033|FG000|Overall Study|Death|4|||
38001735|NCT01763866|69685391|FG008|Overall Study|Death|0|||
38001736|NCT01763866|69685392|FG009|Overall Study|Death|0|||
38001737|NCT01763866|69685393|FG010|Overall Study|Death|0|||
38001738|NCT01763866|69685394|FG011|Overall Study|Death|0|||
38001739|NCT01763866|69685395|FG012|Overall Study|Death|0|||
38001740|NCT01763866|69685396|FG013|Overall Study|Death|0|||
37829877|NCT01327573|69513010|FG001|Overall Study|Physician Decision|1|||
38001741|NCT01763866|69685397|FG014|Overall Study|Death|0|||
38001742|NCT01763866|69685398|FG015|Overall Study|Death|0|||
38001743|NCT01763866|69685399|FG016|Overall Study|Death|1|||
38001744|NCT01763866|69685400|FG017|Overall Study|Death|0|||
38001745|NCT01763866|69685401|FG018|Overall Study|Death|0|||
38001746|NCT01763866|69685402|FG019|Overall Study|Death|0|||
37905125|NCT00907478|69591034|FG001|Overall Study|Death|2|||
37905126|NCT00907478|69591035|FG002|Overall Study|Death|1|||
37905127|NCT00907478|69591033|FG000|Overall Study|Protocol-specified criteria|5|||
37905128|NCT00907478|69591034|FG001|Overall Study|Protocol-specified criteria|2|||
37905129|NCT00907478|69591035|FG002|Overall Study|Protocol-specified criteria|3|||
37905130|NCT00907478|69591033|FG000|Overall Study|Pregnancy|0|||
37905131|NCT00907478|69591034|FG001|Overall Study|Pregnancy|1|||
37905132|NCT00907478|69591035|FG002|Overall Study|Pregnancy|1|||
37905133|NCT00907478|69591033|FG000|Overall Study|Lost to Follow-up|1|||
37905134|NCT00907478|69591034|FG001|Overall Study|Lost to Follow-up|0|||
37905135|NCT00907478|69591035|FG002|Overall Study|Lost to Follow-up|0|||
37905136|NCT00907478|69591033|FG000|Overall Study|Other|3|||
37905137|NCT00907478|69591034|FG001|Overall Study|Other|0|||
37905138|NCT00907478|69591035|FG002|Overall Study|Other|1|||
37905139|NCT00627445|69591047|FG000|Overall Study|Adverse Event|3|||
37905140|NCT00627445|69591048|FG001|Overall Study|Adverse Event|3|||
37905141|NCT00627445|69591047|FG000|Overall Study|Lack of Efficacy|0|||
37905142|NCT00627445|69591048|FG001|Overall Study|Lack of Efficacy|1|||
37905143|NCT00627445|69591047|FG000|Overall Study|Other|6|||
37905144|NCT00627445|69591048|FG001|Overall Study|Other|8|||
37905145|NCT00905840|69591056|FG000|Overall Study|Lost to Follow-up|11|||
37905146|NCT00905840|69591056|FG000|Overall Study|Death|3|||
37905147|NCT00905840|69591056|FG000|Overall Study|Withdrawal by Subject|1|||
37905148|NCT00905840|69591056|FG000|Overall Study|Adverse Event|1|||
37905149|NCT00626821|69591063|FG000|Overall Study|Adverse Event|44|||
37905150|NCT00626821|69591063|FG000|Overall Study|Protocol Violation|33|||
37905151|NCT00626821|69591063|FG000|Overall Study|Withdrawal by Subject|10|||
37905152|NCT00626821|69591063|FG000|Overall Study|Physician Decision|9|||
37905153|NCT00626821|69591063|FG000|Overall Study|Product dysfunction|21|||
37905154|NCT00626821|69591063|FG000|Overall Study|other/unknown reason|104|||
37905155|NCT00625183|69591067|FG000|Overall Study|Disease Progression|1|||
37905156|NCT00904982|69591077|FG000|Overall Study|Withdrawal by Subject|2|||
37905157|NCT00904982|69591078|FG001|Overall Study|Withdrawal by Subject|0|||
37905158|NCT00904982|69591079|FG002|Overall Study|Withdrawal by Subject|0|||
37905159|NCT00904982|69591080|FG003|Overall Study|Withdrawal by Subject|0|||
37905160|NCT00640315|69591092|FG000|Overall Study|Withdrawal by Subject|0|||
37905161|NCT00640315|69591093|FG001|Overall Study|Withdrawal by Subject|1|||
37905162|NCT00904748|69591099|FG000|Overall Study|Withdrawal by Subject|1|||
37905163|NCT00904748|69591100|FG001|Overall Study|Withdrawal by Subject|1|||
37905164|NCT00904748|69591101|FG002|Overall Study|Withdrawal by Subject|1|||
37905165|NCT00904748|69591102|FG003|Overall Study|Withdrawal by Subject|2|||
37905166|NCT00904748|69591103|FG004|Overall Study|Withdrawal by Subject|0|||
37905167|NCT00904748|69591104|FG005|Overall Study|Withdrawal by Subject|0|||
37905168|NCT00904748|69591099|FG000|Overall Study|Adverse Event|0|||
37905169|NCT00904748|69591100|FG001|Overall Study|Adverse Event|0|||
37905170|NCT00904748|69591101|FG002|Overall Study|Adverse Event|0|||
37905171|NCT00904748|69591102|FG003|Overall Study|Adverse Event|0|||
37905172|NCT00904748|69591103|FG004|Overall Study|Adverse Event|1|||
37905173|NCT00904748|69591104|FG005|Overall Study|Adverse Event|0|||
37905174|NCT00574405|69591115|FG000|Overall Study|Withdrawal by Subject|3|||
37905175|NCT00574405|69591116|FG001|Overall Study|Withdrawal by Subject|2|||
37905176|NCT00971243|69591127|FG000|Double Blind Period|Adverse Event|2|||
37905177|NCT00971243|69591128|FG001|Double Blind Period|Adverse Event|3|||
37905178|NCT00971243|69591129|FG002|Double Blind Period|Adverse Event|2|||
37905179|NCT00971243|69591130|FG003|Double Blind Period|Adverse Event|2|||
37905180|NCT00971243|69591131|FG004|Double Blind Period|Adverse Event|3|||
37905181|NCT00971243|69591127|FG000|Double Blind Period|Lost to Follow-up|0|||
37905182|NCT00971243|69591128|FG001|Double Blind Period|Lost to Follow-up|1|||
37905183|NCT00971243|69591129|FG002|Double Blind Period|Lost to Follow-up|1|||
37905184|NCT00971243|69591130|FG003|Double Blind Period|Lost to Follow-up|0|||
37905185|NCT00971243|69591131|FG004|Double Blind Period|Lost to Follow-up|1|||
37905186|NCT00971243|69591127|FG000|Double Blind Period|Physician Decision|10|||
37905187|NCT00971243|69591128|FG001|Double Blind Period|Physician Decision|6|||
37905188|NCT00971243|69591129|FG002|Double Blind Period|Physician Decision|7|||
37905189|NCT00971243|69591130|FG003|Double Blind Period|Physician Decision|6|||
37905190|NCT00971243|69591131|FG004|Double Blind Period|Physician Decision|7|||
37905191|NCT00971243|69591127|FG000|Double Blind Period|Protocol Violation|2|||
37905192|NCT00971243|69591128|FG001|Double Blind Period|Protocol Violation|0|||
37905193|NCT00971243|69591129|FG002|Double Blind Period|Protocol Violation|3|||
37905194|NCT00971243|69591130|FG003|Double Blind Period|Protocol Violation|2|||
37905195|NCT00971243|69591131|FG004|Double Blind Period|Protocol Violation|2|||
37905196|NCT00971243|69591127|FG000|Double Blind Period|Withdrawal by Subject|4|||
37905197|NCT00971243|69591128|FG001|Double Blind Period|Withdrawal by Subject|1|||
37905198|NCT00971243|69591129|FG002|Double Blind Period|Withdrawal by Subject|4|||
37905199|NCT00971243|69591130|FG003|Double Blind Period|Withdrawal by Subject|4|||
37905200|NCT00971243|69591131|FG004|Double Blind Period|Withdrawal by Subject|4|||
37905201|NCT00971243|69591127|FG000|Double Blind Period|Other reasons|1|||
37905202|NCT00971243|69591128|FG001|Double Blind Period|Other reasons|0|||
37905203|NCT00971243|69591129|FG002|Double Blind Period|Other reasons|2|||
38001747|NCT01763866|69685403|FG020|Overall Study|Death|0|||
38001748|NCT01763866|69685404|FG021|Overall Study|Death|0|||
38001749|NCT01763866|69685405|FG022|Overall Study|Death|0|||
38001750|NCT01763866|69685406|FG023|Overall Study|Death|0|||
38001751|NCT00132873|69685456|FG000|Overall Study|Adverse Event|3|||
38001752|NCT00132873|69685456|FG000|Overall Study|Lost to Follow-up|1|||
38001753|NCT00132873|69685456|FG000|Overall Study|Lack of Efficacy|1|||
38001754|NCT00132873|69685456|FG000|Overall Study|Withdrawal by Subject|3|||
38001755|NCT00132873|69685456|FG000|Overall Study|Planned Pregnancy|1|||
38001756|NCT00120627|69685462|FG000|Overall Study|Withdrawal by Subject|5|||
38001757|NCT00120627|69685463|FG001|Overall Study|Withdrawal by Subject|5|||
38001758|NCT03762616|69685478|FG000|Overall Study|Protocol Violation|2|||
38001759|NCT04246996|69685486|FG000|Overall Study|Physician Decision|1|||
38001760|NCT04246996|69685487|FG001|Overall Study|Physician Decision|1|||
38001761|NCT04246996|69685486|FG000|Overall Study|Did not meet eligibility criteria|1|||
38001762|NCT04246996|69685487|FG001|Overall Study|Did not meet eligibility criteria|4|||
38001763|NCT00424463|69685496|FG000|Overall Study|Adverse Event|2|||
38001764|NCT00424463|69685497|FG001|Overall Study|Adverse Event|3|||
38001765|NCT00424463|69685498|FG002|Overall Study|Adverse Event|2|||
38001766|NCT00424463|69685496|FG000|Overall Study|Physician Decision|0|||
38001767|NCT00424463|69685497|FG001|Overall Study|Physician Decision|2|||
38001768|NCT00424463|69685498|FG002|Overall Study|Physician Decision|2|||
38001769|NCT00424463|69685496|FG000|Overall Study|Withdrawal by Subject|4|||
38001770|NCT00424463|69685497|FG001|Overall Study|Withdrawal by Subject|2|||
38001771|NCT00424463|69685498|FG002|Overall Study|Withdrawal by Subject|5|||
38001772|NCT00424463|69685496|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
38001773|NCT00424463|69685497|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
38001774|NCT00424463|69685498|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
38001775|NCT00424463|69685496|FG000|Overall Study|Patient's convenience|0|||
38001776|NCT00424463|69685497|FG001|Overall Study|Patient's convenience|0|||
38001777|NCT00424463|69685498|FG002|Overall Study|Patient's convenience|1|||
38001778|NCT00424385|69685506|FG000|Cohort 0|Withdrawal by Subject|5|||
38001779|NCT00424385|69685506|FG000|Cohort 0|Physician Decision|1|||
38001780|NCT00424385|69685506|FG000|Cohort 1|Withdrawal by Subject|1|||
38001781|NCT00423917|69685512|FG000|Overall Study|Cancel|2|||
38001782|NCT00423917|69685512|FG000|Overall Study|Ineligible|1|||
38001783|NCT00845026|69685518|FG000|Study Period III|Adverse Event|23|||
38001784|NCT00845026|69685519|FG001|Study Period III|Adverse Event|19|||
38001785|NCT00845026|69685518|FG000|Study Period III|Perceived lack of efficacy|27|||
38001786|NCT00845026|69685519|FG001|Study Period III|Perceived lack of efficacy|15|||
38001787|NCT00845026|69685518|FG000|Study Period III|Withdrawal by Subject|19|||
38001788|NCT00845026|69685519|FG001|Study Period III|Withdrawal by Subject|15|||
37697428|NCT02021565|69173942|FG000|Baseline Through Intervention|Protocol Violation|0|||
37697429|NCT02021565|69173943|FG001|Baseline Through Intervention|Protocol Violation|7|||
37829878|NCT01327495|69513023|FG000|Overall Study|Adverse Event|2|||
37829879|NCT01327495|69513024|FG001|Overall Study|Adverse Event|1|||
37829880|NCT01327495|69513025|FG002|Overall Study|Adverse Event|1|||
37829881|NCT01327495|69513026|FG003|Overall Study|Adverse Event|0|||
37829882|NCT01327495|69513027|FG004|Overall Study|Adverse Event|0|||
37829883|NCT01327495|69513028|FG005|Overall Study|Adverse Event|2|||
37829884|NCT01327495|69513023|FG000|Overall Study|Withdrawal by Subject|0|||
37905204|NCT00971243|69591130|FG003|Double Blind Period|Other reasons|0|||
37905205|NCT00971243|69591131|FG004|Double Blind Period|Other reasons|1|||
37905206|NCT00971243|69591127|FG000|Open-label Period|Adverse Event|1|||
37905207|NCT00971243|69591128|FG001|Open-label Period|Adverse Event|0|||
37905208|NCT00971243|69591129|FG002|Open-label Period|Adverse Event|1|||
37905209|NCT00971243|69591130|FG003|Open-label Period|Adverse Event|1|||
37905210|NCT00971243|69591131|FG004|Open-label Period|Adverse Event|0|||
38001789|NCT00845026|69685518|FG000|Study Period III|Entry Criteria not met|8|||
38001790|NCT00845026|69685519|FG001|Study Period III|Entry Criteria not met|11|||
38001791|NCT00845026|69685518|FG000|Study Period III|Lost to Follow-up|4|||
37829885|NCT01327495|69513024|FG001|Overall Study|Withdrawal by Subject|1|||
37829886|NCT01327495|69513025|FG002|Overall Study|Withdrawal by Subject|1|||
37829887|NCT01327495|69513026|FG003|Overall Study|Withdrawal by Subject|0|||
38001792|NCT00845026|69685519|FG001|Study Period III|Lost to Follow-up|5|||
38001793|NCT00845026|69685518|FG000|Study Period III|Protocol Violation|8|||
37905211|NCT00971243|69591127|FG000|Open-label Period|Physician Decision|5|||
38001794|NCT00845026|69685519|FG001|Study Period III|Protocol Violation|1|||
38001795|NCT00845026|69685518|FG000|Study Period III|Scheduled conflict|3|||
38001796|NCT00845026|69685519|FG001|Study Period III|Scheduled conflict|1|||
38001797|NCT00845026|69685518|FG000|Study Period III|Subject is moving or has moved|2|||
37829888|NCT01327495|69513027|FG004|Overall Study|Withdrawal by Subject|1|||
37829889|NCT01327495|69513028|FG005|Overall Study|Withdrawal by Subject|0|||
38001798|NCT00845026|69685519|FG001|Study Period III|Subject is moving or has moved|4|||
37829890|NCT01327495|69513023|FG000|Overall Study|Physician Decision|0|||
38001799|NCT00845026|69685518|FG000|Study Period III|Transportation issues|1|||
38001800|NCT00845026|69685519|FG001|Study Period III|Transportation issues|1|||
38001801|NCT00845026|69685518|FG000|Study Period IV|Adverse Event|4|||
37697430|NCT02021565|69173942|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
37829891|NCT01327495|69513024|FG001|Overall Study|Physician Decision|0|||
37829892|NCT01327495|69513025|FG002|Overall Study|Physician Decision|0|||
37829893|NCT01327495|69513026|FG003|Overall Study|Physician Decision|0|||
37829894|NCT01327495|69513027|FG004|Overall Study|Physician Decision|2|||
37829895|NCT01327495|69513028|FG005|Overall Study|Physician Decision|0|||
37829896|NCT01327339|69513048|FG000|Overall Study|Protocol Violation|8|||
37829897|NCT01327300|69513052|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
37829898|NCT01327300|69513053|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
37829899|NCT01379521|69513071|FG000|Overall Study -Treatment Period|Adverse Event|3|||
37829900|NCT01379521|69513072|FG001|Overall Study -Treatment Period|Adverse Event|0|||
37829901|NCT01379521|69513071|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
37829902|NCT01379521|69513072|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
37829903|NCT01379521|69513071|FG000|Overall Study -Treatment Period|Disease Progression|23|||
37905212|NCT00971243|69591128|FG001|Open-label Period|Physician Decision|9|||
37905213|NCT00971243|69591129|FG002|Open-label Period|Physician Decision|3|||
37905214|NCT00971243|69591130|FG003|Open-label Period|Physician Decision|7|||
37905215|NCT00971243|69591131|FG004|Open-label Period|Physician Decision|2|||
37905216|NCT00971243|69591127|FG000|Open-label Period|Protocol Violation|1|||
37905217|NCT00971243|69591128|FG001|Open-label Period|Protocol Violation|1|||
37905218|NCT00971243|69591129|FG002|Open-label Period|Protocol Violation|1|||
37905219|NCT00971243|69591130|FG003|Open-label Period|Protocol Violation|0|||
37905220|NCT00971243|69591131|FG004|Open-label Period|Protocol Violation|1|||
37905221|NCT00971243|69591127|FG000|Open-label Period|Withdrawal by Subject|1|||
37905222|NCT00971243|69591128|FG001|Open-label Period|Withdrawal by Subject|0|||
37905223|NCT00971243|69591129|FG002|Open-label Period|Withdrawal by Subject|0|||
37905224|NCT00971243|69591130|FG003|Open-label Period|Withdrawal by Subject|2|||
37905225|NCT00971243|69591131|FG004|Open-label Period|Withdrawal by Subject|1|||
37905226|NCT00971243|69591127|FG000|Open-label Period|Other reason|0|||
37905227|NCT00971243|69591128|FG001|Open-label Period|Other reason|0|||
37905228|NCT00971243|69591129|FG002|Open-label Period|Other reason|0|||
37905229|NCT00971243|69591130|FG003|Open-label Period|Other reason|0|||
37905230|NCT00971243|69591131|FG004|Open-label Period|Other reason|2|||
37905231|NCT00568555|69591145|FG000|Overall Study|Withdrawal by Subject|1|||
37905232|NCT00568555|69591146|FG001|Overall Study|Withdrawal by Subject|1|||
37905233|NCT00904670|69591154|FG000|Open Label Phase|Withdrawal by Subject|2|||
37905234|NCT00904670|69591155|FG001|Open Label Phase|Withdrawal by Subject|0|||
37905235|NCT00904670|69591154|FG000|Open Label Phase|Adverse Event|2|||
37905236|NCT00904670|69591155|FG001|Open Label Phase|Adverse Event|0|||
37905237|NCT00904670|69591154|FG000|Open Label Phase|Lack of Efficacy|1|||
37905238|NCT00904670|69591155|FG001|Open Label Phase|Lack of Efficacy|0|||
37905239|NCT00904670|69591154|FG000|Open Label Phase|Lost to Follow-up|1|||
37905240|NCT00904670|69591155|FG001|Open Label Phase|Lost to Follow-up|0|||
37905241|NCT00638443|69591163|FG000|First Intervention|Adverse Event|2|||
37905242|NCT00638443|69591164|FG001|First Intervention|Adverse Event|1|||
37905243|NCT00636181|69591175|FG000|Overall Study|Withdrawal by Subject|8|||
37905244|NCT00636181|69591176|FG001|Overall Study|Withdrawal by Subject|6|||
37905245|NCT00636181|69591177|FG002|Overall Study|Withdrawal by Subject|10|||
37905246|NCT00968669|69591189|FG000|Overall Study|Lost to Follow-up|5|||
37905247|NCT00968669|69591190|FG001|Overall Study|Lost to Follow-up|2|||
37905248|NCT00968669|69591191|FG002|Overall Study|Lost to Follow-up|1|||
37905249|NCT00968669|69591192|FG003|Overall Study|Lost to Follow-up|4|||
37905250|NCT00968669|69591189|FG000|Overall Study|Withdrawal by Subject|9|||
37905251|NCT00968669|69591190|FG001|Overall Study|Withdrawal by Subject|7|||
37905252|NCT00968669|69591191|FG002|Overall Study|Withdrawal by Subject|5|||
37905253|NCT00968669|69591192|FG003|Overall Study|Withdrawal by Subject|3|||
37905254|NCT00968669|69591189|FG000|Overall Study|Pregnancy|0|||
37905255|NCT00968669|69591190|FG001|Overall Study|Pregnancy|0|||
37905256|NCT00968669|69591191|FG002|Overall Study|Pregnancy|2|||
37905257|NCT00968669|69591192|FG003|Overall Study|Pregnancy|0|||
37905258|NCT00968669|69591189|FG000|Overall Study|AE|1|||
38001802|NCT00845026|69685519|FG001|Study Period IV|Adverse Event|0|||
37905259|NCT00968669|69591190|FG001|Overall Study|AE|0|||
37905260|NCT00968669|69591191|FG002|Overall Study|AE|0|||
37905261|NCT00968669|69591192|FG003|Overall Study|AE|0|||
37905262|NCT00968669|69591189|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
37905263|NCT00968669|69591190|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
37905264|NCT00968669|69591191|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
37905265|NCT00968669|69591192|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
37905266|NCT00968669|69591189|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
37905267|NCT00968669|69591190|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
37905268|NCT00968669|69591191|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
38001803|NCT00845026|69685518|FG000|Study Period IV|Perceived lack of efficacy|2|||
38001804|NCT00845026|69685519|FG001|Study Period IV|Perceived lack of efficacy|1|||
38001805|NCT00845026|69685518|FG000|Study Period IV|Protocol Violation|3|||
38001806|NCT00845026|69685519|FG001|Study Period IV|Protocol Violation|1|||
38001807|NCT00845026|69685518|FG000|Study Period IV|Lost to Follow-up|1|||
38001808|NCT00845026|69685519|FG001|Study Period IV|Lost to Follow-up|0|||
38001809|NCT00845026|69685518|FG000|Study Period IV|Withdrawal by Subject|4|||
38001810|NCT00845026|69685519|FG001|Study Period IV|Withdrawal by Subject|1|||
38001811|NCT00845026|69685518|FG000|Study Period IV|Entry Criteria Not Met|1|||
38001812|NCT00845026|69685519|FG001|Study Period IV|Entry Criteria Not Met|0|||
37829904|NCT01379521|69513072|FG001|Overall Study -Treatment Period|Disease Progression|22|||
37829905|NCT01379521|69513071|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
37829906|NCT01379521|69513072|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
37829907|NCT01379521|69513071|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
37829908|NCT01379521|69513072|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
37829909|NCT01379521|69513071|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
37829910|NCT01379521|69513072|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
37829911|NCT01379521|69513071|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
37829912|NCT01379521|69513072|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
37829913|NCT01379521|69513071|FG000|Overall Study -Treatment Period|Death|2|||
37829914|NCT01379521|69513072|FG001|Overall Study -Treatment Period|Death|1|||
37829915|NCT01379521|69513071|FG000|Post-Treatment Evaluations|Disease Progression|22|||
37829916|NCT01379521|69513072|FG001|Post-Treatment Evaluations|Disease Progression|20|||
37829917|NCT01379521|69513071|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
37829918|NCT01379521|69513072|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
37829919|NCT01379521|69513071|FG000|Post-Treatment Evaluations|Death|1|||
37829920|NCT01379521|69513072|FG001|Post-Treatment Evaluations|Death|0|||
37829921|NCT01371994|69513080|FG000|Overall Study|Adverse Event|3|||
37829922|NCT01371994|69513081|FG001|Overall Study|Adverse Event|6|||
37829923|NCT01371994|69513080|FG000|Overall Study|Lack of Efficacy|3|||
37829924|NCT01371994|69513081|FG001|Overall Study|Lack of Efficacy|0|||
37829925|NCT01371994|69513080|FG000|Overall Study|Withdrawal by Subject|13|||
37829926|NCT01371994|69513081|FG001|Overall Study|Withdrawal by Subject|7|||
37829927|NCT01371994|69513080|FG000|Overall Study|Lost to Follow-up|1|||
37829928|NCT01371994|69513081|FG001|Overall Study|Lost to Follow-up|1|||
37829929|NCT01371994|69513080|FG000|Overall Study|Protocol Violation|24|||
37829930|NCT01371994|69513081|FG001|Overall Study|Protocol Violation|17|||
37829931|NCT01371994|69513080|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
37829932|NCT01371994|69513081|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
37829933|NCT01371994|69513080|FG000|Overall Study|Physician Decision|1|||
37829934|NCT01371994|69513081|FG001|Overall Study|Physician Decision|1|||
37829935|NCT01371994|69513080|FG000|Overall Study|Miscellaneous Reasons|6|||
37829936|NCT01371994|69513081|FG001|Overall Study|Miscellaneous Reasons|4|||
37829937|NCT01371877|69513089|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
37829938|NCT01371877|69513090|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
37829939|NCT01371838|69513098|FG000|Overall Study|Withdrawal by Subject|27|||
37829940|NCT01371838|69513099|FG001|Overall Study|Withdrawal by Subject|33|||
37829941|NCT01371838|69513098|FG000|Overall Study|Lost to Follow-up|10|||
37829942|NCT01371838|69513099|FG001|Overall Study|Lost to Follow-up|20|||
37829943|NCT01371838|69513098|FG000|Overall Study|Death|3|||
37829944|NCT01371838|69513099|FG001|Overall Study|Death|4|||
37829945|NCT01371838|69513098|FG000|Overall Study|Protocol Violation|3|||
37829946|NCT01371838|69513099|FG001|Overall Study|Protocol Violation|0|||
37829947|NCT01371838|69513098|FG000|Overall Study|Investigator Decision|3|||
37829948|NCT01371838|69513099|FG001|Overall Study|Investigator Decision|8|||
37829949|NCT01371838|69513098|FG000|Overall Study|Last follow-up visit not conducted|2|||
37829950|NCT01371838|69513099|FG001|Overall Study|Last follow-up visit not conducted|0|||
37829951|NCT01371838|69513098|FG000|Overall Study|Lack of therapeutic response|0|||
37829952|NCT01371838|69513099|FG001|Overall Study|Lack of therapeutic response|1|||
37829953|NCT01371838|69513098|FG000|Overall Study|Surgery|1|||
37829954|NCT01371838|69513099|FG001|Overall Study|Surgery|0|||
37829955|NCT01371721|69513108|FG000|Overall Study|Adverse Event|5|||
37829956|NCT01371721|69513109|FG001|Overall Study|Adverse Event|4|||
37829957|NCT01371721|69513110|FG002|Overall Study|Adverse Event|5|||
37829958|NCT01371721|69513108|FG000|Overall Study|Protocol Violation|6|||
37829959|NCT01371721|69513109|FG001|Overall Study|Protocol Violation|4|||
37829960|NCT01371721|69513110|FG002|Overall Study|Protocol Violation|5|||
37829961|NCT01371721|69513108|FG000|Overall Study|Lost to Follow-up|8|||
37829962|NCT01371721|69513109|FG001|Overall Study|Lost to Follow-up|2|||
37829963|NCT01371721|69513110|FG002|Overall Study|Lost to Follow-up|6|||
37829964|NCT01371721|69513108|FG000|Overall Study|Withdrawal by Subject|5|||
37829965|NCT01371721|69513109|FG001|Overall Study|Withdrawal by Subject|7|||
37829966|NCT01371721|69513110|FG002|Overall Study|Withdrawal by Subject|11|||
37829967|NCT01371721|69513108|FG000|Overall Study|Other|2|||
37829968|NCT01371721|69513109|FG001|Overall Study|Other|3|||
38001813|NCT00845026|69685518|FG000|Study Period IV|Subject is moving or has moved|0|||
38001814|NCT00845026|69685519|FG001|Study Period IV|Subject is moving or has moved|1|||
38001815|NCT00845026|69685518|FG000|Study Period IV|Scheduling conflict|1|||
38001816|NCT00845026|69685519|FG001|Study Period IV|Scheduling conflict|0|||
38001817|NCT00691678|69685527|FG000|Overall Study|Adverse Event|5|||
38001818|NCT00691678|69685527|FG000|Overall Study|life events, pain|11|||
37905269|NCT00968669|69591192|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
37905270|NCT00968669|69591189|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
37905271|NCT00968669|69591190|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
37905272|NCT00968669|69591191|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
37905273|NCT00968669|69591192|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
37905274|NCT00968669|69591189|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
37905275|NCT00968669|69591190|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
37905276|NCT00968669|69591191|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
37905277|NCT00968669|69591192|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
37905278|NCT00968669|69591189|FG000|Overall Study|EARLY WITHDRAWAL|0|||
37905279|NCT00968669|69591190|FG001|Overall Study|EARLY WITHDRAWAL|1|||
37905280|NCT00968669|69591191|FG002|Overall Study|EARLY WITHDRAWAL|0|||
37905281|NCT00968669|69591192|FG003|Overall Study|EARLY WITHDRAWAL|0|||
37905282|NCT00968669|69591189|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
37905283|NCT00968669|69591190|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
37905284|NCT00968669|69591191|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
37905285|NCT00968669|69591192|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
37905286|NCT00968669|69591189|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
37905287|NCT00968669|69591190|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
37905288|NCT00968669|69591191|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
37905289|NCT00968669|69591192|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
37905290|NCT00968669|69591189|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
37905291|NCT00968669|69591190|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
37905292|NCT00968669|69591191|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
37905293|NCT00968669|69591192|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
37905294|NCT00968669|69591189|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
37905295|NCT00968669|69591190|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
37905296|NCT00968669|69591191|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
37905297|NCT00968669|69591192|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
37905298|NCT00968669|69591189|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
37905299|NCT00968669|69591190|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
37905300|NCT00968669|69591191|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
37905301|NCT00968669|69591192|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
37905302|NCT00968669|69591189|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
37905303|NCT00968669|69591190|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
37905304|NCT00968669|69591191|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
37905305|NCT00968669|69591192|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
37905306|NCT00968669|69591189|FG000|Overall Study|SPONSOR DECISION|0|||
37905307|NCT00968669|69591190|FG001|Overall Study|SPONSOR DECISION|1|||
37905308|NCT00968669|69591191|FG002|Overall Study|SPONSOR DECISION|0|||
37905309|NCT00968669|69591192|FG003|Overall Study|SPONSOR DECISION|0|||
37905310|NCT00968669|69591189|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
37905311|NCT00968669|69591190|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
37905312|NCT00968669|69591191|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
37905313|NCT00968669|69591192|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
37905314|NCT00968669|69591189|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
37905315|NCT00968669|69591190|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
37905316|NCT00968669|69591191|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
37905317|NCT00968669|69591192|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
37905318|NCT00968669|69591189|FG000|Overall Study|SUBJECT INCARCERATED|0|||
37905319|NCT00968669|69591190|FG001|Overall Study|SUBJECT INCARCERATED|1|||
37905320|NCT00968669|69591191|FG002|Overall Study|SUBJECT INCARCERATED|0|||
37905321|NCT00968669|69591192|FG003|Overall Study|SUBJECT INCARCERATED|0|||
37905322|NCT00968669|69591189|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
37905323|NCT00968669|69591190|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
37905324|NCT00968669|69591191|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
37905325|NCT00968669|69591192|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
37905326|NCT00968669|69591189|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
37905327|NCT00968669|69591190|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
37905328|NCT00968669|69591191|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
37905329|NCT00968669|69591192|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
38001819|NCT00423605|69685531|FG000|Overall Study|Adverse Event|129|||
38001820|NCT00423605|69685531|FG000|Overall Study|Withdrawal by Subject|36|||
37905330|NCT00568399|69591202|FG000|Overall Study|Death|2|||
37905331|NCT00568399|69591202|FG000|Overall Study|Adverse Event|5|||
37905332|NCT00568399|69591202|FG000|Overall Study|Withdrawal by Subject|8|||
38001821|NCT00423605|69685531|FG000|Overall Study|Lost to Follow-up|15|||
38001822|NCT00423605|69685531|FG000|Overall Study|Lack of Efficacy|38|||
38001823|NCT00423605|69685531|FG000|Overall Study|Sponsor Decision|3|||
38001824|NCT00423605|69685531|FG000|Overall Study|Physician Decision|8|||
38001825|NCT00423605|69685531|FG000|Overall Study|Protocol Violation|7|||
38001826|NCT00423605|69685531|FG000|Overall Study|Not one of the pre-specified options|5|||
38001827|NCT00423449|69685535|FG000|Overall Study|Clinical Adverse Event|1|||
38001828|NCT00423449|69685536|FG001|Overall Study|Clinical Adverse Event|0|||
38001829|NCT00423449|69685537|FG002|Overall Study|Clinical Adverse Event|1|||
38001830|NCT00423449|69685538|FG003|Overall Study|Clinical Adverse Event|8|||
38001831|NCT00423449|69685539|FG004|Overall Study|Clinical Adverse Event|2|||
38001832|NCT00423449|69685535|FG000|Overall Study|Death|1|||
38001833|NCT00423449|69685536|FG001|Overall Study|Death|0|||
37905333|NCT00975143|69591208|FG000|Overall Study|Adverse Event|19|||
37905334|NCT00975143|69591209|FG001|Overall Study|Adverse Event|15|||
37905335|NCT00975143|69591208|FG000|Overall Study|Withdrawal by Subject|15|||
37905336|NCT00975143|69591209|FG001|Overall Study|Withdrawal by Subject|15|||
37905337|NCT00975143|69591208|FG000|Overall Study|Lost to Follow-up|20|||
37905338|NCT00975143|69591209|FG001|Overall Study|Lost to Follow-up|16|||
37905339|NCT00975143|69591208|FG000|Overall Study|Non-compliance|5|||
37905340|NCT00975143|69591209|FG001|Overall Study|Non-compliance|8|||
37905341|NCT00975143|69591208|FG000|Overall Study|Physician Decision|1|||
37905342|NCT00975143|69591209|FG001|Overall Study|Physician Decision|2|||
37905343|NCT00975143|69591208|FG000|Overall Study|Details not available|10|||
37905344|NCT00975143|69591209|FG001|Overall Study|Details not available|4|||
37905345|NCT00974675|69591232|FG000|Overall Study|Adverse Event|2|||
37905346|NCT00974675|69591233|FG001|Overall Study|Adverse Event|1|||
37905347|NCT00974675|69591234|FG002|Overall Study|Adverse Event|1|||
37905348|NCT00974675|69591235|FG003|Overall Study|Adverse Event|1|||
37905349|NCT00974675|69591232|FG000|Overall Study|Physician Decision|0|||
37905350|NCT00974675|69591233|FG001|Overall Study|Physician Decision|0|||
37905351|NCT00974675|69591234|FG002|Overall Study|Physician Decision|1|||
37905352|NCT00974675|69591235|FG003|Overall Study|Physician Decision|0|||
37905353|NCT00974675|69591232|FG000|Overall Study|Participant on holiday; unable to attend|0|||
37905354|NCT00974675|69591233|FG001|Overall Study|Participant on holiday; unable to attend|0|||
37905355|NCT00974675|69591234|FG002|Overall Study|Participant on holiday; unable to attend|0|||
37905356|NCT00974675|69591235|FG003|Overall Study|Participant on holiday; unable to attend|1|||
37905357|NCT00634933|69591248|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
37905358|NCT00634933|69591249|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
37905359|NCT00634933|69591250|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
37905360|NCT00634933|69591251|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
37905361|NCT00634933|69591252|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
37905362|NCT00634933|69591248|FG000|Part A: Baseline to Week 24|Death|1|||
37905363|NCT00634933|69591249|FG001|Part A: Baseline to Week 24|Death|0|||
37905364|NCT00634933|69591250|FG002|Part A: Baseline to Week 24|Death|0|||
37905365|NCT00634933|69591251|FG003|Part A: Baseline to Week 24|Death|0|||
37905366|NCT00634933|69591252|FG004|Part A: Baseline to Week 24|Death|0|||
37905367|NCT00634933|69591248|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
37905368|NCT00634933|69591249|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
37905369|NCT00634933|69591250|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
37905370|NCT00634933|69591251|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
37905371|NCT00634933|69591252|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
37905372|NCT00634933|69591248|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
37905373|NCT00634933|69591249|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
37905374|NCT00634933|69591250|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
37905375|NCT00634933|69591251|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
37905376|NCT00634933|69591252|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
37905377|NCT00634933|69591248|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
37905378|NCT00634933|69591249|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
37905379|NCT00634933|69591250|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
37905380|NCT00634933|69591251|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
37905381|NCT00634933|69591252|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
37905382|NCT00634933|69591248|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
37905383|NCT00634933|69591249|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
37905384|NCT00634933|69591250|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
37905385|NCT00634933|69591251|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
37905386|NCT00634933|69591252|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
37905387|NCT00634933|69591248|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
37905388|NCT00634933|69591249|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
37905389|NCT00634933|69591250|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
37905390|NCT00634933|69591251|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
37905391|NCT00634933|69591252|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
37905392|NCT00634933|69591248|FG000|Part A: Baseline to Week 24|Other|1|||
37905393|NCT00634933|69591249|FG001|Part A: Baseline to Week 24|Other|8|||
37905394|NCT00634933|69591250|FG002|Part A: Baseline to Week 24|Other|5|||
37905395|NCT00634933|69591251|FG003|Part A: Baseline to Week 24|Other|0|||
38001834|NCT00423449|69685537|FG002|Overall Study|Death|2|||
38001835|NCT00423449|69685538|FG003|Overall Study|Death|1|||
38001836|NCT00423449|69685539|FG004|Overall Study|Death|1|||
37829969|NCT01371721|69513110|FG002|Overall Study|Other|0|||
37829970|NCT01371721|69513108|FG000|Overall Study|Lack of Efficacy|2|||
37829971|NCT01371721|69513109|FG001|Overall Study|Lack of Efficacy|4|||
37905396|NCT00634933|69591252|FG004|Part A: Baseline to Week 24|Other|0|||
37905397|NCT00634933|69591248|FG000|Between Part A and Part B|Physician Decision|0|||
37905398|NCT00634933|69591249|FG001|Between Part A and Part B|Physician Decision|1|||
37905399|NCT00634933|69591250|FG002|Between Part A and Part B|Physician Decision|0|||
37905400|NCT00634933|69591251|FG003|Between Part A and Part B|Physician Decision|0|||
37905401|NCT00634933|69591252|FG004|Between Part A and Part B|Physician Decision|0|||
37905402|NCT00634933|69591248|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
37905403|NCT00634933|69591249|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
37905404|NCT00634933|69591250|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
37905405|NCT00634933|69591251|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
37905406|NCT00634933|69591252|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
37905407|NCT00634933|69591248|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
37829972|NCT01371721|69513110|FG002|Overall Study|Lack of Efficacy|3|||
37829973|NCT01371721|69513108|FG000|Overall Study|Randomized but not treated|1|||
37829974|NCT01371721|69513109|FG001|Overall Study|Randomized but not treated|0|||
37829975|NCT01371721|69513110|FG002|Overall Study|Randomized but not treated|0|||
37829976|NCT01366534|69513123|FG000|Overall Study|Lost to Follow-up|1|||
37905408|NCT00634933|69591249|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
37905409|NCT00634933|69591250|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
37905410|NCT00634933|69591251|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
37905411|NCT00634933|69591252|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
37905412|NCT00634933|69591248|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
37905413|NCT00634933|69591249|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
37905414|NCT00634933|69591250|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
37905415|NCT00634933|69591251|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
37905416|NCT00634933|69591252|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
37905417|NCT00634933|69591248|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
37905418|NCT00634933|69591249|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
37905419|NCT00634933|69591250|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
37905420|NCT00634933|69591251|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
37905421|NCT00634933|69591252|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
37905422|NCT00634933|69591248|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
37905423|NCT00634933|69591249|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
37905424|NCT00634933|69591250|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
37905425|NCT00634933|69591251|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
37905426|NCT00634933|69591252|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
37905427|NCT00634933|69591248|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
37905428|NCT00634933|69591249|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
37905429|NCT00634933|69591250|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
37905430|NCT00634933|69591251|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
37905431|NCT00634933|69591252|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
37905432|NCT00634933|69591248|FG000|Part B: Week 24 to Week 52|Other|0|||
37905433|NCT00634933|69591249|FG001|Part B: Week 24 to Week 52|Other|0|||
37905434|NCT00634933|69591250|FG002|Part B: Week 24 to Week 52|Other|5|||
37905435|NCT00634933|69591251|FG003|Part B: Week 24 to Week 52|Other|0|||
37905436|NCT00634933|69591252|FG004|Part B: Week 24 to Week 52|Other|1|||
37905437|NCT00967499|69591266|FG000|Overall Study|Adverse Event|0|||
37905438|NCT00967499|69591267|FG001|Overall Study|Adverse Event|1|||
37905439|NCT00967499|69591266|FG000|Overall Study|Protocol Violation|1|||
37905440|NCT00967499|69591267|FG001|Overall Study|Protocol Violation|0|||
37905441|NCT00967499|69591266|FG000|Overall Study|Sponsor Decision|1|||
37905442|NCT00967499|69591267|FG001|Overall Study|Sponsor Decision|0|||
37905443|NCT00967499|69591266|FG000|Overall Study|Randomized but not treated|63|||
37905444|NCT00967499|69591267|FG001|Overall Study|Randomized but not treated|59|||
37905445|NCT03909971|69591275|FG000|Overall Study|Other Reasons Not Specified|0|||
37905446|NCT03909971|69591276|FG001|Overall Study|Other Reasons Not Specified|1|||
37905447|NCT03909971|69591275|FG000|Overall Study|Global Deterioration of Health Status|2|||
37905448|NCT03909971|69591276|FG001|Overall Study|Global Deterioration of Health Status|1|||
37905449|NCT03909971|69591275|FG000|Overall Study|Progressive Disease|6|||
37905450|NCT03909971|69591276|FG001|Overall Study|Progressive Disease|14|||
37905451|NCT03909971|69591275|FG000|Overall Study|Death|2|||
38001837|NCT00423449|69685535|FG000|Overall Study|Progressive Disease|1|||
37829977|NCT01366534|69513124|FG001|Overall Study|Lost to Follow-up|0|||
37905452|NCT03909971|69591276|FG001|Overall Study|Death|6|||
37905453|NCT00967343|69591283|FG000|Overall Study|Study termination by sponsor|12|||
37905454|NCT00967343|69591283|FG000|Overall Study|Death|24|||
37905455|NCT00967343|69591283|FG000|Overall Study|Relapse|1|||
38001838|NCT00423449|69685536|FG001|Overall Study|Progressive Disease|3|||
38001839|NCT00423449|69685537|FG002|Overall Study|Progressive Disease|8|||
38001840|NCT00423449|69685538|FG003|Overall Study|Progressive Disease|11|||
38001841|NCT00423449|69685539|FG004|Overall Study|Progressive Disease|4|||
38001842|NCT00423449|69685535|FG000|Overall Study|Laboratory Adverse Event|0|||
38001843|NCT00423449|69685536|FG001|Overall Study|Laboratory Adverse Event|1|||
38001844|NCT00423449|69685537|FG002|Overall Study|Laboratory Adverse Event|2|||
38001845|NCT00423449|69685538|FG003|Overall Study|Laboratory Adverse Event|0|||
38001846|NCT00423449|69685539|FG004|Overall Study|Laboratory Adverse Event|0|||
38001847|NCT00423449|69685535|FG000|Overall Study|Other|0|||
38001848|NCT00423449|69685536|FG001|Overall Study|Other|0|||
38001849|NCT00423449|69685537|FG002|Overall Study|Other|0|||
38001850|NCT00423449|69685538|FG003|Overall Study|Other|1|||
38001851|NCT00423449|69685539|FG004|Overall Study|Other|0|||
38001852|NCT00423449|69685535|FG000|Overall Study|Protocol Violation|0|||
38001853|NCT00423449|69685536|FG001|Overall Study|Protocol Violation|0|||
38001854|NCT00423449|69685537|FG002|Overall Study|Protocol Violation|2|||
38001855|NCT00423449|69685538|FG003|Overall Study|Protocol Violation|1|||
38001856|NCT00423449|69685539|FG004|Overall Study|Protocol Violation|0|||
38001857|NCT00423293|69685552|FG000|Overall Study|Ineligible / No protocol treatment|11|||
38001858|NCT00423137|69685560|FG000|Overall Study|Lost to Follow-up|0|||
38001859|NCT00423137|69685561|FG001|Overall Study|Lost to Follow-up|0|||
38001860|NCT00423137|69685562|FG002|Overall Study|Lost to Follow-up|1|||
38001861|NCT00423137|69685563|FG003|Overall Study|Lost to Follow-up|0|||
38001862|NCT00423137|69685560|FG000|Overall Study|Protocol Violation|0|||
38001863|NCT00423137|69685561|FG001|Overall Study|Protocol Violation|0|||
38001864|NCT00423137|69685562|FG002|Overall Study|Protocol Violation|0|||
38001865|NCT00423137|69685563|FG003|Overall Study|Protocol Violation|1|||
38001866|NCT00423137|69685560|FG000|Overall Study|Adverse Event Study disease worse|1|||
38001867|NCT00423137|69685561|FG001|Overall Study|Adverse Event Study disease worse|0|||
38001868|NCT00423137|69685562|FG002|Overall Study|Adverse Event Study disease worse|3|||
38001869|NCT00423137|69685563|FG003|Overall Study|Adverse Event Study disease worse|1|||
38001870|NCT00423137|69685560|FG000|Overall Study|Adverse Event Other|0|||
38001871|NCT00423137|69685561|FG001|Overall Study|Adverse Event Other|0|||
38001872|NCT00423137|69685562|FG002|Overall Study|Adverse Event Other|2|||
38001873|NCT00423137|69685563|FG003|Overall Study|Adverse Event Other|0|||
38001874|NCT00422903|69685578|FG000|Overall Study|Disease Progression|3|||
38001875|NCT00422903|69685579|FG001|Overall Study|Disease Progression|1|||
38001876|NCT00422903|69685578|FG000|Overall Study|Adverse Event|0|||
38001877|NCT00422903|69685579|FG001|Overall Study|Adverse Event|2|||
38001878|NCT00422903|69685578|FG000|Overall Study|Informed Consent Withdrawn|1|||
38001879|NCT00422903|69685579|FG001|Overall Study|Informed Consent Withdrawn|2|||
38001880|NCT00422669|69685588|FG000|Overall Study|The study was terminated early.|98|||
38001881|NCT00422669|69685589|FG001|Overall Study|The study was terminated early.|100|||
38001882|NCT00422669|69685590|FG002|Overall Study|The study was terminated early.|7|||
37905456|NCT00967343|69591283|FG000|Overall Study|Lost to Follow-up|1|||
37905457|NCT00973973|69591289|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
37905458|NCT00973973|69591290|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
37905459|NCT00973973|69591289|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
37905460|NCT00973973|69591290|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
37905461|NCT00973973|69591289|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
37905462|NCT00973973|69591290|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
37905463|NCT00973973|69591289|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
37905464|NCT00973973|69591290|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
37905465|NCT00973973|69591289|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
37905466|NCT00973973|69591290|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
37905467|NCT00973973|69591289|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
37905468|NCT00973973|69591290|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
37905469|NCT00973973|69591289|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
37905470|NCT00973973|69591290|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
37905471|NCT00973973|69591289|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
38001883|NCT00422591|69685596|FG000|Overall Study|Physician Decision|4|||
38001884|NCT00422591|69685596|FG000|Overall Study|Withdrawal by Subject|2|||
38001885|NCT00422513|69685602|FG000|Overall Study|Lack of Efficacy|4|||
38001886|NCT00422513|69685603|FG001|Overall Study|Lack of Efficacy|5|||
38001887|NCT00422513|69685602|FG000|Overall Study|Protocol Violation|23|||
38001888|NCT00422513|69685603|FG001|Overall Study|Protocol Violation|7|||
38001889|NCT00422513|69685602|FG000|Overall Study|Refused Treatment|4|||
38001890|NCT00422513|69685603|FG001|Overall Study|Refused Treatment|2|||
38001891|NCT00422513|69685602|FG000|Overall Study|Withdrawal by Subject|2|||
38001892|NCT00422513|69685603|FG001|Overall Study|Withdrawal by Subject|1|||
38001893|NCT00422513|69685602|FG000|Overall Study|early termination of the study|67|||
38001894|NCT00422513|69685603|FG001|Overall Study|early termination of the study|80|||
38001895|NCT00422513|69685602|FG000|Overall Study|Adverse Event|4|||
38001896|NCT00422513|69685603|FG001|Overall Study|Adverse Event|4|||
38001897|NCT00422513|69685602|FG000|Overall Study|Death|3|||
38001898|NCT00422513|69685603|FG001|Overall Study|Death|7|||
38001899|NCT00202878|69685611|FG000|Overall Study|Death|964|||
38001900|NCT00202878|69685612|FG001|Overall Study|Death|968|||
38001901|NCT00202878|69685611|FG000|Overall Study|Only Vital Status Known|357|||
38001902|NCT00202878|69685612|FG001|Overall Study|Only Vital Status Known|356|||
37697431|NCT02021565|69173943|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
37905472|NCT00973973|69591290|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
37905473|NCT00973973|69591289|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
37905474|NCT00973973|69591290|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
37905475|NCT00973973|69591289|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
37905476|NCT00973973|69591290|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
37905477|NCT00973973|69591289|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
37905478|NCT00973973|69591290|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
37905479|NCT00973973|69591289|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
37905480|NCT00973973|69591290|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
37905481|NCT00633139|69591299|FG000|Overall Study|Non compliance|0|||
37905482|NCT00633139|69591300|FG001|Overall Study|Non compliance|0|||
37905483|NCT00633139|69591301|FG002|Overall Study|Non compliance|1|||
37905484|NCT00633139|69591299|FG000|Overall Study|Withdrawal by Subject|0|||
37905485|NCT00633139|69591300|FG001|Overall Study|Withdrawal by Subject|1|||
37905486|NCT00633139|69591301|FG002|Overall Study|Withdrawal by Subject|0|||
37905487|NCT00965081|69591311|FG000|Overall Study|Adverse Event|14|||
37905488|NCT00965081|69591312|FG001|Overall Study|Adverse Event|9|||
37905489|NCT00965081|69591311|FG000|Overall Study|Lack of Efficacy|2|||
37697432|NCT02021565|69173942|FG000|3-month Follow-up|Death|3|||
37697433|NCT02021565|69173943|FG001|3-month Follow-up|Death|0|||
37697434|NCT02021565|69173942|FG000|3-month Follow-up|Withdrawal by Subject|4|||
37697435|NCT02021565|69173943|FG001|3-month Follow-up|Withdrawal by Subject|0|||
37905490|NCT00965081|69591312|FG001|Overall Study|Lack of Efficacy|5|||
38001903|NCT00202878|69685611|FG000|Overall Study|Lost to Follow-up|44|||
38001904|NCT00202878|69685612|FG001|Overall Study|Lost to Follow-up|49|||
38001905|NCT00202878|69685611|FG000|Overall Study|Site Closure|39|||
38001906|NCT00202878|69685612|FG001|Overall Study|Site Closure|36|||
38001907|NCT00202878|69685611|FG000|Overall Study|Withdrawal by Subject|795|||
38001908|NCT00202878|69685612|FG001|Overall Study|Withdrawal by Subject|808|||
38001909|NCT00414011|69685618|FG000|Overall Study|Physician Decision|3|||
38001910|NCT00414011|69685618|FG000|Overall Study|Withdrawal by Subject|2|||
38001911|NCT00231816|69685625|FG000|Overall Study|Adverse Event|1|||
38001912|NCT00231816|69685626|FG001|Overall Study|Adverse Event|0|||
38001913|NCT00231816|69685625|FG000|Overall Study|Lost to Follow-up|8|||
38001914|NCT00231816|69685626|FG001|Overall Study|Lost to Follow-up|5|||
38001915|NCT00231816|69685625|FG000|Overall Study|Protocol Violation|2|||
38001916|NCT00231816|69685626|FG001|Overall Study|Protocol Violation|3|||
38001917|NCT00231816|69685625|FG000|Overall Study|Withdrawal by Subject|3|||
38001918|NCT00231816|69685626|FG001|Overall Study|Withdrawal by Subject|3|||
38001919|NCT00231816|69685625|FG000|Overall Study|Other|2|||
38001920|NCT00231816|69685626|FG001|Overall Study|Other|1|||
38001921|NCT00260208|69685635|FG000|Overall Study|Subject withdrew consent|11|||
38001922|NCT00260208|69685636|FG001|Overall Study|Subject withdrew consent|7|||
38001923|NCT00260208|69685635|FG000|Overall Study|Lost to Follow-up|6|||
38001924|NCT00260208|69685636|FG001|Overall Study|Lost to Follow-up|1|||
38001925|NCT00260208|69685635|FG000|Overall Study|Death|12|||
38001926|NCT00260208|69685636|FG001|Overall Study|Death|10|||
38001927|NCT00260208|69685635|FG000|Overall Study|Missing|18|||
38001928|NCT00260208|69685636|FG001|Overall Study|Missing|16|||
38001929|NCT00202644|69685644|FG000|Overall Study|Adverse Event|12|||
38001930|NCT00202644|69685645|FG001|Overall Study|Adverse Event|13|||
37905491|NCT00965081|69591311|FG000|Overall Study|Lost to Follow-up|4|||
37905492|NCT00965081|69591312|FG001|Overall Study|Lost to Follow-up|5|||
38001931|NCT00202644|69685644|FG000|Overall Study|Withdrawal by Subject|8|||
38001932|NCT00202644|69685645|FG001|Overall Study|Withdrawal by Subject|6|||
38001933|NCT00202644|69685644|FG000|Overall Study|Lack of Efficacy|6|||
37697436|NCT02021565|69173942|FG000|3-month Follow-up|Protocol Violation|3|||
37905493|NCT00965081|69591311|FG000|Overall Study|Physician Decision|2|||
38001934|NCT00202644|69685645|FG001|Overall Study|Lack of Efficacy|6|||
38001935|NCT00202644|69685644|FG000|Overall Study|Lost to Follow-up|0|||
38001936|NCT00202644|69685645|FG001|Overall Study|Lost to Follow-up|1|||
38001937|NCT00202644|69685644|FG000|Overall Study|Other|9|||
37697437|NCT02021565|69173943|FG001|3-month Follow-up|Protocol Violation|2|||
37697438|NCT02021331|69173953|FG000|Overall Study|Adverse Event|0|||
38001938|NCT00202644|69685645|FG001|Overall Study|Other|1|||
38001939|NCT01235962|69685655|FG000|Overall Study|Withdrawal by Subject|20|||
37905494|NCT00965081|69591312|FG001|Overall Study|Physician Decision|0|||
37905495|NCT00965081|69591311|FG000|Overall Study|Protocol Violation|2|||
37905496|NCT00965081|69591312|FG001|Overall Study|Protocol Violation|5|||
37905497|NCT00965081|69591311|FG000|Overall Study|Sponsor Decision|1|||
37905498|NCT00965081|69591312|FG001|Overall Study|Sponsor Decision|0|||
37905499|NCT00965081|69591311|FG000|Overall Study|Withdrawal by Subject|4|||
37905500|NCT00965081|69591312|FG001|Overall Study|Withdrawal by Subject|7|||
37905501|NCT00965081|69591311|FG000|Overall Study|Switched to Rescue Arm|5|||
37905502|NCT00965081|69591312|FG001|Overall Study|Switched to Rescue Arm|12|||
38001940|NCT01235962|69685656|FG001|Overall Study|Withdrawal by Subject|19|||
38001941|NCT01235962|69685657|FG002|Overall Study|Withdrawal by Subject|62|||
37905503|NCT00961649|69591323|FG000|Overall Study|Adverse Event|4|||
37905504|NCT00961649|69591324|FG001|Overall Study|Adverse Event|0|||
37905505|NCT00961649|69591325|FG002|Overall Study|Adverse Event|0|||
37905506|NCT00961649|69591326|FG003|Overall Study|Adverse Event|2|||
37905507|NCT00961649|69591323|FG000|Overall Study|Inadequate control of IOP|0|||
37905508|NCT00961649|69591324|FG001|Overall Study|Inadequate control of IOP|0|||
37905509|NCT00961649|69591325|FG002|Overall Study|Inadequate control of IOP|0|||
37905510|NCT00961649|69591326|FG003|Overall Study|Inadequate control of IOP|1|||
37905511|NCT00961649|69591323|FG000|Overall Study|Patient has travel plans during holidays|0|||
37905512|NCT00961649|69591324|FG001|Overall Study|Patient has travel plans during holidays|0|||
37905513|NCT00961649|69591325|FG002|Overall Study|Patient has travel plans during holidays|1|||
37905514|NCT00961649|69591326|FG003|Overall Study|Patient has travel plans during holidays|0|||
37905515|NCT00961649|69591323|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
37905516|NCT00961649|69591324|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
37905517|NCT00961649|69591325|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
37905518|NCT00961649|69591326|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
37905519|NCT00961649|69591323|FG000|Overall Study|Study terminated by sponsor|4|||
37905520|NCT00961649|69591324|FG001|Overall Study|Study terminated by sponsor|4|||
37905521|NCT00961649|69591325|FG002|Overall Study|Study terminated by sponsor|4|||
37905522|NCT00961649|69591326|FG003|Overall Study|Study terminated by sponsor|1|||
37905523|NCT00632125|69591336|FG000|Overall Study|Death|82|||
37905524|NCT00632125|69591336|FG000|Overall Study|Withdrawal by Subject|44|||
37905525|NCT00632125|69591336|FG000|Overall Study|Adverse Event|36|||
37905526|NCT00632125|69591336|FG000|Overall Study|Renal transplantation|17|||
37905527|NCT00632125|69591336|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
37905528|NCT00632125|69591336|FG000|Overall Study|Non-compliance|8|||
37905529|NCT00632125|69591336|FG000|Overall Study|Development of uncontrolled hypertension|5|||
37905530|NCT00632125|69591336|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
37905531|NCT00903968|69591342|FG000|Overall Study|Adverse Event|0|||
37905532|NCT00903968|69591343|FG001|Overall Study|Adverse Event|0|||
37905533|NCT00903968|69591344|FG002|Overall Study|Adverse Event|0|||
37905534|NCT00903968|69591345|FG003|Overall Study|Adverse Event|0|||
37905535|NCT00903968|69591346|FG004|Overall Study|Adverse Event|0|||
37905536|NCT00903968|69591347|FG005|Overall Study|Adverse Event|0|||
37905537|NCT00903968|69591348|FG006|Overall Study|Adverse Event|1|||
37905538|NCT00903968|69591349|FG007|Overall Study|Adverse Event|8|||
37905539|NCT00903968|69591342|FG000|Overall Study|DLT|0|||
37905540|NCT00903968|69591343|FG001|Overall Study|DLT|0|||
37905541|NCT00903968|69591344|FG002|Overall Study|DLT|0|||
37905542|NCT00903968|69591345|FG003|Overall Study|DLT|0|||
37905543|NCT00903968|69591346|FG004|Overall Study|DLT|0|||
37905544|NCT00903968|69591347|FG005|Overall Study|DLT|0|||
37905545|NCT00903968|69591348|FG006|Overall Study|DLT|2|||
37905546|NCT00903968|69591349|FG007|Overall Study|DLT|0|||
37905547|NCT00903968|69591342|FG000|Overall Study|Withdrawal by Subject|1|||
37905548|NCT00903968|69591343|FG001|Overall Study|Withdrawal by Subject|0|||
37905549|NCT00903968|69591344|FG002|Overall Study|Withdrawal by Subject|1|||
37905550|NCT00903968|69591345|FG003|Overall Study|Withdrawal by Subject|0|||
37905551|NCT00903968|69591346|FG004|Overall Study|Withdrawal by Subject|1|||
37905552|NCT00903968|69591347|FG005|Overall Study|Withdrawal by Subject|1|||
37905553|NCT00903968|69591348|FG006|Overall Study|Withdrawal by Subject|0|||
37905554|NCT00903968|69591349|FG007|Overall Study|Withdrawal by Subject|4|||
37905555|NCT00903968|69591342|FG000|Overall Study|Non-Compliance|0|||
37905556|NCT00903968|69591343|FG001|Overall Study|Non-Compliance|0|||
37905557|NCT00903968|69591344|FG002|Overall Study|Non-Compliance|0|||
37905558|NCT00903968|69591345|FG003|Overall Study|Non-Compliance|0|||
37905559|NCT00903968|69591346|FG004|Overall Study|Non-Compliance|0|||
37905560|NCT00903968|69591347|FG005|Overall Study|Non-Compliance|1|||
37905561|NCT00903968|69591348|FG006|Overall Study|Non-Compliance|0|||
37905562|NCT00903968|69591349|FG007|Overall Study|Non-Compliance|0|||
37905563|NCT00903968|69591342|FG000|Overall Study|Physician Decision|0|||
37905564|NCT00903968|69591343|FG001|Overall Study|Physician Decision|0|||
37905565|NCT00903968|69591344|FG002|Overall Study|Physician Decision|0|||
37905566|NCT00903968|69591345|FG003|Overall Study|Physician Decision|0|||
37905567|NCT00903968|69591346|FG004|Overall Study|Physician Decision|0|||
37905568|NCT00903968|69591347|FG005|Overall Study|Physician Decision|1|||
37905569|NCT00903968|69591348|FG006|Overall Study|Physician Decision|0|||
38001942|NCT01235962|69685658|FG003|Overall Study|Withdrawal by Subject|49|||
38001943|NCT01235962|69685655|FG000|Overall Study|Lost to Follow-up|21|||
38001944|NCT01235962|69685656|FG001|Overall Study|Lost to Follow-up|16|||
38001945|NCT01235962|69685657|FG002|Overall Study|Lost to Follow-up|47|||
38001946|NCT01235962|69685658|FG003|Overall Study|Lost to Follow-up|32|||
38001947|NCT01235962|69685655|FG000|Overall Study|Physician Decision|5|||
38001948|NCT01235962|69685656|FG001|Overall Study|Physician Decision|0|||
38001949|NCT01235962|69685657|FG002|Overall Study|Physician Decision|9|||
38001950|NCT01235962|69685658|FG003|Overall Study|Physician Decision|5|||
38001951|NCT00259740|69685678|FG000|Overall Study|Physician Decision|1|||
38001952|NCT00259740|69685679|FG001|Overall Study|Physician Decision|1|||
38001953|NCT00259740|69685678|FG000|Overall Study|Adverse Event|0|||
38001954|NCT00259740|69685679|FG001|Overall Study|Adverse Event|2|||
38001955|NCT00259740|69685678|FG000|Overall Study|Withdrawal by Subject|2|||
38001956|NCT00259740|69685679|FG001|Overall Study|Withdrawal by Subject|6|||
38001957|NCT00259740|69685678|FG000|Overall Study|Death|1|||
38001958|NCT00259740|69685679|FG001|Overall Study|Death|1|||
38001959|NCT00259740|69685678|FG000|Overall Study|Disease progression|19|||
38001960|NCT00259740|69685679|FG001|Overall Study|Disease progression|36|||
38001961|NCT00259740|69685678|FG000|Overall Study|Ongoing|17|||
38001962|NCT00259740|69685679|FG001|Overall Study|Ongoing|3|||
38001963|NCT00259740|69685678|FG000|Overall Study|Other|3|||
38001964|NCT00259740|69685679|FG001|Overall Study|Other|0|||
38001965|NCT00259740|69685678|FG000|Overall Study|Requirement for alternative therapy|0|||
38001966|NCT00259740|69685679|FG001|Overall Study|Requirement for alternative therapy|4|||
38001967|NCT00201006|69685688|FG000|Overall Study|Withdrawal by Subject|7|||
38001968|NCT00201006|69685689|FG001|Overall Study|Withdrawal by Subject|2|||
38001969|NCT00201006|69685690|FG002|Overall Study|Withdrawal by Subject|3|||
38001970|NCT00201006|69685688|FG000|Overall Study|Adverse Event|1|||
38001971|NCT00201006|69685689|FG001|Overall Study|Adverse Event|0|||
38001972|NCT00201006|69685690|FG002|Overall Study|Adverse Event|1|||
38001973|NCT00200850|69685701|FG000|Overall Study|relocation|1|||
38001974|NCT00200850|69685702|FG001|Overall Study|relocation|0|||
38001975|NCT00200850|69685703|FG002|Overall Study|relocation|1|||
38001976|NCT00200850|69685701|FG000|Overall Study|too busy|1|||
38001977|NCT00200850|69685702|FG001|Overall Study|too busy|0|||
38001978|NCT00200850|69685703|FG002|Overall Study|too busy|0|||
38001979|NCT00200850|69685701|FG000|Overall Study|Pregnancy|0|||
38001980|NCT00200850|69685702|FG001|Overall Study|Pregnancy|0|||
38001981|NCT00200850|69685703|FG002|Overall Study|Pregnancy|1|||
38001982|NCT00200850|69685701|FG000|Overall Study|Poor adherence|0|||
38001983|NCT00200850|69685702|FG001|Overall Study|Poor adherence|0|||
38001984|NCT00200850|69685703|FG002|Overall Study|Poor adherence|1|||
38001985|NCT00200850|69685701|FG000|Overall Study|optic neuritis|0|||
38001986|NCT00200850|69685702|FG001|Overall Study|optic neuritis|0|||
38001987|NCT00200850|69685703|FG002|Overall Study|optic neuritis|1|||
38001988|NCT00200850|69685701|FG000|Overall Study|Adverse Event|1|||
38001989|NCT00200850|69685702|FG001|Overall Study|Adverse Event|1|||
38001990|NCT00200850|69685703|FG002|Overall Study|Adverse Event|2|||
38001991|NCT03812224|69685713|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
38001992|NCT03812224|69685714|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
38001993|NCT03812224|69685713|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
38001994|NCT03812224|69685714|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
38001995|NCT03812224|69685713|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
38001996|NCT03812224|69685714|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
38001997|NCT03812224|69685713|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
37697439|NCT02021331|69173954|FG001|Overall Study|Adverse Event|2|||
37697440|NCT02085135|69173962|FG000|Overall Study|Adverse Event|4|||
37697441|NCT02085135|69173963|FG001|Overall Study|Adverse Event|7|||
37697442|NCT02085135|69173962|FG000|Overall Study|Lost to Follow-up|2|||
37697443|NCT02085135|69173963|FG001|Overall Study|Lost to Follow-up|2|||
37697444|NCT02085135|69173962|FG000|Overall Study|Withdrawal by Subject|3|||
37697445|NCT02085135|69173963|FG001|Overall Study|Withdrawal by Subject|0|||
37697446|NCT02085135|69173962|FG000|Overall Study|Lack of Efficacy|2|||
38001998|NCT03812224|69685714|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
38001999|NCT00231114|69685723|FG000|Randomized|Withdrawal by Subject|6|||
38002000|NCT00231114|69685724|FG001|Randomized|Withdrawal by Subject|3|||
38002001|NCT00231114|69685723|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
38002002|NCT00231114|69685724|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
38002003|NCT00231114|69685723|FG000|Post-Treatment Period|Lost to Follow-up|6|||
37697447|NCT02085135|69173963|FG001|Overall Study|Lack of Efficacy|0|||
37697448|NCT02441309|69173972|FG000|Overall Study|Disease progression|2|||
38002004|NCT00231114|69685724|FG001|Post-Treatment Period|Lost to Follow-up|1|||
38002005|NCT00231114|69685723|FG000|Post-Treatment Period|Physician Decision|1|||
38002006|NCT00231114|69685724|FG001|Post-Treatment Period|Physician Decision|0|||
38002007|NCT00231114|69685723|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
37697449|NCT02441309|69173973|FG001|Overall Study|Disease progression|1|||
38002008|NCT00231114|69685724|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
38002009|NCT03543046|69685734|FG000|Overall Study|Adverse Event|1|||
38002010|NCT03543046|69685735|FG001|Overall Study|Adverse Event|1|||
38002011|NCT03543046|69685734|FG000|Overall Study|Physician Decision|1|||
37905570|NCT00903968|69591349|FG007|Overall Study|Physician Decision|0|||
37905571|NCT00903968|69591342|FG000|Overall Study|Progressive Disease|2|||
38002012|NCT03543046|69685735|FG001|Overall Study|Physician Decision|1|||
37829978|NCT01366534|69513125|FG002|Overall Study|Lost to Follow-up|0|||
37829979|NCT01366534|69513123|FG000|Overall Study|Migrated|1|||
37829980|NCT01366534|69513124|FG001|Overall Study|Migrated|1|||
37829981|NCT01366534|69513125|FG002|Overall Study|Migrated|0|||
37829982|NCT01366534|69513123|FG000|Overall Study|Declined challenged|0|||
37829983|NCT01366534|69513124|FG001|Overall Study|Declined challenged|1|||
37829984|NCT01366534|69513125|FG002|Overall Study|Declined challenged|0|||
37829985|NCT01365910|69513133|FG000|Overall Study|Withdrawal by Subject|7|||
37829986|NCT01365910|69513133|FG000|Overall Study|disease progression|18|||
37829987|NCT01365910|69513133|FG000|Overall Study|Adverse Event|3|||
37829988|NCT01365910|69513133|FG000|Overall Study|other complicating disease|1|||
37905572|NCT00903968|69591343|FG001|Overall Study|Progressive Disease|3|||
37905573|NCT00903968|69591344|FG002|Overall Study|Progressive Disease|2|||
37905574|NCT00903968|69591345|FG003|Overall Study|Progressive Disease|3|||
37697450|NCT02441309|69173974|FG002|Overall Study|Disease progression|2|||
37697451|NCT02441309|69173972|FG000|Overall Study|Adverse Event|0|||
37829989|NCT01365910|69513133|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
37905575|NCT00903968|69591346|FG004|Overall Study|Progressive Disease|3|||
37905576|NCT00903968|69591347|FG005|Overall Study|Progressive Disease|3|||
37905577|NCT00903968|69591348|FG006|Overall Study|Progressive Disease|0|||
37905578|NCT00903968|69591349|FG007|Overall Study|Progressive Disease|18|||
37905579|NCT00903968|69591342|FG000|Overall Study|Lack of Efficacy|0|||
37905580|NCT00903968|69591343|FG001|Overall Study|Lack of Efficacy|0|||
37905581|NCT00903968|69591344|FG002|Overall Study|Lack of Efficacy|0|||
37905582|NCT00903968|69591345|FG003|Overall Study|Lack of Efficacy|0|||
37905583|NCT00903968|69591346|FG004|Overall Study|Lack of Efficacy|0|||
37905584|NCT00903968|69591347|FG005|Overall Study|Lack of Efficacy|0|||
37905585|NCT00903968|69591348|FG006|Overall Study|Lack of Efficacy|0|||
37905586|NCT00903968|69591349|FG007|Overall Study|Lack of Efficacy|3|||
37905587|NCT00903344|69591372|FG000|Overall Study|Pregnancy|2|||
37905588|NCT00903344|69591373|FG001|Overall Study|Pregnancy|3|||
37905589|NCT00903344|69591372|FG000|Overall Study|Lost to Follow-up|3|||
37905590|NCT00903344|69591373|FG001|Overall Study|Lost to Follow-up|0|||
37905591|NCT00903032|69591381|FG000|Overall Study|Withdrawal by Subject|5|||
37905592|NCT00903032|69591382|FG001|Overall Study|Withdrawal by Subject|3|||
37905593|NCT00903032|69591381|FG000|Overall Study|Lost to Follow-up|2|||
37905594|NCT00903032|69591382|FG001|Overall Study|Lost to Follow-up|2|||
37905595|NCT00902564|69591397|FG000|Overall Study|Withdrawal by Subject|2|||
37905596|NCT00626197|69591404|FG000|Overall Study|Did not cooperate|2|||
37905597|NCT00626197|69591405|FG001|Overall Study|Did not cooperate|6|||
37905598|NCT00626197|69591406|FG002|Overall Study|Did not cooperate|1|||
37905599|NCT00626197|69591404|FG000|Overall Study|Failure to return|6|||
37905600|NCT00626197|69591405|FG001|Overall Study|Failure to return|5|||
37905601|NCT00626197|69591406|FG002|Overall Study|Failure to return|6|||
37905602|NCT00626197|69591404|FG000|Overall Study|Adverse event, serious fatal|3|||
37697452|NCT02441309|69173973|FG001|Overall Study|Adverse Event|1|||
37829990|NCT01365481|69513141|FG000|Overall Study|Adverse Event|6|||
37829991|NCT01365481|69513142|FG001|Overall Study|Adverse Event|9|||
37829992|NCT01365481|69513143|FG002|Overall Study|Adverse Event|0|||
37905603|NCT00626197|69591405|FG001|Overall Study|Adverse event, serious fatal|6|||
37905604|NCT00626197|69591406|FG002|Overall Study|Adverse event, serious fatal|6|||
37905605|NCT00626197|69591404|FG000|Overall Study|Adverse Event|1|||
37905606|NCT00626197|69591405|FG001|Overall Study|Adverse Event|1|||
37905607|NCT00626197|69591406|FG002|Overall Study|Adverse Event|2|||
37905608|NCT00626197|69591404|FG000|Overall Study|Withdrawal by Subject|17|||
37905609|NCT00626197|69591405|FG001|Overall Study|Withdrawal by Subject|17|||
37905610|NCT00626197|69591406|FG002|Overall Study|Withdrawal by Subject|7|||
37905611|NCT00626197|69591404|FG000|Overall Study|Administrative reasons|15|||
38002013|NCT03543046|69685734|FG000|Overall Study|Protocol Violation|1|||
37905612|NCT00626197|69591405|FG001|Overall Study|Administrative reasons|19|||
37905613|NCT00626197|69591406|FG002|Overall Study|Administrative reasons|55|||
37905614|NCT00626275|69591420|FG000|Part A - Treatment Period 1|Adverse Event|1|||
37905615|NCT00626275|69591421|FG001|Part A - Treatment Period 1|Adverse Event|0|||
38002014|NCT03543046|69685735|FG001|Overall Study|Protocol Violation|0|||
38002015|NCT00259272|69685754|FG000|Overall Study|Adverse Event|2|||
38002016|NCT00259272|69685755|FG001|Overall Study|Adverse Event|1|||
38002017|NCT00259272|69685756|FG002|Overall Study|Adverse Event|0|||
37697453|NCT02441309|69173974|FG002|Overall Study|Adverse Event|0|||
37829993|NCT01365481|69513144|FG003|Overall Study|Adverse Event|2|||
37829994|NCT01365481|69513141|FG000|Overall Study|Withdrawal by Subject|0|||
37829995|NCT01365481|69513142|FG001|Overall Study|Withdrawal by Subject|2|||
37829996|NCT01365481|69513143|FG002|Overall Study|Withdrawal by Subject|1|||
37829997|NCT01365481|69513144|FG003|Overall Study|Withdrawal by Subject|1|||
37829998|NCT01365481|69513141|FG000|Overall Study|Lost to Follow-up|1|||
37829999|NCT01365481|69513142|FG001|Overall Study|Lost to Follow-up|1|||
37830000|NCT01365481|69513143|FG002|Overall Study|Lost to Follow-up|2|||
37905616|NCT00626275|69591422|FG002|Part A - Treatment Period 1|Adverse Event|0|||
37905617|NCT00626275|69591423|FG003|Part A - Treatment Period 1|Adverse Event|0|||
37905618|NCT00626275|69591424|FG004|Part A - Treatment Period 1|Adverse Event|0|||
37905619|NCT00626275|69591425|FG005|Part A - Treatment Period 1|Adverse Event|0|||
37905620|NCT00626275|69591426|FG006|Part A - Treatment Period 1|Adverse Event|0|||
37905621|NCT00626275|69591427|FG007|Part A - Treatment Period 1|Adverse Event|0|||
37905622|NCT00626275|69591420|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
37905623|NCT00626275|69591421|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
37905624|NCT00626275|69591422|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
37905625|NCT00626275|69591423|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
37905626|NCT00626275|69591424|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
37905627|NCT00626275|69591425|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
37905628|NCT00626275|69591426|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
37905629|NCT00626275|69591427|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
37905630|NCT00626275|69591420|FG000|Part B|Lost to Follow-up|0|||
37905631|NCT00626275|69591421|FG001|Part B|Lost to Follow-up|0|||
37905632|NCT00626275|69591422|FG002|Part B|Lost to Follow-up|0|||
37905633|NCT00626275|69591423|FG003|Part B|Lost to Follow-up|0|||
37905634|NCT00626275|69591424|FG004|Part B|Lost to Follow-up|0|||
37905635|NCT00626275|69591425|FG005|Part B|Lost to Follow-up|0|||
37905636|NCT00626275|69591426|FG006|Part B|Lost to Follow-up|1|||
37905637|NCT00626275|69591427|FG007|Part B|Lost to Follow-up|0|||
37905638|NCT00626275|69591420|FG000|Part B|Withdrawal by Subject|0|||
37905639|NCT00626275|69591421|FG001|Part B|Withdrawal by Subject|0|||
37905640|NCT00626275|69591422|FG002|Part B|Withdrawal by Subject|0|||
37905641|NCT00626275|69591423|FG003|Part B|Withdrawal by Subject|0|||
37905642|NCT00626275|69591424|FG004|Part B|Withdrawal by Subject|0|||
37905643|NCT00626275|69591425|FG005|Part B|Withdrawal by Subject|0|||
37905644|NCT00626275|69591426|FG006|Part B|Withdrawal by Subject|0|||
37905645|NCT00626275|69591427|FG007|Part B|Withdrawal by Subject|1|||
37905646|NCT00623935|69591441|FG000|Overall Study|Death|1|||
37905647|NCT00623935|69591441|FG000|Overall Study|Patient Declined Transplant|1|||
37905648|NCT00623779|69591448|FG000|Overall Study|Adverse Event|1|||
37905649|NCT00623779|69591449|FG001|Overall Study|Adverse Event|3|||
37905650|NCT00623779|69591450|FG002|Overall Study|Adverse Event|0|||
37905651|NCT00623779|69591448|FG000|Overall Study|Criteria from CSR|2|||
37905652|NCT00623779|69591449|FG001|Overall Study|Criteria from CSR|0|||
37905653|NCT00623779|69591450|FG002|Overall Study|Criteria from CSR|1|||
37905654|NCT00629707|69591481|FG000|Overall Study|Withdrawal by Subject|0|||
37905655|NCT00629707|69591482|FG001|Overall Study|Withdrawal by Subject|1|||
37905656|NCT00629707|69591481|FG000|Overall Study|Physician Decision|0|||
37905657|NCT00629707|69591482|FG001|Overall Study|Physician Decision|1|||
37905658|NCT00902330|69591490|FG000|Overall Study|Too overwhelmed by treatment|2|||
37905659|NCT00902330|69591491|FG001|Overall Study|Too overwhelmed by treatment|5|||
37905660|NCT00902330|69591490|FG000|Overall Study|Adverse Event|1|||
37905661|NCT00902330|69591491|FG001|Overall Study|Adverse Event|0|||
37905662|NCT00902330|69591490|FG000|Overall Study|No post baseline data|1|||
38002018|NCT00259272|69685757|FG003|Overall Study|Adverse Event|3|||
37905663|NCT00902330|69591491|FG001|Overall Study|No post baseline data|0|||
37905664|NCT00901394|69591528|FG000|Overall Study|Physician Decision|1|||
37905665|NCT00901394|69591529|FG001|Overall Study|Physician Decision|1|||
37905666|NCT00901394|69591530|FG002|Overall Study|Physician Decision|2|||
37905667|NCT00896532|69591546|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
38002019|NCT00259272|69685754|FG000|Overall Study|Lack of Efficacy|5|||
37697454|NCT02441309|69173972|FG000|Overall Study|Withdrawal by Subject|1|||
37905668|NCT00896532|69591547|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
37830001|NCT01365481|69513144|FG003|Overall Study|Lost to Follow-up|3|||
37697455|NCT02441309|69173973|FG001|Overall Study|Withdrawal by Subject|0|||
37905669|NCT00896532|69591548|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
37905670|NCT00896532|69591549|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
38002020|NCT00259272|69685755|FG001|Overall Study|Lack of Efficacy|1|||
38002021|NCT00259272|69685756|FG002|Overall Study|Lack of Efficacy|2|||
38002022|NCT00259272|69685757|FG003|Overall Study|Lack of Efficacy|6|||
38002023|NCT00259272|69685754|FG000|Overall Study|Physician Decision|1|||
38002024|NCT00259272|69685755|FG001|Overall Study|Physician Decision|2|||
38002025|NCT00259272|69685756|FG002|Overall Study|Physician Decision|1|||
38002026|NCT00259272|69685757|FG003|Overall Study|Physician Decision|3|||
38002027|NCT00259272|69685754|FG000|Overall Study|Protocol Violation|2|||
38002028|NCT00259272|69685755|FG001|Overall Study|Protocol Violation|0|||
38002029|NCT00259272|69685756|FG002|Overall Study|Protocol Violation|0|||
38002030|NCT00259272|69685757|FG003|Overall Study|Protocol Violation|1|||
38002031|NCT00259272|69685754|FG000|Overall Study|Sponsor Decision|0|||
38002032|NCT00259272|69685755|FG001|Overall Study|Sponsor Decision|1|||
38002033|NCT00259272|69685756|FG002|Overall Study|Sponsor Decision|0|||
38002034|NCT00259272|69685757|FG003|Overall Study|Sponsor Decision|0|||
38002035|NCT00259272|69685754|FG000|Overall Study|Withdrawal by Subject|4|||
38002036|NCT00259272|69685755|FG001|Overall Study|Withdrawal by Subject|2|||
38002037|NCT00259272|69685756|FG002|Overall Study|Withdrawal by Subject|2|||
38002038|NCT00259272|69685757|FG003|Overall Study|Withdrawal by Subject|7|||
38002039|NCT00259272|69685754|FG000|Overall Study|Lost to Follow-up|1|||
38002040|NCT00259272|69685755|FG001|Overall Study|Lost to Follow-up|0|||
38002041|NCT00259272|69685756|FG002|Overall Study|Lost to Follow-up|0|||
38002042|NCT00259272|69685757|FG003|Overall Study|Lost to Follow-up|1|||
38002043|NCT00421889|69685790|FG000|Overall Study|Adverse Event|1|||
38002044|NCT00421889|69685791|FG001|Overall Study|Adverse Event|0|||
38002045|NCT00421889|69685792|FG002|Overall Study|Adverse Event|1|||
38002046|NCT00421889|69685793|FG003|Overall Study|Adverse Event|1|||
38002047|NCT00421889|69685794|FG004|Overall Study|Adverse Event|1|||
38002048|NCT00421889|69685795|FG005|Overall Study|Adverse Event|4|||
38002049|NCT00421889|69685796|FG006|Overall Study|Adverse Event|1|||
38002050|NCT00421889|69685797|FG007|Overall Study|Adverse Event|0|||
38002051|NCT00421889|69685798|FG008|Overall Study|Adverse Event|2|||
38002052|NCT00421889|69685790|FG000|Overall Study|Withdrawal by Subject|1|||
38002053|NCT00421889|69685791|FG001|Overall Study|Withdrawal by Subject|3|||
38002054|NCT00421889|69685792|FG002|Overall Study|Withdrawal by Subject|0|||
38002055|NCT00421889|69685793|FG003|Overall Study|Withdrawal by Subject|0|||
38002056|NCT00421889|69685794|FG004|Overall Study|Withdrawal by Subject|2|||
38002057|NCT00421889|69685795|FG005|Overall Study|Withdrawal by Subject|0|||
38002058|NCT00421889|69685796|FG006|Overall Study|Withdrawal by Subject|0|||
38002059|NCT00421889|69685797|FG007|Overall Study|Withdrawal by Subject|0|||
38002060|NCT00421889|69685798|FG008|Overall Study|Withdrawal by Subject|0|||
38002061|NCT00421889|69685790|FG000|Overall Study|Death|0|||
38002062|NCT00421889|69685791|FG001|Overall Study|Death|0|||
38002063|NCT00421889|69685792|FG002|Overall Study|Death|0|||
38002064|NCT00421889|69685793|FG003|Overall Study|Death|0|||
38002065|NCT00421889|69685794|FG004|Overall Study|Death|1|||
38002066|NCT00421889|69685795|FG005|Overall Study|Death|1|||
38002067|NCT00421889|69685796|FG006|Overall Study|Death|0|||
38002068|NCT00421889|69685797|FG007|Overall Study|Death|0|||
38002069|NCT00421889|69685798|FG008|Overall Study|Death|0|||
38002070|NCT00421889|69685790|FG000|Overall Study|Progressive disease|3|||
38002071|NCT00421889|69685791|FG001|Overall Study|Progressive disease|2|||
38002072|NCT00421889|69685792|FG002|Overall Study|Progressive disease|2|||
38002073|NCT00421889|69685793|FG003|Overall Study|Progressive disease|3|||
38002074|NCT00421889|69685794|FG004|Overall Study|Progressive disease|2|||
38002075|NCT00421889|69685795|FG005|Overall Study|Progressive disease|21|||
38002076|NCT00421889|69685796|FG006|Overall Study|Progressive disease|3|||
38002077|NCT00421889|69685797|FG007|Overall Study|Progressive disease|1|||
38002078|NCT00421889|69685798|FG008|Overall Study|Progressive disease|5|||
38002079|NCT00421889|69685790|FG000|Overall Study|Patient/Investigator request|0|||
38002080|NCT00421889|69685791|FG001|Overall Study|Patient/Investigator request|0|||
38002081|NCT00421889|69685792|FG002|Overall Study|Patient/Investigator request|0|||
38002082|NCT00421889|69685793|FG003|Overall Study|Patient/Investigator request|0|||
38002083|NCT00421889|69685794|FG004|Overall Study|Patient/Investigator request|0|||
38002084|NCT00421889|69685795|FG005|Overall Study|Patient/Investigator request|9|||
38002085|NCT00421889|69685796|FG006|Overall Study|Patient/Investigator request|0|||
38002086|NCT00421889|69685797|FG007|Overall Study|Patient/Investigator request|1|||
38002087|NCT00421889|69685798|FG008|Overall Study|Patient/Investigator request|3|||
38002088|NCT00421889|69685790|FG000|Overall Study|Lost to Follow-up|0|||
38002089|NCT00421889|69685791|FG001|Overall Study|Lost to Follow-up|0|||
38002090|NCT00421889|69685792|FG002|Overall Study|Lost to Follow-up|0|||
38002091|NCT00421889|69685793|FG003|Overall Study|Lost to Follow-up|0|||
38002092|NCT00421889|69685794|FG004|Overall Study|Lost to Follow-up|0|||
38002093|NCT00421889|69685795|FG005|Overall Study|Lost to Follow-up|0|||
38002094|NCT00421889|69685796|FG006|Overall Study|Lost to Follow-up|0|||
38002095|NCT00421889|69685797|FG007|Overall Study|Lost to Follow-up|0|||
38002096|NCT00421889|69685798|FG008|Overall Study|Lost to Follow-up|1|||
38002097|NCT00421733|69685825|FG000|Overall Study|Adverse Event|4|||
38002098|NCT00421733|69685826|FG001|Overall Study|Adverse Event|9|||
38002099|NCT00421733|69685827|FG002|Overall Study|Adverse Event|2|||
38002100|NCT00421733|69685825|FG000|Overall Study|Lost to Follow-up|1|||
38002101|NCT00421733|69685826|FG001|Overall Study|Lost to Follow-up|2|||
37905671|NCT00896532|69591550|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
37905672|NCT00896532|69591551|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
37905673|NCT00896532|69591552|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
37905674|NCT00896532|69591553|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
37905675|NCT00896532|69591554|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
37905676|NCT00896532|69591555|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
37905677|NCT00896532|69591556|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
37905678|NCT00896532|69591557|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
37905679|NCT00896532|69591558|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
37905680|NCT00896532|69591559|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
37905681|NCT00896532|69591560|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
37905682|NCT00896532|69591561|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
37905683|NCT00896532|69591562|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
38002102|NCT00421733|69685827|FG002|Overall Study|Lost to Follow-up|4|||
38002103|NCT00421733|69685825|FG000|Overall Study|Withdrawal by Subject|1|||
38002104|NCT00421733|69685826|FG001|Overall Study|Withdrawal by Subject|2|||
38002105|NCT00421733|69685827|FG002|Overall Study|Withdrawal by Subject|7|||
38002106|NCT00421733|69685825|FG000|Overall Study|Death|0|||
38002107|NCT00421733|69685826|FG001|Overall Study|Death|3|||
38002108|NCT00421733|69685827|FG002|Overall Study|Death|0|||
38002109|NCT00421733|69685825|FG000|Overall Study|Required dialysis|1|||
38002110|NCT00421733|69685826|FG001|Overall Study|Required dialysis|0|||
38002111|NCT00421733|69685827|FG002|Overall Study|Required dialysis|0|||
38002112|NCT00421733|69685825|FG000|Overall Study|Administrative|2|||
38002113|NCT00421733|69685826|FG001|Overall Study|Administrative|0|||
38002114|NCT00421733|69685827|FG002|Overall Study|Administrative|0|||
38002115|NCT00421733|69685825|FG000|Overall Study|Did not satisfy entry criteria|1|||
38002116|NCT00421733|69685826|FG001|Overall Study|Did not satisfy entry criteria|3|||
38002117|NCT00421733|69685827|FG002|Overall Study|Did not satisfy entry criteria|2|||
38002118|NCT00421733|69685825|FG000|Overall Study|Sponsor request|1|||
38002119|NCT00421733|69685826|FG001|Overall Study|Sponsor request|0|||
38002120|NCT00421733|69685827|FG002|Overall Study|Sponsor request|3|||
38002121|NCT00421733|69685825|FG000|Overall Study|Protocol deviation|4|||
38002122|NCT00421733|69685826|FG001|Overall Study|Protocol deviation|7|||
38002123|NCT00421733|69685827|FG002|Overall Study|Protocol deviation|2|||
38002124|NCT00421343|69685839|FG000|Overall Study|Death|1|||
38002125|NCT00421343|69685839|FG000|Overall Study|Withdrawal by Subject|2|||
38002126|NCT00421343|69685839|FG000|Overall Study|Lost to Follow-up|3|||
38002127|NCT00230178|69685846|FG000|Overall Study|Adverse Event|1|||
38002128|NCT00230178|69685847|FG001|Overall Study|Adverse Event|5|||
38002129|NCT00230178|69685848|FG002|Overall Study|Adverse Event|2|||
38002130|NCT00230178|69685846|FG000|Overall Study|Withdrawal by Subject|0|||
38002131|NCT00230178|69685847|FG001|Overall Study|Withdrawal by Subject|0|||
38002132|NCT00230178|69685848|FG002|Overall Study|Withdrawal by Subject|1|||
38002133|NCT00230178|69685846|FG000|Overall Study|Various other reasons|3|||
38002134|NCT00230178|69685847|FG001|Overall Study|Various other reasons|2|||
38002135|NCT00230178|69685848|FG002|Overall Study|Various other reasons|4|||
38002136|NCT00413777|69685858|FG000|Fixed-dose Period|Lost to Follow-up|1|||
38002137|NCT00413777|69685859|FG001|Fixed-dose Period|Lost to Follow-up|1|||
38002138|NCT00413777|69685858|FG000|Fixed-dose Period|Adverse Event|2|||
38002139|NCT00413777|69685859|FG001|Fixed-dose Period|Adverse Event|1|||
38002140|NCT00413777|69685858|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
38002141|NCT00413777|69685859|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
37905684|NCT00896532|69591563|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
38002142|NCT00413777|69685858|FG000|Fixed-dose Period|Withdrew Consent|0|||
38002143|NCT00413777|69685859|FG001|Fixed-dose Period|Withdrew Consent|1|||
38002144|NCT00197028|69685867|FG000|Overall Study|Adverse Event|2|||
38002145|NCT00197028|69685868|FG001|Overall Study|Adverse Event|2|||
38002146|NCT00197028|69685867|FG000|Overall Study|Protocol Violation|2|||
38002147|NCT00197028|69685868|FG001|Overall Study|Protocol Violation|1|||
38002148|NCT00197028|69685867|FG000|Overall Study|Withdrawal by Subject|8|||
38002149|NCT00197028|69685868|FG001|Overall Study|Withdrawal by Subject|12|||
38002150|NCT00197028|69685867|FG000|Overall Study|Lost to Follow-up|1|||
38002151|NCT00197028|69685868|FG001|Overall Study|Lost to Follow-up|0|||
38002152|NCT00197028|69685867|FG000|Overall Study|Other|3|||
38002153|NCT00197028|69685868|FG001|Overall Study|Other|6|||
38002154|NCT00420641|69685877|FG000|Overall Study|Adverse Event|3|||
38002155|NCT00420641|69685878|FG001|Overall Study|Adverse Event|25|||
38002156|NCT00420641|69685879|FG002|Overall Study|Adverse Event|10|||
38002157|NCT00420641|69685877|FG000|Overall Study|Lost to Follow-up|2|||
38002158|NCT00420641|69685878|FG001|Overall Study|Lost to Follow-up|4|||
38002159|NCT00420641|69685879|FG002|Overall Study|Lost to Follow-up|2|||
38002160|NCT00420641|69685877|FG000|Overall Study|Protocol Violation|8|||
38002161|NCT00420641|69685878|FG001|Overall Study|Protocol Violation|8|||
38002162|NCT00420641|69685879|FG002|Overall Study|Protocol Violation|7|||
38002163|NCT00420641|69685877|FG000|Overall Study|Withdrawal by Subject|15|||
38002164|NCT00420641|69685878|FG001|Overall Study|Withdrawal by Subject|21|||
38002165|NCT00420641|69685879|FG002|Overall Study|Withdrawal by Subject|14|||
38002166|NCT00420641|69685877|FG000|Overall Study|Lack of Efficacy|6|||
38002167|NCT00420641|69685878|FG001|Overall Study|Lack of Efficacy|5|||
38002168|NCT00420641|69685879|FG002|Overall Study|Lack of Efficacy|4|||
37830002|NCT01365481|69513141|FG000|Overall Study|Abnormal laboratory value(s)|0|||
37830003|NCT01365481|69513142|FG001|Overall Study|Abnormal laboratory value(s)|1|||
37830004|NCT01365481|69513143|FG002|Overall Study|Abnormal laboratory value(s)|0|||
37830005|NCT01365481|69513144|FG003|Overall Study|Abnormal laboratory value(s)|0|||
37905685|NCT00896532|69591564|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
37905686|NCT00896532|69591565|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
37905687|NCT00896532|69591566|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
37905688|NCT00896532|69591567|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
37905689|NCT00896532|69591568|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
37905690|NCT00896532|69591546|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
37905691|NCT00896532|69591547|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
37905692|NCT00896532|69591548|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
37905693|NCT00896532|69591549|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
37830006|NCT01365481|69513141|FG000|Overall Study|Administrative problems|0|||
37830007|NCT01365481|69513142|FG001|Overall Study|Administrative problems|1|||
37830008|NCT01365481|69513143|FG002|Overall Study|Administrative problems|0|||
37830009|NCT01365481|69513144|FG003|Overall Study|Administrative problems|0|||
37905694|NCT00896532|69591550|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
37905695|NCT00896532|69591551|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
37905696|NCT00896532|69591552|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
37905697|NCT00896532|69591553|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
37905698|NCT00896532|69591554|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
37905699|NCT00896532|69591555|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
37905700|NCT00896532|69591556|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
37905701|NCT00896532|69591557|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
37905702|NCT00896532|69591558|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
37905703|NCT00896532|69591559|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
37905704|NCT00896532|69591560|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
37905705|NCT00896532|69591561|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
37905706|NCT00896532|69591562|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
37905707|NCT00896532|69591563|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
37905708|NCT00896532|69591564|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
37905709|NCT00896532|69591565|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
37905710|NCT00896532|69591566|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
37905711|NCT00896532|69591567|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
37905712|NCT00896532|69591568|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
37905713|NCT00896532|69591546|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
37905714|NCT00896532|69591547|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
37905715|NCT00896532|69591548|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
37905716|NCT00896532|69591549|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
37905717|NCT00896532|69591550|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
37905718|NCT00896532|69591551|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
37905719|NCT00896532|69591552|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
37905720|NCT00896532|69591553|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
37905721|NCT00896532|69591554|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
38002169|NCT00420641|69685877|FG000|Overall Study|Non-compliance|7|||
38002170|NCT00420641|69685878|FG001|Overall Study|Non-compliance|5|||
38002171|NCT00420641|69685879|FG002|Overall Study|Non-compliance|4|||
37830010|NCT01365481|69513141|FG000|Overall Study|Protocol deviation|0|||
37830011|NCT01365481|69513142|FG001|Overall Study|Protocol deviation|1|||
38002172|NCT00420641|69685877|FG000|Overall Study|Other|4|||
38002173|NCT00420641|69685878|FG001|Overall Study|Other|4|||
38002174|NCT00420641|69685879|FG002|Overall Study|Other|3|||
38002175|NCT00257556|69685889|FG000|Overall Study|Adverse Event|1|||
38002176|NCT00257556|69685890|FG001|Overall Study|Adverse Event|4|||
38002177|NCT00257556|69685889|FG000|Overall Study|Physician Decision|6|||
38002178|NCT00257556|69685890|FG001|Overall Study|Physician Decision|0|||
38002179|NCT00257556|69685889|FG000|Overall Study|Did not meet hCG criterion|3|||
37905722|NCT00896532|69591555|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
37905723|NCT00896532|69591556|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
37905724|NCT00896532|69591557|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
38002180|NCT00257556|69685890|FG001|Overall Study|Did not meet hCG criterion|0|||
38002181|NCT00257556|69685889|FG000|Overall Study|other reason|4|||
38002182|NCT00257556|69685890|FG001|Overall Study|other reason|6|||
38002183|NCT00228384|69685898|FG000|Overall Study|Death|9|||
38002184|NCT00228384|69685899|FG001|Overall Study|Death|3|||
38002185|NCT00228384|69685898|FG000|Overall Study|Lost to Follow-up|6|||
38002186|NCT00228384|69685899|FG001|Overall Study|Lost to Follow-up|10|||
38002187|NCT00228384|69685898|FG000|Overall Study|Surgical Intervention (bypass)|5|||
37905725|NCT00896532|69591558|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
37905726|NCT00896532|69591559|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
37905727|NCT00896532|69591560|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
37905728|NCT00896532|69591561|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
37905729|NCT00896532|69591562|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
37905730|NCT00896532|69591563|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
37905731|NCT00896532|69591564|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
37905732|NCT00896532|69591565|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
37905733|NCT00896532|69591566|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
37905734|NCT00896532|69591567|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
37905735|NCT00896532|69591568|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
37905736|NCT00896532|69591546|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
37905737|NCT00896532|69591547|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
37905738|NCT00896532|69591548|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
37905739|NCT00896532|69591549|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
37905740|NCT00896532|69591550|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
37905741|NCT00896532|69591551|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
37905742|NCT00896532|69591552|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
37905743|NCT00896532|69591553|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
37905744|NCT00896532|69591554|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
37905745|NCT00896532|69591555|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
37905746|NCT00896532|69591556|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
37905747|NCT00896532|69591557|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
37905748|NCT00896532|69591558|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
37905749|NCT00896532|69591559|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
37905750|NCT00896532|69591560|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
37905751|NCT00896532|69591561|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
37905752|NCT00896532|69591562|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
37905753|NCT00896532|69591563|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
37905754|NCT00896532|69591564|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
37905755|NCT00896532|69591565|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
37905756|NCT00896532|69591566|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
37905757|NCT00896532|69591567|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
37905758|NCT00896532|69591568|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
37905759|NCT00896532|69591546|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
37905760|NCT00896532|69591547|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
37905761|NCT00896532|69591548|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
37905762|NCT00896532|69591549|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
37905763|NCT00896532|69591550|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
37905764|NCT00896532|69591551|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
37905765|NCT00896532|69591552|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
37905766|NCT00896532|69591553|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
37905767|NCT00896532|69591554|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
37905768|NCT00896532|69591555|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
37905769|NCT00896532|69591556|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
37905770|NCT00896532|69591557|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
37905771|NCT00896532|69591558|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
38002188|NCT00228384|69685899|FG001|Overall Study|Surgical Intervention (bypass)|5|||
38002189|NCT00228384|69685898|FG000|Overall Study|Withdrawal by Subject|9|||
38002190|NCT00228384|69685899|FG001|Overall Study|Withdrawal by Subject|10|||
38002191|NCT00228384|69685898|FG000|Overall Study|Physician Decision|0|||
38002192|NCT00228384|69685899|FG001|Overall Study|Physician Decision|1|||
38002193|NCT00257166|69685907|FG000|Overall Study|Adverse Event|18|||
38002194|NCT00257166|69685908|FG001|Overall Study|Adverse Event|13|||
38002195|NCT00257166|69685907|FG000|Overall Study|Laboratory abnormality|1|||
38002196|NCT00257166|69685908|FG001|Overall Study|Laboratory abnormality|0|||
38002197|NCT00257166|69685907|FG000|Overall Study|Lost to Follow-up|8|||
38002198|NCT00257166|69685908|FG001|Overall Study|Lost to Follow-up|1|||
38002199|NCT00257166|69685907|FG000|Overall Study|Withdrawal by Subject|9|||
38002200|NCT00257166|69685908|FG001|Overall Study|Withdrawal by Subject|2|||
38002201|NCT00257166|69685907|FG000|Overall Study|Other|16|||
38002202|NCT00257166|69685908|FG001|Overall Study|Other|21|||
38002203|NCT00257166|69685907|FG000|Overall Study|Randomized, but not treated|1|||
38002204|NCT00257166|69685908|FG001|Overall Study|Randomized, but not treated|0|||
38002205|NCT00227370|69685916|FG000|Overall Study|Withdrawal by Subject|1|||
38002206|NCT00227370|69685917|FG001|Overall Study|Withdrawal by Subject|2|||
38002207|NCT00227370|69685916|FG000|Overall Study|Death|3|||
38002208|NCT00227370|69685917|FG001|Overall Study|Death|4|||
38002209|NCT00227370|69685916|FG000|Overall Study|Adverse Event|6|||
38002210|NCT00227370|69685917|FG001|Overall Study|Adverse Event|11|||
38002211|NCT00227370|69685916|FG000|Overall Study|Physician Decision|9|||
38002212|NCT00227370|69685917|FG001|Overall Study|Physician Decision|6|||
38002213|NCT00227370|69685916|FG000|Overall Study|Other reasons|2|||
38002214|NCT00227370|69685917|FG001|Overall Study|Other reasons|1|||
38002215|NCT00191100|69685925|FG000|Overall Study|Adverse Event|18|||
38002216|NCT00191100|69685926|FG001|Overall Study|Adverse Event|1|||
38002217|NCT00191100|69685925|FG000|Overall Study|Lost to Follow-up|2|||
38002218|NCT00191100|69685926|FG001|Overall Study|Lost to Follow-up|0|||
38002219|NCT00191100|69685925|FG000|Overall Study|Patient Moved|0|||
38002220|NCT00191100|69685926|FG001|Overall Study|Patient Moved|1|||
38002221|NCT00191100|69685925|FG000|Overall Study|Withdrawal by Subject|9|||
38002222|NCT00191100|69685926|FG001|Overall Study|Withdrawal by Subject|3|||
38002223|NCT00191100|69685925|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
38002224|NCT00191100|69685926|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
38002225|NCT00191100|69685925|FG000|Overall Study|Clinical Relapse|2|||
38002226|NCT00191100|69685926|FG001|Overall Study|Clinical Relapse|1|||
38002227|NCT00191100|69685925|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
38002228|NCT00191100|69685926|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
38002229|NCT00191100|69685925|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
38002230|NCT00191100|69685926|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
38002231|NCT00191100|69685925|FG000|Overall Study|Physician Decision|3|||
38002232|NCT00191100|69685926|FG001|Overall Study|Physician Decision|1|||
38002233|NCT00191100|69685925|FG000|Overall Study|Death from Study Drug Toxicity|2|||
38002234|NCT00191100|69685926|FG001|Overall Study|Death from Study Drug Toxicity|0|||
38002235|NCT00191100|69685925|FG000|Overall Study|Protocol Violation|1|||
38002236|NCT00191100|69685926|FG001|Overall Study|Protocol Violation|1|||
38002237|NCT00191100|69685925|FG000|Overall Study|Death from Other Cause|1|||
38002238|NCT00191100|69685926|FG001|Overall Study|Death from Other Cause|0|||
38002239|NCT00191100|69685925|FG000|Overall Study|Reason Not Specified|0|||
38002240|NCT00191100|69685926|FG001|Overall Study|Reason Not Specified|1|||
38002241|NCT00189540|69685934|FG000|Overall Study|Withdrawal by Subject|3|||
38002242|NCT00189540|69685935|FG001|Overall Study|Withdrawal by Subject|0|||
38002243|NCT00189540|69685934|FG000|Overall Study|Death|4|||
38002244|NCT00189540|69685935|FG001|Overall Study|Death|1|||
38002245|NCT00257010|69685941|FG000|Overall Study|Lack of Efficacy|11|||
38002246|NCT00257010|69685941|FG000|Overall Study|Lost to Follow-up|53|||
38002247|NCT00257010|69685941|FG000|Overall Study|Withdrawal by Subject|34|||
38002248|NCT00257010|69685941|FG000|Overall Study|Adverse Event|10|||
38002249|NCT00257010|69685941|FG000|Overall Study|various|11|||
38002250|NCT00257010|69685941|FG000|Overall Study|no headache reported|9|||
38002251|NCT00256854|69685951|FG000|Overall Study|Withdrawal by Subject|2|||
38002252|NCT00256854|69685952|FG001|Overall Study|Withdrawal by Subject|3|||
38002253|NCT00256854|69685953|FG002|Overall Study|Withdrawal by Subject|0|||
38002254|NCT00256854|69685954|FG003|Overall Study|Withdrawal by Subject|0|||
38002255|NCT00256854|69685955|FG004|Overall Study|Withdrawal by Subject|0|||
37905772|NCT00896532|69591559|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
37905773|NCT00896532|69591560|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
38002256|NCT00256854|69685956|FG005|Overall Study|Withdrawal by Subject|0|||
38002257|NCT00256854|69685951|FG000|Overall Study|Lack of Efficacy|1|||
38002258|NCT00256854|69685952|FG001|Overall Study|Lack of Efficacy|0|||
38002259|NCT00256854|69685953|FG002|Overall Study|Lack of Efficacy|0|||
38002260|NCT00256854|69685954|FG003|Overall Study|Lack of Efficacy|0|||
38002261|NCT00256854|69685955|FG004|Overall Study|Lack of Efficacy|0|||
38002262|NCT00256854|69685956|FG005|Overall Study|Lack of Efficacy|0|||
38002263|NCT00256854|69685951|FG000|Overall Study|Protocol Violation|0|||
38002264|NCT00256854|69685952|FG001|Overall Study|Protocol Violation|1|||
38002265|NCT00256854|69685953|FG002|Overall Study|Protocol Violation|1|||
38002266|NCT00256854|69685954|FG003|Overall Study|Protocol Violation|1|||
38002267|NCT00256854|69685955|FG004|Overall Study|Protocol Violation|0|||
38002268|NCT00256854|69685956|FG005|Overall Study|Protocol Violation|0|||
38002269|NCT00256854|69685951|FG000|Overall Study|Adverse Event|0|||
38002270|NCT00256854|69685952|FG001|Overall Study|Adverse Event|0|||
38002271|NCT00256854|69685953|FG002|Overall Study|Adverse Event|2|||
38002272|NCT00256854|69685954|FG003|Overall Study|Adverse Event|2|||
38002273|NCT00256854|69685955|FG004|Overall Study|Adverse Event|0|||
38002274|NCT00256854|69685956|FG005|Overall Study|Adverse Event|1|||
38002275|NCT00256854|69685951|FG000|Overall Study|Not compliant with the study drug|0|||
38002276|NCT00256854|69685952|FG001|Overall Study|Not compliant with the study drug|0|||
38002277|NCT00256854|69685953|FG002|Overall Study|Not compliant with the study drug|0|||
38002278|NCT00256854|69685954|FG003|Overall Study|Not compliant with the study drug|0|||
38002279|NCT00256854|69685955|FG004|Overall Study|Not compliant with the study drug|1|||
38002280|NCT00256854|69685956|FG005|Overall Study|Not compliant with the study drug|0|||
38002281|NCT00189462|69685973|FG000|Overall Study|Lack of Efficacy|5|||
38002282|NCT00189462|69685974|FG001|Overall Study|Lack of Efficacy|1|||
38002283|NCT00189462|69685973|FG000|Overall Study|Lost to Follow-up|18|||
38002284|NCT00189462|69685974|FG001|Overall Study|Lost to Follow-up|20|||
38002285|NCT00256698|69685982|FG000|Overall Study|Withdrawal by Subject|7|||
38002286|NCT00256698|69685983|FG001|Overall Study|Withdrawal by Subject|7|||
38002287|NCT00256698|69685982|FG000|Overall Study|Adverse Event|13|||
38002288|NCT00256698|69685983|FG001|Overall Study|Adverse Event|6|||
38002289|NCT00256698|69685982|FG000|Overall Study|Protocol Violation|6|||
38002290|NCT00256698|69685983|FG001|Overall Study|Protocol Violation|5|||
38002291|NCT00256698|69685982|FG000|Overall Study|Lost to Follow-up|1|||
38002292|NCT00256698|69685983|FG001|Overall Study|Lost to Follow-up|3|||
38002293|NCT00256698|69685982|FG000|Overall Study|disease progression|97|||
38002294|NCT00256698|69685983|FG001|Overall Study|disease progression|105|||
38002295|NCT00256698|69685982|FG000|Overall Study|still ongoing at data cut-off|41|||
38002296|NCT00256698|69685983|FG001|Overall Study|still ongoing at data cut-off|46|||
38002297|NCT00256698|69685982|FG000|Overall Study|withdrawn due to osteoporosis|1|||
37830012|NCT01365481|69513143|FG002|Overall Study|Protocol deviation|0|||
37830013|NCT01365481|69513144|FG003|Overall Study|Protocol deviation|1|||
37830014|NCT01365481|69513141|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
37830015|NCT01365481|69513142|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
37830016|NCT01365481|69513143|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
37830017|NCT01365481|69513144|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
37830018|NCT01357915|69513156|FG000|Overall Study|Lost to Follow-up|3|||
37830019|NCT01357915|69513157|FG001|Overall Study|Lost to Follow-up|0|||
38002298|NCT00256698|69685983|FG001|Overall Study|withdrawn due to osteoporosis|0|||
38002299|NCT00256698|69685982|FG000|Overall Study|Prematurely Discontinued|1|||
38002300|NCT00256698|69685983|FG001|Overall Study|Prematurely Discontinued|0|||
38002301|NCT00189306|69685989|FG000|Treatment Period|Withdrawal by Subject|2|||
38002302|NCT00189306|69685989|FG000|Treatment Period|Adverse Event|2|||
38002303|NCT00189306|69685989|FG000|Treatment Period|Protocol Violation|1|||
38002304|NCT00189306|69685989|FG000|Posttreatment Period|Death|1|||
38002305|NCT00189306|69685989|FG000|Posttreatment Period|Withdrawal by Subject|2|||
38002306|NCT00189306|69685989|FG000|Posttreatment Period|Noncompliance|1|||
38002307|NCT00189306|69685989|FG000|Posttreatment Period|Target lesion excised|1|||
38002308|NCT00189306|69685989|FG000|Posttreatment Period|Protocol Violation|1|||
38002309|NCT00189306|69685989|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
38002310|NCT00189306|69685989|FG000|Posttreatment Period|Local skin reaction/sign|1|||
38002311|NCT00189306|69685989|FG000|Long-Term Follow-up|Adverse Event|2|||
38002312|NCT00189306|69685989|FG000|Long-Term Follow-up|Death|4|||
38002313|NCT00189306|69685989|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
38002314|NCT00189306|69685989|FG000|Long-Term Follow-up|Intercurrent disease|2|||
38002315|NCT00189306|69685989|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
38002316|NCT00189306|69685989|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
38002317|NCT00187278|69685995|FG000|Overall Study|Protocol Violation|10|||
38002318|NCT00187278|69685996|FG001|Overall Study|Protocol Violation|13|||
38002319|NCT00256308|69686004|FG000|Overall Study|Death|2|||
38002320|NCT00255840|69686010|FG000|Overall Study|Lost to Follow-up|10|||
38002321|NCT00255840|69686011|FG001|Overall Study|Lost to Follow-up|14|||
38002322|NCT00255840|69686010|FG000|Overall Study|Discontinued intervention|53|||
38002323|NCT00255840|69686011|FG001|Overall Study|Discontinued intervention|56|||
38002324|NCT00224874|69686021|FG000|Overall Study|Withdrawal by Subject|0|||
38002325|NCT00224874|69686022|FG001|Overall Study|Withdrawal by Subject|0|||
38002326|NCT00224874|69686023|FG002|Overall Study|Withdrawal by Subject|1|||
38002327|NCT00224874|69686024|FG003|Overall Study|Withdrawal by Subject|0|||
38002328|NCT00186186|69686034|FG000|Overall Study|Lack of Efficacy|3|||
38002329|NCT00186186|69686034|FG000|Overall Study|Withdrawal by Subject|3|||
38002330|NCT00186186|69686034|FG000|Overall Study|Not reported as to reason|2|||
38002331|NCT00185640|69686039|FG000|Overall Study|Not Eligible|4|||
38002332|NCT00185640|69686039|FG000|Overall Study|Withdrawal by Subject|3|||
38002333|NCT00185640|69686039|FG000|Overall Study|Death|138|||
38002334|NCT03760666|69686046|FG000|Overall Study|Adverse Event|2|||
38002335|NCT03760666|69686047|FG001|Overall Study|Adverse Event|4|||
38002336|NCT03760666|69686048|FG002|Overall Study|Adverse Event|1|||
38002337|NCT03760666|69686046|FG000|Overall Study|AML Disease Progression|3|||
38002338|NCT03760666|69686047|FG001|Overall Study|AML Disease Progression|3|||
38002339|NCT03760666|69686048|FG002|Overall Study|AML Disease Progression|0|||
38002340|NCT03760666|69686046|FG000|Overall Study|Physician Decision|0|||
38002341|NCT03760666|69686047|FG001|Overall Study|Physician Decision|3|||
38002342|NCT03760666|69686048|FG002|Overall Study|Physician Decision|0|||
38002343|NCT03760666|69686046|FG000|Overall Study|Withdrawal by Subject|0|||
38002344|NCT03760666|69686047|FG001|Overall Study|Withdrawal by Subject|1|||
38002345|NCT03760666|69686048|FG002|Overall Study|Withdrawal by Subject|0|||
38002346|NCT03760510|69686061|FG000|Overall Study|Not ventilated for 24 hours|105|||
38002347|NCT03760510|69686062|FG001|Overall Study|Not ventilated for 24 hours|97|||
38002348|NCT00224484|69686071|FG000|Overall Study|Serious Adverse Event|1|||
38002349|NCT00224484|69686072|FG001|Overall Study|Serious Adverse Event|1|||
38002350|NCT00224484|69686073|FG002|Overall Study|Serious Adverse Event|0|||
38002351|NCT00224484|69686071|FG000|Overall Study|Non-Serious Adverse Event|5|||
38002352|NCT00224484|69686072|FG001|Overall Study|Non-Serious Adverse Event|7|||
38002353|NCT00224484|69686073|FG002|Overall Study|Non-Serious Adverse Event|3|||
38002354|NCT00224484|69686071|FG000|Overall Study|Protocol Violation|2|||
38002355|NCT00224484|69686072|FG001|Overall Study|Protocol Violation|2|||
38002356|NCT00224484|69686073|FG002|Overall Study|Protocol Violation|0|||
38002357|NCT00224484|69686071|FG000|Overall Study|Withdrawal by Subject|49|||
38002358|NCT00224484|69686072|FG001|Overall Study|Withdrawal by Subject|18|||
38002359|NCT00224484|69686073|FG002|Overall Study|Withdrawal by Subject|16|||
38002360|NCT00224484|69686071|FG000|Overall Study|Migrated/moved from study area|18|||
38002361|NCT00224484|69686072|FG001|Overall Study|Migrated/moved from study area|5|||
38002362|NCT00224484|69686073|FG002|Overall Study|Migrated/moved from study area|5|||
38002363|NCT00224484|69686071|FG000|Overall Study|Lost to Follow-up|66|||
38002364|NCT00224484|69686072|FG001|Overall Study|Lost to Follow-up|28|||
38002365|NCT00224484|69686073|FG002|Overall Study|Lost to Follow-up|36|||
38002366|NCT00224484|69686071|FG000|Overall Study|Reason not specified|5|||
38002367|NCT00224484|69686072|FG001|Overall Study|Reason not specified|4|||
38002368|NCT00224484|69686073|FG002|Overall Study|Reason not specified|2|||
38002369|NCT00254982|69686086|FG000|Overall Study|Other|2|||
38002370|NCT00254982|69686087|FG001|Overall Study|Other|1|||
38002371|NCT00254982|69686086|FG000|Overall Study|Lack of Efficacy|5|||
38002372|NCT00254982|69686087|FG001|Overall Study|Lack of Efficacy|3|||
38002373|NCT00254982|69686086|FG000|Overall Study|Lost to Follow-up|5|||
38002374|NCT00254982|69686087|FG001|Overall Study|Lost to Follow-up|3|||
38002375|NCT00254982|69686086|FG000|Overall Study|Adverse Event|18|||
38002376|NCT00254982|69686087|FG001|Overall Study|Adverse Event|16|||
38002377|NCT00254982|69686086|FG000|Overall Study|Withdrawal by Subject|1|||
38002378|NCT00254982|69686087|FG001|Overall Study|Withdrawal by Subject|1|||
38002379|NCT00254982|69686086|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
38002380|NCT00254982|69686087|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
38002381|NCT00254982|69686086|FG000|Overall Study|Protocol deviation|1|||
38002382|NCT00254982|69686087|FG001|Overall Study|Protocol deviation|1|||
38002383|NCT00254982|69686086|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
38002384|NCT00254982|69686087|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
38002385|NCT00254982|69686086|FG000|Overall Study|Malignancy|0|||
38002386|NCT00254982|69686087|FG001|Overall Study|Malignancy|2|||
38002387|NCT00254982|69686086|FG000|Overall Study|Opportunistic infection|1|||
38002388|NCT00254982|69686087|FG001|Overall Study|Opportunistic infection|0|||
38002389|NCT00254982|69686086|FG000|Overall Study|Abnormal liver function tests|2|||
38002390|NCT00254982|69686087|FG001|Overall Study|Abnormal liver function tests|1|||
38002391|NCT03759340|69686093|FG000|Overall Study|Adverse Event|2|||
38002392|NCT03759340|69686093|FG000|Overall Study|Lost to Follow-up|1|||
38002393|NCT03759340|69686093|FG000|Overall Study|Withdrawal by Subject|15|||
38002394|NCT03759340|69686093|FG000|Overall Study|Study Terminated by Sponsor|38|||
38002395|NCT00224016|69686099|FG000|Titration Period|Withdrawal by Subject|0|||
38002396|NCT00224016|69686100|FG001|Titration Period|Withdrawal by Subject|1|||
38002397|NCT00224016|69686099|FG000|Titration Period|Lost to Follow-up|1|||
38002398|NCT00224016|69686100|FG001|Titration Period|Lost to Follow-up|0|||
38002399|NCT00224016|69686099|FG000|Maintenance Period|Withdrawal by Subject|2|||
38002400|NCT00224016|69686100|FG001|Maintenance Period|Withdrawal by Subject|0|||
38002401|NCT00224016|69686099|FG000|Maintenance Period|Lost to Follow-up|0|||
38002402|NCT00224016|69686100|FG001|Maintenance Period|Lost to Follow-up|1|||
38002403|NCT03757234|69686111|FG000|Overall Study|Adverse Event|0|||
38002404|NCT03757234|69686112|FG001|Overall Study|Adverse Event|0|||
38002405|NCT03757234|69686113|FG002|Overall Study|Adverse Event|0|||
38002406|NCT03757234|69686114|FG003|Overall Study|Adverse Event|0|||
38002407|NCT03757234|69686115|FG004|Overall Study|Adverse Event|1|||
38002408|NCT03757234|69686111|FG000|Overall Study|Lost to Follow-up|1|||
38002409|NCT03757234|69686112|FG001|Overall Study|Lost to Follow-up|0|||
38002410|NCT03757234|69686113|FG002|Overall Study|Lost to Follow-up|0|||
38002411|NCT03757234|69686114|FG003|Overall Study|Lost to Follow-up|0|||
38002412|NCT03757234|69686115|FG004|Overall Study|Lost to Follow-up|1|||
38002413|NCT03757234|69686111|FG000|Overall Study|Withdrawal by Subject|1|||
38002414|NCT03757234|69686112|FG001|Overall Study|Withdrawal by Subject|1|||
38002415|NCT03757234|69686113|FG002|Overall Study|Withdrawal by Subject|0|||
38002416|NCT03757234|69686114|FG003|Overall Study|Withdrawal by Subject|1|||
38002417|NCT03757234|69686115|FG004|Overall Study|Withdrawal by Subject|2|||
38002418|NCT03757234|69686111|FG000|Overall Study|Other|1|||
38002419|NCT03757234|69686112|FG001|Overall Study|Other|1|||
38002420|NCT03757234|69686113|FG002|Overall Study|Other|0|||
38002421|NCT03757234|69686114|FG003|Overall Study|Other|0|||
38002422|NCT03757234|69686115|FG004|Overall Study|Other|0|||
38002423|NCT00223080|69686129|FG000|Overall Study|Withdrawal by Subject|253|||
38002424|NCT00223080|69686130|FG001|Overall Study|Withdrawal by Subject|232|||
38002425|NCT00223080|69686129|FG000|Overall Study|Required contraindicated med|0|||
38002426|NCT00223080|69686130|FG001|Overall Study|Required contraindicated med|1|||
38002427|NCT00223080|69686129|FG000|Overall Study|Non-compliant|7|||
38002428|NCT00223080|69686130|FG001|Overall Study|Non-compliant|7|||
38002429|NCT00223080|69686129|FG000|Overall Study|Moved from study area|37|||
38002430|NCT00223080|69686130|FG001|Overall Study|Moved from study area|47|||
38002431|NCT00223080|69686129|FG000|Overall Study|Lost to Follow-up|259|||
38002432|NCT00223080|69686130|FG001|Overall Study|Lost to Follow-up|284|||
38002433|NCT00223080|69686129|FG000|Overall Study|Death|85|||
38002434|NCT00223080|69686130|FG001|Overall Study|Death|74|||
38002435|NCT00223080|69686129|FG000|Overall Study|Other|14|||
38002436|NCT00223080|69686130|FG001|Overall Study|Other|11|||
38002437|NCT00223080|69686129|FG000|Overall Study|Reason not provided|141|||
38002438|NCT00223080|69686130|FG001|Overall Study|Reason not provided|140|||
38002439|NCT00223080|69686129|FG000|Overall Study|Adverse Event|0|||
38002440|NCT00223080|69686130|FG001|Overall Study|Adverse Event|1|||
38002441|NCT00220740|69686138|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
38002442|NCT00220740|69686139|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
38002443|NCT00220740|69686138|FG000|Efficacy Period|Adverse Event|1|||
38002444|NCT00220740|69686139|FG001|Efficacy Period|Adverse Event|1|||
38002445|NCT00220740|69686138|FG000|Efficacy Period|Withdrawal by Subject|1|||
38002446|NCT00220740|69686139|FG001|Efficacy Period|Withdrawal by Subject|0|||
38002447|NCT00220740|69686138|FG000|Efficacy Period|Protocol Violation|1|||
38002448|NCT00220740|69686139|FG001|Efficacy Period|Protocol Violation|0|||
38002449|NCT00220740|69686138|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
38002450|NCT00220740|69686139|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
38002451|NCT00184002|69686147|FG000|Overall Study|Adverse Event|9|||
38002452|NCT00184002|69686147|FG000|Overall Study|Death|3|||
38002453|NCT00184002|69686147|FG000|Overall Study|Physician Decision|1|||
38002454|NCT00184002|69686147|FG000|Overall Study|Withdrawal by Subject|4|||
38002455|NCT00165672|69686153|FG000|Overall Study|Adverse Event|0|||
38002456|NCT00165672|69686154|FG001|Overall Study|Adverse Event|1|||
38002457|NCT00180414|69686162|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
38002458|NCT00180414|69686163|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
38002459|NCT00174252|69686169|FG000|Overall Study|Protocol Violation|2|||
38002460|NCT00169104|69686177|FG000|Overall Study|Withdrawal by Subject|2|||
38002461|NCT00169104|69686178|FG001|Overall Study|Withdrawal by Subject|0|||
38002462|NCT00169104|69686177|FG000|Overall Study|Protocol Violation|0|||
38002463|NCT00169104|69686178|FG001|Overall Study|Protocol Violation|1|||
38002464|NCT00169104|69686177|FG000|Overall Study|Physician Decision|0|||
38002465|NCT00169104|69686178|FG001|Overall Study|Physician Decision|1|||
38002466|NCT00163020|69686187|FG000|Overall Study|Lost to Follow-up|0|||
38002467|NCT00163020|69686188|FG001|Overall Study|Lost to Follow-up|2|||
38002468|NCT00252720|69686198|FG000|Overall Study|Withdrawal by Subject|95|||
38002469|NCT00252720|69686199|FG001|Overall Study|Withdrawal by Subject|97|||
38002470|NCT00252720|69686198|FG000|Overall Study|Death|7|||
38002471|NCT00252720|69686199|FG001|Overall Study|Death|8|||
38002472|NCT00252720|69686198|FG000|Overall Study|Moving|23|||
38002473|NCT00252720|69686199|FG001|Overall Study|Moving|42|||
38002474|NCT00252720|69686198|FG000|Overall Study|Mainly patients lost to follow-up|7|||
38002475|NCT00252720|69686199|FG001|Overall Study|Mainly patients lost to follow-up|18|||
38002476|NCT00167778|69686205|FG000|Overall Study|Withdrawal by Subject|1|||
38002477|NCT00167310|69686212|FG000|Overall Study|Protocol Violation|5|||
38002478|NCT00167310|69686213|FG001|Overall Study|Protocol Violation|3|||
38002479|NCT00167310|69686212|FG000|Overall Study|Withdrawal by Subject|3|||
38002480|NCT00167310|69686213|FG001|Overall Study|Withdrawal by Subject|7|||
38002481|NCT03754582|69686219|FG000|Treatment Phase|Adverse Event|0|||
38002482|NCT03754582|69686220|FG001|Treatment Phase|Adverse Event|1|||
38002483|NCT03754582|69686221|FG002|Treatment Phase|Adverse Event|0|||
38002484|NCT03754582|69686219|FG000|Follow-up Phase|Other|0|||
38002485|NCT03754582|69686220|FG001|Follow-up Phase|Other|0|||
38002486|NCT03754582|69686221|FG002|Follow-up Phase|Other|1|||
38002487|NCT00161616|69686239|FG000|Overall Study|Withdrawal by Subject|6|||
38002488|NCT00161616|69686240|FG001|Overall Study|Withdrawal by Subject|5|||
38002489|NCT00161616|69686239|FG000|Overall Study|Physician Decision|1|||
38002490|NCT00161616|69686240|FG001|Overall Study|Physician Decision|0|||
38002491|NCT00161616|69686239|FG000|Overall Study|Death|1|||
38002492|NCT00161616|69686240|FG001|Overall Study|Death|1|||
38002493|NCT00161616|69686239|FG000|Overall Study|Lost to Follow-up|17|||
38002494|NCT00161616|69686240|FG001|Overall Study|Lost to Follow-up|13|||
38002495|NCT00161616|69686239|FG000|Overall Study|Protocol deviation|1|||
38002496|NCT00161616|69686240|FG001|Overall Study|Protocol deviation|0|||
38002497|NCT00252564|69686248|FG000|Overall Study|Adverse Event|17|||
38002498|NCT00252564|69686249|FG001|Overall Study|Adverse Event|13|||
38002499|NCT00252564|69686248|FG000|Overall Study|Unrelated Complication|2|||
38002500|NCT00252564|69686249|FG001|Overall Study|Unrelated Complication|1|||
38002501|NCT00252564|69686248|FG000|Overall Study|Disease Progression|14|||
38002502|NCT00252564|69686249|FG001|Overall Study|Disease Progression|20|||
38002503|NCT00252564|69686248|FG000|Overall Study|Death|0|||
38002504|NCT00252564|69686249|FG001|Overall Study|Death|3|||
38002505|NCT00252564|69686248|FG000|Overall Study|Physician Decision|1|||
38002506|NCT00252564|69686249|FG001|Overall Study|Physician Decision|0|||
38002507|NCT00252564|69686248|FG000|Overall Study|Lost to Follow-up|1|||
38002508|NCT00252564|69686249|FG001|Overall Study|Lost to Follow-up|0|||
38002509|NCT00252564|69686248|FG000|Overall Study|Patient Request|4|||
38002510|NCT00252564|69686249|FG001|Overall Study|Patient Request|5|||
38002511|NCT00252564|69686248|FG000|Overall Study|Withdrawal by Subject|0|||
38002512|NCT00252564|69686249|FG001|Overall Study|Withdrawal by Subject|2|||
38002513|NCT00166296|69686257|FG000|Overall Study|Withdrawal by Subject|1|||
38002514|NCT00166296|69686258|FG001|Overall Study|Withdrawal by Subject|3|||
38002515|NCT00166296|69686257|FG000|Overall Study|Adverse Event|2|||
38002516|NCT00166296|69686258|FG001|Overall Study|Adverse Event|4|||
38002517|NCT00166296|69686257|FG000|Overall Study|Lost to Follow-up|4|||
38002518|NCT00166296|69686258|FG001|Overall Study|Lost to Follow-up|2|||
38002519|NCT00252174|69686267|FG000|Overall Study|Withdrawal by Subject|0|||
37697456|NCT02441309|69173974|FG002|Overall Study|Withdrawal by Subject|1|||
37697457|NCT02027025|69173988|FG000|Overall Study|Adverse Event|0|||
37697458|NCT02027025|69173989|FG001|Overall Study|Adverse Event|1|||
37697459|NCT02027025|69173990|FG002|Overall Study|Adverse Event|1|||
37697460|NCT02027025|69173988|FG000|Overall Study|Protocol Violation|1|||
37697461|NCT02027025|69173989|FG001|Overall Study|Protocol Violation|0|||
37697462|NCT02027025|69173990|FG002|Overall Study|Protocol Violation|0|||
37697463|NCT02027025|69173988|FG000|Overall Study|Lost to Follow-up|0|||
37697464|NCT02027025|69173989|FG001|Overall Study|Lost to Follow-up|2|||
37697465|NCT02027025|69173990|FG002|Overall Study|Lost to Follow-up|0|||
38002520|NCT00252174|69686268|FG001|Overall Study|Withdrawal by Subject|1|||
38002521|NCT00252174|69686269|FG002|Overall Study|Withdrawal by Subject|0|||
38002522|NCT00165984|69686277|FG000|Overall Study|Death|15|||
38002523|NCT00160524|69686284|FG000|Overall Study|Adverse Event|119|||
38002524|NCT00160524|69686284|FG000|Overall Study|Adverse Event and Other|94|||
38002525|NCT00160524|69686284|FG000|Overall Study|Protocol Violation|16|||
38002526|NCT00160524|69686284|FG000|Overall Study|Protocol Violation and Other|2|||
38002527|NCT00160524|69686284|FG000|Overall Study|Withdrawal by Subject|141|||
38002528|NCT00160524|69686284|FG000|Overall Study|Withdrawal by Subject and Other|17|||
38002529|NCT00160524|69686284|FG000|Overall Study|Physician Decision|27|||
38002530|NCT00160524|69686284|FG000|Overall Study|Physician Decision and Other|6|||
38002531|NCT00160524|69686284|FG000|Overall Study|Lost to Follow-up|13|||
38002532|NCT00160524|69686284|FG000|Overall Study|Lost to Follow-up and Other|1|||
38002533|NCT00160524|69686284|FG000|Overall Study|Lack of Efficacy|21|||
38002534|NCT00160524|69686284|FG000|Overall Study|Lack of Efficacy and Other|1|||
38002535|NCT00160524|69686284|FG000|Overall Study|Other|20|||
37697466|NCT02027025|69173988|FG000|Overall Study|Withdrawal by Subject|0|||
37697467|NCT02027025|69173989|FG001|Overall Study|Withdrawal by Subject|1|||
37697468|NCT02027025|69173990|FG002|Overall Study|Withdrawal by Subject|0|||
37697469|NCT02027025|69173988|FG000|Overall Study|Sponsor's decision|0|||
37697470|NCT02027025|69173989|FG001|Overall Study|Sponsor's decision|1|||
37830020|NCT01350973|69513166|FG000|Overall Study|Adverse Event|4|||
37830021|NCT01350973|69513167|FG001|Overall Study|Adverse Event|7|||
37830022|NCT01350973|69513168|FG002|Overall Study|Adverse Event|7|||
37830023|NCT01350973|69513166|FG000|Overall Study|Voluntary Withdrawal|2|||
37830024|NCT01350973|69513167|FG001|Overall Study|Voluntary Withdrawal|1|||
37830025|NCT01350973|69513168|FG002|Overall Study|Voluntary Withdrawal|1|||
37830026|NCT01350544|69513178|FG000|Overall Study|Administrative Withdrawal|0|||
37830027|NCT01350544|69513179|FG001|Overall Study|Administrative Withdrawal|1|||
37830028|NCT01350544|69513178|FG000|Overall Study|Death|1|||
38002536|NCT00159822|69686288|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
38002537|NCT00159822|69686288|FG000|Voriconazole Treatment Period|Adverse Event|9|||
38002538|NCT00159822|69686288|FG000|Voriconazole Treatment Period|Death|4|||
38002539|NCT00159822|69686288|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
38002540|NCT00159822|69686288|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
38002541|NCT00159822|69686288|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
38002542|NCT00159822|69686288|FG000|Post-treatment Follow-up Period|Death|1|||
38002543|NCT00159822|69686288|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
38002544|NCT00159822|69686288|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
38002545|NCT00158262|69686294|FG000|Overall Study|Lost to Follow-up|1|||
38002546|NCT00158262|69686295|FG001|Overall Study|Lost to Follow-up|1|||
38002547|NCT00157950|69686303|FG000|Overall Study|Death|1|||
38002548|NCT00157950|69686304|FG001|Overall Study|Death|0|||
38002549|NCT03745768|69686312|FG000|Overall Study|discontinued study|2|||
38002550|NCT03745768|69686313|FG001|Overall Study|discontinued study|0|||
38002551|NCT03745222|69686322|FG000|Overall Study|Withdrawal by Subject|0|||
38002552|NCT03745222|69686323|FG001|Overall Study|Withdrawal by Subject|1|||
38002553|NCT03745222|69686324|FG002|Overall Study|Withdrawal by Subject|0|||
38002554|NCT03743038|69686332|FG000|Overall Study|Physician Decision|1|||
38002555|NCT00153816|69686344|FG000|Overall Study|Death|6|||
38002556|NCT00153816|69686345|FG001|Overall Study|Death|5|||
38002557|NCT00153816|69686346|FG002|Overall Study|Death|4|||
38002558|NCT00153816|69686347|FG003|Overall Study|Death|6|||
38002559|NCT00153816|69686348|FG004|Overall Study|Death|0|||
38002560|NCT00153816|69686349|FG005|Overall Study|Death|2|||
38002561|NCT00153816|69686344|FG000|Overall Study|Lost to Follow-up|7|||
38002562|NCT00153816|69686345|FG001|Overall Study|Lost to Follow-up|8|||
38002563|NCT00153816|69686346|FG002|Overall Study|Lost to Follow-up|5|||
38002564|NCT00153816|69686347|FG003|Overall Study|Lost to Follow-up|8|||
38002565|NCT00153816|69686348|FG004|Overall Study|Lost to Follow-up|7|||
38002566|NCT00153816|69686349|FG005|Overall Study|Lost to Follow-up|9|||
38002567|NCT00153816|69686344|FG000|Overall Study|Withdrawal by Subject|9|||
38002568|NCT00153816|69686345|FG001|Overall Study|Withdrawal by Subject|9|||
38002569|NCT00153816|69686346|FG002|Overall Study|Withdrawal by Subject|9|||
38002570|NCT00153816|69686347|FG003|Overall Study|Withdrawal by Subject|4|||
38002571|NCT00153816|69686348|FG004|Overall Study|Withdrawal by Subject|1|||
38002572|NCT00153816|69686349|FG005|Overall Study|Withdrawal by Subject|5|||
38002573|NCT00153816|69686344|FG000|Overall Study|Follow-up exam not done|8|||
38002574|NCT00153816|69686345|FG001|Overall Study|Follow-up exam not done|7|||
38002575|NCT00153816|69686346|FG002|Overall Study|Follow-up exam not done|11|||
38002576|NCT00153816|69686347|FG003|Overall Study|Follow-up exam not done|10|||
38002577|NCT00153816|69686348|FG004|Overall Study|Follow-up exam not done|8|||
38002578|NCT00153816|69686349|FG005|Overall Study|Follow-up exam not done|9|||
38002579|NCT00153816|69686344|FG000|Overall Study|Follow-up exam done, histology missing|2|||
38002580|NCT00153816|69686345|FG001|Overall Study|Follow-up exam done, histology missing|3|||
38002581|NCT00153816|69686346|FG002|Overall Study|Follow-up exam done, histology missing|3|||
38002582|NCT00153816|69686347|FG003|Overall Study|Follow-up exam done, histology missing|3|||
38002583|NCT00153816|69686348|FG004|Overall Study|Follow-up exam done, histology missing|1|||
38002584|NCT00153816|69686349|FG005|Overall Study|Follow-up exam done, histology missing|2|||
38002585|NCT00151476|69686366|FG000|FAP Identified Subjects|Protocol Violation|0|||
38002586|NCT00151476|69686367|FG001|FAP Identified Subjects|Protocol Violation|1|||
38002587|NCT00151476|69686366|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
38002588|NCT00151476|69686367|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
38002589|NCT00151476|69686366|FG000|FAP Analyzed Subjects|Other study participation|0|||
38002590|NCT00151476|69686367|FG001|FAP Analyzed Subjects|Other study participation|1|||
38002591|NCT00149994|69686376|FG000|Overall Study|Administrative problems:|1|||
38002592|NCT00149994|69686377|FG001|Overall Study|Administrative problems:|0|||
38002593|NCT00149994|69686376|FG000|Overall Study|Protocol Violation|0|||
38002594|NCT00149994|69686377|FG001|Overall Study|Protocol Violation|1|||
38002595|NCT00149214|69686385|FG000|Overall Study|Adverse Event|12|||
38002596|NCT00149214|69686386|FG001|Overall Study|Adverse Event|9|||
38002597|NCT00149214|69686385|FG000|Overall Study|Withdrawal by Subject|4|||
38002598|NCT00149214|69686386|FG001|Overall Study|Withdrawal by Subject|1|||
38002599|NCT00149214|69686385|FG000|Overall Study|Physician Decision|3|||
38002600|NCT00149214|69686386|FG001|Overall Study|Physician Decision|3|||
38002601|NCT00149214|69686385|FG000|Overall Study|Sponsor Decision|0|||
38002602|NCT00149214|69686386|FG001|Overall Study|Sponsor Decision|1|||
38002603|NCT00149214|69686385|FG000|Overall Study|Progressive Disease|7|||
38002604|NCT00149214|69686386|FG001|Overall Study|Progressive Disease|3|||
38002605|NCT00114972|69686403|FG000|Overall Study|Withdrawal by Subject|40|||
38002606|NCT00114972|69686404|FG001|Overall Study|Withdrawal by Subject|7|||
38002607|NCT00114972|69686403|FG000|Overall Study|Lost to Follow-up|8|||
38002608|NCT00114972|69686404|FG001|Overall Study|Lost to Follow-up|5|||
38002609|NCT00129402|69686412|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
38002610|NCT00129402|69686413|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
37905774|NCT00896532|69591561|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
38002611|NCT00129402|69686414|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
38002612|NCT00129402|69686415|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
38002613|NCT00129402|69686416|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
38002614|NCT00129402|69686417|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
38002615|NCT00129402|69686418|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
38002616|NCT00129402|69686412|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
38002617|NCT00129402|69686413|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
38002618|NCT00129402|69686414|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
38002619|NCT00129402|69686415|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
37697471|NCT02027025|69173990|FG002|Overall Study|Sponsor's decision|0|||
37697472|NCT01652729|69174012|FG000|Overall Study|Withdrawal by Subject|14|||
37905775|NCT00896532|69591562|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
37905776|NCT00896532|69591563|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
37905777|NCT00896532|69591564|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
37905778|NCT00896532|69591565|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
37905779|NCT00896532|69591566|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
37905780|NCT00896532|69591567|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
37905781|NCT00896532|69591568|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
37905782|NCT00896532|69591546|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
37905783|NCT00896532|69591547|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
37905784|NCT00896532|69591548|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
37905785|NCT00896532|69591549|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
37905786|NCT00896532|69591550|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
37905787|NCT00896532|69591551|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
37905788|NCT00896532|69591552|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
37905789|NCT00896532|69591553|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
37905790|NCT00896532|69591554|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
37905791|NCT00896532|69591555|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
37905792|NCT00896532|69591556|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
37905793|NCT00896532|69591557|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
37905794|NCT00896532|69591558|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
37905795|NCT00896532|69591559|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
37905796|NCT00896532|69591560|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
37905797|NCT00896532|69591561|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
37905798|NCT00896532|69591562|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
37905799|NCT00896532|69591563|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
37905800|NCT00896532|69591564|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
37905801|NCT00896532|69591565|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
37905802|NCT00896532|69591566|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
37905803|NCT00896532|69591567|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
37905804|NCT00896532|69591568|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
37905805|NCT00896532|69591546|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
37905806|NCT00896532|69591547|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
37905807|NCT00896532|69591548|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
37905808|NCT00896532|69591549|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
37905809|NCT00896532|69591550|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
37905810|NCT00896532|69591551|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
37905811|NCT00896532|69591552|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
37905812|NCT00896532|69591553|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
37905813|NCT00896532|69591554|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
37905814|NCT00896532|69591555|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
37905815|NCT00896532|69591556|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
37905816|NCT00896532|69591557|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
37905817|NCT00896532|69591558|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
37905818|NCT00896532|69591559|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
37905819|NCT00896532|69591560|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
37905820|NCT00896532|69591561|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
37905821|NCT00896532|69591562|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
37905822|NCT00896532|69591563|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
37905823|NCT00896532|69591564|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
37905824|NCT00896532|69591565|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
37905825|NCT00896532|69591566|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
37905826|NCT00896532|69591567|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
37905827|NCT00896532|69591568|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
37905828|NCT00896532|69591546|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
37905829|NCT00896532|69591547|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
38002620|NCT00129402|69686416|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
38002621|NCT00129402|69686417|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
37697473|NCT01652729|69174013|FG001|Overall Study|Withdrawal by Subject|7|||
37697474|NCT01652729|69174014|FG002|Overall Study|Withdrawal by Subject|7|||
38002622|NCT00129402|69686418|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
38002623|NCT00129402|69686412|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
38002624|NCT00129402|69686413|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
38002625|NCT00129402|69686414|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
38002626|NCT00129402|69686415|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
38002627|NCT00129402|69686416|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
38002628|NCT00129402|69686417|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
38002629|NCT00129402|69686418|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
38002630|NCT00129402|69686412|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
38002631|NCT00129402|69686413|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
38002632|NCT00129402|69686414|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
38002633|NCT00129402|69686415|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
38002634|NCT00129402|69686416|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
38002635|NCT00129402|69686417|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
38002636|NCT00129402|69686418|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
38002637|NCT00129402|69686412|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
38002638|NCT00129402|69686413|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
38002639|NCT00129402|69686414|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
38002640|NCT00129402|69686415|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
38002641|NCT00129402|69686416|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
38002642|NCT00129402|69686417|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
38002643|NCT00129402|69686418|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
38002644|NCT00129402|69686412|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
38002645|NCT00129402|69686413|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
38002646|NCT00129402|69686414|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
38002647|NCT00129402|69686415|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
38002648|NCT00129402|69686416|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
38002649|NCT00129402|69686417|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
38002650|NCT00129402|69686418|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
38002651|NCT00129402|69686412|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
38002652|NCT00129402|69686413|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
38002653|NCT00129402|69686414|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
38002654|NCT00129402|69686415|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
38002655|NCT00129402|69686416|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
38002656|NCT00129402|69686417|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
38002657|NCT00129402|69686418|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
38002658|NCT00129402|69686412|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
38002659|NCT00129402|69686413|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
38002660|NCT00129402|69686414|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
38002661|NCT00129402|69686415|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
38002662|NCT00129402|69686416|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
38002663|NCT00129402|69686417|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
38002664|NCT00129402|69686418|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
38002665|NCT00129402|69686412|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
38002666|NCT00129402|69686413|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
38002667|NCT00129402|69686414|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
37905830|NCT00896532|69591548|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
37905831|NCT00896532|69591549|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
37905832|NCT00896532|69591550|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
37905833|NCT00896532|69591551|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
37905834|NCT00896532|69591552|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
37905835|NCT00896532|69591553|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
37905836|NCT00896532|69591554|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
37905837|NCT00896532|69591555|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
37905838|NCT00896532|69591556|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
37905839|NCT00896532|69591557|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
37905840|NCT00896532|69591558|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
37905841|NCT00896532|69591559|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
38002668|NCT00129402|69686415|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
38002669|NCT00129402|69686416|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
38002670|NCT00129402|69686417|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
38002671|NCT00129402|69686418|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
38002672|NCT00129402|69686412|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
38002673|NCT00129402|69686413|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
38002674|NCT00129402|69686414|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
38002675|NCT00129402|69686415|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
38002676|NCT00129402|69686416|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
38002677|NCT00129402|69686417|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
38002678|NCT00129402|69686418|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
38002679|NCT00129402|69686412|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
38002680|NCT00129402|69686413|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
38002681|NCT00129402|69686414|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
38002682|NCT00129402|69686415|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
38002683|NCT00129402|69686416|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
38002684|NCT00129402|69686417|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
38002685|NCT00129402|69686418|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
37697475|NCT01652729|69174012|FG000|Overall Study|Adverse Event|4|||
37697476|NCT01652729|69174013|FG001|Overall Study|Adverse Event|0|||
37697477|NCT01652729|69174014|FG002|Overall Study|Adverse Event|3|||
37697478|NCT01652729|69174012|FG000|Overall Study|Physician Decision|1|||
37697479|NCT01652729|69174013|FG001|Overall Study|Physician Decision|0|||
37697480|NCT01652729|69174014|FG002|Overall Study|Physician Decision|1|||
37697481|NCT01652729|69174012|FG000|Overall Study|Protocol Violation|1|||
37697482|NCT01652729|69174013|FG001|Overall Study|Protocol Violation|0|||
37697483|NCT01652729|69174014|FG002|Overall Study|Protocol Violation|0|||
37697484|NCT01652729|69174012|FG000|Overall Study|Lost to Follow-up|6|||
37697485|NCT01652729|69174013|FG001|Overall Study|Lost to Follow-up|6|||
37697486|NCT01652729|69174014|FG002|Overall Study|Lost to Follow-up|3|||
37697487|NCT01652729|69174012|FG000|Overall Study|Administrative|1|||
37697488|NCT01652729|69174013|FG001|Overall Study|Administrative|0|||
37697489|NCT01652729|69174014|FG002|Overall Study|Administrative|0|||
37697490|NCT02083965|69174024|FG000|Treatment Period|Other|1|||
37697491|NCT02083965|69174025|FG001|Treatment Period|Other|0|||
37697492|NCT02438813|69174033|FG000|Overall Study|Patient Decision|59|||
37697493|NCT02438813|69174033|FG000|Overall Study|Patient Lost to Follow-Up|137|||
37697494|NCT02438813|69174033|FG000|Overall Study|Study Ended by Sponsor|80|||
37697495|NCT02438813|69174033|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
37697496|NCT02437409|69174047|FG000|Overall Study|Withdrawal by Subject|3|||
37697497|NCT02437409|69174047|FG000|Overall Study|Screening failure|12|||
37697498|NCT02459093|69174054|FG000|Overall Study|Protocol Violation|6|||
37697499|NCT02459093|69174055|FG001|Overall Study|Protocol Violation|11|||
37697500|NCT02459093|69174054|FG000|Overall Study|Lost to Follow-up|6|||
37697501|NCT02459093|69174055|FG001|Overall Study|Lost to Follow-up|7|||
37697502|NCT02458469|69174061|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
37697503|NCT02458469|69174062|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
37697504|NCT02458469|69174063|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
37697505|NCT02458469|69174064|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
37697506|NCT02458469|69174065|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
37697507|NCT02458469|69174066|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
37697508|NCT02458469|69174061|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
37697509|NCT02458469|69174062|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
37697510|NCT02458469|69174063|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
37697511|NCT02458469|69174064|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
37697512|NCT02458469|69174065|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
37697513|NCT02458469|69174066|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
37697514|NCT02458469|69174061|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
37697515|NCT02458469|69174062|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
37697516|NCT02458469|69174063|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
37697517|NCT02458469|69174064|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
37697518|NCT02458469|69174065|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
37697519|NCT02458469|69174066|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
37697520|NCT01843348|69174077|FG000|Overall Study|Withdrawal by Subject|4|||
37697521|NCT01843348|69174078|FG001|Overall Study|Withdrawal by Subject|16|||
37697522|NCT01843348|69174079|FG002|Overall Study|Withdrawal by Subject|18|||
37697523|NCT01843348|69174077|FG000|Overall Study|Lost to Follow-up|5|||
37697524|NCT01843348|69174078|FG001|Overall Study|Lost to Follow-up|4|||
37697525|NCT01843348|69174079|FG002|Overall Study|Lost to Follow-up|2|||
37697526|NCT01843348|69174077|FG000|Overall Study|Death|5|||
37697527|NCT01843348|69174078|FG001|Overall Study|Death|3|||
37697528|NCT01843348|69174079|FG002|Overall Study|Death|4|||
37697529|NCT01843348|69174077|FG000|Overall Study|Graft loss/retransplantation|5|||
37697530|NCT01843348|69174078|FG001|Overall Study|Graft loss/retransplantation|8|||
37697531|NCT01843348|69174079|FG002|Overall Study|Graft loss/retransplantation|11|||
38002686|NCT00129402|69686412|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
37905842|NCT00896532|69591560|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
37905843|NCT00896532|69591561|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
38002687|NCT00129402|69686413|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
38002688|NCT00129402|69686414|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
38002689|NCT00129402|69686415|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
38002690|NCT00129402|69686416|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
37697532|NCT01843348|69174077|FG000|Overall Study|Various reasons|4|||
37697533|NCT01843348|69174078|FG001|Overall Study|Various reasons|9|||
37830029|NCT01350544|69513179|FG001|Overall Study|Death|2|||
37830030|NCT01350544|69513178|FG000|Overall Study|Moved out of LA County|2|||
37830031|NCT01350544|69513179|FG001|Overall Study|Moved out of LA County|2|||
37830032|NCT01350544|69513178|FG000|Overall Study|Medical Issues|1|||
37830033|NCT01350544|69513179|FG001|Overall Study|Medical Issues|1|||
37830034|NCT01350544|69513178|FG000|Overall Study|Withdrawal by Subject|0|||
37830035|NCT01350544|69513179|FG001|Overall Study|Withdrawal by Subject|1|||
37830036|NCT01350544|69513178|FG000|Overall Study|Incarceration|1|||
37830037|NCT01350544|69513179|FG001|Overall Study|Incarceration|0|||
37830038|NCT01350544|69513178|FG000|Overall Study|Lost to Follow-up|18|||
37830039|NCT01350544|69513179|FG001|Overall Study|Lost to Follow-up|15|||
37830040|NCT01350505|69513185|FG000|Overall Study|Lost to Follow-up|4|||
37905844|NCT00896532|69591562|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
37905845|NCT00896532|69591563|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
37905846|NCT00896532|69591564|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
37905847|NCT00896532|69591565|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
37905848|NCT00896532|69591566|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
37905849|NCT00896532|69591567|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
37905850|NCT00896532|69591568|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
37905851|NCT00896532|69591546|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
37905852|NCT00896532|69591547|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
37905853|NCT00896532|69591548|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
37905854|NCT00896532|69591549|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
37697534|NCT01843348|69174079|FG002|Overall Study|Various reasons|6|||
37697535|NCT01843192|69174092|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
37830041|NCT01350271|69513192|FG000|Overall Study|Lost to Follow-up|21|||
37830042|NCT01350271|69513193|FG001|Overall Study|Lost to Follow-up|17|||
37830043|NCT01350271|69513194|FG002|Overall Study|Lost to Follow-up|26|||
37830044|NCT01348828|69513205|FG000|Overall Study|Death|20|||
37830045|NCT01348828|69513205|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
37830046|NCT01348828|69513205|FG000|Overall Study|Conversion|2|||
37830047|NCT01348828|69513205|FG000|Overall Study|missed visit|1|||
37830048|NCT01348789|69513209|FG000|Overall Study|Protocol Violation|2|||
37830049|NCT01348789|69513209|FG000|Overall Study|Withdrawal by Subject|2|||
37830050|NCT01342510|69513224|FG000|Overall Study|Protocol Violation|12|||
37830051|NCT01342510|69513225|FG001|Overall Study|Protocol Violation|6|||
37830052|NCT01342510|69513226|FG002|Overall Study|Protocol Violation|13|||
37830053|NCT01342510|69513227|FG003|Overall Study|Protocol Violation|11|||
37830054|NCT01340872|69513247|FG000|Double-blind Phase|Adverse Event|6|||
37830055|NCT01340872|69513248|FG001|Double-blind Phase|Adverse Event|4|||
37830056|NCT01340872|69513249|FG002|Double-blind Phase|Adverse Event|0|||
37830057|NCT01340872|69513250|FG003|Double-blind Phase|Adverse Event|0|||
37830058|NCT01340872|69513247|FG000|Double-blind Phase|Withdrawal by Subject|3|||
37830059|NCT01340872|69513248|FG001|Double-blind Phase|Withdrawal by Subject|5|||
37830060|NCT01340872|69513249|FG002|Double-blind Phase|Withdrawal by Subject|0|||
37830061|NCT01340872|69513250|FG003|Double-blind Phase|Withdrawal by Subject|0|||
37830062|NCT01340872|69513247|FG000|Double-blind Phase|Lost to Follow-up|0|||
37830063|NCT01340872|69513248|FG001|Double-blind Phase|Lost to Follow-up|1|||
37830064|NCT01340872|69513249|FG002|Double-blind Phase|Lost to Follow-up|0|||
37830065|NCT01340872|69513250|FG003|Double-blind Phase|Lost to Follow-up|0|||
37830066|NCT01340872|69513247|FG000|Double-blind Phase|Protocol Violation|0|||
37830067|NCT01340872|69513248|FG001|Double-blind Phase|Protocol Violation|1|||
37830068|NCT01340872|69513249|FG002|Double-blind Phase|Protocol Violation|0|||
37830069|NCT01340872|69513250|FG003|Double-blind Phase|Protocol Violation|0|||
37830070|NCT01340872|69513247|FG000|Open-label Phase|Physician Decision|0|||
37830071|NCT01340872|69513248|FG001|Open-label Phase|Physician Decision|0|||
37830072|NCT01340872|69513249|FG002|Open-label Phase|Physician Decision|2|||
37830073|NCT01340872|69513250|FG003|Open-label Phase|Physician Decision|1|||
37830074|NCT01340872|69513247|FG000|Open-label Phase|Pregnancy|0|||
37830075|NCT01340872|69513248|FG001|Open-label Phase|Pregnancy|0|||
37830076|NCT01340872|69513249|FG002|Open-label Phase|Pregnancy|1|||
37830077|NCT01340872|69513250|FG003|Open-label Phase|Pregnancy|0|||
37830078|NCT01340872|69513247|FG000|Open-label Phase|Adverse Event|0|||
37830079|NCT01340872|69513248|FG001|Open-label Phase|Adverse Event|0|||
37830080|NCT01340872|69513249|FG002|Open-label Phase|Adverse Event|8|||
37830081|NCT01340872|69513250|FG003|Open-label Phase|Adverse Event|4|||
37830082|NCT01340872|69513247|FG000|Open-label Phase|Withdrawal by Subject|0|||
37830083|NCT01340872|69513248|FG001|Open-label Phase|Withdrawal by Subject|0|||
37830084|NCT01340872|69513249|FG002|Open-label Phase|Withdrawal by Subject|1|||
37830085|NCT01340872|69513250|FG003|Open-label Phase|Withdrawal by Subject|6|||
37830086|NCT01340872|69513247|FG000|Open-label Phase|Worsening of IBD|0|||
37830087|NCT01340872|69513248|FG001|Open-label Phase|Worsening of IBD|0|||
37830088|NCT01340872|69513249|FG002|Open-label Phase|Worsening of IBD|1|||
37830089|NCT01340872|69513250|FG003|Open-label Phase|Worsening of IBD|0|||
37830090|NCT01340794|69513264|FG000|Overall Study|Withdrawal by Subject|0|||
37830091|NCT01340794|69513265|FG001|Overall Study|Withdrawal by Subject|1|||
37830092|NCT01340482|69513276|FG000|Overall Study|Adverse Event|2|||
37830093|NCT01340482|69513277|FG001|Overall Study|Adverse Event|0|||
37830094|NCT01340482|69513278|FG002|Overall Study|Adverse Event|0|||
37830095|NCT01340209|69513291|FG000|Overall Study|Adverse Event|1|||
37830096|NCT01340209|69513292|FG001|Overall Study|Adverse Event|1|||
37830097|NCT01340209|69513293|FG002|Overall Study|Adverse Event|2|||
37830098|NCT01340209|69513291|FG000|Overall Study|Protocol Violation|1|||
37830099|NCT01340209|69513292|FG001|Overall Study|Protocol Violation|2|||
37830100|NCT01340209|69513293|FG002|Overall Study|Protocol Violation|1|||
37830101|NCT01340209|69513291|FG000|Overall Study|Withdrawal by Subject|0|||
37830102|NCT01340209|69513292|FG001|Overall Study|Withdrawal by Subject|0|||
37830103|NCT01340209|69513293|FG002|Overall Study|Withdrawal by Subject|1|||
37830104|NCT01340209|69513291|FG000|Overall Study|Other reason not defined above|3|||
37830105|NCT01340209|69513292|FG001|Overall Study|Other reason not defined above|5|||
37905855|NCT00896532|69591550|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
37905856|NCT00896532|69591551|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
37905857|NCT00896532|69591552|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
37905858|NCT00896532|69591553|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
37905859|NCT00896532|69591554|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
37905860|NCT00896532|69591555|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
37905861|NCT00896532|69591556|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
37830106|NCT01340209|69513293|FG002|Overall Study|Other reason not defined above|4|||
37830107|NCT01326910|69513303|FG000|Overall Study|Withdrawal by Subject|3|||
37830108|NCT01326910|69513304|FG001|Overall Study|Withdrawal by Subject|2|||
37905862|NCT00896532|69591557|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
37905863|NCT00896532|69591558|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
37830109|NCT01326910|69513303|FG000|Overall Study|Protocol Violation|1|||
37830110|NCT01326910|69513304|FG001|Overall Study|Protocol Violation|1|||
37830111|NCT01326481|69513310|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
37830112|NCT01325701|69513318|FG000|Overall Study|Adverse Event|12|||
37905864|NCT00896532|69591559|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
37905865|NCT00896532|69591560|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
38002691|NCT00129402|69686417|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
38002692|NCT00129402|69686418|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
38002693|NCT00129402|69686412|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
38002694|NCT00129402|69686413|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
38002695|NCT00129402|69686414|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
38002696|NCT00129402|69686415|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
38002697|NCT00129402|69686416|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
38002698|NCT00129402|69686417|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
38002699|NCT00129402|69686418|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
38002700|NCT03739528|69686428|FG000|Overall Study|Not treated|8|||
38002701|NCT03739528|69686429|FG001|Overall Study|Not treated|12|||
38002702|NCT03739528|69686428|FG000|Overall Study|Treatment and study discontinued|6|||
38002703|NCT03739528|69686429|FG001|Overall Study|Treatment and study discontinued|2|||
37697536|NCT01843192|69174093|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
37905866|NCT00896532|69591561|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
37905867|NCT00896532|69591562|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
37905868|NCT00896532|69591563|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
37905869|NCT00896532|69591564|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
37905870|NCT00896532|69591565|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
37905871|NCT00896532|69591566|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
37905872|NCT00896532|69591567|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
37905873|NCT00896532|69591568|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
37905874|NCT00896532|69591546|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
37905875|NCT00896532|69591547|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
37905876|NCT00896532|69591548|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
37905877|NCT00896532|69591549|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
37905878|NCT00896532|69591550|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
37905879|NCT00896532|69591551|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
37905880|NCT00896532|69591552|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
37905881|NCT00896532|69591553|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
37905882|NCT00896532|69591554|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
37905883|NCT00896532|69591555|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
37905884|NCT00896532|69591556|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
37905885|NCT00896532|69591557|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
37905886|NCT00896532|69591558|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
37905887|NCT00896532|69591559|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
37905888|NCT00896532|69591560|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
37905889|NCT00896532|69591561|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
37905890|NCT00896532|69591562|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
37905891|NCT00896532|69591563|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
37905892|NCT00896532|69591564|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
37905893|NCT00896532|69591565|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
37905894|NCT00896532|69591566|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
37905895|NCT00896532|69591567|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
37905896|NCT00896532|69591568|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
37697537|NCT01843192|69174094|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
37697538|NCT01825876|69174102|FG000|Period 2|Withdrawal by Subject|0|||
37697539|NCT01825876|69174103|FG001|Period 2|Withdrawal by Subject|1|||
37697540|NCT01842958|69174114|FG000|Overall Study|Lost to Follow-up|1|||
37697541|NCT01842958|69174115|FG001|Overall Study|Lost to Follow-up|1|||
37697542|NCT02413229|69174129|FG000|Overall Study|Adverse Event|0|||
37697543|NCT02413229|69174130|FG001|Overall Study|Adverse Event|0|||
37830113|NCT01325701|69513319|FG001|Overall Study|Adverse Event|0|||
37830114|NCT01325701|69513318|FG000|Overall Study|Protocol Violation|1|||
37830115|NCT01325701|69513319|FG001|Overall Study|Protocol Violation|0|||
37830116|NCT01325701|69513318|FG000|Overall Study|Physician Decision|2|||
37830117|NCT01325701|69513319|FG001|Overall Study|Physician Decision|2|||
37830118|NCT01325701|69513318|FG000|Overall Study|Withdrawal by Subject|2|||
37830119|NCT01325701|69513319|FG001|Overall Study|Withdrawal by Subject|1|||
37830120|NCT01325701|69513318|FG000|Overall Study|Rollerover Extension Study|4|||
37830121|NCT01325701|69513319|FG001|Overall Study|Rollerover Extension Study|0|||
37830122|NCT01325623|69513326|FG000|Overall Study|Withdrawal by Subject|3|||
37830123|NCT01325584|69513363|FG000|Overall Study|Death|1|||
37905897|NCT00896532|69591546|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
37830124|NCT01325428|69513367|FG000|Part A|Progressive disease according to RECIST|9|||
38002704|NCT03739528|69686428|FG000|Overall Study|Treatment discontinued + study completed|1|||
38002705|NCT03739528|69686429|FG001|Overall Study|Treatment discontinued + study completed|3|||
38002706|NCT00114738|69686438|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
38002707|NCT00114738|69686439|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
38002708|NCT00114738|69686440|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
38002709|NCT00114738|69686438|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
38002710|NCT00114738|69686439|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
38002711|NCT00114738|69686440|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
38002712|NCT00114738|69686438|FG000|Screening for Randomization|Neuropathy|17|||
38002713|NCT00114738|69686439|FG001|Screening for Randomization|Neuropathy|0|||
38002714|NCT00114738|69686440|FG002|Screening for Randomization|Neuropathy|0|||
38002715|NCT00114738|69686438|FG000|Screening for Randomization|Progressive disease|2|||
38002716|NCT00114738|69686439|FG001|Screening for Randomization|Progressive disease|0|||
38002717|NCT00114738|69686440|FG002|Screening for Randomization|Progressive disease|0|||
38002718|NCT00114738|69686438|FG000|Screening for Randomization|CNS Hemorrhage|1|||
38002719|NCT00114738|69686439|FG001|Screening for Randomization|CNS Hemorrhage|0|||
38002720|NCT00114738|69686440|FG002|Screening for Randomization|CNS Hemorrhage|0|||
38002721|NCT00114738|69686438|FG000|Screening for Randomization|Other|1|||
38002722|NCT00114738|69686439|FG001|Screening for Randomization|Other|0|||
38002723|NCT00114738|69686440|FG002|Screening for Randomization|Other|0|||
38002724|NCT00148122|69686447|FG000|Overall Study|Withdrawal by Subject|2|||
38002725|NCT00147498|69686455|FG000|Overall Study|Adverse Event|1|||
38002726|NCT00147498|69686456|FG001|Overall Study|Adverse Event|6|||
38002727|NCT00147498|69686457|FG002|Overall Study|Adverse Event|7|||
38002728|NCT00147498|69686458|FG003|Overall Study|Adverse Event|3|||
38002729|NCT00147498|69686455|FG000|Overall Study|Lack of Efficacy|1|||
38002730|NCT00147498|69686456|FG001|Overall Study|Lack of Efficacy|1|||
38002731|NCT00147498|69686457|FG002|Overall Study|Lack of Efficacy|1|||
38002732|NCT00147498|69686458|FG003|Overall Study|Lack of Efficacy|8|||
38002733|NCT00147498|69686455|FG000|Overall Study|Laboratory abnormality|0|||
38002734|NCT00147498|69686456|FG001|Overall Study|Laboratory abnormality|0|||
38002735|NCT00147498|69686457|FG002|Overall Study|Laboratory abnormality|2|||
38002736|NCT00147498|69686458|FG003|Overall Study|Laboratory abnormality|0|||
38002737|NCT00147498|69686455|FG000|Overall Study|Participant defaulted|0|||
38002738|NCT00147498|69686456|FG001|Overall Study|Participant defaulted|1|||
38002739|NCT00147498|69686457|FG002|Overall Study|Participant defaulted|4|||
38002740|NCT00147498|69686458|FG003|Overall Study|Participant defaulted|3|||
38002741|NCT00147498|69686455|FG000|Overall Study|Other|1|||
38002742|NCT00147498|69686456|FG001|Overall Study|Other|1|||
38002743|NCT00147498|69686457|FG002|Overall Study|Other|3|||
38002744|NCT00147498|69686458|FG003|Overall Study|Other|3|||
38002745|NCT00113568|69686468|FG000|Overall Study|Adverse Event|97|||
38002746|NCT00113568|69686468|FG000|Overall Study|Death|1|||
38002747|NCT00113568|69686468|FG000|Overall Study|Lack of Efficacy|30|||
38002748|NCT00113568|69686468|FG000|Overall Study|Lost to Follow-up|156|||
37905898|NCT00896532|69591547|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
37905899|NCT00896532|69591548|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
37905900|NCT00896532|69591549|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
37905901|NCT00896532|69591550|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
37905902|NCT00896532|69591551|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
37905903|NCT00896532|69591552|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
37905904|NCT00896532|69591553|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
37905905|NCT00896532|69591554|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
37905906|NCT00896532|69591555|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
37905907|NCT00896532|69591556|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
37905908|NCT00896532|69591557|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
37905909|NCT00896532|69591558|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
37905910|NCT00896532|69591559|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
37905911|NCT00896532|69591560|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
37905912|NCT00896532|69591561|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
37905913|NCT00896532|69591562|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
37905914|NCT00896532|69591563|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
37905915|NCT00896532|69591564|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
37905916|NCT00896532|69591565|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
37905917|NCT00896532|69591566|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
38002749|NCT00113568|69686468|FG000|Overall Study|Protocol Violation|32|||
38002750|NCT00113568|69686468|FG000|Overall Study|Withdrawal by Subject|117|||
38002751|NCT00113568|69686468|FG000|Overall Study|Other|112|||
38002752|NCT00113490|69686474|FG000|Overall Study|Withdrawal by Subject|1|||
38002753|NCT00113490|69686475|FG001|Overall Study|Withdrawal by Subject|3|||
38002754|NCT00113490|69686474|FG000|Overall Study|Lost to Follow-up|1|||
38002755|NCT00113490|69686475|FG001|Overall Study|Lost to Follow-up|0|||
38002756|NCT00146640|69686483|FG000|Overall Study|Adverse Event|12|||
38002757|NCT00146640|69686484|FG001|Overall Study|Adverse Event|10|||
38002758|NCT00146640|69686483|FG000|Overall Study|Medical Reasons|3|||
38002759|NCT00146640|69686484|FG001|Overall Study|Medical Reasons|0|||
38002760|NCT00146640|69686483|FG000|Overall Study|Non-Medical Reasons|8|||
38002761|NCT00146640|69686484|FG001|Overall Study|Non-Medical Reasons|4|||
38002762|NCT00146328|69686502|FG000|Overall Study|Adverse Event|39|||
38002763|NCT00146328|69686503|FG001|Overall Study|Adverse Event|48|||
38002764|NCT00146328|69686504|FG002|Overall Study|Adverse Event|79|||
38002765|NCT00146328|69686502|FG000|Overall Study|Protocol Violation|11|||
38002766|NCT00146328|69686503|FG001|Overall Study|Protocol Violation|6|||
38002767|NCT00146328|69686504|FG002|Overall Study|Protocol Violation|12|||
38002768|NCT00146328|69686502|FG000|Overall Study|Lost to Follow-up|7|||
38002769|NCT00146328|69686503|FG001|Overall Study|Lost to Follow-up|4|||
38002770|NCT00146328|69686504|FG002|Overall Study|Lost to Follow-up|7|||
38002771|NCT00146328|69686502|FG000|Overall Study|Withdrawal by Subject|16|||
38002772|NCT00146328|69686503|FG001|Overall Study|Withdrawal by Subject|16|||
38002773|NCT00146328|69686504|FG002|Overall Study|Withdrawal by Subject|22|||
38002774|NCT00146328|69686502|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
38002775|NCT00146328|69686503|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
38002776|NCT00146328|69686504|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
38002777|NCT00146328|69686502|FG000|Overall Study|Trial ended/site closed|8|||
38002778|NCT00146328|69686503|FG001|Overall Study|Trial ended/site closed|2|||
38002779|NCT00146328|69686504|FG002|Overall Study|Trial ended/site closed|19|||
38002780|NCT00146328|69686502|FG000|Overall Study|Patient decision to end|0|||
38002781|NCT00146328|69686503|FG001|Overall Study|Patient decision to end|1|||
38002782|NCT00146328|69686504|FG002|Overall Study|Patient decision to end|6|||
38002783|NCT00146328|69686502|FG000|Overall Study|Enroll into other trial|2|||
38002784|NCT00146328|69686503|FG001|Overall Study|Enroll into other trial|4|||
38002785|NCT00146328|69686504|FG002|Overall Study|Enroll into other trial|2|||
38002786|NCT00146328|69686502|FG000|Overall Study|Death|0|||
38002787|NCT00146328|69686503|FG001|Overall Study|Death|1|||
38002788|NCT00146328|69686504|FG002|Overall Study|Death|1|||
38002789|NCT00146328|69686502|FG000|Overall Study|Moved|2|||
38002790|NCT00146328|69686503|FG001|Overall Study|Moved|0|||
37905918|NCT00896532|69591567|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
37905919|NCT00896532|69591568|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
37905920|NCT00896532|69591546|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
37905921|NCT00896532|69591547|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
37905922|NCT00896532|69591548|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
37905923|NCT00896532|69591549|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
38002791|NCT00146328|69686504|FG002|Overall Study|Moved|0|||
38002792|NCT00146328|69686502|FG000|Overall Study|Interaction with other medication|2|||
38002793|NCT00146328|69686503|FG001|Overall Study|Interaction with other medication|0|||
38002794|NCT00146328|69686504|FG002|Overall Study|Interaction with other medication|1|||
38002795|NCT03733444|69686515|FG000|Overall Study|Adverse Event|8|||
38002796|NCT03733444|69686516|FG001|Overall Study|Adverse Event|10|||
38002797|NCT03733444|69686517|FG002|Overall Study|Adverse Event|5|||
38002798|NCT03733444|69686515|FG000|Overall Study|Death|20|||
38002799|NCT03733444|69686516|FG001|Overall Study|Death|19|||
38002800|NCT03733444|69686517|FG002|Overall Study|Death|11|||
38002801|NCT03733444|69686515|FG000|Overall Study|Lost to Follow-up|3|||
37905924|NCT00896532|69591550|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
37905925|NCT00896532|69591551|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
37905926|NCT00896532|69591552|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
37905927|NCT00896532|69591553|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
38002802|NCT03733444|69686516|FG001|Overall Study|Lost to Follow-up|0|||
38002803|NCT03733444|69686517|FG002|Overall Study|Lost to Follow-up|1|||
38002804|NCT03733444|69686515|FG000|Overall Study|Lack of Efficacy|0|||
38002805|NCT03733444|69686516|FG001|Overall Study|Lack of Efficacy|1|||
38002806|NCT03733444|69686517|FG002|Overall Study|Lack of Efficacy|1|||
38002807|NCT03733444|69686515|FG000|Overall Study|Physician Decision|2|||
38002808|NCT03733444|69686516|FG001|Overall Study|Physician Decision|1|||
37697544|NCT02413229|69174131|FG002|Overall Study|Adverse Event|0|||
37905928|NCT00896532|69591554|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
37905929|NCT00896532|69591555|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
38002809|NCT03733444|69686517|FG002|Overall Study|Physician Decision|0|||
38002810|NCT03733444|69686515|FG000|Overall Study|Protocol Violation|2|||
38002811|NCT03733444|69686516|FG001|Overall Study|Protocol Violation|1|||
38002812|NCT03733444|69686517|FG002|Overall Study|Protocol Violation|0|||
38002813|NCT03733444|69686515|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
38002814|NCT03733444|69686516|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
37905930|NCT00896532|69591556|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
38002815|NCT03733444|69686517|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
38002816|NCT03733444|69686515|FG000|Overall Study|Study Terminated by Sponsor|203|||
38002817|NCT03733444|69686516|FG001|Overall Study|Study Terminated by Sponsor|209|||
38002818|NCT03733444|69686517|FG002|Overall Study|Study Terminated by Sponsor|221|||
38002819|NCT03733444|69686515|FG000|Overall Study|Withdrawal by Subject|19|||
38002820|NCT03733444|69686516|FG001|Overall Study|Withdrawal by Subject|18|||
38002821|NCT03733444|69686517|FG002|Overall Study|Withdrawal by Subject|16|||
38002822|NCT03733444|69686515|FG000|Overall Study|Miscellaneous|1|||
38002823|NCT03733444|69686516|FG001|Overall Study|Miscellaneous|0|||
38002824|NCT03733444|69686517|FG002|Overall Study|Miscellaneous|1|||
38002825|NCT03733444|69686515|FG000|Overall Study|Not Treated|1|||
38002826|NCT03733444|69686516|FG001|Overall Study|Not Treated|2|||
38002827|NCT03733444|69686517|FG002|Overall Study|Not Treated|1|||
38002828|NCT03731182|69686537|FG000|Overall Study|Lost to Follow-up|2|||
38002829|NCT03731182|69686538|FG001|Overall Study|Lost to Follow-up|0|||
38002830|NCT03731182|69686537|FG000|Overall Study|Physician Decision|1|||
38002831|NCT03731182|69686538|FG001|Overall Study|Physician Decision|0|||
38002832|NCT03731182|69686537|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
38002833|NCT03731182|69686538|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
37697545|NCT02413229|69174132|FG003|Overall Study|Adverse Event|1|||
37697546|NCT02413229|69174133|FG004|Overall Study|Adverse Event|0|||
37697547|NCT02413229|69174134|FG005|Overall Study|Adverse Event|0|||
37697548|NCT02413229|69174135|FG006|Overall Study|Adverse Event|0|||
37697549|NCT02413229|69174136|FG007|Overall Study|Adverse Event|1|||
37830125|NCT01325428|69513367|FG000|Part A|Clinical signs, symptoms of progression|2|||
37830126|NCT01325428|69513367|FG000|Part A|Other adverse event|1|||
37830127|NCT01325428|69513367|FG000|Part A|Refused continue taking trial medication|2|||
37830128|NCT01325428|69513367|FG000|Part A|Other reason not defined above|2|||
37830129|NCT01325428|69513367|FG000|Part B|Refused continue taking trial medication|2|||
37830130|NCT01325428|69513367|FG000|Part B|Other reason not defined above|1|||
37830131|NCT01325350|69513381|FG000|Overall Study|Adverse Event|3|||
37905931|NCT00896532|69591557|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
37905932|NCT00896532|69591558|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
37905933|NCT00896532|69591559|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
37905934|NCT00896532|69591560|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
37905935|NCT00896532|69591561|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
37905936|NCT00896532|69591562|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
37905937|NCT00896532|69591563|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
37905938|NCT00896532|69591564|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
37905939|NCT00896532|69591565|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
37905940|NCT00896532|69591566|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
37905941|NCT00896532|69591567|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
37905942|NCT00896532|69591568|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
37905943|NCT00896532|69591546|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
37905944|NCT00896532|69591547|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
37905945|NCT00896532|69591548|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
37905946|NCT00896532|69591549|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
37905947|NCT00896532|69591550|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
37905948|NCT00896532|69591551|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
37905949|NCT00896532|69591552|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
37905950|NCT00896532|69591553|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
37905951|NCT00896532|69591554|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
37905952|NCT00896532|69591555|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
37905953|NCT00896532|69591556|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
37905954|NCT00896532|69591557|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
37830132|NCT01325350|69513382|FG001|Overall Study|Adverse Event|3|||
38002834|NCT03730012|69686547|FG000|Overall Study|Adverse Event|0|||
38002835|NCT03730012|69686548|FG001|Overall Study|Adverse Event|1|||
37830133|NCT01325350|69513383|FG002|Overall Study|Adverse Event|3|||
38002836|NCT03730012|69686547|FG000|Overall Study|Lack of Efficacy|1|||
38002837|NCT03730012|69686548|FG001|Overall Study|Lack of Efficacy|5|||
38002838|NCT03730012|69686547|FG000|Overall Study|Withdrawal by Subject|0|||
38002839|NCT03730012|69686548|FG001|Overall Study|Withdrawal by Subject|1|||
37697550|NCT02413229|69174129|FG000|Overall Study|Lost to Follow-up|0|||
37697551|NCT02413229|69174130|FG001|Overall Study|Lost to Follow-up|0|||
38002840|NCT03730012|69686547|FG000|Overall Study|Miscellaneous|2|||
38002841|NCT03730012|69686548|FG001|Overall Study|Miscellaneous|1|||
38002842|NCT03728140|69686559|FG000|Overall Study|Abnormal embryo transfer operation|10|||
38002843|NCT03728140|69686560|FG001|Overall Study|Abnormal embryo transfer operation|7|||
38002844|NCT03725722|69686585|FG000|Overall Study|Lack of Efficacy|2|||
38002845|NCT03725722|69686586|FG001|Overall Study|Lack of Efficacy|1|||
38002846|NCT03725722|69686587|FG002|Overall Study|Lack of Efficacy|2|||
38002847|NCT03725722|69686588|FG003|Overall Study|Lack of Efficacy|0|||
38002848|NCT03725722|69686589|FG004|Overall Study|Lack of Efficacy|2|||
38002849|NCT03725722|69686585|FG000|Overall Study|Adverse Event|2|||
38002850|NCT03725722|69686586|FG001|Overall Study|Adverse Event|2|||
38002851|NCT03725722|69686587|FG002|Overall Study|Adverse Event|1|||
38002852|NCT03725722|69686588|FG003|Overall Study|Adverse Event|0|||
38002853|NCT03725722|69686589|FG004|Overall Study|Adverse Event|6|||
38002854|NCT03725722|69686585|FG000|Overall Study|Withdrawal by Subject|4|||
38002855|NCT03725722|69686586|FG001|Overall Study|Withdrawal by Subject|1|||
38002856|NCT03725722|69686587|FG002|Overall Study|Withdrawal by Subject|0|||
38002857|NCT03725722|69686588|FG003|Overall Study|Withdrawal by Subject|4|||
38002858|NCT03725722|69686589|FG004|Overall Study|Withdrawal by Subject|4|||
38002859|NCT03725722|69686585|FG000|Overall Study|Lost to Follow-up|3|||
38002860|NCT03725722|69686586|FG001|Overall Study|Lost to Follow-up|1|||
38002861|NCT03725722|69686587|FG002|Overall Study|Lost to Follow-up|2|||
38002862|NCT03725722|69686588|FG003|Overall Study|Lost to Follow-up|2|||
38002863|NCT03725722|69686589|FG004|Overall Study|Lost to Follow-up|1|||
38002864|NCT03725722|69686585|FG000|Overall Study|Personal reasons|0|||
38002865|NCT03725722|69686586|FG001|Overall Study|Personal reasons|0|||
38002866|NCT03725722|69686587|FG002|Overall Study|Personal reasons|1|||
38002867|NCT03725722|69686588|FG003|Overall Study|Personal reasons|0|||
38002868|NCT03725722|69686589|FG004|Overall Study|Personal reasons|1|||
38002869|NCT03725722|69686585|FG000|Overall Study|COVID-19 situation|0|||
38002870|NCT03725722|69686586|FG001|Overall Study|COVID-19 situation|1|||
38002871|NCT03725722|69686587|FG002|Overall Study|COVID-19 situation|0|||
38002872|NCT03725722|69686588|FG003|Overall Study|COVID-19 situation|0|||
38002873|NCT03725722|69686589|FG004|Overall Study|COVID-19 situation|0|||
38002874|NCT02966314|69686603|FG000|Overall Study|Lost to Follow-up|1|||
38002875|NCT02966314|69686604|FG001|Overall Study|Lost to Follow-up|0|||
38002876|NCT03723070|69686610|FG000|Overall Study|Lost to Follow-up|2|||
38002877|NCT03723070|69686610|FG000|Overall Study|Physician Decision|1|||
38002878|NCT03723070|69686610|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
38002879|NCT03722524|69686618|FG000|Overall Study|Protocol Violation|86|||
38002880|NCT03722524|69686618|FG000|Overall Study|Adverse Event|7|||
38002881|NCT03722524|69686618|FG000|Overall Study|Lost to Follow-up|1|||
38002882|NCT03722524|69686618|FG000|Overall Study|Reason is not stated|1|||
38002883|NCT03722524|69686618|FG000|Overall Study|Physician Decision|1|||
38002884|NCT03722524|69686618|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
38002885|NCT03722446|69686624|FG000|Overall Study|Protocol Violation|15|||
38002886|NCT03722446|69686625|FG001|Overall Study|Protocol Violation|2|||
38002887|NCT00146172|69686639|FG000|Overall Study|Adverse Event|0|||
38002888|NCT00146172|69686640|FG001|Overall Study|Adverse Event|0|||
38002889|NCT00146172|69686641|FG002|Overall Study|Adverse Event|1|||
38002890|NCT00146172|69686642|FG003|Overall Study|Adverse Event|1|||
38002891|NCT00146172|69686643|FG004|Overall Study|Adverse Event|0|||
38002892|NCT00146172|69686644|FG005|Overall Study|Adverse Event|2|||
38002893|NCT00146172|69686645|FG006|Overall Study|Adverse Event|3|||
38002894|NCT00146172|69686646|FG007|Overall Study|Adverse Event|10|||
38002895|NCT00146172|69686639|FG000|Overall Study|Lost to Follow-up|0|||
38002896|NCT00146172|69686640|FG001|Overall Study|Lost to Follow-up|0|||
38002897|NCT00146172|69686641|FG002|Overall Study|Lost to Follow-up|0|||
38002898|NCT00146172|69686642|FG003|Overall Study|Lost to Follow-up|0|||
37697552|NCT02413229|69174131|FG002|Overall Study|Lost to Follow-up|1|||
37697553|NCT02413229|69174132|FG003|Overall Study|Lost to Follow-up|0|||
37830134|NCT01325350|69513384|FG003|Overall Study|Adverse Event|1|||
38002899|NCT00146172|69686643|FG004|Overall Study|Lost to Follow-up|0|||
38002900|NCT00146172|69686644|FG005|Overall Study|Lost to Follow-up|0|||
38002901|NCT00146172|69686645|FG006|Overall Study|Lost to Follow-up|0|||
38002902|NCT00146172|69686646|FG007|Overall Study|Lost to Follow-up|1|||
38002903|NCT00146172|69686639|FG000|Overall Study|Disease Progression|2|||
38002904|NCT00146172|69686640|FG001|Overall Study|Disease Progression|4|||
38002905|NCT00146172|69686641|FG002|Overall Study|Disease Progression|2|||
38002906|NCT00146172|69686642|FG003|Overall Study|Disease Progression|5|||
38002907|NCT00146172|69686643|FG004|Overall Study|Disease Progression|2|||
38002908|NCT00146172|69686644|FG005|Overall Study|Disease Progression|2|||
38002909|NCT00146172|69686645|FG006|Overall Study|Disease Progression|1|||
38002910|NCT00146172|69686646|FG007|Overall Study|Disease Progression|22|||
38002911|NCT00146172|69686639|FG000|Overall Study|Death|0|||
38002912|NCT00146172|69686640|FG001|Overall Study|Death|0|||
38002913|NCT00146172|69686641|FG002|Overall Study|Death|0|||
38002914|NCT00146172|69686642|FG003|Overall Study|Death|0|||
38002915|NCT00146172|69686643|FG004|Overall Study|Death|0|||
38002916|NCT00146172|69686644|FG005|Overall Study|Death|0|||
38002917|NCT00146172|69686645|FG006|Overall Study|Death|1|||
38002918|NCT00146172|69686646|FG007|Overall Study|Death|0|||
38002919|NCT00146172|69686639|FG000|Overall Study|Physician Decision|0|||
38002920|NCT00146172|69686640|FG001|Overall Study|Physician Decision|0|||
38002921|NCT00146172|69686641|FG002|Overall Study|Physician Decision|0|||
38002922|NCT00146172|69686642|FG003|Overall Study|Physician Decision|0|||
38002923|NCT00146172|69686643|FG004|Overall Study|Physician Decision|0|||
37697554|NCT02413229|69174133|FG004|Overall Study|Lost to Follow-up|2|||
37697555|NCT02413229|69174134|FG005|Overall Study|Lost to Follow-up|0|||
37905955|NCT00896532|69591558|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
37905956|NCT00896532|69591559|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
37905957|NCT00896532|69591560|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
37905958|NCT00896532|69591561|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
37905959|NCT00896532|69591562|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
37905960|NCT00896532|69591563|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
37905961|NCT00896532|69591564|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
37905962|NCT00896532|69591565|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
37905963|NCT00896532|69591566|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
37905964|NCT00896532|69591567|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
37905965|NCT00896532|69591568|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
37905966|NCT00896532|69591546|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
37905967|NCT00896532|69591547|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
37905968|NCT00896532|69591548|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
37905969|NCT00896532|69591549|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
37905970|NCT00896532|69591550|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
37905971|NCT00896532|69591551|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
37905972|NCT00896532|69591552|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
37905973|NCT00896532|69591553|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
37905974|NCT00896532|69591554|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
37905975|NCT00896532|69591555|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
37905976|NCT00896532|69591556|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
37905977|NCT00896532|69591557|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
37905978|NCT00896532|69591558|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
37905979|NCT00896532|69591559|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
37905980|NCT00896532|69591560|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
37905981|NCT00896532|69591561|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
37905982|NCT00896532|69591562|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
37905983|NCT00896532|69591563|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
37905984|NCT00896532|69591564|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
37905985|NCT00896532|69591565|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
37905986|NCT00896532|69591566|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
37905987|NCT00896532|69591567|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
37905988|NCT00896532|69591568|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
37905989|NCT00896532|69591546|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
37905990|NCT00896532|69591547|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
37905991|NCT00896532|69591548|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
37905992|NCT00896532|69591549|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
37905993|NCT00896532|69591550|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
37905994|NCT00896532|69591551|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
37905995|NCT00896532|69591552|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
37905996|NCT00896532|69591553|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
37905997|NCT00896532|69591554|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
37905998|NCT00896532|69591555|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
37905999|NCT00896532|69591556|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
37906000|NCT00896532|69591557|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
37906001|NCT00896532|69591558|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
37906002|NCT00896532|69591559|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
37906003|NCT00896532|69591560|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
37906004|NCT00896532|69591561|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
37906005|NCT00896532|69591562|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
37906006|NCT00896532|69591563|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
37906007|NCT00896532|69591564|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
37906008|NCT00896532|69591565|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
37906009|NCT00896532|69591566|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
37906010|NCT00896532|69591567|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
37906011|NCT00896532|69591568|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
38002924|NCT00146172|69686644|FG005|Overall Study|Physician Decision|0|||
38002925|NCT00146172|69686645|FG006|Overall Study|Physician Decision|0|||
38002926|NCT00146172|69686646|FG007|Overall Study|Physician Decision|1|||
38002927|NCT00146172|69686639|FG000|Overall Study|Withdrawal by Subject|0|||
38002928|NCT00146172|69686640|FG001|Overall Study|Withdrawal by Subject|0|||
38002929|NCT00146172|69686641|FG002|Overall Study|Withdrawal by Subject|0|||
38002930|NCT00146172|69686642|FG003|Overall Study|Withdrawal by Subject|0|||
38002931|NCT00146172|69686643|FG004|Overall Study|Withdrawal by Subject|0|||
38002932|NCT00146172|69686644|FG005|Overall Study|Withdrawal by Subject|1|||
38002933|NCT00146172|69686645|FG006|Overall Study|Withdrawal by Subject|1|||
38002934|NCT00146172|69686646|FG007|Overall Study|Withdrawal by Subject|4|||
38002935|NCT00146172|69686639|FG000|Overall Study|Symptomatic Deterioration|1|||
38002936|NCT00146172|69686640|FG001|Overall Study|Symptomatic Deterioration|0|||
38002937|NCT00146172|69686641|FG002|Overall Study|Symptomatic Deterioration|1|||
38002938|NCT00146172|69686642|FG003|Overall Study|Symptomatic Deterioration|0|||
38002939|NCT00146172|69686643|FG004|Overall Study|Symptomatic Deterioration|1|||
38002940|NCT00146172|69686644|FG005|Overall Study|Symptomatic Deterioration|2|||
38002941|NCT00146172|69686645|FG006|Overall Study|Symptomatic Deterioration|0|||
38002942|NCT00146172|69686646|FG007|Overall Study|Symptomatic Deterioration|2|||
38002943|NCT00145626|69686674|FG000|Overall Study|Did not have NK infusions|2|||
38002944|NCT00145626|69686674|FG000|Overall Study|Turned 2 years old before treatment|1|||
38002945|NCT00145626|69686674|FG000|Overall Study|Death|1|||
38002946|NCT00145626|69686674|FG000|Overall Study|Withdrawal by Subject|1|||
38002947|NCT00153062|69686698|FG000|Overall Study|Death|360|||
38002948|NCT00153062|69686699|FG001|Overall Study|Death|352|||
38002949|NCT00153062|69686700|FG002|Overall Study|Death|369|||
38002950|NCT00153062|69686701|FG003|Overall Study|Death|365|||
38002951|NCT00153062|69686698|FG000|Overall Study|Withdrawal by Subject|14|||
38002952|NCT00153062|69686699|FG001|Overall Study|Withdrawal by Subject|30|||
38002953|NCT00153062|69686700|FG002|Overall Study|Withdrawal by Subject|27|||
38002954|NCT00153062|69686701|FG003|Overall Study|Withdrawal by Subject|28|||
38002955|NCT00153062|69686698|FG000|Overall Study|Lost to Follow-up|12|||
38002956|NCT00153062|69686699|FG001|Overall Study|Lost to Follow-up|20|||
38002957|NCT00153062|69686700|FG002|Overall Study|Lost to Follow-up|15|||
38002958|NCT00153062|69686701|FG003|Overall Study|Lost to Follow-up|16|||
37906012|NCT00896532|69591546|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
37906013|NCT00896532|69591547|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
37906014|NCT00896532|69591548|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
37906015|NCT00896532|69591549|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
38002959|NCT00153062|69686698|FG000|Overall Study|Adverse Event|0|||
38002960|NCT00153062|69686699|FG001|Overall Study|Adverse Event|1|||
38002961|NCT00153062|69686700|FG002|Overall Study|Adverse Event|1|||
38002962|NCT00153062|69686701|FG003|Overall Study|Adverse Event|0|||
37906016|NCT00896532|69591550|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
37906017|NCT00896532|69591551|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
37906018|NCT00896532|69591552|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
37906019|NCT00896532|69591553|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
37906020|NCT00896532|69591554|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
37906021|NCT00896532|69591555|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
37906022|NCT00896532|69591556|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
37906023|NCT00896532|69591557|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
37906024|NCT00896532|69591558|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
37906025|NCT00896532|69591559|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
37906026|NCT00896532|69591560|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
37906027|NCT00896532|69591561|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
37906028|NCT00896532|69591562|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
37906029|NCT00896532|69591563|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
37906030|NCT00896532|69591564|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
37906031|NCT00896532|69591565|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
37906032|NCT00896532|69591566|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
37906033|NCT00896532|69591567|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
37906034|NCT00896532|69591568|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
37906035|NCT00896532|69591546|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
37906036|NCT00896532|69591547|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
38002963|NCT00153062|69686698|FG000|Overall Study|Protocol Violation|0|||
38002964|NCT00153062|69686699|FG001|Overall Study|Protocol Violation|2|||
38002965|NCT00153062|69686700|FG002|Overall Study|Protocol Violation|1|||
38002966|NCT00153062|69686701|FG003|Overall Study|Protocol Violation|1|||
38002967|NCT00153062|69686698|FG000|Overall Study|No disposition data available|1|||
38002968|NCT00153062|69686699|FG001|Overall Study|No disposition data available|1|||
38002969|NCT00153062|69686700|FG002|Overall Study|No disposition data available|1|||
38002970|NCT00153062|69686701|FG003|Overall Study|No disposition data available|1|||
38002971|NCT00153062|69686698|FG000|Overall Study|Other|0|||
38002972|NCT00153062|69686699|FG001|Overall Study|Other|0|||
38002973|NCT00153062|69686700|FG002|Overall Study|Other|1|||
38002974|NCT00153062|69686701|FG003|Overall Study|Other|0|||
38002975|NCT00145470|69686713|FG000|Overall Study|Adverse Event|19|||
38002976|NCT00145470|69686714|FG001|Overall Study|Adverse Event|25|||
38002977|NCT00145470|69686713|FG000|Overall Study|Lack of Efficacy|27|||
38002978|NCT00145470|69686714|FG001|Overall Study|Lack of Efficacy|13|||
38002979|NCT00145470|69686713|FG000|Overall Study|Withdrawal by Subject|36|||
38002980|NCT00145470|69686714|FG001|Overall Study|Withdrawal by Subject|34|||
38002981|NCT00145470|69686713|FG000|Overall Study|Lost to Follow-up|21|||
38002982|NCT00145470|69686714|FG001|Overall Study|Lost to Follow-up|17|||
38002983|NCT00145470|69686713|FG000|Overall Study|Reason Not Reported|9|||
38002984|NCT00145470|69686714|FG001|Overall Study|Reason Not Reported|9|||
38002985|NCT00152516|69686720|FG000|Overall Study|Adverse Event|18|||
38002986|NCT00152516|69686720|FG000|Overall Study|Lack and Loss of Efficacy|30|||
37830135|NCT01325350|69513385|FG004|Overall Study|Adverse Event|2|||
37830136|NCT01325350|69513381|FG000|Overall Study|Pregnancy|0|||
37830137|NCT01325350|69513382|FG001|Overall Study|Pregnancy|0|||
37830138|NCT01325350|69513383|FG002|Overall Study|Pregnancy|1|||
37830139|NCT01325350|69513384|FG003|Overall Study|Pregnancy|0|||
37830140|NCT01325350|69513385|FG004|Overall Study|Pregnancy|1|||
37830141|NCT01325350|69513381|FG000|Overall Study|Lost to Follow-up|1|||
37830142|NCT01325350|69513382|FG001|Overall Study|Lost to Follow-up|0|||
37830143|NCT01325350|69513383|FG002|Overall Study|Lost to Follow-up|5|||
37830144|NCT01325350|69513384|FG003|Overall Study|Lost to Follow-up|1|||
37830145|NCT01325350|69513385|FG004|Overall Study|Lost to Follow-up|5|||
37830146|NCT01325350|69513381|FG000|Overall Study|Personal Reasons|2|||
37830147|NCT01325350|69513382|FG001|Overall Study|Personal Reasons|1|||
37830148|NCT01325350|69513383|FG002|Overall Study|Personal Reasons|6|||
37906037|NCT00896532|69591548|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
37906038|NCT00896532|69591549|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
37906039|NCT00896532|69591550|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
37906040|NCT00896532|69591551|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
37906041|NCT00896532|69591552|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
37906042|NCT00896532|69591553|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
37906043|NCT00896532|69591554|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
37906044|NCT00896532|69591555|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
37906045|NCT00896532|69591556|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
37906046|NCT00896532|69591557|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
37906047|NCT00896532|69591558|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
37906048|NCT00896532|69591559|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
37906049|NCT00896532|69591560|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
37906050|NCT00896532|69591561|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
37906051|NCT00896532|69591562|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
37906052|NCT00896532|69591563|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
37906053|NCT00896532|69591564|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
37906054|NCT00896532|69591565|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
37906055|NCT00896532|69591566|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
37906056|NCT00896532|69591567|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
37906057|NCT00896532|69591568|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
37906058|NCT00896532|69591546|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
37906059|NCT00896532|69591547|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
37906060|NCT00896532|69591548|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
37906061|NCT00896532|69591549|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
37906062|NCT00896532|69591550|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
37906063|NCT00896532|69591551|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
37906064|NCT00896532|69591552|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
37906065|NCT00896532|69591553|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
37906066|NCT00896532|69591554|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
37906067|NCT00896532|69591555|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
37906068|NCT00896532|69591556|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
37906069|NCT00896532|69591557|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
38002987|NCT00152516|69686720|FG000|Overall Study|Lost to Follow-up|5|||
38002988|NCT00152516|69686720|FG000|Overall Study|Withdrawal by Subject|8|||
38002989|NCT00152516|69686720|FG000|Overall Study|Protocol Violation|3|||
38002990|NCT00152516|69686720|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
38002991|NCT00152516|69686720|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
38002992|NCT00152516|69686720|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
38002993|NCT00152516|69686720|FG000|Overall Study|Other: Non-Compliance|2|||
37830149|NCT01325350|69513384|FG003|Overall Study|Personal Reasons|5|||
37830150|NCT01325350|69513385|FG004|Overall Study|Personal Reasons|3|||
37830151|NCT01325350|69513381|FG000|Overall Study|Protocol Violation|0|||
37830152|NCT01325350|69513382|FG001|Overall Study|Protocol Violation|0|||
37830153|NCT01325350|69513383|FG002|Overall Study|Protocol Violation|0|||
37830154|NCT01325350|69513384|FG003|Overall Study|Protocol Violation|1|||
38002994|NCT00152516|69686720|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
38002995|NCT00152516|69686720|FG000|Overall Study|Other: Moved Out Of State|1|||
38002996|NCT00152516|69686720|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
38002997|NCT00152516|69686720|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
38002998|NCT00145158|69686726|FG000|Overall Study|premature withdrawal|2|||
38002999|NCT00145158|69686727|FG001|Overall Study|premature withdrawal|3|||
38003000|NCT00150800|69686734|FG000|Overall Study|Adverse Event|89|||
38003001|NCT00150800|69686734|FG000|Overall Study|Death|18|||
38003002|NCT00150800|69686734|FG000|Overall Study|Lack of Efficacy|166|||
38003003|NCT00150800|69686734|FG000|Overall Study|Lost to Follow-up|58|||
38003004|NCT00150800|69686734|FG000|Overall Study|Subject's choice|90|||
38003005|NCT00150800|69686734|FG000|Overall Study|No compliance|18|||
38003006|NCT00150800|69686734|FG000|Overall Study|IP misshandling|1|||
38003007|NCT00150800|69686734|FG000|Overall Study|Site closure|24|||
38003008|NCT00150800|69686734|FG000|Overall Study|Protocol non-adherence|2|||
38003009|NCT00150800|69686734|FG000|Overall Study|Nobody to accompany patient|1|||
38003010|NCT00150800|69686734|FG000|Overall Study|Distance too long for patient|1|||
38003011|NCT00150800|69686734|FG000|Overall Study|Neurosurgery|2|||
38003012|NCT00150800|69686734|FG000|Overall Study|BRV monotherapy|1|||
38003013|NCT00150800|69686734|FG000|Overall Study|Visit refusal|3|||
38003014|NCT00150800|69686734|FG000|Overall Study|Sponsor's request|2|||
38003015|NCT00150800|69686734|FG000|Overall Study|Generalized Epilepsy|1|||
38003016|NCT00150800|69686734|FG000|Overall Study|Moved from area/country|8|||
38003017|NCT00150800|69686734|FG000|Overall Study|PI retiring|2|||
38003018|NCT00150800|69686734|FG000|Overall Study|PI leaving site|2|||
38003019|NCT00150800|69686734|FG000|Overall Study|Patient insurance|1|||
38003020|NCT00150800|69686734|FG000|Overall Study|Surgical intervention|4|||
38003021|NCT00150800|69686734|FG000|Overall Study|Pregnancy planned|1|||
38003022|NCT00150800|69686734|FG000|Overall Study|PI discontinuation request|1|||
38003023|NCT00144300|69686741|FG000|Overall Study|Adverse Event|18|||
38003024|NCT00144300|69686742|FG001|Overall Study|Adverse Event|16|||
38003025|NCT00144300|69686741|FG000|Overall Study|Protocol Violation|1|||
38003026|NCT00144300|69686742|FG001|Overall Study|Protocol Violation|3|||
38003027|NCT00144300|69686741|FG000|Overall Study|Lost to Follow-up|3|||
38003028|NCT00144300|69686742|FG001|Overall Study|Lost to Follow-up|0|||
38003029|NCT00144300|69686741|FG000|Overall Study|Withdrawal by Subject|6|||
38003030|NCT00144300|69686742|FG001|Overall Study|Withdrawal by Subject|6|||
38003031|NCT00144300|69686741|FG000|Overall Study|Other reason (not specified)|1|||
38003032|NCT00144300|69686742|FG001|Overall Study|Other reason (not specified)|3|||
38003033|NCT00149630|69686750|FG000|Overall Study|Incarceration|2|||
38003034|NCT00149630|69686751|FG001|Overall Study|Incarceration|0|||
38003035|NCT00149630|69686750|FG000|Overall Study|Treatment Programs|4|||
38003036|NCT00149630|69686751|FG001|Overall Study|Treatment Programs|5|||
38003037|NCT00149630|69686750|FG000|Overall Study|Adverse Event|2|||
37830155|NCT01325350|69513385|FG004|Overall Study|Protocol Violation|0|||
37830156|NCT01325350|69513381|FG000|Overall Study|Withdrawal by Subject|0|||
37830157|NCT01325350|69513382|FG001|Overall Study|Withdrawal by Subject|0|||
37830158|NCT01325350|69513383|FG002|Overall Study|Withdrawal by Subject|1|||
37830159|NCT01325350|69513384|FG003|Overall Study|Withdrawal by Subject|1|||
37830160|NCT01325350|69513385|FG004|Overall Study|Withdrawal by Subject|0|||
37830161|NCT01325350|69513381|FG000|Overall Study|Did Not Receive Treatment|0|||
37830162|NCT01325350|69513382|FG001|Overall Study|Did Not Receive Treatment|1|||
37906070|NCT00896532|69591558|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
37906071|NCT00896532|69591559|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
37906072|NCT00896532|69591560|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
37906073|NCT00896532|69591561|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
37906074|NCT00896532|69591562|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
37906075|NCT00896532|69591563|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
37906076|NCT00896532|69591564|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
37906077|NCT00896532|69591565|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
37906078|NCT00896532|69591566|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
37906079|NCT00896532|69591567|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
38003038|NCT00149630|69686751|FG001|Overall Study|Adverse Event|0|||
38003039|NCT00127842|69686761|FG000|Overall Study|Adverse Event|15|||
38003040|NCT00127842|69686761|FG000|Overall Study|Withdrawal by Subject|3|||
38003041|NCT00127842|69686761|FG000|Overall Study|Lost to Follow-up|1|||
38003042|NCT00127842|69686761|FG000|Overall Study|Lack of Efficacy|12|||
38003043|NCT00127842|69686761|FG000|Overall Study|Noncompliance|2|||
38003044|NCT00127842|69686761|FG000|Overall Study|Protocol Violation|1|||
38003045|NCT00127842|69686761|FG000|Overall Study|Other|5|||
38003046|NCT03720652|69686767|FG000|Overall Study|Withdrawal by Subject|2|||
37830163|NCT01325350|69513383|FG002|Overall Study|Did Not Receive Treatment|1|||
38003047|NCT03720652|69686768|FG001|Overall Study|Withdrawal by Subject|7|||
38003048|NCT03720652|69686767|FG000|Overall Study|Lost to Follow-up|0|||
38003049|NCT03720652|69686768|FG001|Overall Study|Lost to Follow-up|4|||
38003050|NCT00112866|69686778|FG000|Overall Study|Protocol Violation|1|||
38003051|NCT00112866|69686779|FG001|Overall Study|Protocol Violation|0|||
37830164|NCT01325350|69513384|FG003|Overall Study|Did Not Receive Treatment|0|||
37906080|NCT00896532|69591568|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
37906081|NCT00896532|69591546|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
37906082|NCT00896532|69591547|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
37906083|NCT00896532|69591548|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
37906084|NCT00896532|69591549|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
37906085|NCT00896532|69591550|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
37906086|NCT00896532|69591551|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
37906087|NCT00896532|69591552|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
37906088|NCT00896532|69591553|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
37906089|NCT00896532|69591554|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
37906090|NCT00896532|69591555|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
37906091|NCT00896532|69591556|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
37906092|NCT00896532|69591557|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
37906093|NCT00896532|69591558|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
37906094|NCT00896532|69591559|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
37906095|NCT00896532|69591560|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
37906096|NCT00896532|69591561|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
37906097|NCT00896532|69591562|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
37906098|NCT00896532|69591563|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
37906099|NCT00896532|69591564|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
37906100|NCT00896532|69591565|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
37906101|NCT00896532|69591566|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
37906102|NCT00896532|69591567|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
37906103|NCT00896532|69591568|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
37906104|NCT00896532|69591546|FG000|Months 48-72: Follow-on Phase|Death|0|||
37906105|NCT00896532|69591547|FG001|Months 48-72: Follow-on Phase|Death|0|||
37906106|NCT00896532|69591548|FG002|Months 48-72: Follow-on Phase|Death|0|||
37906107|NCT00896532|69591549|FG003|Months 48-72: Follow-on Phase|Death|0|||
37906108|NCT00896532|69591550|FG004|Months 48-72: Follow-on Phase|Death|0|||
37906109|NCT00896532|69591551|FG005|Months 48-72: Follow-on Phase|Death|0|||
37906110|NCT00896532|69591552|FG006|Months 48-72: Follow-on Phase|Death|0|||
37906111|NCT00896532|69591553|FG007|Months 48-72: Follow-on Phase|Death|0|||
37906112|NCT00896532|69591554|FG008|Months 48-72: Follow-on Phase|Death|0|||
37906113|NCT00896532|69591555|FG009|Months 48-72: Follow-on Phase|Death|0|||
37906114|NCT00896532|69591556|FG010|Months 48-72: Follow-on Phase|Death|0|||
37906115|NCT00896532|69591557|FG011|Months 48-72: Follow-on Phase|Death|0|||
37906116|NCT00896532|69591558|FG012|Months 48-72: Follow-on Phase|Death|0|||
37906117|NCT00896532|69591559|FG013|Months 48-72: Follow-on Phase|Death|0|||
37906118|NCT00896532|69591560|FG014|Months 48-72: Follow-on Phase|Death|0|||
37906119|NCT00896532|69591561|FG015|Months 48-72: Follow-on Phase|Death|0|||
37906120|NCT00896532|69591562|FG016|Months 48-72: Follow-on Phase|Death|0|||
37906121|NCT00896532|69591563|FG017|Months 48-72: Follow-on Phase|Death|0|||
37906122|NCT00896532|69591564|FG018|Months 48-72: Follow-on Phase|Death|1|||
37906123|NCT00896532|69591565|FG019|Months 48-72: Follow-on Phase|Death|0|||
37906124|NCT00896532|69591566|FG020|Months 48-72: Follow-on Phase|Death|0|||
37906125|NCT00896532|69591567|FG021|Months 48-72: Follow-on Phase|Death|0|||
37906126|NCT00896532|69591568|FG022|Months 48-72: Follow-on Phase|Death|0|||
37906127|NCT00896532|69591546|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
37906128|NCT00896532|69591547|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
37906129|NCT00896532|69591548|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
38003052|NCT00112866|69686778|FG000|Overall Study|did not start treatment post-op|1|||
37830165|NCT01325350|69513385|FG004|Overall Study|Did Not Receive Treatment|1|||
37830166|NCT01324999|69513397|FG000|Overall Study|Adverse Event|3|||
37830167|NCT01324999|69513397|FG000|Overall Study|Withdrawal by Subject|2|||
37830168|NCT01324570|69513403|FG000|Overall Study|Adverse Event|4|||
37830169|NCT01324570|69513404|FG001|Overall Study|Adverse Event|7|||
37830170|NCT01324570|69513403|FG000|Overall Study|Withdrawal by Subject|0|||
37830171|NCT01324570|69513404|FG001|Overall Study|Withdrawal by Subject|3|||
37830172|NCT01324570|69513403|FG000|Overall Study|Lack of Efficacy|0|||
37830173|NCT01324570|69513404|FG001|Overall Study|Lack of Efficacy|1|||
37830174|NCT01324570|69513403|FG000|Overall Study|Confirmed or suspected diversion|0|||
37830175|NCT01324570|69513404|FG001|Overall Study|Confirmed or suspected diversion|1|||
37830176|NCT01324570|69513403|FG000|Overall Study|Administrative|0|||
37830177|NCT01324570|69513404|FG001|Overall Study|Administrative|2|||
38003053|NCT00112866|69686779|FG001|Overall Study|did not start treatment post-op|2|||
38003054|NCT00127608|69686793|FG000|Overall Study|VZV DNA negative|1|||
38003055|NCT00149396|69686797|FG000|Overall Study|Death|15|||
38003056|NCT00149396|69686797|FG000|Overall Study|Withdrawal by Subject|1|||
38003057|NCT00149396|69686797|FG000|Overall Study|Subject noncompliance|2|||
38003058|NCT00149396|69686797|FG000|Overall Study|other treatment|5|||
38003059|NCT00223496|69686808|FG000|Overall Study|screen failure|9|||
38003060|NCT00223496|69686808|FG000|Overall Study|Lost to Follow-up|4|||
38003061|NCT00223496|69686808|FG000|Overall Study|Lack of Efficacy|6|||
38003062|NCT00223496|69686808|FG000|Overall Study|Withdrawal by Subject|1|||
38003063|NCT00223496|69686808|FG000|Overall Study|Physician Decision|2|||
38003064|NCT00255944|69686814|FG000|Overall Study|Lost to Follow-up|797|||
38003065|NCT00255944|69686815|FG001|Overall Study|Lost to Follow-up|834|||
38003066|NCT00143598|69686823|FG000|Overall Study|Lost to Follow-up|23|||
38003067|NCT00143598|69686824|FG001|Overall Study|Lost to Follow-up|21|||
38003068|NCT00143598|69686823|FG000|Overall Study|Withdrawal by Subject|33|||
38003069|NCT00143598|69686824|FG001|Overall Study|Withdrawal by Subject|37|||
38003070|NCT00143598|69686823|FG000|Overall Study|Death|36|||
38003071|NCT00143598|69686824|FG001|Overall Study|Death|36|||
38003072|NCT00126672|69686830|FG000|Overall Study|Adverse Event|4|||
38003073|NCT00126672|69686830|FG000|Overall Study|Lost to Follow-up|4|||
38003074|NCT00145574|69686837|FG000|Double Blind|Adverse Event|0|||
38003075|NCT00145574|69686838|FG001|Double Blind|Adverse Event|3|||
38003076|NCT00145574|69686839|FG002|Double Blind|Adverse Event|1|||
38003077|NCT00145574|69686837|FG000|Double Blind|Withdrawal by Subject|1|||
38003078|NCT00145574|69686838|FG001|Double Blind|Withdrawal by Subject|1|||
38003079|NCT00145574|69686839|FG002|Double Blind|Withdrawal by Subject|1|||
38003080|NCT00145574|69686837|FG000|Double Blind|required restricted medicine|0|||
38003081|NCT00145574|69686838|FG001|Double Blind|required restricted medicine|1|||
38003082|NCT00145574|69686839|FG002|Double Blind|required restricted medicine|0|||
38003083|NCT00145574|69686837|FG000|Open Label Long-term Extension|Adverse Event|0|||
38003084|NCT00145574|69686838|FG001|Open Label Long-term Extension|Adverse Event|0|||
38003085|NCT00145574|69686839|FG002|Open Label Long-term Extension|Adverse Event|5|||
38003086|NCT00145574|69686837|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
38003087|NCT00145574|69686838|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
38003088|NCT00145574|69686839|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
38003089|NCT00145574|69686837|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
37906130|NCT00896532|69591549|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
37906131|NCT00896532|69591550|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
37906132|NCT00896532|69591551|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
37906133|NCT00896532|69591552|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
37906134|NCT00896532|69591553|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
37906135|NCT00896532|69591554|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
37906136|NCT00896532|69591555|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
37906137|NCT00896532|69591556|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
37906138|NCT00896532|69591557|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
37906139|NCT00896532|69591558|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
37906140|NCT00896532|69591559|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
37906141|NCT00896532|69591560|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
37906142|NCT00896532|69591561|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
37906143|NCT00896532|69591562|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
37906144|NCT00896532|69591563|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
37906145|NCT00896532|69591564|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
37906146|NCT00896532|69591565|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
37906147|NCT00896532|69591566|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
37906148|NCT00896532|69591567|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
37906149|NCT00896532|69591568|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
37906150|NCT00896532|69591546|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
37906151|NCT00896532|69591547|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
37906152|NCT00896532|69591548|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
38003090|NCT00145574|69686838|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
38003091|NCT00145574|69686839|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
38003092|NCT00145574|69686837|FG000|Open Label Long-term Extension|required restricted medicine|0|||
38003093|NCT00145574|69686838|FG001|Open Label Long-term Extension|required restricted medicine|0|||
38003094|NCT00145574|69686839|FG002|Open Label Long-term Extension|required restricted medicine|1|||
38003095|NCT00145496|69686854|FG000|Overall Study|Adverse Event|42|||
38003096|NCT00145496|69686855|FG001|Overall Study|Adverse Event|30|||
38003097|NCT00145496|69686854|FG000|Overall Study|Lack of Efficacy|12|||
38003098|NCT00145496|69686855|FG001|Overall Study|Lack of Efficacy|7|||
38003099|NCT00145496|69686854|FG000|Overall Study|Withdrawal by Subject|32|||
38003100|NCT00145496|69686855|FG001|Overall Study|Withdrawal by Subject|26|||
38003101|NCT00145496|69686854|FG000|Overall Study|Lost to Follow-up|12|||
38003102|NCT00145496|69686855|FG001|Overall Study|Lost to Follow-up|5|||
38003103|NCT00145496|69686854|FG000|Overall Study|Other|25|||
38003104|NCT00145496|69686855|FG001|Overall Study|Other|13|||
38003105|NCT00255164|69686864|FG000|Overall Study|Adverse Event|10|||
38003106|NCT00255164|69686865|FG001|Overall Study|Adverse Event|6|||
38003107|NCT00255164|69686866|FG002|Overall Study|Adverse Event|9|||
38003108|NCT00255164|69686864|FG000|Overall Study|Lost to Follow-up|4|||
38003109|NCT00255164|69686865|FG001|Overall Study|Lost to Follow-up|3|||
38003110|NCT00255164|69686866|FG002|Overall Study|Lost to Follow-up|4|||
38003111|NCT00255164|69686864|FG000|Overall Study|Withdrawal by Subject|18|||
38003112|NCT00255164|69686865|FG001|Overall Study|Withdrawal by Subject|17|||
38003113|NCT00255164|69686866|FG002|Overall Study|Withdrawal by Subject|8|||
38003114|NCT00255164|69686864|FG000|Overall Study|Noncompliance|0|||
38003115|NCT00255164|69686865|FG001|Overall Study|Noncompliance|1|||
38003116|NCT00255164|69686866|FG002|Overall Study|Noncompliance|2|||
38003117|NCT00255164|69686864|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
38003118|NCT00255164|69686865|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
38003119|NCT00255164|69686866|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
38003120|NCT00255164|69686864|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
38003121|NCT00255164|69686865|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
38003122|NCT00255164|69686866|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
38003123|NCT00255164|69686864|FG000|Overall Study|Possible Barrett's Esophagus|1|||
38003124|NCT00255164|69686865|FG001|Overall Study|Possible Barrett's Esophagus|3|||
38003125|NCT00255164|69686866|FG002|Overall Study|Possible Barrett's Esophagus|8|||
38003126|NCT00255164|69686864|FG000|Overall Study|Esophageal Stricture|0|||
38003127|NCT00255164|69686865|FG001|Overall Study|Esophageal Stricture|0|||
38003128|NCT00255164|69686866|FG002|Overall Study|Esophageal Stricture|1|||
38003129|NCT00255164|69686864|FG000|Overall Study|Therapeutic Failure|11|||
38003130|NCT00255164|69686865|FG001|Overall Study|Therapeutic Failure|2|||
38003131|NCT00255164|69686866|FG002|Overall Study|Therapeutic Failure|3|||
38003132|NCT00126594|69686876|FG000|Overall Study|Ineligible|2|||
38003133|NCT00126594|69686877|FG001|Overall Study|Ineligible|0|||
38003134|NCT00126594|69686876|FG000|Overall Study|Withdrawal by Subject|0|||
38003135|NCT00126594|69686877|FG001|Overall Study|Withdrawal by Subject|4|||
38003136|NCT00126594|69686876|FG000|Overall Study|Physician Decision|1|||
38003137|NCT00126594|69686877|FG001|Overall Study|Physician Decision|3|||
38003138|NCT00126594|69686876|FG000|Overall Study|Adverse Event|7|||
38003139|NCT00126594|69686877|FG001|Overall Study|Adverse Event|5|||
38003140|NCT00126594|69686876|FG000|Overall Study|Non-compliance|0|||
38003141|NCT00126594|69686877|FG001|Overall Study|Non-compliance|1|||
38003142|NCT00126594|69686876|FG000|Overall Study|Disease Progression|29|||
38003143|NCT00126594|69686877|FG001|Overall Study|Disease Progression|24|||
38003144|NCT00126438|69686886|FG000|Overall Study|Withdrawal due to adverse event|1|||
38003145|NCT00126438|69686887|FG001|Overall Study|Withdrawal due to adverse event|0|||
38003146|NCT00126438|69686886|FG000|Overall Study|Lost to Follow-up|22|||
38003147|NCT00126438|69686887|FG001|Overall Study|Lost to Follow-up|0|||
38003148|NCT00126438|69686886|FG000|Overall Study|Protocol Violation|8|||
38003149|NCT00126438|69686887|FG001|Overall Study|Protocol Violation|8|||
37697556|NCT02413229|69174135|FG006|Overall Study|Lost to Follow-up|0|||
37697557|NCT02413229|69174136|FG007|Overall Study|Lost to Follow-up|0|||
37697558|NCT02413229|69174129|FG000|Overall Study|Withdrawal by Subject|1|||
37830178|NCT01324141|69513412|FG000|Overall Study|Declined to participate before treatment started|1|||
37830179|NCT01324141|69513412|FG000|Overall Study|Disease progression on study|1|||
37830180|NCT01324102|69513428|FG000|Overall Study|illness|1|||
37830181|NCT01324102|69513429|FG001|Overall Study|illness|6|||
37830182|NCT01324024|69513436|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
37830183|NCT01324024|69513437|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
37830184|NCT01323946|69513450|FG000|Overall Study|Lost to Follow-up|0|||
37830185|NCT01323946|69513451|FG001|Overall Study|Lost to Follow-up|1|||
37830186|NCT01323946|69513452|FG002|Overall Study|Lost to Follow-up|0|||
37830187|NCT01323946|69513450|FG000|Overall Study|Parents refused the last blood draw|1|||
37830188|NCT01323946|69513451|FG001|Overall Study|Parents refused the last blood draw|0|||
37830189|NCT01323946|69513452|FG002|Overall Study|Parents refused the last blood draw|0|||
37830190|NCT01323946|69513450|FG000|Overall Study|Withdrawal by Subject|2|||
37830191|NCT01323946|69513451|FG001|Overall Study|Withdrawal by Subject|2|||
37830192|NCT01323946|69513452|FG002|Overall Study|Withdrawal by Subject|0|||
37906153|NCT00896532|69591549|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
37697559|NCT02413229|69174130|FG001|Overall Study|Withdrawal by Subject|1|||
37830193|NCT01323790|69513465|FG000|Overall Study|Other|3|||
37906154|NCT00896532|69591550|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
38003150|NCT00126438|69686886|FG000|Overall Study|Withdrawal by Subject|3|||
38003151|NCT00126438|69686887|FG001|Overall Study|Withdrawal by Subject|2|||
38003152|NCT00142584|69686895|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
38003153|NCT00142584|69686896|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
38003154|NCT00142584|69686895|FG000|Overall Study|Withdrawal by Subject|30|||
38003155|NCT00142584|69686896|FG001|Overall Study|Withdrawal by Subject|16|||
38003156|NCT00142584|69686895|FG000|Overall Study|Lost to Follow-up|22|||
38003157|NCT00142584|69686896|FG001|Overall Study|Lost to Follow-up|12|||
38003158|NCT00142584|69686895|FG000|Overall Study|Adverse Event|14|||
38003159|NCT00142584|69686896|FG001|Overall Study|Adverse Event|5|||
38003160|NCT00142584|69686895|FG000|Overall Study|Protocol Violation|4|||
38003161|NCT00142584|69686896|FG001|Overall Study|Protocol Violation|7|||
38003162|NCT00142584|69686895|FG000|Overall Study|Treatment Failure|2|||
37830194|NCT01323790|69513466|FG001|Overall Study|Other|2|||
37830195|NCT01323790|69513467|FG002|Overall Study|Other|1|||
37830196|NCT01323790|69513465|FG000|Overall Study|Lost to Follow-up|11|||
37830197|NCT01323790|69513466|FG001|Overall Study|Lost to Follow-up|9|||
37830198|NCT01323790|69513467|FG002|Overall Study|Lost to Follow-up|9|||
38003163|NCT00142584|69686896|FG001|Overall Study|Treatment Failure|0|||
38003164|NCT00126126|69686906|FG000|Overall Study|Lost to Follow-up|0|||
38003165|NCT00126126|69686907|FG001|Overall Study|Lost to Follow-up|2|||
38003166|NCT00125268|69686915|FG000|Overall Study|Withdrawal by Subject|1|||
38003167|NCT00125268|69686916|FG001|Overall Study|Withdrawal by Subject|1|||
38003168|NCT00125190|69686922|FG000|Overall Study|Subject/Parent Decision|7|||
38003169|NCT00125190|69686922|FG000|Overall Study|Non-compliance|2|||
38003170|NCT00125190|69686922|FG000|Overall Study|Adverse Event|1|||
38003171|NCT00125190|69686922|FG000|Overall Study|Other|1|||
38003172|NCT00125190|69686922|FG000|Overall Study|Lost to Follow-up|4|||
38003173|NCT00141726|69686927|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
38003174|NCT00111228|69686934|FG000|Overall Study|Withdrawal by Subject|5|||
38003175|NCT00111228|69686935|FG001|Overall Study|Withdrawal by Subject|1|||
38003176|NCT00111228|69686936|FG002|Overall Study|Withdrawal by Subject|0|||
38003177|NCT00110994|69686946|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
38003178|NCT00110994|69686947|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
38003179|NCT00110994|69686946|FG000|Double-blind (DB) Treatment|Death|1|||
38003180|NCT00110994|69686947|FG001|Double-blind (DB) Treatment|Death|0|||
38003181|NCT00110994|69686946|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
38003182|NCT00110994|69686947|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
38003183|NCT00110994|69686946|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
38003184|NCT00110994|69686947|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
38003185|NCT00110994|69686946|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
38003186|NCT00110994|69686947|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
38003187|NCT00110994|69686946|FG000|Double-blind (DB) Treatment|other reasons|2|||
38003188|NCT00110994|69686947|FG001|Double-blind (DB) Treatment|other reasons|3|||
38003189|NCT00110994|69686946|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
38003190|NCT00110994|69686947|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
38003191|NCT00110994|69686946|FG000|Active Follow-up|Other reasons|0|||
38003192|NCT00110994|69686947|FG001|Active Follow-up|Other reasons|2|||
38003193|NCT00110994|69686946|FG000|Long Term Follow-up|Death|19|||
38003194|NCT00110994|69686947|FG001|Long Term Follow-up|Death|17|||
38003195|NCT00144170|69686955|FG000|Overall Study|Adverse Event|84|||
38003196|NCT00144170|69686956|FG001|Overall Study|Adverse Event|41|||
38003197|NCT00144170|69686955|FG000|Overall Study|Protocol Violation|23|||
38003198|NCT00144170|69686956|FG001|Overall Study|Protocol Violation|16|||
38003199|NCT00144170|69686955|FG000|Overall Study|Lost to Follow-up|5|||
38003200|NCT00144170|69686956|FG001|Overall Study|Lost to Follow-up|10|||
38003201|NCT00144170|69686955|FG000|Overall Study|Withdrawal by Subject|29|||
38003202|NCT00144170|69686956|FG001|Overall Study|Withdrawal by Subject|13|||
38003203|NCT00144170|69686955|FG000|Overall Study|Other reason not defined above|211|||
38003204|NCT00144170|69686956|FG001|Overall Study|Other reason not defined above|316|||
38003205|NCT00255086|69686964|FG000|Overall Study|Adverse Event|1|||
38003206|NCT00255086|69686965|FG001|Overall Study|Adverse Event|1|||
38003207|NCT00255086|69686964|FG000|Overall Study|Protocol Violation|1|||
38003208|NCT00255086|69686965|FG001|Overall Study|Protocol Violation|1|||
38003209|NCT00110214|69686974|FG000|Overall Study|Never started treatment|21|||
38003210|NCT00110214|69686975|FG001|Overall Study|Never started treatment|20|||
38003211|NCT00110214|69686974|FG000|Overall Study|Disease progression or death|260|||
38003212|NCT00110214|69686975|FG001|Overall Study|Disease progression or death|151|||
38003213|NCT00110214|69686974|FG000|Overall Study|Adverse Event|115|||
38003214|NCT00110214|69686975|FG001|Overall Study|Adverse Event|192|||
38003215|NCT00110214|69686974|FG000|Overall Study|Refused further treatment|52|||
37830199|NCT01323790|69513465|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
38003216|NCT00110214|69686975|FG001|Overall Study|Refused further treatment|65|||
37830200|NCT01323790|69513466|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
37830201|NCT01323790|69513467|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
38003217|NCT00110214|69686974|FG000|Overall Study|Other (not specified)|61|||
38003218|NCT00110214|69686975|FG001|Overall Study|Other (not specified)|75|||
38003219|NCT00124020|69686983|FG000|Overall Study|Death|67|||
38003220|NCT00124020|69686984|FG001|Overall Study|Death|71|||
37906155|NCT00896532|69591551|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
37906156|NCT00896532|69591552|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
37906157|NCT00896532|69591553|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
37906158|NCT00896532|69591554|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
37906159|NCT00896532|69591555|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
37906160|NCT00896532|69591556|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
37906161|NCT00896532|69591557|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
37906162|NCT00896532|69591558|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
37906163|NCT00896532|69591559|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
37906164|NCT00896532|69591560|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
37906165|NCT00896532|69591561|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
37906166|NCT00896532|69591562|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
37906167|NCT00896532|69591563|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
37906168|NCT00896532|69591564|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
37906169|NCT00896532|69591565|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
38003221|NCT00124020|69686983|FG000|Overall Study|Withdrawal by Subject|13|||
38003222|NCT00124020|69686984|FG001|Overall Study|Withdrawal by Subject|11|||
38003223|NCT00124020|69686983|FG000|Overall Study|Lost to Follow-up|5|||
38003224|NCT00124020|69686984|FG001|Overall Study|Lost to Follow-up|8|||
38003225|NCT00124020|69686983|FG000|Overall Study|Other|1|||
38003226|NCT00124020|69686984|FG001|Overall Study|Other|1|||
38003227|NCT00124020|69686983|FG000|Overall Study|Transfer to another hospital|2|||
38003228|NCT00124020|69686984|FG001|Overall Study|Transfer to another hospital|0|||
38003229|NCT00215540|69686993|FG000|Overall Study|Withdrew from study medication|1|||
38003230|NCT00215540|69686994|FG001|Overall Study|Withdrew from study medication|0|||
38003231|NCT00215540|69686995|FG002|Overall Study|Withdrew from study medication|0|||
37906170|NCT00896532|69591566|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
37906171|NCT00896532|69591567|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
37906172|NCT00896532|69591568|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
37906173|NCT00574873|69591617|FG000|Overall Study|Withdrawal by Subject|18|||
37906174|NCT00574873|69591618|FG001|Overall Study|Withdrawal by Subject|19|||
37906175|NCT00574873|69591617|FG000|Overall Study|Investigator request|18|||
37906176|NCT00574873|69591618|FG001|Overall Study|Investigator request|8|||
37906177|NCT00574873|69591617|FG000|Overall Study|Death|15|||
38003232|NCT00143390|69687005|FG000|Overall Study|Death|2|||
38003233|NCT00143390|69687006|FG001|Overall Study|Death|0|||
38003234|NCT00143390|69687005|FG000|Overall Study|Not meeting entry criteria|2|||
38003235|NCT00143390|69687006|FG001|Overall Study|Not meeting entry criteria|5|||
38003236|NCT00143390|69687005|FG000|Overall Study|Withdrawal by Subject|4|||
38003237|NCT00143390|69687006|FG001|Overall Study|Withdrawal by Subject|4|||
38003238|NCT00143390|69687005|FG000|Overall Study|Progressive disease|119|||
38003239|NCT00143390|69687006|FG001|Overall Study|Progressive disease|115|||
38003240|NCT00143390|69687005|FG000|Overall Study|Protocol Violation|2|||
38003241|NCT00143390|69687006|FG001|Overall Study|Protocol Violation|0|||
38003242|NCT00143390|69687005|FG000|Overall Study|Study termination|10|||
37906178|NCT00574873|69591618|FG001|Overall Study|Death|14|||
37906179|NCT00574873|69591617|FG000|Overall Study|Lost to Follow-up|14|||
38003243|NCT00143390|69687006|FG001|Overall Study|Study termination|15|||
38003244|NCT00143390|69687005|FG000|Overall Study|Adverse Event|9|||
38003245|NCT00143390|69687006|FG001|Overall Study|Adverse Event|8|||
38003246|NCT00143390|69687005|FG000|Overall Study|Other|1|||
38003247|NCT00143390|69687006|FG001|Overall Study|Other|2|||
38003248|NCT00141102|69687014|FG000|Overall Study|Adverse Event|233|||
38003249|NCT00141102|69687015|FG001|Overall Study|Adverse Event|305|||
38003250|NCT00141102|69687014|FG000|Overall Study|Laboratory Abnormality|9|||
38003251|NCT00141102|69687015|FG001|Overall Study|Laboratory Abnormality|33|||
38003252|NCT00141102|69687014|FG000|Overall Study|Lack of Efficacy|21|||
38003253|NCT00141102|69687015|FG001|Overall Study|Lack of Efficacy|26|||
38003254|NCT00141102|69687014|FG000|Overall Study|Lost to Follow-up|29|||
38003255|NCT00141102|69687015|FG001|Overall Study|Lost to Follow-up|32|||
38003256|NCT00141102|69687014|FG000|Overall Study|Other|87|||
38003257|NCT00141102|69687015|FG001|Overall Study|Other|76|||
38003258|NCT00141102|69687014|FG000|Overall Study|Withdrawal by Subject|112|||
38003259|NCT00141102|69687015|FG001|Overall Study|Withdrawal by Subject|142|||
38003260|NCT00141102|69687014|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
38003261|NCT00141102|69687015|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
38003262|NCT00141102|69687014|FG000|Overall Study|Death|2|||
38003263|NCT00141102|69687015|FG001|Overall Study|Death|2|||
38003264|NCT00255008|69687026|FG000|Overall Study|Adverse Event|1|||
38003265|NCT00255008|69687027|FG001|Overall Study|Adverse Event|1|||
38003266|NCT00255008|69687028|FG002|Overall Study|Adverse Event|2|||
38003267|NCT00255008|69687029|FG003|Overall Study|Adverse Event|0|||
38003268|NCT00255008|69687026|FG000|Overall Study|Lost to Follow-up|1|||
38003269|NCT00255008|69687027|FG001|Overall Study|Lost to Follow-up|0|||
38003270|NCT00255008|69687028|FG002|Overall Study|Lost to Follow-up|1|||
38003271|NCT00255008|69687029|FG003|Overall Study|Lost to Follow-up|2|||
38003272|NCT00255008|69687026|FG000|Overall Study|Did not meet viral reduction criteria|4|||
38003273|NCT00255008|69687027|FG001|Overall Study|Did not meet viral reduction criteria|5|||
38003274|NCT00255008|69687028|FG002|Overall Study|Did not meet viral reduction criteria|0|||
38003275|NCT00255008|69687029|FG003|Overall Study|Did not meet viral reduction criteria|1|||
38003276|NCT00255008|69687026|FG000|Overall Study|Withdrew consent|0|||
38003277|NCT00255008|69687027|FG001|Overall Study|Withdrew consent|0|||
38003278|NCT00255008|69687028|FG002|Overall Study|Withdrew consent|2|||
38003279|NCT00255008|69687029|FG003|Overall Study|Withdrew consent|0|||
38003280|NCT00255008|69687026|FG000|Overall Study|Sponsor request|18|||
38003281|NCT00255008|69687027|FG001|Overall Study|Sponsor request|3|||
38003282|NCT00255008|69687028|FG002|Overall Study|Sponsor request|8|||
38003283|NCT00255008|69687029|FG003|Overall Study|Sponsor request|17|||
38003284|NCT00255008|69687026|FG000|Overall Study|Adverse lab experience|1|||
38003285|NCT00255008|69687027|FG001|Overall Study|Adverse lab experience|0|||
38003286|NCT00255008|69687028|FG002|Overall Study|Adverse lab experience|0|||
38003287|NCT00255008|69687029|FG003|Overall Study|Adverse lab experience|0|||
38003288|NCT00255008|69687026|FG000|Overall Study|Other|7|||
38003289|NCT00255008|69687027|FG001|Overall Study|Other|0|||
38003290|NCT00255008|69687028|FG002|Overall Study|Other|3|||
38003291|NCT00255008|69687029|FG003|Overall Study|Other|2|||
38003292|NCT03714022|69687041|FG000|Overall Study|Adverse Event|1|||
38003293|NCT03714022|69687042|FG001|Overall Study|Adverse Event|0|||
38003294|NCT03714022|69687041|FG000|Overall Study|Consent withdrawal|0|||
38003295|NCT03714022|69687042|FG001|Overall Study|Consent withdrawal|1|||
38003296|NCT03714022|69687041|FG000|Overall Study|Lost to Follow-up|3|||
38003297|NCT03714022|69687042|FG001|Overall Study|Lost to Follow-up|2|||
37906180|NCT00574873|69591618|FG001|Overall Study|Lost to Follow-up|5|||
37906181|NCT00574873|69591617|FG000|Overall Study|Other|40|||
37906182|NCT00574873|69591618|FG001|Overall Study|Other|4|||
37906183|NCT00574873|69591617|FG000|Overall Study|Discontinuation of study by sponsor|5|||
37906184|NCT00574873|69591618|FG001|Overall Study|Discontinuation of study by sponsor|199|||
37906185|NCT00574873|69591617|FG000|Overall Study|Blank, site closed per local regulations|2|||
37906186|NCT00574873|69591618|FG001|Overall Study|Blank, site closed per local regulations|2|||
37906187|NCT00574873|69591617|FG000|Overall Study|Extension Study|126|||
38003298|NCT00143312|69687048|FG000|Overall Study|Death|11|||
38003299|NCT00143312|69687048|FG000|Overall Study|Adverse Event|2|||
38003300|NCT00143312|69687048|FG000|Overall Study|Lost to Follow-up|1|||
38003301|NCT00143312|69687048|FG000|Overall Study|Other|1|||
38003302|NCT00143312|69687048|FG000|Overall Study|Withdrawal by Subject|1|||
38003303|NCT00254540|69687054|FG000|Overall Study|Adverse Event|6|||
38003304|NCT00254540|69687055|FG001|Overall Study|Adverse Event|7|||
38003305|NCT00254540|69687054|FG000|Overall Study|Lack of Efficacy|13|||
38003306|NCT00254540|69687055|FG001|Overall Study|Lack of Efficacy|13|||
38003307|NCT00254540|69687054|FG000|Overall Study|Death|0|||
38003308|NCT00254540|69687055|FG001|Overall Study|Death|1|||
38003309|NCT00254540|69687054|FG000|Overall Study|Laboratory Test Abnormality|0|||
38003310|NCT00254540|69687055|FG001|Overall Study|Laboratory Test Abnormality|1|||
38003311|NCT00139776|69687064|FG000|Period I|Did not enter Period II|575|||
38003312|NCT00139776|69687065|FG001|Period I|Did not enter Period II|0|||
38003313|NCT00139776|69687066|FG002|Period I|Did not enter Period II|0|||
38003314|NCT00139776|69687067|FG003|Period I|Did not enter Period II|0|||
38003315|NCT00139776|69687064|FG000|Period II|Not Randomized into Period III|0|||
37906188|NCT00574873|69591618|FG001|Overall Study|Extension Study|0|||
38003316|NCT00139776|69687065|FG001|Period II|Not Randomized into Period III|322|||
37830202|NCT01323790|69513465|FG000|Overall Study|Lack of Efficacy|3|||
37830203|NCT01323790|69513466|FG001|Overall Study|Lack of Efficacy|0|||
37830204|NCT01323790|69513467|FG002|Overall Study|Lack of Efficacy|3|||
37830205|NCT01323790|69513465|FG000|Overall Study|Adverse Event|11|||
37830206|NCT01323790|69513466|FG001|Overall Study|Adverse Event|24|||
37830207|NCT01323790|69513467|FG002|Overall Study|Adverse Event|12|||
37830208|NCT01323790|69513465|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
38003317|NCT00139776|69687066|FG002|Period II|Not Randomized into Period III|0|||
38003318|NCT00139776|69687067|FG003|Period II|Not Randomized into Period III|0|||
38003319|NCT00139776|69687064|FG000|Period III|Adverse Event|0|||
38003320|NCT00139776|69687065|FG001|Period III|Adverse Event|0|||
38003321|NCT00139776|69687066|FG002|Period III|Adverse Event|22|||
38003322|NCT00139776|69687067|FG003|Period III|Adverse Event|23|||
38003323|NCT00139776|69687064|FG000|Period III|Other|0|||
38003324|NCT00139776|69687065|FG001|Period III|Other|0|||
37830209|NCT01323790|69513466|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
38003325|NCT00139776|69687066|FG002|Period III|Other|23|||
38003326|NCT00139776|69687067|FG003|Period III|Other|34|||
37830210|NCT01323790|69513467|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
38003327|NCT00139776|69687064|FG000|Period III|Lack of Efficacy|0|||
38003328|NCT00139776|69687065|FG001|Period III|Lack of Efficacy|0|||
38003329|NCT00139776|69687066|FG002|Period III|Lack of Efficacy|10|||
37830211|NCT01323790|69513465|FG000|Overall Study|Withdrawal by Subject|23|||
38003330|NCT00139776|69687067|FG003|Period III|Lack of Efficacy|24|||
38003331|NCT00139776|69687064|FG000|Period III|Lost to Follow-up|0|||
37830212|NCT01323790|69513466|FG001|Overall Study|Withdrawal by Subject|20|||
37830213|NCT01323790|69513467|FG002|Overall Study|Withdrawal by Subject|13|||
37830214|NCT01323790|69513465|FG000|Overall Study|Did Not Receive Treatment|2|||
37830215|NCT01323790|69513466|FG001|Overall Study|Did Not Receive Treatment|0|||
37830216|NCT01323790|69513467|FG002|Overall Study|Did Not Receive Treatment|1|||
37830217|NCT01323790|69513465|FG000|Overall Study|Severe non-compliance with protocol|2|||
37830218|NCT01323790|69513466|FG001|Overall Study|Severe non-compliance with protocol|2|||
37830219|NCT01323790|69513467|FG002|Overall Study|Severe non-compliance with protocol|2|||
37830220|NCT01323673|69513477|FG000|Overall Study|Adverse Event|0|||
37830221|NCT01323673|69513478|FG001|Overall Study|Adverse Event|1|||
37830222|NCT01323673|69513477|FG000|Overall Study|Lost to Follow-up|0|||
37830223|NCT01323673|69513478|FG001|Overall Study|Lost to Follow-up|1|||
37830224|NCT01323673|69513477|FG000|Overall Study|Protocol Violation|1|||
37830225|NCT01323673|69513478|FG001|Overall Study|Protocol Violation|0|||
37830226|NCT01323673|69513477|FG000|Overall Study|Withdrawal by Subject|2|||
37830227|NCT01323673|69513478|FG001|Overall Study|Withdrawal by Subject|3|||
37830228|NCT01323634|69513486|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
37830229|NCT01323634|69513487|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
37830230|NCT01323634|69513488|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
37830231|NCT01323634|69513486|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
37830232|NCT01323634|69513487|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
37830233|NCT01323634|69513488|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
37830234|NCT01323634|69513486|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
37830235|NCT01323634|69513487|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
37830236|NCT01323634|69513488|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
37830237|NCT01323634|69513486|FG000|2-week Run-in Period|Physician Decision|5|||
37830238|NCT01323634|69513487|FG001|2-week Run-in Period|Physician Decision|0|||
37830239|NCT01323634|69513488|FG002|2-week Run-in Period|Physician Decision|0|||
37830240|NCT01323634|69513486|FG000|2-week Run-in Period|Protocol Violation|1|||
37830241|NCT01323634|69513487|FG001|2-week Run-in Period|Protocol Violation|0|||
37830242|NCT01323634|69513488|FG002|2-week Run-in Period|Protocol Violation|0|||
37830243|NCT01323634|69513486|FG000|2-week Run-in Period|Adverse Event|1|||
37830244|NCT01323634|69513487|FG001|2-week Run-in Period|Adverse Event|0|||
37830245|NCT01323634|69513488|FG002|2-week Run-in Period|Adverse Event|0|||
37830246|NCT01323634|69513486|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
37830247|NCT01323634|69513487|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
37830248|NCT01323634|69513488|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
37830249|NCT01323634|69513486|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
37830250|NCT01323634|69513487|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
37830251|NCT01323634|69513488|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
37830252|NCT01323634|69513486|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
37830253|NCT01323634|69513487|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
37830254|NCT01323634|69513488|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
37830255|NCT01323634|69513486|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
37830256|NCT01323634|69513487|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
37830257|NCT01323634|69513488|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
37830258|NCT01323634|69513486|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
37830259|NCT01323634|69513487|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
37830260|NCT01323634|69513488|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
37830261|NCT01323634|69513486|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
37830262|NCT01323634|69513487|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
37830263|NCT01323634|69513488|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
37830264|NCT01323634|69513486|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
37830265|NCT01323634|69513487|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
37830266|NCT01323634|69513488|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
37906189|NCT00902174|69591626|FG000|Overall Study|Adverse Event|27|||
37906190|NCT00902174|69591627|FG001|Overall Study|Adverse Event|7|||
37906191|NCT00902174|69591626|FG000|Overall Study|Lack of Efficacy|1|||
37906192|NCT00902174|69591627|FG001|Overall Study|Lack of Efficacy|5|||
37906193|NCT00902174|69591626|FG000|Overall Study|Death|2|||
37906194|NCT00902174|69591627|FG001|Overall Study|Death|2|||
37906195|NCT00902174|69591626|FG000|Overall Study|Withdrawal by Subject|2|||
37830267|NCT01323478|69513494|FG000|Overall Study|Adverse Event|7|||
37830268|NCT01323478|69513494|FG000|Overall Study|Lack of Efficacy|4|||
37830269|NCT01323478|69513494|FG000|Overall Study|Non-compliance With Study Product|3|||
37830270|NCT01323478|69513494|FG000|Overall Study|Protocol Violation|1|||
37830271|NCT01323478|69513494|FG000|Overall Study|Withdrawal of Consent|1|||
37906196|NCT00902174|69591627|FG001|Overall Study|Withdrawal by Subject|1|||
37906197|NCT00902174|69591626|FG000|Overall Study|Abnormal labs|1|||
38003332|NCT00139776|69687065|FG001|Period III|Lost to Follow-up|0|||
38003333|NCT00139776|69687066|FG002|Period III|Lost to Follow-up|5|||
38003334|NCT00139776|69687067|FG003|Period III|Lost to Follow-up|4|||
38003335|NCT00139776|69687064|FG000|Period III|Withdrawal by Subject|0|||
38003336|NCT00139776|69687065|FG001|Period III|Withdrawal by Subject|0|||
38003337|NCT00139776|69687066|FG002|Period III|Withdrawal by Subject|16|||
38003338|NCT00139776|69687067|FG003|Period III|Withdrawal by Subject|21|||
38003339|NCT00413699|69687076|FG000|Initial Period|Death|25|||
38003340|NCT00413699|69687077|FG001|Initial Period|Death|30|||
38003341|NCT00413699|69687078|FG002|Initial Period|Death|0|||
38003342|NCT00413699|69687076|FG000|Initial Period|Lack of Efficacy|59|||
38003343|NCT00413699|69687077|FG001|Initial Period|Lack of Efficacy|115|||
38003344|NCT00413699|69687078|FG002|Initial Period|Lack of Efficacy|0|||
38003345|NCT00413699|69687076|FG000|Initial Period|Lost to Follow-up|31|||
38003346|NCT00413699|69687077|FG001|Initial Period|Lost to Follow-up|101|||
38003347|NCT00413699|69687078|FG002|Initial Period|Lost to Follow-up|0|||
38003348|NCT00413699|69687076|FG000|Initial Period|Protocol Violation|38|||
38003349|NCT00413699|69687077|FG001|Initial Period|Protocol Violation|89|||
38003350|NCT00413699|69687078|FG002|Initial Period|Protocol Violation|0|||
38003351|NCT00413699|69687076|FG000|Initial Period|Pregnancy|10|||
38003352|NCT00413699|69687077|FG001|Initial Period|Pregnancy|8|||
38003353|NCT00413699|69687078|FG002|Initial Period|Pregnancy|0|||
38003354|NCT00413699|69687076|FG000|Initial Period|Did not meet entrance criteria|2|||
38003355|NCT00413699|69687077|FG001|Initial Period|Did not meet entrance criteria|2|||
38003356|NCT00413699|69687078|FG002|Initial Period|Did not meet entrance criteria|0|||
38003357|NCT00413699|69687076|FG000|Initial Period|Medication error without adverse event|0|||
38003358|NCT00413699|69687077|FG001|Initial Period|Medication error without adverse event|1|||
38003359|NCT00413699|69687078|FG002|Initial Period|Medication error without adverse event|0|||
38003360|NCT00413699|69687076|FG000|Initial Period|Study terminated by Sponsor|0|||
38003361|NCT00413699|69687077|FG001|Initial Period|Study terminated by Sponsor|1|||
38003362|NCT00413699|69687078|FG002|Initial Period|Study terminated by Sponsor|0|||
38003363|NCT00413699|69687076|FG000|Initial Period|Other|67|||
38003364|NCT00413699|69687077|FG001|Initial Period|Other|211|||
38003365|NCT00413699|69687078|FG002|Initial Period|Other|0|||
37906198|NCT00902174|69591627|FG001|Overall Study|Abnormal labs|1|||
38003366|NCT00413699|69687076|FG000|Initial Period|Adverse event related to study drug|178|||
38003367|NCT00413699|69687077|FG001|Initial Period|Adverse event related to study drug|527|||
38003368|NCT00413699|69687078|FG002|Initial Period|Adverse event related to study drug|0|||
38003369|NCT00413699|69687076|FG000|Initial Period|Adverse event not related to study drug|113|||
38003370|NCT00413699|69687077|FG001|Initial Period|Adverse event not related to study drug|248|||
38003371|NCT00413699|69687078|FG002|Initial Period|Adverse event not related to study drug|0|||
38003372|NCT00413699|69687076|FG000|Initial Period|Missing end of study page|0|||
38003373|NCT00413699|69687077|FG001|Initial Period|Missing end of study page|4|||
38003374|NCT00413699|69687078|FG002|Initial Period|Missing end of study page|0|||
38003375|NCT00413699|69687076|FG000|Initial Period|No longer willing to participate|116|||
38003376|NCT00413699|69687077|FG001|Initial Period|No longer willing to participate|368|||
38003377|NCT00413699|69687078|FG002|Initial Period|No longer willing to participate|0|||
37830272|NCT01323478|69513494|FG000|Overall Study|Administrative or Other Reasons|8|||
37830273|NCT01322386|69513500|FG000|Overall Study|Protocol Violation|0|||
37830274|NCT01322386|69513501|FG001|Overall Study|Protocol Violation|1|||
37830275|NCT01322386|69513500|FG000|Overall Study|Physician Decision|0|||
37830276|NCT01322386|69513501|FG001|Overall Study|Physician Decision|1|||
37830277|NCT01322347|69513511|FG000|Overall Study|Adverse Event|7|||
37830278|NCT01322347|69513512|FG001|Overall Study|Adverse Event|2|||
37830279|NCT01322347|69513511|FG000|Overall Study|Death|5|||
37830280|NCT01322347|69513512|FG001|Overall Study|Death|3|||
37830281|NCT01322347|69513511|FG000|Overall Study|Physician Decision|2|||
37830282|NCT01322347|69513512|FG001|Overall Study|Physician Decision|1|||
37906199|NCT00902174|69591626|FG000|Overall Study|Protocol Violation|1|||
37906200|NCT00902174|69591627|FG001|Overall Study|Protocol Violation|1|||
37906201|NCT00902174|69591626|FG000|Overall Study|Administration problem|0|||
37906202|NCT00902174|69591627|FG001|Overall Study|Administration problem|1|||
37906203|NCT00623623|69591651|FG000|Overall Study|Previous enrolment into this study|1|||
38003378|NCT00413699|69687076|FG000|Extension Period|No Longer Willing to Participate|0|||
38003379|NCT00413699|69687077|FG001|Extension Period|No Longer Willing to Participate|0|||
38003380|NCT00413699|69687078|FG002|Extension Period|No Longer Willing to Participate|2|||
37830283|NCT01322347|69513511|FG000|Overall Study|Protocol Violation|5|||
38003381|NCT00413699|69687076|FG000|Extension Period|Protocol Violation|0|||
38003382|NCT00413699|69687077|FG001|Extension Period|Protocol Violation|0|||
38003383|NCT00413699|69687078|FG002|Extension Period|Protocol Violation|1|||
37906204|NCT00623623|69591652|FG001|Overall Study|Previous enrolment into this study|1|||
37906205|NCT00896454|69591658|FG000|Overall Study|Death|10|||
38003384|NCT00413699|69687076|FG000|Extension Period|Adverse Event|0|||
38003385|NCT00413699|69687077|FG001|Extension Period|Adverse Event|0|||
37830284|NCT01322347|69513512|FG001|Overall Study|Protocol Violation|2|||
37830285|NCT01322347|69513511|FG000|Overall Study|Withdrawal by Subject|1|||
37906206|NCT00896454|69591658|FG000|Overall Study|Adverse Event|8|||
38003386|NCT00413699|69687078|FG002|Extension Period|Adverse Event|2|||
38003387|NCT03713320|69687106|FG000|Randomized Period|Adverse Event|1|||
38003388|NCT03713320|69687107|FG001|Randomized Period|Adverse Event|5|||
38003389|NCT03713320|69687108|FG002|Randomized Period|Adverse Event|0|||
38003390|NCT03713320|69687106|FG000|Randomized Period|Physician Decision|1|||
38003391|NCT03713320|69687107|FG001|Randomized Period|Physician Decision|1|||
38003392|NCT03713320|69687108|FG002|Randomized Period|Physician Decision|0|||
38003393|NCT03713320|69687106|FG000|Randomized Period|Withdrawal by Subject|4|||
38003394|NCT03713320|69687107|FG001|Randomized Period|Withdrawal by Subject|0|||
38003395|NCT03713320|69687108|FG002|Randomized Period|Withdrawal by Subject|0|||
38003396|NCT03713320|69687106|FG000|Randomized Period|Participant decision|3|||
38003397|NCT03713320|69687107|FG001|Randomized Period|Participant decision|1|||
38003398|NCT03713320|69687108|FG002|Randomized Period|Participant decision|0|||
38003399|NCT03713320|69687106|FG000|Randomized Period|Study terminated by sponsor|6|||
38003400|NCT03713320|69687107|FG001|Randomized Period|Study terminated by sponsor|3|||
38003401|NCT03713320|69687108|FG002|Randomized Period|Study terminated by sponsor|0|||
38003402|NCT03713320|69687106|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
38003403|NCT03713320|69687107|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
38003404|NCT03713320|69687108|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
38003405|NCT03713320|69687106|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
38003406|NCT03713320|69687107|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
38003407|NCT03713320|69687108|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
38003408|NCT03712930|69687115|FG000|Overall Study|Death|7|||
38003409|NCT03712930|69687115|FG000|Overall Study|Physician Decision|1|||
38003410|NCT03712930|69687115|FG000|Overall Study|Study Terminated by Sponsor|3|||
38003411|NCT03712930|69687115|FG000|Overall Study|Progressive Disease|2|||
38003412|NCT00420407|69687121|FG000|Overall Study|Lost to Follow-up|0|||
38003413|NCT00420407|69687122|FG001|Overall Study|Lost to Follow-up|3|||
38003414|NCT00420407|69687121|FG000|Overall Study|Physician Decision|2|||
38003415|NCT00420407|69687122|FG001|Overall Study|Physician Decision|1|||
38003416|NCT00420407|69687121|FG000|Overall Study|subject identified as detainee|1|||
38003417|NCT00420407|69687122|FG001|Overall Study|subject identified as detainee|0|||
38003418|NCT00420407|69687121|FG000|Overall Study|subject identified as Jehovah's witness|1|||
38003419|NCT00420407|69687122|FG001|Overall Study|subject identified as Jehovah's witness|0|||
38003420|NCT00420407|69687121|FG000|Overall Study|Withdrawal by Subject|0|||
38003421|NCT00420407|69687122|FG001|Overall Study|Withdrawal by Subject|2|||
37830286|NCT01322347|69513512|FG001|Overall Study|Withdrawal by Subject|4|||
37830287|NCT01322347|69513511|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
37830288|NCT01322347|69513512|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
37830289|NCT01322347|69513511|FG000|Overall Study|blood transfusion|5|||
37830290|NCT01322347|69513512|FG001|Overall Study|blood transfusion|5|||
37830291|NCT01322347|69513511|FG000|Overall Study|sponsor decision|1|||
37830292|NCT01322347|69513512|FG001|Overall Study|sponsor decision|3|||
37830293|NCT01322347|69513511|FG000|Overall Study|ineligible|6|||
37830294|NCT01322347|69513512|FG001|Overall Study|ineligible|3|||
37830295|NCT01322347|69513511|FG000|Overall Study|kidney transplant|3|||
37830296|NCT01322347|69513512|FG001|Overall Study|kidney transplant|1|||
37830297|NCT01322347|69513511|FG000|Overall Study|study drug withheld > 12 wks|0|||
38003422|NCT00420095|69687131|FG000|Overall Study|Adverse Event|1|||
38003423|NCT00420095|69687132|FG001|Overall Study|Adverse Event|0|||
38003424|NCT00420095|69687131|FG000|Overall Study|Protocol Violation|1|||
38003425|NCT00420095|69687132|FG001|Overall Study|Protocol Violation|1|||
38003426|NCT00420095|69687131|FG000|Overall Study|Lost to Follow-up|1|||
37830298|NCT01322347|69513512|FG001|Overall Study|study drug withheld > 12 wks|1|||
37830299|NCT01322347|69513511|FG000|Overall Study|moved/changed dialysis|2|||
37830300|NCT01322347|69513512|FG001|Overall Study|moved/changed dialysis|4|||
37830301|NCT01321879|69513519|FG000|Overall Study|Lack of Efficacy|5|||
37830302|NCT01321879|69513519|FG000|Overall Study|Adverse Event|5|||
37830303|NCT01321879|69513519|FG000|Overall Study|Death|3|||
37830304|NCT01321879|69513519|FG000|Overall Study|Withdrawal by Subject|1|||
37830305|NCT01321723|69513526|FG000|Overall Study|Adverse Event|3|||
37830306|NCT01321723|69513527|FG001|Overall Study|Adverse Event|5|||
37830307|NCT01321723|69513528|FG002|Overall Study|Adverse Event|2|||
38003427|NCT00420095|69687132|FG001|Overall Study|Lost to Follow-up|0|||
38003428|NCT00419393|69687138|FG000|Overall Study|Adverse Event|5|||
38003429|NCT00419393|69687138|FG000|Overall Study|Protocol Violation|5|||
38003430|NCT00419393|69687138|FG000|Overall Study|Withdrawal by Subject|7|||
38003431|NCT00419393|69687138|FG000|Overall Study|Other: Sponsor request|3|||
37830308|NCT01321723|69513526|FG000|Overall Study|Withdrawal by Subject|2|||
37830309|NCT01321723|69513527|FG001|Overall Study|Withdrawal by Subject|0|||
37830310|NCT01321723|69513528|FG002|Overall Study|Withdrawal by Subject|2|||
38003432|NCT00419393|69687138|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
38003433|NCT00419393|69687138|FG000|Overall Study|Other: Site closure|1|||
38043624|NCT02180867|69731804|FG000|Overall Study|Death|0|||
38043625|NCT02180867|69731805|FG001|Overall Study|Death|0|||
37830311|NCT01321606|69513538|FG000|Overall Study|Lost to Follow-up|0|||
38003434|NCT00419393|69687138|FG000|Overall Study|Other: Other health problems|1|||
38003435|NCT00419393|69687138|FG000|Overall Study|Other: Investigator decision|1|||
38003436|NCT00419159|69687144|FG000|Overall Study|Adverse Event|7|||
38003437|NCT00419159|69687145|FG001|Overall Study|Adverse Event|15|||
38003438|NCT00419159|69687144|FG000|Overall Study|Abnormal laboratory value(s)|0|||
38003439|NCT00419159|69687145|FG001|Overall Study|Abnormal laboratory value(s)|2|||
38003440|NCT00419159|69687144|FG000|Overall Study|Subject's no longer requires study drug|0|||
38003441|NCT00419159|69687145|FG001|Overall Study|Subject's no longer requires study drug|1|||
38003442|NCT00419159|69687144|FG000|Overall Study|Protocol Violation|1|||
38003443|NCT00419159|69687145|FG001|Overall Study|Protocol Violation|0|||
38003444|NCT00419159|69687144|FG000|Overall Study|Withdrawal by Subject|10|||
38003445|NCT00419159|69687145|FG001|Overall Study|Withdrawal by Subject|3|||
38003446|NCT00419159|69687144|FG000|Overall Study|Lost to Follow-up|0|||
38003447|NCT00419159|69687145|FG001|Overall Study|Lost to Follow-up|1|||
38003448|NCT00419159|69687144|FG000|Overall Study|Death|2|||
38003449|NCT00419159|69687145|FG001|Overall Study|Death|2|||
38003450|NCT00419159|69687144|FG000|Overall Study|Disease progression|79|||
38003451|NCT00419159|69687145|FG001|Overall Study|Disease progression|76|||
38003452|NCT03717064|69687159|FG000|Period 2|Adverse Event|1|||
38003453|NCT03716050|69687171|FG000|Overall Study|Lost to Follow-up|0|||
38003454|NCT03716050|69687172|FG001|Overall Study|Lost to Follow-up|0|||
38003455|NCT03716050|69687173|FG002|Overall Study|Lost to Follow-up|1|||
38003456|NCT03716050|69687174|FG003|Overall Study|Lost to Follow-up|0|||
38003457|NCT03716050|69687175|FG004|Overall Study|Lost to Follow-up|0|||
38003458|NCT03716050|69687176|FG005|Overall Study|Lost to Follow-up|0|||
38003459|NCT03716050|69687177|FG006|Overall Study|Lost to Follow-up|0|||
38003460|NCT03716050|69687178|FG007|Overall Study|Lost to Follow-up|0|||
38003461|NCT03716050|69687171|FG000|Overall Study|Physician Decision|0|||
38003462|NCT03716050|69687172|FG001|Overall Study|Physician Decision|0|||
38003463|NCT03716050|69687173|FG002|Overall Study|Physician Decision|0|||
38003464|NCT03716050|69687174|FG003|Overall Study|Physician Decision|1|||
38003465|NCT03716050|69687175|FG004|Overall Study|Physician Decision|0|||
38003466|NCT03716050|69687176|FG005|Overall Study|Physician Decision|0|||
38003467|NCT03716050|69687177|FG006|Overall Study|Physician Decision|0|||
38003468|NCT03716050|69687178|FG007|Overall Study|Physician Decision|0|||
38003469|NCT03716050|69687171|FG000|Overall Study|Protocol Violation|0|||
38003470|NCT03716050|69687172|FG001|Overall Study|Protocol Violation|0|||
38003471|NCT03716050|69687173|FG002|Overall Study|Protocol Violation|0|||
38003472|NCT03716050|69687174|FG003|Overall Study|Protocol Violation|1|||
38003473|NCT03716050|69687175|FG004|Overall Study|Protocol Violation|0|||
38003474|NCT03716050|69687176|FG005|Overall Study|Protocol Violation|0|||
38003475|NCT03716050|69687177|FG006|Overall Study|Protocol Violation|0|||
38003476|NCT03716050|69687178|FG007|Overall Study|Protocol Violation|2|||
38003477|NCT00413231|69687195|FG000|0 to 30-day Post Treatment|Death|5|||
38003478|NCT00413231|69687195|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
38003479|NCT00413231|69687195|FG000|30-day to 365-day Post Treatment|Death|13|||
38003480|NCT00413231|69687195|FG000|365-day to 60-month Post Treatment|Death|36|||
38003481|NCT00413231|69687195|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
38003482|NCT00413231|69687195|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
38003483|NCT00413231|69687195|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
38003484|NCT00413153|69687215|FG000|Overall Study|Withdrawal by Subject|1|||
38003485|NCT00413153|69687216|FG001|Overall Study|Withdrawal by Subject|1|||
38003486|NCT00413153|69687215|FG000|Overall Study|Adverse Event|1|||
38003487|NCT00413153|69687216|FG001|Overall Study|Adverse Event|0|||
38003488|NCT00412607|69687222|FG000|Overall Study|Withdrawal by Subject|9|||
38003489|NCT00412607|69687222|FG000|Overall Study|Lost to Follow-up|19|||
38003490|NCT00412607|69687222|FG000|Overall Study|Death|61|||
38003491|NCT00412607|69687222|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
37697560|NCT02413229|69174131|FG002|Overall Study|Withdrawal by Subject|0|||
37697561|NCT02413229|69174132|FG003|Overall Study|Withdrawal by Subject|0|||
37830312|NCT01321606|69513539|FG001|Overall Study|Lost to Follow-up|0|||
37830313|NCT01321606|69513540|FG002|Overall Study|Lost to Follow-up|0|||
37830314|NCT01321606|69513541|FG003|Overall Study|Lost to Follow-up|1|||
37830315|NCT01320943|69513553|FG000|Overall Study|Lost to Follow-up|1|||
37830316|NCT01320943|69513554|FG001|Overall Study|Lost to Follow-up|0|||
38003492|NCT00419003|69687231|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
38003493|NCT00419003|69687232|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
38003494|NCT00419003|69687231|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
38003495|NCT00419003|69687232|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
38003496|NCT00418691|69687244|FG000|Overall Study|Lost to Follow-up|1|||
38003497|NCT00418691|69687245|FG001|Overall Study|Lost to Follow-up|2|||
38003498|NCT00418691|69687246|FG002|Overall Study|Lost to Follow-up|3|||
37697562|NCT02413229|69174133|FG004|Overall Study|Withdrawal by Subject|1|||
38003499|NCT00418691|69687244|FG000|Overall Study|Started new medication voiding entry|0|||
37697563|NCT02413229|69174134|FG005|Overall Study|Withdrawal by Subject|0|||
37830317|NCT01320943|69513553|FG000|Overall Study|Physician Decision|0|||
38003500|NCT00418691|69687245|FG001|Overall Study|Started new medication voiding entry|0|||
38003501|NCT00418691|69687246|FG002|Overall Study|Started new medication voiding entry|1|||
38003502|NCT00418691|69687244|FG000|Overall Study|Progressive Disease|1|||
38003503|NCT00418691|69687245|FG001|Overall Study|Progressive Disease|0|||
38003504|NCT00418691|69687246|FG002|Overall Study|Progressive Disease|1|||
38003505|NCT00412373|69687256|FG000|Overall Study|Adverse Event|8|||
38003506|NCT00412373|69687257|FG001|Overall Study|Adverse Event|13|||
38003507|NCT00412373|69687256|FG000|Overall Study|Lack of Efficacy|16|||
38003508|NCT00412373|69687257|FG001|Overall Study|Lack of Efficacy|22|||
38003509|NCT00412373|69687256|FG000|Overall Study|Lost to Follow-up|7|||
38003510|NCT00412373|69687257|FG001|Overall Study|Lost to Follow-up|13|||
38003511|NCT00412373|69687256|FG000|Overall Study|Withdrawal by Subject|8|||
38003512|NCT00412373|69687257|FG001|Overall Study|Withdrawal by Subject|27|||
38003513|NCT00412373|69687256|FG000|Overall Study|Other|2|||
38003514|NCT00412373|69687257|FG001|Overall Study|Other|2|||
38003515|NCT00418379|69687266|FG000|Year 1|Adverse Event|9|||
38003516|NCT00418379|69687267|FG001|Year 1|Adverse Event|15|||
38003517|NCT00418379|69687268|FG002|Year 1|Adverse Event|3|||
38003518|NCT00418379|69687266|FG000|Year 1|Withdrawal by Subject|7|||
38003519|NCT00418379|69687267|FG001|Year 1|Withdrawal by Subject|8|||
38003520|NCT00418379|69687268|FG002|Year 1|Withdrawal by Subject|5|||
38003521|NCT00418379|69687266|FG000|Year 1|Any other reason not above-mentioned|2|||
38003522|NCT00418379|69687267|FG001|Year 1|Any other reason not above-mentioned|5|||
38003523|NCT00418379|69687268|FG002|Year 1|Any other reason not above-mentioned|7|||
38003524|NCT00418379|69687266|FG000|Year 2|Adverse Event|5|||
38003525|NCT00418379|69687267|FG001|Year 2|Adverse Event|2|||
38003526|NCT00418379|69687268|FG002|Year 2|Adverse Event|1|||
38003527|NCT00418379|69687266|FG000|Year 2|Withdrawal by Subject|1|||
38003528|NCT00418379|69687267|FG001|Year 2|Withdrawal by Subject|1|||
38003529|NCT00418379|69687268|FG002|Year 2|Withdrawal by Subject|3|||
38003530|NCT00418379|69687266|FG000|Year 2|Any other reason not above-mentioned|2|||
38003531|NCT00418379|69687267|FG001|Year 2|Any other reason not above-mentioned|1|||
38003532|NCT00418379|69687268|FG002|Year 2|Any other reason not above-mentioned|6|||
38003533|NCT00418379|69687266|FG000|Year 3|Withdrawal by Subject|1|||
38003534|NCT00418379|69687267|FG001|Year 3|Withdrawal by Subject|1|||
38003535|NCT00418379|69687268|FG002|Year 3|Withdrawal by Subject|2|||
38003536|NCT00418379|69687266|FG000|Year 3|Any other reason not above-mentioned|2|||
38003537|NCT00418379|69687267|FG001|Year 3|Any other reason not above-mentioned|1|||
38003538|NCT00418379|69687268|FG002|Year 3|Any other reason not above-mentioned|1|||
38003539|NCT00418379|69687266|FG000|Year 4|Adverse Event|0|||
38003540|NCT00418379|69687267|FG001|Year 4|Adverse Event|1|||
38003541|NCT00418379|69687268|FG002|Year 4|Adverse Event|0|||
38003542|NCT00418379|69687266|FG000|Year 4|Withdrawal by Subject|2|||
38003543|NCT00418379|69687267|FG001|Year 4|Withdrawal by Subject|3|||
38003544|NCT00418379|69687268|FG002|Year 4|Withdrawal by Subject|2|||
38003545|NCT00418379|69687266|FG000|Year 4|Any other reason not above-mentioned|1|||
38003546|NCT00418379|69687267|FG001|Year 4|Any other reason not above-mentioned|1|||
38003547|NCT00418379|69687268|FG002|Year 4|Any other reason not above-mentioned|0|||
38003548|NCT00418379|69687266|FG000|Year 5|Adverse Event|0|||
38003549|NCT00418379|69687267|FG001|Year 5|Adverse Event|1|||
38003550|NCT00418379|69687268|FG002|Year 5|Adverse Event|0|||
38003551|NCT00418379|69687266|FG000|Year 5|Any other reason not above-mentioned|2|||
38003552|NCT00418379|69687267|FG001|Year 5|Any other reason not above-mentioned|4|||
38003553|NCT00418379|69687268|FG002|Year 5|Any other reason not above-mentioned|3|||
38003554|NCT00418145|69687276|FG000|Overall Study|study terminated|6|||
38003555|NCT00417989|69687284|FG000|Overall Study|Withdrawal by Subject|13|||
38003556|NCT00417989|69687285|FG001|Overall Study|Withdrawal by Subject|13|||
38003557|NCT00417989|69687284|FG000|Overall Study|Lost to Follow-up|1|||
38003558|NCT00417989|69687285|FG001|Overall Study|Lost to Follow-up|6|||
38003559|NCT00417989|69687284|FG000|Overall Study|Protocol Violation|1|||
38003560|NCT00417989|69687285|FG001|Overall Study|Protocol Violation|0|||
38003561|NCT00417989|69687284|FG000|Overall Study|Death|0|||
37830318|NCT01320943|69513554|FG001|Overall Study|Physician Decision|1|||
38003562|NCT00417989|69687285|FG001|Overall Study|Death|1|||
38003563|NCT00417989|69687284|FG000|Overall Study|Physician Decision|5|||
38003564|NCT00417989|69687285|FG001|Overall Study|Physician Decision|2|||
37830319|NCT01320943|69513553|FG000|Overall Study|Randomized but not Treated|0|||
38003565|NCT00412217|69687295|FG000|Overall Study|Insufficient Data Available|8|||
38003566|NCT00412217|69687296|FG001|Overall Study|Insufficient Data Available|3|||
37830320|NCT01320943|69513554|FG001|Overall Study|Randomized but not Treated|1|||
38003567|NCT00412217|69687295|FG000|Overall Study|Death|5|||
38003568|NCT00412217|69687296|FG001|Overall Study|Death|4|||
38003569|NCT00412217|69687295|FG000|Overall Study|Disease Progression|2|||
38003570|NCT00412217|69687296|FG001|Overall Study|Disease Progression|3|||
38003571|NCT00412217|69687295|FG000|Overall Study|Investigator Decision|1|||
38003572|NCT00412217|69687296|FG001|Overall Study|Investigator Decision|0|||
38003573|NCT00412217|69687295|FG000|Overall Study|Withdrawal by Subject|2|||
38003574|NCT00412217|69687296|FG001|Overall Study|Withdrawal by Subject|0|||
38003575|NCT00412217|69687295|FG000|Overall Study|Lost to Follow-up|1|||
38003576|NCT00412217|69687296|FG001|Overall Study|Lost to Follow-up|4|||
38003577|NCT00412217|69687295|FG000|Overall Study|Study Terminated by Sponsor|26|||
38003578|NCT00412217|69687296|FG001|Overall Study|Study Terminated by Sponsor|33|||
38003579|NCT00412217|69687295|FG000|Overall Study|Other|1|||
38003580|NCT00412217|69687296|FG001|Overall Study|Other|1|||
38003581|NCT05000164|69687302|FG000|Overall Study|Adverse Event|1|||
38003582|NCT05000164|69687302|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
38003583|NCT05000164|69687302|FG000|Overall Study|Lens Discomfort|3|||
38003584|NCT05000164|69687302|FG000|Overall Study|Withdrew Consent during Study|2|||
38003585|NCT05000164|69687302|FG000|Overall Study|Subject Withdrawn by PI|2|||
38003586|NCT05000164|69687302|FG000|Overall Study|Other Fractured Test Article|1|||
38003587|NCT00123474|69687310|FG000|Randomized to Treatment|Randomized, never treated|1|||
38003588|NCT00123474|69687311|FG001|Randomized to Treatment|Randomized, never treated|4|||
38003589|NCT00123474|69687312|FG002|Randomized to Treatment|Randomized, never treated|2|||
38003590|NCT00123474|69687313|FG003|Randomized to Treatment|Randomized, never treated|1|||
38003591|NCT00123474|69687310|FG000|As Treated at Study Closure|not reported when site closed|1|||
38003592|NCT00123474|69687311|FG001|As Treated at Study Closure|not reported when site closed|0|||
38003593|NCT00123474|69687312|FG002|As Treated at Study Closure|not reported when site closed|1|||
38003594|NCT00123474|69687313|FG003|As Treated at Study Closure|not reported when site closed|0|||
38003595|NCT00123474|69687310|FG000|As Treated at Study Closure|Adverse Event|10|||
38003596|NCT00123474|69687311|FG001|As Treated at Study Closure|Adverse Event|4|||
38003597|NCT00123474|69687312|FG002|As Treated at Study Closure|Adverse Event|10|||
38003598|NCT00123474|69687313|FG003|As Treated at Study Closure|Adverse Event|8|||
38003599|NCT00123474|69687310|FG000|As Treated at Study Closure|Disease Progression|35|||
38003600|NCT00123474|69687311|FG001|As Treated at Study Closure|Disease Progression|42|||
38003601|NCT00123474|69687312|FG002|As Treated at Study Closure|Disease Progression|29|||
38003602|NCT00123474|69687313|FG003|As Treated at Study Closure|Disease Progression|27|||
38003603|NCT00123474|69687310|FG000|As Treated at Study Closure|Investigator Request|12|||
38003604|NCT00123474|69687311|FG001|As Treated at Study Closure|Investigator Request|6|||
38003605|NCT00123474|69687312|FG002|As Treated at Study Closure|Investigator Request|7|||
38003606|NCT00123474|69687313|FG003|As Treated at Study Closure|Investigator Request|5|||
38003607|NCT00123474|69687310|FG000|As Treated at Study Closure|non-specified|54|||
38003608|NCT00123474|69687311|FG001|As Treated at Study Closure|non-specified|47|||
38003609|NCT00123474|69687312|FG002|As Treated at Study Closure|non-specified|57|||
38003610|NCT00123474|69687313|FG003|As Treated at Study Closure|non-specified|60|||
38003611|NCT00123474|69687310|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
38003612|NCT00123474|69687311|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
38003613|NCT00123474|69687312|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
38003614|NCT00123474|69687313|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
38003615|NCT00123474|69687310|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
38003616|NCT00123474|69687311|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
38003617|NCT00123474|69687312|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
38003618|NCT00123474|69687313|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
38003619|NCT00142298|69687354|FG000|Overall Study|Adverse Event|10|||
38003620|NCT00142298|69687355|FG001|Overall Study|Adverse Event|10|||
38003621|NCT00142298|69687356|FG002|Overall Study|Adverse Event|1|||
38003622|NCT00142298|69687357|FG003|Overall Study|Adverse Event|5|||
38003623|NCT00142298|69687358|FG004|Overall Study|Adverse Event|2|||
38003624|NCT00142298|69687359|FG005|Overall Study|Adverse Event|2|||
37830321|NCT02482233|69513569|FG000|Overall Study|Lost to Follow-up|1|||
37830322|NCT02482233|69513570|FG001|Overall Study|Lost to Follow-up|1|||
37830323|NCT01320202|69513580|FG000|Overall Study|Adverse Event|5|||
37830324|NCT01320202|69513581|FG001|Overall Study|Adverse Event|5|||
37830325|NCT01320202|69513580|FG000|Overall Study|Death|5|||
37830326|NCT01320202|69513581|FG001|Overall Study|Death|3|||
37830327|NCT01320202|69513580|FG000|Overall Study|Lost to Follow-up|1|||
37830328|NCT01320202|69513581|FG001|Overall Study|Lost to Follow-up|0|||
37830329|NCT01320202|69513580|FG000|Overall Study|Physician Decision|3|||
37830330|NCT01320202|69513581|FG001|Overall Study|Physician Decision|1|||
37830331|NCT01320202|69513580|FG000|Overall Study|Protocol Violation|2|||
37830332|NCT01320202|69513581|FG001|Overall Study|Protocol Violation|1|||
37830333|NCT01320202|69513580|FG000|Overall Study|Withdrawal by Subject|10|||
37830334|NCT01320202|69513581|FG001|Overall Study|Withdrawal by Subject|3|||
37830335|NCT01320202|69513580|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
37830336|NCT01320202|69513581|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
37830337|NCT01320202|69513580|FG000|Overall Study|kidney transplant|1|||
37830338|NCT01320202|69513581|FG001|Overall Study|kidney transplant|2|||
37830339|NCT01320202|69513580|FG000|Overall Study|blood transfusion|1|||
37906207|NCT00896454|69591658|FG000|Overall Study|Disease Progression|5|||
37906208|NCT00896454|69591658|FG000|Overall Study|Other|4|||
37906209|NCT00896454|69591658|FG000|Overall Study|Requirement for alternative therapy|3|||
37906210|NCT00896454|69591658|FG000|Overall Study|Ongoing in study|2|||
37906211|NCT00896454|69591658|FG000|Overall Study|Withdrawal by Subject|1|||
37906212|NCT00629239|69591664|FG000|Overall Study|Adverse Event|7|||
37906213|NCT00629239|69591665|FG001|Overall Study|Adverse Event|4|||
37906214|NCT00629239|69591664|FG000|Overall Study|Physician Decision|1|||
37906215|NCT00629239|69591665|FG001|Overall Study|Physician Decision|0|||
37906216|NCT00625807|69591673|FG000|Overall Study|schedule conflict|2|||
38003625|NCT00142298|69687360|FG006|Overall Study|Adverse Event|0|||
38003626|NCT00142298|69687361|FG007|Overall Study|Adverse Event|0|||
38003627|NCT00142298|69687362|FG008|Overall Study|Adverse Event|0|||
38003628|NCT00142298|69687363|FG009|Overall Study|Adverse Event|0|||
38003629|NCT00142298|69687354|FG000|Overall Study|Clinical disease progression|1|||
38003630|NCT00142298|69687355|FG001|Overall Study|Clinical disease progression|0|||
38003631|NCT00142298|69687356|FG002|Overall Study|Clinical disease progression|0|||
38003632|NCT00142298|69687357|FG003|Overall Study|Clinical disease progression|0|||
38003633|NCT00142298|69687358|FG004|Overall Study|Clinical disease progression|0|||
38003634|NCT00142298|69687359|FG005|Overall Study|Clinical disease progression|0|||
38003635|NCT00142298|69687360|FG006|Overall Study|Clinical disease progression|0|||
38003636|NCT00142298|69687361|FG007|Overall Study|Clinical disease progression|0|||
38003637|NCT00142298|69687362|FG008|Overall Study|Clinical disease progression|0|||
38003638|NCT00142298|69687363|FG009|Overall Study|Clinical disease progression|0|||
38003639|NCT00142298|69687354|FG000|Overall Study|Death|1|||
38003640|NCT00142298|69687355|FG001|Overall Study|Death|1|||
38003641|NCT00142298|69687356|FG002|Overall Study|Death|1|||
38003642|NCT00142298|69687357|FG003|Overall Study|Death|0|||
38003643|NCT00142298|69687358|FG004|Overall Study|Death|0|||
38003644|NCT00142298|69687359|FG005|Overall Study|Death|6|||
38003645|NCT00142298|69687360|FG006|Overall Study|Death|0|||
38003646|NCT00142298|69687361|FG007|Overall Study|Death|0|||
38003647|NCT00142298|69687362|FG008|Overall Study|Death|0|||
38003648|NCT00142298|69687363|FG009|Overall Study|Death|0|||
38003649|NCT00142298|69687354|FG000|Overall Study|Lack of Efficacy|44|||
38003650|NCT00142298|69687355|FG001|Overall Study|Lack of Efficacy|62|||
38003651|NCT00142298|69687356|FG002|Overall Study|Lack of Efficacy|9|||
38003652|NCT00142298|69687357|FG003|Overall Study|Lack of Efficacy|12|||
38003653|NCT00142298|69687358|FG004|Overall Study|Lack of Efficacy|1|||
38003654|NCT00142298|69687359|FG005|Overall Study|Lack of Efficacy|0|||
38003655|NCT00142298|69687360|FG006|Overall Study|Lack of Efficacy|0|||
38003656|NCT00142298|69687361|FG007|Overall Study|Lack of Efficacy|1|||
38003657|NCT00142298|69687362|FG008|Overall Study|Lack of Efficacy|0|||
38003658|NCT00142298|69687363|FG009|Overall Study|Lack of Efficacy|0|||
38003659|NCT00142298|69687354|FG000|Overall Study|Non-compliance|15|||
38003660|NCT00142298|69687355|FG001|Overall Study|Non-compliance|13|||
38003661|NCT00142298|69687356|FG002|Overall Study|Non-compliance|0|||
38003662|NCT00142298|69687357|FG003|Overall Study|Non-compliance|6|||
38003663|NCT00142298|69687358|FG004|Overall Study|Non-compliance|1|||
37830340|NCT01320202|69513581|FG001|Overall Study|blood transfusion|7|||
37830341|NCT01320202|69513580|FG000|Overall Study|moved/changed dialysis|5|||
37830342|NCT01320202|69513581|FG001|Overall Study|moved/changed dialysis|2|||
37830343|NCT01320202|69513580|FG000|Overall Study|sponsor request|2|||
37830344|NCT01320202|69513581|FG001|Overall Study|sponsor request|0|||
37830345|NCT01320202|69513580|FG000|Overall Study|ineligible|3|||
37830346|NCT01320202|69513581|FG001|Overall Study|ineligible|0|||
37830347|NCT01320202|69513580|FG000|Overall Study|regained renal function|1|||
37830348|NCT01320202|69513581|FG001|Overall Study|regained renal function|0|||
37830349|NCT01319383|69513590|FG000|Overall Study|No ex vivo or in vivo response|4|||
37830350|NCT01319383|69513591|FG001|Overall Study|No ex vivo or in vivo response|0|||
37830351|NCT01319383|69513590|FG000|Overall Study|Physician Decision|3|||
37830352|NCT01319383|69513591|FG001|Overall Study|Physician Decision|0|||
37830353|NCT01319383|69513590|FG000|Overall Study|Lack of Efficacy|5|||
37830354|NCT01319383|69513591|FG001|Overall Study|Lack of Efficacy|9|||
37830355|NCT01319383|69513590|FG000|Overall Study|No in vivo response to interval doses|0|||
37906217|NCT00625807|69591674|FG001|Overall Study|schedule conflict|8|||
37906218|NCT00629083|69591684|FG000|Overall Study|Adverse Event|0|||
37906219|NCT00629083|69591685|FG001|Overall Study|Adverse Event|2|||
37906220|NCT00629083|69591684|FG000|Overall Study|Lack of Efficacy|3|||
37906221|NCT00629083|69591685|FG001|Overall Study|Lack of Efficacy|1|||
37906222|NCT00629083|69591684|FG000|Overall Study|Withdrawal by Subject|10|||
37906223|NCT00629083|69591685|FG001|Overall Study|Withdrawal by Subject|2|||
38003664|NCT00142298|69687359|FG005|Overall Study|Non-compliance|0|||
38003665|NCT00142298|69687360|FG006|Overall Study|Non-compliance|0|||
38003666|NCT00142298|69687361|FG007|Overall Study|Non-compliance|3|||
38003667|NCT00142298|69687362|FG008|Overall Study|Non-compliance|3|||
38003668|NCT00142298|69687363|FG009|Overall Study|Non-compliance|0|||
38003669|NCT00142298|69687354|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
38003670|NCT00142298|69687355|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
37830356|NCT01319383|69513591|FG001|Overall Study|No in vivo response to interval doses|1|||
37830357|NCT01316614|69513608|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
38003671|NCT00142298|69687356|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
38003672|NCT00142298|69687357|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
38003673|NCT00142298|69687358|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
38003674|NCT00142298|69687359|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
38003675|NCT00142298|69687360|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
38003676|NCT00142298|69687361|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
38003677|NCT00142298|69687362|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
38003678|NCT00142298|69687363|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
38003679|NCT00142298|69687354|FG000|Overall Study|Pregnancy|4|||
38003680|NCT00142298|69687355|FG001|Overall Study|Pregnancy|4|||
38003681|NCT00142298|69687356|FG002|Overall Study|Pregnancy|2|||
38003682|NCT00142298|69687357|FG003|Overall Study|Pregnancy|3|||
38003683|NCT00142298|69687358|FG004|Overall Study|Pregnancy|0|||
38003684|NCT00142298|69687359|FG005|Overall Study|Pregnancy|0|||
38003685|NCT00142298|69687360|FG006|Overall Study|Pregnancy|0|||
38003686|NCT00142298|69687361|FG007|Overall Study|Pregnancy|0|||
38003687|NCT00142298|69687362|FG008|Overall Study|Pregnancy|1|||
38003688|NCT00142298|69687363|FG009|Overall Study|Pregnancy|0|||
38003689|NCT00142298|69687354|FG000|Overall Study|Virologic breakthrough|19|||
38003690|NCT00142298|69687355|FG001|Overall Study|Virologic breakthrough|23|||
38003691|NCT00142298|69687356|FG002|Overall Study|Virologic breakthrough|9|||
38003692|NCT00142298|69687357|FG003|Overall Study|Virologic breakthrough|7|||
38003693|NCT00142298|69687358|FG004|Overall Study|Virologic breakthrough|2|||
38003694|NCT00142298|69687359|FG005|Overall Study|Virologic breakthrough|3|||
38003695|NCT00142298|69687360|FG006|Overall Study|Virologic breakthrough|3|||
38003696|NCT00142298|69687361|FG007|Overall Study|Virologic breakthrough|0|||
38003697|NCT00142298|69687362|FG008|Overall Study|Virologic breakthrough|0|||
38003698|NCT00142298|69687363|FG009|Overall Study|Virologic breakthrough|0|||
38003699|NCT00142298|69687354|FG000|Overall Study|Other- not specified|0|||
38003700|NCT00142298|69687355|FG001|Overall Study|Other- not specified|3|||
38003701|NCT00142298|69687356|FG002|Overall Study|Other- not specified|0|||
38003702|NCT00142298|69687357|FG003|Overall Study|Other- not specified|1|||
38003703|NCT00142298|69687358|FG004|Overall Study|Other- not specified|0|||
38003704|NCT00142298|69687359|FG005|Overall Study|Other- not specified|0|||
38003705|NCT00142298|69687360|FG006|Overall Study|Other- not specified|0|||
38003706|NCT00142298|69687361|FG007|Overall Study|Other- not specified|0|||
37906224|NCT00629083|69591684|FG000|Overall Study|Lost to Follow-up|12|||
37906225|NCT00629083|69591685|FG001|Overall Study|Lost to Follow-up|8|||
38003707|NCT00142298|69687362|FG008|Overall Study|Other- not specified|0|||
38003708|NCT00142298|69687363|FG009|Overall Study|Other- not specified|0|||
38003709|NCT00142298|69687354|FG000|Overall Study|Lost to Follow-up|0|||
38003710|NCT00142298|69687355|FG001|Overall Study|Lost to Follow-up|0|||
38003711|NCT00142298|69687356|FG002|Overall Study|Lost to Follow-up|0|||
37830358|NCT01316614|69513608|FG000|Overall Study|Cytology slides not available for review|4|||
37830359|NCT01316614|69513608|FG000|Overall Study|Cystic lesion|5|||
37830360|NCT01316614|69513608|FG000|Overall Study|Inadequate number of passes|2|||
37830361|NCT01316614|69513608|FG000|Overall Study|Medically unstable|1|||
37830362|NCT01316575|69513615|FG000|Overall Study|Withdrawal by Subject|2|||
37906226|NCT00629083|69591684|FG000|Overall Study|Moved out of country/state|2|||
37906227|NCT00629083|69591685|FG001|Overall Study|Moved out of country/state|1|||
37906228|NCT00629083|69591684|FG000|Overall Study|Refused to return for 12 month visit|1|||
37906229|NCT00629083|69591685|FG001|Overall Study|Refused to return for 12 month visit|0|||
37906230|NCT00901628|69591695|FG000|Overall Study|disconnection of catheter|4|||
37906231|NCT00901628|69591696|FG001|Overall Study|disconnection of catheter|8|||
38003712|NCT00142298|69687357|FG003|Overall Study|Lost to Follow-up|0|||
38003713|NCT00142298|69687358|FG004|Overall Study|Lost to Follow-up|0|||
38003714|NCT00142298|69687359|FG005|Overall Study|Lost to Follow-up|0|||
38003715|NCT00142298|69687360|FG006|Overall Study|Lost to Follow-up|2|||
38003716|NCT00142298|69687361|FG007|Overall Study|Lost to Follow-up|0|||
38003717|NCT00142298|69687362|FG008|Overall Study|Lost to Follow-up|0|||
38003718|NCT00142298|69687363|FG009|Overall Study|Lost to Follow-up|0|||
38003719|NCT00142298|69687354|FG000|Overall Study|Treatment Failure|0|||
38003720|NCT00142298|69687355|FG001|Overall Study|Treatment Failure|0|||
38003721|NCT00142298|69687356|FG002|Overall Study|Treatment Failure|0|||
37830363|NCT01316575|69513616|FG001|Overall Study|Withdrawal by Subject|0|||
37830364|NCT01316575|69513615|FG000|Overall Study|Required alternate treatment|0|||
37830365|NCT01316575|69513616|FG001|Overall Study|Required alternate treatment|1|||
37906232|NCT00901628|69591695|FG000|Overall Study|disconnection of drain|0|||
37906233|NCT00901628|69591696|FG001|Overall Study|disconnection of drain|1|||
37906234|NCT00901628|69591695|FG000|Overall Study|peroneal nerve palsy|0|||
37906235|NCT00901628|69591696|FG001|Overall Study|peroneal nerve palsy|1|||
37906236|NCT00623545|69591702|FG000|Overall Study|Adverse Event|6|||
37906237|NCT00623545|69591702|FG000|Overall Study|Withdrawal by Subject|4|||
38003722|NCT00142298|69687357|FG003|Overall Study|Treatment Failure|0|||
37906238|NCT00628927|69591709|FG000|Overall Study|Problems performing blood draw|6|||
37906239|NCT00628927|69591710|FG001|Overall Study|Problems performing blood draw|0|||
37906240|NCT00628927|69591709|FG000|Overall Study|Lost to Follow-up|1|||
37906241|NCT00628927|69591710|FG001|Overall Study|Lost to Follow-up|0|||
37906242|NCT00628927|69591709|FG000|Overall Study|Equipment failure|1|||
37906243|NCT00628927|69591710|FG001|Overall Study|Equipment failure|0|||
37906244|NCT00623467|69591721|FG000|Overall Study|Lost to Follow-up|1|||
37906245|NCT00623467|69591721|FG000|Overall Study|Protocol Violation|4|||
37906246|NCT00623467|69591721|FG000|Overall Study|Withdrawal by Subject|2|||
37906247|NCT00838539|69591739|FG000|Overall Study|Disease Progression|2|||
37906248|NCT00838539|69591740|FG001|Overall Study|Disease Progression|4|||
38003723|NCT00142298|69687358|FG004|Overall Study|Treatment Failure|0|||
38003724|NCT00142298|69687359|FG005|Overall Study|Treatment Failure|2|||
38003725|NCT00142298|69687360|FG006|Overall Study|Treatment Failure|2|||
38003726|NCT00142298|69687361|FG007|Overall Study|Treatment Failure|0|||
38003727|NCT00142298|69687362|FG008|Overall Study|Treatment Failure|0|||
38003728|NCT00142298|69687363|FG009|Overall Study|Treatment Failure|0|||
38003729|NCT03709654|69687387|FG000|Overall Study|Lost to Follow-up|1|||
38003730|NCT03709654|69687388|FG001|Overall Study|Lost to Follow-up|1|||
38003731|NCT03709654|69687387|FG000|Overall Study|Withdrawal by Subject|1|||
38003732|NCT03709654|69687388|FG001|Overall Study|Withdrawal by Subject|1|||
38003733|NCT03709654|69687387|FG000|Overall Study|Adverse Event|1|||
38003734|NCT03709654|69687388|FG001|Overall Study|Adverse Event|0|||
38003735|NCT00412061|69687396|FG000|Double Blind Phase|Disease Progression|101|||
38003736|NCT00412061|69687397|FG001|Double Blind Phase|Disease Progression|154|||
37906249|NCT00838539|69591741|FG002|Overall Study|Disease Progression|3|||
37906250|NCT00838539|69591742|FG003|Overall Study|Disease Progression|2|||
38003737|NCT00412061|69687396|FG000|Double Blind Phase|Adverse Event|61|||
38003738|NCT00412061|69687397|FG001|Double Blind Phase|Adverse Event|16|||
38003739|NCT00412061|69687396|FG000|Double Blind Phase|Final Primary Analysis|26|||
38003740|NCT00412061|69687397|FG001|Double Blind Phase|Final Primary Analysis|14|||
38003741|NCT00412061|69687396|FG000|Double Blind Phase|Withdrawal by Subject|18|||
38003742|NCT00412061|69687397|FG001|Double Blind Phase|Withdrawal by Subject|20|||
38003743|NCT00412061|69687396|FG000|Double Blind Phase|Death|6|||
38003744|NCT00412061|69687397|FG001|Double Blind Phase|Death|3|||
38003745|NCT00412061|69687396|FG000|Double Blind Phase|Protocol Violation|3|||
38003746|NCT00412061|69687397|FG001|Double Blind Phase|Protocol Violation|4|||
38003747|NCT00412061|69687396|FG000|Double Blind Phase|New Cander Therapy|1|||
38003748|NCT00412061|69687397|FG001|Double Blind Phase|New Cander Therapy|1|||
38003749|NCT00412061|69687396|FG000|Double Blind Phase|Lost to Follow-up|0|||
38003750|NCT00412061|69687397|FG001|Double Blind Phase|Lost to Follow-up|1|||
38003751|NCT00412061|69687396|FG000|Open Label Phase|Disease Progression|0|||
38003752|NCT00412061|69687397|FG001|Open Label Phase|Disease Progression|86|||
38003753|NCT00412061|69687396|FG000|Open Label Phase|Adverse Event|0|||
38003754|NCT00412061|69687397|FG001|Open Label Phase|Adverse Event|46|||
37830366|NCT01315678|69513624|FG000|Overall Study|Withdrawal by Subject|7|||
37830367|NCT01315678|69513625|FG001|Overall Study|Withdrawal by Subject|3|||
37830368|NCT01315678|69513624|FG000|Overall Study|Adverse Event|3|||
37830369|NCT01315678|69513625|FG001|Overall Study|Adverse Event|1|||
37830370|NCT01315678|69513624|FG000|Overall Study|Lost to Follow-up|1|||
37830371|NCT01315678|69513625|FG001|Overall Study|Lost to Follow-up|0|||
37830372|NCT01315678|69513624|FG000|Overall Study|similar reason to those listed above|3|||
37830373|NCT01315678|69513625|FG001|Overall Study|similar reason to those listed above|2|||
37830374|NCT01315249|69513635|FG000|Overall Study|Adverse Event|22|||
37830375|NCT01315249|69513636|FG001|Overall Study|Adverse Event|26|||
37830376|NCT01315249|69513635|FG000|Overall Study|Withdrawal by Subject|11|||
37830377|NCT01315249|69513636|FG001|Overall Study|Withdrawal by Subject|10|||
38003755|NCT00412061|69687396|FG000|Open Label Phase|Withdrawal by Subject|0|||
38003756|NCT00412061|69687397|FG001|Open Label Phase|Withdrawal by Subject|15|||
38003757|NCT00412061|69687396|FG000|Open Label Phase|Administrative Problems|0|||
38003758|NCT00412061|69687397|FG001|Open Label Phase|Administrative Problems|13|||
38003759|NCT00412061|69687396|FG000|Open Label Phase|Death|0|||
38003760|NCT00412061|69687397|FG001|Open Label Phase|Death|7|||
38003761|NCT00412061|69687396|FG000|Open Label Phase|Lost to Follow-up|0|||
37830378|NCT01315249|69513635|FG000|Overall Study|Protocol Violation|8|||
37830379|NCT01315249|69513636|FG001|Overall Study|Protocol Violation|5|||
37830380|NCT01315249|69513635|FG000|Overall Study|Abnormal test results|1|||
37830381|NCT01315249|69513636|FG001|Overall Study|Abnormal test results|2|||
37830382|NCT01315249|69513635|FG000|Overall Study|Administrative problems|1|||
37830383|NCT01315249|69513636|FG001|Overall Study|Administrative problems|0|||
37830384|NCT01315249|69513635|FG000|Overall Study|inability to use device|1|||
37906251|NCT00838539|69591743|FG004|Overall Study|Disease Progression|4|||
37906252|NCT00838539|69591744|FG005|Overall Study|Disease Progression|2|||
37906253|NCT00838539|69591745|FG006|Overall Study|Disease Progression|3|||
37906254|NCT00838539|69591746|FG007|Overall Study|Disease Progression|4|||
37906255|NCT00838539|69591747|FG008|Overall Study|Disease Progression|4|||
38003762|NCT00412061|69687397|FG001|Open Label Phase|Lost to Follow-up|2|||
38003763|NCT00412061|69687396|FG000|Open Label Phase|New Cancer Therapy|0|||
38003764|NCT00412061|69687397|FG001|Open Label Phase|New Cancer Therapy|1|||
38003765|NCT00411671|69687415|FG000|Overall Study|Adverse Event|15|||
38003766|NCT00411671|69687415|FG000|Overall Study|Death|2|||
38003767|NCT00411671|69687415|FG000|Overall Study|Lost to Follow-up|3|||
38003768|NCT03835481|69687424|FG000|Double-blind Period|Other not stated below|0|||
38003769|NCT03835481|69687425|FG001|Double-blind Period|Other not stated below|0|||
38003770|NCT03835481|69687426|FG002|Double-blind Period|Other not stated below|0|||
38003771|NCT03835481|69687427|FG003|Double-blind Period|Other not stated below|1|||
38003772|NCT03835481|69687428|FG004|Double-blind Period|Other not stated below|1|||
38003773|NCT03835481|69687424|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
38003774|NCT03835481|69687425|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
38003775|NCT03835481|69687426|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
38003776|NCT03835481|69687427|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
38003777|NCT03835481|69687428|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
38003778|NCT03835481|69687424|FG000|Double-blind Period|Withdrawal by Subject|0|||
38003779|NCT03835481|69687425|FG001|Double-blind Period|Withdrawal by Subject|0|||
38003780|NCT03835481|69687426|FG002|Double-blind Period|Withdrawal by Subject|1|||
38003781|NCT03835481|69687427|FG003|Double-blind Period|Withdrawal by Subject|0|||
38003782|NCT03835481|69687428|FG004|Double-blind Period|Withdrawal by Subject|5|||
38003783|NCT03835481|69687424|FG000|Double-blind Period|Lost to Follow-up|0|||
38003784|NCT03835481|69687425|FG001|Double-blind Period|Lost to Follow-up|0|||
38003785|NCT03835481|69687426|FG002|Double-blind Period|Lost to Follow-up|0|||
38003786|NCT03835481|69687427|FG003|Double-blind Period|Lost to Follow-up|1|||
38003787|NCT03835481|69687428|FG004|Double-blind Period|Lost to Follow-up|0|||
38003788|NCT03835481|69687424|FG000|Double-blind Period|Protocol Violation|0|||
38003789|NCT03835481|69687425|FG001|Double-blind Period|Protocol Violation|2|||
38003790|NCT03835481|69687426|FG002|Double-blind Period|Protocol Violation|0|||
38003791|NCT03835481|69687427|FG003|Double-blind Period|Protocol Violation|1|||
38003792|NCT03835481|69687428|FG004|Double-blind Period|Protocol Violation|0|||
38003793|NCT03835481|69687424|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
38003794|NCT03835481|69687425|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
38003795|NCT03835481|69687426|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
38003796|NCT03835481|69687427|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
38003797|NCT03835481|69687428|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
38003798|NCT03835481|69687424|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
38003799|NCT03835481|69687425|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
38003800|NCT03835481|69687426|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
38003801|NCT03835481|69687427|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
38003802|NCT03835481|69687428|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
38003803|NCT03835481|69687424|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
38003804|NCT03835481|69687425|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
37906256|NCT00838539|69591748|FG009|Overall Study|Disease Progression|5|||
37906257|NCT00838539|69591749|FG010|Overall Study|Disease Progression|1|||
37906258|NCT00838539|69591750|FG011|Overall Study|Disease Progression|4|||
37906259|NCT00838539|69591739|FG000|Overall Study|Adverse Event|1|||
37906260|NCT00838539|69591740|FG001|Overall Study|Adverse Event|1|||
37906261|NCT00838539|69591741|FG002|Overall Study|Adverse Event|1|||
37906262|NCT00838539|69591742|FG003|Overall Study|Adverse Event|1|||
37906263|NCT00838539|69591743|FG004|Overall Study|Adverse Event|2|||
37906264|NCT00838539|69591744|FG005|Overall Study|Adverse Event|1|||
38003805|NCT03835481|69687426|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
38003806|NCT03835481|69687427|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
38003807|NCT03835481|69687428|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
38003808|NCT03835481|69687424|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
38003809|NCT03835481|69687425|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
38003810|NCT03835481|69687426|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
38003811|NCT03835481|69687427|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
37906265|NCT00838539|69591745|FG006|Overall Study|Adverse Event|0|||
38003812|NCT03835481|69687428|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
38003813|NCT03835481|69687424|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
38003814|NCT03835481|69687425|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
38003815|NCT03835481|69687426|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
38003816|NCT03835481|69687427|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
37906266|NCT00838539|69591746|FG007|Overall Study|Adverse Event|2|||
37906267|NCT00838539|69591747|FG008|Overall Study|Adverse Event|0|||
37906268|NCT00838539|69591748|FG009|Overall Study|Adverse Event|1|||
37906269|NCT00838539|69591749|FG010|Overall Study|Adverse Event|2|||
37906270|NCT00838539|69591750|FG011|Overall Study|Adverse Event|0|||
37906271|NCT00838539|69591739|FG000|Overall Study|Withdrawal by Subject|0|||
37906272|NCT00838539|69591740|FG001|Overall Study|Withdrawal by Subject|1|||
38003817|NCT03835481|69687428|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
38003818|NCT03835481|69687424|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
38003819|NCT03835481|69687425|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
38003820|NCT03835481|69687426|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
38003821|NCT03835481|69687427|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
38003822|NCT03835481|69687428|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
38003823|NCT03709576|69687475|FG000|Overall Study|progression prior to enrollment|1|||
38003824|NCT00122460|69687482|FG000|Overall Study|investigational study phase ongoing|7|||
38003825|NCT00122460|69687483|FG001|Overall Study|investigational study phase ongoing|1|||
38003826|NCT00137436|69687489|FG000|Overall Study|Adverse Event|13|||
38003827|NCT00137436|69687489|FG000|Overall Study|Death|2|||
38003828|NCT00137436|69687489|FG000|Overall Study|Lack of Efficacy|17|||
38003829|NCT00137436|69687489|FG000|Overall Study|Withdrawal by Subject|6|||
38003830|NCT00137436|69687489|FG000|Overall Study|Other|5|||
38003831|NCT03834623|69687495|FG000|Overall Study|Progression|0|||
38003832|NCT03834623|69687496|FG001|Overall Study|Progression|1|||
38003833|NCT00410813|69687504|FG000|Overall Study|Adverse Event|6|||
38003834|NCT00410813|69687505|FG001|Overall Study|Adverse Event|11|||
38003835|NCT00410813|69687504|FG000|Overall Study|Progression|32|||
38003836|NCT00410813|69687505|FG001|Overall Study|Progression|21|||
38003837|NCT00410813|69687504|FG000|Overall Study|Not protocol specified|3|||
38003838|NCT00410813|69687505|FG001|Overall Study|Not protocol specified|4|||
38003839|NCT00410813|69687504|FG000|Overall Study|Ineligible|2|||
38003840|NCT00410813|69687505|FG001|Overall Study|Ineligible|4|||
38003841|NCT00410813|69687504|FG000|Overall Study|Death|0|||
38003842|NCT00410813|69687505|FG001|Overall Study|Death|2|||
38003843|NCT00405821|69687536|FG000|Overall Study|Death|5|||
38003844|NCT00405821|69687537|FG001|Overall Study|Death|7|||
38003845|NCT00405821|69687536|FG000|Overall Study|Lost to Follow-up|7|||
38003846|NCT00405821|69687537|FG001|Overall Study|Lost to Follow-up|7|||
38003847|NCT00405821|69687536|FG000|Overall Study|Protocol Violation|1|||
38003848|NCT00405821|69687537|FG001|Overall Study|Protocol Violation|0|||
38003849|NCT00405821|69687536|FG000|Overall Study|initiated ART|9|||
38003850|NCT00405821|69687537|FG001|Overall Study|initiated ART|8|||
38003851|NCT01446016|69687543|FG000|Overall Study|Lost to Follow-up|3|||
38003852|NCT01446016|69687543|FG000|Overall Study|Withdrawal by Subject|1|||
38003853|NCT01446016|69687543|FG000|Overall Study|Toxicity|3|||
38003854|NCT00137046|69687549|FG000|Overall Study|Death|2|||
38003855|NCT00137046|69687550|FG001|Overall Study|Death|1|||
38003856|NCT00137046|69687549|FG000|Overall Study|Adverse Event|16|||
38003857|NCT00137046|69687550|FG001|Overall Study|Adverse Event|5|||
38003858|NCT00137046|69687549|FG000|Overall Study|Laboratory Abnormality|2|||
38003859|NCT00137046|69687550|FG001|Overall Study|Laboratory Abnormality|0|||
38003860|NCT00137046|69687549|FG000|Overall Study|Lack of Efficacy|13|||
38003861|NCT00137046|69687550|FG001|Overall Study|Lack of Efficacy|1|||
38003862|NCT00137046|69687549|FG000|Overall Study|Lost to Follow-up|8|||
38003863|NCT00137046|69687550|FG001|Overall Study|Lost to Follow-up|24|||
38003864|NCT00137046|69687549|FG000|Overall Study|Other|23|||
38003865|NCT00137046|69687550|FG001|Overall Study|Other|19|||
38003866|NCT00137046|69687549|FG000|Overall Study|Withdrawal by Subject|33|||
38003867|NCT00137046|69687550|FG001|Overall Study|Withdrawal by Subject|42|||
38003868|NCT00137046|69687549|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
38003869|NCT00137046|69687550|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
37906273|NCT00838539|69591741|FG002|Overall Study|Withdrawal by Subject|0|||
37906274|NCT00838539|69591742|FG003|Overall Study|Withdrawal by Subject|0|||
37906275|NCT00838539|69591743|FG004|Overall Study|Withdrawal by Subject|0|||
37906276|NCT00838539|69591744|FG005|Overall Study|Withdrawal by Subject|0|||
37906277|NCT00838539|69591745|FG006|Overall Study|Withdrawal by Subject|0|||
37906278|NCT00838539|69591746|FG007|Overall Study|Withdrawal by Subject|0|||
38003870|NCT00137046|69687549|FG000|Overall Study|Withdrew prior to study treatment|1|||
38003871|NCT00137046|69687550|FG001|Overall Study|Withdrew prior to study treatment|1|||
38003872|NCT00122382|69687562|FG000|Double-Blind Study|Adverse Event|9|||
38003873|NCT00122382|69687563|FG001|Double-Blind Study|Adverse Event|11|||
38003874|NCT00122382|69687564|FG002|Double-Blind Study|Adverse Event|0|||
38003875|NCT00122382|69687562|FG000|Double-Blind Study|Death|2|||
37906279|NCT00838539|69591747|FG008|Overall Study|Withdrawal by Subject|0|||
37906280|NCT00838539|69591748|FG009|Overall Study|Withdrawal by Subject|1|||
37906281|NCT00838539|69591749|FG010|Overall Study|Withdrawal by Subject|2|||
37906282|NCT00838539|69591750|FG011|Overall Study|Withdrawal by Subject|0|||
38003876|NCT00122382|69687563|FG001|Double-Blind Study|Death|2|||
38003877|NCT00122382|69687564|FG002|Double-Blind Study|Death|0|||
38003878|NCT00122382|69687562|FG000|Double-Blind Study|Lack of Efficacy|0|||
38003879|NCT00122382|69687563|FG001|Double-Blind Study|Lack of Efficacy|8|||
38003880|NCT00122382|69687564|FG002|Double-Blind Study|Lack of Efficacy|0|||
38003881|NCT00122382|69687562|FG000|Double-Blind Study|Lost to Follow-up|2|||
38003882|NCT00122382|69687563|FG001|Double-Blind Study|Lost to Follow-up|1|||
38003883|NCT00122382|69687564|FG002|Double-Blind Study|Lost to Follow-up|0|||
38003884|NCT00122382|69687562|FG000|Double-Blind Study|Pregnancy|2|||
37906283|NCT00838539|69591739|FG000|Overall Study|Death|0|||
37906284|NCT00838539|69591740|FG001|Overall Study|Death|0|||
37830385|NCT01315249|69513636|FG001|Overall Study|inability to use device|0|||
37830386|NCT01315249|69513635|FG000|Overall Study|Lack of Efficacy|0|||
37830387|NCT01315249|69513636|FG001|Overall Study|Lack of Efficacy|1|||
37830388|NCT01315249|69513635|FG000|Overall Study|Lost to Follow-up|0|||
37830389|NCT01315249|69513636|FG001|Overall Study|Lost to Follow-up|2|||
37906285|NCT00838539|69591741|FG002|Overall Study|Death|0|||
37906286|NCT00838539|69591742|FG003|Overall Study|Death|0|||
37906287|NCT00838539|69591743|FG004|Overall Study|Death|0|||
37906288|NCT00838539|69591744|FG005|Overall Study|Death|0|||
38003885|NCT00122382|69687563|FG001|Double-Blind Study|Pregnancy|0|||
38003886|NCT00122382|69687564|FG002|Double-Blind Study|Pregnancy|0|||
38003887|NCT00122382|69687562|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
38003888|NCT00122382|69687563|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
38003889|NCT00122382|69687564|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
38003890|NCT00122382|69687562|FG000|Double-Blind Study|Withdrawal of Consent|7|||
38003891|NCT00122382|69687563|FG001|Double-Blind Study|Withdrawal of Consent|3|||
38003892|NCT00122382|69687564|FG002|Double-Blind Study|Withdrawal of Consent|0|||
38003893|NCT00122382|69687562|FG000|Double-Blind Study|Protocol Violation|1|||
38003894|NCT00122382|69687563|FG001|Double-Blind Study|Protocol Violation|0|||
38003895|NCT00122382|69687564|FG002|Double-Blind Study|Protocol Violation|0|||
38003896|NCT00122382|69687562|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
38003897|NCT00122382|69687563|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
38003898|NCT00122382|69687564|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
38003899|NCT00122382|69687562|FG000|Double-Blind Study|Randomized but not treated|0|||
38003900|NCT00122382|69687563|FG001|Double-Blind Study|Randomized but not treated|2|||
38003901|NCT00122382|69687564|FG002|Double-Blind Study|Randomized but not treated|0|||
38003902|NCT00122382|69687562|FG000|Open-Label Study|Adverse Event|0|||
38003903|NCT00122382|69687563|FG001|Open-Label Study|Adverse Event|0|||
38003904|NCT00122382|69687564|FG002|Open-Label Study|Adverse Event|11|||
38003905|NCT00122382|69687562|FG000|Open-Label Study|Death|0|||
38003906|NCT00122382|69687563|FG001|Open-Label Study|Death|0|||
38003907|NCT00122382|69687564|FG002|Open-Label Study|Death|2|||
38003908|NCT00122382|69687562|FG000|Open-Label Study|Lack of Efficacy|0|||
38003909|NCT00122382|69687563|FG001|Open-Label Study|Lack of Efficacy|0|||
38003910|NCT00122382|69687564|FG002|Open-Label Study|Lack of Efficacy|3|||
38003911|NCT00122382|69687562|FG000|Open-Label Study|Lost to Follow-up|0|||
38003912|NCT00122382|69687563|FG001|Open-Label Study|Lost to Follow-up|0|||
38003913|NCT00122382|69687564|FG002|Open-Label Study|Lost to Follow-up|3|||
38003914|NCT00122382|69687562|FG000|Open-Label Study|Pregnancy|0|||
37830390|NCT01315249|69513635|FG000|Overall Study|Death|0|||
37830391|NCT01315249|69513636|FG001|Overall Study|Death|1|||
37906289|NCT00838539|69591745|FG006|Overall Study|Death|1|||
37906290|NCT00838539|69591746|FG007|Overall Study|Death|0|||
37906291|NCT00838539|69591747|FG008|Overall Study|Death|0|||
37906292|NCT00838539|69591748|FG009|Overall Study|Death|0|||
37906293|NCT00838539|69591749|FG010|Overall Study|Death|0|||
37906294|NCT00838539|69591750|FG011|Overall Study|Death|0|||
37906295|NCT00838539|69591739|FG000|Overall Study|Physician Decision|0|||
37906296|NCT00838539|69591740|FG001|Overall Study|Physician Decision|0|||
37906297|NCT00838539|69591741|FG002|Overall Study|Physician Decision|0|||
37906298|NCT00838539|69591742|FG003|Overall Study|Physician Decision|0|||
37906299|NCT00838539|69591743|FG004|Overall Study|Physician Decision|0|||
37906300|NCT00838539|69591744|FG005|Overall Study|Physician Decision|0|||
37906301|NCT00838539|69591745|FG006|Overall Study|Physician Decision|0|||
37906302|NCT00838539|69591746|FG007|Overall Study|Physician Decision|0|||
37906303|NCT00838539|69591747|FG008|Overall Study|Physician Decision|1|||
37906304|NCT00838539|69591748|FG009|Overall Study|Physician Decision|0|||
37830392|NCT01315132|69513642|FG000|Overall Study|not treated due to disease progression|1|||
37830393|NCT01313767|69513648|FG000|Overall Study|Adverse Event|1|||
37830394|NCT01313767|69513649|FG001|Overall Study|Adverse Event|0|||
37830395|NCT01313767|69513648|FG000|Overall Study|Lost to Follow-up|1|||
37906305|NCT00838539|69591749|FG010|Overall Study|Physician Decision|0|||
37906306|NCT00838539|69591750|FG011|Overall Study|Physician Decision|0|||
38003915|NCT00122382|69687563|FG001|Open-Label Study|Pregnancy|0|||
38003916|NCT00122382|69687564|FG002|Open-Label Study|Pregnancy|2|||
38003917|NCT00122382|69687562|FG000|Open-Label Study|Poor/Non-Compliance|0|||
38003918|NCT00122382|69687563|FG001|Open-Label Study|Poor/Non-Compliance|0|||
38003919|NCT00122382|69687564|FG002|Open-Label Study|Poor/Non-Compliance|1|||
38003920|NCT00122382|69687562|FG000|Open-Label Study|Withdrawal of Consent|0|||
37906307|NCT00838539|69591739|FG000|Overall Study|Clinical Progression|0|||
37906308|NCT00838539|69591740|FG001|Overall Study|Clinical Progression|0|||
37906309|NCT00838539|69591741|FG002|Overall Study|Clinical Progression|0|||
37906310|NCT00838539|69591742|FG003|Overall Study|Clinical Progression|0|||
38003921|NCT00122382|69687563|FG001|Open-Label Study|Withdrawal of Consent|0|||
38003922|NCT00122382|69687564|FG002|Open-Label Study|Withdrawal of Consent|4|||
37830396|NCT01313767|69513649|FG001|Overall Study|Lost to Follow-up|0|||
37830397|NCT01313767|69513648|FG000|Overall Study|Withdrawal by Subject|2|||
37830398|NCT01313767|69513649|FG001|Overall Study|Withdrawal by Subject|1|||
38003923|NCT01028716|69687582|FG000|Overall Study|Physician Decision|1|||
38003924|NCT00106704|69687589|FG000|Overall Study|Adverse Event|10|||
38003925|NCT00106704|69687590|FG001|Overall Study|Adverse Event|7|||
38003926|NCT00106704|69687589|FG000|Overall Study|Death|2|||
38003927|NCT00106704|69687590|FG001|Overall Study|Death|1|||
38003928|NCT00106704|69687589|FG000|Overall Study|Lack of Efficacy|67|||
38003929|NCT00106704|69687590|FG001|Overall Study|Lack of Efficacy|69|||
38003930|NCT00106704|69687589|FG000|Overall Study|Lost to Follow-up|7|||
38003931|NCT00106704|69687590|FG001|Overall Study|Lost to Follow-up|3|||
38003932|NCT00106704|69687589|FG000|Overall Study|Pregnancy|1|||
38003933|NCT00106704|69687590|FG001|Overall Study|Pregnancy|0|||
38003934|NCT00106704|69687589|FG000|Overall Study|Protocol Violation|4|||
38003935|NCT00106704|69687590|FG001|Overall Study|Protocol Violation|7|||
38003936|NCT00106704|69687589|FG000|Overall Study|Withdrawal by Subject|14|||
38003937|NCT00106704|69687590|FG001|Overall Study|Withdrawal by Subject|21|||
38003938|NCT00106704|69687589|FG000|Overall Study|Patient moved|1|||
38003939|NCT00106704|69687590|FG001|Overall Study|Patient moved|0|||
38003940|NCT00106704|69687589|FG000|Overall Study|Site terminated|0|||
38003941|NCT00106704|69687590|FG001|Overall Study|Site terminated|1|||
38003942|NCT00106704|69687589|FG000|Overall Study|Planned major surgery|1|||
38003943|NCT00106704|69687590|FG001|Overall Study|Planned major surgery|0|||
38003944|NCT00106704|69687589|FG000|Overall Study|Patient Received Glycemic Medication|22|||
38003945|NCT00106704|69687590|FG001|Overall Study|Patient Received Glycemic Medication|41|||
38003946|NCT00106704|69687589|FG000|Overall Study|Unable to re-enter US|1|||
38003947|NCT00106704|69687590|FG001|Overall Study|Unable to re-enter US|0|||
38003948|NCT00106704|69687589|FG000|Overall Study|Laboratory test|1|||
38003949|NCT00106704|69687590|FG001|Overall Study|Laboratory test|1|||
38003950|NCT00105066|69687598|FG000|Overall Study|Adverse Event|2|||
38003951|NCT00105066|69687599|FG001|Overall Study|Adverse Event|5|||
38003952|NCT00104520|69687607|FG000|Overall Study|Unrelated adverse event|34|||
38003953|NCT00104520|69687608|FG001|Overall Study|Unrelated adverse event|47|||
38003954|NCT00104520|69687607|FG000|Overall Study|Study drug intolerance|0|||
38003955|NCT00104520|69687608|FG001|Overall Study|Study drug intolerance|1|||
38003956|NCT00104520|69687607|FG000|Overall Study|Related adverse event|13|||
38003957|NCT00104520|69687608|FG001|Overall Study|Related adverse event|15|||
38003958|NCT00104520|69687607|FG000|Overall Study|Lost to Follow-up|1|||
38003959|NCT00104520|69687608|FG001|Overall Study|Lost to Follow-up|0|||
38003960|NCT00104520|69687607|FG000|Overall Study|Noncompliance|0|||
38003961|NCT00104520|69687608|FG001|Overall Study|Noncompliance|2|||
38003962|NCT00104520|69687607|FG000|Overall Study|Personal/administrative|1|||
38003963|NCT00104520|69687608|FG001|Overall Study|Personal/administrative|1|||
38003964|NCT00104520|69687607|FG000|Overall Study|Other|1|||
38003965|NCT00104520|69687608|FG001|Overall Study|Other|5|||
38003966|NCT00135330|69687617|FG000|Overall Study|Adverse Event|2|||
38003967|NCT00135330|69687618|FG001|Overall Study|Adverse Event|5|||
38003968|NCT00135330|69687619|FG002|Overall Study|Adverse Event|1|||
38003969|NCT00135330|69687617|FG000|Overall Study|Lost to Follow-up|0|||
38003970|NCT00135330|69687618|FG001|Overall Study|Lost to Follow-up|2|||
38003971|NCT00135330|69687619|FG002|Overall Study|Lost to Follow-up|3|||
38003972|NCT00135330|69687617|FG000|Overall Study|Physician Decision|1|||
38003973|NCT00135330|69687618|FG001|Overall Study|Physician Decision|1|||
38003974|NCT00135330|69687619|FG002|Overall Study|Physician Decision|0|||
38003975|NCT00135330|69687617|FG000|Overall Study|Protocol Violation|4|||
38003976|NCT00135330|69687618|FG001|Overall Study|Protocol Violation|3|||
38003977|NCT00135330|69687619|FG002|Overall Study|Protocol Violation|3|||
38003978|NCT00135330|69687617|FG000|Overall Study|Patient Decision|5|||
38003979|NCT00135330|69687618|FG001|Overall Study|Patient Decision|1|||
38003980|NCT00135330|69687619|FG002|Overall Study|Patient Decision|4|||
37830399|NCT01313767|69513648|FG000|Overall Study|Protocol Violation|3|||
37830400|NCT01313767|69513649|FG001|Overall Study|Protocol Violation|1|||
38003981|NCT00135330|69687617|FG000|Overall Study|Sponsor Decision|0|||
38003982|NCT00135330|69687618|FG001|Overall Study|Sponsor Decision|1|||
38003983|NCT00135330|69687619|FG002|Overall Study|Sponsor Decision|0|||
38003984|NCT00134784|69687631|FG000|Overall Study|Withdrawal by Subject|2|||
38003985|NCT00134784|69687632|FG001|Overall Study|Withdrawal by Subject|2|||
38003986|NCT00134784|69687633|FG002|Overall Study|Withdrawal by Subject|2|||
38003987|NCT00134784|69687634|FG003|Overall Study|Withdrawal by Subject|1|||
38003988|NCT00134082|69687641|FG000|Overall Study|Adverse Event|2|||
37830401|NCT01313728|69513655|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
37830402|NCT01313650|69513664|FG000|Overall Study|Adverse Event|9|||
38003989|NCT00134082|69687641|FG000|Overall Study|Death|1|||
38003990|NCT03703336|69687647|FG000|Overall Study|Parent withdrew consent|29|||
38003991|NCT03703336|69687648|FG001|Overall Study|Parent withdrew consent|8|||
38003992|NCT03703336|69687647|FG000|Overall Study|Migration|3|||
38003993|NCT03703336|69687648|FG001|Overall Study|Migration|3|||
38003994|NCT03703336|69687647|FG000|Overall Study|Protocol Violation|3|||
38003995|NCT03703336|69687648|FG001|Overall Study|Protocol Violation|1|||
38003996|NCT03703336|69687647|FG000|Overall Study|Physician Decision|2|||
38003997|NCT03703336|69687648|FG001|Overall Study|Physician Decision|0|||
38003998|NCT03703336|69687647|FG000|Overall Study|Adverse Event|0|||
38003999|NCT03703336|69687648|FG001|Overall Study|Adverse Event|2|||
38004000|NCT03703336|69687647|FG000|Overall Study|Lost to Follow-up|1|||
38004001|NCT03703336|69687648|FG001|Overall Study|Lost to Follow-up|0|||
38004002|NCT03702166|69687654|FG000|Overall Study|Lost to Follow-up|1|||
38004003|NCT03702166|69687654|FG000|Overall Study|Withdrawal by Subject|1|||
38004004|NCT00132678|69687661|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
38004005|NCT00132678|69687662|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
38004006|NCT00132678|69687663|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
38004007|NCT00132678|69687661|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
38004008|NCT00132678|69687662|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
38004009|NCT00132678|69687663|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
38004010|NCT00132678|69687661|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
38004011|NCT00132678|69687662|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
38004012|NCT00132678|69687663|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
38004013|NCT00132678|69687661|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
38004014|NCT00132678|69687662|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
38004015|NCT00132678|69687663|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
38004016|NCT00132678|69687661|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
38004017|NCT00132678|69687662|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
38004018|NCT00132678|69687663|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
38004019|NCT00132678|69687661|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
38004020|NCT00132678|69687662|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
38004021|NCT00132678|69687663|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
38004022|NCT00132678|69687661|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
38004023|NCT00132678|69687662|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
38004024|NCT00132678|69687663|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
38004025|NCT00132678|69687661|FG000|Period III (Open-Label Stabilization)|Death|2|||
38004026|NCT00132678|69687662|FG001|Period III (Open-Label Stabilization)|Death|0|||
38004027|NCT00132678|69687663|FG002|Period III (Open-Label Stabilization)|Death|0|||
38004028|NCT00132678|69687661|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
38004029|NCT00132678|69687662|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
38004030|NCT00132678|69687663|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
38004031|NCT00132678|69687661|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
38004032|NCT00132678|69687662|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
38004033|NCT00132678|69687663|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
38004034|NCT00132678|69687661|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
38004035|NCT00132678|69687662|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
38004036|NCT00132678|69687663|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
38004037|NCT00132678|69687661|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
38004038|NCT00132678|69687662|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
37830403|NCT01313650|69513665|FG001|Overall Study|Adverse Event|34|||
37830404|NCT01313650|69513666|FG002|Overall Study|Adverse Event|24|||
37830405|NCT01313650|69513667|FG003|Overall Study|Adverse Event|23|||
37830406|NCT01313650|69513664|FG000|Overall Study|Lack of Efficacy|37|||
37830407|NCT01313650|69513665|FG001|Overall Study|Lack of Efficacy|20|||
37830408|NCT01313650|69513666|FG002|Overall Study|Lack of Efficacy|32|||
37830409|NCT01313650|69513667|FG003|Overall Study|Lack of Efficacy|20|||
37830410|NCT01313650|69513664|FG000|Overall Study|Lost to Follow-up|1|||
37830411|NCT01313650|69513665|FG001|Overall Study|Lost to Follow-up|0|||
37830412|NCT01313650|69513666|FG002|Overall Study|Lost to Follow-up|3|||
37830413|NCT01313650|69513667|FG003|Overall Study|Lost to Follow-up|2|||
37830414|NCT01313650|69513664|FG000|Overall Study|Withdrawal by Subject|16|||
37830415|NCT01313650|69513665|FG001|Overall Study|Withdrawal by Subject|20|||
37830416|NCT01313650|69513666|FG002|Overall Study|Withdrawal by Subject|15|||
37830417|NCT01313650|69513667|FG003|Overall Study|Withdrawal by Subject|15|||
37830418|NCT01313650|69513664|FG000|Overall Study|Protocol Violation|4|||
37830419|NCT01313650|69513665|FG001|Overall Study|Protocol Violation|7|||
37830420|NCT01313650|69513666|FG002|Overall Study|Protocol Violation|5|||
37830421|NCT01313650|69513667|FG003|Overall Study|Protocol Violation|6|||
37830422|NCT01313650|69513664|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
37830423|NCT01313650|69513665|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
37830424|NCT01313650|69513666|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
38004039|NCT00132678|69687663|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
38004040|NCT00132678|69687661|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
38004041|NCT00132678|69687662|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
38004042|NCT00132678|69687663|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
38004043|NCT00132678|69687661|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
38004044|NCT00132678|69687662|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
38004045|NCT00132678|69687663|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
38004046|NCT00132678|69687661|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
37830425|NCT01313650|69513667|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
37830426|NCT01313299|69513680|FG000|Overall Study|Adverse Event|3|||
37906311|NCT00838539|69591743|FG004|Overall Study|Clinical Progression|0|||
37906312|NCT00838539|69591744|FG005|Overall Study|Clinical Progression|0|||
37906313|NCT00838539|69591745|FG006|Overall Study|Clinical Progression|1|||
37906314|NCT00838539|69591746|FG007|Overall Study|Clinical Progression|0|||
37906315|NCT00838539|69591747|FG008|Overall Study|Clinical Progression|0|||
37906316|NCT00838539|69591748|FG009|Overall Study|Clinical Progression|0|||
37906317|NCT00838539|69591749|FG010|Overall Study|Clinical Progression|0|||
37906318|NCT00838539|69591750|FG011|Overall Study|Clinical Progression|0|||
37906319|NCT00838539|69591739|FG000|Overall Study|Symptomatic Deterioration|0|||
37906320|NCT00838539|69591740|FG001|Overall Study|Symptomatic Deterioration|0|||
37830427|NCT01313299|69513681|FG001|Overall Study|Adverse Event|1|||
37830428|NCT01313299|69513682|FG002|Overall Study|Adverse Event|1|||
37830429|NCT01313299|69513680|FG000|Overall Study|Lost to Follow-up|1|||
37830430|NCT01313299|69513681|FG001|Overall Study|Lost to Follow-up|0|||
37830431|NCT01313299|69513682|FG002|Overall Study|Lost to Follow-up|0|||
37830432|NCT01313299|69513680|FG000|Overall Study|Protocol Violation|2|||
37830433|NCT01313299|69513681|FG001|Overall Study|Protocol Violation|0|||
37830434|NCT01313299|69513682|FG002|Overall Study|Protocol Violation|0|||
37830435|NCT01313299|69513680|FG000|Overall Study|Withdrawal by Subject|1|||
37830436|NCT01313299|69513681|FG001|Overall Study|Withdrawal by Subject|0|||
37906321|NCT00838539|69591741|FG002|Overall Study|Symptomatic Deterioration|1|||
37906322|NCT00838539|69591742|FG003|Overall Study|Symptomatic Deterioration|1|||
37906323|NCT00838539|69591743|FG004|Overall Study|Symptomatic Deterioration|0|||
37906324|NCT00838539|69591744|FG005|Overall Study|Symptomatic Deterioration|1|||
37906325|NCT00838539|69591745|FG006|Overall Study|Symptomatic Deterioration|0|||
37906326|NCT00838539|69591746|FG007|Overall Study|Symptomatic Deterioration|0|||
37906327|NCT00838539|69591747|FG008|Overall Study|Symptomatic Deterioration|0|||
37906328|NCT00838539|69591748|FG009|Overall Study|Symptomatic Deterioration|1|||
37906329|NCT00838539|69591749|FG010|Overall Study|Symptomatic Deterioration|0|||
37906330|NCT00838539|69591750|FG011|Overall Study|Symptomatic Deterioration|0|||
37906331|NCT00837759|69591790|FG000|Overall Study|Protocol Violation|3|||
37906332|NCT00837759|69591790|FG000|Overall Study|Lost to Follow-up|1|||
37906333|NCT00891774|69591794|FG000|Overall Study|Lost to Follow-up|5|||
37906334|NCT00891774|69591794|FG000|Overall Study|Illness (Self/Mother)|3|||
37906335|NCT00891774|69591794|FG000|Overall Study|Withdrawal by Subject|2|||
37906336|NCT00891774|69591794|FG000|Overall Study|Protocol Violation|4|||
37906337|NCT05421754|69591798|FG000|Overall Study|Technical issue with sensor|1|||
37906338|NCT04644276|69591811|FG000|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
37906339|NCT04644276|69591812|FG001|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
37906340|NCT04644276|69591813|FG002|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|1|||
37906341|NCT03845296|69591842|FG000|Overall Study|On Treatment|2|||
37906342|NCT03845296|69591843|FG001|Overall Study|On Treatment|1|||
37906343|NCT03845296|69591842|FG000|Overall Study|Adverse Event|4|||
37906344|NCT03845296|69591843|FG001|Overall Study|Adverse Event|11|||
37906345|NCT03845296|69591842|FG000|Overall Study|Refusal unrelated to adverse event|0|||
37906346|NCT03845296|69591843|FG001|Overall Study|Refusal unrelated to adverse event|1|||
37906347|NCT03845296|69591842|FG000|Overall Study|Progression/relapse|14|||
37906348|NCT03845296|69591843|FG001|Overall Study|Progression/relapse|18|||
37906349|NCT03845296|69591842|FG000|Overall Study|Death|4|||
37906350|NCT03845296|69591843|FG001|Overall Study|Death|0|||
38004047|NCT00132678|69687662|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
38004048|NCT00132678|69687663|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
37830437|NCT01313299|69513682|FG002|Overall Study|Withdrawal by Subject|2|||
38004049|NCT00132678|69687661|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
37830438|NCT01313299|69513680|FG000|Overall Study|Family reason and moved out of state|0|||
37830439|NCT01313299|69513681|FG001|Overall Study|Family reason and moved out of state|2|||
37830440|NCT01313299|69513682|FG002|Overall Study|Family reason and moved out of state|0|||
37906351|NCT03845296|69591842|FG000|Overall Study|Other - not protocol specified|1|||
37906352|NCT03845296|69591843|FG001|Overall Study|Other - not protocol specified|3|||
37906353|NCT01596621|69591888|FG000|Overall Study|Death|4|||
37906354|NCT01596621|69591888|FG000|Overall Study|Withdrawal by Subject|9|||
37906355|NCT01596621|69591888|FG000|Overall Study|Disease Progression|49|||
37906356|NCT01596621|69591888|FG000|Overall Study|Lost to Follow-up|3|||
37906357|NCT01596621|69591888|FG000|Overall Study|Other than specified|13|||
37906358|NCT01337245|69591892|FG000|Overall Study|Lost to Follow-up|1|||
37906359|NCT00566098|69591902|FG000|Collection of MILs|Withdrawal by Subject|1|||
37906360|NCT00566098|69591902|FG000|Collection of MILs|Relapsed|1|||
37906361|NCT00566098|69591902|FG000|Generation of MILs Product|Relapsed|1|||
37906362|NCT00566098|69591902|FG000|Administration of ASCT+MILs|Death|10|||
37906363|NCT00566098|69591902|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
37906364|NCT00248287|69591909|FG000|Overall Study|Adverse Event|11|||
37906365|NCT00248287|69591910|FG001|Overall Study|Adverse Event|10|||
37906366|NCT00248287|69591909|FG000|Overall Study|Death|1|||
37906367|NCT00248287|69591910|FG001|Overall Study|Death|0|||
37906368|NCT00248287|69591909|FG000|Overall Study|Lost to Follow-up|0|||
38004050|NCT00132678|69687662|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
38004051|NCT00132678|69687663|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
38004052|NCT00132678|69687661|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
38004053|NCT00132678|69687662|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
38004054|NCT00132678|69687663|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
38004055|NCT00132678|69687661|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
38004056|NCT00132678|69687662|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
38004057|NCT00132678|69687663|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
38004058|NCT00132678|69687661|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
38004059|NCT00132678|69687662|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
38004060|NCT00132678|69687663|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
38004061|NCT00132678|69687661|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
38004062|NCT00132678|69687662|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
38004063|NCT00132678|69687663|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
37830441|NCT01313299|69513680|FG000|Overall Study|Lack of subject compliance|0|||
37830442|NCT01313299|69513681|FG001|Overall Study|Lack of subject compliance|0|||
37830443|NCT01313299|69513682|FG002|Overall Study|Lack of subject compliance|1|||
37830444|NCT01313221|69513693|FG000|Overall Study|Protocol Violation|0|||
37830445|NCT01313221|69513694|FG001|Overall Study|Protocol Violation|1|||
37830446|NCT01313221|69513695|FG002|Overall Study|Protocol Violation|1|||
37830447|NCT01313221|69513693|FG000|Overall Study|Non-compliance|3|||
37830448|NCT01313221|69513694|FG001|Overall Study|Non-compliance|0|||
37830449|NCT01313221|69513695|FG002|Overall Study|Non-compliance|2|||
37830450|NCT01313221|69513693|FG000|Overall Study|Withdrawal by Subject|2|||
37830451|NCT01313221|69513694|FG001|Overall Study|Withdrawal by Subject|3|||
37830452|NCT01313221|69513695|FG002|Overall Study|Withdrawal by Subject|5|||
37830453|NCT01313221|69513693|FG000|Overall Study|Requirement for alternative therapy|0|||
37906369|NCT00248287|69591910|FG001|Overall Study|Lost to Follow-up|1|||
37906370|NCT00248287|69591909|FG000|Overall Study|Investigator Request|4|||
37906371|NCT00248287|69591910|FG001|Overall Study|Investigator Request|3|||
37906372|NCT00248287|69591909|FG000|Overall Study|Patient Request|5|||
37906373|NCT00248287|69591910|FG001|Overall Study|Patient Request|3|||
37906374|NCT00248287|69591909|FG000|Overall Study|Other|3|||
37906375|NCT00248287|69591910|FG001|Overall Study|Other|2|||
37906376|NCT00837213|69591918|FG000|Overall Study|Lost to Follow-up|3|||
37906377|NCT00837213|69591919|FG001|Overall Study|Lost to Follow-up|2|||
37906378|NCT00837213|69591918|FG000|Overall Study|Withdrawal by Subject|2|||
37906379|NCT00837213|69591919|FG001|Overall Study|Withdrawal by Subject|2|||
37906380|NCT00837213|69591918|FG000|Overall Study|not stated|1|||
37906381|NCT00837213|69591919|FG001|Overall Study|not stated|1|||
37906382|NCT00902486|69591929|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
37906383|NCT00902486|69591930|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
37906384|NCT00902486|69591931|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
37906385|NCT00902486|69591932|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
37906386|NCT00902486|69591933|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
37906387|NCT00902486|69591934|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
37906388|NCT00902486|69591929|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
37906389|NCT00902486|69591930|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
37906390|NCT00902486|69591931|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
38004064|NCT00132678|69687661|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
37906391|NCT00902486|69591932|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
37906392|NCT00902486|69591933|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
37906393|NCT00902486|69591934|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
37906394|NCT00902486|69591929|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
37906395|NCT00902486|69591930|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
37906396|NCT00902486|69591931|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
37906397|NCT00902486|69591932|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
37906398|NCT00902486|69591933|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
37830454|NCT01313221|69513694|FG001|Overall Study|Requirement for alternative therapy|1|||
38004065|NCT00132678|69687662|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
38004066|NCT00132678|69687663|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
38004067|NCT00132678|69687661|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
38004068|NCT00132678|69687662|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
38004069|NCT00132678|69687663|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
38004070|NCT00132678|69687661|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
38004071|NCT00132678|69687662|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
38004072|NCT00132678|69687663|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
38004073|NCT00101868|69687673|FG000|Overall Study|Death|10|||
38004074|NCT00101868|69687674|FG001|Overall Study|Death|10|||
38004075|NCT00101868|69687673|FG000|Overall Study|Withdrawal by Subject|8|||
38004076|NCT00101868|69687674|FG001|Overall Study|Withdrawal by Subject|9|||
38004077|NCT00101868|69687673|FG000|Overall Study|Protocol Violation|3|||
38004078|NCT00101868|69687674|FG001|Overall Study|Protocol Violation|0|||
38004079|NCT00101868|69687673|FG000|Overall Study|Lost to Follow-up|8|||
38004080|NCT00101868|69687674|FG001|Overall Study|Lost to Follow-up|13|||
38004081|NCT00101400|69687682|FG000|Survival Follow-Up|Alive|7|||
38004082|NCT03821064|69687686|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
38004083|NCT00141518|69687693|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
38004084|NCT00141518|69687694|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
38004085|NCT00141518|69687695|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
38004086|NCT00141518|69687693|FG000|Overall Study|Adverse Event|7|||
38004087|NCT00141518|69687694|FG001|Overall Study|Adverse Event|5|||
38004088|NCT00141518|69687695|FG002|Overall Study|Adverse Event|2|||
38004089|NCT00141518|69687693|FG000|Overall Study|Withdrawal by Subject|2|||
38004090|NCT00141518|69687694|FG001|Overall Study|Withdrawal by Subject|0|||
38004091|NCT00141518|69687695|FG002|Overall Study|Withdrawal by Subject|2|||
38004092|NCT00141518|69687693|FG000|Overall Study|Protocol Violation|1|||
38004093|NCT00141518|69687694|FG001|Overall Study|Protocol Violation|1|||
38004094|NCT00141518|69687695|FG002|Overall Study|Protocol Violation|2|||
38004095|NCT00141518|69687693|FG000|Overall Study|Lack of Efficacy|5|||
38004096|NCT00141518|69687694|FG001|Overall Study|Lack of Efficacy|0|||
38004097|NCT00141518|69687695|FG002|Overall Study|Lack of Efficacy|0|||
38004098|NCT00253448|69687705|FG000|Overall Study|Withdrawal by Subject|1|||
38004099|NCT00098748|69687712|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
38004100|NCT00098748|69687713|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
38004101|NCT00098748|69687714|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
38004102|NCT00098748|69687712|FG000|Received Study Treatment|Death|2|||
38004103|NCT00098748|69687713|FG001|Received Study Treatment|Death|1|||
38004104|NCT00098748|69687714|FG002|Received Study Treatment|Death|2|||
38004105|NCT00098748|69687712|FG000|Received Study Treatment|Adverse Event|1|||
38004106|NCT00098748|69687713|FG001|Received Study Treatment|Adverse Event|2|||
37830455|NCT01313221|69513695|FG002|Overall Study|Requirement for alternative therapy|1|||
37830456|NCT01313221|69513693|FG000|Overall Study|Lost to Follow-up|6|||
37830457|NCT01313221|69513694|FG001|Overall Study|Lost to Follow-up|3|||
37830458|NCT01313221|69513695|FG002|Overall Study|Lost to Follow-up|1|||
37830459|NCT01313221|69513693|FG000|Overall Study|Other|1|||
37830460|NCT01313221|69513694|FG001|Overall Study|Other|0|||
37830461|NCT01313221|69513695|FG002|Overall Study|Other|0|||
37830462|NCT01313221|69513693|FG000|Overall Study|Adverse Event|0|||
37830463|NCT01313221|69513694|FG001|Overall Study|Adverse Event|0|||
37830464|NCT01313221|69513695|FG002|Overall Study|Adverse Event|7|||
37830465|NCT01313221|69513693|FG000|Overall Study|Disease progression|0|||
37830466|NCT01313221|69513694|FG001|Overall Study|Disease progression|0|||
37830467|NCT01313221|69513695|FG002|Overall Study|Disease progression|2|||
37830468|NCT01313221|69513693|FG000|Overall Study|Physician Decision|0|||
37830469|NCT01313221|69513694|FG001|Overall Study|Physician Decision|0|||
37830470|NCT01313221|69513695|FG002|Overall Study|Physician Decision|2|||
37830471|NCT01313221|69513693|FG000|Overall Study|Pregnancy|0|||
37830472|NCT01313221|69513694|FG001|Overall Study|Pregnancy|0|||
37830473|NCT01313221|69513695|FG002|Overall Study|Pregnancy|2|||
37830474|NCT01313182|69513705|FG000|Overall Study|Protocol Violation|66|||
38004107|NCT00098748|69687714|FG002|Received Study Treatment|Adverse Event|5|||
38004108|NCT00098748|69687712|FG000|Received Study Treatment|Lack of Efficacy|40|||
38004109|NCT00098748|69687713|FG001|Received Study Treatment|Lack of Efficacy|27|||
38004110|NCT00098748|69687714|FG002|Received Study Treatment|Lack of Efficacy|27|||
38004111|NCT00098748|69687712|FG000|Received Study Treatment|Other|2|||
38004112|NCT00098748|69687713|FG001|Received Study Treatment|Other|2|||
38004113|NCT00098748|69687714|FG002|Received Study Treatment|Other|6|||
38004114|NCT00098748|69687712|FG000|Received Study Treatment|Subject defaulted|3|||
38004115|NCT00098748|69687713|FG001|Received Study Treatment|Subject defaulted|4|||
38004116|NCT00098748|69687714|FG002|Received Study Treatment|Subject defaulted|4|||
38004117|NCT00098748|69687712|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
38004118|NCT00098748|69687713|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
38004119|NCT00098748|69687714|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
37830475|NCT01313182|69513706|FG001|Overall Study|Protocol Violation|92|||
38004120|NCT00098748|69687712|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
38004121|NCT00098748|69687713|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
38004122|NCT00098748|69687714|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
38004123|NCT00098748|69687712|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
38004124|NCT00098748|69687713|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
38004125|NCT00098748|69687714|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
38004126|NCT00098748|69687712|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
38004127|NCT00098748|69687713|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
38004128|NCT00098748|69687714|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
38004129|NCT00098748|69687712|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
38004130|NCT00098748|69687713|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
38004131|NCT00098748|69687714|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
38004132|NCT00130520|69687722|FG000|Overall Study|Adverse Event|11|||
38004133|NCT00130520|69687722|FG000|Overall Study|Death|1|||
38004134|NCT00130520|69687722|FG000|Overall Study|Physician Decision|1|||
38004135|NCT00130520|69687722|FG000|Overall Study|Withdrawal by Subject|1|||
38004136|NCT00130520|69687722|FG000|Overall Study|Disease Progression|23|||
38004137|NCT00130520|69687722|FG000|Overall Study|Protocol non-compliance|1|||
38004138|NCT00130520|69687722|FG000|Overall Study|Did not meet re-treatment criteria|1|||
37906399|NCT00902486|69591934|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
37906400|NCT00902486|69591929|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
37906401|NCT00902486|69591930|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
37906402|NCT00902486|69591931|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
37906403|NCT00902486|69591932|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
37906404|NCT00902486|69591933|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
37906405|NCT00902486|69591934|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
37830476|NCT01312909|69513715|FG000|Overall Study|Randomized but not treated|1|||
37830477|NCT01312909|69513716|FG001|Overall Study|Randomized but not treated|3|||
37830478|NCT01312909|69513717|FG002|Overall Study|Randomized but not treated|1|||
37830479|NCT01312909|69513715|FG000|Overall Study|Adverse Event|1|||
37830480|NCT01312909|69513716|FG001|Overall Study|Adverse Event|0|||
37830481|NCT01312909|69513717|FG002|Overall Study|Adverse Event|3|||
37830482|NCT01312909|69513715|FG000|Overall Study|Protocol Violation|2|||
37830483|NCT01312909|69513716|FG001|Overall Study|Protocol Violation|0|||
37830484|NCT01312909|69513717|FG002|Overall Study|Protocol Violation|2|||
37830485|NCT01312909|69513715|FG000|Overall Study|Other|9|||
37830486|NCT01312909|69513716|FG001|Overall Study|Other|6|||
37830487|NCT01312909|69513717|FG002|Overall Study|Other|11|||
37830488|NCT01312909|69513715|FG000|Overall Study|Withdrawal by Subject|8|||
37830489|NCT01312909|69513716|FG001|Overall Study|Withdrawal by Subject|10|||
37830490|NCT01312909|69513717|FG002|Overall Study|Withdrawal by Subject|7|||
37830491|NCT01312909|69513715|FG000|Overall Study|Lost to Follow-up|21|||
37830492|NCT01312909|69513716|FG001|Overall Study|Lost to Follow-up|17|||
37830493|NCT01312909|69513717|FG002|Overall Study|Lost to Follow-up|20|||
37830494|NCT01312909|69513715|FG000|Overall Study|Insufficient clinical response|0|||
37830495|NCT01312909|69513716|FG001|Overall Study|Insufficient clinical response|0|||
37830496|NCT01312909|69513717|FG002|Overall Study|Insufficient clinical response|1|||
37830497|NCT01312909|69513715|FG000|Overall Study|Entrance criteria not met|0|||
37830498|NCT01312909|69513716|FG001|Overall Study|Entrance criteria not met|0|||
37830499|NCT01312909|69513717|FG002|Overall Study|Entrance criteria not met|2|||
37830500|NCT01312129|69513727|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
37830501|NCT01312129|69513728|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
37830502|NCT01311661|69513734|FG000|Overall Study|Adverse Event|2|||
37830503|NCT01311661|69513734|FG000|Overall Study|Protocol Violation|3|||
37830504|NCT01311661|69513734|FG000|Overall Study|Withdrawal by Subject|2|||
37830505|NCT01311505|69513746|FG000|First Intervention Period|Protocol Violation|0|||
37830506|NCT01311505|69513747|FG001|First Intervention Period|Protocol Violation|1|||
37830507|NCT01310803|69513758|FG000|Overall Study|Subject terminated by Sponsor|1|||
38004139|NCT00132132|69687728|FG000|Overall Study|Lost to Follow-up|7|||
38004140|NCT00132132|69687729|FG001|Overall Study|Lost to Follow-up|2|||
37830508|NCT01310803|69513759|FG001|Overall Study|Subject terminated by Sponsor|0|||
37830509|NCT01310413|69513771|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
37830510|NCT01310413|69513772|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
38004141|NCT00130442|69687737|FG000|Overall Study|Withdrawal by Subject|0|||
38004142|NCT00130442|69687738|FG001|Overall Study|Withdrawal by Subject|1|||
38004143|NCT00130442|69687737|FG000|Overall Study|did not meet criteria|1|||
38004144|NCT00130442|69687738|FG001|Overall Study|did not meet criteria|1|||
38004145|NCT00130208|69687748|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
38004146|NCT00130208|69687749|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
38004147|NCT00130208|69687748|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
38004148|NCT00130208|69687749|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
38004149|NCT00130208|69687748|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
37697564|NCT02413229|69174135|FG006|Overall Study|Withdrawal by Subject|0|||
37697565|NCT02413229|69174136|FG007|Overall Study|Withdrawal by Subject|2|||
37697566|NCT02413229|69174129|FG000|Overall Study|Progressive Disease|0|||
37697567|NCT02413229|69174130|FG001|Overall Study|Progressive Disease|0|||
37697568|NCT02413229|69174131|FG002|Overall Study|Progressive Disease|0|||
37697569|NCT02413229|69174132|FG003|Overall Study|Progressive Disease|0|||
37697570|NCT02413229|69174133|FG004|Overall Study|Progressive Disease|0|||
37697571|NCT02413229|69174134|FG005|Overall Study|Progressive Disease|0|||
37697572|NCT02413229|69174135|FG006|Overall Study|Progressive Disease|0|||
37697573|NCT02413229|69174136|FG007|Overall Study|Progressive Disease|1|||
37697574|NCT01825798|69174156|FG000|Overall Study|Adverse Event|1|||
37697575|NCT01825798|69174157|FG001|Overall Study|Adverse Event|5|||
37697576|NCT01825798|69174156|FG000|Overall Study|Lost to Follow-up|1|||
37697577|NCT01825798|69174157|FG001|Overall Study|Lost to Follow-up|0|||
37697578|NCT01824472|69174166|FG000|Overall Study|Lost to Follow-up|0|||
37830511|NCT01310413|69513773|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
37830512|NCT01310413|69513774|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
37830513|NCT01310413|69513775|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
38004150|NCT00130208|69687749|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
38004151|NCT00130208|69687748|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
38004152|NCT00130208|69687749|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
38004153|NCT00130208|69687748|FG000|Maintenance Period (26 Weeks)|Other|1|||
38004154|NCT00130208|69687749|FG001|Maintenance Period (26 Weeks)|Other|1|||
38004155|NCT00130208|69687748|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
38004156|NCT00130208|69687749|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
38004157|NCT00130208|69687748|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
38004158|NCT00130208|69687749|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
38004159|NCT00130208|69687748|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
38004160|NCT00130208|69687749|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
38004161|NCT00130208|69687748|FG000|Washout Period (8 Weeks)|Other|1|||
38004162|NCT00130208|69687749|FG001|Washout Period (8 Weeks)|Other|1|||
38004163|NCT00253370|69687755|FG000|Overall Study|Adverse Event|18|||
38004164|NCT00253370|69687755|FG000|Overall Study|Disease progression|13|||
38004165|NCT00253370|69687755|FG000|Overall Study|Death|2|||
38004166|NCT00253370|69687755|FG000|Overall Study|Withdrawal by Subject|6|||
38004167|NCT00253370|69687755|FG000|Overall Study|Non-protocol therapy|1|||
38004168|NCT00253370|69687755|FG000|Overall Study|Physician Decision|1|||
38004169|NCT00253370|69687755|FG000|Overall Study|Protocol Violation|1|||
38004170|NCT00253370|69687755|FG000|Overall Study|Abdominal pain due to disease|1|||
38004171|NCT00140426|69687762|FG000|Overall Study|Withdrawal by Subject|0|||
38004172|NCT00140426|69687763|FG001|Overall Study|Withdrawal by Subject|3|||
38004173|NCT00121134|69687778|FG000|Overall Study|Progression of Disease|5|||
38004174|NCT00121134|69687779|FG001|Overall Study|Progression of Disease|3|||
38004175|NCT00121134|69687780|FG002|Overall Study|Progression of Disease|4|||
38004176|NCT00121134|69687781|FG003|Overall Study|Progression of Disease|2|||
38004177|NCT00121134|69687778|FG000|Overall Study|Toxicity|4|||
37830514|NCT01310413|69513776|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
37830515|NCT01310413|69513777|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
37830516|NCT01310413|69513771|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
37830517|NCT01310413|69513772|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
37830518|NCT01310413|69513773|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
37830519|NCT01310413|69513774|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
37830520|NCT01310413|69513775|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
38004178|NCT00121134|69687779|FG001|Overall Study|Toxicity|7|||
38004179|NCT00121134|69687780|FG002|Overall Study|Toxicity|13|||
38004180|NCT00121134|69687781|FG003|Overall Study|Toxicity|5|||
38004181|NCT00121134|69687778|FG000|Overall Study|Physician Decision|6|||
37697579|NCT01824472|69174167|FG001|Overall Study|Lost to Follow-up|0|||
37830521|NCT01310413|69513776|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
38004182|NCT00121134|69687779|FG001|Overall Study|Physician Decision|4|||
38004183|NCT00121134|69687780|FG002|Overall Study|Physician Decision|4|||
37697580|NCT01824472|69174168|FG002|Overall Study|Lost to Follow-up|1|||
37830522|NCT01310413|69513777|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
38004184|NCT00121134|69687781|FG003|Overall Study|Physician Decision|1|||
38004185|NCT00121134|69687778|FG000|Overall Study|Treatment Delay|1|||
38004186|NCT00121134|69687779|FG001|Overall Study|Treatment Delay|0|||
38004187|NCT00121134|69687780|FG002|Overall Study|Treatment Delay|0|||
38004188|NCT00121134|69687781|FG003|Overall Study|Treatment Delay|0|||
38004189|NCT00121134|69687778|FG000|Overall Study|Intercurrent Illness|0|||
38004190|NCT00121134|69687779|FG001|Overall Study|Intercurrent Illness|0|||
38004191|NCT00121134|69687780|FG002|Overall Study|Intercurrent Illness|0|||
38004192|NCT00121134|69687781|FG003|Overall Study|Intercurrent Illness|1|||
38004193|NCT00121134|69687778|FG000|Overall Study|Patient Personal Reasons|0|||
38004194|NCT00121134|69687779|FG001|Overall Study|Patient Personal Reasons|1|||
38004195|NCT00121134|69687780|FG002|Overall Study|Patient Personal Reasons|0|||
38004196|NCT00121134|69687781|FG003|Overall Study|Patient Personal Reasons|0|||
38004197|NCT00119262|69687793|FG000|Overall Study|Lack of Efficacy|0|||
38004198|NCT00119262|69687794|FG001|Overall Study|Lack of Efficacy|3|||
38004199|NCT00119262|69687793|FG000|Overall Study|Withdrawal by Subject|12|||
38004200|NCT00119262|69687794|FG001|Overall Study|Withdrawal by Subject|11|||
38004201|NCT00119262|69687793|FG000|Overall Study|Adverse Event|33|||
38004202|NCT00119262|69687794|FG001|Overall Study|Adverse Event|35|||
38004203|NCT00119262|69687793|FG000|Overall Study|other disease|0|||
38004204|NCT00119262|69687794|FG001|Overall Study|other disease|2|||
38004205|NCT00119262|69687793|FG000|Overall Study|ineligble|1|||
38004206|NCT00119262|69687794|FG001|Overall Study|ineligble|2|||
38004207|NCT00119262|69687793|FG000|Overall Study|others|0|||
38004208|NCT00119262|69687794|FG001|Overall Study|others|5|||
38004209|NCT03703882|69687802|FG000|Overall Study|Adverse Event|1|||
38004210|NCT03703882|69687803|FG001|Overall Study|Adverse Event|0|||
38004211|NCT03703882|69687802|FG000|Overall Study|Lost to Follow-up|0|||
38004212|NCT03703882|69687803|FG001|Overall Study|Lost to Follow-up|2|||
38004213|NCT03703882|69687802|FG000|Overall Study|Non-compliance with study drug|0|||
38004214|NCT03703882|69687803|FG001|Overall Study|Non-compliance with study drug|1|||
38004215|NCT03703882|69687802|FG000|Overall Study|Physician Decision|0|||
38004216|NCT03703882|69687803|FG001|Overall Study|Physician Decision|1|||
37830523|NCT01310413|69513771|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
37830524|NCT01310413|69513772|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
37830525|NCT01310413|69513773|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
37830526|NCT01310413|69513774|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
37830527|NCT01310413|69513775|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
37830528|NCT01310413|69513776|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
37906406|NCT00902486|69591929|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
37906407|NCT00902486|69591930|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
37906408|NCT00902486|69591931|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
37906409|NCT00902486|69591932|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
37906410|NCT00902486|69591933|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
37906411|NCT00902486|69591934|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
37906412|NCT00902486|69591929|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
37906413|NCT00902486|69591930|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
37906414|NCT00902486|69591931|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
37906415|NCT00902486|69591932|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
37906416|NCT00902486|69591933|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
37906417|NCT00902486|69591934|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
38004217|NCT03703882|69687802|FG000|Overall Study|Progressive disease|1|||
38004218|NCT03703882|69687803|FG001|Overall Study|Progressive disease|0|||
37697581|NCT01824472|69174166|FG000|Overall Study|Withdrawal by Subject|1|||
37830529|NCT01310413|69513777|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
37830530|NCT01310413|69513771|FG000|Day 0 to Day 385|Other|1|||
37830531|NCT01310413|69513772|FG001|Day 0 to Day 385|Other|0|||
37830532|NCT01310413|69513773|FG002|Day 0 to Day 385|Other|3|||
37830533|NCT01310413|69513774|FG003|Day 0 to Day 385|Other|0|||
37830534|NCT01310413|69513775|FG004|Day 0 to Day 385|Other|0|||
37830535|NCT01310413|69513776|FG005|Day 0 to Day 385|Other|0|||
37830536|NCT01310413|69513777|FG006|Day 0 to Day 385|Other|0|||
37830537|NCT01310413|69513771|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
37830538|NCT01310413|69513772|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
37830539|NCT01310413|69513773|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
37830540|NCT01310413|69513774|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
37830541|NCT01310413|69513775|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
38004219|NCT03703882|69687802|FG000|Overall Study|Withdrawal by parent/guardian|1|||
38004220|NCT03703882|69687803|FG001|Overall Study|Withdrawal by parent/guardian|0|||
38004221|NCT03703882|69687802|FG000|Overall Study|Starting another treatment|0|||
38004222|NCT03703882|69687803|FG001|Overall Study|Starting another treatment|1|||
38004223|NCT03703882|69687802|FG000|Overall Study|noncompliance with study procedures|0|||
37830542|NCT01310413|69513776|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
37830543|NCT01310413|69513777|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
38004224|NCT03703882|69687803|FG001|Overall Study|noncompliance with study procedures|1|||
38004225|NCT00131664|69687812|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
38004226|NCT00131664|69687813|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
38004227|NCT00131664|69687814|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
38004228|NCT00131664|69687815|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
38004229|NCT00131664|69687816|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
38004230|NCT00131664|69687817|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
38004231|NCT00131664|69687812|FG000|First Period (First 6 Months)|Death|0|||
38004232|NCT00131664|69687813|FG001|First Period (First 6 Months)|Death|1|||
38004233|NCT00131664|69687814|FG002|First Period (First 6 Months)|Death|0|||
38004234|NCT00131664|69687815|FG003|First Period (First 6 Months)|Death|0|||
38004235|NCT00131664|69687816|FG004|First Period (First 6 Months)|Death|0|||
37906418|NCT00902486|69591929|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
38004236|NCT00131664|69687817|FG005|First Period (First 6 Months)|Death|0|||
38004237|NCT00131664|69687812|FG000|First Period (First 6 Months)|Protocol Violation|2|||
38004238|NCT00131664|69687813|FG001|First Period (First 6 Months)|Protocol Violation|2|||
38004239|NCT00131664|69687814|FG002|First Period (First 6 Months)|Protocol Violation|1|||
38004240|NCT00131664|69687815|FG003|First Period (First 6 Months)|Protocol Violation|0|||
38004241|NCT00131664|69687816|FG004|First Period (First 6 Months)|Protocol Violation|0|||
37906419|NCT00902486|69591930|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
37906420|NCT00902486|69591931|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
37906421|NCT00902486|69591932|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
37906422|NCT00902486|69591933|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
37906423|NCT00902486|69591934|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
37906424|NCT00902486|69591929|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
37906425|NCT00902486|69591930|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
37906426|NCT00902486|69591931|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
38004242|NCT00131664|69687817|FG005|First Period (First 6 Months)|Protocol Violation|0|||
37906427|NCT00902486|69591932|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
37906428|NCT00902486|69591933|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
37906429|NCT00902486|69591934|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
37906430|NCT00902486|69591929|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
37906431|NCT00902486|69591930|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
37906432|NCT00902486|69591931|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
37906433|NCT00902486|69591932|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
37906434|NCT00902486|69591933|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
37906435|NCT00902486|69591934|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
37906436|NCT00902486|69591929|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
37906437|NCT00902486|69591930|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
37906438|NCT00902486|69591931|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
37906439|NCT00902486|69591932|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
37906440|NCT00902486|69591933|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
37906441|NCT00902486|69591934|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
37906442|NCT00902486|69591929|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
37906443|NCT00902486|69591930|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
37906444|NCT00902486|69591931|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
37906445|NCT00902486|69591932|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
37906446|NCT00902486|69591933|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
37906447|NCT00902486|69591934|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
37906448|NCT00836745|69591964|FG000|Overall Study|Death|2|||
37906449|NCT00836745|69591964|FG000|Overall Study|Lost to Follow-up|10|||
37906450|NCT00836745|69591964|FG000|Overall Study|Adverse Event|3|||
37906451|NCT00836745|69591964|FG000|Overall Study|Objective progression or relapse|4|||
37906452|NCT00836745|69591964|FG000|Overall Study|Other|2|||
37906453|NCT00891618|69591968|FG000|Overall Study|Withdrawal by Subject|1|||
37906454|NCT00836589|69591972|FG000|Overall Study|Lost to Follow-up|246|||
37906455|NCT00836589|69591972|FG000|Overall Study|Death|429|||
37906456|NCT00836589|69591972|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
37906457|NCT00574795|69591984|FG000|Infant Series|Withdrawal by Subject|2|||
38004243|NCT00131664|69687812|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
38004244|NCT00131664|69687813|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
38004245|NCT00131664|69687814|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
38004246|NCT00131664|69687815|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
37906458|NCT00574795|69591984|FG000|Infant Series|Protocol Violation|2|||
37906459|NCT00574795|69591984|FG000|Infant Series|Adverse Event|1|||
37906460|NCT00574795|69591984|FG000|After Infant Series|Withdrawal by Subject|1|||
38004247|NCT00131664|69687816|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
38004248|NCT00131664|69687817|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
38004249|NCT00131664|69687812|FG000|First Period (First 6 Months)|Adverse Event|9|||
38004250|NCT00131664|69687813|FG001|First Period (First 6 Months)|Adverse Event|4|||
38004251|NCT00131664|69687814|FG002|First Period (First 6 Months)|Adverse Event|5|||
38004252|NCT00131664|69687815|FG003|First Period (First 6 Months)|Adverse Event|0|||
38004253|NCT00131664|69687816|FG004|First Period (First 6 Months)|Adverse Event|0|||
38004254|NCT00131664|69687817|FG005|First Period (First 6 Months)|Adverse Event|0|||
38004255|NCT00131664|69687812|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
38004256|NCT00131664|69687813|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
38004257|NCT00131664|69687814|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
38004258|NCT00131664|69687815|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
38004259|NCT00131664|69687816|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
38004260|NCT00131664|69687817|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
38004261|NCT00131664|69687812|FG000|First Period (First 6 Months)|Administrative reasons|2|||
38004262|NCT00131664|69687813|FG001|First Period (First 6 Months)|Administrative reasons|0|||
38004263|NCT00131664|69687814|FG002|First Period (First 6 Months)|Administrative reasons|5|||
38004264|NCT00131664|69687815|FG003|First Period (First 6 Months)|Administrative reasons|0|||
38004265|NCT00131664|69687816|FG004|First Period (First 6 Months)|Administrative reasons|0|||
38004266|NCT00131664|69687817|FG005|First Period (First 6 Months)|Administrative reasons|0|||
38004267|NCT00131664|69687812|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
38004268|NCT00131664|69687813|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
38004269|NCT00131664|69687814|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
38004270|NCT00131664|69687815|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
38004271|NCT00131664|69687816|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
38004272|NCT00131664|69687817|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
38004273|NCT00131664|69687812|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
38004274|NCT00131664|69687813|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
37906461|NCT00574795|69591984|FG000|After Infant Series|Adverse Event|2|||
37906462|NCT00574795|69591984|FG000|Toddler Dose|Withdrawal by Subject|1|||
37906463|NCT02297516|69592001|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
37906464|NCT02297516|69592002|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
37906465|NCT02297516|69592001|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
37906466|NCT02297516|69592002|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
37906467|NCT02297516|69592001|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
37906468|NCT02297516|69592002|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
37906469|NCT00836277|69592015|FG000|Overall Study|Not evaluable for response|6|||
37906470|NCT00835731|69592021|FG000|Overall Study|Withdrawal by Subject|1|||
37906471|NCT00835731|69592022|FG001|Overall Study|Withdrawal by Subject|0|||
37906472|NCT00835731|69592021|FG000|Overall Study|Physician Decision|1|||
37906473|NCT00835731|69592022|FG001|Overall Study|Physician Decision|1|||
37906474|NCT00835341|69592030|FG000|Overall Study|Lost to Follow-up|3|||
37906475|NCT00835341|69592031|FG001|Overall Study|Lost to Follow-up|12|||
37906476|NCT00574249|69592039|FG000|Overall Study|Adverse Event|6|||
37906477|NCT00574249|69592040|FG001|Overall Study|Adverse Event|18|||
37906478|NCT00574249|69592039|FG000|Overall Study|Lack of Efficacy|5|||
37906479|NCT00574249|69592040|FG001|Overall Study|Lack of Efficacy|3|||
37906480|NCT00574249|69592039|FG000|Overall Study|Lost to Follow-up|4|||
37906481|NCT00574249|69592040|FG001|Overall Study|Lost to Follow-up|3|||
37906482|NCT00574249|69592039|FG000|Overall Study|Protocol Violation|5|||
37906483|NCT00574249|69592040|FG001|Overall Study|Protocol Violation|2|||
37906484|NCT00574249|69592039|FG000|Overall Study|History of carcinoma|1|||
37906485|NCT00574249|69592040|FG001|Overall Study|History of carcinoma|0|||
37906486|NCT00574249|69592039|FG000|Overall Study|Withdrawal by Subject|3|||
37906487|NCT00574249|69592040|FG001|Overall Study|Withdrawal by Subject|0|||
37906488|NCT00574249|69592039|FG000|Overall Study|Physician Decision|1|||
37906489|NCT00574249|69592040|FG001|Overall Study|Physician Decision|0|||
37906490|NCT00574249|69592039|FG000|Overall Study|Pregnancy|1|||
37906491|NCT00574249|69592040|FG001|Overall Study|Pregnancy|0|||
37906492|NCT00574249|69592039|FG000|Overall Study|Excluded by company|0|||
37906493|NCT00574249|69592040|FG001|Overall Study|Excluded by company|1|||
37906494|NCT00574249|69592039|FG000|Overall Study|PPD test taken twice|0|||
37906495|NCT00574249|69592040|FG001|Overall Study|PPD test taken twice|1|||
37906496|NCT00891228|69592049|FG000|Overall Study|Adverse Event|0|||
37906497|NCT00891228|69592050|FG001|Overall Study|Adverse Event|2|||
37906498|NCT00891228|69592051|FG002|Overall Study|Adverse Event|3|||
37906499|NCT00891228|69592049|FG000|Overall Study|Withdrawal by Subject|2|||
37906500|NCT00891228|69592050|FG001|Overall Study|Withdrawal by Subject|4|||
37906501|NCT00891228|69592051|FG002|Overall Study|Withdrawal by Subject|5|||
37906502|NCT00891228|69592049|FG000|Overall Study|Protocol Violation|3|||
38004275|NCT00131664|69687814|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
38004276|NCT00131664|69687815|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
38004277|NCT00131664|69687816|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
38004278|NCT00131664|69687817|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
38004279|NCT00131664|69687812|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
38004280|NCT00131664|69687813|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
38004281|NCT00131664|69687814|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
38004282|NCT00131664|69687815|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
38004283|NCT00131664|69687816|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
38004284|NCT00131664|69687817|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
38004285|NCT00131664|69687812|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
38004286|NCT00131664|69687813|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
38004287|NCT00131664|69687814|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
38004288|NCT00131664|69687815|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
38004289|NCT00131664|69687816|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
38004290|NCT00131664|69687817|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
38004291|NCT00131664|69687812|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
38004292|NCT00131664|69687813|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
38004293|NCT00131664|69687814|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
38004294|NCT00131664|69687815|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
38004295|NCT00131664|69687816|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
38004296|NCT00131664|69687817|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
38004297|NCT00131664|69687812|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
38004298|NCT00131664|69687813|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
38004299|NCT00131664|69687814|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
38004300|NCT00131664|69687815|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
38004301|NCT00131664|69687816|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
38004302|NCT00131664|69687817|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
38004303|NCT00131508|69687830|FG000|Overall Study|Disease progression|0|||
38004304|NCT00131508|69687831|FG001|Overall Study|Disease progression|2|||
38004305|NCT00131508|69687830|FG000|Overall Study|Non-Compliance|2|||
38004306|NCT00131508|69687831|FG001|Overall Study|Non-Compliance|4|||
38004307|NCT00131508|69687830|FG000|Overall Study|Withdrawal by Subject|1|||
38004308|NCT00131508|69687831|FG001|Overall Study|Withdrawal by Subject|2|||
38004309|NCT05050318|69687840|FG000|Overall Study|Protocol Deviation|1|||
38004310|NCT05050318|69687841|FG001|Overall Study|Protocol Deviation|0|||
38004311|NCT05050318|69687842|FG002|Overall Study|Protocol Deviation|0|||
38004312|NCT03699124|69687853|FG000|Overall Study|Adverse Event|6|||
38004313|NCT03699124|69687854|FG001|Overall Study|Adverse Event|5|||
38004314|NCT03699124|69687855|FG002|Overall Study|Adverse Event|2|||
38004315|NCT03699124|69687853|FG000|Overall Study|Death|0|||
38004316|NCT03699124|69687854|FG001|Overall Study|Death|2|||
38004317|NCT03699124|69687855|FG002|Overall Study|Death|0|||
38004318|NCT03699124|69687853|FG000|Overall Study|Lost to Follow-up|20|||
38004319|NCT03699124|69687854|FG001|Overall Study|Lost to Follow-up|16|||
38004320|NCT03699124|69687855|FG002|Overall Study|Lost to Follow-up|15|||
38004321|NCT03699124|69687853|FG000|Overall Study|Protocol Violation|1|||
38004322|NCT03699124|69687854|FG001|Overall Study|Protocol Violation|0|||
38004323|NCT03699124|69687855|FG002|Overall Study|Protocol Violation|0|||
38004324|NCT03699124|69687853|FG000|Overall Study|Withdrawal by Subject|13|||
38004325|NCT03699124|69687854|FG001|Overall Study|Withdrawal by Subject|14|||
38004326|NCT03699124|69687855|FG002|Overall Study|Withdrawal by Subject|13|||
38004327|NCT03699124|69687853|FG000|Overall Study|Other reasons|5|||
38004328|NCT03699124|69687854|FG001|Overall Study|Other reasons|3|||
38004329|NCT03699124|69687855|FG002|Overall Study|Other reasons|10|||
38004330|NCT05002972|69687863|FG000|Overall Study|Withdrawal by Subject|2|||
38004331|NCT04651114|69687867|FG000|Overall Study|Withdrawal by Subject|8|||
37830544|NCT01310413|69513771|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
38004332|NCT04980040|69687871|FG000|Overall Study|Violated the Inclusion Criteria|260|||
38004333|NCT04980040|69687871|FG000|Overall Study|Violated the Administration & Dosage|225|||
38004334|NCT04980040|69687871|FG000|Overall Study|Lost to Safety-Follow-up|4|||
38004335|NCT04980040|69687871|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
38004336|NCT00131352|69687877|FG000|Initial Treatment Period|Adverse Event|1|||
38004337|NCT00131352|69687878|FG001|Initial Treatment Period|Adverse Event|3|||
38004338|NCT00131352|69687877|FG000|Initial Treatment Period|Non-compliant|1|||
38004339|NCT00131352|69687878|FG001|Initial Treatment Period|Non-compliant|2|||
38004340|NCT00131352|69687877|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
38004341|NCT00131352|69687878|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
38004342|NCT00131352|69687877|FG000|Initial Treatment Period|Lack of Efficacy|6|||
38004343|NCT00131352|69687878|FG001|Initial Treatment Period|Lack of Efficacy|4|||
38004344|NCT00131352|69687877|FG000|Initial Treatment Period|Other|0|||
38004345|NCT00131352|69687878|FG001|Initial Treatment Period|Other|2|||
38004346|NCT00131352|69687877|FG000|Repeat Treatment Period|Adverse Event|1|||
38004347|NCT00131352|69687878|FG001|Repeat Treatment Period|Adverse Event|0|||
38004348|NCT00131352|69687877|FG000|Repeat Treatment Period|Other|1|||
38004349|NCT00131352|69687878|FG001|Repeat Treatment Period|Other|0|||
38004350|NCT04633642|69687888|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
38004351|NCT04633642|69687889|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
38004352|NCT00136916|69687897|FG000|Overall Study|Never received study treatment|3|||
38004353|NCT00136916|69687898|FG001|Overall Study|Never received study treatment|5|||
38004354|NCT00136916|69687897|FG000|Overall Study|Death|1|||
38004355|NCT00136916|69687898|FG001|Overall Study|Death|3|||
38004356|NCT00136916|69687897|FG000|Overall Study|Adverse Event|27|||
38004357|NCT00136916|69687898|FG001|Overall Study|Adverse Event|8|||
38004358|NCT00136916|69687897|FG000|Overall Study|Laboratory abnormality|0|||
38004359|NCT00136916|69687898|FG001|Overall Study|Laboratory abnormality|1|||
38004360|NCT00136916|69687897|FG000|Overall Study|Lack of Efficacy|13|||
38004361|NCT00136916|69687898|FG001|Overall Study|Lack of Efficacy|3|||
38004362|NCT00136916|69687897|FG000|Overall Study|Lost to Follow-up|12|||
38004363|NCT00136916|69687898|FG001|Overall Study|Lost to Follow-up|14|||
38004364|NCT00136916|69687897|FG000|Overall Study|Withdrawal by Subject|44|||
38004365|NCT00136916|69687898|FG001|Overall Study|Withdrawal by Subject|46|||
38004366|NCT00136916|69687897|FG000|Overall Study|Other|22|||
38004367|NCT00136916|69687898|FG001|Overall Study|Other|24|||
38004368|NCT00136916|69687897|FG000|Overall Study|Discontinued in follow up period|3|||
38004369|NCT00136916|69687898|FG001|Overall Study|Discontinued in follow up period|0|||
38004370|NCT04633564|69687908|FG000|Period 1|Adverse Event|28|||
38004371|NCT04633564|69687909|FG001|Period 1|Adverse Event|19|||
38004372|NCT04633564|69687908|FG000|Period 1|Death|8|||
38004373|NCT04633564|69687909|FG001|Period 1|Death|7|||
38004374|NCT04633564|69687908|FG000|Period 1|Lost to Follow-up|3|||
38004375|NCT04633564|69687909|FG001|Period 1|Lost to Follow-up|5|||
38004376|NCT04633564|69687908|FG000|Period 1|Physician Decision|4|||
38004377|NCT04633564|69687909|FG001|Period 1|Physician Decision|12|||
38004378|NCT04633564|69687908|FG000|Period 1|Protocol Violation|0|||
38004379|NCT04633564|69687909|FG001|Period 1|Protocol Violation|1|||
37906503|NCT00891228|69592050|FG001|Overall Study|Protocol Violation|1|||
37906504|NCT00891228|69592051|FG002|Overall Study|Protocol Violation|2|||
38004380|NCT04633564|69687908|FG000|Period 1|Withdrawal by Subject|10|||
38004381|NCT04633564|69687909|FG001|Period 1|Withdrawal by Subject|8|||
38004382|NCT04633564|69687908|FG000|Period 1|Progressive disease|47|||
38004383|NCT04633564|69687909|FG001|Period 1|Progressive disease|51|||
38004384|NCT04633564|69687908|FG000|Period 1|Terminated by Sponsor|8|||
38004385|NCT04633564|69687909|FG001|Period 1|Terminated by Sponsor|6|||
38004386|NCT04633564|69687908|FG000|Period 2|Adverse Event|3|||
37830545|NCT01310413|69513772|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
37830546|NCT01310413|69513773|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
37830547|NCT01310413|69513774|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
37830548|NCT01310413|69513775|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
37830549|NCT01310413|69513776|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
37830550|NCT01310413|69513777|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
37830551|NCT01309828|69513808|FG000|Overall Study|Adverse Event|10|||
37830552|NCT01309828|69513809|FG001|Overall Study|Adverse Event|11|||
37906505|NCT00891228|69592049|FG000|Overall Study|Physician Decision|2|||
37906506|NCT00891228|69592050|FG001|Overall Study|Physician Decision|1|||
37906507|NCT00891228|69592051|FG002|Overall Study|Physician Decision|0|||
37830553|NCT01309828|69513808|FG000|Overall Study|Voluntary Withdrawal|5|||
37830554|NCT01309828|69513809|FG001|Overall Study|Voluntary Withdrawal|4|||
37830555|NCT01309828|69513808|FG000|Overall Study|Major Protocol Deviation|0|||
37830556|NCT01309828|69513809|FG001|Overall Study|Major Protocol Deviation|1|||
37906508|NCT00891228|69592049|FG000|Overall Study|Lost to Follow-up|4|||
37906509|NCT00891228|69592050|FG001|Overall Study|Lost to Follow-up|4|||
37906510|NCT00891228|69592051|FG002|Overall Study|Lost to Follow-up|5|||
37906511|NCT00891228|69592049|FG000|Overall Study|Pregnancy|0|||
38004387|NCT04633564|69687909|FG001|Period 2|Adverse Event|4|||
38004388|NCT04633564|69687908|FG000|Period 2|Death|0|||
38004389|NCT04633564|69687909|FG001|Period 2|Death|2|||
38004390|NCT04633564|69687908|FG000|Period 2|Lost to Follow-up|0|||
38004391|NCT04633564|69687909|FG001|Period 2|Lost to Follow-up|1|||
38004392|NCT04633564|69687908|FG000|Period 2|Physician Decision|2|||
38004393|NCT04633564|69687909|FG001|Period 2|Physician Decision|4|||
38004394|NCT04633564|69687908|FG000|Period 2|Withdrawal by Subject|5|||
38004395|NCT04633564|69687909|FG001|Period 2|Withdrawal by Subject|1|||
38004396|NCT04633564|69687908|FG000|Period 2|Progressive Disease|74|||
38004397|NCT04633564|69687909|FG001|Period 2|Progressive Disease|82|||
38004398|NCT04633564|69687908|FG000|Period 2|Terminated by Sponsor|9|||
38004399|NCT04633564|69687909|FG001|Period 2|Terminated by Sponsor|3|||
38043626|NCT02180867|69731806|FG002|Overall Study|Death|0|||
37906512|NCT00891228|69592050|FG001|Overall Study|Pregnancy|1|||
37906513|NCT00891228|69592051|FG002|Overall Study|Pregnancy|0|||
37906514|NCT00896168|69592061|FG000|Overall Study|Adverse Event|4|||
37906515|NCT00896168|69592062|FG001|Overall Study|Adverse Event|7|||
37906516|NCT00896168|69592061|FG000|Overall Study|Treatment failure|8|||
38004400|NCT04960228|69687917|FG000|Overall Study|Withdrawal by Subject|216|||
38004401|NCT04960228|69687918|FG001|Overall Study|Withdrawal by Subject|35|||
38004402|NCT04960228|69687917|FG000|Overall Study|Failed attention check|69|||
38004403|NCT04960228|69687918|FG001|Overall Study|Failed attention check|148|||
38004404|NCT04960228|69687917|FG000|Overall Study|Flagged for response quality by Dynata|3|||
38004405|NCT04960228|69687918|FG001|Overall Study|Flagged for response quality by Dynata|3|||
38004406|NCT04619992|69687926|FG000|Overall Study|Withdrawal by Subject|1|||
38004407|NCT04619992|69687927|FG001|Overall Study|Withdrawal by Subject|0|||
38004408|NCT00136604|69687938|FG000|Overall Study|Lost to Follow-up|1|||
38004409|NCT00136604|69687939|FG001|Overall Study|Lost to Follow-up|0|||
38004410|NCT00136604|69687940|FG002|Overall Study|Lost to Follow-up|0|||
38004411|NCT00136604|69687941|FG003|Overall Study|Lost to Follow-up|0|||
38004412|NCT00136604|69687942|FG004|Overall Study|Lost to Follow-up|1|||
38004413|NCT00136604|69687938|FG000|Overall Study|Migrated/moved from study area|0|||
38004414|NCT00136604|69687939|FG001|Overall Study|Migrated/moved from study area|1|||
38004415|NCT00136604|69687940|FG002|Overall Study|Migrated/moved from study area|0|||
38004416|NCT00136604|69687941|FG003|Overall Study|Migrated/moved from study area|0|||
38004417|NCT00136604|69687942|FG004|Overall Study|Migrated/moved from study area|0|||
38004418|NCT00135512|69687958|FG000|Overall Study|Adverse Event|56|||
38004419|NCT00135512|69687958|FG000|Overall Study|Lack of Efficacy|25|||
38004420|NCT00135512|69687958|FG000|Overall Study|Other|42|||
38004421|NCT00130728|69687964|FG000|Overall Study|Death|258|||
38004422|NCT00130728|69687965|FG001|Overall Study|Death|258|||
38004423|NCT00130728|69687964|FG000|Overall Study|Lost to Follow-up|4|||
38004424|NCT00130728|69687965|FG001|Overall Study|Lost to Follow-up|0|||
38004425|NCT00130728|69687964|FG000|Overall Study|Withdrawal by Subject|0|||
38004426|NCT00130728|69687965|FG001|Overall Study|Withdrawal by Subject|2|||
38004427|NCT00129974|69687971|FG000|Overall Study|Other|1|||
38004428|NCT04947436|69687978|FG000|Overall Study|Lost to Follow-up|3|||
38004429|NCT04947436|69687979|FG001|Overall Study|Lost to Follow-up|7|||
38004430|NCT04947436|69687980|FG002|Overall Study|Lost to Follow-up|5|||
38004431|NCT04947436|69687978|FG000|Overall Study|Death|1|||
38004432|NCT04947436|69687979|FG001|Overall Study|Death|1|||
38004433|NCT04947436|69687980|FG002|Overall Study|Death|1|||
38004434|NCT00119106|69687990|FG000|Overall Study|HIV infected at baseline|179|||
38004435|NCT00119106|69687991|FG001|Overall Study|HIV infected at baseline|178|||
38004436|NCT00135356|69688007|FG000|Overall Study|Adverse Event|6|||
38004437|NCT00135356|69688008|FG001|Overall Study|Adverse Event|2|||
38004438|NCT00135356|69688007|FG000|Overall Study|Lack of Efficacy|2|||
38004439|NCT00135356|69688008|FG001|Overall Study|Lack of Efficacy|0|||
38004440|NCT00135356|69688007|FG000|Overall Study|Lost to Follow-up|3|||
38004441|NCT00135356|69688008|FG001|Overall Study|Lost to Follow-up|1|||
38004442|NCT00135356|69688007|FG000|Overall Study|Surgery for abdominal fat|1|||
38004443|NCT00135356|69688008|FG001|Overall Study|Surgery for abdominal fat|0|||
38004444|NCT00135356|69688007|FG000|Overall Study|Change in antiviral regimen|0|||
38004445|NCT00135356|69688008|FG001|Overall Study|Change in antiviral regimen|1|||
38004446|NCT00135356|69688007|FG000|Overall Study|Poor/noncompliance|1|||
38004447|NCT00135356|69688008|FG001|Overall Study|Poor/noncompliance|1|||
38004448|NCT00135356|69688007|FG000|Overall Study|No longer meets study criteria|2|||
38004449|NCT00135356|69688008|FG001|Overall Study|No longer meets study criteria|0|||
38004450|NCT00135356|69688007|FG000|Overall Study|Withdrawal by Subject|2|||
38004451|NCT00135356|69688008|FG001|Overall Study|Withdrawal by Subject|4|||
37830557|NCT01309828|69513808|FG000|Overall Study|Other|1|||
37830558|NCT01309828|69513809|FG001|Overall Study|Other|0|||
37830559|NCT01309282|69513815|FG000|Overall Study|Lost to Follow-up|1|||
37830560|NCT01309243|69513821|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
37830561|NCT01309243|69513822|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
37830562|NCT01309243|69513821|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
37830563|NCT01309243|69513822|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
37830564|NCT01309243|69513821|FG000|Randomized Phase Through Week 96|Death|0|||
37830565|NCT01309243|69513822|FG001|Randomized Phase Through Week 96|Death|1|||
37830566|NCT01309243|69513821|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
37830567|NCT01309243|69513822|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
37830568|NCT01309243|69513821|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
37830569|NCT01309243|69513822|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
37830570|NCT01309243|69513821|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
37830571|NCT01309243|69513822|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
37830572|NCT01309243|69513821|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
37830573|NCT01309243|69513822|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
37830574|NCT01309243|69513821|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
38004452|NCT00118716|69688016|FG000|Overall Study|Adverse Event|2|||
38004453|NCT00118716|69688017|FG001|Overall Study|Adverse Event|7|||
38004454|NCT00118716|69688016|FG000|Overall Study|Protocol Violation|5|||
38004455|NCT00118716|69688017|FG001|Overall Study|Protocol Violation|4|||
37697582|NCT01824472|69174167|FG001|Overall Study|Withdrawal by Subject|5|||
37697583|NCT01824472|69174168|FG002|Overall Study|Withdrawal by Subject|3|||
37697584|NCT01824472|69174166|FG000|Overall Study|Ineligible post randomization&screening|0|||
37697585|NCT01824472|69174167|FG001|Overall Study|Ineligible post randomization&screening|2|||
37697586|NCT01824472|69174168|FG002|Overall Study|Ineligible post randomization&screening|0|||
37697587|NCT02412761|69174176|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
37697588|NCT02412761|69174177|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
37697589|NCT02412761|69174178|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
37697590|NCT02412761|69174179|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
37906517|NCT00896168|69592062|FG001|Overall Study|Treatment failure|10|||
37906518|NCT00896168|69592061|FG000|Overall Study|Lost to Follow-up|1|||
37906519|NCT00896168|69592062|FG001|Overall Study|Lost to Follow-up|1|||
38004456|NCT00118716|69688016|FG000|Overall Study|Withdrawal by Subject|0|||
38004457|NCT00118716|69688017|FG001|Overall Study|Withdrawal by Subject|1|||
38004458|NCT00118716|69688016|FG000|Overall Study|Exacerbation|2|||
38004459|NCT00118716|69688017|FG001|Overall Study|Exacerbation|2|||
37906520|NCT00896168|69592061|FG000|Overall Study|Other|1|||
38004460|NCT00118716|69688016|FG000|Overall Study|Discontinued by sponsor|1|||
38004461|NCT00118716|69688017|FG001|Overall Study|Discontinued by sponsor|1|||
38004462|NCT00118716|69688016|FG000|Overall Study|Non-compliance|1|||
38004463|NCT00118716|69688017|FG001|Overall Study|Non-compliance|3|||
38004464|NCT00118716|69688016|FG000|Overall Study|misrandomized|1|||
38004465|NCT00118716|69688017|FG001|Overall Study|misrandomized|1|||
38004466|NCT00118716|69688016|FG000|Overall Study|Expired drug use|1|||
38004467|NCT00118716|69688017|FG001|Overall Study|Expired drug use|2|||
38004468|NCT00118716|69688016|FG000|Overall Study|Investigator discretion|0|||
38004469|NCT00118716|69688017|FG001|Overall Study|Investigator discretion|1|||
38004470|NCT04584346|69688025|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
38004471|NCT04584346|69688026|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
38004472|NCT00118482|69688036|FG000|Overall Study|Lost to Follow-up|7|||
38004473|NCT00118482|69688037|FG001|Overall Study|Lost to Follow-up|7|||
38004474|NCT00118482|69688036|FG000|Overall Study|Withdrawal by Subject|23|||
38004475|NCT00118482|69688037|FG001|Overall Study|Withdrawal by Subject|22|||
38004476|NCT00129272|69688045|FG000|Overall Study|Lost to Follow-up|12|||
38004477|NCT00129272|69688046|FG001|Overall Study|Lost to Follow-up|11|||
38004478|NCT00129272|69688045|FG000|Overall Study|Withdrawal by Subject|5|||
38004479|NCT00129272|69688046|FG001|Overall Study|Withdrawal by Subject|11|||
38004480|NCT04899232|69688055|FG000|Screening Period|Physician Decision|1|||
38004481|NCT04899232|69688056|FG001|Screening Period|Physician Decision|0|||
38004482|NCT04899232|69688057|FG002|Screening Period|Physician Decision|0|||
38004483|NCT04899232|69688055|FG000|Screening Period|Withdrawal by Subject|1|||
38004484|NCT04899232|69688056|FG001|Screening Period|Withdrawal by Subject|0|||
38004485|NCT04899232|69688057|FG002|Screening Period|Withdrawal by Subject|0|||
38004486|NCT04899232|69688055|FG000|Screening Period|Participant discharged before receiving intervention|3|||
38004487|NCT04899232|69688056|FG001|Screening Period|Participant discharged before receiving intervention|0|||
38004488|NCT04899232|69688057|FG002|Screening Period|Participant discharged before receiving intervention|0|||
38004489|NCT04559698|69688076|FG000|Overall Study|Lost to Follow-up|14|||
38004490|NCT04559698|69688077|FG001|Overall Study|Lost to Follow-up|15|||
38004491|NCT04559698|69688076|FG000|Overall Study|Withdrawal by Subject|0|||
38004492|NCT04559698|69688077|FG001|Overall Study|Withdrawal by Subject|1|||
38004493|NCT00133952|69688085|FG000|Overall Study|Adverse Event|1|||
38004494|NCT00133952|69688086|FG001|Overall Study|Adverse Event|2|||
37830575|NCT01309243|69513822|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
37830576|NCT01309243|69513821|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
37830577|NCT01309243|69513822|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
37830578|NCT01309243|69513821|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
37830579|NCT01309243|69513822|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
37830580|NCT01309243|69513821|FG000|Extension Phase|Lost to Follow-up|6|||
37830581|NCT01309243|69513822|FG001|Extension Phase|Lost to Follow-up|0|||
37906521|NCT00896168|69592062|FG001|Overall Study|Other|1|||
38004495|NCT00133952|69688085|FG000|Overall Study|Death|3|||
38004496|NCT00133952|69688086|FG001|Overall Study|Death|2|||
38004497|NCT00133952|69688085|FG000|Overall Study|Lost to Follow-up|9|||
38004498|NCT00133952|69688086|FG001|Overall Study|Lost to Follow-up|14|||
38004499|NCT00133952|69688085|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
38004500|NCT00133952|69688086|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
38004501|NCT00133952|69688085|FG000|Overall Study|Protocol Violation|1|||
37697591|NCT02412761|69174180|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
37697592|NCT02412761|69174181|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
37906522|NCT00833703|69592070|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
38004502|NCT00133952|69688086|FG001|Overall Study|Protocol Violation|1|||
38004503|NCT00133952|69688085|FG000|Overall Study|Withdrawal by Subject|20|||
38004504|NCT00133952|69688086|FG001|Overall Study|Withdrawal by Subject|4|||
38004505|NCT00133952|69688085|FG000|Overall Study|Physician Decision|4|||
37906523|NCT00833703|69592071|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
37906524|NCT00833547|69592079|FG000|Overall Study|Withdrawal by Subject|2|||
37906525|NCT00833547|69592080|FG001|Overall Study|Withdrawal by Subject|2|||
37906526|NCT00833469|69592086|FG000|Overall Study|Withdrawal by Subject|1|||
37906527|NCT00833469|69592086|FG000|Overall Study|Lost to Follow-up|1|||
37906528|NCT00832377|69592090|FG000|Overall Study|Protocol Violation|1|||
37906529|NCT00892008|69592094|FG000|Overall Study|Death|5|||
37906530|NCT00892008|69592094|FG000|Overall Study|Lack of Efficacy|3|||
37906531|NCT00892008|69592094|FG000|Overall Study|Lost to Follow-up|142|||
37906532|NCT00892008|69592094|FG000|Overall Study|Other|378|||
37906533|NCT00892008|69592094|FG000|Overall Study|Adverse Event|37|||
37906534|NCT00623233|69592098|FG000|Overall Study|Adverse Event|10|||
37906535|NCT00623233|69592098|FG000|Overall Study|Physician Decision|10|||
37906536|NCT00623233|69592098|FG000|Overall Study|Lost to Follow-up|1|||
37906537|NCT00623233|69592098|FG000|Overall Study|Withdrawal by Subject|3|||
37906538|NCT03369236|69592113|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
37906539|NCT03369236|69592114|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
37906540|NCT03369236|69592113|FG000|Open-label Extension Period|Lack of Efficacy|2|||
37906541|NCT03369236|69592114|FG001|Open-label Extension Period|Lack of Efficacy|1|||
37906542|NCT03369236|69592113|FG000|Open-label Extension Period|Adverse Event|0|||
37906543|NCT03369236|69592114|FG001|Open-label Extension Period|Adverse Event|1|||
37906544|NCT03369236|69592113|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
37906545|NCT03369236|69592114|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
37906546|NCT00621751|69592128|FG000|Overall Study|Adverse Event|0|||
37906547|NCT00621751|69592129|FG001|Overall Study|Adverse Event|1|||
37906548|NCT00891930|69592146|FG000|Part 1: Panitumumab +Irinotecan|Death|38|||
37906549|NCT00891930|69592146|FG000|Part 1: Panitumumab +Irinotecan|Withdrawal by Subject|1|||
37906550|NCT00891930|69592146|FG000|Part 1: Panitumumab +Irinotecan|Lost to Follow-up|1|||
37906551|NCT00891930|69592146|FG000|Part 2: Panitumumab + Ganitumab|Death|30|||
37906552|NCT00891930|69592146|FG000|Part 2: Panitumumab + Ganitumab|Withdrawal by Subject|1|||
37906553|NCT00891462|69592157|FG000|Overall Study|Withdrawal by Subject|9|||
37906554|NCT00891462|69592158|FG001|Overall Study|Withdrawal by Subject|6|||
37906555|NCT00891462|69592159|FG002|Overall Study|Withdrawal by Subject|7|||
37906556|NCT00891462|69592157|FG000|Overall Study|Adverse Event|7|||
37906557|NCT00891462|69592158|FG001|Overall Study|Adverse Event|8|||
37906558|NCT00891462|69592159|FG002|Overall Study|Adverse Event|7|||
37906559|NCT00891462|69592157|FG000|Overall Study|Lack of Efficacy|10|||
37906560|NCT00891462|69592158|FG001|Overall Study|Lack of Efficacy|5|||
37906561|NCT00891462|69592159|FG002|Overall Study|Lack of Efficacy|1|||
37906562|NCT00891462|69592157|FG000|Overall Study|COPD exacerbation|7|||
37906563|NCT00891462|69592158|FG001|Overall Study|COPD exacerbation|4|||
37906564|NCT00891462|69592159|FG002|Overall Study|COPD exacerbation|1|||
37906565|NCT00891462|69592157|FG000|Overall Study|Other Reason|2|||
37906566|NCT00891462|69592158|FG001|Overall Study|Other Reason|5|||
37906567|NCT00891462|69592159|FG002|Overall Study|Other Reason|3|||
37906568|NCT00891462|69592157|FG000|Overall Study|Protocol Violation|2|||
37906569|NCT00891462|69592158|FG001|Overall Study|Protocol Violation|1|||
37906570|NCT00891462|69592159|FG002|Overall Study|Protocol Violation|3|||
37906571|NCT00891462|69592157|FG000|Overall Study|Inclusion/exclusion criteria|0|||
37906572|NCT00891462|69592158|FG001|Overall Study|Inclusion/exclusion criteria|2|||
37906573|NCT00891462|69592159|FG002|Overall Study|Inclusion/exclusion criteria|2|||
37906574|NCT00891462|69592157|FG000|Overall Study|Lost to Follow-up|0|||
38004506|NCT00133952|69688086|FG001|Overall Study|Physician Decision|3|||
38004507|NCT00133952|69688085|FG000|Overall Study|Sponsor Decision|0|||
38004508|NCT00133952|69688086|FG001|Overall Study|Sponsor Decision|1|||
38004509|NCT00118092|69688092|FG000|Overall Study|Withdrawal by Subject|1|||
37906575|NCT00891462|69592158|FG001|Overall Study|Lost to Follow-up|2|||
37906576|NCT00891462|69592159|FG002|Overall Study|Lost to Follow-up|0|||
37906577|NCT00900146|69592174|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
37906578|NCT00900146|69592175|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
37906579|NCT00900146|69592176|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
37906580|NCT00900146|69592177|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
37906581|NCT00900146|69592178|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
37906582|NCT00900146|69592174|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
37906583|NCT00900146|69592175|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
37906584|NCT00900146|69592176|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
37906585|NCT00900146|69592177|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
37906586|NCT00900146|69592178|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
37906587|NCT00900146|69592174|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
37906588|NCT00900146|69592175|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
37906589|NCT00900146|69592176|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
37906590|NCT00900146|69592177|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
37906591|NCT00900146|69592178|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
37906592|NCT00900146|69592174|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
37906593|NCT00900146|69592175|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
37906594|NCT00900146|69592176|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
37906595|NCT00900146|69592177|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
37906596|NCT00900146|69592178|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
37906597|NCT00900146|69592174|FG000|Intermediate: Period III|Lost to Follow-up|2|||
37906598|NCT00900146|69592175|FG001|Intermediate: Period III|Lost to Follow-up|0|||
37906599|NCT00900146|69592176|FG002|Intermediate: Period III|Lost to Follow-up|0|||
37906600|NCT00900146|69592177|FG003|Intermediate: Period III|Lost to Follow-up|0|||
37906601|NCT00900146|69592178|FG004|Intermediate: Period III|Lost to Follow-up|1|||
37906602|NCT00900146|69592174|FG000|Intermediate: Period III|Administrative problems|85|||
37906603|NCT00900146|69592175|FG001|Intermediate: Period III|Administrative problems|92|||
37906604|NCT00900146|69592176|FG002|Intermediate: Period III|Administrative problems|84|||
37906605|NCT00900146|69592177|FG003|Intermediate: Period III|Administrative problems|90|||
37906606|NCT00900146|69592178|FG004|Intermediate: Period III|Administrative problems|163|||
37906607|NCT00895310|69592190|FG000|Overall Study|Withdrawal by Subject|1|||
37906608|NCT00895154|69592196|FG000|Overall Study|Lost to Follow-up|1|||
37906609|NCT00895154|69592197|FG001|Overall Study|Lost to Follow-up|1|||
37906610|NCT00895154|69592196|FG000|Overall Study|Withdrawal by Subject|0|||
37906611|NCT00895154|69592197|FG001|Overall Study|Withdrawal by Subject|1|||
37906612|NCT00888654|69592203|FG000|Overall Study|Problems swallowing oral meds.|1|||
37906613|NCT00888654|69592203|FG000|Overall Study|Not enough oral meds before surgery|3|||
37906614|NCT00888654|69592203|FG000|Overall Study|Surgery aborted|2|||
37906615|NCT00888654|69592203|FG000|Overall Study|Withdrawal by Subject|1|||
37906616|NCT00888654|69592203|FG000|Overall Study|Inelig. due to contraindication of med|1|||
37906617|NCT00888654|69592203|FG000|Overall Study|Change in surg date|1|||
37906618|NCT00888654|69592203|FG000|Overall Study|Stopped meds due to headaches|1|||
37906619|NCT00899678|69592210|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
37906620|NCT00899678|69592211|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
37906621|NCT00899678|69592212|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
37906622|NCT00899678|69592210|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
37906623|NCT00899678|69592211|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
37906624|NCT00899678|69592212|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
37906625|NCT00899678|69592210|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
37906626|NCT00899678|69592211|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
37906627|NCT00899678|69592212|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
37830582|NCT01309204|69513830|FG000|Overall Study|Adverse Event|48|||
37830583|NCT01309204|69513831|FG001|Overall Study|Adverse Event|58|||
37830584|NCT01309204|69513830|FG000|Overall Study|Lost to Follow-up|2|||
37830585|NCT01309204|69513831|FG001|Overall Study|Lost to Follow-up|2|||
37830586|NCT01309204|69513830|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
37830587|NCT01309204|69513831|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
37830588|NCT01309204|69513830|FG000|Overall Study|Inadequate control of IOP|4|||
37830589|NCT01309204|69513831|FG001|Overall Study|Inadequate control of IOP|4|||
37830590|NCT01309204|69513830|FG000|Overall Study|Other|4|||
37830591|NCT01309204|69513831|FG001|Overall Study|Other|1|||
37830592|NCT01309165|69513839|FG000|Overall Study|Lost to Follow-up|4|||
37830593|NCT01309165|69513840|FG001|Overall Study|Lost to Follow-up|3|||
37830594|NCT01309165|69513839|FG000|Overall Study|Return to work|1|||
37830595|NCT01309165|69513840|FG001|Overall Study|Return to work|2|||
37830596|NCT01309165|69513839|FG000|Overall Study|Left country|0|||
37830597|NCT01309165|69513840|FG001|Overall Study|Left country|1|||
37830598|NCT01309165|69513839|FG000|Overall Study|No transportation|0|||
37830599|NCT01309165|69513840|FG001|Overall Study|No transportation|1|||
37830600|NCT01309165|69513839|FG000|Overall Study|Admitted to hospital for second stroke|1|||
37830601|NCT01309165|69513840|FG001|Overall Study|Admitted to hospital for second stroke|0|||
37830602|NCT01308853|69513847|FG000|Overall Study|Adverse Event|1|||
37830603|NCT01308853|69513847|FG000|Overall Study|Lost to Follow-up|2|||
37906628|NCT00899678|69592210|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
37906629|NCT00899678|69592211|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
37830604|NCT01308853|69513847|FG000|Overall Study|Insertion of permanent implants|1|||
37830605|NCT01308736|69513853|FG000|Overall Study|Did not attend a single session|6|||
37830606|NCT01308736|69513854|FG001|Overall Study|Did not attend a single session|5|||
37830607|NCT01308580|69513862|FG000|Overall Study|Lost to Follow-up|12|||
37830608|NCT01308580|69513863|FG001|Overall Study|Lost to Follow-up|7|||
37830609|NCT01308463|69513870|FG000|Overall Study|Study Discontinued|23|||
37830610|NCT01308463|69513870|FG000|Overall Study|Death|4|||
37830611|NCT01308463|69513870|FG000|Overall Study|Revision|2|||
37906630|NCT00899678|69592212|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
37906631|NCT00899678|69592210|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
37906632|NCT00899678|69592211|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
37906633|NCT00899678|69592212|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
37906634|NCT00899678|69592210|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
37906635|NCT00899678|69592211|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
37906636|NCT00899678|69592212|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
37906637|NCT00899678|69592210|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
37906638|NCT00899678|69592211|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
37906639|NCT00899678|69592212|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
37906640|NCT00899678|69592210|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
37906641|NCT00899678|69592211|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
37906642|NCT00899678|69592212|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
37906643|NCT00899678|69592210|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
37906644|NCT00899678|69592211|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
37906645|NCT00899678|69592212|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
37906646|NCT00887484|69592220|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
37906647|NCT00887484|69592220|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
37906648|NCT00887484|69592220|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
37906649|NCT00886938|69592229|FG000|Overall Study|Adverse Event|1|||
37906650|NCT00886938|69592229|FG000|Overall Study|Withdrawal by Subject|1|||
37906651|NCT00620659|69592233|FG000|Treatment Period 1|Adverse Event|1|||
37906652|NCT00620659|69592234|FG001|Treatment Period 1|Adverse Event|0|||
37906653|NCT00620659|69592235|FG002|Treatment Period 1|Adverse Event|0|||
37906654|NCT00620659|69592236|FG003|Treatment Period 1|Adverse Event|3|||
37906655|NCT00620659|69592237|FG004|Treatment Period 1|Adverse Event|0|||
37906656|NCT00620659|69592238|FG005|Treatment Period 1|Adverse Event|0|||
37906657|NCT00620659|69592233|FG000|Treatment Period 1|Protocol Violation|1|||
37906658|NCT00620659|69592234|FG001|Treatment Period 1|Protocol Violation|0|||
37906659|NCT00620659|69592235|FG002|Treatment Period 1|Protocol Violation|0|||
37906660|NCT00620659|69592236|FG003|Treatment Period 1|Protocol Violation|0|||
37906661|NCT00620659|69592237|FG004|Treatment Period 1|Protocol Violation|0|||
37906662|NCT00620659|69592238|FG005|Treatment Period 1|Protocol Violation|0|||
37906663|NCT00620659|69592233|FG000|Treatment Period 1|Withdrawal by Subject|1|||
37906664|NCT00620659|69592234|FG001|Treatment Period 1|Withdrawal by Subject|0|||
37906665|NCT00620659|69592235|FG002|Treatment Period 1|Withdrawal by Subject|1|||
37906666|NCT00620659|69592236|FG003|Treatment Period 1|Withdrawal by Subject|0|||
37906667|NCT00620659|69592237|FG004|Treatment Period 1|Withdrawal by Subject|1|||
37906668|NCT00620659|69592238|FG005|Treatment Period 1|Withdrawal by Subject|0|||
37906669|NCT00620659|69592233|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
37906670|NCT00620659|69592234|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
37906671|NCT00620659|69592235|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
37906672|NCT00620659|69592236|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
37906673|NCT00620659|69592237|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
37906674|NCT00620659|69592238|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
37906675|NCT00620659|69592233|FG000|Treatment Period 2|Adverse Event|0|||
37906676|NCT00620659|69592234|FG001|Treatment Period 2|Adverse Event|3|||
37906677|NCT00620659|69592235|FG002|Treatment Period 2|Adverse Event|0|||
37906678|NCT00620659|69592236|FG003|Treatment Period 2|Adverse Event|0|||
37906679|NCT00620659|69592237|FG004|Treatment Period 2|Adverse Event|2|||
37906680|NCT00620659|69592238|FG005|Treatment Period 2|Adverse Event|0|||
37906681|NCT00620659|69592233|FG000|Treatment Period 2|Withdrawal by Subject|0|||
37906682|NCT00620659|69592234|FG001|Treatment Period 2|Withdrawal by Subject|0|||
37906683|NCT00620659|69592235|FG002|Treatment Period 2|Withdrawal by Subject|1|||
37906684|NCT00620659|69592236|FG003|Treatment Period 2|Withdrawal by Subject|0|||
37906685|NCT00620659|69592237|FG004|Treatment Period 2|Withdrawal by Subject|3|||
37906686|NCT00620659|69592238|FG005|Treatment Period 2|Withdrawal by Subject|0|||
37906687|NCT00620659|69592233|FG000|Placebo Washout Period 2|Adverse Event|2|||
37906688|NCT00620659|69592234|FG001|Placebo Washout Period 2|Adverse Event|0|||
37906689|NCT00620659|69592235|FG002|Placebo Washout Period 2|Adverse Event|0|||
37906690|NCT00620659|69592236|FG003|Placebo Washout Period 2|Adverse Event|0|||
37906691|NCT00620659|69592237|FG004|Placebo Washout Period 2|Adverse Event|0|||
37906692|NCT00620659|69592238|FG005|Placebo Washout Period 2|Adverse Event|0|||
37906693|NCT00620659|69592233|FG000|Treatment Period 3|Adverse Event|0|||
37906694|NCT00620659|69592234|FG001|Treatment Period 3|Adverse Event|2|||
37906695|NCT00620659|69592235|FG002|Treatment Period 3|Adverse Event|0|||
37906696|NCT00620659|69592236|FG003|Treatment Period 3|Adverse Event|0|||
37906697|NCT00620659|69592237|FG004|Treatment Period 3|Adverse Event|0|||
37906698|NCT00620659|69592238|FG005|Treatment Period 3|Adverse Event|0|||
37906699|NCT00620659|69592233|FG000|Treatment Period 3|Withdrawal by Subject|0|||
37906700|NCT00620659|69592234|FG001|Treatment Period 3|Withdrawal by Subject|0|||
37906701|NCT00620659|69592235|FG002|Treatment Period 3|Withdrawal by Subject|0|||
37906702|NCT00620659|69592236|FG003|Treatment Period 3|Withdrawal by Subject|1|||
37906703|NCT00620659|69592237|FG004|Treatment Period 3|Withdrawal by Subject|0|||
37906704|NCT00620659|69592238|FG005|Treatment Period 3|Withdrawal by Subject|0|||
37906705|NCT00894686|69592251|FG000|Overall Study|Withdrawal by Subject|50|||
37906706|NCT00894686|69592251|FG000|Overall Study|Physician Decision|1|||
37906707|NCT00894686|69592251|FG000|Overall Study|Other|5|||
37906708|NCT00885846|69592258|FG000|Overall Study|Withdrawal by Subject|2|||
37906709|NCT00885846|69592259|FG001|Overall Study|Withdrawal by Subject|5|||
37906710|NCT00885846|69592260|FG002|Overall Study|Withdrawal by Subject|2|||
37906711|NCT00621517|69592270|FG000|Overall Study|Lost to Follow-up|3|||
37906712|NCT00621517|69592271|FG001|Overall Study|Lost to Follow-up|3|||
37906713|NCT00621517|69592270|FG000|Overall Study|Withdrawal by Subject|3|||
37906714|NCT00621517|69592271|FG001|Overall Study|Withdrawal by Subject|4|||
37906715|NCT00621517|69592270|FG000|Overall Study|Adverse Event|1|||
37906716|NCT00621517|69592271|FG001|Overall Study|Adverse Event|0|||
37906717|NCT00573937|69592279|FG000|Overall Study|Study Terminated|0|||
37906718|NCT00573937|69592280|FG001|Overall Study|Study Terminated|1|||
37906719|NCT00573859|69592286|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
37906720|NCT00573859|69592286|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
37906721|NCT00831441|69592292|FG000|Randomized|Death|82|||
37906722|NCT00831441|69592293|FG001|Randomized|Death|81|||
37906723|NCT00831441|69592292|FG000|Randomized|Adverse Event|248|||
37906724|NCT00831441|69592293|FG001|Randomized|Adverse Event|321|||
37906725|NCT00831441|69592292|FG000|Randomized|Emergency procedure|2|||
37906726|NCT00831441|69592293|FG001|Randomized|Emergency procedure|2|||
37906727|NCT00831441|69592292|FG000|Randomized|Elective procedure|26|||
37906728|NCT00831441|69592293|FG001|Randomized|Elective procedure|25|||
37906729|NCT00831441|69592292|FG000|Randomized|Physician Decision|26|||
37906730|NCT00831441|69592293|FG001|Randomized|Physician Decision|35|||
37906731|NCT00831441|69592292|FG000|Randomized|No longer met criteria|13|||
37906732|NCT00831441|69592293|FG001|Randomized|No longer met criteria|19|||
37906733|NCT00831441|69592292|FG000|Randomized|Withdrawal by Subject|178|||
37906734|NCT00831441|69592293|FG001|Randomized|Withdrawal by Subject|212|||
37906735|NCT00831441|69592292|FG000|Randomized|Lost to Follow-up|26|||
37906736|NCT00831441|69592293|FG001|Randomized|Lost to Follow-up|35|||
37906737|NCT00831441|69592292|FG000|Randomized|Administrative reason by sponsor|2780|||
37906738|NCT00831441|69592293|FG001|Randomized|Administrative reason by sponsor|2671|||
37906739|NCT00831441|69592292|FG000|Randomized|poor/non-compliance|30|||
37906740|NCT00831441|69592293|FG001|Randomized|poor/non-compliance|38|||
37906741|NCT00831441|69592292|FG000|Randomized|non-specified|276|||
37906742|NCT00831441|69592293|FG001|Randomized|non-specified|266|||
37906743|NCT00831441|69592292|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
37906744|NCT00831441|69592293|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
37906745|NCT00831441|69592292|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
37906746|NCT00831441|69592293|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
37906747|NCT00831441|69592292|FG000|Follow Up (30 Days)|Death|63|||
37906748|NCT00831441|69592293|FG001|Follow Up (30 Days)|Death|86|||
37906749|NCT00831441|69592292|FG000|Follow Up (30 Days)|non-specified|16|||
37906750|NCT00831441|69592293|FG001|Follow Up (30 Days)|non-specified|26|||
37906751|NCT00831441|69592292|FG000|Follow Up (30 Days)|missing end of study status|0|||
37906752|NCT00831441|69592293|FG001|Follow Up (30 Days)|missing end of study status|1|||
37906753|NCT00831129|69592302|FG000|Overall Study|Adverse Event|0|||
37906754|NCT00831129|69592303|FG001|Overall Study|Adverse Event|1|||
37906755|NCT00831129|69592302|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
37906756|NCT00831129|69592303|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
37906757|NCT00620113|69592313|FG000|Overall Study|Adverse Event|3|||
37906758|NCT00620113|69592314|FG001|Overall Study|Adverse Event|2|||
37906759|NCT00620113|69592315|FG002|Overall Study|Adverse Event|2|||
37906760|NCT00620113|69592316|FG003|Overall Study|Adverse Event|1|||
37906761|NCT00620113|69592313|FG000|Overall Study|Lack of Efficacy|2|||
37906762|NCT00620113|69592314|FG001|Overall Study|Lack of Efficacy|3|||
37906763|NCT00620113|69592315|FG002|Overall Study|Lack of Efficacy|0|||
37906764|NCT00620113|69592316|FG003|Overall Study|Lack of Efficacy|2|||
37906765|NCT00620113|69592313|FG000|Overall Study|Physician Decision|1|||
37906766|NCT00620113|69592314|FG001|Overall Study|Physician Decision|0|||
37906767|NCT00620113|69592315|FG002|Overall Study|Physician Decision|0|||
37906768|NCT00620113|69592316|FG003|Overall Study|Physician Decision|2|||
37906769|NCT00620113|69592313|FG000|Overall Study|Protocol Violation|2|||
37906770|NCT00620113|69592314|FG001|Overall Study|Protocol Violation|1|||
37906771|NCT00620113|69592315|FG002|Overall Study|Protocol Violation|0|||
37906772|NCT00620113|69592316|FG003|Overall Study|Protocol Violation|0|||
37906773|NCT00620113|69592313|FG000|Overall Study|Withdrawal by Subject|5|||
37906774|NCT00620113|69592314|FG001|Overall Study|Withdrawal by Subject|1|||
38004510|NCT00118092|69688092|FG000|Overall Study|Protocol Violation|1|||
37906775|NCT00620113|69592315|FG002|Overall Study|Withdrawal by Subject|3|||
37906776|NCT00620113|69592316|FG003|Overall Study|Withdrawal by Subject|5|||
37906777|NCT00830115|69592326|FG000|Overall Study|Adverse Event|2|||
37906778|NCT00830115|69592326|FG000|Overall Study|Improvement/recovery|1|||
37906779|NCT00830037|69592334|FG000|Overall Study|Withdrawal by Subject|2|||
37906780|NCT00830037|69592335|FG001|Overall Study|Withdrawal by Subject|3|||
37906781|NCT00830037|69592334|FG000|Overall Study|Lost to Follow-up|1|||
37906782|NCT00830037|69592335|FG001|Overall Study|Lost to Follow-up|2|||
37906783|NCT00830037|69592334|FG000|Overall Study|Active when terminated by DSMB|15|||
37906784|NCT00830037|69592335|FG001|Overall Study|Active when terminated by DSMB|14|||
37906785|NCT00829413|69592341|FG000|Overall Study|No study drug admimnistered|13|||
37906786|NCT00829413|69592341|FG000|Overall Study|Training Patients|67|||
37906787|NCT00829413|69592341|FG000|Overall Study|No truth standard procedure available|9|||
37906788|NCT00829413|69592341|FG000|Overall Study|Technically inadequate truth standard|2|||
37906789|NCT00829413|69592341|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
37906790|NCT00829179|69592352|FG000|Overall Study|Withdrawal by Subject|1|||
37906791|NCT00591591|69592358|FG000|Overall Study|Withdrawal by Subject|1|||
37906792|NCT00591591|69592359|FG001|Overall Study|Withdrawal by Subject|37|||
37906793|NCT00591591|69592358|FG000|Overall Study|Lack of Efficacy|10|||
37906794|NCT00591591|69592359|FG001|Overall Study|Lack of Efficacy|2|||
37906795|NCT00828945|69592365|FG000|Overall Study|Death|4|||
37906796|NCT00828945|69592365|FG000|Overall Study|Participant was missing|1|||
37906797|NCT00828945|69592365|FG000|Overall Study|Other|36|||
37906798|NCT00966875|69592378|FG000|Part A|Adverse Event|2|||
37906799|NCT00966875|69592379|FG001|Part A|Adverse Event|1|||
37906800|NCT00966875|69592380|FG002|Part A|Adverse Event|0|||
37906801|NCT00966875|69592381|FG003|Part A|Adverse Event|1|||
37906802|NCT00966875|69592382|FG004|Part A|Adverse Event|0|||
37906803|NCT00966875|69592383|FG005|Part A|Adverse Event|1|||
37906804|NCT00966875|69592384|FG006|Part A|Adverse Event|0|||
37906805|NCT00966875|69592385|FG007|Part A|Adverse Event|3|||
37906806|NCT00966875|69592386|FG008|Part A|Adverse Event|3|||
37906807|NCT00966875|69592378|FG000|Part A|Entry Criteria|0|||
37906808|NCT00966875|69592379|FG001|Part A|Entry Criteria|0|||
37906809|NCT00966875|69592380|FG002|Part A|Entry Criteria|0|||
37906810|NCT00966875|69592381|FG003|Part A|Entry Criteria|0|||
37906811|NCT00966875|69592382|FG004|Part A|Entry Criteria|0|||
37906812|NCT00966875|69592383|FG005|Part A|Entry Criteria|2|||
37906813|NCT00966875|69592384|FG006|Part A|Entry Criteria|0|||
37906814|NCT00966875|69592385|FG007|Part A|Entry Criteria|0|||
37906815|NCT00966875|69592386|FG008|Part A|Entry Criteria|0|||
37906816|NCT00966875|69592378|FG000|Part A|Lack of Efficacy|0|||
37906817|NCT00966875|69592379|FG001|Part A|Lack of Efficacy|1|||
37906818|NCT00966875|69592380|FG002|Part A|Lack of Efficacy|0|||
37906819|NCT00966875|69592381|FG003|Part A|Lack of Efficacy|0|||
37906820|NCT00966875|69592382|FG004|Part A|Lack of Efficacy|0|||
37906821|NCT00966875|69592383|FG005|Part A|Lack of Efficacy|0|||
37906822|NCT00966875|69592384|FG006|Part A|Lack of Efficacy|4|||
37906823|NCT00966875|69592385|FG007|Part A|Lack of Efficacy|0|||
37906824|NCT00966875|69592386|FG008|Part A|Lack of Efficacy|0|||
37906825|NCT00966875|69592378|FG000|Part A|Lost to Follow-up|2|||
37906826|NCT00966875|69592379|FG001|Part A|Lost to Follow-up|0|||
37906827|NCT00966875|69592380|FG002|Part A|Lost to Follow-up|0|||
37906828|NCT00966875|69592381|FG003|Part A|Lost to Follow-up|0|||
37906829|NCT00966875|69592382|FG004|Part A|Lost to Follow-up|0|||
37906830|NCT00966875|69592383|FG005|Part A|Lost to Follow-up|1|||
37906831|NCT00966875|69592384|FG006|Part A|Lost to Follow-up|0|||
37906832|NCT00966875|69592385|FG007|Part A|Lost to Follow-up|0|||
37906833|NCT00966875|69592386|FG008|Part A|Lost to Follow-up|0|||
37906834|NCT00966875|69592378|FG000|Part A|Parent/Caregiver Decision|0|||
37906835|NCT00966875|69592379|FG001|Part A|Parent/Caregiver Decision|0|||
37906836|NCT00966875|69592380|FG002|Part A|Parent/Caregiver Decision|0|||
37906837|NCT00966875|69592381|FG003|Part A|Parent/Caregiver Decision|1|||
37906838|NCT00966875|69592382|FG004|Part A|Parent/Caregiver Decision|0|||
37906839|NCT00966875|69592383|FG005|Part A|Parent/Caregiver Decision|0|||
37906840|NCT00966875|69592384|FG006|Part A|Parent/Caregiver Decision|0|||
37906841|NCT00966875|69592385|FG007|Part A|Parent/Caregiver Decision|0|||
37906842|NCT00966875|69592386|FG008|Part A|Parent/Caregiver Decision|0|||
37906843|NCT00966875|69592378|FG000|Part A|Physician Decision|0|||
37906844|NCT00966875|69592379|FG001|Part A|Physician Decision|0|||
37906845|NCT00966875|69592380|FG002|Part A|Physician Decision|0|||
37906846|NCT00966875|69592381|FG003|Part A|Physician Decision|0|||
37906847|NCT00966875|69592382|FG004|Part A|Physician Decision|1|||
37906848|NCT00966875|69592383|FG005|Part A|Physician Decision|0|||
37906849|NCT00966875|69592384|FG006|Part A|Physician Decision|1|||
37906850|NCT00966875|69592385|FG007|Part A|Physician Decision|0|||
37906851|NCT00966875|69592386|FG008|Part A|Physician Decision|2|||
37906852|NCT00966875|69592378|FG000|Part A|Sponsor Decision|0|||
37906853|NCT00966875|69592379|FG001|Part A|Sponsor Decision|0|||
37906854|NCT00966875|69592380|FG002|Part A|Sponsor Decision|1|||
37906855|NCT00966875|69592381|FG003|Part A|Sponsor Decision|0|||
37906856|NCT00966875|69592382|FG004|Part A|Sponsor Decision|1|||
37906857|NCT00966875|69592383|FG005|Part A|Sponsor Decision|0|||
37906858|NCT00966875|69592384|FG006|Part A|Sponsor Decision|0|||
37906859|NCT00966875|69592385|FG007|Part A|Sponsor Decision|2|||
37906860|NCT00966875|69592386|FG008|Part A|Sponsor Decision|1|||
37906861|NCT00966875|69592378|FG000|Part A|Withdrawal by Subject|2|||
37906862|NCT00966875|69592379|FG001|Part A|Withdrawal by Subject|2|||
37906863|NCT00966875|69592380|FG002|Part A|Withdrawal by Subject|1|||
37906864|NCT00966875|69592381|FG003|Part A|Withdrawal by Subject|1|||
37906865|NCT00966875|69592382|FG004|Part A|Withdrawal by Subject|3|||
37906866|NCT00966875|69592383|FG005|Part A|Withdrawal by Subject|0|||
37906867|NCT00966875|69592384|FG006|Part A|Withdrawal by Subject|5|||
37906868|NCT00966875|69592385|FG007|Part A|Withdrawal by Subject|1|||
37906869|NCT00966875|69592386|FG008|Part A|Withdrawal by Subject|1|||
37906870|NCT00966875|69592378|FG000|Part A|Protocol Violation|0|||
37906871|NCT00966875|69592379|FG001|Part A|Protocol Violation|0|||
37906872|NCT00966875|69592380|FG002|Part A|Protocol Violation|0|||
37906873|NCT00966875|69592381|FG003|Part A|Protocol Violation|0|||
37906874|NCT00966875|69592382|FG004|Part A|Protocol Violation|0|||
37906875|NCT00966875|69592383|FG005|Part A|Protocol Violation|0|||
37906876|NCT00966875|69592384|FG006|Part A|Protocol Violation|2|||
37906877|NCT00966875|69592385|FG007|Part A|Protocol Violation|1|||
37906878|NCT00966875|69592386|FG008|Part A|Protocol Violation|1|||
37906879|NCT00966875|69592378|FG000|Part B|Adverse Event|0|||
37906880|NCT00966875|69592379|FG001|Part B|Adverse Event|1|||
37906881|NCT00966875|69592380|FG002|Part B|Adverse Event|1|||
37906882|NCT00966875|69592381|FG003|Part B|Adverse Event|0|||
37906883|NCT00966875|69592382|FG004|Part B|Adverse Event|1|||
37906884|NCT00966875|69592383|FG005|Part B|Adverse Event|0|||
37906885|NCT00966875|69592384|FG006|Part B|Adverse Event|5|||
37906886|NCT00966875|69592385|FG007|Part B|Adverse Event|2|||
37906887|NCT00966875|69592386|FG008|Part B|Adverse Event|2|||
37906888|NCT00966875|69592378|FG000|Part B|Death|0|||
37906889|NCT00966875|69592379|FG001|Part B|Death|0|||
37906890|NCT00966875|69592380|FG002|Part B|Death|1|||
37906891|NCT00966875|69592381|FG003|Part B|Death|0|||
37906892|NCT00966875|69592382|FG004|Part B|Death|0|||
37906893|NCT00966875|69592383|FG005|Part B|Death|0|||
37906894|NCT00966875|69592384|FG006|Part B|Death|0|||
37906895|NCT00966875|69592385|FG007|Part B|Death|1|||
37906896|NCT00966875|69592386|FG008|Part B|Death|0|||
37906897|NCT00966875|69592378|FG000|Part B|Lack of Efficacy|2|||
37906898|NCT00966875|69592379|FG001|Part B|Lack of Efficacy|1|||
37906899|NCT00966875|69592380|FG002|Part B|Lack of Efficacy|1|||
37906900|NCT00966875|69592381|FG003|Part B|Lack of Efficacy|1|||
37906901|NCT00966875|69592382|FG004|Part B|Lack of Efficacy|2|||
37906902|NCT00966875|69592383|FG005|Part B|Lack of Efficacy|3|||
37906903|NCT00966875|69592384|FG006|Part B|Lack of Efficacy|12|||
37906904|NCT00966875|69592385|FG007|Part B|Lack of Efficacy|9|||
37906905|NCT00966875|69592386|FG008|Part B|Lack of Efficacy|6|||
37906906|NCT00966875|69592378|FG000|Part B|Lost to Follow-up|0|||
37906907|NCT00966875|69592379|FG001|Part B|Lost to Follow-up|0|||
37906908|NCT00966875|69592380|FG002|Part B|Lost to Follow-up|0|||
37906909|NCT00966875|69592381|FG003|Part B|Lost to Follow-up|1|||
37906910|NCT00966875|69592382|FG004|Part B|Lost to Follow-up|0|||
37906911|NCT00966875|69592383|FG005|Part B|Lost to Follow-up|0|||
37906912|NCT00966875|69592384|FG006|Part B|Lost to Follow-up|0|||
37906913|NCT00966875|69592385|FG007|Part B|Lost to Follow-up|0|||
37906914|NCT00966875|69592386|FG008|Part B|Lost to Follow-up|1|||
37906915|NCT00966875|69592378|FG000|Part B|Physician Decision|0|||
37906916|NCT00966875|69592379|FG001|Part B|Physician Decision|0|||
37906917|NCT00966875|69592380|FG002|Part B|Physician Decision|1|||
37906918|NCT00966875|69592381|FG003|Part B|Physician Decision|0|||
37906919|NCT00966875|69592382|FG004|Part B|Physician Decision|2|||
37906920|NCT00966875|69592383|FG005|Part B|Physician Decision|1|||
37830612|NCT01308424|69513876|FG000|Baseline Eligibility|Screen Failures|71|||
37830613|NCT01308424|69513877|FG001|Baseline Eligibility|Screen Failures|0|||
37830614|NCT01308424|69513878|FG002|Baseline Eligibility|Screen Failures|0|||
37830615|NCT01308424|69513876|FG000|Randomization|Adverse Event|0|||
37830616|NCT01308424|69513877|FG001|Randomization|Adverse Event|1|||
37830617|NCT01308424|69513878|FG002|Randomization|Adverse Event|1|||
37830618|NCT01308424|69513876|FG000|Randomization|Lost to Follow-up|0|||
37830619|NCT01308424|69513877|FG001|Randomization|Lost to Follow-up|1|||
37830620|NCT01308424|69513878|FG002|Randomization|Lost to Follow-up|0|||
37830621|NCT01308424|69513876|FG000|Randomization|Physician Decision|0|||
37830622|NCT01308424|69513877|FG001|Randomization|Physician Decision|1|||
37906921|NCT00966875|69592384|FG006|Part B|Physician Decision|0|||
37906922|NCT00966875|69592385|FG007|Part B|Physician Decision|0|||
37830623|NCT01308424|69513878|FG002|Randomization|Physician Decision|1|||
37830624|NCT01307800|69513889|FG000|Overall Study|Adverse Event|9|||
37830625|NCT01307800|69513890|FG001|Overall Study|Adverse Event|8|||
37906923|NCT00966875|69592386|FG008|Part B|Physician Decision|2|||
37906924|NCT00966875|69592378|FG000|Part B|Sponsor Decision|1|||
37906925|NCT00966875|69592379|FG001|Part B|Sponsor Decision|0|||
37906926|NCT00966875|69592380|FG002|Part B|Sponsor Decision|0|||
37906927|NCT00966875|69592381|FG003|Part B|Sponsor Decision|0|||
37906928|NCT00966875|69592382|FG004|Part B|Sponsor Decision|0|||
37906929|NCT00966875|69592383|FG005|Part B|Sponsor Decision|1|||
37906930|NCT00966875|69592384|FG006|Part B|Sponsor Decision|0|||
37906931|NCT00966875|69592385|FG007|Part B|Sponsor Decision|2|||
37906932|NCT00966875|69592386|FG008|Part B|Sponsor Decision|1|||
37906933|NCT00966875|69592378|FG000|Part B|Withdrawal by Subject|2|||
37906934|NCT00966875|69592379|FG001|Part B|Withdrawal by Subject|1|||
37906935|NCT00966875|69592380|FG002|Part B|Withdrawal by Subject|2|||
37906936|NCT00966875|69592381|FG003|Part B|Withdrawal by Subject|1|||
37906937|NCT00966875|69592382|FG004|Part B|Withdrawal by Subject|2|||
37906938|NCT00966875|69592383|FG005|Part B|Withdrawal by Subject|1|||
37906939|NCT00966875|69592384|FG006|Part B|Withdrawal by Subject|4|||
37906940|NCT00966875|69592385|FG007|Part B|Withdrawal by Subject|5|||
37906941|NCT00966875|69592386|FG008|Part B|Withdrawal by Subject|5|||
37906942|NCT00966875|69592378|FG000|Part B|Entry Criteria|0|||
37906943|NCT00966875|69592379|FG001|Part B|Entry Criteria|0|||
37906944|NCT00966875|69592380|FG002|Part B|Entry Criteria|0|||
37906945|NCT00966875|69592381|FG003|Part B|Entry Criteria|0|||
37906946|NCT00966875|69592382|FG004|Part B|Entry Criteria|0|||
37906947|NCT00966875|69592383|FG005|Part B|Entry Criteria|0|||
37906948|NCT00966875|69592384|FG006|Part B|Entry Criteria|1|||
37906949|NCT00966875|69592385|FG007|Part B|Entry Criteria|0|||
37906950|NCT00966875|69592386|FG008|Part B|Entry Criteria|1|||
37906951|NCT00828711|69592462|FG000|Overall Study|Lost to Follow-up|1|||
37906952|NCT00828711|69592463|FG001|Overall Study|Lost to Follow-up|0|||
37906953|NCT00828711|69592464|FG002|Overall Study|Lost to Follow-up|0|||
37906954|NCT00966719|69592474|FG000|Overall Study|Lost to Follow-up|6|||
37906955|NCT00966719|69592475|FG001|Overall Study|Lost to Follow-up|11|||
37906956|NCT00818649|69592481|FG000|Overall Study|Declining performance status|2|||
37906957|NCT00818649|69592481|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
37906958|NCT00818649|69592481|FG000|Overall Study|Adverse Event|1|||
37906959|NCT00961571|69592486|FG000|Overall Study|Physician Decision|39|||
37906960|NCT00964223|69592490|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
37906961|NCT00620815|69592498|FG000|Overall Study|Adverse Event|1|||
37906962|NCT00620815|69592499|FG001|Overall Study|Adverse Event|1|||
37906963|NCT00620815|69592500|FG002|Overall Study|Adverse Event|2|||
37906964|NCT00620815|69592498|FG000|Overall Study|Withdrawal by Subject|1|||
37906965|NCT00620815|69592499|FG001|Overall Study|Withdrawal by Subject|2|||
37906966|NCT00620815|69592500|FG002|Overall Study|Withdrawal by Subject|0|||
37906967|NCT00620815|69592498|FG000|Overall Study|Lost to Follow-up|1|||
37906968|NCT00620815|69592499|FG001|Overall Study|Lost to Follow-up|6|||
37906969|NCT00620815|69592500|FG002|Overall Study|Lost to Follow-up|3|||
37906970|NCT00620815|69592498|FG000|Overall Study|Inappropriate enrolment|0|||
37906971|NCT00620815|69592499|FG001|Overall Study|Inappropriate enrolment|0|||
37906972|NCT00620815|69592500|FG002|Overall Study|Inappropriate enrolment|1|||
37906973|NCT00620815|69592498|FG000|Overall Study|Protocol Violation|1|||
37906974|NCT00620815|69592499|FG001|Overall Study|Protocol Violation|2|||
37906975|NCT00620815|69592500|FG002|Overall Study|Protocol Violation|1|||
37906976|NCT03372941|69592526|FG000|Overall Study|Lost to Follow-up|2|||
37906977|NCT03372941|69592527|FG001|Overall Study|Lost to Follow-up|4|||
37906978|NCT00619957|69592535|FG000|Month 24 Double-Blind|Adverse Event|9|||
37906979|NCT00619957|69592536|FG001|Month 24 Double-Blind|Adverse Event|7|||
37906980|NCT00619957|69592535|FG000|Month 24 Double-Blind|Protocol Violation|1|||
37906981|NCT00619957|69592536|FG001|Month 24 Double-Blind|Protocol Violation|0|||
37906982|NCT00619957|69592535|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
37906983|NCT00619957|69592536|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
37906984|NCT00619957|69592535|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
37906985|NCT00619957|69592536|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
37906986|NCT00619957|69592535|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
37906987|NCT00619957|69592536|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
37906988|NCT00619957|69592535|FG000|Month 48 Open-Label|Adverse Event|4|||
37906989|NCT00619957|69592536|FG001|Month 48 Open-Label|Adverse Event|4|||
37906990|NCT00619957|69592535|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
37906991|NCT00619957|69592536|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
37906992|NCT00619957|69592535|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
37906993|NCT00619957|69592536|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
37830626|NCT01307800|69513891|FG002|Overall Study|Adverse Event|10|||
37830627|NCT01307800|69513892|FG003|Overall Study|Adverse Event|14|||
37830628|NCT01307800|69513889|FG000|Overall Study|Entry Criteria Not Met|0|||
37830629|NCT01307800|69513890|FG001|Overall Study|Entry Criteria Not Met|0|||
37830630|NCT01307800|69513891|FG002|Overall Study|Entry Criteria Not Met|0|||
37830631|NCT01307800|69513892|FG003|Overall Study|Entry Criteria Not Met|2|||
37830632|NCT01307800|69513889|FG000|Overall Study|Lost to Follow-up|5|||
37906994|NCT00961415|69592546|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
37906995|NCT00961415|69592547|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
37906996|NCT00961415|69592548|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
37906997|NCT00961415|69592546|FG000|Induction Treatment Phase|Death|77|||
37906998|NCT00961415|69592547|FG001|Induction Treatment Phase|Death|0|||
37906999|NCT00961415|69592548|FG002|Induction Treatment Phase|Death|0|||
37907000|NCT00961415|69592546|FG000|Induction Treatment Phase|Protocol Violation|1|||
37907001|NCT00961415|69592547|FG001|Induction Treatment Phase|Protocol Violation|0|||
37907002|NCT00961415|69592548|FG002|Induction Treatment Phase|Protocol Violation|0|||
37907003|NCT00961415|69592546|FG000|Induction Treatment Phase|Physician Decision|2|||
37830633|NCT01307800|69513890|FG001|Overall Study|Lost to Follow-up|6|||
37907004|NCT00961415|69592547|FG001|Induction Treatment Phase|Physician Decision|0|||
37907005|NCT00961415|69592548|FG002|Induction Treatment Phase|Physician Decision|0|||
37907006|NCT00961415|69592546|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
37907007|NCT00961415|69592547|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
37907008|NCT00961415|69592548|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
37907009|NCT00961415|69592546|FG000|Induction Treatment Phase|Other Reason|5|||
37907010|NCT00961415|69592547|FG001|Induction Treatment Phase|Other Reason|0|||
37907011|NCT00961415|69592548|FG002|Induction Treatment Phase|Other Reason|0|||
37907012|NCT00961415|69592546|FG000|Maintenance Treatment Phase|Death|0|||
37907013|NCT00961415|69592547|FG001|Maintenance Treatment Phase|Death|42|||
37907014|NCT00961415|69592548|FG002|Maintenance Treatment Phase|Death|34|||
37907015|NCT00961415|69592546|FG000|Maintenance Treatment Phase|Investigators decision|0|||
37907016|NCT00961415|69592547|FG001|Maintenance Treatment Phase|Investigators decision|2|||
37907017|NCT00961415|69592548|FG002|Maintenance Treatment Phase|Investigators decision|0|||
37907018|NCT00961415|69592546|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
37907019|NCT00961415|69592547|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
37907020|NCT00961415|69592548|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
37907021|NCT00961415|69592546|FG000|Maintenance Treatment Phase|Other reason|0|||
37907022|NCT00961415|69592547|FG001|Maintenance Treatment Phase|Other reason|1|||
37907023|NCT00961415|69592548|FG002|Maintenance Treatment Phase|Other reason|3|||
37907024|NCT00963599|69592566|FG000|Overall Study|Adverse Event|2|||
37907025|NCT00963599|69592567|FG001|Overall Study|Adverse Event|0|||
37907026|NCT00963599|69592568|FG002|Overall Study|Adverse Event|1|||
37907027|NCT00963599|69592569|FG003|Overall Study|Adverse Event|2|||
37907028|NCT00963599|69592566|FG000|Overall Study|Lack of Efficacy|0|||
37907029|NCT00963599|69592567|FG001|Overall Study|Lack of Efficacy|2|||
37907030|NCT00963599|69592568|FG002|Overall Study|Lack of Efficacy|1|||
37907031|NCT00963599|69592569|FG003|Overall Study|Lack of Efficacy|4|||
37907032|NCT00963599|69592566|FG000|Overall Study|Lost to Follow-up|0|||
37907033|NCT00963599|69592567|FG001|Overall Study|Lost to Follow-up|1|||
37907034|NCT00963599|69592568|FG002|Overall Study|Lost to Follow-up|1|||
37907035|NCT00963599|69592569|FG003|Overall Study|Lost to Follow-up|1|||
38004511|NCT04555096|69688099|FG000|Overall Study|Death|4|||
38004512|NCT04555096|69688100|FG001|Overall Study|Death|4|||
38004513|NCT04555096|69688099|FG000|Overall Study|Withdrawal by Subject|1|||
38004514|NCT04555096|69688100|FG001|Overall Study|Withdrawal by Subject|0|||
38004515|NCT04555096|69688099|FG000|Overall Study|Other|0|||
38004516|NCT04555096|69688100|FG001|Overall Study|Other|1|||
38004517|NCT00097500|69688108|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
38004518|NCT00097500|69688109|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
38004519|NCT00097500|69688108|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
38004520|NCT00097500|69688109|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
38004521|NCT00097500|69688108|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
38004522|NCT00097500|69688109|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
38004523|NCT00097500|69688108|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
38004524|NCT00097500|69688109|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
38004525|NCT00097500|69688108|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
38004526|NCT00097500|69688109|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
38004527|NCT00097500|69688108|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
38004528|NCT00097500|69688109|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
38004529|NCT00097500|69688108|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
38004530|NCT00097500|69688109|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
38004531|NCT04551898|69688119|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
38004532|NCT04551898|69688120|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
38004533|NCT04551898|69688121|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
38004534|NCT04551898|69688122|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
38004535|NCT04551898|69688119|FG000|Overall Study|Withdrawal by Subject|5|||
37830634|NCT01307800|69513891|FG002|Overall Study|Lost to Follow-up|2|||
37830635|NCT01307800|69513892|FG003|Overall Study|Lost to Follow-up|8|||
37830636|NCT01307800|69513889|FG000|Overall Study|Perceived Lack of Efficacy|24|||
37830637|NCT01307800|69513890|FG001|Overall Study|Perceived Lack of Efficacy|23|||
37830638|NCT01307800|69513891|FG002|Overall Study|Perceived Lack of Efficacy|20|||
37830639|NCT01307800|69513892|FG003|Overall Study|Perceived Lack of Efficacy|33|||
37830640|NCT01307800|69513889|FG000|Overall Study|Protocol Violation|0|||
37830641|NCT01307800|69513890|FG001|Overall Study|Protocol Violation|3|||
37830642|NCT01307800|69513891|FG002|Overall Study|Protocol Violation|4|||
37907036|NCT00963599|69592566|FG000|Overall Study|Protocol Violation|2|||
37907037|NCT00963599|69592567|FG001|Overall Study|Protocol Violation|2|||
37907038|NCT00963599|69592568|FG002|Overall Study|Protocol Violation|3|||
37907039|NCT00963599|69592569|FG003|Overall Study|Protocol Violation|4|||
38004536|NCT04551898|69688120|FG001|Overall Study|Withdrawal by Subject|1|||
38004537|NCT04551898|69688121|FG002|Overall Study|Withdrawal by Subject|2|||
37830643|NCT01307800|69513892|FG003|Overall Study|Protocol Violation|5|||
37907040|NCT00963599|69592566|FG000|Overall Study|Withdrawal by Subject|2|||
37907041|NCT00963599|69592567|FG001|Overall Study|Withdrawal by Subject|1|||
37907042|NCT00963599|69592568|FG002|Overall Study|Withdrawal by Subject|3|||
38004538|NCT04551898|69688122|FG003|Overall Study|Withdrawal by Subject|2|||
38004539|NCT04551898|69688119|FG000|Overall Study|Lost to Follow-up|2|||
38004540|NCT04551898|69688120|FG001|Overall Study|Lost to Follow-up|1|||
38004541|NCT04551898|69688121|FG002|Overall Study|Lost to Follow-up|2|||
38004542|NCT04551898|69688122|FG003|Overall Study|Lost to Follow-up|2|||
38004543|NCT04551898|69688119|FG000|Overall Study|Death|1|||
38004544|NCT04551898|69688120|FG001|Overall Study|Death|0|||
38004545|NCT04551898|69688121|FG002|Overall Study|Death|0|||
38004546|NCT04551898|69688122|FG003|Overall Study|Death|0|||
38004547|NCT04551898|69688119|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
38004548|NCT04551898|69688120|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
38004549|NCT04551898|69688121|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
38004550|NCT04551898|69688122|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
38004551|NCT04849780|69688140|FG000|Period 1|Covid-19 Related|1|||
38004552|NCT04849780|69688141|FG001|Period 1|Covid-19 Related|0|||
38004553|NCT04849780|69688140|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
37830644|NCT01307800|69513889|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
37830645|NCT01307800|69513890|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
37830646|NCT01307800|69513891|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
37907043|NCT00963599|69592569|FG003|Overall Study|Withdrawal by Subject|3|||
37907044|NCT00619801|69592581|FG000|Overall Study|Lack of Efficacy|0|||
37907045|NCT00619801|69592582|FG001|Overall Study|Lack of Efficacy|1|||
37907046|NCT00619801|69592581|FG000|Overall Study|Withdrawal by Subject|1|||
37907047|NCT00619801|69592582|FG001|Overall Study|Withdrawal by Subject|1|||
37907048|NCT00619801|69592581|FG000|Overall Study|Loss of efficacy|0|||
37907049|NCT00619801|69592582|FG001|Overall Study|Loss of efficacy|1|||
37907050|NCT00962741|69592588|FG000|Overall Study|Failed to return|3|||
37907051|NCT00962741|69592588|FG000|Overall Study|Lost to Follow-up|2|||
37907052|NCT00962741|69592588|FG000|Overall Study|Withdrawal by Subject|1|||
37907053|NCT00962741|69592588|FG000|Overall Study|Lack of Efficacy|1|||
37907054|NCT00962741|69592588|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
37907055|NCT00619645|69592592|FG000|Overall Study|Adverse Event|1|||
37907056|NCT00619177|69592596|FG000|Overall Study|Adverse Event|18|||
37907057|NCT00619177|69592596|FG000|Overall Study|Lost to Follow-up|2|||
37907058|NCT00619177|69592596|FG000|Overall Study|Lack of Efficacy|1|||
37907059|NCT00619177|69592596|FG000|Overall Study|Missing termination information|481|||
37907060|NCT00619177|69592596|FG000|Overall Study|Not specified reasons|6|||
37907061|NCT00818259|69592607|FG000|Part I|Withdrawal by Subject|1|||
37907062|NCT00818259|69592608|FG001|Part I|Withdrawal by Subject|0|||
37907063|NCT00818259|69592609|FG002|Part I|Withdrawal by Subject|0|||
37907064|NCT00818259|69592610|FG003|Part I|Withdrawal by Subject|0|||
37907065|NCT00818259|69592611|FG004|Part I|Withdrawal by Subject|0|||
37907066|NCT00818259|69592612|FG005|Part I|Withdrawal by Subject|0|||
37907067|NCT00818259|69592613|FG006|Part I|Withdrawal by Subject|0|||
37907068|NCT00818259|69592614|FG007|Part I|Withdrawal by Subject|0|||
37907069|NCT00818259|69592615|FG008|Part I|Withdrawal by Subject|0|||
37907070|NCT00818259|69592607|FG000|Part II|Physician Decision|0|||
37907071|NCT00818259|69592608|FG001|Part II|Physician Decision|0|||
37907072|NCT00818259|69592609|FG002|Part II|Physician Decision|1|||
37907073|NCT00818259|69592610|FG003|Part II|Physician Decision|0|||
37907074|NCT00818259|69592611|FG004|Part II|Physician Decision|0|||
37907075|NCT00818259|69592612|FG005|Part II|Physician Decision|0|||
37907076|NCT00818259|69592613|FG006|Part II|Physician Decision|0|||
38004554|NCT04849780|69688141|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
37830647|NCT01307800|69513892|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
37830648|NCT01307800|69513889|FG000|Overall Study|Sponsor Decision|6|||
37830649|NCT01307800|69513890|FG001|Overall Study|Sponsor Decision|9|||
37830650|NCT01307800|69513891|FG002|Overall Study|Sponsor Decision|12|||
37830651|NCT01307800|69513892|FG003|Overall Study|Sponsor Decision|28|||
37830652|NCT01307800|69513889|FG000|Overall Study|Withdrawal by Subject|10|||
37830653|NCT01307800|69513890|FG001|Overall Study|Withdrawal by Subject|11|||
37830654|NCT01307800|69513891|FG002|Overall Study|Withdrawal by Subject|8|||
37907077|NCT00818259|69592614|FG007|Part II|Physician Decision|0|||
37907078|NCT00818259|69592615|FG008|Part II|Physician Decision|0|||
37907079|NCT00818259|69592607|FG000|Part II|Lack of Efficacy|0|||
37907080|NCT00818259|69592608|FG001|Part II|Lack of Efficacy|0|||
38004555|NCT04849780|69688140|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
38004556|NCT04849780|69688141|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
38004557|NCT04823494|69688155|FG000|Overall Study|Programming software malfunction.|1|||
38004558|NCT04823494|69688156|FG001|Overall Study|Programming software malfunction.|0|||
38004559|NCT04823494|69688155|FG000|Overall Study|Withdrawal by Subject|1|||
37907081|NCT00818259|69592609|FG002|Part II|Lack of Efficacy|0|||
37907082|NCT00818259|69592610|FG003|Part II|Lack of Efficacy|1|||
37907083|NCT00818259|69592611|FG004|Part II|Lack of Efficacy|0|||
37907084|NCT00818259|69592612|FG005|Part II|Lack of Efficacy|0|||
37907085|NCT00818259|69592613|FG006|Part II|Lack of Efficacy|0|||
37907086|NCT00818259|69592614|FG007|Part II|Lack of Efficacy|0|||
37907087|NCT00818259|69592615|FG008|Part II|Lack of Efficacy|0|||
37907088|NCT00818259|69592607|FG000|Part II|Not Treated|0|||
37907089|NCT00818259|69592608|FG001|Part II|Not Treated|0|||
37907090|NCT00818259|69592609|FG002|Part II|Not Treated|0|||
37907091|NCT00818259|69592610|FG003|Part II|Not Treated|1|||
38004560|NCT04823494|69688156|FG001|Overall Study|Withdrawal by Subject|0|||
38004561|NCT04823494|69688155|FG000|Overall Study|Devices lost|0|||
38004562|NCT04823494|69688156|FG001|Overall Study|Devices lost|1|||
38004563|NCT04542694|69688166|FG000|Overall Study|The need for prohibited therapy|2|||
38004564|NCT04542694|69688167|FG001|Overall Study|The need for prohibited therapy|0|||
38004565|NCT04542694|69688166|FG000|Overall Study|Adverse Event|1|||
37907092|NCT00818259|69592611|FG004|Part II|Not Treated|0|||
37907093|NCT00818259|69592612|FG005|Part II|Not Treated|0|||
37907094|NCT00818259|69592613|FG006|Part II|Not Treated|0|||
37907095|NCT00818259|69592614|FG007|Part II|Not Treated|0|||
37907096|NCT00818259|69592615|FG008|Part II|Not Treated|0|||
37907097|NCT00818259|69592607|FG000|Part IV|Physician Decision|0|||
37907098|NCT00818259|69592608|FG001|Part IV|Physician Decision|0|||
37907099|NCT00818259|69592609|FG002|Part IV|Physician Decision|0|||
37907100|NCT00818259|69592610|FG003|Part IV|Physician Decision|0|||
37907101|NCT00818259|69592611|FG004|Part IV|Physician Decision|0|||
37907102|NCT00818259|69592612|FG005|Part IV|Physician Decision|1|||
37907103|NCT00818259|69592613|FG006|Part IV|Physician Decision|0|||
37907104|NCT00818259|69592614|FG007|Part IV|Physician Decision|0|||
37907105|NCT00818259|69592615|FG008|Part IV|Physician Decision|0|||
37907106|NCT00818259|69592607|FG000|Part V|Adverse Event|0|||
37907107|NCT00818259|69592608|FG001|Part V|Adverse Event|0|||
37907108|NCT00818259|69592609|FG002|Part V|Adverse Event|0|||
37907109|NCT00818259|69592610|FG003|Part V|Adverse Event|0|||
37907110|NCT00818259|69592611|FG004|Part V|Adverse Event|0|||
37907111|NCT00818259|69592612|FG005|Part V|Adverse Event|0|||
37907112|NCT00818259|69592613|FG006|Part V|Adverse Event|0|||
37907113|NCT00818259|69592614|FG007|Part V|Adverse Event|1|||
37907114|NCT00818259|69592615|FG008|Part V|Adverse Event|0|||
37907115|NCT00619099|69592633|FG000|Overall Study|Progressive Disease|7|||
37907116|NCT00619099|69592634|FG001|Overall Study|Progressive Disease|5|||
37907117|NCT00619099|69592633|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
38004566|NCT04542694|69688167|FG001|Overall Study|Adverse Event|0|||
38004567|NCT04542694|69688166|FG000|Overall Study|Protocol Violation|1|||
38004568|NCT04542694|69688167|FG001|Overall Study|Protocol Violation|0|||
38004569|NCT00117312|69688177|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
38004570|NCT00117312|69688178|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
38004571|NCT00117312|69688179|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
38004572|NCT00117312|69688180|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
38004573|NCT00117312|69688177|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
38004574|NCT00117312|69688178|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
38004575|NCT00117312|69688179|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
38004576|NCT00117312|69688180|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
38004577|NCT00117312|69688177|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
38004578|NCT00117312|69688178|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
38004579|NCT00117312|69688179|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
38004580|NCT00117312|69688180|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
38004581|NCT00117312|69688177|FG000|Overall Study|Other|0|||
38004582|NCT00117312|69688178|FG001|Overall Study|Other|1|||
38004583|NCT00117312|69688179|FG002|Overall Study|Other|3|||
38004584|NCT00117312|69688180|FG003|Overall Study|Other|1|||
38004585|NCT00117312|69688177|FG000|Overall Study|Patient choice|0|||
38004586|NCT00117312|69688178|FG001|Overall Study|Patient choice|0|||
38004587|NCT00117312|69688179|FG002|Overall Study|Patient choice|2|||
37697593|NCT01842334|69174191|FG000|Overall Study|Withdrawal by Subject|3|||
37697594|NCT01842334|69174192|FG001|Overall Study|Withdrawal by Subject|3|||
37907118|NCT00619099|69592634|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
37907119|NCT00619099|69592633|FG000|Overall Study|Adverse Event|4|||
38004588|NCT00117312|69688180|FG003|Overall Study|Patient choice|1|||
38004589|NCT00117312|69688177|FG000|Overall Study|Adverse Event|0|||
38004590|NCT00117312|69688178|FG001|Overall Study|Adverse Event|2|||
38004591|NCT00117312|69688179|FG002|Overall Study|Adverse Event|0|||
38004592|NCT00117312|69688180|FG003|Overall Study|Adverse Event|0|||
37907120|NCT00619099|69592634|FG001|Overall Study|Adverse Event|3|||
37907121|NCT00619099|69592633|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
37907122|NCT00619099|69592634|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
37907123|NCT00619099|69592633|FG000|Overall Study|Withdrawal by Subject|10|||
37907124|NCT00619099|69592634|FG001|Overall Study|Withdrawal by Subject|2|||
37907125|NCT00619099|69592633|FG000|Overall Study|Physician Decision|9|||
37907126|NCT00619099|69592634|FG001|Overall Study|Physician Decision|6|||
38004593|NCT00117312|69688177|FG000|Overall Study|Protocol Violation|0|||
38004594|NCT00117312|69688178|FG001|Overall Study|Protocol Violation|1|||
38004595|NCT00117312|69688179|FG002|Overall Study|Protocol Violation|3|||
38004596|NCT00117312|69688180|FG003|Overall Study|Protocol Violation|0|||
38004597|NCT00117312|69688177|FG000|Overall Study|PSA decrease <=50%|0|||
38004598|NCT00117312|69688178|FG001|Overall Study|PSA decrease <=50%|2|||
38004599|NCT00117312|69688179|FG002|Overall Study|PSA decrease <=50%|2|||
38004600|NCT00117312|69688180|FG003|Overall Study|PSA decrease <=50%|4|||
38004601|NCT00117312|69688177|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
38004602|NCT00117312|69688178|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
38004603|NCT00117312|69688179|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
38004604|NCT00117312|69688180|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
38004605|NCT00117312|69688177|FG000|Overall Study|Hepatic abnormality|0|||
38004606|NCT00117312|69688178|FG001|Overall Study|Hepatic abnormality|1|||
38004607|NCT00117312|69688179|FG002|Overall Study|Hepatic abnormality|0|||
38004608|NCT00117312|69688180|FG003|Overall Study|Hepatic abnormality|1|||
38004609|NCT00117312|69688177|FG000|Overall Study|Withdrawal by Subject|0|||
38004610|NCT00117312|69688178|FG001|Overall Study|Withdrawal by Subject|2|||
38004611|NCT00117312|69688179|FG002|Overall Study|Withdrawal by Subject|0|||
38004612|NCT00117312|69688180|FG003|Overall Study|Withdrawal by Subject|0|||
38004613|NCT00129116|69688195|FG000|Primary Phase|Lost to Follow-up|1|||
38004614|NCT00129116|69688196|FG001|Primary Phase|Lost to Follow-up|1|||
38004615|NCT00129116|69688197|FG002|Primary Phase|Lost to Follow-up|0|||
38004616|NCT00129116|69688198|FG003|Primary Phase|Lost to Follow-up|1|||
38004617|NCT00129116|69688199|FG004|Primary Phase|Lost to Follow-up|1|||
38004618|NCT00129116|69688195|FG000|Primary Phase|Protocol Violation|0|||
38004619|NCT00129116|69688196|FG001|Primary Phase|Protocol Violation|1|||
38004620|NCT00129116|69688197|FG002|Primary Phase|Protocol Violation|0|||
38004621|NCT00129116|69688198|FG003|Primary Phase|Protocol Violation|0|||
38004622|NCT00129116|69688199|FG004|Primary Phase|Protocol Violation|0|||
38004623|NCT00129116|69688195|FG000|Primary Phase|Adverse Event|1|||
37697595|NCT01842334|69174191|FG000|Overall Study|Moved away mid-study|0|||
37830655|NCT01307800|69513892|FG003|Overall Study|Withdrawal by Subject|15|||
37830656|NCT01307800|69513889|FG000|Overall Study|Participant Moved|0|||
37830657|NCT01307800|69513890|FG001|Overall Study|Participant Moved|2|||
37830658|NCT01307800|69513891|FG002|Overall Study|Participant Moved|1|||
37830659|NCT01307800|69513892|FG003|Overall Study|Participant Moved|3|||
38004624|NCT00129116|69688196|FG001|Primary Phase|Adverse Event|1|||
38004625|NCT00129116|69688197|FG002|Primary Phase|Adverse Event|0|||
38004626|NCT00129116|69688198|FG003|Primary Phase|Adverse Event|0|||
38004627|NCT00129116|69688199|FG004|Primary Phase|Adverse Event|0|||
38004628|NCT00129116|69688195|FG000|Primary Phase|Withdrawal by Subject|0|||
38004629|NCT00129116|69688196|FG001|Primary Phase|Withdrawal by Subject|1|||
38004630|NCT00129116|69688197|FG002|Primary Phase|Withdrawal by Subject|0|||
38004631|NCT00129116|69688198|FG003|Primary Phase|Withdrawal by Subject|0|||
37830660|NCT01307449|69513906|FG000|Overall Study|Adverse Event|1|||
38004632|NCT00129116|69688199|FG004|Primary Phase|Withdrawal by Subject|0|||
38004633|NCT00129116|69688195|FG000|Primary Phase|Other|0|||
38004634|NCT00129116|69688196|FG001|Primary Phase|Other|0|||
38004635|NCT00129116|69688197|FG002|Primary Phase|Other|1|||
38004636|NCT00129116|69688198|FG003|Primary Phase|Other|0|||
38004637|NCT00129116|69688199|FG004|Primary Phase|Other|0|||
38004638|NCT00129116|69688195|FG000|Booster Phase|Lost to Follow-up|2|||
38004639|NCT00129116|69688196|FG001|Booster Phase|Lost to Follow-up|0|||
38004640|NCT00129116|69688197|FG002|Booster Phase|Lost to Follow-up|0|||
38004641|NCT00129116|69688198|FG003|Booster Phase|Lost to Follow-up|0|||
38004642|NCT00129116|69688199|FG004|Booster Phase|Lost to Follow-up|1|||
38004643|NCT00117156|69688211|FG000|Overall Study|Adverse Event|9|||
38004644|NCT00117156|69688211|FG000|Overall Study|Physician Decision|1|||
38004645|NCT00117156|69688211|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
38004646|NCT00096954|69688217|FG000|Overall Study|Adverse Event|3|||
38004647|NCT00096954|69688218|FG001|Overall Study|Adverse Event|1|||
38004648|NCT00096954|69688217|FG000|Overall Study|Withdrawal by Subject|9|||
38004649|NCT00096954|69688218|FG001|Overall Study|Withdrawal by Subject|8|||
38004650|NCT00096954|69688217|FG000|Overall Study|Physician Decision|1|||
38004651|NCT00096954|69688218|FG001|Overall Study|Physician Decision|1|||
38004652|NCT00096954|69688217|FG000|Overall Study|Sponsors Decision|1|||
38004653|NCT00096954|69688218|FG001|Overall Study|Sponsors Decision|1|||
38004654|NCT00096954|69688217|FG000|Overall Study|Pregnancy|1|||
38004655|NCT00096954|69688218|FG001|Overall Study|Pregnancy|1|||
38004656|NCT00096954|69688217|FG000|Overall Study|Initiation of immunotherapy|1|||
38004657|NCT00096954|69688218|FG001|Overall Study|Initiation of immunotherapy|0|||
38004658|NCT00096954|69688217|FG000|Overall Study|Non-compliance|0|||
38004659|NCT00096954|69688218|FG001|Overall Study|Non-compliance|3|||
38004660|NCT00096954|69688217|FG000|Overall Study|Lost to Follow-up|8|||
38004661|NCT00096954|69688218|FG001|Overall Study|Lost to Follow-up|5|||
38004662|NCT00096486|69688228|FG000|Overall Study|Withdrawal by Subject|0|||
38004663|NCT00096486|69688229|FG001|Overall Study|Withdrawal by Subject|0|||
38004664|NCT00096486|69688230|FG002|Overall Study|Withdrawal by Subject|1|||
38004665|NCT00096486|69688231|FG003|Overall Study|Withdrawal by Subject|1|||
38004666|NCT00096486|69688228|FG000|Overall Study|Not Treated|0|||
38004667|NCT00096486|69688229|FG001|Overall Study|Not Treated|0|||
38004668|NCT00096486|69688230|FG002|Overall Study|Not Treated|1|||
38004669|NCT00096486|69688231|FG003|Overall Study|Not Treated|1|||
38004670|NCT00116844|69688243|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
38004671|NCT00116844|69688244|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
38004672|NCT00116844|69688243|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
38004673|NCT00116844|69688244|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
38004674|NCT00116844|69688243|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
38004675|NCT00116844|69688244|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
38004676|NCT00116844|69688243|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
38004677|NCT00116844|69688244|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
38004678|NCT00116844|69688243|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
38004679|NCT00116844|69688244|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
37830661|NCT01307449|69513907|FG001|Overall Study|Adverse Event|0|||
37830662|NCT01307449|69513908|FG002|Overall Study|Adverse Event|0|||
37830663|NCT01307449|69513909|FG003|Overall Study|Adverse Event|0|||
37830664|NCT01307020|69513929|FG000|Overall Study|Lost to Follow-up|0|||
37907127|NCT00962585|69592644|FG000|Overall Study|Adverse Event|0|||
37907128|NCT00962585|69592645|FG001|Overall Study|Adverse Event|2|||
37830665|NCT01307020|69513930|FG001|Overall Study|Lost to Follow-up|0|||
37830666|NCT01307020|69513931|FG002|Overall Study|Lost to Follow-up|1|||
37830667|NCT01307020|69513932|FG003|Overall Study|Lost to Follow-up|1|||
37830668|NCT01307020|69513933|FG004|Overall Study|Lost to Follow-up|0|||
37907129|NCT00962585|69592646|FG002|Overall Study|Adverse Event|1|||
37907130|NCT00962585|69592647|FG003|Overall Study|Adverse Event|0|||
37907131|NCT00962585|69592644|FG000|Overall Study|Lost to Follow-up|3|||
37907132|NCT00962585|69592645|FG001|Overall Study|Lost to Follow-up|0|||
37907133|NCT00962585|69592646|FG002|Overall Study|Lost to Follow-up|1|||
37907134|NCT00962585|69592647|FG003|Overall Study|Lost to Follow-up|0|||
38004680|NCT00116844|69688243|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
38004681|NCT00116844|69688244|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
38004682|NCT00116844|69688243|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
38004683|NCT00116844|69688244|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
38004684|NCT00116844|69688243|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
37830669|NCT01307020|69513934|FG005|Overall Study|Lost to Follow-up|0|||
38004685|NCT00116844|69688244|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
38004686|NCT00116844|69688243|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
38004687|NCT00116844|69688244|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
38004688|NCT00128492|69688252|FG000|Overall Study|AE unrelated to study|2|||
37830670|NCT01307020|69513935|FG006|Overall Study|Lost to Follow-up|1|||
37907135|NCT00962585|69592644|FG000|Overall Study|Protocol Violation|0|||
38004689|NCT00128492|69688253|FG001|Overall Study|AE unrelated to study|9|||
37830671|NCT01307020|69513936|FG007|Overall Study|Lost to Follow-up|0|||
38004690|NCT00128492|69688252|FG000|Overall Study|Study drug intolerance (AE)|2|||
38004691|NCT00128492|69688253|FG001|Overall Study|Study drug intolerance (AE)|8|||
37830672|NCT01307020|69513937|FG008|Overall Study|Lost to Follow-up|0|||
37830673|NCT01307020|69513938|FG009|Overall Study|Lost to Follow-up|0|||
38004692|NCT00128492|69688252|FG000|Overall Study|AE related to study|1|||
38004693|NCT00128492|69688253|FG001|Overall Study|AE related to study|4|||
38004694|NCT00128492|69688252|FG000|Overall Study|Death|1|||
38004695|NCT00128492|69688253|FG001|Overall Study|Death|0|||
38004696|NCT00128492|69688252|FG000|Overall Study|Lost to Follow-up|1|||
38004697|NCT00128492|69688253|FG001|Overall Study|Lost to Follow-up|5|||
38004698|NCT00128492|69688252|FG000|Overall Study|Noncompliance|0|||
38004699|NCT00128492|69688253|FG001|Overall Study|Noncompliance|5|||
38004700|NCT00128492|69688252|FG000|Overall Study|Personal or administrative|10|||
38004701|NCT00128492|69688253|FG001|Overall Study|Personal or administrative|22|||
38004702|NCT00128492|69688252|FG000|Overall Study|Withdrawal by Subject|3|||
38004703|NCT00128492|69688253|FG001|Overall Study|Withdrawal by Subject|5|||
38004704|NCT00128492|69688252|FG000|Overall Study|Pregnancy|0|||
38004705|NCT00128492|69688253|FG001|Overall Study|Pregnancy|1|||
38004706|NCT00132314|69688261|FG000|Overall Study|Lost to Follow-up|70|||
38004707|NCT00132314|69688262|FG001|Overall Study|Lost to Follow-up|62|||
38004708|NCT00132314|69688261|FG000|Overall Study|Lacked SSN|1|||
38004709|NCT00132314|69688262|FG001|Overall Study|Lacked SSN|3|||
38004710|NCT00132314|69688261|FG000|Overall Study|Refused intervention at baseline|2|||
38004711|NCT00132314|69688262|FG001|Overall Study|Refused intervention at baseline|7|||
38004712|NCT04539262|69688276|FG000|Overall Study|Adverse Event|0|||
38004713|NCT04539262|69688277|FG001|Overall Study|Adverse Event|0|||
38004714|NCT04539262|69688278|FG002|Overall Study|Adverse Event|1|||
38004715|NCT04539262|69688279|FG003|Overall Study|Adverse Event|0|||
38004716|NCT04539262|69688280|FG004|Overall Study|Adverse Event|0|||
38004717|NCT04539262|69688281|FG005|Overall Study|Adverse Event|0|||
37907136|NCT00962585|69592645|FG001|Overall Study|Protocol Violation|0|||
37907137|NCT00962585|69592646|FG002|Overall Study|Protocol Violation|1|||
37907138|NCT00962585|69592647|FG003|Overall Study|Protocol Violation|0|||
37907139|NCT00962585|69592644|FG000|Overall Study|Withdrawal by Subject|1|||
38004718|NCT04539262|69688282|FG006|Overall Study|Adverse Event|0|||
38004719|NCT04539262|69688283|FG007|Overall Study|Adverse Event|0|||
38004720|NCT04539262|69688276|FG000|Overall Study|Withdrew Consent|0|||
38004721|NCT04539262|69688277|FG001|Overall Study|Withdrew Consent|0|||
38004722|NCT04539262|69688278|FG002|Overall Study|Withdrew Consent|0|||
38004723|NCT04539262|69688279|FG003|Overall Study|Withdrew Consent|1|||
38004724|NCT04539262|69688280|FG004|Overall Study|Withdrew Consent|0|||
38004725|NCT04539262|69688281|FG005|Overall Study|Withdrew Consent|0|||
38004726|NCT04539262|69688282|FG006|Overall Study|Withdrew Consent|0|||
38004727|NCT04539262|69688283|FG007|Overall Study|Withdrew Consent|0|||
38004728|NCT04539262|69688276|FG000|Overall Study|Randomized, Not treated|0|||
38004729|NCT04539262|69688277|FG001|Overall Study|Randomized, Not treated|1|||
37907140|NCT00962585|69592645|FG001|Overall Study|Withdrawal by Subject|0|||
37907141|NCT00962585|69592646|FG002|Overall Study|Withdrawal by Subject|0|||
37907142|NCT00962585|69592647|FG003|Overall Study|Withdrawal by Subject|0|||
38004730|NCT04539262|69688278|FG002|Overall Study|Randomized, Not treated|0|||
38004731|NCT04539262|69688279|FG003|Overall Study|Randomized, Not treated|0|||
38004732|NCT04539262|69688280|FG004|Overall Study|Randomized, Not treated|0|||
38004733|NCT04539262|69688281|FG005|Overall Study|Randomized, Not treated|0|||
38004734|NCT04539262|69688282|FG006|Overall Study|Randomized, Not treated|1|||
38004735|NCT04539262|69688283|FG007|Overall Study|Randomized, Not treated|0|||
38004736|NCT03702010|69688306|FG000|Follow-up (30days)|Lack of Efficacy|2|||
38004737|NCT03702010|69688307|FG001|Follow-up (30days)|Lack of Efficacy|2|||
38004738|NCT04538170|69688321|FG000|Overall Study|Withdrawal by Subject|104|||
38004739|NCT04538170|69688322|FG001|Overall Study|Withdrawal by Subject|210|||
38004740|NCT04537234|69688334|FG000|Overall Study|Withdrawal by Subject|2|||
38004741|NCT04537234|69688335|FG001|Overall Study|Withdrawal by Subject|0|||
38004742|NCT04537078|69688343|FG000|Overall Study|Protocol Violation|3|||
38004743|NCT04537078|69688344|FG001|Overall Study|Protocol Violation|2|||
38004744|NCT04537078|69688343|FG000|Overall Study|Lost to Follow-up|1|||
38004745|NCT04537078|69688344|FG001|Overall Study|Lost to Follow-up|0|||
38004746|NCT04537078|69688343|FG000|Overall Study|Withdrawal by Subject|0|||
38004747|NCT04537078|69688344|FG001|Overall Study|Withdrawal by Subject|1|||
38004748|NCT04532164|69688357|FG000|Overall Study|Adverse Event|1|||
38004749|NCT04532164|69688357|FG000|Overall Study|Protocol Violation|5|||
38004750|NCT04532164|69688357|FG000|Overall Study|Lost to Follow-up|1|||
38004751|NCT04532164|69688357|FG000|Overall Study|Found to be Ineligible|3|||
38004752|NCT04532164|69688357|FG000|Overall Study|Withdrawal by Subject|14|||
38004753|NCT00116688|69688364|FG000|Overall Study|Protocol deviation|1|||
38004754|NCT00116688|69688365|FG001|Overall Study|Protocol deviation|0|||
38004755|NCT00116688|69688364|FG000|Overall Study|Noncompliance|3|||
37907143|NCT00962585|69592644|FG000|Overall Study|Withdrew Consent|2|||
38004756|NCT00116688|69688365|FG001|Overall Study|Noncompliance|1|||
38004757|NCT00116688|69688364|FG000|Overall Study|Adverse Event|11|||
38004758|NCT00116688|69688365|FG001|Overall Study|Adverse Event|0|||
38004759|NCT00116688|69688364|FG000|Overall Study|Withdrawal by Subject|26|||
38004760|NCT00116688|69688365|FG001|Overall Study|Withdrawal by Subject|2|||
38004761|NCT00116688|69688364|FG000|Overall Study|Requirement for alternative therapy|11|||
38004762|NCT00116688|69688365|FG001|Overall Study|Requirement for alternative therapy|1|||
38004763|NCT00116688|69688364|FG000|Overall Study|Physician Decision|7|||
38004764|NCT00116688|69688365|FG001|Overall Study|Physician Decision|0|||
38004765|NCT00116688|69688364|FG000|Overall Study|Lost to Follow-up|3|||
38004766|NCT00116688|69688365|FG001|Overall Study|Lost to Follow-up|0|||
38004767|NCT00116688|69688364|FG000|Overall Study|Death|15|||
38004768|NCT00116688|69688365|FG001|Overall Study|Death|0|||
38004769|NCT00116688|69688364|FG000|Overall Study|Protocol-specified criteria|3|||
38004770|NCT00116688|69688365|FG001|Overall Study|Protocol-specified criteria|0|||
38004771|NCT00116688|69688364|FG000|Overall Study|Pregnancy|1|||
38004772|NCT00116688|69688365|FG001|Overall Study|Pregnancy|0|||
38004773|NCT00116688|69688364|FG000|Overall Study|Other|11|||
38004774|NCT00116688|69688365|FG001|Overall Study|Other|0|||
38004775|NCT04531540|69688371|FG000|Overall Study|Adverse Event|1|||
38004776|NCT04531540|69688371|FG000|Overall Study|Protocol Violation|3|||
38004777|NCT04531540|69688371|FG000|Overall Study|Withdrawal by Subject|4|||
38004778|NCT04531540|69688371|FG000|Overall Study|Found to be Ineligible|1|||
38004779|NCT04799782|69688375|FG000|Washout|Physician Decision|2|||
38004780|NCT04799782|69688376|FG001|Washout|Physician Decision|0|||
38004781|NCT04799782|69688375|FG000|Washout|Withdrawal by Subject|0|||
38004782|NCT04799782|69688376|FG001|Washout|Withdrawal by Subject|2|||
38004783|NCT04799782|69688375|FG000|Washout|Lost to Follow-up|0|||
38004784|NCT04799782|69688376|FG001|Washout|Lost to Follow-up|1|||
38004785|NCT03697252|69688384|FG000|Overall Study|Adverse Event|3|||
38004786|NCT03697252|69688385|FG001|Overall Study|Adverse Event|2|||
38004787|NCT03697252|69688384|FG000|Overall Study|Withdrawal by Subject|14|||
38004788|NCT03697252|69688385|FG001|Overall Study|Withdrawal by Subject|14|||
38004789|NCT03697252|69688384|FG000|Overall Study|Lost to Follow-up|0|||
38004790|NCT03697252|69688385|FG001|Overall Study|Lost to Follow-up|1|||
38004791|NCT03697252|69688384|FG000|Overall Study|Physician Decision|1|||
38004792|NCT03697252|69688385|FG001|Overall Study|Physician Decision|1|||
38004793|NCT03697252|69688384|FG000|Overall Study|Other|0|||
38004794|NCT03697252|69688385|FG001|Overall Study|Other|1|||
38004795|NCT03701074|69688393|FG000|Overall Study|Physician Decision|1|||
38004796|NCT03701074|69688394|FG001|Overall Study|Physician Decision|0|||
38004797|NCT04728802|69688402|FG000|Overall Study|Withdrawal by Subject|4|||
38004798|NCT04728802|69688403|FG001|Overall Study|Withdrawal by Subject|20|||
38004799|NCT04728802|69688402|FG000|Overall Study|Physician Decision|7|||
37907144|NCT00962585|69592645|FG001|Overall Study|Withdrew Consent|0|||
37907145|NCT00962585|69592646|FG002|Overall Study|Withdrew Consent|0|||
37907146|NCT00962585|69592647|FG003|Overall Study|Withdrew Consent|0|||
37907147|NCT00621985|69592659|FG000|Dexamethasone Admission|Adverse Event|1|||
37907148|NCT00961259|69592669|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
37907149|NCT00961259|69592670|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
37907150|NCT00961259|69592671|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
37907151|NCT00961181|69592680|FG000|Overall Study|Death|2|||
37907152|NCT00961181|69592680|FG000|Overall Study|Withdrawal by Subject|2|||
37907153|NCT00961181|69592680|FG000|Overall Study|Lost to Follow-up|1|||
37907154|NCT00817635|69592689|FG000|Overall Study|Adverse Event|1|||
38004800|NCT04728802|69688403|FG001|Overall Study|Physician Decision|7|||
38004801|NCT04728802|69688402|FG000|Overall Study|Protocol Violation|10|||
38004802|NCT04728802|69688403|FG001|Overall Study|Protocol Violation|4|||
38004803|NCT04728802|69688402|FG000|Overall Study|Transfer|1|||
38004804|NCT04728802|69688403|FG001|Overall Study|Transfer|0|||
38004805|NCT04728802|69688402|FG000|Overall Study|Death|4|||
38004806|NCT04728802|69688403|FG001|Overall Study|Death|5|||
38004807|NCT04728802|69688402|FG000|Overall Study|Other|3|||
38004808|NCT04728802|69688403|FG001|Overall Study|Other|0|||
38004809|NCT04715932|69688411|FG000|Overall Study|Lost to Follow-up|1|||
38004810|NCT04715932|69688412|FG001|Overall Study|Lost to Follow-up|0|||
38004811|NCT00130832|69688420|FG000|Overall Study|Adverse Event|1|||
38004812|NCT00130832|69688421|FG001|Overall Study|Adverse Event|1|||
37907155|NCT00817635|69592690|FG001|Overall Study|Adverse Event|0|||
38004813|NCT00130832|69688420|FG000|Overall Study|Lost to Follow-up|1|||
38004814|NCT00130832|69688421|FG001|Overall Study|Lost to Follow-up|2|||
38004815|NCT00130832|69688420|FG000|Overall Study|Protocol Violation|6|||
38004816|NCT00130832|69688421|FG001|Overall Study|Protocol Violation|8|||
38004817|NCT00130832|69688420|FG000|Overall Study|Withdrawal by Subject|6|||
38004818|NCT00130832|69688421|FG001|Overall Study|Withdrawal by Subject|1|||
38004819|NCT00130832|69688420|FG000|Overall Study|Moved|2|||
38004820|NCT00130832|69688421|FG001|Overall Study|Moved|2|||
38004821|NCT00130832|69688420|FG000|Overall Study|Other|0|||
38004822|NCT00130832|69688421|FG001|Overall Study|Other|3|||
38004823|NCT00096018|69688429|FG000|Overall Study|Became Ineligible (not treated)|0|||
38004824|NCT00096018|69688430|FG001|Overall Study|Became Ineligible (not treated)|3|||
38004825|NCT00096018|69688429|FG000|Overall Study|Miscellaneous (not treated)|0|||
38004826|NCT00096018|69688430|FG001|Overall Study|Miscellaneous (not treated)|2|||
38004827|NCT00096018|69688429|FG000|Overall Study|Adverse Event|0|||
38004828|NCT00096018|69688430|FG001|Overall Study|Adverse Event|5|||
38004829|NCT00096018|69688429|FG000|Overall Study|Death|0|||
38004830|NCT00096018|69688430|FG001|Overall Study|Death|1|||
38004831|NCT00096018|69688429|FG000|Overall Study|Withdrawal by Subject|0|||
38004832|NCT00096018|69688430|FG001|Overall Study|Withdrawal by Subject|2|||
38004833|NCT00096018|69688429|FG000|Overall Study|Miscellaneous|2|||
38004834|NCT00096018|69688430|FG001|Overall Study|Miscellaneous|1|||
38004835|NCT04713748|69688436|FG000|Overall Study|Not enough kits allocated|35|||
38004836|NCT04702984|69688440|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
38004837|NCT04701658|69688446|FG000|Overall Study|Lost to Follow-up|6|||
38004838|NCT00128102|69688452|FG000|Overall Study|Site Discontinued|3|||
38004839|NCT00128102|69688453|FG001|Overall Study|Site Discontinued|6|||
38004840|NCT00128102|69688452|FG000|Overall Study|Other|0|||
38004841|NCT00128102|69688453|FG001|Overall Study|Other|1|||
38004842|NCT00128102|69688452|FG000|Overall Study|Progressive Disease|255|||
38004843|NCT00128102|69688453|FG001|Overall Study|Progressive Disease|285|||
38004844|NCT00128102|69688452|FG000|Overall Study|Adverse Event|34|||
38004845|NCT00128102|69688453|FG001|Overall Study|Adverse Event|11|||
38004846|NCT00128102|69688452|FG000|Overall Study|Death|12|||
38004847|NCT00128102|69688453|FG001|Overall Study|Death|13|||
37907156|NCT00817635|69592691|FG002|Overall Study|Adverse Event|0|||
37907157|NCT00817635|69592692|FG003|Overall Study|Adverse Event|1|||
37907158|NCT00817635|69592693|FG004|Overall Study|Adverse Event|1|||
37907159|NCT00817635|69592689|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
37907160|NCT00817635|69592690|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
37907161|NCT00817635|69592691|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
37907162|NCT00817635|69592692|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
37907163|NCT00817635|69592693|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
37907164|NCT00817635|69592689|FG000|Overall Study|Withdrawal by Subject|2|||
37907165|NCT00817635|69592690|FG001|Overall Study|Withdrawal by Subject|1|||
37907166|NCT00817635|69592691|FG002|Overall Study|Withdrawal by Subject|0|||
37907167|NCT00817635|69592692|FG003|Overall Study|Withdrawal by Subject|1|||
37907168|NCT00817635|69592693|FG004|Overall Study|Withdrawal by Subject|2|||
37907169|NCT00817635|69592689|FG000|Overall Study|Lost to Follow-up|0|||
37907170|NCT00817635|69592690|FG001|Overall Study|Lost to Follow-up|1|||
37907171|NCT00817635|69592691|FG002|Overall Study|Lost to Follow-up|0|||
37907172|NCT00817635|69592692|FG003|Overall Study|Lost to Follow-up|1|||
37907173|NCT00817635|69592693|FG004|Overall Study|Lost to Follow-up|0|||
37907174|NCT00817635|69592689|FG000|Overall Study|Administrative Problems|0|||
37907175|NCT00817635|69592690|FG001|Overall Study|Administrative Problems|0|||
37907176|NCT00817635|69592691|FG002|Overall Study|Administrative Problems|0|||
37907177|NCT00817635|69592692|FG003|Overall Study|Administrative Problems|0|||
37907178|NCT00817635|69592693|FG004|Overall Study|Administrative Problems|1|||
37907179|NCT00817635|69592689|FG000|Overall Study|Protocol Violation|5|||
37907180|NCT00817635|69592690|FG001|Overall Study|Protocol Violation|1|||
37907181|NCT00817635|69592691|FG002|Overall Study|Protocol Violation|3|||
37907182|NCT00817635|69592692|FG003|Overall Study|Protocol Violation|2|||
37907183|NCT00817635|69592693|FG004|Overall Study|Protocol Violation|3|||
37907184|NCT00817479|69592714|FG000|Overall Study|Physician Decision|1|||
38004848|NCT00128102|69688452|FG000|Overall Study|Physician Decision|3|||
38004849|NCT00128102|69688453|FG001|Overall Study|Physician Decision|3|||
38004850|NCT00128102|69688452|FG000|Overall Study|Withdrawal by Subject|19|||
37830674|NCT01307020|69513929|FG000|Overall Study|Electronic data capture failure|0|||
37830675|NCT01307020|69513930|FG001|Overall Study|Electronic data capture failure|1|||
37830676|NCT01307020|69513931|FG002|Overall Study|Electronic data capture failure|0|||
37830677|NCT01307020|69513932|FG003|Overall Study|Electronic data capture failure|0|||
37830678|NCT01307020|69513933|FG004|Overall Study|Electronic data capture failure|0|||
37830679|NCT01307020|69513934|FG005|Overall Study|Electronic data capture failure|0|||
37830680|NCT01307020|69513935|FG006|Overall Study|Electronic data capture failure|0|||
37830681|NCT01307020|69513936|FG007|Overall Study|Electronic data capture failure|0|||
37830682|NCT01307020|69513937|FG008|Overall Study|Electronic data capture failure|0|||
37830683|NCT01307020|69513938|FG009|Overall Study|Electronic data capture failure|0|||
37830684|NCT01306201|69513960|FG000|Overall Study|Arrhythmia|4|||
37830685|NCT01306201|69513960|FG000|Overall Study|Files could not be processed|3|||
37830686|NCT01306201|69513960|FG000|Overall Study|Files unreadable|3|||
37830687|NCT01306162|69513972|FG000|Period 1|Adverse Event|0|||
37830688|NCT01306162|69513973|FG001|Period 1|Adverse Event|0|||
37830689|NCT01306162|69513974|FG002|Period 1|Adverse Event|0|||
37830690|NCT01306162|69513975|FG003|Period 1|Adverse Event|1|||
37907185|NCT00817479|69592715|FG001|Overall Study|Physician Decision|1|||
37907186|NCT00961961|69592725|FG000|Phase I|Withdrawal by Subject|7|||
37907187|NCT00961961|69592726|FG001|Phase I|Withdrawal by Subject|0|||
37907188|NCT00961961|69592727|FG002|Phase I|Withdrawal by Subject|0|||
37907189|NCT00961961|69592728|FG003|Phase I|Withdrawal by Subject|0|||
37907190|NCT00961961|69592725|FG000|Phase I|Lost to Follow-up|10|||
37907191|NCT00961961|69592726|FG001|Phase I|Lost to Follow-up|0|||
38004851|NCT00128102|69688453|FG001|Overall Study|Withdrawal by Subject|11|||
38004852|NCT00128102|69688452|FG000|Overall Study|Protocol Violation|2|||
38004853|NCT00128102|69688453|FG001|Overall Study|Protocol Violation|2|||
38004854|NCT04668274|69688459|FG000|Part 1 Study Period 1|Adverse Event|3|||
38004855|NCT04668274|69688460|FG001|Part 1 Study Period 1|Adverse Event|0|||
38004856|NCT04668274|69688461|FG002|Part 1 Study Period 1|Adverse Event|0|||
38004857|NCT04668274|69688462|FG003|Part 1 Study Period 1|Adverse Event|0|||
37907192|NCT00961961|69592727|FG002|Phase I|Lost to Follow-up|0|||
37907193|NCT00961961|69592728|FG003|Phase I|Lost to Follow-up|0|||
37907194|NCT00961961|69592725|FG000|Phase I|Lack of Efficacy|94|||
38004858|NCT04668274|69688459|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
38004859|NCT04668274|69688460|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
38004860|NCT04668274|69688461|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
38004861|NCT04668274|69688462|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
38004862|NCT04668274|69688459|FG000|Part 1 Study Period 2|Other|0|||
38004863|NCT04668274|69688460|FG001|Part 1 Study Period 2|Other|1|||
38004864|NCT04668274|69688461|FG002|Part 1 Study Period 2|Other|0|||
38004865|NCT04668274|69688462|FG003|Part 1 Study Period 2|Other|0|||
38004866|NCT04668274|69688459|FG000|Part 1 Study Period 3|Adverse Event|0|||
38004867|NCT04668274|69688460|FG001|Part 1 Study Period 3|Adverse Event|0|||
38004868|NCT04668274|69688461|FG002|Part 1 Study Period 3|Adverse Event|1|||
38004869|NCT04668274|69688462|FG003|Part 1 Study Period 3|Adverse Event|0|||
38004870|NCT04668274|69688459|FG000|Part 1 Study Period 3|Other|0|||
38004871|NCT04668274|69688460|FG001|Part 1 Study Period 3|Other|0|||
38004872|NCT04668274|69688461|FG002|Part 1 Study Period 3|Other|2|||
38004873|NCT04668274|69688462|FG003|Part 1 Study Period 3|Other|0|||
38004874|NCT04668274|69688459|FG000|Part 2 Study Period 4|Other|0|||
38004875|NCT04668274|69688460|FG001|Part 2 Study Period 4|Other|0|||
38004876|NCT04668274|69688461|FG002|Part 2 Study Period 4|Other|0|||
38004877|NCT04668274|69688462|FG003|Part 2 Study Period 4|Other|1|||
38004878|NCT04406194|69688477|FG000|Period 1|Withdrawal by Subject|0|||
38004879|NCT04406194|69688478|FG001|Period 1|Withdrawal by Subject|1|||
38004880|NCT03822884|69688493|FG000|Overall Study|Withdrawal by Subject|0|||
38004881|NCT03822884|69688494|FG001|Overall Study|Withdrawal by Subject|0|||
38004882|NCT03822884|69688495|FG002|Overall Study|Withdrawal by Subject|0|||
38004883|NCT03822884|69688496|FG003|Overall Study|Withdrawal by Subject|0|||
38004884|NCT03822884|69688497|FG004|Overall Study|Withdrawal by Subject|1|||
38004885|NCT03822884|69688498|FG005|Overall Study|Withdrawal by Subject|0|||
38004886|NCT03822416|69688508|FG000|Overall Study|Lost to Follow-up|1|||
38004887|NCT03822416|69688509|FG001|Overall Study|Lost to Follow-up|0|||
38004888|NCT03822416|69688508|FG000|Overall Study|Withdrawal by Subject|0|||
38004889|NCT03822416|69688509|FG001|Overall Study|Withdrawal by Subject|1|||
38004890|NCT04405570|69688519|FG000|Overall Study|Adverse Event|0|||
38004891|NCT04405570|69688520|FG001|Overall Study|Adverse Event|1|||
38004892|NCT04405570|69688521|FG002|Overall Study|Adverse Event|1|||
38004893|NCT04405570|69688522|FG003|Overall Study|Adverse Event|1|||
38004894|NCT04405570|69688519|FG000|Overall Study|Lost to Follow-up|0|||
38004895|NCT04405570|69688520|FG001|Overall Study|Lost to Follow-up|1|||
38004896|NCT04405570|69688521|FG002|Overall Study|Lost to Follow-up|0|||
38004897|NCT04405570|69688522|FG003|Overall Study|Lost to Follow-up|0|||
38004898|NCT04405570|69688519|FG000|Overall Study|Physician Decision|0|||
38004899|NCT04405570|69688520|FG001|Overall Study|Physician Decision|0|||
38004900|NCT04405570|69688521|FG002|Overall Study|Physician Decision|1|||
38004901|NCT04405570|69688522|FG003|Overall Study|Physician Decision|0|||
38004902|NCT04405570|69688519|FG000|Overall Study|Withdrawal by Subject|0|||
38004903|NCT04405570|69688520|FG001|Overall Study|Withdrawal by Subject|1|||
38004904|NCT04405570|69688521|FG002|Overall Study|Withdrawal by Subject|1|||
38004905|NCT04405570|69688522|FG003|Overall Study|Withdrawal by Subject|0|||
38004906|NCT04405570|69688519|FG000|Overall Study|Randomized not dosed|0|||
38004907|NCT04405570|69688520|FG001|Overall Study|Randomized not dosed|2|||
38004908|NCT04405570|69688521|FG002|Overall Study|Randomized not dosed|0|||
38004909|NCT04405570|69688522|FG003|Overall Study|Randomized not dosed|0|||
38004910|NCT00127712|69688537|FG000|Overall Study|Adverse Event|3|||
38004911|NCT00127712|69688538|FG001|Overall Study|Adverse Event|0|||
38004912|NCT00127712|69688537|FG000|Overall Study|Lack of GI access to continue|2|||
38004913|NCT00127712|69688538|FG001|Overall Study|Lack of GI access to continue|0|||
38004914|NCT04404010|69688546|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
38004915|NCT04404010|69688547|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
38004916|NCT04401202|69688557|FG000|Overall Study|Lost to Follow-up|2|||
38004917|NCT04401202|69688558|FG001|Overall Study|Lost to Follow-up|2|||
37907195|NCT00961961|69592726|FG001|Phase I|Lack of Efficacy|0|||
37907196|NCT00961961|69592727|FG002|Phase I|Lack of Efficacy|0|||
37907197|NCT00961961|69592728|FG003|Phase I|Lack of Efficacy|0|||
37907198|NCT00961961|69592725|FG000|Phase I|Adverse Event|7|||
37907199|NCT00961961|69592726|FG001|Phase I|Adverse Event|0|||
37907200|NCT00961961|69592727|FG002|Phase I|Adverse Event|0|||
37907201|NCT00961961|69592728|FG003|Phase I|Adverse Event|0|||
38004918|NCT04401202|69688557|FG000|Overall Study|Adverse Event|0|||
38004919|NCT04401202|69688558|FG001|Overall Study|Adverse Event|1|||
38004920|NCT04401202|69688557|FG000|Overall Study|Hospitalized|4|||
38004921|NCT04401202|69688558|FG001|Overall Study|Hospitalized|1|||
38004922|NCT00096356|69688567|FG000|Overall Study|Adverse Event|11|||
38004923|NCT00096356|69688568|FG001|Overall Study|Adverse Event|9|||
38004924|NCT00096356|69688567|FG000|Overall Study|Physician Decision|5|||
38004925|NCT00096356|69688568|FG001|Overall Study|Physician Decision|3|||
38004926|NCT00096356|69688567|FG000|Overall Study|Withdrawal by Subject|17|||
38004927|NCT00096356|69688568|FG001|Overall Study|Withdrawal by Subject|23|||
38004928|NCT00096356|69688567|FG000|Overall Study|Lack of Efficacy|1|||
38004929|NCT00096356|69688568|FG001|Overall Study|Lack of Efficacy|0|||
38004930|NCT00096356|69688567|FG000|Overall Study|multiple reasons|10|||
38004931|NCT00096356|69688568|FG001|Overall Study|multiple reasons|18|||
38004932|NCT04358068|69688577|FG000|Overall Study|Did not initiate study treatment|2|||
38004933|NCT04358068|69688578|FG001|Overall Study|Did not initiate study treatment|2|||
38004934|NCT03694210|69688584|FG000|Overall Study|Death|1|||
38004935|NCT03694210|69688584|FG000|Overall Study|Screen Failure|7|||
38004936|NCT04339972|69688592|FG000|Overall Study|Scheduling Issues|3|||
38004937|NCT04339972|69688593|FG001|Overall Study|Scheduling Issues|3|||
38004938|NCT04339972|69688592|FG000|Overall Study|dropout|1|||
38004939|NCT04339972|69688593|FG001|Overall Study|dropout|1|||
38004940|NCT04339972|69688592|FG000|Overall Study|Technical issues|1|||
38004941|NCT04339972|69688593|FG001|Overall Study|Technical issues|0|||
38004942|NCT04339972|69688592|FG000|Overall Study|Claustraphobia|0|||
38004943|NCT04339972|69688593|FG001|Overall Study|Claustraphobia|1|||
38004944|NCT00096278|69688601|FG000|Overall Study|No follow-up data|15|||
38004945|NCT00096278|69688602|FG001|Overall Study|No follow-up data|18|||
38004946|NCT00096278|69688601|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
38004947|NCT00096278|69688602|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
38004948|NCT00095940|69688617|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
38004949|NCT00095940|69688618|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
38004950|NCT00095940|69688619|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
38004951|NCT00095940|69688620|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
38004952|NCT00095940|69688621|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
38004953|NCT00095940|69688622|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
38004954|NCT00095940|69688623|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
38004955|NCT00095940|69688624|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
38004956|NCT00095940|69688625|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
38004957|NCT00095940|69688617|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
38004958|NCT00095940|69688618|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
38004959|NCT00095940|69688619|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
38004960|NCT00095940|69688620|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
38004961|NCT00095940|69688621|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
38004962|NCT00095940|69688622|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
38004963|NCT00095940|69688623|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
38004964|NCT00095940|69688624|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
38004965|NCT00095940|69688625|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
38004966|NCT00095940|69688617|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
38004967|NCT00095940|69688618|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
38004968|NCT00095940|69688619|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
37907202|NCT00961961|69592725|FG000|Phase I|Physician Decision|8|||
37907203|NCT00961961|69592726|FG001|Phase I|Physician Decision|0|||
37907204|NCT00961961|69592727|FG002|Phase I|Physician Decision|0|||
37907205|NCT00961961|69592728|FG003|Phase I|Physician Decision|0|||
37907206|NCT00961961|69592725|FG000|Phase II|Lost to Follow-up|0|||
37907207|NCT00961961|69592726|FG001|Phase II|Lost to Follow-up|0|||
37907208|NCT00961961|69592727|FG002|Phase II|Lost to Follow-up|10|||
37907209|NCT00961961|69592728|FG003|Phase II|Lost to Follow-up|7|||
37907210|NCT00961961|69592725|FG000|Phase II|Adverse Event|0|||
37907211|NCT00961961|69592726|FG001|Phase II|Adverse Event|0|||
37907212|NCT00961961|69592727|FG002|Phase II|Adverse Event|0|||
37907213|NCT00961961|69592728|FG003|Phase II|Adverse Event|1|||
37907214|NCT00961961|69592725|FG000|Phase II|Physician Decision|0|||
37907215|NCT00961961|69592726|FG001|Phase II|Physician Decision|0|||
37907216|NCT00961961|69592727|FG002|Phase II|Physician Decision|1|||
37907217|NCT00961961|69592728|FG003|Phase II|Physician Decision|0|||
37907218|NCT00961961|69592725|FG000|Phase II|Withdrawal by Subject|0|||
37907219|NCT00961961|69592726|FG001|Phase II|Withdrawal by Subject|0|||
37907220|NCT00961961|69592727|FG002|Phase II|Withdrawal by Subject|1|||
38004969|NCT00095940|69688620|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
38004970|NCT00095940|69688621|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
38004971|NCT00095940|69688622|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
38004972|NCT00095940|69688623|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
37907221|NCT00961961|69592728|FG003|Phase II|Withdrawal by Subject|0|||
37907222|NCT00817089|69592752|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
37907223|NCT00817089|69592753|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
37907224|NCT00817089|69592754|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
37907225|NCT00817089|69592755|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
37907226|NCT00817089|69592752|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
37907227|NCT00817089|69592753|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
37907228|NCT00817089|69592754|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
37907229|NCT00817089|69592755|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
38004973|NCT00095940|69688624|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
38004974|NCT00095940|69688625|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
38004975|NCT00114218|69688643|FG000|Overall Study|Wrong Cell Type|2|||
38004976|NCT00114218|69688643|FG000|Overall Study|Wrong Primary|1|||
38004977|NCT00114218|69688643|FG000|Overall Study|Never Treated|1|||
38004978|NCT00095628|69688647|FG000|Overall Study|Disease progression prior to treatment|1|||
38004979|NCT04380142|69688653|FG000|LD/CD Stabilization Period|Adverse Event|3|||
38004980|NCT04380142|69688654|FG001|LD/CD Stabilization Period|Adverse Event|0|||
38004981|NCT04380142|69688655|FG002|LD/CD Stabilization Period|Adverse Event|0|||
38004982|NCT04380142|69688653|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
37907230|NCT00815919|69592769|FG000|Overall Study|Unrelated Fungal Infection|1|||
37907231|NCT00815919|69592769|FG000|Overall Study|AML Relapse|1|||
37907232|NCT00815919|69592769|FG000|Overall Study|Lack of Efficacy|2|||
37907233|NCT00957905|69592775|FG000|Part B|Not Treated|0|||
37907234|NCT00957905|69592776|FG001|Part B|Not Treated|1|||
37907235|NCT00957905|69592775|FG000|Part B|Physician Decision|0|||
37907236|NCT00957905|69592776|FG001|Part B|Physician Decision|1|||
37907237|NCT00957905|69592775|FG000|Part B|Death|0|||
37907238|NCT00957905|69592776|FG001|Part B|Death|1|||
37907239|NCT00957905|69592775|FG000|Part B|Protocol Violation|0|||
37907240|NCT00957905|69592776|FG001|Part B|Protocol Violation|1|||
37907241|NCT00960323|69592782|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
37907242|NCT00617929|69592790|FG000|Overall Study|Physician Decision|1|||
37907243|NCT00815295|69592797|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
37907244|NCT00815295|69592798|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
37907245|NCT00815295|69592799|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
37907246|NCT00814983|69592809|FG000|Overall Study|Screen failure|1|||
37907247|NCT00814983|69592810|FG001|Overall Study|Screen failure|0|||
37907248|NCT00814983|69592809|FG000|Overall Study|Withdrawal by Subject|1|||
37907249|NCT00814983|69592810|FG001|Overall Study|Withdrawal by Subject|0|||
37907250|NCT00814983|69592809|FG000|Overall Study|Graft failure|1|||
37907251|NCT00814983|69592810|FG001|Overall Study|Graft failure|0|||
37907252|NCT00960869|69592818|FG000|Overall Study|Adverse Event|17|||
37907253|NCT00960869|69592819|FG001|Overall Study|Adverse Event|26|||
37907254|NCT00960869|69592818|FG000|Overall Study|Withdrawal by Subject|16|||
37907255|NCT00960869|69592819|FG001|Overall Study|Withdrawal by Subject|14|||
37907256|NCT00960869|69592818|FG000|Overall Study|Lost to Follow-up|1|||
37907257|NCT00960869|69592819|FG001|Overall Study|Lost to Follow-up|4|||
37907258|NCT00960869|69592818|FG000|Overall Study|Misc|19|||
37907259|NCT00960869|69592819|FG001|Overall Study|Misc|18|||
37907260|NCT00618787|69592827|FG000|Overall Study|Adverse Event|0|||
37907261|NCT00618787|69592828|FG001|Overall Study|Adverse Event|1|||
37907262|NCT00618787|69592827|FG000|Overall Study|Withdrawal by Subject|2|||
37907263|NCT00618787|69592828|FG001|Overall Study|Withdrawal by Subject|1|||
37907264|NCT00618787|69592827|FG000|Overall Study|Lost to Follow-up|1|||
37907265|NCT00618787|69592828|FG001|Overall Study|Lost to Follow-up|0|||
37907266|NCT00813813|69592836|FG000|Overall Study|Withdrawal by Subject|1|||
37907267|NCT00813813|69592837|FG001|Overall Study|Withdrawal by Subject|1|||
37907268|NCT00813813|69592836|FG000|Overall Study|Lost to Follow-up|2|||
37907269|NCT00813813|69592837|FG001|Overall Study|Lost to Follow-up|7|||
37907270|NCT00813813|69592836|FG000|Overall Study|Other|0|||
37907271|NCT00813813|69592837|FG001|Overall Study|Other|1|||
37907272|NCT05317312|69592847|FG000|Overall Study|Withdrawal by Subject|0|||
37907273|NCT05317312|69592848|FG001|Overall Study|Withdrawal by Subject|1|||
37907274|NCT05317312|69592849|FG002|Overall Study|Withdrawal by Subject|0|||
37907275|NCT05317312|69592850|FG003|Overall Study|Withdrawal by Subject|0|||
37907276|NCT05317312|69592847|FG000|Overall Study|Lost to Follow-up|0|||
38004983|NCT04380142|69688654|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
38004984|NCT04380142|69688655|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
38004985|NCT04380142|69688653|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
38004986|NCT04380142|69688654|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
38004987|NCT04380142|69688655|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
37907277|NCT05317312|69592848|FG001|Overall Study|Lost to Follow-up|0|||
37907278|NCT05317312|69592849|FG002|Overall Study|Lost to Follow-up|0|||
37907279|NCT05317312|69592850|FG003|Overall Study|Lost to Follow-up|1|||
37907280|NCT05317312|69592847|FG000|Overall Study|Excluded as exclusion criteria was met.|0|||
37907281|NCT05317312|69592848|FG001|Overall Study|Excluded as exclusion criteria was met.|0|||
37907282|NCT05317312|69592849|FG002|Overall Study|Excluded as exclusion criteria was met.|1|||
37907283|NCT05317312|69592850|FG003|Overall Study|Excluded as exclusion criteria was met.|0|||
37907284|NCT04644315|69592860|FG000|Overall Study|Subject withdrawal of consent|1|||
37907285|NCT04410523|69592870|FG000|Overall Study|Study terminated by sponsor|1|||
37907286|NCT04410523|69592871|FG001|Overall Study|Study terminated by sponsor|3|||
38004988|NCT04380142|69688653|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
38004989|NCT04380142|69688654|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
38004990|NCT04380142|69688655|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
38004991|NCT04380142|69688653|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
38004992|NCT04380142|69688654|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
38004993|NCT04380142|69688655|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
38004994|NCT04380142|69688653|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
38004995|NCT04380142|69688654|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
38004996|NCT04380142|69688655|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
38004997|NCT04380142|69688653|FG000|Double-Blind Treatment Period|Adverse Event|0|||
38004998|NCT04380142|69688654|FG001|Double-Blind Treatment Period|Adverse Event|1|||
38004999|NCT04380142|69688655|FG002|Double-Blind Treatment Period|Adverse Event|14|||
38005000|NCT04380142|69688653|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
38005001|NCT04380142|69688654|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
38005002|NCT04380142|69688655|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
38005003|NCT04380142|69688653|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
38005004|NCT04380142|69688654|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
38005005|NCT04380142|69688655|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
38005006|NCT04380142|69688653|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
38005007|NCT04380142|69688654|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
38005008|NCT04380142|69688655|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
38005009|NCT04380142|69688653|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
38005010|NCT04380142|69688654|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
38005011|NCT04380142|69688655|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
38005012|NCT04380142|69688653|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
38005013|NCT04380142|69688654|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
38005014|NCT04380142|69688655|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
38005015|NCT04335136|69688665|FG000|Overall Study|Death|8|||
38005016|NCT04335136|69688666|FG001|Overall Study|Death|4|||
38005017|NCT04335136|69688665|FG000|Overall Study|Lost to Follow-up|2|||
38005018|NCT04335136|69688666|FG001|Overall Study|Lost to Follow-up|0|||
38005019|NCT04335136|69688665|FG000|Overall Study|Protocol Violation|1|||
38005020|NCT04335136|69688666|FG001|Overall Study|Protocol Violation|0|||
38005021|NCT04335136|69688665|FG000|Overall Study|Withdrawal by Subject|1|||
38005022|NCT04335136|69688666|FG001|Overall Study|Withdrawal by Subject|1|||
38005023|NCT04335136|69688665|FG000|Overall Study|Health-threatening condition|0|||
38005024|NCT04335136|69688666|FG001|Overall Study|Health-threatening condition|1|||
38005025|NCT04335136|69688665|FG000|Overall Study|Adverse Event|0|||
38005026|NCT04335136|69688666|FG001|Overall Study|Adverse Event|1|||
38005027|NCT04335136|69688665|FG000|Overall Study|Erroneously randomized|2|||
38005028|NCT04335136|69688666|FG001|Overall Study|Erroneously randomized|0|||
38005029|NCT04171414|69688672|FG000|Overall Study|Death|1|||
38005030|NCT04171414|69688672|FG000|Overall Study|Withdrawal by Subject|1|||
38005031|NCT04167670|69688679|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
38005032|NCT04167670|69688680|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
38005033|NCT04167670|69688681|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
38005034|NCT04167670|69688679|FG000|Overall Study|Significant protocol deviation|3|||
38005035|NCT04167670|69688680|FG001|Overall Study|Significant protocol deviation|1|||
38005036|NCT04167670|69688681|FG002|Overall Study|Significant protocol deviation|0|||
38005037|NCT04167670|69688679|FG000|Overall Study|Lost to Follow-up|0|||
38005038|NCT04167670|69688680|FG001|Overall Study|Lost to Follow-up|3|||
38005039|NCT04167670|69688681|FG002|Overall Study|Lost to Follow-up|3|||
38005040|NCT04167670|69688679|FG000|Overall Study|Voluntary Withdrawal|0|||
38005041|NCT04167670|69688680|FG001|Overall Study|Voluntary Withdrawal|1|||
38005042|NCT04167670|69688681|FG002|Overall Study|Voluntary Withdrawal|1|||
38005043|NCT04167670|69688679|FG000|Overall Study|Withdrawal of Consent|4|||
38005044|NCT04167670|69688680|FG001|Overall Study|Withdrawal of Consent|1|||
38005045|NCT04167670|69688681|FG002|Overall Study|Withdrawal of Consent|3|||
38005046|NCT04167670|69688679|FG000|Overall Study|Miscellaneous|7|||
38005047|NCT04167670|69688680|FG001|Overall Study|Miscellaneous|5|||
38005048|NCT04167670|69688681|FG002|Overall Study|Miscellaneous|3|||
38005049|NCT00113516|69688689|FG000|Part 1|Adverse Event|6|||
38005050|NCT00113516|69688690|FG001|Part 1|Adverse Event|0|||
38005051|NCT00113516|69688689|FG000|Part 1|Death|3|||
38005052|NCT00113516|69688690|FG001|Part 1|Death|0|||
38005053|NCT00113516|69688689|FG000|Part 1|Other|3|||
38005054|NCT00113516|69688690|FG001|Part 1|Other|0|||
38005055|NCT00113516|69688689|FG000|Part 1|Withdrawal by Subject|2|||
38005056|NCT00113516|69688690|FG001|Part 1|Withdrawal by Subject|0|||
38005057|NCT00113516|69688689|FG000|Part 1|Lack of Efficacy|2|||
38005058|NCT00113516|69688690|FG001|Part 1|Lack of Efficacy|0|||
38005059|NCT00113516|69688689|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
38005060|NCT00113516|69688690|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
38005061|NCT00113516|69688689|FG000|Part 1|Laboratory Abnormality|1|||
38005062|NCT00113516|69688690|FG001|Part 1|Laboratory Abnormality|0|||
38005063|NCT00113516|69688689|FG000|Part 1|Ongoing|1|||
38005064|NCT00113516|69688690|FG001|Part 1|Ongoing|0|||
38005065|NCT00113516|69688689|FG000|Part 1|Missing|65|||
38005066|NCT00113516|69688690|FG001|Part 1|Missing|0|||
38005067|NCT00113516|69688689|FG000|Part 2|Adverse Event|0|||
38005068|NCT00113516|69688690|FG001|Part 2|Adverse Event|16|||
38005069|NCT00113516|69688689|FG000|Part 2|Death|0|||
38005070|NCT00113516|69688690|FG001|Part 2|Death|5|||
38005071|NCT00113516|69688689|FG000|Part 2|Lack of Efficacy|0|||
38005072|NCT00113516|69688690|FG001|Part 2|Lack of Efficacy|37|||
38005073|NCT00113516|69688689|FG000|Part 2|Withdrawal by Subject|0|||
38005074|NCT00113516|69688690|FG001|Part 2|Withdrawal by Subject|3|||
38005075|NCT00113516|69688689|FG000|Part 2|Other|0|||
38005076|NCT00113516|69688690|FG001|Part 2|Other|3|||
38005077|NCT00113516|69688689|FG000|Part 2|Laboratory Abnormality|0|||
38005078|NCT00113516|69688690|FG001|Part 2|Laboratory Abnormality|1|||
38005079|NCT00113516|69688689|FG000|Part 2|Ongoing|0|||
38005080|NCT00113516|69688690|FG001|Part 2|Ongoing|1|||
38005081|NCT04142242|69688702|FG000|Overall Study|Non-compliance with the protocol|1|||
38005082|NCT04142242|69688703|FG001|Overall Study|Non-compliance with the protocol|0|||
38005083|NCT04142242|69688704|FG002|Overall Study|Non-compliance with the protocol|0|||
38005084|NCT04142242|69688705|FG003|Overall Study|Non-compliance with the protocol|0|||
38005085|NCT04142242|69688706|FG004|Overall Study|Non-compliance with the protocol|0|||
38005086|NCT04142242|69688707|FG005|Overall Study|Non-compliance with the protocol|1|||
38005087|NCT04142242|69688702|FG000|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0|||
38005088|NCT04142242|69688703|FG001|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|1|||
38005089|NCT04142242|69688704|FG002|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0|||
38005090|NCT04142242|69688705|FG003|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0|||
38005091|NCT04142242|69688706|FG004|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0|||
38005092|NCT04142242|69688707|FG005|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0|||
38005093|NCT04142242|69688702|FG000|Overall Study|Ongoing|0|||
38005094|NCT04142242|69688703|FG001|Overall Study|Ongoing|0|||
38005095|NCT04142242|69688704|FG002|Overall Study|Ongoing|31|||
38005096|NCT04142242|69688705|FG003|Overall Study|Ongoing|39|||
38005097|NCT04142242|69688706|FG004|Overall Study|Ongoing|0|||
38005098|NCT04142242|69688707|FG005|Overall Study|Ongoing|0|||
38005099|NCT04140292|69688735|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
38005100|NCT04140292|69688736|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
38005101|NCT04138810|69688745|FG000|Overall Study|Withdrawal by Subject|0|||
37907287|NCT04410523|69592872|FG002|Overall Study|Study terminated by sponsor|2|||
37907288|NCT04410523|69592873|FG003|Overall Study|Study terminated by sponsor|6|||
37907289|NCT04410523|69592874|FG004|Overall Study|Study terminated by sponsor|3|||
37907290|NCT04410523|69592875|FG005|Overall Study|Study terminated by sponsor|4|||
37907291|NCT04410523|69592870|FG000|Overall Study|Adverse Event|1|||
37907292|NCT04410523|69592871|FG001|Overall Study|Adverse Event|0|||
37907293|NCT04410523|69592872|FG002|Overall Study|Adverse Event|0|||
38005102|NCT04138810|69688746|FG001|Overall Study|Withdrawal by Subject|1|||
38005103|NCT04138810|69688745|FG000|Overall Study|Subject cancelled surgery|1|||
38005104|NCT04138810|69688746|FG001|Overall Study|Subject cancelled surgery|0|||
38005105|NCT00127166|69688754|FG000|Period I|Protocol Violation|0|||
38005106|NCT00127166|69688755|FG001|Period I|Protocol Violation|2|||
38005107|NCT00127166|69688754|FG000|Period I|Withdrawal by Subject|2|||
38005108|NCT00127166|69688755|FG001|Period I|Withdrawal by Subject|0|||
37830691|NCT01306162|69513972|FG000|Washout 1|Non-compliance to protocol|0|||
37830692|NCT01306162|69513973|FG001|Washout 1|Non-compliance to protocol|1|||
37830693|NCT01306162|69513974|FG002|Washout 1|Non-compliance to protocol|0|||
37830694|NCT01306162|69513975|FG003|Washout 1|Non-compliance to protocol|0|||
37830695|NCT01305577|69513991|FG000|Overall Study|Adverse Event|2|||
37830696|NCT01305577|69513992|FG001|Overall Study|Adverse Event|2|||
37830697|NCT01305577|69513993|FG002|Overall Study|Adverse Event|1|||
38005109|NCT00127166|69688754|FG000|Period I|Patient did not meet inclusion criteria|1|||
37830698|NCT01305577|69513991|FG000|Overall Study|Withdrawal by Subject|7|||
37830699|NCT01305577|69513992|FG001|Overall Study|Withdrawal by Subject|5|||
37830700|NCT01305577|69513993|FG002|Overall Study|Withdrawal by Subject|6|||
38043627|NCT02180867|69731807|FG003|Overall Study|Death|0|||
37830701|NCT01305577|69513991|FG000|Overall Study|Lost to Follow-up|4|||
37830702|NCT01305577|69513992|FG001|Overall Study|Lost to Follow-up|3|||
37830703|NCT01305577|69513993|FG002|Overall Study|Lost to Follow-up|2|||
37907294|NCT04410523|69592873|FG003|Overall Study|Adverse Event|0|||
37907295|NCT04410523|69592874|FG004|Overall Study|Adverse Event|0|||
37907296|NCT04410523|69592875|FG005|Overall Study|Adverse Event|2|||
38043628|NCT02180867|69731808|FG004|Overall Study|Death|1|||
38043629|NCT02180867|69731809|FG005|Overall Study|Death|0|||
38043630|NCT02180867|69731810|FG006|Overall Study|Death|0|||
38043631|NCT02180867|69731804|FG000|Overall Study|Lack of Efficacy|0|||
38043632|NCT02180867|69731805|FG001|Overall Study|Lack of Efficacy|2|||
38005110|NCT00127166|69688755|FG001|Period I|Patient did not meet inclusion criteria|0|||
38005111|NCT00127166|69688754|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
38005112|NCT00127166|69688755|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
38005113|NCT00127166|69688754|FG000|Period II|Withdrawal by Subject|2|||
38005114|NCT00127166|69688755|FG001|Period II|Withdrawal by Subject|0|||
38005115|NCT00127166|69688754|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
38005116|NCT00127166|69688755|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
38005117|NCT00125138|69688765|FG000|Overall Study|Adverse Event|1|||
38005118|NCT00125138|69688766|FG001|Overall Study|Adverse Event|0|||
38005119|NCT00125138|69688767|FG002|Overall Study|Adverse Event|3|||
38005120|NCT00125138|69688768|FG003|Overall Study|Adverse Event|2|||
38005121|NCT00125138|69688765|FG000|Overall Study|Withdrawal by Subject|2|||
38005122|NCT00125138|69688766|FG001|Overall Study|Withdrawal by Subject|3|||
38005123|NCT00125138|69688767|FG002|Overall Study|Withdrawal by Subject|1|||
38005124|NCT00125138|69688768|FG003|Overall Study|Withdrawal by Subject|1|||
38005125|NCT00125138|69688765|FG000|Overall Study|Lack of Efficacy|0|||
38005126|NCT00125138|69688766|FG001|Overall Study|Lack of Efficacy|0|||
38005127|NCT00125138|69688767|FG002|Overall Study|Lack of Efficacy|0|||
38005128|NCT00125138|69688768|FG003|Overall Study|Lack of Efficacy|1|||
38005129|NCT00125138|69688765|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
38005130|NCT00125138|69688766|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
38005131|NCT00125138|69688767|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
38005132|NCT00125138|69688768|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
38005133|NCT04132336|69688785|FG000|Overall Study|Investigator Decision|0|||
38005134|NCT04132336|69688786|FG001|Overall Study|Investigator Decision|1|||
38005135|NCT04132336|69688787|FG002|Overall Study|Investigator Decision|0|||
38005136|NCT04132336|69688788|FG003|Overall Study|Investigator Decision|0|||
38005137|NCT04132336|69688789|FG004|Overall Study|Investigator Decision|0|||
38005138|NCT04132336|69688790|FG005|Overall Study|Investigator Decision|0|||
38005139|NCT04132336|69688791|FG006|Overall Study|Investigator Decision|0|||
38005140|NCT04131556|69688807|FG000|Overall Study|Adverse Event|1|||
38005141|NCT04131556|69688807|FG000|Overall Study|Withdrawal by Subject|1|||
38005142|NCT04295356|69688816|FG000|Overall Study|Physician Decision|1|||
38005143|NCT04295356|69688817|FG001|Overall Study|Physician Decision|0|||
38005144|NCT04295356|69688816|FG000|Overall Study|Lost to Follow-up|0|||
38005145|NCT04295356|69688817|FG001|Overall Study|Lost to Follow-up|3|||
38005146|NCT04295356|69688816|FG000|Overall Study|Protocol Violation|0|||
38005147|NCT04295356|69688817|FG001|Overall Study|Protocol Violation|1|||
38005148|NCT03691948|69688825|FG000|Overall Study|Lost to Follow-up|1|||
38005149|NCT03691948|69688826|FG001|Overall Study|Lost to Follow-up|3|||
38005150|NCT04126174|69688833|FG000|Overall Study|Lost to Follow-up|3|||
38005151|NCT04126174|69688834|FG001|Overall Study|Lost to Follow-up|3|||
38005152|NCT04124926|69688842|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
38005153|NCT04124926|69688843|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
38005154|NCT04124926|69688844|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
38005155|NCT04124926|69688845|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
38005156|NCT04124926|69688846|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
38005157|NCT04124926|69688842|FG000|Healing Phase|Protocol Violation|0|||
38005158|NCT04124926|69688843|FG001|Healing Phase|Protocol Violation|1|||
38005159|NCT04124926|69688844|FG002|Healing Phase|Protocol Violation|0|||
38005160|NCT04124926|69688845|FG003|Healing Phase|Protocol Violation|0|||
38005161|NCT04124926|69688846|FG004|Healing Phase|Protocol Violation|0|||
38005162|NCT04124926|69688842|FG000|Healing Phase|Lost to Follow-up|5|||
38005163|NCT04124926|69688843|FG001|Healing Phase|Lost to Follow-up|4|||
37697596|NCT01842334|69174192|FG001|Overall Study|Moved away mid-study|1|||
37697597|NCT02457611|69174198|FG000|Overall Study|Lost to Follow-up|3|||
37697598|NCT02457065|69174204|FG000|Overall Study|Lost to Follow-up|9|||
37697599|NCT02457065|69174205|FG001|Overall Study|Lost to Follow-up|11|||
37697600|NCT02083653|69174214|FG000|Overall Study|Randomized but not Treated|0|||
37830704|NCT01305577|69513991|FG000|Overall Study|Protocol Deviation|0|||
37830705|NCT01305577|69513992|FG001|Overall Study|Protocol Deviation|1|||
37830706|NCT01305577|69513993|FG002|Overall Study|Protocol Deviation|1|||
37830707|NCT01304329|69514001|FG000|Third Intervention (3 Days)|Adverse Event|0|||
37830708|NCT01304329|69514002|FG001|Third Intervention (3 Days)|Adverse Event|1|||
37830709|NCT01304329|69514003|FG002|Third Intervention (3 Days)|Adverse Event|0|||
37830710|NCT01304329|69514004|FG003|Third Intervention (3 Days)|Adverse Event|0|||
37830711|NCT01304329|69514005|FG004|Third Intervention (3 Days)|Adverse Event|0|||
37830712|NCT01304329|69514006|FG005|Third Intervention (3 Days)|Adverse Event|0|||
37830713|NCT01303861|69514019|FG000|Overall Study|Lost to Follow-up|34|||
37830714|NCT01303861|69514020|FG001|Overall Study|Lost to Follow-up|14|||
37830715|NCT01303861|69514021|FG002|Overall Study|Lost to Follow-up|27|||
37830716|NCT01303861|69514022|FG003|Overall Study|Lost to Follow-up|31|||
37830717|NCT01303861|69514019|FG000|Overall Study|Lack of Efficacy|3|||
37830718|NCT01303861|69514020|FG001|Overall Study|Lack of Efficacy|2|||
37830719|NCT01303861|69514021|FG002|Overall Study|Lack of Efficacy|1|||
38005164|NCT04124926|69688844|FG002|Healing Phase|Lost to Follow-up|0|||
38005165|NCT04124926|69688845|FG003|Healing Phase|Lost to Follow-up|0|||
38005166|NCT04124926|69688846|FG004|Healing Phase|Lost to Follow-up|0|||
38005167|NCT04124926|69688842|FG000|Healing Phase|Voluntary Withdrawal|10|||
38005168|NCT04124926|69688843|FG001|Healing Phase|Voluntary Withdrawal|7|||
38005169|NCT04124926|69688844|FG002|Healing Phase|Voluntary Withdrawal|0|||
38005170|NCT04124926|69688845|FG003|Healing Phase|Voluntary Withdrawal|0|||
38005171|NCT04124926|69688846|FG004|Healing Phase|Voluntary Withdrawal|0|||
38005172|NCT04124926|69688842|FG000|Healing Phase|Withdrawal of Consent|5|||
38005173|NCT04124926|69688843|FG001|Healing Phase|Withdrawal of Consent|3|||
38005174|NCT04124926|69688844|FG002|Healing Phase|Withdrawal of Consent|0|||
38005175|NCT04124926|69688845|FG003|Healing Phase|Withdrawal of Consent|0|||
38005176|NCT04124926|69688846|FG004|Healing Phase|Withdrawal of Consent|0|||
38005177|NCT04124926|69688842|FG000|Healing Phase|Miscellaneous|8|||
38005178|NCT04124926|69688843|FG001|Healing Phase|Miscellaneous|7|||
38005179|NCT04124926|69688844|FG002|Healing Phase|Miscellaneous|0|||
38005180|NCT04124926|69688845|FG003|Healing Phase|Miscellaneous|0|||
38005181|NCT04124926|69688846|FG004|Healing Phase|Miscellaneous|0|||
38005182|NCT04124926|69688842|FG000|Healing Phase|Randomized but not Treated|0|||
38005183|NCT04124926|69688843|FG001|Healing Phase|Randomized but not Treated|3|||
38005184|NCT04124926|69688844|FG002|Healing Phase|Randomized but not Treated|0|||
38005185|NCT04124926|69688845|FG003|Healing Phase|Randomized but not Treated|0|||
38005186|NCT04124926|69688846|FG004|Healing Phase|Randomized but not Treated|0|||
37907297|NCT04410523|69592870|FG000|Overall Study|Lost to Follow-up|0|||
38005187|NCT04124926|69688842|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
38005188|NCT04124926|69688843|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
38005189|NCT04124926|69688844|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
38005190|NCT04124926|69688845|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
38005191|NCT04124926|69688846|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
38005192|NCT04124926|69688842|FG000|Maintenance Phase|Protocol Violation|0|||
38005193|NCT04124926|69688843|FG001|Maintenance Phase|Protocol Violation|0|||
37697601|NCT02083653|69174215|FG001|Overall Study|Randomized but not Treated|2|||
37697602|NCT02083653|69174216|FG002|Overall Study|Randomized but not Treated|7|||
37697603|NCT02083653|69174214|FG000|Overall Study|Adverse Event|12|||
37907298|NCT04410523|69592871|FG001|Overall Study|Lost to Follow-up|1|||
37907299|NCT04410523|69592872|FG002|Overall Study|Lost to Follow-up|0|||
37907300|NCT04410523|69592873|FG003|Overall Study|Lost to Follow-up|0|||
37907301|NCT04410523|69592874|FG004|Overall Study|Lost to Follow-up|0|||
37907302|NCT04410523|69592875|FG005|Overall Study|Lost to Follow-up|0|||
37907303|NCT04410523|69592870|FG000|Overall Study|Physician Decision|0|||
37907304|NCT04410523|69592871|FG001|Overall Study|Physician Decision|1|||
37907305|NCT04410523|69592872|FG002|Overall Study|Physician Decision|0|||
37907306|NCT04410523|69592873|FG003|Overall Study|Physician Decision|0|||
37907307|NCT04410523|69592874|FG004|Overall Study|Physician Decision|0|||
37907308|NCT04410523|69592875|FG005|Overall Study|Physician Decision|0|||
37907309|NCT04410523|69592870|FG000|Overall Study|Pregnancy|0|||
37907310|NCT04410523|69592871|FG001|Overall Study|Pregnancy|0|||
37907311|NCT04410523|69592872|FG002|Overall Study|Pregnancy|0|||
37907312|NCT04410523|69592873|FG003|Overall Study|Pregnancy|0|||
37907313|NCT04410523|69592874|FG004|Overall Study|Pregnancy|0|||
37907314|NCT04410523|69592875|FG005|Overall Study|Pregnancy|1|||
37907315|NCT04410523|69592870|FG000|Overall Study|Protocol deviation|0|||
37907316|NCT04410523|69592871|FG001|Overall Study|Protocol deviation|0|||
37907317|NCT04410523|69592872|FG002|Overall Study|Protocol deviation|0|||
38005194|NCT04124926|69688844|FG002|Maintenance Phase|Protocol Violation|3|||
38005195|NCT04124926|69688845|FG003|Maintenance Phase|Protocol Violation|0|||
37830720|NCT01303861|69514022|FG003|Overall Study|Lack of Efficacy|0|||
37830721|NCT01303861|69514019|FG000|Overall Study|Withdrawal by Subject|16|||
37830722|NCT01303861|69514020|FG001|Overall Study|Withdrawal by Subject|8|||
37830723|NCT01303861|69514021|FG002|Overall Study|Withdrawal by Subject|8|||
37830724|NCT01303861|69514022|FG003|Overall Study|Withdrawal by Subject|23|||
37830725|NCT01303861|69514019|FG000|Overall Study|Adverse Event|4|||
37830726|NCT01303861|69514020|FG001|Overall Study|Adverse Event|1|||
37830727|NCT01303861|69514021|FG002|Overall Study|Adverse Event|0|||
37830728|NCT01303861|69514022|FG003|Overall Study|Adverse Event|5|||
37907318|NCT04410523|69592873|FG003|Overall Study|Protocol deviation|0|||
37907319|NCT04410523|69592874|FG004|Overall Study|Protocol deviation|0|||
37907320|NCT04410523|69592875|FG005|Overall Study|Protocol deviation|2|||
38005196|NCT04124926|69688846|FG004|Maintenance Phase|Protocol Violation|0|||
38005197|NCT04124926|69688842|FG000|Maintenance Phase|Lost to Follow-up|0|||
38005198|NCT04124926|69688843|FG001|Maintenance Phase|Lost to Follow-up|0|||
38005199|NCT04124926|69688844|FG002|Maintenance Phase|Lost to Follow-up|7|||
37697604|NCT02083653|69174215|FG001|Overall Study|Adverse Event|5|||
37907321|NCT04410523|69592870|FG000|Overall Study|Subject decision|2|||
37907322|NCT04410523|69592871|FG001|Overall Study|Subject decision|0|||
38005200|NCT04124926|69688845|FG003|Maintenance Phase|Lost to Follow-up|8|||
38005201|NCT04124926|69688846|FG004|Maintenance Phase|Lost to Follow-up|9|||
37907323|NCT04410523|69592872|FG002|Overall Study|Subject decision|0|||
37907324|NCT04410523|69592873|FG003|Overall Study|Subject decision|1|||
37907325|NCT04410523|69592874|FG004|Overall Study|Subject decision|0|||
37907326|NCT04410523|69592875|FG005|Overall Study|Subject decision|1|||
37907327|NCT03749109|69592914|FG000|Overall Study|Adverse Event|2|||
37907328|NCT03749109|69592915|FG001|Overall Study|Adverse Event|0|||
37907329|NCT03709706|69592924|FG000|Overall Study|Adverse Event|0|||
37907330|NCT03709706|69592925|FG001|Overall Study|Adverse Event|1|||
37907331|NCT03709706|69592924|FG000|Overall Study|Physician Decision|14|||
37907332|NCT03709706|69592925|FG001|Overall Study|Physician Decision|8|||
37907333|NCT03709706|69592924|FG000|Overall Study|Withdrawal by Subject|2|||
37907334|NCT03709706|69592925|FG001|Overall Study|Withdrawal by Subject|1|||
37907335|NCT03709706|69592924|FG000|Overall Study|Death Prior to Lete-cel Infusion|1|||
37907336|NCT03709706|69592925|FG001|Overall Study|Death Prior to Lete-cel Infusion|1|||
37907337|NCT03497689|69592932|FG000|Overall Study|Adverse Event|2|||
37907338|NCT03497689|69592932|FG000|Overall Study|Death|1|||
37907339|NCT03497689|69592932|FG000|Overall Study|Physician Decision|1|||
38005202|NCT04124926|69688842|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
38005203|NCT04124926|69688843|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
38005204|NCT04124926|69688844|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
38005205|NCT04124926|69688845|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
38005206|NCT04124926|69688846|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
38005207|NCT04124926|69688842|FG000|Maintenance Phase|Pregnancy|0|||
38005208|NCT04124926|69688843|FG001|Maintenance Phase|Pregnancy|0|||
38005209|NCT04124926|69688844|FG002|Maintenance Phase|Pregnancy|0|||
38005210|NCT04124926|69688845|FG003|Maintenance Phase|Pregnancy|1|||
38005211|NCT04124926|69688846|FG004|Maintenance Phase|Pregnancy|0|||
38005212|NCT04124926|69688842|FG000|Maintenance Phase|Lack of Efficacy|0|||
38005213|NCT04124926|69688843|FG001|Maintenance Phase|Lack of Efficacy|0|||
38005214|NCT04124926|69688844|FG002|Maintenance Phase|Lack of Efficacy|0|||
38005215|NCT04124926|69688845|FG003|Maintenance Phase|Lack of Efficacy|0|||
38005216|NCT04124926|69688846|FG004|Maintenance Phase|Lack of Efficacy|1|||
38005217|NCT04124926|69688842|FG000|Maintenance Phase|Withdrawal of Consent|0|||
38005218|NCT04124926|69688843|FG001|Maintenance Phase|Withdrawal of Consent|0|||
37907340|NCT03497689|69592932|FG000|Overall Study|Withdrawal by Subject|1|||
37907341|NCT03497689|69592932|FG000|Overall Study|Protocol Violation|2|||
37907342|NCT03492437|69592936|FG000|Treatment Period 2|Withdrawal by Subject|0|||
37907343|NCT03492437|69592937|FG001|Treatment Period 2|Withdrawal by Subject|1|||
37907344|NCT03193853|69592943|FG000|Overall Study|Death|6|||
37907345|NCT02756637|69592949|FG000|Overall Study|Not eligible for initial SWOG study|10|||
37907346|NCT02756637|69592950|FG001|Overall Study|Not eligible for initial SWOG study|10|||
37907347|NCT02756637|69592949|FG000|Overall Study|No available NLR value|44|||
37907348|NCT02756637|69592950|FG001|Overall Study|No available NLR value|44|||
37907349|NCT02756637|69592949|FG000|Overall Study|Did not complete curative therapy|33|||
37907350|NCT02756637|69592950|FG001|Overall Study|Did not complete curative therapy|0|||
37907351|NCT02041195|69592964|FG000|Overall Study|Adverse Event|1|||
38005219|NCT04124926|69688844|FG002|Maintenance Phase|Withdrawal of Consent|5|||
38005220|NCT04124926|69688845|FG003|Maintenance Phase|Withdrawal of Consent|5|||
38005221|NCT04124926|69688846|FG004|Maintenance Phase|Withdrawal of Consent|5|||
38005222|NCT04124926|69688842|FG000|Maintenance Phase|Miscellaneous|0|||
38005223|NCT04124926|69688843|FG001|Maintenance Phase|Miscellaneous|0|||
38005224|NCT04124926|69688844|FG002|Maintenance Phase|Miscellaneous|1|||
38005225|NCT04124926|69688845|FG003|Maintenance Phase|Miscellaneous|2|||
38005226|NCT04124926|69688846|FG004|Maintenance Phase|Miscellaneous|4|||
38005227|NCT04124926|69688842|FG000|Maintenance Phase|Randomized but not Treated|0|||
38005228|NCT04124926|69688843|FG001|Maintenance Phase|Randomized but not Treated|0|||
38005229|NCT04124926|69688844|FG002|Maintenance Phase|Randomized but not Treated|2|||
38005230|NCT04124926|69688845|FG003|Maintenance Phase|Randomized but not Treated|2|||
38005231|NCT04124926|69688846|FG004|Maintenance Phase|Randomized but not Treated|0|||
38005232|NCT04274686|69688858|FG000|Overall Study|Physician Decision|1|||
38005233|NCT04274686|69688859|FG001|Overall Study|Physician Decision|0|||
38005234|NCT04113694|69688867|FG000|Overall Study|Adverse Event|2|||
37697605|NCT02083653|69174216|FG002|Overall Study|Adverse Event|4|||
37697606|NCT02083653|69174214|FG000|Overall Study|Lost to Follow-up|1|||
37697607|NCT02083653|69174215|FG001|Overall Study|Lost to Follow-up|0|||
37697608|NCT02083653|69174216|FG002|Overall Study|Lost to Follow-up|0|||
37907352|NCT02041195|69592965|FG001|Overall Study|Adverse Event|2|||
37907353|NCT02041195|69592966|FG002|Overall Study|Adverse Event|0|||
37907354|NCT02041195|69592967|FG003|Overall Study|Adverse Event|0|||
37907355|NCT02041195|69592968|FG004|Overall Study|Adverse Event|0|||
37907356|NCT02041195|69592969|FG005|Overall Study|Adverse Event|0|||
38005235|NCT04113694|69688867|FG000|Overall Study|Lost to Follow-up|2|||
38005236|NCT04113694|69688867|FG000|Overall Study|Withdrawal by Subject|6|||
38005237|NCT04113694|69688867|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
38005238|NCT04105972|69688876|FG000|Overall Study|Adverse Event|2|||
38005239|NCT04105972|69688877|FG001|Overall Study|Adverse Event|1|||
37697609|NCT02083653|69174214|FG000|Overall Study|Death|2|||
38005240|NCT04102540|69688883|FG000|Overall Study|Withdrawn by PI|2|||
38005241|NCT04102540|69688883|FG000|Overall Study|Lost to Follow-up|6|||
38005242|NCT00124982|69688889|FG000|Short-term Period|Death|1|||
38005243|NCT00124982|69688890|FG001|Short-term Period|Death|1|||
38005244|NCT00124982|69688891|FG002|Short-term Period|Death|0|||
38005245|NCT00124982|69688889|FG000|Short-term Period|Adverse Event|17|||
38005246|NCT00124982|69688890|FG001|Short-term Period|Adverse Event|22|||
38005247|NCT00124982|69688891|FG002|Short-term Period|Adverse Event|0|||
38005248|NCT00124982|69688889|FG000|Short-term Period|Lack of Efficacy|32|||
38005249|NCT00124982|69688890|FG001|Short-term Period|Lack of Efficacy|73|||
38005250|NCT00124982|69688891|FG002|Short-term Period|Lack of Efficacy|0|||
38005251|NCT00124982|69688889|FG000|Short-term Period|Lost to Follow-up|8|||
38005252|NCT00124982|69688890|FG001|Short-term Period|Lost to Follow-up|5|||
38005253|NCT00124982|69688891|FG002|Short-term Period|Lost to Follow-up|0|||
38005254|NCT00124982|69688889|FG000|Short-term Period|Withdrawal of Consent|7|||
38005255|NCT00124982|69688890|FG001|Short-term Period|Withdrawal of Consent|9|||
38005256|NCT00124982|69688891|FG002|Short-term Period|Withdrawal of Consent|0|||
38005257|NCT00124982|69688889|FG000|Short-term Period|Poor/Non-compliance|3|||
38005258|NCT00124982|69688890|FG001|Short-term Period|Poor/Non-compliance|1|||
38005259|NCT00124982|69688891|FG002|Short-term Period|Poor/Non-compliance|0|||
38005260|NCT00124982|69688889|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
38005261|NCT00124982|69688890|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
38005262|NCT00124982|69688891|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
38005263|NCT00124982|69688889|FG000|Short-term Period|Participant Decision|1|||
38005264|NCT00124982|69688890|FG001|Short-term Period|Participant Decision|0|||
38005265|NCT00124982|69688891|FG002|Short-term Period|Participant Decision|0|||
38005266|NCT00124982|69688889|FG000|Short-term Period|Participant Chose Own Doctor|0|||
38005267|NCT00124982|69688890|FG001|Short-term Period|Participant Chose Own Doctor|1|||
38005268|NCT00124982|69688891|FG002|Short-term Period|Participant Chose Own Doctor|0|||
38005269|NCT00124982|69688889|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
38005270|NCT00124982|69688890|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
38005271|NCT00124982|69688891|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
38005272|NCT00124982|69688889|FG000|Short-term Period|Participant Had Lymphopenia|1|||
38005273|NCT00124982|69688890|FG001|Short-term Period|Participant Had Lymphopenia|0|||
38005274|NCT00124982|69688891|FG002|Short-term Period|Participant Had Lymphopenia|0|||
38005275|NCT00124982|69688889|FG000|Long-term Period|Death|0|||
38005276|NCT00124982|69688890|FG001|Long-term Period|Death|0|||
38005277|NCT00124982|69688891|FG002|Long-term Period|Death|1|||
38005278|NCT00124982|69688889|FG000|Long-term Period|Adverse Event|0|||
38005279|NCT00124982|69688890|FG001|Long-term Period|Adverse Event|0|||
38005280|NCT00124982|69688891|FG002|Long-term Period|Adverse Event|17|||
38005281|NCT00124982|69688889|FG000|Long-term Period|Lack of Efficacy|0|||
38005282|NCT00124982|69688890|FG001|Long-term Period|Lack of Efficacy|0|||
38005283|NCT00124982|69688891|FG002|Long-term Period|Lack of Efficacy|46|||
37907357|NCT02041195|69592970|FG006|Overall Study|Adverse Event|3|||
37907358|NCT02041195|69592971|FG007|Overall Study|Adverse Event|0|||
37907359|NCT02041195|69592964|FG000|Overall Study|Withdrawal by Subject|1|||
37907360|NCT02041195|69592965|FG001|Overall Study|Withdrawal by Subject|0|||
37907361|NCT02041195|69592966|FG002|Overall Study|Withdrawal by Subject|0|||
37907362|NCT02041195|69592967|FG003|Overall Study|Withdrawal by Subject|0|||
37907363|NCT02041195|69592968|FG004|Overall Study|Withdrawal by Subject|0|||
37907364|NCT02041195|69592969|FG005|Overall Study|Withdrawal by Subject|0|||
37907365|NCT02041195|69592970|FG006|Overall Study|Withdrawal by Subject|4|||
37907366|NCT02041195|69592971|FG007|Overall Study|Withdrawal by Subject|3|||
37907367|NCT02041195|69592964|FG000|Overall Study|Unable to comply with study visits|0|||
37907368|NCT02041195|69592965|FG001|Overall Study|Unable to comply with study visits|1|||
37907369|NCT02041195|69592966|FG002|Overall Study|Unable to comply with study visits|0|||
37907370|NCT02041195|69592967|FG003|Overall Study|Unable to comply with study visits|0|||
37907371|NCT02041195|69592968|FG004|Overall Study|Unable to comply with study visits|1|||
38005284|NCT00124982|69688889|FG000|Long-term Period|Lost to Follow-up|0|||
37907372|NCT02041195|69592969|FG005|Overall Study|Unable to comply with study visits|0|||
37907373|NCT02041195|69592970|FG006|Overall Study|Unable to comply with study visits|0|||
38005285|NCT00124982|69688890|FG001|Long-term Period|Lost to Follow-up|0|||
38005286|NCT00124982|69688891|FG002|Long-term Period|Lost to Follow-up|4|||
38005287|NCT00124982|69688889|FG000|Long-term Period|Withdrawal by Subject|0|||
38005288|NCT00124982|69688890|FG001|Long-term Period|Withdrawal by Subject|0|||
38005289|NCT00124982|69688891|FG002|Long-term Period|Withdrawal by Subject|16|||
38005290|NCT00124982|69688889|FG000|Long-term Period|Pregnancy|0|||
38005291|NCT00124982|69688890|FG001|Long-term Period|Pregnancy|0|||
38005292|NCT00124982|69688891|FG002|Long-term Period|Pregnancy|1|||
38005293|NCT00124982|69688889|FG000|Long-term Period|Poor/Non-compliance|0|||
38005294|NCT00124982|69688890|FG001|Long-term Period|Poor/Non-compliance|0|||
38005295|NCT00124982|69688891|FG002|Long-term Period|Poor/Non-compliance|2|||
38005296|NCT00124982|69688889|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
38005297|NCT00124982|69688890|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
38005298|NCT00124982|69688891|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
38005299|NCT00124982|69688889|FG000|Long-term Period|Neurologist Recommendation|0|||
38005300|NCT00124982|69688890|FG001|Long-term Period|Neurologist Recommendation|0|||
38005301|NCT00124982|69688891|FG002|Long-term Period|Neurologist Recommendation|1|||
37697610|NCT02083653|69174215|FG001|Overall Study|Death|2|||
37830729|NCT01303861|69514019|FG000|Overall Study|Pregnancy|1|||
37830730|NCT01303861|69514020|FG001|Overall Study|Pregnancy|0|||
37830731|NCT01303861|69514021|FG002|Overall Study|Pregnancy|0|||
37830732|NCT01303861|69514022|FG003|Overall Study|Pregnancy|0|||
37830733|NCT01303627|69514035|FG000|Overall Study|the failure while performing URS|0|||
37830734|NCT01303627|69514036|FG001|Overall Study|the failure while performing URS|1|||
37830735|NCT01303510|69514044|FG000|Overall Study|Lost to Follow-up|1|||
37830736|NCT01303510|69514045|FG001|Overall Study|Lost to Follow-up|0|||
37830737|NCT01303159|69514051|FG000|Overall Study|Death|16|||
37830738|NCT01303159|69514051|FG000|Overall Study|Study Termination|7|||
37830739|NCT01302964|69514057|FG000|Overall Study|Adverse Event|1|||
37830740|NCT01302964|69514058|FG001|Overall Study|Adverse Event|0|||
37830741|NCT01302691|69514066|FG000|Overall Study|Adverse Event|2|||
38005302|NCT04263142|69688905|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
38005303|NCT04263142|69688906|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
38005304|NCT04263142|69688907|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
38005305|NCT04263142|69688908|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
38005306|NCT04263142|69688909|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
37830742|NCT01302691|69514067|FG001|Overall Study|Adverse Event|0|||
38005307|NCT04263142|69688905|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
38005308|NCT04263142|69688906|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
38005309|NCT04263142|69688907|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
38005310|NCT04263142|69688908|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
38005311|NCT04263142|69688909|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
38005312|NCT04095286|69688922|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
38005313|NCT04095286|69688923|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
38005314|NCT04095286|69688924|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
38005315|NCT04095286|69688925|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
38005316|NCT04095286|69688926|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
38005317|NCT04095286|69688927|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
38005318|NCT04095286|69688922|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
38005319|NCT04095286|69688923|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
38005320|NCT04095286|69688924|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
38005321|NCT04095286|69688925|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
38005322|NCT04095286|69688926|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
38005323|NCT04095286|69688927|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
38005324|NCT04095286|69688922|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
38005325|NCT04095286|69688923|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
38005326|NCT04095286|69688924|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
38005327|NCT04095286|69688925|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
38005328|NCT04095286|69688926|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
38005329|NCT04095286|69688927|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
37830743|NCT01302691|69514066|FG000|Overall Study|Death|0|||
37830744|NCT01302691|69514067|FG001|Overall Study|Death|1|||
37830745|NCT01302691|69514066|FG000|Overall Study|Lost to Follow-up|1|||
37830746|NCT01302691|69514067|FG001|Overall Study|Lost to Follow-up|0|||
37830747|NCT01302691|69514066|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
38005330|NCT04095286|69688922|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
38005331|NCT04095286|69688923|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
38005332|NCT04095286|69688924|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
38005333|NCT04095286|69688925|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
38005334|NCT04095286|69688926|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
38043633|NCT02180867|69731806|FG002|Overall Study|Lack of Efficacy|0|||
38043634|NCT02180867|69731807|FG003|Overall Study|Lack of Efficacy|1|||
38043635|NCT02180867|69731808|FG004|Overall Study|Lack of Efficacy|6|||
38043636|NCT02180867|69731809|FG005|Overall Study|Lack of Efficacy|0|||
38043637|NCT02180867|69731810|FG006|Overall Study|Lack of Efficacy|1|||
37830748|NCT01302691|69514067|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
38043638|NCT02180867|69731804|FG000|Overall Study|Physician Decision|1|||
38043639|NCT02180867|69731805|FG001|Overall Study|Physician Decision|3|||
38043640|NCT02180867|69731806|FG002|Overall Study|Physician Decision|1|||
38043641|NCT02180867|69731807|FG003|Overall Study|Physician Decision|10|||
38043642|NCT02180867|69731808|FG004|Overall Study|Physician Decision|9|||
38005335|NCT04095286|69688927|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
38005336|NCT04095286|69688922|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
38005337|NCT04095286|69688923|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
38005338|NCT04095286|69688924|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
38005339|NCT04095286|69688925|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
38005340|NCT04095286|69688926|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
38005341|NCT04095286|69688927|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
38005342|NCT04093414|69688937|FG000|3 Month Follow up|Physician Decision|0|||
38005343|NCT04093414|69688938|FG001|3 Month Follow up|Physician Decision|1|||
38005344|NCT04093414|69688937|FG000|6month Follow up|Physician Decision|1|||
37697611|NCT02083653|69174216|FG002|Overall Study|Death|2|||
37830749|NCT01302691|69514066|FG000|Overall Study|Physician Decision|0|||
37830750|NCT01302691|69514067|FG001|Overall Study|Physician Decision|1|||
37830751|NCT01302691|69514066|FG000|Overall Study|Protocol Violation|1|||
38005345|NCT04093414|69688938|FG001|6month Follow up|Physician Decision|3|||
38005346|NCT04093258|69688944|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
38005347|NCT04093258|69688945|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
38005348|NCT04253236|69688953|FG000|Overall Study|Adverse Event|1|||
38005349|NCT04253236|69688954|FG001|Overall Study|Adverse Event|0|||
38005350|NCT04253236|69688953|FG000|Overall Study|Safety Concerns|1|||
38005351|NCT04253236|69688954|FG001|Overall Study|Safety Concerns|0|||
38005352|NCT04253236|69688953|FG000|Overall Study|Study Terminated by Sponsor|1|||
38005353|NCT04253236|69688954|FG001|Overall Study|Study Terminated by Sponsor|0|||
38005354|NCT04087720|69688960|FG000|Overall Study|Withdrawal by Subject|2|||
38005355|NCT04087720|69688960|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
38005356|NCT04086472|69688969|FG000|Overall Study|Lost to Follow-up|1|||
38005357|NCT04086472|69688970|FG001|Overall Study|Lost to Follow-up|0|||
38005358|NCT04086472|69688971|FG002|Overall Study|Lost to Follow-up|0|||
38005359|NCT04086472|69688972|FG003|Overall Study|Lost to Follow-up|0|||
38005360|NCT04086472|69688973|FG004|Overall Study|Lost to Follow-up|1|||
38005361|NCT04086472|69688969|FG000|Overall Study|Physician Decision|0|||
38005362|NCT04086472|69688970|FG001|Overall Study|Physician Decision|1|||
38005363|NCT04086472|69688971|FG002|Overall Study|Physician Decision|1|||
38005364|NCT04086472|69688972|FG003|Overall Study|Physician Decision|0|||
38005365|NCT04086472|69688973|FG004|Overall Study|Physician Decision|0|||
38005366|NCT04086472|69688969|FG000|Overall Study|Withdrawal by Subject|1|||
38005367|NCT04086472|69688970|FG001|Overall Study|Withdrawal by Subject|1|||
38005368|NCT04086472|69688971|FG002|Overall Study|Withdrawal by Subject|1|||
38005369|NCT04086472|69688972|FG003|Overall Study|Withdrawal by Subject|0|||
38005370|NCT04086472|69688973|FG004|Overall Study|Withdrawal by Subject|0|||
38005371|NCT04086472|69688969|FG000|Overall Study|Various reasons|2|||
38005372|NCT04086472|69688970|FG001|Overall Study|Various reasons|0|||
38005373|NCT04086472|69688971|FG002|Overall Study|Various reasons|0|||
38005374|NCT04086472|69688972|FG003|Overall Study|Various reasons|3|||
38005375|NCT04086472|69688973|FG004|Overall Study|Various reasons|1|||
38005376|NCT04249336|69688989|FG000|Overall Study|Lost to Follow-up|3|||
38005377|NCT04249336|69688990|FG001|Overall Study|Lost to Follow-up|3|||
38005378|NCT04249336|69688991|FG002|Overall Study|Lost to Follow-up|3|||
38005379|NCT04249336|69688992|FG003|Overall Study|Lost to Follow-up|3|||
37830752|NCT01302691|69514067|FG001|Overall Study|Protocol Violation|0|||
37830753|NCT01302418|69514073|FG000|Overall Study|Protocol Violation|9|||
37830754|NCT01302418|69514073|FG000|Overall Study|Non-evaluable|9|||
37830755|NCT01302067|69514080|FG000|Overall Study|Death|0|||
37830756|NCT01302067|69514081|FG001|Overall Study|Death|0|||
37830757|NCT01302067|69514082|FG002|Overall Study|Death|1|||
37830758|NCT01302067|69514080|FG000|Overall Study|Physician Decision|9|||
37830759|NCT01302067|69514081|FG001|Overall Study|Physician Decision|5|||
37830760|NCT01302067|69514082|FG002|Overall Study|Physician Decision|14|||
37830761|NCT01302067|69514080|FG000|Overall Study|Lack of Efficacy|8|||
37697612|NCT02083653|69174214|FG000|Overall Study|Progressive Disease|65|||
37830762|NCT01302067|69514081|FG001|Overall Study|Lack of Efficacy|4|||
37830763|NCT01302067|69514082|FG002|Overall Study|Lack of Efficacy|2|||
38005380|NCT04245202|69689004|FG000|Overall Study|Lack of Efficacy|10|||
38005381|NCT04245202|69689005|FG001|Overall Study|Lack of Efficacy|1|||
38005382|NCT04079842|69689012|FG000|Overall Study|Request of subject|2|||
38005383|NCT04079842|69689012|FG000|Overall Study|Unable to draw Arterial samples|1|||
38005384|NCT04078126|69689016|FG000|Washout|Study put on hold due to COVID-19|0|||
38005385|NCT04078126|69689017|FG001|Washout|Study put on hold due to COVID-19|2|||
38005386|NCT04078126|69689016|FG000|Period 2|Study put on hold due to COVID-19|1|||
38005387|NCT04078126|69689017|FG001|Period 2|Study put on hold due to COVID-19|1|||
38005388|NCT04073368|69689027|FG000|Overall Study|Adverse Event|2|||
38005389|NCT04073368|69689028|FG001|Overall Study|Adverse Event|0|||
38005390|NCT04073368|69689029|FG002|Overall Study|Adverse Event|1|||
38005391|NCT04073368|69689030|FG003|Overall Study|Adverse Event|1|||
38005392|NCT04073368|69689027|FG000|Overall Study|Withdrawal by Subject|2|||
38005393|NCT04073368|69689028|FG001|Overall Study|Withdrawal by Subject|2|||
38005394|NCT04073368|69689029|FG002|Overall Study|Withdrawal by Subject|1|||
38005395|NCT04073368|69689030|FG003|Overall Study|Withdrawal by Subject|1|||
38005396|NCT04073368|69689027|FG000|Overall Study|Lost to Follow-up|1|||
38005397|NCT04073368|69689028|FG001|Overall Study|Lost to Follow-up|1|||
38005398|NCT04073368|69689029|FG002|Overall Study|Lost to Follow-up|1|||
38005399|NCT04073368|69689030|FG003|Overall Study|Lost to Follow-up|0|||
38005400|NCT04073368|69689027|FG000|Overall Study|Protocol Violation|0|||
38005401|NCT04073368|69689028|FG001|Overall Study|Protocol Violation|1|||
38005402|NCT04073368|69689029|FG002|Overall Study|Protocol Violation|0|||
38005403|NCT04073368|69689030|FG003|Overall Study|Protocol Violation|0|||
38005404|NCT04073368|69689027|FG000|Overall Study|Subject noncompliance|7|||
38005405|NCT04073368|69689028|FG001|Overall Study|Subject noncompliance|4|||
38005406|NCT04073368|69689029|FG002|Overall Study|Subject noncompliance|0|||
38005407|NCT04073368|69689030|FG003|Overall Study|Subject noncompliance|0|||
38005408|NCT04380688|69689042|FG000|Overall Study|Death|2|||
38005409|NCT04380688|69689043|FG001|Overall Study|Death|2|||
38005410|NCT04380688|69689042|FG000|Overall Study|Lost to Follow-up|2|||
38005411|NCT04380688|69689043|FG001|Overall Study|Lost to Follow-up|4|||
38005412|NCT04380688|69689042|FG000|Overall Study|Withdrawal by Subject|3|||
38005413|NCT04380688|69689043|FG001|Overall Study|Withdrawal by Subject|3|||
38005414|NCT00124748|69689051|FG000|Overall Study|Adverse Event|8|||
38005415|NCT00124748|69689052|FG001|Overall Study|Adverse Event|39|||
38005416|NCT00124748|69689051|FG000|Overall Study|Abnormal laboratory Value|2|||
38005417|NCT00124748|69689052|FG001|Overall Study|Abnormal laboratory Value|2|||
38005418|NCT00124748|69689051|FG000|Overall Study|Abnormal Procedure|0|||
38005419|NCT00124748|69689052|FG001|Overall Study|Abnormal Procedure|1|||
38005420|NCT00124748|69689051|FG000|Overall Study|Lack of Efficacy|20|||
38005421|NCT00124748|69689052|FG001|Overall Study|Lack of Efficacy|41|||
38005422|NCT00124748|69689051|FG000|Overall Study|No longer requires study drug|1|||
38005423|NCT00124748|69689052|FG001|Overall Study|No longer requires study drug|1|||
38005424|NCT00124748|69689051|FG000|Overall Study|Protocol Violation|3|||
38005425|NCT00124748|69689052|FG001|Overall Study|Protocol Violation|1|||
38005426|NCT00124748|69689051|FG000|Overall Study|Withdrawal by Subject|5|||
38005427|NCT00124748|69689052|FG001|Overall Study|Withdrawal by Subject|15|||
38005428|NCT00124748|69689051|FG000|Overall Study|Lost to Follow-up|2|||
38005429|NCT00124748|69689052|FG001|Overall Study|Lost to Follow-up|7|||
37907374|NCT02041195|69592971|FG007|Overall Study|Unable to comply with study visits|0|||
38005430|NCT00124748|69689051|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
38005431|NCT00124748|69689052|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
38005432|NCT00124748|69689051|FG000|Overall Study|Death|1|||
38005433|NCT00124748|69689052|FG001|Overall Study|Death|3|||
38005434|NCT04070326|69689060|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
38005435|NCT04070326|69689061|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
38005436|NCT03689452|69689071|FG000|Overall Study|Lost to Follow-up|1|||
37830764|NCT01302067|69514080|FG000|Overall Study|Lost to Follow-up|9|||
37830765|NCT01302067|69514081|FG001|Overall Study|Lost to Follow-up|4|||
37907375|NCT01583218|69593030|FG000|Overall Study|Withdrawal by Subject|43|||
37830766|NCT01302067|69514082|FG002|Overall Study|Lost to Follow-up|15|||
37830767|NCT01302067|69514080|FG000|Overall Study|Withdrawal by Subject|13|||
37830768|NCT01302067|69514081|FG001|Overall Study|Withdrawal by Subject|6|||
37830769|NCT01302067|69514082|FG002|Overall Study|Withdrawal by Subject|10|||
37830770|NCT01302067|69514080|FG000|Overall Study|Other|1|||
37830771|NCT01302067|69514081|FG001|Overall Study|Other|1|||
37830772|NCT01302067|69514082|FG002|Overall Study|Other|3|||
37830773|NCT01302067|69514080|FG000|Overall Study|Protocol Violation|11|||
37830774|NCT01302067|69514081|FG001|Overall Study|Protocol Violation|0|||
37830775|NCT01302067|69514082|FG002|Overall Study|Protocol Violation|8|||
37830776|NCT01302067|69514080|FG000|Overall Study|Adverse Event|27|||
37830777|NCT01302067|69514081|FG001|Overall Study|Adverse Event|14|||
37907376|NCT01583218|69593031|FG001|Overall Study|Withdrawal by Subject|29|||
38005437|NCT03689452|69689072|FG001|Overall Study|Lost to Follow-up|1|||
38005438|NCT04067050|69689080|FG000|One Month|Lost to Follow-up|4|||
38005439|NCT04067050|69689081|FG001|One Month|Lost to Follow-up|0|||
38005440|NCT04067050|69689080|FG000|Two Month|Lost to Follow-up|1|||
37830778|NCT01302067|69514082|FG002|Overall Study|Adverse Event|45|||
38005441|NCT04067050|69689081|FG001|Two Month|Lost to Follow-up|0|||
38005442|NCT04067050|69689080|FG000|Two Month|Adverse Event|1|||
38005443|NCT04067050|69689081|FG001|Two Month|Adverse Event|0|||
38005444|NCT04060654|69689087|FG000|Overall Study|Withdrawal by Subject|1|||
38005445|NCT04060654|69689087|FG000|Overall Study|Lost to Follow-up|5|||
38005446|NCT00096200|69689094|FG000|Overall Study|Adverse Event|0|||
38005447|NCT00096200|69689095|FG001|Overall Study|Adverse Event|4|||
38005448|NCT00096200|69689096|FG002|Overall Study|Adverse Event|0|||
38005449|NCT00096200|69689094|FG000|Overall Study|Withdrawal by Subject|1|||
38005450|NCT00096200|69689095|FG001|Overall Study|Withdrawal by Subject|2|||
38005451|NCT00096200|69689096|FG002|Overall Study|Withdrawal by Subject|0|||
38005452|NCT00096200|69689094|FG000|Overall Study|Ineligible pathology|0|||
38005453|NCT00096200|69689095|FG001|Overall Study|Ineligible pathology|1|||
38005454|NCT00096200|69689096|FG002|Overall Study|Ineligible pathology|0|||
38005455|NCT04059094|69689109|FG000|Overall Study|Adverse Event|0|||
38005456|NCT04059094|69689110|FG001|Overall Study|Adverse Event|0|||
38005457|NCT04059094|69689111|FG002|Overall Study|Adverse Event|0|||
38005458|NCT04059094|69689112|FG003|Overall Study|Adverse Event|0|||
38005459|NCT04059094|69689113|FG004|Overall Study|Adverse Event|1|||
38005460|NCT04059094|69689109|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
38005461|NCT04059094|69689110|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
38005462|NCT04059094|69689111|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
38005463|NCT04059094|69689112|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
38005464|NCT04059094|69689113|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
38005465|NCT00096044|69689129|FG000|Overall Study|Withdrawal by Subject|9|||
38005466|NCT00096044|69689129|FG000|Overall Study|Adverse Event|21|||
38005467|NCT00096044|69689129|FG000|Overall Study|Disease Progression|4|||
38005468|NCT03689374|69689135|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
38005469|NCT03689374|69689136|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
38005470|NCT03689374|69689137|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
38005471|NCT03689374|69689135|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
38005472|NCT03689374|69689136|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
38005473|NCT03689374|69689137|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
38005474|NCT03689374|69689135|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
38005475|NCT03689374|69689136|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
38005476|NCT03689374|69689137|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
38005477|NCT03689374|69689135|FG000|Treatment Period (Week 0 to 52)|Death|0|||
38005478|NCT03689374|69689136|FG001|Treatment Period (Week 0 to 52)|Death|11|||
38005479|NCT03689374|69689137|FG002|Treatment Period (Week 0 to 52)|Death|1|||
38005480|NCT00123734|69689143|FG000|Overall Study|Death|3|||
38005481|NCT00123734|69689143|FG000|Overall Study|Lost to Follow-up|3|||
37830779|NCT01301950|69514092|FG000|Overall Study|Surgery was cancelled by patient|0|||
37830780|NCT01301950|69514093|FG001|Overall Study|Surgery was cancelled by patient|1|||
37830781|NCT01301833|69514103|FG000|Overall Study|Adverse Event|7|||
37830782|NCT01301833|69514104|FG001|Overall Study|Adverse Event|5|||
37830783|NCT01301833|69514105|FG002|Overall Study|Adverse Event|5|||
37830784|NCT01301833|69514106|FG003|Overall Study|Adverse Event|5|||
37830785|NCT01301833|69514103|FG000|Overall Study|Lack of Efficacy|1|||
37830786|NCT01301833|69514104|FG001|Overall Study|Lack of Efficacy|1|||
37830787|NCT01301833|69514105|FG002|Overall Study|Lack of Efficacy|0|||
37830788|NCT01301833|69514106|FG003|Overall Study|Lack of Efficacy|0|||
37830789|NCT01301833|69514103|FG000|Overall Study|Physician Decision|3|||
37830790|NCT01301833|69514104|FG001|Overall Study|Physician Decision|1|||
37830791|NCT01301833|69514105|FG002|Overall Study|Physician Decision|1|||
37830792|NCT01301833|69514106|FG003|Overall Study|Physician Decision|0|||
37830793|NCT01301833|69514103|FG000|Overall Study|Withdrawal by Subject|3|||
37830794|NCT01301833|69514104|FG001|Overall Study|Withdrawal by Subject|1|||
37830795|NCT01301833|69514105|FG002|Overall Study|Withdrawal by Subject|1|||
37830796|NCT01301833|69514106|FG003|Overall Study|Withdrawal by Subject|2|||
37830797|NCT01301833|69514103|FG000|Overall Study|Personal matter|1|||
37830798|NCT01301833|69514104|FG001|Overall Study|Personal matter|0|||
37830799|NCT01301833|69514105|FG002|Overall Study|Personal matter|0|||
37830800|NCT01301833|69514106|FG003|Overall Study|Personal matter|0|||
37830801|NCT01301092|69514119|FG000|Overall Study|Lost to Follow-up|0|||
37907377|NCT01583218|69593030|FG000|Overall Study|Death|206|||
37907378|NCT01583218|69593031|FG001|Overall Study|Death|211|||
37907379|NCT01583218|69593030|FG000|Overall Study|Lost to Follow-up|11|||
37907380|NCT01583218|69593031|FG001|Overall Study|Lost to Follow-up|17|||
38005482|NCT00123734|69689143|FG000|Overall Study|Dropout|1|||
38005483|NCT00123734|69689143|FG000|Overall Study|Withdrawal by Subject|1|||
38005484|NCT00112736|69689153|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
38005485|NCT00112736|69689154|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
38005486|NCT00123422|69689169|FG000|Overall Study|Physician Decision|2|||
37830802|NCT01301092|69514120|FG001|Overall Study|Lost to Follow-up|0|||
38005487|NCT00123422|69689170|FG001|Overall Study|Physician Decision|2|||
38005488|NCT00123422|69689171|FG002|Overall Study|Physician Decision|6|||
37907381|NCT01583218|69593030|FG000|Overall Study|Adverse event or serious adverse event|3|||
37830803|NCT01301092|69514121|FG002|Overall Study|Lost to Follow-up|1|||
37830804|NCT01300819|69514136|FG000|Overall Study|Adverse Event|9|||
37830805|NCT01300819|69514137|FG001|Overall Study|Adverse Event|27|||
37830806|NCT01300819|69514136|FG000|Overall Study|Lack of Efficacy|2|||
37830807|NCT01300819|69514137|FG001|Overall Study|Lack of Efficacy|1|||
37907382|NCT01583218|69593031|FG001|Overall Study|Adverse event or serious adverse event|3|||
38005489|NCT00123422|69689169|FG000|Overall Study|Withdrawal by Subject|1|||
38005490|NCT00123422|69689170|FG001|Overall Study|Withdrawal by Subject|2|||
38005491|NCT00123422|69689171|FG002|Overall Study|Withdrawal by Subject|2|||
38005492|NCT00123422|69689169|FG000|Overall Study|Lost to Follow-up|1|||
38005493|NCT00123422|69689170|FG001|Overall Study|Lost to Follow-up|2|||
38005494|NCT00123422|69689171|FG002|Overall Study|Lost to Follow-up|2|||
38005495|NCT04052620|69689181|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
38005496|NCT04052620|69689182|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
37907383|NCT01583218|69593030|FG000|Overall Study|Patient /Family decision|3|||
37907384|NCT01583218|69593031|FG001|Overall Study|Patient /Family decision|0|||
37907385|NCT01583218|69593030|FG000|Overall Study|Cannot contact patient directly|1|||
37907386|NCT01583218|69593031|FG001|Overall Study|Cannot contact patient directly|2|||
37907387|NCT01583218|69593030|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
37907388|NCT01583218|69593031|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
37907389|NCT01583218|69593030|FG000|Overall Study|Patient did not wish to attend visits|0|||
37907390|NCT01583218|69593031|FG001|Overall Study|Patient did not wish to attend visits|1|||
37907391|NCT01583218|69593030|FG000|Overall Study|Patient randomized but not dosed|17|||
37907392|NCT01583218|69593031|FG001|Overall Study|Patient randomized but not dosed|16|||
37907393|NCT01583218|69593030|FG000|Overall Study|Patient was assessed via phone in person|1|||
37907394|NCT01583218|69593031|FG001|Overall Study|Patient was assessed via phone in person|0|||
37907395|NCT01583218|69593030|FG000|Overall Study|Patient deemed ineligible after random|2|||
37907396|NCT01583218|69593031|FG001|Overall Study|Patient deemed ineligible after random|0|||
37907397|NCT01583218|69593030|FG000|Overall Study|Patient was early terminated from study|0|||
37907398|NCT01583218|69593031|FG001|Overall Study|Patient was early terminated from study|1|||
37907399|NCT01583218|69593030|FG000|Overall Study|Patient was randomized due to mistake|1|||
37907400|NCT01583218|69593031|FG001|Overall Study|Patient was randomized due to mistake|0|||
37907401|NCT01583218|69593030|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
37907402|NCT01583218|69593031|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
37907403|NCT01583218|69593030|FG000|Overall Study|Withdraw of consent on day of random|1|||
37907404|NCT01583218|69593031|FG001|Overall Study|Withdraw of consent on day of random|0|||
37907405|NCT00742859|69593041|FG000|Overall Study|Adverse Event|5|||
37907406|NCT00742859|69593042|FG001|Overall Study|Adverse Event|6|||
37907407|NCT00742859|69593043|FG002|Overall Study|Adverse Event|3|||
37907408|NCT00742859|69593044|FG003|Overall Study|Adverse Event|1|||
37907409|NCT00742859|69593041|FG000|Overall Study|Death|1|||
37907410|NCT00742859|69593042|FG001|Overall Study|Death|0|||
37907411|NCT00742859|69593043|FG002|Overall Study|Death|0|||
37907412|NCT00742859|69593044|FG003|Overall Study|Death|1|||
37907413|NCT00742859|69593041|FG000|Overall Study|Physician Decision|1|||
37907414|NCT00742859|69593042|FG001|Overall Study|Physician Decision|2|||
37907415|NCT00742859|69593043|FG002|Overall Study|Physician Decision|0|||
37907416|NCT00742859|69593044|FG003|Overall Study|Physician Decision|0|||
37907417|NCT00742859|69593041|FG000|Overall Study|Withdrawal by Subject|4|||
37907418|NCT00742859|69593042|FG001|Overall Study|Withdrawal by Subject|2|||
37907419|NCT00742859|69593043|FG002|Overall Study|Withdrawal by Subject|4|||
37907420|NCT00742859|69593044|FG003|Overall Study|Withdrawal by Subject|1|||
37907421|NCT00742859|69593041|FG000|Overall Study|Endpoint|0|||
37907422|NCT00742859|69593042|FG001|Overall Study|Endpoint|1|||
37907423|NCT00742859|69593043|FG002|Overall Study|Endpoint|1|||
37907424|NCT00742859|69593044|FG003|Overall Study|Endpoint|2|||
37907425|NCT00742859|69593041|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
37907426|NCT00742859|69593042|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
37907427|NCT00742859|69593043|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
37907428|NCT00742859|69593044|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
37907429|NCT00742859|69593041|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
37907430|NCT00742859|69593042|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
37907431|NCT00742859|69593043|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
37907432|NCT00742859|69593044|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
37907433|NCT00742859|69593041|FG000|Overall Study|Sponsor request patient out of town|0|||
37907434|NCT00742859|69593042|FG001|Overall Study|Sponsor request patient out of town|0|||
37907435|NCT00742859|69593043|FG002|Overall Study|Sponsor request patient out of town|1|||
37907436|NCT00742859|69593044|FG003|Overall Study|Sponsor request patient out of town|1|||
37907437|NCT00742859|69593041|FG000|Overall Study|Site error|0|||
37907438|NCT00742859|69593042|FG001|Overall Study|Site error|0|||
37907439|NCT00742859|69593043|FG002|Overall Study|Site error|1|||
37907440|NCT00742859|69593044|FG003|Overall Study|Site error|1|||
37907441|NCT00667342|69593057|FG000|Overall Study|Protocol Violation|1|||
37907442|NCT00667342|69593058|FG001|Overall Study|Protocol Violation|0|||
37907443|NCT00667342|69593059|FG002|Overall Study|Protocol Violation|0|||
37907444|NCT00667342|69593057|FG000|Overall Study|Withdrawal by Subject|1|||
37907445|NCT00667342|69593058|FG001|Overall Study|Withdrawal by Subject|0|||
37907446|NCT00667342|69593059|FG002|Overall Study|Withdrawal by Subject|0|||
37907447|NCT00667342|69593057|FG000|Overall Study|Physician Decision|3|||
38005497|NCT04052620|69689181|FG000|Overall Study|Withdrawal by Subject|1|||
38005498|NCT04052620|69689182|FG001|Overall Study|Withdrawal by Subject|0|||
38005499|NCT04052620|69689181|FG000|Overall Study|Lost to Follow-up|1|||
38005500|NCT04052620|69689182|FG001|Overall Study|Lost to Follow-up|1|||
38005501|NCT04052620|69689181|FG000|Overall Study|Adverse Event|1|||
38005502|NCT04052620|69689182|FG001|Overall Study|Adverse Event|0|||
38005503|NCT04052620|69689181|FG000|Overall Study|Subject did not meet study Criteria|0|||
38005504|NCT04052620|69689182|FG001|Overall Study|Subject did not meet study Criteria|1|||
38005505|NCT04052620|69689181|FG000|Overall Study|Screened failure, randomized by mistake|0|||
38005506|NCT04052620|69689182|FG001|Overall Study|Screened failure, randomized by mistake|1|||
38005507|NCT04052620|69689181|FG000|Overall Study|Personal reasons|2|||
38005508|NCT04052620|69689182|FG001|Overall Study|Personal reasons|4|||
38005509|NCT04052620|69689181|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
38005510|NCT04052620|69689182|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
38005511|NCT00112580|69689190|FG000|Overall Study|Adverse Event|1|||
38005512|NCT00112580|69689191|FG001|Overall Study|Adverse Event|2|||
38005513|NCT00112580|69689190|FG000|Overall Study|Disease progression|5|||
38005514|NCT00112580|69689191|FG001|Overall Study|Disease progression|16|||
38005515|NCT00112580|69689190|FG000|Overall Study|Participant withdrew consent|2|||
38005516|NCT00112580|69689191|FG001|Overall Study|Participant withdrew consent|1|||
38005517|NCT04238650|69689198|FG000|Overall Study|Withdrawal by Subject|0|||
38005518|NCT04238650|69689199|FG001|Overall Study|Withdrawal by Subject|1|||
38005519|NCT00095576|69689207|FG000|Overall Study|Adverse Event|5|||
38005520|NCT00095576|69689208|FG001|Overall Study|Adverse Event|3|||
38005521|NCT00095576|69689207|FG000|Overall Study|Lost to Follow-up|233|||
38005522|NCT00095576|69689208|FG001|Overall Study|Lost to Follow-up|229|||
38005523|NCT00095576|69689207|FG000|Overall Study|Protocol Violation|1|||
38005524|NCT00095576|69689208|FG001|Overall Study|Protocol Violation|0|||
38005525|NCT00095576|69689207|FG000|Overall Study|Withdrawal by Subject|34|||
38005526|NCT00095576|69689208|FG001|Overall Study|Withdrawal by Subject|47|||
38005527|NCT00095576|69689207|FG000|Overall Study|Option to switch to a rollover study|1097|||
38005528|NCT00095576|69689208|FG001|Overall Study|Option to switch to a rollover study|1099|||
38005529|NCT00095576|69689207|FG000|Overall Study|Site terminated|75|||
38005530|NCT00095576|69689208|FG001|Overall Study|Site terminated|67|||
38005531|NCT00095576|69689207|FG000|Overall Study|Subject moved|30|||
38005532|NCT00095576|69689208|FG001|Overall Study|Subject moved|36|||
38005533|NCT04049578|69689214|FG000|Overall Study|Physician Decision|1|||
38005534|NCT04044352|69689218|FG000|Overall Study|Lost to Follow-up|9|||
38005535|NCT04044352|69689218|FG000|Overall Study|Withdrawal by Subject|2|||
38005536|NCT04043962|69689223|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
38005537|NCT04043962|69689223|FG000|Post-Treatment|Withdrawal by Subject|5|||
38005538|NCT04043962|69689223|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
38005539|NCT04043728|69689230|FG000|Overall Study|Lost to Follow-up|1|||
38005540|NCT04043728|69689231|FG001|Overall Study|Lost to Follow-up|2|||
38005541|NCT04043728|69689232|FG002|Overall Study|Lost to Follow-up|0|||
38005542|NCT04043416|69689242|FG000|Washout|Change in health condition|0|||
38005543|NCT04043416|69689243|FG001|Washout|Change in health condition|1|||
37830808|NCT01300819|69514136|FG000|Overall Study|Withdrawal by Subject|10|||
37830809|NCT01300819|69514137|FG001|Overall Study|Withdrawal by Subject|12|||
37830810|NCT01300819|69514136|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
37830811|NCT01300819|69514137|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
37830812|NCT01300819|69514136|FG000|Overall Study|Refusal to down titrate study drug|0|||
37830813|NCT01300819|69514137|FG001|Overall Study|Refusal to down titrate study drug|1|||
37830814|NCT01300819|69514136|FG000|Overall Study|Administrative reason|0|||
37830815|NCT01300819|69514137|FG001|Overall Study|Administrative reason|1|||
37830816|NCT01300819|69514136|FG000|Overall Study|Safety follow up not done by mistake|0|||
37830817|NCT01300819|69514137|FG001|Overall Study|Safety follow up not done by mistake|1|||
37830818|NCT01300819|69514136|FG000|Overall Study|Follow up call was not done|1|||
37830819|NCT01300819|69514137|FG001|Overall Study|Follow up call was not done|0|||
37830820|NCT01300741|69514143|FG000|Overall Study|Lens deposits|1|||
37830821|NCT01300741|69514143|FG000|Overall Study|Lost to Follow-up|1|||
37830822|NCT01300741|69514143|FG000|Overall Study|Discomfort|1|||
37830823|NCT01300546|69514151|FG000|Overall Study|Withdrawal by Subject|1|||
37830824|NCT01300546|69514152|FG001|Overall Study|Withdrawal by Subject|0|||
37830825|NCT01300546|69514151|FG000|Overall Study|Lost to Follow-up|0|||
37830826|NCT01300546|69514152|FG001|Overall Study|Lost to Follow-up|2|||
37830827|NCT01300546|69514151|FG000|Overall Study|Lack of Efficacy|0|||
37830828|NCT01300546|69514152|FG001|Overall Study|Lack of Efficacy|3|||
37830829|NCT01300546|69514151|FG000|Overall Study|Adverse Event|0|||
37830830|NCT01300546|69514152|FG001|Overall Study|Adverse Event|1|||
37830831|NCT01300351|69514160|FG000|Overall Study|Did not receive treatment|2|||
37830832|NCT01300351|69514161|FG001|Overall Study|Did not receive treatment|0|||
37830833|NCT01300351|69514160|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
37830834|NCT01300351|69514161|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
37830835|NCT01300351|69514160|FG000|Overall Study|Lost to Follow-up|0|||
37907448|NCT00667342|69593058|FG001|Overall Study|Physician Decision|0|||
37907449|NCT00667342|69593059|FG002|Overall Study|Physician Decision|0|||
37907450|NCT00667342|69593057|FG000|Overall Study|Relapse or tumor progression|9|||
37907451|NCT00667342|69593058|FG001|Overall Study|Relapse or tumor progression|0|||
37907452|NCT00667342|69593059|FG002|Overall Study|Relapse or tumor progression|7|||
37907453|NCT00667342|69593057|FG000|Overall Study|Adverse Event|0|||
38005544|NCT00095498|69689255|FG000|Overall Study|Physician Decision|9|||
38005545|NCT00095498|69689256|FG001|Overall Study|Physician Decision|10|||
38005546|NCT00095498|69689257|FG002|Overall Study|Physician Decision|8|||
38005547|NCT00095498|69689255|FG000|Overall Study|Adverse Event|1|||
38005548|NCT00095498|69689256|FG001|Overall Study|Adverse Event|0|||
38005549|NCT00095498|69689257|FG002|Overall Study|Adverse Event|1|||
38005550|NCT00095498|69689255|FG000|Overall Study|Withdrawal by Subject|15|||
38005551|NCT00095498|69689256|FG001|Overall Study|Withdrawal by Subject|16|||
38005552|NCT00095498|69689257|FG002|Overall Study|Withdrawal by Subject|15|||
38005553|NCT00095498|69689255|FG000|Overall Study|Disease progression|0|||
38005554|NCT00095498|69689256|FG001|Overall Study|Disease progression|1|||
38005555|NCT00095498|69689257|FG002|Overall Study|Disease progression|1|||
38005556|NCT00095498|69689255|FG000|Overall Study|Ineligibility determined|3|||
38005557|NCT00095498|69689256|FG001|Overall Study|Ineligibility determined|0|||
38005558|NCT00095498|69689257|FG002|Overall Study|Ineligibility determined|2|||
38005559|NCT00095498|69689255|FG000|Overall Study|Lost to Follow-up|1|||
38005560|NCT00095498|69689256|FG001|Overall Study|Lost to Follow-up|1|||
38005561|NCT00095498|69689257|FG002|Overall Study|Lost to Follow-up|2|||
38005562|NCT00095498|69689255|FG000|Overall Study|Noncompliance|1|||
38005563|NCT00095498|69689256|FG001|Overall Study|Noncompliance|0|||
38005564|NCT00095498|69689257|FG002|Overall Study|Noncompliance|1|||
38005565|NCT00095498|69689255|FG000|Overall Study|Other|6|||
38005566|NCT00095498|69689256|FG001|Overall Study|Other|7|||
38005567|NCT00095498|69689257|FG002|Overall Study|Other|6|||
38005568|NCT00095498|69689255|FG000|Overall Study|Protocol Violation|0|||
38005569|NCT00095498|69689256|FG001|Overall Study|Protocol Violation|0|||
38005570|NCT00095498|69689257|FG002|Overall Study|Protocol Violation|1|||
38005571|NCT00095498|69689255|FG000|Overall Study|Requirement for alternative therapy|1|||
38005572|NCT00095498|69689256|FG001|Overall Study|Requirement for alternative therapy|0|||
38005573|NCT00095498|69689257|FG002|Overall Study|Requirement for alternative therapy|2|||
38005574|NCT04237792|69689271|FG000|Treatment (Day 1)|Adverse Event|1|||
38005575|NCT04237792|69689272|FG001|Treatment (Day 1)|Adverse Event|0|||
38005576|NCT04237792|69689273|FG002|Treatment (Day 1)|Adverse Event|0|||
38005577|NCT04237792|69689274|FG003|Treatment (Day 1)|Adverse Event|0|||
38005578|NCT04237792|69689275|FG004|Treatment (Day 1)|Adverse Event|1|||
38005579|NCT04237792|69689276|FG005|Treatment (Day 1)|Adverse Event|1|||
38005580|NCT04237792|69689271|FG000|Treatment (Day 1)|Other|0|||
38005581|NCT04237792|69689272|FG001|Treatment (Day 1)|Other|0|||
38005582|NCT04237792|69689273|FG002|Treatment (Day 1)|Other|1|||
38005583|NCT04237792|69689274|FG003|Treatment (Day 1)|Other|0|||
38005584|NCT04237792|69689275|FG004|Treatment (Day 1)|Other|0|||
38005585|NCT04237792|69689276|FG005|Treatment (Day 1)|Other|1|||
38005586|NCT04237792|69689271|FG000|Treatment (Day 1)|Not treated|1|||
38005587|NCT04237792|69689272|FG001|Treatment (Day 1)|Not treated|1|||
38005588|NCT04237792|69689273|FG002|Treatment (Day 1)|Not treated|2|||
38005589|NCT04237792|69689274|FG003|Treatment (Day 1)|Not treated|1|||
38005590|NCT04237792|69689275|FG004|Treatment (Day 1)|Not treated|0|||
38005591|NCT04237792|69689276|FG005|Treatment (Day 1)|Not treated|1|||
38005592|NCT00122954|69689307|FG000|Overall Study|Withdrawal by Subject|2|||
38005593|NCT00122954|69689308|FG001|Overall Study|Withdrawal by Subject|2|||
38005594|NCT00122954|69689307|FG000|Overall Study|Protocol Violation|0|||
38005595|NCT00122954|69689308|FG001|Overall Study|Protocol Violation|1|||
38005596|NCT04491994|69689316|FG000|Overall Study|Withdrawal by Subject|10|||
38005597|NCT04491994|69689317|FG001|Overall Study|Withdrawal by Subject|5|||
38005598|NCT04491994|69689316|FG000|Overall Study|developed fever > 3 days|4|||
38005599|NCT04491994|69689317|FG001|Overall Study|developed fever > 3 days|1|||
38005600|NCT04491994|69689316|FG000|Overall Study|Protocol Violation|11|||
37907454|NCT00667342|69593058|FG001|Overall Study|Adverse Event|0|||
38005601|NCT04491994|69689317|FG001|Overall Study|Protocol Violation|2|||
38005602|NCT04491994|69689316|FG000|Overall Study|Lost to Follow-up|4|||
38005603|NCT04491994|69689317|FG001|Overall Study|Lost to Follow-up|3|||
38005604|NCT04041700|69689323|FG000|Overall Study|Pregnancy|1|||
38005605|NCT04041700|69689323|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
38005606|NCT04227340|69689329|FG000|Overall Study|Withdrawal by Subject|3|||
38005607|NCT04033432|69689336|FG000|Overall Study|Progressive Disease|8|||
38005608|NCT04033432|69689336|FG000|Overall Study|Adverse Event|4|||
38005609|NCT04033432|69689336|FG000|Overall Study|Death|1|||
37907455|NCT00667342|69593059|FG002|Overall Study|Adverse Event|1|||
38005610|NCT04223830|69689341|FG000|Overall Study|Lost to Follow-up|9|||
38005611|NCT04223830|69689341|FG000|Overall Study|Adverse Event|1|||
38005612|NCT04032652|69689348|FG000|Overall Study|The study was terminated and the PI has|1|||
38005613|NCT04032652|69689349|FG001|Overall Study|The study was terminated and the PI has|1|||
38005614|NCT04031404|69689355|FG000|Baseline|Lost to Follow-up|0|||
38005615|NCT04031404|69689356|FG001|Baseline|Lost to Follow-up|1|||
38005616|NCT04031404|69689355|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
38005617|NCT04031404|69689356|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
38005618|NCT04031404|69689355|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
38005619|NCT04031404|69689356|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
38005620|NCT04031404|69689355|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
38005621|NCT04031404|69689356|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
38005622|NCT04031404|69689355|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
38005623|NCT04031404|69689356|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
38005624|NCT04476784|69689372|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
38005625|NCT04476784|69689373|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
38005626|NCT04026568|69689384|FG000|Overall Study|study terminated|0|||
37907456|NCT00667342|69593057|FG000|Overall Study|Ineligible|0|||
37907457|NCT00667342|69593058|FG001|Overall Study|Ineligible|0|||
37907458|NCT00667342|69593059|FG002|Overall Study|Ineligible|1|||
37907459|NCT00375609|69593076|FG000|Overall Study|Did not receive treatment|1|||
37907460|NCT00375609|69593077|FG001|Overall Study|Did not receive treatment|0|||
37907461|NCT00375609|69593078|FG002|Overall Study|Did not receive treatment|0|||
37907462|NCT00375609|69593076|FG000|Overall Study|Adverse Event|0|||
37907463|NCT00375609|69593077|FG001|Overall Study|Adverse Event|3|||
37907464|NCT00375609|69593078|FG002|Overall Study|Adverse Event|0|||
37907465|NCT00375609|69593076|FG000|Overall Study|Lost to Follow-up|1|||
37907466|NCT00375609|69593077|FG001|Overall Study|Lost to Follow-up|0|||
37907467|NCT00375609|69593078|FG002|Overall Study|Lost to Follow-up|0|||
37907468|NCT00375609|69593076|FG000|Overall Study|Physician Decision|0|||
37907469|NCT00375609|69593077|FG001|Overall Study|Physician Decision|0|||
37907470|NCT00375609|69593078|FG002|Overall Study|Physician Decision|1|||
37907471|NCT00375609|69593076|FG000|Overall Study|Withdrawal by Subject|1|||
38005627|NCT04026568|69689385|FG001|Overall Study|study terminated|1|||
38005628|NCT04025632|69689393|FG000|Overall Study|Adverse Event|1|||
38005629|NCT04025632|69689394|FG001|Overall Study|Adverse Event|1|||
38005630|NCT04025632|69689393|FG000|Overall Study|Withdrawal by Subject|1|||
38005631|NCT04025632|69689394|FG001|Overall Study|Withdrawal by Subject|1|||
38005632|NCT04025632|69689393|FG000|Overall Study|Study Terminated by Sponsor|10|||
38005633|NCT04025632|69689394|FG001|Overall Study|Study Terminated by Sponsor|9|||
38005634|NCT04025632|69689393|FG000|Overall Study|Physician Decision|3|||
38005635|NCT04025632|69689394|FG001|Overall Study|Physician Decision|1|||
37697613|NCT02083653|69174215|FG001|Overall Study|Progressive Disease|73|||
37830836|NCT01300351|69514161|FG001|Overall Study|Lost to Follow-up|1|||
37830837|NCT01300351|69514160|FG000|Overall Study|Adverse Event|0|||
37830838|NCT01300351|69514161|FG001|Overall Study|Adverse Event|4|||
37907472|NCT00375609|69593077|FG001|Overall Study|Withdrawal by Subject|4|||
37907473|NCT00375609|69593078|FG002|Overall Study|Withdrawal by Subject|0|||
37907474|NCT00375609|69593076|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
37907475|NCT00375609|69593077|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
37907476|NCT00375609|69593078|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
37907477|NCT00960011|69593088|FG000|Overall Study|Death|5|||
37907478|NCT00960011|69593089|FG001|Overall Study|Death|0|||
37907479|NCT00960011|69593088|FG000|Overall Study|Lost to Follow-up|6|||
37907480|NCT00960011|69593089|FG001|Overall Study|Lost to Follow-up|2|||
37907481|NCT00617851|69593133|FG000|Overall Study|Death|0|||
37907482|NCT00617851|69593134|FG001|Overall Study|Death|0|||
37907483|NCT00617851|69593135|FG002|Overall Study|Death|0|||
37907484|NCT00617851|69593136|FG003|Overall Study|Death|1|||
37907485|NCT00617851|69593133|FG000|Overall Study|Withdrawal by Subject|14|||
37907486|NCT00617851|69593134|FG001|Overall Study|Withdrawal by Subject|7|||
38005636|NCT04024228|69689405|FG000|Overall Study|Adverse Event|1|||
38005637|NCT04024228|69689406|FG001|Overall Study|Adverse Event|0|||
38005638|NCT04024228|69689405|FG000|Overall Study|Protocol Deviation|0|||
38005639|NCT04024228|69689406|FG001|Overall Study|Protocol Deviation|2|||
37830839|NCT01300351|69514160|FG000|Overall Study|Withdrawal by Subject|7|||
37830840|NCT01300351|69514161|FG001|Overall Study|Withdrawal by Subject|10|||
37830841|NCT01300234|69514169|FG000|Overall Study|Adverse Event|1|||
37830842|NCT01300234|69514170|FG001|Overall Study|Adverse Event|1|||
37830843|NCT01300234|69514169|FG000|Overall Study|Protocol Violation|2|||
37830844|NCT01300234|69514170|FG001|Overall Study|Protocol Violation|3|||
37830845|NCT01300234|69514169|FG000|Overall Study|Withdrawal by Subject|5|||
37830846|NCT01300234|69514170|FG001|Overall Study|Withdrawal by Subject|9|||
37830847|NCT01300234|69514169|FG000|Overall Study|Lost to Follow-up|14|||
37830848|NCT01300234|69514170|FG001|Overall Study|Lost to Follow-up|12|||
37907487|NCT00617851|69593135|FG002|Overall Study|Withdrawal by Subject|12|||
37907488|NCT00617851|69593136|FG003|Overall Study|Withdrawal by Subject|4|||
37907489|NCT00617851|69593133|FG000|Overall Study|Lost to Follow-up|27|||
37907490|NCT00617851|69593134|FG001|Overall Study|Lost to Follow-up|29|||
37907491|NCT00617851|69593135|FG002|Overall Study|Lost to Follow-up|31|||
37907492|NCT00617851|69593136|FG003|Overall Study|Lost to Follow-up|19|||
37907493|NCT00617851|69593133|FG000|Overall Study|Inappropriate Enrollment|5|||
37907494|NCT00617851|69593134|FG001|Overall Study|Inappropriate Enrollment|4|||
37907495|NCT00617851|69593135|FG002|Overall Study|Inappropriate Enrollment|1|||
37907496|NCT00617851|69593136|FG003|Overall Study|Inappropriate Enrollment|1|||
37907497|NCT00617851|69593133|FG000|Overall Study|Unable to classify|1|||
37907498|NCT00617851|69593134|FG001|Overall Study|Unable to classify|0|||
37907499|NCT00617851|69593135|FG002|Overall Study|Unable to classify|1|||
37907500|NCT00617851|69593136|FG003|Overall Study|Unable to classify|0|||
38005640|NCT04024228|69689405|FG000|Overall Study|Withdrawal by Subject|3|||
38005641|NCT04024228|69689406|FG001|Overall Study|Withdrawal by Subject|4|||
38005642|NCT04023994|69689420|FG000|Overall Study|Lost to Follow-up|0|||
38005643|NCT04023994|69689421|FG001|Overall Study|Lost to Follow-up|1|||
38005644|NCT04023994|69689422|FG002|Overall Study|Lost to Follow-up|2|||
38005645|NCT04023994|69689423|FG003|Overall Study|Lost to Follow-up|0|||
38005646|NCT04023994|69689424|FG004|Overall Study|Lost to Follow-up|0|||
38005647|NCT04023994|69689425|FG005|Overall Study|Lost to Follow-up|0|||
38005648|NCT04023994|69689420|FG000|Overall Study|Withdrawal by Subject|0|||
38005649|NCT04023994|69689421|FG001|Overall Study|Withdrawal by Subject|0|||
38005650|NCT04023994|69689422|FG002|Overall Study|Withdrawal by Subject|0|||
38005651|NCT04023994|69689423|FG003|Overall Study|Withdrawal by Subject|1|||
38005652|NCT04023994|69689424|FG004|Overall Study|Withdrawal by Subject|0|||
38005653|NCT04023994|69689425|FG005|Overall Study|Withdrawal by Subject|0|||
38005654|NCT04023682|69689444|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
38005655|NCT04018612|69689455|FG000|Overall Study|Withdrawal by Subject|1|||
38005656|NCT04018612|69689456|FG001|Overall Study|Withdrawal by Subject|0|||
38005657|NCT04018612|69689457|FG002|Overall Study|Withdrawal by Subject|1|||
38005658|NCT04209400|69689467|FG000|Overall Study|Withdrawal by Subject|0|||
38005659|NCT04209400|69689468|FG001|Overall Study|Withdrawal by Subject|1|||
38005660|NCT04207840|69689474|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
38005661|NCT04207840|69689475|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
38005662|NCT04207840|69689476|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
38005663|NCT04207840|69689474|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
38005664|NCT04207840|69689475|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
38005665|NCT04207840|69689476|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
38005666|NCT04006366|69689484|FG000|Overall Study|Withdrawal by Subject|1|||
37907501|NCT00812955|69593160|FG000|Overall Study|Adverse Event|7|||
37907502|NCT00812955|69593161|FG001|Overall Study|Adverse Event|6|||
37907503|NCT00812955|69593162|FG002|Overall Study|Adverse Event|3|||
37907504|NCT00812955|69593163|FG003|Overall Study|Adverse Event|4|||
37907505|NCT00812955|69593160|FG000|Overall Study|Lost to Follow-up|2|||
37907506|NCT00812955|69593161|FG001|Overall Study|Lost to Follow-up|1|||
37907507|NCT00812955|69593162|FG002|Overall Study|Lost to Follow-up|1|||
37907508|NCT00812955|69593163|FG003|Overall Study|Lost to Follow-up|2|||
38005667|NCT04191148|69689490|FG000|Overall Study|Withdrawal by Subject|1|||
38005668|NCT04191148|69689491|FG001|Overall Study|Withdrawal by Subject|0|||
38005669|NCT04191148|69689490|FG000|Overall Study|Adverse Event|1|||
38005670|NCT04191148|69689491|FG001|Overall Study|Adverse Event|0|||
38005671|NCT04004260|69689501|FG000|Overall Study|Withdrawal by Subject|7|||
38005672|NCT04004260|69689502|FG001|Overall Study|Withdrawal by Subject|3|||
38005673|NCT04004260|69689501|FG000|Overall Study|Lost to Follow-up|22|||
38005674|NCT04004260|69689502|FG001|Overall Study|Lost to Follow-up|12|||
38005675|NCT04004260|69689501|FG000|Overall Study|Did not engage in intervention|13|||
38005676|NCT04004260|69689502|FG001|Overall Study|Did not engage in intervention|17|||
38005677|NCT04470622|69689510|FG000|Overall Study|Withdrawal by Subject|0|||
38005678|NCT04470622|69689511|FG001|Overall Study|Withdrawal by Subject|1|||
38005679|NCT04470622|69689510|FG000|Overall Study|Screen Failure|0|||
38005680|NCT04470622|69689511|FG001|Overall Study|Screen Failure|1|||
38005681|NCT04470622|69689510|FG000|Overall Study|Death|0|||
38005682|NCT04470622|69689511|FG001|Overall Study|Death|1|||
38005683|NCT04465630|69689517|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
38005684|NCT04465630|69689517|FG000|Overall Study|Screen failure|8|||
38005685|NCT04465630|69689517|FG000|Overall Study|Baseline failure|16|||
38005686|NCT04182880|69689524|FG000|Overall Study|Pregnancy|1|||
38005687|NCT04182880|69689525|FG001|Overall Study|Pregnancy|0|||
38005688|NCT04465396|69689535|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
38005689|NCT04465396|69689536|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
38005690|NCT04465396|69689537|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
38005691|NCT04465396|69689538|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
38005692|NCT03999892|69689563|FG000|Overall Study|Lost to Follow-up|1|||
38005693|NCT03996694|69689567|FG000|First Washout (7 Days)|positive urine drug screen|0|||
38005694|NCT03996694|69689568|FG001|First Washout (7 Days)|positive urine drug screen|0|||
37907509|NCT00812955|69593160|FG000|Overall Study|Withdrawal by Subject|1|||
37907510|NCT00812955|69593161|FG001|Overall Study|Withdrawal by Subject|0|||
37907511|NCT00812955|69593162|FG002|Overall Study|Withdrawal by Subject|1|||
37907512|NCT00812955|69593163|FG003|Overall Study|Withdrawal by Subject|2|||
37907513|NCT00812955|69593160|FG000|Overall Study|randomized in error|0|||
38005695|NCT03996694|69689569|FG002|First Washout (7 Days)|positive urine drug screen|1|||
38005696|NCT03996694|69689570|FG003|First Washout (7 Days)|positive urine drug screen|0|||
38005697|NCT03996694|69689571|FG004|First Washout (7 Days)|positive urine drug screen|0|||
38005698|NCT03996694|69689572|FG005|First Washout (7 Days)|positive urine drug screen|0|||
38005699|NCT03996694|69689567|FG000|First Washout (7 Days)|Adverse Event|0|||
38005700|NCT03996694|69689568|FG001|First Washout (7 Days)|Adverse Event|1|||
38005701|NCT03996694|69689569|FG002|First Washout (7 Days)|Adverse Event|0|||
38005702|NCT03996694|69689570|FG003|First Washout (7 Days)|Adverse Event|0|||
38005703|NCT03996694|69689571|FG004|First Washout (7 Days)|Adverse Event|0|||
38005704|NCT03996694|69689572|FG005|First Washout (7 Days)|Adverse Event|0|||
38005705|NCT03996694|69689567|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
38005706|NCT03996694|69689568|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
38005707|NCT03996694|69689569|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
38005708|NCT03996694|69689570|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
38005709|NCT03996694|69689571|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
38005710|NCT03996694|69689572|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
38005711|NCT03996694|69689567|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
38005712|NCT03996694|69689568|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
38005713|NCT03996694|69689569|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
38005714|NCT03996694|69689570|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
38005715|NCT03996694|69689571|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
38005716|NCT03996694|69689572|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
38005717|NCT04179838|69689588|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
38005718|NCT04179838|69689589|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
38005719|NCT04179838|69689588|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
38005720|NCT04179838|69689589|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
38005721|NCT03994120|69689597|FG000|Overall Study|Lost to Follow-up|3|||
38005722|NCT03994120|69689598|FG001|Overall Study|Lost to Follow-up|1|||
38005723|NCT04178590|69689604|FG000|Overall Study|Pregnancy|1|||
38005724|NCT04178590|69689604|FG000|Overall Study|Lost to Follow-up|1|||
38005725|NCT04175392|69689632|FG000|Overall Study|Withdrawal by Subject|3|||
38005726|NCT04175392|69689633|FG001|Overall Study|Withdrawal by Subject|2|||
38005727|NCT03986866|69689641|FG000|Overall Study|Withdrawal by Subject|0|||
38005728|NCT03986866|69689642|FG001|Overall Study|Withdrawal by Subject|3|||
38005729|NCT03986866|69689641|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
38005730|NCT03986866|69689642|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
38005731|NCT03980938|69689650|FG000|Treatment Period 1|Study Terminated|1|||
38005732|NCT03980938|69689651|FG001|Treatment Period 1|Study Terminated|1|||
38005733|NCT03980938|69689650|FG000|Treatment Period 2|Study Terminated|2|||
38005734|NCT03980938|69689651|FG001|Treatment Period 2|Study Terminated|2|||
38005735|NCT03656692|69689657|FG000|Overall Study|Worsening of disease activity|2|||
38005736|NCT03656692|69689657|FG000|Overall Study|Physician Decision|1|||
38005737|NCT04439266|69689661|FG000|Overall Study|Ineligible|1|||
38005738|NCT04439266|69689661|FG000|Overall Study|Adverse Event|1|||
38005739|NCT04439266|69689661|FG000|Overall Study|Death|1|||
38005740|NCT04439266|69689661|FG000|Overall Study|Disease progression|1|||
38005741|NCT04439266|69689661|FG000|Overall Study|Still on treatment|1|||
38005742|NCT03682120|69689669|FG000|Overall Study|Lost to Follow-up|11|||
38005743|NCT03682120|69689670|FG001|Overall Study|Lost to Follow-up|4|||
38005744|NCT03682120|69689671|FG002|Overall Study|Lost to Follow-up|5|||
38005745|NCT03682120|69689672|FG003|Overall Study|Lost to Follow-up|2|||
38005746|NCT03682120|69689669|FG000|Overall Study|Physician Decision|1|||
38005747|NCT03682120|69689670|FG001|Overall Study|Physician Decision|0|||
38005748|NCT03682120|69689671|FG002|Overall Study|Physician Decision|0|||
38005749|NCT03682120|69689672|FG003|Overall Study|Physician Decision|0|||
38005750|NCT03682120|69689669|FG000|Overall Study|Withdrawal by Subject|1|||
38005751|NCT03682120|69689670|FG001|Overall Study|Withdrawal by Subject|2|||
38005752|NCT03682120|69689671|FG002|Overall Study|Withdrawal by Subject|3|||
38005753|NCT03682120|69689672|FG003|Overall Study|Withdrawal by Subject|0|||
38005754|NCT03682120|69689669|FG000|Overall Study|Death|0|||
38005755|NCT03682120|69689670|FG001|Overall Study|Death|1|||
38005756|NCT03682120|69689671|FG002|Overall Study|Death|0|||
38005757|NCT03682120|69689672|FG003|Overall Study|Death|0|||
38005758|NCT03682120|69689669|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
38005759|NCT03682120|69689670|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
38005760|NCT03682120|69689671|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
38005761|NCT03682120|69689672|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
38005762|NCT04428502|69689684|FG000|Overall Study|Did not meet entrance criteria|14|||
38005763|NCT04428424|69689689|FG000|Overall Study|Does not meet entrance criteria|132|||
38005764|NCT04428424|69689689|FG000|Overall Study|Lost to Follow-up|115|||
38005765|NCT03655756|69689693|FG000|Overall Study|Death|1|||
38005766|NCT00095238|69689699|FG000|Overall Study|Lack of Efficacy|9|||
38005767|NCT00095238|69689700|FG001|Overall Study|Lack of Efficacy|9|||
38005768|NCT00095238|69689699|FG000|Overall Study|Adverse Event|331|||
38005769|NCT00095238|69689700|FG001|Overall Study|Adverse Event|287|||
38005770|NCT00095238|69689699|FG000|Overall Study|Subject Withdrew Consent|208|||
38005771|NCT00095238|69689700|FG001|Overall Study|Subject Withdrew Consent|223|||
38005772|NCT00095238|69689699|FG000|Overall Study|Death|154|||
38005773|NCT00095238|69689700|FG001|Overall Study|Death|170|||
38005774|NCT00095238|69689699|FG000|Overall Study|Lost to Follow-up|19|||
38005775|NCT00095238|69689700|FG001|Overall Study|Lost to Follow-up|24|||
38005776|NCT00095238|69689699|FG000|Overall Study|Noncompliance|44|||
38005777|NCT00095238|69689700|FG001|Overall Study|Noncompliance|45|||
38005778|NCT00095238|69689699|FG000|Overall Study|No longer met study criteria|4|||
38005779|NCT00095238|69689700|FG001|Overall Study|No longer met study criteria|5|||
38005780|NCT00095238|69689699|FG000|Overall Study|Study terminated by sponsor|0|||
38005781|NCT00095238|69689700|FG001|Overall Study|Study terminated by sponsor|1|||
38005782|NCT00095238|69689699|FG000|Overall Study|Missing|1|||
38005783|NCT00095238|69689700|FG001|Overall Study|Missing|0|||
38005784|NCT00095238|69689699|FG000|Overall Study|Other Reasons|87|||
38005785|NCT00095238|69689700|FG001|Overall Study|Other Reasons|88|||
38005786|NCT00082368|69689738|FG000|Overall Study|Not treated-pt had poor IV access|1|||
38005787|NCT00094770|69689744|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
38005788|NCT00094770|69689745|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
38005789|NCT00094770|69689744|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
38005790|NCT00094770|69689745|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
38005791|NCT00094770|69689744|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
38005792|NCT00094770|69689745|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
38005793|NCT00094770|69689744|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
38005794|NCT00094770|69689745|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
38005795|NCT00094770|69689744|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
38005796|NCT00094770|69689745|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
38005797|NCT00094770|69689744|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
38005798|NCT00094770|69689745|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
38005799|NCT00094770|69689744|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
38005800|NCT00094770|69689745|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
38005801|NCT00094770|69689744|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
38005802|NCT00094770|69689745|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
38005803|NCT00094770|69689744|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
38005804|NCT00094770|69689745|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
38005805|NCT00094770|69689744|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
38005806|NCT00094770|69689745|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
38005807|NCT00094770|69689744|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
38005808|NCT00094770|69689745|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
38005809|NCT00094770|69689744|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
38005810|NCT00094770|69689745|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
38005811|NCT00094770|69689744|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
37830849|NCT01300234|69514169|FG000|Overall Study|Pregnancy|2|||
37907514|NCT00812955|69593161|FG001|Overall Study|randomized in error|0|||
37907515|NCT00812955|69593162|FG002|Overall Study|randomized in error|1|||
37907516|NCT00812955|69593163|FG003|Overall Study|randomized in error|0|||
37907517|NCT00619489|69593179|FG000|Overall Study|Adverse Event|0|||
37907518|NCT00619489|69593180|FG001|Overall Study|Adverse Event|7|||
37907519|NCT00619489|69593179|FG000|Overall Study|Withdrawal by Subject|1|||
37830850|NCT01300234|69514170|FG001|Overall Study|Pregnancy|1|||
37830851|NCT01300234|69514169|FG000|Overall Study|Participant reached stopping critera|2|||
37830852|NCT01300234|69514170|FG001|Overall Study|Participant reached stopping critera|0|||
37830853|NCT01300234|69514169|FG000|Overall Study|Participant stopped medication|1|||
37830854|NCT01300234|69514170|FG001|Overall Study|Participant stopped medication|1|||
37907520|NCT00619489|69593180|FG001|Overall Study|Withdrawal by Subject|1|||
37907521|NCT00619489|69593179|FG000|Overall Study|Lack of Efficacy|0|||
37907522|NCT00619489|69593180|FG001|Overall Study|Lack of Efficacy|11|||
37907523|NCT00619489|69593179|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
37907524|NCT00619489|69593180|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
38005812|NCT00094770|69689745|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
37830855|NCT01300234|69514169|FG000|Overall Study|Participant refused return to hospital|1|||
37830856|NCT01300234|69514170|FG001|Overall Study|Participant refused return to hospital|0|||
37907525|NCT00959699|69593188|FG000|Treatment Period|Adverse Event|3|||
38005813|NCT00094770|69689744|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
38005814|NCT00094770|69689745|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
38005815|NCT00094770|69689744|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
38005816|NCT00094770|69689745|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
38005817|NCT00094770|69689744|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
38005818|NCT00094770|69689745|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
38005819|NCT00094770|69689744|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
37907526|NCT00959699|69593189|FG001|Treatment Period|Adverse Event|13|||
37907527|NCT00959699|69593188|FG000|Treatment Period|Lack of Efficacy|15|||
38005820|NCT00094770|69689745|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
38005821|NCT00094770|69689744|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
38005822|NCT00094770|69689745|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
38005823|NCT00069576|69689753|FG000|Original Trial|Lost to Follow-up|25|||
38005824|NCT00069576|69689754|FG001|Original Trial|Lost to Follow-up|33|||
38005825|NCT00069576|69689753|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
38005826|NCT00069576|69689754|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
38005827|NCT00069264|69689760|FG000|Overall Study|Adverse Event|3|||
38005828|NCT00069264|69689760|FG000|Overall Study|Progressive Disease|23|||
38005829|NCT00069264|69689760|FG000|Overall Study|Withdrawal by Subject|3|||
38005830|NCT00069264|69689760|FG000|Overall Study|Discon Therapy|3|||
38005831|NCT00069108|69689766|FG000|Overall Study|Withdrawal by Subject|5|||
38005832|NCT00069108|69689767|FG001|Overall Study|Withdrawal by Subject|9|||
38005833|NCT00069108|69689766|FG000|Overall Study|Adverse Event|64|||
38005834|NCT00069108|69689767|FG001|Overall Study|Adverse Event|42|||
38005835|NCT00069108|69689766|FG000|Overall Study|Death|6|||
38005836|NCT00069108|69689767|FG001|Overall Study|Death|6|||
38005837|NCT00069108|69689766|FG000|Overall Study|Administration|15|||
38005838|NCT00069108|69689767|FG001|Overall Study|Administration|4|||
38005839|NCT00069108|69689766|FG000|Overall Study|Insufficient therapy|117|||
38005840|NCT00069108|69689767|FG001|Overall Study|Insufficient therapy|144|||
38005841|NCT00069108|69689766|FG000|Overall Study|Violation criteria|1|||
38005842|NCT00069108|69689767|FG001|Overall Study|Violation criteria|4|||
38005843|NCT00069108|69689766|FG000|Overall Study|Refused treatment|5|||
38005844|NCT00069108|69689767|FG001|Overall Study|Refused treatment|10|||
38005845|NCT00094536|69689774|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
38005846|NCT00094536|69689774|FG000|Treatment and Follow-up|Adverse Event|4|||
38005847|NCT00094536|69689774|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
38005848|NCT00094536|69689774|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
38005849|NCT00094536|69689774|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
38005850|NCT00094536|69689774|FG000|Treatment and Follow-up|Subject non-compliance|9|||
38005851|NCT00094536|69689774|FG000|Treatment and Follow-up|Unable to attend visits|1|||
38005852|NCT00405587|69689782|FG000|Overall Study|Death|0|||
38005853|NCT00405587|69689783|FG001|Overall Study|Death|0|||
38005854|NCT00405587|69689784|FG002|Overall Study|Death|0|||
38005855|NCT00405587|69689785|FG003|Overall Study|Death|1|||
38005856|NCT00405587|69689782|FG000|Overall Study|Disease Progression|22|||
38005857|NCT00405587|69689783|FG001|Overall Study|Disease Progression|23|||
38005858|NCT00405587|69689784|FG002|Overall Study|Disease Progression|21|||
38005859|NCT00405587|69689785|FG003|Overall Study|Disease Progression|17|||
38005860|NCT00405587|69689782|FG000|Overall Study|Physician Decision|3|||
38005861|NCT00405587|69689783|FG001|Overall Study|Physician Decision|2|||
38005862|NCT00405587|69689784|FG002|Overall Study|Physician Decision|0|||
38005863|NCT00405587|69689785|FG003|Overall Study|Physician Decision|0|||
37830857|NCT01299961|69514187|FG000|Overall Study|Adverse Event|3|||
37830858|NCT01299961|69514187|FG000|Overall Study|Lack of Efficacy|2|||
37830859|NCT01299961|69514187|FG000|Overall Study|Lost to Follow-up|1|||
37830860|NCT01299805|69514193|FG000|Overall Study|Adverse Event|2|||
37830861|NCT01299805|69514194|FG001|Overall Study|Adverse Event|0|||
38005864|NCT00405587|69689782|FG000|Overall Study|Adverse Event|1|||
38005865|NCT00405587|69689783|FG001|Overall Study|Adverse Event|0|||
38005866|NCT00405587|69689784|FG002|Overall Study|Adverse Event|0|||
38005867|NCT00405587|69689785|FG003|Overall Study|Adverse Event|0|||
38005868|NCT00405587|69689782|FG000|Overall Study|Lost to Follow-up|0|||
38005869|NCT00405587|69689783|FG001|Overall Study|Lost to Follow-up|1|||
38005870|NCT00405587|69689784|FG002|Overall Study|Lost to Follow-up|1|||
38005871|NCT00405587|69689785|FG003|Overall Study|Lost to Follow-up|0|||
38005872|NCT00405587|69689782|FG000|Overall Study|Radiation induced necrosis|0|||
38005873|NCT00405587|69689783|FG001|Overall Study|Radiation induced necrosis|1|||
38005874|NCT00405587|69689784|FG002|Overall Study|Radiation induced necrosis|0|||
38005875|NCT00405587|69689785|FG003|Overall Study|Radiation induced necrosis|0|||
38005876|NCT00405587|69689782|FG000|Overall Study|Withdrawal by Subject|0|||
38005877|NCT00405587|69689783|FG001|Overall Study|Withdrawal by Subject|0|||
38005878|NCT00405587|69689784|FG002|Overall Study|Withdrawal by Subject|0|||
38005879|NCT00405587|69689785|FG003|Overall Study|Withdrawal by Subject|2|||
37697614|NCT02083653|69174216|FG002|Overall Study|Progressive Disease|63|||
37830862|NCT01299766|69514202|FG000|Overall Study|Death|5|||
37830863|NCT01299766|69514203|FG001|Overall Study|Death|4|||
37830864|NCT01299766|69514202|FG000|Overall Study|Withdrawal by Subject|29|||
38005880|NCT00405587|69689782|FG000|Overall Study|Participant not dosed|0|||
38005881|NCT00405587|69689783|FG001|Overall Study|Participant not dosed|1|||
38005882|NCT00405587|69689784|FG002|Overall Study|Participant not dosed|0|||
38005883|NCT00405587|69689785|FG003|Overall Study|Participant not dosed|0|||
38005884|NCT00405275|69689823|FG000|Overall Study|Death|1|||
38005885|NCT00405275|69689824|FG001|Overall Study|Death|0|||
38005886|NCT00405275|69689823|FG000|Overall Study|Lost to Follow-up|5|||
38005887|NCT00405275|69689824|FG001|Overall Study|Lost to Follow-up|1|||
38005888|NCT00405275|69689823|FG000|Overall Study|Withdrawal by Subject|7|||
38043643|NCT02180867|69731809|FG005|Overall Study|Physician Decision|3|||
38005889|NCT00405275|69689824|FG001|Overall Study|Withdrawal by Subject|9|||
38005890|NCT00405275|69689823|FG000|Overall Study|Unwilling to continue|10|||
38005891|NCT00405275|69689824|FG001|Overall Study|Unwilling to continue|9|||
38005892|NCT00404651|69689834|FG000|Overall Study|Serious Adverse Event|0|||
38005893|NCT00404651|69689835|FG001|Overall Study|Serious Adverse Event|0|||
38005894|NCT00404651|69689836|FG002|Overall Study|Serious Adverse Event|2|||
38005895|NCT00404651|69689837|FG003|Overall Study|Serious Adverse Event|0|||
38005896|NCT00404651|69689834|FG000|Overall Study|Protocol Violation|10|||
38005897|NCT00404651|69689835|FG001|Overall Study|Protocol Violation|5|||
38005898|NCT00404651|69689836|FG002|Overall Study|Protocol Violation|14|||
38005899|NCT00404651|69689837|FG003|Overall Study|Protocol Violation|5|||
38005900|NCT00404651|69689834|FG000|Overall Study|Lost to Follow-up|15|||
38005901|NCT00404651|69689835|FG001|Overall Study|Lost to Follow-up|11|||
38005902|NCT00404651|69689836|FG002|Overall Study|Lost to Follow-up|13|||
38005903|NCT00404651|69689837|FG003|Overall Study|Lost to Follow-up|10|||
38005904|NCT00404651|69689834|FG000|Overall Study|Withdrawal by Subject|14|||
38005905|NCT00404651|69689835|FG001|Overall Study|Withdrawal by Subject|12|||
38005906|NCT00404651|69689836|FG002|Overall Study|Withdrawal by Subject|16|||
38005907|NCT00404651|69689837|FG003|Overall Study|Withdrawal by Subject|6|||
38005908|NCT00404495|69689849|FG000|Overall Study|Death|37|||
38005909|NCT00404495|69689850|FG001|Overall Study|Death|11|||
38005910|NCT00404495|69689849|FG000|Overall Study|Lost to Follow-up|5|||
38005911|NCT00404495|69689850|FG001|Overall Study|Lost to Follow-up|0|||
38005912|NCT00404495|69689849|FG000|Overall Study|Other|1|||
38005913|NCT00404495|69689850|FG001|Overall Study|Other|0|||
38005914|NCT00404495|69689849|FG000|Overall Study|Withdrawal by Subject|1|||
38005915|NCT00404495|69689850|FG001|Overall Study|Withdrawal by Subject|0|||
38005916|NCT00409409|69689858|FG000|Overall Study|Adverse Event|7|||
38005917|NCT00409409|69689859|FG001|Overall Study|Adverse Event|2|||
38005918|NCT00409409|69689858|FG000|Overall Study|Withdrawal by Subject|1|||
38005919|NCT00409409|69689859|FG001|Overall Study|Withdrawal by Subject|1|||
38005920|NCT00409409|69689858|FG000|Overall Study|Any other reason not above-mentioned|0|||
38005921|NCT00409409|69689859|FG001|Overall Study|Any other reason not above-mentioned|1|||
38005922|NCT00409331|69689865|FG000|Overall Study|Physician Decision|1|||
38005923|NCT00409175|69689871|FG000|Overall Study|Adverse Event|4|||
38005924|NCT00409175|69689872|FG001|Overall Study|Adverse Event|3|||
38005925|NCT00409175|69689871|FG000|Overall Study|Withdrawal by Subject|1|||
38005926|NCT00409175|69689872|FG001|Overall Study|Withdrawal by Subject|2|||
38005927|NCT00409175|69689871|FG000|Overall Study|Negative genotype|0|||
38005928|NCT00409175|69689872|FG001|Overall Study|Negative genotype|1|||
38005929|NCT00409175|69689871|FG000|Overall Study|Liver transplantation|13|||
38005930|NCT00409175|69689872|FG001|Overall Study|Liver transplantation|13|||
38005931|NCT00408629|69689880|FG000|Overall Study|Adverse Event|13|||
38005932|NCT00408629|69689881|FG001|Overall Study|Adverse Event|27|||
38005933|NCT00408629|69689880|FG000|Overall Study|Withdrawal by Subject|8|||
38005934|NCT00408629|69689881|FG001|Overall Study|Withdrawal by Subject|4|||
38005935|NCT00408629|69689880|FG000|Overall Study|Lost to Follow-up|1|||
38005936|NCT00408629|69689881|FG001|Overall Study|Lost to Follow-up|1|||
38005937|NCT00408629|69689880|FG000|Overall Study|Lack of Efficacy|63|||
38005938|NCT00408629|69689881|FG001|Overall Study|Lack of Efficacy|73|||
38005939|NCT00408629|69689880|FG000|Overall Study|Protocol Violation|1|||
38005940|NCT00408629|69689881|FG001|Overall Study|Protocol Violation|5|||
38005941|NCT00408629|69689880|FG000|Overall Study|Miscellaneous|11|||
38005942|NCT00408629|69689881|FG001|Overall Study|Miscellaneous|15|||
38005943|NCT00408317|69689888|FG000|First Intervention Period|Adverse Event|0|||
38005944|NCT00408317|69689889|FG001|First Intervention Period|Adverse Event|1|||
38005945|NCT00408317|69689888|FG000|Second Intervention Period|Adverse Event|2|||
38005946|NCT00408317|69689889|FG001|Second Intervention Period|Adverse Event|0|||
38005947|NCT00408317|69689888|FG000|Second Intervention Period|Protocol Violation|0|||
38005948|NCT00408317|69689889|FG001|Second Intervention Period|Protocol Violation|1|||
37697615|NCT02083653|69174214|FG000|Overall Study|Withdrawal by Subject|2|||
37697616|NCT02083653|69174215|FG001|Overall Study|Withdrawal by Subject|1|||
38005949|NCT00408317|69689888|FG000|Second Intervention Period|Withdrawal of consent|0|||
38005950|NCT00408317|69689889|FG001|Second Intervention Period|Withdrawal of consent|1|||
38005951|NCT00112502|69689903|FG000|Overall Study|Withdrawal by Subject|0|||
37697617|NCT02083653|69174216|FG002|Overall Study|Withdrawal by Subject|2|||
37697618|NCT02083653|69174214|FG000|Overall Study|Other Events|0|||
37697619|NCT02083653|69174215|FG001|Overall Study|Other Events|2|||
38005952|NCT00112502|69689904|FG001|Overall Study|Withdrawal by Subject|1|||
38005953|NCT00112502|69689905|FG002|Overall Study|Withdrawal by Subject|1|||
38005954|NCT00112502|69689906|FG003|Overall Study|Withdrawal by Subject|4|||
38005955|NCT00112502|69689907|FG004|Overall Study|Withdrawal by Subject|2|||
38005956|NCT00112502|69689908|FG005|Overall Study|Withdrawal by Subject|5|||
38005957|NCT00112502|69689909|FG006|Overall Study|Withdrawal by Subject|3|||
38005958|NCT00112502|69689910|FG007|Overall Study|Withdrawal by Subject|7|||
38005959|NCT03822182|69689941|FG000|Overall Study|Protocol Violation|0|||
38005960|NCT03822182|69689942|FG001|Overall Study|Protocol Violation|1|||
38005961|NCT03822182|69689943|FG002|Overall Study|Protocol Violation|1|||
38005962|NCT00111800|69689958|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
38005963|NCT00111800|69689959|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
38005964|NCT00111800|69689960|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
38005965|NCT00111800|69689961|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
38005966|NCT00111800|69689962|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
38005967|NCT00111800|69689963|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
38005968|NCT00111800|69689958|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
38005969|NCT00111800|69689959|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
38005970|NCT00111800|69689960|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
38005971|NCT00111800|69689961|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
38005972|NCT00111800|69689962|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
38005973|NCT00111800|69689963|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
38005974|NCT00111800|69689958|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
38005975|NCT00111800|69689959|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
38005976|NCT00111800|69689960|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
38005977|NCT00111800|69689961|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
38005978|NCT00111800|69689962|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
38005979|NCT00111800|69689963|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
38005980|NCT00111800|69689958|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
38005981|NCT00111800|69689959|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
38005982|NCT00111800|69689960|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
38005983|NCT00111800|69689961|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
38005984|NCT00111800|69689962|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
38005985|NCT00111800|69689963|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
38005986|NCT00111800|69689958|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
38005987|NCT00111800|69689959|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
38005988|NCT00111800|69689960|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
38005989|NCT00111800|69689961|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
38005990|NCT00111800|69689962|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
38005991|NCT00111800|69689963|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
38005992|NCT00111800|69689958|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
38005993|NCT00111800|69689959|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
38005994|NCT00111800|69689960|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
38005995|NCT00111800|69689961|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
38005996|NCT00111800|69689962|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
38005997|NCT00111800|69689963|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
38005998|NCT00111800|69689958|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
38005999|NCT00111800|69689959|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
38006000|NCT00111800|69689960|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
38006001|NCT00111800|69689961|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
38006002|NCT00111800|69689962|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
37697620|NCT02083653|69174216|FG002|Overall Study|Other Events|2|||
37830865|NCT01299766|69514203|FG001|Overall Study|Withdrawal by Subject|19|||
37830866|NCT01299727|69514212|FG000|Overall Study|Withdrawal by Subject|1|||
37830867|NCT01299727|69514213|FG001|Overall Study|Withdrawal by Subject|0|||
37830868|NCT01299727|69514214|FG002|Overall Study|Withdrawal by Subject|0|||
37830869|NCT01299727|69514212|FG000|Overall Study|Adverse Event|0|||
37830870|NCT01299727|69514213|FG001|Overall Study|Adverse Event|0|||
37830871|NCT01299727|69514214|FG002|Overall Study|Adverse Event|1|||
37830872|NCT01299727|69514212|FG000|Overall Study|Completed the Treatment Period|3|||
37830873|NCT01299727|69514213|FG001|Overall Study|Completed the Treatment Period|4|||
37830874|NCT01299727|69514214|FG002|Overall Study|Completed the Treatment Period|3|||
37830875|NCT01299571|69514222|FG000|Overall Study|Protocol Violation|107|||
37830876|NCT01299376|69514229|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
37907528|NCT00959699|69593189|FG001|Treatment Period|Lack of Efficacy|6|||
37907529|NCT00959699|69593188|FG000|Treatment Period|Lost to Follow-up|0|||
37907530|NCT00959699|69593189|FG001|Treatment Period|Lost to Follow-up|1|||
38006003|NCT00111800|69689963|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
38006004|NCT00111800|69689958|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
38006005|NCT00111800|69689959|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
38006006|NCT00111800|69689960|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
38006007|NCT00111800|69689961|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
38006008|NCT00111800|69689962|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
37830877|NCT01299376|69514230|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
37830878|NCT01299376|69514229|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
37830879|NCT01299376|69514230|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
37830880|NCT01299376|69514229|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
37830881|NCT01299376|69514230|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
37830882|NCT01299376|69514229|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
37907531|NCT00959699|69593188|FG000|Treatment Period|Withdrawal by Subject|1|||
37907532|NCT00959699|69593189|FG001|Treatment Period|Withdrawal by Subject|3|||
37907533|NCT00959699|69593188|FG000|Treatment Period|Non-Compliance with Protocol|0|||
38006009|NCT00111800|69689963|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
38006010|NCT00111800|69689958|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
38006011|NCT00111800|69689959|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
38006012|NCT00111800|69689960|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
38006013|NCT00111800|69689961|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
38006014|NCT00111800|69689962|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
38006015|NCT00111800|69689963|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
38006016|NCT00111800|69689958|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
38006017|NCT00111800|69689959|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
38006018|NCT00111800|69689960|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
38006019|NCT00111800|69689961|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
38006020|NCT00111800|69689962|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
38006021|NCT00111800|69689963|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
38006022|NCT00111800|69689958|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
38006023|NCT00111800|69689959|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
38006024|NCT00111800|69689960|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
38006025|NCT00111800|69689961|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
38006026|NCT00111800|69689962|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
38006027|NCT00111800|69689963|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
38006028|NCT00111800|69689958|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
38006029|NCT00111800|69689959|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
38006030|NCT00111800|69689960|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
38006031|NCT00111800|69689961|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
38006032|NCT00111800|69689962|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
38006033|NCT00111800|69689963|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
38006034|NCT00111800|69689958|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
38006035|NCT00111800|69689959|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
38006036|NCT00111800|69689960|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
38006037|NCT00111800|69689961|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
38006038|NCT00111800|69689962|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
38006039|NCT00111800|69689963|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
38006040|NCT00111800|69689958|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
38006041|NCT00111800|69689959|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
38006042|NCT00111800|69689960|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
38006043|NCT00111800|69689961|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
38006044|NCT00111800|69689962|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
38006045|NCT00111800|69689963|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
38006046|NCT00111800|69689958|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
38006047|NCT00111800|69689959|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
38006048|NCT00111800|69689960|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
38006049|NCT00111800|69689961|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
37907534|NCT00959699|69593189|FG001|Treatment Period|Non-Compliance with Protocol|1|||
37907535|NCT00959699|69593188|FG000|Treatment Period|Did not receive treatment|0|||
37907536|NCT00959699|69593189|FG001|Treatment Period|Did not receive treatment|1|||
37907537|NCT00959699|69593188|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
37907538|NCT00959699|69593189|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
37907539|NCT00959699|69593188|FG000|Follow-up Period|Lost to Follow-up|3|||
37907540|NCT00959699|69593189|FG001|Follow-up Period|Lost to Follow-up|2|||
37907541|NCT00959699|69593188|FG000|Follow-up Period|Withdrawal by Subject|3|||
37907542|NCT00959699|69593189|FG001|Follow-up Period|Withdrawal by Subject|4|||
37697621|NCT02083653|69174214|FG000|Overall Study|Reason Missing|0|||
38006050|NCT00111800|69689962|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
38006051|NCT00111800|69689963|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
38006052|NCT00111800|69689958|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
38006053|NCT00111800|69689959|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
38006054|NCT00111800|69689960|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
38006055|NCT00111800|69689961|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
38006056|NCT00111800|69689962|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
38006057|NCT00111800|69689963|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
38006058|NCT00111800|69689958|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
38006059|NCT00111800|69689959|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
38006060|NCT00111800|69689960|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
38006061|NCT00111800|69689961|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
38006062|NCT00111800|69689962|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
38006063|NCT00111800|69689963|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
38006064|NCT00111800|69689958|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
38006065|NCT00111800|69689959|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
38006066|NCT00111800|69689960|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
38006067|NCT00111800|69689961|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
38006068|NCT00111800|69689962|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
38006069|NCT00111800|69689963|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
38006070|NCT00111800|69689958|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
38006071|NCT00111800|69689959|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
38006072|NCT00111800|69689960|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
38006073|NCT00111800|69689961|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
38006074|NCT00111800|69689962|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
38006075|NCT00111800|69689963|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
38006076|NCT00111800|69689958|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
38006077|NCT00111800|69689959|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
38006078|NCT00111800|69689960|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
38006079|NCT00111800|69689961|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
38006080|NCT00111800|69689962|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
38006081|NCT00111800|69689963|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
38006082|NCT00111800|69689958|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
38006083|NCT00111800|69689959|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
38006084|NCT00111800|69689960|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
38006085|NCT00111800|69689961|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
38006086|NCT00111800|69689962|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
38006087|NCT00111800|69689963|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
38006088|NCT00111800|69689958|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
38006089|NCT00111800|69689959|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
37697622|NCT02083653|69174215|FG001|Overall Study|Reason Missing|0|||
37830883|NCT01299376|69514230|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
37907543|NCT00617773|69593196|FG000|Overall Study|Physician Decision|1|||
37697623|NCT02083653|69174216|FG002|Overall Study|Reason Missing|4|||
37697624|NCT02436239|69174228|FG000|Open-Lable Treatment Period|Adverse Event|12|||
37697625|NCT02436239|69174229|FG001|Open-Lable Treatment Period|Adverse Event|3|||
37697626|NCT02436239|69174230|FG002|Open-Lable Treatment Period|Adverse Event|4|||
37697627|NCT02436239|69174231|FG003|Open-Lable Treatment Period|Adverse Event|2|||
37830884|NCT01299376|69514229|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
37907544|NCT00617773|69593196|FG000|Overall Study|Lack of compliance with the protocol|1|||
37907545|NCT00617773|69593196|FG000|Overall Study|Withdrawal by Subject|1|||
37907546|NCT00617773|69593196|FG000|Overall Study|Death|1|||
37907547|NCT00617773|69593196|FG000|Overall Study|Progressive disease|19|||
37907548|NCT00617773|69593196|FG000|Overall Study|Protocol Violation|1|||
37830885|NCT01299376|69514230|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
37830886|NCT01299376|69514229|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
37830887|NCT01299376|69514230|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
37830888|NCT01299376|69514229|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
37830889|NCT01299376|69514230|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
37830890|NCT01299376|69514229|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
37830891|NCT01299376|69514230|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
37830892|NCT01299376|69514229|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
37830893|NCT01299376|69514230|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
37830894|NCT01299376|69514229|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
37907549|NCT00956813|69593202|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
38006090|NCT00111800|69689960|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
38006091|NCT00111800|69689961|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
38006092|NCT00111800|69689962|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
38006093|NCT00111800|69689963|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
38006094|NCT00111800|69689958|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
38006095|NCT00111800|69689959|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
38006096|NCT00111800|69689960|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
38006097|NCT00111800|69689961|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
38006098|NCT00111800|69689962|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
38006099|NCT00111800|69689963|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
38006100|NCT00111800|69689958|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
38006101|NCT00111800|69689959|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
38006102|NCT00111800|69689960|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
38006103|NCT00111800|69689961|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
38006104|NCT00111800|69689962|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
38006105|NCT00111800|69689963|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
38006106|NCT00111800|69689958|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
38006107|NCT00111800|69689959|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
38006108|NCT00111800|69689960|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
38006109|NCT00111800|69689961|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
38006110|NCT00111800|69689962|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
38006111|NCT00111800|69689963|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
38006112|NCT00111800|69689958|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
38006113|NCT00111800|69689959|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
38006114|NCT00111800|69689960|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
38006115|NCT00111800|69689961|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
38006116|NCT00111800|69689962|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
38006117|NCT00111800|69689963|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
38006118|NCT00094328|69689986|FG000|Overall Study|Lost to Follow-up|1|||
38006119|NCT00094172|69689992|FG000|Overall Study|Adverse Event|0|||
38006120|NCT00094172|69689993|FG001|Overall Study|Adverse Event|1|||
38006121|NCT00094172|69689992|FG000|Overall Study|Lost to Follow-up|2|||
38006122|NCT00094172|69689993|FG001|Overall Study|Lost to Follow-up|0|||
38006123|NCT00094172|69689992|FG000|Overall Study|Protocol Violation|0|||
38006124|NCT00094172|69689993|FG001|Overall Study|Protocol Violation|1|||
38006125|NCT00094172|69689992|FG000|Overall Study|Withdrawal by Subject|10|||
38006126|NCT00094172|69689993|FG001|Overall Study|Withdrawal by Subject|5|||
38006127|NCT00094172|69689992|FG000|Overall Study|Primary endpoint met.|1|||
38006128|NCT00094172|69689993|FG001|Overall Study|Primary endpoint met.|0|||
38006129|NCT00094172|69689992|FG000|Overall Study|Started other MS therapy due to disease|1|||
38006130|NCT00094172|69689993|FG001|Overall Study|Started other MS therapy due to disease|0|||
38006131|NCT00094094|69689999|FG000|Overall Study|Death|2|||
38006132|NCT00094094|69689999|FG000|Overall Study|Lack of Efficacy|23|||
38006133|NCT00094094|69689999|FG000|Overall Study|Adverse Event|7|||
38006134|NCT00110396|69690003|FG000|Overall Study|Adverse Event|15|||
38006135|NCT00110396|69690003|FG000|Overall Study|Lost to Follow-up|1|||
38006136|NCT00110396|69690003|FG000|Overall Study|Administration of plasmapheresis|1|||
38006137|NCT00110396|69690003|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
38006138|NCT00110396|69690003|FG000|Overall Study|Lack of Efficacy|1|||
38006139|NCT00110396|69690003|FG000|Overall Study|Decided not to continue treatment|1|||
38006140|NCT00110396|69690003|FG000|Overall Study|Patient non-compliance|1|||
38006141|NCT00110396|69690003|FG000|Overall Study|Patient refused to continue|1|||
38006142|NCT00110396|69690003|FG000|Overall Study|Patient refused to participate|1|||
38006143|NCT00110396|69690003|FG000|Overall Study|Patient will|1|||
38006144|NCT00110396|69690003|FG000|Overall Study|Patient's decision|1|||
38006145|NCT00110396|69690003|FG000|Overall Study|Participation in MS vaccine study|1|||
38006146|NCT00110396|69690003|FG000|Overall Study|Pregnancy|1|||
38006147|NCT00110396|69690003|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
38006148|NCT00110396|69690003|FG000|Overall Study|Protocol Violation|2|||
38006149|NCT00110396|69690003|FG000|Overall Study|Patient refused to come back|1|||
38006150|NCT00110396|69690003|FG000|Overall Study|The patient has refused|2|||
38006151|NCT00110396|69690003|FG000|Overall Study|The patient has refused to visit site|1|||
38006152|NCT00110396|69690003|FG000|Overall Study|Patient is to be administered copaxone|1|||
38006153|NCT03819218|69690007|FG000|Overall Study|Protocol Violation|1|||
38006154|NCT00093470|69690013|FG000|Overall Study|Disease progression|39|||
38006155|NCT00093470|69690014|FG001|Overall Study|Disease progression|0|||
38006156|NCT00093470|69690013|FG000|Overall Study|Adverse Event|15|||
38006157|NCT00093470|69690014|FG001|Overall Study|Adverse Event|0|||
38006158|NCT00093470|69690013|FG000|Overall Study|Death|2|||
38006159|NCT00093470|69690014|FG001|Overall Study|Death|0|||
38006160|NCT00093470|69690013|FG000|Overall Study|Withdrawal by Subject|8|||
38006161|NCT00093470|69690014|FG001|Overall Study|Withdrawal by Subject|0|||
38006162|NCT00093470|69690013|FG000|Overall Study|Alternative therapy|2|||
38006163|NCT00093470|69690014|FG001|Overall Study|Alternative therapy|0|||
38006164|NCT00093470|69690013|FG000|Overall Study|Other complicating disease|3|||
38006165|NCT00093470|69690014|FG001|Overall Study|Other complicating disease|0|||
37697628|NCT02436239|69174228|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
37697629|NCT02436239|69174229|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
37697630|NCT02436239|69174230|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
37697631|NCT02436239|69174231|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
37697632|NCT02436239|69174228|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
37697633|NCT02436239|69174229|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
37697634|NCT02436239|69174230|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
37697635|NCT02436239|69174231|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
37697636|NCT02436239|69174228|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
37697637|NCT02436239|69174229|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
37697638|NCT02436239|69174230|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
37697639|NCT02436239|69174231|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
37697640|NCT02436239|69174228|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
37697641|NCT02436239|69174229|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
37697642|NCT02436239|69174230|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
37697643|NCT02436239|69174231|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
37697644|NCT02436239|69174228|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
37697645|NCT02436239|69174229|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
37697646|NCT02436239|69174230|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
37697647|NCT02436239|69174231|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
37697648|NCT02436239|69174228|FG000|Open-Lable Treatment Period|Other Reason|1|||
37697649|NCT02436239|69174229|FG001|Open-Lable Treatment Period|Other Reason|1|||
37697650|NCT02436239|69174230|FG002|Open-Lable Treatment Period|Other Reason|0|||
37697651|NCT02436239|69174231|FG003|Open-Lable Treatment Period|Other Reason|0|||
37697652|NCT02436239|69174228|FG000|Down-Taper Period|Withdrawal by Subject|4|||
37697653|NCT02436239|69174229|FG001|Down-Taper Period|Withdrawal by Subject|4|||
37697654|NCT02436239|69174230|FG002|Down-Taper Period|Withdrawal by Subject|1|||
37697655|NCT02436239|69174231|FG003|Down-Taper Period|Withdrawal by Subject|2|||
37697656|NCT02026011|69174243|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
37697657|NCT02026011|69174244|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
37697658|NCT02026011|69174243|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
37697659|NCT02026011|69174244|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
37697660|NCT02026011|69174243|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
37697661|NCT02026011|69174244|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
37697662|NCT02026011|69174243|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
37697663|NCT02026011|69174244|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
37697664|NCT02436005|69174253|FG000|Second Intervention|Adverse Event|0|||
37697665|NCT02436005|69174254|FG001|Second Intervention|Adverse Event|1|||
37697666|NCT02456909|69174262|FG000|Overall Study|Did not receive allocated intervention|24|||
37697667|NCT02456909|69174263|FG001|Overall Study|Did not receive allocated intervention|26|||
37697668|NCT02456909|69174262|FG000|Overall Study|Did not complete the primary outcome|0|||
37697669|NCT02456909|69174263|FG001|Overall Study|Did not complete the primary outcome|1|||
37697670|NCT02025621|69174271|FG000|Overall Study|Withdrawal by Subject|1|||
37697671|NCT02025621|69174272|FG001|Overall Study|Withdrawal by Subject|0|||
37697672|NCT02025621|69174271|FG000|Overall Study|Death|0|||
37907550|NCT00956813|69593203|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
37907551|NCT00956813|69593202|FG000|Flaxseed and Placebo|Ineligible|3|||
38006166|NCT00093470|69690013|FG000|Overall Study|Physician Decision|2|||
38006167|NCT00093470|69690014|FG001|Overall Study|Physician Decision|0|||
38006168|NCT00093470|69690013|FG000|Overall Study|Never started treatment|1|||
38006169|NCT00093470|69690014|FG001|Overall Study|Never started treatment|0|||
38006170|NCT00093470|69690013|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
38006171|NCT00093470|69690014|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
38006172|NCT00407537|69690022|FG000|Overall Study|Death|5|||
38006173|NCT00407537|69690023|FG001|Overall Study|Death|2|||
38006174|NCT00407537|69690022|FG000|Overall Study|Adverse Event|36|||
38006175|NCT00407537|69690023|FG001|Overall Study|Adverse Event|0|||
38006176|NCT00407537|69690022|FG000|Overall Study|Lost to Follow-up|12|||
37697673|NCT02025621|69174272|FG001|Overall Study|Death|1|||
37697674|NCT02025621|69174271|FG000|Overall Study|No longer eligible|10|||
37697675|NCT02025621|69174272|FG001|Overall Study|No longer eligible|15|||
37907552|NCT00956813|69593203|FG001|Flaxseed and Placebo|Ineligible|1|||
37907553|NCT00955955|69593213|FG000|Overall Study|Lost to Follow-up|2|||
38006177|NCT00407537|69690023|FG001|Overall Study|Lost to Follow-up|19|||
38006178|NCT00407537|69690022|FG000|Overall Study|Other|6|||
38006179|NCT00407537|69690023|FG001|Overall Study|Other|7|||
37907554|NCT00955955|69593214|FG001|Overall Study|Lost to Follow-up|0|||
37907555|NCT00955955|69593215|FG002|Overall Study|Lost to Follow-up|0|||
37907556|NCT00955721|69593231|FG000|Overall Study|Physician Decision|1|||
37907557|NCT00955721|69593232|FG001|Overall Study|Physician Decision|0|||
38006180|NCT00407537|69690022|FG000|Overall Study|Withdrawal by Subject|34|||
38006181|NCT00407537|69690023|FG001|Overall Study|Withdrawal by Subject|16|||
38006182|NCT00094458|69690032|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
38006183|NCT00094458|69690033|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
38006184|NCT00094458|69690034|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
37907558|NCT00955721|69593231|FG000|Overall Study|Death|1|||
37907559|NCT00955721|69593232|FG001|Overall Study|Death|0|||
37907560|NCT00955721|69593231|FG000|Overall Study|Withdrawal by Subject|1|||
38006185|NCT00094458|69690035|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
38006186|NCT00094458|69690036|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
38006187|NCT00094458|69690037|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
38006188|NCT00094458|69690032|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
38006189|NCT00094458|69690033|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
38006190|NCT00094458|69690034|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
38006191|NCT00094458|69690035|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
38006192|NCT00094458|69690036|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
38006193|NCT00094458|69690037|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
38006194|NCT00094458|69690032|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
38006195|NCT00094458|69690033|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
38006196|NCT00094458|69690034|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
38006197|NCT00094458|69690035|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
38006198|NCT00094458|69690036|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
38006199|NCT00094458|69690037|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
38006200|NCT00094458|69690032|FG000|Main Study: Through Week 30|Adverse Event|38|||
38006201|NCT00094458|69690033|FG001|Main Study: Through Week 30|Adverse Event|20|||
38006202|NCT00094458|69690034|FG002|Main Study: Through Week 30|Adverse Event|28|||
38006203|NCT00094458|69690035|FG003|Main Study: Through Week 30|Adverse Event|0|||
38006204|NCT00094458|69690036|FG004|Main Study: Through Week 30|Adverse Event|0|||
38006205|NCT00094458|69690037|FG005|Main Study: Through Week 30|Adverse Event|0|||
38006206|NCT00094458|69690032|FG000|Main Study: Through Week 30|Death|1|||
38006207|NCT00094458|69690033|FG001|Main Study: Through Week 30|Death|0|||
38006208|NCT00094458|69690034|FG002|Main Study: Through Week 30|Death|0|||
38006209|NCT00094458|69690035|FG003|Main Study: Through Week 30|Death|0|||
38006210|NCT00094458|69690036|FG004|Main Study: Through Week 30|Death|0|||
38006211|NCT00094458|69690037|FG005|Main Study: Through Week 30|Death|0|||
38006212|NCT00094458|69690032|FG000|Main Study: Through Week 30|Other|19|||
38006213|NCT00094458|69690033|FG001|Main Study: Through Week 30|Other|16|||
38006214|NCT00094458|69690034|FG002|Main Study: Through Week 30|Other|9|||
38006215|NCT00094458|69690035|FG003|Main Study: Through Week 30|Other|0|||
38006216|NCT00094458|69690036|FG004|Main Study: Through Week 30|Other|0|||
38006217|NCT00094458|69690037|FG005|Main Study: Through Week 30|Other|0|||
37907561|NCT00955721|69593232|FG001|Overall Study|Withdrawal by Subject|0|||
37907562|NCT00573469|69593242|FG000|Overall Study|Adverse Event|1|||
37907563|NCT00573469|69593243|FG001|Overall Study|Adverse Event|1|||
37907564|NCT00573469|69593244|FG002|Overall Study|Adverse Event|1|||
37697676|NCT02025621|69174271|FG000|Overall Study|Surgery initiated before infusion|3|||
37697677|NCT02025621|69174272|FG001|Overall Study|Surgery initiated before infusion|3|||
37907565|NCT00573469|69593242|FG000|Overall Study|Withdrawal by Subject|0|||
37907566|NCT00573469|69593243|FG001|Overall Study|Withdrawal by Subject|2|||
37907567|NCT00573469|69593244|FG002|Overall Study|Withdrawal by Subject|0|||
37907568|NCT00573469|69593242|FG000|Overall Study|Other|5|||
37907569|NCT00573469|69593243|FG001|Overall Study|Other|1|||
37907570|NCT00573469|69593244|FG002|Overall Study|Other|3|||
37907571|NCT00812565|69593260|FG000|Overall Study|Did Not Receive Study Medication|1|||
38006218|NCT00094458|69690032|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
38006219|NCT00094458|69690033|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
38006220|NCT00094458|69690034|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
38006221|NCT00094458|69690035|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
38006222|NCT00094458|69690036|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
38006223|NCT00094458|69690037|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
37907572|NCT00812565|69593261|FG001|Overall Study|Did Not Receive Study Medication|1|||
38006224|NCT00094458|69690032|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
38006225|NCT00094458|69690033|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
38006226|NCT00094458|69690034|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
38006227|NCT00094458|69690035|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
38006228|NCT00094458|69690036|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
38006229|NCT00094458|69690037|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
38006230|NCT00094458|69690032|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
38006231|NCT00094458|69690033|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
38006232|NCT00094458|69690034|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
38006233|NCT00094458|69690035|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
38006234|NCT00094458|69690036|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
38006235|NCT00094458|69690037|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
38006236|NCT00094458|69690032|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
38006237|NCT00094458|69690033|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
38006238|NCT00094458|69690034|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
38006239|NCT00094458|69690035|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
38006240|NCT00094458|69690036|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
38006241|NCT00094458|69690037|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
38006242|NCT00094458|69690032|FG000|OLE: Open-Label Extension|Adverse Event|0|||
38006243|NCT00094458|69690033|FG001|OLE: Open-Label Extension|Adverse Event|0|||
38006244|NCT00094458|69690034|FG002|OLE: Open-Label Extension|Adverse Event|0|||
38006245|NCT00094458|69690035|FG003|OLE: Open-Label Extension|Adverse Event|0|||
38006246|NCT00094458|69690036|FG004|OLE: Open-Label Extension|Adverse Event|3|||
38006247|NCT00094458|69690037|FG005|OLE: Open-Label Extension|Adverse Event|4|||
38006248|NCT00094458|69690032|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
38006249|NCT00094458|69690033|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
38006250|NCT00094458|69690034|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
38006251|NCT00094458|69690035|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
38006252|NCT00094458|69690036|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
38006253|NCT00094458|69690037|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
38006254|NCT00094458|69690032|FG000|OLE: Open-Label Extension|Patient decision|0|||
38006255|NCT00094458|69690033|FG001|OLE: Open-Label Extension|Patient decision|0|||
38006256|NCT00094458|69690034|FG002|OLE: Open-Label Extension|Patient decision|0|||
38006257|NCT00094458|69690035|FG003|OLE: Open-Label Extension|Patient decision|0|||
38006258|NCT00094458|69690036|FG004|OLE: Open-Label Extension|Patient decision|1|||
38006259|NCT00094458|69690037|FG005|OLE: Open-Label Extension|Patient decision|0|||
38006260|NCT00406367|69690053|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
38006261|NCT00406367|69690054|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
38006262|NCT00406367|69690053|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
38006263|NCT00406367|69690054|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
38006264|NCT00406367|69690053|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
38006265|NCT00406367|69690054|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
38006266|NCT00406367|69690053|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
38006267|NCT00406367|69690054|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
38006268|NCT00406367|69690053|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
38006269|NCT00406367|69690054|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
38006270|NCT00406367|69690053|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
38006271|NCT00406367|69690054|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
38006272|NCT00406367|69690053|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
38006273|NCT00406367|69690054|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
38006274|NCT00406367|69690053|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
38006275|NCT00406367|69690054|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
38006276|NCT00406367|69690053|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
38006277|NCT00406367|69690054|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
38006278|NCT00406367|69690053|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
38006279|NCT00406367|69690054|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
38006280|NCT00406367|69690053|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
38006281|NCT00406367|69690054|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
38006282|NCT00406367|69690053|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
38006283|NCT00406367|69690054|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
38006284|NCT00394589|69690063|FG000|Overall Study|Adverse Event|2|||
38006285|NCT00394589|69690064|FG001|Overall Study|Adverse Event|1|||
38006286|NCT00394589|69690065|FG002|Overall Study|Adverse Event|2|||
38006287|NCT00394589|69690063|FG000|Overall Study|Lack of Efficacy|2|||
38006288|NCT00394589|69690064|FG001|Overall Study|Lack of Efficacy|2|||
38006289|NCT00394589|69690065|FG002|Overall Study|Lack of Efficacy|3|||
38006290|NCT00394589|69690063|FG000|Overall Study|Protocol Violation|4|||
38006291|NCT00394589|69690064|FG001|Overall Study|Protocol Violation|0|||
38006292|NCT00394589|69690065|FG002|Overall Study|Protocol Violation|2|||
38006293|NCT00068406|69690073|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
38006294|NCT00068406|69690073|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
38006295|NCT00403559|69690079|FG000|Overall Study|Adverse Event|0|||
38006296|NCT00403559|69690080|FG001|Overall Study|Adverse Event|1|||
38006297|NCT00403559|69690079|FG000|Overall Study|Lost to Follow-up|3|||
38006298|NCT00403559|69690080|FG001|Overall Study|Lost to Follow-up|3|||
38006299|NCT00403559|69690079|FG000|Overall Study|Withdrawal by Subject|1|||
38006300|NCT00403559|69690080|FG001|Overall Study|Withdrawal by Subject|0|||
38006301|NCT00403481|69690088|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
38006302|NCT00403481|69690088|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
38006303|NCT00403481|69690088|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
38006304|NCT00403481|69690088|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
38006305|NCT00403481|69690088|FG000|Olm 40 mg|Adverse Event|2|||
38006306|NCT00403481|69690088|FG000|Olm 40 mg|Protocol Violation|1|||
38006307|NCT00403481|69690088|FG000|Olm 40 mg|Withdrawal by Subject|1|||
38006308|NCT00403481|69690088|FG000|Olm 40 mg|Other|1|||
38006309|NCT00403481|69690088|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
38006310|NCT00403481|69690088|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
38006311|NCT00403481|69690088|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
38006312|NCT00403481|69690088|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
38006313|NCT00403481|69690088|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
38006314|NCT00403481|69690088|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
38006315|NCT00402779|69690097|FG000|Overall Study|Screen Failure|77|||
38006316|NCT00402779|69690098|FG001|Overall Study|Screen Failure|76|||
38006317|NCT00394433|69690104|FG000|Overall Study|Adverse Event|2|||
38006318|NCT00394433|69690104|FG000|Overall Study|Alternative Therapy|1|||
38006319|NCT00092534|69690110|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
38006320|NCT00092534|69690111|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
38006321|NCT00092534|69690112|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
38006322|NCT00092534|69690113|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
38006323|NCT00092534|69690114|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
38006324|NCT00092534|69690110|FG000|Base Study Vaccination Period|Adverse Event|3|||
38006325|NCT00092534|69690111|FG001|Base Study Vaccination Period|Adverse Event|1|||
38006326|NCT00092534|69690112|FG002|Base Study Vaccination Period|Adverse Event|0|||
38006327|NCT00092534|69690113|FG003|Base Study Vaccination Period|Adverse Event|0|||
38006328|NCT00092534|69690114|FG004|Base Study Vaccination Period|Adverse Event|0|||
38006329|NCT00092534|69690110|FG000|Base Study Vaccination Period|Death|5|||
38006330|NCT00092534|69690111|FG001|Base Study Vaccination Period|Death|4|||
38006331|NCT00092534|69690112|FG002|Base Study Vaccination Period|Death|0|||
38006332|NCT00092534|69690113|FG003|Base Study Vaccination Period|Death|0|||
38006333|NCT00092534|69690114|FG004|Base Study Vaccination Period|Death|0|||
38006334|NCT00092534|69690110|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
37907573|NCT00812565|69593262|FG002|Overall Study|Did Not Receive Study Medication|0|||
37907574|NCT00812565|69593263|FG003|Overall Study|Did Not Receive Study Medication|0|||
37907575|NCT00812565|69593264|FG004|Overall Study|Did Not Receive Study Medication|0|||
37907576|NCT00812565|69593265|FG005|Overall Study|Did Not Receive Study Medication|0|||
37907577|NCT00812565|69593266|FG006|Overall Study|Did Not Receive Study Medication|0|||
37907578|NCT00812565|69593267|FG007|Overall Study|Did Not Receive Study Medication|0|||
37907579|NCT00812565|69593260|FG000|Overall Study|Adverse Event|0|||
37907580|NCT00812565|69593261|FG001|Overall Study|Adverse Event|0|||
37907581|NCT00812565|69593262|FG002|Overall Study|Adverse Event|0|||
37907582|NCT00812565|69593263|FG003|Overall Study|Adverse Event|2|||
37907583|NCT00812565|69593264|FG004|Overall Study|Adverse Event|0|||
37907584|NCT00812565|69593265|FG005|Overall Study|Adverse Event|0|||
37907585|NCT00812565|69593266|FG006|Overall Study|Adverse Event|0|||
37907586|NCT00812565|69593267|FG007|Overall Study|Adverse Event|1|||
37907587|NCT00812565|69593260|FG000|Overall Study|Did Not Come to Study Visit|1|||
37907588|NCT00812565|69593261|FG001|Overall Study|Did Not Come to Study Visit|0|||
37907589|NCT00812565|69593262|FG002|Overall Study|Did Not Come to Study Visit|0|||
37907590|NCT00812565|69593263|FG003|Overall Study|Did Not Come to Study Visit|0|||
37907591|NCT00812565|69593264|FG004|Overall Study|Did Not Come to Study Visit|0|||
37907592|NCT00812565|69593265|FG005|Overall Study|Did Not Come to Study Visit|0|||
37907593|NCT00812565|69593266|FG006|Overall Study|Did Not Come to Study Visit|0|||
37907594|NCT00812565|69593267|FG007|Overall Study|Did Not Come to Study Visit|0|||
38006335|NCT00092534|69690111|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
38006336|NCT00092534|69690112|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
37907595|NCT00812565|69593260|FG000|Overall Study|Withdrawal of Consent|1|||
37907596|NCT00812565|69593261|FG001|Overall Study|Withdrawal of Consent|0|||
38006337|NCT00092534|69690113|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
37697678|NCT02020941|69174278|FG000|Overall Study|Adverse Event|1|||
37697679|NCT02020941|69174278|FG000|Overall Study|Physician Decision|2|||
38006338|NCT00092534|69690114|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
38006339|NCT00092534|69690110|FG000|Base Study Vaccination Period|Physician Decision|1|||
38006340|NCT00092534|69690111|FG001|Base Study Vaccination Period|Physician Decision|0|||
38006341|NCT00092534|69690112|FG002|Base Study Vaccination Period|Physician Decision|0|||
38006342|NCT00092534|69690113|FG003|Base Study Vaccination Period|Physician Decision|0|||
38006343|NCT00092534|69690114|FG004|Base Study Vaccination Period|Physician Decision|0|||
38006344|NCT00092534|69690110|FG000|Base Study Vaccination Period|Pregnancy|9|||
38006345|NCT00092534|69690111|FG001|Base Study Vaccination Period|Pregnancy|7|||
38006346|NCT00092534|69690112|FG002|Base Study Vaccination Period|Pregnancy|0|||
38006347|NCT00092534|69690113|FG003|Base Study Vaccination Period|Pregnancy|0|||
38006348|NCT00092534|69690114|FG004|Base Study Vaccination Period|Pregnancy|0|||
38006349|NCT00092534|69690110|FG000|Base Study Vaccination Period|Protocol Violation|2|||
38006350|NCT00092534|69690111|FG001|Base Study Vaccination Period|Protocol Violation|1|||
38006351|NCT00092534|69690112|FG002|Base Study Vaccination Period|Protocol Violation|0|||
38006352|NCT00092534|69690113|FG003|Base Study Vaccination Period|Protocol Violation|0|||
38006353|NCT00092534|69690114|FG004|Base Study Vaccination Period|Protocol Violation|0|||
38006354|NCT00092534|69690110|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
38006355|NCT00092534|69690111|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
38006356|NCT00092534|69690112|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
38006357|NCT00092534|69690113|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
38006358|NCT00092534|69690114|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
38006359|NCT00092534|69690110|FG000|Base Study Vaccination Period|Moved|14|||
38006360|NCT00092534|69690111|FG001|Base Study Vaccination Period|Moved|12|||
38006361|NCT00092534|69690112|FG002|Base Study Vaccination Period|Moved|0|||
38006362|NCT00092534|69690113|FG003|Base Study Vaccination Period|Moved|0|||
38006363|NCT00092534|69690114|FG004|Base Study Vaccination Period|Moved|0|||
38006364|NCT00092534|69690110|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
38006365|NCT00092534|69690111|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
38006366|NCT00092534|69690112|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
38006367|NCT00092534|69690113|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
38006368|NCT00092534|69690114|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
38006369|NCT00092534|69690110|FG000|Base Study Vaccination Period|Travel|1|||
38006370|NCT00092534|69690111|FG001|Base Study Vaccination Period|Travel|0|||
38006371|NCT00092534|69690112|FG002|Base Study Vaccination Period|Travel|0|||
38006372|NCT00092534|69690113|FG003|Base Study Vaccination Period|Travel|0|||
37907597|NCT00812565|69593262|FG002|Overall Study|Withdrawal of Consent|0|||
37907598|NCT00812565|69593263|FG003|Overall Study|Withdrawal of Consent|0|||
37907599|NCT00812565|69593264|FG004|Overall Study|Withdrawal of Consent|1|||
37907600|NCT00812565|69593265|FG005|Overall Study|Withdrawal of Consent|0|||
38006373|NCT00092534|69690114|FG004|Base Study Vaccination Period|Travel|0|||
38006374|NCT00092534|69690110|FG000|Base Study Vaccination Period|Site Closed|0|||
38006375|NCT00092534|69690111|FG001|Base Study Vaccination Period|Site Closed|1|||
38006376|NCT00092534|69690112|FG002|Base Study Vaccination Period|Site Closed|0|||
38006377|NCT00092534|69690113|FG003|Base Study Vaccination Period|Site Closed|0|||
38006378|NCT00092534|69690114|FG004|Base Study Vaccination Period|Site Closed|0|||
38006379|NCT00092534|69690110|FG000|Base Study Follow-Up Period|Adverse Event|2|||
38006380|NCT00092534|69690111|FG001|Base Study Follow-Up Period|Adverse Event|4|||
38006381|NCT00092534|69690112|FG002|Base Study Follow-Up Period|Adverse Event|0|||
38006382|NCT00092534|69690113|FG003|Base Study Follow-Up Period|Adverse Event|0|||
38006383|NCT00092534|69690114|FG004|Base Study Follow-Up Period|Adverse Event|0|||
38006384|NCT00092534|69690110|FG000|Base Study Follow-Up Period|Death|2|||
38006385|NCT00092534|69690111|FG001|Base Study Follow-Up Period|Death|1|||
38006386|NCT00092534|69690112|FG002|Base Study Follow-Up Period|Death|0|||
38006387|NCT00092534|69690113|FG003|Base Study Follow-Up Period|Death|0|||
38006388|NCT00092534|69690114|FG004|Base Study Follow-Up Period|Death|0|||
38006389|NCT00092534|69690110|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
38006390|NCT00092534|69690111|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
38006391|NCT00092534|69690112|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
38006392|NCT00092534|69690113|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
38006393|NCT00092534|69690114|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
37697680|NCT02020941|69174278|FG000|Overall Study|Withdrawal by Subject|1|||
37697681|NCT02020941|69174278|FG000|Overall Study|Disease Progression|4|||
37697682|NCT02024529|69174284|FG000|Overall Study|Withdrawal by Subject|11|||
37907601|NCT00812565|69593266|FG006|Overall Study|Withdrawal of Consent|0|||
38006394|NCT00092534|69690110|FG000|Base Study Follow-Up Period|Pregnancy|6|||
38006395|NCT00092534|69690111|FG001|Base Study Follow-Up Period|Pregnancy|10|||
38006396|NCT00092534|69690112|FG002|Base Study Follow-Up Period|Pregnancy|0|||
38006397|NCT00092534|69690113|FG003|Base Study Follow-Up Period|Pregnancy|0|||
37697683|NCT02024529|69174285|FG001|Overall Study|Withdrawal by Subject|21|||
37907602|NCT00812565|69593267|FG007|Overall Study|Withdrawal of Consent|0|||
38006398|NCT00092534|69690114|FG004|Base Study Follow-Up Period|Pregnancy|0|||
38006399|NCT00092534|69690110|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
38006400|NCT00092534|69690111|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
38006401|NCT00092534|69690112|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
38006402|NCT00092534|69690113|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
38006403|NCT00092534|69690114|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
38043644|NCT02180867|69731810|FG006|Overall Study|Physician Decision|4|||
38006404|NCT00092534|69690110|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
38006405|NCT00092534|69690111|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
38006406|NCT00092534|69690112|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
38006407|NCT00092534|69690113|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
38006408|NCT00092534|69690114|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
38006409|NCT00092534|69690110|FG000|Base Study Follow-Up Period|Moved|62|||
38006410|NCT00092534|69690111|FG001|Base Study Follow-Up Period|Moved|58|||
38006411|NCT00092534|69690112|FG002|Base Study Follow-Up Period|Moved|0|||
38006412|NCT00092534|69690113|FG003|Base Study Follow-Up Period|Moved|0|||
38006413|NCT00092534|69690114|FG004|Base Study Follow-Up Period|Moved|0|||
38006414|NCT00092534|69690110|FG000|Base Study Follow-Up Period|Travel|10|||
38006415|NCT00092534|69690111|FG001|Base Study Follow-Up Period|Travel|7|||
38006416|NCT00092534|69690112|FG002|Base Study Follow-Up Period|Travel|0|||
38006417|NCT00092534|69690113|FG003|Base Study Follow-Up Period|Travel|0|||
38006418|NCT00092534|69690114|FG004|Base Study Follow-Up Period|Travel|0|||
38006419|NCT00092534|69690110|FG000|Base Study Follow-Up Period|Site Closed|0|||
38006420|NCT00092534|69690111|FG001|Base Study Follow-Up Period|Site Closed|2|||
38006421|NCT00092534|69690112|FG002|Base Study Follow-Up Period|Site Closed|0|||
38006422|NCT00092534|69690113|FG003|Base Study Follow-Up Period|Site Closed|0|||
38006423|NCT00092534|69690114|FG004|Base Study Follow-Up Period|Site Closed|0|||
38006424|NCT00092534|69690110|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
38006425|NCT00092534|69690111|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
38006426|NCT00092534|69690112|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
38006427|NCT00092534|69690113|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
38006428|NCT00092534|69690114|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
38006429|NCT00092534|69690110|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
38006430|NCT00092534|69690111|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
38006431|NCT00092534|69690112|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
38006432|NCT00092534|69690113|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
38006433|NCT00092534|69690114|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
38006434|NCT00092534|69690110|FG000|Base Study EXT|Lost to Follow-up|0|||
38006435|NCT00092534|69690111|FG001|Base Study EXT|Lost to Follow-up|0|||
38006436|NCT00092534|69690112|FG002|Base Study EXT|Lost to Follow-up|41|||
38006437|NCT00092534|69690113|FG003|Base Study EXT|Lost to Follow-up|0|||
38006438|NCT00092534|69690114|FG004|Base Study EXT|Lost to Follow-up|0|||
38006439|NCT00092534|69690110|FG000|Base Study EXT|Physician Decision|0|||
38006440|NCT00092534|69690111|FG001|Base Study EXT|Physician Decision|0|||
38006441|NCT00092534|69690112|FG002|Base Study EXT|Physician Decision|1|||
38006442|NCT00092534|69690113|FG003|Base Study EXT|Physician Decision|0|||
38006443|NCT00092534|69690114|FG004|Base Study EXT|Physician Decision|0|||
38006444|NCT00092534|69690110|FG000|Base Study EXT|Pregnancy|0|||
38006445|NCT00092534|69690111|FG001|Base Study EXT|Pregnancy|0|||
38006446|NCT00092534|69690112|FG002|Base Study EXT|Pregnancy|12|||
38006447|NCT00092534|69690113|FG003|Base Study EXT|Pregnancy|0|||
38006448|NCT00092534|69690114|FG004|Base Study EXT|Pregnancy|0|||
38006449|NCT00092534|69690110|FG000|Base Study EXT|Withdrawal by Subject|0|||
37907603|NCT00812565|69593260|FG000|Overall Study|Reason Not Specified|0|||
37907604|NCT00812565|69593261|FG001|Overall Study|Reason Not Specified|0|||
38006450|NCT00092534|69690111|FG001|Base Study EXT|Withdrawal by Subject|0|||
38006451|NCT00092534|69690112|FG002|Base Study EXT|Withdrawal by Subject|18|||
37907605|NCT00812565|69593262|FG002|Overall Study|Reason Not Specified|0|||
37907606|NCT00812565|69593263|FG003|Overall Study|Reason Not Specified|0|||
37907607|NCT00812565|69593264|FG004|Overall Study|Reason Not Specified|0|||
37907608|NCT00812565|69593265|FG005|Overall Study|Reason Not Specified|1|||
37907609|NCT00812565|69593266|FG006|Overall Study|Reason Not Specified|0|||
37907610|NCT00812565|69593267|FG007|Overall Study|Reason Not Specified|0|||
37907611|NCT00812487|69593287|FG000|Overall Study|Lost to Follow-up|2|||
37907612|NCT00812487|69593288|FG001|Overall Study|Lost to Follow-up|0|||
37907613|NCT00812487|69593287|FG000|Overall Study|Withdrawal by Subject|3|||
37907614|NCT00812487|69593288|FG001|Overall Study|Withdrawal by Subject|2|||
37907615|NCT00812487|69593287|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
37907616|NCT00812487|69593288|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
37907617|NCT00812487|69593287|FG000|Overall Study|Protocol Violation|0|||
37907618|NCT00812487|69593288|FG001|Overall Study|Protocol Violation|1|||
37907619|NCT00617461|69593298|FG000|First Treatment Intervention Period|Adverse Event|2|||
38006452|NCT00092534|69690113|FG003|Base Study EXT|Withdrawal by Subject|0|||
37697684|NCT02024529|69174284|FG000|Overall Study|Lost to Follow-up|2|||
37907620|NCT00617461|69593299|FG001|First Treatment Intervention Period|Adverse Event|0|||
37907621|NCT00617461|69593298|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
37907622|NCT00617461|69593299|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
38006453|NCT00092534|69690114|FG004|Base Study EXT|Withdrawal by Subject|0|||
38006454|NCT00092534|69690110|FG000|Base Study EXT|Participant moved|0|||
38006455|NCT00092534|69690111|FG001|Base Study EXT|Participant moved|0|||
38006456|NCT00092534|69690112|FG002|Base Study EXT|Participant moved|6|||
38006457|NCT00092534|69690113|FG003|Base Study EXT|Participant moved|0|||
38006458|NCT00092534|69690114|FG004|Base Study EXT|Participant moved|0|||
38006459|NCT00092534|69690110|FG000|Base Study EXT|Travel|0|||
38006460|NCT00092534|69690111|FG001|Base Study EXT|Travel|0|||
38006461|NCT00092534|69690112|FG002|Base Study EXT|Travel|2|||
38006462|NCT00092534|69690113|FG003|Base Study EXT|Travel|0|||
38006463|NCT00092534|69690114|FG004|Base Study EXT|Travel|0|||
38006464|NCT00092534|69690110|FG000|Base Study EXT|Site closed|0|||
38006465|NCT00092534|69690111|FG001|Base Study EXT|Site closed|0|||
38006466|NCT00092534|69690112|FG002|Base Study EXT|Site closed|21|||
38006467|NCT00092534|69690113|FG003|Base Study EXT|Site closed|0|||
38006468|NCT00092534|69690114|FG004|Base Study EXT|Site closed|0|||
38006469|NCT00092534|69690110|FG000|Base Study EXT|Study ended|0|||
38006470|NCT00092534|69690111|FG001|Base Study EXT|Study ended|0|||
38006471|NCT00092534|69690112|FG002|Base Study EXT|Study ended|29|||
38006472|NCT00092534|69690113|FG003|Base Study EXT|Study ended|0|||
38006473|NCT00092534|69690114|FG004|Base Study EXT|Study ended|0|||
38006474|NCT00092534|69690110|FG000|Base Study EXT|Protocol Violation|0|||
38006475|NCT00092534|69690111|FG001|Base Study EXT|Protocol Violation|0|||
38006476|NCT00092534|69690112|FG002|Base Study EXT|Protocol Violation|15|||
37830895|NCT01299376|69514230|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
37830896|NCT01299376|69514229|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
38006477|NCT00092534|69690113|FG003|Base Study EXT|Protocol Violation|0|||
38006478|NCT00092534|69690114|FG004|Base Study EXT|Protocol Violation|0|||
38006479|NCT00092534|69690110|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
38006480|NCT00092534|69690111|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
38006481|NCT00092534|69690112|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
38006482|NCT00092534|69690113|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
38006483|NCT00092534|69690114|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
38006484|NCT00068250|69690127|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
38006485|NCT00068250|69690128|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
38006486|NCT00068250|69690129|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
38006487|NCT00068250|69690130|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
38006488|NCT00393887|69690140|FG000|Overall Study|Physician Decision|5|||
38006489|NCT00393887|69690141|FG001|Overall Study|Physician Decision|0|||
38006490|NCT00393887|69690140|FG000|Overall Study|Lost to Follow-up|11|||
38006491|NCT00393887|69690141|FG001|Overall Study|Lost to Follow-up|9|||
38006492|NCT00393029|69690149|FG000|Overall Study|Not treated|0|||
38006493|NCT00393029|69690150|FG001|Overall Study|Not treated|1|||
38006494|NCT00402233|69690161|FG000|Overall Study|Adverse Event|1|||
38006495|NCT00402233|69690162|FG001|Overall Study|Adverse Event|7|||
38006496|NCT00402233|69690163|FG002|Overall Study|Adverse Event|9|||
38006497|NCT00402233|69690164|FG003|Overall Study|Adverse Event|9|||
38006498|NCT00402233|69690161|FG000|Overall Study|Protocol Violation|0|||
38006499|NCT00402233|69690162|FG001|Overall Study|Protocol Violation|1|||
38006500|NCT00402233|69690163|FG002|Overall Study|Protocol Violation|0|||
38006501|NCT00402233|69690164|FG003|Overall Study|Protocol Violation|0|||
38006502|NCT00402233|69690161|FG000|Overall Study|Withdrawal by Subject|2|||
38006503|NCT00402233|69690162|FG001|Overall Study|Withdrawal by Subject|1|||
38006504|NCT00402233|69690163|FG002|Overall Study|Withdrawal by Subject|2|||
38006505|NCT00402233|69690164|FG003|Overall Study|Withdrawal by Subject|2|||
38006506|NCT00402233|69690161|FG000|Overall Study|Worsening of disease under study|2|||
38006507|NCT00402233|69690162|FG001|Overall Study|Worsening of disease under study|0|||
38006508|NCT00402233|69690163|FG002|Overall Study|Worsening of disease under study|0|||
38006509|NCT00402233|69690164|FG003|Overall Study|Worsening of disease under study|0|||
38006510|NCT00402233|69690161|FG000|Overall Study|Worsening of other pre-existing disease|0|||
38006511|NCT00402233|69690162|FG001|Overall Study|Worsening of other pre-existing disease|1|||
38006512|NCT00402233|69690163|FG002|Overall Study|Worsening of other pre-existing disease|0|||
38006513|NCT00402233|69690164|FG003|Overall Study|Worsening of other pre-existing disease|0|||
37830897|NCT01299376|69514230|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
37830898|NCT01299025|69514242|FG000|Overall Study|Withdrawal by Subject|2|||
37830899|NCT01299025|69514243|FG001|Overall Study|Withdrawal by Subject|1|||
37830900|NCT01299025|69514242|FG000|Overall Study|Lost to Follow-up|1|||
38006514|NCT00092456|69690178|FG000|Overall Study|Adverse Event|0|||
38006515|NCT00092456|69690179|FG001|Overall Study|Adverse Event|0|||
38006516|NCT00092456|69690180|FG002|Overall Study|Adverse Event|1|||
38006517|NCT00092456|69690181|FG003|Overall Study|Adverse Event|1|||
38006518|NCT00092456|69690178|FG000|Overall Study|Lost to Follow-up|2|||
38006519|NCT00092456|69690179|FG001|Overall Study|Lost to Follow-up|2|||
38006520|NCT00092456|69690180|FG002|Overall Study|Lost to Follow-up|1|||
38006521|NCT00092456|69690181|FG003|Overall Study|Lost to Follow-up|2|||
38006522|NCT00092456|69690178|FG000|Overall Study|Protocol Violation|5|||
38006523|NCT00092456|69690179|FG001|Overall Study|Protocol Violation|7|||
38006524|NCT00092456|69690180|FG002|Overall Study|Protocol Violation|8|||
38006525|NCT00092456|69690181|FG003|Overall Study|Protocol Violation|6|||
38006526|NCT00092456|69690178|FG000|Overall Study|Withdrawal by Subject|13|||
38006527|NCT00092456|69690179|FG001|Overall Study|Withdrawal by Subject|5|||
38006528|NCT00092456|69690180|FG002|Overall Study|Withdrawal by Subject|16|||
37830901|NCT01299025|69514243|FG001|Overall Study|Lost to Follow-up|0|||
38006529|NCT00092456|69690181|FG003|Overall Study|Withdrawal by Subject|6|||
38006530|NCT00092456|69690178|FG000|Overall Study|Moved|1|||
38006531|NCT00092456|69690179|FG001|Overall Study|Moved|1|||
38006532|NCT00092456|69690180|FG002|Overall Study|Moved|0|||
38006533|NCT00092456|69690181|FG003|Overall Study|Moved|1|||
38006534|NCT00092456|69690178|FG000|Overall Study|Other|4|||
38006535|NCT00092456|69690179|FG001|Overall Study|Other|2|||
38006536|NCT00092456|69690180|FG002|Overall Study|Other|3|||
38006537|NCT00092456|69690181|FG003|Overall Study|Other|0|||
38006538|NCT00067470|69690193|FG000|Overall Study|Withdrawal by Subject|0|||
38006539|NCT00067470|69690194|FG001|Overall Study|Withdrawal by Subject|1|||
38006540|NCT00401843|69690203|FG000|Overall Study|Achieved Complete Response|1|||
38006541|NCT00401843|69690204|FG001|Overall Study|Achieved Complete Response|5|||
38006542|NCT00401843|69690205|FG002|Overall Study|Achieved Complete Response|11|||
38006543|NCT00401843|69690203|FG000|Overall Study|Adverse Event|7|||
38006544|NCT00401843|69690204|FG001|Overall Study|Adverse Event|26|||
38006545|NCT00401843|69690205|FG002|Overall Study|Adverse Event|27|||
38006546|NCT00401843|69690203|FG000|Overall Study|Death|0|||
38006547|NCT00401843|69690204|FG001|Overall Study|Death|8|||
38006548|NCT00401843|69690205|FG002|Overall Study|Death|10|||
38006549|NCT00401843|69690203|FG000|Overall Study|Disease progression|10|||
38006550|NCT00401843|69690204|FG001|Overall Study|Disease progression|60|||
37830902|NCT01298596|69514251|FG000|Overall Study|Withdrawal by Subject|1|||
37830903|NCT01298596|69514252|FG001|Overall Study|Withdrawal by Subject|1|||
37830904|NCT01298596|69514251|FG000|Overall Study|Death|5|||
37697685|NCT02024529|69174285|FG001|Overall Study|Lost to Follow-up|4|||
37697686|NCT02020863|69174293|FG000|Overall Study|Discovery of Metastatic disease|4|||
38006551|NCT00401843|69690205|FG002|Overall Study|Disease progression|49|||
38006552|NCT00401843|69690203|FG000|Overall Study|End of Study|1|||
38006553|NCT00401843|69690204|FG001|Overall Study|End of Study|1|||
38006554|NCT00401843|69690205|FG002|Overall Study|End of Study|2|||
38006555|NCT00401843|69690203|FG000|Overall Study|Lost to Follow-up|0|||
38006556|NCT00401843|69690204|FG001|Overall Study|Lost to Follow-up|0|||
38006557|NCT00401843|69690205|FG002|Overall Study|Lost to Follow-up|2|||
38006558|NCT00401843|69690203|FG000|Overall Study|Other Unspecified|0|||
38006559|NCT00401843|69690204|FG001|Overall Study|Other Unspecified|3|||
38006560|NCT00401843|69690205|FG002|Overall Study|Other Unspecified|5|||
38006561|NCT00401843|69690203|FG000|Overall Study|Physician Decision|0|||
38006562|NCT00401843|69690204|FG001|Overall Study|Physician Decision|16|||
38006563|NCT00401843|69690205|FG002|Overall Study|Physician Decision|10|||
38006564|NCT00401843|69690203|FG000|Overall Study|Protocol Violation|0|||
38006565|NCT00401843|69690204|FG001|Overall Study|Protocol Violation|0|||
38006566|NCT00401843|69690205|FG002|Overall Study|Protocol Violation|1|||
38006567|NCT00401843|69690203|FG000|Overall Study|Withdrawal by Subject|1|||
38006568|NCT00401843|69690204|FG001|Overall Study|Withdrawal by Subject|5|||
38006569|NCT00401843|69690205|FG002|Overall Study|Withdrawal by Subject|5|||
38006570|NCT00401843|69690203|FG000|Overall Study|Withdrawal of consent to study agent|1|||
38006571|NCT00401843|69690204|FG001|Overall Study|Withdrawal of consent to study agent|15|||
38006572|NCT00401843|69690205|FG002|Overall Study|Withdrawal of consent to study agent|17|||
38006573|NCT00401843|69690203|FG000|Overall Study|Randomized but not Treated|0|||
37830905|NCT01298596|69514252|FG001|Overall Study|Death|3|||
37907623|NCT00617461|69593298|FG000|First Treatment Intervention Period|Protocol Violation|2|||
37907624|NCT00617461|69593299|FG001|First Treatment Intervention Period|Protocol Violation|1|||
38006574|NCT00401843|69690204|FG001|Overall Study|Randomized but not Treated|2|||
37830906|NCT01298596|69514251|FG000|Overall Study|Lost to Follow-up|6|||
37830907|NCT01298596|69514252|FG001|Overall Study|Lost to Follow-up|14|||
37830908|NCT01298596|69514251|FG000|Overall Study|Referred for further management|16|||
37830909|NCT01298596|69514252|FG001|Overall Study|Referred for further management|15|||
37830910|NCT01298518|69514261|FG000|Overall Study|Withdrawal by Subject|0|||
37830911|NCT01298518|69514262|FG001|Overall Study|Withdrawal by Subject|0|||
37830912|NCT01298518|69514263|FG002|Overall Study|Withdrawal by Subject|1|||
38006575|NCT00401843|69690205|FG002|Overall Study|Randomized but not Treated|3|||
38006576|NCT00401843|69690203|FG000|Overall Study|Received incorrect treatment|0|||
38006577|NCT00401843|69690204|FG001|Overall Study|Received incorrect treatment|3|||
38006578|NCT00401843|69690205|FG002|Overall Study|Received incorrect treatment|0|||
37830913|NCT01298362|69514273|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
37830914|NCT01298362|69514274|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
37830915|NCT01297504|69514282|FG000|Overall Study|Invalid Consent|1|||
38006579|NCT00401531|69690217|FG000|Overall Study|Adverse Event|2|||
38006580|NCT00401531|69690218|FG001|Overall Study|Adverse Event|0|||
38006581|NCT00401531|69690217|FG000|Overall Study|Protocol Violation|3|||
38006582|NCT00401531|69690218|FG001|Overall Study|Protocol Violation|7|||
38006583|NCT00401531|69690217|FG000|Overall Study|Lost to Follow-up|1|||
38006584|NCT00401531|69690218|FG001|Overall Study|Lost to Follow-up|1|||
38006585|NCT00401531|69690217|FG000|Overall Study|Withdrawal by Subject|3|||
38006586|NCT00401531|69690218|FG001|Overall Study|Withdrawal by Subject|2|||
38006587|NCT00401375|69690227|FG000|Overall Study|Protocol Violation|2|||
38006588|NCT00401375|69690228|FG001|Overall Study|Protocol Violation|2|||
38006589|NCT00401375|69690229|FG002|Overall Study|Protocol Violation|1|||
38006590|NCT00401375|69690227|FG000|Overall Study|Adverse Event|6|||
38006591|NCT00401375|69690228|FG001|Overall Study|Adverse Event|11|||
38006592|NCT00401375|69690229|FG002|Overall Study|Adverse Event|10|||
38006593|NCT00401375|69690227|FG000|Overall Study|Withdrawal by Subject|9|||
38006594|NCT00401375|69690228|FG001|Overall Study|Withdrawal by Subject|7|||
38006595|NCT00401375|69690229|FG002|Overall Study|Withdrawal by Subject|7|||
38006596|NCT00401375|69690227|FG000|Overall Study|Lost to Follow-up|0|||
38006597|NCT00401375|69690228|FG001|Overall Study|Lost to Follow-up|1|||
38006598|NCT00401375|69690229|FG002|Overall Study|Lost to Follow-up|1|||
38006599|NCT00401375|69690227|FG000|Overall Study|Other than specified|2|||
38006600|NCT00401375|69690228|FG001|Overall Study|Other than specified|1|||
38006601|NCT00401375|69690229|FG002|Overall Study|Other than specified|3|||
38006602|NCT00401375|69690227|FG000|Overall Study|Randomized but not treated|3|||
38006603|NCT00401375|69690228|FG001|Overall Study|Randomized but not treated|3|||
38006604|NCT00401375|69690229|FG002|Overall Study|Randomized but not treated|3|||
38006605|NCT00400985|69690237|FG000|Overall Study|Withdrawal by Subject|5|||
38006606|NCT00400985|69690237|FG000|Overall Study|system modification|8|||
38006607|NCT00400985|69690237|FG000|Overall Study|Death|30|||
38006608|NCT00400985|69690237|FG000|Overall Study|Lost to Follow-up|9|||
38006609|NCT00400517|69690241|FG000|Overall Study|Withdrawal by Subject|1|||
38006610|NCT00400517|69690241|FG000|Overall Study|Physician Decision|1|||
38006611|NCT00392171|69690245|FG000|Overall Study|Did not meet inclusion criteria|4|||
38006612|NCT00392171|69690245|FG000|Overall Study|Disease progression|101|||
38006613|NCT00391625|69690249|FG000|Month 14|Withdrawal by Subject|1|||
38006614|NCT00391625|69690249|FG000|Month 50|Physician Decision|1|||
37907625|NCT00617461|69593298|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
37907626|NCT00617461|69593299|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
38006615|NCT00091832|69690282|FG000|Overall Study|Physician Decision|1|||
38006616|NCT00091832|69690283|FG001|Overall Study|Physician Decision|0|||
38006617|NCT00091832|69690284|FG002|Overall Study|Physician Decision|0|||
38006618|NCT00091832|69690285|FG003|Overall Study|Physician Decision|0|||
38006619|NCT00091832|69690286|FG004|Overall Study|Physician Decision|0|||
38006620|NCT00091832|69690287|FG005|Overall Study|Physician Decision|0|||
38006621|NCT00091832|69690282|FG000|Overall Study|Adverse Event|0|||
38006622|NCT00091832|69690283|FG001|Overall Study|Adverse Event|0|||
38006623|NCT00091832|69690284|FG002|Overall Study|Adverse Event|0|||
38006624|NCT00091832|69690285|FG003|Overall Study|Adverse Event|1|||
38006625|NCT00091832|69690286|FG004|Overall Study|Adverse Event|3|||
38006626|NCT00091832|69690287|FG005|Overall Study|Adverse Event|0|||
38006627|NCT00091832|69690282|FG000|Overall Study|Withdrawal by Subject|4|||
38006628|NCT00091832|69690283|FG001|Overall Study|Withdrawal by Subject|5|||
38006629|NCT00091832|69690284|FG002|Overall Study|Withdrawal by Subject|0|||
38006630|NCT00091832|69690285|FG003|Overall Study|Withdrawal by Subject|1|||
38006631|NCT00091832|69690286|FG004|Overall Study|Withdrawal by Subject|3|||
38006632|NCT00091832|69690287|FG005|Overall Study|Withdrawal by Subject|1|||
38006633|NCT00091832|69690282|FG000|Overall Study|Death|6|||
38006634|NCT00091832|69690283|FG001|Overall Study|Death|4|||
38006635|NCT00091832|69690284|FG002|Overall Study|Death|5|||
38006636|NCT00091832|69690285|FG003|Overall Study|Death|8|||
38006637|NCT00091832|69690286|FG004|Overall Study|Death|5|||
38006638|NCT00091832|69690287|FG005|Overall Study|Death|6|||
38006639|NCT00091832|69690282|FG000|Overall Study|Disease Progression|2|||
37907627|NCT00617461|69593298|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
38006640|NCT00091832|69690283|FG001|Overall Study|Disease Progression|0|||
38006641|NCT00091832|69690284|FG002|Overall Study|Disease Progression|0|||
38006642|NCT00091832|69690285|FG003|Overall Study|Disease Progression|1|||
38006643|NCT00091832|69690286|FG004|Overall Study|Disease Progression|1|||
38006644|NCT00091832|69690287|FG005|Overall Study|Disease Progression|2|||
38006645|NCT00091832|69690282|FG000|Overall Study|Ineligibility Determined|0|||
38006646|NCT00091832|69690283|FG001|Overall Study|Ineligibility Determined|0|||
38006647|NCT00091832|69690284|FG002|Overall Study|Ineligibility Determined|1|||
38006648|NCT00091832|69690285|FG003|Overall Study|Ineligibility Determined|0|||
38006649|NCT00091832|69690286|FG004|Overall Study|Ineligibility Determined|1|||
38006650|NCT00091832|69690287|FG005|Overall Study|Ineligibility Determined|0|||
38006651|NCT00091832|69690282|FG000|Overall Study|Lost to Follow-up|1|||
38006652|NCT00091832|69690283|FG001|Overall Study|Lost to Follow-up|0|||
38006653|NCT00091832|69690284|FG002|Overall Study|Lost to Follow-up|3|||
38006654|NCT00091832|69690285|FG003|Overall Study|Lost to Follow-up|3|||
38006655|NCT00091832|69690286|FG004|Overall Study|Lost to Follow-up|2|||
38006656|NCT00091832|69690287|FG005|Overall Study|Lost to Follow-up|1|||
38006657|NCT00091832|69690282|FG000|Overall Study|Noncompliance|0|||
38006658|NCT00091832|69690283|FG001|Overall Study|Noncompliance|1|||
38006659|NCT00091832|69690284|FG002|Overall Study|Noncompliance|0|||
38006660|NCT00091832|69690285|FG003|Overall Study|Noncompliance|0|||
38006661|NCT00091832|69690286|FG004|Overall Study|Noncompliance|0|||
38006662|NCT00091832|69690287|FG005|Overall Study|Noncompliance|0|||
38006663|NCT00091832|69690282|FG000|Overall Study|Other|0|||
38006664|NCT00091832|69690283|FG001|Overall Study|Other|1|||
38006665|NCT00091832|69690284|FG002|Overall Study|Other|2|||
38006666|NCT00091832|69690285|FG003|Overall Study|Other|0|||
38006667|NCT00091832|69690286|FG004|Overall Study|Other|0|||
38006668|NCT00091832|69690287|FG005|Overall Study|Other|0|||
38006669|NCT00091832|69690282|FG000|Overall Study|Protocol Violation|0|||
38006670|NCT00091832|69690283|FG001|Overall Study|Protocol Violation|0|||
38006671|NCT00091832|69690284|FG002|Overall Study|Protocol Violation|1|||
38006672|NCT00091832|69690285|FG003|Overall Study|Protocol Violation|0|||
38006673|NCT00091832|69690286|FG004|Overall Study|Protocol Violation|0|||
38006674|NCT00091832|69690287|FG005|Overall Study|Protocol Violation|1|||
38006675|NCT00391391|69690305|FG000|Overall Study|Adverse Event|0|||
38006676|NCT00391391|69690306|FG001|Overall Study|Adverse Event|0|||
38006677|NCT00391391|69690307|FG002|Overall Study|Adverse Event|0|||
38006678|NCT00391391|69690308|FG003|Overall Study|Adverse Event|1|||
38006679|NCT00391391|69690305|FG000|Overall Study|Lost to Follow-up|1|||
38006680|NCT00391391|69690306|FG001|Overall Study|Lost to Follow-up|3|||
38006681|NCT00391391|69690307|FG002|Overall Study|Lost to Follow-up|7|||
38006682|NCT00391391|69690308|FG003|Overall Study|Lost to Follow-up|4|||
38006683|NCT00391391|69690305|FG000|Overall Study|Protocol Violation|2|||
38006684|NCT00391391|69690306|FG001|Overall Study|Protocol Violation|3|||
38006685|NCT00391391|69690307|FG002|Overall Study|Protocol Violation|6|||
38006686|NCT00391391|69690308|FG003|Overall Study|Protocol Violation|7|||
38006687|NCT00391391|69690305|FG000|Overall Study|Withdrawal by Subject|6|||
38006688|NCT00391391|69690306|FG001|Overall Study|Withdrawal by Subject|4|||
38006689|NCT00391391|69690307|FG002|Overall Study|Withdrawal by Subject|10|||
38006690|NCT00391391|69690308|FG003|Overall Study|Withdrawal by Subject|7|||
38006691|NCT00091442|69690320|FG000|Overall Study|Progressive Disease|220|||
38006692|NCT00091442|69690321|FG001|Overall Study|Progressive Disease|189|||
38006693|NCT00091442|69690320|FG000|Overall Study|Physician Decision|61|||
38006694|NCT00091442|69690321|FG001|Overall Study|Physician Decision|58|||
38006695|NCT00091442|69690320|FG000|Overall Study|Withdrawal by Subject|38|||
38006696|NCT00091442|69690321|FG001|Overall Study|Withdrawal by Subject|46|||
38006697|NCT00091442|69690320|FG000|Overall Study|Adverse Event|29|||
37830916|NCT01297504|69514282|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
37830917|NCT01297504|69514282|FG000|Overall Study|No Study Visits|4|||
37830918|NCT01297504|69514282|FG000|Overall Study|Death|3|||
37830919|NCT01297504|69514282|FG000|Overall Study|Lost to Follow-up|43|||
37830920|NCT01297504|69514282|FG000|Overall Study|Withdrawal by Subject|9|||
37830921|NCT01297504|69514282|FG000|Overall Study|Site Closure|3|||
37907628|NCT00617461|69593299|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
37907629|NCT00617461|69593298|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
37907630|NCT00617461|69593299|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
37907631|NCT00617461|69593298|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
37907632|NCT00617461|69593299|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
37907633|NCT00617461|69593298|FG000|Second Treatment Intervention Period|Adverse Event|0|||
37907634|NCT00617461|69593299|FG001|Second Treatment Intervention Period|Adverse Event|1|||
37907635|NCT00617461|69593298|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
37907636|NCT00617461|69593299|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
37907637|NCT00617461|69593298|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
37907638|NCT00617461|69593299|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
37907639|NCT00617461|69593298|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
37907640|NCT00617461|69593299|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
38006698|NCT00091442|69690321|FG001|Overall Study|Adverse Event|48|||
38006699|NCT00091442|69690320|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
38006700|NCT00091442|69690321|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
38006701|NCT00091442|69690320|FG000|Overall Study|Death|9|||
38006702|NCT00091442|69690321|FG001|Overall Study|Death|7|||
38006703|NCT00091442|69690320|FG000|Overall Study|Lost to Follow-up|1|||
38006704|NCT00091442|69690321|FG001|Overall Study|Lost to Follow-up|3|||
38006705|NCT00091442|69690320|FG000|Overall Study|Other|2|||
38006706|NCT00091442|69690321|FG001|Overall Study|Other|6|||
38006707|NCT00390689|69690330|FG000|Overall Study|Adverse Event|2|||
38006708|NCT00390689|69690331|FG001|Overall Study|Adverse Event|5|||
37830922|NCT01297504|69514282|FG000|Overall Study|Protocol Violation|3|||
37830923|NCT01297465|69514292|FG000|Overall Study|Lack of Ovarian Response|1|||
37907641|NCT00812331|69593326|FG000|Overall Study|Adverse Event|1|||
38006709|NCT00390689|69690332|FG002|Overall Study|Adverse Event|2|||
37830924|NCT01297465|69514293|FG001|Overall Study|Lack of Ovarian Response|1|||
38006710|NCT00390689|69690330|FG000|Overall Study|Lack of Efficacy|0|||
38006711|NCT00390689|69690331|FG001|Overall Study|Lack of Efficacy|0|||
38006712|NCT00390689|69690332|FG002|Overall Study|Lack of Efficacy|1|||
38006713|NCT00390689|69690330|FG000|Overall Study|Protocol Violation|1|||
38006714|NCT00390689|69690331|FG001|Overall Study|Protocol Violation|0|||
38006715|NCT00390689|69690332|FG002|Overall Study|Protocol Violation|0|||
38006716|NCT00390689|69690330|FG000|Overall Study|Investigator's judgement|2|||
38006717|NCT00390689|69690331|FG001|Overall Study|Investigator's judgement|0|||
38006718|NCT00390689|69690332|FG002|Overall Study|Investigator's judgement|0|||
38006719|NCT00121238|69690349|FG000|Overall Study|disease progression before intervention|1|||
38006720|NCT00121238|69690349|FG000|Overall Study|Protocol Violation|2|||
38006721|NCT00390455|69690355|FG000|Overall Study|Adverse Event|17|||
38006722|NCT00390455|69690356|FG001|Overall Study|Adverse Event|3|||
37907642|NCT00812331|69593327|FG001|Overall Study|Adverse Event|0|||
37907643|NCT00812331|69593328|FG002|Overall Study|Adverse Event|0|||
37907644|NCT00812331|69593329|FG003|Overall Study|Adverse Event|0|||
37907645|NCT00812331|69593330|FG004|Overall Study|Adverse Event|0|||
37907646|NCT00812253|69593340|FG000|Overall Study|Withdrawal by Subject|3|||
37907647|NCT00812253|69593341|FG001|Overall Study|Withdrawal by Subject|2|||
37907648|NCT00812253|69593340|FG000|Overall Study|Protocol Violation|1|||
37907649|NCT00812253|69593341|FG001|Overall Study|Protocol Violation|1|||
37907650|NCT00812253|69593340|FG000|Overall Study|Lost to Follow-up|2|||
37907651|NCT00812253|69593341|FG001|Overall Study|Lost to Follow-up|0|||
38006723|NCT00390455|69690355|FG000|Overall Study|Withdrawal by Subject|8|||
38006724|NCT00390455|69690356|FG001|Overall Study|Withdrawal by Subject|8|||
38006725|NCT00390455|69690355|FG000|Overall Study|Alternate Treatment|0|||
38006726|NCT00390455|69690356|FG001|Overall Study|Alternate Treatment|1|||
38006727|NCT00390455|69690355|FG000|Overall Study|Other Medical Reasons|7|||
38006728|NCT00390455|69690356|FG001|Overall Study|Other Medical Reasons|11|||
38006729|NCT03812510|69690362|FG000|Overall Study|Lost to Follow-up|39|||
38006730|NCT03812510|69690362|FG000|Overall Study|Withdrawal by Subject|42|||
38006731|NCT03812510|69690362|FG000|Overall Study|Physician Decision|2|||
38006732|NCT03812510|69690362|FG000|Overall Study|Study Terminated by Sponsor|9|||
38006733|NCT03812510|69690362|FG000|Overall Study|Did Not Start Study Medication|55|||
38006734|NCT03812510|69690362|FG000|Overall Study|Adverse Event|5|||
38006735|NCT00390299|69690372|FG000|Overall Study|Cancellation|1|||
38006736|NCT00390299|69690373|FG001|Overall Study|Cancellation|0|||
38006737|NCT00390299|69690374|FG002|Overall Study|Cancellation|0|||
38006738|NCT00390299|69690375|FG003|Overall Study|Cancellation|0|||
38006739|NCT00390299|69690376|FG004|Overall Study|Cancellation|0|||
38006740|NCT00119678|69690392|FG000|Double-blind Treatment Period|Death|1|||
38006741|NCT00119678|69690393|FG001|Double-blind Treatment Period|Death|0|||
38006742|NCT00119678|69690392|FG000|Double-blind Treatment Period|Adverse Event|7|||
37830925|NCT01297465|69514292|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
37830926|NCT01297465|69514293|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
37830927|NCT01297465|69514292|FG000|Overall Study|No Oocytes Retrieved|1|||
37907652|NCT00616759|69593349|FG000|Overall Study|Physician Decision|2|||
37907653|NCT00616759|69593350|FG001|Overall Study|Physician Decision|0|||
37907654|NCT00616759|69593349|FG000|Overall Study|Withdrawal by Subject|1|||
37830928|NCT01297465|69514293|FG001|Overall Study|No Oocytes Retrieved|1|||
37830929|NCT01297465|69514292|FG000|Overall Study|Poor oocyte quality|0|||
37830930|NCT01297465|69514293|FG001|Overall Study|Poor oocyte quality|1|||
37830931|NCT01297465|69514292|FG000|Overall Study|No Fertilization|6|||
37830932|NCT01297465|69514293|FG001|Overall Study|No Fertilization|4|||
37830933|NCT01297465|69514292|FG000|Overall Study|All Embryos Discarded|0|||
37830934|NCT01297465|69514293|FG001|Overall Study|All Embryos Discarded|1|||
37830935|NCT01297465|69514292|FG000|Overall Study|Intention to Freeze all Embryos|0|||
37830936|NCT01297465|69514293|FG001|Overall Study|Intention to Freeze all Embryos|1|||
37830937|NCT01297309|69514299|FG000|Overall Study|Eligibility failure|2|||
37830938|NCT01297309|69514299|FG000|Overall Study|Screen failure|2|||
37830939|NCT01297309|69514299|FG000|Overall Study|Withdrawal by Subject|5|||
37830940|NCT01297309|69514299|FG000|Overall Study|Adverse Event|1|||
37830941|NCT01297309|69514299|FG000|Overall Study|Investigator Decision|2|||
37907655|NCT00616759|69593350|FG001|Overall Study|Withdrawal by Subject|2|||
37907656|NCT00812097|69593360|FG000|Overall Study|Death|3|||
37907657|NCT00812097|69593361|FG001|Overall Study|Death|10|||
37907658|NCT00812097|69593362|FG002|Overall Study|Death|3|||
37907659|NCT00812097|69593363|FG003|Overall Study|Death|3|||
38006743|NCT00119678|69690393|FG001|Double-blind Treatment Period|Adverse Event|1|||
37907660|NCT00812097|69593360|FG000|Overall Study|Withdrawal by Subject|14|||
38006744|NCT00119678|69690392|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
38006745|NCT00119678|69690393|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
38006746|NCT00119678|69690392|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
38006747|NCT00119678|69690393|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
37907661|NCT00812097|69593361|FG001|Overall Study|Withdrawal by Subject|12|||
38006748|NCT00119678|69690392|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
37830942|NCT01297309|69514299|FG000|Overall Study|Death|1|||
37830943|NCT01297309|69514299|FG000|Overall Study|Participant not entering extensionperiod|1|||
37830944|NCT04518462|69514306|FG000|Overall Study|Withdrawal by Subject|0|||
37907662|NCT00812097|69593362|FG002|Overall Study|Withdrawal by Subject|8|||
38006749|NCT00119678|69690393|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
38006750|NCT00119678|69690392|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
38006751|NCT00119678|69690393|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
38006752|NCT00119678|69690392|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
38006753|NCT00119678|69690393|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
38006754|NCT00119678|69690392|FG000|Double-blind Treatment Period|Pregnancy|0|||
38006755|NCT00119678|69690393|FG001|Double-blind Treatment Period|Pregnancy|2|||
38006756|NCT00119678|69690392|FG000|Double-blind Treatment Period|Not treated|1|||
38006757|NCT00119678|69690393|FG001|Double-blind Treatment Period|Not treated|2|||
38006758|NCT00119678|69690392|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
38006759|NCT00119678|69690393|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
38006760|NCT00119678|69690392|FG000|Open-label Treatment Period|Death|1|||
38006761|NCT00119678|69690393|FG001|Open-label Treatment Period|Death|0|||
38006762|NCT00119678|69690392|FG000|Open-label Treatment Period|Adverse Event|3|||
38006763|NCT00119678|69690393|FG001|Open-label Treatment Period|Adverse Event|0|||
38006764|NCT00119678|69690392|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
38006765|NCT00119678|69690393|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
38006766|NCT00119678|69690392|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
38006767|NCT00119678|69690393|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
38006768|NCT00119678|69690392|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
38006769|NCT00119678|69690393|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
38006770|NCT00119678|69690392|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
38006771|NCT00119678|69690393|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
38006772|NCT00119678|69690392|FG000|Open-label Treatment Period|Pregnancy|1|||
38006773|NCT00119678|69690393|FG001|Open-label Treatment Period|Pregnancy|0|||
38006774|NCT00119678|69690392|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
38006775|NCT00119678|69690393|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
38006776|NCT00110084|69690401|FG000|Overall Study|Adverse Event|9|||
38006777|NCT00110084|69690401|FG000|Overall Study|Death|1|||
38006778|NCT00110084|69690401|FG000|Overall Study|Patient Refusal|10|||
38006779|NCT00110084|69690401|FG000|Overall Study|Alternate Therapy|5|||
38006780|NCT00110084|69690401|FG000|Overall Study|Intercurrent Illness|1|||
38006781|NCT00110084|69690401|FG000|Overall Study|Other|2|||
38006782|NCT00390221|69690408|FG000|Overall Study|Lost to Follow-up|0|||
38006783|NCT00390221|69690409|FG001|Overall Study|Lost to Follow-up|3|||
38006784|NCT00390221|69690410|FG002|Overall Study|Lost to Follow-up|0|||
38006785|NCT00390221|69690408|FG000|Overall Study|Adverse Event|1|||
38006786|NCT00390221|69690409|FG001|Overall Study|Adverse Event|4|||
38006787|NCT00390221|69690410|FG002|Overall Study|Adverse Event|3|||
38006788|NCT00390221|69690408|FG000|Overall Study|Investigator Decision|0|||
38006789|NCT00390221|69690409|FG001|Overall Study|Investigator Decision|0|||
38006790|NCT00390221|69690410|FG002|Overall Study|Investigator Decision|1|||
38006791|NCT00390221|69690408|FG000|Overall Study|Withdrawal by Subject|13|||
38006792|NCT00390221|69690409|FG001|Overall Study|Withdrawal by Subject|9|||
38006793|NCT00390221|69690410|FG002|Overall Study|Withdrawal by Subject|7|||
38006794|NCT00390221|69690408|FG000|Overall Study|Subject Non-compliance|1|||
38006795|NCT00390221|69690409|FG001|Overall Study|Subject Non-compliance|0|||
38006796|NCT00390221|69690410|FG002|Overall Study|Subject Non-compliance|2|||
38006797|NCT00390221|69690408|FG000|Overall Study|Other|3|||
38006798|NCT00390221|69690409|FG001|Overall Study|Other|4|||
38006799|NCT00390221|69690410|FG002|Overall Study|Other|2|||
38006800|NCT00389831|69690421|FG000|Overall Study|Lack of Efficacy|0|||
38006801|NCT00389831|69690422|FG001|Overall Study|Lack of Efficacy|2|||
38006802|NCT00389831|69690421|FG000|Overall Study|Did not receive treatment.|0|||
38006803|NCT00389831|69690422|FG001|Overall Study|Did not receive treatment.|2|||
38006804|NCT00389831|69690421|FG000|Overall Study|Other reasons|0|||
38006805|NCT00389831|69690422|FG001|Overall Study|Other reasons|2|||
37907663|NCT00812097|69593363|FG003|Overall Study|Withdrawal by Subject|2|||
37907664|NCT00812097|69593360|FG000|Overall Study|Lost to Follow-up|90|||
37907665|NCT00812097|69593361|FG001|Overall Study|Lost to Follow-up|14|||
38006806|NCT00389831|69690421|FG000|Overall Study|Lost to Follow-up|0|||
38006807|NCT00389831|69690422|FG001|Overall Study|Lost to Follow-up|1|||
38006808|NCT00389597|69690444|FG000|Overall Study|Lost to Follow-up|8|||
38006809|NCT00389597|69690445|FG001|Overall Study|Lost to Follow-up|6|||
38006810|NCT00389597|69690446|FG002|Overall Study|Lost to Follow-up|4|||
38006811|NCT00389597|69690447|FG003|Overall Study|Lost to Follow-up|6|||
38006812|NCT00389519|69690461|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
38006813|NCT00389519|69690462|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
38006814|NCT00389519|69690463|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
38006815|NCT00389519|69690464|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
37907666|NCT00812097|69593362|FG002|Overall Study|Lost to Follow-up|17|||
37907667|NCT00812097|69593363|FG003|Overall Study|Lost to Follow-up|5|||
37907668|NCT00812097|69593360|FG000|Overall Study|Explantation of study device(s)|27|||
38006816|NCT00389519|69690461|FG000|Placebo Run-In|Withdrawal by Subject|19|||
38006817|NCT00389519|69690462|FG001|Placebo Run-In|Withdrawal by Subject|0|||
38006818|NCT00389519|69690463|FG002|Placebo Run-In|Withdrawal by Subject|0|||
38006819|NCT00389519|69690464|FG003|Placebo Run-In|Withdrawal by Subject|0|||
38006820|NCT00389519|69690461|FG000|Placebo Run-In|Reason not specified|40|||
38006821|NCT00389519|69690462|FG001|Placebo Run-In|Reason not specified|0|||
38006822|NCT00389519|69690463|FG002|Placebo Run-In|Reason not specified|0|||
38006823|NCT00389519|69690464|FG003|Placebo Run-In|Reason not specified|0|||
38006824|NCT00389519|69690461|FG000|Randomized|Did not receive study drug|2|||
38006825|NCT00389519|69690462|FG001|Randomized|Did not receive study drug|0|||
38006826|NCT00389519|69690463|FG002|Randomized|Did not receive study drug|0|||
38006827|NCT00389519|69690464|FG003|Randomized|Did not receive study drug|0|||
38006828|NCT00389519|69690461|FG000|Treated|Adverse Event|1|||
38006829|NCT00389519|69690462|FG001|Treated|Adverse Event|0|||
38006830|NCT00389519|69690463|FG002|Treated|Adverse Event|0|||
38006831|NCT00389519|69690464|FG003|Treated|Adverse Event|2|||
38006832|NCT00389519|69690461|FG000|Treated|Reason not specified|1|||
38006833|NCT00389519|69690462|FG001|Treated|Reason not specified|1|||
38006834|NCT00389519|69690463|FG002|Treated|Reason not specified|0|||
38006835|NCT00389519|69690464|FG003|Treated|Reason not specified|2|||
38006836|NCT00389441|69690474|FG000|Overall Study|Adverse Event|7|||
38006837|NCT00389441|69690474|FG000|Overall Study|Death|4|||
38006838|NCT00389441|69690474|FG000|Overall Study|Lost to Follow-up|2|||
38006839|NCT00389441|69690474|FG000|Overall Study|Withdrawal by Subject|4|||
38006840|NCT00389441|69690474|FG000|Overall Study|Physician Decision|1|||
38006841|NCT00389441|69690474|FG000|Overall Study|Protocol Violation|1|||
38006842|NCT00389441|69690474|FG000|Overall Study|Global deterioration of health status|4|||
38006843|NCT00389441|69690474|FG000|Overall Study|Objective progression or relapse|26|||
38006844|NCT00389441|69690474|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
38006845|NCT00389441|69690474|FG000|Overall Study|Clinical progression|1|||
38006846|NCT00118898|69690482|FG000|Overall Study|Death|6|||
38006847|NCT00118898|69690483|FG001|Overall Study|Death|11|||
38006848|NCT00118898|69690484|FG002|Overall Study|Death|6|||
38006849|NCT00118898|69690485|FG003|Overall Study|Death|8|||
38006850|NCT00118898|69690482|FG000|Overall Study|Lost to Follow-up|26|||
38006851|NCT00118898|69690483|FG001|Overall Study|Lost to Follow-up|34|||
38006852|NCT00118898|69690484|FG002|Overall Study|Lost to Follow-up|33|||
38006853|NCT00118898|69690485|FG003|Overall Study|Lost to Follow-up|33|||
38006854|NCT00118898|69690482|FG000|Overall Study|Withdrawal by Subject|10|||
38006855|NCT00118898|69690483|FG001|Overall Study|Withdrawal by Subject|5|||
38006856|NCT00118898|69690484|FG002|Overall Study|Withdrawal by Subject|8|||
38006857|NCT00118898|69690485|FG003|Overall Study|Withdrawal by Subject|8|||
38006858|NCT00118898|69690482|FG000|Overall Study|Site Closure|33|||
38006859|NCT00118898|69690483|FG001|Overall Study|Site Closure|31|||
38006860|NCT00118898|69690484|FG002|Overall Study|Site Closure|28|||
38006861|NCT00118898|69690485|FG003|Overall Study|Site Closure|37|||
38006862|NCT00118898|69690482|FG000|Overall Study|Severe debilitation|1|||
38006863|NCT00118898|69690483|FG001|Overall Study|Severe debilitation|4|||
38006864|NCT00118898|69690484|FG002|Overall Study|Severe debilitation|6|||
38006865|NCT00118898|69690485|FG003|Overall Study|Severe debilitation|4|||
38006866|NCT00118898|69690482|FG000|Overall Study|Not compliant with requirements|11|||
38006867|NCT00118898|69690483|FG001|Overall Study|Not compliant with requirements|13|||
38006868|NCT00118898|69690484|FG002|Overall Study|Not compliant with requirements|11|||
38006869|NCT00118898|69690485|FG003|Overall Study|Not compliant with requirements|11|||
38006870|NCT00118898|69690482|FG000|Overall Study|Not able to get to clinic|34|||
38006871|NCT00118898|69690483|FG001|Overall Study|Not able to get to clinic|43|||
38006872|NCT00118898|69690484|FG002|Overall Study|Not able to get to clinic|31|||
38006873|NCT00118898|69690485|FG003|Overall Study|Not able to get to clinic|40|||
38006874|NCT00118430|69690498|FG000|Overall Study|Withdrawal by Subject|6|||
38006875|NCT00118430|69690499|FG001|Overall Study|Withdrawal by Subject|2|||
38006876|NCT00118430|69690500|FG002|Overall Study|Withdrawal by Subject|0|||
38006877|NCT00118430|69690498|FG000|Overall Study|Lost to Follow-up|15|||
38006878|NCT00118430|69690499|FG001|Overall Study|Lost to Follow-up|22|||
37907669|NCT00812097|69593361|FG001|Overall Study|Explantation of study device(s)|29|||
38006879|NCT00118430|69690500|FG002|Overall Study|Lost to Follow-up|28|||
38006880|NCT00090584|69690509|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
38006881|NCT00090584|69690510|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
38006882|NCT00090584|69690509|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
38006883|NCT00090584|69690510|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
38006884|NCT03670810|69690530|FG000|Main Study|Adverse Event|37|||
38006885|NCT03670810|69690531|FG001|Main Study|Adverse Event|38|||
38006886|NCT03670810|69690532|FG002|Main Study|Adverse Event|3|||
38006887|NCT03670810|69690533|FG003|Main Study|Adverse Event|4|||
38006888|NCT03670810|69690534|FG004|Main Study|Adverse Event|4|||
38006889|NCT03670810|69690535|FG005|Main Study|Adverse Event|5|||
38006890|NCT03670810|69690536|FG006|Main Study|Adverse Event|0|||
38006891|NCT03670810|69690537|FG007|Main Study|Adverse Event|0|||
38006892|NCT03670810|69690538|FG008|Main Study|Adverse Event|0|||
38006893|NCT03670810|69690530|FG000|Main Study|Lack of Efficacy|8|||
38006894|NCT03670810|69690531|FG001|Main Study|Lack of Efficacy|9|||
38006895|NCT03670810|69690532|FG002|Main Study|Lack of Efficacy|3|||
38006896|NCT03670810|69690533|FG003|Main Study|Lack of Efficacy|4|||
38006897|NCT03670810|69690534|FG004|Main Study|Lack of Efficacy|0|||
38006898|NCT03670810|69690535|FG005|Main Study|Lack of Efficacy|0|||
38006899|NCT03670810|69690536|FG006|Main Study|Lack of Efficacy|0|||
38006900|NCT03670810|69690537|FG007|Main Study|Lack of Efficacy|0|||
38006901|NCT03670810|69690538|FG008|Main Study|Lack of Efficacy|0|||
38006902|NCT03670810|69690530|FG000|Main Study|Lost to Follow-up|9|||
38006903|NCT03670810|69690531|FG001|Main Study|Lost to Follow-up|7|||
38006904|NCT03670810|69690532|FG002|Main Study|Lost to Follow-up|4|||
38006905|NCT03670810|69690533|FG003|Main Study|Lost to Follow-up|6|||
38006906|NCT03670810|69690534|FG004|Main Study|Lost to Follow-up|1|||
38006907|NCT03670810|69690535|FG005|Main Study|Lost to Follow-up|0|||
38006908|NCT03670810|69690536|FG006|Main Study|Lost to Follow-up|0|||
38006909|NCT03670810|69690537|FG007|Main Study|Lost to Follow-up|0|||
38006910|NCT03670810|69690538|FG008|Main Study|Lost to Follow-up|0|||
38006911|NCT03670810|69690530|FG000|Main Study|Non-compliance with Study Drug|0|||
38006912|NCT03670810|69690531|FG001|Main Study|Non-compliance with Study Drug|2|||
38006913|NCT03670810|69690532|FG002|Main Study|Non-compliance with Study Drug|3|||
38006914|NCT03670810|69690533|FG003|Main Study|Non-compliance with Study Drug|0|||
38006915|NCT03670810|69690534|FG004|Main Study|Non-compliance with Study Drug|0|||
38006916|NCT03670810|69690535|FG005|Main Study|Non-compliance with Study Drug|0|||
38006917|NCT03670810|69690536|FG006|Main Study|Non-compliance with Study Drug|0|||
38006918|NCT03670810|69690537|FG007|Main Study|Non-compliance with Study Drug|1|||
38006919|NCT03670810|69690538|FG008|Main Study|Non-compliance with Study Drug|0|||
38006920|NCT03670810|69690530|FG000|Main Study|Physician Decision|3|||
38006921|NCT03670810|69690531|FG001|Main Study|Physician Decision|0|||
38006922|NCT03670810|69690532|FG002|Main Study|Physician Decision|1|||
38006923|NCT03670810|69690533|FG003|Main Study|Physician Decision|0|||
38006924|NCT03670810|69690534|FG004|Main Study|Physician Decision|0|||
38006925|NCT03670810|69690535|FG005|Main Study|Physician Decision|0|||
38006926|NCT03670810|69690536|FG006|Main Study|Physician Decision|1|||
38006927|NCT03670810|69690537|FG007|Main Study|Physician Decision|1|||
38006928|NCT03670810|69690538|FG008|Main Study|Physician Decision|0|||
38006929|NCT03670810|69690530|FG000|Main Study|Pregnancy|1|||
38006930|NCT03670810|69690531|FG001|Main Study|Pregnancy|2|||
38006931|NCT03670810|69690532|FG002|Main Study|Pregnancy|0|||
38006932|NCT03670810|69690533|FG003|Main Study|Pregnancy|0|||
38006933|NCT03670810|69690534|FG004|Main Study|Pregnancy|0|||
38006934|NCT03670810|69690535|FG005|Main Study|Pregnancy|0|||
38006935|NCT03670810|69690536|FG006|Main Study|Pregnancy|0|||
38006936|NCT03670810|69690537|FG007|Main Study|Pregnancy|0|||
38006937|NCT03670810|69690538|FG008|Main Study|Pregnancy|0|||
38006938|NCT03670810|69690530|FG000|Main Study|Protocol Deviation|2|||
38006939|NCT03670810|69690531|FG001|Main Study|Protocol Deviation|12|||
38006940|NCT03670810|69690532|FG002|Main Study|Protocol Deviation|8|||
38006941|NCT03670810|69690533|FG003|Main Study|Protocol Deviation|4|||
38006942|NCT03670810|69690534|FG004|Main Study|Protocol Deviation|0|||
38006943|NCT03670810|69690535|FG005|Main Study|Protocol Deviation|0|||
38006944|NCT03670810|69690536|FG006|Main Study|Protocol Deviation|0|||
38006945|NCT03670810|69690537|FG007|Main Study|Protocol Deviation|0|||
38006946|NCT03670810|69690538|FG008|Main Study|Protocol Deviation|0|||
38006947|NCT03670810|69690530|FG000|Main Study|Withdrawal by Subject|21|||
38006948|NCT03670810|69690531|FG001|Main Study|Withdrawal by Subject|21|||
38006949|NCT03670810|69690532|FG002|Main Study|Withdrawal by Subject|8|||
38006950|NCT03670810|69690533|FG003|Main Study|Withdrawal by Subject|9|||
38006951|NCT03670810|69690534|FG004|Main Study|Withdrawal by Subject|5|||
38006952|NCT03670810|69690535|FG005|Main Study|Withdrawal by Subject|2|||
38006953|NCT03670810|69690536|FG006|Main Study|Withdrawal by Subject|1|||
38006954|NCT03670810|69690537|FG007|Main Study|Withdrawal by Subject|1|||
38006955|NCT03670810|69690538|FG008|Main Study|Withdrawal by Subject|0|||
38006956|NCT03670810|69690530|FG000|Main Study|Participant did not want to take the three other treatments|1|||
38006957|NCT03670810|69690531|FG001|Main Study|Participant did not want to take the three other treatments|0|||
38006958|NCT03670810|69690532|FG002|Main Study|Participant did not want to take the three other treatments|0|||
38006959|NCT03670810|69690533|FG003|Main Study|Participant did not want to take the three other treatments|0|||
38006960|NCT03670810|69690534|FG004|Main Study|Participant did not want to take the three other treatments|0|||
38006961|NCT03670810|69690535|FG005|Main Study|Participant did not want to take the three other treatments|0|||
38006962|NCT03670810|69690536|FG006|Main Study|Participant did not want to take the three other treatments|0|||
38006963|NCT03670810|69690537|FG007|Main Study|Participant did not want to take the three other treatments|0|||
38006964|NCT03670810|69690538|FG008|Main Study|Participant did not want to take the three other treatments|0|||
38006965|NCT03670810|69690530|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
38006966|NCT03670810|69690531|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
38006967|NCT03670810|69690532|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
38006968|NCT03670810|69690533|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
38006969|NCT03670810|69690534|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
38006970|NCT03670810|69690535|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
38006971|NCT03670810|69690536|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
38006972|NCT03670810|69690537|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
38006973|NCT03670810|69690538|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
38006974|NCT03670810|69690530|FG000|Main Study|Travel and Coronavirus issues|0|||
38006975|NCT03670810|69690531|FG001|Main Study|Travel and Coronavirus issues|0|||
38006976|NCT03670810|69690532|FG002|Main Study|Travel and Coronavirus issues|0|||
38006977|NCT03670810|69690533|FG003|Main Study|Travel and Coronavirus issues|1|||
38006978|NCT03670810|69690534|FG004|Main Study|Travel and Coronavirus issues|0|||
38006979|NCT03670810|69690535|FG005|Main Study|Travel and Coronavirus issues|0|||
38006980|NCT03670810|69690536|FG006|Main Study|Travel and Coronavirus issues|0|||
38006981|NCT03670810|69690537|FG007|Main Study|Travel and Coronavirus issues|0|||
38006982|NCT03670810|69690538|FG008|Main Study|Travel and Coronavirus issues|0|||
38006983|NCT03670810|69690530|FG000|Open Label Extension|Protocol Deviation|0|||
38006984|NCT03670810|69690531|FG001|Open Label Extension|Protocol Deviation|0|||
38006985|NCT03670810|69690532|FG002|Open Label Extension|Protocol Deviation|0|||
38006986|NCT03670810|69690533|FG003|Open Label Extension|Protocol Deviation|0|||
38006987|NCT03670810|69690534|FG004|Open Label Extension|Protocol Deviation|0|||
38006988|NCT03670810|69690535|FG005|Open Label Extension|Protocol Deviation|0|||
38006989|NCT03670810|69690536|FG006|Open Label Extension|Protocol Deviation|0|||
38006990|NCT03670810|69690537|FG007|Open Label Extension|Protocol Deviation|0|||
38006991|NCT03670810|69690538|FG008|Open Label Extension|Protocol Deviation|5|||
38006992|NCT03670810|69690530|FG000|Open Label Extension|Death|0|||
38006993|NCT03670810|69690531|FG001|Open Label Extension|Death|0|||
38006994|NCT03670810|69690532|FG002|Open Label Extension|Death|0|||
38006995|NCT03670810|69690533|FG003|Open Label Extension|Death|0|||
38006996|NCT03670810|69690534|FG004|Open Label Extension|Death|0|||
38006997|NCT03670810|69690535|FG005|Open Label Extension|Death|0|||
38006998|NCT03670810|69690536|FG006|Open Label Extension|Death|0|||
38006999|NCT03670810|69690537|FG007|Open Label Extension|Death|0|||
38007000|NCT03670810|69690538|FG008|Open Label Extension|Death|1|||
38007001|NCT03670810|69690530|FG000|Open Label Extension|COVID-19|0|||
38007002|NCT03670810|69690531|FG001|Open Label Extension|COVID-19|0|||
38007003|NCT03670810|69690532|FG002|Open Label Extension|COVID-19|0|||
38007004|NCT03670810|69690533|FG003|Open Label Extension|COVID-19|0|||
38007005|NCT03670810|69690534|FG004|Open Label Extension|COVID-19|0|||
38007006|NCT03670810|69690535|FG005|Open Label Extension|COVID-19|0|||
38007007|NCT03670810|69690536|FG006|Open Label Extension|COVID-19|0|||
38007008|NCT03670810|69690537|FG007|Open Label Extension|COVID-19|0|||
38007009|NCT03670810|69690538|FG008|Open Label Extension|COVID-19|1|||
38007010|NCT03670810|69690530|FG000|Open Label Extension|Lack of Efficacy|0|||
38007011|NCT03670810|69690531|FG001|Open Label Extension|Lack of Efficacy|0|||
38007012|NCT03670810|69690532|FG002|Open Label Extension|Lack of Efficacy|0|||
38007013|NCT03670810|69690533|FG003|Open Label Extension|Lack of Efficacy|0|||
38007014|NCT03670810|69690534|FG004|Open Label Extension|Lack of Efficacy|0|||
38007015|NCT03670810|69690535|FG005|Open Label Extension|Lack of Efficacy|0|||
38007016|NCT03670810|69690536|FG006|Open Label Extension|Lack of Efficacy|0|||
38007017|NCT03670810|69690537|FG007|Open Label Extension|Lack of Efficacy|0|||
38007018|NCT03670810|69690538|FG008|Open Label Extension|Lack of Efficacy|39|||
38007019|NCT03670810|69690530|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
37830945|NCT04518462|69514307|FG001|Overall Study|Withdrawal by Subject|0|||
37830946|NCT04518462|69514308|FG002|Overall Study|Withdrawal by Subject|1|||
38007020|NCT03670810|69690531|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
38007021|NCT03670810|69690532|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
38007022|NCT03670810|69690533|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
38007023|NCT03670810|69690534|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
38007024|NCT03670810|69690535|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
38007025|NCT03670810|69690536|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
38007026|NCT03670810|69690537|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
38007027|NCT03670810|69690538|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
38007028|NCT03670810|69690530|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
38007029|NCT03670810|69690531|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
38007030|NCT03670810|69690532|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
38007031|NCT03670810|69690533|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
38007032|NCT03670810|69690534|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
38007033|NCT03670810|69690535|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
38007034|NCT03670810|69690536|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
38007035|NCT03670810|69690537|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
38007036|NCT03670810|69690538|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
38007037|NCT03670810|69690530|FG000|Open Label Extension|Withdrawal by Subject|0|||
38007038|NCT03670810|69690531|FG001|Open Label Extension|Withdrawal by Subject|0|||
38007039|NCT03670810|69690532|FG002|Open Label Extension|Withdrawal by Subject|0|||
38007040|NCT03670810|69690533|FG003|Open Label Extension|Withdrawal by Subject|0|||
38007041|NCT03670810|69690534|FG004|Open Label Extension|Withdrawal by Subject|0|||
38007042|NCT03670810|69690535|FG005|Open Label Extension|Withdrawal by Subject|0|||
38007043|NCT03670810|69690536|FG006|Open Label Extension|Withdrawal by Subject|0|||
38007044|NCT03670810|69690537|FG007|Open Label Extension|Withdrawal by Subject|0|||
38007045|NCT03670810|69690538|FG008|Open Label Extension|Withdrawal by Subject|46|||
38007046|NCT03670810|69690530|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
38007047|NCT03670810|69690531|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
38007048|NCT03670810|69690532|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
38007049|NCT03670810|69690533|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
38007050|NCT03670810|69690534|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
38007051|NCT03670810|69690535|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
38007052|NCT03670810|69690536|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
38007053|NCT03670810|69690537|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
38007054|NCT03670810|69690538|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
38007055|NCT03670810|69690530|FG000|Open Label Extension|Physician Decision|0|||
38007056|NCT03670810|69690531|FG001|Open Label Extension|Physician Decision|0|||
38007057|NCT03670810|69690532|FG002|Open Label Extension|Physician Decision|0|||
38007058|NCT03670810|69690533|FG003|Open Label Extension|Physician Decision|0|||
38007059|NCT03670810|69690534|FG004|Open Label Extension|Physician Decision|0|||
38007060|NCT03670810|69690535|FG005|Open Label Extension|Physician Decision|0|||
38007061|NCT03670810|69690536|FG006|Open Label Extension|Physician Decision|0|||
38007062|NCT03670810|69690537|FG007|Open Label Extension|Physician Decision|0|||
38007063|NCT03670810|69690538|FG008|Open Label Extension|Physician Decision|2|||
38007064|NCT03670810|69690530|FG000|Open Label Extension|Non-compliance with study drug|0|||
38007065|NCT03670810|69690531|FG001|Open Label Extension|Non-compliance with study drug|0|||
38007066|NCT03670810|69690532|FG002|Open Label Extension|Non-compliance with study drug|0|||
37907670|NCT00812097|69593362|FG002|Overall Study|Explantation of study device(s)|14|||
37907671|NCT00812097|69593363|FG003|Overall Study|Explantation of study device(s)|20|||
37907672|NCT00812097|69593360|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
37907673|NCT00812097|69593361|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
37907674|NCT00812097|69593362|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
37907675|NCT00812097|69593363|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
37907676|NCT00811941|69593375|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
37907677|NCT00811941|69593376|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
37907678|NCT00811941|69593375|FG000|All Treated Patients|Adverse Event|2|||
37907679|NCT00811941|69593376|FG001|All Treated Patients|Adverse Event|43|||
37907680|NCT00811941|69593375|FG000|All Treated Patients|Lack of Efficacy|2|||
37907681|NCT00811941|69593376|FG001|All Treated Patients|Lack of Efficacy|3|||
37907682|NCT00811941|69593375|FG000|All Treated Patients|Non-compliance|1|||
37907683|NCT00811941|69593376|FG001|All Treated Patients|Non-compliance|8|||
37907684|NCT00811941|69593375|FG000|All Treated Patients|Protocol Violation|5|||
37907685|NCT00811941|69593376|FG001|All Treated Patients|Protocol Violation|17|||
37907686|NCT00811941|69593375|FG000|All Treated Patients|Withdrawal by Subject|35|||
37907687|NCT00811941|69593376|FG001|All Treated Patients|Withdrawal by Subject|94|||
37907688|NCT00811941|69593375|FG000|All Treated Patients|Lost to Follow-up|3|||
37907689|NCT00811941|69593376|FG001|All Treated Patients|Lost to Follow-up|12|||
37907690|NCT00811941|69593375|FG000|All Treated Patients|Other Reason|4|||
37907691|NCT00811941|69593376|FG001|All Treated Patients|Other Reason|14|||
37907692|NCT00811473|69593384|FG000|Overall Study|Adverse Event|3|||
37907693|NCT00811473|69593385|FG001|Overall Study|Adverse Event|12|||
37907694|NCT00811473|69593384|FG000|Overall Study|Lost to Follow-up|5|||
38007067|NCT03670810|69690533|FG003|Open Label Extension|Non-compliance with study drug|0|||
37907695|NCT00811473|69593385|FG001|Overall Study|Lost to Follow-up|1|||
37907696|NCT00811473|69593384|FG000|Overall Study|Withdrawal by Subject|2|||
37907697|NCT00811473|69593385|FG001|Overall Study|Withdrawal by Subject|4|||
37907698|NCT00811473|69593384|FG000|Overall Study|Severe non-compliance to protocol|2|||
38007068|NCT03670810|69690534|FG004|Open Label Extension|Non-compliance with study drug|0|||
38007069|NCT03670810|69690535|FG005|Open Label Extension|Non-compliance with study drug|0|||
38007070|NCT03670810|69690536|FG006|Open Label Extension|Non-compliance with study drug|0|||
38007071|NCT03670810|69690537|FG007|Open Label Extension|Non-compliance with study drug|0|||
38007072|NCT03670810|69690538|FG008|Open Label Extension|Non-compliance with study drug|5|||
38007073|NCT03670810|69690530|FG000|Open Label Extension|Pregnancy|0|||
38007074|NCT03670810|69690531|FG001|Open Label Extension|Pregnancy|0|||
38007075|NCT03670810|69690532|FG002|Open Label Extension|Pregnancy|0|||
38007076|NCT03670810|69690533|FG003|Open Label Extension|Pregnancy|0|||
38007077|NCT03670810|69690534|FG004|Open Label Extension|Pregnancy|0|||
38007078|NCT03670810|69690535|FG005|Open Label Extension|Pregnancy|0|||
38007079|NCT03670810|69690536|FG006|Open Label Extension|Pregnancy|0|||
38007080|NCT03670810|69690537|FG007|Open Label Extension|Pregnancy|0|||
38007081|NCT03670810|69690538|FG008|Open Label Extension|Pregnancy|3|||
38007082|NCT03670810|69690530|FG000|Open Label Extension|Adverse Event|0|||
38007083|NCT03670810|69690531|FG001|Open Label Extension|Adverse Event|0|||
38007084|NCT03670810|69690532|FG002|Open Label Extension|Adverse Event|0|||
38007085|NCT03670810|69690533|FG003|Open Label Extension|Adverse Event|0|||
38007086|NCT03670810|69690534|FG004|Open Label Extension|Adverse Event|0|||
38007087|NCT03670810|69690535|FG005|Open Label Extension|Adverse Event|0|||
38007088|NCT03670810|69690536|FG006|Open Label Extension|Adverse Event|0|||
38007089|NCT03670810|69690537|FG007|Open Label Extension|Adverse Event|0|||
38007090|NCT03670810|69690538|FG008|Open Label Extension|Adverse Event|24|||
38007091|NCT03670810|69690530|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
37830947|NCT04518462|69514306|FG000|Overall Study|Physician Decision|1|||
37830948|NCT04518462|69514307|FG001|Overall Study|Physician Decision|1|||
37830949|NCT04518462|69514308|FG002|Overall Study|Physician Decision|0|||
37830950|NCT01297270|69514319|FG000|Overall Study|Adverse Event|19|||
37830951|NCT01297270|69514320|FG001|Overall Study|Adverse Event|32|||
37830952|NCT01297270|69514321|FG002|Overall Study|Adverse Event|5|||
37830953|NCT01297270|69514319|FG000|Overall Study|Lack of Efficacy|15|||
37830954|NCT01297270|69514320|FG001|Overall Study|Lack of Efficacy|17|||
37830955|NCT01297270|69514321|FG002|Overall Study|Lack of Efficacy|15|||
37830956|NCT01297270|69514319|FG000|Overall Study|Lost to Follow-up|1|||
37830957|NCT01297270|69514320|FG001|Overall Study|Lost to Follow-up|2|||
37830958|NCT01297270|69514321|FG002|Overall Study|Lost to Follow-up|1|||
37830959|NCT01297270|69514319|FG000|Overall Study|Protocol Violation|0|||
37830960|NCT01297270|69514320|FG001|Overall Study|Protocol Violation|2|||
37830961|NCT01297270|69514321|FG002|Overall Study|Protocol Violation|0|||
37830962|NCT01297270|69514319|FG000|Overall Study|Withdrawal by Subject|7|||
37830963|NCT01297270|69514320|FG001|Overall Study|Withdrawal by Subject|15|||
37830964|NCT01297270|69514321|FG002|Overall Study|Withdrawal by Subject|7|||
37830965|NCT01297270|69514319|FG000|Overall Study|Other reason not defined above|3|||
37830966|NCT01297270|69514320|FG001|Overall Study|Other reason not defined above|3|||
37830967|NCT01297270|69514321|FG002|Overall Study|Other reason not defined above|1|||
37830968|NCT01297270|69514319|FG000|Overall Study|Not treated|0|||
37830969|NCT01297270|69514320|FG001|Overall Study|Not treated|1|||
37830970|NCT01297270|69514321|FG002|Overall Study|Not treated|0|||
37830971|NCT01296568|69514329|FG000|Continued Access Phase|Lost to Follow-up|1|||
37830972|NCT01296568|69514329|FG000|Continued Access Phase|Withdrawal by Subject|1|||
37830973|NCT01296568|69514329|FG000|Continued Access Phase|Disease Progression|1|||
37830974|NCT01296412|69514337|FG000|Overall Study|Adverse Event|8|||
37830975|NCT01296412|69514338|FG001|Overall Study|Adverse Event|29|||
37830976|NCT01296412|69514337|FG000|Overall Study|Lack of Efficacy|1|||
37830977|NCT01296412|69514338|FG001|Overall Study|Lack of Efficacy|0|||
37830978|NCT01296412|69514337|FG000|Overall Study|Lost to Follow-up|10|||
37830979|NCT01296412|69514338|FG001|Overall Study|Lost to Follow-up|7|||
37830980|NCT01296412|69514337|FG000|Overall Study|Non-compliance with study drug|1|||
37830981|NCT01296412|69514338|FG001|Overall Study|Non-compliance with study drug|2|||
37830982|NCT01296412|69514337|FG000|Overall Study|Other reason not specified|20|||
37830983|NCT01296412|69514338|FG001|Overall Study|Other reason not specified|15|||
37830984|NCT01296412|69514337|FG000|Overall Study|Physician Decision|1|||
38007092|NCT03670810|69690531|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
38007093|NCT03670810|69690532|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
38007094|NCT03670810|69690533|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
37830985|NCT01296412|69514338|FG001|Overall Study|Physician Decision|3|||
37830986|NCT01296412|69514337|FG000|Overall Study|Pregnancy|0|||
38007095|NCT03670810|69690534|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
38007096|NCT03670810|69690535|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
37830987|NCT01296412|69514338|FG001|Overall Study|Pregnancy|1|||
37830988|NCT01296412|69514337|FG000|Overall Study|Withdrawal by Subject|10|||
37830989|NCT01296412|69514338|FG001|Overall Study|Withdrawal by Subject|13|||
37830990|NCT01295905|69514346|FG000|Overall Study|Did not meet inclusion criteria|1|||
37830991|NCT01295905|69514347|FG001|Overall Study|Did not meet inclusion criteria|0|||
37907699|NCT00811473|69593385|FG001|Overall Study|Severe non-compliance to protocol|4|||
37907700|NCT00811473|69593384|FG000|Overall Study|Lack of therapeutic response|4|||
37907701|NCT00811473|69593385|FG001|Overall Study|Lack of therapeutic response|1|||
37907702|NCT00811473|69593384|FG000|Overall Study|Condition under investigation worsened|1|||
37907703|NCT00811473|69593385|FG001|Overall Study|Condition under investigation worsened|3|||
37907704|NCT00811473|69593384|FG000|Overall Study|Other 2|4|||
37907705|NCT00811473|69593385|FG001|Overall Study|Other 2|1|||
37907706|NCT00811473|69593384|FG000|Overall Study|Incorrect Enrollment|1|||
37907707|NCT00811473|69593385|FG001|Overall Study|Incorrect Enrollment|0|||
37907708|NCT00811473|69593384|FG000|Overall Study|Safety Reasons|1|||
37907709|NCT00811473|69593385|FG001|Overall Study|Safety Reasons|0|||
37907710|NCT00617305|69593398|FG000|Overall Study|Adverse Event|4|||
37907711|NCT00617305|69593399|FG001|Overall Study|Adverse Event|0|||
37907712|NCT00617305|69593400|FG002|Overall Study|Adverse Event|0|||
37697687|NCT02020863|69174293|FG000|Overall Study|Team chose not to place an a line|1|||
37697688|NCT01824394|69174300|FG000|Overall Study|Early Termination|1|||
37830992|NCT01295905|69514346|FG000|Overall Study|Met exclusion criteria|1|||
37830993|NCT01295905|69514347|FG001|Overall Study|Met exclusion criteria|0|||
37830994|NCT02596035|69514356|FG000|Overall Study|Disease Progression|64|||
38007097|NCT03670810|69690536|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
38007098|NCT03670810|69690537|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
38007099|NCT03670810|69690538|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
38007100|NCT03670810|69690530|FG000|Open Label Extension|Lost to Follow-up|0|||
38007101|NCT03670810|69690531|FG001|Open Label Extension|Lost to Follow-up|0|||
38007102|NCT03670810|69690532|FG002|Open Label Extension|Lost to Follow-up|0|||
38007103|NCT03670810|69690533|FG003|Open Label Extension|Lost to Follow-up|0|||
38007104|NCT03670810|69690534|FG004|Open Label Extension|Lost to Follow-up|0|||
37830995|NCT02596035|69514357|FG001|Overall Study|Disease Progression|32|||
37830996|NCT02596035|69514358|FG002|Overall Study|Disease Progression|1|||
37830997|NCT02596035|69514356|FG000|Overall Study|study drug toxicity|12|||
37830998|NCT02596035|69514357|FG001|Overall Study|study drug toxicity|3|||
37830999|NCT02596035|69514358|FG002|Overall Study|study drug toxicity|0|||
37831000|NCT02596035|69514356|FG000|Overall Study|AE unrelated to study drug|5|||
37831001|NCT02596035|69514357|FG001|Overall Study|AE unrelated to study drug|2|||
37831002|NCT02596035|69514358|FG002|Overall Study|AE unrelated to study drug|0|||
37907713|NCT00617305|69593398|FG000|Overall Study|Death|1|||
37907714|NCT00617305|69593399|FG001|Overall Study|Death|0|||
37907715|NCT00617305|69593400|FG002|Overall Study|Death|0|||
37907716|NCT00617305|69593398|FG000|Overall Study|Physician Decision|1|||
37907717|NCT00617305|69593399|FG001|Overall Study|Physician Decision|0|||
37907718|NCT00617305|69593400|FG002|Overall Study|Physician Decision|0|||
37907719|NCT00617305|69593398|FG000|Overall Study|Protocol Violation|1|||
37907720|NCT00617305|69593399|FG001|Overall Study|Protocol Violation|0|||
37907721|NCT00617305|69593400|FG002|Overall Study|Protocol Violation|1|||
37907722|NCT00617305|69593398|FG000|Overall Study|Withdrawal by Subject|1|||
37907723|NCT00617305|69593399|FG001|Overall Study|Withdrawal by Subject|0|||
37907724|NCT00617305|69593400|FG002|Overall Study|Withdrawal by Subject|0|||
37907725|NCT00811395|69593417|FG000|Extension Treatment|Adverse Event|1|||
37907726|NCT00811395|69593418|FG001|Extension Treatment|Adverse Event|2|||
37907727|NCT00811395|69593419|FG002|Extension Treatment|Adverse Event|2|||
37907728|NCT00811395|69593420|FG003|Extension Treatment|Adverse Event|2|||
37907729|NCT00811395|69593421|FG004|Extension Treatment|Adverse Event|0|||
37907730|NCT00811395|69593422|FG005|Extension Treatment|Adverse Event|1|||
37907731|NCT00811395|69593417|FG000|Extension Treatment|Progressive disease|1|||
37907732|NCT00811395|69593418|FG001|Extension Treatment|Progressive disease|1|||
37907733|NCT00811395|69593419|FG002|Extension Treatment|Progressive disease|0|||
37907734|NCT00811395|69593420|FG003|Extension Treatment|Progressive disease|0|||
37907735|NCT00811395|69593421|FG004|Extension Treatment|Progressive disease|0|||
37907736|NCT00811395|69593422|FG005|Extension Treatment|Progressive disease|0|||
37907737|NCT00811395|69593417|FG000|Extension Treatment|Participant did not wish to continue|0|||
37907738|NCT00811395|69593418|FG001|Extension Treatment|Participant did not wish to continue|3|||
37907739|NCT00811395|69593419|FG002|Extension Treatment|Participant did not wish to continue|0|||
37907740|NCT00811395|69593420|FG003|Extension Treatment|Participant did not wish to continue|1|||
37907741|NCT00811395|69593421|FG004|Extension Treatment|Participant did not wish to continue|0|||
37907742|NCT00811395|69593422|FG005|Extension Treatment|Participant did not wish to continue|1|||
37907743|NCT00811395|69593417|FG000|Extension Treatment|Other than above|0|||
38007105|NCT03670810|69690535|FG005|Open Label Extension|Lost to Follow-up|0|||
38007106|NCT03670810|69690536|FG006|Open Label Extension|Lost to Follow-up|0|||
38007107|NCT03670810|69690537|FG007|Open Label Extension|Lost to Follow-up|0|||
38007108|NCT03670810|69690538|FG008|Open Label Extension|Lost to Follow-up|23|||
38007109|NCT00089648|69690552|FG000|Overall Study|Adverse Event|7|||
38007110|NCT00089648|69690552|FG000|Overall Study|Withdrawal by Subject|1|||
38007111|NCT00089648|69690552|FG000|Overall Study|Lack of Efficacy|33|||
38007112|NCT00118040|69690559|FG000|Overall Study|Adverse Event|0|||
38007113|NCT00118040|69690560|FG001|Overall Study|Adverse Event|1|||
38007114|NCT00118040|69690561|FG002|Overall Study|Adverse Event|0|||
38007115|NCT00118040|69690559|FG000|Overall Study|Withdrawal by Subject|0|||
38007116|NCT00118040|69690560|FG001|Overall Study|Withdrawal by Subject|0|||
38007117|NCT00118040|69690561|FG002|Overall Study|Withdrawal by Subject|2|||
38007118|NCT00118040|69690559|FG000|Overall Study|Medical Contraindication|0|||
38007119|NCT00118040|69690560|FG001|Overall Study|Medical Contraindication|0|||
37831003|NCT02596035|69514356|FG000|Overall Study|participant request to discontinue study treatment|2|||
37831004|NCT02596035|69514357|FG001|Overall Study|participant request to discontinue study treatment|0|||
37831005|NCT02596035|69514358|FG002|Overall Study|participant request to discontinue study treatment|0|||
37831006|NCT02596035|69514356|FG000|Overall Study|participant withdrew consent|2|||
37831007|NCT02596035|69514357|FG001|Overall Study|participant withdrew consent|2|||
37831008|NCT02596035|69514358|FG002|Overall Study|participant withdrew consent|0|||
37831009|NCT02596035|69514356|FG000|Overall Study|Poor/Non Comlpiance|0|||
37831010|NCT02596035|69514357|FG001|Overall Study|Poor/Non Comlpiance|1|||
37831011|NCT02596035|69514358|FG002|Overall Study|Poor/Non Comlpiance|0|||
37831012|NCT02596035|69514356|FG000|Overall Study|participant no longer meets study criteria|1|||
37831013|NCT02596035|69514357|FG001|Overall Study|participant no longer meets study criteria|0|||
37831014|NCT02596035|69514358|FG002|Overall Study|participant no longer meets study criteria|0|||
37831015|NCT02596035|69514356|FG000|Overall Study|other reasons|11|||
37831016|NCT02596035|69514357|FG001|Overall Study|other reasons|4|||
37831017|NCT02596035|69514358|FG002|Overall Study|other reasons|0|||
37831018|NCT02595372|69514367|FG000|Overall Study|Adverse Event|6|||
37831019|NCT02595372|69514367|FG000|Overall Study|Physician Decision|2|||
37831020|NCT02595372|69514367|FG000|Overall Study|Disease Progression|1|||
37831021|NCT01248962|69514387|FG000|Overall Study|Withdrawal by Subject|1|||
37831022|NCT01248962|69514388|FG001|Overall Study|Withdrawal by Subject|1|||
37831023|NCT01248962|69514387|FG000|Overall Study|Adverse Event|2|||
37831024|NCT01248962|69514388|FG001|Overall Study|Adverse Event|1|||
37831025|NCT01248962|69514387|FG000|Overall Study|Complete Response after 4 Cycles|1|||
37831026|NCT01248962|69514388|FG001|Overall Study|Complete Response after 4 Cycles|0|||
37831027|NCT01248962|69514387|FG000|Overall Study|Complete Response after 3 Cycles|0|||
37831028|NCT01248962|69514388|FG001|Overall Study|Complete Response after 3 Cycles|1|||
37831029|NCT01248962|69514387|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
37831030|NCT01248962|69514388|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
37831031|NCT01248455|69514395|FG000|Overall Study|switched to alternate treatment|1|||
37831032|NCT01247090|69514402|FG000|Overall Study|Physician Decision|1|||
37831033|NCT01247090|69514403|FG001|Overall Study|Physician Decision|0|||
37831034|NCT01247090|69514404|FG002|Overall Study|Physician Decision|0|||
37831035|NCT01247090|69514402|FG000|Overall Study|Withdrawal by Subject|0|||
37831036|NCT01247090|69514403|FG001|Overall Study|Withdrawal by Subject|1|||
38007120|NCT00118040|69690561|FG002|Overall Study|Medical Contraindication|1|||
38007121|NCT00118040|69690559|FG000|Overall Study|Non-Compliant Participant|1|||
37831037|NCT01247090|69514404|FG002|Overall Study|Withdrawal by Subject|0|||
37697689|NCT01824394|69174301|FG001|Overall Study|Early Termination|1|||
37831038|NCT01249664|69514414|FG000|Overall Study|Withdrawal by Subject|5|||
38007122|NCT00118040|69690560|FG001|Overall Study|Non-Compliant Participant|1|||
38007123|NCT00118040|69690561|FG002|Overall Study|Non-Compliant Participant|2|||
38007124|NCT00118040|69690559|FG000|Overall Study|Other|0|||
38007125|NCT00118040|69690560|FG001|Overall Study|Other|0|||
38007126|NCT00118040|69690561|FG002|Overall Study|Other|1|||
38007127|NCT00389207|69690577|FG000|Overall Study|Adverse Event|26|||
38007128|NCT00389207|69690578|FG001|Overall Study|Adverse Event|32|||
38007129|NCT00389207|69690579|FG002|Overall Study|Adverse Event|10|||
38007130|NCT00389207|69690577|FG000|Overall Study|Protocol Violation|3|||
38007131|NCT00389207|69690578|FG001|Overall Study|Protocol Violation|1|||
38007132|NCT00389207|69690579|FG002|Overall Study|Protocol Violation|4|||
38007133|NCT00389207|69690577|FG000|Overall Study|Lost to Follow-up|12|||
38007134|NCT00389207|69690578|FG001|Overall Study|Lost to Follow-up|9|||
38007135|NCT00389207|69690579|FG002|Overall Study|Lost to Follow-up|7|||
38007136|NCT00389207|69690577|FG000|Overall Study|Withdrawal by Subject|5|||
38007137|NCT00389207|69690578|FG001|Overall Study|Withdrawal by Subject|7|||
38007138|NCT00389207|69690579|FG002|Overall Study|Withdrawal by Subject|11|||
38007139|NCT00389207|69690577|FG000|Overall Study|Other|17|||
38007140|NCT00389207|69690578|FG001|Overall Study|Other|23|||
38007141|NCT00389207|69690579|FG002|Overall Study|Other|9|||
38007142|NCT00388973|69690594|FG000|Overall Study|Adverse Event|16|||
38007143|NCT00388973|69690595|FG001|Overall Study|Adverse Event|6|||
38007144|NCT00388973|69690594|FG000|Overall Study|Lack of Efficacy|1|||
38007145|NCT00388973|69690595|FG001|Overall Study|Lack of Efficacy|12|||
38007146|NCT00388973|69690594|FG000|Overall Study|Protocol Violation|3|||
38007147|NCT00388973|69690595|FG001|Overall Study|Protocol Violation|0|||
38007148|NCT00388973|69690594|FG000|Overall Study|Withdrawal by Subject|14|||
38007149|NCT00388973|69690595|FG001|Overall Study|Withdrawal by Subject|17|||
38007150|NCT00388973|69690594|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
38007151|NCT00388973|69690595|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
38007152|NCT00388973|69690594|FG000|Overall Study|Did not complete 61 days of treatment|5|||
38007153|NCT00388973|69690595|FG001|Overall Study|Did not complete 61 days of treatment|4|||
38007154|NCT00388973|69690594|FG000|Overall Study|Left region|0|||
38007155|NCT00388973|69690595|FG001|Overall Study|Left region|1|||
38007156|NCT00388973|69690594|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
38007157|NCT00388973|69690595|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
38007158|NCT00388583|69690603|FG000|Overall Study|Protocol Violation|1|||
38007159|NCT00388583|69690604|FG001|Overall Study|Protocol Violation|0|||
38007160|NCT00388583|69690603|FG000|Overall Study|Withdrawal by Subject|3|||
37907744|NCT00811395|69593418|FG001|Extension Treatment|Other than above|0|||
37907745|NCT00811395|69593419|FG002|Extension Treatment|Other than above|1|||
37907746|NCT00811395|69593420|FG003|Extension Treatment|Other than above|0|||
37907747|NCT00811395|69593421|FG004|Extension Treatment|Other than above|0|||
37907748|NCT00811395|69593422|FG005|Extension Treatment|Other than above|0|||
37907749|NCT00955409|69593449|FG000|Overall Study|Lack of Efficacy|1|||
38007161|NCT00388583|69690604|FG001|Overall Study|Withdrawal by Subject|3|||
38007162|NCT00388583|69690603|FG000|Overall Study|Serious Adverse Event|2|||
38007163|NCT00388583|69690604|FG001|Overall Study|Serious Adverse Event|0|||
38007164|NCT00388583|69690603|FG000|Overall Study|Did not receive vaccine|0|||
38007165|NCT00388583|69690604|FG001|Overall Study|Did not receive vaccine|1|||
38007166|NCT00117572|69690612|FG000|Overall Study|Site withdrew before starting treatment|2|||
38007167|NCT00117572|69690613|FG001|Overall Study|Site withdrew before starting treatment|3|||
38007168|NCT00117572|69690612|FG000|Overall Study|Withdrawal by Subject|3|||
38007169|NCT00117572|69690613|FG001|Overall Study|Withdrawal by Subject|3|||
37697690|NCT01824394|69174302|FG002|Overall Study|Early Termination|3|||
37697691|NCT01824394|69174300|FG000|Overall Study|Withdrawn due to Study Termination|91|||
37697692|NCT01824394|69174301|FG001|Overall Study|Withdrawn due to Study Termination|83|||
37697693|NCT01824394|69174302|FG002|Overall Study|Withdrawn due to Study Termination|41|||
37831039|NCT01249664|69514415|FG001|Overall Study|Withdrawal by Subject|0|||
37831040|NCT01249664|69514414|FG000|Overall Study|Adverse Event|1|||
37831041|NCT01249664|69514415|FG001|Overall Study|Adverse Event|0|||
37831042|NCT01249274|69514425|FG000|Overall Study|Lost to Follow-up|3|||
37831043|NCT01249274|69514426|FG001|Overall Study|Lost to Follow-up|4|||
37831044|NCT01249274|69514425|FG000|Overall Study|Received inpatient substance treatment|1|||
37907750|NCT00955409|69593450|FG001|Overall Study|Lack of Efficacy|0|||
37907751|NCT00955409|69593451|FG002|Overall Study|Lack of Efficacy|0|||
37907752|NCT00955409|69593452|FG003|Overall Study|Lack of Efficacy|0|||
38007170|NCT00117572|69690612|FG000|Overall Study|Protocol Violation|1|||
38007171|NCT00117572|69690613|FG001|Overall Study|Protocol Violation|0|||
38007172|NCT00388505|69690621|FG000|Overall Study|Adverse Event or Death|43|||
38007173|NCT00388505|69690622|FG001|Overall Study|Adverse Event or Death|17|||
38007174|NCT00388505|69690621|FG000|Overall Study|Withdrawal by Subject|24|||
38007175|NCT00388505|69690622|FG001|Overall Study|Withdrawal by Subject|9|||
38007176|NCT00388505|69690621|FG000|Overall Study|Lost to Follow-up|5|||
38007177|NCT00388505|69690622|FG001|Overall Study|Lost to Follow-up|3|||
38007178|NCT00388505|69690621|FG000|Overall Study|Inappropriate Enrollment|0|||
37697694|NCT01824394|69174300|FG000|Overall Study|Lost to Follow-up|0|||
37831045|NCT01249274|69514426|FG001|Overall Study|Received inpatient substance treatment|2|||
38007179|NCT00388505|69690622|FG001|Overall Study|Inappropriate Enrollment|1|||
37831046|NCT01249157|69514434|FG000|Overall Study|Withdrawal by Subject|1|||
38007180|NCT00388505|69690621|FG000|Overall Study|Administrative Reason|1|||
37697695|NCT01824394|69174301|FG001|Overall Study|Lost to Follow-up|9|||
37697696|NCT01824394|69174302|FG002|Overall Study|Lost to Follow-up|3|||
37697697|NCT01824394|69174300|FG000|Overall Study|Death|3|||
37697698|NCT01824394|69174301|FG001|Overall Study|Death|2|||
37697699|NCT01824394|69174302|FG002|Overall Study|Death|4|||
37697700|NCT01824394|69174300|FG000|Overall Study|Discontinued Subjects|1|||
37697701|NCT01824394|69174301|FG001|Overall Study|Discontinued Subjects|1|||
37697702|NCT01824394|69174302|FG002|Overall Study|Discontinued Subjects|2|||
37697703|NCT01824394|69174300|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
37697704|NCT01824394|69174301|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
37697705|NCT01824394|69174302|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
37697706|NCT01823536|69174316|FG000|Overall Study|Lost to Follow-up|1|||
37697707|NCT01823536|69174317|FG001|Overall Study|Lost to Follow-up|0|||
37697708|NCT01823536|69174318|FG002|Overall Study|Lost to Follow-up|0|||
37697709|NCT01823536|69174319|FG003|Overall Study|Lost to Follow-up|1|||
37697710|NCT01823536|69174320|FG004|Overall Study|Lost to Follow-up|1|||
37697711|NCT01823536|69174321|FG005|Overall Study|Lost to Follow-up|0|||
37697712|NCT01823536|69174316|FG000|Overall Study|Protocol Violation|0|||
37697713|NCT01823536|69174317|FG001|Overall Study|Protocol Violation|1|||
37697714|NCT01823536|69174318|FG002|Overall Study|Protocol Violation|0|||
37697715|NCT01823536|69174319|FG003|Overall Study|Protocol Violation|0|||
38007181|NCT00388505|69690622|FG001|Overall Study|Administrative Reason|0|||
38007182|NCT00388505|69690621|FG000|Overall Study|Protocol Violation|6|||
38007183|NCT00388505|69690622|FG001|Overall Study|Protocol Violation|5|||
38007184|NCT00388505|69690621|FG000|Overall Study|Unable to classify|4|||
38007185|NCT00388505|69690622|FG001|Overall Study|Unable to classify|3|||
38007186|NCT00388349|69690628|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
38007187|NCT00388349|69690629|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
38007188|NCT00117338|69690639|FG000|Overall Study|Adverse Event|0|||
38007189|NCT00117338|69690640|FG001|Overall Study|Adverse Event|1|||
38007190|NCT00117338|69690639|FG000|Overall Study|Protocol Violation|3|||
38007191|NCT00117338|69690640|FG001|Overall Study|Protocol Violation|2|||
38007192|NCT00117338|69690639|FG000|Overall Study|Withdrawal by Subject|1|||
38007193|NCT00117338|69690640|FG001|Overall Study|Withdrawal by Subject|0|||
38007194|NCT00117338|69690639|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
38007195|NCT00117338|69690640|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
38007196|NCT00117338|69690639|FG000|Overall Study|Lack of Efficacy|0|||
38007197|NCT00117338|69690640|FG001|Overall Study|Lack of Efficacy|1|||
38007198|NCT00388037|69690646|FG000|Overall Study|Protocol Violation|1|||
38007199|NCT00387881|69690652|FG000|Overall Study|Lost to Follow-up|23|||
38007200|NCT00387881|69690653|FG001|Overall Study|Lost to Follow-up|23|||
38007201|NCT00387881|69690652|FG000|Overall Study|Protocol Violation|2|||
38007202|NCT00387881|69690653|FG001|Overall Study|Protocol Violation|12|||
38007203|NCT00387881|69690652|FG000|Overall Study|Withdrawal by Subject|15|||
38007204|NCT00387881|69690653|FG001|Overall Study|Withdrawal by Subject|18|||
38007205|NCT00387881|69690652|FG000|Overall Study|Sponsor terminated Study|0|||
38007206|NCT00387881|69690653|FG001|Overall Study|Sponsor terminated Study|1|||
38007207|NCT00387881|69690652|FG000|Overall Study|Not eligible|6|||
38007208|NCT00387881|69690653|FG001|Overall Study|Not eligible|7|||
38007209|NCT00387881|69690652|FG000|Overall Study|No opportunity to treat headache|32|||
38007210|NCT00387881|69690653|FG001|Overall Study|No opportunity to treat headache|34|||
38007211|NCT00387881|69690652|FG000|Overall Study|Not otherwise specified|11|||
38007212|NCT00387881|69690653|FG001|Overall Study|Not otherwise specified|7|||
38007213|NCT00084656|69690662|FG000|Overall Study|Other reasons|0|||
38007214|NCT00084656|69690663|FG001|Overall Study|Other reasons|12|||
38007215|NCT00084656|69690664|FG002|Overall Study|Other reasons|11|||
38007216|NCT00084656|69690662|FG000|Overall Study|Withdrawal by Subject|15|||
38007217|NCT00084656|69690663|FG001|Overall Study|Withdrawal by Subject|4|||
38007218|NCT00084656|69690664|FG002|Overall Study|Withdrawal by Subject|4|||
38007219|NCT00084656|69690662|FG000|Overall Study|Disease relapse|0|||
38007220|NCT00084656|69690663|FG001|Overall Study|Disease relapse|9|||
38007221|NCT00084656|69690664|FG002|Overall Study|Disease relapse|10|||
38007222|NCT00084656|69690662|FG000|Overall Study|Disease progression|9|||
38007223|NCT00084656|69690663|FG001|Overall Study|Disease progression|0|||
37697716|NCT01823536|69174320|FG004|Overall Study|Protocol Violation|0|||
37697717|NCT01823536|69174321|FG005|Overall Study|Protocol Violation|0|||
37697718|NCT01823536|69174316|FG000|Overall Study|Withdrawal by Subject|1|||
37697719|NCT01823536|69174317|FG001|Overall Study|Withdrawal by Subject|1|||
37697720|NCT01823536|69174318|FG002|Overall Study|Withdrawal by Subject|0|||
37697721|NCT01823536|69174319|FG003|Overall Study|Withdrawal by Subject|0|||
38007224|NCT00084656|69690664|FG002|Overall Study|Disease progression|0|||
38007225|NCT00084656|69690662|FG000|Overall Study|Lost to Follow-up|1|||
37697722|NCT01823536|69174320|FG004|Overall Study|Withdrawal by Subject|0|||
37697723|NCT01823536|69174321|FG005|Overall Study|Withdrawal by Subject|0|||
38007226|NCT00084656|69690663|FG001|Overall Study|Lost to Follow-up|0|||
38007227|NCT00084656|69690664|FG002|Overall Study|Lost to Follow-up|1|||
38007228|NCT00387725|69690678|FG000|Overall Study|Adverse Event|0|||
38007229|NCT00387725|69690679|FG001|Overall Study|Adverse Event|0|||
38007230|NCT00387725|69690680|FG002|Overall Study|Adverse Event|0|||
38007231|NCT00387725|69690681|FG003|Overall Study|Adverse Event|1|||
38007232|NCT00387725|69690678|FG000|Overall Study|Protocol Violation|0|||
38007233|NCT00387725|69690679|FG001|Overall Study|Protocol Violation|1|||
38007234|NCT00387725|69690680|FG002|Overall Study|Protocol Violation|0|||
38007235|NCT00387725|69690681|FG003|Overall Study|Protocol Violation|0|||
38007236|NCT00387725|69690678|FG000|Overall Study|Withdrawal by Subject|1|||
38007237|NCT00387725|69690679|FG001|Overall Study|Withdrawal by Subject|0|||
38007238|NCT00387725|69690680|FG002|Overall Study|Withdrawal by Subject|1|||
38007239|NCT00387725|69690681|FG003|Overall Study|Withdrawal by Subject|0|||
38007240|NCT00387725|69690678|FG000|Overall Study|Parent/legal guardian request|0|||
38007241|NCT00387725|69690679|FG001|Overall Study|Parent/legal guardian request|0|||
38007242|NCT00387725|69690680|FG002|Overall Study|Parent/legal guardian request|1|||
38007243|NCT00387725|69690681|FG003|Overall Study|Parent/legal guardian request|1|||
38007244|NCT00102596|69690691|FG000|Part A|Screen failures|6|||
38007245|NCT00102596|69690692|FG001|Part A|Screen failures|0|||
38007246|NCT00102596|69690691|FG000|Part A|Adverse Event|1|||
38007247|NCT00102596|69690692|FG001|Part A|Adverse Event|0|||
38007248|NCT00387647|69690699|FG000|Overall Study|Death|18|||
38007249|NCT00386009|69690705|FG000|Overall Study|Adverse Event|0|||
38007250|NCT00386009|69690706|FG001|Overall Study|Adverse Event|2|||
38007251|NCT00386009|69690705|FG000|Overall Study|Death|1|||
38007252|NCT00386009|69690706|FG001|Overall Study|Death|0|||
38007253|NCT00386009|69690705|FG000|Overall Study|Entry Criteria Not Met|0|||
38007254|NCT00386009|69690706|FG001|Overall Study|Entry Criteria Not Met|2|||
38007255|NCT00386009|69690705|FG000|Overall Study|Lost to Follow-up|1|||
38007256|NCT00386009|69690706|FG001|Overall Study|Lost to Follow-up|1|||
38007257|NCT00386009|69690705|FG000|Overall Study|Protocol Violation|1|||
38007258|NCT00386009|69690706|FG001|Overall Study|Protocol Violation|0|||
38007259|NCT00386009|69690705|FG000|Overall Study|Sponsor Decision|1|||
38007260|NCT00386009|69690706|FG001|Overall Study|Sponsor Decision|1|||
38007261|NCT00386009|69690705|FG000|Overall Study|Withdrawal by Subject|5|||
38007262|NCT00386009|69690706|FG001|Overall Study|Withdrawal by Subject|4|||
38007263|NCT00373685|69690714|FG000|Overall Study|Death|2|||
38007264|NCT00373685|69690715|FG001|Overall Study|Death|1|||
38007265|NCT00373685|69690714|FG000|Overall Study|Adverse Event|278|||
38007266|NCT00373685|69690715|FG001|Overall Study|Adverse Event|253|||
38007267|NCT00373685|69690714|FG000|Overall Study|Insufficient clinical response|169|||
38007268|NCT00373685|69690715|FG001|Overall Study|Insufficient clinical response|119|||
38007269|NCT00373685|69690714|FG000|Overall Study|Did not meet entrance criteria|167|||
38007270|NCT00373685|69690715|FG001|Overall Study|Did not meet entrance criteria|184|||
38007271|NCT00373685|69690714|FG000|Overall Study|Lost to follow up|83|||
38007272|NCT00373685|69690715|FG001|Overall Study|Lost to follow up|103|||
38007273|NCT00373685|69690714|FG000|Overall Study|No longer willing to participate|337|||
38007274|NCT00373685|69690715|FG001|Overall Study|No longer willing to participate|352|||
38007275|NCT00373685|69690714|FG000|Overall Study|Other|149|||
38007276|NCT00373685|69690715|FG001|Overall Study|Other|146|||
38007277|NCT00373685|69690714|FG000|Overall Study|Protocol Violation|191|||
38007278|NCT00373685|69690715|FG001|Overall Study|Protocol Violation|182|||
38007279|NCT00373685|69690714|FG000|Overall Study|Final Status Unknown|12|||
38007280|NCT00373685|69690715|FG001|Overall Study|Final Status Unknown|4|||
38007281|NCT00373685|69690714|FG000|Overall Study|Randomized, not treated|51|||
37831047|NCT01249118|69514438|FG000|First Washout Period|Physician Decision|0|||
37831048|NCT01249118|69514439|FG001|First Washout Period|Physician Decision|1|||
37831049|NCT01249118|69514440|FG002|First Washout Period|Physician Decision|0|||
37831050|NCT01248884|69514450|FG000|Overall Study|Withdrawal by Subject|1|||
37831051|NCT01248884|69514451|FG001|Overall Study|Withdrawal by Subject|3|||
37831052|NCT01248884|69514452|FG002|Overall Study|Withdrawal by Subject|1|||
37831053|NCT01248884|69514450|FG000|Overall Study|Adverse Event|1|||
37831054|NCT01248884|69514451|FG001|Overall Study|Adverse Event|0|||
37831055|NCT01248884|69514452|FG002|Overall Study|Adverse Event|0|||
37831056|NCT01248728|69514464|FG000|Overall Study|Adverse Event|1|||
37831057|NCT01248728|69514465|FG001|Overall Study|Adverse Event|1|||
37831058|NCT01248728|69514464|FG000|Overall Study|Withdrawal by Subject|2|||
37831059|NCT01248728|69514465|FG001|Overall Study|Withdrawal by Subject|1|||
37831060|NCT01248728|69514464|FG000|Overall Study|Lack of Efficacy|1|||
38007282|NCT00373685|69690715|FG001|Overall Study|Randomized, not treated|77|||
38007283|NCT00373529|69690721|FG000|Overall Study|Physician Decision|19|||
38007284|NCT00373529|69690721|FG000|Overall Study|Withdrawal by Subject|7|||
38007285|NCT00373529|69690721|FG000|Overall Study|Adverse Event|7|||
38007286|NCT00373529|69690721|FG000|Overall Study|Treatment failure|36|||
38007287|NCT00373529|69690721|FG000|Overall Study|Disease recurrence|10|||
37831061|NCT01248728|69514465|FG001|Overall Study|Lack of Efficacy|0|||
37831062|NCT01246973|69514475|FG000|Overall Study|Other|38|||
37831063|NCT01246973|69514476|FG001|Overall Study|Other|25|||
37831064|NCT01246973|69514475|FG000|Overall Study|Adverse Event|16|||
38007288|NCT00373529|69690721|FG000|Overall Study|Death|16|||
38007289|NCT00373529|69690721|FG000|Overall Study|Need for treatment prohibited by study|1|||
38007290|NCT00373529|69690721|FG000|Overall Study|Other|8|||
38007291|NCT00373529|69690721|FG000|Overall Study|Failed independent confirmation of AML|3|||
38007292|NCT00373529|69690721|FG000|Overall Study|Consent violation|1|||
38007293|NCT00373295|69690725|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
38007294|NCT00373295|69690726|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
38007295|NCT00373295|69690727|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
38007296|NCT00373295|69690728|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
38007297|NCT00373295|69690729|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
38007298|NCT00373295|69690730|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
38007299|NCT00385541|69690740|FG000|Overall Study|severe pain, clinician requested unblind|0|||
38007300|NCT00385541|69690741|FG001|Overall Study|severe pain, clinician requested unblind|1|||
38007301|NCT00392015|69690753|FG000|Overall Study|Lost to Follow-up|2|||
38007302|NCT00392015|69690754|FG001|Overall Study|Lost to Follow-up|0|||
38007303|NCT00392015|69690755|FG002|Overall Study|Lost to Follow-up|2|||
38007304|NCT00392015|69690756|FG003|Overall Study|Lost to Follow-up|1|||
38007305|NCT00392015|69690757|FG004|Overall Study|Lost to Follow-up|1|||
38007306|NCT00392015|69690758|FG005|Overall Study|Lost to Follow-up|0|||
38007307|NCT00392015|69690753|FG000|Overall Study|Withdrawal by Subject|0|||
38007308|NCT00392015|69690754|FG001|Overall Study|Withdrawal by Subject|0|||
38007309|NCT00392015|69690755|FG002|Overall Study|Withdrawal by Subject|2|||
38007310|NCT00392015|69690756|FG003|Overall Study|Withdrawal by Subject|0|||
38007311|NCT00392015|69690757|FG004|Overall Study|Withdrawal by Subject|0|||
38007312|NCT00392015|69690758|FG005|Overall Study|Withdrawal by Subject|0|||
38007313|NCT00392015|69690753|FG000|Overall Study|Adverse Event|0|||
38007314|NCT00392015|69690754|FG001|Overall Study|Adverse Event|0|||
38007315|NCT00392015|69690755|FG002|Overall Study|Adverse Event|0|||
38007316|NCT00392015|69690756|FG003|Overall Study|Adverse Event|0|||
38007317|NCT00392015|69690757|FG004|Overall Study|Adverse Event|1|||
38007318|NCT00392015|69690758|FG005|Overall Study|Adverse Event|0|||
38007319|NCT00392015|69690753|FG000|Overall Study|Previous trial recipient|0|||
38007320|NCT00392015|69690754|FG001|Overall Study|Previous trial recipient|0|||
38007321|NCT00392015|69690755|FG002|Overall Study|Previous trial recipient|0|||
38007322|NCT00392015|69690756|FG003|Overall Study|Previous trial recipient|0|||
38007323|NCT00392015|69690757|FG004|Overall Study|Previous trial recipient|1|||
38007324|NCT00392015|69690758|FG005|Overall Study|Previous trial recipient|0|||
38007325|NCT00094302|69690779|FG000|Overall Study|Lost to Follow-up|43|||
38007326|NCT00094302|69690780|FG001|Overall Study|Lost to Follow-up|41|||
38007327|NCT00094302|69690779|FG000|Overall Study|Physician Decision|5|||
38007328|NCT00094302|69690780|FG001|Overall Study|Physician Decision|8|||
38007329|NCT00094302|69690779|FG000|Overall Study|Withdrawal by Subject|103|||
38007330|NCT00094302|69690780|FG001|Overall Study|Withdrawal by Subject|111|||
38007331|NCT00094302|69690779|FG000|Overall Study|Death|266|||
38007332|NCT00094302|69690780|FG001|Overall Study|Death|246|||
38007333|NCT00372905|69690786|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
38007334|NCT00372905|69690787|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
38007335|NCT00372905|69690788|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
38007336|NCT00372905|69690789|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
38007337|NCT00372905|69690786|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
38007338|NCT00372905|69690787|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
38007339|NCT00372905|69690788|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
38007340|NCT00372905|69690789|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
38007341|NCT00372905|69690786|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
38007342|NCT00372905|69690787|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
38007343|NCT00372905|69690788|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
38007344|NCT00372905|69690789|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
38007345|NCT00372905|69690786|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
38007346|NCT00372905|69690787|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
38007347|NCT00372905|69690788|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
38007348|NCT00372905|69690789|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
38007349|NCT00372905|69690786|FG000|Follow up Until Relapse or Progression|Study closed|0|||
38007350|NCT00372905|69690787|FG001|Follow up Until Relapse or Progression|Study closed|0|||
38007351|NCT00372905|69690788|FG002|Follow up Until Relapse or Progression|Study closed|0|||
38007352|NCT00372905|69690789|FG003|Follow up Until Relapse or Progression|Study closed|3|||
38007353|NCT00372905|69690786|FG000|Follow up Until Relapse or Progression|Other|0|||
38007354|NCT00372905|69690787|FG001|Follow up Until Relapse or Progression|Other|1|||
38007355|NCT00372905|69690788|FG002|Follow up Until Relapse or Progression|Other|0|||
38007356|NCT00372905|69690789|FG003|Follow up Until Relapse or Progression|Other|0|||
38007357|NCT00384839|69690799|FG000|Overall Study|Adverse Event|4|||
38007358|NCT00384839|69690799|FG000|Overall Study|Investigator Request|1|||
38007359|NCT00384839|69690799|FG000|Overall Study|Patient Request|1|||
38007360|NCT00384839|69690799|FG000|Overall Study|Ineligible|2|||
38007361|NCT00384293|69690805|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
38007362|NCT00384293|69690806|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
38007363|NCT00384293|69690807|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
38007364|NCT00384293|69690805|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
38007365|NCT00384293|69690806|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
38007366|NCT00384293|69690807|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
38007367|NCT00384293|69690805|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
38007368|NCT00384293|69690806|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
38007369|NCT00384293|69690807|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
38007370|NCT00384293|69690805|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
38007371|NCT00384293|69690806|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
38007372|NCT00384293|69690807|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
38007373|NCT00384293|69690805|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
38007374|NCT00384293|69690806|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
38007375|NCT00384293|69690807|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
38007376|NCT00384293|69690805|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
38007377|NCT00384293|69690806|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
38007378|NCT00384293|69690807|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
37831065|NCT01246973|69514476|FG001|Overall Study|Adverse Event|9|||
37907753|NCT00955409|69593453|FG004|Overall Study|Lack of Efficacy|0|||
37831066|NCT01246973|69514475|FG000|Overall Study|Withdrawal by Subject|7|||
37831067|NCT01246973|69514476|FG001|Overall Study|Withdrawal by Subject|13|||
37831068|NCT01246466|69514482|FG000|Overall Study|Death|1|||
37831069|NCT01246466|69514482|FG000|Overall Study|Withdrawal by Subject|1|||
37831070|NCT01245764|69514491|FG000|Study Phase A|Other|3|||
37831071|NCT01245764|69514492|FG001|Study Phase A|Other|2|||
37831072|NCT01245764|69514493|FG002|Study Phase A|Other|3|||
37831073|NCT01245764|69514494|FG003|Study Phase A|Other|1|||
37831074|NCT01245764|69514491|FG000|Study Phase A|Protocol Violation|6|||
37831075|NCT01245764|69514492|FG001|Study Phase A|Protocol Violation|3|||
37831076|NCT01245764|69514493|FG002|Study Phase A|Protocol Violation|2|||
37831077|NCT01245764|69514494|FG003|Study Phase A|Protocol Violation|2|||
37831078|NCT01245764|69514491|FG000|Study Phase A|Lost to Follow-up|0|||
37831079|NCT01245764|69514492|FG001|Study Phase A|Lost to Follow-up|0|||
37831080|NCT01245764|69514493|FG002|Study Phase A|Lost to Follow-up|5|||
37831081|NCT01245764|69514494|FG003|Study Phase A|Lost to Follow-up|0|||
37831082|NCT01245140|69514514|FG000|Overall Study|Adverse Event|1|||
37831083|NCT01245140|69514515|FG001|Overall Study|Adverse Event|3|||
37831084|NCT01245140|69514514|FG000|Overall Study|Lack of Efficacy|2|||
37831085|NCT01245140|69514515|FG001|Overall Study|Lack of Efficacy|4|||
37831086|NCT01245140|69514514|FG000|Overall Study|Protocol Violation|0|||
37831087|NCT01245140|69514515|FG001|Overall Study|Protocol Violation|1|||
37831088|NCT01245140|69514514|FG000|Overall Study|Withdrawal by Subject|0|||
37831089|NCT01245140|69514515|FG001|Overall Study|Withdrawal by Subject|1|||
37831090|NCT01245140|69514514|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
37831091|NCT01245140|69514515|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
37831092|NCT01245101|69514523|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
37831093|NCT01245101|69514524|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
37831094|NCT01245101|69514523|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
37831095|NCT01245101|69514524|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
37831096|NCT01245101|69514523|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
37831097|NCT01245101|69514524|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
37831098|NCT01245062|69514532|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
37831099|NCT01245062|69514533|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
37831100|NCT01245062|69514534|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
37831101|NCT01245062|69514532|FG000|Randomization and Crossover Phase|Physician Decision|2|||
37831102|NCT01245062|69514533|FG001|Randomization and Crossover Phase|Physician Decision|4|||
37831103|NCT01245062|69514534|FG002|Randomization and Crossover Phase|Physician Decision|0|||
37831104|NCT01245062|69514532|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
37907754|NCT00955409|69593454|FG005|Overall Study|Lack of Efficacy|0|||
37831105|NCT01245062|69514533|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
37831106|NCT01245062|69514534|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
37831107|NCT01245062|69514532|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
37831108|NCT01245062|69514533|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
37831109|NCT01245062|69514534|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
37831110|NCT01245062|69514532|FG000|Cross-over Phase|Lost to Follow-up|0|||
37831111|NCT01245062|69514533|FG001|Cross-over Phase|Lost to Follow-up|0|||
37907755|NCT00955409|69593455|FG006|Overall Study|Lack of Efficacy|0|||
38007379|NCT00384293|69690805|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
38007380|NCT00384293|69690806|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
38007381|NCT00384293|69690807|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
38007382|NCT00384293|69690805|FG000|Post-randomization Period|Adverse Event|0|||
38007383|NCT00384293|69690806|FG001|Post-randomization Period|Adverse Event|23|||
38007384|NCT00384293|69690807|FG002|Post-randomization Period|Adverse Event|7|||
38007385|NCT00384293|69690805|FG000|Post-randomization Period|Lost to Follow-up|0|||
38007386|NCT00384293|69690806|FG001|Post-randomization Period|Lost to Follow-up|2|||
38007387|NCT00384293|69690807|FG002|Post-randomization Period|Lost to Follow-up|1|||
38007388|NCT00384293|69690805|FG000|Post-randomization Period|Protocol Violation|0|||
38007389|NCT00384293|69690806|FG001|Post-randomization Period|Protocol Violation|1|||
38007390|NCT00384293|69690807|FG002|Post-randomization Period|Protocol Violation|0|||
38007391|NCT00384293|69690805|FG000|Post-randomization Period|Withdrawal by Subject|0|||
38007392|NCT00384293|69690806|FG001|Post-randomization Period|Withdrawal by Subject|8|||
38007393|NCT00384293|69690807|FG002|Post-randomization Period|Withdrawal by Subject|6|||
38007394|NCT00384293|69690805|FG000|Post-randomization Period|Trial Termination|0|||
38007395|NCT00384293|69690806|FG001|Post-randomization Period|Trial Termination|180|||
38007396|NCT00384293|69690807|FG002|Post-randomization Period|Trial Termination|204|||
38007397|NCT00384293|69690805|FG000|Post-randomization Period|Patient Randomized in Error|0|||
37907756|NCT00955409|69593456|FG007|Overall Study|Lack of Efficacy|0|||
37907757|NCT00955409|69593457|FG008|Overall Study|Lack of Efficacy|0|||
37907758|NCT00955409|69593458|FG009|Overall Study|Lack of Efficacy|0|||
37907759|NCT00955409|69593449|FG000|Overall Study|Withdrawal by Subject|1|||
37907760|NCT00955409|69593450|FG001|Overall Study|Withdrawal by Subject|0|||
38007398|NCT00384293|69690806|FG001|Post-randomization Period|Patient Randomized in Error|0|||
38007399|NCT00384293|69690807|FG002|Post-randomization Period|Patient Randomized in Error|1|||
38007400|NCT00067002|69690817|FG000|Overall Study|Early Death|1|||
38007401|NCT00067002|69690818|FG001|Overall Study|Early Death|2|||
38007402|NCT00067002|69690817|FG000|Overall Study|Delayed|1|||
38007403|NCT00067002|69690818|FG001|Overall Study|Delayed|1|||
38007404|NCT00067002|69690817|FG000|Overall Study|Graft Failure|5|||
38007405|NCT00067002|69690818|FG001|Overall Study|Graft Failure|6|||
38007406|NCT00091572|69690826|FG000|Overall Study|Lost to Follow-up|1|||
38007407|NCT00091572|69690827|FG001|Overall Study|Lost to Follow-up|1|||
38007408|NCT00091572|69690826|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
38007409|NCT00091572|69690827|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
38007410|NCT00091572|69690826|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
38007411|NCT00091572|69690827|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
38007412|NCT00091572|69690826|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
38007413|NCT00091572|69690827|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
38007414|NCT00091572|69690826|FG000|Overall Study|Other Reason|6|||
38007415|NCT00091572|69690827|FG001|Overall Study|Other Reason|13|||
38007416|NCT00091572|69690826|FG000|Overall Study|Ongoing (still on treatment)|8|||
38007417|NCT00091572|69690827|FG001|Overall Study|Ongoing (still on treatment)|12|||
38007418|NCT00091572|69690826|FG000|Overall Study|Major Protocol Violation|2|||
38007419|NCT00091572|69690827|FG001|Overall Study|Major Protocol Violation|0|||
38007420|NCT00091572|69690826|FG000|Overall Study|Toxicity (Related AE)|53|||
38007421|NCT00091572|69690827|FG001|Overall Study|Toxicity (Related AE)|9|||
38007422|NCT00084266|69690835|FG000|Overall Study|Death|42|||
38007423|NCT00084266|69690836|FG001|Overall Study|Death|39|||
38007424|NCT00084266|69690835|FG000|Overall Study|Adverse Event|8|||
38007425|NCT00084266|69690836|FG001|Overall Study|Adverse Event|5|||
38007426|NCT00084266|69690835|FG000|Overall Study|Lack of Efficacy|2|||
38007427|NCT00084266|69690836|FG001|Overall Study|Lack of Efficacy|4|||
38007428|NCT00084266|69690835|FG000|Overall Study|Lost to Follow-up|5|||
38007429|NCT00084266|69690836|FG001|Overall Study|Lost to Follow-up|3|||
38007430|NCT00084266|69690835|FG000|Overall Study|Participant not willing to participate|3|||
38007431|NCT00084266|69690836|FG001|Overall Study|Participant not willing to participate|8|||
38007432|NCT00084266|69690835|FG000|Overall Study|Other|360|||
38007433|NCT00084266|69690836|FG001|Overall Study|Other|344|||
38007434|NCT00084266|69690835|FG000|Overall Study|Randomized not treated|21|||
37907761|NCT00955409|69593451|FG002|Overall Study|Withdrawal by Subject|5|||
37907762|NCT00955409|69593452|FG003|Overall Study|Withdrawal by Subject|2|||
37907763|NCT00955409|69593453|FG004|Overall Study|Withdrawal by Subject|0|||
37907764|NCT00955409|69593454|FG005|Overall Study|Withdrawal by Subject|0|||
37907765|NCT00955409|69593455|FG006|Overall Study|Withdrawal by Subject|2|||
37907766|NCT00955409|69593456|FG007|Overall Study|Withdrawal by Subject|0|||
38007435|NCT00084266|69690836|FG001|Overall Study|Randomized not treated|20|||
37907767|NCT00955409|69593457|FG008|Overall Study|Withdrawal by Subject|1|||
37907768|NCT00955409|69593458|FG009|Overall Study|Withdrawal by Subject|0|||
38007436|NCT00091026|69690844|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
38007437|NCT00091026|69690845|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
38007438|NCT00091026|69690844|FG000|Overall Study|Patient withdrew and never received trea|0|||
38007439|NCT00091026|69690845|FG001|Overall Study|Patient withdrew and never received trea|2|||
38007440|NCT00091026|69690844|FG000|Overall Study|Unknown-never received treatment|0|||
38007441|NCT00091026|69690845|FG001|Overall Study|Unknown-never received treatment|1|||
38007442|NCT00116558|69690854|FG000|Overall Study|Death|11|||
38007443|NCT00116558|69690855|FG001|Overall Study|Death|5|||
38007444|NCT00116558|69690856|FG002|Overall Study|Death|3|||
38007445|NCT00116558|69690854|FG000|Overall Study|Withdrawal by Subject|17|||
38007446|NCT00116558|69690855|FG001|Overall Study|Withdrawal by Subject|3|||
38007447|NCT00116558|69690856|FG002|Overall Study|Withdrawal by Subject|12|||
38007448|NCT00116558|69690854|FG000|Overall Study|disease progression|3|||
38007449|NCT00116558|69690855|FG001|Overall Study|disease progression|7|||
38007450|NCT00116558|69690856|FG002|Overall Study|disease progression|18|||
38007451|NCT00116168|69690867|FG000|Overall Study|Lost to Follow-up|6|||
38007452|NCT00116168|69690868|FG001|Overall Study|Lost to Follow-up|5|||
38007453|NCT00116168|69690869|FG002|Overall Study|Lost to Follow-up|0|||
38007454|NCT00116168|69690870|FG003|Overall Study|Lost to Follow-up|0|||
38007455|NCT00115934|69690882|FG000|Overall Study|Lost to Follow-up|1|||
38007456|NCT00115934|69690883|FG001|Overall Study|Lost to Follow-up|0|||
38007457|NCT00115934|69690882|FG000|Overall Study|Did not receive intervention|3|||
38007458|NCT00115934|69690883|FG001|Overall Study|Did not receive intervention|2|||
38007459|NCT00115778|69690889|FG000|Overall Study|Withdrawal by Subject|0|||
38007460|NCT00115778|69690890|FG001|Overall Study|Withdrawal by Subject|1|||
38007461|NCT00100178|69690899|FG000|Overall Study|Lost to Follow-up|0|||
38007462|NCT00100178|69690900|FG001|Overall Study|Lost to Follow-up|6|||
38007463|NCT00100178|69690901|FG002|Overall Study|Lost to Follow-up|5|||
38007464|NCT00100178|69690899|FG000|Overall Study|Adverse Event|2|||
38007465|NCT00100178|69690900|FG001|Overall Study|Adverse Event|2|||
38007466|NCT00100178|69690901|FG002|Overall Study|Adverse Event|1|||
38007467|NCT00100178|69690899|FG000|Overall Study|Withdrawal by Subject|1|||
38007468|NCT00100178|69690900|FG001|Overall Study|Withdrawal by Subject|1|||
38007469|NCT00100178|69690901|FG002|Overall Study|Withdrawal by Subject|1|||
38007470|NCT00100178|69690899|FG000|Overall Study|Physician Decision|6|||
38007471|NCT00100178|69690900|FG001|Overall Study|Physician Decision|1|||
38007472|NCT00100178|69690901|FG002|Overall Study|Physician Decision|3|||
38007473|NCT00099632|69690915|FG000|Overall Study|Lost to Follow-up|1|||
38007474|NCT00099632|69690916|FG001|Overall Study|Lost to Follow-up|0|||
38007475|NCT00099632|69690917|FG002|Overall Study|Lost to Follow-up|3|||
38007476|NCT00099632|69690918|FG003|Overall Study|Lost to Follow-up|1|||
38007477|NCT00099632|69690919|FG004|Overall Study|Lost to Follow-up|1|||
38007478|NCT00099632|69690920|FG005|Overall Study|Lost to Follow-up|0|||
38007479|NCT00099632|69690915|FG000|Overall Study|Withdrawal by Subject|0|||
38007480|NCT00099632|69690916|FG001|Overall Study|Withdrawal by Subject|1|||
38007481|NCT00099632|69690917|FG002|Overall Study|Withdrawal by Subject|0|||
38007482|NCT00099632|69690918|FG003|Overall Study|Withdrawal by Subject|0|||
38007483|NCT00099632|69690919|FG004|Overall Study|Withdrawal by Subject|0|||
38007484|NCT00099632|69690920|FG005|Overall Study|Withdrawal by Subject|1|||
38007485|NCT00099632|69690915|FG000|Overall Study|Protocol Violation|0|||
38007486|NCT00099632|69690916|FG001|Overall Study|Protocol Violation|0|||
38007487|NCT00099632|69690917|FG002|Overall Study|Protocol Violation|0|||
38007488|NCT00099632|69690918|FG003|Overall Study|Protocol Violation|0|||
37907769|NCT00955409|69593449|FG000|Overall Study|Caregiver Request|2|||
38007489|NCT00099632|69690919|FG004|Overall Study|Protocol Violation|0|||
38007490|NCT00099632|69690920|FG005|Overall Study|Protocol Violation|1|||
38007491|NCT00098774|69690934|FG000|Overall Study|Adverse Event|2|||
38007492|NCT00098774|69690934|FG000|Overall Study|Disease Progression|9|||
37907770|NCT00955409|69593450|FG001|Overall Study|Caregiver Request|0|||
38007493|NCT00098774|69690934|FG000|Overall Study|Withdrawal by Subject|1|||
38007494|NCT00098774|69690934|FG000|Overall Study|Failed (to respond) during induction|4|||
37907771|NCT00955409|69593451|FG002|Overall Study|Caregiver Request|6|||
38007495|NCT00098774|69690934|FG000|Overall Study|Physician Decision|2|||
38007496|NCT00384059|69690940|FG000|Infant Series|Not consented|2|||
38007497|NCT00384059|69690941|FG001|Infant Series|Not consented|6|||
38007498|NCT00384059|69690940|FG000|Infant Series|Withdrawal by Subject|2|||
38007499|NCT00384059|69690941|FG001|Infant Series|Withdrawal by Subject|2|||
38007500|NCT00384059|69690940|FG000|Infant Series|Adverse Event|1|||
38007501|NCT00384059|69690941|FG001|Infant Series|Adverse Event|2|||
38007502|NCT00384059|69690940|FG000|Infant Series|Protocol Violation|1|||
38007503|NCT00384059|69690941|FG001|Infant Series|Protocol Violation|2|||
38007504|NCT00384059|69690940|FG000|Infant Series|Lost to Follow-up|0|||
38007505|NCT00384059|69690941|FG001|Infant Series|Lost to Follow-up|1|||
38007506|NCT00384059|69690940|FG000|After Infant Series|Protocol Violation|2|||
38007507|NCT00384059|69690941|FG001|After Infant Series|Protocol Violation|3|||
38007508|NCT00384059|69690940|FG000|After Infant Series|Withdrawal by Subject|2|||
38007509|NCT00384059|69690941|FG001|After Infant Series|Withdrawal by Subject|2|||
38007510|NCT00384059|69690940|FG000|After Infant Series|Failed to Return|0|||
38007511|NCT00384059|69690941|FG001|After Infant Series|Failed to Return|2|||
38007512|NCT00384059|69690940|FG000|After Infant Series|Adverse Event|0|||
38007513|NCT00384059|69690941|FG001|After Infant Series|Adverse Event|1|||
38007514|NCT00384059|69690940|FG000|After Infant Series|Physician Decision|0|||
38007515|NCT00384059|69690941|FG001|After Infant Series|Physician Decision|1|||
38007516|NCT00384059|69690940|FG000|After Infant Series|Lost to Follow-up|0|||
38007517|NCT00384059|69690941|FG001|After Infant Series|Lost to Follow-up|1|||
37697724|NCT01823536|69174316|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
37697725|NCT01823536|69174317|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
37697726|NCT01823536|69174318|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
37697727|NCT01823536|69174319|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
37697728|NCT01823536|69174320|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
37697729|NCT01823536|69174321|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
37697730|NCT01823536|69174316|FG000|Overall Study|Met exclusion criterion No 6|0|||
37697731|NCT01823536|69174317|FG001|Overall Study|Met exclusion criterion No 6|0|||
37697732|NCT01823536|69174318|FG002|Overall Study|Met exclusion criterion No 6|0|||
37907772|NCT00955409|69593452|FG003|Overall Study|Caregiver Request|5|||
37907773|NCT00955409|69593453|FG004|Overall Study|Caregiver Request|0|||
37907774|NCT00955409|69593454|FG005|Overall Study|Caregiver Request|2|||
37907775|NCT00955409|69593455|FG006|Overall Study|Caregiver Request|3|||
37907776|NCT00955409|69593456|FG007|Overall Study|Caregiver Request|1|||
37907777|NCT00955409|69593457|FG008|Overall Study|Caregiver Request|3|||
37907778|NCT00955409|69593458|FG009|Overall Study|Caregiver Request|0|||
37907779|NCT00955409|69593449|FG000|Overall Study|Investigator Request|0|||
37907780|NCT00955409|69593450|FG001|Overall Study|Investigator Request|0|||
37907781|NCT00955409|69593451|FG002|Overall Study|Investigator Request|1|||
37907782|NCT00955409|69593452|FG003|Overall Study|Investigator Request|0|||
37907783|NCT00955409|69593453|FG004|Overall Study|Investigator Request|0|||
37907784|NCT00955409|69593454|FG005|Overall Study|Investigator Request|0|||
37907785|NCT00955409|69593455|FG006|Overall Study|Investigator Request|0|||
37907786|NCT00955409|69593456|FG007|Overall Study|Investigator Request|0|||
37907787|NCT00955409|69593457|FG008|Overall Study|Investigator Request|0|||
37907788|NCT00955409|69593458|FG009|Overall Study|Investigator Request|0|||
37907789|NCT00955409|69593449|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
37907790|NCT00955409|69593450|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
37907791|NCT00955409|69593451|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
37907792|NCT00955409|69593452|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
37907793|NCT00955409|69593453|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
37907794|NCT00955409|69593454|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
37907795|NCT00955409|69593455|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
37907796|NCT00955409|69593456|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
37907797|NCT00955409|69593457|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
37907798|NCT00955409|69593458|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
37907799|NCT00955409|69593449|FG000|Overall Study|Lost to Follow-up|0|||
37907800|NCT00955409|69593450|FG001|Overall Study|Lost to Follow-up|0|||
37907801|NCT00955409|69593451|FG002|Overall Study|Lost to Follow-up|1|||
37907802|NCT00955409|69593452|FG003|Overall Study|Lost to Follow-up|0|||
37907803|NCT00955409|69593453|FG004|Overall Study|Lost to Follow-up|0|||
37907804|NCT00955409|69593454|FG005|Overall Study|Lost to Follow-up|0|||
37907805|NCT00955409|69593455|FG006|Overall Study|Lost to Follow-up|1|||
37907806|NCT00955409|69593456|FG007|Overall Study|Lost to Follow-up|0|||
37907807|NCT00955409|69593457|FG008|Overall Study|Lost to Follow-up|0|||
37907808|NCT00955409|69593458|FG009|Overall Study|Lost to Follow-up|0|||
37907809|NCT00955409|69593449|FG000|Overall Study|Failed to Return|2|||
37907810|NCT00955409|69593450|FG001|Overall Study|Failed to Return|0|||
37907811|NCT00955409|69593451|FG002|Overall Study|Failed to Return|0|||
37907812|NCT00955409|69593452|FG003|Overall Study|Failed to Return|0|||
37697733|NCT01823536|69174319|FG003|Overall Study|Met exclusion criterion No 6|1|||
37697734|NCT01823536|69174320|FG004|Overall Study|Met exclusion criterion No 6|0|||
37697735|NCT01823536|69174321|FG005|Overall Study|Met exclusion criterion No 6|0|||
37697736|NCT01823536|69174316|FG000|Overall Study|Subject moved out of the state|0|||
37907813|NCT00955409|69593453|FG004|Overall Study|Failed to Return|0|||
37907814|NCT00955409|69593454|FG005|Overall Study|Failed to Return|0|||
37907815|NCT00955409|69593455|FG006|Overall Study|Failed to Return|0|||
37697737|NCT01823536|69174317|FG001|Overall Study|Subject moved out of the state|0|||
37697738|NCT01823536|69174318|FG002|Overall Study|Subject moved out of the state|0|||
37697739|NCT01823536|69174319|FG003|Overall Study|Subject moved out of the state|0|||
37697740|NCT01823536|69174320|FG004|Overall Study|Subject moved out of the state|1|||
37907816|NCT00955409|69593456|FG007|Overall Study|Failed to Return|2|||
37907817|NCT00955409|69593457|FG008|Overall Study|Failed to Return|0|||
37907818|NCT00955409|69593458|FG009|Overall Study|Failed to Return|0|||
38007518|NCT00384059|69690940|FG000|Toddler Dose|Lost to Follow-up|1|||
37907819|NCT00955409|69593449|FG000|Overall Study|Adverse Event (AE)|2|||
37907820|NCT00955409|69593450|FG001|Overall Study|Adverse Event (AE)|0|||
37907821|NCT00955409|69593451|FG002|Overall Study|Adverse Event (AE)|0|||
37907822|NCT00955409|69593452|FG003|Overall Study|Adverse Event (AE)|0|||
37907823|NCT00955409|69593453|FG004|Overall Study|Adverse Event (AE)|0|||
37907824|NCT00955409|69593454|FG005|Overall Study|Adverse Event (AE)|1|||
37907825|NCT00955409|69593455|FG006|Overall Study|Adverse Event (AE)|2|||
37907826|NCT00955409|69593456|FG007|Overall Study|Adverse Event (AE)|0|||
37907827|NCT00955409|69593457|FG008|Overall Study|Adverse Event (AE)|2|||
37907828|NCT00955409|69593458|FG009|Overall Study|Adverse Event (AE)|0|||
37907829|NCT00955409|69593449|FG000|Overall Study|Reason not Specified|2|||
37907830|NCT00955409|69593450|FG001|Overall Study|Reason not Specified|1|||
37907831|NCT00955409|69593451|FG002|Overall Study|Reason not Specified|13|||
37907832|NCT00955409|69593452|FG003|Overall Study|Reason not Specified|1|||
37907833|NCT00955409|69593453|FG004|Overall Study|Reason not Specified|2|||
37907834|NCT00955409|69593454|FG005|Overall Study|Reason not Specified|0|||
37907835|NCT00955409|69593455|FG006|Overall Study|Reason not Specified|16|||
37697741|NCT01823536|69174321|FG005|Overall Study|Subject moved out of the state|0|||
37697742|NCT01841554|69174334|FG000|Overall Study|Death|7|||
37697743|NCT01841554|69174334|FG000|Overall Study|No Implantation|1|||
37697744|NCT01841554|69174334|FG000|Overall Study|Discontinued Follow Up|5|||
38007519|NCT00384059|69690941|FG001|Toddler Dose|Lost to Follow-up|1|||
38007520|NCT00384059|69690940|FG000|Toddler Dose|Failed to return|0|||
38007521|NCT00384059|69690941|FG001|Toddler Dose|Failed to return|1|||
38007522|NCT00383123|69690970|FG000|Overall Study|Adverse Event|1|||
38007523|NCT00383123|69690971|FG001|Overall Study|Adverse Event|0|||
38007524|NCT00383123|69690970|FG000|Overall Study|Lost to Follow-up|68|||
38007525|NCT00383123|69690971|FG001|Overall Study|Lost to Follow-up|61|||
38007526|NCT00383123|69690970|FG000|Overall Study|Protocol Violation|5|||
38007527|NCT00383123|69690971|FG001|Overall Study|Protocol Violation|1|||
38007528|NCT00383123|69690970|FG000|Overall Study|Withdrawal by Subject|27|||
38007529|NCT00383123|69690971|FG001|Overall Study|Withdrawal by Subject|18|||
38007530|NCT00383123|69690970|FG000|Overall Study|Other reason|10|||
38007531|NCT00383123|69690971|FG001|Overall Study|Other reason|6|||
38007532|NCT00382967|69690979|FG000|Overall Study|Protocol Violation|1|||
38007533|NCT00382967|69690980|FG001|Overall Study|Protocol Violation|1|||
38007534|NCT00858364|69690988|FG000|Overall Study|Administrative Decision|3|||
38007535|NCT00858364|69690989|FG001|Overall Study|Administrative Decision|2|||
38007536|NCT00858364|69690988|FG000|Overall Study|Adverse Event|5|||
38007537|NCT00858364|69690989|FG001|Overall Study|Adverse Event|2|||
38007538|NCT00858364|69690988|FG000|Overall Study|Withdrawal by Subject|44|||
38007539|NCT00858364|69690989|FG001|Overall Study|Withdrawal by Subject|118|||
38007540|NCT00858364|69690988|FG000|Overall Study|Ineligibility Determined|1|||
38007541|NCT00858364|69690989|FG001|Overall Study|Ineligibility Determined|10|||
38007542|NCT00858364|69690988|FG000|Overall Study|Lost to Follow-up|24|||
38007543|NCT00858364|69690989|FG001|Overall Study|Lost to Follow-up|54|||
38007544|NCT00858364|69690988|FG000|Overall Study|Noncompliance|3|||
38007545|NCT00858364|69690989|FG001|Overall Study|Noncompliance|4|||
38007546|NCT00858364|69690988|FG000|Overall Study|Protocol Deviation|0|||
38007547|NCT00858364|69690989|FG001|Overall Study|Protocol Deviation|2|||
38007548|NCT00858364|69690988|FG000|Overall Study|Other|9|||
38007549|NCT00858364|69690989|FG001|Overall Study|Other|17|||
38007550|NCT00858364|69690988|FG000|Overall Study|Missing|1|||
38007551|NCT00858364|69690989|FG001|Overall Study|Missing|1|||
38007552|NCT00858364|69690988|FG000|Overall Study|Still on-study|114|||
38007553|NCT00858364|69690989|FG001|Overall Study|Still on-study|247|||
38007554|NCT00382733|69690995|FG000|Overall Study|Withdrawal by Subject|0|||
38007555|NCT00382733|69690996|FG001|Overall Study|Withdrawal by Subject|1|||
38007556|NCT00382733|69690997|FG002|Overall Study|Withdrawal by Subject|0|||
38007557|NCT00382733|69690998|FG003|Overall Study|Withdrawal by Subject|0|||
37907836|NCT00955409|69593456|FG007|Overall Study|Reason not Specified|0|||
37907837|NCT00955409|69593457|FG008|Overall Study|Reason not Specified|8|||
37907838|NCT00955409|69593458|FG009|Overall Study|Reason not Specified|1|||
37907839|NCT00615901|69593484|FG000|Overall Study|Withdrawal by Subject|2|||
38007558|NCT00382733|69690999|FG004|Overall Study|Withdrawal by Subject|0|||
38007559|NCT03631732|69691014|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
38007560|NCT03631732|69691015|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
38007561|NCT03631732|69691014|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
38007562|NCT03631732|69691015|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
38007563|NCT03631732|69691014|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
38007564|NCT03631732|69691015|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
38007565|NCT03631732|69691014|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
38007566|NCT03631732|69691015|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
38007567|NCT03631732|69691014|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
37907840|NCT00615901|69593484|FG000|Overall Study|Adverse Event|7|||
37907841|NCT00616603|69593496|FG000|Overall Study|Physician Decision|2|||
37907842|NCT00616603|69593497|FG001|Overall Study|Physician Decision|0|||
38007568|NCT03631732|69691015|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
38007569|NCT03631732|69691014|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
38007570|NCT03631732|69691015|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
38007571|NCT03631732|69691014|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
38007572|NCT03631732|69691015|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
38007573|NCT03631732|69691014|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
38007574|NCT03631732|69691015|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
38007575|NCT03631732|69691014|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
38007576|NCT03631732|69691015|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
38007577|NCT03631732|69691014|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
38007578|NCT03631732|69691015|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
38007579|NCT03630016|69691025|FG000|Overall Study|Poor Sensor Placement|1|||
37907843|NCT00616603|69593498|FG002|Overall Study|Physician Decision|2|||
37907844|NCT00573313|69593510|FG000|Overall Study|Protocol Violation|5|||
37907845|NCT00573313|69593511|FG001|Overall Study|Protocol Violation|0|||
37907846|NCT00573313|69593512|FG002|Overall Study|Protocol Violation|6|||
37907847|NCT00573313|69593513|FG003|Overall Study|Protocol Violation|0|||
37907848|NCT00953615|69593520|FG000|Overall Study|Adverse Event|1|||
37907849|NCT00810615|69593526|FG000|Overall Study|Withdrawal by Subject|1|||
37907850|NCT00810615|69593527|FG001|Overall Study|Withdrawal by Subject|1|||
37907851|NCT00573391|69593547|FG000|Overall Study|study stopped|2|||
37907852|NCT00573391|69593548|FG001|Overall Study|study stopped|2|||
37907853|NCT00573391|69593547|FG000|Overall Study|Death|1|||
37907854|NCT00573391|69593548|FG001|Overall Study|Death|0|||
37907855|NCT00590967|69593556|FG000|Overall Study|Withdrawal by Subject|1|||
37907856|NCT00590967|69593557|FG001|Overall Study|Withdrawal by Subject|1|||
37907857|NCT00590967|69593556|FG000|Overall Study|Ineligible|1|||
38007580|NCT03628924|69691032|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
38007581|NCT03628924|69691033|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
38007582|NCT03628924|69691034|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
38007583|NCT03628924|69691035|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
38007584|NCT03628924|69691036|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
38007585|NCT03628924|69691037|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
38007586|NCT03628924|69691038|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
38007587|NCT03628924|69691032|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
38007588|NCT03628924|69691033|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
38007589|NCT03628924|69691034|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
38007590|NCT03628924|69691035|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
38007591|NCT03628924|69691036|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
38007592|NCT03628924|69691037|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
38007593|NCT03628924|69691038|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
38007594|NCT03628924|69691032|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
38007595|NCT03628924|69691033|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
38007596|NCT03628924|69691034|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
38007597|NCT03628924|69691035|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
38007598|NCT03628924|69691036|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
38007599|NCT03628924|69691037|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
38007600|NCT03628924|69691038|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
37831112|NCT01245062|69514534|FG002|Cross-over Phase|Lost to Follow-up|1|||
37831113|NCT01245062|69514532|FG000|Cross-over Phase|Physician Decision|0|||
37831114|NCT01245062|69514533|FG001|Cross-over Phase|Physician Decision|0|||
37831115|NCT01245062|69514534|FG002|Cross-over Phase|Physician Decision|1|||
37831116|NCT01245062|69514532|FG000|Cross-over Phase|Withdrew Consent|0|||
37831117|NCT01245062|69514533|FG001|Cross-over Phase|Withdrew Consent|0|||
37831118|NCT01245062|69514534|FG002|Cross-over Phase|Withdrew Consent|4|||
37831119|NCT01245062|69514532|FG000|Cross-over Phase|Study closed/ terminated|0|||
37831120|NCT01245062|69514533|FG001|Cross-over Phase|Study closed/ terminated|0|||
37831121|NCT01245062|69514534|FG002|Cross-over Phase|Study closed/ terminated|11|||
37831122|NCT01244984|69514545|FG000|Overall Study|Adverse Event|2|||
37831123|NCT01244984|69514546|FG001|Overall Study|Adverse Event|11|||
37831124|NCT01244984|69514547|FG002|Overall Study|Adverse Event|2|||
37831125|NCT01244984|69514545|FG000|Overall Study|Protocol Violation|1|||
37831126|NCT01244984|69514546|FG001|Overall Study|Protocol Violation|0|||
37831127|NCT01244984|69514547|FG002|Overall Study|Protocol Violation|0|||
37907858|NCT00590967|69593557|FG001|Overall Study|Ineligible|0|||
37907859|NCT00590967|69593556|FG000|Overall Study|Poor performance status|0|||
37831128|NCT01244984|69514545|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
38007601|NCT03628924|69691032|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
38007602|NCT03628924|69691033|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
38007603|NCT03628924|69691034|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
38007604|NCT03628924|69691035|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
38007605|NCT03628924|69691036|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
38007606|NCT03628924|69691037|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
38007607|NCT03628924|69691038|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
38007608|NCT03628924|69691032|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
38007609|NCT03628924|69691033|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
38007610|NCT03628924|69691034|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
38007611|NCT03628924|69691035|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
38007612|NCT03628924|69691036|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
38007613|NCT03628924|69691037|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
38007614|NCT03628924|69691038|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
38007615|NCT03628924|69691032|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
38007616|NCT03628924|69691033|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
38007617|NCT03628924|69691034|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
38007618|NCT03628924|69691035|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
38007619|NCT03628924|69691036|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
38007620|NCT03628924|69691037|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
38007621|NCT03628924|69691038|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
38007622|NCT03628924|69691032|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
38007623|NCT03628924|69691033|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
38007624|NCT03628924|69691034|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
38007625|NCT03628924|69691035|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
38007626|NCT03628924|69691036|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
38007627|NCT03628924|69691037|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
38007628|NCT03628924|69691038|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
38007629|NCT03628924|69691032|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
38007630|NCT03628924|69691033|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
38007631|NCT03628924|69691034|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
38007632|NCT03628924|69691035|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
38007633|NCT03628924|69691036|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
38007634|NCT03628924|69691037|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
38007635|NCT03628924|69691038|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
38007636|NCT03628924|69691032|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
37907860|NCT00590967|69593557|FG001|Overall Study|Poor performance status|1|||
37907861|NCT00590967|69593556|FG000|Overall Study|Non-compliant|0|||
37907862|NCT00590967|69593557|FG001|Overall Study|Non-compliant|2|||
37907863|NCT00590967|69593556|FG000|Overall Study|Did not sign consent form|0|||
37907864|NCT00590967|69593557|FG001|Overall Study|Did not sign consent form|1|||
37907865|NCT00590967|69593556|FG000|Overall Study|Did not receive chemo per protocol|1|||
37907866|NCT00590967|69593557|FG001|Overall Study|Did not receive chemo per protocol|0|||
37907867|NCT00590577|69593567|FG000|Overall Study|Lack of Efficacy|31|||
37907868|NCT00590577|69593568|FG001|Overall Study|Lack of Efficacy|28|||
38007637|NCT03628924|69691033|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
37831129|NCT01244984|69514546|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
37831130|NCT01244984|69514547|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
37831131|NCT01244984|69514545|FG000|Overall Study|Withdrawal by Subject|1|||
37831132|NCT01244984|69514546|FG001|Overall Study|Withdrawal by Subject|2|||
37831133|NCT01244984|69514547|FG002|Overall Study|Withdrawal by Subject|2|||
37831134|NCT01244516|69514559|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
37831135|NCT01244516|69514560|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
37831136|NCT01244516|69514561|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
37831137|NCT01244516|69514559|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
37831138|NCT01244516|69514560|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
37831139|NCT01244516|69514561|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
37831140|NCT01244516|69514559|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
37831141|NCT01244516|69514560|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
37831142|NCT01244516|69514561|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
37831143|NCT01244516|69514559|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
37907869|NCT00590577|69593569|FG002|Overall Study|Lack of Efficacy|23|||
38007638|NCT03628924|69691034|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
38007639|NCT03628924|69691035|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
38007640|NCT03628924|69691036|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
37831144|NCT01244516|69514560|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
37831145|NCT01244516|69514561|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
37831146|NCT01244516|69514559|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
37907870|NCT00590577|69593570|FG003|Overall Study|Lack of Efficacy|45|||
37831147|NCT01244516|69514560|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
37831148|NCT01244516|69514561|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
37831149|NCT01244516|69514559|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
37831150|NCT01244516|69514560|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
37831151|NCT01244516|69514561|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
37831152|NCT01244516|69514559|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
37831153|NCT01244516|69514560|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
37831154|NCT01244516|69514561|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
37831155|NCT01244126|69514573|FG000|Overall Study|Protocol Violation|3|||
37831156|NCT01244126|69514574|FG001|Overall Study|Protocol Violation|3|||
37831157|NCT01244126|69514575|FG002|Overall Study|Protocol Violation|9|||
37831158|NCT01243892|69514585|FG000|Overall Study|Did not meet eligibility criteria|2|||
37831159|NCT01243892|69514586|FG001|Overall Study|Did not meet eligibility criteria|0|||
37831160|NCT01243775|69514592|FG000|Overall Study|Withdrawal by Subject|2|||
37831161|NCT01243268|69514596|FG000|Overall Study|Lost to Follow-up|4|||
37831162|NCT01243268|69514596|FG000|Overall Study|Protocol Violation|51|||
37831163|NCT01243268|69514596|FG000|Overall Study|Deviation with contract date|7|||
37831164|NCT01243268|69514596|FG000|Overall Study|Duplicate subject|2|||
37831165|NCT01242371|69514602|FG000|Overall Study|Withdrawal by Subject|2|||
37831166|NCT01242371|69514603|FG001|Overall Study|Withdrawal by Subject|2|||
37831167|NCT01242371|69514602|FG000|Overall Study|Protocol Violation|0|||
37831168|NCT01242371|69514603|FG001|Overall Study|Protocol Violation|3|||
37907871|NCT00590577|69593567|FG000|Overall Study|Withdrawal by Subject|23|||
37907872|NCT00590577|69593568|FG001|Overall Study|Withdrawal by Subject|28|||
37907873|NCT00590577|69593569|FG002|Overall Study|Withdrawal by Subject|30|||
37907874|NCT00590577|69593570|FG003|Overall Study|Withdrawal by Subject|26|||
37907875|NCT00590577|69593567|FG000|Overall Study|Adverse Event|10|||
37907876|NCT00590577|69593568|FG001|Overall Study|Adverse Event|10|||
37907877|NCT00590577|69593569|FG002|Overall Study|Adverse Event|13|||
37907878|NCT00590577|69593570|FG003|Overall Study|Adverse Event|11|||
37907879|NCT00590577|69593567|FG000|Overall Study|Lost to Follow-up|12|||
37907880|NCT00590577|69593568|FG001|Overall Study|Lost to Follow-up|6|||
37907881|NCT00590577|69593569|FG002|Overall Study|Lost to Follow-up|6|||
37907882|NCT00590577|69593570|FG003|Overall Study|Lost to Follow-up|9|||
37907883|NCT00590577|69593567|FG000|Overall Study|Pregnancy|0|||
37907884|NCT00590577|69593568|FG001|Overall Study|Pregnancy|1|||
37907885|NCT00590577|69593569|FG002|Overall Study|Pregnancy|0|||
37907886|NCT00590577|69593570|FG003|Overall Study|Pregnancy|0|||
37907887|NCT00590577|69593567|FG000|Overall Study|Various reasons|1|||
37907888|NCT00590577|69593568|FG001|Overall Study|Various reasons|3|||
37907889|NCT00590577|69593569|FG002|Overall Study|Various reasons|1|||
37907890|NCT00590577|69593570|FG003|Overall Study|Various reasons|2|||
37907891|NCT00614575|69593580|FG000|Overall Study|Adverse Event|106|||
37907892|NCT00614575|69593580|FG000|Overall Study|Lost to Follow-up|55|||
37907893|NCT00614575|69593580|FG000|Overall Study|Lack of Efficacy|14|||
37907894|NCT00614575|69593580|FG000|Overall Study|Withdrawal by Subject|6|||
37907895|NCT00614575|69593580|FG000|Overall Study|Death|3|||
37907896|NCT00614575|69593580|FG000|Overall Study|Physician Decision|2|||
38007641|NCT03628924|69691037|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
38007642|NCT03628924|69691038|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
38007643|NCT03628924|69691032|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
38007644|NCT03628924|69691033|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
38007645|NCT03628924|69691034|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
38007646|NCT03628924|69691035|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
38007647|NCT03628924|69691036|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
38007648|NCT03628924|69691037|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
37907897|NCT00614575|69593580|FG000|Overall Study|No data were collected.|18|||
37907898|NCT00614575|69593580|FG000|Overall Study|Irregularly enrolled patients|23|||
37907899|NCT00614575|69593580|FG000|Overall Study|No treatment|1|||
37907900|NCT00805935|69593588|FG000|Overall Study|Stimulation Failure|1|||
37907901|NCT00805935|69593589|FG001|Overall Study|Stimulation Failure|5|||
38007649|NCT03628924|69691038|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
37831169|NCT01242176|69514609|FG000|Washout Period of 7 Days|Adverse Event|0|||
37831170|NCT01242176|69514610|FG001|Washout Period of 7 Days|Adverse Event|2|||
37831171|NCT01242176|69514609|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
37831172|NCT01242176|69514610|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
37831173|NCT01242020|69514618|FG000|Overall Study|Withdrawal by Subject|2|||
37907902|NCT00805935|69593590|FG002|Overall Study|Stimulation Failure|2|||
37907903|NCT00805935|69593591|FG003|Overall Study|Stimulation Failure|2|||
37907904|NCT00805935|69593588|FG000|Overall Study|Cycle cancelled|0|||
37907905|NCT00805935|69593589|FG001|Overall Study|Cycle cancelled|0|||
37907906|NCT00805935|69593590|FG002|Overall Study|Cycle cancelled|2|||
37907907|NCT00805935|69593591|FG003|Overall Study|Cycle cancelled|0|||
37831174|NCT01242020|69514619|FG001|Overall Study|Withdrawal by Subject|0|||
37907908|NCT00805935|69593588|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
37907909|NCT00805935|69593589|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
37907910|NCT00805935|69593590|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
37907911|NCT00805935|69593591|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
37907912|NCT00805935|69593588|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
37907913|NCT00805935|69593589|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
37907914|NCT00805935|69593590|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
37907915|NCT00805935|69593591|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
37907916|NCT00805935|69593588|FG000|Overall Study|Lost to Follow-up|1|||
37907917|NCT00805935|69593589|FG001|Overall Study|Lost to Follow-up|0|||
37907918|NCT00805935|69593590|FG002|Overall Study|Lost to Follow-up|0|||
37907919|NCT00805935|69593591|FG003|Overall Study|Lost to Follow-up|0|||
37907920|NCT00805935|69593588|FG000|Overall Study|No positive serum pregnancy|8|||
38007650|NCT03627832|69691052|FG000|Overall Study|Withdrawal by Subject|10|||
38007651|NCT03627832|69691053|FG001|Overall Study|Withdrawal by Subject|1|||
38007652|NCT00112437|69691064|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
38007653|NCT00112437|69691065|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
38007654|NCT00112437|69691066|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
38007655|NCT00112437|69691067|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
38007656|NCT00112437|69691068|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
38007657|NCT00112437|69691069|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
38007658|NCT00112437|69691070|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
38007659|NCT00112437|69691071|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
38007660|NCT00112437|69691072|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
38007661|NCT00112437|69691073|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
38007662|NCT00112437|69691074|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
38007663|NCT00112437|69691075|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
38007664|NCT00112437|69691076|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
38007665|NCT00112437|69691077|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
38007666|NCT00112437|69691078|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
38007667|NCT00112437|69691079|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
38007668|NCT00112437|69691080|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
37831175|NCT01242020|69514618|FG000|Overall Study|Failed screening|1|||
37831176|NCT01242020|69514619|FG001|Overall Study|Failed screening|0|||
37831177|NCT01241786|69514625|FG000|Overall Study|Lack of Efficacy|5|||
37831178|NCT01241318|69514632|FG000|Overall Study|Woman: false pregnancies|27|||
37831179|NCT01241318|69514633|FG001|Overall Study|Woman: false pregnancies|15|||
37831180|NCT01241318|69514632|FG000|Overall Study|Woman: miscarriage/abortion|46|||
37831181|NCT01241318|69514633|FG001|Overall Study|Woman: miscarriage/abortion|38|||
37831182|NCT01241318|69514632|FG000|Overall Study|Withdrawal by Subject|175|||
37831183|NCT01241318|69514633|FG001|Overall Study|Withdrawal by Subject|46|||
37831184|NCT01241318|69514632|FG000|Overall Study|Lost to Follow-up|740|||
37831185|NCT01241318|69514633|FG001|Overall Study|Lost to Follow-up|455|||
37831186|NCT01241318|69514632|FG000|Overall Study|Death|2|||
37831187|NCT01241318|69514633|FG001|Overall Study|Death|4|||
37831188|NCT01241318|69514632|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
37831189|NCT01241318|69514633|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
37831190|NCT01241318|69514632|FG000|Overall Study|Woman: Stillborn infant|129|||
37831191|NCT01241318|69514633|FG001|Overall Study|Woman: Stillborn infant|146|||
37831192|NCT01241279|69514644|FG000|Overall Study|Lost to Follow-up|0|||
37831193|NCT01241279|69514645|FG001|Overall Study|Lost to Follow-up|1|||
37831194|NCT01241240|69514653|FG000|Overall Study|Adverse Event|5|||
37831195|NCT01241240|69514654|FG001|Overall Study|Adverse Event|4|||
37831196|NCT01241240|69514653|FG000|Overall Study|Lost to Follow-up|2|||
37831197|NCT01241240|69514654|FG001|Overall Study|Lost to Follow-up|4|||
37831198|NCT01241240|69514653|FG000|Overall Study|Personal Reasons|1|||
38007669|NCT00112437|69691081|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
38007670|NCT00112437|69691082|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
37831199|NCT01241240|69514654|FG001|Overall Study|Personal Reasons|1|||
37831200|NCT01240811|69514663|FG000|Overall Study|Physician Decision|0|||
37907921|NCT00805935|69593589|FG001|Overall Study|No positive serum pregnancy|7|||
38007671|NCT00112437|69691083|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
38007672|NCT00112437|69691084|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
38007673|NCT00112437|69691085|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
38007674|NCT00112437|69691086|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
38007675|NCT00112437|69691087|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
38007676|NCT00112437|69691088|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
38007677|NCT00112437|69691089|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
38007678|NCT00112437|69691064|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
38007679|NCT00112437|69691065|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
38007680|NCT00112437|69691066|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
38007681|NCT00112437|69691067|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
38007682|NCT00112437|69691068|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
38007683|NCT00112437|69691069|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
38007684|NCT00112437|69691070|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
38007685|NCT00112437|69691071|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
38007686|NCT00112437|69691072|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
38007687|NCT00112437|69691073|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
38007688|NCT00112437|69691074|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
38007689|NCT00112437|69691075|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
38007690|NCT00112437|69691076|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
38007691|NCT00112437|69691077|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
38007692|NCT00112437|69691078|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
38007693|NCT00112437|69691079|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
38007694|NCT00112437|69691080|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
38007695|NCT00112437|69691081|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
37831201|NCT01240811|69514664|FG001|Overall Study|Physician Decision|1|||
37831202|NCT01240811|69514665|FG002|Overall Study|Physician Decision|0|||
37831203|NCT01240811|69514663|FG000|Overall Study|Withdrawal by Subject|0|||
37831204|NCT01240811|69514664|FG001|Overall Study|Withdrawal by Subject|0|||
37907922|NCT00805935|69593590|FG002|Overall Study|No positive serum pregnancy|6|||
38007696|NCT00112437|69691082|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
38007697|NCT00112437|69691083|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
37831205|NCT01240811|69514665|FG002|Overall Study|Withdrawal by Subject|1|||
37831206|NCT01240382|69514677|FG000|Overall Study|Adverse Event|2|||
37831207|NCT01240382|69514678|FG001|Overall Study|Adverse Event|1|||
37831208|NCT01240382|69514677|FG000|Overall Study|Lack of Efficacy|0|||
37831209|NCT01240382|69514678|FG001|Overall Study|Lack of Efficacy|2|||
37831210|NCT01240382|69514677|FG000|Overall Study|Fear of adverse events|0|||
37831211|NCT01240382|69514678|FG001|Overall Study|Fear of adverse events|1|||
37907923|NCT00805935|69593591|FG003|Overall Study|No positive serum pregnancy|5|||
37907924|NCT00805935|69593588|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
37907925|NCT00805935|69593589|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
37831212|NCT01244828|69514684|FG000|Overall Study|Adverse Event|37|||
37831213|NCT01244828|69514684|FG000|Overall Study|Withdrawal by Subject|31|||
37907926|NCT00805935|69593590|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
37907927|NCT00805935|69593591|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
37907928|NCT00805935|69593588|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
37907929|NCT00805935|69593589|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
37907930|NCT00805935|69593590|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
37907931|NCT00805935|69593591|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
37907932|NCT00805935|69593588|FG000|Overall Study|Biochemical pregnancy|0|||
37907933|NCT00805935|69593589|FG001|Overall Study|Biochemical pregnancy|1|||
37907934|NCT00805935|69593590|FG002|Overall Study|Biochemical pregnancy|0|||
37907935|NCT00805935|69593591|FG003|Overall Study|Biochemical pregnancy|0|||
37907936|NCT00805935|69593588|FG000|Overall Study|Chemical pregnancy|0|||
37831214|NCT01244828|69514684|FG000|Overall Study|Lack of Efficacy|7|||
37907937|NCT00805935|69593589|FG001|Overall Study|Chemical pregnancy|5|||
37907938|NCT00805935|69593590|FG002|Overall Study|Chemical pregnancy|3|||
37907939|NCT00805935|69593591|FG003|Overall Study|Chemical pregnancy|2|||
37907940|NCT00805935|69593588|FG000|Overall Study|Ectopic pregnancy|0|||
37907941|NCT00805935|69593589|FG001|Overall Study|Ectopic pregnancy|0|||
38007698|NCT00112437|69691084|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
38007699|NCT00112437|69691085|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
38007700|NCT00112437|69691086|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
38007701|NCT00112437|69691087|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
37831215|NCT01244828|69514684|FG000|Overall Study|Lost to Follow-up|2|||
37907942|NCT00805935|69593590|FG002|Overall Study|Ectopic pregnancy|1|||
37907943|NCT00805935|69593591|FG003|Overall Study|Ectopic pregnancy|0|||
37907944|NCT00805935|69593588|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
37907945|NCT00805935|69593589|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
37907946|NCT00805935|69593590|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
37907947|NCT00805935|69593591|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
38007702|NCT00112437|69691088|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
38007703|NCT00112437|69691089|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
38007704|NCT00112437|69691064|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
38007705|NCT00112437|69691065|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
37907948|NCT00805545|69593605|FG000|Overall Study|Protocol Violation|3|||
37907949|NCT00805545|69593606|FG001|Overall Study|Protocol Violation|2|||
37907950|NCT00805545|69593605|FG000|Overall Study|Protocol Violation|3|||
37907951|NCT00805545|69593606|FG001|Overall Study|Protocol Violation|1|||
37907952|NCT00590031|69593638|FG000|Overall Study|Adverse Event|3|||
37907953|NCT00590031|69593638|FG000|Overall Study|Withdrawal by Subject|1|||
37907954|NCT00590031|69593638|FG000|Overall Study|Metastatic Disease|1|||
37907955|NCT00590031|69593638|FG000|Overall Study|Admin Hold|1|||
37907956|NCT00615199|69593646|FG000|Overall Study|Adverse Event|3|||
37907957|NCT00615199|69593647|FG001|Overall Study|Adverse Event|1|||
37907958|NCT00615199|69593648|FG002|Overall Study|Adverse Event|1|||
37907959|NCT00615199|69593649|FG003|Overall Study|Adverse Event|0|||
37907960|NCT00615199|69593646|FG000|Overall Study|Lack of Efficacy|2|||
37907961|NCT00615199|69593647|FG001|Overall Study|Lack of Efficacy|0|||
37907962|NCT00615199|69593648|FG002|Overall Study|Lack of Efficacy|0|||
37907963|NCT00615199|69593649|FG003|Overall Study|Lack of Efficacy|1|||
37907964|NCT00615199|69593646|FG000|Overall Study|Lost to Follow-up|1|||
37907965|NCT00615199|69593647|FG001|Overall Study|Lost to Follow-up|0|||
37907966|NCT00615199|69593648|FG002|Overall Study|Lost to Follow-up|0|||
37907967|NCT00615199|69593649|FG003|Overall Study|Lost to Follow-up|0|||
37907968|NCT00615199|69593646|FG000|Overall Study|Other|0|||
37907969|NCT00615199|69593647|FG001|Overall Study|Other|0|||
37907970|NCT00615199|69593648|FG002|Overall Study|Other|0|||
37907971|NCT00615199|69593649|FG003|Overall Study|Other|1|||
37907972|NCT00615199|69593646|FG000|Overall Study|Withdrawal by Subject|2|||
37907973|NCT00615199|69593647|FG001|Overall Study|Withdrawal by Subject|1|||
37907974|NCT00615199|69593648|FG002|Overall Study|Withdrawal by Subject|0|||
37907975|NCT00615199|69593649|FG003|Overall Study|Withdrawal by Subject|0|||
37907976|NCT00613951|69593662|FG000|Overall Study|Adverse Event|1|||
37907977|NCT00613951|69593663|FG001|Overall Study|Adverse Event|0|||
37907978|NCT00613951|69593664|FG002|Overall Study|Adverse Event|1|||
37907979|NCT00613951|69593662|FG000|Overall Study|Lack of Efficacy|0|||
37907980|NCT00613951|69593663|FG001|Overall Study|Lack of Efficacy|1|||
37907981|NCT00613951|69593664|FG002|Overall Study|Lack of Efficacy|1|||
37907982|NCT00613951|69593662|FG000|Overall Study|Protocol Violation|1|||
38007706|NCT00112437|69691066|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
38007707|NCT00112437|69691067|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
38007708|NCT00112437|69691068|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
38007709|NCT00112437|69691069|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
38007710|NCT00112437|69691070|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
38007711|NCT00112437|69691071|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
38007712|NCT00112437|69691072|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
38007713|NCT00112437|69691073|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
38007714|NCT00112437|69691074|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
38007715|NCT00112437|69691075|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
38007716|NCT00112437|69691076|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
38007717|NCT00112437|69691077|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
38007718|NCT00112437|69691078|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
38007719|NCT00112437|69691079|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
38007720|NCT00112437|69691080|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
38007721|NCT00112437|69691081|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
38007722|NCT00112437|69691082|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
37697745|NCT01841554|69174334|FG000|Overall Study|Study exit due to secondary intervention|6|||
37697746|NCT01823224|69174340|FG000|Overall Study|Lost to Follow-up|5|||
37697747|NCT01823224|69174341|FG001|Overall Study|Lost to Follow-up|6|||
37907983|NCT00613951|69593663|FG001|Overall Study|Protocol Violation|1|||
37907984|NCT00613951|69593664|FG002|Overall Study|Protocol Violation|1|||
37907985|NCT00613951|69593662|FG000|Overall Study|Unclassified|5|||
37907986|NCT00613951|69593663|FG001|Overall Study|Unclassified|3|||
38007723|NCT00112437|69691083|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
37907987|NCT00613951|69593664|FG002|Overall Study|Unclassified|2|||
37907988|NCT00805467|69593679|FG000|Overall Study|Lack of Efficacy|0|||
37907989|NCT00805467|69593680|FG001|Overall Study|Lack of Efficacy|8|||
37697748|NCT01823224|69174340|FG000|Overall Study|didn't qualify|1|||
37907990|NCT00805467|69593681|FG002|Overall Study|Lack of Efficacy|13|||
37907991|NCT00805467|69593682|FG003|Overall Study|Lack of Efficacy|86|||
37907992|NCT00805467|69593679|FG000|Overall Study|Lost to Follow-up|0|||
37831216|NCT01244828|69514684|FG000|Overall Study|Other reason (not specified)|1|||
37831217|NCT01249833|69514690|FG000|Overall Study|Lost to Follow-up|0|||
37831218|NCT01249833|69514691|FG001|Overall Study|Lost to Follow-up|1|||
37907993|NCT00805467|69593680|FG001|Overall Study|Lost to Follow-up|1|||
37907994|NCT00805467|69593681|FG002|Overall Study|Lost to Follow-up|7|||
37907995|NCT00805467|69593682|FG003|Overall Study|Lost to Follow-up|21|||
37907996|NCT00805467|69593679|FG000|Overall Study|Withdrawal by Subject|0|||
37907997|NCT00805467|69593680|FG001|Overall Study|Withdrawal by Subject|6|||
37907998|NCT00805467|69593681|FG002|Overall Study|Withdrawal by Subject|45|||
37907999|NCT00805467|69593682|FG003|Overall Study|Withdrawal by Subject|50|||
37908000|NCT00805467|69593679|FG000|Overall Study|Protocol Violation|0|||
37908001|NCT00805467|69593680|FG001|Overall Study|Protocol Violation|3|||
37908002|NCT00805467|69593681|FG002|Overall Study|Protocol Violation|0|||
37908003|NCT00805467|69593682|FG003|Overall Study|Protocol Violation|5|||
37908004|NCT00805467|69593679|FG000|Overall Study|Adverse Event|0|||
37908005|NCT00805467|69593680|FG001|Overall Study|Adverse Event|13|||
37908006|NCT00805467|69593681|FG002|Overall Study|Adverse Event|26|||
37908007|NCT00805467|69593682|FG003|Overall Study|Adverse Event|57|||
37908008|NCT00805467|69593679|FG000|Overall Study|Death|0|||
37908009|NCT00805467|69593680|FG001|Overall Study|Death|2|||
37908010|NCT00805467|69593681|FG002|Overall Study|Death|7|||
37908011|NCT00805467|69593682|FG003|Overall Study|Death|5|||
37908012|NCT00805467|69593679|FG000|Overall Study|Physician Decision|0|||
37908013|NCT00805467|69593680|FG001|Overall Study|Physician Decision|1|||
37908014|NCT00805467|69593681|FG002|Overall Study|Physician Decision|2|||
37908015|NCT00805467|69593682|FG003|Overall Study|Physician Decision|6|||
37908016|NCT00805467|69593679|FG000|Overall Study|Not reported|0|||
37908017|NCT00805467|69593680|FG001|Overall Study|Not reported|0|||
37908018|NCT00805467|69593681|FG002|Overall Study|Not reported|3|||
37831219|NCT01249404|69514700|FG000|Overall Study|Study treatment not received|0|||
37831220|NCT01249404|69514701|FG001|Overall Study|Study treatment not received|1|||
37831221|NCT01249404|69514702|FG002|Overall Study|Study treatment not received|2|||
37831222|NCT01249404|69514700|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
37831223|NCT01249404|69514701|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
37831224|NCT01249404|69514702|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
37831225|NCT01249404|69514700|FG000|Overall Study|Adverse Event|2|||
37831226|NCT01249404|69514701|FG001|Overall Study|Adverse Event|2|||
37831227|NCT01249404|69514702|FG002|Overall Study|Adverse Event|2|||
37831228|NCT01249404|69514700|FG000|Overall Study|Withdrawal by Subject|2|||
37831229|NCT01249404|69514701|FG001|Overall Study|Withdrawal by Subject|2|||
37831230|NCT01249404|69514702|FG002|Overall Study|Withdrawal by Subject|0|||
37831231|NCT01249404|69514700|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
37831232|NCT01249404|69514701|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
37908019|NCT00805467|69593682|FG003|Overall Study|Not reported|7|||
37908020|NCT00958841|69593692|FG000|Overall Study|Abnormal laboratory value(s)|1|||
37908021|NCT00958841|69593692|FG000|Overall Study|Abnormal test procedure result(s)|3|||
37908022|NCT00958841|69593692|FG000|Overall Study|Administrative problems|1|||
37908023|NCT00958841|69593692|FG000|Overall Study|Adverse Event|8|||
37908024|NCT00958841|69593692|FG000|Overall Study|New cancer therapy|5|||
37908025|NCT00958841|69593692|FG000|Overall Study|Withdrawal by Subject|1|||
37908026|NCT00958841|69593692|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
37908027|NCT00958841|69593692|FG000|Overall Study|Completed M6/did not enter extension|27|||
37908028|NCT00958841|69593692|FG000|Overall Study|Discontinued prior to M*|28|||
37908029|NCT03927105|69593755|FG000|Overall Study|Death|1|||
37908030|NCT03927105|69593755|FG000|Overall Study|In observation for potential re-treatment|2|||
37908031|NCT03927105|69593755|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
37908032|NCT00613327|69593759|FG000|Overall Study|Adverse Event|38|||
37908033|NCT00613327|69593759|FG000|Overall Study|Lost to Follow-up|8|||
37908034|NCT00613327|69593759|FG000|Overall Study|Withdrawal by Subject|6|||
37908035|NCT00613327|69593759|FG000|Overall Study|Protocol Violation|2|||
37908036|NCT00613327|69593759|FG000|Overall Study|Other|47|||
37908037|NCT00954941|69593765|FG000|Overall Study|Received treatment at home|1|||
37908038|NCT00954941|69593766|FG001|Overall Study|Received treatment at home|0|||
37908039|NCT00954941|69593765|FG000|Overall Study|Withdrawal by Subject|1|||
37908040|NCT00954941|69593766|FG001|Overall Study|Withdrawal by Subject|0|||
37908041|NCT00954941|69593765|FG000|Overall Study|Insurance Denial|2|||
37831233|NCT01249404|69514702|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
37831234|NCT01249404|69514700|FG000|Overall Study|Non compliance to visit schedule|0|||
37831235|NCT01249404|69514701|FG001|Overall Study|Non compliance to visit schedule|1|||
37831236|NCT01249404|69514702|FG002|Overall Study|Non compliance to visit schedule|0|||
37831237|NCT01249365|69514710|FG000|Overall Study|Lost to Follow-up|1|||
37831238|NCT01249131|69514714|FG000|Washout Period of 10 Days|Adverse Event|0|||
37908042|NCT00954941|69593766|FG001|Overall Study|Insurance Denial|2|||
37908043|NCT00954941|69593765|FG000|Overall Study|Physician Decision|2|||
37908044|NCT00954941|69593766|FG001|Overall Study|Physician Decision|2|||
37908045|NCT00954941|69593765|FG000|Overall Study|Ineligible|2|||
37908046|NCT00954941|69593766|FG001|Overall Study|Ineligible|2|||
37908047|NCT00954941|69593765|FG000|Overall Study|Adverse Event|0|||
38007724|NCT00112437|69691084|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
38007725|NCT00112437|69691085|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
38007726|NCT00112437|69691086|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
38007727|NCT00112437|69691087|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
38007728|NCT00112437|69691088|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
38007729|NCT00112437|69691089|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
38007730|NCT00112437|69691064|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
38007731|NCT00112437|69691065|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
38007732|NCT00112437|69691066|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
38007733|NCT00112437|69691067|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
38007734|NCT00112437|69691068|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
38007735|NCT00112437|69691069|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
38007736|NCT00112437|69691070|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
38007737|NCT00112437|69691071|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
38007738|NCT00112437|69691072|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
38007739|NCT00112437|69691073|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
38007740|NCT00112437|69691074|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
38007741|NCT00112437|69691075|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
38007742|NCT00112437|69691076|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
38007743|NCT00112437|69691077|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
38007744|NCT00112437|69691078|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
38007745|NCT00112437|69691079|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
38007746|NCT00112437|69691080|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
38007747|NCT00112437|69691081|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
38007748|NCT00112437|69691082|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
38007749|NCT00112437|69691083|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
38007750|NCT00112437|69691084|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
38007751|NCT00112437|69691085|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
38007752|NCT00112437|69691086|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
38007753|NCT00112437|69691087|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
37908048|NCT00954941|69593766|FG001|Overall Study|Adverse Event|1|||
37908049|NCT00954707|69593772|FG000|Overall Study|Death|34|||
37908050|NCT00954707|69593772|FG000|Overall Study|Withdrawal by Subject|100|||
37908051|NCT00954707|69593772|FG000|Overall Study|Lost to Follow-up|33|||
37908052|NCT00589797|69593778|FG000|Overall Study|Death|1|||
37908053|NCT00589797|69593779|FG001|Overall Study|Death|0|||
37908054|NCT00589797|69593778|FG000|Overall Study|Lost to Follow-up|12|||
37908055|NCT00589797|69593779|FG001|Overall Study|Lost to Follow-up|9|||
37908056|NCT00589797|69593778|FG000|Overall Study|Physician Decision|8|||
37908057|NCT00589797|69593779|FG001|Overall Study|Physician Decision|3|||
37908058|NCT00589797|69593778|FG000|Overall Study|Withdrawal by Subject|6|||
37908059|NCT00589797|69593779|FG001|Overall Study|Withdrawal by Subject|5|||
37908060|NCT00589797|69593778|FG000|Overall Study|Non-Randomized Training Subjects|46|||
37908061|NCT00589797|69593779|FG001|Overall Study|Non-Randomized Training Subjects|6|||
37908062|NCT00613171|69593785|FG000|Overall Study|Adverse Event|7|||
37908063|NCT00613171|69593785|FG000|Overall Study|Withdrawal by Subject|3|||
37908064|NCT00613171|69593785|FG000|Overall Study|Reason not Specified|4|||
37908065|NCT00896480|69593790|FG000|Overall Study|Disease progression/recurrence|21|||
38007754|NCT00112437|69691088|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
38007755|NCT00112437|69691089|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
38007756|NCT00112437|69691064|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
38007757|NCT00112437|69691065|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
38007758|NCT00112437|69691066|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
38007759|NCT00112437|69691067|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
38007760|NCT00112437|69691068|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
38007761|NCT00112437|69691069|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
38007762|NCT00112437|69691070|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
38007763|NCT00112437|69691071|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
38007764|NCT00112437|69691072|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
38007765|NCT00112437|69691073|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
37908066|NCT00953225|69593799|FG000|Overall Study|Withdrawal by Subject|2|||
37908067|NCT00953225|69593800|FG001|Overall Study|Withdrawal by Subject|0|||
37908068|NCT00613015|69593812|FG000|Overall Study|Lost to Follow-up|0|||
38007766|NCT00112437|69691074|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
38007767|NCT00112437|69691075|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
38007768|NCT00112437|69691076|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
38007769|NCT00112437|69691077|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
37908069|NCT00613015|69593813|FG001|Overall Study|Lost to Follow-up|1|||
37908070|NCT00613015|69593814|FG002|Overall Study|Lost to Follow-up|3|||
37908071|NCT00613015|69593815|FG003|Overall Study|Lost to Follow-up|3|||
38007770|NCT00112437|69691078|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
38007771|NCT00112437|69691079|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
38007772|NCT00112437|69691080|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
38007773|NCT00112437|69691081|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
38007774|NCT00112437|69691082|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
38007775|NCT00112437|69691083|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
38007776|NCT00112437|69691084|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
38007777|NCT00112437|69691085|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
38007778|NCT00112437|69691086|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
38007779|NCT00112437|69691087|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
38007780|NCT00112437|69691088|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
38007781|NCT00112437|69691089|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
38007782|NCT00112437|69691064|FG000|Year 1 (12-Month Base Study)|moved|0|||
38007783|NCT00112437|69691065|FG001|Year 1 (12-Month Base Study)|moved|1|||
38007784|NCT00112437|69691066|FG002|Year 1 (12-Month Base Study)|moved|1|||
38007785|NCT00112437|69691067|FG003|Year 1 (12-Month Base Study)|moved|0|||
38007786|NCT00112437|69691068|FG004|Year 1 (12-Month Base Study)|moved|0|||
38007787|NCT00112437|69691069|FG005|Year 1 (12-Month Base Study)|moved|0|||
38007788|NCT00112437|69691070|FG006|Year 1 (12-Month Base Study)|moved|0|||
38007789|NCT00112437|69691071|FG007|Year 1 (12-Month Base Study)|moved|0|||
38007790|NCT00112437|69691072|FG008|Year 1 (12-Month Base Study)|moved|0|||
38007791|NCT00112437|69691073|FG009|Year 1 (12-Month Base Study)|moved|0|||
38007792|NCT00112437|69691074|FG010|Year 1 (12-Month Base Study)|moved|0|||
38007793|NCT00112437|69691075|FG011|Year 1 (12-Month Base Study)|moved|0|||
38007794|NCT00112437|69691076|FG012|Year 1 (12-Month Base Study)|moved|0|||
38007795|NCT00112437|69691077|FG013|Year 1 (12-Month Base Study)|moved|0|||
38007796|NCT00112437|69691078|FG014|Year 1 (12-Month Base Study)|moved|0|||
38007797|NCT00112437|69691079|FG015|Year 1 (12-Month Base Study)|moved|0|||
38007798|NCT00112437|69691080|FG016|Year 1 (12-Month Base Study)|moved|0|||
38007799|NCT00112437|69691081|FG017|Year 1 (12-Month Base Study)|moved|0|||
38007800|NCT00112437|69691082|FG018|Year 1 (12-Month Base Study)|moved|0|||
38007801|NCT00112437|69691083|FG019|Year 1 (12-Month Base Study)|moved|0|||
38007802|NCT00112437|69691084|FG020|Year 1 (12-Month Base Study)|moved|0|||
38007803|NCT00112437|69691085|FG021|Year 1 (12-Month Base Study)|moved|0|||
38007804|NCT00112437|69691086|FG022|Year 1 (12-Month Base Study)|moved|0|||
38007805|NCT00112437|69691087|FG023|Year 1 (12-Month Base Study)|moved|0|||
38007806|NCT00112437|69691088|FG024|Year 1 (12-Month Base Study)|moved|0|||
38007807|NCT00112437|69691089|FG025|Year 1 (12-Month Base Study)|moved|0|||
38007808|NCT00112437|69691064|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
38007809|NCT00112437|69691065|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
38007810|NCT00112437|69691066|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
38007811|NCT00112437|69691067|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
38007812|NCT00112437|69691068|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
37831239|NCT01249131|69514715|FG001|Washout Period of 10 Days|Adverse Event|0|||
37831240|NCT01249131|69514716|FG002|Washout Period of 10 Days|Adverse Event|0|||
37831241|NCT01249131|69514717|FG003|Washout Period of 10 Days|Adverse Event|0|||
37831242|NCT01249131|69514718|FG004|Washout Period of 10 Days|Adverse Event|1|||
37831243|NCT01249131|69514719|FG005|Washout Period of 10 Days|Adverse Event|0|||
37831244|NCT01249092|69514727|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
37908072|NCT00613015|69593816|FG004|Overall Study|Lost to Follow-up|2|||
37908073|NCT00613015|69593817|FG005|Overall Study|Lost to Follow-up|3|||
37908074|NCT00803595|69593834|FG000|Overall Study|Adverse Event|3|||
37908075|NCT00803595|69593835|FG001|Overall Study|Adverse Event|4|||
37908076|NCT00803595|69593836|FG002|Overall Study|Adverse Event|1|||
37908077|NCT00803595|69593834|FG000|Overall Study|Protocol Violation|7|||
37908078|NCT00803595|69593835|FG001|Overall Study|Protocol Violation|2|||
37908079|NCT00803595|69593836|FG002|Overall Study|Protocol Violation|12|||
37908080|NCT00803595|69593834|FG000|Overall Study|Withdrawal by Subject|5|||
37908081|NCT00803595|69593835|FG001|Overall Study|Withdrawal by Subject|2|||
37908082|NCT00803595|69593836|FG002|Overall Study|Withdrawal by Subject|3|||
37831245|NCT01249092|69514727|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
37831246|NCT01248936|69514733|FG000|Overall Study|Sponsor Decision|259|||
37831247|NCT01248936|69514733|FG000|Overall Study|Progression of Disease|50|||
37831248|NCT01248936|69514733|FG000|Overall Study|Death|26|||
37908083|NCT00953927|69593846|FG000|Overall Study|Lost to Follow-up|61|||
37908084|NCT00953927|69593847|FG001|Overall Study|Lost to Follow-up|65|||
37908085|NCT00953927|69593846|FG000|Overall Study|Withdrawal by Subject|36|||
38007813|NCT00112437|69691069|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
38007814|NCT00112437|69691070|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
38007815|NCT00112437|69691071|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
37908086|NCT00953927|69593847|FG001|Overall Study|Withdrawal by Subject|25|||
37908087|NCT00953927|69593846|FG000|Overall Study|Death|7|||
38007816|NCT00112437|69691072|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
38007817|NCT00112437|69691073|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
38007818|NCT00112437|69691074|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
38007819|NCT00112437|69691075|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
38007820|NCT00112437|69691076|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
38007821|NCT00112437|69691077|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
38007822|NCT00112437|69691078|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
38007823|NCT00112437|69691079|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
38007824|NCT00112437|69691080|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
38007825|NCT00112437|69691081|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
38007826|NCT00112437|69691082|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
38007827|NCT00112437|69691083|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
38007828|NCT00112437|69691084|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
38007829|NCT00112437|69691085|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
38007830|NCT00112437|69691086|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
38007831|NCT00112437|69691087|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
38007832|NCT00112437|69691088|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
38007833|NCT00112437|69691089|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
38007834|NCT00112437|69691064|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
38007835|NCT00112437|69691065|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
38007836|NCT00112437|69691066|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
38007837|NCT00112437|69691067|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
38007838|NCT00112437|69691068|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
38007839|NCT00112437|69691069|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
38007840|NCT00112437|69691070|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
38007841|NCT00112437|69691071|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
38007842|NCT00112437|69691072|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
38007843|NCT00112437|69691073|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
38007844|NCT00112437|69691074|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
38007845|NCT00112437|69691075|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
38007846|NCT00112437|69691076|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
38007847|NCT00112437|69691077|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
38007848|NCT00112437|69691078|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
38007849|NCT00112437|69691079|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
38007850|NCT00112437|69691080|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
38007851|NCT00112437|69691081|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
38007852|NCT00112437|69691082|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
38007853|NCT00112437|69691083|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
38007854|NCT00112437|69691084|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
38007855|NCT00112437|69691085|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
38007856|NCT00112437|69691086|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
38007857|NCT00112437|69691087|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
38007858|NCT00112437|69691088|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
38007859|NCT00112437|69691089|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
38007860|NCT00112437|69691064|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
38007861|NCT00112437|69691065|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
38007862|NCT00112437|69691066|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
38007863|NCT00112437|69691067|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
38007864|NCT00112437|69691068|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
37831249|NCT01248936|69514733|FG000|Overall Study|Withdrawal of Consent|20|||
37831250|NCT01248936|69514733|FG000|Overall Study|Adverse Event|8|||
37831251|NCT01248936|69514733|FG000|Overall Study|Lost to Follow-up|7|||
37831252|NCT01248936|69514733|FG000|Overall Study|Refused Treatment|1|||
37831253|NCT01248936|69514733|FG000|Overall Study|Other reason|3|||
37831254|NCT01248780|69514740|FG000|Overall Study|Lack of Efficacy|2|||
37831255|NCT01248780|69514741|FG001|Overall Study|Lack of Efficacy|0|||
37831256|NCT01248780|69514740|FG000|Overall Study|Lost to Follow-up|0|||
37908088|NCT00953927|69593847|FG001|Overall Study|Death|4|||
37831257|NCT01248780|69514741|FG001|Overall Study|Lost to Follow-up|1|||
37831258|NCT01248780|69514740|FG000|Overall Study|Death|0|||
37831259|NCT01248780|69514741|FG001|Overall Study|Death|1|||
38007865|NCT00112437|69691069|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
38007866|NCT00112437|69691070|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
38007867|NCT00112437|69691071|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
38007868|NCT00112437|69691072|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
38007869|NCT00112437|69691073|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
38007870|NCT00112437|69691074|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
38007871|NCT00112437|69691075|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
38007872|NCT00112437|69691076|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
38007873|NCT00112437|69691077|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
38007874|NCT00112437|69691078|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
38007875|NCT00112437|69691079|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
38007876|NCT00112437|69691080|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
38007877|NCT00112437|69691081|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
38007878|NCT00112437|69691082|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
38007879|NCT00112437|69691083|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
38007880|NCT00112437|69691084|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
38007881|NCT00112437|69691085|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
38007882|NCT00112437|69691086|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
38007883|NCT00112437|69691087|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
38007884|NCT00112437|69691088|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
38007885|NCT00112437|69691089|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
38007886|NCT00112437|69691064|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
38007887|NCT00112437|69691065|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
38007888|NCT00112437|69691066|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
38007889|NCT00112437|69691067|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
38007890|NCT00112437|69691068|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
38007891|NCT00112437|69691069|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
38007892|NCT00112437|69691070|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
38007893|NCT00112437|69691071|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
38007894|NCT00112437|69691072|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
38007895|NCT00112437|69691073|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
38007896|NCT00112437|69691074|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
38007897|NCT00112437|69691075|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
38007898|NCT00112437|69691076|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
38007899|NCT00112437|69691077|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
38007900|NCT00112437|69691078|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
38007901|NCT00112437|69691079|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
38007902|NCT00112437|69691080|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
38007903|NCT00112437|69691081|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
38007904|NCT00112437|69691082|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
38007905|NCT00112437|69691083|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
38007906|NCT00112437|69691084|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
38007907|NCT00112437|69691085|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
38007908|NCT00112437|69691086|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
38007909|NCT00112437|69691087|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
38007910|NCT00112437|69691088|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
38007911|NCT00112437|69691089|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
38007912|NCT00112437|69691064|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
38007913|NCT00112437|69691065|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
38007914|NCT00112437|69691066|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
38007915|NCT00112437|69691067|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
38007916|NCT00112437|69691068|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
38007917|NCT00112437|69691069|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
38007918|NCT00112437|69691070|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
38007919|NCT00112437|69691071|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
38007920|NCT00112437|69691072|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
38007921|NCT00112437|69691073|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
38007922|NCT00112437|69691074|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
38007923|NCT00112437|69691075|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
38007924|NCT00112437|69691076|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
38007925|NCT00112437|69691077|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
38007926|NCT00112437|69691078|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
38007927|NCT00112437|69691079|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
38007928|NCT00112437|69691080|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
38007929|NCT00112437|69691081|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
38007930|NCT00112437|69691082|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
38007931|NCT00112437|69691083|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
38007932|NCT00112437|69691084|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
38007933|NCT00112437|69691085|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
38007934|NCT00112437|69691086|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
38007935|NCT00112437|69691087|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
38007936|NCT00112437|69691088|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
38007937|NCT00112437|69691089|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
38007938|NCT00112437|69691064|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
38007939|NCT00112437|69691065|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
38007940|NCT00112437|69691066|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
38007941|NCT00112437|69691067|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
38007942|NCT00112437|69691068|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
38007943|NCT00112437|69691069|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
38007944|NCT00112437|69691070|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
38007945|NCT00112437|69691071|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
38007946|NCT00112437|69691072|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
38007947|NCT00112437|69691073|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
38007948|NCT00112437|69691074|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
38007949|NCT00112437|69691075|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
37908089|NCT00953927|69593846|FG000|Overall Study|Other study discontinuation|1|||
37908090|NCT00953927|69593847|FG001|Overall Study|Other study discontinuation|1|||
37908091|NCT00611767|69593855|FG000|Overall Study|Withdrawal by Subject|4|||
37908092|NCT00611767|69593856|FG001|Overall Study|Withdrawal by Subject|1|||
37908093|NCT00611767|69593855|FG000|Overall Study|Thiopental not available|3|||
37908094|NCT00611767|69593856|FG001|Overall Study|Thiopental not available|0|||
37908095|NCT00611767|69593855|FG000|Overall Study|didn't like the medication|1|||
37908096|NCT00611767|69593856|FG001|Overall Study|didn't like the medication|1|||
38007950|NCT00112437|69691076|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
38007951|NCT00112437|69691077|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
38007952|NCT00112437|69691078|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
38007953|NCT00112437|69691079|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
38007954|NCT00112437|69691080|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
38007955|NCT00112437|69691081|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
38007956|NCT00112437|69691082|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
38007957|NCT00112437|69691083|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
37908097|NCT00611767|69593855|FG000|Overall Study|Physician Decision|1|||
37908098|NCT00611767|69593856|FG001|Overall Study|Physician Decision|0|||
37908099|NCT00803361|69593864|FG000|Overall Study|Adverse Event|13|||
37908100|NCT00803361|69593865|FG001|Overall Study|Adverse Event|3|||
37908101|NCT00803361|69593864|FG000|Overall Study|Lack of Efficacy|4|||
37908102|NCT00803361|69593865|FG001|Overall Study|Lack of Efficacy|13|||
37908103|NCT00803361|69593864|FG000|Overall Study|Lost to Follow-up|1|||
37908104|NCT00803361|69593865|FG001|Overall Study|Lost to Follow-up|2|||
37908105|NCT00803361|69593864|FG000|Overall Study|Physician Decision|1|||
37908106|NCT00803361|69593865|FG001|Overall Study|Physician Decision|0|||
37908107|NCT00803361|69593864|FG000|Overall Study|Protocol Violation|2|||
37908108|NCT00803361|69593865|FG001|Overall Study|Protocol Violation|4|||
37908109|NCT00803361|69593864|FG000|Overall Study|Withdrawal by Subject|5|||
37908110|NCT00803361|69593865|FG001|Overall Study|Withdrawal by Subject|6|||
37908111|NCT00611533|69593871|FG000|First Intervention (6 Weeks)|Never started study|0|||
37908112|NCT00611533|69593872|FG001|First Intervention (6 Weeks)|Never started study|1|||
37908113|NCT00611533|69593871|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
37908114|NCT00611533|69593872|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
37908115|NCT00611533|69593871|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
37908116|NCT00611533|69593872|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
37908117|NCT00953147|69593891|FG000|Overall Study|Adverse Event|8|||
37908118|NCT00953147|69593892|FG001|Overall Study|Adverse Event|16|||
37908119|NCT00953147|69593893|FG002|Overall Study|Adverse Event|6|||
37908120|NCT00953147|69593891|FG000|Overall Study|Protocol Violation|2|||
37908121|NCT00953147|69593892|FG001|Overall Study|Protocol Violation|8|||
37908122|NCT00953147|69593893|FG002|Overall Study|Protocol Violation|4|||
37908123|NCT00953147|69593891|FG000|Overall Study|Withdrawal by Subject|13|||
37908124|NCT00953147|69593892|FG001|Overall Study|Withdrawal by Subject|15|||
37908125|NCT00953147|69593893|FG002|Overall Study|Withdrawal by Subject|12|||
37908126|NCT00953147|69593891|FG000|Overall Study|Lost to Follow-up|8|||
38007958|NCT00112437|69691084|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
38007959|NCT00112437|69691085|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
38007960|NCT00112437|69691086|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
37697749|NCT01823224|69174341|FG001|Overall Study|didn't qualify|2|||
37908127|NCT00953147|69593892|FG001|Overall Study|Lost to Follow-up|9|||
37908128|NCT00953147|69593893|FG002|Overall Study|Lost to Follow-up|4|||
37908129|NCT00953147|69593891|FG000|Overall Study|Physician Decision|2|||
37908130|NCT00953147|69593892|FG001|Overall Study|Physician Decision|7|||
37697750|NCT01823224|69174340|FG000|Overall Study|pharmacy error|0|||
37697751|NCT01823224|69174341|FG001|Overall Study|pharmacy error|1|||
37697752|NCT01823224|69174340|FG000|Overall Study|missed med dose|0|||
37697753|NCT01823224|69174341|FG001|Overall Study|missed med dose|1|||
37697754|NCT01823224|69174340|FG000|Overall Study|Withdrawal by Subject|0|||
37908131|NCT00953147|69593893|FG002|Overall Study|Physician Decision|3|||
37908132|NCT00953147|69593891|FG000|Overall Study|Other|4|||
37908133|NCT00953147|69593892|FG001|Overall Study|Other|11|||
37908134|NCT00953147|69593893|FG002|Overall Study|Other|13|||
37908135|NCT00803205|69593903|FG000|Overall Study|Adverse Event|7|||
37908136|NCT00803205|69593904|FG001|Overall Study|Adverse Event|2|||
37908137|NCT00803205|69593903|FG000|Overall Study|Lost to Follow-up|1|||
37908138|NCT00803205|69593904|FG001|Overall Study|Lost to Follow-up|0|||
37908139|NCT00803205|69593903|FG000|Overall Study|Withdrawal by Subject|9|||
37908140|NCT00803205|69593904|FG001|Overall Study|Withdrawal by Subject|9|||
37831260|NCT01248780|69514740|FG000|Overall Study|Adverse Event|2|||
37831261|NCT01248780|69514741|FG001|Overall Study|Adverse Event|7|||
37831262|NCT01248780|69514740|FG000|Overall Study|Protocol Violation|1|||
37831263|NCT01248780|69514741|FG001|Overall Study|Protocol Violation|1|||
37831264|NCT01248780|69514740|FG000|Overall Study|Withdrawal by Subject|4|||
37831265|NCT01248780|69514741|FG001|Overall Study|Withdrawal by Subject|4|||
37831266|NCT01248780|69514740|FG000|Overall Study|Not treated|0|||
37908141|NCT00803205|69593903|FG000|Overall Study|Physician Decision|1|||
37908142|NCT00803205|69593904|FG001|Overall Study|Physician Decision|0|||
37908143|NCT00803205|69593903|FG000|Overall Study|Protocol Violation|1|||
37908144|NCT00803205|69593904|FG001|Overall Study|Protocol Violation|1|||
37908145|NCT00803205|69593903|FG000|Overall Study|Medical Monitor Decision|1|||
37908146|NCT00803205|69593904|FG001|Overall Study|Medical Monitor Decision|0|||
37908147|NCT00803205|69593903|FG000|Overall Study|Acquired a Lung Infection|0|||
37697755|NCT01823224|69174341|FG001|Overall Study|Withdrawal by Subject|1|||
37697756|NCT01840228|69174351|FG000|Overall Study|Lost to Follow-up|1|||
37697757|NCT01840228|69174352|FG001|Overall Study|Lost to Follow-up|1|||
37697758|NCT01839916|69174362|FG000|Overall Study|Death|9|||
38007961|NCT00112437|69691087|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
38007962|NCT00112437|69691088|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
38007963|NCT00112437|69691089|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
38007964|NCT00112437|69691064|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
38007965|NCT00112437|69691065|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
38007966|NCT00112437|69691066|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
37908148|NCT00803205|69593904|FG001|Overall Study|Acquired a Lung Infection|1|||
37908149|NCT00803205|69593903|FG000|Overall Study|Sponsor Decision|0|||
38007967|NCT00112437|69691067|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
38007968|NCT00112437|69691068|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
38007969|NCT00112437|69691069|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
38007970|NCT00112437|69691070|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
38007971|NCT00112437|69691071|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
38007972|NCT00112437|69691072|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
38007973|NCT00112437|69691073|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
38007974|NCT00112437|69691074|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
38007975|NCT00112437|69691075|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
38007976|NCT00112437|69691076|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
38007977|NCT00112437|69691077|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
38007978|NCT00112437|69691078|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
37831267|NCT01248780|69514741|FG001|Overall Study|Not treated|1|||
38007979|NCT00112437|69691079|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
38007980|NCT00112437|69691080|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
37831268|NCT01248468|69514750|FG000|Overall Study|Administrative problem|1|||
37908150|NCT00803205|69593904|FG001|Overall Study|Sponsor Decision|1|||
37908151|NCT00952523|69593910|FG000|Overall Study|Withdrawal by Subject|7|||
37908152|NCT02232737|69593919|FG000|Overall Study|Lost to Follow-up|18|||
38007981|NCT00112437|69691081|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
37831269|NCT01248468|69514751|FG001|Overall Study|Administrative problem|0|||
37831270|NCT01248468|69514752|FG002|Overall Study|Administrative problem|0|||
37908153|NCT02232737|69593920|FG001|Overall Study|Lost to Follow-up|28|||
37908154|NCT02232737|69593921|FG002|Overall Study|Lost to Follow-up|33|||
37908155|NCT02232737|69593919|FG000|Overall Study|Personal reasons|7|||
37908156|NCT02232737|69593920|FG001|Overall Study|Personal reasons|8|||
37908157|NCT02232737|69593921|FG002|Overall Study|Personal reasons|14|||
37908158|NCT02232737|69593919|FG000|Overall Study|Adverse Event|6|||
37908159|NCT02232737|69593920|FG001|Overall Study|Adverse Event|3|||
38007982|NCT00112437|69691082|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
38007983|NCT00112437|69691083|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
38007984|NCT00112437|69691084|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
38007985|NCT00112437|69691085|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
38007986|NCT00112437|69691086|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
38007987|NCT00112437|69691087|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
38007988|NCT00112437|69691088|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
38007989|NCT00112437|69691089|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
38007990|NCT00112437|69691064|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
38007991|NCT00112437|69691065|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
38007992|NCT00112437|69691066|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
38007993|NCT00112437|69691067|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
38007994|NCT00112437|69691068|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
38007995|NCT00112437|69691069|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
38007996|NCT00112437|69691070|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
38007997|NCT00112437|69691071|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
38007998|NCT00112437|69691072|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
38007999|NCT00112437|69691073|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
38008000|NCT00112437|69691074|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
38008001|NCT00112437|69691075|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
38008002|NCT00112437|69691076|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
38008003|NCT00112437|69691077|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
38008004|NCT00112437|69691078|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
38008005|NCT00112437|69691079|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
38008006|NCT00112437|69691080|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
38008007|NCT00112437|69691081|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
38008008|NCT00112437|69691082|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
38008009|NCT00112437|69691083|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
38008010|NCT00112437|69691084|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
38008011|NCT00112437|69691085|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
38008012|NCT00112437|69691086|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
38008013|NCT00112437|69691087|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
38008014|NCT00112437|69691088|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
38008015|NCT00112437|69691089|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
38008016|NCT00112437|69691064|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
38008017|NCT00112437|69691065|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
38008018|NCT00112437|69691066|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
38008019|NCT00112437|69691067|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
38008020|NCT00112437|69691068|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
38008021|NCT00112437|69691069|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
38008022|NCT00112437|69691070|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
38008023|NCT00112437|69691071|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
38008024|NCT00112437|69691072|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
38008025|NCT00112437|69691073|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
38008026|NCT00112437|69691074|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
38008027|NCT00112437|69691075|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
38008028|NCT00112437|69691076|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
38008029|NCT00112437|69691077|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
38008030|NCT00112437|69691078|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
38008031|NCT00112437|69691079|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
38008032|NCT00112437|69691080|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
38008033|NCT00112437|69691081|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
38008034|NCT00112437|69691082|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
38008035|NCT00112437|69691083|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
38008036|NCT00112437|69691084|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
38008037|NCT00112437|69691085|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
38008038|NCT00112437|69691086|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
38008039|NCT00112437|69691087|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
38008040|NCT00112437|69691088|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
38008041|NCT00112437|69691089|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
38008042|NCT00112437|69691064|FG000|Year 2 (12-Month Extension)|Moved|0|||
38008043|NCT00112437|69691065|FG001|Year 2 (12-Month Extension)|Moved|0|||
38008044|NCT00112437|69691066|FG002|Year 2 (12-Month Extension)|Moved|0|||
38008045|NCT00112437|69691067|FG003|Year 2 (12-Month Extension)|Moved|0|||
38008046|NCT00112437|69691068|FG004|Year 2 (12-Month Extension)|Moved|0|||
38008047|NCT00112437|69691069|FG005|Year 2 (12-Month Extension)|Moved|0|||
38008048|NCT00112437|69691070|FG006|Year 2 (12-Month Extension)|Moved|0|||
38008049|NCT00112437|69691071|FG007|Year 2 (12-Month Extension)|Moved|0|||
38008050|NCT00112437|69691072|FG008|Year 2 (12-Month Extension)|Moved|0|||
38008051|NCT00112437|69691073|FG009|Year 2 (12-Month Extension)|Moved|1|||
38008052|NCT00112437|69691074|FG010|Year 2 (12-Month Extension)|Moved|0|||
38008053|NCT00112437|69691075|FG011|Year 2 (12-Month Extension)|Moved|0|||
38008054|NCT00112437|69691076|FG012|Year 2 (12-Month Extension)|Moved|0|||
38008055|NCT00112437|69691077|FG013|Year 2 (12-Month Extension)|Moved|0|||
38008056|NCT00112437|69691078|FG014|Year 2 (12-Month Extension)|Moved|0|||
38008057|NCT00112437|69691079|FG015|Year 2 (12-Month Extension)|Moved|0|||
38008058|NCT00112437|69691080|FG016|Year 2 (12-Month Extension)|Moved|0|||
38008059|NCT00112437|69691081|FG017|Year 2 (12-Month Extension)|Moved|0|||
38008060|NCT00112437|69691082|FG018|Year 2 (12-Month Extension)|Moved|0|||
38008061|NCT00112437|69691083|FG019|Year 2 (12-Month Extension)|Moved|0|||
38008062|NCT00112437|69691084|FG020|Year 2 (12-Month Extension)|Moved|0|||
38008063|NCT00112437|69691085|FG021|Year 2 (12-Month Extension)|Moved|0|||
38008064|NCT00112437|69691086|FG022|Year 2 (12-Month Extension)|Moved|0|||
38008065|NCT00112437|69691087|FG023|Year 2 (12-Month Extension)|Moved|0|||
37908160|NCT02232737|69593921|FG002|Overall Study|Adverse Event|8|||
37908161|NCT02232737|69593919|FG000|Overall Study|Incarcerated|2|||
37908162|NCT02232737|69593920|FG001|Overall Study|Incarcerated|1|||
37908163|NCT02232737|69593921|FG002|Overall Study|Incarcerated|2|||
37908164|NCT02232737|69593919|FG000|Overall Study|Withdrawal by Subject|0|||
37908165|NCT02232737|69593920|FG001|Overall Study|Withdrawal by Subject|1|||
37908166|NCT02232737|69593921|FG002|Overall Study|Withdrawal by Subject|2|||
37908167|NCT02232737|69593919|FG000|Overall Study|Death|0|||
37908168|NCT02232737|69593920|FG001|Overall Study|Death|1|||
37908169|NCT02232737|69593921|FG002|Overall Study|Death|1|||
37908170|NCT02232737|69593919|FG000|Overall Study|Physician Decision|1|||
37908171|NCT02232737|69593920|FG001|Overall Study|Physician Decision|3|||
37908172|NCT02232737|69593921|FG002|Overall Study|Physician Decision|1|||
37908173|NCT02232737|69593919|FG000|Overall Study|Protocol Violation|1|||
37908174|NCT02232737|69593920|FG001|Overall Study|Protocol Violation|0|||
37908175|NCT02232737|69593921|FG002|Overall Study|Protocol Violation|1|||
37908176|NCT02232737|69593919|FG000|Overall Study|Reason unknown|1|||
37908177|NCT02232737|69593920|FG001|Overall Study|Reason unknown|0|||
37908178|NCT02232737|69593921|FG002|Overall Study|Reason unknown|0|||
37908179|NCT00952367|69593929|FG000|Overall Study|Withdrawal by Subject|2|||
37908180|NCT00952367|69593929|FG000|Overall Study|Noncoordination|1|||
37908181|NCT00952367|69593929|FG000|Overall Study|Protocol Violation|3|||
37908182|NCT00948857|69593935|FG000|Overall Study|Lost to Follow-up|1|||
37908183|NCT00948857|69593936|FG001|Overall Study|Lost to Follow-up|0|||
37908184|NCT00948389|69593951|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
37908185|NCT00948389|69593952|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
37908186|NCT00948389|69593953|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
37908187|NCT00948389|69593954|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
37908188|NCT00948389|69593955|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
37908189|NCT00948389|69593951|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
37908190|NCT00948389|69593952|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
37908191|NCT00948389|69593953|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
37908192|NCT00948389|69593954|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
37908193|NCT00948389|69593955|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
37908194|NCT00948389|69593951|FG000|Overall Study|Both Progression and Toxicity|1|||
37908195|NCT00948389|69593952|FG001|Overall Study|Both Progression and Toxicity|0|||
37908196|NCT00948389|69593953|FG002|Overall Study|Both Progression and Toxicity|0|||
37908197|NCT00948389|69593954|FG003|Overall Study|Both Progression and Toxicity|0|||
37908198|NCT00948389|69593955|FG004|Overall Study|Both Progression and Toxicity|0|||
37908199|NCT00948155|69593971|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
37908200|NCT00948155|69593972|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
37908201|NCT00948155|69593971|FG000|Washout 14 Days|Lost to Follow-up|1|||
37908202|NCT00948155|69593972|FG001|Washout 14 Days|Lost to Follow-up|2|||
37908203|NCT00958217|69593982|FG000|Overall Study|Death|2|||
37908204|NCT00958217|69593983|FG001|Overall Study|Death|1|||
37908205|NCT00958217|69593982|FG000|Overall Study|Withdrawal by Subject|4|||
37908206|NCT00958217|69593983|FG001|Overall Study|Withdrawal by Subject|3|||
37908207|NCT00958217|69593982|FG000|Overall Study|Lost to Follow-up|17|||
37908208|NCT00958217|69593983|FG001|Overall Study|Lost to Follow-up|19|||
37908209|NCT00958217|69593982|FG000|Overall Study|Moved out of area|1|||
37908210|NCT00958217|69593983|FG001|Overall Study|Moved out of area|1|||
38008066|NCT00112437|69691088|FG024|Year 2 (12-Month Extension)|Moved|0|||
38008067|NCT00112437|69691089|FG025|Year 2 (12-Month Extension)|Moved|0|||
38008068|NCT00112437|69691064|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
38008069|NCT00112437|69691065|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
37908211|NCT00958217|69593982|FG000|Overall Study|Inpatient hospitalization|0|||
37908212|NCT00958217|69593983|FG001|Overall Study|Inpatient hospitalization|1|||
38008070|NCT00112437|69691066|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
38008071|NCT00112437|69691067|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
38008072|NCT00112437|69691068|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
38008073|NCT00112437|69691069|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
37831271|NCT01248468|69514750|FG000|Overall Study|Lost to Follow-up|9|||
38008074|NCT00112437|69691070|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
38008075|NCT00112437|69691071|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
38008076|NCT00112437|69691072|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
38008077|NCT00112437|69691073|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
38008078|NCT00112437|69691074|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
38008079|NCT00112437|69691075|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
38008080|NCT00112437|69691076|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
38008081|NCT00112437|69691077|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
38008082|NCT00112437|69691078|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
38008083|NCT00112437|69691079|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
38008084|NCT00112437|69691080|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
38008085|NCT00112437|69691081|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
38008086|NCT00112437|69691082|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
38008087|NCT00112437|69691083|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
38008088|NCT00112437|69691084|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
38008089|NCT00112437|69691085|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
38008090|NCT00112437|69691086|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
38008091|NCT00112437|69691087|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
38008092|NCT00112437|69691088|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
38008093|NCT00112437|69691089|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
38008094|NCT00112437|69691064|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
38008095|NCT00112437|69691065|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
38008096|NCT00112437|69691066|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
38008097|NCT00112437|69691067|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
38008098|NCT00112437|69691068|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
38008099|NCT00112437|69691069|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
38008100|NCT00112437|69691070|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
38008101|NCT00112437|69691071|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
38008102|NCT00112437|69691072|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
38008103|NCT00112437|69691073|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
38008104|NCT00112437|69691074|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
38008105|NCT00112437|69691075|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
38008106|NCT00112437|69691076|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
38008107|NCT00112437|69691077|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
38008108|NCT00112437|69691078|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
38008109|NCT00112437|69691079|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
38008110|NCT00112437|69691080|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
38008111|NCT00112437|69691081|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
38008112|NCT00112437|69691082|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
38008113|NCT00112437|69691083|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
38008114|NCT00112437|69691084|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
38008115|NCT00112437|69691085|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
38008116|NCT00112437|69691086|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
38008117|NCT00112437|69691087|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
38008118|NCT00112437|69691088|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
38008119|NCT00112437|69691089|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
38008120|NCT00112437|69691064|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
37697759|NCT01839916|69174362|FG000|Overall Study|Physician Decision|17|||
37831272|NCT01248468|69514751|FG001|Overall Study|Lost to Follow-up|12|||
37831273|NCT01248468|69514752|FG002|Overall Study|Lost to Follow-up|4|||
37831274|NCT01248468|69514750|FG000|Overall Study|Pregnancy|1|||
37831275|NCT01248468|69514751|FG001|Overall Study|Pregnancy|0|||
37831276|NCT01248468|69514752|FG002|Overall Study|Pregnancy|0|||
37831277|NCT01248468|69514750|FG000|Overall Study|Withdrawal by Subject|4|||
37831278|NCT01248468|69514751|FG001|Overall Study|Withdrawal by Subject|2|||
37831279|NCT01248468|69514752|FG002|Overall Study|Withdrawal by Subject|0|||
37831280|NCT01247922|69514760|FG000|Overall Study|Disease progression|4|||
37831281|NCT01246206|69514764|FG000|Overall Study|Patient did not receive study regiments.|1|||
37831282|NCT01246011|69514771|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
37831283|NCT01246011|69514772|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
37831284|NCT01246011|69514773|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
38008121|NCT00112437|69691065|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
38008122|NCT00112437|69691066|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
37831285|NCT01246011|69514771|FG000|Overall Study|Withdrawal by Subject|0|||
37831286|NCT01246011|69514772|FG001|Overall Study|Withdrawal by Subject|0|||
37908213|NCT00891020|69593993|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
37908214|NCT00891020|69593994|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
37908215|NCT00891020|69593995|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
37908216|NCT00891020|69593993|FG000|24 Week Treatment Period|Death|0|||
37908217|NCT00891020|69593994|FG001|24 Week Treatment Period|Death|2|||
37908218|NCT00891020|69593995|FG002|24 Week Treatment Period|Death|0|||
37908219|NCT00891020|69593993|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
37908220|NCT00891020|69593994|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
37908221|NCT00891020|69593995|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
37908222|NCT00891020|69593993|FG000|24 Week Treatment Period|Failure to return|4|||
37908223|NCT00891020|69593994|FG001|24 Week Treatment Period|Failure to return|5|||
37908224|NCT00891020|69593995|FG002|24 Week Treatment Period|Failure to return|5|||
37908225|NCT00891020|69593993|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
37908226|NCT00891020|69593994|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
37908227|NCT00891020|69593995|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
37908228|NCT00891020|69593993|FG000|24 Week Treatment Period|Other protocol violation|1|||
37908229|NCT00891020|69593994|FG001|24 Week Treatment Period|Other protocol violation|1|||
37908230|NCT00891020|69593995|FG002|24 Week Treatment Period|Other protocol violation|2|||
37908231|NCT00891020|69593993|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
37908232|NCT00891020|69593994|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
37908233|NCT00891020|69593995|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
37908234|NCT00891020|69593993|FG000|24 Week Treatment Period|Withdrew consent|6|||
37908235|NCT00891020|69593994|FG001|24 Week Treatment Period|Withdrew consent|3|||
37908236|NCT00891020|69593995|FG002|24 Week Treatment Period|Withdrew consent|15|||
37908237|NCT00891020|69593993|FG000|24 Week Treatment Period|Administrative/Other|5|||
37908238|NCT00891020|69593994|FG001|24 Week Treatment Period|Administrative/Other|6|||
37908239|NCT00891020|69593995|FG002|24 Week Treatment Period|Administrative/Other|1|||
37908240|NCT00891020|69593993|FG000|Long-term Extension Period|Adverse Event|1|||
37908241|NCT00891020|69593994|FG001|Long-term Extension Period|Adverse Event|11|||
37908242|NCT00891020|69593995|FG002|Long-term Extension Period|Adverse Event|10|||
37908243|NCT00891020|69593993|FG000|Long-term Extension Period|Death|0|||
38008123|NCT00112437|69691067|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
37831287|NCT01246011|69514773|FG002|Overall Study|Withdrawal by Subject|1|||
37831288|NCT01244490|69514785|FG000|Overall Study|Lack of Efficacy|14|||
37831289|NCT01244490|69514786|FG001|Overall Study|Lack of Efficacy|5|||
37831290|NCT01244490|69514787|FG002|Overall Study|Lack of Efficacy|5|||
37831291|NCT01244490|69514785|FG000|Overall Study|Withdrawal by Subject|4|||
37831292|NCT01244490|69514786|FG001|Overall Study|Withdrawal by Subject|4|||
37831293|NCT01244490|69514787|FG002|Overall Study|Withdrawal by Subject|9|||
37831294|NCT01244490|69514785|FG000|Overall Study|Adverse Event|1|||
37831295|NCT01244490|69514786|FG001|Overall Study|Adverse Event|9|||
37831296|NCT01244490|69514787|FG002|Overall Study|Adverse Event|5|||
37831297|NCT01244490|69514785|FG000|Overall Study|Lost to Follow-up|0|||
37831298|NCT01244490|69514786|FG001|Overall Study|Lost to Follow-up|6|||
37831299|NCT01244490|69514787|FG002|Overall Study|Lost to Follow-up|3|||
37831300|NCT01244490|69514785|FG000|Overall Study|Other|0|||
37831301|NCT01244490|69514786|FG001|Overall Study|Other|0|||
37831302|NCT01244490|69514787|FG002|Overall Study|Other|1|||
37831303|NCT01243944|69514797|FG000|Overall Study|Adverse Event|15|||
37831304|NCT01243944|69514798|FG001|Overall Study|Adverse Event|13|||
37831305|NCT01243944|69514797|FG000|Overall Study|Lost to Follow-up|2|||
37831306|NCT01243944|69514798|FG001|Overall Study|Lost to Follow-up|1|||
37831307|NCT01243944|69514797|FG000|Overall Study|Physician Decision|2|||
37831308|NCT01243944|69514798|FG001|Overall Study|Physician Decision|7|||
38008124|NCT00112437|69691068|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
38008125|NCT00112437|69691069|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
38008126|NCT00112437|69691070|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
38008127|NCT00112437|69691071|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
38008128|NCT00112437|69691072|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
38008129|NCT00112437|69691073|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
38008130|NCT00112437|69691074|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
38008131|NCT00112437|69691075|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
38008132|NCT00112437|69691076|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
38008133|NCT00112437|69691077|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
38008134|NCT00112437|69691078|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
38008135|NCT00112437|69691079|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
38008136|NCT00112437|69691080|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
38008137|NCT00112437|69691081|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
38008138|NCT00112437|69691082|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
38008139|NCT00112437|69691083|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
38008140|NCT00112437|69691084|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
38008141|NCT00112437|69691085|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
38008142|NCT00112437|69691086|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
38008143|NCT00112437|69691087|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
38008144|NCT00112437|69691088|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
38008145|NCT00112437|69691089|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
38008146|NCT00112437|69691064|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
38008147|NCT00112437|69691065|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
38008148|NCT00112437|69691066|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
38008149|NCT00112437|69691067|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
38008150|NCT00112437|69691068|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
38008151|NCT00112437|69691069|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
38008152|NCT00112437|69691070|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
38008153|NCT00112437|69691071|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
38008154|NCT00112437|69691072|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
38008155|NCT00112437|69691073|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
38008156|NCT00112437|69691074|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
38008157|NCT00112437|69691075|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
38008158|NCT00112437|69691076|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
38008159|NCT00112437|69691077|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
37908244|NCT00891020|69593994|FG001|Long-term Extension Period|Death|0|||
37908245|NCT00891020|69593995|FG002|Long-term Extension Period|Death|1|||
37908246|NCT00891020|69593993|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
37908247|NCT00891020|69593994|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
37908248|NCT00891020|69593995|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
37908249|NCT00891020|69593993|FG000|Long-term Extension Period|Protocol Violation|0|||
38008160|NCT00112437|69691078|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
38008161|NCT00112437|69691079|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
38008162|NCT00112437|69691080|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
38008163|NCT00112437|69691081|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
37831309|NCT01243944|69514797|FG000|Overall Study|Disease progression|12|||
37831310|NCT01243944|69514798|FG001|Overall Study|Disease progression|11|||
37831311|NCT01243944|69514797|FG000|Overall Study|Protocol deviation|1|||
37831312|NCT01243944|69514798|FG001|Overall Study|Protocol deviation|1|||
37831313|NCT01243944|69514797|FG000|Overall Study|Participant decision|10|||
37831314|NCT01243944|69514798|FG001|Overall Study|Participant decision|15|||
38008164|NCT00112437|69691082|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
38008165|NCT00112437|69691083|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
38008166|NCT00112437|69691084|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
38008167|NCT00112437|69691085|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
38008168|NCT00112437|69691086|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
38008169|NCT00112437|69691087|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
38008170|NCT00112437|69691088|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
38008171|NCT00112437|69691089|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
37697760|NCT01839916|69174362|FG000|Overall Study|Relapse|12|||
37697761|NCT01839916|69174362|FG000|Overall Study|GVHD|2|||
37908250|NCT00891020|69593994|FG001|Long-term Extension Period|Protocol Violation|1|||
37697762|NCT01839916|69174362|FG000|Overall Study|Graft Failure|1|||
37908251|NCT00891020|69593995|FG002|Long-term Extension Period|Protocol Violation|1|||
37831315|NCT01243944|69514797|FG000|Overall Study|Death|2|||
37831316|NCT01243944|69514798|FG001|Overall Study|Death|3|||
37831317|NCT01243944|69514797|FG000|Overall Study|Non-compliance with study treatment|1|||
37908252|NCT00891020|69593993|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
37831318|NCT01243944|69514798|FG001|Overall Study|Non-compliance with study treatment|0|||
38008172|NCT00112437|69691064|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
37697763|NCT01823146|69174368|FG000|Overall Study|Withdrawal by Subject|0|||
37697764|NCT01823146|69174369|FG001|Overall Study|Withdrawal by Subject|1|||
37697765|NCT01823146|69174368|FG000|Overall Study|Lost to Follow-up|2|||
37697766|NCT01823146|69174369|FG001|Overall Study|Lost to Follow-up|1|||
37697767|NCT02083185|69174378|FG000|Overall Study|Lost to Follow-up|0|||
37697768|NCT02083185|69174379|FG001|Overall Study|Lost to Follow-up|3|||
37697769|NCT02083185|69174380|FG002|Overall Study|Lost to Follow-up|0|||
37697770|NCT02083185|69174378|FG000|Overall Study|Withdrawal by Subject|9|||
37697771|NCT02083185|69174379|FG001|Overall Study|Withdrawal by Subject|15|||
38008173|NCT00112437|69691065|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
37697772|NCT02083185|69174380|FG002|Overall Study|Withdrawal by Subject|1|||
37697773|NCT02083185|69174378|FG000|Overall Study|Death|2|||
37697774|NCT02083185|69174379|FG001|Overall Study|Death|2|||
37697775|NCT02083185|69174380|FG002|Overall Study|Death|1|||
37697776|NCT02083185|69174378|FG000|Overall Study|Reason not Specified|9|||
37697777|NCT02083185|69174379|FG001|Overall Study|Reason not Specified|6|||
37697778|NCT02083185|69174380|FG002|Overall Study|Reason not Specified|5|||
37697779|NCT02083185|69174378|FG000|Overall Study|Study Terminated by Sponsor|0|||
37697780|NCT02083185|69174379|FG001|Overall Study|Study Terminated by Sponsor|1|||
37697781|NCT02083185|69174380|FG002|Overall Study|Study Terminated by Sponsor|0|||
37697782|NCT02083185|69174378|FG000|Overall Study|Did not Receive Study Drug|0|||
37697783|NCT02083185|69174379|FG001|Overall Study|Did not Receive Study Drug|2|||
37697784|NCT02083185|69174380|FG002|Overall Study|Did not Receive Study Drug|0|||
37697785|NCT02019927|69174394|FG000|Overall Study|Lost to Follow-up|2|||
37697786|NCT02019927|69174395|FG001|Overall Study|Lost to Follow-up|4|||
37697787|NCT02019927|69174396|FG002|Overall Study|Lost to Follow-up|1|||
37697788|NCT02019927|69174397|FG003|Overall Study|Lost to Follow-up|2|||
37697789|NCT02019927|69174398|FG004|Overall Study|Lost to Follow-up|3|||
37697790|NCT02019927|69174399|FG005|Overall Study|Lost to Follow-up|1|||
37697791|NCT02412371|69174423|FG000|Overall Study|Withdrawal by Subject|0|||
38008174|NCT00112437|69691066|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
38008175|NCT00112437|69691067|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
38008176|NCT00112437|69691068|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
38008177|NCT00112437|69691069|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
38008178|NCT00112437|69691070|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
38008179|NCT00112437|69691071|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
38008180|NCT00112437|69691072|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
38008181|NCT00112437|69691073|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
38008182|NCT00112437|69691074|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
38008183|NCT00112437|69691075|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
38008184|NCT00112437|69691076|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
38008185|NCT00112437|69691077|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
38008186|NCT00112437|69691078|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
38008187|NCT00112437|69691079|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
38008188|NCT00112437|69691080|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
38008189|NCT00112437|69691081|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
38008190|NCT00112437|69691082|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
38008191|NCT00112437|69691083|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
38008192|NCT00112437|69691084|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
37697792|NCT02412371|69174424|FG001|Overall Study|Withdrawal by Subject|2|||
37697793|NCT02412371|69174425|FG002|Overall Study|Withdrawal by Subject|0|||
37697794|NCT02412371|69174426|FG003|Overall Study|Withdrawal by Subject|1|||
37697795|NCT02412371|69174427|FG004|Overall Study|Withdrawal by Subject|1|||
37831319|NCT01243242|69514807|FG000|Overall Study|Adverse Event|1|||
37831320|NCT01243242|69514808|FG001|Overall Study|Adverse Event|1|||
37831321|NCT01243242|69514807|FG000|Overall Study|Withdrawal by Subject|1|||
37831322|NCT01243242|69514808|FG001|Overall Study|Withdrawal by Subject|1|||
37831323|NCT01243242|69514807|FG000|Overall Study|Physician Decision|0|||
37831324|NCT01243242|69514808|FG001|Overall Study|Physician Decision|1|||
37831325|NCT01243242|69514807|FG000|Overall Study|sponsor decision|0|||
37831326|NCT01243242|69514808|FG001|Overall Study|sponsor decision|1|||
37831327|NCT01243242|69514807|FG000|Overall Study|non compliance|1|||
37831328|NCT01243242|69514808|FG001|Overall Study|non compliance|0|||
37831329|NCT01242813|69514814|FG000|Overall Study|Lost to Follow-up|2|||
38008193|NCT00112437|69691085|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
38008194|NCT00112437|69691086|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
38008195|NCT00112437|69691087|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
37831330|NCT01242111|69514818|FG000|Overall Study|Adverse Event|1|||
37697796|NCT02412371|69174428|FG005|Overall Study|Withdrawal by Subject|0|||
37908253|NCT00891020|69593994|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
38008196|NCT00112437|69691088|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
38008197|NCT00112437|69691089|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
37697797|NCT02412371|69174423|FG000|Overall Study|Sponsor Discontinued Study|1|||
37697798|NCT02412371|69174424|FG001|Overall Study|Sponsor Discontinued Study|4|||
37831331|NCT01242111|69514818|FG000|Overall Study|Withdrawal by Subject|1|||
37831332|NCT01242111|69514818|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
38008198|NCT00112437|69691064|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
38008199|NCT00112437|69691065|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
38008200|NCT00112437|69691066|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
38008201|NCT00112437|69691067|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
38008202|NCT00112437|69691068|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
38008203|NCT00112437|69691069|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
38008204|NCT00112437|69691070|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
38008205|NCT00112437|69691071|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
38008206|NCT00112437|69691072|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
38008207|NCT00112437|69691073|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
38008208|NCT00112437|69691074|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
38008209|NCT00112437|69691075|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
38008210|NCT00112437|69691076|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
38008211|NCT00112437|69691077|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
38008212|NCT00112437|69691078|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
38008213|NCT00112437|69691079|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
38008214|NCT00112437|69691080|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
37908254|NCT00891020|69593995|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
38008215|NCT00112437|69691081|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
38008216|NCT00112437|69691082|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
38008217|NCT00112437|69691083|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
38008218|NCT00112437|69691084|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
38008219|NCT00112437|69691085|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
38008220|NCT00112437|69691086|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
38008221|NCT00112437|69691087|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
38008222|NCT00112437|69691088|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
38008223|NCT00112437|69691089|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
38008224|NCT00112437|69691064|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
38008225|NCT00112437|69691065|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
38008226|NCT00112437|69691066|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
38008227|NCT00112437|69691067|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
38008228|NCT00112437|69691068|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
38008229|NCT00112437|69691069|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
38008230|NCT00112437|69691070|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
38008231|NCT00112437|69691071|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
38008232|NCT00112437|69691072|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
38008233|NCT00112437|69691073|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
38008234|NCT00112437|69691074|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
38008235|NCT00112437|69691075|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
38008236|NCT00112437|69691076|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
38008237|NCT00112437|69691077|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
38008238|NCT00112437|69691078|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
38008239|NCT00112437|69691079|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
38008240|NCT00112437|69691080|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
38008241|NCT00112437|69691081|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
38008242|NCT00112437|69691082|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
38008243|NCT00112437|69691083|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
38008244|NCT00112437|69691084|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
38008245|NCT00112437|69691085|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
38008246|NCT00112437|69691086|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
38008247|NCT00112437|69691087|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
37831333|NCT01241604|69514822|FG000|Screening Period|Screen Failure|3|||
37831334|NCT01241604|69514823|FG001|Screening Period|Screen Failure|0|||
37831335|NCT01241604|69514824|FG002|Screening Period|Screen Failure|0|||
37831336|NCT01241292|69514833|FG000|Overall Study|Administrative Reason by Sponsor|1|||
37831337|NCT01241292|69514834|FG001|Overall Study|Administrative Reason by Sponsor|0|||
37831338|NCT01241292|69514833|FG000|Overall Study|Disease Progression|2|||
37831339|NCT01241292|69514834|FG001|Overall Study|Disease Progression|0|||
38008248|NCT00112437|69691088|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
38008249|NCT00112437|69691089|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
37831340|NCT01241292|69514833|FG000|Overall Study|Study Drug Toxicity|0|||
37831341|NCT01241292|69514834|FG001|Overall Study|Study Drug Toxicity|1|||
38008250|NCT00112437|69691064|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
38008251|NCT00112437|69691065|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
38008252|NCT00112437|69691066|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
38008253|NCT00112437|69691067|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
38008254|NCT00112437|69691068|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
38008255|NCT00112437|69691069|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
38008256|NCT00112437|69691070|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
38008257|NCT00112437|69691071|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
38008258|NCT00112437|69691072|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
38008259|NCT00112437|69691073|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
38008260|NCT00112437|69691074|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
38008261|NCT00112437|69691075|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
38008262|NCT00112437|69691076|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
38008263|NCT00112437|69691077|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
38008264|NCT00112437|69691078|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
38008265|NCT00112437|69691079|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
38008266|NCT00112437|69691080|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
38008267|NCT00112437|69691081|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
38008268|NCT00112437|69691082|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
38008269|NCT00112437|69691083|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
38008270|NCT00112437|69691084|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
38008271|NCT00112437|69691085|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
38008272|NCT00112437|69691086|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
38008273|NCT00112437|69691087|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
38008274|NCT00112437|69691088|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
38008275|NCT00112437|69691089|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
38008276|NCT00112437|69691064|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
38008277|NCT00112437|69691065|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
38008278|NCT00112437|69691066|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
38008279|NCT00112437|69691067|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
38008280|NCT00112437|69691068|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
38008281|NCT00112437|69691069|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
38008282|NCT00112437|69691070|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
38008283|NCT00112437|69691071|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
38008284|NCT00112437|69691072|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
38008285|NCT00112437|69691073|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
38008286|NCT00112437|69691074|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
38008287|NCT00112437|69691075|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
38008288|NCT00112437|69691076|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
38008289|NCT00112437|69691077|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
38008290|NCT00112437|69691078|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
38008291|NCT00112437|69691079|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
38008292|NCT00112437|69691080|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
38008293|NCT00112437|69691081|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
38008294|NCT00112437|69691082|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
38008295|NCT00112437|69691083|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
37831342|NCT01241292|69514833|FG000|Overall Study|Participant Discontinued Treatment|0|||
37831343|NCT01241292|69514834|FG001|Overall Study|Participant Discontinued Treatment|2|||
37831344|NCT01240863|69514846|FG000|Open-label Titration Period|Adverse Event|47|||
37831345|NCT01240863|69514847|FG001|Open-label Titration Period|Adverse Event|0|||
37831346|NCT01240863|69514848|FG002|Open-label Titration Period|Adverse Event|0|||
37831347|NCT01240863|69514846|FG000|Open-label Titration Period|Lack of Efficacy|19|||
37831348|NCT01240863|69514847|FG001|Open-label Titration Period|Lack of Efficacy|0|||
37831349|NCT01240863|69514848|FG002|Open-label Titration Period|Lack of Efficacy|0|||
37831350|NCT01240863|69514846|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
37831351|NCT01240863|69514847|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
37831352|NCT01240863|69514848|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
37831353|NCT01240863|69514846|FG000|Open-label Titration Period|Protocol Violation|7|||
37831354|NCT01240863|69514847|FG001|Open-label Titration Period|Protocol Violation|0|||
37831355|NCT01240863|69514848|FG002|Open-label Titration Period|Protocol Violation|0|||
37831356|NCT01240863|69514846|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
38008296|NCT00112437|69691084|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
38008297|NCT00112437|69691085|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
38008298|NCT00112437|69691086|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
38008299|NCT00112437|69691087|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
38008300|NCT00112437|69691088|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
38008301|NCT00112437|69691089|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
38008302|NCT00112437|69691064|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
38008303|NCT00112437|69691065|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
38008304|NCT00112437|69691066|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
38008305|NCT00112437|69691067|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
38008306|NCT00112437|69691068|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
38008307|NCT00112437|69691069|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
38008308|NCT00112437|69691070|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
38008309|NCT00112437|69691071|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
38008310|NCT00112437|69691072|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
38008311|NCT00112437|69691073|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
38008312|NCT00112437|69691074|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
38008313|NCT00112437|69691075|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
38008314|NCT00112437|69691076|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
38008315|NCT00112437|69691077|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
38008316|NCT00112437|69691078|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
38008317|NCT00112437|69691079|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
38008318|NCT00112437|69691080|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
38008319|NCT00112437|69691081|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
38008320|NCT00112437|69691082|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
38008321|NCT00112437|69691083|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
38008322|NCT00112437|69691084|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
38008323|NCT00112437|69691085|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
38008324|NCT00112437|69691086|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
38008325|NCT00112437|69691087|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
38008326|NCT00112437|69691088|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
38008327|NCT00112437|69691089|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
38008328|NCT00112437|69691064|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
38008329|NCT00112437|69691065|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
38008330|NCT00112437|69691066|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
38008331|NCT00112437|69691067|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
38008332|NCT00112437|69691068|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
38008333|NCT00112437|69691069|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
38008334|NCT00112437|69691070|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
38008335|NCT00112437|69691071|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
38008336|NCT00112437|69691072|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
38008337|NCT00112437|69691073|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
38008338|NCT00112437|69691074|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
38008339|NCT00112437|69691075|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
38008340|NCT00112437|69691076|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
38008341|NCT00112437|69691077|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
38008342|NCT00112437|69691078|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
38008343|NCT00112437|69691079|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
38008344|NCT00112437|69691080|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
38008345|NCT00112437|69691081|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
38008346|NCT00112437|69691082|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
38008347|NCT00112437|69691083|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
38008348|NCT00112437|69691084|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
37908255|NCT00891020|69593993|FG000|Long-term Extension Period|Failure to return|0|||
37908256|NCT00891020|69593994|FG001|Long-term Extension Period|Failure to return|2|||
37831357|NCT01240863|69514847|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
37831358|NCT01240863|69514848|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
37831359|NCT01240863|69514846|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
37831360|NCT01240863|69514847|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
37831361|NCT01240863|69514848|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
37831362|NCT01240863|69514846|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
37831363|NCT01240863|69514847|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
37831364|NCT01240863|69514848|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
37831365|NCT01240863|69514846|FG000|Open-label Titration Period|Other|7|||
37831366|NCT01240863|69514847|FG001|Open-label Titration Period|Other|0|||
37831367|NCT01240863|69514848|FG002|Open-label Titration Period|Other|0|||
38008349|NCT00112437|69691085|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
38008350|NCT00112437|69691086|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
38008351|NCT00112437|69691087|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
38008352|NCT00112437|69691088|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
38008353|NCT00112437|69691089|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
38008354|NCT00112437|69691064|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
38008355|NCT00112437|69691065|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
38008356|NCT00112437|69691066|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
38008357|NCT00112437|69691067|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
38008358|NCT00112437|69691068|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
38008359|NCT00112437|69691069|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
38008360|NCT00112437|69691070|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
38008361|NCT00112437|69691071|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
38008362|NCT00112437|69691072|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
38008363|NCT00112437|69691073|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
37831368|NCT01240863|69514846|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
38008364|NCT00112437|69691074|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
38008365|NCT00112437|69691075|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
38008366|NCT00112437|69691076|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
38008367|NCT00112437|69691077|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
38008368|NCT00112437|69691078|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
38008369|NCT00112437|69691079|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
38008370|NCT00112437|69691080|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
38008371|NCT00112437|69691081|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
38008372|NCT00112437|69691082|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
38008373|NCT00112437|69691083|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
38008374|NCT00112437|69691084|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
38008375|NCT00112437|69691085|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
38008376|NCT00112437|69691086|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
38008377|NCT00112437|69691087|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
38008378|NCT00112437|69691088|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
38008379|NCT00112437|69691089|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
38008380|NCT00112437|69691064|FG000|Years 6-10 (60-Month Extension)|Death|0|||
38008381|NCT00112437|69691065|FG001|Years 6-10 (60-Month Extension)|Death|0|||
38008382|NCT00112437|69691066|FG002|Years 6-10 (60-Month Extension)|Death|0|||
38008383|NCT00112437|69691067|FG003|Years 6-10 (60-Month Extension)|Death|0|||
38008384|NCT00112437|69691068|FG004|Years 6-10 (60-Month Extension)|Death|0|||
38008385|NCT00112437|69691069|FG005|Years 6-10 (60-Month Extension)|Death|0|||
38008386|NCT00112437|69691070|FG006|Years 6-10 (60-Month Extension)|Death|0|||
38008387|NCT00112437|69691071|FG007|Years 6-10 (60-Month Extension)|Death|0|||
38008388|NCT00112437|69691072|FG008|Years 6-10 (60-Month Extension)|Death|0|||
38008389|NCT00112437|69691073|FG009|Years 6-10 (60-Month Extension)|Death|0|||
38008390|NCT00112437|69691074|FG010|Years 6-10 (60-Month Extension)|Death|0|||
38008391|NCT00112437|69691075|FG011|Years 6-10 (60-Month Extension)|Death|0|||
38008392|NCT00112437|69691076|FG012|Years 6-10 (60-Month Extension)|Death|0|||
38008393|NCT00112437|69691077|FG013|Years 6-10 (60-Month Extension)|Death|0|||
38008394|NCT00112437|69691078|FG014|Years 6-10 (60-Month Extension)|Death|0|||
38008395|NCT00112437|69691079|FG015|Years 6-10 (60-Month Extension)|Death|0|||
38008396|NCT00112437|69691080|FG016|Years 6-10 (60-Month Extension)|Death|0|||
38008397|NCT00112437|69691081|FG017|Years 6-10 (60-Month Extension)|Death|0|||
38008398|NCT00112437|69691082|FG018|Years 6-10 (60-Month Extension)|Death|0|||
38008399|NCT00112437|69691083|FG019|Years 6-10 (60-Month Extension)|Death|0|||
38008400|NCT00112437|69691084|FG020|Years 6-10 (60-Month Extension)|Death|0|||
38008401|NCT00112437|69691085|FG021|Years 6-10 (60-Month Extension)|Death|0|||
38008402|NCT00112437|69691086|FG022|Years 6-10 (60-Month Extension)|Death|0|||
38008403|NCT00112437|69691087|FG023|Years 6-10 (60-Month Extension)|Death|2|||
38008404|NCT00112437|69691088|FG024|Years 6-10 (60-Month Extension)|Death|0|||
38008405|NCT00112437|69691089|FG025|Years 6-10 (60-Month Extension)|Death|0|||
38008406|NCT00112437|69691064|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
38008407|NCT00112437|69691065|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
38008408|NCT00112437|69691066|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
38008409|NCT00112437|69691067|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
38008410|NCT00112437|69691068|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
38008411|NCT00112437|69691069|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
38008412|NCT00112437|69691070|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
38008413|NCT00112437|69691071|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
38008414|NCT00112437|69691072|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
38008415|NCT00112437|69691073|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
38008416|NCT00112437|69691074|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
38008417|NCT00112437|69691075|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
37831369|NCT01240863|69514847|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
37831370|NCT01240863|69514848|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
37831371|NCT01240863|69514846|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
37831372|NCT01240863|69514847|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
37831373|NCT01240863|69514848|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
37831374|NCT01240863|69514846|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
37831375|NCT01240863|69514847|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
37831376|NCT01240863|69514848|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
37831377|NCT01240863|69514846|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
37831378|NCT01240863|69514847|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
37831379|NCT01240863|69514848|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
37831380|NCT01240863|69514846|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
37831381|NCT01240863|69514847|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
37831382|NCT01240863|69514848|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
37831383|NCT01240863|69514846|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
37831384|NCT01240863|69514847|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
37831385|NCT01240863|69514848|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
37831386|NCT01240863|69514846|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
37831387|NCT01240863|69514847|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
37831388|NCT01240863|69514848|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
37831389|NCT01240863|69514846|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
37831390|NCT01240863|69514847|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
37831391|NCT01240863|69514848|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
37831392|NCT01240746|69514863|FG000|Overall Study|Adverse Event|2|||
37908257|NCT00891020|69593995|FG002|Long-term Extension Period|Failure to return|3|||
38008418|NCT00112437|69691076|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
38008419|NCT00112437|69691077|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
38008420|NCT00112437|69691078|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
38008421|NCT00112437|69691079|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
38008422|NCT00112437|69691080|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
38008423|NCT00112437|69691081|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
38008424|NCT00112437|69691082|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
38008425|NCT00112437|69691083|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
38008426|NCT00112437|69691084|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
38008427|NCT00112437|69691085|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
38008428|NCT00112437|69691086|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
38008429|NCT00112437|69691087|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
38008430|NCT00112437|69691088|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
38008431|NCT00112437|69691089|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
38008432|NCT00112437|69691064|FG000|Years 6-10 (60-Month Extension)|Other|0|||
38008433|NCT00112437|69691065|FG001|Years 6-10 (60-Month Extension)|Other|0|||
38008434|NCT00112437|69691066|FG002|Years 6-10 (60-Month Extension)|Other|0|||
38008435|NCT00112437|69691067|FG003|Years 6-10 (60-Month Extension)|Other|0|||
38008436|NCT00112437|69691068|FG004|Years 6-10 (60-Month Extension)|Other|0|||
38008437|NCT00112437|69691069|FG005|Years 6-10 (60-Month Extension)|Other|0|||
38008438|NCT00112437|69691070|FG006|Years 6-10 (60-Month Extension)|Other|0|||
38008439|NCT00112437|69691071|FG007|Years 6-10 (60-Month Extension)|Other|0|||
38008440|NCT00112437|69691072|FG008|Years 6-10 (60-Month Extension)|Other|0|||
38008441|NCT00112437|69691073|FG009|Years 6-10 (60-Month Extension)|Other|0|||
38008442|NCT00112437|69691074|FG010|Years 6-10 (60-Month Extension)|Other|0|||
38008443|NCT00112437|69691075|FG011|Years 6-10 (60-Month Extension)|Other|0|||
38008444|NCT00112437|69691076|FG012|Years 6-10 (60-Month Extension)|Other|0|||
38008445|NCT00112437|69691077|FG013|Years 6-10 (60-Month Extension)|Other|0|||
38008446|NCT00112437|69691078|FG014|Years 6-10 (60-Month Extension)|Other|0|||
38008447|NCT00112437|69691079|FG015|Years 6-10 (60-Month Extension)|Other|0|||
38008448|NCT00112437|69691080|FG016|Years 6-10 (60-Month Extension)|Other|0|||
38008449|NCT00112437|69691081|FG017|Years 6-10 (60-Month Extension)|Other|0|||
38008450|NCT00112437|69691082|FG018|Years 6-10 (60-Month Extension)|Other|0|||
38008451|NCT00112437|69691083|FG019|Years 6-10 (60-Month Extension)|Other|0|||
38008452|NCT00112437|69691084|FG020|Years 6-10 (60-Month Extension)|Other|0|||
38008453|NCT00112437|69691085|FG021|Years 6-10 (60-Month Extension)|Other|0|||
38008454|NCT00112437|69691086|FG022|Years 6-10 (60-Month Extension)|Other|0|||
38008455|NCT00112437|69691087|FG023|Years 6-10 (60-Month Extension)|Other|0|||
38008456|NCT00112437|69691088|FG024|Years 6-10 (60-Month Extension)|Other|1|||
38008457|NCT00112437|69691089|FG025|Years 6-10 (60-Month Extension)|Other|0|||
38008458|NCT00112437|69691064|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
38008459|NCT00112437|69691065|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
38008460|NCT00112437|69691066|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
38008461|NCT00112437|69691067|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
38008462|NCT00112437|69691068|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
38008463|NCT00112437|69691069|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
38008464|NCT00112437|69691070|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
38008465|NCT00112437|69691071|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
38008466|NCT00112437|69691072|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
38008467|NCT00112437|69691073|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
38008468|NCT00112437|69691074|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
38008469|NCT00112437|69691075|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
38008470|NCT00112437|69691076|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
38008471|NCT00112437|69691077|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
37908258|NCT00891020|69593993|FG000|Long-term Extension Period|Administrative|1|||
37908259|NCT00891020|69593994|FG001|Long-term Extension Period|Administrative|2|||
37908260|NCT00891020|69593995|FG002|Long-term Extension Period|Administrative|2|||
37908261|NCT00611455|69594007|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
37908262|NCT00611455|69594008|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
37908263|NCT00611455|69594009|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
37908264|NCT00611455|69594007|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
37908265|NCT00611455|69594008|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
38008472|NCT00112437|69691078|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
38008473|NCT00112437|69691079|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
38008474|NCT00112437|69691080|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
38008475|NCT00112437|69691081|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
38008476|NCT00112437|69691082|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
38008477|NCT00112437|69691083|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
38008478|NCT00112437|69691084|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
38008479|NCT00112437|69691085|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
38008480|NCT00112437|69691086|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
38008481|NCT00112437|69691087|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
38008482|NCT00112437|69691088|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
38008483|NCT00112437|69691089|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
38008484|NCT00112437|69691064|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
38008485|NCT00112437|69691065|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
38008486|NCT00112437|69691066|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
38008487|NCT00112437|69691067|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
38008488|NCT00112437|69691068|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
38008489|NCT00112437|69691069|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
38008490|NCT00112437|69691070|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
38008491|NCT00112437|69691071|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
38008492|NCT00112437|69691072|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
38008493|NCT00112437|69691073|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
38008494|NCT00112437|69691074|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
38008495|NCT00112437|69691075|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
38008496|NCT00112437|69691076|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
38008497|NCT00112437|69691077|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
38008498|NCT00112437|69691078|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
38008499|NCT00112437|69691079|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
38008500|NCT00112437|69691080|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
38008501|NCT00112437|69691081|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
38008502|NCT00112437|69691082|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
38008503|NCT00112437|69691083|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
38008504|NCT00112437|69691084|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
37697799|NCT02412371|69174425|FG002|Overall Study|Sponsor Discontinued Study|6|||
37697800|NCT02412371|69174426|FG003|Overall Study|Sponsor Discontinued Study|4|||
38008505|NCT00112437|69691085|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
38008506|NCT00112437|69691086|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
38008507|NCT00112437|69691087|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
38008508|NCT00112437|69691088|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
38008509|NCT00112437|69691089|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
38008510|NCT03653416|69691145|FG000|Overall Study|Protocol Violation|6|||
38008511|NCT03653416|69691146|FG001|Overall Study|Protocol Violation|1|||
38008512|NCT00112359|69691154|FG000|Overall Study|Unrelated adverse event|16|||
38008513|NCT00112359|69691155|FG001|Overall Study|Unrelated adverse event|8|||
37831393|NCT01240746|69514864|FG001|Overall Study|Adverse Event|0|||
37831394|NCT01240746|69514865|FG002|Overall Study|Adverse Event|10|||
37831395|NCT01240746|69514863|FG000|Overall Study|Lost to Follow-up|23|||
37831396|NCT01240746|69514864|FG001|Overall Study|Lost to Follow-up|20|||
37831397|NCT01240746|69514865|FG002|Overall Study|Lost to Follow-up|102|||
37831398|NCT01240746|69514863|FG000|Overall Study|Protocol Violation|24|||
37831399|NCT01240746|69514864|FG001|Overall Study|Protocol Violation|15|||
37831400|NCT01240746|69514865|FG002|Overall Study|Protocol Violation|72|||
37831401|NCT01240746|69514863|FG000|Overall Study|Withdrawal by Subject|10|||
37831402|NCT01240746|69514864|FG001|Overall Study|Withdrawal by Subject|13|||
37831403|NCT01240746|69514865|FG002|Overall Study|Withdrawal by Subject|59|||
37831404|NCT01240590|69514878|FG000|Phase I|Refused further treatment|0|||
37831405|NCT01240590|69514879|FG001|Phase I|Refused further treatment|0|||
37831406|NCT01240590|69514880|FG002|Phase I|Refused further treatment|3|||
37831407|NCT01240590|69514881|FG003|Phase I|Refused further treatment|0|||
37831408|NCT01240590|69514882|FG004|Phase I|Refused further treatment|0|||
37831409|NCT01240590|69514878|FG000|Phase II|Refused further treatment|0|||
37831410|NCT01240590|69514879|FG001|Phase II|Refused further treatment|0|||
37831411|NCT01240590|69514880|FG002|Phase II|Refused further treatment|0|||
37908266|NCT00611455|69594009|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
38008514|NCT00112359|69691154|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
37831412|NCT01240590|69514881|FG003|Phase II|Refused further treatment|2|||
37908267|NCT00611455|69594007|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
37831413|NCT01240590|69514882|FG004|Phase II|Refused further treatment|1|||
38008515|NCT00112359|69691155|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
38008516|NCT00112359|69691154|FG000|Overall Study|Related adverse event|5|||
38008517|NCT00112359|69691155|FG001|Overall Study|Related adverse event|3|||
38008518|NCT00112359|69691154|FG000|Overall Study|Lost to Follow-up|0|||
38008519|NCT00112359|69691155|FG001|Overall Study|Lost to Follow-up|1|||
38008520|NCT00112359|69691154|FG000|Overall Study|Personal/administrative|1|||
38008521|NCT00112359|69691155|FG001|Overall Study|Personal/administrative|1|||
38008522|NCT00112359|69691154|FG000|Overall Study|Other|3|||
38008523|NCT00112359|69691155|FG001|Overall Study|Other|0|||
38008524|NCT00119379|69691163|FG000|Overall Study|Adverse Event|4|||
38008525|NCT00119379|69691164|FG001|Overall Study|Adverse Event|1|||
38008526|NCT00118911|69691172|FG000|Overall Study|Withdrawal by Subject|2|||
38008527|NCT00118911|69691173|FG001|Overall Study|Withdrawal by Subject|5|||
38008528|NCT00131937|69691179|FG000|Overall Study|Adverse Event|3|||
38008529|NCT00131937|69691179|FG000|Overall Study|Withdrawal by Subject|2|||
38008530|NCT00131937|69691179|FG000|Overall Study|Physician Decision|1|||
38008531|NCT00131937|69691179|FG000|Overall Study|Disease Progression|7|||
38008532|NCT00131937|69691179|FG000|Overall Study|Alternative therapy|1|||
38008533|NCT00131469|69691185|FG000|Overall Study|Withdrawal by Subject|3|||
38008534|NCT00131469|69691186|FG001|Overall Study|Withdrawal by Subject|4|||
38008535|NCT00131469|69691185|FG000|Overall Study|Protocol Violation|3|||
38008536|NCT00131469|69691186|FG001|Overall Study|Protocol Violation|1|||
38008537|NCT00131469|69691185|FG000|Overall Study|Death|0|||
38008538|NCT00131469|69691186|FG001|Overall Study|Death|1|||
38008539|NCT00131469|69691185|FG000|Overall Study|Lost to Follow-up|0|||
38008540|NCT00131469|69691186|FG001|Overall Study|Lost to Follow-up|1|||
38008541|NCT00131469|69691185|FG000|Overall Study|scan not analyzable|3|||
38008542|NCT00131469|69691186|FG001|Overall Study|scan not analyzable|6|||
38008543|NCT00372593|69691195|FG000|Overall Study|Adverse Event|43|||
38008544|NCT00372593|69691196|FG001|Overall Study|Adverse Event|45|||
38008545|NCT00372593|69691197|FG002|Overall Study|Adverse Event|0|||
38008546|NCT00372593|69691195|FG000|Overall Study|Death|16|||
38008547|NCT00372593|69691196|FG001|Overall Study|Death|20|||
38008548|NCT00372593|69691197|FG002|Overall Study|Death|1|||
38008549|NCT00372593|69691195|FG000|Overall Study|Lack of Efficacy|82|||
37908268|NCT00611455|69594008|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
37908269|NCT00611455|69594009|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
37908270|NCT00611455|69594007|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
37908271|NCT00611455|69594008|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
37908272|NCT00611455|69594009|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
37908273|NCT00611455|69594007|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
37908274|NCT00611455|69594008|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
37908275|NCT00611455|69594009|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
37908276|NCT00611455|69594007|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
37908277|NCT00611455|69594008|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
37908278|NCT00611455|69594009|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
37908279|NCT00611455|69594007|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
37908280|NCT00611455|69594008|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
37908281|NCT00611455|69594009|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
37908282|NCT00611455|69594007|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
37908283|NCT00611455|69594008|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
37908284|NCT00611455|69594009|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
37908285|NCT00611455|69594007|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
37908286|NCT00611455|69594008|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
37908287|NCT00611455|69594009|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
37908288|NCT00611455|69594007|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
37908289|NCT00611455|69594008|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
38008550|NCT00372593|69691196|FG001|Overall Study|Lack of Efficacy|71|||
38008551|NCT00372593|69691197|FG002|Overall Study|Lack of Efficacy|2|||
38008552|NCT00372593|69691195|FG000|Overall Study|Lost to Follow-up|1|||
38008553|NCT00372593|69691196|FG001|Overall Study|Lost to Follow-up|0|||
38008554|NCT00372593|69691197|FG002|Overall Study|Lost to Follow-up|0|||
38008555|NCT00372593|69691195|FG000|Overall Study|Physician Decision|42|||
38008556|NCT00372593|69691196|FG001|Overall Study|Physician Decision|41|||
38008557|NCT00372593|69691197|FG002|Overall Study|Physician Decision|0|||
38008558|NCT00372593|69691195|FG000|Overall Study|Ineligible|20|||
38008559|NCT00372593|69691196|FG001|Overall Study|Ineligible|21|||
38008560|NCT00372593|69691197|FG002|Overall Study|Ineligible|1|||
37908290|NCT00611455|69594009|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
37908291|NCT00611455|69594007|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
37908292|NCT00611455|69594008|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
37908293|NCT00611455|69594009|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
37908294|NCT00611455|69594007|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
37908295|NCT00611455|69594008|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
37908296|NCT00611455|69594009|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
37908297|NCT00611455|69594007|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
37908298|NCT00611455|69594008|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
37908299|NCT00611455|69594009|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
37908300|NCT00611455|69594007|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
37908301|NCT00611455|69594008|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
37908302|NCT00611455|69594009|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
37908303|NCT00611455|69594007|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
37908304|NCT00611455|69594008|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
37908305|NCT00611455|69594009|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
37697801|NCT02412371|69174427|FG004|Overall Study|Sponsor Discontinued Study|5|||
37831414|NCT01240200|69514910|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
37908306|NCT00611455|69594007|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
37908307|NCT00611455|69594008|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
37908308|NCT00611455|69594009|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
37908309|NCT00611455|69594007|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
37908310|NCT00611455|69594008|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
37908311|NCT00611455|69594009|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
37908312|NCT00611455|69594007|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
37908313|NCT00611455|69594008|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
37908314|NCT00611455|69594009|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
37908315|NCT00611455|69594007|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
37908316|NCT00611455|69594008|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
37908317|NCT00611455|69594009|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
37908318|NCT00611455|69594007|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
37908319|NCT00611455|69594008|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
37908320|NCT00611455|69594009|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
37908321|NCT00611455|69594007|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
37908322|NCT00611455|69594008|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
37908323|NCT00611455|69594009|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
37908324|NCT00952289|69594021|FG000|All Participants|Death|9|||
37908325|NCT00952289|69594022|FG001|All Participants|Death|9|||
37908326|NCT00952289|69594021|FG000|All Participants|Adverse Event|8|||
37908327|NCT00952289|69594022|FG001|All Participants|Adverse Event|8|||
37908328|NCT00952289|69594021|FG000|All Participants|Disease progression|3|||
37908329|NCT00952289|69594022|FG001|All Participants|Disease progression|12|||
37908330|NCT00952289|69594021|FG000|All Participants|Withdrawal by Subject|1|||
37908331|NCT00952289|69594022|FG001|All Participants|Withdrawal by Subject|10|||
37908332|NCT00952289|69594021|FG000|All Participants|Data lost during site relocation|0|||
37908333|NCT00952289|69594022|FG001|All Participants|Data lost during site relocation|1|||
37908334|NCT00952289|69594021|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
37908335|NCT00952289|69594022|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
37908336|NCT00952289|69594021|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
37908337|NCT00952289|69594022|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
37908338|NCT00952289|69594021|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
37908339|NCT00952289|69594022|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
37908340|NCT00952289|69594021|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
37908341|NCT00952289|69594022|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
37908342|NCT00952289|69594021|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
37908343|NCT00952289|69594022|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
37831415|NCT01240200|69514911|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
37831416|NCT01356966|69514922|FG000|Overall Study|Withdrawal by Subject|1|||
37831417|NCT01356966|69514923|FG001|Overall Study|Withdrawal by Subject|2|||
37831418|NCT01356966|69514922|FG000|Overall Study|Physician Decision|1|||
37831419|NCT01356966|69514923|FG001|Overall Study|Physician Decision|0|||
37831420|NCT05289271|69514961|FG000|Overall Study|Mistakenly allocated, untreated|1|||
37831421|NCT05289271|69514962|FG001|Overall Study|Mistakenly allocated, untreated|0|||
37908344|NCT00947531|69594030|FG000|Overall Study|Withdrawal by Subject|10|||
37908345|NCT00947531|69594031|FG001|Overall Study|Withdrawal by Subject|7|||
37697802|NCT02412371|69174428|FG005|Overall Study|Sponsor Discontinued Study|0|||
37697803|NCT02412371|69174423|FG000|Overall Study|Death|4|||
37697804|NCT02412371|69174424|FG001|Overall Study|Death|2|||
37697805|NCT02412371|69174425|FG002|Overall Study|Death|1|||
37697806|NCT02412371|69174426|FG003|Overall Study|Death|3|||
37697807|NCT02412371|69174427|FG004|Overall Study|Death|5|||
37697808|NCT02412371|69174428|FG005|Overall Study|Death|2|||
37697809|NCT02412371|69174423|FG000|Overall Study|Other|2|||
37697810|NCT02412371|69174424|FG001|Overall Study|Other|1|||
37697811|NCT02412371|69174425|FG002|Overall Study|Other|0|||
37908346|NCT00947531|69594030|FG000|Overall Study|Administrative Reason|0|||
37908347|NCT00947531|69594031|FG001|Overall Study|Administrative Reason|1|||
37908348|NCT00947531|69594030|FG000|Overall Study|Adverse Event|2|||
37908349|NCT00947531|69594031|FG001|Overall Study|Adverse Event|2|||
37908350|NCT00947531|69594030|FG000|Overall Study|Lack of Efficacy|1|||
37908351|NCT00947531|69594031|FG001|Overall Study|Lack of Efficacy|0|||
37908352|NCT00947531|69594030|FG000|Overall Study|Other|1|||
37908353|NCT00947531|69594031|FG001|Overall Study|Other|1|||
37908354|NCT00612313|69594039|FG000|Overall Study|Withdrawal by Subject|6|||
37908355|NCT00612313|69594040|FG001|Overall Study|Withdrawal by Subject|9|||
37908356|NCT00612313|69594039|FG000|Overall Study|Lost to Follow-up|11|||
37908357|NCT00612313|69594040|FG001|Overall Study|Lost to Follow-up|4|||
37908358|NCT00890552|69594052|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
37908359|NCT00890552|69594052|FG000|On-treatment|Early prog disease/ death|10|||
37908360|NCT00946985|69594056|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
37908361|NCT00946985|69594056|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
37908362|NCT00946985|69594056|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
37908363|NCT00946985|69594056|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
37908364|NCT00946985|69594056|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
37908365|NCT00946985|69594056|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
37908366|NCT00946985|69594056|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
37908367|NCT00946985|69594056|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
37908368|NCT00946985|69594056|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
37908369|NCT00611923|69594062|FG000|Overall Study|Withdrawal by Subject|2|||
37908370|NCT00611923|69594063|FG001|Overall Study|Withdrawal by Subject|2|||
37908371|NCT00609973|69594073|FG000|Overall Study|Adverse Event|2|||
37908372|NCT00609973|69594074|FG001|Overall Study|Adverse Event|1|||
37908373|NCT00609973|69594073|FG000|Overall Study|Protocol Violation|4|||
37908374|NCT00609973|69594074|FG001|Overall Study|Protocol Violation|3|||
37908375|NCT00609973|69594073|FG000|Overall Study|Lost to Follow-up|2|||
37908376|NCT00609973|69594074|FG001|Overall Study|Lost to Follow-up|1|||
37908377|NCT00609973|69594073|FG000|Overall Study|Withdrawal by Subject|0|||
37908378|NCT00609973|69594074|FG001|Overall Study|Withdrawal by Subject|1|||
37908379|NCT00803049|69594084|FG000|Overall Study|Adverse Event|21|||
37908380|NCT00803049|69594085|FG001|Overall Study|Adverse Event|33|||
37908381|NCT00803049|69594086|FG002|Overall Study|Adverse Event|13|||
37908382|NCT00803049|69594087|FG003|Overall Study|Adverse Event|27|||
37908383|NCT00803049|69594084|FG000|Overall Study|Lack of Efficacy|10|||
37908384|NCT00803049|69594085|FG001|Overall Study|Lack of Efficacy|19|||
37908385|NCT00803049|69594086|FG002|Overall Study|Lack of Efficacy|6|||
37908386|NCT00803049|69594087|FG003|Overall Study|Lack of Efficacy|13|||
37908387|NCT00803049|69594084|FG000|Overall Study|Lost to Follow-up|0|||
37908388|NCT00803049|69594085|FG001|Overall Study|Lost to Follow-up|2|||
37908389|NCT00803049|69594086|FG002|Overall Study|Lost to Follow-up|0|||
37908390|NCT00803049|69594087|FG003|Overall Study|Lost to Follow-up|3|||
38008561|NCT03666988|69691212|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
38008562|NCT03666988|69691213|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
38008563|NCT03666988|69691214|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
38008564|NCT03666988|69691215|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
38008565|NCT03666988|69691216|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
38008566|NCT03666988|69691217|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
38008567|NCT03666988|69691212|FG000|Part 1 (Up to 28 Months)|Other|0|||
38008568|NCT03666988|69691213|FG001|Part 1 (Up to 28 Months)|Other|1|||
38008569|NCT03666988|69691214|FG002|Part 1 (Up to 28 Months)|Other|1|||
38008570|NCT03666988|69691215|FG003|Part 1 (Up to 28 Months)|Other|0|||
38008571|NCT03666988|69691216|FG004|Part 1 (Up to 28 Months)|Other|0|||
38008572|NCT03666988|69691217|FG005|Part 1 (Up to 28 Months)|Other|0|||
38008573|NCT03666988|69691212|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
38008574|NCT03666988|69691213|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
37908391|NCT00803049|69594084|FG000|Overall Study|Death|2|||
38008575|NCT03666988|69691214|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
37697812|NCT02412371|69174426|FG003|Overall Study|Other|0|||
37908392|NCT00803049|69594085|FG001|Overall Study|Death|1|||
38008576|NCT03666988|69691215|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
38008577|NCT03666988|69691216|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
37697813|NCT02412371|69174427|FG004|Overall Study|Other|1|||
37908393|NCT00803049|69594086|FG002|Overall Study|Death|0|||
38008578|NCT03666988|69691217|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
38008579|NCT03666988|69691212|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
37831422|NCT05080660|69515003|FG000|Overall Study|Adverse Event|4|||
37908394|NCT00803049|69594087|FG003|Overall Study|Death|2|||
37908395|NCT00803049|69594084|FG000|Overall Study|Progressive Disease|6|||
37908396|NCT00803049|69594085|FG001|Overall Study|Progressive Disease|10|||
37908397|NCT00803049|69594086|FG002|Overall Study|Progressive Disease|6|||
37908398|NCT00803049|69594087|FG003|Overall Study|Progressive Disease|6|||
37908399|NCT00803049|69594084|FG000|Overall Study|Withdrawal by Subject|19|||
37908400|NCT00803049|69594085|FG001|Overall Study|Withdrawal by Subject|43|||
37908401|NCT00803049|69594086|FG002|Overall Study|Withdrawal by Subject|16|||
37908402|NCT00803049|69594087|FG003|Overall Study|Withdrawal by Subject|44|||
37908403|NCT00803049|69594084|FG000|Overall Study|Protocol Violation|0|||
37908404|NCT00803049|69594085|FG001|Overall Study|Protocol Violation|1|||
37908405|NCT00803049|69594086|FG002|Overall Study|Protocol Violation|1|||
37908406|NCT00803049|69594087|FG003|Overall Study|Protocol Violation|0|||
37908407|NCT00803049|69594084|FG000|Overall Study|Randomized and Not Treated|0|||
37908408|NCT00803049|69594085|FG001|Overall Study|Randomized and Not Treated|0|||
37908409|NCT00803049|69594086|FG002|Overall Study|Randomized and Not Treated|0|||
37831423|NCT05080660|69515004|FG001|Overall Study|Adverse Event|0|||
37831424|NCT05080660|69515003|FG000|Overall Study|Non-compliance With Study Drug and Procedures|1|||
37831425|NCT05080660|69515004|FG001|Overall Study|Non-compliance With Study Drug and Procedures|0|||
37831426|NCT05080660|69515003|FG000|Overall Study|Physician Decision|1|||
37908410|NCT00803049|69594087|FG003|Overall Study|Randomized and Not Treated|2|||
37908411|NCT00803049|69594084|FG000|Overall Study|Other than Specified Above|3|||
37908412|NCT00803049|69594085|FG001|Overall Study|Other than Specified Above|9|||
37908413|NCT00803049|69594086|FG002|Overall Study|Other than Specified Above|2|||
37908414|NCT00803049|69594087|FG003|Overall Study|Other than Specified Above|5|||
37908415|NCT00890084|69594097|FG000|Overall Study|Adverse Event|16|||
37908416|NCT00890084|69594097|FG000|Overall Study|Lost to Follow-up|126|||
37908417|NCT00802893|69594110|FG000|Overall Study|study terminated|3|||
37908418|NCT00608569|69594131|FG000|Overall Study|Death|4|||
37908419|NCT00608569|69594132|FG001|Overall Study|Death|3|||
37908420|NCT00608569|69594131|FG000|Overall Study|Lost to Follow-up|4|||
37908421|NCT00608569|69594132|FG001|Overall Study|Lost to Follow-up|5|||
37908422|NCT00608569|69594131|FG000|Overall Study|Withdrawal by Subject|1|||
37908423|NCT00608569|69594132|FG001|Overall Study|Withdrawal by Subject|0|||
37908424|NCT00608569|69594131|FG000|Overall Study|Adverse Event|1|||
37908425|NCT00608569|69594132|FG001|Overall Study|Adverse Event|0|||
37908426|NCT00608569|69594131|FG000|Overall Study|Unable to adhere with study requirements|0|||
37908427|NCT00608569|69594132|FG001|Overall Study|Unable to adhere with study requirements|1|||
37908428|NCT00610675|69594138|FG000|Overall Study|Untreated|4|||
37908429|NCT00610675|69594138|FG000|Overall Study|Adverse Event|67|||
37908430|NCT00610675|69594138|FG000|Overall Study|Insufficient Effect|31|||
37908431|NCT00610675|69594138|FG000|Overall Study|Withdrawal by Subject|28|||
38008580|NCT03666988|69691213|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
37831427|NCT05080660|69515004|FG001|Overall Study|Physician Decision|0|||
37831428|NCT05080660|69515003|FG000|Overall Study|Protocol Deviation|2|||
37831429|NCT05080660|69515004|FG001|Overall Study|Protocol Deviation|0|||
37831430|NCT05080660|69515003|FG000|Overall Study|Withdrawal by Subject|5|||
37831431|NCT05080660|69515004|FG001|Overall Study|Withdrawal by Subject|2|||
37831432|NCT05005312|69515012|FG000|Overall Study|Enrolled, but not treated|0|||
37831433|NCT05005312|69515013|FG001|Overall Study|Enrolled, but not treated|1|||
37831434|NCT04867902|69515028|FG000|Overall Study|Lost to Follow-up|1|||
37831435|NCT04867902|69515028|FG000|Overall Study|Withdrawal by Subject|2|||
37831436|NCT04867902|69515028|FG000|Overall Study|Protocol Violation|1|||
37831437|NCT04677179|69515035|FG000|Induction Treatment Period|Adverse Event|1|||
37831438|NCT04677179|69515036|FG001|Induction Treatment Period|Adverse Event|0|||
37831439|NCT04677179|69515037|FG002|Induction Treatment Period|Adverse Event|0|||
37831440|NCT04677179|69515038|FG003|Induction Treatment Period|Adverse Event|0|||
37831441|NCT04677179|69515039|FG004|Induction Treatment Period|Adverse Event|0|||
37831442|NCT04677179|69515040|FG005|Induction Treatment Period|Adverse Event|0|||
37831443|NCT04677179|69515041|FG006|Induction Treatment Period|Adverse Event|0|||
37831444|NCT04677179|69515042|FG007|Induction Treatment Period|Adverse Event|0|||
37831445|NCT04677179|69515043|FG008|Induction Treatment Period|Adverse Event|0|||
37831446|NCT04677179|69515044|FG009|Induction Treatment Period|Adverse Event|0|||
37831447|NCT04677179|69515035|FG000|Induction Treatment Period|Physician Decision|1|||
37908432|NCT00610675|69594138|FG000|Overall Study|Reasons unrelated to trial|27|||
37908433|NCT00610675|69594138|FG000|Overall Study|Lack of Compliance|7|||
38008581|NCT03666988|69691214|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
37908434|NCT00610675|69594138|FG000|Overall Study|Lost to Follow-up|31|||
37831448|NCT04677179|69515036|FG001|Induction Treatment Period|Physician Decision|0|||
37831449|NCT04677179|69515037|FG002|Induction Treatment Period|Physician Decision|1|||
37908435|NCT00610675|69594138|FG000|Overall Study|Other reason (not specified)|25|||
38008582|NCT03666988|69691215|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
37908436|NCT00888134|69594142|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
37908437|NCT00888134|69594142|FG000|Follow-up|being followed for long-term survival|1|||
37908438|NCT00573157|69594149|FG000|Overall Study|Adverse Event|3|||
37908439|NCT00573157|69594150|FG001|Overall Study|Adverse Event|1|||
38008583|NCT03666988|69691216|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
38008584|NCT03666988|69691217|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
38008585|NCT03666988|69691212|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
38008586|NCT03666988|69691213|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
38008587|NCT03666988|69691214|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
38008588|NCT03666988|69691215|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
38008589|NCT03666988|69691216|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
38008590|NCT03666988|69691217|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
38008591|NCT00382109|69691237|FG000|Overall Study|Adverse Event|3|||
38008592|NCT00382109|69691238|FG001|Overall Study|Adverse Event|0|||
38008593|NCT00382109|69691237|FG000|Overall Study|Physician Decision|6|||
38008594|NCT00382109|69691238|FG001|Overall Study|Physician Decision|1|||
38008595|NCT00382109|69691237|FG000|Overall Study|Withdrawal by Subject|1|||
38008596|NCT00382109|69691238|FG001|Overall Study|Withdrawal by Subject|0|||
38008597|NCT00382109|69691237|FG000|Overall Study|ineligible|2|||
38008598|NCT00382109|69691238|FG001|Overall Study|ineligible|0|||
38008599|NCT00382109|69691237|FG000|Overall Study|Other|0|||
38008600|NCT00382109|69691238|FG001|Overall Study|Other|2|||
38008601|NCT00382109|69691237|FG000|Overall Study|consent withdrawal|0|||
38008602|NCT00382109|69691238|FG001|Overall Study|consent withdrawal|1|||
38008603|NCT03651622|69691250|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
38008604|NCT03651622|69691251|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
37908440|NCT00573157|69594149|FG000|Overall Study|Other|1|||
37908441|NCT00573157|69594150|FG001|Overall Study|Other|1|||
37908442|NCT00802737|69594159|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
37908443|NCT00802737|69594160|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
37908444|NCT00802737|69594161|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
37908445|NCT00802737|69594159|FG000|Overall Study|Death|6|||
37908446|NCT00802737|69594160|FG001|Overall Study|Death|5|||
37908447|NCT00802737|69594161|FG002|Overall Study|Death|1|||
37908448|NCT00802737|69594159|FG000|Overall Study|Adverse Event|1|||
37908449|NCT00802737|69594160|FG001|Overall Study|Adverse Event|0|||
37908450|NCT00802737|69594161|FG002|Overall Study|Adverse Event|0|||
37908451|NCT00802737|69594159|FG000|Overall Study|Received Prohibited Therapy|1|||
38008605|NCT03651622|69691252|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
38008606|NCT03651622|69691250|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
38008607|NCT03651622|69691251|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
38008608|NCT03651622|69691252|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
38008609|NCT03651622|69691250|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
38008610|NCT03651622|69691251|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
38008611|NCT03651622|69691252|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
38008612|NCT03651622|69691250|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
38008613|NCT03651622|69691251|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
38008614|NCT03651622|69691252|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
38008615|NCT03651622|69691250|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
38008616|NCT03651622|69691251|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
37831450|NCT04677179|69515038|FG003|Induction Treatment Period|Physician Decision|0|||
37831451|NCT04677179|69515039|FG004|Induction Treatment Period|Physician Decision|0|||
37831452|NCT04677179|69515040|FG005|Induction Treatment Period|Physician Decision|0|||
37831453|NCT04677179|69515041|FG006|Induction Treatment Period|Physician Decision|0|||
37831454|NCT04677179|69515042|FG007|Induction Treatment Period|Physician Decision|0|||
37831455|NCT04677179|69515043|FG008|Induction Treatment Period|Physician Decision|0|||
37831456|NCT04677179|69515044|FG009|Induction Treatment Period|Physician Decision|0|||
37908452|NCT00802737|69594160|FG001|Overall Study|Received Prohibited Therapy|0|||
37908453|NCT00802737|69594161|FG002|Overall Study|Received Prohibited Therapy|0|||
37908454|NCT00802737|69594159|FG000|Overall Study|Ongoing CLL-Treatment|0|||
37908455|NCT00802737|69594160|FG001|Overall Study|Ongoing CLL-Treatment|1|||
37908456|NCT00802737|69594161|FG002|Overall Study|Ongoing CLL-Treatment|0|||
37908457|NCT00802737|69594159|FG000|Overall Study|Participant too Unwell|0|||
37908458|NCT00802737|69594160|FG001|Overall Study|Participant too Unwell|2|||
37908459|NCT00802737|69594161|FG002|Overall Study|Participant too Unwell|0|||
37908460|NCT00588861|69594172|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
38008617|NCT03651622|69691252|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
38008618|NCT00381797|69691265|FG000|Overall Study|Withdrawal by Subject|1|||
38008619|NCT00381797|69691266|FG001|Overall Study|Withdrawal by Subject|1|||
38008620|NCT00381797|69691267|FG002|Overall Study|Withdrawal by Subject|0|||
38008621|NCT00381797|69691268|FG003|Overall Study|Withdrawal by Subject|0|||
38008622|NCT00381797|69691269|FG004|Overall Study|Withdrawal by Subject|2|||
38008623|NCT00381797|69691265|FG000|Overall Study|Ineligible|0|||
38008624|NCT00381797|69691266|FG001|Overall Study|Ineligible|0|||
38008625|NCT00381797|69691267|FG002|Overall Study|Ineligible|0|||
38008626|NCT00381797|69691268|FG003|Overall Study|Ineligible|1|||
38008627|NCT00381797|69691269|FG004|Overall Study|Ineligible|0|||
38008628|NCT03665038|69691305|FG000|Overall Study|Lost to Follow-up|0|||
38008629|NCT03665038|69691306|FG001|Overall Study|Lost to Follow-up|0|||
38008630|NCT03665038|69691307|FG002|Overall Study|Lost to Follow-up|1|||
38008631|NCT03664024|69691317|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
38008632|NCT03664024|69691317|FG000|Overall Study|Lost to Follow-up|2|||
38008633|NCT03664024|69691317|FG000|Overall Study|Withdrawal by Subject|2|||
38008634|NCT03664024|69691317|FG000|Overall Study|Death|80|||
38008635|NCT00381563|69691326|FG000|Overall Study|Withdrawal by Subject|5|||
38008636|NCT00381563|69691327|FG001|Overall Study|Withdrawal by Subject|5|||
38008637|NCT00381563|69691326|FG000|Overall Study|Lost to Follow-up|2|||
38008638|NCT00381563|69691327|FG001|Overall Study|Lost to Follow-up|0|||
38008639|NCT00381563|69691326|FG000|Overall Study|Protocol Violation|0|||
38008640|NCT00381563|69691327|FG001|Overall Study|Protocol Violation|1|||
38008641|NCT03624946|69691334|FG000|Overall Study|Lost to Follow-up|0|||
38008642|NCT03624946|69691335|FG001|Overall Study|Lost to Follow-up|1|||
38008643|NCT00381095|69691347|FG000|Overall Study|Death|3|||
38008644|NCT00381095|69691348|FG001|Overall Study|Death|4|||
38008645|NCT00381095|69691347|FG000|Overall Study|Lack of Efficacy|2|||
38008646|NCT00381095|69691348|FG001|Overall Study|Lack of Efficacy|4|||
38008647|NCT00381095|69691347|FG000|Overall Study|Other|2|||
38008648|NCT00381095|69691348|FG001|Overall Study|Other|2|||
38008649|NCT00381095|69691347|FG000|Overall Study|Protocol Violation|1|||
38008650|NCT00381095|69691348|FG001|Overall Study|Protocol Violation|1|||
38008651|NCT00381095|69691347|FG000|Overall Study|Withdrawal by Subject|3|||
38008652|NCT00381095|69691348|FG001|Overall Study|Withdrawal by Subject|3|||
38008653|NCT00381095|69691347|FG000|Overall Study|Adverse Event|2|||
38008654|NCT00381095|69691348|FG001|Overall Study|Adverse Event|7|||
38008655|NCT03619174|69691356|FG000|Overall Study|Lost to Follow-up|3|||
38008656|NCT03619174|69691357|FG001|Overall Study|Lost to Follow-up|0|||
38008657|NCT03619174|69691356|FG000|Overall Study|Withdrawal by Subject|4|||
38008658|NCT03619174|69691357|FG001|Overall Study|Withdrawal by Subject|3|||
38008659|NCT03619174|69691356|FG000|Overall Study|Pregnancy|1|||
38008660|NCT03619174|69691357|FG001|Overall Study|Pregnancy|1|||
38008661|NCT03619174|69691356|FG000|Overall Study|Discomfort during treatment|1|||
37908461|NCT00588861|69594173|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
37908462|NCT00588861|69594172|FG000|6 Months|Patients did not return for follow-up|98|||
37908463|NCT00588861|69594173|FG001|6 Months|Patients did not return for follow-up|73|||
37908464|NCT00588861|69594172|FG000|1 Year|Patients did not return for follow-up|89|||
37908465|NCT00588861|69594173|FG001|1 Year|Patients did not return for follow-up|82|||
37908466|NCT00588861|69594172|FG000|2 Years|Patients did not return for follow-up|92|||
37908467|NCT00588861|69594173|FG001|2 Years|Patients did not return for follow-up|87|||
37908468|NCT00588861|69594172|FG000|4 Years|Patients did not return for follow-up|91|||
37908469|NCT00588861|69594173|FG001|4 Years|Patients did not return for follow-up|103|||
37908470|NCT00588861|69594172|FG000|6 Years|Patients did not return for follow-up|104|||
37908471|NCT00588861|69594173|FG001|6 Years|Patients did not return for follow-up|109|||
37908472|NCT00588861|69594172|FG000|8 Years|Patients did not return for follow-up|105|||
38008662|NCT03619174|69691357|FG001|Overall Study|Discomfort during treatment|0|||
38008663|NCT00112047|69691365|FG000|Randomized Phase|Lost to Follow-up|26|||
38008664|NCT00112047|69691366|FG001|Randomized Phase|Lost to Follow-up|33|||
38008665|NCT00112047|69691365|FG000|Randomized Phase|Adverse Event|10|||
38008666|NCT00112047|69691366|FG001|Randomized Phase|Adverse Event|10|||
38008667|NCT00112047|69691365|FG000|Randomized Phase|Withrawal of consent|10|||
38008668|NCT00112047|69691366|FG001|Randomized Phase|Withrawal of consent|18|||
38008669|NCT00112047|69691365|FG000|Randomized Phase|Sub-optimal virological response|3|||
38008670|NCT00112047|69691366|FG001|Randomized Phase|Sub-optimal virological response|13|||
38008671|NCT00112047|69691365|FG000|Randomized Phase|Noncompliance|8|||
38008672|NCT00112047|69691366|FG001|Randomized Phase|Noncompliance|4|||
38008673|NCT00112047|69691365|FG000|Randomized Phase|Protocol Violation|2|||
38008674|NCT00112047|69691366|FG001|Randomized Phase|Protocol Violation|0|||
38008675|NCT00112047|69691365|FG000|Randomized Phase|Pregnancy|3|||
37908473|NCT00588861|69594173|FG001|8 Years|Patients did not return for follow-up|114|||
38008676|NCT00112047|69691366|FG001|Randomized Phase|Pregnancy|1|||
38008677|NCT00112047|69691365|FG000|Randomized Phase|Death|1|||
38008678|NCT00112047|69691366|FG001|Randomized Phase|Death|3|||
38008679|NCT00112047|69691365|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
38008680|NCT00112047|69691366|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
38008681|NCT00112047|69691365|FG000|Randomized Phase|Inability to swallow pills|0|||
38008682|NCT00112047|69691366|FG001|Randomized Phase|Inability to swallow pills|1|||
38008683|NCT00112047|69691365|FG000|Randomized Phase|Incarceration|3|||
38008684|NCT00112047|69691366|FG001|Randomized Phase|Incarceration|2|||
37908474|NCT00588861|69594172|FG000|10 Years|Incomplete due to study termination|107|||
37908475|NCT00588861|69594173|FG001|10 Years|Incomplete due to study termination|114|||
37908476|NCT00887978|69594181|FG000|Overall Study|Adverse Event|18|||
37908477|NCT00887978|69594182|FG001|Overall Study|Adverse Event|5|||
37908478|NCT00887978|69594181|FG000|Overall Study|Clinical Worsening|4|||
37908479|NCT00887978|69594182|FG001|Overall Study|Clinical Worsening|4|||
37908480|NCT00887978|69594181|FG000|Overall Study|Death|2|||
37908481|NCT00887978|69594182|FG001|Overall Study|Death|3|||
37908482|NCT00887978|69594181|FG000|Overall Study|Withdrawal by Subject|1|||
37908483|NCT00887978|69594182|FG001|Overall Study|Withdrawal by Subject|2|||
37908484|NCT00887978|69594181|FG000|Overall Study|Lost to Follow-up|0|||
37908485|NCT00887978|69594182|FG001|Overall Study|Lost to Follow-up|1|||
38008685|NCT00112047|69691365|FG000|Randomized Phase|Moved out of State|0|||
38008686|NCT00112047|69691366|FG001|Randomized Phase|Moved out of State|1|||
38008687|NCT00112047|69691365|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
38008688|NCT00112047|69691366|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
38008689|NCT00112047|69691365|FG000|Randomized Phase|High Hepatitis B DNA|0|||
38008690|NCT00112047|69691366|FG001|Randomized Phase|High Hepatitis B DNA|1|||
37908486|NCT00608023|69594191|FG000|Overall Study|Withdrawal by Subject|8|||
37908487|NCT00608023|69594192|FG001|Overall Study|Withdrawal by Subject|10|||
38008691|NCT00112047|69691365|FG000|Atripla Phase|Adverse Event|2|||
38008692|NCT00112047|69691366|FG001|Atripla Phase|Adverse Event|1|||
38008693|NCT00112047|69691365|FG000|Atripla Phase|Lost to Follow-up|5|||
38008694|NCT00112047|69691366|FG001|Atripla Phase|Lost to Follow-up|7|||
38008695|NCT00112047|69691365|FG000|Atripla Phase|Pregnancy|0|||
38008696|NCT00112047|69691366|FG001|Atripla Phase|Pregnancy|1|||
38008697|NCT00112047|69691365|FG000|Atripla Phase|Death|0|||
38008698|NCT00112047|69691366|FG001|Atripla Phase|Death|2|||
38008699|NCT00112047|69691365|FG000|Atripla Phase|Withdrew consent|7|||
38008700|NCT00112047|69691366|FG001|Atripla Phase|Withdrew consent|7|||
38008701|NCT00112047|69691365|FG000|Atripla Phase|Sub-optimal virological response|0|||
38008702|NCT00112047|69691366|FG001|Atripla Phase|Sub-optimal virological response|1|||
38008703|NCT00112047|69691365|FG000|Atripla Phase|Non-compliance|1|||
38008704|NCT00112047|69691366|FG001|Atripla Phase|Non-compliance|0|||
38008705|NCT00112047|69691365|FG000|Atripla Phase|Other|3|||
38008706|NCT00112047|69691366|FG001|Atripla Phase|Other|1|||
38008707|NCT03658876|69691379|FG000|Overall Study|Protocol Violation|3|||
38008708|NCT03658876|69691380|FG001|Overall Study|Protocol Violation|2|||
38008709|NCT03658876|69691379|FG000|Overall Study|Withdrawal by Subject|2|||
38008710|NCT03658876|69691380|FG001|Overall Study|Withdrawal by Subject|0|||
38008711|NCT03658876|69691379|FG000|Overall Study|Death|0|||
38008712|NCT03658876|69691380|FG001|Overall Study|Death|1|||
38008713|NCT03658876|69691379|FG000|Overall Study|Intercurrent illness|6|||
38008714|NCT03658876|69691380|FG001|Overall Study|Intercurrent illness|4|||
38008715|NCT03658876|69691379|FG000|Overall Study|Transplantation/other operation|1|||
38008716|NCT03658876|69691380|FG001|Overall Study|Transplantation/other operation|5|||
38008717|NCT03618628|69691386|FG000|Overall Study|Death|1|||
38008718|NCT03618628|69691386|FG000|Overall Study|Lost to Follow-up|1|||
38008719|NCT03617770|69691392|FG000|Overall Study|Lost to Follow-up|1|||
38008720|NCT03617770|69691393|FG001|Overall Study|Lost to Follow-up|0|||
38008721|NCT03616600|69691401|FG000|Overall Study|Withdrawal by Subject|1|||
38008722|NCT03616600|69691402|FG001|Overall Study|Withdrawal by Subject|0|||
38008723|NCT00380393|69691411|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
38008724|NCT00380393|69691412|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
38008725|NCT00380393|69691411|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
38008726|NCT00380393|69691412|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
38008727|NCT00380393|69691411|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
38008728|NCT00380393|69691412|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
38008729|NCT00380393|69691411|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
37908488|NCT00608023|69594193|FG002|Overall Study|Withdrawal by Subject|7|||
37908489|NCT00608023|69594191|FG000|Overall Study|Adverse Event|1|||
37908490|NCT00608023|69594192|FG001|Overall Study|Adverse Event|4|||
38008730|NCT00380393|69691412|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
38008731|NCT00380393|69691411|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
38008732|NCT00380393|69691412|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
38008733|NCT00380393|69691411|FG000|Month 14|Withdrawal by Subject|9|||
38008734|NCT00380393|69691412|FG001|Month 14|Withdrawal by Subject|7|||
38008735|NCT00380393|69691411|FG000|Month 14|Death|1|||
38008736|NCT00380393|69691412|FG001|Month 14|Death|0|||
37908491|NCT00608023|69594193|FG002|Overall Study|Adverse Event|5|||
37908492|NCT00608023|69594191|FG000|Overall Study|Lost to Follow-up|2|||
37908493|NCT00608023|69594192|FG001|Overall Study|Lost to Follow-up|2|||
38008737|NCT00380393|69691411|FG000|Month 14|Lost to Follow-up|0|||
38008738|NCT00380393|69691412|FG001|Month 14|Lost to Follow-up|1|||
37908494|NCT00608023|69594193|FG002|Overall Study|Lost to Follow-up|1|||
37908495|NCT00608023|69594191|FG000|Overall Study|Protocol Violation|1|||
38008739|NCT00380393|69691411|FG000|Month 14|Migrated/moved from study area|39|||
38008740|NCT00380393|69691412|FG001|Month 14|Migrated/moved from study area|42|||
38008741|NCT00380393|69691411|FG000|Month 14|Protocol Violation|2|||
38008742|NCT00380393|69691412|FG001|Month 14|Protocol Violation|0|||
38008743|NCT00380393|69691411|FG000|Month 14|Others|6|||
38008744|NCT00380393|69691412|FG001|Month 14|Others|6|||
38008745|NCT00380081|69691424|FG000|Overall Study|Withdrawal by Subject|0|||
38008746|NCT00380081|69691425|FG001|Overall Study|Withdrawal by Subject|0|||
38008747|NCT00380081|69691426|FG002|Overall Study|Withdrawal by Subject|0|||
38008748|NCT00380081|69691427|FG003|Overall Study|Withdrawal by Subject|0|||
38008749|NCT00380081|69691428|FG004|Overall Study|Withdrawal by Subject|1|||
38008750|NCT00380081|69691429|FG005|Overall Study|Withdrawal by Subject|0|||
38008751|NCT00380081|69691424|FG000|Overall Study|Family Emergency|0|||
38008752|NCT00380081|69691425|FG001|Overall Study|Family Emergency|0|||
38008753|NCT00380081|69691426|FG002|Overall Study|Family Emergency|0|||
38008754|NCT00380081|69691427|FG003|Overall Study|Family Emergency|0|||
38008755|NCT00380081|69691428|FG004|Overall Study|Family Emergency|0|||
38008756|NCT00380081|69691429|FG005|Overall Study|Family Emergency|1|||
38008757|NCT03579940|69691448|FG000|Period 2|Withdrawal by Subject|0|||
38008758|NCT03579940|69691449|FG001|Period 2|Withdrawal by Subject|0|||
38008759|NCT03579940|69691450|FG002|Period 2|Withdrawal by Subject|1|||
38008760|NCT03579940|69691451|FG003|Period 2|Withdrawal by Subject|0|||
38008761|NCT03579940|69691452|FG004|Period 2|Withdrawal by Subject|0|||
38008762|NCT03579940|69691453|FG005|Period 2|Withdrawal by Subject|0|||
38008763|NCT03579940|69691454|FG006|Period 2|Withdrawal by Subject|0|||
38008764|NCT03579940|69691455|FG007|Period 2|Withdrawal by Subject|0|||
38008765|NCT03579940|69691456|FG008|Period 2|Withdrawal by Subject|0|||
38008766|NCT03579940|69691457|FG009|Period 2|Withdrawal by Subject|0|||
38008767|NCT03579940|69691458|FG010|Period 2|Withdrawal by Subject|0|||
38008768|NCT00098306|69691493|FG000|Double Blind|Randomized, not treated|9|||
38008769|NCT00098306|69691494|FG001|Double Blind|Randomized, not treated|5|||
38008770|NCT00098306|69691495|FG002|Double Blind|Randomized, not treated|2|||
38008771|NCT00098306|69691496|FG003|Double Blind|Randomized, not treated|0|||
38008772|NCT00098306|69691497|FG004|Double Blind|Randomized, not treated|0|||
38008773|NCT00098306|69691498|FG005|Double Blind|Randomized, not treated|0|||
38008774|NCT00098306|69691499|FG006|Double Blind|Randomized, not treated|0|||
38008775|NCT00098306|69691493|FG000|Double Blind|Ongoing at cut-off date|151|||
38008776|NCT00098306|69691494|FG001|Double Blind|Ongoing at cut-off date|166|||
38008777|NCT00098306|69691495|FG002|Double Blind|Ongoing at cut-off date|72|||
38008778|NCT00098306|69691496|FG003|Double Blind|Ongoing at cut-off date|0|||
38008779|NCT00098306|69691497|FG004|Double Blind|Ongoing at cut-off date|0|||
38008780|NCT00098306|69691498|FG005|Double Blind|Ongoing at cut-off date|0|||
38008781|NCT00098306|69691499|FG006|Double Blind|Ongoing at cut-off date|0|||
38008782|NCT00098306|69691493|FG000|Double Blind|Adverse Event|11|||
38008783|NCT00098306|69691494|FG001|Double Blind|Adverse Event|10|||
38008784|NCT00098306|69691495|FG002|Double Blind|Adverse Event|6|||
38008785|NCT00098306|69691496|FG003|Double Blind|Adverse Event|0|||
38008786|NCT00098306|69691497|FG004|Double Blind|Adverse Event|0|||
38008787|NCT00098306|69691498|FG005|Double Blind|Adverse Event|0|||
37831457|NCT04677179|69515035|FG000|Induction Treatment Period|Protocol Violation|0|||
37831458|NCT04677179|69515036|FG001|Induction Treatment Period|Protocol Violation|1|||
37831459|NCT04677179|69515037|FG002|Induction Treatment Period|Protocol Violation|0|||
37831460|NCT04677179|69515038|FG003|Induction Treatment Period|Protocol Violation|0|||
37831461|NCT04677179|69515039|FG004|Induction Treatment Period|Protocol Violation|0|||
37831462|NCT04677179|69515040|FG005|Induction Treatment Period|Protocol Violation|0|||
37908496|NCT00608023|69594192|FG001|Overall Study|Protocol Violation|3|||
37831463|NCT04677179|69515041|FG006|Induction Treatment Period|Protocol Violation|0|||
37831464|NCT04677179|69515042|FG007|Induction Treatment Period|Protocol Violation|0|||
37831465|NCT04677179|69515043|FG008|Induction Treatment Period|Protocol Violation|0|||
37908497|NCT00608023|69594193|FG002|Overall Study|Protocol Violation|1|||
37908498|NCT00608023|69594191|FG000|Overall Study|Unknown reason|0|||
37908499|NCT00608023|69594192|FG001|Overall Study|Unknown reason|3|||
37908500|NCT00608023|69594193|FG002|Overall Study|Unknown reason|0|||
37908501|NCT00802659|69594208|FG000|Overall Study|Physician Decision|0|||
37908502|NCT00802659|69594209|FG001|Overall Study|Physician Decision|1|||
38008788|NCT00098306|69691499|FG006|Double Blind|Adverse Event|0|||
38008789|NCT00098306|69691493|FG000|Double Blind|Lack of Efficacy|43|||
38008790|NCT00098306|69691494|FG001|Double Blind|Lack of Efficacy|34|||
38008791|NCT00098306|69691495|FG002|Double Blind|Lack of Efficacy|17|||
38008792|NCT00098306|69691496|FG003|Double Blind|Lack of Efficacy|0|||
38008793|NCT00098306|69691497|FG004|Double Blind|Lack of Efficacy|0|||
38008794|NCT00098306|69691498|FG005|Double Blind|Lack of Efficacy|0|||
38008795|NCT00098306|69691499|FG006|Double Blind|Lack of Efficacy|0|||
38008796|NCT00098306|69691493|FG000|Double Blind|Death|1|||
38008797|NCT00098306|69691494|FG001|Double Blind|Death|4|||
38008798|NCT00098306|69691495|FG002|Double Blind|Death|1|||
38008799|NCT00098306|69691496|FG003|Double Blind|Death|0|||
38008800|NCT00098306|69691497|FG004|Double Blind|Death|0|||
38008801|NCT00098306|69691498|FG005|Double Blind|Death|0|||
38008802|NCT00098306|69691499|FG006|Double Blind|Death|0|||
38008803|NCT00098306|69691493|FG000|Double Blind|Participant defaulted|19|||
38008804|NCT00098306|69691494|FG001|Double Blind|Participant defaulted|18|||
38008805|NCT00098306|69691495|FG002|Double Blind|Participant defaulted|11|||
38008806|NCT00098306|69691496|FG003|Double Blind|Participant defaulted|0|||
38008807|NCT00098306|69691497|FG004|Double Blind|Participant defaulted|0|||
38008808|NCT00098306|69691498|FG005|Double Blind|Participant defaulted|0|||
38008809|NCT00098306|69691499|FG006|Double Blind|Participant defaulted|0|||
38008810|NCT00098306|69691493|FG000|Double Blind|Un-specified|7|||
38008811|NCT00098306|69691494|FG001|Double Blind|Un-specified|3|||
38008812|NCT00098306|69691495|FG002|Double Blind|Un-specified|11|||
38008813|NCT00098306|69691496|FG003|Double Blind|Un-specified|0|||
38008814|NCT00098306|69691497|FG004|Double Blind|Un-specified|0|||
38008815|NCT00098306|69691498|FG005|Double Blind|Un-specified|0|||
38008816|NCT00098306|69691499|FG006|Double Blind|Un-specified|0|||
38008817|NCT00098306|69691493|FG000|Open Label|Lack of Efficacy|0|||
38008818|NCT00098306|69691494|FG001|Open Label|Lack of Efficacy|0|||
38008819|NCT00098306|69691495|FG002|Open Label|Lack of Efficacy|0|||
38008820|NCT00098306|69691496|FG003|Open Label|Lack of Efficacy|13|||
38008821|NCT00098306|69691497|FG004|Open Label|Lack of Efficacy|0|||
38008822|NCT00098306|69691498|FG005|Open Label|Lack of Efficacy|0|||
38008823|NCT00098306|69691499|FG006|Open Label|Lack of Efficacy|0|||
38008824|NCT00098306|69691493|FG000|Open Label|Adverse Event|0|||
38008825|NCT00098306|69691494|FG001|Open Label|Adverse Event|0|||
37908503|NCT00802659|69594210|FG002|Overall Study|Physician Decision|0|||
37908504|NCT00802659|69594211|FG003|Overall Study|Physician Decision|0|||
37908505|NCT00607789|69594223|FG000|Overall Study|Adverse Event|3|||
37908506|NCT00607789|69594224|FG001|Overall Study|Adverse Event|0|||
37908507|NCT00607789|69594223|FG000|Overall Study|Lack of Efficacy|0|||
37908508|NCT00607789|69594224|FG001|Overall Study|Lack of Efficacy|1|||
37908509|NCT00607789|69594223|FG000|Overall Study|Inadequate adherence|3|||
37908510|NCT00607789|69594224|FG001|Overall Study|Inadequate adherence|0|||
37908511|NCT00607789|69594223|FG000|Overall Study|Lost to Follow-up|0|||
37908512|NCT00607789|69594224|FG001|Overall Study|Lost to Follow-up|5|||
37908513|NCT00607789|69594223|FG000|Overall Study|Withdrawal by Subject|1|||
37908514|NCT00607789|69594224|FG001|Overall Study|Withdrawal by Subject|0|||
37908515|NCT00887822|69594232|FG000|Overall Study|Insufficient therapeutic response|53|||
37908516|NCT00887822|69594233|FG001|Overall Study|Insufficient therapeutic response|55|||
37908517|NCT00887822|69594232|FG000|Overall Study|Adverse Event|14|||
37908518|NCT00887822|69594233|FG001|Overall Study|Adverse Event|17|||
37908519|NCT00887822|69594232|FG000|Overall Study|Failure to return|11|||
37908520|NCT00887822|69594233|FG001|Overall Study|Failure to return|11|||
37908521|NCT00887822|69594232|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
38008826|NCT00098306|69691495|FG002|Open Label|Adverse Event|0|||
38008827|NCT00098306|69691496|FG003|Open Label|Adverse Event|2|||
38008828|NCT00098306|69691497|FG004|Open Label|Adverse Event|0|||
38008829|NCT00098306|69691498|FG005|Open Label|Adverse Event|0|||
37831466|NCT04677179|69515044|FG009|Induction Treatment Period|Protocol Violation|0|||
37831467|NCT04677179|69515035|FG000|Induction Treatment Period|Withdrawal by Subject|4|||
37831468|NCT04677179|69515036|FG001|Induction Treatment Period|Withdrawal by Subject|1|||
37831469|NCT04677179|69515037|FG002|Induction Treatment Period|Withdrawal by Subject|1|||
37831470|NCT04677179|69515038|FG003|Induction Treatment Period|Withdrawal by Subject|0|||
37831471|NCT04677179|69515039|FG004|Induction Treatment Period|Withdrawal by Subject|0|||
37831472|NCT04677179|69515040|FG005|Induction Treatment Period|Withdrawal by Subject|0|||
37831473|NCT04677179|69515041|FG006|Induction Treatment Period|Withdrawal by Subject|0|||
37831474|NCT04677179|69515042|FG007|Induction Treatment Period|Withdrawal by Subject|0|||
37831475|NCT04677179|69515043|FG008|Induction Treatment Period|Withdrawal by Subject|0|||
37831476|NCT04677179|69515044|FG009|Induction Treatment Period|Withdrawal by Subject|0|||
37831477|NCT04677179|69515035|FG000|Induction Treatment Period|Study terminated by sponsor|7|||
37908522|NCT00887822|69594233|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
38008830|NCT00098306|69691499|FG006|Open Label|Adverse Event|0|||
38008831|NCT00098306|69691493|FG000|Open Label|Death|0|||
38008832|NCT00098306|69691494|FG001|Open Label|Death|0|||
38008833|NCT00098306|69691495|FG002|Open Label|Death|0|||
38008834|NCT00098306|69691496|FG003|Open Label|Death|4|||
38008835|NCT00098306|69691497|FG004|Open Label|Death|0|||
37697814|NCT02412371|69174428|FG005|Overall Study|Other|3|||
38008836|NCT00098306|69691498|FG005|Open Label|Death|0|||
37831478|NCT04677179|69515036|FG001|Induction Treatment Period|Study terminated by sponsor|11|||
37908523|NCT00887822|69594232|FG000|Overall Study|Administrative/Other than specified|5|||
37908524|NCT00887822|69594233|FG001|Overall Study|Administrative/Other than specified|4|||
37908525|NCT00887822|69594232|FG000|Overall Study|Death|2|||
37908526|NCT00887822|69594233|FG001|Overall Study|Death|3|||
38008837|NCT00098306|69691499|FG006|Open Label|Death|0|||
38008838|NCT00098306|69691493|FG000|Open Label|Participant defaulted|0|||
38008839|NCT00098306|69691494|FG001|Open Label|Participant defaulted|0|||
38008840|NCT00098306|69691495|FG002|Open Label|Participant defaulted|0|||
38008841|NCT00098306|69691496|FG003|Open Label|Participant defaulted|24|||
38008842|NCT00098306|69691497|FG004|Open Label|Participant defaulted|0|||
38008843|NCT00098306|69691498|FG005|Open Label|Participant defaulted|0|||
37908527|NCT00887822|69594232|FG000|Overall Study|Protocol Violation|0|||
37908528|NCT00887822|69594233|FG001|Overall Study|Protocol Violation|1|||
37908529|NCT00887822|69594232|FG000|Overall Study|Randomized but not treated|0|||
37908530|NCT00887822|69594233|FG001|Overall Study|Randomized but not treated|1|||
37908531|NCT00951665|69594245|FG000|Phase 1b|Adverse Event|2|||
38008844|NCT00098306|69691499|FG006|Open Label|Participant defaulted|0|||
38008845|NCT00098306|69691493|FG000|Open Label|Un-specified|0|||
38008846|NCT00098306|69691494|FG001|Open Label|Un-specified|0|||
38008847|NCT00098306|69691495|FG002|Open Label|Un-specified|0|||
38008848|NCT00098306|69691496|FG003|Open Label|Un-specified|15|||
38008849|NCT00098306|69691497|FG004|Open Label|Un-specified|0|||
38008850|NCT00098306|69691498|FG005|Open Label|Un-specified|0|||
38008851|NCT00098306|69691499|FG006|Open Label|Un-specified|0|||
38008852|NCT00098306|69691493|FG000|Open Label|Ongoing at cut-off date|0|||
38008853|NCT00098306|69691494|FG001|Open Label|Ongoing at cut-off date|0|||
38008854|NCT00098306|69691495|FG002|Open Label|Ongoing at cut-off date|0|||
38008855|NCT00098306|69691496|FG003|Open Label|Ongoing at cut-off date|269|||
38008856|NCT00098306|69691497|FG004|Open Label|Ongoing at cut-off date|62|||
37908532|NCT00951665|69594246|FG001|Phase 1b|Adverse Event|1|||
37908533|NCT00951665|69594247|FG002|Phase 1b|Adverse Event|0|||
37908534|NCT00951665|69594248|FG003|Phase 1b|Adverse Event|1|||
37908535|NCT00951665|69594249|FG004|Phase 1b|Adverse Event|0|||
37908536|NCT00951665|69594250|FG005|Phase 1b|Adverse Event|0|||
37908537|NCT00951665|69594245|FG000|Phase 1b|Death|1|||
37908538|NCT00951665|69594246|FG001|Phase 1b|Death|0|||
38008857|NCT00098306|69691498|FG005|Open Label|Ongoing at cut-off date|0|||
38008858|NCT00098306|69691499|FG006|Open Label|Ongoing at cut-off date|0|||
38008859|NCT00098306|69691493|FG000|Observational Phase|Death|0|||
38008860|NCT00098306|69691494|FG001|Observational Phase|Death|0|||
38008861|NCT00098306|69691495|FG002|Observational Phase|Death|0|||
38008862|NCT00098306|69691496|FG003|Observational Phase|Death|0|||
38008863|NCT00098306|69691497|FG004|Observational Phase|Death|0|||
38008864|NCT00098306|69691498|FG005|Observational Phase|Death|5|||
38008865|NCT00098306|69691499|FG006|Observational Phase|Death|4|||
38008866|NCT00098306|69691493|FG000|Observational Phase|Participant defaulted|0|||
38008867|NCT00098306|69691494|FG001|Observational Phase|Participant defaulted|0|||
38008868|NCT00098306|69691495|FG002|Observational Phase|Participant defaulted|0|||
38008869|NCT00098306|69691496|FG003|Observational Phase|Participant defaulted|0|||
37831479|NCT04677179|69515037|FG002|Induction Treatment Period|Study terminated by sponsor|0|||
37831480|NCT04677179|69515038|FG003|Induction Treatment Period|Study terminated by sponsor|0|||
37908539|NCT00951665|69594247|FG002|Phase 1b|Death|2|||
37908540|NCT00951665|69594248|FG003|Phase 1b|Death|0|||
37908541|NCT00951665|69594249|FG004|Phase 1b|Death|0|||
37908542|NCT00951665|69594250|FG005|Phase 1b|Death|0|||
37908543|NCT00951665|69594245|FG000|Phase 1b|Physician Decision|4|||
37908544|NCT00951665|69594246|FG001|Phase 1b|Physician Decision|0|||
37908545|NCT00951665|69594247|FG002|Phase 1b|Physician Decision|1|||
37908546|NCT00951665|69594248|FG003|Phase 1b|Physician Decision|0|||
37908547|NCT00951665|69594249|FG004|Phase 1b|Physician Decision|0|||
37908548|NCT00951665|69594250|FG005|Phase 1b|Physician Decision|0|||
37908549|NCT00951665|69594245|FG000|Phase 1b|Withdrawal by Subject|0|||
37831481|NCT04677179|69515039|FG004|Induction Treatment Period|Study terminated by sponsor|0|||
37831482|NCT04677179|69515040|FG005|Induction Treatment Period|Study terminated by sponsor|0|||
37831483|NCT04677179|69515041|FG006|Induction Treatment Period|Study terminated by sponsor|0|||
37831484|NCT04677179|69515042|FG007|Induction Treatment Period|Study terminated by sponsor|0|||
37831485|NCT04677179|69515043|FG008|Induction Treatment Period|Study terminated by sponsor|0|||
37831486|NCT04677179|69515044|FG009|Induction Treatment Period|Study terminated by sponsor|0|||
37908550|NCT00951665|69594246|FG001|Phase 1b|Withdrawal by Subject|1|||
37908551|NCT00951665|69594247|FG002|Phase 1b|Withdrawal by Subject|0|||
37908552|NCT00951665|69594248|FG003|Phase 1b|Withdrawal by Subject|0|||
37908553|NCT00951665|69594249|FG004|Phase 1b|Withdrawal by Subject|0|||
37908554|NCT00951665|69594250|FG005|Phase 1b|Withdrawal by Subject|0|||
37908555|NCT00951665|69594245|FG000|Phase 1b|Disease Progression|13|||
38008870|NCT00098306|69691497|FG004|Observational Phase|Participant defaulted|0|||
38008871|NCT00098306|69691498|FG005|Observational Phase|Participant defaulted|34|||
38008872|NCT00098306|69691499|FG006|Observational Phase|Participant defaulted|18|||
38008873|NCT00098306|69691493|FG000|Observational Phase|Un-specified|0|||
38008874|NCT00098306|69691494|FG001|Observational Phase|Un-specified|0|||
38008875|NCT00098306|69691495|FG002|Observational Phase|Un-specified|0|||
38008876|NCT00098306|69691496|FG003|Observational Phase|Un-specified|0|||
38008877|NCT00098306|69691497|FG004|Observational Phase|Un-specified|0|||
38008878|NCT00098306|69691498|FG005|Observational Phase|Un-specified|7|||
38008879|NCT00098306|69691499|FG006|Observational Phase|Un-specified|4|||
37908556|NCT00951665|69594246|FG001|Phase 1b|Disease Progression|2|||
37908557|NCT00951665|69594247|FG002|Phase 1b|Disease Progression|14|||
37908558|NCT00951665|69594248|FG003|Phase 1b|Disease Progression|0|||
37908559|NCT00951665|69594249|FG004|Phase 1b|Disease Progression|0|||
37908560|NCT00951665|69594250|FG005|Phase 1b|Disease Progression|0|||
38008880|NCT03615040|69691514|FG000|Overall Study|Withdrawal by Subject|2|||
38008881|NCT03615040|69691515|FG001|Overall Study|Withdrawal by Subject|1|||
38008882|NCT03615040|69691514|FG000|Overall Study|Physician Decision|2|||
38008883|NCT03615040|69691515|FG001|Overall Study|Physician Decision|2|||
38008884|NCT03615040|69691514|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
38008885|NCT03615040|69691515|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
38008886|NCT03615040|69691514|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
38008887|NCT03615040|69691515|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
38008888|NCT03615040|69691514|FG000|Overall Study|Death|0|||
38008889|NCT03615040|69691515|FG001|Overall Study|Death|2|||
38008890|NCT00068822|69691523|FG000|First Randomized Intervention|Lost to Follow-up|1|||
38008891|NCT00068822|69691524|FG001|First Randomized Intervention|Lost to Follow-up|2|||
38008892|NCT00068588|69691533|FG000|Overall Study|Adverse Event|0|||
38008893|NCT00068588|69691534|FG001|Overall Study|Adverse Event|0|||
38008894|NCT00068588|69691535|FG002|Overall Study|Adverse Event|2|||
38008895|NCT00068588|69691533|FG000|Overall Study|Withdrawal by Subject|0|||
38008896|NCT00068588|69691534|FG001|Overall Study|Withdrawal by Subject|0|||
38008897|NCT00068588|69691535|FG002|Overall Study|Withdrawal by Subject|1|||
38008898|NCT00068588|69691533|FG000|Overall Study|Poor KPS|0|||
38008899|NCT00068588|69691534|FG001|Overall Study|Poor KPS|0|||
38008900|NCT00068588|69691535|FG002|Overall Study|Poor KPS|1|||
38008901|NCT03650452|69691544|FG000|Overall Study|Physician Decision|1|||
38008902|NCT03650452|69691545|FG001|Overall Study|Physician Decision|0|||
38008903|NCT03650452|69691544|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
38008904|NCT03650452|69691545|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
38008905|NCT03650452|69691544|FG000|Overall Study|Adverse Event|3|||
38008906|NCT03650452|69691545|FG001|Overall Study|Adverse Event|4|||
37908561|NCT00951665|69594245|FG000|Phase 1b|Protocol Violation|2|||
37908562|NCT00951665|69594246|FG001|Phase 1b|Protocol Violation|0|||
37908563|NCT00951665|69594247|FG002|Phase 1b|Protocol Violation|0|||
37908564|NCT00951665|69594248|FG003|Phase 1b|Protocol Violation|0|||
37908565|NCT00951665|69594249|FG004|Phase 1b|Protocol Violation|0|||
37908566|NCT00951665|69594250|FG005|Phase 1b|Protocol Violation|0|||
37908567|NCT00951665|69594245|FG000|Phase 2a|Adverse Event|0|||
37908568|NCT00951665|69594246|FG001|Phase 2a|Adverse Event|0|||
37908569|NCT00951665|69594247|FG002|Phase 2a|Adverse Event|0|||
37908570|NCT00951665|69594248|FG003|Phase 2a|Adverse Event|0|||
37908571|NCT00951665|69594249|FG004|Phase 2a|Adverse Event|2|||
37908572|NCT00951665|69594250|FG005|Phase 2a|Adverse Event|0|||
37908573|NCT00951665|69594245|FG000|Phase 2a|Death|0|||
37908574|NCT00951665|69594246|FG001|Phase 2a|Death|0|||
37908575|NCT00951665|69594247|FG002|Phase 2a|Death|0|||
37908576|NCT00951665|69594248|FG003|Phase 2a|Death|0|||
37908577|NCT00951665|69594249|FG004|Phase 2a|Death|1|||
37908578|NCT00951665|69594250|FG005|Phase 2a|Death|1|||
37908579|NCT00951665|69594245|FG000|Phase 2a|Lost to Follow-up|0|||
37908580|NCT00951665|69594246|FG001|Phase 2a|Lost to Follow-up|0|||
37908581|NCT00951665|69594247|FG002|Phase 2a|Lost to Follow-up|0|||
37908582|NCT00951665|69594248|FG003|Phase 2a|Lost to Follow-up|0|||
37908583|NCT00951665|69594249|FG004|Phase 2a|Lost to Follow-up|1|||
37908584|NCT00951665|69594250|FG005|Phase 2a|Lost to Follow-up|0|||
37908585|NCT00951665|69594245|FG000|Phase 2a|Physician Decision|0|||
37908586|NCT00951665|69594246|FG001|Phase 2a|Physician Decision|0|||
37908587|NCT00951665|69594247|FG002|Phase 2a|Physician Decision|0|||
37908588|NCT00951665|69594248|FG003|Phase 2a|Physician Decision|0|||
37908589|NCT00951665|69594249|FG004|Phase 2a|Physician Decision|0|||
37908590|NCT00951665|69594250|FG005|Phase 2a|Physician Decision|1|||
37908591|NCT00951665|69594245|FG000|Phase 2a|Withdrawal by Subject|0|||
37908592|NCT00951665|69594246|FG001|Phase 2a|Withdrawal by Subject|0|||
37908593|NCT00951665|69594247|FG002|Phase 2a|Withdrawal by Subject|0|||
37908594|NCT00951665|69594248|FG003|Phase 2a|Withdrawal by Subject|0|||
37908595|NCT00951665|69594249|FG004|Phase 2a|Withdrawal by Subject|2|||
37908596|NCT00951665|69594250|FG005|Phase 2a|Withdrawal by Subject|0|||
37908597|NCT00951665|69594245|FG000|Phase 2a|Disease Progression|0|||
37908598|NCT00951665|69594246|FG001|Phase 2a|Disease Progression|0|||
38008907|NCT03650452|69691544|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
38008908|NCT03650452|69691545|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
38008909|NCT03575806|69691553|FG000|Overall Study|Withdrawal by Subject|0|||
38008910|NCT03575806|69691554|FG001|Overall Study|Withdrawal by Subject|2|||
38008911|NCT03575806|69691553|FG000|Overall Study|Protocol Violation|0|||
38008912|NCT03575806|69691554|FG001|Overall Study|Protocol Violation|2|||
37908599|NCT00951665|69594247|FG002|Phase 2a|Disease Progression|0|||
37908600|NCT00951665|69594248|FG003|Phase 2a|Disease Progression|0|||
37908601|NCT00951665|69594249|FG004|Phase 2a|Disease Progression|6|||
37908602|NCT00951665|69594250|FG005|Phase 2a|Disease Progression|5|||
37908603|NCT00801099|69594284|FG000|Overall Study|Lost to Follow-up|101|||
37908604|NCT00887744|69594288|FG000|Overall Study|Adverse Event|3|||
37908605|NCT00887744|69594288|FG000|Overall Study|Death|1|||
37908606|NCT00887744|69594288|FG000|Overall Study|Lost to Follow-up|3|||
37908607|NCT00887744|69594288|FG000|Overall Study|Withdrawal by Subject|18|||
37908608|NCT00887744|69594288|FG000|Overall Study|Various reasons|9|||
38008913|NCT03610048|69691560|FG000|Overall Study|Study terminated by sponsor|84|||
38008914|NCT03610048|69691560|FG000|Overall Study|Adverse Event|32|||
38008915|NCT03610048|69691560|FG000|Overall Study|Withdrawal by Subject|31|||
38008916|NCT03610048|69691560|FG000|Overall Study|Lost to Follow-up|8|||
38008917|NCT03610048|69691560|FG000|Overall Study|Other|4|||
38008918|NCT03610048|69691560|FG000|Overall Study|Physician Decision|1|||
38008919|NCT03610048|69691560|FG000|Overall Study|Pregnancy|1|||
38008920|NCT03608254|69691564|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
38008921|NCT03608254|69691564|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
38008922|NCT03606460|69691570|FG000|Overall Study|Lost to Follow-up|1|||
38008923|NCT03606460|69691571|FG001|Overall Study|Lost to Follow-up|8|||
38008924|NCT03605836|69691582|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
38008925|NCT03605836|69691583|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
38008926|NCT03605836|69691584|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
38008927|NCT03605836|69691585|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
38008928|NCT03605836|69691582|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
38008929|NCT03605836|69691583|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
38008930|NCT03605836|69691584|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
38008931|NCT03605836|69691585|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
37831487|NCT04677179|69515035|FG000|Maintenance Treatment Period|Lack of Efficacy|0|||
37831488|NCT04677179|69515036|FG001|Maintenance Treatment Period|Lack of Efficacy|0|||
37831489|NCT04677179|69515037|FG002|Maintenance Treatment Period|Lack of Efficacy|0|||
37831490|NCT04677179|69515038|FG003|Maintenance Treatment Period|Lack of Efficacy|0|||
37831491|NCT04677179|69515039|FG004|Maintenance Treatment Period|Lack of Efficacy|1|||
37831492|NCT04677179|69515040|FG005|Maintenance Treatment Period|Lack of Efficacy|0|||
37831493|NCT04677179|69515041|FG006|Maintenance Treatment Period|Lack of Efficacy|0|||
37908609|NCT00951509|69594292|FG000|Overall Study|Withdrawal by Subject|2|||
37908610|NCT00610441|69594304|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
37908611|NCT00610441|69594305|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
37908612|NCT00610441|69594306|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
37908613|NCT00610441|69594307|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
37908614|NCT00610441|69594304|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
37908615|NCT00610441|69594305|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
37908616|NCT00610441|69594306|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
37908617|NCT00610441|69594307|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
37908618|NCT00610441|69594304|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
37908619|NCT00610441|69594305|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
37908620|NCT00610441|69594306|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
37908621|NCT00610441|69594307|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
37908622|NCT00610441|69594304|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
37908623|NCT00610441|69594305|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
37908624|NCT00610441|69594306|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
37908625|NCT00610441|69594307|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
37908626|NCT00610441|69594304|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
37908627|NCT00610441|69594305|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
38008932|NCT03605836|69691582|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
38008933|NCT03605836|69691583|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
38008934|NCT03605836|69691584|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
38008935|NCT03605836|69691585|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
38008936|NCT03605836|69691582|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
38008937|NCT03605836|69691583|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
38008938|NCT03605836|69691584|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
38008939|NCT03605836|69691585|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
38008940|NCT03605836|69691582|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
38008941|NCT03605836|69691583|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
38008942|NCT03605836|69691584|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
38008943|NCT03605836|69691585|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
38008944|NCT03605836|69691582|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
38008945|NCT03605836|69691583|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
37831494|NCT04677179|69515042|FG007|Maintenance Treatment Period|Lack of Efficacy|0|||
37831495|NCT04677179|69515043|FG008|Maintenance Treatment Period|Lack of Efficacy|0|||
37908628|NCT00610441|69594306|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
37908629|NCT00610441|69594307|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
37908630|NCT00610441|69594304|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
38008946|NCT03605836|69691584|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
37831496|NCT04677179|69515044|FG009|Maintenance Treatment Period|Lack of Efficacy|0|||
38008947|NCT03605836|69691585|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
38008948|NCT03605836|69691582|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
38008949|NCT03605836|69691583|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
38008950|NCT03605836|69691584|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
38008951|NCT03605836|69691585|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
38008952|NCT03605836|69691582|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
38008953|NCT03605836|69691583|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
38008954|NCT03605836|69691584|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
38008955|NCT03605836|69691585|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
38008956|NCT03605836|69691582|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
38008957|NCT03605836|69691583|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
38008958|NCT03605836|69691584|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
38008959|NCT03605836|69691585|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
38008960|NCT03605836|69691582|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
38008961|NCT03605836|69691583|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
38008962|NCT03605836|69691584|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
38008963|NCT03605836|69691585|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
38008964|NCT03605836|69691582|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
38008965|NCT03605836|69691583|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
38008966|NCT03605836|69691584|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
38008967|NCT03605836|69691585|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
38008968|NCT03605836|69691582|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
38008969|NCT03605836|69691583|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
38008970|NCT03605836|69691584|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
38008971|NCT03605836|69691585|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
38008972|NCT03605836|69691582|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
38008973|NCT03605836|69691583|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
38008974|NCT03605836|69691584|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
38008975|NCT03605836|69691585|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
38008976|NCT03605836|69691582|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
38008977|NCT03605836|69691583|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
38008978|NCT03605836|69691584|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
38008979|NCT03605836|69691585|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
38008980|NCT03605836|69691582|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
38008981|NCT03605836|69691583|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
38008982|NCT03605836|69691584|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
38008983|NCT03605836|69691585|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
38008984|NCT03605836|69691582|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
38008985|NCT03605836|69691583|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
38008986|NCT03605836|69691584|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
38008987|NCT03605836|69691585|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
38008988|NCT03605836|69691582|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
38008989|NCT03605836|69691583|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
38008990|NCT03605836|69691584|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
38008991|NCT03605836|69691585|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
38008992|NCT03605836|69691582|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
38008993|NCT03605836|69691583|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
38008994|NCT03605836|69691584|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
38008995|NCT03605836|69691585|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
38008996|NCT03605836|69691582|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
38008997|NCT03605836|69691583|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
38008998|NCT03605836|69691584|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
38008999|NCT03605836|69691585|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
38009000|NCT03605836|69691582|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
38009001|NCT03605836|69691583|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
37697815|NCT02411747|69174445|FG000|Overall Study|Withdrawal by Subject|1|||
37697816|NCT02411747|69174446|FG001|Overall Study|Withdrawal by Subject|0|||
37908631|NCT00610441|69594305|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
37908632|NCT00610441|69594306|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
38009002|NCT03605836|69691584|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
38009003|NCT03605836|69691585|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
38009004|NCT03605836|69691582|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
38009005|NCT03605836|69691583|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
38009006|NCT03605836|69691584|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
38009007|NCT03605836|69691585|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
38009008|NCT03605836|69691582|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
37908633|NCT00610441|69594307|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
37908634|NCT00610441|69594304|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
37908635|NCT00610441|69594305|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
37908636|NCT00610441|69594306|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
37908637|NCT00610441|69594307|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
37908638|NCT00610441|69594304|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
37908639|NCT00610441|69594305|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
37908640|NCT00610441|69594306|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
37908641|NCT00610441|69594307|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
37908642|NCT00610441|69594304|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
37908643|NCT00610441|69594305|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
37908644|NCT00610441|69594306|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
37908645|NCT00610441|69594307|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
37908646|NCT00799617|69594321|FG000|Main Testosterone Trial|Randomized in error|1|||
37908647|NCT00799617|69594322|FG001|Main Testosterone Trial|Randomized in error|1|||
37908648|NCT00799617|69594321|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
38009009|NCT03605836|69691583|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
38009010|NCT03605836|69691584|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
38009011|NCT03605836|69691585|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
38009012|NCT03605680|69691598|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
38009013|NCT03605680|69691599|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
38009014|NCT03605680|69691600|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
38009015|NCT03605680|69691601|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
38009016|NCT03605680|69691598|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
38009017|NCT03605680|69691599|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
38009018|NCT03605680|69691600|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
38009019|NCT03605680|69691601|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
38009020|NCT03605680|69691598|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
37908649|NCT00799617|69594322|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
38009021|NCT03605680|69691599|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
38009022|NCT03605680|69691600|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
38009023|NCT03605680|69691601|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
38009024|NCT03605680|69691598|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
38009025|NCT03605680|69691599|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
38009026|NCT03605680|69691600|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
38009027|NCT03605680|69691601|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
38009028|NCT03605680|69691598|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
38009029|NCT03605680|69691599|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
38009030|NCT03605680|69691600|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
38009031|NCT03605680|69691601|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
38009032|NCT03605680|69691598|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
38009033|NCT03605680|69691599|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
38009034|NCT03605680|69691600|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
38009035|NCT03605680|69691601|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
38009036|NCT03605680|69691598|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
38009037|NCT03605680|69691599|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
38009038|NCT03605680|69691600|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
38009039|NCT03605680|69691601|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
38009040|NCT03605680|69691598|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
38009041|NCT03605680|69691599|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
38009042|NCT03605680|69691600|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
38009043|NCT03605680|69691601|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
38009044|NCT03605680|69691598|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
38009045|NCT03605680|69691599|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
38009046|NCT03605680|69691600|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
37697817|NCT02411747|69174445|FG000|Overall Study|Protocol Violation|2|||
38009047|NCT03605680|69691601|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
37908650|NCT00799617|69594321|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
37908651|NCT00799617|69594322|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
38009048|NCT03605680|69691598|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
37831497|NCT04677179|69515035|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
37831498|NCT04677179|69515036|FG001|Maintenance Treatment Period|Withdrawal by Subject|0|||
37831499|NCT04677179|69515037|FG002|Maintenance Treatment Period|Withdrawal by Subject|0|||
37831500|NCT04677179|69515038|FG003|Maintenance Treatment Period|Withdrawal by Subject|1|||
37831501|NCT04677179|69515039|FG004|Maintenance Treatment Period|Withdrawal by Subject|0|||
37831502|NCT04677179|69515040|FG005|Maintenance Treatment Period|Withdrawal by Subject|0|||
37831503|NCT04677179|69515041|FG006|Maintenance Treatment Period|Withdrawal by Subject|0|||
37831504|NCT04677179|69515042|FG007|Maintenance Treatment Period|Withdrawal by Subject|0|||
37831505|NCT04677179|69515043|FG008|Maintenance Treatment Period|Withdrawal by Subject|0|||
37831506|NCT04677179|69515044|FG009|Maintenance Treatment Period|Withdrawal by Subject|0|||
37831507|NCT04677179|69515035|FG000|Maintenance Treatment Period|Study terminated by sponsor|0|||
37831508|NCT04677179|69515036|FG001|Maintenance Treatment Period|Study terminated by sponsor|0|||
37831509|NCT04677179|69515037|FG002|Maintenance Treatment Period|Study terminated by sponsor|0|||
37831510|NCT04677179|69515038|FG003|Maintenance Treatment Period|Study terminated by sponsor|7|||
37831511|NCT04677179|69515039|FG004|Maintenance Treatment Period|Study terminated by sponsor|9|||
37831512|NCT04677179|69515040|FG005|Maintenance Treatment Period|Study terminated by sponsor|5|||
37831513|NCT04677179|69515041|FG006|Maintenance Treatment Period|Study terminated by sponsor|0|||
37831514|NCT04677179|69515042|FG007|Maintenance Treatment Period|Study terminated by sponsor|0|||
37831515|NCT04677179|69515043|FG008|Maintenance Treatment Period|Study terminated by sponsor|0|||
37831516|NCT04677179|69515044|FG009|Maintenance Treatment Period|Study terminated by sponsor|0|||
37831517|NCT04677179|69515035|FG000|Extension Treatment Period|Lack of Efficacy|0|||
37697818|NCT02411747|69174446|FG001|Overall Study|Protocol Violation|4|||
37697819|NCT01822756|69174457|FG000|Overall Study|Adverse Event|0|||
37697820|NCT01822756|69174458|FG001|Overall Study|Adverse Event|0|||
37697821|NCT01822756|69174459|FG002|Overall Study|Adverse Event|0|||
37697822|NCT01822756|69174460|FG003|Overall Study|Adverse Event|2|||
37697823|NCT01822756|69174461|FG004|Overall Study|Adverse Event|0|||
37697824|NCT01822756|69174457|FG000|Overall Study|Disease progression|11|||
38009049|NCT03605680|69691599|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
38009050|NCT03605680|69691600|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
38009051|NCT03605680|69691601|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
38009052|NCT03605680|69691598|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
38009053|NCT03605680|69691599|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
38009054|NCT03605680|69691600|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
38009055|NCT03605680|69691601|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
38009056|NCT03605680|69691598|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
38009057|NCT03605680|69691599|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
38009058|NCT03605680|69691600|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
38009059|NCT03605680|69691601|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
38009060|NCT03605680|69691598|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
38009061|NCT03605680|69691599|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
38009062|NCT03605680|69691600|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
38009063|NCT03605680|69691601|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
38009064|NCT03605680|69691598|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
38009065|NCT03605680|69691599|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
38009066|NCT03605680|69691600|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
38009067|NCT03605680|69691601|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
38009068|NCT03605680|69691598|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
38009069|NCT03605680|69691599|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
37697825|NCT01822756|69174458|FG001|Overall Study|Disease progression|1|||
37697826|NCT01822756|69174459|FG002|Overall Study|Disease progression|7|||
37831518|NCT04677179|69515036|FG001|Extension Treatment Period|Lack of Efficacy|0|||
37908652|NCT00799617|69594321|FG000|Sexual Funtion Trial|No Baseline Data|4|||
37908653|NCT00799617|69594322|FG001|Sexual Funtion Trial|No Baseline Data|7|||
37908654|NCT00799617|69594321|FG000|Physical Function Trial|Lost to Follow-up|6|||
38009070|NCT03605680|69691600|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
37831519|NCT04677179|69515037|FG002|Extension Treatment Period|Lack of Efficacy|0|||
37831520|NCT04677179|69515038|FG003|Extension Treatment Period|Lack of Efficacy|0|||
37908655|NCT00799617|69594322|FG001|Physical Function Trial|Lost to Follow-up|11|||
37908656|NCT00799617|69594321|FG000|Vitality Trial|Lost to Follow-up|7|||
37697827|NCT01822756|69174460|FG003|Overall Study|Disease progression|2|||
37697828|NCT01822756|69174461|FG004|Overall Study|Disease progression|6|||
37697829|NCT01822756|69174457|FG000|Overall Study|Death|2|||
37697830|NCT01822756|69174458|FG001|Overall Study|Death|2|||
37908657|NCT00799617|69594322|FG001|Vitality Trial|Lost to Follow-up|22|||
37908658|NCT00799617|69594321|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
37908659|NCT00799617|69594322|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
37908660|NCT00799617|69594321|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
37908661|NCT00799617|69594322|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
37908662|NCT00799617|69594321|FG000|Bone Trial|Month 12 scan not available|6|||
37908663|NCT00799617|69594322|FG001|Bone Trial|Month 12 scan not available|16|||
37908664|NCT00799617|69594321|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
37908665|NCT00799617|69594322|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
38009071|NCT03605680|69691601|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
38009072|NCT03605680|69691598|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
38009073|NCT03605680|69691599|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
38009074|NCT03605680|69691600|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
37908666|NCT00799617|69594321|FG000|Anemia Trial|Withdrawal by Subject|3|||
37908667|NCT00799617|69594322|FG001|Anemia Trial|Withdrawal by Subject|3|||
37908668|NCT00607087|69594331|FG000|Overall Study|Withdrawal by Subject|9|||
37908669|NCT00607087|69594332|FG001|Overall Study|Withdrawal by Subject|4|||
38009075|NCT03605680|69691601|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
37831521|NCT04677179|69515039|FG004|Extension Treatment Period|Lack of Efficacy|0|||
37831522|NCT04677179|69515040|FG005|Extension Treatment Period|Lack of Efficacy|0|||
37831523|NCT04677179|69515041|FG006|Extension Treatment Period|Lack of Efficacy|6|||
37831524|NCT04677179|69515042|FG007|Extension Treatment Period|Lack of Efficacy|0|||
37831525|NCT04677179|69515043|FG008|Extension Treatment Period|Lack of Efficacy|0|||
37831526|NCT04677179|69515044|FG009|Extension Treatment Period|Lack of Efficacy|0|||
37831527|NCT04677179|69515035|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
37831528|NCT04677179|69515036|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
37831529|NCT04677179|69515037|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
37831530|NCT04677179|69515038|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
37831531|NCT04677179|69515039|FG004|Extension Treatment Period|Withdrawal by Subject|0|||
37831532|NCT04677179|69515040|FG005|Extension Treatment Period|Withdrawal by Subject|0|||
37831533|NCT04677179|69515041|FG006|Extension Treatment Period|Withdrawal by Subject|2|||
37831534|NCT04677179|69515042|FG007|Extension Treatment Period|Withdrawal by Subject|0|||
37831535|NCT04677179|69515043|FG008|Extension Treatment Period|Withdrawal by Subject|0|||
37831536|NCT04677179|69515044|FG009|Extension Treatment Period|Withdrawal by Subject|0|||
37831537|NCT04677179|69515035|FG000|Extension Treatment Period|Study terminated by sponsor|0|||
37831538|NCT04677179|69515036|FG001|Extension Treatment Period|Study terminated by sponsor|0|||
37831539|NCT04677179|69515037|FG002|Extension Treatment Period|Study terminated by sponsor|0|||
37831540|NCT04677179|69515038|FG003|Extension Treatment Period|Study terminated by sponsor|0|||
37831541|NCT04677179|69515039|FG004|Extension Treatment Period|Study terminated by sponsor|0|||
37831542|NCT04677179|69515040|FG005|Extension Treatment Period|Study terminated by sponsor|0|||
37831543|NCT04677179|69515041|FG006|Extension Treatment Period|Study terminated by sponsor|18|||
37831544|NCT04677179|69515042|FG007|Extension Treatment Period|Study terminated by sponsor|0|||
37831545|NCT04677179|69515043|FG008|Extension Treatment Period|Study terminated by sponsor|0|||
37831546|NCT04677179|69515044|FG009|Extension Treatment Period|Study terminated by sponsor|0|||
37831547|NCT04677179|69515035|FG000|Post-Treatment Follow-up Period|Adverse Event|0|||
37831548|NCT04677179|69515036|FG001|Post-Treatment Follow-up Period|Adverse Event|0|||
37831549|NCT04677179|69515037|FG002|Post-Treatment Follow-up Period|Adverse Event|0|||
37831550|NCT04677179|69515038|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
37831551|NCT04677179|69515039|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
37831552|NCT04677179|69515040|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
37831553|NCT04677179|69515041|FG006|Post-Treatment Follow-up Period|Adverse Event|0|||
37831554|NCT04677179|69515042|FG007|Post-Treatment Follow-up Period|Adverse Event|1|||
37831555|NCT04677179|69515043|FG008|Post-Treatment Follow-up Period|Adverse Event|0|||
37831556|NCT04677179|69515044|FG009|Post-Treatment Follow-up Period|Adverse Event|0|||
37831557|NCT04677179|69515035|FG000|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
37831558|NCT04677179|69515036|FG001|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
37908670|NCT00607087|69594333|FG002|Overall Study|Withdrawal by Subject|4|||
37908671|NCT00607087|69594331|FG000|Overall Study|Adverse Event|3|||
37908672|NCT00607087|69594332|FG001|Overall Study|Adverse Event|2|||
37908673|NCT00607087|69594333|FG002|Overall Study|Adverse Event|3|||
38009076|NCT03605680|69691598|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
38009077|NCT03605680|69691599|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
37831559|NCT04677179|69515037|FG002|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
37831560|NCT04677179|69515038|FG003|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
37831561|NCT04677179|69515039|FG004|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
37908674|NCT00607087|69594331|FG000|Overall Study|Other reason|1|||
37908675|NCT00607087|69594332|FG001|Overall Study|Other reason|5|||
37908676|NCT00607087|69594333|FG002|Overall Study|Other reason|2|||
37908677|NCT00607087|69594331|FG000|Overall Study|Poor compliance to protocol|1|||
37908678|NCT00607087|69594332|FG001|Overall Study|Poor compliance to protocol|0|||
38009078|NCT03605680|69691600|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
38009079|NCT03605680|69691601|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
38009080|NCT03605680|69691598|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
38009081|NCT03605680|69691599|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
38009082|NCT03605680|69691600|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
38009083|NCT03605680|69691601|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
38009084|NCT03605680|69691598|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
38009085|NCT03605680|69691599|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
38009086|NCT03605680|69691600|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
38009087|NCT03605680|69691601|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
38009088|NCT03572218|69691612|FG000|Overall Study|Lost to Follow-up|3|||
38009089|NCT03572218|69691613|FG001|Overall Study|Lost to Follow-up|2|||
38009090|NCT03572218|69691612|FG000|Overall Study|No longer available for study visits|2|||
38009091|NCT03572218|69691613|FG001|Overall Study|No longer available for study visits|1|||
38009092|NCT03572218|69691612|FG000|Overall Study|No longer interested|1|||
38009093|NCT03572218|69691613|FG001|Overall Study|No longer interested|2|||
38009094|NCT00111813|69691619|FG000|Overall Study|Adverse Event|1|||
38009095|NCT00111813|69691620|FG001|Overall Study|Adverse Event|2|||
38009096|NCT00111813|69691621|FG002|Overall Study|Adverse Event|4|||
38009097|NCT00111813|69691622|FG003|Overall Study|Adverse Event|2|||
38009098|NCT00111813|69691623|FG004|Overall Study|Adverse Event|2|||
38009099|NCT00111813|69691624|FG005|Overall Study|Adverse Event|2|||
38009100|NCT00111813|69691619|FG000|Overall Study|Progressive disease|2|||
38009101|NCT00111813|69691620|FG001|Overall Study|Progressive disease|1|||
38009102|NCT00111813|69691621|FG002|Overall Study|Progressive disease|5|||
38009103|NCT00111813|69691622|FG003|Overall Study|Progressive disease|3|||
38009104|NCT00111813|69691623|FG004|Overall Study|Progressive disease|4|||
38009105|NCT00111813|69691624|FG005|Overall Study|Progressive disease|3|||
38009106|NCT00111813|69691619|FG000|Overall Study|Lack of Efficacy|0|||
38009107|NCT00111813|69691620|FG001|Overall Study|Lack of Efficacy|0|||
38009108|NCT00111813|69691621|FG002|Overall Study|Lack of Efficacy|0|||
38009109|NCT00111813|69691622|FG003|Overall Study|Lack of Efficacy|0|||
38009110|NCT00111813|69691623|FG004|Overall Study|Lack of Efficacy|0|||
38009111|NCT00111813|69691624|FG005|Overall Study|Lack of Efficacy|1|||
38009112|NCT00111813|69691619|FG000|Overall Study|Other|0|||
38009113|NCT00111813|69691620|FG001|Overall Study|Other|0|||
38009114|NCT00111813|69691621|FG002|Overall Study|Other|1|||
38009115|NCT00111813|69691622|FG003|Overall Study|Other|0|||
38009116|NCT00111813|69691623|FG004|Overall Study|Other|0|||
38009117|NCT00111813|69691624|FG005|Overall Study|Other|0|||
38009118|NCT00118287|69691639|FG000|Overall Study|Intracranial haemorrhage|1|||
38009119|NCT00118287|69691639|FG000|Overall Study|Muscle pain|1|||
38009120|NCT00130689|69691643|FG000|Overall Study|Progressive Disease|29|||
38009121|NCT00130689|69691643|FG000|Overall Study|Death|1|||
38009122|NCT00130689|69691643|FG000|Overall Study|Clinical Deterioration|4|||
38009123|NCT00130689|69691643|FG000|Overall Study|Withdrawal by Subject|3|||
38009124|NCT00130689|69691643|FG000|Overall Study|Ineligible|6|||
38009125|NCT03605212|69691652|FG000|Treatment Period|Adverse Event|1|||
38009126|NCT03605212|69691653|FG001|Treatment Period|Adverse Event|0|||
38009127|NCT03605212|69691654|FG002|Treatment Period|Adverse Event|0|||
38009128|NCT03605212|69691655|FG003|Treatment Period|Adverse Event|0|||
38009129|NCT03605212|69691656|FG004|Treatment Period|Adverse Event|0|||
38009130|NCT03605212|69691652|FG000|Treatment Period|Physician Decision|0|||
38009131|NCT03605212|69691653|FG001|Treatment Period|Physician Decision|0|||
38009132|NCT03605212|69691654|FG002|Treatment Period|Physician Decision|0|||
38009133|NCT03605212|69691655|FG003|Treatment Period|Physician Decision|0|||
38009134|NCT03605212|69691656|FG004|Treatment Period|Physician Decision|1|||
38009135|NCT03603652|69691669|FG000|Overall Study|Death|2|||
38009136|NCT00117507|69691673|FG000|Overall Study|Adverse Event|4|||
38009137|NCT00117507|69691673|FG000|Overall Study|Abnormal laboratory values|3|||
37697831|NCT01822756|69174459|FG002|Overall Study|Death|1|||
38009138|NCT00117507|69691673|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
38009139|NCT00117507|69691673|FG000|Overall Study|Patient withdrew consent|4|||
38009140|NCT00117507|69691673|FG000|Overall Study|Death|3|||
38009141|NCT03603496|69691680|FG000|Overall Study|Death|19|||
38009142|NCT03603496|69691681|FG001|Overall Study|Death|24|||
38009143|NCT03603496|69691680|FG000|Overall Study|Lost to Follow-up|141|||
38009144|NCT03603496|69691681|FG001|Overall Study|Lost to Follow-up|141|||
38009145|NCT03603496|69691680|FG000|Overall Study|Withdrawal by Subject|26|||
38009146|NCT03603496|69691681|FG001|Overall Study|Withdrawal by Subject|20|||
38009147|NCT03603028|69691687|FG000|Overall Study|Withdrawal by Subject|1|||
38009148|NCT03602482|69691693|FG000|Overall Study|Withdrawal by Subject|6|||
38009149|NCT03602482|69691694|FG001|Overall Study|Withdrawal by Subject|7|||
38009150|NCT03602482|69691695|FG002|Overall Study|Withdrawal by Subject|0|||
38009151|NCT03602482|69691696|FG003|Overall Study|Withdrawal by Subject|0|||
38009152|NCT00096135|69691711|FG000|Overall Study|Physician Decision|20|||
38009153|NCT00096135|69691712|FG001|Overall Study|Physician Decision|4|||
38009154|NCT00096135|69691711|FG000|Overall Study|Refusal of further protocol therapy|4|||
38009155|NCT00096135|69691712|FG001|Overall Study|Refusal of further protocol therapy|1|||
38009156|NCT00096135|69691711|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
38009157|NCT00096135|69691712|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
38009158|NCT00096135|69691711|FG000|Overall Study|Other, specify|15|||
38009159|NCT00096135|69691712|FG001|Overall Study|Other, specify|3|||
38009160|NCT00096135|69691711|FG000|Overall Study|Ineligible|2|||
38009161|NCT00096135|69691712|FG001|Overall Study|Ineligible|0|||
38009162|NCT00116805|69691720|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
38009163|NCT00116805|69691721|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
38009164|NCT00116805|69691720|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
37908679|NCT00607087|69594333|FG002|Overall Study|Poor compliance to protocol|1|||
37908680|NCT00607087|69594331|FG000|Overall Study|Lost to Follow-up|1|||
37908681|NCT00607087|69594332|FG001|Overall Study|Lost to Follow-up|0|||
38009165|NCT00116805|69691721|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
38009166|NCT00116805|69691720|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
38009167|NCT00116805|69691721|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
38009168|NCT00116805|69691720|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
38009169|NCT00116805|69691721|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
38009170|NCT00116805|69691720|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
38009171|NCT00116805|69691721|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
38009172|NCT00116805|69691720|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
38009173|NCT00116805|69691721|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
38009174|NCT00116805|69691720|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
38009175|NCT00116805|69691721|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
38009176|NCT00116805|69691720|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
38009177|NCT00116805|69691721|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
38009178|NCT00116805|69691720|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
38009179|NCT00116805|69691721|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
38009180|NCT00116805|69691720|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
38009181|NCT00116805|69691721|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
38009182|NCT00116805|69691720|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
38009183|NCT00116805|69691721|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
38009184|NCT00116805|69691720|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
38009185|NCT00116805|69691721|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
38009186|NCT00116805|69691720|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
38009187|NCT00116805|69691721|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
38009188|NCT00116805|69691720|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
38009189|NCT00116805|69691721|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
38009190|NCT00116805|69691720|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
38009191|NCT00116805|69691721|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
38009192|NCT00116805|69691720|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
38009193|NCT00116805|69691721|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
38009194|NCT00116805|69691720|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
38009195|NCT00116805|69691721|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
38009196|NCT00116805|69691720|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
37831562|NCT04677179|69515040|FG005|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
37831563|NCT04677179|69515041|FG006|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
38009197|NCT00116805|69691721|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
38009198|NCT00116805|69691720|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
38009199|NCT00116805|69691721|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
37831564|NCT04677179|69515042|FG007|Post-Treatment Follow-up Period|Lack of Efficacy|2|||
37831565|NCT04677179|69515043|FG008|Post-Treatment Follow-up Period|Lack of Efficacy|3|||
37831566|NCT04677179|69515044|FG009|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
37831567|NCT04677179|69515035|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
37831568|NCT04677179|69515036|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
37831569|NCT04677179|69515037|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
37908682|NCT00607087|69594333|FG002|Overall Study|Lost to Follow-up|0|||
37908683|NCT00607087|69594331|FG000|Period 1|Withdrawal by Subject|7|||
38009200|NCT00116805|69691720|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
38009201|NCT00116805|69691721|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
38009202|NCT00116805|69691720|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
38009203|NCT00116805|69691721|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
37908684|NCT00607087|69594332|FG001|Period 1|Withdrawal by Subject|2|||
37908685|NCT00607087|69594333|FG002|Period 1|Withdrawal by Subject|3|||
38009204|NCT00116805|69691720|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
38009205|NCT00116805|69691721|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
38009206|NCT00116805|69691720|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
38009207|NCT00116805|69691721|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
38009208|NCT00116805|69691720|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
38009209|NCT00116805|69691721|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
38009210|NCT00116805|69691720|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
38009211|NCT00116805|69691721|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
38009212|NCT00116805|69691720|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
38009213|NCT00116805|69691721|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
38009214|NCT00116805|69691720|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
38009215|NCT00116805|69691721|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
38009216|NCT00116805|69691720|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
38009217|NCT00116805|69691721|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
38009218|NCT00116805|69691720|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
38009219|NCT00116805|69691721|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
38009220|NCT00116805|69691720|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
38009221|NCT00116805|69691721|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
38009222|NCT00116805|69691720|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
38009223|NCT00116805|69691721|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
38009224|NCT00116805|69691720|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
38009225|NCT00116805|69691721|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
38009226|NCT00116805|69691720|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
38009227|NCT00116805|69691721|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
38009228|NCT00116805|69691720|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
38009229|NCT00116805|69691721|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
38009230|NCT00116805|69691720|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
38009231|NCT00116805|69691721|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
38009232|NCT00116805|69691720|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
38009233|NCT00116805|69691721|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
38009234|NCT00116805|69691720|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
38009235|NCT00116805|69691721|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
38009236|NCT00116805|69691720|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
38009237|NCT00116805|69691721|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
38009238|NCT00116805|69691720|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
38009239|NCT00116805|69691721|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
38009240|NCT00116805|69691720|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
38009241|NCT00116805|69691721|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
38009242|NCT00116805|69691720|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
38009243|NCT00116805|69691721|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
38009244|NCT00116805|69691720|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
38009245|NCT00116805|69691721|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
38009246|NCT00116805|69691720|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
38009247|NCT00116805|69691721|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
38009248|NCT00116805|69691720|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
38009249|NCT00116805|69691721|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
38009250|NCT00116805|69691720|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
38009251|NCT00116805|69691721|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
38009252|NCT00116649|69691736|FG000|Overall Study|Adverse Event|20|||
38009253|NCT00116649|69691736|FG000|Overall Study|Lack of Efficacy|1|||
38009254|NCT00116649|69691736|FG000|Overall Study|Lost to Follow-up|32|||
38009255|NCT00116649|69691736|FG000|Overall Study|Withdrawal by Subject|68|||
38009256|NCT00116649|69691736|FG000|Overall Study|Local Skin Reaction|9|||
38009257|NCT00116649|69691736|FG000|Overall Study|Various Reasons|18|||
38009258|NCT00116649|69691736|FG000|Overall Study|Protocol Specified|7|||
38009259|NCT00083889|69691742|FG000|Overall Study|Adverse Event|76|||
38009260|NCT00083889|69691743|FG001|Overall Study|Adverse Event|86|||
38009261|NCT00083889|69691742|FG000|Overall Study|Protocol Violation|2|||
38009262|NCT00083889|69691743|FG001|Overall Study|Protocol Violation|2|||
38009263|NCT00083889|69691742|FG000|Overall Study|Withdrawal by Subject|22|||
38009264|NCT00083889|69691743|FG001|Overall Study|Withdrawal by Subject|24|||
38009265|NCT00083889|69691742|FG000|Overall Study|Lack of Efficacy|240|||
38009266|NCT00083889|69691743|FG001|Overall Study|Lack of Efficacy|219|||
38009267|NCT00083889|69691742|FG000|Overall Study|Decision of sponsor|32|||
38009268|NCT00083889|69691743|FG001|Overall Study|Decision of sponsor|4|||
38009269|NCT00083889|69691742|FG000|Overall Study|Randomized: did not take study drug|0|||
38009270|NCT00083889|69691743|FG001|Overall Study|Randomized: did not take study drug|15|||
38009271|NCT00083889|69691742|FG000|Overall Study|Completed on marketed sunitinub|3|||
38009272|NCT00083889|69691743|FG001|Overall Study|Completed on marketed sunitinub|0|||
38009273|NCT00083889|69691742|FG000|Overall Study|Crossover to SU011248|0|||
38009274|NCT00083889|69691743|FG001|Overall Study|Crossover to SU011248|25|||
37908686|NCT00607087|69594331|FG000|Period 1|Adverse Event|3|||
37908687|NCT00607087|69594332|FG001|Period 1|Adverse Event|0|||
37908688|NCT00607087|69594333|FG002|Period 1|Adverse Event|0|||
37908689|NCT00607087|69594331|FG000|Period 1|Poor compliance to protocol|1|||
37908690|NCT00607087|69594332|FG001|Period 1|Poor compliance to protocol|0|||
37908691|NCT00607087|69594333|FG002|Period 1|Poor compliance to protocol|0|||
38009275|NCT03572062|69691762|FG000|Overall Study|Adverse Event|0|||
38009276|NCT03572062|69691763|FG001|Overall Study|Adverse Event|0|||
38009277|NCT03572062|69691764|FG002|Overall Study|Adverse Event|0|||
38009278|NCT03572062|69691765|FG003|Overall Study|Adverse Event|0|||
38009279|NCT03572062|69691766|FG004|Overall Study|Adverse Event|0|||
38009280|NCT03572062|69691767|FG005|Overall Study|Adverse Event|0|||
38009281|NCT03572062|69691768|FG006|Overall Study|Adverse Event|0|||
38009282|NCT03572062|69691769|FG007|Overall Study|Adverse Event|0|||
38009283|NCT03572062|69691770|FG008|Overall Study|Adverse Event|1|||
38009284|NCT03572062|69691771|FG009|Overall Study|Adverse Event|3|||
38009285|NCT03572062|69691762|FG000|Overall Study|Death|0|||
38009286|NCT03572062|69691763|FG001|Overall Study|Death|0|||
38009287|NCT03572062|69691764|FG002|Overall Study|Death|0|||
38009288|NCT03572062|69691765|FG003|Overall Study|Death|0|||
38009289|NCT03572062|69691766|FG004|Overall Study|Death|0|||
37831570|NCT04677179|69515038|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
37831571|NCT04677179|69515039|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
37831572|NCT04677179|69515040|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
37831573|NCT04677179|69515041|FG006|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
37908692|NCT00607087|69594331|FG000|Period 1|Lost to Follow-up|1|||
37908693|NCT00607087|69594332|FG001|Period 1|Lost to Follow-up|0|||
37908694|NCT00607087|69594333|FG002|Period 1|Lost to Follow-up|0|||
37908695|NCT00607087|69594331|FG000|Period 1|Other reason|0|||
37908696|NCT00607087|69594332|FG001|Period 1|Other reason|4|||
37908697|NCT00607087|69594333|FG002|Period 1|Other reason|2|||
37908698|NCT00607087|69594331|FG000|Period 2|Withdrawal by Subject|0|||
37908699|NCT00607087|69594332|FG001|Period 2|Withdrawal by Subject|1|||
37908700|NCT00607087|69594333|FG002|Period 2|Withdrawal by Subject|1|||
37908701|NCT00607087|69594331|FG000|Period 2|Other reason|1|||
37908702|NCT00607087|69594332|FG001|Period 2|Other reason|1|||
37908703|NCT00607087|69594333|FG002|Period 2|Other reason|0|||
37908704|NCT00607087|69594331|FG000|Period 2|Adverse Event|0|||
37908705|NCT00607087|69594332|FG001|Period 2|Adverse Event|1|||
37831574|NCT04677179|69515042|FG007|Post-Treatment Follow-up Period|Lost to Follow-up|1|||
37831575|NCT04677179|69515043|FG008|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
37831576|NCT04677179|69515044|FG009|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
37831577|NCT04677179|69515035|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
37831578|NCT04677179|69515036|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
37831579|NCT04677179|69515037|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
37831580|NCT04677179|69515038|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
37831581|NCT04677179|69515039|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
37831582|NCT04677179|69515040|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
37831583|NCT04677179|69515041|FG006|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
37831584|NCT04677179|69515042|FG007|Post-Treatment Follow-up Period|Withdrawal by Subject|3|||
37831585|NCT04677179|69515043|FG008|Post-Treatment Follow-up Period|Withdrawal by Subject|1|||
37831586|NCT04677179|69515044|FG009|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
37831587|NCT04677179|69515035|FG000|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
37831588|NCT04677179|69515036|FG001|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
37908706|NCT00607087|69594333|FG002|Period 2|Adverse Event|3|||
37908707|NCT00607087|69594331|FG000|Period 2|Poor compliance to protocol|0|||
37908708|NCT00607087|69594332|FG001|Period 2|Poor compliance to protocol|0|||
38009290|NCT03572062|69691767|FG005|Overall Study|Death|1|||
38009291|NCT03572062|69691768|FG006|Overall Study|Death|0|||
38009292|NCT03572062|69691769|FG007|Overall Study|Death|0|||
38009293|NCT03572062|69691770|FG008|Overall Study|Death|0|||
37831589|NCT04677179|69515037|FG002|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
37908709|NCT00607087|69594333|FG002|Period 2|Poor compliance to protocol|1|||
37908710|NCT00607087|69594331|FG000|Period 3|Withdrawal by Subject|2|||
37908711|NCT00607087|69594332|FG001|Period 3|Withdrawal by Subject|1|||
37908712|NCT00607087|69594333|FG002|Period 3|Withdrawal by Subject|0|||
37908713|NCT00607087|69594331|FG000|Period 3|Adverse Event|0|||
37908714|NCT00607087|69594332|FG001|Period 3|Adverse Event|1|||
38009294|NCT03572062|69691771|FG009|Overall Study|Death|0|||
38009295|NCT03572062|69691762|FG000|Overall Study|Lost to Follow-up|0|||
38009296|NCT03572062|69691763|FG001|Overall Study|Lost to Follow-up|0|||
38009297|NCT03572062|69691764|FG002|Overall Study|Lost to Follow-up|0|||
38009298|NCT03572062|69691765|FG003|Overall Study|Lost to Follow-up|0|||
38009299|NCT03572062|69691766|FG004|Overall Study|Lost to Follow-up|0|||
38009300|NCT03572062|69691767|FG005|Overall Study|Lost to Follow-up|1|||
38009301|NCT03572062|69691768|FG006|Overall Study|Lost to Follow-up|1|||
38009302|NCT03572062|69691769|FG007|Overall Study|Lost to Follow-up|0|||
38009303|NCT03572062|69691770|FG008|Overall Study|Lost to Follow-up|0|||
38009304|NCT03572062|69691771|FG009|Overall Study|Lost to Follow-up|0|||
38009305|NCT03572062|69691762|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
38009306|NCT03572062|69691763|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
38009307|NCT03572062|69691764|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
38009308|NCT03572062|69691765|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
38009309|NCT03572062|69691766|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
38009310|NCT03572062|69691767|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
38009311|NCT03572062|69691768|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
38009312|NCT03572062|69691769|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
38009313|NCT03572062|69691770|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
38009314|NCT03572062|69691771|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
38009315|NCT03572062|69691762|FG000|Overall Study|Study Terminated By Sponsor|0|||
38009316|NCT03572062|69691763|FG001|Overall Study|Study Terminated By Sponsor|0|||
38009317|NCT03572062|69691764|FG002|Overall Study|Study Terminated By Sponsor|0|||
38009318|NCT03572062|69691765|FG003|Overall Study|Study Terminated By Sponsor|0|||
38009319|NCT03572062|69691766|FG004|Overall Study|Study Terminated By Sponsor|0|||
38009320|NCT03572062|69691767|FG005|Overall Study|Study Terminated By Sponsor|0|||
38009321|NCT03572062|69691768|FG006|Overall Study|Study Terminated By Sponsor|0|||
38009322|NCT03572062|69691769|FG007|Overall Study|Study Terminated By Sponsor|0|||
38009323|NCT03572062|69691770|FG008|Overall Study|Study Terminated By Sponsor|29|||
38009324|NCT03572062|69691771|FG009|Overall Study|Study Terminated By Sponsor|27|||
38009325|NCT03572062|69691762|FG000|Overall Study|Physician Decision|0|||
38009326|NCT03572062|69691763|FG001|Overall Study|Physician Decision|0|||
38009327|NCT03572062|69691764|FG002|Overall Study|Physician Decision|0|||
38009328|NCT03572062|69691765|FG003|Overall Study|Physician Decision|0|||
38009329|NCT03572062|69691766|FG004|Overall Study|Physician Decision|0|||
38009330|NCT03572062|69691767|FG005|Overall Study|Physician Decision|0|||
38009331|NCT03572062|69691768|FG006|Overall Study|Physician Decision|0|||
38009332|NCT03572062|69691769|FG007|Overall Study|Physician Decision|0|||
38009333|NCT03572062|69691770|FG008|Overall Study|Physician Decision|1|||
38009334|NCT03572062|69691771|FG009|Overall Study|Physician Decision|0|||
38009335|NCT03572062|69691762|FG000|Overall Study|Withdrawal by Subject|0|||
38009336|NCT03572062|69691763|FG001|Overall Study|Withdrawal by Subject|0|||
38009337|NCT03572062|69691764|FG002|Overall Study|Withdrawal by Subject|0|||
38009338|NCT03572062|69691765|FG003|Overall Study|Withdrawal by Subject|0|||
38009339|NCT03572062|69691766|FG004|Overall Study|Withdrawal by Subject|0|||
38009340|NCT03572062|69691767|FG005|Overall Study|Withdrawal by Subject|0|||
38009341|NCT03572062|69691768|FG006|Overall Study|Withdrawal by Subject|0|||
38009342|NCT03572062|69691769|FG007|Overall Study|Withdrawal by Subject|0|||
38009343|NCT03572062|69691770|FG008|Overall Study|Withdrawal by Subject|0|||
38009344|NCT03572062|69691771|FG009|Overall Study|Withdrawal by Subject|1|||
38009345|NCT03572062|69691762|FG000|Overall Study|Randomized But Not Treated|0|||
38009346|NCT03572062|69691763|FG001|Overall Study|Randomized But Not Treated|0|||
38009347|NCT03572062|69691764|FG002|Overall Study|Randomized But Not Treated|0|||
38009348|NCT03572062|69691765|FG003|Overall Study|Randomized But Not Treated|0|||
38009349|NCT03572062|69691766|FG004|Overall Study|Randomized But Not Treated|1|||
38009350|NCT03572062|69691767|FG005|Overall Study|Randomized But Not Treated|2|||
38009351|NCT03572062|69691768|FG006|Overall Study|Randomized But Not Treated|0|||
37697832|NCT01822756|69174460|FG003|Overall Study|Death|0|||
37831590|NCT04677179|69515038|FG003|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
37831591|NCT04677179|69515039|FG004|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
37831592|NCT04677179|69515040|FG005|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
37831593|NCT04677179|69515041|FG006|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
37831594|NCT04677179|69515042|FG007|Post-Treatment Follow-up Period|Study terminated by sponsor|18|||
37831595|NCT04677179|69515043|FG008|Post-Treatment Follow-up Period|Study terminated by sponsor|26|||
37831596|NCT04677179|69515044|FG009|Post-Treatment Follow-up Period|Study terminated by sponsor|11|||
37831597|NCT04590937|69515061|FG000|Period 2 - BI 730357+Cocktail|COVID-19 related|1|||
37908715|NCT00607087|69594333|FG002|Period 3|Adverse Event|0|||
38009352|NCT03572062|69691769|FG007|Overall Study|Randomized But Not Treated|1|||
38009353|NCT03572062|69691770|FG008|Overall Study|Randomized But Not Treated|0|||
38009354|NCT03572062|69691771|FG009|Overall Study|Randomized But Not Treated|0|||
38009355|NCT03571516|69691793|FG000|Overall Study|Severe diarrhea|1|||
38009356|NCT03571516|69691794|FG001|Overall Study|Severe diarrhea|0|||
38009357|NCT03571516|69691793|FG000|Overall Study|Withdrawal by Subject|0|||
38009358|NCT03571516|69691794|FG001|Overall Study|Withdrawal by Subject|1|||
38009359|NCT03600376|69691802|FG000|Overall Study|Adverse Event|1|||
38009360|NCT03600376|69691803|FG001|Overall Study|Adverse Event|1|||
38009361|NCT03600376|69691802|FG000|Overall Study|Transferred to other facility|1|||
38009362|NCT03600376|69691803|FG001|Overall Study|Transferred to other facility|0|||
38009363|NCT03600376|69691802|FG000|Overall Study|Investigator Decision|0|||
37908716|NCT00610363|69594343|FG000|Overall Study|Non-compliance with protocol|0|||
37908717|NCT00610363|69594344|FG001|Overall Study|Non-compliance with protocol|1|||
37908718|NCT00610363|69594343|FG000|Overall Study|Adverse Event|3|||
37908719|NCT00610363|69594344|FG001|Overall Study|Adverse Event|1|||
37908720|NCT00610363|69594343|FG000|Overall Study|Lack of Efficacy|2|||
37908721|NCT00610363|69594344|FG001|Overall Study|Lack of Efficacy|0|||
37908722|NCT00610363|69594343|FG000|Overall Study|Lost to Follow-up|4|||
37908723|NCT00610363|69594344|FG001|Overall Study|Lost to Follow-up|0|||
37908724|NCT00610363|69594343|FG000|Overall Study|Withdrawal by Subject|1|||
37908725|NCT00610363|69594344|FG001|Overall Study|Withdrawal by Subject|0|||
37908726|NCT00610363|69594343|FG000|Overall Study|Other than specified above|1|||
37908727|NCT00610363|69594344|FG001|Overall Study|Other than specified above|1|||
37908728|NCT00887588|69594353|FG000|Core Period|Death|1|||
37908729|NCT00887588|69594354|FG001|Core Period|Death|1|||
37908730|NCT00887588|69594353|FG000|Core Period|Lost to Follow-up|3|||
37908731|NCT00887588|69594354|FG001|Core Period|Lost to Follow-up|1|||
37908732|NCT00887588|69594353|FG000|Core Period|Withdrawal by Subject|6|||
37908733|NCT00887588|69594354|FG001|Core Period|Withdrawal by Subject|8|||
37908734|NCT00887588|69594353|FG000|Core Period|Adverse Event|9|||
37908735|NCT00887588|69594354|FG001|Core Period|Adverse Event|11|||
37908736|NCT00887588|69594353|FG000|Extension Period|Adverse Event|4|||
37908737|NCT00887588|69594354|FG001|Extension Period|Adverse Event|4|||
37908738|NCT00887588|69594353|FG000|Extension Period|Death|0|||
37908739|NCT00887588|69594354|FG001|Extension Period|Death|1|||
37908740|NCT00887588|69594353|FG000|Extension Period|Protocol deviation|1|||
37908741|NCT00887588|69594354|FG001|Extension Period|Protocol deviation|0|||
37908742|NCT00887588|69594353|FG000|Extension Period|Lost to Follow-up|1|||
37908743|NCT00887588|69594354|FG001|Extension Period|Lost to Follow-up|0|||
37908744|NCT00945893|69594362|FG000|Overall Study|Lost to Follow-up|2|||
37908745|NCT00945893|69594363|FG001|Overall Study|Lost to Follow-up|8|||
38009364|NCT03600376|69691803|FG001|Overall Study|Investigator Decision|4|||
38009365|NCT03600376|69691802|FG000|Overall Study|Determined to be ineligible for study|0|||
38009366|NCT03600376|69691803|FG001|Overall Study|Determined to be ineligible for study|1|||
38009367|NCT03599362|69691809|FG000|Overall Study|Screen Failure|3|||
38009368|NCT03598036|69691815|FG000|Overall Study|Withdrawal by Subject|1|||
38009369|NCT03598036|69691816|FG001|Overall Study|Withdrawal by Subject|0|||
38009370|NCT00082407|69691826|FG000|Overall Study|Adverse Event|20|||
38009371|NCT00082407|69691827|FG001|Overall Study|Adverse Event|0|||
38009372|NCT00082407|69691826|FG000|Overall Study|Protocol Violation|14|||
38009373|NCT00082407|69691827|FG001|Overall Study|Protocol Violation|12|||
38009374|NCT00082407|69691826|FG000|Overall Study|Patient Decision|13|||
38009375|NCT00082407|69691827|FG001|Overall Study|Patient Decision|6|||
38009376|NCT00082407|69691826|FG000|Overall Study|Physician Decision|5|||
38009377|NCT00082407|69691827|FG001|Overall Study|Physician Decision|3|||
38009378|NCT00082407|69691826|FG000|Overall Study|Loss of Glucose Control|2|||
38009379|NCT00082407|69691827|FG001|Overall Study|Loss of Glucose Control|2|||
38009380|NCT00082407|69691826|FG000|Overall Study|Death|2|||
38009381|NCT00082407|69691827|FG001|Overall Study|Death|1|||
38009382|NCT00082407|69691826|FG000|Overall Study|Lost to Follow-up|0|||
38009383|NCT00082407|69691827|FG001|Overall Study|Lost to Follow-up|3|||
38009384|NCT03643432|69691835|FG000|Overall Study|Lost to Follow-up|1|||
38009385|NCT03643432|69691836|FG001|Overall Study|Lost to Follow-up|0|||
38009386|NCT03810183|69691844|FG000|Overall Study|Study terminated by Sponsor|2|||
37697833|NCT01822756|69174461|FG004|Overall Study|Death|0|||
37697834|NCT01822756|69174457|FG000|Overall Study|Lost to Follow-up|1|||
37697835|NCT01822756|69174458|FG001|Overall Study|Lost to Follow-up|0|||
37697836|NCT01822756|69174459|FG002|Overall Study|Lost to Follow-up|1|||
37697837|NCT01822756|69174460|FG003|Overall Study|Lost to Follow-up|0|||
37697838|NCT01822756|69174461|FG004|Overall Study|Lost to Follow-up|1|||
37697839|NCT01822756|69174457|FG000|Overall Study|Physician Decision|0|||
37697840|NCT01822756|69174458|FG001|Overall Study|Physician Decision|1|||
37697841|NCT01822756|69174459|FG002|Overall Study|Physician Decision|0|||
37697842|NCT01822756|69174460|FG003|Overall Study|Physician Decision|0|||
37697843|NCT01822756|69174461|FG004|Overall Study|Physician Decision|0|||
37908746|NCT00945893|69594362|FG000|Overall Study|Withdrawal of consent|1|||
37908747|NCT00945893|69594363|FG001|Overall Study|Withdrawal of consent|2|||
37908748|NCT00799383|69594375|FG000|Overall Study|Protocol Violation|1|||
37908749|NCT00799383|69594376|FG001|Overall Study|Protocol Violation|1|||
38009387|NCT03810183|69691845|FG001|Overall Study|Study terminated by Sponsor|1|||
38009388|NCT03597022|69691855|FG000|Overall Study|Premature termination of the study|7|||
38009389|NCT03597022|69691856|FG001|Overall Study|Premature termination of the study|7|||
38009390|NCT03597022|69691857|FG002|Overall Study|Premature termination of the study|8|||
38009391|NCT03597022|69691855|FG000|Overall Study|Serious adverse event|1|||
37697844|NCT01822756|69174457|FG000|Overall Study|disease progression & patient preference|2|||
37697845|NCT01822756|69174458|FG001|Overall Study|disease progression & patient preference|0|||
37908750|NCT00799383|69594375|FG000|Overall Study|Adverse Event|0|||
37908751|NCT00799383|69594376|FG001|Overall Study|Adverse Event|1|||
37908752|NCT00799383|69594375|FG000|Overall Study|Lost to Follow-up|1|||
38009392|NCT03597022|69691856|FG001|Overall Study|Serious adverse event|1|||
37697846|NCT01822756|69174459|FG002|Overall Study|disease progression & patient preference|1|||
37697847|NCT01822756|69174460|FG003|Overall Study|disease progression & patient preference|0|||
37697848|NCT01822756|69174461|FG004|Overall Study|disease progression & patient preference|0|||
37697849|NCT01822678|69174476|FG000|Overall Study|Withdrawal by Subject|5|||
37697850|NCT01822678|69174477|FG001|Overall Study|Withdrawal by Subject|4|||
37697851|NCT01822678|69174478|FG002|Overall Study|Withdrawal by Subject|4|||
37697852|NCT01822678|69174476|FG000|Overall Study|Adverse Event|4|||
37697853|NCT01822678|69174477|FG001|Overall Study|Adverse Event|3|||
37697854|NCT01822678|69174478|FG002|Overall Study|Adverse Event|1|||
37697855|NCT01822678|69174476|FG000|Overall Study|Lack of Efficacy|3|||
37697856|NCT01822678|69174477|FG001|Overall Study|Lack of Efficacy|6|||
37697857|NCT01822678|69174478|FG002|Overall Study|Lack of Efficacy|5|||
37697858|NCT01822678|69174476|FG000|Overall Study|Lost to Follow-up|0|||
37697859|NCT01822678|69174477|FG001|Overall Study|Lost to Follow-up|2|||
37697860|NCT01822678|69174478|FG002|Overall Study|Lost to Follow-up|1|||
37697861|NCT01822366|69174490|FG000|Overall Study|Lost to Follow-up|5|||
37697862|NCT01822366|69174491|FG001|Overall Study|Lost to Follow-up|1|||
37697863|NCT01822366|69174492|FG002|Overall Study|Lost to Follow-up|5|||
37697864|NCT01822366|69174493|FG003|Overall Study|Lost to Follow-up|1|||
37697865|NCT01822366|69174490|FG000|Overall Study|Withdrawal by Subject|0|||
37697866|NCT01822366|69174491|FG001|Overall Study|Withdrawal by Subject|6|||
37697867|NCT01822366|69174492|FG002|Overall Study|Withdrawal by Subject|0|||
37697868|NCT01822366|69174493|FG003|Overall Study|Withdrawal by Subject|6|||
37697869|NCT01822366|69174490|FG000|Overall Study|Partial Intervention Completion|0|||
37697870|NCT01822366|69174491|FG001|Overall Study|Partial Intervention Completion|15|||
37831598|NCT04576897|69515075|FG000|Overall Study|37 scans were determined by the sponsor to be invalid.|37|||
37831599|NCT04166435|69515107|FG000|Overall Study|2 patients ineligible for response|2|||
38009393|NCT03597022|69691857|FG002|Overall Study|Serious adverse event|0|||
38009394|NCT03571204|69691868|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
38009395|NCT03571204|69691869|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
38009396|NCT03571204|69691870|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
38009397|NCT03571204|69691868|FG000|Overall Study|Physician Decision|0|||
38009398|NCT03571204|69691869|FG001|Overall Study|Physician Decision|1|||
38009399|NCT03571204|69691870|FG002|Overall Study|Physician Decision|0|||
38009400|NCT03569098|69691882|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
38009401|NCT03569098|69691883|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
38009402|NCT03569098|69691884|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
38009403|NCT03569098|69691882|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
38009404|NCT03569098|69691883|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
38009405|NCT03569098|69691884|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
38009406|NCT03569098|69691882|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
38009407|NCT03569098|69691883|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
38009408|NCT03569098|69691884|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
38009409|NCT03569098|69691882|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
38009410|NCT03569098|69691883|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
38009411|NCT03569098|69691884|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
38009412|NCT03569098|69691882|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
38009413|NCT03569098|69691883|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
38009414|NCT03569098|69691884|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
38009415|NCT03569098|69691882|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
38009416|NCT03569098|69691883|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
38009417|NCT03569098|69691884|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
38009418|NCT03569098|69691882|FG000|Double-Blind Treatment Cycle 1|Other|1|||
38009419|NCT03569098|69691883|FG001|Double-Blind Treatment Cycle 1|Other|0|||
38009420|NCT03569098|69691884|FG002|Double-Blind Treatment Cycle 1|Other|1|||
38009421|NCT03569098|69691882|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
38009422|NCT03569098|69691883|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
38009423|NCT03569098|69691884|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
38009424|NCT03569098|69691882|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
38009425|NCT03569098|69691883|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
38009426|NCT03569098|69691884|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
38009427|NCT03569098|69691882|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
38009428|NCT03569098|69691883|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
38009429|NCT03569098|69691884|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
38009430|NCT03569098|69691882|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
38009431|NCT03569098|69691883|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
38009432|NCT03569098|69691884|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
38009433|NCT03569098|69691882|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
38009434|NCT03569098|69691883|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
38009435|NCT03569098|69691884|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
37697871|NCT01822366|69174492|FG002|Overall Study|Partial Intervention Completion|0|||
38009436|NCT03569098|69691882|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
38009437|NCT03569098|69691883|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
38009438|NCT03569098|69691884|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
38009439|NCT03568942|69691895|FG000|Overall Study|Family emergency|1|||
37908753|NCT00799383|69594376|FG001|Overall Study|Lost to Follow-up|2|||
37908754|NCT00799383|69594375|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
37908755|NCT00799383|69594376|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
37908756|NCT00799383|69594375|FG000|Overall Study|Withdrawal by Subject|0|||
37908757|NCT00799383|69594376|FG001|Overall Study|Withdrawal by Subject|1|||
37908758|NCT00610207|69594382|FG000|Overall Study|Lost to Follow-up|3|||
37908759|NCT00798759|69594388|FG000|Overall Study|Adverse Event|3|||
37908760|NCT00798759|69594389|FG001|Overall Study|Adverse Event|3|||
37908761|NCT00798759|69594388|FG000|Overall Study|Lost to Follow-up|1|||
37908762|NCT00798759|69594389|FG001|Overall Study|Lost to Follow-up|1|||
37908763|NCT00798759|69594388|FG000|Overall Study|Protocol Violation|4|||
37908764|NCT00798759|69594389|FG001|Overall Study|Protocol Violation|8|||
37908765|NCT00798759|69594388|FG000|Overall Study|Other|0|||
37908766|NCT00798759|69594389|FG001|Overall Study|Other|1|||
37908767|NCT00887432|69594397|FG000|Overall Study|Start Excluded Therapy|3|||
37908768|NCT00887432|69594398|FG001|Overall Study|Start Excluded Therapy|0|||
37908769|NCT00887432|69594397|FG000|Overall Study|Did not complete treatment|6|||
37908770|NCT00887432|69594398|FG001|Overall Study|Did not complete treatment|8|||
37908771|NCT00887432|69594397|FG000|Overall Study|Protocol Violation|2|||
37908772|NCT00887432|69594398|FG001|Overall Study|Protocol Violation|3|||
37908773|NCT00887432|69594397|FG000|Overall Study|Withdrawal by Subject|3|||
37908774|NCT00887432|69594398|FG001|Overall Study|Withdrawal by Subject|2|||
37908775|NCT00887432|69594397|FG000|Overall Study|Lost to Follow-up|1|||
37908776|NCT00887432|69594398|FG001|Overall Study|Lost to Follow-up|0|||
37908777|NCT00887432|69594397|FG000|Overall Study|No reason provided|0|||
37908778|NCT00887432|69594398|FG001|Overall Study|No reason provided|1|||
37908779|NCT00951275|69594404|FG000|Overall Study|Administrative Reason|1|||
37908780|NCT00951275|69594404|FG000|Overall Study|Adverse Event|7|||
37908781|NCT00951275|69594404|FG000|Overall Study|Withdrawal by Subject|4|||
37908782|NCT00951275|69594404|FG000|Overall Study|Protocol Violation|1|||
37908783|NCT00798603|69594408|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
38009440|NCT03568942|69691895|FG000|Overall Study|Lost to Follow-up|1|||
38009441|NCT00110019|69691901|FG000|Overall Study|Lack of Efficacy|253|||
38009442|NCT00110019|69691902|FG001|Overall Study|Lack of Efficacy|285|||
38009443|NCT00110019|69691901|FG000|Overall Study|Adverse Event|61|||
38009444|NCT00110019|69691902|FG001|Overall Study|Adverse Event|40|||
38009445|NCT00110019|69691901|FG000|Overall Study|Death|13|||
38009446|NCT00110019|69691902|FG001|Overall Study|Death|15|||
38009447|NCT00110019|69691901|FG000|Overall Study|Withdrawal by Subject|21|||
38009448|NCT00110019|69691902|FG001|Overall Study|Withdrawal by Subject|9|||
38009449|NCT00110019|69691901|FG000|Overall Study|alternative therapy|5|||
38009450|NCT00110019|69691902|FG001|Overall Study|alternative therapy|1|||
38009451|NCT00110019|69691901|FG000|Overall Study|complicating disease|1|||
38009452|NCT00110019|69691902|FG001|Overall Study|complicating disease|1|||
38009453|NCT00110019|69691901|FG000|Overall Study|symptom deterioration|13|||
38009454|NCT00110019|69691902|FG001|Overall Study|symptom deterioration|16|||
38009455|NCT00110019|69691901|FG000|Overall Study|Not start protocol therapy|17|||
38009456|NCT00110019|69691902|FG001|Overall Study|Not start protocol therapy|16|||
38009457|NCT00110019|69691901|FG000|Overall Study|other reasons|22|||
38009458|NCT00110019|69691902|FG001|Overall Study|other reasons|30|||
38009459|NCT03595618|69691912|FG000|Overall Study|Adverse Event|16|||
38009460|NCT03595618|69691913|FG001|Overall Study|Adverse Event|17|||
38009461|NCT03595618|69691914|FG002|Overall Study|Adverse Event|20|||
38009462|NCT03595618|69691915|FG003|Overall Study|Adverse Event|8|||
38009463|NCT03595618|69691912|FG000|Overall Study|Withdrawal by Subject|12|||
38009464|NCT03595618|69691913|FG001|Overall Study|Withdrawal by Subject|14|||
38009465|NCT03595618|69691914|FG002|Overall Study|Withdrawal by Subject|14|||
38009466|NCT03595618|69691915|FG003|Overall Study|Withdrawal by Subject|10|||
38009467|NCT03595618|69691912|FG000|Overall Study|Lost to Follow-up|6|||
38009468|NCT03595618|69691913|FG001|Overall Study|Lost to Follow-up|4|||
38009469|NCT03595618|69691914|FG002|Overall Study|Lost to Follow-up|5|||
37908784|NCT00798603|69594408|FG000|Overall Study|Withdrawal by Subject|10|||
37908785|NCT00798603|69594408|FG000|Overall Study|Adverse Event|22|||
37908786|NCT00798603|69594408|FG000|Overall Study|Physician Decision|1|||
38009470|NCT03595618|69691915|FG003|Overall Study|Lost to Follow-up|6|||
38009471|NCT03595618|69691912|FG000|Overall Study|Protocol Violation|2|||
38009472|NCT03595618|69691913|FG001|Overall Study|Protocol Violation|0|||
38009473|NCT03595618|69691914|FG002|Overall Study|Protocol Violation|6|||
37908787|NCT00798603|69594408|FG000|Overall Study|Lack of insurance coverage|1|||
37908788|NCT00887354|69594414|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
37908789|NCT00887354|69594415|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
38009474|NCT03595618|69691915|FG003|Overall Study|Protocol Violation|2|||
38009475|NCT03595618|69691912|FG000|Overall Study|Physician Decision|0|||
38009476|NCT03595618|69691913|FG001|Overall Study|Physician Decision|0|||
38009477|NCT03595618|69691914|FG002|Overall Study|Physician Decision|1|||
38009478|NCT03595618|69691915|FG003|Overall Study|Physician Decision|2|||
38009479|NCT03595618|69691912|FG000|Overall Study|Miscellaneous|7|||
38009480|NCT03595618|69691913|FG001|Overall Study|Miscellaneous|5|||
38009481|NCT03595618|69691914|FG002|Overall Study|Miscellaneous|10|||
38009482|NCT03595618|69691915|FG003|Overall Study|Miscellaneous|6|||
38009483|NCT02954848|69691927|FG000|Overall Study|Randomized but Not Treated|0|||
38009484|NCT02954848|69691928|FG001|Overall Study|Randomized but Not Treated|1|||
38009485|NCT02954848|69691927|FG000|Overall Study|Adverse Event|2|||
38009486|NCT02954848|69691928|FG001|Overall Study|Adverse Event|3|||
38009487|NCT02954848|69691927|FG000|Overall Study|Withdrawal by Participant|0|||
38009488|NCT02954848|69691928|FG001|Overall Study|Withdrawal by Participant|1|||
38009489|NCT03642262|69691934|FG000|Period 1|Withdrawal by Subject|1|||
38009490|NCT03642262|69691935|FG001|Period 1|Withdrawal by Subject|1|||
38009491|NCT03642262|69691934|FG000|Period 1|Adverse Event|0|||
38009492|NCT03642262|69691935|FG001|Period 1|Adverse Event|1|||
38009493|NCT00109707|69691945|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
38009494|NCT00109707|69691946|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
38009495|NCT00109707|69691947|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
38009496|NCT00109707|69691945|FG000|Overall Study|Abnormal laboratory values|1|||
38009497|NCT00109707|69691946|FG001|Overall Study|Abnormal laboratory values|0|||
38009498|NCT00109707|69691947|FG002|Overall Study|Abnormal laboratory values|0|||
38009499|NCT00109707|69691945|FG000|Overall Study|Administrative problems|2|||
38009500|NCT00109707|69691946|FG001|Overall Study|Administrative problems|0|||
38009501|NCT00109707|69691947|FG002|Overall Study|Administrative problems|1|||
38009502|NCT00109707|69691945|FG000|Overall Study|Adverse Event|10|||
38009503|NCT00109707|69691946|FG001|Overall Study|Adverse Event|2|||
38009504|NCT00109707|69691947|FG002|Overall Study|Adverse Event|3|||
38009505|NCT00109707|69691945|FG000|Overall Study|Death|4|||
38009506|NCT00109707|69691946|FG001|Overall Study|Death|0|||
38009507|NCT00109707|69691947|FG002|Overall Study|Death|0|||
38009508|NCT00109707|69691945|FG000|Overall Study|Disease progression|12|||
38009509|NCT00109707|69691946|FG001|Overall Study|Disease progression|4|||
38009510|NCT00109707|69691947|FG002|Overall Study|Disease progression|3|||
38009511|NCT00109707|69691945|FG000|Overall Study|Lost to Follow-up|3|||
38009512|NCT00109707|69691946|FG001|Overall Study|Lost to Follow-up|0|||
38009513|NCT00109707|69691947|FG002|Overall Study|Lost to Follow-up|0|||
38009514|NCT00109707|69691945|FG000|Overall Study|Protocol Violation|1|||
38009515|NCT00109707|69691946|FG001|Overall Study|Protocol Violation|0|||
38009516|NCT00109707|69691947|FG002|Overall Study|Protocol Violation|0|||
38009517|NCT00109707|69691945|FG000|Overall Study|Patient withdrew consent|6|||
38009518|NCT00109707|69691946|FG001|Overall Study|Patient withdrew consent|1|||
38009519|NCT00109707|69691947|FG002|Overall Study|Patient withdrew consent|0|||
38009520|NCT00095979|69691959|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
38009521|NCT00082173|69691970|FG000|Overall Study|Withdrawal by Subject|3|||
38009522|NCT00082173|69691971|FG001|Overall Study|Withdrawal by Subject|5|||
38009523|NCT00082173|69691970|FG000|Overall Study|Lost to Follow-up|1|||
38009524|NCT00082173|69691971|FG001|Overall Study|Lost to Follow-up|0|||
38009525|NCT00082173|69691970|FG000|Overall Study|Adverse Event|1|||
38009526|NCT00082173|69691971|FG001|Overall Study|Adverse Event|0|||
38009527|NCT00082173|69691970|FG000|Overall Study|Culture negative or resistant at baselin|5|||
38009528|NCT00082173|69691971|FG001|Overall Study|Culture negative or resistant at baselin|6|||
38009529|NCT00108069|69691979|FG000|Overall Study|Never rec'd study drug|0|||
38009530|NCT00108069|69691980|FG001|Overall Study|Never rec'd study drug|1|||
38009531|NCT00108069|69691979|FG000|Overall Study|Adverse Event|1|||
38009532|NCT00108069|69691980|FG001|Overall Study|Adverse Event|1|||
38009533|NCT00108069|69691979|FG000|Overall Study|Withdrawal by Subject|1|||
38009534|NCT00108069|69691980|FG001|Overall Study|Withdrawal by Subject|0|||
38009535|NCT00108069|69691979|FG000|Overall Study|Death|1|||
38009536|NCT00108069|69691980|FG001|Overall Study|Death|0|||
38009537|NCT00108069|69691979|FG000|Overall Study|Progessive disease|27|||
38009538|NCT00108069|69691980|FG001|Overall Study|Progessive disease|11|||
38009539|NCT00079274|69691999|FG000|Overall Study|Withdrawal by Subject|111|||
38009540|NCT00079274|69692000|FG001|Overall Study|Withdrawal by Subject|10|||
38009541|NCT00079274|69692001|FG002|Overall Study|Withdrawal by Subject|12|||
38009542|NCT00079274|69692002|FG003|Overall Study|Withdrawal by Subject|163|||
38009543|NCT00079274|69692003|FG004|Overall Study|Withdrawal by Subject|7|||
38009544|NCT00079274|69692004|FG005|Overall Study|Withdrawal by Subject|8|||
38009545|NCT00079274|69692005|FG006|Overall Study|Withdrawal by Subject|0|||
38009546|NCT00079274|69691999|FG000|Overall Study|Adverse Event|130|||
38009547|NCT00079274|69692000|FG001|Overall Study|Adverse Event|8|||
38009548|NCT00079274|69692001|FG002|Overall Study|Adverse Event|8|||
38009549|NCT00079274|69692002|FG003|Overall Study|Adverse Event|184|||
38009550|NCT00079274|69692003|FG004|Overall Study|Adverse Event|7|||
38009551|NCT00079274|69692004|FG005|Overall Study|Adverse Event|8|||
38009552|NCT00079274|69692005|FG006|Overall Study|Adverse Event|0|||
38009553|NCT00079274|69691999|FG000|Overall Study|Recurrence|21|||
37697872|NCT01822366|69174493|FG003|Overall Study|Partial Intervention Completion|15|||
37697873|NCT01838590|69174525|FG000|Overall Study|Lack of Efficacy|12|||
37697874|NCT01838590|69174526|FG001|Overall Study|Lack of Efficacy|4|||
37697875|NCT01838590|69174525|FG000|Overall Study|Lost to Follow-up|0|||
37697876|NCT01838590|69174526|FG001|Overall Study|Lost to Follow-up|1|||
37697877|NCT01611454|69174538|FG000|Overall Study|Lack of Efficacy|18|||
37697878|NCT01611454|69174539|FG001|Overall Study|Lack of Efficacy|10|||
37697879|NCT01611298|69174549|FG000|Overall Study|Relapsed|2|||
37697880|NCT01822132|69174555|FG000|Overall Study|Lost to Follow-up|4|||
37697881|NCT01822132|69174556|FG001|Overall Study|Lost to Follow-up|2|||
37697882|NCT01821898|69174570|FG000|Overall Study|Withdrawal by Subject|2|||
37908790|NCT00887354|69594414|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
37908791|NCT00887354|69594415|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
37908792|NCT00887354|69594414|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
37908793|NCT00887354|69594415|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
37908794|NCT00887354|69594414|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
37908795|NCT00887354|69594415|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
37908796|NCT00887354|69594414|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
37908797|NCT00887354|69594415|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
37908798|NCT00887354|69594414|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
37908799|NCT00887354|69594415|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
37908800|NCT00887354|69594414|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
37908801|NCT00887354|69594415|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
37908802|NCT00887354|69594414|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
37908803|NCT00887354|69594415|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
37908804|NCT00887354|69594414|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
38009554|NCT00079274|69692000|FG001|Overall Study|Recurrence|0|||
37697883|NCT01821898|69174571|FG001|Overall Study|Withdrawal by Subject|1|||
37697884|NCT02411591|69174581|FG000|Overall Study|Adverse Event|0|||
38009555|NCT00079274|69692001|FG002|Overall Study|Recurrence|1|||
38009556|NCT00079274|69692002|FG003|Overall Study|Recurrence|15|||
38009557|NCT00079274|69692003|FG004|Overall Study|Recurrence|0|||
38009558|NCT00079274|69692004|FG005|Overall Study|Recurrence|2|||
38009559|NCT00079274|69692005|FG006|Overall Study|Recurrence|0|||
38009560|NCT00079274|69691999|FG000|Overall Study|Alternate Treatment|6|||
38009561|NCT00079274|69692000|FG001|Overall Study|Alternate Treatment|1|||
38009562|NCT00079274|69692001|FG002|Overall Study|Alternate Treatment|0|||
38009563|NCT00079274|69692002|FG003|Overall Study|Alternate Treatment|3|||
37697885|NCT02411591|69174582|FG001|Overall Study|Adverse Event|4|||
37697886|NCT02411591|69174583|FG002|Overall Study|Adverse Event|2|||
37697887|NCT02411591|69174581|FG000|Overall Study|Withdrawal by Subject|0|||
37697888|NCT02411591|69174582|FG001|Overall Study|Withdrawal by Subject|3|||
37697889|NCT02411591|69174583|FG002|Overall Study|Withdrawal by Subject|0|||
37697890|NCT02411591|69174581|FG000|Overall Study|Physician Decision|0|||
37697891|NCT02411591|69174582|FG001|Overall Study|Physician Decision|3|||
37697892|NCT02411591|69174583|FG002|Overall Study|Physician Decision|1|||
37697893|NCT02454959|69174599|FG000|Overall Study|Protocol-Specified Criteria|3|||
37697894|NCT02454959|69174599|FG000|Overall Study|Physician Decision|1|||
37697895|NCT02454959|69174599|FG000|Overall Study|Withdrawal by Subject|3|||
37697896|NCT02454959|69174599|FG000|Overall Study|Adverse Event|2|||
37697897|NCT01821118|69174607|FG000|Overall Study|Death|0|||
38009564|NCT00079274|69692003|FG004|Overall Study|Alternate Treatment|0|||
38009565|NCT00079274|69692004|FG005|Overall Study|Alternate Treatment|0|||
37697898|NCT01821118|69174608|FG001|Overall Study|Death|1|||
37697899|NCT01650779|69174614|FG000|Overall Study|Withdrawal by Subject|1|||
37697900|NCT02411201|69174618|FG000|Overall Study|Adverse Event|2|||
37697901|NCT02411201|69174618|FG000|Overall Study|Withdrawal by Subject|2|||
37697902|NCT02411201|69174618|FG000|Overall Study|Age group completed|2|||
37697903|NCT01838044|69174626|FG000|Overall Study|Adverse Event|4|||
37697904|NCT01838044|69174627|FG001|Overall Study|Adverse Event|6|||
37697905|NCT01838044|69174626|FG000|Overall Study|Protocol Violation|3|||
38009566|NCT00079274|69692005|FG006|Overall Study|Alternate Treatment|0|||
38009567|NCT00079274|69691999|FG000|Overall Study|Other Medical Problems|6|||
38009568|NCT00079274|69692000|FG001|Overall Study|Other Medical Problems|1|||
37697906|NCT01838044|69174627|FG001|Overall Study|Protocol Violation|3|||
37697907|NCT01838044|69174626|FG000|Overall Study|Withdrawal by Subject|0|||
38009569|NCT00079274|69692001|FG002|Overall Study|Other Medical Problems|0|||
38009570|NCT00079274|69692002|FG003|Overall Study|Other Medical Problems|7|||
38009571|NCT00079274|69692003|FG004|Overall Study|Other Medical Problems|0|||
38009572|NCT00079274|69692004|FG005|Overall Study|Other Medical Problems|0|||
37697908|NCT01838044|69174627|FG001|Overall Study|Withdrawal by Subject|2|||
37697909|NCT01838044|69174626|FG000|Overall Study|Insufficient clinical response|1|||
38009573|NCT00079274|69692005|FG006|Overall Study|Other Medical Problems|0|||
38009574|NCT00079274|69691999|FG000|Overall Study|Death|4|||
38009575|NCT00079274|69692000|FG001|Overall Study|Death|0|||
38009576|NCT00079274|69692001|FG002|Overall Study|Death|1|||
38009577|NCT00079274|69692002|FG003|Overall Study|Death|15|||
38009578|NCT00079274|69692003|FG004|Overall Study|Death|0|||
38009579|NCT00079274|69692004|FG005|Overall Study|Death|0|||
38009580|NCT00079274|69692005|FG006|Overall Study|Death|0|||
38009581|NCT00079274|69691999|FG000|Overall Study|Cytogenetic resistance|0|||
38009582|NCT00079274|69692000|FG001|Overall Study|Cytogenetic resistance|0|||
38009583|NCT00079274|69692001|FG002|Overall Study|Cytogenetic resistance|0|||
38009584|NCT00079274|69692002|FG003|Overall Study|Cytogenetic resistance|2|||
38009585|NCT00079274|69692003|FG004|Overall Study|Cytogenetic resistance|0|||
37908805|NCT00887354|69594415|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
37908806|NCT00887354|69594414|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
37908807|NCT00887354|69594415|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
37908808|NCT00887354|69594414|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
37908809|NCT00887354|69594415|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
37908810|NCT00887354|69594414|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
38009586|NCT00079274|69692004|FG005|Overall Study|Cytogenetic resistance|0|||
38009587|NCT00079274|69692005|FG006|Overall Study|Cytogenetic resistance|0|||
38009588|NCT00079274|69691999|FG000|Overall Study|Other|43|||
37697910|NCT01838044|69174627|FG001|Overall Study|Insufficient clinical response|2|||
37908811|NCT00887354|69594415|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
37908812|NCT00887354|69594414|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
37908813|NCT00887354|69594415|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
37908814|NCT00887354|69594414|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
37908815|NCT00887354|69594415|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
37908816|NCT00887354|69594414|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
37908817|NCT00887354|69594415|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
37908818|NCT00951041|69594424|FG000|Overall Study|Withdrawal by Subject|1|||
37908819|NCT00951041|69594425|FG001|Overall Study|Withdrawal by Subject|1|||
37908820|NCT00951041|69594424|FG000|Overall Study|Lost to Follow-up|1|||
37908821|NCT00951041|69594425|FG001|Overall Study|Lost to Follow-up|0|||
37908822|NCT00951041|69594424|FG000|Overall Study|Other|3|||
37908823|NCT00951041|69594425|FG001|Overall Study|Other|0|||
37908824|NCT02763462|69594432|FG000|Overall Study|Protocol Violation|6|||
37908825|NCT00610129|69594446|FG000|Overall Study|Not treated since patients ineligible|3|||
37908826|NCT00945815|69594450|FG000|Overall Study|Death|3|||
37908827|NCT00945815|69594450|FG000|Overall Study|Not protocol specified|1|||
37908828|NCT00945815|69594450|FG000|Overall Study|Ineligible|3|||
38009589|NCT00079274|69692000|FG001|Overall Study|Other|7|||
38009590|NCT00079274|69692001|FG002|Overall Study|Other|5|||
38009591|NCT00079274|69692002|FG003|Overall Study|Other|55|||
37697911|NCT01838044|69174626|FG000|Overall Study|Medication error without associated AE|0|||
37697912|NCT01838044|69174627|FG001|Overall Study|Medication error without associated AE|1|||
37697913|NCT01838044|69174626|FG000|Overall Study|Lost to Follow-up|0|||
37697914|NCT01838044|69174627|FG001|Overall Study|Lost to Follow-up|2|||
37697915|NCT02410811|69174638|FG000|Overall Study|Withdrawal by Subject|0|||
37831600|NCT04124965|69515113|FG000|Overall Study|Adverse event, non-fatal|3|||
38009592|NCT00079274|69692003|FG004|Overall Study|Other|1|||
38009593|NCT00079274|69692004|FG005|Overall Study|Other|2|||
37831601|NCT04124965|69515114|FG001|Overall Study|Adverse event, non-fatal|1|||
37831602|NCT04124965|69515113|FG000|Overall Study|Withdrawal by Subject|1|||
37831603|NCT04124965|69515114|FG001|Overall Study|Withdrawal by Subject|1|||
37831604|NCT04124965|69515113|FG000|Overall Study|Rolled Over To MG0007 Study|25|||
37831605|NCT04124965|69515114|FG001|Overall Study|Rolled Over To MG0007 Study|28|||
37831606|NCT04124965|69515113|FG000|Overall Study|Pregnancy|1|||
37831607|NCT04124965|69515114|FG001|Overall Study|Pregnancy|0|||
37831608|NCT04124965|69515113|FG000|Overall Study|Sponsor and participant decision|0|||
37831609|NCT04124965|69515114|FG001|Overall Study|Sponsor and participant decision|1|||
37831610|NCT04124965|69515113|FG000|Overall Study|Personal surgery|0|||
37831611|NCT04124965|69515114|FG001|Overall Study|Personal surgery|1|||
37831612|NCT04124965|69515113|FG000|Overall Study|Physician Decision|0|||
37831613|NCT04124965|69515114|FG001|Overall Study|Physician Decision|1|||
37831614|NCT04098068|69515120|FG000|Overall Study|Disease Progression|7|||
37831615|NCT04098068|69515120|FG000|Overall Study|Withdrawal by Subject|2|||
37831616|NCT04098068|69515120|FG000|Overall Study|New Cancer Diagnosis|1|||
37831617|NCT04021862|69515127|FG000|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
37831618|NCT04021862|69515128|FG001|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|1|||
37831619|NCT04021862|69515129|FG002|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
37908829|NCT00945815|69594450|FG000|Overall Study|Did not begin protocol therapy|1|||
38009594|NCT00079274|69692005|FG006|Overall Study|Other|0|||
38009595|NCT00079040|69692018|FG000|Overall Study|Withdrew before treatment|1|||
38009596|NCT00079040|69692018|FG000|Overall Study|Ineligible|1|||
37908830|NCT00606307|69594454|FG000|Overall Study|Adverse Event|2|||
38009597|NCT00078806|69692022|FG000|Part 1A|Adverse Event|2|||
38009598|NCT00078806|69692023|FG001|Part 1A|Adverse Event|0|||
38009599|NCT00078806|69692024|FG002|Part 1A|Adverse Event|0|||
38009600|NCT00078806|69692025|FG003|Part 1A|Adverse Event|0|||
38009601|NCT00078806|69692022|FG000|Part 1A|Lack of Efficacy|7|||
38009602|NCT00078806|69692023|FG001|Part 1A|Lack of Efficacy|0|||
38009603|NCT00078806|69692024|FG002|Part 1A|Lack of Efficacy|0|||
38009604|NCT00078806|69692025|FG003|Part 1A|Lack of Efficacy|0|||
38009605|NCT00078806|69692022|FG000|Part 1A|Other|1|||
38009606|NCT00078806|69692023|FG001|Part 1A|Other|0|||
38009607|NCT00078806|69692024|FG002|Part 1A|Other|0|||
38009608|NCT00078806|69692025|FG003|Part 1A|Other|0|||
38009609|NCT00078806|69692022|FG000|Part 1B|Adverse Event|1|||
38009610|NCT00078806|69692023|FG001|Part 1B|Adverse Event|0|||
38009611|NCT00078806|69692024|FG002|Part 1B|Adverse Event|0|||
38009612|NCT00078806|69692025|FG003|Part 1B|Adverse Event|0|||
38009613|NCT00078806|69692022|FG000|Part 1B|Lack of Efficacy|7|||
38009614|NCT00078806|69692023|FG001|Part 1B|Lack of Efficacy|0|||
38009615|NCT00078806|69692024|FG002|Part 1B|Lack of Efficacy|0|||
38009616|NCT00078806|69692025|FG003|Part 1B|Lack of Efficacy|0|||
38009617|NCT00078806|69692022|FG000|Part 2|Adverse Event|0|||
38009618|NCT00078806|69692023|FG001|Part 2|Adverse Event|1|||
38009619|NCT00078806|69692024|FG002|Part 2|Adverse Event|0|||
38009620|NCT00078806|69692025|FG003|Part 2|Adverse Event|0|||
38009621|NCT00078338|69692042|FG000|Overall Study|Adverse Event|31|||
38009622|NCT00078338|69692043|FG001|Overall Study|Adverse Event|24|||
38009623|NCT00078338|69692042|FG000|Overall Study|Lost to Follow-up|17|||
38009624|NCT00078338|69692043|FG001|Overall Study|Lost to Follow-up|2|||
38009625|NCT00078338|69692042|FG000|Overall Study|Protocol Violation|2|||
38009626|NCT00078338|69692043|FG001|Overall Study|Protocol Violation|2|||
38009627|NCT00078338|69692042|FG000|Overall Study|Disease Progression|4|||
38009628|NCT00078338|69692043|FG001|Overall Study|Disease Progression|7|||
38009629|NCT00078338|69692042|FG000|Overall Study|Other|28|||
38009630|NCT00078338|69692043|FG001|Overall Study|Other|16|||
38009631|NCT00078338|69692042|FG000|Overall Study|Subjects randomized, but not treated|3|||
38009632|NCT00078338|69692043|FG001|Overall Study|Subjects randomized, but not treated|3|||
38009633|NCT03808688|69692051|FG000|Overall Study|Adverse Event|13|||
38009634|NCT03808688|69692052|FG001|Overall Study|Adverse Event|17|||
38009635|NCT03808688|69692051|FG000|Overall Study|Lack of Efficacy|2|||
38009636|NCT03808688|69692052|FG001|Overall Study|Lack of Efficacy|0|||
38009637|NCT03808688|69692051|FG000|Overall Study|Lost to Follow-up|0|||
38009638|NCT03808688|69692052|FG001|Overall Study|Lost to Follow-up|2|||
38009639|NCT03808688|69692051|FG000|Overall Study|Withdrawal by Subject|1|||
38009640|NCT03808688|69692052|FG001|Overall Study|Withdrawal by Subject|0|||
38009641|NCT03808688|69692051|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
38009642|NCT03808688|69692052|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
38009643|NCT03808688|69692051|FG000|Overall Study|IOP Too High|1|||
38009644|NCT03808688|69692052|FG001|Overall Study|IOP Too High|1|||
38009645|NCT03808688|69692051|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
38009646|NCT03808688|69692052|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
38009647|NCT03808688|69692051|FG000|Overall Study|Visit Out of Window|0|||
38009648|NCT03808688|69692052|FG001|Overall Study|Visit Out of Window|1|||
38009649|NCT03808688|69692051|FG000|Overall Study|Medication Non-Compliance|0|||
38009650|NCT03808688|69692052|FG001|Overall Study|Medication Non-Compliance|1|||
38009651|NCT03808298|69692060|FG000|Overall Study|Adverse Event|3|||
38009652|NCT03808298|69692060|FG000|Overall Study|Physician Decision|1|||
38009653|NCT03808298|69692060|FG000|Overall Study|Withdrawal by Subject|1|||
38009654|NCT03808298|69692060|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
38009655|NCT00077636|69692091|FG000|Overall Study|Refused Treatment|9|||
38009656|NCT00077636|69692092|FG001|Overall Study|Refused Treatment|31|||
38009657|NCT00077636|69692091|FG000|Overall Study|Admin|3|||
38009658|NCT00077636|69692092|FG001|Overall Study|Admin|3|||
38009659|NCT00077636|69692091|FG000|Overall Study|Withdrawal by Subject|2|||
38009660|NCT00077636|69692092|FG001|Overall Study|Withdrawal by Subject|2|||
38009661|NCT00077636|69692091|FG000|Overall Study|Adverse Event|17|||
38009662|NCT00077636|69692092|FG001|Overall Study|Adverse Event|34|||
38009663|NCT00077636|69692091|FG000|Overall Study|Protocol Violation|0|||
38009664|NCT00077636|69692092|FG001|Overall Study|Protocol Violation|2|||
37831620|NCT04021862|69515130|FG003|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
37831621|NCT04021862|69515131|FG004|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
37831622|NCT04021862|69515132|FG005|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
37831623|NCT04021862|69515127|FG000|Placebo Controlled Period (Week 0-16)|Adverse Event|2|||
37831624|NCT04021862|69515128|FG001|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
37831625|NCT04021862|69515129|FG002|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
37831626|NCT04021862|69515130|FG003|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
38009665|NCT00077636|69692091|FG000|Overall Study|Lost to Follow-up|10|||
38009666|NCT00077636|69692092|FG001|Overall Study|Lost to Follow-up|18|||
38009667|NCT00077636|69692091|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
38009668|NCT00077636|69692092|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
38009669|NCT00095199|69692103|FG000|Overall Study|Adverse Event|40|||
38009670|NCT00095199|69692104|FG001|Overall Study|Adverse Event|22|||
38009671|NCT00095199|69692105|FG002|Overall Study|Adverse Event|26|||
38009672|NCT00095199|69692106|FG003|Overall Study|Adverse Event|11|||
38009673|NCT00095199|69692103|FG000|Overall Study|Progressive disease|213|||
38009674|NCT00095199|69692104|FG001|Overall Study|Progressive disease|179|||
38009675|NCT00095199|69692105|FG002|Overall Study|Progressive disease|105|||
38009676|NCT00095199|69692106|FG003|Overall Study|Progressive disease|98|||
38009677|NCT00095199|69692103|FG000|Overall Study|Death|10|||
38009678|NCT00095199|69692104|FG001|Overall Study|Death|6|||
38009679|NCT00095199|69692105|FG002|Overall Study|Death|11|||
38009680|NCT00095199|69692106|FG003|Overall Study|Death|9|||
38009681|NCT00095199|69692103|FG000|Overall Study|Withdrawal by Subject|21|||
38009682|NCT00095199|69692104|FG001|Overall Study|Withdrawal by Subject|16|||
38009683|NCT00095199|69692105|FG002|Overall Study|Withdrawal by Subject|13|||
38009684|NCT00095199|69692106|FG003|Overall Study|Withdrawal by Subject|22|||
38009685|NCT00095199|69692103|FG000|Overall Study|Protocol Violation|4|||
38009686|NCT00095199|69692104|FG001|Overall Study|Protocol Violation|4|||
38009687|NCT00095199|69692105|FG002|Overall Study|Protocol Violation|2|||
38009688|NCT00095199|69692106|FG003|Overall Study|Protocol Violation|0|||
38009689|NCT00095199|69692103|FG000|Overall Study|Liver function test results elevated|0|||
38009690|NCT00095199|69692104|FG001|Overall Study|Liver function test results elevated|0|||
38009691|NCT00095199|69692105|FG002|Overall Study|Liver function test results elevated|1|||
37908831|NCT00606307|69594454|FG000|Overall Study|Withdrawal by Subject|2|||
37908832|NCT00606307|69594454|FG000|Overall Study|Disease progression|6|||
37908833|NCT00606307|69594454|FG000|Overall Study|QTc prolongation|1|||
37908834|NCT00798369|69594464|FG000|Overall Study|Subject withdrew consent|0|||
37908835|NCT00798369|69594465|FG001|Overall Study|Subject withdrew consent|0|||
37908836|NCT00798369|69594466|FG002|Overall Study|Subject withdrew consent|1|||
37908837|NCT00798369|69594467|FG003|Overall Study|Subject withdrew consent|1|||
37908838|NCT00798369|69594468|FG004|Overall Study|Subject withdrew consent|0|||
37908839|NCT00798369|69594469|FG005|Overall Study|Subject withdrew consent|2|||
37908840|NCT00798369|69594464|FG000|Overall Study|Lost to Follow-up|1|||
37908841|NCT00798369|69594465|FG001|Overall Study|Lost to Follow-up|1|||
37908842|NCT00798369|69594466|FG002|Overall Study|Lost to Follow-up|1|||
38009692|NCT00095199|69692106|FG003|Overall Study|Liver function test results elevated|1|||
38009693|NCT00095199|69692103|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
38009694|NCT00095199|69692104|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
38009695|NCT00095199|69692105|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
38009696|NCT00095199|69692106|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
38009697|NCT00095199|69692103|FG000|Overall Study|Physician Decision|5|||
38009698|NCT00095199|69692104|FG001|Overall Study|Physician Decision|6|||
38009699|NCT00095199|69692105|FG002|Overall Study|Physician Decision|1|||
38009700|NCT00095199|69692106|FG003|Overall Study|Physician Decision|1|||
38009701|NCT00095199|69692103|FG000|Overall Study|Not eligible|1|||
38009702|NCT00095199|69692104|FG001|Overall Study|Not eligible|7|||
38009703|NCT00095199|69692105|FG002|Overall Study|Not eligible|0|||
38009704|NCT00095199|69692106|FG003|Overall Study|Not eligible|1|||
37697916|NCT02410811|69174639|FG001|Overall Study|Withdrawal by Subject|0|||
37908843|NCT00798369|69594467|FG003|Overall Study|Lost to Follow-up|0|||
37908844|NCT00798369|69594468|FG004|Overall Study|Lost to Follow-up|1|||
37908845|NCT00798369|69594469|FG005|Overall Study|Lost to Follow-up|0|||
37908846|NCT00798369|69594464|FG000|Overall Study|Adminstrative problems|0|||
37908847|NCT00798369|69594465|FG001|Overall Study|Adminstrative problems|0|||
37908848|NCT00798369|69594466|FG002|Overall Study|Adminstrative problems|0|||
38009705|NCT00095199|69692103|FG000|Overall Study|Started Palliative Radiotherapy|1|||
38009706|NCT00095199|69692104|FG001|Overall Study|Started Palliative Radiotherapy|0|||
38009707|NCT00095199|69692105|FG002|Overall Study|Started Palliative Radiotherapy|0|||
38009708|NCT00095199|69692106|FG003|Overall Study|Started Palliative Radiotherapy|0|||
38009709|NCT00095199|69692103|FG000|Overall Study|Started radiotherapy regimen|0|||
37697917|NCT02410811|69174640|FG002|Overall Study|Withdrawal by Subject|1|||
37697918|NCT02410811|69174641|FG003|Overall Study|Withdrawal by Subject|0|||
37697919|NCT02435381|69174651|FG000|Overall Study|Lost to Follow-up|2|||
37697920|NCT02435381|69174652|FG001|Overall Study|Lost to Follow-up|1|||
38009710|NCT00095199|69692104|FG001|Overall Study|Started radiotherapy regimen|1|||
38009711|NCT00095199|69692105|FG002|Overall Study|Started radiotherapy regimen|0|||
38009712|NCT00095199|69692106|FG003|Overall Study|Started radiotherapy regimen|0|||
38009713|NCT00095199|69692103|FG000|Overall Study|Primary tumor removed in other surgery|0|||
38009714|NCT00095199|69692104|FG001|Overall Study|Primary tumor removed in other surgery|1|||
37697921|NCT01837966|69174668|FG000|Overall Study|Withdrawal by Subject|2|||
37908849|NCT00798369|69594467|FG003|Overall Study|Adminstrative problems|0|||
37908850|NCT00798369|69594468|FG004|Overall Study|Adminstrative problems|0|||
37908851|NCT00798369|69594469|FG005|Overall Study|Adminstrative problems|1|||
38009715|NCT00095199|69692105|FG002|Overall Study|Primary tumor removed in other surgery|0|||
38009716|NCT00095199|69692106|FG003|Overall Study|Primary tumor removed in other surgery|0|||
38009717|NCT00095199|69692103|FG000|Overall Study|Data inadvertently lost by site|1|||
37908852|NCT00950963|69594486|FG000|Overall Study|Lost to Follow-up|29|||
37908853|NCT00950963|69594487|FG001|Overall Study|Lost to Follow-up|24|||
37908854|NCT00608959|69594495|FG000|Part 1|Did not meet eligibility criteria|1|||
37908855|NCT00945659|69594508|FG000|Overall Study|Lost to Follow-up|7|||
37908856|NCT00945659|69594509|FG001|Overall Study|Lost to Follow-up|20|||
37908857|NCT00945659|69594510|FG002|Overall Study|Lost to Follow-up|17|||
37908858|NCT00798135|69594518|FG000|Overall Study|Disease progression, relapse|11|||
37908859|NCT00798135|69594518|FG000|Overall Study|Disease progression, refractory|1|||
37908860|NCT00798135|69594518|FG000|Overall Study|Physician Decision|1|||
37908861|NCT00941603|69594528|FG000|Overall Study|Adverse Event|10|||
37908862|NCT00941603|69594529|FG001|Overall Study|Adverse Event|15|||
37908863|NCT00941603|69594530|FG002|Overall Study|Adverse Event|5|||
37908864|NCT00941603|69594531|FG003|Overall Study|Adverse Event|1|||
37908865|NCT00941603|69594532|FG004|Overall Study|Adverse Event|4|||
37908866|NCT00941603|69594533|FG005|Overall Study|Adverse Event|0|||
37908867|NCT00941603|69594528|FG000|Overall Study|Lost to Follow-up|0|||
37908868|NCT00941603|69594529|FG001|Overall Study|Lost to Follow-up|0|||
37908869|NCT00941603|69594530|FG002|Overall Study|Lost to Follow-up|0|||
37908870|NCT00941603|69594531|FG003|Overall Study|Lost to Follow-up|1|||
37908871|NCT00941603|69594532|FG004|Overall Study|Lost to Follow-up|0|||
37908872|NCT00941603|69594533|FG005|Overall Study|Lost to Follow-up|2|||
37908873|NCT00941603|69594528|FG000|Overall Study|Withdrawal by Subject|0|||
37908874|NCT00941603|69594529|FG001|Overall Study|Withdrawal by Subject|0|||
37908875|NCT00941603|69594530|FG002|Overall Study|Withdrawal by Subject|0|||
37908876|NCT00941603|69594531|FG003|Overall Study|Withdrawal by Subject|2|||
37908877|NCT00941603|69594532|FG004|Overall Study|Withdrawal by Subject|0|||
37908878|NCT00941603|69594533|FG005|Overall Study|Withdrawal by Subject|1|||
37908879|NCT00941603|69594528|FG000|Overall Study|Protocol Violation|0|||
38009718|NCT00095199|69692104|FG001|Overall Study|Data inadvertently lost by site|0|||
38009719|NCT00095199|69692105|FG002|Overall Study|Data inadvertently lost by site|0|||
37908880|NCT00941603|69594529|FG001|Overall Study|Protocol Violation|1|||
37908881|NCT00941603|69594530|FG002|Overall Study|Protocol Violation|0|||
37908882|NCT00941603|69594531|FG003|Overall Study|Protocol Violation|0|||
37908883|NCT00941603|69594532|FG004|Overall Study|Protocol Violation|0|||
38009720|NCT00095199|69692106|FG003|Overall Study|Data inadvertently lost by site|0|||
38009721|NCT00075764|69692123|FG000|Overall Study|Adverse Event|5|||
38009722|NCT00075764|69692124|FG001|Overall Study|Adverse Event|12|||
38009723|NCT00075764|69692123|FG000|Overall Study|Death|4|||
38009724|NCT00075764|69692124|FG001|Overall Study|Death|8|||
38009725|NCT00075764|69692123|FG000|Overall Study|Withdrawal by Subject|28|||
38009726|NCT00075764|69692124|FG001|Overall Study|Withdrawal by Subject|18|||
38009727|NCT00075764|69692123|FG000|Overall Study|Progression|269|||
38009728|NCT00075764|69692124|FG001|Overall Study|Progression|274|||
38009729|NCT00075764|69692123|FG000|Overall Study|Still on treatment|8|||
38009730|NCT00075764|69692124|FG001|Overall Study|Still on treatment|15|||
38009731|NCT00075764|69692123|FG000|Overall Study|Delinquent|4|||
38009732|NCT00075764|69692124|FG001|Overall Study|Delinquent|2|||
38009733|NCT00075764|69692123|FG000|Overall Study|Not protocol specified|27|||
38009734|NCT00075764|69692124|FG001|Overall Study|Not protocol specified|19|||
38009735|NCT00075764|69692123|FG000|Overall Study|Under review|0|||
38009736|NCT00075764|69692124|FG001|Overall Study|Under review|1|||
38009737|NCT03568162|69692138|FG000|Overall Study|Adverse Event|0|||
38009738|NCT03568162|69692139|FG001|Overall Study|Adverse Event|1|||
38009739|NCT03568162|69692140|FG002|Overall Study|Adverse Event|2|||
37908884|NCT00941603|69594533|FG005|Overall Study|Protocol Violation|0|||
37908885|NCT00941603|69594528|FG000|Overall Study|Did not meet protocol eligibility|1|||
37908886|NCT00941603|69594529|FG001|Overall Study|Did not meet protocol eligibility|0|||
37908887|NCT00941603|69594530|FG002|Overall Study|Did not meet protocol eligibility|0|||
37908888|NCT00941603|69594531|FG003|Overall Study|Did not meet protocol eligibility|0|||
37908889|NCT00941603|69594532|FG004|Overall Study|Did not meet protocol eligibility|0|||
37908890|NCT00941603|69594533|FG005|Overall Study|Did not meet protocol eligibility|0|||
37908891|NCT00797823|69594550|FG000|First Period (Initial Randomization)|Physician Decision|1|||
37908892|NCT00797823|69594551|FG001|First Period (Initial Randomization)|Physician Decision|0|||
38009740|NCT03568162|69692141|FG003|Overall Study|Adverse Event|0|||
38009741|NCT03568162|69692142|FG004|Overall Study|Adverse Event|0|||
38009742|NCT03568162|69692143|FG005|Overall Study|Adverse Event|1|||
38009743|NCT03568162|69692138|FG000|Overall Study|Death|0|||
37908893|NCT00797823|69594552|FG002|First Period (Initial Randomization)|Physician Decision|0|||
37908894|NCT00797667|69594562|FG000|Overall Study|Lack of Efficacy|0|||
37908895|NCT00797667|69594563|FG001|Overall Study|Lack of Efficacy|1|||
37908896|NCT00797667|69594564|FG002|Overall Study|Lack of Efficacy|0|||
37908897|NCT00797667|69594562|FG000|Overall Study|Lost to Follow-up|8|||
37908898|NCT00797667|69594563|FG001|Overall Study|Lost to Follow-up|12|||
37908899|NCT00797667|69594564|FG002|Overall Study|Lost to Follow-up|2|||
38009744|NCT03568162|69692139|FG001|Overall Study|Death|0|||
38009745|NCT03568162|69692140|FG002|Overall Study|Death|0|||
38009746|NCT03568162|69692141|FG003|Overall Study|Death|0|||
38009747|NCT03568162|69692142|FG004|Overall Study|Death|1|||
38009748|NCT03568162|69692143|FG005|Overall Study|Death|0|||
37908900|NCT00797667|69594562|FG000|Overall Study|Physician Decision|3|||
37908901|NCT00797667|69594563|FG001|Overall Study|Physician Decision|1|||
37908902|NCT00797667|69594564|FG002|Overall Study|Physician Decision|0|||
37908903|NCT00797667|69594562|FG000|Overall Study|Pregnancy|2|||
37908904|NCT00797667|69594563|FG001|Overall Study|Pregnancy|0|||
37908905|NCT00797667|69594564|FG002|Overall Study|Pregnancy|0|||
37908906|NCT00797667|69594562|FG000|Overall Study|Protocol Violation|2|||
37908907|NCT00797667|69594563|FG001|Overall Study|Protocol Violation|7|||
37908908|NCT00797667|69594564|FG002|Overall Study|Protocol Violation|0|||
37908909|NCT00797667|69594562|FG000|Overall Study|Study Terminated by Sponsor|217|||
37908910|NCT00797667|69594563|FG001|Overall Study|Study Terminated by Sponsor|216|||
37908911|NCT00797667|69594564|FG002|Overall Study|Study Terminated by Sponsor|115|||
37908912|NCT00797667|69594562|FG000|Overall Study|Withdrawal by Subject|9|||
37908913|NCT00797667|69594563|FG001|Overall Study|Withdrawal by Subject|14|||
37908914|NCT00797667|69594564|FG002|Overall Study|Withdrawal by Subject|2|||
37908915|NCT00797667|69594562|FG000|Overall Study|Adverse Event|19|||
37908916|NCT00797667|69594563|FG001|Overall Study|Adverse Event|8|||
37908917|NCT00797667|69594564|FG002|Overall Study|Adverse Event|8|||
37908918|NCT00950807|69594572|FG000|Treatment Period 1|Lack of Efficacy|1|||
37908919|NCT00950807|69594573|FG001|Treatment Period 1|Lack of Efficacy|0|||
37908920|NCT00950807|69594574|FG002|Treatment Period 1|Lack of Efficacy|0|||
37908921|NCT00950807|69594575|FG003|Treatment Period 1|Lack of Efficacy|0|||
37697922|NCT01837966|69174669|FG001|Overall Study|Withdrawal by Subject|1|||
37697923|NCT02435147|69174675|FG000|Overall Study|non-evaluable DXA scan|11|||
37697924|NCT02435069|69174679|FG000|Dose Response - First Intervention|Adverse Event|0|||
37697925|NCT02435069|69174680|FG001|Dose Response - First Intervention|Adverse Event|1|||
38009749|NCT03568162|69692138|FG000|Overall Study|Lost to Follow-up|3|||
38009750|NCT03568162|69692139|FG001|Overall Study|Lost to Follow-up|2|||
38009751|NCT03568162|69692140|FG002|Overall Study|Lost to Follow-up|4|||
38009752|NCT03568162|69692141|FG003|Overall Study|Lost to Follow-up|2|||
38009753|NCT03568162|69692142|FG004|Overall Study|Lost to Follow-up|3|||
38009754|NCT03568162|69692143|FG005|Overall Study|Lost to Follow-up|2|||
38009755|NCT03568162|69692138|FG000|Overall Study|Physician Decision|0|||
38009756|NCT03568162|69692139|FG001|Overall Study|Physician Decision|1|||
38009757|NCT03568162|69692140|FG002|Overall Study|Physician Decision|1|||
38009758|NCT03568162|69692141|FG003|Overall Study|Physician Decision|0|||
38009759|NCT03568162|69692142|FG004|Overall Study|Physician Decision|1|||
38009760|NCT03568162|69692143|FG005|Overall Study|Physician Decision|0|||
37697926|NCT02435069|69174681|FG002|Dose Response - First Intervention|Adverse Event|1|||
37697927|NCT02435069|69174682|FG003|Dose Response - First Intervention|Adverse Event|0|||
37697928|NCT02435069|69174683|FG004|Dose Response - First Intervention|Adverse Event|0|||
37697929|NCT02435069|69174679|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
37908922|NCT00950807|69594576|FG004|Treatment Period 1|Lack of Efficacy|0|||
37908923|NCT00950807|69594577|FG005|Treatment Period 1|Lack of Efficacy|1|||
37908924|NCT00950807|69594578|FG006|Treatment Period 1|Lack of Efficacy|0|||
37908925|NCT00950807|69594579|FG007|Treatment Period 1|Lack of Efficacy|0|||
37908926|NCT00950807|69594580|FG008|Treatment Period 1|Lack of Efficacy|0|||
37908927|NCT00950807|69594581|FG009|Treatment Period 1|Lack of Efficacy|0|||
37908928|NCT00950807|69594572|FG000|Treatment Period 1|Protocol Violation|1|||
37908929|NCT00950807|69594573|FG001|Treatment Period 1|Protocol Violation|0|||
37908930|NCT00950807|69594574|FG002|Treatment Period 1|Protocol Violation|0|||
37908931|NCT00950807|69594575|FG003|Treatment Period 1|Protocol Violation|0|||
37908932|NCT00950807|69594576|FG004|Treatment Period 1|Protocol Violation|0|||
37908933|NCT00950807|69594577|FG005|Treatment Period 1|Protocol Violation|0|||
37908934|NCT00950807|69594578|FG006|Treatment Period 1|Protocol Violation|0|||
37908935|NCT00950807|69594579|FG007|Treatment Period 1|Protocol Violation|0|||
37908936|NCT00950807|69594580|FG008|Treatment Period 1|Protocol Violation|0|||
37908937|NCT00950807|69594581|FG009|Treatment Period 1|Protocol Violation|0|||
37908938|NCT00950807|69594572|FG000|Treatment Period 1|Lost to Follow-up|0|||
37908939|NCT00950807|69594573|FG001|Treatment Period 1|Lost to Follow-up|0|||
37908940|NCT00950807|69594574|FG002|Treatment Period 1|Lost to Follow-up|1|||
37908941|NCT00950807|69594575|FG003|Treatment Period 1|Lost to Follow-up|0|||
37908942|NCT00950807|69594576|FG004|Treatment Period 1|Lost to Follow-up|0|||
37908943|NCT00950807|69594577|FG005|Treatment Period 1|Lost to Follow-up|0|||
38009761|NCT03568162|69692138|FG000|Overall Study|Pregnancy|0|||
37908944|NCT00950807|69594578|FG006|Treatment Period 1|Lost to Follow-up|0|||
37908945|NCT00950807|69594579|FG007|Treatment Period 1|Lost to Follow-up|0|||
37908946|NCT00950807|69594580|FG008|Treatment Period 1|Lost to Follow-up|0|||
37908947|NCT00950807|69594581|FG009|Treatment Period 1|Lost to Follow-up|0|||
37908948|NCT00950807|69594572|FG000|Treatment Period 1|Withdrawal by Subject|1|||
38009762|NCT03568162|69692139|FG001|Overall Study|Pregnancy|0|||
38009763|NCT03568162|69692140|FG002|Overall Study|Pregnancy|0|||
37908949|NCT00950807|69594573|FG001|Treatment Period 1|Withdrawal by Subject|0|||
37908950|NCT00950807|69594574|FG002|Treatment Period 1|Withdrawal by Subject|0|||
37908951|NCT00950807|69594575|FG003|Treatment Period 1|Withdrawal by Subject|0|||
37908952|NCT00950807|69594576|FG004|Treatment Period 1|Withdrawal by Subject|1|||
38009764|NCT03568162|69692141|FG003|Overall Study|Pregnancy|1|||
37908953|NCT00950807|69594577|FG005|Treatment Period 1|Withdrawal by Subject|0|||
37908954|NCT00950807|69594578|FG006|Treatment Period 1|Withdrawal by Subject|0|||
37908955|NCT00950807|69594579|FG007|Treatment Period 1|Withdrawal by Subject|0|||
37908956|NCT00950807|69594580|FG008|Treatment Period 1|Withdrawal by Subject|1|||
37908957|NCT00950807|69594581|FG009|Treatment Period 1|Withdrawal by Subject|0|||
37908958|NCT00950807|69594572|FG000|Treatment Period 1|Adverse Event|0|||
38009765|NCT03568162|69692142|FG004|Overall Study|Pregnancy|0|||
38009766|NCT03568162|69692143|FG005|Overall Study|Pregnancy|0|||
38009767|NCT03568162|69692138|FG000|Overall Study|Protocol Violation|1|||
38009768|NCT03568162|69692139|FG001|Overall Study|Protocol Violation|0|||
38009769|NCT03568162|69692140|FG002|Overall Study|Protocol Violation|1|||
38009770|NCT03568162|69692141|FG003|Overall Study|Protocol Violation|1|||
37908959|NCT00950807|69594573|FG001|Treatment Period 1|Adverse Event|0|||
37908960|NCT00950807|69594574|FG002|Treatment Period 1|Adverse Event|0|||
37908961|NCT00950807|69594575|FG003|Treatment Period 1|Adverse Event|0|||
38009771|NCT03568162|69692142|FG004|Overall Study|Protocol Violation|1|||
38009772|NCT03568162|69692143|FG005|Overall Study|Protocol Violation|1|||
37831627|NCT04021862|69515131|FG004|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
37831628|NCT04021862|69515132|FG005|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
37831629|NCT04021862|69515127|FG000|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
37831630|NCT04021862|69515128|FG001|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
37831631|NCT04021862|69515129|FG002|Placebo Controlled Period (Week 0-16)|Pregnancy|1|||
37831632|NCT04021862|69515130|FG003|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
37908962|NCT00950807|69594576|FG004|Treatment Period 1|Adverse Event|0|||
37908963|NCT00950807|69594577|FG005|Treatment Period 1|Adverse Event|1|||
37908964|NCT00950807|69594578|FG006|Treatment Period 1|Adverse Event|0|||
37908965|NCT00950807|69594579|FG007|Treatment Period 1|Adverse Event|0|||
37908966|NCT00950807|69594580|FG008|Treatment Period 1|Adverse Event|0|||
37908967|NCT00950807|69594581|FG009|Treatment Period 1|Adverse Event|0|||
37908968|NCT00950807|69594572|FG000|Washout Period 1|Lack of Efficacy|0|||
37908969|NCT00950807|69594573|FG001|Washout Period 1|Lack of Efficacy|0|||
37908970|NCT00950807|69594574|FG002|Washout Period 1|Lack of Efficacy|0|||
37831633|NCT04021862|69515131|FG004|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
37831634|NCT04021862|69515132|FG005|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
37831635|NCT04021862|69515127|FG000|Placebo Controlled Period (Week 0-16)|Other|0|||
37831636|NCT04021862|69515128|FG001|Placebo Controlled Period (Week 0-16)|Other|0|||
37831637|NCT04021862|69515129|FG002|Placebo Controlled Period (Week 0-16)|Other|1|||
37831638|NCT04021862|69515130|FG003|Placebo Controlled Period (Week 0-16)|Other|0|||
37831639|NCT04021862|69515131|FG004|Placebo Controlled Period (Week 0-16)|Other|0|||
37831640|NCT04021862|69515132|FG005|Placebo Controlled Period (Week 0-16)|Other|0|||
37831641|NCT04021862|69515127|FG000|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
37831642|NCT04021862|69515128|FG001|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
37831643|NCT04021862|69515129|FG002|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
37831644|NCT04021862|69515130|FG003|Active Treatment Period (Week 16-32)|Withdrawal by Subject|1|||
37831645|NCT04021862|69515131|FG004|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
37831646|NCT04021862|69515132|FG005|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
37831647|NCT04003155|69515149|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
37831648|NCT04003155|69515150|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
37831649|NCT04003155|69515151|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
37908971|NCT00950807|69594575|FG003|Washout Period 1|Lack of Efficacy|0|||
37908972|NCT00950807|69594576|FG004|Washout Period 1|Lack of Efficacy|0|||
37908973|NCT00950807|69594577|FG005|Washout Period 1|Lack of Efficacy|0|||
37908974|NCT00950807|69594578|FG006|Washout Period 1|Lack of Efficacy|1|||
38009773|NCT03568162|69692138|FG000|Overall Study|Withdrawal by Subject|15|||
38009774|NCT03568162|69692139|FG001|Overall Study|Withdrawal by Subject|15|||
38009775|NCT03568162|69692140|FG002|Overall Study|Withdrawal by Subject|26|||
38009776|NCT03568162|69692141|FG003|Overall Study|Withdrawal by Subject|22|||
37831650|NCT04003155|69515152|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
37908975|NCT00950807|69594579|FG007|Washout Period 1|Lack of Efficacy|0|||
37908976|NCT00950807|69594580|FG008|Washout Period 1|Lack of Efficacy|0|||
37831651|NCT04003155|69515153|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
37831652|NCT04003155|69515149|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
37831653|NCT04003155|69515150|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
37908977|NCT00950807|69594581|FG009|Washout Period 1|Lack of Efficacy|0|||
37908978|NCT00950807|69594572|FG000|Washout Period 1|Withdrawal by Subject|0|||
37908979|NCT00950807|69594573|FG001|Washout Period 1|Withdrawal by Subject|0|||
37908980|NCT00950807|69594574|FG002|Washout Period 1|Withdrawal by Subject|0|||
37908981|NCT00950807|69594575|FG003|Washout Period 1|Withdrawal by Subject|0|||
37908982|NCT00950807|69594576|FG004|Washout Period 1|Withdrawal by Subject|0|||
37908983|NCT00950807|69594577|FG005|Washout Period 1|Withdrawal by Subject|0|||
38009777|NCT03568162|69692142|FG004|Overall Study|Withdrawal by Subject|6|||
38009778|NCT03568162|69692143|FG005|Overall Study|Withdrawal by Subject|9|||
38009779|NCT03568162|69692138|FG000|Overall Study|Others|3|||
38009780|NCT03568162|69692139|FG001|Overall Study|Others|4|||
38009781|NCT03568162|69692140|FG002|Overall Study|Others|1|||
38009782|NCT03568162|69692141|FG003|Overall Study|Others|4|||
38009783|NCT03568162|69692142|FG004|Overall Study|Others|2|||
38009784|NCT03568162|69692143|FG005|Overall Study|Others|1|||
38009785|NCT03567616|69692162|FG000|Overall Study|Disease progression|4|||
38009786|NCT03567616|69692162|FG000|Overall Study|Withdrawal by Subject|1|||
38009787|NCT03567616|69692162|FG000|Overall Study|Physician Decision|1|||
38009788|NCT03567616|69692162|FG000|Overall Study|Death|1|||
38009789|NCT03567616|69692162|FG000|Overall Study|Adverse Event|1|||
38009790|NCT03567382|69692171|FG000|Overall Study|Lost to Follow-up|1|||
38009791|NCT03567382|69692172|FG001|Overall Study|Lost to Follow-up|21|||
38009792|NCT03567382|69692173|FG002|Overall Study|Lost to Follow-up|1|||
38009793|NCT03567382|69692174|FG003|Overall Study|Lost to Follow-up|21|||
38009794|NCT03567382|69692171|FG000|Overall Study|Withdrawal by Subject|2|||
38009795|NCT03567382|69692172|FG001|Overall Study|Withdrawal by Subject|14|||
37908984|NCT00950807|69594578|FG006|Washout Period 1|Withdrawal by Subject|0|||
37908985|NCT00950807|69594579|FG007|Washout Period 1|Withdrawal by Subject|0|||
37908986|NCT00950807|69594580|FG008|Washout Period 1|Withdrawal by Subject|1|||
37908987|NCT00950807|69594581|FG009|Washout Period 1|Withdrawal by Subject|0|||
37908988|NCT00950807|69594572|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
37908989|NCT00950807|69594573|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
37908990|NCT00950807|69594574|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
37908991|NCT00950807|69594575|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
37908992|NCT00950807|69594576|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
37908993|NCT00950807|69594577|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
37908994|NCT00950807|69594578|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
37908995|NCT00950807|69594579|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
37908996|NCT00950807|69594580|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
37908997|NCT00950807|69594581|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
37908998|NCT00950807|69594572|FG000|Washout Period 1|Adverse Event|2|||
37908999|NCT00950807|69594573|FG001|Washout Period 1|Adverse Event|0|||
37909000|NCT00950807|69594574|FG002|Washout Period 1|Adverse Event|0|||
37909001|NCT00950807|69594575|FG003|Washout Period 1|Adverse Event|1|||
37909002|NCT00950807|69594576|FG004|Washout Period 1|Adverse Event|1|||
37909003|NCT00950807|69594577|FG005|Washout Period 1|Adverse Event|0|||
37909004|NCT00950807|69594578|FG006|Washout Period 1|Adverse Event|0|||
37909005|NCT00950807|69594579|FG007|Washout Period 1|Adverse Event|0|||
37909006|NCT00950807|69594580|FG008|Washout Period 1|Adverse Event|0|||
37909007|NCT00950807|69594581|FG009|Washout Period 1|Adverse Event|0|||
37909008|NCT00950807|69594572|FG000|Treatment Period 2|Lack of Efficacy|1|||
37909009|NCT00950807|69594573|FG001|Treatment Period 2|Lack of Efficacy|0|||
37909010|NCT00950807|69594574|FG002|Treatment Period 2|Lack of Efficacy|0|||
37909011|NCT00950807|69594575|FG003|Treatment Period 2|Lack of Efficacy|0|||
37909012|NCT00950807|69594576|FG004|Treatment Period 2|Lack of Efficacy|0|||
37909013|NCT00950807|69594577|FG005|Treatment Period 2|Lack of Efficacy|0|||
37909014|NCT00950807|69594578|FG006|Treatment Period 2|Lack of Efficacy|0|||
37909015|NCT00950807|69594579|FG007|Treatment Period 2|Lack of Efficacy|0|||
37909016|NCT00950807|69594580|FG008|Treatment Period 2|Lack of Efficacy|0|||
37909017|NCT00950807|69594581|FG009|Treatment Period 2|Lack of Efficacy|0|||
37909018|NCT00950807|69594572|FG000|Treatment Period 2|Withdrawal by Subject|0|||
37909019|NCT00950807|69594573|FG001|Treatment Period 2|Withdrawal by Subject|0|||
37909020|NCT00950807|69594574|FG002|Treatment Period 2|Withdrawal by Subject|0|||
37909021|NCT00950807|69594575|FG003|Treatment Period 2|Withdrawal by Subject|0|||
37909022|NCT00950807|69594576|FG004|Treatment Period 2|Withdrawal by Subject|0|||
37909023|NCT00950807|69594577|FG005|Treatment Period 2|Withdrawal by Subject|0|||
37909024|NCT00950807|69594578|FG006|Treatment Period 2|Withdrawal by Subject|1|||
37909025|NCT00950807|69594579|FG007|Treatment Period 2|Withdrawal by Subject|2|||
38009796|NCT03567382|69692173|FG002|Overall Study|Withdrawal by Subject|1|||
38009797|NCT03567382|69692174|FG003|Overall Study|Withdrawal by Subject|12|||
38009798|NCT03595384|69692185|FG000|Overall Study|Other time commitments|8|||
37697930|NCT02435069|69174680|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
37909026|NCT00950807|69594580|FG008|Treatment Period 2|Withdrawal by Subject|0|||
37909027|NCT00950807|69594581|FG009|Treatment Period 2|Withdrawal by Subject|0|||
38009799|NCT03595384|69692185|FG000|Overall Study|Changes to session time|7|||
38009800|NCT03595384|69692185|FG000|Overall Study|Relocation out of country|1|||
38009801|NCT03591874|69692191|FG000|Overall Study|Adverse Event|4|||
37909028|NCT00950807|69594572|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
37909029|NCT00950807|69594573|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
37909030|NCT00950807|69594574|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
37909031|NCT00950807|69594575|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
37909032|NCT00950807|69594576|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
38009802|NCT03591874|69692192|FG001|Overall Study|Adverse Event|0|||
38009803|NCT03591874|69692191|FG000|Overall Study|Withdrawal by Subject|2|||
37909033|NCT00950807|69594577|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
37909034|NCT00950807|69594578|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
37909035|NCT00950807|69594579|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
37909036|NCT00950807|69594580|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
37909037|NCT00950807|69594581|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
37909038|NCT00950807|69594572|FG000|Treatment Period 2|Adverse Event|0|||
37909039|NCT00950807|69594573|FG001|Treatment Period 2|Adverse Event|1|||
37909040|NCT00950807|69594574|FG002|Treatment Period 2|Adverse Event|0|||
37909041|NCT00950807|69594575|FG003|Treatment Period 2|Adverse Event|1|||
37909042|NCT00950807|69594576|FG004|Treatment Period 2|Adverse Event|0|||
37909043|NCT00950807|69594577|FG005|Treatment Period 2|Adverse Event|1|||
38009804|NCT03591874|69692192|FG001|Overall Study|Withdrawal by Subject|1|||
38009805|NCT03591874|69692191|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
38009806|NCT03591874|69692192|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
38009807|NCT03591874|69692191|FG000|Overall Study|On Study at Time of Study Termination|12|||
38009808|NCT03591874|69692192|FG001|Overall Study|On Study at Time of Study Termination|6|||
38009809|NCT03566680|69692198|FG000|Overall Study|Pregnancy|1|||
38009810|NCT03566680|69692198|FG000|Overall Study|Lost to Follow-up|13|||
38009811|NCT03566680|69692198|FG000|Overall Study|Withdrawal by Subject|3|||
37909044|NCT00950807|69594578|FG006|Treatment Period 2|Adverse Event|0|||
37909045|NCT00950807|69594579|FG007|Treatment Period 2|Adverse Event|1|||
37909046|NCT00950807|69594580|FG008|Treatment Period 2|Adverse Event|0|||
37909047|NCT00950807|69594581|FG009|Treatment Period 2|Adverse Event|0|||
37909048|NCT00950807|69594572|FG000|Washout Period 2|Lack of Efficacy|1|||
37909049|NCT00950807|69594573|FG001|Washout Period 2|Lack of Efficacy|0|||
37909050|NCT00950807|69594574|FG002|Washout Period 2|Lack of Efficacy|0|||
37909051|NCT00950807|69594575|FG003|Washout Period 2|Lack of Efficacy|0|||
37909052|NCT00950807|69594576|FG004|Washout Period 2|Lack of Efficacy|0|||
37909053|NCT00950807|69594577|FG005|Washout Period 2|Lack of Efficacy|0|||
37909054|NCT00950807|69594578|FG006|Washout Period 2|Lack of Efficacy|0|||
37909055|NCT00950807|69594579|FG007|Washout Period 2|Lack of Efficacy|0|||
37909056|NCT00950807|69594580|FG008|Washout Period 2|Lack of Efficacy|0|||
37909057|NCT00950807|69594581|FG009|Washout Period 2|Lack of Efficacy|0|||
37909058|NCT00950807|69594572|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
37909059|NCT00950807|69594573|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
37909060|NCT00950807|69594574|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
37909061|NCT00950807|69594575|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
37909062|NCT00950807|69594576|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
37909063|NCT00950807|69594577|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
37909064|NCT00950807|69594578|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
37909065|NCT00950807|69594579|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
37909066|NCT00950807|69594580|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
37909067|NCT00950807|69594581|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
38009812|NCT00106353|69692204|FG000|Part 1|Disease progression|3|||
38009813|NCT00106353|69692205|FG001|Part 1|Disease progression|4|||
38009814|NCT00106353|69692206|FG002|Part 1|Disease progression|1|||
38009815|NCT00106353|69692207|FG003|Part 1|Disease progression|3|||
37697931|NCT02435069|69174681|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
37831654|NCT04003155|69515151|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
37831655|NCT04003155|69515152|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
37831656|NCT04003155|69515153|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
37831657|NCT04003155|69515149|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
37831658|NCT04003155|69515150|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
37831659|NCT04003155|69515151|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
37831660|NCT04003155|69515152|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
37831661|NCT04003155|69515153|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
37831662|NCT04003155|69515149|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
37909068|NCT00950807|69594572|FG000|Washout Period 2|Adverse Event|3|||
37909069|NCT00950807|69594573|FG001|Washout Period 2|Adverse Event|0|||
37909070|NCT00950807|69594574|FG002|Washout Period 2|Adverse Event|0|||
37909071|NCT00950807|69594575|FG003|Washout Period 2|Adverse Event|1|||
37909072|NCT00950807|69594576|FG004|Washout Period 2|Adverse Event|0|||
37909073|NCT00950807|69594577|FG005|Washout Period 2|Adverse Event|0|||
37909074|NCT00950807|69594578|FG006|Washout Period 2|Adverse Event|0|||
37909075|NCT00950807|69594579|FG007|Washout Period 2|Adverse Event|0|||
37909076|NCT00950807|69594580|FG008|Washout Period 2|Adverse Event|0|||
38009816|NCT00106353|69692208|FG004|Part 1|Disease progression|0|||
38009817|NCT00106353|69692209|FG005|Part 1|Disease progression|0|||
38009818|NCT00106353|69692210|FG006|Part 1|Disease progression|0|||
38009819|NCT00106353|69692204|FG000|Part 1|Withdrawal by Subject|0|||
38009820|NCT00106353|69692205|FG001|Part 1|Withdrawal by Subject|0|||
38009821|NCT00106353|69692206|FG002|Part 1|Withdrawal by Subject|1|||
38009822|NCT00106353|69692207|FG003|Part 1|Withdrawal by Subject|2|||
38009823|NCT00106353|69692208|FG004|Part 1|Withdrawal by Subject|0|||
38009824|NCT00106353|69692209|FG005|Part 1|Withdrawal by Subject|0|||
38009825|NCT00106353|69692210|FG006|Part 1|Withdrawal by Subject|0|||
38009826|NCT00106353|69692204|FG000|Part 1|Symptomatic deterioration|0|||
37909077|NCT00950807|69594581|FG009|Washout Period 2|Adverse Event|0|||
38009827|NCT00106353|69692205|FG001|Part 1|Symptomatic deterioration|0|||
38009828|NCT00106353|69692206|FG002|Part 1|Symptomatic deterioration|1|||
38009829|NCT00106353|69692207|FG003|Part 1|Symptomatic deterioration|0|||
38009830|NCT00106353|69692208|FG004|Part 1|Symptomatic deterioration|0|||
38009831|NCT00106353|69692209|FG005|Part 1|Symptomatic deterioration|0|||
38009832|NCT00106353|69692210|FG006|Part 1|Symptomatic deterioration|0|||
38009833|NCT00106353|69692204|FG000|Part 1|Entered follow-up phase|1|||
38009834|NCT00106353|69692205|FG001|Part 1|Entered follow-up phase|1|||
38009835|NCT00106353|69692206|FG002|Part 1|Entered follow-up phase|0|||
38009836|NCT00106353|69692207|FG003|Part 1|Entered follow-up phase|1|||
38009837|NCT00106353|69692208|FG004|Part 1|Entered follow-up phase|0|||
38009838|NCT00106353|69692209|FG005|Part 1|Entered follow-up phase|0|||
38009839|NCT00106353|69692210|FG006|Part 1|Entered follow-up phase|0|||
38009840|NCT00106353|69692204|FG000|Part 1|Adverse Event|0|||
38009841|NCT00106353|69692205|FG001|Part 1|Adverse Event|0|||
38009842|NCT00106353|69692206|FG002|Part 1|Adverse Event|0|||
38009843|NCT00106353|69692207|FG003|Part 1|Adverse Event|1|||
38009844|NCT00106353|69692208|FG004|Part 1|Adverse Event|0|||
38009845|NCT00106353|69692209|FG005|Part 1|Adverse Event|0|||
38009846|NCT00106353|69692210|FG006|Part 1|Adverse Event|0|||
38009847|NCT00106353|69692204|FG000|Part 2|Disease progression|0|||
38009848|NCT00106353|69692205|FG001|Part 2|Disease progression|0|||
38009849|NCT00106353|69692206|FG002|Part 2|Disease progression|0|||
38009850|NCT00106353|69692207|FG003|Part 2|Disease progression|0|||
38009851|NCT00106353|69692208|FG004|Part 2|Disease progression|8|||
38009852|NCT00106353|69692209|FG005|Part 2|Disease progression|14|||
38009853|NCT00106353|69692210|FG006|Part 2|Disease progression|13|||
38009854|NCT00106353|69692204|FG000|Part 2|Death|0|||
38009855|NCT00106353|69692205|FG001|Part 2|Death|0|||
38009856|NCT00106353|69692206|FG002|Part 2|Death|0|||
38009857|NCT00106353|69692207|FG003|Part 2|Death|0|||
38009858|NCT00106353|69692208|FG004|Part 2|Death|3|||
38009859|NCT00106353|69692209|FG005|Part 2|Death|0|||
38009860|NCT00106353|69692210|FG006|Part 2|Death|1|||
38009861|NCT00106353|69692204|FG000|Part 2|Symptomatic deterioration|0|||
37831663|NCT04003155|69515150|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
37831664|NCT04003155|69515151|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
37831665|NCT04003155|69515152|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
37831666|NCT04003155|69515153|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
37831667|NCT04003155|69515149|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
37831668|NCT04003155|69515150|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
37831669|NCT04003155|69515151|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
37831670|NCT04003155|69515152|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
37831671|NCT04003155|69515153|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
37831672|NCT04003155|69515149|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
37831673|NCT04003155|69515150|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
38009862|NCT00106353|69692205|FG001|Part 2|Symptomatic deterioration|0|||
38009863|NCT00106353|69692206|FG002|Part 2|Symptomatic deterioration|0|||
38009864|NCT00106353|69692207|FG003|Part 2|Symptomatic deterioration|0|||
38009865|NCT00106353|69692208|FG004|Part 2|Symptomatic deterioration|3|||
38009866|NCT00106353|69692209|FG005|Part 2|Symptomatic deterioration|0|||
38009867|NCT00106353|69692210|FG006|Part 2|Symptomatic deterioration|0|||
38009868|NCT00106353|69692204|FG000|Part 2|Adverse Event|0|||
38009869|NCT00106353|69692205|FG001|Part 2|Adverse Event|0|||
38009870|NCT00106353|69692206|FG002|Part 2|Adverse Event|0|||
38009871|NCT00106353|69692207|FG003|Part 2|Adverse Event|0|||
38009872|NCT00106353|69692208|FG004|Part 2|Adverse Event|0|||
38009873|NCT00106353|69692209|FG005|Part 2|Adverse Event|2|||
38009874|NCT00106353|69692210|FG006|Part 2|Adverse Event|1|||
38009875|NCT00106353|69692204|FG000|Part 2|Other|0|||
38009876|NCT00106353|69692205|FG001|Part 2|Other|0|||
38009877|NCT00106353|69692206|FG002|Part 2|Other|0|||
38009878|NCT00106353|69692207|FG003|Part 2|Other|0|||
38009879|NCT00106353|69692208|FG004|Part 2|Other|1|||
38009880|NCT00106353|69692209|FG005|Part 2|Other|1|||
38009881|NCT00106353|69692210|FG006|Part 2|Other|1|||
38009882|NCT00106353|69692204|FG000|Part 2|Withdrawal by Subject|0|||
38009883|NCT00106353|69692205|FG001|Part 2|Withdrawal by Subject|0|||
38009884|NCT00106353|69692206|FG002|Part 2|Withdrawal by Subject|0|||
38009885|NCT00106353|69692207|FG003|Part 2|Withdrawal by Subject|0|||
38009886|NCT00106353|69692208|FG004|Part 2|Withdrawal by Subject|1|||
38009887|NCT00106353|69692209|FG005|Part 2|Withdrawal by Subject|0|||
38009888|NCT00106353|69692210|FG006|Part 2|Withdrawal by Subject|0|||
38009889|NCT00106353|69692204|FG000|Part 2|Physician Decision|0|||
38009890|NCT00106353|69692205|FG001|Part 2|Physician Decision|0|||
38009891|NCT00106353|69692206|FG002|Part 2|Physician Decision|0|||
38009892|NCT00106353|69692207|FG003|Part 2|Physician Decision|0|||
37909078|NCT00950807|69594572|FG000|Treatment Period 3|Withdrawal by Subject|0|||
37909079|NCT00950807|69594573|FG001|Treatment Period 3|Withdrawal by Subject|0|||
37909080|NCT00950807|69594574|FG002|Treatment Period 3|Withdrawal by Subject|0|||
37909081|NCT00950807|69594575|FG003|Treatment Period 3|Withdrawal by Subject|0|||
37909082|NCT00950807|69594576|FG004|Treatment Period 3|Withdrawal by Subject|0|||
37909083|NCT00950807|69594577|FG005|Treatment Period 3|Withdrawal by Subject|0|||
37909084|NCT00950807|69594578|FG006|Treatment Period 3|Withdrawal by Subject|0|||
37909085|NCT00950807|69594579|FG007|Treatment Period 3|Withdrawal by Subject|0|||
37909086|NCT00950807|69594580|FG008|Treatment Period 3|Withdrawal by Subject|0|||
37909087|NCT00950807|69594581|FG009|Treatment Period 3|Withdrawal by Subject|1|||
37909088|NCT00950807|69594572|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
37909089|NCT00950807|69594573|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
37909090|NCT00950807|69594574|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
37909091|NCT00950807|69594575|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
37909092|NCT00950807|69594576|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
37831674|NCT04003155|69515151|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
37909093|NCT00950807|69594577|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
37909094|NCT00950807|69594578|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
37909095|NCT00950807|69594579|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
37909096|NCT00950807|69594580|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
37909097|NCT00950807|69594581|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
37909098|NCT00950807|69594572|FG000|Treatment Period 3|Adverse Event|0|||
37909099|NCT00950807|69594573|FG001|Treatment Period 3|Adverse Event|0|||
37909100|NCT00950807|69594574|FG002|Treatment Period 3|Adverse Event|0|||
37909101|NCT00950807|69594575|FG003|Treatment Period 3|Adverse Event|0|||
37909102|NCT00950807|69594576|FG004|Treatment Period 3|Adverse Event|0|||
37909103|NCT00950807|69594577|FG005|Treatment Period 3|Adverse Event|0|||
37831675|NCT04003155|69515152|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
37831676|NCT04003155|69515153|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
37831677|NCT04003155|69515149|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
37831678|NCT04003155|69515150|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
37831679|NCT04003155|69515151|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
37831680|NCT04003155|69515152|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
37831681|NCT04003155|69515153|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
37909104|NCT00950807|69594578|FG006|Treatment Period 3|Adverse Event|1|||
38009893|NCT00106353|69692208|FG004|Part 2|Physician Decision|0|||
38009894|NCT00106353|69692209|FG005|Part 2|Physician Decision|1|||
38009895|NCT00106353|69692210|FG006|Part 2|Physician Decision|0|||
38009896|NCT00080301|69692233|FG000|Overall Study|Randomized but Never Treated|5|||
38009897|NCT00080301|69692234|FG001|Overall Study|Randomized but Never Treated|10|||
38009898|NCT00080301|69692233|FG000|Overall Study|Still on Treatment as of CSR date|0|||
38009899|NCT00080301|69692234|FG001|Overall Study|Still on Treatment as of CSR date|1|||
37909105|NCT00950807|69594579|FG007|Treatment Period 3|Adverse Event|0|||
37909106|NCT00950807|69594580|FG008|Treatment Period 3|Adverse Event|0|||
37909107|NCT00950807|69594581|FG009|Treatment Period 3|Adverse Event|0|||
37909108|NCT00797511|69594603|FG000|Overall Study|Withdrawal by Subject|1|||
37909109|NCT00608881|69594610|FG000|Overall Study|Death|22|||
37909110|NCT00608881|69594611|FG001|Overall Study|Death|13|||
37909111|NCT00608881|69594610|FG000|Overall Study|Adverse Event|5|||
37909112|NCT00608881|69594611|FG001|Overall Study|Adverse Event|3|||
37909113|NCT00608881|69594610|FG000|Overall Study|Lost to Follow-up|28|||
37909114|NCT00608881|69594611|FG001|Overall Study|Lost to Follow-up|14|||
37909115|NCT00608881|69594610|FG000|Overall Study|Withdrawal by Subject|18|||
37909116|NCT00608881|69594611|FG001|Overall Study|Withdrawal by Subject|29|||
37909117|NCT00608881|69594610|FG000|Overall Study|Physician Decision|5|||
37909118|NCT00608881|69594611|FG001|Overall Study|Physician Decision|5|||
37909119|NCT00608881|69594610|FG000|Overall Study|Institutionalized|1|||
37909120|NCT00608881|69594611|FG001|Overall Study|Institutionalized|2|||
37909121|NCT00945191|69594617|FG000|Overall Study|Did not achieve a complete response|18|||
37909122|NCT00945191|69594617|FG000|Overall Study|Participant relocated to another state|1|||
37909123|NCT00945191|69594617|FG000|Overall Study|Disease progression|3|||
37909124|NCT00945191|69594617|FG000|Overall Study|Serious adverse event or adverse event|1|||
37909125|NCT00945191|69594617|FG000|Overall Study|Investigator's discretion|1|||
37909126|NCT00606931|69594621|FG000|Overall Study|Withdrawal by Subject|3|||
37909127|NCT00792909|69594628|FG000|Overall Study|Withdrawal by Subject|0|||
37909128|NCT00792909|69594629|FG001|Overall Study|Withdrawal by Subject|1|||
37909129|NCT00792909|69594630|FG002|Overall Study|Withdrawal by Subject|0|||
37909130|NCT00944645|69594641|FG000|Period 2|Adverse Event|1|||
37909131|NCT00944645|69594642|FG001|Period 2|Adverse Event|0|||
37909132|NCT00944645|69594641|FG000|Period 2|Lost to Follow-up|0|||
37909133|NCT00944645|69594642|FG001|Period 2|Lost to Follow-up|3|||
37909134|NCT00944645|69594641|FG000|Period 2|Withdrawal by Subject|7|||
37909135|NCT00944645|69594642|FG001|Period 2|Withdrawal by Subject|6|||
37909136|NCT00606229|69594648|FG000|Overall Study|Adverse Event|11|||
37909137|NCT00606229|69594648|FG000|Overall Study|Lack of Efficacy|1|||
37909138|NCT00606229|69594648|FG000|Overall Study|Withdrawal by Subject|4|||
37909139|NCT00606229|69594648|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
37909140|NCT00606229|69594648|FG000|Overall Study|change of residence or other commitments|2|||
37909141|NCT00950651|69594654|FG000|Overall Study|Adverse Event|17|||
37909142|NCT00950651|69594655|FG001|Overall Study|Adverse Event|20|||
37909143|NCT00950651|69594654|FG000|Overall Study|Death|1|||
37909144|NCT00950651|69594655|FG001|Overall Study|Death|0|||
37909145|NCT00950651|69594654|FG000|Overall Study|Lack of Efficacy|2|||
37909146|NCT00950651|69594655|FG001|Overall Study|Lack of Efficacy|2|||
37909147|NCT00950651|69594654|FG000|Overall Study|Protocol Violation|3|||
37909148|NCT00950651|69594655|FG001|Overall Study|Protocol Violation|4|||
37909149|NCT00950651|69594654|FG000|Overall Study|Withdrawal by Subject|8|||
37909150|NCT00950651|69594655|FG001|Overall Study|Withdrawal by Subject|9|||
37909151|NCT00605293|69594663|FG000|Overall Study|Death|2|||
37909152|NCT00605293|69594664|FG001|Overall Study|Death|1|||
38009900|NCT00079677|69692243|FG000|Overall Study|Adverse Event|5|||
38009901|NCT00079677|69692244|FG001|Overall Study|Adverse Event|6|||
38009902|NCT00079677|69692243|FG000|Overall Study|Lack of Efficacy|1|||
38009903|NCT00079677|69692244|FG001|Overall Study|Lack of Efficacy|0|||
37831682|NCT04003155|69515149|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
37831683|NCT04003155|69515150|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
37831684|NCT04003155|69515151|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
37831685|NCT04003155|69515152|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
37831686|NCT04003155|69515153|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
37831687|NCT04003155|69515149|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
37831688|NCT04003155|69515150|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
37831689|NCT04003155|69515151|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
37909153|NCT00605293|69594663|FG000|Overall Study|Insufficient Therapeutic Response|2|||
37909154|NCT00605293|69594664|FG001|Overall Study|Insufficient Therapeutic Response|0|||
37909155|NCT00605293|69594663|FG000|Overall Study|Adverse Event|1|||
37909156|NCT00605293|69594664|FG001|Overall Study|Adverse Event|0|||
37909157|NCT00605293|69594663|FG000|Overall Study|Holidays Dialysis Out|1|||
37909158|NCT00605293|69594664|FG001|Overall Study|Holidays Dialysis Out|0|||
37909159|NCT00605293|69594663|FG000|Overall Study|Blood Transfusion|7|||
37909160|NCT00605293|69594664|FG001|Overall Study|Blood Transfusion|1|||
37909161|NCT00605293|69594663|FG000|Overall Study|Renal Transplantation|3|||
37909162|NCT00605293|69594664|FG001|Overall Study|Renal Transplantation|1|||
37909163|NCT00605293|69594663|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
37909164|NCT00605293|69594664|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
37909165|NCT00605293|69594663|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
38009904|NCT00079677|69692243|FG000|Overall Study|Lost to Follow-up|2|||
37909166|NCT00605293|69594664|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
37909167|NCT00605293|69594663|FG000|Overall Study|Principal Investigator Decision|0|||
37909168|NCT00605293|69594664|FG001|Overall Study|Principal Investigator Decision|1|||
38009905|NCT00079677|69692244|FG001|Overall Study|Lost to Follow-up|2|||
38009906|NCT00079677|69692243|FG000|Overall Study|Physician Decision|3|||
38009907|NCT00079677|69692244|FG001|Overall Study|Physician Decision|0|||
38009908|NCT00079677|69692243|FG000|Overall Study|Protocol Violation|2|||
38009909|NCT00079677|69692244|FG001|Overall Study|Protocol Violation|3|||
38009910|NCT00079677|69692243|FG000|Overall Study|Withdrawal by Subject|5|||
38009911|NCT00079677|69692244|FG001|Overall Study|Withdrawal by Subject|3|||
38009912|NCT00079677|69692243|FG000|Overall Study|Miscellaneous|2|||
38009913|NCT00079677|69692244|FG001|Overall Study|Miscellaneous|0|||
38009914|NCT00095121|69692252|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
38009915|NCT00095121|69692253|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
38009916|NCT00095121|69692252|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
38009917|NCT00095121|69692253|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
38009918|NCT00094809|69692271|FG000|Overall Study|Protocol deviation|2|||
38009919|NCT00094809|69692272|FG001|Overall Study|Protocol deviation|2|||
38009920|NCT00094809|69692271|FG000|Overall Study|Noncompliance|1|||
38009921|NCT00094809|69692272|FG001|Overall Study|Noncompliance|0|||
38009922|NCT00094809|69692271|FG000|Overall Study|Adverse Event|3|||
38009923|NCT00094809|69692272|FG001|Overall Study|Adverse Event|1|||
38009924|NCT00094809|69692271|FG000|Overall Study|Withdrawal by Subject|8|||
38009925|NCT00094809|69692272|FG001|Overall Study|Withdrawal by Subject|9|||
38009926|NCT00094809|69692271|FG000|Overall Study|Disease progression|3|||
38009927|NCT00094809|69692272|FG001|Overall Study|Disease progression|3|||
38009928|NCT00094809|69692271|FG000|Overall Study|Physician Decision|3|||
38009929|NCT00094809|69692272|FG001|Overall Study|Physician Decision|5|||
37831690|NCT04003155|69515152|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
37831691|NCT04003155|69515153|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
37909169|NCT00572533|69594672|FG000|Overall Study|Death|4|||
37909170|NCT00572533|69594673|FG001|Overall Study|Death|1|||
37831692|NCT04003142|69515174|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
37831693|NCT04003142|69515175|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
37831694|NCT04003142|69515176|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
37831695|NCT04003142|69515177|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
37831696|NCT04003142|69515178|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
37831697|NCT04003142|69515174|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
37909171|NCT00572533|69594672|FG000|Overall Study|Received Kidney Transplant|2|||
37909172|NCT00572533|69594673|FG001|Overall Study|Received Kidney Transplant|1|||
37909173|NCT00572533|69594672|FG000|Overall Study|Social Issues|1|||
37909174|NCT00572533|69594673|FG001|Overall Study|Social Issues|0|||
37909175|NCT00572533|69594672|FG000|Overall Study|Transfer out of Facility|0|||
37909176|NCT00572533|69594673|FG001|Overall Study|Transfer out of Facility|1|||
37909177|NCT00949715|69594681|FG000|Overall Study|Physician Decision|1|||
37909178|NCT00949715|69594682|FG001|Overall Study|Physician Decision|0|||
37909179|NCT00949715|69594681|FG000|Overall Study|Lost to Follow-up|1|||
37909180|NCT00949715|69594682|FG001|Overall Study|Lost to Follow-up|0|||
37909181|NCT00949715|69594681|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
37909182|NCT00949715|69594682|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
37909183|NCT00791661|69594690|FG000|7 Day Wash-out|Adverse Event|0|||
37909184|NCT00791661|69594691|FG001|7 Day Wash-out|Adverse Event|0|||
37909185|NCT00791661|69594692|FG002|7 Day Wash-out|Adverse Event|1|||
37909186|NCT00791661|69594690|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
37909187|NCT00791661|69594691|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
37909188|NCT00791661|69594692|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
37909189|NCT00943787|69594716|FG000|Overall Study|Physician Decision|4|||
37909190|NCT00943787|69594716|FG000|Overall Study|Withdrawal by Subject|3|||
37909191|NCT00949325|69594720|FG000|Overall Study|Adverse Event|0|||
37909192|NCT00949325|69594721|FG001|Overall Study|Adverse Event|2|||
37909193|NCT00949325|69594722|FG002|Overall Study|Adverse Event|0|||
37909194|NCT00943319|69594738|FG000|Overall Study|Death|1|||
37909195|NCT00790647|69594742|FG000|Overall Study|Adverse Event|1|||
37909196|NCT00790569|69594751|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
37909197|NCT00790569|69594752|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
37909198|NCT00790569|69594753|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
38009930|NCT00094809|69692271|FG000|Overall Study|Lost to Follow-up|6|||
38009931|NCT00094809|69692272|FG001|Overall Study|Lost to Follow-up|6|||
38009932|NCT00094809|69692271|FG000|Overall Study|Death|19|||
38009933|NCT00094809|69692272|FG001|Overall Study|Death|25|||
37831698|NCT04003142|69515175|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
38009934|NCT00094809|69692271|FG000|Overall Study|Protocol-specified criteria|1|||
38009935|NCT00094809|69692272|FG001|Overall Study|Protocol-specified criteria|1|||
38009936|NCT00094809|69692271|FG000|Overall Study|Other|2|||
38009937|NCT00094809|69692272|FG001|Overall Study|Other|4|||
38009938|NCT00094809|69692271|FG000|Overall Study|Informed consent signed after treatment|1|||
37909199|NCT00790569|69594751|FG000|End of Treatment (6 Month Interview)|Death|0|||
37909200|NCT00790569|69594752|FG001|End of Treatment (6 Month Interview)|Death|2|||
37909201|NCT00790569|69594753|FG002|End of Treatment (6 Month Interview)|Death|1|||
37909202|NCT00790569|69594751|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
37909203|NCT00790569|69594752|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
37909204|NCT00790569|69594753|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
37909205|NCT00790569|69594751|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
37909206|NCT00790569|69594752|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
37909207|NCT00790569|69594753|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
37909208|NCT00790569|69594751|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
37909209|NCT00790569|69594752|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
37697932|NCT02435069|69174682|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
37697933|NCT02435069|69174683|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
37697934|NCT02454101|69174705|FG000|Overall Study|Adverse Event|2|||
37697935|NCT02454101|69174706|FG001|Overall Study|Adverse Event|3|||
37697936|NCT02454101|69174705|FG000|Overall Study|Lost to Follow-up|3|||
37697937|NCT02454101|69174706|FG001|Overall Study|Lost to Follow-up|4|||
37697938|NCT02409719|69174714|FG000|Overall Study|Lost to Follow-up|3|||
37697939|NCT02409719|69174715|FG001|Overall Study|Lost to Follow-up|3|||
37697940|NCT01820572|69174723|FG000|Randomization|Not Treated|2|||
37697941|NCT01820572|69174724|FG001|Randomization|Not Treated|1|||
37697942|NCT01820572|69174723|FG000|Treatment Period|Adverse Event|12|||
37697943|NCT01820572|69174724|FG001|Treatment Period|Adverse Event|7|||
37697944|NCT01820572|69174723|FG000|Treatment Period|Death|3|||
37697945|NCT01820572|69174724|FG001|Treatment Period|Death|3|||
37697946|NCT01820572|69174723|FG000|Treatment Period|Lack of Efficacy|1|||
37697947|NCT01820572|69174724|FG001|Treatment Period|Lack of Efficacy|0|||
37697948|NCT01820572|69174723|FG000|Treatment Period|poor/non compliance|0|||
37697949|NCT01820572|69174724|FG001|Treatment Period|poor/non compliance|3|||
37697950|NCT01820572|69174723|FG000|Treatment Period|request to discontinue|6|||
37697951|NCT01820572|69174724|FG001|Treatment Period|request to discontinue|11|||
37697952|NCT01820572|69174723|FG000|Treatment Period|No longer meets study criteria|3|||
37697953|NCT01820572|69174724|FG001|Treatment Period|No longer meets study criteria|10|||
37697954|NCT01820572|69174723|FG000|Treatment Period|withdrew consent|1|||
37697955|NCT01820572|69174724|FG001|Treatment Period|withdrew consent|2|||
37697956|NCT01820260|69174744|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
37697957|NCT01820260|69174745|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
37697958|NCT01820260|69174746|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
37697959|NCT01820260|69174747|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
37697960|NCT01820260|69174748|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
37697961|NCT01820260|69174749|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
37697962|NCT01820260|69174750|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
37697963|NCT01820260|69174751|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
37697964|NCT01820260|69174752|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
37697965|NCT01820260|69174753|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
37697966|NCT01820260|69174754|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
37697967|NCT01820260|69174755|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
37697968|NCT01820260|69174756|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
37697969|NCT01820260|69174757|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
37697970|NCT01820260|69174744|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
37697971|NCT01820260|69174745|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
37697972|NCT01820260|69174746|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
37697973|NCT01820260|69174747|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
37697974|NCT01820260|69174748|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
37697975|NCT01820260|69174749|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
37697976|NCT01820260|69174750|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
37697977|NCT01820260|69174751|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
37697978|NCT01820260|69174752|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
37697979|NCT01820260|69174753|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
37697980|NCT01820260|69174754|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
37697981|NCT01820260|69174755|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
37697982|NCT01820260|69174756|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
37697983|NCT01820260|69174757|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
37697984|NCT01610596|69174795|FG000|Overall Study|Lost to Follow-up|0|||
37697985|NCT01610596|69174796|FG001|Overall Study|Lost to Follow-up|1|||
37697986|NCT01818700|69174802|FG000|Overall Study|Adverse Event|67|||
37697987|NCT01818700|69174802|FG000|Overall Study|Lack of Efficacy|2|||
37697988|NCT01818700|69174802|FG000|Overall Study|Lost to Follow-up|5|||
37697989|NCT01818700|69174802|FG000|Overall Study|Withdrawal by Subject|27|||
37697990|NCT01818700|69174802|FG000|Overall Study|Protocol Violation|2|||
37831699|NCT04003142|69515176|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
38009939|NCT00094809|69692272|FG001|Overall Study|Informed consent signed after treatment|0|||
38009940|NCT00094809|69692271|FG000|Overall Study|Study drug not received|2|||
38009941|NCT00094809|69692272|FG001|Overall Study|Study drug not received|8|||
38009942|NCT00094809|69692271|FG000|Overall Study|Other|1|||
38009943|NCT00094809|69692272|FG001|Overall Study|Other|1|||
38009944|NCT00075218|69692280|FG000|Double-Blind Treatment|Adverse Event|23|||
38009945|NCT00075218|69692281|FG001|Double-Blind Treatment|Adverse Event|4|||
38009946|NCT00075218|69692282|FG002|Double-Blind Treatment|Adverse Event|0|||
38009947|NCT00075218|69692280|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
38009948|NCT00075218|69692281|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
38009949|NCT00075218|69692282|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
38009950|NCT00075218|69692280|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
38009951|NCT00075218|69692281|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
38009952|NCT00075218|69692282|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
38009953|NCT00075218|69692280|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
38009954|NCT00075218|69692281|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
38009955|NCT00075218|69692282|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
38009956|NCT00075218|69692280|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
38009957|NCT00075218|69692281|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
38009958|NCT00075218|69692282|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
38009959|NCT00075218|69692280|FG000|Double-Blind Treatment|No study medication taken|2|||
38009960|NCT00075218|69692281|FG001|Double-Blind Treatment|No study medication taken|0|||
38009961|NCT00075218|69692282|FG002|Double-Blind Treatment|No study medication taken|0|||
37831700|NCT04003142|69515177|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
37831701|NCT04003142|69515178|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
38009962|NCT00075218|69692280|FG000|Open-Label Treatment|Lack of Efficacy|0|||
38009963|NCT00075218|69692281|FG001|Open-Label Treatment|Lack of Efficacy|0|||
38009964|NCT00075218|69692282|FG002|Open-Label Treatment|Lack of Efficacy|174|||
38009965|NCT00075218|69692280|FG000|Open-Label Treatment|Adverse Event|0|||
38009966|NCT00075218|69692281|FG001|Open-Label Treatment|Adverse Event|0|||
38009967|NCT00075218|69692282|FG002|Open-Label Treatment|Adverse Event|51|||
38009968|NCT00075218|69692280|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
38009969|NCT00075218|69692281|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
38009970|NCT00075218|69692282|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
38009971|NCT00075218|69692280|FG000|Open-Label Treatment|Decision of Sponsor|0|||
38009972|NCT00075218|69692281|FG001|Open-Label Treatment|Decision of Sponsor|0|||
38009973|NCT00075218|69692282|FG002|Open-Label Treatment|Decision of Sponsor|8|||
38009974|NCT00075218|69692280|FG000|Open-Label Treatment|Protocol Violation|0|||
38009975|NCT00075218|69692281|FG001|Open-Label Treatment|Protocol Violation|0|||
38009976|NCT00075218|69692282|FG002|Open-Label Treatment|Protocol Violation|1|||
38009977|NCT00075218|69692280|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
38009978|NCT00075218|69692281|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
38009979|NCT00075218|69692282|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
38009980|NCT00094653|69692292|FG000|Overall Study|Death|306|||
38009981|NCT00094653|69692293|FG001|Overall Study|Death|100|||
38009982|NCT00094653|69692294|FG002|Overall Study|Death|119|||
38009983|NCT00094653|69692292|FG000|Overall Study|Subject Withdrew Consent|10|||
38009984|NCT00094653|69692293|FG001|Overall Study|Subject Withdrew Consent|2|||
38009985|NCT00094653|69692294|FG002|Overall Study|Subject Withdrew Consent|3|||
38009986|NCT00094653|69692292|FG000|Overall Study|Other|2|||
38009987|NCT00094653|69692293|FG001|Overall Study|Other|2|||
37831702|NCT04003142|69515174|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
37831703|NCT04003142|69515175|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
37831704|NCT04003142|69515176|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
37831705|NCT04003142|69515177|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
37831706|NCT04003142|69515178|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
38009988|NCT00094653|69692294|FG002|Overall Study|Other|2|||
38009989|NCT00094653|69692292|FG000|Overall Study|Lost to Follow-up|3|||
38009990|NCT00094653|69692293|FG001|Overall Study|Lost to Follow-up|2|||
38009991|NCT00094653|69692294|FG002|Overall Study|Lost to Follow-up|1|||
38009992|NCT00094653|69692292|FG000|Overall Study|Protocol Violation|0|||
37831707|NCT04003142|69515174|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
38009993|NCT00094653|69692293|FG001|Overall Study|Protocol Violation|0|||
38009994|NCT00094653|69692294|FG002|Overall Study|Protocol Violation|1|||
38009995|NCT00104247|69692305|FG000|Overall Study|Withdrawal by Subject|1|||
38009996|NCT00104247|69692306|FG001|Overall Study|Withdrawal by Subject|0|||
38009997|NCT00104247|69692305|FG000|Overall Study|Noncompliant with dosing|0|||
38009998|NCT00104247|69692306|FG001|Overall Study|Noncompliant with dosing|1|||
38009999|NCT03591406|69692314|FG000|Overall Study|Adverse Event|5|||
38010000|NCT03591406|69692315|FG001|Overall Study|Adverse Event|3|||
38010001|NCT03591406|69692314|FG000|Overall Study|Protocol Violation|2|||
38010002|NCT03591406|69692315|FG001|Overall Study|Protocol Violation|1|||
38010003|NCT03591406|69692314|FG000|Overall Study|Withdrawal by Subject|0|||
38010004|NCT03591406|69692315|FG001|Overall Study|Withdrawal by Subject|5|||
38010005|NCT03560986|69692323|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
38010006|NCT03560986|69692324|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
38010007|NCT03560986|69692323|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
38010008|NCT03560986|69692324|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
38010009|NCT03560986|69692323|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
38010010|NCT03560986|69692324|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
38010011|NCT03560986|69692323|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
38010012|NCT03560986|69692324|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
38010013|NCT03560986|69692323|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
38010014|NCT03560986|69692324|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
38010015|NCT03560986|69692323|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
38010016|NCT03560986|69692324|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
38010017|NCT03560986|69692323|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
38010018|NCT03560986|69692324|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
38010019|NCT03560518|69692339|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
38010020|NCT03560518|69692340|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
38010021|NCT03560518|69692341|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
38010022|NCT03560518|69692339|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
38010023|NCT03560518|69692340|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
38010024|NCT03560518|69692341|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
38010025|NCT03560518|69692339|FG000|Double Blind Treatment Period|Protocol Violation|1|||
38010026|NCT03560518|69692340|FG001|Double Blind Treatment Period|Protocol Violation|2|||
38010027|NCT03560518|69692341|FG002|Double Blind Treatment Period|Protocol Violation|0|||
38010028|NCT03560518|69692339|FG000|Double Blind Treatment Period|Pregnancy|0|||
38010029|NCT03560518|69692340|FG001|Double Blind Treatment Period|Pregnancy|2|||
38010030|NCT03560518|69692341|FG002|Double Blind Treatment Period|Pregnancy|0|||
38010031|NCT03560518|69692339|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
38010032|NCT03560518|69692340|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
38010033|NCT03560518|69692341|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
37831708|NCT04003142|69515175|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
37831709|NCT04003142|69515176|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
38010034|NCT03560518|69692339|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
38010035|NCT03560518|69692340|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
38010036|NCT03560518|69692341|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
38010037|NCT03560518|69692339|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
38010038|NCT03560518|69692340|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
38010039|NCT03560518|69692341|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
38010040|NCT03560518|69692339|FG000|Double Blind Treatment Period|Adverse Event|0|||
38010041|NCT03560518|69692340|FG001|Double Blind Treatment Period|Adverse Event|3|||
38010042|NCT03560518|69692341|FG002|Double Blind Treatment Period|Adverse Event|1|||
38010043|NCT03560206|69692351|FG000|Overall Study|Lost to Follow-up|19|||
38010044|NCT03560206|69692352|FG001|Overall Study|Lost to Follow-up|11|||
38010045|NCT03560206|69692351|FG000|Overall Study|Withdrawal by Subject|2|||
38010046|NCT03560206|69692352|FG001|Overall Study|Withdrawal by Subject|4|||
38010047|NCT03560206|69692351|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
38010048|NCT03560206|69692352|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
38010049|NCT03560206|69692351|FG000|Overall Study|Busy schedule|14|||
38010050|NCT03560206|69692352|FG001|Overall Study|Busy schedule|2|||
38010051|NCT03560206|69692351|FG000|Overall Study|patients' new health condition such as cancer|10|||
38010052|NCT03560206|69692352|FG001|Overall Study|patients' new health condition such as cancer|1|||
38010053|NCT02892760|69692358|FG000|Overall Study|Withdrawal by Subject|3|||
38010054|NCT03635086|69692367|FG000|Overall Study|Withdrawal of consent|0|||
38010055|NCT03635086|69692368|FG001|Overall Study|Withdrawal of consent|0|||
37697991|NCT01818700|69174802|FG000|Overall Study|Other|1|||
37831710|NCT04003142|69515177|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
37831711|NCT04003142|69515178|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
37697992|NCT01817764|69174810|FG000|Overall Study|Adverse Event|7|||
37697993|NCT01817764|69174811|FG001|Overall Study|Adverse Event|10|||
38010056|NCT03635086|69692369|FG002|Overall Study|Withdrawal of consent|1|||
38010057|NCT03635086|69692370|FG003|Overall Study|Withdrawal of consent|0|||
38010058|NCT03635086|69692371|FG004|Overall Study|Withdrawal of consent|0|||
38010059|NCT03635086|69692367|FG000|Overall Study|Adverse Event|0|||
38010060|NCT03635086|69692368|FG001|Overall Study|Adverse Event|1|||
38010061|NCT03635086|69692369|FG002|Overall Study|Adverse Event|0|||
38010062|NCT03635086|69692370|FG003|Overall Study|Adverse Event|0|||
38010063|NCT03635086|69692371|FG004|Overall Study|Adverse Event|0|||
38010064|NCT03635086|69692367|FG000|Overall Study|Lost to Follow-up|1|||
38010065|NCT03635086|69692368|FG001|Overall Study|Lost to Follow-up|0|||
38010066|NCT03635086|69692369|FG002|Overall Study|Lost to Follow-up|0|||
38010067|NCT03635086|69692370|FG003|Overall Study|Lost to Follow-up|0|||
38010068|NCT03635086|69692371|FG004|Overall Study|Lost to Follow-up|0|||
38010069|NCT03588910|69692386|FG000|Overall Study|Withdrawal by Subject|1|||
38010070|NCT03588910|69692387|FG001|Overall Study|Withdrawal by Subject|0|||
38010071|NCT03588910|69692386|FG000|Overall Study|Allergy|2|||
38010072|NCT03588910|69692387|FG001|Overall Study|Allergy|0|||
38010073|NCT03588910|69692386|FG000|Overall Study|Protocol Violation|0|||
38010074|NCT03588910|69692387|FG001|Overall Study|Protocol Violation|3|||
37697994|NCT01817764|69174810|FG000|Overall Study|Lack of Efficacy|9|||
37697995|NCT01817764|69174811|FG001|Overall Study|Lack of Efficacy|7|||
37697996|NCT01817764|69174810|FG000|Overall Study|Protocol Violation|7|||
37697997|NCT01817764|69174811|FG001|Overall Study|Protocol Violation|5|||
37697998|NCT01817764|69174810|FG000|Overall Study|Lost to Follow-up|1|||
37697999|NCT01817764|69174811|FG001|Overall Study|Lost to Follow-up|4|||
37698000|NCT01817764|69174810|FG000|Overall Study|Withdrawal by Subject|10|||
37831712|NCT04003142|69515174|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
38010075|NCT03588910|69692386|FG000|Overall Study|Did not complete Day 1 Survey|5|||
38010076|NCT03588910|69692387|FG001|Overall Study|Did not complete Day 1 Survey|10|||
38010077|NCT03588910|69692386|FG000|Overall Study|Did not complete Day 7 Survey|5|||
38010078|NCT03588910|69692387|FG001|Overall Study|Did not complete Day 7 Survey|2|||
38010079|NCT03587974|69692395|FG000|Overall Study|caregiver demented, care recipient died|3|||
38010080|NCT03587974|69692396|FG001|Overall Study|caregiver demented, care recipient died|3|||
38010081|NCT03587974|69692395|FG000|Overall Study|Withdrawal by Subject|2|||
38010082|NCT03587974|69692396|FG001|Overall Study|Withdrawal by Subject|1|||
38010083|NCT00103857|69692409|FG000|54-Week Base Study|Adverse Event|12|||
38010084|NCT00103857|69692410|FG001|54-Week Base Study|Adverse Event|9|||
37831713|NCT04003142|69515175|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
37831714|NCT04003142|69515176|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
37831715|NCT04003142|69515177|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
37831716|NCT04003142|69515178|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
37831717|NCT04003142|69515174|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
37831718|NCT04003142|69515175|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
37831719|NCT04003142|69515176|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
37831720|NCT04003142|69515177|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
37831721|NCT04003142|69515178|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
37831722|NCT04003142|69515174|FG000|Extension Period (40 Weeks)|Death|0|||
37831723|NCT04003142|69515175|FG001|Extension Period (40 Weeks)|Death|0|||
37831724|NCT04003142|69515176|FG002|Extension Period (40 Weeks)|Death|0|||
37831725|NCT04003142|69515177|FG003|Extension Period (40 Weeks)|Death|0|||
37831726|NCT04003142|69515178|FG004|Extension Period (40 Weeks)|Death|1|||
37831727|NCT04003142|69515174|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
37831728|NCT04003142|69515175|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
37831729|NCT04003142|69515176|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
37831730|NCT04003142|69515177|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
37831731|NCT04003142|69515178|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
37831732|NCT04003142|69515174|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
37831733|NCT04003142|69515175|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
38010085|NCT00103857|69692411|FG002|54-Week Base Study|Adverse Event|11|||
38010086|NCT00103857|69692412|FG003|54-Week Base Study|Adverse Event|6|||
37698001|NCT01817764|69174811|FG001|Overall Study|Withdrawal by Subject|12|||
37831734|NCT04003142|69515176|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
37831735|NCT04003142|69515177|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
37831736|NCT04003142|69515178|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
38010087|NCT00103857|69692413|FG004|54-Week Base Study|Adverse Event|5|||
38010088|NCT00103857|69692414|FG005|54-Week Base Study|Adverse Event|11|||
38010089|NCT00103857|69692415|FG006|54-Week Base Study|Adverse Event|3|||
38010090|NCT00103857|69692409|FG000|54-Week Base Study|Death|0|||
38010091|NCT00103857|69692410|FG001|54-Week Base Study|Death|0|||
38010092|NCT00103857|69692411|FG002|54-Week Base Study|Death|0|||
37698002|NCT01803880|69174820|FG000|Overall Study|Adverse Event|1|||
37698003|NCT01803880|69174821|FG001|Overall Study|Adverse Event|0|||
37698004|NCT01803880|69174822|FG002|Overall Study|Adverse Event|0|||
37698005|NCT01803880|69174820|FG000|Overall Study|Withdrawal by Subject|1|||
37698006|NCT01803880|69174821|FG001|Overall Study|Withdrawal by Subject|1|||
37698007|NCT01803880|69174822|FG002|Overall Study|Withdrawal by Subject|4|||
37698008|NCT01803880|69174820|FG000|Overall Study|Physician Decision|0|||
37698009|NCT01803880|69174821|FG001|Overall Study|Physician Decision|0|||
37698010|NCT01803880|69174822|FG002|Overall Study|Physician Decision|1|||
37698011|NCT01803880|69174820|FG000|Overall Study|Unable to return for follow-up visits|0|||
37698012|NCT01803880|69174821|FG001|Overall Study|Unable to return for follow-up visits|1|||
37698013|NCT01803880|69174822|FG002|Overall Study|Unable to return for follow-up visits|2|||
37698014|NCT01803880|69174820|FG000|Overall Study|Lost to Follow-up|1|||
37698015|NCT01803880|69174821|FG001|Overall Study|Lost to Follow-up|2|||
37698016|NCT01803880|69174822|FG002|Overall Study|Lost to Follow-up|3|||
37698017|NCT01803880|69174820|FG000|Overall Study|Protocol Violation|1|||
37698018|NCT01803880|69174821|FG001|Overall Study|Protocol Violation|0|||
37698019|NCT01803880|69174822|FG002|Overall Study|Protocol Violation|0|||
37698020|NCT01803880|69174820|FG000|Overall Study|Early study termination|0|||
38010093|NCT00103857|69692412|FG003|54-Week Base Study|Death|0|||
38010094|NCT00103857|69692413|FG004|54-Week Base Study|Death|1|||
38010095|NCT00103857|69692414|FG005|54-Week Base Study|Death|1|||
38010096|NCT00103857|69692415|FG006|54-Week Base Study|Death|0|||
37831737|NCT04003142|69515174|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
37698021|NCT01803880|69174821|FG001|Overall Study|Early study termination|6|||
37698022|NCT01803880|69174822|FG002|Overall Study|Early study termination|5|||
37698023|NCT01803880|69174820|FG000|Overall Study|Incomplete data entry by sites|2|||
37698024|NCT01803880|69174821|FG001|Overall Study|Incomplete data entry by sites|0|||
37698025|NCT01803880|69174822|FG002|Overall Study|Incomplete data entry by sites|0|||
37698026|NCT01803646|69174834|FG000|Overall Study|Protocol Violation|1|||
37698027|NCT01803646|69174835|FG001|Overall Study|Protocol Violation|0|||
37698028|NCT01803646|69174834|FG000|Overall Study|Adverse Event|1|||
37698029|NCT01803646|69174835|FG001|Overall Study|Adverse Event|1|||
37698030|NCT01803646|69174834|FG000|Overall Study|Withdrawal by Subject|9|||
37698031|NCT01803646|69174835|FG001|Overall Study|Withdrawal by Subject|6|||
37698032|NCT01803646|69174834|FG000|Overall Study|Randomization error|1|||
37698033|NCT01803646|69174835|FG001|Overall Study|Randomization error|2|||
37698034|NCT01803646|69174834|FG000|Overall Study|Lost to Follow-up|5|||
37698035|NCT01803646|69174835|FG001|Overall Study|Lost to Follow-up|1|||
37698036|NCT01817530|69174849|FG000|Overall Study|Exclusionary Medication Received|0|||
37698037|NCT01817530|69174850|FG001|Overall Study|Exclusionary Medication Received|0|||
37698038|NCT01817530|69174851|FG002|Overall Study|Exclusionary Medication Received|0|||
37698039|NCT01817530|69174852|FG003|Overall Study|Exclusionary Medication Received|0|||
37698040|NCT01817530|69174853|FG004|Overall Study|Exclusionary Medication Received|1|||
37698041|NCT01817530|69174854|FG005|Overall Study|Exclusionary Medication Received|0|||
37698042|NCT01817530|69174855|FG006|Overall Study|Exclusionary Medication Received|0|||
37698043|NCT01817530|69174856|FG007|Overall Study|Exclusionary Medication Received|0|||
38010097|NCT00103857|69692409|FG000|54-Week Base Study|Lack of Efficacy|11|||
38010098|NCT00103857|69692410|FG001|54-Week Base Study|Lack of Efficacy|14|||
38010099|NCT00103857|69692411|FG002|54-Week Base Study|Lack of Efficacy|8|||
38010100|NCT00103857|69692412|FG003|54-Week Base Study|Lack of Efficacy|4|||
38010101|NCT00103857|69692413|FG004|54-Week Base Study|Lack of Efficacy|3|||
37698044|NCT01817530|69174849|FG000|Overall Study|Adverse Event|6|||
37831738|NCT04003142|69515175|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
37831739|NCT04003142|69515176|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
37831740|NCT04003142|69515177|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
37831741|NCT04003142|69515178|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
37831742|NCT04003142|69515174|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
37831743|NCT04003142|69515175|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
37831744|NCT04003142|69515176|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
37831745|NCT04003142|69515177|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
37831746|NCT04003142|69515178|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
37698045|NCT01817530|69174850|FG001|Overall Study|Adverse Event|3|||
37698046|NCT01817530|69174851|FG002|Overall Study|Adverse Event|2|||
37698047|NCT01817530|69174852|FG003|Overall Study|Adverse Event|5|||
37698048|NCT01817530|69174853|FG004|Overall Study|Adverse Event|0|||
37698049|NCT01817530|69174854|FG005|Overall Study|Adverse Event|10|||
37831747|NCT03971422|69515199|FG000|Overall Study|Lost to Follow-up|0|||
37698050|NCT01817530|69174855|FG006|Overall Study|Adverse Event|5|||
37698051|NCT01817530|69174856|FG007|Overall Study|Adverse Event|8|||
37831748|NCT03971422|69515200|FG001|Overall Study|Lost to Follow-up|1|||
37831749|NCT03971422|69515201|FG002|Overall Study|Lost to Follow-up|0|||
38010102|NCT00103857|69692414|FG005|54-Week Base Study|Lack of Efficacy|14|||
38010103|NCT00103857|69692415|FG006|54-Week Base Study|Lack of Efficacy|19|||
38010104|NCT00103857|69692409|FG000|54-Week Base Study|Lost to Follow-up|5|||
38010105|NCT00103857|69692410|FG001|54-Week Base Study|Lost to Follow-up|4|||
38010106|NCT00103857|69692411|FG002|54-Week Base Study|Lost to Follow-up|7|||
38010107|NCT00103857|69692412|FG003|54-Week Base Study|Lost to Follow-up|5|||
38010108|NCT00103857|69692413|FG004|54-Week Base Study|Lost to Follow-up|10|||
38010109|NCT00103857|69692414|FG005|54-Week Base Study|Lost to Follow-up|9|||
38010110|NCT00103857|69692415|FG006|54-Week Base Study|Lost to Follow-up|3|||
38010111|NCT00103857|69692409|FG000|54-Week Base Study|Physician Decision|1|||
38010112|NCT00103857|69692410|FG001|54-Week Base Study|Physician Decision|1|||
38010113|NCT00103857|69692411|FG002|54-Week Base Study|Physician Decision|0|||
38010114|NCT00103857|69692412|FG003|54-Week Base Study|Physician Decision|0|||
38010115|NCT00103857|69692413|FG004|54-Week Base Study|Physician Decision|1|||
38010116|NCT00103857|69692414|FG005|54-Week Base Study|Physician Decision|0|||
38010117|NCT00103857|69692415|FG006|54-Week Base Study|Physician Decision|0|||
38010118|NCT00103857|69692409|FG000|54-Week Base Study|Pregnancy|1|||
38010119|NCT00103857|69692410|FG001|54-Week Base Study|Pregnancy|0|||
38010120|NCT00103857|69692411|FG002|54-Week Base Study|Pregnancy|0|||
38010121|NCT00103857|69692412|FG003|54-Week Base Study|Pregnancy|0|||
38010122|NCT00103857|69692413|FG004|54-Week Base Study|Pregnancy|1|||
38010123|NCT00103857|69692414|FG005|54-Week Base Study|Pregnancy|0|||
38010124|NCT00103857|69692415|FG006|54-Week Base Study|Pregnancy|1|||
38010125|NCT00103857|69692409|FG000|54-Week Base Study|Protocol Violation|6|||
38010126|NCT00103857|69692410|FG001|54-Week Base Study|Protocol Violation|4|||
38010127|NCT00103857|69692411|FG002|54-Week Base Study|Protocol Violation|2|||
38010128|NCT00103857|69692412|FG003|54-Week Base Study|Protocol Violation|4|||
38010129|NCT00103857|69692413|FG004|54-Week Base Study|Protocol Violation|0|||
38010130|NCT00103857|69692414|FG005|54-Week Base Study|Protocol Violation|3|||
38010131|NCT00103857|69692415|FG006|54-Week Base Study|Protocol Violation|3|||
38010132|NCT00103857|69692409|FG000|54-Week Base Study|Withdrawal by Subject|17|||
38010133|NCT00103857|69692410|FG001|54-Week Base Study|Withdrawal by Subject|16|||
38010134|NCT00103857|69692411|FG002|54-Week Base Study|Withdrawal by Subject|16|||
38010135|NCT00103857|69692412|FG003|54-Week Base Study|Withdrawal by Subject|15|||
38010136|NCT00103857|69692413|FG004|54-Week Base Study|Withdrawal by Subject|10|||
38010137|NCT00103857|69692414|FG005|54-Week Base Study|Withdrawal by Subject|15|||
38010138|NCT00103857|69692415|FG006|54-Week Base Study|Withdrawal by Subject|4|||
38010139|NCT00103857|69692409|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
38010140|NCT00103857|69692410|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
38010141|NCT00103857|69692411|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
38010142|NCT00103857|69692412|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
38010143|NCT00103857|69692413|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
38010144|NCT00103857|69692414|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
38010145|NCT00103857|69692415|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
38010146|NCT00103857|69692409|FG000|54-Week Base Study|patient moved|0|||
38010147|NCT00103857|69692410|FG001|54-Week Base Study|patient moved|1|||
38010148|NCT00103857|69692411|FG002|54-Week Base Study|patient moved|1|||
38010149|NCT00103857|69692412|FG003|54-Week Base Study|patient moved|2|||
38010150|NCT00103857|69692413|FG004|54-Week Base Study|patient moved|3|||
38010151|NCT00103857|69692414|FG005|54-Week Base Study|patient moved|1|||
38010152|NCT00103857|69692415|FG006|54-Week Base Study|patient moved|0|||
38010153|NCT00103857|69692409|FG000|54-Week Base Study|non-compliance with study procedures|1|||
38010154|NCT00103857|69692410|FG001|54-Week Base Study|non-compliance with study procedures|2|||
38010155|NCT00103857|69692411|FG002|54-Week Base Study|non-compliance with study procedures|0|||
38010156|NCT00103857|69692412|FG003|54-Week Base Study|non-compliance with study procedures|0|||
38010157|NCT00103857|69692413|FG004|54-Week Base Study|non-compliance with study procedures|0|||
38010158|NCT00103857|69692414|FG005|54-Week Base Study|non-compliance with study procedures|2|||
38010159|NCT00103857|69692415|FG006|54-Week Base Study|non-compliance with study procedures|0|||
38010160|NCT00103857|69692409|FG000|54-Week Base Study|patient incarcerated|0|||
37831750|NCT03971422|69515199|FG000|Overall Study|Lack of Efficacy|5|||
38010161|NCT00103857|69692410|FG001|54-Week Base Study|patient incarcerated|0|||
38010162|NCT00103857|69692411|FG002|54-Week Base Study|patient incarcerated|0|||
38010163|NCT00103857|69692412|FG003|54-Week Base Study|patient incarcerated|0|||
38010164|NCT00103857|69692413|FG004|54-Week Base Study|patient incarcerated|1|||
38010165|NCT00103857|69692414|FG005|54-Week Base Study|patient incarcerated|1|||
38010166|NCT00103857|69692415|FG006|54-Week Base Study|patient incarcerated|0|||
38010167|NCT00103857|69692409|FG000|54-Week Base Study|laboratory reporting error|0|||
38010168|NCT00103857|69692410|FG001|54-Week Base Study|laboratory reporting error|0|||
38010169|NCT00103857|69692411|FG002|54-Week Base Study|laboratory reporting error|0|||
38010170|NCT00103857|69692412|FG003|54-Week Base Study|laboratory reporting error|0|||
38010171|NCT00103857|69692413|FG004|54-Week Base Study|laboratory reporting error|1|||
38010172|NCT00103857|69692414|FG005|54-Week Base Study|laboratory reporting error|0|||
38010173|NCT00103857|69692415|FG006|54-Week Base Study|laboratory reporting error|0|||
38010174|NCT00103857|69692409|FG000|54-Week Base Study|site error|0|||
37831751|NCT03971422|69515200|FG001|Overall Study|Lack of Efficacy|1|||
38010175|NCT00103857|69692410|FG001|54-Week Base Study|site error|0|||
37698052|NCT01817530|69174849|FG000|Overall Study|Subject Noncompliant|3|||
37698053|NCT01817530|69174850|FG001|Overall Study|Subject Noncompliant|1|||
38010176|NCT00103857|69692411|FG002|54-Week Base Study|site error|0|||
38010177|NCT00103857|69692412|FG003|54-Week Base Study|site error|0|||
38010178|NCT00103857|69692413|FG004|54-Week Base Study|site error|0|||
38010179|NCT00103857|69692414|FG005|54-Week Base Study|site error|1|||
38010180|NCT00103857|69692415|FG006|54-Week Base Study|site error|0|||
38010181|NCT00103857|69692409|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
38010182|NCT00103857|69692410|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
38010183|NCT00103857|69692411|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
38010184|NCT00103857|69692412|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
38010185|NCT00103857|69692413|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
38010186|NCT00103857|69692414|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
38010187|NCT00103857|69692415|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
38010188|NCT00103857|69692409|FG000|50-Week Extension Study|Adverse Event|2|||
38010189|NCT00103857|69692410|FG001|50-Week Extension Study|Adverse Event|3|||
38010190|NCT00103857|69692411|FG002|50-Week Extension Study|Adverse Event|2|||
38010191|NCT00103857|69692412|FG003|50-Week Extension Study|Adverse Event|0|||
38010192|NCT00103857|69692413|FG004|50-Week Extension Study|Adverse Event|1|||
38010193|NCT00103857|69692414|FG005|50-Week Extension Study|Adverse Event|1|||
38010194|NCT00103857|69692415|FG006|50-Week Extension Study|Adverse Event|0|||
38010195|NCT00103857|69692409|FG000|50-Week Extension Study|Death|0|||
38010196|NCT00103857|69692410|FG001|50-Week Extension Study|Death|0|||
38010197|NCT00103857|69692411|FG002|50-Week Extension Study|Death|0|||
38010198|NCT00103857|69692412|FG003|50-Week Extension Study|Death|1|||
38010199|NCT00103857|69692413|FG004|50-Week Extension Study|Death|0|||
38010200|NCT00103857|69692414|FG005|50-Week Extension Study|Death|1|||
38010201|NCT00103857|69692415|FG006|50-Week Extension Study|Death|0|||
38010202|NCT00103857|69692409|FG000|50-Week Extension Study|Lack of Efficacy|26|||
38010203|NCT00103857|69692410|FG001|50-Week Extension Study|Lack of Efficacy|15|||
38010204|NCT00103857|69692411|FG002|50-Week Extension Study|Lack of Efficacy|13|||
38010205|NCT00103857|69692412|FG003|50-Week Extension Study|Lack of Efficacy|16|||
38010206|NCT00103857|69692413|FG004|50-Week Extension Study|Lack of Efficacy|8|||
38010207|NCT00103857|69692414|FG005|50-Week Extension Study|Lack of Efficacy|8|||
38010208|NCT00103857|69692415|FG006|50-Week Extension Study|Lack of Efficacy|0|||
38010209|NCT00103857|69692409|FG000|50-Week Extension Study|Lost to Follow-up|4|||
38010210|NCT00103857|69692410|FG001|50-Week Extension Study|Lost to Follow-up|0|||
38010211|NCT00103857|69692411|FG002|50-Week Extension Study|Lost to Follow-up|1|||
38010212|NCT00103857|69692412|FG003|50-Week Extension Study|Lost to Follow-up|4|||
38010213|NCT00103857|69692413|FG004|50-Week Extension Study|Lost to Follow-up|3|||
38010214|NCT00103857|69692414|FG005|50-Week Extension Study|Lost to Follow-up|3|||
38010215|NCT00103857|69692415|FG006|50-Week Extension Study|Lost to Follow-up|0|||
38010216|NCT00103857|69692409|FG000|50-Week Extension Study|Physician Decision|0|||
38010217|NCT00103857|69692410|FG001|50-Week Extension Study|Physician Decision|1|||
38010218|NCT00103857|69692411|FG002|50-Week Extension Study|Physician Decision|1|||
38010219|NCT00103857|69692412|FG003|50-Week Extension Study|Physician Decision|0|||
38010220|NCT00103857|69692413|FG004|50-Week Extension Study|Physician Decision|0|||
38010221|NCT00103857|69692414|FG005|50-Week Extension Study|Physician Decision|0|||
38010222|NCT00103857|69692415|FG006|50-Week Extension Study|Physician Decision|0|||
38010223|NCT00103857|69692409|FG000|50-Week Extension Study|Pregnancy|0|||
38010224|NCT00103857|69692410|FG001|50-Week Extension Study|Pregnancy|0|||
37831752|NCT03971422|69515201|FG002|Overall Study|Lack of Efficacy|1|||
38010225|NCT00103857|69692411|FG002|50-Week Extension Study|Pregnancy|1|||
38010226|NCT00103857|69692412|FG003|50-Week Extension Study|Pregnancy|0|||
37831753|NCT03971422|69515199|FG000|Overall Study|Adverse event, not fatal|2|||
37831754|NCT03971422|69515200|FG001|Overall Study|Adverse event, not fatal|2|||
37831755|NCT03971422|69515201|FG002|Overall Study|Adverse event, not fatal|5|||
37831756|NCT03971422|69515199|FG000|Overall Study|Worsening of MG Symptoms|1|||
37831757|NCT03971422|69515200|FG001|Overall Study|Worsening of MG Symptoms|4|||
37831758|NCT03971422|69515201|FG002|Overall Study|Worsening of MG Symptoms|2|||
37831759|NCT03971422|69515199|FG000|Overall Study|Roll over to MG0007 (NCT04650854)|10|||
37831760|NCT03971422|69515200|FG001|Overall Study|Roll over to MG0007 (NCT04650854)|6|||
37831761|NCT03971422|69515201|FG002|Overall Study|Roll over to MG0007 (NCT04650854)|9|||
37831762|NCT03971422|69515199|FG000|Overall Study|Roll over to MG0004 (NCT04124965)|7|||
37831763|NCT03971422|69515200|FG001|Overall Study|Roll over to MG0004 (NCT04124965)|8|||
38010227|NCT00103857|69692413|FG004|50-Week Extension Study|Pregnancy|1|||
38010228|NCT00103857|69692414|FG005|50-Week Extension Study|Pregnancy|0|||
38010229|NCT00103857|69692415|FG006|50-Week Extension Study|Pregnancy|0|||
38010230|NCT00103857|69692409|FG000|50-Week Extension Study|Protocol Violation|1|||
38010231|NCT00103857|69692410|FG001|50-Week Extension Study|Protocol Violation|1|||
37698054|NCT01817530|69174851|FG002|Overall Study|Subject Noncompliant|0|||
37831764|NCT03971422|69515201|FG002|Overall Study|Roll over to MG0004 (NCT04124965)|6|||
37831765|NCT03971422|69515199|FG000|Overall Study|Due to COVID-19 pandemic|0|||
37831766|NCT03971422|69515200|FG001|Overall Study|Due to COVID-19 pandemic|1|||
37698055|NCT01817530|69174852|FG003|Overall Study|Subject Noncompliant|4|||
37698056|NCT01817530|69174853|FG004|Overall Study|Subject Noncompliant|0|||
37698057|NCT01817530|69174854|FG005|Overall Study|Subject Noncompliant|1|||
37698058|NCT01817530|69174855|FG006|Overall Study|Subject Noncompliant|1|||
37698059|NCT01817530|69174856|FG007|Overall Study|Subject Noncompliant|1|||
37698060|NCT01817530|69174849|FG000|Overall Study|Lack of Efficacy|1|||
37698061|NCT01817530|69174850|FG001|Overall Study|Lack of Efficacy|0|||
37698062|NCT01817530|69174851|FG002|Overall Study|Lack of Efficacy|0|||
37698063|NCT01817530|69174852|FG003|Overall Study|Lack of Efficacy|0|||
37698064|NCT01817530|69174853|FG004|Overall Study|Lack of Efficacy|0|||
37698065|NCT01817530|69174854|FG005|Overall Study|Lack of Efficacy|1|||
37698066|NCT01817530|69174855|FG006|Overall Study|Lack of Efficacy|0|||
37698067|NCT01817530|69174856|FG007|Overall Study|Lack of Efficacy|1|||
37698068|NCT01817530|69174849|FG000|Overall Study|Pregnancy|0|||
37698069|NCT01817530|69174850|FG001|Overall Study|Pregnancy|0|||
37698070|NCT01817530|69174851|FG002|Overall Study|Pregnancy|0|||
37698071|NCT01817530|69174852|FG003|Overall Study|Pregnancy|0|||
37698072|NCT01817530|69174853|FG004|Overall Study|Pregnancy|0|||
37698073|NCT01817530|69174854|FG005|Overall Study|Pregnancy|1|||
37698074|NCT01817530|69174855|FG006|Overall Study|Pregnancy|0|||
37698075|NCT01817530|69174856|FG007|Overall Study|Pregnancy|0|||
37698076|NCT01817530|69174849|FG000|Overall Study|Other|0|||
37698077|NCT01817530|69174850|FG001|Overall Study|Other|1|||
37698078|NCT01817530|69174851|FG002|Overall Study|Other|0|||
37698079|NCT01817530|69174852|FG003|Overall Study|Other|0|||
37698080|NCT01817530|69174853|FG004|Overall Study|Other|1|||
37698081|NCT01817530|69174854|FG005|Overall Study|Other|0|||
37698082|NCT01817530|69174855|FG006|Overall Study|Other|5|||
37698083|NCT01817530|69174856|FG007|Overall Study|Other|0|||
37698084|NCT01817530|69174849|FG000|Overall Study|Surgery or Invasive Intervention|1|||
37698085|NCT01817530|69174850|FG001|Overall Study|Surgery or Invasive Intervention|0|||
37698086|NCT01817530|69174851|FG002|Overall Study|Surgery or Invasive Intervention|0|||
37698087|NCT01817530|69174852|FG003|Overall Study|Surgery or Invasive Intervention|0|||
37698088|NCT01817530|69174853|FG004|Overall Study|Surgery or Invasive Intervention|1|||
37698089|NCT01817530|69174854|FG005|Overall Study|Surgery or Invasive Intervention|1|||
37698090|NCT01817530|69174855|FG006|Overall Study|Surgery or Invasive Intervention|1|||
37698091|NCT01817530|69174856|FG007|Overall Study|Surgery or Invasive Intervention|0|||
37698092|NCT01817530|69174849|FG000|Overall Study|Consent Withdrawn by Subject|3|||
37698093|NCT01817530|69174850|FG001|Overall Study|Consent Withdrawn by Subject|4|||
37698094|NCT01817530|69174851|FG002|Overall Study|Consent Withdrawn by Subject|7|||
37698095|NCT01817530|69174852|FG003|Overall Study|Consent Withdrawn by Subject|3|||
37698096|NCT01817530|69174853|FG004|Overall Study|Consent Withdrawn by Subject|5|||
37698097|NCT01817530|69174854|FG005|Overall Study|Consent Withdrawn by Subject|3|||
37698098|NCT01817530|69174855|FG006|Overall Study|Consent Withdrawn by Subject|3|||
37698099|NCT01817530|69174856|FG007|Overall Study|Consent Withdrawn by Subject|10|||
37698100|NCT01817530|69174849|FG000|Overall Study|Lost to Follow-up|1|||
37698101|NCT01817530|69174850|FG001|Overall Study|Lost to Follow-up|4|||
37698102|NCT01817530|69174851|FG002|Overall Study|Lost to Follow-up|2|||
37698103|NCT01817530|69174852|FG003|Overall Study|Lost to Follow-up|1|||
37698104|NCT01817530|69174853|FG004|Overall Study|Lost to Follow-up|3|||
37698105|NCT01817530|69174854|FG005|Overall Study|Lost to Follow-up|2|||
37698106|NCT01817530|69174855|FG006|Overall Study|Lost to Follow-up|8|||
37698107|NCT01817530|69174856|FG007|Overall Study|Lost to Follow-up|4|||
37698108|NCT01816984|69174874|FG000|Overall Study|declining health status|1|||
37698109|NCT01816906|69174880|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
37698110|NCT01816906|69174881|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
37698111|NCT01816906|69174880|FG000|Six Months|Lost to Follow-up|14|||
37698112|NCT01816906|69174881|FG001|Six Months|Lost to Follow-up|16|||
37698113|NCT01816906|69174880|FG000|12 Months|Adverse Event|2|||
37698114|NCT01816906|69174881|FG001|12 Months|Adverse Event|2|||
37698115|NCT01816906|69174880|FG000|12 Months|Death|0|||
37698116|NCT01816906|69174881|FG001|12 Months|Death|2|||
37698117|NCT01816906|69174880|FG000|12 Months|Lost to Follow-up|2|||
37698118|NCT01816906|69174881|FG001|12 Months|Lost to Follow-up|1|||
37698119|NCT01816594|69174890|FG000|Overall Study|Local Progress|0|||
37698120|NCT01816594|69174891|FG001|Overall Study|Local Progress|2|||
37698121|NCT01816594|69174890|FG000|Overall Study|Adverse Event|9|||
37698122|NCT01816594|69174891|FG001|Overall Study|Adverse Event|0|||
37698123|NCT01816594|69174890|FG000|Overall Study|Withdrawal by Subject|1|||
37698124|NCT01816594|69174891|FG001|Overall Study|Withdrawal by Subject|0|||
37698125|NCT01816594|69174890|FG000|Overall Study|Physician Decision|1|||
37698126|NCT01816594|69174891|FG001|Overall Study|Physician Decision|0|||
37698127|NCT01802320|69174903|FG000|Overall Study|Death|1|||
37698128|NCT01802320|69174903|FG000|Overall Study|Withdrawal by Subject|1|||
37698129|NCT02453711|69174916|FG000|Overall Study|Withdrawal by Subject|5|||
37698130|NCT02453711|69174917|FG001|Overall Study|Withdrawal by Subject|4|||
37698131|NCT02453711|69174918|FG002|Overall Study|Withdrawal by Subject|6|||
37698132|NCT02453711|69174919|FG003|Overall Study|Withdrawal by Subject|4|||
37698133|NCT02453711|69174920|FG004|Overall Study|Withdrawal by Subject|1|||
37698134|NCT02453711|69174921|FG005|Overall Study|Withdrawal by Subject|1|||
37698135|NCT02453711|69174922|FG006|Overall Study|Withdrawal by Subject|0|||
37698136|NCT02453711|69174923|FG007|Overall Study|Withdrawal by Subject|1|||
37698137|NCT02453711|69174924|FG008|Overall Study|Withdrawal by Subject|7|||
37698138|NCT02453711|69174916|FG000|Overall Study|Lost to Follow-up|5|||
37698139|NCT02453711|69174917|FG001|Overall Study|Lost to Follow-up|3|||
37698140|NCT02453711|69174918|FG002|Overall Study|Lost to Follow-up|2|||
37698141|NCT02453711|69174919|FG003|Overall Study|Lost to Follow-up|3|||
37698142|NCT02453711|69174920|FG004|Overall Study|Lost to Follow-up|1|||
37698143|NCT02453711|69174921|FG005|Overall Study|Lost to Follow-up|5|||
37698144|NCT02453711|69174922|FG006|Overall Study|Lost to Follow-up|2|||
37698145|NCT02453711|69174923|FG007|Overall Study|Lost to Follow-up|6|||
37698146|NCT02453711|69174924|FG008|Overall Study|Lost to Follow-up|6|||
37698147|NCT02453711|69174916|FG000|Overall Study|Death|0|||
37698148|NCT02453711|69174917|FG001|Overall Study|Death|0|||
37698149|NCT02453711|69174918|FG002|Overall Study|Death|0|||
37698150|NCT02453711|69174919|FG003|Overall Study|Death|0|||
37698151|NCT02453711|69174920|FG004|Overall Study|Death|0|||
37698152|NCT02453711|69174921|FG005|Overall Study|Death|0|||
37698153|NCT02453711|69174922|FG006|Overall Study|Death|1|||
37698154|NCT02453711|69174923|FG007|Overall Study|Death|0|||
37698155|NCT02453711|69174924|FG008|Overall Study|Death|0|||
37698156|NCT02453711|69174916|FG000|Overall Study|Unclassified|1|||
37698157|NCT02453711|69174917|FG001|Overall Study|Unclassified|0|||
37698158|NCT02453711|69174918|FG002|Overall Study|Unclassified|1|||
37698159|NCT02453711|69174919|FG003|Overall Study|Unclassified|0|||
37698160|NCT02453711|69174920|FG004|Overall Study|Unclassified|0|||
37698161|NCT02453711|69174921|FG005|Overall Study|Unclassified|0|||
37698162|NCT02453711|69174922|FG006|Overall Study|Unclassified|0|||
37698163|NCT02453711|69174923|FG007|Overall Study|Unclassified|0|||
37698164|NCT02453711|69174924|FG008|Overall Study|Unclassified|0|||
37698165|NCT02453555|69174946|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
37698166|NCT02453555|69174947|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
37698167|NCT02453555|69174948|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
37698168|NCT02453555|69174949|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
37698169|NCT02453555|69174950|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
37698170|NCT02453555|69174951|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
37698171|NCT02453555|69174946|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
37698172|NCT02453555|69174947|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
37698173|NCT02453555|69174948|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
37698174|NCT02453555|69174949|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
37698175|NCT02453555|69174950|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
37698176|NCT02453555|69174951|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
37698177|NCT02453555|69174946|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
37698178|NCT02453555|69174947|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
37698179|NCT02453555|69174948|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
37698180|NCT02453555|69174949|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
37698181|NCT02453555|69174950|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
37698182|NCT02453555|69174951|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
37698183|NCT02453555|69174946|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
37698184|NCT02453555|69174947|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
37698185|NCT02453555|69174948|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
37698186|NCT02453555|69174949|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
37698187|NCT02453555|69174950|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
37698188|NCT02453555|69174951|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
37698189|NCT02453555|69174946|FG000|Extension Period|Adverse Event|0|||
37698190|NCT02453555|69174947|FG001|Extension Period|Adverse Event|0|||
37698191|NCT02453555|69174948|FG002|Extension Period|Adverse Event|1|||
37698192|NCT02453555|69174949|FG003|Extension Period|Adverse Event|2|||
37698193|NCT02453555|69174950|FG004|Extension Period|Adverse Event|1|||
38010232|NCT00103857|69692411|FG002|50-Week Extension Study|Protocol Violation|1|||
38010233|NCT00103857|69692412|FG003|50-Week Extension Study|Protocol Violation|2|||
38010234|NCT00103857|69692413|FG004|50-Week Extension Study|Protocol Violation|0|||
37698194|NCT02453555|69174951|FG005|Extension Period|Adverse Event|1|||
37698195|NCT02453555|69174946|FG000|Extension Period|Protocol Violation|0|||
37698196|NCT02453555|69174947|FG001|Extension Period|Protocol Violation|0|||
37698197|NCT02453555|69174948|FG002|Extension Period|Protocol Violation|1|||
37698198|NCT02453555|69174949|FG003|Extension Period|Protocol Violation|0|||
37698199|NCT02453555|69174950|FG004|Extension Period|Protocol Violation|0|||
37698200|NCT02453555|69174951|FG005|Extension Period|Protocol Violation|0|||
37698201|NCT02453555|69174946|FG000|Extension Period|Withdrawal by Subject|0|||
37698202|NCT02453555|69174947|FG001|Extension Period|Withdrawal by Subject|0|||
38010235|NCT00103857|69692414|FG005|50-Week Extension Study|Protocol Violation|1|||
38010236|NCT00103857|69692415|FG006|50-Week Extension Study|Protocol Violation|0|||
38010237|NCT00103857|69692409|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
38010238|NCT00103857|69692410|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
38010239|NCT00103857|69692411|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
38010240|NCT00103857|69692412|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
38010241|NCT00103857|69692413|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
38010242|NCT00103857|69692414|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
38010243|NCT00103857|69692415|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
38010244|NCT00103857|69692409|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
38010245|NCT00103857|69692410|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
38010246|NCT00103857|69692411|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
38010247|NCT00103857|69692412|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
38010248|NCT00103857|69692413|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
38010249|NCT00103857|69692414|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
38010250|NCT00103857|69692415|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
38010251|NCT00103857|69692409|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
38010252|NCT00103857|69692410|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
38010253|NCT00103857|69692411|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
38010254|NCT00103857|69692412|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
38010255|NCT00103857|69692413|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
38010256|NCT00103857|69692414|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
38010257|NCT00103857|69692415|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
38010258|NCT00103857|69692409|FG000|50-Week Extension Study|patient moved|0|||
38010259|NCT00103857|69692410|FG001|50-Week Extension Study|patient moved|0|||
38010260|NCT00103857|69692411|FG002|50-Week Extension Study|patient moved|1|||
38010261|NCT00103857|69692412|FG003|50-Week Extension Study|patient moved|2|||
38010262|NCT00103857|69692413|FG004|50-Week Extension Study|patient moved|0|||
38010263|NCT00103857|69692414|FG005|50-Week Extension Study|patient moved|0|||
38010264|NCT00103857|69692415|FG006|50-Week Extension Study|patient moved|0|||
38010265|NCT00103857|69692409|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
38010266|NCT00103857|69692410|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
38010267|NCT00103857|69692411|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
38010268|NCT00103857|69692412|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
38010269|NCT00103857|69692413|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
38010270|NCT00103857|69692414|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
38010271|NCT00103857|69692415|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
38010272|NCT00103857|69692409|FG000|50-Week Extension Study|reason unspecified|0|||
38010273|NCT00103857|69692410|FG001|50-Week Extension Study|reason unspecified|0|||
38010274|NCT00103857|69692411|FG002|50-Week Extension Study|reason unspecified|0|||
38010275|NCT00103857|69692412|FG003|50-Week Extension Study|reason unspecified|0|||
38010276|NCT00103857|69692413|FG004|50-Week Extension Study|reason unspecified|1|||
38010277|NCT00103857|69692414|FG005|50-Week Extension Study|reason unspecified|0|||
38010278|NCT00103857|69692415|FG006|50-Week Extension Study|reason unspecified|0|||
38010279|NCT03587584|69692432|FG000|Overall Study|SOC deviations|4|||
37698203|NCT02453555|69174948|FG002|Extension Period|Withdrawal by Subject|1|||
37698204|NCT02453555|69174949|FG003|Extension Period|Withdrawal by Subject|0|||
37698205|NCT02453555|69174950|FG004|Extension Period|Withdrawal by Subject|0|||
37698206|NCT02453555|69174951|FG005|Extension Period|Withdrawal by Subject|0|||
37831767|NCT03971422|69515201|FG002|Overall Study|Due to COVID-19 pandemic|1|||
37831768|NCT03770260|69515216|FG000|Overall Study|Disease progression|0|||
37831769|NCT03770260|69515217|FG001|Overall Study|Disease progression|1|||
37831770|NCT03770260|69515218|FG002|Overall Study|Disease progression|0|||
37831771|NCT03770260|69515219|FG003|Overall Study|Disease progression|0|||
37831772|NCT03737110|69515230|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
37831773|NCT03737110|69515231|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
37831774|NCT03737110|69515232|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
37831775|NCT03737110|69515233|FG003|Run-in (RI) Period|Lack of Efficacy|0|||
37831776|NCT03737110|69515234|FG004|Run-in (RI) Period|Lack of Efficacy|0|||
37831777|NCT03737110|69515235|FG005|Run-in (RI) Period|Lack of Efficacy|0|||
37831778|NCT03737110|69515230|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
37831779|NCT03737110|69515231|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
37831780|NCT03737110|69515232|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
37909210|NCT00790569|69594753|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
37909211|NCT00790569|69594751|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
37909212|NCT00790569|69594752|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
37698207|NCT02453321|69174964|FG000|Overall Study|Weakness|1|||
37831781|NCT03737110|69515233|FG003|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
37698208|NCT02453321|69174965|FG001|Overall Study|Weakness|1|||
37698209|NCT02453321|69174966|FG002|Overall Study|Weakness|2|||
37698210|NCT02453321|69174964|FG000|Overall Study|Deep Venous Thrombosis|0|||
37831782|NCT03737110|69515234|FG004|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
38010280|NCT03587584|69692433|FG001|Overall Study|SOC deviations|6|||
38010281|NCT03587584|69692432|FG000|Overall Study|Incomplete data|0|||
38010282|NCT03587584|69692433|FG001|Overall Study|Incomplete data|3|||
38010283|NCT03586726|69692439|FG000|Overall Study|Withdrawal by Subject|1|||
38010284|NCT03586648|69692443|FG000|Period 1|Withdrawal by Subject|0|||
38010285|NCT03586648|69692444|FG001|Period 1|Withdrawal by Subject|1|||
38010286|NCT03586648|69692443|FG000|Period 1|Lost to Follow-up|1|||
38010287|NCT03586648|69692444|FG001|Period 1|Lost to Follow-up|1|||
38010288|NCT03586648|69692443|FG000|Period 1|Adverse Event|1|||
38010289|NCT03586648|69692444|FG001|Period 1|Adverse Event|0|||
38010290|NCT03586648|69692443|FG000|Period 1|Study related symptoms or complaints|2|||
38010291|NCT03586648|69692444|FG001|Period 1|Study related symptoms or complaints|1|||
38010292|NCT03586648|69692443|FG000|Period 1|Physician Decision|0|||
38010293|NCT03586648|69692444|FG001|Period 1|Physician Decision|1|||
38010294|NCT03586648|69692443|FG000|Period 2|Adverse Event|1|||
38010295|NCT03586648|69692444|FG001|Period 2|Adverse Event|0|||
38010296|NCT02892448|69692453|FG000|Overall Study|Screening failure|2|||
38010297|NCT02892448|69692454|FG001|Overall Study|Screening failure|2|||
38010298|NCT02892448|69692455|FG002|Overall Study|Screening failure|1|||
38010299|NCT03585712|69692463|FG000|Treatment Period 1|Protocol Violation|1|||
38010300|NCT03585712|69692464|FG001|Treatment Period 1|Protocol Violation|0|||
38010301|NCT03585712|69692465|FG002|Treatment Period 1|Protocol Violation|0|||
38010302|NCT03585712|69692463|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
38010303|NCT03585712|69692464|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
38010304|NCT03585712|69692465|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
38010305|NCT03585712|69692463|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
38010306|NCT03585712|69692464|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
38010307|NCT03585712|69692465|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
38010308|NCT03585712|69692463|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
38010309|NCT03585712|69692464|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
38010310|NCT03585712|69692465|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
38010311|NCT03585244|69692482|FG000|Overall Study|Withdrawal by Subject|15|||
38010312|NCT00074984|69692488|FG000|Overall Study|Death|1|||
38010313|NCT00074984|69692489|FG001|Overall Study|Death|2|||
38010314|NCT00074984|69692488|FG000|Overall Study|Withdrawal by Subject|2|||
38010315|NCT00074984|69692489|FG001|Overall Study|Withdrawal by Subject|3|||
38010316|NCT00074984|69692488|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
38010317|NCT00074984|69692489|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
38010318|NCT03583606|69692499|FG000|Overall Study|Lost to Follow-up|0|||
38010319|NCT03583606|69692500|FG001|Overall Study|Lost to Follow-up|1|||
38010320|NCT03583606|69692501|FG002|Overall Study|Lost to Follow-up|0|||
38010321|NCT03583606|69692499|FG000|Overall Study|Ineligible at baseline|1|||
38010322|NCT03583606|69692500|FG001|Overall Study|Ineligible at baseline|0|||
38010323|NCT03583606|69692501|FG002|Overall Study|Ineligible at baseline|0|||
38010324|NCT03583450|69692512|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
38010325|NCT03583450|69692513|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
38010326|NCT03583372|69692525|FG000|Overall Study|Withdrawal by Subject|6|||
38010327|NCT03583372|69692526|FG001|Overall Study|Withdrawal by Subject|11|||
38010328|NCT03583372|69692527|FG002|Overall Study|Withdrawal by Subject|7|||
38010329|NCT03583372|69692528|FG003|Overall Study|Withdrawal by Subject|8|||
38010330|NCT03583372|69692525|FG000|Overall Study|Lost to Follow-up|4|||
38010331|NCT03583372|69692526|FG001|Overall Study|Lost to Follow-up|6|||
38010332|NCT03583372|69692527|FG002|Overall Study|Lost to Follow-up|3|||
38010333|NCT03583372|69692528|FG003|Overall Study|Lost to Follow-up|2|||
38010334|NCT03583372|69692525|FG000|Overall Study|Adverse Event|1|||
38010335|NCT03583372|69692526|FG001|Overall Study|Adverse Event|3|||
38010336|NCT03583372|69692527|FG002|Overall Study|Adverse Event|4|||
38010337|NCT03583372|69692528|FG003|Overall Study|Adverse Event|4|||
38010338|NCT03583372|69692525|FG000|Overall Study|Physician Decision|0|||
38010339|NCT03583372|69692526|FG001|Overall Study|Physician Decision|1|||
38010340|NCT03583372|69692527|FG002|Overall Study|Physician Decision|1|||
38010341|NCT03583372|69692528|FG003|Overall Study|Physician Decision|1|||
38010342|NCT03583372|69692525|FG000|Overall Study|Lack of Efficacy|0|||
38010343|NCT03583372|69692526|FG001|Overall Study|Lack of Efficacy|1|||
38010344|NCT03583372|69692527|FG002|Overall Study|Lack of Efficacy|0|||
38010345|NCT03583372|69692528|FG003|Overall Study|Lack of Efficacy|1|||
38010346|NCT03583372|69692525|FG000|Overall Study|Death|1|||
38010347|NCT03583372|69692526|FG001|Overall Study|Death|0|||
38010348|NCT03583372|69692527|FG002|Overall Study|Death|0|||
38010349|NCT03583372|69692528|FG003|Overall Study|Death|0|||
38010350|NCT03583372|69692525|FG000|Overall Study|Protocol Violation|0|||
38010351|NCT03583372|69692526|FG001|Overall Study|Protocol Violation|1|||
38010352|NCT03583372|69692527|FG002|Overall Study|Protocol Violation|0|||
38010353|NCT03583372|69692528|FG003|Overall Study|Protocol Violation|0|||
38010354|NCT03583372|69692525|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
38010355|NCT03583372|69692526|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
38010356|NCT03583372|69692527|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
38010357|NCT03583372|69692528|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
38010358|NCT03583372|69692525|FG000|Overall Study|Did Not Receive Study Drug|0|||
38010359|NCT03583372|69692526|FG001|Overall Study|Did Not Receive Study Drug|1|||
38010360|NCT03583372|69692527|FG002|Overall Study|Did Not Receive Study Drug|0|||
38010361|NCT03583372|69692528|FG003|Overall Study|Did Not Receive Study Drug|0|||
38010362|NCT03583372|69692525|FG000|Overall Study|Captured as Other in the Database|1|||
38010363|NCT03583372|69692526|FG001|Overall Study|Captured as Other in the Database|2|||
38010364|NCT03583372|69692527|FG002|Overall Study|Captured as Other in the Database|4|||
38010365|NCT03583372|69692528|FG003|Overall Study|Captured as Other in the Database|1|||
38010366|NCT03582826|69692540|FG000|Overall Study|Lost to Follow-up|39|||
38010367|NCT03582826|69692541|FG001|Overall Study|Lost to Follow-up|0|||
38010368|NCT03582826|69692540|FG000|Overall Study|Withdrawal by Subject|2|||
38010369|NCT03582826|69692541|FG001|Overall Study|Withdrawal by Subject|0|||
38010370|NCT03518008|69692556|FG000|Period 2, Second Week of Wear|Family emergency|0|||
38010371|NCT03518008|69692557|FG001|Period 2, Second Week of Wear|Family emergency|1|||
38010372|NCT03810014|69692567|FG000|Overall Study|Pregnancy|2|||
38010373|NCT03810014|69692568|FG001|Overall Study|Pregnancy|2|||
38010374|NCT03810014|69692569|FG002|Overall Study|Pregnancy|0|||
38010375|NCT03810014|69692570|FG003|Overall Study|Pregnancy|2|||
38010376|NCT04978363|69692591|FG000|Overall Study|Other medical issues unrelated to the study|0|||
38010377|NCT04978363|69692592|FG001|Overall Study|Other medical issues unrelated to the study|0|||
38010378|NCT04978363|69692593|FG002|Overall Study|Other medical issues unrelated to the study|0|||
38010379|NCT04978363|69692594|FG003|Overall Study|Other medical issues unrelated to the study|0|||
38010380|NCT04978363|69692595|FG004|Overall Study|Other medical issues unrelated to the study|1|||
38010381|NCT04978363|69692596|FG005|Overall Study|Other medical issues unrelated to the study|0|||
38010382|NCT04978363|69692597|FG006|Overall Study|Other medical issues unrelated to the study|0|||
38010383|NCT04978363|69692598|FG007|Overall Study|Other medical issues unrelated to the study|0|||
38010384|NCT04978363|69692599|FG008|Overall Study|Other medical issues unrelated to the study|0|||
38010385|NCT04978363|69692600|FG009|Overall Study|Other medical issues unrelated to the study|0|||
38010386|NCT04978363|69692601|FG010|Overall Study|Other medical issues unrelated to the study|0|||
38010387|NCT04978363|69692591|FG000|Overall Study|Unable to meet the necessary time commitment|0|||
38010388|NCT04978363|69692592|FG001|Overall Study|Unable to meet the necessary time commitment|0|||
38010389|NCT04978363|69692593|FG002|Overall Study|Unable to meet the necessary time commitment|1|||
38010390|NCT04978363|69692594|FG003|Overall Study|Unable to meet the necessary time commitment|0|||
38010391|NCT04978363|69692595|FG004|Overall Study|Unable to meet the necessary time commitment|0|||
38010392|NCT04978363|69692596|FG005|Overall Study|Unable to meet the necessary time commitment|0|||
38010393|NCT04978363|69692597|FG006|Overall Study|Unable to meet the necessary time commitment|0|||
38010394|NCT04978363|69692598|FG007|Overall Study|Unable to meet the necessary time commitment|0|||
38010395|NCT04978363|69692599|FG008|Overall Study|Unable to meet the necessary time commitment|0|||
38010396|NCT04978363|69692600|FG009|Overall Study|Unable to meet the necessary time commitment|0|||
38010397|NCT04978363|69692601|FG010|Overall Study|Unable to meet the necessary time commitment|0|||
38010398|NCT04978363|69692591|FG000|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
38010399|NCT04978363|69692592|FG001|Overall Study|Didn't feel safe and had pain with hands-free crutch|1|||
38010400|NCT04978363|69692593|FG002|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
38010401|NCT04978363|69692594|FG003|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
38010402|NCT04978363|69692595|FG004|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
38010403|NCT04978363|69692596|FG005|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
38010404|NCT04978363|69692597|FG006|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
38010405|NCT04978363|69692598|FG007|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
38010406|NCT04978363|69692599|FG008|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
38010407|NCT04978363|69692600|FG009|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
38010408|NCT04978363|69692601|FG010|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
38010409|NCT04101422|69692681|FG000|Overall Study|Ineligible|1|||
38010410|NCT04101422|69692682|FG001|Overall Study|Ineligible|0|||
38010411|NCT04101422|69692683|FG002|Overall Study|Ineligible|9|||
38010412|NCT04101422|69692684|FG003|Overall Study|Ineligible|0|||
38010413|NCT04101422|69692681|FG000|Overall Study|Withdrawal by Subject|0|||
38010414|NCT04101422|69692682|FG001|Overall Study|Withdrawal by Subject|0|||
38010415|NCT04101422|69692683|FG002|Overall Study|Withdrawal by Subject|1|||
38010416|NCT04101422|69692684|FG003|Overall Study|Withdrawal by Subject|0|||
38010417|NCT04101422|69692681|FG000|Overall Study|Not attending to the stimuli|0|||
38010418|NCT04101422|69692682|FG001|Overall Study|Not attending to the stimuli|0|||
38010419|NCT04101422|69692683|FG002|Overall Study|Not attending to the stimuli|4|||
38010420|NCT04101422|69692684|FG003|Overall Study|Not attending to the stimuli|0|||
38010421|NCT04101422|69692681|FG000|Overall Study|Did not download app|0|||
38010422|NCT04101422|69692682|FG001|Overall Study|Did not download app|0|||
38010423|NCT04101422|69692683|FG002|Overall Study|Did not download app|0|||
38010424|NCT04101422|69692684|FG003|Overall Study|Did not download app|17|||
38010425|NCT04101422|69692681|FG000|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
38010426|NCT04101422|69692682|FG001|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
38010427|NCT04101422|69692683|FG002|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
38010428|NCT04101422|69692684|FG003|Overall Study|Did not use app on 4 or more occasions per protocol|3|||
38010429|NCT03841604|69692696|FG000|Overall Study|Withdrawal by Subject|3|||
38010430|NCT03841604|69692697|FG001|Overall Study|Withdrawal by Subject|1|||
38010431|NCT03841604|69692696|FG000|Overall Study|Adverse Event|4|||
38010432|NCT03841604|69692697|FG001|Overall Study|Adverse Event|2|||
38010433|NCT03841604|69692696|FG000|Overall Study|Physician Decision|1|||
38010434|NCT03841604|69692697|FG001|Overall Study|Physician Decision|0|||
38010435|NCT03541187|69692714|FG000|Overall Study|Lost to Follow-up|2|||
38010436|NCT03541187|69692715|FG001|Overall Study|Lost to Follow-up|6|||
38010437|NCT03541187|69692714|FG000|Overall Study|Pregnancy|0|||
38010438|NCT03541187|69692715|FG001|Overall Study|Pregnancy|1|||
38010439|NCT03541187|69692714|FG000|Overall Study|Withdrawal by Subject|6|||
38010440|NCT03541187|69692715|FG001|Overall Study|Withdrawal by Subject|2|||
38010441|NCT03541187|69692714|FG000|Overall Study|Moved out of town|1|||
38010442|NCT03541187|69692715|FG001|Overall Study|Moved out of town|0|||
38010443|NCT03541187|69692714|FG000|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
38010444|NCT03541187|69692715|FG001|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
38010445|NCT03541187|69692714|FG000|Overall Study|Did not meet randomization criteria|1|||
38010446|NCT03541187|69692715|FG001|Overall Study|Did not meet randomization criteria|1|||
38010447|NCT03541187|69692714|FG000|Overall Study|Potential inability to tolerate maintenance dose|1|||
38010448|NCT03541187|69692715|FG001|Overall Study|Potential inability to tolerate maintenance dose|0|||
38010449|NCT03541187|69692714|FG000|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|0|||
38010450|NCT03541187|69692715|FG001|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|1|||
38010451|NCT03240081|69692736|FG000|Overall Study|Withdrawal by Subject|0|||
38010452|NCT03240081|69692737|FG001|Overall Study|Withdrawal by Subject|2|||
38010453|NCT03240081|69692736|FG000|Overall Study|Lost to Follow-up|0|||
38010454|NCT03240081|69692737|FG001|Overall Study|Lost to Follow-up|1|||
38010455|NCT03003520|69692758|FG000|Overall Study|Adverse Event|9|||
38010456|NCT03003520|69692759|FG001|Overall Study|Adverse Event|0|||
38010457|NCT03003520|69692758|FG000|Overall Study|Death|1|||
38010458|NCT03003520|69692759|FG001|Overall Study|Death|0|||
38010459|NCT03003520|69692758|FG000|Overall Study|Other reasons|4|||
38010460|NCT03003520|69692759|FG001|Overall Study|Other reasons|0|||
38010461|NCT03003520|69692758|FG000|Overall Study|Withdrawal by Subject|6|||
38010462|NCT03003520|69692759|FG001|Overall Study|Withdrawal by Subject|0|||
38010463|NCT03003520|69692758|FG000|Overall Study|Progressive disease|9|||
38010464|NCT03003520|69692759|FG001|Overall Study|Progressive disease|1|||
38010465|NCT02958527|69692782|FG000|Overall Study|Not collected CRFs|12|||
38010466|NCT02586025|69692804|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
38010467|NCT02586025|69692805|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
38010468|NCT02586025|69692804|FG000|Neoadjuvant Treatment|Progression of Disease|2|||
38010469|NCT02586025|69692805|FG001|Neoadjuvant Treatment|Progression of Disease|3|||
38010470|NCT02586025|69692804|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
38010471|NCT02586025|69692805|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
38010472|NCT02586025|69692804|FG000|Neoadjuvant Treatment|Death|1|||
38010473|NCT02586025|69692805|FG001|Neoadjuvant Treatment|Death|0|||
38010474|NCT02586025|69692804|FG000|Neoadjuvant Treatment|Adverse Event|1|||
38010475|NCT02586025|69692805|FG001|Neoadjuvant Treatment|Adverse Event|0|||
38010476|NCT02586025|69692804|FG000|Neoadjuvant Treatment|Physician Decision|2|||
38010477|NCT02586025|69692805|FG001|Neoadjuvant Treatment|Physician Decision|1|||
38010478|NCT02586025|69692804|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
38010479|NCT02586025|69692805|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
38010480|NCT02586025|69692804|FG000|Adjuvant Treatment|Recurrent Disease|4|||
38010481|NCT02586025|69692805|FG001|Adjuvant Treatment|Recurrent Disease|5|||
37831783|NCT03737110|69515235|FG005|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
37831784|NCT03737110|69515230|FG000|Run-in (RI) Period|Adverse Event|4|||
38010482|NCT02586025|69692804|FG000|Adjuvant Treatment|Physician Decision|0|||
38010483|NCT02586025|69692805|FG001|Adjuvant Treatment|Physician Decision|1|||
38010484|NCT02586025|69692804|FG000|Adjuvant Treatment|Pregnancy|1|||
38010485|NCT02586025|69692805|FG001|Adjuvant Treatment|Pregnancy|0|||
38010486|NCT02586025|69692804|FG000|Treatment-Free Follow-Up|Death|11|||
38010487|NCT02586025|69692805|FG001|Treatment-Free Follow-Up|Death|11|||
38010488|NCT02586025|69692804|FG000|Treatment-Free Follow-Up|Lost to Follow-up|9|||
38010489|NCT02586025|69692805|FG001|Treatment-Free Follow-Up|Lost to Follow-up|4|||
38010490|NCT02586025|69692804|FG000|Treatment-Free Follow-Up|Withdrawal by Subject|13|||
38010491|NCT02586025|69692805|FG001|Treatment-Free Follow-Up|Withdrawal by Subject|3|||
38010492|NCT02586025|69692804|FG000|Treatment-Free Follow-Up|Non-compliance|0|||
38010493|NCT02586025|69692805|FG001|Treatment-Free Follow-Up|Non-compliance|1|||
38010494|NCT02586025|69692804|FG000|Treatment-Free Follow-Up|Reason Not Specified|0|||
38010495|NCT02586025|69692805|FG001|Treatment-Free Follow-Up|Reason Not Specified|3|||
38010496|NCT01721577|69692823|FG000|Overall Study|Lack of Efficacy|1|||
38010497|NCT01721577|69692824|FG001|Overall Study|Lack of Efficacy|0|||
38010498|NCT01721577|69692823|FG000|Overall Study|Death|1|||
38010499|NCT01721577|69692824|FG001|Overall Study|Death|0|||
38010500|NCT01721577|69692823|FG000|Overall Study|Dose Escalation to 400mg BID|0|||
38010501|NCT01721577|69692824|FG001|Overall Study|Dose Escalation to 400mg BID|1|||
38010502|NCT01721577|69692823|FG000|Overall Study|Adverse Event|0|||
38010503|NCT01721577|69692824|FG001|Overall Study|Adverse Event|2|||
38010504|NCT01411332|69692841|FG000|Enrollment|Protocol Violation|0|||
38010505|NCT01411332|69692842|FG001|Enrollment|Protocol Violation|1|||
38010506|NCT01411332|69692841|FG000|Enrollment|Withdrawal by Subject|0|||
38010507|NCT01411332|69692842|FG001|Enrollment|Withdrawal by Subject|1|||
38010508|NCT01411332|69692841|FG000|Treatment|Lost to Follow-up|1|||
38010509|NCT01411332|69692842|FG001|Treatment|Lost to Follow-up|0|||
38010510|NCT01194570|69692851|FG000|Overall Study|Death|1|||
38010511|NCT01194570|69692852|FG001|Overall Study|Death|3|||
38010512|NCT01194570|69692851|FG000|Overall Study|Ongoing at CCOD|162|||
38010513|NCT01194570|69692852|FG001|Overall Study|Ongoing at CCOD|387|||
38010514|NCT01194570|69692851|FG000|Overall Study|Physician Decision|2|||
38010515|NCT01194570|69692852|FG001|Overall Study|Physician Decision|6|||
38010516|NCT01194570|69692851|FG000|Overall Study|Reason not specified|13|||
38010517|NCT01194570|69692852|FG001|Overall Study|Reason not specified|20|||
38010518|NCT01194570|69692851|FG000|Overall Study|Protocol Violation|0|||
38010519|NCT01194570|69692852|FG001|Overall Study|Protocol Violation|2|||
38010520|NCT01194570|69692851|FG000|Overall Study|Non-compliance with study drug|2|||
38010521|NCT01194570|69692852|FG001|Overall Study|Non-compliance with study drug|2|||
38010522|NCT01194570|69692851|FG000|Overall Study|Adverse Event|12|||
38010523|NCT01194570|69692852|FG001|Overall Study|Adverse Event|18|||
38010524|NCT01194570|69692851|FG000|Overall Study|Non-compliance|2|||
38010525|NCT01194570|69692852|FG001|Overall Study|Non-compliance|2|||
38010526|NCT01194570|69692851|FG000|Overall Study|Lack of Efficacy|27|||
38010527|NCT01194570|69692852|FG001|Overall Study|Lack of Efficacy|21|||
38010528|NCT01194570|69692851|FG000|Overall Study|Withdrawal by Subject|21|||
38010529|NCT01194570|69692852|FG001|Overall Study|Withdrawal by Subject|22|||
38010530|NCT01194570|69692851|FG000|Overall Study|Pregnancy|1|||
38010531|NCT01194570|69692852|FG001|Overall Study|Pregnancy|1|||
38010532|NCT01194570|69692851|FG000|Overall Study|Lost to Follow-up|1|||
38010533|NCT01194570|69692852|FG001|Overall Study|Lost to Follow-up|4|||
38010534|NCT04881747|69692878|FG000|Period 2 Washout|Adverse Event|1|||
37698211|NCT02453321|69174965|FG001|Overall Study|Deep Venous Thrombosis|1|||
37698212|NCT02453321|69174966|FG002|Overall Study|Deep Venous Thrombosis|0|||
37698213|NCT01610284|69174979|FG000|Randomization Phase|Adverse Event|1|||
37698214|NCT01610284|69174980|FG001|Randomization Phase|Adverse Event|0|||
37698215|NCT01610284|69174979|FG000|Randomization Phase|Physician Decision|1|||
37698216|NCT01610284|69174980|FG001|Randomization Phase|Physician Decision|1|||
37698217|NCT01610284|69174979|FG000|Randomization Phase|Death|0|||
37698218|NCT01610284|69174980|FG001|Randomization Phase|Death|1|||
37698219|NCT01610284|69174979|FG000|Treatment Phase|Adverse Event|80|||
37698220|NCT01610284|69174980|FG001|Treatment Phase|Adverse Event|12|||
37698221|NCT01610284|69174979|FG000|Treatment Phase|Lost to Follow-up|1|||
37698222|NCT01610284|69174980|FG001|Treatment Phase|Lost to Follow-up|0|||
37698223|NCT01610284|69174979|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
37698224|NCT01610284|69174980|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
37698225|NCT01610284|69174979|FG000|Treatment Phase|Physician Decision|27|||
37698226|NCT01610284|69174980|FG001|Treatment Phase|Physician Decision|24|||
38010535|NCT04881747|69692879|FG001|Period 2 Washout|Adverse Event|0|||
38010536|NCT04881747|69692880|FG002|Period 2 Washout|Adverse Event|0|||
38010537|NCT04881747|69692881|FG003|Period 2 Washout|Adverse Event|0|||
38010538|NCT04881747|69692882|FG004|Period 2 Washout|Adverse Event|1|||
38010539|NCT04881747|69692883|FG005|Period 2 Washout|Adverse Event|0|||
38010540|NCT04881747|69692878|FG000|Period 2 Washout|Withdrawal by Subject|1|||
38010541|NCT04881747|69692879|FG001|Period 2 Washout|Withdrawal by Subject|0|||
38010542|NCT04881747|69692880|FG002|Period 2 Washout|Withdrawal by Subject|0|||
38010543|NCT04881747|69692881|FG003|Period 2 Washout|Withdrawal by Subject|1|||
38010544|NCT04881747|69692882|FG004|Period 2 Washout|Withdrawal by Subject|0|||
38010545|NCT04881747|69692883|FG005|Period 2 Washout|Withdrawal by Subject|0|||
38010546|NCT04795622|69692893|FG000|Overall Study|Adverse Event|1|||
37698227|NCT01610284|69174979|FG000|Treatment Phase|Progressive Disease|377|||
37698228|NCT01610284|69174980|FG001|Treatment Phase|Progressive Disease|486|||
37698229|NCT01610284|69174979|FG000|Treatment Phase|Protocol Deviation|2|||
37698230|NCT01610284|69174980|FG001|Treatment Phase|Protocol Deviation|3|||
37698231|NCT01610284|69174979|FG000|Treatment Phase|Study terminated by Sponsor|18|||
37698232|NCT01610284|69174980|FG001|Treatment Phase|Study terminated by Sponsor|15|||
37698233|NCT01610284|69174979|FG000|Treatment Phase|Subject/Guardian Decision|55|||
37698234|NCT01610284|69174980|FG001|Treatment Phase|Subject/Guardian Decision|23|||
37698235|NCT01610284|69174979|FG000|Treatment Phase|Death|6|||
38010547|NCT04795622|69692894|FG001|Overall Study|Adverse Event|0|||
38010548|NCT04795622|69692893|FG000|Overall Study|Withdrawal by Subject|3|||
38010549|NCT04795622|69692894|FG001|Overall Study|Withdrawal by Subject|3|||
38010550|NCT04795622|69692893|FG000|Overall Study|Protocol Violation|0|||
38010551|NCT04795622|69692894|FG001|Overall Study|Protocol Violation|2|||
38010552|NCT04795622|69692893|FG000|Overall Study|Lost to Follow-up|2|||
38010553|NCT04795622|69692894|FG001|Overall Study|Lost to Follow-up|3|||
38010554|NCT04795622|69692893|FG000|Overall Study|Other|7|||
38010555|NCT04795622|69692894|FG001|Overall Study|Other|8|||
38010556|NCT04652245|69692915|FG000|Wash-Out Period|Adverse Event|0|||
38010557|NCT04652245|69692916|FG001|Wash-Out Period|Adverse Event|2|||
38010558|NCT04652245|69692915|FG000|Wash-Out Period|Withdrawal by Subject|0|||
38010559|NCT04652245|69692916|FG001|Wash-Out Period|Withdrawal by Subject|2|||
38010560|NCT04405739|69692933|FG000|Overall Study|Adverse Event|0|||
38010561|NCT04405739|69692934|FG001|Overall Study|Adverse Event|1|||
38010562|NCT04405739|69692935|FG002|Overall Study|Adverse Event|0|||
38010563|NCT04405739|69692936|FG003|Overall Study|Adverse Event|0|||
38010564|NCT04405739|69692933|FG000|Overall Study|Lost to Follow-up|0|||
38010565|NCT04405739|69692934|FG001|Overall Study|Lost to Follow-up|2|||
38010566|NCT04405739|69692935|FG002|Overall Study|Lost to Follow-up|1|||
38010567|NCT04405739|69692936|FG003|Overall Study|Lost to Follow-up|3|||
38010568|NCT04405739|69692933|FG000|Overall Study|Withdrawal by Subject|0|||
38010569|NCT04405739|69692934|FG001|Overall Study|Withdrawal by Subject|2|||
38010570|NCT04405739|69692935|FG002|Overall Study|Withdrawal by Subject|1|||
38010571|NCT04405739|69692936|FG003|Overall Study|Withdrawal by Subject|1|||
38010572|NCT04405739|69692933|FG000|Overall Study|Death|0|||
38010573|NCT04405739|69692934|FG001|Overall Study|Death|0|||
38010574|NCT04405739|69692935|FG002|Overall Study|Death|1|||
38010575|NCT04405739|69692936|FG003|Overall Study|Death|0|||
38010576|NCT04405739|69692933|FG000|Overall Study|Transferred to rehab|0|||
38010577|NCT04405739|69692934|FG001|Overall Study|Transferred to rehab|0|||
38010578|NCT04405739|69692935|FG002|Overall Study|Transferred to rehab|0|||
38010579|NCT04405739|69692936|FG003|Overall Study|Transferred to rehab|1|||
38010580|NCT04405739|69692933|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
38010581|NCT04405739|69692934|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
38010582|NCT04405739|69692935|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
38010583|NCT04405739|69692936|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
38010584|NCT04954326|69692969|FG000|Overall Study|Protocol Violation|0|||
38010585|NCT04954326|69692970|FG001|Overall Study|Protocol Violation|1|||
38010586|NCT04954326|69692969|FG000|Overall Study|Death|0|||
38010587|NCT04954326|69692970|FG001|Overall Study|Death|2|||
38010588|NCT04954326|69692969|FG000|Overall Study|Physician Decision|0|||
38010589|NCT04954326|69692970|FG001|Overall Study|Physician Decision|1|||
38010590|NCT04914819|69692978|FG000|Overall Study|Pregnancy|3|||
38010591|NCT04914819|69692979|FG001|Overall Study|Pregnancy|1|||
38010592|NCT04914819|69692978|FG000|Overall Study|Discontinued study|4|||
38010593|NCT04914819|69692979|FG001|Overall Study|Discontinued study|1|||
38010594|NCT04914819|69692978|FG000|Overall Study|Lost to Follow-up|7|||
38010595|NCT04914819|69692979|FG001|Overall Study|Lost to Follow-up|0|||
38010596|NCT04818346|69692994|FG000|24-Week Placebo-Controlled Period|Adverse Event|1|||
38010597|NCT04818346|69692995|FG001|24-Week Placebo-Controlled Period|Adverse Event|2|||
38010598|NCT04818346|69692996|FG002|24-Week Placebo-Controlled Period|Adverse Event|0|||
38010599|NCT04818346|69692997|FG003|24-Week Placebo-Controlled Period|Adverse Event|3|||
38010600|NCT04818346|69692994|FG000|24-Week Placebo-Controlled Period|Lost to Follow-up|3|||
38010601|NCT04818346|69692995|FG001|24-Week Placebo-Controlled Period|Lost to Follow-up|2|||
38010602|NCT04818346|69692996|FG002|24-Week Placebo-Controlled Period|Lost to Follow-up|3|||
37698236|NCT01610284|69174980|FG001|Treatment Phase|Death|5|||
38010603|NCT04818346|69692997|FG003|24-Week Placebo-Controlled Period|Lost to Follow-up|1|||
38010604|NCT04818346|69692994|FG000|24-Week Placebo-Controlled Period|Physician Decision|1|||
38010605|NCT04818346|69692995|FG001|24-Week Placebo-Controlled Period|Physician Decision|0|||
38010606|NCT04818346|69692996|FG002|24-Week Placebo-Controlled Period|Physician Decision|0|||
38010607|NCT04818346|69692997|FG003|24-Week Placebo-Controlled Period|Physician Decision|0|||
38010608|NCT04818346|69692994|FG000|24-Week Placebo-Controlled Period|Protocol Violation|0|||
38010609|NCT04818346|69692995|FG001|24-Week Placebo-Controlled Period|Protocol Violation|0|||
38010610|NCT04818346|69692996|FG002|24-Week Placebo-Controlled Period|Protocol Violation|1|||
38010611|NCT04818346|69692997|FG003|24-Week Placebo-Controlled Period|Protocol Violation|1|||
38010612|NCT04818346|69692994|FG000|24-Week Placebo-Controlled Period|Withdrawal by Subject|1|||
38010613|NCT04818346|69692995|FG001|24-Week Placebo-Controlled Period|Withdrawal by Subject|1|||
37698237|NCT01610284|69174979|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
38010614|NCT04818346|69692996|FG002|24-Week Placebo-Controlled Period|Withdrawal by Subject|6|||
38010615|NCT04818346|69692997|FG003|24-Week Placebo-Controlled Period|Withdrawal by Subject|2|||
38010616|NCT04818346|69692994|FG000|24-Week Placebo-Controlled Period|Subject Terminated by Sponsor|1|||
38010617|NCT04818346|69692995|FG001|24-Week Placebo-Controlled Period|Subject Terminated by Sponsor|0|||
38010618|NCT04818346|69692996|FG002|24-Week Placebo-Controlled Period|Subject Terminated by Sponsor|0|||
38010619|NCT04818346|69692997|FG003|24-Week Placebo-Controlled Period|Subject Terminated by Sponsor|0|||
38010620|NCT04818346|69692994|FG000|24-Week Placebo-Controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|1|||
38010621|NCT04818346|69692995|FG001|24-Week Placebo-Controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
38010622|NCT04818346|69692996|FG002|24-Week Placebo-Controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
38010623|NCT04818346|69692997|FG003|24-Week Placebo-Controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
38010624|NCT04818346|69692994|FG000|24-Week Placebo-Controlled Period|Use of Prohibited Concomitant Medication|0|||
38010625|NCT04818346|69692995|FG001|24-Week Placebo-Controlled Period|Use of Prohibited Concomitant Medication|0|||
38010626|NCT04818346|69692996|FG002|24-Week Placebo-Controlled Period|Use of Prohibited Concomitant Medication|1|||
38010627|NCT04818346|69692997|FG003|24-Week Placebo-Controlled Period|Use of Prohibited Concomitant Medication|0|||
38010628|NCT04818346|69692994|FG000|24-Week Placebo-Controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
38010629|NCT04818346|69692995|FG001|24-Week Placebo-Controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
38010630|NCT04818346|69692996|FG002|24-Week Placebo-Controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
38010631|NCT04818346|69692997|FG003|24-Week Placebo-Controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|1|||
38010632|NCT04723394|69693009|FG000|Overall Study|Adverse Event|0|||
38010633|NCT04723394|69693010|FG001|Overall Study|Adverse Event|3|||
38010634|NCT04723394|69693009|FG000|Overall Study|Death|8|||
38010635|NCT04723394|69693010|FG001|Overall Study|Death|8|||
38010636|NCT04723394|69693009|FG000|Overall Study|Lost to Follow-up|20|||
38010637|NCT04723394|69693010|FG001|Overall Study|Lost to Follow-up|17|||
38010638|NCT04723394|69693009|FG000|Overall Study|Physician Decision|1|||
38010639|NCT04723394|69693010|FG001|Overall Study|Physician Decision|0|||
38010640|NCT04723394|69693009|FG000|Overall Study|Withdrawal by Subject|20|||
38010641|NCT04723394|69693010|FG001|Overall Study|Withdrawal by Subject|34|||
38010642|NCT04723394|69693009|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
38010643|NCT04723394|69693010|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|2|||
38010644|NCT04478266|69693022|FG000|Overall Study|Adverse Event|17|||
38010645|NCT04478266|69693023|FG001|Overall Study|Adverse Event|18|||
38010646|NCT04478266|69693022|FG000|Overall Study|Progressive disease|99|||
38010647|NCT04478266|69693023|FG001|Overall Study|Progressive disease|118|||
38010648|NCT04478266|69693022|FG000|Overall Study|Poor compliance to protocol|1|||
38010649|NCT04478266|69693023|FG001|Overall Study|Poor compliance to protocol|0|||
38010650|NCT04478266|69693022|FG000|Overall Study|Withdrawal by Subject|14|||
38010651|NCT04478266|69693023|FG001|Overall Study|Withdrawal by Subject|16|||
38010652|NCT04478266|69693022|FG000|Overall Study|Other: unspecified|5|||
38010653|NCT04478266|69693023|FG001|Overall Study|Other: unspecified|4|||
38010654|NCT04478266|69693022|FG000|Overall Study|Randomized not treated|1|||
38010655|NCT04478266|69693023|FG001|Overall Study|Randomized not treated|1|||
38010656|NCT04478266|69693022|FG000|Overall Study|Ongoing|397|||
38010657|NCT04478266|69693023|FG001|Overall Study|Ongoing|377|||
38010658|NCT04409002|69693031|FG000|Overall Study|Disease progression prior to starting study treatment|3|||
38010659|NCT04289363|69693037|FG000|Overall Study|Lost to Follow-up|14|||
38010660|NCT04289363|69693038|FG001|Overall Study|Lost to Follow-up|0|||
38010661|NCT04235959|69693047|FG000|Overall Study|Protocol Violation|0|||
38010662|NCT04235959|69693048|FG001|Overall Study|Protocol Violation|1|||
38010663|NCT04235959|69693049|FG002|Overall Study|Protocol Violation|0|||
38010664|NCT04235959|69693047|FG000|Overall Study|Adverse Event|1|||
38010665|NCT04235959|69693048|FG001|Overall Study|Adverse Event|0|||
38010666|NCT04235959|69693049|FG002|Overall Study|Adverse Event|0|||
38010667|NCT03525613|69693084|FG000|Overall Study|Adverse Event|11|||
37698238|NCT01610284|69174980|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
37831785|NCT03737110|69515231|FG001|Run-in (RI) Period|Adverse Event|0|||
37831786|NCT03737110|69515232|FG002|Run-in (RI) Period|Adverse Event|0|||
37831787|NCT03737110|69515233|FG003|Run-in (RI) Period|Adverse Event|0|||
37831788|NCT03737110|69515234|FG004|Run-in (RI) Period|Adverse Event|0|||
37831789|NCT03737110|69515235|FG005|Run-in (RI) Period|Adverse Event|0|||
37831790|NCT03737110|69515230|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
37831791|NCT03737110|69515231|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
37831792|NCT03737110|69515232|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
37831793|NCT03737110|69515233|FG003|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
37831794|NCT03737110|69515234|FG004|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
38010668|NCT03525613|69693085|FG001|Overall Study|Adverse Event|8|||
38010669|NCT03525613|69693086|FG002|Overall Study|Adverse Event|3|||
38010670|NCT03525613|69693087|FG003|Overall Study|Adverse Event|3|||
38010671|NCT03525613|69693084|FG000|Overall Study|Lost to Follow-up|4|||
38010672|NCT03525613|69693085|FG001|Overall Study|Lost to Follow-up|5|||
38010673|NCT03525613|69693086|FG002|Overall Study|Lost to Follow-up|3|||
38010674|NCT03525613|69693087|FG003|Overall Study|Lost to Follow-up|2|||
38010675|NCT03525613|69693084|FG000|Overall Study|Physician Decision|0|||
38010676|NCT03525613|69693085|FG001|Overall Study|Physician Decision|1|||
38010677|NCT03525613|69693086|FG002|Overall Study|Physician Decision|0|||
38010678|NCT03525613|69693087|FG003|Overall Study|Physician Decision|1|||
38010679|NCT03525613|69693084|FG000|Overall Study|Consent Withdrawal|25|||
38010680|NCT03525613|69693085|FG001|Overall Study|Consent Withdrawal|16|||
38010681|NCT03525613|69693086|FG002|Overall Study|Consent Withdrawal|12|||
38010682|NCT03525613|69693087|FG003|Overall Study|Consent Withdrawal|9|||
38010683|NCT03525613|69693084|FG000|Overall Study|Death|20|||
38010684|NCT03525613|69693085|FG001|Overall Study|Death|9|||
38010685|NCT03525613|69693086|FG002|Overall Study|Death|7|||
38010686|NCT03525613|69693087|FG003|Overall Study|Death|1|||
38010687|NCT03525613|69693084|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|9|||
38010688|NCT03525613|69693085|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
38010689|NCT03525613|69693086|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|5|||
38010690|NCT03525613|69693087|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|8|||
38010691|NCT03500692|69693101|FG000|Overall Study|Death|163|||
38010692|NCT03500692|69693101|FG000|Overall Study|Lost to Follow-up|76|||
38010693|NCT03500692|69693101|FG000|Overall Study|Termination Reasons|3|||
38010694|NCT03404960|69693116|FG000|Overall Study|Adverse Event|0|||
38010695|NCT03404960|69693117|FG001|Overall Study|Adverse Event|2|||
38010696|NCT03404960|69693116|FG000|Overall Study|Rapidly declined before 1st follow-up scan|0|||
38010697|NCT03404960|69693117|FG001|Overall Study|Rapidly declined before 1st follow-up scan|2|||
38010698|NCT03404960|69693116|FG000|Overall Study|Bowel obstruction|0|||
38010699|NCT03404960|69693117|FG001|Overall Study|Bowel obstruction|1|||
38010700|NCT03404960|69693116|FG000|Overall Study|Incorrect pathological diagnosis on internal review|2|||
38010701|NCT03404960|69693117|FG001|Overall Study|Incorrect pathological diagnosis on internal review|0|||
38010702|NCT03298022|69693123|FG000|Overall Study|Lack of Efficacy|4|||
38010703|NCT03298022|69693123|FG000|Overall Study|Withdrawal by Subject|7|||
38010704|NCT03298022|69693123|FG000|Overall Study|Adverse Event|1|||
38010705|NCT03298022|69693123|FG000|Overall Study|disease relapse|1|||
38010706|NCT03264404|69693133|FG000|Overall Study|Death|2|||
38010707|NCT03264404|69693133|FG000|Overall Study|Physician Decision|1|||
38010708|NCT03264404|69693133|FG000|Overall Study|Disease Progression|28|||
38010709|NCT03264404|69693133|FG000|Overall Study|Adverse Event|1|||
38010710|NCT03264404|69693133|FG000|Overall Study|Off study prior to treatment|2|||
38010711|NCT03118570|69693151|FG000|Overall Study|Adverse Event|2|||
38010712|NCT03118570|69693152|FG001|Overall Study|Adverse Event|0|||
38010713|NCT03118570|69693153|FG002|Overall Study|Adverse Event|0|||
38010714|NCT03118570|69693154|FG003|Overall Study|Adverse Event|0|||
38010715|NCT03118570|69693155|FG004|Overall Study|Adverse Event|3|||
37698239|NCT01610284|69174979|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
37698240|NCT01610284|69174980|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
37698241|NCT01610284|69174979|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
37698242|NCT01610284|69174980|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
37698243|NCT01610284|69174979|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
37698244|NCT01610284|69174980|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
37698245|NCT01610284|69174979|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
37698246|NCT01610284|69174980|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
37698247|NCT01610284|69174979|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
37909213|NCT00790569|69594753|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
37909214|NCT00939029|69594763|FG000|Overall Study|Withdrawal by Subject|3|||
37909215|NCT00939029|69594764|FG001|Overall Study|Withdrawal by Subject|7|||
37909216|NCT00939029|69594763|FG000|Overall Study|Lost to Follow-up|3|||
37909217|NCT00939029|69594764|FG001|Overall Study|Lost to Follow-up|4|||
37909218|NCT00939029|69594763|FG000|Overall Study|Adverse Event|0|||
37909219|NCT00939029|69594764|FG001|Overall Study|Adverse Event|1|||
37909220|NCT00587847|69594770|FG000|Overall Study|Lack of Efficacy|5|||
37909221|NCT00587847|69594770|FG000|Overall Study|Adverse Event|2|||
37909222|NCT00784563|69594778|FG000|Years 1 & 2|Withdrawal by Subject|3|||
37909223|NCT00784563|69594779|FG001|Years 1 & 2|Withdrawal by Subject|2|||
37909224|NCT00784563|69594780|FG002|Years 1 & 2|Withdrawal by Subject|0|||
37909225|NCT00784563|69594778|FG000|Years 1 & 2|Adverse Event|0|||
37909226|NCT00784563|69594779|FG001|Years 1 & 2|Adverse Event|3|||
37909227|NCT00784563|69594780|FG002|Years 1 & 2|Adverse Event|0|||
37909228|NCT00784563|69594778|FG000|Year 3|Withdrawal by Subject|0|||
37909229|NCT00784563|69594779|FG001|Year 3|Withdrawal by Subject|0|||
37909230|NCT00784563|69594780|FG002|Year 3|Withdrawal by Subject|2|||
37909231|NCT00784563|69594778|FG000|Year 3|Adverse Event|0|||
38010716|NCT03118570|69693151|FG000|Overall Study|Withdrawal by Subject|0|||
38010717|NCT03118570|69693152|FG001|Overall Study|Withdrawal by Subject|1|||
38010718|NCT03118570|69693153|FG002|Overall Study|Withdrawal by Subject|4|||
38010719|NCT03118570|69693154|FG003|Overall Study|Withdrawal by Subject|0|||
38010720|NCT03118570|69693155|FG004|Overall Study|Withdrawal by Subject|1|||
38010721|NCT03118570|69693151|FG000|Overall Study|Lost to Follow-up|2|||
38010722|NCT03118570|69693152|FG001|Overall Study|Lost to Follow-up|3|||
38010723|NCT03118570|69693153|FG002|Overall Study|Lost to Follow-up|1|||
38010724|NCT03118570|69693154|FG003|Overall Study|Lost to Follow-up|0|||
38010725|NCT03118570|69693155|FG004|Overall Study|Lost to Follow-up|1|||
38010726|NCT03118570|69693151|FG000|Overall Study|Other, Not Specified|1|||
38010727|NCT03118570|69693152|FG001|Overall Study|Other, Not Specified|3|||
38010728|NCT03118570|69693153|FG002|Overall Study|Other, Not Specified|0|||
38010729|NCT03118570|69693154|FG003|Overall Study|Other, Not Specified|0|||
38010730|NCT03118570|69693155|FG004|Overall Study|Other, Not Specified|0|||
38010731|NCT02971683|69693170|FG000|Double-Blind (24 Weeks)|Other reasons|0|||
38010732|NCT02971683|69693171|FG001|Double-Blind (24 Weeks)|Other reasons|1|||
38010733|NCT02971683|69693170|FG000|Double-Blind (24 Weeks)|Poor/Non-Compliance|0|||
38010734|NCT02971683|69693171|FG001|Double-Blind (24 Weeks)|Poor/Non-Compliance|1|||
38010735|NCT02971683|69693170|FG000|Double-Blind (24 Weeks)|Lost to Follow-up|1|||
38010736|NCT02971683|69693171|FG001|Double-Blind (24 Weeks)|Lost to Follow-up|0|||
38010737|NCT02971683|69693170|FG000|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
38010738|NCT02971683|69693171|FG001|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
38010739|NCT02971683|69693170|FG000|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
38010740|NCT02971683|69693171|FG001|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
38010741|NCT02971683|69693170|FG000|Double-Blind (24 Weeks)|Adverse Event|0|||
38010742|NCT02971683|69693171|FG001|Double-Blind (24 Weeks)|Adverse Event|2|||
38010743|NCT02971683|69693170|FG000|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
38010744|NCT02971683|69693171|FG001|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
38010745|NCT02971683|69693170|FG000|Double-Blind (24 Weeks)|Participant no longer meets study criteria|1|||
38010746|NCT02971683|69693171|FG001|Double-Blind (24 Weeks)|Participant no longer meets study criteria|0|||
38010747|NCT02971683|69693170|FG000|Open-Label|Lost to Follow-up|1|||
38010748|NCT02971683|69693171|FG001|Open-Label|Lost to Follow-up|0|||
38010749|NCT02971683|69693170|FG000|Open-Label|Participants withdrew consent|0|||
38010750|NCT02971683|69693171|FG001|Open-Label|Participants withdrew consent|2|||
38010751|NCT02971683|69693170|FG000|Open-Label|Participant request to discontinue study treatment|1|||
38010752|NCT02971683|69693171|FG001|Open-Label|Participant request to discontinue study treatment|0|||
38010753|NCT02971683|69693170|FG000|Open-Label|Lack of Efficacy|2|||
38010754|NCT02971683|69693171|FG001|Open-Label|Lack of Efficacy|0|||
38010755|NCT02971683|69693170|FG000|Long-Term Open Label|Administrative reason by sponsor|20|||
38010756|NCT02971683|69693171|FG001|Long-Term Open Label|Administrative reason by sponsor|17|||
38010757|NCT02971683|69693170|FG000|Long-Term Open Label|Participant withdrew consent|1|||
38010758|NCT02971683|69693171|FG001|Long-Term Open Label|Participant withdrew consent|0|||
38010759|NCT02971683|69693170|FG000|Long-Term Open Label|Participant request to discontinue study treatment|1|||
38010760|NCT02971683|69693171|FG001|Long-Term Open Label|Participant request to discontinue study treatment|1|||
38010761|NCT02971683|69693170|FG000|Long-Term Open Label|Adverse Event|1|||
38010762|NCT02971683|69693171|FG001|Long-Term Open Label|Adverse Event|2|||
38010763|NCT02971683|69693170|FG000|Long-Term Open Label|Lack of Efficacy|1|||
38010764|NCT02971683|69693171|FG001|Long-Term Open Label|Lack of Efficacy|1|||
38010765|NCT02949219|69693177|FG000|Overall Study|Withdrawal by Subject|1|||
37831795|NCT03737110|69515235|FG005|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
37831796|NCT03737110|69515230|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
37831797|NCT03737110|69515231|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
37831798|NCT03737110|69515232|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
37831799|NCT03737110|69515233|FG003|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
38010766|NCT02899299|69693183|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
37909232|NCT00784563|69594779|FG001|Year 3|Adverse Event|0|||
37909233|NCT00784563|69594780|FG002|Year 3|Adverse Event|1|||
37909234|NCT00938717|69594788|FG000|Overall Study|Adverse Event|10|||
37909235|NCT00938717|69594789|FG001|Overall Study|Adverse Event|41|||
38010767|NCT02899299|69693184|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
38010768|NCT02899299|69693183|FG000|Pre-treatment|Participant withdrew consent|1|||
38010769|NCT02899299|69693184|FG001|Pre-treatment|Participant withdrew consent|11|||
37831800|NCT03737110|69515234|FG004|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
37831801|NCT03737110|69515235|FG005|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
37831802|NCT03737110|69515230|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
37831803|NCT03737110|69515231|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
37909236|NCT00938717|69594788|FG000|Overall Study|Protocol Violation|11|||
38010770|NCT02899299|69693183|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
38010771|NCT02899299|69693184|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
37909237|NCT00938717|69594789|FG001|Overall Study|Protocol Violation|8|||
38010772|NCT02899299|69693183|FG000|Pre-treatment|Not reported|0|||
37909238|NCT00938717|69594788|FG000|Overall Study|Withdrawal by Subject|26|||
37909239|NCT00938717|69594789|FG001|Overall Study|Withdrawal by Subject|24|||
37909240|NCT00938717|69594788|FG000|Overall Study|Lost to Follow-up|13|||
37909241|NCT00938717|69594789|FG001|Overall Study|Lost to Follow-up|18|||
37909242|NCT00938717|69594788|FG000|Overall Study|Lack of Efficacy|33|||
37909243|NCT00938717|69594789|FG001|Overall Study|Lack of Efficacy|15|||
38010773|NCT02899299|69693184|FG001|Pre-treatment|Not reported|1|||
38010774|NCT02899299|69693183|FG000|Treatment|Disease Progression|182|||
38010775|NCT02899299|69693184|FG001|Treatment|Disease Progression|44|||
38010776|NCT02899299|69693183|FG000|Treatment|Study Drug Toxicity|59|||
38010777|NCT02899299|69693184|FG001|Treatment|Study Drug Toxicity|24|||
38010778|NCT02899299|69693183|FG000|Treatment|Adverse Event unrelated to Study Drug|12|||
38010779|NCT02899299|69693184|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
38010780|NCT02899299|69693183|FG000|Treatment|Participant request to discontinue Study treatment|4|||
38010781|NCT02899299|69693184|FG001|Treatment|Participant request to discontinue Study treatment|10|||
38010782|NCT02899299|69693183|FG000|Treatment|Participant withdrew consent|6|||
38010783|NCT02899299|69693184|FG001|Treatment|Participant withdrew consent|3|||
38010784|NCT02899299|69693183|FG000|Treatment|Lost to Follow-up|0|||
38010785|NCT02899299|69693184|FG001|Treatment|Lost to Follow-up|1|||
38010786|NCT02899299|69693183|FG000|Treatment|Maximum Clinical Benefit|10|||
38010787|NCT02899299|69693184|FG001|Treatment|Maximum Clinical Benefit|2|||
38010788|NCT02899299|69693183|FG000|Treatment|Poor/Non-compliance|1|||
38010789|NCT02899299|69693184|FG001|Treatment|Poor/Non-compliance|0|||
38010790|NCT02899299|69693183|FG000|Treatment|Participant no longer meets Study criteria|4|||
38010791|NCT02899299|69693184|FG001|Treatment|Participant no longer meets Study criteria|0|||
38010792|NCT02899299|69693183|FG000|Treatment|Administrative reason by Sponsor|2|||
38010793|NCT02899299|69693184|FG001|Treatment|Administrative reason by Sponsor|0|||
38010794|NCT02899299|69693183|FG000|Treatment|Other reasons|11|||
38010795|NCT02899299|69693184|FG001|Treatment|Other reasons|2|||
38010796|NCT02899299|69693183|FG000|Treatment|Not reported: Includes participants who achieved max duration of treatment|4|||
38010797|NCT02899299|69693184|FG001|Treatment|Not reported: Includes participants who achieved max duration of treatment|189|||
38010798|NCT02899195|69693190|FG000|Concurrent Durvalumab|Adverse Event|4|||
38010799|NCT02899195|69693190|FG000|Concurrent Durvalumab|Physician Decision|1|||
38010800|NCT02899195|69693190|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
38010801|NCT02899195|69693190|FG000|Concurrent Durvalumab|Progressive Disease|5|||
38010802|NCT02899195|69693190|FG000|Maintenance Durvalumab|Adverse Event|1|||
38010803|NCT02899195|69693190|FG000|Maintenance Durvalumab|Physician Decision|1|||
38010804|NCT02899195|69693190|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
38010805|NCT02899195|69693190|FG000|Maintenance Durvalumab|Progressive Disease|31|||
38010806|NCT02527200|69693261|FG000|Overall Study|Withdrawal by Subject|3|||
38010807|NCT02527200|69693262|FG001|Overall Study|Withdrawal by Subject|2|||
38010808|NCT02527200|69693263|FG002|Overall Study|Withdrawal by Subject|1|||
38010809|NCT02527200|69693264|FG003|Overall Study|Withdrawal by Subject|0|||
38010810|NCT02527200|69693261|FG000|Overall Study|Unclassified|0|||
38010811|NCT02527200|69693262|FG001|Overall Study|Unclassified|1|||
38010812|NCT02527200|69693263|FG002|Overall Study|Unclassified|0|||
38010813|NCT02527200|69693264|FG003|Overall Study|Unclassified|0|||
38010814|NCT02527200|69693261|FG000|Overall Study|Lost to Follow-up|0|||
38010815|NCT02527200|69693262|FG001|Overall Study|Lost to Follow-up|0|||
38010816|NCT02527200|69693263|FG002|Overall Study|Lost to Follow-up|1|||
38010817|NCT02527200|69693264|FG003|Overall Study|Lost to Follow-up|0|||
38010818|NCT02510040|69693281|FG000|Overall Study|Deemed no longer eligible|18|||
38010819|NCT02510040|69693282|FG001|Overall Study|Deemed no longer eligible|3|||
37831804|NCT03737110|69515232|FG002|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
37831805|NCT03737110|69515233|FG003|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
37831806|NCT03737110|69515234|FG004|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
37831807|NCT03737110|69515235|FG005|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
37831808|NCT03737110|69515230|FG000|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
37831809|NCT03737110|69515231|FG001|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
37831810|NCT03737110|69515232|FG002|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
37831811|NCT03737110|69515233|FG003|Long-Term Extension (LTE) Period|Withdrawal by Subject|1|||
37831812|NCT03737110|69515234|FG004|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
37909244|NCT00938717|69594788|FG000|Overall Study|Other reason|5|||
37909245|NCT00938717|69594789|FG001|Overall Study|Other reason|2|||
37909246|NCT00587223|69594795|FG000|Overall Study|Adverse Event|1|||
37909247|NCT00938639|69594804|FG000|Overall Study|Moved away from study area|0|||
38010820|NCT02510040|69693283|FG002|Overall Study|Deemed no longer eligible|1|||
38010821|NCT02296125|69693307|FG000|Overall Study|Withdrawal by Subject|18|||
38010822|NCT02296125|69693308|FG001|Overall Study|Withdrawal by Subject|8|||
38010823|NCT02296125|69693309|FG002|Overall Study|Withdrawal by Subject|6|||
38010824|NCT02296125|69693310|FG003|Overall Study|Withdrawal by Subject|2|||
38010825|NCT02296125|69693307|FG000|Overall Study|Adverse Event|41|||
38010826|NCT02296125|69693308|FG001|Overall Study|Adverse Event|52|||
38010827|NCT02296125|69693309|FG002|Overall Study|Adverse Event|9|||
37698248|NCT01610284|69174980|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
37698249|NCT02452463|69174989|FG000|Overall Study|Death|1|||
37698250|NCT02452463|69174990|FG001|Overall Study|Death|0|||
37698251|NCT02452463|69174991|FG002|Overall Study|Death|0|||
38010828|NCT02296125|69693310|FG003|Overall Study|Adverse Event|4|||
38010829|NCT02296125|69693307|FG000|Overall Study|Severe non-compliance to protocol|0|||
38010830|NCT02296125|69693308|FG001|Overall Study|Severe non-compliance to protocol|1|||
38010831|NCT02296125|69693309|FG002|Overall Study|Severe non-compliance to protocol|0|||
38010832|NCT02296125|69693310|FG003|Overall Study|Severe non-compliance to protocol|0|||
38010833|NCT02296125|69693307|FG000|Overall Study|Condition under investigation worsened|153|||
38010834|NCT02296125|69693308|FG001|Overall Study|Condition under investigation worsened|199|||
38010835|NCT02296125|69693309|FG002|Overall Study|Condition under investigation worsened|39|||
38010836|NCT02296125|69693310|FG003|Overall Study|Condition under investigation worsened|56|||
38010837|NCT02296125|69693307|FG000|Overall Study|Any reason not specifically recorded|6|||
38010838|NCT02296125|69693308|FG001|Overall Study|Any reason not specifically recorded|4|||
38010839|NCT02296125|69693309|FG002|Overall Study|Any reason not specifically recorded|2|||
38010840|NCT02296125|69693310|FG003|Overall Study|Any reason not specifically recorded|0|||
38010841|NCT01935089|69693325|FG000|Overall Study|Adverse Event|2|||
37909248|NCT00938639|69594805|FG001|Overall Study|Moved away from study area|1|||
37909249|NCT00938639|69594804|FG000|Overall Study|Lost to Follow-up|1|||
37909250|NCT00938639|69594805|FG001|Overall Study|Lost to Follow-up|2|||
37909251|NCT00938639|69594804|FG000|Overall Study|Family issues|1|||
37909252|NCT00938639|69594805|FG001|Overall Study|Family issues|1|||
37909253|NCT00938639|69594804|FG000|Overall Study|Participant noncompliance|1|||
37909254|NCT00938639|69594805|FG001|Overall Study|Participant noncompliance|0|||
37909255|NCT00783705|69594817|FG000|Overall Study|Adverse Event|2|||
37909256|NCT00783705|69594818|FG001|Overall Study|Adverse Event|0|||
37909257|NCT00783705|69594817|FG000|Overall Study|Withdrawal by Subject|3|||
37909258|NCT00783705|69594818|FG001|Overall Study|Withdrawal by Subject|2|||
37909259|NCT00783705|69594817|FG000|Overall Study|Lost to Follow-up|1|||
37909260|NCT00783705|69594818|FG001|Overall Study|Lost to Follow-up|3|||
37909261|NCT00604669|69594824|FG000|Overall Study|lack of information in chart|7|||
37909262|NCT00938327|69594828|FG000|Overall Study|Adverse Event|2|||
37909263|NCT00938327|69594828|FG000|Overall Study|Protocol Violation|1|||
37909264|NCT00938327|69594828|FG000|Overall Study|Withdrawal by Subject|4|||
37909265|NCT00938327|69594828|FG000|Overall Study|Lost to Follow-up|37|||
37909266|NCT00938327|69594828|FG000|Overall Study|2nd dose received outside of the study|7|||
38010842|NCT01935089|69693325|FG000|Overall Study|Withdrawal by Subject|1|||
38010843|NCT00571727|69693361|FG000|Overall Study|Did not enter in this study|1|||
38010844|NCT00571727|69693361|FG000|Overall Study|Non-compliance|4|||
38010845|NCT00571727|69693361|FG000|Overall Study|Lost to Follow-up|30|||
37698252|NCT02452463|69174989|FG000|Overall Study|Study Suspended|1|||
37698253|NCT02452463|69174990|FG001|Overall Study|Study Suspended|0|||
37698254|NCT02452463|69174991|FG002|Overall Study|Study Suspended|0|||
37698255|NCT02452463|69174989|FG000|Overall Study|Recommended by DSMB|0|||
37698256|NCT02452463|69174990|FG001|Overall Study|Recommended by DSMB|1|||
37698257|NCT02452463|69174991|FG002|Overall Study|Recommended by DSMB|0|||
37698258|NCT02452463|69174989|FG000|Overall Study|Withdrawal by Subject|0|||
37698259|NCT02452463|69174990|FG001|Overall Study|Withdrawal by Subject|1|||
37698260|NCT02452463|69174991|FG002|Overall Study|Withdrawal by Subject|0|||
37698261|NCT02432105|69175002|FG000|Overall Study|Lost to Follow-up|1|||
37831813|NCT03737110|69515235|FG005|Long-Term Extension (LTE) Period|Withdrawal by Subject|2|||
37831814|NCT03737110|69515230|FG000|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
37831815|NCT03737110|69515231|FG001|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
37831816|NCT03737110|69515232|FG002|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
37831817|NCT03737110|69515233|FG003|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
37831818|NCT03737110|69515234|FG004|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|1|||
37831819|NCT03737110|69515235|FG005|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
37831820|NCT03592771|69515286|FG000|Overall Study|Adverse Event|2|||
37831821|NCT03592771|69515287|FG001|Overall Study|Adverse Event|0|||
37831822|NCT03592771|69515288|FG002|Overall Study|Adverse Event|1|||
37831823|NCT03592771|69515286|FG000|Overall Study|Death|0|||
37909267|NCT00938327|69594828|FG000|Overall Study|Vaccine not received as out of stock|9|||
37909268|NCT00887198|69594834|FG000|Randomized Period|Ongoing|42|||
37909269|NCT00887198|69594835|FG001|Randomized Period|Ongoing|0|||
37909270|NCT00887198|69594836|FG002|Randomized Period|Ongoing|0|||
38010846|NCT00571727|69693361|FG000|Overall Study|Poor growth|1|||
38010847|NCT00571727|69693361|FG000|Overall Study|Parent/patient decision|2|||
37698262|NCT02432105|69175003|FG001|Overall Study|Lost to Follow-up|1|||
37698263|NCT02432105|69175004|FG002|Overall Study|Lost to Follow-up|0|||
37909271|NCT00887198|69594834|FG000|Randomized Period|Adverse Event|50|||
37698264|NCT02432105|69175002|FG000|Overall Study|Withdrawal by Subject|1|||
37698265|NCT02432105|69175003|FG001|Overall Study|Withdrawal by Subject|0|||
37909272|NCT00887198|69594835|FG001|Randomized Period|Adverse Event|33|||
37909273|NCT00887198|69594836|FG002|Randomized Period|Adverse Event|0|||
37909274|NCT00887198|69594834|FG000|Randomized Period|Lost to Follow-up|1|||
37909275|NCT00887198|69594835|FG001|Randomized Period|Lost to Follow-up|0|||
37909276|NCT00887198|69594836|FG002|Randomized Period|Lost to Follow-up|0|||
38010848|NCT00571727|69693361|FG000|Overall Study|Participant transferred to commercial drug|14|||
38010849|NCT00571727|69693361|FG000|Overall Study|Unable to provide study drug|6|||
38010850|NCT00571727|69693361|FG000|Overall Study|On-treatment at end of study|8|||
38010851|NCT00489307|69693367|FG000|Overall Study|Death|1|||
38010852|NCT00489307|69693368|FG001|Overall Study|Death|1|||
38010853|NCT00489307|69693367|FG000|Overall Study|Lost to Follow-up|2|||
38010854|NCT00489307|69693368|FG001|Overall Study|Lost to Follow-up|2|||
38010855|NCT00489307|69693367|FG000|Overall Study|Physician Decision|1|||
38010856|NCT00489307|69693368|FG001|Overall Study|Physician Decision|0|||
38010857|NCT00489307|69693367|FG000|Overall Study|Withdrawal by Subject|2|||
38010858|NCT00489307|69693368|FG001|Overall Study|Withdrawal by Subject|4|||
38010859|NCT00489307|69693367|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
38010860|NCT00489307|69693368|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
38010861|NCT00489307|69693367|FG000|Overall Study|Surgery after assignment|1|||
38010862|NCT00489307|69693368|FG001|Overall Study|Surgery after assignment|0|||
38010863|NCT00489307|69693367|FG000|Overall Study|Did not fill up the forms|2|||
38010864|NCT00489307|69693368|FG001|Overall Study|Did not fill up the forms|1|||
38010865|NCT00489307|69693367|FG000|Overall Study|Patient or family refusal|5|||
38010866|NCT00489307|69693368|FG001|Overall Study|Patient or family refusal|9|||
38010867|NCT00427349|69693374|FG000|Overall Study|Lack of Efficacy|23|||
38010868|NCT00427349|69693374|FG000|Overall Study|Adverse Event|14|||
38010869|NCT00427349|69693374|FG000|Overall Study|Death|1|||
38010870|NCT00427349|69693374|FG000|Overall Study|Withdrawal by Subject|3|||
38010871|NCT00427349|69693374|FG000|Overall Study|Alternative therapy|1|||
37909277|NCT00887198|69594834|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
37909278|NCT00887198|69594835|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
37909279|NCT00887198|69594836|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
38010872|NCT00427349|69693374|FG000|Overall Study|Other|2|||
38010873|NCT00427349|69693374|FG000|Overall Study|Ineligible|1|||
38010874|NCT00427349|69693374|FG000|Overall Study|Never started therapy|1|||
38010875|NCT00309985|69693380|FG000|Overall Study|Disease progression|12|||
38010876|NCT00309985|69693381|FG001|Overall Study|Disease progression|0|||
38010877|NCT00309985|69693380|FG000|Overall Study|Adverse Event|30|||
38010878|NCT00309985|69693381|FG001|Overall Study|Adverse Event|0|||
38010879|NCT00309985|69693380|FG000|Overall Study|Death|2|||
38010880|NCT00309985|69693381|FG001|Overall Study|Death|0|||
38010881|NCT00309985|69693380|FG000|Overall Study|Withdrawal by Subject|5|||
38010882|NCT00309985|69693381|FG001|Overall Study|Withdrawal by Subject|1|||
38010883|NCT00309985|69693380|FG000|Overall Study|Physician Decision|3|||
38010884|NCT00309985|69693381|FG001|Overall Study|Physician Decision|0|||
38010885|NCT00309985|69693380|FG000|Overall Study|Never started treatment|7|||
38010886|NCT00309985|69693381|FG001|Overall Study|Never started treatment|0|||
38010887|NCT00309985|69693380|FG000|Overall Study|Complicating disease|1|||
37909280|NCT00887198|69594834|FG000|Randomized Period|Withdrawal by Subject|41|||
38010888|NCT00309985|69693381|FG001|Overall Study|Complicating disease|0|||
38010889|NCT00309985|69693380|FG000|Overall Study|Non-compliance|1|||
38010890|NCT00309985|69693381|FG001|Overall Study|Non-compliance|0|||
38010891|NCT00309985|69693380|FG000|Overall Study|Chemotherapy discontinued only|1|||
38010892|NCT00309985|69693381|FG001|Overall Study|Chemotherapy discontinued only|0|||
38010893|NCT00098787|69693403|FG000|Overall Study|Never started treatment|3|||
38010894|NCT00098787|69693404|FG001|Overall Study|Never started treatment|2|||
38010895|NCT00098787|69693405|FG002|Overall Study|Never started treatment|1|||
38010896|NCT00098787|69693403|FG000|Overall Study|Ineligible|9|||
38010897|NCT00098787|69693404|FG001|Overall Study|Ineligible|7|||
38010898|NCT00098787|69693405|FG002|Overall Study|Ineligible|3|||
38010899|NCT00098787|69693403|FG000|Overall Study|Disease progression|28|||
38010900|NCT00098787|69693404|FG001|Overall Study|Disease progression|17|||
37909281|NCT00887198|69594835|FG001|Randomized Period|Withdrawal by Subject|56|||
37909282|NCT00887198|69594836|FG002|Randomized Period|Withdrawal by Subject|0|||
38010901|NCT00098787|69693405|FG002|Overall Study|Disease progression|23|||
38010902|NCT00098787|69693403|FG000|Overall Study|Adverse Event|8|||
38010903|NCT00098787|69693404|FG001|Overall Study|Adverse Event|17|||
38010904|NCT00098787|69693405|FG002|Overall Study|Adverse Event|8|||
38010905|NCT00098787|69693403|FG000|Overall Study|Death|6|||
38010906|NCT00098787|69693404|FG001|Overall Study|Death|1|||
38010907|NCT00098787|69693405|FG002|Overall Study|Death|0|||
38010908|NCT00098787|69693403|FG000|Overall Study|Withdrawal by Subject|4|||
38010909|NCT00098787|69693404|FG001|Overall Study|Withdrawal by Subject|12|||
38010910|NCT00098787|69693405|FG002|Overall Study|Withdrawal by Subject|6|||
38010911|NCT00098787|69693403|FG000|Overall Study|Alternative therapy|8|||
38010912|NCT00098787|69693404|FG001|Overall Study|Alternative therapy|13|||
38010913|NCT00098787|69693405|FG002|Overall Study|Alternative therapy|13|||
38010914|NCT00098787|69693403|FG000|Overall Study|Other|7|||
38010915|NCT00098787|69693404|FG001|Overall Study|Other|6|||
37909283|NCT00887198|69594834|FG000|Randomized Period|Progressive disease|366|||
37909284|NCT00887198|69594835|FG001|Randomized Period|Progressive disease|370|||
37909285|NCT00887198|69594836|FG002|Randomized Period|Progressive disease|0|||
37909286|NCT00887198|69594834|FG000|Randomized Period|Other|42|||
38010916|NCT00098787|69693405|FG002|Overall Study|Other|9|||
38010917|NCT00091169|69693415|FG000|Overall Study|Disease progression|3|||
38010918|NCT00091169|69693416|FG001|Overall Study|Disease progression|1|||
38010919|NCT00091169|69693415|FG000|Overall Study|Adverse Event|11|||
38010920|NCT00091169|69693416|FG001|Overall Study|Adverse Event|17|||
38010921|NCT00091169|69693415|FG000|Overall Study|Death|4|||
38010922|NCT00091169|69693416|FG001|Overall Study|Death|1|||
38010923|NCT00091169|69693415|FG000|Overall Study|Withdrawal by Subject|10|||
38010924|NCT00091169|69693416|FG001|Overall Study|Withdrawal by Subject|13|||
38010925|NCT00091169|69693415|FG000|Overall Study|Other|3|||
37909287|NCT00887198|69594835|FG001|Randomized Period|Other|30|||
37909288|NCT00887198|69594836|FG002|Randomized Period|Other|0|||
37909289|NCT00887198|69594834|FG000|Randomized Period|Randomized, Not treated|4|||
37909290|NCT00887198|69594835|FG001|Randomized Period|Randomized, Not treated|2|||
37909291|NCT00887198|69594836|FG002|Randomized Period|Randomized, Not treated|0|||
37909292|NCT00887198|69594834|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
37909293|NCT00887198|69594835|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
37909294|NCT00887198|69594836|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
37909295|NCT00887198|69594834|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
37909296|NCT00887198|69594835|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
37909297|NCT00887198|69594836|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
37909298|NCT00887198|69594834|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
37909299|NCT00887198|69594835|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
37909300|NCT00887198|69594836|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
37909301|NCT00887198|69594834|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
37909302|NCT00887198|69594835|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
37909303|NCT00887198|69594836|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
37909304|NCT00887198|69594834|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
37909305|NCT00887198|69594835|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
37909306|NCT00887198|69594836|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
37909307|NCT00887198|69594834|FG000|Cross Over (Placebo to AA)|Other|0|||
37909308|NCT00887198|69594835|FG001|Cross Over (Placebo to AA)|Other|0|||
37909309|NCT00887198|69594836|FG002|Cross Over (Placebo to AA)|Other|19|||
37909310|NCT00782067|69594844|FG000|Overall Study|Adverse Event|35|||
37909311|NCT00782067|69594844|FG000|Overall Study|Subject withdrew consent|11|||
37909312|NCT00782067|69594844|FG000|Overall Study|Lost to Follow-up|2|||
37909313|NCT00782067|69594844|FG000|Overall Study|Administrative problems|14|||
37909314|NCT00782067|69594844|FG000|Overall Study|Death|9|||
37909315|NCT00782067|69594844|FG000|Overall Study|Disease progression|43|||
37909316|NCT00782067|69594844|FG000|Overall Study|Protocol deviation|2|||
37909317|NCT00886340|69594850|FG000|Overall Study|Withdrawal by Subject|0|||
37909318|NCT00886340|69594851|FG001|Overall Study|Withdrawal by Subject|7|||
37909319|NCT00605215|69594860|FG000|Overall Study|Death|0|||
37909320|NCT00605215|69594861|FG001|Overall Study|Death|0|||
37909321|NCT00605215|69594862|FG002|Overall Study|Death|1|||
37909322|NCT00605215|69594860|FG000|Overall Study|Adverse Event|19|||
37909323|NCT00605215|69594861|FG001|Overall Study|Adverse Event|21|||
37909324|NCT00605215|69594862|FG002|Overall Study|Adverse Event|26|||
37909325|NCT00605215|69594860|FG000|Overall Study|Refusal to sign the re-consent form|8|||
37909326|NCT00605215|69594861|FG001|Overall Study|Refusal to sign the re-consent form|3|||
37909327|NCT00605215|69594862|FG002|Overall Study|Refusal to sign the re-consent form|3|||
37909328|NCT00605215|69594860|FG000|Overall Study|Withdrawal by Subject|39|||
38010926|NCT00091169|69693416|FG001|Overall Study|Other|4|||
37698266|NCT02432105|69175004|FG002|Overall Study|Withdrawal by Subject|1|||
37698267|NCT02432105|69175002|FG000|Overall Study|Culture positive for yeast|0|||
37698268|NCT02432105|69175003|FG001|Overall Study|Culture positive for yeast|1|||
37698269|NCT02432105|69175004|FG002|Overall Study|Culture positive for yeast|0|||
37698270|NCT02432105|69175002|FG000|Overall Study|Randomized in error|0|||
37698271|NCT02432105|69175003|FG001|Overall Study|Randomized in error|0|||
37698272|NCT02432105|69175004|FG002|Overall Study|Randomized in error|2|||
37698273|NCT02431793|69175016|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
37698274|NCT02431793|69175017|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
37909329|NCT00605215|69594861|FG001|Overall Study|Withdrawal by Subject|37|||
37909330|NCT00605215|69594862|FG002|Overall Study|Withdrawal by Subject|27|||
37909331|NCT00605215|69594860|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
38010927|NCT00091169|69693415|FG000|Overall Study|Not start protocol therapy|26|||
38010928|NCT00091169|69693416|FG001|Overall Study|Not start protocol therapy|17|||
37698275|NCT02431793|69175018|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
37698276|NCT02431793|69175016|FG000|Overall Study|Withdrawal by Subject|7|||
37698277|NCT02431793|69175017|FG001|Overall Study|Withdrawal by Subject|5|||
37698278|NCT02431793|69175018|FG002|Overall Study|Withdrawal by Subject|5|||
37698279|NCT02431793|69175016|FG000|Overall Study|Lost to Follow-up|101|||
37698280|NCT02431793|69175017|FG001|Overall Study|Lost to Follow-up|122|||
37698281|NCT02431793|69175018|FG002|Overall Study|Lost to Follow-up|104|||
37698282|NCT01801930|69175030|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
37698283|NCT01801930|69175031|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
37909332|NCT00605215|69594861|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
37909333|NCT00605215|69594862|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
37909334|NCT00605215|69594860|FG000|Overall Study|Protocol Violation|3|||
37909335|NCT00605215|69594861|FG001|Overall Study|Protocol Violation|4|||
37909336|NCT00605215|69594862|FG002|Overall Study|Protocol Violation|1|||
37909337|NCT00605215|69594860|FG000|Overall Study|Pregnancy|8|||
37909338|NCT00605215|69594861|FG001|Overall Study|Pregnancy|5|||
37909339|NCT00605215|69594862|FG002|Overall Study|Pregnancy|4|||
37909340|NCT00605215|69594860|FG000|Overall Study|Lost to Follow-up|8|||
37909341|NCT00605215|69594861|FG001|Overall Study|Lost to Follow-up|5|||
37909342|NCT00605215|69594862|FG002|Overall Study|Lost to Follow-up|2|||
37909343|NCT00605215|69594860|FG000|Overall Study|Other than specified|0|||
37909344|NCT00605215|69594861|FG001|Overall Study|Other than specified|2|||
37909345|NCT00605215|69594862|FG002|Overall Study|Other than specified|1|||
37909346|NCT00604279|69594872|FG000|Overall Study|Lack of Efficacy|22|||
37909347|NCT00604279|69594873|FG001|Overall Study|Lack of Efficacy|9|||
37909348|NCT00604279|69594872|FG000|Overall Study|Lost to Follow-up|9|||
37909349|NCT00604279|69594873|FG001|Overall Study|Lost to Follow-up|14|||
37909350|NCT00604279|69594872|FG000|Overall Study|Pregnancy|2|||
37909351|NCT00604279|69594873|FG001|Overall Study|Pregnancy|0|||
37909352|NCT00604279|69594872|FG000|Overall Study|Protocol Violation|3|||
37909353|NCT00604279|69594873|FG001|Overall Study|Protocol Violation|1|||
37909354|NCT00604279|69594872|FG000|Overall Study|Withdrawal by Subject|16|||
37909355|NCT00604279|69594873|FG001|Overall Study|Withdrawal by Subject|5|||
37909356|NCT00604279|69594872|FG000|Overall Study|Adverse Event|4|||
37909357|NCT00604279|69594873|FG001|Overall Study|Adverse Event|5|||
37909358|NCT00604279|69594872|FG000|Overall Study|Other|8|||
37909359|NCT00604279|69594873|FG001|Overall Study|Other|4|||
38010929|NCT00075946|69693428|FG000|Overall Study|Path ineligible: undetermined histology|0|||
38010930|NCT00075946|69693429|FG001|Overall Study|Path ineligible: undetermined histology|0|||
38010931|NCT00075946|69693430|FG002|Overall Study|Path ineligible: undetermined histology|0|||
38010932|NCT00075946|69693431|FG003|Overall Study|Path ineligible: undetermined histology|0|||
38010933|NCT00075946|69693432|FG004|Overall Study|Path ineligible: undetermined histology|6|||
38010934|NCT00075946|69693428|FG000|Overall Study|Did not achieve response after induction|0|||
38010935|NCT00075946|69693429|FG001|Overall Study|Did not achieve response after induction|0|||
38010936|NCT00075946|69693430|FG002|Overall Study|Did not achieve response after induction|0|||
38010937|NCT00075946|69693431|FG003|Overall Study|Did not achieve response after induction|0|||
38010938|NCT00075946|69693432|FG004|Overall Study|Did not achieve response after induction|182|||
38010939|NCT00075946|69693428|FG000|Overall Study|Incorrectly randomized (no response)|5|||
38010940|NCT00075946|69693429|FG001|Overall Study|Incorrectly randomized (no response)|5|||
38010941|NCT00075946|69693430|FG002|Overall Study|Incorrectly randomized (no response)|5|||
38010942|NCT00075946|69693431|FG003|Overall Study|Incorrectly randomized (no response)|1|||
38010943|NCT00075946|69693432|FG004|Overall Study|Incorrectly randomized (no response)|0|||
38010944|NCT00075946|69693428|FG000|Overall Study|Still on treatment at time of analysis|52|||
38010945|NCT00075946|69693429|FG001|Overall Study|Still on treatment at time of analysis|19|||
38010946|NCT00075946|69693430|FG002|Overall Study|Still on treatment at time of analysis|3|||
38010947|NCT00075946|69693431|FG003|Overall Study|Still on treatment at time of analysis|9|||
38010948|NCT00075946|69693432|FG004|Overall Study|Still on treatment at time of analysis|0|||
38010949|NCT00075946|69693428|FG000|Overall Study|Adverse Event|2|||
38010950|NCT00075946|69693429|FG001|Overall Study|Adverse Event|10|||
38010951|NCT00075946|69693430|FG002|Overall Study|Adverse Event|0|||
38010952|NCT00075946|69693431|FG003|Overall Study|Adverse Event|2|||
38010953|NCT00075946|69693432|FG004|Overall Study|Adverse Event|0|||
38010954|NCT00075946|69693428|FG000|Overall Study|Death|0|||
38010955|NCT00075946|69693429|FG001|Overall Study|Death|1|||
38010956|NCT00075946|69693430|FG002|Overall Study|Death|0|||
37909360|NCT00938015|69594879|FG000|Overall Study|Death|2|||
37909361|NCT00938015|69594879|FG000|Overall Study|Lost to Follow-up|32|||
38010957|NCT00075946|69693431|FG003|Overall Study|Death|0|||
37698284|NCT01801930|69175032|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
37698285|NCT01801930|69175033|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
37909362|NCT00938015|69594879|FG000|Overall Study|Adverse Event|32|||
37909363|NCT00938015|69594879|FG000|Overall Study|Non-responder|52|||
37909364|NCT00938015|69594879|FG000|Overall Study|Reason not related to Etanercept|29|||
37909365|NCT00781911|69594885|FG000|Overall Study|Adverse Event|4|||
37909366|NCT00781911|69594886|FG001|Overall Study|Adverse Event|4|||
38010958|NCT00075946|69693432|FG004|Overall Study|Death|0|||
38010959|NCT00075946|69693428|FG000|Overall Study|Withdrawal by Subject|23|||
38010960|NCT00075946|69693429|FG001|Overall Study|Withdrawal by Subject|58|||
38010961|NCT00075946|69693430|FG002|Overall Study|Withdrawal by Subject|4|||
38010962|NCT00075946|69693431|FG003|Overall Study|Withdrawal by Subject|9|||
38010963|NCT00075946|69693432|FG004|Overall Study|Withdrawal by Subject|0|||
38010964|NCT00075946|69693428|FG000|Overall Study|Alternative therapy|16|||
38010965|NCT00075946|69693429|FG001|Overall Study|Alternative therapy|2|||
38010966|NCT00075946|69693430|FG002|Overall Study|Alternative therapy|5|||
38010967|NCT00075946|69693431|FG003|Overall Study|Alternative therapy|0|||
38010968|NCT00075946|69693432|FG004|Overall Study|Alternative therapy|0|||
38010969|NCT00075946|69693428|FG000|Overall Study|Other complicating disease|7|||
38010970|NCT00075946|69693429|FG001|Overall Study|Other complicating disease|13|||
38010971|NCT00075946|69693430|FG002|Overall Study|Other complicating disease|1|||
38010972|NCT00075946|69693431|FG003|Overall Study|Other complicating disease|4|||
38010973|NCT00075946|69693432|FG004|Overall Study|Other complicating disease|0|||
38010974|NCT00075946|69693428|FG000|Overall Study|No response to retreatment|23|||
38010975|NCT00075946|69693429|FG001|Overall Study|No response to retreatment|0|||
38010976|NCT00075946|69693430|FG002|Overall Study|No response to retreatment|2|||
38010977|NCT00075946|69693431|FG003|Overall Study|No response to retreatment|0|||
38010978|NCT00075946|69693432|FG004|Overall Study|No response to retreatment|0|||
38010979|NCT00075946|69693428|FG000|Overall Study|Time to progression less than 6 months|15|||
38010980|NCT00075946|69693429|FG001|Overall Study|Time to progression less than 6 months|30|||
38010981|NCT00075946|69693430|FG002|Overall Study|Time to progression less than 6 months|8|||
38010982|NCT00075946|69693431|FG003|Overall Study|Time to progression less than 6 months|3|||
38010983|NCT00075946|69693432|FG004|Overall Study|Time to progression less than 6 months|0|||
38010984|NCT00075946|69693428|FG000|Overall Study|Other|5|||
38010985|NCT00075946|69693429|FG001|Overall Study|Other|13|||
38010986|NCT00075946|69693430|FG002|Overall Study|Other|0|||
38010987|NCT00075946|69693431|FG003|Overall Study|Other|2|||
38010988|NCT00075946|69693432|FG004|Overall Study|Other|0|||
38010989|NCT00057876|69693449|FG000|Overall Study|Adverse Event|8|||
38010990|NCT00057876|69693450|FG001|Overall Study|Adverse Event|8|||
38010991|NCT00057876|69693449|FG000|Overall Study|Death|2|||
38010992|NCT00057876|69693450|FG001|Overall Study|Death|1|||
38010993|NCT00057876|69693449|FG000|Overall Study|Withdrawal by Subject|5|||
38010994|NCT00057876|69693450|FG001|Overall Study|Withdrawal by Subject|6|||
38010995|NCT00057876|69693449|FG000|Overall Study|Lack of Efficacy|10|||
38010996|NCT00057876|69693450|FG001|Overall Study|Lack of Efficacy|8|||
38010997|NCT00057876|69693449|FG000|Overall Study|Ineligible|1|||
38010998|NCT00057876|69693450|FG001|Overall Study|Ineligible|2|||
38010999|NCT00057876|69693449|FG000|Overall Study|other reason|2|||
38011000|NCT00057876|69693450|FG001|Overall Study|other reason|2|||
38011001|NCT00057876|69693449|FG000|Overall Study|other complicating disease|1|||
38011002|NCT00057876|69693450|FG001|Overall Study|other complicating disease|0|||
38011003|NCT00057837|69693458|FG000|Overall Study|Progression/relapse|12|||
38011004|NCT00057837|69693459|FG001|Overall Study|Progression/relapse|14|||
38011005|NCT00057837|69693458|FG000|Overall Study|Adverse Event|2|||
38011006|NCT00057837|69693459|FG001|Overall Study|Adverse Event|12|||
38011007|NCT00057837|69693458|FG000|Overall Study|Death|5|||
37831824|NCT03592771|69515287|FG001|Overall Study|Death|1|||
37831825|NCT03592771|69515288|FG002|Overall Study|Death|1|||
37831826|NCT03592771|69515286|FG000|Overall Study|Lost to Follow-up|5|||
37831827|NCT03592771|69515287|FG001|Overall Study|Lost to Follow-up|11|||
37831828|NCT03592771|69515288|FG002|Overall Study|Lost to Follow-up|15|||
37831829|NCT03592771|69515286|FG000|Overall Study|Withdrawal by Subject|0|||
37831830|NCT03592771|69515287|FG001|Overall Study|Withdrawal by Subject|2|||
37831831|NCT03592771|69515288|FG002|Overall Study|Withdrawal by Subject|0|||
37831832|NCT03495154|69515296|FG000|Overall Study|Screen Failures Pre-Operatively|4|||
37831833|NCT03495154|69515296|FG000|Overall Study|Withdrawn Prior to Surgery|10|||
37831834|NCT03495154|69515296|FG000|Overall Study|Screen Failures During Surgery|6|||
37831835|NCT03495154|69515296|FG000|Overall Study|Death|2|||
38011008|NCT00057837|69693459|FG001|Overall Study|Death|4|||
38011009|NCT00057837|69693458|FG000|Overall Study|Withdrawal by Subject|5|||
38011010|NCT00057837|69693459|FG001|Overall Study|Withdrawal by Subject|3|||
38011011|NCT00057837|69693458|FG000|Overall Study|Alternative therapy|0|||
38011012|NCT00057837|69693459|FG001|Overall Study|Alternative therapy|1|||
37831836|NCT03495154|69515296|FG000|Overall Study|Lost to Follow-up|16|||
38011013|NCT00057837|69693458|FG000|Overall Study|Other complicating disease|2|||
37831837|NCT03495154|69515296|FG000|Overall Study|Withdrawal by Subject|2|||
38011014|NCT00057837|69693459|FG001|Overall Study|Other complicating disease|1|||
38011015|NCT00057837|69693458|FG000|Overall Study|Physician Decision|1|||
38011016|NCT00057837|69693459|FG001|Overall Study|Physician Decision|0|||
38011017|NCT00057837|69693458|FG000|Overall Study|Ineligible|3|||
38011018|NCT00057837|69693459|FG001|Overall Study|Ineligible|3|||
37831838|NCT03495154|69515296|FG000|Overall Study|Unable to gather information from subject due to age and limited abilities|1|||
38011019|NCT00057837|69693458|FG000|Overall Study|Never started treatment|1|||
38011020|NCT00057837|69693459|FG001|Overall Study|Never started treatment|1|||
37831839|NCT03334253|69515336|FG000|Overall Study|Withdrawal by Subject|1|||
37831840|NCT03334253|69515337|FG001|Overall Study|Withdrawal by Subject|0|||
37831841|NCT03334253|69515336|FG000|Overall Study|Lost to Follow-up|4|||
38011021|NCT00046930|69693467|FG000|Overall Study|Ineligible|12|||
38011022|NCT00046930|69693468|FG001|Overall Study|Ineligible|4|||
38011023|NCT00042939|69693479|FG000|Overall Study|Adverse Event|6|||
38011024|NCT00042939|69693480|FG001|Overall Study|Adverse Event|7|||
38011025|NCT00042939|69693479|FG000|Overall Study|Death|3|||
38011026|NCT00042939|69693480|FG001|Overall Study|Death|2|||
38011027|NCT00042939|69693479|FG000|Overall Study|Withdrawal by Subject|3|||
38011028|NCT00042939|69693480|FG001|Overall Study|Withdrawal by Subject|4|||
38011029|NCT00042939|69693479|FG000|Overall Study|Other disease|1|||
38011030|NCT00042939|69693480|FG001|Overall Study|Other disease|0|||
38011031|NCT00042939|69693479|FG000|Overall Study|Ineligible|2|||
38011032|NCT00042939|69693480|FG001|Overall Study|Ineligible|2|||
38011033|NCT00042939|69693479|FG000|Overall Study|Deterioration of health|3|||
38011034|NCT00042939|69693480|FG001|Overall Study|Deterioration of health|4|||
38011035|NCT00042939|69693479|FG000|Overall Study|QOL diminished|1|||
38011036|NCT00042939|69693480|FG001|Overall Study|QOL diminished|0|||
38011037|NCT00042939|69693479|FG000|Overall Study|Rising ca 19-9|1|||
38011038|NCT00042939|69693480|FG001|Overall Study|Rising ca 19-9|0|||
38011039|NCT00042939|69693479|FG000|Overall Study|Patient non-compliance|1|||
38011040|NCT00042939|69693480|FG001|Overall Study|Patient non-compliance|0|||
38011041|NCT00042939|69693479|FG000|Overall Study|Still on treatment|1|||
37831842|NCT03334253|69515337|FG001|Overall Study|Lost to Follow-up|3|||
37909367|NCT00781911|69594885|FG000|Overall Study|Withdrawal by Subject|1|||
37909368|NCT00781911|69594886|FG001|Overall Study|Withdrawal by Subject|2|||
37909369|NCT00781911|69594885|FG000|Overall Study|Physician Decision|0|||
37909370|NCT00781911|69594886|FG001|Overall Study|Physician Decision|2|||
37909371|NCT00781911|69594885|FG000|Overall Study|Sponsor Decision|1|||
37909372|NCT00781911|69594886|FG001|Overall Study|Sponsor Decision|0|||
37909373|NCT00605917|69594894|FG000|Overall Study|Protocol Violation|79|||
37909374|NCT00781599|69594931|FG000|Overall Study|Lost to Follow-up|7|||
37909375|NCT00781599|69594932|FG001|Overall Study|Lost to Follow-up|4|||
38011042|NCT00042939|69693480|FG001|Overall Study|Still on treatment|0|||
38011043|NCT00042939|69693479|FG000|Overall Study|Treatment break > 4 weeks|0|||
38011044|NCT00042939|69693480|FG001|Overall Study|Treatment break > 4 weeks|1|||
38011045|NCT00042939|69693479|FG000|Overall Study|Did not start treatment|2|||
38011046|NCT00042939|69693480|FG001|Overall Study|Did not start treatment|1|||
38011047|NCT00008385|69693488|FG000|Overall Study|Off treatment reasons not reported|79|||
38011048|NCT00008385|69693489|FG001|Overall Study|Off treatment reasons not reported|70|||
38011049|NCT00008385|69693488|FG000|Overall Study|Progressive disease|52|||
38011050|NCT00008385|69693489|FG001|Overall Study|Progressive disease|117|||
38011051|NCT00008385|69693488|FG000|Overall Study|Adverse Event|8|||
38011052|NCT00008385|69693489|FG001|Overall Study|Adverse Event|20|||
37831843|NCT03334253|69515336|FG000|Overall Study|Moved residence|2|||
37831844|NCT03334253|69515337|FG001|Overall Study|Moved residence|2|||
37831845|NCT03314857|69515343|FG000|Overall Study|Death|4|||
37831846|NCT03314857|69515343|FG000|Overall Study|Physician Decision|1|||
37831847|NCT03302156|69515349|FG000|Overall Study|no visible evidence of tumor on MRI|0|||
37831848|NCT03302156|69515350|FG001|Overall Study|no visible evidence of tumor on MRI|1|||
37831849|NCT03302156|69515351|FG002|Overall Study|no visible evidence of tumor on MRI|0|||
37831850|NCT03268954|69515360|FG000|Overall Study|Ongoing|23|||
37831851|NCT03268954|69515361|FG001|Overall Study|Ongoing|31|||
37831852|NCT03268954|69515360|FG000|Overall Study|Adverse Event|53|||
37831853|NCT03268954|69515361|FG001|Overall Study|Adverse Event|62|||
38011053|NCT00008385|69693488|FG000|Overall Study|Death|12|||
37909376|NCT00605839|69594950|FG000|Overall Study|Protocol Violation|1|||
37909377|NCT00605839|69594951|FG001|Overall Study|Protocol Violation|0|||
38011054|NCT00008385|69693489|FG001|Overall Study|Death|18|||
38011055|NCT00008385|69693488|FG000|Overall Study|Withdrawal by Subject|67|||
38011056|NCT00008385|69693489|FG001|Overall Study|Withdrawal by Subject|157|||
38011057|NCT00008385|69693488|FG000|Overall Study|Start non-protocol therapy|3|||
38011058|NCT00008385|69693489|FG001|Overall Study|Start non-protocol therapy|1|||
38011059|NCT00008385|69693488|FG000|Overall Study|Other complicating disease|17|||
37909378|NCT00605839|69594952|FG002|Overall Study|Protocol Violation|0|||
37909379|NCT00781365|69594962|FG000|Overall Study|Withdrawal by Subject|13|||
37909380|NCT00781365|69594963|FG001|Overall Study|Withdrawal by Subject|8|||
37909381|NCT00781365|69594962|FG000|Overall Study|Did Not Attend Visit|20|||
37909382|NCT00781365|69594963|FG001|Overall Study|Did Not Attend Visit|28|||
37909383|NCT00781365|69594962|FG000|Overall Study|Language barrier|1|||
37909384|NCT00781365|69594963|FG001|Overall Study|Language barrier|0|||
37909385|NCT00937547|69594972|FG000|Overall Study|misdiagnosis|1|||
37909386|NCT00937547|69594973|FG001|Overall Study|misdiagnosis|6|||
37909387|NCT00937547|69594974|FG002|Overall Study|misdiagnosis|7|||
37909388|NCT00780975|69594982|FG000|Overall Study|Progressive disease|3|||
37909389|NCT00780975|69594982|FG000|Overall Study|Toxicity|5|||
37909390|NCT00780273|69594986|FG000|Overall Study|Death|1|||
37909391|NCT00780273|69594986|FG000|Overall Study|Lost to Follow-up|1|||
37909392|NCT00779259|69594991|FG000|Quinine Alone|Adverse Event|2|||
37909393|NCT00779025|69595009|FG000|Overall Study|Withdrawal by Subject|1|||
37909394|NCT00936065|69595017|FG000|Overall Study|Adverse Event|1|||
37909395|NCT00936065|69595018|FG001|Overall Study|Adverse Event|0|||
37909396|NCT00936065|69595019|FG002|Overall Study|Adverse Event|1|||
38011060|NCT00008385|69693489|FG001|Overall Study|Other complicating disease|30|||
38011061|NCT00008385|69693488|FG000|Overall Study|Maximum dose reached|0|||
38011062|NCT00008385|69693489|FG001|Overall Study|Maximum dose reached|2|||
38011063|NCT00008385|69693488|FG000|Overall Study|Other|105|||
38011064|NCT00008385|69693489|FG001|Overall Study|Other|212|||
38011065|NCT00008385|69693488|FG000|Overall Study|Not start protocol therapy|44|||
38011066|NCT00008385|69693489|FG001|Overall Study|Not start protocol therapy|175|||
38011067|NCT00003907|69693504|FG000|Overall Study|Adverse Event|2|||
38011068|NCT00003907|69693505|FG001|Overall Study|Adverse Event|11|||
38011069|NCT00003907|69693504|FG000|Overall Study|Death|2|||
38011070|NCT00003907|69693505|FG001|Overall Study|Death|0|||
37831854|NCT03268954|69515360|FG000|Overall Study|Withdrawal by Subject|25|||
37831855|NCT03268954|69515361|FG001|Overall Study|Withdrawal by Subject|16|||
38011071|NCT00003907|69693504|FG000|Overall Study|Withdrawal by Subject|1|||
38011072|NCT00003907|69693505|FG001|Overall Study|Withdrawal by Subject|3|||
37831856|NCT03268954|69515360|FG000|Overall Study|Progressive Disease|61|||
37831857|NCT03268954|69515361|FG001|Overall Study|Progressive Disease|48|||
38011073|NCT00003907|69693504|FG000|Overall Study|Progressive disease|4|||
37831858|NCT03268954|69515360|FG000|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|25|||
37831859|NCT03268954|69515361|FG001|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|30|||
37831860|NCT03268954|69515360|FG000|Overall Study|Reason not Specified|40|||
37831861|NCT03268954|69515361|FG001|Overall Study|Reason not Specified|40|||
37831862|NCT03235739|69515369|FG000|Overall Study|Withdrawal by Subject|2|||
37831863|NCT03235739|69515370|FG001|Overall Study|Withdrawal by Subject|2|||
38011074|NCT00003907|69693505|FG001|Overall Study|Progressive disease|4|||
38011075|NCT00003907|69693504|FG000|Overall Study|Complicating disease|1|||
38011076|NCT00003907|69693505|FG001|Overall Study|Complicating disease|0|||
38011077|NCT00003907|69693504|FG000|Overall Study|Other|1|||
38011078|NCT00003907|69693505|FG001|Overall Study|Other|3|||
38011079|NCT00003907|69693504|FG000|Overall Study|ineligible or not treated|2|||
38011080|NCT00003907|69693505|FG001|Overall Study|ineligible or not treated|2|||
38011081|NCT04241315|69693513|FG000|Overall Study|Withdrawal by Subject|0|||
38011082|NCT04241315|69693514|FG001|Overall Study|Withdrawal by Subject|1|||
37831864|NCT03235739|69515369|FG000|Overall Study|Physician Decision|0|||
37831865|NCT03235739|69515370|FG001|Overall Study|Physician Decision|1|||
37831866|NCT03176771|69515379|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|3|||
37909397|NCT00936065|69595017|FG000|Overall Study|Lack of Efficacy|1|||
37909398|NCT00936065|69595018|FG001|Overall Study|Lack of Efficacy|0|||
37909399|NCT00936065|69595019|FG002|Overall Study|Lack of Efficacy|1|||
37909400|NCT00936065|69595017|FG000|Overall Study|Lost to Follow-up|1|||
37909401|NCT00936065|69595018|FG001|Overall Study|Lost to Follow-up|0|||
38011083|NCT04225026|69693520|FG000|Overall Study|Withdrawal by Subject|4|||
38011084|NCT04225026|69693520|FG000|Overall Study|Adverse Event|1|||
38011085|NCT04225026|69693520|FG000|Overall Study|Other|1|||
37831867|NCT03176771|69515380|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|5|||
37909402|NCT00936065|69595019|FG002|Overall Study|Lost to Follow-up|0|||
37909403|NCT00936065|69595017|FG000|Overall Study|Protocol Violation|1|||
37909404|NCT00936065|69595018|FG001|Overall Study|Protocol Violation|2|||
37909405|NCT00936065|69595019|FG002|Overall Study|Protocol Violation|1|||
37909406|NCT00936065|69595017|FG000|Overall Study|Withdrawal by Subject|0|||
37909407|NCT00936065|69595018|FG001|Overall Study|Withdrawal by Subject|2|||
38011086|NCT04225026|69693520|FG000|Overall Study|Death|11|||
38011087|NCT04225026|69693520|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
38011088|NCT03493958|69693926|FG000|Overall Study|Withdrawal by Subject|6|||
37831868|NCT03176771|69515381|FG002|Double-Blind Placebo-Controlled Period|Adverse Event|14|||
37831869|NCT03176771|69515382|FG003|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
37831870|NCT03176771|69515383|FG004|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
37831871|NCT03176771|69515379|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
37909408|NCT00936065|69595019|FG002|Overall Study|Withdrawal by Subject|4|||
38011089|NCT03493958|69693926|FG000|Overall Study|Lost to Follow-up|7|||
38011090|NCT03493958|69693926|FG000|Overall Study|Did not complete all required study procedures|2|||
38011091|NCT03486223|69693932|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
38011092|NCT03486223|69693933|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
38011093|NCT03482024|69693944|FG000|Overall Study|Physician Decision|1|||
38011094|NCT03482024|69693945|FG001|Overall Study|Physician Decision|0|||
38011095|NCT03482024|69693946|FG002|Overall Study|Physician Decision|0|||
38011096|NCT03482024|69693947|FG003|Overall Study|Physician Decision|0|||
38011097|NCT03482024|69693948|FG004|Overall Study|Physician Decision|0|||
38011098|NCT03468309|69693960|FG000|Overall Study|Lost to Follow-up|4|||
38011099|NCT03468309|69693960|FG000|Overall Study|Withdrawal by Subject|2|||
38011100|NCT03423147|69693966|FG000|Overall Study|Lost to Follow-up|5|||
37698286|NCT01801930|69175030|FG000|Overall Study|DLT occurs|0|||
37698287|NCT01801930|69175031|FG001|Overall Study|DLT occurs|1|||
37698288|NCT01801930|69175032|FG002|Overall Study|DLT occurs|0|||
37698289|NCT01801930|69175033|FG003|Overall Study|DLT occurs|0|||
37698290|NCT01610206|69175045|FG000|Overall Study|Adverse Event|10|||
37698291|NCT01610206|69175046|FG001|Overall Study|Adverse Event|30|||
37698292|NCT01816048|69175052|FG000|Overall Study|Adverse Event|1|||
37698293|NCT01816048|69175052|FG000|Overall Study|Death|1|||
37698294|NCT01816048|69175052|FG000|Overall Study|Withdrawal by Subject|1|||
37698295|NCT01816048|69175052|FG000|Overall Study|Disease Progression|3|||
37698296|NCT01612858|69175059|FG000|Overall Study|Withdrawal by Subject|5|||
37698297|NCT01612858|69175060|FG001|Overall Study|Withdrawal by Subject|1|||
37698298|NCT01612780|69175066|FG000|Overall Study|Treatment not completed|1|||
37698299|NCT01612780|69175066|FG000|Overall Study|Withdrawal by Subject|5|||
37698300|NCT01612702|69175072|FG000|Overall Study|Protocol Violation|11|||
37698301|NCT01612702|69175073|FG001|Overall Study|Protocol Violation|11|||
37698302|NCT02431559|69175083|FG000|Overall Study|Adverse Event|0|||
37831872|NCT03176771|69515380|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|2|||
37831873|NCT03176771|69515381|FG002|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
37831874|NCT03176771|69515382|FG003|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
37831875|NCT03176771|69515383|FG004|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
37831876|NCT03176771|69515379|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|2|||
37831877|NCT03176771|69515380|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|8|||
37831878|NCT03176771|69515381|FG002|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|10|||
37909409|NCT04441788|69595030|FG000|Overall Study|Voluntary Withdrawl|0|||
37909410|NCT04441788|69595031|FG001|Overall Study|Voluntary Withdrawl|1|||
37909411|NCT04441788|69595032|FG002|Overall Study|Voluntary Withdrawl|0|||
37909412|NCT04441788|69595030|FG000|Overall Study|Ineligibility|1|||
37909413|NCT04441788|69595031|FG001|Overall Study|Ineligibility|0|||
37909414|NCT04441788|69595032|FG002|Overall Study|Ineligibility|0|||
37909415|NCT04441788|69595030|FG000|Overall Study|Adverse Event|0|||
37909416|NCT04441788|69595031|FG001|Overall Study|Adverse Event|0|||
37909417|NCT04441788|69595032|FG002|Overall Study|Adverse Event|4|||
37909418|NCT04441788|69595030|FG000|Overall Study|Study Terminated by Sponsor|16|||
37909419|NCT04441788|69595031|FG001|Overall Study|Study Terminated by Sponsor|16|||
37909420|NCT04441788|69595032|FG002|Overall Study|Study Terminated by Sponsor|12|||
37909421|NCT00604825|69595048|FG000|Overall Study|Adverse Event|2|||
37909422|NCT00604825|69595049|FG001|Overall Study|Adverse Event|6|||
37909423|NCT00604825|69595050|FG002|Overall Study|Adverse Event|7|||
37909424|NCT00604825|69595051|FG003|Overall Study|Adverse Event|4|||
37909425|NCT00604825|69595048|FG000|Overall Study|Lost to Follow-up|0|||
37909426|NCT00604825|69595049|FG001|Overall Study|Lost to Follow-up|3|||
37909427|NCT00604825|69595050|FG002|Overall Study|Lost to Follow-up|1|||
37909428|NCT00604825|69595051|FG003|Overall Study|Lost to Follow-up|0|||
37909429|NCT00604825|69595048|FG000|Overall Study|Protocol Violation|0|||
37909430|NCT00604825|69595049|FG001|Overall Study|Protocol Violation|1|||
37909431|NCT00604825|69595050|FG002|Overall Study|Protocol Violation|0|||
37909432|NCT00604825|69595051|FG003|Overall Study|Protocol Violation|0|||
37698303|NCT02431559|69175084|FG001|Overall Study|Adverse Event|1|||
37698304|NCT02431559|69175085|FG002|Overall Study|Adverse Event|0|||
37909433|NCT00604825|69595048|FG000|Overall Study|Withdrawal by Subject|4|||
37909434|NCT00604825|69595049|FG001|Overall Study|Withdrawal by Subject|3|||
37909435|NCT00604825|69595050|FG002|Overall Study|Withdrawal by Subject|5|||
37909436|NCT00604825|69595051|FG003|Overall Study|Withdrawal by Subject|5|||
37909437|NCT00604825|69595048|FG000|Overall Study|Lack of Efficacy|3|||
38011101|NCT03423147|69693967|FG001|Overall Study|Lost to Follow-up|8|||
37698305|NCT02431559|69175086|FG003|Overall Study|Adverse Event|4|||
37698306|NCT02431559|69175083|FG000|Overall Study|Progressive disease|2|||
37698307|NCT02431559|69175084|FG001|Overall Study|Progressive disease|1|||
37698308|NCT02431559|69175085|FG002|Overall Study|Progressive disease|4|||
37698309|NCT02431559|69175086|FG003|Overall Study|Progressive disease|22|||
37698310|NCT02431559|69175083|FG000|Overall Study|Withdrawal by Subject|0|||
37698311|NCT02431559|69175084|FG001|Overall Study|Withdrawal by Subject|1|||
37698312|NCT02431559|69175085|FG002|Overall Study|Withdrawal by Subject|0|||
37698313|NCT02431559|69175086|FG003|Overall Study|Withdrawal by Subject|4|||
37909438|NCT00604825|69595049|FG001|Overall Study|Lack of Efficacy|2|||
37698314|NCT02431559|69175083|FG000|Overall Study|Physician Decision|0|||
37698315|NCT02431559|69175084|FG001|Overall Study|Physician Decision|0|||
37698316|NCT02431559|69175085|FG002|Overall Study|Physician Decision|0|||
37698317|NCT02431559|69175086|FG003|Overall Study|Physician Decision|1|||
37698318|NCT02388269|69175100|FG000|Overall Study|Adverse Event|2|||
37698319|NCT02388269|69175101|FG001|Overall Study|Adverse Event|0|||
37698320|NCT02388269|69175102|FG002|Overall Study|Adverse Event|0|||
37698321|NCT02388269|69175100|FG000|Overall Study|Withdrawal by Subject|1|||
37698322|NCT02388269|69175101|FG001|Overall Study|Withdrawal by Subject|2|||
37698323|NCT02388269|69175102|FG002|Overall Study|Withdrawal by Subject|0|||
37698324|NCT02388269|69175100|FG000|Overall Study|less than 50% stimulations|1|||
37698325|NCT02388269|69175101|FG001|Overall Study|less than 50% stimulations|0|||
37698326|NCT02388269|69175102|FG002|Overall Study|less than 50% stimulations|0|||
37698327|NCT02388269|69175100|FG000|Overall Study|no diary data|3|||
37698328|NCT02388269|69175101|FG001|Overall Study|no diary data|0|||
37698329|NCT02388269|69175102|FG002|Overall Study|no diary data|0|||
37698330|NCT02388269|69175100|FG000|Overall Study|Protocol Violation|2|||
37698331|NCT02388269|69175101|FG001|Overall Study|Protocol Violation|0|||
37698332|NCT02388269|69175102|FG002|Overall Study|Protocol Violation|0|||
37698333|NCT02388269|69175100|FG000|Overall Study|Screen Failure|0|||
37698334|NCT02388269|69175101|FG001|Overall Study|Screen Failure|0|||
37698335|NCT02388269|69175102|FG002|Overall Study|Screen Failure|10|||
37698336|NCT01652573|69175128|FG000|Overall Study|Adverse Event|0|||
37698337|NCT01652573|69175129|FG001|Overall Study|Adverse Event|1|||
37698338|NCT02388191|69175137|FG000|Overall Study|Patient did not receive IUD|1|||
37909439|NCT00604825|69595050|FG002|Overall Study|Lack of Efficacy|1|||
37909440|NCT00604825|69595051|FG003|Overall Study|Lack of Efficacy|0|||
37909441|NCT00604825|69595048|FG000|Overall Study|Did not meet eligibility criteria|0|||
37909442|NCT00604825|69595049|FG001|Overall Study|Did not meet eligibility criteria|0|||
37909443|NCT00604825|69595050|FG002|Overall Study|Did not meet eligibility criteria|2|||
37909444|NCT00604825|69595051|FG003|Overall Study|Did not meet eligibility criteria|0|||
37909445|NCT00604825|69595048|FG000|Overall Study|Physician Decision|0|||
37909446|NCT00604825|69595049|FG001|Overall Study|Physician Decision|0|||
37909447|NCT00604825|69595050|FG002|Overall Study|Physician Decision|0|||
37909448|NCT00604825|69595051|FG003|Overall Study|Physician Decision|1|||
37909449|NCT00604825|69595048|FG000|Overall Study|Exclusion criterion met|0|||
37909450|NCT00604825|69595049|FG001|Overall Study|Exclusion criterion met|0|||
37909451|NCT00604825|69595050|FG002|Overall Study|Exclusion criterion met|0|||
37909452|NCT00604825|69595051|FG003|Overall Study|Exclusion criterion met|1|||
37909453|NCT00937391|69595063|FG000|Stage 2|Withdrawal by Subject|1|||
37909454|NCT00937157|69595080|FG000|Overall Study|Pregnancy|1|||
37909455|NCT00937157|69595080|FG000|Overall Study|Lost to Follow-up|3|||
37909456|NCT00777153|69595087|FG000|Overall Study|Lost to Follow-up|1|||
37909457|NCT00777153|69595088|FG001|Overall Study|Lost to Follow-up|1|||
37909458|NCT00777153|69595089|FG002|Overall Study|Lost to Follow-up|0|||
37698339|NCT02388191|69175138|FG001|Overall Study|Patient did not receive IUD|0|||
37831879|NCT03176771|69515382|FG003|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
37831880|NCT03176771|69515383|FG004|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
37831881|NCT03176771|69515379|FG000|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
37831882|NCT03176771|69515380|FG001|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
37831883|NCT03176771|69515381|FG002|Double-Blind Placebo-Controlled Period|Incorrect allocation|1|||
37831884|NCT03176771|69515382|FG003|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
37831885|NCT03176771|69515383|FG004|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
37831886|NCT03176771|69515379|FG000|Double-Blind Extension Period|Adverse Event|0|||
37831887|NCT03176771|69515380|FG001|Double-Blind Extension Period|Adverse Event|0|||
37831888|NCT03176771|69515381|FG002|Double-Blind Extension Period|Adverse Event|0|||
37831889|NCT03176771|69515382|FG003|Double-Blind Extension Period|Adverse Event|15|||
37909459|NCT00777153|69595087|FG000|Overall Study|Death|85|||
37909460|NCT00777153|69595088|FG001|Overall Study|Death|73|||
37909461|NCT00777153|69595089|FG002|Overall Study|Death|33|||
37909462|NCT00777153|69595087|FG000|Overall Study|Withdrawal by Subject|3|||
37909463|NCT00777153|69595088|FG001|Overall Study|Withdrawal by Subject|4|||
37698340|NCT01815736|69175146|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
37698341|NCT01815736|69175147|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
37698342|NCT01815736|69175146|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
37698343|NCT01815736|69175147|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
37698344|NCT01815736|69175146|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
37909464|NCT00777153|69595089|FG002|Overall Study|Withdrawal by Subject|3|||
37909465|NCT00777153|69595087|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
37909466|NCT00777153|69595088|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
37909467|NCT00777153|69595089|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
37909468|NCT00567541|69595103|FG000|Overall Study|Adverse Event|0|||
37909469|NCT00567541|69595104|FG001|Overall Study|Adverse Event|1|||
37909470|NCT00776997|69595110|FG000|Overall Study|Adverse Event|2|||
37909471|NCT00940823|69595116|FG000|Overall Study|Death|8|||
37909472|NCT00940823|69595117|FG001|Overall Study|Death|12|||
37909473|NCT00940823|69595116|FG000|Overall Study|Lost to Follow-up|27|||
37698345|NCT01815736|69175147|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
37698346|NCT01815736|69175146|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
37698347|NCT01815736|69175147|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
37698348|NCT01815736|69175146|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
37698349|NCT01815736|69175147|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
37698350|NCT01815736|69175146|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
37698351|NCT01815736|69175147|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
37698352|NCT01815736|69175146|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
37909474|NCT00940823|69595117|FG001|Overall Study|Lost to Follow-up|20|||
37909475|NCT00936611|69595125|FG000|Overall Study|Progressive Disease|3|||
37909476|NCT00936611|69595125|FG000|Overall Study|New Systemic Therapy|22|||
37909477|NCT00936611|69595125|FG000|Overall Study|Lost to Follow-up|1|||
37909478|NCT00936611|69595125|FG000|Overall Study|Withdrawal by Subject|2|||
37909479|NCT00936611|69595125|FG000|Overall Study|Still on Follow-up|1|||
37909480|NCT00936611|69595125|FG000|Overall Study|Still on Active Therapy|7|||
37909481|NCT00936611|69595125|FG000|Overall Study|Ineligible for Study Drug|3|||
37909482|NCT00936221|69595148|FG000|Overall Study|Withdrawal by Subject|1|||
37909483|NCT00936221|69595149|FG001|Overall Study|Withdrawal by Subject|1|||
37909484|NCT00776919|69595159|FG000|Overall Study|Withdrawal by Subject|16|||
37909485|NCT00776919|69595160|FG001|Overall Study|Withdrawal by Subject|14|||
37909486|NCT00776919|69595161|FG002|Overall Study|Withdrawal by Subject|15|||
37909487|NCT00776919|69595162|FG003|Overall Study|Withdrawal by Subject|26|||
37698353|NCT01815736|69175147|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
37698354|NCT01815736|69175146|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
37698355|NCT01815736|69175147|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
37698356|NCT01815736|69175146|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
37698357|NCT01815736|69175147|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
37698358|NCT01815736|69175146|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
37698359|NCT01815736|69175147|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
37698360|NCT01815736|69175146|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
37698361|NCT01815736|69175147|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
37698362|NCT01815736|69175146|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
37698363|NCT01815736|69175147|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
37698364|NCT01815736|69175146|FG000|Extension Treatment Phase- After Week 96|Death|1|||
37698365|NCT01815736|69175147|FG001|Extension Treatment Phase- After Week 96|Death|0|||
37698366|NCT01651949|69175158|FG000|Overall Study|Unknown status|4|||
37698367|NCT01651949|69175159|FG001|Overall Study|Unknown status|4|||
37831890|NCT03176771|69515383|FG004|Double-Blind Extension Period|Adverse Event|18|||
37831891|NCT03176771|69515379|FG000|Double-Blind Extension Period|Death|0|||
37831892|NCT03176771|69515380|FG001|Double-Blind Extension Period|Death|0|||
37831893|NCT03176771|69515381|FG002|Double-Blind Extension Period|Death|0|||
37831894|NCT03176771|69515382|FG003|Double-Blind Extension Period|Death|3|||
37831895|NCT03176771|69515383|FG004|Double-Blind Extension Period|Death|4|||
37831896|NCT03176771|69515379|FG000|Double-Blind Extension Period|Physician Decision|0|||
37831897|NCT03176771|69515380|FG001|Double-Blind Extension Period|Physician Decision|0|||
37831898|NCT03176771|69515381|FG002|Double-Blind Extension Period|Physician Decision|0|||
37831899|NCT03176771|69515382|FG003|Double-Blind Extension Period|Physician Decision|3|||
37831900|NCT03176771|69515383|FG004|Double-Blind Extension Period|Physician Decision|1|||
37909488|NCT00776919|69595159|FG000|Overall Study|Lost to Follow-up|8|||
37698368|NCT01651949|69175160|FG002|Overall Study|Unknown status|0|||
37698369|NCT01651949|69175158|FG000|Overall Study|Lost to Follow-up|30|||
37698370|NCT01651949|69175159|FG001|Overall Study|Lost to Follow-up|56|||
37698371|NCT01651949|69175160|FG002|Overall Study|Lost to Follow-up|20|||
37698372|NCT01651949|69175158|FG000|Overall Study|Protocol Violation|0|||
37698373|NCT01651949|69175159|FG001|Overall Study|Protocol Violation|2|||
37698374|NCT01651949|69175160|FG002|Overall Study|Protocol Violation|1|||
37698375|NCT01651949|69175158|FG000|Overall Study|Physician Decision|0|||
37698376|NCT01651949|69175159|FG001|Overall Study|Physician Decision|2|||
37698377|NCT01651949|69175160|FG002|Overall Study|Physician Decision|0|||
37698378|NCT01651949|69175158|FG000|Overall Study|Adverse Event|0|||
37698379|NCT01651949|69175159|FG001|Overall Study|Adverse Event|2|||
37909489|NCT00776919|69595160|FG001|Overall Study|Lost to Follow-up|12|||
37909490|NCT00776919|69595161|FG002|Overall Study|Lost to Follow-up|11|||
37909491|NCT00776919|69595162|FG003|Overall Study|Lost to Follow-up|8|||
37909492|NCT00776919|69595159|FG000|Overall Study|Adverse Event|1|||
37909493|NCT00776919|69595160|FG001|Overall Study|Adverse Event|0|||
37909494|NCT00776919|69595161|FG002|Overall Study|Adverse Event|2|||
37909495|NCT00776919|69595162|FG003|Overall Study|Adverse Event|2|||
37909496|NCT00776919|69595159|FG000|Overall Study|Protocol Violation|1|||
37909497|NCT00776919|69595160|FG001|Overall Study|Protocol Violation|2|||
37909498|NCT00776919|69595161|FG002|Overall Study|Protocol Violation|0|||
37909499|NCT00776919|69595162|FG003|Overall Study|Protocol Violation|1|||
37909500|NCT00776919|69595159|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
37909501|NCT00776919|69595160|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
37909502|NCT00776919|69595161|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
37909503|NCT00776919|69595162|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
37909504|NCT00775983|69595189|FG000|Overall Study|Protocol Violation|1|||
38011102|NCT03423147|69693966|FG000|Overall Study|Withdrawal by Subject|1|||
38011103|NCT03423147|69693967|FG001|Overall Study|Withdrawal by Subject|0|||
38011104|NCT03423147|69693966|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
38011105|NCT03423147|69693967|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
38011106|NCT03423147|69693966|FG000|Overall Study|Age < 18|1|||
38011107|NCT03423147|69693967|FG001|Overall Study|Age < 18|0|||
38011108|NCT03423147|69693966|FG000|Overall Study|No Trial of Labor|0|||
38011109|NCT03423147|69693967|FG001|Overall Study|No Trial of Labor|1|||
38011110|NCT03322631|69693977|FG000|Overall Study|Withdrawal by Subject|0|||
38011111|NCT03322631|69693978|FG001|Overall Study|Withdrawal by Subject|1|||
38011112|NCT03322631|69693979|FG002|Overall Study|Withdrawal by Subject|0|||
38011113|NCT03322631|69693980|FG003|Overall Study|Withdrawal by Subject|0|||
37698380|NCT01651949|69175160|FG002|Overall Study|Adverse Event|1|||
37698381|NCT01651949|69175158|FG000|Overall Study|Screen failure|2|||
37698382|NCT01651949|69175159|FG001|Overall Study|Screen failure|2|||
37698383|NCT01651949|69175160|FG002|Overall Study|Screen failure|0|||
37698384|NCT01651949|69175158|FG000|Overall Study|Withdrawal by Subject|17|||
37698385|NCT01651949|69175159|FG001|Overall Study|Withdrawal by Subject|18|||
37831901|NCT03176771|69515379|FG000|Double-Blind Extension Period|Withdrawal by Subject|0|||
37831902|NCT03176771|69515380|FG001|Double-Blind Extension Period|Withdrawal by Subject|0|||
37831903|NCT03176771|69515381|FG002|Double-Blind Extension Period|Withdrawal by Subject|0|||
38011114|NCT03322631|69693977|FG000|Overall Study|Adverse Event|0|||
38011115|NCT03322631|69693978|FG001|Overall Study|Adverse Event|0|||
37698386|NCT01651949|69175160|FG002|Overall Study|Withdrawal by Subject|9|||
37698387|NCT02387957|69175171|FG000|Overall Study|The study was discontinued|21|||
37698388|NCT02387957|69175172|FG001|Overall Study|The study was discontinued|21|||
37698389|NCT02387957|69175173|FG002|Overall Study|The study was discontinued|20|||
37831904|NCT03176771|69515382|FG003|Double-Blind Extension Period|Withdrawal by Subject|24|||
37831905|NCT03176771|69515383|FG004|Double-Blind Extension Period|Withdrawal by Subject|26|||
37831906|NCT02864394|69515399|FG000|Overall Study|Death|184|||
37831907|NCT02864394|69515400|FG001|Overall Study|Death|189|||
37831908|NCT02864394|69515399|FG000|Overall Study|Lost to Follow-up|0|||
37831909|NCT02864394|69515400|FG001|Overall Study|Lost to Follow-up|2|||
37831910|NCT02864394|69515399|FG000|Overall Study|Sponsor Decision|26|||
37831911|NCT02864394|69515400|FG001|Overall Study|Sponsor Decision|11|||
37831912|NCT02864394|69515399|FG000|Overall Study|Withdrawal by Subject|3|||
37831913|NCT02864394|69515400|FG001|Overall Study|Withdrawal by Subject|10|||
37831914|NCT02829918|69515407|FG000|Overall Study|Death|2|||
37831915|NCT02829918|69515407|FG000|Overall Study|Withdrawal by Subject|4|||
37831916|NCT02829918|69515407|FG000|Overall Study|Adverse Event|1|||
37831917|NCT02829918|69515407|FG000|Overall Study|Progression|1|||
37909505|NCT00775983|69595190|FG001|Overall Study|Protocol Violation|2|||
37698390|NCT01800916|69175181|FG000|Test Period 1 (1 Week)|Convex product user|0|||
37698391|NCT01800916|69175182|FG001|Test Period 1 (1 Week)|Convex product user|0|||
37698392|NCT01800916|69175183|FG002|Test Period 1 (1 Week)|Convex product user|0|||
37909506|NCT00775593|69595196|FG000|Overall Study|Unmet eligibility criteria|6|||
37909507|NCT00775593|69595196|FG000|Overall Study|Death|1|||
37909508|NCT00939809|69595200|FG000|Overall Study|Adverse Event|2|||
37909509|NCT00939809|69595200|FG000|Overall Study|Death|1|||
37909510|NCT00934661|69595206|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
37909511|NCT00934661|69595207|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
37909512|NCT00775437|69595213|FG000|Overall Study|Loss of efficacy|2|||
37909513|NCT00775437|69595213|FG000|Overall Study|Withdrawal by Subject|3|||
37909514|NCT00775437|69595213|FG000|Overall Study|Lost to Follow-up|1|||
37909515|NCT00775203|69595219|FG000|Overall Study|Adverse Event|25|||
37909516|NCT00775203|69595220|FG001|Overall Study|Adverse Event|6|||
37909517|NCT00775203|69595219|FG000|Overall Study|Lack of Efficacy|8|||
37909518|NCT00775203|69595220|FG001|Overall Study|Lack of Efficacy|9|||
37909519|NCT00775203|69595219|FG000|Overall Study|Withdrawal by Subject|11|||
37909520|NCT00775203|69595220|FG001|Overall Study|Withdrawal by Subject|9|||
37909521|NCT00775203|69595219|FG000|Overall Study|Lost to Follow-up|11|||
37909522|NCT00775203|69595220|FG001|Overall Study|Lost to Follow-up|15|||
37909523|NCT00775203|69595219|FG000|Overall Study|Administrative reason|2|||
37909524|NCT00775203|69595220|FG001|Overall Study|Administrative reason|0|||
37909525|NCT00775203|69595219|FG000|Overall Study|Noncompliance|4|||
37909526|NCT00775203|69595220|FG001|Overall Study|Noncompliance|2|||
37909527|NCT00775203|69595219|FG000|Overall Study|Protocol Violation|0|||
37909528|NCT00775203|69595220|FG001|Overall Study|Protocol Violation|1|||
37909529|NCT00775203|69595219|FG000|Overall Study|Entered other study|1|||
37909530|NCT00775203|69595220|FG001|Overall Study|Entered other study|0|||
37909531|NCT00775203|69595219|FG000|Overall Study|Physician Decision|0|||
37909532|NCT00775203|69595220|FG001|Overall Study|Physician Decision|1|||
37909533|NCT00568321|69595229|FG000|Overall Study|Adverse Event|1|||
37909534|NCT00568321|69595230|FG001|Overall Study|Adverse Event|0|||
37909535|NCT00568321|69595231|FG002|Overall Study|Adverse Event|0|||
37909536|NCT00568321|69595229|FG000|Overall Study|Lack of Efficacy|8|||
37909537|NCT00568321|69595230|FG001|Overall Study|Lack of Efficacy|5|||
37909538|NCT00568321|69595231|FG002|Overall Study|Lack of Efficacy|6|||
37909539|NCT00568321|69595229|FG000|Overall Study|Lost to Follow-up|0|||
37909540|NCT00568321|69595230|FG001|Overall Study|Lost to Follow-up|0|||
37909541|NCT00568321|69595231|FG002|Overall Study|Lost to Follow-up|1|||
37909542|NCT00568321|69595229|FG000|Overall Study|Withdrawal by Subject|2|||
37909543|NCT00568321|69595230|FG001|Overall Study|Withdrawal by Subject|0|||
37909544|NCT00568321|69595231|FG002|Overall Study|Withdrawal by Subject|0|||
37909545|NCT00568321|69595229|FG000|Overall Study|Protocol Violation|0|||
37909546|NCT00568321|69595230|FG001|Overall Study|Protocol Violation|0|||
37909547|NCT00568321|69595231|FG002|Overall Study|Protocol Violation|1|||
37909548|NCT00568321|69595229|FG000|Overall Study|Randomized, not treated|2|||
37909549|NCT00568321|69595230|FG001|Overall Study|Randomized, not treated|0|||
37909550|NCT00568321|69595231|FG002|Overall Study|Randomized, not treated|1|||
37909551|NCT00774345|69595243|FG000|Pre-treatment|Other reasons|2|||
37909552|NCT00774345|69595244|FG001|Pre-treatment|Other reasons|0|||
37909553|NCT00774345|69595243|FG000|Treatment|Adverse Event|61|||
37909554|NCT00774345|69595244|FG001|Treatment|Adverse Event|15|||
37909555|NCT00774345|69595243|FG000|Treatment|Progressive Disease without histologic transformation|51|||
37831918|NCT02789020|69515413|FG000|Overall Study|Withdrawal by Subject|6|||
37831919|NCT02789020|69515414|FG001|Overall Study|Withdrawal by Subject|5|||
37831920|NCT02768792|69515420|FG000|Overall Study|Adverse Event|1|||
37831921|NCT02427841|69515455|FG000|Overall Study|Lack of Efficacy|5|||
37831922|NCT02427841|69515455|FG000|Overall Study|Physician Decision|2|||
37831923|NCT02427841|69515455|FG000|Overall Study|Withdrawal by Subject|1|||
37831924|NCT02348216|69515467|FG000|Overall Study|Death|4|||
37831925|NCT02348216|69515468|FG001|Overall Study|Death|27|||
37831926|NCT02348216|69515469|FG002|Overall Study|Death|3|||
37831927|NCT02348216|69515470|FG003|Overall Study|Death|18|||
37831928|NCT02348216|69515471|FG004|Overall Study|Death|9|||
37831929|NCT02348216|69515472|FG005|Overall Study|Death|23|||
37831930|NCT02348216|69515473|FG006|Overall Study|Death|6|||
37831931|NCT02348216|69515467|FG000|Overall Study|Full consent withdrawal|0|||
37831932|NCT02348216|69515468|FG001|Overall Study|Full consent withdrawal|0|||
37831933|NCT02348216|69515469|FG002|Overall Study|Full consent withdrawal|0|||
37831934|NCT02348216|69515470|FG003|Overall Study|Full consent withdrawal|1|||
37831935|NCT02348216|69515471|FG004|Overall Study|Full consent withdrawal|0|||
37831936|NCT02348216|69515472|FG005|Overall Study|Full consent withdrawal|0|||
37831937|NCT02348216|69515473|FG006|Overall Study|Full consent withdrawal|1|||
37909556|NCT00774345|69595244|FG001|Treatment|Progressive Disease without histologic transformation|111|||
37909557|NCT00774345|69595243|FG000|Treatment|Progressive Disease with histologic transformation|4|||
37831938|NCT02348216|69515467|FG000|Overall Study|Lost to Follow-up|0|||
37831939|NCT02348216|69515468|FG001|Overall Study|Lost to Follow-up|0|||
37909558|NCT00774345|69595244|FG001|Treatment|Progressive Disease with histologic transformation|2|||
37909559|NCT00774345|69595243|FG000|Treatment|Withdrawal by Subject|5|||
37909560|NCT00774345|69595244|FG001|Treatment|Withdrawal by Subject|2|||
37909561|NCT00774345|69595243|FG000|Treatment|Lost to Follow-up|1|||
37909562|NCT00774345|69595244|FG001|Treatment|Lost to Follow-up|1|||
37909563|NCT00774345|69595243|FG000|Treatment|Death|4|||
37909564|NCT00774345|69595244|FG001|Treatment|Death|0|||
37909565|NCT00774345|69595243|FG000|Treatment|Other Reasons|32|||
37909566|NCT00774345|69595244|FG001|Treatment|Other Reasons|26|||
37909567|NCT00773253|69595256|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
37909568|NCT00773253|69595257|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
37909569|NCT00773175|69595267|FG000|Overall Study|Adverse Event|2|||
37909570|NCT00773175|69595268|FG001|Overall Study|Adverse Event|0|||
37909571|NCT00773175|69595267|FG000|Overall Study|Consent Withdrawn|0|||
37909572|NCT00773175|69595268|FG001|Overall Study|Consent Withdrawn|2|||
37909573|NCT00566527|69595282|FG000|Overall Study|Reason not provided|3|||
37909574|NCT00566527|69595283|FG001|Overall Study|Reason not provided|11|||
37909575|NCT00566527|69595284|FG002|Overall Study|Reason not provided|10|||
37909576|NCT00566527|69595282|FG000|Overall Study|Adverse Event|2|||
37909577|NCT00566527|69595283|FG001|Overall Study|Adverse Event|0|||
38011116|NCT03322631|69693979|FG002|Overall Study|Adverse Event|1|||
38011117|NCT03322631|69693980|FG003|Overall Study|Adverse Event|0|||
38011118|NCT03018704|69693999|FG000|Overall Study|Lost to Follow-up|1|||
38011119|NCT03018704|69694000|FG001|Overall Study|Lost to Follow-up|1|||
38011120|NCT02663349|69694006|FG000|Overall Study|Withdrawal by Subject|6|||
38011121|NCT02558491|69694010|FG000|First Invention|Withdrawal by Subject|3|||
38011122|NCT02558491|69694011|FG001|First Invention|Withdrawal by Subject|1|||
38011123|NCT02558491|69694010|FG000|First Invention|Data collection issues|1|||
38011124|NCT02558491|69694011|FG001|First Invention|Data collection issues|0|||
38011125|NCT02558491|69694010|FG000|First Invention|Stopping criteria|0|||
38011126|NCT02558491|69694011|FG001|First Invention|Stopping criteria|1|||
38011127|NCT02558491|69694010|FG000|First Invention|Changed parameters during trial|1|||
38011128|NCT02558491|69694011|FG001|First Invention|Changed parameters during trial|0|||
37909578|NCT00566527|69595284|FG002|Overall Study|Adverse Event|1|||
37909579|NCT00566527|69595282|FG000|Overall Study|Physician Decision|3|||
37909580|NCT00566527|69595283|FG001|Overall Study|Physician Decision|8|||
37909581|NCT00566527|69595284|FG002|Overall Study|Physician Decision|20|||
37909582|NCT00566527|69595282|FG000|Overall Study|Lost to Follow-up|3|||
37909583|NCT00566527|69595283|FG001|Overall Study|Lost to Follow-up|4|||
37909584|NCT00566527|69595284|FG002|Overall Study|Lost to Follow-up|4|||
37909585|NCT00566527|69595282|FG000|Overall Study|Withdrawal by Subject|6|||
37909586|NCT00566527|69595283|FG001|Overall Study|Withdrawal by Subject|43|||
37909587|NCT00566527|69595284|FG002|Overall Study|Withdrawal by Subject|43|||
37909588|NCT00773097|69595294|FG000|Overall Study|Withdrawal by Subject|1|||
37909589|NCT00773097|69595294|FG000|Overall Study|Physician Decision|6|||
37909590|NCT00933335|69595300|FG000|Overall Study|Lost to Follow-up|1|||
37909591|NCT00933335|69595301|FG001|Overall Study|Lost to Follow-up|3|||
37909592|NCT00933335|69595300|FG000|Overall Study|Withdrawal by Subject|0|||
37909593|NCT00933335|69595301|FG001|Overall Study|Withdrawal by Subject|1|||
37909594|NCT00933335|69595300|FG000|Overall Study|Progressive Disease|0|||
37909595|NCT00933335|69595301|FG001|Overall Study|Progressive Disease|11|||
37909596|NCT00933335|69595300|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
37909597|NCT00933335|69595301|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
37909598|NCT00933335|69595300|FG000|Overall Study|Co-morbid Illness|1|||
37909599|NCT00933335|69595301|FG001|Overall Study|Co-morbid Illness|0|||
37909600|NCT00772941|69595313|FG000|Overall Study|CRFs not available|195|||
37909601|NCT00772941|69595313|FG000|Overall Study|Study not completed|16|||
37909602|NCT00772941|69595313|FG000|Overall Study|Missed Visits|374|||
37909603|NCT00772941|69595313|FG000|Overall Study|Poor Compliance|7|||
37909604|NCT00772941|69595313|FG000|Overall Study|GPSP Violation|90|||
37909605|NCT00772707|69595340|FG000|Overall Study|Withdrawn|3|||
37909606|NCT00772629|69595346|FG000|Overall Study|Subject was not vaccinated|1|||
37909607|NCT00772629|69595347|FG001|Overall Study|Subject was not vaccinated|0|||
37909608|NCT00939341|69595353|FG000|Overall Study|Adverse Event|15|||
37909609|NCT00939341|69595353|FG000|Overall Study|Pregnancy|1|||
37909610|NCT00939341|69595353|FG000|Overall Study|Lost to Follow-up|23|||
38011129|NCT02558491|69694010|FG000|Second Intervention|Withdrawal by Subject|1|||
38011130|NCT02558491|69694011|FG001|Second Intervention|Withdrawal by Subject|0|||
38011131|NCT02558491|69694010|FG000|Second Intervention|Stopping Criteria|1|||
37698393|NCT01800916|69175184|FG003|Test Period 1 (1 Week)|Convex product user|1|||
38011132|NCT02558491|69694011|FG001|Second Intervention|Stopping Criteria|0|||
37909611|NCT00939341|69595353|FG000|Overall Study|Withdrawal by Subject|13|||
37909612|NCT00939341|69595353|FG000|Overall Study|Protocol Violation|6|||
37909613|NCT00939341|69595353|FG000|Overall Study|Incorrect enrolment|8|||
37909614|NCT04292470|69595382|FG000|Overall Study|Withdrawal by Subject|0|||
37909615|NCT04292470|69595383|FG001|Overall Study|Withdrawal by Subject|1|||
38011133|NCT02490878|69694020|FG000|Overall Study|deemed ineligible|0|||
37909616|NCT04217590|69595391|FG000|Overall Study|Other|1|||
37909617|NCT04217590|69595392|FG001|Overall Study|Other|1|||
37909618|NCT04217590|69595391|FG000|Overall Study|Withdrawal by Subject|3|||
37909619|NCT04217590|69595392|FG001|Overall Study|Withdrawal by Subject|1|||
37909620|NCT04217590|69595391|FG000|Overall Study|Death|0|||
37909621|NCT04217590|69595392|FG001|Overall Study|Death|1|||
38011134|NCT02490878|69694021|FG001|Overall Study|deemed ineligible|1|||
38011135|NCT02490878|69694020|FG000|Overall Study|progression prior to treatment|0|||
38011136|NCT02490878|69694021|FG001|Overall Study|progression prior to treatment|1|||
38011137|NCT02490878|69694020|FG000|Overall Study|only submitted baseline QOL|0|||
38011138|NCT02490878|69694021|FG001|Overall Study|only submitted baseline QOL|1|||
38011139|NCT02421601|69694027|FG000|Overall Study|Adverse Event|4|||
38011140|NCT02421601|69694027|FG000|Overall Study|Lack of Efficacy|5|||
38011141|NCT02421601|69694027|FG000|Overall Study|Physician Decision|1|||
38011142|NCT02421601|69694027|FG000|Overall Study|Withdrawal by Subject|31|||
38011143|NCT02421601|69694027|FG000|Overall Study|Others|41|||
38011144|NCT01934218|69694033|FG000|Double-blind Phase|Adverse Event|8|||
38011145|NCT01934218|69694034|FG001|Double-blind Phase|Adverse Event|8|||
38011146|NCT01934218|69694033|FG000|Double-blind Phase|Lack of Efficacy|6|||
38011147|NCT01934218|69694034|FG001|Double-blind Phase|Lack of Efficacy|7|||
38011148|NCT01934218|69694033|FG000|Double-blind Phase|Lost to Follow-up|7|||
38011149|NCT01934218|69694034|FG001|Double-blind Phase|Lost to Follow-up|14|||
38011150|NCT01934218|69694033|FG000|Double-blind Phase|Physician Decision|1|||
38011151|NCT01934218|69694034|FG001|Double-blind Phase|Physician Decision|2|||
38011152|NCT01934218|69694033|FG000|Double-blind Phase|Protocol Violation|4|||
38011153|NCT01934218|69694034|FG001|Double-blind Phase|Protocol Violation|0|||
38011154|NCT01934218|69694033|FG000|Double-blind Phase|Withdrawal by Subject|16|||
38011155|NCT01934218|69694034|FG001|Double-blind Phase|Withdrawal by Subject|13|||
38011156|NCT01934218|69694033|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
38011157|NCT01934218|69694034|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
38011158|NCT01934218|69694033|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
38011159|NCT01934218|69694034|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
38011160|NCT01934218|69694033|FG000|Open-Label Phase|Adverse Event|2|||
38011161|NCT01934218|69694034|FG001|Open-Label Phase|Adverse Event|4|||
38011162|NCT01934218|69694033|FG000|Open-Label Phase|Lack of Efficacy|1|||
38011163|NCT01934218|69694034|FG001|Open-Label Phase|Lack of Efficacy|4|||
38011164|NCT01934218|69694033|FG000|Open-Label Phase|Lost to Follow-up|4|||
38011165|NCT01934218|69694034|FG001|Open-Label Phase|Lost to Follow-up|2|||
38011166|NCT01934218|69694033|FG000|Open-Label Phase|Physician Decision|1|||
38011167|NCT01934218|69694034|FG001|Open-Label Phase|Physician Decision|0|||
38011168|NCT01934218|69694033|FG000|Open-Label Phase|Protocol Violation|1|||
38011169|NCT01934218|69694034|FG001|Open-Label Phase|Protocol Violation|0|||
38011170|NCT01934218|69694033|FG000|Open-Label Phase|Withdrawal by Subject|13|||
38011171|NCT01934218|69694034|FG001|Open-Label Phase|Withdrawal by Subject|11|||
38011172|NCT01934218|69694033|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
38011173|NCT01934218|69694034|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
38011174|NCT01934218|69694033|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
38011175|NCT01934218|69694034|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
38011176|NCT01702805|69694042|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
38011177|NCT01702805|69694043|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
38011178|NCT01702805|69694042|FG000|Overall Study|Incomplete Follow-up|18|||
37698394|NCT01800916|69175185|FG004|Test Period 1 (1 Week)|Convex product user|0|||
37698395|NCT01800916|69175186|FG005|Test Period 1 (1 Week)|Convex product user|0|||
37698396|NCT01800916|69175187|FG006|Test Period 1 (1 Week)|Convex product user|0|||
37831940|NCT02348216|69515469|FG002|Overall Study|Lost to Follow-up|0|||
37831941|NCT02348216|69515470|FG003|Overall Study|Lost to Follow-up|0|||
37831942|NCT02348216|69515471|FG004|Overall Study|Lost to Follow-up|0|||
37831943|NCT02348216|69515472|FG005|Overall Study|Lost to Follow-up|0|||
37909622|NCT03963232|69595400|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
37831944|NCT02348216|69515473|FG006|Overall Study|Lost to Follow-up|1|||
37831945|NCT02348216|69515467|FG000|Overall Study|Still on study|3|||
37831946|NCT02348216|69515468|FG001|Overall Study|Still on study|50|||
37831947|NCT02348216|69515469|FG002|Overall Study|Still on study|21|||
37831948|NCT02348216|69515470|FG003|Overall Study|Still on study|19|||
37831949|NCT02348216|69515471|FG004|Overall Study|Still on study|32|||
37831950|NCT02348216|69515472|FG005|Overall Study|Still on study|27|||
37831951|NCT02348216|69515473|FG006|Overall Study|Still on study|32|||
37831952|NCT02348216|69515467|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
37909623|NCT03963232|69595401|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
37831953|NCT02348216|69515468|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
37909624|NCT03963232|69595400|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
38011179|NCT01702805|69694043|FG001|Overall Study|Incomplete Follow-up|15|||
38011180|NCT01702805|69694042|FG000|Overall Study|Vital Status Assessment Only|40|||
38011181|NCT01702805|69694043|FG001|Overall Study|Vital Status Assessment Only|39|||
38011182|NCT01702805|69694042|FG000|Overall Study|Lost to Follow-up|5|||
38011183|NCT01702805|69694043|FG001|Overall Study|Lost to Follow-up|5|||
38011184|NCT00097370|69694053|FG000|Stage 1|Adverse Event|3|||
38011185|NCT00097370|69694053|FG000|Stage 1|Withdrawal by Subject|1|||
38011186|NCT00097370|69694053|FG000|Stage 1|Lack of Efficacy|2|||
38011187|NCT00097370|69694053|FG000|Stage 2|Adverse Event|5|||
38011188|NCT00097370|69694053|FG000|Stage 2|Withdrawal by Subject|1|||
38011189|NCT00097370|69694053|FG000|Stage 2|Lack of Efficacy|3|||
38011190|NCT00097370|69694053|FG000|Stage 2|Pregnancy|1|||
38011191|NCT00097370|69694053|FG000|Stage 2|Sponsor Terminated Study|2|||
38011192|NCT00097370|69694053|FG000|Stage 2|Lost to Follow-up|1|||
38011193|NCT00097370|69694053|FG000|Stage 3|Adverse Event|2|||
38011194|NCT00097370|69694053|FG000|Stage 3|Withdrawal by Subject|3|||
38011195|NCT00097370|69694053|FG000|Stage 3|Lack of Efficacy|1|||
38011196|NCT00097370|69694053|FG000|Stage 3|Sponsor Terminated Study|52|||
38011197|NCT00097370|69694053|FG000|Stage 3|Lost to Follow-up|1|||
38011198|NCT03515824|69694060|FG000|Overall Study|Death|3|||
38011199|NCT03515824|69694061|FG001|Overall Study|Death|2|||
38011200|NCT03515824|69694062|FG002|Overall Study|Death|6|||
38011201|NCT03515824|69694063|FG003|Overall Study|Death|0|||
38011202|NCT03515824|69694060|FG000|Overall Study|Lost to Follow-up|0|||
38011203|NCT03515824|69694061|FG001|Overall Study|Lost to Follow-up|1|||
38011204|NCT03515824|69694062|FG002|Overall Study|Lost to Follow-up|1|||
38011205|NCT03515824|69694063|FG003|Overall Study|Lost to Follow-up|0|||
38011206|NCT03515824|69694060|FG000|Overall Study|Study terminated by sponsor|0|||
38011207|NCT03515824|69694061|FG001|Overall Study|Study terminated by sponsor|1|||
38011208|NCT03515824|69694062|FG002|Overall Study|Study terminated by sponsor|6|||
38011209|NCT03515824|69694063|FG003|Overall Study|Study terminated by sponsor|0|||
38011210|NCT03515824|69694060|FG000|Overall Study|Status not recorded|0|||
38011211|NCT03515824|69694061|FG001|Overall Study|Status not recorded|0|||
38011212|NCT03515824|69694062|FG002|Overall Study|Status not recorded|2|||
38011213|NCT03515824|69694063|FG003|Overall Study|Status not recorded|0|||
38011214|NCT01089374|69694073|FG000|Overall Study|Lost to Follow-up|3|||
38011215|NCT01089374|69694074|FG001|Overall Study|Lost to Follow-up|0|||
38011216|NCT01089374|69694073|FG000|Overall Study|Withdrawal by Subject|1|||
38011217|NCT01089374|69694074|FG001|Overall Study|Withdrawal by Subject|0|||
38011218|NCT01089374|69694073|FG000|Overall Study|Study closed early - low accrual|6|||
38011219|NCT01089374|69694074|FG001|Overall Study|Study closed early - low accrual|0|||
38011220|NCT03511378|69694081|FG000|Overall Study|Withdrawal by Subject|2|||
38011221|NCT03511378|69694082|FG001|Overall Study|Withdrawal by Subject|2|||
38011222|NCT03511378|69694081|FG000|Overall Study|Patient not coming or schedule visit|1|||
38011223|NCT03511378|69694082|FG001|Overall Study|Patient not coming or schedule visit|0|||
38011224|NCT03511066|69694091|FG000|Overall Study|Withdrawal by Subject|1|||
38011225|NCT03511066|69694092|FG001|Overall Study|Withdrawal by Subject|2|||
38011226|NCT03511066|69694093|FG002|Overall Study|Withdrawal by Subject|3|||
38011227|NCT03511066|69694091|FG000|Overall Study|Lost to Follow-up|2|||
38011228|NCT03511066|69694092|FG001|Overall Study|Lost to Follow-up|3|||
38011229|NCT03511066|69694093|FG002|Overall Study|Lost to Follow-up|0|||
38011230|NCT03510910|69694103|FG000|Overall Study|Incomplete Survey|2|||
38011231|NCT03510910|69694104|FG001|Overall Study|Incomplete Survey|3|||
38011232|NCT03509350|69694112|FG000|Overall Study|Withdrawal by Subject|0|||
38011233|NCT03509350|69694113|FG001|Overall Study|Withdrawal by Subject|2|||
38011234|NCT03478696|69694121|FG000|Overall Study|Adverse Event|1|||
38011235|NCT03478696|69694122|FG001|Overall Study|Adverse Event|5|||
38011236|NCT03478696|69694121|FG000|Overall Study|Lost to Follow-up|1|||
38011237|NCT03478696|69694122|FG001|Overall Study|Lost to Follow-up|0|||
38011238|NCT03478696|69694121|FG000|Overall Study|Physician Decision|6|||
38011239|NCT03478696|69694122|FG001|Overall Study|Physician Decision|3|||
38011240|NCT03478696|69694121|FG000|Overall Study|Withdrawal by Subject|9|||
38011241|NCT03478696|69694122|FG001|Overall Study|Withdrawal by Subject|4|||
38011242|NCT03477838|69694128|FG000|Overall Study|Lost to Follow-up|14|||
38011243|NCT00072176|69694134|FG000|Overall Study|Withdrawal by Subject|1|||
38011244|NCT00072176|69694135|FG001|Overall Study|Withdrawal by Subject|0|||
37698397|NCT01800916|69175188|FG007|Test Period 1 (1 Week)|Convex product user|0|||
37831954|NCT02348216|69515469|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
37831955|NCT02348216|69515470|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
38011245|NCT00072176|69694134|FG000|Overall Study|Protocol Violation|0|||
37831956|NCT02348216|69515471|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
38011246|NCT00072176|69694135|FG001|Overall Study|Protocol Violation|1|||
38011247|NCT00071396|69694141|FG000|Overall Study|Withdrawal by Subject|1|||
38011248|NCT00071396|69694141|FG000|Overall Study|Physician Decision|2|||
38011249|NCT03473236|69694155|FG000|Overall Study|Withdrawal by Subject|0|||
38011250|NCT03473236|69694156|FG001|Overall Study|Withdrawal by Subject|0|||
38011251|NCT03473236|69694157|FG002|Overall Study|Withdrawal by Subject|0|||
38011252|NCT03473236|69694158|FG003|Overall Study|Withdrawal by Subject|0|||
38011253|NCT03473236|69694159|FG004|Overall Study|Withdrawal by Subject|0|||
38011254|NCT03473236|69694160|FG005|Overall Study|Withdrawal by Subject|1|||
38011255|NCT03473236|69694161|FG006|Overall Study|Withdrawal by Subject|0|||
38011256|NCT03473236|69694162|FG007|Overall Study|Withdrawal by Subject|0|||
38011257|NCT03473236|69694163|FG008|Overall Study|Withdrawal by Subject|1|||
38011258|NCT03473236|69694164|FG009|Overall Study|Withdrawal by Subject|0|||
38011259|NCT03550378|69694196|FG000|Overall Study|Death|0|||
38011260|NCT03550378|69694197|FG001|Overall Study|Death|1|||
38011261|NCT03472534|69694204|FG000|Overall Study|Withdrawal by Subject|9|||
38011262|NCT03472534|69694204|FG000|Overall Study|Adverse Event|2|||
38011263|NCT03549130|69694210|FG000|Overall Study|Adverse Event|0|||
38011264|NCT03549130|69694211|FG001|Overall Study|Adverse Event|1|||
38011265|NCT03549130|69694210|FG000|Overall Study|Lost to Follow-up|0|||
38011266|NCT03549130|69694211|FG001|Overall Study|Lost to Follow-up|1|||
38011267|NCT03470194|69694221|FG000|Overall Study|Lost to Follow-up|11|||
38011268|NCT03470194|69694222|FG001|Overall Study|Lost to Follow-up|17|||
38011269|NCT03469336|69694228|FG000|Overall Study|Adverse Event|1|||
38011270|NCT03469258|69694238|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
37831957|NCT02348216|69515472|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
37831958|NCT02348216|69515473|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
37831959|NCT02094261|69515511|FG000|Overall Study|Death|24|||
37831960|NCT02094261|69515511|FG000|Overall Study|Lost to Follow-up|1|||
37831961|NCT02094261|69515511|FG000|Overall Study|Withdrawal by Subject|4|||
37831962|NCT02094261|69515511|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
37831963|NCT02037529|69515517|FG000|Overall Study|Withdrawal by Subject|1|||
37831964|NCT02037529|69515518|FG001|Overall Study|Withdrawal by Subject|3|||
37831965|NCT02037529|69515517|FG000|Overall Study|Adverse Event|0|||
37909625|NCT03963232|69595401|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
38011271|NCT03503188|69694244|FG000|Overall Study|Non eligible in the sub study|0|||
38011272|NCT03503188|69694245|FG001|Overall Study|Non eligible in the sub study|1|||
38011273|NCT03502798|69694253|FG000|Overall Study|equipment failure|0|||
38011274|NCT03502798|69694254|FG001|Overall Study|equipment failure|7|||
38011275|NCT00066170|69694264|FG000|Overall Study|Adverse Event|2|||
38011276|NCT00066170|69694265|FG001|Overall Study|Adverse Event|4|||
38011277|NCT00066170|69694266|FG002|Overall Study|Adverse Event|1|||
38011278|NCT00066170|69694267|FG003|Overall Study|Adverse Event|7|||
38011279|NCT00066170|69694264|FG000|Overall Study|Serious Adverse Event|0|||
38011280|NCT00066170|69694265|FG001|Overall Study|Serious Adverse Event|0|||
38011281|NCT00066170|69694266|FG002|Overall Study|Serious Adverse Event|1|||
38011282|NCT00066170|69694267|FG003|Overall Study|Serious Adverse Event|1|||
38011283|NCT00066170|69694264|FG000|Overall Study|Lost to Follow-up|0|||
38011284|NCT00066170|69694265|FG001|Overall Study|Lost to Follow-up|1|||
38011285|NCT00066170|69694266|FG002|Overall Study|Lost to Follow-up|0|||
38011286|NCT00066170|69694267|FG003|Overall Study|Lost to Follow-up|0|||
38011287|NCT00066170|69694264|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
38011288|NCT00066170|69694265|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
38011289|NCT00066170|69694266|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
38011290|NCT00066170|69694267|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
38011291|NCT00066170|69694264|FG000|Overall Study|Protocol Violation|3|||
38011292|NCT00066170|69694265|FG001|Overall Study|Protocol Violation|0|||
38011293|NCT00066170|69694266|FG002|Overall Study|Protocol Violation|0|||
38011294|NCT00066170|69694267|FG003|Overall Study|Protocol Violation|0|||
38011295|NCT00066170|69694264|FG000|Overall Study|Other|1|||
38011296|NCT00066170|69694265|FG001|Overall Study|Other|5|||
38011297|NCT00066170|69694266|FG002|Overall Study|Other|2|||
38011298|NCT00066170|69694267|FG003|Overall Study|Other|0|||
38011299|NCT00065468|69694280|FG000|Overall Study|Death|172|||
38011300|NCT00065468|69694281|FG001|Overall Study|Death|169|||
38011301|NCT00065468|69694282|FG002|Overall Study|Death|171|||
38011302|NCT00065468|69694280|FG000|Overall Study|Withdrawal by Subject|3|||
38011303|NCT00065468|69694281|FG001|Overall Study|Withdrawal by Subject|4|||
38011304|NCT00065468|69694282|FG002|Overall Study|Withdrawal by Subject|5|||
38011305|NCT00065468|69694280|FG000|Overall Study|Lost to Follow-up|5|||
38011306|NCT00065468|69694281|FG001|Overall Study|Lost to Follow-up|3|||
38011307|NCT00065468|69694282|FG002|Overall Study|Lost to Follow-up|2|||
38011308|NCT00065468|69694280|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
38011309|NCT00065468|69694281|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
38011310|NCT00065468|69694282|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
37909626|NCT03963232|69595400|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
37909627|NCT03963232|69595401|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
37909628|NCT03963232|69595400|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
38011311|NCT00065468|69694280|FG000|Overall Study|Disease progression|0|||
38011312|NCT00065468|69694281|FG001|Overall Study|Disease progression|0|||
38011313|NCT00065468|69694282|FG002|Overall Study|Disease progression|1|||
38011314|NCT00065468|69694280|FG000|Overall Study|Other|14|||
38011315|NCT00065468|69694281|FG001|Overall Study|Other|24|||
38011316|NCT00065468|69694282|FG002|Overall Study|Other|18|||
38011317|NCT00071006|69694290|FG000|Overall Study|Lack of Efficacy|7|||
38011318|NCT00071006|69694290|FG000|Overall Study|Adverse Event|1|||
38011319|NCT00071006|69694290|FG000|Overall Study|Withdrawal by Subject|1|||
38011320|NCT00071006|69694290|FG000|Overall Study|Other|3|||
38011321|NCT00094575|69694296|FG000|Overall Study|Death|146|||
38011322|NCT00094575|69694297|FG001|Overall Study|Death|146|||
38011323|NCT00057746|69694308|FG000|Overall Study|Withdrawal by Subject|0|||
38011324|NCT00057746|69694309|FG001|Overall Study|Withdrawal by Subject|0|||
38011325|NCT00057746|69694310|FG002|Overall Study|Withdrawal by Subject|1|||
38011326|NCT00094107|69694318|FG000|Overall Study|Lack of Efficacy|23|||
38011327|NCT00094107|69694318|FG000|Overall Study|Death|5|||
38011328|NCT00094107|69694318|FG000|Overall Study|Adverse Event|3|||
38011329|NCT00094107|69694318|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
38011330|NCT00102063|69694325|FG000|Overall Study|Lack of Efficacy|5|||
38011331|NCT00102063|69694326|FG001|Overall Study|Lack of Efficacy|1|||
38011332|NCT00102063|69694327|FG002|Overall Study|Lack of Efficacy|1|||
38011333|NCT00102063|69694325|FG000|Overall Study|Adverse Event|7|||
38011334|NCT00102063|69694326|FG001|Overall Study|Adverse Event|4|||
38011335|NCT00102063|69694327|FG002|Overall Study|Adverse Event|2|||
38011336|NCT00102063|69694325|FG000|Overall Study|Withdrawal by Subject|4|||
38011337|NCT00102063|69694326|FG001|Overall Study|Withdrawal by Subject|12|||
38011338|NCT00102063|69694327|FG002|Overall Study|Withdrawal by Subject|5|||
38011339|NCT00102063|69694325|FG000|Overall Study|Lost to Follow-up|0|||
38011340|NCT00102063|69694326|FG001|Overall Study|Lost to Follow-up|0|||
38011341|NCT00102063|69694327|FG002|Overall Study|Lost to Follow-up|1|||
38011342|NCT00102063|69694325|FG000|Overall Study|Protocol Violation|0|||
38011343|NCT00102063|69694326|FG001|Overall Study|Protocol Violation|1|||
38011344|NCT00102063|69694327|FG002|Overall Study|Protocol Violation|1|||
38011345|NCT00065156|69694335|FG000|Overall Study|Adverse Event|37|||
38011346|NCT00065156|69694335|FG000|Overall Study|Lack of Efficacy|52|||
38011347|NCT00065156|69694335|FG000|Overall Study|Withdrawal by Subject|8|||
38011348|NCT00065156|69694335|FG000|Overall Study|Lost to Follow-up|1|||
38011349|NCT00065156|69694335|FG000|Overall Study|Death|11|||
38011350|NCT00065156|69694335|FG000|Overall Study|Study Closed by Sponsor|2|||
38011351|NCT00065156|69694335|FG000|Overall Study|Disease Progression|7|||
38011352|NCT00065156|69694335|FG000|Overall Study|Investigator Decision|2|||
38011353|NCT00065156|69694335|FG000|Overall Study|Non-Compliance|2|||
38011354|NCT00065156|69694335|FG000|Overall Study|Loss of Response|1|||
38011355|NCT00065156|69694335|FG000|Overall Study|Secondary Malign Disease|1|||
38011356|NCT00064298|69694341|FG000|Overall Study|Withdrawal by Subject|2|||
38011357|NCT00064298|69694342|FG001|Overall Study|Withdrawal by Subject|1|||
38011358|NCT00064298|69694341|FG000|Overall Study|Lost to Follow-up|2|||
38011359|NCT00064298|69694342|FG001|Overall Study|Lost to Follow-up|2|||
38011360|NCT00064298|69694341|FG000|Overall Study|Death|0|||
38011361|NCT00064298|69694342|FG001|Overall Study|Death|1|||
38011362|NCT00064298|69694341|FG000|Overall Study|Disease Progression|2|||
38011363|NCT00064298|69694342|FG001|Overall Study|Disease Progression|1|||
38011364|NCT00078819|69694350|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
38011365|NCT00078819|69694351|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
38011366|NCT00078819|69694352|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
38011367|NCT00078819|69694353|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
38011368|NCT00078819|69694350|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
38011369|NCT00078819|69694351|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
38011370|NCT00078819|69694352|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
38011371|NCT00078819|69694353|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
38011372|NCT00078819|69694350|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
38011373|NCT00078819|69694351|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
38011374|NCT00078819|69694352|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
38011375|NCT00078819|69694353|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
38011376|NCT00078819|69694350|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
37831966|NCT02037529|69515518|FG001|Overall Study|Adverse Event|1|||
37831967|NCT02030028|69515525|FG000|Overall Study|Withdrawal by Subject|4|||
37831968|NCT02030028|69515525|FG000|Overall Study|lack of transportation|1|||
37831969|NCT01956123|69515531|FG000|COS Cycle 2|Protocol Violation|8|||
38011377|NCT00078819|69694351|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
38011378|NCT00078819|69694352|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
38011379|NCT00078819|69694353|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
38011380|NCT00078819|69694350|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
38011381|NCT00078819|69694351|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
38011382|NCT00078819|69694352|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
38011383|NCT00078819|69694353|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
38011384|NCT00078819|69694350|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
38011385|NCT00078819|69694351|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
38011386|NCT00078819|69694352|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
38011387|NCT00078819|69694353|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
38011388|NCT00078819|69694350|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
38011389|NCT00078819|69694351|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
38011390|NCT00078819|69694352|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
38011391|NCT00078819|69694353|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
37831970|NCT01956123|69515532|FG001|COS Cycle 2|Protocol Violation|3|||
38011392|NCT00078819|69694350|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
38011393|NCT00078819|69694351|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
38011394|NCT00078819|69694352|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
38011395|NCT00078819|69694353|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
38011396|NCT00098865|69694370|FG000|Overall Study|Progressive Disease|6|||
38011397|NCT00098865|69694370|FG000|Overall Study|Adverse Event|2|||
38011398|NCT00098865|69694370|FG000|Overall Study|Alternative Therapy|1|||
38011399|NCT02954458|69694378|FG000|Overall Study|Adverse Event|0|||
38011400|NCT02954458|69694379|FG001|Overall Study|Adverse Event|0|||
38011401|NCT02954458|69694380|FG002|Overall Study|Adverse Event|0|||
38011402|NCT02954458|69694381|FG003|Overall Study|Adverse Event|1|||
38011403|NCT02954458|69694378|FG000|Overall Study|Withdrawal by Subject|0|||
38011404|NCT02954458|69694379|FG001|Overall Study|Withdrawal by Subject|0|||
38011405|NCT02954458|69694380|FG002|Overall Study|Withdrawal by Subject|0|||
38011406|NCT02954458|69694381|FG003|Overall Study|Withdrawal by Subject|1|||
38011407|NCT02954458|69694378|FG000|Overall Study|Physician Decision|0|||
38011408|NCT02954458|69694379|FG001|Overall Study|Physician Decision|0|||
38011409|NCT02954458|69694380|FG002|Overall Study|Physician Decision|1|||
38011410|NCT02954458|69694381|FG003|Overall Study|Physician Decision|1|||
38011411|NCT02954458|69694378|FG000|Overall Study|Lost to Follow-up|1|||
38011412|NCT02954458|69694379|FG001|Overall Study|Lost to Follow-up|0|||
38011413|NCT02954458|69694380|FG002|Overall Study|Lost to Follow-up|0|||
38011414|NCT02954458|69694381|FG003|Overall Study|Lost to Follow-up|1|||
38011415|NCT02954458|69694378|FG000|Overall Study|Death|0|||
38011416|NCT02954458|69694379|FG001|Overall Study|Death|0|||
38011417|NCT02954458|69694380|FG002|Overall Study|Death|0|||
38011418|NCT02954458|69694381|FG003|Overall Study|Death|1|||
38011419|NCT02954458|69694378|FG000|Overall Study|Other|0|||
38011420|NCT02954458|69694379|FG001|Overall Study|Other|0|||
38011421|NCT02954458|69694380|FG002|Overall Study|Other|0|||
38011422|NCT02954458|69694381|FG003|Overall Study|Other|7|||
38011423|NCT03500224|69694395|FG000|Overall Study|Withdrawal by Subject|2|||
38011424|NCT00077649|69694403|FG000|Overall Study|Adverse Event|5|||
38011425|NCT00077649|69694404|FG001|Overall Study|Adverse Event|1|||
38011426|NCT00077649|69694405|FG002|Overall Study|Adverse Event|7|||
38011427|NCT00077649|69694406|FG003|Overall Study|Adverse Event|9|||
38011428|NCT00077649|69694403|FG000|Overall Study|Lack of Efficacy|5|||
38011429|NCT00077649|69694404|FG001|Overall Study|Lack of Efficacy|3|||
38011430|NCT00077649|69694405|FG002|Overall Study|Lack of Efficacy|3|||
38011431|NCT00077649|69694406|FG003|Overall Study|Lack of Efficacy|2|||
38011432|NCT00077649|69694403|FG000|Overall Study|Withdrawal by Subject|0|||
38011433|NCT00077649|69694404|FG001|Overall Study|Withdrawal by Subject|1|||
38011434|NCT00077649|69694405|FG002|Overall Study|Withdrawal by Subject|1|||
38011435|NCT00077649|69694406|FG003|Overall Study|Withdrawal by Subject|2|||
38011436|NCT00077649|69694403|FG000|Overall Study|Lost to Follow-up|2|||
38011437|NCT00077649|69694404|FG001|Overall Study|Lost to Follow-up|2|||
38011438|NCT00077649|69694405|FG002|Overall Study|Lost to Follow-up|3|||
38011439|NCT00077649|69694406|FG003|Overall Study|Lost to Follow-up|2|||
38011440|NCT00077649|69694403|FG000|Overall Study|Abnormality of Laboratory Test|1|||
38011441|NCT00077649|69694404|FG001|Overall Study|Abnormality of Laboratory Test|2|||
38011442|NCT00077649|69694405|FG002|Overall Study|Abnormality of Laboratory Test|1|||
38011443|NCT00077649|69694406|FG003|Overall Study|Abnormality of Laboratory Test|2|||
38011444|NCT00077649|69694403|FG000|Overall Study|Randomized but never dosed|1|||
38011445|NCT00077649|69694404|FG001|Overall Study|Randomized but never dosed|0|||
38011446|NCT00077649|69694405|FG002|Overall Study|Randomized but never dosed|0|||
38011447|NCT00077649|69694406|FG003|Overall Study|Randomized but never dosed|0|||
38011448|NCT00038948|69694422|FG000|Overall Study|Adverse Event|131|||
38011449|NCT00038948|69694423|FG001|Overall Study|Adverse Event|43|||
38011450|NCT00038948|69694422|FG000|Overall Study|Lost to Follow-up|4|||
38011451|NCT00038948|69694423|FG001|Overall Study|Lost to Follow-up|4|||
38011452|NCT00038948|69694422|FG000|Overall Study|Nonmedical event|5|||
38011453|NCT00038948|69694423|FG001|Overall Study|Nonmedical event|7|||
38011454|NCT00038948|69694422|FG000|Overall Study|Withdrawal by Subject|23|||
38011455|NCT00038948|69694423|FG001|Overall Study|Withdrawal by Subject|10|||
38011456|NCT00038948|69694422|FG000|Overall Study|Protocol Violation|3|||
38011457|NCT00038948|69694423|FG001|Overall Study|Protocol Violation|7|||
38011458|NCT00038948|69694422|FG000|Overall Study|Lack of Efficacy|3|||
38011459|NCT00038948|69694423|FG001|Overall Study|Lack of Efficacy|6|||
38011460|NCT00054704|69694437|FG000|Overall Study|Lack of Efficacy|2|||
38011461|NCT00054704|69694438|FG001|Overall Study|Lack of Efficacy|3|||
38011462|NCT00054704|69694437|FG000|Overall Study|Adverse Event|3|||
38011463|NCT00054704|69694438|FG001|Overall Study|Adverse Event|1|||
38011464|NCT00054704|69694437|FG000|Overall Study|Lost to Follow-up|0|||
38011465|NCT00054704|69694438|FG001|Overall Study|Lost to Follow-up|1|||
38011466|NCT00031694|69694444|FG000|Overall Study|Adverse Event|12|||
38011467|NCT00031694|69694444|FG000|Overall Study|Death|2|||
38011468|NCT00031694|69694444|FG000|Overall Study|Withdrawal by Subject|5|||
38011469|NCT00093795|69694452|FG000|Overall Study|No follow up data|20|||
37909629|NCT03963232|69595401|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
37909630|NCT03963232|69595400|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
37909631|NCT03963232|69595401|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
37909632|NCT03963232|69595400|FG000|Open-Label Treatment Phase|Adverse Event|1|||
37909633|NCT03963232|69595401|FG001|Open-Label Treatment Phase|Adverse Event|2|||
37909634|NCT03963232|69595400|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
37909635|NCT03963232|69595401|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
37909636|NCT03963232|69595400|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
37909637|NCT03963232|69595401|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
37909638|NCT03963232|69595400|FG000|Open-Label Treatment Phase|Pregnancy|1|||
37909639|NCT03963232|69595401|FG001|Open-Label Treatment Phase|Pregnancy|0|||
37909640|NCT03963232|69595400|FG000|Follow-up Phase|Withdrawal by Subject|7|||
37909641|NCT03963232|69595401|FG001|Follow-up Phase|Withdrawal by Subject|5|||
37909642|NCT03963232|69595400|FG000|Follow-up Phase|Protocol Violation|0|||
37909643|NCT03963232|69595401|FG001|Follow-up Phase|Protocol Violation|2|||
37909644|NCT03963232|69595400|FG000|Follow-up Phase|Adverse Event|0|||
37909645|NCT03963232|69595401|FG001|Follow-up Phase|Adverse Event|1|||
37909646|NCT03963232|69595400|FG000|Follow-up Phase|Lost to Follow-up|0|||
37909647|NCT03963232|69595401|FG001|Follow-up Phase|Lost to Follow-up|1|||
37909648|NCT03856593|69595425|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
37909649|NCT03856593|69595426|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
37909650|NCT03785925|69595434|FG000|Overall Study|Withdrawal by Subject|15|||
37909651|NCT03785925|69595434|FG000|Overall Study|Lost to Follow-up|1|||
37909652|NCT03427411|69595445|FG000|Overall Study|Screen failure - platelets too low|0|||
37909653|NCT03427411|69595446|FG001|Overall Study|Screen failure - platelets too low|1|||
37909654|NCT03330106|69595454|FG000|Part A|Withdrawal by Subject|1|||
37909655|NCT03330106|69595455|FG001|Part A|Withdrawal by Subject|1|||
37909656|NCT03330106|69595456|FG002|Part A|Withdrawal by Subject|0|||
37909657|NCT03330106|69595457|FG003|Part A|Withdrawal by Subject|0|||
37909658|NCT03330106|69595454|FG000|Part A|Death|2|||
37909659|NCT03330106|69595455|FG001|Part A|Death|1|||
37909660|NCT03330106|69595456|FG002|Part A|Death|0|||
37909661|NCT03330106|69595457|FG003|Part A|Death|0|||
37909662|NCT03330106|69595454|FG000|Part A|Adverse Event|0|||
37909663|NCT03330106|69595455|FG001|Part A|Adverse Event|1|||
37909664|NCT03330106|69595456|FG002|Part A|Adverse Event|0|||
37909665|NCT03330106|69595457|FG003|Part A|Adverse Event|0|||
37909666|NCT03330106|69595454|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
37909667|NCT03330106|69595455|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
37909668|NCT03330106|69595456|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
37909669|NCT03330106|69595457|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
37909670|NCT03330106|69595454|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
37909671|NCT03330106|69595455|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
37909672|NCT03330106|69595456|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
37909673|NCT03330106|69595457|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
37909674|NCT03330106|69595454|FG000|Part A|Progressive Disease|0|||
37831971|NCT01956123|69515533|FG002|COS Cycle 2|Protocol Violation|0|||
37831972|NCT01956123|69515534|FG003|COS Cycle 2|Protocol Violation|0|||
37831973|NCT01956123|69515531|FG000|COS Cycle 2|Adverse Event|3|||
37831974|NCT01956123|69515532|FG001|COS Cycle 2|Adverse Event|4|||
37831975|NCT01956123|69515533|FG002|COS Cycle 2|Adverse Event|0|||
37831976|NCT01956123|69515534|FG003|COS Cycle 2|Adverse Event|0|||
37831977|NCT01956123|69515531|FG000|COS Cycle 2|Personal Reasons|2|||
37831978|NCT01956123|69515532|FG001|COS Cycle 2|Personal Reasons|0|||
37831979|NCT01956123|69515533|FG002|COS Cycle 2|Personal Reasons|0|||
37831980|NCT01956123|69515534|FG003|COS Cycle 2|Personal Reasons|0|||
37831981|NCT01956123|69515531|FG000|COS Cycle 2|Withdrawal by Subject|1|||
37831982|NCT01956123|69515532|FG001|COS Cycle 2|Withdrawal by Subject|0|||
37831983|NCT01956123|69515533|FG002|COS Cycle 2|Withdrawal by Subject|0|||
37831984|NCT01956123|69515534|FG003|COS Cycle 2|Withdrawal by Subject|0|||
37831985|NCT01956123|69515531|FG000|COS Cycle 3|Protocol Violation|0|||
37831986|NCT01956123|69515532|FG001|COS Cycle 3|Protocol Violation|0|||
37831987|NCT01956123|69515533|FG002|COS Cycle 3|Protocol Violation|2|||
37831988|NCT01956123|69515534|FG003|COS Cycle 3|Protocol Violation|1|||
37831989|NCT01956123|69515531|FG000|COS Cycle 3|Adverse Event|0|||
37831990|NCT01956123|69515532|FG001|COS Cycle 3|Adverse Event|0|||
37831991|NCT01956123|69515533|FG002|COS Cycle 3|Adverse Event|3|||
37831992|NCT01956123|69515534|FG003|COS Cycle 3|Adverse Event|0|||
37831993|NCT01956123|69515531|FG000|COS Cycle 3|Personal Reasons|0|||
37831994|NCT01956123|69515532|FG001|COS Cycle 3|Personal Reasons|0|||
37831995|NCT01956123|69515533|FG002|COS Cycle 3|Personal Reasons|1|||
37831996|NCT01956123|69515534|FG003|COS Cycle 3|Personal Reasons|0|||
37831997|NCT01956123|69515531|FG000|COS Cycle 3|Withdrawal by Subject|0|||
37909675|NCT03330106|69595455|FG001|Part A|Progressive Disease|1|||
38011470|NCT00093795|69694453|FG001|Overall Study|No follow up data|16|||
38011471|NCT00093795|69694454|FG002|Overall Study|No follow up data|17|||
38011472|NCT03467152|69694464|FG000|Overall Study|Adverse Event|4|||
38011473|NCT03467152|69694465|FG001|Overall Study|Adverse Event|5|||
38011474|NCT03467152|69694466|FG002|Overall Study|Adverse Event|0|||
38011475|NCT03467152|69694464|FG000|Overall Study|Subject Choice|1|||
38011476|NCT03467152|69694465|FG001|Overall Study|Subject Choice|3|||
38011477|NCT03467152|69694466|FG002|Overall Study|Subject Choice|0|||
38011478|NCT03467152|69694464|FG000|Overall Study|Lost to Follow-up|1|||
38011479|NCT03467152|69694465|FG001|Overall Study|Lost to Follow-up|0|||
38011480|NCT03467152|69694466|FG002|Overall Study|Lost to Follow-up|0|||
38011481|NCT03467152|69694464|FG000|Overall Study|Withdrawal by Subject|4|||
38011482|NCT03467152|69694465|FG001|Overall Study|Withdrawal by Subject|2|||
38011483|NCT03467152|69694466|FG002|Overall Study|Withdrawal by Subject|0|||
38011484|NCT03467152|69694464|FG000|Overall Study|Others|3|||
38011485|NCT03467152|69694465|FG001|Overall Study|Others|0|||
38011486|NCT03467152|69694466|FG002|Overall Study|Others|0|||
38011487|NCT03467152|69694464|FG000|Overall Study|Not treated|3|||
38011488|NCT03467152|69694465|FG001|Overall Study|Not treated|1|||
38011489|NCT03467152|69694466|FG002|Overall Study|Not treated|6|||
38011490|NCT03466060|69694475|FG000|Period 1|Test Lens Damage|0|||
38011491|NCT03466060|69694476|FG001|Period 1|Test Lens Damage|2|||
38011492|NCT03466060|69694477|FG002|Period 1|Test Lens Damage|0|||
38011493|NCT03466060|69694478|FG003|Period 1|Test Lens Damage|0|||
38011494|NCT03466060|69694479|FG004|Period 1|Test Lens Damage|0|||
38011495|NCT03466060|69694480|FG005|Period 1|Test Lens Damage|0|||
38011496|NCT03466060|69694475|FG000|Period 1|Withdrawal by Subject|0|||
38011497|NCT03466060|69694476|FG001|Period 1|Withdrawal by Subject|0|||
38011498|NCT03466060|69694477|FG002|Period 1|Withdrawal by Subject|2|||
38011499|NCT03466060|69694478|FG003|Period 1|Withdrawal by Subject|0|||
38011500|NCT03466060|69694479|FG004|Period 1|Withdrawal by Subject|0|||
38011501|NCT03466060|69694480|FG005|Period 1|Withdrawal by Subject|0|||
38011502|NCT03466060|69694475|FG000|Period 1|Lost to Follow-up|0|||
38011503|NCT03466060|69694476|FG001|Period 1|Lost to Follow-up|0|||
38011504|NCT03466060|69694477|FG002|Period 1|Lost to Follow-up|0|||
38011505|NCT03466060|69694478|FG003|Period 1|Lost to Follow-up|1|||
38011506|NCT03466060|69694479|FG004|Period 1|Lost to Follow-up|0|||
38011507|NCT03466060|69694480|FG005|Period 1|Lost to Follow-up|0|||
38011508|NCT03466060|69694475|FG000|Period 1|Grade 2 Conjunctivitis|0|||
38011509|NCT03466060|69694476|FG001|Period 1|Grade 2 Conjunctivitis|0|||
38011510|NCT03466060|69694477|FG002|Period 1|Grade 2 Conjunctivitis|1|||
38011511|NCT03466060|69694478|FG003|Period 1|Grade 2 Conjunctivitis|0|||
38011512|NCT03466060|69694479|FG004|Period 1|Grade 2 Conjunctivitis|0|||
38011513|NCT03466060|69694480|FG005|Period 1|Grade 2 Conjunctivitis|0|||
38011514|NCT03466060|69694475|FG000|Period 2|Lens Handling Difficulties|0|||
38011515|NCT03466060|69694476|FG001|Period 2|Lens Handling Difficulties|0|||
38011516|NCT03466060|69694477|FG002|Period 2|Lens Handling Difficulties|1|||
38011517|NCT03466060|69694478|FG003|Period 2|Lens Handling Difficulties|0|||
38011518|NCT03466060|69694479|FG004|Period 2|Lens Handling Difficulties|0|||
38011519|NCT03466060|69694480|FG005|Period 2|Lens Handling Difficulties|0|||
38011520|NCT00092547|69694496|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
38011521|NCT00092547|69694497|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
38011522|NCT00092547|69694498|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
38011523|NCT00092547|69694496|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
38011524|NCT00092547|69694497|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
38011525|NCT00092547|69694498|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
38011526|NCT00092547|69694496|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
38011527|NCT00092547|69694497|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
38011528|NCT00092547|69694498|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
38011529|NCT00092547|69694496|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
38011530|NCT00092547|69694497|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
38011531|NCT00092547|69694498|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
38011532|NCT00092547|69694496|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
38011533|NCT00092547|69694497|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
38011534|NCT00092547|69694498|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
38011535|NCT00092547|69694496|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
38011536|NCT00092547|69694497|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
38011537|NCT00092547|69694498|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
38011538|NCT00092547|69694496|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
38011539|NCT00092547|69694497|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
38011540|NCT00092547|69694498|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
38011541|NCT00092547|69694496|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
38011542|NCT00092547|69694497|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
38011543|NCT00092547|69694498|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
38011544|NCT00092547|69694496|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
38011545|NCT00092547|69694497|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
38011546|NCT00092547|69694498|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
38011547|NCT00092547|69694496|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
38011548|NCT00092547|69694497|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
38011549|NCT00092547|69694498|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
38011550|NCT00092547|69694496|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
38011551|NCT00092547|69694497|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
38011552|NCT00092547|69694498|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
38011553|NCT00092547|69694496|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
38011554|NCT00092547|69694497|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
38011555|NCT00092547|69694498|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
38011556|NCT00092547|69694496|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
38011557|NCT00092547|69694497|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
38011558|NCT00092547|69694498|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
38011559|NCT00092547|69694496|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
38011560|NCT00092547|69694497|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
38011561|NCT00092547|69694498|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
38011562|NCT00092547|69694496|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
38011563|NCT00092547|69694497|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
38011564|NCT00092547|69694498|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
38011565|NCT00092547|69694496|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
38011566|NCT00092547|69694497|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
38011567|NCT00092547|69694498|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
38011568|NCT00092547|69694496|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
38011569|NCT00092547|69694497|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
38011570|NCT00092547|69694498|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
38011571|NCT00092547|69694496|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
38011572|NCT00092547|69694497|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
38011573|NCT00092547|69694498|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
38011574|NCT00092547|69694496|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
38011575|NCT00092547|69694497|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
38011576|NCT00092547|69694498|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
38011577|NCT00092547|69694496|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
38011578|NCT00092547|69694497|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
38011579|NCT00092547|69694498|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
38011580|NCT00092547|69694496|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
38011581|NCT00092547|69694497|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
38011582|NCT00092547|69694498|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
38011583|NCT03802994|69694514|FG000|Overall Study|Lost to Follow-up|0|||
38011584|NCT03802994|69694515|FG001|Overall Study|Lost to Follow-up|2|||
38011585|NCT03802994|69694516|FG002|Overall Study|Lost to Follow-up|3|||
38011586|NCT03802994|69694517|FG003|Overall Study|Lost to Follow-up|2|||
38011587|NCT03802994|69694518|FG004|Overall Study|Lost to Follow-up|2|||
38011588|NCT03465904|69694543|FG000|Overall Study|Withdrawal by Subject|9|||
38011589|NCT03465904|69694544|FG001|Overall Study|Withdrawal by Subject|5|||
38011590|NCT03465904|69694543|FG000|Overall Study|Lost to Follow-up|10|||
38011591|NCT03465904|69694544|FG001|Overall Study|Lost to Follow-up|9|||
38011592|NCT03465904|69694543|FG000|Overall Study|Protocol Violation|8|||
38011593|NCT03465904|69694544|FG001|Overall Study|Protocol Violation|5|||
38011594|NCT03465904|69694543|FG000|Overall Study|Ineligible for mITT analysis|62|||
38011595|NCT03465904|69694544|FG001|Overall Study|Ineligible for mITT analysis|47|||
38011596|NCT03802916|69694552|FG000|Overall Study|Adverse Event|0|||
38011597|NCT03802916|69694553|FG001|Overall Study|Adverse Event|1|||
38011598|NCT03802916|69694552|FG000|Overall Study|Withdrawal by Subject|0|||
38011599|NCT03802916|69694553|FG001|Overall Study|Withdrawal by Subject|1|||
38011600|NCT00076011|69694561|FG000|Overall Study|Death|1|||
38011601|NCT00076011|69694561|FG000|Overall Study|Adverse Event|10|||
38011602|NCT00076011|69694561|FG000|Overall Study|Lack of Efficacy|25|||
38011603|NCT00076011|69694561|FG000|Overall Study|Withdrawal by Subject|1|||
37831998|NCT01956123|69515532|FG001|COS Cycle 3|Withdrawal by Subject|0|||
38011604|NCT00076011|69694561|FG000|Overall Study|Study terminated by sponsor|3|||
38011605|NCT00076011|69694561|FG000|Overall Study|Other|11|||
38011606|NCT00076011|69694561|FG000|Overall Study|Ongoing|1|||
38011607|NCT03465436|69694569|FG000|Period 1|Protocol Violation|0|||
38011608|NCT03465436|69694570|FG001|Period 1|Protocol Violation|0|||
38011609|NCT03465436|69694571|FG002|Period 1|Protocol Violation|1|||
37831999|NCT01956123|69515533|FG002|COS Cycle 3|Withdrawal by Subject|0|||
37832000|NCT01956123|69515534|FG003|COS Cycle 3|Withdrawal by Subject|1|||
38011610|NCT03465436|69694572|FG003|Period 1|Protocol Violation|0|||
38011611|NCT03465436|69694569|FG000|Period 2|Protocol Violation|0|||
38011612|NCT03465436|69694570|FG001|Period 2|Protocol Violation|1|||
38011613|NCT03465436|69694571|FG002|Period 2|Protocol Violation|0|||
38011614|NCT03465436|69694572|FG003|Period 2|Protocol Violation|0|||
38011615|NCT03465436|69694569|FG000|Period 3|Protocol Violation|1|||
38011616|NCT03465436|69694570|FG001|Period 3|Protocol Violation|1|||
38011617|NCT03465436|69694571|FG002|Period 3|Protocol Violation|0|||
38011618|NCT03465436|69694572|FG003|Period 3|Protocol Violation|0|||
38011619|NCT03465436|69694569|FG000|Period 4|Protocol Violation|0|||
38011620|NCT03465436|69694570|FG001|Period 4|Protocol Violation|0|||
38011621|NCT03465436|69694571|FG002|Period 4|Protocol Violation|1|||
38011622|NCT03465436|69694572|FG003|Period 4|Protocol Violation|0|||
38011623|NCT00053846|69694586|FG000|Overall Study|Changed mind|8|||
38011624|NCT00053846|69694587|FG001|Overall Study|Changed mind|13|||
38011625|NCT00053846|69694586|FG000|Overall Study|Became too ill|8|||
38011626|NCT00053846|69694587|FG001|Overall Study|Became too ill|7|||
38011627|NCT00053846|69694586|FG000|Overall Study|Expired|5|||
38011628|NCT00053846|69694587|FG001|Overall Study|Expired|0|||
38011629|NCT00053846|69694586|FG000|Overall Study|Became ineligible|3|||
38011630|NCT00053846|69694587|FG001|Overall Study|Became ineligible|1|||
38011631|NCT00053846|69694586|FG000|Overall Study|Did not return data|1|||
38011632|NCT00053846|69694587|FG001|Overall Study|Did not return data|2|||
38011633|NCT00053846|69694586|FG000|Overall Study|Quit due to side effects|1|||
38011634|NCT00053846|69694587|FG001|Overall Study|Quit due to side effects|3|||
38011635|NCT00053846|69694586|FG000|Overall Study|Pills too large|0|||
38011636|NCT00053846|69694587|FG001|Overall Study|Pills too large|1|||
38011637|NCT00090987|69694593|FG000|Overall Study|Adverse Event|5|||
38011638|NCT00090987|69694593|FG000|Overall Study|Lack of Efficacy|7|||
38011639|NCT00090987|69694593|FG000|Overall Study|Withdrawal by Subject|3|||
38011640|NCT00090987|69694593|FG000|Overall Study|alternative therapy|1|||
38011641|NCT00090987|69694593|FG000|Overall Study|Non-compliance|4|||
38011642|NCT00090987|69694593|FG000|Overall Study|Incarcerated|1|||
38011643|NCT03464422|69694597|FG000|Overall Study|Lost to Follow-up|2|||
38011644|NCT03464422|69694597|FG000|Overall Study|Withdrawal by Subject|2|||
38011645|NCT03489304|69694603|FG000|Overall Study|Lost to Follow-up|4|||
38011646|NCT03543358|69694607|FG000|Overall Study|Death|1|||
38011647|NCT03543358|69694608|FG001|Overall Study|Death|0|||
38011648|NCT03543358|69694607|FG000|Overall Study|Disease Progression|1|||
38011649|NCT03543358|69694608|FG001|Overall Study|Disease Progression|0|||
38011650|NCT03543358|69694607|FG000|Overall Study|Parent Study Closure|1|||
38011651|NCT03543358|69694608|FG001|Overall Study|Parent Study Closure|0|||
38011652|NCT03485950|69694614|FG000|Overall Study|Adverse Event|1|||
38011653|NCT03485950|69694615|FG001|Overall Study|Adverse Event|0|||
38011654|NCT03485950|69694614|FG000|Overall Study|Death|3|||
38011655|NCT03485950|69694615|FG001|Overall Study|Death|2|||
38011656|NCT03485950|69694614|FG000|Overall Study|Withdrawal by Subject|3|||
38011657|NCT03485950|69694615|FG001|Overall Study|Withdrawal by Subject|0|||
38011658|NCT00060944|69694623|FG000|Overall Study|Adverse Event|12|||
38011659|NCT00060944|69694624|FG001|Overall Study|Adverse Event|10|||
38011660|NCT00060944|69694623|FG000|Overall Study|Death|2|||
38011661|NCT00060944|69694624|FG001|Overall Study|Death|3|||
38011662|NCT00060944|69694623|FG000|Overall Study|Withdrawal by Subject|18|||
38011663|NCT00060944|69694624|FG001|Overall Study|Withdrawal by Subject|5|||
38011664|NCT00060944|69694623|FG000|Overall Study|Disease Progression|93|||
38011665|NCT00060944|69694624|FG001|Overall Study|Disease Progression|94|||
38011666|NCT00060944|69694623|FG000|Overall Study|Lost to Follow-up|1|||
38011667|NCT00060944|69694624|FG001|Overall Study|Lost to Follow-up|0|||
38011668|NCT00060944|69694623|FG000|Overall Study|Subject Ineligible To Continue|2|||
38011669|NCT00060944|69694624|FG001|Overall Study|Subject Ineligible To Continue|1|||
38011670|NCT00060944|69694623|FG000|Overall Study|Treatment Switch|0|||
38011671|NCT00060944|69694624|FG001|Overall Study|Treatment Switch|13|||
38011672|NCT00060944|69694623|FG000|Overall Study|Other|2|||
38011673|NCT00060944|69694624|FG001|Overall Study|Other|4|||
38011674|NCT00060944|69694623|FG000|Overall Study|randomized but not treated|6|||
38011675|NCT00060944|69694624|FG001|Overall Study|randomized but not treated|4|||
38011676|NCT03462082|69694630|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
38011677|NCT03462082|69694631|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
38011678|NCT03462082|69694632|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
38011679|NCT03462082|69694633|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
38011680|NCT03462082|69694634|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
38011681|NCT03462082|69694635|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
38011682|NCT03462082|69694636|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
38011683|NCT03462082|69694637|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
38011684|NCT03461146|69694647|FG000|Overall Study|Adverse Event|2|||
38011685|NCT03461146|69694647|FG000|Overall Study|Physician Decision|1|||
38011686|NCT03541252|69694651|FG000|Overall Study|Withdrawal by Subject|1|||
38011687|NCT00031460|69694657|FG000|Overall Study|Lost to Follow-up|0|||
38011688|NCT00031460|69694658|FG001|Overall Study|Lost to Follow-up|1|||
38011689|NCT00031460|69694657|FG000|Overall Study|Withdrawal by Subject|1|||
38011690|NCT00031460|69694658|FG001|Overall Study|Withdrawal by Subject|1|||
38011691|NCT00031460|69694657|FG000|Overall Study|Non-Compliant|1|||
38011692|NCT00031460|69694658|FG001|Overall Study|Non-Compliant|1|||
38011693|NCT00031460|69694657|FG000|Overall Study|Death|0|||
38011694|NCT00031460|69694658|FG001|Overall Study|Death|1|||
38011695|NCT00031460|69694657|FG000|Overall Study|Reactivation of Disease|5|||
38011696|NCT00031460|69694658|FG001|Overall Study|Reactivation of Disease|9|||
38011697|NCT00031460|69694657|FG000|Overall Study|Disruption of blinded drug supply|2|||
38011698|NCT00031460|69694658|FG001|Overall Study|Disruption of blinded drug supply|0|||
38011699|NCT00031460|69694657|FG000|Overall Study|Confirmed unevaluable|0|||
38011700|NCT00031460|69694658|FG001|Overall Study|Confirmed unevaluable|1|||
38011701|NCT03540160|69694664|FG000|Overall Study|Protocol Violation|1|||
38011702|NCT03540160|69694664|FG000|Overall Study|Physician Decision|8|||
38011703|NCT03540160|69694664|FG000|Overall Study|Lack of Efficacy|60|||
38011704|NCT03540160|69694664|FG000|Overall Study|Pregnancy|1|||
38011705|NCT03540160|69694664|FG000|Overall Study|Adverse Event|20|||
38011706|NCT03540160|69694664|FG000|Overall Study|Withdrawal by Subject|68|||
38011707|NCT03540160|69694664|FG000|Overall Study|COVID-19|2|||
38011708|NCT03540160|69694664|FG000|Overall Study|Study Closure|10|||
38011709|NCT03540160|69694664|FG000|Overall Study|Lost to Follow-up|18|||
38011710|NCT03540160|69694664|FG000|Overall Study|Sponsor decision|191|||
38011711|NCT03459196|69694668|FG000|Overall Study|Subject didn't receive study catheter|2|||
38011712|NCT03459040|69694672|FG000|Overall Study|Death|8|||
38011713|NCT03459040|69694672|FG000|Overall Study|Withdrawal by Subject|1|||
38011714|NCT03457636|69694677|FG000|Overall Study|Lost to Follow-up|2|||
38011715|NCT03481816|69694683|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
38011716|NCT03481816|69694684|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
38011717|NCT03481816|69694683|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
38011718|NCT03481816|69694684|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
38011719|NCT03481816|69694683|FG000|Dose Expansion|Withdrawal by Subject|0|||
38011720|NCT03481816|69694684|FG001|Dose Expansion|Withdrawal by Subject|2|||
38011721|NCT03481816|69694683|FG000|Dose Expansion|Physician Decision|0|||
38011722|NCT03481816|69694684|FG001|Dose Expansion|Physician Decision|5|||
38011723|NCT03538054|69694692|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
38011724|NCT03538054|69694692|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
38011725|NCT03538054|69694692|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
38011726|NCT03480802|69694700|FG000|Overall Study|Lost to Follow-up|5|||
38011727|NCT03480802|69694701|FG001|Overall Study|Lost to Follow-up|1|||
38011728|NCT03480802|69694700|FG000|Overall Study|Withdrawal by Subject|2|||
38011729|NCT03480802|69694701|FG001|Overall Study|Withdrawal by Subject|1|||
38011730|NCT03480802|69694700|FG000|Overall Study|Relocated|0|||
38011731|NCT03480802|69694701|FG001|Overall Study|Relocated|1|||
38011732|NCT00050960|69694711|FG000|Overall Study|Progressive Disease|137|||
38011733|NCT00050960|69694712|FG001|Overall Study|Progressive Disease|93|||
38011734|NCT00050960|69694711|FG000|Overall Study|Stable Disease|19|||
38011735|NCT00050960|69694712|FG001|Overall Study|Stable Disease|48|||
38011736|NCT00050960|69694711|FG000|Overall Study|Partial Response|14|||
38011737|NCT00050960|69694712|FG001|Overall Study|Partial Response|19|||
38011738|NCT00050960|69694711|FG000|Overall Study|Complete Response|0|||
38011739|NCT00050960|69694712|FG001|Overall Study|Complete Response|2|||
38011740|NCT00050960|69694711|FG000|Overall Study|Adverse Event|62|||
38011741|NCT00050960|69694712|FG001|Overall Study|Adverse Event|61|||
38011742|NCT00050960|69694711|FG000|Overall Study|Lost to Follow-up|0|||
38011743|NCT00050960|69694712|FG001|Overall Study|Lost to Follow-up|1|||
38011744|NCT00050960|69694711|FG000|Overall Study|Withdrawal by Subject|23|||
38011745|NCT00050960|69694712|FG001|Overall Study|Withdrawal by Subject|18|||
38011746|NCT00050960|69694711|FG000|Overall Study|Administrative|31|||
38011747|NCT00050960|69694712|FG001|Overall Study|Administrative|46|||
38011748|NCT00050960|69694711|FG000|Overall Study|Non-compliance|3|||
38011749|NCT00050960|69694712|FG001|Overall Study|Non-compliance|1|||
38011750|NCT00050960|69694711|FG000|Overall Study|Death|13|||
38011751|NCT00050960|69694712|FG001|Overall Study|Death|15|||
38011752|NCT03456856|69694718|FG000|Overall Study|Lost to Follow-up|2|||
38011753|NCT03456856|69694718|FG000|Overall Study|Withdrawal by Subject|1|||
38011754|NCT00058214|69694722|FG000|Overall Study|Adverse Event|1|||
38011755|NCT00097773|69694730|FG000|Overall Study|Lost to Follow-up|2|||
38011756|NCT00097773|69694731|FG001|Overall Study|Lost to Follow-up|2|||
38011757|NCT00097773|69694732|FG002|Overall Study|Lost to Follow-up|0|||
38011758|NCT00097773|69694733|FG003|Overall Study|Lost to Follow-up|1|||
38011759|NCT00097773|69694730|FG000|Overall Study|Physician Decision|2|||
38011760|NCT00097773|69694731|FG001|Overall Study|Physician Decision|2|||
38011761|NCT00097773|69694732|FG002|Overall Study|Physician Decision|3|||
38011762|NCT00097773|69694733|FG003|Overall Study|Physician Decision|1|||
38011763|NCT00097773|69694730|FG000|Overall Study|Withdrawal by Subject|3|||
38011764|NCT00097773|69694731|FG001|Overall Study|Withdrawal by Subject|3|||
38011765|NCT00097773|69694732|FG002|Overall Study|Withdrawal by Subject|3|||
38011766|NCT00097773|69694733|FG003|Overall Study|Withdrawal by Subject|1|||
38011767|NCT00097773|69694730|FG000|Overall Study|Adverse Event|0|||
38011768|NCT00097773|69694731|FG001|Overall Study|Adverse Event|1|||
38011769|NCT00097773|69694732|FG002|Overall Study|Adverse Event|0|||
38011770|NCT00097773|69694733|FG003|Overall Study|Adverse Event|0|||
38011771|NCT00097773|69694730|FG000|Overall Study|Other|1|||
38011772|NCT00097773|69694731|FG001|Overall Study|Other|0|||
38011773|NCT00097773|69694732|FG002|Overall Study|Other|2|||
38011774|NCT00097773|69694733|FG003|Overall Study|Other|0|||
38011775|NCT03480022|69694750|FG000|Overall Study|Pregnancy|2|||
38011776|NCT03480022|69694751|FG001|Overall Study|Pregnancy|0|||
38011777|NCT03480022|69694750|FG000|Overall Study|Adverse Event|6|||
38011778|NCT03480022|69694751|FG001|Overall Study|Adverse Event|0|||
38011779|NCT03480022|69694750|FG000|Overall Study|Lack of Efficacy|0|||
38011780|NCT03480022|69694751|FG001|Overall Study|Lack of Efficacy|2|||
38011781|NCT03480022|69694750|FG000|Overall Study|Physician Decision|0|||
38011782|NCT03480022|69694751|FG001|Overall Study|Physician Decision|1|||
38011783|NCT03480022|69694750|FG000|Overall Study|Withdrawal by Subject|2|||
38011784|NCT03480022|69694751|FG001|Overall Study|Withdrawal by Subject|0|||
38011785|NCT03480022|69694750|FG000|Overall Study|Medication concerns|1|||
38011786|NCT03480022|69694751|FG001|Overall Study|Medication concerns|0|||
38011787|NCT03480022|69694750|FG000|Overall Study|Family member COVID exposure|0|||
38011788|NCT03480022|69694751|FG001|Overall Study|Family member COVID exposure|1|||
38011789|NCT03533608|69694757|FG000|Overall Study|Withdrawal by Subject|3|||
38011790|NCT03533608|69694757|FG000|Overall Study|Physician Decision|2|||
38011791|NCT00049322|69694764|FG000|Overall Study|disease burden|0|||
38011792|NCT00049322|69694765|FG001|Overall Study|disease burden|3|||
38011793|NCT00049322|69694764|FG000|Overall Study|Adverse Event|1|||
38011794|NCT00049322|69694765|FG001|Overall Study|Adverse Event|0|||
38011795|NCT00049322|69694764|FG000|Overall Study|refused angio|0|||
38011796|NCT00049322|69694765|FG001|Overall Study|refused angio|3|||
38011797|NCT03437512|69694775|FG000|Randomized|Withdrawal by Subject|0|||
38011798|NCT03437512|69694776|FG001|Randomized|Withdrawal by Subject|2|||
38011799|NCT03437512|69694775|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
38011800|NCT03437512|69694776|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
38011801|NCT00058058|69694782|FG000|Overall Study|Withdrawal by Subject|4|||
38011802|NCT00058058|69694782|FG000|Overall Study|Ineligible|20|||
38011803|NCT00058058|69694782|FG000|Overall Study|Claustrophobic|5|||
38011804|NCT00058058|69694782|FG000|Overall Study|technical issues|6|||
38011805|NCT00058058|69694782|FG000|Overall Study|Poor positioning, illness,pain|3|||
38011806|NCT03532048|69694789|FG000|Overall Study|Lost to Follow-up|12|||
38011807|NCT03532048|69694790|FG001|Overall Study|Lost to Follow-up|17|||
38011808|NCT03532048|69694789|FG000|Overall Study|Withdrawal by Subject|7|||
38011809|NCT03532048|69694790|FG001|Overall Study|Withdrawal by Subject|0|||
38011810|NCT00008138|69694796|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
38011811|NCT00008138|69694796|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
38011812|NCT00008138|69694796|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
38011813|NCT00008138|69694796|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
38011814|NCT00008138|69694796|FG000|Interval Debulking|Withdrawal by Subject|2|||
38011815|NCT00008138|69694796|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
38011816|NCT00008138|69694796|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
38011817|NCT00008138|69694796|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
38011818|NCT03436732|69694803|FG000|Overall Study|Not treated-enrolled in different study|1|||
38011819|NCT03436732|69694804|FG001|Overall Study|Not treated-enrolled in different study|0|||
38011820|NCT03436732|69694803|FG000|Overall Study|Off study after cycle 1|1|||
38011821|NCT03436732|69694804|FG001|Overall Study|Off study after cycle 1|0|||
38011822|NCT03436732|69694803|FG000|Overall Study|Adverse Event|2|||
38011823|NCT03436732|69694804|FG001|Overall Study|Adverse Event|0|||
38011824|NCT03436732|69694803|FG000|Overall Study|Death|0|||
38011825|NCT03436732|69694804|FG001|Overall Study|Death|1|||
38011826|NCT03436420|69694811|FG000|Overall Study|Lack of Efficacy|3|||
38011827|NCT00027560|69694815|FG000|Overall Study|Withdrawal by Subject|1|||
38011828|NCT03451084|69694825|FG000|Overall Study|Withdrawal by Subject|2|||
38011829|NCT03451084|69694826|FG001|Overall Study|Withdrawal by Subject|1|||
38011830|NCT03451084|69694827|FG002|Overall Study|Withdrawal by Subject|2|||
38011831|NCT03451084|69694828|FG003|Overall Study|Withdrawal by Subject|1|||
38011832|NCT03451084|69694825|FG000|Overall Study|Disease recurrence|0|||
38011833|NCT03451084|69694826|FG001|Overall Study|Disease recurrence|2|||
38011834|NCT03451084|69694827|FG002|Overall Study|Disease recurrence|0|||
38011835|NCT03451084|69694828|FG003|Overall Study|Disease recurrence|0|||
38011836|NCT03451084|69694825|FG000|Overall Study|Lack of Efficacy|0|||
38011837|NCT03451084|69694826|FG001|Overall Study|Lack of Efficacy|3|||
38011838|NCT03451084|69694827|FG002|Overall Study|Lack of Efficacy|0|||
38011839|NCT03451084|69694828|FG003|Overall Study|Lack of Efficacy|1|||
38011840|NCT03451084|69694825|FG000|Overall Study|Death|1|||
38011841|NCT03451084|69694826|FG001|Overall Study|Death|0|||
38011842|NCT03451084|69694827|FG002|Overall Study|Death|2|||
38011843|NCT03451084|69694828|FG003|Overall Study|Death|0|||
38011844|NCT03451084|69694825|FG000|Overall Study|Physician Decision|0|||
38011845|NCT03451084|69694826|FG001|Overall Study|Physician Decision|0|||
38011846|NCT03451084|69694827|FG002|Overall Study|Physician Decision|2|||
38011847|NCT03451084|69694828|FG003|Overall Study|Physician Decision|2|||
38011848|NCT03451084|69694825|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
38011849|NCT03451084|69694826|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
38011850|NCT03451084|69694827|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
38011851|NCT03451084|69694828|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
38011852|NCT03451006|69694840|FG000|Overall Study|Withdrawal by Subject|2|||
38011853|NCT03451006|69694841|FG001|Overall Study|Withdrawal by Subject|2|||
38011854|NCT03450070|69694847|FG000|Overall Study|Withdrawal by Subject|8|||
38011855|NCT03449758|69694851|FG000|Overall Study|Major protocol deviation|1|||
38011856|NCT03449758|69694851|FG000|Overall Study|Treatment inefficacy|5|||
38011857|NCT03449758|69694851|FG000|Overall Study|Adverse Event|9|||
38011858|NCT03449758|69694851|FG000|Overall Study|Consent withdrawal|1|||
38011859|NCT03449758|69694851|FG000|Overall Study|Other unspecified reason|3|||
38011860|NCT03449446|69694863|FG000|Overall Study|Randomized but Never Treated|0|||
38011861|NCT03449446|69694864|FG001|Overall Study|Randomized but Never Treated|0|||
38011862|NCT03449446|69694865|FG002|Overall Study|Randomized but Never Treated|1|||
38011863|NCT03449446|69694866|FG003|Overall Study|Randomized but Never Treated|1|||
38011864|NCT03449446|69694867|FG004|Overall Study|Randomized but Never Treated|1|||
38011865|NCT03449446|69694868|FG005|Overall Study|Randomized but Never Treated|0|||
38011866|NCT03449446|69694869|FG006|Overall Study|Randomized but Never Treated|0|||
38011867|NCT03449446|69694863|FG000|Overall Study|Unknown Reason|33|||
38011868|NCT03449446|69694864|FG001|Overall Study|Unknown Reason|1|||
38011869|NCT03449446|69694865|FG002|Overall Study|Unknown Reason|1|||
38011870|NCT03449446|69694866|FG003|Overall Study|Unknown Reason|1|||
38011871|NCT03449446|69694867|FG004|Overall Study|Unknown Reason|2|||
38011872|NCT03449446|69694868|FG005|Overall Study|Unknown Reason|2|||
38011873|NCT03449446|69694869|FG006|Overall Study|Unknown Reason|0|||
38011874|NCT03449446|69694863|FG000|Overall Study|Withdrew Consent|1|||
38011875|NCT03449446|69694864|FG001|Overall Study|Withdrew Consent|3|||
38011876|NCT03449446|69694865|FG002|Overall Study|Withdrew Consent|1|||
38011877|NCT03449446|69694866|FG003|Overall Study|Withdrew Consent|4|||
38011878|NCT03449446|69694867|FG004|Overall Study|Withdrew Consent|4|||
38011879|NCT03449446|69694868|FG005|Overall Study|Withdrew Consent|4|||
38011880|NCT03449446|69694869|FG006|Overall Study|Withdrew Consent|1|||
38011881|NCT03449446|69694863|FG000|Overall Study|Adverse Event|1|||
38011882|NCT03449446|69694864|FG001|Overall Study|Adverse Event|2|||
38011883|NCT03449446|69694865|FG002|Overall Study|Adverse Event|1|||
38011884|NCT03449446|69694866|FG003|Overall Study|Adverse Event|0|||
38011885|NCT03449446|69694867|FG004|Overall Study|Adverse Event|0|||
38011886|NCT03449446|69694868|FG005|Overall Study|Adverse Event|2|||
38011887|NCT03449446|69694869|FG006|Overall Study|Adverse Event|0|||
38011888|NCT03449446|69694863|FG000|Overall Study|Lost to Follow-up|0|||
38011889|NCT03449446|69694864|FG001|Overall Study|Lost to Follow-up|0|||
38011890|NCT03449446|69694865|FG002|Overall Study|Lost to Follow-up|2|||
38011891|NCT03449446|69694866|FG003|Overall Study|Lost to Follow-up|1|||
38011892|NCT03449446|69694867|FG004|Overall Study|Lost to Follow-up|3|||
38011893|NCT03449446|69694868|FG005|Overall Study|Lost to Follow-up|0|||
38011894|NCT03449446|69694869|FG006|Overall Study|Lost to Follow-up|0|||
38011895|NCT03449446|69694863|FG000|Overall Study|Investigator's Discretion|0|||
38011896|NCT03449446|69694864|FG001|Overall Study|Investigator's Discretion|1|||
38011897|NCT03449446|69694865|FG002|Overall Study|Investigator's Discretion|1|||
38011898|NCT03449446|69694866|FG003|Overall Study|Investigator's Discretion|2|||
38011899|NCT03449446|69694867|FG004|Overall Study|Investigator's Discretion|0|||
38011900|NCT03449446|69694868|FG005|Overall Study|Investigator's Discretion|0|||
38011901|NCT03449446|69694869|FG006|Overall Study|Investigator's Discretion|0|||
38011902|NCT03449446|69694863|FG000|Overall Study|Non Compliance with Study Drug|1|||
38011903|NCT03449446|69694864|FG001|Overall Study|Non Compliance with Study Drug|0|||
38011904|NCT03449446|69694865|FG002|Overall Study|Non Compliance with Study Drug|0|||
38011905|NCT03449446|69694866|FG003|Overall Study|Non Compliance with Study Drug|0|||
38011906|NCT03449446|69694867|FG004|Overall Study|Non Compliance with Study Drug|0|||
38011907|NCT03449446|69694868|FG005|Overall Study|Non Compliance with Study Drug|0|||
38011908|NCT03449446|69694869|FG006|Overall Study|Non Compliance with Study Drug|0|||
38011909|NCT03449446|69694863|FG000|Overall Study|Protocol Violation|0|||
38011910|NCT03449446|69694864|FG001|Overall Study|Protocol Violation|0|||
38011911|NCT03449446|69694865|FG002|Overall Study|Protocol Violation|0|||
38011912|NCT03449446|69694866|FG003|Overall Study|Protocol Violation|0|||
38011913|NCT03449446|69694867|FG004|Overall Study|Protocol Violation|1|||
38011914|NCT03449446|69694868|FG005|Overall Study|Protocol Violation|1|||
38011915|NCT03449446|69694869|FG006|Overall Study|Protocol Violation|0|||
38011916|NCT03449446|69694863|FG000|Overall Study|Death|0|||
38011917|NCT03449446|69694864|FG001|Overall Study|Death|0|||
38011918|NCT03449446|69694865|FG002|Overall Study|Death|0|||
38011919|NCT03449446|69694866|FG003|Overall Study|Death|0|||
38011920|NCT03449446|69694867|FG004|Overall Study|Death|1|||
38011921|NCT03449446|69694868|FG005|Overall Study|Death|0|||
38011922|NCT03449446|69694869|FG006|Overall Study|Death|0|||
38011923|NCT03449134|69694888|FG000|52-Week Treatment Period|Death|2|||
38011924|NCT03449134|69694889|FG001|52-Week Treatment Period|Death|1|||
38011925|NCT03449134|69694890|FG002|52-Week Treatment Period|Death|0|||
38011926|NCT03449134|69694888|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
38011927|NCT03449134|69694889|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
38011928|NCT03449134|69694890|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
38011929|NCT03449134|69694888|FG000|52-Week Treatment Period|Physician Decision|2|||
38011930|NCT03449134|69694889|FG001|52-Week Treatment Period|Physician Decision|3|||
38011931|NCT03449134|69694890|FG002|52-Week Treatment Period|Physician Decision|3|||
38011932|NCT03449134|69694888|FG000|52-Week Treatment Period|Screen Failure|1|||
38011933|NCT03449134|69694889|FG001|52-Week Treatment Period|Screen Failure|0|||
38011934|NCT03449134|69694890|FG002|52-Week Treatment Period|Screen Failure|1|||
38011935|NCT03449134|69694888|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
38011936|NCT03449134|69694889|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
38011937|NCT03449134|69694890|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
38011938|NCT03449134|69694888|FG000|52-Week Treatment Period|Site Closure|1|||
38011939|NCT03449134|69694889|FG001|52-Week Treatment Period|Site Closure|0|||
38011940|NCT03449134|69694890|FG002|52-Week Treatment Period|Site Closure|0|||
38011941|NCT03529162|69694903|FG000|Overall Study|Lost to Follow-up|2|||
38011942|NCT03529162|69694904|FG001|Overall Study|Lost to Follow-up|2|||
38011943|NCT03447730|69694915|FG000|Overall Study|Adverse Event|0|||
38011944|NCT03447730|69694916|FG001|Overall Study|Adverse Event|2|||
38011945|NCT03447730|69694917|FG002|Overall Study|Adverse Event|0|||
38011946|NCT03429556|69694929|FG000|Overall Study|Lost to Follow-up|0|||
38011947|NCT03429556|69694930|FG001|Overall Study|Lost to Follow-up|1|||
38011948|NCT03429556|69694931|FG002|Overall Study|Lost to Follow-up|0|||
38011949|NCT03429556|69694932|FG003|Overall Study|Lost to Follow-up|0|||
38011950|NCT03428152|69694944|FG000|Overall Study|Physician Decision|4|||
38011951|NCT03428152|69694945|FG001|Overall Study|Physician Decision|2|||
38011952|NCT03428152|69694944|FG000|Overall Study|Protocol Violation|3|||
38011953|NCT03428152|69694945|FG001|Overall Study|Protocol Violation|5|||
38011954|NCT03428152|69694944|FG000|Overall Study|Lack of Efficacy|0|||
38011955|NCT03428152|69694945|FG001|Overall Study|Lack of Efficacy|4|||
38011956|NCT03444766|69694951|FG000|Overall Study|Other Reasons|2|||
38011957|NCT03444766|69694951|FG000|Overall Study|Participant Withdrew Consent|5|||
38011958|NCT03444766|69694951|FG000|Overall Study|Lost to Follow-up|2|||
38011959|NCT03444766|69694951|FG000|Overall Study|Death|2|||
38011960|NCT03444766|69694951|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
38011961|NCT03444766|69694951|FG000|Overall Study|Disease Progression|49|||
38011962|NCT03426436|69694955|FG000|Overall Study|Incorrect lead placement|12|||
38011963|NCT03426436|69694955|FG000|Overall Study|Withdrawal by Subject|2|||
38011964|NCT03426436|69694955|FG000|Overall Study|Consent issue|1|||
38011965|NCT03426436|69694955|FG000|Overall Study|ECGs not saved|4|||
38011966|NCT03425188|69694959|FG000|Overall Study|Withdrawal by Subject|1|||
38011967|NCT03423238|69694966|FG000|Overall Study|Lost to Follow-up|1|||
38011968|NCT03423238|69694967|FG001|Overall Study|Lost to Follow-up|0|||
38011969|NCT03423238|69694966|FG000|Overall Study|Withdrawal by Subject|1|||
38011970|NCT03423238|69694967|FG001|Overall Study|Withdrawal by Subject|0|||
38011971|NCT02953678|69694974|FG000|Overall Study|Adverse Event|20|||
38011972|NCT02953678|69694974|FG000|Overall Study|Death|7|||
38011973|NCT02953678|69694974|FG000|Overall Study|Physician Decision|23|||
38011974|NCT02953678|69694974|FG000|Overall Study|Progressive Disease of GVHD|7|||
38011975|NCT02953678|69694974|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
38011976|NCT02953678|69694974|FG000|Overall Study|Withdrawal by participant|3|||
38011977|NCT02953678|69694974|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
38011978|NCT02953678|69694974|FG000|Overall Study|Participants were transferred to commercial product.|3|||
38011979|NCT03412084|69694981|FG000|Overall Study|Withdrawal by Subject|2|||
38011980|NCT03412084|69694982|FG001|Overall Study|Withdrawal by Subject|0|||
38011981|NCT03412084|69694981|FG000|Overall Study|Participant moved|1|||
38011982|NCT03412084|69694982|FG001|Overall Study|Participant moved|0|||
38011983|NCT03412084|69694981|FG000|Overall Study|Lost to Follow-up|1|||
38011984|NCT03412084|69694982|FG001|Overall Study|Lost to Follow-up|1|||
38011985|NCT00090753|69694990|FG000|First Treatment Period|Adverse Event|20|||
38011986|NCT00090753|69694991|FG001|First Treatment Period|Adverse Event|8|||
38011987|NCT00090753|69694990|FG000|First Treatment Period|Death|88|||
38011988|NCT00090753|69694991|FG001|First Treatment Period|Death|62|||
38011989|NCT00090753|69694990|FG000|First Treatment Period|Lack of Efficacy|2|||
38011990|NCT00090753|69694991|FG001|First Treatment Period|Lack of Efficacy|1|||
38011991|NCT00090753|69694990|FG000|First Treatment Period|Refused Treatment|32|||
38011992|NCT00090753|69694991|FG001|First Treatment Period|Refused Treatment|25|||
38011993|NCT00090753|69694990|FG000|First Treatment Period|Lost to Follow-up|4|||
38011994|NCT00090753|69694991|FG001|First Treatment Period|Lost to Follow-up|4|||
38011995|NCT00090753|69694990|FG000|First Treatment Period|Renal Transplant|70|||
38011996|NCT00090753|69694991|FG001|First Treatment Period|Renal Transplant|50|||
38011997|NCT00090753|69694990|FG000|First Treatment Period|Mircera Commercialization|1|||
38011998|NCT00090753|69694991|FG001|First Treatment Period|Mircera Commercialization|0|||
38011999|NCT00090753|69694990|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
38012000|NCT00090753|69694991|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
38012001|NCT00090753|69694990|FG000|Extended Treatment Period|Adverse Event|11|||
38012002|NCT00090753|69694991|FG001|Extended Treatment Period|Adverse Event|0|||
38012003|NCT00090753|69694990|FG000|Extended Treatment Period|Death|58|||
38012004|NCT00090753|69694991|FG001|Extended Treatment Period|Death|30|||
38012005|NCT00090753|69694990|FG000|Extended Treatment Period|Lack of Efficacy|1|||
38012006|NCT00090753|69694991|FG001|Extended Treatment Period|Lack of Efficacy|0|||
38012007|NCT00090753|69694990|FG000|Extended Treatment Period|Refused Treatment|18|||
38012008|NCT00090753|69694991|FG001|Extended Treatment Period|Refused Treatment|12|||
38012009|NCT00090753|69694990|FG000|Extended Treatment Period|Lost to Follow-up|3|||
38012010|NCT00090753|69694991|FG001|Extended Treatment Period|Lost to Follow-up|1|||
38012011|NCT00090753|69694990|FG000|Extended Treatment Period|Renal Transplant|15|||
38012012|NCT00090753|69694991|FG001|Extended Treatment Period|Renal Transplant|12|||
38012013|NCT00090753|69694990|FG000|Extended Treatment Period|Mircera Commercialization|188|||
38012014|NCT00090753|69694991|FG001|Extended Treatment Period|Mircera Commercialization|93|||
38012015|NCT00090753|69694990|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
38012016|NCT00090753|69694991|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
38012017|NCT00048932|69694999|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
38012018|NCT00048932|69695000|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
38012019|NCT00048932|69695001|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
38012020|NCT00048932|69694999|FG000|Double Blind Period (DB)|Adverse Event|51|||
38012021|NCT00048932|69695000|FG001|Double Blind Period (DB)|Adverse Event|19|||
38012022|NCT00048932|69695001|FG002|Double Blind Period (DB)|Adverse Event|0|||
38012023|NCT00048932|69694999|FG000|Double Blind Period (DB)|Death|5|||
38012024|NCT00048932|69695000|FG001|Double Blind Period (DB)|Death|3|||
38012025|NCT00048932|69695001|FG002|Double Blind Period (DB)|Death|0|||
38012026|NCT00048932|69694999|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
38012027|NCT00048932|69695000|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
38012028|NCT00048932|69695001|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
38012029|NCT00048932|69694999|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
38012030|NCT00048932|69695000|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
38012031|NCT00048932|69695001|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
38012032|NCT00048932|69694999|FG000|Double Blind Period (DB)|Relocation|1|||
38012033|NCT00048932|69695000|FG001|Double Blind Period (DB)|Relocation|0|||
38012034|NCT00048932|69695001|FG002|Double Blind Period (DB)|Relocation|0|||
38012035|NCT00048932|69694999|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
38012036|NCT00048932|69695000|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
38012037|NCT00048932|69695001|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
38012038|NCT00048932|69694999|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
38012039|NCT00048932|69695000|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
38012040|NCT00048932|69695001|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
38012041|NCT00048932|69694999|FG000|Double Blind Period (DB)|Pregnancy|1|||
38012042|NCT00048932|69695000|FG001|Double Blind Period (DB)|Pregnancy|0|||
38012043|NCT00048932|69695001|FG002|Double Blind Period (DB)|Pregnancy|0|||
38012044|NCT00048932|69694999|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
38012045|NCT00048932|69695000|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
38012046|NCT00048932|69695001|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
38012047|NCT00048932|69694999|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
38012048|NCT00048932|69695000|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
38012049|NCT00048932|69695001|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
38012050|NCT00048932|69694999|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
38012051|NCT00048932|69695000|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
38012052|NCT00048932|69695001|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
38012053|NCT00048932|69694999|FG000|Open Label Period (OL)|Death|0|||
38012054|NCT00048932|69695000|FG001|Open Label Period (OL)|Death|0|||
38012055|NCT00048932|69695001|FG002|Open Label Period (OL)|Death|25|||
38012056|NCT00048932|69694999|FG000|Open Label Period (OL)|Adverse Event|0|||
38012057|NCT00048932|69695000|FG001|Open Label Period (OL)|Adverse Event|0|||
38012058|NCT00048932|69695001|FG002|Open Label Period (OL)|Adverse Event|103|||
38012059|NCT00048932|69694999|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
38012060|NCT00048932|69695000|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
38012061|NCT00048932|69695001|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
38012062|NCT00048932|69694999|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
38012063|NCT00048932|69695000|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
38012064|NCT00048932|69695001|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
38012065|NCT00048932|69694999|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
38012066|NCT00048932|69695000|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
38012067|NCT00048932|69695001|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
38012068|NCT00048932|69694999|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
38012069|NCT00048932|69695000|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
38012070|NCT00048932|69695001|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
38012071|NCT00048932|69694999|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
38012072|NCT00048932|69695000|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
38012073|NCT00048932|69695001|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
38012074|NCT00048932|69694999|FG000|Open Label Period (OL)|Pregnancy|0|||
38012075|NCT00048932|69695000|FG001|Open Label Period (OL)|Pregnancy|0|||
38012076|NCT00048932|69695001|FG002|Open Label Period (OL)|Pregnancy|6|||
38012077|NCT00048932|69694999|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
38012078|NCT00048932|69695000|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
38012079|NCT00048932|69695001|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
38012080|NCT00048932|69694999|FG000|Open Label Period (OL)|Investigator Retiring|0|||
38012081|NCT00048932|69695000|FG001|Open Label Period (OL)|Investigator Retiring|0|||
38012082|NCT00048932|69695001|FG002|Open Label Period (OL)|Investigator Retiring|2|||
38012083|NCT00048932|69694999|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
38012084|NCT00048932|69695000|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
38012085|NCT00048932|69695001|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
38012086|NCT00048932|69694999|FG000|Open Label Period (OL)|Participant Relocated|0|||
38012087|NCT00048932|69695000|FG001|Open Label Period (OL)|Participant Relocated|0|||
38012088|NCT00048932|69695001|FG002|Open Label Period (OL)|Participant Relocated|6|||
38012089|NCT00048932|69694999|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
38012090|NCT00048932|69695000|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
38012091|NCT00048932|69695001|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
38012092|NCT00048932|69694999|FG000|Open Label Period (OL)|Site Closure|0|||
38012093|NCT00048932|69695000|FG001|Open Label Period (OL)|Site Closure|0|||
38012094|NCT00048932|69695001|FG002|Open Label Period (OL)|Site Closure|3|||
38012095|NCT00048932|69694999|FG000|Open Label Period (OL)|Trial Terminated|0|||
38012096|NCT00048932|69695000|FG001|Open Label Period (OL)|Trial Terminated|0|||
38012097|NCT00048932|69695001|FG002|Open Label Period (OL)|Trial Terminated|1|||
38012098|NCT00048932|69694999|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
38012099|NCT00048932|69695000|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
38012100|NCT00048932|69695001|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
38012101|NCT00048932|69694999|FG000|Open Label Period (OL)|Patient Decision|0|||
38012102|NCT00048932|69695000|FG001|Open Label Period (OL)|Patient Decision|0|||
38012103|NCT00048932|69695001|FG002|Open Label Period (OL)|Patient Decision|4|||
38012104|NCT00048932|69694999|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
38012105|NCT00048932|69695000|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
38012106|NCT00048932|69695001|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
38012107|NCT00048932|69694999|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
38012108|NCT00048932|69695000|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
38012109|NCT00048932|69695001|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
38012110|NCT00048932|69694999|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
38012111|NCT00048932|69695000|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
38012112|NCT00048932|69695001|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
38012113|NCT00048932|69694999|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
38012114|NCT00048932|69695000|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
38012115|NCT00048932|69695001|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
38012116|NCT00048932|69694999|FG000|Open Label Period (OL)|Investigator Decision|0|||
38012117|NCT00048932|69695000|FG001|Open Label Period (OL)|Investigator Decision|0|||
38012118|NCT00048932|69695001|FG002|Open Label Period (OL)|Investigator Decision|4|||
38012119|NCT00048932|69694999|FG000|Open Label Period (OL)|Site Staff Issues|0|||
38012120|NCT00048932|69695000|FG001|Open Label Period (OL)|Site Staff Issues|0|||
38012121|NCT00048932|69695001|FG002|Open Label Period (OL)|Site Staff Issues|2|||
38012122|NCT00048932|69694999|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
38012123|NCT00048932|69695000|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
38012124|NCT00048932|69695001|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
38012125|NCT00048932|69694999|FG000|Open Label Period (OL)|Participant Surgery|0|||
38012126|NCT00048932|69695000|FG001|Open Label Period (OL)|Participant Surgery|0|||
38012127|NCT00048932|69695001|FG002|Open Label Period (OL)|Participant Surgery|1|||
38012128|NCT00073983|69695010|FG000|Overall Study|not evaluable|1|||
38012129|NCT03812679|69695016|FG000|Overall Study|Adverse Event|2|||
38012130|NCT03812679|69695016|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
38012131|NCT03812679|69695016|FG000|Overall Study|Renal transplant|1|||
38012132|NCT03812679|69695016|FG000|Overall Study|Withdrawal by Subject|1|||
38012133|NCT03812679|69695016|FG000|Overall Study|Termination of study|2|||
38012134|NCT03812679|69695016|FG000|Overall Study|Water device replacement|1|||
38012135|NCT02952820|69695023|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
38012136|NCT02952820|69695024|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
38012137|NCT02952820|69695025|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
38012138|NCT02952820|69695023|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
38012139|NCT02952820|69695024|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
38012140|NCT02952820|69695025|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
38012141|NCT02952820|69695023|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
38012142|NCT02952820|69695024|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
38012143|NCT02952820|69695025|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
38012144|NCT02952820|69695023|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
38012145|NCT02952820|69695024|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
38012146|NCT02952820|69695025|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
38012147|NCT02952820|69695023|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
38012148|NCT02952820|69695024|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
38012149|NCT02952820|69695025|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
38012150|NCT02952820|69695023|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
38012151|NCT02952820|69695024|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
38012152|NCT02952820|69695025|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
38012153|NCT02952820|69695023|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
38012154|NCT02952820|69695024|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
38012155|NCT02952820|69695025|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
38012156|NCT02952820|69695023|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
38012157|NCT02952820|69695024|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
38012158|NCT02952820|69695025|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
38012159|NCT02952820|69695023|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
38012160|NCT02952820|69695024|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
38012161|NCT02952820|69695025|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
38012162|NCT02952820|69695023|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
38012163|NCT02952820|69695024|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
38012164|NCT02952820|69695025|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
38012165|NCT02952820|69695023|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
38012166|NCT02952820|69695024|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
38012167|NCT02952820|69695025|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
38012168|NCT02952820|69695023|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
38012169|NCT02952820|69695024|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
38012170|NCT02952820|69695025|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
38012171|NCT02952820|69695023|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
38012172|NCT02952820|69695024|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
38012173|NCT02952820|69695025|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
38012174|NCT02952820|69695023|FG000|Active Treatment Period (6 Months)|Not treated|0|||
38012175|NCT02952820|69695024|FG001|Active Treatment Period (6 Months)|Not treated|0|||
38012176|NCT02952820|69695025|FG002|Active Treatment Period (6 Months)|Not treated|1|||
38012177|NCT00006392|69695040|FG000|Overall Study|Ineligible|11|||
38012178|NCT00006392|69695041|FG001|Overall Study|Ineligible|3|||
38012179|NCT00006392|69695042|FG002|Overall Study|Ineligible|5|||
38012180|NCT00006392|69695043|FG003|Overall Study|Ineligible|5|||
38012181|NCT00006392|69695040|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
38012182|NCT00006392|69695041|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
38012183|NCT00006392|69695042|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
38012184|NCT00006392|69695043|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
38012185|NCT00379769|69695057|FG000|Main Study|Death|57|||
38012186|NCT00379769|69695058|FG001|Main Study|Death|67|||
38012187|NCT00379769|69695059|FG002|Main Study|Death|54|||
38012188|NCT00379769|69695060|FG003|Main Study|Death|72|||
38012189|NCT00379769|69695061|FG004|Main Study|Death|0|||
38012190|NCT00379769|69695062|FG005|Main Study|Death|0|||
38012191|NCT00379769|69695057|FG000|Main Study|Adverse Event|5|||
38012192|NCT00379769|69695058|FG001|Main Study|Adverse Event|8|||
38012193|NCT00379769|69695059|FG002|Main Study|Adverse Event|10|||
38012194|NCT00379769|69695060|FG003|Main Study|Adverse Event|11|||
38012195|NCT00379769|69695061|FG004|Main Study|Adverse Event|0|||
37698398|NCT01800916|69175189|FG008|Test Period 1 (1 Week)|Convex product user|0|||
37698399|NCT01800916|69175181|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
37698400|NCT01800916|69175182|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
38012196|NCT00379769|69695062|FG005|Main Study|Adverse Event|0|||
38012197|NCT00379769|69695057|FG000|Main Study|Lost to Follow-up|29|||
38012198|NCT00379769|69695058|FG001|Main Study|Lost to Follow-up|29|||
38012199|NCT00379769|69695059|FG002|Main Study|Lost to Follow-up|25|||
38012200|NCT00379769|69695060|FG003|Main Study|Lost to Follow-up|26|||
38012201|NCT00379769|69695061|FG004|Main Study|Lost to Follow-up|0|||
38012202|NCT00379769|69695062|FG005|Main Study|Lost to Follow-up|0|||
38012203|NCT00379769|69695057|FG000|Main Study|Withdrawal by Subject|46|||
38012204|NCT00379769|69695058|FG001|Main Study|Withdrawal by Subject|56|||
38012205|NCT00379769|69695059|FG002|Main Study|Withdrawal by Subject|72|||
38012206|NCT00379769|69695060|FG003|Main Study|Withdrawal by Subject|70|||
38012207|NCT00379769|69695061|FG004|Main Study|Withdrawal by Subject|0|||
38012208|NCT00379769|69695062|FG005|Main Study|Withdrawal by Subject|0|||
38012209|NCT00379769|69695057|FG000|Main Study|Moved to survival status follow-up only|27|||
38012210|NCT00379769|69695058|FG001|Main Study|Moved to survival status follow-up only|25|||
38012211|NCT00379769|69695059|FG002|Main Study|Moved to survival status follow-up only|32|||
38012212|NCT00379769|69695060|FG003|Main Study|Moved to survival status follow-up only|36|||
38012213|NCT00379769|69695061|FG004|Main Study|Moved to survival status follow-up only|0|||
38012214|NCT00379769|69695062|FG005|Main Study|Moved to survival status follow-up only|0|||
38012215|NCT00379769|69695057|FG000|Main Study|Participant moved|3|||
38012216|NCT00379769|69695058|FG001|Main Study|Participant moved|2|||
38012217|NCT00379769|69695059|FG002|Main Study|Participant moved|3|||
38012218|NCT00379769|69695060|FG003|Main Study|Participant moved|3|||
38012219|NCT00379769|69695061|FG004|Main Study|Participant moved|0|||
38012220|NCT00379769|69695062|FG005|Main Study|Participant moved|0|||
38012221|NCT00379769|69695057|FG000|Main Study|Poor compliance|3|||
38012222|NCT00379769|69695058|FG001|Main Study|Poor compliance|2|||
38012223|NCT00379769|69695059|FG002|Main Study|Poor compliance|2|||
38012224|NCT00379769|69695060|FG003|Main Study|Poor compliance|1|||
38012225|NCT00379769|69695061|FG004|Main Study|Poor compliance|0|||
38012226|NCT00379769|69695062|FG005|Main Study|Poor compliance|0|||
38012227|NCT00379769|69695057|FG000|Main Study|Prohibited glucose lowering medication|0|||
38012228|NCT00379769|69695058|FG001|Main Study|Prohibited glucose lowering medication|3|||
38012229|NCT00379769|69695059|FG002|Main Study|Prohibited glucose lowering medication|0|||
38012230|NCT00379769|69695060|FG003|Main Study|Prohibited glucose lowering medication|1|||
38012231|NCT00379769|69695061|FG004|Main Study|Prohibited glucose lowering medication|0|||
38012232|NCT00379769|69695062|FG005|Main Study|Prohibited glucose lowering medication|0|||
38012233|NCT00379769|69695057|FG000|Main Study|Site closed|4|||
38012234|NCT00379769|69695058|FG001|Main Study|Site closed|4|||
38012235|NCT00379769|69695059|FG002|Main Study|Site closed|4|||
38012236|NCT00379769|69695060|FG003|Main Study|Site closed|8|||
38012237|NCT00379769|69695061|FG004|Main Study|Site closed|0|||
38012238|NCT00379769|69695062|FG005|Main Study|Site closed|0|||
38012239|NCT00379769|69695057|FG000|Main Study|Entry criteria violation|0|||
38012240|NCT00379769|69695058|FG001|Main Study|Entry criteria violation|0|||
38012241|NCT00379769|69695059|FG002|Main Study|Entry criteria violation|1|||
38012242|NCT00379769|69695060|FG003|Main Study|Entry criteria violation|1|||
38012243|NCT00379769|69695061|FG004|Main Study|Entry criteria violation|0|||
38012244|NCT00379769|69695062|FG005|Main Study|Entry criteria violation|0|||
38012245|NCT00379769|69695057|FG000|Main Study|Participant did not take study drug|0|||
38012246|NCT00379769|69695058|FG001|Main Study|Participant did not take study drug|0|||
38012247|NCT00379769|69695059|FG002|Main Study|Participant did not take study drug|1|||
38012248|NCT00379769|69695060|FG003|Main Study|Participant did not take study drug|0|||
38012249|NCT00379769|69695061|FG004|Main Study|Participant did not take study drug|0|||
38012250|NCT00379769|69695062|FG005|Main Study|Participant did not take study drug|0|||
38012251|NCT00379769|69695057|FG000|Main Study|Physician Decision|2|||
38012252|NCT00379769|69695058|FG001|Main Study|Physician Decision|2|||
38012253|NCT00379769|69695059|FG002|Main Study|Physician Decision|1|||
38012254|NCT00379769|69695060|FG003|Main Study|Physician Decision|1|||
38012255|NCT00379769|69695061|FG004|Main Study|Physician Decision|0|||
38012256|NCT00379769|69695062|FG005|Main Study|Physician Decision|0|||
38012257|NCT00379769|69695057|FG000|Main Study|Participant completed study at visit 27|1|||
38012258|NCT00379769|69695058|FG001|Main Study|Participant completed study at visit 27|0|||
38012259|NCT00379769|69695059|FG002|Main Study|Participant completed study at visit 27|0|||
38012260|NCT00379769|69695060|FG003|Main Study|Participant completed study at visit 27|0|||
38012261|NCT00379769|69695061|FG004|Main Study|Participant completed study at visit 27|0|||
37832001|NCT01191697|69515554|FG000|Overall Study|Death|1|||
37832002|NCT01191697|69515554|FG000|Overall Study|Physician Decision|2|||
38012262|NCT00379769|69695062|FG005|Main Study|Participant completed study at visit 27|0|||
38012263|NCT00379769|69695057|FG000|Main Study|Personal reasons|1|||
38012264|NCT00379769|69695058|FG001|Main Study|Personal reasons|0|||
38012265|NCT00379769|69695059|FG002|Main Study|Personal reasons|0|||
38012266|NCT00379769|69695060|FG003|Main Study|Personal reasons|0|||
38012267|NCT00379769|69695061|FG004|Main Study|Personal reasons|0|||
38012268|NCT00379769|69695062|FG005|Main Study|Personal reasons|0|||
38012269|NCT00379769|69695057|FG000|Main Study|Risk of heart failure|0|||
38012270|NCT00379769|69695058|FG001|Main Study|Risk of heart failure|1|||
38012271|NCT00379769|69695059|FG002|Main Study|Risk of heart failure|0|||
38012272|NCT00379769|69695060|FG003|Main Study|Risk of heart failure|0|||
38012273|NCT00379769|69695061|FG004|Main Study|Risk of heart failure|0|||
38012274|NCT00379769|69695062|FG005|Main Study|Risk of heart failure|0|||
38012275|NCT00379769|69695057|FG000|Main Study|Investigator refused to log temperature|0|||
38012276|NCT00379769|69695058|FG001|Main Study|Investigator refused to log temperature|0|||
38012277|NCT00379769|69695059|FG002|Main Study|Investigator refused to log temperature|1|||
38012278|NCT00379769|69695060|FG003|Main Study|Investigator refused to log temperature|0|||
38012279|NCT00379769|69695061|FG004|Main Study|Investigator refused to log temperature|0|||
38012280|NCT00379769|69695062|FG005|Main Study|Investigator refused to log temperature|0|||
38012281|NCT00379769|69695057|FG000|Main Study|Reason unspecified|0|||
38012282|NCT00379769|69695058|FG001|Main Study|Reason unspecified|0|||
38012283|NCT00379769|69695059|FG002|Main Study|Reason unspecified|1|||
38012284|NCT00379769|69695060|FG003|Main Study|Reason unspecified|0|||
38012285|NCT00379769|69695061|FG004|Main Study|Reason unspecified|0|||
38012286|NCT00379769|69695062|FG005|Main Study|Reason unspecified|0|||
38012287|NCT00379769|69695057|FG000|Observational Follow-up|Death|0|||
38012288|NCT00379769|69695058|FG001|Observational Follow-up|Death|0|||
38012289|NCT00379769|69695059|FG002|Observational Follow-up|Death|0|||
38012290|NCT00379769|69695060|FG003|Observational Follow-up|Death|0|||
38012291|NCT00379769|69695061|FG004|Observational Follow-up|Death|78|||
38012292|NCT00379769|69695062|FG005|Observational Follow-up|Death|70|||
38012293|NCT00379769|69695057|FG000|Observational Follow-up|Adverse Event|0|||
38012294|NCT00379769|69695058|FG001|Observational Follow-up|Adverse Event|0|||
38012295|NCT00379769|69695059|FG002|Observational Follow-up|Adverse Event|0|||
38012296|NCT00379769|69695060|FG003|Observational Follow-up|Adverse Event|0|||
38012297|NCT00379769|69695061|FG004|Observational Follow-up|Adverse Event|1|||
38012298|NCT00379769|69695062|FG005|Observational Follow-up|Adverse Event|0|||
38012299|NCT00379769|69695057|FG000|Observational Follow-up|Lost to Follow-up|0|||
38012300|NCT00379769|69695058|FG001|Observational Follow-up|Lost to Follow-up|0|||
38012301|NCT00379769|69695059|FG002|Observational Follow-up|Lost to Follow-up|0|||
38012302|NCT00379769|69695060|FG003|Observational Follow-up|Lost to Follow-up|0|||
38012303|NCT00379769|69695061|FG004|Observational Follow-up|Lost to Follow-up|25|||
38012304|NCT00379769|69695062|FG005|Observational Follow-up|Lost to Follow-up|27|||
38012305|NCT00379769|69695057|FG000|Observational Follow-up|Withdrawal by Subject|0|||
38012306|NCT00379769|69695058|FG001|Observational Follow-up|Withdrawal by Subject|0|||
38012307|NCT00379769|69695059|FG002|Observational Follow-up|Withdrawal by Subject|0|||
38012308|NCT00379769|69695060|FG003|Observational Follow-up|Withdrawal by Subject|0|||
38012309|NCT00379769|69695061|FG004|Observational Follow-up|Withdrawal by Subject|12|||
38012310|NCT00379769|69695062|FG005|Observational Follow-up|Withdrawal by Subject|12|||
38012311|NCT00379769|69695057|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
38012312|NCT00379769|69695058|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
38012313|NCT00379769|69695059|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
38012314|NCT00379769|69695060|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
38012315|NCT00379769|69695061|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
38012316|NCT00379769|69695062|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
38012317|NCT00379769|69695057|FG000|Observational Follow-up|Physician Decision|0|||
38012318|NCT00379769|69695058|FG001|Observational Follow-up|Physician Decision|0|||
38012319|NCT00379769|69695059|FG002|Observational Follow-up|Physician Decision|0|||
38012320|NCT00379769|69695060|FG003|Observational Follow-up|Physician Decision|0|||
38012321|NCT00379769|69695061|FG004|Observational Follow-up|Physician Decision|8|||
38012322|NCT00379769|69695062|FG005|Observational Follow-up|Physician Decision|8|||
38012323|NCT00379769|69695057|FG000|Observational Follow-up|Site Closed Early|0|||
38012324|NCT00379769|69695058|FG001|Observational Follow-up|Site Closed Early|0|||
38012325|NCT00379769|69695059|FG002|Observational Follow-up|Site Closed Early|0|||
38012326|NCT00379769|69695060|FG003|Observational Follow-up|Site Closed Early|0|||
38012327|NCT00379769|69695061|FG004|Observational Follow-up|Site Closed Early|6|||
38012328|NCT00379769|69695062|FG005|Observational Follow-up|Site Closed Early|7|||
38012329|NCT00379769|69695057|FG000|Observational Follow-up|Participant Moved|0|||
38012330|NCT00379769|69695058|FG001|Observational Follow-up|Participant Moved|0|||
38012331|NCT00379769|69695059|FG002|Observational Follow-up|Participant Moved|0|||
38012332|NCT00379769|69695060|FG003|Observational Follow-up|Participant Moved|0|||
38012333|NCT00379769|69695061|FG004|Observational Follow-up|Participant Moved|0|||
38012334|NCT00379769|69695062|FG005|Observational Follow-up|Participant Moved|1|||
38012335|NCT00379769|69695057|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
38012336|NCT00379769|69695058|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
38012337|NCT00379769|69695059|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
38012338|NCT00379769|69695060|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
38012339|NCT00379769|69695061|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
38012340|NCT00379769|69695062|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
38012341|NCT00006164|69695091|FG000|Overall Study|Withdrew or lost to follow-up|70|||
38012342|NCT00006164|69695092|FG001|Overall Study|Withdrew or lost to follow-up|81|||
38012343|NCT00378599|69695098|FG000|Overall Study|Adverse Event|38|||
38012344|NCT00378599|69695098|FG000|Overall Study|Protocol Violation|2|||
38012345|NCT00378599|69695098|FG000|Overall Study|Treatment failure|7|||
38012346|NCT00378599|69695098|FG000|Overall Study|Withdrawal by Subject|5|||
38012347|NCT00378209|69695102|FG000|Overall Study|Progressive disease|11|||
38012348|NCT00378209|69695102|FG000|Overall Study|Adverse Event|3|||
38012349|NCT00378209|69695102|FG000|Overall Study|Initiation of non-protocol therapy|3|||
38012350|NCT00378209|69695102|FG000|Overall Study|Physician Decision|3|||
38012351|NCT00378209|69695102|FG000|Overall Study|Death|1|||
38012352|NCT00378209|69695102|FG000|Overall Study|Treatment delay|1|||
38012353|NCT03410992|69695109|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
38012354|NCT03410992|69695110|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
38012355|NCT03410992|69695111|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
38012356|NCT03410992|69695112|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
38012357|NCT03410992|69695113|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
38012358|NCT03410992|69695114|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
38012359|NCT03410992|69695115|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
38012360|NCT03410992|69695116|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
38012361|NCT03410992|69695117|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
38012362|NCT03410992|69695118|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
38012363|NCT03410992|69695119|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
38012364|NCT03410992|69695109|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
38012365|NCT03410992|69695110|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
38012366|NCT03410992|69695111|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
38012367|NCT03410992|69695112|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
38012368|NCT03410992|69695113|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
38012369|NCT03410992|69695114|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
38012370|NCT03410992|69695115|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
38012371|NCT03410992|69695116|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
38012372|NCT03410992|69695117|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
38012373|NCT03410992|69695118|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
38012374|NCT03410992|69695119|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
38012375|NCT03410992|69695109|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
38012376|NCT03410992|69695110|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
38012377|NCT03410992|69695111|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
38012378|NCT03410992|69695112|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
38012379|NCT03410992|69695113|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
38012380|NCT03410992|69695114|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
38012381|NCT03410992|69695115|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
38012382|NCT03410992|69695116|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
38012383|NCT03410992|69695117|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
38012384|NCT03410992|69695118|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
38012385|NCT03410992|69695119|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
38012386|NCT03410992|69695109|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
38012387|NCT03410992|69695110|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
38012388|NCT03410992|69695111|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
38012389|NCT03410992|69695112|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
38012390|NCT03410992|69695113|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
38012391|NCT03410992|69695114|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
38012392|NCT03410992|69695115|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
38012393|NCT03410992|69695116|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
38012394|NCT03410992|69695117|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
38012395|NCT03410992|69695118|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
38012396|NCT03410992|69695119|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
38012397|NCT03410992|69695109|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
38012398|NCT03410992|69695110|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
38012399|NCT03410992|69695111|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
38012400|NCT03410992|69695112|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
38012401|NCT03410992|69695113|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
38012402|NCT03410992|69695114|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
38012403|NCT03410992|69695115|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
38012404|NCT03410992|69695116|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
38012405|NCT03410992|69695117|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
38012406|NCT03410992|69695118|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
38012407|NCT03410992|69695119|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
38012408|NCT03410992|69695109|FG000|Week 16 Assessment|Incorrect escapers|0|||
38012409|NCT03410992|69695110|FG001|Week 16 Assessment|Incorrect escapers|6|||
38012410|NCT03410992|69695111|FG002|Week 16 Assessment|Incorrect escapers|0|||
38012411|NCT03410992|69695112|FG003|Week 16 Assessment|Incorrect escapers|0|||
38012412|NCT03410992|69695113|FG004|Week 16 Assessment|Incorrect escapers|0|||
38012413|NCT03410992|69695114|FG005|Week 16 Assessment|Incorrect escapers|0|||
38012414|NCT03410992|69695115|FG006|Week 16 Assessment|Incorrect escapers|0|||
38012415|NCT03410992|69695116|FG007|Week 16 Assessment|Incorrect escapers|0|||
38012416|NCT03410992|69695117|FG008|Week 16 Assessment|Incorrect escapers|0|||
38012417|NCT03410992|69695118|FG009|Week 16 Assessment|Incorrect escapers|0|||
38012418|NCT03410992|69695119|FG010|Week 16 Assessment|Incorrect escapers|0|||
38012419|NCT03410992|69695109|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
38012420|NCT03410992|69695110|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
38012421|NCT03410992|69695111|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
38012422|NCT03410992|69695112|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
38012423|NCT03410992|69695113|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
38012424|NCT03410992|69695114|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
38012425|NCT03410992|69695115|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
38012426|NCT03410992|69695116|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
38012427|NCT03410992|69695117|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
38012428|NCT03410992|69695118|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
38012429|NCT03410992|69695119|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
38012430|NCT03410992|69695109|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
38012431|NCT03410992|69695110|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
38012432|NCT03410992|69695111|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
38012433|NCT03410992|69695112|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
38012434|NCT03410992|69695113|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
38012435|NCT03410992|69695114|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
38012436|NCT03410992|69695115|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
38012437|NCT03410992|69695116|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
38012438|NCT03410992|69695117|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
38012439|NCT03410992|69695118|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
38012440|NCT03410992|69695119|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
38012441|NCT03410992|69695109|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
38012442|NCT03410992|69695110|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
38012443|NCT03410992|69695111|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
38012444|NCT03410992|69695112|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
38012445|NCT03410992|69695113|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
38012446|NCT03410992|69695114|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
38012447|NCT03410992|69695115|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
38012448|NCT03410992|69695116|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
38012449|NCT03410992|69695117|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
38012450|NCT03410992|69695118|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
38012451|NCT03410992|69695119|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
38012452|NCT03410992|69695109|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
38012453|NCT03410992|69695110|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
38012454|NCT03410992|69695111|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
38012455|NCT03410992|69695112|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
38012456|NCT03410992|69695113|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
38012457|NCT03410992|69695114|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
38012458|NCT03410992|69695115|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
38012459|NCT03410992|69695116|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
38012460|NCT03410992|69695117|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
37909676|NCT03330106|69595456|FG002|Part A|Progressive Disease|0|||
38012461|NCT03410992|69695118|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
38012462|NCT03410992|69695119|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
38012463|NCT03410992|69695109|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
38012464|NCT03410992|69695110|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
38012465|NCT03410992|69695111|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
38012466|NCT03410992|69695112|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
38012467|NCT03410992|69695113|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
38012468|NCT03410992|69695114|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
38012469|NCT03410992|69695115|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
38012470|NCT03410992|69695116|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
38012471|NCT03410992|69695117|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
38012472|NCT03410992|69695118|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
38012473|NCT03410992|69695119|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
38012474|NCT03410992|69695109|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
38012475|NCT03410992|69695110|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
38012476|NCT03410992|69695111|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
38012477|NCT03410992|69695112|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
38012478|NCT03410992|69695113|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
38012479|NCT03410992|69695114|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
38012480|NCT03410992|69695115|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
38012481|NCT03410992|69695116|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
38012482|NCT03410992|69695117|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
38012483|NCT03410992|69695118|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
38012484|NCT03410992|69695119|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
38012485|NCT00377819|69695151|FG000|Overall Study|Adverse Event|2|||
38012486|NCT00377819|69695152|FG001|Overall Study|Adverse Event|3|||
38012487|NCT00377819|69695151|FG000|Overall Study|Withdrawal by Subject|10|||
38012488|NCT00377819|69695152|FG001|Overall Study|Withdrawal by Subject|4|||
38012489|NCT00377819|69695151|FG000|Overall Study|Death|0|||
38012490|NCT00377819|69695152|FG001|Overall Study|Death|1|||
38012491|NCT00377819|69695151|FG000|Overall Study|Lost to Follow-up|0|||
38012492|NCT00377819|69695152|FG001|Overall Study|Lost to Follow-up|1|||
38012493|NCT00377819|69695151|FG000|Overall Study|Protocol Violation|1|||
38012494|NCT00377819|69695152|FG001|Overall Study|Protocol Violation|1|||
38012495|NCT03419962|69695158|FG000|Overall Study|Change to other medication|1|||
38012496|NCT03419962|69695158|FG000|Overall Study|Refusal of continuing with trial drug|1|||
38012497|NCT03419962|69695158|FG000|Overall Study|Lost to Follow-up|3|||
38012498|NCT03419962|69695158|FG000|Overall Study|Difficulty in inhaling the doses|1|||
38012499|NCT03419962|69695158|FG000|Overall Study|Missing completion data|31|||
38012500|NCT00377429|69695162|FG000|Overall Study|Withdrawal by Subject|5|||
38012501|NCT00377429|69695162|FG000|Overall Study|Adverse Event|8|||
38012502|NCT00377429|69695162|FG000|Overall Study|Physician Decision|1|||
37832003|NCT01191697|69515554|FG000|Overall Study|Pursue chemoradiation|2|||
37909677|NCT03330106|69595457|FG003|Part A|Progressive Disease|0|||
37909678|NCT03330106|69595454|FG000|Part B|Lost to Follow-up|0|||
37909679|NCT03330106|69595455|FG001|Part B|Lost to Follow-up|0|||
37909680|NCT03330106|69595456|FG002|Part B|Lost to Follow-up|0|||
37909681|NCT03330106|69595457|FG003|Part B|Lost to Follow-up|1|||
37909682|NCT03330106|69595454|FG000|Part B|Withdrawal by Subject|0|||
37909683|NCT03330106|69595455|FG001|Part B|Withdrawal by Subject|0|||
37909684|NCT03330106|69595456|FG002|Part B|Withdrawal by Subject|4|||
37909685|NCT03330106|69595457|FG003|Part B|Withdrawal by Subject|0|||
37909686|NCT03330106|69595454|FG000|Part B|Death|0|||
38012503|NCT00377429|69695162|FG000|Overall Study|Patient non-compliance|1|||
38012504|NCT00376961|69695166|FG000|Initial Registration|Adverse Event|1|||
38012505|NCT00376961|69695167|FG001|Initial Registration|Adverse Event|0|||
38012506|NCT00376961|69695166|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
38012507|NCT00376961|69695167|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
38012508|NCT00376961|69695166|FG000|Initial Registration|Progression/relapse|1|||
38012509|NCT00376961|69695167|FG001|Initial Registration|Progression/relapse|0|||
38012510|NCT00376961|69695166|FG000|Initial Registration|Ineligible|3|||
38012511|NCT00376961|69695167|FG001|Initial Registration|Ineligible|0|||
37832004|NCT01191697|69515554|FG000|Overall Study|Break from chemotherapy|2|||
37832005|NCT01191697|69515554|FG000|Overall Study|Withdrawal by Subject|1|||
37832006|NCT01191697|69515554|FG000|Overall Study|Surveillance|1|||
37832007|NCT01191697|69515554|FG000|Overall Study|Adverse Event|2|||
37832008|NCT01191697|69515554|FG000|Overall Study|Subject never received treatment and wasn't analyzed.|1|||
37832009|NCT01191697|69515554|FG000|Overall Study|Not completed but analyzed|25|||
37832010|NCT01044745|69515558|FG000|Overall Study|Ineiligible|2|||
37832011|NCT00557193|69515563|FG000|Induction|Adverse Event|2|||
37832012|NCT00557193|69515564|FG001|Induction|Adverse Event|0|||
37832013|NCT00557193|69515565|FG002|Induction|Adverse Event|0|||
37832014|NCT00557193|69515566|FG003|Induction|Adverse Event|0|||
37832015|NCT00557193|69515567|FG004|Induction|Adverse Event|0|||
37832016|NCT00557193|69515568|FG005|Induction|Adverse Event|0|||
38012512|NCT00376961|69695166|FG000|Maintenance|Adverse Event|0|||
37832017|NCT00557193|69515563|FG000|Induction|Death|6|||
37832018|NCT00557193|69515564|FG001|Induction|Death|0|||
37909687|NCT03330106|69595455|FG001|Part B|Death|0|||
37909688|NCT03330106|69595456|FG002|Part B|Death|2|||
37909689|NCT03330106|69595457|FG003|Part B|Death|0|||
37909690|NCT03330106|69595454|FG000|Part B|Clinical Progression|0|||
37909691|NCT03330106|69595455|FG001|Part B|Clinical Progression|0|||
37909692|NCT03330106|69595456|FG002|Part B|Clinical Progression|1|||
37909693|NCT03330106|69595457|FG003|Part B|Clinical Progression|1|||
37909694|NCT03330106|69595454|FG000|Part B|Symptomatic Deterioration|0|||
37909695|NCT03330106|69595455|FG001|Part B|Symptomatic Deterioration|0|||
37909696|NCT03330106|69595456|FG002|Part B|Symptomatic Deterioration|0|||
38012513|NCT00376961|69695167|FG001|Maintenance|Adverse Event|1|||
38012514|NCT00376961|69695166|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
38012515|NCT00376961|69695167|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
38012516|NCT00376961|69695166|FG000|Maintenance|Progression/relapse|0|||
38012517|NCT00376961|69695167|FG001|Maintenance|Progression/relapse|18|||
38012518|NCT00376961|69695166|FG000|Maintenance|Ineligible|0|||
37698401|NCT01800916|69175183|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
37698402|NCT01800916|69175184|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
37698403|NCT01800916|69175185|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
37698404|NCT01800916|69175186|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
37698405|NCT01800916|69175187|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
37698406|NCT01800916|69175188|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
37698407|NCT01800916|69175189|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
37698408|NCT01800058|69175199|FG000|Overall Study|Lost to Follow-up|1|||
37832019|NCT00557193|69515565|FG002|Induction|Death|0|||
37832020|NCT00557193|69515566|FG003|Induction|Death|0|||
37909697|NCT03330106|69595457|FG003|Part B|Symptomatic Deterioration|1|||
37909698|NCT03330106|69595454|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
38012519|NCT00376961|69695167|FG001|Maintenance|Ineligible|3|||
38012520|NCT03418324|69695177|FG000|Overall Study|Death|0|||
38012521|NCT03418324|69695178|FG001|Overall Study|Death|1|||
38012522|NCT03418324|69695177|FG000|Overall Study|Physician Decision|1|||
38012523|NCT03418324|69695178|FG001|Overall Study|Physician Decision|1|||
38012524|NCT00376259|69695186|FG000|Overall Study|Sponsor request - study termination|21|||
38012525|NCT00376259|69695187|FG001|Overall Study|Sponsor request - study termination|21|||
38012526|NCT00376259|69695186|FG000|Overall Study|Patient request|1|||
38012527|NCT00376259|69695187|FG001|Overall Study|Patient request|0|||
38012528|NCT03410056|69695197|FG000|Overall Study|Decision by Sponsor|0|||
38012529|NCT03410056|69695198|FG001|Overall Study|Decision by Sponsor|0|||
38012530|NCT03410056|69695199|FG002|Overall Study|Decision by Sponsor|3|||
38012531|NCT03410056|69695200|FG003|Overall Study|Decision by Sponsor|0|||
38012532|NCT03410056|69695201|FG004|Overall Study|Decision by Sponsor|0|||
38012533|NCT03410056|69695202|FG005|Overall Study|Decision by Sponsor|0|||
38012534|NCT03410056|69695203|FG006|Overall Study|Decision by Sponsor|0|||
38012535|NCT03410056|69695197|FG000|Overall Study|Withdrawal by Subject|0|||
38012536|NCT03410056|69695198|FG001|Overall Study|Withdrawal by Subject|2|||
38012537|NCT03410056|69695199|FG002|Overall Study|Withdrawal by Subject|5|||
38012538|NCT03410056|69695200|FG003|Overall Study|Withdrawal by Subject|5|||
37909699|NCT03330106|69595455|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
38012539|NCT03410056|69695201|FG004|Overall Study|Withdrawal by Subject|0|||
38012540|NCT03410056|69695202|FG005|Overall Study|Withdrawal by Subject|0|||
38012541|NCT03410056|69695203|FG006|Overall Study|Withdrawal by Subject|0|||
38012542|NCT03409666|69695221|FG000|Overall Study|Physician Decision|0|||
38012543|NCT03409666|69695222|FG001|Overall Study|Physician Decision|1|||
38012544|NCT03409666|69695221|FG000|Overall Study|Protocol Violation|0|||
38012545|NCT03409666|69695222|FG001|Overall Study|Protocol Violation|3|||
38012546|NCT03440944|69695230|FG000|Overall Study|Physician Decision|1|||
38012547|NCT03440944|69695231|FG001|Overall Study|Physician Decision|0|||
38012548|NCT03440944|69695230|FG000|Overall Study|No Acceptable Vasculature|0|||
38012549|NCT03440944|69695231|FG001|Overall Study|No Acceptable Vasculature|1|||
38012550|NCT00365105|69695240|FG000|Overall Study|Protocol Violation|5|||
37832021|NCT00557193|69515567|FG004|Induction|Death|0|||
37832022|NCT00557193|69515568|FG005|Induction|Death|0|||
37832023|NCT00557193|69515563|FG000|Induction|Physician Decision|3|||
37832024|NCT00557193|69515564|FG001|Induction|Physician Decision|0|||
37832025|NCT00557193|69515565|FG002|Induction|Physician Decision|0|||
37832026|NCT00557193|69515566|FG003|Induction|Physician Decision|0|||
37832027|NCT00557193|69515567|FG004|Induction|Physician Decision|0|||
37832028|NCT00557193|69515568|FG005|Induction|Physician Decision|0|||
37832029|NCT00557193|69515563|FG000|Induction|Withdrawal by Subject|1|||
38012551|NCT00365105|69695241|FG001|Overall Study|Protocol Violation|8|||
38012552|NCT00399893|69695249|FG000|Overall Study|Withdrawal by Subject|1|||
38012553|NCT00399893|69695250|FG001|Overall Study|Withdrawal by Subject|0|||
38012554|NCT00048542|69695260|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
38012555|NCT00048542|69695261|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
38012556|NCT00048542|69695262|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
37832030|NCT00557193|69515564|FG001|Induction|Withdrawal by Subject|0|||
37909700|NCT03330106|69595456|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
37698409|NCT01815580|69175206|FG000|Overall Study|Lost to Follow-up|4|||
37698410|NCT01815580|69175207|FG001|Overall Study|Lost to Follow-up|7|||
37832031|NCT00557193|69515565|FG002|Induction|Withdrawal by Subject|0|||
38012557|NCT00048542|69695263|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
38012558|NCT00048542|69695264|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
38012559|NCT00048542|69695265|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
38012560|NCT00048542|69695266|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
38012561|NCT00048542|69695267|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
38012562|NCT00048542|69695260|FG000|Double-Blind Phase|Protocol Violation|0|||
38012563|NCT00048542|69695261|FG001|Double-Blind Phase|Protocol Violation|0|||
38012564|NCT00048542|69695262|FG002|Double-Blind Phase|Protocol Violation|1|||
38012565|NCT00048542|69695263|FG003|Double-Blind Phase|Protocol Violation|0|||
38012566|NCT00048542|69695264|FG004|Double-Blind Phase|Protocol Violation|0|||
38012567|NCT00048542|69695265|FG005|Double-Blind Phase|Protocol Violation|0|||
38012568|NCT00048542|69695266|FG006|Double-Blind Phase|Protocol Violation|0|||
38012569|NCT00048542|69695267|FG007|Double-Blind Phase|Protocol Violation|0|||
38012570|NCT00048542|69695260|FG000|Double-Blind Phase|Sponsor request or decision|2|||
38012571|NCT00048542|69695261|FG001|Double-Blind Phase|Sponsor request or decision|0|||
38012572|NCT00048542|69695262|FG002|Double-Blind Phase|Sponsor request or decision|0|||
38012573|NCT00048542|69695263|FG003|Double-Blind Phase|Sponsor request or decision|0|||
38012574|NCT00048542|69695264|FG004|Double-Blind Phase|Sponsor request or decision|0|||
38012575|NCT00048542|69695265|FG005|Double-Blind Phase|Sponsor request or decision|0|||
38012576|NCT00048542|69695266|FG006|Double-Blind Phase|Sponsor request or decision|0|||
38012577|NCT00048542|69695267|FG007|Double-Blind Phase|Sponsor request or decision|0|||
38012578|NCT00048542|69695260|FG000|Double-Blind Phase|Randomized in error|1|||
38012579|NCT00048542|69695261|FG001|Double-Blind Phase|Randomized in error|0|||
38012580|NCT00048542|69695262|FG002|Double-Blind Phase|Randomized in error|0|||
38012581|NCT00048542|69695263|FG003|Double-Blind Phase|Randomized in error|0|||
38012582|NCT00048542|69695264|FG004|Double-Blind Phase|Randomized in error|0|||
38012583|NCT00048542|69695265|FG005|Double-Blind Phase|Randomized in error|0|||
38012584|NCT00048542|69695266|FG006|Double-Blind Phase|Randomized in error|0|||
38012585|NCT00048542|69695267|FG007|Double-Blind Phase|Randomized in error|0|||
38012586|NCT00048542|69695260|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
38012587|NCT00048542|69695261|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
38012588|NCT00048542|69695262|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
38012589|NCT00048542|69695263|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
38012590|NCT00048542|69695264|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
38012591|NCT00048542|69695265|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
38012592|NCT00048542|69695266|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
38012593|NCT00048542|69695267|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
38012594|NCT00048542|69695260|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
38012595|NCT00048542|69695261|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
38012596|NCT00048542|69695262|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
38012597|NCT00048542|69695263|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
38012598|NCT00048542|69695264|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
38012599|NCT00048542|69695265|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
38012600|NCT00048542|69695266|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
38012601|NCT00048542|69695267|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
38012602|NCT00048542|69695260|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
38012603|NCT00048542|69695261|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
38012604|NCT00048542|69695262|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
38012605|NCT00048542|69695263|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
38012606|NCT00048542|69695264|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
38012607|NCT00048542|69695265|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
38012608|NCT00048542|69695266|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
38012609|NCT00048542|69695267|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
38012610|NCT00048542|69695260|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
38012611|NCT00048542|69695261|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
38012612|NCT00048542|69695262|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
38012613|NCT00048542|69695263|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
38012614|NCT00048542|69695264|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
37832032|NCT00557193|69515566|FG003|Induction|Withdrawal by Subject|0|||
38012615|NCT00048542|69695265|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
38012616|NCT00048542|69695266|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
38012617|NCT00048542|69695267|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
38012618|NCT00048542|69695260|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
38012619|NCT00048542|69695261|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
38012620|NCT00048542|69695262|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
38012621|NCT00048542|69695263|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
38012622|NCT00048542|69695264|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
37832033|NCT00557193|69515567|FG004|Induction|Withdrawal by Subject|0|||
38012623|NCT00048542|69695265|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
38012624|NCT00048542|69695266|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
38012625|NCT00048542|69695267|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
38012626|NCT00048542|69695260|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
38012627|NCT00048542|69695261|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
38012628|NCT00048542|69695262|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
38012629|NCT00048542|69695263|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
38012630|NCT00048542|69695264|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
38012631|NCT00048542|69695265|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
38012632|NCT00048542|69695266|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
38012633|NCT00048542|69695267|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
38012634|NCT00048542|69695260|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
38012635|NCT00048542|69695261|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
38012636|NCT00048542|69695262|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
38012637|NCT00048542|69695263|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
38012638|NCT00048542|69695264|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
38012639|NCT00048542|69695265|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
38012640|NCT00048542|69695266|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
38012641|NCT00048542|69695267|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
38012642|NCT00048542|69695260|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
38012643|NCT00048542|69695261|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
38012644|NCT00048542|69695262|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
38012645|NCT00048542|69695263|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
38012646|NCT00048542|69695264|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
38012647|NCT00048542|69695265|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
38012648|NCT00048542|69695266|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
38012649|NCT00048542|69695267|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
38012650|NCT00048542|69695260|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
38012651|NCT00048542|69695261|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
38012652|NCT00048542|69695262|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
38012653|NCT00048542|69695263|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
38012654|NCT00048542|69695264|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
38012655|NCT00048542|69695265|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
38012656|NCT00048542|69695266|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
38012657|NCT00048542|69695267|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
38012658|NCT00048542|69695260|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
38012659|NCT00048542|69695261|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
38012660|NCT00048542|69695262|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
37909701|NCT03330106|69595457|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
37909702|NCT03330106|69595454|FG000|Part B|Progressive Disease|0|||
37909703|NCT03330106|69595455|FG001|Part B|Progressive Disease|0|||
37909704|NCT03330106|69595456|FG002|Part B|Progressive Disease|11|||
37909705|NCT03330106|69595457|FG003|Part B|Progressive Disease|4|||
37909706|NCT03164564|69595469|FG000|Overall Study|Death|3|||
37909707|NCT03164564|69595470|FG001|Overall Study|Death|0|||
37909708|NCT03164564|69595469|FG000|Overall Study|Withdrawal by Subject|20|||
37909709|NCT03164564|69595470|FG001|Overall Study|Withdrawal by Subject|15|||
37909710|NCT03164564|69595469|FG000|Overall Study|Lost to Follow-up|2|||
37909711|NCT03164564|69595470|FG001|Overall Study|Lost to Follow-up|0|||
37909712|NCT03164564|69595469|FG000|Overall Study|Physician Decision|0|||
37909713|NCT03164564|69595470|FG001|Overall Study|Physician Decision|1|||
37909714|NCT03164564|69595469|FG000|Overall Study|Adverse Event|0|||
37909715|NCT03164564|69595470|FG001|Overall Study|Adverse Event|1|||
37909716|NCT03164564|69595469|FG000|Overall Study|Ongoing|1586|||
37909717|NCT03164564|69595470|FG001|Overall Study|Ongoing|1586|||
37909718|NCT02821754|69595490|FG000|Overall Study|Procedure not required prior to amendment change|13|||
37909719|NCT02821754|69595491|FG001|Overall Study|Procedure not required prior to amendment change|11|||
37909720|NCT02821754|69595492|FG002|Overall Study|Procedure not required prior to amendment change|0|||
37909721|NCT02821754|69595490|FG000|Overall Study|Participant's Clinical status|2|||
37909722|NCT02821754|69595491|FG001|Overall Study|Participant's Clinical status|0|||
37909723|NCT02821754|69595492|FG002|Overall Study|Participant's Clinical status|0|||
37909724|NCT02821754|69595490|FG000|Overall Study|Participant removed for noncompliance|1|||
37909725|NCT02821754|69595491|FG001|Overall Study|Participant removed for noncompliance|0|||
37909726|NCT02821754|69595492|FG002|Overall Study|Participant removed for noncompliance|0|||
37698411|NCT01815580|69175206|FG000|Overall Study|Withdrawal by Subject|3|||
37909727|NCT02821754|69595490|FG000|Overall Study|Drug not available.|0|||
37909728|NCT02821754|69595491|FG001|Overall Study|Drug not available.|0|||
37909729|NCT02821754|69595492|FG002|Overall Study|Drug not available.|1|||
37909730|NCT02821754|69595490|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
37909731|NCT02821754|69595491|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
37909732|NCT02821754|69595492|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
37909733|NCT02708108|69595500|FG000|Overall Study|Death|1|||
37909734|NCT02708108|69595501|FG001|Overall Study|Death|2|||
37909735|NCT02708108|69595500|FG000|Overall Study|Regimen change|1|||
37909736|NCT02708108|69595501|FG001|Overall Study|Regimen change|0|||
37909737|NCT02708108|69595500|FG000|Overall Study|No MRD and no imaging available|0|||
37909738|NCT02708108|69595501|FG001|Overall Study|No MRD and no imaging available|1|||
37909739|NCT02617589|69595510|FG000|Randomization|Request to Discontinue Study Treatment|1|||
37909740|NCT02617589|69595511|FG001|Randomization|Request to Discontinue Study Treatment|3|||
37909741|NCT02617589|69595510|FG000|Randomization|Participant Withdrew Consent|1|||
37909742|NCT02617589|69595511|FG001|Randomization|Participant Withdrew Consent|2|||
37909743|NCT02617589|69595510|FG000|Treatment|Other Reasons|3|||
37909744|NCT02617589|69595511|FG001|Treatment|Other Reasons|3|||
37909745|NCT02617589|69595510|FG000|Treatment|Poor/Non Compliance|1|||
37909746|NCT02617589|69595511|FG001|Treatment|Poor/Non Compliance|1|||
37909747|NCT02617589|69595510|FG000|Treatment|Maximum Clinical Benefit|0|||
38012661|NCT00048542|69695263|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
38012662|NCT00048542|69695264|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
38012663|NCT00048542|69695265|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
38012664|NCT00048542|69695266|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
38012665|NCT00048542|69695267|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
38012666|NCT00048542|69695260|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
38012667|NCT00048542|69695261|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
38012668|NCT00048542|69695262|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
38012669|NCT00048542|69695263|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
38012670|NCT00048542|69695264|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
38012671|NCT00048542|69695265|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
38012672|NCT00048542|69695266|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
38012673|NCT00048542|69695267|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
38012674|NCT03814590|69695310|FG000|Overall Study|Adverse Event|0|||
38012675|NCT03814590|69695311|FG001|Overall Study|Adverse Event|0|||
38012676|NCT03814590|69695312|FG002|Overall Study|Adverse Event|0|||
38012677|NCT03814590|69695313|FG003|Overall Study|Adverse Event|0|||
38012678|NCT03814590|69695314|FG004|Overall Study|Adverse Event|0|||
38012679|NCT03814590|69695315|FG005|Overall Study|Adverse Event|1|||
38012680|NCT03814590|69695316|FG006|Overall Study|Adverse Event|1|||
38012681|NCT03814590|69695317|FG007|Overall Study|Adverse Event|1|||
38012682|NCT03814590|69695318|FG008|Overall Study|Adverse Event|0|||
38012683|NCT03814590|69695319|FG009|Overall Study|Adverse Event|0|||
38012684|NCT03814590|69695320|FG010|Overall Study|Adverse Event|1|||
38012685|NCT03814590|69695321|FG011|Overall Study|Adverse Event|0|||
38012686|NCT03814590|69695322|FG012|Overall Study|Adverse Event|3|||
38012687|NCT03814590|69695323|FG013|Overall Study|Adverse Event|0|||
38012688|NCT03814590|69695310|FG000|Overall Study|Lost to Follow-up|0|||
38012689|NCT03814590|69695311|FG001|Overall Study|Lost to Follow-up|2|||
38012690|NCT03814590|69695312|FG002|Overall Study|Lost to Follow-up|1|||
38012691|NCT03814590|69695313|FG003|Overall Study|Lost to Follow-up|0|||
38012692|NCT03814590|69695314|FG004|Overall Study|Lost to Follow-up|1|||
38012693|NCT03814590|69695315|FG005|Overall Study|Lost to Follow-up|1|||
37909748|NCT02617589|69595511|FG001|Treatment|Maximum Clinical Benefit|2|||
37909749|NCT02617589|69595510|FG000|Treatment|Participant Withdrew Consent|2|||
38012694|NCT03814590|69695316|FG006|Overall Study|Lost to Follow-up|1|||
37698412|NCT01815580|69175207|FG001|Overall Study|Withdrawal by Subject|4|||
37832034|NCT00557193|69515568|FG005|Induction|Withdrawal by Subject|0|||
37832035|NCT00557193|69515563|FG000|Induction|Refusal of Further Protocol Therapy|2|||
37832036|NCT00557193|69515564|FG001|Induction|Refusal of Further Protocol Therapy|0|||
37832037|NCT00557193|69515565|FG002|Induction|Refusal of Further Protocol Therapy|0|||
37832038|NCT00557193|69515566|FG003|Induction|Refusal of Further Protocol Therapy|0|||
37832039|NCT00557193|69515567|FG004|Induction|Refusal of Further Protocol Therapy|0|||
37832040|NCT00557193|69515568|FG005|Induction|Refusal of Further Protocol Therapy|0|||
37832041|NCT00557193|69515563|FG000|Induction|Ineligible|8|||
37832042|NCT00557193|69515564|FG001|Induction|Ineligible|0|||
37832043|NCT00557193|69515565|FG002|Induction|Ineligible|0|||
37909750|NCT02617589|69595511|FG001|Treatment|Participant Withdrew Consent|6|||
38012695|NCT03814590|69695317|FG007|Overall Study|Lost to Follow-up|1|||
38012696|NCT03814590|69695318|FG008|Overall Study|Lost to Follow-up|0|||
38012697|NCT03814590|69695319|FG009|Overall Study|Lost to Follow-up|0|||
38012698|NCT03814590|69695320|FG010|Overall Study|Lost to Follow-up|1|||
37832044|NCT00557193|69515566|FG003|Induction|Ineligible|0|||
37832045|NCT00557193|69515567|FG004|Induction|Ineligible|0|||
37832046|NCT00557193|69515568|FG005|Induction|Ineligible|0|||
38012699|NCT03814590|69695321|FG011|Overall Study|Lost to Follow-up|0|||
38012700|NCT03814590|69695322|FG012|Overall Study|Lost to Follow-up|0|||
38012701|NCT03814590|69695323|FG013|Overall Study|Lost to Follow-up|1|||
38012702|NCT03814590|69695310|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
38012703|NCT03814590|69695311|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
38012704|NCT03814590|69695312|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
38012705|NCT03814590|69695313|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
38012706|NCT03814590|69695314|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
38012707|NCT03814590|69695315|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
38012708|NCT03814590|69695316|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
38012709|NCT03814590|69695317|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
38012710|NCT03814590|69695318|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
38012711|NCT03814590|69695319|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
38012712|NCT03814590|69695320|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
38012713|NCT03814590|69695321|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
38012714|NCT03814590|69695322|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
38012715|NCT03814590|69695323|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
38012716|NCT03814590|69695310|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
38012717|NCT03814590|69695311|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
38012718|NCT03814590|69695312|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
38012719|NCT03814590|69695313|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
38012720|NCT03814590|69695314|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
38012721|NCT03814590|69695315|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
38012722|NCT03814590|69695316|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
38012723|NCT03814590|69695317|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
38012724|NCT03814590|69695318|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
38012725|NCT03814590|69695319|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
38012726|NCT03814590|69695320|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
38012727|NCT03814590|69695321|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
38012728|NCT03814590|69695322|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
38012729|NCT03814590|69695323|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
38012730|NCT03814590|69695310|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
38012731|NCT03814590|69695311|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
38012732|NCT03814590|69695312|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
38012733|NCT03814590|69695313|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
37909751|NCT02617589|69595510|FG000|Treatment|Participant Request to Discontinue|12|||
37909752|NCT02617589|69595511|FG001|Treatment|Participant Request to Discontinue|21|||
37832047|NCT00557193|69515563|FG000|Induction|Inevaluable for post Induction|2|||
37909753|NCT02617589|69595510|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
37909754|NCT02617589|69595511|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
37909755|NCT02617589|69595510|FG000|Treatment|Death|1|||
37909756|NCT02617589|69595511|FG001|Treatment|Death|1|||
37909757|NCT02617589|69595510|FG000|Treatment|Study Drug Toxicity|27|||
37909758|NCT02617589|69595511|FG001|Treatment|Study Drug Toxicity|20|||
37909759|NCT02617589|69595510|FG000|Treatment|Disease Progression|216|||
37909760|NCT02617589|69595511|FG001|Treatment|Disease Progression|136|||
37909761|NCT02471807|69595517|FG000|Overall Study|Death|14|||
37909762|NCT02471807|69595517|FG000|Overall Study|Withdrawal by Subject|2|||
37909763|NCT02471807|69595517|FG000|Overall Study|Explant|5|||
37832048|NCT00557193|69515564|FG001|Induction|Inevaluable for post Induction|0|||
37832049|NCT00557193|69515565|FG002|Induction|Inevaluable for post Induction|0|||
37832050|NCT00557193|69515566|FG003|Induction|Inevaluable for post Induction|0|||
37832051|NCT00557193|69515567|FG004|Induction|Inevaluable for post Induction|0|||
37832052|NCT00557193|69515568|FG005|Induction|Inevaluable for post Induction|0|||
37832053|NCT00557193|69515563|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
37832054|NCT00557193|69515564|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
37832055|NCT00557193|69515565|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
37832056|NCT00557193|69515566|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
37832057|NCT00557193|69515567|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
37832058|NCT00557193|69515568|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
37832059|NCT00557193|69515563|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
37832060|NCT00557193|69515564|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
37832061|NCT00557193|69515565|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
37909764|NCT02471807|69595517|FG000|Overall Study|Lost to Follow-up|1|||
38012734|NCT03814590|69695314|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
38012735|NCT03814590|69695315|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
38012736|NCT03814590|69695316|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
38012737|NCT03814590|69695317|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
38012738|NCT03814590|69695318|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
38012739|NCT03814590|69695319|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
38012740|NCT03814590|69695320|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
38012741|NCT03814590|69695321|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
38012742|NCT03814590|69695322|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
38012743|NCT03814590|69695323|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
38012744|NCT03814590|69695310|FG000|Overall Study|UNKNOWN REASON|0|||
38012745|NCT03814590|69695311|FG001|Overall Study|UNKNOWN REASON|0|||
38012746|NCT03814590|69695312|FG002|Overall Study|UNKNOWN REASON|0|||
38012747|NCT03814590|69695313|FG003|Overall Study|UNKNOWN REASON|0|||
38012748|NCT03814590|69695314|FG004|Overall Study|UNKNOWN REASON|0|||
38012749|NCT03814590|69695315|FG005|Overall Study|UNKNOWN REASON|0|||
38012750|NCT03814590|69695316|FG006|Overall Study|UNKNOWN REASON|0|||
38012751|NCT03814590|69695317|FG007|Overall Study|UNKNOWN REASON|1|||
38012752|NCT03814590|69695318|FG008|Overall Study|UNKNOWN REASON|0|||
38012753|NCT03814590|69695319|FG009|Overall Study|UNKNOWN REASON|0|||
38012754|NCT03814590|69695320|FG010|Overall Study|UNKNOWN REASON|0|||
38012755|NCT03814590|69695321|FG011|Overall Study|UNKNOWN REASON|0|||
38012756|NCT03814590|69695322|FG012|Overall Study|UNKNOWN REASON|0|||
38012757|NCT03814590|69695323|FG013|Overall Study|UNKNOWN REASON|0|||
38012758|NCT00048074|69695366|FG000|Overall Study|Adverse Event|46|||
38012759|NCT00048074|69695367|FG001|Overall Study|Adverse Event|41|||
38012760|NCT00048074|69695368|FG002|Overall Study|Adverse Event|53|||
38012761|NCT00048074|69695366|FG000|Overall Study|Death|3|||
38012762|NCT00048074|69695367|FG001|Overall Study|Death|3|||
38012763|NCT00048074|69695368|FG002|Overall Study|Death|2|||
38012764|NCT00048074|69695366|FG000|Overall Study|Lost to Follow-up|2|||
38012765|NCT00048074|69695367|FG001|Overall Study|Lost to Follow-up|6|||
38012766|NCT00048074|69695368|FG002|Overall Study|Lost to Follow-up|6|||
38012767|NCT00048074|69695366|FG000|Overall Study|Withdrawal by Subject|28|||
38012768|NCT00048074|69695367|FG001|Overall Study|Withdrawal by Subject|30|||
38012769|NCT00048074|69695368|FG002|Overall Study|Withdrawal by Subject|35|||
38012770|NCT00048074|69695366|FG000|Overall Study|Protocol Violation|1|||
38012771|NCT00048074|69695367|FG001|Overall Study|Protocol Violation|3|||
38012772|NCT00048074|69695368|FG002|Overall Study|Protocol Violation|0|||
38012773|NCT00048074|69695366|FG000|Overall Study|Study participation was terminated|0|||
38012774|NCT00048074|69695367|FG001|Overall Study|Study participation was terminated|1|||
38012775|NCT00048074|69695368|FG002|Overall Study|Study participation was terminated|0|||
38012776|NCT00048074|69695366|FG000|Overall Study|Husband ill|0|||
38012777|NCT00048074|69695367|FG001|Overall Study|Husband ill|1|||
38012778|NCT00048074|69695368|FG002|Overall Study|Husband ill|0|||
38012779|NCT00048074|69695366|FG000|Overall Study|Poor compliance|0|||
38012780|NCT00048074|69695367|FG001|Overall Study|Poor compliance|1|||
38012781|NCT00048074|69695368|FG002|Overall Study|Poor compliance|0|||
38012782|NCT00048074|69695366|FG000|Overall Study|Out of station|0|||
38012783|NCT00048074|69695367|FG001|Overall Study|Out of station|1|||
38012784|NCT00048074|69695368|FG002|Overall Study|Out of station|1|||
37698413|NCT01815580|69175206|FG000|Overall Study|Excluded from analysis|5|||
37698414|NCT01815580|69175207|FG001|Overall Study|Excluded from analysis|4|||
38012785|NCT00048074|69695366|FG000|Overall Study|Social reasons|1|||
38012786|NCT00048074|69695367|FG001|Overall Study|Social reasons|0|||
38012787|NCT00048074|69695368|FG002|Overall Study|Social reasons|0|||
38012788|NCT03831191|69695380|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
38012789|NCT03831191|69695381|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
38012790|NCT03831191|69695382|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
38012791|NCT03831191|69695383|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
38012792|NCT03831191|69695384|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
37698415|NCT01799590|69175221|FG000|Overall Study|Adverse Event|13|||
38012793|NCT03831191|69695385|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
38012794|NCT03831191|69695386|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
38012795|NCT03831191|69695387|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
38012796|NCT03831191|69695388|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
38012797|NCT03831191|69695389|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
38012798|NCT03831191|69695390|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
38012799|NCT03831191|69695391|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
38012800|NCT03831191|69695392|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
38012801|NCT03831191|69695393|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
38012802|NCT03831191|69695394|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
38012803|NCT03831191|69695380|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
38012804|NCT03831191|69695381|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
38012805|NCT03831191|69695382|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
38012806|NCT03831191|69695383|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
38012807|NCT03831191|69695384|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
38012808|NCT03831191|69695385|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
38012809|NCT03831191|69695386|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
38012810|NCT03831191|69695387|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
38012811|NCT03831191|69695388|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
38012812|NCT03831191|69695389|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
38012813|NCT03831191|69695390|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
38012814|NCT03831191|69695391|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
38012815|NCT03831191|69695392|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
38012816|NCT03831191|69695393|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
38012817|NCT03831191|69695394|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
38012818|NCT03831191|69695380|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
38012819|NCT03831191|69695381|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
38012820|NCT03831191|69695382|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
38012821|NCT03831191|69695383|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
38012822|NCT03831191|69695384|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
38012823|NCT03831191|69695385|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
38012824|NCT03831191|69695386|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
38012825|NCT03831191|69695387|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
38012826|NCT03831191|69695388|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
38012827|NCT03831191|69695389|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
38012828|NCT03831191|69695390|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
38012829|NCT03831191|69695391|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
38012830|NCT03831191|69695392|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
38012831|NCT03831191|69695393|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
38012832|NCT03831191|69695394|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
38012833|NCT03831191|69695380|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
38012834|NCT03831191|69695381|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
38012835|NCT03831191|69695382|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
38012836|NCT03831191|69695383|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
38012837|NCT03831191|69695384|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
38012838|NCT03831191|69695385|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
38012839|NCT03831191|69695386|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
38012840|NCT03831191|69695387|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
38012841|NCT03831191|69695388|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
38012842|NCT03831191|69695389|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
38012843|NCT03831191|69695390|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
38012844|NCT03831191|69695391|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
38012845|NCT03831191|69695392|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
38012846|NCT03831191|69695393|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
38012847|NCT03831191|69695394|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
38012848|NCT03831191|69695380|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
38012849|NCT03831191|69695381|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
38012850|NCT03831191|69695382|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
38012851|NCT03831191|69695383|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
38012852|NCT03831191|69695384|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
38012853|NCT03831191|69695385|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
38012854|NCT03831191|69695386|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
38012855|NCT03831191|69695387|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
38012856|NCT03831191|69695388|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
38012857|NCT03831191|69695389|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
38012858|NCT03831191|69695390|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
38012859|NCT03831191|69695391|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
38012860|NCT03831191|69695392|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
38012861|NCT03831191|69695393|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
38012862|NCT03831191|69695394|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
38012863|NCT03831191|69695380|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
38012864|NCT03831191|69695381|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
38012865|NCT03831191|69695382|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
38012866|NCT03831191|69695383|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
38012867|NCT03831191|69695384|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
38012868|NCT03831191|69695385|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
38012869|NCT03831191|69695386|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
38012870|NCT03831191|69695387|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
38012871|NCT03831191|69695388|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
37698416|NCT01799590|69175222|FG001|Overall Study|Adverse Event|7|||
38012872|NCT03831191|69695389|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
38012873|NCT03831191|69695390|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
38012874|NCT03831191|69695391|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
38012875|NCT03831191|69695392|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
38012876|NCT03831191|69695393|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
38012877|NCT03831191|69695394|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
38012878|NCT03831191|69695380|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
38012879|NCT03831191|69695381|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
38012880|NCT03831191|69695382|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
38012881|NCT03831191|69695383|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
38012882|NCT03831191|69695384|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
38012883|NCT03831191|69695385|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
38012884|NCT03831191|69695386|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
38012885|NCT03831191|69695387|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
38012886|NCT03831191|69695388|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
38012887|NCT03831191|69695389|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
38012888|NCT03831191|69695390|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
38012889|NCT03831191|69695391|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
38012890|NCT03831191|69695392|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
38012891|NCT03831191|69695393|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
38012892|NCT03831191|69695394|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
38012893|NCT03831191|69695380|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
38012894|NCT03831191|69695381|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
38012895|NCT03831191|69695382|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
38012896|NCT03831191|69695383|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
38012897|NCT03831191|69695384|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
38012898|NCT03831191|69695385|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
38012899|NCT03831191|69695386|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
38012900|NCT03831191|69695387|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
38012901|NCT03831191|69695388|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
38012902|NCT03831191|69695389|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
38012903|NCT03831191|69695390|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
38012904|NCT03831191|69695391|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
38012905|NCT03831191|69695392|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
38012906|NCT03831191|69695393|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
38012907|NCT03831191|69695394|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
38012908|NCT03831191|69695380|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
38012909|NCT03831191|69695381|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
38012910|NCT03831191|69695382|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
38012911|NCT03831191|69695383|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
38012912|NCT03831191|69695384|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
38012913|NCT03831191|69695385|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
38012914|NCT03831191|69695386|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
38012915|NCT03831191|69695387|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
38012916|NCT03831191|69695388|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
38012917|NCT03831191|69695389|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
38012918|NCT03831191|69695390|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
38012919|NCT03831191|69695391|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
38012920|NCT03831191|69695392|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
38012921|NCT03831191|69695393|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
38012922|NCT03831191|69695394|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
38012923|NCT03831191|69695380|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
38012924|NCT03831191|69695381|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
38012925|NCT03831191|69695382|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
38012926|NCT03831191|69695383|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
38012927|NCT03831191|69695384|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
38012928|NCT03831191|69695385|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
38012929|NCT03831191|69695386|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
38012930|NCT03831191|69695387|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
38012931|NCT03831191|69695388|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
38012932|NCT03831191|69695389|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
38012933|NCT03831191|69695390|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
38012934|NCT03831191|69695391|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
38012935|NCT03831191|69695392|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
38012936|NCT03831191|69695393|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
38012937|NCT03831191|69695394|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
38012938|NCT00005906|69695427|FG000|Overall Study|Lack of Efficacy|3|||
38012939|NCT00066690|69695434|FG000|Overall Study|Adverse Event|145|||
38012940|NCT00066690|69695435|FG001|Overall Study|Adverse Event|58|||
38012941|NCT00066690|69695436|FG002|Overall Study|Adverse Event|126|||
38012942|NCT00066690|69695434|FG000|Overall Study|Death|3|||
38012943|NCT00066690|69695435|FG001|Overall Study|Death|0|||
38012944|NCT00066690|69695436|FG002|Overall Study|Death|2|||
38012945|NCT00066690|69695434|FG000|Overall Study|Lack of Efficacy|114|||
38012946|NCT00066690|69695435|FG001|Overall Study|Lack of Efficacy|110|||
38012947|NCT00066690|69695436|FG002|Overall Study|Lack of Efficacy|76|||
38012948|NCT00066690|69695434|FG000|Overall Study|Lost to Follow-up|40|||
38012949|NCT00066690|69695435|FG001|Overall Study|Lost to Follow-up|21|||
38012950|NCT00066690|69695436|FG002|Overall Study|Lost to Follow-up|29|||
38012951|NCT00066690|69695434|FG000|Overall Study|Withdrawal by Subject|50|||
38012952|NCT00066690|69695435|FG001|Overall Study|Withdrawal by Subject|55|||
38012953|NCT00066690|69695436|FG002|Overall Study|Withdrawal by Subject|49|||
38012954|NCT00066690|69695434|FG000|Overall Study|Treatment Ongoing|246|||
38012955|NCT00066690|69695435|FG001|Overall Study|Treatment Ongoing|278|||
38012956|NCT00066690|69695436|FG002|Overall Study|Treatment Ongoing|282|||
38012957|NCT03409276|69695452|FG000|Overall Study|Withdrawal by Subject|0|||
38012958|NCT03409276|69695453|FG001|Overall Study|Withdrawal by Subject|0|||
38012959|NCT03409276|69695454|FG002|Overall Study|Withdrawal by Subject|0|||
38012960|NCT03409276|69695455|FG003|Overall Study|Withdrawal by Subject|0|||
38012961|NCT03409276|69695456|FG004|Overall Study|Withdrawal by Subject|1|||
38012962|NCT03409276|69695452|FG000|Overall Study|Lost to Follow-up|0|||
38012963|NCT03409276|69695453|FG001|Overall Study|Lost to Follow-up|0|||
38012964|NCT03409276|69695454|FG002|Overall Study|Lost to Follow-up|0|||
38012965|NCT03409276|69695455|FG003|Overall Study|Lost to Follow-up|2|||
38012966|NCT03409276|69695456|FG004|Overall Study|Lost to Follow-up|2|||
38012967|NCT00004562|69695474|FG000|Overall Study|Lost to Follow-up|102|||
38012968|NCT00004562|69695475|FG001|Overall Study|Lost to Follow-up|91|||
37909765|NCT02364557|69595523|FG000|Overall Study|Protocol Violation|3|||
37909766|NCT02364557|69595524|FG001|Overall Study|Protocol Violation|1|||
38012969|NCT00004412|69695484|FG000|Randomized Period|Moved to Crossover Period|3|||
38012970|NCT00004412|69695485|FG001|Randomized Period|Moved to Crossover Period|0|||
38012971|NCT00004412|69695486|FG002|Randomized Period|Moved to Crossover Period|0|||
38012972|NCT03440320|69695496|FG000|Overall Study|Withdrawal by Subject|0|||
38012973|NCT03440320|69695497|FG001|Overall Study|Withdrawal by Subject|1|||
38012974|NCT00004088|69695505|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
38012975|NCT00004088|69695505|FG000|Overall Study|Withdrawal by Subject|1|||
38012976|NCT00004088|69695505|FG000|Overall Study|Protocol Violation|3|||
38012977|NCT00004088|69695505|FG000|Overall Study|Physician Decision|1|||
38012978|NCT03439072|69695509|FG000|Overall Study|Withdrawal by Subject|2|||
38012979|NCT03439072|69695510|FG001|Overall Study|Withdrawal by Subject|3|||
38012980|NCT03439072|69695509|FG000|Overall Study|Physician Decision|0|||
38012981|NCT03439072|69695510|FG001|Overall Study|Physician Decision|1|||
38012982|NCT00078312|69695516|FG000|Overall Study|Adverse Event|43|||
38012983|NCT00078312|69695516|FG000|Overall Study|Lack of Efficacy|15|||
38012984|NCT00078312|69695516|FG000|Overall Study|Lost to Follow-up|41|||
38012985|NCT00078312|69695516|FG000|Overall Study|Physician Decision|9|||
38012986|NCT00078312|69695516|FG000|Overall Study|Protocol Violation|3|||
38012987|NCT00078312|69695516|FG000|Overall Study|Withdrawal by Subject|33|||
38012988|NCT00078312|69695516|FG000|Overall Study|Miscellaneous|33|||
38012989|NCT00003896|69695520|FG000|Overall Study|Adverse Event|16|||
38012990|NCT00003896|69695520|FG000|Overall Study|Withdrawal by Subject|1|||
38012991|NCT00003896|69695520|FG000|Overall Study|Lack of Efficacy|1|||
38012992|NCT00003896|69695520|FG000|Overall Study|Death|3|||
38012993|NCT00003896|69695520|FG000|Overall Study|not protocol specified|3|||
38012994|NCT00003896|69695520|FG000|Overall Study|ineligible|5|||
37909767|NCT01899326|69595553|FG000|Overall Study|Withdrawal by Subject|1|||
38012995|NCT00003830|69695527|FG000|Overall Study|No follow up data|3|||
38012996|NCT00003830|69695528|FG001|Overall Study|No follow up data|0|||
38012997|NCT00003830|69695527|FG000|Overall Study|Sentinel node positive patients|829|||
38012998|NCT00003830|69695528|FG001|Overall Study|Sentinel node positive patients|793|||
38012999|NCT03407482|69695536|FG000|Overall Study|Adverse Event|12|||
38013000|NCT03407482|69695536|FG000|Overall Study|Disease Relapse|1|||
38013001|NCT03407482|69695536|FG000|Overall Study|Lost to Follow-up|1|||
37909768|NCT01899326|69595553|FG000|Overall Study|Adverse Event|2|||
38013002|NCT03407482|69695536|FG000|Overall Study|Non-Compliance With Study Drug|1|||
38013003|NCT03407482|69695536|FG000|Overall Study|Pregnancy|2|||
38013004|NCT03407482|69695536|FG000|Overall Study|Protocol Violation|1|||
38013005|NCT03407482|69695536|FG000|Overall Study|Study Terminated By Sponsor|106|||
38013006|NCT03407482|69695536|FG000|Overall Study|Withdrawal by Subject|6|||
38013007|NCT03407482|69695536|FG000|Overall Study|Data Entry Error|1|||
38013008|NCT00003782|69695543|FG000|Overall Study|No follow up data|30|||
38013009|NCT00003782|69695544|FG001|Overall Study|No follow up data|31|||
38013010|NCT00003782|69695545|FG002|Overall Study|No follow up data|26|||
38013011|NCT03389308|69695553|FG000|Overall Study|Withdrawal by Subject|5|||
38013012|NCT03389308|69695553|FG000|Overall Study|Lost to Follow-up|3|||
38013013|NCT03389308|69695553|FG000|Overall Study|Adverse Event|2|||
38013014|NCT03389308|69695553|FG000|Overall Study|Sponsor Request|2|||
38013015|NCT03407170|69695557|FG000|Overall Study|Adverse Event|1|||
38013016|NCT03406858|69695561|FG000|Overall Study|Failure to receive treatment drug.|1|||
38013017|NCT03406858|69695561|FG000|Overall Study|ineligible|1|||
38013018|NCT03406702|69695565|FG000|Overall Study|Missed Day 27 Dosing|1|||
38013019|NCT00003656|69695583|FG000|Overall Study|Adverse Event|0|||
38013020|NCT00003656|69695584|FG001|Overall Study|Adverse Event|1|||
38013021|NCT00003590|69695591|FG000|Overall Study|Ineligible Patient|1|||
38013022|NCT00003590|69695591|FG000|Overall Study|Adverse Event|7|||
38013023|NCT00003590|69695591|FG000|Overall Study|Withdrawal by Subject|1|||
38013024|NCT00003590|69695591|FG000|Overall Study|Lack of Efficacy|11|||
38013025|NCT00003590|69695591|FG000|Overall Study|Death|1|||
38013026|NCT00003590|69695591|FG000|Overall Study|Physician Decision|1|||
38013027|NCT03416374|69695597|FG000|Between Treatment Period I and II|Other|0|||
38013028|NCT03416374|69695598|FG001|Between Treatment Period I and II|Other|9|||
38013029|NCT03416374|69695597|FG000|Treatment Period II|Lack of Efficacy|3|||
38013030|NCT03416374|69695598|FG001|Treatment Period II|Lack of Efficacy|11|||
38013031|NCT03416374|69695597|FG000|Treatment Period II|Adverse Event|1|||
38013032|NCT03416374|69695598|FG001|Treatment Period II|Adverse Event|4|||
38013033|NCT03416374|69695597|FG000|Treatment Period II|Death|0|||
38013034|NCT03416374|69695598|FG001|Treatment Period II|Death|1|||
38013035|NCT03416374|69695597|FG000|Treatment Period II|Other|0|||
38013036|NCT03416374|69695598|FG001|Treatment Period II|Other|2|||
38013037|NCT03799952|69695609|FG000|Overall Study|Program was too easy, discontinued|1|||
38013038|NCT03799952|69695610|FG001|Overall Study|Program was too easy, discontinued|0|||
38013039|NCT03799952|69695609|FG000|Overall Study|Lost to Follow-up|0|||
38013040|NCT03799952|69695610|FG001|Overall Study|Lost to Follow-up|2|||
38013041|NCT00077766|69695618|FG000|Overall Study|Adverse Event|1|||
38013042|NCT00077766|69695619|FG001|Overall Study|Adverse Event|1|||
38013043|NCT00077766|69695618|FG000|Overall Study|Withdrawal by Subject|4|||
38013044|NCT00077766|69695619|FG001|Overall Study|Withdrawal by Subject|3|||
38013045|NCT00077766|69695618|FG000|Overall Study|Death|12|||
38013046|NCT00077766|69695619|FG001|Overall Study|Death|10|||
38013047|NCT00077766|69695618|FG000|Overall Study|Lost to Follow-up|2|||
38013048|NCT00077766|69695619|FG001|Overall Study|Lost to Follow-up|0|||
38013049|NCT00077766|69695618|FG000|Overall Study|Protocol Violation|1|||
38013050|NCT00077766|69695619|FG001|Overall Study|Protocol Violation|0|||
38013051|NCT00077766|69695618|FG000|Overall Study|Kidney Transplantation|9|||
38013052|NCT00077766|69695619|FG001|Overall Study|Kidney Transplantation|5|||
38013053|NCT00077766|69695618|FG000|Overall Study|Transplantation|5|||
38013054|NCT00077766|69695619|FG001|Overall Study|Transplantation|1|||
38013055|NCT00077766|69695618|FG000|Overall Study|Investigators Discretion|1|||
38013056|NCT00077766|69695619|FG001|Overall Study|Investigators Discretion|0|||
38013057|NCT00077766|69695618|FG000|Overall Study|Participant's decision|1|||
38013058|NCT00077766|69695619|FG001|Overall Study|Participant's decision|0|||
38013059|NCT00077766|69695618|FG000|Overall Study|Dialysis Discontinued|1|||
38013060|NCT00077766|69695619|FG001|Overall Study|Dialysis Discontinued|0|||
38013061|NCT00077766|69695618|FG000|Overall Study|Dialysis|0|||
38013062|NCT00077766|69695619|FG001|Overall Study|Dialysis|1|||
38013063|NCT00077766|69695618|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
38013064|NCT00077766|69695619|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
38013065|NCT00077766|69695618|FG000|Overall Study|Started Nocturnal Dialysis|0|||
38013066|NCT00077766|69695619|FG001|Overall Study|Started Nocturnal Dialysis|1|||
38013067|NCT00077766|69695618|FG000|Overall Study|Stop Dialysis|0|||
38013068|NCT00077766|69695619|FG001|Overall Study|Stop Dialysis|1|||
38013069|NCT00077766|69695618|FG000|Overall Study|Participants Vacation|2|||
38013070|NCT00077766|69695619|FG001|Overall Study|Participants Vacation|1|||
38013071|NCT03799718|69695626|FG000|Overall Study|Adverse Event|2|||
38013072|NCT03388138|69695632|FG000|Overall Study|Protocol Violation|1|||
38013073|NCT03388138|69695633|FG001|Overall Study|Protocol Violation|0|||
38013074|NCT02952898|69695642|FG000|Overall Study|Withdrawal by Subject|10|||
38013075|NCT02952898|69695643|FG001|Overall Study|Withdrawal by Subject|8|||
38013076|NCT02952898|69695644|FG002|Overall Study|Withdrawal by Subject|8|||
38013077|NCT02952898|69695642|FG000|Overall Study|Adverse Event|8|||
38013078|NCT02952898|69695643|FG001|Overall Study|Adverse Event|8|||
38013079|NCT02952898|69695644|FG002|Overall Study|Adverse Event|3|||
38013080|NCT02952898|69695642|FG000|Overall Study|Lost to Follow-up|3|||
38013081|NCT02952898|69695643|FG001|Overall Study|Lost to Follow-up|2|||
38013082|NCT02952898|69695644|FG002|Overall Study|Lost to Follow-up|2|||
38013083|NCT02952898|69695642|FG000|Overall Study|Non-compliance with study drug|1|||
38013084|NCT02952898|69695643|FG001|Overall Study|Non-compliance with study drug|1|||
38013085|NCT02952898|69695644|FG002|Overall Study|Non-compliance with study drug|2|||
38013086|NCT00045734|69695652|FG000|Overall Study|Protocol Violation|1|||
38013087|NCT03387046|69695658|FG000|Overall Study|Adverse Event|1|||
38013088|NCT03387046|69695659|FG001|Overall Study|Adverse Event|1|||
38013089|NCT00045110|69695668|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
38013090|NCT00045110|69695669|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
38013091|NCT00045110|69695670|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
38013092|NCT00045110|69695668|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
38013093|NCT00045110|69695669|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
38013094|NCT00045110|69695670|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
38013095|NCT00045110|69695668|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
38013096|NCT00045110|69695669|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
38013097|NCT00045110|69695670|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
38013098|NCT03353740|69695687|FG000|Overall Study|Images for these participants not viable|52|||
38013099|NCT00003476|69695691|FG000|Overall Study|Not evaluable|1|||
38013100|NCT00003470|69695695|FG000|Overall Study|Not evaluable|6|||
38013101|NCT03386344|69695702|FG000|Overall Study|Adverse Event|6|||
38013102|NCT03386344|69695703|FG001|Overall Study|Adverse Event|3|||
38013103|NCT03386344|69695704|FG002|Overall Study|Adverse Event|1|||
38013104|NCT03386344|69695702|FG000|Overall Study|Poor Compliance to Protocol|0|||
38013105|NCT03386344|69695703|FG001|Overall Study|Poor Compliance to Protocol|1|||
38013106|NCT03386344|69695704|FG002|Overall Study|Poor Compliance to Protocol|0|||
38013107|NCT03386344|69695702|FG000|Overall Study|Study Terminated by Sponsor|101|||
38013108|NCT03386344|69695703|FG001|Overall Study|Study Terminated by Sponsor|102|||
38013109|NCT03386344|69695704|FG002|Overall Study|Study Terminated by Sponsor|106|||
38013110|NCT03386344|69695702|FG000|Overall Study|Lost to Follow-up|3|||
38013111|NCT03386344|69695703|FG001|Overall Study|Lost to Follow-up|2|||
38013112|NCT03386344|69695704|FG002|Overall Study|Lost to Follow-up|1|||
38013113|NCT03386344|69695702|FG000|Overall Study|At the Participant's own Request|7|||
38013114|NCT03386344|69695703|FG001|Overall Study|At the Participant's own Request|7|||
38013115|NCT03386344|69695704|FG002|Overall Study|At the Participant's own Request|8|||
38013116|NCT03386344|69695702|FG000|Overall Study|Reason not Specified|0|||
38013117|NCT03386344|69695703|FG001|Overall Study|Reason not Specified|1|||
38013118|NCT03386344|69695704|FG002|Overall Study|Reason not Specified|0|||
38013119|NCT00399035|69695715|FG000|Overall Study|Death|289|||
38013120|NCT00399035|69695716|FG001|Overall Study|Death|141|||
38013121|NCT00399035|69695717|FG002|Overall Study|Death|234|||
38013122|NCT00399035|69695715|FG000|Overall Study|Lost to Follow-up|2|||
38013123|NCT00399035|69695716|FG001|Overall Study|Lost to Follow-up|1|||
38013124|NCT00399035|69695717|FG002|Overall Study|Lost to Follow-up|5|||
38013125|NCT00399035|69695715|FG000|Overall Study|Withdrawal by Subject|19|||
38013126|NCT00399035|69695716|FG001|Overall Study|Withdrawal by Subject|15|||
38013127|NCT00399035|69695717|FG002|Overall Study|Withdrawal by Subject|12|||
38013128|NCT00399035|69695715|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
38013129|NCT00399035|69695716|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
38013130|NCT00399035|69695717|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
38013131|NCT00399035|69695715|FG000|Overall Study|Severe non-compliance with protocol|2|||
38013132|NCT00399035|69695716|FG001|Overall Study|Severe non-compliance with protocol|1|||
38013133|NCT00399035|69695717|FG002|Overall Study|Severe non-compliance with protocol|0|||
38013134|NCT00073749|69695731|FG000|Overall Study|Disease Progression|2|||
38013135|NCT00073749|69695732|FG001|Overall Study|Disease Progression|0|||
38013136|NCT00073749|69695733|FG002|Overall Study|Disease Progression|3|||
38013137|NCT00073749|69695734|FG003|Overall Study|Disease Progression|2|||
38013138|NCT00073749|69695735|FG004|Overall Study|Disease Progression|3|||
38013139|NCT00073749|69695736|FG005|Overall Study|Disease Progression|1|||
38013140|NCT00073749|69695737|FG006|Overall Study|Disease Progression|3|||
38013141|NCT00073749|69695731|FG000|Overall Study|Death|0|||
38013142|NCT00073749|69695732|FG001|Overall Study|Death|1|||
38013143|NCT00073749|69695733|FG002|Overall Study|Death|1|||
38013144|NCT00073749|69695734|FG003|Overall Study|Death|0|||
38013145|NCT00073749|69695735|FG004|Overall Study|Death|0|||
38013146|NCT00073749|69695736|FG005|Overall Study|Death|0|||
38013147|NCT00073749|69695737|FG006|Overall Study|Death|29|||
38013148|NCT00073749|69695731|FG000|Overall Study|Adverse Event|0|||
38013149|NCT00073749|69695732|FG001|Overall Study|Adverse Event|3|||
38013150|NCT00073749|69695733|FG002|Overall Study|Adverse Event|6|||
38013151|NCT00073749|69695734|FG003|Overall Study|Adverse Event|4|||
38013152|NCT00073749|69695735|FG004|Overall Study|Adverse Event|2|||
38013153|NCT00073749|69695736|FG005|Overall Study|Adverse Event|1|||
38013154|NCT00073749|69695737|FG006|Overall Study|Adverse Event|0|||
38013155|NCT00073749|69695731|FG000|Overall Study|Physician Decision|0|||
38013156|NCT00073749|69695732|FG001|Overall Study|Physician Decision|0|||
38013157|NCT00073749|69695733|FG002|Overall Study|Physician Decision|1|||
38013158|NCT00073749|69695734|FG003|Overall Study|Physician Decision|0|||
37698417|NCT01799590|69175223|FG002|Overall Study|Adverse Event|5|||
37698418|NCT01799590|69175221|FG000|Overall Study|Pregnancy|2|||
37698419|NCT01799590|69175222|FG001|Overall Study|Pregnancy|0|||
37698420|NCT01799590|69175223|FG002|Overall Study|Pregnancy|0|||
37698421|NCT01799590|69175221|FG000|Overall Study|Lack of Efficacy|3|||
37698422|NCT01799590|69175222|FG001|Overall Study|Lack of Efficacy|1|||
37698423|NCT01799590|69175223|FG002|Overall Study|Lack of Efficacy|3|||
37698424|NCT01799590|69175221|FG000|Overall Study|Participants convenience|4|||
37698425|NCT01799590|69175222|FG001|Overall Study|Participants convenience|4|||
38013159|NCT00073749|69695735|FG004|Overall Study|Physician Decision|0|||
38013160|NCT00073749|69695736|FG005|Overall Study|Physician Decision|2|||
38013161|NCT00073749|69695737|FG006|Overall Study|Physician Decision|0|||
38013162|NCT00073749|69695731|FG000|Overall Study|Withdrawal by Subject|0|||
38013163|NCT00073749|69695732|FG001|Overall Study|Withdrawal by Subject|1|||
38013164|NCT00073749|69695733|FG002|Overall Study|Withdrawal by Subject|0|||
38013165|NCT00073749|69695734|FG003|Overall Study|Withdrawal by Subject|0|||
38013166|NCT00073749|69695735|FG004|Overall Study|Withdrawal by Subject|1|||
38013167|NCT00073749|69695736|FG005|Overall Study|Withdrawal by Subject|0|||
38013168|NCT00073749|69695737|FG006|Overall Study|Withdrawal by Subject|2|||
38013169|NCT00073749|69695731|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
38013170|NCT00073749|69695732|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
38013171|NCT00073749|69695733|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
38013172|NCT00073749|69695734|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
38013173|NCT00073749|69695735|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
38013174|NCT00073749|69695736|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
38013175|NCT00073749|69695737|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
38013176|NCT00073749|69695731|FG000|Overall Study|Lost to Follow-up|0|||
38013177|NCT00073749|69695732|FG001|Overall Study|Lost to Follow-up|0|||
38013178|NCT00073749|69695733|FG002|Overall Study|Lost to Follow-up|0|||
38013179|NCT00073749|69695734|FG003|Overall Study|Lost to Follow-up|0|||
38013180|NCT00073749|69695735|FG004|Overall Study|Lost to Follow-up|0|||
38013181|NCT00073749|69695736|FG005|Overall Study|Lost to Follow-up|0|||
38013182|NCT00073749|69695737|FG006|Overall Study|Lost to Follow-up|2|||
38013183|NCT00073749|69695731|FG000|Overall Study|Other|0|||
38013184|NCT00073749|69695732|FG001|Overall Study|Other|0|||
38013185|NCT00073749|69695733|FG002|Overall Study|Other|0|||
38013186|NCT00073749|69695734|FG003|Overall Study|Other|0|||
38013187|NCT00073749|69695735|FG004|Overall Study|Other|0|||
38013188|NCT00073749|69695736|FG005|Overall Study|Other|2|||
38013189|NCT00073749|69695737|FG006|Overall Study|Other|0|||
38013190|NCT00398567|69695759|FG000|Overall Study|Disease Progression|3|||
38013191|NCT00398567|69695760|FG001|Overall Study|Disease Progression|4|||
38013192|NCT00398567|69695761|FG002|Overall Study|Disease Progression|27|||
38013193|NCT00398567|69695759|FG000|Overall Study|Withdrawal by Subject|1|||
38013194|NCT00398567|69695760|FG001|Overall Study|Withdrawal by Subject|0|||
38013195|NCT00398567|69695761|FG002|Overall Study|Withdrawal by Subject|4|||
38013196|NCT00398567|69695759|FG000|Overall Study|Adverse Event|0|||
38013197|NCT00398567|69695760|FG001|Overall Study|Adverse Event|0|||
38013198|NCT00398567|69695761|FG002|Overall Study|Adverse Event|2|||
38013199|NCT00398567|69695759|FG000|Overall Study|Protocol Violation|0|||
38013200|NCT00398567|69695760|FG001|Overall Study|Protocol Violation|0|||
38013201|NCT00398567|69695761|FG002|Overall Study|Protocol Violation|1|||
38013202|NCT05249569|69695767|FG000|Overall Study|Sponsor pulled support for one of the study drugs.|1|||
38013203|NCT04779879|69695790|FG000|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
38013204|NCT04779879|69695791|FG001|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
38013205|NCT04779879|69695792|FG002|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
38013206|NCT04779879|69695793|FG003|Part B: Up to Week 36|Randomized, but did not receive treatment|1|||
38013207|NCT04779879|69695794|FG004|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
38013208|NCT04779879|69695795|FG005|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
38013209|NCT04779879|69695790|FG000|Part B: Up to Week 36|Withdrawal by Subject|0|||
38013210|NCT04779879|69695791|FG001|Part B: Up to Week 36|Withdrawal by Subject|0|||
38013211|NCT04779879|69695792|FG002|Part B: Up to Week 36|Withdrawal by Subject|0|||
38013212|NCT04779879|69695793|FG003|Part B: Up to Week 36|Withdrawal by Subject|1|||
38013213|NCT04779879|69695794|FG004|Part B: Up to Week 36|Withdrawal by Subject|0|||
38013214|NCT04779879|69695795|FG005|Part B: Up to Week 36|Withdrawal by Subject|0|||
37698426|NCT01799590|69175223|FG002|Overall Study|Participants convenience|2|||
37698427|NCT01799590|69175221|FG000|Overall Study|Aggravation of complications|0|||
38013215|NCT04779879|69695790|FG000|Part C: Up to Week 36|Death|0|||
38013216|NCT04779879|69695791|FG001|Part C: Up to Week 36|Death|0|||
38013217|NCT04779879|69695792|FG002|Part C: Up to Week 36|Death|0|||
38013218|NCT04779879|69695793|FG003|Part C: Up to Week 36|Death|0|||
38013219|NCT04779879|69695794|FG004|Part C: Up to Week 36|Death|0|||
38013220|NCT04779879|69695795|FG005|Part C: Up to Week 36|Death|1|||
38013221|NCT04779879|69695790|FG000|Part C: Up to Week 36|Withdrawal by Subject|0|||
38013222|NCT04779879|69695791|FG001|Part C: Up to Week 36|Withdrawal by Subject|0|||
38013223|NCT04779879|69695792|FG002|Part C: Up to Week 36|Withdrawal by Subject|0|||
38013224|NCT04779879|69695793|FG003|Part C: Up to Week 36|Withdrawal by Subject|0|||
38013225|NCT04779879|69695794|FG004|Part C: Up to Week 36|Withdrawal by Subject|4|||
38013226|NCT04779879|69695795|FG005|Part C: Up to Week 36|Withdrawal by Subject|2|||
38013227|NCT04535167|69695836|FG000|Treatment|Adverse Event|0|||
38013228|NCT04535167|69695837|FG001|Treatment|Adverse Event|0|||
38013229|NCT04535167|69695838|FG002|Treatment|Adverse Event|0|||
38013230|NCT04535167|69695839|FG003|Treatment|Adverse Event|0|||
38013231|NCT04535167|69695840|FG004|Treatment|Adverse Event|0|||
38013232|NCT04535167|69695841|FG005|Treatment|Adverse Event|0|||
38013233|NCT04535167|69695842|FG006|Treatment|Adverse Event|1|||
38013234|NCT04535167|69695836|FG000|Follow-Up|Death|0|||
38013235|NCT04535167|69695837|FG001|Follow-Up|Death|0|||
38013236|NCT04535167|69695838|FG002|Follow-Up|Death|0|||
38013237|NCT04535167|69695839|FG003|Follow-Up|Death|0|||
38013238|NCT04535167|69695840|FG004|Follow-Up|Death|0|||
38013239|NCT04535167|69695841|FG005|Follow-Up|Death|0|||
38013240|NCT04535167|69695842|FG006|Follow-Up|Death|1|||
38013241|NCT04535167|69695836|FG000|Follow-Up|Lost to Follow-up|0|||
38013242|NCT04535167|69695837|FG001|Follow-Up|Lost to Follow-up|0|||
38013243|NCT04535167|69695838|FG002|Follow-Up|Lost to Follow-up|0|||
38013244|NCT04535167|69695839|FG003|Follow-Up|Lost to Follow-up|1|||
38013245|NCT04535167|69695840|FG004|Follow-Up|Lost to Follow-up|0|||
38013246|NCT04535167|69695841|FG005|Follow-Up|Lost to Follow-up|0|||
38013247|NCT04535167|69695842|FG006|Follow-Up|Lost to Follow-up|0|||
38013248|NCT04223791|69695860|FG000|Overall Study|Lost to Follow-up|0|||
38013249|NCT04223791|69695861|FG001|Overall Study|Lost to Follow-up|4|||
38013250|NCT04223791|69695860|FG000|Overall Study|Physician Decision|5|||
38013251|NCT04223791|69695861|FG001|Overall Study|Physician Decision|1|||
38013252|NCT04223791|69695860|FG000|Overall Study|Protocol Violation|1|||
38013253|NCT04223791|69695861|FG001|Overall Study|Protocol Violation|1|||
38013254|NCT04223791|69695860|FG000|Overall Study|Withdrawal by Subject|10|||
38013255|NCT04223791|69695861|FG001|Overall Study|Withdrawal by Subject|12|||
38013256|NCT04223791|69695860|FG000|Overall Study|Pregnancy|1|||
38013257|NCT04223791|69695861|FG001|Overall Study|Pregnancy|1|||
38013258|NCT04223791|69695860|FG000|Overall Study|Ongoing in Study|305|||
38013259|NCT04223791|69695861|FG001|Overall Study|Ongoing in Study|302|||
38013260|NCT04115293|69695869|FG000|Overall Study|Adverse Event|0|||
38013261|NCT04115293|69695870|FG001|Overall Study|Adverse Event|2|||
38013262|NCT04115293|69695869|FG000|Overall Study|Withdrawal by Subject|2|||
38013263|NCT04115293|69695870|FG001|Overall Study|Withdrawal by Subject|1|||
38013264|NCT04115293|69695869|FG000|Overall Study|Physician Decision|1|||
38013265|NCT04115293|69695870|FG001|Overall Study|Physician Decision|0|||
38013266|NCT04115293|69695869|FG000|Overall Study|Death|1|||
38013267|NCT04115293|69695870|FG001|Overall Study|Death|1|||
38013268|NCT04035499|69695876|FG000|Overall Study|Death|2|||
38013269|NCT04035499|69695876|FG000|Overall Study|Withdrawal by Subject|1|||
38013270|NCT03915067|69695883|FG000|Overall Study|Adverse Event|0|||
38013271|NCT03915067|69695884|FG001|Overall Study|Adverse Event|0|||
38013272|NCT03915067|69695885|FG002|Overall Study|Adverse Event|1|||
38013273|NCT03915067|69695883|FG000|Overall Study|Withdrawal by Subject|4|||
38013274|NCT03915067|69695884|FG001|Overall Study|Withdrawal by Subject|3|||
38013275|NCT03915067|69695885|FG002|Overall Study|Withdrawal by Subject|0|||
38013276|NCT03915067|69695883|FG000|Overall Study|Lost to Follow-up|3|||
38013277|NCT03915067|69695884|FG001|Overall Study|Lost to Follow-up|2|||
38013278|NCT03915067|69695885|FG002|Overall Study|Lost to Follow-up|0|||
38013279|NCT03915067|69695883|FG000|Overall Study|Protocol Deviation|0|||
38013280|NCT03915067|69695884|FG001|Overall Study|Protocol Deviation|0|||
38013281|NCT03915067|69695885|FG002|Overall Study|Protocol Deviation|1|||
38013282|NCT03915067|69695883|FG000|Overall Study|Covid-19 Related Issues|2|||
38013283|NCT03915067|69695884|FG001|Overall Study|Covid-19 Related Issues|4|||
38013284|NCT03915067|69695885|FG002|Overall Study|Covid-19 Related Issues|4|||
38013285|NCT03915067|69695883|FG000|Overall Study|Randomized With Incorrect C-APPS|1|||
38013286|NCT03915067|69695884|FG001|Overall Study|Randomized With Incorrect C-APPS|0|||
38013287|NCT03915067|69695885|FG002|Overall Study|Randomized With Incorrect C-APPS|0|||
38013288|NCT03654404|69695893|FG000|Overall Study|Death|1|||
38013289|NCT03654404|69695893|FG000|Overall Study|Lost to Follow-up|2|||
38013290|NCT03654404|69695893|FG000|Overall Study|Withdrawal by Subject|5|||
38013291|NCT03447314|69695958|FG000|Part 1 (Up to 47 Months and 13 Days)|Death|6|||
38013292|NCT03447314|69695959|FG001|Part 1 (Up to 47 Months and 13 Days)|Death|5|||
38013293|NCT03447314|69695960|FG002|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
38013294|NCT03447314|69695961|FG003|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
38013295|NCT03447314|69695962|FG004|Part 1 (Up to 47 Months and 13 Days)|Death|1|||
38013296|NCT03447314|69695963|FG005|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
38013297|NCT03447314|69695964|FG006|Part 1 (Up to 47 Months and 13 Days)|Death|2|||
38013298|NCT03447314|69695965|FG007|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
38013299|NCT03447314|69695966|FG008|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
38013300|NCT03447314|69695967|FG009|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
38013301|NCT03447314|69695968|FG010|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
38013302|NCT03447314|69695969|FG011|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
38013303|NCT03447314|69695970|FG012|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
38013304|NCT03447314|69695971|FG013|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
38013305|NCT03447314|69695972|FG014|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
38013306|NCT03447314|69695973|FG015|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
38013307|NCT03447314|69695974|FG016|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
38013308|NCT03447314|69695975|FG017|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
38013309|NCT03447314|69695958|FG000|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
38013310|NCT03447314|69695959|FG001|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
38013311|NCT03447314|69695960|FG002|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
38013312|NCT03447314|69695961|FG003|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
38013313|NCT03447314|69695962|FG004|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
38013314|NCT03447314|69695963|FG005|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
38013315|NCT03447314|69695964|FG006|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
38013316|NCT03447314|69695965|FG007|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
38013317|NCT03447314|69695966|FG008|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
38013318|NCT03447314|69695967|FG009|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
38013319|NCT03447314|69695968|FG010|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
38013320|NCT03447314|69695969|FG011|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
38013321|NCT03447314|69695970|FG012|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
38013322|NCT03447314|69695971|FG013|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
38013323|NCT03447314|69695972|FG014|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
38013324|NCT03447314|69695973|FG015|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
38013325|NCT03447314|69695974|FG016|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
38013326|NCT03447314|69695975|FG017|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
38013327|NCT03447314|69695958|FG000|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
38013328|NCT03447314|69695959|FG001|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
38013329|NCT03447314|69695960|FG002|Part 1 (Up to 47 Months and 13 Days)|Disease progression|1|||
38013330|NCT03447314|69695961|FG003|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
38013331|NCT03447314|69695962|FG004|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
38013332|NCT03447314|69695963|FG005|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
38013333|NCT03447314|69695964|FG006|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
38013334|NCT03447314|69695965|FG007|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
38013335|NCT03447314|69695966|FG008|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
38013336|NCT03447314|69695967|FG009|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
38013337|NCT03447314|69695968|FG010|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
38013338|NCT03447314|69695969|FG011|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
38013339|NCT03447314|69695970|FG012|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
38013340|NCT03447314|69695971|FG013|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
38013341|NCT03447314|69695972|FG014|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
38013342|NCT03447314|69695973|FG015|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
38013343|NCT03447314|69695974|FG016|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
38013344|NCT03447314|69695975|FG017|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
38013345|NCT03447314|69695958|FG000|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
38013346|NCT03447314|69695959|FG001|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
38013347|NCT03447314|69695960|FG002|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|1|||
38013348|NCT03447314|69695961|FG003|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
38013349|NCT03447314|69695962|FG004|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
38013350|NCT03447314|69695963|FG005|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
37909769|NCT01899326|69595553|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
37909770|NCT01572480|69595558|FG000|Participants Enrolled|Withdrawal by Subject|1|||
37909771|NCT01572480|69595558|FG000|Drug Administration|Discontinued drug/Off Study|1|||
37909772|NCT01572480|69595558|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
37909773|NCT01572480|69595558|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
37909774|NCT01126190|69595565|FG000|Double-Blind Phase|Death|0|||
37909775|NCT01126190|69595566|FG001|Double-Blind Phase|Death|1|||
37909776|NCT01126190|69595567|FG002|Double-Blind Phase|Death|0|||
37909777|NCT01126190|69595565|FG000|Double-Blind Phase|Adverse Event|1|||
37909778|NCT01126190|69595566|FG001|Double-Blind Phase|Adverse Event|2|||
37909779|NCT01126190|69595567|FG002|Double-Blind Phase|Adverse Event|0|||
37909780|NCT01126190|69595565|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
37909781|NCT01126190|69595566|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
37909782|NCT01126190|69595567|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
37909783|NCT01126190|69595565|FG000|Double-Blind Phase|Request of Investigator|1|||
37909784|NCT01126190|69595566|FG001|Double-Blind Phase|Request of Investigator|0|||
38013351|NCT03447314|69695964|FG006|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
38013352|NCT03447314|69695965|FG007|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
38013353|NCT03447314|69695966|FG008|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
38013354|NCT03447314|69695967|FG009|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
38013355|NCT03447314|69695968|FG010|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
38013356|NCT03447314|69695969|FG011|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
38013357|NCT03447314|69695970|FG012|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
38013358|NCT03447314|69695971|FG013|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
38013359|NCT03447314|69695972|FG014|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
38013360|NCT03447314|69695973|FG015|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
38013361|NCT03447314|69695974|FG016|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
38013362|NCT03447314|69695975|FG017|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
38013363|NCT03447314|69695958|FG000|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
38013364|NCT03447314|69695959|FG001|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
38013365|NCT03447314|69695960|FG002|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
38013366|NCT03447314|69695961|FG003|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
38013367|NCT03447314|69695962|FG004|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
38013368|NCT03447314|69695963|FG005|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
38013369|NCT03447314|69695964|FG006|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
38013370|NCT03447314|69695965|FG007|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
38013371|NCT03447314|69695966|FG008|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
38013372|NCT03447314|69695967|FG009|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
38013373|NCT03447314|69695968|FG010|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|1|||
38013374|NCT03447314|69695969|FG011|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
38013375|NCT03447314|69695970|FG012|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
38013376|NCT03447314|69695971|FG013|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
38013377|NCT03447314|69695972|FG014|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
38013378|NCT03447314|69695973|FG015|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
38013379|NCT03447314|69695974|FG016|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
38013380|NCT03447314|69695975|FG017|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
38013381|NCT03447314|69695958|FG000|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
38013382|NCT03447314|69695959|FG001|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
38013383|NCT03447314|69695960|FG002|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
38013384|NCT03447314|69695961|FG003|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
38013385|NCT03447314|69695962|FG004|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
38013386|NCT03447314|69695963|FG005|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
38013387|NCT03447314|69695964|FG006|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
38013388|NCT03447314|69695965|FG007|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
38013389|NCT03447314|69695966|FG008|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
38013390|NCT03447314|69695967|FG009|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
38013391|NCT03447314|69695968|FG010|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
38013392|NCT03447314|69695969|FG011|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
38013393|NCT03447314|69695970|FG012|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
38013394|NCT03447314|69695971|FG013|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
38013395|NCT03447314|69695972|FG014|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
38013396|NCT03447314|69695973|FG015|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
38013397|NCT03447314|69695974|FG016|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
38013398|NCT03447314|69695975|FG017|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
37698428|NCT01799590|69175222|FG001|Overall Study|Aggravation of complications|1|||
37698429|NCT01799590|69175223|FG002|Overall Study|Aggravation of complications|1|||
37698430|NCT01799590|69175221|FG000|Overall Study|Using drugs with restricted days of use|0|||
37698431|NCT01799590|69175222|FG001|Overall Study|Using drugs with restricted days of use|3|||
37698432|NCT01799590|69175223|FG002|Overall Study|Using drugs with restricted days of use|2|||
37832062|NCT00557193|69515566|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
37698433|NCT01799590|69175221|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
37698434|NCT01799590|69175222|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
37698435|NCT01799590|69175223|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
37698436|NCT01799590|69175221|FG000|Overall Study|Other|3|||
37832063|NCT00557193|69515567|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
38013399|NCT03423121|69696018|FG000|Overall Study|Lost to Follow-up|2|||
38013400|NCT03423121|69696019|FG001|Overall Study|Lost to Follow-up|6|||
38013401|NCT03423121|69696018|FG000|Overall Study|Adverse Event|1|||
38013402|NCT03423121|69696019|FG001|Overall Study|Adverse Event|0|||
38013403|NCT03335475|69696027|FG000|Overall Study|Did not wear accelerometer|4|||
37832064|NCT00557193|69515568|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
37832065|NCT00557193|69515563|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
38013404|NCT03335475|69696028|FG001|Overall Study|Did not wear accelerometer|0|||
38013405|NCT03335475|69696027|FG000|Overall Study|Withdrawal by Subject|0|||
38013406|NCT03335475|69696028|FG001|Overall Study|Withdrawal by Subject|1|||
38013407|NCT03252756|69696036|FG000|Overall Study|Protocol Violation|2|||
38013408|NCT03252756|69696037|FG001|Overall Study|Protocol Violation|4|||
38013409|NCT03252756|69696036|FG000|Overall Study|COVID-19 Pandemic|1|||
38013410|NCT03252756|69696037|FG001|Overall Study|COVID-19 Pandemic|1|||
38013411|NCT03252756|69696036|FG000|Overall Study|Study Drug Expiration|0|||
38013412|NCT03252756|69696037|FG001|Overall Study|Study Drug Expiration|1|||
38013413|NCT03164356|69696049|FG000|Overall Study|Lost to Follow-up|1|||
38013414|NCT03164356|69696050|FG001|Overall Study|Lost to Follow-up|1|||
38013415|NCT03164356|69696051|FG002|Overall Study|Lost to Follow-up|2|||
38013416|NCT03164356|69696052|FG003|Overall Study|Lost to Follow-up|1|||
38013417|NCT03164356|69696049|FG000|Overall Study|Physician Decision|0|||
38013418|NCT03164356|69696050|FG001|Overall Study|Physician Decision|0|||
38013419|NCT03164356|69696051|FG002|Overall Study|Physician Decision|3|||
38013420|NCT03164356|69696052|FG003|Overall Study|Physician Decision|0|||
38013421|NCT03164356|69696049|FG000|Overall Study|Protocol Violation|2|||
38013422|NCT03164356|69696050|FG001|Overall Study|Protocol Violation|1|||
38013423|NCT03164356|69696051|FG002|Overall Study|Protocol Violation|0|||
38013424|NCT03164356|69696052|FG003|Overall Study|Protocol Violation|0|||
38013425|NCT03164356|69696049|FG000|Overall Study|Withdrawal by Subject|1|||
38013426|NCT03164356|69696050|FG001|Overall Study|Withdrawal by Subject|0|||
38013427|NCT03164356|69696051|FG002|Overall Study|Withdrawal by Subject|0|||
38013428|NCT03164356|69696052|FG003|Overall Study|Withdrawal by Subject|0|||
38013429|NCT03164356|69696049|FG000|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
38013430|NCT03164356|69696050|FG001|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
38013431|NCT03164356|69696051|FG002|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
38013432|NCT03164356|69696052|FG003|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
38013433|NCT03164356|69696049|FG000|Overall Study|Subject Incarcerated|0|||
38013434|NCT03164356|69696050|FG001|Overall Study|Subject Incarcerated|1|||
38013435|NCT03164356|69696051|FG002|Overall Study|Subject Incarcerated|0|||
38013436|NCT03164356|69696052|FG003|Overall Study|Subject Incarcerated|0|||
38013437|NCT03164356|69696049|FG000|Overall Study|Prosthetist unable to participate|0|||
38013438|NCT03164356|69696050|FG001|Overall Study|Prosthetist unable to participate|2|||
38013439|NCT03164356|69696051|FG002|Overall Study|Prosthetist unable to participate|1|||
38013440|NCT03164356|69696052|FG003|Overall Study|Prosthetist unable to participate|0|||
38013441|NCT01925131|69696087|FG000|Overall Study|Death|0|||
38013442|NCT01925131|69696088|FG001|Overall Study|Death|0|||
37832066|NCT00557193|69515564|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
37832067|NCT00557193|69515565|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
37832068|NCT00557193|69515566|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
37832069|NCT00557193|69515567|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
37832070|NCT00557193|69515568|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
37832071|NCT00557193|69515563|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
37832072|NCT00557193|69515564|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
37832073|NCT00557193|69515565|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
37909785|NCT01126190|69595567|FG002|Double-Blind Phase|Request of Investigator|0|||
37909786|NCT01126190|69595565|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
37909787|NCT01126190|69595566|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
37909788|NCT01126190|69595567|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
37909789|NCT01126190|69595565|FG000|Double-Blind Phase|Non-compliance|1|||
37909790|NCT01126190|69595566|FG001|Double-Blind Phase|Non-compliance|0|||
37909791|NCT01126190|69595567|FG002|Double-Blind Phase|Non-compliance|0|||
37909792|NCT01126190|69595565|FG000|Double-Blind Phase|Lost to Follow-up|1|||
37909793|NCT01126190|69595566|FG001|Double-Blind Phase|Lost to Follow-up|3|||
37909794|NCT01126190|69595567|FG002|Double-Blind Phase|Lost to Follow-up|0|||
38013443|NCT01925131|69696089|FG002|Overall Study|Death|1|||
38013444|NCT01925131|69696090|FG003|Overall Study|Death|0|||
38013445|NCT01925131|69696091|FG004|Overall Study|Death|0|||
38013446|NCT01925131|69696092|FG005|Overall Study|Death|0|||
38013447|NCT01925131|69696087|FG000|Overall Study|Progression/Relapse|1|||
37698437|NCT01799590|69175222|FG001|Overall Study|Other|0|||
38013448|NCT01925131|69696088|FG001|Overall Study|Progression/Relapse|1|||
38013449|NCT01925131|69696089|FG002|Overall Study|Progression/Relapse|4|||
38013450|NCT01925131|69696090|FG003|Overall Study|Progression/Relapse|0|||
38013451|NCT01925131|69696091|FG004|Overall Study|Progression/Relapse|0|||
38013452|NCT01925131|69696092|FG005|Overall Study|Progression/Relapse|1|||
38013453|NCT01925131|69696087|FG000|Overall Study|Patient Refusal|1|||
38013454|NCT01925131|69696088|FG001|Overall Study|Patient Refusal|0|||
38013455|NCT01925131|69696089|FG002|Overall Study|Patient Refusal|0|||
38013456|NCT01925131|69696090|FG003|Overall Study|Patient Refusal|0|||
38013457|NCT01925131|69696091|FG004|Overall Study|Patient Refusal|0|||
38013458|NCT01925131|69696092|FG005|Overall Study|Patient Refusal|0|||
38013459|NCT01925131|69696087|FG000|Overall Study|Adverse Event|0|||
38013460|NCT01925131|69696088|FG001|Overall Study|Adverse Event|0|||
38013461|NCT01925131|69696089|FG002|Overall Study|Adverse Event|2|||
38013462|NCT01925131|69696090|FG003|Overall Study|Adverse Event|0|||
38013463|NCT01925131|69696091|FG004|Overall Study|Adverse Event|1|||
38013464|NCT01925131|69696092|FG005|Overall Study|Adverse Event|3|||
38013465|NCT01925131|69696087|FG000|Overall Study|Other - Not Protocol Specified|3|||
38013466|NCT01925131|69696088|FG001|Overall Study|Other - Not Protocol Specified|1|||
38013467|NCT01925131|69696089|FG002|Overall Study|Other - Not Protocol Specified|2|||
38013468|NCT01925131|69696090|FG003|Overall Study|Other - Not Protocol Specified|5|||
38013469|NCT01925131|69696091|FG004|Overall Study|Other - Not Protocol Specified|10|||
38013470|NCT01925131|69696092|FG005|Overall Study|Other - Not Protocol Specified|6|||
38013471|NCT01698918|69696108|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
38013472|NCT01698918|69696108|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
38013473|NCT01698918|69696108|FG000|First Line Treatment (Core+Extension)|Death|2|||
38013474|NCT01698918|69696108|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
38013475|NCT01698918|69696108|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
38013476|NCT01698918|69696108|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
38013477|NCT01698918|69696108|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
38013478|NCT01698918|69696108|FG000|Second Line Treatment (Core+Extension)|Death|1|||
38013479|NCT01698918|69696108|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
38013480|NCT01698918|69696108|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
38013481|NCT01208974|69696121|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
38013482|NCT01208974|69696122|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
38013483|NCT01208974|69696123|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
38013484|NCT01208974|69696124|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
38013485|NCT01208974|69696121|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
38013486|NCT01208974|69696122|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
38013487|NCT01208974|69696123|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
38013488|NCT01208974|69696124|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
38013489|NCT01208974|69696121|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
38013490|NCT01208974|69696122|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
38013491|NCT01208974|69696123|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
38013492|NCT01208974|69696124|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
38013493|NCT00840177|69696134|FG000|Overall Study|Adverse Event|5|||
38013494|NCT00840177|69696135|FG001|Overall Study|Adverse Event|1|||
38013495|NCT00840177|69696136|FG002|Overall Study|Adverse Event|1|||
38013496|NCT00840177|69696134|FG000|Overall Study|Refusal unrelated to adverse events|1|||
38013497|NCT00840177|69696135|FG001|Overall Study|Refusal unrelated to adverse events|0|||
38013498|NCT00840177|69696136|FG002|Overall Study|Refusal unrelated to adverse events|1|||
38013499|NCT00840177|69696134|FG000|Overall Study|Progression/relapse|2|||
38013500|NCT00840177|69696135|FG001|Overall Study|Progression/relapse|0|||
38013501|NCT00840177|69696136|FG002|Overall Study|Progression/relapse|0|||
38013502|NCT00840177|69696134|FG000|Overall Study|Death|4|||
38013503|NCT00840177|69696135|FG001|Overall Study|Death|5|||
37909795|NCT01126190|69595565|FG000|Open-Label Phase|Death|0|||
37909796|NCT01126190|69595566|FG001|Open-Label Phase|Death|0|||
37909797|NCT01126190|69595567|FG002|Open-Label Phase|Death|1|||
37909798|NCT01126190|69595565|FG000|Open-Label Phase|Adverse Event|0|||
37909799|NCT01126190|69595566|FG001|Open-Label Phase|Adverse Event|0|||
37909800|NCT01126190|69595567|FG002|Open-Label Phase|Adverse Event|4|||
38013504|NCT00840177|69696136|FG002|Overall Study|Death|5|||
38013505|NCT00840177|69696134|FG000|Overall Study|not protocol specified|6|||
38013506|NCT00840177|69696135|FG001|Overall Study|not protocol specified|3|||
38013507|NCT00840177|69696136|FG002|Overall Study|not protocol specified|0|||
38013508|NCT00840177|69696134|FG000|Overall Study|Ineligible|0|||
38013509|NCT00840177|69696135|FG001|Overall Study|Ineligible|0|||
38013510|NCT00840177|69696136|FG002|Overall Study|Ineligible|3|||
38013511|NCT00840177|69696134|FG000|Overall Study|Did not start treatment|0|||
37698438|NCT01799590|69175223|FG002|Overall Study|Other|1|||
37698439|NCT01815424|69175234|FG000|Week 0 to 16|Adverse Event|1|||
37698440|NCT01815424|69175235|FG001|Week 0 to 16|Adverse Event|3|||
37909801|NCT01126190|69595565|FG000|Open-Label Phase|Withdrawal by Subject|0|||
38013512|NCT00840177|69696135|FG001|Overall Study|Did not start treatment|0|||
38013513|NCT00840177|69696136|FG002|Overall Study|Did not start treatment|1|||
37832074|NCT00557193|69515566|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
37832075|NCT00557193|69515567|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
38013514|NCT01347580|69696146|FG000|Overall Study|Withdrawal by Subject|13|||
38013515|NCT01347580|69696147|FG001|Overall Study|Withdrawal by Subject|23|||
38013516|NCT01347580|69696146|FG000|Overall Study|Death|30|||
38013517|NCT01347580|69696147|FG001|Overall Study|Death|19|||
38013518|NCT01347580|69696146|FG000|Overall Study|Protocol Violation|10|||
38013519|NCT01347580|69696147|FG001|Overall Study|Protocol Violation|7|||
38013520|NCT01347580|69696146|FG000|Overall Study|Lost to Follow-up|3|||
38013521|NCT01347580|69696147|FG001|Overall Study|Lost to Follow-up|1|||
38013522|NCT01347580|69696146|FG000|Overall Study|Had other reason|9|||
38013523|NCT01347580|69696147|FG001|Overall Study|Had other reason|6|||
38013524|NCT00398411|69696155|FG000|Overall Study|Death|0|||
38013525|NCT00398411|69696156|FG001|Overall Study|Death|1|||
38013526|NCT03352414|69696164|FG000|Overall Study|Ineligible by operative criteria|12|||
38013527|NCT03352414|69696165|FG001|Overall Study|Ineligible by operative criteria|10|||
38013528|NCT00364793|69696177|FG000|Overall Study|Adverse Event|2|||
38013529|NCT00364793|69696178|FG001|Overall Study|Adverse Event|0|||
38013530|NCT00364793|69696179|FG002|Overall Study|Adverse Event|0|||
38013531|NCT00364793|69696180|FG003|Overall Study|Adverse Event|0|||
38013532|NCT00364793|69696177|FG000|Overall Study|Death|1|||
38013533|NCT00364793|69696178|FG001|Overall Study|Death|0|||
38013534|NCT00364793|69696179|FG002|Overall Study|Death|1|||
38013535|NCT00364793|69696180|FG003|Overall Study|Death|0|||
38013536|NCT00364793|69696177|FG000|Overall Study|Lack of Efficacy|3|||
38013537|NCT00364793|69696178|FG001|Overall Study|Lack of Efficacy|3|||
38013538|NCT00364793|69696179|FG002|Overall Study|Lack of Efficacy|1|||
38013539|NCT00364793|69696180|FG003|Overall Study|Lack of Efficacy|1|||
38013540|NCT00364793|69696177|FG000|Overall Study|Lost to Follow-up|1|||
38013541|NCT00364793|69696178|FG001|Overall Study|Lost to Follow-up|0|||
38013542|NCT00364793|69696179|FG002|Overall Study|Lost to Follow-up|2|||
38013543|NCT00364793|69696180|FG003|Overall Study|Lost to Follow-up|0|||
38013544|NCT00364793|69696177|FG000|Overall Study|Poor or non-compliance|1|||
37909802|NCT01126190|69595566|FG001|Open-Label Phase|Withdrawal by Subject|0|||
37909803|NCT01126190|69595567|FG002|Open-Label Phase|Withdrawal by Subject|6|||
37909804|NCT00939185|69595600|FG000|Overall Study|Adverse Event|3|||
37909805|NCT00939185|69595600|FG000|Overall Study|Lack of Efficacy|1|||
37909806|NCT00939185|69595600|FG000|Overall Study|Lost to Follow-up|6|||
37909807|NCT00939185|69595600|FG000|Overall Study|Other|3|||
37909808|NCT00939185|69595600|FG000|Overall Study|Withdrawal by Subject|2|||
37909809|NCT00939185|69595600|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
38013545|NCT00364793|69696178|FG001|Overall Study|Poor or non-compliance|1|||
38013546|NCT00364793|69696179|FG002|Overall Study|Poor or non-compliance|0|||
38013547|NCT00364793|69696180|FG003|Overall Study|Poor or non-compliance|1|||
38013548|NCT00364793|69696177|FG000|Overall Study|No longer meets criteria|0|||
38013549|NCT00364793|69696178|FG001|Overall Study|No longer meets criteria|0|||
38013550|NCT00364793|69696179|FG002|Overall Study|No longer meets criteria|0|||
38013551|NCT00364793|69696180|FG003|Overall Study|No longer meets criteria|1|||
38013552|NCT00364793|69696177|FG000|Overall Study|Withdrawal by Subject|0|||
38013553|NCT00364793|69696178|FG001|Overall Study|Withdrawal by Subject|1|||
38013554|NCT00364793|69696179|FG002|Overall Study|Withdrawal by Subject|0|||
38013555|NCT00364793|69696180|FG003|Overall Study|Withdrawal by Subject|0|||
37832076|NCT00557193|69515568|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
37832077|NCT00557193|69515563|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
37832078|NCT00557193|69515564|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
37832079|NCT00557193|69515565|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
37832080|NCT00557193|69515566|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
37832081|NCT00557193|69515567|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
37832082|NCT00557193|69515568|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
37832083|NCT00557193|69515563|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
37909810|NCT03977155|69595607|FG000|Overall Study|Adverse Event|3|||
37909811|NCT03977155|69595608|FG001|Overall Study|Adverse Event|0|||
38013556|NCT03351478|69696196|FG000|Overall Study|At the subject's own request|11|||
38013557|NCT03351478|69696197|FG001|Overall Study|At the subject's own request|12|||
38013558|NCT03351478|69696198|FG002|Overall Study|At the subject's own request|5|||
38013559|NCT03351478|69696196|FG000|Overall Study|Adverse Event|1|||
37909812|NCT03977155|69595609|FG002|Overall Study|Adverse Event|0|||
38013560|NCT03351478|69696197|FG001|Overall Study|Adverse Event|2|||
38013561|NCT03351478|69696198|FG002|Overall Study|Adverse Event|1|||
38013562|NCT03351478|69696196|FG000|Overall Study|Poor compliance to protocol|1|||
38013563|NCT03351478|69696197|FG001|Overall Study|Poor compliance to protocol|0|||
38013564|NCT03351478|69696198|FG002|Overall Study|Poor compliance to protocol|0|||
38013565|NCT03351478|69696196|FG000|Overall Study|Reason not Specified|1|||
38013566|NCT03351478|69696197|FG001|Overall Study|Reason not Specified|3|||
38013567|NCT03351478|69696198|FG002|Overall Study|Reason not Specified|0|||
38013568|NCT03351478|69696196|FG000|Overall Study|Lost to Follow-up|0|||
38013569|NCT03351478|69696197|FG001|Overall Study|Lost to Follow-up|0|||
38013570|NCT03351478|69696198|FG002|Overall Study|Lost to Follow-up|1|||
38013571|NCT00363545|69696208|FG000|Overall Study|Serious Adverse Event|0|||
38013572|NCT00363545|69696209|FG001|Overall Study|Serious Adverse Event|1|||
38013573|NCT00363545|69696208|FG000|Overall Study|Withdrawal by Subject|12|||
38013574|NCT00363545|69696209|FG001|Overall Study|Withdrawal by Subject|15|||
38013575|NCT00363545|69696208|FG000|Overall Study|Migrated/moved from study area|3|||
38013576|NCT00363545|69696209|FG001|Overall Study|Migrated/moved from study area|6|||
38013577|NCT00363545|69696208|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
38013578|NCT00363545|69696209|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
38013579|NCT00363545|69696208|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
38013580|NCT00363545|69696209|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
38013581|NCT00363545|69696208|FG000|Overall Study|Others|1|||
38013582|NCT00363545|69696209|FG001|Overall Study|Others|0|||
38013583|NCT03351244|69696218|FG000|Overall Study|Adverse Event|7|||
38013584|NCT03351244|69696219|FG001|Overall Study|Adverse Event|11|||
38013585|NCT03351244|69696220|FG002|Overall Study|Adverse Event|12|||
38013586|NCT03351244|69696218|FG000|Overall Study|Investigator's decision|0|||
38013587|NCT03351244|69696219|FG001|Overall Study|Investigator's decision|0|||
38013588|NCT03351244|69696220|FG002|Overall Study|Investigator's decision|2|||
38013589|NCT03351244|69696218|FG000|Overall Study|System error|0|||
38013590|NCT03351244|69696219|FG001|Overall Study|System error|0|||
38013591|NCT03351244|69696220|FG002|Overall Study|System error|2|||
38013592|NCT03351244|69696218|FG000|Overall Study|COVID-19 restrictions|3|||
38013593|NCT03351244|69696219|FG001|Overall Study|COVID-19 restrictions|0|||
38013594|NCT03351244|69696220|FG002|Overall Study|COVID-19 restrictions|1|||
38013595|NCT03351244|69696218|FG000|Overall Study|Non-compliance|2|||
38013596|NCT03351244|69696219|FG001|Overall Study|Non-compliance|5|||
38013597|NCT03351244|69696220|FG002|Overall Study|Non-compliance|0|||
38013598|NCT03351244|69696218|FG000|Overall Study|Withdrawal by Subject|11|||
38013599|NCT03351244|69696219|FG001|Overall Study|Withdrawal by Subject|16|||
38013600|NCT03351244|69696220|FG002|Overall Study|Withdrawal by Subject|13|||
38013601|NCT03351244|69696218|FG000|Overall Study|Lost to Follow-up|2|||
38013602|NCT03351244|69696219|FG001|Overall Study|Lost to Follow-up|6|||
38013603|NCT03351244|69696220|FG002|Overall Study|Lost to Follow-up|4|||
38013604|NCT03351244|69696218|FG000|Overall Study|Protocol Violation|2|||
38013605|NCT03351244|69696219|FG001|Overall Study|Protocol Violation|2|||
38013606|NCT03351244|69696220|FG002|Overall Study|Protocol Violation|0|||
38013607|NCT03386032|69696233|FG000|Overall Study|Lack of Efficacy|6|||
38013608|NCT03386032|69696234|FG001|Overall Study|Lack of Efficacy|2|||
38013609|NCT03386032|69696235|FG002|Overall Study|Lack of Efficacy|0|||
38013610|NCT03386032|69696233|FG000|Overall Study|Adverse Event|2|||
38013611|NCT03386032|69696234|FG001|Overall Study|Adverse Event|2|||
38013612|NCT03386032|69696235|FG002|Overall Study|Adverse Event|0|||
38013613|NCT03386032|69696233|FG000|Overall Study|Withdrawal by Subject|1|||
38013614|NCT03386032|69696234|FG001|Overall Study|Withdrawal by Subject|0|||
38013615|NCT03386032|69696235|FG002|Overall Study|Withdrawal by Subject|0|||
38013616|NCT03386032|69696233|FG000|Overall Study|Lost to Follow-up|9|||
38013617|NCT03386032|69696234|FG001|Overall Study|Lost to Follow-up|3|||
38013618|NCT03386032|69696235|FG002|Overall Study|Lost to Follow-up|0|||
38013619|NCT00077610|69696246|FG000|Overall Study|Adverse Event|9|||
38013620|NCT00077610|69696247|FG001|Overall Study|Adverse Event|7|||
38013621|NCT00077610|69696248|FG002|Overall Study|Adverse Event|1|||
38013622|NCT00077610|69696246|FG000|Overall Study|Lost to Follow-up|0|||
38013623|NCT00077610|69696247|FG001|Overall Study|Lost to Follow-up|1|||
37909813|NCT03977155|69595607|FG000|Overall Study|Lost to Follow-up|0|||
38013624|NCT00077610|69696248|FG002|Overall Study|Lost to Follow-up|2|||
38013625|NCT00077610|69696246|FG000|Overall Study|Withdrawal by Subject|4|||
38013626|NCT00077610|69696247|FG001|Overall Study|Withdrawal by Subject|10|||
38013627|NCT00077610|69696248|FG002|Overall Study|Withdrawal by Subject|6|||
38013628|NCT00077610|69696246|FG000|Overall Study|Death|17|||
38013629|NCT00077610|69696247|FG001|Overall Study|Death|13|||
38013630|NCT00077610|69696248|FG002|Overall Study|Death|13|||
38013631|NCT00077610|69696246|FG000|Overall Study|Renal transplant|12|||
38013632|NCT00077610|69696247|FG001|Overall Study|Renal transplant|15|||
38013633|NCT00077610|69696248|FG002|Overall Study|Renal transplant|11|||
38013634|NCT00077610|69696246|FG000|Overall Study|Withdrew from dialysis care|5|||
38013635|NCT00077610|69696247|FG001|Overall Study|Withdrew from dialysis care|0|||
38013636|NCT00077610|69696248|FG002|Overall Study|Withdrew from dialysis care|3|||
38013637|NCT00077610|69696246|FG000|Overall Study|Insufficient Therapeutic Response|1|||
38013638|NCT00077610|69696247|FG001|Overall Study|Insufficient Therapeutic Response|0|||
38013639|NCT00077610|69696248|FG002|Overall Study|Insufficient Therapeutic Response|0|||
38013640|NCT00077610|69696246|FG000|Overall Study|Multiple blood transfusions|0|||
38013641|NCT00077610|69696247|FG001|Overall Study|Multiple blood transfusions|0|||
38013642|NCT00077610|69696248|FG002|Overall Study|Multiple blood transfusions|1|||
38013643|NCT00077610|69696246|FG000|Overall Study|Principal Investigator's decision|1|||
38013644|NCT00077610|69696247|FG001|Overall Study|Principal Investigator's decision|0|||
38013645|NCT00077610|69696248|FG002|Overall Study|Principal Investigator's decision|1|||
38013646|NCT00077610|69696246|FG000|Overall Study|Worsening of health condition|1|||
38013647|NCT00077610|69696247|FG001|Overall Study|Worsening of health condition|1|||
38013648|NCT00077610|69696248|FG002|Overall Study|Worsening of health condition|0|||
38013649|NCT00077610|69696246|FG000|Overall Study|Given Epogen in hospital|1|||
38013650|NCT00077610|69696247|FG001|Overall Study|Given Epogen in hospital|0|||
38013651|NCT00077610|69696248|FG002|Overall Study|Given Epogen in hospital|0|||
38013652|NCT00077610|69696246|FG000|Overall Study|Transferred to other unit|0|||
38013653|NCT00077610|69696247|FG001|Overall Study|Transferred to other unit|0|||
38013654|NCT00077610|69696248|FG002|Overall Study|Transferred to other unit|1|||
38013655|NCT00077610|69696246|FG000|Overall Study|Transferred to nursing home|0|||
38013656|NCT00077610|69696247|FG001|Overall Study|Transferred to nursing home|0|||
38013657|NCT00077610|69696248|FG002|Overall Study|Transferred to nursing home|1|||
38013658|NCT00077610|69696246|FG000|Overall Study|Transfer to satellite unit|1|||
38013659|NCT00077610|69696247|FG001|Overall Study|Transfer to satellite unit|0|||
38013660|NCT00077610|69696248|FG002|Overall Study|Transfer to satellite unit|0|||
38013661|NCT00077610|69696246|FG000|Overall Study|Transfer to other center for surgery|1|||
38013662|NCT00077610|69696247|FG001|Overall Study|Transfer to other center for surgery|0|||
38013663|NCT00077610|69696248|FG002|Overall Study|Transfer to other center for surgery|0|||
38013664|NCT00077610|69696246|FG000|Overall Study|Change in dialysis modality|1|||
38013665|NCT00077610|69696247|FG001|Overall Study|Change in dialysis modality|0|||
38013666|NCT00077610|69696248|FG002|Overall Study|Change in dialysis modality|0|||
38013667|NCT00077610|69696246|FG000|Overall Study|Relocation|0|||
38013668|NCT00077610|69696247|FG001|Overall Study|Relocation|8|||
38013669|NCT00077610|69696248|FG002|Overall Study|Relocation|5|||
38013670|NCT00077610|69696246|FG000|Overall Study|Financial issues|0|||
38013671|NCT00077610|69696247|FG001|Overall Study|Financial issues|1|||
38013672|NCT00077610|69696248|FG002|Overall Study|Financial issues|0|||
38013673|NCT00077610|69696246|FG000|Overall Study|Sponsors decision to withdraw|0|||
38013674|NCT00077610|69696247|FG001|Overall Study|Sponsors decision to withdraw|0|||
38013675|NCT00077610|69696248|FG002|Overall Study|Sponsors decision to withdraw|1|||
38013676|NCT03385564|69696265|FG000|Overall Study|Adverse Event|0|||
38013677|NCT03385564|69696266|FG001|Overall Study|Adverse Event|0|||
38013678|NCT03385564|69696267|FG002|Overall Study|Adverse Event|3|||
38013679|NCT03385564|69696268|FG003|Overall Study|Adverse Event|3|||
38013680|NCT03385564|69696265|FG000|Overall Study|Other than listed|0|||
38013681|NCT03385564|69696266|FG001|Overall Study|Other than listed|0|||
38013682|NCT03385564|69696267|FG002|Overall Study|Other than listed|0|||
38013683|NCT03385564|69696268|FG003|Overall Study|Other than listed|5|||
38013684|NCT03385564|69696265|FG000|Overall Study|Withdrawal by Subject|0|||
38013685|NCT03385564|69696266|FG001|Overall Study|Withdrawal by Subject|1|||
38013686|NCT03385564|69696267|FG002|Overall Study|Withdrawal by Subject|1|||
38013687|NCT03385564|69696268|FG003|Overall Study|Withdrawal by Subject|0|||
38013688|NCT03385564|69696265|FG000|Overall Study|Lack of Efficacy|0|||
38013689|NCT03385564|69696266|FG001|Overall Study|Lack of Efficacy|0|||
38013690|NCT03385564|69696267|FG002|Overall Study|Lack of Efficacy|0|||
38013691|NCT03385564|69696268|FG003|Overall Study|Lack of Efficacy|1|||
38013692|NCT03385564|69696265|FG000|Overall Study|Death|0|||
38013693|NCT03385564|69696266|FG001|Overall Study|Death|0|||
37698441|NCT01815424|69175236|FG002|Week 0 to 16|Adverse Event|3|||
37909814|NCT03977155|69595608|FG001|Overall Study|Lost to Follow-up|1|||
38013694|NCT03385564|69696267|FG002|Overall Study|Death|1|||
38013695|NCT03385564|69696268|FG003|Overall Study|Death|0|||
38013696|NCT00066222|69696278|FG000|Overall Study|No protocol treatment received|1|||
38013697|NCT00397943|69696287|FG000|Overall Study|Unspecified reasons|12|||
38013698|NCT00397943|69696288|FG001|Overall Study|Unspecified reasons|9|||
38013699|NCT00397943|69696289|FG002|Overall Study|Unspecified reasons|0|||
38013700|NCT00397943|69696290|FG003|Overall Study|Unspecified reasons|0|||
38013701|NCT00397943|69696291|FG004|Overall Study|Unspecified reasons|0|||
38013702|NCT00066066|69696306|FG000|Overall Study|Lost to Follow-up|6|||
38013703|NCT00066066|69696307|FG001|Overall Study|Lost to Follow-up|4|||
37698442|NCT01815424|69175237|FG003|Week 0 to 16|Adverse Event|0|||
38013704|NCT00066066|69696308|FG002|Overall Study|Lost to Follow-up|7|||
38013705|NCT00066066|69696309|FG003|Overall Study|Lost to Follow-up|4|||
38013706|NCT00066066|69696310|FG004|Overall Study|Lost to Follow-up|3|||
38013707|NCT00066066|69696311|FG005|Overall Study|Lost to Follow-up|5|||
38013708|NCT00363467|69696325|FG000|Overall Study|Physician Decision|1|||
38013709|NCT00397631|69696331|FG000|Overall Study|Adverse Event|5|||
38013710|NCT00397631|69696332|FG001|Overall Study|Adverse Event|6|||
38013711|NCT00397631|69696331|FG000|Overall Study|Lack of Efficacy|7|||
38013712|NCT00397631|69696332|FG001|Overall Study|Lack of Efficacy|10|||
38013713|NCT00397631|69696331|FG000|Overall Study|Lost to Follow-up|8|||
38013714|NCT00397631|69696332|FG001|Overall Study|Lost to Follow-up|9|||
38013715|NCT00397631|69696331|FG000|Overall Study|Physician Decision|2|||
38013716|NCT00397631|69696332|FG001|Overall Study|Physician Decision|0|||
38013717|NCT00397631|69696331|FG000|Overall Study|Protocol Violation|0|||
38013718|NCT00397631|69696332|FG001|Overall Study|Protocol Violation|1|||
38013719|NCT00397631|69696331|FG000|Overall Study|Withdrawal by Subject|7|||
38013720|NCT00397631|69696332|FG001|Overall Study|Withdrawal by Subject|14|||
38013721|NCT00397631|69696331|FG000|Overall Study|protocol discontinuation criteria|1|||
38013722|NCT00397631|69696332|FG001|Overall Study|protocol discontinuation criteria|4|||
38013723|NCT00077376|69696338|FG000|Overall Study|Adverse Event|8|||
38013724|NCT00077376|69696338|FG000|Overall Study|Withdrawal by Subject|2|||
38013725|NCT00077376|69696338|FG000|Overall Study|Death|1|||
38013726|NCT00077376|69696338|FG000|Overall Study|Physician Decision|1|||
38013727|NCT00077376|69696338|FG000|Overall Study|Alternative therapy|5|||
38013728|NCT00077376|69696338|FG000|Overall Study|Complicating disease|1|||
38013729|NCT00077376|69696338|FG000|Overall Study|Still on treatment|1|||
38013730|NCT00077376|69696338|FG000|Overall Study|Symptomatic deterioration|1|||
38013731|NCT00077376|69696338|FG000|Overall Study|Surgery|1|||
38013732|NCT00077376|69696338|FG000|Overall Study|Insurance ran out|1|||
38013733|NCT00363311|69696344|FG000|Overall Study|Adverse Event|6|||
38013734|NCT00363311|69696345|FG001|Overall Study|Adverse Event|4|||
38013735|NCT00363311|69696344|FG000|Overall Study|Lost to Follow-up|3|||
38013736|NCT00363311|69696345|FG001|Overall Study|Lost to Follow-up|0|||
38013737|NCT00363311|69696344|FG000|Overall Study|Protocol Violation|1|||
38013738|NCT00363311|69696345|FG001|Overall Study|Protocol Violation|2|||
38013739|NCT00363311|69696344|FG000|Overall Study|Withdrawal by Subject|12|||
38013740|NCT00363311|69696345|FG001|Overall Study|Withdrawal by Subject|6|||
38013741|NCT00363311|69696344|FG000|Overall Study|Physician Decision|1|||
38013742|NCT00363311|69696345|FG001|Overall Study|Physician Decision|1|||
38013743|NCT00363311|69696344|FG000|Overall Study|Sponsor Terminated Study|2|||
38013744|NCT00363311|69696345|FG001|Overall Study|Sponsor Terminated Study|2|||
38013745|NCT00363311|69696344|FG000|Overall Study|Disease Progression|46|||
38013746|NCT00363311|69696345|FG001|Overall Study|Disease Progression|26|||
38013747|NCT00363311|69696344|FG000|Overall Study|Non-Compliance|1|||
38013748|NCT00363311|69696345|FG001|Overall Study|Non-Compliance|1|||
38013749|NCT00363311|69696344|FG000|Overall Study|Participant Refused Biopsy|1|||
38013750|NCT00363311|69696345|FG001|Overall Study|Participant Refused Biopsy|0|||
37698443|NCT01815424|69175238|FG004|Week 0 to 16|Adverse Event|0|||
37698444|NCT01815424|69175234|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
37909815|NCT03977155|69595609|FG002|Overall Study|Lost to Follow-up|0|||
37909816|NCT03977155|69595607|FG000|Overall Study|Withdrawal by Subject|1|||
37909817|NCT03977155|69595608|FG001|Overall Study|Withdrawal by Subject|1|||
37909818|NCT03977155|69595609|FG002|Overall Study|Withdrawal by Subject|2|||
37909819|NCT03977155|69595607|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
37909820|NCT03977155|69595608|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
37909821|NCT03977155|69595609|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
37909822|NCT00930059|69595634|FG000|Overall Study|Death|1|||
37909823|NCT00930059|69595635|FG001|Overall Study|Death|0|||
37909824|NCT00930059|69595634|FG000|Overall Study|Did not meet entrance criteria|1|||
37909825|NCT00930059|69595635|FG001|Overall Study|Did not meet entrance criteria|1|||
37909826|NCT00930059|69595634|FG000|Overall Study|Withdrawal by Subject|3|||
37909827|NCT00930059|69595635|FG001|Overall Study|Withdrawal by Subject|4|||
37909828|NCT00930059|69595634|FG000|Overall Study|Other|1|||
37909829|NCT00930059|69595635|FG001|Overall Study|Other|0|||
37909830|NCT00930059|69595634|FG000|Overall Study|1 site terminated by sponsor|1|||
37909831|NCT00930059|69595635|FG001|Overall Study|1 site terminated by sponsor|1|||
37909832|NCT00930059|69595634|FG000|Overall Study|Adverse Event|1|||
37909833|NCT00930059|69595635|FG001|Overall Study|Adverse Event|6|||
37909834|NCT00772005|69595654|FG000|Overall Study|Adverse Event|9|||
38013751|NCT00363311|69696344|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
37909835|NCT00772005|69595655|FG001|Overall Study|Adverse Event|14|||
38013752|NCT00363311|69696345|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
38013753|NCT00363311|69696344|FG000|Overall Study|Participant Opted for Treatment|1|||
38013754|NCT00363311|69696345|FG001|Overall Study|Participant Opted for Treatment|0|||
37698445|NCT01815424|69175235|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
38013755|NCT00363311|69696344|FG000|Overall Study|Participant Moved to Another Country|1|||
38013756|NCT00363311|69696345|FG001|Overall Study|Participant Moved to Another Country|0|||
38013757|NCT00363311|69696344|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
38013758|NCT00363311|69696345|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
38013759|NCT00363311|69696344|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
38013760|NCT00363311|69696345|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
38013761|NCT00363311|69696344|FG000|Overall Study|Participant Moved to Louisiana|0|||
38013762|NCT00363311|69696345|FG001|Overall Study|Participant Moved to Louisiana|1|||
38013763|NCT00362609|69696353|FG000|Overall Study|Withdrawal by Subject|0|||
38013764|NCT00362609|69696354|FG001|Overall Study|Withdrawal by Subject|1|||
38013765|NCT00362609|69696353|FG000|Overall Study|Protocol Violation|0|||
38013766|NCT00362609|69696354|FG001|Overall Study|Protocol Violation|1|||
38013767|NCT00362375|69696362|FG000|Overall Study|Lost to Follow-up|40|||
38013768|NCT00362375|69696363|FG001|Overall Study|Lost to Follow-up|35|||
38013769|NCT00362297|69696371|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
38013770|NCT00362297|69696372|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
38013771|NCT00065442|69696380|FG000|Overall Study|Lost to Follow-up|1|||
38013772|NCT00065442|69696381|FG001|Overall Study|Lost to Follow-up|1|||
38013773|NCT00065442|69696380|FG000|Overall Study|Death|121|||
38013774|NCT00065442|69696381|FG001|Overall Study|Death|210|||
38013775|NCT00065442|69696380|FG000|Overall Study|Withdrawal by Subject|3|||
38013776|NCT00065442|69696381|FG001|Overall Study|Withdrawal by Subject|9|||
38013777|NCT00090402|69696390|FG000|Overall Study|Death|1|||
38013778|NCT00090402|69696391|FG001|Overall Study|Death|1|||
38013779|NCT00090402|69696392|FG002|Overall Study|Death|0|||
38013780|NCT00090402|69696390|FG000|Overall Study|subject moved|0|||
38013781|NCT00090402|69696391|FG001|Overall Study|subject moved|1|||
38013782|NCT00090402|69696392|FG002|Overall Study|subject moved|0|||
38013783|NCT00090402|69696390|FG000|Overall Study|stopped taking study medication|1|||
38013784|NCT00090402|69696391|FG001|Overall Study|stopped taking study medication|0|||
38013785|NCT00090402|69696392|FG002|Overall Study|stopped taking study medication|1|||
38013786|NCT00361283|69696403|FG000|Overall Study|Lost to Follow-up|27|||
38013787|NCT00077064|69696409|FG000|Overall Study|Adverse Event|0|||
38013788|NCT00077064|69696410|FG001|Overall Study|Adverse Event|4|||
38013789|NCT00077064|69696409|FG000|Overall Study|Patient refusal|0|||
38013790|NCT00077064|69696410|FG001|Overall Study|Patient refusal|2|||
38013791|NCT00396383|69696417|FG000|Overall Study|Death|2|||
38013792|NCT00396383|69696417|FG000|Overall Study|Lost to Follow-up|1|||
38013793|NCT00395447|69696423|FG000|Overall Study|Death|37|||
38013794|NCT00395447|69696424|FG001|Overall Study|Death|32|||
38013795|NCT00395447|69696423|FG000|Overall Study|Lost to Follow-up|52|||
38013796|NCT00395447|69696424|FG001|Overall Study|Lost to Follow-up|43|||
38013797|NCT00395447|69696423|FG000|Overall Study|Withdrawal by Subject|24|||
38013798|NCT00395447|69696424|FG001|Overall Study|Withdrawal by Subject|19|||
38013799|NCT00395447|69696423|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
38013800|NCT00395447|69696424|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
38013801|NCT03404674|69696436|FG000|Overall Study|Inability to Attend Future Visits|0|||
38013802|NCT03404674|69696437|FG001|Overall Study|Inability to Attend Future Visits|1|||
38013803|NCT03404674|69696438|FG002|Overall Study|Inability to Attend Future Visits|1|||
38013804|NCT03404674|69696439|FG003|Overall Study|Inability to Attend Future Visits|0|||
38013805|NCT03404674|69696440|FG004|Overall Study|Inability to Attend Future Visits|0|||
38013806|NCT03404674|69696441|FG005|Overall Study|Inability to Attend Future Visits|0|||
38013807|NCT03404674|69696436|FG000|Overall Study|Behavioral Problems|0|||
38013808|NCT03404674|69696437|FG001|Overall Study|Behavioral Problems|0|||
38013809|NCT03404674|69696438|FG002|Overall Study|Behavioral Problems|1|||
38013810|NCT03404674|69696439|FG003|Overall Study|Behavioral Problems|0|||
38013811|NCT03404674|69696440|FG004|Overall Study|Behavioral Problems|0|||
38013812|NCT03404674|69696441|FG005|Overall Study|Behavioral Problems|0|||
38013813|NCT03404674|69696436|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
38013814|NCT03404674|69696437|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
38013815|NCT03404674|69696438|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
38013816|NCT03404674|69696439|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
38013817|NCT03404674|69696440|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
38013818|NCT03404674|69696441|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
38013819|NCT00064662|69696458|FG000|Overall Study|Death|1|||
38013820|NCT00064662|69696459|FG001|Overall Study|Death|1|||
38013821|NCT00064662|69696458|FG000|Overall Study|Lost to Follow-up|57|||
38013822|NCT00064662|69696459|FG001|Overall Study|Lost to Follow-up|44|||
38013823|NCT00064662|69696458|FG000|Overall Study|Withdrawal by Subject|14|||
38013824|NCT00064662|69696459|FG001|Overall Study|Withdrawal by Subject|14|||
38013825|NCT00064662|69696458|FG000|Overall Study|Administratively withdrawn|2|||
38013826|NCT00064662|69696459|FG001|Overall Study|Administratively withdrawn|2|||
38013827|NCT03404518|69696467|FG000|Overall Study|Lost to Follow-up|28|||
38013828|NCT03404518|69696468|FG001|Overall Study|Lost to Follow-up|30|||
38013829|NCT03404518|69696467|FG000|Overall Study|Protocol Violation|13|||
38013830|NCT03404518|69696468|FG001|Overall Study|Protocol Violation|6|||
38013831|NCT03404206|69696477|FG000|Overall Study|Withdrawal by Subject|1|||
38013832|NCT03404206|69696478|FG001|Overall Study|Withdrawal by Subject|1|||
38013833|NCT03404206|69696479|FG002|Overall Study|Withdrawal by Subject|0|||
38013834|NCT03404206|69696477|FG000|Overall Study|Lost to Follow-up|3|||
38013835|NCT03404206|69696478|FG001|Overall Study|Lost to Follow-up|1|||
38013836|NCT03404206|69696479|FG002|Overall Study|Lost to Follow-up|0|||
38013837|NCT03403426|69696487|FG000|Overall Study|Death|1|||
38013838|NCT03403426|69696487|FG000|Overall Study|Lost to Follow-up|2|||
38013839|NCT00394901|69696495|FG000|Baseline Phase|Protocol Violation|0|||
38013840|NCT00394901|69696496|FG001|Baseline Phase|Protocol Violation|0|||
38013841|NCT00394901|69696497|FG002|Baseline Phase|Protocol Violation|1|||
38013842|NCT00394901|69696498|FG003|Baseline Phase|Protocol Violation|0|||
38013843|NCT00394901|69696495|FG000|Double-blind Phase|Adverse Event|5|||
38013844|NCT00394901|69696496|FG001|Double-blind Phase|Adverse Event|7|||
38013845|NCT00394901|69696497|FG002|Double-blind Phase|Adverse Event|16|||
38013846|NCT00394901|69696498|FG003|Double-blind Phase|Adverse Event|20|||
38013847|NCT00394901|69696495|FG000|Double-blind Phase|Lack of Efficacy|6|||
38013848|NCT00394901|69696496|FG001|Double-blind Phase|Lack of Efficacy|4|||
38013849|NCT00394901|69696497|FG002|Double-blind Phase|Lack of Efficacy|1|||
38013850|NCT00394901|69696498|FG003|Double-blind Phase|Lack of Efficacy|3|||
38013851|NCT00394901|69696495|FG000|Double-blind Phase|Withdrawal by Subject|2|||
38013852|NCT00394901|69696496|FG001|Double-blind Phase|Withdrawal by Subject|0|||
38013853|NCT00394901|69696497|FG002|Double-blind Phase|Withdrawal by Subject|0|||
38013854|NCT00394901|69696498|FG003|Double-blind Phase|Withdrawal by Subject|0|||
38013855|NCT00394901|69696495|FG000|Double-blind Phase|Lost to Follow-up|0|||
38013856|NCT00394901|69696496|FG001|Double-blind Phase|Lost to Follow-up|0|||
38013857|NCT00394901|69696497|FG002|Double-blind Phase|Lost to Follow-up|0|||
38013858|NCT00394901|69696498|FG003|Double-blind Phase|Lost to Follow-up|1|||
38013859|NCT00394901|69696495|FG000|Double-blind Phase|Protocol Violation|0|||
38013860|NCT00394901|69696496|FG001|Double-blind Phase|Protocol Violation|0|||
38013861|NCT00394901|69696497|FG002|Double-blind Phase|Protocol Violation|0|||
38013862|NCT00394901|69696498|FG003|Double-blind Phase|Protocol Violation|1|||
38013863|NCT00394901|69696495|FG000|Double-blind Phase|Death|1|||
38013864|NCT00394901|69696496|FG001|Double-blind Phase|Death|0|||
38013865|NCT00394901|69696497|FG002|Double-blind Phase|Death|0|||
38013866|NCT00394901|69696498|FG003|Double-blind Phase|Death|0|||
38013867|NCT00394901|69696495|FG000|Double-blind Phase|Subject's Personal Reason|1|||
38013868|NCT00394901|69696496|FG001|Double-blind Phase|Subject's Personal Reason|0|||
38013869|NCT00394901|69696497|FG002|Double-blind Phase|Subject's Personal Reason|0|||
38013870|NCT00394901|69696498|FG003|Double-blind Phase|Subject's Personal Reason|1|||
38013871|NCT00394901|69696495|FG000|Double-blind Phase|Lack of Compliance|0|||
38013872|NCT00394901|69696496|FG001|Double-blind Phase|Lack of Compliance|3|||
38013873|NCT00394901|69696497|FG002|Double-blind Phase|Lack of Compliance|0|||
38013874|NCT00394901|69696498|FG003|Double-blind Phase|Lack of Compliance|0|||
38013875|NCT00394901|69696495|FG000|Double-blind Phase|Entry into another study was found|0|||
38013876|NCT00394901|69696496|FG001|Double-blind Phase|Entry into another study was found|0|||
38013877|NCT00394901|69696497|FG002|Double-blind Phase|Entry into another study was found|1|||
38013878|NCT00394901|69696498|FG003|Double-blind Phase|Entry into another study was found|0|||
38013879|NCT00394901|69696495|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
38013880|NCT00394901|69696496|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
38013881|NCT00394901|69696497|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
38013882|NCT00394901|69696498|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
38013883|NCT03349060|69696514|FG000|Overall Study|Adverse Event|9|||
38013884|NCT03349060|69696515|FG001|Overall Study|Adverse Event|9|||
38013885|NCT03349060|69696516|FG002|Overall Study|Adverse Event|7|||
38013886|NCT03349060|69696514|FG000|Overall Study|Lack of Efficacy|1|||
38013887|NCT03349060|69696515|FG001|Overall Study|Lack of Efficacy|0|||
38013888|NCT03349060|69696516|FG002|Overall Study|Lack of Efficacy|2|||
38013889|NCT03349060|69696514|FG000|Overall Study|Lost to Follow-up|2|||
38013890|NCT03349060|69696515|FG001|Overall Study|Lost to Follow-up|1|||
38013891|NCT03349060|69696516|FG002|Overall Study|Lost to Follow-up|1|||
38013892|NCT03349060|69696514|FG000|Overall Study|Protocol Violation|2|||
38013893|NCT03349060|69696515|FG001|Overall Study|Protocol Violation|2|||
38013894|NCT03349060|69696516|FG002|Overall Study|Protocol Violation|1|||
38013895|NCT03349060|69696514|FG000|Overall Study|Withdrawal by Subject|5|||
38013896|NCT03349060|69696515|FG001|Overall Study|Withdrawal by Subject|3|||
38013897|NCT03349060|69696516|FG002|Overall Study|Withdrawal by Subject|4|||
38013898|NCT03349060|69696514|FG000|Overall Study|Medication error,no linked adverse event|0|||
38013899|NCT03349060|69696515|FG001|Overall Study|Medication error,no linked adverse event|0|||
38013900|NCT03349060|69696516|FG002|Overall Study|Medication error,no linked adverse event|1|||
38013901|NCT03349060|69696514|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
38013902|NCT03349060|69696515|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
38013903|NCT03349060|69696516|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
38013904|NCT03349060|69696514|FG000|Overall Study|Other|2|||
38013905|NCT03349060|69696515|FG001|Overall Study|Other|1|||
38013906|NCT03349060|69696516|FG002|Overall Study|Other|0|||
38013907|NCT03348904|69696527|FG000|Overall Study|Administrative reason by the sponsor|0|||
38013908|NCT03348904|69696528|FG001|Overall Study|Administrative reason by the sponsor|1|||
38013909|NCT03348904|69696529|FG002|Overall Study|Administrative reason by the sponsor|0|||
38013910|NCT00359021|69696539|FG000|Overall Study|Adverse Event|26|||
38013911|NCT00359021|69696540|FG001|Overall Study|Adverse Event|8|||
38013912|NCT00359021|69696539|FG000|Overall Study|Subject Non-Compliant|1|||
38013913|NCT00359021|69696540|FG001|Overall Study|Subject Non-Compliant|2|||
38013914|NCT00359021|69696539|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
38013915|NCT00359021|69696540|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
38013916|NCT00359021|69696539|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
38013917|NCT00359021|69696540|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
38013918|NCT00359021|69696539|FG000|Overall Study|Withdrawal by Subject|2|||
38013919|NCT00359021|69696540|FG001|Overall Study|Withdrawal by Subject|9|||
38013920|NCT00359021|69696539|FG000|Overall Study|Lost to Follow-up|1|||
38013921|NCT00359021|69696540|FG001|Overall Study|Lost to Follow-up|0|||
38013922|NCT00359021|69696539|FG000|Overall Study|Other|4|||
38013923|NCT00359021|69696540|FG001|Overall Study|Other|1|||
38013924|NCT00359021|69696539|FG000|Overall Study|Pregnancy|1|||
38013925|NCT00359021|69696540|FG001|Overall Study|Pregnancy|0|||
38013926|NCT00360269|69696550|FG000|Overall Study|Lost to Follow-up|7|||
38013927|NCT00360269|69696551|FG001|Overall Study|Lost to Follow-up|9|||
38013928|NCT00360269|69696550|FG000|Overall Study|Physician Decision|1|||
38013929|NCT00360269|69696551|FG001|Overall Study|Physician Decision|2|||
38013930|NCT00360269|69696550|FG000|Overall Study|Adverse Event|1|||
38013931|NCT00360269|69696551|FG001|Overall Study|Adverse Event|0|||
38013932|NCT00360269|69696550|FG000|Overall Study|Withdrawal by Subject|1|||
38013933|NCT00360269|69696551|FG001|Overall Study|Withdrawal by Subject|1|||
38013934|NCT00076752|69696557|FG000|Overall Study|Death|2|||
38013935|NCT00076752|69696557|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
38013936|NCT03384940|69696565|FG000|Overall Study|Progressive disease|36|||
38013937|NCT03384940|69696566|FG001|Overall Study|Progressive disease|11|||
38013938|NCT03384940|69696567|FG002|Overall Study|Progressive disease|13|||
38013939|NCT03384940|69696565|FG000|Overall Study|Clinical progression|4|||
38013940|NCT03384940|69696566|FG001|Overall Study|Clinical progression|0|||
38013941|NCT03384940|69696567|FG002|Overall Study|Clinical progression|3|||
38013942|NCT03384940|69696565|FG000|Overall Study|Adverse Event|7|||
38013943|NCT03384940|69696566|FG001|Overall Study|Adverse Event|1|||
38013944|NCT03384940|69696567|FG002|Overall Study|Adverse Event|1|||
38013945|NCT03384940|69696565|FG000|Overall Study|Withdrawal by Subject|3|||
38013946|NCT03384940|69696566|FG001|Overall Study|Withdrawal by Subject|1|||
38013947|NCT03384940|69696567|FG002|Overall Study|Withdrawal by Subject|0|||
38013948|NCT03384940|69696565|FG000|Overall Study|Physician Decision|1|||
38013949|NCT03384940|69696566|FG001|Overall Study|Physician Decision|1|||
38013950|NCT03384940|69696567|FG002|Overall Study|Physician Decision|0|||
37909836|NCT00772005|69595656|FG002|Overall Study|Adverse Event|10|||
38013951|NCT03384940|69696565|FG000|Overall Study|Death|2|||
38013952|NCT03384940|69696566|FG001|Overall Study|Death|1|||
37909837|NCT00772005|69595657|FG003|Overall Study|Adverse Event|13|||
38013953|NCT03384940|69696567|FG002|Overall Study|Death|0|||
38013954|NCT03384940|69696565|FG000|Overall Study|Other|0|||
38013955|NCT03384940|69696566|FG001|Overall Study|Other|0|||
38013956|NCT03384940|69696567|FG002|Overall Study|Other|1|||
38013957|NCT00075582|69696577|FG000|Overall Study|Adverse Event|3|||
38013958|NCT00075582|69696578|FG001|Overall Study|Adverse Event|1|||
38013959|NCT00075582|69696577|FG000|Overall Study|Lack of Efficacy|4|||
38013960|NCT00075582|69696578|FG001|Overall Study|Lack of Efficacy|8|||
38013961|NCT00075582|69696577|FG000|Overall Study|Physician Decision|5|||
38013962|NCT00075582|69696578|FG001|Overall Study|Physician Decision|8|||
38013963|NCT00075582|69696577|FG000|Overall Study|Withdrawal by Subject|2|||
38013964|NCT00075582|69696578|FG001|Overall Study|Withdrawal by Subject|2|||
38013965|NCT00075582|69696577|FG000|Overall Study|Ineligible for study|36|||
38013966|NCT00075582|69696578|FG001|Overall Study|Ineligible for study|16|||
38013967|NCT00063258|69696590|FG000|Overall Study|Physician Decision|2|||
38013968|NCT00063258|69696591|FG001|Overall Study|Physician Decision|0|||
38013969|NCT00063258|69696590|FG000|Overall Study|Lack of Efficacy|2|||
38013970|NCT00063258|69696591|FG001|Overall Study|Lack of Efficacy|0|||
38013971|NCT00088530|69696599|FG000|Overall Study|Progressive/Relapsed Disease|28|||
38013972|NCT00088530|69696600|FG001|Overall Study|Progressive/Relapsed Disease|39|||
38013973|NCT00088530|69696599|FG000|Overall Study|Adverse Event|15|||
38013974|NCT00088530|69696600|FG001|Overall Study|Adverse Event|9|||
38013975|NCT00088530|69696599|FG000|Overall Study|Withdrawal by Subject|2|||
38013976|NCT00088530|69696600|FG001|Overall Study|Withdrawal by Subject|5|||
38013977|NCT00088530|69696599|FG000|Overall Study|Lost to Follow-up|2|||
38013978|NCT00088530|69696600|FG001|Overall Study|Lost to Follow-up|0|||
38013979|NCT00088530|69696599|FG000|Overall Study|Physician Decision|2|||
38013980|NCT00088530|69696600|FG001|Overall Study|Physician Decision|0|||
38013981|NCT00088530|69696599|FG000|Overall Study|Sponsor decision|0|||
38013982|NCT00088530|69696600|FG001|Overall Study|Sponsor decision|1|||
38013983|NCT00088530|69696599|FG000|Overall Study|Patient never treated|1|||
38013984|NCT00088530|69696600|FG001|Overall Study|Patient never treated|0|||
38013985|NCT00359801|69696608|FG000|Overall Study|Lost to Follow-up|72|||
38013986|NCT00359801|69696609|FG001|Overall Study|Lost to Follow-up|58|||
38013987|NCT00359801|69696608|FG000|Overall Study|Withdrawal by Subject|143|||
38013988|NCT00359801|69696609|FG001|Overall Study|Withdrawal by Subject|96|||
38013989|NCT00359801|69696608|FG000|Overall Study|Other|66|||
38013990|NCT00359801|69696609|FG001|Overall Study|Other|46|||
38013991|NCT00359801|69696608|FG000|Overall Study|Final Status Unknown: missing data|7|||
38013992|NCT00359801|69696609|FG001|Overall Study|Final Status Unknown: missing data|4|||
38013993|NCT00359801|69696608|FG000|Overall Study|Sponsor Decision|17|||
38013994|NCT00359801|69696609|FG001|Overall Study|Sponsor Decision|16|||
38013995|NCT00045032|69696618|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
38013996|NCT00045032|69696619|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
38013997|NCT00045032|69696620|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
38013998|NCT00045032|69696618|FG000|Overall Study|Death|22|||
38013999|NCT00045032|69696619|FG001|Overall Study|Death|24|||
38014000|NCT00045032|69696620|FG002|Overall Study|Death|17|||
38014001|NCT00045032|69696618|FG000|Overall Study|Insufficient Therapeutic Response|542|||
38014002|NCT00045032|69696619|FG001|Overall Study|Insufficient Therapeutic Response|437|||
38014003|NCT00045032|69696620|FG002|Overall Study|Insufficient Therapeutic Response|445|||
38014004|NCT00045032|69696618|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
38014005|NCT00045032|69696619|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
38014006|NCT00045032|69696620|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
38014007|NCT00045032|69696618|FG000|Overall Study|Other Protocol Violation|2|||
38014008|NCT00045032|69696619|FG001|Overall Study|Other Protocol Violation|0|||
38014009|NCT00045032|69696620|FG002|Overall Study|Other Protocol Violation|1|||
38014010|NCT00045032|69696618|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
38014011|NCT00045032|69696619|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
38014012|NCT00045032|69696620|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
38014013|NCT00045032|69696618|FG000|Overall Study|Failure to Return|57|||
38014014|NCT00045032|69696619|FG001|Overall Study|Failure to Return|62|||
38014015|NCT00045032|69696620|FG002|Overall Study|Failure to Return|61|||
38014016|NCT00045032|69696618|FG000|Overall Study|Other|93|||
38014017|NCT00045032|69696619|FG001|Overall Study|Other|84|||
38014018|NCT00045032|69696620|FG002|Overall Study|Other|105|||
38014019|NCT00356915|69696633|FG000|Overall Study|Non compliance|1|||
38014020|NCT00356915|69696634|FG001|Overall Study|Non compliance|2|||
38014021|NCT00356915|69696635|FG002|Overall Study|Non compliance|1|||
38014022|NCT00356915|69696633|FG000|Overall Study|Protocol Violation|2|||
38014023|NCT00356915|69696634|FG001|Overall Study|Protocol Violation|3|||
38014024|NCT00356915|69696635|FG002|Overall Study|Protocol Violation|2|||
38014025|NCT00356915|69696633|FG000|Overall Study|Withdrawal by Subject|14|||
38014026|NCT00356915|69696634|FG001|Overall Study|Withdrawal by Subject|14|||
38014027|NCT00356915|69696635|FG002|Overall Study|Withdrawal by Subject|10|||
38014028|NCT00356915|69696633|FG000|Overall Study|Lack of Efficacy|0|||
38014029|NCT00356915|69696634|FG001|Overall Study|Lack of Efficacy|0|||
38014030|NCT00356915|69696635|FG002|Overall Study|Lack of Efficacy|3|||
38014031|NCT00356915|69696633|FG000|Overall Study|Lost to Follow-up|27|||
38014032|NCT00356915|69696634|FG001|Overall Study|Lost to Follow-up|34|||
38014033|NCT00356915|69696635|FG002|Overall Study|Lost to Follow-up|14|||
38014034|NCT00356915|69696633|FG000|Overall Study|Administrative Decision|0|||
38014035|NCT00356915|69696634|FG001|Overall Study|Administrative Decision|0|||
38014036|NCT00356915|69696635|FG002|Overall Study|Administrative Decision|1|||
38014037|NCT00356915|69696633|FG000|Overall Study|Physician Decision|0|||
38014038|NCT00356915|69696634|FG001|Overall Study|Physician Decision|2|||
38014039|NCT00356915|69696635|FG002|Overall Study|Physician Decision|0|||
38014040|NCT00356915|69696633|FG000|Overall Study|Adverse Event|21|||
38014041|NCT00356915|69696634|FG001|Overall Study|Adverse Event|31|||
38014042|NCT00356915|69696635|FG002|Overall Study|Adverse Event|8|||
38014043|NCT00356915|69696633|FG000|Overall Study|Miscellaneous reasons|11|||
38014044|NCT00356915|69696634|FG001|Overall Study|Miscellaneous reasons|8|||
38014045|NCT00356915|69696635|FG002|Overall Study|Miscellaneous reasons|3|||
38014046|NCT00356759|69696651|FG000|Overall Study|Death|5|||
38014047|NCT00356759|69696652|FG001|Overall Study|Death|2|||
38014048|NCT00356759|69696651|FG000|Overall Study|Withdrawal by Subject|2|||
38014049|NCT00356759|69696652|FG001|Overall Study|Withdrawal by Subject|2|||
38014050|NCT00356759|69696651|FG000|Overall Study|Adverse Event|1|||
38014051|NCT00356759|69696652|FG001|Overall Study|Adverse Event|3|||
38014052|NCT00356759|69696651|FG000|Overall Study|Lost to Follow-up|1|||
38014053|NCT00356759|69696652|FG001|Overall Study|Lost to Follow-up|1|||
38014054|NCT00356759|69696651|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
38014055|NCT00356759|69696652|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
38014056|NCT03804710|69696660|FG000|Overall Study|Adverse Event|0|||
38014057|NCT03804710|69696661|FG001|Overall Study|Adverse Event|3|||
38014058|NCT03804710|69696660|FG000|Overall Study|Withdrawal by Subject|2|||
38014059|NCT03804710|69696661|FG001|Overall Study|Withdrawal by Subject|1|||
38014060|NCT03804710|69696660|FG000|Overall Study|Other|0|||
38014061|NCT03804710|69696661|FG001|Overall Study|Other|1|||
38014062|NCT00356603|69696673|FG000|Overall Study|Other|6|||
38014063|NCT00356603|69696674|FG001|Overall Study|Other|3|||
38014064|NCT00002558|69696684|FG000|Overall Study|Withdrawal by Subject|0|||
38014065|NCT00002558|69696685|FG001|Overall Study|Withdrawal by Subject|1|||
38014066|NCT00002540|69696693|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
38014067|NCT00002540|69696694|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
38014068|NCT00002540|69696693|FG000|Overall Study|Died Before Randomization|2|||
38014069|NCT00002540|69696694|FG001|Overall Study|Died Before Randomization|6|||
38014070|NCT00002540|69696693|FG000|Overall Study|Died Before ASU (Control)|202|||
38014071|NCT00002540|69696694|FG001|Overall Study|Died Before ASU (Control)|0|||
38014072|NCT00002540|69696693|FG000|Overall Study|Refused ASU (Control)|597|||
38014073|NCT00002540|69696694|FG001|Overall Study|Refused ASU (Control)|0|||
38014074|NCT00002540|69696693|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
38014075|NCT00002540|69696694|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
38014076|NCT00001880|69696700|FG000|Overall Study|Death|14|||
38014077|NCT00043550|69696707|FG000|Overall Study|Withdrawal by Subject|22|||
38014078|NCT00043550|69696708|FG001|Overall Study|Withdrawal by Subject|12|||
38014079|NCT00043550|69696709|FG002|Overall Study|Withdrawal by Subject|20|||
38014080|NCT00041756|69696722|FG000|Overall Study|Adverse Event|4|||
38014081|NCT00041756|69696723|FG001|Overall Study|Adverse Event|10|||
38014082|NCT00041756|69696724|FG002|Overall Study|Adverse Event|6|||
38014083|NCT00041756|69696725|FG003|Overall Study|Adverse Event|11|||
38014084|NCT00041756|69696726|FG004|Overall Study|Adverse Event|34|||
38014085|NCT00041756|69696722|FG000|Overall Study|Protocol Violation|1|||
38014086|NCT00041756|69696723|FG001|Overall Study|Protocol Violation|1|||
38014087|NCT00041756|69696724|FG002|Overall Study|Protocol Violation|2|||
38014088|NCT00041756|69696725|FG003|Overall Study|Protocol Violation|2|||
38014089|NCT00041756|69696726|FG004|Overall Study|Protocol Violation|1|||
38014090|NCT00041756|69696722|FG000|Overall Study|Withdrawal by Subject|3|||
38014091|NCT00041756|69696723|FG001|Overall Study|Withdrawal by Subject|3|||
38014092|NCT00041756|69696724|FG002|Overall Study|Withdrawal by Subject|4|||
38014093|NCT00041756|69696725|FG003|Overall Study|Withdrawal by Subject|2|||
38014094|NCT00041756|69696726|FG004|Overall Study|Withdrawal by Subject|3|||
38014095|NCT00041756|69696722|FG000|Overall Study|Lost to Follow-up|0|||
38014096|NCT00041756|69696723|FG001|Overall Study|Lost to Follow-up|1|||
38014097|NCT00041756|69696724|FG002|Overall Study|Lost to Follow-up|0|||
38014098|NCT00041756|69696725|FG003|Overall Study|Lost to Follow-up|1|||
38014099|NCT00041756|69696726|FG004|Overall Study|Lost to Follow-up|0|||
38014100|NCT00041756|69696722|FG000|Overall Study|Unable to meet protocol criteria|0|||
38014101|NCT00041756|69696723|FG001|Overall Study|Unable to meet protocol criteria|0|||
38014102|NCT00041756|69696724|FG002|Overall Study|Unable to meet protocol criteria|1|||
38014103|NCT00041756|69696725|FG003|Overall Study|Unable to meet protocol criteria|0|||
38014104|NCT00041756|69696726|FG004|Overall Study|Unable to meet protocol criteria|1|||
38014105|NCT00041756|69696722|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
37698446|NCT01815424|69175236|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
38014106|NCT00041756|69696723|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
38014107|NCT00041756|69696724|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
38014108|NCT00041756|69696725|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
38014109|NCT00041756|69696726|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
38014110|NCT00041132|69696738|FG000|Overall Study|Adverse Event|19|||
38014111|NCT00041132|69696738|FG000|Overall Study|Death|1|||
38014112|NCT00041132|69696738|FG000|Overall Study|Not Eligible|7|||
38014113|NCT00041132|69696738|FG000|Overall Study|Withdrawal by Subject|1|||
38014114|NCT00041132|69696738|FG000|Overall Study|Physician Decision|2|||
38014115|NCT00040742|69696746|FG000|Overall Study|Death|0|||
38014116|NCT00040742|69696747|FG001|Overall Study|Death|0|||
38014117|NCT00040742|69696748|FG002|Overall Study|Death|1|||
38014118|NCT00040742|69696749|FG003|Overall Study|Death|0|||
38014119|NCT00040742|69696746|FG000|Overall Study|Adverse Event|15|||
38014120|NCT00040742|69696747|FG001|Overall Study|Adverse Event|16|||
38014121|NCT00040742|69696748|FG002|Overall Study|Adverse Event|21|||
38014122|NCT00040742|69696749|FG003|Overall Study|Adverse Event|9|||
38014123|NCT00040742|69696746|FG000|Overall Study|Withdrawal by Subject|7|||
38014124|NCT00040742|69696747|FG001|Overall Study|Withdrawal by Subject|15|||
38014125|NCT00040742|69696748|FG002|Overall Study|Withdrawal by Subject|10|||
38014126|NCT00040742|69696749|FG003|Overall Study|Withdrawal by Subject|13|||
38014127|NCT00040742|69696746|FG000|Overall Study|Chemotoxicity|4|||
38014128|NCT00040742|69696747|FG001|Overall Study|Chemotoxicity|3|||
38014129|NCT00040742|69696748|FG002|Overall Study|Chemotoxicity|5|||
38014130|NCT00040742|69696749|FG003|Overall Study|Chemotoxicity|2|||
38014131|NCT00040742|69696746|FG000|Overall Study|Incomplete Forms|6|||
38014132|NCT00040742|69696747|FG001|Overall Study|Incomplete Forms|10|||
38014133|NCT00040742|69696748|FG002|Overall Study|Incomplete Forms|4|||
38014134|NCT00040742|69696749|FG003|Overall Study|Incomplete Forms|5|||
38014135|NCT00040742|69696746|FG000|Overall Study|Other medical|7|||
38014136|NCT00040742|69696747|FG001|Overall Study|Other medical|5|||
38014137|NCT00040742|69696748|FG002|Overall Study|Other medical|5|||
38014138|NCT00040742|69696749|FG003|Overall Study|Other medical|5|||
38014139|NCT00040664|69696759|FG000|Overall Study|Adverse Event|12|||
38014140|NCT00040664|69696760|FG001|Overall Study|Adverse Event|3|||
38014141|NCT00040664|69696761|FG002|Overall Study|Adverse Event|2|||
38014142|NCT00040664|69696762|FG003|Overall Study|Adverse Event|7|||
38014143|NCT00040664|69696759|FG000|Overall Study|Lack of Efficacy|9|||
38014144|NCT00040664|69696760|FG001|Overall Study|Lack of Efficacy|2|||
38014145|NCT00040664|69696761|FG002|Overall Study|Lack of Efficacy|3|||
38014146|NCT00040664|69696762|FG003|Overall Study|Lack of Efficacy|4|||
38014147|NCT00040664|69696759|FG000|Overall Study|Insufficient CD4 response|1|||
38014148|NCT00040664|69696760|FG001|Overall Study|Insufficient CD4 response|0|||
38014149|NCT00040664|69696761|FG002|Overall Study|Insufficient CD4 response|1|||
37832084|NCT00557193|69515564|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
37832085|NCT00557193|69515565|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
37832086|NCT00557193|69515566|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
37832087|NCT00557193|69515567|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
37832088|NCT00557193|69515568|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
37832089|NCT00557193|69515563|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
37832090|NCT00557193|69515564|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
37832091|NCT00557193|69515565|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
37832092|NCT00557193|69515566|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
37832093|NCT00557193|69515567|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
37832094|NCT00557193|69515568|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
37832095|NCT00557193|69515563|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
37832096|NCT00557193|69515564|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
37832097|NCT00557193|69515565|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
37832098|NCT00557193|69515566|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
37909838|NCT00772005|69595654|FG000|Overall Study|Lack of Efficacy|0|||
38014150|NCT00040664|69696762|FG003|Overall Study|Insufficient CD4 response|0|||
38014151|NCT00040664|69696759|FG000|Overall Study|Lost to Follow-up|4|||
38014152|NCT00040664|69696760|FG001|Overall Study|Lost to Follow-up|2|||
38014153|NCT00040664|69696761|FG002|Overall Study|Lost to Follow-up|0|||
38014154|NCT00040664|69696762|FG003|Overall Study|Lost to Follow-up|2|||
38014155|NCT00040664|69696759|FG000|Overall Study|Protocol Violation|2|||
38014156|NCT00040664|69696760|FG001|Overall Study|Protocol Violation|1|||
38014157|NCT00040664|69696761|FG002|Overall Study|Protocol Violation|0|||
38014158|NCT00040664|69696762|FG003|Overall Study|Protocol Violation|1|||
38014159|NCT00040664|69696759|FG000|Overall Study|Withdrawal by Subject|7|||
38014160|NCT00040664|69696760|FG001|Overall Study|Withdrawal by Subject|0|||
38014161|NCT00040664|69696761|FG002|Overall Study|Withdrawal by Subject|3|||
38014162|NCT00040664|69696762|FG003|Overall Study|Withdrawal by Subject|4|||
37698447|NCT01815424|69175237|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
38014163|NCT00040664|69696759|FG000|Overall Study|Pregnancy|3|||
38014164|NCT00040664|69696760|FG001|Overall Study|Pregnancy|0|||
38014165|NCT00040664|69696761|FG002|Overall Study|Pregnancy|0|||
38014166|NCT00040664|69696762|FG003|Overall Study|Pregnancy|3|||
38014167|NCT00040664|69696759|FG000|Overall Study|Medication adherence/compliance problems|8|||
38014168|NCT00040664|69696760|FG001|Overall Study|Medication adherence/compliance problems|2|||
38014169|NCT00040664|69696761|FG002|Overall Study|Medication adherence/compliance problems|1|||
38014170|NCT00040664|69696762|FG003|Overall Study|Medication adherence/compliance problems|5|||
38014171|NCT00040664|69696759|FG000|Overall Study|Poor taste|2|||
38014172|NCT00040664|69696760|FG001|Overall Study|Poor taste|0|||
38014173|NCT00040664|69696761|FG002|Overall Study|Poor taste|2|||
38014174|NCT00040664|69696762|FG003|Overall Study|Poor taste|0|||
38014175|NCT00040664|69696759|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
38014176|NCT00040664|69696760|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
38014177|NCT00040664|69696761|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
38014178|NCT00040664|69696762|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
38014179|NCT00040664|69696759|FG000|Overall Study|Change of formulation|2|||
38014180|NCT00040664|69696760|FG001|Overall Study|Change of formulation|2|||
38014181|NCT00040664|69696761|FG002|Overall Study|Change of formulation|0|||
38014182|NCT00040664|69696762|FG003|Overall Study|Change of formulation|0|||
38014183|NCT00040664|69696759|FG000|Overall Study|Non-viability of oral suspension|1|||
38014184|NCT00040664|69696760|FG001|Overall Study|Non-viability of oral suspension|0|||
38014185|NCT00040664|69696761|FG002|Overall Study|Non-viability of oral suspension|1|||
38014186|NCT00040664|69696762|FG003|Overall Study|Non-viability of oral suspension|0|||
38014187|NCT02952586|69696782|FG000|Lead-In Phase (7 Days)|Death|0|||
38014188|NCT02952586|69696783|FG001|Lead-In Phase (7 Days)|Death|1|||
38014189|NCT02952586|69696782|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
38014190|NCT02952586|69696783|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
38014191|NCT02952586|69696782|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
38014192|NCT02952586|69696783|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
38014193|NCT02952586|69696782|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
38014194|NCT02952586|69696783|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
38014195|NCT02952586|69696782|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
38014196|NCT02952586|69696783|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
38014197|NCT02952586|69696782|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
38014198|NCT02952586|69696783|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
38014199|NCT02952586|69696782|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
38014200|NCT02952586|69696783|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
38014201|NCT02952586|69696782|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
38014202|NCT02952586|69696783|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
38014203|NCT02952586|69696782|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
38014204|NCT02952586|69696783|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
38014205|NCT02952586|69696782|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
38014206|NCT02952586|69696783|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
38014207|NCT02952586|69696782|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
38014208|NCT02952586|69696783|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
38014209|NCT02952586|69696782|FG000|CRT for Cisplatin (63 Days)|Death|3|||
38014210|NCT02952586|69696783|FG001|CRT for Cisplatin (63 Days)|Death|8|||
38014211|NCT02952586|69696782|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
38014212|NCT02952586|69696783|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
38014213|NCT02952586|69696782|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
38014214|NCT02952586|69696783|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
38014215|NCT02952586|69696782|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
38014216|NCT02952586|69696783|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
38014217|NCT02952586|69696782|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
38014218|NCT02952586|69696783|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
38014219|NCT02952586|69696782|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
38014220|NCT02952586|69696783|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
38014221|NCT02952586|69696782|FG000|CRT for Cisplatin (63 Days)|Other|1|||
38014222|NCT02952586|69696783|FG001|CRT for Cisplatin (63 Days)|Other|1|||
38014223|NCT02952586|69696782|FG000|CRT for IMRT (63 Days)|Death|5|||
38014224|NCT02952586|69696783|FG001|CRT for IMRT (63 Days)|Death|8|||
38014225|NCT02952586|69696782|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
38014226|NCT02952586|69696783|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
38014227|NCT02952586|69696782|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
38014228|NCT02952586|69696783|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
38014229|NCT02952586|69696782|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
38014230|NCT02952586|69696783|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
38014231|NCT02952586|69696782|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
38014232|NCT02952586|69696783|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
38014233|NCT02952586|69696782|FG000|CRT for IMRT (63 Days)|Other|1|||
38014234|NCT02952586|69696783|FG001|CRT for IMRT (63 Days)|Other|0|||
38014235|NCT02952586|69696782|FG000|Maintenance Phase (12 Months)|Death|17|||
38014236|NCT02952586|69696783|FG001|Maintenance Phase (12 Months)|Death|11|||
38014237|NCT02952586|69696782|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
38014238|NCT02952586|69696783|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
38014239|NCT02952586|69696782|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
38014240|NCT02952586|69696783|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
38014241|NCT02952586|69696782|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
38014242|NCT02952586|69696783|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
38014243|NCT02952586|69696782|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
38014244|NCT02952586|69696783|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
38014245|NCT02952586|69696782|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
38014246|NCT02952586|69696783|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
38014247|NCT02952586|69696782|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
38014248|NCT02952586|69696783|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
38014249|NCT02952586|69696782|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
38014250|NCT02952586|69696783|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
38014251|NCT02952586|69696782|FG000|Maintenance Phase (12 Months)|Other|2|||
38014252|NCT02952586|69696783|FG001|Maintenance Phase (12 Months)|Other|1|||
38014253|NCT02952586|69696782|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
38014254|NCT02952586|69696783|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
38014255|NCT02952586|69696782|FG000|Follow-Up Phase (90 Days)|Death|12|||
38014256|NCT02952586|69696783|FG001|Follow-Up Phase (90 Days)|Death|10|||
38014257|NCT02952586|69696782|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
38014258|NCT02952586|69696783|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
38014259|NCT02952586|69696782|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
38014260|NCT02952586|69696783|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
38014261|NCT02952586|69696782|FG000|Follow-Up Phase (90 Days)|Other|7|||
38014262|NCT02952586|69696783|FG001|Follow-Up Phase (90 Days)|Other|5|||
38014263|NCT02952586|69696782|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
38014264|NCT02952586|69696783|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
38014265|NCT02952586|69696782|FG000|LT Follow-up (up to 45 Months)|Death|51|||
38014266|NCT02952586|69696783|FG001|LT Follow-up (up to 45 Months)|Death|31|||
38014267|NCT02952586|69696782|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
38014268|NCT02952586|69696783|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
38014269|NCT02952586|69696782|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
38014270|NCT02952586|69696783|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
38014271|NCT02952586|69696782|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
38014272|NCT02952586|69696783|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
38014273|NCT03384316|69696792|FG000|Overall Study|Screen failure|0|||
38014274|NCT03384316|69696793|FG001|Overall Study|Screen failure|1|||
38014275|NCT03403192|69696805|FG000|Overall Study|Lost to Follow-up|1|||
38014276|NCT03403192|69696806|FG001|Overall Study|Lost to Follow-up|2|||
38014277|NCT03403192|69696807|FG002|Overall Study|Lost to Follow-up|0|||
38014278|NCT03403192|69696808|FG003|Overall Study|Lost to Follow-up|0|||
38014279|NCT03403192|69696805|FG000|Overall Study|Unable to respond|0|||
38014280|NCT03403192|69696806|FG001|Overall Study|Unable to respond|1|||
38014281|NCT03403192|69696807|FG002|Overall Study|Unable to respond|0|||
38014282|NCT03403192|69696808|FG003|Overall Study|Unable to respond|0|||
38014283|NCT03403192|69696805|FG000|Overall Study|Incomplete|3|||
38014284|NCT03403192|69696806|FG001|Overall Study|Incomplete|1|||
38014285|NCT03403192|69696807|FG002|Overall Study|Incomplete|3|||
38014286|NCT03403192|69696808|FG003|Overall Study|Incomplete|6|||
38014287|NCT00356525|69696822|FG000|Overall Study|Progressive Disease|8|||
38014288|NCT00356525|69696823|FG001|Overall Study|Progressive Disease|5|||
38014289|NCT00356525|69696824|FG002|Overall Study|Progressive Disease|4|||
38014290|NCT00356525|69696825|FG003|Overall Study|Progressive Disease|2|||
38014291|NCT00356525|69696822|FG000|Overall Study|Adverse Event|1|||
38014292|NCT00356525|69696823|FG001|Overall Study|Adverse Event|3|||
38014293|NCT00356525|69696824|FG002|Overall Study|Adverse Event|1|||
38014294|NCT00356525|69696825|FG003|Overall Study|Adverse Event|1|||
38014295|NCT00356525|69696822|FG000|Overall Study|Lost to Follow-up|1|||
38014296|NCT00356525|69696823|FG001|Overall Study|Lost to Follow-up|0|||
38014297|NCT00356525|69696824|FG002|Overall Study|Lost to Follow-up|0|||
38014298|NCT00356525|69696825|FG003|Overall Study|Lost to Follow-up|0|||
38014299|NCT00356525|69696822|FG000|Overall Study|Physician Decision|2|||
38014300|NCT00356525|69696823|FG001|Overall Study|Physician Decision|2|||
38014301|NCT00356525|69696824|FG002|Overall Study|Physician Decision|2|||
38014302|NCT00356525|69696825|FG003|Overall Study|Physician Decision|1|||
38014303|NCT00356525|69696822|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
38014304|NCT00356525|69696823|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
38014305|NCT00356525|69696824|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
38014306|NCT00356525|69696825|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
38014307|NCT00356525|69696822|FG000|Overall Study|Withdrawal by Subject|1|||
38014308|NCT00356525|69696823|FG001|Overall Study|Withdrawal by Subject|1|||
38014309|NCT00356525|69696824|FG002|Overall Study|Withdrawal by Subject|0|||
38014310|NCT00356525|69696825|FG003|Overall Study|Withdrawal by Subject|3|||
38014311|NCT00356525|69696822|FG000|Overall Study|Death|0|||
38014312|NCT00356525|69696823|FG001|Overall Study|Death|0|||
38014313|NCT00356525|69696824|FG002|Overall Study|Death|0|||
38014314|NCT00356525|69696825|FG003|Overall Study|Death|1|||
38014315|NCT00356525|69696822|FG000|Overall Study|Sponsor Decision|0|||
38014316|NCT00356525|69696823|FG001|Overall Study|Sponsor Decision|0|||
38014317|NCT00356525|69696824|FG002|Overall Study|Sponsor Decision|0|||
38014318|NCT00356525|69696825|FG003|Overall Study|Sponsor Decision|1|||
38014319|NCT00356369|69696837|FG000|Active Phase|Withdrawal by Subject|2|||
38014320|NCT00356369|69696838|FG001|Active Phase|Withdrawal by Subject|1|||
38014321|NCT03383614|69696848|FG000|Overall Study|Withdrawal by Subject|0|||
38014322|NCT03383614|69696849|FG001|Overall Study|Withdrawal by Subject|1|||
38014323|NCT03383614|69696850|FG002|Overall Study|Withdrawal by Subject|0|||
38014324|NCT03383614|69696851|FG003|Overall Study|Withdrawal by Subject|0|||
38014325|NCT03403036|69696866|FG000|Overall Study|Lack of Efficacy|5|||
38014326|NCT00356135|69696873|FG000|Overall Study|Protocol Violation|1|||
38014327|NCT00356135|69696874|FG001|Overall Study|Protocol Violation|0|||
38014328|NCT00356135|69696875|FG002|Overall Study|Protocol Violation|0|||
38014329|NCT00356135|69696873|FG000|Overall Study|Adverse Event|1|||
38014330|NCT00356135|69696874|FG001|Overall Study|Adverse Event|0|||
38014331|NCT00356135|69696875|FG002|Overall Study|Adverse Event|0|||
38014332|NCT00356135|69696873|FG000|Overall Study|Lost to Follow-up|0|||
38014333|NCT00356135|69696874|FG001|Overall Study|Lost to Follow-up|0|||
38014334|NCT00356135|69696875|FG002|Overall Study|Lost to Follow-up|1|||
38014335|NCT00356135|69696873|FG000|Overall Study|Physician Decision|1|||
38014336|NCT00356135|69696874|FG001|Overall Study|Physician Decision|1|||
38014337|NCT00356135|69696875|FG002|Overall Study|Physician Decision|1|||
38014338|NCT00356135|69696873|FG000|Overall Study|Subject non-compliance|1|||
38014339|NCT00356135|69696874|FG001|Overall Study|Subject non-compliance|1|||
38014340|NCT00356135|69696875|FG002|Overall Study|Subject non-compliance|3|||
38014341|NCT03383146|69696887|FG000|Overall Study|Screen Failure|1|||
38014342|NCT03383146|69696888|FG001|Overall Study|Screen Failure|0|||
38014343|NCT03383146|69696887|FG000|Overall Study|Adverse Event|6|||
38014344|NCT03383146|69696888|FG001|Overall Study|Adverse Event|18|||
38014345|NCT03383146|69696887|FG000|Overall Study|Lack of Efficacy|0|||
38014346|NCT03383146|69696888|FG001|Overall Study|Lack of Efficacy|3|||
38014347|NCT03383146|69696887|FG000|Overall Study|Withdrawal by Subject|20|||
38014348|NCT03383146|69696888|FG001|Overall Study|Withdrawal by Subject|36|||
38014349|NCT03383146|69696887|FG000|Overall Study|Lost to Follow-up|5|||
38014350|NCT03383146|69696888|FG001|Overall Study|Lost to Follow-up|15|||
38014351|NCT03383146|69696887|FG000|Overall Study|Death|0|||
38014352|NCT03383146|69696888|FG001|Overall Study|Death|2|||
37832099|NCT00557193|69515567|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
37832100|NCT00557193|69515568|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
37832101|NCT00557193|69515563|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
37832102|NCT00557193|69515564|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
37832103|NCT00557193|69515565|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
38014353|NCT03383146|69696887|FG000|Overall Study|Physician Decision|0|||
38014354|NCT03383146|69696888|FG001|Overall Study|Physician Decision|1|||
38014355|NCT03383146|69696887|FG000|Overall Study|Protocol Deviation|1|||
38014356|NCT03383146|69696888|FG001|Overall Study|Protocol Deviation|8|||
38014357|NCT03383146|69696887|FG000|Overall Study|Study Terminated by the Sponsor|48|||
38014358|NCT03383146|69696888|FG001|Overall Study|Study Terminated by the Sponsor|95|||
38014359|NCT03383146|69696887|FG000|Overall Study|Reason not Specified|4|||
38014360|NCT03383146|69696888|FG001|Overall Study|Reason not Specified|6|||
38014361|NCT03616964|69696898|FG000|Overall Study|Adverse Event|15|||
38014362|NCT03616964|69696899|FG001|Overall Study|Adverse Event|10|||
37832104|NCT00557193|69515566|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
37832105|NCT00557193|69515567|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
37832106|NCT00557193|69515568|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
37832107|NCT01295827|69515605|FG000|Overall Study|Adverse Event|1|||
37832108|NCT01295827|69515606|FG001|Overall Study|Adverse Event|2|||
37832109|NCT01295827|69515607|FG002|Overall Study|Adverse Event|2|||
37832110|NCT01295827|69515608|FG003|Overall Study|Adverse Event|1|||
37832111|NCT01295827|69515609|FG004|Overall Study|Adverse Event|1|||
37832112|NCT01295827|69515610|FG005|Overall Study|Adverse Event|4|||
38014363|NCT03616964|69696900|FG002|Overall Study|Adverse Event|16|||
38014364|NCT03616964|69696898|FG000|Overall Study|Death|3|||
38014365|NCT03616964|69696899|FG001|Overall Study|Death|0|||
38014366|NCT03616964|69696900|FG002|Overall Study|Death|4|||
38014367|NCT03616964|69696898|FG000|Overall Study|Lack of Efficacy|4|||
38014368|NCT03616964|69696899|FG001|Overall Study|Lack of Efficacy|8|||
38014369|NCT03616964|69696900|FG002|Overall Study|Lack of Efficacy|8|||
38014370|NCT03616964|69696898|FG000|Overall Study|Lost to Follow-up|2|||
38014371|NCT03616964|69696899|FG001|Overall Study|Lost to Follow-up|1|||
38014372|NCT03616964|69696900|FG002|Overall Study|Lost to Follow-up|3|||
38014373|NCT03616964|69696898|FG000|Overall Study|Withdrawal by Subject|18|||
38014374|NCT03616964|69696899|FG001|Overall Study|Withdrawal by Subject|14|||
38014375|NCT03616964|69696900|FG002|Overall Study|Withdrawal by Subject|21|||
38014376|NCT03616964|69696898|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
38014377|NCT03616964|69696899|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
38014378|NCT03616964|69696900|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
38014379|NCT03616964|69696898|FG000|Overall Study|Sponsor's Decision|1|||
38014380|NCT03616964|69696899|FG001|Overall Study|Sponsor's Decision|0|||
38014381|NCT03616964|69696900|FG002|Overall Study|Sponsor's Decision|0|||
38014382|NCT03616964|69696898|FG000|Overall Study|Physician Decision|0|||
38014383|NCT03616964|69696899|FG001|Overall Study|Physician Decision|2|||
38014384|NCT03616964|69696900|FG002|Overall Study|Physician Decision|0|||
38014385|NCT03616964|69696898|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
38014386|NCT03616964|69696899|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
38014387|NCT03616964|69696900|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
38014388|NCT03616964|69696898|FG000|Overall Study|Protocol Violation|0|||
38014389|NCT03616964|69696899|FG001|Overall Study|Protocol Violation|1|||
38014390|NCT03616964|69696900|FG002|Overall Study|Protocol Violation|0|||
38014391|NCT03616964|69696898|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
38014392|NCT03616964|69696899|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
38014393|NCT03616964|69696900|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
38014394|NCT03616964|69696898|FG000|Overall Study|Randomized but Never Treated|1|||
38014395|NCT03616964|69696899|FG001|Overall Study|Randomized but Never Treated|1|||
38014396|NCT03616964|69696900|FG002|Overall Study|Randomized but Never Treated|1|||
38014397|NCT00350519|69696912|FG000|Overall Study|Death|0|||
38014398|NCT00350519|69696913|FG001|Overall Study|Death|1|||
38014399|NCT00350519|69696912|FG000|Overall Study|Physician Decision|0|||
38014400|NCT00350519|69696913|FG001|Overall Study|Physician Decision|1|||
38014401|NCT00350519|69696912|FG000|Overall Study|Protocol Violation|1|||
38014402|NCT00350519|69696913|FG001|Overall Study|Protocol Violation|2|||
38014403|NCT00350519|69696912|FG000|Overall Study|Withdrawal by Subject|3|||
38014404|NCT00350519|69696913|FG001|Overall Study|Withdrawal by Subject|2|||
38014405|NCT03382912|69696921|FG000|Overall Study|Physician Decision|0|||
38014406|NCT03382912|69696922|FG001|Overall Study|Physician Decision|1|||
38014407|NCT03382912|69696921|FG000|Overall Study|Sponsor Decision|6|||
38014408|NCT03382912|69696922|FG001|Overall Study|Sponsor Decision|6|||
38014409|NCT03382912|69696921|FG000|Overall Study|Withdrawal by Subject|0|||
38014410|NCT03382912|69696922|FG001|Overall Study|Withdrawal by Subject|5|||
38014411|NCT00350207|69696931|FG000|Overall Study|Adverse Event|5|||
38014412|NCT00350207|69696932|FG001|Overall Study|Adverse Event|2|||
38014413|NCT00350207|69696933|FG002|Overall Study|Adverse Event|2|||
38014414|NCT00350207|69696931|FG000|Overall Study|Lack of Efficacy|1|||
38014415|NCT00350207|69696932|FG001|Overall Study|Lack of Efficacy|0|||
38014416|NCT00350207|69696933|FG002|Overall Study|Lack of Efficacy|2|||
38014417|NCT00350207|69696931|FG000|Overall Study|Lost to Follow-up|1|||
38014418|NCT00350207|69696932|FG001|Overall Study|Lost to Follow-up|0|||
38014419|NCT00350207|69696933|FG002|Overall Study|Lost to Follow-up|1|||
38014420|NCT00350207|69696931|FG000|Overall Study|Withdrawal by Subject|0|||
38014421|NCT00350207|69696932|FG001|Overall Study|Withdrawal by Subject|1|||
38014422|NCT00350207|69696933|FG002|Overall Study|Withdrawal by Subject|1|||
38014423|NCT00350207|69696931|FG000|Overall Study|Other|1|||
37832113|NCT01295827|69515611|FG006|Overall Study|Adverse Event|15|||
38014424|NCT00350207|69696932|FG001|Overall Study|Other|3|||
38014425|NCT00350207|69696933|FG002|Overall Study|Other|1|||
38014426|NCT00349973|69696943|FG000|Overall Study|Adverse Event|3|||
38014427|NCT00349973|69696944|FG001|Overall Study|Adverse Event|3|||
38014428|NCT00349973|69696943|FG000|Overall Study|Withdrawal by Subject|1|||
38014429|NCT00349973|69696944|FG001|Overall Study|Withdrawal by Subject|0|||
38014430|NCT03187262|69696950|FG000|Induction|Lack of Efficacy|2|||
38014431|NCT03187262|69696950|FG000|Induction|Progressive Disease|4|||
38014432|NCT03187262|69696950|FG000|Consolidation|Progressive Disease|5|||
38014433|NCT03381196|69696956|FG000|Overall Study|Withdrawal by Subject|7|||
38014434|NCT03381196|69696957|FG001|Overall Study|Withdrawal by Subject|7|||
38014435|NCT03381196|69696956|FG000|Overall Study|Other|0|||
38014436|NCT03381196|69696957|FG001|Overall Study|Other|1|||
38014437|NCT03381196|69696956|FG000|Overall Study|Lost to Follow-up|5|||
38014438|NCT03381196|69696957|FG001|Overall Study|Lost to Follow-up|4|||
38014439|NCT03381196|69696956|FG000|Overall Study|Death|0|||
37832114|NCT01295827|69515612|FG007|Overall Study|Adverse Event|49|||
37832115|NCT01295827|69515613|FG008|Overall Study|Adverse Event|22|||
37832116|NCT01295827|69515614|FG009|Overall Study|Adverse Event|7|||
37832117|NCT01295827|69515615|FG010|Overall Study|Adverse Event|50|||
37832118|NCT01295827|69515616|FG011|Overall Study|Adverse Event|21|||
37832119|NCT01295827|69515617|FG012|Overall Study|Adverse Event|0|||
37832120|NCT01295827|69515618|FG013|Overall Study|Adverse Event|0|||
37832121|NCT01295827|69515619|FG014|Overall Study|Adverse Event|0|||
37832122|NCT01295827|69515605|FG000|Overall Study|Lost to Follow-up|0|||
37832123|NCT01295827|69515606|FG001|Overall Study|Lost to Follow-up|0|||
37832124|NCT01295827|69515607|FG002|Overall Study|Lost to Follow-up|3|||
37832125|NCT01295827|69515608|FG003|Overall Study|Lost to Follow-up|0|||
37832126|NCT01295827|69515609|FG004|Overall Study|Lost to Follow-up|1|||
37832127|NCT01295827|69515610|FG005|Overall Study|Lost to Follow-up|0|||
37832128|NCT01295827|69515611|FG006|Overall Study|Lost to Follow-up|4|||
37832129|NCT01295827|69515612|FG007|Overall Study|Lost to Follow-up|8|||
37832130|NCT01295827|69515613|FG008|Overall Study|Lost to Follow-up|7|||
37832131|NCT01295827|69515614|FG009|Overall Study|Lost to Follow-up|4|||
37832132|NCT01295827|69515615|FG010|Overall Study|Lost to Follow-up|7|||
37832133|NCT01295827|69515616|FG011|Overall Study|Lost to Follow-up|3|||
37832134|NCT01295827|69515617|FG012|Overall Study|Lost to Follow-up|0|||
37832135|NCT01295827|69515618|FG013|Overall Study|Lost to Follow-up|0|||
37832136|NCT01295827|69515619|FG014|Overall Study|Lost to Follow-up|0|||
37832137|NCT01295827|69515605|FG000|Overall Study|Not Reported|0|||
37832138|NCT01295827|69515606|FG001|Overall Study|Not Reported|0|||
37832139|NCT01295827|69515607|FG002|Overall Study|Not Reported|0|||
37832140|NCT01295827|69515608|FG003|Overall Study|Not Reported|1|||
37832141|NCT01295827|69515609|FG004|Overall Study|Not Reported|0|||
37832142|NCT01295827|69515610|FG005|Overall Study|Not Reported|0|||
37832143|NCT01295827|69515611|FG006|Overall Study|Not Reported|24|||
37832144|NCT01295827|69515612|FG007|Overall Study|Not Reported|58|||
37832145|NCT01295827|69515613|FG008|Overall Study|Not Reported|41|||
37832146|NCT01295827|69515614|FG009|Overall Study|Not Reported|2|||
37832147|NCT01295827|69515615|FG010|Overall Study|Not Reported|23|||
37832148|NCT01295827|69515616|FG011|Overall Study|Not Reported|13|||
37832149|NCT01295827|69515617|FG012|Overall Study|Not Reported|0|||
37832150|NCT01295827|69515618|FG013|Overall Study|Not Reported|0|||
37832151|NCT01295827|69515619|FG014|Overall Study|Not Reported|0|||
37832152|NCT01295827|69515605|FG000|Overall Study|Progressive Disease|2|||
37832153|NCT01295827|69515606|FG001|Overall Study|Progressive Disease|1|||
37832154|NCT01295827|69515607|FG002|Overall Study|Progressive Disease|5|||
37832155|NCT01295827|69515608|FG003|Overall Study|Progressive Disease|2|||
37832156|NCT01295827|69515609|FG004|Overall Study|Progressive Disease|0|||
37832157|NCT01295827|69515610|FG005|Overall Study|Progressive Disease|1|||
37832158|NCT01295827|69515611|FG006|Overall Study|Progressive Disease|87|||
37832159|NCT01295827|69515612|FG007|Overall Study|Progressive Disease|144|||
37832160|NCT01295827|69515613|FG008|Overall Study|Progressive Disease|85|||
37832161|NCT01295827|69515614|FG009|Overall Study|Progressive Disease|40|||
37832162|NCT01295827|69515615|FG010|Overall Study|Progressive Disease|175|||
37832163|NCT01295827|69515616|FG011|Overall Study|Progressive Disease|136|||
37832164|NCT01295827|69515617|FG012|Overall Study|Progressive Disease|0|||
37832165|NCT01295827|69515618|FG013|Overall Study|Progressive Disease|0|||
38014440|NCT03381196|69696957|FG001|Overall Study|Death|1|||
37832166|NCT01295827|69515619|FG014|Overall Study|Progressive Disease|0|||
38014441|NCT03381196|69696956|FG000|Overall Study|Adverse Event|1|||
38014442|NCT03381196|69696957|FG001|Overall Study|Adverse Event|0|||
37832167|NCT01295827|69515605|FG000|Overall Study|Screen Failure|0|||
37832168|NCT01295827|69515606|FG001|Overall Study|Screen Failure|0|||
37832169|NCT01295827|69515607|FG002|Overall Study|Screen Failure|0|||
37832170|NCT01295827|69515608|FG003|Overall Study|Screen Failure|0|||
37832171|NCT01295827|69515609|FG004|Overall Study|Screen Failure|0|||
37832172|NCT01295827|69515610|FG005|Overall Study|Screen Failure|0|||
38014443|NCT03381196|69696956|FG000|Overall Study|Randomized, not treated|3|||
38014444|NCT03381196|69696957|FG001|Overall Study|Randomized, not treated|6|||
37832173|NCT01295827|69515611|FG006|Overall Study|Screen Failure|2|||
37832174|NCT01295827|69515612|FG007|Overall Study|Screen Failure|2|||
38014445|NCT02950558|69696965|FG000|Overall Study|Lost to Follow-up|2|||
37832175|NCT01295827|69515613|FG008|Overall Study|Screen Failure|2|||
38014446|NCT02950558|69696966|FG001|Overall Study|Lost to Follow-up|0|||
37832176|NCT01295827|69515614|FG009|Overall Study|Screen Failure|0|||
37832177|NCT01295827|69515615|FG010|Overall Study|Screen Failure|1|||
37832178|NCT01295827|69515616|FG011|Overall Study|Screen Failure|0|||
37832179|NCT01295827|69515617|FG012|Overall Study|Screen Failure|0|||
38014447|NCT03345472|69696973|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
38014448|NCT03345472|69696973|FG000|Implant to 3 Months|Physician Decision|1|||
38014449|NCT03345472|69696973|FG000|Implant to 3 Months|Adverse Event|1|||
38014450|NCT03345472|69696973|FG000|3 Months to 12 Months|Physician Decision|3|||
38014451|NCT03345472|69696973|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
38014452|NCT03345472|69696973|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
38014453|NCT03345472|69696973|FG000|3 Months to 12 Months|Adverse Event|1|||
38014454|NCT03345472|69696973|FG000|3 Months to 12 Months|Death|1|||
38014455|NCT00349349|69696980|FG000|Overall Study|Adverse Event|5|||
38014456|NCT00349349|69696981|FG001|Overall Study|Adverse Event|6|||
38014457|NCT00349349|69696982|FG002|Overall Study|Adverse Event|2|||
38014458|NCT00349349|69696980|FG000|Overall Study|Withdrawal by Subject|5|||
38014459|NCT00349349|69696981|FG001|Overall Study|Withdrawal by Subject|2|||
38014460|NCT00349349|69696982|FG002|Overall Study|Withdrawal by Subject|1|||
38014461|NCT00349349|69696980|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
38014462|NCT00349349|69696981|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
38014463|NCT00349349|69696982|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
38014464|NCT00349349|69696980|FG000|Overall Study|Death|13|||
38014465|NCT00349349|69696981|FG001|Overall Study|Death|10|||
38014466|NCT00349349|69696982|FG002|Overall Study|Death|1|||
38014467|NCT00349349|69696980|FG000|Overall Study|Other Treatment Selected|2|||
38014468|NCT00349349|69696981|FG001|Overall Study|Other Treatment Selected|0|||
38014469|NCT00349349|69696982|FG002|Overall Study|Other Treatment Selected|0|||
38014470|NCT00349349|69696980|FG000|Overall Study|Participant Reduced General Condition|0|||
38014471|NCT00349349|69696981|FG001|Overall Study|Participant Reduced General Condition|1|||
38014472|NCT00349349|69696982|FG002|Overall Study|Participant Reduced General Condition|0|||
38014473|NCT00349349|69696980|FG000|Overall Study|Physician Decision|1|||
38014474|NCT00349349|69696981|FG001|Overall Study|Physician Decision|2|||
38014475|NCT00349349|69696982|FG002|Overall Study|Physician Decision|1|||
38014476|NCT00349349|69696980|FG000|Overall Study|No Response|0|||
38014477|NCT00349349|69696981|FG001|Overall Study|No Response|3|||
38014478|NCT00349349|69696982|FG002|Overall Study|No Response|0|||
38014479|NCT00349349|69696980|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
38014480|NCT00349349|69696981|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
38014481|NCT00349349|69696982|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
38014482|NCT02950480|69696994|FG000|Overall Study|Withdrawal by Subject|1|||
38014483|NCT02950480|69696995|FG001|Overall Study|Withdrawal by Subject|0|||
37832180|NCT01295827|69515618|FG013|Overall Study|Screen Failure|0|||
37832181|NCT01295827|69515619|FG014|Overall Study|Screen Failure|0|||
37832182|NCT01295827|69515605|FG000|Overall Study|Withdrawal by Subject|1|||
37832183|NCT01295827|69515606|FG001|Overall Study|Withdrawal by Subject|0|||
37832184|NCT01295827|69515607|FG002|Overall Study|Withdrawal by Subject|2|||
37832185|NCT01295827|69515608|FG003|Overall Study|Withdrawal by Subject|0|||
37832186|NCT01295827|69515609|FG004|Overall Study|Withdrawal by Subject|0|||
37832187|NCT01295827|69515610|FG005|Overall Study|Withdrawal by Subject|1|||
37832188|NCT01295827|69515611|FG006|Overall Study|Withdrawal by Subject|13|||
37698448|NCT01815424|69175238|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
38014484|NCT00348881|69697003|FG000|Overall Study|Lost to Follow-up|12|||
38014485|NCT00348881|69697004|FG001|Overall Study|Lost to Follow-up|6|||
37698449|NCT01815424|69175234|FG000|Week 0 to 16|Lost to Follow-up|0|||
37698450|NCT01815424|69175235|FG001|Week 0 to 16|Lost to Follow-up|1|||
37698451|NCT01815424|69175236|FG002|Week 0 to 16|Lost to Follow-up|0|||
37698452|NCT01815424|69175237|FG003|Week 0 to 16|Lost to Follow-up|0|||
37832189|NCT01295827|69515612|FG007|Overall Study|Withdrawal by Subject|35|||
37832190|NCT01295827|69515613|FG008|Overall Study|Withdrawal by Subject|11|||
38014486|NCT00348881|69697003|FG000|Overall Study|Withdrawal by Subject|3|||
37832191|NCT01295827|69515614|FG009|Overall Study|Withdrawal by Subject|2|||
37832192|NCT01295827|69515615|FG010|Overall Study|Withdrawal by Subject|18|||
37832193|NCT01295827|69515616|FG011|Overall Study|Withdrawal by Subject|13|||
37832194|NCT01295827|69515617|FG012|Overall Study|Withdrawal by Subject|0|||
37832195|NCT01295827|69515618|FG013|Overall Study|Withdrawal by Subject|0|||
37832196|NCT01295827|69515619|FG014|Overall Study|Withdrawal by Subject|0|||
38014487|NCT00348881|69697004|FG001|Overall Study|Withdrawal by Subject|4|||
38014488|NCT00348881|69697003|FG000|Overall Study|Adverse Event|2|||
38014489|NCT00348881|69697004|FG001|Overall Study|Adverse Event|0|||
38014490|NCT00348881|69697003|FG000|Overall Study|Serious Adverse Event|0|||
38014491|NCT00348881|69697004|FG001|Overall Study|Serious Adverse Event|2|||
37698453|NCT01815424|69175238|FG004|Week 0 to 16|Lost to Follow-up|0|||
37832197|NCT01295827|69515605|FG000|Overall Study|Other|0|||
37698454|NCT01815424|69175234|FG000|Week 0 to 16|Withdrawal by Subject|0|||
38014492|NCT03376516|69697014|FG000|Overall Study|Not treated|1|||
38014493|NCT03376516|69697014|FG000|Overall Study|Consent withdrawn|1|||
38014494|NCT03797144|69697040|FG000|Enrollment|Protocol Violation|4|||
38014495|NCT03797144|69697041|FG001|Enrollment|Protocol Violation|1|||
38014496|NCT03797144|69697040|FG000|Surgery|Protocol Violation|1|||
38014497|NCT03797144|69697041|FG001|Surgery|Protocol Violation|0|||
38014498|NCT03797144|69697040|FG000|3 Month|Early termination cut-off date|2|||
38014499|NCT03797144|69697041|FG001|3 Month|Early termination cut-off date|0|||
38014500|NCT03797144|69697040|FG000|12 Month|Early termination cut-off date|8|||
38014501|NCT03797144|69697041|FG001|12 Month|Early termination cut-off date|9|||
38014502|NCT03797144|69697040|FG000|24 Month|Early termination cut-off date|1|||
38014503|NCT03797144|69697041|FG001|24 Month|Early termination cut-off date|1|||
38014504|NCT00347009|69697048|FG000|Overall Study|Death|1|||
38014505|NCT00347009|69697048|FG000|Overall Study|Adverse Event|6|||
38014506|NCT00347009|69697048|FG000|Overall Study|Withdrawal by Subject|3|||
38014507|NCT00347009|69697048|FG000|Overall Study|Physician Decision|5|||
38014508|NCT00347009|69697048|FG000|Overall Study|Lost to Follow-up|4|||
38014509|NCT00347009|69697048|FG000|Overall Study|Protocol Violation|2|||
38014510|NCT00347009|69697048|FG000|Overall Study|Adverse Laboratory Experience|1|||
38014511|NCT00347009|69697048|FG000|Overall Study|Insufficient Viral Suppression|3|||
38014512|NCT00347009|69697048|FG000|Overall Study|Increased ALT/HBV DNA|1|||
38014513|NCT00347009|69697048|FG000|Overall Study|Serious Adverse Event|1|||
38014514|NCT00346775|69697056|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
38014515|NCT00346775|69697057|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
38014516|NCT00346775|69697056|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
38014517|NCT00346775|69697057|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
38014518|NCT00346775|69697056|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
38014519|NCT00346775|69697057|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
38014520|NCT00346697|69697069|FG000|Overall Study|Lost to Follow-up|0|||
38014521|NCT00346697|69697070|FG001|Overall Study|Lost to Follow-up|1|||
38014522|NCT03400852|69697080|FG000|Blinded Treatment Period|Physician Decision|0|||
38014523|NCT03400852|69697081|FG001|Blinded Treatment Period|Physician Decision|1|||
38014524|NCT03400852|69697082|FG002|Blinded Treatment Period|Physician Decision|0|||
38014525|NCT03400852|69697080|FG000|Blinded Treatment Period|Adverse Event|1|||
38014526|NCT03400852|69697081|FG001|Blinded Treatment Period|Adverse Event|1|||
38014527|NCT03400852|69697082|FG002|Blinded Treatment Period|Adverse Event|0|||
38014528|NCT03400852|69697080|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
38014529|NCT03400852|69697081|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
38014530|NCT03400852|69697082|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
38014531|NCT03400852|69697080|FG000|Open Label Period|Physician Decision|0|||
37832198|NCT01295827|69515606|FG001|Overall Study|Other|0|||
37832199|NCT01295827|69515607|FG002|Overall Study|Other|0|||
37832200|NCT01295827|69515608|FG003|Overall Study|Other|0|||
37832201|NCT01295827|69515609|FG004|Overall Study|Other|0|||
37832202|NCT01295827|69515610|FG005|Overall Study|Other|0|||
37832203|NCT01295827|69515611|FG006|Overall Study|Other|1|||
37832204|NCT01295827|69515612|FG007|Overall Study|Other|1|||
37832205|NCT01295827|69515613|FG008|Overall Study|Other|1|||
37832206|NCT01295827|69515614|FG009|Overall Study|Other|0|||
37832207|NCT01295827|69515615|FG010|Overall Study|Other|2|||
37832208|NCT01295827|69515616|FG011|Overall Study|Other|0|||
37832209|NCT01295827|69515617|FG012|Overall Study|Other|0|||
37832210|NCT01295827|69515618|FG013|Overall Study|Other|0|||
37832211|NCT01295827|69515619|FG014|Overall Study|Other|0|||
37832212|NCT01295671|69515675|FG000|Overall Study|Lost to Follow-up|4|||
37832213|NCT01295671|69515676|FG001|Overall Study|Lost to Follow-up|6|||
37832214|NCT01295671|69515677|FG002|Overall Study|Lost to Follow-up|3|||
37832215|NCT01295671|69515675|FG000|Overall Study|Withdrawal by Subject|3|||
37832216|NCT01295671|69515676|FG001|Overall Study|Withdrawal by Subject|1|||
37832217|NCT01295671|69515677|FG002|Overall Study|Withdrawal by Subject|0|||
37832218|NCT01295320|69515685|FG000|Overall Study|Adverse Event|2|||
37832219|NCT01295320|69515685|FG000|Overall Study|Lost to Follow-up|4|||
37909839|NCT00772005|69595655|FG001|Overall Study|Lack of Efficacy|1|||
38014532|NCT03400852|69697081|FG001|Open Label Period|Physician Decision|0|||
38014533|NCT03400852|69697082|FG002|Open Label Period|Physician Decision|1|||
38014534|NCT03400852|69697080|FG000|Open Label Period|Study terminated by sponsor|0|||
38014535|NCT03400852|69697081|FG001|Open Label Period|Study terminated by sponsor|0|||
38014536|NCT03400852|69697082|FG002|Open Label Period|Study terminated by sponsor|21|||
38014537|NCT03398356|69697093|FG000|Before Treatment|Lost to Follow-up|1|||
37832220|NCT01295320|69515685|FG000|Overall Study|Withdrawal by Subject|2|||
38014538|NCT03398356|69697094|FG001|Before Treatment|Lost to Follow-up|2|||
37832221|NCT01295320|69515685|FG000|Overall Study|Subject was bedridden|1|||
37832222|NCT01295320|69515685|FG000|Overall Study|Unable to travel|1|||
37832223|NCT01295281|69515691|FG000|First Intervention (7 Days)|Death|0|||
37909840|NCT00772005|69595656|FG002|Overall Study|Lack of Efficacy|0|||
38014539|NCT03398356|69697095|FG002|Before Treatment|Lost to Follow-up|0|||
37832224|NCT01295281|69515692|FG001|First Intervention (7 Days)|Death|1|||
38014540|NCT03398356|69697093|FG000|Before Treatment|drug intolerance|2|||
38014541|NCT03398356|69697094|FG001|Before Treatment|drug intolerance|1|||
38014542|NCT03398356|69697095|FG002|Before Treatment|drug intolerance|0|||
38014543|NCT03398356|69697093|FG000|Before Treatment|Withdrawal by Subject|0|||
38014544|NCT03398356|69697094|FG001|Before Treatment|Withdrawal by Subject|5|||
38014545|NCT03398356|69697095|FG002|Before Treatment|Withdrawal by Subject|0|||
38014546|NCT03398356|69697093|FG000|Before Treatment|Physician Decision|0|||
38014547|NCT03398356|69697094|FG001|Before Treatment|Physician Decision|0|||
38014548|NCT03398356|69697095|FG002|Before Treatment|Physician Decision|11|||
38014549|NCT03398356|69697093|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
38014550|NCT03398356|69697094|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
38014551|NCT03398356|69697095|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
38014552|NCT00346151|69697103|FG000|Overall Study|Withdrawal by Subject|3|||
38014553|NCT00130286|69697111|FG000|Overall Study|Withdrawal by Subject|0|||
38014554|NCT00130286|69697112|FG001|Overall Study|Withdrawal by Subject|1|||
38014555|NCT00130286|69697113|FG002|Overall Study|Withdrawal by Subject|2|||
38014556|NCT00130286|69697114|FG003|Overall Study|Withdrawal by Subject|2|||
38014557|NCT00130286|69697111|FG000|Overall Study|Adverse Event|0|||
38014558|NCT00130286|69697112|FG001|Overall Study|Adverse Event|0|||
38014559|NCT00130286|69697113|FG002|Overall Study|Adverse Event|2|||
38014560|NCT00130286|69697114|FG003|Overall Study|Adverse Event|0|||
38014561|NCT00130286|69697111|FG000|Overall Study|Missing lab specimens|0|||
38014562|NCT00130286|69697112|FG001|Overall Study|Missing lab specimens|2|||
38014563|NCT00130286|69697113|FG002|Overall Study|Missing lab specimens|0|||
38014564|NCT00130286|69697114|FG003|Overall Study|Missing lab specimens|0|||
38014565|NCT00346073|69697126|FG000|Overall Study|Serious Adverse Event|2|||
38014566|NCT00346073|69697127|FG001|Overall Study|Serious Adverse Event|0|||
38014567|NCT00346073|69697126|FG000|Overall Study|Lost to Follow-up|39|||
38014568|NCT00346073|69697127|FG001|Overall Study|Lost to Follow-up|24|||
38014569|NCT03374488|69697135|FG000|Overall Study|Death|13|||
38014570|NCT03374488|69697136|FG001|Overall Study|Death|13|||
38014571|NCT03374488|69697135|FG000|Overall Study|Withdrawal by Subject|3|||
38014572|NCT03374488|69697136|FG001|Overall Study|Withdrawal by Subject|1|||
38014573|NCT03374488|69697135|FG000|Overall Study|Physician Decision|3|||
38014574|NCT03374488|69697136|FG001|Overall Study|Physician Decision|0|||
38014575|NCT00345683|69697145|FG000|Overall Study|Lost to Follow-up|19|||
38014576|NCT00345683|69697146|FG001|Overall Study|Lost to Follow-up|7|||
38014577|NCT00345683|69697145|FG000|Overall Study|Other|6|||
38014578|NCT00345683|69697146|FG001|Overall Study|Other|2|||
38014579|NCT03828383|69697154|FG000|Overall Study|Lost to Follow-up|3|||
38014580|NCT03828383|69697155|FG001|Overall Study|Lost to Follow-up|2|||
38014581|NCT03828383|69697154|FG000|Overall Study|Withdrawal by Subject|4|||
38014582|NCT03828383|69697155|FG001|Overall Study|Withdrawal by Subject|5|||
38014583|NCT00345605|69697161|FG000|Arm 1|Adverse Event|0|||
38014584|NCT00345605|69697162|FG001|Arm 1|Adverse Event|1|||
38014585|NCT00345605|69697161|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
38014586|NCT00345605|69697162|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
37832225|NCT01294696|69515700|FG000|Overall Study|Screening failures|7|||
37832226|NCT01294696|69515700|FG000|Overall Study|Protocol Violation|8|||
37832227|NCT01294696|69515700|FG000|Overall Study|Missing BPI Response|7|||
37832228|NCT01294696|69515700|FG000|Overall Study|Site closure|52|||
37832229|NCT01294579|69515705|FG000|Overall Study|Disease progression|12|||
37832230|NCT01294579|69515705|FG000|Overall Study|Adverse Event|11|||
37832231|NCT01294579|69515705|FG000|Overall Study|Study closed/terminated|3|||
37832232|NCT01294579|69515705|FG000|Overall Study|Lost to Follow-up|1|||
37832233|NCT01294579|69515705|FG000|Overall Study|Physician Decision|3|||
37832234|NCT01294579|69515705|FG000|Overall Study|Withdrawal by Subject|5|||
37832235|NCT01294462|69515711|FG000|Overall Study|Lost to Follow-up|1|||
37832236|NCT01294462|69515712|FG001|Overall Study|Lost to Follow-up|0|||
37832237|NCT01294462|69515711|FG000|Overall Study|Withdrawal by Subject|65|||
37832238|NCT01294462|69515712|FG001|Overall Study|Withdrawal by Subject|63|||
37832239|NCT01294423|69515721|FG000|Overall Study|Adverse Event|1|||
37832240|NCT01294423|69515722|FG001|Overall Study|Adverse Event|2|||
38014587|NCT03394924|69697173|FG000|Overall Study|Adverse Event|0|||
38014588|NCT03394924|69697174|FG001|Overall Study|Adverse Event|5|||
37832241|NCT01294423|69515723|FG002|Overall Study|Adverse Event|3|||
38014589|NCT03394924|69697175|FG002|Overall Study|Adverse Event|0|||
38014590|NCT03394924|69697173|FG000|Overall Study|Withdrawal by Subject|2|||
38014591|NCT03394924|69697174|FG001|Overall Study|Withdrawal by Subject|0|||
38014592|NCT03394924|69697175|FG002|Overall Study|Withdrawal by Subject|0|||
38014593|NCT03394924|69697173|FG000|Overall Study|Lost to Follow-up|0|||
38014594|NCT03394924|69697174|FG001|Overall Study|Lost to Follow-up|1|||
37832242|NCT01294423|69515721|FG000|Overall Study|Withdrawal by Subject|1|||
38014595|NCT03394924|69697175|FG002|Overall Study|Lost to Follow-up|0|||
37832243|NCT01294423|69515722|FG001|Overall Study|Withdrawal by Subject|2|||
38014596|NCT03394924|69697173|FG000|Overall Study|Did not meet all inclusion criteria|1|||
38014597|NCT03394924|69697174|FG001|Overall Study|Did not meet all inclusion criteria|0|||
38014598|NCT03394924|69697175|FG002|Overall Study|Did not meet all inclusion criteria|0|||
38014599|NCT00345293|69697185|FG000|Overall Study|Unable to access line for sample|1|||
38014600|NCT00345293|69697186|FG001|Overall Study|Unable to access line for sample|0|||
38014601|NCT00345293|69697185|FG000|Overall Study|Withdrawal by Subject|1|||
38014602|NCT00345293|69697186|FG001|Overall Study|Withdrawal by Subject|0|||
38014603|NCT00355121|69697195|FG000|Overall Study|Did not receive study vaccine|1|||
38014604|NCT00355121|69697196|FG001|Overall Study|Did not receive study vaccine|0|||
38014605|NCT00355121|69697197|FG002|Overall Study|Did not receive study vaccine|1|||
38014606|NCT00355121|69697195|FG000|Overall Study|Adverse Event|0|||
38014607|NCT00355121|69697196|FG001|Overall Study|Adverse Event|1|||
38014608|NCT00355121|69697197|FG002|Overall Study|Adverse Event|0|||
38014609|NCT00355121|69697195|FG000|Overall Study|Protocol Violation|7|||
38014610|NCT00355121|69697196|FG001|Overall Study|Protocol Violation|9|||
38014611|NCT00355121|69697197|FG002|Overall Study|Protocol Violation|1|||
38014612|NCT00355121|69697195|FG000|Overall Study|Lost to Follow-up|4|||
38014613|NCT00355121|69697196|FG001|Overall Study|Lost to Follow-up|7|||
38014614|NCT00355121|69697197|FG002|Overall Study|Lost to Follow-up|1|||
38014615|NCT00355121|69697195|FG000|Overall Study|Withdrawal by Subject|9|||
38014616|NCT00355121|69697196|FG001|Overall Study|Withdrawal by Subject|10|||
38014617|NCT00355121|69697197|FG002|Overall Study|Withdrawal by Subject|2|||
38014618|NCT00355121|69697195|FG000|Overall Study|Serious adverse events|0|||
38014619|NCT00355121|69697196|FG001|Overall Study|Serious adverse events|2|||
38014620|NCT00355121|69697197|FG002|Overall Study|Serious adverse events|0|||
38014621|NCT00343889|69697210|FG000|Overall Study|Lost to Follow-up|2|||
38014622|NCT00343889|69697211|FG001|Overall Study|Lost to Follow-up|0|||
38014623|NCT00343889|69697210|FG000|Overall Study|Withdrawal by Subject|0|||
38014624|NCT00343889|69697211|FG001|Overall Study|Withdrawal by Subject|1|||
38014625|NCT00343889|69697210|FG000|Overall Study|Protocol Violation|1|||
38014626|NCT00343889|69697211|FG001|Overall Study|Protocol Violation|0|||
38014627|NCT00354341|69697219|FG000|Overall Study|Adverse Event|1|||
38014628|NCT00354341|69697220|FG001|Overall Study|Adverse Event|0|||
38014629|NCT00354341|69697219|FG000|Overall Study|Death|0|||
38014630|NCT00354341|69697220|FG001|Overall Study|Death|2|||
38014631|NCT00354341|69697219|FG000|Overall Study|Refused treatment|1|||
38014632|NCT00354341|69697220|FG001|Overall Study|Refused treatment|2|||
38014633|NCT00354341|69697219|FG000|Overall Study|Failure to return|0|||
38014634|NCT00354341|69697220|FG001|Overall Study|Failure to return|1|||
38014635|NCT00354341|69697219|FG000|Overall Study|Other|1|||
38014636|NCT00354341|69697220|FG001|Overall Study|Other|2|||
38014637|NCT00354107|69697226|FG000|Overall Study|Adverse Event|2|||
38014638|NCT00354107|69697226|FG000|Overall Study|Physician Decision|2|||
38014639|NCT00354107|69697226|FG000|Overall Study|Withdrawal by Subject|1|||
38014640|NCT00354029|69697232|FG000|Overall Study|Protocol Violation|4|||
38014641|NCT00354029|69697233|FG001|Overall Study|Protocol Violation|2|||
38014642|NCT00353873|69697241|FG000|Overall Study|Protocol Violation|1|||
38014643|NCT00353873|69697242|FG001|Overall Study|Protocol Violation|2|||
38014644|NCT00353873|69697241|FG000|Overall Study|Exacerbation|1|||
38014645|NCT00353873|69697242|FG001|Overall Study|Exacerbation|0|||
38014646|NCT00353873|69697241|FG000|Overall Study|Adverse Event|1|||
38014647|NCT00353873|69697242|FG001|Overall Study|Adverse Event|0|||
38014648|NCT00353873|69697241|FG000|Overall Study|Physician Decision|2|||
38014649|NCT00353873|69697242|FG001|Overall Study|Physician Decision|0|||
38014650|NCT00353873|69697241|FG000|Overall Study|Withdrawal by Subject|1|||
38014651|NCT00353873|69697242|FG001|Overall Study|Withdrawal by Subject|1|||
38014652|NCT03796676|69697251|FG000|Overall Study|Adverse Event|2|||
38014653|NCT03796676|69697252|FG001|Overall Study|Adverse Event|1|||
38014654|NCT03796676|69697253|FG002|Overall Study|Adverse Event|2|||
38014655|NCT03796676|69697251|FG000|Overall Study|Lost to Follow-up|2|||
38014656|NCT03796676|69697252|FG001|Overall Study|Lost to Follow-up|1|||
38014657|NCT03796676|69697253|FG002|Overall Study|Lost to Follow-up|0|||
38014658|NCT03796676|69697251|FG000|Overall Study|Protocol Violation|0|||
38014659|NCT03796676|69697252|FG001|Overall Study|Protocol Violation|0|||
37909841|NCT00772005|69595657|FG003|Overall Study|Lack of Efficacy|0|||
38014660|NCT03796676|69697253|FG002|Overall Study|Protocol Violation|1|||
38014661|NCT03796676|69697251|FG000|Overall Study|Withdrawal by Subject|1|||
38014662|NCT03796676|69697252|FG001|Overall Study|Withdrawal by Subject|1|||
38014663|NCT03796676|69697253|FG002|Overall Study|Withdrawal by Subject|0|||
38014664|NCT03796676|69697251|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
38014665|NCT03796676|69697252|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
38014666|NCT03796676|69697253|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
38014667|NCT03342898|69697267|FG000|Overall Study|Adverse Event|3|||
38014668|NCT03342898|69697268|FG001|Overall Study|Adverse Event|1|||
38014669|NCT03342898|69697269|FG002|Overall Study|Adverse Event|0|||
38014670|NCT03342898|69697267|FG000|Overall Study|Lost to Follow-up|44|||
38014671|NCT03342898|69697268|FG001|Overall Study|Lost to Follow-up|40|||
38014672|NCT03342898|69697269|FG002|Overall Study|Lost to Follow-up|42|||
38014673|NCT03342898|69697267|FG000|Overall Study|Withdrawal of Consent|5|||
38014674|NCT03342898|69697268|FG001|Overall Study|Withdrawal of Consent|9|||
38014675|NCT03342898|69697269|FG002|Overall Study|Withdrawal of Consent|11|||
38014676|NCT03342898|69697267|FG000|Overall Study|Death|0|||
38014677|NCT03342898|69697268|FG001|Overall Study|Death|1|||
38014678|NCT03342898|69697269|FG002|Overall Study|Death|1|||
38014679|NCT03342898|69697267|FG000|Overall Study|Reason not Specified|2|||
38014680|NCT03342898|69697268|FG001|Overall Study|Reason not Specified|2|||
38014681|NCT03342898|69697269|FG002|Overall Study|Reason not Specified|0|||
38014682|NCT00339833|69697279|FG000|Overall Study|Withdrawal by Subject|1|||
38014683|NCT00339833|69697280|FG001|Overall Study|Withdrawal by Subject|2|||
38014684|NCT00339833|69697279|FG000|Overall Study|toothache|0|||
38014685|NCT00339833|69697280|FG001|Overall Study|toothache|1|||
38014686|NCT00339833|69697279|FG000|Overall Study|indigestion|0|||
38014687|NCT00339833|69697280|FG001|Overall Study|indigestion|1|||
38014688|NCT00339833|69697279|FG000|Overall Study|Chest pain|0|||
38014689|NCT00339833|69697280|FG001|Overall Study|Chest pain|1|||
38014690|NCT00339833|69697279|FG000|Overall Study|minor infection|0|||
38014691|NCT00339833|69697280|FG001|Overall Study|minor infection|1|||
38014692|NCT00339833|69697279|FG000|Overall Study|Poor venous access|2|||
38014693|NCT00339833|69697280|FG001|Overall Study|Poor venous access|2|||
38014694|NCT00339833|69697279|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
38014695|NCT00339833|69697280|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
38014696|NCT00339833|69697279|FG000|Overall Study|Error in data records|1|||
38014697|NCT00339833|69697280|FG001|Overall Study|Error in data records|0|||
38014698|NCT03793556|69697288|FG000|Overall Study|Withdrawal by Subject|12|||
38014699|NCT03793556|69697289|FG001|Overall Study|Withdrawal by Subject|1|||
38014700|NCT03793556|69697288|FG000|Overall Study|Lost to Follow-up|1|||
38014701|NCT03793556|69697289|FG001|Overall Study|Lost to Follow-up|1|||
38014702|NCT03392194|69697300|FG000|Overall Study|Withdrawal by Subject|1|||
38014703|NCT03392194|69697301|FG001|Overall Study|Withdrawal by Subject|2|||
38014704|NCT03392194|69697300|FG000|Overall Study|Conflicts with personal schedule|1|||
38014705|NCT03392194|69697301|FG001|Overall Study|Conflicts with personal schedule|0|||
38014706|NCT03828617|69697311|FG000|Overall Study|Lost to Follow-up|22|||
38014707|NCT03828617|69697312|FG001|Overall Study|Lost to Follow-up|12|||
38014708|NCT03828617|69697313|FG002|Overall Study|Lost to Follow-up|23|||
38014709|NCT03828617|69697314|FG003|Overall Study|Lost to Follow-up|7|||
38014710|NCT03828617|69697311|FG000|Overall Study|No longer met eligibility criteria|0|||
38014711|NCT03828617|69697312|FG001|Overall Study|No longer met eligibility criteria|1|||
38014712|NCT03828617|69697313|FG002|Overall Study|No longer met eligibility criteria|1|||
38014713|NCT03828617|69697314|FG003|Overall Study|No longer met eligibility criteria|3|||
38014714|NCT03828617|69697311|FG000|Overall Study|Protocol Violation|0|||
38014715|NCT03828617|69697312|FG001|Overall Study|Protocol Violation|2|||
38014716|NCT03828617|69697313|FG002|Overall Study|Protocol Violation|0|||
38014717|NCT03828617|69697314|FG003|Overall Study|Protocol Violation|0|||
38014718|NCT03828617|69697311|FG000|Overall Study|Withdrawal by Subject|2|||
38014719|NCT03828617|69697312|FG001|Overall Study|Withdrawal by Subject|0|||
38014720|NCT03828617|69697313|FG002|Overall Study|Withdrawal by Subject|2|||
38014721|NCT03828617|69697314|FG003|Overall Study|Withdrawal by Subject|0|||
38014722|NCT03391960|69697323|FG000|Overall Study|Protocol Violation|0|||
38014723|NCT03391960|69697324|FG001|Overall Study|Protocol Violation||||
38014724|NCT03390166|69697350|FG000|Overall Study|Death|0|||
38014725|NCT03390166|69697351|FG001|Overall Study|Death|1|||
38014726|NCT03390166|69697350|FG000|Overall Study|Lost to Follow-up|6|||
38014727|NCT03390166|69697351|FG001|Overall Study|Lost to Follow-up|4|||
38014728|NCT03390166|69697350|FG000|Overall Study|Physician Decision|2|||
38014729|NCT03390166|69697351|FG001|Overall Study|Physician Decision|1|||
38014730|NCT03390166|69697350|FG000|Overall Study|Move from study area|3|||
38014731|NCT03390166|69697351|FG001|Overall Study|Move from study area|2|||
38014732|NCT03390166|69697350|FG000|Overall Study|To militarycamp for conscript|1|||
38014733|NCT03390166|69697351|FG001|Overall Study|To militarycamp for conscript|0|||
38014734|NCT03390166|69697350|FG000|Overall Study|To drug therapy course|0|||
38014735|NCT03390166|69697351|FG001|Overall Study|To drug therapy course|1|||
38014736|NCT03390166|69697350|FG000|Overall Study|Move to work oversea|0|||
38014737|NCT03390166|69697351|FG001|Overall Study|Move to work oversea|1|||
38014738|NCT03828539|69697359|FG000|Overall Study|Adverse Event|3|||
38014739|NCT03828539|69697360|FG001|Overall Study|Adverse Event|12|||
38014740|NCT03828539|69697359|FG000|Overall Study|Patient's/guardian's decision|3|||
38014741|NCT03828539|69697360|FG001|Overall Study|Patient's/guardian's decision|5|||
38014742|NCT03828539|69697359|FG000|Overall Study|Lost to Follow-up|4|||
38014743|NCT03828539|69697360|FG001|Overall Study|Lost to Follow-up|2|||
38014744|NCT03828539|69697359|FG000|Overall Study|Protocol Violation|3|||
38014745|NCT03828539|69697360|FG001|Overall Study|Protocol Violation|2|||
38014746|NCT03828539|69697359|FG000|Overall Study|Withdrawal of informed consent|2|||
38014747|NCT03828539|69697360|FG001|Overall Study|Withdrawal of informed consent|1|||
38014748|NCT03828539|69697359|FG000|Overall Study|New therapy for study indication|1|||
38014749|NCT03828539|69697360|FG001|Overall Study|New therapy for study indication|0|||
38014750|NCT03336502|69697368|FG000|Overall Study|Physician Decision|0|||
38014751|NCT03336502|69697369|FG001|Overall Study|Physician Decision|1|||
38014752|NCT03336502|69697368|FG000|Overall Study|Prohibited Drugs|1|||
38014753|NCT03336502|69697369|FG001|Overall Study|Prohibited Drugs|1|||
38014754|NCT03336502|69697368|FG000|Overall Study|Death|1|||
38014755|NCT03336502|69697369|FG001|Overall Study|Death|2|||
38014756|NCT03336502|69697368|FG000|Overall Study|Adverse Event|2|||
38014757|NCT03336502|69697369|FG001|Overall Study|Adverse Event|5|||
38014758|NCT00338741|69697377|FG000|Overall Study|Lost to Follow-up|2|||
38014759|NCT00338741|69697378|FG001|Overall Study|Lost to Follow-up|0|||
38014760|NCT03370510|69697386|FG000|Overall Study|COVID-19|2|||
38014761|NCT03370510|69697387|FG001|Overall Study|COVID-19|0|||
38014762|NCT00351611|69697395|FG000|Overall Study|Adverse Event|11|||
38014763|NCT00351611|69697396|FG001|Overall Study|Adverse Event|3|||
38014764|NCT00351611|69697395|FG000|Overall Study|Death|1|||
38014765|NCT00351611|69697396|FG001|Overall Study|Death|0|||
38014766|NCT00351611|69697395|FG000|Overall Study|Lost to Follow-up|1|||
38014767|NCT00351611|69697396|FG001|Overall Study|Lost to Follow-up|0|||
38014768|NCT00351611|69697395|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
38014769|NCT00351611|69697396|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
38014770|NCT00351611|69697395|FG000|Overall Study|Other|1|||
38014771|NCT00351611|69697396|FG001|Overall Study|Other|0|||
38014772|NCT00351611|69697395|FG000|Overall Study|Protocol Violation|0|||
38014773|NCT00351611|69697396|FG001|Overall Study|Protocol Violation|2|||
38014774|NCT00351533|69697404|FG000|Overall Study|Extubated before first BAL|1|||
38014775|NCT00351533|69697405|FG001|Overall Study|Extubated before first BAL|0|||
38014776|NCT00351533|69697404|FG000|Overall Study|Lost to Follow-up|1|||
38014777|NCT00351533|69697405|FG001|Overall Study|Lost to Follow-up|3|||
38014778|NCT00351533|69697404|FG000|Overall Study|Physician Decision|0|||
38014779|NCT00351533|69697405|FG001|Overall Study|Physician Decision|1|||
38014780|NCT00351533|69697404|FG000|Overall Study|Withdrawal by Subject|0|||
38014781|NCT00351533|69697405|FG001|Overall Study|Withdrawal by Subject|1|||
37909842|NCT00772005|69595654|FG000|Overall Study|Withdrawal by Subject|3|||
37909843|NCT00772005|69595655|FG001|Overall Study|Withdrawal by Subject|7|||
37909844|NCT00772005|69595656|FG002|Overall Study|Withdrawal by Subject|10|||
37909845|NCT00772005|69595657|FG003|Overall Study|Withdrawal by Subject|2|||
37909846|NCT00772005|69595654|FG000|Overall Study|Protocol Violation|2|||
37909847|NCT00772005|69595655|FG001|Overall Study|Protocol Violation|4|||
37909848|NCT00772005|69595656|FG002|Overall Study|Protocol Violation|1|||
37909849|NCT00772005|69595657|FG003|Overall Study|Protocol Violation|6|||
37909850|NCT00772005|69595654|FG000|Overall Study|Lost to Follow-up|7|||
37909851|NCT00772005|69595655|FG001|Overall Study|Lost to Follow-up|3|||
37909852|NCT00772005|69595656|FG002|Overall Study|Lost to Follow-up|6|||
37909853|NCT00772005|69595657|FG003|Overall Study|Lost to Follow-up|3|||
37909854|NCT00772005|69595654|FG000|Overall Study|Non-compliance with study procedures|1|||
37909855|NCT00772005|69595655|FG001|Overall Study|Non-compliance with study procedures|1|||
37909856|NCT00772005|69595656|FG002|Overall Study|Non-compliance with study procedures|0|||
37909857|NCT00772005|69595657|FG003|Overall Study|Non-compliance with study procedures|1|||
37909858|NCT00772005|69595654|FG000|Overall Study|Non-compliance with drug administration|3|||
37909859|NCT00772005|69595655|FG001|Overall Study|Non-compliance with drug administration|0|||
37909860|NCT00772005|69595656|FG002|Overall Study|Non-compliance with drug administration|1|||
37909861|NCT00772005|69595657|FG003|Overall Study|Non-compliance with drug administration|1|||
37909862|NCT00939107|69595669|FG000|Overall Study|Lost to Follow-up|14|||
37909863|NCT00939107|69595670|FG001|Overall Study|Lost to Follow-up|12|||
37909864|NCT00927485|69595678|FG000|Overall Study|Adverse Event|4|||
37909865|NCT00927485|69595679|FG001|Overall Study|Adverse Event|2|||
37909866|NCT00927485|69595678|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
38014782|NCT00351377|69697411|FG000|Overall Study|Adverse Event|5|||
38014783|NCT00351377|69697411|FG000|Overall Study|Death|1|||
38014784|NCT00351377|69697411|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
37909867|NCT00927485|69595679|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
37909868|NCT00927251|69595685|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
37909869|NCT00927095|69595692|FG000|Overall Study|Adverse Event|3|||
37909870|NCT00927095|69595693|FG001|Overall Study|Adverse Event|1|||
37909871|NCT00927095|69595694|FG002|Overall Study|Adverse Event|0|||
37909872|NCT00927095|69595692|FG000|Overall Study|Withdrawal by Subject|2|||
38014785|NCT00337727|69697417|FG000|Overall Study|Adverse Event|5|||
38014786|NCT00337727|69697418|FG001|Overall Study|Adverse Event|3|||
38014787|NCT00337727|69697417|FG000|Overall Study|Lost to Follow-up|5|||
38014788|NCT00337727|69697418|FG001|Overall Study|Lost to Follow-up|4|||
37909873|NCT00927095|69595693|FG001|Overall Study|Withdrawal by Subject|1|||
38014789|NCT00337727|69697417|FG000|Overall Study|Physician Decision|1|||
38014790|NCT00337727|69697418|FG001|Overall Study|Physician Decision|0|||
38014791|NCT00337727|69697417|FG000|Overall Study|Protocol Violation|4|||
38014792|NCT00337727|69697418|FG001|Overall Study|Protocol Violation|0|||
38014793|NCT00337727|69697417|FG000|Overall Study|Withdrawal by Subject|3|||
38014794|NCT00337727|69697418|FG001|Overall Study|Withdrawal by Subject|5|||
38014795|NCT00324233|69697426|FG000|First Period|unable to insert catheter|1|||
38014796|NCT00324233|69697427|FG001|First Period|unable to insert catheter|0|||
38014797|NCT00324233|69697426|FG000|Second Period|unable to insert catheter|1|||
38014798|NCT00324233|69697427|FG001|Second Period|unable to insert catheter|1|||
38014799|NCT00324233|69697426|FG000|Second Period|Protocol Violation|4|||
38014800|NCT00324233|69697427|FG001|Second Period|Protocol Violation|6|||
38014801|NCT03335566|69697435|FG000|Overall Study|Adverse Event|0|||
38014802|NCT03335566|69697436|FG001|Overall Study|Adverse Event|1|||
38014803|NCT03335566|69697435|FG000|Overall Study|Lost to Follow-up|1|||
38014804|NCT03335566|69697436|FG001|Overall Study|Lost to Follow-up|0|||
38014805|NCT03335566|69697435|FG000|Overall Study|Technical Problems|1|||
38014806|NCT03335566|69697436|FG001|Overall Study|Technical Problems|0|||
38014807|NCT03335566|69697435|FG000|Overall Study|Protocol Violation|1|||
38014808|NCT03335566|69697436|FG001|Overall Study|Protocol Violation|0|||
38014809|NCT03335566|69697435|FG000|Overall Study|Other than specified above|1|||
38014810|NCT03335566|69697436|FG001|Overall Study|Other than specified above|2|||
38014811|NCT03369418|69697444|FG000|Overall Study|Withdrawal by Subject|3|||
38014812|NCT03369418|69697445|FG001|Overall Study|Withdrawal by Subject|3|||
38014813|NCT03334630|69697453|FG000|Overall Study|Withdrawal by Subject|7|||
38014814|NCT03334630|69697454|FG001|Overall Study|Withdrawal by Subject|7|||
38014815|NCT03334630|69697453|FG000|Overall Study|Lost to Follow-up|3|||
38014816|NCT03334630|69697454|FG001|Overall Study|Lost to Follow-up|1|||
38014817|NCT03334630|69697453|FG000|Overall Study|Adverse Event|0|||
38014818|NCT03334630|69697454|FG001|Overall Study|Adverse Event|1|||
38014819|NCT03334630|69697453|FG000|Overall Study|Physician Decision|1|||
38014820|NCT03334630|69697454|FG001|Overall Study|Physician Decision|1|||
38014821|NCT03334630|69697453|FG000|Overall Study|Enrollment closed|2|||
38014822|NCT03334630|69697454|FG001|Overall Study|Enrollment closed|1|||
38014823|NCT03334630|69697453|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
38014824|NCT03334630|69697454|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
38014825|NCT03334630|69697453|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
38014826|NCT03334630|69697454|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
38014827|NCT03368170|69697462|FG000|Overall Study|Adverse Event|2|||
38014828|NCT03368170|69697463|FG001|Overall Study|Adverse Event|1|||
38014829|NCT00324155|69697471|FG000|Enrolled and Randomized|No longer met study criteria|3|||
38014830|NCT00324155|69697472|FG001|Enrolled and Randomized|No longer met study criteria|0|||
38014831|NCT00324155|69697471|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
38014832|NCT00324155|69697472|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
38014833|NCT00324155|69697471|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
38014834|NCT00324155|69697472|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
38014835|NCT00324155|69697471|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
38014836|NCT00324155|69697472|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
38014837|NCT00324155|69697471|FG000|Received Treatment in Induction Phase|Death|8|||
38014838|NCT00324155|69697472|FG001|Received Treatment in Induction Phase|Death|15|||
38014839|NCT00324155|69697471|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
38014840|NCT00324155|69697472|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
38014841|NCT00324155|69697471|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
38014842|NCT00324155|69697472|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
38014843|NCT00324155|69697471|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
38014844|NCT00324155|69697472|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
38014845|NCT00324155|69697471|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
38014846|NCT00324155|69697472|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
38014847|NCT00324155|69697471|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
38014848|NCT00324155|69697472|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
38014849|NCT00324155|69697471|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
38014850|NCT00324155|69697472|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
38014851|NCT00324155|69697471|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
38014852|NCT00324155|69697472|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
38014853|NCT00324155|69697471|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
38014854|NCT00324155|69697472|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
38014855|NCT00324155|69697471|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
38014856|NCT00324155|69697472|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
38014857|NCT00324155|69697471|FG000|Follow-up Phase|On-going participants still on drug|11|||
38014858|NCT00324155|69697472|FG001|Follow-up Phase|On-going participants still on drug|6|||
38014859|NCT03334396|69697499|FG000|Overall Study|Adverse Event|1|||
38014860|NCT03334396|69697500|FG001|Overall Study|Adverse Event|0|||
38014861|NCT03334396|69697501|FG002|Overall Study|Adverse Event|1|||
38014862|NCT03334396|69697502|FG003|Overall Study|Adverse Event|0|||
38014863|NCT03334396|69697503|FG004|Overall Study|Adverse Event|0|||
38014864|NCT03334396|69697504|FG005|Overall Study|Adverse Event|0|||
38014865|NCT03334396|69697505|FG006|Overall Study|Adverse Event|0|||
38014866|NCT03334396|69697506|FG007|Overall Study|Adverse Event|0|||
38014867|NCT03334396|69697499|FG000|Overall Study|Lack of Efficacy|10|||
38014868|NCT03334396|69697500|FG001|Overall Study|Lack of Efficacy|4|||
38014869|NCT03334396|69697501|FG002|Overall Study|Lack of Efficacy|1|||
38014870|NCT03334396|69697502|FG003|Overall Study|Lack of Efficacy|3|||
38014871|NCT03334396|69697503|FG004|Overall Study|Lack of Efficacy|1|||
38014872|NCT03334396|69697504|FG005|Overall Study|Lack of Efficacy|0|||
38014873|NCT03334396|69697505|FG006|Overall Study|Lack of Efficacy|0|||
38014874|NCT03334396|69697506|FG007|Overall Study|Lack of Efficacy|1|||
38014875|NCT03334396|69697499|FG000|Overall Study|Lost to Follow-up|0|||
38014876|NCT03334396|69697500|FG001|Overall Study|Lost to Follow-up|0|||
38014877|NCT03334396|69697501|FG002|Overall Study|Lost to Follow-up|1|||
38014878|NCT03334396|69697502|FG003|Overall Study|Lost to Follow-up|0|||
38014879|NCT03334396|69697503|FG004|Overall Study|Lost to Follow-up|0|||
38014880|NCT03334396|69697504|FG005|Overall Study|Lost to Follow-up|0|||
38014881|NCT03334396|69697505|FG006|Overall Study|Lost to Follow-up|1|||
38014882|NCT03334396|69697506|FG007|Overall Study|Lost to Follow-up|0|||
38014883|NCT03334396|69697499|FG000|Overall Study|Physician Decision|1|||
38014884|NCT03334396|69697500|FG001|Overall Study|Physician Decision|0|||
38014885|NCT03334396|69697501|FG002|Overall Study|Physician Decision|0|||
38014886|NCT03334396|69697502|FG003|Overall Study|Physician Decision|0|||
38014887|NCT03334396|69697503|FG004|Overall Study|Physician Decision|0|||
38014888|NCT03334396|69697504|FG005|Overall Study|Physician Decision|0|||
38014889|NCT03334396|69697505|FG006|Overall Study|Physician Decision|0|||
38014890|NCT03334396|69697506|FG007|Overall Study|Physician Decision|0|||
38014891|NCT03334396|69697499|FG000|Overall Study|Withdrawal by Subject|10|||
38014892|NCT03334396|69697500|FG001|Overall Study|Withdrawal by Subject|5|||
38014893|NCT03334396|69697501|FG002|Overall Study|Withdrawal by Subject|7|||
38014894|NCT03334396|69697502|FG003|Overall Study|Withdrawal by Subject|2|||
38014895|NCT03334396|69697503|FG004|Overall Study|Withdrawal by Subject|2|||
38014896|NCT03334396|69697504|FG005|Overall Study|Withdrawal by Subject|1|||
38014897|NCT03334396|69697505|FG006|Overall Study|Withdrawal by Subject|2|||
38014898|NCT03334396|69697506|FG007|Overall Study|Withdrawal by Subject|0|||
38014899|NCT03334396|69697499|FG000|Overall Study|Pregnancy|0|||
38014900|NCT03334396|69697500|FG001|Overall Study|Pregnancy|1|||
38014901|NCT03334396|69697501|FG002|Overall Study|Pregnancy|0|||
38014902|NCT03334396|69697502|FG003|Overall Study|Pregnancy|0|||
38014903|NCT03334396|69697503|FG004|Overall Study|Pregnancy|0|||
38014904|NCT03334396|69697504|FG005|Overall Study|Pregnancy|0|||
38014905|NCT03334396|69697505|FG006|Overall Study|Pregnancy|0|||
38014906|NCT03334396|69697506|FG007|Overall Study|Pregnancy|0|||
38014907|NCT03334396|69697499|FG000|Overall Study|Ineligible|0|||
38014908|NCT03334396|69697500|FG001|Overall Study|Ineligible|1|||
38014909|NCT03334396|69697501|FG002|Overall Study|Ineligible|0|||
38014910|NCT03334396|69697502|FG003|Overall Study|Ineligible|0|||
38014911|NCT03334396|69697503|FG004|Overall Study|Ineligible|0|||
38014912|NCT03334396|69697504|FG005|Overall Study|Ineligible|0|||
38014913|NCT03334396|69697505|FG006|Overall Study|Ineligible|0|||
38014914|NCT03334396|69697506|FG007|Overall Study|Ineligible|0|||
38014915|NCT03334396|69697499|FG000|Overall Study|Started New Job|1|||
38014916|NCT03334396|69697500|FG001|Overall Study|Started New Job|0|||
38014917|NCT03334396|69697501|FG002|Overall Study|Started New Job|0|||
38014918|NCT03334396|69697502|FG003|Overall Study|Started New Job|0|||
38014919|NCT03334396|69697503|FG004|Overall Study|Started New Job|0|||
38014920|NCT03334396|69697504|FG005|Overall Study|Started New Job|0|||
38014921|NCT03334396|69697505|FG006|Overall Study|Started New Job|0|||
38014922|NCT03334396|69697506|FG007|Overall Study|Started New Job|0|||
37832244|NCT01294423|69515723|FG002|Overall Study|Withdrawal by Subject|2|||
38014923|NCT03338998|69697525|FG000|Treatment Period|Withdrawal by Subject|1|||
38014924|NCT03338998|69697526|FG001|Treatment Period|Withdrawal by Subject|1|||
37832245|NCT01294423|69515721|FG000|Overall Study|subject no longer meets study criteria|2|||
37832246|NCT01294423|69515722|FG001|Overall Study|subject no longer meets study criteria|5|||
38014925|NCT03338998|69697525|FG000|Treatment Period|Adverse Event|0|||
38014926|NCT03338998|69697526|FG001|Treatment Period|Adverse Event|2|||
38014927|NCT03338998|69697525|FG000|Treatment Period|Protocol deviation|1|||
38014928|NCT03338998|69697526|FG001|Treatment Period|Protocol deviation|0|||
38014929|NCT03338998|69697525|FG000|Treatment Period|Physician Decision|2|||
38014930|NCT03338998|69697526|FG001|Treatment Period|Physician Decision|0|||
38014931|NCT03338998|69697525|FG000|Treatment Period|Subject failed swallow test|4|||
38014932|NCT03338998|69697526|FG001|Treatment Period|Subject failed swallow test|0|||
38014933|NCT03338998|69697525|FG000|Safety Follow-Up Period|Adverse Event|0|||
38014934|NCT03338998|69697526|FG001|Safety Follow-Up Period|Adverse Event|1|||
38014935|NCT03338998|69697525|FG000|Safety Follow-Up Period|Protocol deviation|1|||
38014936|NCT03338998|69697526|FG001|Safety Follow-Up Period|Protocol deviation|0|||
38014937|NCT03338998|69697525|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
38014938|NCT03338998|69697526|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
38014939|NCT03338296|69697535|FG000|Overall Study|Adverse Event|0|||
38014940|NCT03338296|69697536|FG001|Overall Study|Adverse Event|1|||
38014941|NCT03338296|69697535|FG000|Overall Study|Withdrawal by Subject|14|||
38014942|NCT03338296|69697536|FG001|Overall Study|Withdrawal by Subject|13|||
38014943|NCT03338296|69697535|FG000|Overall Study|Lost to Follow-up|10|||
38014944|NCT03338296|69697536|FG001|Overall Study|Lost to Follow-up|10|||
38014945|NCT03338296|69697535|FG000|Overall Study|Study Terminated by Sponsor|77|||
38014946|NCT03338296|69697536|FG001|Overall Study|Study Terminated by Sponsor|76|||
38014947|NCT03338296|69697535|FG000|Overall Study|Other|2|||
38014948|NCT03338296|69697536|FG001|Overall Study|Other|7|||
38014949|NCT03338296|69697535|FG000|Overall Study|Missing|0|||
38014950|NCT03338296|69697536|FG001|Overall Study|Missing|1|||
38014951|NCT03338062|69697544|FG000|Overall Study|Alternative Therapy|1|||
38014952|NCT03338062|69697545|FG001|Overall Study|Alternative Therapy|0|||
38014953|NCT03364192|69697552|FG000|Overall Study|Ineligible|10|||
38014954|NCT03364192|69697552|FG000|Overall Study|Withdrawal by Subject|5|||
38014955|NCT03364192|69697552|FG000|Overall Study|Lost to Follow-up|1|||
38014956|NCT03783962|69697559|FG000|Overall Study|Lost to Follow-up|3|||
38014957|NCT03783962|69697560|FG001|Overall Study|Lost to Follow-up|6|||
38014958|NCT03783962|69697559|FG000|Overall Study|Protocol Violation|0|||
38014959|NCT03783962|69697560|FG001|Overall Study|Protocol Violation|1|||
38014960|NCT03361228|69697568|FG000|Overall Study|Other|1|||
38014961|NCT03361228|69697569|FG001|Overall Study|Other|1|||
38014962|NCT03361228|69697568|FG000|Overall Study|Death|3|||
38014963|NCT03361228|69697569|FG001|Overall Study|Death|0|||
38014964|NCT03359590|69697575|FG000|First Intervention|Withdrawal by Subject|1|||
38014965|NCT03359590|69697576|FG001|First Intervention|Withdrawal by Subject|1|||
38014966|NCT03359590|69697575|FG000|First Intervention|Protocol Violation|0|||
38014967|NCT03359590|69697576|FG001|First Intervention|Protocol Violation|1|||
38014968|NCT05085964|69697584|FG000|Overall Study|Premature termination of study|21|||
38014969|NCT05085964|69697585|FG001|Overall Study|Premature termination of study|0|||
38014970|NCT02891200|69697594|FG000|Overall Study|Lost to Follow-up|31|||
38014971|NCT02891200|69697595|FG001|Overall Study|Lost to Follow-up|36|||
38014972|NCT02891200|69697594|FG000|Overall Study|Death|10|||
38014973|NCT02891200|69697595|FG001|Overall Study|Death|9|||
38014974|NCT02891200|69697594|FG000|Overall Study|Withdrawal by Subject|1|||
38014975|NCT02891200|69697595|FG001|Overall Study|Withdrawal by Subject|4|||
38014976|NCT02946580|69697603|FG000|Overall Study|Withdrawal by Subject|1|||
38014977|NCT02946580|69697604|FG001|Overall Study|Withdrawal by Subject|2|||
38014978|NCT02946580|69697603|FG000|Overall Study|Adverse Event|0|||
38014979|NCT02946580|69697604|FG001|Overall Study|Adverse Event|2|||
38014980|NCT02946580|69697603|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
38014981|NCT02946580|69697604|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
38014982|NCT00323609|69697612|FG000|Overall Study|Death|16|||
38014983|NCT00323609|69697613|FG001|Overall Study|Death|21|||
38014984|NCT00323609|69697614|FG002|Overall Study|Death|0|||
38014985|NCT00323609|69697615|FG003|Overall Study|Death|0|||
38014986|NCT00323609|69697612|FG000|Overall Study|Lost to Follow-up|9|||
38014987|NCT00323609|69697613|FG001|Overall Study|Lost to Follow-up|10|||
38014988|NCT00323609|69697614|FG002|Overall Study|Lost to Follow-up|0|||
38014989|NCT00323609|69697615|FG003|Overall Study|Lost to Follow-up|0|||
38014990|NCT00323609|69697612|FG000|Overall Study|Physician Decision|2|||
37832247|NCT01294423|69515723|FG002|Overall Study|subject no longer meets study criteria|2|||
37832248|NCT01294423|69515721|FG000|Overall Study|poor/non-compliance|1|||
38014991|NCT00323609|69697613|FG001|Overall Study|Physician Decision|0|||
38014992|NCT00323609|69697614|FG002|Overall Study|Physician Decision|0|||
38014993|NCT00323609|69697615|FG003|Overall Study|Physician Decision|1|||
38014994|NCT00323609|69697612|FG000|Overall Study|Withdrawal by Subject|11|||
38014995|NCT00323609|69697613|FG001|Overall Study|Withdrawal by Subject|23|||
38014996|NCT00323609|69697614|FG002|Overall Study|Withdrawal by Subject|4|||
38014997|NCT00323609|69697615|FG003|Overall Study|Withdrawal by Subject|4|||
38014998|NCT00323609|69697612|FG000|Overall Study|Other non-VCF-related medical condition|3|||
38014999|NCT00323609|69697613|FG001|Overall Study|Other non-VCF-related medical condition|2|||
38015000|NCT00323609|69697614|FG002|Overall Study|Other non-VCF-related medical condition|0|||
38015001|NCT00323609|69697615|FG003|Overall Study|Other non-VCF-related medical condition|0|||
38015002|NCT00323609|69697612|FG000|Overall Study|Sponsor discontinued trial|29|||
38015003|NCT00323609|69697613|FG001|Overall Study|Sponsor discontinued trial|29|||
38015004|NCT00323609|69697614|FG002|Overall Study|Sponsor discontinued trial|0|||
38015005|NCT00323609|69697615|FG003|Overall Study|Sponsor discontinued trial|0|||
38015006|NCT00323609|69697612|FG000|Overall Study|Unrelenting or severe back pain|1|||
38015007|NCT00323609|69697613|FG001|Overall Study|Unrelenting or severe back pain|1|||
38015008|NCT00323609|69697614|FG002|Overall Study|Unrelenting or severe back pain|0|||
38015009|NCT00323609|69697615|FG003|Overall Study|Unrelenting or severe back pain|0|||
38015010|NCT00323609|69697612|FG000|Overall Study|Logistical withdrawal|9|||
38015011|NCT00323609|69697613|FG001|Overall Study|Logistical withdrawal|5|||
38015012|NCT00323609|69697614|FG002|Overall Study|Logistical withdrawal|0|||
38015013|NCT00323609|69697615|FG003|Overall Study|Logistical withdrawal|1|||
38015014|NCT00323609|69697612|FG000|Overall Study|Other reason|11|||
38015015|NCT00323609|69697613|FG001|Overall Study|Other reason|8|||
38015016|NCT00323609|69697614|FG002|Overall Study|Other reason|4|||
38015017|NCT00323609|69697615|FG003|Overall Study|Other reason|9|||
38015018|NCT04598152|69697621|FG000|Overall Study|Lost to Follow-up|0|||
38015019|NCT04598152|69697622|FG001|Overall Study|Lost to Follow-up|1|||
38015020|NCT00323297|69697630|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
38015021|NCT00323297|69697631|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
38015022|NCT00323297|69697630|FG000|Part A (Double Blind Randomized)|Death|0|||
38015023|NCT00323297|69697631|FG001|Part A (Double Blind Randomized)|Death|1|||
38015024|NCT00323297|69697630|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
38015025|NCT00323297|69697631|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
38015026|NCT00323297|69697630|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
38015027|NCT00323297|69697631|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
38015028|NCT00323297|69697630|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
38015029|NCT00323297|69697631|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
38015030|NCT00323297|69697630|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
38015031|NCT00323297|69697631|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
38015032|NCT00323297|69697630|FG000|Part B (Open-label)|Death|0|||
38015033|NCT00323297|69697631|FG001|Part B (Open-label)|Death|1|||
38015034|NCT00323297|69697630|FG000|Part B (Open-label)|Reason unspecified|0|||
38015035|NCT00323297|69697631|FG001|Part B (Open-label)|Reason unspecified|1|||
38015036|NCT00323297|69697630|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
38015037|NCT00323297|69697631|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
38015038|NCT00323297|69697630|FG000|Part B (Open-label)|Lack of Efficacy|3|||
38015039|NCT00323297|69697631|FG001|Part B (Open-label)|Lack of Efficacy|1|||
38015040|NCT00323297|69697630|FG000|Part B (Open-label)|Adverse Event|5|||
38015041|NCT00323297|69697631|FG001|Part B (Open-label)|Adverse Event|5|||
38015042|NCT00323297|69697630|FG000|Part B (Open-label)|Protocol Violation|0|||
38015043|NCT00323297|69697631|FG001|Part B (Open-label)|Protocol Violation|1|||
38015044|NCT00323063|69697639|FG000|Overall Study|Adverse Event|1|||
38015045|NCT00323063|69697640|FG001|Overall Study|Adverse Event|0|||
38015046|NCT00323063|69697639|FG000|Overall Study|brain mets discovered prior to treatment|1|||
38015047|NCT00323063|69697640|FG001|Overall Study|brain mets discovered prior to treatment|0|||
38015048|NCT00322049|69697650|FG000|Overall Study|Moved out of area|0|||
38015049|NCT00322049|69697651|FG001|Overall Study|Moved out of area|0|||
38015050|NCT00322049|69697652|FG002|Overall Study|Moved out of area|0|||
38015051|NCT00322049|69697653|FG003|Overall Study|Moved out of area|1|||
38015052|NCT00322049|69697650|FG000|Overall Study|Infected with Dengue during study|0|||
38015053|NCT00322049|69697651|FG001|Overall Study|Infected with Dengue during study|1|||
38015054|NCT00322049|69697652|FG002|Overall Study|Infected with Dengue during study|0|||
38015055|NCT00322049|69697653|FG003|Overall Study|Infected with Dengue during study|0|||
38015056|NCT00321893|69697674|FG000|Overall Study|Non-Compliance/Refusal|16|||
38015057|NCT00321893|69697675|FG001|Overall Study|Non-Compliance/Refusal|10|||
38015058|NCT00321893|69697674|FG000|Overall Study|Lost to Follow-up|2|||
38015059|NCT00321893|69697675|FG001|Overall Study|Lost to Follow-up|1|||
38015060|NCT00321893|69697674|FG000|Overall Study|Adverse Event|6|||
38015061|NCT00321893|69697675|FG001|Overall Study|Adverse Event|3|||
38015062|NCT00371345|69697683|FG000|Overall Study|Disease Progression|21|||
38015063|NCT00371345|69697684|FG001|Overall Study|Disease Progression|35|||
38015064|NCT00371345|69697683|FG000|Overall Study|Study Drug Toxicity|1|||
38015065|NCT00371345|69697684|FG001|Overall Study|Study Drug Toxicity|7|||
38015066|NCT00371345|69697683|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
38015067|NCT00371345|69697684|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
38015068|NCT00371345|69697683|FG000|Overall Study|Participant Request|1|||
38015069|NCT00371345|69697684|FG001|Overall Study|Participant Request|1|||
38015070|NCT00371345|69697683|FG000|Overall Study|Participant Withdrew Consent|0|||
38015071|NCT00371345|69697684|FG001|Overall Study|Participant Withdrew Consent|1|||
38015072|NCT00321737|69697707|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
38015073|NCT00321737|69697708|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
38015074|NCT00321737|69697709|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
38015075|NCT00321737|69697707|FG000|Overall Study|Adverse Event|11|||
38015076|NCT00321737|69697708|FG001|Overall Study|Adverse Event|3|||
38015077|NCT00321737|69697709|FG002|Overall Study|Adverse Event|6|||
38015078|NCT00321737|69697707|FG000|Overall Study|Lost to Follow-up|5|||
38015079|NCT00321737|69697708|FG001|Overall Study|Lost to Follow-up|5|||
38015080|NCT00321737|69697709|FG002|Overall Study|Lost to Follow-up|6|||
38015081|NCT00321737|69697707|FG000|Overall Study|Withdrawal by Subject|19|||
38015082|NCT00321737|69697708|FG001|Overall Study|Withdrawal by Subject|12|||
38015083|NCT00321737|69697709|FG002|Overall Study|Withdrawal by Subject|17|||
38015084|NCT00321737|69697707|FG000|Overall Study|Protocol Violation|0|||
38015085|NCT00321737|69697708|FG001|Overall Study|Protocol Violation|0|||
38015086|NCT00321737|69697709|FG002|Overall Study|Protocol Violation|1|||
38015087|NCT00321737|69697707|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
38015088|NCT00321737|69697708|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
38015089|NCT00321737|69697709|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
38015090|NCT00321737|69697707|FG000|Overall Study|Possible Barrett's Esophagus|2|||
38015091|NCT00321737|69697708|FG001|Overall Study|Possible Barrett's Esophagus|1|||
38015092|NCT00321737|69697709|FG002|Overall Study|Possible Barrett's Esophagus|1|||
38015093|NCT00321737|69697707|FG000|Overall Study|Therapeutic Failure|6|||
38015094|NCT00321737|69697708|FG001|Overall Study|Therapeutic Failure|0|||
38015095|NCT00321737|69697709|FG002|Overall Study|Therapeutic Failure|2|||
38015096|NCT00321737|69697707|FG000|Overall Study|Pregnancy|0|||
38015097|NCT00321737|69697708|FG001|Overall Study|Pregnancy|2|||
38015098|NCT00321737|69697709|FG002|Overall Study|Pregnancy|0|||
38015099|NCT00321737|69697707|FG000|Overall Study|Noncompliance|2|||
38015100|NCT00321737|69697708|FG001|Overall Study|Noncompliance|0|||
38015101|NCT00321737|69697709|FG002|Overall Study|Noncompliance|0|||
38015102|NCT00321737|69697707|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
38015103|NCT00321737|69697708|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
38015104|NCT00321737|69697709|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
38015105|NCT00320801|69697719|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
38015106|NCT00320801|69697720|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
38015107|NCT00320801|69697721|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
38015108|NCT00320801|69697722|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
38015109|NCT00320801|69697719|FG000|Open-label Run-in Period|Adverse Event|33|||
38015110|NCT00320801|69697720|FG001|Open-label Run-in Period|Adverse Event|0|||
38015111|NCT00320801|69697721|FG002|Open-label Run-in Period|Adverse Event|0|||
38015112|NCT00320801|69697722|FG003|Open-label Run-in Period|Adverse Event|0|||
38015113|NCT00320801|69697719|FG000|Open-label Run-in Period|Administrative|10|||
38015114|NCT00320801|69697720|FG001|Open-label Run-in Period|Administrative|0|||
38015115|NCT00320801|69697721|FG002|Open-label Run-in Period|Administrative|0|||
38015116|NCT00320801|69697722|FG003|Open-label Run-in Period|Administrative|0|||
38015117|NCT00320801|69697719|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
38015118|NCT00320801|69697720|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
38015119|NCT00320801|69697721|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
38015120|NCT00320801|69697722|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
38015121|NCT00320801|69697719|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
38015122|NCT00320801|69697720|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
38015123|NCT00320801|69697721|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
38015124|NCT00320801|69697722|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
38015125|NCT00320801|69697719|FG000|Open-label Run-in Period|Did not qualify|1|||
38015126|NCT00320801|69697720|FG001|Open-label Run-in Period|Did not qualify|0|||
38015127|NCT00320801|69697721|FG002|Open-label Run-in Period|Did not qualify|0|||
38015128|NCT00320801|69697722|FG003|Open-label Run-in Period|Did not qualify|0|||
38015129|NCT00320801|69697719|FG000|Double-blind Phase|Withdrawal by Subject|0|||
38015130|NCT00320801|69697720|FG001|Double-blind Phase|Withdrawal by Subject|0|||
38015131|NCT00320801|69697721|FG002|Double-blind Phase|Withdrawal by Subject|1|||
38015132|NCT00320801|69697722|FG003|Double-blind Phase|Withdrawal by Subject|0|||
38015133|NCT00320801|69697719|FG000|Double-blind Phase|Adverse Event|0|||
38015134|NCT00320801|69697720|FG001|Double-blind Phase|Adverse Event|2|||
38015135|NCT00320801|69697721|FG002|Double-blind Phase|Adverse Event|8|||
38015136|NCT00320801|69697722|FG003|Double-blind Phase|Adverse Event|0|||
38015137|NCT00320801|69697719|FG000|Double-blind Phase|Administrative|0|||
38015138|NCT00320801|69697720|FG001|Double-blind Phase|Administrative|0|||
38015139|NCT00320801|69697721|FG002|Double-blind Phase|Administrative|4|||
38015140|NCT00320801|69697722|FG003|Double-blind Phase|Administrative|0|||
38015141|NCT00320801|69697719|FG000|Double-blind Phase|Lack of Efficacy|0|||
38015142|NCT00320801|69697720|FG001|Double-blind Phase|Lack of Efficacy|9|||
38015143|NCT00320801|69697721|FG002|Double-blind Phase|Lack of Efficacy|1|||
38015144|NCT00320801|69697722|FG003|Double-blind Phase|Lack of Efficacy|0|||
38015145|NCT00320801|69697719|FG000|Extension Phase|Withdrawal by Subject|0|||
38015146|NCT00320801|69697720|FG001|Extension Phase|Withdrawal by Subject|0|||
38015147|NCT00320801|69697721|FG002|Extension Phase|Withdrawal by Subject|0|||
38015148|NCT00320801|69697722|FG003|Extension Phase|Withdrawal by Subject|6|||
38015149|NCT00320801|69697719|FG000|Extension Phase|Adverse Event|0|||
38015150|NCT00320801|69697720|FG001|Extension Phase|Adverse Event|0|||
38015151|NCT00320801|69697721|FG002|Extension Phase|Adverse Event|0|||
38015152|NCT00320801|69697722|FG003|Extension Phase|Adverse Event|8|||
38015153|NCT00320801|69697719|FG000|Extension Phase|Administrative|0|||
38015154|NCT00320801|69697720|FG001|Extension Phase|Administrative|0|||
38015155|NCT00320801|69697721|FG002|Extension Phase|Administrative|0|||
38015156|NCT00320801|69697722|FG003|Extension Phase|Administrative|29|||
38015157|NCT00320801|69697719|FG000|Extension Phase|Lack of Efficacy|0|||
38015158|NCT00320801|69697720|FG001|Extension Phase|Lack of Efficacy|0|||
38015159|NCT00320801|69697721|FG002|Extension Phase|Lack of Efficacy|0|||
38015160|NCT00320801|69697722|FG003|Extension Phase|Lack of Efficacy|2|||
38015161|NCT00320801|69697719|FG000|Extension Phase|Lost to Follow-up|0|||
38015162|NCT00320801|69697720|FG001|Extension Phase|Lost to Follow-up|0|||
38015163|NCT00320801|69697721|FG002|Extension Phase|Lost to Follow-up|0|||
38015164|NCT00320801|69697722|FG003|Extension Phase|Lost to Follow-up|3|||
38015165|NCT00320489|69697734|FG000|Overall Study|Adverse Event|26|||
38015166|NCT00320489|69697735|FG001|Overall Study|Adverse Event|25|||
38015167|NCT00320489|69697734|FG000|Overall Study|Clinical Relapse|26|||
38015168|NCT00320489|69697735|FG001|Overall Study|Clinical Relapse|20|||
38015169|NCT00320489|69697734|FG000|Overall Study|Death|0|||
38015170|NCT00320489|69697735|FG001|Overall Study|Death|2|||
38015171|NCT00320489|69697734|FG000|Overall Study|Entry Criteria Exclusion|2|||
38015172|NCT00320489|69697735|FG001|Overall Study|Entry Criteria Exclusion|4|||
38015173|NCT00320489|69697734|FG000|Overall Study|Lack of Efficacy|16|||
38015174|NCT00320489|69697735|FG001|Overall Study|Lack of Efficacy|7|||
38015175|NCT00320489|69697734|FG000|Overall Study|Lost to Follow-up|21|||
38015176|NCT00320489|69697735|FG001|Overall Study|Lost to Follow-up|22|||
38015177|NCT00320489|69697734|FG000|Overall Study|Physician Decision|8|||
38015178|NCT00320489|69697735|FG001|Overall Study|Physician Decision|8|||
38015179|NCT00320489|69697734|FG000|Overall Study|Protocol Violation|4|||
38015180|NCT00320489|69697735|FG001|Overall Study|Protocol Violation|4|||
38015181|NCT00320489|69697734|FG000|Overall Study|Sponsor Decision|3|||
38015182|NCT00320489|69697735|FG001|Overall Study|Sponsor Decision|3|||
38015183|NCT00320489|69697734|FG000|Overall Study|Withdrawal by Subject|39|||
38015184|NCT00320489|69697735|FG001|Overall Study|Withdrawal by Subject|41|||
38015185|NCT03928028|69697744|FG000|Overall Study|Physician Decision|9|||
38015186|NCT03928028|69697745|FG001|Overall Study|Physician Decision|6|||
38015187|NCT03928028|69697746|FG002|Overall Study|Physician Decision|3|||
38015188|NCT03928028|69697744|FG000|Overall Study|Withdrawal by Subject|12|||
38015189|NCT03928028|69697745|FG001|Overall Study|Withdrawal by Subject|3|||
38015190|NCT03928028|69697746|FG002|Overall Study|Withdrawal by Subject|3|||
38015191|NCT00320411|69697754|FG000|Overall Study|No investigational product admin.|4|||
38015192|NCT00320255|69697764|FG000|Overall Study|Lack of Efficacy|1|||
38015193|NCT00320255|69697765|FG001|Overall Study|Lack of Efficacy|0|||
38015194|NCT00320255|69697766|FG002|Overall Study|Lack of Efficacy|0|||
38015195|NCT00320255|69697767|FG003|Overall Study|Lack of Efficacy|0|||
38015196|NCT00320255|69697768|FG004|Overall Study|Lack of Efficacy|0|||
38015197|NCT00320255|69697769|FG005|Overall Study|Lack of Efficacy|0|||
38015198|NCT00320255|69697764|FG000|Overall Study|Adverse Event|5|||
38015199|NCT00320255|69697765|FG001|Overall Study|Adverse Event|2|||
38015200|NCT00320255|69697766|FG002|Overall Study|Adverse Event|3|||
38015201|NCT00320255|69697767|FG003|Overall Study|Adverse Event|2|||
38015202|NCT00320255|69697768|FG004|Overall Study|Adverse Event|0|||
38015203|NCT00320255|69697769|FG005|Overall Study|Adverse Event|0|||
38015204|NCT00320255|69697764|FG000|Overall Study|Withdrawal by Subject|1|||
38015205|NCT00320255|69697765|FG001|Overall Study|Withdrawal by Subject|2|||
38015206|NCT00320255|69697766|FG002|Overall Study|Withdrawal by Subject|2|||
38015207|NCT00320255|69697767|FG003|Overall Study|Withdrawal by Subject|4|||
38015208|NCT00320255|69697768|FG004|Overall Study|Withdrawal by Subject|0|||
38015209|NCT00320255|69697769|FG005|Overall Study|Withdrawal by Subject|0|||
38015210|NCT00320255|69697764|FG000|Overall Study|Poor compliance/noncompliance|1|||
38015211|NCT00320255|69697765|FG001|Overall Study|Poor compliance/noncompliance|1|||
38015212|NCT00320255|69697766|FG002|Overall Study|Poor compliance/noncompliance|0|||
38015213|NCT00320255|69697767|FG003|Overall Study|Poor compliance/noncompliance|1|||
38015214|NCT00320255|69697768|FG004|Overall Study|Poor compliance/noncompliance|0|||
38015215|NCT00320255|69697769|FG005|Overall Study|Poor compliance/noncompliance|0|||
38015216|NCT00320255|69697764|FG000|Overall Study|No longer meets study criteria|0|||
37832249|NCT01294423|69515722|FG001|Overall Study|poor/non-compliance|0|||
38015217|NCT00320255|69697765|FG001|Overall Study|No longer meets study criteria|0|||
38015218|NCT00320255|69697766|FG002|Overall Study|No longer meets study criteria|0|||
38015219|NCT00320255|69697767|FG003|Overall Study|No longer meets study criteria|1|||
38015220|NCT00320255|69697768|FG004|Overall Study|No longer meets study criteria|0|||
37832250|NCT01294423|69515723|FG002|Overall Study|poor/non-compliance|1|||
38015221|NCT00320255|69697769|FG005|Overall Study|No longer meets study criteria|0|||
38015222|NCT00320255|69697764|FG000|Overall Study|Other|3|||
38015223|NCT00320255|69697765|FG001|Overall Study|Other|2|||
38015224|NCT00320255|69697766|FG002|Overall Study|Other|1|||
38015225|NCT00320255|69697767|FG003|Overall Study|Other|0|||
38015226|NCT00320255|69697768|FG004|Overall Study|Other|0|||
38015227|NCT00320255|69697769|FG005|Overall Study|Other|0|||
38015228|NCT00370331|69697786|FG000|Overall Study|Adverse Event|4|||
38015229|NCT00370331|69697787|FG001|Overall Study|Adverse Event|13|||
38015230|NCT00370331|69697786|FG000|Overall Study|Withdrawal by Subject|2|||
38015231|NCT00370331|69697787|FG001|Overall Study|Withdrawal by Subject|4|||
38015232|NCT00370331|69697786|FG000|Overall Study|Lost to Follow-up|0|||
38015233|NCT00370331|69697787|FG001|Overall Study|Lost to Follow-up|3|||
38015234|NCT00370331|69697786|FG000|Overall Study|Lack of Efficacy|0|||
38015235|NCT00370331|69697787|FG001|Overall Study|Lack of Efficacy|1|||
38015236|NCT00370331|69697786|FG000|Overall Study|Non-compliance|0|||
38015237|NCT00370331|69697787|FG001|Overall Study|Non-compliance|1|||
38015238|NCT00370331|69697786|FG000|Overall Study|Protocol Violation|1|||
38015239|NCT00370331|69697787|FG001|Overall Study|Protocol Violation|1|||
38015240|NCT02962960|69697796|FG000|Overall Study|Withdrawal by Subject|1|||
38015241|NCT02962960|69697797|FG001|Overall Study|Withdrawal by Subject|1|||
38015242|NCT02962960|69697798|FG002|Overall Study|Withdrawal by Subject|0|||
38015243|NCT02962960|69697796|FG000|Overall Study|Adverse Event|1|||
38015244|NCT02962960|69697797|FG001|Overall Study|Adverse Event|1|||
38015245|NCT02962960|69697798|FG002|Overall Study|Adverse Event|0|||
38015246|NCT02962960|69697796|FG000|Overall Study|Protocol Violation|1|||
38015247|NCT02962960|69697797|FG001|Overall Study|Protocol Violation|0|||
38015248|NCT02962960|69697798|FG002|Overall Study|Protocol Violation|0|||
38015249|NCT00369941|69697810|FG000|Overall Study|Never Treated|1|||
38015250|NCT00369941|69697811|FG001|Overall Study|Never Treated|2|||
38015251|NCT00369941|69697810|FG000|Overall Study|Adverse Event|14|||
38015252|NCT00369941|69697811|FG001|Overall Study|Adverse Event|28|||
38015253|NCT00369941|69697810|FG000|Overall Study|Lack of Efficacy|6|||
38015254|NCT00369941|69697811|FG001|Overall Study|Lack of Efficacy|10|||
38015255|NCT00369941|69697810|FG000|Overall Study|Lost to Follow-up|12|||
38015256|NCT00369941|69697811|FG001|Overall Study|Lost to Follow-up|22|||
38015257|NCT00369941|69697810|FG000|Overall Study|Protocol Violation|5|||
38015258|NCT00369941|69697811|FG001|Overall Study|Protocol Violation|3|||
38015259|NCT00369941|69697810|FG000|Overall Study|Withdrawal by Subject|5|||
38015260|NCT00369941|69697811|FG001|Overall Study|Withdrawal by Subject|18|||
38015261|NCT00369941|69697810|FG000|Overall Study|Pregnancy|4|||
38015262|NCT00369941|69697811|FG001|Overall Study|Pregnancy|2|||
38015263|NCT00369941|69697810|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
37832251|NCT01294150|69515733|FG000|Overall Study|Physician Decision|2|||
37832252|NCT01294150|69515734|FG001|Overall Study|Physician Decision|2|||
37832253|NCT01292473|69515746|FG000|Overall Study|Adverse Event|1|||
37832254|NCT01292473|69515747|FG001|Overall Study|Adverse Event|0|||
37832255|NCT01292473|69515748|FG002|Overall Study|Adverse Event|1|||
37832256|NCT01292473|69515749|FG003|Overall Study|Adverse Event|1|||
37832257|NCT01292473|69515746|FG000|Overall Study|Lost to Follow-up|1|||
37832258|NCT01292473|69515747|FG001|Overall Study|Lost to Follow-up|1|||
37832259|NCT01292473|69515748|FG002|Overall Study|Lost to Follow-up|2|||
37909874|NCT00927095|69595694|FG002|Overall Study|Withdrawal by Subject|1|||
37909875|NCT00927095|69595692|FG000|Overall Study|Physician Decision|1|||
37909876|NCT00927095|69595693|FG001|Overall Study|Physician Decision|2|||
37909877|NCT00927095|69595694|FG002|Overall Study|Physician Decision|1|||
37909878|NCT00932165|69595702|FG000|Overall Study|Lost to Follow-up|1|||
37910970|NCT00918203|69597479|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
37910971|NCT00918203|69597477|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
37910972|NCT00918203|69597478|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
37910973|NCT00918203|69597479|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
37910974|NCT00918281|69597491|FG000|Overall Study|Physician Decision|29|||
37910975|NCT02770716|69597500|FG000|Overall Study|Death|101|||
37910976|NCT02770716|69597501|FG001|Overall Study|Death|45|||
37910977|NCT02770716|69597500|FG000|Overall Study|Withdrawal by Subject|4|||
37910978|NCT02770716|69597501|FG001|Overall Study|Withdrawal by Subject|2|||
37910979|NCT02770716|69597500|FG000|Overall Study|Lost to Follow-up|1|||
37910980|NCT02770716|69597501|FG001|Overall Study|Lost to Follow-up|0|||
37910981|NCT02770716|69597500|FG000|Overall Study|Various reasons|6|||
37910982|NCT02770716|69597501|FG001|Overall Study|Various reasons|2|||
38015264|NCT00369941|69697811|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
38015265|NCT00369941|69697810|FG000|Overall Study|Moved|11|||
38015266|NCT00369941|69697811|FG001|Overall Study|Moved|5|||
37832260|NCT01292473|69515749|FG003|Overall Study|Lost to Follow-up|2|||
37832261|NCT01292473|69515746|FG000|Overall Study|Withdrawal by Subject|3|||
37910983|NCT00917579|69597507|FG000|Washout >= 2 Weeks|Adverse Event|1|||
37910984|NCT00917579|69597508|FG001|Washout >= 2 Weeks|Adverse Event|0|||
37910985|NCT00917579|69597507|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
38015267|NCT00369941|69697810|FG000|Overall Study|Treatment with Prohibited Medication|3|||
38015268|NCT00369941|69697811|FG001|Overall Study|Treatment with Prohibited Medication|1|||
38015269|NCT00369941|69697810|FG000|Overall Study|Employment Interfered with Study Visits|1|||
38015270|NCT00369941|69697811|FG001|Overall Study|Employment Interfered with Study Visits|0|||
38015271|NCT00369941|69697810|FG000|Overall Study|Study Site Terminated|2|||
38015272|NCT00369941|69697811|FG001|Overall Study|Study Site Terminated|0|||
37910986|NCT00917579|69597508|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
38015273|NCT00369941|69697810|FG000|Overall Study|Miscellaneous|3|||
38015274|NCT00369941|69697811|FG001|Overall Study|Miscellaneous|3|||
38015275|NCT00319553|69697820|FG000|Overall Study|Protocol Violation|1|||
38015276|NCT00319553|69697821|FG001|Overall Study|Protocol Violation|2|||
38015277|NCT00319553|69697820|FG000|Overall Study|Lost to Follow-up|2|||
38015278|NCT00319553|69697821|FG001|Overall Study|Lost to Follow-up|1|||
38015279|NCT00319553|69697820|FG000|Overall Study|Withdrawal by Subject|1|||
38015280|NCT00319553|69697821|FG001|Overall Study|Withdrawal by Subject|1|||
38015281|NCT00369785|69697829|FG000|Overall Study|Physician Decision|3|||
38015282|NCT00369785|69697830|FG001|Overall Study|Physician Decision|2|||
38015283|NCT00369785|69697829|FG000|Overall Study|Death|1|||
38015284|NCT00369785|69697830|FG001|Overall Study|Death|2|||
38015285|NCT00369785|69697829|FG000|Overall Study|Withdrawal by Subject|7|||
38015286|NCT00369785|69697830|FG001|Overall Study|Withdrawal by Subject|6|||
38015287|NCT00369785|69697829|FG000|Overall Study|Toxicity|6|||
38015288|NCT00369785|69697830|FG001|Overall Study|Toxicity|4|||
38015289|NCT00369785|69697829|FG000|Overall Study|Never started|0|||
38015290|NCT00369785|69697830|FG001|Overall Study|Never started|2|||
38015291|NCT00369785|69697829|FG000|Overall Study|Progression|4|||
38015292|NCT00369785|69697830|FG001|Overall Study|Progression|4|||
38015293|NCT00369785|69697829|FG000|Overall Study|Multiple reasons|6|||
38015294|NCT00369785|69697830|FG001|Overall Study|Multiple reasons|5|||
38015295|NCT00369707|69697836|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
38015296|NCT00369707|69697836|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
38015297|NCT00369707|69697836|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
38015298|NCT00369707|69697836|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
38015299|NCT00369707|69697836|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
38015300|NCT00369707|69697836|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
38015301|NCT00369707|69697836|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
38015302|NCT00369707|69697836|FG000|Follow up for 2 Years After Treatment|Death|1|||
38015303|NCT00369707|69697836|FG000|Follow up for 2 Years After Treatment|Other|2|||
38015304|NCT02943460|69697843|FG000|Blinded Study Phase|Adverse Event|3|||
38015305|NCT02943460|69697844|FG001|Blinded Study Phase|Adverse Event|0|||
38015306|NCT02943460|69697845|FG002|Blinded Study Phase|Adverse Event|0|||
38015307|NCT02943460|69697843|FG000|Blinded Study Phase|Withdrew Consent|0|||
38015308|NCT02943460|69697844|FG001|Blinded Study Phase|Withdrew Consent|1|||
38015309|NCT02943460|69697845|FG002|Blinded Study Phase|Withdrew Consent|0|||
38015310|NCT02943460|69697843|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
38015311|NCT02943460|69697844|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
38015312|NCT02943460|69697845|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
38015313|NCT02943460|69697843|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
38015314|NCT02943460|69697844|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
38015315|NCT02943460|69697845|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
38015316|NCT02943460|69697843|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
38015317|NCT02943460|69697844|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
38015318|NCT02943460|69697845|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
38015319|NCT03768206|69697856|FG000|Overall Study|Lost to Follow-up|2|||
38015320|NCT03768206|69697857|FG001|Overall Study|Lost to Follow-up|1|||
38015321|NCT03768206|69697856|FG000|Overall Study|Withdrawal by Subject|0|||
38015322|NCT03768206|69697857|FG001|Overall Study|Withdrawal by Subject|1|||
38015323|NCT03767894|69697864|FG000|Overall Study|Withdrawal by Subject|1|||
38015324|NCT03766646|69697870|FG000|Overall Study|Withdrawal by Subject|1|||
38015325|NCT03766646|69697871|FG001|Overall Study|Withdrawal by Subject|0|||
38015326|NCT03766646|69697870|FG000|Overall Study|Protocol Violation|0|||
38015327|NCT03766646|69697871|FG001|Overall Study|Protocol Violation|3|||
38015328|NCT03765164|69697879|FG000|Pre-intervention|Withdrawal by Subject|5|||
38015329|NCT03765164|69697880|FG001|Pre-intervention|Withdrawal by Subject|6|||
38015330|NCT00369629|69697886|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
38015331|NCT00369629|69697887|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
38015332|NCT00369629|69697888|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
38015333|NCT00369629|69697889|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
38015334|NCT00369629|69697886|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
38015335|NCT00369629|69697887|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
38015336|NCT00369629|69697888|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
38015337|NCT00369629|69697889|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
38015338|NCT00369629|69697886|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
38015339|NCT00369629|69697887|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
38015340|NCT00369629|69697888|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
38015341|NCT00369629|69697889|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
38015342|NCT00369629|69697886|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
38015343|NCT00369629|69697887|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
38015344|NCT00369629|69697888|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
38015345|NCT00369629|69697889|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
38015346|NCT00369629|69697886|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
38015347|NCT00369629|69697887|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
38015348|NCT00369629|69697888|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
38015349|NCT00369629|69697889|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
38015350|NCT00369629|69697886|FG000|Completed 4 More Cycles|Progressive disease|2|||
38015351|NCT00369629|69697887|FG001|Completed 4 More Cycles|Progressive disease|1|||
38015352|NCT00369629|69697888|FG002|Completed 4 More Cycles|Progressive disease|2|||
38015353|NCT00369629|69697889|FG003|Completed 4 More Cycles|Progressive disease|0|||
38015354|NCT00369629|69697886|FG000|Follow up for 1 Year|Death|2|||
38015355|NCT00369629|69697887|FG001|Follow up for 1 Year|Death|1|||
38015356|NCT00369629|69697888|FG002|Follow up for 1 Year|Death|1|||
38015357|NCT00369629|69697889|FG003|Follow up for 1 Year|Death|0|||
38015358|NCT00369629|69697886|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
38015359|NCT00369629|69697887|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
38015360|NCT00369629|69697888|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
38015361|NCT00369629|69697889|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
38015362|NCT00369629|69697886|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
38015363|NCT00369629|69697887|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
38015364|NCT00369629|69697888|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
38015365|NCT00369629|69697889|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
38015366|NCT02469064|69697901|FG000|Overall Study|Request not to receive intervention.|1|||
38015367|NCT02469064|69697902|FG001|Overall Study|Request not to receive intervention.|3|||
38015368|NCT02446912|69697911|FG000|Overall Study|Adverse Event|3|||
38015369|NCT02446912|69697912|FG001|Overall Study|Adverse Event|13|||
37832262|NCT01292473|69515747|FG001|Overall Study|Withdrawal by Subject|4|||
37832263|NCT01292473|69515748|FG002|Overall Study|Withdrawal by Subject|3|||
37832264|NCT01292473|69515749|FG003|Overall Study|Withdrawal by Subject|3|||
37832265|NCT01292473|69515746|FG000|Overall Study|Physician Decision|0|||
37832266|NCT01292473|69515747|FG001|Overall Study|Physician Decision|1|||
37832267|NCT01292473|69515748|FG002|Overall Study|Physician Decision|0|||
37832268|NCT01292473|69515749|FG003|Overall Study|Physician Decision|0|||
37832269|NCT01292473|69515746|FG000|Overall Study|Disease Progression|0|||
37832270|NCT01292473|69515747|FG001|Overall Study|Disease Progression|1|||
37832271|NCT01292473|69515748|FG002|Overall Study|Disease Progression|3|||
37832272|NCT01292473|69515749|FG003|Overall Study|Disease Progression|6|||
37832273|NCT01292239|69515765|FG000|Overall Study|Other|1|||
37832274|NCT01292239|69515766|FG001|Overall Study|Other|1|||
37832275|NCT01292239|69515765|FG000|Overall Study|Withdrawal by Subject|3|||
37832276|NCT01292239|69515766|FG001|Overall Study|Withdrawal by Subject|6|||
37832277|NCT01291225|69515774|FG000|Overall Study|Lost to Follow-up|85|||
37832278|NCT01291225|69515775|FG001|Overall Study|Lost to Follow-up|39|||
37832279|NCT01290796|69515785|FG000|Overall Study|Lost to Follow-up|21|||
37832280|NCT01290796|69515785|FG000|Overall Study|Withdrawal by Subject|4|||
37832281|NCT01290796|69515785|FG000|Overall Study|Physician Decision|2|||
37909879|NCT04888494|69595709|FG000|Overall Study|Lost to Follow-up|2|||
37909880|NCT04888494|69595710|FG001|Overall Study|Lost to Follow-up|3|||
37909881|NCT04888494|69595709|FG000|Overall Study|We dropped the participant due to safety concerns for the staff.|1|||
37909882|NCT04888494|69595710|FG001|Overall Study|We dropped the participant due to safety concerns for the staff.|0|||
37909883|NCT04761822|69595770|FG000|Overall Study|Adverse Event|3|||
37909884|NCT04761822|69595771|FG001|Overall Study|Adverse Event|1|||
37909885|NCT04761822|69595772|FG002|Overall Study|Adverse Event|1|||
37909886|NCT04761822|69595773|FG003|Overall Study|Adverse Event|3|||
37909887|NCT04761822|69595770|FG000|Overall Study|Lost to Follow-up|1|||
37909888|NCT04761822|69595771|FG001|Overall Study|Lost to Follow-up|0|||
37909889|NCT04761822|69595772|FG002|Overall Study|Lost to Follow-up|2|||
37909890|NCT04761822|69595773|FG003|Overall Study|Lost to Follow-up|3|||
37909891|NCT04761822|69595770|FG000|Overall Study|Physician Decision|0|||
37909892|NCT04761822|69595771|FG001|Overall Study|Physician Decision|1|||
37909893|NCT04761822|69595772|FG002|Overall Study|Physician Decision|0|||
37909894|NCT04761822|69595773|FG003|Overall Study|Physician Decision|0|||
37909895|NCT04761822|69595770|FG000|Overall Study|Withdrawal by Subject|3|||
37832282|NCT01290796|69515785|FG000|Overall Study|Secondary Surgical Intervention|2|||
37832283|NCT01290796|69515785|FG000|Overall Study|Withdrawal by Sponsor|1|||
37909896|NCT04761822|69595771|FG001|Overall Study|Withdrawal by Subject|8|||
37909897|NCT04761822|69595772|FG002|Overall Study|Withdrawal by Subject|1|||
37909898|NCT04761822|69595773|FG003|Overall Study|Withdrawal by Subject|11|||
37832284|NCT01290757|69515791|FG000|Overall Study|Adverse Event|1|||
37832285|NCT01290757|69515792|FG001|Overall Study|Adverse Event|0|||
37832286|NCT01290757|69515791|FG000|Overall Study|Protocol Violation|1|||
37909899|NCT04761822|69595770|FG000|Overall Study|Previously rec'd COVID-19 vaccine|1|||
38015370|NCT02446912|69697913|FG002|Overall Study|Adverse Event|5|||
38015371|NCT02446912|69697911|FG000|Overall Study|Condition under investigation worsened|0|||
38015372|NCT02446912|69697912|FG001|Overall Study|Condition under investigation worsened|1|||
37909900|NCT04761822|69595771|FG001|Overall Study|Previously rec'd COVID-19 vaccine|0|||
38015373|NCT02446912|69697913|FG002|Overall Study|Condition under investigation worsened|1|||
38015374|NCT02446912|69697911|FG000|Overall Study|Study-specific withdrawal criteria|1|||
38015375|NCT02446912|69697912|FG001|Overall Study|Study-specific withdrawal criteria|0|||
38015376|NCT02446912|69697913|FG002|Overall Study|Study-specific withdrawal criteria|0|||
38015377|NCT02446912|69697911|FG000|Overall Study|Lack of Efficacy|1|||
38015378|NCT02446912|69697912|FG001|Overall Study|Lack of Efficacy|4|||
38015379|NCT02446912|69697913|FG002|Overall Study|Lack of Efficacy|7|||
38015380|NCT02446912|69697911|FG000|Overall Study|Lost to Follow-up|0|||
38015381|NCT02446912|69697912|FG001|Overall Study|Lost to Follow-up|0|||
38015382|NCT02446912|69697913|FG002|Overall Study|Lost to Follow-up|2|||
38015383|NCT02446912|69697911|FG000|Overall Study|Severe non-compliance to protocol|1|||
38015384|NCT02446912|69697912|FG001|Overall Study|Severe non-compliance to protocol|0|||
38015385|NCT02446912|69697913|FG002|Overall Study|Severe non-compliance to protocol|1|||
38015386|NCT02446912|69697911|FG000|Overall Study|Withdrawal by Subject|10|||
38015387|NCT02446912|69697912|FG001|Overall Study|Withdrawal by Subject|15|||
38015388|NCT02446912|69697913|FG002|Overall Study|Withdrawal by Subject|15|||
38015389|NCT02446912|69697911|FG000|Overall Study|Miscellaneous|2|||
38015390|NCT02446912|69697912|FG001|Overall Study|Miscellaneous|2|||
38015391|NCT02446912|69697913|FG002|Overall Study|Miscellaneous|4|||
38015392|NCT00736840|69697921|FG000|Overall Study|Lost to Follow-up|13|||
38015393|NCT00318461|69697930|FG000|Double-Blind, 6 Months|Adverse Event|11|||
38015394|NCT00318461|69697931|FG001|Double-Blind, 6 Months|Adverse Event|23|||
38015395|NCT00318461|69697932|FG002|Double-Blind, 6 Months|Adverse Event|29|||
38015396|NCT00318461|69697933|FG003|Double-Blind, 6 Months|Adverse Event|2|||
38015397|NCT00318461|69697934|FG004|Double-Blind, 6 Months|Adverse Event|8|||
38015398|NCT00318461|69697930|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
38015399|NCT00318461|69697931|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
38015400|NCT00318461|69697932|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
38015401|NCT00318461|69697933|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
38015402|NCT00318461|69697934|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
38015403|NCT00318461|69697930|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
38015404|NCT00318461|69697931|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
38015405|NCT00318461|69697932|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
38015406|NCT00318461|69697933|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
38015407|NCT00318461|69697934|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
38015408|NCT00318461|69697930|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
38015409|NCT00318461|69697931|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
38015410|NCT00318461|69697932|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
38015411|NCT00318461|69697933|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
38015412|NCT00318461|69697934|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
38015413|NCT00318461|69697930|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
38015414|NCT00318461|69697931|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
38015415|NCT00318461|69697932|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
38015416|NCT00318461|69697933|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
38015417|NCT00318461|69697934|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
38015418|NCT00318461|69697930|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
38015419|NCT00318461|69697931|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
38015420|NCT00318461|69697932|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
38015421|NCT00318461|69697933|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
38015422|NCT00318461|69697934|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
38015423|NCT00318461|69697930|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
38015424|NCT00318461|69697931|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
37909901|NCT04761822|69595772|FG002|Overall Study|Previously rec'd COVID-19 vaccine|0|||
37909902|NCT04761822|69595773|FG003|Overall Study|Previously rec'd COVID-19 vaccine|0|||
37909903|NCT04761822|69595770|FG000|Overall Study|Participant requested unblinding|0|||
37909904|NCT04761822|69595771|FG001|Overall Study|Participant requested unblinding|0|||
37909905|NCT04761822|69595772|FG002|Overall Study|Participant requested unblinding|0|||
37909906|NCT04761822|69595773|FG003|Overall Study|Participant requested unblinding|1|||
37909907|NCT04573972|69595802|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
38015425|NCT00318461|69697932|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
38015426|NCT00318461|69697933|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
38015427|NCT00318461|69697934|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
38015428|NCT00318461|69697930|FG000|Double-Blind, 6 Months|Move|0|||
38015429|NCT00318461|69697931|FG001|Double-Blind, 6 Months|Move|1|||
38015430|NCT00318461|69697932|FG002|Double-Blind, 6 Months|Move|0|||
38015431|NCT00318461|69697933|FG003|Double-Blind, 6 Months|Move|0|||
38015432|NCT00318461|69697934|FG004|Double-Blind, 6 Months|Move|0|||
38015433|NCT00318461|69697930|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
37909908|NCT04573972|69595803|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
37909909|NCT04391309|69595831|FG000|Overall Study|Death|1|||
37909910|NCT04391309|69595832|FG001|Overall Study|Death|1|||
38015434|NCT00318461|69697931|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
38015435|NCT00318461|69697932|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
38015436|NCT00318461|69697933|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
38015437|NCT00318461|69697934|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
38015438|NCT00318461|69697930|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
38015439|NCT00318461|69697931|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
38015440|NCT00318461|69697932|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
38015441|NCT00318461|69697933|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
38015442|NCT00318461|69697934|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
38015443|NCT00318461|69697930|FG000|Double-Blind, 6 Months|Work commitment|0|||
38015444|NCT00318461|69697931|FG001|Double-Blind, 6 Months|Work commitment|0|||
38015445|NCT00318461|69697932|FG002|Double-Blind, 6 Months|Work commitment|0|||
38015446|NCT00318461|69697933|FG003|Double-Blind, 6 Months|Work commitment|0|||
38015447|NCT00318461|69697934|FG004|Double-Blind, 6 Months|Work commitment|1|||
37832287|NCT01290757|69515792|FG001|Overall Study|Protocol Violation|1|||
37832288|NCT01290757|69515791|FG000|Overall Study|Other|0|||
37832289|NCT01290757|69515792|FG001|Overall Study|Other|1|||
37832290|NCT01290718|69515798|FG000|Overall Study|Early termination of the study|4|||
37832291|NCT01290679|69515804|FG000|Overall Study|Adverse Event|2|||
37832292|NCT01290679|69515805|FG001|Overall Study|Adverse Event|0|||
37832293|NCT01290679|69515804|FG000|Overall Study|Lost to Follow-up|8|||
37832294|NCT01290679|69515805|FG001|Overall Study|Lost to Follow-up|10|||
37832295|NCT01290679|69515804|FG000|Overall Study|Protocol Violation|0|||
37832296|NCT01290679|69515805|FG001|Overall Study|Protocol Violation|1|||
37832297|NCT01290679|69515804|FG000|Overall Study|Withdrawal by Subject|6|||
37832298|NCT01290679|69515805|FG001|Overall Study|Withdrawal by Subject|5|||
37832299|NCT01290679|69515804|FG000|Overall Study|Subject Entered Another Trial|0|||
37832300|NCT01290679|69515805|FG001|Overall Study|Subject Entered Another Trial|5|||
37832301|NCT01290601|69515813|FG000|Overall Study|Adverse Event|0|||
37832302|NCT01290601|69515814|FG001|Overall Study|Adverse Event|2|||
37832303|NCT01290601|69515815|FG002|Overall Study|Adverse Event|0|||
37832304|NCT01290601|69515816|FG003|Overall Study|Adverse Event|0|||
37832305|NCT01290601|69515813|FG000|Overall Study|Lack of Efficacy|2|||
37832306|NCT01290601|69515814|FG001|Overall Study|Lack of Efficacy|1|||
37832307|NCT01290601|69515815|FG002|Overall Study|Lack of Efficacy|0|||
37832308|NCT01290601|69515816|FG003|Overall Study|Lack of Efficacy|0|||
37832309|NCT01290601|69515813|FG000|Overall Study|Lost to Follow-up|7|||
37832310|NCT01290601|69515814|FG001|Overall Study|Lost to Follow-up|2|||
37832311|NCT01290601|69515815|FG002|Overall Study|Lost to Follow-up|0|||
37832312|NCT01290601|69515816|FG003|Overall Study|Lost to Follow-up|0|||
37832313|NCT01290601|69515813|FG000|Overall Study|Other|1|||
37832314|NCT01290601|69515814|FG001|Overall Study|Other|0|||
37832315|NCT01290601|69515815|FG002|Overall Study|Other|0|||
37832316|NCT01290601|69515816|FG003|Overall Study|Other|0|||
37832317|NCT01290601|69515813|FG000|Overall Study|Protocol Violation|1|||
37832318|NCT01290601|69515814|FG001|Overall Study|Protocol Violation|0|||
37832319|NCT01290601|69515815|FG002|Overall Study|Protocol Violation|0|||
37832320|NCT01290601|69515816|FG003|Overall Study|Protocol Violation|0|||
37832321|NCT01290523|69515822|FG000|Overall Study|Death|3|||
37832322|NCT01290094|69515826|FG000|Overall Study|Withdrawal by Subject|1|||
37832323|NCT01290094|69515826|FG000|Overall Study|Lost to Follow-up|5|||
37832324|NCT01289821|69515839|FG000|Treatment Period|Withdrawal by Subject|1|||
37832325|NCT01289821|69515839|FG000|Treatment Period|Physician Decision|3|||
37832326|NCT01289821|69515839|FG000|Treatment Period|Adverse Event|4|||
37832327|NCT01289821|69515839|FG000|Treatment Period|Radiological Progression|43|||
37832328|NCT01289821|69515839|FG000|Treatment Period|Clinical Progression|2|||
37832329|NCT01289821|69515839|FG000|Treatment Period|Therapeutic procedure required|1|||
37832330|NCT01289821|69515839|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
37832331|NCT01289821|69515839|FG000|Safety Follow-up Period|Protocol Violation|3|||
37832332|NCT01289821|69515839|FG000|Safety Follow-up Period|Unspecified reason|1|||
37832333|NCT01289821|69515839|FG000|Survival Follow-up Period|Protocol Violation|1|||
37832334|NCT01289821|69515839|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
37832335|NCT01289821|69515839|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
37832336|NCT01289782|69515845|FG000|Overall Study|Lost to Follow-up|14|||
38015448|NCT00318461|69697930|FG000|Double-Blind, 6 Months|Investigator decision|0|||
38015449|NCT00318461|69697931|FG001|Double-Blind, 6 Months|Investigator decision|0|||
37832337|NCT01289782|69515846|FG001|Overall Study|Lost to Follow-up|7|||
37832338|NCT01289782|69515845|FG000|Overall Study|Protocol Violation|1|||
38015450|NCT00318461|69697932|FG002|Double-Blind, 6 Months|Investigator decision|0|||
37832339|NCT01289782|69515846|FG001|Overall Study|Protocol Violation|1|||
37832340|NCT01289782|69515845|FG000|Overall Study|Withdrawal by Subject|8|||
37832341|NCT01289782|69515846|FG001|Overall Study|Withdrawal by Subject|2|||
37832342|NCT01289782|69515845|FG000|Overall Study|Sponsor's Decision|1|||
37909911|NCT04391309|69595831|FG000|Overall Study|Lost to Follow-up|3|||
38015451|NCT00318461|69697933|FG003|Double-Blind, 6 Months|Investigator decision|0|||
38015452|NCT00318461|69697934|FG004|Double-Blind, 6 Months|Investigator decision|1|||
38015453|NCT00318461|69697930|FG000|Double-Blind, 6 Months|Lack of time|1|||
38015454|NCT00318461|69697931|FG001|Double-Blind, 6 Months|Lack of time|0|||
38015455|NCT00318461|69697932|FG002|Double-Blind, 6 Months|Lack of time|0|||
38015456|NCT00318461|69697933|FG003|Double-Blind, 6 Months|Lack of time|0|||
38015457|NCT00318461|69697934|FG004|Double-Blind, 6 Months|Lack of time|0|||
38015458|NCT00318461|69697930|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
38015459|NCT00318461|69697931|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
38015460|NCT00318461|69697932|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
38015461|NCT00318461|69697933|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
38015462|NCT00318461|69697934|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
38015463|NCT00318461|69697930|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
38015464|NCT00318461|69697931|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
38015465|NCT00318461|69697932|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
38015466|NCT00318461|69697933|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
38015467|NCT00318461|69697934|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
38015468|NCT00318461|69697930|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
38015469|NCT00318461|69697931|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
38015470|NCT00318461|69697932|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
38015471|NCT00318461|69697933|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
38015472|NCT00318461|69697934|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
38015473|NCT00318461|69697930|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
38015474|NCT00318461|69697931|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
38015475|NCT00318461|69697932|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
38015476|NCT00318461|69697933|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
38015477|NCT00318461|69697934|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
38015478|NCT00318461|69697930|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
38015479|NCT00318461|69697931|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
38015480|NCT00318461|69697932|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
38015481|NCT00318461|69697933|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
38015482|NCT00318461|69697934|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
38015483|NCT00318461|69697930|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
38015484|NCT00318461|69697931|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
38015485|NCT00318461|69697932|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
38015486|NCT00318461|69697933|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
38015487|NCT00318461|69697934|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
38015488|NCT00318461|69697930|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
38015489|NCT00318461|69697931|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
38015490|NCT00318461|69697932|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
38015491|NCT00318461|69697933|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
38015492|NCT00318461|69697934|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
38015493|NCT00318461|69697930|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
38015494|NCT00318461|69697931|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
38015495|NCT00318461|69697932|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
37832343|NCT01289782|69515846|FG001|Overall Study|Sponsor's Decision|0|||
38015496|NCT00318461|69697933|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
38015497|NCT00318461|69697934|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
38015498|NCT03764072|69697961|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
38015499|NCT03764072|69697962|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
38015500|NCT03764072|69697963|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
38015501|NCT03764072|69697964|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
37832344|NCT01289782|69515845|FG000|Overall Study|Reason not specified|1|||
37832345|NCT01289782|69515846|FG001|Overall Study|Reason not specified|2|||
37832346|NCT01289353|69515852|FG000|Overall Study|Lost to Follow-up|2|||
37832347|NCT01289119|69515862|FG000|Overall Study|Adverse Event|2|||
37832348|NCT01289119|69515863|FG001|Overall Study|Adverse Event|1|||
37832349|NCT01289119|69515864|FG002|Overall Study|Adverse Event|0|||
38015502|NCT03764072|69697965|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
38015503|NCT03764072|69697966|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
38015504|NCT03764072|69697961|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
37832350|NCT01289119|69515865|FG003|Overall Study|Adverse Event|2|||
38015505|NCT03764072|69697962|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
38015506|NCT03764072|69697963|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
38015507|NCT03764072|69697964|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
38015508|NCT03764072|69697965|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
37832351|NCT01289119|69515866|FG004|Overall Study|Adverse Event|1|||
37909912|NCT04391309|69595832|FG001|Overall Study|Lost to Follow-up|2|||
37909913|NCT04391309|69595831|FG000|Overall Study|Withdrawal by Subject|2|||
37909914|NCT04391309|69595832|FG001|Overall Study|Withdrawal by Subject|2|||
37909915|NCT04202965|69595860|FG000|Overall Study|Adverse Event|3|||
37909916|NCT04202965|69595860|FG000|Overall Study|Did not meet inclusion criteria|1|||
37909917|NCT04056624|69595868|FG000|Overall Study|Withdrawal by Subject|0|||
37909918|NCT04056624|69595869|FG001|Overall Study|Withdrawal by Subject|0|||
37909919|NCT04056624|69595870|FG002|Overall Study|Withdrawal by Subject|1|||
37909920|NCT04056624|69595868|FG000|Overall Study|Protocol Violation|1|||
37909921|NCT04056624|69595869|FG001|Overall Study|Protocol Violation|2|||
37909922|NCT04056624|69595870|FG002|Overall Study|Protocol Violation|0|||
37909923|NCT03870763|69595890|FG000|Overall Study|Study terminated by sponsor|0|||
37909924|NCT03870763|69595891|FG001|Overall Study|Study terminated by sponsor|2|||
37909925|NCT03870763|69595892|FG002|Overall Study|Study terminated by sponsor|0|||
37909926|NCT03870763|69595890|FG000|Overall Study|Withdrawal by Subject|0|||
37909927|NCT03870763|69595891|FG001|Overall Study|Withdrawal by Subject|1|||
37909928|NCT03870763|69595892|FG002|Overall Study|Withdrawal by Subject|0|||
37909929|NCT03870763|69595890|FG000|Overall Study|Worsening of multiple sclerosis attack|0|||
37909930|NCT03870763|69595891|FG001|Overall Study|Worsening of multiple sclerosis attack|0|||
37909931|NCT03870763|69595892|FG002|Overall Study|Worsening of multiple sclerosis attack|1|||
37909932|NCT03647501|69595902|FG000|Overall Study|Lost to Follow-up|1|||
37909933|NCT03647501|69595903|FG001|Overall Study|Lost to Follow-up|1|||
37909934|NCT03647501|69595902|FG000|Overall Study|Withdrawal by Subject|0|||
37909935|NCT03647501|69595903|FG001|Overall Study|Withdrawal by Subject|1|||
37909936|NCT03587142|69595935|FG000|Overall Study|Lost to Follow-up|5|||
37909937|NCT03587142|69595936|FG001|Overall Study|Lost to Follow-up|3|||
37909938|NCT03587142|69595935|FG000|Overall Study|Did not complete the f4 visit|3|||
37909939|NCT03587142|69595936|FG001|Overall Study|Did not complete the f4 visit|7|||
37909940|NCT03493854|69595944|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
37909941|NCT03493854|69595945|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
37909942|NCT03493854|69595944|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
37832352|NCT01289119|69515867|FG005|Overall Study|Adverse Event|0|||
37832353|NCT01289119|69515862|FG000|Overall Study|Major Protocol Deviation|2|||
37909943|NCT03493854|69595945|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
37909944|NCT03493854|69595944|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
37909945|NCT03493854|69595945|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
37909946|NCT03493854|69595944|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
37909947|NCT03493854|69595945|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
37909948|NCT03493854|69595944|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
37832354|NCT01289119|69515863|FG001|Overall Study|Major Protocol Deviation|1|||
38015509|NCT03764072|69697966|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
38015510|NCT03764072|69697961|FG000|Overall Study|Lost to Follow-up|0|||
38015511|NCT03764072|69697962|FG001|Overall Study|Lost to Follow-up|0|||
38015512|NCT03764072|69697963|FG002|Overall Study|Lost to Follow-up|0|||
38015513|NCT03764072|69697964|FG003|Overall Study|Lost to Follow-up|0|||
38015514|NCT03764072|69697965|FG004|Overall Study|Lost to Follow-up|1|||
38015515|NCT03764072|69697966|FG005|Overall Study|Lost to Follow-up|0|||
38015516|NCT03333928|69697988|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
38015517|NCT03333928|69697989|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
38015518|NCT03333928|69697990|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
38015519|NCT03333928|69697988|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
38015520|NCT03333928|69697989|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
38015521|NCT03333928|69697990|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
38015522|NCT03333928|69697988|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
38015523|NCT03333928|69697989|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
38015524|NCT03333928|69697990|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
38015525|NCT03333928|69697988|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
38015526|NCT03333928|69697989|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
38015527|NCT03333928|69697990|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
38015528|NCT03333928|69697988|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
38015529|NCT03333928|69697989|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
38015530|NCT03333928|69697990|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
38015531|NCT03333928|69697988|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
38015532|NCT03333928|69697989|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
38015533|NCT03333928|69697990|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
38015534|NCT03333928|69697988|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
38015535|NCT03333928|69697989|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
38015536|NCT03333928|69697990|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
38015537|NCT03333928|69697988|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
38015538|NCT03333928|69697989|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
38015539|NCT03333928|69697990|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
38015540|NCT02945410|69698012|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
38015541|NCT02945410|69698013|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
38015542|NCT02945410|69698014|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
38015543|NCT02945410|69698015|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
38015544|NCT02945410|69698016|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
38015545|NCT02945410|69698017|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
38015546|NCT02945410|69698012|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
38015547|NCT02945410|69698013|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
38015548|NCT02945410|69698014|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
38015549|NCT02945410|69698015|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
38015550|NCT02945410|69698016|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
38015551|NCT02945410|69698017|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
38015552|NCT02945410|69698012|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
38015553|NCT02945410|69698013|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
38015554|NCT02945410|69698014|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
38015555|NCT02945410|69698015|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
38015556|NCT02945410|69698016|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
38015557|NCT02945410|69698017|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
38015558|NCT02945254|69698027|FG000|Overall Study|Lost to Follow-up|1|||
38015559|NCT02945254|69698028|FG001|Overall Study|Lost to Follow-up|0|||
38015560|NCT02945254|69698027|FG000|Overall Study|Withdrawal by Subject|1|||
38015561|NCT02945254|69698028|FG001|Overall Study|Withdrawal by Subject|0|||
38015562|NCT02943070|69698046|FG000|Overall Study|Physician Decision|1|||
38015563|NCT02943070|69698046|FG000|Overall Study|Adverse Event|2|||
38015564|NCT02943070|69698046|FG000|Overall Study|Death|2|||
38015565|NCT02943070|69698046|FG000|Overall Study|Withdrawal by Subject|3|||
37832355|NCT01289119|69515864|FG002|Overall Study|Major Protocol Deviation|3|||
37832356|NCT01289119|69515865|FG003|Overall Study|Major Protocol Deviation|0|||
37832357|NCT01289119|69515866|FG004|Overall Study|Major Protocol Deviation|2|||
37832358|NCT01289119|69515867|FG005|Overall Study|Major Protocol Deviation|1|||
37832359|NCT01289119|69515862|FG000|Overall Study|Lost to Follow-up|0|||
38015566|NCT02943070|69698046|FG000|Overall Study|Lost to Follow-up|4|||
38015567|NCT02943070|69698046|FG000|Overall Study|Retreatment or TURP|13|||
37832360|NCT01289119|69515863|FG001|Overall Study|Lost to Follow-up|3|||
37832361|NCT01289119|69515864|FG002|Overall Study|Lost to Follow-up|0|||
37832362|NCT01289119|69515865|FG003|Overall Study|Lost to Follow-up|0|||
38015568|NCT02943070|69698046|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
38015569|NCT03332212|69698070|FG000|Overall Study|Not treated|0|||
38015570|NCT03332212|69698071|FG001|Overall Study|Not treated|1|||
38015571|NCT03332212|69698072|FG002|Overall Study|Not treated|0|||
38015572|NCT03332212|69698073|FG003|Overall Study|Not treated|0|||
38015573|NCT03332212|69698070|FG000|Overall Study|Adverse Event|0|||
38015574|NCT03332212|69698071|FG001|Overall Study|Adverse Event|0|||
38015575|NCT03332212|69698072|FG002|Overall Study|Adverse Event|0|||
38015576|NCT03332212|69698073|FG003|Overall Study|Adverse Event|1|||
38015577|NCT03332212|69698070|FG000|Overall Study|worsening of disease under study|1|||
38015578|NCT03332212|69698071|FG001|Overall Study|worsening of disease under study|1|||
38015579|NCT03332212|69698072|FG002|Overall Study|worsening of disease under study|0|||
38015580|NCT03332212|69698073|FG003|Overall Study|worsening of disease under study|0|||
38015581|NCT03331666|69698083|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
38015582|NCT03331666|69698084|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
38015583|NCT03331042|69698094|FG000|Overall Study|Protocol Violation|1|||
38015584|NCT03331042|69698095|FG001|Overall Study|Protocol Violation|0|||
38015585|NCT03331042|69698096|FG002|Overall Study|Protocol Violation|0|||
38015586|NCT03331042|69698097|FG003|Overall Study|Protocol Violation|0|||
38015587|NCT03331042|69698094|FG000|Overall Study|Physician Decision|0|||
38015588|NCT03331042|69698095|FG001|Overall Study|Physician Decision|0|||
38015589|NCT03331042|69698096|FG002|Overall Study|Physician Decision|1|||
38015590|NCT03331042|69698097|FG003|Overall Study|Physician Decision|0|||
38015591|NCT03331042|69698094|FG000|Overall Study|Lost to Follow-up|0|||
38015592|NCT03331042|69698095|FG001|Overall Study|Lost to Follow-up|0|||
38015593|NCT03331042|69698096|FG002|Overall Study|Lost to Follow-up|0|||
38015594|NCT03331042|69698097|FG003|Overall Study|Lost to Follow-up|1|||
38015595|NCT03762668|69698115|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
38015596|NCT03762668|69698116|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
38015597|NCT03762200|69698122|FG000|Overall Study|Death|2|||
38015598|NCT03711370|69698128|FG000|Overall Study|Lost to Follow-up|16|||
38015599|NCT03711370|69698129|FG001|Overall Study|Lost to Follow-up|10|||
38015600|NCT03711370|69698128|FG000|Overall Study|Pre-test or Post-test visits were >2 weeks apart|0|||
38015601|NCT03711370|69698129|FG001|Overall Study|Pre-test or Post-test visits were >2 weeks apart|6|||
38015602|NCT03329404|69698145|FG000|Overall Study|The study was suspended.|1|||
38015603|NCT03329404|69698146|FG001|Overall Study|The study was suspended.|4|||
38015604|NCT03478930|69698154|FG000|Overall Study|Adverse Event|0|||
38015605|NCT03478930|69698155|FG001|Overall Study|Adverse Event|1|||
38015606|NCT03478930|69698154|FG000|Overall Study|Lack of Efficacy|3|||
38015607|NCT03478930|69698155|FG001|Overall Study|Lack of Efficacy|3|||
38015608|NCT03478930|69698154|FG000|Overall Study|Withdrawal by Subject|6|||
38015609|NCT03478930|69698155|FG001|Overall Study|Withdrawal by Subject|5|||
38015610|NCT03038438|69698161|FG000|Overall Study|Death|3|||
38015611|NCT03038438|69698161|FG000|Overall Study|Lost to Follow-up|8|||
38015612|NCT03038438|69698161|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
38015613|NCT03038438|69698161|FG000|Overall Study|Withdrawal by Subject|5|||
38015614|NCT03038438|69698161|FG000|Overall Study|No 36-Month Follow-Up|18|||
38015615|NCT03523000|69698165|FG000|Overall Study|Withdrawal by Subject|3|||
38015616|NCT03523000|69698166|FG001|Overall Study|Withdrawal by Subject|0|||
38015617|NCT03523000|69698165|FG000|Overall Study|Unsuccessful trial|2|||
38015618|NCT03523000|69698166|FG001|Overall Study|Unsuccessful trial|0|||
38015619|NCT03327220|69698177|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
38015620|NCT03327220|69698178|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
38015621|NCT03327220|69698177|FG000|Overall Study|Investigator Decision|2|||
38015622|NCT03327220|69698178|FG001|Overall Study|Investigator Decision|0|||
38015623|NCT03327220|69698177|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
38015624|NCT03327220|69698178|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
38015625|NCT03327220|69698177|FG000|Overall Study|Fungal infection|1|||
38015626|NCT03327220|69698178|FG001|Overall Study|Fungal infection|0|||
38015627|NCT03327220|69698177|FG000|Overall Study|Discharged to Rehabilitation|0|||
38015628|NCT03327220|69698178|FG001|Overall Study|Discharged to Rehabilitation|1|||
38015629|NCT03327220|69698177|FG000|Overall Study|Missing|1|||
38015630|NCT03327220|69698178|FG001|Overall Study|Missing|0|||
38015631|NCT00318149|69698190|FG000|Overall Study|Adverse Event|0|||
38015632|NCT00318149|69698191|FG001|Overall Study|Adverse Event|0|||
38015633|NCT00318149|69698192|FG002|Overall Study|Adverse Event|0|||
38015634|NCT00318149|69698193|FG003|Overall Study|Adverse Event|0|||
38015635|NCT00318149|69698194|FG004|Overall Study|Adverse Event|0|||
38015636|NCT00318149|69698195|FG005|Overall Study|Adverse Event|2|||
38015637|NCT00317603|69698211|FG000|Overall Study|Progressive Disease|3|||
38015638|NCT03326518|69698218|FG000|Overall Study|Protocol Violation|1|||
38015639|NCT03326518|69698219|FG001|Overall Study|Protocol Violation|0|||
38015640|NCT03326518|69698220|FG002|Overall Study|Protocol Violation|0|||
38015641|NCT03326518|69698218|FG000|Overall Study|Withdrawal by Subject|1|||
38015642|NCT03326518|69698219|FG001|Overall Study|Withdrawal by Subject|0|||
38015643|NCT03326518|69698220|FG002|Overall Study|Withdrawal by Subject|0|||
37909949|NCT03493854|69595945|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
37909950|NCT03493854|69595944|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
38015644|NCT03326518|69698218|FG000|Overall Study|Lost to Follow-up|1|||
38015645|NCT03326518|69698219|FG001|Overall Study|Lost to Follow-up|0|||
38015646|NCT03326518|69698220|FG002|Overall Study|Lost to Follow-up|1|||
38015647|NCT00317369|69698231|FG000|Overall Study|Adverse Event|2|||
38015648|NCT00317369|69698232|FG001|Overall Study|Adverse Event|1|||
38015649|NCT00317369|69698233|FG002|Overall Study|Adverse Event|0|||
38015650|NCT00317369|69698231|FG000|Overall Study|Lack of Efficacy|0|||
38015651|NCT00317369|69698232|FG001|Overall Study|Lack of Efficacy|1|||
38015652|NCT00317369|69698233|FG002|Overall Study|Lack of Efficacy|1|||
38015653|NCT00317369|69698231|FG000|Overall Study|Withdrawal by Subject|0|||
38015654|NCT00317369|69698232|FG001|Overall Study|Withdrawal by Subject|0|||
38015655|NCT00317369|69698233|FG002|Overall Study|Withdrawal by Subject|1|||
38015656|NCT03325894|69698243|FG000|Overall Study|Adverse Event|2|||
38015657|NCT03325894|69698244|FG001|Overall Study|Adverse Event|3|||
38015658|NCT03325894|69698243|FG000|Overall Study|Protocol Violation|1|||
38015659|NCT03325894|69698244|FG001|Overall Study|Protocol Violation|2|||
38015660|NCT03325894|69698243|FG000|Overall Study|Withdrawal by Subject|10|||
38015661|NCT03325894|69698244|FG001|Overall Study|Withdrawal by Subject|6|||
38015662|NCT03325894|69698243|FG000|Overall Study|Lost to Follow-up|4|||
38015663|NCT03325894|69698244|FG001|Overall Study|Lost to Follow-up|9|||
38015664|NCT03325894|69698243|FG000|Overall Study|Lack of Efficacy|8|||
38015665|NCT03325894|69698244|FG001|Overall Study|Lack of Efficacy|14|||
38015666|NCT03325894|69698243|FG000|Overall Study|Study Terminated by Sponsor|38|||
38015667|NCT03325894|69698244|FG001|Overall Study|Study Terminated by Sponsor|43|||
38015668|NCT03325894|69698243|FG000|Overall Study|Other (Not received Treatment)|1|||
38015669|NCT03325894|69698244|FG001|Overall Study|Other (Not received Treatment)|0|||
38015670|NCT01239368|69698263|FG000|Overall Study|Principal investigator discretion|1|||
38015671|NCT01239368|69698264|FG001|Overall Study|Principal investigator discretion|0|||
38015672|NCT01239368|69698265|FG002|Overall Study|Principal investigator discretion|0|||
38015673|NCT01239368|69698266|FG003|Overall Study|Principal investigator discretion|0|||
38015674|NCT01239368|69698267|FG004|Overall Study|Principal investigator discretion|1|||
38015675|NCT01239368|69698268|FG005|Overall Study|Principal investigator discretion|2|||
38015676|NCT01239368|69698269|FG006|Overall Study|Principal investigator discretion|0|||
38015677|NCT01239368|69698270|FG007|Overall Study|Principal investigator discretion|0|||
38015678|NCT01239368|69698271|FG008|Overall Study|Principal investigator discretion|0|||
38015679|NCT01239368|69698272|FG009|Overall Study|Principal investigator discretion|1|||
38015680|NCT01239368|69698263|FG000|Overall Study|Disease progression on study|1|||
38015681|NCT01239368|69698264|FG001|Overall Study|Disease progression on study|1|||
38015682|NCT01239368|69698265|FG002|Overall Study|Disease progression on study|1|||
38015683|NCT01239368|69698266|FG003|Overall Study|Disease progression on study|1|||
38015684|NCT01239368|69698267|FG004|Overall Study|Disease progression on study|4|||
38015685|NCT01239368|69698268|FG005|Overall Study|Disease progression on study|2|||
38015686|NCT01239368|69698269|FG006|Overall Study|Disease progression on study|5|||
38015687|NCT01239368|69698270|FG007|Overall Study|Disease progression on study|0|||
38015688|NCT01239368|69698271|FG008|Overall Study|Disease progression on study|0|||
38015689|NCT01239368|69698272|FG009|Overall Study|Disease progression on study|2|||
38015690|NCT01239368|69698263|FG000|Overall Study|Refused further treatment|0|||
38015691|NCT01239368|69698264|FG001|Overall Study|Refused further treatment|0|||
38015692|NCT01239368|69698265|FG002|Overall Study|Refused further treatment|0|||
38015693|NCT01239368|69698266|FG003|Overall Study|Refused further treatment|0|||
38015694|NCT01239368|69698267|FG004|Overall Study|Refused further treatment|0|||
38015695|NCT01239368|69698268|FG005|Overall Study|Refused further treatment|0|||
38015696|NCT01239368|69698269|FG006|Overall Study|Refused further treatment|0|||
38015697|NCT01239368|69698270|FG007|Overall Study|Refused further treatment|0|||
38015698|NCT01239368|69698271|FG008|Overall Study|Refused further treatment|0|||
38015699|NCT01239368|69698272|FG009|Overall Study|Refused further treatment|1|||
38015700|NCT01239368|69698263|FG000|Overall Study|Death|0|||
38015701|NCT01239368|69698264|FG001|Overall Study|Death|0|||
38015702|NCT01239368|69698265|FG002|Overall Study|Death|0|||
38015703|NCT01239368|69698266|FG003|Overall Study|Death|0|||
38015704|NCT01239368|69698267|FG004|Overall Study|Death|0|||
38015705|NCT01239368|69698268|FG005|Overall Study|Death|0|||
38015706|NCT01239368|69698269|FG006|Overall Study|Death|1|||
38015707|NCT01239368|69698270|FG007|Overall Study|Death|0|||
38015708|NCT01239368|69698271|FG008|Overall Study|Death|0|||
38015709|NCT01239368|69698272|FG009|Overall Study|Death|0|||
38015710|NCT00369161|69698320|FG000|Overall Study|Adverse Event|15|||
38015711|NCT00369161|69698321|FG001|Overall Study|Adverse Event|13|||
38015712|NCT00369161|69698320|FG000|Overall Study|Abnormal laboratory value|0|||
38015713|NCT00369161|69698321|FG001|Overall Study|Abnormal laboratory value|1|||
38015714|NCT00369161|69698320|FG000|Overall Study|Lack of Efficacy|3|||
38015715|NCT00369161|69698321|FG001|Overall Study|Lack of Efficacy|1|||
38015716|NCT00369161|69698320|FG000|Overall Study|Protocol Violation|0|||
38015717|NCT00369161|69698321|FG001|Overall Study|Protocol Violation|2|||
38015718|NCT00369161|69698320|FG000|Overall Study|Withdrawal by Subject|2|||
38015719|NCT00369161|69698321|FG001|Overall Study|Withdrawal by Subject|3|||
38015720|NCT00369161|69698320|FG000|Overall Study|Death|1|||
38015721|NCT00369161|69698321|FG001|Overall Study|Death|2|||
38015722|NCT00369161|69698320|FG000|Overall Study|Graft loss|4|||
38015723|NCT00369161|69698321|FG001|Overall Study|Graft loss|0|||
38015724|NCT00369161|69698320|FG000|Overall Study|Administrative Problem|2|||
38015725|NCT00369161|69698321|FG001|Overall Study|Administrative Problem|2|||
38015726|NCT00337571|69698331|FG000|Overall Study|Lack of Efficacy|3|||
38015727|NCT00337571|69698332|FG001|Overall Study|Lack of Efficacy|0|||
38015728|NCT00337571|69698333|FG002|Overall Study|Lack of Efficacy|0|||
38015729|NCT00337571|69698334|FG003|Overall Study|Lack of Efficacy|0|||
38015730|NCT00337571|69698331|FG000|Overall Study|Adverse Event|4|||
38015731|NCT00337571|69698332|FG001|Overall Study|Adverse Event|5|||
38015732|NCT00337571|69698333|FG002|Overall Study|Adverse Event|8|||
38015733|NCT00337571|69698334|FG003|Overall Study|Adverse Event|4|||
38015734|NCT00337571|69698331|FG000|Overall Study|Withdrawal by Subject|2|||
38015735|NCT00337571|69698332|FG001|Overall Study|Withdrawal by Subject|2|||
38015736|NCT00337571|69698333|FG002|Overall Study|Withdrawal by Subject|1|||
38015737|NCT00337571|69698334|FG003|Overall Study|Withdrawal by Subject|0|||
38015738|NCT00337571|69698331|FG000|Overall Study|Lost to Follow-up|3|||
38015739|NCT00337571|69698332|FG001|Overall Study|Lost to Follow-up|1|||
38015740|NCT00337571|69698333|FG002|Overall Study|Lost to Follow-up|0|||
38015741|NCT00337571|69698334|FG003|Overall Study|Lost to Follow-up|1|||
38015742|NCT00337571|69698331|FG000|Overall Study|Poor/noncompliance|1|||
38015743|NCT00337571|69698332|FG001|Overall Study|Poor/noncompliance|1|||
38015744|NCT00337571|69698333|FG002|Overall Study|Poor/noncompliance|1|||
38015745|NCT00337571|69698334|FG003|Overall Study|Poor/noncompliance|1|||
38015746|NCT00337571|69698331|FG000|Overall Study|No longer met study criteria|1|||
38015747|NCT00337571|69698332|FG001|Overall Study|No longer met study criteria|0|||
38015748|NCT00337571|69698333|FG002|Overall Study|No longer met study criteria|0|||
38015749|NCT00337571|69698334|FG003|Overall Study|No longer met study criteria|0|||
38015750|NCT00337571|69698331|FG000|Overall Study|High Potassium level|0|||
38015751|NCT00337571|69698332|FG001|Overall Study|High Potassium level|0|||
38015752|NCT00337571|69698333|FG002|Overall Study|High Potassium level|0|||
38015753|NCT00337571|69698334|FG003|Overall Study|High Potassium level|1|||
38015754|NCT00368927|69698346|FG000|Overall Study|Lost to Follow-up|2|||
38015755|NCT00368927|69698347|FG001|Overall Study|Lost to Follow-up|0|||
38015756|NCT00368927|69698346|FG000|Overall Study|Adverse Event|1|||
38015757|NCT00368927|69698347|FG001|Overall Study|Adverse Event|1|||
38015758|NCT00368927|69698346|FG000|Overall Study|Withdrawal by Subject|1|||
38015759|NCT00368927|69698347|FG001|Overall Study|Withdrawal by Subject|2|||
38015760|NCT00368927|69698346|FG000|Overall Study|Physician Decision|1|||
38015761|NCT00368927|69698347|FG001|Overall Study|Physician Decision|0|||
38015762|NCT00316589|69698370|FG000|Overall Study|Withdrawal by Subject|0|||
38015763|NCT00316589|69698371|FG001|Overall Study|Withdrawal by Subject|5|||
38015764|NCT00316589|69698372|FG002|Overall Study|Withdrawal by Subject|0|||
38015765|NCT00316589|69698373|FG003|Overall Study|Withdrawal by Subject|1|||
38015766|NCT00316589|69698370|FG000|Overall Study|Subject unwilling/unable to comply|0|||
38015767|NCT00316589|69698371|FG001|Overall Study|Subject unwilling/unable to comply|6|||
38015768|NCT00316589|69698372|FG002|Overall Study|Subject unwilling/unable to comply|0|||
38015769|NCT00316589|69698373|FG003|Overall Study|Subject unwilling/unable to comply|2|||
38015770|NCT00316589|69698370|FG000|Overall Study|Adverse Event|1|||
38015771|NCT00316589|69698371|FG001|Overall Study|Adverse Event|0|||
38015772|NCT00316589|69698372|FG002|Overall Study|Adverse Event|0|||
38015773|NCT00316589|69698373|FG003|Overall Study|Adverse Event|1|||
38015774|NCT00316589|69698370|FG000|Overall Study|Physician Decision|0|||
38015775|NCT00316589|69698371|FG001|Overall Study|Physician Decision|1|||
38015776|NCT00316589|69698372|FG002|Overall Study|Physician Decision|0|||
38015777|NCT00316589|69698373|FG003|Overall Study|Physician Decision|0|||
38015778|NCT00316589|69698370|FG000|Overall Study|Other reason|0|||
38015779|NCT00316589|69698371|FG001|Overall Study|Other reason|12|||
38015780|NCT00316589|69698372|FG002|Overall Study|Other reason|1|||
38015781|NCT00316589|69698373|FG003|Overall Study|Other reason|1|||
38015782|NCT00316277|69698387|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
38015783|NCT00316277|69698388|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
38015784|NCT00316277|69698387|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
38015785|NCT00316277|69698388|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
38015786|NCT00316277|69698387|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
38015787|NCT00316277|69698388|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
38015788|NCT00316277|69698387|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
38015789|NCT00316277|69698388|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
38015790|NCT00316277|69698387|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
38015791|NCT00316277|69698388|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
38015792|NCT00368849|69698402|FG000|Overall Study|Withdrawal by Subject|0|||
38015793|NCT00368849|69698403|FG001|Overall Study|Withdrawal by Subject|1|||
38015794|NCT00368849|69698402|FG000|Overall Study|Physician Decision|0|||
38015795|NCT00368849|69698403|FG001|Overall Study|Physician Decision|1|||
38015796|NCT00316199|69698410|FG000|Overall Study|Adverse Event|2|||
38015797|NCT00316199|69698410|FG000|Overall Study|Death|8|||
38015798|NCT00316199|69698410|FG000|Overall Study|Lost to Follow-up|2|||
38015799|NCT00316121|69698416|FG000|Overall Study|Death|1|||
38015800|NCT00316121|69698417|FG001|Overall Study|Death|0|||
38015801|NCT00316121|69698416|FG000|Overall Study|Lost to Follow-up|14|||
38015802|NCT00316121|69698417|FG001|Overall Study|Lost to Follow-up|8|||
38015803|NCT00316121|69698416|FG000|Overall Study|Withdrawal by Subject|2|||
38015804|NCT00316121|69698417|FG001|Overall Study|Withdrawal by Subject|0|||
38015805|NCT00316121|69698416|FG000|Overall Study|Reason is missing|1|||
38015806|NCT00316121|69698417|FG001|Overall Study|Reason is missing|0|||
38015807|NCT00316121|69698416|FG000|Overall Study|Subject relocated|1|||
38015808|NCT00316121|69698417|FG001|Overall Study|Subject relocated|1|||
38015809|NCT00316121|69698416|FG000|Overall Study|Subject refused to return|1|||
38015810|NCT00316121|69698417|FG001|Overall Study|Subject refused to return|0|||
38015811|NCT00316121|69698416|FG000|Overall Study|Subject no show for visit x 3|1|||
38015812|NCT00316121|69698417|FG001|Overall Study|Subject no show for visit x 3|0|||
38015813|NCT00316121|69698416|FG000|Overall Study|Subject did not have 24 month visit|1|||
38015814|NCT00316121|69698417|FG001|Overall Study|Subject did not have 24 month visit|0|||
38015815|NCT00337103|69698436|FG000|Overall Study|Progressive Disease|414|||
38015816|NCT00337103|69698437|FG001|Overall Study|Progressive Disease|410|||
38015817|NCT00337103|69698436|FG000|Overall Study|Adverse Event|45|||
38015818|NCT00337103|69698437|FG001|Overall Study|Adverse Event|59|||
38015819|NCT00337103|69698436|FG000|Overall Study|Subject Choice|34|||
38015820|NCT00337103|69698437|FG001|Overall Study|Subject Choice|27|||
38015821|NCT00337103|69698436|FG000|Overall Study|Clinical Progression|27|||
38015822|NCT00337103|69698437|FG001|Overall Study|Clinical Progression|24|||
38015823|NCT00337103|69698436|FG000|Overall Study|Physician Decision|15|||
38015824|NCT00337103|69698437|FG001|Overall Study|Physician Decision|14|||
38015825|NCT00337103|69698436|FG000|Overall Study|Withdrawal by Subject|8|||
38015826|NCT00337103|69698437|FG001|Overall Study|Withdrawal by Subject|5|||
38015827|NCT00337103|69698436|FG000|Overall Study|Other|5|||
38015828|NCT00337103|69698437|FG001|Overall Study|Other|6|||
38015829|NCT00337103|69698436|FG000|Overall Study|Entry Criteria Not Met|4|||
38015830|NCT00337103|69698437|FG001|Overall Study|Entry Criteria Not Met|1|||
38015831|NCT00337103|69698436|FG000|Overall Study|Lost to Follow-up|1|||
38015832|NCT00337103|69698437|FG001|Overall Study|Lost to Follow-up|2|||
38015833|NCT00337103|69698436|FG000|Overall Study|Death|1|||
38015834|NCT00337103|69698437|FG001|Overall Study|Death|0|||
38015835|NCT00415532|69698446|FG000|Treatment Period|Adverse Event|2|||
38015836|NCT00415532|69698447|FG001|Treatment Period|Adverse Event|3|||
38015837|NCT00415532|69698446|FG000|Treatment Period|Death|2|||
38015838|NCT00415532|69698447|FG001|Treatment Period|Death|1|||
38015839|NCT00415532|69698446|FG000|Treatment Period|Lost to Follow-up|1|||
38015840|NCT00415532|69698447|FG001|Treatment Period|Lost to Follow-up|1|||
38015841|NCT00415532|69698446|FG000|Treatment Period|Protocol Violation|1|||
38015842|NCT00415532|69698447|FG001|Treatment Period|Protocol Violation|0|||
38015843|NCT00415532|69698446|FG000|Treatment Period|Withdrawal by Subject|6|||
38015844|NCT00415532|69698447|FG001|Treatment Period|Withdrawal by Subject|6|||
38015845|NCT00415532|69698446|FG000|Treatment Period|Other|2|||
38015846|NCT00415532|69698447|FG001|Treatment Period|Other|2|||
38015847|NCT00415532|69698446|FG000|Treatment Period|Ineligibility determined|1|||
38015848|NCT00415532|69698447|FG001|Treatment Period|Ineligibility determined|1|||
38015849|NCT00415532|69698446|FG000|Treatment Period|Noncompliance|1|||
38015850|NCT00415532|69698447|FG001|Treatment Period|Noncompliance|1|||
38015851|NCT00415532|69698446|FG000|Treatment Period|Requirement for alternative therapy|1|||
38015852|NCT00415532|69698447|FG001|Treatment Period|Requirement for alternative therapy|0|||
38015853|NCT00415532|69698446|FG000|Safety Follow Up Period|Adverse Event|1|||
38015854|NCT00415532|69698447|FG001|Safety Follow Up Period|Adverse Event|3|||
38015855|NCT00415532|69698446|FG000|Safety Follow Up Period|Death|3|||
38015856|NCT00415532|69698447|FG001|Safety Follow Up Period|Death|0|||
38015857|NCT00415532|69698446|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
38015858|NCT00415532|69698447|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
38015859|NCT00415532|69698446|FG000|Safety Follow Up Period|Other|1|||
38015860|NCT00415532|69698447|FG001|Safety Follow Up Period|Other|4|||
38015861|NCT00415532|69698446|FG000|Safety Follow Up Period|Ineligibility determined|1|||
38015862|NCT00415532|69698447|FG001|Safety Follow Up Period|Ineligibility determined|1|||
38015863|NCT00415532|69698446|FG000|Safety Follow Up Period|Noncompliance|1|||
38015864|NCT00415532|69698447|FG001|Safety Follow Up Period|Noncompliance|0|||
38015865|NCT00415532|69698446|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
38015866|NCT00415532|69698447|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
38015867|NCT00315731|69698453|FG000|Overall Study|Lost to Follow-up|1|||
38015868|NCT00315731|69698453|FG000|Overall Study|Death|5|||
38015869|NCT00062868|69698480|FG000|Dose Level 1|Death|2|||
38015870|NCT00062868|69698481|FG001|Dose Level 1|Death|0|||
38015871|NCT00062868|69698482|FG002|Dose Level 1|Death|0|||
38015872|NCT00062868|69698483|FG003|Dose Level 1|Death|2|||
38015873|NCT00062868|69698484|FG004|Dose Level 1|Death|0|||
38015874|NCT00062868|69698485|FG005|Dose Level 1|Death|0|||
38015875|NCT00062868|69698486|FG006|Dose Level 1|Death|3|||
38015876|NCT00062868|69698487|FG007|Dose Level 1|Death|0|||
38015877|NCT00062868|69698488|FG008|Dose Level 1|Death|0|||
38015878|NCT00062868|69698489|FG009|Dose Level 1|Death|0|||
38015879|NCT00062868|69698490|FG010|Dose Level 1|Death|0|||
38015880|NCT00062868|69698491|FG011|Dose Level 1|Death|0|||
38015881|NCT00062868|69698492|FG012|Dose Level 1|Death|0|||
38015882|NCT00062868|69698493|FG013|Dose Level 1|Death|0|||
38015883|NCT00062868|69698494|FG014|Dose Level 1|Death|0|||
38015884|NCT00062868|69698495|FG015|Dose Level 1|Death|0|||
38015885|NCT00062868|69698496|FG016|Dose Level 1|Death|0|||
38015886|NCT00062868|69698497|FG017|Dose Level 1|Death|0|||
38015887|NCT00062868|69698498|FG018|Dose Level 1|Death|7|||
38015888|NCT00062868|69698499|FG019|Dose Level 1|Death|0|||
38015889|NCT00062868|69698500|FG020|Dose Level 1|Death|1|||
38015890|NCT00062868|69698480|FG000|Dose Level 1|Lost to Follow-up|0|||
38015891|NCT00062868|69698481|FG001|Dose Level 1|Lost to Follow-up|0|||
38015892|NCT00062868|69698482|FG002|Dose Level 1|Lost to Follow-up|0|||
38015893|NCT00062868|69698483|FG003|Dose Level 1|Lost to Follow-up|0|||
38015894|NCT00062868|69698484|FG004|Dose Level 1|Lost to Follow-up|0|||
38015895|NCT00062868|69698485|FG005|Dose Level 1|Lost to Follow-up|0|||
37698455|NCT01815424|69175235|FG001|Week 0 to 16|Withdrawal by Subject|0|||
37698456|NCT01815424|69175236|FG002|Week 0 to 16|Withdrawal by Subject|1|||
37698457|NCT01815424|69175237|FG003|Week 0 to 16|Withdrawal by Subject|0|||
37698458|NCT01815424|69175238|FG004|Week 0 to 16|Withdrawal by Subject|0|||
37909951|NCT03493854|69595945|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
37909952|NCT03493854|69595944|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
37909953|NCT03493854|69595945|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
37909954|NCT03493854|69595944|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Ongoing Adjuvant Treatment|229|||
37909955|NCT03493854|69595945|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Ongoing Adjuvant Treatment|228|||
37909956|NCT03493854|69595944|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|2|||
37909957|NCT03493854|69595945|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|2|||
37909958|NCT03493854|69595944|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
37909959|NCT03493854|69595945|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|1|||
37909960|NCT03493854|69595944|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|3|||
37909961|NCT03493854|69595945|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
37909962|NCT03493854|69595944|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Protocol Violation|1|||
37909963|NCT03493854|69595945|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Protocol Violation|0|||
37909964|NCT03493854|69595944|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
37909965|NCT03493854|69595945|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|0|||
37909966|NCT03493854|69595944|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|5|||
37909967|NCT03493854|69595945|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|3|||
37909968|NCT03493854|69595944|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|1|||
37909969|NCT03493854|69595945|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|1|||
38015896|NCT00062868|69698486|FG006|Dose Level 1|Lost to Follow-up|0|||
38015897|NCT00062868|69698487|FG007|Dose Level 1|Lost to Follow-up|0|||
38015898|NCT00062868|69698488|FG008|Dose Level 1|Lost to Follow-up|0|||
38015899|NCT00062868|69698489|FG009|Dose Level 1|Lost to Follow-up|0|||
37698459|NCT01815424|69175234|FG000|Week 0 to 16|Other|1|||
37698460|NCT01815424|69175235|FG001|Week 0 to 16|Other|0|||
37698461|NCT01815424|69175236|FG002|Week 0 to 16|Other|3|||
37698462|NCT01815424|69175237|FG003|Week 0 to 16|Other|0|||
37698463|NCT01815424|69175238|FG004|Week 0 to 16|Other|0|||
37698464|NCT01815424|69175234|FG000|Week 0 to 16|Protocol Violation|1|||
37698465|NCT01815424|69175235|FG001|Week 0 to 16|Protocol Violation|0|||
37698466|NCT01815424|69175236|FG002|Week 0 to 16|Protocol Violation|0|||
37698467|NCT01815424|69175237|FG003|Week 0 to 16|Protocol Violation|0|||
37698468|NCT01815424|69175238|FG004|Week 0 to 16|Protocol Violation|0|||
37698469|NCT01815424|69175234|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
37698470|NCT01815424|69175235|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
38015900|NCT00062868|69698490|FG010|Dose Level 1|Lost to Follow-up|0|||
38015901|NCT00062868|69698491|FG011|Dose Level 1|Lost to Follow-up|0|||
38015902|NCT00062868|69698492|FG012|Dose Level 1|Lost to Follow-up|1|||
38015903|NCT00062868|69698493|FG013|Dose Level 1|Lost to Follow-up|0|||
38015904|NCT00062868|69698494|FG014|Dose Level 1|Lost to Follow-up|0|||
38015905|NCT00062868|69698495|FG015|Dose Level 1|Lost to Follow-up|0|||
37698471|NCT01815424|69175236|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
37698472|NCT01815424|69175237|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
37698473|NCT01815424|69175238|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
37698474|NCT01815424|69175234|FG000|Week 16 to 52|Other|0|||
38015906|NCT00062868|69698496|FG016|Dose Level 1|Lost to Follow-up|0|||
38015907|NCT00062868|69698497|FG017|Dose Level 1|Lost to Follow-up|0|||
38015908|NCT00062868|69698498|FG018|Dose Level 1|Lost to Follow-up|2|||
38015909|NCT00062868|69698499|FG019|Dose Level 1|Lost to Follow-up|0|||
38015910|NCT00062868|69698500|FG020|Dose Level 1|Lost to Follow-up|1|||
38015911|NCT00062868|69698480|FG000|Dose Level 2|Death|0|||
38015912|NCT00062868|69698481|FG001|Dose Level 2|Death|3|||
38015913|NCT00062868|69698482|FG002|Dose Level 2|Death|0|||
38015914|NCT00062868|69698483|FG003|Dose Level 2|Death|0|||
38015915|NCT00062868|69698484|FG004|Dose Level 2|Death|2|||
38015916|NCT00062868|69698485|FG005|Dose Level 2|Death|0|||
38015917|NCT00062868|69698486|FG006|Dose Level 2|Death|0|||
38015918|NCT00062868|69698487|FG007|Dose Level 2|Death|0|||
38015919|NCT00062868|69698488|FG008|Dose Level 2|Death|0|||
38015920|NCT00062868|69698489|FG009|Dose Level 2|Death|0|||
38015921|NCT00062868|69698490|FG010|Dose Level 2|Death|1|||
38015922|NCT00062868|69698491|FG011|Dose Level 2|Death|0|||
38015923|NCT00062868|69698492|FG012|Dose Level 2|Death|0|||
38015924|NCT00062868|69698493|FG013|Dose Level 2|Death|0|||
38015925|NCT00062868|69698494|FG014|Dose Level 2|Death|0|||
38015926|NCT00062868|69698495|FG015|Dose Level 2|Death|0|||
38015927|NCT00062868|69698496|FG016|Dose Level 2|Death|2|||
37909970|NCT03493854|69595944|FG000|Treatment-Free Follow-Up (up to 3 Years)|Ongoing in Follow-Up|18|||
37909971|NCT03493854|69595945|FG001|Treatment-Free Follow-Up (up to 3 Years)|Ongoing in Follow-Up|16|||
38015928|NCT00062868|69698497|FG017|Dose Level 2|Death|0|||
38015929|NCT00062868|69698498|FG018|Dose Level 2|Death|0|||
38015930|NCT00062868|69698499|FG019|Dose Level 2|Death|0|||
38015931|NCT00062868|69698500|FG020|Dose Level 2|Death|0|||
38015932|NCT00062868|69698480|FG000|Dose Level 2|Lost to Follow-up|0|||
38015933|NCT00062868|69698481|FG001|Dose Level 2|Lost to Follow-up|0|||
38015934|NCT00062868|69698482|FG002|Dose Level 2|Lost to Follow-up|0|||
38015935|NCT00062868|69698483|FG003|Dose Level 2|Lost to Follow-up|0|||
38015936|NCT00062868|69698484|FG004|Dose Level 2|Lost to Follow-up|0|||
38015937|NCT00062868|69698485|FG005|Dose Level 2|Lost to Follow-up|0|||
38015938|NCT00062868|69698486|FG006|Dose Level 2|Lost to Follow-up|0|||
38015939|NCT00062868|69698487|FG007|Dose Level 2|Lost to Follow-up|0|||
38015940|NCT00062868|69698488|FG008|Dose Level 2|Lost to Follow-up|0|||
38015941|NCT00062868|69698489|FG009|Dose Level 2|Lost to Follow-up|0|||
38015942|NCT00062868|69698490|FG010|Dose Level 2|Lost to Follow-up|0|||
38015943|NCT00062868|69698491|FG011|Dose Level 2|Lost to Follow-up|0|||
38015944|NCT00062868|69698492|FG012|Dose Level 2|Lost to Follow-up|0|||
38015945|NCT00062868|69698493|FG013|Dose Level 2|Lost to Follow-up|1|||
38015946|NCT00062868|69698494|FG014|Dose Level 2|Lost to Follow-up|0|||
38015947|NCT00062868|69698495|FG015|Dose Level 2|Lost to Follow-up|0|||
38015948|NCT00062868|69698496|FG016|Dose Level 2|Lost to Follow-up|1|||
38015949|NCT00062868|69698497|FG017|Dose Level 2|Lost to Follow-up|0|||
38015950|NCT00062868|69698498|FG018|Dose Level 2|Lost to Follow-up|0|||
38015951|NCT00062868|69698499|FG019|Dose Level 2|Lost to Follow-up|0|||
38015952|NCT00062868|69698500|FG020|Dose Level 2|Lost to Follow-up|0|||
38015953|NCT00062868|69698480|FG000|Dose Level 3|Death|0|||
38015954|NCT00062868|69698481|FG001|Dose Level 3|Death|0|||
38015955|NCT00062868|69698482|FG002|Dose Level 3|Death|0|||
38015956|NCT00062868|69698483|FG003|Dose Level 3|Death|0|||
38015957|NCT00062868|69698484|FG004|Dose Level 3|Death|0|||
38015958|NCT00062868|69698485|FG005|Dose Level 3|Death|0|||
38015959|NCT00062868|69698486|FG006|Dose Level 3|Death|0|||
38015960|NCT00062868|69698487|FG007|Dose Level 3|Death|0|||
38015961|NCT00062868|69698488|FG008|Dose Level 3|Death|0|||
37909972|NCT03188705|69595951|FG000|Clopidogrel Treatment|Withdrawal by Subject|1|||
37909973|NCT03188705|69595951|FG000|Clopidogrel Plus Aspirin Treatment|Withdrawal by Subject|1|||
37909974|NCT03032484|69595956|FG000|Overall Study Cycle 1 (C1)|Withdrawal by Subject|1|||
37909975|NCT03032484|69595957|FG001|Overall Study Cycle 1 (C1)|Withdrawal by Subject|0|||
37909976|NCT03032484|69595956|FG000|Start of Second Cycle (C2)|Withdrawal by Subject|1|||
37909977|NCT03032484|69595957|FG001|Start of Second Cycle (C2)|Withdrawal by Subject|0|||
37909978|NCT02975349|69595966|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
37909979|NCT02975349|69595967|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
38015962|NCT00062868|69698489|FG009|Dose Level 3|Death|0|||
38015963|NCT00062868|69698490|FG010|Dose Level 3|Death|0|||
38015964|NCT00062868|69698491|FG011|Dose Level 3|Death|1|||
37909980|NCT02975349|69595968|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
38015965|NCT00062868|69698492|FG012|Dose Level 3|Death|0|||
38015966|NCT00062868|69698493|FG013|Dose Level 3|Death|0|||
38015967|NCT00062868|69698494|FG014|Dose Level 3|Death|0|||
38015968|NCT00062868|69698495|FG015|Dose Level 3|Death|0|||
38015969|NCT00062868|69698496|FG016|Dose Level 3|Death|0|||
38015970|NCT00062868|69698497|FG017|Dose Level 3|Death|1|||
38015971|NCT00062868|69698498|FG018|Dose Level 3|Death|0|||
38015972|NCT00062868|69698499|FG019|Dose Level 3|Death|0|||
38015973|NCT00062868|69698500|FG020|Dose Level 3|Death|0|||
38015974|NCT00062868|69698480|FG000|Dose Level 3|Lost to Follow-up|0|||
38015975|NCT00062868|69698481|FG001|Dose Level 3|Lost to Follow-up|0|||
38015976|NCT00062868|69698482|FG002|Dose Level 3|Lost to Follow-up|0|||
38015977|NCT00062868|69698483|FG003|Dose Level 3|Lost to Follow-up|0|||
38015978|NCT00062868|69698484|FG004|Dose Level 3|Lost to Follow-up|0|||
38015979|NCT00062868|69698485|FG005|Dose Level 3|Lost to Follow-up|0|||
38015980|NCT00062868|69698486|FG006|Dose Level 3|Lost to Follow-up|0|||
38015981|NCT00062868|69698487|FG007|Dose Level 3|Lost to Follow-up|0|||
38015982|NCT00062868|69698488|FG008|Dose Level 3|Lost to Follow-up|0|||
38015983|NCT00062868|69698489|FG009|Dose Level 3|Lost to Follow-up|0|||
38015984|NCT00062868|69698490|FG010|Dose Level 3|Lost to Follow-up|0|||
38015985|NCT00062868|69698491|FG011|Dose Level 3|Lost to Follow-up|0|||
38015986|NCT00062868|69698492|FG012|Dose Level 3|Lost to Follow-up|0|||
38015987|NCT00062868|69698493|FG013|Dose Level 3|Lost to Follow-up|0|||
38015988|NCT00062868|69698494|FG014|Dose Level 3|Lost to Follow-up|1|||
38015989|NCT00062868|69698495|FG015|Dose Level 3|Lost to Follow-up|0|||
38015990|NCT00062868|69698496|FG016|Dose Level 3|Lost to Follow-up|0|||
38015991|NCT00062868|69698497|FG017|Dose Level 3|Lost to Follow-up|0|||
38015992|NCT00062868|69698498|FG018|Dose Level 3|Lost to Follow-up|0|||
38015993|NCT00062868|69698499|FG019|Dose Level 3|Lost to Follow-up|0|||
38015994|NCT00062868|69698500|FG020|Dose Level 3|Lost to Follow-up|0|||
38015995|NCT00062868|69698480|FG000|Dose Level 3|Withdrew|0|||
38015996|NCT00062868|69698481|FG001|Dose Level 3|Withdrew|0|||
38015997|NCT00062868|69698482|FG002|Dose Level 3|Withdrew|2|||
38015998|NCT00062868|69698483|FG003|Dose Level 3|Withdrew|0|||
38015999|NCT00062868|69698484|FG004|Dose Level 3|Withdrew|0|||
38016000|NCT00062868|69698485|FG005|Dose Level 3|Withdrew|0|||
38016001|NCT00062868|69698486|FG006|Dose Level 3|Withdrew|0|||
38016002|NCT00062868|69698487|FG007|Dose Level 3|Withdrew|0|||
38016003|NCT00062868|69698488|FG008|Dose Level 3|Withdrew|0|||
38016004|NCT00062868|69698489|FG009|Dose Level 3|Withdrew|0|||
38016005|NCT00062868|69698490|FG010|Dose Level 3|Withdrew|0|||
38016006|NCT00062868|69698491|FG011|Dose Level 3|Withdrew|0|||
38016007|NCT00062868|69698492|FG012|Dose Level 3|Withdrew|0|||
38016008|NCT00062868|69698493|FG013|Dose Level 3|Withdrew|0|||
38016009|NCT00062868|69698494|FG014|Dose Level 3|Withdrew|0|||
38016010|NCT00062868|69698495|FG015|Dose Level 3|Withdrew|0|||
38016011|NCT00062868|69698496|FG016|Dose Level 3|Withdrew|0|||
38016012|NCT00062868|69698497|FG017|Dose Level 3|Withdrew|0|||
38016013|NCT00062868|69698498|FG018|Dose Level 3|Withdrew|0|||
38016014|NCT00062868|69698499|FG019|Dose Level 3|Withdrew|0|||
38016015|NCT00062868|69698500|FG020|Dose Level 3|Withdrew|0|||
38016016|NCT00075504|69698546|FG000|Overall Study|Withdrawal by Subject|9|||
38016017|NCT00075504|69698547|FG001|Overall Study|Withdrawal by Subject|7|||
38016018|NCT00062166|69698553|FG000|Overall Study|Withdrawal by Subject|6|||
38016019|NCT00087438|69698558|FG000|Overall Study|Ineligible / No protocol treatment|4|||
38016020|NCT00321464|69698566|FG000|Overall Study|Death|169|||
38016021|NCT00321464|69698567|FG001|Overall Study|Death|174|||
38016022|NCT00321464|69698566|FG000|Overall Study|Disease progression|124|||
38016023|NCT00321464|69698567|FG001|Overall Study|Disease progression|124|||
38016024|NCT00321464|69698566|FG000|Overall Study|Withdrawal by Subject|117|||
38016025|NCT00321464|69698567|FG001|Overall Study|Withdrawal by Subject|118|||
38016026|NCT00321464|69698566|FG000|Overall Study|Participant request|57|||
38016027|NCT00321464|69698567|FG001|Overall Study|Participant request|61|||
38016028|NCT00321464|69698566|FG000|Overall Study|Adverse Event|43|||
38016029|NCT00321464|69698567|FG001|Overall Study|Adverse Event|28|||
38016030|NCT00321464|69698566|FG000|Overall Study|Physician Decision|15|||
38016031|NCT00321464|69698567|FG001|Overall Study|Physician Decision|14|||
38016032|NCT00321464|69698566|FG000|Overall Study|Noncompliance|4|||
38016033|NCT00321464|69698567|FG001|Overall Study|Noncompliance|10|||
38016034|NCT00321464|69698566|FG000|Overall Study|Lost to Follow-up|7|||
37909981|NCT02975349|69595969|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
37909982|NCT02975349|69595970|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
37909983|NCT02975349|69595971|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
37909984|NCT02975349|69595966|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
37909985|NCT02975349|69595967|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
37909986|NCT02975349|69595968|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
37909987|NCT02975349|69595969|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
37909988|NCT02975349|69595970|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
38016035|NCT00321464|69698567|FG001|Overall Study|Lost to Follow-up|8|||
38016036|NCT00321464|69698566|FG000|Overall Study|Protocol deviation|0|||
38016037|NCT00321464|69698567|FG001|Overall Study|Protocol deviation|2|||
38016038|NCT00321464|69698566|FG000|Overall Study|Ineligibility determined|2|||
38016039|NCT00321464|69698567|FG001|Overall Study|Ineligibility determined|1|||
38016040|NCT00321464|69698566|FG000|Overall Study|Other|21|||
38016041|NCT00321464|69698567|FG001|Overall Study|Other|18|||
38016042|NCT02889796|69698577|FG000|Overall Study|Withdrew Consent|18|||
38016043|NCT02889796|69698578|FG001|Overall Study|Withdrew Consent|29|||
38016044|NCT02889796|69698579|FG002|Overall Study|Withdrew Consent|20|||
38016045|NCT02889796|69698580|FG003|Overall Study|Withdrew Consent|1|||
38016046|NCT02889796|69698581|FG004|Overall Study|Withdrew Consent|2|||
38016047|NCT02889796|69698582|FG005|Overall Study|Withdrew Consent|35|||
38016048|NCT02889796|69698577|FG000|Overall Study|Investigator's Discretion|10|||
38016049|NCT02889796|69698578|FG001|Overall Study|Investigator's Discretion|9|||
38016050|NCT02889796|69698579|FG002|Overall Study|Investigator's Discretion|10|||
38016051|NCT02889796|69698580|FG003|Overall Study|Investigator's Discretion|3|||
38016052|NCT02889796|69698581|FG004|Overall Study|Investigator's Discretion|0|||
38016053|NCT02889796|69698582|FG005|Overall Study|Investigator's Discretion|15|||
38016054|NCT02889796|69698577|FG000|Overall Study|Adverse Event|17|||
38016055|NCT02889796|69698578|FG001|Overall Study|Adverse Event|8|||
38016056|NCT02889796|69698579|FG002|Overall Study|Adverse Event|8|||
38016057|NCT02889796|69698580|FG003|Overall Study|Adverse Event|4|||
38016058|NCT02889796|69698581|FG004|Overall Study|Adverse Event|1|||
38016059|NCT02889796|69698582|FG005|Overall Study|Adverse Event|7|||
38016060|NCT02889796|69698577|FG000|Overall Study|Lost to Follow-up|5|||
38016061|NCT02889796|69698578|FG001|Overall Study|Lost to Follow-up|7|||
38016062|NCT02889796|69698579|FG002|Overall Study|Lost to Follow-up|2|||
38016063|NCT02889796|69698580|FG003|Overall Study|Lost to Follow-up|0|||
38016064|NCT02889796|69698581|FG004|Overall Study|Lost to Follow-up|2|||
38016065|NCT02889796|69698582|FG005|Overall Study|Lost to Follow-up|6|||
38016066|NCT02889796|69698577|FG000|Overall Study|Protocol Violation|0|||
38016067|NCT02889796|69698578|FG001|Overall Study|Protocol Violation|1|||
38016068|NCT02889796|69698579|FG002|Overall Study|Protocol Violation|3|||
38016069|NCT02889796|69698580|FG003|Overall Study|Protocol Violation|0|||
38016070|NCT02889796|69698581|FG004|Overall Study|Protocol Violation|0|||
38016071|NCT02889796|69698582|FG005|Overall Study|Protocol Violation|4|||
38016072|NCT02889796|69698577|FG000|Overall Study|Non-compliance With Study Drug|0|||
38016073|NCT02889796|69698578|FG001|Overall Study|Non-compliance With Study Drug|2|||
38016074|NCT02889796|69698579|FG002|Overall Study|Non-compliance With Study Drug|0|||
38016075|NCT02889796|69698580|FG003|Overall Study|Non-compliance With Study Drug|0|||
38016076|NCT02889796|69698581|FG004|Overall Study|Non-compliance With Study Drug|1|||
38016077|NCT02889796|69698582|FG005|Overall Study|Non-compliance With Study Drug|2|||
38016078|NCT02889796|69698577|FG000|Overall Study|Death|1|||
38016079|NCT02889796|69698578|FG001|Overall Study|Death|1|||
38016080|NCT02889796|69698579|FG002|Overall Study|Death|0|||
38016081|NCT02889796|69698580|FG003|Overall Study|Death|1|||
38016082|NCT02889796|69698581|FG004|Overall Study|Death|0|||
38016083|NCT02889796|69698582|FG005|Overall Study|Death|1|||
38016084|NCT02889796|69698577|FG000|Overall Study|Pregnancy|0|||
38016085|NCT02889796|69698578|FG001|Overall Study|Pregnancy|1|||
38016086|NCT02889796|69698579|FG002|Overall Study|Pregnancy|1|||
38016087|NCT02889796|69698580|FG003|Overall Study|Pregnancy|0|||
38016088|NCT02889796|69698581|FG004|Overall Study|Pregnancy|0|||
38016089|NCT02889796|69698582|FG005|Overall Study|Pregnancy|0|||
38016090|NCT02889796|69698577|FG000|Overall Study|Randomized but not Dosed|2|||
38016091|NCT02889796|69698578|FG001|Overall Study|Randomized but not Dosed|0|||
38016092|NCT02889796|69698579|FG002|Overall Study|Randomized but not Dosed|0|||
38016093|NCT02889796|69698580|FG003|Overall Study|Randomized but not Dosed|0|||
38016094|NCT02889796|69698581|FG004|Overall Study|Randomized but not Dosed|0|||
38016095|NCT02889796|69698582|FG005|Overall Study|Randomized but not Dosed|2|||
38016096|NCT02889562|69698607|FG000|Overall Study|Physician Decision|0|||
38016097|NCT02889562|69698608|FG001|Overall Study|Physician Decision|1|||
38016098|NCT02889562|69698607|FG000|Overall Study|Withdrawal by Subject|0|||
38016099|NCT02889562|69698608|FG001|Overall Study|Withdrawal by Subject|1|||
38016100|NCT03323164|69698616|FG000|Overall Study|Poor quality imaging/scans|2|||
38016101|NCT03323164|69698617|FG001|Overall Study|Poor quality imaging/scans|2|||
38016102|NCT03323086|69698629|FG000|Overall Study|Lost to Follow-up|3|||
38016103|NCT03323086|69698630|FG001|Overall Study|Lost to Follow-up|2|||
38016104|NCT02888080|69698638|FG000|Overall Study|Subject / Guardian decision|1|||
38016105|NCT02888080|69698639|FG001|Overall Study|Subject / Guardian decision|3|||
38016106|NCT02888080|69698638|FG000|Overall Study|New Therapy for study indication|1|||
38016107|NCT02888080|69698639|FG001|Overall Study|New Therapy for study indication|0|||
38016108|NCT02888080|69698638|FG000|Overall Study|Lack of Efficacy|0|||
38016109|NCT02888080|69698639|FG001|Overall Study|Lack of Efficacy|1|||
38016110|NCT02888080|69698638|FG000|Overall Study|Adverse Event|0|||
38016111|NCT02888080|69698639|FG001|Overall Study|Adverse Event|1|||
38016112|NCT03322462|69698645|FG000|Overall Study|Technical difficulties|2|||
38016113|NCT03322462|69698645|FG000|Overall Study|Other|1|||
38016114|NCT00086580|69698653|FG000|Treatment Period|Disease progression|9|||
38016115|NCT00086580|69698654|FG001|Treatment Period|Disease progression|8|||
38016116|NCT00086580|69698653|FG000|Treatment Period|Unable to comply with protocol|3|||
38016117|NCT00086580|69698654|FG001|Treatment Period|Unable to comply with protocol|1|||
38016118|NCT00086580|69698653|FG000|Treatment Period|Withdrawal by Subject|7|||
38016119|NCT00086580|69698654|FG001|Treatment Period|Withdrawal by Subject|8|||
38016120|NCT00086580|69698653|FG000|Treatment Period|Physician Decision|13|||
38016121|NCT00086580|69698654|FG001|Treatment Period|Physician Decision|7|||
38016122|NCT00086580|69698653|FG000|Treatment Period|AE - not treatment related|7|||
38016123|NCT00086580|69698654|FG001|Treatment Period|AE - not treatment related|7|||
38016124|NCT00086580|69698653|FG000|Treatment Period|Toxicity - treatment related|15|||
38016125|NCT00086580|69698654|FG001|Treatment Period|Toxicity - treatment related|15|||
38016126|NCT00086580|69698653|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
38016127|NCT00086580|69698654|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
38016128|NCT00086580|69698653|FG000|Treatment Period|Death|5|||
38016129|NCT00086580|69698654|FG001|Treatment Period|Death|7|||
38016130|NCT00086580|69698653|FG000|Treatment Period|Other|5|||
38016131|NCT00086580|69698654|FG001|Treatment Period|Other|3|||
38016132|NCT00086580|69698653|FG000|Follow-up Period|Disease progression|72|||
38016133|NCT00086580|69698654|FG001|Follow-up Period|Disease progression|99|||
38016134|NCT00086580|69698653|FG000|Follow-up Period|Unable to comply with protocol|5|||
38016135|NCT00086580|69698654|FG001|Follow-up Period|Unable to comply with protocol|0|||
38016136|NCT00086580|69698653|FG000|Follow-up Period|Withdrawal by Subject|6|||
38016137|NCT00086580|69698654|FG001|Follow-up Period|Withdrawal by Subject|6|||
38016138|NCT00086580|69698653|FG000|Follow-up Period|Physician Decision|0|||
38016139|NCT00086580|69698654|FG001|Follow-up Period|Physician Decision|1|||
38016140|NCT00086580|69698653|FG000|Follow-up Period|AE - not related|1|||
38016141|NCT00086580|69698654|FG001|Follow-up Period|AE - not related|0|||
38016142|NCT00086580|69698653|FG000|Follow-up Period|Death|13|||
38016143|NCT00086580|69698654|FG001|Follow-up Period|Death|7|||
38016144|NCT00086580|69698653|FG000|Follow-up Period|Other|7|||
38016145|NCT00086580|69698654|FG001|Follow-up Period|Other|6|||
38016146|NCT00086580|69698653|FG000|Observation Period|Unable to comply with protocol|1|||
38016147|NCT00086580|69698654|FG001|Observation Period|Unable to comply with protocol|1|||
38016148|NCT00086580|69698653|FG000|Observation Period|Withdrawal by Subject|4|||
38016149|NCT00086580|69698654|FG001|Observation Period|Withdrawal by Subject|2|||
38016150|NCT00086580|69698653|FG000|Observation Period|Death|33|||
38016151|NCT00086580|69698654|FG001|Observation Period|Death|55|||
38016152|NCT00086580|69698653|FG000|Observation Period|Other|8|||
38016153|NCT00086580|69698654|FG001|Observation Period|Other|7|||
38016154|NCT00086502|69698662|FG000|Overall Study|Adverse Event|11|||
38016155|NCT00086502|69698663|FG001|Overall Study|Adverse Event|2|||
38016156|NCT00086502|69698662|FG000|Overall Study|Lack of Efficacy|0|||
38016157|NCT00086502|69698663|FG001|Overall Study|Lack of Efficacy|2|||
38016158|NCT00086502|69698662|FG000|Overall Study|Lost to Follow-up|3|||
38016159|NCT00086502|69698663|FG001|Overall Study|Lost to Follow-up|1|||
38016160|NCT00086502|69698662|FG000|Overall Study|Physician Decision|1|||
38016161|NCT00086502|69698663|FG001|Overall Study|Physician Decision|1|||
38016162|NCT00086502|69698662|FG000|Overall Study|Pregnancy|0|||
38016163|NCT00086502|69698663|FG001|Overall Study|Pregnancy|1|||
38016164|NCT00086502|69698662|FG000|Overall Study|Protocol Violation|3|||
38016165|NCT00086502|69698663|FG001|Overall Study|Protocol Violation|3|||
38016166|NCT00086502|69698662|FG000|Overall Study|Withdrawal by Subject|5|||
38016167|NCT00086502|69698663|FG001|Overall Study|Withdrawal by Subject|6|||
38016168|NCT00086502|69698662|FG000|Overall Study|Patient Moved|1|||
38016169|NCT00086502|69698663|FG001|Overall Study|Patient Moved|1|||
38016170|NCT00086502|69698662|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
38016171|NCT00086502|69698663|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
38016172|NCT00086502|69698662|FG000|Overall Study|Patient Accidentally Unblinded|1|||
38016173|NCT00086502|69698663|FG001|Overall Study|Patient Accidentally Unblinded|0|||
38016174|NCT03826667|69698669|FG000|Overall Study|Protocol deviation|21|||
38016175|NCT03636542|69698681|FG000|Overall Study|Lost to Follow-up|1|||
38016176|NCT03636542|69698682|FG001|Overall Study|Lost to Follow-up|1|||
38016177|NCT03636542|69698681|FG000|Overall Study|Physician Decision|0|||
38016178|NCT03636542|69698682|FG001|Overall Study|Physician Decision|1|||
38016179|NCT03636542|69698681|FG000|Overall Study|Withdrawal by Subject|1|||
38016180|NCT03636542|69698682|FG001|Overall Study|Withdrawal by Subject|0|||
38016181|NCT03305770|69698690|FG000|Overall Study|Physician Decision - prior to dispense|0|||
38016182|NCT03305770|69698691|FG001|Overall Study|Physician Decision - prior to dispense|1|||
38016183|NCT03305770|69698690|FG000|Overall Study|Subject moved|1|||
38016184|NCT03305770|69698691|FG001|Overall Study|Subject moved|0|||
38016185|NCT00086190|69698702|FG000|Overall Study|Adverse Event|6|||
38016186|NCT00086190|69698703|FG001|Overall Study|Adverse Event|2|||
38016187|NCT00086190|69698704|FG002|Overall Study|Adverse Event|2|||
38016188|NCT00086190|69698702|FG000|Overall Study|Withdrawal by Subject|0|||
38016189|NCT00086190|69698703|FG001|Overall Study|Withdrawal by Subject|2|||
38016190|NCT00086190|69698704|FG002|Overall Study|Withdrawal by Subject|2|||
38016191|NCT00086190|69698702|FG000|Overall Study|Protocol Violation|1|||
38016192|NCT00086190|69698703|FG001|Overall Study|Protocol Violation|0|||
38016193|NCT00086190|69698704|FG002|Overall Study|Protocol Violation|0|||
38016194|NCT00086190|69698702|FG000|Overall Study|Moved|1|||
38016195|NCT00086190|69698703|FG001|Overall Study|Moved|0|||
38016196|NCT00086190|69698704|FG002|Overall Study|Moved|0|||
38016197|NCT00086190|69698702|FG000|Overall Study|Worsening depression|0|||
38016198|NCT00086190|69698703|FG001|Overall Study|Worsening depression|0|||
38016199|NCT00086190|69698704|FG002|Overall Study|Worsening depression|2|||
38016200|NCT03320824|69698714|FG000|Overall Study|Withdrawal by Subject|8|||
38016201|NCT03320824|69698715|FG001|Overall Study|Withdrawal by Subject|1|||
38016202|NCT03320824|69698714|FG000|Overall Study|Lost to Follow-up|10|||
37909989|NCT02975349|69595971|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
37909990|NCT02975349|69595966|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
38016203|NCT03320824|69698715|FG001|Overall Study|Lost to Follow-up|1|||
38016204|NCT03320824|69698714|FG000|Overall Study|moved out of state|0|||
38016205|NCT03320824|69698715|FG001|Overall Study|moved out of state|1|||
38016206|NCT03320824|69698714|FG000|Overall Study|could not complete final visit|0|||
38016207|NCT03320824|69698715|FG001|Overall Study|could not complete final visit|1|||
38016208|NCT03275350|69698727|FG000|Overall Study|Lost to Follow-up|4|||
38016209|NCT03275350|69698728|FG001|Overall Study|Lost to Follow-up|6|||
38016210|NCT03275350|69698727|FG000|Overall Study|Death|2|||
38016211|NCT03275350|69698728|FG001|Overall Study|Death|1|||
38016212|NCT03275350|69698727|FG000|Overall Study|Physician Decision|1|||
38016213|NCT03275350|69698728|FG001|Overall Study|Physician Decision|0|||
38016214|NCT03275350|69698727|FG000|Overall Study|Incarcerated|1|||
38016215|NCT03275350|69698728|FG001|Overall Study|Incarcerated|1|||
38016216|NCT03319732|69698735|FG000|Overall Study|Adverse Event|40|||
38016217|NCT03319732|69698735|FG000|Overall Study|Withdrawal by Subject|50|||
38016218|NCT03319732|69698735|FG000|Overall Study|MS relapse|10|||
38016219|NCT03319732|69698735|FG000|Overall Study|reason not specified|5|||
38016220|NCT03304522|69698742|FG000|Overall Study|Adverse Event|0|||
38016221|NCT03304522|69698743|FG001|Overall Study|Adverse Event|4|||
38016222|NCT03304522|69698742|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
38016223|NCT03304522|69698743|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
38016224|NCT03304522|69698742|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
38016225|NCT03304522|69698743|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
38016226|NCT03304522|69698742|FG000|Overall Study|Other|0|||
38016227|NCT03304522|69698743|FG001|Overall Study|Other|1|||
38016228|NCT03315286|69698751|FG000|Overall Study|Lost to Follow-up|0|||
38016229|NCT03315286|69698752|FG001|Overall Study|Lost to Follow-up|3|||
38016230|NCT03315286|69698751|FG000|Overall Study|Withdrawal by Subject|1|||
38016231|NCT03315286|69698752|FG001|Overall Study|Withdrawal by Subject|0|||
38016232|NCT03315286|69698751|FG000|Overall Study|Protocol Violation|0|||
38016233|NCT03315286|69698752|FG001|Overall Study|Protocol Violation|1|||
38016234|NCT03273946|69698758|FG000|Overall Study|Withdrawal by Subject|5|||
38016235|NCT03273946|69698758|FG000|Overall Study|Unwillingness of the guardian|1|||
38016236|NCT03273946|69698758|FG000|Overall Study|Participant refused to use the drug|2|||
38016237|NCT03273946|69698758|FG000|Overall Study|Participant relative refused to use drug|1|||
38016238|NCT00314951|69698764|FG000|Treatment|Didn't meet criteria for mITT population|16|||
38016239|NCT00314951|69698765|FG001|Treatment|Didn't meet criteria for mITT population|11|||
38016240|NCT00314951|69698764|FG000|Follow-up|mITT failure|44|||
38016241|NCT00314951|69698765|FG001|Follow-up|mITT failure|34|||
38016242|NCT00085644|69698773|FG000|Double-Blind Period|Adverse Event|5|||
38016243|NCT00085644|69698774|FG001|Double-Blind Period|Adverse Event|2|||
38016244|NCT00085644|69698775|FG002|Double-Blind Period|Adverse Event|0|||
38016245|NCT00085644|69698773|FG000|Double-Blind Period|Withdrawal by Subject|3|||
38016246|NCT00085644|69698774|FG001|Double-Blind Period|Withdrawal by Subject|0|||
38016247|NCT00085644|69698775|FG002|Double-Blind Period|Withdrawal by Subject|0|||
38016248|NCT00085644|69698773|FG000|Double-Blind Period|Lost to Follow-up|2|||
38016249|NCT00085644|69698774|FG001|Double-Blind Period|Lost to Follow-up|1|||
38016250|NCT00085644|69698775|FG002|Double-Blind Period|Lost to Follow-up|0|||
38016251|NCT00085644|69698773|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
38016252|NCT00085644|69698774|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
38016253|NCT00085644|69698775|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
38016254|NCT00085644|69698773|FG000|Double-Blind Period|Contemplating pregnancy|1|||
38016255|NCT00085644|69698774|FG001|Double-Blind Period|Contemplating pregnancy|0|||
38016256|NCT00085644|69698775|FG002|Double-Blind Period|Contemplating pregnancy|0|||
38016257|NCT00085644|69698773|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
37909991|NCT02975349|69595967|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
38016258|NCT00085644|69698774|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
38016259|NCT00085644|69698775|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
38016260|NCT00085644|69698773|FG000|Open-Label Period|Adverse Event|0|||
38016261|NCT00085644|69698774|FG001|Open-Label Period|Adverse Event|0|||
38016262|NCT00085644|69698775|FG002|Open-Label Period|Adverse Event|38|||
38016263|NCT00085644|69698773|FG000|Open-Label Period|Withdrawal by Subject|0|||
38016264|NCT00085644|69698774|FG001|Open-Label Period|Withdrawal by Subject|0|||
38016265|NCT00085644|69698775|FG002|Open-Label Period|Withdrawal by Subject|29|||
38016266|NCT00085644|69698773|FG000|Open-Label Period|Lost to Follow-up|0|||
38016267|NCT00085644|69698774|FG001|Open-Label Period|Lost to Follow-up|0|||
38016268|NCT00085644|69698775|FG002|Open-Label Period|Lost to Follow-up|13|||
38016269|NCT00085644|69698773|FG000|Open-Label Period|Lack of Efficacy|0|||
38016270|NCT00085644|69698774|FG001|Open-Label Period|Lack of Efficacy|0|||
38016271|NCT00085644|69698775|FG002|Open-Label Period|Lack of Efficacy|15|||
38016272|NCT00085644|69698773|FG000|Open-Label Period|Pregnancy|0|||
38016273|NCT00085644|69698774|FG001|Open-Label Period|Pregnancy|0|||
38016274|NCT00085644|69698775|FG002|Open-Label Period|Pregnancy|3|||
38016275|NCT00085644|69698773|FG000|Open-Label Period|Contemplating pregnancy|0|||
38016276|NCT00085644|69698774|FG001|Open-Label Period|Contemplating pregnancy|0|||
38016277|NCT00085644|69698775|FG002|Open-Label Period|Contemplating pregnancy|3|||
38016278|NCT00085644|69698773|FG000|Open-Label Period|Protocol Violation|0|||
38016279|NCT00085644|69698774|FG001|Open-Label Period|Protocol Violation|0|||
38016280|NCT00085644|69698775|FG002|Open-Label Period|Protocol Violation|4|||
38016281|NCT00085644|69698773|FG000|Open-Label Period|Personal reason|0|||
38016282|NCT00085644|69698774|FG001|Open-Label Period|Personal reason|0|||
38016283|NCT00085644|69698775|FG002|Open-Label Period|Personal reason|4|||
38016284|NCT03315208|69698784|FG000|Overall Study|Lost to Follow-up|11|||
38016285|NCT03315208|69698785|FG001|Overall Study|Lost to Follow-up|6|||
38016286|NCT03315208|69698784|FG000|Overall Study|Withdrawal by Subject|2|||
38016287|NCT03315208|69698785|FG001|Overall Study|Withdrawal by Subject|0|||
38016288|NCT00314795|69698792|FG000|Overall Study|Adverse Event|8|||
38016289|NCT00314795|69698792|FG000|Overall Study|Death|4|||
38016290|NCT00314795|69698792|FG000|Overall Study|Reason not Specified|3|||
38016291|NCT00314795|69698792|FG000|Overall Study|Renal Transplant|3|||
38016292|NCT00314795|69698792|FG000|Overall Study|Participants Withdrew Consent|2|||
38016293|NCT00314327|69698796|FG000|Overall Study|Withdrawal by Subject|1|||
38016294|NCT00336479|69698804|FG000|Overall Study|Adverse Event|8|||
38016295|NCT00336479|69698805|FG001|Overall Study|Adverse Event|11|||
38016296|NCT00336479|69698806|FG002|Overall Study|Adverse Event|18|||
38016297|NCT00336479|69698807|FG003|Overall Study|Adverse Event|4|||
38016298|NCT00336479|69698804|FG000|Overall Study|Noncompliant|1|||
38016299|NCT00336479|69698805|FG001|Overall Study|Noncompliant|7|||
38016300|NCT00336479|69698806|FG002|Overall Study|Noncompliant|3|||
38016301|NCT00336479|69698807|FG003|Overall Study|Noncompliant|0|||
38016302|NCT00336479|69698804|FG000|Overall Study|Physician Decision|2|||
38016303|NCT00336479|69698805|FG001|Overall Study|Physician Decision|3|||
38016304|NCT00336479|69698806|FG002|Overall Study|Physician Decision|1|||
38016305|NCT00336479|69698807|FG003|Overall Study|Physician Decision|0|||
38016306|NCT00336479|69698804|FG000|Overall Study|Lost to Follow-up|3|||
38016307|NCT00336479|69698805|FG001|Overall Study|Lost to Follow-up|2|||
38016308|NCT00336479|69698806|FG002|Overall Study|Lost to Follow-up|0|||
38016309|NCT00336479|69698807|FG003|Overall Study|Lost to Follow-up|0|||
38016310|NCT00336479|69698804|FG000|Overall Study|Withdrawal by Subject|3|||
38016311|NCT00336479|69698805|FG001|Overall Study|Withdrawal by Subject|2|||
38016312|NCT00336479|69698806|FG002|Overall Study|Withdrawal by Subject|3|||
38016313|NCT00336479|69698807|FG003|Overall Study|Withdrawal by Subject|0|||
38016314|NCT00336479|69698804|FG000|Overall Study|Other|0|||
38016315|NCT00336479|69698805|FG001|Overall Study|Other|0|||
38016316|NCT00336479|69698806|FG002|Overall Study|Other|1|||
38016317|NCT00336479|69698807|FG003|Overall Study|Other|0|||
38016318|NCT00336479|69698804|FG000|Overall Study|Virologic Stopping Rule|20|||
38016319|NCT00336479|69698805|FG001|Overall Study|Virologic Stopping Rule|0|||
38016320|NCT00336479|69698806|FG002|Overall Study|Virologic Stopping Rule|0|||
38016321|NCT00336479|69698807|FG003|Overall Study|Virologic Stopping Rule|0|||
38016322|NCT00314249|69698820|FG000|Overall Study|Adverse Event|73|||
38016323|NCT00314249|69698821|FG001|Overall Study|Adverse Event|94|||
38016324|NCT00314249|69698820|FG000|Overall Study|Lack of Efficacy|33|||
38016325|NCT00314249|69698821|FG001|Overall Study|Lack of Efficacy|24|||
38016326|NCT00314249|69698820|FG000|Overall Study|Withdrawal by Subject|21|||
38016327|NCT00314249|69698821|FG001|Overall Study|Withdrawal by Subject|28|||
37909992|NCT02975349|69595968|FG002|Active Treatment Period (24 Weeks)|Adverse Event|1|||
37909993|NCT02975349|69595969|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
38016328|NCT00314249|69698820|FG000|Overall Study|Lost to Follow-up|15|||
38016329|NCT00314249|69698821|FG001|Overall Study|Lost to Follow-up|9|||
38016330|NCT00314249|69698820|FG000|Overall Study|Physician Decision|1|||
38016331|NCT00314249|69698821|FG001|Overall Study|Physician Decision|1|||
37698475|NCT01815424|69175235|FG001|Week 16 to 52|Other|1|||
37909994|NCT02975349|69595970|FG004|Active Treatment Period (24 Weeks)|Adverse Event|6|||
37909995|NCT02975349|69595971|FG005|Active Treatment Period (24 Weeks)|Adverse Event|2|||
38016332|NCT00314249|69698820|FG000|Overall Study|Withdrawn for other reasons|4|||
38016333|NCT00314249|69698821|FG001|Overall Study|Withdrawn for other reasons|1|||
38016334|NCT00314249|69698820|FG000|Overall Study|Non-Compliant|5|||
38016335|NCT00314249|69698821|FG001|Overall Study|Non-Compliant|6|||
38016336|NCT03315130|69698830|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
38016337|NCT03315130|69698831|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
38016338|NCT03315130|69698832|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
38016339|NCT03315130|69698833|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
38016340|NCT03315130|69698830|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
38016341|NCT03315130|69698831|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
38016342|NCT03315130|69698832|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
38016343|NCT03315130|69698833|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
38016344|NCT03315130|69698830|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
38016345|NCT03315130|69698831|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
38016346|NCT03315130|69698832|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
38016347|NCT03315130|69698833|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
38016348|NCT03315130|69698830|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
38016349|NCT03315130|69698831|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
38016350|NCT03315130|69698832|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
37909996|NCT02975349|69595966|FG000|Active Treatment Period (24 Weeks)|Un-specified|0|||
37909997|NCT02975349|69595967|FG001|Active Treatment Period (24 Weeks)|Un-specified|0|||
37909998|NCT02975349|69595968|FG002|Active Treatment Period (24 Weeks)|Un-specified|1|||
37909999|NCT02975349|69595969|FG003|Active Treatment Period (24 Weeks)|Un-specified|0|||
37910000|NCT02975349|69595970|FG004|Active Treatment Period (24 Weeks)|Un-specified|0|||
37910001|NCT02975349|69595971|FG005|Active Treatment Period (24 Weeks)|Un-specified|0|||
37910002|NCT02975349|69595966|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
37910003|NCT02975349|69595967|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
37910004|NCT02975349|69595968|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
37910005|NCT02975349|69595969|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|2|||
37910006|NCT02975349|69595970|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
37910007|NCT02975349|69595971|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
37910008|NCT02975349|69595966|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
37910009|NCT02975349|69595967|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
37910010|NCT02975349|69595968|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
37910011|NCT02975349|69595969|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
37910012|NCT02975349|69595970|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
37910013|NCT02975349|69595971|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
37910014|NCT02975349|69595966|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
37910015|NCT02975349|69595967|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
37910016|NCT02975349|69595968|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
37910017|NCT02975349|69595969|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
37910018|NCT02975349|69595970|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
37910019|NCT02975349|69595971|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
37910020|NCT02975349|69595966|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
37910021|NCT02975349|69595967|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
37910022|NCT02975349|69595968|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
37910023|NCT02975349|69595969|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
37910024|NCT02975349|69595970|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
37910025|NCT02975349|69595971|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
37910026|NCT02975349|69595966|FG000|Blinded Extension Period (24 Weeks)|Un-specified|0|||
37910027|NCT02975349|69595967|FG001|Blinded Extension Period (24 Weeks)|Un-specified|0|||
37910028|NCT02975349|69595968|FG002|Blinded Extension Period (24 Weeks)|Un-specified|0|||
37910029|NCT02975349|69595969|FG003|Blinded Extension Period (24 Weeks)|Un-specified|1|||
37910030|NCT02975349|69595970|FG004|Blinded Extension Period (24 Weeks)|Un-specified|0|||
37910031|NCT02975349|69595971|FG005|Blinded Extension Period (24 Weeks)|Un-specified|0|||
37910032|NCT02520141|69596042|FG000|Overall Study|Rapid decline clinically and thus unable to enroll|1|||
37910033|NCT02513394|69596050|FG000|Overall Study|Withdrawal by Subject|11|||
37910034|NCT02513394|69596051|FG001|Overall Study|Withdrawal by Subject|23|||
37910035|NCT02513394|69596050|FG000|Overall Study|Ineligible|1|||
37910036|NCT02513394|69596051|FG001|Overall Study|Ineligible|0|||
37910037|NCT02329847|69596063|FG000|Overall Study|Death|4|||
37910038|NCT02329847|69596064|FG001|Overall Study|Death|4|||
37910039|NCT02329847|69596065|FG002|Overall Study|Death|22|||
37910040|NCT02329847|69596066|FG003|Overall Study|Death|12|||
37910041|NCT02329847|69596067|FG004|Overall Study|Death|20|||
37910042|NCT02329847|69596068|FG005|Overall Study|Death|13|||
37910043|NCT02329847|69596063|FG000|Overall Study|Lost to Follow-up|0|||
37910044|NCT02329847|69596064|FG001|Overall Study|Lost to Follow-up|0|||
37910045|NCT02329847|69596065|FG002|Overall Study|Lost to Follow-up|2|||
37910046|NCT02329847|69596066|FG003|Overall Study|Lost to Follow-up|3|||
37910047|NCT02329847|69596067|FG004|Overall Study|Lost to Follow-up|0|||
37910048|NCT02329847|69596068|FG005|Overall Study|Lost to Follow-up|1|||
37910049|NCT02329847|69596063|FG000|Overall Study|Physician Decision|0|||
37910050|NCT02329847|69596064|FG001|Overall Study|Physician Decision|0|||
37910051|NCT02329847|69596065|FG002|Overall Study|Physician Decision|0|||
37910052|NCT02329847|69596066|FG003|Overall Study|Physician Decision|0|||
37910053|NCT02329847|69596067|FG004|Overall Study|Physician Decision|1|||
37910054|NCT02329847|69596068|FG005|Overall Study|Physician Decision|0|||
37910055|NCT02329847|69596063|FG000|Overall Study|Withdrawal by Subject|2|||
37910056|NCT02329847|69596064|FG001|Overall Study|Withdrawal by Subject|1|||
37910057|NCT02329847|69596065|FG002|Overall Study|Withdrawal by Subject|5|||
37910058|NCT02329847|69596066|FG003|Overall Study|Withdrawal by Subject|7|||
37910059|NCT02329847|69596067|FG004|Overall Study|Withdrawal by Subject|8|||
37910060|NCT02329847|69596068|FG005|Overall Study|Withdrawal by Subject|3|||
37910061|NCT02329847|69596063|FG000|Overall Study|Other|1|||
37910062|NCT02329847|69596064|FG001|Overall Study|Other|2|||
37910063|NCT02329847|69596065|FG002|Overall Study|Other|6|||
37910064|NCT02329847|69596066|FG003|Overall Study|Other|13|||
37910065|NCT02329847|69596067|FG004|Overall Study|Other|10|||
37910066|NCT02329847|69596068|FG005|Overall Study|Other|3|||
37910067|NCT02314624|69596089|FG000|Overall Study|No participating patient|16|||
37910068|NCT02314624|69596090|FG001|Overall Study|No participating patient|13|||
37910069|NCT02314624|69596089|FG000|Overall Study|Participant withdrew|7|||
37910070|NCT02314624|69596090|FG001|Overall Study|Participant withdrew|2|||
37910071|NCT02314624|69596089|FG000|Overall Study|Lost to Follow-up|2|||
37910072|NCT02314624|69596090|FG001|Overall Study|Lost to Follow-up|5|||
37910073|NCT02314624|69596089|FG000|Overall Study|Dropped/Excluded by PI|6|||
37910074|NCT02314624|69596090|FG001|Overall Study|Dropped/Excluded by PI|6|||
37910075|NCT01419080|69596119|FG000|Overall Study|Withdrawal by Subject|75|||
37910076|NCT01419080|69596119|FG000|Overall Study|Death|30|||
37910077|NCT01419080|69596119|FG000|Overall Study|Lost to Follow-up|23|||
37910078|NCT01419080|69596119|FG000|Overall Study|Too Ill|3|||
37910079|NCT01164228|69596127|FG000|Overall Study|Progression|24|||
37910080|NCT01164228|69596128|FG001|Overall Study|Progression|25|||
37910081|NCT01164228|69596127|FG000|Overall Study|Adverse Event|13|||
37910082|NCT01164228|69596128|FG001|Overall Study|Adverse Event|7|||
37910083|NCT01164228|69596127|FG000|Overall Study|Death|1|||
37910084|NCT01164228|69596128|FG001|Overall Study|Death|1|||
37910085|NCT01164228|69596127|FG000|Overall Study|Withdrawal by Subject|2|||
37910086|NCT01164228|69596128|FG001|Overall Study|Withdrawal by Subject|0|||
37910087|NCT01164228|69596127|FG000|Overall Study|Physician Decision|1|||
37910088|NCT01164228|69596128|FG001|Overall Study|Physician Decision|2|||
37910089|NCT01164228|69596127|FG000|Overall Study|Symptomatic deterioration|1|||
37910090|NCT01164228|69596128|FG001|Overall Study|Symptomatic deterioration|0|||
37910091|NCT01164228|69596127|FG000|Overall Study|Never started treatment|1|||
37910092|NCT01164228|69596128|FG001|Overall Study|Never started treatment|3|||
37910093|NCT01164228|69596127|FG000|Overall Study|Ineligible|1|||
37910094|NCT01164228|69596128|FG001|Overall Study|Ineligible|0|||
37910095|NCT00554515|69596134|FG000|Overall Study|Withdrawal by Subject|3|||
37910096|NCT00554515|69596134|FG000|Overall Study|Disease progression|52|||
37910097|NCT00554515|69596134|FG000|Overall Study|Physician Decision|18|||
37910098|NCT00554515|69596134|FG000|Overall Study|Withdrawal by Subject|11|||
37910099|NCT00554515|69596134|FG000|Overall Study|Adverse Event|9|||
37910100|NCT00554515|69596134|FG000|Overall Study|Death|2|||
38016351|NCT03315130|69698833|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
38016352|NCT03315130|69698830|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
38016353|NCT03315130|69698831|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
38016354|NCT03315130|69698832|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
38016355|NCT03315130|69698833|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
38016356|NCT03315130|69698830|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
38016357|NCT03315130|69698831|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
38016358|NCT03315130|69698832|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
38016359|NCT03315130|69698833|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
38016360|NCT03273166|69698853|FG000|Overall Study|Withdrawn prior to Completion|31|||
38016361|NCT03314662|69698861|FG000|Overall Study|Withdrawal by Subject|1|||
38016362|NCT03314662|69698862|FG001|Overall Study|Withdrawal by Subject|1|||
38016363|NCT03314662|69698863|FG002|Overall Study|Withdrawal by Subject|1|||
38016364|NCT03314662|69698861|FG000|Overall Study|Lost to Follow-up|5|||
38016365|NCT03314662|69698862|FG001|Overall Study|Lost to Follow-up|4|||
38016366|NCT03314662|69698863|FG002|Overall Study|Lost to Follow-up|4|||
38016367|NCT03314662|69698861|FG000|Overall Study|Death|2|||
38016368|NCT03314662|69698862|FG001|Overall Study|Death|0|||
38016369|NCT03314662|69698863|FG002|Overall Study|Death|0|||
38016370|NCT03271528|69698881|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
38016371|NCT03271528|69698882|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
38016372|NCT03271528|69698881|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
37910101|NCT00554515|69596134|FG000|Overall Study|Achieved Stable Disease|7|||
37910102|NCT00554515|69596134|FG000|Overall Study|Other|1|||
37910103|NCT00554515|69596134|FG000|Overall Study|Misc|15|||
37910104|NCT00049517|69596161|FG000|Induction|Disease progression|0|||
37910105|NCT00049517|69596162|FG001|Induction|Disease progression|0|||
37910106|NCT00049517|69596163|FG002|Induction|Disease progression|0|||
37910107|NCT00049517|69596164|FG003|Induction|Disease progression|0|||
37910108|NCT00049517|69596165|FG004|Induction|Disease progression|18|||
38016373|NCT03271528|69698882|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
38016374|NCT03271528|69698881|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
38016375|NCT03271528|69698882|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
38016376|NCT03271528|69698881|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
38016377|NCT03271528|69698882|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
38016378|NCT03271528|69698881|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
38016379|NCT03271528|69698882|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
38016380|NCT03271528|69698881|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
38016381|NCT03271528|69698882|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
38016382|NCT03271528|69698881|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
38016383|NCT03271528|69698882|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
38016384|NCT03301714|69698891|FG000|Overall Study|Lost to Follow-up|10|||
38016385|NCT03301714|69698892|FG001|Overall Study|Lost to Follow-up|4|||
38016386|NCT03301714|69698893|FG002|Overall Study|Lost to Follow-up|4|||
38016387|NCT03301714|69698891|FG000|Overall Study|Did not receive allocated intervention|0|||
38016388|NCT03301714|69698892|FG001|Overall Study|Did not receive allocated intervention|2|||
38016389|NCT03301714|69698893|FG002|Overall Study|Did not receive allocated intervention|3|||
38016390|NCT03299686|69698906|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
38016391|NCT03299686|69698907|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
38016392|NCT03299686|69698906|FG000|Treatment Epoch|Physician Decision|1|||
38016393|NCT03299686|69698907|FG001|Treatment Epoch|Physician Decision|0|||
38016394|NCT03299686|69698906|FG000|Treatment Epoch|Adverse Event|8|||
38016395|NCT03299686|69698907|FG001|Treatment Epoch|Adverse Event|4|||
38016396|NCT03299686|69698906|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
38016397|NCT03299686|69698907|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
38016398|NCT03462758|69698915|FG000|Overall Study|Chose no or other method of contraception|20|||
38016399|NCT03462758|69698916|FG001|Overall Study|Chose no or other method of contraception|23|||
38016400|NCT03462758|69698915|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
38016401|NCT03462758|69698916|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
38016402|NCT03462758|69698915|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
38016403|NCT03462758|69698916|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
38016404|NCT03462758|69698915|FG000|Overall Study|Medical contraindication|2|||
38016405|NCT03462758|69698916|FG001|Overall Study|Medical contraindication|2|||
38016406|NCT03462758|69698915|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
38016407|NCT03462758|69698916|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
38016408|NCT00075270|69698924|FG000|Overall Study|Withdrawal by Subject|28|||
38016409|NCT00075270|69698925|FG001|Overall Study|Withdrawal by Subject|21|||
38016410|NCT00075270|69698924|FG000|Overall Study|Lost to Follow-up|25|||
38016411|NCT00075270|69698925|FG001|Overall Study|Lost to Follow-up|28|||
38016412|NCT00075270|69698924|FG000|Overall Study|Protocol Violation|0|||
38016413|NCT00075270|69698925|FG001|Overall Study|Protocol Violation|2|||
38016414|NCT00075270|69698924|FG000|Overall Study|Death|198|||
38016415|NCT00075270|69698925|FG001|Overall Study|Death|215|||
38016416|NCT00075270|69698924|FG000|Overall Study|Other/Unknown|9|||
38016417|NCT00075270|69698925|FG001|Overall Study|Other/Unknown|5|||
38016418|NCT00075270|69698924|FG000|Overall Study|Missing|26|||
38016419|NCT00075270|69698925|FG001|Overall Study|Missing|13|||
38016420|NCT00074958|69698932|FG000|Overall Study|Adverse Event|1|||
38016421|NCT02940574|69698938|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
38016422|NCT02940574|69698939|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
38016423|NCT02940574|69698938|FG000|1-year Follow-up|Lost to Follow-up|3|||
38016424|NCT02940574|69698939|FG001|1-year Follow-up|Lost to Follow-up|4|||
37832363|NCT01289119|69515866|FG004|Overall Study|Lost to Follow-up|0|||
37832364|NCT01289119|69515867|FG005|Overall Study|Lost to Follow-up|1|||
37832365|NCT01289119|69515862|FG000|Overall Study|Withdrawal by Subject|4|||
37832366|NCT01289119|69515863|FG001|Overall Study|Withdrawal by Subject|2|||
37832367|NCT01289119|69515864|FG002|Overall Study|Withdrawal by Subject|4|||
37832368|NCT01289119|69515865|FG003|Overall Study|Withdrawal by Subject|3|||
37832369|NCT01289119|69515866|FG004|Overall Study|Withdrawal by Subject|1|||
37832370|NCT01289119|69515867|FG005|Overall Study|Withdrawal by Subject|1|||
37832371|NCT01289119|69515862|FG000|Overall Study|Pregnancy|0|||
38016425|NCT03760250|69698958|FG000|Overall Study|Withdrawal by Subject|1|||
38016426|NCT03760250|69698958|FG000|Overall Study|Physician Decision|1|||
38016427|NCT03757988|69698962|FG000|Overall Study|Withdrawal by Subject|1|||
38016428|NCT00313781|69698969|FG000|Before Crossover|Death|22|||
38016429|NCT00313781|69698970|FG001|Before Crossover|Death|8|||
38016430|NCT00313781|69698971|FG002|Before Crossover|Death|0|||
38016431|NCT00313781|69698969|FG000|Before Crossover|Lost to Follow-up|0|||
38016432|NCT00313781|69698970|FG001|Before Crossover|Lost to Follow-up|3|||
38016433|NCT00313781|69698971|FG002|Before Crossover|Lost to Follow-up|0|||
37832372|NCT01289119|69515863|FG001|Overall Study|Pregnancy|1|||
37832373|NCT01289119|69515864|FG002|Overall Study|Pregnancy|0|||
38016434|NCT00313781|69698969|FG000|Before Crossover|Withdrawal by Subject|3|||
38016435|NCT00313781|69698970|FG001|Before Crossover|Withdrawal by Subject|1|||
38016436|NCT00313781|69698971|FG002|Before Crossover|Withdrawal by Subject|0|||
38016437|NCT00313781|69698969|FG000|Before Crossover|Other|45|||
38016438|NCT00313781|69698970|FG001|Before Crossover|Other|30|||
38016439|NCT00313781|69698971|FG002|Before Crossover|Other|0|||
38016440|NCT00313781|69698969|FG000|Before Crossover|Crossover|0|||
38016441|NCT00313781|69698970|FG001|Before Crossover|Crossover|37|||
38016442|NCT00313781|69698971|FG002|Before Crossover|Crossover|0|||
38016443|NCT00313781|69698969|FG000|Before Crossover|Randomized, not treated|5|||
38016444|NCT00313781|69698970|FG001|Before Crossover|Randomized, not treated|0|||
38016445|NCT00313781|69698971|FG002|Before Crossover|Randomized, not treated|0|||
38016446|NCT00313781|69698969|FG000|After Crossover|Death|0|||
38016447|NCT00313781|69698970|FG001|After Crossover|Death|0|||
38016448|NCT00313781|69698971|FG002|After Crossover|Death|6|||
38016449|NCT00313781|69698969|FG000|After Crossover|Withdrawal by Subject|0|||
38016450|NCT00313781|69698970|FG001|After Crossover|Withdrawal by Subject|0|||
38016451|NCT00313781|69698971|FG002|After Crossover|Withdrawal by Subject|3|||
38016452|NCT00313781|69698969|FG000|After Crossover|Other|0|||
38016453|NCT00313781|69698970|FG001|After Crossover|Other|0|||
38016454|NCT00313781|69698971|FG002|After Crossover|Other|18|||
38016455|NCT00368537|69698982|FG000|Randomization|No study drug dosed|13|||
38016456|NCT00368537|69698983|FG001|Randomization|No study drug dosed|6|||
38016457|NCT00368537|69698982|FG000|Baseline Participants|Lost to Follow-up|16|||
38016458|NCT00368537|69698983|FG001|Baseline Participants|Lost to Follow-up|17|||
38016459|NCT00368537|69698982|FG000|Baseline Participants|Withdrawal by Subject|6|||
38016460|NCT00368537|69698983|FG001|Baseline Participants|Withdrawal by Subject|4|||
38016461|NCT00368537|69698982|FG000|Baseline Participants|Death|1|||
38016462|NCT00368537|69698983|FG001|Baseline Participants|Death|2|||
38016463|NCT00368537|69698982|FG000|Baseline Participants|No susceptibility|1|||
38016464|NCT00368537|69698983|FG001|Baseline Participants|No susceptibility|0|||
38016465|NCT00368537|69698982|FG000|Baseline Participants|Patient uncompliant|0|||
38016466|NCT00368537|69698983|FG001|Baseline Participants|Patient uncompliant|1|||
38016467|NCT00313703|69698993|FG000|Overall Study|Lost to Follow-up|11|||
37698476|NCT01815424|69175236|FG002|Week 16 to 52|Other|0|||
37698477|NCT01815424|69175237|FG003|Week 16 to 52|Other|0|||
37698478|NCT01815424|69175238|FG004|Week 16 to 52|Other|0|||
37832374|NCT01289119|69515865|FG003|Overall Study|Pregnancy|0|||
37832375|NCT01289119|69515866|FG004|Overall Study|Pregnancy|0|||
37832376|NCT01289119|69515867|FG005|Overall Study|Pregnancy|0|||
37832377|NCT01289119|69515862|FG000|Overall Study|Lack of Efficacy|0|||
37832378|NCT01289119|69515863|FG001|Overall Study|Lack of Efficacy|1|||
37832379|NCT01289119|69515864|FG002|Overall Study|Lack of Efficacy|1|||
37832380|NCT01289119|69515865|FG003|Overall Study|Lack of Efficacy|1|||
37832381|NCT01289119|69515866|FG004|Overall Study|Lack of Efficacy|1|||
37832382|NCT01289119|69515867|FG005|Overall Study|Lack of Efficacy|1|||
37832383|NCT01289119|69515862|FG000|Overall Study|Other|1|||
37832384|NCT01289119|69515863|FG001|Overall Study|Other|0|||
37832385|NCT01289119|69515864|FG002|Overall Study|Other|1|||
37832386|NCT01289119|69515865|FG003|Overall Study|Other|0|||
37832387|NCT01289119|69515866|FG004|Overall Study|Other|0|||
37832388|NCT01289119|69515867|FG005|Overall Study|Other|0|||
37832389|NCT01289041|69515881|FG000|Overall Study|Adverse Event|24|||
37832390|NCT01289041|69515881|FG000|Overall Study|Physician Decision|1|||
37832391|NCT01289041|69515881|FG000|Overall Study|Progressive Disease|41|||
37832392|NCT01289041|69515881|FG000|Overall Study|Withdrawal by Subject|3|||
37832393|NCT01289041|69515881|FG000|Overall Study|Death|1|||
37832394|NCT01288729|69515889|FG000|Overall Study|Withdrawal by Subject|1|||
37910109|NCT00049517|69596166|FG005|Induction|Disease progression|11|||
37698479|NCT01815424|69175234|FG000|Week 16 to 52|Adverse Event|0|||
37698480|NCT01815424|69175235|FG001|Week 16 to 52|Adverse Event|0|||
37698481|NCT01815424|69175236|FG002|Week 16 to 52|Adverse Event|0|||
37832395|NCT01288729|69515890|FG001|Overall Study|Withdrawal by Subject|0|||
37832396|NCT01288612|69515899|FG000|Overall Study|Unable to contact|11|||
37832397|NCT01288612|69515900|FG001|Overall Study|Unable to contact|16|||
37832398|NCT01288612|69515901|FG002|Overall Study|Unable to contact|20|||
37832399|NCT01288612|69515899|FG000|Overall Study|Declined|78|||
37910110|NCT00049517|69596161|FG000|Induction|Adverse Event|0|||
38016468|NCT00313703|69698994|FG001|Overall Study|Lost to Follow-up|2|||
38016469|NCT00313703|69698995|FG002|Overall Study|Lost to Follow-up|5|||
38016470|NCT00313703|69698996|FG003|Overall Study|Lost to Follow-up|12|||
38016471|NCT00313313|69699009|FG000|Overall Study|Lack of Efficacy|14|||
38016472|NCT00313313|69699010|FG001|Overall Study|Lack of Efficacy|9|||
37698482|NCT01815424|69175237|FG003|Week 16 to 52|Adverse Event|0|||
38016473|NCT00313313|69699011|FG002|Overall Study|Lack of Efficacy|20|||
38016474|NCT00313313|69699009|FG000|Overall Study|Withdrawal of consent by subject|18|||
37698483|NCT01815424|69175238|FG004|Week 16 to 52|Adverse Event|1|||
37698484|NCT01815424|69175234|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
38016475|NCT00313313|69699010|FG001|Overall Study|Withdrawal of consent by subject|17|||
38016476|NCT00313313|69699011|FG002|Overall Study|Withdrawal of consent by subject|31|||
38016477|NCT00313313|69699009|FG000|Overall Study|Lost to Follow-up|10|||
38016478|NCT00313313|69699010|FG001|Overall Study|Lost to Follow-up|7|||
38016479|NCT00313313|69699011|FG002|Overall Study|Lost to Follow-up|9|||
38016480|NCT00313313|69699009|FG000|Overall Study|Adverse Event|15|||
38016481|NCT00313313|69699010|FG001|Overall Study|Adverse Event|16|||
38016482|NCT00313313|69699011|FG002|Overall Study|Adverse Event|12|||
38016483|NCT00313313|69699009|FG000|Overall Study|Physician Decision|2|||
38016484|NCT00313313|69699010|FG001|Overall Study|Physician Decision|6|||
38016485|NCT00313313|69699011|FG002|Overall Study|Physician Decision|4|||
38016486|NCT00313313|69699009|FG000|Overall Study|Poor/Noncompliance|3|||
38016487|NCT00313313|69699010|FG001|Overall Study|Poor/Noncompliance|6|||
38016488|NCT00313313|69699011|FG002|Overall Study|Poor/Noncompliance|2|||
38016489|NCT00313313|69699009|FG000|Overall Study|Pregnancy|1|||
38016490|NCT00313313|69699010|FG001|Overall Study|Pregnancy|2|||
38016491|NCT00313313|69699011|FG002|Overall Study|Pregnancy|0|||
38016492|NCT00313313|69699009|FG000|Overall Study|Death|0|||
38016493|NCT00313313|69699010|FG001|Overall Study|Death|0|||
38016494|NCT00313313|69699011|FG002|Overall Study|Death|2|||
38016495|NCT00313313|69699009|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
38016496|NCT00313313|69699010|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
38016497|NCT00313313|69699011|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
38016498|NCT00312845|69699021|FG000|Overall Study|Adverse Event|19|||
38016499|NCT00312845|69699022|FG001|Overall Study|Adverse Event|5|||
38016500|NCT00312845|69699021|FG000|Overall Study|Death|2|||
38016501|NCT00312845|69699022|FG001|Overall Study|Death|2|||
37698485|NCT01815424|69175235|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
37698486|NCT01815424|69175236|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
37698487|NCT01815424|69175237|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
37698488|NCT01815424|69175238|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
38016502|NCT00312845|69699021|FG000|Overall Study|Withdrawal by Subject|14|||
38016503|NCT00312845|69699022|FG001|Overall Study|Withdrawal by Subject|6|||
38016504|NCT00312845|69699021|FG000|Overall Study|Disease Progression|56|||
38016505|NCT00312845|69699022|FG001|Overall Study|Disease Progression|77|||
38016506|NCT00312845|69699021|FG000|Overall Study|Lost to Follow-up|2|||
38016507|NCT00312845|69699022|FG001|Overall Study|Lost to Follow-up|0|||
38016508|NCT00312845|69699021|FG000|Overall Study|Other|6|||
38016509|NCT00312845|69699022|FG001|Overall Study|Other|5|||
38016510|NCT00368069|69699030|FG000|Overall Study|Adverse Event|5|||
38016511|NCT00368069|69699031|FG001|Overall Study|Adverse Event|2|||
38016512|NCT00368069|69699030|FG000|Overall Study|Lack of Efficacy|0|||
38016513|NCT00368069|69699031|FG001|Overall Study|Lack of Efficacy|1|||
38016514|NCT00368069|69699030|FG000|Overall Study|Lost to Follow-up|1|||
38016515|NCT00368069|69699031|FG001|Overall Study|Lost to Follow-up|0|||
38016516|NCT00368069|69699030|FG000|Overall Study|Protocol Violation|0|||
38016517|NCT00368069|69699031|FG001|Overall Study|Protocol Violation|2|||
38016518|NCT00368069|69699030|FG000|Overall Study|Withdrawal of Consent|2|||
38016519|NCT00368069|69699031|FG001|Overall Study|Withdrawal of Consent|1|||
38016520|NCT00368069|69699030|FG000|Overall Study|no blood sampling possible|0|||
38016521|NCT00368069|69699031|FG001|Overall Study|no blood sampling possible|1|||
38016522|NCT00367991|69699039|FG000|Overall Study|Withdrawal by Subject|1|||
38016523|NCT00367991|69699040|FG001|Overall Study|Withdrawal by Subject|1|||
38016524|NCT00367991|69699039|FG000|Overall Study|Adverse Event|1|||
38016525|NCT00367991|69699040|FG001|Overall Study|Adverse Event|1|||
38016526|NCT00367835|69699048|FG000|Overall Study|Adverse Event|14|||
38016527|NCT00367835|69699049|FG001|Overall Study|Adverse Event|1|||
38016528|NCT00367835|69699048|FG000|Overall Study|Protocol Violation|1|||
38016529|NCT00367835|69699049|FG001|Overall Study|Protocol Violation|7|||
38016530|NCT00367835|69699048|FG000|Overall Study|Withdrawal by Subject|7|||
38016531|NCT00367835|69699049|FG001|Overall Study|Withdrawal by Subject|6|||
38016532|NCT00367835|69699048|FG000|Overall Study|Lost to Follow-up|1|||
38016533|NCT00367835|69699049|FG001|Overall Study|Lost to Follow-up|4|||
38016534|NCT00367835|69699048|FG000|Overall Study|Lack of Efficacy|3|||
37832400|NCT01288612|69515900|FG001|Overall Study|Declined|63|||
37832401|NCT01288612|69515901|FG002|Overall Study|Declined|62|||
38016535|NCT00367835|69699049|FG001|Overall Study|Lack of Efficacy|12|||
38016536|NCT00367835|69699048|FG000|Overall Study|Subject in juvenile detention center|1|||
38016537|NCT00367835|69699049|FG001|Overall Study|Subject in juvenile detention center|0|||
38016538|NCT00367835|69699048|FG000|Overall Study|refused blood collection|1|||
38016539|NCT00367835|69699049|FG001|Overall Study|refused blood collection|0|||
37698489|NCT01815424|69175234|FG000|Week 16 to 52|Lost to Follow-up|0|||
38016540|NCT00367835|69699048|FG000|Overall Study|Did not respond to calls|1|||
38016541|NCT00367835|69699049|FG001|Overall Study|Did not respond to calls|0|||
38016542|NCT00367835|69699048|FG000|Overall Study|History of lead poisoning|0|||
38016543|NCT00367835|69699049|FG001|Overall Study|History of lead poisoning|1|||
38016544|NCT03267940|69699061|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
38016545|NCT03267940|69699062|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
38016546|NCT03267940|69699063|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
38016547|NCT03267940|69699064|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
38016548|NCT03267940|69699065|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
38016549|NCT03267940|69699066|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
38016550|NCT03267940|69699061|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
38016551|NCT03267940|69699062|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
38016552|NCT03267940|69699063|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
38016553|NCT03267940|69699064|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
38016554|NCT03267940|69699065|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
38016555|NCT03267940|69699066|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
38016556|NCT03267940|69699061|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
38016557|NCT03267940|69699062|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
38016558|NCT03267940|69699063|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
38016559|NCT03267940|69699064|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
38016560|NCT03267940|69699065|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
38016561|NCT03267940|69699066|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
38016562|NCT03267940|69699061|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
38016563|NCT03267940|69699062|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
38016564|NCT03267940|69699063|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
38016565|NCT03267940|69699064|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
38016566|NCT03267940|69699065|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
38016567|NCT03267940|69699066|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
38016568|NCT03267940|69699061|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
38016569|NCT03267940|69699062|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
38016570|NCT03267940|69699063|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
38016571|NCT03267940|69699064|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
38016572|NCT03267940|69699065|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
38016573|NCT03267940|69699066|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
38016574|NCT03267940|69699061|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
38016575|NCT03267940|69699062|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
38016576|NCT03267940|69699063|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
38016577|NCT03267940|69699064|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
38016578|NCT03267940|69699065|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
38016579|NCT03267940|69699066|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
38016580|NCT03267940|69699061|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
38016581|NCT03267940|69699062|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
38016582|NCT03267940|69699063|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
38016583|NCT03267940|69699064|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
38016584|NCT03267940|69699065|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
38016585|NCT03267940|69699066|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
38016586|NCT03267940|69699061|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
38016587|NCT03267940|69699062|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
38016588|NCT03267940|69699063|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
38016589|NCT03267940|69699064|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
38016590|NCT03267940|69699065|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
38016591|NCT03267940|69699066|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
38016592|NCT03267940|69699061|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
38016593|NCT03267940|69699062|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
38016594|NCT03267940|69699063|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
38016595|NCT03267940|69699064|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
38016596|NCT03267940|69699065|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
38016597|NCT03267940|69699066|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
38016598|NCT03296566|69699086|FG000|Overall Study|Lost to Follow-up|19|||
38016599|NCT03296566|69699087|FG001|Overall Study|Lost to Follow-up|46|||
38016600|NCT03296566|69699086|FG000|Overall Study|Withdrawal by Subject|0|||
38016601|NCT03296566|69699087|FG001|Overall Study|Withdrawal by Subject|3|||
38016602|NCT03755882|69699093|FG000|Period 1|Protocol Violation|1|||
38016603|NCT03755882|69699094|FG001|Period 1|Protocol Violation|0|||
38016604|NCT03755882|69699093|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
38016605|NCT03755882|69699094|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
38016606|NCT00312377|69699102|FG000|Overall Study|Death|403|||
38016607|NCT00312377|69699103|FG001|Overall Study|Death|418|||
38016608|NCT00312377|69699102|FG000|Overall Study|Withdrawal by Subject|23|||
38016609|NCT00312377|69699103|FG001|Overall Study|Withdrawal by Subject|30|||
38016610|NCT00312377|69699102|FG000|Overall Study|Lost to Follow-up|9|||
38016611|NCT00312377|69699103|FG001|Overall Study|Lost to Follow-up|12|||
38016612|NCT00312377|69699102|FG000|Overall Study|Non-compliance|0|||
38016613|NCT00312377|69699103|FG001|Overall Study|Non-compliance|2|||
38016614|NCT00312377|69699102|FG000|Overall Study|Randomised but never received treatment|6|||
38016615|NCT00312377|69699103|FG001|Overall Study|Randomised but never received treatment|6|||
38016616|NCT00312377|69699102|FG000|Overall Study|Discontinue treatment survival follow up|202|||
38016617|NCT00312377|69699103|FG001|Overall Study|Discontinue treatment survival follow up|200|||
38016618|NCT00312377|69699102|FG000|Overall Study|Site ended participation in study|1|||
38016619|NCT00312377|69699103|FG001|Overall Study|Site ended participation in study|0|||
38016620|NCT03295318|69699112|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
38016621|NCT03295318|69699113|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
38016622|NCT03295318|69699114|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
38016623|NCT03295318|69699112|FG000|Overall Study|Death|1|||
38016624|NCT03295318|69699113|FG001|Overall Study|Death|1|||
38016625|NCT03295318|69699114|FG002|Overall Study|Death|1|||
38016626|NCT03295318|69699112|FG000|Overall Study|Protocol Violation|4|||
38016627|NCT03295318|69699113|FG001|Overall Study|Protocol Violation|3|||
38016628|NCT03295318|69699114|FG002|Overall Study|Protocol Violation|3|||
38016629|NCT03295318|69699112|FG000|Overall Study|Withdrawal by Subject|0|||
38016630|NCT03295318|69699113|FG001|Overall Study|Withdrawal by Subject|0|||
38016631|NCT03295318|69699114|FG002|Overall Study|Withdrawal by Subject|1|||
38016632|NCT03295318|69699112|FG000|Overall Study|Subject discontinued due to travel|0|||
38016633|NCT03295318|69699113|FG001|Overall Study|Subject discontinued due to travel|1|||
38016634|NCT03295318|69699114|FG002|Overall Study|Subject discontinued due to travel|0|||
38016635|NCT03311230|69699144|FG000|Overall Study|Withdrawal by Subject|1|||
38016636|NCT03311230|69699145|FG001|Overall Study|Withdrawal by Subject|4|||
38016637|NCT03311230|69699146|FG002|Overall Study|Withdrawal by Subject|2|||
38016638|NCT03311230|69699147|FG003|Overall Study|Withdrawal by Subject|7|||
38016639|NCT03311230|69699144|FG000|Overall Study|Unrelated injury|0|||
38016640|NCT03311230|69699145|FG001|Overall Study|Unrelated injury|1|||
38016641|NCT03311230|69699146|FG002|Overall Study|Unrelated injury|0|||
38016642|NCT03311230|69699147|FG003|Overall Study|Unrelated injury|0|||
38016643|NCT00312221|69699160|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
38016644|NCT00312221|69699161|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
38016645|NCT00312221|69699162|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
38016646|NCT00312221|69699163|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
38016647|NCT00312221|69699160|FG000|Open-label Run-in Period|Adverse Event|74|||
38016648|NCT00312221|69699161|FG001|Open-label Run-in Period|Adverse Event|0|||
38016649|NCT00312221|69699162|FG002|Open-label Run-in Period|Adverse Event|0|||
38016650|NCT00312221|69699163|FG003|Open-label Run-in Period|Adverse Event|0|||
38016651|NCT00312221|69699160|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
38016652|NCT00312221|69699161|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
38016653|NCT00312221|69699162|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
38016654|NCT00312221|69699163|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
38016655|NCT00312221|69699160|FG000|Open-label Run-in Period|Administrative|42|||
38016656|NCT00312221|69699161|FG001|Open-label Run-in Period|Administrative|0|||
38016657|NCT00312221|69699162|FG002|Open-label Run-in Period|Administrative|0|||
38016658|NCT00312221|69699163|FG003|Open-label Run-in Period|Administrative|0|||
38016659|NCT00312221|69699160|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
38016660|NCT00312221|69699161|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
38016661|NCT00312221|69699162|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
38016662|NCT00312221|69699163|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
38016663|NCT00312221|69699160|FG000|Open-label Run-in Period|Did not qualify|5|||
38016664|NCT00312221|69699161|FG001|Open-label Run-in Period|Did not qualify|0|||
38016665|NCT00312221|69699162|FG002|Open-label Run-in Period|Did not qualify|0|||
38016666|NCT00312221|69699163|FG003|Open-label Run-in Period|Did not qualify|0|||
38016667|NCT00312221|69699160|FG000|Double-blind Phase|Withdrawal by Subject|0|||
38016668|NCT00312221|69699161|FG001|Double-blind Phase|Withdrawal by Subject|6|||
38016669|NCT00312221|69699162|FG002|Double-blind Phase|Withdrawal by Subject|8|||
38016670|NCT00312221|69699163|FG003|Double-blind Phase|Withdrawal by Subject|7|||
38016671|NCT00312221|69699160|FG000|Double-blind Phase|Adverse Event|0|||
38016672|NCT00312221|69699161|FG001|Double-blind Phase|Adverse Event|10|||
38016673|NCT00312221|69699162|FG002|Double-blind Phase|Adverse Event|19|||
38016674|NCT00312221|69699163|FG003|Double-blind Phase|Adverse Event|18|||
38016675|NCT00312221|69699160|FG000|Double-blind Phase|Lost to Follow-up|0|||
38016676|NCT00312221|69699161|FG001|Double-blind Phase|Lost to Follow-up|0|||
38016677|NCT00312221|69699162|FG002|Double-blind Phase|Lost to Follow-up|2|||
38016678|NCT00312221|69699163|FG003|Double-blind Phase|Lost to Follow-up|2|||
38016679|NCT00312221|69699160|FG000|Double-blind Phase|Administrative|0|||
38016680|NCT00312221|69699161|FG001|Double-blind Phase|Administrative|26|||
38016681|NCT00312221|69699162|FG002|Double-blind Phase|Administrative|37|||
38016682|NCT00312221|69699163|FG003|Double-blind Phase|Administrative|33|||
38016683|NCT00312221|69699160|FG000|Double-blind Phase|Lack of Efficacy|0|||
38016684|NCT00312221|69699161|FG001|Double-blind Phase|Lack of Efficacy|17|||
38016685|NCT00312221|69699162|FG002|Double-blind Phase|Lack of Efficacy|6|||
38016686|NCT00312221|69699163|FG003|Double-blind Phase|Lack of Efficacy|10|||
38016687|NCT03294538|69699187|FG000|Overall Study|Adverse Event|0|||
38016688|NCT03294538|69699188|FG001|Overall Study|Adverse Event|1|||
38016689|NCT03294538|69699189|FG002|Overall Study|Adverse Event|1|||
38016690|NCT03294538|69699187|FG000|Overall Study|Lost to Follow-up|1|||
38016691|NCT03294538|69699188|FG001|Overall Study|Lost to Follow-up|0|||
38016692|NCT03294538|69699189|FG002|Overall Study|Lost to Follow-up|0|||
38016693|NCT03294538|69699187|FG000|Overall Study|Outside of Visit Window|4|||
38016694|NCT03294538|69699188|FG001|Overall Study|Outside of Visit Window|4|||
38016695|NCT03294538|69699189|FG002|Overall Study|Outside of Visit Window|1|||
38016696|NCT03265600|69699199|FG000|Overall Study|Lost to Follow-up|17|||
37832402|NCT01288612|69515899|FG000|Overall Study|Unable to intubate|0|||
37832403|NCT01288612|69515900|FG001|Overall Study|Unable to intubate|3|||
38016697|NCT03265600|69699200|FG001|Overall Study|Lost to Follow-up|5|||
38016698|NCT03265600|69699199|FG000|Overall Study|Withdrawal by Subject|4|||
38016699|NCT03265600|69699200|FG001|Overall Study|Withdrawal by Subject|2|||
38016700|NCT03265600|69699199|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
38016701|NCT03265600|69699200|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
38016702|NCT00335153|69699206|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
38016703|NCT00335153|69699206|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
38016704|NCT00335153|69699206|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
38016705|NCT00335153|69699206|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
38016706|NCT00335153|69699206|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
38016707|NCT00335153|69699206|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
38016708|NCT00335153|69699206|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
38016709|NCT00335153|69699206|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
38016710|NCT00335153|69699206|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
38016711|NCT00335153|69699206|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
38016712|NCT03265132|69699212|FG000|Overall Study|Adverse Event|0|||
38016713|NCT03265132|69699213|FG001|Overall Study|Adverse Event|1|||
38016714|NCT03265132|69699212|FG000|Overall Study|Lack of Efficacy|0|||
38016715|NCT03265132|69699213|FG001|Overall Study|Lack of Efficacy|2|||
38016716|NCT03265132|69699212|FG000|Overall Study|Progressive disease|0|||
38016717|NCT03265132|69699213|FG001|Overall Study|Progressive disease|2|||
38016718|NCT03265132|69699212|FG000|Overall Study|Withdrawal by Subject|0|||
38016719|NCT03265132|69699213|FG001|Overall Study|Withdrawal by Subject|1|||
38016720|NCT02939950|69699223|FG000|Overall Study|Lost to Follow-up|13|||
38016721|NCT02939950|69699224|FG001|Overall Study|Lost to Follow-up|16|||
38016722|NCT02939950|69699223|FG000|Overall Study|Positive slit lamp findings|0|||
38016723|NCT02939950|69699224|FG001|Overall Study|Positive slit lamp findings|1|||
38016724|NCT02939950|69699223|FG000|Overall Study|Chalazion upper lid|0|||
38016725|NCT02939950|69699224|FG001|Overall Study|Chalazion upper lid|1|||
38016726|NCT02939950|69699223|FG000|Overall Study|Lack of motivation|0|||
38016727|NCT02939950|69699224|FG001|Overall Study|Lack of motivation|2|||
38016728|NCT02939950|69699223|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
38016729|NCT02939950|69699224|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
38016730|NCT02939950|69699223|FG000|Overall Study|Military orders|1|||
38016731|NCT02939950|69699224|FG001|Overall Study|Military orders|0|||
38016732|NCT02939950|69699223|FG000|Overall Study|Participant Relocated|5|||
38016733|NCT02939950|69699224|FG001|Overall Study|Participant Relocated|3|||
38016734|NCT02939950|69699223|FG000|Overall Study|Study related symptoms|8|||
37832404|NCT01288612|69515901|FG002|Overall Study|Unable to intubate|0|||
37832405|NCT01287832|69515911|FG000|Overall Study|Adverse Event|1|||
38016735|NCT02939950|69699224|FG001|Overall Study|Study related symptoms|8|||
38016736|NCT02939950|69699223|FG000|Overall Study|Unacceptable lens movement|2|||
38016737|NCT02939950|69699224|FG001|Overall Study|Unacceptable lens movement|0|||
38016738|NCT02939950|69699223|FG000|Overall Study|Protocol Violation|6|||
38016739|NCT02939950|69699224|FG001|Overall Study|Protocol Violation|3|||
38016740|NCT02939950|69699223|FG000|Overall Study|Physician Decision|2|||
38016741|NCT02939950|69699224|FG001|Overall Study|Physician Decision|0|||
38016742|NCT02939950|69699223|FG000|Overall Study|Pregnancy|6|||
38016743|NCT02939950|69699224|FG001|Overall Study|Pregnancy|7|||
38016744|NCT02939950|69699223|FG000|Overall Study|Withdrawal by Subject|12|||
38016745|NCT02939950|69699224|FG001|Overall Study|Withdrawal by Subject|28|||
38016746|NCT02939950|69699223|FG000|Overall Study|Adverse Event|7|||
38016747|NCT02939950|69699224|FG001|Overall Study|Adverse Event|3|||
38016748|NCT02939950|69699223|FG000|Overall Study|Randomized, not dispensed|1|||
38016749|NCT02939950|69699224|FG001|Overall Study|Randomized, not dispensed|0|||
38016750|NCT02939950|69699223|FG000|Overall Study|Ineligible at Baseline|2|||
38016751|NCT02939950|69699224|FG001|Overall Study|Ineligible at Baseline|8|||
38016752|NCT03753542|69699232|FG000|Overall Study|Lost to Follow-up|9|||
38016753|NCT03753542|69699233|FG001|Overall Study|Lost to Follow-up|14|||
38016754|NCT03292588|69699241|FG000|Overall Study|Death|1|||
38016755|NCT03292588|69699242|FG001|Overall Study|Death|0|||
38016756|NCT03292588|69699241|FG000|Overall Study|Lost to Follow-up|12|||
38016757|NCT03292588|69699242|FG001|Overall Study|Lost to Follow-up|16|||
38016758|NCT03292588|69699241|FG000|Overall Study|Physician Decision|0|||
38016759|NCT03292588|69699242|FG001|Overall Study|Physician Decision|1|||
38016760|NCT03292588|69699241|FG000|Overall Study|Withdrawal by Subject|4|||
38016761|NCT03292588|69699242|FG001|Overall Study|Withdrawal by Subject|4|||
38016762|NCT03292588|69699241|FG000|Overall Study|Move out of town|1|||
38016763|NCT03292588|69699242|FG001|Overall Study|Move out of town|0|||
38016764|NCT03292588|69699241|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
38016765|NCT03292588|69699242|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
38016766|NCT03752528|69699250|FG000|Part A|Lost to Follow-up|1|||
38016767|NCT03752528|69699250|FG000|Part A|Protocol Violation|1|||
38016768|NCT03752528|69699250|FG000|Part B|Protocol Violation|1|||
38016769|NCT03752528|69699250|FG000|Part B|Study terminated by sponsor|3|||
38016770|NCT00334295|69699257|FG000|Overall Study|Patients received fewer than 3 injection|5|||
38016771|NCT03292432|69699263|FG000|Overall Study|Lost to Follow-up|11|||
38016772|NCT03292432|69699264|FG001|Overall Study|Lost to Follow-up|8|||
38016773|NCT03292432|69699263|FG000|Overall Study|Death|2|||
38016774|NCT03292432|69699264|FG001|Overall Study|Death|1|||
38016775|NCT03292432|69699263|FG000|Overall Study|Withdrawal by Subject|1|||
38016776|NCT03292432|69699264|FG001|Overall Study|Withdrawal by Subject|2|||
38016777|NCT03292432|69699263|FG000|Overall Study|Site closed before any data collected|1|||
38016778|NCT03292432|69699264|FG001|Overall Study|Site closed before any data collected|0|||
38016779|NCT03291808|69699270|FG000|Overall Study|Lost to Follow-up|6|||
38016780|NCT03291808|69699270|FG000|Overall Study|Research burden|4|||
38016781|NCT03263806|69699276|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
38016782|NCT03263806|69699277|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
38016783|NCT03263806|69699276|FG000|Overall Study|Withdrawal by Subject|0|||
38016784|NCT03263806|69699277|FG001|Overall Study|Withdrawal by Subject|1|||
38016785|NCT03263806|69699276|FG000|Overall Study|Study Termination|5|||
38016786|NCT03263806|69699277|FG001|Overall Study|Study Termination|6|||
38016787|NCT03751280|69699285|FG000|Overall Study|Adverse Event|0|||
38016788|NCT03751280|69699286|FG001|Overall Study|Adverse Event|1|||
38016789|NCT03751280|69699285|FG000|Overall Study|Lost to Follow-up|3|||
38016790|NCT03751280|69699286|FG001|Overall Study|Lost to Follow-up|5|||
38016791|NCT03751280|69699285|FG000|Overall Study|Physician Decision|0|||
38016792|NCT03751280|69699286|FG001|Overall Study|Physician Decision|2|||
38016793|NCT03751280|69699285|FG000|Overall Study|Protocol Violation|0|||
38016794|NCT03751280|69699286|FG001|Overall Study|Protocol Violation|2|||
38016795|NCT03751280|69699285|FG000|Overall Study|Withdrawal by Subject|5|||
38016796|NCT03751280|69699286|FG001|Overall Study|Withdrawal by Subject|2|||
38016797|NCT00311363|69699296|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
38016798|NCT00311363|69699297|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
38016799|NCT00311363|69699298|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
38016800|NCT00311363|69699296|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
38016801|NCT00311363|69699297|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
38016802|NCT00311363|69699298|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
38016803|NCT00311363|69699296|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
38016804|NCT00311363|69699297|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
38016805|NCT00311363|69699298|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
38016806|NCT00311363|69699296|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
38016807|NCT00311363|69699297|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
38016808|NCT00311363|69699298|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
38016809|NCT00311363|69699296|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
38016810|NCT00311363|69699297|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
38016811|NCT00311363|69699298|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
38016812|NCT00311363|69699296|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
37698490|NCT01815424|69175235|FG001|Week 16 to 52|Lost to Follow-up|2|||
38016813|NCT00311363|69699297|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
38016814|NCT00311363|69699298|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
38016815|NCT00311363|69699296|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
38016816|NCT00311363|69699297|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
38016817|NCT00311363|69699298|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
37832406|NCT01287832|69515912|FG001|Overall Study|Adverse Event|0|||
37832407|NCT01287832|69515911|FG000|Overall Study|Death|0|||
37910111|NCT00049517|69596162|FG001|Induction|Adverse Event|0|||
37910112|NCT00049517|69596163|FG002|Induction|Adverse Event|0|||
37910113|NCT00049517|69596164|FG003|Induction|Adverse Event|0|||
37910114|NCT00049517|69596165|FG004|Induction|Adverse Event|5|||
37910115|NCT00049517|69596166|FG005|Induction|Adverse Event|7|||
37910116|NCT00049517|69596161|FG000|Induction|Death|0|||
37910117|NCT00049517|69596162|FG001|Induction|Death|0|||
37910118|NCT00049517|69596163|FG002|Induction|Death|0|||
37910119|NCT00049517|69596164|FG003|Induction|Death|0|||
37910120|NCT00049517|69596165|FG004|Induction|Death|9|||
37832408|NCT01287832|69515912|FG001|Overall Study|Death|1|||
37832409|NCT01287754|69515920|FG000|Overall Study|Death|2|||
37832410|NCT01287754|69515921|FG001|Overall Study|Death|12|||
37832411|NCT01287754|69515920|FG000|Overall Study|Lost to Follow-up|1|||
37832412|NCT01287754|69515921|FG001|Overall Study|Lost to Follow-up|6|||
37832413|NCT01287754|69515920|FG000|Overall Study|Protocol Violation|0|||
37832414|NCT01287754|69515921|FG001|Overall Study|Protocol Violation|3|||
37832415|NCT01287520|69515936|FG000|Overall Study|Adverse Event|2|||
37832416|NCT01287520|69515937|FG001|Overall Study|Adverse Event|2|||
37910121|NCT00049517|69596166|FG005|Induction|Death|6|||
37910122|NCT00049517|69596161|FG000|Induction|Withdrawal by Subject|0|||
37910123|NCT00049517|69596162|FG001|Induction|Withdrawal by Subject|0|||
37910124|NCT00049517|69596163|FG002|Induction|Withdrawal by Subject|0|||
37832417|NCT01287520|69515938|FG002|Overall Study|Adverse Event|2|||
37910125|NCT00049517|69596164|FG003|Induction|Withdrawal by Subject|0|||
37910126|NCT00049517|69596165|FG004|Induction|Withdrawal by Subject|1|||
37832418|NCT01287520|69515939|FG003|Overall Study|Adverse Event|1|||
37832419|NCT01287520|69515940|FG004|Overall Study|Adverse Event|1|||
37832420|NCT01287520|69515941|FG005|Overall Study|Adverse Event|2|||
37832421|NCT01287520|69515942|FG006|Overall Study|Adverse Event|0|||
37832422|NCT01287520|69515943|FG007|Overall Study|Adverse Event|2|||
37832423|NCT01287520|69515944|FG008|Overall Study|Adverse Event|0|||
37832424|NCT01287520|69515936|FG000|Overall Study|Physician Decision|1|||
37832425|NCT01287520|69515937|FG001|Overall Study|Physician Decision|1|||
37910127|NCT00049517|69596166|FG005|Induction|Withdrawal by Subject|3|||
37910128|NCT00049517|69596161|FG000|Induction|Alternative therapy|0|||
37910129|NCT00049517|69596162|FG001|Induction|Alternative therapy|0|||
37910130|NCT00049517|69596163|FG002|Induction|Alternative therapy|0|||
37910131|NCT00049517|69596164|FG003|Induction|Alternative therapy|0|||
37910132|NCT00049517|69596165|FG004|Induction|Alternative therapy|2|||
37910133|NCT00049517|69596166|FG005|Induction|Alternative therapy|2|||
37910134|NCT00049517|69596161|FG000|Induction|Other complicating disease|0|||
37910135|NCT00049517|69596162|FG001|Induction|Other complicating disease|0|||
37910136|NCT00049517|69596163|FG002|Induction|Other complicating disease|0|||
37910137|NCT00049517|69596164|FG003|Induction|Other complicating disease|0|||
37832426|NCT01287520|69515938|FG002|Overall Study|Physician Decision|2|||
37832427|NCT01287520|69515939|FG003|Overall Study|Physician Decision|0|||
37910138|NCT00049517|69596165|FG004|Induction|Other complicating disease|3|||
37910139|NCT00049517|69596166|FG005|Induction|Other complicating disease|0|||
37910140|NCT00049517|69596161|FG000|Induction|Reasons not reported|0|||
37910141|NCT00049517|69596162|FG001|Induction|Reasons not reported|0|||
37910142|NCT00049517|69596163|FG002|Induction|Reasons not reported|0|||
37910143|NCT00049517|69596164|FG003|Induction|Reasons not reported|0|||
37910144|NCT00049517|69596165|FG004|Induction|Reasons not reported|22|||
37910145|NCT00049517|69596166|FG005|Induction|Reasons not reported|25|||
38016818|NCT00311363|69699296|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
38016819|NCT00311363|69699297|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
38016820|NCT00311363|69699298|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
37832428|NCT01287520|69515940|FG004|Overall Study|Physician Decision|1|||
37832429|NCT01287520|69515941|FG005|Overall Study|Physician Decision|1|||
37832430|NCT01287520|69515942|FG006|Overall Study|Physician Decision|0|||
37910146|NCT00049517|69596161|FG000|Conditioning/Transplant|Disease progression|14|||
37910147|NCT00049517|69596162|FG001|Conditioning/Transplant|Disease progression|6|||
37832431|NCT01287520|69515943|FG007|Overall Study|Physician Decision|1|||
37832432|NCT01287520|69515944|FG008|Overall Study|Physician Decision|0|||
37832433|NCT01287520|69515936|FG000|Overall Study|Progressive disease|0|||
37832434|NCT01287520|69515937|FG001|Overall Study|Progressive disease|4|||
37910148|NCT00049517|69596163|FG002|Conditioning/Transplant|Disease progression|10|||
37910149|NCT00049517|69596164|FG003|Conditioning/Transplant|Disease progression|6|||
37832435|NCT01287520|69515938|FG002|Overall Study|Progressive disease|1|||
37832436|NCT01287520|69515939|FG003|Overall Study|Progressive disease|6|||
37910150|NCT00049517|69596165|FG004|Conditioning/Transplant|Disease progression|0|||
37910151|NCT00049517|69596166|FG005|Conditioning/Transplant|Disease progression|0|||
37910152|NCT00049517|69596161|FG000|Conditioning/Transplant|Adverse Event|2|||
37910153|NCT00049517|69596162|FG001|Conditioning/Transplant|Adverse Event|1|||
37910154|NCT00049517|69596163|FG002|Conditioning/Transplant|Adverse Event|4|||
38016821|NCT00311363|69699296|FG000|24-Week Single-Blind Treatment Period|Death|1|||
38016822|NCT00311363|69699297|FG001|24-Week Single-Blind Treatment Period|Death|0|||
38016823|NCT00311363|69699298|FG002|24-Week Single-Blind Treatment Period|Death|0|||
38016824|NCT00311363|69699296|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
38016825|NCT00311363|69699297|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
38016826|NCT00311363|69699298|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
38016827|NCT00311363|69699296|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
38016828|NCT00311363|69699297|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
38016829|NCT00311363|69699298|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
38016830|NCT00311363|69699296|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
38016831|NCT00311363|69699297|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
38016832|NCT00311363|69699298|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
38016833|NCT00311363|69699296|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
38016834|NCT00311363|69699297|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
38016835|NCT00311363|69699298|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
38016836|NCT00311363|69699296|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
38016837|NCT00311363|69699297|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
38016838|NCT00311363|69699298|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
38016839|NCT00311363|69699296|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
38016840|NCT00311363|69699297|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
38016841|NCT00311363|69699298|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
38016842|NCT00333983|69699311|FG000|Overall Study|Lost to Follow-up|2|||
38016843|NCT00333983|69699312|FG001|Overall Study|Lost to Follow-up|1|||
38016844|NCT00333983|69699313|FG002|Overall Study|Lost to Follow-up|0|||
38016845|NCT00333983|69699311|FG000|Overall Study|Adverse Event|1|||
38016846|NCT00333983|69699312|FG001|Overall Study|Adverse Event|1|||
38016847|NCT00333983|69699313|FG002|Overall Study|Adverse Event|1|||
38016848|NCT00333983|69699311|FG000|Overall Study|Withdrawal by Subject|0|||
38016849|NCT00333983|69699312|FG001|Overall Study|Withdrawal by Subject|3|||
38016850|NCT00333983|69699313|FG002|Overall Study|Withdrawal by Subject|1|||
38016851|NCT03262012|69699325|FG000|Overall Study|Withdrawal by Subject|15|||
38016852|NCT03262012|69699326|FG001|Overall Study|Withdrawal by Subject|13|||
38016853|NCT03262012|69699327|FG002|Overall Study|Withdrawal by Subject|8|||
38016854|NCT03262012|69699328|FG003|Overall Study|Withdrawal by Subject|7|||
38016855|NCT03262012|69699325|FG000|Overall Study|Adverse Event|10|||
38016856|NCT03262012|69699326|FG001|Overall Study|Adverse Event|12|||
38016857|NCT03262012|69699327|FG002|Overall Study|Adverse Event|4|||
38016858|NCT03262012|69699328|FG003|Overall Study|Adverse Event|6|||
38016859|NCT03262012|69699325|FG000|Overall Study|Physician Decision|2|||
38016860|NCT03262012|69699326|FG001|Overall Study|Physician Decision|5|||
38016861|NCT03262012|69699327|FG002|Overall Study|Physician Decision|1|||
38016862|NCT03262012|69699328|FG003|Overall Study|Physician Decision|0|||
38016863|NCT03262012|69699325|FG000|Overall Study|Lack of Efficacy|0|||
38016864|NCT03262012|69699326|FG001|Overall Study|Lack of Efficacy|5|||
38016865|NCT03262012|69699327|FG002|Overall Study|Lack of Efficacy|1|||
38016866|NCT03262012|69699328|FG003|Overall Study|Lack of Efficacy|2|||
38016867|NCT03262012|69699325|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
38016868|NCT03262012|69699326|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
38016869|NCT03262012|69699327|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
38016870|NCT03262012|69699328|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
38016871|NCT03288142|69699340|FG000|Overall Study|Lost to Follow-up|22|||
38016872|NCT03288142|69699341|FG001|Overall Study|Lost to Follow-up|15|||
38016873|NCT00310817|69699353|FG000|Overall Study|AE or Death|3|||
38016874|NCT00310817|69699354|FG001|Overall Study|AE or Death|1|||
38016875|NCT00310817|69699355|FG002|Overall Study|AE or Death|0|||
38016876|NCT00310817|69699356|FG003|Overall Study|AE or Death|0|||
38016877|NCT00310817|69699353|FG000|Overall Study|Withdrawal by Subject|1|||
38016878|NCT00310817|69699354|FG001|Overall Study|Withdrawal by Subject|4|||
38016879|NCT00310817|69699355|FG002|Overall Study|Withdrawal by Subject|6|||
38016880|NCT00310817|69699356|FG003|Overall Study|Withdrawal by Subject|7|||
38016881|NCT00310817|69699353|FG000|Overall Study|Lost to Follow-up|2|||
38016882|NCT00310817|69699354|FG001|Overall Study|Lost to Follow-up|1|||
38016883|NCT00310817|69699355|FG002|Overall Study|Lost to Follow-up|0|||
38016884|NCT00310817|69699356|FG003|Overall Study|Lost to Follow-up|0|||
38016885|NCT00310817|69699353|FG000|Overall Study|Inappropriate Enrollment|1|||
38016886|NCT00310817|69699354|FG001|Overall Study|Inappropriate Enrollment|0|||
38016887|NCT00310817|69699355|FG002|Overall Study|Inappropriate Enrollment|1|||
38016888|NCT00310817|69699356|FG003|Overall Study|Inappropriate Enrollment|0|||
38016889|NCT00310817|69699353|FG000|Overall Study|Protocol Violation|1|||
38016890|NCT00310817|69699354|FG001|Overall Study|Protocol Violation|1|||
38016891|NCT00310817|69699355|FG002|Overall Study|Protocol Violation|1|||
38016892|NCT00310817|69699356|FG003|Overall Study|Protocol Violation|1|||
38016893|NCT00310817|69699353|FG000|Overall Study|Unable to classify|3|||
38016894|NCT00310817|69699354|FG001|Overall Study|Unable to classify|1|||
38016895|NCT00310817|69699355|FG002|Overall Study|Unable to classify|0|||
38016896|NCT00310817|69699356|FG003|Overall Study|Unable to classify|0|||
38016897|NCT02940886|69699401|FG000|Overall Study|Adverse Event|7|||
38016898|NCT02940886|69699402|FG001|Overall Study|Adverse Event|3|||
38016899|NCT02940886|69699401|FG000|Overall Study|Protocol Violation|0|||
38016900|NCT02940886|69699402|FG001|Overall Study|Protocol Violation|2|||
38016901|NCT02940886|69699401|FG000|Overall Study|Withdrawal by Subject|28|||
38016902|NCT02940886|69699402|FG001|Overall Study|Withdrawal by Subject|20|||
38016903|NCT02940886|69699401|FG000|Overall Study|Death|1|||
38016904|NCT02940886|69699402|FG001|Overall Study|Death|0|||
38016905|NCT02940886|69699401|FG000|Overall Study|Lack of Efficacy|1|||
38016906|NCT02940886|69699402|FG001|Overall Study|Lack of Efficacy|0|||
38016907|NCT02940886|69699401|FG000|Overall Study|Lost to Follow-up|49|||
38016908|NCT02940886|69699402|FG001|Overall Study|Lost to Follow-up|21|||
38016909|NCT02940886|69699401|FG000|Overall Study|Physician Decision|9|||
38016910|NCT02940886|69699402|FG001|Overall Study|Physician Decision|4|||
38016911|NCT02940886|69699401|FG000|Overall Study|Sponsor decision|0|||
38016912|NCT02940886|69699402|FG001|Overall Study|Sponsor decision|1|||
38016913|NCT02940886|69699401|FG000|Overall Study|No treatment|7|||
38016914|NCT02940886|69699402|FG001|Overall Study|No treatment|2|||
38016915|NCT02940886|69699401|FG000|Overall Study|Enrolment error|0|||
38016916|NCT02940886|69699402|FG001|Overall Study|Enrolment error|1|||
38016917|NCT03285958|69699412|FG000|Overall Study|Lost to Follow-up|1|||
38016918|NCT03285958|69699413|FG001|Overall Study|Lost to Follow-up|1|||
38016919|NCT03285958|69699412|FG000|Overall Study|Withdrawal by Subject|1|||
38016920|NCT03285958|69699413|FG001|Overall Study|Withdrawal by Subject|0|||
38016921|NCT03285958|69699412|FG000|Overall Study|Not able to attend required orientation|3|||
38016922|NCT03285958|69699413|FG001|Overall Study|Not able to attend required orientation|0|||
38016923|NCT03285646|69699422|FG000|Overall Study|Adverse Event|1|||
38016924|NCT03285646|69699423|FG001|Overall Study|Adverse Event|0|||
38016925|NCT03285646|69699422|FG000|Overall Study|Withdrawal by Subject|10|||
38016926|NCT03285646|69699423|FG001|Overall Study|Withdrawal by Subject|2|||
38016927|NCT03285646|69699422|FG000|Overall Study|Lost to Follow-up|2|||
38016928|NCT03285646|69699423|FG001|Overall Study|Lost to Follow-up|1|||
38016929|NCT03285646|69699422|FG000|Overall Study|Investigator/Sponsor Decision|0|||
38016930|NCT03285646|69699423|FG001|Overall Study|Investigator/Sponsor Decision|1|||
38016931|NCT03309202|69699434|FG000|Overall Study|Lost to Follow-up|1|||
38016932|NCT03309202|69699435|FG001|Overall Study|Lost to Follow-up|0|||
38016933|NCT03309202|69699436|FG002|Overall Study|Lost to Follow-up|0|||
38016934|NCT03309202|69699437|FG003|Overall Study|Lost to Follow-up|0|||
38016935|NCT00074490|69699452|FG000|Overall Study|Progressive malignancy|0|||
38016936|NCT00074490|69699453|FG001|Overall Study|Progressive malignancy|7|||
38016937|NCT00074490|69699454|FG002|Overall Study|Progressive malignancy|0|||
38016938|NCT00074490|69699455|FG003|Overall Study|Progressive malignancy|0|||
38016939|NCT00074490|69699456|FG004|Overall Study|Progressive malignancy|3|||
38016940|NCT00074490|69699457|FG005|Overall Study|Progressive malignancy|0|||
38016941|NCT03285490|69699472|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
38016942|NCT03285490|69699473|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
38016943|NCT03285490|69699472|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
38016944|NCT03285490|69699473|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
38016945|NCT02939716|69699480|FG000|Overall Study|scanner failure|0|||
38016946|NCT02939716|69699481|FG001|Overall Study|scanner failure|0|||
38016947|NCT02939716|69699482|FG002|Overall Study|scanner failure|0|||
38016948|NCT02939716|69699483|FG003|Overall Study|scanner failure|1|||
38016949|NCT02939716|69699484|FG004|Overall Study|scanner failure|1|||
38016950|NCT02939716|69699485|FG005|Overall Study|scanner failure|1|||
38016951|NCT00367133|69699514|FG000|2 Years|Death|20|||
38016952|NCT00367133|69699515|FG001|2 Years|Death|12|||
37832437|NCT01287520|69515940|FG004|Overall Study|Progressive disease|1|||
37832438|NCT01287520|69515941|FG005|Overall Study|Progressive disease|0|||
37832439|NCT01287520|69515942|FG006|Overall Study|Progressive disease|2|||
37832440|NCT01287520|69515943|FG007|Overall Study|Progressive disease|2|||
37832441|NCT01287520|69515944|FG008|Overall Study|Progressive disease|4|||
37832442|NCT01287520|69515936|FG000|Overall Study|Withdrawal by Subject|0|||
37832443|NCT01287520|69515937|FG001|Overall Study|Withdrawal by Subject|0|||
37832444|NCT01287520|69515938|FG002|Overall Study|Withdrawal by Subject|0|||
37832445|NCT01287520|69515939|FG003|Overall Study|Withdrawal by Subject|0|||
37832446|NCT01287520|69515940|FG004|Overall Study|Withdrawal by Subject|0|||
37832447|NCT01287520|69515941|FG005|Overall Study|Withdrawal by Subject|1|||
38016953|NCT00367133|69699516|FG002|2 Years|Death|12|||
38016954|NCT00367133|69699514|FG000|2 Years|Dropped|34|||
38016955|NCT00367133|69699515|FG001|2 Years|Dropped|19|||
38016956|NCT00367133|69699516|FG002|2 Years|Dropped|33|||
38016957|NCT00367133|69699514|FG000|2 Years|Missed visit|4|||
38016958|NCT00367133|69699515|FG001|2 Years|Missed visit|5|||
38016959|NCT00367133|69699516|FG002|2 Years|Missed visit|4|||
38016960|NCT00367055|69699526|FG000|Overall Study|Adverse Event|6|||
38016961|NCT00367055|69699527|FG001|Overall Study|Adverse Event|3|||
38016962|NCT00367055|69699526|FG000|Overall Study|Patient's Willing|3|||
38016963|NCT00367055|69699527|FG001|Overall Study|Patient's Willing|2|||
38016964|NCT00367055|69699526|FG000|Overall Study|Lack of Efficacy|1|||
38016965|NCT00367055|69699527|FG001|Overall Study|Lack of Efficacy|2|||
38016966|NCT00367055|69699526|FG000|Overall Study|Lost to Follow-up|1|||
38016967|NCT00367055|69699527|FG001|Overall Study|Lost to Follow-up|1|||
38016968|NCT00367055|69699526|FG000|Overall Study|Protocol Violation|0|||
38016969|NCT00367055|69699527|FG001|Overall Study|Protocol Violation|1|||
38016970|NCT00367055|69699526|FG000|Overall Study|Stopping Criterion Met|0|||
38016971|NCT00367055|69699527|FG001|Overall Study|Stopping Criterion Met|1|||
38016972|NCT00367055|69699526|FG000|Overall Study|Participant Living too Far from Hospital|0|||
38016973|NCT00367055|69699527|FG001|Overall Study|Participant Living too Far from Hospital|1|||
38016974|NCT00057330|69699535|FG000|Overall Study|Adverse Event|9|||
38016975|NCT00057330|69699536|FG001|Overall Study|Adverse Event|12|||
38016976|NCT00057330|69699535|FG000|Overall Study|Death|1|||
38016977|NCT00057330|69699536|FG001|Overall Study|Death|0|||
38016978|NCT00057330|69699535|FG000|Overall Study|Protocol Violation|1|||
38016979|NCT00057330|69699536|FG001|Overall Study|Protocol Violation|1|||
38016980|NCT00057330|69699535|FG000|Overall Study|Withdrawal by Subject|115|||
38016981|NCT00057330|69699536|FG001|Overall Study|Withdrawal by Subject|84|||
38016982|NCT00057330|69699535|FG000|Overall Study|Lost to Follow-up|745|||
38016983|NCT00057330|69699536|FG001|Overall Study|Lost to Follow-up|617|||
38016984|NCT00057330|69699535|FG000|Overall Study|Physician Decision|1|||
38016985|NCT00057330|69699536|FG001|Overall Study|Physician Decision|0|||
38016986|NCT00057330|69699535|FG000|Overall Study|Other|260|||
38016987|NCT00057330|69699536|FG001|Overall Study|Other|206|||
38016988|NCT03283696|69699544|FG000|Overall Study|Physician Decision|5|||
38016989|NCT03283696|69699545|FG001|Overall Study|Physician Decision|6|||
38016990|NCT03283696|69699544|FG000|Overall Study|Withdrawal by Subject|2|||
38016991|NCT03283696|69699545|FG001|Overall Study|Withdrawal by Subject|0|||
38016992|NCT02939560|69699551|FG000|Overall Study|Withdrawal by Subject|2|||
38016993|NCT02939560|69699551|FG000|Overall Study|Protocol Violation|1|||
38016994|NCT03748706|69699555|FG000|Overall Study|Lost to Follow-up|1|||
38016995|NCT03747302|69699561|FG000|Overall Study|Withdrawal by Subject|1|||
38016996|NCT03747302|69699562|FG001|Overall Study|Withdrawal by Subject|2|||
38016997|NCT00056862|69699572|FG000|Overall Study|Protocol Violation|1|||
38016998|NCT00056862|69699573|FG001|Overall Study|Protocol Violation|0|||
38016999|NCT00056316|69699581|FG000|Overall Study|Withdrawal by Subject|2|||
38017000|NCT00056316|69699582|FG001|Overall Study|Withdrawal by Subject|2|||
38017001|NCT00056316|69699581|FG000|Overall Study|Death/NH placement of pt|1|||
38017002|NCT00056316|69699582|FG001|Overall Study|Death/NH placement of pt|1|||
38017003|NCT03308968|69699591|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
38017004|NCT03308968|69699592|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
38017005|NCT03308968|69699593|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
38017006|NCT03308968|69699591|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
38017007|NCT03308968|69699592|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
38017008|NCT03308968|69699593|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
38017009|NCT03308968|69699591|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
38017010|NCT03308968|69699592|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
38017011|NCT03308968|69699593|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
38017012|NCT03308968|69699591|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
38017013|NCT03308968|69699592|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
38017014|NCT03308968|69699593|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
38017015|NCT03308968|69699591|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
38017016|NCT03308968|69699592|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
38017017|NCT03308968|69699593|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
38017018|NCT03308968|69699591|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
38017019|NCT03308968|69699592|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
38017020|NCT03308968|69699593|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
38017021|NCT03308968|69699591|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
38017022|NCT03308968|69699592|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
38017023|NCT03308968|69699593|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
38017024|NCT03308968|69699591|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
38017025|NCT03308968|69699592|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
38017026|NCT03308968|69699593|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
38017027|NCT03308968|69699591|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
38017028|NCT03308968|69699592|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
38017029|NCT03308968|69699593|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
38017030|NCT03308968|69699591|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
38017031|NCT03308968|69699592|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
38017032|NCT03308968|69699593|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
38017033|NCT03308968|69699591|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
38017034|NCT03308968|69699592|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
38017035|NCT03308968|69699593|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
38017036|NCT03308968|69699591|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
38017037|NCT03308968|69699592|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
38017038|NCT03308968|69699593|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
38017039|NCT03308968|69699591|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
38017040|NCT03308968|69699592|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
38017041|NCT03308968|69699593|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
38017042|NCT03308968|69699591|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
38017043|NCT03308968|69699592|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
38017044|NCT03308968|69699593|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
38017045|NCT02940730|69699606|FG000|Intervention 2|Physician Decision|7|||
38017046|NCT02940730|69699607|FG001|Intervention 2|Physician Decision|0|||
38017047|NCT03741062|69699615|FG000|Overall Study|Protocol Violation|1|||
38017048|NCT03741062|69699616|FG001|Overall Study|Protocol Violation|0|||
38017049|NCT03281668|69699622|FG000|Overall Study|Physician Decision|1|||
38017050|NCT03281668|69699622|FG000|Overall Study|scheduling conflict, family circumstance|2|||
38017051|NCT03281668|69699622|FG000|Overall Study|Withdrawal by Subject|4|||
38017052|NCT03281668|69699622|FG000|Overall Study|Lost to Follow-up|1|||
38017053|NCT03307174|69699628|FG000|Overall Study|Unplanned ICU Administrion|5|||
38017054|NCT03307174|69699629|FG001|Overall Study|Unplanned ICU Administrion|3|||
38017055|NCT03307174|69699628|FG000|Overall Study|Aborted Surgery|1|||
38017056|NCT03307174|69699629|FG001|Overall Study|Aborted Surgery|2|||
38017057|NCT03307174|69699628|FG000|Overall Study|Hypotension|6|||
38017058|NCT03307174|69699629|FG001|Overall Study|Hypotension|0|||
38017059|NCT03307174|69699628|FG000|Overall Study|Nonfunctional epidural|1|||
38017060|NCT03307174|69699629|FG001|Overall Study|Nonfunctional epidural|1|||
38017061|NCT03307174|69699628|FG000|Overall Study|Planned epidural removal|1|||
38017062|NCT03307174|69699629|FG001|Overall Study|Planned epidural removal|0|||
38017063|NCT03307174|69699628|FG000|Overall Study|Intrathecal catheter placement|0|||
38017064|NCT03307174|69699629|FG001|Overall Study|Intrathecal catheter placement|1|||
38017065|NCT03258814|69699637|FG000|Overall Study|Early Termination|4|||
38017066|NCT03258814|69699638|FG001|Overall Study|Early Termination|3|||
38017067|NCT03258814|69699639|FG002|Overall Study|Early Termination|10|||
38017068|NCT03257410|69699648|FG000|Overall Study|Adverse Event|2|||
38017069|NCT03257410|69699649|FG001|Overall Study|Adverse Event|3|||
38017070|NCT03257410|69699648|FG000|Overall Study|Protocol Violation|1|||
38017071|NCT03257410|69699649|FG001|Overall Study|Protocol Violation|2|||
38017072|NCT03257410|69699648|FG000|Overall Study|Lost to Follow-up|1|||
38017073|NCT03257410|69699649|FG001|Overall Study|Lost to Follow-up|0|||
38017074|NCT03257410|69699648|FG000|Overall Study|Withdrawal by Subject|1|||
38017075|NCT03257410|69699649|FG001|Overall Study|Withdrawal by Subject|2|||
38017076|NCT03257410|69699648|FG000|Overall Study|Physician Decision|1|||
38017077|NCT03257410|69699649|FG001|Overall Study|Physician Decision|1|||
38017078|NCT03257410|69699648|FG000|Overall Study|Renal transplantation|2|||
38017079|NCT03257410|69699649|FG001|Overall Study|Renal transplantation|0|||
38017080|NCT03257410|69699648|FG000|Overall Study|Switch to peritoneal dialysis|1|||
38017081|NCT03257410|69699649|FG001|Overall Study|Switch to peritoneal dialysis|0|||
38017082|NCT03257410|69699648|FG000|Overall Study|Death|3|||
38017083|NCT03257410|69699649|FG001|Overall Study|Death|2|||
38017084|NCT03257410|69699648|FG000|Overall Study|Change to another dialysis center|2|||
38017085|NCT03257410|69699649|FG001|Overall Study|Change to another dialysis center|2|||
38017086|NCT03257410|69699648|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
38017087|NCT03257410|69699649|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
37698491|NCT01815424|69175236|FG002|Week 16 to 52|Lost to Follow-up|0|||
37698492|NCT01815424|69175237|FG003|Week 16 to 52|Lost to Follow-up|2|||
37698493|NCT01815424|69175238|FG004|Week 16 to 52|Lost to Follow-up|1|||
38017088|NCT03257410|69699648|FG000|Overall Study|Miscellaneous|2|||
38017089|NCT03257410|69699649|FG001|Overall Study|Miscellaneous|2|||
38017090|NCT03257410|69699648|FG000|Overall Study|Other|0|||
38017091|NCT03257410|69699649|FG001|Overall Study|Other|1|||
38017092|NCT00056160|69699657|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
38017093|NCT00056160|69699658|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
38017094|NCT00056160|69699657|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
38017095|NCT00056160|69699658|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
38017096|NCT00056160|69699657|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
38017097|NCT00056160|69699658|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
37698494|NCT01815424|69175234|FG000|Week 16 to 52|Withdrawal by Subject|1|||
37698495|NCT01815424|69175235|FG001|Week 16 to 52|Withdrawal by Subject|2|||
38017098|NCT00056160|69699657|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
38017099|NCT00056160|69699658|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
38017100|NCT00056160|69699657|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
38017101|NCT00056160|69699658|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
38017102|NCT00056160|69699657|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
37698496|NCT01815424|69175236|FG002|Week 16 to 52|Withdrawal by Subject|0|||
37698497|NCT01815424|69175237|FG003|Week 16 to 52|Withdrawal by Subject|0|||
38017103|NCT00056160|69699658|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
38017104|NCT00056160|69699657|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
38017105|NCT00056160|69699658|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
38017106|NCT00056160|69699657|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
38017107|NCT00056160|69699658|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
38017108|NCT00056160|69699657|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
38017109|NCT00056160|69699658|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
38017110|NCT00056160|69699657|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
38017111|NCT00056160|69699658|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
38017112|NCT00056160|69699657|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
38017113|NCT00056160|69699658|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
38017114|NCT00056160|69699657|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
38017115|NCT00056160|69699658|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
38017116|NCT00056160|69699657|FG000|Final Follow-up|Transferred into expanded access study.|3|||
38017117|NCT00056160|69699658|FG001|Final Follow-up|Transferred into expanded access study.|0|||
38017118|NCT00056160|69699657|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
38017119|NCT00056160|69699658|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
38017120|NCT00056160|69699657|FG000|Final Follow-up|Adverse Event|1|||
38017121|NCT00056160|69699658|FG001|Final Follow-up|Adverse Event|0|||
38017122|NCT00061932|69699666|FG000|Overall Study|Withdrawal by Subject|13|||
38017123|NCT00061932|69699667|FG001|Overall Study|Withdrawal by Subject|4|||
38017124|NCT03280264|69699674|FG000|Overall Study|Adverse Event|1|||
38017125|NCT03280264|69699674|FG000|Overall Study|Physician Decision|1|||
38017126|NCT03280264|69699674|FG000|Overall Study|Withdrawal by Subject|1|||
38017127|NCT00060840|69699681|FG000|Overall Study|Change in surgical plan|2|||
38017128|NCT00060840|69699682|FG001|Overall Study|Change in surgical plan|6|||
38017129|NCT00060840|69699681|FG000|Overall Study|Death|0|||
38017130|NCT00060840|69699682|FG001|Overall Study|Death|1|||
38017131|NCT00060840|69699681|FG000|Overall Study|Withdrawal by Subject|0|||
38017132|NCT00060840|69699682|FG001|Overall Study|Withdrawal by Subject|1|||
38017133|NCT00060840|69699681|FG000|Overall Study|Subinvestigator unavailable|0|||
38017134|NCT00060840|69699682|FG001|Overall Study|Subinvestigator unavailable|1|||
38017135|NCT00060840|69699681|FG000|Overall Study|Physician Decision|1|||
38017136|NCT00060840|69699682|FG001|Overall Study|Physician Decision|0|||
38017137|NCT00060840|69699681|FG000|Overall Study|Other|1|||
38017138|NCT00060840|69699682|FG001|Overall Study|Other|0|||
38017139|NCT03280108|69699690|FG000|Overall Study|Lost to Follow-up|2|||
38017140|NCT03280108|69699691|FG001|Overall Study|Lost to Follow-up|0|||
38017141|NCT00059202|69699704|FG000|Overall Study|Withdrawal by Subject|5|||
38017142|NCT00059202|69699705|FG001|Overall Study|Withdrawal by Subject|9|||
38017143|NCT00059202|69699704|FG000|Overall Study|Protocol Violation|1|||
38017144|NCT00059202|69699705|FG001|Overall Study|Protocol Violation|3|||
38017145|NCT00059202|69699704|FG000|Overall Study|drug toxicity|0|||
38017146|NCT00059202|69699705|FG001|Overall Study|drug toxicity|3|||
38017147|NCT03278626|69699714|FG000|Overall Study|Death|2|||
38017148|NCT03278626|69699714|FG000|Overall Study|Toxicity|1|||
38017149|NCT03278626|69699714|FG000|Overall Study|Disease Progression|2|||
38017150|NCT03277846|69699720|FG000|Overall Study|Inpatient stay too brief|12|||
38017151|NCT03277846|69699721|FG001|Overall Study|Inpatient stay too brief|11|||
38017152|NCT00073008|69699729|FG000|Overall Study|Missing|6|||
38017153|NCT00073008|69699730|FG001|Overall Study|Missing|6|||
38017154|NCT00073008|69699729|FG000|Overall Study|Withdrawal by Subject|2|||
38017155|NCT00073008|69699730|FG001|Overall Study|Withdrawal by Subject|2|||
38017156|NCT00073008|69699729|FG000|Overall Study|Lost to Follow-up|1|||
38017157|NCT00073008|69699730|FG001|Overall Study|Lost to Follow-up|3|||
38017158|NCT00073008|69699729|FG000|Overall Study|Death|46|||
38017159|NCT00073008|69699730|FG001|Overall Study|Death|47|||
38017160|NCT00073008|69699729|FG000|Overall Study|"Other selected on Case Report Form"|7|||
38017161|NCT00073008|69699730|FG001|Overall Study|"Other selected on Case Report Form"|5|||
38017162|NCT00058422|69699736|FG000|Overall Study|Not treated|2|||
38017163|NCT00072384|69699740|FG000|Overall Study|Physician Decision|1|||
38017164|NCT00072384|69699740|FG000|Overall Study|Ineligible|8|||
38017165|NCT00054132|69699746|FG000|Overall Study|Not Treated|1|||
38017166|NCT00053898|69699753|FG000|Overall Study|No follow-up data from any source|9|||
38017167|NCT00053898|69699754|FG001|Overall Study|No follow-up data from any source|12|||
38017168|NCT00053898|69699753|FG000|Overall Study|Follow-up from telephone contact only|5|||
38017169|NCT00053898|69699754|FG001|Overall Study|Follow-up from telephone contact only|1|||
38017170|NCT03256552|69699790|FG000|Overall Study|Protocol Violation|1|||
38017171|NCT03256552|69699790|FG000|Overall Study|Physician Decision|1|||
38017172|NCT03256552|69699790|FG000|Overall Study|Adverse Event|1|||
38017173|NCT03256552|69699790|FG000|Overall Study|Withdrawal by Subject|2|||
38017174|NCT00071058|69699800|FG000|Overall Study|brain tumor-removed from study|1|||
38017175|NCT00053352|69699807|FG000|Overall Study|Lost to Follow-up|0|||
38017176|NCT00053352|69699808|FG001|Overall Study|Lost to Follow-up|1|||
38017177|NCT00053352|69699807|FG000|Overall Study|Physician Decision|11|||
38017178|NCT00053352|69699808|FG001|Overall Study|Physician Decision|1|||
38017179|NCT00053352|69699807|FG000|Overall Study|Withdrawal by Subject|1|||
38017180|NCT00053352|69699808|FG001|Overall Study|Withdrawal by Subject|0|||
38017181|NCT00053352|69699807|FG000|Overall Study|Ineligible|8|||
38017182|NCT00053352|69699808|FG001|Overall Study|Ineligible|8|||
38017183|NCT00053352|69699807|FG000|Overall Study|Disease at new site|1|||
38017184|NCT00053352|69699808|FG001|Overall Study|Disease at new site|0|||
38017185|NCT03245398|69699817|FG000|Overall Study|Travelled to another island|1|||
38017186|NCT03245398|69699818|FG001|Overall Study|Travelled to another island|0|||
38017187|NCT03244618|69699828|FG000|Overall Study|Lost to Follow-up|3|||
38017188|NCT03244618|69699829|FG001|Overall Study|Lost to Follow-up|4|||
38017189|NCT03244618|69699828|FG000|Overall Study|Protocol Violation|4|||
38017190|NCT03244618|69699829|FG001|Overall Study|Protocol Violation|3|||
38017191|NCT03244618|69699828|FG000|Overall Study|Withdrawal by Subject|0|||
37832448|NCT01287520|69515942|FG006|Overall Study|Withdrawal by Subject|0|||
37832449|NCT01287520|69515943|FG007|Overall Study|Withdrawal by Subject|0|||
37832450|NCT01287520|69515944|FG008|Overall Study|Withdrawal by Subject|1|||
37832451|NCT01287403|69515993|FG000|1st Intervention (1 Day)|Adverse Event|1|||
37910155|NCT00049517|69596164|FG003|Conditioning/Transplant|Adverse Event|8|||
37910156|NCT00049517|69596165|FG004|Conditioning/Transplant|Adverse Event|0|||
37910157|NCT00049517|69596166|FG005|Conditioning/Transplant|Adverse Event|0|||
37910158|NCT00049517|69596161|FG000|Conditioning/Transplant|Death|1|||
37910159|NCT00049517|69596162|FG001|Conditioning/Transplant|Death|0|||
37910160|NCT00049517|69596163|FG002|Conditioning/Transplant|Death|0|||
37910161|NCT00049517|69596164|FG003|Conditioning/Transplant|Death|2|||
37910162|NCT00049517|69596165|FG004|Conditioning/Transplant|Death|0|||
37910163|NCT00049517|69596166|FG005|Conditioning/Transplant|Death|0|||
37910164|NCT00049517|69596161|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
37910165|NCT00049517|69596162|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
37910166|NCT00049517|69596163|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
37910167|NCT00049517|69596164|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
38017192|NCT03244618|69699829|FG001|Overall Study|Withdrawal by Subject|2|||
38017193|NCT00052962|69699837|FG000|Overall Study|Not evaluable|0|||
37832452|NCT01287364|69516009|FG000|Overall Study|Adverse Event|0|||
37832453|NCT01287364|69516010|FG001|Overall Study|Adverse Event|3|||
37832454|NCT01287364|69516009|FG000|Overall Study|Protocol Violation|5|||
37832455|NCT01287364|69516010|FG001|Overall Study|Protocol Violation|5|||
37832456|NCT01287364|69516009|FG000|Overall Study|Other Reason|4|||
37832457|NCT01287364|69516010|FG001|Overall Study|Other Reason|2|||
37832458|NCT02889835|69516029|FG000|Overall Study|Lost to Follow-up|13|||
37832459|NCT02889835|69516030|FG001|Overall Study|Lost to Follow-up|13|||
37832460|NCT02889835|69516031|FG002|Overall Study|Lost to Follow-up|13|||
37832461|NCT02889835|69516029|FG000|Overall Study|Withdrawal by Subject|2|||
37832462|NCT02889835|69516030|FG001|Overall Study|Withdrawal by Subject|2|||
37832463|NCT02889835|69516031|FG002|Overall Study|Withdrawal by Subject|2|||
37832464|NCT02889835|69516029|FG000|Overall Study|Protocol Violation|1|||
37832465|NCT02889835|69516030|FG001|Overall Study|Protocol Violation|1|||
37832466|NCT02889835|69516031|FG002|Overall Study|Protocol Violation|1|||
37832467|NCT02889835|69516029|FG000|Overall Study|Exclusion Criteria -change in oral status|1|||
37832468|NCT02889835|69516030|FG001|Overall Study|Exclusion Criteria -change in oral status|1|||
37832469|NCT02889835|69516031|FG002|Overall Study|Exclusion Criteria -change in oral status|1|||
37832470|NCT02889835|69516029|FG000|Overall Study|Death|1|||
37832471|NCT02889835|69516030|FG001|Overall Study|Death|1|||
37832472|NCT02889835|69516031|FG002|Overall Study|Death|1|||
37832473|NCT01287013|69516042|FG000|Overall Study|Non-evaluable|3|||
37832474|NCT01287013|69516043|FG001|Overall Study|Non-evaluable|5|||
37832475|NCT01287013|69516044|FG002|Overall Study|Non-evaluable|21|||
38017194|NCT00052962|69699838|FG001|Overall Study|Not evaluable|2|||
38017195|NCT00052962|69699837|FG000|Overall Study|Not randomized/not evaluable|1|||
38017196|NCT00052962|69699838|FG001|Overall Study|Not randomized/not evaluable|0|||
38017197|NCT00051636|69699846|FG000|Period 1 - Core|Adverse Event|2|||
37832476|NCT01286779|69516052|FG000|Overall Study|Withdrawal by Subject|9|||
37832477|NCT01286779|69516052|FG000|Overall Study|Protocol Violation|5|||
37910168|NCT00049517|69596165|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
37910169|NCT00049517|69596166|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
37910170|NCT00049517|69596161|FG000|Conditioning/Transplant|Alternative therapy|4|||
37910171|NCT00049517|69596162|FG001|Conditioning/Transplant|Alternative therapy|4|||
37910172|NCT00049517|69596163|FG002|Conditioning/Transplant|Alternative therapy|2|||
37832478|NCT01286779|69516052|FG000|Overall Study|Physician Decision|2|||
37832479|NCT01286779|69516052|FG000|Overall Study|Participant had scheduled surgery|1|||
37832480|NCT01286779|69516052|FG000|Overall Study|Participant moved to another country|1|||
37832481|NCT01286779|69516052|FG000|Overall Study|Discontinued by sponsor|1|||
38017198|NCT00051636|69699847|FG001|Period 1 - Core|Adverse Event|2|||
38017199|NCT00051636|69699846|FG000|Period 1 - Core|Protocol Violation|1|||
38017200|NCT00051636|69699847|FG001|Period 1 - Core|Protocol Violation|0|||
38017201|NCT00051636|69699846|FG000|Period 1 - Core|Withdrawal by Subject|1|||
38017202|NCT00051636|69699847|FG001|Period 1 - Core|Withdrawal by Subject|2|||
38017203|NCT00051636|69699846|FG000|Period 1 - Core|Lost to Follow-up|0|||
38017204|NCT00051636|69699847|FG001|Period 1 - Core|Lost to Follow-up|2|||
38017205|NCT00051636|69699846|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
38017206|NCT00051636|69699847|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
38017207|NCT00051636|69699846|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
38017208|NCT00051636|69699847|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
38017209|NCT00051636|69699846|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
38017210|NCT00051636|69699847|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
38017211|NCT00051636|69699846|FG000|Period 2- Extended Observation Period|Death|4|||
38017212|NCT00051636|69699847|FG001|Period 2- Extended Observation Period|Death|5|||
38017213|NCT00051636|69699846|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
38017214|NCT00051636|69699847|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
38017215|NCT03255382|69699855|FG000|Overall Study|Adverse Event|3|||
38017216|NCT03255382|69699856|FG001|Overall Study|Adverse Event|0|||
38017217|NCT03255382|69699855|FG000|Overall Study|Lost to Follow-up|2|||
38017218|NCT03255382|69699856|FG001|Overall Study|Lost to Follow-up|0|||
38017219|NCT03255382|69699855|FG000|Overall Study|Withdrawal by Subject|2|||
38017220|NCT03255382|69699856|FG001|Overall Study|Withdrawal by Subject|0|||
38017221|NCT03255382|69699855|FG000|Overall Study|Other|6|||
38017222|NCT03255382|69699856|FG001|Overall Study|Other|0|||
38017223|NCT03254602|69699863|FG000|Overall Study|Lost to Follow-up|4|||
38017224|NCT00038142|69699869|FG000|Overall Study|Ineligible|1|||
38017225|NCT00038142|69699870|FG001|Overall Study|Ineligible|0|||
38017226|NCT00038142|69699869|FG000|Overall Study|Progressive Disease|11|||
38017227|NCT00038142|69699870|FG001|Overall Study|Progressive Disease|7|||
38017228|NCT00038142|69699869|FG000|Overall Study|Death|1|||
38017229|NCT00038142|69699870|FG001|Overall Study|Death|0|||
38017230|NCT00038142|69699869|FG000|Overall Study|Adverse Event|1|||
38017231|NCT00038142|69699870|FG001|Overall Study|Adverse Event|0|||
38017232|NCT00038142|69699869|FG000|Overall Study|Unknown Reason|8|||
38017233|NCT00038142|69699870|FG001|Overall Study|Unknown Reason|0|||
38017234|NCT00366899|69699878|FG000|Infant Series|Withdrawal by Subject|4|||
38017235|NCT00366899|69699879|FG001|Infant Series|Withdrawal by Subject|7|||
38017236|NCT00366899|69699878|FG000|Infant Series|Protocol Violation|2|||
38017237|NCT00366899|69699879|FG001|Infant Series|Protocol Violation|1|||
38017238|NCT00366899|69699878|FG000|Infant Series|Failed to return|1|||
38017239|NCT00366899|69699879|FG001|Infant Series|Failed to return|1|||
38017240|NCT00366899|69699878|FG000|Infant Series|Lost to Follow-up|0|||
38017241|NCT00366899|69699879|FG001|Infant Series|Lost to Follow-up|2|||
38017242|NCT00366899|69699878|FG000|Infant Series|Adverse Event|0|||
38017243|NCT00366899|69699879|FG001|Infant Series|Adverse Event|1|||
38017244|NCT00366899|69699878|FG000|Infant Series|Physician Decision|1|||
38017245|NCT00366899|69699879|FG001|Infant Series|Physician Decision|0|||
38017246|NCT00366899|69699878|FG000|Infant Series|Randomized but not consented|1|||
38017247|NCT00366899|69699879|FG001|Infant Series|Randomized but not consented|0|||
38017248|NCT00366899|69699878|FG000|After Infant Series|Lost to Follow-up|4|||
38017249|NCT00366899|69699879|FG001|After Infant Series|Lost to Follow-up|3|||
38017250|NCT00366899|69699878|FG000|After Infant Series|Withdrawal by Subject|1|||
38017251|NCT00366899|69699879|FG001|After Infant Series|Withdrawal by Subject|4|||
38017252|NCT00366899|69699878|FG000|After Infant Series|Adverse Event|1|||
38017253|NCT00366899|69699879|FG001|After Infant Series|Adverse Event|2|||
38017254|NCT00366899|69699878|FG000|After Infant Series|Protocol Violation|1|||
38017255|NCT00366899|69699879|FG001|After Infant Series|Protocol Violation|0|||
38017256|NCT00366899|69699878|FG000|Toddler Dose|Withdrawal by Subject|1|||
38017257|NCT00366899|69699879|FG001|Toddler Dose|Withdrawal by Subject|1|||
38017258|NCT00366899|69699878|FG000|Toddler Dose|Protocol Violation|1|||
38017259|NCT00366899|69699879|FG001|Toddler Dose|Protocol Violation|0|||
38017260|NCT03254134|69699913|FG000|Overall Study|Not eligible patients|599|||
37698498|NCT01815424|69175238|FG004|Week 16 to 52|Withdrawal by Subject|0|||
37698499|NCT02431247|69175253|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
38017261|NCT03254134|69699914|FG001|Overall Study|Not eligible patients|3630|||
38017262|NCT00037830|69699923|FG000|Overall Study|Adverse Event|2|||
38017263|NCT00037830|69699924|FG001|Overall Study|Adverse Event|0|||
38017264|NCT00037830|69699925|FG002|Overall Study|Adverse Event|0|||
38017265|NCT00037830|69699923|FG000|Overall Study|Withdrawal by Subject|4|||
38017266|NCT00037830|69699924|FG001|Overall Study|Withdrawal by Subject|5|||
38017267|NCT00037830|69699925|FG002|Overall Study|Withdrawal by Subject|1|||
38017268|NCT00037830|69699923|FG000|Overall Study|Protocol Violation|2|||
38017269|NCT00037830|69699924|FG001|Overall Study|Protocol Violation|2|||
37698500|NCT02431247|69175254|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
38017270|NCT00037830|69699925|FG002|Overall Study|Protocol Violation|0|||
38017271|NCT00037830|69699923|FG000|Overall Study|Unrelated Medical Problem|2|||
38017272|NCT00037830|69699924|FG001|Overall Study|Unrelated Medical Problem|0|||
38017273|NCT00037830|69699925|FG002|Overall Study|Unrelated Medical Problem|0|||
38017274|NCT03242434|69699935|FG000|Overall Study|Death|0|||
38017275|NCT03242434|69699936|FG001|Overall Study|Death|2|||
38017276|NCT02939014|69699945|FG000|Overall Study|Lost to Follow-up|1|||
38017277|NCT02939014|69699946|FG001|Overall Study|Lost to Follow-up|0|||
38017278|NCT02939014|69699945|FG000|Overall Study|Death|4|||
38017279|NCT02939014|69699946|FG001|Overall Study|Death|3|||
38017280|NCT00051558|69699955|FG000|Overall Study|Adverse Event|30|||
38017281|NCT00051558|69699956|FG001|Overall Study|Adverse Event|18|||
38017282|NCT00051558|69699955|FG000|Overall Study|Withdrawal by Subject|29|||
38017283|NCT00051558|69699956|FG001|Overall Study|Withdrawal by Subject|42|||
38017284|NCT00051558|69699955|FG000|Overall Study|Death|9|||
38017285|NCT00051558|69699956|FG001|Overall Study|Death|15|||
38017286|NCT00051558|69699955|FG000|Overall Study|Lost to Follow-up|4|||
38017287|NCT00051558|69699956|FG001|Overall Study|Lost to Follow-up|13|||
38017288|NCT00051558|69699955|FG000|Overall Study|Protocol Violation|3|||
38017289|NCT00051558|69699956|FG001|Overall Study|Protocol Violation|4|||
38017290|NCT00051558|69699955|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
38017291|NCT00051558|69699956|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
38017292|NCT00051558|69699955|FG000|Overall Study|Sponsor Decision|6|||
38017293|NCT00051558|69699956|FG001|Overall Study|Sponsor Decision|1|||
38017294|NCT00051558|69699955|FG000|Overall Study|Other|2|||
38017295|NCT00051558|69699956|FG001|Overall Study|Other|1|||
38017296|NCT00051558|69699955|FG000|Overall Study|Significant Lab Value|2|||
38017297|NCT00051558|69699956|FG001|Overall Study|Significant Lab Value|0|||
38017298|NCT00051558|69699955|FG000|Overall Study|Physician Decision|5|||
38017299|NCT00051558|69699956|FG001|Overall Study|Physician Decision|0|||
38017300|NCT03251482|69699967|FG000|Overall Study|Withdrawal by Subject|0|||
38017301|NCT03251482|69699968|FG001|Overall Study|Withdrawal by Subject|1|||
38017302|NCT03251482|69699969|FG002|Overall Study|Withdrawal by Subject|0|||
38017303|NCT03251482|69699970|FG003|Overall Study|Withdrawal by Subject|0|||
38017304|NCT03251482|69699971|FG004|Overall Study|Withdrawal by Subject|0|||
38017305|NCT03249454|69699983|FG000|Overall Study|Withdrawal by Subject|0|||
38017306|NCT03249454|69699984|FG001|Overall Study|Withdrawal by Subject|0|||
38017307|NCT03249454|69699985|FG002|Overall Study|Withdrawal by Subject|0|||
38017308|NCT03249454|69699986|FG003|Overall Study|Withdrawal by Subject|0|||
38017309|NCT03249454|69699987|FG004|Overall Study|Withdrawal by Subject|0|||
38017310|NCT03249454|69699988|FG005|Overall Study|Withdrawal by Subject|0|||
38017311|NCT03249454|69699989|FG006|Overall Study|Withdrawal by Subject|0|||
38017312|NCT03249454|69699990|FG007|Overall Study|Withdrawal by Subject|0|||
38017313|NCT03249454|69699991|FG008|Overall Study|Withdrawal by Subject|0|||
38017314|NCT03249454|69699992|FG009|Overall Study|Withdrawal by Subject|1|||
38017315|NCT03249454|69699993|FG010|Overall Study|Withdrawal by Subject|1|||
38017316|NCT03732248|69700006|FG000|Overall Study|Withdrawal by Subject|1|||
38017317|NCT03732248|69700007|FG001|Overall Study|Withdrawal by Subject|0|||
38017318|NCT00310037|69700015|FG000|Overall Study|Adverse Event|7|||
38017319|NCT00310037|69700016|FG001|Overall Study|Adverse Event|14|||
38017320|NCT00310037|69700015|FG000|Overall Study|Withdrawal by Subject|4|||
38017321|NCT00310037|69700016|FG001|Overall Study|Withdrawal by Subject|3|||
38017322|NCT00310037|69700015|FG000|Overall Study|Progression|6|||
38017323|NCT00310037|69700016|FG001|Overall Study|Progression|0|||
38017324|NCT00310037|69700015|FG000|Overall Study|Non-protocol treatment|1|||
38017325|NCT00310037|69700016|FG001|Overall Study|Non-protocol treatment|0|||
38017326|NCT00309959|69700022|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
38017327|NCT03238924|69700033|FG000|Overall Study|Withdrawal by Subject|2|||
38017328|NCT03238924|69700034|FG001|Overall Study|Withdrawal by Subject|2|||
38017329|NCT03247816|69700040|FG000|Overall Study|Adverse Event|12|||
38017330|NCT03247816|69700040|FG000|Overall Study|Physician Decision|3|||
38017331|NCT03247816|69700040|FG000|Overall Study|Lack of Efficacy|1|||
38017332|NCT03247816|69700040|FG000|Overall Study|Lost to Follow-up|10|||
38017333|NCT03247816|69700040|FG000|Overall Study|Missing Feraccru stop date|3|||
38017334|NCT00333359|69700058|FG000|Overall Study|Adverse Event|29|||
38017335|NCT00333359|69700059|FG001|Overall Study|Adverse Event|35|||
38017336|NCT00333359|69700058|FG000|Overall Study|Withdrawal by Subject|19|||
37832482|NCT01286740|69516066|FG000|Overall Study|Enrolled but not treated|1|||
37832483|NCT01286740|69516066|FG000|Overall Study|Protocol Violation|1|||
37832484|NCT01286311|69516072|FG000|Overall Study|Physician did not want outreach sent|14|||
37832485|NCT01286311|69516073|FG001|Overall Study|Physician did not want outreach sent|0|||
37832486|NCT01286077|69516081|FG000|Overall Study|Adverse Event|2|||
37832487|NCT01286077|69516082|FG001|Overall Study|Adverse Event|0|||
38017337|NCT00333359|69700059|FG001|Overall Study|Withdrawal by Subject|37|||
38017338|NCT00333359|69700058|FG000|Overall Study|Physician Decision|2|||
38017339|NCT00333359|69700059|FG001|Overall Study|Physician Decision|2|||
38017340|NCT00333359|69700058|FG000|Overall Study|Protocol Non-compliance|2|||
38017341|NCT00333359|69700059|FG001|Overall Study|Protocol Non-compliance|8|||
38017342|NCT00333359|69700058|FG000|Overall Study|Lost to Follow-up|15|||
38017343|NCT00333359|69700059|FG001|Overall Study|Lost to Follow-up|25|||
37910173|NCT00049517|69596164|FG003|Conditioning/Transplant|Alternative therapy|1|||
38017344|NCT00333359|69700058|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
38017345|NCT00333359|69700059|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
38017346|NCT00333359|69700058|FG000|Overall Study|Treatment Failure|3|||
38017347|NCT00333359|69700059|FG001|Overall Study|Treatment Failure|8|||
38017348|NCT00333359|69700058|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
38017349|NCT00333359|69700059|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
38017350|NCT03246724|69700071|FG000|Overall Study|Withdrawal by Subject|5|||
38017351|NCT03246724|69700072|FG001|Overall Study|Withdrawal by Subject|2|||
38017352|NCT03246724|69700073|FG002|Overall Study|Withdrawal by Subject|4|||
38017353|NCT03246724|69700074|FG003|Overall Study|Withdrawal by Subject|2|||
38017354|NCT03246724|69700071|FG000|Overall Study|Ineligible on day of surgery|7|||
38017355|NCT03246724|69700072|FG001|Overall Study|Ineligible on day of surgery|2|||
38017356|NCT03246724|69700073|FG002|Overall Study|Ineligible on day of surgery|0|||
38017357|NCT03246724|69700074|FG003|Overall Study|Ineligible on day of surgery|3|||
38017358|NCT03246724|69700071|FG000|Overall Study|Study completed before surgical date|2|||
38017359|NCT03246724|69700072|FG001|Overall Study|Study completed before surgical date|1|||
38017360|NCT03246724|69700073|FG002|Overall Study|Study completed before surgical date|8|||
38017361|NCT03246724|69700074|FG003|Overall Study|Study completed before surgical date|1|||
38017362|NCT03246724|69700071|FG000|Overall Study|Transferred to other arm|0|||
38017363|NCT03246724|69700072|FG001|Overall Study|Transferred to other arm|0|||
38017364|NCT03246724|69700073|FG002|Overall Study|Transferred to other arm|1|||
38017365|NCT03246724|69700074|FG003|Overall Study|Transferred to other arm|0|||
38017366|NCT03246724|69700071|FG000|Overall Study|Unable to obtain medication timely|0|||
38017367|NCT03246724|69700072|FG001|Overall Study|Unable to obtain medication timely|2|||
38017368|NCT03246724|69700073|FG002|Overall Study|Unable to obtain medication timely|2|||
38017369|NCT03246724|69700074|FG003|Overall Study|Unable to obtain medication timely|1|||
38017370|NCT03246724|69700071|FG000|Overall Study|Re-consented to participate|0|||
38017371|NCT03246724|69700072|FG001|Overall Study|Re-consented to participate|0|||
38017372|NCT03246724|69700073|FG002|Overall Study|Re-consented to participate|0|||
38017373|NCT03246724|69700074|FG003|Overall Study|Re-consented to participate|1|||
38017374|NCT03246646|69700086|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
38017375|NCT03246646|69700087|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
38017376|NCT03246646|69700086|FG000|Overall Study|Withdrawal by Subject|3|||
38017377|NCT03246646|69700087|FG001|Overall Study|Withdrawal by Subject|0|||
38017378|NCT03246646|69700086|FG000|Overall Study|Lost to Follow-up|7|||
38017379|NCT03246646|69700087|FG001|Overall Study|Lost to Follow-up|0|||
38017380|NCT01347112|69700095|FG000|Overall Study|Withdrawal by Subject|1|||
38017381|NCT01347112|69700096|FG001|Overall Study|Withdrawal by Subject|7|||
38017382|NCT01347112|69700095|FG000|Overall Study|Lost to Follow-up|3|||
38017383|NCT01347112|69700096|FG001|Overall Study|Lost to Follow-up|5|||
38017384|NCT00308711|69700106|FG000|Overall Study|Withdrawal by Subject|1|||
38017385|NCT00308711|69700107|FG001|Overall Study|Withdrawal by Subject|0|||
38017386|NCT00308711|69700108|FG002|Overall Study|Withdrawal by Subject|1|||
38017387|NCT00308711|69700106|FG000|Overall Study|Protocol Violation|0|||
38017388|NCT00308711|69700107|FG001|Overall Study|Protocol Violation|1|||
38017389|NCT00308711|69700108|FG002|Overall Study|Protocol Violation|1|||
38017390|NCT00308711|69700106|FG000|Overall Study|Lost to Follow-up|0|||
38017391|NCT00308711|69700107|FG001|Overall Study|Lost to Follow-up|1|||
38017392|NCT00308711|69700108|FG002|Overall Study|Lost to Follow-up|0|||
38017393|NCT00308711|69700106|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
38017394|NCT00308711|69700107|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
38017395|NCT00308711|69700108|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
38017396|NCT00308711|69700106|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
38017397|NCT00308711|69700107|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
38017398|NCT00308711|69700108|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
38017399|NCT00308555|69700118|FG000|Overall Study|Withdrawal by Subject|1|||
38017400|NCT00308555|69700119|FG001|Overall Study|Withdrawal by Subject|0|||
37832488|NCT01286077|69516081|FG000|Overall Study|Death|1|||
37832489|NCT01286077|69516082|FG001|Overall Study|Death|0|||
37832490|NCT01286077|69516081|FG000|Overall Study|Protocol Violation|1|||
37832491|NCT01286077|69516082|FG001|Overall Study|Protocol Violation|1|||
37832492|NCT01286077|69516081|FG000|Overall Study|Withdrawal by Subject|0|||
37832493|NCT01286077|69516082|FG001|Overall Study|Withdrawal by Subject|2|||
37832494|NCT01286077|69516081|FG000|Overall Study|Intercurrent illness|1|||
37832495|NCT01286077|69516082|FG001|Overall Study|Intercurrent illness|0|||
37832496|NCT01286077|69516081|FG000|Overall Study|Non-compliance|1|||
37832497|NCT01286077|69516082|FG001|Overall Study|Non-compliance|0|||
38017401|NCT00308555|69700118|FG000|Overall Study|Physician Decision|2|||
38017402|NCT00308555|69700119|FG001|Overall Study|Physician Decision|0|||
37832498|NCT01286077|69516081|FG000|Overall Study|The subject starts with alternative MMY|0|||
38017403|NCT00050778|69700128|FG000|Overall Study|Adverse Event|13|||
38017404|NCT00050778|69700129|FG001|Overall Study|Adverse Event|3|||
38017405|NCT00050778|69700130|FG002|Overall Study|Adverse Event|2|||
38017406|NCT00050778|69700128|FG000|Overall Study|Death|0|||
38017407|NCT00050778|69700129|FG001|Overall Study|Death|1|||
38017408|NCT00050778|69700130|FG002|Overall Study|Death|1|||
38017409|NCT00050778|69700128|FG000|Overall Study|Lack of Efficacy|16|||
38017410|NCT00050778|69700129|FG001|Overall Study|Lack of Efficacy|2|||
38017411|NCT00050778|69700130|FG002|Overall Study|Lack of Efficacy|2|||
38017412|NCT00050778|69700128|FG000|Overall Study|Lost to Follow-up|0|||
38017413|NCT00050778|69700129|FG001|Overall Study|Lost to Follow-up|2|||
38017414|NCT00050778|69700130|FG002|Overall Study|Lost to Follow-up|4|||
38017415|NCT00050778|69700128|FG000|Overall Study|Physician Decision|3|||
38017416|NCT00050778|69700129|FG001|Overall Study|Physician Decision|0|||
38017417|NCT00050778|69700130|FG002|Overall Study|Physician Decision|2|||
38017418|NCT00050778|69700128|FG000|Overall Study|Protocol Violation|2|||
38017419|NCT00050778|69700129|FG001|Overall Study|Protocol Violation|0|||
38017420|NCT00050778|69700130|FG002|Overall Study|Protocol Violation|1|||
38017421|NCT00050778|69700128|FG000|Overall Study|Withdrawal by Subject|6|||
38017422|NCT00050778|69700129|FG001|Overall Study|Withdrawal by Subject|8|||
38017423|NCT00050778|69700130|FG002|Overall Study|Withdrawal by Subject|4|||
38017424|NCT00050778|69700128|FG000|Overall Study|Randomized but not treated|4|||
38017425|NCT00050778|69700129|FG001|Overall Study|Randomized but not treated|5|||
38017426|NCT00050778|69700130|FG002|Overall Study|Randomized but not treated|2|||
38017427|NCT00050778|69700128|FG000|Overall Study|Familial and personal reasons|1|||
38017428|NCT00050778|69700129|FG001|Overall Study|Familial and personal reasons|0|||
38017429|NCT00050778|69700130|FG002|Overall Study|Familial and personal reasons|0|||
38017430|NCT00050622|69700140|FG000|Overall Study|Adverse Event|1|||
38017431|NCT00308087|69700166|FG000|Overall Study|Progressive Disease|19|||
38017432|NCT00308087|69700167|FG001|Overall Study|Progressive Disease|21|||
38017433|NCT00308087|69700166|FG000|Overall Study|Study Closure|11|||
38017434|NCT00308087|69700167|FG001|Overall Study|Study Closure|12|||
38017435|NCT00308087|69700166|FG000|Overall Study|Withdrawal by Subject|2|||
38017436|NCT00308087|69700167|FG001|Overall Study|Withdrawal by Subject|1|||
38017437|NCT00308087|69700166|FG000|Overall Study|Other|4|||
38017438|NCT00308087|69700167|FG001|Overall Study|Other|3|||
38017439|NCT00307931|69700173|FG000|Overall Study|Adverse Event|1|||
38017440|NCT02796170|69700179|FG000|Overall Study|Lost to Follow-up|3|||
38017441|NCT02796170|69700180|FG001|Overall Study|Lost to Follow-up|0|||
38017442|NCT00049842|69700188|FG000|Treatment Phase|Adverse Event|47|||
38017443|NCT00049842|69700189|FG001|Treatment Phase|Adverse Event|12|||
38017444|NCT00049842|69700188|FG000|Treatment Phase|Withdrawal by Subject|35|||
38017445|NCT00049842|69700189|FG001|Treatment Phase|Withdrawal by Subject|46|||
38017446|NCT00049842|69700188|FG000|Treatment Phase|Non-compliance with protocol|7|||
38017447|NCT00049842|69700189|FG001|Treatment Phase|Non-compliance with protocol|8|||
38017448|NCT00049842|69700188|FG000|Treatment Phase|Lost to Follow-up|4|||
38017449|NCT00049842|69700189|FG001|Treatment Phase|Lost to Follow-up|8|||
38017450|NCT00049842|69700188|FG000|Treatment Phase|Administrative|0|||
38017451|NCT00049842|69700189|FG001|Treatment Phase|Administrative|3|||
38017452|NCT00049842|69700188|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
38017453|NCT00049842|69700189|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
38017454|NCT00049842|69700188|FG000|Follow-up Phase|Adverse Event|6|||
38017455|NCT00049842|69700189|FG001|Follow-up Phase|Adverse Event|1|||
38017456|NCT00049842|69700188|FG000|Follow-up Phase|Other|1|||
38017457|NCT00049842|69700189|FG001|Follow-up Phase|Other|4|||
38017458|NCT00307151|69700199|FG000|Overall Study|Death|4|||
38017459|NCT00307151|69700200|FG001|Overall Study|Death|3|||
38017460|NCT00307151|69700201|FG002|Overall Study|Death|10|||
38017461|NCT00307151|69700202|FG003|Overall Study|Death|3|||
38017462|NCT00307151|69700199|FG000|Overall Study|Severe debilitation, unable to continue|1|||
38017463|NCT00307151|69700200|FG001|Overall Study|Severe debilitation, unable to continue|0|||
38017464|NCT00307151|69700201|FG002|Overall Study|Severe debilitation, unable to continue|0|||
38017465|NCT00307151|69700202|FG003|Overall Study|Severe debilitation, unable to continue|0|||
38017466|NCT00307151|69700199|FG000|Overall Study|Subject unable to get to clinic|1|||
38017467|NCT00307151|69700200|FG001|Overall Study|Subject unable to get to clinic|0|||
38017468|NCT00307151|69700201|FG002|Overall Study|Subject unable to get to clinic|6|||
38017469|NCT00307151|69700202|FG003|Overall Study|Subject unable to get to clinic|2|||
38017470|NCT00307151|69700199|FG000|Overall Study|Withdrew consent|0|||
37910174|NCT00049517|69596165|FG004|Conditioning/Transplant|Alternative therapy|1|||
38017471|NCT00307151|69700200|FG001|Overall Study|Withdrew consent|1|||
38017472|NCT00307151|69700201|FG002|Overall Study|Withdrew consent|1|||
38017473|NCT00307151|69700202|FG003|Overall Study|Withdrew consent|3|||
38017474|NCT00307151|69700199|FG000|Overall Study|Not willing to adhere to study reqs|2|||
38017475|NCT00307151|69700200|FG001|Overall Study|Not willing to adhere to study reqs|0|||
38017476|NCT00307151|69700201|FG002|Overall Study|Not willing to adhere to study reqs|2|||
38017477|NCT00307151|69700202|FG003|Overall Study|Not willing to adhere to study reqs|2|||
38017478|NCT00307151|69700199|FG000|Overall Study|Clinic unable to contact subject|3|||
38017479|NCT00307151|69700200|FG001|Overall Study|Clinic unable to contact subject|3|||
38017480|NCT00307151|69700201|FG002|Overall Study|Clinic unable to contact subject|1|||
38017481|NCT00307151|69700202|FG003|Overall Study|Clinic unable to contact subject|1|||
38017482|NCT02654132|69700214|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
38017483|NCT02654132|69700215|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
38017484|NCT02654132|69700214|FG000|Treatment Period|Disease progression|43|||
38017485|NCT02654132|69700215|FG001|Treatment Period|Disease progression|38|||
38017486|NCT02654132|69700214|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
38017487|NCT02654132|69700215|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
38017488|NCT02654132|69700214|FG000|Treatment Period|Other reasons|4|||
38017489|NCT02654132|69700215|FG001|Treatment Period|Other reasons|2|||
38017490|NCT02654132|69700214|FG000|Treatment Period|Study drug toxicity|2|||
38017491|NCT02654132|69700215|FG001|Treatment Period|Study drug toxicity|2|||
38017492|NCT02654132|69700214|FG000|Treatment Period|Withdrawal by Subject|2|||
38017493|NCT02654132|69700215|FG001|Treatment Period|Withdrawal by Subject|1|||
38017494|NCT02654132|69700214|FG000|Treatment Period|Maximum Clinical Benefit|0|||
38017495|NCT02654132|69700215|FG001|Treatment Period|Maximum Clinical Benefit|2|||
38017496|NCT02654132|69700214|FG000|Treatment Period|Participant request to discontinue|2|||
38017497|NCT02654132|69700215|FG001|Treatment Period|Participant request to discontinue|0|||
38017498|NCT02654132|69700214|FG000|Treatment Period|Administrative reasons by sponsor|0|||
38017499|NCT02654132|69700215|FG001|Treatment Period|Administrative reasons by sponsor|1|||
38017500|NCT02654132|69700214|FG000|Treatment Period|Death|1|||
38017501|NCT02654132|69700215|FG001|Treatment Period|Death|0|||
38017502|NCT03241342|69700224|FG000|Overall Study|Adverse Event|5|||
38017503|NCT03241342|69700225|FG001|Overall Study|Adverse Event|8|||
38017504|NCT03241342|69700226|FG002|Overall Study|Adverse Event|4|||
38017505|NCT03241342|69700224|FG000|Overall Study|Lack of Efficacy|0|||
38017506|NCT03241342|69700225|FG001|Overall Study|Lack of Efficacy|0|||
38017507|NCT03241342|69700226|FG002|Overall Study|Lack of Efficacy|1|||
38017508|NCT03241342|69700224|FG000|Overall Study|noncompliance with study drug|2|||
38017509|NCT03241342|69700225|FG001|Overall Study|noncompliance with study drug|1|||
38017510|NCT03241342|69700226|FG002|Overall Study|noncompliance with study drug|1|||
38017511|NCT03241342|69700224|FG000|Overall Study|sponsor decision|0|||
38017512|NCT03241342|69700225|FG001|Overall Study|sponsor decision|1|||
38017513|NCT03241342|69700226|FG002|Overall Study|sponsor decision|2|||
38017514|NCT03241342|69700224|FG000|Overall Study|not reported|15|||
38017515|NCT03241342|69700225|FG001|Overall Study|not reported|21|||
38017516|NCT03241342|69700226|FG002|Overall Study|not reported|19|||
38017517|NCT00306995|69700241|FG000|Study Part I|Withdrawal by Subject|0|||
38017518|NCT00306995|69700242|FG001|Study Part I|Withdrawal by Subject|0|||
38017519|NCT00306995|69700243|FG002|Study Part I|Withdrawal by Subject|0|||
38017520|NCT00306995|69700244|FG003|Study Part I|Withdrawal by Subject|0|||
38017521|NCT00306995|69700245|FG004|Study Part I|Withdrawal by Subject|0|||
38017522|NCT00306995|69700246|FG005|Study Part I|Withdrawal by Subject|0|||
38017523|NCT00306995|69700247|FG006|Study Part I|Withdrawal by Subject|1|||
38017524|NCT00306995|69700241|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
38017525|NCT00306995|69700242|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
38017526|NCT00306995|69700243|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
38017527|NCT00306995|69700244|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
38017528|NCT00306995|69700245|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
38017529|NCT00306995|69700246|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
38017530|NCT00306995|69700247|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
38017531|NCT00121108|69700294|FG000|Overall Study|Lost to Follow-up|10|||
37832499|NCT01286077|69516082|FG001|Overall Study|The subject starts with alternative MMY|3|||
37832500|NCT01286077|69516081|FG000|Overall Study|Patient's decision to stop treatment|3|||
37832501|NCT01286077|69516082|FG001|Overall Study|Patient's decision to stop treatment|0|||
37832502|NCT01286077|69516081|FG000|Overall Study|Progression of disease|0|||
38017532|NCT00121108|69700295|FG001|Overall Study|Lost to Follow-up|22|||
38017533|NCT00121108|69700294|FG000|Overall Study|Withdrawal by Subject|106|||
38017534|NCT00121108|69700295|FG001|Overall Study|Withdrawal by Subject|195|||
38017535|NCT00121108|69700294|FG000|Overall Study|Death|5|||
37832503|NCT01286077|69516082|FG001|Overall Study|Progression of disease|1|||
37832504|NCT01286077|69516081|FG000|Overall Study|refill medication not received in time|1|||
38017536|NCT00121108|69700295|FG001|Overall Study|Death|8|||
38017537|NCT02387996|69700302|FG000|Overall Study|Disease Progression|167|||
38017538|NCT02387996|69700302|FG000|Overall Study|Study Drug Toxicity|31|||
38017539|NCT02387996|69700302|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
38017540|NCT02387996|69700302|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
38017541|NCT02387996|69700302|FG000|Overall Study|Subject Withdrew Consent|5|||
38017542|NCT02387996|69700302|FG000|Overall Study|Lost to Follow-up|1|||
38017543|NCT02387996|69700302|FG000|Overall Study|Poor/Non-Compliance|1|||
38017544|NCT02387996|69700302|FG000|Overall Study|Other Reasons|5|||
38017545|NCT02387996|69700302|FG000|Overall Study|Death|1|||
38017546|NCT03212326|69700306|FG000|Overall Study|Physician Decision|4|||
38017547|NCT03229486|69700345|FG000|Overall Study|Protocol Violation|0|||
38017548|NCT03229486|69700346|FG001|Overall Study|Protocol Violation|1|||
38017549|NCT01779050|69700354|FG000|Overall Study|Withdrawal by Subject|1|||
38017550|NCT01779050|69700355|FG001|Overall Study|Withdrawal by Subject|0|||
38017551|NCT00306527|69700365|FG000|Overall Study|Lost to Follow-up|3|||
38017552|NCT00306527|69700366|FG001|Overall Study|Lost to Follow-up|4|||
38017553|NCT00306527|69700367|FG002|Overall Study|Lost to Follow-up|3|||
38017554|NCT00306527|69700368|FG003|Overall Study|Lost to Follow-up|0|||
38017555|NCT00306527|69700365|FG000|Overall Study|Withdrawal by Subject|2|||
38017556|NCT00306527|69700366|FG001|Overall Study|Withdrawal by Subject|3|||
38017557|NCT00306527|69700367|FG002|Overall Study|Withdrawal by Subject|0|||
38017558|NCT00306527|69700368|FG003|Overall Study|Withdrawal by Subject|3|||
38017559|NCT00306527|69700365|FG000|Overall Study|Adverse Event|0|||
38017560|NCT00306527|69700366|FG001|Overall Study|Adverse Event|0|||
38017561|NCT00306527|69700367|FG002|Overall Study|Adverse Event|1|||
38017562|NCT00306527|69700368|FG003|Overall Study|Adverse Event|1|||
38017563|NCT00306527|69700365|FG000|Overall Study|Death|1|||
38017564|NCT00306527|69700366|FG001|Overall Study|Death|0|||
38017565|NCT00306527|69700367|FG002|Overall Study|Death|1|||
38017566|NCT00306527|69700368|FG003|Overall Study|Death|2|||
38017567|NCT00306293|69700382|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
38017568|NCT00306293|69700383|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
38017569|NCT00306293|69700382|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
38017570|NCT00306293|69700383|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
38017571|NCT00306293|69700382|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
38017572|NCT00306293|69700383|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
38017573|NCT00306293|69700382|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
38017574|NCT00306293|69700383|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
38017575|NCT00306293|69700382|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
38017576|NCT00306293|69700383|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
38017577|NCT00306293|69700382|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
38017578|NCT00306293|69700383|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
38017579|NCT00306293|69700382|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
38017580|NCT00306293|69700383|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
38017581|NCT00306293|69700382|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
38017582|NCT00306293|69700383|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
38017583|NCT00294671|69700393|FG000|Overall Study|Lack of Efficacy|11|||
38017584|NCT00294671|69700394|FG001|Overall Study|Lack of Efficacy|23|||
38017585|NCT00294671|69700393|FG000|Overall Study|Liver transplant|7|||
38017586|NCT00294671|69700394|FG001|Overall Study|Liver transplant|9|||
38017587|NCT00294671|69700393|FG000|Overall Study|Drug related adverse event (AE)|4|||
38017588|NCT00294671|69700394|FG001|Overall Study|Drug related adverse event (AE)|2|||
38017589|NCT00294671|69700393|FG000|Overall Study|Non-drug related AE|3|||
38017590|NCT00294671|69700394|FG001|Overall Study|Non-drug related AE|2|||
38017591|NCT00294671|69700393|FG000|Overall Study|Lost to Follow-up|1|||
38017592|NCT00294671|69700394|FG001|Overall Study|Lost to Follow-up|3|||
38017593|NCT00294671|69700393|FG000|Overall Study|Non-compliance|1|||
38017594|NCT00294671|69700394|FG001|Overall Study|Non-compliance|0|||
38017595|NCT00294671|69700393|FG000|Overall Study|Death|0|||
38017596|NCT00294671|69700394|FG001|Overall Study|Death|1|||
38017597|NCT01495598|69700400|FG000|Overall Study|Death during follow up period|2|||
38017598|NCT01495598|69700400|FG000|Overall Study|Death on study|1|||
38017599|NCT01495598|69700400|FG000|Overall Study|Lost to Follow-up|3|||
38017600|NCT01495598|69700400|FG000|Overall Study|Physician Decision|8|||
38017601|NCT02937454|69700431|FG000|Overall Study|Adverse Event|0|||
38017602|NCT02937454|69700432|FG001|Overall Study|Adverse Event|1|||
38017603|NCT02937454|69700431|FG000|Overall Study|Death|98|||
38017604|NCT02937454|69700432|FG001|Overall Study|Death|95|||
38017605|NCT02937454|69700431|FG000|Overall Study|Lost to Follow-up|1|||
38017606|NCT02937454|69700432|FG001|Overall Study|Lost to Follow-up|1|||
38017607|NCT02937454|69700431|FG000|Overall Study|Physician Decision|0|||
38017608|NCT02937454|69700432|FG001|Overall Study|Physician Decision|1|||
38017609|NCT02937454|69700431|FG000|Overall Study|Protocol Violation|6|||
38017610|NCT02937454|69700432|FG001|Overall Study|Protocol Violation|10|||
38017611|NCT02937454|69700431|FG000|Overall Study|Withdrawal by Subject|27|||
38017612|NCT02937454|69700432|FG001|Overall Study|Withdrawal by Subject|15|||
38017613|NCT02937454|69700431|FG000|Overall Study|Other|8|||
38017614|NCT02937454|69700432|FG001|Overall Study|Other|5|||
38017615|NCT03211858|69700451|FG000|Overall Study|Adverse Event|8|||
38017616|NCT03211858|69700452|FG001|Overall Study|Adverse Event|6|||
38017617|NCT03211858|69700451|FG000|Overall Study|Lack of Efficacy|0|||
38017618|NCT03211858|69700452|FG001|Overall Study|Lack of Efficacy|4|||
38017619|NCT03211858|69700451|FG000|Overall Study|Poor compliance to protocol|6|||
38017620|NCT03211858|69700452|FG001|Overall Study|Poor compliance to protocol|2|||
38017621|NCT03211858|69700451|FG000|Overall Study|Non-serious Hypoglycemia|1|||
38017622|NCT03211858|69700452|FG001|Overall Study|Non-serious Hypoglycemia|0|||
38017623|NCT03211858|69700451|FG000|Overall Study|Other than specified above|22|||
38017624|NCT03211858|69700452|FG001|Overall Study|Other than specified above|21|||
38017625|NCT03211156|69700464|FG000|Overall Study|Withdrawal by Subject|0|||
38017626|NCT03211156|69700465|FG001|Overall Study|Withdrawal by Subject|2|||
38017627|NCT03211156|69700464|FG000|Overall Study|Lost to Follow-up|1|||
38017628|NCT03211156|69700465|FG001|Overall Study|Lost to Follow-up|1|||
38017629|NCT03211156|69700464|FG000|Overall Study|Adverse Event|1|||
38017630|NCT03211156|69700465|FG001|Overall Study|Adverse Event|0|||
38017631|NCT04472494|69700473|FG000|Pre-treatment|Other reasons|2|||
38017632|NCT04472494|69700474|FG001|Pre-treatment|Other reasons|0|||
38017633|NCT04472494|69700473|FG000|Treatment|Death|5|||
38017634|NCT04472494|69700474|FG001|Treatment|Death|2|||
38017635|NCT04472494|69700473|FG000|Treatment|Hospital discharge|1|||
38017636|NCT04472494|69700474|FG001|Treatment|Hospital discharge|1|||
38017637|NCT04419506|69700484|FG000|Overall Study|Adverse Event|0|||
38017638|NCT04419506|69700485|FG001|Overall Study|Adverse Event|10|||
38017639|NCT04419506|69700486|FG002|Overall Study|Adverse Event|0|||
38017640|NCT04419506|69700487|FG003|Overall Study|Adverse Event|3|||
38017641|NCT04419506|69700484|FG000|Overall Study|Withdrawal by Subject|0|||
38017642|NCT04419506|69700485|FG001|Overall Study|Withdrawal by Subject|0|||
38017643|NCT04419506|69700486|FG002|Overall Study|Withdrawal by Subject|0|||
38017644|NCT04419506|69700487|FG003|Overall Study|Withdrawal by Subject|1|||
38017645|NCT04419506|69700484|FG000|Overall Study|poor-compliance|0|||
38017646|NCT04419506|69700485|FG001|Overall Study|poor-compliance|0|||
38017647|NCT04419506|69700486|FG002|Overall Study|poor-compliance|0|||
38017648|NCT04419506|69700487|FG003|Overall Study|poor-compliance|1|||
38017649|NCT03236506|69700500|FG000|Overall Study|Death|1|||
38017650|NCT03236506|69700501|FG001|Overall Study|Death|1|||
38017651|NCT03236506|69700502|FG002|Overall Study|Death|1|||
38017652|NCT03236506|69700500|FG000|Overall Study|Withdrawal by Subject|3|||
38017653|NCT03236506|69700501|FG001|Overall Study|Withdrawal by Subject|3|||
38017654|NCT03236506|69700502|FG002|Overall Study|Withdrawal by Subject|4|||
38017655|NCT03236506|69700500|FG000|Overall Study|Did not initiate treatment|2|||
38017656|NCT03236506|69700501|FG001|Overall Study|Did not initiate treatment|1|||
38017657|NCT03236506|69700502|FG002|Overall Study|Did not initiate treatment|2|||
38017658|NCT03227692|69700521|FG000|Overall Study|Protocol Violation|1|||
38017659|NCT03227692|69700522|FG001|Overall Study|Protocol Violation|1|||
38017660|NCT03227692|69700521|FG000|Overall Study|Lost to Follow-up|4|||
38017661|NCT03227692|69700522|FG001|Overall Study|Lost to Follow-up|2|||
38017662|NCT03227692|69700521|FG000|Overall Study|Adverse Event|0|||
38017663|NCT03227692|69700522|FG001|Overall Study|Adverse Event|2|||
38017664|NCT03210220|69700530|FG000|Overall Study|Physician Decision|1|||
38017665|NCT03210220|69700531|FG001|Overall Study|Physician Decision|0|||
38017666|NCT03209518|69700537|FG000|Overall Study|Case Report Forms Uncollected|1|||
38017667|NCT03209518|69700537|FG000|Overall Study|Protocol Deviation|1|||
38017668|NCT03725852|69700543|FG000|Overall Study|Death|1|||
38017669|NCT03725852|69700544|FG001|Overall Study|Death|0|||
38017670|NCT03725852|69700543|FG000|Overall Study|Withdrawal by Subject|1|||
38017671|NCT03725852|69700544|FG001|Overall Study|Withdrawal by Subject|0|||
38017672|NCT03725852|69700543|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
38017673|NCT03725852|69700544|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
38017674|NCT00304031|69700553|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
38017675|NCT00304031|69700554|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
38017676|NCT00304031|69700555|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
37832505|NCT01286077|69516082|FG001|Overall Study|refill medication not received in time|0|||
37910175|NCT00049517|69596166|FG005|Conditioning/Transplant|Alternative therapy|0|||
38017677|NCT00304031|69700553|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
38017678|NCT00304031|69700554|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
38017679|NCT00304031|69700555|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
38017680|NCT00304031|69700553|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
38017681|NCT00304031|69700554|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
38017682|NCT00304031|69700555|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
38017683|NCT00304031|69700553|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
38017684|NCT00304031|69700554|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
38017685|NCT00304031|69700555|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
38017686|NCT00304031|69700553|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
38017687|NCT00304031|69700554|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
38017688|NCT00304031|69700555|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
38017689|NCT00304031|69700553|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
38017690|NCT00304031|69700554|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
38017691|NCT00304031|69700555|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
38017692|NCT00304031|69700553|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
38017693|NCT00304031|69700554|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
38017694|NCT00304031|69700555|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
38017695|NCT00304031|69700553|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
38017696|NCT00304031|69700554|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
38017697|NCT00304031|69700555|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
38017698|NCT00304031|69700553|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
38017699|NCT00304031|69700554|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
38017700|NCT00304031|69700555|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
38017701|NCT00332189|69700570|FG000|Overall Study|Adverse Event|3|||
38017702|NCT00332189|69700570|FG000|Overall Study|Uncooperative/Noncompliant|3|||
38017703|NCT00332189|69700570|FG000|Overall Study|Withdrawal by Subject|9|||
38017704|NCT00332189|69700570|FG000|Overall Study|Lack of Efficacy|4|||
38017705|NCT00332189|69700570|FG000|Overall Study|Moved out of country|2|||
38017706|NCT00331799|69700575|FG000|Overall Study|Withdrawal by Subject|2|||
38017707|NCT00331799|69700575|FG000|Overall Study|Sedation|1|||
38017708|NCT00303719|69700581|FG000|Overall Study|Not evaluable, prior therapies|0|||
38017709|NCT00303719|69700582|FG001|Overall Study|Not evaluable, prior therapies|30|||
38017710|NCT00303719|69700581|FG000|Overall Study|Lost to Follow-up|0|||
38017711|NCT00303719|69700582|FG001|Overall Study|Lost to Follow-up|7|||
38017712|NCT00331409|69700589|FG000|Overall Study|Lack of Efficacy|4|||
38017713|NCT00303485|69700595|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
38017714|NCT00303485|69700596|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
38017715|NCT00303485|69700595|FG000|Overall Study|Failure to return|0|||
38017716|NCT00303485|69700596|FG001|Overall Study|Failure to return|1|||
38017717|NCT00303485|69700595|FG000|Overall Study|Withdrawal by Subject|1|||
38017718|NCT00303485|69700596|FG001|Overall Study|Withdrawal by Subject|0|||
38017719|NCT03235726|69700610|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
38017720|NCT03235726|69700611|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
38017721|NCT03235726|69700612|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
38017722|NCT03235726|69700613|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
38017723|NCT03235726|69700614|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
38017724|NCT03235726|69700615|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
38017725|NCT03235726|69700616|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
38017726|NCT03235726|69700617|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
38017727|NCT03235726|69700618|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
38017728|NCT03235726|69700619|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
38017729|NCT03235726|69700610|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
38017730|NCT03235726|69700611|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
38017731|NCT03235726|69700612|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
38017732|NCT03235726|69700613|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
38017733|NCT03235726|69700614|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
38017734|NCT03235726|69700615|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
38017735|NCT03235726|69700616|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
38017736|NCT03235726|69700617|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
38017737|NCT03235726|69700618|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
38017738|NCT03235726|69700619|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
38017739|NCT00303953|69700654|FG000|Overall Study|Ineligible|1|||
38017740|NCT00303953|69700654|FG000|Overall Study|Death|1|||
38017741|NCT00303953|69700654|FG000|Overall Study|Adverse Event|4|||
38017742|NCT00303953|69700654|FG000|Overall Study|Lack of Efficacy|12|||
38017743|NCT00303953|69700654|FG000|Overall Study|Physician Decision|1|||
38017744|NCT02935894|69700658|FG000|Overall Study|Subject dismissed|1|||
38017745|NCT03224182|69700664|FG000|Overall Study|Study Drug Not Instilled|6|||
38017746|NCT03224182|69700665|FG001|Overall Study|Study Drug Not Instilled|1|||
38017747|NCT03224182|69700664|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
38017748|NCT03224182|69700665|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
38017749|NCT03224182|69700664|FG000|Overall Study|Withdrew of Consent|4|||
38017750|NCT03224182|69700665|FG001|Overall Study|Withdrew of Consent|2|||
38017751|NCT03224182|69700664|FG000|Overall Study|Investigator Decision|3|||
38017752|NCT03224182|69700665|FG001|Overall Study|Investigator Decision|1|||
38017753|NCT03224182|69700664|FG000|Overall Study|Sponsor Decision|26|||
38017754|NCT03224182|69700665|FG001|Overall Study|Sponsor Decision|12|||
38017755|NCT03224182|69700664|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
38017756|NCT03224182|69700665|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
38017757|NCT03224182|69700664|FG000|Overall Study|Lost to Follow-up|1|||
38017758|NCT03224182|69700665|FG001|Overall Study|Lost to Follow-up|0|||
38017759|NCT03224182|69700664|FG000|Overall Study|Participant Had Recurrence|11|||
38017760|NCT03224182|69700665|FG001|Overall Study|Participant Had Recurrence|5|||
38017761|NCT03224182|69700664|FG000|Overall Study|Death|0|||
38017762|NCT03224182|69700665|FG001|Overall Study|Death|1|||
38017763|NCT03224182|69700664|FG000|Overall Study|Reason not Specified|3|||
38017764|NCT03224182|69700665|FG001|Overall Study|Reason not Specified|3|||
38017765|NCT03224182|69700664|FG000|Overall Study|Other|1|||
38017766|NCT03224182|69700665|FG001|Overall Study|Other|0|||
38017767|NCT02935192|69700673|FG000|Overall Study|Withdrawal by Subject|8|||
38017768|NCT02935192|69700674|FG001|Overall Study|Withdrawal by Subject|4|||
38017769|NCT03722264|69700680|FG000|Overall Study|Physician Decision|3|||
38017770|NCT03722030|69700688|FG000|Overall Study|Withdrawal by Subject|1|||
38017771|NCT03722030|69700689|FG001|Overall Study|Withdrawal by Subject|0|||
38017772|NCT03221842|69700696|FG000|Period 1 (Open-label)|Adverse Event|4|||
38017773|NCT03221842|69700697|FG001|Period 1 (Open-label)|Adverse Event|0|||
38017774|NCT03221842|69700696|FG000|Period 1 (Open-label)|Physician Decision|2|||
38017775|NCT03221842|69700697|FG001|Period 1 (Open-label)|Physician Decision|0|||
38017776|NCT03221842|69700696|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
38017777|NCT03221842|69700697|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
38017778|NCT03221842|69700696|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
38017779|NCT03221842|69700697|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
38017780|NCT03221842|69700696|FG000|Period 1 (Open-label)|Other|2|||
38017781|NCT03221842|69700697|FG001|Period 1 (Open-label)|Other|0|||
38017782|NCT03221842|69700696|FG000|Period 2 (Randomized, Blinded)|Death|0|||
38017783|NCT03221842|69700697|FG001|Period 2 (Randomized, Blinded)|Death|1|||
37832506|NCT01285960|69516088|FG000|Overall Study|Withdrawal by Subject|2|||
37832507|NCT01285960|69516088|FG000|Overall Study|Lost to Follow-up|2|||
37832508|NCT01285960|69516088|FG000|Overall Study|2 subjects received less 10 sonications|2|||
37832509|NCT01285609|69516099|FG000|Randomized|Progressive Disease|41|||
37832510|NCT01285609|69516100|FG001|Randomized|Progressive Disease|61|||
37832511|NCT01285609|69516099|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
37832512|NCT01285609|69516100|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
37910176|NCT00049517|69596161|FG000|Conditioning/Transplant|Other complicating disease|2|||
37910177|NCT00049517|69596162|FG001|Conditioning/Transplant|Other complicating disease|0|||
37910178|NCT00049517|69596163|FG002|Conditioning/Transplant|Other complicating disease|0|||
37910179|NCT00049517|69596164|FG003|Conditioning/Transplant|Other complicating disease|4|||
37910180|NCT00049517|69596165|FG004|Conditioning/Transplant|Other complicating disease|0|||
37910181|NCT00049517|69596166|FG005|Conditioning/Transplant|Other complicating disease|1|||
37910182|NCT00049517|69596161|FG000|Conditioning/Transplant|Reasons not reported|25|||
37910183|NCT00049517|69596162|FG001|Conditioning/Transplant|Reasons not reported|31|||
37910184|NCT00049517|69596163|FG002|Conditioning/Transplant|Reasons not reported|18|||
37910185|NCT00049517|69596164|FG003|Conditioning/Transplant|Reasons not reported|15|||
37910186|NCT00049517|69596165|FG004|Conditioning/Transplant|Reasons not reported|5|||
37910187|NCT00049517|69596166|FG005|Conditioning/Transplant|Reasons not reported|5|||
37910188|NCT00926783|69596176|FG000|Overall Study|Incomplete CFAE Procedures|3|||
37910189|NCT00926783|69596177|FG001|Overall Study|Incomplete CFAE Procedures|3|||
37910190|NCT00929669|69596183|FG000|Overall Study|elevated glucose levels|1|||
37910191|NCT00566995|69596187|FG000|Overall Study|Toxicity|4|||
37910192|NCT00566995|69596187|FG000|Overall Study|Withdrew consent|3|||
37910193|NCT00926393|69596193|FG000|Overall Study|Withdrawal by Subject|1|||
37910194|NCT00926393|69596194|FG001|Overall Study|Withdrawal by Subject|2|||
37910195|NCT00926393|69596193|FG000|Overall Study|Adverse Event|1|||
37910196|NCT00926393|69596194|FG001|Overall Study|Adverse Event|1|||
37832513|NCT01285609|69516099|FG000|Randomized|Study Drug Toxicity|13|||
37832514|NCT01285609|69516100|FG001|Randomized|Study Drug Toxicity|14|||
37832515|NCT01285609|69516099|FG000|Randomized|Death|5|||
37832516|NCT01285609|69516100|FG001|Randomized|Death|7|||
37832517|NCT01285609|69516099|FG000|Randomized|Withdrawal by Subject|8|||
37832518|NCT01285609|69516100|FG001|Randomized|Withdrawal by Subject|11|||
37910197|NCT00926237|69596200|FG000|Overall Study|Withdrawal by Subject|2|||
37910198|NCT00926237|69596201|FG001|Overall Study|Withdrawal by Subject|1|||
37910199|NCT00931463|69596213|FG000|Overall Study|Death|8|||
38017784|NCT03221842|69700696|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
38017785|NCT03221842|69700697|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
38017786|NCT03364738|69700707|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
38017787|NCT03364738|69700707|FG000|Overall Study|Withdrawal by Subject|1|||
38017788|NCT03364738|69700707|FG000|Overall Study|Adverse Event|1|||
38017789|NCT00303329|69700714|FG000|Overall Study|Adverse Event|7|||
38017790|NCT00303329|69700715|FG001|Overall Study|Adverse Event|14|||
37832519|NCT01285609|69516099|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
37832520|NCT01285609|69516100|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
37832521|NCT01285609|69516099|FG000|Randomized|Undisclosed Reasons|1|||
37832522|NCT01285609|69516100|FG001|Randomized|Undisclosed Reasons|0|||
37832523|NCT01285609|69516099|FG000|Randomized|Randomized but not Treated|4|||
37832524|NCT01285609|69516100|FG001|Randomized|Randomized but not Treated|4|||
37832525|NCT01285609|69516099|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
37832526|NCT01285609|69516100|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
37832527|NCT01285609|69516099|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
37832528|NCT01285609|69516100|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
37910200|NCT00931463|69596214|FG001|Overall Study|Death|4|||
37910201|NCT00931463|69596213|FG000|Overall Study|Withdrawal by Subject|5|||
37910202|NCT00931463|69596214|FG001|Overall Study|Withdrawal by Subject|0|||
37910203|NCT00931463|69596213|FG000|Overall Study|Lost to Follow-up|4|||
37910204|NCT00931463|69596214|FG001|Overall Study|Lost to Follow-up|1|||
37910205|NCT00929201|69596220|FG000|Period 1|Withdrawal by Subject|0|||
37910206|NCT00929201|69596221|FG001|Period 1|Withdrawal by Subject|1|||
37910207|NCT00926003|69596231|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
37910208|NCT00926003|69596232|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
37910209|NCT00926003|69596233|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
37910210|NCT00926003|69596231|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
37910211|NCT00926003|69596232|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
37910212|NCT00926003|69596233|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
37910213|NCT00928889|69596243|FG000|Overall Study|Lost to Follow-up|3|||
37910214|NCT00928889|69596244|FG001|Overall Study|Lost to Follow-up|1|||
37910215|NCT00928889|69596243|FG000|Overall Study|Protocol Violation|0|||
37910216|NCT00928889|69596244|FG001|Overall Study|Protocol Violation|1|||
37910217|NCT00928889|69596243|FG000|Overall Study|Adverse Event|1|||
37910218|NCT00928889|69596244|FG001|Overall Study|Adverse Event|0|||
37910219|NCT00928889|69596243|FG000|Overall Study|Other|1|||
37910220|NCT00928889|69596244|FG001|Overall Study|Other|0|||
37910221|NCT03978091|69596256|FG000|Overall Study|Lost to Follow-up|0|||
37910222|NCT03978091|69596257|FG001|Overall Study|Lost to Follow-up|0|||
37910223|NCT03978091|69596258|FG002|Overall Study|Lost to Follow-up|1|||
37910224|NCT03978091|69596259|FG003|Overall Study|Lost to Follow-up|0|||
37910225|NCT03978091|69596260|FG004|Overall Study|Lost to Follow-up|0|||
37910226|NCT03978091|69596261|FG005|Overall Study|Lost to Follow-up|0|||
37910227|NCT03978091|69596256|FG000|Overall Study|Withdrawal by Subject|0|||
37832529|NCT01285609|69516099|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
37832530|NCT01285609|69516100|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
37832531|NCT01285609|69516099|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
37832532|NCT01285609|69516100|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
37832533|NCT01285609|69516099|FG000|Treated With Blinded Therapy|Death|11|||
37832534|NCT01285609|69516100|FG001|Treated With Blinded Therapy|Death|3|||
37832535|NCT01285609|69516099|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
37832536|NCT01285609|69516100|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
37910228|NCT03978091|69596257|FG001|Overall Study|Withdrawal by Subject|0|||
37910229|NCT03978091|69596258|FG002|Overall Study|Withdrawal by Subject|0|||
37910230|NCT03978091|69596259|FG003|Overall Study|Withdrawal by Subject|1|||
37910231|NCT03978091|69596260|FG004|Overall Study|Withdrawal by Subject|1|||
37910232|NCT03978091|69596261|FG005|Overall Study|Withdrawal by Subject|0|||
37910233|NCT00564733|69596284|FG000|Overall Study|Withdrawal by Subject|4|||
37910234|NCT00564733|69596284|FG000|Overall Study|Ineligible|5|||
37910235|NCT00931385|69596288|FG000|Overall Study|Adverse Event|2|||
37910236|NCT00931385|69596289|FG001|Overall Study|Adverse Event|1|||
37698501|NCT02431247|69175255|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
37698502|NCT02431247|69175253|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
37910237|NCT00931385|69596290|FG002|Overall Study|Adverse Event|0|||
37910238|NCT00931385|69596291|FG003|Overall Study|Adverse Event|3|||
37910239|NCT00931385|69596288|FG000|Overall Study|Protocol Violation|0|||
37910240|NCT00931385|69596289|FG001|Overall Study|Protocol Violation|0|||
37910241|NCT00931385|69596290|FG002|Overall Study|Protocol Violation|1|||
37910242|NCT00931385|69596291|FG003|Overall Study|Protocol Violation|0|||
37698503|NCT02431247|69175254|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
37698504|NCT02431247|69175255|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
37698505|NCT02431247|69175253|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
37698506|NCT02431247|69175254|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
37698507|NCT02431247|69175255|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
37910243|NCT00931385|69596288|FG000|Overall Study|Withdrawal by Subject|0|||
37832537|NCT01285609|69516099|FG000|Treated With Blinded Therapy|Not Reported|0|||
37832538|NCT01285609|69516100|FG001|Treated With Blinded Therapy|Not Reported|2|||
37832539|NCT01285609|69516099|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
37832540|NCT01285609|69516100|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
37910244|NCT00931385|69596289|FG001|Overall Study|Withdrawal by Subject|1|||
37910245|NCT00931385|69596290|FG002|Overall Study|Withdrawal by Subject|0|||
38017791|NCT00303329|69700714|FG000|Overall Study|Abnormal Laboratory Values|0|||
38017792|NCT00303329|69700715|FG001|Overall Study|Abnormal Laboratory Values|1|||
38017793|NCT00303329|69700714|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
38017794|NCT00303329|69700715|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
38017795|NCT00303329|69700714|FG000|Overall Study|Condition no longer requires study drug|0|||
38017796|NCT00303329|69700715|FG001|Overall Study|Condition no longer requires study drug|8|||
38017797|NCT00303329|69700714|FG000|Overall Study|Protocol Violation|3|||
38017798|NCT00303329|69700715|FG001|Overall Study|Protocol Violation|0|||
38017799|NCT00303329|69700714|FG000|Overall Study|Withdrawal by Subject|9|||
38017800|NCT00303329|69700715|FG001|Overall Study|Withdrawal by Subject|15|||
38017801|NCT00303329|69700714|FG000|Overall Study|Lost to Follow-up|0|||
38017802|NCT00303329|69700715|FG001|Overall Study|Lost to Follow-up|1|||
38017803|NCT00303329|69700714|FG000|Overall Study|Administrative problems|1|||
38017804|NCT00303329|69700715|FG001|Overall Study|Administrative problems|0|||
38017805|NCT00303329|69700714|FG000|Overall Study|Death|2|||
38017806|NCT00303329|69700715|FG001|Overall Study|Death|12|||
38017807|NCT00303329|69700714|FG000|Overall Study|Stopped at end of core|3|||
38017808|NCT00303329|69700715|FG001|Overall Study|Stopped at end of core|9|||
38017809|NCT00303329|69700714|FG000|Overall Study|Stopped at end of extension 1|1|||
38017810|NCT00303329|69700715|FG001|Overall Study|Stopped at end of extension 1|0|||
38017811|NCT00329849|69700723|FG000|Overall Study|Withdrawal by Subject|6|||
38017812|NCT00329849|69700724|FG001|Overall Study|Withdrawal by Subject|4|||
38017813|NCT02934178|69700736|FG000|Received Vaccination 2|Death|0|||
38017814|NCT02934178|69700737|FG001|Received Vaccination 2|Death|1|||
38017815|NCT02934178|69700736|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
38017816|NCT02934178|69700737|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
38017817|NCT00329303|69700746|FG000|Overall Study|Lack of Efficacy|1|||
38017818|NCT00329303|69700747|FG001|Overall Study|Lack of Efficacy|0|||
38017819|NCT00329303|69700746|FG000|Overall Study|Decision of the sponsor|0|||
38017820|NCT00329303|69700747|FG001|Overall Study|Decision of the sponsor|1|||
38017821|NCT00329303|69700746|FG000|Overall Study|Patient no longer available|1|||
38017822|NCT00329303|69700747|FG001|Overall Study|Patient no longer available|0|||
38017823|NCT00329303|69700746|FG000|Overall Study|Patient relocated|0|||
38017824|NCT00329303|69700747|FG001|Overall Study|Patient relocated|1|||
38017825|NCT03216850|69700754|FG000|Overall Study|Pre-analytical error|6|||
38017826|NCT00302159|69700758|FG000|Overall Study|pt declined before treatment started|1|||
38017827|NCT00302159|69700758|FG000|Overall Study|pt started Avastin|1|||
38017828|NCT00302081|69700766|FG000|Overall Study|Adverse Event|6|||
38017829|NCT00302081|69700767|FG001|Overall Study|Adverse Event|5|||
38017830|NCT00302081|69700768|FG002|Overall Study|Adverse Event|4|||
38017831|NCT00302081|69700766|FG000|Overall Study|Lost to Follow-up|21|||
38017832|NCT00302081|69700767|FG001|Overall Study|Lost to Follow-up|18|||
38017833|NCT00302081|69700768|FG002|Overall Study|Lost to Follow-up|28|||
38017834|NCT00302081|69700766|FG000|Overall Study|Withdrawal by Subject|8|||
38017835|NCT00302081|69700767|FG001|Overall Study|Withdrawal by Subject|12|||
38017836|NCT00302081|69700768|FG002|Overall Study|Withdrawal by Subject|8|||
38017837|NCT00302081|69700766|FG000|Overall Study|Protocol Violation|5|||
38017838|NCT00302081|69700767|FG001|Overall Study|Protocol Violation|1|||
38017839|NCT00302081|69700768|FG002|Overall Study|Protocol Violation|2|||
38017840|NCT00302081|69700766|FG000|Overall Study|Lack of Efficacy|1|||
38017841|NCT00302081|69700767|FG001|Overall Study|Lack of Efficacy|0|||
38017842|NCT00302081|69700768|FG002|Overall Study|Lack of Efficacy|5|||
38017843|NCT00302081|69700766|FG000|Overall Study|Death|2|||
38017844|NCT00302081|69700767|FG001|Overall Study|Death|1|||
38017845|NCT00302081|69700768|FG002|Overall Study|Death|0|||
38017846|NCT00302081|69700766|FG000|Overall Study|Other|13|||
38017847|NCT00302081|69700767|FG001|Overall Study|Other|6|||
38017848|NCT00302081|69700768|FG002|Overall Study|Other|5|||
38017849|NCT00302003|69700776|FG000|Overall Study|Lack of Efficacy|62|||
38017850|NCT00302003|69700776|FG000|Overall Study|Lost to Follow-up|1|||
38017851|NCT00302003|69700776|FG000|Overall Study|Physician Decision|2|||
38017852|NCT00302003|69700776|FG000|Overall Study|Withdrawal by Subject|5|||
38017853|NCT00302003|69700776|FG000|Overall Study|Ineligible|9|||
38017854|NCT00302003|69700776|FG000|Overall Study|Protocol Violation|1|||
38017855|NCT00036270|69700782|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
38017856|NCT00036270|69700783|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
37910246|NCT00931385|69596291|FG003|Overall Study|Withdrawal by Subject|1|||
38017857|NCT00036270|69700782|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
38017858|NCT00036270|69700783|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
38017859|NCT00036270|69700782|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
38017860|NCT00036270|69700783|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
38017861|NCT00036270|69700782|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
38017862|NCT00036270|69700783|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
38017863|NCT00036270|69700782|FG000|Study Treatment to 5 Year Report|Other|277|||
38017864|NCT00036270|69700783|FG001|Study Treatment to 5 Year Report|Other|288|||
38017865|NCT00036270|69700782|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
38017866|NCT00036270|69700783|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
38017867|NCT00036270|69700782|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
38017868|NCT00036270|69700783|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
38017869|NCT00036270|69700782|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
38017870|NCT00036270|69700783|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
38017871|NCT00036270|69700782|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
38017872|NCT00036270|69700783|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
38017873|NCT00036270|69700782|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
38017874|NCT00036270|69700783|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
38017875|NCT00036270|69700782|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
38017876|NCT00036270|69700783|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
37910247|NCT00931385|69596288|FG000|Overall Study|Lost to Follow-up|0|||
37910248|NCT00931385|69596289|FG001|Overall Study|Lost to Follow-up|0|||
38017877|NCT00301067|69700789|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
38017878|NCT00301067|69700790|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
38017879|NCT00301067|69700791|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
38017880|NCT00301067|69700792|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
38017881|NCT00301067|69700789|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
38017882|NCT00301067|69700790|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
38017883|NCT00301067|69700791|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
38017884|NCT00301067|69700792|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
38017885|NCT00301067|69700789|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
38017886|NCT00301067|69700790|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
38017887|NCT00301067|69700791|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
38017888|NCT00301067|69700792|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
38017889|NCT00301067|69700789|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
38017890|NCT00301067|69700790|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
38017891|NCT00301067|69700791|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
38017892|NCT00301067|69700792|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
37910249|NCT00931385|69596290|FG002|Overall Study|Lost to Follow-up|0|||
37910250|NCT00931385|69596291|FG003|Overall Study|Lost to Follow-up|1|||
37910251|NCT00565747|69596307|FG000|Overall Study|No embryo transfer|67|||
37910252|NCT00565747|69596308|FG001|Overall Study|No embryo transfer|73|||
37910253|NCT00563797|69596316|FG000|Overall Study|Lost to Follow-up|7|||
37910254|NCT00563797|69596317|FG001|Overall Study|Lost to Follow-up|2|||
37910255|NCT00771927|69596336|FG000|Overall Study|Adverse Event|100|||
37910256|NCT00771927|69596337|FG001|Overall Study|Adverse Event|105|||
37910257|NCT00771927|69596336|FG000|Overall Study|Lack of Efficacy|70|||
37910258|NCT00771927|69596337|FG001|Overall Study|Lack of Efficacy|42|||
37910259|NCT00771927|69596336|FG000|Overall Study|Lost to Follow-up|46|||
37910260|NCT00771927|69596337|FG001|Overall Study|Lost to Follow-up|46|||
37910261|NCT00771927|69596336|FG000|Overall Study|Withdrawal by Subject|16|||
37910262|NCT00771927|69596337|FG001|Overall Study|Withdrawal by Subject|17|||
37910263|NCT00771927|69596336|FG000|Overall Study|Other reason|23|||
37910264|NCT00771927|69596337|FG001|Overall Study|Other reason|27|||
37910265|NCT00771849|69596345|FG000|Overall Study|Lost to Follow-up|1|||
37910266|NCT00771849|69596346|FG001|Overall Study|Lost to Follow-up|2|||
37910267|NCT00771849|69596345|FG000|Overall Study|Withdrawal by Subject|1|||
37910268|NCT00771849|69596346|FG001|Overall Study|Withdrawal by Subject|1|||
37910269|NCT00771849|69596345|FG000|Overall Study|Not vaccinated|0|||
37910270|NCT00771849|69596346|FG001|Overall Study|Not vaccinated|1|||
37910271|NCT00564889|69596352|FG000|Overall Study|Death|7|||
37910272|NCT00564889|69596352|FG000|Overall Study|Adverse Event|12|||
37910273|NCT00564889|69596352|FG000|Overall Study|Alternative treatment|3|||
37910274|NCT00564889|69596352|FG000|Overall Study|Disease progression|3|||
37910275|NCT00564889|69596352|FG000|Overall Study|Other, not specified|4|||
38017893|NCT00301067|69700789|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
38017894|NCT00301067|69700790|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
38017895|NCT00301067|69700791|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
38017896|NCT00301067|69700792|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
38017897|NCT00301067|69700789|FG000|Follow up Until Death|Alive at last data cut point|1|||
38017898|NCT00301067|69700790|FG001|Follow up Until Death|Alive at last data cut point|0|||
37910276|NCT00560833|69596370|FG000|Overall Study|Adverse Event|16|||
37910277|NCT00560833|69596371|FG001|Overall Study|Adverse Event|10|||
37910278|NCT00560833|69596372|FG002|Overall Study|Adverse Event|25|||
37910279|NCT00560833|69596373|FG003|Overall Study|Adverse Event|23|||
37910280|NCT00560833|69596374|FG004|Overall Study|Adverse Event|35|||
37910281|NCT00560833|69596370|FG000|Overall Study|Lost to Follow-up|0|||
38017899|NCT00301067|69700791|FG002|Follow up Until Death|Alive at last data cut point|0|||
38017900|NCT00301067|69700792|FG003|Follow up Until Death|Alive at last data cut point|1|||
38017901|NCT00007020|69700803|FG000|Overall Study|Death|16|||
38017902|NCT00007020|69700803|FG000|Overall Study|Lost to Follow-up|13|||
38017903|NCT00007020|69700803|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
38017904|NCT00007020|69700803|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
38017905|NCT00007020|69700803|FG000|Overall Study|Pt cared for by outside physician|4|||
38017906|NCT00007020|69700803|FG000|Overall Study|No evidence of treatment|6|||
38017907|NCT00300755|69700812|FG000|Overall Study|Adverse Event|1|||
38017908|NCT00300755|69700813|FG001|Overall Study|Adverse Event|2|||
38017909|NCT00300755|69700814|FG002|Overall Study|Adverse Event|1|||
38017910|NCT00300755|69700812|FG000|Overall Study|Withdrawal by Subject|0|||
38017911|NCT00300755|69700813|FG001|Overall Study|Withdrawal by Subject|2|||
38017912|NCT00300755|69700814|FG002|Overall Study|Withdrawal by Subject|0|||
38017913|NCT00300755|69700812|FG000|Overall Study|Protocol Violation|0|||
38017914|NCT00300755|69700813|FG001|Overall Study|Protocol Violation|0|||
38017915|NCT00300755|69700814|FG002|Overall Study|Protocol Violation|1|||
38017916|NCT00033540|69700822|FG000|Overall Study|Adverse Event|14|||
38017917|NCT00033540|69700822|FG000|Overall Study|Death|1|||
38017918|NCT00033540|69700822|FG000|Overall Study|Progression|26|||
38017919|NCT00033540|69700822|FG000|Overall Study|Withdrawal by Subject|6|||
38017920|NCT00033540|69700822|FG000|Overall Study|Other|5|||
38017921|NCT00033540|69700822|FG000|Overall Study|Ineligible|3|||
38017922|NCT00033540|69700822|FG000|Overall Study|Never received treatment|2|||
38017923|NCT00300365|69700829|FG000|Overall Study|Lost to Follow-up|1|||
38017924|NCT00300365|69700830|FG001|Overall Study|Lost to Follow-up|0|||
38017925|NCT00300365|69700829|FG000|Overall Study|Physician Decision|2|||
38017926|NCT00300365|69700830|FG001|Overall Study|Physician Decision|0|||
38017927|NCT00300365|69700829|FG000|Overall Study|Withdrawal by Subject|1|||
38017928|NCT00300365|69700830|FG001|Overall Study|Withdrawal by Subject|0|||
38017929|NCT00300365|69700829|FG000|Overall Study|Adverse Event|0|||
38017930|NCT00300365|69700830|FG001|Overall Study|Adverse Event|2|||
38017931|NCT00048048|69700845|FG000|Core Treatment|Withdrawal by Subject|0|||
38017932|NCT00048048|69700846|FG001|Core Treatment|Withdrawal by Subject|0|||
38017933|NCT00048048|69700847|FG002|Core Treatment|Withdrawal by Subject|1|||
38017934|NCT00048048|69700848|FG003|Core Treatment|Withdrawal by Subject|0|||
38017935|NCT00048048|69700849|FG004|Core Treatment|Withdrawal by Subject|0|||
38017936|NCT00048048|69700850|FG005|Core Treatment|Withdrawal by Subject|0|||
38017937|NCT00048048|69700851|FG006|Core Treatment|Withdrawal by Subject|0|||
38017938|NCT00048048|69700852|FG007|Core Treatment|Withdrawal by Subject|0|||
38017939|NCT00048048|69700853|FG008|Core Treatment|Withdrawal by Subject|0|||
38017940|NCT00048048|69700854|FG009|Core Treatment|Withdrawal by Subject|0|||
38017941|NCT00048048|69700855|FG010|Core Treatment|Withdrawal by Subject|0|||
38017942|NCT00048048|69700856|FG011|Core Treatment|Withdrawal by Subject|0|||
38017943|NCT00048048|69700845|FG000|Core Treatment|Adverse Event|0|||
38017944|NCT00048048|69700846|FG001|Core Treatment|Adverse Event|0|||
38017945|NCT00048048|69700847|FG002|Core Treatment|Adverse Event|0|||
38017946|NCT00048048|69700848|FG003|Core Treatment|Adverse Event|0|||
38017947|NCT00048048|69700849|FG004|Core Treatment|Adverse Event|0|||
38017948|NCT00048048|69700850|FG005|Core Treatment|Adverse Event|0|||
38017949|NCT00048048|69700851|FG006|Core Treatment|Adverse Event|0|||
38017950|NCT00048048|69700852|FG007|Core Treatment|Adverse Event|1|||
38017951|NCT00048048|69700853|FG008|Core Treatment|Adverse Event|0|||
38017952|NCT00048048|69700854|FG009|Core Treatment|Adverse Event|0|||
38017953|NCT00048048|69700855|FG010|Core Treatment|Adverse Event|0|||
38017954|NCT00048048|69700856|FG011|Core Treatment|Adverse Event|0|||
38017955|NCT00048048|69700845|FG000|Extension Year 1|Early withdrawals|0|||
38017956|NCT00048048|69700846|FG001|Extension Year 1|Early withdrawals|0|||
38017957|NCT00048048|69700847|FG002|Extension Year 1|Early withdrawals|0|||
38017958|NCT00048048|69700848|FG003|Extension Year 1|Early withdrawals|0|||
37698508|NCT02431247|69175253|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
38017959|NCT00048048|69700849|FG004|Extension Year 1|Early withdrawals|0|||
38017960|NCT00048048|69700850|FG005|Extension Year 1|Early withdrawals|0|||
38017961|NCT00048048|69700851|FG006|Extension Year 1|Early withdrawals|0|||
38017962|NCT00048048|69700852|FG007|Extension Year 1|Early withdrawals|0|||
38017963|NCT00048048|69700853|FG008|Extension Year 1|Early withdrawals|0|||
38017964|NCT00048048|69700854|FG009|Extension Year 1|Early withdrawals|2|||
38017965|NCT00048048|69700855|FG010|Extension Year 1|Early withdrawals|2|||
38017966|NCT00048048|69700856|FG011|Extension Year 1|Early withdrawals|4|||
37910282|NCT00560833|69596371|FG001|Overall Study|Lost to Follow-up|0|||
38017967|NCT00048048|69700845|FG000|Extension Year 2|Early withdrawals|0|||
38017968|NCT00048048|69700846|FG001|Extension Year 2|Early withdrawals|0|||
38017969|NCT00048048|69700847|FG002|Extension Year 2|Early withdrawals|0|||
38017970|NCT00048048|69700848|FG003|Extension Year 2|Early withdrawals|0|||
38017971|NCT00048048|69700849|FG004|Extension Year 2|Early withdrawals|0|||
38017972|NCT00048048|69700850|FG005|Extension Year 2|Early withdrawals|0|||
38017973|NCT00048048|69700851|FG006|Extension Year 2|Early withdrawals|0|||
37832541|NCT01285609|69516099|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
37832542|NCT01285609|69516100|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
37832543|NCT01285609|69516099|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
37832544|NCT01285609|69516100|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
37832545|NCT01285609|69516099|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
37832546|NCT01285609|69516100|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
37832547|NCT01285609|69516099|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
37832548|NCT01285609|69516100|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
37832549|NCT01285609|69516099|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
37832550|NCT01285609|69516100|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
37832551|NCT01285609|69516099|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
37832552|NCT01285609|69516100|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
37832553|NCT01285609|69516099|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
37832554|NCT01285609|69516100|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
37832555|NCT01285609|69516099|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
37832556|NCT01285609|69516100|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
37832557|NCT01285609|69516099|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
37832558|NCT01285609|69516100|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
37832559|NCT01285492|69516110|FG000|Overall Study|Adverse Event|11|||
37832560|NCT01285492|69516111|FG001|Overall Study|Adverse Event|0|||
37832561|NCT01285492|69516110|FG000|Overall Study|Protocol Violation|3|||
37832562|NCT01285492|69516111|FG001|Overall Study|Protocol Violation|0|||
37832563|NCT01285492|69516110|FG000|Overall Study|Withdrawal by Subject|2|||
37832564|NCT01285492|69516111|FG001|Overall Study|Withdrawal by Subject|1|||
37832565|NCT01285492|69516110|FG000|Overall Study|Death|1|||
37832566|NCT01285492|69516111|FG001|Overall Study|Death|0|||
37832567|NCT01284634|69516121|FG000|Overall Study|Adverse Event|1|||
37832568|NCT01284634|69516122|FG001|Overall Study|Adverse Event|0|||
37832569|NCT01284634|69516123|FG002|Overall Study|Adverse Event|2|||
37832570|NCT01284634|69516124|FG003|Overall Study|Adverse Event|1|||
37832571|NCT01284361|69516134|FG000|Overall Study|Withdrawal by Subject|1|||
37832572|NCT01284361|69516134|FG000|Overall Study|Protocol Violation|5|||
37832573|NCT01284361|69516134|FG000|Overall Study|Adverse Event|1|||
37832574|NCT01284361|69516134|FG000|Overall Study|Lost to Follow-up|2|||
37832575|NCT01284127|69516141|FG000|Overall Study|Adverse Event|2|||
37832576|NCT01284127|69516141|FG000|Overall Study|Withdrawal by Subject|4|||
37832577|NCT01284127|69516141|FG000|Overall Study|Physician Decision|1|||
37832578|NCT01283971|69516147|FG000|Overall Study|Adverse Event|3|||
37832579|NCT01283971|69516148|FG001|Overall Study|Adverse Event|5|||
37832580|NCT01283971|69516147|FG000|Overall Study|Insufficient therapeutic responses|3|||
37832581|NCT01283971|69516148|FG001|Overall Study|Insufficient therapeutic responses|3|||
37832582|NCT01283971|69516147|FG000|Overall Study|Protocol Violation|5|||
37832583|NCT01283971|69516148|FG001|Overall Study|Protocol Violation|1|||
37832584|NCT01283971|69516147|FG000|Overall Study|Refused treatment|3|||
37832585|NCT01283971|69516148|FG001|Overall Study|Refused treatment|1|||
37832586|NCT01283971|69516147|FG000|Overall Study|Failure to return|0|||
37832587|NCT01283971|69516148|FG001|Overall Study|Failure to return|1|||
37832588|NCT01283971|69516147|FG000|Overall Study|Administrative reasons|1|||
37832589|NCT01283971|69516148|FG001|Overall Study|Administrative reasons|1|||
37832590|NCT01283581|69516157|FG000|Overall Study|Lost to Follow-up|8|||
37832591|NCT01283581|69516158|FG001|Overall Study|Lost to Follow-up|6|||
37832592|NCT01283581|69516159|FG002|Overall Study|Lost to Follow-up|8|||
37832593|NCT01283581|69516157|FG000|Overall Study|Withdrawal by Subject|2|||
37832594|NCT01283581|69516158|FG001|Overall Study|Withdrawal by Subject|5|||
38017974|NCT00048048|69700852|FG007|Extension Year 2|Early withdrawals|0|||
38017975|NCT00048048|69700853|FG008|Extension Year 2|Early withdrawals|0|||
38017976|NCT00048048|69700854|FG009|Extension Year 2|Early withdrawals|0|||
38017977|NCT00048048|69700855|FG010|Extension Year 2|Early withdrawals|4|||
38017978|NCT00048048|69700856|FG011|Extension Year 2|Early withdrawals|2|||
38017979|NCT00300053|69700886|FG000|Overall Study|Patient/Caregiver Preference|2|||
38017980|NCT00300053|69700887|FG001|Overall Study|Patient/Caregiver Preference|2|||
38017981|NCT00300053|69700888|FG002|Overall Study|Patient/Caregiver Preference|3|||
38017982|NCT00300053|69700886|FG000|Overall Study|Death|0|||
38017983|NCT00300053|69700887|FG001|Overall Study|Death|0|||
38017984|NCT00300053|69700888|FG002|Overall Study|Death|3|||
38017985|NCT00300053|69700886|FG000|Overall Study|Lost to Follow-up|0|||
38017986|NCT00300053|69700887|FG001|Overall Study|Lost to Follow-up|1|||
38017987|NCT00300053|69700888|FG002|Overall Study|Lost to Follow-up|0|||
38017988|NCT00299975|69700900|FG000|Overall Study|Adverse Event|1|||
38017989|NCT00299975|69700901|FG001|Overall Study|Adverse Event|0|||
38017990|NCT00299975|69700902|FG002|Overall Study|Adverse Event|2|||
38017991|NCT00299975|69700900|FG000|Overall Study|Pregnancy|0|||
38017992|NCT00299975|69700901|FG001|Overall Study|Pregnancy|0|||
38017993|NCT00299975|69700902|FG002|Overall Study|Pregnancy|1|||
38017994|NCT00299975|69700900|FG000|Overall Study|Lack of Efficacy|1|||
38017995|NCT00299975|69700901|FG001|Overall Study|Lack of Efficacy|0|||
38017996|NCT00299975|69700902|FG002|Overall Study|Lack of Efficacy|1|||
38017997|NCT00299975|69700900|FG000|Overall Study|Lost to Follow-up|1|||
38017998|NCT00299975|69700901|FG001|Overall Study|Lost to Follow-up|0|||
38017999|NCT00299975|69700902|FG002|Overall Study|Lost to Follow-up|0|||
38018000|NCT00299975|69700900|FG000|Overall Study|Withdrawal by Subject|0|||
38018001|NCT00299975|69700901|FG001|Overall Study|Withdrawal by Subject|1|||
38018002|NCT00299975|69700902|FG002|Overall Study|Withdrawal by Subject|3|||
38018003|NCT00299975|69700900|FG000|Overall Study|Physician Decision|0|||
38018004|NCT00299975|69700901|FG001|Overall Study|Physician Decision|0|||
38018005|NCT00299975|69700902|FG002|Overall Study|Physician Decision|1|||
38018006|NCT00004980|69700912|FG000|Overall Study|Withdrawal by Subject|1|||
38018007|NCT00004980|69700913|FG001|Overall Study|Withdrawal by Subject|0|||
38018008|NCT00004980|69700912|FG000|Overall Study|memory difficulties|1|||
38018009|NCT00004980|69700913|FG001|Overall Study|memory difficulties|1|||
38018010|NCT00004980|69700912|FG000|Overall Study|Physician Decision|0|||
38018011|NCT00004980|69700913|FG001|Overall Study|Physician Decision|1|||
38018012|NCT00326963|69700919|FG000|Overall Study|Adverse Event|2|||
38018013|NCT00326963|69700919|FG000|Overall Study|Injection site reaction|1|||
38018014|NCT00326963|69700919|FG000|Overall Study|Death|1|||
38018015|NCT00326963|69700919|FG000|Overall Study|Failure to return|10|||
38018016|NCT00326963|69700919|FG000|Overall Study|Withdrawal by Subject|10|||
37910283|NCT00560833|69596372|FG002|Overall Study|Lost to Follow-up|1|||
38018017|NCT00326963|69700919|FG000|Overall Study|Refused treatment / did not cooperate|5|||
38018018|NCT00326963|69700919|FG000|Overall Study|Violation of selection criteria at entry|2|||
38018019|NCT00326963|69700919|FG000|Overall Study|Other protocol violation|1|||
38018020|NCT00326963|69700919|FG000|Overall Study|Administrative / other|1|||
38018021|NCT00326885|69700924|FG000|Overall Study|Adverse Event|1|||
38018022|NCT00326885|69700924|FG000|Overall Study|Withdrawal by Subject|3|||
38018023|NCT00326885|69700924|FG000|Overall Study|Physician Decision|1|||
38018024|NCT00326885|69700924|FG000|Overall Study|Hospice withdrew consent|2|||
38018025|NCT00326495|69700929|FG000|Overall Study|Switched to alternative treatment|1|||
38018026|NCT00326495|69700929|FG000|Overall Study|Disease progression before treatment|1|||
38018027|NCT00326495|69700929|FG000|Overall Study|Refused further treatment|2|||
38018028|NCT00326495|69700929|FG000|Overall Study|Subject off study before assessment|1|||
38018029|NCT00326417|69700935|FG000|Overall Study|Withdrawal by Subject|0|||
38018030|NCT00326417|69700936|FG001|Overall Study|Withdrawal by Subject|0|||
38018031|NCT00326417|69700937|FG002|Overall Study|Withdrawal by Subject|1|||
38018032|NCT00326417|69700938|FG003|Overall Study|Withdrawal by Subject|0|||
38018033|NCT00326417|69700935|FG000|Overall Study|Arm Closed|7|||
38018034|NCT00326417|69700936|FG001|Overall Study|Arm Closed|0|||
38018035|NCT00326417|69700937|FG002|Overall Study|Arm Closed|0|||
38018036|NCT00326417|69700938|FG003|Overall Study|Arm Closed|3|||
38018037|NCT00326417|69700935|FG000|Overall Study|Death|7|||
38018038|NCT00326417|69700936|FG001|Overall Study|Death|0|||
38018039|NCT00326417|69700937|FG002|Overall Study|Death|0|||
38018040|NCT00326417|69700938|FG003|Overall Study|Death|0|||
38018041|NCT03825341|69700948|FG000|Overall Study|Withdrawal by Subject|0|||
38018042|NCT03825341|69700949|FG001|Overall Study|Withdrawal by Subject|1|||
38018043|NCT00297479|69700960|FG000|Overall Study|Lost to Follow-up|37|||
38018044|NCT00297479|69700961|FG001|Overall Study|Lost to Follow-up|54|||
38018045|NCT00297479|69700962|FG002|Overall Study|Lost to Follow-up|51|||
38018046|NCT00688870|69700972|FG000|Infant Series|Parent or legal guardian request|4|||
38018047|NCT00688870|69700973|FG001|Infant Series|Parent or legal guardian request|0|||
38018048|NCT00297167|69700983|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
38018049|NCT00297167|69700984|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
38018050|NCT00297167|69700985|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
38018051|NCT00297167|69700983|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
38018052|NCT00297167|69700984|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
38018053|NCT00297167|69700985|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
38018054|NCT03216226|69700994|FG000|Overall Study|Adverse Event|3|||
38018055|NCT03216226|69700995|FG001|Overall Study|Adverse Event|0|||
38018056|NCT03216226|69700994|FG000|Overall Study|Protocol Violation|1|||
38018057|NCT03216226|69700995|FG001|Overall Study|Protocol Violation|3|||
38018058|NCT03216226|69700994|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
38018059|NCT03216226|69700995|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
38018060|NCT03216226|69700994|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
38018061|NCT03216226|69700995|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
38018062|NCT03216226|69700994|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
38018063|NCT03216226|69700995|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
38018064|NCT03215758|69701003|FG000|Overall Study|Technical Problems|1|||
38018065|NCT03215758|69701004|FG001|Overall Study|Technical Problems|0|||
38018066|NCT03215758|69701003|FG000|Overall Study|Protocol deviation|0|||
38018067|NCT03215758|69701004|FG001|Overall Study|Protocol deviation|1|||
38018068|NCT03215758|69701003|FG000|Overall Study|Physician Decision|0|||
38018069|NCT03215758|69701004|FG001|Overall Study|Physician Decision|1|||
38018070|NCT03215758|69701003|FG000|Overall Study|Death|0|||
38018071|NCT03215758|69701004|FG001|Overall Study|Death|1|||
38018072|NCT03215758|69701003|FG000|Overall Study|Adverse Event|1|||
38018073|NCT03215758|69701004|FG001|Overall Study|Adverse Event|2|||
38018074|NCT03215758|69701003|FG000|Overall Study|Subject/Guardian Decision|3|||
38018075|NCT03215758|69701004|FG001|Overall Study|Subject/Guardian Decision|3|||
38018076|NCT00290771|69701012|FG000|Overall Study|Disease progression|95|||
38018077|NCT00290771|69701013|FG001|Overall Study|Disease progression|73|||
37910284|NCT00560833|69596373|FG003|Overall Study|Lost to Follow-up|0|||
37910285|NCT00560833|69596374|FG004|Overall Study|Lost to Follow-up|0|||
37910286|NCT00560833|69596370|FG000|Overall Study|Lack of Efficacy|22|||
37910287|NCT00560833|69596371|FG001|Overall Study|Lack of Efficacy|9|||
37910288|NCT00560833|69596372|FG002|Overall Study|Lack of Efficacy|6|||
37910289|NCT00560833|69596373|FG003|Overall Study|Lack of Efficacy|4|||
37910290|NCT00560833|69596374|FG004|Overall Study|Lack of Efficacy|4|||
37910291|NCT00560833|69596370|FG000|Overall Study|Participant uncooperative|5|||
37910292|NCT00560833|69596371|FG001|Overall Study|Participant uncooperative|5|||
38018078|NCT00290771|69701012|FG000|Overall Study|Death|11|||
38018079|NCT00290771|69701013|FG001|Overall Study|Death|10|||
38018080|NCT00290771|69701012|FG000|Overall Study|Adverse Event|12|||
38018081|NCT00290771|69701013|FG001|Overall Study|Adverse Event|6|||
37910293|NCT00560833|69596372|FG002|Overall Study|Participant uncooperative|4|||
38018082|NCT00290771|69701012|FG000|Overall Study|Withdrawal by Subject|5|||
38018083|NCT00290771|69701013|FG001|Overall Study|Withdrawal by Subject|6|||
37910294|NCT00560833|69596373|FG003|Overall Study|Participant uncooperative|4|||
37910295|NCT00560833|69596374|FG004|Overall Study|Participant uncooperative|2|||
38018084|NCT00290771|69701012|FG000|Overall Study|Administrative problems|2|||
38018085|NCT00290771|69701013|FG001|Overall Study|Administrative problems|1|||
38018086|NCT00290771|69701012|FG000|Overall Study|Protocol Violation|2|||
38018087|NCT00290771|69701013|FG001|Overall Study|Protocol Violation|0|||
38018088|NCT00290771|69701012|FG000|Overall Study|Lost to Follow-up|0|||
38018089|NCT00290771|69701013|FG001|Overall Study|Lost to Follow-up|1|||
38018090|NCT00274625|69701022|FG000|Overall Study|Lost to Follow-up|46|||
38018091|NCT00274625|69701023|FG001|Overall Study|Lost to Follow-up|54|||
38018092|NCT00274625|69701022|FG000|Overall Study|Excluded from analysis|14|||
38018093|NCT00274625|69701023|FG001|Overall Study|Excluded from analysis|8|||
38018094|NCT00290693|69701029|FG000|Overall Study|Withdrawal by Subject|2|||
38018095|NCT03214666|69701040|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
38018096|NCT03214666|69701041|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
38018097|NCT03214666|69701042|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
38018098|NCT03214666|69701043|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
38018099|NCT03214666|69701044|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
38018100|NCT03214666|69701045|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
38018101|NCT00274469|69701062|FG000|Overall Study|Death|63|||
38018102|NCT00274469|69701063|FG001|Overall Study|Death|74|||
38018103|NCT00274469|69701062|FG000|Overall Study|Did not consent to OS follow-up|16|||
38018104|NCT00274469|69701063|FG001|Overall Study|Did not consent to OS follow-up|19|||
38018105|NCT03214588|69701072|FG000|Overall Study|Adverse Event|1|||
38018106|NCT03214588|69701073|FG001|Overall Study|Adverse Event|0|||
38018107|NCT03214588|69701074|FG002|Overall Study|Adverse Event|2|||
38018108|NCT03214588|69701072|FG000|Overall Study|Reason Not Specified|0|||
38018109|NCT03214588|69701073|FG001|Overall Study|Reason Not Specified|1|||
37910296|NCT00560833|69596370|FG000|Overall Study|Other|1|||
37910297|NCT00560833|69596371|FG001|Overall Study|Other|1|||
37910298|NCT00560833|69596372|FG002|Overall Study|Other|3|||
37910299|NCT00560833|69596373|FG003|Overall Study|Other|0|||
38018110|NCT03214588|69701074|FG002|Overall Study|Reason Not Specified|0|||
38018111|NCT03166618|69701084|FG000|Overall Study|Study was Terminated|0|||
38018112|NCT03166618|69701085|FG001|Overall Study|Study was Terminated|1|||
38018113|NCT03162796|69701102|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
38018114|NCT03162796|69701103|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
38018115|NCT03162796|69701104|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
38018116|NCT03162796|69701102|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
38018117|NCT03162796|69701103|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
38018118|NCT03162796|69701104|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
38018119|NCT03162796|69701102|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
38018120|NCT03162796|69701103|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
38018121|NCT03162796|69701104|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
38018122|NCT03162796|69701102|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
38018123|NCT03162796|69701103|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
38018124|NCT03162796|69701104|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
38018125|NCT03162796|69701102|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
38018126|NCT03162796|69701103|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
38018127|NCT03162796|69701104|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
38018128|NCT03162796|69701102|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
38018129|NCT03162796|69701103|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
38018130|NCT03162796|69701104|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
38018131|NCT03162796|69701102|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
38018132|NCT03162796|69701103|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
38018133|NCT03162796|69701104|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
38018134|NCT03162796|69701102|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
38018135|NCT03162796|69701103|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
38018136|NCT03162796|69701104|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
38018137|NCT03162796|69701102|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
38018138|NCT03162796|69701103|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
37910300|NCT00560833|69596374|FG004|Overall Study|Other|0|||
38018139|NCT03162796|69701104|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
38018140|NCT03162796|69701102|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
37910301|NCT00560833|69596370|FG000|Overall Study|Never received drug|0|||
38018141|NCT03162796|69701103|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
38018142|NCT03162796|69701104|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
38018143|NCT03162796|69701102|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
38018144|NCT03162796|69701103|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
38018145|NCT03162796|69701104|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
38018146|NCT03162328|69701117|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
38018147|NCT03162328|69701118|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
38018148|NCT03162328|69701119|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
38018149|NCT03162328|69701117|FG000|Screening Period|Withdrawal by Subject|1|||
38018150|NCT03162328|69701118|FG001|Screening Period|Withdrawal by Subject|0|||
38018151|NCT03162328|69701119|FG002|Screening Period|Withdrawal by Subject|0|||
38018152|NCT03162328|69701117|FG000|Study Period|Withdrawal by Subject|0|||
38018153|NCT03162328|69701118|FG001|Study Period|Withdrawal by Subject|0|||
38018154|NCT03162328|69701119|FG002|Study Period|Withdrawal by Subject|1|||
38018155|NCT00272987|69701133|FG000|Overall Study|Adverse Event|1|||
38018156|NCT00272987|69701134|FG001|Overall Study|Adverse Event|0|||
38018157|NCT00272987|69701135|FG002|Overall Study|Adverse Event|0|||
38018158|NCT00272987|69701133|FG000|Overall Study|Lost to Follow-up|3|||
38018159|NCT00272987|69701134|FG001|Overall Study|Lost to Follow-up|1|||
38018160|NCT00272987|69701135|FG002|Overall Study|Lost to Follow-up|1|||
38018161|NCT00272987|69701133|FG000|Overall Study|Withdrawal by Subject|1|||
38018162|NCT00272987|69701134|FG001|Overall Study|Withdrawal by Subject|0|||
38018163|NCT00272987|69701135|FG002|Overall Study|Withdrawal by Subject|3|||
38018164|NCT00272987|69701133|FG000|Overall Study|Sponsor Terminated study|0|||
38018165|NCT00272987|69701134|FG001|Overall Study|Sponsor Terminated study|1|||
38018166|NCT00272987|69701135|FG002|Overall Study|Sponsor Terminated study|1|||
38018167|NCT00272987|69701133|FG000|Overall Study|Disease progression|1|||
38018168|NCT00272987|69701134|FG001|Overall Study|Disease progression|1|||
38018169|NCT00272987|69701135|FG002|Overall Study|Disease progression|2|||
38018170|NCT00272987|69701133|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
38018171|NCT00272987|69701134|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
38018172|NCT00272987|69701135|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
38018173|NCT00272987|69701133|FG000|Overall Study|Death|1|||
38018174|NCT00272987|69701134|FG001|Overall Study|Death|0|||
38018175|NCT00272987|69701135|FG002|Overall Study|Death|0|||
38018176|NCT01730950|69701145|FG000|Overall Study|Protocol Violation|6|||
38018177|NCT01730950|69701146|FG001|Overall Study|Protocol Violation|6|||
38018178|NCT00271505|69701153|FG000|Overall Study|Screen Failure|3|||
38018179|NCT00271505|69701153|FG000|Overall Study|Adverse Event|1|||
38018180|NCT00271505|69701153|FG000|Overall Study|Death|1|||
38018181|NCT01642186|69701161|FG000|Overall Study|Death|0|||
38018182|NCT01642186|69701162|FG001|Overall Study|Death|2|||
38018183|NCT01642186|69701163|FG002|Overall Study|Death|2|||
38018184|NCT01642186|69701161|FG000|Overall Study|Lost to Follow-up|0|||
38018185|NCT01642186|69701162|FG001|Overall Study|Lost to Follow-up|0|||
38018186|NCT01642186|69701163|FG002|Overall Study|Lost to Follow-up|1|||
38018187|NCT00423514|69701173|FG000|Overall Study|Ineligible|1|||
38018188|NCT00423514|69701174|FG001|Overall Study|Ineligible|0|||
38018189|NCT00289991|69701182|FG000|Overall Study|Death|35|||
38018190|NCT00289991|69701183|FG001|Overall Study|Death|38|||
38018191|NCT00289991|69701182|FG000|Overall Study|Adverse Event|15|||
38018192|NCT00289991|69701183|FG001|Overall Study|Adverse Event|13|||
38018193|NCT00289991|69701182|FG000|Overall Study|Failure of prophylaxis|1|||
38018194|NCT00289991|69701183|FG001|Overall Study|Failure of prophylaxis|1|||
38018195|NCT00289991|69701182|FG000|Overall Study|Fungal breakthrough infection|0|||
38018196|NCT00289991|69701183|FG001|Overall Study|Fungal breakthrough infection|1|||
38018197|NCT00289991|69701182|FG000|Overall Study|Lost to Follow-up|0|||
38018198|NCT00289991|69701183|FG001|Overall Study|Lost to Follow-up|1|||
38018199|NCT00289991|69701182|FG000|Overall Study|Withdrawal by Subject|2|||
38018200|NCT00289991|69701183|FG001|Overall Study|Withdrawal by Subject|12|||
38018201|NCT00289991|69701182|FG000|Overall Study|Other|5|||
37910302|NCT00560833|69596371|FG001|Overall Study|Never received drug|1|||
38018202|NCT00289991|69701183|FG001|Overall Study|Other|14|||
38018203|NCT00289913|69701194|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
38018204|NCT00289913|69701195|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
38018205|NCT00289913|69701196|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
38018206|NCT00289913|69701197|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
38018207|NCT00289913|69701198|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
38018208|NCT00289913|69701194|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
38018209|NCT00289913|69701195|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
37910303|NCT00560833|69596372|FG002|Overall Study|Never received drug|0|||
38018210|NCT00289913|69701196|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
37910304|NCT00560833|69596373|FG003|Overall Study|Never received drug|0|||
38018211|NCT00289913|69701197|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
38018212|NCT00289913|69701198|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
38018213|NCT00289913|69701194|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
38018214|NCT00289913|69701195|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
38018215|NCT00289913|69701196|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
38018216|NCT00289913|69701197|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
38018217|NCT00289913|69701198|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
38018218|NCT00289913|69701194|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
38018219|NCT00289913|69701195|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
38018220|NCT00289913|69701196|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
38018221|NCT00289913|69701197|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
38018222|NCT00289913|69701198|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
38018223|NCT00289913|69701194|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
38018224|NCT00289913|69701195|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
38018225|NCT00289913|69701196|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
38018226|NCT00289913|69701197|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
38018227|NCT00289913|69701198|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
38018228|NCT00289913|69701194|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
38018229|NCT00289913|69701195|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
38018230|NCT00289913|69701196|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
38018231|NCT00289913|69701197|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
38018232|NCT00289913|69701198|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
38018233|NCT00289913|69701194|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
38018234|NCT00289913|69701195|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
38018235|NCT00289913|69701196|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
38018236|NCT00289913|69701197|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
38018237|NCT00289913|69701198|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
38018238|NCT00289913|69701194|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
38018239|NCT00289913|69701195|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
38018240|NCT00289913|69701196|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
38018241|NCT00289913|69701197|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
38018242|NCT00289913|69701198|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
38018243|NCT00289913|69701194|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
38018244|NCT00289913|69701195|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
38018245|NCT00289913|69701196|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
38018246|NCT00289913|69701197|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
38018247|NCT00289913|69701198|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
38018248|NCT00289913|69701194|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
38018249|NCT00289913|69701195|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
38018250|NCT00289913|69701196|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
38018251|NCT00289913|69701197|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
38018252|NCT00289913|69701198|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
38018253|NCT00289913|69701194|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
38018254|NCT00289913|69701195|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
38018255|NCT00289913|69701196|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
38018256|NCT00289913|69701197|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
38018257|NCT00289913|69701198|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
38018258|NCT00289913|69701194|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
38018259|NCT00289913|69701195|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
38018260|NCT00289913|69701196|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
38018261|NCT00289913|69701197|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
38018262|NCT00289913|69701198|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
38018263|NCT00289913|69701194|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
38018264|NCT00289913|69701195|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
38018265|NCT00289913|69701196|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
38018266|NCT00289913|69701197|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
38018267|NCT00289913|69701198|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
38018268|NCT00289913|69701194|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
38018269|NCT00289913|69701195|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
38018270|NCT00289913|69701196|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
38018271|NCT00289913|69701197|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
38018272|NCT00289913|69701198|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
37698509|NCT02431247|69175254|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
38018273|NCT00289913|69701194|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
38018274|NCT00289913|69701195|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
38018275|NCT00289913|69701196|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
38018276|NCT00289913|69701197|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
38018277|NCT00289913|69701198|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
38018278|NCT00289913|69701194|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
38018279|NCT00289913|69701195|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
38018280|NCT00289913|69701196|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
38018281|NCT00289913|69701197|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
38018282|NCT00289913|69701198|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
38018283|NCT00289913|69701194|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
38018284|NCT00289913|69701195|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
38018285|NCT00289913|69701196|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
38018286|NCT00289913|69701197|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
38018287|NCT00289913|69701198|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
38018288|NCT00289913|69701194|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
38018289|NCT00289913|69701195|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
38018290|NCT00289913|69701196|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
38018291|NCT00289913|69701197|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
38018292|NCT00289913|69701198|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
38018293|NCT00289913|69701194|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
38018294|NCT00289913|69701195|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
38018295|NCT00289913|69701196|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
38018296|NCT00289913|69701197|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
38018297|NCT00289913|69701198|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
37698510|NCT02431247|69175255|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
37832595|NCT01283581|69516159|FG002|Overall Study|Withdrawal by Subject|2|||
37832596|NCT01283581|69516157|FG000|Overall Study|Adverse Event|1|||
37832597|NCT01283581|69516158|FG001|Overall Study|Adverse Event|1|||
37832598|NCT01283581|69516159|FG002|Overall Study|Adverse Event|4|||
37832599|NCT01283581|69516157|FG000|Overall Study|Physician Decision|0|||
37832600|NCT01283581|69516158|FG001|Overall Study|Physician Decision|1|||
37832601|NCT01283581|69516159|FG002|Overall Study|Physician Decision|2|||
37832602|NCT01283581|69516157|FG000|Overall Study|Protocol Violation|0|||
37910305|NCT00560833|69596374|FG004|Overall Study|Never received drug|1|||
37910306|NCT00771615|69596395|FG000|Overall Study|Withdrawal by Subject|0|||
37910307|NCT00771615|69596396|FG001|Overall Study|Withdrawal by Subject|1|||
37910308|NCT00771615|69596397|FG002|Overall Study|Withdrawal by Subject|0|||
37832603|NCT01283581|69516158|FG001|Overall Study|Protocol Violation|1|||
37832604|NCT01283581|69516159|FG002|Overall Study|Protocol Violation|2|||
37832605|NCT01283581|69516157|FG000|Overall Study|Noncompliance|1|||
37832606|NCT01283581|69516158|FG001|Overall Study|Noncompliance|0|||
37832607|NCT01283581|69516159|FG002|Overall Study|Noncompliance|0|||
37832608|NCT01283581|69516157|FG000|Overall Study|Investigator unblinded|0|||
37832609|NCT01283581|69516158|FG001|Overall Study|Investigator unblinded|0|||
37832610|NCT01283581|69516159|FG002|Overall Study|Investigator unblinded|1|||
37832611|NCT01283581|69516157|FG000|Overall Study|"Early termination"|0|||
37832612|NCT01283581|69516158|FG001|Overall Study|"Early termination"|0|||
37832613|NCT01283581|69516159|FG002|Overall Study|"Early termination"|1|||
37832614|NCT01283542|69516170|FG000|Main Phase|Acute or progressive vision loss|1|||
37910309|NCT00771615|69596398|FG003|Overall Study|Withdrawal by Subject|0|||
37910310|NCT00771615|69596399|FG004|Overall Study|Withdrawal by Subject|0|||
37910311|NCT00771615|69596400|FG005|Overall Study|Withdrawal by Subject|0|||
37910312|NCT00771615|69596401|FG006|Overall Study|Withdrawal by Subject|0|||
37910313|NCT00771615|69596402|FG007|Overall Study|Withdrawal by Subject|1|||
37910314|NCT00771615|69596403|FG008|Overall Study|Withdrawal by Subject|0|||
37910315|NCT00771615|69596395|FG000|Overall Study|Lost to Follow-up|1|||
37910316|NCT00771615|69596396|FG001|Overall Study|Lost to Follow-up|1|||
37910317|NCT00771615|69596397|FG002|Overall Study|Lost to Follow-up|1|||
37910318|NCT00771615|69596398|FG003|Overall Study|Lost to Follow-up|1|||
37910319|NCT00771615|69596399|FG004|Overall Study|Lost to Follow-up|0|||
37910320|NCT00771615|69596400|FG005|Overall Study|Lost to Follow-up|1|||
37832615|NCT01283542|69516170|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
38018298|NCT00289913|69701194|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
37832616|NCT01283542|69516170|FG000|Main Phase|abnormal laboratory values|5|||
37832617|NCT01283542|69516170|FG000|Extension Phase|Physician Decision|1|||
37832618|NCT01283542|69516170|FG000|Extension Phase|Adverse Event|1|||
37832619|NCT01283542|69516170|FG000|Extension Phase|Administrative problems|1|||
37910321|NCT00771615|69596401|FG006|Overall Study|Lost to Follow-up|1|||
37910322|NCT00771615|69596402|FG007|Overall Study|Lost to Follow-up|0|||
37910323|NCT00771615|69596403|FG008|Overall Study|Lost to Follow-up|0|||
37910324|NCT02723604|69596432|FG000|Overall Study|ineligible|1|||
37910325|NCT02723604|69596432|FG000|Overall Study|never received treatment|1|||
37910326|NCT00560755|69596436|FG000|Overall Study|Protocol Violation|15|||
37910327|NCT00560755|69596436|FG000|Overall Study|Withdrawal by Subject|26|||
37910328|NCT00560755|69596436|FG000|Overall Study|Lost to Follow-up|9|||
38018299|NCT00289913|69701195|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
38018300|NCT00289913|69701196|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
38018301|NCT00289913|69701197|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
38018302|NCT00289913|69701198|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
38018303|NCT00289913|69701194|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
38018304|NCT00289913|69701195|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
38018305|NCT00289913|69701196|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
38018306|NCT00289913|69701197|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
38018307|NCT00289913|69701198|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
38018308|NCT00289913|69701194|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
38018309|NCT00289913|69701195|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
38018310|NCT00289913|69701196|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
37832620|NCT01283386|69516194|FG000|Overall Study|Death|2|||
37910329|NCT00560755|69596436|FG000|Overall Study|Adverse Event|8|||
37910330|NCT00560755|69596436|FG000|Overall Study|Physician Decision|2|||
37910331|NCT00770991|69596443|FG000|Overall Study|Physician Decision|2|||
37910332|NCT00770991|69596444|FG001|Overall Study|Physician Decision|0|||
37910333|NCT00770991|69596443|FG000|Overall Study|Withdrawal by Subject|1|||
37910334|NCT00770991|69596444|FG001|Overall Study|Withdrawal by Subject|0|||
37910335|NCT00770991|69596443|FG000|Overall Study|Adverse Event|1|||
37910336|NCT00770991|69596444|FG001|Overall Study|Adverse Event|5|||
37910337|NCT00770991|69596443|FG000|Overall Study|Pregnancy|1|||
37910338|NCT00770991|69596444|FG001|Overall Study|Pregnancy|0|||
37910339|NCT00925769|69596455|FG000|Overall Study|Major toxicity|1|||
37910340|NCT00925769|69596456|FG001|Overall Study|Major toxicity|0|||
37910341|NCT00925769|69596457|FG002|Overall Study|Major toxicity|1|||
37910342|NCT00925769|69596458|FG003|Overall Study|Major toxicity|1|||
37910343|NCT00925769|69596459|FG004|Overall Study|Major toxicity|0|||
37910344|NCT00925769|69596460|FG005|Overall Study|Major toxicity|0|||
37910345|NCT00925769|69596455|FG000|Overall Study|Disease progression|4|||
37910346|NCT00925769|69596456|FG001|Overall Study|Disease progression|5|||
37910347|NCT00925769|69596457|FG002|Overall Study|Disease progression|3|||
37910348|NCT00925769|69596458|FG003|Overall Study|Disease progression|4|||
37910349|NCT00925769|69596459|FG004|Overall Study|Disease progression|2|||
37910350|NCT00925769|69596460|FG005|Overall Study|Disease progression|3|||
37910351|NCT00925769|69596455|FG000|Overall Study|Death|0|||
37910352|NCT00925769|69596456|FG001|Overall Study|Death|0|||
38018311|NCT00289913|69701197|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
38018312|NCT00289913|69701198|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
37832621|NCT01283386|69516195|FG001|Overall Study|Death|0|||
37832622|NCT01283386|69516194|FG000|Overall Study|Withdrawal by Subject|2|||
37832623|NCT01283386|69516195|FG001|Overall Study|Withdrawal by Subject|1|||
37832624|NCT01283386|69516194|FG000|Overall Study|Relapse of underlying disease|1|||
37832625|NCT01283386|69516195|FG001|Overall Study|Relapse of underlying disease|3|||
37832626|NCT01283386|69516194|FG000|Overall Study|Progression of underlying disease|2|||
37832627|NCT01283386|69516195|FG001|Overall Study|Progression of underlying disease|7|||
37832628|NCT01283386|69516194|FG000|Overall Study|Reason not specified|1|||
37832629|NCT01283386|69516195|FG001|Overall Study|Reason not specified|0|||
37832630|NCT01283386|69516194|FG000|Overall Study|Protocol Violation|0|||
37832631|NCT01283386|69516195|FG001|Overall Study|Protocol Violation|1|||
37832632|NCT01283152|69516203|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
37832633|NCT01283152|69516204|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
37832634|NCT01283152|69516203|FG000|Overall Study|Refused HESA|1|||
37832635|NCT01283152|69516204|FG001|Overall Study|Refused HESA|0|||
37832636|NCT01283035|69516210|FG000|Overall Study|Subject later found ineligible|1|||
37832637|NCT01283464|69516216|FG000|Overall Study|Lost to Follow-up|0|||
37832638|NCT01283464|69516217|FG001|Overall Study|Lost to Follow-up|1|||
37910353|NCT00925769|69596457|FG002|Overall Study|Death|1|||
37910354|NCT00925769|69596458|FG003|Overall Study|Death|0|||
37910355|NCT00925769|69596459|FG004|Overall Study|Death|0|||
37910356|NCT00925769|69596460|FG005|Overall Study|Death|0|||
37910357|NCT00925769|69596455|FG000|Overall Study|Physician Decision|1|||
37832639|NCT01283464|69516216|FG000|Overall Study|Withdrawal by Subject|1|||
37910358|NCT00925769|69596456|FG001|Overall Study|Physician Decision|0|||
37910359|NCT00925769|69596457|FG002|Overall Study|Physician Decision|0|||
37910360|NCT00925769|69596458|FG003|Overall Study|Physician Decision|0|||
37910361|NCT00925769|69596459|FG004|Overall Study|Physician Decision|0|||
37910362|NCT00925769|69596460|FG005|Overall Study|Physician Decision|0|||
37910363|NCT00925769|69596455|FG000|Overall Study|Missing documentation|0|||
37910364|NCT00925769|69596456|FG001|Overall Study|Missing documentation|1|||
37910365|NCT00925769|69596457|FG002|Overall Study|Missing documentation|0|||
38018313|NCT00289913|69701194|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
38018314|NCT00289913|69701195|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
38018315|NCT00289913|69701196|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
38018316|NCT00289913|69701197|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
38018317|NCT00289913|69701198|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
38018318|NCT00289913|69701194|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
38018319|NCT00289913|69701195|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
38018320|NCT00289913|69701196|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
38018321|NCT00289913|69701197|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
38018322|NCT00289913|69701198|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
38018323|NCT00289913|69701194|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
38018324|NCT00289913|69701195|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
38018325|NCT00289913|69701196|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
38018326|NCT00289913|69701197|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
38018327|NCT00289913|69701198|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
38018328|NCT00289913|69701194|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
38018329|NCT00289913|69701195|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
38018330|NCT00289913|69701196|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
37910366|NCT00925769|69596458|FG003|Overall Study|Missing documentation|0|||
37910367|NCT00925769|69596459|FG004|Overall Study|Missing documentation|0|||
37910368|NCT00925769|69596460|FG005|Overall Study|Missing documentation|0|||
37910369|NCT00925769|69596455|FG000|Overall Study|End of study visit not done|0|||
37910370|NCT00925769|69596456|FG001|Overall Study|End of study visit not done|0|||
37910371|NCT00925769|69596457|FG002|Overall Study|End of study visit not done|1|||
37910372|NCT00925769|69596458|FG003|Overall Study|End of study visit not done|0|||
37910373|NCT00925769|69596459|FG004|Overall Study|End of study visit not done|0|||
37910374|NCT00925769|69596460|FG005|Overall Study|End of study visit not done|0|||
37910375|NCT00925769|69596455|FG000|Overall Study|Participant is unable to swallow drug|0|||
37910376|NCT00925769|69596456|FG001|Overall Study|Participant is unable to swallow drug|0|||
37910377|NCT00925769|69596457|FG002|Overall Study|Participant is unable to swallow drug|0|||
37910378|NCT00925769|69596458|FG003|Overall Study|Participant is unable to swallow drug|1|||
38018331|NCT00289913|69701197|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
38018332|NCT00289913|69701198|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
38018333|NCT00289913|69701194|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
38018334|NCT00289913|69701195|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
38018335|NCT00289913|69701196|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
38018336|NCT00289913|69701197|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
38018337|NCT00289913|69701198|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
38018338|NCT00289913|69701194|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
38018339|NCT00289913|69701195|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
38018340|NCT00289913|69701196|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
38018341|NCT00289913|69701197|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
38018342|NCT00289913|69701198|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
38018343|NCT00289913|69701194|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
38018344|NCT00289913|69701195|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
38018345|NCT00289913|69701196|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
38018346|NCT00289913|69701197|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
38018347|NCT00289913|69701198|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
38018348|NCT00289913|69701194|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
38018349|NCT00289913|69701195|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
37832640|NCT01283464|69516217|FG001|Overall Study|Withdrawal by Subject|0|||
37832641|NCT01283464|69516216|FG000|Overall Study|Physician Decision|1|||
37832642|NCT01283464|69516217|FG001|Overall Study|Physician Decision|0|||
37832643|NCT01282801|69516225|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
37832644|NCT01282801|69516226|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
37832645|NCT01282372|69516232|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
37832646|NCT01282372|69516232|FG000|Overall Study|Lost to Follow-up|23|||
37832647|NCT01282372|69516232|FG000|Overall Study|Withdrawal by Subject|11|||
37910379|NCT00925769|69596459|FG004|Overall Study|Participant is unable to swallow drug|0|||
37910380|NCT00925769|69596460|FG005|Overall Study|Participant is unable to swallow drug|0|||
37832648|NCT01282372|69516232|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
37910381|NCT00925769|69596455|FG000|Overall Study|Adverse Event|0|||
37910382|NCT00925769|69596456|FG001|Overall Study|Adverse Event|0|||
37910383|NCT00925769|69596457|FG002|Overall Study|Adverse Event|0|||
37910384|NCT00925769|69596458|FG003|Overall Study|Adverse Event|0|||
37832649|NCT01282372|69516232|FG000|Overall Study|Death|1|||
37832650|NCT01282372|69516232|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
37832651|NCT01282372|69516232|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
37832652|NCT01282372|69516232|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
37832653|NCT01282372|69516232|FG000|Overall Study|Adverse Event|12|||
37832654|NCT01282294|69516243|FG000|Overall Study|Lost to Follow-up|14|||
37832655|NCT01282294|69516243|FG000|Overall Study|Screening failure|1|||
37832656|NCT01282294|69516243|FG000|Overall Study|Adverse Event|1|||
37832657|NCT01282294|69516243|FG000|Overall Study|Patient non-compliance|2|||
37832658|NCT01282294|69516243|FG000|Overall Study|Physician Decision|1|||
38018350|NCT00289913|69701196|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
38018351|NCT00289913|69701197|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
38018352|NCT00289913|69701198|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
38018353|NCT00289913|69701194|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
38018354|NCT00289913|69701195|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
37832659|NCT01282216|69516249|FG000|Overall Study|Graft failure|0|||
37832660|NCT01282216|69516250|FG001|Overall Study|Graft failure|0|||
37832661|NCT01282216|69516251|FG002|Overall Study|Graft failure|3|||
37832662|NCT01282216|69516252|FG003|Overall Study|Graft failure|2|||
37832663|NCT01282216|69516249|FG000|Overall Study|Physician Decision|0|||
37832664|NCT01282216|69516250|FG001|Overall Study|Physician Decision|0|||
37832665|NCT01282216|69516251|FG002|Overall Study|Physician Decision|11|||
37832666|NCT01282216|69516252|FG003|Overall Study|Physician Decision|0|||
37832667|NCT01282216|69516249|FG000|Overall Study|Relapse|0|||
37832668|NCT01282216|69516250|FG001|Overall Study|Relapse|0|||
37832669|NCT01282216|69516251|FG002|Overall Study|Relapse|17|||
37832670|NCT01282216|69516252|FG003|Overall Study|Relapse|6|||
37832671|NCT01282216|69516249|FG000|Overall Study|Death|0|||
37832672|NCT01282216|69516250|FG001|Overall Study|Death|0|||
37832673|NCT01282216|69516251|FG002|Overall Study|Death|2|||
37832674|NCT01282216|69516252|FG003|Overall Study|Death|0|||
37832675|NCT01281865|69516260|FG000|Overall Study|Adverse Event|1|||
37832676|NCT01281865|69516261|FG001|Overall Study|Adverse Event|1|||
37832677|NCT01281865|69516260|FG000|Overall Study|Withdrawal by Subject|1|||
37832678|NCT01281865|69516261|FG001|Overall Study|Withdrawal by Subject|0|||
37832679|NCT01281865|69516260|FG000|Overall Study|Lack of Efficacy|1|||
37832680|NCT01281865|69516261|FG001|Overall Study|Lack of Efficacy|0|||
37832681|NCT01281202|69516269|FG000|Overall Study|Adverse Event|2|||
37832682|NCT01281202|69516270|FG001|Overall Study|Adverse Event|0|||
37832683|NCT01281202|69516269|FG000|Overall Study|Withdrawal by Subject|2|||
37832684|NCT01281202|69516270|FG001|Overall Study|Withdrawal by Subject|2|||
37832685|NCT01281202|69516269|FG000|Overall Study|Protocol Violation|11|||
37832686|NCT01281202|69516270|FG001|Overall Study|Protocol Violation|10|||
37832687|NCT01281202|69516269|FG000|Overall Study|Administrative|2|||
37832688|NCT01281202|69516270|FG001|Overall Study|Administrative|8|||
37832689|NCT01281202|69516269|FG000|Overall Study|Lost to Follow-up|11|||
37832690|NCT01281202|69516270|FG001|Overall Study|Lost to Follow-up|13|||
37832691|NCT01281202|69516269|FG000|Overall Study|Incarceration|0|||
37832692|NCT01281202|69516270|FG001|Overall Study|Incarceration|3|||
37832693|NCT01281124|69516278|FG000|Overall Study|Death|1|||
37832694|NCT01280968|69516286|FG000|Overall Study|Lost to Follow-up|8|||
37832695|NCT01280968|69516287|FG001|Overall Study|Lost to Follow-up|2|||
37832696|NCT01280968|69516286|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
37832697|NCT01280968|69516287|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
37832698|NCT01280968|69516286|FG000|Overall Study|Commuting Problems|2|||
37832699|NCT01280968|69516287|FG001|Overall Study|Commuting Problems|0|||
37832700|NCT01280968|69516286|FG000|Overall Study|Anxiety|2|||
37832701|NCT01280968|69516287|FG001|Overall Study|Anxiety|0|||
37832702|NCT01280968|69516286|FG000|Overall Study|Adverse Event|1|||
37832703|NCT01280968|69516287|FG001|Overall Study|Adverse Event|0|||
37832704|NCT01280968|69516286|FG000|Overall Study|Scheduling Conflicts|1|||
37832705|NCT01280968|69516287|FG001|Overall Study|Scheduling Conflicts|1|||
37832706|NCT01280968|69516286|FG000|Overall Study|Pre-existing Neurological Condition|1|||
37832707|NCT01280968|69516287|FG001|Overall Study|Pre-existing Neurological Condition|0|||
37910385|NCT00925769|69596459|FG004|Overall Study|Adverse Event|1|||
38018355|NCT00289913|69701196|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
37832708|NCT01280968|69516286|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
37832709|NCT01280968|69516287|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
37832710|NCT01280812|69516297|FG000|Overall Study|Withdrawal by Subject|2|||
37832711|NCT01280812|69516298|FG001|Overall Study|Withdrawal by Subject|1|||
37832712|NCT01280812|69516299|FG002|Overall Study|Withdrawal by Subject|0|||
37832713|NCT01280812|69516297|FG000|Overall Study|Lost to Follow-up|1|||
37832714|NCT01280812|69516298|FG001|Overall Study|Lost to Follow-up|1|||
37910386|NCT00925769|69596460|FG005|Overall Study|Adverse Event|0|||
37832715|NCT01280812|69516299|FG002|Overall Study|Lost to Follow-up|1|||
37832716|NCT01280656|69516311|FG000|Overall Study|Adverse Event|1|||
37832717|NCT01280656|69516312|FG001|Overall Study|Adverse Event|14|||
37832718|NCT01280656|69516313|FG002|Overall Study|Adverse Event|13|||
37832719|NCT01280656|69516311|FG000|Overall Study|Lack of Efficacy|1|||
37832720|NCT01280656|69516312|FG001|Overall Study|Lack of Efficacy|22|||
37832721|NCT01280656|69516313|FG002|Overall Study|Lack of Efficacy|38|||
37832722|NCT01280656|69516311|FG000|Overall Study|Treatment shortening (RGT)|0|||
37832723|NCT01280656|69516312|FG001|Overall Study|Treatment shortening (RGT)|4|||
37832724|NCT01280656|69516313|FG002|Overall Study|Treatment shortening (RGT)|5|||
37832725|NCT01280656|69516311|FG000|Overall Study|Other|1|||
37832726|NCT01280656|69516312|FG001|Overall Study|Other|7|||
37832727|NCT01280656|69516313|FG002|Overall Study|Other|7|||
37832728|NCT01280617|69516323|FG000|Overall Study|Adverse Event|0|||
37832729|NCT01280617|69516324|FG001|Overall Study|Adverse Event|1|||
37832730|NCT01280266|69516332|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
37832731|NCT01280266|69516333|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
37832732|NCT01280266|69516332|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
37832733|NCT01280266|69516333|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
37832734|NCT01279447|69516345|FG000|Overall Study|Lost to Follow-up|3|||
37832735|NCT01279447|69516346|FG001|Overall Study|Lost to Follow-up|1|||
37832736|NCT01276639|69516368|FG000|Week 0 to 16|Death|1|||
37832737|NCT01276639|69516369|FG001|Week 0 to 16|Death|0|||
37832738|NCT01276639|69516370|FG002|Week 0 to 16|Death|0|||
37832739|NCT01276639|69516371|FG003|Week 0 to 16|Death|0|||
37832740|NCT01276639|69516372|FG004|Week 0 to 16|Death|0|||
37832741|NCT01276639|69516368|FG000|Week 0 to 16|Adverse Event|11|||
37832742|NCT01276639|69516369|FG001|Week 0 to 16|Adverse Event|8|||
37832743|NCT01276639|69516370|FG002|Week 0 to 16|Adverse Event|11|||
37832744|NCT01276639|69516371|FG003|Week 0 to 16|Adverse Event|0|||
37910387|NCT00770913|69596479|FG000|Overall Study|Adverse Event|1|||
37910388|NCT00770913|69596480|FG001|Overall Study|Adverse Event|3|||
37910389|NCT00770913|69596481|FG002|Overall Study|Adverse Event|6|||
37910390|NCT00770913|69596479|FG000|Overall Study|Refusal to continue participation|6|||
37910391|NCT00770913|69596480|FG001|Overall Study|Refusal to continue participation|4|||
37910392|NCT00770913|69596481|FG002|Overall Study|Refusal to continue participation|5|||
37910393|NCT00770913|69596479|FG000|Overall Study|Physician Decision|0|||
37910394|NCT00770913|69596480|FG001|Overall Study|Physician Decision|1|||
37910395|NCT00770913|69596481|FG002|Overall Study|Physician Decision|1|||
37910396|NCT00770913|69596479|FG000|Overall Study|Protocol Violation|3|||
37910397|NCT00770913|69596480|FG001|Overall Study|Protocol Violation|0|||
37910398|NCT00770913|69596481|FG002|Overall Study|Protocol Violation|1|||
38018356|NCT00289913|69701197|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
38018357|NCT00289913|69701198|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
38018358|NCT00289289|69701216|FG000|Overall Study|Withdrawal by Subject|5|||
38018359|NCT00289289|69701217|FG001|Overall Study|Withdrawal by Subject|3|||
38018360|NCT00289289|69701218|FG002|Overall Study|Withdrawal by Subject|15|||
38018361|NCT00289289|69701216|FG000|Overall Study|Lost to Follow-up|1|||
38018362|NCT00289289|69701217|FG001|Overall Study|Lost to Follow-up|0|||
38018363|NCT00289289|69701218|FG002|Overall Study|Lost to Follow-up|1|||
38018364|NCT00289289|69701216|FG000|Overall Study|Death|4|||
38018365|NCT00289289|69701217|FG001|Overall Study|Death|2|||
38018366|NCT00289289|69701218|FG002|Overall Study|Death|5|||
38018367|NCT00289289|69701216|FG000|Overall Study|No implant attempted|0|||
38018368|NCT00289289|69701217|FG001|Overall Study|No implant attempted|0|||
38018369|NCT00289289|69701218|FG002|Overall Study|No implant attempted|1|||
37832745|NCT01276639|69516372|FG004|Week 0 to 16|Adverse Event|0|||
37832746|NCT01276639|69516368|FG000|Week 0 to 16|Lack of Efficacy|20|||
37832747|NCT01276639|69516369|FG001|Week 0 to 16|Lack of Efficacy|15|||
37832748|NCT01276639|69516370|FG002|Week 0 to 16|Lack of Efficacy|25|||
37910399|NCT00770913|69596479|FG000|Overall Study|Incorrect drug was allocated|1|||
38018370|NCT00289289|69701216|FG000|Overall Study|Physician Decision|1|||
37832749|NCT01276639|69516371|FG003|Week 0 to 16|Lack of Efficacy|0|||
37832750|NCT01276639|69516372|FG004|Week 0 to 16|Lack of Efficacy|0|||
37832751|NCT01276639|69516368|FG000|Week 0 to 16|Lost to Follow-up|3|||
37832752|NCT01276639|69516369|FG001|Week 0 to 16|Lost to Follow-up|5|||
37832753|NCT01276639|69516370|FG002|Week 0 to 16|Lost to Follow-up|3|||
37832754|NCT01276639|69516371|FG003|Week 0 to 16|Lost to Follow-up|0|||
37832755|NCT01276639|69516372|FG004|Week 0 to 16|Lost to Follow-up|0|||
37832756|NCT01276639|69516368|FG000|Week 0 to 16|Withdrawal by Subject|8|||
37832757|NCT01276639|69516369|FG001|Week 0 to 16|Withdrawal by Subject|5|||
37910400|NCT00770913|69596480|FG001|Overall Study|Incorrect drug was allocated|0|||
37910401|NCT00770913|69596481|FG002|Overall Study|Incorrect drug was allocated|0|||
37910402|NCT00562861|69596491|FG000|Overall Study|Adverse Event|1|||
37910403|NCT00562861|69596492|FG001|Overall Study|Adverse Event|1|||
37910404|NCT00562861|69596491|FG000|Overall Study|Lack of Efficacy|5|||
38018371|NCT00289289|69701217|FG001|Overall Study|Physician Decision|0|||
38018372|NCT00289289|69701218|FG002|Overall Study|Physician Decision|6|||
38018373|NCT00289289|69701216|FG000|Overall Study|Non-study device implanted|2|||
38018374|NCT00289289|69701217|FG001|Overall Study|Non-study device implanted|1|||
38018375|NCT00289289|69701218|FG002|Overall Study|Non-study device implanted|3|||
38018376|NCT00289289|69701216|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
38018377|NCT00289289|69701217|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
38018378|NCT00289289|69701218|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
38018379|NCT00289289|69701216|FG000|Overall Study|Other Exit Reason|6|||
38018380|NCT00289289|69701217|FG001|Overall Study|Other Exit Reason|4|||
38018381|NCT00289289|69701218|FG002|Overall Study|Other Exit Reason|12|||
38018382|NCT00270257|69701227|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
38018383|NCT00270257|69701228|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
38018384|NCT00269633|69701238|FG000|Overall Study|Withdrawal by Subject|1|||
38018385|NCT00269633|69701239|FG001|Overall Study|Withdrawal by Subject|0|||
38018386|NCT00269477|69701249|FG000|Overall Study|Protocol Violation|5|||
38018387|NCT00269477|69701250|FG001|Overall Study|Protocol Violation|5|||
38018388|NCT00269477|69701251|FG002|Overall Study|Protocol Violation|1|||
38018389|NCT00269477|69701252|FG003|Overall Study|Protocol Violation|0|||
38018390|NCT00269477|69701249|FG000|Overall Study|Missed post-vaccination blood draw|0|||
38018391|NCT00269477|69701250|FG001|Overall Study|Missed post-vaccination blood draw|1|||
38018392|NCT00269477|69701251|FG002|Overall Study|Missed post-vaccination blood draw|0|||
38018393|NCT00269477|69701252|FG003|Overall Study|Missed post-vaccination blood draw|0|||
38018394|NCT00269399|69701264|FG000|Overall Study|Lack of Efficacy|27|||
38018395|NCT00269399|69701265|FG001|Overall Study|Lack of Efficacy|10|||
38018396|NCT00269399|69701264|FG000|Overall Study|Adverse Event|10|||
38018397|NCT00269399|69701265|FG001|Overall Study|Adverse Event|4|||
38018398|NCT00269399|69701264|FG000|Overall Study|Withdrawal by Subject|2|||
38018399|NCT00269399|69701265|FG001|Overall Study|Withdrawal by Subject|5|||
38018400|NCT00269399|69701264|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
38018401|NCT00269399|69701265|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
38018402|NCT00269399|69701264|FG000|Overall Study|Other|0|||
38018403|NCT00269399|69701265|FG001|Overall Study|Other|4|||
38018404|NCT00269399|69701264|FG000|Overall Study|Development of exclusion criteria|0|||
38018405|NCT00269399|69701265|FG001|Overall Study|Development of exclusion criteria|1|||
38018406|NCT00269087|69701271|FG000|Overall Study|Adverse Event|20|||
38018407|NCT00269087|69701271|FG000|Overall Study|Withdrawal by Subject|1|||
38018408|NCT00269087|69701271|FG000|Overall Study|Exacerbation of COPD|13|||
38018409|NCT00289133|69701277|FG000|Overall Study|Non-study device implanted|12|||
38018410|NCT00289133|69701278|FG001|Overall Study|Non-study device implanted|0|||
38018411|NCT00289133|69701277|FG000|Overall Study|Protocol Violation|32|||
38018412|NCT00289133|69701278|FG001|Overall Study|Protocol Violation|38|||
38018413|NCT00289133|69701277|FG000|Overall Study|Withdrawal by Subject|9|||
38018414|NCT00289133|69701278|FG001|Overall Study|Withdrawal by Subject|10|||
38018415|NCT00289133|69701277|FG000|Overall Study|Death|5|||
38018416|NCT00289133|69701278|FG001|Overall Study|Death|10|||
38018417|NCT00289133|69701277|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
38018418|NCT00289133|69701278|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
38018419|NCT00289133|69701277|FG000|Overall Study|Physician Decision|41|||
38018420|NCT00289133|69701278|FG001|Overall Study|Physician Decision|45|||
38018421|NCT00289133|69701277|FG000|Overall Study|Revision|8|||
38018422|NCT00289133|69701278|FG001|Overall Study|Revision|6|||
38018423|NCT00289133|69701277|FG000|Overall Study|Lost to Follow-up|92|||
38018424|NCT00289133|69701278|FG001|Overall Study|Lost to Follow-up|115|||
38018425|NCT00288587|69701290|FG000|Overall Study|Death|4|||
38018426|NCT00288587|69701291|FG001|Overall Study|Death|4|||
38018427|NCT00288587|69701290|FG000|Overall Study|Transplant|0|||
38018428|NCT00288587|69701291|FG001|Overall Study|Transplant|3|||
38018429|NCT00288587|69701290|FG000|Overall Study|Adverse Event|0|||
38018430|NCT00288587|69701291|FG001|Overall Study|Adverse Event|1|||
38018431|NCT00288587|69701290|FG000|Overall Study|Physician Decision|0|||
38018432|NCT00288587|69701291|FG001|Overall Study|Physician Decision|2|||
38018433|NCT00288587|69701290|FG000|Overall Study|Severe Aortic Stenosis|1|||
38018434|NCT00288587|69701291|FG001|Overall Study|Severe Aortic Stenosis|0|||
38018435|NCT00268463|69701299|FG000|Overall Study|study terminated due to low accrual|10|||
38018436|NCT00268463|69701300|FG001|Overall Study|study terminated due to low accrual|12|||
38018437|NCT00288509|69701306|FG000|Treatment Cycle 1|Adverse Event|1|||
38018438|NCT00288509|69701306|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
38018439|NCT00288509|69701306|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
38018440|NCT00288509|69701306|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
38018441|NCT00288509|69701306|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
38018442|NCT00288509|69701306|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
38018443|NCT00288509|69701306|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
38018444|NCT00288509|69701306|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
38018445|NCT00288509|69701306|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
38018446|NCT00288509|69701306|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
38018447|NCT00288509|69701306|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
38018448|NCT00288509|69701306|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
38018449|NCT00288509|69701306|FG000|Treatment Cycle 4|Physician Decision|4|||
38018450|NCT00288509|69701306|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
38018451|NCT00266825|69701312|FG000|Completed Follow-Up|Lost to Follow-up|14|||
38018452|NCT00266825|69701313|FG001|Completed Follow-Up|Lost to Follow-up|19|||
38018453|NCT00266825|69701312|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
38018454|NCT00266825|69701313|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
38018455|NCT00265889|69701321|FG000|Overall Study|Physician Decision|1|||
38018456|NCT00265889|69701321|FG000|Overall Study|Protocol Violation|1|||
38018457|NCT00265889|69701321|FG000|Overall Study|Insurance denied the request|3|||
38018458|NCT03209362|69701327|FG000|Overall Study|Adverse Event|0|||
38018459|NCT03209362|69701328|FG001|Overall Study|Adverse Event|1|||
38018460|NCT03209362|69701327|FG000|Overall Study|Lost to Follow-up|0|||
38018461|NCT03209362|69701328|FG001|Overall Study|Lost to Follow-up|1|||
38018462|NCT03209362|69701327|FG000|Overall Study|Withdrawal by Subject|2|||
38018463|NCT03209362|69701328|FG001|Overall Study|Withdrawal by Subject|0|||
38018464|NCT03209362|69701327|FG000|Overall Study|Other|0|||
38018465|NCT03209362|69701328|FG001|Overall Study|Other|1|||
38018466|NCT02932462|69701336|FG000|Overall Study|Adverse Event|1|||
38018467|NCT02932462|69701337|FG001|Overall Study|Adverse Event|2|||
38018468|NCT02932462|69701336|FG000|Overall Study|Lost to Follow-up|4|||
38018469|NCT02932462|69701337|FG001|Overall Study|Lost to Follow-up|1|||
38018470|NCT02932462|69701336|FG000|Overall Study|Protocol Violation|0|||
38018471|NCT02932462|69701337|FG001|Overall Study|Protocol Violation|5|||
38018472|NCT02932462|69701336|FG000|Overall Study|Withdrawal by Subject|1|||
38018473|NCT02932462|69701337|FG001|Overall Study|Withdrawal by Subject|4|||
37698511|NCT02431247|69175253|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
37698512|NCT02431247|69175254|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
37698513|NCT02431247|69175255|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
37698514|NCT02431247|69175253|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
37698515|NCT02431247|69175254|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
37698516|NCT02431247|69175255|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
37698517|NCT02431247|69175253|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
37698518|NCT02431247|69175254|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
37698519|NCT02431247|69175255|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
37698520|NCT02431247|69175253|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
37698521|NCT02431247|69175254|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
37698522|NCT02431247|69175255|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
37698523|NCT02431247|69175253|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
37698524|NCT02431247|69175254|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
37698525|NCT02431247|69175255|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
37698526|NCT02431247|69175253|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
37698527|NCT02431247|69175254|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
37698528|NCT02431247|69175255|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
37698529|NCT02431247|69175253|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
37698530|NCT02431247|69175254|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
37698531|NCT02431247|69175255|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
37698532|NCT02431247|69175253|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
37698533|NCT02431247|69175254|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
37698534|NCT02431247|69175255|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
37698535|NCT02431247|69175253|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
37698536|NCT02431247|69175254|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
38018474|NCT02932462|69701336|FG000|Overall Study|Non-Compliance With Study Drug|0|||
38018475|NCT02932462|69701337|FG001|Overall Study|Non-Compliance With Study Drug|1|||
38018476|NCT02932462|69701336|FG000|Overall Study|Progressive Disease|1|||
38018477|NCT02932462|69701337|FG001|Overall Study|Progressive Disease|0|||
38018478|NCT03206788|69701345|FG000|Overall Study|Withdrawal by Subject|0|||
38018479|NCT03206788|69701346|FG001|Overall Study|Withdrawal by Subject|1|||
38018480|NCT03206788|69701345|FG000|Overall Study|Adverse Event|0|||
38018481|NCT03206788|69701346|FG001|Overall Study|Adverse Event|1|||
37698537|NCT02431247|69175255|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
37698538|NCT02431247|69175253|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
37910405|NCT00562861|69596492|FG001|Overall Study|Lack of Efficacy|5|||
38018482|NCT03206788|69701345|FG000|Overall Study|Physician Decision|0|||
38018483|NCT03206788|69701346|FG001|Overall Study|Physician Decision|1|||
38018484|NCT03205150|69701355|FG000|Overall Study|Protocol deviation|1|||
38018485|NCT03205150|69701356|FG001|Overall Study|Protocol deviation|3|||
38018486|NCT03205150|69701357|FG002|Overall Study|Protocol deviation|0|||
38018487|NCT03205150|69701355|FG000|Overall Study|Patient/guardian decision|0|||
38018488|NCT03205150|69701356|FG001|Overall Study|Patient/guardian decision|3|||
38018489|NCT03205150|69701357|FG002|Overall Study|Patient/guardian decision|0|||
38018490|NCT03205150|69701355|FG000|Overall Study|Adverse Event|1|||
38018491|NCT03205150|69701356|FG001|Overall Study|Adverse Event|1|||
38018492|NCT03205150|69701357|FG002|Overall Study|Adverse Event|1|||
38018493|NCT03205150|69701355|FG000|Overall Study|Lost to Follow-up|0|||
38018494|NCT03205150|69701356|FG001|Overall Study|Lost to Follow-up|0|||
38018495|NCT03205150|69701357|FG002|Overall Study|Lost to Follow-up|1|||
38018496|NCT02932306|69701368|FG000|Overall Study|Withdrawal by Subject|16|||
38018497|NCT02932306|69701369|FG001|Overall Study|Withdrawal by Subject|25|||
38018498|NCT02932306|69701368|FG000|Overall Study|Adverse Event|3|||
38018499|NCT02932306|69701369|FG001|Overall Study|Adverse Event|0|||
38018500|NCT02932306|69701368|FG000|Overall Study|Pregnancy|2|||
38018501|NCT02932306|69701369|FG001|Overall Study|Pregnancy|0|||
38018502|NCT02932306|69701368|FG000|Overall Study|Protocol Violation|1|||
38018503|NCT02932306|69701369|FG001|Overall Study|Protocol Violation|1|||
38018504|NCT02932306|69701368|FG000|Overall Study|Noncompliance with Study Drug|1|||
38018505|NCT02932306|69701369|FG001|Overall Study|Noncompliance with Study Drug|1|||
38018506|NCT02932306|69701368|FG000|Overall Study|Lost to Follow-up|36|||
38018507|NCT02932306|69701369|FG001|Overall Study|Lost to Follow-up|40|||
38018508|NCT02932306|69701368|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
38018509|NCT02932306|69701369|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
38018510|NCT02932306|69701368|FG000|Overall Study|Lack of Efficacy|0|||
38018511|NCT02932306|69701369|FG001|Overall Study|Lack of Efficacy|2|||
38018512|NCT02932306|69701368|FG000|Overall Study|Worsening condition|2|||
38018513|NCT02932306|69701369|FG001|Overall Study|Worsening condition|0|||
38018514|NCT02932306|69701368|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
38018515|NCT02932306|69701369|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
38018516|NCT02932228|69701377|FG000|Overall Study|Death|8|||
38018517|NCT02932228|69701378|FG001|Overall Study|Death|23|||
38018518|NCT02932228|69701377|FG000|Overall Study|not eligible upon chart review|2|||
38018519|NCT02932228|69701378|FG001|Overall Study|not eligible upon chart review|5|||
38018520|NCT02931838|69701392|FG000|Overall Study|Reason not provided by investigator|1|||
38018521|NCT02931838|69701393|FG001|Overall Study|Reason not provided by investigator|0|||
38018522|NCT02931838|69701394|FG002|Overall Study|Reason not provided by investigator|1|||
38018523|NCT02931838|69701395|FG003|Overall Study|Reason not provided by investigator|0|||
38018524|NCT02931838|69701396|FG004|Overall Study|Reason not provided by investigator|0|||
38018525|NCT02931838|69701397|FG005|Overall Study|Reason not provided by investigator|0|||
38018526|NCT02931838|69701392|FG000|Overall Study|Poor/non-compliance|0|||
38018527|NCT02931838|69701393|FG001|Overall Study|Poor/non-compliance|0|||
38018528|NCT02931838|69701394|FG002|Overall Study|Poor/non-compliance|1|||
38018529|NCT02931838|69701395|FG003|Overall Study|Poor/non-compliance|0|||
38018530|NCT02931838|69701396|FG004|Overall Study|Poor/non-compliance|0|||
38018531|NCT02931838|69701397|FG005|Overall Study|Poor/non-compliance|0|||
38018532|NCT02931838|69701392|FG000|Overall Study|Lack of Efficacy|5|||
38018533|NCT02931838|69701393|FG001|Overall Study|Lack of Efficacy|4|||
38018534|NCT02931838|69701394|FG002|Overall Study|Lack of Efficacy|0|||
38018535|NCT02931838|69701395|FG003|Overall Study|Lack of Efficacy|0|||
38018536|NCT02931838|69701396|FG004|Overall Study|Lack of Efficacy|0|||
38018537|NCT02931838|69701397|FG005|Overall Study|Lack of Efficacy|1|||
38018538|NCT02931838|69701392|FG000|Overall Study|Lost to Follow-up|1|||
38018539|NCT02931838|69701393|FG001|Overall Study|Lost to Follow-up|0|||
38018540|NCT02931838|69701394|FG002|Overall Study|Lost to Follow-up|1|||
38018541|NCT02931838|69701395|FG003|Overall Study|Lost to Follow-up|1|||
38018542|NCT02931838|69701396|FG004|Overall Study|Lost to Follow-up|2|||
38018543|NCT02931838|69701397|FG005|Overall Study|Lost to Follow-up|0|||
38018544|NCT02931838|69701392|FG000|Overall Study|Subject request to discontinue treatment|4|||
38018545|NCT02931838|69701393|FG001|Overall Study|Subject request to discontinue treatment|3|||
38018546|NCT02931838|69701394|FG002|Overall Study|Subject request to discontinue treatment|3|||
38018547|NCT02931838|69701395|FG003|Overall Study|Subject request to discontinue treatment|0|||
38018548|NCT02931838|69701396|FG004|Overall Study|Subject request to discontinue treatment|1|||
38018549|NCT02931838|69701397|FG005|Overall Study|Subject request to discontinue treatment|0|||
38018550|NCT02931838|69701392|FG000|Overall Study|Withdrawal by Subject|1|||
37698539|NCT02431247|69175254|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
37698540|NCT02431247|69175255|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
37698541|NCT01814878|69175269|FG000|Overall Study|Adverse Event|16|||
38018551|NCT02931838|69701393|FG001|Overall Study|Withdrawal by Subject|2|||
38018552|NCT02931838|69701394|FG002|Overall Study|Withdrawal by Subject|0|||
38018553|NCT02931838|69701395|FG003|Overall Study|Withdrawal by Subject|1|||
38018554|NCT02931838|69701396|FG004|Overall Study|Withdrawal by Subject|0|||
38018555|NCT02931838|69701397|FG005|Overall Study|Withdrawal by Subject|0|||
38018556|NCT02931838|69701392|FG000|Overall Study|Adverse Event|2|||
38018557|NCT02931838|69701393|FG001|Overall Study|Adverse Event|1|||
37698542|NCT01814878|69175270|FG001|Overall Study|Adverse Event|5|||
38018558|NCT02931838|69701394|FG002|Overall Study|Adverse Event|2|||
38018559|NCT02931838|69701395|FG003|Overall Study|Adverse Event|1|||
38018560|NCT02931838|69701396|FG004|Overall Study|Adverse Event|3|||
37910406|NCT00562861|69596491|FG000|Overall Study|noncompliance, moved|7|||
37910407|NCT00562861|69596492|FG001|Overall Study|noncompliance, moved|2|||
37910408|NCT00562861|69596491|FG000|Overall Study|Lost to Follow-up|7|||
37910409|NCT00562861|69596492|FG001|Overall Study|Lost to Follow-up|3|||
37910410|NCT00770679|69596498|FG000|Overall Study|Lost to Follow-up|3|||
37910411|NCT00770679|69596498|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
37910412|NCT00770601|69596502|FG000|Overall Study|Withdrawal by Subject|1|||
37910413|NCT00770367|69596508|FG000|First Intervention|Withdrawal by Subject|0|||
37910414|NCT00770367|69596509|FG001|First Intervention|Withdrawal by Subject|2|||
37910415|NCT00770367|69596508|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
37910416|NCT00770367|69596509|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
37910417|NCT00770367|69596508|FG000|Second Intervention|Lost to Follow-up|2|||
37910418|NCT00770367|69596509|FG001|Second Intervention|Lost to Follow-up|0|||
37910419|NCT00931307|69596517|FG000|Overall Study|Lack of Efficacy|12|||
37910420|NCT00931307|69596517|FG000|Overall Study|Biomicroscopy|1|||
37910421|NCT00930761|69596523|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
37910422|NCT00930761|69596524|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
37910423|NCT00930761|69596523|FG000|Overall Study|less than 3 music therapy sessions|0|||
37910424|NCT00930761|69596524|FG001|Overall Study|less than 3 music therapy sessions|3|||
37910425|NCT00770289|69596530|FG000|Overall Study|Other|6|||
37910426|NCT00770211|69596541|FG000|Overall Study|Lost to Follow-up|1|||
37910427|NCT00770211|69596542|FG001|Overall Study|Lost to Follow-up|0|||
37910428|NCT00770211|69596541|FG000|Overall Study|Withdrawal by Subject|0|||
37910429|NCT00770211|69596542|FG001|Overall Study|Withdrawal by Subject|2|||
37910430|NCT00928187|69596551|FG000|Overall Study|Death|1|||
37910431|NCT00928187|69596552|FG001|Overall Study|Death|2|||
37910432|NCT00928187|69596553|FG002|Overall Study|Death|3|||
37910433|NCT00928187|69596551|FG000|Overall Study|Lost to Follow-up|1|||
37910434|NCT00928187|69596552|FG001|Overall Study|Lost to Follow-up|2|||
37910435|NCT00928187|69596553|FG002|Overall Study|Lost to Follow-up|1|||
37910436|NCT00928187|69596551|FG000|Overall Study|Withdrawal by Subject|0|||
37910437|NCT00928187|69596552|FG001|Overall Study|Withdrawal by Subject|1|||
37910438|NCT00928187|69596553|FG002|Overall Study|Withdrawal by Subject|1|||
37910439|NCT00928187|69596551|FG000|Overall Study|Protocol Violation|0|||
37910440|NCT00928187|69596552|FG001|Overall Study|Protocol Violation|1|||
37910441|NCT00928187|69596553|FG002|Overall Study|Protocol Violation|0|||
37910442|NCT00769119|69596563|FG000|Overall Study|Voluntary discontinuation|0|||
37910443|NCT00769119|69596564|FG001|Overall Study|Voluntary discontinuation|2|||
37910444|NCT00769119|69596563|FG000|Overall Study|Adverse Event|1|||
37910445|NCT00769119|69596564|FG001|Overall Study|Adverse Event|1|||
37910446|NCT00769119|69596563|FG000|Overall Study|Disallowed medication|1|||
37910447|NCT00769119|69596564|FG001|Overall Study|Disallowed medication|0|||
37910448|NCT00927953|69596572|FG000|Overall Study|Death|2|||
37910449|NCT00927953|69596573|FG001|Overall Study|Death|1|||
37910450|NCT00768651|69596580|FG000|Overall Study|Withdrawal by Subject|1|||
37910451|NCT00756717|69596585|FG000|Overall Study|Withdrawal by Subject|2|||
37910452|NCT04987762|69596595|FG000|Overall Study|Study was Terminated by Sponsor|103|||
37910453|NCT04817332|69596622|FG000|Overall Study|Lost to Follow-up|3|||
37910454|NCT04817332|69596623|FG001|Overall Study|Lost to Follow-up|3|||
38018561|NCT02931838|69701397|FG005|Overall Study|Adverse Event|1|||
38018562|NCT03201562|69701419|FG000|Overall Study|Physician Decision|0|||
38018563|NCT03201562|69701420|FG001|Overall Study|Physician Decision|0|||
38018564|NCT03201562|69701421|FG002|Overall Study|Physician Decision|1|||
38018565|NCT03201562|69701419|FG000|Overall Study|Adverse Event|0|||
37832758|NCT01276639|69516370|FG002|Week 0 to 16|Withdrawal by Subject|4|||
37832759|NCT01276639|69516371|FG003|Week 0 to 16|Withdrawal by Subject|0|||
37832760|NCT01276639|69516372|FG004|Week 0 to 16|Withdrawal by Subject|0|||
37832761|NCT01276639|69516368|FG000|Week 0 to 16|Other|7|||
37832762|NCT01276639|69516369|FG001|Week 0 to 16|Other|7|||
37832763|NCT01276639|69516370|FG002|Week 0 to 16|Other|2|||
37832764|NCT01276639|69516371|FG003|Week 0 to 16|Other|0|||
37832765|NCT01276639|69516372|FG004|Week 0 to 16|Other|0|||
37832766|NCT01276639|69516368|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
37832767|NCT01276639|69516369|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
37910455|NCT04817332|69596622|FG000|Overall Study|Protocol Violation|2|||
38018566|NCT03201562|69701420|FG001|Overall Study|Adverse Event|0|||
37910456|NCT04817332|69596623|FG001|Overall Study|Protocol Violation|0|||
37910457|NCT04797637|69596631|FG000|Overall Study|Lost to Follow-up|23|||
37910458|NCT04797637|69596632|FG001|Overall Study|Lost to Follow-up|32|||
37910459|NCT04797637|69596631|FG000|Overall Study|Withdrawal by Subject|0|||
37910460|NCT04797637|69596632|FG001|Overall Study|Withdrawal by Subject|1|||
37910461|NCT04779489|69596638|FG000|Overall Study|Physician Decision|1|||
37910462|NCT04300296|69596669|FG000|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|1|||
37910463|NCT04300296|69596670|FG001|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
37910464|NCT04300296|69596671|FG002|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
37910465|NCT04300296|69596672|FG003|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
38018567|NCT03201562|69701421|FG002|Overall Study|Adverse Event|1|||
38018568|NCT03201562|69701419|FG000|Overall Study|Lost to Follow-up|0|||
38018569|NCT03201562|69701420|FG001|Overall Study|Lost to Follow-up|1|||
38018570|NCT03201562|69701421|FG002|Overall Study|Lost to Follow-up|2|||
38018571|NCT03200860|69701431|FG000|Overall Study|Withdrawal by Subject|1|||
38018572|NCT03200860|69701432|FG001|Overall Study|Withdrawal by Subject|0|||
38018573|NCT03198754|69701440|FG000|Overall Study|Withdrawal by Subject|5|||
38018574|NCT03198754|69701441|FG001|Overall Study|Withdrawal by Subject|4|||
38018575|NCT03198754|69701440|FG000|Overall Study|Lost to Follow-up|4|||
38018576|NCT03198754|69701441|FG001|Overall Study|Lost to Follow-up|3|||
38018577|NCT03198754|69701440|FG000|Overall Study|Ineligible|2|||
38018578|NCT03198754|69701441|FG001|Overall Study|Ineligible|1|||
38018579|NCT03198520|69701447|FG000|Overall Study|Physician Decision|2|||
38018580|NCT03198520|69701447|FG000|Overall Study|Protocol Violation|2|||
38018581|NCT03198520|69701447|FG000|Overall Study|Withdrawal by Subject|1|||
38018582|NCT03198520|69701447|FG000|Overall Study|Study Ended|1|||
38018583|NCT03194464|69701459|FG000|Overall Study|data not usable|2|||
38018584|NCT03192904|69701467|FG000|Overall Study|Physician Decision|3|||
38018585|NCT03192904|69701468|FG001|Overall Study|Physician Decision|1|||
38018586|NCT03192904|69701467|FG000|Overall Study|Lost to Follow-up|0|||
38018587|NCT03192904|69701468|FG001|Overall Study|Lost to Follow-up|1|||
38018588|NCT03188536|69701474|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
38018589|NCT03188536|69701474|FG000|Overall Study|Not participated/met inclusion criteria|1|||
38018590|NCT03187756|69701478|FG000|Overall Study|Termination of study|4|||
38018591|NCT03187132|69701484|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
38018592|NCT03187132|69701485|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
38018593|NCT03187132|69701484|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
38018594|NCT03187132|69701485|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
38018595|NCT03187132|69701484|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
38018596|NCT03187132|69701485|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
38018597|NCT03187132|69701484|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
38018598|NCT03187132|69701485|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
38018599|NCT03187132|69701484|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
38018600|NCT03187132|69701485|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
38018601|NCT03187132|69701484|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
38018602|NCT03187132|69701485|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
38018603|NCT03187132|69701484|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
38018604|NCT03187132|69701485|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
38018605|NCT03187132|69701484|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
38018606|NCT03187132|69701485|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
38018607|NCT03187132|69701484|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
38018608|NCT03187132|69701485|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
38018609|NCT03187132|69701484|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
38018610|NCT03187132|69701485|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
38018611|NCT03187132|69701484|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
38018612|NCT03187132|69701485|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
38018613|NCT03184558|69701491|FG000|Overall Study|Withdrawal by Subject|2|||
38018614|NCT03184558|69701491|FG000|Overall Study|Death|16|||
38018615|NCT03184558|69701491|FG000|Overall Study|Lost to Follow-up|2|||
38018616|NCT03184558|69701491|FG000|Overall Study|Other|9|||
38018617|NCT03183778|69701495|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
38018618|NCT03182686|69701501|FG000|Overall Study|Lost to Follow-up|2|||
38018619|NCT03182686|69701502|FG001|Overall Study|Lost to Follow-up|0|||
38018620|NCT03182686|69701501|FG000|Overall Study|Adverse Event|2|||
38018621|NCT03182686|69701502|FG001|Overall Study|Adverse Event|0|||
38018622|NCT03182686|69701501|FG000|Overall Study|Withdrawal by Subject|3|||
38018623|NCT03182686|69701502|FG001|Overall Study|Withdrawal by Subject|0|||
38018624|NCT03181594|69701508|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
38018625|NCT03181594|69701508|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
38018626|NCT03181594|69701508|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
38018627|NCT03181594|69701508|FG000|Initial Study Protocol (12-month FU)|Death|1|||
38018628|NCT03181594|69701508|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
38018629|NCT03181594|69701508|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
38018630|NCT03180736|69701514|FG000|Overall Study|Adverse Event|3|||
38018631|NCT03180736|69701515|FG001|Overall Study|Adverse Event|4|||
38018632|NCT03180736|69701514|FG000|Overall Study|Death|10|||
37832768|NCT01276639|69516370|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
38018633|NCT03180736|69701515|FG001|Overall Study|Death|7|||
38018634|NCT03180736|69701514|FG000|Overall Study|Withdrawal by Subject|5|||
38018635|NCT03180736|69701515|FG001|Overall Study|Withdrawal by Subject|12|||
38018636|NCT03180736|69701514|FG000|Overall Study|Lost to Follow-up|1|||
38018637|NCT03180736|69701515|FG001|Overall Study|Lost to Follow-up|0|||
37832769|NCT01276639|69516371|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
38018638|NCT03180736|69701514|FG000|Overall Study|Lack of Efficacy|66|||
38018639|NCT03180736|69701515|FG001|Overall Study|Lack of Efficacy|87|||
38018640|NCT03180736|69701514|FG000|Overall Study|Physician Decision|4|||
38018641|NCT03180736|69701515|FG001|Overall Study|Physician Decision|7|||
38018642|NCT03180736|69701514|FG000|Overall Study|randomized but not treated|2|||
38018643|NCT03180736|69701515|FG001|Overall Study|randomized but not treated|3|||
38018644|NCT03178942|69701528|FG000|Overall Study|Withdrawal by Subject|2|||
38018645|NCT03178942|69701529|FG001|Overall Study|Withdrawal by Subject|0|||
38018646|NCT03178942|69701528|FG000|Overall Study|Lost to Follow-up|1|||
38018647|NCT03178942|69701529|FG001|Overall Study|Lost to Follow-up|2|||
38018648|NCT03175198|69701535|FG000|Overall Study|Adverse Event|480|||
38018649|NCT03175198|69701535|FG000|Overall Study|No actual visit|120|||
38018650|NCT03175198|69701535|FG000|Overall Study|Registration rule not followed|4|||
38018651|NCT03175198|69701535|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
38018652|NCT03175198|69701535|FG000|Overall Study|Other personal reason|509|||
38018653|NCT03175198|69701535|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
38018654|NCT03175198|69701535|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
38018655|NCT03175198|69701535|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
38018656|NCT03175198|69701535|FG000|Overall Study|To conduct invasive treatment of operation|53|||
38018657|NCT03175198|69701535|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
38018658|NCT03175120|69701541|FG000|Overall Study|Adverse Event|2|||
38018659|NCT03175120|69701542|FG001|Overall Study|Adverse Event|2|||
38018660|NCT03175120|69701541|FG000|Overall Study|Protocol Violation|5|||
38018661|NCT03175120|69701542|FG001|Overall Study|Protocol Violation|2|||
38018662|NCT03175120|69701541|FG000|Overall Study|Lost to Follow-up|1|||
38018663|NCT03175120|69701542|FG001|Overall Study|Lost to Follow-up|0|||
38018664|NCT03175120|69701541|FG000|Overall Study|Withdrawal by Subject|2|||
38018665|NCT03175120|69701542|FG001|Overall Study|Withdrawal by Subject|5|||
38018666|NCT03175120|69701541|FG000|Overall Study|Other|2|||
38018667|NCT03175120|69701542|FG001|Overall Study|Other|3|||
38018668|NCT03172702|69701548|FG000|Overall Study|Adverse Event|9|||
38018669|NCT03172702|69701548|FG000|Overall Study|Death|2|||
38018670|NCT03172702|69701548|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
38018671|NCT03172702|69701548|FG000|Overall Study|Withdrawal by Subject|5|||
38018672|NCT03172702|69701548|FG000|Overall Study|Other|2|||
38018673|NCT02795182|69701557|FG000|Overall Study|Death|5|||
38018674|NCT02795182|69701558|FG001|Overall Study|Death|4|||
38018675|NCT02795182|69701559|FG002|Overall Study|Death|4|||
38018676|NCT02795182|69701560|FG003|Overall Study|Death|18|||
38018677|NCT02795182|69701557|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
38018678|NCT02795182|69701558|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
38018679|NCT02795182|69701559|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
38018680|NCT02795182|69701560|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
38018681|NCT02795182|69701557|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
38018682|NCT02795182|69701558|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
38018683|NCT02795182|69701559|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
38018684|NCT02795182|69701560|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
38018685|NCT02795182|69701557|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
38018686|NCT02795182|69701558|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
38018687|NCT02795182|69701559|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
38018688|NCT02795182|69701560|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
38018689|NCT02795182|69701557|FG000|Overall Study|Withdrawal by Subject|4|||
38018690|NCT02795182|69701558|FG001|Overall Study|Withdrawal by Subject|0|||
38018691|NCT02795182|69701559|FG002|Overall Study|Withdrawal by Subject|0|||
38018692|NCT02795182|69701560|FG003|Overall Study|Withdrawal by Subject|3|||
38018693|NCT02795182|69701557|FG000|Overall Study|Lost to Follow-up|0|||
38018694|NCT02795182|69701558|FG001|Overall Study|Lost to Follow-up|0|||
38018695|NCT02795182|69701559|FG002|Overall Study|Lost to Follow-up|1|||
38018696|NCT02795182|69701560|FG003|Overall Study|Lost to Follow-up|1|||
38018697|NCT02795182|69701557|FG000|Overall Study|Roll Over to Long Term Extension|3|||
38018698|NCT02795182|69701558|FG001|Overall Study|Roll Over to Long Term Extension|3|||
38018699|NCT02795182|69701559|FG002|Overall Study|Roll Over to Long Term Extension|2|||
38018700|NCT02795182|69701560|FG003|Overall Study|Roll Over to Long Term Extension|5|||
38018701|NCT02795182|69701557|FG000|Overall Study|Progressive Disease|0|||
38018702|NCT02795182|69701558|FG001|Overall Study|Progressive Disease|1|||
38018703|NCT02795182|69701559|FG002|Overall Study|Progressive Disease|0|||
38018704|NCT02795182|69701560|FG003|Overall Study|Progressive Disease|4|||
38018705|NCT02795182|69701557|FG000|Overall Study|Physician Decision|0|||
38018706|NCT02795182|69701558|FG001|Overall Study|Physician Decision|0|||
38018707|NCT02795182|69701559|FG002|Overall Study|Physician Decision|0|||
38018708|NCT02795182|69701560|FG003|Overall Study|Physician Decision|1|||
38018709|NCT03167242|69701589|FG000|Overall Study|Patient/Guardian Decision|0|||
38018710|NCT03167242|69701590|FG001|Overall Study|Patient/Guardian Decision|1|||
38018711|NCT03167242|69701591|FG002|Overall Study|Patient/Guardian Decision|2|||
38018712|NCT03167242|69701592|FG003|Overall Study|Patient/Guardian Decision|1|||
38018713|NCT03167242|69701593|FG004|Overall Study|Patient/Guardian Decision|1|||
38018714|NCT03167242|69701594|FG005|Overall Study|Patient/Guardian Decision|1|||
38018715|NCT03167242|69701595|FG006|Overall Study|Patient/Guardian Decision|0|||
38018716|NCT03167242|69701596|FG007|Overall Study|Patient/Guardian Decision|0|||
38018717|NCT03167242|69701597|FG008|Overall Study|Patient/Guardian Decision|0|||
38018718|NCT03167242|69701598|FG009|Overall Study|Patient/Guardian Decision|0|||
38018719|NCT03167242|69701599|FG010|Overall Study|Patient/Guardian Decision|1|||
38018720|NCT03167242|69701600|FG011|Overall Study|Patient/Guardian Decision|0|||
38018721|NCT03167242|69701589|FG000|Overall Study|Lost to Follow-up|0|||
38018722|NCT03167242|69701590|FG001|Overall Study|Lost to Follow-up|0|||
38018723|NCT03167242|69701591|FG002|Overall Study|Lost to Follow-up|1|||
38018724|NCT03167242|69701592|FG003|Overall Study|Lost to Follow-up|0|||
38018725|NCT03167242|69701593|FG004|Overall Study|Lost to Follow-up|0|||
38018726|NCT03167242|69701594|FG005|Overall Study|Lost to Follow-up|1|||
38018727|NCT03167242|69701595|FG006|Overall Study|Lost to Follow-up|2|||
38018728|NCT03167242|69701596|FG007|Overall Study|Lost to Follow-up|1|||
38018729|NCT03167242|69701597|FG008|Overall Study|Lost to Follow-up|0|||
38018730|NCT03167242|69701598|FG009|Overall Study|Lost to Follow-up|0|||
38018731|NCT03167242|69701599|FG010|Overall Study|Lost to Follow-up|1|||
38018732|NCT03167242|69701600|FG011|Overall Study|Lost to Follow-up|1|||
38018733|NCT03167242|69701589|FG000|Overall Study|Reason not provided|0|||
38018734|NCT03167242|69701590|FG001|Overall Study|Reason not provided|0|||
38018735|NCT03167242|69701591|FG002|Overall Study|Reason not provided|0|||
38018736|NCT03167242|69701592|FG003|Overall Study|Reason not provided|0|||
38018737|NCT03167242|69701593|FG004|Overall Study|Reason not provided|0|||
38018738|NCT03167242|69701594|FG005|Overall Study|Reason not provided|0|||
38018739|NCT03167242|69701595|FG006|Overall Study|Reason not provided|0|||
38018740|NCT03167242|69701596|FG007|Overall Study|Reason not provided|0|||
38018741|NCT03167242|69701597|FG008|Overall Study|Reason not provided|1|||
38018742|NCT03167242|69701598|FG009|Overall Study|Reason not provided|0|||
38018743|NCT03167242|69701599|FG010|Overall Study|Reason not provided|0|||
38018744|NCT03167242|69701600|FG011|Overall Study|Reason not provided|0|||
38018745|NCT03286426|69701636|FG000|Overall Study|Physician Decision|3|||
38018746|NCT02882152|69701655|FG000|Overall Study|Lost to Follow-up|1|||
38018747|NCT02882152|69701656|FG001|Overall Study|Lost to Follow-up|0|||
38018748|NCT00286091|69701664|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
38018749|NCT00286091|69701665|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
38018750|NCT00286091|69701664|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
38018751|NCT00286091|69701665|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
38018752|NCT00286091|69701664|FG000|Double-blind Treatment Phase|Death|58|||
38018753|NCT00286091|69701665|FG001|Double-blind Treatment Phase|Death|65|||
38018754|NCT00286091|69701664|FG000|Double-blind Treatment Phase|Adverse Event|28|||
38018755|NCT00286091|69701665|FG001|Double-blind Treatment Phase|Adverse Event|40|||
38018756|NCT00286091|69701664|FG000|Double-blind Treatment Phase|Disease Progression|22|||
38018757|NCT00286091|69701665|FG001|Double-blind Treatment Phase|Disease Progression|35|||
38018758|NCT00286091|69701664|FG000|Double-blind Treatment Phase|Other|25|||
38018759|NCT00286091|69701665|FG001|Double-blind Treatment Phase|Other|33|||
38018760|NCT00286091|69701664|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
38018761|NCT00286091|69701665|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
38018762|NCT00286091|69701664|FG000|Double-blind Treatment Phase|Noncompliance|8|||
38018763|NCT00286091|69701665|FG001|Double-blind Treatment Phase|Noncompliance|8|||
38018764|NCT00286091|69701664|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
38018765|NCT00286091|69701665|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
38018766|NCT00286091|69701664|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
38018767|NCT00286091|69701665|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
38018768|NCT00286091|69701664|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
38018769|NCT00286091|69701665|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
38018770|NCT00286091|69701664|FG000|Open-label Treatment Phase|Physician Decision|24|||
38018771|NCT00286091|69701665|FG001|Open-label Treatment Phase|Physician Decision|21|||
38018772|NCT00286091|69701664|FG000|Open-label Treatment Phase|Adverse Event|5|||
38018773|NCT00286091|69701665|FG001|Open-label Treatment Phase|Adverse Event|16|||
38018774|NCT00286091|69701664|FG000|Open-label Treatment Phase|Other|11|||
38018775|NCT00286091|69701665|FG001|Open-label Treatment Phase|Other|11|||
38018776|NCT00286091|69701664|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
37910466|NCT04300296|69596673|FG004|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
38018777|NCT00286091|69701665|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
38018778|NCT00286091|69701664|FG000|Open-label Treatment Phase|Death|10|||
38018779|NCT00286091|69701665|FG001|Open-label Treatment Phase|Death|7|||
38018780|NCT00286091|69701664|FG000|Open-label Treatment Phase|Disease Progression|9|||
38018781|NCT00286091|69701665|FG001|Open-label Treatment Phase|Disease Progression|3|||
38018782|NCT00286091|69701664|FG000|Open-label Treatment Phase|Noncompliance|3|||
38018783|NCT00286091|69701665|FG001|Open-label Treatment Phase|Noncompliance|1|||
38018784|NCT00286091|69701664|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
38018785|NCT00286091|69701665|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
38018786|NCT00286091|69701664|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
38018787|NCT00286091|69701665|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
38018788|NCT00286091|69701664|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
38018789|NCT00286091|69701665|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
38018790|NCT00285857|69701673|FG000|Overall Study|Withdrawal by Subject|2|||
38018791|NCT00285857|69701673|FG000|Overall Study|Inadequate initial breast cytology|1|||
38018792|NCT00285857|69701673|FG000|Overall Study|Adverse Event|1|||
38018793|NCT00284141|69701682|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
38018794|NCT00284141|69701682|FG000|Overall Study|Adverse Event|19|||
38018795|NCT00284141|69701682|FG000|Overall Study|Participant's request|9|||
38018796|NCT00284141|69701682|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
38018797|NCT00284141|69701682|FG000|Overall Study|Clinical deterioration / death|2|||
38018798|NCT00284141|69701682|FG000|Overall Study|General decline|1|||
38018799|NCT00284141|69701682|FG000|Overall Study|Pneumonia|1|||
38018800|NCT00284141|69701682|FG000|Overall Study|Did not take study medication|2|||
38018801|NCT00284141|69701682|FG000|Overall Study|Ongoing treatment|2|||
38018802|NCT00265343|69701690|FG000|Overall Study|Adverse Event|10|||
38018803|NCT00265343|69701691|FG001|Overall Study|Adverse Event|7|||
38018804|NCT00265343|69701690|FG000|Overall Study|Withdrawal by Subject|3|||
38018805|NCT00265343|69701691|FG001|Overall Study|Withdrawal by Subject|9|||
38018806|NCT00265343|69701690|FG000|Overall Study|Other|8|||
38018807|NCT00265343|69701691|FG001|Overall Study|Other|3|||
38018808|NCT00283595|69701699|FG000|Overall Study|Withdrawal by Subject|1|||
38018809|NCT00283595|69701700|FG001|Overall Study|Withdrawal by Subject|2|||
38018810|NCT00265109|69701706|FG000|Overall Study|Withdrawal by Subject|5|||
38018811|NCT00265109|69701706|FG000|Overall Study|Adverse Event|1|||
38018812|NCT03235024|69701713|FG000|Overall Study|Adverse Event|2|||
38018813|NCT03235024|69701714|FG001|Overall Study|Adverse Event|2|||
38018814|NCT03235024|69701713|FG000|Overall Study|Death|1|||
38018815|NCT03235024|69701714|FG001|Overall Study|Death|0|||
38018816|NCT03235024|69701713|FG000|Overall Study|Lost to Follow-up|2|||
38018817|NCT03235024|69701714|FG001|Overall Study|Lost to Follow-up|5|||
38018818|NCT03235024|69701713|FG000|Overall Study|Protocol Violation|1|||
38018819|NCT03235024|69701714|FG001|Overall Study|Protocol Violation|0|||
38018820|NCT03235024|69701713|FG000|Overall Study|Withdrawal by Subject|0|||
38018821|NCT03235024|69701714|FG001|Overall Study|Withdrawal by Subject|3|||
38018822|NCT03233308|69701720|FG000|Overall Study|Adverse Event|1|||
38018823|NCT03233308|69701720|FG000|Overall Study|Protocol Violation|1|||
38018824|NCT00283439|69701735|FG000|Overall Study|Adverse Event|0|||
38018825|NCT00283439|69701736|FG001|Overall Study|Adverse Event|0|||
38018826|NCT00283439|69701737|FG002|Overall Study|Adverse Event|0|||
38018827|NCT00283439|69701738|FG003|Overall Study|Adverse Event|1|||
38018828|NCT00283439|69701735|FG000|Overall Study|Death|0|||
38018829|NCT00283439|69701736|FG001|Overall Study|Death|0|||
38018830|NCT00283439|69701737|FG002|Overall Study|Death|1|||
38018831|NCT00283439|69701738|FG003|Overall Study|Death|0|||
38018832|NCT00283439|69701735|FG000|Overall Study|Disease progression|0|||
38018833|NCT00283439|69701736|FG001|Overall Study|Disease progression|1|||
38018834|NCT00283439|69701737|FG002|Overall Study|Disease progression|0|||
38018835|NCT00283439|69701738|FG003|Overall Study|Disease progression|0|||
38018836|NCT00283439|69701735|FG000|Overall Study|Requirement for alternative therapy|1|||
38018837|NCT00283439|69701736|FG001|Overall Study|Requirement for alternative therapy|2|||
38018838|NCT00283439|69701737|FG002|Overall Study|Requirement for alternative therapy|5|||
38018839|NCT00283439|69701738|FG003|Overall Study|Requirement for alternative therapy|2|||
38018840|NCT00283439|69701735|FG000|Overall Study|Stem cell transplant|6|||
38018841|NCT00283439|69701736|FG001|Overall Study|Stem cell transplant|6|||
38018842|NCT00283439|69701737|FG002|Overall Study|Stem cell transplant|4|||
38018843|NCT00283439|69701738|FG003|Overall Study|Stem cell transplant|3|||
38018844|NCT00283439|69701735|FG000|Overall Study|Treatment discontinued|0|||
38018845|NCT00283439|69701736|FG001|Overall Study|Treatment discontinued|2|||
38018846|NCT00283439|69701737|FG002|Overall Study|Treatment discontinued|1|||
38018847|NCT00283439|69701738|FG003|Overall Study|Treatment discontinued|3|||
38018848|NCT00283439|69701735|FG000|Overall Study|Other|1|||
38018849|NCT00283439|69701736|FG001|Overall Study|Other|0|||
38018850|NCT00283439|69701737|FG002|Overall Study|Other|0|||
38018851|NCT00283439|69701738|FG003|Overall Study|Other|0|||
38018852|NCT03233230|69701752|FG000|Overall Study|Adverse Event|6|||
38018853|NCT03233230|69701753|FG001|Overall Study|Adverse Event|3|||
38018854|NCT03233230|69701754|FG002|Overall Study|Adverse Event|6|||
38018855|NCT03233230|69701755|FG003|Overall Study|Adverse Event|3|||
38018856|NCT03233230|69701752|FG000|Overall Study|Protocol Violation|1|||
38018857|NCT03233230|69701753|FG001|Overall Study|Protocol Violation|2|||
38018858|NCT03233230|69701754|FG002|Overall Study|Protocol Violation|1|||
38018859|NCT03233230|69701755|FG003|Overall Study|Protocol Violation|1|||
38018860|NCT03233230|69701752|FG000|Overall Study|Lack of Efficacy|1|||
38018861|NCT03233230|69701753|FG001|Overall Study|Lack of Efficacy|0|||
38018862|NCT03233230|69701754|FG002|Overall Study|Lack of Efficacy|0|||
38018863|NCT03233230|69701755|FG003|Overall Study|Lack of Efficacy|0|||
38018864|NCT03233230|69701752|FG000|Overall Study|Other|5|||
38018865|NCT03233230|69701753|FG001|Overall Study|Other|5|||
38018866|NCT03233230|69701754|FG002|Overall Study|Other|5|||
38018867|NCT03233230|69701755|FG003|Overall Study|Other|3|||
38018868|NCT03233230|69701752|FG000|Overall Study|Withdrawal by Subject|2|||
38018869|NCT03233230|69701753|FG001|Overall Study|Withdrawal by Subject|2|||
38018870|NCT03233230|69701754|FG002|Overall Study|Withdrawal by Subject|0|||
38018871|NCT03233230|69701755|FG003|Overall Study|Withdrawal by Subject|1|||
38018872|NCT03233230|69701752|FG000|Overall Study|Lost to Follow-up|0|||
38018873|NCT03233230|69701753|FG001|Overall Study|Lost to Follow-up|3|||
38018874|NCT03233230|69701754|FG002|Overall Study|Lost to Follow-up|0|||
38018875|NCT03233230|69701755|FG003|Overall Study|Lost to Follow-up|0|||
38018876|NCT00283049|69701768|FG000|Overall Study|Adverse Event|6|||
38018877|NCT00283049|69701769|FG001|Overall Study|Adverse Event|1|||
38018878|NCT00283049|69701770|FG002|Overall Study|Adverse Event|4|||
38018879|NCT00283049|69701768|FG000|Overall Study|Protocol Violation|3|||
38018880|NCT00283049|69701769|FG001|Overall Study|Protocol Violation|0|||
38018881|NCT00283049|69701770|FG002|Overall Study|Protocol Violation|3|||
38018882|NCT00283049|69701768|FG000|Overall Study|Death|1|||
38018883|NCT00283049|69701769|FG001|Overall Study|Death|1|||
38018884|NCT00283049|69701770|FG002|Overall Study|Death|1|||
38018885|NCT00283049|69701768|FG000|Overall Study|Lack of Efficacy|0|||
38018886|NCT00283049|69701769|FG001|Overall Study|Lack of Efficacy|1|||
38018887|NCT00283049|69701770|FG002|Overall Study|Lack of Efficacy|1|||
38018888|NCT00283049|69701768|FG000|Overall Study|Lost to Follow-up|4|||
38018889|NCT00283049|69701769|FG001|Overall Study|Lost to Follow-up|2|||
38018890|NCT00283049|69701770|FG002|Overall Study|Lost to Follow-up|5|||
38018891|NCT00283049|69701768|FG000|Overall Study|Withdrawal by Subject|26|||
38018892|NCT00283049|69701769|FG001|Overall Study|Withdrawal by Subject|24|||
38018893|NCT00283049|69701770|FG002|Overall Study|Withdrawal by Subject|19|||
38018894|NCT00283049|69701768|FG000|Overall Study|Discontinuation of Study|18|||
38018895|NCT00283049|69701769|FG001|Overall Study|Discontinuation of Study|16|||
38018896|NCT00283049|69701770|FG002|Overall Study|Discontinuation of Study|20|||
38018897|NCT00283049|69701768|FG000|Overall Study|No longer requires study treatment|0|||
38018898|NCT00283049|69701769|FG001|Overall Study|No longer requires study treatment|0|||
38018899|NCT00283049|69701770|FG002|Overall Study|No longer requires study treatment|1|||
38018900|NCT00264875|69701778|FG000|Overall Study|Adverse Event|6|||
38018901|NCT00264875|69701778|FG000|Overall Study|Lost to Follow-up|6|||
38018902|NCT00264875|69701778|FG000|Overall Study|Protocol Violation|11|||
38018903|NCT00264875|69701778|FG000|Overall Study|Withdrawal by Subject|7|||
38018904|NCT03152110|69701782|FG000|Overall Study|Withdrawal by Subject|3|||
38018905|NCT03151408|69701789|FG000|Overall Study|Adverse Event|24|||
38018906|NCT03151408|69701790|FG001|Overall Study|Adverse Event|23|||
38018907|NCT03151408|69701789|FG000|Overall Study|Death|46|||
38018908|NCT03151408|69701790|FG001|Overall Study|Death|26|||
38018909|NCT03151408|69701789|FG000|Overall Study|Physician Decision|13|||
38018910|NCT03151408|69701790|FG001|Overall Study|Physician Decision|19|||
38018911|NCT03151408|69701789|FG000|Overall Study|Withdrawal by Subject|16|||
38018912|NCT03151408|69701790|FG001|Overall Study|Withdrawal by Subject|20|||
38018913|NCT03151408|69701789|FG000|Overall Study|Progressive disease|45|||
38018914|NCT03151408|69701790|FG001|Overall Study|Progressive disease|61|||
38018915|NCT03151408|69701789|FG000|Overall Study|non-compliance by patient|1|||
38018916|NCT03151408|69701790|FG001|Overall Study|non-compliance by patient|0|||
38018917|NCT03151408|69701789|FG000|Overall Study|other reasons|56|||
38018918|NCT03151408|69701790|FG001|Overall Study|other reasons|52|||
38018919|NCT03151408|69701789|FG000|Overall Study|randomized and not treated|2|||
37698543|NCT01814878|69175269|FG000|Overall Study|Withdrawal by Subject|20|||
38018920|NCT03151408|69701790|FG001|Overall Study|randomized and not treated|2|||
37698544|NCT01814878|69175270|FG001|Overall Study|Withdrawal by Subject|16|||
38018921|NCT00546754|69701798|FG000|Overall Study|Serious Adverse Event|1|||
38018922|NCT00546754|69701799|FG001|Overall Study|Serious Adverse Event|1|||
38018923|NCT00546754|69701798|FG000|Overall Study|Adverse Event|11|||
37698545|NCT01814878|69175269|FG000|Overall Study|Protocol Violation|5|||
38018924|NCT00546754|69701799|FG001|Overall Study|Adverse Event|16|||
37698546|NCT01814878|69175270|FG001|Overall Study|Protocol Violation|5|||
38018925|NCT00546754|69701798|FG000|Overall Study|Lack of Efficacy|1|||
38018926|NCT00546754|69701799|FG001|Overall Study|Lack of Efficacy|1|||
38018927|NCT00546754|69701798|FG000|Overall Study|Lost to Follow-up|9|||
38018928|NCT00546754|69701799|FG001|Overall Study|Lost to Follow-up|15|||
38018929|NCT00546754|69701798|FG000|Overall Study|Protocol Violation|3|||
38018930|NCT00546754|69701799|FG001|Overall Study|Protocol Violation|0|||
38018931|NCT00546754|69701798|FG000|Overall Study|Withdrawal by Subject|6|||
38018932|NCT00546754|69701799|FG001|Overall Study|Withdrawal by Subject|7|||
38018933|NCT00546754|69701798|FG000|Overall Study|Dyspnea|1|||
38018934|NCT00546754|69701799|FG001|Overall Study|Dyspnea|0|||
38018935|NCT00546754|69701798|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
38018936|NCT00546754|69701799|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
38018937|NCT00546754|69701798|FG000|Overall Study|Hip Replacement|1|||
38018938|NCT00546754|69701799|FG001|Overall Study|Hip Replacement|0|||
38018939|NCT00546754|69701798|FG000|Overall Study|Suicide|1|||
38018940|NCT00546754|69701799|FG001|Overall Study|Suicide|0|||
38018941|NCT00546754|69701798|FG000|Overall Study|Missing Cooperation|1|||
38018942|NCT00546754|69701799|FG001|Overall Study|Missing Cooperation|0|||
38018943|NCT00546754|69701798|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
38018944|NCT00546754|69701799|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
38018945|NCT00546754|69701798|FG000|Overall Study|Patient's Decision|0|||
38018946|NCT00546754|69701799|FG001|Overall Study|Patient's Decision|1|||
38018947|NCT00546754|69701798|FG000|Overall Study|Missing|14|||
38018948|NCT00546754|69701799|FG001|Overall Study|Missing|7|||
38018949|NCT00282347|69701807|FG000|Treatment Period|Death|2|||
38018950|NCT00282347|69701808|FG001|Treatment Period|Death|0|||
38018951|NCT00282347|69701807|FG000|Treatment Period|Lost to Follow-up|2|||
38018952|NCT00282347|69701808|FG001|Treatment Period|Lost to Follow-up|5|||
38018953|NCT00282347|69701807|FG000|Treatment Period|Withdrawal by Subject|1|||
38018954|NCT00282347|69701808|FG001|Treatment Period|Withdrawal by Subject|3|||
38018955|NCT00282347|69701807|FG000|Treatment Period|Physician Decision|0|||
38018956|NCT00282347|69701808|FG001|Treatment Period|Physician Decision|1|||
38018957|NCT00282347|69701807|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
38018958|NCT00282347|69701808|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
38018959|NCT00282347|69701807|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
38018960|NCT00282347|69701808|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
38018961|NCT00282347|69701807|FG000|Safety Follow-up Period|Physician Decision|1|||
38018962|NCT00282347|69701808|FG001|Safety Follow-up Period|Physician Decision|1|||
38018963|NCT00282347|69701807|FG000|Safety Follow-up Period|Protocol Deviation|0|||
38018964|NCT00282347|69701808|FG001|Safety Follow-up Period|Protocol Deviation|2|||
38018965|NCT00282347|69701807|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
38018966|NCT00282347|69701808|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
38018967|NCT00282347|69701807|FG000|B Cell Follow-up Period|Physician Decision|1|||
38018968|NCT00282347|69701808|FG001|B Cell Follow-up Period|Physician Decision|0|||
38018969|NCT00282347|69701807|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
38018970|NCT00282347|69701808|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
38018971|NCT00405964|69701818|FG000|Overall Study|Treatment Failure|17|||
38018972|NCT00405964|69701819|FG001|Overall Study|Treatment Failure|45|||
38018973|NCT00405964|69701818|FG000|Overall Study|Adverse Event|7|||
38018974|NCT00405964|69701819|FG001|Overall Study|Adverse Event|16|||
38018975|NCT00405964|69701818|FG000|Overall Study|Lost to Follow-up|5|||
38018976|NCT00405964|69701819|FG001|Overall Study|Lost to Follow-up|5|||
38018977|NCT00405964|69701818|FG000|Overall Study|Withdrawal by Subject|19|||
38018978|NCT00405964|69701819|FG001|Overall Study|Withdrawal by Subject|23|||
38018979|NCT00405964|69701818|FG000|Overall Study|Protocol Violation|11|||
38018980|NCT00405964|69701819|FG001|Overall Study|Protocol Violation|6|||
38018981|NCT00264797|69701827|FG000|Overall Study|Withdrawal by Subject|11|||
38018982|NCT00264797|69701828|FG001|Overall Study|Withdrawal by Subject|11|||
38018983|NCT00264797|69701827|FG000|Overall Study|Lost to Follow-up|9|||
37698547|NCT01814878|69175269|FG000|Overall Study|Physician Decision|3|||
37910467|NCT04300296|69596674|FG005|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
37910468|NCT04300296|69596669|FG000|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
38018984|NCT00264797|69701828|FG001|Overall Study|Lost to Follow-up|17|||
38018985|NCT00264797|69701827|FG000|Overall Study|Moved from area|3|||
38018986|NCT00264797|69701828|FG001|Overall Study|Moved from area|1|||
38018987|NCT00264797|69701827|FG000|Overall Study|Practical Problems|2|||
38018988|NCT00264797|69701828|FG001|Overall Study|Practical Problems|3|||
38018989|NCT00264797|69701827|FG000|Overall Study|Incarceration|4|||
38018990|NCT00264797|69701828|FG001|Overall Study|Incarceration|5|||
38018991|NCT00264797|69701827|FG000|Overall Study|Pressure/advice from Outsiders|1|||
38018992|NCT00264797|69701828|FG001|Overall Study|Pressure/advice from Outsiders|1|||
38018993|NCT00264797|69701827|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
38018994|NCT00264797|69701828|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
38018995|NCT00264797|69701827|FG000|Overall Study|Other|3|||
38018996|NCT00264797|69701828|FG001|Overall Study|Other|4|||
38018997|NCT03148756|69701836|FG000|Overall Study|Study Terminated|0|||
38018998|NCT03148756|69701837|FG001|Overall Study|Study Terminated|1|||
38018999|NCT00282113|69701846|FG000|Overall Study|Removed at parents request|1|||
38019000|NCT00282113|69701847|FG001|Overall Study|Removed at parents request|0|||
38019001|NCT00282113|69701848|FG002|Overall Study|Removed at parents request|0|||
38019002|NCT00281957|69701858|FG000|Overall Study|Adverse Event|7|||
38019003|NCT00281957|69701859|FG001|Overall Study|Adverse Event|2|||
38019004|NCT00281957|69701858|FG000|Overall Study|Death|1|||
38019005|NCT00281957|69701859|FG001|Overall Study|Death|0|||
38019006|NCT00281957|69701858|FG000|Overall Study|Progression/relapse|47|||
38019007|NCT00281957|69701859|FG001|Overall Study|Progression/relapse|35|||
38019008|NCT00281957|69701858|FG000|Overall Study|Not protocol specified|8|||
38019009|NCT00281957|69701859|FG001|Overall Study|Not protocol specified|1|||
38019010|NCT00281957|69701858|FG000|Overall Study|Not eligible|1|||
38019011|NCT00281957|69701859|FG001|Overall Study|Not eligible|2|||
38019012|NCT00281957|69701858|FG000|Overall Study|Did not start treatment|3|||
38019013|NCT00281957|69701859|FG001|Overall Study|Did not start treatment|1|||
38019014|NCT00281957|69701858|FG000|Overall Study|Refusal unrelated to adverse events|0|||
38019015|NCT00281957|69701859|FG001|Overall Study|Refusal unrelated to adverse events|1|||
38019016|NCT00281099|69701869|FG000|Overall Study|Death|46|||
38019017|NCT00281099|69701870|FG001|Overall Study|Death|57|||
38019018|NCT00281099|69701869|FG000|Overall Study|Lost to Follow-up|10|||
38019019|NCT00281099|69701870|FG001|Overall Study|Lost to Follow-up|19|||
38019020|NCT00281099|69701869|FG000|Overall Study|Withdrawal by Subject|65|||
38019021|NCT00281099|69701870|FG001|Overall Study|Withdrawal by Subject|70|||
38019022|NCT00281099|69701869|FG000|Overall Study|Physician Decision|79|||
38019023|NCT00281099|69701870|FG001|Overall Study|Physician Decision|72|||
38019024|NCT00281099|69701869|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
38019025|NCT00281099|69701870|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
38019026|NCT00262925|69701877|FG000|Overall Study|Lack of Efficacy|3|||
38019027|NCT00262925|69701877|FG000|Overall Study|Adverse Event|4|||
38019028|NCT00262925|69701877|FG000|Overall Study|Death|2|||
38019029|NCT00262925|69701877|FG000|Overall Study|alternative therapy|1|||
38019030|NCT00262925|69701877|FG000|Overall Study|Other|1|||
38019031|NCT03720470|69701887|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
38019032|NCT03720470|69701888|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
38019033|NCT03720470|69701889|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
38019034|NCT03720470|69701890|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
38019035|NCT03720470|69701891|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
38019036|NCT03720470|69701892|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
38019037|NCT03720470|69701887|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
38019038|NCT03720470|69701888|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
38019039|NCT03720470|69701889|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
38019040|NCT03720470|69701890|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
38019041|NCT03720470|69701891|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
38019042|NCT03720470|69701892|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
38019043|NCT03720470|69701887|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
38019044|NCT03720470|69701888|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
38019045|NCT03720470|69701889|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
38019046|NCT03720470|69701890|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
38019047|NCT03720470|69701891|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
38019048|NCT03720470|69701892|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
38019049|NCT03720470|69701887|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
38019050|NCT03720470|69701888|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
38019051|NCT03720470|69701889|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
38019052|NCT03720470|69701890|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
38019053|NCT03720470|69701891|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
38019054|NCT03720470|69701892|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
38019055|NCT03720470|69701887|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
37698548|NCT01814878|69175270|FG001|Overall Study|Physician Decision|1|||
38019056|NCT03720470|69701888|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
38019057|NCT03720470|69701889|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
38019058|NCT03720470|69701890|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
38019059|NCT03720470|69701891|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
38019060|NCT03720470|69701892|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
38019061|NCT03720470|69701887|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
38019062|NCT03720470|69701888|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
38019063|NCT03720470|69701889|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
38019064|NCT03720470|69701890|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
38019065|NCT03720470|69701891|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
38019066|NCT03720470|69701892|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
38019067|NCT03720470|69701887|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
38019068|NCT03720470|69701888|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
38019069|NCT03720470|69701889|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
38019070|NCT03720470|69701890|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
38019071|NCT03720470|69701891|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
38019072|NCT03720470|69701892|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
38019073|NCT03720470|69701887|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
38019074|NCT03720470|69701888|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
38019075|NCT03720470|69701889|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
38019076|NCT03720470|69701890|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
38019077|NCT03720470|69701891|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
38019078|NCT03720470|69701892|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
38019079|NCT03720470|69701887|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
38019080|NCT03720470|69701888|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
38019081|NCT03720470|69701889|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
38019082|NCT03720470|69701890|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
38019083|NCT03720470|69701891|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
38019084|NCT03720470|69701892|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
38019085|NCT03720470|69701887|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
38019086|NCT03720470|69701888|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
38019087|NCT03720470|69701889|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
38019088|NCT03720470|69701890|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
38019089|NCT03720470|69701891|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
38019090|NCT03720470|69701892|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
38019091|NCT03720470|69701887|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
38019092|NCT03720470|69701888|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
38019093|NCT03720470|69701889|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
38019094|NCT03720470|69701890|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
38019095|NCT03720470|69701891|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
38019096|NCT03720470|69701892|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
38019097|NCT03720470|69701887|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
38019098|NCT03720470|69701888|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
38019099|NCT03720470|69701889|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
38019100|NCT03720470|69701890|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
38019101|NCT03720470|69701891|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
38019102|NCT03720470|69701892|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
38019103|NCT03720470|69701887|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
38019104|NCT03720470|69701888|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
38019105|NCT03720470|69701889|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
38019106|NCT03720470|69701890|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
38019107|NCT03720470|69701891|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
38019108|NCT03720470|69701892|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
38019109|NCT03720470|69701887|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
38019110|NCT03720470|69701888|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
38019111|NCT03720470|69701889|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
38019112|NCT03720470|69701890|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
38019113|NCT03720470|69701891|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
38019114|NCT03720470|69701892|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
38019115|NCT03720470|69701887|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
38019116|NCT03720470|69701888|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
38019117|NCT03720470|69701889|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
38019118|NCT03720470|69701890|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
38019119|NCT03720470|69701891|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
38019120|NCT03720470|69701892|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
38019121|NCT03720470|69701887|FG000|Treatment Period: Final 4 Weeks|Other|0|||
38019122|NCT03720470|69701888|FG001|Treatment Period: Final 4 Weeks|Other|1|||
38019123|NCT03720470|69701889|FG002|Treatment Period: Final 4 Weeks|Other|0|||
38019124|NCT03720470|69701890|FG003|Treatment Period: Final 4 Weeks|Other|2|||
38019125|NCT03720470|69701891|FG004|Treatment Period: Final 4 Weeks|Other|1|||
37698549|NCT01814878|69175269|FG000|Overall Study|Screening failure (drop-out)|0|||
37698550|NCT01814878|69175270|FG001|Overall Study|Screening failure (drop-out)|3|||
38019126|NCT03720470|69701892|FG005|Treatment Period: Final 4 Weeks|Other|0|||
38019127|NCT00262847|69701915|FG000|Overall Study|Disease Progression|309|||
38019128|NCT00262847|69701916|FG001|Overall Study|Disease Progression|274|||
38019129|NCT00262847|69701917|FG002|Overall Study|Disease Progression|195|||
38019130|NCT00262847|69701915|FG000|Overall Study|Patient Refusal|41|||
38019131|NCT00262847|69701916|FG001|Overall Study|Patient Refusal|52|||
38019132|NCT00262847|69701917|FG002|Overall Study|Patient Refusal|47|||
38019133|NCT00262847|69701915|FG000|Overall Study|Adverse Event|74|||
38019134|NCT00262847|69701916|FG001|Overall Study|Adverse Event|88|||
38019135|NCT00262847|69701917|FG002|Overall Study|Adverse Event|108|||
38019136|NCT00262847|69701915|FG000|Overall Study|Death|8|||
38019137|NCT00262847|69701916|FG001|Overall Study|Death|8|||
38019138|NCT00262847|69701917|FG002|Overall Study|Death|11|||
38019139|NCT00262847|69701915|FG000|Overall Study|Concomitant disease|3|||
38019140|NCT00262847|69701916|FG001|Overall Study|Concomitant disease|2|||
38019141|NCT00262847|69701917|FG002|Overall Study|Concomitant disease|4|||
38019142|NCT00262847|69701915|FG000|Overall Study|Other Reasons|79|||
38019143|NCT00262847|69701916|FG001|Overall Study|Other Reasons|88|||
38019144|NCT00262847|69701917|FG002|Overall Study|Other Reasons|27|||
38019145|NCT00262847|69701915|FG000|Overall Study|Did not receive study treatment|4|||
38019146|NCT00262847|69701916|FG001|Overall Study|Did not receive study treatment|1|||
38019147|NCT00262847|69701917|FG002|Overall Study|Did not receive study treatment|4|||
38019148|NCT00280397|69701928|FG000|Overall Study|Adverse Event|1|||
38019149|NCT00262301|69701937|FG000|Double-blind Phase|Lost to Follow-up|1|||
38019150|NCT00262301|69701938|FG001|Double-blind Phase|Lost to Follow-up|0|||
38019151|NCT00262301|69701939|FG002|Double-blind Phase|Lost to Follow-up|0|||
38019152|NCT00262301|69701937|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
38019153|NCT00262301|69701938|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
38019154|NCT00262301|69701939|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
38019155|NCT00279305|69701949|FG000|Overall Study|Pregnancy|1|||
38019156|NCT00279305|69701950|FG001|Overall Study|Pregnancy|0|||
38019157|NCT00279305|69701949|FG000|Overall Study|Withdrawal by Subject|2|||
38019158|NCT00279305|69701950|FG001|Overall Study|Withdrawal by Subject|0|||
38019159|NCT00279305|69701949|FG000|Overall Study|Dificulting establishing IV|1|||
38019160|NCT00279305|69701950|FG001|Overall Study|Dificulting establishing IV|0|||
38019161|NCT00279305|69701949|FG000|Overall Study|FDA Safety Alert|4|||
38019162|NCT00279305|69701950|FG001|Overall Study|FDA Safety Alert|1|||
38019163|NCT00278993|69701956|FG000|Overall Study|Adverse Event|24|||
38019164|NCT00278993|69701956|FG000|Overall Study|Withdrawal by Subject|5|||
38019165|NCT00278993|69701956|FG000|Overall Study|Progressive Disease|65|||
38019166|NCT00278993|69701956|FG000|Overall Study|Physician Decision|9|||
38019167|NCT00278993|69701956|FG000|Overall Study|Not Otherwise Specified|4|||
38019168|NCT00277355|69701962|FG000|Overall Study|Withdrawal by Subject|3|||
38019169|NCT00277355|69701963|FG001|Overall Study|Withdrawal by Subject|3|||
38019170|NCT00277355|69701962|FG000|Overall Study|Lost to Follow-up|2|||
38019171|NCT00277355|69701963|FG001|Overall Study|Lost to Follow-up|2|||
38019172|NCT00277355|69701962|FG000|Overall Study|Adverse Event|5|||
38019173|NCT00277355|69701963|FG001|Overall Study|Adverse Event|0|||
38019174|NCT00277355|69701962|FG000|Overall Study|Death|3|||
38019175|NCT00277355|69701963|FG001|Overall Study|Death|0|||
38019176|NCT00277355|69701962|FG000|Overall Study|Physician Decision|1|||
38019177|NCT00277355|69701963|FG001|Overall Study|Physician Decision|0|||
38019178|NCT00262223|69701972|FG000|Treatment Phase|Withdrawal by Subject|3|||
38019179|NCT00262223|69701973|FG001|Treatment Phase|Withdrawal by Subject|6|||
38019180|NCT00262223|69701972|FG000|Treatment Phase|Adverse Event|1|||
38019181|NCT00262223|69701973|FG001|Treatment Phase|Adverse Event|2|||
38019182|NCT00262223|69701972|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
38019183|NCT00262223|69701973|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
38019184|NCT00262223|69701972|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
38019185|NCT00262223|69701973|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
38019186|NCT00262223|69701972|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
38019187|NCT00262223|69701973|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
38019188|NCT00276419|69701982|FG000|First Intervention|Adverse Event|1|||
38019189|NCT00276419|69701983|FG001|First Intervention|Adverse Event|0|||
38019190|NCT00276419|69701982|FG000|First Intervention|Withdrawal by Subject|0|||
38019191|NCT00276419|69701983|FG001|First Intervention|Withdrawal by Subject|2|||
38019192|NCT00262067|69702004|FG000|Overall Study|Death|190|||
38019193|NCT00262067|69702005|FG001|Overall Study|Death|89|||
38019194|NCT00262067|69702006|FG002|Overall Study|Death|186|||
38019195|NCT00262067|69702007|FG003|Overall Study|Death|99|||
38019196|NCT00262067|69702004|FG000|Overall Study|Lost to Follow-up|5|||
38019197|NCT00262067|69702005|FG001|Overall Study|Lost to Follow-up|4|||
37698551|NCT01814878|69175269|FG000|Overall Study|Other|2|||
37698552|NCT01814878|69175270|FG001|Overall Study|Other|0|||
38019198|NCT00262067|69702006|FG002|Overall Study|Lost to Follow-up|7|||
38019199|NCT00262067|69702007|FG003|Overall Study|Lost to Follow-up|5|||
38019200|NCT00262067|69702004|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
38019201|NCT00262067|69702005|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
38019202|NCT00262067|69702006|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
38019203|NCT00262067|69702007|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
38019204|NCT00262067|69702004|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
38019205|NCT00262067|69702005|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
38019206|NCT00262067|69702006|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
38019207|NCT00262067|69702007|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
38019208|NCT00275561|69702019|FG000|Overall Study|Withdrawal by Subject|0|||
38019209|NCT00275561|69702020|FG001|Overall Study|Withdrawal by Subject|1|||
38019210|NCT00275561|69702019|FG000|Overall Study|Travel|1|||
38019211|NCT00275561|69702020|FG001|Overall Study|Travel|1|||
38019212|NCT00275561|69702019|FG000|Overall Study|Scheduling|1|||
38019213|NCT00275561|69702020|FG001|Overall Study|Scheduling|2|||
38019214|NCT00275561|69702019|FG000|Overall Study|Family Issues|0|||
38019215|NCT00275561|69702020|FG001|Overall Study|Family Issues|2|||
38019216|NCT00274937|69702030|FG000|Overall Study|Physician Decision|10|||
38019217|NCT00274937|69702030|FG000|Overall Study|Withdrawal by Subject|6|||
38019218|NCT00274937|69702030|FG000|Overall Study|Progressive Disease|4|||
38019219|NCT00251693|69702037|FG000|Overall Study|Adverse Event|17|||
38019220|NCT00251693|69702038|FG001|Overall Study|Adverse Event|9|||
38019221|NCT00251693|69702039|FG002|Overall Study|Adverse Event|9|||
38019222|NCT00251693|69702037|FG000|Overall Study|Protocol Violation|2|||
38019223|NCT00251693|69702038|FG001|Overall Study|Protocol Violation|0|||
38019224|NCT00251693|69702039|FG002|Overall Study|Protocol Violation|2|||
38019225|NCT00251693|69702037|FG000|Overall Study|Lost to Follow-up|12|||
38019226|NCT00251693|69702038|FG001|Overall Study|Lost to Follow-up|7|||
38019227|NCT00251693|69702039|FG002|Overall Study|Lost to Follow-up|8|||
38019228|NCT00251693|69702037|FG000|Overall Study|Withdrawal by Subject|11|||
38019229|NCT00251693|69702038|FG001|Overall Study|Withdrawal by Subject|17|||
38019230|NCT00251693|69702039|FG002|Overall Study|Withdrawal by Subject|14|||
38019231|NCT00251693|69702037|FG000|Overall Study|Lack of Efficacy|0|||
38019232|NCT00251693|69702038|FG001|Overall Study|Lack of Efficacy|1|||
38019233|NCT00251693|69702039|FG002|Overall Study|Lack of Efficacy|0|||
38019234|NCT00251693|69702037|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
37698553|NCT02407457|69175278|FG000|1 Month|Death|3|||
38019235|NCT00251693|69702038|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
38019236|NCT00251693|69702039|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
38019237|NCT00251693|69702037|FG000|Overall Study|Noncompliant|0|||
38019238|NCT00251693|69702038|FG001|Overall Study|Noncompliant|0|||
38019239|NCT00251693|69702039|FG002|Overall Study|Noncompliant|2|||
38019240|NCT00251693|69702037|FG000|Overall Study|Possible Barrett's esophagus|3|||
38019241|NCT00251693|69702038|FG001|Overall Study|Possible Barrett's esophagus|5|||
38019242|NCT00251693|69702039|FG002|Overall Study|Possible Barrett's esophagus|2|||
38019243|NCT00251693|69702037|FG000|Overall Study|Subject request/subject unavailable|1|||
38019244|NCT00251693|69702038|FG001|Overall Study|Subject request/subject unavailable|2|||
38019245|NCT00251693|69702039|FG002|Overall Study|Subject request/subject unavailable|0|||
38019246|NCT00251693|69702037|FG000|Overall Study|Abnormal laboratory findings|0|||
38019247|NCT00251693|69702038|FG001|Overall Study|Abnormal laboratory findings|0|||
38019248|NCT00251693|69702039|FG002|Overall Study|Abnormal laboratory findings|1|||
38019249|NCT00250835|69702047|FG000|Overall Study|Withdrawal by Subject|1|||
38019250|NCT03716024|69702057|FG000|Overall Study|Randomized, not Treated|7|||
38019251|NCT03716024|69702058|FG001|Overall Study|Randomized, not Treated|8|||
38019252|NCT03716024|69702057|FG000|Overall Study|Adverse Event|1|||
38019253|NCT03716024|69702058|FG001|Overall Study|Adverse Event|2|||
38019254|NCT03716024|69702057|FG000|Overall Study|Treatment Failure|1|||
38019255|NCT03716024|69702058|FG001|Overall Study|Treatment Failure|0|||
38019256|NCT03716024|69702057|FG000|Overall Study|Lost to Follow-up|2|||
38019257|NCT03716024|69702058|FG001|Overall Study|Lost to Follow-up|6|||
38019258|NCT03716024|69702057|FG000|Overall Study|Withdrawal by Subject|0|||
38019259|NCT03716024|69702058|FG001|Overall Study|Withdrawal by Subject|1|||
38019260|NCT03716024|69702057|FG000|Overall Study|Missing Reason|0|||
38019261|NCT03716024|69702058|FG001|Overall Study|Missing Reason|1|||
38019262|NCT00250679|69702067|FG000|Overall Study|Adverse Event|12|||
38019263|NCT00250679|69702068|FG001|Overall Study|Adverse Event|15|||
38019264|NCT00250679|69702069|FG002|Overall Study|Adverse Event|16|||
38019265|NCT00250679|69702067|FG000|Overall Study|Protocol Violation|2|||
38019266|NCT00250679|69702068|FG001|Overall Study|Protocol Violation|4|||
38019267|NCT00250679|69702069|FG002|Overall Study|Protocol Violation|3|||
38019268|NCT00250679|69702067|FG000|Overall Study|Withdrawal by Subject|15|||
38019269|NCT00250679|69702068|FG001|Overall Study|Withdrawal by Subject|18|||
38019270|NCT00250679|69702069|FG002|Overall Study|Withdrawal by Subject|15|||
38019271|NCT00250679|69702067|FG000|Overall Study|Lost to Follow-up|3|||
38019272|NCT00250679|69702068|FG001|Overall Study|Lost to Follow-up|4|||
38019273|NCT00250679|69702069|FG002|Overall Study|Lost to Follow-up|2|||
38019274|NCT00250679|69702067|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
38019275|NCT00250679|69702068|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
38019276|NCT00250679|69702069|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
38019277|NCT00250679|69702067|FG000|Overall Study|Lack of Efficacy|0|||
38019278|NCT00250679|69702068|FG001|Overall Study|Lack of Efficacy|1|||
38019279|NCT00250679|69702069|FG002|Overall Study|Lack of Efficacy|3|||
38019280|NCT00250679|69702067|FG000|Overall Study|Technical Holter issues|1|||
38019281|NCT00250679|69702068|FG001|Overall Study|Technical Holter issues|0|||
38019282|NCT00250679|69702069|FG002|Overall Study|Technical Holter issues|2|||
38019283|NCT00250679|69702067|FG000|Overall Study|Moved|1|||
38019284|NCT00250679|69702068|FG001|Overall Study|Moved|1|||
37698554|NCT02407457|69175279|FG001|1 Month|Death|0|||
38019285|NCT00250679|69702069|FG002|Overall Study|Moved|0|||
38019286|NCT00250679|69702067|FG000|Overall Study|Non-compliance|1|||
38019287|NCT00250679|69702068|FG001|Overall Study|Non-compliance|1|||
38019288|NCT00250679|69702069|FG002|Overall Study|Non-compliance|0|||
37910469|NCT04300296|69596670|FG001|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
38019289|NCT00250679|69702067|FG000|Overall Study|various single events: hip surgery,diary|3|||
38019290|NCT00250679|69702068|FG001|Overall Study|various single events: hip surgery,diary|1|||
38019291|NCT00250679|69702069|FG002|Overall Study|various single events: hip surgery,diary|1|||
38019292|NCT00261833|69702079|FG000|Overall Study|Death|1|||
38019293|NCT00261833|69702080|FG001|Overall Study|Death|3|||
38019294|NCT00261833|69702079|FG000|Overall Study|Adverse Event|1|||
38019295|NCT00261833|69702080|FG001|Overall Study|Adverse Event|4|||
38019296|NCT00261833|69702079|FG000|Overall Study|Withdrawal by Subject|5|||
38019297|NCT00261833|69702080|FG001|Overall Study|Withdrawal by Subject|7|||
38019298|NCT00261833|69702079|FG000|Overall Study|Protocol Violation|0|||
38019299|NCT00261833|69702080|FG001|Overall Study|Protocol Violation|1|||
38019300|NCT00261833|69702079|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
38019301|NCT00261833|69702080|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
38019302|NCT00261833|69702079|FG000|Overall Study|Lung transplantation|1|||
38019303|NCT00261833|69702080|FG001|Overall Study|Lung transplantation|1|||
38019304|NCT00261833|69702079|FG000|Overall Study|Missing reason|1|||
38019305|NCT00261833|69702080|FG001|Overall Study|Missing reason|0|||
38019306|NCT00261833|69702079|FG000|Overall Study|Not interested in being participant|0|||
38019307|NCT00261833|69702080|FG001|Overall Study|Not interested in being participant|1|||
38019308|NCT03713684|69702091|FG000|Overall Study|Adverse Event|1|||
38019309|NCT03713684|69702092|FG001|Overall Study|Adverse Event|3|||
38019310|NCT03713684|69702093|FG002|Overall Study|Adverse Event|1|||
37698555|NCT02407457|69175278|FG000|1 Month|Lost to Follow-up|1|||
37698556|NCT02407457|69175279|FG001|1 Month|Lost to Follow-up|1|||
37698557|NCT02407457|69175278|FG000|1 Month|missed visit|2|||
37698558|NCT02407457|69175279|FG001|1 Month|missed visit|6|||
37698559|NCT02407457|69175278|FG000|6-Month|Death|2|||
38019311|NCT03713684|69702094|FG003|Overall Study|Adverse Event|0|||
38019312|NCT03713684|69702091|FG000|Overall Study|Poor compliance to protocol|2|||
38019313|NCT03713684|69702092|FG001|Overall Study|Poor compliance to protocol|1|||
38019314|NCT03713684|69702093|FG002|Overall Study|Poor compliance to protocol|0|||
38019315|NCT03713684|69702094|FG003|Overall Study|Poor compliance to protocol|1|||
38019316|NCT03713684|69702091|FG000|Overall Study|Withdrawal by Subject|14|||
38019317|NCT03713684|69702092|FG001|Overall Study|Withdrawal by Subject|6|||
38019318|NCT03713684|69702093|FG002|Overall Study|Withdrawal by Subject|14|||
38019319|NCT03713684|69702094|FG003|Overall Study|Withdrawal by Subject|16|||
38019320|NCT03713684|69702091|FG000|Overall Study|Other than specified|69|||
37698560|NCT02407457|69175279|FG001|6-Month|Death|8|||
37698561|NCT02407457|69175278|FG000|6-Month|Lost to Follow-up|2|||
37698562|NCT02407457|69175279|FG001|6-Month|Lost to Follow-up|2|||
37698563|NCT02407457|69175278|FG000|6-Month|missed visit|15|||
37698564|NCT02407457|69175279|FG001|6-Month|missed visit|12|||
37698565|NCT02407457|69175278|FG000|6-Month|Over Due|1|||
37698566|NCT02407457|69175279|FG001|6-Month|Over Due|2|||
37698567|NCT02407457|69175278|FG000|6-Month|Open Repair|0|||
37698568|NCT02407457|69175279|FG001|6-Month|Open Repair|1|||
37698569|NCT02407457|69175278|FG000|1 Year|Death|6|||
38019321|NCT03713684|69702092|FG001|Overall Study|Other than specified|77|||
38019322|NCT03713684|69702093|FG002|Overall Study|Other than specified|73|||
38019323|NCT03713684|69702094|FG003|Overall Study|Other than specified|70|||
38019324|NCT03711266|69702104|FG000|Overall Study|Lost to Follow-up|10|||
38019325|NCT03150862|69702116|FG000|Overall Study|Death|2|||
38019326|NCT03150862|69702117|FG001|Overall Study|Death|7|||
38019327|NCT03150862|69702118|FG002|Overall Study|Death|8|||
38019328|NCT03150862|69702119|FG003|Overall Study|Death|27|||
38019329|NCT03150862|69702120|FG004|Overall Study|Death|4|||
38019330|NCT03150862|69702121|FG005|Overall Study|Death|8|||
38019331|NCT03150862|69702122|FG006|Overall Study|Death|6|||
38019332|NCT03150862|69702123|FG007|Overall Study|Death|21|||
38019333|NCT03150862|69702116|FG000|Overall Study|Withdrawal by Subject|1|||
38019334|NCT03150862|69702117|FG001|Overall Study|Withdrawal by Subject|1|||
37698570|NCT02407457|69175279|FG001|1 Year|Death|11|||
37698571|NCT02407457|69175278|FG000|1 Year|Lost to Follow-up|3|||
37698572|NCT02407457|69175279|FG001|1 Year|Lost to Follow-up|2|||
37698573|NCT02407457|69175278|FG000|1 Year|Missed Visit|18|||
37698574|NCT02407457|69175279|FG001|1 Year|Missed Visit|10|||
37698575|NCT02407457|69175278|FG000|1 Year|Over Due|6|||
37698576|NCT02407457|69175279|FG001|1 Year|Over Due|4|||
37698577|NCT02407457|69175278|FG000|1 Year|Open Repair|0|||
37698578|NCT02407457|69175279|FG001|1 Year|Open Repair|1|||
37698579|NCT02407457|69175278|FG000|2-year|Death|14|||
37698580|NCT02407457|69175279|FG001|2-year|Death|8|||
37698581|NCT02407457|69175278|FG000|2-year|Lost to Follow-up|6|||
38019335|NCT03150862|69702118|FG002|Overall Study|Withdrawal by Subject|0|||
38019336|NCT03150862|69702119|FG003|Overall Study|Withdrawal by Subject|3|||
38019337|NCT03150862|69702120|FG004|Overall Study|Withdrawal by Subject|1|||
38019338|NCT03150862|69702121|FG005|Overall Study|Withdrawal by Subject|1|||
38019339|NCT03150862|69702122|FG006|Overall Study|Withdrawal by Subject|1|||
37698582|NCT02407457|69175279|FG001|2-year|Lost to Follow-up|9|||
37698583|NCT02407457|69175278|FG000|2-year|Missed Visit|13|||
37698584|NCT02407457|69175279|FG001|2-year|Missed Visit|11|||
38019340|NCT03150862|69702123|FG007|Overall Study|Withdrawal by Subject|3|||
38019341|NCT03150862|69702116|FG000|Overall Study|Lost to Follow-up|0|||
38019342|NCT03150862|69702117|FG001|Overall Study|Lost to Follow-up|0|||
38019343|NCT03150862|69702118|FG002|Overall Study|Lost to Follow-up|1|||
37698585|NCT02407457|69175278|FG000|2-year|Over Due|1|||
37698586|NCT02407457|69175279|FG001|2-year|Over Due|5|||
37698587|NCT02407457|69175278|FG000|2-year|Open Repair|0|||
37698588|NCT02407457|69175279|FG001|2-year|Open Repair|2|||
37698589|NCT02407457|69175278|FG000|3-year|Death|11|||
37698590|NCT02407457|69175279|FG001|3-year|Death|10|||
37698591|NCT02407457|69175278|FG000|3-year|Lost to Follow-up|6|||
38019344|NCT03150862|69702119|FG003|Overall Study|Lost to Follow-up|0|||
37698592|NCT02407457|69175279|FG001|3-year|Lost to Follow-up|9|||
37698593|NCT02407457|69175278|FG000|3-year|Missed Visit|21|||
37698594|NCT02407457|69175279|FG001|3-year|Missed Visit|16|||
37698595|NCT02407457|69175278|FG000|3-year|Over Due|4|||
37698596|NCT02407457|69175279|FG001|3-year|Over Due|3|||
37698597|NCT02407457|69175278|FG000|4-year|Death|14|||
37698598|NCT02407457|69175279|FG001|4-year|Death|7|||
37698599|NCT02407457|69175278|FG000|4-year|Lost to Follow-up|9|||
37698600|NCT02407457|69175279|FG001|4-year|Lost to Follow-up|12|||
37698601|NCT02407457|69175278|FG000|4-year|Over Due|10|||
37698602|NCT02407457|69175279|FG001|4-year|Over Due|5|||
37698603|NCT02407457|69175278|FG000|4-year|Missed Visit|13|||
37698604|NCT02407457|69175279|FG001|4-year|Missed Visit|13|||
37698605|NCT02407457|69175278|FG000|4-year|Pending visit|19|||
37698606|NCT02407457|69175279|FG001|4-year|Pending visit|14|||
37698607|NCT02407457|69175278|FG000|4-year|Not Due|16|||
37698608|NCT02407457|69175279|FG001|4-year|Not Due|10|||
37698609|NCT02407457|69175278|FG000|5-year|Death|6|||
37698610|NCT02407457|69175279|FG001|5-year|Death|1|||
37698611|NCT02407457|69175278|FG000|5-year|Lost to Follow-up|4|||
37698612|NCT02407457|69175279|FG001|5-year|Lost to Follow-up|4|||
37698613|NCT02407457|69175278|FG000|5-year|Missed Visit|10|||
37698614|NCT02407457|69175279|FG001|5-year|Missed Visit|9|||
37698615|NCT02407457|69175278|FG000|5-year|Pending Visit|18|||
37698616|NCT02407457|69175279|FG001|5-year|Pending Visit|17|||
37698617|NCT02407457|69175278|FG000|5-year|Not Due|54|||
37698618|NCT02407457|69175279|FG001|5-year|Not Due|46|||
37698619|NCT01814800|69175285|FG000|Overall Study|Adverse Event|2|||
37698620|NCT01814800|69175285|FG000|Overall Study|Pregnancy|1|||
37698621|NCT01814800|69175285|FG000|Overall Study|Sponsor decision|1|||
37698622|NCT01814800|69175285|FG000|Overall Study|Subject relocation|1|||
37698623|NCT01814332|69175291|FG000|Overall Study|Adverse Event|8|||
37698624|NCT01814332|69175292|FG001|Overall Study|Adverse Event|3|||
37698625|NCT01814332|69175291|FG000|Overall Study|Withdrawal by Subject|3|||
37698626|NCT01814332|69175292|FG001|Overall Study|Withdrawal by Subject|8|||
37698627|NCT01814332|69175291|FG000|Overall Study|Protocol Violation|0|||
37698628|NCT01814332|69175292|FG001|Overall Study|Protocol Violation|4|||
37910470|NCT04300296|69596671|FG002|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
37910471|NCT04300296|69596672|FG003|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
37910472|NCT04300296|69596673|FG004|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|1|||
37910473|NCT04300296|69596674|FG005|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
37910474|NCT04300296|69596669|FG000|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
37910475|NCT04300296|69596670|FG001|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|2|||
37910476|NCT04300296|69596671|FG002|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
37910477|NCT04300296|69596672|FG003|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
37910478|NCT04300296|69596673|FG004|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
37910479|NCT04300296|69596674|FG005|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
37910480|NCT04300296|69596669|FG000|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
37910481|NCT04300296|69596670|FG001|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
37910482|NCT04300296|69596671|FG002|Treatment Period 2: 16 to 32 Weeks|Adverse Event|2|||
37910483|NCT04300296|69596672|FG003|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
37910484|NCT04300296|69596673|FG004|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
37910485|NCT04300296|69596674|FG005|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
37910486|NCT04300296|69596669|FG000|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
37910487|NCT04300296|69596670|FG001|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
37910488|NCT04300296|69596671|FG002|Treatment Period 2: 16 to 32 Weeks|Progressive disease|1|||
37910489|NCT04300296|69596672|FG003|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
37910490|NCT04300296|69596673|FG004|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
37698629|NCT01814332|69175291|FG000|Overall Study|Lost to Follow-up|5|||
37698630|NCT01814332|69175292|FG001|Overall Study|Lost to Follow-up|1|||
37698631|NCT02407223|69175301|FG000|Overall Study|Adverse Event|1|||
37698632|NCT02407223|69175302|FG001|Overall Study|Adverse Event|0|||
37698633|NCT02407223|69175303|FG002|Overall Study|Adverse Event|1|||
37698634|NCT02407223|69175301|FG000|Overall Study|Lack of Efficacy|6|||
37698635|NCT02407223|69175302|FG001|Overall Study|Lack of Efficacy|6|||
37698636|NCT02407223|69175303|FG002|Overall Study|Lack of Efficacy|4|||
37698637|NCT02407223|69175301|FG000|Overall Study|Lost to Follow-up|1|||
37698638|NCT02407223|69175302|FG001|Overall Study|Lost to Follow-up|0|||
37698639|NCT02407223|69175303|FG002|Overall Study|Lost to Follow-up|2|||
37698640|NCT02407223|69175301|FG000|Overall Study|Withdrawal by Subject|2|||
37698641|NCT02407223|69175302|FG001|Overall Study|Withdrawal by Subject|4|||
37698642|NCT02407223|69175303|FG002|Overall Study|Withdrawal by Subject|4|||
37698643|NCT02407223|69175301|FG000|Overall Study|Study Terminated by Sponsor|77|||
37698644|NCT02407223|69175302|FG001|Overall Study|Study Terminated by Sponsor|80|||
37698645|NCT02407223|69175303|FG002|Overall Study|Study Terminated by Sponsor|86|||
37698646|NCT02407223|69175301|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
37698647|NCT02407223|69175302|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
37698648|NCT02407223|69175303|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
37698649|NCT02407223|69175301|FG000|Overall Study|Other|29|||
37698650|NCT02407223|69175302|FG001|Overall Study|Other|27|||
37698651|NCT02407223|69175303|FG002|Overall Study|Other|25|||
37698652|NCT01797562|69175313|FG000|Overall Study|Protocol Violation|5|||
37698653|NCT01813474|69175321|FG000|Overall Study|Withdrawal by Subject|0|||
37698654|NCT01813474|69175322|FG001|Overall Study|Withdrawal by Subject|0|||
37698655|NCT01813474|69175323|FG002|Overall Study|Withdrawal by Subject|1|||
37698656|NCT01813474|69175321|FG000|Overall Study|Adverse Event|1|||
37698657|NCT01813474|69175322|FG001|Overall Study|Adverse Event|1|||
37698658|NCT01813474|69175323|FG002|Overall Study|Adverse Event|0|||
37698659|NCT01813474|69175321|FG000|Overall Study|Lack of Efficacy|2|||
37698660|NCT01813474|69175322|FG001|Overall Study|Lack of Efficacy|6|||
37698661|NCT01813474|69175323|FG002|Overall Study|Lack of Efficacy|9|||
37698662|NCT01813474|69175321|FG000|Overall Study|Death|0|||
37698663|NCT01813474|69175322|FG001|Overall Study|Death|0|||
37698664|NCT01813474|69175323|FG002|Overall Study|Death|1|||
37698665|NCT01868542|69175334|FG000|Overall Study|Protocol Violation|0|||
37698666|NCT01868542|69175335|FG001|Overall Study|Protocol Violation|1|||
37698667|NCT01868542|69175334|FG000|Overall Study|Unclassified|0|||
37698668|NCT01868542|69175335|FG001|Overall Study|Unclassified|1|||
37698669|NCT01797094|69175343|FG000|Overall Study|Adverse Event|1|||
37698670|NCT01797094|69175344|FG001|Overall Study|Adverse Event|1|||
37698671|NCT01797094|69175343|FG000|Overall Study|Personal Reasons|4|||
38019345|NCT03150862|69702120|FG004|Overall Study|Lost to Follow-up|0|||
38019346|NCT03150862|69702121|FG005|Overall Study|Lost to Follow-up|0|||
38019347|NCT03150862|69702122|FG006|Overall Study|Lost to Follow-up|0|||
38019348|NCT03150862|69702123|FG007|Overall Study|Lost to Follow-up|2|||
38019349|NCT03150862|69702116|FG000|Overall Study|Sponsor's decision|0|||
38019350|NCT03150862|69702117|FG001|Overall Study|Sponsor's decision|0|||
38019351|NCT03150862|69702118|FG002|Overall Study|Sponsor's decision|0|||
38019352|NCT03150862|69702119|FG003|Overall Study|Sponsor's decision|10|||
38019353|NCT03150862|69702120|FG004|Overall Study|Sponsor's decision|3|||
38019354|NCT03150862|69702121|FG005|Overall Study|Sponsor's decision|0|||
38019355|NCT03150862|69702122|FG006|Overall Study|Sponsor's decision|1|||
38019356|NCT03150862|69702123|FG007|Overall Study|Sponsor's decision|1|||
38019357|NCT03150862|69702116|FG000|Overall Study|Change in Methylation status|0|||
38019358|NCT03150862|69702117|FG001|Overall Study|Change in Methylation status|0|||
38019359|NCT03150862|69702118|FG002|Overall Study|Change in Methylation status|0|||
38019360|NCT03150862|69702119|FG003|Overall Study|Change in Methylation status|0|||
38019361|NCT03150862|69702120|FG004|Overall Study|Change in Methylation status|1|||
37698672|NCT01797094|69175344|FG001|Overall Study|Personal Reasons|0|||
37698673|NCT01797094|69175343|FG000|Overall Study|Protocol Violation|0|||
37698674|NCT01797094|69175344|FG001|Overall Study|Protocol Violation|1|||
37698675|NCT01797094|69175343|FG000|Overall Study|Other Miscellaneous Reasons|1|||
37698676|NCT01797094|69175344|FG001|Overall Study|Other Miscellaneous Reasons|0|||
37698677|NCT02383589|69175352|FG000|Treatment Period|Adverse Event|1|||
37698678|NCT02383589|69175353|FG001|Treatment Period|Adverse Event|3|||
37698679|NCT02383589|69175352|FG000|Treatment Period|Lost to Follow-up|0|||
37698680|NCT02383589|69175353|FG001|Treatment Period|Lost to Follow-up|1|||
37698681|NCT02383589|69175352|FG000|Treatment Period|Withdrawal by Subject|0|||
37698682|NCT02383589|69175353|FG001|Treatment Period|Withdrawal by Subject|5|||
37698683|NCT02383589|69175352|FG000|Treatment Period|Non-compliance with study drug|0|||
37698684|NCT02383589|69175353|FG001|Treatment Period|Non-compliance with study drug|1|||
37698685|NCT02383589|69175352|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
38019362|NCT03150862|69702121|FG005|Overall Study|Change in Methylation status|0|||
38019363|NCT03150862|69702122|FG006|Overall Study|Change in Methylation status|0|||
38019364|NCT03150862|69702123|FG007|Overall Study|Change in Methylation status|0|||
37698686|NCT02383589|69175353|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
37698687|NCT02383589|69175352|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
37698688|NCT02383589|69175353|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
37698689|NCT02383589|69175352|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
37698690|NCT02383589|69175353|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
37698691|NCT01810432|69175361|FG000|Washout|Protocol Violation|0|||
38019365|NCT03150862|69702116|FG000|Overall Study|Roll over in to Long Term Extension|0|||
38019366|NCT03150862|69702117|FG001|Overall Study|Roll over in to Long Term Extension|0|||
37698692|NCT01810432|69175362|FG001|Washout|Protocol Violation|1|||
37698693|NCT01810432|69175361|FG000|Washout|Adverse Event|1|||
37698694|NCT01810432|69175362|FG001|Washout|Adverse Event|0|||
37698695|NCT01810432|69175361|FG000|Period 2|Withdrawal by Subject|2|||
37698696|NCT01810432|69175362|FG001|Period 2|Withdrawal by Subject|1|||
37698697|NCT01810432|69175361|FG000|Period 2|Physician Decision|1|||
37698698|NCT01810432|69175362|FG001|Period 2|Physician Decision|0|||
37698699|NCT01810432|69175361|FG000|Period 2|Lost to Follow-up|1|||
37698700|NCT01810432|69175362|FG001|Period 2|Lost to Follow-up|1|||
37698701|NCT01796860|69175368|FG000|Overall Study|Withdrawal by Subject|3|||
37698702|NCT01796548|69175372|FG000|Overall Study|Lost to Follow-up|1|||
38019367|NCT03150862|69702118|FG002|Overall Study|Roll over in to Long Term Extension|0|||
38019368|NCT03150862|69702119|FG003|Overall Study|Roll over in to Long Term Extension|0|||
38019369|NCT03150862|69702120|FG004|Overall Study|Roll over in to Long Term Extension|0|||
37698703|NCT01796548|69175372|FG000|Overall Study|Other|2|||
37698704|NCT02406677|69175378|FG000|Overall Study|Death|16|||
37698705|NCT02406677|69175379|FG001|Overall Study|Death|8|||
37698706|NCT02406677|69175378|FG000|Overall Study|Discharged without P2Y12|1|||
37698707|NCT02406677|69175379|FG001|Overall Study|Discharged without P2Y12|3|||
37698708|NCT02406677|69175378|FG000|Overall Study|Discharged on prasugrel|283|||
37698709|NCT02406677|69175379|FG001|Overall Study|Discharged on prasugrel|587|||
37698710|NCT02406677|69175378|FG000|Overall Study|Withdrawal by Subject|1|||
37698711|NCT02406677|69175379|FG001|Overall Study|Withdrawal by Subject|0|||
37698712|NCT02404805|69175395|FG000|Overall Study|Withdrawal by Subject|1|||
37698713|NCT02404805|69175396|FG001|Overall Study|Withdrawal by Subject|0|||
37698714|NCT02404805|69175397|FG002|Overall Study|Withdrawal by Subject|0|||
37698715|NCT02404805|69175398|FG003|Overall Study|Withdrawal by Subject|0|||
37698716|NCT02404805|69175399|FG004|Overall Study|Withdrawal by Subject|0|||
37698717|NCT02404805|69175400|FG005|Overall Study|Withdrawal by Subject|0|||
37698718|NCT02430311|69175411|FG000|Part A|Adverse Event|0|||
37698719|NCT02430311|69175412|FG001|Part A|Adverse Event|1|||
37698720|NCT02430311|69175411|FG000|Part A|Withdrawal by Subject|1|||
37698721|NCT02430311|69175412|FG001|Part A|Withdrawal by Subject|0|||
37698722|NCT02430311|69175411|FG000|Part B|Meet study-specific withdrawal criteria|6|||
37698723|NCT02430311|69175412|FG001|Part B|Meet study-specific withdrawal criteria|6|||
37698724|NCT02430311|69175411|FG000|Part B|Withdrawal by Subject|2|||
37698725|NCT02430311|69175412|FG001|Part B|Withdrawal by Subject|2|||
37698726|NCT02430311|69175411|FG000|Part B|Adverse Event|1|||
37698727|NCT02430311|69175412|FG001|Part B|Adverse Event|0|||
37698728|NCT02430311|69175411|FG000|Part B|Death|1|||
37698729|NCT02430311|69175412|FG001|Part B|Death|0|||
37698730|NCT02404649|69175429|FG000|Overall Study|Adverse Event|1|||
37698731|NCT02404649|69175430|FG001|Overall Study|Adverse Event|2|||
37698732|NCT02383355|69175438|FG000|Overall Study|Adverse Event|2|||
37698733|NCT02383355|69175439|FG001|Overall Study|Adverse Event|0|||
37698734|NCT02381795|69175445|FG000|Overall Study|Withdrawal by Subject|1|||
37698735|NCT02381795|69175445|FG000|Overall Study|Study Terminated|2|||
37698736|NCT02404493|69175451|FG000|Overall Study|Adverse Event|1|||
37698737|NCT02404493|69175452|FG001|Overall Study|Adverse Event|1|||
37698738|NCT02380859|69175460|FG000|Overall Study|Withdrawal by Subject|2|||
37698739|NCT02380859|69175461|FG001|Overall Study|Withdrawal by Subject|0|||
37698740|NCT02380703|69175469|FG000|Overall Study|Withdrawal by Subject|12|||
37698741|NCT02380703|69175470|FG001|Overall Study|Withdrawal by Subject|9|||
37698742|NCT02380703|69175469|FG000|Overall Study|Lost to Follow-up|12|||
37698743|NCT02380703|69175470|FG001|Overall Study|Lost to Follow-up|12|||
37698744|NCT02380703|69175469|FG000|Overall Study|Caregiver death|1|||
37698745|NCT02380703|69175470|FG001|Overall Study|Caregiver death|0|||
37698746|NCT02380703|69175469|FG000|Overall Study|Person with dementia (PWD) death|7|||
37698747|NCT02380703|69175470|FG001|Overall Study|Person with dementia (PWD) death|8|||
37698748|NCT02380703|69175469|FG000|Overall Study|Entered Long-term Care|4|||
37698749|NCT02380703|69175470|FG001|Overall Study|Entered Long-term Care|7|||
37698750|NCT02379923|69175476|FG000|Overall Study|Death|5|||
37698751|NCT02379221|69175483|FG000|Overall Study|Lost to Follow-up|1|||
37698752|NCT02404103|69175494|FG000|Overall Study|Adverse Event|1|||
37698753|NCT02404103|69175495|FG001|Overall Study|Adverse Event|0|||
37698754|NCT02404103|69175494|FG000|Overall Study|Lost to Follow-up|3|||
37698755|NCT02404103|69175495|FG001|Overall Study|Lost to Follow-up|3|||
37698756|NCT02404025|69175511|FG000|Overall Study|Adverse Event|1|||
37698757|NCT02404025|69175511|FG000|Overall Study|Lack of Efficacy|3|||
37698758|NCT02377817|69175517|FG000|Overall Study|Transportation/childcare barriers.|2|||
37698759|NCT02377817|69175518|FG001|Overall Study|Transportation/childcare barriers.|0|||
37698760|NCT02377817|69175517|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
37698761|NCT02377817|69175518|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
37698762|NCT02403635|69175526|FG000|Overall Study|Not eligible|9|||
37698763|NCT02402933|69175546|FG000|Overall Study|Withdrawal by Subject|4|||
37698764|NCT02402933|69175546|FG000|Overall Study|Discontinued; Site Termination|10|||
37698765|NCT01796470|69175555|FG000|Overall Study|Adverse Event|4|||
37698766|NCT01796470|69175556|FG001|Overall Study|Adverse Event|2|||
37698767|NCT01796470|69175557|FG002|Overall Study|Adverse Event|2|||
37698768|NCT01796470|69175558|FG003|Overall Study|Adverse Event|1|||
37832770|NCT01276639|69516372|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
37832771|NCT01276639|69516368|FG000|Week 16 to 52|Death|1|||
37832772|NCT01276639|69516369|FG001|Week 16 to 52|Death|0|||
37832773|NCT01276639|69516370|FG002|Week 16 to 52|Death|0|||
37698769|NCT01796470|69175559|FG004|Overall Study|Adverse Event|3|||
37698770|NCT01796470|69175555|FG000|Overall Study|Death|2|||
37698771|NCT01796470|69175556|FG001|Overall Study|Death|0|||
37698772|NCT01796470|69175557|FG002|Overall Study|Death|0|||
37698773|NCT01796470|69175558|FG003|Overall Study|Death|0|||
37698774|NCT01796470|69175559|FG004|Overall Study|Death|1|||
37698775|NCT01796470|69175555|FG000|Overall Study|Initiated New Therapy|9|||
37698776|NCT01796470|69175556|FG001|Overall Study|Initiated New Therapy|0|||
37698777|NCT01796470|69175557|FG002|Overall Study|Initiated New Therapy|0|||
37698778|NCT01796470|69175558|FG003|Overall Study|Initiated New Therapy|0|||
37698779|NCT01796470|69175559|FG004|Overall Study|Initiated New Therapy|2|||
37698780|NCT01796470|69175555|FG000|Overall Study|Lost to Follow-up|0|||
37698781|NCT01796470|69175556|FG001|Overall Study|Lost to Follow-up|1|||
37698782|NCT01796470|69175557|FG002|Overall Study|Lost to Follow-up|0|||
37698783|NCT01796470|69175558|FG003|Overall Study|Lost to Follow-up|0|||
37698784|NCT01796470|69175559|FG004|Overall Study|Lost to Follow-up|0|||
37698785|NCT01796470|69175555|FG000|Overall Study|Physician Decision|5|||
37698786|NCT01796470|69175556|FG001|Overall Study|Physician Decision|4|||
37832774|NCT01276639|69516371|FG003|Week 16 to 52|Death|0|||
37832775|NCT01276639|69516372|FG004|Week 16 to 52|Death|0|||
37832776|NCT01276639|69516368|FG000|Week 16 to 52|Adverse Event|10|||
38019370|NCT03150862|69702121|FG005|Overall Study|Roll over in to Long Term Extension|0|||
38019371|NCT03150862|69702122|FG006|Overall Study|Roll over in to Long Term Extension|0|||
38019372|NCT03150862|69702123|FG007|Overall Study|Roll over in to Long Term Extension|1|||
38019373|NCT03150862|69702116|FG000|Overall Study|Progressive Disease|0|||
38019374|NCT03150862|69702117|FG001|Overall Study|Progressive Disease|0|||
38019375|NCT03150862|69702118|FG002|Overall Study|Progressive Disease|0|||
38019376|NCT03150862|69702119|FG003|Overall Study|Progressive Disease|0|||
38019377|NCT03150862|69702120|FG004|Overall Study|Progressive Disease|0|||
38019378|NCT03150862|69702121|FG005|Overall Study|Progressive Disease|0|||
38019379|NCT03150862|69702122|FG006|Overall Study|Progressive Disease|0|||
38019380|NCT03150862|69702123|FG007|Overall Study|Progressive Disease|2|||
38019381|NCT00260429|69702152|FG000|Overall Study|failure to follow appointments|1|||
38019382|NCT00260429|69702153|FG001|Overall Study|failure to follow appointments|0|||
38019383|NCT00260429|69702152|FG000|Overall Study|scheduled hand surgery|1|||
38019384|NCT00260429|69702153|FG001|Overall Study|scheduled hand surgery|0|||
38019385|NCT00379288|69702163|FG000|Overall Study|Adverse Event|5|||
38019386|NCT00379288|69702164|FG001|Overall Study|Adverse Event|6|||
38019387|NCT00379288|69702165|FG002|Overall Study|Adverse Event|2|||
38019388|NCT00379288|69702166|FG003|Overall Study|Adverse Event|0|||
38019389|NCT00379288|69702163|FG000|Overall Study|Treatment Failure|0|||
38019390|NCT00379288|69702164|FG001|Overall Study|Treatment Failure|1|||
38019391|NCT00379288|69702165|FG002|Overall Study|Treatment Failure|0|||
38019392|NCT00379288|69702166|FG003|Overall Study|Treatment Failure|1|||
37832777|NCT01276639|69516369|FG001|Week 16 to 52|Adverse Event|13|||
37832778|NCT01276639|69516370|FG002|Week 16 to 52|Adverse Event|0|||
37832779|NCT01276639|69516371|FG003|Week 16 to 52|Adverse Event|1|||
37832780|NCT01276639|69516372|FG004|Week 16 to 52|Adverse Event|3|||
37832781|NCT01276639|69516368|FG000|Week 16 to 52|Lack of Efficacy|99|||
37832782|NCT01276639|69516369|FG001|Week 16 to 52|Lack of Efficacy|71|||
37832783|NCT01276639|69516370|FG002|Week 16 to 52|Lack of Efficacy|0|||
37832784|NCT01276639|69516371|FG003|Week 16 to 52|Lack of Efficacy|14|||
37832785|NCT01276639|69516372|FG004|Week 16 to 52|Lack of Efficacy|13|||
37832786|NCT01276639|69516368|FG000|Week 16 to 52|Lost to Follow-up|3|||
37832787|NCT01276639|69516369|FG001|Week 16 to 52|Lost to Follow-up|1|||
38019393|NCT00379288|69702163|FG000|Overall Study|Lost to Follow-up|3|||
38019394|NCT00379288|69702164|FG001|Overall Study|Lost to Follow-up|3|||
38019395|NCT00379288|69702165|FG002|Overall Study|Lost to Follow-up|2|||
38019396|NCT00379288|69702166|FG003|Overall Study|Lost to Follow-up|0|||
38019397|NCT00379288|69702163|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
38019398|NCT00379288|69702164|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
38019399|NCT00379288|69702165|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
38019400|NCT00379288|69702166|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
37832788|NCT01276639|69516370|FG002|Week 16 to 52|Lost to Follow-up|0|||
37832789|NCT01276639|69516371|FG003|Week 16 to 52|Lost to Follow-up|0|||
38019401|NCT00379288|69702163|FG000|Overall Study|Subject withdrew-related to study drug|1|||
38019402|NCT00379288|69702164|FG001|Overall Study|Subject withdrew-related to study drug|0|||
38019403|NCT00379288|69702165|FG002|Overall Study|Subject withdrew-related to study drug|0|||
37698787|NCT01796470|69175557|FG002|Overall Study|Physician Decision|1|||
37698788|NCT01796470|69175558|FG003|Overall Study|Physician Decision|0|||
37698789|NCT01796470|69175559|FG004|Overall Study|Physician Decision|1|||
37698790|NCT01796470|69175555|FG000|Overall Study|Progressive Disease|7|||
37832790|NCT01276639|69516372|FG004|Week 16 to 52|Lost to Follow-up|1|||
38019404|NCT00379288|69702166|FG003|Overall Study|Subject withdrew-related to study drug|1|||
38019405|NCT00379288|69702163|FG000|Overall Study|Noncompliance with protocol|8|||
38019406|NCT00379288|69702164|FG001|Overall Study|Noncompliance with protocol|6|||
38019407|NCT00379288|69702165|FG002|Overall Study|Noncompliance with protocol|2|||
38019408|NCT00379288|69702166|FG003|Overall Study|Noncompliance with protocol|1|||
38019409|NCT00379288|69702163|FG000|Overall Study|Did not meet protocol eligibility|0|||
38019410|NCT00379288|69702164|FG001|Overall Study|Did not meet protocol eligibility|1|||
38019411|NCT00379288|69702165|FG002|Overall Study|Did not meet protocol eligibility|0|||
38019412|NCT00379288|69702166|FG003|Overall Study|Did not meet protocol eligibility|2|||
38019413|NCT00379288|69702163|FG000|Overall Study|Administrative|2|||
38019414|NCT00379288|69702164|FG001|Overall Study|Administrative|2|||
38019415|NCT00379288|69702165|FG002|Overall Study|Administrative|0|||
38019416|NCT00379288|69702166|FG003|Overall Study|Administrative|1|||
38019417|NCT00243503|69702176|FG000|Overall Study|Adverse Event|11|||
38019418|NCT00243503|69702176|FG000|Overall Study|Withdrawal by Subject|1|||
38019419|NCT00243503|69702176|FG000|Overall Study|Lack of Efficacy|44|||
37698791|NCT01796470|69175556|FG001|Overall Study|Progressive Disease|7|||
37698792|NCT01796470|69175557|FG002|Overall Study|Progressive Disease|3|||
37698793|NCT01796470|69175558|FG003|Overall Study|Progressive Disease|2|||
38019420|NCT00243503|69702176|FG000|Overall Study|Death|1|||
38019421|NCT00243503|69702176|FG000|Overall Study|Other|1|||
38019422|NCT00239837|69702183|FG000|Overall Study|Lost to Follow-up|3|||
38019423|NCT00239837|69702184|FG001|Overall Study|Lost to Follow-up|7|||
38019424|NCT00259649|69702192|FG000|Overall Study|Lost to Follow-up|7|||
38019425|NCT00259649|69702192|FG000|Overall Study|irregular menses|3|||
38019426|NCT03712280|69702200|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
38019427|NCT03712280|69702201|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
38019428|NCT03712280|69702202|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
37698794|NCT01796470|69175559|FG004|Overall Study|Progressive Disease|0|||
37698795|NCT01796470|69175555|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
37698796|NCT01796470|69175556|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
37832791|NCT01276639|69516368|FG000|Week 16 to 52|Withdrawal by Subject|4|||
37832792|NCT01276639|69516369|FG001|Week 16 to 52|Withdrawal by Subject|4|||
37832793|NCT01276639|69516370|FG002|Week 16 to 52|Withdrawal by Subject|0|||
37832794|NCT01276639|69516371|FG003|Week 16 to 52|Withdrawal by Subject|0|||
37832795|NCT01276639|69516372|FG004|Week 16 to 52|Withdrawal by Subject|1|||
37832796|NCT01276639|69516368|FG000|Week 16 to 52|Other|10|||
37832797|NCT01276639|69516369|FG001|Week 16 to 52|Other|12|||
37832798|NCT01276639|69516370|FG002|Week 16 to 52|Other|0|||
37832799|NCT01276639|69516371|FG003|Week 16 to 52|Other|1|||
37832800|NCT01276639|69516372|FG004|Week 16 to 52|Other|3|||
37832801|NCT01275625|69516387|FG000|Overall Study|Death|1|||
37832802|NCT01275625|69516387|FG000|Overall Study|Lack of Efficacy|2|||
37832803|NCT01275625|69516387|FG000|Overall Study|Lost to Follow-up|1|||
37910491|NCT04300296|69596674|FG005|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
37910492|NCT04300296|69596669|FG000|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
37910493|NCT04300296|69596670|FG001|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|1|||
37910494|NCT04300296|69596671|FG002|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
37910495|NCT04300296|69596672|FG003|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
37910496|NCT04300296|69596673|FG004|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
37910497|NCT04300296|69596674|FG005|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
38019429|NCT03712280|69702203|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
37910498|NCT04300296|69596669|FG000|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|2|||
38019430|NCT03712280|69702200|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
38019431|NCT03712280|69702201|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
38019432|NCT03712280|69702202|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
38019433|NCT03712280|69702203|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
38019434|NCT03712280|69702200|FG000|Overall Study|Adverse Event|0|||
38019435|NCT03712280|69702201|FG001|Overall Study|Adverse Event|0|||
38019436|NCT03712280|69702202|FG002|Overall Study|Adverse Event|1|||
38019437|NCT03712280|69702203|FG003|Overall Study|Adverse Event|0|||
38019438|NCT01345240|69702218|FG000|Overall Study|Adverse Event|3|||
38019439|NCT01345240|69702219|FG001|Overall Study|Adverse Event|5|||
38019440|NCT01345240|69702220|FG002|Overall Study|Adverse Event|4|||
37698797|NCT01796470|69175557|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
37698798|NCT01796470|69175558|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
38019441|NCT01345240|69702221|FG003|Overall Study|Adverse Event|2|||
38019442|NCT01345240|69702222|FG004|Overall Study|Adverse Event|1|||
38019443|NCT01345240|69702218|FG000|Overall Study|Lost to Follow-up|8|||
38019444|NCT01345240|69702219|FG001|Overall Study|Lost to Follow-up|9|||
38019445|NCT01345240|69702220|FG002|Overall Study|Lost to Follow-up|14|||
38019446|NCT01345240|69702221|FG003|Overall Study|Lost to Follow-up|7|||
38019447|NCT01345240|69702222|FG004|Overall Study|Lost to Follow-up|9|||
38019448|NCT03707912|69702254|FG000|Overall Study|Violation of inclusion criteria|1|||
38019449|NCT03707912|69702255|FG001|Overall Study|Violation of inclusion criteria|0|||
38019450|NCT02883244|69702263|FG000|Overall Study|Lost to Follow-up|0|||
38019451|NCT02883244|69702264|FG001|Overall Study|Lost to Follow-up|1|||
38019452|NCT02882854|69702272|FG000|Overall Study|Lost to Follow-up|1|||
38019453|NCT02882854|69702273|FG001|Overall Study|Lost to Follow-up|2|||
38019454|NCT02882854|69702272|FG000|Overall Study|Physician Decision|0|||
38019455|NCT02882854|69702273|FG001|Overall Study|Physician Decision|1|||
38019456|NCT03707522|69702283|FG000|Overall Study|Lost to Follow-up|24|||
38019457|NCT03707522|69702284|FG001|Overall Study|Lost to Follow-up|27|||
38019458|NCT03707522|69702285|FG002|Overall Study|Lost to Follow-up|41|||
38019459|NCT03707522|69702286|FG003|Overall Study|Lost to Follow-up|36|||
38019460|NCT03150082|69702296|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
38019461|NCT03150082|69702297|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
37698799|NCT01796470|69175559|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
37698800|NCT01796470|69175555|FG000|Overall Study|Withdrawal by Subject|7|||
37698801|NCT01796470|69175556|FG001|Overall Study|Withdrawal by Subject|0|||
37698802|NCT01796470|69175557|FG002|Overall Study|Withdrawal by Subject|0|||
37698803|NCT01796470|69175558|FG003|Overall Study|Withdrawal by Subject|0|||
37698804|NCT01796470|69175559|FG004|Overall Study|Withdrawal by Subject|1|||
37698805|NCT01868074|69175577|FG000|Overall Study|Lost to Follow-up|3|||
37698806|NCT01868074|69175578|FG001|Overall Study|Lost to Follow-up|2|||
37698807|NCT01868074|69175577|FG000|Overall Study|Withdrawal by Subject|4|||
37698808|NCT01868074|69175578|FG001|Overall Study|Withdrawal by Subject|2|||
37698809|NCT01810042|69175584|FG000|Overall Study|Lost to Follow-up|10|||
37698810|NCT02424539|69175591|FG000|Overall Study|Adverse Event|0|||
38019462|NCT03142750|69702325|FG000|Overall Study|Lost to Follow-up|4|||
38019463|NCT03142750|69702326|FG001|Overall Study|Lost to Follow-up|1|||
38019464|NCT03149848|69702336|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
38019465|NCT03149848|69702336|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
38019466|NCT03706040|69702346|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
37698811|NCT02424539|69175592|FG001|Overall Study|Adverse Event|0|||
37698812|NCT02424539|69175593|FG002|Overall Study|Adverse Event|1|||
37698813|NCT02424539|69175591|FG000|Overall Study|Physician Decision|0|||
37698814|NCT02424539|69175592|FG001|Overall Study|Physician Decision|0|||
37698815|NCT02424539|69175593|FG002|Overall Study|Physician Decision|1|||
37698816|NCT02424539|69175591|FG000|Overall Study|Withdrawal by Subject|3|||
37698817|NCT02424539|69175592|FG001|Overall Study|Withdrawal by Subject|1|||
37698818|NCT02424539|69175593|FG002|Overall Study|Withdrawal by Subject|0|||
37698819|NCT02424539|69175591|FG000|Overall Study|Other: Reached stopping criteria|11|||
37698820|NCT02424539|69175592|FG001|Overall Study|Other: Reached stopping criteria|7|||
37698821|NCT02424539|69175593|FG002|Overall Study|Other: Reached stopping criteria|6|||
37832804|NCT01275625|69516387|FG000|Overall Study|Withdrawal by Subject|3|||
37832805|NCT01275625|69516387|FG000|Overall Study|Protocol Violation|1|||
38019467|NCT03706040|69702347|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
38019468|NCT03706040|69702348|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
38019469|NCT03706040|69702349|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
38019470|NCT03706040|69702350|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
38019471|NCT03706040|69702351|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
38019472|NCT03706040|69702352|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
38019473|NCT03706040|69702346|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
38019474|NCT03706040|69702347|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
37698822|NCT01809262|69175601|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
38019475|NCT03706040|69702348|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
38019476|NCT03706040|69702349|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
37698823|NCT01809262|69175602|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
37698824|NCT01809262|69175603|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
37832806|NCT01275625|69516387|FG000|Overall Study|Adverse Event|4|||
37832807|NCT01275625|69516387|FG000|Overall Study|Other|1|||
37832808|NCT01272193|69516393|FG000|Overall Study|Adverse Event|1|||
37832809|NCT01272193|69516394|FG001|Overall Study|Adverse Event|1|||
37910499|NCT04300296|69596670|FG001|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
37698825|NCT01809262|69175604|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
37698826|NCT01809262|69175605|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
37698827|NCT01809262|69175606|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
37698828|NCT01809262|69175607|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
37698829|NCT01809262|69175608|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
37698830|NCT01809262|69175609|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
37698831|NCT01809262|69175610|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
37698832|NCT01809262|69175601|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
37698833|NCT01809262|69175602|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
37698834|NCT01809262|69175603|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
37698835|NCT01809262|69175604|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
37832810|NCT01272193|69516393|FG000|Overall Study|Lack of Efficacy|0|||
37832811|NCT01272193|69516394|FG001|Overall Study|Lack of Efficacy|3|||
37832812|NCT01272193|69516393|FG000|Overall Study|Withdrawal Criteria|1|||
37832813|NCT01272193|69516394|FG001|Overall Study|Withdrawal Criteria|1|||
37832814|NCT01272193|69516393|FG000|Overall Study|Unclassified|8|||
37832815|NCT01272193|69516394|FG001|Overall Study|Unclassified|7|||
37910500|NCT04300296|69596671|FG002|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
37910501|NCT04300296|69596672|FG003|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
37910502|NCT04300296|69596673|FG004|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|3|||
37910503|NCT04300296|69596674|FG005|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
37910504|NCT03989440|69596718|FG000|Overall Study|COVID-19 travel restrictions|0|||
37910505|NCT03989440|69596719|FG001|Overall Study|COVID-19 travel restrictions|0|||
37910506|NCT03989440|69596720|FG002|Overall Study|COVID-19 travel restrictions|1|||
37910507|NCT03989440|69596721|FG003|Overall Study|COVID-19 travel restrictions|0|||
37910508|NCT03989440|69596722|FG004|Overall Study|COVID-19 travel restrictions|0|||
37910509|NCT03989440|69596723|FG005|Overall Study|COVID-19 travel restrictions|0|||
37910510|NCT03989440|69596718|FG000|Overall Study|Unsuccessful lumbar puncture|0|||
37910511|NCT03989440|69596719|FG001|Overall Study|Unsuccessful lumbar puncture|0|||
37910512|NCT03989440|69596720|FG002|Overall Study|Unsuccessful lumbar puncture|0|||
37910513|NCT03989440|69596721|FG003|Overall Study|Unsuccessful lumbar puncture|1|||
37910514|NCT03989440|69596722|FG004|Overall Study|Unsuccessful lumbar puncture|0|||
37910515|NCT03989440|69596723|FG005|Overall Study|Unsuccessful lumbar puncture|0|||
37910516|NCT03908437|69596741|FG000|Overall Study|Death|0|||
37910517|NCT03908437|69596742|FG001|Overall Study|Death|1|||
37910518|NCT03908437|69596741|FG000|Overall Study|Lost to Follow-up|31|||
37832816|NCT01270828|69516406|FG000|Pregabalin CR SB|Reason Unspecified|0|||
37832817|NCT01270828|69516407|FG001|Pregabalin CR SB|Reason Unspecified|0|||
37832818|NCT01270828|69516408|FG002|Pregabalin CR SB|Reason Unspecified|8|||
37832819|NCT01270828|69516406|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
37832820|NCT01270828|69516407|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
37832821|NCT01270828|69516408|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
37910519|NCT03908437|69596742|FG001|Overall Study|Lost to Follow-up|24|||
37698836|NCT01809262|69175605|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
37698837|NCT01809262|69175606|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
37698838|NCT01809262|69175607|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
37832822|NCT01270828|69516406|FG000|Pregabalin CR SB|Related adverse event|0|||
37910520|NCT03274895|69596776|FG000|Overall Study|Lack of Efficacy|1|||
37832823|NCT01270828|69516407|FG001|Pregabalin CR SB|Related adverse event|0|||
37910521|NCT03274895|69596777|FG001|Overall Study|Lack of Efficacy|0|||
38019477|NCT03706040|69702350|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
38019478|NCT03706040|69702351|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
38019479|NCT03706040|69702352|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
38019480|NCT03706040|69702346|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
38019481|NCT03706040|69702347|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
38019482|NCT03706040|69702348|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
38019483|NCT03706040|69702349|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
38019484|NCT03706040|69702350|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
38019485|NCT03706040|69702351|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
38019486|NCT03706040|69702352|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
38019487|NCT03706040|69702346|FG000|Period A (Week 0 to Week 16)|Other|2|||
38019488|NCT03706040|69702347|FG001|Period A (Week 0 to Week 16)|Other|0|||
38019489|NCT03706040|69702348|FG002|Period A (Week 0 to Week 16)|Other|2|||
37698839|NCT01809262|69175608|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
37698840|NCT01809262|69175609|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
37698841|NCT01809262|69175610|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
37698842|NCT01808248|69175624|FG000|Overall Study|Lack of Efficacy|3|||
37698843|NCT01808248|69175624|FG000|Overall Study|Withdrawal by Subject|1|||
37698844|NCT01808248|69175624|FG000|Overall Study|Lost to Follow-up|1|||
37698845|NCT02424383|69175630|FG000|Overall Study|Withdrawal by Subject|32|||
37698846|NCT02424383|69175630|FG000|Overall Study|Death|170|||
37698847|NCT02424383|69175630|FG000|Overall Study|Sponsor's decision|3|||
37698848|NCT02424383|69175630|FG000|Overall Study|Investigator's decision|44|||
37698849|NCT02424383|69175630|FG000|Overall Study|Lost to Follow-up|81|||
37698850|NCT02424383|69175630|FG000|Overall Study|Other|7|||
37698851|NCT02424383|69175630|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
37698852|NCT01867294|69175638|FG000|Overall Study|Withdrawal by Subject|1|||
37698853|NCT01867294|69175639|FG001|Overall Study|Withdrawal by Subject|1|||
37698854|NCT01867294|69175640|FG002|Overall Study|Withdrawal by Subject|0|||
37698855|NCT01867294|69175641|FG003|Overall Study|Withdrawal by Subject|0|||
37698856|NCT02424149|69175651|FG000|Overall Study|surgery cancelled|2|||
37698857|NCT02424149|69175652|FG001|Overall Study|surgery cancelled|0|||
37698858|NCT02424149|69175651|FG000|Overall Study|Withdrawal by Subject|0|||
37698859|NCT02424149|69175652|FG001|Overall Study|Withdrawal by Subject|1|||
38019490|NCT03706040|69702349|FG003|Period A (Week 0 to Week 16)|Other|0|||
38019491|NCT03706040|69702350|FG004|Period A (Week 0 to Week 16)|Other|0|||
38019492|NCT03706040|69702351|FG005|Period A (Week 0 to Week 16)|Other|0|||
38019493|NCT03706040|69702352|FG006|Period A (Week 0 to Week 16)|Other|0|||
38019494|NCT03706040|69702346|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
38019495|NCT03706040|69702347|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
38019496|NCT03706040|69702348|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
38019497|NCT03706040|69702349|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
38019498|NCT03706040|69702350|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
37698860|NCT02423291|69175658|FG000|Overall Study|Lack of Efficacy|14|||
37698861|NCT02423291|69175658|FG000|Overall Study|Adverse Event|1|||
37698862|NCT02401529|69175664|FG000|Overall Study|Lost to Follow-up|2|||
37698863|NCT02401529|69175665|FG001|Overall Study|Lost to Follow-up|1|||
38019499|NCT03706040|69702351|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
38019500|NCT03706040|69702352|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
38019501|NCT03706040|69702346|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
38019502|NCT03706040|69702347|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
38019503|NCT03706040|69702348|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
38019504|NCT03706040|69702349|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
38019505|NCT03706040|69702350|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
38019506|NCT03706040|69702351|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
38019507|NCT03706040|69702352|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
38019508|NCT03706040|69702346|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
38019509|NCT03706040|69702347|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
38019510|NCT03706040|69702348|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
38019511|NCT03706040|69702349|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
38019512|NCT03706040|69702350|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
38019513|NCT03706040|69702351|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
38019514|NCT03706040|69702352|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
38019515|NCT03706040|69702346|FG000|Period B (Week 16 to Week 52)|Other|0|||
38019516|NCT03706040|69702347|FG001|Period B (Week 16 to Week 52)|Other|0|||
37832824|NCT01270828|69516408|FG002|Pregabalin CR SB|Related adverse event|46|||
37832825|NCT01270828|69516406|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
37832826|NCT01270828|69516407|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
37832827|NCT01270828|69516408|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
37832828|NCT01270828|69516406|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
37832829|NCT01270828|69516407|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
37832830|NCT01270828|69516408|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
37832831|NCT01270828|69516406|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
37832832|NCT01270828|69516407|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
37832833|NCT01270828|69516408|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
37832834|NCT01270828|69516406|FG000|Pregabalin CR SB|Unrelated AE|0|||
37832835|NCT01270828|69516407|FG001|Pregabalin CR SB|Unrelated AE|0|||
37832836|NCT01270828|69516408|FG002|Pregabalin CR SB|Unrelated AE|8|||
37832837|NCT01270828|69516406|FG000|Pregabalin CR SB|Protocol Violation|0|||
37832838|NCT01270828|69516407|FG001|Pregabalin CR SB|Protocol Violation|0|||
37832839|NCT01270828|69516408|FG002|Pregabalin CR SB|Protocol Violation|8|||
37832840|NCT01270828|69516406|FG000|Double Blind Phase|Death|0|||
37832841|NCT01270828|69516407|FG001|Double Blind Phase|Death|1|||
37832842|NCT01270828|69516408|FG002|Double Blind Phase|Death|0|||
37832843|NCT01270828|69516406|FG000|Double Blind Phase|Protocol Violation|0|||
37698864|NCT02401529|69175664|FG000|Overall Study|Physician Decision|2|||
37698865|NCT02401529|69175665|FG001|Overall Study|Physician Decision|6|||
37698866|NCT02401529|69175664|FG000|Overall Study|Protocol Violation|5|||
37698867|NCT02401529|69175665|FG001|Overall Study|Protocol Violation|0|||
37698868|NCT01867216|69175679|FG000|Overall Study|Withdrawal by Subject|2|||
37832844|NCT01270828|69516407|FG001|Double Blind Phase|Protocol Violation|1|||
37910522|NCT03274895|69596776|FG000|Overall Study|Adverse Event|8|||
37832845|NCT01270828|69516408|FG002|Double Blind Phase|Protocol Violation|0|||
37832846|NCT01270828|69516406|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
37832847|NCT01270828|69516407|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
37832848|NCT01270828|69516408|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
37910523|NCT03274895|69596777|FG001|Overall Study|Adverse Event|7|||
37910524|NCT03274895|69596776|FG000|Overall Study|Lost to Follow-up|1|||
37832849|NCT01270828|69516406|FG000|Double Blind Phase|Reason Unspecified|7|||
37832850|NCT01270828|69516407|FG001|Double Blind Phase|Reason Unspecified|4|||
37832851|NCT01270828|69516408|FG002|Double Blind Phase|Reason Unspecified|0|||
37910525|NCT03274895|69596777|FG001|Overall Study|Lost to Follow-up|0|||
37910526|NCT03274895|69596776|FG000|Overall Study|Diagnosis not confirmed|3|||
38019517|NCT03706040|69702348|FG002|Period B (Week 16 to Week 52)|Other|0|||
37910527|NCT03274895|69596777|FG001|Overall Study|Diagnosis not confirmed|4|||
37698869|NCT01867216|69175680|FG001|Overall Study|Withdrawal by Subject|0|||
37698870|NCT01867216|69175681|FG002|Overall Study|Withdrawal by Subject|0|||
37698871|NCT01867216|69175682|FG003|Overall Study|Withdrawal by Subject|0|||
37698872|NCT01867216|69175683|FG004|Overall Study|Withdrawal by Subject|1|||
37698873|NCT01867216|69175684|FG005|Overall Study|Withdrawal by Subject|0|||
37698874|NCT01867216|69175685|FG006|Overall Study|Withdrawal by Subject|1|||
37698875|NCT01867216|69175679|FG000|Overall Study|Physician Decision|1|||
37698876|NCT01867216|69175680|FG001|Overall Study|Physician Decision|0|||
37698877|NCT01867216|69175681|FG002|Overall Study|Physician Decision|0|||
37698878|NCT01867216|69175682|FG003|Overall Study|Physician Decision|0|||
37698879|NCT01867216|69175683|FG004|Overall Study|Physician Decision|0|||
37698880|NCT01867216|69175684|FG005|Overall Study|Physician Decision|0|||
37698881|NCT01867216|69175685|FG006|Overall Study|Physician Decision|0|||
37698882|NCT01867216|69175679|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
37698883|NCT01867216|69175680|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
37698884|NCT01867216|69175681|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
37698885|NCT01867216|69175682|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
37698886|NCT01867216|69175683|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
37698887|NCT01867216|69175684|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
37698888|NCT01867216|69175685|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
37698889|NCT01866826|69175707|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
37698890|NCT01866826|69175708|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
37698891|NCT01866826|69175707|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
37698892|NCT01866826|69175708|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
37698893|NCT01866826|69175707|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
37698894|NCT01866826|69175708|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
37698895|NCT01791244|69175725|FG000|Overall Study|Adverse Event|5|||
37698896|NCT01791244|69175726|FG001|Overall Study|Adverse Event|7|||
37698897|NCT01791244|69175725|FG000|Overall Study|Insufficient clinical response|10|||
37698898|NCT01791244|69175726|FG001|Overall Study|Insufficient clinical response|10|||
37698899|NCT01791244|69175725|FG000|Overall Study|Laboratory Abnormality|0|||
37698900|NCT01791244|69175726|FG001|Overall Study|Laboratory Abnormality|1|||
37698901|NCT01865812|69175734|FG000|Primary Treatment Phase|Adverse Event|2|||
37698902|NCT01865812|69175735|FG001|Primary Treatment Phase|Adverse Event|0|||
37698903|NCT01865812|69175734|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
37698904|NCT01865812|69175735|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
37698905|NCT01865812|69175734|FG000|Long-term Safety Extension Phase|Pruritus|0|||
37698906|NCT01865812|69175735|FG001|Long-term Safety Extension Phase|Pruritus|3|||
37698907|NCT01865812|69175734|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
37698908|NCT01865812|69175735|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
37698909|NCT01865812|69175734|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
37698910|NCT01865812|69175735|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
37698911|NCT01808092|69175744|FG000|Overall Study|Death|39|||
37698912|NCT01808092|69175745|FG001|Overall Study|Death|29|||
37698913|NCT01808092|69175744|FG000|Overall Study|Lost to Follow-up|3|||
37698914|NCT01808092|69175745|FG001|Overall Study|Lost to Follow-up|7|||
37698915|NCT01808092|69175744|FG000|Overall Study|Withdrawal by Subject|9|||
37698916|NCT01808092|69175745|FG001|Overall Study|Withdrawal by Subject|4|||
37698917|NCT01808092|69175744|FG000|Overall Study|Other Eligibility criteria|3|||
37698918|NCT01808092|69175745|FG001|Overall Study|Other Eligibility criteria|5|||
37698919|NCT01774084|69175753|FG000|Overall Study|Personal reasons|1|||
37698920|NCT01774084|69175754|FG001|Overall Study|Personal reasons|0|||
37698921|NCT01807234|69175766|FG000|Overall Study|Lost to Follow-up|2|||
37698922|NCT01807234|69175767|FG001|Overall Study|Lost to Follow-up|5|||
37698923|NCT01807234|69175768|FG002|Overall Study|Lost to Follow-up|1|||
37698924|NCT01807234|69175769|FG003|Overall Study|Lost to Follow-up|1|||
37832852|NCT01270828|69516406|FG000|Double Blind Phase|Withdrawal by Subject|6|||
37832853|NCT01270828|69516407|FG001|Double Blind Phase|Withdrawal by Subject|15|||
37832854|NCT01270828|69516408|FG002|Double Blind Phase|Withdrawal by Subject|0|||
37832855|NCT01270828|69516406|FG000|Double Blind Phase|Lost to Follow-up|1|||
37832856|NCT01270828|69516407|FG001|Double Blind Phase|Lost to Follow-up|2|||
37832857|NCT01270828|69516408|FG002|Double Blind Phase|Lost to Follow-up|0|||
37832858|NCT01270828|69516406|FG000|Double Blind Phase|Lack of Efficacy|2|||
37910528|NCT03035201|69596799|FG000|Overall Study|Death|9|||
37910529|NCT03035201|69596800|FG001|Overall Study|Death|12|||
37698925|NCT01807234|69175770|FG004|Overall Study|Lost to Follow-up|1|||
37698926|NCT01807234|69175771|FG005|Overall Study|Lost to Follow-up|2|||
37698927|NCT01807234|69175766|FG000|Overall Study|Withdrawal by Subject|3|||
37832859|NCT01270828|69516407|FG001|Double Blind Phase|Lack of Efficacy|11|||
37832860|NCT01270828|69516408|FG002|Double Blind Phase|Lack of Efficacy|0|||
37910530|NCT03035201|69596801|FG002|Overall Study|Death|9|||
37910531|NCT03035201|69596802|FG003|Overall Study|Death|10|||
37698928|NCT01807234|69175767|FG001|Overall Study|Withdrawal by Subject|1|||
37698929|NCT01807234|69175768|FG002|Overall Study|Withdrawal by Subject|1|||
37698930|NCT01807234|69175769|FG003|Overall Study|Withdrawal by Subject|1|||
37698931|NCT01807234|69175770|FG004|Overall Study|Withdrawal by Subject|2|||
37698932|NCT01807234|69175771|FG005|Overall Study|Withdrawal by Subject|1|||
37698933|NCT01807234|69175766|FG000|Overall Study|Lack of Efficacy|0|||
37698934|NCT01807234|69175767|FG001|Overall Study|Lack of Efficacy|0|||
37698935|NCT01807234|69175768|FG002|Overall Study|Lack of Efficacy|0|||
37698936|NCT01807234|69175769|FG003|Overall Study|Lack of Efficacy|0|||
37698937|NCT01807234|69175770|FG004|Overall Study|Lack of Efficacy|1|||
37698938|NCT01807234|69175771|FG005|Overall Study|Lack of Efficacy|1|||
37698939|NCT01790932|69175781|FG000|Overall Study|Disease Progression|41|||
37698940|NCT01790932|69175781|FG000|Overall Study|Adverse Event|7|||
37698941|NCT01790932|69175781|FG000|Overall Study|Physician Decision|1|||
37698942|NCT01790932|69175781|FG000|Overall Study|Withdrawal by Subject|1|||
37698943|NCT02377427|69175787|FG000|Part A (Up to Week 20)|Physician Decision|1|||
37698944|NCT02377427|69175788|FG001|Part A (Up to Week 20)|Physician Decision|0|||
37698945|NCT02377427|69175789|FG002|Part A (Up to Week 20)|Physician Decision|0|||
37698946|NCT02377427|69175790|FG003|Part A (Up to Week 20)|Physician Decision|0|||
37698947|NCT02377427|69175791|FG004|Part A (Up to Week 20)|Physician Decision|0|||
37698948|NCT02377427|69175787|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
37698949|NCT02377427|69175788|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
37698950|NCT02377427|69175789|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
37698951|NCT02377427|69175790|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
37698952|NCT02377427|69175791|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
37698953|NCT02377427|69175787|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
37698954|NCT02377427|69175788|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
37698955|NCT02377427|69175789|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
37698956|NCT02377427|69175790|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
37698957|NCT02377427|69175791|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
37698958|NCT02377427|69175787|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
37698959|NCT02377427|69175788|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
37698960|NCT02377427|69175789|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
37698961|NCT02377427|69175790|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
37698962|NCT02377427|69175791|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
37698963|NCT02421887|69175806|FG000|Overall Study|Lost to Follow-up|5|||
37698964|NCT02421887|69175807|FG001|Overall Study|Lost to Follow-up|0|||
37698965|NCT02421887|69175806|FG000|Overall Study|Withdrawal by Subject|8|||
37698966|NCT02421887|69175807|FG001|Overall Study|Withdrawal by Subject|5|||
37698967|NCT02421887|69175806|FG000|Overall Study|Physician Decision|2|||
37698968|NCT02421887|69175807|FG001|Overall Study|Physician Decision|4|||
37698969|NCT02421887|69175806|FG000|Overall Study|Adverse Event|2|||
37698970|NCT02421887|69175807|FG001|Overall Study|Adverse Event|0|||
37698971|NCT01609582|69175815|FG000|Overall Study|Adverse Event|20|||
37698972|NCT01609582|69175816|FG001|Overall Study|Adverse Event|18|||
37698973|NCT01609582|69175815|FG000|Overall Study|Lost to Follow-up|10|||
37698974|NCT01609582|69175816|FG001|Overall Study|Lost to Follow-up|10|||
38019518|NCT03706040|69702349|FG003|Period B (Week 16 to Week 52)|Other|4|||
38019519|NCT03706040|69702350|FG004|Period B (Week 16 to Week 52)|Other|5|||
38019520|NCT03706040|69702351|FG005|Period B (Week 16 to Week 52)|Other|23|||
37698975|NCT01609582|69175815|FG000|Overall Study|Withdrawal by Subject|21|||
37698976|NCT01609582|69175816|FG001|Overall Study|Withdrawal by Subject|15|||
37698977|NCT01609582|69175815|FG000|Overall Study|Study Terminated by Sponsor|1543|||
37698978|NCT01609582|69175816|FG001|Overall Study|Study Terminated by Sponsor|1548|||
37698979|NCT01609582|69175815|FG000|Overall Study|Other|9|||
37698980|NCT01609582|69175816|FG001|Overall Study|Other|10|||
37698981|NCT01609582|69175815|FG000|Overall Study|Randomized, but not treated|0|||
37698982|NCT01609582|69175816|FG001|Overall Study|Randomized, but not treated|3|||
37698983|NCT01789606|69175824|FG000|Overall Study|Participant not Purchased the Product|0|||
37698984|NCT01789606|69175825|FG001|Overall Study|Participant not Purchased the Product|20|||
37698985|NCT01789606|69175824|FG000|Overall Study|Withdrawal by Subject|0|||
37698986|NCT01789606|69175825|FG001|Overall Study|Withdrawal by Subject|1|||
37698987|NCT01789606|69175824|FG000|Overall Study|Ineligible|6|||
37698988|NCT01789606|69175825|FG001|Overall Study|Ineligible|2|||
37698989|NCT01789606|69175824|FG000|Overall Study|Administrative Reasons|17|||
37698990|NCT01789606|69175825|FG001|Overall Study|Administrative Reasons|6|||
37698991|NCT01789606|69175824|FG000|Overall Study|No Study Medication Taken|0|||
37698992|NCT01789606|69175825|FG001|Overall Study|No Study Medication Taken|1|||
37698993|NCT01789606|69175824|FG000|Overall Study|Protocol Violation|0|||
37698994|NCT01789606|69175825|FG001|Overall Study|Protocol Violation|55|||
37698995|NCT01789606|69175824|FG000|Overall Study|Adverse Event|0|||
37698996|NCT01789606|69175825|FG001|Overall Study|Adverse Event|3|||
37698997|NCT01789606|69175824|FG000|Overall Study|Lost to Follow-up|0|||
37698998|NCT01789606|69175825|FG001|Overall Study|Lost to Follow-up|14|||
37698999|NCT01789606|69175824|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
37699000|NCT01789606|69175825|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
37699001|NCT01788358|69175830|FG000|Overall Study|Other|11|||
37699002|NCT01788358|69175830|FG000|Overall Study|Logistical difficulties|1|||
37699003|NCT01788358|69175830|FG000|Overall Study|Lost to Follow-up|5|||
37699004|NCT01788358|69175830|FG000|Overall Study|Protocol Violation|3|||
37699005|NCT01788358|69175830|FG000|Overall Study|Withdrawal by Subject|26|||
37699006|NCT01788358|69175830|FG000|Overall Study|Lack of Efficacy|1|||
37699007|NCT01788358|69175830|FG000|Overall Study|Adverse Event|51|||
37699008|NCT01773226|69175834|FG000|Overall Study|Withdrawal by Subject|1|||
37699009|NCT01773070|69175838|FG000|Overall Study|Withdrawal by Subject|24|||
37699010|NCT01773070|69175838|FG000|Overall Study|Lost to Follow-up|39|||
37699011|NCT01773070|69175838|FG000|Overall Study|Other|15|||
37699012|NCT01773070|69175838|FG000|Overall Study|Death (unrelated to study procedures)|3|||
37699013|NCT01772368|69175842|FG000|Overall Study|Adverse Event|1|||
37699014|NCT01772368|69175842|FG000|Overall Study|Withdrawal by Subject|3|||
37699015|NCT01772368|69175842|FG000|Overall Study|Protocol Violation|2|||
37699016|NCT01772368|69175842|FG000|Overall Study|Other|1|||
37699017|NCT01788046|69175860|FG000|Overall Study|Withdrawal by Subject|12|||
37699018|NCT01788046|69175861|FG001|Overall Study|Withdrawal by Subject|12|||
37699019|NCT01788046|69175860|FG000|Overall Study|Lost to Follow-up|12|||
37699020|NCT01788046|69175861|FG001|Overall Study|Lost to Follow-up|19|||
37699021|NCT01788046|69175860|FG000|Overall Study|Death|7|||
37699022|NCT01788046|69175861|FG001|Overall Study|Death|5|||
37699023|NCT01788046|69175860|FG000|Overall Study|Protocol Specified Criteria|25|||
37699024|NCT01788046|69175861|FG001|Overall Study|Protocol Specified Criteria|1|||
37699025|NCT01806298|69175867|FG000|Overall Study|Adverse Event|3|||
37699026|NCT01806298|69175867|FG000|Overall Study|Protocol Non-compliance|1|||
37699027|NCT01806298|69175867|FG000|Overall Study|Withdrawal by Subject|1|||
37699028|NCT01806298|69175867|FG000|Overall Study|Other|5|||
37699029|NCT01772134|69175874|FG000|Overall Study|Adverse Event|6|||
37699030|NCT01772134|69175875|FG001|Overall Study|Adverse Event|5|||
37699031|NCT01772134|69175876|FG002|Overall Study|Adverse Event|10|||
37699032|NCT01772134|69175874|FG000|Overall Study|Withdrew Consent|3|||
37699033|NCT01772134|69175875|FG001|Overall Study|Withdrew Consent|1|||
37699034|NCT01772134|69175876|FG002|Overall Study|Withdrew Consent|5|||
37699035|NCT01772134|69175874|FG000|Overall Study|Lost to Follow-up|2|||
37699036|NCT01772134|69175875|FG001|Overall Study|Lost to Follow-up|0|||
37699037|NCT01772134|69175876|FG002|Overall Study|Lost to Follow-up|0|||
37699038|NCT01772134|69175874|FG000|Overall Study|Protocol Deviation|4|||
37699039|NCT01772134|69175875|FG001|Overall Study|Protocol Deviation|3|||
37699040|NCT01772134|69175876|FG002|Overall Study|Protocol Deviation|3|||
37699041|NCT01772134|69175874|FG000|Overall Study|Lack of Efficacy|11|||
37699042|NCT01772134|69175875|FG001|Overall Study|Lack of Efficacy|5|||
37699043|NCT01772134|69175876|FG002|Overall Study|Lack of Efficacy|3|||
37699044|NCT01772134|69175874|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
37699045|NCT01772134|69175875|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
37699046|NCT01772134|69175876|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
37699047|NCT01772134|69175874|FG000|Overall Study|Randomized Study Medication Not Received|2|||
37699048|NCT01772134|69175875|FG001|Overall Study|Randomized Study Medication Not Received|0|||
37699049|NCT01772134|69175876|FG002|Overall Study|Randomized Study Medication Not Received|1|||
37699050|NCT01994889|69175887|FG000|Overall Study|Adverse Event|5|||
37699051|NCT01994889|69175888|FG001|Overall Study|Adverse Event|12|||
37699052|NCT01994889|69175889|FG002|Overall Study|Adverse Event|11|||
37699053|NCT01994889|69175887|FG000|Overall Study|Cardiac Device Implantation|0|||
37699054|NCT01994889|69175888|FG001|Overall Study|Cardiac Device Implantation|2|||
37699055|NCT01994889|69175889|FG002|Overall Study|Cardiac Device Implantation|0|||
37699056|NCT01994889|69175887|FG000|Overall Study|Organ Transplantation|1|||
37699057|NCT01994889|69175888|FG001|Overall Study|Organ Transplantation|5|||
37699058|NCT01994889|69175889|FG002|Overall Study|Organ Transplantation|5|||
37699059|NCT01994889|69175887|FG000|Overall Study|No longer willing to participate|8|||
37699060|NCT01994889|69175888|FG001|Overall Study|No longer willing to participate|17|||
37699061|NCT01994889|69175889|FG002|Overall Study|No longer willing to participate|37|||
37699062|NCT01994889|69175887|FG000|Overall Study|Lost to Follow-up|0|||
37699063|NCT01994889|69175888|FG001|Overall Study|Lost to Follow-up|1|||
37699064|NCT01994889|69175889|FG002|Overall Study|Lost to Follow-up|0|||
37699065|NCT01994889|69175887|FG000|Overall Study|Protocol Violation|0|||
37699066|NCT01994889|69175888|FG001|Overall Study|Protocol Violation|1|||
37699067|NCT01994889|69175889|FG002|Overall Study|Protocol Violation|1|||
37699068|NCT01994889|69175887|FG000|Overall Study|Death|14|||
38019521|NCT03706040|69702352|FG006|Period B (Week 16 to Week 52)|Other|17|||
38019522|NCT03770000|69702373|FG000|Overall Study|Premature discontinuation due to PD|0|||
38019523|NCT03770000|69702374|FG001|Overall Study|Premature discontinuation due to PD|0|||
38019524|NCT03770000|69702375|FG002|Overall Study|Premature discontinuation due to PD|1|||
38019525|NCT03770000|69702376|FG003|Overall Study|Premature discontinuation due to PD|3|||
38019526|NCT03770000|69702377|FG004|Overall Study|Premature discontinuation due to PD|2|||
38019527|NCT03158272|69702396|FG000|Overall Study|Disease progression|3|||
38019528|NCT03158272|69702397|FG001|Overall Study|Disease progression|3|||
38019529|NCT03158272|69702398|FG002|Overall Study|Disease progression|4|||
38019530|NCT03158272|69702399|FG003|Overall Study|Disease progression|6|||
38019531|NCT03158272|69702396|FG000|Overall Study|Death|0|||
38019532|NCT03158272|69702397|FG001|Overall Study|Death|0|||
38019533|NCT03158272|69702398|FG002|Overall Study|Death|1|||
38019534|NCT03158272|69702399|FG003|Overall Study|Death|0|||
38019535|NCT03158272|69702396|FG000|Overall Study|Other reasons|0|||
38019536|NCT03158272|69702397|FG001|Overall Study|Other reasons|0|||
38019537|NCT03158272|69702398|FG002|Overall Study|Other reasons|1|||
38019538|NCT03158272|69702399|FG003|Overall Study|Other reasons|0|||
38019539|NCT03158272|69702396|FG000|Overall Study|Adverse event unrelated to the drug|0|||
38019540|NCT03158272|69702397|FG001|Overall Study|Adverse event unrelated to the drug|1|||
38019541|NCT03158272|69702398|FG002|Overall Study|Adverse event unrelated to the drug|0|||
38019542|NCT03158272|69702399|FG003|Overall Study|Adverse event unrelated to the drug|0|||
38019543|NCT03705494|69702413|FG000|Overall Study|Lost to Follow-up|2|||
38019544|NCT03705494|69702414|FG001|Overall Study|Lost to Follow-up|1|||
38019545|NCT03705494|69702413|FG000|Overall Study|Withdrawal by Subject|5|||
38019546|NCT03705494|69702414|FG001|Overall Study|Withdrawal by Subject|2|||
38019547|NCT01431508|69702420|FG000|Overall Study|Lack of Efficacy|1|||
38019548|NCT01431508|69702420|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
38019549|NCT00654628|69702424|FG000|6-week Active Treatment Period|Adverse Event|9|||
38019550|NCT00654628|69702424|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
38019551|NCT00654628|69702424|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
38019552|NCT00654628|69702424|FG000|6-week Active Treatment Period|Out of window period|1|||
38019553|NCT00654628|69702424|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
38019554|NCT00654628|69702424|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
38019555|NCT00536380|69702431|FG000|Overall Study|Adverse Event|0|||
38019556|NCT00536380|69702432|FG001|Overall Study|Adverse Event|2|||
38019557|NCT00536380|69702433|FG002|Overall Study|Adverse Event|2|||
38019558|NCT00536380|69702431|FG000|Overall Study|Lost to Follow-up|0|||
38019559|NCT00536380|69702432|FG001|Overall Study|Lost to Follow-up|0|||
38019560|NCT00536380|69702433|FG002|Overall Study|Lost to Follow-up|1|||
38019561|NCT00536380|69702431|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
38019562|NCT00536380|69702432|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
38019563|NCT00536380|69702433|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
38019564|NCT00536380|69702431|FG000|Overall Study|Withdrawal related to study drug|7|||
38019565|NCT00536380|69702432|FG001|Overall Study|Withdrawal related to study drug|5|||
37699069|NCT01994889|69175888|FG001|Overall Study|Death|25|||
37699070|NCT01994889|69175889|FG002|Overall Study|Death|38|||
37699071|NCT02082483|69175898|FG000|Overall Study|Lost to Follow-up|1|||
38019566|NCT00536380|69702433|FG002|Overall Study|Withdrawal related to study drug|2|||
38019567|NCT00536380|69702431|FG000|Overall Study|Noncompliance with protocol|3|||
38019568|NCT00536380|69702432|FG001|Overall Study|Noncompliance with protocol|2|||
38019569|NCT00536380|69702433|FG002|Overall Study|Noncompliance with protocol|2|||
38019570|NCT00536380|69702431|FG000|Overall Study|Did not meet protocol eligibility|0|||
38019571|NCT00536380|69702432|FG001|Overall Study|Did not meet protocol eligibility|0|||
38019572|NCT00536380|69702433|FG002|Overall Study|Did not meet protocol eligibility|1|||
38019573|NCT00536380|69702431|FG000|Overall Study|Administrative|0|||
38019574|NCT00536380|69702432|FG001|Overall Study|Administrative|0|||
38019575|NCT00536380|69702433|FG002|Overall Study|Administrative|1|||
38019576|NCT00496834|69702443|FG000|Overall Study|Withdrawal by Subject|4|||
38019577|NCT00496834|69702444|FG001|Overall Study|Withdrawal by Subject|6|||
38019578|NCT00496834|69702443|FG000|Overall Study|Contraindicated medication administered|0|||
38019579|NCT00496834|69702444|FG001|Overall Study|Contraindicated medication administered|1|||
38019580|NCT00496834|69702443|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
38019581|NCT00496834|69702444|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
38019582|NCT00496834|69702443|FG000|Overall Study|Adverse Event|5|||
38019583|NCT00496834|69702444|FG001|Overall Study|Adverse Event|3|||
38019584|NCT00496834|69702443|FG000|Overall Study|IP administration violation|2|||
38019585|NCT00496834|69702444|FG001|Overall Study|IP administration violation|0|||
38019586|NCT00496834|69702443|FG000|Overall Study|Lost to Follow-up|2|||
38019587|NCT00496834|69702444|FG001|Overall Study|Lost to Follow-up|0|||
38019588|NCT00496834|69702443|FG000|Overall Study|Blood Pressure control failure|2|||
38019589|NCT00496834|69702444|FG001|Overall Study|Blood Pressure control failure|1|||
38019590|NCT05244122|69702452|FG000|Overall Study|Withdrawal by Subject|318|||
38019591|NCT00166504|69702473|FG000|Overall Study|Adverse Event|3|||
38019592|NCT00166504|69702474|FG001|Overall Study|Adverse Event|3|||
38019593|NCT00166504|69702473|FG000|Overall Study|Lost to Follow-up|1|||
38019594|NCT00166504|69702474|FG001|Overall Study|Lost to Follow-up|1|||
38019595|NCT00166504|69702473|FG000|Overall Study|Withdrawal by Subject|1|||
38019596|NCT00166504|69702474|FG001|Overall Study|Withdrawal by Subject|0|||
38019597|NCT03137992|69702480|FG000|Washout Period 1|Adverse Event|1|||
38019598|NCT03137992|69702481|FG001|Washout Period 1|Adverse Event|1|||
38019599|NCT03137992|69702482|FG002|Washout Period 1|Adverse Event|0|||
38019600|NCT03137992|69702483|FG003|Washout Period 1|Adverse Event|0|||
38019601|NCT03137992|69702484|FG004|Washout Period 1|Adverse Event|0|||
38019602|NCT03137992|69702485|FG005|Washout Period 1|Adverse Event|1|||
38019603|NCT03137992|69702480|FG000|Washout Period 1|Withdrawal by Subject|0|||
38019604|NCT03137992|69702481|FG001|Washout Period 1|Withdrawal by Subject|1|||
38019605|NCT03137992|69702482|FG002|Washout Period 1|Withdrawal by Subject|1|||
38019606|NCT03137992|69702483|FG003|Washout Period 1|Withdrawal by Subject|0|||
38019607|NCT03137992|69702484|FG004|Washout Period 1|Withdrawal by Subject|0|||
38019608|NCT03137992|69702485|FG005|Washout Period 1|Withdrawal by Subject|0|||
38019609|NCT03137992|69702480|FG000|Washout Period 1|Principal Investigator Discretion|0|||
38019610|NCT03137992|69702481|FG001|Washout Period 1|Principal Investigator Discretion|1|||
38019611|NCT03137992|69702482|FG002|Washout Period 1|Principal Investigator Discretion|0|||
38019612|NCT03137992|69702483|FG003|Washout Period 1|Principal Investigator Discretion|0|||
38019613|NCT03137992|69702484|FG004|Washout Period 1|Principal Investigator Discretion|0|||
38019614|NCT03137992|69702485|FG005|Washout Period 1|Principal Investigator Discretion|0|||
38019615|NCT03137992|69702480|FG000|Washout Period 1|COPD Exacerbation|1|||
38019616|NCT03137992|69702481|FG001|Washout Period 1|COPD Exacerbation|1|||
38019617|NCT03137992|69702482|FG002|Washout Period 1|COPD Exacerbation|1|||
38019618|NCT03137992|69702483|FG003|Washout Period 1|COPD Exacerbation|0|||
38019619|NCT03137992|69702484|FG004|Washout Period 1|COPD Exacerbation|1|||
38019620|NCT03137992|69702485|FG005|Washout Period 1|COPD Exacerbation|1|||
38019621|NCT03137992|69702480|FG000|Washout Period 1|Subject Noncompliance|1|||
38019622|NCT03137992|69702481|FG001|Washout Period 1|Subject Noncompliance|0|||
37699072|NCT02082483|69175899|FG001|Overall Study|Lost to Follow-up|1|||
37699073|NCT02082483|69175898|FG000|Overall Study|Withdrawal by Subject|2|||
37699074|NCT02082483|69175899|FG001|Overall Study|Withdrawal by Subject|1|||
37699075|NCT02082483|69175898|FG000|Overall Study|Physician Decision|1|||
37699076|NCT02082483|69175899|FG001|Overall Study|Physician Decision|1|||
37699077|NCT02082483|69175898|FG000|Overall Study|Death|2|||
37699078|NCT02082483|69175899|FG001|Overall Study|Death|3|||
37699079|NCT02017899|69175912|FG000|Overall Study|Withdrawal by Subject|0|||
37699080|NCT02017899|69175913|FG001|Overall Study|Withdrawal by Subject|0|||
37699081|NCT02017899|69175914|FG002|Overall Study|Withdrawal by Subject|0|||
37699082|NCT02017899|69175915|FG003|Overall Study|Withdrawal by Subject|1|||
37699083|NCT02017899|69175916|FG004|Overall Study|Withdrawal by Subject|1|||
37699084|NCT02017899|69175917|FG005|Overall Study|Withdrawal by Subject|0|||
37699085|NCT01993329|69175937|FG000|Period 2|Adverse Event|0|||
38019623|NCT03137992|69702482|FG002|Washout Period 1|Subject Noncompliance|0|||
38019624|NCT03137992|69702483|FG003|Washout Period 1|Subject Noncompliance|0|||
37699086|NCT01993329|69175938|FG001|Period 2|Adverse Event|0|||
37699087|NCT01993329|69175939|FG002|Period 2|Adverse Event|0|||
38019625|NCT03137992|69702484|FG004|Washout Period 1|Subject Noncompliance|1|||
38019626|NCT03137992|69702485|FG005|Washout Period 1|Subject Noncompliance|0|||
38019627|NCT03137992|69702480|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
38019628|NCT03137992|69702481|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
38019629|NCT03137992|69702482|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
38019630|NCT03137992|69702483|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
38019631|NCT03137992|69702484|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
37699088|NCT01993329|69175940|FG003|Period 2|Adverse Event|0|||
37699089|NCT01993329|69175941|FG004|Period 2|Adverse Event|0|||
37699090|NCT01993329|69175942|FG005|Period 2|Adverse Event|1|||
37699091|NCT01993329|69175937|FG000|Wash-out|Personal reasons|0|||
37699092|NCT01993329|69175938|FG001|Wash-out|Personal reasons|1|||
37699093|NCT01993329|69175939|FG002|Wash-out|Personal reasons|0|||
37699094|NCT01993329|69175940|FG003|Wash-out|Personal reasons|0|||
37699095|NCT01993329|69175941|FG004|Wash-out|Personal reasons|0|||
37699096|NCT01993329|69175942|FG005|Wash-out|Personal reasons|0|||
37699097|NCT02016183|69175954|FG000|Overall Study|Case Report Forms Uncollected|13|||
37699098|NCT02016183|69175954|FG000|Overall Study|Protocol Violation|52|||
37699099|NCT02377349|69175960|FG000|Overall Study|Serious Adverse Event|1|||
37699100|NCT02377349|69175961|FG001|Overall Study|Serious Adverse Event|0|||
37699101|NCT02377349|69175960|FG000|Overall Study|Protocol Violation|3|||
37699102|NCT02377349|69175961|FG001|Overall Study|Protocol Violation|2|||
37699103|NCT02377349|69175960|FG000|Overall Study|Withdrawal by Subject|5|||
37699104|NCT02377349|69175961|FG001|Overall Study|Withdrawal by Subject|3|||
37699105|NCT02377349|69175960|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
37699106|NCT02377349|69175961|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
37699107|NCT02377349|69175960|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
37699108|NCT02377349|69175961|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
37699109|NCT02377349|69175960|FG000|Overall Study|Other|0|||
37699110|NCT02377349|69175961|FG001|Overall Study|Other|1|||
37699111|NCT02421419|69175979|FG000|Overall Study|Physician Decision|0|||
37699112|NCT02421419|69175980|FG001|Overall Study|Physician Decision|0|||
37699113|NCT02421419|69175981|FG002|Overall Study|Physician Decision|1|||
37699114|NCT02016105|69175991|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
37699115|NCT02016105|69175992|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
37699116|NCT02016105|69175993|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
37699117|NCT02016105|69175994|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
37699118|NCT02016105|69175995|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
37699119|NCT02016105|69175996|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
37699120|NCT02016105|69175991|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
37699121|NCT02016105|69175992|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
37699122|NCT02016105|69175993|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
37699123|NCT02016105|69175994|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
37699124|NCT02016105|69175995|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
38019632|NCT03137992|69702485|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
38019633|NCT03137992|69702480|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
38019634|NCT03137992|69702481|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
38019635|NCT03137992|69702482|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
38019636|NCT03137992|69702483|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
37699125|NCT02016105|69175996|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
37699126|NCT02016105|69175991|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
37699127|NCT02016105|69175992|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
37699128|NCT02016105|69175993|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
37699129|NCT02016105|69175994|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
37699130|NCT02016105|69175995|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
37699131|NCT02016105|69175996|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
37699132|NCT02016105|69175991|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
37699133|NCT02016105|69175992|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
37699134|NCT02016105|69175993|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
37699135|NCT02016105|69175994|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
37699136|NCT02016105|69175995|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
37699137|NCT02016105|69175996|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
37699138|NCT02016105|69175991|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
37699139|NCT02016105|69175992|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
37699140|NCT02016105|69175993|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
37699141|NCT02016105|69175994|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
37699142|NCT02016105|69175995|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
37699143|NCT02016105|69175996|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
37699144|NCT02016105|69175991|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
37699145|NCT02016105|69175992|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
37699146|NCT02016105|69175993|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
37699147|NCT02016105|69175994|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
37699148|NCT02016105|69175995|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
37699149|NCT02016105|69175996|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
37699150|NCT02016105|69175991|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
37699151|NCT02016105|69175992|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
37699152|NCT02016105|69175993|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
37699153|NCT02016105|69175994|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
37699154|NCT02016105|69175995|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
37699155|NCT02016105|69175996|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
38019637|NCT03137992|69702484|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
37699156|NCT02016105|69175991|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
37699157|NCT02016105|69175992|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
37699158|NCT02016105|69175993|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
37699159|NCT02016105|69175994|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
37699160|NCT02016105|69175995|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
37699161|NCT02016105|69175996|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
37699162|NCT02016105|69175991|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
37699163|NCT02016105|69175992|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
37699164|NCT02016105|69175993|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
37699165|NCT02016105|69175994|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
37699166|NCT02016105|69175995|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
37699167|NCT02016105|69175996|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
37699168|NCT02016105|69175991|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
37699169|NCT02016105|69175992|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
37699170|NCT02016105|69175993|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
37699171|NCT02016105|69175994|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
37699172|NCT02016105|69175995|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
37699173|NCT02016105|69175996|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
37699174|NCT02016105|69175991|FG000|TREATMENT PERIOD 2|Death|0|||
37699175|NCT02016105|69175992|FG001|TREATMENT PERIOD 2|Death|0|||
37699176|NCT02016105|69175993|FG002|TREATMENT PERIOD 2|Death|0|||
37699177|NCT02016105|69175994|FG003|TREATMENT PERIOD 2|Death|0|||
37699178|NCT02016105|69175995|FG004|TREATMENT PERIOD 2|Death|0|||
37699179|NCT02016105|69175996|FG005|TREATMENT PERIOD 2|Death|1|||
37699180|NCT02016105|69175991|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
37699181|NCT02016105|69175992|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
38019638|NCT03137992|69702485|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
38019639|NCT03137992|69702480|FG000|Period 2 (Visit 3)|Adverse Event|0|||
37699182|NCT02016105|69175993|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
37699183|NCT02016105|69175994|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
37699184|NCT02016105|69175995|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
37699185|NCT02016105|69175996|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
37699186|NCT02016105|69175991|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
37699187|NCT02016105|69175992|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
37699188|NCT02016105|69175993|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
37699189|NCT02016105|69175994|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
37699190|NCT02016105|69175995|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
37699191|NCT02016105|69175996|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
38019640|NCT03137992|69702481|FG001|Period 2 (Visit 3)|Adverse Event|1|||
38019641|NCT03137992|69702482|FG002|Period 2 (Visit 3)|Adverse Event|0|||
38019642|NCT03137992|69702483|FG003|Period 2 (Visit 3)|Adverse Event|0|||
38019643|NCT03137992|69702484|FG004|Period 2 (Visit 3)|Adverse Event|0|||
38019644|NCT03137992|69702485|FG005|Period 2 (Visit 3)|Adverse Event|0|||
38019645|NCT03137992|69702480|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
37699192|NCT02016105|69175991|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
37699193|NCT02016105|69175992|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
37699194|NCT02016105|69175993|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
37699195|NCT02016105|69175994|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
38019646|NCT03137992|69702481|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
38019647|NCT03137992|69702482|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
38019648|NCT03137992|69702483|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
38019649|NCT03137992|69702484|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
38019650|NCT03137992|69702485|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
38019651|NCT03137992|69702480|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
38019652|NCT03137992|69702481|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
38019653|NCT03137992|69702482|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
38019654|NCT03137992|69702483|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
37699196|NCT02016105|69175995|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
37699197|NCT02016105|69175996|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
37699198|NCT02016105|69175991|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
37910532|NCT03035201|69596799|FG000|Overall Study|Withdrawal by Subject|51|||
37910533|NCT03035201|69596800|FG001|Overall Study|Withdrawal by Subject|49|||
38019655|NCT03137992|69702484|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
37699199|NCT02016105|69175992|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
37699200|NCT02016105|69175993|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
38019656|NCT03137992|69702485|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
38019657|NCT03137992|69702480|FG000|Washout Period 2|COPD Exacerbation|1|||
38019658|NCT03137992|69702481|FG001|Washout Period 2|COPD Exacerbation|1|||
38019659|NCT03137992|69702482|FG002|Washout Period 2|COPD Exacerbation|0|||
37699201|NCT02016105|69175994|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
37699202|NCT02016105|69175995|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
37699203|NCT02016105|69175996|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
37699204|NCT02016105|69175991|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
37699205|NCT02016105|69175992|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
37699206|NCT02016105|69175993|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
37699207|NCT02016105|69175994|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
37699208|NCT02016105|69175995|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
37699209|NCT02016105|69175996|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
37699210|NCT02016105|69175991|FG000|EXTENSION PERIOD|Adverse Event|0|||
37699211|NCT02016105|69175992|FG001|EXTENSION PERIOD|Adverse Event|0|||
37699212|NCT02016105|69175993|FG002|EXTENSION PERIOD|Adverse Event|2|||
37699213|NCT02016105|69175994|FG003|EXTENSION PERIOD|Adverse Event|0|||
37699214|NCT02016105|69175995|FG004|EXTENSION PERIOD|Adverse Event|1|||
37699215|NCT02016105|69175996|FG005|EXTENSION PERIOD|Adverse Event|0|||
37699216|NCT02016105|69175991|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
37699217|NCT02016105|69175992|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
37699218|NCT02016105|69175993|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
37699219|NCT02016105|69175994|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
37699220|NCT02016105|69175995|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
37699221|NCT02016105|69175996|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
37699222|NCT02016105|69175991|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
37699223|NCT02016105|69175992|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
37699224|NCT02016105|69175993|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
37699225|NCT02016105|69175994|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
37699226|NCT02016105|69175995|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
37699227|NCT02016105|69175996|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
37699228|NCT02016105|69175991|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
37699229|NCT02016105|69175992|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
37699230|NCT02016105|69175993|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
37699231|NCT02016105|69175994|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
37699232|NCT02016105|69175995|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
37699233|NCT02016105|69175996|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
37699234|NCT02400905|69176010|FG000|Overall Study|Death|24|||
37699235|NCT02400905|69176010|FG000|Overall Study|Lost to Follow-up|18|||
37699236|NCT02400905|69176010|FG000|Overall Study|Withdrawal by Subject|16|||
37699237|NCT02400905|69176010|FG000|Overall Study|Physician Decision|4|||
37699238|NCT02400905|69176010|FG000|Overall Study|Other|1|||
37699239|NCT02400749|69176017|FG000|Week 0 -16|Withdrawal by Subject|5|||
37699240|NCT02400749|69176018|FG001|Week 0 -16|Withdrawal by Subject|5|||
37699241|NCT02400749|69176017|FG000|Week 0 -16|Adverse Event|3|||
37699242|NCT02400749|69176018|FG001|Week 0 -16|Adverse Event|1|||
37699243|NCT02400749|69176017|FG000|Week 0 -16|Lost to Follow-up|2|||
37699244|NCT02400749|69176018|FG001|Week 0 -16|Lost to Follow-up|0|||
37699245|NCT02400749|69176017|FG000|Week 0 -16|Protocol Violation|1|||
37699246|NCT02400749|69176018|FG001|Week 0 -16|Protocol Violation|0|||
37699247|NCT02400749|69176017|FG000|Week 17 - 32|Withdrawal by Subject|3|||
37699248|NCT02400749|69176018|FG001|Week 17 - 32|Withdrawal by Subject|2|||
37699249|NCT02400749|69176017|FG000|Week 17 - 32|Adverse Event|2|||
37699250|NCT02400749|69176018|FG001|Week 17 - 32|Adverse Event|1|||
37699251|NCT02420327|69176024|FG000|Overall Study|Adverse Event|7|||
37699252|NCT02420327|69176024|FG000|Overall Study|Pregnancy|1|||
37699253|NCT02420327|69176024|FG000|Overall Study|Withdrawal by Subject|6|||
37699254|NCT02420327|69176024|FG000|Overall Study|Lost to Follow-up|1|||
37699255|NCT02420327|69176024|FG000|Overall Study|Protocol Violation|1|||
37699256|NCT02374853|69176036|FG000|Overall Study|Surgery Cancelled|5|||
37699257|NCT02374853|69176037|FG001|Overall Study|Surgery Cancelled|11|||
37699258|NCT02015793|69176045|FG000|Overall Study|Adverse Event|3|||
37699259|NCT02015793|69176046|FG001|Overall Study|Adverse Event|3|||
37699260|NCT02015793|69176045|FG000|Overall Study|Withdrawal by Subject|1|||
37699261|NCT02015793|69176046|FG001|Overall Study|Withdrawal by Subject|1|||
37699262|NCT02347631|69176060|FG000|First Intervention (2 Months)|Adverse Event|1|||
37699263|NCT02347631|69176061|FG001|First Intervention (2 Months)|Adverse Event|1|||
37699264|NCT02347631|69176060|FG000|First Intervention (2 Months)|Pregnancy|1|||
37699265|NCT02347631|69176061|FG001|First Intervention (2 Months)|Pregnancy|0|||
37699266|NCT02347631|69176060|FG000|First Intervention (2 Months)|Moved out of area|0|||
37699267|NCT02347631|69176061|FG001|First Intervention (2 Months)|Moved out of area|2|||
37699268|NCT02347631|69176060|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
37699269|NCT02347631|69176061|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
37699270|NCT02347631|69176060|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
37699271|NCT02347631|69176061|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
37910534|NCT03035201|69596801|FG002|Overall Study|Withdrawal by Subject|37|||
37910535|NCT03035201|69596802|FG003|Overall Study|Withdrawal by Subject|46|||
37910536|NCT03035201|69596799|FG000|Overall Study|Lost to Follow-up|67|||
37699272|NCT02347631|69176060|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
37699273|NCT02347631|69176061|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
37699274|NCT02347631|69176060|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
37699275|NCT02347631|69176061|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
37699276|NCT02347631|69176060|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
37910537|NCT03035201|69596800|FG001|Overall Study|Lost to Follow-up|51|||
37699277|NCT02347631|69176061|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
37699278|NCT02015637|69176071|FG000|Overall Study|Lost to Follow-up|3|||
37699279|NCT02015637|69176072|FG001|Overall Study|Lost to Follow-up|5|||
37699280|NCT02015637|69176071|FG000|Overall Study|Adverse Event|3|||
37699281|NCT02015637|69176072|FG001|Overall Study|Adverse Event|0|||
37699282|NCT02015637|69176071|FG000|Overall Study|Did not take study drug|2|||
37699283|NCT02015637|69176072|FG001|Overall Study|Did not take study drug|0|||
37699284|NCT02347085|69176078|FG000|Overall Study|Adverse Event|2|||
37699285|NCT02347085|69176078|FG000|Overall Study|Lack of Efficacy|1|||
37699286|NCT02347085|69176078|FG000|Overall Study|Withdrawal by Subject|4|||
37699287|NCT02347085|69176078|FG000|Overall Study|Lost to Follow-up|1|||
37699288|NCT02347085|69176078|FG000|Overall Study|Protocol Criteria|2|||
37699289|NCT02374463|69176086|FG000|Overall Study|Withdrawal by Subject|3|||
37699290|NCT02374463|69176087|FG001|Overall Study|Withdrawal by Subject|3|||
37699291|NCT02015481|69176094|FG000|Overall Study|Death|1|||
37699292|NCT02374307|69176101|FG000|3-months Follow-up|Lost to Follow-up|1|||
37699293|NCT02374307|69176102|FG001|3-months Follow-up|Lost to Follow-up|2|||
37699294|NCT02374307|69176101|FG000|3-months Follow-up|Withdrawal by Subject|1|||
37699295|NCT02374307|69176102|FG001|3-months Follow-up|Withdrawal by Subject|4|||
37699296|NCT02374307|69176101|FG000|3-months Follow-up|Death|1|||
37699297|NCT02374307|69176102|FG001|3-months Follow-up|Death|2|||
37699298|NCT02374307|69176101|FG000|3-months Follow-up|Missed first follow-up|5|||
37699299|NCT02374307|69176102|FG001|3-months Follow-up|Missed first follow-up|1|||
37699300|NCT02374307|69176101|FG000|6-months Follow-up|Lost to Follow-up|1|||
37699301|NCT02374307|69176102|FG001|6-months Follow-up|Lost to Follow-up|2|||
37699302|NCT02374307|69176101|FG000|6-months Follow-up|Death|2|||
37699303|NCT02374307|69176102|FG001|6-months Follow-up|Death|1|||
37699304|NCT02374307|69176101|FG000|6-months Follow-up|Withdrawal by Subject|0|||
37699305|NCT02374307|69176102|FG001|6-months Follow-up|Withdrawal by Subject|3|||
37699306|NCT02397473|69176110|FG000|Treatment Phase|Adverse Event|1|||
37910538|NCT03035201|69596801|FG002|Overall Study|Lost to Follow-up|64|||
37910539|NCT03035201|69596802|FG003|Overall Study|Lost to Follow-up|69|||
37910540|NCT02969915|69596824|FG000|Overall Study|Death|104|||
37910541|NCT02969915|69596825|FG001|Overall Study|Death|125|||
38019660|NCT03137992|69702483|FG003|Washout Period 2|COPD Exacerbation|0|||
38019661|NCT03137992|69702484|FG004|Washout Period 2|COPD Exacerbation|1|||
38019662|NCT03137992|69702485|FG005|Washout Period 2|COPD Exacerbation|0|||
38019663|NCT03137992|69702480|FG000|Washout Period 2|Subject Non-compliance|0|||
38019664|NCT03137992|69702481|FG001|Washout Period 2|Subject Non-compliance|1|||
38019665|NCT03137992|69702482|FG002|Washout Period 2|Subject Non-compliance|0|||
38019666|NCT03137992|69702483|FG003|Washout Period 2|Subject Non-compliance|0|||
38019667|NCT03137992|69702484|FG004|Washout Period 2|Subject Non-compliance|0|||
38019668|NCT03137992|69702485|FG005|Washout Period 2|Subject Non-compliance|0|||
38019669|NCT03137992|69702480|FG000|Washout Period 2|Adverse Event|0|||
38019670|NCT03137992|69702481|FG001|Washout Period 2|Adverse Event|0|||
38019671|NCT03137992|69702482|FG002|Washout Period 2|Adverse Event|0|||
38019672|NCT03137992|69702483|FG003|Washout Period 2|Adverse Event|1|||
38019673|NCT03137992|69702484|FG004|Washout Period 2|Adverse Event|1|||
38019674|NCT03137992|69702485|FG005|Washout Period 2|Adverse Event|0|||
38019675|NCT03137992|69702480|FG000|Washout Period 2|Withdrawal by Subject|1|||
38019676|NCT03137992|69702481|FG001|Washout Period 2|Withdrawal by Subject|0|||
38019677|NCT03137992|69702482|FG002|Washout Period 2|Withdrawal by Subject|0|||
38019678|NCT03137992|69702483|FG003|Washout Period 2|Withdrawal by Subject|0|||
38019679|NCT03137992|69702484|FG004|Washout Period 2|Withdrawal by Subject|1|||
38019680|NCT03137992|69702485|FG005|Washout Period 2|Withdrawal by Subject|0|||
38019681|NCT03137992|69702480|FG000|Washout Period 2|Sponsor Decision|0|||
38019682|NCT03137992|69702481|FG001|Washout Period 2|Sponsor Decision|0|||
38019683|NCT03137992|69702482|FG002|Washout Period 2|Sponsor Decision|0|||
38019684|NCT03137992|69702483|FG003|Washout Period 2|Sponsor Decision|0|||
38019685|NCT03137992|69702484|FG004|Washout Period 2|Sponsor Decision|0|||
38019686|NCT03137992|69702485|FG005|Washout Period 2|Sponsor Decision|1|||
38019687|NCT03137992|69702480|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
38019688|NCT03137992|69702481|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
38019689|NCT03137992|69702482|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
38019690|NCT03137992|69702483|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
37699307|NCT02397473|69176111|FG001|Treatment Phase|Adverse Event|2|||
37699308|NCT02397473|69176110|FG000|Treatment Phase|Lack of Efficacy|8|||
37699309|NCT02397473|69176111|FG001|Treatment Phase|Lack of Efficacy|1|||
37699310|NCT02397473|69176110|FG000|Treatment Phase|Lost to Follow-up|1|||
37699311|NCT02397473|69176111|FG001|Treatment Phase|Lost to Follow-up|0|||
37699312|NCT02397473|69176110|FG000|Treatment Phase|Withdrawal by Subject|2|||
37699313|NCT02397473|69176111|FG001|Treatment Phase|Withdrawal by Subject|1|||
37699314|NCT02397473|69176110|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
38019691|NCT03137992|69702484|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
38019692|NCT03137992|69702485|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
38019693|NCT03137992|69702480|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
38019694|NCT03137992|69702481|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
38019695|NCT03137992|69702482|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
38019696|NCT03137992|69702483|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
38019697|NCT03137992|69702484|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
38019698|NCT03137992|69702485|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
38019699|NCT03137992|69702480|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
38019700|NCT03137992|69702481|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
38019701|NCT03137992|69702482|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
38019702|NCT03137992|69702483|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
38019703|NCT03137992|69702484|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
38019704|NCT03137992|69702485|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
38019705|NCT03137992|69702480|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
38019706|NCT03137992|69702481|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
38019707|NCT03137992|69702482|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
38019708|NCT03137992|69702483|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
38019709|NCT03137992|69702484|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
38019710|NCT03137992|69702485|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
38019711|NCT03137992|69702480|FG000|Part 2 (Open-label Extension)|Per study team|1|||
38019712|NCT03137992|69702481|FG001|Part 2 (Open-label Extension)|Per study team|0|||
38019713|NCT03137992|69702482|FG002|Part 2 (Open-label Extension)|Per study team|0|||
38019714|NCT03137992|69702483|FG003|Part 2 (Open-label Extension)|Per study team|0|||
38019715|NCT03137992|69702484|FG004|Part 2 (Open-label Extension)|Per study team|0|||
38019716|NCT03137992|69702485|FG005|Part 2 (Open-label Extension)|Per study team|0|||
38019717|NCT03137992|69702480|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
38019718|NCT03137992|69702481|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
38019719|NCT03137992|69702482|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
38019720|NCT03137992|69702483|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
38019721|NCT03137992|69702484|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
38019722|NCT03137992|69702485|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
38019723|NCT03704636|69702493|FG000|Overall Study|Inadequate Venous Flow|3|||
38019724|NCT05096312|69702508|FG000|Overall Study|Lost to Follow-up|2|||
38019725|NCT05096312|69702509|FG001|Overall Study|Lost to Follow-up|4|||
38019726|NCT05096312|69702508|FG000|Overall Study|Adverse Event|1|||
38019727|NCT05096312|69702509|FG001|Overall Study|Adverse Event|0|||
38019728|NCT04908488|69702517|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
38019729|NCT04908488|69702518|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
38019730|NCT04908488|69702517|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
38019731|NCT04908488|69702518|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
38019732|NCT04876274|69702529|FG000|Overall Study|Lost to Follow-up|9|||
38019733|NCT04876274|69702530|FG001|Overall Study|Lost to Follow-up|12|||
38019734|NCT04865354|69702538|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
38019735|NCT04865354|69702539|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
38019736|NCT04865354|69702538|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
38019737|NCT04865354|69702539|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
38019738|NCT04865354|69702538|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
38019739|NCT04865354|69702539|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
38019740|NCT04860518|69702550|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
38019741|NCT04860518|69702551|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
38019742|NCT03110380|69702559|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
38019743|NCT03110380|69702560|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
38019744|NCT03110380|69702561|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
38019745|NCT03110380|69702562|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
38019746|NCT03110380|69702559|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
38019747|NCT03110380|69702560|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
38019748|NCT03110380|69702561|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
38019749|NCT03110380|69702562|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
37910542|NCT02969915|69596824|FG000|Overall Study|Lost to Follow-up|108|||
38019750|NCT03110380|69702559|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
38019751|NCT03110380|69702560|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
38019752|NCT03110380|69702561|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
38019753|NCT03110380|69702562|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
38019754|NCT03110380|69702559|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
38019755|NCT03110380|69702560|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
38019756|NCT03110380|69702561|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
38019757|NCT03110380|69702562|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
38019758|NCT03110380|69702559|FG000|Double-Blind Treatment Phase|Death|2|||
38019759|NCT03110380|69702560|FG001|Double-Blind Treatment Phase|Death|1|||
38019760|NCT03110380|69702561|FG002|Double-Blind Treatment Phase|Death|0|||
38019761|NCT03110380|69702562|FG003|Double-Blind Treatment Phase|Death|0|||
38019762|NCT03110380|69702559|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
38019763|NCT03110380|69702560|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
38019764|NCT03110380|69702561|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
38019765|NCT03110380|69702562|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
38019766|NCT03110380|69702559|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
38019767|NCT03110380|69702560|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
38019768|NCT03110380|69702561|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
38019769|NCT03110380|69702562|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
38019770|NCT03110380|69702559|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
38019771|NCT03110380|69702560|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
38019772|NCT03110380|69702561|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
38019773|NCT03110380|69702562|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
38019774|NCT03110380|69702559|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
38019775|NCT03110380|69702560|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
38019776|NCT03110380|69702561|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
38019777|NCT03110380|69702562|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
38019778|NCT03110380|69702559|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
38019779|NCT03110380|69702560|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
38019780|NCT03110380|69702561|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
38019781|NCT03110380|69702562|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
38019782|NCT03110380|69702559|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
38019783|NCT03110380|69702560|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
38019784|NCT03110380|69702561|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
38019785|NCT03110380|69702562|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
38019786|NCT04851314|69702572|FG000|Overall Study|Unable to complete research set-up procedures|0|||
38019787|NCT04851314|69702573|FG001|Overall Study|Unable to complete research set-up procedures|2|||
38019788|NCT04851314|69702572|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
38019789|NCT04851314|69702573|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
38019790|NCT04848662|69702581|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
38019791|NCT04848662|69702582|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
38019792|NCT03701516|69702588|FG000|Period 1|Lost to Follow-up|0|||
38019793|NCT03701516|69702589|FG001|Period 1|Lost to Follow-up|1|||
38019794|NCT03701516|69702588|FG000|Period 1|Adverse Event|0|||
38019795|NCT03701516|69702589|FG001|Period 1|Adverse Event|2|||
38019796|NCT03701516|69702588|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
38019797|NCT03701516|69702589|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
38019798|NCT03701516|69702588|FG000|Period 1|Non Compliance to Protocol|2|||
38019799|NCT03701516|69702589|FG001|Period 1|Non Compliance to Protocol|1|||
38019800|NCT03701516|69702588|FG000|Period 1|Withdrawal by Subject|0|||
38019801|NCT03701516|69702589|FG001|Period 1|Withdrawal by Subject|1|||
38019802|NCT03701516|69702588|FG000|Period 2|failed to meet all eligibility creiteria|1|||
38019803|NCT03701516|69702589|FG001|Period 2|failed to meet all eligibility creiteria|0|||
38019804|NCT03701516|69702588|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
38019805|NCT03701516|69702589|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
38019806|NCT03700892|69702597|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
38019807|NCT03700892|69702598|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
38019808|NCT03700892|69702599|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
38019809|NCT03700736|69702610|FG000|Overall Study|Pregnancy|1|||
38019810|NCT03700736|69702611|FG001|Overall Study|Pregnancy|1|||
37832861|NCT01270828|69516406|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
38019811|NCT03700736|69702610|FG000|Overall Study|Withdrawal by Subject|2|||
38019812|NCT03700736|69702611|FG001|Overall Study|Withdrawal by Subject|6|||
38019813|NCT04737278|69702622|FG000|Overall Study|Lost to Follow-up|1|||
38019814|NCT04737278|69702623|FG001|Overall Study|Lost to Follow-up|1|||
38019815|NCT04737278|69702622|FG000|Overall Study|Withdrawal by Subject|1|||
38019816|NCT04737278|69702623|FG001|Overall Study|Withdrawal by Subject|0|||
38019817|NCT04737278|69702622|FG000|Overall Study|Protocol Violation|1|||
38019818|NCT04737278|69702623|FG001|Overall Study|Protocol Violation|1|||
38019819|NCT04737278|69702622|FG000|Overall Study|failure to complete questionnaire|1|||
38019820|NCT04737278|69702623|FG001|Overall Study|failure to complete questionnaire|1|||
38019821|NCT04725500|69702629|FG000|Screening|Screen Failure|26|||
38019822|NCT04725500|69702629|FG000|Screening|Withdrawal by Subject|1|||
38019823|NCT04725500|69702629|FG000|2 Week Take Home|Screen Fail|5|||
38019824|NCT04684394|69702635|FG000|Overall Study|Death|1|||
38019825|NCT04684394|69702636|FG001|Overall Study|Death|2|||
38019826|NCT04684394|69702635|FG000|Overall Study|Lost to Follow-up|1|||
38019827|NCT04684394|69702636|FG001|Overall Study|Lost to Follow-up|0|||
38019828|NCT04684394|69702635|FG000|Overall Study|Withdrawal by Subject|2|||
38019829|NCT04684394|69702636|FG001|Overall Study|Withdrawal by Subject|0|||
38019830|NCT04684394|69702635|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
37832862|NCT01270828|69516407|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
37832863|NCT01270828|69516408|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
37832864|NCT01270828|69516406|FG000|Double Blind Phase|Adverse event related to study drug|5|||
37832865|NCT01270828|69516407|FG001|Double Blind Phase|Adverse event related to study drug|7|||
37832866|NCT01270828|69516408|FG002|Double Blind Phase|Adverse event related to study drug|0|||
37832867|NCT01269385|69516416|FG000|Overall Study|Adverse Event|1|||
37832868|NCT01269385|69516417|FG001|Overall Study|Adverse Event|1|||
37832869|NCT01269385|69516418|FG002|Overall Study|Adverse Event|0|||
37832870|NCT01269385|69516419|FG003|Overall Study|Adverse Event|0|||
37832871|NCT01268683|69516429|FG000|Overall Study|Lost to Follow-up|1|||
37832872|NCT01268683|69516429|FG000|Overall Study|Death|1|||
37832873|NCT01268566|69516433|FG000|Overall Study|Lost to Follow-up|1|||
37832874|NCT01268566|69516433|FG000|Overall Study|Withdrawal by Subject|12|||
37832875|NCT01268566|69516433|FG000|Overall Study|Death|30|||
37832876|NCT01268488|69516437|FG000|Overall Study|Adverse Event|3|||
37832877|NCT01268488|69516437|FG000|Overall Study|Physician Decision|2|||
37832878|NCT01268098|69516444|FG000|Overall Study|Adverse Event|1|||
37832879|NCT01268098|69516445|FG001|Overall Study|Adverse Event|0|||
37832880|NCT01268059|69516455|FG000|Overall Study|Lost to Follow-up|0|||
37832881|NCT01268059|69516456|FG001|Overall Study|Lost to Follow-up|1|||
37832882|NCT01268059|69516457|FG002|Overall Study|Lost to Follow-up|0|||
37832883|NCT01268059|69516458|FG003|Overall Study|Lost to Follow-up|0|||
37832884|NCT01268059|69516455|FG000|Overall Study|Withdrawal by Subject|7|||
37832885|NCT01268059|69516456|FG001|Overall Study|Withdrawal by Subject|4|||
37832886|NCT01268059|69516457|FG002|Overall Study|Withdrawal by Subject|0|||
37832887|NCT01268059|69516458|FG003|Overall Study|Withdrawal by Subject|0|||
37832888|NCT01268059|69516455|FG000|Overall Study|Death|20|||
37832889|NCT01268059|69516456|FG001|Overall Study|Death|30|||
37832890|NCT01268059|69516457|FG002|Overall Study|Death|3|||
37832891|NCT01268059|69516458|FG003|Overall Study|Death|5|||
37832892|NCT01268059|69516455|FG000|Overall Study|Progression of disease|1|||
37832893|NCT01268059|69516456|FG001|Overall Study|Progression of disease|0|||
37832894|NCT01268059|69516457|FG002|Overall Study|Progression of disease|0|||
37832895|NCT01268059|69516458|FG003|Overall Study|Progression of disease|0|||
37832896|NCT01267825|69516473|FG000|Overall Study|study terminated. no data collected.|1|||
37832897|NCT01267825|69516474|FG001|Overall Study|study terminated. no data collected.|0|||
37832898|NCT01260181|69516480|FG000|Overall Study|Decision of Investigator|1|||
37832899|NCT01260142|69516490|FG000|Treatment Period 1|Study on hold|1|||
37832900|NCT01260142|69516491|FG001|Treatment Period 1|Study on hold|1|||
37832901|NCT01260142|69516492|FG002|Treatment Period 1|Study on hold|0|||
37832902|NCT01260142|69516493|FG003|Treatment Period 1|Study on hold|0|||
37910543|NCT02969915|69596825|FG001|Overall Study|Lost to Follow-up|112|||
37910544|NCT02969915|69596824|FG000|Overall Study|Censored due to COVID-19|481|||
37832903|NCT01260142|69516494|FG004|Treatment Period 1|Study on hold|1|||
37832904|NCT01260142|69516495|FG005|Treatment Period 1|Study on hold|2|||
37832905|NCT01260142|69516490|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
37832906|NCT01260142|69516491|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
37832907|NCT01260142|69516492|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
37832908|NCT01260142|69516493|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
37832909|NCT01260142|69516494|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
37832910|NCT01260142|69516495|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
37832911|NCT01260142|69516490|FG000|Treatment Period 1|Withdrawal by Subject|0|||
37832912|NCT01260142|69516491|FG001|Treatment Period 1|Withdrawal by Subject|0|||
37832913|NCT01260142|69516492|FG002|Treatment Period 1|Withdrawal by Subject|0|||
37832914|NCT01260142|69516493|FG003|Treatment Period 1|Withdrawal by Subject|0|||
37832915|NCT01260142|69516494|FG004|Treatment Period 1|Withdrawal by Subject|0|||
37832916|NCT01260142|69516495|FG005|Treatment Period 1|Withdrawal by Subject|1|||
37832917|NCT01259869|69516515|FG000|Overall Study|Duplicated registration|1|||
37910545|NCT02969915|69596825|FG001|Overall Study|Censored due to COVID-19|471|||
38019831|NCT04684394|69702636|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
38019832|NCT04674644|69702642|FG000|Overall Study|with missing data|37|||
38019833|NCT04668950|69702649|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
38019834|NCT04668950|69702650|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
38019835|NCT04668950|69702649|FG000|Overall Study|Could not confirm started study medication|15|||
38019836|NCT04668950|69702650|FG001|Overall Study|Could not confirm started study medication|15|||
38019837|NCT04668950|69702649|FG000|Overall Study|Could not confirm baseline status|6|||
38019838|NCT04668950|69702650|FG001|Overall Study|Could not confirm baseline status|2|||
38019839|NCT04668950|69702649|FG000|Overall Study|Drop out and did not start medication|15|||
37699315|NCT02397473|69176111|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
38019840|NCT04668950|69702650|FG001|Overall Study|Drop out and did not start medication|17|||
38019841|NCT04668950|69702649|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
38019842|NCT04668950|69702650|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
38019843|NCT04668950|69702649|FG000|Overall Study|Other|2|||
38019844|NCT04668950|69702650|FG001|Overall Study|Other|4|||
38019845|NCT03078478|69702658|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
38019846|NCT03078478|69702659|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
38019847|NCT03078478|69702658|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
38019848|NCT03078478|69702659|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
38019849|NCT03078478|69702658|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
38019850|NCT03078478|69702659|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
38019851|NCT03078478|69702658|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
38019852|NCT03078478|69702659|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
38019853|NCT03078478|69702658|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
38019854|NCT03078478|69702659|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
38019855|NCT03078478|69702658|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
38019856|NCT03078478|69702659|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
38019857|NCT03078478|69702658|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
38019858|NCT03078478|69702659|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
38019859|NCT03078478|69702658|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
38019860|NCT03078478|69702659|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
38019861|NCT02879578|69702668|FG000|Overall Study|Adverse Event|1|||
38019862|NCT02879578|69702669|FG001|Overall Study|Adverse Event|2|||
38019863|NCT02879578|69702670|FG002|Overall Study|Adverse Event|14|||
38019864|NCT02879578|69702668|FG000|Overall Study|Protocol Violation|0|||
38019865|NCT02879578|69702669|FG001|Overall Study|Protocol Violation|1|||
38019866|NCT02879578|69702670|FG002|Overall Study|Protocol Violation|1|||
38019867|NCT02879578|69702668|FG000|Overall Study|Withdrawal by Subject|8|||
38019868|NCT02879578|69702669|FG001|Overall Study|Withdrawal by Subject|6|||
38019869|NCT02879578|69702670|FG002|Overall Study|Withdrawal by Subject|9|||
38019870|NCT02879578|69702668|FG000|Overall Study|Lost to Follow-up|1|||
38019871|NCT02879578|69702669|FG001|Overall Study|Lost to Follow-up|0|||
38019872|NCT02879578|69702670|FG002|Overall Study|Lost to Follow-up|4|||
38019873|NCT02879578|69702668|FG000|Overall Study|Physician Decision|0|||
38019874|NCT02879578|69702669|FG001|Overall Study|Physician Decision|0|||
38019875|NCT02879578|69702670|FG002|Overall Study|Physician Decision|4|||
38019876|NCT00045942|69702687|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
38019877|NCT00045942|69702688|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
38019878|NCT00045942|69702689|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
38019879|NCT00045942|69702690|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
38019880|NCT00045942|69702691|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
38019881|NCT00045942|69702692|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
38019882|NCT00045942|69702693|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
38019883|NCT00045942|69702694|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
38019884|NCT00045942|69702695|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
38019885|NCT00045942|69702687|FG000|PKC412A2104 (Core)|Adverse Event|5|||
38019886|NCT00045942|69702688|FG001|PKC412A2104 (Core)|Adverse Event|0|||
38019887|NCT00045942|69702689|FG002|PKC412A2104 (Core)|Adverse Event|0|||
38019888|NCT00045942|69702690|FG003|PKC412A2104 (Core)|Adverse Event|0|||
38019889|NCT00045942|69702691|FG004|PKC412A2104 (Core)|Adverse Event|0|||
38019890|NCT00045942|69702692|FG005|PKC412A2104 (Core)|Adverse Event|0|||
38019891|NCT00045942|69702693|FG006|PKC412A2104 (Core)|Adverse Event|0|||
38019892|NCT00045942|69702694|FG007|PKC412A2104 (Core)|Adverse Event|0|||
38019893|NCT00045942|69702695|FG008|PKC412A2104 (Core)|Adverse Event|0|||
38019894|NCT00045942|69702687|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
37699316|NCT02397473|69176110|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
37699317|NCT02397473|69176111|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
38019895|NCT00045942|69702688|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
38019896|NCT00045942|69702689|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
37699318|NCT02397473|69176110|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
38019897|NCT00045942|69702690|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
38019898|NCT00045942|69702691|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
38019899|NCT00045942|69702692|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
38019900|NCT00045942|69702693|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
38019901|NCT00045942|69702694|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
38019902|NCT00045942|69702695|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
38019903|NCT00045942|69702687|FG000|PKC412A2104 (Core)|Death|1|||
38019904|NCT00045942|69702688|FG001|PKC412A2104 (Core)|Death|0|||
38019905|NCT00045942|69702689|FG002|PKC412A2104 (Core)|Death|0|||
38019906|NCT00045942|69702690|FG003|PKC412A2104 (Core)|Death|0|||
38019907|NCT00045942|69702691|FG004|PKC412A2104 (Core)|Death|0|||
38019908|NCT00045942|69702692|FG005|PKC412A2104 (Core)|Death|0|||
38019909|NCT00045942|69702693|FG006|PKC412A2104 (Core)|Death|0|||
38019910|NCT00045942|69702694|FG007|PKC412A2104 (Core)|Death|0|||
38019911|NCT00045942|69702695|FG008|PKC412A2104 (Core)|Death|0|||
38019912|NCT00045942|69702687|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
38019913|NCT00045942|69702688|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
38019914|NCT00045942|69702689|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
38019915|NCT00045942|69702690|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
38019916|NCT00045942|69702691|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
38019917|NCT00045942|69702692|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
38019918|NCT00045942|69702693|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
38019919|NCT00045942|69702694|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
38019920|NCT00045942|69702695|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
38019921|NCT00045942|69702687|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
38019922|NCT00045942|69702688|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
38019923|NCT00045942|69702689|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
38019924|NCT00045942|69702690|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
38019925|NCT00045942|69702691|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
38019926|NCT00045942|69702692|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
38019927|NCT00045942|69702693|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
38019928|NCT00045942|69702694|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
38019929|NCT00045942|69702695|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
38019930|NCT00045942|69702687|FG000|PKC412A2104E1|Lack of Efficacy|0|||
38019931|NCT00045942|69702688|FG001|PKC412A2104E1|Lack of Efficacy|11|||
38019932|NCT00045942|69702689|FG002|PKC412A2104E1|Lack of Efficacy|11|||
38019933|NCT00045942|69702690|FG003|PKC412A2104E1|Lack of Efficacy|23|||
38019934|NCT00045942|69702691|FG004|PKC412A2104E1|Lack of Efficacy|17|||
38019935|NCT00045942|69702692|FG005|PKC412A2104E1|Lack of Efficacy|0|||
38019936|NCT00045942|69702693|FG006|PKC412A2104E1|Lack of Efficacy|0|||
38019937|NCT00045942|69702694|FG007|PKC412A2104E1|Lack of Efficacy|0|||
38019938|NCT00045942|69702695|FG008|PKC412A2104E1|Lack of Efficacy|0|||
38019939|NCT00045942|69702687|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
38019940|NCT00045942|69702688|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
38019941|NCT00045942|69702689|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
38019942|NCT00045942|69702690|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
38019943|NCT00045942|69702691|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
38019944|NCT00045942|69702692|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
38019945|NCT00045942|69702693|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
38019946|NCT00045942|69702694|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
38019947|NCT00045942|69702695|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
38019948|NCT00045942|69702687|FG000|PKC412A2104E1|Adverse Event|0|||
38019949|NCT00045942|69702688|FG001|PKC412A2104E1|Adverse Event|1|||
38019950|NCT00045942|69702689|FG002|PKC412A2104E1|Adverse Event|1|||
38019951|NCT00045942|69702690|FG003|PKC412A2104E1|Adverse Event|3|||
38019952|NCT00045942|69702691|FG004|PKC412A2104E1|Adverse Event|6|||
38019953|NCT00045942|69702692|FG005|PKC412A2104E1|Adverse Event|0|||
38019954|NCT00045942|69702693|FG006|PKC412A2104E1|Adverse Event|0|||
38019955|NCT00045942|69702694|FG007|PKC412A2104E1|Adverse Event|0|||
38019956|NCT00045942|69702695|FG008|PKC412A2104E1|Adverse Event|0|||
38019957|NCT00045942|69702687|FG000|PKC412A2104E1|Death|0|||
38019958|NCT00045942|69702688|FG001|PKC412A2104E1|Death|4|||
38019959|NCT00045942|69702689|FG002|PKC412A2104E1|Death|1|||
38019960|NCT00045942|69702690|FG003|PKC412A2104E1|Death|1|||
38019961|NCT00045942|69702691|FG004|PKC412A2104E1|Death|1|||
38019962|NCT00045942|69702692|FG005|PKC412A2104E1|Death|0|||
38019963|NCT00045942|69702693|FG006|PKC412A2104E1|Death|0|||
38019964|NCT00045942|69702694|FG007|PKC412A2104E1|Death|0|||
38019965|NCT00045942|69702695|FG008|PKC412A2104E1|Death|0|||
38019966|NCT00045942|69702687|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
37832918|NCT01259713|69516521|FG000|Overall Study|Adverse Event|54|||
37832919|NCT01259713|69516522|FG001|Overall Study|Adverse Event|23|||
37832920|NCT01259713|69516521|FG000|Overall Study|Death Not Related to IFI|8|||
38019967|NCT00045942|69702688|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
38019968|NCT00045942|69702689|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
38019969|NCT00045942|69702690|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
38019970|NCT00045942|69702691|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
38019971|NCT00045942|69702692|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
38019972|NCT00045942|69702693|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
38019973|NCT00045942|69702694|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
38019974|NCT00045942|69702695|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
38019975|NCT00045942|69702687|FG000|PKC412A2104E2|Lost to Follow-up|0|||
38019976|NCT00045942|69702688|FG001|PKC412A2104E2|Lost to Follow-up|0|||
38019977|NCT00045942|69702689|FG002|PKC412A2104E2|Lost to Follow-up|0|||
38019978|NCT00045942|69702690|FG003|PKC412A2104E2|Lost to Follow-up|0|||
38019979|NCT00045942|69702691|FG004|PKC412A2104E2|Lost to Follow-up|0|||
38019980|NCT00045942|69702692|FG005|PKC412A2104E2|Lost to Follow-up|0|||
38019981|NCT00045942|69702693|FG006|PKC412A2104E2|Lost to Follow-up|0|||
38019982|NCT00045942|69702694|FG007|PKC412A2104E2|Lost to Follow-up|3|||
38019983|NCT00045942|69702695|FG008|PKC412A2104E2|Lost to Follow-up|0|||
38019984|NCT00045942|69702687|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
38019985|NCT00045942|69702688|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
38019986|NCT00045942|69702689|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
38019987|NCT00045942|69702690|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
38019988|NCT00045942|69702691|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
38019989|NCT00045942|69702692|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
38019990|NCT00045942|69702693|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
38019991|NCT00045942|69702694|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
38019992|NCT00045942|69702695|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
38019993|NCT00045942|69702687|FG000|PKC412A2104E2|Lack of Efficacy|0|||
38019994|NCT00045942|69702688|FG001|PKC412A2104E2|Lack of Efficacy|0|||
38019995|NCT00045942|69702689|FG002|PKC412A2104E2|Lack of Efficacy|0|||
38019996|NCT00045942|69702690|FG003|PKC412A2104E2|Lack of Efficacy|0|||
38019997|NCT00045942|69702691|FG004|PKC412A2104E2|Lack of Efficacy|0|||
38019998|NCT00045942|69702692|FG005|PKC412A2104E2|Lack of Efficacy|3|||
38019999|NCT00045942|69702693|FG006|PKC412A2104E2|Lack of Efficacy|2|||
38020000|NCT00045942|69702694|FG007|PKC412A2104E2|Lack of Efficacy|2|||
38020001|NCT00045942|69702695|FG008|PKC412A2104E2|Lack of Efficacy|6|||
38020002|NCT00045942|69702687|FG000|PKC412A2104E2|Adverse Event|0|||
38020003|NCT00045942|69702688|FG001|PKC412A2104E2|Adverse Event|0|||
38020004|NCT00045942|69702689|FG002|PKC412A2104E2|Adverse Event|0|||
38020005|NCT00045942|69702690|FG003|PKC412A2104E2|Adverse Event|0|||
38020006|NCT00045942|69702691|FG004|PKC412A2104E2|Adverse Event|0|||
38020007|NCT00045942|69702692|FG005|PKC412A2104E2|Adverse Event|4|||
38020008|NCT00045942|69702693|FG006|PKC412A2104E2|Adverse Event|3|||
38020009|NCT00045942|69702694|FG007|PKC412A2104E2|Adverse Event|1|||
38020010|NCT00045942|69702695|FG008|PKC412A2104E2|Adverse Event|0|||
37832921|NCT01259713|69516522|FG001|Overall Study|Death Not Related to IFI|1|||
37832922|NCT01259713|69516521|FG000|Overall Study|Investigators Discretion|14|||
37832923|NCT01259713|69516522|FG001|Overall Study|Investigators Discretion|6|||
37832924|NCT01259713|69516521|FG000|Overall Study|Lack of Efficacy|2|||
37832925|NCT01259713|69516522|FG001|Overall Study|Lack of Efficacy|0|||
38020011|NCT00045942|69702687|FG000|PKC412A2104E2|Death|0|||
38020012|NCT00045942|69702688|FG001|PKC412A2104E2|Death|0|||
38020013|NCT00045942|69702689|FG002|PKC412A2104E2|Death|0|||
38020014|NCT00045942|69702690|FG003|PKC412A2104E2|Death|0|||
38020015|NCT00045942|69702691|FG004|PKC412A2104E2|Death|0|||
38020016|NCT00045942|69702692|FG005|PKC412A2104E2|Death|1|||
38020017|NCT00045942|69702693|FG006|PKC412A2104E2|Death|2|||
38020018|NCT00045942|69702694|FG007|PKC412A2104E2|Death|0|||
38020019|NCT00045942|69702695|FG008|PKC412A2104E2|Death|0|||
38020020|NCT04386616|69702722|FG000|Overall Study|Death|22|||
38020021|NCT04386616|69702723|FG001|Overall Study|Death|22|||
38020022|NCT04386616|69702724|FG002|Overall Study|Death|21|||
38020023|NCT04386616|69702722|FG000|Overall Study|Lost to Follow-up|5|||
38020024|NCT04386616|69702723|FG001|Overall Study|Lost to Follow-up|8|||
38020025|NCT04386616|69702724|FG002|Overall Study|Lost to Follow-up|6|||
38020026|NCT04386616|69702722|FG000|Overall Study|Withdrawal by Subject|2|||
38020027|NCT04386616|69702723|FG001|Overall Study|Withdrawal by Subject|4|||
38020028|NCT04386616|69702724|FG002|Overall Study|Withdrawal by Subject|1|||
38020029|NCT04386616|69702722|FG000|Overall Study|Adverse Event|1|||
38020030|NCT04386616|69702723|FG001|Overall Study|Adverse Event|1|||
38020031|NCT04386616|69702724|FG002|Overall Study|Adverse Event|0|||
38020032|NCT00045708|69702744|FG000|Phase 1|early progressive disease|0|||
38020033|NCT00045708|69702745|FG001|Phase 1|early progressive disease|1|||
38020034|NCT00045708|69702746|FG002|Phase 1|early progressive disease|0|||
38020035|NCT00045630|69702763|FG000|Overall Study|Adverse Event|1|||
38020036|NCT00045630|69702763|FG000|Overall Study|Refusal unrelated to adverse event|1|||
38020037|NCT00045630|69702763|FG000|Overall Study|Progression/relapse|1|||
38020038|NCT00045630|69702763|FG000|Overall Study|Death|1|||
38020039|NCT00045630|69702763|FG000|Overall Study|Ineligible|2|||
38020040|NCT00003702|69702769|FG000|Overall Study|Ineligible cell types|2|||
38020041|NCT00003702|69702770|FG001|Overall Study|Ineligible cell types|2|||
38020042|NCT00003702|69702769|FG000|Overall Study|Did not meet criteria for persistence|8|||
38020043|NCT00003702|69702770|FG001|Overall Study|Did not meet criteria for persistence|5|||
38020044|NCT00003702|69702769|FG000|Overall Study|WHO score > 6|2|||
38020045|NCT00003702|69702770|FG001|Overall Study|WHO score > 6|1|||
38020046|NCT00003702|69702769|FG000|Overall Study|Inadequate documentation of disease|1|||
38020047|NCT00003702|69702770|FG001|Overall Study|Inadequate documentation of disease|3|||
38020048|NCT00031590|69702777|FG000|Overall Study|Adverse Event|1|||
38020049|NCT00031590|69702777|FG000|Overall Study|Withdrawal by parents|2|||
38020050|NCT00239681|69702784|FG000|Overall Study|Adverse Event|100|||
38020051|NCT00239681|69702785|FG001|Overall Study|Adverse Event|99|||
38020052|NCT00239681|69702784|FG000|Overall Study|Withdrawal by Subject|458|||
38020053|NCT00239681|69702785|FG001|Overall Study|Withdrawal by Subject|489|||
38020054|NCT00239681|69702784|FG000|Overall Study|Lost to Follow-up|28|||
38020055|NCT00239681|69702785|FG001|Overall Study|Lost to Follow-up|22|||
38020056|NCT00239681|69702784|FG000|Overall Study|Protocol Violation|4|||
38020057|NCT00239681|69702785|FG001|Overall Study|Protocol Violation|4|||
38020058|NCT00239681|69702784|FG000|Overall Study|Physician Decision|13|||
38020059|NCT00239681|69702785|FG001|Overall Study|Physician Decision|17|||
38020060|NCT00239681|69702784|FG000|Overall Study|No information chacked on CaseReportForm|90|||
38020061|NCT00239681|69702785|FG001|Overall Study|No information chacked on CaseReportForm|84|||
38020062|NCT02878330|69702793|FG000|Overall Study|Death|3|||
38020063|NCT02878330|69702794|FG001|Overall Study|Death|2|||
38020064|NCT02878330|69702793|FG000|Overall Study|Lost to Follow-up|11|||
38020065|NCT02878330|69702794|FG001|Overall Study|Lost to Follow-up|26|||
38020066|NCT02878330|69702793|FG000|Overall Study|Withdrawal by Subject|11|||
38020067|NCT02878330|69702794|FG001|Overall Study|Withdrawal by Subject|21|||
38020068|NCT02878330|69702793|FG000|Overall Study|Other|4|||
38020069|NCT02878330|69702794|FG001|Overall Study|Other|7|||
38020070|NCT00238433|69702801|FG000|Overall Study|Screen failure|1|||
38020071|NCT00238433|69702801|FG000|Overall Study|Lost to Follow-up|1|||
38020072|NCT00238433|69702801|FG000|Overall Study|Death|1|||
38020073|NCT00045162|69702808|FG000|Overall Study|Ineligible|12|||
38020074|NCT00045162|69702809|FG001|Overall Study|Ineligible|8|||
38020075|NCT00045162|69702808|FG000|Overall Study|Not treated|7|||
38020076|NCT00045162|69702809|FG001|Overall Study|Not treated|2|||
38020077|NCT00045162|69702808|FG000|Overall Study|Adverse Event|55|||
38020078|NCT00045162|69702809|FG001|Overall Study|Adverse Event|50|||
38020079|NCT00045162|69702808|FG000|Overall Study|Lack of Efficacy|32|||
38020080|NCT00045162|69702809|FG001|Overall Study|Lack of Efficacy|29|||
38020081|NCT00045162|69702808|FG000|Overall Study|Death|10|||
38020082|NCT00045162|69702809|FG001|Overall Study|Death|10|||
38020083|NCT00045162|69702808|FG000|Overall Study|Withdrawal by Subject|5|||
38020084|NCT00045162|69702809|FG001|Overall Study|Withdrawal by Subject|3|||
38020085|NCT00045162|69702808|FG000|Overall Study|Other|21|||
38020086|NCT00045162|69702809|FG001|Overall Study|Other|16|||
38020087|NCT02748616|69702815|FG000|Overall Study|Lost to Follow-up|1|||
38020088|NCT02748616|69702815|FG000|Overall Study|Withdrawal by Subject|2|||
38020089|NCT02748616|69702815|FG000|Overall Study|Physician Decision|2|||
38020090|NCT02748616|69702815|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
38020091|NCT00238121|69702821|FG000|Overall Study|Withdrawal by Subject|1|||
38020092|NCT00238121|69702822|FG001|Overall Study|Withdrawal by Subject|1|||
38020093|NCT00238121|69702821|FG000|Overall Study|Adverse Event|2|||
38020094|NCT00238121|69702822|FG001|Overall Study|Adverse Event|1|||
38020095|NCT03139552|69702827|FG000|Overall Study|unable to attend tasting due to schedule|3|||
38020096|NCT03804918|69702838|FG000|Overall Study|Participant did not use the app|1|||
38020097|NCT03139240|69702846|FG000|Overall Study|Lost to Follow-up|0|||
38020098|NCT03139240|69702847|FG001|Overall Study|Lost to Follow-up|1|||
38020099|NCT03139240|69702848|FG002|Overall Study|Lost to Follow-up|1|||
38020100|NCT03139240|69702849|FG003|Overall Study|Lost to Follow-up|0|||
38020101|NCT00237809|69702861|FG000|Overall Study|Lost to Follow-up|11|||
37699319|NCT02397473|69176111|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
37910546|NCT02906332|69596831|FG000|Overall Study|Withdrawal by Subject|1|||
37910547|NCT02827877|69596854|FG000|Overall Study|Withdrawal by Subject|1|||
37910548|NCT02755597|69596860|FG000|Overall Study|Withdrew consent|27|||
37910549|NCT02755597|69596861|FG001|Overall Study|Withdrew consent|11|||
37910550|NCT02755597|69596860|FG000|Overall Study|Lost to Follow-up|1|||
37910551|NCT02755597|69596861|FG001|Overall Study|Lost to Follow-up|0|||
37910552|NCT02755597|69596860|FG000|Overall Study|Death|78|||
37910553|NCT02755597|69596861|FG001|Overall Study|Death|36|||
37910554|NCT02755597|69596860|FG000|Overall Study|Study terminated by Sponsor|67|||
37910555|NCT02755597|69596861|FG001|Overall Study|Study terminated by Sponsor|47|||
37910556|NCT02755597|69596860|FG000|Overall Study|Other, not specified|20|||
37910557|NCT02755597|69596861|FG001|Overall Study|Other, not specified|3|||
37910558|NCT02755597|69596860|FG000|Overall Study|Participant missing reason for study discontinuation|1|||
37910559|NCT02755597|69596861|FG001|Overall Study|Participant missing reason for study discontinuation|0|||
37910560|NCT02598557|69596870|FG000|Overall Study|Withdrawal by Subject|1|||
37910561|NCT02598557|69596871|FG001|Overall Study|Withdrawal by Subject|0|||
37910562|NCT02598557|69596872|FG002|Overall Study|Withdrawal by Subject|1|||
37910563|NCT02598557|69596870|FG000|Overall Study|Participant did not start treatment|2|||
37910564|NCT02598557|69596871|FG001|Overall Study|Participant did not start treatment|1|||
37910565|NCT02598557|69596872|FG002|Overall Study|Participant did not start treatment|1|||
37910566|NCT02598557|69596870|FG000|Overall Study|Unavailable specimen for endpoint evaluations|0|||
37910567|NCT02598557|69596871|FG001|Overall Study|Unavailable specimen for endpoint evaluations|0|||
37910568|NCT02598557|69596872|FG002|Overall Study|Unavailable specimen for endpoint evaluations|1|||
37910569|NCT02598557|69596870|FG000|Overall Study|Adverse Event|1|||
37910570|NCT02598557|69596871|FG001|Overall Study|Adverse Event|1|||
37910571|NCT02598557|69596872|FG002|Overall Study|Adverse Event|0|||
37910572|NCT02340780|69596880|FG000|Overall Study|Ineligible|1|||
38020102|NCT00237809|69702862|FG001|Overall Study|Lost to Follow-up|10|||
38020103|NCT00237809|69702863|FG002|Overall Study|Lost to Follow-up|9|||
38020104|NCT00237809|69702864|FG003|Overall Study|Lost to Follow-up|9|||
38020105|NCT00003498|69702874|FG000|Overall Study|Not evaluable.|4|||
38020106|NCT00003492|69702878|FG000|Overall Study|Not evaluable|6|||
38020107|NCT03136198|69702884|FG000|Overall Study|Withdrawal by Subject|0|||
38020108|NCT03136198|69702885|FG001|Overall Study|Withdrawal by Subject|1|||
38020109|NCT00042666|69702891|FG000|Overall Study|Adverse Event|2|||
38020110|NCT00042666|69702891|FG000|Overall Study|Death|4|||
38020111|NCT00042666|69702891|FG000|Overall Study|Protocol Violation|1|||
38020112|NCT00042666|69702891|FG000|Overall Study|Participant/Physician Perception|1|||
38020113|NCT00042666|69702891|FG000|Overall Study|Progressive Disease|41|||
38020114|NCT00042666|69702891|FG000|Overall Study|Other|1|||
38020115|NCT00042666|69702891|FG000|Overall Study|Other|4|||
38020116|NCT00042432|69702898|FG000|Overall Study|Adverse Event|4|||
38020117|NCT00042432|69702899|FG001|Overall Study|Adverse Event|1|||
38020118|NCT00042432|69702898|FG000|Overall Study|Withdrawal by Subject|1|||
38020119|NCT00042432|69702899|FG001|Overall Study|Withdrawal by Subject|3|||
38020120|NCT00042432|69702898|FG000|Overall Study|Death|0|||
38020121|NCT00042432|69702899|FG001|Overall Study|Death|2|||
38020122|NCT00042432|69702898|FG000|Overall Study|Ineligibility determined|1|||
38020123|NCT00042432|69702899|FG001|Overall Study|Ineligibility determined|0|||
38020124|NCT00042432|69702898|FG000|Overall Study|Initiation of maintenance dialysis|1|||
38020125|NCT00042432|69702899|FG001|Overall Study|Initiation of maintenance dialysis|1|||
38020126|NCT00042432|69702898|FG000|Overall Study|Other|2|||
38020127|NCT00042432|69702899|FG001|Overall Study|Other|0|||
38020128|NCT00003474|69702905|FG000|Overall Study|Not Evaluable|14|||
38020129|NCT01542736|69702909|FG000|Overall Study|Death|1|||
38020130|NCT01346410|69702913|FG000|Overall Study|Death|1|||
38020131|NCT00003456|69702917|FG000|Overall Study|Not evaluable|8|||
38020132|NCT02719522|69702921|FG000|Overall Study|Implant Failure|4|||
38020133|NCT02719522|69702921|FG000|Overall Study|Death|2|||
38020134|NCT02719522|69702921|FG000|Overall Study|Lost to Follow-up|5|||
38020135|NCT00237185|69702927|FG000|Core|Adverse Event|3|||
38020136|NCT00237185|69702928|FG001|Core|Adverse Event|4|||
38020137|NCT00237185|69702927|FG000|Core|Abnormal laboratory value|0|||
38020138|NCT00237185|69702928|FG001|Core|Abnormal laboratory value|4|||
38020139|NCT00237185|69702927|FG000|Core|Abnormal test procedure results|1|||
38020140|NCT00237185|69702928|FG001|Core|Abnormal test procedure results|0|||
38020141|NCT00237185|69702927|FG000|Core|Lack of Efficacy|30|||
38020142|NCT00237185|69702928|FG001|Core|Lack of Efficacy|23|||
38020143|NCT00237185|69702927|FG000|Core|Protocol Violation|1|||
38020144|NCT00237185|69702928|FG001|Core|Protocol Violation|1|||
38020145|NCT00237185|69702927|FG000|Core|Withdrawal by Subject|4|||
38020146|NCT00237185|69702928|FG001|Core|Withdrawal by Subject|4|||
38020147|NCT00237185|69702927|FG000|Core|Administrative problems|0|||
38020148|NCT00237185|69702928|FG001|Core|Administrative problems|1|||
38020149|NCT00237185|69702927|FG000|Core|Death|4|||
38020150|NCT00237185|69702928|FG001|Core|Death|0|||
38020151|NCT00237185|69702927|FG000|Core|Determined ineligible post randomization|1|||
38020152|NCT00237185|69702928|FG001|Core|Determined ineligible post randomization|0|||
38020153|NCT00237185|69702927|FG000|Extension|Adverse Event|1|||
38020154|NCT00237185|69702928|FG001|Extension|Adverse Event|0|||
38020155|NCT00237185|69702927|FG000|Extension|Abnormal laboratory value|0|||
38020156|NCT00237185|69702928|FG001|Extension|Abnormal laboratory value|1|||
38020157|NCT00237185|69702927|FG000|Extension|Lack of Efficacy|9|||
38020158|NCT00237185|69702928|FG001|Extension|Lack of Efficacy|14|||
38020159|NCT00237185|69702927|FG000|Extension|Condition no longer required study drug|0|||
38020160|NCT00237185|69702928|FG001|Extension|Condition no longer required study drug|1|||
38020161|NCT00237185|69702927|FG000|Extension|Withdrawal by Subject|3|||
38020162|NCT00237185|69702928|FG001|Extension|Withdrawal by Subject|2|||
38020163|NCT00237185|69702927|FG000|Extension|Lost to Follow-up|1|||
38020164|NCT00237185|69702928|FG001|Extension|Lost to Follow-up|0|||
38020165|NCT00237185|69702927|FG000|Extension|Administrative problems|1|||
38020166|NCT00237185|69702928|FG001|Extension|Administrative problems|0|||
38020167|NCT00237185|69702927|FG000|Extension|Death|1|||
38020168|NCT00237185|69702928|FG001|Extension|Death|1|||
38020169|NCT00003222|69702936|FG000|Overall Study|Physician Decision|0|||
38020170|NCT00003222|69702937|FG001|Overall Study|Physician Decision|1|||
38020171|NCT02877082|69702943|FG000|Overall Study|Trial was closed early|5|||
38020172|NCT02875834|69702951|FG000|Open-label Phase|Withdrawal by Subject|3|||
38020173|NCT02875834|69702952|FG001|Open-label Phase|Withdrawal by Subject|0|||
38020174|NCT02875834|69702953|FG002|Open-label Phase|Withdrawal by Subject|0|||
38020175|NCT02875834|69702954|FG003|Open-label Phase|Withdrawal by Subject|0|||
38020176|NCT02875834|69702951|FG000|Open-label Phase|(Not collected)|4|||
38020177|NCT02875834|69702952|FG001|Open-label Phase|(Not collected)|0|||
38020178|NCT02875834|69702953|FG002|Open-label Phase|(Not collected)|0|||
38020179|NCT02875834|69702954|FG003|Open-label Phase|(Not collected)|0|||
38020180|NCT02875834|69702951|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
38020181|NCT02875834|69702952|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
38020182|NCT02875834|69702953|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
38020183|NCT02875834|69702954|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
38020184|NCT02875834|69702951|FG000|Randomized Treatment Phase|Protocol Violation|0|||
38020185|NCT02875834|69702952|FG001|Randomized Treatment Phase|Protocol Violation|2|||
38020186|NCT02875834|69702953|FG002|Randomized Treatment Phase|Protocol Violation|0|||
38020187|NCT02875834|69702954|FG003|Randomized Treatment Phase|Protocol Violation|0|||
38020188|NCT02875834|69702951|FG000|Randomized Treatment Phase|(Not collected)|0|||
38020189|NCT02875834|69702952|FG001|Randomized Treatment Phase|(Not collected)|9|||
38020190|NCT02875834|69702953|FG002|Randomized Treatment Phase|(Not collected)|10|||
38020191|NCT02875834|69702954|FG003|Randomized Treatment Phase|(Not collected)|9|||
38020192|NCT02875366|69702966|FG000|Overall Study|Adverse Event|0|||
38020193|NCT02875366|69702967|FG001|Overall Study|Adverse Event|2|||
38020194|NCT02875366|69702966|FG000|Overall Study|Noncompliance|0|||
38020195|NCT02875366|69702967|FG001|Overall Study|Noncompliance|1|||
38020196|NCT00002850|69702976|FG000|Overall Study|Death|4|||
38020197|NCT00002850|69702977|FG001|Overall Study|Death|1|||
38020198|NCT00002850|69702978|FG002|Overall Study|Death|3|||
38020199|NCT00002850|69702976|FG000|Overall Study|Protocol Violation|1|||
38020200|NCT00002850|69702977|FG001|Overall Study|Protocol Violation|0|||
38020201|NCT00002850|69702978|FG002|Overall Study|Protocol Violation|1|||
38020202|NCT00002850|69702976|FG000|Overall Study|Withdrawal by Subject|0|||
38020203|NCT00002850|69702977|FG001|Overall Study|Withdrawal by Subject|1|||
38020204|NCT00002850|69702978|FG002|Overall Study|Withdrawal by Subject|0|||
38020205|NCT00002766|69702988|FG000|Overall Study|Withdrawal by Subject|0|||
38020206|NCT00002766|69702989|FG001|Overall Study|Withdrawal by Subject|1|||
38020207|NCT00002766|69702988|FG000|Overall Study|Patient Not Treated|1|||
38020208|NCT00002766|69702989|FG001|Overall Study|Patient Not Treated|2|||
38020209|NCT00002766|69702988|FG000|Overall Study|Adverse Event|1|||
38020210|NCT00002766|69702989|FG001|Overall Study|Adverse Event|1|||
38020211|NCT00002766|69702988|FG000|Overall Study|Protocol Violation|1|||
38020212|NCT00002766|69702989|FG001|Overall Study|Protocol Violation|0|||
38020213|NCT02306122|69703002|FG000|Initial Physician Randomization|Physician Decision|0|||
38020214|NCT02306122|69703003|FG001|Initial Physician Randomization|Physician Decision|0|||
38020215|NCT02306122|69703004|FG002|Initial Physician Randomization|Physician Decision|0|||
38020216|NCT02306122|69703005|FG003|Initial Physician Randomization|Physician Decision|0|||
38020217|NCT02306122|69703006|FG004|Initial Physician Randomization|Physician Decision|0|||
38020218|NCT02306122|69703007|FG005|Initial Physician Randomization|Physician Decision|0|||
38020219|NCT02306122|69703008|FG006|Initial Physician Randomization|Physician Decision|0|||
38020220|NCT02306122|69703009|FG007|Initial Physician Randomization|Physician Decision|0|||
38020221|NCT02306122|69703010|FG008|Initial Physician Randomization|Physician Decision|1|||
38020222|NCT02306122|69703011|FG009|Initial Physician Randomization|Physician Decision|0|||
38020223|NCT02306122|69703012|FG010|Initial Physician Randomization|Physician Decision|0|||
38020224|NCT00001962|69703030|FG000|Overall Study|Lack of Efficacy|18|||
38020225|NCT00001962|69703030|FG000|Overall Study|Lack of Accrual|6|||
38020226|NCT00001962|69703030|FG000|Overall Study|Death|1|||
38020227|NCT00001962|69703030|FG000|Overall Study|Lost to Follow-up|2|||
38020228|NCT00001962|69703030|FG000|Overall Study|Adverse Event|1|||
38020229|NCT00028002|69703034|FG000|Overall Study|Withdrawal by Subject|3|||
37699320|NCT02397473|69176110|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
37699321|NCT02397473|69176111|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
37699322|NCT02397473|69176110|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
37699323|NCT02397473|69176111|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
37699324|NCT02344745|69176122|FG000|Overall Study|Data collection sheets were lost|2|||
37699325|NCT02344745|69176123|FG001|Overall Study|Data collection sheets were lost|0|||
37699326|NCT02370641|69176131|FG000|Overall Study|dropped study|4|||
37699327|NCT02370641|69176132|FG001|Overall Study|dropped study|2|||
37699328|NCT01621191|69176138|FG000|Overall Study|Adverse Event|9|||
37699329|NCT01621191|69176138|FG000|Overall Study|Withdrawal by Subject|8|||
37699330|NCT01621191|69176138|FG000|Overall Study|Lack of Efficacy|6|||
37699331|NCT01621191|69176138|FG000|Overall Study|Lost to Follow-up|1|||
37699332|NCT01621191|69176138|FG000|Overall Study|Site Removed From Study|1|||
37699333|NCT02343263|69176146|FG000|Overall Study|Physician Decision|5|||
37699334|NCT02343263|69176147|FG001|Overall Study|Physician Decision|3|||
37699335|NCT02343263|69176148|FG002|Overall Study|Physician Decision|1|||
37699336|NCT02081859|69176162|FG000|Overall Study|No fertilization|2|||
37699337|NCT02081859|69176163|FG001|Overall Study|No fertilization|2|||
37699338|NCT02081859|69176162|FG000|Overall Study|No sperm|1|||
38020230|NCT00028002|69703034|FG000|Overall Study|Ineligible|8|||
38020231|NCT00256997|69703041|FG000|Overall Study|Protocol Violation|1|||
38020232|NCT00256997|69703042|FG001|Overall Study|Protocol Violation|4|||
38020233|NCT00256997|69703041|FG000|Overall Study|Lack of Efficacy|1|||
38020234|NCT00256997|69703042|FG001|Overall Study|Lack of Efficacy|4|||
37699339|NCT02081859|69176163|FG001|Overall Study|No sperm|0|||
38020235|NCT00256997|69703041|FG000|Overall Study|Death|2|||
38020236|NCT00256997|69703042|FG001|Overall Study|Death|0|||
38020237|NCT00256997|69703041|FG000|Overall Study|Adverse Event|4|||
38020238|NCT00256997|69703042|FG001|Overall Study|Adverse Event|0|||
38020239|NCT00256997|69703041|FG000|Overall Study|Lost to Follow-up|3|||
37699340|NCT02081859|69176162|FG000|Overall Study|Unanticipated freeze all cycle|2|||
37699341|NCT02081859|69176163|FG001|Overall Study|Unanticipated freeze all cycle|6|||
37699342|NCT02081859|69176162|FG000|Overall Study|< 4 embryos|27|||
37699343|NCT02081859|69176163|FG001|Overall Study|< 4 embryos|23|||
37699344|NCT02081859|69176162|FG000|Overall Study|Other reasons|2|||
37699345|NCT02081859|69176163|FG001|Overall Study|Other reasons|0|||
37699346|NCT02342639|69176171|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
37699347|NCT02342639|69176172|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
37699348|NCT02342639|69176171|FG000|Overall Study|Protocol Violation|0|||
37699349|NCT02342639|69176172|FG001|Overall Study|Protocol Violation|2|||
37699350|NCT01625091|69176182|FG000|Intervention|Death|1|||
37910573|NCT01470417|69596895|FG000|Overall Study|Disease progression|0|||
38020240|NCT00256997|69703042|FG001|Overall Study|Lost to Follow-up|5|||
38020241|NCT00256997|69703041|FG000|Overall Study|Withdrawal by Subject|13|||
38020242|NCT00256997|69703042|FG001|Overall Study|Withdrawal by Subject|3|||
38020243|NCT00256997|69703041|FG000|Overall Study|Started but not treated|2|||
38020244|NCT00256997|69703042|FG001|Overall Study|Started but not treated|0|||
38020245|NCT00256997|69703041|FG000|Overall Study|Other|5|||
38020246|NCT00256997|69703042|FG001|Overall Study|Other|8|||
38020247|NCT00256997|69703041|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
38020248|NCT00256997|69703042|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
38020249|NCT00256997|69703041|FG000|Overall Study|Participant Non-compliant|3|||
38020250|NCT00256997|69703042|FG001|Overall Study|Participant Non-compliant|6|||
38020251|NCT00256997|69703041|FG000|Overall Study|Investigator Withdrew Participant|2|||
38020252|NCT00256997|69703042|FG001|Overall Study|Investigator Withdrew Participant|1|||
38020253|NCT00027846|69703052|FG000|Overall Study|Lost to Follow-up|0|||
38020254|NCT00027846|69703053|FG001|Overall Study|Lost to Follow-up|41|||
38020255|NCT00027846|69703054|FG002|Overall Study|Lost to Follow-up|9|||
38020256|NCT00027846|69703052|FG000|Overall Study|Withdrawal by Subject|0|||
38020257|NCT00027846|69703053|FG001|Overall Study|Withdrawal by Subject|14|||
38020258|NCT00027846|69703054|FG002|Overall Study|Withdrawal by Subject|7|||
38020259|NCT00027846|69703052|FG000|Overall Study|Ineligible for study|2|||
37910574|NCT01470417|69596896|FG001|Overall Study|Disease progression|2|||
37910575|NCT00820248|69596934|FG000|Overall Study|No treated|4|||
37910576|NCT00820248|69596935|FG001|Overall Study|No treated|1|||
37910577|NCT00668642|69596952|FG000|First Off-cycle|Cancer progression|1|||
38020260|NCT00027846|69703053|FG001|Overall Study|Ineligible for study|6|||
38020261|NCT00027846|69703054|FG002|Overall Study|Ineligible for study|14|||
38020262|NCT00027846|69703052|FG000|Overall Study|Entry into another COG therapeutic study|0|||
38020263|NCT00027846|69703053|FG001|Overall Study|Entry into another COG therapeutic study|5|||
38020264|NCT00027846|69703054|FG002|Overall Study|Entry into another COG therapeutic study|2|||
38020265|NCT00027846|69703052|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
38020266|NCT00027846|69703053|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
38020267|NCT00027846|69703054|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
38020268|NCT00027378|69703066|FG000|Overall Study|Physician Decision|0|||
38020269|NCT00027378|69703067|FG001|Overall Study|Physician Decision|3|||
38020270|NCT00235391|69703079|FG000|Overall Study|Adverse Event|4|||
38020271|NCT00235391|69703080|FG001|Overall Study|Adverse Event|5|||
38020272|NCT00235391|69703081|FG002|Overall Study|Adverse Event|10|||
38020273|NCT00235391|69703082|FG003|Overall Study|Adverse Event|72|||
38020274|NCT00235391|69703083|FG004|Overall Study|Adverse Event|5|||
37910578|NCT00668642|69596953|FG001|First Off-cycle|Cancer progression|0|||
37910579|NCT00668642|69596952|FG000|Second AAT Treatment (On-cycle 2)|Cancer progression|2|||
38020275|NCT00235391|69703084|FG005|Overall Study|Adverse Event|2|||
38020276|NCT00235391|69703079|FG000|Overall Study|Abnormal laboratory value(s)|3|||
38020277|NCT00235391|69703080|FG001|Overall Study|Abnormal laboratory value(s)|5|||
37699351|NCT01625091|69176183|FG001|Intervention|Death|1|||
38020278|NCT00235391|69703081|FG002|Overall Study|Abnormal laboratory value(s)|4|||
38020279|NCT00235391|69703082|FG003|Overall Study|Abnormal laboratory value(s)|27|||
38020280|NCT00235391|69703083|FG004|Overall Study|Abnormal laboratory value(s)|1|||
37699352|NCT01625091|69176182|FG000|Intervention|Withdrawal by Subject|4|||
38020281|NCT00235391|69703084|FG005|Overall Study|Abnormal laboratory value(s)|2|||
38020282|NCT00235391|69703079|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
38020283|NCT00235391|69703080|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
38020284|NCT00235391|69703081|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
38020285|NCT00235391|69703082|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
38020286|NCT00235391|69703083|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
38020287|NCT00235391|69703084|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
38020288|NCT00235391|69703079|FG000|Overall Study|Condition no longer requires treatment|3|||
38020289|NCT00235391|69703080|FG001|Overall Study|Condition no longer requires treatment|0|||
38020290|NCT00235391|69703081|FG002|Overall Study|Condition no longer requires treatment|0|||
38020291|NCT00235391|69703082|FG003|Overall Study|Condition no longer requires treatment|11|||
38020292|NCT00235391|69703083|FG004|Overall Study|Condition no longer requires treatment|1|||
38020293|NCT00235391|69703084|FG005|Overall Study|Condition no longer requires treatment|0|||
38020294|NCT00235391|69703079|FG000|Overall Study|Protocol deviation|0|||
38020295|NCT00235391|69703080|FG001|Overall Study|Protocol deviation|0|||
38020296|NCT00235391|69703081|FG002|Overall Study|Protocol deviation|1|||
38020297|NCT00235391|69703082|FG003|Overall Study|Protocol deviation|11|||
38020298|NCT00235391|69703083|FG004|Overall Study|Protocol deviation|0|||
38020299|NCT00235391|69703084|FG005|Overall Study|Protocol deviation|0|||
38020300|NCT00235391|69703079|FG000|Overall Study|Withdrawal by Subject|2|||
38020301|NCT00235391|69703080|FG001|Overall Study|Withdrawal by Subject|3|||
38020302|NCT00235391|69703081|FG002|Overall Study|Withdrawal by Subject|3|||
38020303|NCT00235391|69703082|FG003|Overall Study|Withdrawal by Subject|61|||
38020304|NCT00235391|69703083|FG004|Overall Study|Withdrawal by Subject|5|||
38020305|NCT00235391|69703084|FG005|Overall Study|Withdrawal by Subject|0|||
38020306|NCT00235391|69703079|FG000|Overall Study|Lost to Follow-up|0|||
38020307|NCT00235391|69703080|FG001|Overall Study|Lost to Follow-up|3|||
38020308|NCT00235391|69703081|FG002|Overall Study|Lost to Follow-up|3|||
38020309|NCT00235391|69703082|FG003|Overall Study|Lost to Follow-up|16|||
38020310|NCT00235391|69703083|FG004|Overall Study|Lost to Follow-up|0|||
38020311|NCT00235391|69703084|FG005|Overall Study|Lost to Follow-up|0|||
38020312|NCT00235391|69703079|FG000|Overall Study|Administrative problems|0|||
38020313|NCT00235391|69703080|FG001|Overall Study|Administrative problems|0|||
38020314|NCT00235391|69703081|FG002|Overall Study|Administrative problems|0|||
38020315|NCT00235391|69703082|FG003|Overall Study|Administrative problems|1|||
38020316|NCT00235391|69703083|FG004|Overall Study|Administrative problems|0|||
38020317|NCT00235391|69703084|FG005|Overall Study|Administrative problems|0|||
38020318|NCT00235391|69703079|FG000|Overall Study|Death|0|||
38020319|NCT00235391|69703080|FG001|Overall Study|Death|0|||
38020320|NCT00235391|69703081|FG002|Overall Study|Death|1|||
38020321|NCT00235391|69703082|FG003|Overall Study|Death|4|||
38020322|NCT00235391|69703083|FG004|Overall Study|Death|0|||
38020323|NCT00235391|69703084|FG005|Overall Study|Death|0|||
38020324|NCT00234533|69703128|FG000|Overall Study|Withdrawal by Subject|6|||
38020325|NCT00234533|69703128|FG000|Overall Study|Adverse Event|2|||
38020326|NCT00234533|69703128|FG000|Overall Study|Enrolled but not treated|3|||
38020327|NCT00026208|69703135|FG000|Overall Study|Complications of auto accident|1|||
38020328|NCT00026208|69703136|FG001|Overall Study|Complications of auto accident|0|||
38020329|NCT00025662|69703142|FG000|Overall Study|Withdrawal by Subject|2|||
38020330|NCT00025662|69703142|FG000|Overall Study|Technical failure of manipulation|1|||
38020331|NCT00025506|69703146|FG000|Overall Study|Ineligible: clerical error|1|||
38020332|NCT00025506|69703146|FG000|Overall Study|Ineligible: wrong cell type|5|||
38020333|NCT00025506|69703146|FG000|Overall Study|Ineligible: inadequate pathology|2|||
38020334|NCT00025506|69703146|FG000|Overall Study|Never Treated|2|||
38020335|NCT00024258|69703155|FG000|Overall Study|Withdrawal by Subject|1|||
38020336|NCT00024258|69703155|FG000|Overall Study|Disease Progression|8|||
38020337|NCT00023712|69703161|FG000|Overall Study|Not platinum sensitive|1|||
38020338|NCT00023712|69703162|FG001|Overall Study|Not platinum sensitive|0|||
38020339|NCT00023712|69703161|FG000|Overall Study|Never treated|1|||
38020340|NCT00023712|69703162|FG001|Overall Study|Never treated|1|||
38020341|NCT00023322|69703178|FG000|Overall Study|Lost to Follow-up|1|||
38020342|NCT04640168|69703184|FG000|Overall Study|Withdrawal by Subject|8|||
38020343|NCT04640168|69703185|FG001|Overall Study|Withdrawal by Subject|7|||
38020344|NCT04640168|69703184|FG000|Overall Study|Lost to Follow-up|1|||
38020345|NCT04640168|69703185|FG001|Overall Study|Lost to Follow-up|0|||
38020346|NCT04640168|69703184|FG000|Overall Study|Enrolled but not treated|12|||
38020347|NCT04640168|69703185|FG001|Overall Study|Enrolled but not treated|12|||
38020348|NCT00022698|69703193|FG000|Overall Study|Adverse Event|5|||
38020349|NCT00022698|69703194|FG001|Overall Study|Adverse Event|9|||
38020350|NCT00022698|69703193|FG000|Overall Study|Death|0|||
38020351|NCT00022698|69703194|FG001|Overall Study|Death|2|||
38020352|NCT00022698|69703193|FG000|Overall Study|Failure to return|0|||
38020353|NCT00022698|69703194|FG001|Overall Study|Failure to return|1|||
38020354|NCT00022698|69703193|FG000|Overall Study|Refused treatment|0|||
38020355|NCT00022698|69703194|FG001|Overall Study|Refused treatment|2|||
38020356|NCT00022698|69703193|FG000|Overall Study|Insufficient therapeutic response|2|||
38020357|NCT00022698|69703194|FG001|Overall Study|Insufficient therapeutic response|14|||
38020358|NCT00022698|69703193|FG000|Overall Study|Administrative /other|1|||
38020359|NCT00022698|69703194|FG001|Overall Study|Administrative /other|7|||
38020360|NCT00234065|69703204|FG000|Overall Study|Adverse Event|268|||
38020361|NCT00234065|69703205|FG001|Overall Study|Adverse Event|166|||
38020362|NCT00234065|69703204|FG000|Overall Study|Withdrawal by Subject|73|||
38020363|NCT00234065|69703205|FG001|Overall Study|Withdrawal by Subject|56|||
38020364|NCT00234065|69703204|FG000|Overall Study|Physician Decision|23|||
38020365|NCT00234065|69703205|FG001|Overall Study|Physician Decision|22|||
38020366|NCT00234065|69703204|FG000|Overall Study|Not Classified|111|||
38020367|NCT00234065|69703205|FG001|Overall Study|Not Classified|112|||
38020368|NCT00233987|69703211|FG000|Overall Study|Withdrawal by Subject|1|||
38020369|NCT00233987|69703211|FG000|Overall Study|Lack of Efficacy|2|||
38020370|NCT00233987|69703211|FG000|Overall Study|Reason Under Review|1|||
38020371|NCT00233987|69703211|FG000|Overall Study|Other - Not Protocol Specified|5|||
38020372|NCT00233987|69703211|FG000|Overall Study|Eligible but No Treatment Received|2|||
38020373|NCT00233987|69703211|FG000|Overall Study|Ineligible|4|||
38020374|NCT04623242|69703220|FG000|Overall Study|Withdrawal by Subject|7|||
38020375|NCT04623242|69703221|FG001|Overall Study|Withdrawal by Subject|12|||
38020376|NCT04623242|69703222|FG002|Overall Study|Withdrawal by Subject|5|||
38020377|NCT04623242|69703223|FG003|Overall Study|Withdrawal by Subject|7|||
38020378|NCT04623242|69703224|FG004|Overall Study|Withdrawal by Subject|0|||
38020379|NCT04623242|69703220|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
38020380|NCT04623242|69703221|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
38020381|NCT04623242|69703222|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
38020382|NCT04623242|69703223|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
38020383|NCT04623242|69703224|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
38020384|NCT04623242|69703220|FG000|Overall Study|Subject unblinded to mutation status|0|||
38020385|NCT04623242|69703221|FG001|Overall Study|Subject unblinded to mutation status|0|||
38020386|NCT04623242|69703222|FG002|Overall Study|Subject unblinded to mutation status|0|||
38020387|NCT04623242|69703223|FG003|Overall Study|Subject unblinded to mutation status|13|||
38020388|NCT04623242|69703224|FG004|Overall Study|Subject unblinded to mutation status|0|||
38020389|NCT00233363|69703241|FG000|Overall Study|Adverse Event|1|||
38020390|NCT00233363|69703242|FG001|Overall Study|Adverse Event|2|||
38020391|NCT00233363|69703241|FG000|Overall Study|Lack of Efficacy|0|||
38020392|NCT00233363|69703242|FG001|Overall Study|Lack of Efficacy|2|||
38020393|NCT00233363|69703241|FG000|Overall Study|Withdrawal by Subject|1|||
38020394|NCT00233363|69703242|FG001|Overall Study|Withdrawal by Subject|1|||
38020395|NCT00233363|69703241|FG000|Overall Study|Aggravation of complication|1|||
38020396|NCT00233363|69703242|FG001|Overall Study|Aggravation of complication|0|||
38020397|NCT01147666|69703263|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
38020398|NCT01147666|69703264|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
38020399|NCT01147666|69703265|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
38020400|NCT01147666|69703266|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
38020401|NCT01147666|69703267|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
38020402|NCT01147666|69703268|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
38020403|NCT01147666|69703269|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
38020404|NCT01147666|69703270|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
38020405|NCT01147666|69703271|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
38020406|NCT01147666|69703272|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
38020407|NCT01147666|69703273|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
38020408|NCT01147666|69703274|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
38020409|NCT01147666|69703275|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
38020410|NCT01147666|69703276|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
38020411|NCT01147666|69703277|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
38020412|NCT01147666|69703263|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
37910580|NCT00668642|69596953|FG001|Second AAT Treatment (On-cycle 2)|Cancer progression|1|||
37910581|NCT00609791|69596959|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
37910582|NCT00101101|69596972|FG000|Overall Study|never received vaccine|20|||
37910583|NCT03962101|69596976|FG000|Overall Study|Adverse Event|1|||
37910584|NCT03962101|69596976|FG000|Overall Study|Physician Decision|2|||
37910585|NCT03962101|69596976|FG000|Overall Study|Not related to medical events|1|||
37910586|NCT00923351|69596983|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
37910587|NCT00923351|69596984|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
38020413|NCT01147666|69703264|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
38020414|NCT01147666|69703265|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
38020415|NCT01147666|69703266|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
38020416|NCT01147666|69703267|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
38020417|NCT01147666|69703268|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
38020418|NCT01147666|69703269|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
38020419|NCT01147666|69703270|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
38020420|NCT01147666|69703271|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
38020421|NCT01147666|69703272|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
38020422|NCT01147666|69703273|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
38020423|NCT01147666|69703274|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
38020424|NCT01147666|69703275|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
38020425|NCT01147666|69703276|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
38020426|NCT01147666|69703277|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
38020427|NCT01147666|69703263|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
38020428|NCT01147666|69703264|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
38020429|NCT01147666|69703265|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
38020430|NCT01147666|69703266|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
38020431|NCT01147666|69703267|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
38020432|NCT01147666|69703268|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
38020433|NCT01147666|69703269|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
38020434|NCT01147666|69703270|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
38020435|NCT01147666|69703271|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
38020436|NCT01147666|69703272|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
38020437|NCT01147666|69703273|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
38020438|NCT01147666|69703274|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
38020439|NCT01147666|69703275|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
38020440|NCT01147666|69703276|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
38020441|NCT01147666|69703277|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
38020442|NCT01147666|69703263|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
38020443|NCT01147666|69703264|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
38020444|NCT01147666|69703265|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
38020445|NCT01147666|69703266|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
38020446|NCT01147666|69703267|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
38020447|NCT01147666|69703268|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
38020448|NCT01147666|69703269|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
38020449|NCT01147666|69703270|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
38020450|NCT01147666|69703271|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
38020451|NCT01147666|69703272|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
38020452|NCT01147666|69703273|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
38020453|NCT01147666|69703274|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
38020454|NCT01147666|69703275|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
38020455|NCT01147666|69703276|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
38020456|NCT01147666|69703277|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
38020457|NCT01147666|69703263|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
38020458|NCT01147666|69703264|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
38020459|NCT01147666|69703265|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
38020460|NCT01147666|69703266|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
38020461|NCT01147666|69703267|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
38020462|NCT01147666|69703268|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
38020463|NCT01147666|69703269|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
38020464|NCT01147666|69703270|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
38020465|NCT01147666|69703271|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
38020466|NCT01147666|69703272|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
38020467|NCT01147666|69703273|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
38020468|NCT01147666|69703274|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
38020469|NCT01147666|69703275|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
38020470|NCT01147666|69703276|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
38020471|NCT01147666|69703277|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
38020472|NCT01147666|69703263|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
38020473|NCT01147666|69703264|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
38020474|NCT01147666|69703265|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
38020475|NCT01147666|69703266|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
38020476|NCT01147666|69703267|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
38020477|NCT01147666|69703268|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
38020478|NCT01147666|69703269|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
38020479|NCT01147666|69703270|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
38020480|NCT01147666|69703271|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
38020481|NCT01147666|69703272|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
38020482|NCT01147666|69703273|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
38020483|NCT01147666|69703274|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
38020484|NCT01147666|69703275|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
38020485|NCT01147666|69703276|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
38020486|NCT01147666|69703277|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
38020487|NCT01147666|69703263|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
38020488|NCT01147666|69703264|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
38020489|NCT01147666|69703265|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
38020490|NCT01147666|69703266|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
38020491|NCT01147666|69703267|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
38020492|NCT01147666|69703268|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
38020493|NCT01147666|69703269|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
38020494|NCT01147666|69703270|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
38020495|NCT01147666|69703271|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
38020496|NCT01147666|69703272|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
38020497|NCT01147666|69703273|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
38020498|NCT01147666|69703274|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
38020499|NCT01147666|69703275|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
38020500|NCT01147666|69703276|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
38020501|NCT01147666|69703277|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
38020502|NCT01147666|69703263|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
38020503|NCT01147666|69703264|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
38020504|NCT01147666|69703265|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
38020505|NCT01147666|69703266|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
38020506|NCT01147666|69703267|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
38020507|NCT01147666|69703268|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
38020508|NCT01147666|69703269|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
38020509|NCT01147666|69703270|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
38020510|NCT01147666|69703271|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
38020511|NCT01147666|69703272|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
38020512|NCT01147666|69703273|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
38020513|NCT01147666|69703274|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
38020514|NCT01147666|69703275|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
38020515|NCT01147666|69703276|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
38020516|NCT01147666|69703277|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
38020517|NCT01147666|69703263|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
38020518|NCT01147666|69703264|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
38020519|NCT01147666|69703265|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
38020520|NCT01147666|69703266|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
38020521|NCT01147666|69703267|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
38020522|NCT01147666|69703268|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
38020523|NCT01147666|69703269|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
38020524|NCT01147666|69703270|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
38020525|NCT01147666|69703271|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
38020526|NCT01147666|69703272|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
38020527|NCT01147666|69703273|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
38020528|NCT01147666|69703274|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
38020529|NCT01147666|69703275|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
38020530|NCT01147666|69703276|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
38020531|NCT01147666|69703277|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
38020532|NCT01147666|69703263|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
38020533|NCT01147666|69703264|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
38020534|NCT01147666|69703265|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
38020535|NCT01147666|69703266|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
38020536|NCT01147666|69703267|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
38020537|NCT01147666|69703268|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
38020538|NCT01147666|69703269|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
38020539|NCT01147666|69703270|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
38020540|NCT01147666|69703271|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
38020541|NCT01147666|69703272|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
38020542|NCT01147666|69703273|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
38020543|NCT01147666|69703274|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
37699353|NCT01625091|69176183|FG001|Intervention|Withdrawal by Subject|1|||
37699354|NCT01625091|69176182|FG000|Intervention|Adverse Event|0|||
37910588|NCT00923351|69596985|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
38020544|NCT01147666|69703275|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
38020545|NCT01147666|69703276|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
38020546|NCT01147666|69703277|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
38020547|NCT01147666|69703263|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
38020548|NCT01147666|69703264|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
38020549|NCT01147666|69703265|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
38020550|NCT01147666|69703266|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
38020551|NCT01147666|69703267|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
38020552|NCT01147666|69703268|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
38020553|NCT01147666|69703269|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
38020554|NCT01147666|69703270|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
38020555|NCT01147666|69703271|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
38020556|NCT01147666|69703272|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
38020557|NCT01147666|69703273|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
38020558|NCT01147666|69703274|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
38020559|NCT01147666|69703275|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
38020560|NCT01147666|69703276|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
38020561|NCT01147666|69703277|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
38020562|NCT01147666|69703263|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
38020563|NCT01147666|69703264|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
38020564|NCT01147666|69703265|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
38020565|NCT01147666|69703266|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
38020566|NCT01147666|69703267|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
38020567|NCT01147666|69703268|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
38020568|NCT01147666|69703269|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
38020569|NCT01147666|69703270|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
38020570|NCT01147666|69703271|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
38020571|NCT01147666|69703272|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
38020572|NCT01147666|69703273|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
38020573|NCT01147666|69703274|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
38020574|NCT01147666|69703275|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
38020575|NCT01147666|69703276|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
38020576|NCT01147666|69703277|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
38020577|NCT01147666|69703263|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
38020578|NCT01147666|69703264|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
38020579|NCT01147666|69703265|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
38020580|NCT01147666|69703266|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
38020581|NCT01147666|69703267|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
38020582|NCT01147666|69703268|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
38020583|NCT01147666|69703269|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
38020584|NCT01147666|69703270|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
38020585|NCT01147666|69703271|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
38020586|NCT01147666|69703272|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
38020587|NCT01147666|69703273|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
38020588|NCT01147666|69703274|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
38020589|NCT01147666|69703275|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
38020590|NCT01147666|69703276|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
38020591|NCT01147666|69703277|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
38020592|NCT01147666|69703263|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
38020593|NCT01147666|69703264|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
38020594|NCT01147666|69703265|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
38020595|NCT01147666|69703266|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
38020596|NCT01147666|69703267|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
38020597|NCT01147666|69703268|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
38020598|NCT01147666|69703269|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
38020599|NCT01147666|69703270|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
38020600|NCT01147666|69703271|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
38020601|NCT01147666|69703272|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
38020602|NCT01147666|69703273|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
38020603|NCT01147666|69703274|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
38020604|NCT01147666|69703275|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
38020605|NCT01147666|69703276|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
38020606|NCT01147666|69703277|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
38020607|NCT00256295|69703339|FG000|Overall Study|Withdrawal by Subject|3|||
38020608|NCT00256295|69703339|FG000|Overall Study|Death|1|||
38020609|NCT02877004|69703346|FG000|Overall Study|Pregnancy|0|||
38020610|NCT02877004|69703347|FG001|Overall Study|Pregnancy|0|||
37910589|NCT00755937|69596991|FG000|Recruitment|Unknown if infliximab received|164|||
38020611|NCT02877004|69703348|FG002|Overall Study|Pregnancy|1|||
38020612|NCT04617860|69703378|FG000|Overall Study|Adverse Event|0|||
38020613|NCT04617860|69703379|FG001|Overall Study|Adverse Event|2|||
38020614|NCT04617860|69703380|FG002|Overall Study|Adverse Event|2|||
38020615|NCT04617860|69703378|FG000|Overall Study|Withdrawal by Subject|0|||
38020616|NCT04617860|69703379|FG001|Overall Study|Withdrawal by Subject|0|||
38020617|NCT04617860|69703380|FG002|Overall Study|Withdrawal by Subject|2|||
38020618|NCT04617860|69703378|FG000|Overall Study|Physician Decision|0|||
38020619|NCT04617860|69703379|FG001|Overall Study|Physician Decision|1|||
38020620|NCT04617860|69703380|FG002|Overall Study|Physician Decision|0|||
38020621|NCT04617860|69703378|FG000|Overall Study|Sponsor Decision|0|||
38020622|NCT04617860|69703379|FG001|Overall Study|Sponsor Decision|3|||
38020623|NCT04617860|69703380|FG002|Overall Study|Sponsor Decision|1|||
38020624|NCT04617860|69703378|FG000|Overall Study|Termination of Study by Sponsor|8|||
38020625|NCT04617860|69703379|FG001|Overall Study|Termination of Study by Sponsor|4|||
38020626|NCT04617860|69703380|FG002|Overall Study|Termination of Study by Sponsor|13|||
38020627|NCT04608500|69703392|FG000|Overall Study|Adverse Event|2|||
38020628|NCT04608500|69703393|FG001|Overall Study|Adverse Event|0|||
38020629|NCT04608500|69703392|FG000|Overall Study|Lost to Follow-up|15|||
38020630|NCT04608500|69703393|FG001|Overall Study|Lost to Follow-up|9|||
38020631|NCT04608500|69703392|FG000|Overall Study|Participant request|11|||
38020632|NCT04608500|69703393|FG001|Overall Study|Participant request|7|||
38020633|NCT04608500|69703392|FG000|Overall Study|Protocol Violation|1|||
38020634|NCT04608500|69703393|FG001|Overall Study|Protocol Violation|0|||
38020635|NCT04608500|69703392|FG000|Overall Study|Other|6|||
38020636|NCT04608500|69703393|FG001|Overall Study|Other|2|||
38020637|NCT04585646|69703399|FG000|First Intervention|Physician Decision|1|||
38020638|NCT04585646|69703400|FG001|First Intervention|Physician Decision|0|||
38020639|NCT04585646|69703399|FG000|First Intervention|Lost to Follow-up|0|||
38020640|NCT04585646|69703400|FG001|First Intervention|Lost to Follow-up|3|||
38020641|NCT04585646|69703399|FG000|First Intervention|Withdrawal by Subject|0|||
38020642|NCT04585646|69703400|FG001|First Intervention|Withdrawal by Subject|1|||
38020643|NCT04584788|69703416|FG000|Overall Study|Physician Decision|8|||
38020644|NCT04584788|69703416|FG000|Overall Study|Withdrawal by Subject|1|||
38020645|NCT04584788|69703416|FG000|Overall Study|Adverse Event|3|||
38020646|NCT04575038|69703422|FG000|Overall Study|Withdrawal by Subject|1|||
38020647|NCT04575038|69703423|FG001|Overall Study|Withdrawal by Subject|1|||
38020648|NCT03066622|69703431|FG000|Overall Study|Lost to Follow-up|24|||
38020649|NCT03066622|69703432|FG001|Overall Study|Lost to Follow-up|25|||
38020650|NCT03066622|69703431|FG000|Overall Study|Withdrawal by Subject|2|||
38020651|NCT03066622|69703432|FG001|Overall Study|Withdrawal by Subject|1|||
38020652|NCT04501952|69703464|FG000|Overall Study|Adverse Event|0|||
38020653|NCT04501952|69703465|FG001|Overall Study|Adverse Event|3|||
38020654|NCT04501952|69703464|FG000|Overall Study|Investigator's Discretion|0|||
38020655|NCT04501952|69703465|FG001|Overall Study|Investigator's Discretion|1|||
38020656|NCT04501952|69703464|FG000|Overall Study|Protocol Violation|1|||
38020657|NCT04501952|69703465|FG001|Overall Study|Protocol Violation|1|||
38020658|NCT04501952|69703464|FG000|Overall Study|Withdrew Consent|5|||
38020659|NCT04501952|69703465|FG001|Overall Study|Withdrew Consent|4|||
38020660|NCT04501952|69703464|FG000|Overall Study|Lost to Follow-up|7|||
38020661|NCT04501952|69703465|FG001|Overall Study|Lost to Follow-up|2|||
38020662|NCT04501952|69703464|FG000|Overall Study|Randomized and Never Treated|13|||
38020663|NCT04501952|69703465|FG001|Overall Study|Randomized and Never Treated|9|||
38020664|NCT02930122|69703483|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
38020665|NCT02930122|69703484|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
38020666|NCT03697460|69703491|FG000|Overall Study|Withdrawal by Subject|3|||
38020667|NCT00070018|69703495|FG000|Overall Study|Adverse Event|2|||
38020668|NCT00070018|69703495|FG000|Overall Study|Lack of Efficacy|1|||
38020669|NCT00070018|69703495|FG000|Overall Study|Withdrawal by Subject|1|||
38020670|NCT00231413|69703506|FG000|Overall Study|Non-serious AE|0|||
38020671|NCT00231413|69703507|FG001|Overall Study|Non-serious AE|0|||
37699355|NCT01625091|69176183|FG001|Intervention|Adverse Event|2|||
38020672|NCT00231413|69703508|FG002|Overall Study|Non-serious AE|1|||
38020673|NCT00231413|69703509|FG003|Overall Study|Non-serious AE|0|||
38020674|NCT00231413|69703510|FG004|Overall Study|Non-serious AE|0|||
38020675|NCT00231413|69703511|FG005|Overall Study|Non-serious AE|0|||
38020676|NCT00231413|69703512|FG006|Overall Study|Non-serious AE|1|||
38020677|NCT00231413|69703506|FG000|Overall Study|Withdrawal by Subject|3|||
38020678|NCT00231413|69703507|FG001|Overall Study|Withdrawal by Subject|1|||
38020679|NCT00231413|69703508|FG002|Overall Study|Withdrawal by Subject|4|||
38020680|NCT00231413|69703509|FG003|Overall Study|Withdrawal by Subject|2|||
37699356|NCT01625091|69176182|FG000|Intervention|Lost to Follow-up|4|||
38020681|NCT00231413|69703510|FG004|Overall Study|Withdrawal by Subject|2|||
38020682|NCT00231413|69703511|FG005|Overall Study|Withdrawal by Subject|0|||
38020683|NCT00231413|69703512|FG006|Overall Study|Withdrawal by Subject|3|||
38020684|NCT00231413|69703506|FG000|Overall Study|Migrated/moved from study area|0|||
38020685|NCT00231413|69703507|FG001|Overall Study|Migrated/moved from study area|0|||
38020686|NCT00231413|69703508|FG002|Overall Study|Migrated/moved from study area|1|||
38020687|NCT00231413|69703509|FG003|Overall Study|Migrated/moved from study area|0|||
38020688|NCT00231413|69703510|FG004|Overall Study|Migrated/moved from study area|0|||
38020689|NCT00231413|69703511|FG005|Overall Study|Migrated/moved from study area|1|||
38020690|NCT00231413|69703512|FG006|Overall Study|Migrated/moved from study area|0|||
38020691|NCT00231413|69703506|FG000|Overall Study|Lost to Follow-up|4|||
38020692|NCT00231413|69703507|FG001|Overall Study|Lost to Follow-up|4|||
38020693|NCT00231413|69703508|FG002|Overall Study|Lost to Follow-up|1|||
38020694|NCT00231413|69703509|FG003|Overall Study|Lost to Follow-up|1|||
38020695|NCT00231413|69703510|FG004|Overall Study|Lost to Follow-up|1|||
38020696|NCT00231413|69703511|FG005|Overall Study|Lost to Follow-up|4|||
38020697|NCT00231413|69703512|FG006|Overall Study|Lost to Follow-up|0|||
38020698|NCT00231413|69703506|FG000|Overall Study|Pregnancy|1|||
38020699|NCT00231413|69703507|FG001|Overall Study|Pregnancy|0|||
38020700|NCT00231413|69703508|FG002|Overall Study|Pregnancy|0|||
38020701|NCT00231413|69703509|FG003|Overall Study|Pregnancy|0|||
38020702|NCT00231413|69703510|FG004|Overall Study|Pregnancy|0|||
38020703|NCT00231413|69703511|FG005|Overall Study|Pregnancy|0|||
38020704|NCT00231413|69703512|FG006|Overall Study|Pregnancy|0|||
38020705|NCT04494646|69703530|FG000|Overall Study|Adverse Event|0|||
38020706|NCT04494646|69703531|FG001|Overall Study|Adverse Event|1|||
38020707|NCT04494646|69703530|FG000|Overall Study|Withdrawal by Subject|0|||
38020708|NCT04494646|69703531|FG001|Overall Study|Withdrawal by Subject|1|||
38020709|NCT04529096|69703539|FG000|Overall Study|Adverse Event|6|||
38020710|NCT04529096|69703540|FG001|Overall Study|Adverse Event|1|||
38020711|NCT04529096|69703539|FG000|Overall Study|Lack of Efficacy|1|||
38020712|NCT04529096|69703540|FG001|Overall Study|Lack of Efficacy|0|||
38020713|NCT04529096|69703539|FG000|Overall Study|Lost to Follow-up|1|||
38020714|NCT04529096|69703540|FG001|Overall Study|Lost to Follow-up|1|||
38020715|NCT04529096|69703539|FG000|Overall Study|Non-Compliance With Study Drug|0|||
38020716|NCT04529096|69703540|FG001|Overall Study|Non-Compliance With Study Drug|1|||
38020717|NCT04529096|69703539|FG000|Overall Study|Physician Decision|1|||
38020718|NCT04529096|69703540|FG001|Overall Study|Physician Decision|3|||
38020719|NCT04529096|69703539|FG000|Overall Study|Withdrawal by Subject|5|||
38020720|NCT04529096|69703540|FG001|Overall Study|Withdrawal by Subject|0|||
38020721|NCT00231179|69703548|FG000|Overall Study|Lost to Follow-up|21|||
38020722|NCT00231179|69703549|FG001|Overall Study|Lost to Follow-up|21|||
38020723|NCT00231179|69703548|FG000|Overall Study|Withdrawal by Subject|3|||
38020724|NCT00231179|69703549|FG001|Overall Study|Withdrawal by Subject|3|||
38020725|NCT00229931|69703557|FG000|Overall Study|Death|1|||
38020726|NCT00229931|69703558|FG001|Overall Study|Death|0|||
38020727|NCT00229931|69703557|FG000|Overall Study|Lost to Follow-up|3|||
38020728|NCT00229931|69703558|FG001|Overall Study|Lost to Follow-up|2|||
38020729|NCT03135028|69703564|FG000|Overall Study|Death|6|||
38020730|NCT03135028|69703564|FG000|Overall Study|Study Terminated by Sponsor|2|||
38020731|NCT03135028|69703564|FG000|Overall Study|Withdrew Consent|1|||
38020732|NCT00228917|69703576|FG000|Overall Study|Migrated/moved from study area|0|||
38020733|NCT00228917|69703577|FG001|Overall Study|Migrated/moved from study area|0|||
38020734|NCT00228917|69703578|FG002|Overall Study|Migrated/moved from study area|0|||
38020735|NCT00228917|69703579|FG003|Overall Study|Migrated/moved from study area|0|||
38020736|NCT00228917|69703580|FG004|Overall Study|Migrated/moved from study area|0|||
38020737|NCT00228917|69703581|FG005|Overall Study|Migrated/moved from study area|2|||
38020738|NCT00228917|69703582|FG006|Overall Study|Migrated/moved from study area|0|||
38020739|NCT00228917|69703583|FG007|Overall Study|Migrated/moved from study area|0|||
38020740|NCT00227903|69703599|FG000|Overall Study|Withdrawal by Subject|2|||
38020741|NCT00227903|69703600|FG001|Overall Study|Withdrawal by Subject|5|||
38020742|NCT00227903|69703599|FG000|Overall Study|Subject moved out of area|1|||
38020743|NCT00227903|69703600|FG001|Overall Study|Subject moved out of area|2|||
38020744|NCT00227903|69703599|FG000|Overall Study|Lost to Follow-up|1|||
38020745|NCT00227903|69703600|FG001|Overall Study|Lost to Follow-up|3|||
38020746|NCT00227903|69703599|FG000|Overall Study|Miscarriage|1|||
38020747|NCT00227903|69703600|FG001|Overall Study|Miscarriage|0|||
38020748|NCT04411628|69703610|FG000|Overall Study|Withdrawal by Subject|1|||
38020749|NCT04411628|69703611|FG001|Overall Study|Withdrawal by Subject|1|||
38020750|NCT04411628|69703612|FG002|Overall Study|Withdrawal by Subject|2|||
38020751|NCT04411628|69703613|FG003|Overall Study|Withdrawal by Subject|0|||
38020752|NCT04411628|69703610|FG000|Overall Study|Lost to Follow-up|0|||
38020753|NCT04411628|69703611|FG001|Overall Study|Lost to Follow-up|1|||
38020754|NCT04411628|69703612|FG002|Overall Study|Lost to Follow-up|0|||
38020755|NCT04411628|69703613|FG003|Overall Study|Lost to Follow-up|0|||
38020756|NCT00227591|69703626|FG000|Overall Study|Withdrawal by Subject|1|||
38020757|NCT04512482|69703632|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
38020758|NCT04512482|69703633|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
38020759|NCT00226811|69703639|FG000|Overall Study|Death|8|||
38020760|NCT00226811|69703639|FG000|Overall Study|Adverse Event|11|||
38020761|NCT00226811|69703639|FG000|Overall Study|Lack of Efficacy|55|||
38020762|NCT00226811|69703639|FG000|Overall Study|Withdrawal by Subject|2|||
38020763|NCT02951052|69703645|FG000|Overall Study|Adverse Event|13|||
38020764|NCT02951052|69703646|FG001|Overall Study|Adverse Event|5|||
38020765|NCT02951052|69703645|FG000|Overall Study|Withdrawal by Subject|1|||
38020766|NCT02951052|69703646|FG001|Overall Study|Withdrawal by Subject|5|||
38020767|NCT02951052|69703645|FG000|Overall Study|Physician Decision|2|||
38020768|NCT02951052|69703646|FG001|Overall Study|Physician Decision|0|||
38020769|NCT02951052|69703645|FG000|Overall Study|Lost to Follow-up|1|||
38020770|NCT02951052|69703646|FG001|Overall Study|Lost to Follow-up|1|||
38020771|NCT02951052|69703645|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
38020772|NCT02951052|69703646|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
38020773|NCT02951052|69703645|FG000|Overall Study|Protocol Violation|5|||
38020774|NCT02951052|69703646|FG001|Overall Study|Protocol Violation|3|||
38020775|NCT02951052|69703645|FG000|Overall Study|Lack of Efficacy|3|||
38020776|NCT02951052|69703646|FG001|Overall Study|Lack of Efficacy|4|||
38020777|NCT02951052|69703645|FG000|Overall Study|Ongoing|1|||
38020778|NCT02951052|69703646|FG001|Overall Study|Ongoing|0|||
38020779|NCT00226655|69703656|FG000|Overall Study|Death|13|||
38020780|NCT00226655|69703656|FG000|Overall Study|Withdrawal by Subject|15|||
38020781|NCT00226655|69703656|FG000|Overall Study|Adverse Event|35|||
38020782|NCT00226655|69703656|FG000|Overall Study|Physician Decision|6|||
38020783|NCT00226655|69703656|FG000|Overall Study|Clinical deterioration|10|||
38020784|NCT03124108|69703672|FG000|Overall Study|Adverse Event|0|||
38020785|NCT03124108|69703673|FG001|Overall Study|Adverse Event|1|||
38020786|NCT03124108|69703674|FG002|Overall Study|Adverse Event|0|||
38020787|NCT04475588|69703686|FG000|Overall Study|Adverse Event|2|||
38020788|NCT04475588|69703687|FG001|Overall Study|Adverse Event|0|||
38020789|NCT04353596|69703696|FG000|Overall Study|Protocol Violation|4|||
38020790|NCT04353596|69703697|FG001|Overall Study|Protocol Violation|4|||
38020791|NCT04353596|69703696|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
38020792|NCT04353596|69703697|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
38020793|NCT04350788|69703705|FG000|Overall Study|Lost to Follow-up|6|||
38020794|NCT04350788|69703706|FG001|Overall Study|Lost to Follow-up|2|||
38020795|NCT04350788|69703705|FG000|Overall Study|Withdrawal by Subject|2|||
38020796|NCT04350788|69703706|FG001|Overall Study|Withdrawal by Subject|4|||
38020797|NCT04350788|69703705|FG000|Overall Study|Protocol Violation|4|||
38020798|NCT04350788|69703706|FG001|Overall Study|Protocol Violation|0|||
38020799|NCT03852316|69703717|FG000|Overall Study|Protocol Violation|1|||
38020800|NCT03852316|69703717|FG000|Overall Study|Withdrawal by Subject|2|||
38020801|NCT03852316|69703717|FG000|Overall Study|Enrolled but Device not Utilized|1|||
38020802|NCT04335812|69703723|FG000|Overall Study|Withdrawal by Subject|1|||
38020803|NCT04335812|69703724|FG001|Overall Study|Withdrawal by Subject|3|||
38020804|NCT04335812|69703723|FG000|Overall Study|Lost to Follow-up|12|||
38020805|NCT04335812|69703724|FG001|Overall Study|Lost to Follow-up|12|||
38020806|NCT04335812|69703723|FG000|Overall Study|Did not engage in the intervention|22|||
38020807|NCT04335812|69703724|FG001|Overall Study|Did not engage in the intervention|18|||
38020808|NCT03127384|69703730|FG000|Overall Study|Lost to Follow-up|4|||
38020809|NCT03127384|69703730|FG000|Overall Study|Subject request|2|||
38020810|NCT04398134|69703757|FG000|Overall Study|Adverse Event|0|||
38020811|NCT04398134|69703758|FG001|Overall Study|Adverse Event|0|||
38020812|NCT04398134|69703759|FG002|Overall Study|Adverse Event|1|||
38020813|NCT04398134|69703760|FG003|Overall Study|Adverse Event|0|||
38020814|NCT04398134|69703757|FG000|Overall Study|Withdrawal by Subject|2|||
37699357|NCT01625091|69176183|FG001|Intervention|Lost to Follow-up|4|||
38020815|NCT04398134|69703758|FG001|Overall Study|Withdrawal by Subject|0|||
38020816|NCT04398134|69703759|FG002|Overall Study|Withdrawal by Subject|0|||
38020817|NCT04398134|69703760|FG003|Overall Study|Withdrawal by Subject|1|||
38020818|NCT04398134|69703757|FG000|Overall Study|Study Terminated by Sponsor|30|||
38020819|NCT04398134|69703758|FG001|Overall Study|Study Terminated by Sponsor|11|||
38020820|NCT04398134|69703759|FG002|Overall Study|Study Terminated by Sponsor|32|||
38020821|NCT04398134|69703760|FG003|Overall Study|Study Terminated by Sponsor|11|||
38020822|NCT03122860|69703776|FG000|Overall Study|Discontinued Before Treatment|1|||
38020823|NCT03122860|69703777|FG001|Overall Study|Discontinued Before Treatment|1|||
37699358|NCT01625091|69176182|FG000|Intervention|Study termination|2|||
37910590|NCT00755937|69596991|FG000|Observational Follow-up|Lost to Follow-up|148|||
38020824|NCT03122860|69703778|FG002|Overall Study|Discontinued Before Treatment|2|||
38020825|NCT03122860|69703779|FG003|Overall Study|Discontinued Before Treatment|0|||
38020826|NCT03122860|69703780|FG004|Overall Study|Discontinued Before Treatment|1|||
38020827|NCT03122860|69703781|FG005|Overall Study|Discontinued Before Treatment|0|||
38020828|NCT03122860|69703776|FG000|Overall Study|Adverse Event|1|||
38020829|NCT03122860|69703777|FG001|Overall Study|Adverse Event|0|||
38020830|NCT03122860|69703778|FG002|Overall Study|Adverse Event|1|||
38020831|NCT03122860|69703779|FG003|Overall Study|Adverse Event|1|||
38020832|NCT03122860|69703780|FG004|Overall Study|Adverse Event|0|||
38020833|NCT03122860|69703781|FG005|Overall Study|Adverse Event|0|||
38020834|NCT03122860|69703776|FG000|Overall Study|Lost to Follow-up|5|||
38020835|NCT03122860|69703777|FG001|Overall Study|Lost to Follow-up|2|||
38020836|NCT03122860|69703778|FG002|Overall Study|Lost to Follow-up|3|||
38020837|NCT03122860|69703779|FG003|Overall Study|Lost to Follow-up|3|||
38020838|NCT03122860|69703780|FG004|Overall Study|Lost to Follow-up|5|||
38020839|NCT03122860|69703781|FG005|Overall Study|Lost to Follow-up|4|||
38020840|NCT03122860|69703776|FG000|Overall Study|Subject Non-Compliance|0|||
38020841|NCT03122860|69703777|FG001|Overall Study|Subject Non-Compliance|0|||
38020842|NCT03122860|69703778|FG002|Overall Study|Subject Non-Compliance|1|||
38020843|NCT03122860|69703779|FG003|Overall Study|Subject Non-Compliance|0|||
38020844|NCT03122860|69703780|FG004|Overall Study|Subject Non-Compliance|0|||
38020845|NCT03122860|69703781|FG005|Overall Study|Subject Non-Compliance|0|||
38020846|NCT03122860|69703776|FG000|Overall Study|Withdrawal by Subject|3|||
38020847|NCT03122860|69703777|FG001|Overall Study|Withdrawal by Subject|2|||
38020848|NCT03122860|69703778|FG002|Overall Study|Withdrawal by Subject|5|||
38020849|NCT03122860|69703779|FG003|Overall Study|Withdrawal by Subject|7|||
38020850|NCT03122860|69703780|FG004|Overall Study|Withdrawal by Subject|9|||
38020851|NCT03122860|69703781|FG005|Overall Study|Withdrawal by Subject|8|||
38020852|NCT03798366|69703798|FG000|Overall Study|Lost to Follow-up|0|||
38020853|NCT03798366|69703799|FG001|Overall Study|Lost to Follow-up|1|||
38020854|NCT04327388|69703808|FG000|Overall Study|Adverse Event|17|||
38020855|NCT04327388|69703809|FG001|Overall Study|Adverse Event|18|||
38020856|NCT04327388|69703810|FG002|Overall Study|Adverse Event|9|||
38020857|NCT04327388|69703808|FG000|Overall Study|Other|1|||
38020858|NCT04327388|69703809|FG001|Overall Study|Other|2|||
38020859|NCT04327388|69703810|FG002|Overall Study|Other|0|||
38020860|NCT04327388|69703808|FG000|Overall Study|Randomized and not treated|2|||
38020861|NCT04327388|69703809|FG001|Overall Study|Randomized and not treated|0|||
38020862|NCT04327388|69703810|FG002|Overall Study|Randomized and not treated|2|||
38020863|NCT03796728|69703818|FG000|Overall Study|Lost to Follow-up|8|||
38020864|NCT03796728|69703818|FG000|Overall Study|Reason not Specified|16|||
38020865|NCT00352534|69703824|FG000|Initial Staging|Ineligible|8|||
38020866|NCT00352534|69703825|FG001|Initial Staging|Ineligible|9|||
38020867|NCT00352534|69703826|FG002|Initial Staging|Ineligible|0|||
38020868|NCT00352534|69703827|FG003|Initial Staging|Ineligible|0|||
38020869|NCT00352534|69703828|FG004|Initial Staging|Ineligible|0|||
38020870|NCT00352534|69703829|FG005|Initial Staging|Ineligible|0|||
38020871|NCT00352534|69703830|FG006|Initial Staging|Ineligible|0|||
38020872|NCT00352534|69703824|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
38020873|NCT00352534|69703825|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
38020874|NCT00352534|69703826|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
38020875|NCT00352534|69703827|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
38020876|NCT00352534|69703828|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
38020877|NCT00352534|69703829|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
38020878|NCT00352534|69703830|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
38020879|NCT00352534|69703824|FG000|Final Risk Group Assignment|Physician Decision|0|||
38020880|NCT00352534|69703825|FG001|Final Risk Group Assignment|Physician Decision|0|||
38020881|NCT00352534|69703826|FG002|Final Risk Group Assignment|Physician Decision|0|||
38020882|NCT00352534|69703827|FG003|Final Risk Group Assignment|Physician Decision|0|||
38020883|NCT00352534|69703828|FG004|Final Risk Group Assignment|Physician Decision|0|||
38020884|NCT00352534|69703829|FG005|Final Risk Group Assignment|Physician Decision|8|||
38020885|NCT00352534|69703830|FG006|Final Risk Group Assignment|Physician Decision|0|||
38020886|NCT00352534|69703824|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
38020887|NCT00352534|69703825|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
38020888|NCT00352534|69703826|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
38020889|NCT00352534|69703827|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
38020890|NCT00352534|69703828|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
38020891|NCT00352534|69703829|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
38020892|NCT00352534|69703830|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
38020893|NCT00352534|69703824|FG000|Final Risk Group Assignment|Ineligible|0|||
38020894|NCT00352534|69703825|FG001|Final Risk Group Assignment|Ineligible|0|||
38020895|NCT00352534|69703826|FG002|Final Risk Group Assignment|Ineligible|3|||
38020896|NCT00352534|69703827|FG003|Final Risk Group Assignment|Ineligible|1|||
38020897|NCT00352534|69703828|FG004|Final Risk Group Assignment|Ineligible|0|||
38020898|NCT00352534|69703829|FG005|Final Risk Group Assignment|Ineligible|13|||
38020899|NCT00352534|69703830|FG006|Final Risk Group Assignment|Ineligible|0|||
38020900|NCT00352534|69703824|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
38020901|NCT00352534|69703825|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
38020902|NCT00352534|69703826|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
38020903|NCT00352534|69703827|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
38020904|NCT00352534|69703828|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
38020905|NCT00352534|69703829|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
38020906|NCT00352534|69703830|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
38020907|NCT00352534|69703824|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
38020908|NCT00352534|69703825|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
38020909|NCT00352534|69703826|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
38020910|NCT00352534|69703827|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
38020911|NCT00352534|69703828|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
38020912|NCT00352534|69703829|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
38020913|NCT00352534|69703830|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
38020914|NCT00352534|69703824|FG000|Final Risk Group Assignment|Death|0|||
38020915|NCT00352534|69703825|FG001|Final Risk Group Assignment|Death|0|||
38020916|NCT00352534|69703826|FG002|Final Risk Group Assignment|Death|0|||
38020917|NCT00352534|69703827|FG003|Final Risk Group Assignment|Death|0|||
38020918|NCT00352534|69703828|FG004|Final Risk Group Assignment|Death|0|||
38020919|NCT00352534|69703829|FG005|Final Risk Group Assignment|Death|2|||
38020920|NCT00352534|69703830|FG006|Final Risk Group Assignment|Death|0|||
38020921|NCT04323800|69703842|FG000|Overall Study|Withdrawal by Subject|4|||
38020922|NCT04323800|69703843|FG001|Overall Study|Withdrawal by Subject|4|||
38020923|NCT04323800|69703842|FG000|Overall Study|Incomplete transfusion|1|||
38020924|NCT04323800|69703843|FG001|Overall Study|Incomplete transfusion|0|||
38020925|NCT04323800|69703842|FG000|Overall Study|Other|0|||
38020926|NCT04323800|69703843|FG001|Overall Study|Other|1|||
38020927|NCT04323800|69703842|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
38020928|NCT04323800|69703843|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
38020929|NCT04321460|69703851|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
38020930|NCT04321460|69703852|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
38020931|NCT03122548|69703858|FG000|Overall Study|Death|2|||
38020932|NCT03122548|69703858|FG000|Overall Study|Progression - subject went into hospice|1|||
38020933|NCT03122548|69703858|FG000|Overall Study|Study Terminated by Sponsor|2|||
38020934|NCT04459598|69703864|FG000|Overall Study|Adverse Event|1|||
38020935|NCT04459598|69703865|FG001|Overall Study|Adverse Event|1|||
38020936|NCT02929498|69703874|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
38020937|NCT02929498|69703875|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
38020938|NCT02929498|69703876|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
38020939|NCT02929498|69703874|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
37910591|NCT00755079|69596997|FG000|Overall Study|Lost to Follow-up|1|||
37910592|NCT00755079|69596998|FG001|Overall Study|Lost to Follow-up|3|||
37910593|NCT00755079|69596997|FG000|Overall Study|Adverse Event|0|||
37910594|NCT00755079|69596998|FG001|Overall Study|Adverse Event|1|||
37910595|NCT00755079|69596997|FG000|Overall Study|Withdrawal by Subject|0|||
37910596|NCT00755079|69596998|FG001|Overall Study|Withdrawal by Subject|2|||
37910597|NCT00925301|69597006|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
37910598|NCT00925301|69597007|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
37910599|NCT00925301|69597008|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
37910600|NCT00925301|69597009|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
37910601|NCT00925301|69597006|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
37910602|NCT00925301|69597007|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
37910603|NCT00925301|69597008|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
37910604|NCT00925301|69597009|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
37910605|NCT00925301|69597006|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
38020940|NCT02929498|69703875|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
38020941|NCT02929498|69703876|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
38020942|NCT03792672|69703882|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
38020943|NCT03792672|69703883|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
38020944|NCT03792672|69703884|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
38020945|NCT03792672|69703885|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
38020946|NCT03792672|69703886|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
38020947|NCT03792672|69703887|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
38020948|NCT03792672|69703882|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
38020949|NCT03792672|69703883|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
38020950|NCT03792672|69703884|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
38020951|NCT03792672|69703885|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
38020952|NCT03792672|69703886|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
38020953|NCT03792672|69703887|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
38020954|NCT03792672|69703882|FG000|Treatment Period 4 (2 Days)|Other|1|||
38020955|NCT03792672|69703883|FG001|Treatment Period 4 (2 Days)|Other|0|||
38020956|NCT03792672|69703884|FG002|Treatment Period 4 (2 Days)|Other|0|||
38020957|NCT03792672|69703885|FG003|Treatment Period 4 (2 Days)|Other|0|||
38020958|NCT03792672|69703886|FG004|Treatment Period 4 (2 Days)|Other|0|||
37699359|NCT01625091|69176183|FG001|Intervention|Study termination|3|||
37699360|NCT01625091|69176182|FG000|Post-intervention|Death|0|||
37910606|NCT00925301|69597007|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
37910607|NCT00925301|69597008|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
37910608|NCT00925301|69597009|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
37910609|NCT00925301|69597006|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
37910610|NCT00925301|69597007|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
37910611|NCT00925301|69597008|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
37910612|NCT00925301|69597009|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
37910613|NCT00925301|69597006|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
37910614|NCT00925301|69597007|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
37910615|NCT00925301|69597008|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
37910616|NCT00925301|69597009|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
37910617|NCT00925301|69597006|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
37910618|NCT00925301|69597007|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
37910619|NCT00925301|69597008|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
37910620|NCT00925301|69597009|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
37910621|NCT00925301|69597006|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
37910622|NCT00925301|69597007|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
37910623|NCT00925301|69597008|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
37910624|NCT00925301|69597009|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
37910625|NCT00754065|69597022|FG000|Overall Study|Never received treatment|12|||
37910626|NCT00754065|69597023|FG001|Overall Study|Never received treatment|2|||
37910627|NCT00754065|69597022|FG000|Overall Study|Adverse Event|19|||
37910628|NCT00754065|69597023|FG001|Overall Study|Adverse Event|25|||
37910629|NCT00754065|69597022|FG000|Overall Study|Lost to Follow-up|7|||
37910630|NCT00754065|69597023|FG001|Overall Study|Lost to Follow-up|11|||
37910631|NCT00754065|69597022|FG000|Overall Study|Protocol Violation|12|||
37910632|NCT00754065|69597023|FG001|Overall Study|Protocol Violation|10|||
37910633|NCT00754065|69597022|FG000|Overall Study|Withdrawal by Subject|4|||
37910634|NCT00754065|69597023|FG001|Overall Study|Withdrawal by Subject|5|||
37910635|NCT00754065|69597022|FG000|Overall Study|Pregnancy|6|||
37910636|NCT00754065|69597023|FG001|Overall Study|Pregnancy|0|||
37910637|NCT00754065|69597022|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
37910638|NCT00754065|69597023|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
37910639|NCT04138056|69597043|FG000|Primary Study|Lost to Follow-up|3|||
37910640|NCT04138056|69597044|FG001|Primary Study|Lost to Follow-up|4|||
37910641|NCT04138056|69597045|FG002|Primary Study|Lost to Follow-up|1|||
37910642|NCT04138056|69597046|FG003|Primary Study|Lost to Follow-up|1|||
37910643|NCT04138056|69597047|FG004|Primary Study|Lost to Follow-up|4|||
37910644|NCT04138056|69597043|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
37910645|NCT04138056|69597044|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
37910646|NCT04138056|69597045|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
37910647|NCT04138056|69597046|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
37910648|NCT04138056|69597047|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
37910649|NCT04138056|69597043|FG000|Extension Study|Lost to Follow-up|1|||
37910650|NCT04138056|69597044|FG001|Extension Study|Lost to Follow-up|2|||
37910651|NCT04138056|69597045|FG002|Extension Study|Lost to Follow-up|1|||
38020959|NCT03792672|69703887|FG005|Treatment Period 4 (2 Days)|Other|0|||
38020960|NCT03120676|69703902|FG000|Overall Study|Not treated|1|||
38020961|NCT03120520|69703910|FG000|Overall Study|Lost to Follow-up|1|||
38020962|NCT03120520|69703911|FG001|Overall Study|Lost to Follow-up|1|||
37699361|NCT01625091|69176183|FG001|Post-intervention|Death|1|||
37910652|NCT04138056|69597046|FG003|Extension Study|Lost to Follow-up|0|||
37910653|NCT04138056|69597047|FG004|Extension Study|Lost to Follow-up|1|||
37910654|NCT00753675|69597093|FG000|Overall Study|other reason|11|||
37910655|NCT00753675|69597094|FG001|Overall Study|other reason|12|||
37910656|NCT00753675|69597095|FG002|Overall Study|other reason|13|||
37910657|NCT00753675|69597093|FG000|Overall Study|Death|1|||
37910658|NCT00753675|69597094|FG001|Overall Study|Death|2|||
37910659|NCT00753675|69597095|FG002|Overall Study|Death|4|||
37910660|NCT00753675|69597093|FG000|Overall Study|Adverse Event|11|||
37910661|NCT00753675|69597094|FG001|Overall Study|Adverse Event|9|||
37910662|NCT00753675|69597095|FG002|Overall Study|Adverse Event|4|||
37910663|NCT00753675|69597093|FG000|Overall Study|Objective progression of disease|35|||
37910664|NCT00753675|69597094|FG001|Overall Study|Objective progression of disease|35|||
38020963|NCT03120520|69703912|FG002|Overall Study|Lost to Follow-up|1|||
38020964|NCT03120520|69703913|FG003|Overall Study|Lost to Follow-up|1|||
38020965|NCT03120520|69703910|FG000|Overall Study|Withdrawal by Subject|3|||
38020966|NCT03120520|69703911|FG001|Overall Study|Withdrawal by Subject|2|||
38020967|NCT03120520|69703912|FG002|Overall Study|Withdrawal by Subject|3|||
38020968|NCT03120520|69703913|FG003|Overall Study|Withdrawal by Subject|2|||
38020969|NCT03120520|69703910|FG000|Overall Study|Other|0|||
38020970|NCT03120520|69703911|FG001|Overall Study|Other|1|||
38020971|NCT03120520|69703912|FG002|Overall Study|Other|0|||
38020972|NCT03120520|69703913|FG003|Overall Study|Other|0|||
38020973|NCT03787212|69703923|FG000|Period 1|Study Termination|2|||
38020974|NCT03787212|69703924|FG001|Period 1|Study Termination|2|||
38020975|NCT03125200|69703937|FG000|Overall Study|Study Termination|0|||
38020976|NCT03125200|69703938|FG001|Overall Study|Study Termination|0|||
38020977|NCT03125200|69703939|FG002|Overall Study|Study Termination|0|||
38020978|NCT03125200|69703940|FG003|Overall Study|Study Termination|1|||
38020979|NCT03125200|69703941|FG004|Overall Study|Study Termination|1|||
38020980|NCT03125200|69703942|FG005|Overall Study|Study Termination|2|||
38020981|NCT03125200|69703943|FG006|Overall Study|Study Termination|1|||
38020982|NCT03125200|69703937|FG000|Overall Study|Clinical Progression|0|||
38020983|NCT03125200|69703938|FG001|Overall Study|Clinical Progression|0|||
38020984|NCT03125200|69703939|FG002|Overall Study|Clinical Progression|0|||
38020985|NCT03125200|69703940|FG003|Overall Study|Clinical Progression|1|||
38020986|NCT03125200|69703941|FG004|Overall Study|Clinical Progression|0|||
38020987|NCT03125200|69703942|FG005|Overall Study|Clinical Progression|1|||
38020988|NCT03125200|69703943|FG006|Overall Study|Clinical Progression|0|||
38020989|NCT03125200|69703937|FG000|Overall Study|Progressive Disease|2|||
38020990|NCT03125200|69703938|FG001|Overall Study|Progressive Disease|1|||
38020991|NCT03125200|69703939|FG002|Overall Study|Progressive Disease|2|||
38020992|NCT03125200|69703940|FG003|Overall Study|Progressive Disease|1|||
38020993|NCT03125200|69703941|FG004|Overall Study|Progressive Disease|2|||
38020994|NCT03125200|69703942|FG005|Overall Study|Progressive Disease|0|||
38020995|NCT03125200|69703943|FG006|Overall Study|Progressive Disease|1|||
38020996|NCT03125200|69703937|FG000|Overall Study|Lack of Efficacy|0|||
38020997|NCT03125200|69703938|FG001|Overall Study|Lack of Efficacy|0|||
38020998|NCT03125200|69703939|FG002|Overall Study|Lack of Efficacy|0|||
37699362|NCT01625091|69176182|FG000|Post-intervention|Lost to Follow-up|2|||
37910665|NCT00753675|69597095|FG002|Overall Study|Objective progression of disease|35|||
37910666|NCT00753675|69597093|FG000|Overall Study|Withdrawal by Subject|0|||
37910667|NCT00753675|69597094|FG001|Overall Study|Withdrawal by Subject|1|||
37910668|NCT00753675|69597095|FG002|Overall Study|Withdrawal by Subject|0|||
38020999|NCT03125200|69703940|FG003|Overall Study|Lack of Efficacy|1|||
38021000|NCT03125200|69703941|FG004|Overall Study|Lack of Efficacy|0|||
38021001|NCT03125200|69703942|FG005|Overall Study|Lack of Efficacy|0|||
38021002|NCT03125200|69703943|FG006|Overall Study|Lack of Efficacy|0|||
38021003|NCT03125200|69703937|FG000|Overall Study|Toxicity|0|||
38021004|NCT03125200|69703938|FG001|Overall Study|Toxicity|0|||
38021005|NCT03125200|69703939|FG002|Overall Study|Toxicity|0|||
38021006|NCT03125200|69703940|FG003|Overall Study|Toxicity|1|||
38021007|NCT03125200|69703941|FG004|Overall Study|Toxicity|0|||
38021008|NCT03125200|69703942|FG005|Overall Study|Toxicity|0|||
38021009|NCT03125200|69703943|FG006|Overall Study|Toxicity|0|||
38021010|NCT03125200|69703937|FG000|Overall Study|Consent Withdrawn by Subject|0|||
38021011|NCT03125200|69703938|FG001|Overall Study|Consent Withdrawn by Subject|1|||
38021012|NCT03125200|69703939|FG002|Overall Study|Consent Withdrawn by Subject|0|||
38021013|NCT03125200|69703940|FG003|Overall Study|Consent Withdrawn by Subject|0|||
38021014|NCT03125200|69703941|FG004|Overall Study|Consent Withdrawn by Subject|1|||
38021015|NCT03125200|69703942|FG005|Overall Study|Consent Withdrawn by Subject|0|||
38021016|NCT03125200|69703943|FG006|Overall Study|Consent Withdrawn by Subject|1|||
38021017|NCT03132220|69703964|FG000|Overall Study|Lost to Follow-up|17|||
38021018|NCT03132220|69703965|FG001|Overall Study|Lost to Follow-up|8|||
38021019|NCT03132220|69703964|FG000|Overall Study|Withdrawal by Subject|1|||
38021020|NCT03132220|69703965|FG001|Overall Study|Withdrawal by Subject|4|||
38021021|NCT03119662|69703973|FG000|Overall Study|Withdrawal by Subject|0|||
38021022|NCT03119662|69703974|FG001|Overall Study|Withdrawal by Subject|1|||
38021023|NCT02728804|69703980|FG000|Overall Study|Ineligible|3|||
38021024|NCT02728804|69703980|FG000|Overall Study|Did not complete baseline questionnaire|9|||
38021025|NCT02728804|69703980|FG000|Overall Study|Death|99|||
38021026|NCT02699554|69703996|FG000|Overall Study|Lost to Follow-up|9|||
38021027|NCT03783780|69704010|FG000|Overall Study|Withdrawn prior to completion|1|||
38021028|NCT03783702|69704017|FG000|Overall Study|Lost to Follow-up|6|||
38021029|NCT03783702|69704018|FG001|Overall Study|Lost to Follow-up|8|||
38021030|NCT03783702|69704017|FG000|Overall Study|Protocol Violation|1|||
38021031|NCT03783702|69704018|FG001|Overall Study|Protocol Violation|3|||
38021032|NCT03575572|69704026|FG000|Overall Study|Withdrawal by Subject|2|||
38021033|NCT03575572|69704026|FG000|Overall Study|Physician Decision|2|||
38021034|NCT03116698|69704052|FG000|Overall Study|Adverse Event|1|||
38021035|NCT03116698|69704053|FG001|Overall Study|Adverse Event|1|||
38021036|NCT03116698|69704054|FG002|Overall Study|Adverse Event|1|||
38021037|NCT03116698|69704055|FG003|Overall Study|Adverse Event|0|||
38021038|NCT03116698|69704052|FG000|Overall Study|Withdrawal by Subject|1|||
38021039|NCT03116698|69704053|FG001|Overall Study|Withdrawal by Subject|4|||
38021040|NCT03116698|69704054|FG002|Overall Study|Withdrawal by Subject|5|||
38021041|NCT03116698|69704055|FG003|Overall Study|Withdrawal by Subject|2|||
38021042|NCT03116698|69704052|FG000|Overall Study|Lost to Follow-up|2|||
37699363|NCT01625091|69176183|FG001|Post-intervention|Lost to Follow-up|0|||
37699364|NCT01625091|69176182|FG000|Post-intervention|Study termination|2|||
37699365|NCT01625091|69176183|FG001|Post-intervention|Study termination|1|||
37699366|NCT02396849|69176191|FG000|Overall Study|Lost to Follow-up|1|||
37910669|NCT00753675|69597093|FG000|Overall Study|Lost to Follow-up|1|||
37910670|NCT00753675|69597094|FG001|Overall Study|Lost to Follow-up|0|||
37910671|NCT00753675|69597095|FG002|Overall Study|Lost to Follow-up|0|||
37910672|NCT00586521|69597103|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
37910673|NCT00923273|69597112|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
37910674|NCT00923273|69597113|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
37910675|NCT00923273|69597114|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
37910676|NCT00923273|69597115|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
37910677|NCT00923273|69597116|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
37910678|NCT00923273|69597112|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
37910679|NCT00923273|69597113|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
37910680|NCT00923273|69597114|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
37910681|NCT00923273|69597115|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
37910682|NCT00923273|69597116|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
37910683|NCT00923195|69597136|FG000|Overall Study|Death|0|||
37910684|NCT00923195|69597137|FG001|Overall Study|Death|1|||
37910685|NCT00753519|69597145|FG000|Overall Study|Withdrawal by Subject|0|||
37699367|NCT02396849|69176192|FG001|Overall Study|Lost to Follow-up|1|||
38021043|NCT03116698|69704053|FG001|Overall Study|Lost to Follow-up|0|||
38021044|NCT03116698|69704054|FG002|Overall Study|Lost to Follow-up|0|||
38021045|NCT03116698|69704055|FG003|Overall Study|Lost to Follow-up|0|||
38021046|NCT03116698|69704052|FG000|Overall Study|Physician Decision|1|||
38021047|NCT03116698|69704053|FG001|Overall Study|Physician Decision|1|||
38021048|NCT03116698|69704054|FG002|Overall Study|Physician Decision|0|||
38021049|NCT03116698|69704055|FG003|Overall Study|Physician Decision|0|||
38021050|NCT03116698|69704052|FG000|Overall Study|Protocol Violation|1|||
38021051|NCT03116698|69704053|FG001|Overall Study|Protocol Violation|0|||
38021052|NCT03116698|69704054|FG002|Overall Study|Protocol Violation|0|||
38021053|NCT03116698|69704055|FG003|Overall Study|Protocol Violation|0|||
38021054|NCT03116698|69704052|FG000|Overall Study|Death|0|||
38021055|NCT03116698|69704053|FG001|Overall Study|Death|0|||
38021056|NCT03116698|69704054|FG002|Overall Study|Death|2|||
38021057|NCT03116698|69704055|FG003|Overall Study|Death|0|||
38021058|NCT03116152|69704067|FG000|Overall Study|Disease Progression|49|||
38021059|NCT03116152|69704068|FG001|Overall Study|Disease Progression|47|||
38021060|NCT03116152|69704067|FG000|Overall Study|Death|5|||
38021061|NCT03116152|69704068|FG001|Overall Study|Death|2|||
38021062|NCT03116152|69704067|FG000|Overall Study|Adverse Event|21|||
38021063|NCT03116152|69704068|FG001|Overall Study|Adverse Event|7|||
38021064|NCT03116152|69704067|FG000|Overall Study|Protocol Violation|2|||
38021065|NCT03116152|69704068|FG001|Overall Study|Protocol Violation|2|||
38021066|NCT03116152|69704067|FG000|Overall Study|Withdrawal by Subject|0|||
38021067|NCT03116152|69704068|FG001|Overall Study|Withdrawal by Subject|1|||
38021068|NCT03116152|69704067|FG000|Overall Study|Physician Decision|3|||
38021069|NCT03116152|69704068|FG001|Overall Study|Physician Decision|2|||
38021070|NCT03116152|69704067|FG000|Overall Study|other|11|||
38021071|NCT03116152|69704068|FG001|Overall Study|other|34|||
38021072|NCT00226499|69704079|FG000|Overall Study|Adverse Event|10|||
38021073|NCT00226499|69704080|FG001|Overall Study|Adverse Event|6|||
38021074|NCT00226499|69704081|FG002|Overall Study|Adverse Event|3|||
38021075|NCT00226499|69704079|FG000|Overall Study|Others|1064|||
38021076|NCT00226499|69704080|FG001|Overall Study|Others|1066|||
38021077|NCT00226499|69704081|FG002|Overall Study|Others|356|||
38021078|NCT01400776|69704095|FG000|Overall Study|Adverse Event|7|||
38021079|NCT01400776|69704096|FG001|Overall Study|Adverse Event|2|||
38021080|NCT01400776|69704097|FG002|Overall Study|Adverse Event|9|||
38021081|NCT01400776|69704098|FG003|Overall Study|Adverse Event|2|||
38021082|NCT01400776|69704095|FG000|Overall Study|Lost to Follow-up|1|||
38021083|NCT01400776|69704096|FG001|Overall Study|Lost to Follow-up|0|||
38021084|NCT01400776|69704097|FG002|Overall Study|Lost to Follow-up|4|||
38021085|NCT01400776|69704098|FG003|Overall Study|Lost to Follow-up|1|||
38021086|NCT01400776|69704095|FG000|Overall Study|Withdrew Consent|4|||
38021087|NCT01400776|69704096|FG001|Overall Study|Withdrew Consent|2|||
38021088|NCT01400776|69704097|FG002|Overall Study|Withdrew Consent|6|||
38021089|NCT01400776|69704098|FG003|Overall Study|Withdrew Consent|1|||
38021090|NCT01400776|69704095|FG000|Overall Study|Protocol Deviation|6|||
38021091|NCT01400776|69704096|FG001|Overall Study|Protocol Deviation|1|||
38021092|NCT01400776|69704097|FG002|Overall Study|Protocol Deviation|5|||
38021093|NCT01400776|69704098|FG003|Overall Study|Protocol Deviation|2|||
38021094|NCT01400776|69704095|FG000|Overall Study|Reason not Specified|3|||
38021095|NCT01400776|69704096|FG001|Overall Study|Reason not Specified|0|||
38021096|NCT01400776|69704097|FG002|Overall Study|Reason not Specified|4|||
38021097|NCT01400776|69704098|FG003|Overall Study|Reason not Specified|3|||
38021098|NCT03131596|69704110|FG000|Overall Study|Protocol Violation|3|||
38021099|NCT03131596|69704111|FG001|Overall Study|Protocol Violation|3|||
38021100|NCT03131596|69704110|FG000|Overall Study|Lost to Follow-up|3|||
38021101|NCT03131596|69704111|FG001|Overall Study|Lost to Follow-up|0|||
38021102|NCT00255047|69704125|FG000|Overall Study|Serious Adverse Events|2|||
38021103|NCT00255047|69704126|FG001|Overall Study|Serious Adverse Events|1|||
38021104|NCT00255047|69704127|FG002|Overall Study|Serious Adverse Events|2|||
38021105|NCT00255047|69704128|FG003|Overall Study|Serious Adverse Events|1|||
38021106|NCT00255047|69704125|FG000|Overall Study|Adverse Event|0|||
38021107|NCT00255047|69704126|FG001|Overall Study|Adverse Event|3|||
38021108|NCT00255047|69704127|FG002|Overall Study|Adverse Event|2|||
38021109|NCT00255047|69704128|FG003|Overall Study|Adverse Event|1|||
38021110|NCT00255047|69704125|FG000|Overall Study|Protocol Violation|13|||
38021111|NCT00255047|69704126|FG001|Overall Study|Protocol Violation|13|||
38021112|NCT00255047|69704127|FG002|Overall Study|Protocol Violation|16|||
38021113|NCT00255047|69704128|FG003|Overall Study|Protocol Violation|20|||
38021114|NCT00255047|69704125|FG000|Overall Study|Lost to Follow-up|9|||
38021115|NCT00255047|69704126|FG001|Overall Study|Lost to Follow-up|8|||
38021116|NCT00255047|69704127|FG002|Overall Study|Lost to Follow-up|5|||
38021117|NCT00255047|69704128|FG003|Overall Study|Lost to Follow-up|6|||
38021118|NCT00255047|69704125|FG000|Overall Study|Withdrawal by Subject|24|||
38021119|NCT00255047|69704126|FG001|Overall Study|Withdrawal by Subject|23|||
38021120|NCT00255047|69704127|FG002|Overall Study|Withdrawal by Subject|25|||
38021121|NCT00255047|69704128|FG003|Overall Study|Withdrawal by Subject|18|||
38021122|NCT00225251|69704140|FG000|Overall Study|Withdrawal by Subject|1|||
38021123|NCT00225251|69704141|FG001|Overall Study|Withdrawal by Subject|1|||
38021124|NCT00254501|69704149|FG000|Overall Study|Lost to Follow-up|1|||
38021125|NCT00254501|69704150|FG001|Overall Study|Lost to Follow-up|1|||
38021126|NCT00253643|69704162|FG000|Overall Study|Withdrawal by Subject|0|||
38021127|NCT00253643|69704163|FG001|Overall Study|Withdrawal by Subject|0|||
38021128|NCT00253643|69704164|FG002|Overall Study|Withdrawal by Subject|1|||
38021129|NCT00253643|69704165|FG003|Overall Study|Withdrawal by Subject|1|||
38021130|NCT00253643|69704162|FG000|Overall Study|Non-Compliance|0|||
38021131|NCT00253643|69704163|FG001|Overall Study|Non-Compliance|0|||
38021132|NCT00253643|69704164|FG002|Overall Study|Non-Compliance|0|||
38021133|NCT00253643|69704165|FG003|Overall Study|Non-Compliance|2|||
38021134|NCT00221195|69704177|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
38021135|NCT00221195|69704178|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
38021136|NCT00221195|69704177|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
38021137|NCT00221195|69704178|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
38021138|NCT00221195|69704177|FG000|Washout Period (Months 7-9)|Death|0|||
38021139|NCT00221195|69704178|FG001|Washout Period (Months 7-9)|Death|1|||
38021140|NCT00221195|69704177|FG000|Therapy 2 (Months 10-15)|Death|1|||
38021141|NCT00221195|69704178|FG001|Therapy 2 (Months 10-15)|Death|0|||
38021142|NCT00221195|69704177|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
38021143|NCT00221195|69704178|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
38021144|NCT00220805|69704187|FG000|Overall Study|Adverse Event|1|||
37910686|NCT00753519|69597146|FG001|Overall Study|Withdrawal by Subject|2|||
37910687|NCT00919061|69597154|FG000|Overall Study|Adverse Event|1|||
37910688|NCT00919061|69597154|FG000|Overall Study|Withdrawal by Subject|1|||
37910689|NCT00747435|69597158|FG000|Overall Study|Lost to Follow-up|2|||
37910690|NCT00747435|69597158|FG000|Overall Study|Withdrawal by Subject|3|||
37910691|NCT00747435|69597158|FG000|Overall Study|Still undergoing follow up|1|||
37910692|NCT00918749|69597165|FG000|Overall Study|Adverse Event|1|||
37910693|NCT00918749|69597166|FG001|Overall Study|Adverse Event|0|||
37910694|NCT00918749|69597167|FG002|Overall Study|Adverse Event|1|||
37910695|NCT00918749|69597165|FG000|Overall Study|Lost to Follow-up|0|||
37910696|NCT00918749|69597166|FG001|Overall Study|Lost to Follow-up|0|||
37910697|NCT00918749|69597167|FG002|Overall Study|Lost to Follow-up|1|||
37910698|NCT00918749|69597165|FG000|Overall Study|Withdrawal by Subject|5|||
38021145|NCT00220805|69704188|FG001|Overall Study|Adverse Event|3|||
37910699|NCT00918749|69597166|FG001|Overall Study|Withdrawal by Subject|3|||
37910700|NCT00918749|69597167|FG002|Overall Study|Withdrawal by Subject|5|||
38021146|NCT00220805|69704187|FG000|Overall Study|Withdrawal by Subject|3|||
38021147|NCT00220805|69704188|FG001|Overall Study|Withdrawal by Subject|0|||
38021148|NCT00220805|69704187|FG000|Overall Study|Lack of Efficacy|1|||
37910701|NCT00918749|69597165|FG000|Overall Study|No Study Medication Taken|1|||
37910702|NCT00918749|69597166|FG001|Overall Study|No Study Medication Taken|0|||
37910703|NCT00918749|69597167|FG002|Overall Study|No Study Medication Taken|0|||
38021149|NCT00220805|69704188|FG001|Overall Study|Lack of Efficacy|0|||
38021150|NCT00220805|69704187|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
38021151|NCT00220805|69704188|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
38021152|NCT00220727|69704196|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
38021153|NCT00220727|69704197|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
38021154|NCT03971357|69704207|FG000|Overall Study|Lack of Efficacy|0|||
38021155|NCT03971357|69704208|FG001|Overall Study|Lack of Efficacy|1|||
38021156|NCT04310566|69704214|FG000|Period 1|Study Termination due to COVID-19|15|||
38021157|NCT04310566|69704215|FG001|Period 1|Study Termination due to COVID-19|17|||
38021158|NCT04310566|69704214|FG000|Period 1|Protocol Violation|0|||
38021159|NCT04310566|69704215|FG001|Period 1|Protocol Violation|1|||
38021160|NCT04310566|69704214|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
38021161|NCT04310566|69704215|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
38021162|NCT04310566|69704214|FG000|Period 1|Lost to Follow-up|1|||
38021163|NCT04310566|69704215|FG001|Period 1|Lost to Follow-up|0|||
38021164|NCT04310566|69704214|FG000|Period 1|Withdrawal by Subject|0|||
38021165|NCT04310566|69704215|FG001|Period 1|Withdrawal by Subject|1|||
38021166|NCT04310566|69704214|FG000|Period 2|Study Termination|7|||
38021167|NCT04310566|69704215|FG001|Period 2|Study Termination|5|||
38021168|NCT00252239|69704225|FG000|Overall Study|Withdrawal by Subject|1|||
38021169|NCT00252239|69704226|FG001|Overall Study|Withdrawal by Subject|0|||
38021170|NCT00252239|69704227|FG002|Overall Study|Withdrawal by Subject|0|||
38021171|NCT00252239|69704228|FG003|Overall Study|Withdrawal by Subject|1|||
38021172|NCT00252239|69704225|FG000|Overall Study|Lost to Follow-up|0|||
38021173|NCT00252239|69704226|FG001|Overall Study|Lost to Follow-up|0|||
38021174|NCT00252239|69704227|FG002|Overall Study|Lost to Follow-up|2|||
38021175|NCT00252239|69704228|FG003|Overall Study|Lost to Follow-up|0|||
38021176|NCT03103906|69704240|FG000|Overall Study|Adverse Event|2|||
38021177|NCT03103906|69704241|FG001|Overall Study|Adverse Event|3|||
38021178|NCT03103906|69704240|FG000|Overall Study|Other|2|||
38021179|NCT03103906|69704241|FG001|Overall Study|Other|0|||
38021180|NCT04799158|69704251|FG000|Run-In Period|Adverse Event|6|||
38021181|NCT04799158|69704252|FG001|Run-In Period|Adverse Event|0|||
38021182|NCT04799158|69704253|FG002|Run-In Period|Adverse Event|0|||
38021183|NCT04799158|69704254|FG003|Run-In Period|Adverse Event|0|||
38021184|NCT04799158|69704255|FG004|Run-In Period|Adverse Event|0|||
38021185|NCT04799158|69704251|FG000|Run-In Period|Lost to Follow-up|4|||
38021186|NCT04799158|69704252|FG001|Run-In Period|Lost to Follow-up|0|||
38021187|NCT04799158|69704253|FG002|Run-In Period|Lost to Follow-up|0|||
38021188|NCT04799158|69704254|FG003|Run-In Period|Lost to Follow-up|0|||
38021189|NCT04799158|69704255|FG004|Run-In Period|Lost to Follow-up|0|||
38021190|NCT04799158|69704251|FG000|Run-In Period|Significant Protocol Deviation|1|||
38021191|NCT04799158|69704252|FG001|Run-In Period|Significant Protocol Deviation|0|||
38021192|NCT04799158|69704253|FG002|Run-In Period|Significant Protocol Deviation|0|||
38021193|NCT04799158|69704254|FG003|Run-In Period|Significant Protocol Deviation|0|||
38021194|NCT04799158|69704255|FG004|Run-In Period|Significant Protocol Deviation|0|||
38021195|NCT04799158|69704251|FG000|Run-In Period|Withdrawal by Subject|11|||
38021196|NCT04799158|69704252|FG001|Run-In Period|Withdrawal by Subject|0|||
37699368|NCT02396849|69176191|FG000|Overall Study|Did not tolerate intervention|1|||
38021197|NCT04799158|69704253|FG002|Run-In Period|Withdrawal by Subject|0|||
38021198|NCT04799158|69704254|FG003|Run-In Period|Withdrawal by Subject|0|||
38021199|NCT04799158|69704255|FG004|Run-In Period|Withdrawal by Subject|0|||
38021200|NCT04799158|69704251|FG000|Run-In Period|Miscellaneous|3|||
37910704|NCT00746733|69597175|FG000|Second Intervention|Adverse Event|1|||
38021201|NCT04799158|69704252|FG001|Run-In Period|Miscellaneous|0|||
37699369|NCT02396849|69176192|FG001|Overall Study|Did not tolerate intervention|1|||
37910705|NCT00746733|69597176|FG001|Second Intervention|Adverse Event|0|||
37910706|NCT00746733|69597175|FG000|Third Intervention|Withdrawal by Subject|1|||
37699370|NCT02370251|69176200|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
37910707|NCT00746733|69597176|FG001|Third Intervention|Withdrawal by Subject|1|||
37910708|NCT00745875|69597191|FG000|Overall Study|Continuing study treatment|4|||
37910709|NCT00745875|69597192|FG001|Overall Study|Continuing study treatment|4|||
37910710|NCT00555217|69597200|FG000|Overall Study|Withdrawal by Subject|35|||
37910711|NCT00555217|69597201|FG001|Overall Study|Withdrawal by Subject|31|||
37910712|NCT00555217|69597200|FG000|Overall Study|Lost to Follow-up|19|||
37910713|NCT00555217|69597201|FG001|Overall Study|Lost to Follow-up|20|||
37910714|NCT00555217|69597200|FG000|Overall Study|close out sites|21|||
37910715|NCT00555217|69597201|FG001|Overall Study|close out sites|17|||
37910716|NCT00745251|69597209|FG000|Overall Study|Adverse Event|1|||
37910717|NCT00745251|69597210|FG001|Overall Study|Adverse Event|2|||
37910718|NCT00745251|69597209|FG000|Overall Study|Withdrawal by Subject|1|||
37910719|NCT00745251|69597210|FG001|Overall Study|Withdrawal by Subject|1|||
37910720|NCT00745095|69597222|FG000|Overall Study|Declined to participate|1|||
37910721|NCT00745095|69597223|FG001|Overall Study|Declined to participate|0|||
37910722|NCT00745095|69597224|FG002|Overall Study|Declined to participate|0|||
37910723|NCT00745095|69597225|FG003|Overall Study|Declined to participate|0|||
37910724|NCT00745095|69597226|FG004|Overall Study|Declined to participate|92|||
37910725|NCT00745095|69597227|FG005|Overall Study|Declined to participate|95|||
37910726|NCT00745095|69597222|FG000|Overall Study|Ineligible due to GFR criteria|0|||
37910727|NCT00745095|69597223|FG001|Overall Study|Ineligible due to GFR criteria|2|||
37910728|NCT00745095|69597224|FG002|Overall Study|Ineligible due to GFR criteria|3|||
38021202|NCT04799158|69704253|FG002|Run-In Period|Miscellaneous|0|||
38021203|NCT04799158|69704254|FG003|Run-In Period|Miscellaneous|0|||
38021204|NCT04799158|69704255|FG004|Run-In Period|Miscellaneous|0|||
37699371|NCT02370251|69176200|FG000|Overall Study|Death|4|||
38021205|NCT04799158|69704251|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
37699372|NCT02396537|69176206|FG000|Overall Study|Protocol Violation|0|||
37699373|NCT02396537|69176207|FG001|Overall Study|Protocol Violation|1|||
37699374|NCT02342171|69176215|FG000|Overall Study|Death|4|||
37699375|NCT02342171|69176216|FG001|Overall Study|Death|87|||
37699376|NCT02342171|69176215|FG000|Overall Study|Received favipiravir|10|||
37699377|NCT02342171|69176216|FG001|Overall Study|Received favipiravir|0|||
37699378|NCT02342171|69176215|FG000|Overall Study|Missing cycle treshold value|1|||
38021206|NCT04799158|69704252|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
37910729|NCT00745095|69597225|FG003|Overall Study|Ineligible due to GFR criteria|3|||
37910730|NCT00745095|69597226|FG004|Overall Study|Ineligible due to GFR criteria|30|||
37910731|NCT00745095|69597227|FG005|Overall Study|Ineligible due to GFR criteria|28|||
37910732|NCT00744939|69597248|FG000|Overall Study|Withdrawal by Subject|9|||
37910733|NCT00744939|69597248|FG000|Overall Study|Protocol Violation|13|||
37910734|NCT00744939|69597248|FG000|Overall Study|Death|24|||
37910735|NCT00744939|69597248|FG000|Overall Study|distance|4|||
37910736|NCT00744939|69597248|FG000|Overall Study|Lost to Follow-up|12|||
37910737|NCT00744939|69597248|FG000|Overall Study|Medical history exclusionary|1|||
37910738|NCT00744939|69597248|FG000|Overall Study|Did not receive Magnevist|7|||
37910739|NCT00744939|69597248|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
37910740|NCT00744939|69597248|FG000|Overall Study|coma|1|||
37910741|NCT00744939|69597248|FG000|Overall Study|incorrect race|1|||
37910742|NCT00744861|69597264|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
37910743|NCT00744861|69597265|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
37910744|NCT00744861|69597266|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
37910745|NCT00744861|69597267|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
37910746|NCT00744861|69597264|FG000|Feasibility Stage 1|Pregnancy|0|||
37910747|NCT00744861|69597265|FG001|Feasibility Stage 1|Pregnancy|1|||
37910748|NCT00744861|69597266|FG002|Feasibility Stage 1|Pregnancy|0|||
37910749|NCT00744861|69597267|FG003|Feasibility Stage 1|Pregnancy|0|||
37910750|NCT00744861|69597264|FG000|Pivotal Stage 2|Adverse Event|0|||
37910751|NCT00744861|69597265|FG001|Pivotal Stage 2|Adverse Event|0|||
37910752|NCT00744861|69597266|FG002|Pivotal Stage 2|Adverse Event|6|||
37910753|NCT00744861|69597267|FG003|Pivotal Stage 2|Adverse Event|11|||
37910754|NCT00744861|69597264|FG000|Pivotal Stage 2|Death|0|||
37910755|NCT00744861|69597265|FG001|Pivotal Stage 2|Death|0|||
38021207|NCT04799158|69704253|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
37910756|NCT00744861|69597266|FG002|Pivotal Stage 2|Death|0|||
37910757|NCT00744861|69597267|FG003|Pivotal Stage 2|Death|1|||
37910758|NCT00744861|69597264|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
37910759|NCT00744861|69597265|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
37910760|NCT00744861|69597266|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
37910761|NCT00744861|69597267|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
37910762|NCT00744861|69597264|FG000|Pivotal Stage 2|Physician Decision|0|||
37910763|NCT00744861|69597265|FG001|Pivotal Stage 2|Physician Decision|0|||
37910764|NCT00744861|69597266|FG002|Pivotal Stage 2|Physician Decision|3|||
37910765|NCT00744861|69597267|FG003|Pivotal Stage 2|Physician Decision|1|||
37910766|NCT00744861|69597264|FG000|Pivotal Stage 2|Protocol Violation|0|||
37910767|NCT00744861|69597265|FG001|Pivotal Stage 2|Protocol Violation|0|||
37910768|NCT00744861|69597266|FG002|Pivotal Stage 2|Protocol Violation|0|||
37910769|NCT00744861|69597267|FG003|Pivotal Stage 2|Protocol Violation|1|||
37910770|NCT00744861|69597264|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
37832926|NCT01259713|69516521|FG000|Overall Study|Protocol Violation|5|||
37832927|NCT01259713|69516522|FG001|Overall Study|Protocol Violation|4|||
38021208|NCT04799158|69704254|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
38021209|NCT04799158|69704255|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
38021210|NCT04799158|69704251|FG000|On-Demand Treatment Period|Adverse Event|0|||
38021211|NCT04799158|69704252|FG001|On-Demand Treatment Period|Adverse Event|1|||
38021212|NCT04799158|69704253|FG002|On-Demand Treatment Period|Adverse Event|0|||
38021213|NCT04799158|69704254|FG003|On-Demand Treatment Period|Adverse Event|0|||
38021214|NCT04799158|69704255|FG004|On-Demand Treatment Period|Adverse Event|1|||
38021215|NCT04799158|69704251|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
38021216|NCT04799158|69704252|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
38021217|NCT04799158|69704253|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
38021218|NCT04799158|69704254|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
38021219|NCT04799158|69704255|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
38021220|NCT04799158|69704251|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
38021221|NCT04799158|69704252|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
38021222|NCT04799158|69704253|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
38021223|NCT04799158|69704254|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
38021224|NCT04799158|69704255|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
38021225|NCT04799158|69704251|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
38021226|NCT04799158|69704252|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
38021227|NCT04799158|69704253|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
38021228|NCT04799158|69704254|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
38021229|NCT04799158|69704255|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
38021230|NCT04799158|69704251|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
38021231|NCT04799158|69704252|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
38021232|NCT04799158|69704253|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
38021233|NCT04799158|69704254|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
38021234|NCT04799158|69704255|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
38021235|NCT04799158|69704251|FG000|On-Demand Treatment Period|Miscellaneous|0|||
38021236|NCT04799158|69704252|FG001|On-Demand Treatment Period|Miscellaneous|0|||
37832928|NCT01259713|69516521|FG000|Overall Study|Subject Withdrew Consent|12|||
37832929|NCT01259713|69516522|FG001|Overall Study|Subject Withdrew Consent|7|||
38021237|NCT04799158|69704253|FG002|On-Demand Treatment Period|Miscellaneous|0|||
37832930|NCT01259401|69516530|FG000|4-month Follow-up|Death|0|||
37832931|NCT01259401|69516531|FG001|4-month Follow-up|Death|1|||
37832932|NCT01259401|69516530|FG000|4-month Follow-up|Lost to Follow-up|0|||
37832933|NCT01259401|69516531|FG001|4-month Follow-up|Lost to Follow-up|1|||
37832934|NCT01313923|69516546|FG000|Overall Study|Physician Decision|3|||
37832935|NCT01313884|69516550|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
37832936|NCT01135459|69516556|FG000|Overall Study|Adverse Event|8|||
37832937|NCT01135459|69516557|FG001|Overall Study|Adverse Event|10|||
37832938|NCT01135459|69516556|FG000|Overall Study|Lack of Efficacy|3|||
37832939|NCT01135459|69516557|FG001|Overall Study|Lack of Efficacy|1|||
37832940|NCT01135459|69516556|FG000|Overall Study|Withdrawal by Subject|2|||
37832941|NCT01135459|69516557|FG001|Overall Study|Withdrawal by Subject|3|||
37832942|NCT01135459|69516556|FG000|Overall Study|Protocol Violation|5|||
37832943|NCT01135459|69516557|FG001|Overall Study|Protocol Violation|3|||
37832944|NCT01135459|69516556|FG000|Overall Study|Lost to Follow-up|2|||
37832945|NCT01135459|69516557|FG001|Overall Study|Lost to Follow-up|1|||
37832946|NCT01135459|69516556|FG000|Overall Study|Non-compliance to study procedures|0|||
37832947|NCT01135459|69516557|FG001|Overall Study|Non-compliance to study procedures|1|||
37832948|NCT01135459|69516556|FG000|Overall Study|Other than specified|1|||
37832949|NCT01135459|69516557|FG001|Overall Study|Other than specified|1|||
37832950|NCT01259284|69516566|FG000|Overall Study|Study Termination|2|||
37832951|NCT01259284|69516567|FG001|Overall Study|Study Termination|0|||
37832952|NCT01259284|69516568|FG002|Overall Study|Study Termination|0|||
37910771|NCT00744861|69597265|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
37910772|NCT00744861|69597266|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
37910773|NCT00744861|69597267|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
37910774|NCT00744861|69597264|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
37910775|NCT00744861|69597265|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
37910776|NCT00744861|69597266|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
37910777|NCT00744861|69597267|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
37832953|NCT01259245|69516578|FG000|Overall Study|Withdrawal by Subject|27|||
37832954|NCT01259245|69516579|FG001|Overall Study|Withdrawal by Subject|24|||
37832955|NCT01259245|69516578|FG000|Overall Study|Death|1|||
37832956|NCT01259245|69516579|FG001|Overall Study|Death|2|||
37832957|NCT01259089|69516587|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
37910778|NCT03969589|69597277|FG000|Overall Study|Lost to Follow-up|3|||
37910779|NCT03969589|69597278|FG001|Overall Study|Lost to Follow-up|2|||
37910780|NCT03969589|69597277|FG000|Overall Study|Declined Follow-Up|0|||
37910781|NCT03969589|69597278|FG001|Overall Study|Declined Follow-Up|1|||
37910782|NCT00744627|69597286|FG000|Overall Study|Adverse Event|6|||
37910783|NCT00744627|69597287|FG001|Overall Study|Adverse Event|9|||
37910784|NCT00744627|69597286|FG000|Overall Study|Lack of Efficacy|7|||
37910785|NCT00744627|69597287|FG001|Overall Study|Lack of Efficacy|3|||
37910786|NCT00744627|69597286|FG000|Overall Study|Noncompliance|0|||
37910787|NCT00744627|69597287|FG001|Overall Study|Noncompliance|1|||
37910788|NCT00744627|69597286|FG000|Overall Study|Protocol Deviations|0|||
37910789|NCT00744627|69597287|FG001|Overall Study|Protocol Deviations|2|||
37910790|NCT00744627|69597286|FG000|Overall Study|Voluntary Withdrawal|9|||
37910791|NCT00744627|69597287|FG001|Overall Study|Voluntary Withdrawal|6|||
37910792|NCT00744627|69597286|FG000|Overall Study|Lost to Follow-up|2|||
37910793|NCT00744627|69597287|FG001|Overall Study|Lost to Follow-up|1|||
37910794|NCT00744627|69597286|FG000|Overall Study|Other|1|||
37910795|NCT00744627|69597287|FG001|Overall Study|Other|0|||
37910796|NCT03959137|69597293|FG000|Overall Study|Protocol Violation|6|||
37910797|NCT00562627|69597300|FG000|Overall Study|Protocol Violation|1|||
37910798|NCT00562627|69597301|FG001|Overall Study|Protocol Violation|1|||
37910799|NCT00562627|69597302|FG002|Overall Study|Protocol Violation|1|||
37910800|NCT00562159|69597312|FG000|Overall Study|Adverse Event|11|||
37832958|NCT01259089|69516588|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
37832959|NCT01259089|69516589|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
37832960|NCT01259089|69516590|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
37832961|NCT01259089|69516591|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
37832962|NCT01259089|69516592|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
37832963|NCT01259089|69516587|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
37832964|NCT01259089|69516588|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
37832965|NCT01259089|69516589|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
37832966|NCT01259089|69516590|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
37910801|NCT00562159|69597313|FG001|Overall Study|Adverse Event|8|||
37910802|NCT00562159|69597312|FG000|Overall Study|Lost to Follow-up|5|||
37910803|NCT00562159|69597313|FG001|Overall Study|Lost to Follow-up|4|||
38021238|NCT04799158|69704254|FG003|On-Demand Treatment Period|Miscellaneous|0|||
37910804|NCT00562159|69597312|FG000|Overall Study|Withdrawal by Subject|9|||
37910805|NCT00562159|69597313|FG001|Overall Study|Withdrawal by Subject|8|||
37910806|NCT00562159|69597312|FG000|Overall Study|Protocol Violation|12|||
37910807|NCT00562159|69597313|FG001|Overall Study|Protocol Violation|12|||
37832967|NCT01259089|69516591|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
37832968|NCT01259089|69516592|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
37832969|NCT01259089|69516587|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
38021239|NCT04799158|69704255|FG004|On-Demand Treatment Period|Miscellaneous|1|||
38021240|NCT01319422|69704268|FG000|Overall Study|Withdrawal by Subject|1|||
38021241|NCT01319422|69704269|FG001|Overall Study|Withdrawal by Subject|0|||
38021242|NCT03102034|69704277|FG000|Overall Study|Withdrawal by Subject|1|||
38021243|NCT03102034|69704278|FG001|Overall Study|Withdrawal by Subject|0|||
38021244|NCT03774576|69704284|FG000|Period 2|Adverse Event|1|||
38021245|NCT02928952|69704295|FG000|Overall Study|Lost to Follow-up|5|||
38021246|NCT02928952|69704296|FG001|Overall Study|Lost to Follow-up|5|||
38021247|NCT02928952|69704295|FG000|Overall Study|Withdrawal by Subject|5|||
38021248|NCT02928952|69704296|FG001|Overall Study|Withdrawal by Subject|1|||
38021249|NCT02928952|69704295|FG000|Overall Study|Physician Decision|0|||
38021250|NCT02928952|69704296|FG001|Overall Study|Physician Decision|1|||
37832970|NCT01259089|69516588|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
37832971|NCT01259089|69516589|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
37832972|NCT01259089|69516590|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
37832973|NCT01259089|69516591|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
37832974|NCT01259089|69516592|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
37832975|NCT01259089|69516587|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
37832976|NCT01259089|69516588|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
37832977|NCT01259089|69516589|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
37832978|NCT01259089|69516590|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
37832979|NCT01259089|69516591|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
37832980|NCT01259089|69516592|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
37832981|NCT01259089|69516587|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
37832982|NCT01259089|69516588|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
37832983|NCT01259089|69516589|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
37832984|NCT01259089|69516590|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
37832985|NCT01259089|69516591|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
37832986|NCT01259089|69516592|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
37832987|NCT01259089|69516587|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
37832988|NCT01259089|69516588|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
37832989|NCT01259089|69516589|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
37832990|NCT01259089|69516590|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
37832991|NCT01259089|69516591|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
37832992|NCT01259089|69516592|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
37832993|NCT01259089|69516587|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
37832994|NCT01259089|69516588|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
37832995|NCT01259089|69516589|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
37832996|NCT01259089|69516590|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
37832997|NCT01259089|69516591|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
37832998|NCT01259089|69516592|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
37832999|NCT01259089|69516587|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
37833000|NCT01259089|69516588|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
37833001|NCT01259089|69516589|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
37833002|NCT01259089|69516590|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
37833003|NCT01259089|69516591|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
37833004|NCT01259089|69516592|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
37833005|NCT01259089|69516587|FG000|Survival Follow up for Two Years|Death|3|||
37833006|NCT01259089|69516588|FG001|Survival Follow up for Two Years|Death|2|||
37833007|NCT01259089|69516589|FG002|Survival Follow up for Two Years|Death|2|||
38021251|NCT03773796|69704302|FG000|Overall Study|Adverse Event|1|||
38021252|NCT03773796|69704302|FG000|Overall Study|Withdrawal by Subject|1|||
38021253|NCT03773796|69704302|FG000|Overall Study|Lack of Efficacy|1|||
38021254|NCT02927938|69704310|FG000|Overall Study|Death|0|||
37833008|NCT01259089|69516590|FG003|Survival Follow up for Two Years|Death|3|||
37833009|NCT01259089|69516591|FG004|Survival Follow up for Two Years|Death|6|||
37833010|NCT01259089|69516592|FG005|Survival Follow up for Two Years|Death|13|||
37833011|NCT01259089|69516587|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
38021255|NCT02927938|69704311|FG001|Overall Study|Death|1|||
37833012|NCT01259089|69516588|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
37833013|NCT01259089|69516589|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
38021256|NCT02927938|69704312|FG002|Overall Study|Death|0|||
38021257|NCT02927938|69704313|FG003|Overall Study|Death|4|||
38021258|NCT02927938|69704310|FG000|Overall Study|Early Study Termination|1|||
37910808|NCT00562159|69597312|FG000|Overall Study|Did not meet protocol eligibility|1|||
37910809|NCT00562159|69597313|FG001|Overall Study|Did not meet protocol eligibility|1|||
37910810|NCT04223778|69597322|FG000|Overall Study|Ongoing|322|||
37910811|NCT04223778|69597323|FG001|Overall Study|Ongoing|326|||
37910812|NCT04223778|69597322|FG000|Overall Study|Death|0|||
37910813|NCT04223778|69597323|FG001|Overall Study|Death|1|||
37910814|NCT04223778|69597322|FG000|Overall Study|Lost to Follow-up|1|||
37910815|NCT04223778|69597323|FG001|Overall Study|Lost to Follow-up|5|||
37910816|NCT04223778|69597322|FG000|Overall Study|Physician Decision|3|||
37910817|NCT04223778|69597323|FG001|Overall Study|Physician Decision|1|||
37910818|NCT04223778|69597322|FG000|Overall Study|Withdrawal by Subject|10|||
37910819|NCT04223778|69597323|FG001|Overall Study|Withdrawal by Subject|1|||
37910820|NCT04223778|69597322|FG000|Overall Study|Lack of Efficacy|0|||
37910821|NCT04223778|69597323|FG001|Overall Study|Lack of Efficacy|2|||
37910822|NCT00921557|69597332|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
37910823|NCT00921557|69597333|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
37910824|NCT00921557|69597334|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
37910825|NCT00921557|69597332|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
37910826|NCT00921557|69597333|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
37910827|NCT00921557|69597334|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
37910828|NCT00921557|69597332|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
37910829|NCT00921557|69597333|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
37910830|NCT00921557|69597334|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
37910831|NCT00921557|69597332|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
37833014|NCT01259089|69516590|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
37833015|NCT01259089|69516591|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
37833016|NCT01259089|69516592|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
37833017|NCT01259089|69516587|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
37833018|NCT01259089|69516588|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
37833019|NCT01259089|69516589|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
37833020|NCT01259089|69516590|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
37833021|NCT01259089|69516591|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
37833022|NCT01259089|69516592|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
37833023|NCT01258738|69516608|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
37833024|NCT01258738|69516609|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
37833025|NCT01258738|69516608|FG000|Double-blind Period|Withdrawal by Subject|2|||
37833026|NCT01258738|69516609|FG001|Double-blind Period|Withdrawal by Subject|2|||
37833027|NCT01258738|69516608|FG000|Double-blind Period|Protocol Violation|1|||
37833028|NCT01258738|69516609|FG001|Double-blind Period|Protocol Violation|1|||
37833029|NCT01258738|69516608|FG000|Double-blind Period|Adverse Event|3|||
37833030|NCT01258738|69516609|FG001|Double-blind Period|Adverse Event|1|||
37910832|NCT00921557|69597333|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
37910833|NCT00921557|69597334|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
37910834|NCT00921557|69597332|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
37910835|NCT00921557|69597333|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
37910836|NCT00921557|69597334|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
37833031|NCT01258738|69516608|FG000|Open-label Period|Did not meet inclusion criteria|0|||
37833032|NCT01258738|69516609|FG001|Open-label Period|Did not meet inclusion criteria|1|||
37833033|NCT01258738|69516608|FG000|Open-label Period|Insufficient clinical response|5|||
37833034|NCT01258738|69516609|FG001|Open-label Period|Insufficient clinical response|3|||
37833035|NCT01258738|69516608|FG000|Open-label Period|Lost to Follow-up|0|||
37833036|NCT01258738|69516609|FG001|Open-label Period|Lost to Follow-up|2|||
37699379|NCT02342171|69176216|FG001|Overall Study|Missing cycle treshold value|0|||
37833037|NCT01258738|69516608|FG000|Open-label Period|Withdrawal by Subject|5|||
37833038|NCT01258738|69516609|FG001|Open-label Period|Withdrawal by Subject|6|||
37833039|NCT01258738|69516608|FG000|Open-label Period|Protocol Violation|2|||
37910837|NCT00744471|69597351|FG000|Overall Study|Randomized but not treated|1|||
37910838|NCT00744471|69597352|FG001|Overall Study|Randomized but not treated|1|||
37833040|NCT01258738|69516609|FG001|Open-label Period|Protocol Violation|2|||
37833041|NCT01258738|69516608|FG000|Open-label Period|Adverse Event|4|||
37833042|NCT01258738|69516609|FG001|Open-label Period|Adverse Event|5|||
37833043|NCT01258738|69516608|FG000|Open-label Period|Other Reasons|0|||
37910839|NCT00744471|69597353|FG002|Overall Study|Randomized but not treated|4|||
37910840|NCT00744471|69597354|FG003|Overall Study|Randomized but not treated|0|||
37910841|NCT00744471|69597351|FG000|Overall Study|Death|0|||
37910842|NCT00744471|69597352|FG001|Overall Study|Death|0|||
37910843|NCT00744471|69597353|FG002|Overall Study|Death|0|||
37910844|NCT00744471|69597354|FG003|Overall Study|Death|1|||
37910845|NCT00744471|69597351|FG000|Overall Study|Adverse Event|6|||
37910846|NCT00744471|69597352|FG001|Overall Study|Adverse Event|7|||
37910847|NCT00744471|69597353|FG002|Overall Study|Adverse Event|5|||
37910848|NCT00744471|69597354|FG003|Overall Study|Adverse Event|9|||
37910849|NCT00744471|69597351|FG000|Overall Study|Withdrawal by Subject|9|||
37910850|NCT00744471|69597352|FG001|Overall Study|Withdrawal by Subject|9|||
37910851|NCT00744471|69597353|FG002|Overall Study|Withdrawal by Subject|15|||
37910852|NCT00744471|69597354|FG003|Overall Study|Withdrawal by Subject|12|||
37910853|NCT00744471|69597351|FG000|Overall Study|Protocol Violation|1|||
37910854|NCT00744471|69597352|FG001|Overall Study|Protocol Violation|4|||
38021259|NCT02927938|69704311|FG001|Overall Study|Early Study Termination|5|||
38021260|NCT02927938|69704312|FG002|Overall Study|Early Study Termination|4|||
38021261|NCT02927938|69704313|FG003|Overall Study|Early Study Termination|3|||
38021262|NCT03765138|69704321|FG000|Overall Study|Lost to Follow-up|1|||
38021263|NCT03768726|69704328|FG000|Treatment Phase|Adverse Event|2|||
38021264|NCT03768726|69704329|FG001|Treatment Phase|Adverse Event|2|||
38021265|NCT03768726|69704328|FG000|Treatment Phase|Lost to Follow-up|1|||
38021266|NCT03768726|69704329|FG001|Treatment Phase|Lost to Follow-up|0|||
38021267|NCT03768726|69704328|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
38021268|NCT03768726|69704329|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
38021269|NCT03768726|69704328|FG000|Treatment Phase|Withdrawal by Subject|3|||
38021270|NCT03768726|69704329|FG001|Treatment Phase|Withdrawal by Subject|1|||
38021271|NCT03768726|69704328|FG000|Follow-Up|Adverse Event|2|||
38021272|NCT03768726|69704329|FG001|Follow-Up|Adverse Event|2|||
38021273|NCT03768726|69704328|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
38021274|NCT03768726|69704329|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
38021275|NCT03768726|69704328|FG000|Follow-Up|Withdrawal by Subject|2|||
38021276|NCT03768726|69704329|FG001|Follow-Up|Withdrawal by Subject|0|||
38021277|NCT03768726|69704328|FG000|Follow-Up|Other|1|||
38021278|NCT03768726|69704329|FG001|Follow-Up|Other|0|||
38021279|NCT03769896|69704337|FG000|Open-label Phase|Lack of Efficacy|5|||
38021280|NCT03769896|69704338|FG001|Open-label Phase|Lack of Efficacy|0|||
38021281|NCT03769896|69704337|FG000|Open-label Phase|Adverse Event|3|||
38021282|NCT03769896|69704338|FG001|Open-label Phase|Adverse Event|0|||
38021283|NCT03769896|69704337|FG000|Open-label Phase|Withdrawal by Subject|1|||
38021284|NCT03769896|69704338|FG001|Open-label Phase|Withdrawal by Subject|0|||
38021285|NCT05047601|69704348|FG000|Overall Study|Lost to Follow-up|9|||
38021286|NCT05047601|69704349|FG001|Overall Study|Lost to Follow-up|11|||
38021287|NCT05047601|69704350|FG002|Overall Study|Lost to Follow-up|7|||
38021288|NCT05047601|69704348|FG000|Overall Study|Withdrawal by Subject|25|||
38021289|NCT05047601|69704349|FG001|Overall Study|Withdrawal by Subject|36|||
38021290|NCT05047601|69704350|FG002|Overall Study|Withdrawal by Subject|23|||
37699380|NCT02342171|69176215|FG000|Overall Study|Unknown outcome|0|||
38021291|NCT05047601|69704348|FG000|Overall Study|Other|10|||
37910855|NCT00744471|69597353|FG002|Overall Study|Protocol Violation|1|||
37910856|NCT00744471|69597354|FG003|Overall Study|Protocol Violation|2|||
38021292|NCT05047601|69704349|FG001|Overall Study|Other|6|||
38021293|NCT05047601|69704350|FG002|Overall Study|Other|5|||
38021294|NCT04658784|69704360|FG000|6-month Follow-up|Lost to Follow-up|2|||
38021295|NCT04658784|69704361|FG001|6-month Follow-up|Lost to Follow-up|5|||
37833044|NCT01258738|69516609|FG001|Open-label Period|Other Reasons|1|||
37833045|NCT01258738|69516608|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
37833046|NCT01258738|69516609|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
37833047|NCT01258660|69516617|FG000|Overall Study|Adverse Event|2|||
37833048|NCT01258660|69516618|FG001|Overall Study|Adverse Event|4|||
37833049|NCT01258660|69516617|FG000|Overall Study|Withdrawal by Subject|3|||
37833050|NCT01258660|69516618|FG001|Overall Study|Withdrawal by Subject|0|||
37833051|NCT01258660|69516617|FG000|Overall Study|due to relocation|2|||
37833052|NCT01258660|69516618|FG001|Overall Study|due to relocation|0|||
37833053|NCT01258660|69516617|FG000|Overall Study|Protocol Violation|0|||
37833054|NCT01258660|69516618|FG001|Overall Study|Protocol Violation|1|||
37699381|NCT02342171|69176216|FG001|Overall Study|Unknown outcome|1|||
37833055|NCT01258660|69516617|FG000|Overall Study|Invalid for primary analysis data set|4|||
37833056|NCT01258660|69516618|FG001|Overall Study|Invalid for primary analysis data set|6|||
37833057|NCT01258348|69516625|FG000|Overall Study|Adverse Event|1|||
37833058|NCT01258348|69516626|FG001|Overall Study|Adverse Event|1|||
37833059|NCT01258348|69516627|FG002|Overall Study|Adverse Event|3|||
37833060|NCT01258348|69516628|FG003|Overall Study|Adverse Event|2|||
37833061|NCT01258348|69516629|FG004|Overall Study|Adverse Event|4|||
37833062|NCT01258348|69516625|FG000|Overall Study|Progressive Disease|0|||
37833063|NCT01258348|69516626|FG001|Overall Study|Progressive Disease|3|||
37833064|NCT01258348|69516627|FG002|Overall Study|Progressive Disease|0|||
37833065|NCT01258348|69516628|FG003|Overall Study|Progressive Disease|2|||
37833066|NCT01258348|69516629|FG004|Overall Study|Progressive Disease|2|||
37833067|NCT01258348|69516625|FG000|Overall Study|Physician Decision|0|||
37910857|NCT00744471|69597351|FG000|Overall Study|Entered extension study|41|||
37833068|NCT01258348|69516626|FG001|Overall Study|Physician Decision|0|||
37833069|NCT01258348|69516627|FG002|Overall Study|Physician Decision|0|||
37833070|NCT01258348|69516628|FG003|Overall Study|Physician Decision|2|||
37833071|NCT01258348|69516629|FG004|Overall Study|Physician Decision|0|||
37833072|NCT01258348|69516625|FG000|Overall Study|Withdrawal by Subject|0|||
37699382|NCT02342171|69176215|FG000|Overall Study|Missing age data|0|||
37699383|NCT02342171|69176216|FG001|Overall Study|Missing age data|1|||
37699384|NCT01624467|69176221|FG000|Overall Study|Withdrawal by Subject|2|||
37833073|NCT01258348|69516626|FG001|Overall Study|Withdrawal by Subject|1|||
37833074|NCT01258348|69516627|FG002|Overall Study|Withdrawal by Subject|0|||
37833075|NCT01258348|69516628|FG003|Overall Study|Withdrawal by Subject|0|||
37833076|NCT01258348|69516629|FG004|Overall Study|Withdrawal by Subject|0|||
37833077|NCT01258075|69516645|FG000|Overall Study|Adverse Event|8|||
37833078|NCT01258075|69516646|FG001|Overall Study|Adverse Event|3|||
37910858|NCT00744471|69597352|FG001|Overall Study|Entered extension study|84|||
37910859|NCT00744471|69597353|FG002|Overall Study|Entered extension study|100|||
37699385|NCT01624467|69176221|FG000|Overall Study|Lost to Follow-up|1|||
37699386|NCT01624467|69176221|FG000|Overall Study|Adverse Event|7|||
37699387|NCT01624467|69176221|FG000|Overall Study|Progressive Disease|19|||
37699388|NCT01624467|69176221|FG000|Overall Study|Per Sponsor Requirement|1|||
37833079|NCT01258075|69516645|FG000|Overall Study|Lost to Follow-up|11|||
37699389|NCT01624467|69176221|FG000|Overall Study|Subject Withdrew from Treatment|1|||
37833080|NCT01258075|69516646|FG001|Overall Study|Lost to Follow-up|6|||
37833081|NCT01258075|69516645|FG000|Overall Study|Withdrawal by Subject|10|||
37833082|NCT01258075|69516646|FG001|Overall Study|Withdrawal by Subject|7|||
37833083|NCT01258075|69516645|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
37833084|NCT01258075|69516646|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
37910860|NCT00744471|69597354|FG003|Overall Study|Entered extension study|91|||
37910861|NCT00744471|69597351|FG000|Overall Study|Other|2|||
38021296|NCT04606394|69704367|FG000|Overall Study|Withdrawal by Subject|3|||
38021297|NCT04606394|69704367|FG000|Overall Study|Exclusion criteria screen failure|12|||
38021298|NCT04585451|69704381|FG000|Overall Study|Withdrawal by Subject|26|||
37833085|NCT01258075|69516645|FG000|Overall Study|Other|12|||
37833086|NCT01258075|69516646|FG001|Overall Study|Other|5|||
37833087|NCT01257568|69516652|FG000|Overall Study|Lost to Follow-up|2|||
37833088|NCT01257568|69516652|FG000|Overall Study|Withdrawal by Subject|6|||
37833089|NCT01257568|69516652|FG000|Overall Study|Terminated|1|||
37699390|NCT01624233|69176227|FG000|Period 2 - Induction|Adverse Event|1|||
37699391|NCT01624233|69176227|FG000|Period 3 - Maintenance|Adverse Event|2|||
37699392|NCT01624233|69176227|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
37699393|NCT01624233|69176227|FG000|Period 3 - Maintenance|Physician Decision|2|||
37699394|NCT01624233|69176227|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
37699395|NCT01624233|69176227|FG000|Period 4 - Drug Free Period|Relapsed|61|||
37699396|NCT01624233|69176227|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
37699397|NCT01624233|69176227|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
37699398|NCT01624233|69176227|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
37699399|NCT01624233|69176227|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
37833090|NCT01257568|69516652|FG000|Overall Study|Component Revision|24|||
37833091|NCT01256788|69516661|FG000|Overall Study|Lost to Follow-up|5|||
37833092|NCT01256788|69516662|FG001|Overall Study|Lost to Follow-up|8|||
37833093|NCT01256788|69516663|FG002|Overall Study|Lost to Follow-up|3|||
37833094|NCT01256671|69516671|FG000|Overall Study|Adverse Event|29|||
37833095|NCT01256671|69516671|FG000|Overall Study|Lost to Follow-up|16|||
37910862|NCT00744471|69597352|FG001|Overall Study|Other|3|||
37910863|NCT00744471|69597353|FG002|Overall Study|Other|6|||
37910864|NCT00744471|69597354|FG003|Overall Study|Other|2|||
37910865|NCT00744471|69597351|FG000|Overall Study|Lack of Efficacy|83|||
37910866|NCT00744471|69597352|FG001|Overall Study|Lack of Efficacy|37|||
37910867|NCT00744471|69597353|FG002|Overall Study|Lack of Efficacy|19|||
37910868|NCT00744471|69597354|FG003|Overall Study|Lack of Efficacy|31|||
37910869|NCT00744471|69597351|FG000|Overall Study|Lost to Follow-up|0|||
37833096|NCT01256671|69516671|FG000|Overall Study|Withdrawal by Subject|31|||
37833097|NCT01256671|69516671|FG000|Overall Study|Physician Decision|3|||
37833098|NCT01256671|69516671|FG000|Overall Study|Lack of Efficacy|4|||
37833099|NCT01256671|69516671|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
37833100|NCT01256476|69516677|FG000|Overall Study|Adverse Event|2|||
37833101|NCT01256476|69516678|FG001|Overall Study|Adverse Event|1|||
37833102|NCT01256476|69516677|FG000|Overall Study|Withdrawal by Subject|2|||
37833103|NCT01256476|69516678|FG001|Overall Study|Withdrawal by Subject|1|||
37833104|NCT01256476|69516677|FG000|Overall Study|Lost to Follow-up|1|||
37833105|NCT01256476|69516678|FG001|Overall Study|Lost to Follow-up|2|||
37833106|NCT01256476|69516677|FG000|Overall Study|Persistent ALT or AST elevation|1|||
37833107|NCT01256476|69516678|FG001|Overall Study|Persistent ALT or AST elevation|0|||
37833108|NCT01256476|69516677|FG000|Overall Study|Physician Decision|0|||
37833109|NCT01256476|69516678|FG001|Overall Study|Physician Decision|1|||
37833110|NCT01256476|69516677|FG000|Overall Study|Subject non-compliance|0|||
37833111|NCT01256476|69516678|FG001|Overall Study|Subject non-compliance|1|||
37833112|NCT01256476|69516677|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
37833113|NCT01256476|69516678|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
37833114|NCT01256008|69516687|FG000|Overall Study|Lost to Follow-up|6|||
37910870|NCT00744471|69597352|FG001|Overall Study|Lost to Follow-up|0|||
37910871|NCT00744471|69597353|FG002|Overall Study|Lost to Follow-up|2|||
37910872|NCT00744471|69597354|FG003|Overall Study|Lost to Follow-up|0|||
37910873|NCT00744237|69597367|FG000|Overall Study|Lack of Efficacy|1|||
37910874|NCT00744237|69597368|FG001|Overall Study|Lack of Efficacy|1|||
37910875|NCT00744237|69597369|FG002|Overall Study|Lack of Efficacy|0|||
37910876|NCT00744237|69597367|FG000|Overall Study|Withdrawal by Subject|9|||
37910877|NCT00744237|69597368|FG001|Overall Study|Withdrawal by Subject|5|||
37910878|NCT00744237|69597369|FG002|Overall Study|Withdrawal by Subject|3|||
38021299|NCT04585451|69704382|FG001|Overall Study|Withdrawal by Subject|0|||
38021300|NCT04362189|69704407|FG000|Overall Study|Lost to Follow-up|0|||
38021301|NCT04362189|69704408|FG001|Overall Study|Lost to Follow-up|1|||
38021302|NCT04362189|69704407|FG000|Overall Study|Withdrawal by Subject|1|||
38021303|NCT04362189|69704408|FG001|Overall Study|Withdrawal by Subject|0|||
38021304|NCT04362189|69704407|FG000|Overall Study|FDA Clinical Hold|7|||
38021305|NCT04362189|69704408|FG001|Overall Study|FDA Clinical Hold|2|||
38021306|NCT04362189|69704407|FG000|Overall Study|Discharge or Transfer to other Hospital|3|||
38021307|NCT04362189|69704408|FG001|Overall Study|Discharge or Transfer to other Hospital|0|||
37910879|NCT00744237|69597367|FG000|Overall Study|Lost to Follow-up|1|||
37910880|NCT00744237|69597368|FG001|Overall Study|Lost to Follow-up|1|||
37910881|NCT00744237|69597369|FG002|Overall Study|Lost to Follow-up|1|||
37910882|NCT00744237|69597367|FG000|Overall Study|Protocol Violation|3|||
38021308|NCT04362189|69704407|FG000|Overall Study|Adverse Event|0|||
38021309|NCT04362189|69704408|FG001|Overall Study|Adverse Event|2|||
37833115|NCT01256008|69516688|FG001|Overall Study|Lost to Follow-up|4|||
37833116|NCT01256008|69516689|FG002|Overall Study|Lost to Follow-up|11|||
37699400|NCT01624233|69176227|FG000|Period 6: Follow-up|Adverse Event|3|||
37699401|NCT01624233|69176227|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
37699402|NCT01624233|69176227|FG000|Period 6: Follow-up|Physician Decision|1|||
37699403|NCT01624233|69176227|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
37699404|NCT01993017|69176238|FG000|Overall Study|Death|23|||
38021310|NCT04362189|69704407|FG000|Overall Study|Death|4|||
38021311|NCT04362189|69704408|FG001|Overall Study|Death|1|||
38021312|NCT04181788|69704482|FG000|TREATMENT|Adverse Event|0|||
38021313|NCT04181788|69704483|FG001|TREATMENT|Adverse Event|2|||
38021314|NCT04181788|69704484|FG002|TREATMENT|Adverse Event|1|||
38021315|NCT04181788|69704485|FG003|TREATMENT|Adverse Event|0|||
37699405|NCT01993017|69176239|FG001|Overall Study|Death|26|||
38021316|NCT04181788|69704486|FG004|TREATMENT|Adverse Event|1|||
38021317|NCT04181788|69704487|FG005|TREATMENT|Adverse Event|3|||
37833117|NCT01256008|69516687|FG000|Overall Study|Withdrawal by Subject|2|||
37833118|NCT01256008|69516688|FG001|Overall Study|Withdrawal by Subject|3|||
37833119|NCT01256008|69516689|FG002|Overall Study|Withdrawal by Subject|10|||
37833120|NCT01255423|69516701|FG000|Overall Study|Abnormal Laboratory value|3|||
37833121|NCT01255423|69516702|FG001|Overall Study|Abnormal Laboratory value|2|||
37833122|NCT01255423|69516701|FG000|Overall Study|Use of prohibited medications|0|||
37833123|NCT01255423|69516702|FG001|Overall Study|Use of prohibited medications|1|||
37833124|NCT01255306|69516710|FG000|Overall Study|Physician Decision|1|||
37910883|NCT00744237|69597368|FG001|Overall Study|Protocol Violation|4|||
37910884|NCT00744237|69597369|FG002|Overall Study|Protocol Violation|3|||
37699406|NCT01993017|69176240|FG002|Overall Study|Death|18|||
37699407|NCT01993017|69176238|FG000|Overall Study|Could not be contacted|43|||
37699408|NCT01993017|69176239|FG001|Overall Study|Could not be contacted|42|||
37699409|NCT01993017|69176240|FG002|Overall Study|Could not be contacted|38|||
37699410|NCT01993017|69176238|FG000|Overall Study|Dropped out|19|||
37699411|NCT01993017|69176239|FG001|Overall Study|Dropped out|6|||
37833125|NCT01255306|69516711|FG001|Overall Study|Physician Decision|1|||
37699412|NCT01993017|69176240|FG002|Overall Study|Dropped out|11|||
37699413|NCT01993017|69176238|FG000|Overall Study|Other reasons|17|||
37910885|NCT00744237|69597367|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
37910886|NCT00744237|69597368|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
37910887|NCT00744237|69597369|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
38021318|NCT04181788|69704482|FG000|TREATMENT|Death|0|||
38021319|NCT04181788|69704483|FG001|TREATMENT|Death|0|||
38021320|NCT04181788|69704484|FG002|TREATMENT|Death|0|||
38021321|NCT04181788|69704485|FG003|TREATMENT|Death|0|||
38021322|NCT04181788|69704486|FG004|TREATMENT|Death|8|||
38021323|NCT04181788|69704487|FG005|TREATMENT|Death|8|||
38021324|NCT04181788|69704482|FG000|TREATMENT|Physician Decision|0|||
38021325|NCT04181788|69704483|FG001|TREATMENT|Physician Decision|0|||
38021326|NCT04181788|69704484|FG002|TREATMENT|Physician Decision|0|||
38021327|NCT04181788|69704485|FG003|TREATMENT|Physician Decision|0|||
38021328|NCT04181788|69704486|FG004|TREATMENT|Physician Decision|0|||
38021329|NCT04181788|69704487|FG005|TREATMENT|Physician Decision|1|||
38021330|NCT04181788|69704482|FG000|TREATMENT|Progressive disease|3|||
38021331|NCT04181788|69704483|FG001|TREATMENT|Progressive disease|3|||
38021332|NCT04181788|69704484|FG002|TREATMENT|Progressive disease|5|||
38021333|NCT04181788|69704485|FG003|TREATMENT|Progressive disease|7|||
37699414|NCT01993017|69176239|FG001|Overall Study|Other reasons|11|||
37699415|NCT01993017|69176240|FG002|Overall Study|Other reasons|7|||
37910888|NCT00744237|69597367|FG000|Overall Study|Dosing Error|1|||
37910889|NCT00744237|69597368|FG001|Overall Study|Dosing Error|0|||
37910890|NCT00744237|69597369|FG002|Overall Study|Dosing Error|1|||
38021334|NCT04181788|69704486|FG004|TREATMENT|Progressive disease|20|||
38021335|NCT04181788|69704487|FG005|TREATMENT|Progressive disease|38|||
37833126|NCT01254721|69516722|FG000|Overall Study|Lost to Follow-up|0|||
38021336|NCT04181788|69704482|FG000|TREATMENT|Global deterioration of health status|0|||
37910891|NCT00744237|69597367|FG000|Overall Study|Study Drug Error|1|||
37833127|NCT01254721|69516723|FG001|Overall Study|Lost to Follow-up|4|||
37833128|NCT01254721|69516722|FG000|Overall Study|Lack of Efficacy|4|||
37833129|NCT01254721|69516723|FG001|Overall Study|Lack of Efficacy|2|||
37833130|NCT01254721|69516722|FG000|Overall Study|Death|0|||
37833131|NCT01254721|69516723|FG001|Overall Study|Death|1|||
37833132|NCT01254721|69516722|FG000|Overall Study|technical problum|1|||
37833133|NCT01254721|69516723|FG001|Overall Study|technical problum|0|||
37833134|NCT01254721|69516722|FG000|Overall Study|Adverse Event|2|||
37833135|NCT01254721|69516723|FG001|Overall Study|Adverse Event|3|||
37833136|NCT01254721|69516722|FG000|Overall Study|Withdrawal by Subject|8|||
37910892|NCT00744237|69597368|FG001|Overall Study|Study Drug Error|0|||
37910893|NCT00744237|69597369|FG002|Overall Study|Study Drug Error|0|||
37910894|NCT00744237|69597367|FG000|Overall Study|Prohibited Concomitant Medication|0|||
37910895|NCT00744237|69597368|FG001|Overall Study|Prohibited Concomitant Medication|0|||
37699416|NCT01993017|69176238|FG000|Overall Study|Ineligible after randomization|4|||
37699417|NCT01993017|69176239|FG001|Overall Study|Ineligible after randomization|5|||
37699418|NCT01993017|69176240|FG002|Overall Study|Ineligible after randomization|5|||
37699419|NCT01992549|69176249|FG000|Overall Study|Lost to Follow-up|2|||
37699420|NCT01992549|69176249|FG000|Overall Study|Serious Adverse Event|1|||
37699421|NCT01992549|69176249|FG000|Overall Study|Product Switch to Extend Half Life|1|||
37699422|NCT01992159|69176263|FG000|Overall Study|Withdrawal by Subject|4|||
37699423|NCT01992159|69176264|FG001|Overall Study|Withdrawal by Subject|7|||
37699424|NCT01992159|69176265|FG002|Overall Study|Withdrawal by Subject|0|||
37699425|NCT01992159|69176266|FG003|Overall Study|Withdrawal by Subject|3|||
37699426|NCT01992159|69176263|FG000|Overall Study|Adverse Event|0|||
37699427|NCT01992159|69176264|FG001|Overall Study|Adverse Event|1|||
37699428|NCT01992159|69176265|FG002|Overall Study|Adverse Event|0|||
37910896|NCT00744237|69597369|FG002|Overall Study|Prohibited Concomitant Medication|1|||
37910897|NCT00744237|69597367|FG000|Overall Study|Poor Compliance|0|||
37910898|NCT00744237|69597368|FG001|Overall Study|Poor Compliance|2|||
38021337|NCT04181788|69704483|FG001|TREATMENT|Global deterioration of health status|2|||
38021338|NCT04181788|69704484|FG002|TREATMENT|Global deterioration of health status|0|||
37699429|NCT01992159|69176266|FG003|Overall Study|Adverse Event|1|||
37699430|NCT01992159|69176263|FG000|Overall Study|Death|0|||
37699431|NCT01992159|69176264|FG001|Overall Study|Death|0|||
37699432|NCT01992159|69176265|FG002|Overall Study|Death|1|||
37699433|NCT01992159|69176266|FG003|Overall Study|Death|0|||
37699434|NCT01988493|69176281|FG000|Overall Study|Randomized but not treated|0|||
37699435|NCT01988493|69176282|FG001|Overall Study|Randomized but not treated|0|||
37699436|NCT01988493|69176283|FG002|Overall Study|Randomized but not treated|0|||
37699437|NCT01988493|69176284|FG003|Overall Study|Randomized but not treated|0|||
37699438|NCT01988493|69176285|FG004|Overall Study|Randomized but not treated|1|||
37699439|NCT02081079|69176301|FG000|Overall Study|Lack of Efficacy|3|||
37699440|NCT02081079|69176302|FG001|Overall Study|Lack of Efficacy|2|||
37699441|NCT02081079|69176301|FG000|Overall Study|Lost to Follow-up|1|||
37699442|NCT02081079|69176302|FG001|Overall Study|Lost to Follow-up|0|||
37699443|NCT02081001|69176314|FG000|Overall Study|Adverse Event|0|||
37699444|NCT02081001|69176315|FG001|Overall Study|Adverse Event|0|||
37699445|NCT02081001|69176316|FG002|Overall Study|Adverse Event|0|||
37699446|NCT02081001|69176317|FG003|Overall Study|Adverse Event|0|||
37699447|NCT02081001|69176318|FG004|Overall Study|Adverse Event|1|||
37699448|NCT02081001|69176319|FG005|Overall Study|Adverse Event|0|||
37699449|NCT02081001|69176320|FG006|Overall Study|Adverse Event|0|||
37699450|NCT02081001|69176321|FG007|Overall Study|Adverse Event|0|||
37699451|NCT02081001|69176322|FG008|Overall Study|Adverse Event|0|||
37699452|NCT02081001|69176323|FG009|Overall Study|Adverse Event|0|||
37699453|NCT02081001|69176324|FG010|Overall Study|Adverse Event|0|||
37699454|NCT02081001|69176325|FG011|Overall Study|Adverse Event|0|||
37699455|NCT02080221|69176336|FG000|Overall Study|Withdrawal by Subject|1|||
37699456|NCT02080221|69176336|FG000|Overall Study|Clinical Progression of Disease|1|||
37699457|NCT02079909|69176343|FG000|Overall Study|Adverse Event|23|||
37699458|NCT02079909|69176344|FG001|Overall Study|Adverse Event|23|||
37699459|NCT02079909|69176345|FG002|Overall Study|Adverse Event|7|||
37699460|NCT02079909|69176343|FG000|Overall Study|Withdrawal by Subject|9|||
37699461|NCT02079909|69176344|FG001|Overall Study|Withdrawal by Subject|17|||
37699462|NCT02079909|69176345|FG002|Overall Study|Withdrawal by Subject|4|||
37699463|NCT02079909|69176343|FG000|Overall Study|Lost to Follow-up|2|||
37699464|NCT02079909|69176344|FG001|Overall Study|Lost to Follow-up|3|||
37699465|NCT02079909|69176345|FG002|Overall Study|Lost to Follow-up|1|||
37699466|NCT02079909|69176343|FG000|Overall Study|Death|2|||
37699467|NCT02079909|69176344|FG001|Overall Study|Death|2|||
37699468|NCT02079909|69176345|FG002|Overall Study|Death|0|||
37699469|NCT02079909|69176343|FG000|Overall Study|Lack of Efficacy|0|||
37699470|NCT02079909|69176344|FG001|Overall Study|Lack of Efficacy|0|||
37699471|NCT02079909|69176345|FG002|Overall Study|Lack of Efficacy|1|||
37699472|NCT02079909|69176343|FG000|Overall Study|Protocol Violation|0|||
37699473|NCT02079909|69176344|FG001|Overall Study|Protocol Violation|1|||
37699474|NCT02079909|69176345|FG002|Overall Study|Protocol Violation|1|||
37699475|NCT02079909|69176343|FG000|Overall Study|Physician Decision|0|||
37699476|NCT02079909|69176344|FG001|Overall Study|Physician Decision|1|||
37699477|NCT02079909|69176345|FG002|Overall Study|Physician Decision|1|||
37699478|NCT02079909|69176343|FG000|Overall Study|Relocation etc.|2|||
37699479|NCT02079909|69176344|FG001|Overall Study|Relocation etc.|2|||
37699480|NCT02079909|69176345|FG002|Overall Study|Relocation etc.|3|||
37699481|NCT02014467|69176355|FG000|Overall Study|Adverse Event|4|||
37699482|NCT02014467|69176356|FG001|Overall Study|Adverse Event|0|||
37699483|NCT02014467|69176355|FG000|Overall Study|Protocol Violation|3|||
37699484|NCT02014467|69176356|FG001|Overall Study|Protocol Violation|0|||
37699485|NCT02014467|69176355|FG000|Overall Study|Physician Decision|2|||
37699486|NCT02014467|69176356|FG001|Overall Study|Physician Decision|3|||
38021339|NCT04181788|69704485|FG003|TREATMENT|Global deterioration of health status|0|||
37699487|NCT02014467|69176355|FG000|Overall Study|Withdrawal by Subject|16|||
37699488|NCT02014467|69176356|FG001|Overall Study|Withdrawal by Subject|4|||
37699489|NCT02013765|69176362|FG000|Overall Study|Trial was terminated by sponsor|1|||
37699490|NCT02013687|69176370|FG000|Overall Study|Lost to Follow-up|0|||
37699491|NCT02013687|69176371|FG001|Overall Study|Lost to Follow-up|0|||
37699492|NCT02013687|69176372|FG002|Overall Study|Lost to Follow-up|1|||
37699493|NCT02013687|69176373|FG003|Overall Study|Lost to Follow-up|0|||
37699494|NCT02013687|69176370|FG000|Overall Study|Protocol Violation|0|||
37699495|NCT02013687|69176371|FG001|Overall Study|Protocol Violation|0|||
37699496|NCT02013687|69176372|FG002|Overall Study|Protocol Violation|0|||
37699497|NCT02013687|69176373|FG003|Overall Study|Protocol Violation|1|||
37699498|NCT02013687|69176370|FG000|Overall Study|Withdrawal by Subject|0|||
37699499|NCT02013687|69176371|FG001|Overall Study|Withdrawal by Subject|0|||
37833137|NCT01254721|69516723|FG001|Overall Study|Withdrawal by Subject|11|||
37833138|NCT01254721|69516722|FG000|Overall Study|Wrongly randomization|0|||
38021340|NCT04181788|69704486|FG004|TREATMENT|Global deterioration of health status|2|||
38021341|NCT04181788|69704487|FG005|TREATMENT|Global deterioration of health status|8|||
38021342|NCT04181788|69704482|FG000|TREATMENT|Withdrawal by Subject|1|||
38021343|NCT04181788|69704483|FG001|TREATMENT|Withdrawal by Subject|2|||
38021344|NCT04181788|69704484|FG002|TREATMENT|Withdrawal by Subject|0|||
37833139|NCT01254721|69516723|FG001|Overall Study|Wrongly randomization|1|||
38021345|NCT04181788|69704485|FG003|TREATMENT|Withdrawal by Subject|0|||
38021346|NCT04181788|69704486|FG004|TREATMENT|Withdrawal by Subject|3|||
38021347|NCT04181788|69704487|FG005|TREATMENT|Withdrawal by Subject|5|||
38021348|NCT04181788|69704482|FG000|TREATMENT|Other unspecified|0|||
38021349|NCT04181788|69704483|FG001|TREATMENT|Other unspecified|0|||
38021350|NCT04181788|69704484|FG002|TREATMENT|Other unspecified|0|||
38021351|NCT04181788|69704485|FG003|TREATMENT|Other unspecified|0|||
38021352|NCT04181788|69704486|FG004|TREATMENT|Other unspecified|0|||
38021353|NCT04181788|69704487|FG005|TREATMENT|Other unspecified|2|||
38021354|NCT04181788|69704482|FG000|TREATMENT|Ongoing|0|||
37833140|NCT01254643|69516729|FG000|Overall Study|Withdrawal by Subject|1|||
37833141|NCT01254604|69516735|FG000|Overall Study|Lost to Follow-up|1|||
37910899|NCT00744237|69597369|FG002|Overall Study|Poor Compliance|0|||
37910900|NCT00744237|69597367|FG000|Overall Study|Administrative. Site Closed|1|||
37910901|NCT00744237|69597368|FG001|Overall Study|Administrative. Site Closed|1|||
37910902|NCT00744237|69597369|FG002|Overall Study|Administrative. Site Closed|1|||
37910903|NCT00744237|69597367|FG000|Overall Study|Adverse Event|9|||
37910904|NCT00744237|69597368|FG001|Overall Study|Adverse Event|13|||
37910905|NCT00744237|69597369|FG002|Overall Study|Adverse Event|5|||
37910906|NCT00743145|69597377|FG000|Overall Study|Withdrawal by Subject|1|||
37910907|NCT00743145|69597377|FG000|Overall Study|Adverse Event|2|||
37910908|NCT00743145|69597377|FG000|Overall Study|Pregnancy|1|||
37910909|NCT00920855|69597394|FG000|Overall Study|Adverse Event|1|||
37910910|NCT00920855|69597395|FG001|Overall Study|Adverse Event|1|||
37910911|NCT00920855|69597396|FG002|Overall Study|Adverse Event|4|||
37910912|NCT00920855|69597394|FG000|Overall Study|Withdrawal by Subject|2|||
37833142|NCT01254604|69516736|FG001|Overall Study|Lost to Follow-up|1|||
37833143|NCT01254604|69516735|FG000|Overall Study|Protocol Violation|2|||
37833144|NCT01254604|69516736|FG001|Overall Study|Protocol Violation|2|||
37833145|NCT01254604|69516735|FG000|Overall Study|Withdrawal by Subject|2|||
37833146|NCT01254604|69516736|FG001|Overall Study|Withdrawal by Subject|4|||
37833147|NCT01254604|69516735|FG000|Overall Study|Adverse Event|3|||
37833148|NCT01254604|69516736|FG001|Overall Study|Adverse Event|2|||
37833149|NCT01254565|69516748|FG000|Overall Study|Non-compliance to Study Procedures|0|||
37833150|NCT01254565|69516749|FG001|Overall Study|Non-compliance to Study Procedures|0|||
37833151|NCT01254565|69516750|FG002|Overall Study|Non-compliance to Study Procedures|0|||
37833152|NCT01254565|69516751|FG003|Overall Study|Non-compliance to Study Procedures|0|||
37833153|NCT01254565|69516752|FG004|Overall Study|Non-compliance to Study Procedures|1|||
37833154|NCT01254565|69516753|FG005|Overall Study|Non-compliance to Study Procedures|0|||
37833155|NCT01254565|69516748|FG000|Overall Study|Did not Receive Treatment|1|||
37833156|NCT01254565|69516749|FG001|Overall Study|Did not Receive Treatment|1|||
37833157|NCT01254565|69516750|FG002|Overall Study|Did not Receive Treatment|0|||
37833158|NCT01254565|69516751|FG003|Overall Study|Did not Receive Treatment|0|||
37833159|NCT01254565|69516752|FG004|Overall Study|Did not Receive Treatment|3|||
37833160|NCT01254565|69516753|FG005|Overall Study|Did not Receive Treatment|4|||
37833161|NCT01254565|69516748|FG000|Overall Study|Other|0|||
37833162|NCT01254565|69516749|FG001|Overall Study|Other|0|||
37833163|NCT01254565|69516750|FG002|Overall Study|Other|0|||
37833164|NCT01254565|69516751|FG003|Overall Study|Other|1|||
37833165|NCT01254565|69516752|FG004|Overall Study|Other|0|||
37833166|NCT01254565|69516753|FG005|Overall Study|Other|0|||
37833167|NCT01254409|69516771|FG000|Overall Study|Adverse Event|0|||
37833168|NCT01254409|69516772|FG001|Overall Study|Adverse Event|1|||
37833169|NCT01254409|69516773|FG002|Overall Study|Adverse Event|0|||
37833170|NCT01254409|69516774|FG003|Overall Study|Adverse Event|0|||
37910913|NCT00920855|69597395|FG001|Overall Study|Withdrawal by Subject|1|||
38021355|NCT04181788|69704483|FG001|TREATMENT|Ongoing|3|||
38021356|NCT04181788|69704484|FG002|TREATMENT|Ongoing|0|||
37833171|NCT01254331|69516787|FG000|Initial Phase|Adverse Event|3|||
37833172|NCT01254331|69516787|FG000|Initial Phase|Withdrawal by Subject|1|||
37833173|NCT01254331|69516787|FG000|Initial Phase|Pregnancy|1|||
37910914|NCT00920855|69597396|FG002|Overall Study|Withdrawal by Subject|6|||
38021357|NCT04181788|69704485|FG003|TREATMENT|Ongoing|5|||
37833174|NCT01254331|69516787|FG000|Extension Phase|Lack of Efficacy|1|||
37833175|NCT01254331|69516787|FG000|Extension Phase|Lost to Follow-up|3|||
37833176|NCT01254292|69516802|FG000|Comparative Phase|Adverse Event|25|||
37833177|NCT01254292|69516803|FG001|Comparative Phase|Adverse Event|25|||
37833178|NCT01254292|69516802|FG000|Comparative Phase|Lost to Follow-up|3|||
37833179|NCT01254292|69516803|FG001|Comparative Phase|Lost to Follow-up|21|||
37833180|NCT01254292|69516802|FG000|Comparative Phase|Pregnancy|2|||
37833181|NCT01254292|69516803|FG001|Comparative Phase|Pregnancy|6|||
37833182|NCT01254292|69516802|FG000|Comparative Phase|Withdrawal by Subject|20|||
37833183|NCT01254292|69516803|FG001|Comparative Phase|Withdrawal by Subject|21|||
37833184|NCT01254292|69516802|FG000|Comparative Phase|Protocol Violation|1|||
37833185|NCT01254292|69516803|FG001|Comparative Phase|Protocol Violation|2|||
37833186|NCT01254292|69516802|FG000|Comparative Phase|Wish for pregnancy|4|||
37833187|NCT01254292|69516803|FG001|Comparative Phase|Wish for pregnancy|6|||
37833188|NCT01254292|69516802|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
37910915|NCT00920855|69597394|FG000|Overall Study|Disease progression|2|||
38021358|NCT04181788|69704486|FG004|TREATMENT|Ongoing|7|||
38021359|NCT04181788|69704487|FG005|TREATMENT|Ongoing|15|||
38021360|NCT04181788|69704482|FG000|FOLLOW-UP|Death|0|||
38021361|NCT04181788|69704483|FG001|FOLLOW-UP|Death|0|||
38021362|NCT04181788|69704484|FG002|FOLLOW-UP|Death|1|||
37833189|NCT01254292|69516803|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
37833190|NCT01254292|69516802|FG000|LCS12 Extension Phase|Adverse Event|9|||
37833191|NCT01254292|69516803|FG001|LCS12 Extension Phase|Adverse Event|0|||
37833192|NCT01254292|69516802|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
37833193|NCT01254292|69516803|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
37833194|NCT01254292|69516802|FG000|LCS12 Extension Phase|Other unknown|4|||
37833195|NCT01254292|69516803|FG001|LCS12 Extension Phase|Other unknown|0|||
37833196|NCT01254292|69516802|FG000|LCS12 Extension Phase|Pregnancy|2|||
37833197|NCT01254292|69516803|FG001|LCS12 Extension Phase|Pregnancy|0|||
37833198|NCT01254292|69516802|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
37833199|NCT01254292|69516803|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
37833200|NCT01254019|69516812|FG000|Overall Study|Adverse Event|0|||
37833201|NCT01254019|69516813|FG001|Overall Study|Adverse Event|2|||
37833202|NCT01254019|69516812|FG000|Overall Study|Protocol Violation|1|||
37833203|NCT01254019|69516813|FG001|Overall Study|Protocol Violation|0|||
37833204|NCT01254019|69516812|FG000|Overall Study|Withdrawal by Subject|0|||
37833205|NCT01254019|69516813|FG001|Overall Study|Withdrawal by Subject|2|||
37833206|NCT01253317|69516822|FG000|Overall Study|Adverse Event|2|||
37833207|NCT01253200|69516835|FG000|Overall Study|Death|1|||
37833208|NCT01253200|69516836|FG001|Overall Study|Death|0|||
37833209|NCT01253200|69516837|FG002|Overall Study|Death|0|||
37833210|NCT01253200|69516838|FG003|Overall Study|Death|0|||
37833211|NCT01253200|69516839|FG004|Overall Study|Death|0|||
37833212|NCT01253200|69516835|FG000|Overall Study|Lost to Follow-up|1|||
37833213|NCT01253200|69516836|FG001|Overall Study|Lost to Follow-up|1|||
37833214|NCT01253200|69516837|FG002|Overall Study|Lost to Follow-up|0|||
37833215|NCT01253200|69516838|FG003|Overall Study|Lost to Follow-up|0|||
37833216|NCT01253200|69516839|FG004|Overall Study|Lost to Follow-up|0|||
37833217|NCT01253200|69516835|FG000|Overall Study|Withdrawal by Subject|2|||
37833218|NCT01253200|69516836|FG001|Overall Study|Withdrawal by Subject|0|||
37833219|NCT01253200|69516837|FG002|Overall Study|Withdrawal by Subject|0|||
37833220|NCT01253200|69516838|FG003|Overall Study|Withdrawal by Subject|0|||
37833221|NCT01253200|69516839|FG004|Overall Study|Withdrawal by Subject|0|||
37833222|NCT01253200|69516835|FG000|Overall Study|Protocol Violation|1|||
38021363|NCT04181788|69704485|FG003|FOLLOW-UP|Death|2|||
37699500|NCT02013687|69176372|FG002|Overall Study|Withdrawal by Subject|0|||
37699501|NCT02013687|69176373|FG003|Overall Study|Withdrawal by Subject|1|||
37699502|NCT02013687|69176370|FG000|Overall Study|Missed visits due to patient travel|0|||
37699503|NCT02013687|69176371|FG001|Overall Study|Missed visits due to patient travel|0|||
37699504|NCT02013687|69176372|FG002|Overall Study|Missed visits due to patient travel|1|||
37699505|NCT02013687|69176373|FG003|Overall Study|Missed visits due to patient travel|0|||
37699506|NCT02013609|69176387|FG000|Overall Study|Withdrawal by Subject|9|||
37833223|NCT01253200|69516836|FG001|Overall Study|Protocol Violation|4|||
37833224|NCT01253200|69516837|FG002|Overall Study|Protocol Violation|0|||
37833225|NCT01253200|69516838|FG003|Overall Study|Protocol Violation|0|||
37833226|NCT01253200|69516839|FG004|Overall Study|Protocol Violation|5|||
37833227|NCT01253200|69516835|FG000|Overall Study|intents|10|||
37833228|NCT01253200|69516836|FG001|Overall Study|intents|10|||
37833229|NCT01253200|69516837|FG002|Overall Study|intents|1|||
37833230|NCT01253200|69516838|FG003|Overall Study|intents|3|||
37833231|NCT01253200|69516839|FG004|Overall Study|intents|0|||
37833232|NCT01253200|69516835|FG000|Overall Study|Attempts|6|||
37833233|NCT01253200|69516836|FG001|Overall Study|Attempts|4|||
37833234|NCT01253200|69516837|FG002|Overall Study|Attempts|1|||
37833235|NCT01253200|69516838|FG003|Overall Study|Attempts|2|||
37833236|NCT01253200|69516839|FG004|Overall Study|Attempts|0|||
37833237|NCT01253044|69516850|FG000|Overall Study|Lost to Follow-up|38|||
37833238|NCT01253044|69516851|FG001|Overall Study|Lost to Follow-up|29|||
37833239|NCT01252966|69516859|FG000|Overall Study|Lost to Follow-up|16|||
37833240|NCT01252966|69516860|FG001|Overall Study|Lost to Follow-up|10|||
37833241|NCT01252966|69516859|FG000|Overall Study|Withdrawal by Subject|7|||
37699507|NCT02013609|69176387|FG000|Overall Study|Lost to Follow-up|3|||
37699508|NCT02013609|69176387|FG000|Overall Study|Adverse Event|3|||
37699509|NCT02013609|69176387|FG000|Overall Study|Met Withdrawal Criteria|3|||
37699510|NCT01988337|69176391|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
37699511|NCT02013531|69176397|FG000|Overall Study|Lost to Follow-up|3|||
37833242|NCT01252966|69516860|FG001|Overall Study|Withdrawal by Subject|3|||
37833243|NCT01252810|69516870|FG000|Overall Study|Withdrawal by Subject|4|||
37833244|NCT01252810|69516871|FG001|Overall Study|Withdrawal by Subject|1|||
37833245|NCT01252810|69516870|FG000|Overall Study|Lost to Follow-up|0|||
37699512|NCT02013531|69176397|FG000|Overall Study|Met Withdrawal Criteria|1|||
37833246|NCT01252810|69516871|FG001|Overall Study|Lost to Follow-up|1|||
37833247|NCT01252810|69516870|FG000|Overall Study|Physician Decision|2|||
37833248|NCT01252810|69516871|FG001|Overall Study|Physician Decision|1|||
37833249|NCT01252810|69516870|FG000|Overall Study|Various reasons|8|||
37833250|NCT01252810|69516871|FG001|Overall Study|Various reasons|0|||
37833251|NCT01252186|69516880|FG000|Overall Study|Adverse Event|9|||
37833252|NCT01252186|69516881|FG001|Overall Study|Adverse Event|6|||
37833253|NCT01252186|69516882|FG002|Overall Study|Adverse Event|8|||
37833254|NCT01252186|69516880|FG000|Overall Study|Withdrawal by Subject|2|||
37833255|NCT01252186|69516881|FG001|Overall Study|Withdrawal by Subject|5|||
37833256|NCT01252186|69516882|FG002|Overall Study|Withdrawal by Subject|2|||
37833257|NCT01252186|69516880|FG000|Overall Study|Physician Decision|0|||
37833258|NCT01252186|69516881|FG001|Overall Study|Physician Decision|0|||
37833259|NCT01252186|69516882|FG002|Overall Study|Physician Decision|1|||
37833260|NCT01252186|69516880|FG000|Overall Study|Non-compliance|0|||
37833261|NCT01252186|69516881|FG001|Overall Study|Non-compliance|3|||
37833262|NCT01252186|69516882|FG002|Overall Study|Non-compliance|4|||
37833263|NCT01252186|69516880|FG000|Overall Study|Protocol Violation|0|||
37833264|NCT01252186|69516881|FG001|Overall Study|Protocol Violation|0|||
37833265|NCT01252186|69516882|FG002|Overall Study|Protocol Violation|1|||
37833266|NCT01252186|69516880|FG000|Overall Study|Pregnancy|2|||
37833267|NCT01252186|69516881|FG001|Overall Study|Pregnancy|2|||
37833268|NCT01252186|69516882|FG002|Overall Study|Pregnancy|0|||
37833269|NCT01252186|69516880|FG000|Overall Study|Sponsor Request|2|||
37833270|NCT01252186|69516881|FG001|Overall Study|Sponsor Request|1|||
37833271|NCT01252186|69516882|FG002|Overall Study|Sponsor Request|0|||
37833272|NCT01252186|69516880|FG000|Overall Study|Lost to Follow-up|10|||
37833273|NCT01252186|69516881|FG001|Overall Study|Lost to Follow-up|10|||
37833274|NCT01252186|69516882|FG002|Overall Study|Lost to Follow-up|11|||
37833275|NCT01252186|69516880|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
37833276|NCT01252186|69516881|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
37833277|NCT01252186|69516882|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
37833278|NCT01251952|69516917|FG000|Overall Study|Adverse Event|1|||
37833279|NCT01251367|69516921|FG000|Overall Study|Protocol Violation|1|||
37833280|NCT01251367|69516921|FG000|Overall Study|Lack of Efficacy|2|||
37833281|NCT01251367|69516921|FG000|Overall Study|Adverse Event|19|||
37699513|NCT02013531|69176397|FG000|Overall Study|Withdrawal by Subject|1|||
37699514|NCT01988103|69176404|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
37699515|NCT01988103|69176405|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
37833282|NCT01251367|69516921|FG000|Overall Study|Withdrawal by Subject|36|||
37833283|NCT01251367|69516921|FG000|Overall Study|Lost to Follow-up|5|||
37910916|NCT00920855|69597395|FG001|Overall Study|Disease progression|1|||
37833284|NCT01251367|69516921|FG000|Overall Study|Subject Required Alternative Treatment|7|||
37833285|NCT01251367|69516921|FG000|Overall Study|No Study Drug Available|1|||
37833286|NCT01251367|69516921|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
37910917|NCT00920855|69597396|FG002|Overall Study|Disease progression|10|||
37833287|NCT01251367|69516921|FG000|Overall Study|End of Study Visit Performed in Error|1|||
37833288|NCT01250509|69516927|FG000|Overall Study|Lost to Follow-up|5|||
37833289|NCT01250509|69516928|FG001|Overall Study|Lost to Follow-up|2|||
37833290|NCT01250119|69516936|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
37833291|NCT01250119|69516937|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
38021364|NCT04181788|69704486|FG004|FOLLOW-UP|Death|8|||
37833292|NCT01250119|69516936|FG000|Diagnostic Phase|Participants Not Tested|44|||
38021365|NCT04181788|69704487|FG005|FOLLOW-UP|Death|20|||
38021366|NCT04181788|69704482|FG000|FOLLOW-UP|Lost to Follow-up|0|||
38021367|NCT04181788|69704483|FG001|FOLLOW-UP|Lost to Follow-up|0|||
37699516|NCT01988103|69176406|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
37699517|NCT01988103|69176407|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
38021368|NCT04181788|69704484|FG002|FOLLOW-UP|Lost to Follow-up|0|||
38021369|NCT04181788|69704485|FG003|FOLLOW-UP|Lost to Follow-up|0|||
38021370|NCT04181788|69704486|FG004|FOLLOW-UP|Lost to Follow-up|0|||
37699518|NCT01988103|69176408|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
37833293|NCT01250119|69516937|FG001|Diagnostic Phase|Participants Not Tested|0|||
37833294|NCT01250119|69516936|FG000|Treatment Phase|Progressive Disease|0|||
37833295|NCT01250119|69516937|FG001|Treatment Phase|Progressive Disease|32|||
37833296|NCT01250119|69516936|FG000|Treatment Phase|Death|0|||
37833297|NCT01250119|69516937|FG001|Treatment Phase|Death|2|||
37833298|NCT01250119|69516936|FG000|Treatment Phase|Withdrawal by Subject|0|||
37833299|NCT01250119|69516937|FG001|Treatment Phase|Withdrawal by Subject|1|||
37833300|NCT01250119|69516936|FG000|Treatment Phase|Adverse Event|0|||
37833301|NCT01250119|69516937|FG001|Treatment Phase|Adverse Event|2|||
37833302|NCT01250119|69516936|FG000|Treatment Phase|Unknown reason|0|||
37833303|NCT01250119|69516937|FG001|Treatment Phase|Unknown reason|4|||
37833304|NCT01250002|69516946|FG000|Overall Study|Change to open surgical procedure|4|||
37833305|NCT01250002|69516947|FG001|Overall Study|Change to open surgical procedure|3|||
37833306|NCT01246960|69516955|FG000|Overall Study|Lost to Follow-up|3|||
37833307|NCT01246960|69516956|FG001|Overall Study|Lost to Follow-up|1|||
37833308|NCT01246960|69516955|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
37833309|NCT01246960|69516956|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
37833310|NCT01244620|69516962|FG000|Overall Study|Study terminated|4|||
37833311|NCT01244620|69516963|FG001|Overall Study|Study terminated|4|||
37833312|NCT01244620|69516964|FG002|Overall Study|Study terminated|4|||
37833313|NCT01244620|69516965|FG003|Overall Study|Study terminated|4|||
37833314|NCT01267201|69516975|FG000|First Intervention Period|Withdrawal by Subject|1|||
37833315|NCT01267201|69516976|FG001|First Intervention Period|Withdrawal by Subject|0|||
37833316|NCT01267201|69516977|FG002|First Intervention Period|Withdrawal by Subject|0|||
37833317|NCT01267201|69516978|FG003|First Intervention Period|Withdrawal by Subject|0|||
37833318|NCT01267201|69516979|FG004|First Intervention Period|Withdrawal by Subject|0|||
37833319|NCT01267201|69516980|FG005|First Intervention Period|Withdrawal by Subject|0|||
37833320|NCT01267201|69516975|FG000|Second Intervention Period|Withdrawal by Subject|0|||
37833321|NCT01267201|69516976|FG001|Second Intervention Period|Withdrawal by Subject|1|||
37833322|NCT01267201|69516977|FG002|Second Intervention Period|Withdrawal by Subject|0|||
37833323|NCT01267201|69516978|FG003|Second Intervention Period|Withdrawal by Subject|0|||
37833324|NCT01267201|69516979|FG004|Second Intervention Period|Withdrawal by Subject|0|||
37833325|NCT01267201|69516980|FG005|Second Intervention Period|Withdrawal by Subject|0|||
37833326|NCT01266967|69516990|FG000|Overall Study|Death|69|||
37833327|NCT01266967|69516991|FG001|Overall Study|Death|61|||
37833328|NCT01266967|69516990|FG000|Overall Study|Study Closed/Terminated|15|||
37833329|NCT01266967|69516991|FG001|Overall Study|Study Closed/Terminated|17|||
37833330|NCT01266967|69516990|FG000|Overall Study|Lost to Follow-up|2|||
37833331|NCT01266967|69516991|FG001|Overall Study|Lost to Follow-up|1|||
37833332|NCT01266967|69516990|FG000|Overall Study|Physician Decision|0|||
37833333|NCT01266967|69516991|FG001|Overall Study|Physician Decision|1|||
37833334|NCT01266967|69516990|FG000|Overall Study|Withdrawal by Subject|3|||
37833335|NCT01266967|69516991|FG001|Overall Study|Withdrawal by Subject|3|||
38021371|NCT04181788|69704487|FG005|FOLLOW-UP|Lost to Follow-up|2|||
38021372|NCT04181788|69704482|FG000|FOLLOW-UP|Withdrawal by Subject|0|||
37833336|NCT01266850|69517005|FG000|Overall Study|Lost to Follow-up|19|||
37833337|NCT01266850|69517006|FG001|Overall Study|Lost to Follow-up|19|||
37833338|NCT01266850|69517007|FG002|Overall Study|Lost to Follow-up|13|||
37699519|NCT01988103|69176404|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
37699520|NCT01988103|69176405|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
37699521|NCT01988103|69176406|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
37699522|NCT01988103|69176407|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
37699523|NCT01988103|69176408|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
37699524|NCT01988103|69176404|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
37699525|NCT01988103|69176405|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
38021373|NCT04181788|69704483|FG001|FOLLOW-UP|Withdrawal by Subject|0|||
38021374|NCT04181788|69704484|FG002|FOLLOW-UP|Withdrawal by Subject|0|||
37833339|NCT01266850|69517008|FG003|Overall Study|Lost to Follow-up|13|||
37833340|NCT01266850|69517009|FG004|Overall Study|Lost to Follow-up|12|||
37833341|NCT01266850|69517005|FG000|Overall Study|Withdrawal by Subject|8|||
37833342|NCT01266850|69517006|FG001|Overall Study|Withdrawal by Subject|9|||
37833343|NCT01266850|69517007|FG002|Overall Study|Withdrawal by Subject|6|||
37833344|NCT01266850|69517008|FG003|Overall Study|Withdrawal by Subject|9|||
37833345|NCT01266850|69517009|FG004|Overall Study|Withdrawal by Subject|12|||
37833346|NCT01266850|69517005|FG000|Overall Study|Physician Decision|3|||
37833347|NCT01266850|69517006|FG001|Overall Study|Physician Decision|6|||
37833348|NCT01266850|69517007|FG002|Overall Study|Physician Decision|4|||
37699526|NCT01988103|69176406|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
37699527|NCT01988103|69176407|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
37833349|NCT01266850|69517008|FG003|Overall Study|Physician Decision|4|||
37833350|NCT01266850|69517009|FG004|Overall Study|Physician Decision|3|||
38021375|NCT04181788|69704485|FG003|FOLLOW-UP|Withdrawal by Subject|0|||
38021376|NCT04181788|69704486|FG004|FOLLOW-UP|Withdrawal by Subject|1|||
38021377|NCT04181788|69704487|FG005|FOLLOW-UP|Withdrawal by Subject|0|||
37833351|NCT01266850|69517005|FG000|Overall Study|Protocol Violation|0|||
37699528|NCT01988103|69176408|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
37910918|NCT00920855|69597394|FG000|Overall Study|Noncompliance to study medication|0|||
38021378|NCT04181788|69704482|FG000|FOLLOW-UP|Other unspecified|0|||
38021379|NCT04181788|69704483|FG001|FOLLOW-UP|Other unspecified|1|||
38021380|NCT04181788|69704484|FG002|FOLLOW-UP|Other unspecified|0|||
38021381|NCT04181788|69704485|FG003|FOLLOW-UP|Other unspecified|0|||
38021382|NCT04181788|69704486|FG004|FOLLOW-UP|Other unspecified|0|||
38021383|NCT04181788|69704487|FG005|FOLLOW-UP|Other unspecified|3|||
38021384|NCT04181788|69704482|FG000|FOLLOW-UP|Ongoing|0|||
38021385|NCT04181788|69704483|FG001|FOLLOW-UP|Ongoing|0|||
38021386|NCT04181788|69704484|FG002|FOLLOW-UP|Ongoing|1|||
38021387|NCT04181788|69704485|FG003|FOLLOW-UP|Ongoing|3|||
38021388|NCT04181788|69704486|FG004|FOLLOW-UP|Ongoing|2|||
38021389|NCT04181788|69704487|FG005|FOLLOW-UP|Ongoing|2|||
38021390|NCT04120194|69704510|FG000|Overall Study|Lost to Follow-up|11|||
38021391|NCT04120194|69704511|FG001|Overall Study|Lost to Follow-up|8|||
38021392|NCT04120194|69704510|FG000|Overall Study|Adverse Event|4|||
37833352|NCT01266850|69517006|FG001|Overall Study|Protocol Violation|1|||
37833353|NCT01266850|69517007|FG002|Overall Study|Protocol Violation|0|||
37910919|NCT00920855|69597395|FG001|Overall Study|Noncompliance to study medication|0|||
37910920|NCT00920855|69597396|FG002|Overall Study|Noncompliance to study medication|1|||
37910921|NCT00920855|69597394|FG000|Overall Study|Response plateau; started maintenance|0|||
37910922|NCT00920855|69597395|FG001|Overall Study|Response plateau; started maintenance|0|||
37910923|NCT00920855|69597396|FG002|Overall Study|Response plateau; started maintenance|1|||
37910924|NCT00742209|69597410|FG000|Overall Study|Adverse Event|11|||
37699529|NCT01988103|69176404|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
37699530|NCT01988103|69176405|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
37833354|NCT01266850|69517008|FG003|Overall Study|Protocol Violation|1|||
37833355|NCT01266850|69517009|FG004|Overall Study|Protocol Violation|2|||
37833356|NCT01266850|69517005|FG000|Overall Study|Adverse Event|0|||
37833357|NCT01266850|69517006|FG001|Overall Study|Adverse Event|0|||
38021393|NCT04120194|69704511|FG001|Overall Study|Adverse Event|5|||
37833358|NCT01266850|69517007|FG002|Overall Study|Adverse Event|0|||
37833359|NCT01266850|69517008|FG003|Overall Study|Adverse Event|0|||
37910925|NCT00742209|69597411|FG001|Overall Study|Adverse Event|4|||
37699531|NCT01988103|69176406|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
37833360|NCT01266850|69517009|FG004|Overall Study|Adverse Event|1|||
37833361|NCT01266850|69517005|FG000|Overall Study|Site Closure|0|||
37833362|NCT01266850|69517006|FG001|Overall Study|Site Closure|1|||
37833363|NCT01266850|69517007|FG002|Overall Study|Site Closure|1|||
37833364|NCT01266850|69517008|FG003|Overall Study|Site Closure|1|||
37833365|NCT01266850|69517009|FG004|Overall Study|Site Closure|0|||
37833366|NCT01266460|69517021|FG000|Overall Study|Adverse Event|3|||
37833367|NCT01266460|69517021|FG000|Overall Study|Withdrawal by Subject|5|||
38021394|NCT04120194|69704510|FG000|Overall Study|Voluntary withdrawal unrelated to adverse event|1|||
38021395|NCT04120194|69704511|FG001|Overall Study|Voluntary withdrawal unrelated to adverse event|2|||
38021396|NCT04120194|69704510|FG000|Overall Study|Miscellaneous|4|||
38021397|NCT04120194|69704511|FG001|Overall Study|Miscellaneous|5|||
37833368|NCT01266460|69517021|FG000|Overall Study|Disease Progression|18|||
37833369|NCT01266460|69517021|FG000|Overall Study|Not otherwise specified|8|||
37833370|NCT01266265|69517027|FG000|Overall Study|Death|95|||
37833371|NCT01266265|69517028|FG001|Overall Study|Death|73|||
37833372|NCT01266265|69517027|FG000|Overall Study|Lost to Follow-up|23|||
37833373|NCT01266265|69517028|FG001|Overall Study|Lost to Follow-up|28|||
37833374|NCT01266265|69517027|FG000|Overall Study|Withdrawal by Subject|13|||
37833375|NCT01266265|69517028|FG001|Overall Study|Withdrawal by Subject|11|||
37833376|NCT01266265|69517027|FG000|Overall Study|Respiratory-related adverse event|2|||
37833377|NCT01266265|69517028|FG001|Overall Study|Respiratory-related adverse event|1|||
37833378|NCT01266265|69517027|FG000|Overall Study|Transferred care to another provider|22|||
37833379|NCT01266265|69517028|FG001|Overall Study|Transferred care to another provider|28|||
37833380|NCT01266265|69517027|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
37833381|NCT01266265|69517028|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
37833382|NCT01266265|69517027|FG000|Overall Study|Enrolled in another clinical study|15|||
37833383|NCT01266265|69517028|FG001|Overall Study|Enrolled in another clinical study|26|||
37833384|NCT01266265|69517027|FG000|Overall Study|Non-compliance|8|||
37833385|NCT01266265|69517028|FG001|Overall Study|Non-compliance|5|||
37833386|NCT01266265|69517027|FG000|Overall Study|Lung transplant|6|||
37833387|NCT01266265|69517028|FG001|Overall Study|Lung transplant|5|||
37833388|NCT01266265|69517027|FG000|Overall Study|Site closed early|4|||
37833389|NCT01266265|69517028|FG001|Overall Study|Site closed early|3|||
37833390|NCT01266265|69517027|FG000|Overall Study|Clinical worsening|1|||
37833391|NCT01266265|69517028|FG001|Overall Study|Clinical worsening|1|||
37833392|NCT01266148|69517053|FG000|Overall Study|Adverse Event|2|||
37833393|NCT01266148|69517054|FG001|Overall Study|Adverse Event|0|||
37833394|NCT01266148|69517053|FG000|Overall Study|Ongoing rejection|1|||
37833395|NCT01266148|69517054|FG001|Overall Study|Ongoing rejection|0|||
37833396|NCT01266148|69517053|FG000|Overall Study|2 2R rejections|1|||
37833397|NCT01266148|69517054|FG001|Overall Study|2 2R rejections|0|||
37833398|NCT01266148|69517053|FG000|Overall Study|Death|2|||
37833399|NCT01266148|69517054|FG001|Overall Study|Death|3|||
38021398|NCT04050670|69704517|FG000|Period 3|Physician Decision|0|||
37833400|NCT01266148|69517053|FG000|Overall Study|missing mGFR value + AE|1|||
37833401|NCT01266148|69517054|FG001|Overall Study|missing mGFR value + AE|0|||
37833402|NCT01266070|69517060|FG000|Overall Study|Adverse Event|3|||
37833403|NCT01266070|69517060|FG000|Overall Study|Protocol Violation|1|||
37833404|NCT01265992|69517064|FG000|Overall Study|Lost to Follow-up|1|||
37833405|NCT01265992|69517064|FG000|Overall Study|Withdrawal by Subject|1|||
37833406|NCT01265992|69517064|FG000|Overall Study|Adverse Event|1|||
37833407|NCT01265992|69517064|FG000|Overall Study|Administrative reasons|2|||
37833408|NCT01265992|69517064|FG000|Overall Study|Stopped treatment|3|||
37833409|NCT01265992|69517064|FG000|Overall Study|Did not receive treatment|1|||
37833410|NCT01265953|69517070|FG000|Overall Study|Non compliance|5|||
37833411|NCT01265953|69517071|FG001|Overall Study|Non compliance|3|||
37833412|NCT01265875|69517077|FG000|Overall Study|Uncooperative/unreliable|1|||
37833413|NCT01265797|69517084|FG000|Run-in Month|Withdrawal by Subject|0|||
37833414|NCT01265797|69517085|FG001|Run-in Month|Withdrawal by Subject|4|||
37833415|NCT01265797|69517084|FG000|Run-in Month|1st seizure during run-in month|0|||
37833416|NCT01265797|69517085|FG001|Run-in Month|1st seizure during run-in month|1|||
37910926|NCT00742209|69597412|FG002|Overall Study|Adverse Event|17|||
37910927|NCT00742209|69597413|FG003|Overall Study|Adverse Event|16|||
37910928|NCT00742209|69597414|FG004|Overall Study|Adverse Event|13|||
37699532|NCT01988103|69176407|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
37699533|NCT01988103|69176408|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
37699534|NCT01988103|69176404|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
37699535|NCT01988103|69176405|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
37699536|NCT01988103|69176406|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
37699537|NCT01988103|69176407|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
37699538|NCT01988103|69176408|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
37699539|NCT01988103|69176404|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
37699540|NCT01988103|69176405|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
37699541|NCT01988103|69176406|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
37699542|NCT01988103|69176407|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
37699543|NCT01988103|69176408|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
37699544|NCT01988103|69176404|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
37699545|NCT01988103|69176405|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
37699546|NCT01988103|69176406|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
37699547|NCT01988103|69176407|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
37699548|NCT01988103|69176408|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
37699549|NCT02013375|69176423|FG000|Overall Study|Did not engraft|1|||
37699550|NCT02013375|69176423|FG000|Overall Study|Did not engraft|1|||
37699551|NCT02079519|69176428|FG000|Overall Study|Disease Progression|9|||
37699552|NCT02079519|69176428|FG000|Overall Study|Adverse Event|1|||
37699553|NCT01987557|69176435|FG000|Overall Study|Protocol Violation|1|||
37699554|NCT01987557|69176436|FG001|Overall Study|Protocol Violation|0|||
37699555|NCT01987557|69176437|FG002|Overall Study|Protocol Violation|1|||
37699556|NCT01987557|69176435|FG000|Overall Study|Withdrawal by Subject|2|||
37833417|NCT01265797|69517084|FG000|Blinded Month|Lack of Efficacy|5|||
37699557|NCT01987557|69176436|FG001|Overall Study|Withdrawal by Subject|1|||
37833418|NCT01265797|69517085|FG001|Blinded Month|Lack of Efficacy|0|||
37833419|NCT01265797|69517084|FG000|Blinded Month|Lost to Follow-up|1|||
37833420|NCT01265797|69517085|FG001|Blinded Month|Lost to Follow-up|0|||
37833421|NCT01265797|69517084|FG000|Blinded Month|Protocol Violation|2|||
37833422|NCT01265797|69517085|FG001|Blinded Month|Protocol Violation|1|||
37833423|NCT01265797|69517084|FG000|Blinded Month|Adverse Event|2|||
37833424|NCT01265797|69517085|FG001|Blinded Month|Adverse Event|0|||
37833425|NCT01265797|69517084|FG000|Blinded Month|Diary data incomplete|0|||
37833426|NCT01265797|69517085|FG001|Blinded Month|Diary data incomplete|1|||
37833427|NCT01265797|69517084|FG000|Open Label Month|Lost to Follow-up|0|||
37833428|NCT01265797|69517085|FG001|Open Label Month|Lost to Follow-up|1|||
37833429|NCT01265719|69517095|FG000|Overall Study|Does not meet entrance criteria|0|||
37833430|NCT01265719|69517096|FG001|Overall Study|Does not meet entrance criteria|3|||
37833431|NCT01265719|69517095|FG000|Overall Study|Other reasons|2|||
37833432|NCT01265719|69517096|FG001|Overall Study|Other reasons|0|||
37833433|NCT01265719|69517095|FG000|Overall Study|Withdrawal by Subject|8|||
37833434|NCT01265719|69517096|FG001|Overall Study|Withdrawal by Subject|3|||
37833435|NCT01265719|69517095|FG000|Overall Study|Lost to Follow-up|2|||
37833436|NCT01265719|69517096|FG001|Overall Study|Lost to Follow-up|7|||
37833437|NCT01265719|69517095|FG000|Overall Study|Adverse Event|2|||
37833438|NCT01265719|69517096|FG001|Overall Study|Adverse Event|0|||
37833439|NCT01265563|69517128|FG000|Overall Study|Withdrawal by Subject|0|||
37833440|NCT01265563|69517129|FG001|Overall Study|Withdrawal by Subject|1|||
37833441|NCT01265563|69517130|FG002|Overall Study|Withdrawal by Subject|1|||
37833442|NCT01265563|69517131|FG003|Overall Study|Withdrawal by Subject|0|||
37833443|NCT01265563|69517132|FG004|Overall Study|Withdrawal by Subject|2|||
37833444|NCT01265056|69517151|FG000|Initial Study Period|Withdrawal by Subject|1|||
37833445|NCT01265056|69517152|FG001|Initial Study Period|Withdrawal by Subject|1|||
37833446|NCT01265056|69517151|FG000|Initial Study Period|Withdrawal by Subject|1|||
37833447|NCT01265056|69517152|FG001|Initial Study Period|Withdrawal by Subject|1|||
37833448|NCT01265056|69517151|FG000|Follow up|Lost to Follow-up|7|||
37833449|NCT01265056|69517152|FG001|Follow up|Lost to Follow-up|3|||
37833450|NCT01264939|69517160|FG000|Overall Study|Adverse Event|1|||
37833451|NCT01264939|69517161|FG001|Overall Study|Adverse Event|3|||
37833452|NCT01264939|69517160|FG000|Overall Study|Lost to Follow-up|0|||
37833453|NCT01264939|69517161|FG001|Overall Study|Lost to Follow-up|3|||
37833454|NCT01264939|69517160|FG000|Overall Study|Physician Decision|1|||
37833455|NCT01264939|69517161|FG001|Overall Study|Physician Decision|1|||
37833456|NCT01264939|69517160|FG000|Overall Study|Patient/Guardian Decision|8|||
37833457|NCT01264939|69517161|FG001|Overall Study|Patient/Guardian Decision|10|||
37833458|NCT01264939|69517160|FG000|Overall Study|Disease Progression|8|||
37833459|NCT01264939|69517161|FG001|Overall Study|Disease Progression|11|||
37833460|NCT01264081|69517167|FG000|Participants Screened|Screening failures|30|||
37833461|NCT01264081|69517167|FG000|Started Treatment|Withdrawal by Subject|1|||
37833462|NCT01264081|69517167|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
37833463|NCT01263925|69517173|FG000|Overall Study|Protocol Violation|1|||
38021399|NCT04050670|69704518|FG001|Period 3|Physician Decision|1|||
38021400|NCT04050670|69704519|FG002|Period 3|Physician Decision|0|||
38021401|NCT04016714|69704542|FG000|Overall Study|Death|1|||
37699558|NCT01987557|69176437|FG002|Overall Study|Withdrawal by Subject|2|||
37833464|NCT01263925|69517174|FG001|Overall Study|Protocol Violation|0|||
37833465|NCT01263925|69517173|FG000|Overall Study|Lack of Efficacy|0|||
37833466|NCT01263925|69517174|FG001|Overall Study|Lack of Efficacy|1|||
37833467|NCT01263925|69517173|FG000|Overall Study|Adverse Event|23|||
37833468|NCT01263925|69517174|FG001|Overall Study|Adverse Event|22|||
37910929|NCT00742209|69597410|FG000|Overall Study|Participant Withdrew Consent|8|||
37910930|NCT00742209|69597411|FG001|Overall Study|Participant Withdrew Consent|4|||
37833469|NCT01263925|69517173|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
37833470|NCT01263925|69517174|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
38021402|NCT04016714|69704543|FG001|Overall Study|Death|0|||
37699559|NCT01987557|69176435|FG000|Overall Study|Adverse Event|0|||
37833471|NCT01263925|69517173|FG000|Overall Study|Withdrawal by Subject|6|||
37833472|NCT01263925|69517174|FG001|Overall Study|Withdrawal by Subject|8|||
37833473|NCT01263925|69517173|FG000|Overall Study|Other|4|||
37910931|NCT00742209|69597412|FG002|Overall Study|Participant Withdrew Consent|14|||
38021403|NCT04016714|69704542|FG000|Overall Study|Lost to Follow-up|3|||
37833474|NCT01263925|69517174|FG001|Overall Study|Other|4|||
37833475|NCT01263925|69517173|FG000|Overall Study|Lost to Follow-up|3|||
37833476|NCT01263925|69517174|FG001|Overall Study|Lost to Follow-up|1|||
37833477|NCT01263925|69517173|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
37833478|NCT01263925|69517174|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
37833479|NCT01263925|69517173|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
37833480|NCT01263925|69517174|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
37833481|NCT01263925|69517173|FG000|Overall Study|AE/ Withdrawal|1|||
37833482|NCT01263925|69517174|FG001|Overall Study|AE/ Withdrawal|4|||
37833483|NCT01263925|69517173|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
37833484|NCT01263925|69517174|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
37833485|NCT01263925|69517173|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
37910932|NCT00742209|69597413|FG003|Overall Study|Participant Withdrew Consent|7|||
38021404|NCT04016714|69704543|FG001|Overall Study|Lost to Follow-up|1|||
38021405|NCT04016714|69704542|FG000|Overall Study|Physician Decision|3|||
38021406|NCT04016714|69704543|FG001|Overall Study|Physician Decision|3|||
38021407|NCT04016714|69704542|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
38021408|NCT04016714|69704543|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
37910933|NCT00742209|69597414|FG004|Overall Study|Participant Withdrew Consent|4|||
37910934|NCT00742209|69597410|FG000|Overall Study|Protocol Violation|6|||
37910935|NCT00742209|69597411|FG001|Overall Study|Protocol Violation|5|||
38021409|NCT03997409|69704552|FG000|Overall Study|Protocol Violation|1|||
38021410|NCT03997409|69704553|FG001|Overall Study|Protocol Violation|1|||
38021411|NCT03997409|69704554|FG002|Overall Study|Protocol Violation|0|||
38021412|NCT03997409|69704552|FG000|Overall Study|Withdrawal by Subject|3|||
38021413|NCT03997409|69704553|FG001|Overall Study|Withdrawal by Subject|0|||
38021414|NCT03997409|69704554|FG002|Overall Study|Withdrawal by Subject|0|||
38021415|NCT03997409|69704552|FG000|Overall Study|Lost to Follow-up|0|||
38021416|NCT03997409|69704553|FG001|Overall Study|Lost to Follow-up|0|||
38021417|NCT03997409|69704554|FG002|Overall Study|Lost to Follow-up|1|||
38021418|NCT03946124|69704562|FG000|Overall Study|Withdrawal by Subject|19|||
38021419|NCT03812029|69704571|FG000|Overall Study|Protocol Violation|1|||
38021420|NCT03812029|69704572|FG001|Overall Study|Protocol Violation|0|||
38021421|NCT03812029|69704573|FG002|Overall Study|Protocol Violation|0|||
38021422|NCT03812029|69704574|FG003|Overall Study|Protocol Violation|1|||
38021423|NCT03812029|69704575|FG004|Overall Study|Protocol Violation|0|||
38021424|NCT03812029|69704571|FG000|Overall Study|Withdrawal by Subject|1|||
38021425|NCT03812029|69704572|FG001|Overall Study|Withdrawal by Subject|0|||
38021426|NCT03812029|69704573|FG002|Overall Study|Withdrawal by Subject|0|||
38021427|NCT03812029|69704574|FG003|Overall Study|Withdrawal by Subject|2|||
37699560|NCT01987557|69176436|FG001|Overall Study|Adverse Event|2|||
37699561|NCT01987557|69176437|FG002|Overall Study|Adverse Event|0|||
37699562|NCT02078817|69176445|FG000|Overall Study|Withdrawal by Subject|1|||
37699563|NCT02011893|69176449|FG000|Enrollment to Randomization|Adverse Event|2|||
38021428|NCT03812029|69704575|FG004|Overall Study|Withdrawal by Subject|2|||
38021429|NCT03812029|69704571|FG000|Overall Study|Stopping rules|0|||
37699564|NCT02011893|69176450|FG001|Enrollment to Randomization|Adverse Event|0|||
37699565|NCT02011893|69176451|FG002|Enrollment to Randomization|Adverse Event|0|||
37699566|NCT02011893|69176449|FG000|Enrollment to Randomization|Physician Decision|10|||
38021430|NCT03812029|69704572|FG001|Overall Study|Stopping rules|1|||
38021431|NCT03812029|69704573|FG002|Overall Study|Stopping rules|0|||
37699567|NCT02011893|69176450|FG001|Enrollment to Randomization|Physician Decision|0|||
37699568|NCT02011893|69176451|FG002|Enrollment to Randomization|Physician Decision|0|||
37699569|NCT02011893|69176449|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
37699570|NCT02011893|69176450|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
37699571|NCT02011893|69176451|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
38021432|NCT03812029|69704574|FG003|Overall Study|Stopping rules|0|||
37699572|NCT02011893|69176449|FG000|Enrollment to Randomization|Screening Failure|29|||
37699573|NCT02011893|69176450|FG001|Enrollment to Randomization|Screening Failure|0|||
37699574|NCT02011893|69176451|FG002|Enrollment to Randomization|Screening Failure|0|||
37910936|NCT00742209|69597412|FG002|Overall Study|Protocol Violation|4|||
37910937|NCT00742209|69597413|FG003|Overall Study|Protocol Violation|5|||
38021433|NCT03812029|69704575|FG004|Overall Study|Stopping rules|0|||
37833486|NCT01263925|69517174|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
37833487|NCT01263925|69517173|FG000|Overall Study|Withdrawal/ Not specified|0|||
37833488|NCT01263925|69517174|FG001|Overall Study|Withdrawal/ Not specified|1|||
38021434|NCT03812029|69704571|FG000|Overall Study|Adverse Event|0|||
38021435|NCT03812029|69704572|FG001|Overall Study|Adverse Event|9|||
38021436|NCT03812029|69704573|FG002|Overall Study|Adverse Event|0|||
38021437|NCT03812029|69704574|FG003|Overall Study|Adverse Event|3|||
38021438|NCT03812029|69704575|FG004|Overall Study|Adverse Event|5|||
38021439|NCT03812029|69704571|FG000|Overall Study|Lost to Follow-up|0|||
38021440|NCT03812029|69704572|FG001|Overall Study|Lost to Follow-up|0|||
38021441|NCT03812029|69704573|FG002|Overall Study|Lost to Follow-up|0|||
38021442|NCT03812029|69704574|FG003|Overall Study|Lost to Follow-up|0|||
38021443|NCT03812029|69704575|FG004|Overall Study|Lost to Follow-up|3|||
38021444|NCT03747575|69704593|FG000|Overall Study|Withdrawal by Subject|6|||
38021445|NCT03747575|69704594|FG001|Overall Study|Withdrawal by Subject|3|||
38021446|NCT03747575|69704593|FG000|Overall Study|Lost to Follow-up|3|||
37833489|NCT01263691|69517186|FG000|Overall Study|Lost to Follow-up|1|||
37910938|NCT00742209|69597414|FG004|Overall Study|Protocol Violation|3|||
37699575|NCT02011893|69176449|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
37833490|NCT01263691|69517187|FG001|Overall Study|Lost to Follow-up|0|||
37833491|NCT01263691|69517188|FG002|Overall Study|Lost to Follow-up|1|||
37833492|NCT01263691|69517189|FG003|Overall Study|Lost to Follow-up|1|||
37833493|NCT01263691|69517190|FG004|Overall Study|Lost to Follow-up|0|||
37833494|NCT01263691|69517191|FG005|Overall Study|Lost to Follow-up|0|||
37833495|NCT01263691|69517186|FG000|Overall Study|Withdrawal by Subject|1|||
37833496|NCT01263691|69517187|FG001|Overall Study|Withdrawal by Subject|0|||
37833497|NCT01263691|69517188|FG002|Overall Study|Withdrawal by Subject|0|||
37833498|NCT01263691|69517189|FG003|Overall Study|Withdrawal by Subject|0|||
37833499|NCT01263691|69517190|FG004|Overall Study|Withdrawal by Subject|0|||
37833500|NCT01263691|69517191|FG005|Overall Study|Withdrawal by Subject|0|||
37833501|NCT01263691|69517186|FG000|Overall Study|Adverse Event|1|||
37833502|NCT01263691|69517187|FG001|Overall Study|Adverse Event|0|||
37833503|NCT01263691|69517188|FG002|Overall Study|Adverse Event|0|||
37833504|NCT01263691|69517189|FG003|Overall Study|Adverse Event|0|||
37910939|NCT00742209|69597410|FG000|Overall Study|Lost to Follow-up|3|||
37910940|NCT00742209|69597411|FG001|Overall Study|Lost to Follow-up|4|||
38021447|NCT03747575|69704594|FG001|Overall Study|Lost to Follow-up|3|||
38021448|NCT03747575|69704593|FG000|Overall Study|Adverse Event|0|||
38021449|NCT03747575|69704594|FG001|Overall Study|Adverse Event|1|||
37910941|NCT00742209|69597412|FG002|Overall Study|Lost to Follow-up|5|||
37910942|NCT00742209|69597413|FG003|Overall Study|Lost to Follow-up|5|||
37910943|NCT00742209|69597414|FG004|Overall Study|Lost to Follow-up|3|||
37910944|NCT00742209|69597410|FG000|Overall Study|Lack of Efficacy|6|||
37910945|NCT00742209|69597411|FG001|Overall Study|Lack of Efficacy|1|||
37910946|NCT00742209|69597412|FG002|Overall Study|Lack of Efficacy|1|||
37910947|NCT00742209|69597413|FG003|Overall Study|Lack of Efficacy|3|||
37910948|NCT00742209|69597414|FG004|Overall Study|Lack of Efficacy|1|||
37910949|NCT00742209|69597410|FG000|Overall Study|Investigator Discretion|0|||
37910950|NCT00742209|69597411|FG001|Overall Study|Investigator Discretion|0|||
37910951|NCT00742209|69597412|FG002|Overall Study|Investigator Discretion|5|||
37910952|NCT00742209|69597413|FG003|Overall Study|Investigator Discretion|1|||
37910953|NCT00742209|69597414|FG004|Overall Study|Investigator Discretion|1|||
38021450|NCT03657043|69704603|FG000|Overall Study|Withdrawal by Subject|1|||
38021451|NCT03657043|69704604|FG001|Overall Study|Withdrawal by Subject|1|||
37910954|NCT00741819|69597427|FG000|Overall Study|Adverse Event|3|||
38021452|NCT03657043|69704605|FG002|Overall Study|Withdrawal by Subject|0|||
37833505|NCT01263691|69517190|FG004|Overall Study|Adverse Event|0|||
37833506|NCT01263691|69517191|FG005|Overall Study|Adverse Event|0|||
38021453|NCT03657043|69704606|FG003|Overall Study|Withdrawal by Subject|0|||
38021454|NCT03657043|69704607|FG004|Overall Study|Withdrawal by Subject|4|||
38021455|NCT03657043|69704603|FG000|Overall Study|Study closure by Sponsor|0|||
38021456|NCT03657043|69704604|FG001|Overall Study|Study closure by Sponsor|2|||
38021457|NCT03657043|69704605|FG002|Overall Study|Study closure by Sponsor|0|||
38021458|NCT03657043|69704606|FG003|Overall Study|Study closure by Sponsor|0|||
38021459|NCT03657043|69704607|FG004|Overall Study|Study closure by Sponsor|17|||
38021460|NCT03657043|69704603|FG000|Overall Study|Lost to Follow-up|0|||
38021461|NCT03657043|69704604|FG001|Overall Study|Lost to Follow-up|0|||
38021462|NCT03657043|69704605|FG002|Overall Study|Lost to Follow-up|0|||
38021463|NCT03657043|69704606|FG003|Overall Study|Lost to Follow-up|0|||
38021464|NCT03657043|69704607|FG004|Overall Study|Lost to Follow-up|4|||
38021465|NCT03657043|69704603|FG000|Overall Study|Death|6|||
37699576|NCT02011893|69176450|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
38021466|NCT03657043|69704604|FG001|Overall Study|Death|5|||
38021467|NCT03657043|69704605|FG002|Overall Study|Death|0|||
38021468|NCT03657043|69704606|FG003|Overall Study|Death|0|||
38021469|NCT03657043|69704607|FG004|Overall Study|Death|53|||
37833507|NCT01263496|69517268|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
38021470|NCT03657043|69704603|FG000|Overall Study|Met exclusion criteria after enrollment|1|||
38021471|NCT03657043|69704604|FG001|Overall Study|Met exclusion criteria after enrollment|0|||
38021472|NCT03657043|69704605|FG002|Overall Study|Met exclusion criteria after enrollment|0|||
38021473|NCT03657043|69704606|FG003|Overall Study|Met exclusion criteria after enrollment|0|||
38021474|NCT03657043|69704607|FG004|Overall Study|Met exclusion criteria after enrollment|0|||
38021475|NCT03657043|69704603|FG000|Overall Study|Adverse Event|0|||
38021476|NCT03657043|69704604|FG001|Overall Study|Adverse Event|0|||
38021477|NCT03657043|69704605|FG002|Overall Study|Adverse Event|0|||
38021478|NCT03657043|69704606|FG003|Overall Study|Adverse Event|0|||
38021479|NCT03657043|69704607|FG004|Overall Study|Adverse Event|2|||
38021480|NCT03657043|69704603|FG000|Overall Study|Withdrawal - subsequent treatment|0|||
37833508|NCT01263496|69517269|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
37833509|NCT01263496|69517270|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
38021481|NCT03657043|69704604|FG001|Overall Study|Withdrawal - subsequent treatment|0|||
38021482|NCT03657043|69704605|FG002|Overall Study|Withdrawal - subsequent treatment|0|||
38021483|NCT03657043|69704606|FG003|Overall Study|Withdrawal - subsequent treatment|0|||
38021484|NCT03657043|69704607|FG004|Overall Study|Withdrawal - subsequent treatment|1|||
38021548|NCT03526861|69704656|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
38043449|NCT03954704|69731549|FG004|Overall Study|Study Terminated by Sponsor|1|||
37833620|NCT01262872|69517334|FG007|Step 2|Migrated/moved from study area|3|||
37833621|NCT01262677|69517371|FG000|Overall Study|Does not meet entrance criteria|0|||
37833622|NCT01262677|69517372|FG001|Overall Study|Does not meet entrance criteria|2|||
37833623|NCT01262677|69517373|FG002|Overall Study|Does not meet entrance criteria|0|||
37833624|NCT01262677|69517371|FG000|Overall Study|Insufficient clinical response|0|||
37833625|NCT01262677|69517372|FG001|Overall Study|Insufficient clinical response|0|||
37910987|NCT00915551|69597516|FG000|Overall Study|Withdrawal by Subject|0|||
37910988|NCT00915551|69597517|FG001|Overall Study|Withdrawal by Subject|1|||
37910989|NCT00915473|69597525|FG000|Screening|Withdrawal by Subject|1|||
37910990|NCT00915473|69597526|FG001|Screening|Withdrawal by Subject|0|||
37910991|NCT00915473|69597525|FG000|4-week Follow Up|Lost to Follow-up|1|||
37833626|NCT01262677|69517373|FG002|Overall Study|Insufficient clinical response|1|||
37833627|NCT01262677|69517371|FG000|Overall Study|Lost to Follow-up|1|||
37833628|NCT01262677|69517372|FG001|Overall Study|Lost to Follow-up|0|||
37833629|NCT01262677|69517373|FG002|Overall Study|Lost to Follow-up|2|||
37833630|NCT01262677|69517371|FG000|Overall Study|No longer willing to participate|3|||
37833631|NCT01262677|69517372|FG001|Overall Study|No longer willing to participate|3|||
37910992|NCT00915473|69597526|FG001|4-week Follow Up|Lost to Follow-up|5|||
37910993|NCT00917501|69597534|FG000|Overall Study|Lost to Follow-up|4|||
37910994|NCT00917501|69597535|FG001|Overall Study|Lost to Follow-up|1|||
37910995|NCT00917501|69597534|FG000|Overall Study|Withdrawal by Subject|3|||
37910996|NCT00917501|69597535|FG001|Overall Study|Withdrawal by Subject|1|||
37910997|NCT00917501|69597534|FG000|Overall Study|Lack of Efficacy|1|||
37910998|NCT00917501|69597535|FG001|Overall Study|Lack of Efficacy|2|||
37910999|NCT00917501|69597534|FG000|Overall Study|trouble swollowing capsules|0|||
37911000|NCT00917501|69597535|FG001|Overall Study|trouble swollowing capsules|1|||
37911001|NCT00917267|69597554|FG000|Overall Study|Adverse Event|15|||
37699585|NCT02011893|69176450|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
37699586|NCT02011893|69176451|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
37699587|NCT02011893|69176449|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
37699588|NCT02011893|69176450|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
37699589|NCT02011893|69176451|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
37699590|NCT02011113|69176456|FG000|Overall Study|Adverse Event|4|||
37699591|NCT02011113|69176456|FG000|Overall Study|Disease Progression (DP)|16|||
37699592|NCT02011113|69176456|FG000|Overall Study|Death|1|||
37699593|NCT02011113|69176456|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
37699594|NCT02011113|69176456|FG000|Overall Study|Investigator's judgement- DP|3|||
37699595|NCT02011113|69176456|FG000|Overall Study|Study terminated by sponsor|11|||
37699596|NCT01807156|69176461|FG000|Overall Study|Physician Decision|1|||
37699597|NCT01987479|69176465|FG000|Overall Study|Protocol Violation|1|||
37699598|NCT01987479|69176465|FG000|Overall Study|Physician Decision|2|||
37699599|NCT01987479|69176465|FG000|Overall Study|Participant/legal guardian decision|1|||
37699600|NCT01987479|69176465|FG000|Overall Study|Other|5|||
37699601|NCT01987479|69176465|FG000|Overall Study|Lost to Follow-up|1|||
37699602|NCT01987479|69176465|FG000|Overall Study|Adverse Event|7|||
37699603|NCT01620489|69176471|FG000|Overall Study|Adverse Event|17|||
37699604|NCT01620489|69176472|FG001|Overall Study|Adverse Event|4|||
37699605|NCT01620489|69176471|FG000|Overall Study|Protocol Violation|0|||
37699606|NCT01620489|69176472|FG001|Overall Study|Protocol Violation|3|||
37699607|NCT01620489|69176471|FG000|Overall Study|Withdrawal Criteria|17|||
37699608|NCT01620489|69176472|FG001|Overall Study|Withdrawal Criteria|25|||
37699609|NCT01620489|69176471|FG000|Overall Study|Unclassified|1|||
37699610|NCT01620489|69176472|FG001|Overall Study|Unclassified|2|||
37699611|NCT02076165|69176480|FG000|Overall Study|Lost to Follow-up|7|||
37699612|NCT02076165|69176481|FG001|Overall Study|Lost to Follow-up|5|||
37699613|NCT02076165|69176480|FG000|Overall Study|Refused follow-up assessment|1|||
37699614|NCT02076165|69176481|FG001|Overall Study|Refused follow-up assessment|1|||
37699615|NCT01620255|69176492|FG000|Overall Study|Withdrawal by Subject|4|||
37699616|NCT01620255|69176493|FG001|Overall Study|Withdrawal by Subject|1|||
37699617|NCT01620255|69176494|FG002|Overall Study|Withdrawal by Subject|1|||
37699618|NCT01620255|69176495|FG003|Overall Study|Withdrawal by Subject|2|||
37699619|NCT01620255|69176496|FG004|Overall Study|Withdrawal by Subject|4|||
37699620|NCT01620255|69176492|FG000|Overall Study|Participant underwent fecal transplant|0|||
37699621|NCT01620255|69176493|FG001|Overall Study|Participant underwent fecal transplant|0|||
37699622|NCT01620255|69176494|FG002|Overall Study|Participant underwent fecal transplant|1|||
37699623|NCT01620255|69176495|FG003|Overall Study|Participant underwent fecal transplant|0|||
37699624|NCT01620255|69176496|FG004|Overall Study|Participant underwent fecal transplant|0|||
37699625|NCT01620255|69176492|FG000|Overall Study|Non-compliance|0|||
37699626|NCT01620255|69176493|FG001|Overall Study|Non-compliance|1|||
37699627|NCT01620255|69176494|FG002|Overall Study|Non-compliance|0|||
37833632|NCT01262677|69517373|FG002|Overall Study|No longer willing to participate|2|||
37833633|NCT01262677|69517371|FG000|Overall Study|Reason not provided|2|||
37911002|NCT00917267|69597555|FG001|Overall Study|Adverse Event|36|||
37911003|NCT00917267|69597554|FG000|Overall Study|Physician Decision|2|||
37833634|NCT01262677|69517372|FG001|Overall Study|Reason not provided|1|||
37911004|NCT00917267|69597555|FG001|Overall Study|Physician Decision|4|||
37911005|NCT00917267|69597554|FG000|Overall Study|Protocol Violation|9|||
37911006|NCT00917267|69597555|FG001|Overall Study|Protocol Violation|18|||
37911007|NCT00917267|69597554|FG000|Overall Study|Withdrawal by Subject|5|||
37911008|NCT00917267|69597555|FG001|Overall Study|Withdrawal by Subject|12|||
37911009|NCT00917267|69597554|FG000|Overall Study|Lost to follow up|0|||
37911010|NCT00917267|69597555|FG001|Overall Study|Lost to follow up|2|||
37911011|NCT00917267|69597554|FG000|Overall Study|Entry Criteria Not Met|1|||
37911012|NCT00917267|69597555|FG001|Overall Study|Entry Criteria Not Met|0|||
37911013|NCT00917267|69597554|FG000|Overall Study|Sponsor Decision|5|||
37911014|NCT00917267|69597555|FG001|Overall Study|Sponsor Decision|5|||
37911015|NCT00917267|69597554|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
37911016|NCT00917267|69597555|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
37911017|NCT00920699|69597568|FG000|Overall Study|Withdrawal by Subject|2|||
37911018|NCT00920699|69597569|FG001|Overall Study|Withdrawal by Subject|0|||
37911019|NCT00920699|69597570|FG002|Overall Study|Withdrawal by Subject|2|||
37911020|NCT00920699|69597568|FG000|Overall Study|no longer met eligibility|0|||
37911021|NCT00920699|69597569|FG001|Overall Study|no longer met eligibility|1|||
37911022|NCT00920699|69597570|FG002|Overall Study|no longer met eligibility|0|||
37911023|NCT00920699|69597568|FG000|Overall Study|Lost to Follow-up|0|||
37911024|NCT00920699|69597569|FG001|Overall Study|Lost to Follow-up|0|||
37911025|NCT00920699|69597570|FG002|Overall Study|Lost to Follow-up|2|||
37911026|NCT03462576|69597581|FG000|Overall Study|Protocol Violation|5|||
37911027|NCT03462576|69597582|FG001|Overall Study|Protocol Violation|11|||
37911028|NCT03462576|69597583|FG002|Overall Study|Protocol Violation|7|||
37911029|NCT03462576|69597581|FG000|Overall Study|Device Malfunction|0|||
37911030|NCT03462576|69597582|FG001|Overall Study|Device Malfunction|0|||
37911031|NCT03462576|69597583|FG002|Overall Study|Device Malfunction|1|||
37911032|NCT00916721|69597593|FG000|Overall Study|Lost to Follow-up|0|||
37911033|NCT00916721|69597594|FG001|Overall Study|Lost to Follow-up|1|||
37911034|NCT00916721|69597593|FG000|Overall Study|Adverse Event|6|||
37911035|NCT00916721|69597594|FG001|Overall Study|Adverse Event|3|||
37911036|NCT00916721|69597593|FG000|Overall Study|Withdrawal by Subject|2|||
37911037|NCT00916721|69597594|FG001|Overall Study|Withdrawal by Subject|2|||
37911038|NCT00916721|69597593|FG000|Overall Study|Protocol Violation|2|||
37911039|NCT00916721|69597594|FG001|Overall Study|Protocol Violation|4|||
37911040|NCT00915005|69597602|FG000|Overall Study|Withdrawal by Subject|4|||
37911041|NCT00915005|69597603|FG001|Overall Study|Withdrawal by Subject|4|||
37911042|NCT00915005|69597602|FG000|Overall Study|Patient preferred protons therapy|6|||
37911043|NCT00915005|69597603|FG001|Overall Study|Patient preferred protons therapy|0|||
37911044|NCT00915005|69597602|FG000|Overall Study|Insurance denial|3|||
37833635|NCT01262677|69517373|FG002|Overall Study|Reason not provided|3|||
37833636|NCT01262677|69517371|FG000|Overall Study|Protocol Violation|0|||
37833637|NCT01262677|69517372|FG001|Overall Study|Protocol Violation|1|||
37833638|NCT01262677|69517373|FG002|Overall Study|Protocol Violation|1|||
37833639|NCT01262677|69517371|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
37833640|NCT01262677|69517372|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
37833641|NCT01262677|69517373|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
37833642|NCT01262638|69517385|FG000|Overall Study|Adverse Event|3|||
37833643|NCT01262638|69517386|FG001|Overall Study|Adverse Event|4|||
37833644|NCT01262638|69517387|FG002|Overall Study|Adverse Event|3|||
37833645|NCT01262638|69517388|FG003|Overall Study|Adverse Event|4|||
37833646|NCT01262638|69517385|FG000|Overall Study|Protocol Violation|1|||
37833647|NCT01262638|69517386|FG001|Overall Study|Protocol Violation|0|||
37833648|NCT01262638|69517387|FG002|Overall Study|Protocol Violation|0|||
37833649|NCT01262638|69517388|FG003|Overall Study|Protocol Violation|1|||
37833650|NCT01262638|69517385|FG000|Overall Study|Withdrawal by Subject|2|||
37833651|NCT01262638|69517386|FG001|Overall Study|Withdrawal by Subject|1|||
37833652|NCT01262638|69517387|FG002|Overall Study|Withdrawal by Subject|0|||
37911045|NCT00915005|69597603|FG001|Overall Study|Insurance denial|15|||
37911046|NCT01143246|69597611|FG000|Overall Study|Adverse Event|24|||
37911047|NCT01143246|69597612|FG001|Overall Study|Adverse Event|28|||
37911048|NCT01143246|69597611|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
37911049|NCT01143246|69597612|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
37911050|NCT01143246|69597611|FG000|Overall Study|Lost to Follow-up|0|||
37911051|NCT01143246|69597612|FG001|Overall Study|Lost to Follow-up|1|||
37911052|NCT01143246|69597611|FG000|Overall Study|Death|16|||
37911053|NCT01143246|69597612|FG001|Overall Study|Death|15|||
37911054|NCT01143246|69597611|FG000|Overall Study|Reason not Specified|3|||
37833653|NCT01262638|69517388|FG003|Overall Study|Withdrawal by Subject|1|||
37911055|NCT01143246|69597612|FG001|Overall Study|Reason not Specified|5|||
37911056|NCT00561925|69597626|FG000|14 Day Lead-In Period|Adverse Event|38|||
37911057|NCT00561925|69597627|FG001|14 Day Lead-In Period|Adverse Event|0|||
37911058|NCT00561925|69597628|FG002|14 Day Lead-In Period|Adverse Event|0|||
37911059|NCT00561925|69597629|FG003|14 Day Lead-In Period|Adverse Event|0|||
37911060|NCT00561925|69597630|FG004|14 Day Lead-In Period|Adverse Event|0|||
37911061|NCT00561925|69597626|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
37911062|NCT00561925|69597627|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
37911063|NCT00561925|69597628|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
37911064|NCT00561925|69597629|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
37911065|NCT00561925|69597630|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
37911066|NCT00561925|69597626|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
37911067|NCT00561925|69597627|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
37911068|NCT00561925|69597628|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
37911069|NCT00561925|69597629|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
37911070|NCT00561925|69597630|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
37911071|NCT00561925|69597626|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
37911072|NCT00561925|69597627|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
37911073|NCT00561925|69597628|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
37911074|NCT00561925|69597629|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
37911075|NCT00561925|69597630|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
37911076|NCT00561925|69597626|FG000|14 Day Lead-In Period|Other|5|||
37911077|NCT00561925|69597627|FG001|14 Day Lead-In Period|Other|0|||
37911078|NCT00561925|69597628|FG002|14 Day Lead-In Period|Other|0|||
37911079|NCT00561925|69597629|FG003|14 Day Lead-In Period|Other|0|||
37911080|NCT00561925|69597630|FG004|14 Day Lead-In Period|Other|0|||
37911081|NCT00561925|69597626|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
37911082|NCT00561925|69597627|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
37911083|NCT00561925|69597628|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
37911084|NCT00561925|69597629|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
37911085|NCT00561925|69597630|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
37911086|NCT00561925|69597626|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
37911087|NCT00561925|69597627|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
37911088|NCT00561925|69597628|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
37911089|NCT00561925|69597629|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
37911090|NCT00561925|69597630|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
37911091|NCT00561925|69597626|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
37911092|NCT00561925|69597627|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
37911093|NCT00561925|69597628|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
37911094|NCT00561925|69597629|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
37911095|NCT00561925|69597630|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
37911096|NCT00561925|69597626|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
37833654|NCT01262638|69517385|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
37833655|NCT01262638|69517386|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
37833656|NCT01262638|69517387|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
37911097|NCT00561925|69597627|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
37911098|NCT00561925|69597628|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
37911099|NCT00561925|69597629|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
37833657|NCT01262638|69517388|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
37833658|NCT01262638|69517385|FG000|Overall Study|Lost to Follow-up|1|||
37833659|NCT01262638|69517386|FG001|Overall Study|Lost to Follow-up|1|||
37911100|NCT00561925|69597630|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
37911101|NCT00561925|69597626|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
37911102|NCT00561925|69597627|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
37911103|NCT00561925|69597628|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
37911104|NCT00561925|69597629|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
37833660|NCT01262638|69517387|FG002|Overall Study|Lost to Follow-up|1|||
37833661|NCT01262638|69517388|FG003|Overall Study|Lost to Follow-up|1|||
37833662|NCT01262638|69517385|FG000|Overall Study|Participant Went Out of Town|0|||
37911105|NCT00561925|69597630|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
37911106|NCT00561925|69597626|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
37911107|NCT00561925|69597627|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
37911108|NCT00561925|69597628|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
37911109|NCT00561925|69597629|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
37911110|NCT00561925|69597630|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
37911111|NCT00561925|69597626|FG000|144-week Double-blind, Double-dummy|Death|0|||
37911112|NCT00561925|69597627|FG001|144-week Double-blind, Double-dummy|Death|6|||
37833663|NCT01262638|69517386|FG001|Overall Study|Participant Went Out of Town|0|||
37911113|NCT00561925|69597628|FG002|144-week Double-blind, Double-dummy|Death|3|||
37911114|NCT00561925|69597629|FG003|144-week Double-blind, Double-dummy|Death|0|||
37911115|NCT00561925|69597630|FG004|144-week Double-blind, Double-dummy|Death|0|||
37911116|NCT00561925|69597626|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
37911117|NCT00561925|69597627|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
37911118|NCT00561925|69597628|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
37911119|NCT00561925|69597629|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
37911120|NCT00561925|69597630|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
37911121|NCT00561925|69597626|FG000|144-week Double-blind, Double-dummy|Other|0|||
37911122|NCT00561925|69597627|FG001|144-week Double-blind, Double-dummy|Other|8|||
37911123|NCT00561925|69597628|FG002|144-week Double-blind, Double-dummy|Other|11|||
37911124|NCT00561925|69597629|FG003|144-week Double-blind, Double-dummy|Other|0|||
37911125|NCT00561925|69597630|FG004|144-week Double-blind, Double-dummy|Other|0|||
37911126|NCT00561925|69597626|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
37911127|NCT00561925|69597627|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
37911128|NCT00561925|69597628|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
37911129|NCT00561925|69597629|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
37911130|NCT00561925|69597630|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
37911131|NCT00549445|69597650|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
37911132|NCT00549445|69597651|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
37911133|NCT00601107|69597661|FG000|Overall Study|Adverse Event|0|||
37911134|NCT00601107|69597662|FG001|Overall Study|Adverse Event|1|||
37833664|NCT01262638|69517387|FG002|Overall Study|Participant Went Out of Town|1|||
37833665|NCT01262638|69517388|FG003|Overall Study|Participant Went Out of Town|0|||
37833666|NCT01262560|69517404|FG000|Overall Study|Protocol Violation|0|||
37911135|NCT00601107|69597663|FG002|Overall Study|Adverse Event|3|||
37911136|NCT00601107|69597664|FG003|Overall Study|Adverse Event|0|||
37911137|NCT00601107|69597661|FG000|Overall Study|Withdrawal by Subject|5|||
37911138|NCT00601107|69597662|FG001|Overall Study|Withdrawal by Subject|4|||
37911139|NCT00601107|69597663|FG002|Overall Study|Withdrawal by Subject|7|||
37911140|NCT00601107|69597664|FG003|Overall Study|Withdrawal by Subject|4|||
37911141|NCT00601107|69597661|FG000|Overall Study|Lost to Follow-up|3|||
37911142|NCT00601107|69597662|FG001|Overall Study|Lost to Follow-up|3|||
37911143|NCT00601107|69597663|FG002|Overall Study|Lost to Follow-up|0|||
37911144|NCT00601107|69597664|FG003|Overall Study|Lost to Follow-up|3|||
37911145|NCT00601107|69597661|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
37911146|NCT00601107|69597662|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
37911147|NCT00601107|69597663|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
37911148|NCT00601107|69597664|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
37911149|NCT00601107|69597661|FG000|Overall Study|Worsening of Psoriasis|4|||
37911150|NCT00601107|69597662|FG001|Overall Study|Worsening of Psoriasis|1|||
37911151|NCT00601107|69597663|FG002|Overall Study|Worsening of Psoriasis|1|||
37911152|NCT00601107|69597664|FG003|Overall Study|Worsening of Psoriasis|4|||
37833667|NCT01262560|69517405|FG001|Overall Study|Protocol Violation|1|||
37833668|NCT01262560|69517406|FG002|Overall Study|Protocol Violation|2|||
37833669|NCT01262365|69517417|FG000|Overall Study|Lack of Efficacy|35|||
37833670|NCT01262365|69517418|FG001|Overall Study|Lack of Efficacy|30|||
37833671|NCT01262365|69517419|FG002|Overall Study|Lack of Efficacy|47|||
37833672|NCT01262365|69517417|FG000|Overall Study|Protocol Violation|3|||
37911153|NCT00601107|69597661|FG000|Overall Study|Undefined|1|||
37911154|NCT00601107|69597662|FG001|Overall Study|Undefined|0|||
37911155|NCT00601107|69597663|FG002|Overall Study|Undefined|1|||
37833673|NCT01262365|69517418|FG001|Overall Study|Protocol Violation|1|||
37833674|NCT01262365|69517419|FG002|Overall Study|Protocol Violation|1|||
37833675|NCT01262365|69517417|FG000|Overall Study|Lost to Follow-up|3|||
37833676|NCT01262365|69517418|FG001|Overall Study|Lost to Follow-up|7|||
37833677|NCT01262365|69517419|FG002|Overall Study|Lost to Follow-up|6|||
37833678|NCT01262365|69517417|FG000|Overall Study|Withdrawal by Subject|17|||
37833679|NCT01262365|69517418|FG001|Overall Study|Withdrawal by Subject|22|||
37833680|NCT01262365|69517419|FG002|Overall Study|Withdrawal by Subject|22|||
37833681|NCT01262365|69517417|FG000|Overall Study|Death|1|||
37833682|NCT01262365|69517418|FG001|Overall Study|Death|2|||
37833683|NCT01262365|69517419|FG002|Overall Study|Death|1|||
37833684|NCT01262365|69517417|FG000|Overall Study|Adverse Event|26|||
37833685|NCT01262365|69517418|FG001|Overall Study|Adverse Event|16|||
37833686|NCT01262365|69517419|FG002|Overall Study|Adverse Event|11|||
37911156|NCT00601107|69597664|FG003|Overall Study|Undefined|0|||
37911157|NCT00914927|69597681|FG000|Overall Study|Adverse Event|0|||
37911158|NCT00914927|69597682|FG001|Overall Study|Adverse Event|0|||
37911159|NCT00914927|69597683|FG002|Overall Study|Adverse Event|0|||
37833687|NCT01262365|69517417|FG000|Overall Study|sponsor decision|1|||
37833688|NCT01262365|69517418|FG001|Overall Study|sponsor decision|1|||
37833689|NCT01262365|69517419|FG002|Overall Study|sponsor decision|0|||
37833690|NCT01262365|69517417|FG000|Overall Study|Randomization error|1|||
37833691|NCT01262365|69517418|FG001|Overall Study|Randomization error|0|||
37833692|NCT01262365|69517419|FG002|Overall Study|Randomization error|2|||
37833693|NCT01262365|69517417|FG000|Overall Study|Non-compliance|1|||
37833694|NCT01262365|69517418|FG001|Overall Study|Non-compliance|0|||
37833695|NCT01262365|69517419|FG002|Overall Study|Non-compliance|2|||
37699628|NCT01620255|69176495|FG003|Overall Study|Non-compliance|0|||
37699629|NCT01620255|69176496|FG004|Overall Study|Non-compliance|0|||
37699630|NCT01620255|69176492|FG000|Overall Study|Adverse Event|0|||
37699631|NCT01620255|69176493|FG001|Overall Study|Adverse Event|4|||
37699632|NCT01620255|69176494|FG002|Overall Study|Adverse Event|0|||
37699633|NCT01620255|69176495|FG003|Overall Study|Adverse Event|1|||
37699634|NCT01620255|69176496|FG004|Overall Study|Adverse Event|1|||
37699635|NCT01620255|69176492|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
37699636|NCT01620255|69176493|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
37699637|NCT01620255|69176494|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
37699638|NCT01620255|69176495|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
37699639|NCT01620255|69176496|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
37699640|NCT02010567|69176513|FG000|Overall Study|Adverse Event|0|||
37833696|NCT01262365|69517417|FG000|Overall Study|Suspected pregnancy|1|||
37833697|NCT01262365|69517418|FG001|Overall Study|Suspected pregnancy|0|||
37911160|NCT00914927|69597684|FG003|Overall Study|Adverse Event|0|||
37911161|NCT00914927|69597685|FG004|Overall Study|Adverse Event|1|||
37911162|NCT00914927|69597686|FG005|Overall Study|Adverse Event|0|||
37911163|NCT00914927|69597687|FG006|Overall Study|Adverse Event|0|||
37911164|NCT00914927|69597681|FG000|Overall Study|Withdrawal by Subject|0|||
37911165|NCT00914927|69597682|FG001|Overall Study|Withdrawal by Subject|1|||
37911166|NCT00914927|69597683|FG002|Overall Study|Withdrawal by Subject|0|||
37911167|NCT00914927|69597684|FG003|Overall Study|Withdrawal by Subject|1|||
37911168|NCT00914927|69597685|FG004|Overall Study|Withdrawal by Subject|0|||
37911169|NCT00914927|69597686|FG005|Overall Study|Withdrawal by Subject|0|||
37911170|NCT00914927|69597687|FG006|Overall Study|Withdrawal by Subject|0|||
37911171|NCT00914927|69597681|FG000|Overall Study|Lost to Follow-up|0|||
37911172|NCT00914927|69597682|FG001|Overall Study|Lost to Follow-up|0|||
37833698|NCT01262365|69517419|FG002|Overall Study|Suspected pregnancy|0|||
37833699|NCT01262365|69517417|FG000|Overall Study|Patient pregnant|1|||
37833700|NCT01262365|69517418|FG001|Overall Study|Patient pregnant|0|||
37833701|NCT01262365|69517419|FG002|Overall Study|Patient pregnant|1|||
37833702|NCT01262365|69517417|FG000|Overall Study|Toxicity related to study drug|0|||
37833703|NCT01262365|69517418|FG001|Overall Study|Toxicity related to study drug|1|||
37833704|NCT01262365|69517419|FG002|Overall Study|Toxicity related to study drug|0|||
37833705|NCT01262365|69517417|FG000|Overall Study|Cannot tolerate the protocol|0|||
37911173|NCT00914927|69597683|FG002|Overall Study|Lost to Follow-up|0|||
37911174|NCT00914927|69597684|FG003|Overall Study|Lost to Follow-up|1|||
37911175|NCT00914927|69597685|FG004|Overall Study|Lost to Follow-up|0|||
37911176|NCT00914927|69597686|FG005|Overall Study|Lost to Follow-up|0|||
37911177|NCT00914927|69597687|FG006|Overall Study|Lost to Follow-up|0|||
37911178|NCT00914927|69597681|FG000|Overall Study|Administrative/Other|2|||
37911179|NCT00914927|69597682|FG001|Overall Study|Administrative/Other|1|||
38021549|NCT03526861|69704657|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
38021550|NCT03526861|69704649|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
38021551|NCT03526861|69704650|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
38043450|NCT03954704|69731550|FG005|Overall Study|Study Terminated by Sponsor|4|||
38043451|NCT03954704|69731551|FG006|Overall Study|Study Terminated by Sponsor|2|||
37699641|NCT02010567|69176514|FG001|Overall Study|Adverse Event|0|||
37699642|NCT02010567|69176515|FG002|Overall Study|Adverse Event|1|||
37699643|NCT02010567|69176516|FG003|Overall Study|Adverse Event|0|||
37699644|NCT02010567|69176517|FG004|Overall Study|Adverse Event|1|||
37699645|NCT01806064|69176532|FG000|Overall Study|Randomized Not Enrolled|0|||
37699646|NCT01806064|69176533|FG001|Overall Study|Randomized Not Enrolled|0|||
37699647|NCT01806064|69176534|FG002|Overall Study|Randomized Not Enrolled|0|||
37699648|NCT01806064|69176535|FG003|Overall Study|Randomized Not Enrolled|1|||
37833706|NCT01262365|69517418|FG001|Overall Study|Cannot tolerate the protocol|1|||
37833707|NCT01262365|69517419|FG002|Overall Study|Cannot tolerate the protocol|0|||
37833708|NCT01262365|69517417|FG000|Overall Study|Patient unavailable|0|||
38043452|NCT03954704|69731545|FG000|Overall Study|Enrolled but not Treated|0|||
38043453|NCT03954704|69731546|FG001|Overall Study|Enrolled but not Treated|0|||
38043454|NCT03954704|69731547|FG002|Overall Study|Enrolled but not Treated|0|||
38043455|NCT03954704|69731548|FG003|Overall Study|Enrolled but not Treated|0|||
38043456|NCT03954704|69731549|FG004|Overall Study|Enrolled but not Treated|0|||
38043457|NCT03954704|69731550|FG005|Overall Study|Enrolled but not Treated|1|||
38043458|NCT03954704|69731551|FG006|Overall Study|Enrolled but not Treated|0|||
38043459|NCT03737994|69731594|FG000|Overall Study|Withdrawal by Subject|0|||
38043460|NCT03737994|69731595|FG001|Overall Study|Withdrawal by Subject|0|||
38043461|NCT03737994|69731596|FG002|Overall Study|Withdrawal by Subject|0|||
38043462|NCT03737994|69731597|FG003|Overall Study|Withdrawal by Subject|0|||
37911180|NCT00914927|69597683|FG002|Overall Study|Administrative/Other|0|||
37911181|NCT00914927|69597684|FG003|Overall Study|Administrative/Other|0|||
37911182|NCT00914927|69597685|FG004|Overall Study|Administrative/Other|1|||
37911183|NCT00914927|69597686|FG005|Overall Study|Administrative/Other|0|||
37911184|NCT00914927|69597687|FG006|Overall Study|Administrative/Other|0|||
37911185|NCT00914849|69597714|FG000|Overall Study|Withdrawal by Subject|1|||
37911186|NCT00914849|69597715|FG001|Overall Study|Withdrawal by Subject|0|||
37833709|NCT01262365|69517418|FG001|Overall Study|Patient unavailable|0|||
37833710|NCT01262365|69517419|FG002|Overall Study|Patient unavailable|1|||
37833711|NCT03932812|69517429|FG000|Overall Study|Lost to Follow-up|12|||
37833712|NCT03932812|69517430|FG001|Overall Study|Lost to Follow-up|14|||
37833713|NCT03932812|69517429|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
37911187|NCT00914849|69597714|FG000|Overall Study|Not eligible|0|||
37911188|NCT00914849|69597715|FG001|Overall Study|Not eligible|1|||
37911189|NCT00912743|69597723|FG000|Overall Study|Adverse Event|3|||
37911190|NCT00912743|69597724|FG001|Overall Study|Adverse Event|1|||
37911191|NCT00912743|69597723|FG000|Overall Study|Lack of Efficacy|9|||
37911192|NCT00912743|69597724|FG001|Overall Study|Lack of Efficacy|18|||
37911193|NCT00912743|69597723|FG000|Overall Study|Toxicity|0|||
37911194|NCT00912743|69597724|FG001|Overall Study|Toxicity|1|||
37911195|NCT00912743|69597723|FG000|Overall Study|End of treatment form was not collected|1|||
37911196|NCT00912743|69597724|FG001|Overall Study|End of treatment form was not collected|0|||
37911197|NCT00914459|69597732|FG000|Overall Study|Protocol Violation|0|||
37699649|NCT01806064|69176536|FG004|Overall Study|Randomized Not Enrolled|2|||
37699650|NCT01804582|69176554|FG000|Overall Study|Lost to Follow-up|47|||
37699651|NCT01804582|69176555|FG001|Overall Study|Lost to Follow-up|56|||
37699652|NCT01804582|69176554|FG000|Overall Study|Physician Decision|2|||
37699653|NCT01804582|69176555|FG001|Overall Study|Physician Decision|0|||
37699654|NCT01787188|69176565|FG000|Overall Study|Adverse Event|2|||
37699655|NCT01787188|69176566|FG001|Overall Study|Adverse Event|4|||
37699656|NCT01787188|69176567|FG002|Overall Study|Adverse Event|6|||
37699657|NCT01787188|69176565|FG000|Overall Study|Lack of Efficacy|7|||
37699658|NCT01787188|69176566|FG001|Overall Study|Lack of Efficacy|3|||
37699659|NCT01787188|69176567|FG002|Overall Study|Lack of Efficacy|5|||
37699660|NCT01787188|69176565|FG000|Overall Study|Non-compliance with Study Drug|0|||
37699661|NCT01787188|69176566|FG001|Overall Study|Non-compliance with Study Drug|1|||
37699662|NCT01787188|69176567|FG002|Overall Study|Non-compliance with Study Drug|0|||
37699663|NCT01787188|69176565|FG000|Overall Study|Withdrawal by Subject|4|||
37699664|NCT01787188|69176566|FG001|Overall Study|Withdrawal by Subject|3|||
37699665|NCT01787188|69176567|FG002|Overall Study|Withdrawal by Subject|2|||
37699666|NCT01787188|69176565|FG000|Overall Study|Protocol Violation|3|||
37699667|NCT01787188|69176566|FG001|Overall Study|Protocol Violation|2|||
37699668|NCT01787188|69176567|FG002|Overall Study|Protocol Violation|3|||
37699669|NCT01787188|69176565|FG000|Overall Study|Lost to Follow-up|1|||
37699670|NCT01787188|69176566|FG001|Overall Study|Lost to Follow-up|2|||
37699671|NCT01787188|69176567|FG002|Overall Study|Lost to Follow-up|2|||
37699672|NCT01787188|69176565|FG000|Overall Study|Other, including patient moved|0|||
37699673|NCT01787188|69176566|FG001|Overall Study|Other, including patient moved|3|||
37699674|NCT01787188|69176567|FG002|Overall Study|Other, including patient moved|0|||
37699675|NCT01787032|69176581|FG000|Overall Study|Protocol Violation|0|||
37699676|NCT01787032|69176582|FG001|Overall Study|Protocol Violation|0|||
37699677|NCT01787032|69176583|FG002|Overall Study|Protocol Violation|0|||
37699678|NCT01787032|69176584|FG003|Overall Study|Protocol Violation|0|||
37699679|NCT01787032|69176585|FG004|Overall Study|Protocol Violation|1|||
37699680|NCT01787032|69176586|FG005|Overall Study|Protocol Violation|1|||
37699681|NCT01737268|69176596|FG000|Overall Study|Adverse Event|6|||
37699682|NCT01737268|69176596|FG000|Overall Study|Worsening of Target Disease|2|||
37699683|NCT01737268|69176596|FG000|Overall Study|In consideration of the patient's safety|1|||
37699684|NCT01769404|69176601|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
37699685|NCT01769404|69176602|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
37833714|NCT03932812|69517430|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
37833715|NCT01262287|69517439|FG000|Overall Study|Lost to Follow-up|2|||
37833716|NCT01262287|69517440|FG001|Overall Study|Lost to Follow-up|1|||
37833717|NCT01262092|69517452|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
37911198|NCT00914459|69597733|FG001|Overall Study|Protocol Violation|1|||
37911199|NCT00914459|69597732|FG000|Overall Study|Parent/Legal guardian request|1|||
37911200|NCT00914459|69597733|FG001|Overall Study|Parent/Legal guardian request|0|||
37699686|NCT01769404|69176601|FG000|Treatment Period 1|Withdrawal by Subject|3|||
37699687|NCT01769404|69176602|FG001|Treatment Period 1|Withdrawal by Subject|0|||
37699688|NCT01769404|69176601|FG000|Treatment Period 1|Sponsor decision|1|||
37699689|NCT01769404|69176602|FG001|Treatment Period 1|Sponsor decision|0|||
37699690|NCT01769404|69176601|FG000|Treatment Period 2|Sponsor decision|7|||
37699691|NCT01769404|69176602|FG001|Treatment Period 2|Sponsor decision|0|||
37833718|NCT01262092|69517453|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
37833719|NCT01262092|69517452|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
37833720|NCT01262092|69517453|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
37833721|NCT01262092|69517452|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
37833722|NCT01262092|69517453|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
37833723|NCT01262092|69517452|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
37833724|NCT01262092|69517453|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
37833725|NCT01261975|69517459|FG000|Overall Study|Surgical complication|1|||
37833726|NCT01261780|69517468|FG000|Overall Study|Withdrawal by Subject|1|||
38021552|NCT03526861|69704651|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
38021553|NCT03526861|69704652|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
37833727|NCT01261780|69517469|FG001|Overall Study|Withdrawal by Subject|0|||
37833728|NCT01261780|69517468|FG000|Overall Study|Event not related to subject|1|||
37833729|NCT01261780|69517469|FG001|Overall Study|Event not related to subject|2|||
37833730|NCT01261624|69517477|FG000|Week 0 to Week 12|Disease Progression|1|||
37833731|NCT01261624|69517478|FG001|Week 0 to Week 12|Disease Progression|1|||
37833732|NCT01261624|69517477|FG000|Week 0 to Week 12|Insufficient Response|0|||
37833733|NCT01261624|69517478|FG001|Week 0 to Week 12|Insufficient Response|2|||
37833734|NCT01261624|69517477|FG000|Week 13 to Week 24|Insufficient Response|0|||
37833735|NCT01261624|69517478|FG001|Week 13 to Week 24|Insufficient Response|1|||
37833736|NCT03694522|69517492|FG000|Overall Study|Withdrawal by Subject|8|||
37833737|NCT03694522|69517493|FG001|Overall Study|Withdrawal by Subject|10|||
37833738|NCT03694522|69517492|FG000|Overall Study|Physician Decision|53|||
37833739|NCT03694522|69517493|FG001|Overall Study|Physician Decision|54|||
37833740|NCT03694522|69517492|FG000|Overall Study|Other|1|||
37833741|NCT03694522|69517493|FG001|Overall Study|Other|1|||
37833742|NCT03694522|69517492|FG000|Overall Study|Lost to Follow-up|0|||
37833743|NCT03694522|69517493|FG001|Overall Study|Lost to Follow-up|1|||
37911201|NCT00912509|69597743|FG000|Overall Study|Lost to Follow-up|1|||
37911202|NCT00912509|69597744|FG001|Overall Study|Lost to Follow-up|0|||
37911203|NCT00912509|69597743|FG000|Overall Study|Lack of Efficacy|4|||
37911204|NCT00912509|69597744|FG001|Overall Study|Lack of Efficacy|3|||
37911205|NCT00913835|69597764|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
37911206|NCT00913835|69597765|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
37911207|NCT00913835|69597764|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
37911208|NCT00913835|69597765|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
37911209|NCT00913835|69597764|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
37911210|NCT00913835|69597765|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
37911211|NCT00913835|69597764|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
37911212|NCT00913835|69597765|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
37911213|NCT00913835|69597764|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
37911214|NCT00913835|69597765|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
37911215|NCT00913523|69597790|FG000|Overall Study|Withdrawal by Subject|3|||
37911216|NCT00913523|69597791|FG001|Overall Study|Withdrawal by Subject|2|||
37911217|NCT00913523|69597792|FG002|Overall Study|Withdrawal by Subject|2|||
37911218|NCT00913523|69597790|FG000|Overall Study|Lost to Follow-up|1|||
37911219|NCT00913523|69597791|FG001|Overall Study|Lost to Follow-up|1|||
37911220|NCT00913523|69597792|FG002|Overall Study|Lost to Follow-up|1|||
37911221|NCT00913523|69597790|FG000|Overall Study|Adverse Event|1|||
37911222|NCT00913523|69597791|FG001|Overall Study|Adverse Event|0|||
37911223|NCT00913523|69597792|FG002|Overall Study|Adverse Event|0|||
37911224|NCT00913523|69597790|FG000|Overall Study|Protocol Violation|5|||
37911225|NCT00913523|69597791|FG001|Overall Study|Protocol Violation|8|||
37911226|NCT00913523|69597792|FG002|Overall Study|Protocol Violation|8|||
37911227|NCT00913523|69597790|FG000|Overall Study|Pregnancy|1|||
37911228|NCT00913523|69597791|FG001|Overall Study|Pregnancy|3|||
37911229|NCT00913523|69597792|FG002|Overall Study|Pregnancy|0|||
37911230|NCT00913523|69597790|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
37911231|NCT00913523|69597791|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
37911232|NCT00913523|69597792|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
37911233|NCT00912197|69597802|FG000|Overall Study|Withdrawal by Subject|3|||
37911234|NCT00912197|69597803|FG001|Overall Study|Withdrawal by Subject|3|||
37911235|NCT00910247|69597811|FG000|Overall Study|Adverse Event|15|||
37911236|NCT00910247|69597811|FG000|Overall Study|Death|2|||
37911237|NCT00910247|69597811|FG000|Overall Study|Lost to Follow-up|10|||
37911238|NCT00910247|69597811|FG000|Overall Study|Physician Decision|3|||
37911239|NCT00910247|69597811|FG000|Overall Study|Protocol Violation|10|||
37911240|NCT00910247|69597811|FG000|Overall Study|Withdrawal by Subject|25|||
37911241|NCT00910247|69597811|FG000|Overall Study|Not collected|4|||
37911242|NCT00659334|69597822|FG000|Overall Study|Screen Failure|8|||
37911243|NCT00659334|69597823|FG001|Overall Study|Screen Failure|5|||
37911244|NCT00659334|69597824|FG002|Overall Study|Screen Failure|0|||
38021554|NCT03526861|69704653|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
37833744|NCT01261390|69517503|FG000|Overall Study|Significant Concurrent Illness|1|||
37833745|NCT01261390|69517504|FG001|Overall Study|Significant Concurrent Illness|0|||
37833746|NCT01261390|69517505|FG002|Overall Study|Significant Concurrent Illness|1|||
37833747|NCT01261390|69517506|FG003|Overall Study|Significant Concurrent Illness|0|||
37911245|NCT00659334|69597825|FG003|Overall Study|Screen Failure|0|||
37911246|NCT00659334|69597826|FG004|Overall Study|Screen Failure|0|||
37911247|NCT00659334|69597827|FG005|Overall Study|Screen Failure|0|||
37911248|NCT00659334|69597828|FG006|Overall Study|Screen Failure|1|||
37911249|NCT00910091|69597850|FG000|Pre-assignment|Withdrawal by Subject|0|||
37911250|NCT00910091|69597851|FG001|Pre-assignment|Withdrawal by Subject|2|||
37911251|NCT00910091|69597850|FG000|Treatment and Survival|Withdrawal by Subject|3|||
37911252|NCT00910091|69597851|FG001|Treatment and Survival|Withdrawal by Subject|4|||
37911253|NCT00910091|69597850|FG000|Treatment and Survival|Adverse Event|1|||
37911254|NCT00910091|69597851|FG001|Treatment and Survival|Adverse Event|0|||
37911255|NCT00909857|69597860|FG000|Overall Study|Withdrawal by Subject|6|||
37911256|NCT00909857|69597861|FG001|Overall Study|Withdrawal by Subject|10|||
37911257|NCT00909857|69597860|FG000|Overall Study|Adverse Event|5|||
37911258|NCT00909857|69597861|FG001|Overall Study|Adverse Event|5|||
37911259|NCT00909857|69597860|FG000|Overall Study|Lost to Follow-up|2|||
37911260|NCT00909857|69597861|FG001|Overall Study|Lost to Follow-up|5|||
37911261|NCT00909857|69597860|FG000|Overall Study|Protocol Violation|2|||
37911262|NCT00909857|69597861|FG001|Overall Study|Protocol Violation|1|||
37911263|NCT00909857|69597860|FG000|Overall Study|Pregnancy|1|||
37911264|NCT00909857|69597861|FG001|Overall Study|Pregnancy|0|||
37911265|NCT00909857|69597860|FG000|Overall Study|Other|1|||
37911266|NCT00909857|69597861|FG001|Overall Study|Other|0|||
37699692|NCT01769326|69176614|FG000|Overall Study|Lost to Follow-up|1|||
37833748|NCT01261390|69517503|FG000|Overall Study|Dissatisfaction with Treatment|2|||
37833749|NCT01261390|69517504|FG001|Overall Study|Dissatisfaction with Treatment|1|||
37833750|NCT01261390|69517505|FG002|Overall Study|Dissatisfaction with Treatment|1|||
37833751|NCT01261390|69517506|FG003|Overall Study|Dissatisfaction with Treatment|2|||
37833752|NCT01261390|69517503|FG000|Overall Study|Relocation|0|||
37911267|NCT00909857|69597860|FG000|Overall Study|Did not receive study medication|19|||
37911268|NCT00909857|69597861|FG001|Overall Study|Did not receive study medication|24|||
37911269|NCT00911807|69597870|FG000|Overall Study|Adverse Event|2|||
37911270|NCT00911807|69597871|FG001|Overall Study|Adverse Event|1|||
37911271|NCT00911807|69597872|FG002|Overall Study|Adverse Event|5|||
37911272|NCT00911807|69597870|FG000|Overall Study|Death|0|||
37911273|NCT00911807|69597871|FG001|Overall Study|Death|0|||
37911274|NCT00911807|69597872|FG002|Overall Study|Death|1|||
37911275|NCT00911807|69597870|FG000|Overall Study|Protocol Violation|6|||
37911276|NCT00911807|69597871|FG001|Overall Study|Protocol Violation|4|||
37911277|NCT00911807|69597872|FG002|Overall Study|Protocol Violation|9|||
37911278|NCT00911807|69597870|FG000|Overall Study|Withdrawal by Subject|8|||
37699693|NCT01769326|69176615|FG001|Overall Study|Lost to Follow-up|2|||
37699694|NCT01769326|69176616|FG002|Overall Study|Lost to Follow-up|0|||
37699695|NCT01769326|69176617|FG003|Overall Study|Lost to Follow-up|0|||
37699696|NCT01769326|69176614|FG000|Overall Study|unrelated injry|1|||
37833753|NCT01261390|69517504|FG001|Overall Study|Relocation|1|||
37833754|NCT01261390|69517505|FG002|Overall Study|Relocation|0|||
37833755|NCT01261390|69517506|FG003|Overall Study|Relocation|0|||
37833756|NCT01261390|69517503|FG000|Overall Study|Loss of Interest in the Study|3|||
37833757|NCT01261390|69517504|FG001|Overall Study|Loss of Interest in the Study|1|||
37833758|NCT01261390|69517505|FG002|Overall Study|Loss of Interest in the Study|0|||
37833759|NCT01261390|69517506|FG003|Overall Study|Loss of Interest in the Study|0|||
37833760|NCT01261390|69517503|FG000|Overall Study|Lost to Follow-up|1|||
37833761|NCT01261390|69517504|FG001|Overall Study|Lost to Follow-up|6|||
37911279|NCT00911807|69597871|FG001|Overall Study|Withdrawal by Subject|10|||
37911280|NCT00911807|69597872|FG002|Overall Study|Withdrawal by Subject|7|||
37911281|NCT00911807|69597870|FG000|Overall Study|Organizational reasons|1|||
37911282|NCT00911807|69597871|FG001|Overall Study|Organizational reasons|3|||
37911283|NCT00911807|69597872|FG002|Overall Study|Organizational reasons|1|||
37911284|NCT04287920|69597899|FG000|Overall Study|Lost to Follow-up|1|||
37911285|NCT04287920|69597900|FG001|Overall Study|Lost to Follow-up|1|||
37911286|NCT04287920|69597899|FG000|Overall Study|Withdrawal by Subject|0|||
37911287|NCT04287920|69597900|FG001|Overall Study|Withdrawal by Subject|3|||
37833762|NCT01261390|69517505|FG002|Overall Study|Lost to Follow-up|5|||
37833763|NCT01261390|69517506|FG003|Overall Study|Lost to Follow-up|6|||
37833764|NCT03391882|69517527|FG000|Study Overall|Adverse Event|3|||
37833765|NCT03391882|69517528|FG001|Study Overall|Adverse Event|6|||
37911288|NCT00909779|69597908|FG000|Overall Study|Adverse Event|53|||
37833766|NCT03391882|69517529|FG002|Study Overall|Adverse Event|1|||
37833767|NCT03391882|69517530|FG003|Study Overall|Adverse Event|1|||
37833768|NCT03391882|69517531|FG004|Study Overall|Adverse Event|3|||
37833769|NCT03391882|69517532|FG005|Study Overall|Adverse Event|1|||
37833770|NCT03391882|69517527|FG000|Study Overall|Lack of Efficacy|13|||
37833771|NCT03391882|69517528|FG001|Study Overall|Lack of Efficacy|9|||
37833772|NCT03391882|69517529|FG002|Study Overall|Lack of Efficacy|0|||
37833773|NCT03391882|69517530|FG003|Study Overall|Lack of Efficacy|0|||
37833774|NCT03391882|69517531|FG004|Study Overall|Lack of Efficacy|0|||
37833775|NCT03391882|69517532|FG005|Study Overall|Lack of Efficacy|0|||
37833776|NCT03391882|69517527|FG000|Study Overall|Withdrawal by Subject|3|||
37911289|NCT00909779|69597909|FG001|Overall Study|Adverse Event|55|||
37833777|NCT03391882|69517528|FG001|Study Overall|Withdrawal by Subject|3|||
37833778|NCT03391882|69517529|FG002|Study Overall|Withdrawal by Subject|2|||
37833779|NCT03391882|69517530|FG003|Study Overall|Withdrawal by Subject|2|||
37833780|NCT03391882|69517531|FG004|Study Overall|Withdrawal by Subject|1|||
37833781|NCT03391882|69517532|FG005|Study Overall|Withdrawal by Subject|3|||
37833782|NCT03391882|69517527|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
37833783|NCT03391882|69517528|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
37833784|NCT03391882|69517529|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
37833785|NCT03391882|69517530|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
37833786|NCT03391882|69517531|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
37833787|NCT03391882|69517532|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
37833788|NCT03391882|69517527|FG000|Study Overall|Protocol Violation|1|||
37833789|NCT03391882|69517528|FG001|Study Overall|Protocol Violation|0|||
37833790|NCT03391882|69517529|FG002|Study Overall|Protocol Violation|0|||
37833791|NCT03391882|69517530|FG003|Study Overall|Protocol Violation|0|||
37833792|NCT03391882|69517531|FG004|Study Overall|Protocol Violation|0|||
37833793|NCT03391882|69517532|FG005|Study Overall|Protocol Violation|0|||
37833794|NCT03391882|69517527|FG000|Part A - Titration Phase|Adverse Event|3|||
37833795|NCT03391882|69517528|FG001|Part A - Titration Phase|Adverse Event|6|||
37833796|NCT03391882|69517529|FG002|Part A - Titration Phase|Adverse Event|0|||
37833797|NCT03391882|69517530|FG003|Part A - Titration Phase|Adverse Event|0|||
37833798|NCT03391882|69517531|FG004|Part A - Titration Phase|Adverse Event|0|||
37833799|NCT03391882|69517532|FG005|Part A - Titration Phase|Adverse Event|0|||
37911290|NCT00909779|69597908|FG000|Overall Study|Lack of Efficacy|7|||
37911291|NCT00909779|69597909|FG001|Overall Study|Lack of Efficacy|4|||
37911292|NCT00909779|69597908|FG000|Overall Study|Lost to Follow-up|19|||
37911293|NCT00909779|69597909|FG001|Overall Study|Lost to Follow-up|15|||
37911294|NCT00909779|69597908|FG000|Overall Study|Physician Decision|8|||
37911295|NCT00909779|69597909|FG001|Overall Study|Physician Decision|2|||
37911296|NCT00909779|69597908|FG000|Overall Study|Protocol Violation|2|||
37911297|NCT00909779|69597909|FG001|Overall Study|Protocol Violation|5|||
37911298|NCT00909779|69597908|FG000|Overall Study|Withdrawal by Subject|116|||
37911299|NCT00909779|69597909|FG001|Overall Study|Withdrawal by Subject|80|||
37911300|NCT00909779|69597908|FG000|Overall Study|Site Ceasing Operation|2|||
37911301|NCT00909779|69597909|FG001|Overall Study|Site Ceasing Operation|2|||
37911302|NCT00909779|69597908|FG000|Overall Study|Medical Monitor Decision|1|||
37911303|NCT00909779|69597909|FG001|Overall Study|Medical Monitor Decision|0|||
37911304|NCT00909779|69597908|FG000|Overall Study|Noncompliance|1|||
37911305|NCT00909779|69597909|FG001|Overall Study|Noncompliance|1|||
37911306|NCT00909779|69597908|FG000|Overall Study|Randomized in error|1|||
37911307|NCT00909779|69597909|FG001|Overall Study|Randomized in error|1|||
37911308|NCT00910871|69597917|FG000|Overall Study|Adverse Event|5|||
37911309|NCT00910871|69597917|FG000|Overall Study|Death|12|||
37911310|NCT00910871|69597917|FG000|Overall Study|Lost to Follow-up|8|||
37911311|NCT00910871|69597917|FG000|Overall Study|Protocol Violation|11|||
37911312|NCT00910871|69597917|FG000|Overall Study|Withdrawal by Subject|12|||
37911313|NCT00910871|69597917|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
37911314|NCT00910871|69597917|FG000|Overall Study|Undefined|1|||
38021555|NCT03526861|69704654|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
37833800|NCT03391882|69517527|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
37833801|NCT03391882|69517528|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
37833802|NCT03391882|69517529|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
37911315|NCT02631941|69597942|FG000|Overall Study|Physician Decision|0|||
37911316|NCT02631941|69597943|FG001|Overall Study|Physician Decision|1|||
37911317|NCT02631941|69597944|FG002|Overall Study|Physician Decision|0|||
37911318|NCT02631941|69597945|FG003|Overall Study|Physician Decision|0|||
37911319|NCT02631941|69597946|FG004|Overall Study|Physician Decision|0|||
37911320|NCT02631941|69597947|FG005|Overall Study|Physician Decision|0|||
37911321|NCT02631941|69597948|FG006|Overall Study|Physician Decision|0|||
37833803|NCT03391882|69517530|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
37833804|NCT03391882|69517531|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
37833805|NCT03391882|69517532|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
37833806|NCT03391882|69517527|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
37833807|NCT03391882|69517528|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
37911322|NCT02631941|69597949|FG007|Overall Study|Physician Decision|0|||
37911323|NCT02631941|69597950|FG008|Overall Study|Physician Decision|0|||
37699697|NCT01769326|69176615|FG001|Overall Study|unrelated injry|1|||
37699698|NCT01769326|69176616|FG002|Overall Study|unrelated injry|0|||
37699699|NCT01769326|69176617|FG003|Overall Study|unrelated injry|0|||
37699700|NCT01769326|69176614|FG000|Overall Study|got a job|0|||
37833808|NCT03391882|69517529|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
37699701|NCT01769326|69176615|FG001|Overall Study|got a job|1|||
37699702|NCT01769326|69176616|FG002|Overall Study|got a job|0|||
37699703|NCT01769326|69176617|FG003|Overall Study|got a job|0|||
37699704|NCT01769326|69176614|FG000|Overall Study|Got sick and could not complete study|0|||
37699705|NCT01769326|69176615|FG001|Overall Study|Got sick and could not complete study|0|||
37699706|NCT01769326|69176616|FG002|Overall Study|Got sick and could not complete study|1|||
37699707|NCT01769326|69176617|FG003|Overall Study|Got sick and could not complete study|0|||
37699708|NCT01786564|69176627|FG000|Overall Study|Lost to Follow-up|47|||
37699709|NCT01786564|69176627|FG000|Overall Study|Ineligible|17|||
37699710|NCT01786330|69176633|FG000|Overall Study|Withdrawal by Subject|0|||
37699711|NCT01786330|69176634|FG001|Overall Study|Withdrawal by Subject|1|||
37699712|NCT01786330|69176633|FG000|Overall Study|Lost to Follow-up|0|||
37699713|NCT01786330|69176634|FG001|Overall Study|Lost to Follow-up|1|||
37699714|NCT01786330|69176633|FG000|Overall Study|Excluded intraoperatively|0|||
37699715|NCT01786330|69176634|FG001|Overall Study|Excluded intraoperatively|1|||
37699716|NCT01786330|69176633|FG000|Overall Study|Protocol Violation|1|||
37699717|NCT01786330|69176634|FG001|Overall Study|Protocol Violation|0|||
37699718|NCT01786174|69176642|FG000|Overall Study|Discontinued Study Drug|2|||
37699719|NCT01786174|69176643|FG001|Overall Study|Discontinued Study Drug|0|||
37699720|NCT01736566|69176654|FG000|Long Term Follow-up|Still collecting data|42|||
37699721|NCT01736566|69176655|FG001|Long Term Follow-up|Still collecting data|0|||
37699722|NCT01736566|69176656|FG002|Long Term Follow-up|Still collecting data|49|||
37699723|NCT01736566|69176657|FG003|Long Term Follow-up|Still collecting data|0|||
37699724|NCT01736566|69176658|FG004|Long Term Follow-up|Still collecting data|1|||
37699725|NCT01768858|69176683|FG000|Overall Study|Lost to Follow-up|9|||
37699726|NCT01768858|69176683|FG000|Overall Study|Lack of Efficacy|8|||
37699727|NCT01768858|69176683|FG000|Overall Study|Serious Adverse Event|1|||
37699728|NCT01768858|69176683|FG000|Overall Study|Participant moved to Germany|1|||
37699729|NCT01768858|69176683|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
37699730|NCT01768858|69176683|FG000|Overall Study|Exanthema|1|||
37699731|NCT01768858|69176683|FG000|Overall Study|Withdrawal by Subject|1|||
37699732|NCT01736254|69176687|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
37699733|NCT01736254|69176687|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
37699734|NCT01767376|69176698|FG000|Overall Study|Lost to Follow-up|3|||
37699735|NCT01767376|69176699|FG001|Overall Study|Lost to Follow-up|2|||
37699736|NCT01767376|69176700|FG002|Overall Study|Lost to Follow-up|0|||
37699737|NCT01767376|69176698|FG000|Overall Study|Withdrawal by Subject|1|||
37833809|NCT03391882|69517530|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
37833810|NCT03391882|69517531|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
37833811|NCT03391882|69517532|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
37833812|NCT03391882|69517527|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
37833813|NCT03391882|69517528|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
37833814|NCT03391882|69517529|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
37833815|NCT03391882|69517530|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
37833816|NCT03391882|69517531|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
37833817|NCT03391882|69517532|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
37833818|NCT03391882|69517527|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
37833819|NCT03391882|69517528|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
37833820|NCT03391882|69517529|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
37833821|NCT03391882|69517530|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
37833822|NCT03391882|69517531|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
37833823|NCT03391882|69517532|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
37833824|NCT03391882|69517527|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
37833825|NCT03391882|69517528|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
37833826|NCT03391882|69517529|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
37699738|NCT01767376|69176699|FG001|Overall Study|Withdrawal by Subject|1|||
37699739|NCT01767376|69176700|FG002|Overall Study|Withdrawal by Subject|0|||
37699740|NCT01767142|69176710|FG000|Overall Study|Lost to Follow-up|3|||
37699741|NCT01785628|69176716|FG000|Overall Study|Lost to Follow-up|2|||
37699742|NCT01785628|69176717|FG001|Overall Study|Lost to Follow-up|3|||
37699743|NCT01785472|69176726|FG000|Overall Study|Adverse Event|5|||
37699744|NCT01785472|69176727|FG001|Overall Study|Adverse Event|4|||
37699745|NCT01785472|69176728|FG002|Overall Study|Adverse Event|6|||
37699746|NCT01785472|69176726|FG000|Overall Study|Lack of Efficacy|2|||
37699747|NCT01785472|69176727|FG001|Overall Study|Lack of Efficacy|0|||
37699748|NCT01785472|69176728|FG002|Overall Study|Lack of Efficacy|1|||
37833827|NCT03391882|69517530|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
37699749|NCT01785472|69176726|FG000|Overall Study|Lost to Follow-up|1|||
37699750|NCT01785472|69176727|FG001|Overall Study|Lost to Follow-up|2|||
37699751|NCT01785472|69176728|FG002|Overall Study|Lost to Follow-up|0|||
37699752|NCT01785472|69176726|FG000|Overall Study|Physician Decision|1|||
37699753|NCT01785472|69176727|FG001|Overall Study|Physician Decision|1|||
37699754|NCT01785472|69176728|FG002|Overall Study|Physician Decision|1|||
37699755|NCT01785472|69176726|FG000|Overall Study|Protocol deviation|0|||
37833828|NCT03391882|69517531|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
37833829|NCT03391882|69517532|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
37833830|NCT03391882|69517527|FG000|Part B - Treatment Phase|Adverse Event|0|||
37833831|NCT03391882|69517528|FG001|Part B - Treatment Phase|Adverse Event|0|||
37833832|NCT03391882|69517529|FG002|Part B - Treatment Phase|Adverse Event|1|||
37833833|NCT03391882|69517530|FG003|Part B - Treatment Phase|Adverse Event|1|||
37833834|NCT03391882|69517531|FG004|Part B - Treatment Phase|Adverse Event|3|||
37833835|NCT03391882|69517532|FG005|Part B - Treatment Phase|Adverse Event|1|||
38021556|NCT03526861|69704655|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
38021557|NCT03526861|69704656|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
38021558|NCT03526861|69704657|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
37699756|NCT01785472|69176727|FG001|Overall Study|Protocol deviation|2|||
37699757|NCT01785472|69176728|FG002|Overall Study|Protocol deviation|2|||
37699758|NCT01785472|69176726|FG000|Overall Study|Subject/guardian decision|15|||
37699759|NCT01785472|69176727|FG001|Overall Study|Subject/guardian decision|10|||
37699760|NCT01785472|69176728|FG002|Overall Study|Subject/guardian decision|11|||
37699761|NCT01785472|69176726|FG000|Overall Study|Technical problems|0|||
37699762|NCT01785472|69176727|FG001|Overall Study|Technical problems|0|||
37699763|NCT01785472|69176728|FG002|Overall Study|Technical problems|1|||
37699764|NCT01785160|69176738|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
37699765|NCT01785160|69176738|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
37833836|NCT03391882|69517527|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
37833837|NCT03391882|69517528|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
37833838|NCT03391882|69517529|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
37833839|NCT03391882|69517530|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
37833840|NCT03391882|69517531|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
37833841|NCT03391882|69517532|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
37833842|NCT01261000|69517542|FG000|Overall Study|Screen failure|1|||
37833843|NCT01234402|69517575|FG000|Overall Study|Lost to Follow-up|0|||
37833844|NCT01234402|69517576|FG001|Overall Study|Lost to Follow-up|1|||
37833845|NCT01234402|69517577|FG002|Overall Study|Lost to Follow-up|3|||
37699766|NCT01736176|69176744|FG000|Overall Study|Adverse Event|3|||
37699767|NCT01736176|69176744|FG000|Overall Study|Withdrawal by Subject|4|||
37699768|NCT01736176|69176744|FG000|Overall Study|Lack of Efficacy|3|||
37699769|NCT01736176|69176744|FG000|Overall Study|Unable to Complete PEG Placement|1|||
37699770|NCT01735630|69176754|FG000|Overall Study|Adverse Event|8|||
37699771|NCT01735630|69176755|FG001|Overall Study|Adverse Event|7|||
37699772|NCT01735630|69176754|FG000|Overall Study|Lost to Follow-up|1|||
37699773|NCT01735630|69176755|FG001|Overall Study|Lost to Follow-up|0|||
37699774|NCT01735630|69176754|FG000|Overall Study|Physician Decision|0|||
37699775|NCT01735630|69176755|FG001|Overall Study|Physician Decision|1|||
37699776|NCT01735630|69176754|FG000|Overall Study|Sponsor Decision|2|||
37699777|NCT01735630|69176755|FG001|Overall Study|Sponsor Decision|1|||
38021559|NCT03526861|69704649|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
38021560|NCT03526861|69704650|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
38021561|NCT03526861|69704651|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
38021562|NCT03526861|69704652|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
38021563|NCT03526861|69704653|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
37699778|NCT01735630|69176754|FG000|Overall Study|Withdrawal by Subject|7|||
37699779|NCT01735630|69176755|FG001|Overall Study|Withdrawal by Subject|9|||
38021564|NCT03526861|69704654|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
37699780|NCT01735396|69176761|FG000|Overall Study|not evaluable|1|||
37699781|NCT01766206|69176765|FG000|Overall Study|Withdrawal by Subject|22|||
37699782|NCT01766206|69176765|FG000|Overall Study|Lost to Follow-up|10|||
37699783|NCT01766206|69176765|FG000|Overall Study|Inappropriate enrollment|18|||
37833846|NCT01234402|69517575|FG000|Overall Study|Withdrawal by Subject|1|||
37833847|NCT01234402|69517576|FG001|Overall Study|Withdrawal by Subject|3|||
37699784|NCT01766206|69176765|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
37699785|NCT01734850|69176772|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
37699786|NCT01734850|69176773|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
37699787|NCT01734850|69176774|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
37699788|NCT01734850|69176772|FG000|Overall Study|Not infused due to manufacturing failure|0|||
37699789|NCT01734850|69176773|FG001|Overall Study|Not infused due to manufacturing failure|0|||
37699790|NCT01734850|69176774|FG002|Overall Study|Not infused due to manufacturing failure|1|||
37699791|NCT01766050|69176785|FG000|Overall Study|Adverse Event|1|||
37699792|NCT01766050|69176785|FG000|Overall Study|Lost to Follow-up|1|||
37699793|NCT01766050|69176785|FG000|Overall Study|Withdrawal by Subject|2|||
37699794|NCT02341625|69176813|FG000|Overall Study|Disease Progression|2|||
37699795|NCT02341625|69176814|FG001|Overall Study|Disease Progression|2|||
37699796|NCT02341625|69176815|FG002|Overall Study|Disease Progression|3|||
37699797|NCT02341625|69176816|FG003|Overall Study|Disease Progression|6|||
37699798|NCT02341625|69176817|FG004|Overall Study|Disease Progression|7|||
37699799|NCT02341625|69176818|FG005|Overall Study|Disease Progression|7|||
37699800|NCT02341625|69176819|FG006|Overall Study|Disease Progression|28|||
37699801|NCT02341625|69176820|FG007|Overall Study|Disease Progression|5|||
37699802|NCT02341625|69176821|FG008|Overall Study|Disease Progression|4|||
37699803|NCT02341625|69176822|FG009|Overall Study|Disease Progression|19|||
37699804|NCT02341625|69176813|FG000|Overall Study|Study Drug Toxicity|0|||
37699805|NCT02341625|69176814|FG001|Overall Study|Study Drug Toxicity|0|||
37699806|NCT02341625|69176815|FG002|Overall Study|Study Drug Toxicity|0|||
37699807|NCT02341625|69176816|FG003|Overall Study|Study Drug Toxicity|1|||
37699808|NCT02341625|69176817|FG004|Overall Study|Study Drug Toxicity|0|||
37699809|NCT02341625|69176818|FG005|Overall Study|Study Drug Toxicity|3|||
37699810|NCT02341625|69176819|FG006|Overall Study|Study Drug Toxicity|10|||
37699811|NCT02341625|69176820|FG007|Overall Study|Study Drug Toxicity|0|||
37699812|NCT02341625|69176821|FG008|Overall Study|Study Drug Toxicity|0|||
37699813|NCT02341625|69176822|FG009|Overall Study|Study Drug Toxicity|3|||
37699814|NCT02341625|69176813|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
37699815|NCT02341625|69176814|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
37699816|NCT02341625|69176815|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
37699817|NCT02341625|69176816|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
37699818|NCT02341625|69176817|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
37699819|NCT02341625|69176818|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
37699820|NCT02341625|69176819|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
37699821|NCT02341625|69176820|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
37699822|NCT02341625|69176821|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
37699823|NCT02341625|69176822|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
37699824|NCT02341625|69176813|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
37699825|NCT02341625|69176814|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
37699826|NCT02341625|69176815|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
37699827|NCT02341625|69176816|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
37699828|NCT02341625|69176817|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
37699829|NCT02341625|69176818|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
37699830|NCT02341625|69176819|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
37699831|NCT02341625|69176820|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
37699832|NCT02341625|69176821|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
37699833|NCT02341625|69176822|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
37699834|NCT02341625|69176813|FG000|Overall Study|Participant Withdrew Consent|0|||
37833848|NCT01234402|69517577|FG002|Overall Study|Withdrawal by Subject|4|||
37833849|NCT01234402|69517575|FG000|Overall Study|Never treated: Death|0|||
37833850|NCT01234402|69517576|FG001|Overall Study|Never treated: Death|0|||
37833851|NCT01234402|69517577|FG002|Overall Study|Never treated: Death|1|||
37833852|NCT01234402|69517575|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
37833853|NCT01234402|69517576|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
37833854|NCT01234402|69517577|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
37833855|NCT01234402|69517575|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
37833856|NCT01234402|69517576|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
37833857|NCT01234402|69517577|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
37833858|NCT01260922|69517589|FG000|First Intervention|Withdrawal by Subject|0|||
37833859|NCT01260922|69517590|FG001|First Intervention|Withdrawal by Subject|1|||
37833860|NCT01260922|69517589|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
37833861|NCT01260922|69517590|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
37833862|NCT01260922|69517589|FG000|Second Intervention|Emesis|0|||
37833863|NCT01260922|69517590|FG001|Second Intervention|Emesis|2|||
37833864|NCT01233817|69517596|FG000|Overall Study|Lost to Follow-up|1|||
37833865|NCT01233817|69517596|FG000|Overall Study|Withdrawal by Subject|2|||
37833866|NCT01233232|69517603|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
37833867|NCT01233232|69517604|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
37833868|NCT01233232|69517605|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
37833869|NCT01233076|69517615|FG000|Period 2, One Week|Lost to Follow-up|1|||
37833870|NCT01233076|69517616|FG001|Period 2, One Week|Lost to Follow-up|0|||
37833871|NCT01212094|69517625|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
37833872|NCT01212094|69517626|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
37911324|NCT02631941|69597951|FG009|Overall Study|Physician Decision|0|||
37699835|NCT02341625|69176814|FG001|Overall Study|Participant Withdrew Consent|0|||
37699836|NCT02341625|69176815|FG002|Overall Study|Participant Withdrew Consent|0|||
37699837|NCT02341625|69176816|FG003|Overall Study|Participant Withdrew Consent|1|||
37699838|NCT02341625|69176817|FG004|Overall Study|Participant Withdrew Consent|0|||
37699839|NCT02341625|69176818|FG005|Overall Study|Participant Withdrew Consent|0|||
37699840|NCT02341625|69176819|FG006|Overall Study|Participant Withdrew Consent|0|||
37699841|NCT02341625|69176820|FG007|Overall Study|Participant Withdrew Consent|0|||
37699842|NCT02341625|69176821|FG008|Overall Study|Participant Withdrew Consent|0|||
37699843|NCT02341625|69176822|FG009|Overall Study|Participant Withdrew Consent|0|||
37699844|NCT02341625|69176813|FG000|Overall Study|Completed Treatment as per Protocol|0|||
37699845|NCT02341625|69176814|FG001|Overall Study|Completed Treatment as per Protocol|0|||
37699846|NCT02341625|69176815|FG002|Overall Study|Completed Treatment as per Protocol|0|||
37699847|NCT02341625|69176816|FG003|Overall Study|Completed Treatment as per Protocol|0|||
37699848|NCT02341625|69176817|FG004|Overall Study|Completed Treatment as per Protocol|0|||
37699849|NCT02341625|69176818|FG005|Overall Study|Completed Treatment as per Protocol|0|||
37699850|NCT02341625|69176819|FG006|Overall Study|Completed Treatment as per Protocol|0|||
37699851|NCT02341625|69176820|FG007|Overall Study|Completed Treatment as per Protocol|0|||
37699852|NCT02341625|69176821|FG008|Overall Study|Completed Treatment as per Protocol|0|||
37699853|NCT02341625|69176822|FG009|Overall Study|Completed Treatment as per Protocol|1|||
37699854|NCT02341625|69176813|FG000|Overall Study|Other Reasons|0|||
37699855|NCT02341625|69176814|FG001|Overall Study|Other Reasons|0|||
37699856|NCT02341625|69176815|FG002|Overall Study|Other Reasons|0|||
37699857|NCT02341625|69176816|FG003|Overall Study|Other Reasons|0|||
37699858|NCT02341625|69176817|FG004|Overall Study|Other Reasons|1|||
37699859|NCT02341625|69176818|FG005|Overall Study|Other Reasons|0|||
37699860|NCT02341625|69176819|FG006|Overall Study|Other Reasons|5|||
37699861|NCT02341625|69176820|FG007|Overall Study|Other Reasons|0|||
37699862|NCT02341625|69176821|FG008|Overall Study|Other Reasons|0|||
37699863|NCT02341625|69176822|FG009|Overall Study|Other Reasons|2|||
37699864|NCT02341625|69176813|FG000|Overall Study|Not Reported|0|||
37699865|NCT02341625|69176814|FG001|Overall Study|Not Reported|0|||
37699866|NCT02341625|69176815|FG002|Overall Study|Not Reported|0|||
37699867|NCT02341625|69176816|FG003|Overall Study|Not Reported|0|||
37699868|NCT02341625|69176817|FG004|Overall Study|Not Reported|0|||
37699869|NCT02341625|69176818|FG005|Overall Study|Not Reported|0|||
37699870|NCT02341625|69176819|FG006|Overall Study|Not Reported|0|||
37699871|NCT02341625|69176820|FG007|Overall Study|Not Reported|0|||
37699872|NCT02341625|69176821|FG008|Overall Study|Not Reported|0|||
37699873|NCT02341625|69176822|FG009|Overall Study|Not Reported|3|||
37699874|NCT02370095|69176869|FG000|Overall Study|Withdrawal by Subject|0|||
37699875|NCT02370095|69176870|FG001|Overall Study|Withdrawal by Subject|1|||
37699876|NCT01783678|69176882|FG000|Overall Study|Randomized but Not Treated|0|||
37699877|NCT01783678|69176883|FG001|Overall Study|Randomized but Not Treated|0|||
37699878|NCT01783678|69176884|FG002|Overall Study|Randomized but Not Treated|0|||
37699879|NCT01783678|69176885|FG003|Overall Study|Randomized but Not Treated|1|||
37699880|NCT01783678|69176886|FG004|Overall Study|Randomized but Not Treated|0|||
37699881|NCT01783678|69176887|FG005|Overall Study|Randomized but Not Treated|0|||
37699882|NCT01783678|69176882|FG000|Overall Study|Lack of Efficacy|1|||
37699883|NCT01783678|69176883|FG001|Overall Study|Lack of Efficacy|13|||
37699884|NCT01783678|69176884|FG002|Overall Study|Lack of Efficacy|1|||
37699885|NCT01783678|69176885|FG003|Overall Study|Lack of Efficacy|3|||
37699886|NCT01783678|69176886|FG004|Overall Study|Lack of Efficacy|6|||
37699887|NCT01783678|69176887|FG005|Overall Study|Lack of Efficacy|5|||
37699888|NCT01783678|69176882|FG000|Overall Study|Lost to Follow-up|0|||
37699889|NCT01783678|69176883|FG001|Overall Study|Lost to Follow-up|4|||
37699890|NCT01783678|69176884|FG002|Overall Study|Lost to Follow-up|0|||
37699891|NCT01783678|69176885|FG003|Overall Study|Lost to Follow-up|2|||
37699892|NCT01783678|69176886|FG004|Overall Study|Lost to Follow-up|1|||
37699893|NCT01783678|69176887|FG005|Overall Study|Lost to Follow-up|0|||
37699894|NCT01783678|69176882|FG000|Overall Study|Withdrew Consent|1|||
37699895|NCT01783678|69176883|FG001|Overall Study|Withdrew Consent|1|||
37699896|NCT01783678|69176884|FG002|Overall Study|Withdrew Consent|0|||
37699897|NCT01783678|69176885|FG003|Overall Study|Withdrew Consent|2|||
37699898|NCT01783678|69176886|FG004|Overall Study|Withdrew Consent|0|||
37699899|NCT01783678|69176887|FG005|Overall Study|Withdrew Consent|0|||
37699900|NCT01734772|69176904|FG000|Overall Study|Adverse Event|1|||
37699901|NCT01734772|69176905|FG001|Overall Study|Adverse Event|2|||
37699902|NCT01734772|69176904|FG000|Overall Study|Withdrawal by Subject|0|||
37699903|NCT01734772|69176905|FG001|Overall Study|Withdrawal by Subject|1|||
37699904|NCT02340221|69176919|FG000|Overall Study|Death|100|||
37699905|NCT02340221|69176920|FG001|Overall Study|Death|197|||
37699906|NCT02340221|69176919|FG000|Overall Study|Withdrawal by Participant|24|||
37699907|NCT02340221|69176920|FG001|Overall Study|Withdrawal by Participant|37|||
37699908|NCT02340221|69176919|FG000|Overall Study|Lost to Follow-up|4|||
37699909|NCT02340221|69176920|FG001|Overall Study|Lost to Follow-up|15|||
37699910|NCT02340221|69176919|FG000|Overall Study|Reason Not Specified|85|||
37699911|NCT02340221|69176920|FG001|Overall Study|Reason Not Specified|165|||
37699912|NCT02340221|69176919|FG000|Overall Study|Study Terminated by Sponsor|1|||
37699913|NCT02340221|69176920|FG001|Overall Study|Study Terminated by Sponsor|3|||
37699914|NCT02395133|69176931|FG000|Overall Study|Adverse Event|4|||
37699915|NCT02395133|69176932|FG001|Overall Study|Adverse Event|1|||
37699916|NCT02395133|69176933|FG002|Overall Study|Adverse Event|3|||
37699917|NCT02395133|69176934|FG003|Overall Study|Adverse Event|0|||
37699918|NCT02395133|69176931|FG000|Overall Study|Lack of Efficacy|1|||
37699919|NCT02395133|69176932|FG001|Overall Study|Lack of Efficacy|0|||
37699920|NCT02395133|69176933|FG002|Overall Study|Lack of Efficacy|1|||
37699921|NCT02395133|69176934|FG003|Overall Study|Lack of Efficacy|1|||
37699922|NCT02395133|69176931|FG000|Overall Study|Protocol Violation|1|||
37699923|NCT02395133|69176932|FG001|Overall Study|Protocol Violation|1|||
37699924|NCT02395133|69176933|FG002|Overall Study|Protocol Violation|0|||
37699925|NCT02395133|69176934|FG003|Overall Study|Protocol Violation|3|||
37699926|NCT02395133|69176931|FG000|Overall Study|Lost to Follow-up|0|||
37699927|NCT02395133|69176932|FG001|Overall Study|Lost to Follow-up|1|||
37699928|NCT02395133|69176933|FG002|Overall Study|Lost to Follow-up|1|||
37699929|NCT02395133|69176934|FG003|Overall Study|Lost to Follow-up|0|||
37699930|NCT02395133|69176931|FG000|Overall Study|Pregnancy|0|||
37699931|NCT02395133|69176932|FG001|Overall Study|Pregnancy|0|||
37699932|NCT02395133|69176933|FG002|Overall Study|Pregnancy|3|||
37699933|NCT02395133|69176934|FG003|Overall Study|Pregnancy|0|||
37699934|NCT02395133|69176931|FG000|Overall Study|Consent withdrawn with no reason given|1|||
37699935|NCT02395133|69176932|FG001|Overall Study|Consent withdrawn with no reason given|3|||
37699936|NCT02395133|69176933|FG002|Overall Study|Consent withdrawn with no reason given|0|||
37699937|NCT02395133|69176934|FG003|Overall Study|Consent withdrawn with no reason given|2|||
37699938|NCT02395133|69176931|FG000|Overall Study|Consent withdrawn with personal reason|0|||
37699939|NCT02395133|69176932|FG001|Overall Study|Consent withdrawn with personal reason|1|||
37699940|NCT02395133|69176933|FG002|Overall Study|Consent withdrawn with personal reason|0|||
37699941|NCT02395133|69176934|FG003|Overall Study|Consent withdrawn with personal reason|3|||
37833873|NCT01212094|69517627|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
37833874|NCT01212094|69517625|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
37833875|NCT01212094|69517626|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
37833876|NCT01212094|69517627|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
37833877|NCT01212094|69517625|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
37833878|NCT01212094|69517626|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
37833879|NCT01212094|69517627|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
37833880|NCT01212094|69517625|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
37833881|NCT01212094|69517626|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
37833882|NCT01212094|69517627|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
37833883|NCT01212094|69517625|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
37833884|NCT01212094|69517626|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
37833885|NCT01212094|69517627|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
37833886|NCT01212094|69517625|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
37833887|NCT01212094|69517626|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
37833888|NCT01212094|69517627|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
37833889|NCT01232569|69517636|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
37833890|NCT01232569|69517637|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
37833891|NCT01232569|69517638|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
37833892|NCT01232569|69517639|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
37833893|NCT01232569|69517636|FG000|Double-blind Treatment Period|Escape|2|||
37833894|NCT01232569|69517637|FG001|Double-blind Treatment Period|Escape|2|||
37833895|NCT01232569|69517638|FG002|Double-blind Treatment Period|Escape|0|||
37833896|NCT01232569|69517639|FG003|Double-blind Treatment Period|Escape|0|||
37833897|NCT01232569|69517636|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
37833898|NCT01232569|69517637|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
37833899|NCT01232569|69517638|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
37833900|NCT01232569|69517639|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
37833901|NCT01232569|69517636|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
37833902|NCT01232569|69517637|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
37833903|NCT01232569|69517638|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
37833904|NCT01232569|69517639|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
37833905|NCT01232569|69517636|FG000|Double-blind Treatment Period|Physician Decision|1|||
37833906|NCT01232569|69517637|FG001|Double-blind Treatment Period|Physician Decision|0|||
37833907|NCT01232569|69517638|FG002|Double-blind Treatment Period|Physician Decision|0|||
37833908|NCT01232569|69517639|FG003|Double-blind Treatment Period|Physician Decision|0|||
37833909|NCT01232569|69517636|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
37833910|NCT01232569|69517637|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
37833911|NCT01232569|69517638|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
37833912|NCT01232569|69517639|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
37833913|NCT01232569|69517636|FG000|Double-blind Treatment Period|Death|2|||
37833914|NCT01232569|69517637|FG001|Double-blind Treatment Period|Death|0|||
37833915|NCT01232569|69517638|FG002|Double-blind Treatment Period|Death|0|||
37833916|NCT01232569|69517639|FG003|Double-blind Treatment Period|Death|0|||
37833917|NCT01211665|69517650|FG000|Overall Study|Withdrawal by Subject|1|||
37833918|NCT01211665|69517651|FG001|Overall Study|Withdrawal by Subject|0|||
37833919|NCT01211665|69517650|FG000|Overall Study|Death|1|||
37833920|NCT01211665|69517651|FG001|Overall Study|Death|0|||
37833921|NCT01232491|69517659|FG000|Overall Study|Adverse Event|13|||
37833922|NCT01232491|69517660|FG001|Overall Study|Adverse Event|8|||
37833923|NCT01232491|69517659|FG000|Overall Study|Lack of Efficacy|1|||
37699942|NCT02395133|69176931|FG000|Overall Study|Sponsor decision|2|||
37699943|NCT02395133|69176932|FG001|Overall Study|Sponsor decision|0|||
37699944|NCT02395133|69176933|FG002|Overall Study|Sponsor decision|0|||
37699945|NCT02395133|69176934|FG003|Overall Study|Sponsor decision|1|||
37699946|NCT02395133|69176931|FG000|Overall Study|Other than specified above|5|||
37699947|NCT02395133|69176932|FG001|Overall Study|Other than specified above|2|||
37911325|NCT02631941|69597942|FG000|Overall Study|Adverse Event|0|||
37699948|NCT02395133|69176933|FG002|Overall Study|Other than specified above|2|||
37699949|NCT02395133|69176934|FG003|Overall Study|Other than specified above|4|||
37699950|NCT02395055|69176946|FG000|Overall Study|Withdrawal by Subject|7|||
37699951|NCT02395055|69176947|FG001|Overall Study|Withdrawal by Subject|3|||
37699952|NCT02369159|69176955|FG000|Overall Study|Adverse Event|0|||
37699953|NCT02369159|69176956|FG001|Overall Study|Adverse Event|1|||
37699954|NCT02369159|69176955|FG000|Overall Study|Lost to Follow-up|1|||
37699955|NCT02369159|69176956|FG001|Overall Study|Lost to Follow-up|1|||
37699956|NCT02369159|69176955|FG000|Overall Study|Withdrawal by Subject|7|||
37833924|NCT01232491|69517660|FG001|Overall Study|Lack of Efficacy|5|||
37833925|NCT01232491|69517659|FG000|Overall Study|Protocol Violation|13|||
37833926|NCT01232491|69517660|FG001|Overall Study|Protocol Violation|11|||
37833927|NCT01232491|69517659|FG000|Overall Study|Withdrawal Criteria|12|||
37833928|NCT01232491|69517660|FG001|Overall Study|Withdrawal Criteria|21|||
37833929|NCT01232491|69517659|FG000|Overall Study|Other|21|||
37833930|NCT01232491|69517660|FG001|Overall Study|Other|18|||
37833931|NCT01232452|69517668|FG000|Overall Study|Adverse Event|17|||
37699957|NCT02369159|69176956|FG001|Overall Study|Withdrawal by Subject|0|||
37699958|NCT02368691|69176973|FG000|Overall Study|Death|13|||
37833932|NCT01232452|69517669|FG001|Overall Study|Adverse Event|15|||
37833933|NCT01232452|69517668|FG000|Overall Study|Withdrawal by Subject|11|||
37833934|NCT01232452|69517669|FG001|Overall Study|Withdrawal by Subject|8|||
37833935|NCT01232452|69517668|FG000|Overall Study|Physician Decision|8|||
37833936|NCT01232452|69517669|FG001|Overall Study|Physician Decision|12|||
37833937|NCT01232452|69517668|FG000|Overall Study|Protocol entry criterion not met|0|||
37833938|NCT01232452|69517669|FG001|Overall Study|Protocol entry criterion not met|2|||
37833939|NCT01232452|69517668|FG000|Overall Study|Sponsor Decision|3|||
37833940|NCT01232452|69517669|FG001|Overall Study|Sponsor Decision|1|||
37833941|NCT01232452|69517668|FG000|Overall Study|Protocol Violation|0|||
37833942|NCT01232452|69517669|FG001|Overall Study|Protocol Violation|1|||
37833943|NCT01211197|69517675|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
37833944|NCT01211197|69517676|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
37833945|NCT01211197|69517677|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
37833946|NCT01211197|69517678|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
37833947|NCT01211197|69517679|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
37833948|NCT01211197|69517680|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
37833949|NCT01211197|69517675|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
37833950|NCT01211197|69517676|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
37699959|NCT02368691|69176973|FG000|Overall Study|Lack of Efficacy|15|||
37699960|NCT02368691|69176973|FG000|Overall Study|Physician Decision|4|||
37699961|NCT02394665|69176980|FG000|Overall Study|Physician Decision|1|||
37699962|NCT02394665|69176981|FG001|Overall Study|Physician Decision|0|||
37699963|NCT02394665|69176982|FG002|Overall Study|Physician Decision|0|||
37699964|NCT02367911|69176992|FG000|Overall Study|Withdrawal by Subject|3|||
37699965|NCT02367911|69176993|FG001|Overall Study|Withdrawal by Subject|2|||
37699966|NCT02367911|69176992|FG000|Overall Study|Lost to Follow-up|2|||
37699967|NCT02367911|69176993|FG001|Overall Study|Lost to Follow-up|2|||
37699968|NCT02339285|69177002|FG000|Overall Study|Withdrawal by Subject|0|||
37699969|NCT02339285|69177003|FG001|Overall Study|Withdrawal by Subject|1|||
37699970|NCT02339285|69177004|FG002|Overall Study|Withdrawal by Subject|1|||
37699971|NCT02339285|69177002|FG000|Overall Study|Lost to Follow-up|1|||
37699972|NCT02339285|69177003|FG001|Overall Study|Lost to Follow-up|1|||
37699973|NCT02339285|69177004|FG002|Overall Study|Lost to Follow-up|1|||
37699974|NCT02339285|69177002|FG000|Overall Study|Protocol Deviation|0|||
37699975|NCT02339285|69177003|FG001|Overall Study|Protocol Deviation|1|||
37699976|NCT02339285|69177004|FG002|Overall Study|Protocol Deviation|0|||
37699977|NCT02367833|69177015|FG000|Overall Study|Withdrawal by Subject|1|||
37833951|NCT01211197|69517677|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
37833952|NCT01211197|69517678|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
37833953|NCT01211197|69517679|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
37833954|NCT01211197|69517680|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
37699978|NCT02367833|69177016|FG001|Overall Study|Withdrawal by Subject|1|||
37699979|NCT02367833|69177017|FG002|Overall Study|Withdrawal by Subject|0|||
37699980|NCT02367521|69177027|FG000|Overall Study|severe headache after intervention|2|||
37699981|NCT02367521|69177028|FG001|Overall Study|severe headache after intervention|0|||
37699982|NCT02367521|69177027|FG000|Overall Study|unable to find transportation|2|||
37699983|NCT02367521|69177028|FG001|Overall Study|unable to find transportation|0|||
37833955|NCT01232296|69517690|FG000|Overall Study|Adverse Event|24|||
37911326|NCT02631941|69597943|FG001|Overall Study|Adverse Event|1|||
37833956|NCT01232296|69517691|FG001|Overall Study|Adverse Event|12|||
37833957|NCT01232296|69517690|FG000|Overall Study|Physician Decision|1|||
37833958|NCT01232296|69517691|FG001|Overall Study|Physician Decision|1|||
37833959|NCT01232296|69517690|FG000|Overall Study|Progressive disease|43|||
37833960|NCT01232296|69517691|FG001|Overall Study|Progressive disease|61|||
37833961|NCT01232296|69517690|FG000|Overall Study|Study terminated by sponsor|0|||
37833962|NCT01232296|69517691|FG001|Overall Study|Study terminated by sponsor|1|||
37833963|NCT01232296|69517690|FG000|Overall Study|Technical problems|3|||
37833964|NCT01232296|69517691|FG001|Overall Study|Technical problems|0|||
37833965|NCT01232296|69517690|FG000|Overall Study|Subject/guardian decision|10|||
37833966|NCT01232296|69517691|FG001|Overall Study|Subject/guardian decision|2|||
37833967|NCT01232296|69517690|FG000|Overall Study|Death|1|||
37833968|NCT01232296|69517691|FG001|Overall Study|Death|6|||
37833969|NCT01231984|69517699|FG000|Study Period 1|Withdrawal by Subject|0|||
37833970|NCT01231984|69517700|FG001|Study Period 1|Withdrawal by Subject|0|||
37833971|NCT01231984|69517701|FG002|Study Period 1|Withdrawal by Subject|0|||
37833972|NCT01231984|69517702|FG003|Study Period 1|Withdrawal by Subject|1|||
37833973|NCT01231984|69517699|FG000|Study Period 1|Lost to Follow-up|1|||
37833974|NCT01231984|69517700|FG001|Study Period 1|Lost to Follow-up|1|||
37833975|NCT01231984|69517701|FG002|Study Period 1|Lost to Follow-up|1|||
37833976|NCT01231984|69517702|FG003|Study Period 1|Lost to Follow-up|0|||
37833977|NCT01231984|69517699|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
37833978|NCT01231984|69517700|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
37833979|NCT01231984|69517701|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
37833980|NCT01231984|69517702|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
37833981|NCT01231984|69517699|FG000|Study Period 1|Screen Failure|0|||
37833982|NCT01231984|69517700|FG001|Study Period 1|Screen Failure|0|||
37833983|NCT01231984|69517701|FG002|Study Period 1|Screen Failure|0|||
37833984|NCT01231984|69517702|FG003|Study Period 1|Screen Failure|1|||
37833985|NCT01231984|69517699|FG000|Study Period 1|Non-compliance with study requirements|5|||
37833986|NCT01231984|69517700|FG001|Study Period 1|Non-compliance with study requirements|0|||
37833987|NCT01231984|69517701|FG002|Study Period 1|Non-compliance with study requirements|2|||
37833988|NCT01231984|69517702|FG003|Study Period 1|Non-compliance with study requirements|1|||
37833989|NCT01231984|69517699|FG000|Study Period 1|Protocol Violation|3|||
37833990|NCT01231984|69517700|FG001|Study Period 1|Protocol Violation|4|||
37833991|NCT01231984|69517701|FG002|Study Period 1|Protocol Violation|2|||
37833992|NCT01231984|69517702|FG003|Study Period 1|Protocol Violation|3|||
37833993|NCT01231984|69517699|FG000|Study Period 1|Adverse Event|1|||
37833994|NCT01231984|69517700|FG001|Study Period 1|Adverse Event|0|||
37833995|NCT01231984|69517701|FG002|Study Period 1|Adverse Event|0|||
37833996|NCT01231984|69517702|FG003|Study Period 1|Adverse Event|0|||
37699984|NCT02338193|69177037|FG000|Overall Study|Withdrawal by Subject|0|||
37699985|NCT02338193|69177038|FG001|Overall Study|Withdrawal by Subject|0|||
37699986|NCT02338193|69177039|FG002|Overall Study|Withdrawal by Subject|2|||
37699987|NCT02338193|69177037|FG000|Overall Study|Pregnancy|0|||
37699988|NCT02338193|69177038|FG001|Overall Study|Pregnancy|1|||
38021565|NCT03526861|69704655|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
38043463|NCT03737994|69731598|FG004|Overall Study|Withdrawal by Subject|0|||
37699989|NCT02338193|69177039|FG002|Overall Study|Pregnancy|1|||
37699990|NCT02338193|69177037|FG000|Overall Study|Noncompliant with visits|2|||
37699991|NCT02338193|69177038|FG001|Overall Study|Noncompliant with visits|2|||
37699992|NCT02338193|69177039|FG002|Overall Study|Noncompliant with visits|7|||
37699993|NCT02338193|69177037|FG000|Overall Study|moved out of state|0|||
37699994|NCT02338193|69177038|FG001|Overall Study|moved out of state|1|||
37699995|NCT02338193|69177039|FG002|Overall Study|moved out of state|0|||
37699996|NCT02338193|69177037|FG000|Overall Study|intolerant of side effects|1|||
37699997|NCT02338193|69177038|FG001|Overall Study|intolerant of side effects|0|||
37699998|NCT02338193|69177039|FG002|Overall Study|intolerant of side effects|0|||
37699999|NCT01783444|69177050|FG000|Treatment Phase|Adverse Event|9|||
37700000|NCT01783444|69177051|FG001|Treatment Phase|Adverse Event|20|||
37700001|NCT01783444|69177052|FG002|Treatment Phase|Adverse Event|19|||
37700002|NCT01783444|69177050|FG000|Treatment Phase|Disease Progression|76|||
37833997|NCT01231984|69517699|FG000|Study Period 1|Other|0|||
37833998|NCT01231984|69517700|FG001|Study Period 1|Other|0|||
37833999|NCT01231984|69517701|FG002|Study Period 1|Other|0|||
37834000|NCT01231984|69517702|FG003|Study Period 1|Other|1|||
37834001|NCT01231984|69517699|FG000|Study Period 2|Withdrawal by Subject|1|||
37834002|NCT01231984|69517700|FG001|Study Period 2|Withdrawal by Subject|1|||
37834003|NCT01231984|69517701|FG002|Study Period 2|Withdrawal by Subject|0|||
37700003|NCT01783444|69177051|FG001|Treatment Phase|Disease Progression|66|||
37700004|NCT01783444|69177052|FG002|Treatment Phase|Disease Progression|64|||
37700005|NCT01783444|69177050|FG000|Treatment Phase|Death|2|||
37700006|NCT01783444|69177051|FG001|Treatment Phase|Death|2|||
37700007|NCT01783444|69177052|FG002|Treatment Phase|Death|2|||
37700008|NCT01783444|69177050|FG000|Treatment Phase|Protocol Violation|1|||
37700009|NCT01783444|69177051|FG001|Treatment Phase|Protocol Violation|1|||
37834004|NCT01231984|69517702|FG003|Study Period 2|Withdrawal by Subject|0|||
37834005|NCT01231984|69517699|FG000|Study Period 2|Lost to Follow-up|1|||
37834006|NCT01231984|69517700|FG001|Study Period 2|Lost to Follow-up|0|||
37834007|NCT01231984|69517701|FG002|Study Period 2|Lost to Follow-up|0|||
37834008|NCT01231984|69517702|FG003|Study Period 2|Lost to Follow-up|3|||
37834009|NCT01231984|69517699|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
37834010|NCT01231984|69517700|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
37834011|NCT01231984|69517701|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
37834012|NCT01231984|69517702|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
37834013|NCT01210807|69517722|FG000|Overall Study|Lost to Follow-up|1|||
37834014|NCT01210807|69517723|FG001|Overall Study|Lost to Follow-up|2|||
38021566|NCT03526861|69704656|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
38021567|NCT03526861|69704657|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
37700010|NCT01783444|69177052|FG002|Treatment Phase|Protocol Violation|2|||
37700011|NCT01783444|69177050|FG000|Treatment Phase|Withdrawal by Subject|6|||
37700012|NCT01783444|69177051|FG001|Treatment Phase|Withdrawal by Subject|8|||
37700013|NCT01783444|69177052|FG002|Treatment Phase|Withdrawal by Subject|9|||
37700014|NCT01783444|69177050|FG000|Treatment Phase|Administrative problems|2|||
37700015|NCT01783444|69177051|FG001|Treatment Phase|Administrative problems|0|||
37700016|NCT01783444|69177052|FG002|Treatment Phase|Administrative problems|1|||
37700017|NCT01783444|69177050|FG000|Treatment Phase|Physician Decision|8|||
37700018|NCT01783444|69177051|FG001|Treatment Phase|Physician Decision|6|||
37700019|NCT01783444|69177052|FG002|Treatment Phase|Physician Decision|5|||
37700020|NCT01783444|69177050|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
37700021|NCT01783444|69177051|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
37700022|NCT01783444|69177052|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
37700023|NCT01783444|69177050|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
37700024|NCT01783444|69177051|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
37700025|NCT01783444|69177052|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
37700026|NCT01783444|69177050|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
37700027|NCT01783444|69177051|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
37700028|NCT01783444|69177052|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
37700029|NCT01783444|69177050|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
37700030|NCT01783444|69177051|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
37700031|NCT01783444|69177052|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
37700032|NCT01783444|69177050|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
37700033|NCT01783444|69177051|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
37700034|NCT01783444|69177052|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
37700035|NCT01783444|69177050|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
37700036|NCT01783444|69177051|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
37700037|NCT01783444|69177052|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
37700038|NCT02367131|69177061|FG000|Overall Study|Adverse Event|64|||
37834015|NCT01210807|69517722|FG000|Overall Study|Not implanted bilaterally|2|||
37834016|NCT01210807|69517723|FG001|Overall Study|Not implanted bilaterally|1|||
37834017|NCT01231555|69517732|FG000|Overall Study|Study terminated|8|||
37834018|NCT01231555|69517733|FG001|Overall Study|Study terminated|5|||
37834019|NCT01231555|69517734|FG002|Overall Study|Study terminated|8|||
37834020|NCT01231555|69517732|FG000|Overall Study|Withdrawal by Subject|0|||
37834021|NCT01231555|69517733|FG001|Overall Study|Withdrawal by Subject|2|||
37834022|NCT01231555|69517734|FG002|Overall Study|Withdrawal by Subject|0|||
37700039|NCT02367131|69177061|FG000|Overall Study|No visit since the first visit|4|||
37700040|NCT02367131|69177061|FG000|Overall Study|Request by patient|54|||
37700041|NCT02367131|69177061|FG000|Overall Study|Improvement/remission|2|||
37700042|NCT02367131|69177061|FG000|Overall Study|No change/progressive disease|78|||
37700043|NCT02367131|69177061|FG000|Overall Study|Other than stated above|20|||
37700044|NCT02394275|69177065|FG000|Overall Study|Adverse Event|22|||
37700045|NCT02394275|69177065|FG000|Overall Study|Lost to Follow-up|7|||
37700046|NCT01608724|69177070|FG000|Overall Study|Withdrawal by Subject|131|||
37700047|NCT01608724|69177070|FG000|Overall Study|Lost to Follow-up|41|||
37700048|NCT01608724|69177070|FG000|Overall Study|Study-specific discontinuation criteria|32|||
37700049|NCT01608724|69177070|FG000|Overall Study|Adverse Event|29|||
37700050|NCT01608724|69177070|FG000|Overall Study|Protocol Violation|6|||
37700051|NCT01608724|69177070|FG000|Overall Study|bood sugar too high, etc.|3|||
37700052|NCT01608724|69177070|FG000|Overall Study|Safety reasons|1|||
37700053|NCT02366195|69177074|FG000|Overall Study|Protocol-specified criteria|3|||
37700054|NCT02366195|69177074|FG000|Overall Study|Withdrawal by Subject|9|||
37700055|NCT02366195|69177074|FG000|Overall Study|Lost to Follow-up|1|||
37700056|NCT02366195|69177074|FG000|Overall Study|Death|41|||
37700057|NCT02364947|69177081|FG000|Overall Study|Withdrawal by Subject|10|||
37700058|NCT02364947|69177082|FG001|Overall Study|Withdrawal by Subject|8|||
37700059|NCT02364947|69177083|FG002|Overall Study|Withdrawal by Subject|9|||
37700060|NCT02364947|69177081|FG000|Overall Study|Adverse Event|45|||
37700061|NCT02364947|69177082|FG001|Overall Study|Adverse Event|33|||
37700062|NCT02364947|69177083|FG002|Overall Study|Adverse Event|11|||
37700063|NCT02364947|69177081|FG000|Overall Study|Protocol Violation|1|||
37700064|NCT02364947|69177082|FG001|Overall Study|Protocol Violation|1|||
37700065|NCT02364947|69177083|FG002|Overall Study|Protocol Violation|1|||
37700066|NCT02364947|69177081|FG000|Overall Study|Physician Decision|3|||
37700067|NCT02364947|69177082|FG001|Overall Study|Physician Decision|2|||
37700068|NCT02364947|69177083|FG002|Overall Study|Physician Decision|5|||
37700069|NCT02364947|69177081|FG000|Overall Study|Death|0|||
37700070|NCT02364947|69177082|FG001|Overall Study|Death|1|||
37700071|NCT02364947|69177083|FG002|Overall Study|Death|0|||
37700072|NCT02392481|69177095|FG000|Overall Study|Adverse Event|0|||
37700073|NCT02392481|69177096|FG001|Overall Study|Adverse Event|0|||
37700074|NCT02392481|69177097|FG002|Overall Study|Adverse Event|1|||
37700075|NCT02392481|69177098|FG003|Overall Study|Adverse Event|2|||
37700076|NCT02392481|69177095|FG000|Overall Study|Withdrawal by Subject|0|||
37700077|NCT02392481|69177096|FG001|Overall Study|Withdrawal by Subject|0|||
37700078|NCT02392481|69177097|FG002|Overall Study|Withdrawal by Subject|1|||
37700079|NCT02392481|69177098|FG003|Overall Study|Withdrawal by Subject|0|||
37700080|NCT02392403|69177108|FG000|Overall Study|Adverse Event|1|||
37700081|NCT02392403|69177108|FG000|Overall Study|Death|1|||
37700082|NCT02392403|69177108|FG000|Overall Study|Withdrawal by Subject|1|||
37700083|NCT02392247|69177112|FG000|Overall Study|Withdrawal by Subject|1|||
37700084|NCT02392247|69177112|FG000|Overall Study|Surgery cancelled; no data|1|||
37700085|NCT02337725|69177118|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
37700086|NCT02337725|69177119|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
37700087|NCT02337725|69177118|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
37700088|NCT02337725|69177119|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
37700089|NCT02337725|69177118|FG000|Overall Study|Major Protocol Deviation|0|||
37700090|NCT02337725|69177119|FG001|Overall Study|Major Protocol Deviation|1|||
37700091|NCT02337725|69177118|FG000|Overall Study|Voluntary Withdrawal|14|||
37700092|NCT02337725|69177119|FG001|Overall Study|Voluntary Withdrawal|3|||
37700093|NCT02337725|69177118|FG000|Overall Study|Lack of Efficacy|4|||
37700094|NCT02337725|69177119|FG001|Overall Study|Lack of Efficacy|0|||
37700095|NCT02337491|69177127|FG000|Overall Study|Death|1|||
37700096|NCT02337491|69177128|FG001|Overall Study|Death|1|||
37700097|NCT02337491|69177127|FG000|Overall Study|Adverse Event|0|||
37700098|NCT02337491|69177128|FG001|Overall Study|Adverse Event|1|||
37700099|NCT02337491|69177127|FG000|Overall Study|Withdrawal by Subject|3|||
37700100|NCT02337491|69177128|FG001|Overall Study|Withdrawal by Subject|0|||
37700101|NCT02337491|69177127|FG000|Overall Study|Progressive Disease|44|||
37700102|NCT02337491|69177128|FG001|Overall Study|Progressive Disease|28|||
37700103|NCT02337491|69177127|FG000|Overall Study|On Treatment|2|||
37700104|NCT02337491|69177128|FG001|Overall Study|On Treatment|0|||
37700105|NCT01765582|69177138|FG000|Overall Study|Other|3|||
37700106|NCT01765582|69177139|FG001|Overall Study|Other|6|||
37700107|NCT01765582|69177140|FG002|Overall Study|Other|9|||
38043464|NCT03737994|69731599|FG005|Overall Study|Withdrawal by Subject|0|||
37700108|NCT01765582|69177138|FG000|Overall Study|Lost to Follow-up|2|||
37700109|NCT01765582|69177139|FG001|Overall Study|Lost to Follow-up|2|||
37700110|NCT01765582|69177140|FG002|Overall Study|Lost to Follow-up|1|||
37700111|NCT01765582|69177138|FG000|Overall Study|Death|31|||
37700112|NCT01765582|69177139|FG001|Overall Study|Death|36|||
37700113|NCT01765582|69177140|FG002|Overall Study|Death|33|||
37700114|NCT01765582|69177138|FG000|Overall Study|Sponsor Decision|46|||
37700115|NCT01765582|69177139|FG001|Overall Study|Sponsor Decision|42|||
37700116|NCT01765582|69177140|FG002|Overall Study|Sponsor Decision|42|||
37700117|NCT01765582|69177138|FG000|Overall Study|Withdrawal of Consent|11|||
37700118|NCT01765582|69177139|FG001|Overall Study|Withdrawal of Consent|6|||
37700119|NCT01765582|69177140|FG002|Overall Study|Withdrawal of Consent|10|||
37700120|NCT01649375|69177152|FG000|Up to Week 16|Adverse Event|2|||
37700121|NCT01649375|69177153|FG001|Up to Week 16|Adverse Event|5|||
37700122|NCT01649375|69177154|FG002|Up to Week 16|Adverse Event|4|||
37700123|NCT01649375|69177155|FG003|Up to Week 16|Adverse Event|0|||
37700124|NCT01649375|69177156|FG004|Up to Week 16|Adverse Event|0|||
37700125|NCT01649375|69177152|FG000|Up to Week 16|Lack of Efficacy|0|||
37834023|NCT01210690|69517742|FG000|Overall Study|Adverse Event|7|||
37700126|NCT01649375|69177153|FG001|Up to Week 16|Lack of Efficacy|0|||
37700127|NCT01649375|69177154|FG002|Up to Week 16|Lack of Efficacy|1|||
37700128|NCT01649375|69177155|FG003|Up to Week 16|Lack of Efficacy|0|||
37700129|NCT01649375|69177156|FG004|Up to Week 16|Lack of Efficacy|0|||
37700130|NCT01649375|69177152|FG000|Up to Week 16|Physician Decision|0|||
37700131|NCT01649375|69177153|FG001|Up to Week 16|Physician Decision|0|||
37700132|NCT01649375|69177154|FG002|Up to Week 16|Physician Decision|1|||
37700133|NCT01649375|69177155|FG003|Up to Week 16|Physician Decision|0|||
37700134|NCT01649375|69177156|FG004|Up to Week 16|Physician Decision|0|||
37700135|NCT01649375|69177152|FG000|Up to Week 16|Withdrawal by Subject|2|||
37700136|NCT01649375|69177153|FG001|Up to Week 16|Withdrawal by Subject|1|||
37700137|NCT01649375|69177154|FG002|Up to Week 16|Withdrawal by Subject|2|||
37700138|NCT01649375|69177155|FG003|Up to Week 16|Withdrawal by Subject|0|||
37834024|NCT01210690|69517742|FG000|Overall Study|Lack of Efficacy|12|||
37911327|NCT02631941|69597944|FG002|Overall Study|Adverse Event|0|||
37911328|NCT02631941|69597945|FG003|Overall Study|Adverse Event|0|||
37911329|NCT02631941|69597946|FG004|Overall Study|Adverse Event|0|||
37911330|NCT02631941|69597947|FG005|Overall Study|Adverse Event|0|||
37911331|NCT02631941|69597948|FG006|Overall Study|Adverse Event|0|||
37911332|NCT02631941|69597949|FG007|Overall Study|Adverse Event|0|||
37911333|NCT02631941|69597950|FG008|Overall Study|Adverse Event|0|||
37911334|NCT02631941|69597951|FG009|Overall Study|Adverse Event|0|||
37911335|NCT02631941|69597942|FG000|Overall Study|Withdrawal by Subject|0|||
37911336|NCT02631941|69597943|FG001|Overall Study|Withdrawal by Subject|0|||
37911337|NCT02631941|69597944|FG002|Overall Study|Withdrawal by Subject|0|||
37911338|NCT02631941|69597945|FG003|Overall Study|Withdrawal by Subject|0|||
37911339|NCT02631941|69597946|FG004|Overall Study|Withdrawal by Subject|1|||
37911340|NCT02631941|69597947|FG005|Overall Study|Withdrawal by Subject|0|||
37911341|NCT02631941|69597948|FG006|Overall Study|Withdrawal by Subject|0|||
37911342|NCT02631941|69597949|FG007|Overall Study|Withdrawal by Subject|1|||
37911343|NCT02631941|69597950|FG008|Overall Study|Withdrawal by Subject|0|||
37911344|NCT02631941|69597951|FG009|Overall Study|Withdrawal by Subject|0|||
37911345|NCT02631941|69597942|FG000|Overall Study|Lost to Follow-up|0|||
37911346|NCT02631941|69597943|FG001|Overall Study|Lost to Follow-up|0|||
37834025|NCT01210690|69517742|FG000|Overall Study|Lost to Follow-up|3|||
37834026|NCT01210690|69517742|FG000|Overall Study|Disease Remission|1|||
37834027|NCT01210690|69517742|FG000|Overall Study|Withdrawal by Subject|1|||
37834028|NCT01210690|69517742|FG000|Overall Study|Patient refused to swallow|1|||
37834029|NCT01210690|69517742|FG000|Overall Study|Patient could not take glucose|1|||
37834030|NCT01210651|69517749|FG000|Overall Study|Lost to Follow-up|1|||
37834031|NCT01210651|69517750|FG001|Overall Study|Lost to Follow-up|1|||
37834032|NCT01210651|69517749|FG000|Overall Study|schedule conflicts|1|||
37834033|NCT01210651|69517750|FG001|Overall Study|schedule conflicts|5|||
37834034|NCT01210651|69517749|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
37834035|NCT01210651|69517750|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
37834036|NCT01210651|69517749|FG000|Overall Study|Withdrawal by Subject|1|||
37834037|NCT01210651|69517750|FG001|Overall Study|Withdrawal by Subject|1|||
37834038|NCT01210651|69517749|FG000|Overall Study|Injury outside study|2|||
37834039|NCT01210651|69517750|FG001|Overall Study|Injury outside study|0|||
37834040|NCT01210495|69517829|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
37834041|NCT01210495|69517830|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
37834042|NCT01210495|69517831|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
37834043|NCT01210495|69517832|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
37834044|NCT01210495|69517829|FG000|Overall Study|Death|14|||
37834045|NCT01210495|69517830|FG001|Overall Study|Death|7|||
37834046|NCT01210495|69517831|FG002|Overall Study|Death|112|||
37834047|NCT01210495|69517832|FG003|Overall Study|Death|54|||
37834048|NCT01210495|69517829|FG000|Overall Study|Study Terminated by Sponsor|0|||
37911347|NCT02631941|69597944|FG002|Overall Study|Lost to Follow-up|0|||
37911348|NCT02631941|69597945|FG003|Overall Study|Lost to Follow-up|0|||
37911349|NCT02631941|69597946|FG004|Overall Study|Lost to Follow-up|0|||
37911350|NCT02631941|69597947|FG005|Overall Study|Lost to Follow-up|0|||
37911351|NCT02631941|69597948|FG006|Overall Study|Lost to Follow-up|0|||
37911352|NCT02631941|69597949|FG007|Overall Study|Lost to Follow-up|0|||
37911353|NCT02631941|69597950|FG008|Overall Study|Lost to Follow-up|1|||
37911354|NCT02631941|69597951|FG009|Overall Study|Lost to Follow-up|0|||
37911355|NCT00908375|69597963|FG000|Overall Study|Withdrawal by Subject|2|||
37911356|NCT00908375|69597964|FG001|Overall Study|Withdrawal by Subject|4|||
37911357|NCT00908375|69597963|FG000|Overall Study|Lost to Follow-up|8|||
37911358|NCT00908375|69597964|FG001|Overall Study|Lost to Follow-up|6|||
37911359|NCT00909389|69597970|FG000|Overall Study|Adverse Event|6|||
37911360|NCT00909389|69597970|FG000|Overall Study|Death|4|||
37911361|NCT00909389|69597970|FG000|Overall Study|Poor Compliance|16|||
37911362|NCT00909389|69597970|FG000|Overall Study|Lost to Follow-up|4|||
37911363|NCT00909389|69597970|FG000|Overall Study|No Information|103|||
37911364|NCT00910715|69597977|FG000|Overall Study|Lost to Follow-up|22|||
37911365|NCT00910715|69597978|FG001|Overall Study|Lost to Follow-up|26|||
37911366|NCT00910715|69597979|FG002|Overall Study|Lost to Follow-up|0|||
37911367|NCT00600483|69598050|FG000|Overall Study|Lost to Follow-up|26|||
37911368|NCT00600483|69598051|FG001|Overall Study|Lost to Follow-up|47|||
37911369|NCT00600483|69598050|FG000|Overall Study|Randomized but not treated|10|||
37911370|NCT00600483|69598051|FG001|Overall Study|Randomized but not treated|0|||
37911371|NCT00600171|69598063|FG000|Overall Study|Adverse Event|0|||
37911372|NCT00600171|69598064|FG001|Overall Study|Adverse Event|1|||
37911373|NCT00600171|69598065|FG002|Overall Study|Adverse Event|0|||
37911374|NCT00600171|69598066|FG003|Overall Study|Adverse Event|0|||
37911375|NCT00600171|69598067|FG004|Overall Study|Adverse Event|1|||
37911376|NCT00600171|69598068|FG005|Overall Study|Adverse Event|0|||
37911377|NCT00600171|69598063|FG000|Overall Study|Lack of Efficacy|9|||
37911378|NCT00600171|69598064|FG001|Overall Study|Lack of Efficacy|12|||
37911379|NCT00600171|69598065|FG002|Overall Study|Lack of Efficacy|3|||
37911380|NCT00600171|69598066|FG003|Overall Study|Lack of Efficacy|5|||
37911381|NCT00600171|69598067|FG004|Overall Study|Lack of Efficacy|4|||
37911382|NCT00600171|69598068|FG005|Overall Study|Lack of Efficacy|0|||
37911383|NCT00600171|69598063|FG000|Overall Study|Protocol Violation|1|||
37911384|NCT00600171|69598064|FG001|Overall Study|Protocol Violation|2|||
37911385|NCT00600171|69598065|FG002|Overall Study|Protocol Violation|0|||
37911386|NCT00600171|69598066|FG003|Overall Study|Protocol Violation|1|||
37911387|NCT00600171|69598067|FG004|Overall Study|Protocol Violation|0|||
37911388|NCT00600171|69598068|FG005|Overall Study|Protocol Violation|0|||
37911389|NCT00600171|69598063|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
37911390|NCT00600171|69598064|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
37911391|NCT00600171|69598065|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
37911392|NCT00600171|69598066|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
37911393|NCT00600171|69598067|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
38021568|NCT03526861|69704649|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
38021569|NCT03526861|69704650|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
38021570|NCT03526861|69704651|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
38021571|NCT03526861|69704652|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
38021572|NCT03526861|69704653|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
38021573|NCT03526861|69704654|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
38021574|NCT03526861|69704655|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
38021575|NCT03526861|69704656|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
38021576|NCT03526861|69704657|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
38021577|NCT03510884|69704681|FG000|Double-blind Period (up to Week 24)|Adverse Event|0|||
38021578|NCT03510884|69704682|FG001|Double-blind Period (up to Week 24)|Adverse Event|0|||
38021579|NCT03510884|69704683|FG002|Double-blind Period (up to Week 24)|Adverse Event|0|||
38021580|NCT03510884|69704684|FG003|Double-blind Period (up to Week 24)|Adverse Event|2|||
38021581|NCT03510884|69704681|FG000|Double-blind Period (up to Week 24)|Participant moved|0|||
38021582|NCT03510884|69704682|FG001|Double-blind Period (up to Week 24)|Participant moved|1|||
38021583|NCT03510884|69704683|FG002|Double-blind Period (up to Week 24)|Participant moved|0|||
38021584|NCT03510884|69704684|FG003|Double-blind Period (up to Week 24)|Participant moved|0|||
38021585|NCT03510884|69704681|FG000|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
38021586|NCT03510884|69704682|FG001|Double-blind Period (up to Week 24)|Life events made continuing too difficult|1|||
38021587|NCT03510884|69704683|FG002|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
38021588|NCT03510884|69704684|FG003|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
38021589|NCT03510884|69704681|FG000|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
38021590|NCT03510884|69704682|FG001|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|2|||
38021591|NCT03510884|69704683|FG002|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
38021592|NCT03510884|69704684|FG003|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
38021593|NCT03510884|69704681|FG000|Double-blind Period (up to Week 24)|Other than specified above|0|||
38021594|NCT03510884|69704682|FG001|Double-blind Period (up to Week 24)|Other than specified above|0|||
38021595|NCT03510884|69704683|FG002|Double-blind Period (up to Week 24)|Other than specified above|1|||
38021596|NCT03510884|69704684|FG003|Double-blind Period (up to Week 24)|Other than specified above|1|||
38021597|NCT03510884|69704681|FG000|Open Label Period (up to Week 104)|Adverse Event|1|||
38021598|NCT03510884|69704682|FG001|Open Label Period (up to Week 104)|Adverse Event|0|||
38021599|NCT03510884|69704683|FG002|Open Label Period (up to Week 104)|Adverse Event|0|||
38021600|NCT03510884|69704684|FG003|Open Label Period (up to Week 104)|Adverse Event|0|||
38021601|NCT03510884|69704681|FG000|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
38021602|NCT03510884|69704682|FG001|Open Label Period (up to Week 104)|Lack of Efficacy|1|||
38021603|NCT03510884|69704683|FG002|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
38021604|NCT03510884|69704684|FG003|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
38021605|NCT03510884|69704681|FG000|Open Label Period (up to Week 104)|Participant moved|1|||
38021606|NCT03510884|69704682|FG001|Open Label Period (up to Week 104)|Participant moved|0|||
38021607|NCT03510884|69704683|FG002|Open Label Period (up to Week 104)|Participant moved|1|||
38021608|NCT03510884|69704684|FG003|Open Label Period (up to Week 104)|Participant moved|0|||
38021609|NCT03510884|69704681|FG000|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
38021610|NCT03510884|69704682|FG001|Open Label Period (up to Week 104)|Life events made continuing too difficult|1|||
38021611|NCT03510884|69704683|FG002|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
38021612|NCT03510884|69704684|FG003|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
37677362|NCT01659255|69152296|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
38021613|NCT03510884|69704681|FG000|Open Label Period (up to Week 104)|Other than specified above|1|||
38021614|NCT03510884|69704682|FG001|Open Label Period (up to Week 104)|Other than specified above|1|||
38021615|NCT03510884|69704683|FG002|Open Label Period (up to Week 104)|Other than specified above|0|||
38021616|NCT03510884|69704684|FG003|Open Label Period (up to Week 104)|Other than specified above|0|||
38021617|NCT03488472|69704722|FG000|Overall Study|disease progression additional mets|1|||
38021618|NCT03456453|69704728|FG000|Overall Study|Withdrawal by Subject|2|||
38021619|NCT03456453|69704729|FG001|Overall Study|Withdrawal by Subject|0|||
38021620|NCT03456453|69704728|FG000|Overall Study|Not released to community|1|||
38021621|NCT03456453|69704729|FG001|Overall Study|Not released to community|5|||
38021622|NCT03456453|69704728|FG000|Overall Study|Lost to Follow-up|0|||
38021623|NCT03456453|69704729|FG001|Overall Study|Lost to Follow-up|2|||
38021624|NCT03455829|69704740|FG000|Overall Study|Death|2|||
38021625|NCT03455829|69704741|FG001|Overall Study|Death|3|||
38021626|NCT03455829|69704742|FG002|Overall Study|Death|2|||
38021627|NCT03455829|69704743|FG003|Overall Study|Death|4|||
38021628|NCT03455829|69704744|FG004|Overall Study|Death|2|||
38021629|NCT03455829|69704740|FG000|Overall Study|Study terminated and patients did not have progressive disease or died|5|||
38021630|NCT03455829|69704741|FG001|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
38021631|NCT03455829|69704742|FG002|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
38021632|NCT03455829|69704743|FG003|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
38021633|NCT03455829|69704744|FG004|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
38021634|NCT03455829|69704740|FG000|Overall Study|Disease progression|0|||
38021635|NCT03455829|69704741|FG001|Overall Study|Disease progression|0|||
38021636|NCT03455829|69704742|FG002|Overall Study|Disease progression|0|||
38021637|NCT03455829|69704743|FG003|Overall Study|Disease progression|1|||
38021638|NCT03455829|69704744|FG004|Overall Study|Disease progression|1|||
38021639|NCT03441334|69704758|FG000|Overall Study|Withdrawal by Subject|1|||
38021640|NCT03441334|69704759|FG001|Overall Study|Withdrawal by Subject|0|||
38021641|NCT03429244|69704790|FG000|Overall Study|Withdrawal by Subject|2|||
38021642|NCT03429244|69704791|FG001|Overall Study|Withdrawal by Subject|1|||
38021643|NCT03429244|69704792|FG002|Overall Study|Withdrawal by Subject|1|||
38021644|NCT03250117|69704805|FG000|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|1|||
38021645|NCT03250117|69704806|FG001|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
38021646|NCT03250117|69704807|FG002|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
38021647|NCT03250117|69704808|FG003|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
38021648|NCT03230838|69704814|FG000|Overall Study|Withdrawal by Subject|3|||
38021649|NCT03230838|69704815|FG001|Overall Study|Withdrawal by Subject|0|||
38021650|NCT03230838|69704814|FG000|Overall Study|Temperature excursion|1|||
38021651|NCT03230838|69704815|FG001|Overall Study|Temperature excursion|0|||
38021652|NCT03217136|69704823|FG000|Overall Study|Lost to Follow-up|2|||
38021653|NCT03217136|69704824|FG001|Overall Study|Lost to Follow-up|1|||
38021654|NCT03217136|69704823|FG000|Overall Study|Site Randomized Participant in Error|0|||
38021655|NCT03217136|69704824|FG001|Overall Study|Site Randomized Participant in Error|1|||
38021656|NCT03217136|69704823|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
38021657|NCT03217136|69704824|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
38021658|NCT03217136|69704823|FG000|Overall Study|Dispensing Error|1|||
38021659|NCT03217136|69704824|FG001|Overall Study|Dispensing Error|0|||
38021660|NCT03217136|69704823|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
38021661|NCT03217136|69704824|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
38021662|NCT03213665|69704830|FG000|Overall Study|Adverse Event|1|||
38021663|NCT03213665|69704830|FG000|Overall Study|Physician Decision|2|||
38021664|NCT03213665|69704830|FG000|Overall Study|Withdrawal by Subject|3|||
38021665|NCT03213665|69704830|FG000|Overall Study|Progressive Disease|13|||
38021666|NCT03179761|69704836|FG000|Overall Study|Death|2|||
38021667|NCT03179761|69704837|FG001|Overall Study|Death|5|||
38021668|NCT03179761|69704836|FG000|Overall Study|Lost to Follow-up|2|||
38021669|NCT03179761|69704837|FG001|Overall Study|Lost to Follow-up|2|||
38021670|NCT03179761|69704836|FG000|Overall Study|Protocol Violation|1|||
38021671|NCT03179761|69704837|FG001|Overall Study|Protocol Violation|0|||
38021672|NCT03179761|69704836|FG000|Overall Study|Withdrawal by Subject|1|||
38021673|NCT03179761|69704837|FG001|Overall Study|Withdrawal by Subject|4|||
38021674|NCT03179761|69704836|FG000|Overall Study|Investigator Request|0|||
38021675|NCT03179761|69704837|FG001|Overall Study|Investigator Request|2|||
38021676|NCT03173248|69704845|FG000|Overall Study|Death|28|||
38021677|NCT03173248|69704846|FG001|Overall Study|Death|46|||
38021678|NCT03173248|69704845|FG000|Overall Study|Lost to Follow-up|0|||
38021679|NCT03173248|69704846|FG001|Overall Study|Lost to Follow-up|1|||
38021680|NCT03173248|69704845|FG000|Overall Study|Withdrawal by Subject|6|||
38021681|NCT03173248|69704846|FG001|Overall Study|Withdrawal by Subject|4|||
38021682|NCT03173248|69704845|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
38021683|NCT03173248|69704846|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
38021684|NCT03155841|69704854|FG000|Overall Study|Protocol Violation|3|||
38021685|NCT03155841|69704855|FG001|Overall Study|Protocol Violation|4|||
38021686|NCT03122886|69704863|FG000|Overall Study|Withdrawal by Subject|1|||
38021687|NCT03122886|69704864|FG001|Overall Study|Withdrawal by Subject|2|||
38021688|NCT03114891|69704874|FG000|First Treatment Round|Lost to Follow-up|0|||
37911394|NCT00600171|69598068|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
37911395|NCT00600171|69598063|FG000|Overall Study|Withdrawal by Subject|3|||
37911396|NCT00600171|69598064|FG001|Overall Study|Withdrawal by Subject|0|||
37911397|NCT00600171|69598065|FG002|Overall Study|Withdrawal by Subject|0|||
37911398|NCT00600171|69598066|FG003|Overall Study|Withdrawal by Subject|1|||
37911399|NCT00600171|69598067|FG004|Overall Study|Withdrawal by Subject|1|||
37911400|NCT00600171|69598068|FG005|Overall Study|Withdrawal by Subject|1|||
37911401|NCT00600171|69598063|FG000|Overall Study|Physician Decision|0|||
37911402|NCT00600171|69598064|FG001|Overall Study|Physician Decision|1|||
37911403|NCT00600171|69598065|FG002|Overall Study|Physician Decision|0|||
37911404|NCT00600171|69598066|FG003|Overall Study|Physician Decision|1|||
37911405|NCT00600171|69598067|FG004|Overall Study|Physician Decision|0|||
37911406|NCT00600171|69598068|FG005|Overall Study|Physician Decision|2|||
37911407|NCT00600171|69598063|FG000|Overall Study|Lost to Follow-up|0|||
37911408|NCT00600171|69598064|FG001|Overall Study|Lost to Follow-up|0|||
37911409|NCT00600171|69598065|FG002|Overall Study|Lost to Follow-up|0|||
37911410|NCT00600171|69598066|FG003|Overall Study|Lost to Follow-up|1|||
37911411|NCT00600171|69598067|FG004|Overall Study|Lost to Follow-up|0|||
37911412|NCT00600171|69598068|FG005|Overall Study|Lost to Follow-up|0|||
37911413|NCT04035668|69598087|FG000|Overall Study|Adverse Event|3|||
37911414|NCT04035668|69598088|FG001|Overall Study|Adverse Event|4|||
37911415|NCT04035668|69598089|FG002|Overall Study|Adverse Event|2|||
37911416|NCT04035668|69598087|FG000|Overall Study|Lost to Follow-up|0|||
37911417|NCT04035668|69598088|FG001|Overall Study|Lost to Follow-up|1|||
37911418|NCT04035668|69598089|FG002|Overall Study|Lost to Follow-up|0|||
37911419|NCT04035668|69598087|FG000|Overall Study|Physician Decision|2|||
37911420|NCT04035668|69598088|FG001|Overall Study|Physician Decision|1|||
37911421|NCT04035668|69598089|FG002|Overall Study|Physician Decision|1|||
37911422|NCT04035668|69598087|FG000|Overall Study|Subject Decision|2|||
37911423|NCT04035668|69598088|FG001|Overall Study|Subject Decision|2|||
37911424|NCT04035668|69598089|FG002|Overall Study|Subject Decision|0|||
37911425|NCT00885495|69598109|FG000|Overall Study|Adverse Event|1|||
37911426|NCT00885495|69598110|FG001|Overall Study|Adverse Event|2|||
37911427|NCT00885495|69598109|FG000|Overall Study|Protocol Violation|0|||
37911428|NCT00885495|69598110|FG001|Overall Study|Protocol Violation|1|||
37911429|NCT00885495|69598109|FG000|Overall Study|Withdrawal by Subject|1|||
37911430|NCT00885495|69598110|FG001|Overall Study|Withdrawal by Subject|0|||
37911431|NCT00885105|69598123|FG000|Overall Study|Withdrawal by Subject|0|||
37911432|NCT00885105|69598124|FG001|Overall Study|Withdrawal by Subject|8|||
37911433|NCT00885105|69598123|FG000|Overall Study|Adverse Event|1|||
37911434|NCT00885105|69598124|FG001|Overall Study|Adverse Event|0|||
37911435|NCT00885105|69598123|FG000|Overall Study|Protocol Violation|0|||
37911436|NCT00885105|69598124|FG001|Overall Study|Protocol Violation|2|||
37911437|NCT03945188|69598132|FG000|Overall Study|Protocol Violation|1|||
37911438|NCT03945188|69598133|FG001|Overall Study|Protocol Violation|0|||
37911439|NCT03945188|69598132|FG000|Overall Study|Disease worsening|79|||
37911440|NCT03945188|69598133|FG001|Overall Study|Disease worsening|73|||
37911441|NCT03945188|69598132|FG000|Overall Study|Physician Decision|2|||
37911442|NCT03945188|69598133|FG001|Overall Study|Physician Decision|2|||
37911443|NCT03945188|69598132|FG000|Overall Study|Lack of Efficacy|7|||
37911444|NCT03945188|69598133|FG001|Overall Study|Lack of Efficacy|4|||
37911445|NCT03945188|69598132|FG000|Overall Study|Pregnancy|2|||
37911446|NCT03945188|69598133|FG001|Overall Study|Pregnancy|0|||
37911447|NCT03945188|69598132|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
37911448|NCT03945188|69598133|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
37911449|NCT03945188|69598132|FG000|Overall Study|Adverse Event|10|||
38021689|NCT03114891|69704875|FG001|First Treatment Round|Lost to Follow-up|1|||
37700139|NCT01649375|69177156|FG004|Up to Week 16|Withdrawal by Subject|0|||
37911450|NCT03945188|69598133|FG001|Overall Study|Adverse Event|5|||
37911451|NCT03945188|69598132|FG000|Overall Study|Other|2|||
37911452|NCT03945188|69598133|FG001|Overall Study|Other|2|||
37911453|NCT03945188|69598132|FG000|Overall Study|Lost to Follow-up|1|||
37911454|NCT03945188|69598133|FG001|Overall Study|Lost to Follow-up|2|||
37911455|NCT00884949|69598139|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
37911456|NCT00884949|69598139|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
37911457|NCT00884793|69598152|FG000|Overall Study|Withdrawal by Subject|1|||
37911458|NCT00884325|69598158|FG000|Overall Study|Lost to Follow-up|1|||
37911459|NCT00884325|69598159|FG001|Overall Study|Lost to Follow-up|2|||
37911460|NCT00884325|69598158|FG000|Overall Study|Lack of Efficacy|0|||
37911461|NCT00884325|69598159|FG001|Overall Study|Lack of Efficacy|1|||
37911462|NCT00884325|69598158|FG000|Overall Study|Withdrawal by Subject|1|||
38021690|NCT03114891|69704876|FG002|First Treatment Round|Lost to Follow-up|1|||
38021691|NCT03114891|69704877|FG003|First Treatment Round|Lost to Follow-up|0|||
38021692|NCT03114891|69704874|FG000|First Treatment Round|Withdrawal by Subject|0|||
38021693|NCT03114891|69704875|FG001|First Treatment Round|Withdrawal by Subject|2|||
38021694|NCT03114891|69704876|FG002|First Treatment Round|Withdrawal by Subject|0|||
38021695|NCT03114891|69704877|FG003|First Treatment Round|Withdrawal by Subject|1|||
38021696|NCT03114891|69704874|FG000|3 Week Break|Lost to Follow-up|1|||
38021697|NCT03114891|69704875|FG001|3 Week Break|Lost to Follow-up|0|||
38021698|NCT03114891|69704876|FG002|3 Week Break|Lost to Follow-up|0|||
38021699|NCT03114891|69704877|FG003|3 Week Break|Lost to Follow-up|1|||
38021700|NCT03114891|69704874|FG000|3 Week Break|Withdrawal by Subject|0|||
38021701|NCT03114891|69704875|FG001|3 Week Break|Withdrawal by Subject|1|||
38021702|NCT03114891|69704876|FG002|3 Week Break|Withdrawal by Subject|0|||
38021703|NCT03114891|69704877|FG003|3 Week Break|Withdrawal by Subject|0|||
37700140|NCT01649375|69177152|FG000|Up to Week 16|Death|1|||
37700141|NCT01649375|69177153|FG001|Up to Week 16|Death|0|||
37700142|NCT01649375|69177154|FG002|Up to Week 16|Death|0|||
37700143|NCT01649375|69177155|FG003|Up to Week 16|Death|0|||
37700144|NCT01649375|69177156|FG004|Up to Week 16|Death|0|||
37700145|NCT01649375|69177152|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
37700146|NCT01649375|69177153|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
37700147|NCT01649375|69177154|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
37834049|NCT01210495|69517830|FG001|Overall Study|Study Terminated by Sponsor|0|||
37834050|NCT01210495|69517831|FG002|Overall Study|Study Terminated by Sponsor|4|||
37834051|NCT01210495|69517832|FG003|Overall Study|Study Terminated by Sponsor|11|||
37834052|NCT01210495|69517829|FG000|Overall Study|Lost to Follow-up|0|||
37700148|NCT01649375|69177155|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
37700149|NCT01649375|69177156|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
37700150|NCT01649375|69177152|FG000|Week 16 up to Week 260|Non-compliance|0|||
37700151|NCT01649375|69177153|FG001|Week 16 up to Week 260|Non-compliance|1|||
37700152|NCT01649375|69177154|FG002|Week 16 up to Week 260|Non-compliance|0|||
37700153|NCT01649375|69177155|FG003|Week 16 up to Week 260|Non-compliance|1|||
37700154|NCT01649375|69177156|FG004|Week 16 up to Week 260|Non-compliance|0|||
37700155|NCT01649375|69177152|FG000|Week 16 up to Week 260|Physician Decision|0|||
37700156|NCT01649375|69177153|FG001|Week 16 up to Week 260|Physician Decision|2|||
37700157|NCT01649375|69177154|FG002|Week 16 up to Week 260|Physician Decision|0|||
37700158|NCT01649375|69177155|FG003|Week 16 up to Week 260|Physician Decision|0|||
37700159|NCT01649375|69177156|FG004|Week 16 up to Week 260|Physician Decision|0|||
37700160|NCT01649375|69177152|FG000|Week 16 up to Week 260|Technical issues|0|||
37700161|NCT01649375|69177153|FG001|Week 16 up to Week 260|Technical issues|1|||
37700162|NCT01649375|69177154|FG002|Week 16 up to Week 260|Technical issues|0|||
37700163|NCT01649375|69177155|FG003|Week 16 up to Week 260|Technical issues|1|||
37700164|NCT01649375|69177156|FG004|Week 16 up to Week 260|Technical issues|0|||
37700165|NCT01649375|69177152|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
37700166|NCT01649375|69177153|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
37700167|NCT01649375|69177154|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
37700168|NCT01649375|69177155|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
37700169|NCT01649375|69177156|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
37700170|NCT01649375|69177152|FG000|Week 16 up to Week 260|Death|1|||
37700171|NCT01649375|69177153|FG001|Week 16 up to Week 260|Death|1|||
37700172|NCT01649375|69177154|FG002|Week 16 up to Week 260|Death|0|||
37700173|NCT01649375|69177155|FG003|Week 16 up to Week 260|Death|0|||
37700174|NCT01649375|69177156|FG004|Week 16 up to Week 260|Death|0|||
37700175|NCT01649375|69177152|FG000|Week 16 up to Week 260|Adverse Event|5|||
37700176|NCT01649375|69177153|FG001|Week 16 up to Week 260|Adverse Event|2|||
37700177|NCT01649375|69177154|FG002|Week 16 up to Week 260|Adverse Event|0|||
37700178|NCT01649375|69177155|FG003|Week 16 up to Week 260|Adverse Event|3|||
37700179|NCT01649375|69177156|FG004|Week 16 up to Week 260|Adverse Event|2|||
37700180|NCT02336555|69177166|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
37700181|NCT02336555|69177167|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
37700182|NCT02336555|69177166|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
37700183|NCT02336555|69177167|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
37700184|NCT02336555|69177166|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
37700185|NCT02336555|69177167|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
37834053|NCT01210495|69517830|FG001|Overall Study|Lost to Follow-up|0|||
37834054|NCT01210495|69517831|FG002|Overall Study|Lost to Follow-up|1|||
37834055|NCT01210495|69517832|FG003|Overall Study|Lost to Follow-up|1|||
38021704|NCT03114891|69704874|FG000|Second Treatment Round|Lost to Follow-up|1|||
37700186|NCT01648283|69177173|FG000|Overall Study|Withdrawal by Subject|14|||
37700187|NCT01649297|69177184|FG000|Overall Study|Adverse Event|5|||
37700188|NCT01649297|69177185|FG001|Overall Study|Adverse Event|5|||
37700189|NCT01649297|69177186|FG002|Overall Study|Adverse Event|4|||
37700190|NCT01649297|69177187|FG003|Overall Study|Adverse Event|13|||
37700191|NCT01649297|69177188|FG004|Overall Study|Adverse Event|1|||
37700192|NCT01649297|69177184|FG000|Overall Study|Lack of Efficacy|0|||
37834056|NCT01210495|69517829|FG000|Overall Study|Other unspecified|0|||
38021705|NCT03114891|69704875|FG001|Second Treatment Round|Lost to Follow-up|0|||
38021706|NCT03114891|69704876|FG002|Second Treatment Round|Lost to Follow-up|0|||
38021707|NCT03114891|69704877|FG003|Second Treatment Round|Lost to Follow-up|0|||
38021708|NCT03114891|69704874|FG000|Second Treatment Round|Physician Decision|1|||
38021709|NCT03114891|69704875|FG001|Second Treatment Round|Physician Decision|0|||
38021710|NCT03114891|69704876|FG002|Second Treatment Round|Physician Decision|0|||
38021711|NCT03114891|69704877|FG003|Second Treatment Round|Physician Decision|0|||
38021712|NCT03057847|69704919|FG000|Overall Study|Lost to Follow-up|16|||
38021713|NCT02946463|69704934|FG000|Primary Evaluation Period|Physician Decision|0|||
38021714|NCT02946463|69704935|FG001|Primary Evaluation Period|Physician Decision|1|||
38021715|NCT02946463|69704934|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
38021716|NCT02946463|69704935|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
38021717|NCT02928224|69704945|FG000|Overall Study|Randomized, Not Treated|0|||
38021718|NCT02928224|69704946|FG001|Overall Study|Randomized, Not Treated|2|||
38021719|NCT02928224|69704947|FG002|Overall Study|Randomized, Not Treated|4|||
38021720|NCT02928224|69704948|FG003|Overall Study|Randomized, Not Treated|28|||
38021721|NCT02928224|69704945|FG000|Overall Study|Treatment Ongoing|6|||
38021722|NCT02928224|69704946|FG001|Overall Study|Treatment Ongoing|78|||
38021723|NCT02928224|69704947|FG002|Overall Study|Treatment Ongoing|78|||
38021724|NCT02928224|69704948|FG003|Overall Study|Treatment Ongoing|37|||
38021725|NCT02928224|69704945|FG000|Overall Study|Progressive Disease|23|||
38021726|NCT02928224|69704946|FG001|Overall Study|Progressive Disease|104|||
38021727|NCT02928224|69704947|FG002|Overall Study|Progressive Disease|101|||
38021728|NCT02928224|69704948|FG003|Overall Study|Progressive Disease|103|||
38021729|NCT02928224|69704945|FG000|Overall Study|Adverse Event|2|||
38021730|NCT02928224|69704946|FG001|Overall Study|Adverse Event|11|||
38021731|NCT02928224|69704947|FG002|Overall Study|Adverse Event|11|||
38021732|NCT02928224|69704948|FG003|Overall Study|Adverse Event|10|||
38021733|NCT02928224|69704945|FG000|Overall Study|Changes in Patient's Condition|3|||
38021734|NCT02928224|69704946|FG001|Overall Study|Changes in Patient's Condition|9|||
38021735|NCT02928224|69704947|FG002|Overall Study|Changes in Patient's Condition|9|||
38021736|NCT02928224|69704948|FG003|Overall Study|Changes in Patient's Condition|13|||
38021737|NCT02928224|69704945|FG000|Overall Study|Death|1|||
38021738|NCT02928224|69704946|FG001|Overall Study|Death|7|||
38021739|NCT02928224|69704947|FG002|Overall Study|Death|5|||
38021740|NCT02928224|69704948|FG003|Overall Study|Death|11|||
38021741|NCT02928224|69704945|FG000|Overall Study|Withdrawal by Subject|1|||
38021742|NCT02928224|69704946|FG001|Overall Study|Withdrawal by Subject|4|||
38021743|NCT02928224|69704947|FG002|Overall Study|Withdrawal by Subject|3|||
38021744|NCT02928224|69704948|FG003|Overall Study|Withdrawal by Subject|9|||
38021745|NCT02928224|69704945|FG000|Overall Study|Dose Interruptions>28|1|||
38021746|NCT02928224|69704946|FG001|Overall Study|Dose Interruptions>28|2|||
38021747|NCT02928224|69704947|FG002|Overall Study|Dose Interruptions>28|2|||
38021748|NCT02928224|69704948|FG003|Overall Study|Dose Interruptions>28|4|||
38021749|NCT02928224|69704945|FG000|Overall Study|Patient Decision to Discontinue Drug|0|||
38021750|NCT02928224|69704946|FG001|Overall Study|Patient Decision to Discontinue Drug|2|||
38021751|NCT02928224|69704947|FG002|Overall Study|Patient Decision to Discontinue Drug|2|||
38021752|NCT02928224|69704948|FG003|Overall Study|Patient Decision to Discontinue Drug|4|||
37700193|NCT01649297|69177185|FG001|Overall Study|Lack of Efficacy|0|||
37700194|NCT01649297|69177186|FG002|Overall Study|Lack of Efficacy|0|||
37700195|NCT01649297|69177187|FG003|Overall Study|Lack of Efficacy|0|||
37834057|NCT01210495|69517830|FG001|Overall Study|Other unspecified|0|||
37834058|NCT01210495|69517831|FG002|Overall Study|Other unspecified|6|||
37834059|NCT01210495|69517832|FG003|Overall Study|Other unspecified|0|||
37834060|NCT01231516|69517844|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
37834061|NCT01231516|69517845|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
37834062|NCT01231516|69517844|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
37834063|NCT01231516|69517845|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
37834064|NCT01231516|69517844|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
37700196|NCT01649297|69177188|FG004|Overall Study|Lack of Efficacy|1|||
37700197|NCT01649297|69177184|FG000|Overall Study|Non compliant with Protocol|1|||
37834065|NCT01231516|69517845|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
38021753|NCT02928224|69704945|FG000|Overall Study|Physician Decision|0|||
38021754|NCT02928224|69704946|FG001|Overall Study|Physician Decision|2|||
38021755|NCT02928224|69704947|FG002|Overall Study|Physician Decision|4|||
38021756|NCT02928224|69704948|FG003|Overall Study|Physician Decision|2|||
38021757|NCT02928224|69704945|FG000|Overall Study|not listed|0|||
38021758|NCT02928224|69704946|FG001|Overall Study|not listed|3|||
38021759|NCT02928224|69704947|FG002|Overall Study|not listed|1|||
38021760|NCT02928224|69704948|FG003|Overall Study|not listed|0|||
38021761|NCT02860039|69704988|FG000|Overall Study|Death|4|||
38021762|NCT02860039|69704989|FG001|Overall Study|Death|0|||
38021763|NCT02860039|69704988|FG000|Overall Study|Lost to Follow-up|2|||
38021764|NCT02860039|69704989|FG001|Overall Study|Lost to Follow-up|2|||
38021765|NCT02860039|69704988|FG000|Overall Study|Protocol Violation|3|||
37834066|NCT01231516|69517844|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
37911463|NCT00884325|69598159|FG001|Overall Study|Withdrawal by Subject|1|||
37911464|NCT00884325|69598158|FG000|Overall Study|Not provided|1|||
37911465|NCT00884325|69598159|FG001|Overall Study|Not provided|0|||
37911466|NCT00883779|69598167|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
37911467|NCT00883779|69598168|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
37911468|NCT00883779|69598167|FG000|Primary Study Treatment Phase|Disease progression|75|||
38021766|NCT02860039|69704989|FG001|Overall Study|Protocol Violation|1|||
38021767|NCT02860039|69704988|FG000|Overall Study|Withdrawal by Subject|1|||
38021768|NCT02860039|69704989|FG001|Overall Study|Withdrawal by Subject|0|||
38021769|NCT02860039|69704988|FG000|Overall Study|Not otherwise eligible|1|||
38021770|NCT02860039|69704989|FG001|Overall Study|Not otherwise eligible|1|||
37700198|NCT01649297|69177185|FG001|Overall Study|Non compliant with Protocol|0|||
37700199|NCT01649297|69177186|FG002|Overall Study|Non compliant with Protocol|3|||
37700200|NCT01649297|69177187|FG003|Overall Study|Non compliant with Protocol|2|||
37700201|NCT01649297|69177188|FG004|Overall Study|Non compliant with Protocol|1|||
37700202|NCT01649297|69177184|FG000|Overall Study|Lost to Follow-up|1|||
37700203|NCT01649297|69177185|FG001|Overall Study|Lost to Follow-up|1|||
37700204|NCT01649297|69177186|FG002|Overall Study|Lost to Follow-up|4|||
37700205|NCT01649297|69177187|FG003|Overall Study|Lost to Follow-up|3|||
37700206|NCT01649297|69177188|FG004|Overall Study|Lost to Follow-up|0|||
37700207|NCT01649297|69177184|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
37700208|NCT01649297|69177185|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
37700209|NCT01649297|69177186|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
37700210|NCT01649297|69177187|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
37700211|NCT01649297|69177188|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
37700212|NCT01649297|69177184|FG000|Overall Study|For other reason|4|||
37834067|NCT01231516|69517845|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
37834068|NCT01231516|69517844|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
37834069|NCT01231516|69517845|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
37834070|NCT01231516|69517844|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
37834071|NCT01231516|69517845|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
37834072|NCT01231516|69517844|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
37834073|NCT01231516|69517845|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
37834074|NCT01231516|69517844|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
37834075|NCT01231516|69517845|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
37834076|NCT01231516|69517844|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
37834077|NCT01231516|69517845|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
37834078|NCT01231516|69517844|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
37834079|NCT01231516|69517845|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
37834080|NCT01231516|69517844|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
37834081|NCT01231516|69517845|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
37834082|NCT01231516|69517844|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
37834083|NCT01231516|69517845|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
37834084|NCT01231516|69517844|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
37834085|NCT01231516|69517845|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
37834086|NCT01231516|69517844|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
37834087|NCT01231516|69517845|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
37834088|NCT01231516|69517844|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
37834089|NCT01231516|69517845|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
37834090|NCT01231516|69517844|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
37834091|NCT01231516|69517845|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
37834092|NCT01231321|69517851|FG000|Overall Study|Adverse Event|3|||
37834093|NCT01231321|69517851|FG000|Overall Study|Lack of Efficacy|2|||
37834094|NCT01210222|69517861|FG000|Overall Study|Ineligible|2|||
37834095|NCT01210222|69517861|FG000|Overall Study|Never treated|1|||
37834096|NCT01210144|69517873|FG000|Overall Study|Lack of ovarian response|1|||
37834097|NCT01210144|69517874|FG001|Overall Study|Lack of ovarian response|0|||
37834098|NCT01210144|69517873|FG000|Overall Study|No fertilization|1|||
37834099|NCT01210144|69517874|FG001|Overall Study|No fertilization|0|||
37834100|NCT01210144|69517873|FG000|Overall Study|No transfer|1|||
37834101|NCT01210144|69517874|FG001|Overall Study|No transfer|0|||
37834102|NCT01209949|69517881|FG000|Overall Study|Lost to Follow-up|3|||
37834103|NCT01209832|69517885|FG000|Period 1|Sponsor Decision and was not dosed|1|||
37834104|NCT01209832|69517885|FG000|Period 2|Sponsor Decision|1|||
37834105|NCT01230892|69517898|FG000|Overall Study|Withdrawal by Subject|1|||
37834106|NCT01230892|69517899|FG001|Overall Study|Withdrawal by Subject|1|||
37834107|NCT01230892|69517898|FG000|Overall Study|Lost to Follow-up|2|||
38021771|NCT02761694|69705019|FG000|Overall Study|Lack of Efficacy|0|||
37700213|NCT01649297|69177185|FG001|Overall Study|For other reason|1|||
37700214|NCT01649297|69177186|FG002|Overall Study|For other reason|2|||
38021772|NCT02761694|69705020|FG001|Overall Study|Lack of Efficacy|0|||
38021773|NCT02761694|69705021|FG002|Overall Study|Lack of Efficacy|0|||
38021774|NCT02761694|69705022|FG003|Overall Study|Lack of Efficacy|0|||
38021775|NCT02761694|69705023|FG004|Overall Study|Lack of Efficacy|0|||
38021776|NCT02761694|69705024|FG005|Overall Study|Lack of Efficacy|0|||
38021777|NCT02761694|69705025|FG006|Overall Study|Lack of Efficacy|6|||
38021778|NCT02761694|69705026|FG007|Overall Study|Lack of Efficacy|0|||
38021779|NCT02761694|69705027|FG008|Overall Study|Lack of Efficacy|0|||
38021780|NCT02761694|69705028|FG009|Overall Study|Lack of Efficacy|1|||
38021781|NCT02761694|69705029|FG010|Overall Study|Lack of Efficacy|1|||
37700215|NCT01649297|69177187|FG003|Overall Study|For other reason|0|||
37834108|NCT01230892|69517899|FG001|Overall Study|Lost to Follow-up|0|||
37834109|NCT01230814|69517907|FG000|Overall Study|Lost to Follow-up|11|||
37834110|NCT01230814|69517908|FG001|Overall Study|Lost to Follow-up|3|||
37834111|NCT01230814|69517907|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
37834112|NCT01230814|69517908|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
37834113|NCT01230307|69517916|FG000|Overall Study|LVAD Placement|0|||
37834114|NCT01230307|69517917|FG001|Overall Study|LVAD Placement|2|||
37834115|NCT01209598|69517925|FG000|Overall Study|Withdrawal by Subject|1|||
37834116|NCT01209598|69517926|FG001|Overall Study|Withdrawal by Subject|0|||
37834117|NCT01209520|69517933|FG000|Overall Study|Withdrawal by Subject|3|||
37834118|NCT01209325|69517937|FG000|Overall Study|Lost to Follow-up|24|||
37834119|NCT01209325|69517937|FG000|Overall Study|Adverse Event|1|||
37834120|NCT01209325|69517937|FG000|Overall Study|Relocated|3|||
37834121|NCT01209325|69517937|FG000|Overall Study|Refusal after starting therapy|8|||
37834122|NCT01209325|69517937|FG000|Overall Study|Protocol Violation|4|||
38021782|NCT02761694|69705030|FG011|Overall Study|Lack of Efficacy|4|||
37700216|NCT01649297|69177188|FG004|Overall Study|For other reason|0|||
37700217|NCT01648205|69177200|FG000|Placebo|Pregnancy|1|||
37700218|NCT01648205|69177200|FG000|Placebo|Withdrawal by Subject|1|||
37700219|NCT01648205|69177200|FG000|Placebo|Protocol Violation|2|||
37700220|NCT01648205|69177200|FG000|Ranolazine|Death|1|||
37700221|NCT01648205|69177200|FG000|Ranolazine|Withdrawal by Subject|1|||
37700222|NCT01648205|69177200|FG000|Ranolazine|Protocol Violation|3|||
37700223|NCT02362451|69177210|FG000|Overall Study|Withdrawal by Subject|0|||
37700224|NCT02362451|69177211|FG001|Overall Study|Withdrawal by Subject|1|||
37700225|NCT02362451|69177210|FG000|Overall Study|Lack of Efficacy|2|||
37700226|NCT02362451|69177211|FG001|Overall Study|Lack of Efficacy|0|||
37700227|NCT02362451|69177210|FG000|Overall Study|Progression|1|||
37700228|NCT02362451|69177211|FG001|Overall Study|Progression|0|||
37700229|NCT02362451|69177210|FG000|Overall Study|Participant chose other therapy.|1|||
37700230|NCT02362451|69177211|FG001|Overall Study|Participant chose other therapy.|0|||
37700231|NCT01734382|69177220|FG000|Part 1|Adverse Event|2|||
37700232|NCT01734382|69177221|FG001|Part 1|Adverse Event|0|||
37700233|NCT01734382|69177222|FG002|Part 1|Adverse Event|0|||
37700234|NCT01734382|69177220|FG000|Part 2|Adverse Event|0|||
37700235|NCT01734382|69177221|FG001|Part 2|Adverse Event|0|||
37700236|NCT01734382|69177222|FG002|Part 2|Adverse Event|1|||
37700237|NCT01734382|69177220|FG000|Part 2|Lack of Efficacy|0|||
37700238|NCT01734382|69177221|FG001|Part 2|Lack of Efficacy|1|||
37700239|NCT01734382|69177222|FG002|Part 2|Lack of Efficacy|1|||
37700240|NCT01734382|69177220|FG000|Part 2|Other|0|||
37700241|NCT01734382|69177221|FG001|Part 2|Other|0|||
37700242|NCT01734382|69177222|FG002|Part 2|Other|1|||
37700243|NCT01734382|69177220|FG000|Part 2|Physician Decision|0|||
37700244|NCT01734382|69177221|FG001|Part 2|Physician Decision|0|||
37700245|NCT01734382|69177222|FG002|Part 2|Physician Decision|3|||
37700246|NCT01734382|69177220|FG000|Part 2|Protocol Violation|0|||
37700247|NCT01734382|69177221|FG001|Part 2|Protocol Violation|1|||
37700248|NCT01734382|69177222|FG002|Part 2|Protocol Violation|0|||
37700249|NCT01734382|69177220|FG000|Part 2|Withdrawal by Subject|0|||
37700250|NCT01734382|69177221|FG001|Part 2|Withdrawal by Subject|0|||
37700251|NCT01734382|69177222|FG002|Part 2|Withdrawal by Subject|1|||
37700252|NCT02391311|69177236|FG000|Overall Study|Lost to Follow-up|2|||
37834123|NCT01209325|69517937|FG000|Overall Study|Refusal prior to therapy|1|||
37834124|NCT01209325|69517937|FG000|Overall Study|Incarceration|2|||
37700253|NCT02391311|69177237|FG001|Overall Study|Lost to Follow-up|1|||
37700254|NCT02391311|69177236|FG000|Overall Study|deemed ineligible after baseline|1|||
37700255|NCT02391311|69177237|FG001|Overall Study|deemed ineligible after baseline|1|||
37700256|NCT01765426|69177247|FG000|Overall Study|Lost to Follow-up|0|||
37700257|NCT01765426|69177248|FG001|Overall Study|Lost to Follow-up|1|||
37834125|NCT01209286|69517975|FG000|Overall Study|Adverse Event|4|||
37834126|NCT01209286|69517976|FG001|Overall Study|Adverse Event|3|||
37834127|NCT01209286|69517977|FG002|Overall Study|Adverse Event|1|||
37834128|NCT01209286|69517975|FG000|Overall Study|Hematological Relapse After Remission|0|||
38021783|NCT02761694|69705019|FG000|Overall Study|Death|0|||
37700258|NCT01765426|69177249|FG002|Overall Study|Lost to Follow-up|0|||
37700259|NCT01765426|69177250|FG003|Overall Study|Lost to Follow-up|0|||
37700260|NCT01765270|69177262|FG000|Overall Study|Physician Decision|1|||
37700261|NCT01765270|69177263|FG001|Overall Study|Physician Decision|0|||
37700262|NCT01765270|69177262|FG000|Overall Study|Withdrawal by Subject|0|||
38021784|NCT02761694|69705020|FG001|Overall Study|Death|0|||
37700263|NCT01765270|69177263|FG001|Overall Study|Withdrawal by Subject|1|||
37700264|NCT01733758|69177274|FG000|Overall Study|Adverse Event|5|||
37700265|NCT01733758|69177275|FG001|Overall Study|Adverse Event|7|||
37700266|NCT01733758|69177276|FG002|Overall Study|Adverse Event|8|||
37700267|NCT01733758|69177277|FG003|Overall Study|Adverse Event|1|||
37834129|NCT01209286|69517976|FG001|Overall Study|Hematological Relapse After Remission|1|||
38021785|NCT02761694|69705021|FG002|Overall Study|Death|0|||
38021786|NCT02761694|69705022|FG003|Overall Study|Death|0|||
38021787|NCT02761694|69705023|FG004|Overall Study|Death|0|||
38021788|NCT02761694|69705024|FG005|Overall Study|Death|0|||
38021789|NCT02761694|69705025|FG006|Overall Study|Death|2|||
38021790|NCT02761694|69705026|FG007|Overall Study|Death|0|||
38021791|NCT02761694|69705027|FG008|Overall Study|Death|2|||
38021792|NCT02761694|69705028|FG009|Overall Study|Death|2|||
38021793|NCT02761694|69705029|FG010|Overall Study|Death|1|||
38021794|NCT02761694|69705030|FG011|Overall Study|Death|0|||
38021795|NCT02761694|69705019|FG000|Overall Study|Physician Decision|0|||
38021796|NCT02761694|69705020|FG001|Overall Study|Physician Decision|0|||
38021797|NCT02761694|69705021|FG002|Overall Study|Physician Decision|0|||
38021798|NCT02761694|69705022|FG003|Overall Study|Physician Decision|0|||
38021799|NCT02761694|69705023|FG004|Overall Study|Physician Decision|0|||
38021800|NCT02761694|69705024|FG005|Overall Study|Physician Decision|0|||
37700268|NCT01733758|69177274|FG000|Overall Study|Withdrawal by Subject|1|||
37700269|NCT01733758|69177275|FG001|Overall Study|Withdrawal by Subject|1|||
37834130|NCT01209286|69517977|FG002|Overall Study|Hematological Relapse After Remission|1|||
37834131|NCT01209286|69517975|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
37834132|NCT01209286|69517976|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
37834133|NCT01209286|69517977|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
37834134|NCT01209286|69517975|FG000|Overall Study|Physician Decision|0|||
37834135|NCT01209286|69517976|FG001|Overall Study|Physician Decision|2|||
37834136|NCT01209286|69517977|FG002|Overall Study|Physician Decision|0|||
37834137|NCT01209286|69517975|FG000|Overall Study|Other|0|||
37834138|NCT01209286|69517976|FG001|Overall Study|Other|1|||
37834139|NCT01209286|69517977|FG002|Overall Study|Other|0|||
37834140|NCT05048719|69518010|FG000|Overall Study|Withdrawal by Subject|2|||
37834141|NCT05048719|69518011|FG001|Overall Study|Withdrawal by Subject|1|||
37834142|NCT05048719|69518012|FG002|Overall Study|Withdrawal by Subject|3|||
37834143|NCT05048719|69518013|FG003|Overall Study|Withdrawal by Subject|1|||
37834144|NCT05048719|69518014|FG004|Overall Study|Withdrawal by Subject|0|||
37834145|NCT05048719|69518015|FG005|Overall Study|Withdrawal by Subject|2|||
37834146|NCT05048719|69518016|FG006|Overall Study|Withdrawal by Subject|1|||
37834147|NCT05048719|69518017|FG007|Overall Study|Withdrawal by Subject|1|||
37834148|NCT05048719|69518018|FG008|Overall Study|Withdrawal by Subject|0|||
37834149|NCT05048719|69518010|FG000|Overall Study|Death|1|||
37834150|NCT05048719|69518011|FG001|Overall Study|Death|0|||
37834151|NCT05048719|69518012|FG002|Overall Study|Death|0|||
37834152|NCT05048719|69518013|FG003|Overall Study|Death|0|||
37834153|NCT05048719|69518014|FG004|Overall Study|Death|0|||
37834154|NCT05048719|69518015|FG005|Overall Study|Death|0|||
37834155|NCT05048719|69518016|FG006|Overall Study|Death|0|||
37834156|NCT05048719|69518017|FG007|Overall Study|Death|0|||
37834157|NCT05048719|69518018|FG008|Overall Study|Death|0|||
37834158|NCT05048719|69518010|FG000|Overall Study|Adverse Event|0|||
37834159|NCT05048719|69518011|FG001|Overall Study|Adverse Event|1|||
37834160|NCT05048719|69518012|FG002|Overall Study|Adverse Event|2|||
37834161|NCT05048719|69518013|FG003|Overall Study|Adverse Event|0|||
37834162|NCT05048719|69518014|FG004|Overall Study|Adverse Event|1|||
37834163|NCT05048719|69518015|FG005|Overall Study|Adverse Event|0|||
37834164|NCT05048719|69518016|FG006|Overall Study|Adverse Event|0|||
37834165|NCT05048719|69518017|FG007|Overall Study|Adverse Event|0|||
37834166|NCT05048719|69518018|FG008|Overall Study|Adverse Event|0|||
37834167|NCT05048719|69518010|FG000|Overall Study|Lost to Follow-up|0|||
37834168|NCT05048719|69518011|FG001|Overall Study|Lost to Follow-up|0|||
37834169|NCT05048719|69518012|FG002|Overall Study|Lost to Follow-up|1|||
37834170|NCT05048719|69518013|FG003|Overall Study|Lost to Follow-up|3|||
37834171|NCT05048719|69518014|FG004|Overall Study|Lost to Follow-up|1|||
37834172|NCT05048719|69518015|FG005|Overall Study|Lost to Follow-up|1|||
37834173|NCT05048719|69518016|FG006|Overall Study|Lost to Follow-up|1|||
37834174|NCT05048719|69518017|FG007|Overall Study|Lost to Follow-up|1|||
37834175|NCT05048719|69518018|FG008|Overall Study|Lost to Follow-up|0|||
37834176|NCT05048719|69518010|FG000|Overall Study|Physician Decision|0|||
38021801|NCT02761694|69705025|FG006|Overall Study|Physician Decision|1|||
37700270|NCT01733758|69177276|FG002|Overall Study|Withdrawal by Subject|5|||
37700271|NCT01733758|69177277|FG003|Overall Study|Withdrawal by Subject|3|||
38021802|NCT02761694|69705026|FG007|Overall Study|Physician Decision|0|||
37700272|NCT01733758|69177274|FG000|Overall Study|Persistent Hyperglycemia|3|||
37700273|NCT01733758|69177275|FG001|Overall Study|Persistent Hyperglycemia|2|||
37700274|NCT01733758|69177276|FG002|Overall Study|Persistent Hyperglycemia|0|||
37700275|NCT01733758|69177277|FG003|Overall Study|Persistent Hyperglycemia|0|||
37700276|NCT01733758|69177274|FG000|Overall Study|Protocol Violation|0|||
37700277|NCT01733758|69177275|FG001|Overall Study|Protocol Violation|1|||
37700278|NCT01733758|69177276|FG002|Overall Study|Protocol Violation|2|||
37700279|NCT01733758|69177277|FG003|Overall Study|Protocol Violation|2|||
37911469|NCT00883779|69598168|FG001|Primary Study Treatment Phase|Disease progression|59|||
37911470|NCT00883779|69598167|FG000|Primary Study Treatment Phase|Adverse Event|16|||
37911471|NCT00883779|69598168|FG001|Primary Study Treatment Phase|Adverse Event|16|||
37911472|NCT00883779|69598167|FG000|Primary Study Treatment Phase|Death|2|||
37911473|NCT00883779|69598168|FG001|Primary Study Treatment Phase|Death|3|||
37911474|NCT00883779|69598167|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
37911475|NCT00883779|69598168|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
37911476|NCT00883779|69598167|FG000|Primary Study Treatment Phase|Other|3|||
37911477|NCT00883779|69598168|FG001|Primary Study Treatment Phase|Other|0|||
37911478|NCT00883779|69598167|FG000|Post-Study Treatment Phase|Adverse Event|2|||
38021803|NCT02761694|69705027|FG008|Overall Study|Physician Decision|0|||
37700280|NCT01733758|69177274|FG000|Overall Study|Non-compliance|1|||
37834177|NCT05048719|69518011|FG001|Overall Study|Physician Decision|0|||
37834178|NCT05048719|69518012|FG002|Overall Study|Physician Decision|0|||
37834179|NCT05048719|69518013|FG003|Overall Study|Physician Decision|0|||
37834180|NCT05048719|69518014|FG004|Overall Study|Physician Decision|0|||
37834181|NCT05048719|69518015|FG005|Overall Study|Physician Decision|0|||
37834182|NCT05048719|69518016|FG006|Overall Study|Physician Decision|0|||
37834183|NCT05048719|69518017|FG007|Overall Study|Physician Decision|1|||
37834184|NCT05048719|69518018|FG008|Overall Study|Physician Decision|1|||
37834185|NCT05048719|69518010|FG000|Overall Study|Patient Decision due To Changes in Personal Life|1|||
37834186|NCT05048719|69518011|FG001|Overall Study|Patient Decision due To Changes in Personal Life|0|||
37834187|NCT05048719|69518012|FG002|Overall Study|Patient Decision due To Changes in Personal Life|0|||
37834188|NCT05048719|69518013|FG003|Overall Study|Patient Decision due To Changes in Personal Life|0|||
37834189|NCT05048719|69518014|FG004|Overall Study|Patient Decision due To Changes in Personal Life|0|||
37834190|NCT05048719|69518015|FG005|Overall Study|Patient Decision due To Changes in Personal Life|0|||
37834191|NCT05048719|69518016|FG006|Overall Study|Patient Decision due To Changes in Personal Life|0|||
37834192|NCT05048719|69518017|FG007|Overall Study|Patient Decision due To Changes in Personal Life|0|||
37834193|NCT05048719|69518018|FG008|Overall Study|Patient Decision due To Changes in Personal Life|0|||
37834194|NCT05048719|69518010|FG000|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
37834195|NCT05048719|69518011|FG001|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|1|||
37834196|NCT05048719|69518012|FG002|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
37834197|NCT05048719|69518013|FG003|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
37834198|NCT05048719|69518014|FG004|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
37834199|NCT05048719|69518015|FG005|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
37834200|NCT05048719|69518016|FG006|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
37834201|NCT05048719|69518017|FG007|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
37834202|NCT05048719|69518018|FG008|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
37834203|NCT05048719|69518010|FG000|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
37834204|NCT05048719|69518011|FG001|Overall Study|Sponsor decision due To inadvertent Enrollment|1|||
37834205|NCT05048719|69518012|FG002|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
37834206|NCT05048719|69518013|FG003|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
37834207|NCT05048719|69518014|FG004|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
37911479|NCT00883779|69598168|FG001|Post-Study Treatment Phase|Adverse Event|3|||
37911480|NCT00883779|69598167|FG000|Post-Study Treatment Phase|Death|1|||
37911481|NCT00883779|69598168|FG001|Post-Study Treatment Phase|Death|3|||
37911482|NCT00883779|69598167|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
37911483|NCT00883779|69598168|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
37911484|NCT00883779|69598167|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
37911485|NCT00883779|69598168|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
38021804|NCT02761694|69705028|FG009|Overall Study|Physician Decision|0|||
38021805|NCT02761694|69705029|FG010|Overall Study|Physician Decision|0|||
38021806|NCT02761694|69705030|FG011|Overall Study|Physician Decision|0|||
38021807|NCT02761694|69705019|FG000|Overall Study|Withdrawal by Subject|0|||
38021808|NCT02761694|69705020|FG001|Overall Study|Withdrawal by Subject|0|||
38021809|NCT02761694|69705021|FG002|Overall Study|Withdrawal by Subject|0|||
38021810|NCT02761694|69705022|FG003|Overall Study|Withdrawal by Subject|1|||
38021811|NCT02761694|69705023|FG004|Overall Study|Withdrawal by Subject|0|||
37700281|NCT01733758|69177275|FG001|Overall Study|Non-compliance|0|||
37700282|NCT01733758|69177276|FG002|Overall Study|Non-compliance|0|||
37700283|NCT01733758|69177277|FG003|Overall Study|Non-compliance|0|||
38021812|NCT02761694|69705024|FG005|Overall Study|Withdrawal by Subject|0|||
38021813|NCT02761694|69705025|FG006|Overall Study|Withdrawal by Subject|4|||
38021814|NCT02761694|69705026|FG007|Overall Study|Withdrawal by Subject|0|||
38021815|NCT02761694|69705027|FG008|Overall Study|Withdrawal by Subject|2|||
38021816|NCT02761694|69705028|FG009|Overall Study|Withdrawal by Subject|1|||
38021817|NCT02761694|69705029|FG010|Overall Study|Withdrawal by Subject|0|||
38021818|NCT02761694|69705030|FG011|Overall Study|Withdrawal by Subject|0|||
38021819|NCT02761694|69705019|FG000|Overall Study|Lost to Follow-up|0|||
38021820|NCT02761694|69705020|FG001|Overall Study|Lost to Follow-up|0|||
38021821|NCT02761694|69705021|FG002|Overall Study|Lost to Follow-up|0|||
38021822|NCT02761694|69705022|FG003|Overall Study|Lost to Follow-up|0|||
38021823|NCT02761694|69705023|FG004|Overall Study|Lost to Follow-up|0|||
38021824|NCT02761694|69705024|FG005|Overall Study|Lost to Follow-up|0|||
38021825|NCT02761694|69705025|FG006|Overall Study|Lost to Follow-up|1|||
38021826|NCT02761694|69705026|FG007|Overall Study|Lost to Follow-up|0|||
38021827|NCT02761694|69705027|FG008|Overall Study|Lost to Follow-up|0|||
38021828|NCT02761694|69705028|FG009|Overall Study|Lost to Follow-up|0|||
38021829|NCT02761694|69705029|FG010|Overall Study|Lost to Follow-up|0|||
38021830|NCT02761694|69705030|FG011|Overall Study|Lost to Follow-up|1|||
38021831|NCT02761694|69705019|FG000|Overall Study|Adverse Event|0|||
38021832|NCT02761694|69705020|FG001|Overall Study|Adverse Event|0|||
38021833|NCT02761694|69705021|FG002|Overall Study|Adverse Event|0|||
38021834|NCT02761694|69705022|FG003|Overall Study|Adverse Event|0|||
38021835|NCT02761694|69705023|FG004|Overall Study|Adverse Event|0|||
38021836|NCT02761694|69705024|FG005|Overall Study|Adverse Event|0|||
38021837|NCT02761694|69705025|FG006|Overall Study|Adverse Event|1|||
38021838|NCT02761694|69705026|FG007|Overall Study|Adverse Event|0|||
38021839|NCT02761694|69705027|FG008|Overall Study|Adverse Event|1|||
38021840|NCT02761694|69705028|FG009|Overall Study|Adverse Event|0|||
38021841|NCT02761694|69705029|FG010|Overall Study|Adverse Event|0|||
38021842|NCT02761694|69705030|FG011|Overall Study|Adverse Event|1|||
38021843|NCT02761694|69705019|FG000|Overall Study|Other|4|||
38021844|NCT02761694|69705020|FG001|Overall Study|Other|4|||
38021845|NCT02761694|69705021|FG002|Overall Study|Other|1|||
38021846|NCT02761694|69705022|FG003|Overall Study|Other|2|||
38021847|NCT02761694|69705023|FG004|Overall Study|Other|3|||
38021848|NCT02761694|69705024|FG005|Overall Study|Other|3|||
38021849|NCT02761694|69705025|FG006|Overall Study|Other|18|||
38021850|NCT02761694|69705026|FG007|Overall Study|Other|8|||
38021851|NCT02761694|69705027|FG008|Overall Study|Other|0|||
38021852|NCT02761694|69705028|FG009|Overall Study|Other|1|||
38021853|NCT02761694|69705029|FG010|Overall Study|Other|1|||
38021854|NCT02761694|69705030|FG011|Overall Study|Other|0|||
38021855|NCT02726386|69705059|FG000|Overall Study|Adverse Event|17|||
38021856|NCT02726386|69705060|FG001|Overall Study|Adverse Event|20|||
38021857|NCT02726386|69705059|FG000|Overall Study|Withdrawal by Subject|14|||
38021858|NCT02726386|69705060|FG001|Overall Study|Withdrawal by Subject|28|||
38021859|NCT02726386|69705059|FG000|Overall Study|Other reasons|7|||
38021860|NCT02726386|69705060|FG001|Overall Study|Other reasons|8|||
38021861|NCT02574481|69705082|FG000|Overall Study|Withdrawal by Subject|29|||
38021862|NCT02574481|69705083|FG001|Overall Study|Withdrawal by Subject|15|||
38021863|NCT02574481|69705084|FG002|Overall Study|Withdrawal by Subject|4|||
37911486|NCT00883779|69598167|FG000|Post-Study Treatment Phase|Disease progression|103|||
37911487|NCT00883779|69598168|FG001|Post-Study Treatment Phase|Disease progression|122|||
37911488|NCT00883779|69598167|FG000|Post-Study Treatment Phase|Other|3|||
37911489|NCT00883779|69598168|FG001|Post-Study Treatment Phase|Other|0|||
37911490|NCT00883779|69598167|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
37911491|NCT00883779|69598168|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
37911492|NCT00883779|69598167|FG000|Off-study Phase|Death|185|||
38021864|NCT02574481|69705085|FG003|Overall Study|Withdrawal by Subject|1|||
38021865|NCT02574481|69705082|FG000|Overall Study|Adverse Event|5|||
38021866|NCT02574481|69705083|FG001|Overall Study|Adverse Event|1|||
38021867|NCT02574481|69705084|FG002|Overall Study|Adverse Event|1|||
38021868|NCT02574481|69705085|FG003|Overall Study|Adverse Event|0|||
38021869|NCT02574481|69705082|FG000|Overall Study|Visit Missed|15|||
38021870|NCT02574481|69705083|FG001|Overall Study|Visit Missed|7|||
38021871|NCT02574481|69705084|FG002|Overall Study|Visit Missed|5|||
38021872|NCT02574481|69705085|FG003|Overall Study|Visit Missed|0|||
38021873|NCT02574481|69705082|FG000|Overall Study|Other|7|||
38021874|NCT02574481|69705083|FG001|Overall Study|Other|2|||
38021875|NCT02574481|69705084|FG002|Overall Study|Other|0|||
38021876|NCT02574481|69705085|FG003|Overall Study|Other|0|||
38021877|NCT02574481|69705082|FG000|Overall Study|Death|48|||
38021878|NCT02574481|69705083|FG001|Overall Study|Death|26|||
38021879|NCT02574481|69705084|FG002|Overall Study|Death|12|||
38021880|NCT02574481|69705085|FG003|Overall Study|Death|4|||
38021881|NCT02574481|69705082|FG000|Overall Study|Physician Decision|5|||
37911493|NCT00883779|69598168|FG001|Off-study Phase|Death|174|||
38021882|NCT02574481|69705083|FG001|Overall Study|Physician Decision|2|||
38021883|NCT02574481|69705084|FG002|Overall Study|Physician Decision|0|||
38021884|NCT02574481|69705085|FG003|Overall Study|Physician Decision|0|||
38021885|NCT02574481|69705082|FG000|Overall Study|Lost to Follow-up|5|||
38021886|NCT02574481|69705083|FG001|Overall Study|Lost to Follow-up|1|||
37911494|NCT00883779|69598167|FG000|Off-study Phase|Refused treatment|1|||
37911495|NCT00883779|69598168|FG001|Off-study Phase|Refused treatment|1|||
37911496|NCT00883779|69598167|FG000|Off-study Phase|Failure to return|5|||
37911497|NCT00883779|69598168|FG001|Off-study Phase|Failure to return|6|||
37911498|NCT00883779|69598167|FG000|Off-study Phase|Other|18|||
37911499|NCT00883779|69598168|FG001|Off-study Phase|Other|21|||
37911500|NCT04159701|69598176|FG000|Period 1: Treatment Period|Pregnancy|1|||
37911501|NCT04159701|69598177|FG001|Period 1: Treatment Period|Pregnancy|0|||
37911502|NCT04159701|69598176|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
37911503|NCT04159701|69598177|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
37911504|NCT04159701|69598176|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
37911505|NCT04159701|69598177|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
37911506|NCT04159701|69598176|FG000|Washout Period|site terminated by sponsor|0|||
37911507|NCT04159701|69598177|FG001|Washout Period|site terminated by sponsor|1|||
37911508|NCT04159701|69598176|FG000|Washout Period|study terminated by sponsor|10|||
37911509|NCT04159701|69598177|FG001|Washout Period|study terminated by sponsor|3|||
37911510|NCT04159701|69598176|FG000|Washout Period|Withdrawal by Subject|1|||
37911511|NCT04159701|69598177|FG001|Washout Period|Withdrawal by Subject|0|||
37911512|NCT04159701|69598176|FG000|Washout Period|Inadvertent Enrollment|1|||
37911513|NCT04159701|69598177|FG001|Washout Period|Inadvertent Enrollment|0|||
37911514|NCT04159701|69598176|FG000|Washout Period|Miscellaneous|1|||
37911515|NCT04159701|69598177|FG001|Washout Period|Miscellaneous|0|||
37911516|NCT04159701|69598176|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
37834208|NCT05048719|69518015|FG005|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
37834209|NCT05048719|69518016|FG006|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
37834210|NCT05048719|69518017|FG007|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
37834211|NCT05048719|69518018|FG008|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
37834212|NCT05048719|69518010|FG000|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
37834213|NCT05048719|69518011|FG001|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
37834214|NCT05048719|69518012|FG002|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
37834215|NCT05048719|69518013|FG003|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|1|||
37834216|NCT05048719|69518014|FG004|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
37834217|NCT05048719|69518015|FG005|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
37834218|NCT05048719|69518016|FG006|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
37834219|NCT05048719|69518017|FG007|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
37834220|NCT05048719|69518018|FG008|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
37834221|NCT05048719|69518010|FG000|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
37834222|NCT05048719|69518011|FG001|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
37834223|NCT05048719|69518012|FG002|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
37834224|NCT05048719|69518013|FG003|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
37834225|NCT05048719|69518014|FG004|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
37834226|NCT05048719|69518015|FG005|Overall Study|Site Terminated Participant due to Sponsor Directions|1|||
37834227|NCT05048719|69518016|FG006|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
37834228|NCT05048719|69518017|FG007|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
37834229|NCT05048719|69518018|FG008|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
37834230|NCT04949802|69518043|FG000|Overall Study|Lost to Follow-up|3|||
37834231|NCT04626297|69518059|FG000|Overall Study|Adverse Event|5|||
37834232|NCT04626297|69518060|FG001|Overall Study|Adverse Event|3|||
37834233|NCT04626297|69518059|FG000|Overall Study|Lost to Follow-up|7|||
37834234|NCT04626297|69518060|FG001|Overall Study|Lost to Follow-up|3|||
37834235|NCT04626297|69518059|FG000|Overall Study|Protocol Violation|5|||
37911517|NCT04159701|69598177|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
37911518|NCT04159701|69598176|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
37911519|NCT04159701|69598177|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
37911520|NCT04159701|69598176|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
37911521|NCT04159701|69598177|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
37911522|NCT04159701|69598176|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
37911523|NCT04159701|69598177|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
37911524|NCT04159701|69598176|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
38021887|NCT02574481|69705084|FG002|Overall Study|Lost to Follow-up|3|||
37700284|NCT01733758|69177274|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
38021888|NCT02574481|69705085|FG003|Overall Study|Lost to Follow-up|0|||
37700285|NCT01733758|69177275|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
38021889|NCT02438722|69705100|FG000|Overall Study|Adverse Event|12|||
37834236|NCT04626297|69518060|FG001|Overall Study|Protocol Violation|1|||
37834237|NCT04626297|69518059|FG000|Overall Study|Withdrawal by Subject|20|||
37834238|NCT04626297|69518060|FG001|Overall Study|Withdrawal by Subject|6|||
37834239|NCT04626297|69518059|FG000|Overall Study|Sponsor decision|2|||
37834240|NCT04626297|69518060|FG001|Overall Study|Sponsor decision|1|||
37834241|NCT04211766|69518072|FG000|Overall Study|Withdrawal by Subject|5|||
37834242|NCT04211766|69518073|FG001|Overall Study|Withdrawal by Subject|1|||
37911525|NCT04159701|69598177|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
37911526|NCT00880269|69598189|FG000|Overall Study|Protocol Violation|1|||
37911527|NCT00880269|69598190|FG001|Overall Study|Protocol Violation|0|||
37911528|NCT00880269|69598189|FG000|Overall Study|Disease Progression|13|||
37911529|NCT00880269|69598190|FG001|Overall Study|Disease Progression|11|||
37911530|NCT00880269|69598189|FG000|Overall Study|New Cancer Therapy|1|||
37911531|NCT00880269|69598190|FG001|Overall Study|New Cancer Therapy|0|||
37911532|NCT00880269|69598189|FG000|Overall Study|Death|4|||
37911533|NCT00880269|69598190|FG001|Overall Study|Death|2|||
37911534|NCT00880269|69598189|FG000|Overall Study|Lost to Follow-up|0|||
37911535|NCT00880269|69598190|FG001|Overall Study|Lost to Follow-up|1|||
37911536|NCT00880269|69598189|FG000|Overall Study|Withdrawal by Subject|3|||
37911537|NCT00880269|69598190|FG001|Overall Study|Withdrawal by Subject|4|||
37911538|NCT00880269|69598189|FG000|Overall Study|Adverse Event|10|||
37700286|NCT01733758|69177276|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
37700287|NCT01733758|69177277|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
37700288|NCT01733758|69177274|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
37700289|NCT01733758|69177275|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
37700290|NCT01733758|69177276|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
37700291|NCT01733758|69177277|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
37700292|NCT01607554|69177289|FG000|Overall Study|Disease progression|2|||
37700293|NCT01607476|69177296|FG000|Overall Study|Withdrawal by Subject|1|||
37700294|NCT01607476|69177297|FG001|Overall Study|Withdrawal by Subject|0|||
37700295|NCT01607476|69177298|FG002|Overall Study|Withdrawal by Subject|1|||
37700296|NCT01607476|69177296|FG000|Overall Study|Lost to Follow-up|0|||
37700297|NCT01607476|69177297|FG001|Overall Study|Lost to Follow-up|0|||
37911539|NCT00880269|69598190|FG001|Overall Study|Adverse Event|9|||
37911540|NCT00880191|69598198|FG000|Overall Study|Refused further treatment|4|||
37911541|NCT00880191|69598199|FG001|Overall Study|Refused further treatment|1|||
37911542|NCT00880191|69598198|FG000|Overall Study|Adverse Event|8|||
37911543|NCT00880191|69598199|FG001|Overall Study|Adverse Event|6|||
37911544|NCT00880191|69598198|FG000|Overall Study|Hospitalization/efficacy|1|||
37911545|NCT00880191|69598199|FG001|Overall Study|Hospitalization/efficacy|1|||
37911546|NCT00597519|69598205|FG000|Overall Study|Death|1|||
37911547|NCT00879333|69598211|FG000|Overall Study|Adverse Event|94|||
37911548|NCT00879333|69598212|FG001|Overall Study|Adverse Event|34|||
37911549|NCT00879333|69598211|FG000|Overall Study|Abnormal Laboratory Value|1|||
38021890|NCT02438722|69705101|FG001|Overall Study|Adverse Event|9|||
38021891|NCT02438722|69705100|FG000|Overall Study|Refusal unrelated to AE|2|||
37834243|NCT04154189|69518083|FG000|Overall Study|Death|16|||
38021892|NCT02438722|69705101|FG001|Overall Study|Refusal unrelated to AE|5|||
38021893|NCT02438722|69705100|FG000|Overall Study|Disease progression/relapse|46|||
38021894|NCT02438722|69705101|FG001|Overall Study|Disease progression/relapse|51|||
38021895|NCT02438722|69705100|FG000|Overall Study|Death|0|||
38021896|NCT02438722|69705101|FG001|Overall Study|Death|3|||
38021897|NCT02438722|69705100|FG000|Overall Study|Physician Decision|2|||
38021898|NCT02438722|69705101|FG001|Overall Study|Physician Decision|2|||
38021899|NCT02438722|69705100|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
38021900|NCT02438722|69705101|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
38021901|NCT02438722|69705100|FG000|Overall Study|Withdrawal by Subject|0|||
38021902|NCT02438722|69705101|FG001|Overall Study|Withdrawal by Subject|1|||
38021903|NCT02438722|69705100|FG000|Overall Study|On protocol treatment|15|||
37834244|NCT04154189|69518084|FG001|Overall Study|Death|15|||
37834245|NCT04154189|69518083|FG000|Overall Study|Withdrawal by Subject|4|||
37834246|NCT04154189|69518084|FG001|Overall Study|Withdrawal by Subject|6|||
37834247|NCT04154189|69518083|FG000|Overall Study|Ongoing|20|||
37911550|NCT00879333|69598212|FG001|Overall Study|Abnormal Laboratory Value|0|||
37911551|NCT00879333|69598211|FG000|Overall Study|Withdrawal by Subject|20|||
37911552|NCT00879333|69598212|FG001|Overall Study|Withdrawal by Subject|7|||
37911553|NCT00879333|69598211|FG000|Overall Study|Lost to Follow-up|2|||
37911554|NCT00879333|69598212|FG001|Overall Study|Lost to Follow-up|1|||
37911555|NCT00879333|69598211|FG000|Overall Study|Administrative Problems|2|||
37911556|NCT00879333|69598212|FG001|Overall Study|Administrative Problems|0|||
37911557|NCT00879333|69598211|FG000|Overall Study|Death|16|||
37911558|NCT00879333|69598212|FG001|Overall Study|Death|5|||
37911559|NCT00879333|69598211|FG000|Overall Study|Disease Progression|292|||
37911560|NCT00879333|69598212|FG001|Overall Study|Disease Progression|169|||
37911561|NCT00879333|69598211|FG000|Overall Study|Protocol Violation|1|||
38021904|NCT02438722|69705101|FG001|Overall Study|On protocol treatment|14|||
38021905|NCT02438722|69705100|FG000|Overall Study|Did not receive protocol treatment|5|||
38021906|NCT02438722|69705101|FG001|Overall Study|Did not receive protocol treatment|0|||
38021907|NCT02376829|69705118|FG000|Overall Study|Withdrawal by Subject|27|||
38021908|NCT02376829|69705119|FG001|Overall Study|Withdrawal by Subject|44|||
38021909|NCT02297438|69705128|FG000|Overall Study|Death|79|||
38021910|NCT02297438|69705129|FG001|Overall Study|Death|86|||
38021911|NCT02297438|69705128|FG000|Overall Study|Lost to Follow-up|9|||
38021912|NCT02297438|69705129|FG001|Overall Study|Lost to Follow-up|7|||
38021913|NCT02297438|69705128|FG000|Overall Study|Withdrawal by Subject|7|||
38021914|NCT02297438|69705129|FG001|Overall Study|Withdrawal by Subject|0|||
38021915|NCT02297438|69705128|FG000|Overall Study|Other|9|||
38021916|NCT02297438|69705129|FG001|Overall Study|Other|5|||
38021917|NCT02297438|69705128|FG000|Overall Study|Ongoing|65|||
38021918|NCT02297438|69705129|FG001|Overall Study|Ongoing|73|||
38021919|NCT02297139|69705137|FG000|Overall Study|Disease progression|0|||
38021920|NCT02297139|69705138|FG001|Overall Study|Disease progression|1|||
38021921|NCT02297139|69705137|FG000|Overall Study|Study drug toxicity|0|||
38021922|NCT02297139|69705138|FG001|Overall Study|Study drug toxicity|4|||
38021923|NCT02297139|69705137|FG000|Overall Study|Participant request to discontinue study treatment|0|||
38021924|NCT02297139|69705138|FG001|Overall Study|Participant request to discontinue study treatment|1|||
38021925|NCT02297139|69705137|FG000|Overall Study|Maximum clinical benefit|1|||
38021926|NCT02297139|69705138|FG001|Overall Study|Maximum clinical benefit|0|||
38021927|NCT02297139|69705137|FG000|Overall Study|Administrative reason by sponsor|0|||
38021928|NCT02297139|69705138|FG001|Overall Study|Administrative reason by sponsor|2|||
38021929|NCT02297139|69705137|FG000|Overall Study|Other reasons|0|||
38021930|NCT02297139|69705138|FG001|Overall Study|Other reasons|8|||
38021931|NCT02100722|69705155|FG000|Overall Study|Withdrawal pre-procedure|4|||
38021932|NCT02100722|69705156|FG001|Overall Study|Withdrawal pre-procedure|9|||
38021933|NCT02100722|69705155|FG000|Overall Study|Withdrawal post-procedure|0|||
38021934|NCT02100722|69705156|FG001|Overall Study|Withdrawal post-procedure|3|||
38021935|NCT02100722|69705155|FG000|Overall Study|Lost to Follow-up|2|||
38021936|NCT02100722|69705156|FG001|Overall Study|Lost to Follow-up|2|||
38021937|NCT02100722|69705155|FG000|Overall Study|Continuing on study|751|||
38021938|NCT02100722|69705156|FG001|Overall Study|Continuing on study|729|||
38021939|NCT02028988|69705172|FG000|Overall Study|Withdrawal by Subject|2|||
38021940|NCT02004236|69705179|FG000|Overall Study|Lack of Efficacy|0|||
38021941|NCT02004236|69705180|FG001|Overall Study|Lack of Efficacy|0|||
38021942|NCT02004236|69705181|FG002|Overall Study|Lack of Efficacy|16|||
38021943|NCT01784068|69705208|FG000|NTCS Phase|Adverse Event|5|||
37911562|NCT00879333|69598212|FG001|Overall Study|Protocol Violation|1|||
37911563|NCT03481556|69598224|FG000|Overall Study|Adverse Event|1|||
37911564|NCT03481556|69598225|FG001|Overall Study|Adverse Event|0|||
37911565|NCT03481556|69598226|FG002|Overall Study|Adverse Event|0|||
37911566|NCT03481556|69598227|FG003|Overall Study|Adverse Event|0|||
37911567|NCT03481556|69598224|FG000|Overall Study|Death|4|||
37911568|NCT03481556|69598225|FG001|Overall Study|Death|2|||
37911569|NCT03481556|69598226|FG002|Overall Study|Death|3|||
37911570|NCT03481556|69598227|FG003|Overall Study|Death|16|||
37911571|NCT03481556|69598224|FG000|Overall Study|Study Terminated by Sponsor|10|||
37911572|NCT03481556|69598225|FG001|Overall Study|Study Terminated by Sponsor|5|||
37911573|NCT03481556|69598226|FG002|Overall Study|Study Terminated by Sponsor|2|||
37911574|NCT03481556|69598227|FG003|Overall Study|Study Terminated by Sponsor|9|||
37911575|NCT00596427|69598245|FG000|Overall Study|Withdrawal by Subject|2|||
37911576|NCT00596427|69598246|FG001|Overall Study|Withdrawal by Subject|2|||
37911577|NCT00596427|69598245|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
37911578|NCT00596427|69598246|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
37911579|NCT00596427|69598245|FG000|Overall Study|Protocol Violation|1|||
37911580|NCT00596427|69598246|FG001|Overall Study|Protocol Violation|0|||
37911581|NCT02732210|69598255|FG000|Overall Study|Site Closed|0|||
38021944|NCT01784068|69705209|FG001|NTCS Phase|Adverse Event|0|||
38021945|NCT01784068|69705208|FG000|NTCS Phase|Physician Decision|2|||
38021946|NCT01784068|69705209|FG001|NTCS Phase|Physician Decision|0|||
38021947|NCT01784068|69705208|FG000|NTCS Phase|Patient/guardian decision|3|||
38021948|NCT01784068|69705209|FG001|NTCS Phase|Patient/guardian decision|0|||
38021949|NCT01784068|69705208|FG000|NTCS Phase|Death|2|||
38021950|NCT01784068|69705209|FG001|NTCS Phase|Death|0|||
38021951|NCT01784068|69705208|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
37911582|NCT02732210|69598256|FG001|Overall Study|Site Closed|11|||
37911583|NCT02732210|69598255|FG000|Overall Study|Study Ended|13|||
37911584|NCT02732210|69598256|FG001|Overall Study|Study Ended|13|||
37911585|NCT02732210|69598255|FG000|Overall Study|Withdrawal by Subject|28|||
37911586|NCT02732210|69598256|FG001|Overall Study|Withdrawal by Subject|87|||
37911587|NCT02732210|69598255|FG000|Overall Study|Lost to Follow-up|5|||
37911588|NCT02732210|69598256|FG001|Overall Study|Lost to Follow-up|57|||
38021952|NCT01784068|69705209|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
38021953|NCT01784068|69705208|FG000|TFR Phase|Physician Decision|0|||
38021954|NCT01784068|69705209|FG001|TFR Phase|Physician Decision|1|||
37700298|NCT01607476|69177298|FG002|Overall Study|Lost to Follow-up|2|||
38021955|NCT01784068|69705208|FG000|TFR Phase|Patient/guardian decision|0|||
38021956|NCT01784068|69705209|FG001|TFR Phase|Patient/guardian decision|3|||
38021957|NCT01784068|69705208|FG000|TFR Phase|Death|0|||
37911589|NCT02732210|69598255|FG000|Overall Study|Death|4|||
37911590|NCT02732210|69598256|FG001|Overall Study|Death|15|||
37911591|NCT02732210|69598255|FG000|Overall Study|Other|35|||
37911592|NCT02732210|69598256|FG001|Overall Study|Other|103|||
37911593|NCT02732210|69598255|FG000|Overall Study|Missing|0|||
37911594|NCT02732210|69598256|FG001|Overall Study|Missing|8|||
37911595|NCT00595959|69598262|FG000|Overall Study|Withdrawal by Subject|1|||
37911596|NCT00595959|69598262|FG000|Overall Study|Lost to Follow-up|1|||
37911597|NCT00436748|69598300|FG000|Overall Study|Ineligibility Determined|1|||
37911598|NCT00436748|69598301|FG001|Overall Study|Ineligibility Determined|1|||
37911599|NCT00436748|69598300|FG000|Overall Study|Adverse Event|0|||
37911600|NCT00436748|69598301|FG001|Overall Study|Adverse Event|2|||
37911601|NCT00436748|69598300|FG000|Overall Study|Consent Withdrawn|1|||
37911602|NCT00436748|69598301|FG001|Overall Study|Consent Withdrawn|4|||
37911603|NCT00436748|69598300|FG000|Overall Study|Administrative Decision|1|||
37911604|NCT00436748|69598301|FG001|Overall Study|Administrative Decision|0|||
37911605|NCT00436748|69598300|FG000|Overall Study|Lost to Follow-up|0|||
37911606|NCT00436748|69598301|FG001|Overall Study|Lost to Follow-up|1|||
37911607|NCT00436748|69598300|FG000|Overall Study|Protocol-specified Criteria|5|||
37700299|NCT01765192|69177308|FG000|Treatment Period 1|Adverse Event|0|||
37700300|NCT01765192|69177309|FG001|Treatment Period 1|Adverse Event|1|||
37700301|NCT01765192|69177308|FG000|Washout Period|Voluntary Withdrawal|1|||
37700302|NCT01765192|69177309|FG001|Washout Period|Voluntary Withdrawal|1|||
37700303|NCT01765192|69177308|FG000|Washout Period|Reason not specified|1|||
37700304|NCT01765192|69177309|FG001|Washout Period|Reason not specified|0|||
37700305|NCT01765192|69177308|FG000|Treatment Period 2|Reason not specified|0|||
37700306|NCT01765192|69177309|FG001|Treatment Period 2|Reason not specified|2|||
37911608|NCT00436748|69598301|FG001|Overall Study|Protocol-specified Criteria|4|||
37911609|NCT00436748|69598300|FG000|Overall Study|Other|3|||
37911610|NCT00436748|69598301|FG001|Overall Study|Other|0|||
37911611|NCT03342404|69598309|FG000|Overall Study|Withdrawal by Subject|9|||
37911612|NCT03342404|69598310|FG001|Overall Study|Withdrawal by Subject|10|||
37911613|NCT03342404|69598309|FG000|Overall Study|Lack of Efficacy|1|||
37911614|NCT03342404|69598310|FG001|Overall Study|Lack of Efficacy|17|||
37911615|NCT03342404|69598309|FG000|Overall Study|Adverse Event|3|||
37911616|NCT03342404|69598310|FG001|Overall Study|Adverse Event|4|||
37911617|NCT03342404|69598309|FG000|Overall Study|Noncompliance with study drug|1|||
37911618|NCT03342404|69598310|FG001|Overall Study|Noncompliance with study drug|0|||
37911619|NCT03342404|69598309|FG000|Overall Study|Other reasons|1|||
37911620|NCT03342404|69598310|FG001|Overall Study|Other reasons|0|||
37911621|NCT02703272|69598320|FG000|Overall Study|Death|4|||
37911622|NCT02703272|69598321|FG001|Overall Study|Death|9|||
37911623|NCT02703272|69598322|FG002|Overall Study|Death|19|||
37911624|NCT02703272|69598323|FG003|Overall Study|Death|10|||
37911625|NCT02703272|69598320|FG000|Overall Study|Withdrawal by Subject|0|||
37911626|NCT02703272|69598321|FG001|Overall Study|Withdrawal by Subject|0|||
37911627|NCT02703272|69598322|FG002|Overall Study|Withdrawal by Subject|4|||
37911628|NCT02703272|69598323|FG003|Overall Study|Withdrawal by Subject|2|||
37911629|NCT02703272|69598320|FG000|Overall Study|Study Terminated by Sponsor|6|||
37911630|NCT02703272|69598321|FG001|Overall Study|Study Terminated by Sponsor|1|||
37911631|NCT02703272|69598322|FG002|Overall Study|Study Terminated by Sponsor|12|||
37911632|NCT02703272|69598323|FG003|Overall Study|Study Terminated by Sponsor|4|||
37911633|NCT02703272|69598320|FG000|Overall Study|Other|1|||
37911634|NCT02703272|69598321|FG001|Overall Study|Other|0|||
37911635|NCT02703272|69598322|FG002|Overall Study|Other|0|||
37911636|NCT02703272|69598323|FG003|Overall Study|Other|0|||
37911637|NCT02568215|69598363|FG000|Overall Study|Death|1|||
37911638|NCT02568215|69598364|FG001|Overall Study|Death|2|||
37911639|NCT02568215|69598365|FG002|Overall Study|Death|0|||
37911640|NCT02568215|69598363|FG000|Overall Study|Physician Decision|2|||
37911641|NCT02568215|69598364|FG001|Overall Study|Physician Decision|2|||
37911642|NCT02568215|69598365|FG002|Overall Study|Physician Decision|2|||
37911643|NCT02568215|69598363|FG000|Overall Study|Lost to Follow-up|29|||
37911644|NCT02568215|69598364|FG001|Overall Study|Lost to Follow-up|32|||
37911645|NCT02568215|69598365|FG002|Overall Study|Lost to Follow-up|41|||
37911646|NCT02568215|69598363|FG000|Overall Study|Withdrawal by Subject|21|||
37911647|NCT02568215|69598364|FG001|Overall Study|Withdrawal by Subject|19|||
38021958|NCT01784068|69705209|FG001|TFR Phase|Death|1|||
38021959|NCT01784068|69705208|FG000|TFR Phase|Lack of Efficacy|0|||
38021960|NCT01784068|69705209|FG001|TFR Phase|Lack of Efficacy|88|||
37834248|NCT04154189|69518084|FG001|Overall Study|Ongoing|20|||
37834249|NCT03905512|69518107|FG000|Overall Study|Withdrawal by Subject|9|||
37834250|NCT03905512|69518108|FG001|Overall Study|Withdrawal by Subject|8|||
37834251|NCT03905512|69518107|FG000|Overall Study|Adverse Event|1|||
37834252|NCT03905512|69518108|FG001|Overall Study|Adverse Event|2|||
37834253|NCT03905512|69518107|FG000|Overall Study|Lost to Follow-up|4|||
37834254|NCT03905512|69518108|FG001|Overall Study|Lost to Follow-up|3|||
37834255|NCT03905512|69518107|FG000|Overall Study|Other than Specified|7|||
37834256|NCT03905512|69518108|FG001|Overall Study|Other than Specified|4|||
37834257|NCT03891875|69518117|FG000|Overall Study|Withdrawal by Subject|20|||
37834258|NCT03891875|69518118|FG001|Overall Study|Withdrawal by Subject|3|||
37834259|NCT03891875|69518117|FG000|Overall Study|Adverse Event|10|||
37834260|NCT03891875|69518118|FG001|Overall Study|Adverse Event|4|||
37911648|NCT02568215|69598365|FG002|Overall Study|Withdrawal by Subject|22|||
37911649|NCT02568215|69598363|FG000|Overall Study|Protocol Violation|1|||
37911650|NCT02568215|69598364|FG001|Overall Study|Protocol Violation|1|||
37911651|NCT02568215|69598365|FG002|Overall Study|Protocol Violation|0|||
37911652|NCT02568215|69598363|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
37911653|NCT02568215|69598364|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
37911654|NCT02568215|69598365|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
37911655|NCT02568215|69598363|FG000|Overall Study|Other|0|||
37911656|NCT02568215|69598364|FG001|Overall Study|Other|1|||
37834261|NCT03891875|69518117|FG000|Overall Study|Physician Decision|1|||
37834262|NCT03891875|69518118|FG001|Overall Study|Physician Decision|1|||
37911657|NCT02568215|69598365|FG002|Overall Study|Other|4|||
37911658|NCT00908141|69598402|FG000|Overall Study|Withdrawal by Subject|0|||
37911659|NCT00908141|69598403|FG001|Overall Study|Withdrawal by Subject|1|||
37911660|NCT00906347|69598411|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
37911661|NCT00906347|69598412|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
37911662|NCT00906347|69598411|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
38021961|NCT01642251|69705223|FG000|Overall Study|Progressive disease|0|||
38021962|NCT01642251|69705224|FG001|Overall Study|Progressive disease|0|||
38021963|NCT01642251|69705225|FG002|Overall Study|Progressive disease|3|||
38021964|NCT01642251|69705226|FG003|Overall Study|Progressive disease|3|||
38021965|NCT01642251|69705223|FG000|Overall Study|Adverse Event|0|||
38021966|NCT01642251|69705224|FG001|Overall Study|Adverse Event|0|||
38021967|NCT01642251|69705225|FG002|Overall Study|Adverse Event|5|||
38021968|NCT01642251|69705226|FG003|Overall Study|Adverse Event|4|||
38021969|NCT01642251|69705223|FG000|Overall Study|Death|0|||
38021970|NCT01642251|69705224|FG001|Overall Study|Death|0|||
38021971|NCT01642251|69705225|FG002|Overall Study|Death|1|||
38021972|NCT01642251|69705226|FG003|Overall Study|Death|3|||
38021973|NCT01642251|69705223|FG000|Overall Study|Withdrawal by Subject|0|||
38021974|NCT01642251|69705224|FG001|Overall Study|Withdrawal by Subject|0|||
38021975|NCT01642251|69705225|FG002|Overall Study|Withdrawal by Subject|1|||
38021976|NCT01642251|69705226|FG003|Overall Study|Withdrawal by Subject|3|||
38021977|NCT01642251|69705223|FG000|Overall Study|Alternative therapy|0|||
38021978|NCT01642251|69705224|FG001|Overall Study|Alternative therapy|0|||
38021979|NCT01642251|69705225|FG002|Overall Study|Alternative therapy|0|||
38021980|NCT01642251|69705226|FG003|Overall Study|Alternative therapy|2|||
38021981|NCT01642251|69705223|FG000|Overall Study|Other complicating disease|0|||
37834263|NCT03891875|69518117|FG000|Overall Study|Protocol Violation|1|||
37834264|NCT03891875|69518118|FG001|Overall Study|Protocol Violation|0|||
37834265|NCT03891875|69518117|FG000|Overall Study|Lost to Follow-up|1|||
37834266|NCT03891875|69518118|FG001|Overall Study|Lost to Follow-up|0|||
37834267|NCT03891875|69518117|FG000|Overall Study|COVID-19 infection|1|||
37834268|NCT03891875|69518118|FG001|Overall Study|COVID-19 infection|0|||
37834269|NCT03830164|69518127|FG000|Overall Study|Adverse Event|0|||
37911663|NCT00906347|69598412|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
37911664|NCT00906347|69598411|FG000|Received Study Drug|Refused study drug|1|||
38021982|NCT01642251|69705224|FG001|Overall Study|Other complicating disease|0|||
38021983|NCT01642251|69705225|FG002|Overall Study|Other complicating disease|1|||
38021984|NCT01642251|69705226|FG003|Overall Study|Other complicating disease|0|||
38021985|NCT01642251|69705223|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
38021986|NCT01642251|69705224|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
38021987|NCT01642251|69705225|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
38021988|NCT01642251|69705226|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
38021989|NCT01606137|69705235|FG000|Overall Study|Adverse Event|85|||
38021990|NCT01606137|69705235|FG000|Overall Study|Withdrawal by Subject|74|||
38021991|NCT01606137|69705235|FG000|Overall Study|Lack of Efficacy|56|||
38021992|NCT01606137|69705235|FG000|Overall Study|Lost to Follow-up|15|||
38021993|NCT01606137|69705235|FG000|Overall Study|Protocol Violation|1|||
38021994|NCT01606137|69705235|FG000|Overall Study|Patient non-compliance|9|||
38021995|NCT01606137|69705235|FG000|Overall Study|Death|1|||
38021996|NCT01606137|69705235|FG000|Overall Study|Decreased/no pain|4|||
38021997|NCT01606137|69705235|FG000|Overall Study|Issues with driving|4|||
38021998|NCT01606137|69705235|FG000|Overall Study|multiple sclerosis less stable|1|||
38021999|NCT01606137|69705235|FG000|Overall Study|Increased bilirubin|1|||
38022000|NCT01606137|69705235|FG000|Overall Study|Spray causes nausea|1|||
38022001|NCT01606137|69705235|FG000|Overall Study|Not enough improvement|4|||
38022002|NCT01606137|69705235|FG000|Overall Study|Wanted to try another treatment|1|||
38022003|NCT01606137|69705235|FG000|Overall Study|Patient leaving country|1|||
38022004|NCT01606137|69705235|FG000|Overall Study|Personal reasons|1|||
38022005|NCT01606137|69705235|FG000|Overall Study|Unable to tolerate study med. taste|1|||
38022006|NCT01606137|69705235|FG000|Overall Study|Patient moving|1|||
38022007|NCT01606137|69705235|FG000|Overall Study|Unable to collect consistent data|1|||
38022008|NCT01532518|69705242|FG000|Overall Study|Withdrawal by Subject|0|||
38022009|NCT01532518|69705243|FG001|Overall Study|Withdrawal by Subject|0|||
38022010|NCT01532518|69705244|FG002|Overall Study|Withdrawal by Subject|1|||
38022011|NCT00844285|69705272|FG000|Overall Study|Other|0|||
38022012|NCT00844285|69705273|FG001|Overall Study|Other|1|||
38022013|NCT00844285|69705274|FG002|Overall Study|Other|0|||
38022014|NCT00844285|69705272|FG000|Overall Study|Other than specified|95|||
38022015|NCT00844285|69705273|FG001|Overall Study|Other than specified|129|||
37911665|NCT00906347|69598412|FG001|Received Study Drug|Refused study drug|0|||
37911666|NCT00906347|69598411|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
37911667|NCT00906347|69598412|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
37911668|NCT00906035|69598421|FG000|Overall Study|Withdrawal by Subject|2|||
37911669|NCT00906035|69598422|FG001|Overall Study|Withdrawal by Subject|3|||
37911670|NCT00906035|69598423|FG002|Overall Study|Withdrawal by Subject|0|||
37911671|NCT00905489|69598431|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
37911672|NCT00905489|69598431|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
37911673|NCT00905489|69598431|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
37911674|NCT02704754|69598442|FG000|Overall Study|Lost to Follow-up|1|||
37911675|NCT02704754|69598443|FG001|Overall Study|Lost to Follow-up|1|||
37911676|NCT02704754|69598442|FG000|Overall Study|Lack of Efficacy|1|||
37911677|NCT02704754|69598443|FG001|Overall Study|Lack of Efficacy|0|||
37911678|NCT02704754|69598442|FG000|Overall Study|Withdrawal by Subject|1|||
37911679|NCT02704754|69598443|FG001|Overall Study|Withdrawal by Subject|0|||
37911680|NCT03170882|69598451|FG000|Overall Study|Death|17|||
37911681|NCT03170882|69598452|FG001|Overall Study|Death|29|||
37911682|NCT03170882|69598451|FG000|Overall Study|Lost to Follow-up|0|||
37911683|NCT03170882|69598452|FG001|Overall Study|Lost to Follow-up|1|||
37911684|NCT03170882|69598451|FG000|Overall Study|Withdrawal by Subject|4|||
37911685|NCT03170882|69598452|FG001|Overall Study|Withdrawal by Subject|7|||
38022016|NCT00844285|69705274|FG002|Overall Study|Other than specified|12|||
38022017|NCT00844285|69705272|FG000|Overall Study|Site closure|256|||
38022018|NCT00844285|69705273|FG001|Overall Study|Site closure|450|||
38022019|NCT00844285|69705274|FG002|Overall Study|Site closure|50|||
38022020|NCT00844285|69705272|FG000|Overall Study|Follow-up < 8 years|16|||
38022021|NCT00844285|69705273|FG001|Overall Study|Follow-up < 8 years|23|||
38022022|NCT00844285|69705274|FG002|Overall Study|Follow-up < 8 years|4|||
38022023|NCT00844285|69705272|FG000|Overall Study|Protocol Violation|26|||
38022024|NCT00844285|69705273|FG001|Overall Study|Protocol Violation|28|||
38022025|NCT00844285|69705274|FG002|Overall Study|Protocol Violation|54|||
37911686|NCT03170882|69598451|FG000|Overall Study|Reason not Specified|28|||
37911687|NCT03170882|69598452|FG001|Overall Study|Reason not Specified|36|||
37911688|NCT00907517|69598463|FG000|Overall Study|Progressive Disease|3|||
38022026|NCT00844285|69705272|FG000|Overall Study|Death|22|||
37911689|NCT00907517|69598464|FG001|Overall Study|Progressive Disease|3|||
37911690|NCT00907517|69598465|FG002|Overall Study|Progressive Disease|4|||
38022027|NCT00844285|69705273|FG001|Overall Study|Death|21|||
38022028|NCT00844285|69705274|FG002|Overall Study|Death|8|||
38022029|NCT00844285|69705272|FG000|Overall Study|Withdrew Consent|344|||
38022030|NCT00844285|69705273|FG001|Overall Study|Withdrew Consent|466|||
37911691|NCT00907517|69598466|FG003|Overall Study|Progressive Disease|4|||
37911692|NCT00907517|69598467|FG004|Overall Study|Progressive Disease|4|||
37911693|NCT00907517|69598463|FG000|Overall Study|Symptomatic Deterioration|0|||
37911694|NCT00907517|69598464|FG001|Overall Study|Symptomatic Deterioration|0|||
37911695|NCT00907517|69598465|FG002|Overall Study|Symptomatic Deterioration|0|||
37911696|NCT00907517|69598466|FG003|Overall Study|Symptomatic Deterioration|0|||
37911697|NCT00907517|69598467|FG004|Overall Study|Symptomatic Deterioration|1|||
37911698|NCT00905255|69598481|FG000|Overall Study|Adverse Event|7|||
37911699|NCT00905255|69598482|FG001|Overall Study|Adverse Event|5|||
37911700|NCT00905255|69598481|FG000|Overall Study|Withdrawal by Subject|5|||
37911701|NCT00905255|69598482|FG001|Overall Study|Withdrawal by Subject|4|||
37911702|NCT00905255|69598481|FG000|Overall Study|Familial and Personal Reasons|1|||
37911703|NCT00905255|69598482|FG001|Overall Study|Familial and Personal Reasons|0|||
37911704|NCT00905021|69598489|FG000|Overall Study|Adverse Event|2|||
37911705|NCT00906971|69598496|FG000|Overall Study|Withdrawal by Subject|8|||
37911706|NCT00906971|69598497|FG001|Overall Study|Withdrawal by Subject|2|||
37911707|NCT00906971|69598496|FG000|Overall Study|Lost to Follow-up|0|||
37911708|NCT00906971|69598497|FG001|Overall Study|Lost to Follow-up|1|||
37911709|NCT00903929|69598503|FG000|Overall Study|Withdrawal by Subject|0|||
37911710|NCT00903929|69598504|FG001|Overall Study|Withdrawal by Subject|0|||
37911711|NCT00903929|69598505|FG002|Overall Study|Withdrawal by Subject|1|||
37911712|NCT00903929|69598506|FG003|Overall Study|Withdrawal by Subject|2|||
37911713|NCT00903929|69598503|FG000|Overall Study|Adverse Event|0|||
37911714|NCT00903929|69598504|FG001|Overall Study|Adverse Event|0|||
37911715|NCT00903929|69598505|FG002|Overall Study|Adverse Event|0|||
37911716|NCT00903929|69598506|FG003|Overall Study|Adverse Event|1|||
37911717|NCT00903695|69598513|FG000|Overall Study|medical exclusion after 1st testing|1|||
37911718|NCT00903695|69598514|FG001|Overall Study|medical exclusion after 1st testing|0|||
37911719|NCT00903695|69598513|FG000|Overall Study|lung cancer|1|||
37911720|NCT00903695|69598514|FG001|Overall Study|lung cancer|0|||
37911721|NCT00903617|69598526|FG000|Overall Study|Adverse Event|0|||
37911722|NCT00903617|69598527|FG001|Overall Study|Adverse Event|1|||
37911723|NCT00903617|69598528|FG002|Overall Study|Adverse Event|1|||
37911724|NCT00903617|69598529|FG003|Overall Study|Adverse Event|0|||
37911725|NCT00903617|69598526|FG000|Overall Study|Protocol-defined stopping criteria|0|||
37911726|NCT00903617|69598527|FG001|Overall Study|Protocol-defined stopping criteria|2|||
37911727|NCT00903617|69598528|FG002|Overall Study|Protocol-defined stopping criteria|0|||
37911728|NCT00903617|69598529|FG003|Overall Study|Protocol-defined stopping criteria|0|||
37911729|NCT00903617|69598526|FG000|Overall Study|Lost to Follow-up|2|||
37911730|NCT00903617|69598527|FG001|Overall Study|Lost to Follow-up|0|||
37911731|NCT00903617|69598528|FG002|Overall Study|Lost to Follow-up|1|||
37911732|NCT00903617|69598529|FG003|Overall Study|Lost to Follow-up|1|||
37911733|NCT00903617|69598526|FG000|Overall Study|Withdrawal by Subject|1|||
37911734|NCT00903617|69598527|FG001|Overall Study|Withdrawal by Subject|2|||
37911735|NCT00903617|69598528|FG002|Overall Study|Withdrawal by Subject|3|||
37911736|NCT00903617|69598529|FG003|Overall Study|Withdrawal by Subject|0|||
37911737|NCT00903383|69598544|FG000|Overall Study|Adverse Event|1|||
37911738|NCT00903383|69598545|FG001|Overall Study|Adverse Event|2|||
37911739|NCT00903383|69598546|FG002|Overall Study|Adverse Event|3|||
37911740|NCT00903383|69598547|FG003|Overall Study|Adverse Event|1|||
37911741|NCT00903383|69598544|FG000|Overall Study|Physician Decision|1|||
37911742|NCT00903383|69598545|FG001|Overall Study|Physician Decision|2|||
37911743|NCT00903383|69598546|FG002|Overall Study|Physician Decision|0|||
37911744|NCT00903383|69598547|FG003|Overall Study|Physician Decision|0|||
37911745|NCT00903383|69598544|FG000|Overall Study|Lost to Follow-up|0|||
37911746|NCT00903383|69598545|FG001|Overall Study|Lost to Follow-up|0|||
37911747|NCT00903383|69598546|FG002|Overall Study|Lost to Follow-up|0|||
37911748|NCT00903383|69598547|FG003|Overall Study|Lost to Follow-up|1|||
37911749|NCT00903383|69598544|FG000|Overall Study|Decision of Sponsor|1|||
37911750|NCT00903383|69598545|FG001|Overall Study|Decision of Sponsor|0|||
37911751|NCT00903383|69598546|FG002|Overall Study|Decision of Sponsor|0|||
37911752|NCT00903383|69598547|FG003|Overall Study|Decision of Sponsor|0|||
37911753|NCT00903383|69598544|FG000|Overall Study|Withdrawal by Subject|4|||
38022031|NCT00844285|69705274|FG002|Overall Study|Withdrew Consent|70|||
38022032|NCT00844285|69705272|FG000|Overall Study|Lost to Follow-up|330|||
38022033|NCT00844285|69705273|FG001|Overall Study|Lost to Follow-up|486|||
37911754|NCT00903383|69598545|FG001|Overall Study|Withdrawal by Subject|1|||
37911755|NCT00903383|69598546|FG002|Overall Study|Withdrawal by Subject|0|||
37911756|NCT00903383|69598547|FG003|Overall Study|Withdrawal by Subject|2|||
37911757|NCT00903383|69598544|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
37911758|NCT00903383|69598545|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
37911759|NCT00903383|69598546|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
37911760|NCT00903383|69598547|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
37911761|NCT00903383|69598544|FG000|Overall Study|Patient Decision|0|||
37911762|NCT00903383|69598545|FG001|Overall Study|Patient Decision|0|||
37911763|NCT00903383|69598546|FG002|Overall Study|Patient Decision|0|||
37911764|NCT00903383|69598547|FG003|Overall Study|Patient Decision|1|||
37911765|NCT02314026|69598557|FG000|Overall Study|Protocol Violation|28|||
37911766|NCT01617096|69598567|FG000|Overall Study|Withdrawal by Subject|96|||
37911767|NCT01617096|69598568|FG001|Overall Study|Withdrawal by Subject|81|||
38022034|NCT00844285|69705274|FG002|Overall Study|Lost to Follow-up|74|||
38022035|NCT00711646|69705302|FG000|Overall Study|Adverse Event|6|||
38022036|NCT00711646|69705303|FG001|Overall Study|Adverse Event|1|||
38022037|NCT00711646|69705302|FG000|Overall Study|Withdrawal by Subject|4|||
38022038|NCT00711646|69705303|FG001|Overall Study|Withdrawal by Subject|0|||
38022039|NCT00711646|69705302|FG000|Overall Study|Protocol Violation|0|||
38022040|NCT00711646|69705303|FG001|Overall Study|Protocol Violation|1|||
38022041|NCT00711646|69705302|FG000|Overall Study|Lost to Follow-up|1|||
38022042|NCT00711646|69705303|FG001|Overall Study|Lost to Follow-up|0|||
38022043|NCT00711646|69705302|FG000|Overall Study|administrative decision|0|||
38022044|NCT00711646|69705303|FG001|Overall Study|administrative decision|1|||
38022045|NCT00711646|69705302|FG000|Overall Study|patient non-compliance|1|||
38022046|NCT00711646|69705303|FG001|Overall Study|patient non-compliance|0|||
38022047|NCT00640133|69705329|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
38022048|NCT00640133|69705330|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
38022049|NCT00640133|69705329|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
38022050|NCT00640133|69705330|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
38022051|NCT00640133|69705329|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
38022052|NCT00640133|69705330|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
38022053|NCT00379340|69705343|FG000|Overall Study|Death|0|||
38022054|NCT00379340|69705344|FG001|Overall Study|Death|0|||
38022055|NCT00379340|69705345|FG002|Overall Study|Death|0|||
38022056|NCT00379340|69705346|FG003|Overall Study|Death|2|||
38022057|NCT00379340|69705347|FG004|Overall Study|Death|0|||
38022058|NCT00379340|69705343|FG000|Overall Study|Lack of Efficacy|6|||
38022059|NCT00379340|69705344|FG001|Overall Study|Lack of Efficacy|1|||
38022060|NCT00379340|69705345|FG002|Overall Study|Lack of Efficacy|0|||
38022061|NCT00379340|69705346|FG003|Overall Study|Lack of Efficacy|4|||
38022062|NCT00379340|69705347|FG004|Overall Study|Lack of Efficacy|3|||
38022063|NCT00379340|69705343|FG000|Overall Study|Physician Decision|6|||
38022064|NCT00379340|69705344|FG001|Overall Study|Physician Decision|2|||
38022065|NCT00379340|69705345|FG002|Overall Study|Physician Decision|1|||
38022066|NCT00379340|69705346|FG003|Overall Study|Physician Decision|2|||
38022067|NCT00379340|69705347|FG004|Overall Study|Physician Decision|3|||
38022068|NCT00379340|69705343|FG000|Overall Study|Withdrawal by Subject|0|||
38022069|NCT00379340|69705344|FG001|Overall Study|Withdrawal by Subject|0|||
38022070|NCT00379340|69705345|FG002|Overall Study|Withdrawal by Subject|0|||
37911768|NCT01617096|69598567|FG000|Overall Study|Lost to Follow-up|37|||
37911769|NCT01617096|69598568|FG001|Overall Study|Lost to Follow-up|32|||
37911770|NCT01617096|69598567|FG000|Overall Study|Physician Decision|10|||
37911771|NCT01617096|69598568|FG001|Overall Study|Physician Decision|18|||
37911772|NCT01617096|69598567|FG000|Overall Study|Death|4|||
37911773|NCT01617096|69598568|FG001|Overall Study|Death|3|||
37911774|NCT01617096|69598567|FG000|Overall Study|Other|1|||
37911775|NCT01617096|69598568|FG001|Overall Study|Other|3|||
37911776|NCT00900731|69598597|FG000|Overall Study|Adverse Event|31|||
37911777|NCT00900731|69598598|FG001|Overall Study|Adverse Event|27|||
37911778|NCT00900731|69598597|FG000|Overall Study|Withdrawal by Subject|8|||
37911779|NCT00900731|69598598|FG001|Overall Study|Withdrawal by Subject|7|||
37911780|NCT00900731|69598597|FG000|Overall Study|Protocol Deviation|8|||
37911781|NCT00900731|69598598|FG001|Overall Study|Protocol Deviation|11|||
37911782|NCT00900731|69598597|FG000|Overall Study|Administrative Problems|5|||
37911783|NCT00900731|69598598|FG001|Overall Study|Administrative Problems|4|||
37911784|NCT00900731|69598597|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
37911785|NCT00900731|69598598|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
37911786|NCT00900731|69598597|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
37911787|NCT00900731|69598598|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
37911788|NCT00900731|69598597|FG000|Overall Study|Lost to Follow-up|2|||
37911789|NCT00900731|69598598|FG001|Overall Study|Lost to Follow-up|3|||
37911790|NCT00900731|69598597|FG000|Overall Study|Lack of Efficacy|1|||
37911791|NCT00900731|69598598|FG001|Overall Study|Lack of Efficacy|3|||
37911792|NCT00900731|69598597|FG000|Overall Study|Death|0|||
37911793|NCT00900731|69598598|FG001|Overall Study|Death|2|||
37911794|NCT03842436|69598604|FG000|Overall Study|Lost to Follow-up|1|||
37911795|NCT00602472|69598644|FG000|Overall Study|Adverse Event|5|||
38022071|NCT00379340|69705346|FG003|Overall Study|Withdrawal by Subject|1|||
38022072|NCT00379340|69705347|FG004|Overall Study|Withdrawal by Subject|0|||
38022073|NCT00379340|69705343|FG000|Overall Study|Refusal of further protocol therapy|1|||
38022074|NCT00379340|69705344|FG001|Overall Study|Refusal of further protocol therapy|0|||
38022075|NCT00379340|69705345|FG002|Overall Study|Refusal of further protocol therapy|1|||
38022076|NCT00379340|69705346|FG003|Overall Study|Refusal of further protocol therapy|1|||
37911796|NCT00602472|69598645|FG001|Overall Study|Adverse Event|23|||
37911797|NCT00602472|69598644|FG000|Overall Study|Protocol Violation|4|||
37911798|NCT00602472|69598645|FG001|Overall Study|Protocol Violation|19|||
37911799|NCT00602472|69598644|FG000|Overall Study|Withdrawal by Subject|8|||
38022077|NCT00379340|69705347|FG004|Overall Study|Refusal of further protocol therapy|7|||
37911800|NCT00602472|69598645|FG001|Overall Study|Withdrawal by Subject|14|||
37911801|NCT00602472|69598644|FG000|Overall Study|Other incl. lack of efficacy|4|||
37911802|NCT00602472|69598645|FG001|Overall Study|Other incl. lack of efficacy|2|||
37911803|NCT00901901|69598680|FG000|Treatment Period|Adverse Event|120|||
37911804|NCT00901901|69598681|FG001|Treatment Period|Adverse Event|128|||
37911805|NCT00901901|69598680|FG000|Treatment Period|Withdrawal by Subject|26|||
37911806|NCT00901901|69598681|FG001|Treatment Period|Withdrawal by Subject|24|||
37911807|NCT00901901|69598680|FG000|Treatment Period|Physician Decision|2|||
37911808|NCT00901901|69598681|FG001|Treatment Period|Physician Decision|2|||
37911809|NCT00901901|69598680|FG000|Treatment Period|Lost to Follow-up|3|||
37911810|NCT00901901|69598681|FG001|Treatment Period|Lost to Follow-up|5|||
37911811|NCT00901901|69598680|FG000|Treatment Period|Noncompliance with study medication|4|||
37911812|NCT00901901|69598681|FG001|Treatment Period|Noncompliance with study medication|1|||
37911813|NCT00901901|69598680|FG000|Treatment Period|Missing|1|||
37911814|NCT00901901|69598681|FG001|Treatment Period|Missing|0|||
37911815|NCT00901901|69598680|FG000|Treatment Period|Never treated|0|||
37911816|NCT00901901|69598681|FG001|Treatment Period|Never treated|3|||
37911817|NCT00901901|69598680|FG000|Treatment Period|Protocol driven decision point|0|||
37911818|NCT00901901|69598681|FG001|Treatment Period|Protocol driven decision point|2|||
37911819|NCT00901901|69598680|FG000|Treatment Period|Study terminated by sponsor|2|||
37911820|NCT00901901|69598681|FG001|Treatment Period|Study terminated by sponsor|0|||
37911821|NCT00901901|69598680|FG000|Treatment Period|Protocol Violation|5|||
37911822|NCT00901901|69598681|FG001|Treatment Period|Protocol Violation|9|||
37911823|NCT00901901|69598680|FG000|Treatment Period|Switch to commercial drug|1|||
37911824|NCT00901901|69598681|FG001|Treatment Period|Switch to commercial drug|1|||
37911825|NCT00901901|69598680|FG000|Treatment Period|Transfer to treatment continuation study|5|||
37911826|NCT00901901|69598681|FG001|Treatment Period|Transfer to treatment continuation study|2|||
38022078|NCT00379340|69705343|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
38022079|NCT00379340|69705344|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
38022080|NCT00379340|69705345|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
38022081|NCT00379340|69705346|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
38022082|NCT00379340|69705347|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
38022083|NCT00379340|69705343|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
37911827|NCT00901901|69598680|FG000|Follow-up Period|Death|181|||
37911828|NCT00901901|69598681|FG001|Follow-up Period|Death|208|||
37911829|NCT00901901|69598680|FG000|Follow-up Period|Protocol driven decision point|47|||
37911830|NCT00901901|69598681|FG001|Follow-up Period|Protocol driven decision point|36|||
38022084|NCT00379340|69705344|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
38022085|NCT00379340|69705345|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
38022086|NCT00379340|69705346|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
38022087|NCT00379340|69705347|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
38022088|NCT00301808|69705360|FG000|Overall Study|Adverse Event|5|||
38022089|NCT00301808|69705360|FG000|Overall Study|Death|3|||
38022090|NCT00301808|69705360|FG000|Overall Study|Lack of Efficacy|4|||
38022091|NCT04979858|69705388|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
38022092|NCT04979858|69705389|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
38022093|NCT04030598|69705437|FG000|Overall Study|Voluntary Withdrawal|0|||
38022094|NCT04030598|69705438|FG001|Overall Study|Voluntary Withdrawal|1|||
37911831|NCT00901901|69598680|FG000|Follow-up Period|Withdrawal by Subject|6|||
37911832|NCT00901901|69598681|FG001|Follow-up Period|Withdrawal by Subject|9|||
37911833|NCT00901901|69598680|FG000|Follow-up Period|Lost to Follow-up|12|||
37911834|NCT00901901|69598681|FG001|Follow-up Period|Lost to Follow-up|8|||
37911835|NCT00901901|69598680|FG000|Follow-up Period|Missing|94|||
37911836|NCT00901901|69598681|FG001|Follow-up Period|Missing|80|||
37911837|NCT02143778|69598689|FG000|Overall Study|Withdrawal by Subject|2|||
37911838|NCT02143778|69598689|FG000|Overall Study|Device malfunction|1|||
37911839|NCT00896363|69598733|FG000|Overall Study|Adverse Event|3|||
37911840|NCT00896363|69598734|FG001|Overall Study|Adverse Event|4|||
37911841|NCT00896363|69598735|FG002|Overall Study|Adverse Event|2|||
38022095|NCT04030598|69705439|FG002|Overall Study|Voluntary Withdrawal|0|||
38022096|NCT03777436|69705458|FG000|Placebo-controlled Phase|Adverse Event|8|||
37834270|NCT03830164|69518128|FG001|Overall Study|Adverse Event|2|||
37911842|NCT00896363|69598733|FG000|Overall Study|Lack of Efficacy|0|||
37911843|NCT00896363|69598734|FG001|Overall Study|Lack of Efficacy|2|||
38022097|NCT03777436|69705459|FG001|Placebo-controlled Phase|Adverse Event|10|||
37911844|NCT00896363|69598735|FG002|Overall Study|Lack of Efficacy|1|||
37911845|NCT00896363|69598733|FG000|Overall Study|Withdrawal by Subject|3|||
37911846|NCT00896363|69598734|FG001|Overall Study|Withdrawal by Subject|5|||
37911847|NCT00896363|69598735|FG002|Overall Study|Withdrawal by Subject|5|||
37911848|NCT00900029|69598751|FG000|Overall Study|Lost to Follow-up|0|||
37911849|NCT00900029|69598752|FG001|Overall Study|Lost to Follow-up|2|||
37911850|NCT00900029|69598753|FG002|Overall Study|Lost to Follow-up|1|||
37911851|NCT00900029|69598754|FG003|Overall Study|Lost to Follow-up|4|||
37911852|NCT00900029|69598755|FG004|Overall Study|Lost to Follow-up|4|||
37911853|NCT00900029|69598751|FG000|Overall Study|Withdrawal by Subject|2|||
37911854|NCT00900029|69598752|FG001|Overall Study|Withdrawal by Subject|2|||
37911855|NCT00900029|69598753|FG002|Overall Study|Withdrawal by Subject|1|||
37911856|NCT00900029|69598754|FG003|Overall Study|Withdrawal by Subject|1|||
37911857|NCT00900029|69598755|FG004|Overall Study|Withdrawal by Subject|1|||
37911858|NCT00900029|69598751|FG000|Overall Study|Adverse Event|0|||
37911859|NCT00900029|69598752|FG001|Overall Study|Adverse Event|0|||
37911860|NCT00900029|69598753|FG002|Overall Study|Adverse Event|1|||
38022098|NCT03777436|69705460|FG002|Placebo-controlled Phase|Adverse Event|0|||
38022099|NCT03777436|69705458|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
37911861|NCT00900029|69598754|FG003|Overall Study|Adverse Event|1|||
37911862|NCT00900029|69598755|FG004|Overall Study|Adverse Event|1|||
37911863|NCT00900029|69598751|FG000|Overall Study|Death|1|||
37911864|NCT00900029|69598752|FG001|Overall Study|Death|0|||
37911865|NCT00900029|69598753|FG002|Overall Study|Death|0|||
37911866|NCT00900029|69598754|FG003|Overall Study|Death|1|||
37911867|NCT00900029|69598755|FG004|Overall Study|Death|0|||
37911868|NCT00896051|69598773|FG000|Overall Study|Adverse Event|2|||
37911869|NCT00896051|69598774|FG001|Overall Study|Adverse Event|1|||
37911870|NCT00896051|69598773|FG000|Overall Study|Lost to Follow-up|3|||
37911871|NCT00896051|69598774|FG001|Overall Study|Lost to Follow-up|2|||
37911872|NCT00896051|69598773|FG000|Overall Study|Withdrawal by Subject|3|||
37911873|NCT00896051|69598774|FG001|Overall Study|Withdrawal by Subject|2|||
37911874|NCT00896051|69598773|FG000|Overall Study|Subject noncompliant|1|||
37911875|NCT00896051|69598774|FG001|Overall Study|Subject noncompliant|3|||
37911876|NCT00896051|69598773|FG000|Overall Study|Other|1|||
37911877|NCT00896051|69598774|FG001|Overall Study|Other|1|||
37911878|NCT00894647|69598791|FG000|Overall Study|Adverse Event|5|||
37911879|NCT00894647|69598792|FG001|Overall Study|Adverse Event|4|||
37911880|NCT00894647|69598791|FG000|Overall Study|Withdrawal by Subject|4|||
37911881|NCT00894647|69598792|FG001|Overall Study|Withdrawal by Subject|4|||
37911882|NCT00894647|69598791|FG000|Overall Study|Lost to Follow-up|0|||
37911883|NCT00894647|69598792|FG001|Overall Study|Lost to Follow-up|2|||
37911884|NCT00894647|69598791|FG000|Overall Study|Non-compliance with study procedures|0|||
37911885|NCT00894647|69598792|FG001|Overall Study|Non-compliance with study procedures|2|||
37911886|NCT00894647|69598791|FG000|Overall Study|Other, not due to AE|1|||
37911887|NCT00894647|69598792|FG001|Overall Study|Other, not due to AE|2|||
37911888|NCT00892775|69598800|FG000|Overall Study|Protocol Violation|1|||
37911889|NCT00892775|69598801|FG001|Overall Study|Protocol Violation|0|||
37911890|NCT00892775|69598800|FG000|Overall Study|Subject difficulties with blood drawing|1|||
37911891|NCT00892775|69598801|FG001|Overall Study|Subject difficulties with blood drawing|0|||
37911892|NCT00892775|69598800|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
37911893|NCT00892775|69598801|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
37911894|NCT00892775|69598800|FG000|Overall Study|Migrated/ moved from study area|1|||
37911895|NCT00892775|69598801|FG001|Overall Study|Migrated/ moved from study area|0|||
37911896|NCT00892775|69598800|FG000|Overall Study|Withdrawal by Subject|0|||
37911897|NCT00892775|69598801|FG001|Overall Study|Withdrawal by Subject|1|||
37911898|NCT00892775|69598800|FG000|Overall Study|Lost to Follow-up|1|||
38022100|NCT03777436|69705459|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
38022101|NCT03777436|69705460|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
38022102|NCT03777436|69705458|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
38022103|NCT03777436|69705459|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
38022104|NCT03777436|69705460|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
38022105|NCT03777436|69705458|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
38022106|NCT03777436|69705459|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
37911899|NCT00892775|69598801|FG001|Overall Study|Lost to Follow-up|0|||
38022107|NCT03777436|69705460|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
38022108|NCT03777436|69705458|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
38022109|NCT03777436|69705459|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
38022110|NCT03777436|69705460|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
37911900|NCT00895895|69598812|FG000|Period 1|Adverse Event|7|||
37911901|NCT00895895|69598813|FG001|Period 1|Adverse Event|6|||
37911902|NCT00895895|69598814|FG002|Period 1|Adverse Event|4|||
37911903|NCT00895895|69598815|FG003|Period 1|Adverse Event|6|||
37911904|NCT00895895|69598816|FG004|Period 1|Adverse Event|7|||
37911905|NCT00895895|69598812|FG000|Period 1|Death|0|||
37911906|NCT00895895|69598813|FG001|Period 1|Death|0|||
37911907|NCT00895895|69598814|FG002|Period 1|Death|0|||
37911908|NCT00895895|69598815|FG003|Period 1|Death|0|||
37911909|NCT00895895|69598816|FG004|Period 1|Death|1|||
37911910|NCT00895895|69598812|FG000|Period 1|discontinued by sponsor|2|||
37911911|NCT00895895|69598813|FG001|Period 1|discontinued by sponsor|1|||
38022111|NCT03777436|69705458|FG000|Placebo-controlled Phase|Physician Decision|0|||
37911912|NCT00895895|69598814|FG002|Period 1|discontinued by sponsor|2|||
37911913|NCT00895895|69598815|FG003|Period 1|discontinued by sponsor|1|||
38022112|NCT03777436|69705459|FG001|Placebo-controlled Phase|Physician Decision|1|||
38022113|NCT03777436|69705460|FG002|Placebo-controlled Phase|Physician Decision|0|||
38022114|NCT03777436|69705458|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
38022115|NCT03777436|69705459|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
38022116|NCT03777436|69705460|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
38022117|NCT03777436|69705458|FG000|Apremilast Extension Phase|Adverse Event|0|||
38022118|NCT03777436|69705459|FG001|Apremilast Extension Phase|Adverse Event|0|||
38022119|NCT03777436|69705460|FG002|Apremilast Extension Phase|Adverse Event|6|||
38022120|NCT03777436|69705458|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
38022121|NCT03777436|69705459|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
38022122|NCT03777436|69705460|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
38022123|NCT03777436|69705458|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
38022124|NCT03777436|69705459|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
38022125|NCT03777436|69705460|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
38022126|NCT03777436|69705458|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
38022127|NCT03777436|69705459|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
38022128|NCT03777436|69705460|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
38022129|NCT03777436|69705458|FG000|Apremilast Extension Phase|Miscellaneous|0|||
38022130|NCT03777436|69705459|FG001|Apremilast Extension Phase|Miscellaneous|0|||
38022131|NCT03777436|69705460|FG002|Apremilast Extension Phase|Miscellaneous|1|||
38022132|NCT03156023|69705476|FG000|Overall Study|Withdrawal by Subject|1|||
38022133|NCT03156023|69705477|FG001|Overall Study|Withdrawal by Subject|0|||
38022134|NCT03156023|69705478|FG002|Overall Study|Withdrawal by Subject|2|||
38022135|NCT03156023|69705479|FG003|Overall Study|Withdrawal by Subject|1|||
38022136|NCT03156023|69705480|FG004|Overall Study|Withdrawal by Subject|1|||
38022137|NCT03156023|69705476|FG000|Overall Study|Lost to Follow-up|0|||
38022138|NCT03156023|69705477|FG001|Overall Study|Lost to Follow-up|0|||
38022139|NCT03156023|69705478|FG002|Overall Study|Lost to Follow-up|0|||
38022140|NCT03156023|69705479|FG003|Overall Study|Lost to Follow-up|0|||
38022141|NCT03156023|69705480|FG004|Overall Study|Lost to Follow-up|1|||
38022142|NCT03025880|69705498|FG000|Overall Study|Adverse Event|1|||
38022143|NCT03025880|69705499|FG001|Overall Study|Adverse Event|0|||
37911914|NCT00895895|69598816|FG004|Period 1|discontinued by sponsor|1|||
37911915|NCT00895895|69598812|FG000|Period 1|failed to return|0|||
37911916|NCT00895895|69598813|FG001|Period 1|failed to return|0|||
37911917|NCT00895895|69598814|FG002|Period 1|failed to return|1|||
37911918|NCT00895895|69598815|FG003|Period 1|failed to return|0|||
37911919|NCT00895895|69598816|FG004|Period 1|failed to return|1|||
37911920|NCT00895895|69598812|FG000|Period 1|investigator request|0|||
37911921|NCT00895895|69598813|FG001|Period 1|investigator request|1|||
37911922|NCT00895895|69598814|FG002|Period 1|investigator request|0|||
37911923|NCT00895895|69598815|FG003|Period 1|investigator request|0|||
37911924|NCT00895895|69598816|FG004|Period 1|investigator request|0|||
37911925|NCT00895895|69598812|FG000|Period 1|Lost to Follow-up|2|||
37911926|NCT00895895|69598813|FG001|Period 1|Lost to Follow-up|1|||
37911927|NCT00895895|69598814|FG002|Period 1|Lost to Follow-up|3|||
37911928|NCT00895895|69598815|FG003|Period 1|Lost to Follow-up|2|||
37911929|NCT00895895|69598816|FG004|Period 1|Lost to Follow-up|3|||
37911930|NCT00895895|69598812|FG000|Period 1|Other|1|||
37911931|NCT00895895|69598813|FG001|Period 1|Other|2|||
37911932|NCT00895895|69598814|FG002|Period 1|Other|1|||
37911933|NCT00895895|69598815|FG003|Period 1|Other|1|||
37911934|NCT00895895|69598816|FG004|Period 1|Other|1|||
38022144|NCT03025880|69705498|FG000|Overall Study|Death|1|||
38022145|NCT03025880|69705499|FG001|Overall Study|Death|1|||
38022146|NCT03025880|69705498|FG000|Overall Study|Withdrawal by Subject|0|||
38022147|NCT03025880|69705499|FG001|Overall Study|Withdrawal by Subject|1|||
38022148|NCT03025880|69705498|FG000|Overall Study|Physician Decision|0|||
38022149|NCT03025880|69705499|FG001|Overall Study|Physician Decision|1|||
38022150|NCT03025880|69705498|FG000|Overall Study|Progressive Disease|12|||
38022151|NCT03025880|69705499|FG001|Overall Study|Progressive Disease|19|||
38022152|NCT02027376|69705516|FG000|Overall Study|Death|1|||
38022153|NCT02027376|69705517|FG001|Overall Study|Death|0|||
38022154|NCT02027376|69705518|FG002|Overall Study|Death|0|||
37911935|NCT00895895|69598812|FG000|Period 1|Protocol Violation|0|||
37911936|NCT00895895|69598813|FG001|Period 1|Protocol Violation|1|||
37911937|NCT00895895|69598814|FG002|Period 1|Protocol Violation|0|||
38022155|NCT01924533|69705530|FG000|Overall Study|Death|181|||
37911938|NCT00895895|69598815|FG003|Period 1|Protocol Violation|0|||
37911939|NCT00895895|69598816|FG004|Period 1|Protocol Violation|0|||
37911940|NCT00895895|69598812|FG000|Period 1|Withdrawal by Subject|6|||
37911941|NCT00895895|69598813|FG001|Period 1|Withdrawal by Subject|6|||
37911942|NCT00895895|69598814|FG002|Period 1|Withdrawal by Subject|8|||
38022156|NCT01924533|69705531|FG001|Overall Study|Death|200|||
38022157|NCT01924533|69705530|FG000|Overall Study|Lost to Follow-up|0|||
38022158|NCT01924533|69705531|FG001|Overall Study|Lost to Follow-up|1|||
37911943|NCT00895895|69598815|FG003|Period 1|Withdrawal by Subject|2|||
37911944|NCT00895895|69598816|FG004|Period 1|Withdrawal by Subject|4|||
37911945|NCT00895895|69598812|FG000|Period 1|unsatisfactory response-efficacy|2|||
37911946|NCT00895895|69598813|FG001|Period 1|unsatisfactory response-efficacy|0|||
37911947|NCT00895895|69598814|FG002|Period 1|unsatisfactory response-efficacy|0|||
37911948|NCT00895895|69598815|FG003|Period 1|unsatisfactory response-efficacy|0|||
37911949|NCT00895895|69598816|FG004|Period 1|unsatisfactory response-efficacy|0|||
37911950|NCT00895895|69598812|FG000|Period 1|randomized and not treated|1|||
37911951|NCT00895895|69598813|FG001|Period 1|randomized and not treated|3|||
37911952|NCT00895895|69598814|FG002|Period 1|randomized and not treated|1|||
37911953|NCT00895895|69598815|FG003|Period 1|randomized and not treated|1|||
37911954|NCT00895895|69598816|FG004|Period 1|randomized and not treated|2|||
37911955|NCT00895895|69598812|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
38022159|NCT01924533|69705530|FG000|Overall Study|Withdrawal by Subject|7|||
38022160|NCT01924533|69705531|FG001|Overall Study|Withdrawal by Subject|3|||
38022161|NCT01924533|69705530|FG000|Overall Study|Other Eligibility criteria|1|||
38022162|NCT01924533|69705531|FG001|Overall Study|Other Eligibility criteria|1|||
38022163|NCT01606436|69705537|FG000|Overall Study|Withdrawal by Subject|0|||
38022164|NCT01606436|69705538|FG001|Overall Study|Withdrawal by Subject|0|||
38022165|NCT01606436|69705539|FG002|Overall Study|Withdrawal by Subject|1|||
38022166|NCT01606436|69705540|FG003|Overall Study|Withdrawal by Subject|1|||
38022167|NCT01606436|69705541|FG004|Overall Study|Withdrawal by Subject|1|||
38022168|NCT01606436|69705542|FG005|Overall Study|Withdrawal by Subject|0|||
38022169|NCT01606436|69705537|FG000|Overall Study|Adverse Event|0|||
38022170|NCT01606436|69705538|FG001|Overall Study|Adverse Event|0|||
38022171|NCT01606436|69705539|FG002|Overall Study|Adverse Event|1|||
38022172|NCT01606436|69705540|FG003|Overall Study|Adverse Event|0|||
38022173|NCT01606436|69705541|FG004|Overall Study|Adverse Event|0|||
38022174|NCT01606436|69705542|FG005|Overall Study|Adverse Event|0|||
38022175|NCT01606436|69705537|FG000|Overall Study|Sponsor Decision|0|||
38022176|NCT01606436|69705538|FG001|Overall Study|Sponsor Decision|0|||
38022177|NCT01606436|69705539|FG002|Overall Study|Sponsor Decision|0|||
38022178|NCT01606436|69705540|FG003|Overall Study|Sponsor Decision|1|||
38022179|NCT01606436|69705541|FG004|Overall Study|Sponsor Decision|0|||
38022180|NCT01606436|69705542|FG005|Overall Study|Sponsor Decision|0|||
38022181|NCT00219557|69705562|FG000|Phase 1|Lack of Efficacy|3|||
38022182|NCT00219557|69705563|FG001|Phase 1|Lack of Efficacy|0|||
38022183|NCT00219557|69705564|FG002|Phase 1|Lack of Efficacy|0|||
38022184|NCT00219557|69705562|FG000|Phase 1|Adverse Event|2|||
38022185|NCT00219557|69705563|FG001|Phase 1|Adverse Event|0|||
38022186|NCT00219557|69705564|FG002|Phase 1|Adverse Event|0|||
38022187|NCT00219557|69705562|FG000|Phase 1|Withdrawal by Subject|1|||
38022188|NCT00219557|69705563|FG001|Phase 1|Withdrawal by Subject|0|||
38022189|NCT00219557|69705564|FG002|Phase 1|Withdrawal by Subject|0|||
38022190|NCT00219557|69705562|FG000|Phase 1|Started chemotherapy at other institute|1|||
38022191|NCT00219557|69705563|FG001|Phase 1|Started chemotherapy at other institute|0|||
38022192|NCT00219557|69705564|FG002|Phase 1|Started chemotherapy at other institute|0|||
38022193|NCT00219557|69705562|FG000|Phase 2|Lack of Efficacy|0|||
38022194|NCT00219557|69705563|FG001|Phase 2|Lack of Efficacy|21|||
38022195|NCT00219557|69705564|FG002|Phase 2|Lack of Efficacy|15|||
37911956|NCT00895895|69598813|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
37911957|NCT00895895|69598814|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
37911958|NCT00895895|69598815|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
37911959|NCT00895895|69598816|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
38022196|NCT00219557|69705562|FG000|Phase 2|Adverse Event|0|||
38022197|NCT00219557|69705563|FG001|Phase 2|Adverse Event|22|||
37834271|NCT03830164|69518129|FG002|Overall Study|Adverse Event|0|||
37834272|NCT03830164|69518127|FG000|Overall Study|Lack of Efficacy|1|||
37834273|NCT03830164|69518128|FG001|Overall Study|Lack of Efficacy|5|||
37834274|NCT03830164|69518129|FG002|Overall Study|Lack of Efficacy|0|||
37834275|NCT03830164|69518127|FG000|Overall Study|Lost to Follow-up|0|||
37834276|NCT03830164|69518128|FG001|Overall Study|Lost to Follow-up|1|||
37834277|NCT03830164|69518129|FG002|Overall Study|Lost to Follow-up|0|||
37834278|NCT03830164|69518127|FG000|Overall Study|Withdrawal by Subject|1|||
37834279|NCT03830164|69518128|FG001|Overall Study|Withdrawal by Subject|0|||
37834280|NCT03830164|69518129|FG002|Overall Study|Withdrawal by Subject|0|||
37834281|NCT03775486|69518139|FG000|Initial Therapy Phase|Other reason provided|0|||
37911960|NCT00895895|69598812|FG000|After Period 1, Prior to Period 2|Other|0|||
38022198|NCT00219557|69705564|FG002|Phase 2|Adverse Event|2|||
38022199|NCT00219557|69705562|FG000|Phase 2|Death|0|||
38022200|NCT00219557|69705563|FG001|Phase 2|Death|8|||
37911961|NCT00895895|69598813|FG001|After Period 1, Prior to Period 2|Other|0|||
37911962|NCT00895895|69598814|FG002|After Period 1, Prior to Period 2|Other|1|||
37911963|NCT00895895|69598815|FG003|After Period 1, Prior to Period 2|Other|0|||
38022201|NCT00219557|69705564|FG002|Phase 2|Death|2|||
37834282|NCT03775486|69518140|FG001|Initial Therapy Phase|Other reason provided|15|||
38022202|NCT00219557|69705562|FG000|Phase 2|Other|0|||
38022203|NCT00219557|69705563|FG001|Phase 2|Other|8|||
38022204|NCT00219557|69705564|FG002|Phase 2|Other|6|||
37911964|NCT00895895|69598816|FG004|After Period 1, Prior to Period 2|Other|0|||
37911965|NCT00895895|69598812|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
37911966|NCT00895895|69598813|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
37911967|NCT00895895|69598814|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
37911968|NCT00895895|69598815|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
37911969|NCT00895895|69598816|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
37911970|NCT00895895|69598812|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
37911971|NCT00895895|69598813|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
37911972|NCT00895895|69598814|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
37911973|NCT00895895|69598815|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
37911974|NCT00895895|69598816|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
37911975|NCT00895895|69598812|FG000|Period 2|Adverse Event|3|||
37911976|NCT00895895|69598813|FG001|Period 2|Adverse Event|3|||
37911977|NCT00895895|69598814|FG002|Period 2|Adverse Event|5|||
37911978|NCT00895895|69598815|FG003|Period 2|Adverse Event|2|||
37911979|NCT00895895|69598816|FG004|Period 2|Adverse Event|5|||
37911980|NCT00895895|69598812|FG000|Period 2|Death|0|||
37911981|NCT00895895|69598813|FG001|Period 2|Death|0|||
37911982|NCT00895895|69598814|FG002|Period 2|Death|1|||
37911983|NCT00895895|69598815|FG003|Period 2|Death|0|||
37911984|NCT00895895|69598816|FG004|Period 2|Death|0|||
37911985|NCT00895895|69598812|FG000|Period 2|discontinued by sponsor|44|||
37911986|NCT00895895|69598813|FG001|Period 2|discontinued by sponsor|44|||
37911987|NCT00895895|69598814|FG002|Period 2|discontinued by sponsor|38|||
37911988|NCT00895895|69598815|FG003|Period 2|discontinued by sponsor|46|||
37911989|NCT00895895|69598816|FG004|Period 2|discontinued by sponsor|37|||
37911990|NCT00895895|69598812|FG000|Period 2|failed to return|2|||
37911991|NCT00895895|69598813|FG001|Period 2|failed to return|0|||
37911992|NCT00895895|69598814|FG002|Period 2|failed to return|0|||
37911993|NCT00895895|69598815|FG003|Period 2|failed to return|0|||
37911994|NCT00895895|69598816|FG004|Period 2|failed to return|0|||
37911995|NCT00895895|69598812|FG000|Period 2|investigator request|2|||
37911996|NCT00895895|69598813|FG001|Period 2|investigator request|0|||
37911997|NCT00895895|69598814|FG002|Period 2|investigator request|0|||
37911998|NCT00895895|69598815|FG003|Period 2|investigator request|0|||
37911999|NCT00895895|69598816|FG004|Period 2|investigator request|0|||
37912000|NCT00895895|69598812|FG000|Period 2|Lost to Follow-up|1|||
37912001|NCT00895895|69598813|FG001|Period 2|Lost to Follow-up|2|||
37912002|NCT00895895|69598814|FG002|Period 2|Lost to Follow-up|1|||
37912003|NCT00895895|69598815|FG003|Period 2|Lost to Follow-up|1|||
37912004|NCT00895895|69598816|FG004|Period 2|Lost to Follow-up|0|||
37912005|NCT00895895|69598812|FG000|Period 2|Other|1|||
37912006|NCT00895895|69598813|FG001|Period 2|Other|1|||
37912007|NCT00895895|69598814|FG002|Period 2|Other|3|||
37912008|NCT00895895|69598815|FG003|Period 2|Other|1|||
37912009|NCT00895895|69598816|FG004|Period 2|Other|1|||
37912010|NCT00895895|69598812|FG000|Period 2|Protocol Violation|1|||
37912011|NCT00895895|69598813|FG001|Period 2|Protocol Violation|0|||
37912012|NCT00895895|69598814|FG002|Period 2|Protocol Violation|1|||
37912013|NCT00895895|69598815|FG003|Period 2|Protocol Violation|1|||
37912014|NCT00895895|69598816|FG004|Period 2|Protocol Violation|1|||
37912015|NCT00895895|69598812|FG000|Period 2|Withdrawal by Subject|0|||
37912016|NCT00895895|69598813|FG001|Period 2|Withdrawal by Subject|2|||
37912017|NCT00895895|69598814|FG002|Period 2|Withdrawal by Subject|0|||
38022205|NCT00219557|69705562|FG000|Phase 2|Withdrawal by Subject|0|||
38022206|NCT00219557|69705563|FG001|Phase 2|Withdrawal by Subject|9|||
38022207|NCT00219557|69705564|FG002|Phase 2|Withdrawal by Subject|5|||
38022208|NCT00219557|69705562|FG000|Phase 2|Treatment not received|0|||
38022209|NCT00219557|69705563|FG001|Phase 2|Treatment not received|1|||
37912018|NCT00895895|69598815|FG003|Period 2|Withdrawal by Subject|3|||
38022210|NCT00219557|69705564|FG002|Phase 2|Treatment not received|3|||
38022211|NCT00251927|69705579|FG000|Overall Study|Adverse Event|3|||
38022212|NCT00251927|69705580|FG001|Overall Study|Adverse Event|15|||
37912019|NCT00895895|69598816|FG004|Period 2|Withdrawal by Subject|5|||
37912020|NCT00895895|69598812|FG000|Period 2|unsatisfactory response-efficacy|2|||
37912021|NCT00895895|69598813|FG001|Period 2|unsatisfactory response-efficacy|1|||
37912022|NCT00895895|69598814|FG002|Period 2|unsatisfactory response-efficacy|0|||
37912023|NCT00895895|69598815|FG003|Period 2|unsatisfactory response-efficacy|0|||
37912024|NCT00895895|69598816|FG004|Period 2|unsatisfactory response-efficacy|0|||
37912025|NCT00895661|69598834|FG000|Overall Study|Death|1|||
37912026|NCT00895661|69598834|FG000|Overall Study|reason unknown|2|||
37912027|NCT00895583|69598840|FG000|Overall Study|Adverse Event|28|||
37912028|NCT00895583|69598841|FG001|Overall Study|Adverse Event|4|||
37912029|NCT00895583|69598840|FG000|Overall Study|Death|2|||
37912030|NCT00895583|69598841|FG001|Overall Study|Death|1|||
37912031|NCT00895583|69598840|FG000|Overall Study|Physician Decision|3|||
37912032|NCT00895583|69598841|FG001|Overall Study|Physician Decision|1|||
37912033|NCT00895583|69598840|FG000|Overall Study|Lost to Follow-up|1|||
37912034|NCT00895583|69598841|FG001|Overall Study|Lost to Follow-up|3|||
37912035|NCT00895583|69598840|FG000|Overall Study|Protocol Violation|1|||
38022213|NCT00251927|69705579|FG000|Overall Study|Lack of Efficacy|22|||
37912036|NCT00895583|69598841|FG001|Overall Study|Protocol Violation|0|||
37912037|NCT00895583|69598840|FG000|Overall Study|Withdrawal by Subject|4|||
37912038|NCT00895583|69598841|FG001|Overall Study|Withdrawal by Subject|2|||
37912039|NCT00895583|69598840|FG000|Overall Study|Lack of Efficacy|5|||
37912040|NCT00895583|69598841|FG001|Overall Study|Lack of Efficacy|0|||
37912041|NCT00895583|69598840|FG000|Overall Study|Other|0|||
37912042|NCT00895583|69598841|FG001|Overall Study|Other|1|||
37912043|NCT00894413|69598858|FG000|Overall Study|Physician Decision|0|||
37912044|NCT00894413|69598859|FG001|Overall Study|Physician Decision|2|||
37912045|NCT00894413|69598858|FG000|Overall Study|Adverse Event|0|||
37912046|NCT00894413|69598859|FG001|Overall Study|Adverse Event|2|||
37912047|NCT00894413|69598858|FG000|Overall Study|Withdrawal by Subject|0|||
37912048|NCT00894413|69598859|FG001|Overall Study|Withdrawal by Subject|4|||
37912049|NCT00895037|69598868|FG000|Overall Study|Death|0|||
37912050|NCT00895037|69598869|FG001|Overall Study|Death|2|||
37912051|NCT00895037|69598870|FG002|Overall Study|Death|1|||
37912052|NCT00892151|69598878|FG000|Overall Study|Protocol Violation|1|||
37912053|NCT01706705|69598882|FG000|Overall Study|Death|1|||
37912054|NCT01706705|69598882|FG000|Overall Study|Lack of Efficacy|13|||
37912055|NCT01706705|69598882|FG000|Overall Study|Non-clinical|6|||
37912056|NCT00894803|69598898|FG000|Overall Study|Death|20|||
37912057|NCT00894803|69598899|FG001|Overall Study|Death|4|||
37912058|NCT00894803|69598898|FG000|Overall Study|Lost to Follow-up|0|||
37912059|NCT00894803|69598899|FG001|Overall Study|Lost to Follow-up|1|||
37912060|NCT00601458|69598908|FG000|Overall Study|Dosing Error|1|||
37912061|NCT00601458|69598909|FG001|Overall Study|Dosing Error|0|||
37912062|NCT00601458|69598910|FG002|Overall Study|Dosing Error|0|||
37912063|NCT00601458|69598908|FG000|Overall Study|Incomplete Data|0|||
37912064|NCT00601458|69598909|FG001|Overall Study|Incomplete Data|2|||
37912065|NCT00601458|69598910|FG002|Overall Study|Incomplete Data|0|||
37912066|NCT00601458|69598908|FG000|Overall Study|Protocol Violation|3|||
37912067|NCT00601458|69598909|FG001|Overall Study|Protocol Violation|2|||
37912068|NCT00601458|69598910|FG002|Overall Study|Protocol Violation|1|||
37912069|NCT00601458|69598908|FG000|Overall Study|Early Termination|0|||
37912070|NCT00601458|69598909|FG001|Overall Study|Early Termination|1|||
37912071|NCT00601458|69598910|FG002|Overall Study|Early Termination|1|||
37912072|NCT02141282|69598922|FG000|Overall Study|Adverse event, not related to progression|8|||
37912073|NCT02141282|69598923|FG001|Overall Study|Adverse event, not related to progression|1|||
37912074|NCT02141282|69598924|FG002|Overall Study|Adverse event, not related to progression|3|||
37912075|NCT02141282|69598925|FG003|Overall Study|Adverse event, not related to progression|1|||
37912076|NCT02141282|69598922|FG000|Overall Study|Adverse event, related to progression|1|||
37912077|NCT02141282|69598923|FG001|Overall Study|Adverse event, related to progression|0|||
37912078|NCT02141282|69598924|FG002|Overall Study|Adverse event, related to progression|2|||
37912079|NCT02141282|69598925|FG003|Overall Study|Adverse event, related to progression|0|||
37912080|NCT02141282|69598922|FG000|Overall Study|COVID-19 infection|1|||
37912081|NCT02141282|69598923|FG001|Overall Study|COVID-19 infection|0|||
37912082|NCT02141282|69598924|FG002|Overall Study|COVID-19 infection|0|||
37912083|NCT02141282|69598925|FG003|Overall Study|COVID-19 infection|0|||
37912084|NCT02141282|69598922|FG000|Overall Study|Lost to Follow-up|0|||
37912085|NCT02141282|69598923|FG001|Overall Study|Lost to Follow-up|0|||
37912086|NCT02141282|69598924|FG002|Overall Study|Lost to Follow-up|4|||
37912087|NCT02141282|69598925|FG003|Overall Study|Lost to Follow-up|2|||
37912088|NCT02141282|69598922|FG000|Overall Study|Other, not specified|14|||
37912089|NCT02141282|69598923|FG001|Overall Study|Other, not specified|11|||
37912090|NCT02141282|69598924|FG002|Overall Study|Other, not specified|23|||
37912091|NCT02141282|69598925|FG003|Overall Study|Other, not specified|9|||
37912092|NCT02141282|69598922|FG000|Overall Study|Progressive disease, Richter's|4|||
37912093|NCT02141282|69598923|FG001|Overall Study|Progressive disease, Richter's|1|||
37912094|NCT02141282|69598924|FG002|Overall Study|Progressive disease, Richter's|1|||
37912095|NCT02141282|69598925|FG003|Overall Study|Progressive disease, Richter's|1|||
37912096|NCT02141282|69598922|FG000|Overall Study|Progressive disease per protocol|12|||
37912097|NCT02141282|69598923|FG001|Overall Study|Progressive disease per protocol|7|||
37912098|NCT02141282|69598924|FG002|Overall Study|Progressive disease per protocol|9|||
37912099|NCT02141282|69598925|FG003|Overall Study|Progressive disease per protocol|2|||
37912100|NCT02141282|69598922|FG000|Overall Study|Stem cell transplant|1|||
37912101|NCT02141282|69598923|FG001|Overall Study|Stem cell transplant|0|||
38022214|NCT00251927|69705580|FG001|Overall Study|Lack of Efficacy|16|||
38022215|NCT00251927|69705579|FG000|Overall Study|Lost to Follow-up|22|||
38022216|NCT00251927|69705580|FG001|Overall Study|Lost to Follow-up|8|||
37912102|NCT02141282|69598924|FG002|Overall Study|Stem cell transplant|1|||
37912103|NCT02141282|69598925|FG003|Overall Study|Stem cell transplant|0|||
37912104|NCT02141282|69598922|FG000|Overall Study|Study terminated by Sponsor|0|||
37912105|NCT02141282|69598923|FG001|Overall Study|Study terminated by Sponsor|1|||
37912106|NCT02141282|69598924|FG002|Overall Study|Study terminated by Sponsor|0|||
37912107|NCT02141282|69598925|FG003|Overall Study|Study terminated by Sponsor|0|||
37912108|NCT02141282|69598922|FG000|Overall Study|Subject non-compliance|0|||
37912109|NCT02141282|69598923|FG001|Overall Study|Subject non-compliance|0|||
37912110|NCT02141282|69598924|FG002|Overall Study|Subject non-compliance|1|||
37912111|NCT02141282|69598925|FG003|Overall Study|Subject non-compliance|0|||
37912112|NCT02141282|69598922|FG000|Overall Study|Withdrew consent|2|||
37912113|NCT02141282|69598923|FG001|Overall Study|Withdrew consent|0|||
37912114|NCT02141282|69598924|FG002|Overall Study|Withdrew consent|4|||
37912115|NCT02141282|69598925|FG003|Overall Study|Withdrew consent|0|||
37912116|NCT00003479|69598938|FG000|Overall Study|Not evaluable|3|||
37912117|NCT00891839|69598942|FG000|Overall Study|Adverse Event|2|||
37912118|NCT00891839|69598942|FG000|Overall Study|Withdrawal by Subject|2|||
37912119|NCT00891839|69598942|FG000|Overall Study|Disease progression|3|||
37912120|NCT00600756|69598948|FG000|Analysis After 6 Months|Adverse Event|43|||
37912121|NCT00600756|69598949|FG001|Analysis After 6 Months|Adverse Event|33|||
37912122|NCT00600756|69598948|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
37912123|NCT00600756|69598949|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
37912124|NCT00600756|69598948|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
37912125|NCT00600756|69598949|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
37912126|NCT00600756|69598948|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
37912127|NCT00600756|69598949|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
37912128|NCT00600756|69598948|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
37912129|NCT00600756|69598949|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
37912130|NCT00600756|69598948|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
37912131|NCT00600756|69598949|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
37912132|NCT00600756|69598948|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
37912133|NCT00600756|69598949|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
37912134|NCT00600756|69598948|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
37912135|NCT00600756|69598949|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
37912136|NCT00600756|69598948|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
37912137|NCT00600756|69598949|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
37912138|NCT00600756|69598948|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
37912139|NCT00600756|69598949|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
37912140|NCT00600756|69598948|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
37912141|NCT00600756|69598949|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
37912142|NCT00600756|69598948|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
37912143|NCT00600756|69598949|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
37912144|NCT00600756|69598948|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
37912145|NCT00600756|69598949|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
37912146|NCT00600756|69598948|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
37912147|NCT00600756|69598949|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
37912148|NCT00890825|69598961|FG000|Overall Study|Withdrawal by Subject|1|||
38022217|NCT00251927|69705579|FG000|Overall Study|Protocol Violation|1|||
38022218|NCT00251927|69705580|FG001|Overall Study|Protocol Violation|2|||
38022219|NCT00251927|69705579|FG000|Overall Study|Pregnancy|2|||
38022220|NCT00251927|69705580|FG001|Overall Study|Pregnancy|0|||
38022221|NCT00251927|69705579|FG000|Overall Study|Withdrawal by Subject|40|||
38022222|NCT00251927|69705580|FG001|Overall Study|Withdrawal by Subject|25|||
37700307|NCT01765192|69177308|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
37700308|NCT01765192|69177309|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
37700309|NCT01733680|69177317|FG000|Overall Study|Withdrawal by Subject|0|||
37912149|NCT00890825|69598962|FG001|Overall Study|Withdrawal by Subject|0|||
37912150|NCT00890825|69598961|FG000|Overall Study|Alive at data cut off (DCO)|13|||
37912151|NCT00890825|69598962|FG001|Overall Study|Alive at data cut off (DCO)|14|||
37912152|NCT00890201|69598970|FG000|Overall Study|Protocol Violation|5|||
37912153|NCT00890201|69598971|FG001|Overall Study|Protocol Violation|56|||
37912154|NCT00891527|69598977|FG000|Overall Study|Withdrawal by Subject|2|||
37912155|NCT03861078|69598982|FG000|Overall Study|COVID-19 shut down|4|||
37912156|NCT03861078|69598982|FG000|Overall Study|Lost to Follow-up|1|||
37912157|NCT03861078|69598982|FG000|Overall Study|Protocol Violation|2|||
37912158|NCT03861078|69598982|FG000|Overall Study|lack of venous access|1|||
37912159|NCT04950465|69599013|FG000|Overall Study|Lost to Follow-up|1|||
37912160|NCT04950465|69599014|FG001|Overall Study|Lost to Follow-up|0|||
37912161|NCT04950465|69599015|FG002|Overall Study|Lost to Follow-up|0|||
37912162|NCT04495816|69599037|FG000|Overall Study|Lost to Follow-up|10|||
37912163|NCT04495816|69599038|FG001|Overall Study|Lost to Follow-up|4|||
37912164|NCT04495816|69599037|FG000|Overall Study|Withdrawal by Subject|3|||
37912165|NCT04495816|69599038|FG001|Overall Study|Withdrawal by Subject|5|||
37912166|NCT04267562|69599053|FG000|Assessed for Eligibility|Screen Failure|64|||
37912167|NCT04267562|69599053|FG000|Assessed for Eligibility|Trial enrollment reached|23|||
37912168|NCT04267562|69599053|FG000|Assessed for Eligibility|Withdrawal by Subject|9|||
37700310|NCT01733680|69177318|FG001|Overall Study|Withdrawal by Subject|1|||
37700311|NCT02336165|69177333|FG000|Overall Study|Death|3|||
37912169|NCT04267562|69599053|FG000|Assessed for Eligibility|Site closure|6|||
37912170|NCT04267562|69599053|FG000|Assessed for Eligibility|Lost to Follow-up|2|||
37912171|NCT04267562|69599053|FG000|Assessed for Eligibility|Physician Decision|1|||
37912172|NCT03891901|69599064|FG000|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|1|||
37912173|NCT03891901|69599065|FG001|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
37912174|NCT03891901|69599066|FG002|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
37912175|NCT03891901|69599067|FG003|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
37912176|NCT03891901|69599068|FG004|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
37912177|NCT03891901|69599069|FG005|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
37912178|NCT03891901|69599070|FG006|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
37912179|NCT03891901|69599071|FG007|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
37912180|NCT03891901|69599072|FG008|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
37912181|NCT03891901|69599064|FG000|Overall Study|Adverse Event|2|||
37912182|NCT03891901|69599065|FG001|Overall Study|Adverse Event|2|||
37912183|NCT03891901|69599066|FG002|Overall Study|Adverse Event|0|||
37912184|NCT03891901|69599067|FG003|Overall Study|Adverse Event|0|||
37912185|NCT03891901|69599068|FG004|Overall Study|Adverse Event|0|||
37912186|NCT03891901|69599069|FG005|Overall Study|Adverse Event|0|||
37912187|NCT03891901|69599070|FG006|Overall Study|Adverse Event|0|||
37912188|NCT03891901|69599071|FG007|Overall Study|Adverse Event|0|||
37912189|NCT03891901|69599072|FG008|Overall Study|Adverse Event|0|||
37912190|NCT03891901|69599064|FG000|Overall Study|Poor venous access|1|||
37912191|NCT03891901|69599065|FG001|Overall Study|Poor venous access|0|||
37912192|NCT03891901|69599066|FG002|Overall Study|Poor venous access|0|||
37912193|NCT03891901|69599067|FG003|Overall Study|Poor venous access|0|||
37912194|NCT03891901|69599068|FG004|Overall Study|Poor venous access|0|||
37912195|NCT03891901|69599069|FG005|Overall Study|Poor venous access|0|||
37912196|NCT03891901|69599070|FG006|Overall Study|Poor venous access|0|||
37912197|NCT03891901|69599071|FG007|Overall Study|Poor venous access|0|||
37912198|NCT03891901|69599072|FG008|Overall Study|Poor venous access|0|||
37912199|NCT03891901|69599064|FG000|Overall Study|Withdrawal by Subject|0|||
37912200|NCT03891901|69599065|FG001|Overall Study|Withdrawal by Subject|2|||
37912201|NCT03891901|69599066|FG002|Overall Study|Withdrawal by Subject|0|||
37912202|NCT03891901|69599067|FG003|Overall Study|Withdrawal by Subject|0|||
37912203|NCT03891901|69599068|FG004|Overall Study|Withdrawal by Subject|0|||
37912204|NCT03891901|69599069|FG005|Overall Study|Withdrawal by Subject|0|||
37912205|NCT03891901|69599070|FG006|Overall Study|Withdrawal by Subject|0|||
37912206|NCT03891901|69599071|FG007|Overall Study|Withdrawal by Subject|0|||
37912207|NCT03891901|69599072|FG008|Overall Study|Withdrawal by Subject|0|||
37912208|NCT03827018|69599084|FG000|Overall Study|Adverse Event|1|||
37912209|NCT03827018|69599085|FG001|Overall Study|Adverse Event|0|||
37834283|NCT03775486|69518139|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
37834284|NCT03775486|69518140|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
37912210|NCT03827018|69599084|FG000|Overall Study|Withdrawal by Subject|2|||
37912211|NCT03827018|69599085|FG001|Overall Study|Withdrawal by Subject|2|||
37912212|NCT03827018|69599084|FG000|Overall Study|Lack of Efficacy|0|||
37912213|NCT03827018|69599085|FG001|Overall Study|Lack of Efficacy|1|||
37834285|NCT03775486|69518139|FG000|Initial Therapy Phase|Protocol Violation|0|||
37834286|NCT03775486|69518140|FG001|Initial Therapy Phase|Protocol Violation|2|||
37834287|NCT03775486|69518139|FG000|Initial Therapy Phase|Adverse Event|0|||
37834288|NCT03775486|69518140|FG001|Initial Therapy Phase|Adverse Event|34|||
37834289|NCT03775486|69518139|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
37834290|NCT03775486|69518140|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
37834291|NCT03775486|69518139|FG000|Maintenance Phase|Withdrawal by Subject|13|||
37912214|NCT03635424|69599100|FG000|Overall Study|Adverse Event|1|||
37912215|NCT03635424|69599100|FG000|Overall Study|Death|1|||
37912216|NCT03635424|69599100|FG000|Overall Study|Device not implanted|1|||
37912217|NCT03575325|69599113|FG000|Overall Study|Death|1|||
38022223|NCT00251927|69705579|FG000|Overall Study|Study-specific discont. achieved|13|||
38022224|NCT00251927|69705580|FG001|Overall Study|Study-specific discont. achieved|2|||
37834292|NCT03775486|69518140|FG001|Maintenance Phase|Withdrawal by Subject|12|||
37834293|NCT03775486|69518139|FG000|Maintenance Phase|Death|44|||
37834294|NCT03775486|69518140|FG001|Maintenance Phase|Death|45|||
37834295|NCT03769181|69518151|FG000|Overall Study|Adverse Event|1|||
37834296|NCT03769181|69518152|FG001|Overall Study|Adverse Event|0|||
37912218|NCT03439254|69599122|FG000|Double-blind Phase (18 Months)|Adverse Event|11|||
37912219|NCT03439254|69599123|FG001|Double-blind Phase (18 Months)|Adverse Event|12|||
37912220|NCT03439254|69599124|FG002|Double-blind Phase (18 Months)|Adverse Event|15|||
37912221|NCT03439254|69599125|FG003|Double-blind Phase (18 Months)|Adverse Event|0|||
37912222|NCT03439254|69599126|FG004|Double-blind Phase (18 Months)|Adverse Event|0|||
37912223|NCT03439254|69599127|FG005|Double-blind Phase (18 Months)|Adverse Event|0|||
37912224|NCT03439254|69599122|FG000|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|1|||
37912225|NCT03439254|69599123|FG001|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
37912226|NCT03439254|69599124|FG002|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
37912227|NCT03439254|69599125|FG003|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
37912228|NCT03439254|69599126|FG004|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
37912229|NCT03439254|69599127|FG005|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
37912230|NCT03439254|69599122|FG000|Double-blind Phase (18 Months)|Death|1|||
37912231|NCT03439254|69599123|FG001|Double-blind Phase (18 Months)|Death|2|||
37912232|NCT03439254|69599124|FG002|Double-blind Phase (18 Months)|Death|2|||
37912233|NCT03439254|69599125|FG003|Double-blind Phase (18 Months)|Death|0|||
37912234|NCT03439254|69599126|FG004|Double-blind Phase (18 Months)|Death|0|||
37912235|NCT03439254|69599127|FG005|Double-blind Phase (18 Months)|Death|0|||
37912236|NCT03439254|69599122|FG000|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
37912237|NCT03439254|69599123|FG001|Double-blind Phase (18 Months)|Lost to Follow-up|1|||
37912238|NCT03439254|69599124|FG002|Double-blind Phase (18 Months)|Lost to Follow-up|5|||
37912239|NCT03439254|69599125|FG003|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
37912240|NCT03439254|69599126|FG004|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
37912241|NCT03439254|69599127|FG005|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
37912242|NCT03439254|69599122|FG000|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|1|||
37912243|NCT03439254|69599123|FG001|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
37912244|NCT03439254|69599124|FG002|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
37912245|NCT03439254|69599125|FG003|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
37912246|NCT03439254|69599126|FG004|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
37912247|NCT03439254|69599127|FG005|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
37834297|NCT03769181|69518153|FG002|Overall Study|Adverse Event|2|||
37834298|NCT03769181|69518154|FG003|Overall Study|Adverse Event|4|||
37834299|NCT03769181|69518151|FG000|Overall Study|Withdrawal by Subject|1|||
37834300|NCT03769181|69518152|FG001|Overall Study|Withdrawal by Subject|0|||
37834301|NCT03769181|69518153|FG002|Overall Study|Withdrawal by Subject|2|||
37834302|NCT03769181|69518154|FG003|Overall Study|Withdrawal by Subject|1|||
37834303|NCT03769181|69518151|FG000|Overall Study|Progressive disease|9|||
37834304|NCT03769181|69518152|FG001|Overall Study|Progressive disease|7|||
37834305|NCT03769181|69518153|FG002|Overall Study|Progressive disease|13|||
37834306|NCT03769181|69518154|FG003|Overall Study|Progressive disease|6|||
37912248|NCT03439254|69599122|FG000|Double-blind Phase (18 Months)|Participant moved to Kansas|1|||
38022225|NCT00251927|69705579|FG000|Overall Study|Study procedure non-compliance|5|||
38022226|NCT00251927|69705580|FG001|Overall Study|Study procedure non-compliance|6|||
38022227|NCT00165503|69705587|FG000|Overall Study|Death|1|||
38022228|NCT00165503|69705587|FG000|Overall Study|Lost to Follow-up|12|||
37834307|NCT03769181|69518151|FG000|Overall Study|Other - Unspecified|2|||
37834308|NCT03769181|69518152|FG001|Overall Study|Other - Unspecified|1|||
37834309|NCT03769181|69518153|FG002|Overall Study|Other - Unspecified|0|||
38022229|NCT00165503|69705587|FG000|Overall Study|Unresectable|3|||
38022230|NCT00162773|69705591|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
38022231|NCT00209339|69705595|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
38022232|NCT00209339|69705595|FG000|At 12 Months Follow-up|Death|1|||
38022233|NCT00209339|69705595|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
38022234|NCT00209339|69705595|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
37912249|NCT03439254|69599123|FG001|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
38022235|NCT00209339|69705595|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
38022236|NCT00209339|69705595|FG000|At 24 Months Follow-up|Death|1|||
38022237|NCT00209339|69705595|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
38022238|NCT00209339|69705595|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
38022239|NCT00209339|69705595|FG000|At 4 Years Follow-up|Death|1|||
38022240|NCT00209339|69705595|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
38022241|NCT00209339|69705595|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
37912250|NCT03439254|69599124|FG002|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
37912251|NCT03439254|69599125|FG003|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
37912252|NCT03439254|69599126|FG004|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
37912253|NCT03439254|69599127|FG005|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
37912254|NCT03439254|69599122|FG000|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|1|||
37912255|NCT03439254|69599123|FG001|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
37912256|NCT03439254|69599124|FG002|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
37912257|NCT03439254|69599125|FG003|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
37912258|NCT03439254|69599126|FG004|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
37834310|NCT03769181|69518154|FG003|Overall Study|Other - Unspecified|0|||
37834311|NCT03621696|69518197|FG000|Overall Study|Not eligible|0|||
37834312|NCT03621696|69518198|FG001|Overall Study|Not eligible|0|||
37834313|NCT03621696|69518199|FG002|Overall Study|Not eligible|0|||
37912259|NCT03439254|69599127|FG005|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
37912260|NCT03439254|69599122|FG000|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
37912261|NCT03439254|69599123|FG001|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|1|||
37912262|NCT03439254|69599124|FG002|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
37912263|NCT03439254|69599125|FG003|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
37912264|NCT03439254|69599126|FG004|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
37912265|NCT03439254|69599127|FG005|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
37912266|NCT03439254|69599122|FG000|Double-blind Phase (18 Months)|Drug Holiday|0|||
37834314|NCT03621696|69518200|FG003|Overall Study|Not eligible|5|||
37834315|NCT03621696|69518197|FG000|Overall Study|Withdrawal by Subject|1|||
37834316|NCT03621696|69518198|FG001|Overall Study|Withdrawal by Subject|1|||
37834317|NCT03621696|69518199|FG002|Overall Study|Withdrawal by Subject|1|||
37834318|NCT03621696|69518200|FG003|Overall Study|Withdrawal by Subject|0|||
37834319|NCT03621696|69518197|FG000|Overall Study|Physician Decision|0|||
37834320|NCT03621696|69518198|FG001|Overall Study|Physician Decision|0|||
37834321|NCT03621696|69518199|FG002|Overall Study|Physician Decision|1|||
37834322|NCT03621696|69518200|FG003|Overall Study|Physician Decision|0|||
37834323|NCT03594747|69518211|FG000|Overall Study|Remain on study at the time of data cut off|69|||
37834324|NCT03594747|69518212|FG001|Overall Study|Remain on study at the time of data cut off|67|||
37834325|NCT03594747|69518213|FG002|Overall Study|Remain on study at the time of data cut off|53|||
37834326|NCT03594747|69518211|FG000|Overall Study|Death|48|||
37834327|NCT03594747|69518212|FG001|Overall Study|Death|47|||
37834328|NCT03594747|69518213|FG002|Overall Study|Death|52|||
37834329|NCT03594747|69518211|FG000|Overall Study|Withdrawal by Subject|3|||
37834330|NCT03594747|69518212|FG001|Overall Study|Withdrawal by Subject|4|||
37834331|NCT03594747|69518213|FG002|Overall Study|Withdrawal by Subject|14|||
37834332|NCT03594747|69518211|FG000|Overall Study|Lost to Follow-up|0|||
37834333|NCT03594747|69518212|FG001|Overall Study|Lost to Follow-up|0|||
37834334|NCT03594747|69518213|FG002|Overall Study|Lost to Follow-up|1|||
37834335|NCT03594747|69518211|FG000|Overall Study|Physician Decision|0|||
37834336|NCT03594747|69518212|FG001|Overall Study|Physician Decision|1|||
37834337|NCT03594747|69518213|FG002|Overall Study|Physician Decision|0|||
37834338|NCT03594747|69518211|FG000|Overall Study|Did not meet inclusion criteria|0|||
37834339|NCT03594747|69518212|FG001|Overall Study|Did not meet inclusion criteria|0|||
37834340|NCT03594747|69518213|FG002|Overall Study|Did not meet inclusion criteria|1|||
37834341|NCT03592641|69518221|FG000|Overall Study|Withdrawal by Subject|1|||
37834342|NCT03468985|69518229|FG000|Overall Study|Adverse Event|0|||
37834343|NCT03468985|69518230|FG001|Overall Study|Adverse Event|2|||
37834344|NCT03468985|69518231|FG002|Overall Study|Adverse Event|0|||
37834345|NCT03468985|69518232|FG003|Overall Study|Adverse Event|0|||
37834346|NCT03468985|69518229|FG000|Overall Study|Withdrawal by Subject|0|||
37834347|NCT03468985|69518230|FG001|Overall Study|Withdrawal by Subject|0|||
37834348|NCT03468985|69518231|FG002|Overall Study|Withdrawal by Subject|0|||
37834349|NCT03468985|69518232|FG003|Overall Study|Withdrawal by Subject|1|||
37834350|NCT03434418|69518251|FG000|Overall Study|Disease Progression|11|||
37834351|NCT03434418|69518251|FG000|Overall Study|Adverse Event|2|||
37834352|NCT03434418|69518251|FG000|Overall Study|Physician Decision|1|||
37834353|NCT03434418|69518251|FG000|Overall Study|Decline in Performance Status (PS)|1|||
37834354|NCT03366103|69518266|FG000|Overall Study|Disease Progression|3|||
37834355|NCT03366103|69518267|FG001|Overall Study|Disease Progression|1|||
37834356|NCT03366103|69518268|FG002|Overall Study|Disease Progression|0|||
37834357|NCT03366103|69518266|FG000|Overall Study|Adverse Event|0|||
37834358|NCT03366103|69518267|FG001|Overall Study|Adverse Event|1|||
37834359|NCT03366103|69518268|FG002|Overall Study|Adverse Event|0|||
37834360|NCT03253679|69518279|FG000|Overall Study|Screen Failure|1|||
37834361|NCT03099148|69518300|FG000|Wash-out|scheduling conflict|0|||
37834362|NCT03099148|69518301|FG001|Wash-out|scheduling conflict|1|||
37834363|NCT03099148|69518302|FG002|Wash-out|scheduling conflict|0|||
37834364|NCT03099148|69518303|FG003|Wash-out|scheduling conflict|0|||
37834365|NCT03099148|69518300|FG000|Wash-out|Adverse Event|0|||
37834366|NCT03099148|69518301|FG001|Wash-out|Adverse Event|1|||
37834367|NCT03099148|69518302|FG002|Wash-out|Adverse Event|0|||
37834368|NCT03099148|69518303|FG003|Wash-out|Adverse Event|0|||
37834369|NCT03091192|69518316|FG000|Overall Study|Study terminated by sponsor|21|||
37834370|NCT03091192|69518317|FG001|Overall Study|Study terminated by sponsor|14|||
37834371|NCT03091192|69518316|FG000|Overall Study|Death|9|||
37834372|NCT03091192|69518317|FG001|Overall Study|Death|13|||
37834373|NCT03091192|69518316|FG000|Overall Study|Withdrawal by Subject|2|||
37834374|NCT03091192|69518317|FG001|Overall Study|Withdrawal by Subject|0|||
37834375|NCT03091192|69518316|FG000|Overall Study|Lost to Follow-up|1|||
37834376|NCT03091192|69518317|FG001|Overall Study|Lost to Follow-up|0|||
37834377|NCT03088813|69518327|FG000|Part 1: Dose Evaluation (Up to Week 172)|Lost to Follow-up|0|||
37834378|NCT03088813|69518328|FG001|Part 1: Dose Evaluation (Up to Week 172)|Lost to Follow-up|1|||
37834379|NCT03088813|69518329|FG002|Part 1: Dose Evaluation (Up to Week 172)|Lost to Follow-up|0|||
37912267|NCT03439254|69599123|FG001|Double-blind Phase (18 Months)|Drug Holiday|0|||
37912268|NCT03439254|69599124|FG002|Double-blind Phase (18 Months)|Drug Holiday|1|||
37912269|NCT03439254|69599125|FG003|Double-blind Phase (18 Months)|Drug Holiday|0|||
37912270|NCT03439254|69599126|FG004|Double-blind Phase (18 Months)|Drug Holiday|0|||
37912271|NCT03439254|69599127|FG005|Double-blind Phase (18 Months)|Drug Holiday|0|||
37912272|NCT03439254|69599122|FG000|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
37912273|NCT03439254|69599123|FG001|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
37912274|NCT03439254|69599124|FG002|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|1|||
37912275|NCT03439254|69599125|FG003|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
37912276|NCT03439254|69599126|FG004|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
37912277|NCT03439254|69599127|FG005|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
37912278|NCT03439254|69599122|FG000|Double-blind Phase (18 Months)|Site closure|0|||
37912279|NCT03439254|69599123|FG001|Double-blind Phase (18 Months)|Site closure|0|||
37912280|NCT03439254|69599124|FG002|Double-blind Phase (18 Months)|Site closure|1|||
37834380|NCT03088813|69518330|FG003|Part 1: Dose Evaluation (Up to Week 172)|Lost to Follow-up|0|||
37834381|NCT03088813|69518327|FG000|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
37834382|NCT03088813|69518328|FG001|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|1|||
37834383|NCT03088813|69518329|FG002|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
37834384|NCT03088813|69518330|FG003|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
37834385|NCT03088813|69518327|FG000|Part 1: Dose Evaluation (Up to Week 172)|Ongoing|1|||
37834386|NCT03088813|69518328|FG001|Part 1: Dose Evaluation (Up to Week 172)|Ongoing|1|||
37912281|NCT03439254|69599125|FG003|Double-blind Phase (18 Months)|Site closure|0|||
37912282|NCT03439254|69599126|FG004|Double-blind Phase (18 Months)|Site closure|0|||
37912283|NCT03439254|69599127|FG005|Double-blind Phase (18 Months)|Site closure|0|||
37912284|NCT03439254|69599122|FG000|Double-blind Phase (18 Months)|Physician Decision|0|||
37912285|NCT03439254|69599123|FG001|Double-blind Phase (18 Months)|Physician Decision|0|||
37912286|NCT03439254|69599124|FG002|Double-blind Phase (18 Months)|Physician Decision|1|||
37912287|NCT03439254|69599125|FG003|Double-blind Phase (18 Months)|Physician Decision|0|||
37912288|NCT03439254|69599126|FG004|Double-blind Phase (18 Months)|Physician Decision|0|||
37912289|NCT03439254|69599127|FG005|Double-blind Phase (18 Months)|Physician Decision|0|||
37912290|NCT03439254|69599122|FG000|Double-blind Phase (18 Months)|Progressive Disease|1|||
37912291|NCT03439254|69599123|FG001|Double-blind Phase (18 Months)|Progressive Disease|0|||
37912292|NCT03439254|69599124|FG002|Double-blind Phase (18 Months)|Progressive Disease|0|||
37912293|NCT03439254|69599125|FG003|Double-blind Phase (18 Months)|Progressive Disease|0|||
37912294|NCT03439254|69599126|FG004|Double-blind Phase (18 Months)|Progressive Disease|0|||
37912295|NCT03439254|69599127|FG005|Double-blind Phase (18 Months)|Progressive Disease|0|||
37912296|NCT03439254|69599122|FG000|Double-blind Phase (18 Months)|Withdrawal by Subject|12|||
37912297|NCT03439254|69599123|FG001|Double-blind Phase (18 Months)|Withdrawal by Subject|6|||
37834387|NCT03088813|69518329|FG002|Part 1: Dose Evaluation (Up to Week 172)|Ongoing|0|||
37834388|NCT03088813|69518330|FG003|Part 1: Dose Evaluation (Up to Week 172)|Ongoing|0|||
37834389|NCT03088813|69518327|FG000|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
37834390|NCT03088813|69518328|FG001|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
37834391|NCT03088813|69518329|FG002|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|1|||
37834392|NCT03088813|69518330|FG003|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
37834393|NCT03088813|69518327|FG000|Part 2: Randomized Study (Upto Week 197)|Physician Decision|0|||
37834394|NCT03088813|69518328|FG001|Part 2: Randomized Study (Upto Week 197)|Physician Decision|0|||
37834395|NCT03088813|69518329|FG002|Part 2: Randomized Study (Upto Week 197)|Physician Decision|2|||
37834396|NCT03088813|69518330|FG003|Part 2: Randomized Study (Upto Week 197)|Physician Decision|2|||
37834397|NCT03088813|69518327|FG000|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
37834398|NCT03088813|69518328|FG001|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
37834399|NCT03088813|69518329|FG002|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|2|||
37834400|NCT03088813|69518330|FG003|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|3|||
37834401|NCT03088813|69518327|FG000|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
37834402|NCT03088813|69518328|FG001|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
37912298|NCT03439254|69599124|FG002|Double-blind Phase (18 Months)|Withdrawal by Subject|9|||
37912299|NCT03439254|69599125|FG003|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
37912300|NCT03439254|69599126|FG004|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
37912301|NCT03439254|69599127|FG005|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
37912302|NCT03439254|69599122|FG000|Open Label Extension Phase (12 Months)|Adverse Event|0|||
37912303|NCT03439254|69599123|FG001|Open Label Extension Phase (12 Months)|Adverse Event|0|||
37912304|NCT03439254|69599124|FG002|Open Label Extension Phase (12 Months)|Adverse Event|0|||
37912305|NCT03439254|69599125|FG003|Open Label Extension Phase (12 Months)|Adverse Event|8|||
37912306|NCT03439254|69599126|FG004|Open Label Extension Phase (12 Months)|Adverse Event|5|||
37912307|NCT03439254|69599127|FG005|Open Label Extension Phase (12 Months)|Adverse Event|7|||
37912308|NCT03439254|69599122|FG000|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
37912309|NCT03439254|69599123|FG001|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
37912310|NCT03439254|69599124|FG002|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
37834403|NCT03088813|69518329|FG002|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|18|||
37834404|NCT03088813|69518330|FG003|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|12|||
37834405|NCT03088813|69518327|FG000|Part 2: Randomized Study (Upto Week 197)|Ongoing in follow-up|0|||
37834406|NCT03088813|69518328|FG001|Part 2: Randomized Study (Upto Week 197)|Ongoing in follow-up|0|||
37834407|NCT03088813|69518329|FG002|Part 2: Randomized Study (Upto Week 197)|Ongoing in follow-up|20|||
37834408|NCT03088813|69518330|FG003|Part 2: Randomized Study (Upto Week 197)|Ongoing in follow-up|37|||
37834409|NCT03088813|69518327|FG000|Part 2: Randomized Study (Upto Week 197)|Ongoing on treatment|0|||
37834410|NCT03088813|69518328|FG001|Part 2: Randomized Study (Upto Week 197)|Ongoing on treatment|0|||
37834411|NCT03088813|69518329|FG002|Part 2: Randomized Study (Upto Week 197)|Ongoing on treatment|7|||
37834412|NCT03088813|69518330|FG003|Part 2: Randomized Study (Upto Week 197)|Ongoing on treatment|3|||
37834413|NCT03088813|69518327|FG000|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
37834414|NCT03088813|69518328|FG001|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
37834415|NCT03088813|69518329|FG002|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
37834416|NCT03088813|69518330|FG003|Part 2: Randomized Study (Upto Week 197)|Screen failure|1|||
37834417|NCT03061474|69518343|FG000|Overall Study|Adverse Event|2|||
37834418|NCT03061474|69518344|FG001|Overall Study|Adverse Event|0|||
37834419|NCT03061474|69518343|FG000|Overall Study|Safety Risk|0|||
37834420|NCT03061474|69518344|FG001|Overall Study|Safety Risk|1|||
37834421|NCT03061474|69518343|FG000|Overall Study|Participant unwilling or unable to participate|0|||
37834422|NCT03061474|69518344|FG001|Overall Study|Participant unwilling or unable to participate|2|||
37834423|NCT03061474|69518343|FG000|Overall Study|Lost to Follow-up|0|||
37834424|NCT03061474|69518344|FG001|Overall Study|Lost to Follow-up|1|||
37834425|NCT03040726|69518352|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|4|||
37834426|NCT03040726|69518353|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|0|||
37834427|NCT03040726|69518352|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
37834428|NCT03040726|69518353|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
37834429|NCT03040726|69518352|FG000|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|4|||
37834430|NCT03040726|69518353|FG001|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|3|||
37912311|NCT03439254|69599125|FG003|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
37912312|NCT03439254|69599126|FG004|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
37912313|NCT03439254|69599127|FG005|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
37912314|NCT03439254|69599122|FG000|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
37912315|NCT03439254|69599123|FG001|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
37912316|NCT03439254|69599124|FG002|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
37912317|NCT03439254|69599125|FG003|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
37912318|NCT03439254|69599126|FG004|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
37912319|NCT03439254|69599127|FG005|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|1|||
37912320|NCT03439254|69599122|FG000|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
37912321|NCT03439254|69599123|FG001|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
37912322|NCT03439254|69599124|FG002|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
37912323|NCT03439254|69599125|FG003|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
37912324|NCT03439254|69599126|FG004|Open Label Extension Phase (12 Months)|Lost to Follow-up|2|||
37912325|NCT03439254|69599127|FG005|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
37912326|NCT03439254|69599122|FG000|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
37912327|NCT03439254|69599123|FG001|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
37912328|NCT03439254|69599124|FG002|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
37912329|NCT03439254|69599125|FG003|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
37912330|NCT03439254|69599126|FG004|Open Label Extension Phase (12 Months)|Increase CR from Baseline|1|||
37912331|NCT03439254|69599127|FG005|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
37912332|NCT03439254|69599122|FG000|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
37912333|NCT03439254|69599123|FG001|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
37912334|NCT03439254|69599124|FG002|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
37912335|NCT03439254|69599125|FG003|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
37912336|NCT03439254|69599126|FG004|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
37912337|NCT03439254|69599127|FG005|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|1|||
37912338|NCT03439254|69599122|FG000|Open Label Extension Phase (12 Months)|Physician Decision|0|||
37912339|NCT03439254|69599123|FG001|Open Label Extension Phase (12 Months)|Physician Decision|0|||
37912340|NCT03439254|69599124|FG002|Open Label Extension Phase (12 Months)|Physician Decision|0|||
37912341|NCT03439254|69599125|FG003|Open Label Extension Phase (12 Months)|Physician Decision|1|||
37912342|NCT03439254|69599126|FG004|Open Label Extension Phase (12 Months)|Physician Decision|0|||
37912343|NCT03439254|69599127|FG005|Open Label Extension Phase (12 Months)|Physician Decision|0|||
37912344|NCT03439254|69599122|FG000|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
38022242|NCT00209339|69705595|FG000|At 5 Years Follow-up|Death|1|||
37912345|NCT03439254|69599123|FG001|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
37834431|NCT03040726|69518352|FG000|Overall Study|Reasons for not completing Blinded phase: Hospitalization|0|||
37834432|NCT03040726|69518353|FG001|Overall Study|Reasons for not completing Blinded phase: Hospitalization|2|||
37834433|NCT03040726|69518352|FG000|Overall Study|Reasons for not completing Blinded phase : Withdrawal|1|||
37834434|NCT03040726|69518353|FG001|Overall Study|Reasons for not completing Blinded phase : Withdrawal|0|||
37912346|NCT03439254|69599124|FG002|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
37912347|NCT03439254|69599125|FG003|Open Label Extension Phase (12 Months)|Progressive Disease|1|||
37912348|NCT03439254|69599126|FG004|Open Label Extension Phase (12 Months)|Progressive Disease|2|||
37912349|NCT03439254|69599127|FG005|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
37912350|NCT03439254|69599122|FG000|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
37912351|NCT03439254|69599123|FG001|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
37912352|NCT03439254|69599124|FG002|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
37912353|NCT03439254|69599125|FG003|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
37912354|NCT03439254|69599126|FG004|Open Label Extension Phase (12 Months)|Withdrawal by Subject|3|||
37912355|NCT03439254|69599127|FG005|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
37912356|NCT03434379|69599143|FG000|Global Period|Lost to Follow-up|3|||
37912357|NCT03434379|69599144|FG001|Global Period|Lost to Follow-up|6|||
37834435|NCT02899728|69518362|FG000|Overall Study|Withdrawal by Subject|1|||
37834436|NCT02899728|69518363|FG001|Overall Study|Withdrawal by Subject|1|||
37912358|NCT03434379|69599145|FG002|Global Period|Lost to Follow-up|0|||
37912359|NCT03434379|69599146|FG003|Global Period|Lost to Follow-up|0|||
37912360|NCT03434379|69599143|FG000|Global Period|Death|115|||
37912361|NCT03434379|69599144|FG001|Global Period|Death|228|||
37912362|NCT03434379|69599145|FG002|Global Period|Death|0|||
37912363|NCT03434379|69599146|FG003|Global Period|Death|0|||
37912364|NCT03434379|69599143|FG000|Global Period|Withdrawal by Subject|20|||
37834437|NCT02899065|69518371|FG000|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|1|||
37834438|NCT02899065|69518372|FG001|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|5|||
37834439|NCT02899065|69518371|FG000|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|3|||
37834440|NCT02899065|69518372|FG001|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|0|||
37834441|NCT02899065|69518371|FG000|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|21|||
37834442|NCT02899065|69518372|FG001|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|16|||
37834443|NCT02893930|69518378|FG000|Overall Study|Adverse Event|3|||
37834444|NCT02893930|69518378|FG000|Overall Study|Death|1|||
37834445|NCT02893930|69518378|FG000|Overall Study|Disease progression|5|||
37834446|NCT02893930|69518378|FG000|Overall Study|Withdrawal by Subject|2|||
37834447|NCT02893930|69518378|FG000|Overall Study|Physician Decision|1|||
37834448|NCT02893930|69518378|FG000|Overall Study|Ineligible|1|||
37834449|NCT02873195|69518384|FG000|Overall Study|Ineligible|5|||
37834450|NCT02873195|69518385|FG001|Overall Study|Ineligible|0|||
37834451|NCT02780804|69518394|FG000|Overall Study|Death|1|||
37834452|NCT02780804|69518395|FG001|Overall Study|Death|0|||
37834453|NCT02780804|69518396|FG002|Overall Study|Death|0|||
37834454|NCT02780804|69518394|FG000|Overall Study|Lack of Efficacy|5|||
37834455|NCT02780804|69518395|FG001|Overall Study|Lack of Efficacy|8|||
37834456|NCT02780804|69518396|FG002|Overall Study|Lack of Efficacy|4|||
37834457|NCT02780804|69518394|FG000|Overall Study|Physician Decision|0|||
37834458|NCT02780804|69518395|FG001|Overall Study|Physician Decision|0|||
37834459|NCT02780804|69518396|FG002|Overall Study|Physician Decision|2|||
37834460|NCT02780804|69518394|FG000|Overall Study|Withdrawal by Subject|0|||
37912365|NCT03434379|69599144|FG001|Global Period|Withdrawal by Subject|21|||
37912366|NCT03434379|69599145|FG002|Global Period|Withdrawal by Subject|0|||
37912367|NCT03434379|69599146|FG003|Global Period|Withdrawal by Subject|0|||
37912368|NCT03434379|69599143|FG000|Global Period|Reason Unspecified|0|||
37912369|NCT03434379|69599144|FG001|Global Period|Reason Unspecified|1|||
37912370|NCT03434379|69599145|FG002|Global Period|Reason Unspecified|0|||
37912371|NCT03434379|69599146|FG003|Global Period|Reason Unspecified|0|||
37912372|NCT03434379|69599143|FG000|Global Period|Study Ended by Sponsor|26|||
37912373|NCT03434379|69599144|FG001|Global Period|Study Ended by Sponsor|80|||
37912374|NCT03434379|69599145|FG002|Global Period|Study Ended by Sponsor|0|||
37912375|NCT03434379|69599146|FG003|Global Period|Study Ended by Sponsor|0|||
37912376|NCT03434379|69599143|FG000|Global Period|Physician Decision|1|||
37912377|NCT03434379|69599144|FG001|Global Period|Physician Decision|0|||
37912378|NCT03434379|69599145|FG002|Global Period|Physician Decision|0|||
37834461|NCT02780804|69518395|FG001|Overall Study|Withdrawal by Subject|1|||
37834462|NCT02780804|69518396|FG002|Overall Study|Withdrawal by Subject|0|||
37834463|NCT02629393|69518405|FG000|Overall Study|MOCD Type A not genetically confirmed|2|||
37834464|NCT02629393|69518405|FG000|Overall Study|Physician Decision|1|||
37912379|NCT03434379|69599146|FG003|Global Period|Physician Decision|0|||
37912380|NCT03434379|69599143|FG000|China Extension Period|Lost to Follow-up|0|||
37912381|NCT03434379|69599144|FG001|China Extension Period|Lost to Follow-up|0|||
37912382|NCT03434379|69599145|FG002|China Extension Period|Lost to Follow-up|2|||
37912383|NCT03434379|69599146|FG003|China Extension Period|Lost to Follow-up|3|||
37834465|NCT02500797|69518452|FG000|Overall Study|Cancel (rapid disease progression)|0|||
37834466|NCT02500797|69518453|FG001|Overall Study|Cancel (rapid disease progression)|0|||
37834467|NCT02500797|69518454|FG002|Overall Study|Cancel (rapid disease progression)|0|||
37834468|NCT02500797|69518455|FG003|Overall Study|Cancel (rapid disease progression)|0|||
37834469|NCT02500797|69518456|FG004|Overall Study|Cancel (rapid disease progression)|1|||
37834470|NCT02500797|69518457|FG005|Overall Study|Cancel (rapid disease progression)|1|||
37834471|NCT02500797|69518458|FG006|Overall Study|Cancel (rapid disease progression)|0|||
37834472|NCT02500797|69518459|FG007|Overall Study|Cancel (rapid disease progression)|0|||
37834473|NCT02500797|69518452|FG000|Overall Study|Withdrawal by Subject|1|||
37834474|NCT02500797|69518453|FG001|Overall Study|Withdrawal by Subject|0|||
37834475|NCT02500797|69518454|FG002|Overall Study|Withdrawal by Subject|0|||
37834476|NCT02500797|69518455|FG003|Overall Study|Withdrawal by Subject|0|||
37834477|NCT02500797|69518456|FG004|Overall Study|Withdrawal by Subject|0|||
37834478|NCT02500797|69518457|FG005|Overall Study|Withdrawal by Subject|0|||
37912384|NCT03434379|69599143|FG000|China Extension Period|Death|0|||
37912385|NCT03434379|69599144|FG001|China Extension Period|Death|0|||
37912386|NCT03434379|69599145|FG002|China Extension Period|Death|46|||
37912387|NCT03434379|69599146|FG003|China Extension Period|Death|88|||
37912388|NCT03434379|69599143|FG000|China Extension Period|Withdrawal by Subject|0|||
37834479|NCT02500797|69518458|FG006|Overall Study|Withdrawal by Subject|0|||
37834480|NCT02500797|69518459|FG007|Overall Study|Withdrawal by Subject|0|||
37834481|NCT02017704|69518492|FG000|Overall Study|Withdrawal by Subject|2|||
37834482|NCT02017704|69518493|FG001|Overall Study|Withdrawal by Subject|0|||
37834483|NCT02005471|69518503|FG000|Main Study|Adverse Event|0|||
37834484|NCT02005471|69518504|FG001|Main Study|Adverse Event|1|||
37834485|NCT02005471|69518505|FG002|Main Study|Adverse Event|0|||
37912389|NCT03434379|69599144|FG001|China Extension Period|Withdrawal by Subject|0|||
37834486|NCT02005471|69518506|FG003|Main Study|Adverse Event|0|||
37834487|NCT02005471|69518503|FG000|Main Study|Death|83|||
37834488|NCT02005471|69518504|FG001|Main Study|Death|52|||
37912390|NCT03434379|69599145|FG002|China Extension Period|Withdrawal by Subject|8|||
37912391|NCT03434379|69599146|FG003|China Extension Period|Withdrawal by Subject|6|||
37912392|NCT03434379|69599143|FG000|China Extension Period|Study Ended by Sponsor|0|||
37912393|NCT03434379|69599144|FG001|China Extension Period|Study Ended by Sponsor|0|||
37912394|NCT03434379|69599145|FG002|China Extension Period|Study Ended by Sponsor|5|||
37912395|NCT03434379|69599146|FG003|China Extension Period|Study Ended by Sponsor|36|||
37912396|NCT03309046|69599160|FG000|Overall Study|Withdrawal by Subject|4|||
37912397|NCT03309046|69599161|FG001|Overall Study|Withdrawal by Subject|17|||
37912398|NCT03228186|69599167|FG000|Overall Study|Patient never started treatment|1|||
37912399|NCT02872116|69599174|FG000|Pre-Treatment|Disease Progression|0|||
37912400|NCT02872116|69599175|FG001|Pre-Treatment|Disease Progression|1|||
37912401|NCT02872116|69599176|FG002|Pre-Treatment|Disease Progression|0|||
37912402|NCT02872116|69599174|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
37912403|NCT02872116|69599175|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
37912404|NCT02872116|69599176|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
37912405|NCT02872116|69599174|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
37912406|NCT02872116|69599175|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
37912407|NCT02872116|69599176|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
37912408|NCT02872116|69599174|FG000|Pre-Treatment|Participant withdrew consent|2|||
37912409|NCT02872116|69599175|FG001|Pre-Treatment|Participant withdrew consent|20|||
37912410|NCT02872116|69599176|FG002|Pre-Treatment|Participant withdrew consent|3|||
37912411|NCT02872116|69599174|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
37912412|NCT02872116|69599175|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
37912413|NCT02872116|69599176|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
37912414|NCT02872116|69599174|FG000|Pre-Treatment|Other reasons|1|||
37912415|NCT02872116|69599175|FG001|Pre-Treatment|Other reasons|2|||
37912416|NCT02872116|69599176|FG002|Pre-Treatment|Other reasons|2|||
37912417|NCT02872116|69599174|FG000|Treatment|Death|122|||
37912418|NCT02872116|69599175|FG001|Treatment|Death|94|||
37912419|NCT02872116|69599176|FG002|Treatment|Death|68|||
37912420|NCT02872116|69599174|FG000|Treatment|Lost to Follow-up|5|||
37912421|NCT02872116|69599175|FG001|Treatment|Lost to Follow-up|7|||
37912422|NCT02872116|69599176|FG002|Treatment|Lost to Follow-up|3|||
37912423|NCT02872116|69599174|FG000|Treatment|Participant withdrew consent|20|||
37912424|NCT02872116|69599175|FG001|Treatment|Participant withdrew consent|40|||
37912425|NCT02872116|69599176|FG002|Treatment|Participant withdrew consent|8|||
37912426|NCT02872116|69599174|FG000|Treatment|Other reasons|12|||
37834489|NCT02005471|69518505|FG002|Main Study|Death|0|||
37834490|NCT02005471|69518506|FG003|Main Study|Death|0|||
37834491|NCT02005471|69518503|FG000|Main Study|Lost to Follow-up|4|||
37834492|NCT02005471|69518504|FG001|Main Study|Lost to Follow-up|5|||
37834493|NCT02005471|69518505|FG002|Main Study|Lost to Follow-up|0|||
37834494|NCT02005471|69518506|FG003|Main Study|Lost to Follow-up|0|||
37834495|NCT02005471|69518503|FG000|Main Study|Physician Decision|3|||
37834496|NCT02005471|69518504|FG001|Main Study|Physician Decision|1|||
37834497|NCT02005471|69518505|FG002|Main Study|Physician Decision|0|||
37912427|NCT02872116|69599175|FG001|Treatment|Other reasons|12|||
37834498|NCT02005471|69518506|FG003|Main Study|Physician Decision|0|||
37912428|NCT02872116|69599176|FG002|Treatment|Other reasons|5|||
37912429|NCT02869633|69599190|FG000|Overall Study|Death|2|||
37834499|NCT02005471|69518503|FG000|Main Study|Withdrawal by Subject|26|||
37834500|NCT02005471|69518504|FG001|Main Study|Withdrawal by Subject|11|||
37834501|NCT02005471|69518505|FG002|Main Study|Withdrawal by Subject|0|||
37912430|NCT02869633|69599191|FG001|Overall Study|Death|1|||
37912431|NCT02869633|69599190|FG000|Overall Study|Patient refused follow-up|1|||
37834502|NCT02005471|69518506|FG003|Main Study|Withdrawal by Subject|0|||
37834503|NCT02005471|69518503|FG000|Main Study|Reason not Specified|0|||
37834504|NCT02005471|69518504|FG001|Main Study|Reason not Specified|6|||
37834505|NCT02005471|69518505|FG002|Main Study|Reason not Specified|0|||
37834506|NCT02005471|69518506|FG003|Main Study|Reason not Specified|0|||
37834507|NCT02005471|69518503|FG000|Main Study|Randomized but not Dosed|8|||
37834508|NCT02005471|69518504|FG001|Main Study|Randomized but not Dosed|0|||
37834509|NCT02005471|69518505|FG002|Main Study|Randomized but not Dosed|0|||
37834510|NCT02005471|69518506|FG003|Main Study|Randomized but not Dosed|0|||
37834511|NCT02005471|69518503|FG000|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
37834512|NCT02005471|69518504|FG001|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
37834513|NCT02005471|69518505|FG002|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
37834514|NCT02005471|69518506|FG003|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|1|||
37834515|NCT02005471|69518503|FG000|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
37834516|NCT02005471|69518504|FG001|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
37834517|NCT02005471|69518505|FG002|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
37834518|NCT02005471|69518506|FG003|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
37834519|NCT02005471|69518503|FG000|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
37834520|NCT02005471|69518504|FG001|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
37834521|NCT02005471|69518505|FG002|Re-Treatment/Crossover (R/C) Substudy|Death|1|||
37834522|NCT02005471|69518506|FG003|Re-Treatment/Crossover (R/C) Substudy|Death|8|||
37834523|NCT01977651|69518517|FG000|4 Month Treatment Period|Adverse Event|34|||
37834524|NCT01977651|69518517|FG000|4 Month Treatment Period|Death|3|||
37834525|NCT01977651|69518517|FG000|4 Month Treatment Period|Progressive Disease|43|||
37834526|NCT01977651|69518517|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
37834527|NCT01977651|69518517|FG000|4 Month Treatment Period|Physician Decision|4|||
37834528|NCT01977651|69518517|FG000|1 Year Extension Period|Adverse Event|14|||
37834529|NCT01977651|69518517|FG000|1 Year Extension Period|Death|10|||
37834530|NCT01977651|69518517|FG000|1 Year Extension Period|Lost to Follow-up|2|||
37834531|NCT01977651|69518517|FG000|1 Year Extension Period|Progressive Disease|86|||
37834532|NCT01977651|69518517|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
37834533|NCT01977651|69518517|FG000|1 Year Extension Period|Physician Decision|6|||
37834534|NCT01977651|69518517|FG000|1 Year Extension Period|Miscellaneous|1|||
37834535|NCT01977651|69518517|FG000|Post 1 Year Extension Period|Adverse Event|5|||
37834536|NCT01977651|69518517|FG000|Post 1 Year Extension Period|Death|13|||
37834537|NCT01977651|69518517|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
37834538|NCT01977651|69518517|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
37834539|NCT01977651|69518517|FG000|Post 1 Year Extension Period|Physician Decision|4|||
37834540|NCT01977651|69518517|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
37834541|NCT01949311|69518521|FG000|Overall Study|Lost to Follow-up|73|||
37834542|NCT01949311|69518521|FG000|Overall Study|Terminated by Sponsor|708|||
37834543|NCT01949311|69518521|FG000|Overall Study|Withdrawal by Subject|375|||
37834544|NCT01949311|69518521|FG000|Overall Study|Lack of Efficacy|50|||
37834545|NCT01949311|69518521|FG000|Overall Study|Protocol Deviation|34|||
37834546|NCT01949311|69518521|FG000|Overall Study|Pregnancy|20|||
37834547|NCT01949311|69518521|FG000|Overall Study|Physician Decision|9|||
37834548|NCT01949311|69518521|FG000|Overall Study|Other|4|||
37834549|NCT01949311|69518521|FG000|Overall Study|Adverse Event|107|||
37834550|NCT01933932|69518528|FG000|Overall Study|Death|173|||
37834551|NCT01933932|69518529|FG001|Overall Study|Death|163|||
37834552|NCT01933932|69518528|FG000|Overall Study|Withdrawal by Subject|11|||
37834553|NCT01933932|69518529|FG001|Overall Study|Withdrawal by Subject|14|||
37834554|NCT01933932|69518528|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
37834555|NCT01933932|69518529|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
37834556|NCT01892722|69518537|FG000|Overall Study|Protocol deviation|0|||
37834557|NCT01892722|69518538|FG001|Overall Study|Protocol deviation|1|||
37834558|NCT01892722|69518537|FG000|Overall Study|Administrative problems|0|||
37834559|NCT01892722|69518538|FG001|Overall Study|Administrative problems|1|||
37834560|NCT01892722|69518537|FG000|Overall Study|Patient/guardian decision|0|||
37834561|NCT01892722|69518538|FG001|Overall Study|Patient/guardian decision|2|||
37834562|NCT01892722|69518537|FG000|Overall Study|Physician Decision|1|||
37834563|NCT01892722|69518538|FG001|Overall Study|Physician Decision|2|||
37834564|NCT01892722|69518537|FG000|Overall Study|Adverse Event|3|||
37834565|NCT01892722|69518538|FG001|Overall Study|Adverse Event|2|||
37834566|NCT01892722|69518537|FG000|Overall Study|Lack of Efficacy|0|||
37834567|NCT01892722|69518538|FG001|Overall Study|Lack of Efficacy|7|||
37834568|NCT01892722|69518537|FG000|Overall Study|Withdrawal by Subject|3|||
37834569|NCT01892722|69518538|FG001|Overall Study|Withdrawal by Subject|5|||
37834570|NCT01698008|69518556|FG000|Overall Study|Withdrawal by Subject|1|||
37834571|NCT01698008|69518557|FG001|Overall Study|Withdrawal by Subject|2|||
37834572|NCT01622868|69518565|FG000|Overall Study|Protocol Violation|7|||
37834573|NCT01622868|69518566|FG001|Overall Study|Protocol Violation|0|||
37834574|NCT01208233|69518595|FG000|Overall Study|Adverse Event|0|||
37834575|NCT01208233|69518596|FG001|Overall Study|Adverse Event|1|||
37834576|NCT01208233|69518597|FG002|Overall Study|Adverse Event|2|||
37834577|NCT01208233|69518598|FG003|Overall Study|Adverse Event|0|||
37834578|NCT01208233|69518599|FG004|Overall Study|Adverse Event|3|||
37834579|NCT01208233|69518600|FG005|Overall Study|Adverse Event|5|||
37834580|NCT01208233|69518595|FG000|Overall Study|Death|0|||
37834581|NCT01208233|69518596|FG001|Overall Study|Death|0|||
37834582|NCT01208233|69518597|FG002|Overall Study|Death|0|||
37834583|NCT01208233|69518598|FG003|Overall Study|Death|0|||
37834584|NCT01208233|69518599|FG004|Overall Study|Death|3|||
37834585|NCT01208233|69518600|FG005|Overall Study|Death|5|||
37834586|NCT01208233|69518595|FG000|Overall Study|Did not meet entrance criteria|2|||
37834587|NCT01208233|69518596|FG001|Overall Study|Did not meet entrance criteria|1|||
37834588|NCT01208233|69518597|FG002|Overall Study|Did not meet entrance criteria|1|||
37834589|NCT01208233|69518598|FG003|Overall Study|Did not meet entrance criteria|0|||
37834590|NCT01208233|69518599|FG004|Overall Study|Did not meet entrance criteria|1|||
37834591|NCT01208233|69518600|FG005|Overall Study|Did not meet entrance criteria|0|||
37834592|NCT01208233|69518595|FG000|Overall Study|Medication error without adverse event|0|||
37834593|NCT01208233|69518596|FG001|Overall Study|Medication error without adverse event|0|||
37834594|NCT01208233|69518597|FG002|Overall Study|Medication error without adverse event|0|||
37834595|NCT01208233|69518598|FG003|Overall Study|Medication error without adverse event|0|||
37834596|NCT01208233|69518599|FG004|Overall Study|Medication error without adverse event|0|||
37834597|NCT01208233|69518600|FG005|Overall Study|Medication error without adverse event|1|||
37834598|NCT01208233|69518595|FG000|Overall Study|Study terminated by sponsor|0|||
37834599|NCT01208233|69518596|FG001|Overall Study|Study terminated by sponsor|0|||
37834600|NCT01208233|69518597|FG002|Overall Study|Study terminated by sponsor|0|||
37834601|NCT01208233|69518598|FG003|Overall Study|Study terminated by sponsor|0|||
37834602|NCT01208233|69518599|FG004|Overall Study|Study terminated by sponsor|10|||
37834603|NCT01208233|69518600|FG005|Overall Study|Study terminated by sponsor|7|||
37834604|NCT01208233|69518595|FG000|Overall Study|Protocol Violation|0|||
37834605|NCT01208233|69518596|FG001|Overall Study|Protocol Violation|0|||
37834606|NCT01208233|69518597|FG002|Overall Study|Protocol Violation|0|||
37834607|NCT01208233|69518598|FG003|Overall Study|Protocol Violation|0|||
37834608|NCT01208233|69518599|FG004|Overall Study|Protocol Violation|3|||
37834609|NCT01208233|69518600|FG005|Overall Study|Protocol Violation|0|||
37834610|NCT01208233|69518595|FG000|Overall Study|Other|2|||
37834611|NCT01208233|69518596|FG001|Overall Study|Other|1|||
37834612|NCT01208233|69518597|FG002|Overall Study|Other|0|||
37834613|NCT01208233|69518598|FG003|Overall Study|Other|0|||
37834614|NCT01208233|69518599|FG004|Overall Study|Other|0|||
37834615|NCT01208233|69518600|FG005|Overall Study|Other|1|||
37834616|NCT01208233|69518595|FG000|Overall Study|Withdrawal by Subject|1|||
37834617|NCT01208233|69518596|FG001|Overall Study|Withdrawal by Subject|0|||
37834618|NCT01208233|69518597|FG002|Overall Study|Withdrawal by Subject|1|||
37834619|NCT01208233|69518598|FG003|Overall Study|Withdrawal by Subject|1|||
37834620|NCT01208233|69518599|FG004|Overall Study|Withdrawal by Subject|4|||
37834621|NCT01208233|69518600|FG005|Overall Study|Withdrawal by Subject|2|||
37834622|NCT01208038|69518620|FG000|Overall Study|Withdrawal by Subject|1|||
37834623|NCT01207687|69518624|FG000|Overall Study|Adverse Event|1|||
37834624|NCT01207687|69518624|FG000|Overall Study|Withdrawal by Subject|1|||
37834625|NCT01207453|69518636|FG000|First Intervention|Adverse Event|2|||
37834626|NCT01207453|69518637|FG001|First Intervention|Adverse Event|1|||
37834627|NCT01207453|69518636|FG000|Washout|Adverse Event|1|||
37834628|NCT01207453|69518637|FG001|Washout|Adverse Event|0|||
37834629|NCT01207453|69518636|FG000|Washout|Lost to Follow-up|1|||
37834630|NCT01207453|69518637|FG001|Washout|Lost to Follow-up|0|||
37834631|NCT01207453|69518636|FG000|2nd Intervention|Adverse Event|1|||
37834632|NCT01207453|69518637|FG001|2nd Intervention|Adverse Event|2|||
37834633|NCT01207453|69518636|FG000|2nd Intervention|Lost to Follow-up|1|||
37834634|NCT01207453|69518637|FG001|2nd Intervention|Lost to Follow-up|0|||
37834635|NCT01207414|69518648|FG000|Overall Study|Adverse Event|25|||
37834636|NCT01207414|69518649|FG001|Overall Study|Adverse Event|39|||
37834637|NCT01207414|69518648|FG000|Overall Study|Abnormal test procedure results|0|||
37834638|NCT01207414|69518649|FG001|Overall Study|Abnormal test procedure results|1|||
37834639|NCT01207414|69518648|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
37834640|NCT01207414|69518649|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
37834641|NCT01207414|69518648|FG000|Overall Study|Patient withdrew consent|14|||
37834642|NCT01207414|69518649|FG001|Overall Study|Patient withdrew consent|11|||
37834643|NCT01207414|69518648|FG000|Overall Study|Lost to Follow-up|15|||
37834644|NCT01207414|69518649|FG001|Overall Study|Lost to Follow-up|17|||
37834645|NCT01207414|69518648|FG000|Overall Study|Administrative problems|1|||
37834646|NCT01207414|69518649|FG001|Overall Study|Administrative problems|1|||
37834647|NCT01207414|69518648|FG000|Overall Study|Protocol deviation|12|||
37834648|NCT01207414|69518649|FG001|Overall Study|Protocol deviation|9|||
37834649|NCT01207414|69518648|FG000|Overall Study|Randomized in error|1|||
37834650|NCT01207414|69518649|FG001|Overall Study|Randomized in error|0|||
37834651|NCT01207219|69518658|FG000|Overall Study|changed diagnosis during study period|5|||
37834652|NCT01207219|69518659|FG001|Overall Study|changed diagnosis during study period|3|||
37834653|NCT01207219|69518660|FG002|Overall Study|changed diagnosis during study period|1|||
37834654|NCT01207219|69518658|FG000|Overall Study|Lost to Follow-up|6|||
37834655|NCT01207219|69518659|FG001|Overall Study|Lost to Follow-up|8|||
37834656|NCT01207219|69518660|FG002|Overall Study|Lost to Follow-up|6|||
37834657|NCT01206517|69518674|FG000|Overall Study|Withdrawal by Subject|0|||
37834658|NCT01206517|69518675|FG001|Overall Study|Withdrawal by Subject|0|||
37834659|NCT01206517|69518676|FG002|Overall Study|Withdrawal by Subject|2|||
37834660|NCT01206517|69518677|FG003|Overall Study|Withdrawal by Subject|0|||
37834661|NCT01206517|69518678|FG004|Overall Study|Withdrawal by Subject|1|||
37834662|NCT01206517|69518679|FG005|Overall Study|Withdrawal by Subject|0|||
37834663|NCT01206439|69518690|FG000|Overall Study|subject did not meet inclusion criteria|1|||
37834664|NCT01206322|69518696|FG000|Overall Study|Adverse Event|0|||
37834665|NCT01206322|69518697|FG001|Overall Study|Adverse Event|0|||
37834666|NCT01206322|69518698|FG002|Overall Study|Adverse Event|0|||
37834667|NCT01206322|69518699|FG003|Overall Study|Adverse Event|1|||
37834668|NCT01206166|69518711|FG000|Overall Study|No evaluable data|2|||
37834669|NCT01206166|69518712|FG001|Overall Study|No evaluable data|3|||
37834670|NCT01207102|69518721|FG000|Overall Study|Withdrawal by Subject|5|||
37834671|NCT01207102|69518721|FG000|Overall Study|Adverse Event|2|||
37834672|NCT01207102|69518721|FG000|Overall Study|progression|2|||
37834673|NCT01207102|69518721|FG000|Overall Study|Withdrawal by Treating Physician|1|||
37834674|NCT01205776|69518737|FG000|Overall Study|Lost to Follow-up|53|||
37834675|NCT01205776|69518738|FG001|Overall Study|Lost to Follow-up|61|||
37834676|NCT01205776|69518737|FG000|Overall Study|Withdrawal by Subject|11|||
37834677|NCT01205776|69518738|FG001|Overall Study|Withdrawal by Subject|34|||
37834678|NCT01205581|69518750|FG000|Overall Study|Withdrawal by Subject|1|||
37834679|NCT01205581|69518751|FG001|Overall Study|Withdrawal by Subject|0|||
37834680|NCT01205581|69518752|FG002|Overall Study|Withdrawal by Subject|0|||
37834681|NCT01205581|69518753|FG003|Overall Study|Withdrawal by Subject|0|||
37834682|NCT01205581|69518754|FG004|Overall Study|Withdrawal by Subject|0|||
37834683|NCT01205581|69518755|FG005|Overall Study|Withdrawal by Subject|0|||
37834684|NCT01205269|69518786|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
37834685|NCT01205269|69518787|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
37834686|NCT01205269|69518788|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
37700312|NCT02336165|69177334|FG001|Overall Study|Death|0|||
37700313|NCT02336165|69177335|FG002|Overall Study|Death|0|||
37700314|NCT02336165|69177336|FG003|Overall Study|Death|0|||
37700315|NCT02336165|69177337|FG004|Overall Study|Death|1|||
37700316|NCT02336165|69177333|FG000|Overall Study|Physician Decision|2|||
37700317|NCT02336165|69177334|FG001|Overall Study|Physician Decision|2|||
37700318|NCT02336165|69177335|FG002|Overall Study|Physician Decision|1|||
37700319|NCT02336165|69177336|FG003|Overall Study|Physician Decision|1|||
37700320|NCT02336165|69177337|FG004|Overall Study|Physician Decision|0|||
37700321|NCT02336165|69177333|FG000|Overall Study|Withdrawal by Subject|0|||
37700322|NCT02336165|69177334|FG001|Overall Study|Withdrawal by Subject|0|||
37700323|NCT02336165|69177335|FG002|Overall Study|Withdrawal by Subject|1|||
37834687|NCT01205269|69518789|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
37834688|NCT01205269|69518790|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
37834689|NCT01205269|69518791|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
37834690|NCT01240915|69518816|FG000|Overall Study|Adverse Event|0|||
37834691|NCT01240915|69518817|FG001|Overall Study|Adverse Event|0|||
37834692|NCT01240915|69518818|FG002|Overall Study|Adverse Event|0|||
37834693|NCT01240915|69518819|FG003|Overall Study|Adverse Event|1|||
37834694|NCT01240915|69518820|FG004|Overall Study|Adverse Event|0|||
37834695|NCT01240915|69518821|FG005|Overall Study|Adverse Event|2|||
37834696|NCT01240915|69518822|FG006|Overall Study|Adverse Event|0|||
37834697|NCT01240915|69518823|FG007|Overall Study|Adverse Event|0|||
37834698|NCT01240915|69518824|FG008|Overall Study|Adverse Event|1|||
37912432|NCT02869633|69599191|FG001|Overall Study|Patient refused follow-up|0|||
37700324|NCT02336165|69177336|FG003|Overall Study|Withdrawal by Subject|0|||
37700325|NCT02336165|69177337|FG004|Overall Study|Withdrawal by Subject|1|||
37700326|NCT02336165|69177333|FG000|Overall Study|Adverse Event|4|||
37700327|NCT02336165|69177334|FG001|Overall Study|Adverse Event|1|||
37700328|NCT02336165|69177335|FG002|Overall Study|Adverse Event|2|||
37834699|NCT01240915|69518816|FG000|Overall Study|Lost to Follow-up|0|||
37834700|NCT01240915|69518817|FG001|Overall Study|Lost to Follow-up|0|||
37834701|NCT01240915|69518818|FG002|Overall Study|Lost to Follow-up|0|||
37834702|NCT01240915|69518819|FG003|Overall Study|Lost to Follow-up|0|||
37834703|NCT01240915|69518820|FG004|Overall Study|Lost to Follow-up|1|||
37834704|NCT01240915|69518821|FG005|Overall Study|Lost to Follow-up|1|||
37834705|NCT01240915|69518822|FG006|Overall Study|Lost to Follow-up|0|||
37834706|NCT01240915|69518823|FG007|Overall Study|Lost to Follow-up|1|||
37834707|NCT01240915|69518824|FG008|Overall Study|Lost to Follow-up|1|||
37834708|NCT01240915|69518816|FG000|Overall Study|Withdrawal by Subject|2|||
37834709|NCT01240915|69518817|FG001|Overall Study|Withdrawal by Subject|1|||
37834710|NCT01240915|69518818|FG002|Overall Study|Withdrawal by Subject|0|||
37834711|NCT01240915|69518819|FG003|Overall Study|Withdrawal by Subject|2|||
37834712|NCT01240915|69518820|FG004|Overall Study|Withdrawal by Subject|0|||
37834713|NCT01240915|69518821|FG005|Overall Study|Withdrawal by Subject|4|||
37834714|NCT01240915|69518822|FG006|Overall Study|Withdrawal by Subject|2|||
37834715|NCT01240915|69518823|FG007|Overall Study|Withdrawal by Subject|3|||
37834716|NCT01240915|69518824|FG008|Overall Study|Withdrawal by Subject|3|||
37834717|NCT01240915|69518816|FG000|Overall Study|Other|0|||
37700329|NCT02336165|69177336|FG003|Overall Study|Adverse Event|4|||
37700330|NCT02336165|69177337|FG004|Overall Study|Adverse Event|1|||
37834718|NCT01240915|69518817|FG001|Overall Study|Other|0|||
37700331|NCT02336165|69177333|FG000|Overall Study|Progressive disease|23|||
37700332|NCT02336165|69177334|FG001|Overall Study|Progressive disease|22|||
37834719|NCT01240915|69518818|FG002|Overall Study|Other|0|||
37700333|NCT02336165|69177335|FG002|Overall Study|Progressive disease|27|||
37700334|NCT02336165|69177336|FG003|Overall Study|Progressive disease|24|||
37700335|NCT02336165|69177337|FG004|Overall Study|Progressive disease|19|||
37700336|NCT02336165|69177333|FG000|Overall Study|Non-compliance|1|||
37700337|NCT02336165|69177334|FG001|Overall Study|Non-compliance|0|||
37700338|NCT02336165|69177335|FG002|Overall Study|Non-compliance|0|||
37700339|NCT02336165|69177336|FG003|Overall Study|Non-compliance|1|||
37834720|NCT01240915|69518819|FG003|Overall Study|Other|0|||
37834721|NCT01240915|69518820|FG004|Overall Study|Other|2|||
37912433|NCT02869633|69599190|FG000|Overall Study|Provider discretion|1|||
37700340|NCT02336165|69177337|FG004|Overall Study|Non-compliance|0|||
37834722|NCT01240915|69518821|FG005|Overall Study|Other|0|||
37834723|NCT01240915|69518822|FG006|Overall Study|Other|0|||
37834724|NCT01240915|69518823|FG007|Overall Study|Other|0|||
37834725|NCT01240915|69518824|FG008|Overall Study|Other|0|||
37834726|NCT01240915|69518816|FG000|Overall Study|Insufficient Clinical Response|0|||
37834727|NCT01240915|69518817|FG001|Overall Study|Insufficient Clinical Response|0|||
37834728|NCT01240915|69518818|FG002|Overall Study|Insufficient Clinical Response|0|||
37834729|NCT01240915|69518819|FG003|Overall Study|Insufficient Clinical Response|0|||
37834730|NCT01240915|69518820|FG004|Overall Study|Insufficient Clinical Response|1|||
37834731|NCT01240915|69518821|FG005|Overall Study|Insufficient Clinical Response|3|||
37834732|NCT01240915|69518822|FG006|Overall Study|Insufficient Clinical Response|6|||
37834733|NCT01240915|69518823|FG007|Overall Study|Insufficient Clinical Response|0|||
38022243|NCT03823391|69705601|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
38022244|NCT03823391|69705602|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
38022245|NCT03823391|69705601|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
38022246|NCT03823391|69705602|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
38022247|NCT00209027|69705612|FG000|Overall Study|study terminated|10|||
38022248|NCT00209027|69705613|FG001|Overall Study|study terminated|0|||
38022249|NCT00208325|69705623|FG000|Overall Study|Death|18|||
38022250|NCT00208325|69705624|FG001|Overall Study|Death|19|||
38022251|NCT00208325|69705625|FG002|Overall Study|Death|7|||
37834734|NCT01240915|69518824|FG008|Overall Study|Insufficient Clinical Response|3|||
37834735|NCT01239745|69518846|FG000|Overall Study|Study terminated by sponsor|45|||
37834736|NCT01239745|69518846|FG000|Overall Study|Adverse Event|1|||
37834737|NCT01239472|69518852|FG000|Overall Study|Withdrawal by Subject|5|||
37834738|NCT01239472|69518853|FG001|Overall Study|Withdrawal by Subject|1|||
37834739|NCT01239472|69518852|FG000|Overall Study|Adverse Event|0|||
37834740|NCT01239472|69518853|FG001|Overall Study|Adverse Event|1|||
37834741|NCT01239472|69518852|FG000|Overall Study|Lack of Efficacy|0|||
37834742|NCT01239472|69518853|FG001|Overall Study|Lack of Efficacy|1|||
37834743|NCT01229449|69518866|FG000|Overall Study|Withdrawal by Subject|0|||
37834744|NCT01229449|69518867|FG001|Overall Study|Withdrawal by Subject|3|||
37834745|NCT01229449|69518868|FG002|Overall Study|Withdrawal by Subject|0|||
37834746|NCT01229449|69518869|FG003|Overall Study|Withdrawal by Subject|1|||
37834747|NCT01229449|69518870|FG004|Overall Study|Withdrawal by Subject|1|||
37834748|NCT01229449|69518866|FG000|Overall Study|Lost to Follow-up|1|||
37834749|NCT01229449|69518867|FG001|Overall Study|Lost to Follow-up|1|||
37834750|NCT01229449|69518868|FG002|Overall Study|Lost to Follow-up|1|||
37834751|NCT01229449|69518869|FG003|Overall Study|Lost to Follow-up|0|||
37834752|NCT01229449|69518870|FG004|Overall Study|Lost to Follow-up|0|||
37834753|NCT01229449|69518866|FG000|Overall Study|Physician Decision|0|||
37834754|NCT01229449|69518867|FG001|Overall Study|Physician Decision|0|||
37834755|NCT01229449|69518868|FG002|Overall Study|Physician Decision|1|||
37834756|NCT01229449|69518869|FG003|Overall Study|Physician Decision|0|||
37834757|NCT01229449|69518870|FG004|Overall Study|Physician Decision|0|||
37834758|NCT01239316|69518882|FG000|Overall Study|Progression/Relapse|11|||
37834759|NCT01239316|69518882|FG000|Overall Study|Adverse Event|1|||
37834760|NCT01239160|69518888|FG000|Overall Study|Lost to Follow-up|3|||
37834761|NCT01239160|69518889|FG001|Overall Study|Lost to Follow-up|5|||
37834762|NCT01239160|69518890|FG002|Overall Study|Lost to Follow-up|0|||
37834763|NCT01239160|69518888|FG000|Overall Study|Withdrawal by Subject|17|||
37834764|NCT01239160|69518889|FG001|Overall Study|Withdrawal by Subject|6|||
37834765|NCT01239160|69518890|FG002|Overall Study|Withdrawal by Subject|2|||
37834766|NCT01239160|69518888|FG000|Overall Study|Physician Decision|5|||
37834767|NCT01239160|69518889|FG001|Overall Study|Physician Decision|7|||
37834768|NCT01239160|69518890|FG002|Overall Study|Physician Decision|2|||
37834769|NCT01239160|69518888|FG000|Overall Study|Early Termination Due to Study Closure|0|||
37834770|NCT01239160|69518889|FG001|Overall Study|Early Termination Due to Study Closure|1|||
37834771|NCT01239160|69518890|FG002|Overall Study|Early Termination Due to Study Closure|6|||
37834772|NCT01239121|69518899|FG000|Overall Study|Withdrawal by Subject|2|||
37834773|NCT01239121|69518900|FG001|Overall Study|Withdrawal by Subject|4|||
37834774|NCT01239121|69518901|FG002|Overall Study|Withdrawal by Subject|0|||
37834775|NCT01239043|69518911|FG000|Overall Study|Protocol Violation|2|||
37834776|NCT01239043|69518912|FG001|Overall Study|Protocol Violation|1|||
37834777|NCT01238848|69518920|FG000|Overall Study|Physician Decision|13|||
37834778|NCT01238848|69518921|FG001|Overall Study|Physician Decision|5|||
37834779|NCT01238575|69518929|FG000|Overall Study|Lack of Efficacy|2|||
37834780|NCT01238575|69518930|FG001|Overall Study|Lack of Efficacy|4|||
37834781|NCT01238575|69518929|FG000|Overall Study|Adverse Event|2|||
37834782|NCT01238575|69518930|FG001|Overall Study|Adverse Event|0|||
37834783|NCT05376215|69518942|FG000|Overall Study|Withdrawal by Subject|2|||
37834784|NCT05376215|69518943|FG001|Overall Study|Withdrawal by Subject|1|||
37834785|NCT05376215|69518942|FG000|Overall Study|Lost to Follow-up|0|||
37834786|NCT05376215|69518943|FG001|Overall Study|Lost to Follow-up|1|||
37834787|NCT04447794|69518972|FG000|Overall Study|Lost to Follow-up|2|||
37834788|NCT04447794|69518973|FG001|Overall Study|Lost to Follow-up|3|||
37834789|NCT04447794|69518974|FG002|Overall Study|Lost to Follow-up|8|||
37834790|NCT04447794|69518972|FG000|Overall Study|Withdrawal by Subject|1|||
37834791|NCT04447794|69518973|FG001|Overall Study|Withdrawal by Subject|1|||
37834792|NCT04447794|69518974|FG002|Overall Study|Withdrawal by Subject|0|||
37834793|NCT04138576|69518987|FG000|Overall Study|Due to epidemiological situation (COVID-19) patients were dropped out from the study.|16|||
37834794|NCT04009291|69519001|FG000|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
37834795|NCT04009291|69519002|FG001|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
37834796|NCT04009291|69519003|FG002|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
37834797|NCT04009291|69519004|FG003|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
37834798|NCT04009291|69519005|FG004|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|1|||
37834799|NCT04009291|69519001|FG000|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
37834800|NCT04009291|69519002|FG001|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
37834801|NCT04009291|69519003|FG002|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
37834802|NCT04009291|69519004|FG003|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
37834803|NCT04009291|69519005|FG004|Open-Label Period (Weeks 4 to 266)|Study Ongoing|58|||
37834804|NCT03811340|69519016|FG000|Overall Study|subjects did not complete the survey.|90|||
37834805|NCT03668119|69519031|FG000|Pre-treatment|Disease Progression|1|||
37834806|NCT03668119|69519032|FG001|Pre-treatment|Disease Progression|0|||
37834807|NCT03668119|69519031|FG000|Treatment|Disease Progression|75|||
37834808|NCT03668119|69519032|FG001|Treatment|Disease Progression|55|||
37834809|NCT03668119|69519031|FG000|Treatment|Study drug toxicity|19|||
37834810|NCT03668119|69519032|FG001|Treatment|Study drug toxicity|1|||
37834811|NCT03668119|69519031|FG000|Treatment|Death|3|||
37834812|NCT03668119|69519032|FG001|Treatment|Death|0|||
37834813|NCT03668119|69519031|FG000|Treatment|Adverse Event unrelated to Study drug|4|||
37834814|NCT03668119|69519032|FG001|Treatment|Adverse Event unrelated to Study drug|3|||
37834815|NCT03668119|69519031|FG000|Treatment|Withdrawal by Subject|2|||
37834816|NCT03668119|69519032|FG001|Treatment|Withdrawal by Subject|1|||
37834817|NCT03668119|69519031|FG000|Treatment|Participant request to discontinue study treatment|3|||
37834818|NCT03668119|69519032|FG001|Treatment|Participant request to discontinue study treatment|1|||
37834819|NCT03668119|69519031|FG000|Treatment|Maximum Clinical Benefit|0|||
37834820|NCT03668119|69519032|FG001|Treatment|Maximum Clinical Benefit|1|||
37834821|NCT03668119|69519031|FG000|Treatment|Participants completed treatment|20|||
37834822|NCT03668119|69519032|FG001|Treatment|Participants completed treatment|8|||
37834823|NCT03668119|69519031|FG000|Treatment|Other reasons|1|||
37834824|NCT03668119|69519032|FG001|Treatment|Other reasons|2|||
37834825|NCT03555591|69519040|FG000|Overall Study|Protocol Violation|77|||
37834826|NCT03224819|69519062|FG000|Overall Study|Withdrawal by Subject|0|||
37834827|NCT03224819|69519063|FG001|Overall Study|Withdrawal by Subject|0|||
37834828|NCT03224819|69519064|FG002|Overall Study|Withdrawal by Subject|0|||
37834829|NCT03224819|69519065|FG003|Overall Study|Withdrawal by Subject|0|||
37834830|NCT03224819|69519066|FG004|Overall Study|Withdrawal by Subject|0|||
37834831|NCT03224819|69519067|FG005|Overall Study|Withdrawal by Subject|0|||
37834832|NCT03224819|69519068|FG006|Overall Study|Withdrawal by Subject|0|||
37834833|NCT03224819|69519069|FG007|Overall Study|Withdrawal by Subject|0|||
37834834|NCT03224819|69519070|FG008|Overall Study|Withdrawal by Subject|0|||
37834835|NCT03224819|69519071|FG009|Overall Study|Withdrawal by Subject|0|||
37834836|NCT03224819|69519072|FG010|Overall Study|Withdrawal by Subject|0|||
37834837|NCT03224819|69519073|FG011|Overall Study|Withdrawal by Subject|0|||
37834838|NCT03224819|69519074|FG012|Overall Study|Withdrawal by Subject|1|||
37834839|NCT03224819|69519075|FG013|Overall Study|Withdrawal by Subject|0|||
37834840|NCT03224819|69519062|FG000|Overall Study|Sponsor Decision|0|||
37834841|NCT03224819|69519063|FG001|Overall Study|Sponsor Decision|0|||
37834842|NCT03224819|69519064|FG002|Overall Study|Sponsor Decision|0|||
37834843|NCT03224819|69519065|FG003|Overall Study|Sponsor Decision|1|||
37834844|NCT03224819|69519066|FG004|Overall Study|Sponsor Decision|1|||
37834845|NCT03224819|69519067|FG005|Overall Study|Sponsor Decision|2|||
37834846|NCT03224819|69519068|FG006|Overall Study|Sponsor Decision|1|||
37834847|NCT03224819|69519069|FG007|Overall Study|Sponsor Decision|1|||
37834848|NCT03224819|69519070|FG008|Overall Study|Sponsor Decision|1|||
37834849|NCT03224819|69519071|FG009|Overall Study|Sponsor Decision|2|||
37834850|NCT03224819|69519072|FG010|Overall Study|Sponsor Decision|1|||
37912434|NCT02869633|69599191|FG001|Overall Study|Provider discretion|0|||
37912435|NCT02869633|69599190|FG000|Overall Study|Investigator decision|1|||
37912436|NCT02869633|69599191|FG001|Overall Study|Investigator decision|0|||
37912437|NCT02869633|69599190|FG000|Overall Study|Lost to Follow-up|0|||
37912438|NCT02869633|69599191|FG001|Overall Study|Lost to Follow-up|1|||
37912439|NCT02869633|69599190|FG000|Overall Study|Not eligible|6|||
37912440|NCT02869633|69599191|FG001|Overall Study|Not eligible|1|||
37912441|NCT02869633|69599190|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
37912442|NCT02869633|69599191|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
37912443|NCT02869633|69599190|FG000|Overall Study|Withdrawal by Subject|0|||
37912444|NCT02869633|69599191|FG001|Overall Study|Withdrawal by Subject|1|||
37912445|NCT02855268|69599201|FG000|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
37912446|NCT02855268|69599202|FG001|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
37912447|NCT02855268|69599201|FG000|DB Period (up to 48 Weeks)|Adverse Event|0|||
37912448|NCT02855268|69599202|FG001|DB Period (up to 48 Weeks)|Adverse Event|2|||
37912449|NCT02855268|69599201|FG000|DB Period (up to 48 Weeks)|Sponsor Decision|4|||
37912450|NCT02855268|69599202|FG001|DB Period (up to 48 Weeks)|Sponsor Decision|7|||
37912451|NCT02855268|69599201|FG000|OLE Period (up to 96 Weeks)|Adverse Event|0|||
37912452|NCT02855268|69599202|FG001|OLE Period (up to 96 Weeks)|Adverse Event|2|||
37912453|NCT02855268|69599201|FG000|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
38022252|NCT00208325|69705626|FG003|Overall Study|Death|5|||
38022253|NCT00208325|69705623|FG000|Overall Study|Withdrawal by Subject|0|||
37834851|NCT03224819|69519073|FG011|Overall Study|Sponsor Decision|1|||
37912454|NCT02855268|69599202|FG001|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
38022254|NCT00208325|69705624|FG001|Overall Study|Withdrawal by Subject|1|||
37834852|NCT03224819|69519074|FG012|Overall Study|Sponsor Decision|1|||
37834853|NCT03224819|69519075|FG013|Overall Study|Sponsor Decision|0|||
37834854|NCT03224819|69519062|FG000|Overall Study|Lost to Follow-up|0|||
37834855|NCT03224819|69519063|FG001|Overall Study|Lost to Follow-up|0|||
37834856|NCT03224819|69519064|FG002|Overall Study|Lost to Follow-up|0|||
37834857|NCT03224819|69519065|FG003|Overall Study|Lost to Follow-up|0|||
37834858|NCT03224819|69519066|FG004|Overall Study|Lost to Follow-up|0|||
37834859|NCT03224819|69519067|FG005|Overall Study|Lost to Follow-up|0|||
37834860|NCT03224819|69519068|FG006|Overall Study|Lost to Follow-up|0|||
37912455|NCT02855268|69599201|FG000|OLE Period (up to 96 Weeks)|Early study termination by sponsor|7|||
38022255|NCT00208325|69705625|FG002|Overall Study|Withdrawal by Subject|0|||
37834861|NCT03224819|69519069|FG007|Overall Study|Lost to Follow-up|0|||
37834862|NCT03224819|69519070|FG008|Overall Study|Lost to Follow-up|1|||
37834863|NCT03224819|69519071|FG009|Overall Study|Lost to Follow-up|0|||
37834864|NCT03224819|69519072|FG010|Overall Study|Lost to Follow-up|0|||
37834865|NCT03224819|69519073|FG011|Overall Study|Lost to Follow-up|0|||
37834866|NCT03224819|69519074|FG012|Overall Study|Lost to Follow-up|0|||
37834867|NCT03224819|69519075|FG013|Overall Study|Lost to Follow-up|0|||
37834868|NCT03224819|69519062|FG000|Overall Study|Death|0|||
37834869|NCT03224819|69519063|FG001|Overall Study|Death|1|||
37834870|NCT03224819|69519064|FG002|Overall Study|Death|0|||
37834871|NCT03224819|69519065|FG003|Overall Study|Death|0|||
37834872|NCT03224819|69519066|FG004|Overall Study|Death|0|||
37834873|NCT03224819|69519067|FG005|Overall Study|Death|0|||
37834874|NCT03224819|69519068|FG006|Overall Study|Death|0|||
37834875|NCT03224819|69519069|FG007|Overall Study|Death|1|||
37834876|NCT03224819|69519070|FG008|Overall Study|Death|0|||
37834877|NCT03224819|69519071|FG009|Overall Study|Death|0|||
37834878|NCT03224819|69519072|FG010|Overall Study|Death|0|||
37834879|NCT03224819|69519073|FG011|Overall Study|Death|1|||
37834880|NCT03224819|69519074|FG012|Overall Study|Death|0|||
37834881|NCT03224819|69519075|FG013|Overall Study|Death|0|||
37834882|NCT02549573|69519118|FG000|Overall Study|Withdrawal by Subject|0|||
37834883|NCT02549573|69519119|FG001|Overall Study|Withdrawal by Subject|2|||
37834884|NCT02549573|69519118|FG000|Overall Study|Protocol Violation|0|||
37834885|NCT02549573|69519119|FG001|Overall Study|Protocol Violation|1|||
37834886|NCT02378181|69519127|FG000|Overall Study|Lost to Follow-up|2|||
37834887|NCT02378181|69519128|FG001|Overall Study|Lost to Follow-up|5|||
37834888|NCT02378181|69519127|FG000|Overall Study|Withdrawal by Subject|1|||
37834889|NCT02378181|69519128|FG001|Overall Study|Withdrawal by Subject|1|||
37834890|NCT02378181|69519127|FG000|Overall Study|Incarcerated|0|||
37834891|NCT02378181|69519128|FG001|Overall Study|Incarcerated|1|||
37834892|NCT02201108|69519136|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
37834893|NCT02201108|69519137|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
37834894|NCT02201108|69519136|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
37834895|NCT02201108|69519137|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
37834896|NCT02201108|69519136|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
37834897|NCT02201108|69519137|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
37834898|NCT02201108|69519136|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
37700341|NCT02336165|69177333|FG000|Overall Study|Other|1|||
37700342|NCT02336165|69177334|FG001|Overall Study|Other|0|||
37700343|NCT02336165|69177335|FG002|Overall Study|Other|0|||
37700344|NCT02336165|69177336|FG003|Overall Study|Other|1|||
37700345|NCT02336165|69177337|FG004|Overall Study|Other|0|||
37700346|NCT02360111|69177353|FG000|Overall Study|Death|2|||
37700347|NCT02334683|69177359|FG000|First 12 Week Period|Lost to Follow-up|1|||
37700348|NCT02334683|69177360|FG001|First 12 Week Period|Lost to Follow-up|0|||
37700349|NCT02334683|69177359|FG000|Second 12 Week Period|Adverse Event|0|||
37700350|NCT02334683|69177360|FG001|Second 12 Week Period|Adverse Event|1|||
37700351|NCT02319044|69177369|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
37700352|NCT02319044|69177370|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
37700353|NCT02319044|69177371|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
37834899|NCT02201108|69519137|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
37834900|NCT02201108|69519136|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
37834901|NCT02201108|69519137|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
37834902|NCT02201108|69519136|FG000|Open Label Period (up to Week 192)|Other reason|4|||
37834903|NCT02201108|69519137|FG001|Open Label Period (up to Week 192)|Other reason|7|||
37834904|NCT02201108|69519136|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
37834905|NCT02201108|69519137|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
37834906|NCT02180243|69519158|FG000|Overall Study|Withdrawal by Subject|12|||
37834907|NCT02180243|69519159|FG001|Overall Study|Withdrawal by Subject|12|||
37834908|NCT02180243|69519158|FG000|Overall Study|Lost to Follow-up|12|||
37834909|NCT02180243|69519159|FG001|Overall Study|Lost to Follow-up|2|||
37834910|NCT01772563|69519166|FG000|Cycle 1|Dose limiting toxicity|2|||
37834911|NCT01772563|69519166|FG000|Cycle 1|Progressive disease|2|||
37834912|NCT01772563|69519166|FG000|Cycle 2 and Beyond|Progressive disease|17|||
37834913|NCT01772563|69519166|FG000|Cycle 2 and Beyond|Refused continuing medication|4|||
37834914|NCT01772563|69519166|FG000|Cycle 2 and Beyond|Withdrawal by Subject|2|||
37834915|NCT01445171|69519172|FG000|Overall Study|Lost to Follow-up|11|||
37834916|NCT01445171|69519172|FG000|Overall Study|Withdrawal by Subject|16|||
37834917|NCT01445171|69519172|FG000|Overall Study|Death|51|||
37834918|NCT01445171|69519172|FG000|Overall Study|Subjects declined to return for followup|9|||
37834919|NCT01445171|69519172|FG000|Overall Study|Consented but did not receive device|8|||
37834920|NCT00492050|69519178|FG000|Overall Study|Adverse Event|1|||
37834921|NCT00492050|69519178|FG000|Overall Study|Lack of Efficacy|1|||
37834922|NCT00492050|69519178|FG000|Overall Study|Withdrawal by Subject|3|||
37834923|NCT00492050|69519178|FG000|Overall Study|Unable to collect SCT|2|||
37834924|NCT00492050|69519178|FG000|Overall Study|Progressive Disease|2|||
37834925|NCT01237951|69519182|FG000|Overall Study|Death|1|||
37834926|NCT01239394|69519186|FG000|Overall Study|Adverse Event|1|||
37834927|NCT01237678|69519193|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
37834928|NCT01237678|69519194|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
37834929|NCT01237678|69519195|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
37834930|NCT01237678|69519193|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
37834931|NCT01237678|69519194|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
37834932|NCT01237678|69519195|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
37834933|NCT01237678|69519193|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
37834934|NCT01237678|69519194|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
37834935|NCT01237678|69519195|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
37834936|NCT01237678|69519193|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
37834937|NCT01237678|69519194|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
37834938|NCT01237678|69519195|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
37834939|NCT01237678|69519193|FG000|Phase II|Adverse Event|0|||
37834940|NCT01237678|69519194|FG001|Phase II|Adverse Event|39|||
37834941|NCT01237678|69519195|FG002|Phase II|Adverse Event|9|||
37834942|NCT01237678|69519193|FG000|Phase II|Death|0|||
37834943|NCT01237678|69519194|FG001|Phase II|Death|0|||
37834944|NCT01237678|69519195|FG002|Phase II|Death|2|||
37834945|NCT01237678|69519193|FG000|Phase II|Lack of Efficacy|0|||
37834946|NCT01237678|69519194|FG001|Phase II|Lack of Efficacy|25|||
37834947|NCT01237678|69519195|FG002|Phase II|Lack of Efficacy|3|||
37834948|NCT01237678|69519193|FG000|Phase II|Withdrawal by Subject|0|||
37834949|NCT01237678|69519194|FG001|Phase II|Withdrawal by Subject|1|||
37834950|NCT01237678|69519195|FG002|Phase II|Withdrawal by Subject|5|||
37834951|NCT01237678|69519193|FG000|Phase II|Completed Cycles 4-6|0|||
37834952|NCT01237678|69519194|FG001|Phase II|Completed Cycles 4-6|11|||
37834953|NCT01237678|69519195|FG002|Phase II|Completed Cycles 4-6|21|||
37834954|NCT01237678|69519193|FG000|Phase II|Sponsor Decision/Study Closed|0|||
37834955|NCT01237678|69519194|FG001|Phase II|Sponsor Decision/Study Closed|18|||
37912456|NCT02855268|69599202|FG001|OLE Period (up to 96 Weeks)|Early study termination by sponsor|16|||
37912457|NCT02840721|69599217|FG000|Treatment Period|Adverse Event|1|||
37912458|NCT02840721|69599217|FG000|Follow-Up|Lack of Efficacy|1|||
37700354|NCT02319044|69177369|FG000|Overall Study|Withdrawal by Subject|3|||
37700355|NCT02319044|69177370|FG001|Overall Study|Withdrawal by Subject|3|||
37700356|NCT02319044|69177371|FG002|Overall Study|Withdrawal by Subject|6|||
37700357|NCT02319044|69177369|FG000|Overall Study|Condition under investigation worsened|100|||
37700358|NCT02319044|69177370|FG001|Overall Study|Condition under investigation worsened|50|||
37700359|NCT02319044|69177371|FG002|Overall Study|Condition under investigation worsened|46|||
37700360|NCT02319044|69177369|FG000|Overall Study|Adverse Event|17|||
37700361|NCT02319044|69177370|FG001|Overall Study|Adverse Event|2|||
37700362|NCT02319044|69177371|FG002|Overall Study|Adverse Event|8|||
37700363|NCT02319044|69177369|FG000|Overall Study|Study specific discontinuation criteria|2|||
37912459|NCT02840721|69599217|FG000|Follow-Up|Withdrawal by Subject|4|||
37700364|NCT02319044|69177370|FG001|Overall Study|Study specific discontinuation criteria|2|||
37700365|NCT02319044|69177371|FG002|Overall Study|Study specific discontinuation criteria|1|||
37834956|NCT01237678|69519195|FG002|Phase II|Sponsor Decision/Study Closed|7|||
37834957|NCT01237678|69519193|FG000|Phase II|Randomized but were not treated|0|||
37834958|NCT01237678|69519194|FG001|Phase II|Randomized but were not treated|4|||
37834959|NCT01237678|69519195|FG002|Phase II|Randomized but were not treated|3|||
37834960|NCT01229371|69519218|FG000|Overall Study|Withdrawal by Subject|0|||
37834961|NCT01229371|69519219|FG001|Overall Study|Withdrawal by Subject|1|||
37912460|NCT02840721|69599217|FG000|Follow-Up|Withdrawal of Consent|2|||
37834962|NCT01229371|69519220|FG002|Overall Study|Withdrawal by Subject|0|||
37834963|NCT01229371|69519221|FG003|Overall Study|Withdrawal by Subject|0|||
37834964|NCT01237327|69519233|FG000|Overall Study|Protocol Violation: Core Study|1|||
37834965|NCT01237327|69519234|FG001|Overall Study|Protocol Violation: Core Study|0|||
37834966|NCT01237327|69519233|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
37834967|NCT01237327|69519234|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
37834968|NCT01237327|69519233|FG000|Overall Study|Progression of Disease: Core Study|18|||
37834969|NCT01237327|69519234|FG001|Overall Study|Progression of Disease: Core Study|22|||
37834970|NCT01237327|69519233|FG000|Overall Study|Progression of Disease: Extension Study|15|||
37834971|NCT01237327|69519234|FG001|Overall Study|Progression of Disease: Extension Study|13|||
37912461|NCT02777593|69599226|FG000|Overall Study|Still in study|28|||
37912462|NCT02777593|69599227|FG001|Overall Study|Still in study|71|||
37912463|NCT02777593|69599228|FG002|Overall Study|Still in study|5|||
37912464|NCT02777593|69599229|FG003|Overall Study|Still in study|6|||
37912465|NCT02777593|69599230|FG004|Overall Study|Still in study|6|||
37912466|NCT02777593|69599226|FG000|Overall Study|Death|19|||
37912467|NCT02777593|69599227|FG001|Overall Study|Death|24|||
37912468|NCT02777593|69599228|FG002|Overall Study|Death|0|||
37912469|NCT02777593|69599229|FG003|Overall Study|Death|5|||
37912470|NCT02777593|69599230|FG004|Overall Study|Death|0|||
37912471|NCT02777593|69599226|FG000|Overall Study|Withdrawal by Subject|6|||
37912472|NCT02777593|69599227|FG001|Overall Study|Withdrawal by Subject|3|||
37912473|NCT02777593|69599228|FG002|Overall Study|Withdrawal by Subject|1|||
37912474|NCT02777593|69599229|FG003|Overall Study|Withdrawal by Subject|1|||
37912475|NCT02777593|69599230|FG004|Overall Study|Withdrawal by Subject|0|||
37912476|NCT02777593|69599226|FG000|Overall Study|Lost to Follow-up|4|||
37912477|NCT02777593|69599227|FG001|Overall Study|Lost to Follow-up|12|||
37912478|NCT02777593|69599228|FG002|Overall Study|Lost to Follow-up|4|||
37912479|NCT02777593|69599229|FG003|Overall Study|Lost to Follow-up|0|||
37912480|NCT02777593|69599230|FG004|Overall Study|Lost to Follow-up|0|||
37912481|NCT02777593|69599226|FG000|Overall Study|Physician Decision|2|||
37912482|NCT02777593|69599227|FG001|Overall Study|Physician Decision|2|||
37912483|NCT02777593|69599228|FG002|Overall Study|Physician Decision|0|||
37912484|NCT02777593|69599229|FG003|Overall Study|Physician Decision|0|||
37912485|NCT02777593|69599230|FG004|Overall Study|Physician Decision|0|||
37912486|NCT02777593|69599226|FG000|Overall Study|Discontinued due to Other|3|||
37912487|NCT02777593|69599227|FG001|Overall Study|Discontinued due to Other|0|||
37912488|NCT02777593|69599228|FG002|Overall Study|Discontinued due to Other|0|||
37912489|NCT02777593|69599229|FG003|Overall Study|Discontinued due to Other|0|||
37912490|NCT02777593|69599230|FG004|Overall Study|Discontinued due to Other|0|||
37912491|NCT02701283|69599245|FG000|Overall Study|Death|25|||
37912492|NCT02701283|69599246|FG001|Overall Study|Death|29|||
37912493|NCT02701283|69599247|FG002|Overall Study|Death|19|||
37912494|NCT02701283|69599245|FG000|Overall Study|Lost to Follow-up|3|||
37912495|NCT02701283|69599246|FG001|Overall Study|Lost to Follow-up|8|||
37912496|NCT02701283|69599247|FG002|Overall Study|Lost to Follow-up|1|||
37912497|NCT02701283|69599245|FG000|Overall Study|Withdrawal by Subject|12|||
37912498|NCT02701283|69599246|FG001|Overall Study|Withdrawal by Subject|41|||
37912499|NCT02701283|69599247|FG002|Overall Study|Withdrawal by Subject|1|||
37912500|NCT02701283|69599245|FG000|Overall Study|Missed 2-year visit|22|||
37912501|NCT02701283|69599246|FG001|Overall Study|Missed 2-year visit|27|||
37912502|NCT02701283|69599247|FG002|Overall Study|Missed 2-year visit|0|||
37912503|NCT02701283|69599245|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
37912504|NCT02701283|69599246|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
37912505|NCT02701283|69599247|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
37912506|NCT02399085|69599267|FG000|Overall Study|Adverse Event|16|||
37912507|NCT02399085|69599267|FG000|Overall Study|Death|2|||
37912508|NCT02399085|69599267|FG000|Overall Study|Withdrawal by Subject|8|||
37912509|NCT02399085|69599267|FG000|Overall Study|Progressive disease/ Disease relapse|42|||
37912510|NCT02399085|69599267|FG000|Overall Study|Physician Decision|5|||
37912511|NCT01317160|69599275|FG000|Overall Study|Incorrect inclusion|1|||
37912512|NCT01317160|69599276|FG001|Overall Study|Incorrect inclusion|1|||
37912513|NCT01317160|69599275|FG000|Overall Study|Lost to Follow-up|3|||
37912514|NCT01317160|69599276|FG001|Overall Study|Lost to Follow-up|3|||
37912515|NCT01317160|69599275|FG000|Overall Study|Withdrawal by Subject|0|||
37912516|NCT01317160|69599276|FG001|Overall Study|Withdrawal by Subject|2|||
37912517|NCT00891371|69599282|FG000|Pre-assignment|Inclusion/exclusion|5|||
37912518|NCT00891371|69599282|FG000|Pre-assignment|Consent withdrawal|1|||
37912519|NCT00891371|69599282|FG000|Treatment|Lack of Efficacy|5|||
37912520|NCT00891371|69599282|FG000|Treatment|Adverse Event|2|||
37912521|NCT00891371|69599282|FG000|Treatment|Death|1|||
37912522|NCT00891371|69599282|FG000|Treatment|Lost to Follow-up|1|||
37912523|NCT00890045|69599288|FG000|Overall Study|Death|0|||
37912524|NCT00890045|69599289|FG001|Overall Study|Death|1|||
37912525|NCT00890045|69599288|FG000|Overall Study|Did not receive HeRO Graft|0|||
37912526|NCT00890045|69599289|FG001|Overall Study|Did not receive HeRO Graft|2|||
37912527|NCT00890045|69599288|FG000|Overall Study|Lost to Follow-up|5|||
37834972|NCT01237327|69519233|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
37834973|NCT01237327|69519234|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
37834974|NCT01237327|69519233|FG000|Overall Study|Withdrawal by Subject|1|||
37834975|NCT01237327|69519234|FG001|Overall Study|Withdrawal by Subject|3|||
37834976|NCT01237327|69519233|FG000|Overall Study|Lost to Follow-up|3|||
37834977|NCT01237327|69519234|FG001|Overall Study|Lost to Follow-up|0|||
37834978|NCT01237054|69519240|FG000|Overall Study|imaging 10C0096|1|||
37834979|NCT01236352|69519277|FG000|Overall Study|Death|0|||
37834980|NCT01236352|69519278|FG001|Overall Study|Death|0|||
37834981|NCT01236352|69519279|FG002|Overall Study|Death|0|||
37834982|NCT01236352|69519280|FG003|Overall Study|Death|0|||
37834983|NCT01236352|69519281|FG004|Overall Study|Death|0|||
37834984|NCT01236352|69519282|FG005|Overall Study|Death|0|||
37834985|NCT01236352|69519283|FG006|Overall Study|Death|0|||
37834986|NCT01236352|69519284|FG007|Overall Study|Death|1|||
37834987|NCT01236352|69519285|FG008|Overall Study|Death|0|||
37834988|NCT01236352|69519286|FG009|Overall Study|Death|0|||
37834989|NCT01236352|69519287|FG010|Overall Study|Death|0|||
37834990|NCT01236352|69519277|FG000|Overall Study|Withdrawal by Subject|0|||
37834991|NCT01236352|69519278|FG001|Overall Study|Withdrawal by Subject|0|||
37834992|NCT01236352|69519279|FG002|Overall Study|Withdrawal by Subject|0|||
37834993|NCT01236352|69519280|FG003|Overall Study|Withdrawal by Subject|0|||
37834994|NCT01236352|69519281|FG004|Overall Study|Withdrawal by Subject|0|||
37834995|NCT01236352|69519282|FG005|Overall Study|Withdrawal by Subject|0|||
37912528|NCT00890045|69599289|FG001|Overall Study|Lost to Follow-up|7|||
37912529|NCT00891293|69599295|FG000|Overall Study|Adverse Event|2|||
37912530|NCT00891293|69599295|FG000|Overall Study|Protocol Violation|2|||
37834996|NCT01236352|69519283|FG006|Overall Study|Withdrawal by Subject|0|||
37834997|NCT01236352|69519284|FG007|Overall Study|Withdrawal by Subject|0|||
37834998|NCT01236352|69519285|FG008|Overall Study|Withdrawal by Subject|0|||
37912531|NCT00891293|69599295|FG000|Overall Study|Laboratory abnormality|4|||
37834999|NCT01236352|69519286|FG009|Overall Study|Withdrawal by Subject|2|||
37835000|NCT01236352|69519287|FG010|Overall Study|Withdrawal by Subject|1|||
37835001|NCT01236352|69519277|FG000|Overall Study|Adverse Event|0|||
37835002|NCT01236352|69519278|FG001|Overall Study|Adverse Event|0|||
37912532|NCT00891293|69599295|FG000|Overall Study|Lost to Follow-up|7|||
37835003|NCT01236352|69519279|FG002|Overall Study|Adverse Event|0|||
37835004|NCT01236352|69519280|FG003|Overall Study|Adverse Event|0|||
37912533|NCT00891293|69599295|FG000|Overall Study|Subject withdrew consent|7|||
37835005|NCT01236352|69519281|FG004|Overall Study|Adverse Event|0|||
37835006|NCT01236352|69519282|FG005|Overall Study|Adverse Event|0|||
37835007|NCT01236352|69519283|FG006|Overall Study|Adverse Event|2|||
37835008|NCT01236352|69519284|FG007|Overall Study|Adverse Event|0|||
37835009|NCT01236352|69519285|FG008|Overall Study|Adverse Event|0|||
37835010|NCT01236352|69519286|FG009|Overall Study|Adverse Event|4|||
37835011|NCT01236352|69519287|FG010|Overall Study|Adverse Event|1|||
37835012|NCT01236352|69519277|FG000|Overall Study|Study drug toxicity|0|||
37835013|NCT01236352|69519278|FG001|Overall Study|Study drug toxicity|0|||
37835014|NCT01236352|69519279|FG002|Overall Study|Study drug toxicity|0|||
37835015|NCT01236352|69519280|FG003|Overall Study|Study drug toxicity|0|||
37835016|NCT01236352|69519281|FG004|Overall Study|Study drug toxicity|0|||
37835017|NCT01236352|69519282|FG005|Overall Study|Study drug toxicity|1|||
37835018|NCT01236352|69519283|FG006|Overall Study|Study drug toxicity|1|||
37835019|NCT01236352|69519284|FG007|Overall Study|Study drug toxicity|0|||
37835020|NCT01236352|69519285|FG008|Overall Study|Study drug toxicity|0|||
37835021|NCT01236352|69519286|FG009|Overall Study|Study drug toxicity|2|||
37835022|NCT01236352|69519287|FG010|Overall Study|Study drug toxicity|2|||
37835023|NCT01236352|69519277|FG000|Overall Study|Disease progression|1|||
37835024|NCT01236352|69519278|FG001|Overall Study|Disease progression|2|||
37835025|NCT01236352|69519279|FG002|Overall Study|Disease progression|1|||
37835026|NCT01236352|69519280|FG003|Overall Study|Disease progression|2|||
37835027|NCT01236352|69519281|FG004|Overall Study|Disease progression|2|||
37835028|NCT01236352|69519282|FG005|Overall Study|Disease progression|2|||
37835029|NCT01236352|69519283|FG006|Overall Study|Disease progression|1|||
37835030|NCT01236352|69519284|FG007|Overall Study|Disease progression|3|||
37835031|NCT01236352|69519285|FG008|Overall Study|Disease progression|2|||
37835032|NCT01236352|69519286|FG009|Overall Study|Disease progression|2|||
37835033|NCT01236352|69519287|FG010|Overall Study|Disease progression|2|||
37835034|NCT01236352|69519277|FG000|Overall Study|Poor/Non-compliance|1|||
37835035|NCT01236352|69519278|FG001|Overall Study|Poor/Non-compliance|0|||
37835036|NCT01236352|69519279|FG002|Overall Study|Poor/Non-compliance|0|||
37835037|NCT01236352|69519280|FG003|Overall Study|Poor/Non-compliance|0|||
37835038|NCT01236352|69519281|FG004|Overall Study|Poor/Non-compliance|0|||
37835039|NCT01236352|69519282|FG005|Overall Study|Poor/Non-compliance|0|||
37835040|NCT01236352|69519283|FG006|Overall Study|Poor/Non-compliance|0|||
37835041|NCT01236352|69519284|FG007|Overall Study|Poor/Non-compliance|0|||
37835042|NCT01236352|69519285|FG008|Overall Study|Poor/Non-compliance|0|||
37835043|NCT01236352|69519286|FG009|Overall Study|Poor/Non-compliance|0|||
37835044|NCT01236352|69519287|FG010|Overall Study|Poor/Non-compliance|0|||
37835045|NCT01236352|69519277|FG000|Overall Study|Maximum clinical benefit|1|||
37835046|NCT01236352|69519278|FG001|Overall Study|Maximum clinical benefit|1|||
37835047|NCT01236352|69519279|FG002|Overall Study|Maximum clinical benefit|1|||
37835048|NCT01236352|69519280|FG003|Overall Study|Maximum clinical benefit|0|||
37835049|NCT01236352|69519281|FG004|Overall Study|Maximum clinical benefit|2|||
37835050|NCT01236352|69519282|FG005|Overall Study|Maximum clinical benefit|0|||
37835051|NCT01236352|69519283|FG006|Overall Study|Maximum clinical benefit|3|||
37835052|NCT01236352|69519284|FG007|Overall Study|Maximum clinical benefit|1|||
37835053|NCT01236352|69519285|FG008|Overall Study|Maximum clinical benefit|1|||
37835054|NCT01236352|69519286|FG009|Overall Study|Maximum clinical benefit|4|||
37835055|NCT01236352|69519287|FG010|Overall Study|Maximum clinical benefit|2|||
37835056|NCT01236352|69519277|FG000|Overall Study|Subject request to discontinue treatment|0|||
37835057|NCT01236352|69519278|FG001|Overall Study|Subject request to discontinue treatment|0|||
37835058|NCT01236352|69519279|FG002|Overall Study|Subject request to discontinue treatment|1|||
37835059|NCT01236352|69519280|FG003|Overall Study|Subject request to discontinue treatment|1|||
37835060|NCT01236352|69519281|FG004|Overall Study|Subject request to discontinue treatment|0|||
37835061|NCT01236352|69519282|FG005|Overall Study|Subject request to discontinue treatment|1|||
37835062|NCT01236352|69519283|FG006|Overall Study|Subject request to discontinue treatment|0|||
37835063|NCT01236352|69519284|FG007|Overall Study|Subject request to discontinue treatment|0|||
37835064|NCT01236352|69519285|FG008|Overall Study|Subject request to discontinue treatment|0|||
37835065|NCT01236352|69519286|FG009|Overall Study|Subject request to discontinue treatment|1|||
37835066|NCT01236352|69519287|FG010|Overall Study|Subject request to discontinue treatment|4|||
37835067|NCT01236352|69519277|FG000|Overall Study|Subject to receive drug via EAP|1|||
37835068|NCT01236352|69519278|FG001|Overall Study|Subject to receive drug via EAP|1|||
37835069|NCT01236352|69519279|FG002|Overall Study|Subject to receive drug via EAP|1|||
37835070|NCT01236352|69519280|FG003|Overall Study|Subject to receive drug via EAP|0|||
37835071|NCT01236352|69519281|FG004|Overall Study|Subject to receive drug via EAP|0|||
37835072|NCT01236352|69519282|FG005|Overall Study|Subject to receive drug via EAP|0|||
37835073|NCT01236352|69519283|FG006|Overall Study|Subject to receive drug via EAP|0|||
37835074|NCT01236352|69519284|FG007|Overall Study|Subject to receive drug via EAP|2|||
37835075|NCT01236352|69519285|FG008|Overall Study|Subject to receive drug via EAP|0|||
37835076|NCT01236352|69519286|FG009|Overall Study|Subject to receive drug via EAP|4|||
37835077|NCT01236352|69519287|FG010|Overall Study|Subject to receive drug via EAP|0|||
37835078|NCT01236352|69519277|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
37835079|NCT01236352|69519278|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
37835080|NCT01236352|69519279|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
37835081|NCT01236352|69519280|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
37835082|NCT01236352|69519281|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
37835083|NCT01236352|69519282|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
37835084|NCT01236352|69519283|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
37835085|NCT01236352|69519284|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
37835086|NCT01236352|69519285|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
37835087|NCT01236352|69519286|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
37835088|NCT01236352|69519287|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
37835089|NCT01236352|69519277|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
37835090|NCT01236352|69519278|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
37835091|NCT01236352|69519279|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
37835092|NCT01236352|69519280|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
37835093|NCT01236352|69519281|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
37835094|NCT01236352|69519282|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
37835095|NCT01236352|69519283|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
37912534|NCT00891293|69599295|FG000|Overall Study|Sponsor termination|62|||
37912535|NCT00889421|69599299|FG000|Overall Study|Lack of Efficacy|3|||
37912536|NCT00889265|69599303|FG000|Overall Study|Adverse Event|1|||
37912537|NCT00889265|69599303|FG000|Overall Study|Lost to Follow-up|5|||
37912538|NCT00889265|69599303|FG000|Overall Study|Protocol Violation|1|||
37912539|NCT00603746|69599313|FG000|Overall Study|Adverse Event|2|||
37912540|NCT00603746|69599314|FG001|Overall Study|Adverse Event|3|||
37912541|NCT00603746|69599315|FG002|Overall Study|Adverse Event|0|||
37912542|NCT00603746|69599316|FG003|Overall Study|Adverse Event|1|||
37912543|NCT00603746|69599317|FG004|Overall Study|Adverse Event|0|||
37912544|NCT00603746|69599318|FG005|Overall Study|Adverse Event|4|||
37912545|NCT00603746|69599313|FG000|Overall Study|Lack of Efficacy|34|||
37912546|NCT00603746|69599314|FG001|Overall Study|Lack of Efficacy|11|||
37912547|NCT00603746|69599315|FG002|Overall Study|Lack of Efficacy|6|||
37912548|NCT00603746|69599316|FG003|Overall Study|Lack of Efficacy|11|||
37912549|NCT00603746|69599317|FG004|Overall Study|Lack of Efficacy|12|||
37912550|NCT00603746|69599318|FG005|Overall Study|Lack of Efficacy|8|||
37912551|NCT00603746|69599313|FG000|Overall Study|Protocol Violation|0|||
37912552|NCT00603746|69599314|FG001|Overall Study|Protocol Violation|3|||
37912553|NCT00603746|69599315|FG002|Overall Study|Protocol Violation|1|||
37912554|NCT00603746|69599316|FG003|Overall Study|Protocol Violation|0|||
37912555|NCT00603746|69599317|FG004|Overall Study|Protocol Violation|1|||
37912556|NCT00603746|69599318|FG005|Overall Study|Protocol Violation|0|||
37912557|NCT00603746|69599313|FG000|Overall Study|Lost to Follow-up|0|||
37912558|NCT00603746|69599314|FG001|Overall Study|Lost to Follow-up|1|||
37912559|NCT00603746|69599315|FG002|Overall Study|Lost to Follow-up|1|||
37912560|NCT00603746|69599316|FG003|Overall Study|Lost to Follow-up|0|||
37912561|NCT00603746|69599317|FG004|Overall Study|Lost to Follow-up|0|||
37912562|NCT00603746|69599318|FG005|Overall Study|Lost to Follow-up|0|||
37912563|NCT00603746|69599313|FG000|Overall Study|Physician Decision|1|||
37912564|NCT00603746|69599314|FG001|Overall Study|Physician Decision|0|||
37835096|NCT01236352|69519284|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
37912565|NCT00603746|69599315|FG002|Overall Study|Physician Decision|0|||
37912566|NCT00603746|69599316|FG003|Overall Study|Physician Decision|0|||
37912567|NCT00603746|69599317|FG004|Overall Study|Physician Decision|1|||
37912568|NCT00603746|69599318|FG005|Overall Study|Physician Decision|0|||
37912569|NCT00603746|69599313|FG000|Overall Study|Withdrawal by Subject|1|||
37912570|NCT00603746|69599314|FG001|Overall Study|Withdrawal by Subject|0|||
37912571|NCT00603746|69599315|FG002|Overall Study|Withdrawal by Subject|0|||
37912572|NCT00603746|69599316|FG003|Overall Study|Withdrawal by Subject|1|||
37912573|NCT00603746|69599317|FG004|Overall Study|Withdrawal by Subject|3|||
37912574|NCT00603746|69599318|FG005|Overall Study|Withdrawal by Subject|1|||
37912575|NCT00888329|69599334|FG000|Overall Study|Physician Decision|6|||
37912576|NCT00888329|69599335|FG001|Overall Study|Physician Decision|9|||
37912577|NCT00603590|69599343|FG000|Overall Study|Did not attend study clinic|39|||
37912578|NCT00603590|69599344|FG001|Overall Study|Did not attend study clinic|30|||
37912579|NCT00603590|69599343|FG000|Overall Study|Refused blood test|5|||
37912580|NCT00603590|69599344|FG001|Overall Study|Refused blood test|1|||
37912581|NCT00603590|69599343|FG000|Overall Study|Patient discontinued study drug|22|||
37912582|NCT00603590|69599344|FG001|Overall Study|Patient discontinued study drug|15|||
37912583|NCT00603590|69599343|FG000|Overall Study|Adverse Event|2|||
37912584|NCT00603590|69599344|FG001|Overall Study|Adverse Event|0|||
37912585|NCT00603590|69599343|FG000|Overall Study|Lost to Follow-up|8|||
37912586|NCT00603590|69599344|FG001|Overall Study|Lost to Follow-up|4|||
37912587|NCT00603590|69599343|FG000|Overall Study|Cardiovascular event|0|||
37912588|NCT00603590|69599344|FG001|Overall Study|Cardiovascular event|1|||
37912589|NCT00888173|69599350|FG000|Overall Study|Wrong Primary|1|||
37912590|NCT00888173|69599350|FG000|Overall Study|Ineligible: required test not done|1|||
37912591|NCT00887549|69599363|FG000|Induction Therapy|Adverse Event|8|||
37912592|NCT00887549|69599363|FG000|Induction Therapy|Physician Decision|1|||
37912593|NCT00887549|69599363|FG000|Induction Therapy|Progressive Disease|13|||
37912594|NCT00887549|69599363|FG000|Induction Therapy|Death due to Study Disease|4|||
37912595|NCT00887549|69599363|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
37912596|NCT00887549|69599363|FG000|Maintenance Therapy|Adverse Event|16|||
37912597|NCT00887549|69599363|FG000|Maintenance Therapy|Physician Decision|1|||
37912598|NCT00887549|69599363|FG000|Maintenance Therapy|Progressive Disease|25|||
37912599|NCT00887549|69599363|FG000|Maintenance Therapy|Death due to adverse event|1|||
37912600|NCT00887315|69599369|FG000|Overall Study|Study termination|7|||
38022256|NCT00208325|69705626|FG003|Overall Study|Withdrawal by Subject|0|||
38022257|NCT00208325|69705623|FG000|Overall Study|Revision|4|||
38022258|NCT00208325|69705624|FG001|Overall Study|Revision|1|||
38022259|NCT00208325|69705625|FG002|Overall Study|Revision|0|||
38022260|NCT00208325|69705626|FG003|Overall Study|Revision|4|||
38022261|NCT00208325|69705623|FG000|Overall Study|Lost to Follow-up|1|||
38022262|NCT00208325|69705624|FG001|Overall Study|Lost to Follow-up|0|||
38022263|NCT00208325|69705625|FG002|Overall Study|Lost to Follow-up|2|||
38022264|NCT00208325|69705626|FG003|Overall Study|Lost to Follow-up|0|||
38022265|NCT00208325|69705623|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
38022266|NCT00208325|69705624|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
38022267|NCT00208325|69705625|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
37912601|NCT00887315|69599370|FG001|Overall Study|Study termination|4|||
37912602|NCT03608826|69599376|FG000|Overall Study|Death|3|||
37912603|NCT03608826|69599376|FG000|Overall Study|Heart Transplant|3|||
37912604|NCT03608826|69599376|FG000|Overall Study|Physician Decision|4|||
37912605|NCT00887159|69599383|FG000|Overall Study|Disease progression|6|||
37912606|NCT00887159|69599384|FG001|Overall Study|Disease progression|39|||
37912607|NCT00887159|69599385|FG002|Overall Study|Disease progression|33|||
37912608|NCT00887159|69599383|FG000|Overall Study|Adverse Event|3|||
37912609|NCT00887159|69599384|FG001|Overall Study|Adverse Event|4|||
37912610|NCT00887159|69599385|FG002|Overall Study|Adverse Event|17|||
37912611|NCT00887159|69599383|FG000|Overall Study|Death|2|||
38022268|NCT00208325|69705626|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
37912612|NCT00887159|69599384|FG001|Overall Study|Death|2|||
37912613|NCT00887159|69599385|FG002|Overall Study|Death|0|||
37912614|NCT00887159|69599383|FG000|Overall Study|Withdrawal by Subject|4|||
37912615|NCT00887159|69599384|FG001|Overall Study|Withdrawal by Subject|4|||
37912616|NCT00887159|69599385|FG002|Overall Study|Withdrawal by Subject|2|||
37912617|NCT00887159|69599383|FG000|Overall Study|Alternative therapy|2|||
37912618|NCT00887159|69599384|FG001|Overall Study|Alternative therapy|0|||
38022269|NCT00208325|69705623|FG000|Overall Study|Does not wish to Continue in Study|5|||
38022270|NCT00208325|69705624|FG001|Overall Study|Does not wish to Continue in Study|8|||
38022271|NCT00208325|69705625|FG002|Overall Study|Does not wish to Continue in Study|3|||
38022272|NCT00208325|69705626|FG003|Overall Study|Does not wish to Continue in Study|2|||
37912619|NCT00887159|69599385|FG002|Overall Study|Alternative therapy|0|||
37912620|NCT00887159|69599383|FG000|Overall Study|Physician Decision|1|||
37912621|NCT00887159|69599384|FG001|Overall Study|Physician Decision|1|||
37912622|NCT00887159|69599385|FG002|Overall Study|Physician Decision|0|||
38022273|NCT00208325|69705623|FG000|Overall Study|Other|2|||
38022274|NCT00208325|69705624|FG001|Overall Study|Other|1|||
38022275|NCT00208325|69705625|FG002|Overall Study|Other|1|||
38022276|NCT00208325|69705626|FG003|Overall Study|Other|0|||
38022277|NCT00208325|69705623|FG000|Overall Study|Mis-Randomized|17|||
38022278|NCT00208325|69705624|FG001|Overall Study|Mis-Randomized|20|||
38022279|NCT00208325|69705625|FG002|Overall Study|Mis-Randomized|0|||
37912623|NCT00887159|69599383|FG000|Overall Study|Sympomatic deterioration|1|||
37912624|NCT00887159|69599384|FG001|Overall Study|Sympomatic deterioration|0|||
37912625|NCT00887159|69599385|FG002|Overall Study|Sympomatic deterioration|0|||
37912626|NCT00887159|69599383|FG000|Overall Study|Treatment delayed|1|||
37912627|NCT00887159|69599384|FG001|Overall Study|Treatment delayed|1|||
37912628|NCT00887159|69599385|FG002|Overall Study|Treatment delayed|0|||
38022280|NCT00208325|69705626|FG003|Overall Study|Mis-Randomized|0|||
38022281|NCT00160667|69705639|FG000|Overall Study|Adverse Event|3|||
37912629|NCT00887159|69599383|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
37912630|NCT00887159|69599384|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
37912631|NCT00887159|69599385|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
37912632|NCT00887159|69599383|FG000|Overall Study|Received more tx instead of observation|1|||
37912633|NCT00887159|69599384|FG001|Overall Study|Received more tx instead of observation|0|||
37912634|NCT00887159|69599385|FG002|Overall Study|Received more tx instead of observation|0|||
37912635|NCT00887159|69599383|FG000|Overall Study|Ineligible|5|||
37912636|NCT00887159|69599384|FG001|Overall Study|Ineligible|1|||
38022282|NCT00160667|69705640|FG001|Overall Study|Adverse Event|1|||
38022283|NCT00160667|69705641|FG002|Overall Study|Adverse Event|4|||
38022284|NCT00160667|69705639|FG000|Overall Study|Withdrawal by Subject|2|||
38022285|NCT00160667|69705640|FG001|Overall Study|Withdrawal by Subject|0|||
38022286|NCT00160667|69705641|FG002|Overall Study|Withdrawal by Subject|1|||
38022287|NCT00160667|69705639|FG000|Overall Study|Lack of Efficacy|0|||
37912637|NCT00887159|69599385|FG002|Overall Study|Ineligible|0|||
37912638|NCT00887159|69599383|FG000|Overall Study|Never started assigned therapy|3|||
37912639|NCT00887159|69599384|FG001|Overall Study|Never started assigned therapy|3|||
37912640|NCT00887159|69599385|FG002|Overall Study|Never started assigned therapy|4|||
37912641|NCT00886769|69599397|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
37912642|NCT00886769|69599398|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
37912643|NCT00886613|69599407|FG000|Overall Study|Protocol deviation (Part B)|1|||
37912644|NCT00886613|69599408|FG001|Overall Study|Protocol deviation (Part B)|0|||
37912645|NCT00886613|69599409|FG002|Overall Study|Protocol deviation (Part B)|0|||
37912646|NCT00886613|69599407|FG000|Overall Study|Lost to follow-up (Part B)|1|||
38022288|NCT00160667|69705640|FG001|Overall Study|Lack of Efficacy|1|||
38022289|NCT00160667|69705641|FG002|Overall Study|Lack of Efficacy|0|||
38022290|NCT00160667|69705639|FG000|Overall Study|Protocol Violation|0|||
38022291|NCT00160667|69705640|FG001|Overall Study|Protocol Violation|1|||
38022292|NCT00160667|69705641|FG002|Overall Study|Protocol Violation|0|||
38022293|NCT00160667|69705639|FG000|Overall Study|Patient decision|0|||
38022294|NCT00160667|69705640|FG001|Overall Study|Patient decision|0|||
38022295|NCT00160667|69705641|FG002|Overall Study|Patient decision|1|||
38022296|NCT00206375|69705653|FG000|Overall Study|Lost to Follow-up|1|||
38022297|NCT00206375|69705654|FG001|Overall Study|Lost to Follow-up|0|||
38022298|NCT00206375|69705655|FG002|Overall Study|Lost to Follow-up|0|||
38022299|NCT00206375|69705653|FG000|Overall Study|Withdrawal by Subject|2|||
38022300|NCT00206375|69705654|FG001|Overall Study|Withdrawal by Subject|1|||
38022301|NCT00206375|69705655|FG002|Overall Study|Withdrawal by Subject|3|||
38022302|NCT00206375|69705653|FG000|Overall Study|Study terminated due to lack of funds|0|||
38022303|NCT00206375|69705654|FG001|Overall Study|Study terminated due to lack of funds|1|||
38022304|NCT00206375|69705655|FG002|Overall Study|Study terminated due to lack of funds|1|||
38022305|NCT00160199|69705665|FG000|Overall Study|Adverse Event|5|||
38022306|NCT00160199|69705666|FG001|Overall Study|Adverse Event|14|||
38022307|NCT00160199|69705665|FG000|Overall Study|Lack of Efficacy|0|||
38022308|NCT00160199|69705666|FG001|Overall Study|Lack of Efficacy|1|||
38022309|NCT00160199|69705665|FG000|Overall Study|Lost to Follow-up|7|||
38022310|NCT00160199|69705666|FG001|Overall Study|Lost to Follow-up|7|||
38022311|NCT00160199|69705665|FG000|Overall Study|Withdrawal by Subject|4|||
37912647|NCT00886613|69599408|FG001|Overall Study|Lost to follow-up (Part B)|0|||
38022312|NCT00160199|69705666|FG001|Overall Study|Withdrawal by Subject|6|||
38022313|NCT00160199|69705665|FG000|Overall Study|Administrative|0|||
37912648|NCT00886613|69599409|FG002|Overall Study|Lost to follow-up (Part B)|1|||
37912649|NCT00886613|69599407|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
38022314|NCT00160199|69705666|FG001|Overall Study|Administrative|1|||
38022315|NCT00160199|69705665|FG000|Overall Study|Protocol Violation|8|||
38022316|NCT00160199|69705666|FG001|Overall Study|Protocol Violation|8|||
38022317|NCT00157157|69705672|FG000|Overall Study|Withdrawal by Subject|6|||
38022318|NCT00157157|69705672|FG000|Overall Study|Physician Decision|1|||
37700366|NCT02319044|69177369|FG000|Overall Study|Not treated|0|||
38022319|NCT00157157|69705672|FG000|Overall Study|Lost to Follow-up|1|||
38022320|NCT00157157|69705672|FG000|Overall Study|Enrolled in another study|1|||
37912650|NCT00886613|69599408|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
37912651|NCT00886613|69599409|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
37912652|NCT00886379|69599425|FG000|Overall Study|Transferred Schools|0|||
37912653|NCT00886379|69599426|FG001|Overall Study|Transferred Schools|0|||
38022321|NCT00157157|69705672|FG000|Overall Study|Met exclusion criteria|1|||
38022322|NCT00157157|69705672|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
37912654|NCT00886379|69599427|FG002|Overall Study|Transferred Schools|2|||
37912655|NCT00886379|69599428|FG003|Overall Study|Transferred Schools|1|||
37912656|NCT00886379|69599429|FG004|Overall Study|Transferred Schools|1|||
37912657|NCT00886379|69599425|FG000|Overall Study|Final blood draw not obtained|3|||
37912658|NCT00886379|69599426|FG001|Overall Study|Final blood draw not obtained|3|||
37912659|NCT00886379|69599427|FG002|Overall Study|Final blood draw not obtained|4|||
37912660|NCT00886379|69599428|FG003|Overall Study|Final blood draw not obtained|2|||
37912661|NCT00886379|69599429|FG004|Overall Study|Final blood draw not obtained|2|||
37912662|NCT00599196|69599441|FG000|Overall Study|Lack of Efficacy|22|||
37912663|NCT00599196|69599441|FG000|Overall Study|Adverse Event|93|||
37912664|NCT00599196|69599441|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
37912665|NCT00599196|69599441|FG000|Overall Study|Subject withdrew consent|43|||
37912666|NCT00599196|69599441|FG000|Overall Study|Study ended per sponsor|197|||
37912667|NCT00599196|69599441|FG000|Overall Study|Lost to Follow-up|17|||
37912668|NCT00599196|69599441|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
37912669|NCT00599196|69599441|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
37912670|NCT00599196|69599441|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
37912671|NCT00599196|69599441|FG000|Overall Study|Other: Pt Moved To Australia|1|||
37912672|NCT00599196|69599441|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
37912673|NCT00599196|69599441|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
37912674|NCT00603512|69599450|FG000|Overall Study|Adverse Event|0|||
37912675|NCT00603512|69599451|FG001|Overall Study|Adverse Event|2|||
37912676|NCT00603512|69599452|FG002|Overall Study|Adverse Event|4|||
37912677|NCT00603512|69599453|FG003|Overall Study|Adverse Event|4|||
37912678|NCT00603512|69599454|FG004|Overall Study|Adverse Event|2|||
37912679|NCT00603512|69599450|FG000|Overall Study|Lack of Efficacy|0|||
37912680|NCT00603512|69599451|FG001|Overall Study|Lack of Efficacy|1|||
37912681|NCT00603512|69599452|FG002|Overall Study|Lack of Efficacy|0|||
37912682|NCT00603512|69599453|FG003|Overall Study|Lack of Efficacy|0|||
37912683|NCT00603512|69599454|FG004|Overall Study|Lack of Efficacy|1|||
37912684|NCT00603512|69599450|FG000|Overall Study|Other|2|||
37912685|NCT00603512|69599451|FG001|Overall Study|Other|1|||
37912686|NCT00603512|69599452|FG002|Overall Study|Other|0|||
37912687|NCT00603512|69599453|FG003|Overall Study|Other|1|||
37912688|NCT00603512|69599454|FG004|Overall Study|Other|1|||
37912689|NCT00603512|69599450|FG000|Overall Study|Withdrawal by Subject|0|||
37912690|NCT00603512|69599451|FG001|Overall Study|Withdrawal by Subject|0|||
37912691|NCT00603512|69599452|FG002|Overall Study|Withdrawal by Subject|0|||
37912692|NCT00603512|69599453|FG003|Overall Study|Withdrawal by Subject|0|||
37912693|NCT00603512|69599454|FG004|Overall Study|Withdrawal by Subject|1|||
37912694|NCT00603512|69599450|FG000|Overall Study|Randomized but not treated|0|||
37912695|NCT00603512|69599451|FG001|Overall Study|Randomized but not treated|1|||
37912696|NCT00603512|69599452|FG002|Overall Study|Randomized but not treated|1|||
37912697|NCT00603512|69599453|FG003|Overall Study|Randomized but not treated|2|||
37912698|NCT00603512|69599454|FG004|Overall Study|Randomized but not treated|0|||
37700367|NCT02319044|69177370|FG001|Overall Study|Not treated|2|||
37700368|NCT02319044|69177371|FG002|Overall Study|Not treated|2|||
37912699|NCT04242875|69599466|FG000|Overall Study|Adverse Event|2|||
37912700|NCT00603278|69599480|FG000|Overall Study|Lack of Efficacy|35|||
37912701|NCT00603278|69599481|FG001|Overall Study|Lack of Efficacy|10|||
37912702|NCT00603278|69599482|FG002|Overall Study|Lack of Efficacy|11|||
38022323|NCT00203411|69705683|FG000|Follow-up|Progressive Disease|4|||
38022324|NCT00203021|69705690|FG000|Overall Study|Death|4|||
38022325|NCT00203021|69705691|FG001|Overall Study|Death|1|||
38022326|NCT00203021|69705690|FG000|Overall Study|Adverse Event|10|||
38022327|NCT00203021|69705691|FG001|Overall Study|Adverse Event|5|||
37912703|NCT00603278|69599483|FG003|Overall Study|Lack of Efficacy|8|||
37912704|NCT00603278|69599484|FG004|Overall Study|Lack of Efficacy|7|||
37912705|NCT00603278|69599485|FG005|Overall Study|Lack of Efficacy|14|||
37912706|NCT00603278|69599480|FG000|Overall Study|Adverse Event|0|||
37912707|NCT00603278|69599481|FG001|Overall Study|Adverse Event|3|||
37912708|NCT00603278|69599482|FG002|Overall Study|Adverse Event|1|||
37912709|NCT00603278|69599483|FG003|Overall Study|Adverse Event|0|||
37700369|NCT01649765|69177382|FG000|Overall Study|Adverse Event|5|||
37912710|NCT00603278|69599484|FG004|Overall Study|Adverse Event|2|||
38022328|NCT00203021|69705690|FG000|Overall Study|Withdrawal by Subject|45|||
38022329|NCT00203021|69705691|FG001|Overall Study|Withdrawal by Subject|48|||
37912711|NCT00603278|69599485|FG005|Overall Study|Adverse Event|1|||
37912712|NCT00603278|69599480|FG000|Overall Study|Withdrawal by Subject|2|||
37912713|NCT00603278|69599481|FG001|Overall Study|Withdrawal by Subject|3|||
37912714|NCT00603278|69599482|FG002|Overall Study|Withdrawal by Subject|1|||
37912715|NCT00603278|69599483|FG003|Overall Study|Withdrawal by Subject|2|||
37912716|NCT00603278|69599484|FG004|Overall Study|Withdrawal by Subject|1|||
37912717|NCT00603278|69599485|FG005|Overall Study|Withdrawal by Subject|2|||
37912718|NCT00603278|69599480|FG000|Overall Study|Protocol Violation|3|||
37912719|NCT00603278|69599481|FG001|Overall Study|Protocol Violation|0|||
37912720|NCT00603278|69599482|FG002|Overall Study|Protocol Violation|1|||
37912721|NCT00603278|69599483|FG003|Overall Study|Protocol Violation|1|||
37912722|NCT00603278|69599484|FG004|Overall Study|Protocol Violation|0|||
37912723|NCT00603278|69599485|FG005|Overall Study|Protocol Violation|1|||
37912724|NCT00603278|69599480|FG000|Overall Study|Physician Decision|0|||
37912725|NCT00603278|69599481|FG001|Overall Study|Physician Decision|1|||
37912726|NCT00603278|69599482|FG002|Overall Study|Physician Decision|0|||
37912727|NCT00603278|69599483|FG003|Overall Study|Physician Decision|0|||
37912728|NCT00603278|69599484|FG004|Overall Study|Physician Decision|2|||
37912729|NCT00603278|69599485|FG005|Overall Study|Physician Decision|1|||
37912730|NCT00603278|69599480|FG000|Overall Study|Lost to Follow-up|1|||
37912731|NCT00603278|69599481|FG001|Overall Study|Lost to Follow-up|0|||
37912732|NCT00603278|69599482|FG002|Overall Study|Lost to Follow-up|0|||
37912733|NCT00603278|69599483|FG003|Overall Study|Lost to Follow-up|0|||
37912734|NCT00603278|69599484|FG004|Overall Study|Lost to Follow-up|1|||
37912735|NCT00603278|69599485|FG005|Overall Study|Lost to Follow-up|0|||
37912736|NCT00876447|69599501|FG000|Overall Study|Other miscellaneous reasons|3|||
37912737|NCT00876447|69599502|FG001|Overall Study|Other miscellaneous reasons|8|||
37912738|NCT00876447|69599501|FG000|Overall Study|Site closure|19|||
37912739|NCT00876447|69599502|FG001|Overall Study|Site closure|14|||
37912740|NCT00876447|69599501|FG000|Overall Study|Protocol Violation|9|||
37912741|NCT00876447|69599502|FG001|Overall Study|Protocol Violation|3|||
37912742|NCT00876447|69599501|FG000|Overall Study|Personal reasons|30|||
37912743|NCT00876447|69599502|FG001|Overall Study|Personal reasons|28|||
37912744|NCT00876447|69599501|FG000|Overall Study|Lost to Follow-up|6|||
37912745|NCT00876447|69599502|FG001|Overall Study|Lost to Follow-up|15|||
37912746|NCT00876447|69599501|FG000|Overall Study|Pregnancy|4|||
37912747|NCT00876447|69599502|FG001|Overall Study|Pregnancy|2|||
37912748|NCT00876447|69599501|FG000|Overall Study|Lack of Efficacy|5|||
37912749|NCT00876447|69599502|FG001|Overall Study|Lack of Efficacy|3|||
37912750|NCT00876447|69599501|FG000|Overall Study|Adverse Event|4|||
37912751|NCT00876447|69599502|FG001|Overall Study|Adverse Event|8|||
37912752|NCT00598650|69599532|FG000|Overall Study|Withdrawal by Subject|3|||
37912753|NCT00598650|69599532|FG000|Overall Study|Adverse Event|18|||
37912754|NCT00598650|69599532|FG000|Overall Study|No treatment for 3 weeks|1|||
37912755|NCT00598650|69599532|FG000|Overall Study|Not eligible|1|||
37912756|NCT00598650|69599532|FG000|Overall Study|Prohibited Concomitant Medication|2|||
37912757|NCT00598650|69599532|FG000|Overall Study|Physician Decision|2|||
37912758|NCT04249076|69599539|FG000|Overall Study|Adverse Event|1|||
37912759|NCT04249076|69599540|FG001|Overall Study|Adverse Event|1|||
37912760|NCT04249076|69599539|FG000|Overall Study|Protocol Violation|1|||
37912761|NCT04249076|69599540|FG001|Overall Study|Protocol Violation|2|||
37912762|NCT04249076|69599539|FG000|Overall Study|Lack of Efficacy|0|||
37912763|NCT04249076|69599540|FG001|Overall Study|Lack of Efficacy|1|||
37912764|NCT04249076|69599539|FG000|Overall Study|Withdrawal by Subject|0|||
37912765|NCT04249076|69599540|FG001|Overall Study|Withdrawal by Subject|1|||
37912766|NCT04150107|69599548|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
38022330|NCT00203021|69705690|FG000|Overall Study|Lost to Follow-up|9|||
38022331|NCT00203021|69705691|FG001|Overall Study|Lost to Follow-up|7|||
38022332|NCT00203021|69705690|FG000|Overall Study|Other than specified|11|||
37912767|NCT04150107|69599549|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
37912768|NCT04150107|69599548|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
37912769|NCT04150107|69599549|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
37912770|NCT00875979|69599559|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
37912771|NCT00875979|69599560|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
38022333|NCT00203021|69705691|FG001|Overall Study|Other than specified|16|||
38022334|NCT00201851|69705700|FG000|Overall Study|Lost to Follow-up|2|||
37912772|NCT00875979|69599559|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
37912773|NCT00875979|69599560|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
37912774|NCT00875979|69599559|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
37912775|NCT00875979|69599560|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
37912776|NCT00875979|69599559|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
37912777|NCT00875979|69599560|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
37912778|NCT00875979|69599559|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
38022335|NCT00201851|69705701|FG001|Overall Study|Lost to Follow-up|1|||
37912779|NCT00875979|69599560|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
38022336|NCT00201851|69705702|FG002|Overall Study|Lost to Follow-up|0|||
37835097|NCT01236352|69519285|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
37835098|NCT01236352|69519286|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
37835099|NCT01236352|69519287|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
37835100|NCT01236352|69519277|FG000|Overall Study|Lack of response to drug|0|||
37835101|NCT01236352|69519278|FG001|Overall Study|Lack of response to drug|0|||
37835102|NCT01236352|69519279|FG002|Overall Study|Lack of response to drug|0|||
37835103|NCT01236352|69519280|FG003|Overall Study|Lack of response to drug|0|||
37835104|NCT01236352|69519281|FG004|Overall Study|Lack of response to drug|0|||
38022337|NCT00201851|69705700|FG000|Overall Study|Ineligible post enrollment|6|||
37912780|NCT00875979|69599559|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
37912781|NCT00875979|69599560|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
37912782|NCT00875979|69599559|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
37912783|NCT00875979|69599560|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
37912784|NCT00875979|69599559|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
37912785|NCT00875979|69599560|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
37912786|NCT00875979|69599559|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
37912787|NCT00875979|69599560|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
37912788|NCT00602420|69599568|FG000|Overall Study|Death|1|||
37912789|NCT00602420|69599569|FG001|Overall Study|Death|4|||
37912790|NCT00602420|69599568|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
37912791|NCT00602420|69599569|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
37912792|NCT00602420|69599568|FG000|Overall Study|Withdrawal by Subject|18|||
37912793|NCT00602420|69599569|FG001|Overall Study|Withdrawal by Subject|17|||
37912794|NCT00602420|69599568|FG000|Overall Study|Adverse Event|1|||
37912795|NCT00602420|69599569|FG001|Overall Study|Adverse Event|0|||
37912796|NCT00875667|69599583|FG000|Overall Study|Adverse Event|29|||
37912797|NCT00875667|69599584|FG001|Overall Study|Adverse Event|10|||
37912798|NCT00875667|69599583|FG000|Overall Study|Withdrawal by Subject|17|||
37912799|NCT00875667|69599584|FG001|Overall Study|Withdrawal by Subject|5|||
37912800|NCT00875667|69599583|FG000|Overall Study|Death|7|||
37912801|NCT00875667|69599584|FG001|Overall Study|Death|2|||
37912802|NCT00875667|69599583|FG000|Overall Study|Protocol Violation|2|||
37912803|NCT00875667|69599584|FG001|Overall Study|Protocol Violation|0|||
37912804|NCT00875667|69599583|FG000|Overall Study|Disease Progression|100|||
38022338|NCT00201851|69705701|FG001|Overall Study|Ineligible post enrollment|1|||
38022339|NCT00201851|69705702|FG002|Overall Study|Ineligible post enrollment|1|||
38022340|NCT00200057|69705710|FG000|Overall Study|Lack of Efficacy|3|||
38022341|NCT00200057|69705710|FG000|Overall Study|Exited due to terminal illness of PI|2|||
38022342|NCT00200057|69705710|FG000|Overall Study|Withdrawal by Subject|1|||
38022343|NCT00200057|69705710|FG000|Overall Study|Change in medical condition|1|||
38022344|NCT00200057|69705710|FG000|Overall Study|Infection|1|||
38022345|NCT00200057|69705710|FG000|Overall Study|Death|1|||
38022346|NCT03129100|69705719|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
38022347|NCT03129100|69705720|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
38022348|NCT03129100|69705721|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
38022349|NCT03129100|69705722|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
38022350|NCT03129100|69705723|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
38022351|NCT03129100|69705724|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
37912805|NCT00875667|69599584|FG001|Overall Study|Disease Progression|49|||
37912806|NCT00875667|69599583|FG000|Overall Study|Miscellaneous|12|||
37912807|NCT00875667|69599584|FG001|Overall Study|Miscellaneous|6|||
37912808|NCT00875667|69599583|FG000|Overall Study|Randomized but no Study Drug Given|3|||
37912809|NCT00875667|69599584|FG001|Overall Study|Randomized but no Study Drug Given|1|||
38022352|NCT03129100|69705725|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
38022353|NCT03129100|69705726|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
38022354|NCT03129100|69705727|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
38022355|NCT03129100|69705728|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
38022356|NCT03129100|69705729|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
38022357|NCT03129100|69705730|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
38022358|NCT03129100|69705731|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
38022359|NCT03129100|69705732|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
38022360|NCT03129100|69705733|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
38022361|NCT03129100|69705734|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
38022362|NCT03129100|69705735|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
38022363|NCT03129100|69705736|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
38022364|NCT03129100|69705737|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
38022365|NCT03129100|69705738|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
38022366|NCT03129100|69705739|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
38022367|NCT03129100|69705740|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
38022368|NCT03129100|69705741|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
38022369|NCT03129100|69705742|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
37912810|NCT00602030|69599594|FG000|Lead-in Phase|Disease Progression|2|||
38022370|NCT03129100|69705743|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
38022371|NCT03129100|69705744|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
38022372|NCT03129100|69705719|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
38022373|NCT03129100|69705720|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
38022374|NCT03129100|69705721|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
37912811|NCT00602030|69599595|FG001|Lead-in Phase|Disease Progression|3|||
37912812|NCT00602030|69599596|FG002|Lead-in Phase|Disease Progression|0|||
37912813|NCT00602030|69599597|FG003|Lead-in Phase|Disease Progression|0|||
37912814|NCT00602030|69599598|FG004|Lead-in Phase|Disease Progression|0|||
37912815|NCT00602030|69599594|FG000|Lead-in Phase|Adverse Event|0|||
37912816|NCT00602030|69599595|FG001|Lead-in Phase|Adverse Event|2|||
37912817|NCT00602030|69599596|FG002|Lead-in Phase|Adverse Event|0|||
37912818|NCT00602030|69599597|FG003|Lead-in Phase|Adverse Event|0|||
37912819|NCT00602030|69599598|FG004|Lead-in Phase|Adverse Event|0|||
37912820|NCT00602030|69599594|FG000|Double-blind Phase|Disease progression|0|||
37912821|NCT00602030|69599595|FG001|Double-blind Phase|Disease progression|0|||
37912822|NCT00602030|69599596|FG002|Double-blind Phase|Disease progression|33|||
37912823|NCT00602030|69599597|FG003|Double-blind Phase|Disease progression|30|||
37912824|NCT00602030|69599598|FG004|Double-blind Phase|Disease progression|0|||
37912825|NCT00602030|69599594|FG000|Double-blind Phase|Adverse Event|0|||
37912826|NCT00602030|69599595|FG001|Double-blind Phase|Adverse Event|0|||
37912827|NCT00602030|69599596|FG002|Double-blind Phase|Adverse Event|9|||
37912828|NCT00602030|69599597|FG003|Double-blind Phase|Adverse Event|18|||
37912829|NCT00602030|69599598|FG004|Double-blind Phase|Adverse Event|0|||
37912830|NCT00602030|69599594|FG000|Double-blind Phase|Consent withdrawal|0|||
37912831|NCT00602030|69599595|FG001|Double-blind Phase|Consent withdrawal|0|||
37912832|NCT00602030|69599596|FG002|Double-blind Phase|Consent withdrawal|4|||
37912833|NCT00602030|69599597|FG003|Double-blind Phase|Consent withdrawal|3|||
37912834|NCT00602030|69599598|FG004|Double-blind Phase|Consent withdrawal|0|||
37912835|NCT00602030|69599594|FG000|Double-blind Phase|Death|0|||
37912836|NCT00602030|69599595|FG001|Double-blind Phase|Death|0|||
37912837|NCT00602030|69599596|FG002|Double-blind Phase|Death|3|||
37912838|NCT00602030|69599597|FG003|Double-blind Phase|Death|3|||
37912839|NCT00602030|69599598|FG004|Double-blind Phase|Death|0|||
37912840|NCT00602030|69599594|FG000|Double-blind Phase|Administrative decision|0|||
37912841|NCT00602030|69599595|FG001|Double-blind Phase|Administrative decision|0|||
37912842|NCT00602030|69599596|FG002|Double-blind Phase|Administrative decision|0|||
37912843|NCT00602030|69599597|FG003|Double-blind Phase|Administrative decision|2|||
37912844|NCT00602030|69599598|FG004|Double-blind Phase|Administrative decision|0|||
37912845|NCT00602030|69599594|FG000|Double-blind Phase|Ineligibility|0|||
37912846|NCT00602030|69599595|FG001|Double-blind Phase|Ineligibility|0|||
37912847|NCT00602030|69599596|FG002|Double-blind Phase|Ineligibility|0|||
37912848|NCT00602030|69599597|FG003|Double-blind Phase|Ineligibility|1|||
37912849|NCT00602030|69599598|FG004|Double-blind Phase|Ineligibility|0|||
37912850|NCT00602030|69599594|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
37912851|NCT00602030|69599595|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
37912852|NCT00602030|69599596|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
37912853|NCT00602030|69599597|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
37912854|NCT00602030|69599598|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
37912855|NCT00602030|69599594|FG000|Double-blind Phase|Reason not specified|0|||
37912856|NCT00602030|69599595|FG001|Double-blind Phase|Reason not specified|0|||
37912857|NCT00602030|69599596|FG002|Double-blind Phase|Reason not specified|4|||
37912858|NCT00602030|69599597|FG003|Double-blind Phase|Reason not specified|2|||
37912859|NCT00602030|69599598|FG004|Double-blind Phase|Reason not specified|0|||
37912860|NCT00602030|69599594|FG000|Crossover Phase|Disease Progression|0|||
37912861|NCT00602030|69599595|FG001|Crossover Phase|Disease Progression|0|||
37912862|NCT00602030|69599596|FG002|Crossover Phase|Disease Progression|0|||
37912863|NCT00602030|69599597|FG003|Crossover Phase|Disease Progression|0|||
37912864|NCT00602030|69599598|FG004|Crossover Phase|Disease Progression|11|||
37912865|NCT00602030|69599594|FG000|Crossover Phase|Adverse Event|0|||
37912866|NCT00602030|69599595|FG001|Crossover Phase|Adverse Event|0|||
37912867|NCT00602030|69599596|FG002|Crossover Phase|Adverse Event|0|||
37912868|NCT00602030|69599597|FG003|Crossover Phase|Adverse Event|0|||
37912869|NCT00602030|69599598|FG004|Crossover Phase|Adverse Event|3|||
37912870|NCT00602030|69599594|FG000|Crossover Phase|Consent withdrawal|0|||
37912871|NCT00602030|69599595|FG001|Crossover Phase|Consent withdrawal|0|||
37912872|NCT00602030|69599596|FG002|Crossover Phase|Consent withdrawal|0|||
37912873|NCT00602030|69599597|FG003|Crossover Phase|Consent withdrawal|0|||
37912874|NCT00602030|69599598|FG004|Crossover Phase|Consent withdrawal|2|||
37912875|NCT00549757|69599612|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
37912876|NCT00549757|69599613|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
37912877|NCT00549757|69599612|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
37912878|NCT00549757|69599613|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
37912879|NCT00549757|69599612|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
37700370|NCT01649765|69177383|FG001|Overall Study|Adverse Event|3|||
37912880|NCT00549757|69599613|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
37912881|NCT00549757|69599612|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
37912882|NCT00549757|69599613|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
37912883|NCT00549757|69599612|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
37912884|NCT00549757|69599613|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
37912885|NCT00549757|69599612|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
37912886|NCT00549757|69599613|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
37912887|NCT00549757|69599612|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
37912888|NCT00549757|69599613|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
37912889|NCT00549757|69599612|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
37912890|NCT00549757|69599613|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
37912891|NCT00549757|69599612|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
37912892|NCT00549757|69599613|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
37912893|NCT00549757|69599612|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
37912894|NCT00549757|69599613|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
37912895|NCT00549757|69599612|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
37912896|NCT00549757|69599613|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
37912897|NCT00549757|69599612|FG000|Extension Period (in Average 9 Months)|Death|143|||
37912898|NCT00549757|69599613|FG001|Extension Period (in Average 9 Months)|Death|136|||
37912899|NCT00549757|69599612|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
37912900|NCT00549757|69599613|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
37912901|NCT00549757|69599612|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
37912902|NCT00549757|69599613|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
37912903|NCT00549757|69599612|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
37912904|NCT00549757|69599613|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
37912905|NCT00549601|69599628|FG000|Randomized|Protocol Violation|0|||
37912906|NCT00549601|69599629|FG001|Randomized|Protocol Violation|0|||
37912907|NCT00549601|69599630|FG002|Randomized|Protocol Violation|1|||
37912908|NCT00549601|69599628|FG000|Randomized|Withdrawal by Subject|0|||
37912909|NCT00549601|69599629|FG001|Randomized|Withdrawal by Subject|1|||
37912910|NCT00549601|69599630|FG002|Randomized|Withdrawal by Subject|1|||
37912911|NCT00549601|69599628|FG000|Received Study Drug|Adverse Event|2|||
37912912|NCT00549601|69599629|FG001|Received Study Drug|Adverse Event|5|||
37912913|NCT00549601|69599630|FG002|Received Study Drug|Adverse Event|1|||
37912914|NCT00549601|69599628|FG000|Received Study Drug|Death|0|||
37912915|NCT00549601|69599629|FG001|Received Study Drug|Death|1|||
37912916|NCT00549601|69599630|FG002|Received Study Drug|Death|0|||
37912917|NCT00549601|69599628|FG000|Received Study Drug|Lost to Follow-up|0|||
37912918|NCT00549601|69599629|FG001|Received Study Drug|Lost to Follow-up|1|||
37912919|NCT00549601|69599630|FG002|Received Study Drug|Lost to Follow-up|1|||
37912920|NCT00549601|69599628|FG000|Received Study Drug|Protocol Violation|3|||
37912921|NCT00549601|69599629|FG001|Received Study Drug|Protocol Violation|4|||
37912922|NCT00549601|69599630|FG002|Received Study Drug|Protocol Violation|1|||
37912923|NCT00549601|69599628|FG000|Received Study Drug|Withdrawal by Subject|2|||
37912924|NCT00549601|69599629|FG001|Received Study Drug|Withdrawal by Subject|0|||
37912925|NCT00549601|69599630|FG002|Received Study Drug|Withdrawal by Subject|1|||
37912926|NCT00601640|69599656|FG000|Overall Study|Withdrawal by Subject|3|||
37912927|NCT00601640|69599657|FG001|Overall Study|Withdrawal by Subject|0|||
37912928|NCT00601640|69599658|FG002|Overall Study|Withdrawal by Subject|7|||
37912929|NCT00601640|69599656|FG000|Overall Study|Death|1|||
37912930|NCT00601640|69599657|FG001|Overall Study|Death|0|||
37912931|NCT00601640|69599658|FG002|Overall Study|Death|0|||
37912932|NCT00601640|69599656|FG000|Overall Study|Adverse Event|0|||
37912933|NCT00601640|69599657|FG001|Overall Study|Adverse Event|4|||
37912934|NCT00601640|69599658|FG002|Overall Study|Adverse Event|2|||
37912935|NCT00601640|69599656|FG000|Overall Study|intercurrent illness|1|||
37912936|NCT00601640|69599657|FG001|Overall Study|intercurrent illness|0|||
37912937|NCT00601640|69599658|FG002|Overall Study|intercurrent illness|0|||
37912938|NCT00601640|69599656|FG000|Overall Study|change in eligibility status|0|||
37912939|NCT00601640|69599657|FG001|Overall Study|change in eligibility status|1|||
37912940|NCT00601640|69599658|FG002|Overall Study|change in eligibility status|1|||
37912941|NCT02805725|69599673|FG000|Phase I (Dose Escalation Part)|Clinical progression|0|||
38022375|NCT03129100|69705722|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
38022376|NCT03129100|69705723|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
37912942|NCT02805725|69599674|FG001|Phase I (Dose Escalation Part)|Clinical progression|0|||
37912943|NCT02805725|69599675|FG002|Phase I (Dose Escalation Part)|Clinical progression|1|||
38022377|NCT03129100|69705724|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
38022378|NCT03129100|69705725|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
38022379|NCT03129100|69705726|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
37912944|NCT02805725|69599676|FG003|Phase I (Dose Escalation Part)|Clinical progression|0|||
37912945|NCT02805725|69599677|FG004|Phase I (Dose Escalation Part)|Clinical progression|0|||
37912946|NCT02805725|69599673|FG000|Phase I (Dose Escalation Part)|Adverse Event|0|||
37912947|NCT02805725|69599674|FG001|Phase I (Dose Escalation Part)|Adverse Event|0|||
37912948|NCT02805725|69599675|FG002|Phase I (Dose Escalation Part)|Adverse Event|1|||
37912949|NCT02805725|69599676|FG003|Phase I (Dose Escalation Part)|Adverse Event|2|||
37912950|NCT02805725|69599677|FG004|Phase I (Dose Escalation Part)|Adverse Event|0|||
37912951|NCT02805725|69599673|FG000|Phase II|Protocol Violation|0|||
37912952|NCT02805725|69599674|FG001|Phase II|Protocol Violation|0|||
37912953|NCT02805725|69599675|FG002|Phase II|Protocol Violation|0|||
37912954|NCT02805725|69599676|FG003|Phase II|Protocol Violation|0|||
37912955|NCT02805725|69599677|FG004|Phase II|Protocol Violation|6|||
37912956|NCT00546871|69599694|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
37912957|NCT00546871|69599695|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
37912958|NCT00546871|69599694|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
37912959|NCT00546871|69599695|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
37912960|NCT00546871|69599694|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
37912961|NCT00546871|69599695|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
37912962|NCT00546871|69599694|FG000|Study Extension Period|Protocol Violation|1|||
37912963|NCT00546871|69599695|FG001|Study Extension Period|Protocol Violation|0|||
37912964|NCT00546871|69599694|FG000|Study Extension Period|Withdrawal by Subject|0|||
37912965|NCT00546871|69599695|FG001|Study Extension Period|Withdrawal by Subject|1|||
37912966|NCT03951805|69599728|FG000|Overall Study|Adverse Event|1|||
38022380|NCT03129100|69705727|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
38022381|NCT03129100|69705728|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
38022382|NCT03129100|69705729|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
38022383|NCT03129100|69705730|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
38022384|NCT03129100|69705731|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
38022385|NCT03129100|69705732|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
38022386|NCT03129100|69705733|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
38022387|NCT03129100|69705734|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
38022388|NCT03129100|69705735|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
38022389|NCT03129100|69705736|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
38022390|NCT03129100|69705737|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
38022391|NCT03129100|69705738|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
38022392|NCT03129100|69705739|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
38022393|NCT03129100|69705740|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
38022394|NCT03129100|69705741|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
38022395|NCT03129100|69705742|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
38022396|NCT03129100|69705743|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
38022397|NCT03129100|69705744|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
38022398|NCT03129100|69705719|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
38022399|NCT03129100|69705720|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
38022400|NCT03129100|69705721|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
38022401|NCT03129100|69705722|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
38022402|NCT03129100|69705723|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
38022403|NCT03129100|69705724|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
38022404|NCT03129100|69705725|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
38022405|NCT03129100|69705726|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
38022406|NCT03129100|69705727|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
38022407|NCT03129100|69705728|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
38022408|NCT03129100|69705729|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
38022409|NCT03129100|69705730|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
38022410|NCT03129100|69705731|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
38022411|NCT03129100|69705732|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
38022412|NCT03129100|69705733|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
37835105|NCT01236352|69519282|FG005|Overall Study|Lack of response to drug|0|||
37835106|NCT01236352|69519283|FG006|Overall Study|Lack of response to drug|0|||
37835107|NCT01236352|69519284|FG007|Overall Study|Lack of response to drug|0|||
37835108|NCT01236352|69519285|FG008|Overall Study|Lack of response to drug|0|||
37835109|NCT01236352|69519286|FG009|Overall Study|Lack of response to drug|1|||
37835110|NCT01236352|69519287|FG010|Overall Study|Lack of response to drug|1|||
37835111|NCT01236352|69519277|FG000|Overall Study|Patient transferred to IST|0|||
37835112|NCT01236352|69519278|FG001|Overall Study|Patient transferred to IST|0|||
37835113|NCT01236352|69519279|FG002|Overall Study|Patient transferred to IST|0|||
37835114|NCT01236352|69519280|FG003|Overall Study|Patient transferred to IST|0|||
37835115|NCT01236352|69519281|FG004|Overall Study|Patient transferred to IST|0|||
37835116|NCT01236352|69519282|FG005|Overall Study|Patient transferred to IST|0|||
37912967|NCT03951805|69599729|FG001|Overall Study|Adverse Event|0|||
37912968|NCT03951805|69599730|FG002|Overall Study|Adverse Event|0|||
37912969|NCT03951805|69599731|FG003|Overall Study|Adverse Event|0|||
37912970|NCT03944707|69599743|FG000|Overall Study|Adverse Event|0|||
38022413|NCT03129100|69705734|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
37835117|NCT01236352|69519283|FG006|Overall Study|Patient transferred to IST|0|||
38022414|NCT03129100|69705735|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
38022415|NCT03129100|69705736|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
38022416|NCT03129100|69705737|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
38022417|NCT03129100|69705738|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
38022418|NCT03129100|69705739|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
38022419|NCT03129100|69705740|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
38022420|NCT03129100|69705741|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
38022421|NCT03129100|69705742|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
38022422|NCT03129100|69705743|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
38022423|NCT03129100|69705744|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
38022424|NCT03129100|69705719|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
38022425|NCT03129100|69705720|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
38022426|NCT03129100|69705721|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
38022427|NCT03129100|69705722|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
38022428|NCT03129100|69705723|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
38022429|NCT03129100|69705724|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
38022430|NCT03129100|69705725|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
38022431|NCT03129100|69705726|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
38022432|NCT03129100|69705727|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
38022433|NCT03129100|69705728|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
38022434|NCT03129100|69705729|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
38022435|NCT03129100|69705730|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
38022436|NCT03129100|69705731|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
38022437|NCT03129100|69705732|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
38022438|NCT03129100|69705733|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
38022439|NCT03129100|69705734|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
38022440|NCT03129100|69705735|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
38022441|NCT03129100|69705736|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
38022442|NCT03129100|69705737|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
38022443|NCT03129100|69705738|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
38022444|NCT03129100|69705739|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
38022445|NCT03129100|69705740|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
38022446|NCT03129100|69705741|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
38022447|NCT03129100|69705742|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
38022448|NCT03129100|69705743|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
38022449|NCT03129100|69705744|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
38022450|NCT03129100|69705719|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
38022451|NCT03129100|69705720|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
38022452|NCT03129100|69705721|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
38022453|NCT03129100|69705722|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
37835118|NCT01236352|69519284|FG007|Overall Study|Patient transferred to IST|0|||
37835119|NCT01236352|69519285|FG008|Overall Study|Patient transferred to IST|0|||
37835120|NCT01236352|69519286|FG009|Overall Study|Patient transferred to IST|2|||
37835121|NCT01236352|69519287|FG010|Overall Study|Patient transferred to IST|6|||
37835122|NCT01236118|69519314|FG000|Overall Study|Adverse Event|2|||
37835123|NCT01236118|69519315|FG001|Overall Study|Adverse Event|0|||
37835124|NCT01236118|69519316|FG002|Overall Study|Adverse Event|2|||
37835125|NCT01236118|69519314|FG000|Overall Study|Physician Decision|0|||
37835126|NCT01236118|69519315|FG001|Overall Study|Physician Decision|1|||
37835127|NCT01236118|69519316|FG002|Overall Study|Physician Decision|0|||
37835128|NCT01236118|69519314|FG000|Overall Study|Withdrawal by Subject|0|||
37835129|NCT01236118|69519315|FG001|Overall Study|Withdrawal by Subject|0|||
37835130|NCT01236118|69519316|FG002|Overall Study|Withdrawal by Subject|1|||
37835131|NCT01236001|69519326|FG000|Overall Study|Adverse Event|5|||
37835132|NCT01236001|69519327|FG001|Overall Study|Adverse Event|14|||
37835133|NCT01236001|69519326|FG000|Overall Study|Lack of Efficacy|6|||
37835134|NCT01236001|69519327|FG001|Overall Study|Lack of Efficacy|6|||
37835135|NCT01236001|69519326|FG000|Overall Study|Lost to Follow-up|6|||
37912971|NCT03944707|69599744|FG001|Overall Study|Adverse Event|2|||
37912972|NCT03944707|69599743|FG000|Overall Study|Study terminated by sponsor|12|||
37912973|NCT03944707|69599744|FG001|Overall Study|Study terminated by sponsor|7|||
37912974|NCT03944707|69599743|FG000|Overall Study|Subject decision|0|||
37912975|NCT03944707|69599744|FG001|Overall Study|Subject decision|1|||
37912976|NCT00549055|69599750|FG000|Overall Study|Adverse Event|4|||
37912977|NCT00549055|69599750|FG000|Overall Study|Lack of Efficacy|18|||
37700371|NCT01649765|69177382|FG000|Overall Study|Lack of Efficacy|1|||
37912978|NCT00549055|69599750|FG000|Overall Study|Stabilization|5|||
37912979|NCT00549055|69599750|FG000|Overall Study|Progression to fibrosis|2|||
37835136|NCT01236001|69519327|FG001|Overall Study|Lost to Follow-up|1|||
37835137|NCT01236001|69519326|FG000|Overall Study|Incompliance|1|||
37835138|NCT01236001|69519327|FG001|Overall Study|Incompliance|0|||
37835139|NCT01236001|69519326|FG000|Overall Study|Planned Visit After End of Study|0|||
37912980|NCT00549055|69599750|FG000|Overall Study|Decrease of size|1|||
37912981|NCT00549055|69599750|FG000|Overall Study|Active choroidal neovascula increased|1|||
37912982|NCT00549055|69599750|FG000|Overall Study|Vitreous hemorrhage|1|||
37912983|NCT00549055|69599750|FG000|Overall Study|Growth choroidal neovascularisation|1|||
37912984|NCT00549055|69599750|FG000|Overall Study|Choroidal neovascularization|1|||
37912985|NCT00549055|69599750|FG000|Overall Study|Very low visual acuity (VA)|1|||
37912986|NCT00883116|69599756|FG000|Overall Study|Adverse event unrelated to study drug|5|||
37912987|NCT00883116|69599757|FG001|Overall Study|Adverse event unrelated to study drug|10|||
38022454|NCT03129100|69705723|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
38022455|NCT03129100|69705724|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
38022456|NCT03129100|69705725|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
38022457|NCT03129100|69705726|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
38022458|NCT03129100|69705727|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
37912988|NCT00883116|69599756|FG000|Overall Study|Death|6|||
37912989|NCT00883116|69599757|FG001|Overall Study|Death|2|||
37912990|NCT00883116|69599756|FG000|Overall Study|Disease progression|130|||
37912991|NCT00883116|69599757|FG001|Overall Study|Disease progression|128|||
37912992|NCT00883116|69599756|FG000|Overall Study|Lost to Follow-up|0|||
37912993|NCT00883116|69599757|FG001|Overall Study|Lost to Follow-up|1|||
37912994|NCT00883116|69599756|FG000|Overall Study|Maximum clinical benefit|13|||
37912995|NCT00883116|69599757|FG001|Overall Study|Maximum clinical benefit|46|||
37912996|NCT00883116|69599756|FG000|Overall Study|Not identified|3|||
37912997|NCT00883116|69599757|FG001|Overall Study|Not identified|6|||
37912998|NCT00883116|69599756|FG000|Overall Study|Study drug toxicity|36|||
37912999|NCT00883116|69599757|FG001|Overall Study|Study drug toxicity|16|||
37913000|NCT00883116|69599756|FG000|Overall Study|Withdrawal by Subject|14|||
37913001|NCT00883116|69599757|FG001|Overall Study|Withdrawal by Subject|8|||
37913002|NCT00883116|69599756|FG000|Overall Study|No longer meets study criteria|2|||
37913003|NCT00883116|69599757|FG001|Overall Study|No longer meets study criteria|2|||
37913004|NCT00594399|69599776|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
37913005|NCT00594399|69599777|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
37913006|NCT00594399|69599778|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
37913007|NCT00594399|69599776|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
37913008|NCT00594399|69599777|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
38022459|NCT03129100|69705728|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
38022460|NCT03129100|69705729|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
38022461|NCT03129100|69705730|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
38022462|NCT03129100|69705731|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
38022463|NCT03129100|69705732|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
38022464|NCT03129100|69705733|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
38022465|NCT03129100|69705734|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
37700372|NCT01649765|69177383|FG001|Overall Study|Lack of Efficacy|1|||
38022466|NCT03129100|69705735|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
38022467|NCT03129100|69705736|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
37913009|NCT00594399|69599778|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
37913010|NCT00594399|69599776|FG000|Initial 3 Month Counseling|Personal issues|2|||
37913011|NCT00594399|69599777|FG001|Initial 3 Month Counseling|Personal issues|0|||
37913012|NCT00594399|69599778|FG002|Initial 3 Month Counseling|Personal issues|0|||
37913013|NCT00594399|69599776|FG000|Initial 3 Month Counseling|Too busy|7|||
37913014|NCT00594399|69599777|FG001|Initial 3 Month Counseling|Too busy|1|||
38022468|NCT03129100|69705737|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
38022469|NCT03129100|69705738|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
38022470|NCT03129100|69705739|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
38022471|NCT03129100|69705740|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
38022472|NCT03129100|69705741|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
38022473|NCT03129100|69705742|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
38022474|NCT03129100|69705743|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
38022475|NCT03129100|69705744|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
38022476|NCT03129100|69705719|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
38022477|NCT03129100|69705720|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
38022478|NCT03129100|69705721|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
38022479|NCT03129100|69705722|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
38022480|NCT03129100|69705723|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
38022481|NCT03129100|69705724|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
38022482|NCT03129100|69705725|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
38022483|NCT03129100|69705726|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
38022484|NCT03129100|69705727|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
38022485|NCT03129100|69705728|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
38022486|NCT03129100|69705729|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
38022487|NCT03129100|69705730|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
38022488|NCT03129100|69705731|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
38022489|NCT03129100|69705732|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
38022490|NCT03129100|69705733|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
38022491|NCT03129100|69705734|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
38022492|NCT03129100|69705735|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
38022493|NCT03129100|69705736|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
38022494|NCT03129100|69705737|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
38022495|NCT03129100|69705738|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
38022496|NCT03129100|69705739|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
38022497|NCT03129100|69705740|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
38022498|NCT03129100|69705741|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
38022499|NCT03129100|69705742|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
38022500|NCT03129100|69705743|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
38022501|NCT03129100|69705744|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
38022502|NCT03129100|69705719|FG000|Period2 Extension Period (Group A and B)|Death|0|||
38022503|NCT03129100|69705720|FG001|Period2 Extension Period (Group A and B)|Death|0|||
38022504|NCT03129100|69705721|FG002|Period2 Extension Period (Group A and B)|Death|1|||
38022505|NCT03129100|69705722|FG003|Period2 Extension Period (Group A and B)|Death|0|||
38022506|NCT03129100|69705723|FG004|Period2 Extension Period (Group A and B)|Death|0|||
38022507|NCT03129100|69705724|FG005|Period2 Extension Period (Group A and B)|Death|0|||
38022508|NCT03129100|69705725|FG006|Period2 Extension Period (Group A and B)|Death|0|||
38022509|NCT03129100|69705726|FG007|Period2 Extension Period (Group A and B)|Death|0|||
38022510|NCT03129100|69705727|FG008|Period2 Extension Period (Group A and B)|Death|0|||
38022511|NCT03129100|69705728|FG009|Period2 Extension Period (Group A and B)|Death|0|||
37835140|NCT01236001|69519327|FG001|Overall Study|Planned Visit After End of Study|1|||
37835141|NCT01229254|69519337|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
37835142|NCT01229254|69519338|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
37835143|NCT01229254|69519339|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
37835144|NCT01229254|69519337|FG000|Overall Study|Adverse Event|4|||
37835145|NCT01229254|69519338|FG001|Overall Study|Adverse Event|5|||
37835146|NCT01229254|69519339|FG002|Overall Study|Adverse Event|3|||
37835147|NCT01229254|69519337|FG000|Overall Study|Lost to Follow-up|3|||
37835148|NCT01229254|69519338|FG001|Overall Study|Lost to Follow-up|0|||
37835149|NCT01229254|69519339|FG002|Overall Study|Lost to Follow-up|1|||
37835150|NCT01229254|69519337|FG000|Overall Study|Physician Decision|0|||
37835151|NCT01229254|69519338|FG001|Overall Study|Physician Decision|3|||
37913015|NCT00594399|69599778|FG002|Initial 3 Month Counseling|Too busy|0|||
38022512|NCT03129100|69705729|FG010|Period2 Extension Period (Group A and B)|Death|0|||
38022513|NCT03129100|69705730|FG011|Period2 Extension Period (Group A and B)|Death|0|||
38022514|NCT03129100|69705731|FG012|Period2 Extension Period (Group A and B)|Death|0|||
38022515|NCT03129100|69705732|FG013|Period2 Extension Period (Group A and B)|Death|0|||
38022516|NCT03129100|69705733|FG014|Period2 Extension Period (Group A and B)|Death|0|||
38022517|NCT03129100|69705734|FG015|Period2 Extension Period (Group A and B)|Death|0|||
38022518|NCT03129100|69705735|FG016|Period2 Extension Period (Group A and B)|Death|0|||
38022519|NCT03129100|69705736|FG017|Period2 Extension Period (Group A and B)|Death|0|||
38022520|NCT03129100|69705737|FG018|Period2 Extension Period (Group A and B)|Death|0|||
38022521|NCT03129100|69705738|FG019|Period2 Extension Period (Group A and B)|Death|0|||
37835152|NCT01229254|69519339|FG002|Overall Study|Physician Decision|0|||
37835153|NCT01229254|69519337|FG000|Overall Study|Protocol Violation|4|||
38022522|NCT03129100|69705739|FG020|Period2 Extension Period (Group A and B)|Death|0|||
38022523|NCT03129100|69705740|FG021|Period2 Extension Period (Group A and B)|Death|0|||
38022524|NCT03129100|69705741|FG022|Period2 Extension Period (Group A and B)|Death|0|||
38022525|NCT03129100|69705742|FG023|Period2 Extension Period (Group A and B)|Death|0|||
38022526|NCT03129100|69705743|FG024|Period2 Extension Period (Group A and B)|Death|0|||
38022527|NCT03129100|69705744|FG025|Period2 Extension Period (Group A and B)|Death|0|||
37913016|NCT00594399|69599776|FG000|Initial 3 Month Counseling|Pain|2|||
37913017|NCT00594399|69599777|FG001|Initial 3 Month Counseling|Pain|0|||
37913018|NCT00594399|69599778|FG002|Initial 3 Month Counseling|Pain|0|||
37913019|NCT00594399|69599776|FG000|Initial 3 Month Counseling|Moved|1|||
37913020|NCT00594399|69599777|FG001|Initial 3 Month Counseling|Moved|0|||
37913021|NCT00594399|69599778|FG002|Initial 3 Month Counseling|Moved|0|||
37913022|NCT00594399|69599776|FG000|Initial 3 Month Counseling|Family illness|1|||
37913023|NCT00594399|69599777|FG001|Initial 3 Month Counseling|Family illness|0|||
37913024|NCT00594399|69599778|FG002|Initial 3 Month Counseling|Family illness|0|||
37913025|NCT00594399|69599776|FG000|Rerandomization Arm 1 Only|Death|2|||
37913026|NCT00594399|69599777|FG001|Rerandomization Arm 1 Only|Death|1|||
37913027|NCT00594399|69599778|FG002|Rerandomization Arm 1 Only|Death|0|||
37913028|NCT00594399|69599776|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
37913029|NCT00594399|69599777|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
37913030|NCT00594399|69599778|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
37913031|NCT00546715|69599788|FG000|Overall Study|Withdrawal by Subject|0|||
37913032|NCT00546715|69599789|FG001|Overall Study|Withdrawal by Subject|1|||
37913033|NCT00546715|69599790|FG002|Overall Study|Withdrawal by Subject|0|||
37913034|NCT00546715|69599791|FG003|Overall Study|Withdrawal by Subject|0|||
37913035|NCT00874029|69599801|FG000|Overall Study|Withdrawal by Subject|10|||
37913036|NCT00874029|69599801|FG000|Overall Study|Pregnancy|4|||
37913037|NCT00874029|69599801|FG000|Overall Study|Physician Decision|1|||
37913038|NCT00874029|69599801|FG000|Overall Study|Adverse Event|1|||
37913039|NCT00874029|69599801|FG000|Overall Study|Lost to Follow-up|5|||
37913040|NCT00546637|69599817|FG000|Overall Study|Adverse Event|46|||
37913041|NCT00546637|69599818|FG001|Overall Study|Adverse Event|20|||
37913042|NCT00546637|69599817|FG000|Overall Study|Lack of Efficacy|5|||
37913043|NCT00546637|69599818|FG001|Overall Study|Lack of Efficacy|5|||
37913044|NCT00546637|69599817|FG000|Overall Study|Lost to Follow-up|2|||
37913045|NCT00546637|69599818|FG001|Overall Study|Lost to Follow-up|2|||
37913046|NCT00546637|69599817|FG000|Overall Study|Other|10|||
37913047|NCT00546637|69599818|FG001|Overall Study|Other|12|||
37913048|NCT00546637|69599817|FG000|Overall Study|Withdrawal by Subject|7|||
37913049|NCT00546637|69599818|FG001|Overall Study|Withdrawal by Subject|9|||
37913050|NCT00546637|69599817|FG000|Overall Study|Randomized, but not treated|3|||
37913051|NCT00546637|69599818|FG001|Overall Study|Randomized, but not treated|1|||
37913052|NCT00546481|69599826|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
37913053|NCT00546481|69599827|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
37913054|NCT00546481|69599828|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
38022528|NCT03129100|69705719|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
38022529|NCT03129100|69705720|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
37913055|NCT00546481|69599826|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
37913056|NCT00546481|69599827|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
37913057|NCT00546481|69599828|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
37913058|NCT00546481|69599826|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
37913059|NCT00546481|69599827|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
37913060|NCT00546481|69599828|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
37913061|NCT00546481|69599826|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
37913062|NCT00546481|69599827|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
37913063|NCT00546481|69599828|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
37913064|NCT00546481|69599826|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
37913065|NCT00546481|69599827|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
37913066|NCT00546481|69599828|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
37913067|NCT00546481|69599826|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
37913068|NCT00546481|69599827|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
37913069|NCT00546481|69599828|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
37913070|NCT00546481|69599826|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
37913071|NCT00546481|69599827|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
37913072|NCT00546481|69599828|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
37913073|NCT00546481|69599826|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
37913074|NCT00546481|69599827|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
37913075|NCT00546481|69599828|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
37913076|NCT00546481|69599826|FG000|Maintenance Phase (CERA)|Other Reason|0|||
37913077|NCT00546481|69599827|FG001|Maintenance Phase (CERA)|Other Reason|0|||
37913078|NCT00546481|69599828|FG002|Maintenance Phase (CERA)|Other Reason|1|||
37913079|NCT00880698|69599840|FG000|Overall Study|Death|0|||
37913080|NCT00880698|69599841|FG001|Overall Study|Death|0|||
37913081|NCT00880698|69599842|FG002|Overall Study|Death|1|||
37913082|NCT00880698|69599843|FG003|Overall Study|Death|2|||
37913083|NCT00880698|69599840|FG000|Overall Study|Lost to Follow-up|1|||
37913084|NCT00880698|69599841|FG001|Overall Study|Lost to Follow-up|3|||
37913085|NCT00880698|69599842|FG002|Overall Study|Lost to Follow-up|0|||
37913086|NCT00880698|69599843|FG003|Overall Study|Lost to Follow-up|1|||
37913087|NCT00880620|69599859|FG000|Overall Study|Adverse Event|4|||
37913088|NCT00880620|69599860|FG001|Overall Study|Adverse Event|5|||
37913089|NCT00880620|69599861|FG002|Overall Study|Adverse Event|15|||
37913090|NCT00880620|69599862|FG003|Overall Study|Adverse Event|15|||
38022530|NCT03129100|69705721|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
38022531|NCT03129100|69705722|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
38022532|NCT03129100|69705723|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
38022533|NCT03129100|69705724|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
38022534|NCT03129100|69705725|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
38022535|NCT03129100|69705726|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
38022536|NCT03129100|69705727|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
38022537|NCT03129100|69705728|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
38022538|NCT03129100|69705729|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
38022539|NCT03129100|69705730|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
38022540|NCT03129100|69705731|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
38022541|NCT03129100|69705732|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
38022542|NCT03129100|69705733|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
38022543|NCT03129100|69705734|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
38022544|NCT03129100|69705735|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
38022545|NCT03129100|69705736|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
38022546|NCT03129100|69705737|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
38022547|NCT03129100|69705738|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
38022548|NCT03129100|69705739|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
38022549|NCT03129100|69705740|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
38022550|NCT03129100|69705741|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
38022551|NCT03129100|69705742|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
38022552|NCT03129100|69705743|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
38022553|NCT03129100|69705744|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
38022554|NCT03129100|69705719|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
38022555|NCT03129100|69705720|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
37700373|NCT01649765|69177382|FG000|Overall Study|Physician Decision|0|||
37700374|NCT01649765|69177383|FG001|Overall Study|Physician Decision|3|||
37700375|NCT01649765|69177382|FG000|Overall Study|Protocol Violation|1|||
38022556|NCT03129100|69705721|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
38022557|NCT03129100|69705722|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
38022558|NCT03129100|69705723|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
38022559|NCT03129100|69705724|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
38022560|NCT03129100|69705725|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
38022561|NCT03129100|69705726|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
38022562|NCT03129100|69705727|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
37700376|NCT01649765|69177383|FG001|Overall Study|Protocol Violation|0|||
37913091|NCT00880620|69599859|FG000|Overall Study|Death|0|||
37913092|NCT00880620|69599860|FG001|Overall Study|Death|0|||
37913093|NCT00880620|69599861|FG002|Overall Study|Death|1|||
37913094|NCT00880620|69599862|FG003|Overall Study|Death|0|||
38022563|NCT03129100|69705728|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
38022564|NCT03129100|69705729|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
38022565|NCT03129100|69705730|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
37913095|NCT00880620|69599859|FG000|Overall Study|Lack of Efficacy|12|||
37913096|NCT00880620|69599860|FG001|Overall Study|Lack of Efficacy|4|||
38022566|NCT03129100|69705731|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
37913097|NCT00880620|69599861|FG002|Overall Study|Lack of Efficacy|0|||
37913098|NCT00880620|69599862|FG003|Overall Study|Lack of Efficacy|1|||
37913099|NCT00880620|69599859|FG000|Overall Study|Lost to Follow-up|0|||
37913100|NCT00880620|69599860|FG001|Overall Study|Lost to Follow-up|1|||
37913101|NCT00880620|69599861|FG002|Overall Study|Lost to Follow-up|1|||
37913102|NCT00880620|69599862|FG003|Overall Study|Lost to Follow-up|0|||
37913103|NCT00880620|69599859|FG000|Overall Study|Protocol Violation|0|||
37913104|NCT00880620|69599860|FG001|Overall Study|Protocol Violation|1|||
38022567|NCT03129100|69705732|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
38022568|NCT03129100|69705733|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
38022569|NCT03129100|69705734|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
38022570|NCT03129100|69705735|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
38022571|NCT03129100|69705736|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
38022572|NCT03129100|69705737|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
38022573|NCT03129100|69705738|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
38022574|NCT03129100|69705739|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
38022575|NCT03129100|69705740|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
38022576|NCT03129100|69705741|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
38022577|NCT03129100|69705742|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
38022578|NCT03129100|69705743|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
38022579|NCT03129100|69705744|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
38022580|NCT03129100|69705719|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
38022581|NCT03129100|69705720|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
38022582|NCT03129100|69705721|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
38022583|NCT03129100|69705722|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
38022584|NCT03129100|69705723|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
38022585|NCT03129100|69705724|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
38022586|NCT03129100|69705725|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
38022587|NCT03129100|69705726|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
38022588|NCT03129100|69705727|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
38022589|NCT03129100|69705728|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
38022590|NCT03129100|69705729|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
38022591|NCT03129100|69705730|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
38022592|NCT03129100|69705731|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
38022593|NCT03129100|69705732|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
38022594|NCT03129100|69705733|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
38022595|NCT03129100|69705734|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
38022596|NCT03129100|69705735|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
38022597|NCT03129100|69705736|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
38022598|NCT03129100|69705737|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
38022599|NCT03129100|69705738|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
38022600|NCT03129100|69705739|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
38022601|NCT03129100|69705740|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
38022602|NCT03129100|69705741|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
38022603|NCT03129100|69705742|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
38022604|NCT03129100|69705743|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
38022605|NCT03129100|69705744|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
38022606|NCT03129100|69705719|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
38022607|NCT03129100|69705720|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
38022608|NCT03129100|69705721|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
38022609|NCT03129100|69705722|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
38022610|NCT03129100|69705723|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
38022611|NCT03129100|69705724|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
38022612|NCT03129100|69705725|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
38022613|NCT03129100|69705726|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
38022614|NCT03129100|69705727|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
38022615|NCT03129100|69705728|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
38022616|NCT03129100|69705729|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
38022617|NCT03129100|69705730|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
38022618|NCT03129100|69705731|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
38022619|NCT03129100|69705732|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
38022620|NCT03129100|69705733|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
38022621|NCT03129100|69705734|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
38022622|NCT03129100|69705735|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
38022623|NCT03129100|69705736|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
38022624|NCT03129100|69705737|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
38022625|NCT03129100|69705738|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
38022626|NCT03129100|69705739|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
38022627|NCT03129100|69705740|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
38022628|NCT03129100|69705741|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
38022629|NCT03129100|69705742|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
38022630|NCT03129100|69705743|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
38022631|NCT03129100|69705744|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
38022632|NCT03129100|69705719|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
38022633|NCT03129100|69705720|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
38022634|NCT03129100|69705721|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
38022635|NCT03129100|69705722|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
38022636|NCT03129100|69705723|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
38022637|NCT03129100|69705724|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
38022638|NCT03129100|69705725|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
38022639|NCT03129100|69705726|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
38022640|NCT03129100|69705727|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
38022641|NCT03129100|69705728|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
38022642|NCT03129100|69705729|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
38022643|NCT03129100|69705730|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
38022644|NCT03129100|69705731|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
38022645|NCT03129100|69705732|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
38022646|NCT03129100|69705733|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
38022647|NCT03129100|69705734|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
38022648|NCT03129100|69705735|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
38022649|NCT03129100|69705736|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
38022650|NCT03129100|69705737|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
38022651|NCT03129100|69705738|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
38022652|NCT03129100|69705739|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
38022653|NCT03129100|69705740|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
38022654|NCT03129100|69705741|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
38022655|NCT03129100|69705742|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
38022656|NCT03129100|69705743|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
38022657|NCT03129100|69705744|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
38022658|NCT03129100|69705719|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
38022659|NCT03129100|69705720|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
38022660|NCT03129100|69705721|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
38022661|NCT03129100|69705722|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
38022662|NCT03129100|69705723|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
38022663|NCT03129100|69705724|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
38022664|NCT03129100|69705725|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
38022665|NCT03129100|69705726|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
38022666|NCT03129100|69705727|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
38022667|NCT03129100|69705728|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
38022668|NCT03129100|69705729|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
38022669|NCT03129100|69705730|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
38022670|NCT03129100|69705731|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
38022671|NCT03129100|69705732|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
38022672|NCT03129100|69705733|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
38022673|NCT03129100|69705734|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
38022674|NCT03129100|69705735|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
38022675|NCT03129100|69705736|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
38022676|NCT03129100|69705737|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
38022677|NCT03129100|69705738|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
38022678|NCT03129100|69705739|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
38022679|NCT03129100|69705740|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
38022680|NCT03129100|69705741|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
38022681|NCT03129100|69705742|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
38022682|NCT03129100|69705743|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
38022683|NCT03129100|69705744|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
38022684|NCT03129100|69705719|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
38022685|NCT03129100|69705720|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
38022686|NCT03129100|69705721|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
38022687|NCT03129100|69705722|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
38022688|NCT03129100|69705723|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
38022689|NCT03129100|69705724|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
38022690|NCT03129100|69705725|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
38022691|NCT03129100|69705726|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
38022692|NCT03129100|69705727|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
38022693|NCT03129100|69705728|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
38022694|NCT03129100|69705729|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
38022695|NCT03129100|69705730|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
38022696|NCT03129100|69705731|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
38022697|NCT03129100|69705732|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
38022698|NCT03129100|69705733|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
37700377|NCT01649765|69177382|FG000|Overall Study|Withdrawal by Subject|2|||
37700378|NCT01649765|69177383|FG001|Overall Study|Withdrawal by Subject|1|||
37835154|NCT01229254|69519338|FG001|Overall Study|Protocol Violation|6|||
37835155|NCT01229254|69519339|FG002|Overall Study|Protocol Violation|5|||
37835156|NCT01229254|69519337|FG000|Overall Study|Withdrawal by Subject|1|||
37835157|NCT01229254|69519338|FG001|Overall Study|Withdrawal by Subject|0|||
37835158|NCT01229254|69519339|FG002|Overall Study|Withdrawal by Subject|1|||
37835159|NCT01229254|69519337|FG000|Overall Study|Non-compliance with Study Drug|0|||
37835160|NCT01229254|69519338|FG001|Overall Study|Non-compliance with Study Drug|1|||
37835161|NCT01229254|69519339|FG002|Overall Study|Non-compliance with Study Drug|1|||
37835162|NCT01235728|69519348|FG000|Overall Study|Protocol Violation|0|||
37835163|NCT01235728|69519349|FG001|Overall Study|Protocol Violation|0|||
37835164|NCT01235728|69519350|FG002|Overall Study|Protocol Violation|0|||
37835165|NCT01235728|69519351|FG003|Overall Study|Protocol Violation|1|||
37835166|NCT01235728|69519352|FG004|Overall Study|Protocol Violation|0|||
37835167|NCT01235728|69519353|FG005|Overall Study|Protocol Violation|0|||
37835168|NCT01235728|69519354|FG006|Overall Study|Protocol Violation|0|||
37835169|NCT01235728|69519355|FG007|Overall Study|Protocol Violation|0|||
37835170|NCT01235689|69519365|FG000|Overall Study|Adverse Event|12|||
37835171|NCT01235689|69519366|FG001|Overall Study|Adverse Event|16|||
37835172|NCT01235689|69519365|FG000|Overall Study|Lack of Efficacy|12|||
37835173|NCT01235689|69519366|FG001|Overall Study|Lack of Efficacy|5|||
37700379|NCT02317562|69177390|FG000|Overall Study|Physician Decision|1|||
37700380|NCT02317562|69177390|FG000|Overall Study|early termination of the study|8|||
37700381|NCT02317562|69177390|FG000|Overall Study|Lack of Efficacy|4|||
37700382|NCT02317562|69177390|FG000|Overall Study|Withdrawal by Subject|1|||
37700383|NCT02317016|69177394|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
37700384|NCT02317016|69177394|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
37700385|NCT02317016|69177394|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
37700386|NCT02317016|69177394|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
37835174|NCT01235689|69519365|FG000|Overall Study|Withdrawal by Subject|3|||
37835175|NCT01235689|69519366|FG001|Overall Study|Withdrawal by Subject|4|||
37835176|NCT01235689|69519365|FG000|Overall Study|Lost to Follow-up|1|||
37835177|NCT01235689|69519366|FG001|Overall Study|Lost to Follow-up|2|||
37835178|NCT01235689|69519365|FG000|Overall Study|Miscellaneous|1|||
37835179|NCT01235689|69519366|FG001|Overall Study|Miscellaneous|5|||
37835180|NCT01229176|69519380|FG000|Overall Study|Withdrawal by Subject|0|||
37835181|NCT01229176|69519381|FG001|Overall Study|Withdrawal by Subject|0|||
37835182|NCT01229176|69519382|FG002|Overall Study|Withdrawal by Subject|0|||
37835183|NCT01229176|69519383|FG003|Overall Study|Withdrawal by Subject|1|||
37835184|NCT01229176|69519384|FG004|Overall Study|Withdrawal by Subject|1|||
37835185|NCT01229176|69519385|FG005|Overall Study|Withdrawal by Subject|1|||
37835186|NCT01229176|69519386|FG006|Overall Study|Withdrawal by Subject|0|||
37835187|NCT01229176|69519387|FG007|Overall Study|Withdrawal by Subject|1|||
37835188|NCT01229176|69519380|FG000|Overall Study|Lost to Follow-up|0|||
37835189|NCT01229176|69519381|FG001|Overall Study|Lost to Follow-up|3|||
37835190|NCT01229176|69519382|FG002|Overall Study|Lost to Follow-up|0|||
37835191|NCT01229176|69519383|FG003|Overall Study|Lost to Follow-up|0|||
38022699|NCT03129100|69705734|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
38022700|NCT03129100|69705735|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
38022701|NCT03129100|69705736|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
38022702|NCT03129100|69705737|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
38022703|NCT03129100|69705738|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
38022704|NCT03129100|69705739|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
38022705|NCT03129100|69705740|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
38022706|NCT03129100|69705741|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
38022707|NCT03129100|69705742|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
38022708|NCT03129100|69705743|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
38022709|NCT03129100|69705744|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
38022710|NCT03129100|69705719|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
38022711|NCT03129100|69705720|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
38022712|NCT03129100|69705721|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
38022713|NCT03129100|69705722|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
38022714|NCT03129100|69705723|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
38022715|NCT03129100|69705724|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
38022716|NCT03129100|69705725|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
37700387|NCT02317016|69177394|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
37835192|NCT01229176|69519384|FG004|Overall Study|Lost to Follow-up|1|||
37835193|NCT01229176|69519385|FG005|Overall Study|Lost to Follow-up|1|||
37835194|NCT01229176|69519386|FG006|Overall Study|Lost to Follow-up|0|||
37835195|NCT01229176|69519387|FG007|Overall Study|Lost to Follow-up|2|||
37835196|NCT01228747|69519407|FG000|Overall Study|Adverse Event|8|||
37835197|NCT01228747|69519408|FG001|Overall Study|Adverse Event|4|||
37835198|NCT01228747|69519407|FG000|Overall Study|Lack of Efficacy|40|||
37835199|NCT01228747|69519408|FG001|Overall Study|Lack of Efficacy|27|||
37835200|NCT01228747|69519407|FG000|Overall Study|Protocol Violation|6|||
37835201|NCT01228747|69519408|FG001|Overall Study|Protocol Violation|5|||
37835202|NCT01228747|69519407|FG000|Overall Study|Lost to Follow-up|4|||
37835203|NCT01228747|69519408|FG001|Overall Study|Lost to Follow-up|3|||
37835204|NCT01228747|69519407|FG000|Overall Study|Withdrawal by Subject|5|||
37835205|NCT01228747|69519408|FG001|Overall Study|Withdrawal by Subject|1|||
38022717|NCT03129100|69705726|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
38022718|NCT03129100|69705727|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
38022719|NCT03129100|69705728|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
37835206|NCT01228747|69519407|FG000|Overall Study|Other Reason|2|||
37835207|NCT01228747|69519408|FG001|Overall Study|Other Reason|5|||
37835208|NCT01228591|69519414|FG000|Baseline|Lack of Efficacy|1|||
37835209|NCT01228591|69519415|FG001|Baseline|Lack of Efficacy|2|||
37835210|NCT01235338|69519427|FG000|Overall Study|Adverse Event|3|||
37835211|NCT01235338|69519428|FG001|Overall Study|Adverse Event|2|||
37835212|NCT01235338|69519427|FG000|Overall Study|Protocol Violation|1|||
38022720|NCT03129100|69705729|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
38022721|NCT03129100|69705730|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
38022722|NCT03129100|69705731|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
38022723|NCT03129100|69705732|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
38022724|NCT03129100|69705733|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
38022725|NCT03129100|69705734|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
38022726|NCT03129100|69705735|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
38022727|NCT03129100|69705736|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
38022728|NCT03129100|69705737|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
38022729|NCT03129100|69705738|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
38022730|NCT03129100|69705739|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
38022731|NCT03129100|69705740|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
38022732|NCT03129100|69705741|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
38022733|NCT03129100|69705742|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
38022734|NCT03129100|69705743|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
38022735|NCT03129100|69705744|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
38022736|NCT03129100|69705719|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
38022737|NCT03129100|69705720|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
38022738|NCT03129100|69705721|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
38022739|NCT03129100|69705722|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
38022740|NCT03129100|69705723|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
38022741|NCT03129100|69705724|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
38022742|NCT03129100|69705725|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
38022743|NCT03129100|69705726|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
38022744|NCT03129100|69705727|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
38022745|NCT03129100|69705728|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
38022746|NCT03129100|69705729|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
38022747|NCT03129100|69705730|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
38022748|NCT03129100|69705731|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
38022749|NCT03129100|69705732|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
38022750|NCT03129100|69705733|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
38022751|NCT03129100|69705734|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
38022752|NCT03129100|69705735|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
38022753|NCT03129100|69705736|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
38022754|NCT03129100|69705737|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
38022755|NCT03129100|69705738|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
38022756|NCT03129100|69705739|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
38022757|NCT03129100|69705740|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
38022758|NCT03129100|69705741|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
38022759|NCT03129100|69705742|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
38022760|NCT03129100|69705743|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
38022761|NCT03129100|69705744|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
38022762|NCT03129100|69705719|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
38022763|NCT03129100|69705720|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
38022764|NCT03129100|69705721|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
38022765|NCT03129100|69705722|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
38022766|NCT03129100|69705723|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
38022767|NCT03129100|69705724|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
37835213|NCT01235338|69519428|FG001|Overall Study|Protocol Violation|1|||
37835214|NCT01235338|69519427|FG000|Overall Study|Withdrawal by Subject|5|||
37835215|NCT01235338|69519428|FG001|Overall Study|Withdrawal by Subject|0|||
37913105|NCT00880620|69599861|FG002|Overall Study|Protocol Violation|0|||
37835216|NCT01235338|69519427|FG000|Overall Study|Exclusion criteria violations|1|||
37835217|NCT01235338|69519428|FG001|Overall Study|Exclusion criteria violations|1|||
37835218|NCT01235338|69519427|FG000|Overall Study|Positive drug screen|0|||
37835219|NCT01235338|69519428|FG001|Overall Study|Positive drug screen|1|||
37835220|NCT01235338|69519427|FG000|Overall Study|Prohibited meds|1|||
38022768|NCT03129100|69705725|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
38022769|NCT03129100|69705726|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
38022770|NCT03129100|69705727|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
38022771|NCT03129100|69705728|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
38022772|NCT03129100|69705729|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
38022773|NCT03129100|69705730|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
38022774|NCT03129100|69705731|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
38022775|NCT03129100|69705732|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
38022776|NCT03129100|69705733|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
38022777|NCT03129100|69705734|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
38022778|NCT03129100|69705735|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
38022779|NCT03129100|69705736|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
38022780|NCT03129100|69705737|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
38022781|NCT03129100|69705738|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
38022782|NCT03129100|69705739|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
38022783|NCT03129100|69705740|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
38022784|NCT03129100|69705741|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
38022785|NCT03129100|69705742|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
38022786|NCT03129100|69705743|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
38022787|NCT03129100|69705744|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
38022788|NCT03129100|69705719|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
38022789|NCT03129100|69705720|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
38022790|NCT03129100|69705721|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
38022791|NCT03129100|69705722|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
38022792|NCT03129100|69705723|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
37700388|NCT02317016|69177394|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
37835221|NCT01235338|69519428|FG001|Overall Study|Prohibited meds|0|||
37835222|NCT01234675|69519436|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
37835223|NCT01234675|69519437|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
37835224|NCT01234675|69519436|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
37835225|NCT01234675|69519437|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
37835226|NCT01228318|69519445|FG000|Overall Study|Clinic no show to receive intervention|1|||
37835227|NCT01228318|69519446|FG001|Overall Study|Clinic no show to receive intervention|0|||
37835228|NCT01228318|69519445|FG000|Overall Study|Unable to contact|2|||
37835229|NCT01228318|69519446|FG001|Overall Study|Unable to contact|5|||
37835230|NCT01228318|69519445|FG000|Overall Study|Moved|0|||
37835231|NCT01228318|69519446|FG001|Overall Study|Moved|2|||
37835232|NCT01228318|69519445|FG000|Overall Study|Incarcerated|1|||
37835233|NCT01228318|69519446|FG001|Overall Study|Incarcerated|0|||
37835234|NCT01227967|69519454|FG000|Overall Study|Protocol Violation|3|||
37835235|NCT01227967|69519455|FG001|Overall Study|Protocol Violation|1|||
37835236|NCT01227967|69519454|FG000|Overall Study|Death|0|||
37835237|NCT01227967|69519455|FG001|Overall Study|Death|1|||
37835238|NCT01227967|69519454|FG000|Overall Study|Lost to Follow-up|8|||
37835239|NCT01227967|69519455|FG001|Overall Study|Lost to Follow-up|3|||
37835240|NCT01227967|69519454|FG000|Overall Study|Withdrawal by Subject|4|||
37913106|NCT00880620|69599862|FG003|Overall Study|Protocol Violation|2|||
37913107|NCT00880620|69599859|FG000|Overall Study|Withdrawal by Subject|4|||
37913108|NCT00880620|69599860|FG001|Overall Study|Withdrawal by Subject|3|||
37913109|NCT00880620|69599861|FG002|Overall Study|Withdrawal by Subject|1|||
37913110|NCT00880620|69599862|FG003|Overall Study|Withdrawal by Subject|3|||
37913111|NCT00880620|69599859|FG000|Overall Study|Noncompliance|0|||
37913112|NCT00880620|69599860|FG001|Overall Study|Noncompliance|0|||
37913113|NCT00880620|69599861|FG002|Overall Study|Noncompliance|1|||
37913114|NCT00880620|69599862|FG003|Overall Study|Noncompliance|1|||
37835241|NCT01227967|69519455|FG001|Overall Study|Withdrawal by Subject|3|||
37835242|NCT01227967|69519454|FG000|Overall Study|Physician Decision|0|||
37835243|NCT01227967|69519455|FG001|Overall Study|Physician Decision|1|||
37835244|NCT01227967|69519454|FG000|Overall Study|Never Started Treatment|0|||
37913115|NCT00880620|69599859|FG000|Overall Study|Other|1|||
37913116|NCT00880620|69599860|FG001|Overall Study|Other|1|||
37913117|NCT00880620|69599861|FG002|Overall Study|Other|2|||
37835245|NCT01227967|69519455|FG001|Overall Study|Never Started Treatment|4|||
37913118|NCT00880620|69599862|FG003|Overall Study|Other|2|||
37913119|NCT00881868|69599888|FG000|Overall Study|Adverse Event|0|||
37913120|NCT00881868|69599889|FG001|Overall Study|Adverse Event|1|||
37913121|NCT00881868|69599888|FG000|Overall Study|Lost to Follow-up|2|||
37913122|NCT00881868|69599889|FG001|Overall Study|Lost to Follow-up|1|||
37913123|NCT00881868|69599888|FG000|Overall Study|Physician Decision|4|||
37913124|NCT00881868|69599889|FG001|Overall Study|Physician Decision|0|||
37913125|NCT00881868|69599888|FG000|Overall Study|Protocol Violation|2|||
37913126|NCT00881868|69599889|FG001|Overall Study|Protocol Violation|0|||
37913127|NCT00881712|69599898|FG000|Overall Study|Death|1|||
37913128|NCT00881712|69599899|FG001|Overall Study|Death|0|||
37913129|NCT00881712|69599900|FG002|Overall Study|Death|0|||
37913130|NCT00881712|69599898|FG000|Overall Study|Withdrawal by Subject|1|||
37913131|NCT00881712|69599899|FG001|Overall Study|Withdrawal by Subject|0|||
37913132|NCT00881712|69599900|FG002|Overall Study|Withdrawal by Subject|0|||
37913133|NCT03955471|69599908|FG000|Overall Study|Death|22|||
37913134|NCT03955471|69599908|FG000|Overall Study|Lost to Follow-up|1|||
37913135|NCT03955471|69599908|FG000|Overall Study|Withdrawal by Subject|6|||
37913136|NCT03955471|69599908|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
37913137|NCT00880542|69599912|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
37913138|NCT00880542|69599912|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
37913139|NCT00880542|69599912|FG000|REP: Surgical Resection|progressive disease|1|||
37913140|NCT00885534|69599916|FG000|Overall Study|Patient deemed ineligible|1|||
37913141|NCT00885378|69599922|FG000|Overall Study|Lack of Efficacy|2|||
37913142|NCT00885378|69599923|FG001|Overall Study|Lack of Efficacy|2|||
37913143|NCT00885378|69599922|FG000|Overall Study|Withdrawal by Subject|1|||
37913144|NCT00885378|69599923|FG001|Overall Study|Withdrawal by Subject|2|||
37913145|NCT00885378|69599922|FG000|Overall Study|Lost to Follow-up|1|||
37913146|NCT00885378|69599923|FG001|Overall Study|Lost to Follow-up|2|||
37913147|NCT00885378|69599922|FG000|Overall Study|Poor/Noncompliance|2|||
37913148|NCT00885378|69599923|FG001|Overall Study|Poor/Noncompliance|2|||
37913149|NCT00885378|69599922|FG000|Overall Study|Protocol Violation|2|||
37913150|NCT00885378|69599923|FG001|Overall Study|Protocol Violation|0|||
37913151|NCT00545779|69599929|FG000|Overall Study|Violation of selection criteria at entry|8|||
37913152|NCT00545779|69599929|FG000|Overall Study|Other protocol violation|1|||
37913153|NCT00545779|69599929|FG000|Overall Study|Did not cooperate|7|||
37913154|NCT00545779|69599929|FG000|Overall Study|Withdrawal by Subject|20|||
37913155|NCT00545779|69599929|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
37913156|NCT00545779|69599929|FG000|Overall Study|Failure to return|3|||
37913157|NCT00597714|69599939|FG000|Overall Study|Death|56|||
37913158|NCT00597714|69599940|FG001|Overall Study|Death|46|||
37913159|NCT00597714|69599941|FG002|Overall Study|Death|0|||
37913160|NCT00597714|69599939|FG000|Overall Study|Recipient death|0|||
37913161|NCT00597714|69599940|FG001|Overall Study|Recipient death|0|||
37913162|NCT00597714|69599941|FG002|Overall Study|Recipient death|10|||
37913163|NCT03938857|69599954|FG000|Overall Study|Physician Decision|1|||
37913164|NCT03938857|69599955|FG001|Overall Study|Physician Decision|0|||
37913165|NCT03938857|69599956|FG002|Overall Study|Physician Decision|0|||
37913166|NCT03938857|69599957|FG003|Overall Study|Physician Decision|0|||
37913167|NCT00884832|69599969|FG000|Overall Study|Withdrawal by Subject|0|||
37913168|NCT00884832|69599970|FG001|Overall Study|Withdrawal by Subject|1|||
37913169|NCT03938545|69599980|FG000|Overall Study|Lost to Follow-up|0|||
37913170|NCT03938545|69599981|FG001|Overall Study|Lost to Follow-up|0|||
37913171|NCT03938545|69599982|FG002|Overall Study|Lost to Follow-up|0|||
37913172|NCT03938545|69599983|FG003|Overall Study|Lost to Follow-up|1|||
37913173|NCT03938545|69599980|FG000|Overall Study|Non-compliance with study drug|0|||
37913174|NCT03938545|69599981|FG001|Overall Study|Non-compliance with study drug|0|||
37913175|NCT03938545|69599982|FG002|Overall Study|Non-compliance with study drug|1|||
37913176|NCT03938545|69599983|FG003|Overall Study|Non-compliance with study drug|0|||
37913177|NCT03938545|69599980|FG000|Overall Study|Pregnancy|1|||
37913178|NCT03938545|69599981|FG001|Overall Study|Pregnancy|0|||
37913179|NCT03938545|69599982|FG002|Overall Study|Pregnancy|0|||
37913180|NCT03938545|69599983|FG003|Overall Study|Pregnancy|0|||
37913181|NCT03938545|69599980|FG000|Overall Study|Study terminated by sponsor|6|||
37913182|NCT03938545|69599981|FG001|Overall Study|Study terminated by sponsor|4|||
37913183|NCT03938545|69599982|FG002|Overall Study|Study terminated by sponsor|2|||
37913184|NCT03938545|69599983|FG003|Overall Study|Study terminated by sponsor|4|||
37913185|NCT03938545|69599980|FG000|Overall Study|Withdrawal by Subject|0|||
37913186|NCT03938545|69599981|FG001|Overall Study|Withdrawal by Subject|1|||
37913187|NCT03938545|69599982|FG002|Overall Study|Withdrawal by Subject|0|||
37913188|NCT03938545|69599983|FG003|Overall Study|Withdrawal by Subject|0|||
37913189|NCT03938545|69599980|FG000|Overall Study|Adverse Event|1|||
38022793|NCT03129100|69705724|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
38022794|NCT03129100|69705725|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
38022795|NCT03129100|69705726|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
38022796|NCT03129100|69705727|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
38022797|NCT03129100|69705728|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
38022798|NCT03129100|69705729|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
38022799|NCT03129100|69705730|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
38022800|NCT03129100|69705731|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
38022801|NCT03129100|69705732|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
38022802|NCT03129100|69705733|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
38022803|NCT03129100|69705734|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
37700389|NCT02317016|69177394|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
37700390|NCT02311478|69177402|FG000|Overall Study|Withdrawal by Subject|1|||
37700391|NCT02311478|69177402|FG000|Overall Study|Lost to Follow-up|5|||
37700392|NCT02311478|69177402|FG000|Overall Study|Failed IUD Insertion|1|||
37700393|NCT02388932|69177407|FG000|Overall Study|Death|1|||
37835246|NCT01227967|69519454|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
37835247|NCT01227967|69519455|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
37835248|NCT01227928|69519463|FG000|Overall Study|Lost to Follow-up|4|||
37835249|NCT01227928|69519464|FG001|Overall Study|Lost to Follow-up|2|||
37835250|NCT01227928|69519463|FG000|Overall Study|Withdrawal by Subject|4|||
37835251|NCT01227928|69519464|FG001|Overall Study|Withdrawal by Subject|3|||
37835252|NCT01227928|69519463|FG000|Overall Study|Death|14|||
37835253|NCT01227928|69519464|FG001|Overall Study|Death|12|||
37835254|NCT01227889|69519472|FG000|Randomized Phase (RP)|Adverse Event|13|||
37835255|NCT01227889|69519473|FG001|Randomized Phase (RP)|Adverse Event|0|||
37835256|NCT01227889|69519472|FG000|Randomized Phase (RP)|Physician Decision|13|||
37835257|NCT01227889|69519473|FG001|Randomized Phase (RP)|Physician Decision|5|||
37835258|NCT01227889|69519472|FG000|Randomized Phase (RP)|Progressive Disease|135|||
37835259|NCT01227889|69519473|FG001|Randomized Phase (RP)|Progressive Disease|52|||
37835260|NCT01227889|69519472|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
37835261|NCT01227889|69519473|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
37835262|NCT01227889|69519472|FG000|Randomized Phase (RP)|Missing|1|||
37835263|NCT01227889|69519473|FG001|Randomized Phase (RP)|Missing|3|||
37835264|NCT01227889|69519472|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
37835265|NCT01227889|69519473|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
37835266|NCT01227889|69519472|FG000|Crossover Phase|Adverse Event|0|||
37835267|NCT01227889|69519473|FG001|Crossover Phase|Adverse Event|1|||
37835268|NCT01227889|69519472|FG000|Crossover Phase|Physician Decision|0|||
37835269|NCT01227889|69519473|FG001|Crossover Phase|Physician Decision|3|||
37835270|NCT01227889|69519472|FG000|Crossover Phase|Progressive Disease|0|||
37835271|NCT01227889|69519473|FG001|Crossover Phase|Progressive Disease|31|||
37835272|NCT01227889|69519472|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
37835273|NCT01227889|69519473|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
37835274|NCT01227889|69519472|FG000|Crossover Phase|Withdrawal by Subject|0|||
37835275|NCT01227889|69519473|FG001|Crossover Phase|Withdrawal by Subject|1|||
37835276|NCT01227577|69519487|FG000|Overall Study|Protocol deviation|3|||
37700394|NCT02388776|69177412|FG000|Overall Study|Death|1|||
37913190|NCT03938545|69599981|FG001|Overall Study|Adverse Event|0|||
37913191|NCT03938545|69599982|FG002|Overall Study|Adverse Event|0|||
37913192|NCT03938545|69599983|FG003|Overall Study|Adverse Event|0|||
37913193|NCT00879996|69599995|FG000|Overall Study|Lost to Follow-up|7|||
37913194|NCT00879996|69599996|FG001|Overall Study|Lost to Follow-up|6|||
37913195|NCT00879996|69599995|FG000|Overall Study|non-compliance|6|||
37913196|NCT00879996|69599996|FG001|Overall Study|non-compliance|4|||
37913197|NCT00879996|69599995|FG000|Overall Study|Physician Decision|1|||
37913198|NCT00879996|69599996|FG001|Overall Study|Physician Decision|2|||
37913199|NCT00879996|69599995|FG000|Overall Study|psychiatric problem|0|||
37913200|NCT00879996|69599996|FG001|Overall Study|psychiatric problem|1|||
37913201|NCT00879996|69599995|FG000|Overall Study|put on parole|1|||
37913202|NCT00879996|69599996|FG001|Overall Study|put on parole|0|||
37913203|NCT00873093|69600009|FG000|Overall Study|Adverse Event|0|||
37913204|NCT00873093|69600010|FG001|Overall Study|Adverse Event|2|||
37913205|NCT00873093|69600011|FG002|Overall Study|Adverse Event|0|||
37913206|NCT00873093|69600012|FG003|Overall Study|Adverse Event|0|||
37913207|NCT00873093|69600013|FG004|Overall Study|Adverse Event|0|||
37913208|NCT00873093|69600009|FG000|Overall Study|Death|0|||
37913209|NCT00873093|69600010|FG001|Overall Study|Death|3|||
37913210|NCT00873093|69600011|FG002|Overall Study|Death|2|||
37913211|NCT00873093|69600012|FG003|Overall Study|Death|0|||
37913212|NCT00873093|69600013|FG004|Overall Study|Death|0|||
37913213|NCT00873093|69600009|FG000|Overall Study|Physician Decision|0|||
37913214|NCT00873093|69600010|FG001|Overall Study|Physician Decision|17|||
37913215|NCT00873093|69600011|FG002|Overall Study|Physician Decision|10|||
37913216|NCT00873093|69600012|FG003|Overall Study|Physician Decision|10|||
38022804|NCT03129100|69705735|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
38022805|NCT03129100|69705736|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
37835277|NCT01227577|69519487|FG000|Overall Study|Death|3|||
37835278|NCT01227577|69519487|FG000|Overall Study|Administrative problems|2|||
37835279|NCT01227577|69519487|FG000|Overall Study|Lost to Follow-up|1|||
37835280|NCT01227577|69519487|FG000|Overall Study|Withdrawal by Subject|4|||
37835281|NCT01227577|69519487|FG000|Overall Study|Lack of Efficacy|5|||
37835282|NCT01227577|69519487|FG000|Overall Study|Adverse Event|17|||
37835283|NCT01227421|69519507|FG000|Overall Study|Lost to Follow-up|6|||
37835284|NCT01227421|69519508|FG001|Overall Study|Lost to Follow-up|7|||
37835285|NCT01227421|69519509|FG002|Overall Study|Lost to Follow-up|5|||
37835286|NCT01227421|69519507|FG000|Overall Study|Adverse Event|2|||
37835287|NCT01227421|69519508|FG001|Overall Study|Adverse Event|7|||
37835288|NCT01227421|69519509|FG002|Overall Study|Adverse Event|2|||
37913217|NCT00873093|69600013|FG004|Overall Study|Physician Decision|2|||
37913218|NCT00873093|69600009|FG000|Overall Study|Withdrawal by Subject|1|||
37913219|NCT00873093|69600010|FG001|Overall Study|Withdrawal by Subject|4|||
37913220|NCT00873093|69600011|FG002|Overall Study|Withdrawal by Subject|4|||
37835289|NCT01227421|69519507|FG000|Overall Study|Withdrawal by Subject|1|||
37913221|NCT00873093|69600012|FG003|Overall Study|Withdrawal by Subject|0|||
37913222|NCT00873093|69600013|FG004|Overall Study|Withdrawal by Subject|0|||
37913223|NCT00873093|69600009|FG000|Overall Study|Ineligible|0|||
37835290|NCT01227421|69519508|FG001|Overall Study|Withdrawal by Subject|2|||
37835291|NCT01227421|69519509|FG002|Overall Study|Withdrawal by Subject|1|||
37913224|NCT00873093|69600010|FG001|Overall Study|Ineligible|1|||
37913225|NCT00873093|69600011|FG002|Overall Study|Ineligible|0|||
37835292|NCT01227421|69519507|FG000|Overall Study|Protocol Violation|1|||
37835293|NCT01227421|69519508|FG001|Overall Study|Protocol Violation|1|||
37835294|NCT01227421|69519509|FG002|Overall Study|Protocol Violation|2|||
37835295|NCT01227421|69519507|FG000|Overall Study|Randomized in error|1|||
37835296|NCT01227421|69519508|FG001|Overall Study|Randomized in error|1|||
37835297|NCT01227421|69519509|FG002|Overall Study|Randomized in error|0|||
37835298|NCT01227265|69519520|FG000|Overall Study|Did Not Receive Treatment|1|||
37835299|NCT01227265|69519521|FG001|Overall Study|Did Not Receive Treatment|2|||
37835300|NCT01227265|69519522|FG002|Overall Study|Did Not Receive Treatment|0|||
37835301|NCT01227265|69519520|FG000|Overall Study|Administrative|1|||
37913226|NCT00873093|69600012|FG003|Overall Study|Ineligible|1|||
37913227|NCT00873093|69600013|FG004|Overall Study|Ineligible|0|||
37913228|NCT00884286|69600037|FG000|Overall Study|Progressive disease|21|||
37913229|NCT00884286|69600038|FG001|Overall Study|Progressive disease|28|||
37913230|NCT00884286|69600037|FG000|Overall Study|Toxicity|4|||
37913231|NCT00884286|69600038|FG001|Overall Study|Toxicity|1|||
37835302|NCT01227265|69519521|FG001|Overall Study|Administrative|0|||
37835303|NCT01227265|69519522|FG002|Overall Study|Administrative|2|||
37913232|NCT00884286|69600037|FG000|Overall Study|Death|2|||
37913233|NCT00884286|69600038|FG001|Overall Study|Death|2|||
37913234|NCT00884286|69600037|FG000|Overall Study|Physician Decision|1|||
37913235|NCT00884286|69600038|FG001|Overall Study|Physician Decision|0|||
37913236|NCT00884286|69600037|FG000|Overall Study|Septic shock|1|||
37913237|NCT00884286|69600038|FG001|Overall Study|Septic shock|0|||
37913238|NCT00884286|69600037|FG000|Overall Study|Thrombus in right auricle|1|||
37913239|NCT00884286|69600038|FG001|Overall Study|Thrombus in right auricle|0|||
37913240|NCT00884286|69600037|FG000|Overall Study|Not treated|2|||
37913241|NCT00884286|69600038|FG001|Overall Study|Not treated|1|||
37913242|NCT00884286|69600037|FG000|Overall Study|Comprised lung carcinoma|0|||
37913243|NCT00884286|69600038|FG001|Overall Study|Comprised lung carcinoma|1|||
37913244|NCT00873015|69600049|FG000|Overall Study|Withdrawal by Subject|0|||
37913245|NCT00873015|69600050|FG001|Overall Study|Withdrawal by Subject|1|||
37913246|NCT00873015|69600051|FG002|Overall Study|Withdrawal by Subject|0|||
37913247|NCT00873015|69600052|FG003|Overall Study|Withdrawal by Subject|0|||
37913248|NCT03921151|69600067|FG000|Overall Study|Withdrawal by Subject|11|||
37913249|NCT03921151|69600068|FG001|Overall Study|Withdrawal by Subject|16|||
37913250|NCT00872001|69600080|FG000|Overall Study|Adverse Event|34|||
37913251|NCT00872001|69600081|FG001|Overall Study|Adverse Event|23|||
37913252|NCT00872001|69600080|FG000|Overall Study|Protocol Defined Clinical Event|5|||
37913253|NCT00872001|69600081|FG001|Overall Study|Protocol Defined Clinical Event|7|||
37913254|NCT00872001|69600080|FG000|Overall Study|Lost to Follow-up|13|||
37913255|NCT00872001|69600081|FG001|Overall Study|Lost to Follow-up|12|||
37913256|NCT00872001|69600080|FG000|Overall Study|Withdrawal by Subject|18|||
37913257|NCT00872001|69600081|FG001|Overall Study|Withdrawal by Subject|30|||
37913258|NCT00872001|69600080|FG000|Overall Study|Protocol Violation|5|||
37913259|NCT00872001|69600081|FG001|Overall Study|Protocol Violation|8|||
37913260|NCT00872001|69600080|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
37913261|NCT00872001|69600081|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
37913262|NCT00872001|69600080|FG000|Overall Study|Administrative|23|||
37913263|NCT00872001|69600081|FG001|Overall Study|Administrative|15|||
37913264|NCT00871923|69600089|FG000|Overall Study|Death|1|||
37913265|NCT00871923|69600089|FG000|Overall Study|Withdrawal by Subject|1|||
37913266|NCT03922945|69600096|FG000|Overall Study|Adverse Event|1|||
37913267|NCT03922945|69600097|FG001|Overall Study|Adverse Event|1|||
37913268|NCT03922945|69600098|FG002|Overall Study|Adverse Event|2|||
37913269|NCT03922945|69600096|FG000|Overall Study|Lost to Follow-up|13|||
37913270|NCT03922945|69600097|FG001|Overall Study|Lost to Follow-up|9|||
37913271|NCT03922945|69600098|FG002|Overall Study|Lost to Follow-up|20|||
37913272|NCT03922945|69600096|FG000|Overall Study|Lack of Efficacy|2|||
37835304|NCT01227265|69519520|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
37835305|NCT01227265|69519521|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
37835306|NCT01227265|69519522|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
37913273|NCT03922945|69600097|FG001|Overall Study|Lack of Efficacy|0|||
37913274|NCT03922945|69600098|FG002|Overall Study|Lack of Efficacy|1|||
37913275|NCT03922945|69600096|FG000|Overall Study|Protocol Non-Compliance|0|||
38022806|NCT03129100|69705737|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
37835307|NCT01227265|69519520|FG000|Overall Study|Protocol Violation|2|||
37913276|NCT03922945|69600097|FG001|Overall Study|Protocol Non-Compliance|0|||
37913277|NCT03922945|69600098|FG002|Overall Study|Protocol Non-Compliance|1|||
37835308|NCT01227265|69519521|FG001|Overall Study|Protocol Violation|1|||
37913278|NCT03922945|69600096|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
37913279|NCT03922945|69600097|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
37913280|NCT03922945|69600098|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
37913281|NCT03922945|69600096|FG000|Overall Study|All Other Personal Reasons|1|||
38022807|NCT03129100|69705738|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
38022808|NCT03129100|69705739|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
38022809|NCT03129100|69705740|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
38022810|NCT03129100|69705741|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
38022811|NCT03129100|69705742|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
38022812|NCT03129100|69705743|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
38022813|NCT03129100|69705744|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
38022814|NCT03129100|69705719|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
38022815|NCT03129100|69705720|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
38022816|NCT03129100|69705721|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
38022817|NCT03129100|69705722|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
38022818|NCT03129100|69705723|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
38022819|NCT03129100|69705724|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
38022820|NCT03129100|69705725|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
38022821|NCT03129100|69705726|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
38022822|NCT03129100|69705727|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
38022823|NCT03129100|69705728|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
38022824|NCT03129100|69705729|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
38022825|NCT03129100|69705730|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
38022826|NCT03129100|69705731|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
38022827|NCT03129100|69705732|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
38022828|NCT03129100|69705733|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
38022829|NCT03129100|69705734|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
38022830|NCT03129100|69705735|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
38022831|NCT03129100|69705736|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
38022832|NCT03129100|69705737|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
38022833|NCT03129100|69705738|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
38022834|NCT03129100|69705739|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
38022835|NCT03129100|69705740|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
38022836|NCT03129100|69705741|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
38022837|NCT03129100|69705742|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
38022838|NCT03129100|69705743|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
38022839|NCT03129100|69705744|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
38022840|NCT03129100|69705719|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
38022841|NCT03129100|69705720|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
38022842|NCT03129100|69705721|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
38022843|NCT03129100|69705722|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
38022844|NCT03129100|69705723|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
38022845|NCT03129100|69705724|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
38022846|NCT03129100|69705725|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
37835309|NCT01227265|69519522|FG002|Overall Study|Protocol Violation|0|||
37835310|NCT01227265|69519520|FG000|Overall Study|Withdrawal by Subject|7|||
37835311|NCT01227265|69519521|FG001|Overall Study|Withdrawal by Subject|7|||
37835312|NCT01227265|69519522|FG002|Overall Study|Withdrawal by Subject|3|||
37835313|NCT01227265|69519520|FG000|Overall Study|Lost to Follow-up|2|||
37835314|NCT01227265|69519521|FG001|Overall Study|Lost to Follow-up|0|||
37835315|NCT01227265|69519522|FG002|Overall Study|Lost to Follow-up|3|||
37835316|NCT01227265|69519520|FG000|Overall Study|Adverse Event|6|||
37835317|NCT01227265|69519521|FG001|Overall Study|Adverse Event|10|||
37835318|NCT01227265|69519522|FG002|Overall Study|Adverse Event|5|||
37835319|NCT01226095|69519530|FG000|Overall Study|Poor compliance|1|||
37835320|NCT01225822|69519546|FG000|Overall Study|Adverse Event|13|||
37913282|NCT03922945|69600097|FG001|Overall Study|All Other Personal Reasons|1|||
37913283|NCT03922945|69600098|FG002|Overall Study|All Other Personal Reasons|2|||
37913284|NCT03922477|69600109|FG000|Overall Study|Death|9|||
37913285|NCT03922477|69600109|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
37913286|NCT03922477|69600109|FG000|Overall Study|Physician Decision|1|||
37913287|NCT03922477|69600109|FG000|Overall Study|Withdrawal by Subject|2|||
37913288|NCT00867165|69600115|FG000|Overall Study|Adverse Event|3|||
37913289|NCT00867165|69600116|FG001|Overall Study|Adverse Event|0|||
38022847|NCT03129100|69705726|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
38022848|NCT03129100|69705727|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
38022849|NCT03129100|69705728|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
38022850|NCT03129100|69705729|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
38022851|NCT03129100|69705730|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
37835321|NCT01225822|69519547|FG001|Overall Study|Adverse Event|31|||
37835322|NCT01225822|69519548|FG002|Overall Study|Adverse Event|18|||
37913290|NCT00867165|69600115|FG000|Overall Study|Withdrawal by Subject|1|||
37913291|NCT00867165|69600116|FG001|Overall Study|Withdrawal by Subject|0|||
37913292|NCT00867087|69600122|FG000|Overall Study|Other|1|||
37913293|NCT00867087|69600122|FG000|Overall Study|Withdrawal by Subject|4|||
37913294|NCT00867087|69600122|FG000|Overall Study|Death|37|||
37913295|NCT00545233|69600128|FG000|Overall Study|Adverse Event|10|||
37913296|NCT00545233|69600129|FG001|Overall Study|Adverse Event|5|||
37913297|NCT00545233|69600128|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
37700395|NCT02388776|69177412|FG000|Overall Study|Lost to Follow-up|1|||
37700396|NCT02316548|69177419|FG000|Overall Study|Protocol Violation|0|||
37700397|NCT02316548|69177420|FG001|Overall Study|Protocol Violation|1|||
37700398|NCT02281760|69177426|FG000|Overall Study|Withdrawal by Subject|1|||
37700399|NCT02390531|69177438|FG000|Overall Study|Death|0|||
37700400|NCT02390531|69177439|FG001|Overall Study|Death|2|||
37700401|NCT02390531|69177440|FG002|Overall Study|Death|0|||
37700402|NCT02390531|69177441|FG003|Overall Study|Death|1|||
37700403|NCT02390531|69177442|FG004|Overall Study|Death|0|||
37700404|NCT02390531|69177443|FG005|Overall Study|Death|0|||
37700405|NCT02390531|69177444|FG006|Overall Study|Death|0|||
37700406|NCT02390531|69177445|FG007|Overall Study|Death|1|||
37700407|NCT02390531|69177438|FG000|Overall Study|Protocol Violation|0|||
37700408|NCT02390531|69177439|FG001|Overall Study|Protocol Violation|0|||
37700409|NCT02390531|69177440|FG002|Overall Study|Protocol Violation|0|||
37700410|NCT02390531|69177441|FG003|Overall Study|Protocol Violation|0|||
37700411|NCT02390531|69177442|FG004|Overall Study|Protocol Violation|1|||
37700412|NCT02390531|69177443|FG005|Overall Study|Protocol Violation|0|||
37700413|NCT02390531|69177444|FG006|Overall Study|Protocol Violation|2|||
37700414|NCT02390531|69177445|FG007|Overall Study|Protocol Violation|0|||
37700415|NCT02390219|69177481|FG000|Overall Study|Death|1|||
37700416|NCT02390219|69177481|FG000|Overall Study|Physician Decision|1|||
37700417|NCT02390219|69177481|FG000|Overall Study|Adverse Event|6|||
37700418|NCT02390219|69177481|FG000|Overall Study|Withdrawal by Subject|1|||
37700419|NCT02390219|69177481|FG000|Overall Study|Lost to Follow-up|2|||
37700420|NCT02390219|69177481|FG000|Overall Study|Other|2|||
37700421|NCT02334215|69177488|FG000|Overall Study|Death|1|||
37700422|NCT02334215|69177489|FG001|Overall Study|Death|1|||
37700423|NCT02334215|69177490|FG002|Overall Study|Death|0|||
37700424|NCT02334215|69177488|FG000|Overall Study|Lost to Follow-up|1|||
37700425|NCT02334215|69177489|FG001|Overall Study|Lost to Follow-up|0|||
37835323|NCT01225822|69519549|FG003|Overall Study|Adverse Event|23|||
37835324|NCT01225822|69519550|FG004|Overall Study|Adverse Event|14|||
37835325|NCT01225822|69519546|FG000|Overall Study|Protocol Violation|6|||
37835326|NCT01225822|69519547|FG001|Overall Study|Protocol Violation|8|||
37835327|NCT01225822|69519548|FG002|Overall Study|Protocol Violation|6|||
37835328|NCT01225822|69519549|FG003|Overall Study|Protocol Violation|7|||
37835329|NCT01225822|69519550|FG004|Overall Study|Protocol Violation|4|||
37835330|NCT01225822|69519546|FG000|Overall Study|Lost to Follow-up|0|||
37835331|NCT01225822|69519547|FG001|Overall Study|Lost to Follow-up|0|||
38022852|NCT03129100|69705731|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
38022853|NCT03129100|69705732|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
37913298|NCT00545233|69600129|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
37700426|NCT02334215|69177490|FG002|Overall Study|Lost to Follow-up|4|||
37700427|NCT02334215|69177488|FG000|Overall Study|Withdrawal by Subject|2|||
37700428|NCT02334215|69177489|FG001|Overall Study|Withdrawal by Subject|2|||
37700429|NCT02334215|69177490|FG002|Overall Study|Withdrawal by Subject|1|||
37835332|NCT01225822|69519548|FG002|Overall Study|Lost to Follow-up|0|||
37913299|NCT00545233|69600128|FG000|Overall Study|Protocol Violation|2|||
37835333|NCT01225822|69519549|FG003|Overall Study|Lost to Follow-up|1|||
37835334|NCT01225822|69519550|FG004|Overall Study|Lost to Follow-up|0|||
37835335|NCT01225822|69519546|FG000|Overall Study|Withdrawal by Subject|6|||
37835336|NCT01225822|69519547|FG001|Overall Study|Withdrawal by Subject|7|||
37835337|NCT01225822|69519548|FG002|Overall Study|Withdrawal by Subject|7|||
37913300|NCT00545233|69600129|FG001|Overall Study|Protocol Violation|0|||
37913301|NCT00545233|69600128|FG000|Overall Study|Refused Treatment|9|||
38022854|NCT03129100|69705733|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
37835338|NCT01225822|69519549|FG003|Overall Study|Withdrawal by Subject|11|||
37835339|NCT01225822|69519550|FG004|Overall Study|Withdrawal by Subject|6|||
37835340|NCT01225822|69519546|FG000|Overall Study|Other|13|||
37835341|NCT01225822|69519547|FG001|Overall Study|Other|10|||
37835342|NCT01225822|69519548|FG002|Overall Study|Other|7|||
37835343|NCT01225822|69519549|FG003|Overall Study|Other|10|||
37835344|NCT01225822|69519550|FG004|Overall Study|Other|7|||
37835345|NCT01225549|69519565|FG000|Period 4 - Washout|Disallowed medication|0|||
38022855|NCT03129100|69705734|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
38022856|NCT03129100|69705735|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
37835346|NCT01225549|69519566|FG001|Period 4 - Washout|Disallowed medication|1|||
37835347|NCT01225549|69519567|FG002|Period 4 - Washout|Disallowed medication|0|||
38022857|NCT03129100|69705736|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
37677363|NCT01659255|69152297|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
37835348|NCT01225549|69519568|FG003|Period 4 - Washout|Disallowed medication|0|||
37835349|NCT01225549|69519569|FG004|Period 4 - Washout|Disallowed medication|0|||
37835350|NCT01225549|69519570|FG005|Period 4 - Washout|Disallowed medication|0|||
37835351|NCT01225549|69519571|FG006|Period 4 - Washout|Disallowed medication|0|||
37835352|NCT01225549|69519572|FG007|Period 4 - Washout|Disallowed medication|0|||
37835353|NCT01225549|69519573|FG008|Period 4 - Washout|Disallowed medication|0|||
37835354|NCT01225549|69519574|FG009|Period 4 - Washout|Disallowed medication|0|||
37835355|NCT01225549|69519565|FG000|Period 6 - Washout|Disallowed medication|0|||
37835356|NCT01225549|69519566|FG001|Period 6 - Washout|Disallowed medication|0|||
37835357|NCT01225549|69519567|FG002|Period 6 - Washout|Disallowed medication|0|||
37835358|NCT01225549|69519568|FG003|Period 6 - Washout|Disallowed medication|1|||
37835359|NCT01225549|69519569|FG004|Period 6 - Washout|Disallowed medication|0|||
37835360|NCT01225549|69519570|FG005|Period 6 - Washout|Disallowed medication|0|||
37835361|NCT01225549|69519571|FG006|Period 6 - Washout|Disallowed medication|0|||
37835362|NCT01225549|69519572|FG007|Period 6 - Washout|Disallowed medication|0|||
37835363|NCT01225549|69519573|FG008|Period 6 - Washout|Disallowed medication|0|||
37835364|NCT01225549|69519574|FG009|Period 6 - Washout|Disallowed medication|0|||
37835365|NCT01225159|69519586|FG000|Overall Study|Change operation|1|||
37835366|NCT01225159|69519587|FG001|Overall Study|Change operation|0|||
37835367|NCT01224925|69519595|FG000|Overall Study|Lost to Follow-up|3|||
37835368|NCT01224925|69519596|FG001|Overall Study|Lost to Follow-up|2|||
37835369|NCT01223404|69519604|FG000|First Intervention (1 Day)|Adverse Event|0|||
37835370|NCT01223404|69519605|FG001|First Intervention (1 Day)|Adverse Event|0|||
37835371|NCT01223404|69519606|FG002|First Intervention (1 Day)|Adverse Event|0|||
37835372|NCT01223404|69519607|FG003|First Intervention (1 Day)|Adverse Event|1|||
37835373|NCT01223404|69519608|FG004|First Intervention (1 Day)|Adverse Event|0|||
37835374|NCT01223404|69519609|FG005|First Intervention (1 Day)|Adverse Event|0|||
37835375|NCT01223404|69519604|FG000|Second Intervention (1 Day)|Adverse Event|1|||
37835376|NCT01223404|69519605|FG001|Second Intervention (1 Day)|Adverse Event|0|||
37835377|NCT01223404|69519606|FG002|Second Intervention (1 Day)|Adverse Event|0|||
37835378|NCT01223404|69519607|FG003|Second Intervention (1 Day)|Adverse Event|0|||
37835379|NCT01223404|69519608|FG004|Second Intervention (1 Day)|Adverse Event|0|||
37835380|NCT01223404|69519609|FG005|Second Intervention (1 Day)|Adverse Event|0|||
37835381|NCT01223404|69519604|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
37835382|NCT01223404|69519605|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
37835383|NCT01223404|69519606|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
37835384|NCT01223404|69519607|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
37835385|NCT01223404|69519608|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
37835386|NCT01223404|69519609|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
37835387|NCT01223365|69519657|FG000|Open-label Titration Period|Enrolled but not treated|1|||
37835388|NCT01223365|69519657|FG000|Open-label Titration Period|Adverse Event|23|||
37835389|NCT01223365|69519657|FG000|Open-label Titration Period|Lack of Efficacy|3|||
37835390|NCT01223365|69519657|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
37835391|NCT01223365|69519657|FG000|Open-label Titration Period|Protocol Violation|1|||
37835392|NCT01223365|69519657|FG000|Open-label Titration Period|Lost to Follow-up|2|||
37835393|NCT01223365|69519657|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
37835394|NCT01223365|69519657|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
37835395|NCT01223365|69519657|FG000|Open-label Titration Period|Starting physical therapy|1|||
37835396|NCT01223365|69519657|FG000|Open-label Treatment Period|Adverse Event|39|||
37835397|NCT01223365|69519657|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
37835398|NCT01223365|69519657|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
37835399|NCT01223365|69519657|FG000|Open-label Treatment Period|Protocol Violation|15|||
37835400|NCT01223365|69519657|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
37835401|NCT01223365|69519657|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
37835402|NCT01223365|69519657|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
37835403|NCT01223365|69519657|FG000|Open-label Treatment Period|Moved out of area|2|||
37835404|NCT01223365|69519657|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
37835405|NCT01223365|69519657|FG000|Open-label Treatment Period|"Out of window"|1|||
37835406|NCT01223365|69519657|FG000|Open-label Treatment Period|Starting physical therapy|1|||
37835407|NCT01223365|69519657|FG000|Open-label Treatment Period|Physician Decision|2|||
37835408|NCT01222507|69519666|FG000|Overall Study|Physician Decision|1|||
37835409|NCT01222507|69519666|FG000|Overall Study|Withdrawal by Subject|1|||
37835410|NCT01222078|69519670|FG000|Overall Study|Early termination of the study|1|||
37835411|NCT01221727|69519677|FG000|Overall Study|Physician Decision|2|||
37835412|NCT01221727|69519678|FG001|Overall Study|Physician Decision|0|||
37835413|NCT01221727|69519677|FG000|Overall Study|Withdrawal by Subject|1|||
37835414|NCT01221727|69519678|FG001|Overall Study|Withdrawal by Subject|1|||
37835415|NCT01221181|69519690|FG000|Overall Study|Lost to Follow-up|1|||
37835416|NCT01220557|69519696|FG000|Overall Study|Lost to Follow-up|5|||
37835417|NCT01220557|69519697|FG001|Overall Study|Lost to Follow-up|3|||
37835418|NCT01220557|69519696|FG000|Overall Study|attended less than 6 lessons|1|||
37835419|NCT01220557|69519697|FG001|Overall Study|attended less than 6 lessons|2|||
37835420|NCT01220401|69519703|FG000|Overall Study|Withdrawal by Subject|2|||
37835421|NCT01220401|69519703|FG000|Overall Study|Protocol Violation|1|||
37835422|NCT01220167|69519710|FG000|Period 3|Urine positive for substance abuse|0|||
37835423|NCT01220167|69519711|FG001|Period 3|Urine positive for substance abuse|1|||
37835424|NCT01220167|69519712|FG002|Period 3|Urine positive for substance abuse|0|||
37835425|NCT01220128|69519725|FG000|Overall Study|Progressive disease|0|||
37835426|NCT01220128|69519726|FG001|Overall Study|Progressive disease|0|||
37835427|NCT01220128|69519727|FG002|Overall Study|Progressive disease|2|||
37835428|NCT01220128|69519728|FG003|Overall Study|Progressive disease|0|||
37835429|NCT01220128|69519729|FG004|Overall Study|Progressive disease|0|||
37913302|NCT00545233|69600129|FG001|Overall Study|Refused Treatment|7|||
37913303|NCT00545233|69600128|FG000|Overall Study|Failure to Return|4|||
37913304|NCT00545233|69600129|FG001|Overall Study|Failure to Return|6|||
37913305|NCT00545233|69600128|FG000|Overall Study|Insufficient response|14|||
37913306|NCT00545233|69600129|FG001|Overall Study|Insufficient response|15|||
37913307|NCT00545233|69600128|FG000|Overall Study|Physician Decision|2|||
37913308|NCT00545233|69600129|FG001|Overall Study|Physician Decision|1|||
37913309|NCT02393248|69600161|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
37913310|NCT02393248|69600162|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
37913311|NCT02393248|69600163|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
37913312|NCT02393248|69600164|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
37913313|NCT02393248|69600165|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
37913314|NCT02393248|69600166|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
37913315|NCT02393248|69600167|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
37913316|NCT02393248|69600168|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
37913317|NCT02393248|69600169|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
37913318|NCT02393248|69600170|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
37913319|NCT02393248|69600171|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
37913320|NCT02393248|69600172|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
38022858|NCT03129100|69705737|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
37835430|NCT01220128|69519730|FG005|Overall Study|Progressive disease|0|||
37835431|NCT01220128|69519731|FG006|Overall Study|Progressive disease|0|||
37835432|NCT01220128|69519725|FG000|Overall Study|Sponsor study termination|0|||
37835433|NCT01220128|69519726|FG001|Overall Study|Sponsor study termination|1|||
37835434|NCT01220128|69519727|FG002|Overall Study|Sponsor study termination|0|||
37835435|NCT01220128|69519728|FG003|Overall Study|Sponsor study termination|0|||
37835436|NCT01220128|69519729|FG004|Overall Study|Sponsor study termination|0|||
37835437|NCT01220128|69519730|FG005|Overall Study|Sponsor study termination|0|||
37835438|NCT01220128|69519731|FG006|Overall Study|Sponsor study termination|1|||
37835439|NCT01220128|69519725|FG000|Overall Study|Adverse event, serious fatal|2|||
37835440|NCT01220128|69519726|FG001|Overall Study|Adverse event, serious fatal|0|||
37835441|NCT01220128|69519727|FG002|Overall Study|Adverse event, serious fatal|0|||
37835442|NCT01220128|69519728|FG003|Overall Study|Adverse event, serious fatal|0|||
37835443|NCT01220128|69519729|FG004|Overall Study|Adverse event, serious fatal|0|||
37835444|NCT01220128|69519730|FG005|Overall Study|Adverse event, serious fatal|0|||
37835445|NCT01220128|69519731|FG006|Overall Study|Adverse event, serious fatal|1|||
37835446|NCT01220128|69519725|FG000|Overall Study|Adverse event, non-fatal|1|||
37835447|NCT01220128|69519726|FG001|Overall Study|Adverse event, non-fatal|0|||
37913321|NCT02393248|69600173|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
38022859|NCT03129100|69705738|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
37913322|NCT02393248|69600174|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
37835448|NCT01220128|69519727|FG002|Overall Study|Adverse event, non-fatal|0|||
37835449|NCT01220128|69519728|FG003|Overall Study|Adverse event, non-fatal|0|||
37835450|NCT01220128|69519729|FG004|Overall Study|Adverse event, non-fatal|0|||
37835451|NCT01220128|69519730|FG005|Overall Study|Adverse event, non-fatal|0|||
37835452|NCT01220128|69519731|FG006|Overall Study|Adverse event, non-fatal|3|||
37835453|NCT01220128|69519725|FG000|Overall Study|Other|0|||
37835454|NCT01220128|69519726|FG001|Overall Study|Other|0|||
37835455|NCT01220128|69519727|FG002|Overall Study|Other|1|||
37835456|NCT01220128|69519728|FG003|Overall Study|Other|0|||
37835457|NCT01220128|69519729|FG004|Overall Study|Other|0|||
37835458|NCT01220128|69519730|FG005|Overall Study|Other|0|||
37913323|NCT02393248|69600175|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
37913324|NCT02393248|69600176|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
37913325|NCT02393248|69600177|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
37913326|NCT02393248|69600178|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
37913327|NCT02393248|69600179|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
37913328|NCT02393248|69600180|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
37913329|NCT02393248|69600181|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
37913330|NCT02393248|69600182|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
37913331|NCT02393248|69600183|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
37913332|NCT02393248|69600184|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
37835459|NCT01220128|69519731|FG006|Overall Study|Other|0|||
37835460|NCT01220128|69519725|FG000|Overall Study|Consent withdrawn by subject|1|||
37835461|NCT01220128|69519726|FG001|Overall Study|Consent withdrawn by subject|0|||
37835462|NCT01220128|69519727|FG002|Overall Study|Consent withdrawn by subject|0|||
37835463|NCT01220128|69519728|FG003|Overall Study|Consent withdrawn by subject|0|||
37835464|NCT01220128|69519729|FG004|Overall Study|Consent withdrawn by subject|0|||
37835465|NCT01220128|69519730|FG005|Overall Study|Consent withdrawn by subject|0|||
37835466|NCT01220128|69519731|FG006|Overall Study|Consent withdrawn by subject|0|||
37835467|NCT01219933|69519748|FG000|Overall Study|Adverse Event|8|||
37835468|NCT01219933|69519748|FG000|Overall Study|No LDA reached|5|||
37835469|NCT01219933|69519748|FG000|Overall Study|No LDA maintained|7|||
37835470|NCT01219933|69519748|FG000|Overall Study|Lost to Follow-up|3|||
37835471|NCT01219933|69519748|FG000|Overall Study|GC free|1|||
37835472|NCT01219933|69519748|FG000|Overall Study|Withdrawal by Subject|5|||
37835473|NCT01219933|69519748|FG000|Overall Study|Protocol Violation|8|||
37835474|NCT01219933|69519748|FG000|Overall Study|Lack of Efficacy|1|||
37835475|NCT01218802|69519755|FG000|Overall Study|Lost to Follow-up|5|||
37835476|NCT01218802|69519756|FG001|Overall Study|Lost to Follow-up|6|||
37835477|NCT01218802|69519755|FG000|Overall Study|Withdrawal by Subject|3|||
37835478|NCT01218802|69519756|FG001|Overall Study|Withdrawal by Subject|10|||
37835479|NCT01218802|69519755|FG000|Overall Study|Adverse Event|0|||
37835480|NCT01218802|69519756|FG001|Overall Study|Adverse Event|2|||
37835481|NCT01218802|69519755|FG000|Overall Study|Incarcerated|2|||
37835482|NCT01218802|69519756|FG001|Overall Study|Incarcerated|0|||
37835483|NCT01218646|69519766|FG000|Overall Study|Adverse Event|0|||
37913333|NCT02393248|69600185|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
37913334|NCT02393248|69600161|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
37913335|NCT02393248|69600162|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
37913336|NCT02393248|69600163|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
37913337|NCT02393248|69600164|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
37913338|NCT02393248|69600165|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
37913339|NCT02393248|69600166|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
37913340|NCT02393248|69600167|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
37913341|NCT02393248|69600168|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
37913342|NCT02393248|69600169|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
37913343|NCT02393248|69600170|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
37913344|NCT02393248|69600171|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
37913345|NCT02393248|69600172|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
37913346|NCT02393248|69600173|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
37913347|NCT02393248|69600174|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
37913348|NCT02393248|69600175|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
37913349|NCT02393248|69600176|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
37913350|NCT02393248|69600177|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
37913351|NCT02393248|69600178|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
37835484|NCT01218646|69519767|FG001|Overall Study|Adverse Event|0|||
37835485|NCT01218646|69519768|FG002|Overall Study|Adverse Event|1|||
37835486|NCT01218646|69519769|FG003|Overall Study|Adverse Event|0|||
37835487|NCT01218646|69519766|FG000|Overall Study|Lost to Follow-up|1|||
37835488|NCT01218646|69519767|FG001|Overall Study|Lost to Follow-up|0|||
37835489|NCT01218646|69519768|FG002|Overall Study|Lost to Follow-up|0|||
37835490|NCT01218646|69519769|FG003|Overall Study|Lost to Follow-up|0|||
37913352|NCT02393248|69600179|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
37913353|NCT02393248|69600180|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
37913354|NCT02393248|69600181|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
37913355|NCT02393248|69600182|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
37913356|NCT02393248|69600183|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
37913357|NCT02393248|69600184|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
37913358|NCT02393248|69600185|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
37913359|NCT02393248|69600161|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
37913360|NCT02393248|69600162|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
37913361|NCT02393248|69600163|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
37913362|NCT02393248|69600164|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
37913363|NCT02393248|69600165|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
37913364|NCT02393248|69600166|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
37913365|NCT02393248|69600167|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
37913366|NCT02393248|69600168|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
37913367|NCT02393248|69600169|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
37913368|NCT02393248|69600170|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
37913369|NCT02393248|69600171|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
38022860|NCT03129100|69705739|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
38022861|NCT03129100|69705740|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
37835491|NCT01218646|69519766|FG000|Overall Study|Protocol Violation|0|||
37835492|NCT01218646|69519767|FG001|Overall Study|Protocol Violation|0|||
37835493|NCT01218646|69519768|FG002|Overall Study|Protocol Violation|1|||
37835494|NCT01218646|69519769|FG003|Overall Study|Protocol Violation|1|||
37835495|NCT01188772|69519783|FG000|Overall Study|Randomized but Not Treated|0|||
37835496|NCT01188772|69519784|FG001|Overall Study|Randomized but Not Treated|1|||
37913370|NCT02393248|69600172|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
37913371|NCT02393248|69600173|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
37913372|NCT02393248|69600174|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
37913373|NCT02393248|69600175|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
37913374|NCT02393248|69600176|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
37913375|NCT02393248|69600177|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
37913376|NCT02393248|69600178|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
37913377|NCT02393248|69600179|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
37913378|NCT02393248|69600180|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
37913379|NCT02393248|69600181|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
37913380|NCT02393248|69600182|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
37913381|NCT02393248|69600183|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
37913382|NCT02393248|69600184|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
37913383|NCT02393248|69600185|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
37913384|NCT02393248|69600161|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
37913385|NCT02393248|69600162|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
37913386|NCT02393248|69600163|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
37913387|NCT02393248|69600164|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
37913388|NCT02393248|69600165|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
37913389|NCT02393248|69600166|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
37700430|NCT02334215|69177488|FG000|Overall Study|Not released from incarceration on time|3|||
37835497|NCT01188772|69519785|FG002|Overall Study|Randomized but Not Treated|0|||
37913390|NCT02393248|69600167|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
37700431|NCT02334215|69177489|FG001|Overall Study|Not released from incarceration on time|3|||
37835498|NCT01188772|69519786|FG003|Overall Study|Randomized but Not Treated|0|||
37835499|NCT01188772|69519783|FG000|Overall Study|Adverse Event|0|||
37835500|NCT01188772|69519784|FG001|Overall Study|Adverse Event|1|||
37835501|NCT01188772|69519785|FG002|Overall Study|Adverse Event|2|||
37835502|NCT01188772|69519786|FG003|Overall Study|Adverse Event|0|||
37835503|NCT01188772|69519783|FG000|Overall Study|Lost to Follow-up|4|||
37835504|NCT01188772|69519784|FG001|Overall Study|Lost to Follow-up|1|||
37835505|NCT01188772|69519785|FG002|Overall Study|Lost to Follow-up|1|||
37835506|NCT01188772|69519786|FG003|Overall Study|Lost to Follow-up|1|||
37835507|NCT01188772|69519783|FG000|Overall Study|Non-responder|0|||
37835508|NCT01188772|69519784|FG001|Overall Study|Non-responder|0|||
37835509|NCT01188772|69519785|FG002|Overall Study|Non-responder|3|||
37835510|NCT01188772|69519786|FG003|Overall Study|Non-responder|0|||
37835511|NCT01188772|69519783|FG000|Overall Study|Physician Decision|0|||
37835512|NCT01188772|69519784|FG001|Overall Study|Physician Decision|0|||
37835513|NCT01188772|69519785|FG002|Overall Study|Physician Decision|1|||
37835514|NCT01188772|69519786|FG003|Overall Study|Physician Decision|0|||
37835515|NCT01188772|69519783|FG000|Overall Study|Terminated by Sponsor|0|||
37835516|NCT01188772|69519784|FG001|Overall Study|Terminated by Sponsor|0|||
37835517|NCT01188772|69519785|FG002|Overall Study|Terminated by Sponsor|1|||
37835518|NCT01188772|69519786|FG003|Overall Study|Terminated by Sponsor|0|||
37835519|NCT01188772|69519783|FG000|Overall Study|Treatment Failure|0|||
37835520|NCT01188772|69519784|FG001|Overall Study|Treatment Failure|0|||
37835521|NCT01188772|69519785|FG002|Overall Study|Treatment Failure|1|||
37835522|NCT01188772|69519786|FG003|Overall Study|Treatment Failure|0|||
37835523|NCT01188772|69519783|FG000|Overall Study|Virologic Failure|1|||
37835524|NCT01188772|69519784|FG001|Overall Study|Virologic Failure|0|||
37835525|NCT01188772|69519785|FG002|Overall Study|Virologic Failure|0|||
37835526|NCT01188772|69519786|FG003|Overall Study|Virologic Failure|0|||
37835527|NCT01188772|69519783|FG000|Overall Study|Withdrawal by Subject|0|||
37835528|NCT01188772|69519784|FG001|Overall Study|Withdrawal by Subject|0|||
37835529|NCT01188772|69519785|FG002|Overall Study|Withdrawal by Subject|2|||
37835530|NCT01188772|69519786|FG003|Overall Study|Withdrawal by Subject|0|||
37835531|NCT01188655|69519799|FG000|Overall Study|Lack of Efficacy|1|||
37835532|NCT01188655|69519799|FG000|Overall Study|Lost to Follow-up|1|||
37835533|NCT01188655|69519799|FG000|Overall Study|Other|11|||
37913391|NCT02393248|69600168|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
37835534|NCT01188538|69519805|FG000|Overall Study|Lost to Follow-up|0|||
37835535|NCT01188538|69519806|FG001|Overall Study|Lost to Follow-up|1|||
37835536|NCT01188343|69519817|FG000|Overall Study|Not vaccinated|0|||
37835537|NCT01188343|69519818|FG001|Overall Study|Not vaccinated|2|||
37913392|NCT02393248|69600169|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
37913393|NCT02393248|69600170|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
37913394|NCT02393248|69600171|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
37913395|NCT02393248|69600172|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
37913396|NCT02393248|69600173|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
37913397|NCT02393248|69600174|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
37913398|NCT02393248|69600175|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
37913399|NCT02393248|69600176|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
37913400|NCT02393248|69600177|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
37913401|NCT02393248|69600178|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
37913402|NCT02393248|69600179|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
37835538|NCT01188343|69519819|FG002|Overall Study|Not vaccinated|1|||
37835539|NCT01188343|69519817|FG000|Overall Study|Withdrawal by Subject|1|||
37835540|NCT01188343|69519818|FG001|Overall Study|Withdrawal by Subject|24|||
37835541|NCT01188343|69519819|FG002|Overall Study|Withdrawal by Subject|0|||
37835542|NCT01188226|69519830|FG000|Overall Study|Withdrawal by Subject|4|||
37835543|NCT01218100|69519848|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
37835544|NCT01218100|69519849|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
37835545|NCT01218100|69519850|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
37835546|NCT01218100|69519851|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
37835547|NCT01218100|69519848|FG000|Overall Study|Adverse Event|4|||
37835548|NCT01218100|69519849|FG001|Overall Study|Adverse Event|6|||
37835549|NCT01218100|69519850|FG002|Overall Study|Adverse Event|6|||
37835550|NCT01218100|69519851|FG003|Overall Study|Adverse Event|7|||
37835551|NCT01218100|69519848|FG000|Overall Study|Lack of Efficacy|9|||
37835552|NCT01218100|69519849|FG001|Overall Study|Lack of Efficacy|6|||
37835553|NCT01218100|69519850|FG002|Overall Study|Lack of Efficacy|5|||
37835554|NCT01218100|69519851|FG003|Overall Study|Lack of Efficacy|12|||
37835555|NCT01218100|69519848|FG000|Overall Study|Protocol Violation|0|||
37835556|NCT01218100|69519849|FG001|Overall Study|Protocol Violation|0|||
37835557|NCT01218100|69519850|FG002|Overall Study|Protocol Violation|1|||
37835558|NCT01218100|69519851|FG003|Overall Study|Protocol Violation|1|||
37835559|NCT01218100|69519848|FG000|Overall Study|Withdrawal by Subject|5|||
37835560|NCT01218100|69519849|FG001|Overall Study|Withdrawal by Subject|2|||
37835561|NCT01218100|69519850|FG002|Overall Study|Withdrawal by Subject|6|||
37835562|NCT01218100|69519851|FG003|Overall Study|Withdrawal by Subject|7|||
37835563|NCT01218100|69519848|FG000|Overall Study|Lost to Follow-up|3|||
37835564|NCT01218100|69519849|FG001|Overall Study|Lost to Follow-up|8|||
37835565|NCT01218100|69519850|FG002|Overall Study|Lost to Follow-up|2|||
37835566|NCT01218100|69519851|FG003|Overall Study|Lost to Follow-up|1|||
37913403|NCT02393248|69600180|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
37913404|NCT02393248|69600181|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
37913405|NCT02393248|69600182|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
37913406|NCT02393248|69600183|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
37913407|NCT02393248|69600184|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
37913408|NCT02393248|69600185|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
37913409|NCT02393248|69600161|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
37913410|NCT02393248|69600162|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
37913411|NCT02393248|69600163|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
37913412|NCT02393248|69600164|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
37913413|NCT02393248|69600165|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
37913414|NCT02393248|69600166|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
37913415|NCT02393248|69600167|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
37913416|NCT02393248|69600168|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
37913417|NCT02393248|69600169|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
37913418|NCT02393248|69600170|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
37913419|NCT02393248|69600171|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
37913420|NCT02393248|69600172|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
37913421|NCT02393248|69600173|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
37913422|NCT02393248|69600174|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
37913423|NCT02393248|69600175|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
37913424|NCT02393248|69600176|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
37913425|NCT02393248|69600177|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
37913426|NCT02393248|69600178|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
37913427|NCT02393248|69600179|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
37913428|NCT02393248|69600180|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
37913429|NCT02393248|69600181|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
37913430|NCT02393248|69600182|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
37913431|NCT02393248|69600183|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
37913432|NCT02393248|69600184|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
37913433|NCT02393248|69600185|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
37913434|NCT02393248|69600161|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
37913435|NCT02393248|69600162|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
37913436|NCT02393248|69600163|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
38022862|NCT03129100|69705741|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
38022863|NCT03129100|69705742|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
38022864|NCT03129100|69705743|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
38022865|NCT03129100|69705744|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
38022866|NCT03129100|69705719|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
38022867|NCT03129100|69705720|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
38022868|NCT03129100|69705721|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
37835567|NCT01218100|69519848|FG000|Overall Study|Other Reason|2|||
37835568|NCT01218100|69519849|FG001|Overall Study|Other Reason|2|||
37835569|NCT01218100|69519850|FG002|Overall Study|Other Reason|6|||
37835570|NCT01218100|69519851|FG003|Overall Study|Other Reason|4|||
37835571|NCT01187953|69519897|FG000|Overall Study|Death|11|||
37835572|NCT01187953|69519898|FG001|Overall Study|Death|13|||
37835573|NCT01187953|69519897|FG000|Overall Study|Adverse Event|1|||
37835574|NCT01187953|69519898|FG001|Overall Study|Adverse Event|2|||
37913437|NCT02393248|69600164|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
37913438|NCT02393248|69600165|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
37913439|NCT02393248|69600166|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
37913440|NCT02393248|69600167|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
37913441|NCT02393248|69600168|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
37913442|NCT02393248|69600169|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
37913443|NCT02393248|69600170|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
37913444|NCT02393248|69600171|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
37913445|NCT02393248|69600172|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
37913446|NCT02393248|69600173|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
37913447|NCT02393248|69600174|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
37913448|NCT02393248|69600175|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
37913449|NCT02393248|69600176|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
37913450|NCT02393248|69600177|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
37913451|NCT02393248|69600178|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
37913452|NCT02393248|69600179|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
37913453|NCT02393248|69600180|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
37913454|NCT02393248|69600181|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
37913455|NCT02393248|69600182|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
37913456|NCT02393248|69600183|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
37913457|NCT02393248|69600184|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
37913458|NCT02393248|69600185|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
37913459|NCT02393248|69600161|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
37913460|NCT02393248|69600162|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
37913461|NCT02393248|69600163|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
37913462|NCT02393248|69600164|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
37913463|NCT02393248|69600165|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
37913464|NCT02393248|69600166|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
37913465|NCT02393248|69600167|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
37913466|NCT02393248|69600168|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
37913467|NCT02393248|69600169|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
37913468|NCT02393248|69600170|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
37913469|NCT02393248|69600171|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
37913470|NCT02393248|69600172|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
37913471|NCT02393248|69600173|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
37913472|NCT02393248|69600174|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
37913473|NCT02393248|69600175|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
37913474|NCT02393248|69600176|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
37913475|NCT02393248|69600177|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
37913476|NCT02393248|69600178|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
37913477|NCT02393248|69600179|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
37913478|NCT02393248|69600180|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
37913479|NCT02393248|69600181|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
37913480|NCT02393248|69600182|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
37913481|NCT02393248|69600183|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
37913482|NCT02393248|69600184|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
37913483|NCT02393248|69600185|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
37913484|NCT02393248|69600161|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
37913485|NCT02393248|69600162|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
37913486|NCT02393248|69600163|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
37913487|NCT02393248|69600164|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
37913488|NCT02393248|69600165|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
37913489|NCT02393248|69600166|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
37913490|NCT02393248|69600167|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
37913491|NCT02393248|69600168|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
37913492|NCT02393248|69600169|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
37913493|NCT02393248|69600170|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
38022869|NCT03129100|69705722|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
38022870|NCT03129100|69705723|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
38022871|NCT03129100|69705724|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
38022872|NCT03129100|69705725|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
37913494|NCT02393248|69600171|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
37913495|NCT02393248|69600172|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
37913496|NCT02393248|69600173|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
37913497|NCT02393248|69600174|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
37913498|NCT02393248|69600175|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
37913499|NCT02393248|69600176|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
37913500|NCT02393248|69600177|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
37913501|NCT02393248|69600178|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
37913502|NCT02393248|69600179|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
37913503|NCT02393248|69600180|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
37913504|NCT02393248|69600181|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
37913505|NCT02393248|69600182|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
37913506|NCT02393248|69600183|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
37913507|NCT02393248|69600184|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
37913508|NCT02393248|69600185|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
37913509|NCT02393248|69600161|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
37913510|NCT02393248|69600162|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
37913511|NCT02393248|69600163|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
37913512|NCT02393248|69600164|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
37913513|NCT02393248|69600165|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
37913514|NCT02393248|69600166|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
37913515|NCT02393248|69600167|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
37913516|NCT02393248|69600168|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
37913517|NCT02393248|69600169|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
37913518|NCT02393248|69600170|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
37913519|NCT02393248|69600171|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
37913520|NCT02393248|69600172|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
37913521|NCT02393248|69600173|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
37913522|NCT02393248|69600174|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
37913523|NCT02393248|69600175|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
37835575|NCT01187953|69519897|FG000|Overall Study|Lost to Follow-up|0|||
37835576|NCT01187953|69519898|FG001|Overall Study|Lost to Follow-up|3|||
37835577|NCT01187953|69519897|FG000|Overall Study|Withdrawal by Subject|3|||
37835578|NCT01187953|69519898|FG001|Overall Study|Withdrawal by Subject|3|||
37835579|NCT01217944|69519914|FG000|Overall Study|Protocol Violation|1|||
37835580|NCT01217944|69519915|FG001|Overall Study|Protocol Violation|1|||
37835581|NCT01217944|69519916|FG002|Overall Study|Protocol Violation|0|||
37835582|NCT01217944|69519914|FG000|Overall Study|Lost to Follow-up|3|||
37835583|NCT01217944|69519915|FG001|Overall Study|Lost to Follow-up|1|||
37835584|NCT01217944|69519916|FG002|Overall Study|Lost to Follow-up|0|||
37835585|NCT01217944|69519914|FG000|Overall Study|Withdrawal by Subject|1|||
37913524|NCT02393248|69600176|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
37913525|NCT02393248|69600177|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
37913526|NCT02393248|69600178|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
37913527|NCT02393248|69600179|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
37913528|NCT02393248|69600180|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
37913529|NCT02393248|69600181|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
37913530|NCT02393248|69600182|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
37913531|NCT02393248|69600183|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
37913532|NCT02393248|69600184|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
37913533|NCT02393248|69600185|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
37913534|NCT02393248|69600161|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
37913535|NCT02393248|69600162|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
37913536|NCT02393248|69600163|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
37913537|NCT02393248|69600164|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
37913538|NCT02393248|69600165|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
37913539|NCT02393248|69600166|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
37913540|NCT02393248|69600167|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
37913541|NCT02393248|69600168|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
37913542|NCT02393248|69600169|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
37913543|NCT02393248|69600170|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
37913544|NCT02393248|69600171|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
37913545|NCT02393248|69600172|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
37913546|NCT02393248|69600173|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
37913547|NCT02393248|69600174|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
37835586|NCT01217944|69519915|FG001|Overall Study|Withdrawal by Subject|2|||
37835587|NCT01217944|69519916|FG002|Overall Study|Withdrawal by Subject|0|||
37835588|NCT01217944|69519914|FG000|Overall Study|Lack of Efficacy|1|||
37835589|NCT01217944|69519915|FG001|Overall Study|Lack of Efficacy|0|||
37913548|NCT02393248|69600175|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
37913549|NCT02393248|69600176|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
37913550|NCT02393248|69600177|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
37913551|NCT02393248|69600178|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
37913552|NCT02393248|69600179|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
37913553|NCT02393248|69600180|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
37835590|NCT01217944|69519916|FG002|Overall Study|Lack of Efficacy|0|||
37913554|NCT02393248|69600181|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
37913555|NCT02393248|69600182|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
37835591|NCT01187446|69519928|FG000|Overall Study|Patient started non-protocol therapy|0|||
37835592|NCT01187446|69519929|FG001|Overall Study|Patient started non-protocol therapy|1|||
37835593|NCT01187407|69519939|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
37835594|NCT01187407|69519940|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
37835595|NCT01187407|69519941|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
37835596|NCT01187407|69519942|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
37835597|NCT01187407|69519943|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
37835598|NCT01187407|69519939|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
37835599|NCT01187407|69519940|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
37835600|NCT01187407|69519941|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
37835601|NCT01187407|69519942|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
37835602|NCT01187407|69519943|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
37835603|NCT01187407|69519939|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
37835604|NCT01187407|69519940|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
37835605|NCT01187407|69519941|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
37835606|NCT01187407|69519942|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
37835607|NCT01187407|69519943|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
37835608|NCT01187407|69519939|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
37835609|NCT01187407|69519940|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
37835610|NCT01187407|69519941|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
37835611|NCT01187407|69519942|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
37835612|NCT01187407|69519943|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
37835613|NCT01187407|69519939|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
37835614|NCT01187407|69519940|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
37835615|NCT01187407|69519941|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
37835616|NCT01187407|69519942|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
37835617|NCT01187407|69519943|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
37835618|NCT01187407|69519939|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
37835619|NCT01187407|69519940|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
37835620|NCT01187407|69519941|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
37913556|NCT02393248|69600183|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
37913557|NCT02393248|69600184|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
37913558|NCT02393248|69600185|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
37913559|NCT02393248|69600161|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
37913560|NCT02393248|69600162|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
37913561|NCT02393248|69600163|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
37913562|NCT02393248|69600164|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
37913563|NCT02393248|69600165|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
37913564|NCT02393248|69600166|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
37913565|NCT02393248|69600167|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
37913566|NCT02393248|69600168|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
37913567|NCT02393248|69600169|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
37913568|NCT02393248|69600170|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
37913569|NCT02393248|69600171|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
37913570|NCT02393248|69600172|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
37913571|NCT02393248|69600173|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
37913572|NCT02393248|69600174|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
37913573|NCT02393248|69600175|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
37913574|NCT02393248|69600176|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
37913575|NCT02393248|69600177|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
37913576|NCT02393248|69600178|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
37913577|NCT02393248|69600179|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
37913578|NCT02393248|69600180|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
37913579|NCT02393248|69600181|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
37913580|NCT02393248|69600182|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
37913581|NCT02393248|69600183|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
37835621|NCT01187407|69519942|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
37835622|NCT01187407|69519943|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
37835623|NCT01187407|69519939|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
37835624|NCT01187407|69519940|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
37835625|NCT01187407|69519941|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
37835626|NCT01187407|69519942|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
37835627|NCT01187407|69519943|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
37835628|NCT01187407|69519939|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
37835629|NCT01187407|69519940|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
37835630|NCT01187407|69519941|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
37835631|NCT01187407|69519942|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
37835632|NCT01187407|69519943|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
37835633|NCT01187407|69519939|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
37835634|NCT01187407|69519940|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
37913582|NCT02393248|69600184|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
37913583|NCT02393248|69600185|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
37913584|NCT02393248|69600161|FG000|Part 3: Combination Therapy|Death|0|||
37913585|NCT02393248|69600162|FG001|Part 3: Combination Therapy|Death|0|||
37913586|NCT02393248|69600163|FG002|Part 3: Combination Therapy|Death|0|||
37913587|NCT02393248|69600164|FG003|Part 3: Combination Therapy|Death|0|||
37913588|NCT02393248|69600165|FG004|Part 3: Combination Therapy|Death|0|||
37913589|NCT02393248|69600166|FG005|Part 3: Combination Therapy|Death|0|||
37913590|NCT02393248|69600167|FG006|Part 3: Combination Therapy|Death|0|||
37913591|NCT02393248|69600168|FG007|Part 3: Combination Therapy|Death|0|||
37913592|NCT02393248|69600169|FG008|Part 3: Combination Therapy|Death|0|||
37913593|NCT02393248|69600170|FG009|Part 3: Combination Therapy|Death|0|||
37913594|NCT02393248|69600171|FG010|Part 3: Combination Therapy|Death|0|||
37913595|NCT02393248|69600172|FG011|Part 3: Combination Therapy|Death|0|||
37913596|NCT02393248|69600173|FG012|Part 3: Combination Therapy|Death|0|||
37913597|NCT02393248|69600174|FG013|Part 3: Combination Therapy|Death|0|||
37913598|NCT02393248|69600175|FG014|Part 3: Combination Therapy|Death|0|||
37913599|NCT02393248|69600176|FG015|Part 3: Combination Therapy|Death|1|||
37913600|NCT02393248|69600177|FG016|Part 3: Combination Therapy|Death|7|||
37913601|NCT02393248|69600178|FG017|Part 3: Combination Therapy|Death|5|||
37913602|NCT02393248|69600179|FG018|Part 3: Combination Therapy|Death|5|||
37913603|NCT02393248|69600180|FG019|Part 3: Combination Therapy|Death|3|||
37913604|NCT02393248|69600181|FG020|Part 3: Combination Therapy|Death|7|||
37913605|NCT02393248|69600182|FG021|Part 3: Combination Therapy|Death|5|||
37913606|NCT02393248|69600183|FG022|Part 3: Combination Therapy|Death|6|||
37913607|NCT02393248|69600184|FG023|Part 3: Combination Therapy|Death|3|||
37913608|NCT02393248|69600185|FG024|Part 3: Combination Therapy|Death|0|||
37913609|NCT02393248|69600161|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
37913610|NCT02393248|69600162|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
37913611|NCT02393248|69600163|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
37913612|NCT02393248|69600164|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
37913613|NCT02393248|69600165|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
37913614|NCT02393248|69600166|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
37913615|NCT02393248|69600167|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
37913616|NCT02393248|69600168|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
37913617|NCT02393248|69600169|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
37913618|NCT02393248|69600170|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
37913619|NCT02393248|69600171|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
37913620|NCT02393248|69600172|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
37913621|NCT02393248|69600173|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
37913622|NCT02393248|69600174|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
37913623|NCT02393248|69600175|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
37913624|NCT02393248|69600176|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
37913625|NCT02393248|69600177|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
37913626|NCT02393248|69600178|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
37913627|NCT02393248|69600179|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
37913628|NCT02393248|69600180|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
37913629|NCT02393248|69600181|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
37913630|NCT02393248|69600182|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
38022873|NCT03129100|69705726|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
38022874|NCT03129100|69705727|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
38022875|NCT03129100|69705728|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
38022876|NCT03129100|69705729|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
37913631|NCT02393248|69600183|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
37913632|NCT02393248|69600184|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
37913633|NCT02393248|69600185|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
37913634|NCT02393248|69600161|FG000|Part 3: Combination Therapy|Disease Progression|0|||
37913635|NCT02393248|69600162|FG001|Part 3: Combination Therapy|Disease Progression|0|||
38022877|NCT03129100|69705730|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
37835635|NCT01187407|69519941|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
37835636|NCT01187407|69519942|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
37835637|NCT01187407|69519943|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
37835638|NCT01187407|69519939|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
37835639|NCT01187407|69519940|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
37835640|NCT01187407|69519941|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
37835641|NCT01187407|69519942|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
38022878|NCT03129100|69705731|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
38022879|NCT03129100|69705732|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
38022880|NCT03129100|69705733|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
38022881|NCT03129100|69705734|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
38022882|NCT03129100|69705735|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
37835642|NCT01187407|69519943|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
37835643|NCT01187407|69519939|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
37835644|NCT01187407|69519940|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
37835645|NCT01187407|69519941|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
37835646|NCT01187407|69519942|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
37835647|NCT01187407|69519943|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
37835648|NCT01187407|69519939|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
37835649|NCT01187407|69519940|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
37835650|NCT01187407|69519941|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
37835651|NCT01187407|69519942|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
37835652|NCT01187407|69519943|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
37835653|NCT01187407|69519939|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
37835654|NCT01187407|69519940|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
37835655|NCT01187407|69519941|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
37835656|NCT01187407|69519942|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
37835657|NCT01187407|69519943|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
37835658|NCT01187407|69519939|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
37835659|NCT01187407|69519940|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
37835660|NCT01187407|69519941|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
37835661|NCT01187407|69519942|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
37835662|NCT01187407|69519943|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
37835663|NCT01186978|69519960|FG000|Overall Study|Withdrawal by Subject|1|||
37835664|NCT01186939|69519964|FG000|Overall Study|Death|7|||
37835665|NCT01186939|69519964|FG000|Overall Study|Withdrawal by Subject|2|||
37835666|NCT01186939|69519964|FG000|Overall Study|No longer receiving clinical benefit|17|||
37835667|NCT01186939|69519964|FG000|Overall Study|Program closed|5|||
37835668|NCT01186939|69519964|FG000|Overall Study|Sponsor decision|4|||
37835669|NCT01186939|69519964|FG000|Overall Study|Started additional treatment|1|||
37835670|NCT01186939|69519964|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
37835671|NCT01186939|69519964|FG000|Overall Study|Myocardial infarction|1|||
37835672|NCT01186939|69519964|FG000|Overall Study|Bone marrow transplant|1|||
37835673|NCT01186939|69519964|FG000|Overall Study|Transformation to AML|1|||
37835674|NCT04938648|69519989|FG000|Overall Study|Patient admitted to SNF hospice/LTC|2|||
37835675|NCT04938648|69519990|FG001|Overall Study|Patient admitted to SNF hospice/LTC|1|||
37835676|NCT04938648|69519989|FG000|Overall Study|Patient too ill|0|||
37835677|NCT04938648|69519990|FG001|Overall Study|Patient too ill|1|||
37835678|NCT04938648|69519989|FG000|Overall Study|Patient in rehab at the time of intervention|1|||
37835679|NCT04938648|69519990|FG001|Overall Study|Patient in rehab at the time of intervention|0|||
37835680|NCT04938648|69519989|FG000|Overall Study|Patient did not have memory problems|1|||
37835681|NCT04938648|69519990|FG001|Overall Study|Patient did not have memory problems|1|||
37835682|NCT04938648|69519989|FG000|Overall Study|Intervention could not be scheduled within protocol window|1|||
37835683|NCT04938648|69519990|FG001|Overall Study|Intervention could not be scheduled within protocol window|0|||
37835684|NCT04938648|69519989|FG000|Overall Study|Care partner could not be reached|0|||
37835685|NCT04938648|69519990|FG001|Overall Study|Care partner could not be reached|1|||
37835686|NCT04938648|69519989|FG000|Overall Study|Patient no longer receiving care at an eligible clinic|0|||
37835687|NCT04938648|69519990|FG001|Overall Study|Patient no longer receiving care at an eligible clinic|2|||
37835688|NCT04938648|69519989|FG000|Overall Study|Withdrawal by Subject|2|||
37835689|NCT04938648|69519990|FG001|Overall Study|Withdrawal by Subject|1|||
37913636|NCT02393248|69600163|FG002|Part 3: Combination Therapy|Disease Progression|0|||
37913637|NCT02393248|69600164|FG003|Part 3: Combination Therapy|Disease Progression|0|||
38022883|NCT03129100|69705736|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
38022884|NCT03129100|69705737|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
38022885|NCT03129100|69705738|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
38022886|NCT03129100|69705739|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
37913638|NCT02393248|69600165|FG004|Part 3: Combination Therapy|Disease Progression|0|||
37913639|NCT02393248|69600166|FG005|Part 3: Combination Therapy|Disease Progression|0|||
38022887|NCT03129100|69705740|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
38022888|NCT03129100|69705741|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
38022889|NCT03129100|69705742|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
37700432|NCT02334215|69177490|FG002|Overall Study|Not released from incarceration on time|3|||
37700433|NCT02334215|69177488|FG000|Overall Study|Incarcerated|0|||
37700434|NCT02334215|69177489|FG001|Overall Study|Incarcerated|0|||
37700435|NCT02334215|69177490|FG002|Overall Study|Incarcerated|7|||
37700436|NCT02359877|69177502|FG000|Overall Study|Withdrawal by Subject|1|||
37700437|NCT02359877|69177503|FG001|Overall Study|Withdrawal by Subject|0|||
37700438|NCT02359877|69177504|FG002|Overall Study|Withdrawal by Subject|0|||
37700439|NCT02359877|69177505|FG003|Overall Study|Withdrawal by Subject|2|||
37700440|NCT02359877|69177502|FG000|Overall Study|Adverse Event|0|||
37700441|NCT02359877|69177503|FG001|Overall Study|Adverse Event|0|||
37700442|NCT02359877|69177504|FG002|Overall Study|Adverse Event|0|||
37700443|NCT02359877|69177505|FG003|Overall Study|Adverse Event|1|||
37700444|NCT02389829|69177535|FG000|Overall Study|Lost to Follow-up|0|||
37700445|NCT02389829|69177536|FG001|Overall Study|Lost to Follow-up|1|||
37700446|NCT02358863|69177542|FG000|Overall Study|Physician Decision|3|||
37700447|NCT02358473|69177546|FG000|Overall Study|Disease Progession|6|||
37700448|NCT02358473|69177546|FG000|Overall Study|Adverse Event|3|||
37700449|NCT02358473|69177546|FG000|Overall Study|Withdrawal by Subject|2|||
37700450|NCT02358473|69177546|FG000|Overall Study|Physician Decision|2|||
37700451|NCT02357459|69177553|FG000|Overall Study|Adverse Event|0|||
37700452|NCT02357459|69177554|FG001|Overall Study|Adverse Event|1|||
37700453|NCT02357459|69177555|FG002|Overall Study|Adverse Event|1|||
37700454|NCT02357459|69177553|FG000|Overall Study|Withdrawal by Subject|5|||
37700455|NCT02357459|69177554|FG001|Overall Study|Withdrawal by Subject|3|||
37700456|NCT02357459|69177555|FG002|Overall Study|Withdrawal by Subject|3|||
37700457|NCT02357459|69177553|FG000|Overall Study|Physician Decision|0|||
37700458|NCT02357459|69177554|FG001|Overall Study|Physician Decision|2|||
37700459|NCT02357459|69177555|FG002|Overall Study|Physician Decision|0|||
37700460|NCT02357459|69177553|FG000|Overall Study|Protocol Violation|1|||
37700461|NCT02357459|69177554|FG001|Overall Study|Protocol Violation|1|||
37700462|NCT02357459|69177555|FG002|Overall Study|Protocol Violation|0|||
37700463|NCT02357459|69177553|FG000|Overall Study|Lost to Follow-up|1|||
37700464|NCT02357459|69177554|FG001|Overall Study|Lost to Follow-up|3|||
37700465|NCT02357459|69177555|FG002|Overall Study|Lost to Follow-up|0|||
37700466|NCT02357459|69177553|FG000|Overall Study|Lack of Efficacy|7|||
37700467|NCT02357459|69177554|FG001|Overall Study|Lack of Efficacy|4|||
37700468|NCT02357459|69177555|FG002|Overall Study|Lack of Efficacy|4|||
37700469|NCT02357459|69177553|FG000|Overall Study|Patient Relocated|2|||
37700470|NCT02357459|69177554|FG001|Overall Study|Patient Relocated|0|||
37700471|NCT02357459|69177555|FG002|Overall Study|Patient Relocated|0|||
37700472|NCT02357459|69177553|FG000|Overall Study|Instruction from PCP|1|||
37700473|NCT02357459|69177554|FG001|Overall Study|Instruction from PCP|0|||
37700474|NCT02357459|69177555|FG002|Overall Study|Instruction from PCP|0|||
37700475|NCT02357459|69177553|FG000|Overall Study|Incarceration|0|||
37700476|NCT02357459|69177554|FG001|Overall Study|Incarceration|0|||
37700477|NCT02357459|69177555|FG002|Overall Study|Incarceration|1|||
37700478|NCT02357459|69177553|FG000|Overall Study|Pre-planned Knee surgery|0|||
37700479|NCT02357459|69177554|FG001|Overall Study|Pre-planned Knee surgery|0|||
37700480|NCT02357459|69177555|FG002|Overall Study|Pre-planned Knee surgery|2|||
37700481|NCT02357459|69177553|FG000|Overall Study|Job Commitments|0|||
37700482|NCT02357459|69177554|FG001|Overall Study|Job Commitments|0|||
37700483|NCT02357459|69177555|FG002|Overall Study|Job Commitments|1|||
37700484|NCT02332889|69177566|FG000|Overall Study|Physician Decision|1|||
37700485|NCT02357147|69177572|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
37700486|NCT02357147|69177573|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
37700487|NCT02357147|69177572|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
37700488|NCT02357147|69177573|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
37700489|NCT02357147|69177572|FG000|Combination Treatment Phase|Investigator Discretion|1|||
37700490|NCT02357147|69177573|FG001|Combination Treatment Phase|Investigator Discretion|1|||
37700491|NCT02357147|69177572|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
37700492|NCT02357147|69177573|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
37700493|NCT02357147|69177572|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
37700494|NCT02357147|69177573|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
37700495|NCT02357147|69177572|FG000|Combination Treatment Phase|Adverse Event|12|||
37700496|NCT02357147|69177573|FG001|Combination Treatment Phase|Adverse Event|4|||
37700497|NCT02357147|69177572|FG000|Combination Treatment Phase|Death|1|||
37700498|NCT02357147|69177573|FG001|Combination Treatment Phase|Death|1|||
37700499|NCT02357147|69177572|FG000|Combination Treatment Phase|Sponsor Decision|0|||
37913640|NCT02393248|69600167|FG006|Part 3: Combination Therapy|Disease Progression|0|||
38022890|NCT03129100|69705743|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
37835690|NCT04564092|69519997|FG000|Overall Study|Withdrawal by Subject|1|||
37835691|NCT01658826|69520038|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
37835692|NCT01658826|69520039|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
37835693|NCT01658826|69520038|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
37835694|NCT01658826|69520039|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
37835695|NCT01658826|69520038|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
37835696|NCT01658826|69520039|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
37835697|NCT01658826|69520038|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
37835698|NCT01658826|69520039|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
37835699|NCT01658826|69520038|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
37835700|NCT01658826|69520039|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
37835701|NCT01658826|69520038|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
37835702|NCT01658826|69520039|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
37835703|NCT01658826|69520038|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
37835704|NCT01658826|69520039|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
37913641|NCT02393248|69600168|FG007|Part 3: Combination Therapy|Disease Progression|0|||
37913642|NCT02393248|69600169|FG008|Part 3: Combination Therapy|Disease Progression|0|||
37913643|NCT02393248|69600170|FG009|Part 3: Combination Therapy|Disease Progression|0|||
37913644|NCT02393248|69600171|FG010|Part 3: Combination Therapy|Disease Progression|0|||
37913645|NCT02393248|69600172|FG011|Part 3: Combination Therapy|Disease Progression|0|||
37913646|NCT02393248|69600173|FG012|Part 3: Combination Therapy|Disease Progression|0|||
37913647|NCT02393248|69600174|FG013|Part 3: Combination Therapy|Disease Progression|0|||
37913648|NCT02393248|69600175|FG014|Part 3: Combination Therapy|Disease Progression|0|||
37913649|NCT02393248|69600176|FG015|Part 3: Combination Therapy|Disease Progression|0|||
37913650|NCT02393248|69600177|FG016|Part 3: Combination Therapy|Disease Progression|0|||
37913651|NCT02393248|69600178|FG017|Part 3: Combination Therapy|Disease Progression|0|||
37913652|NCT02393248|69600179|FG018|Part 3: Combination Therapy|Disease Progression|0|||
37913653|NCT02393248|69600180|FG019|Part 3: Combination Therapy|Disease Progression|0|||
37913654|NCT02393248|69600181|FG020|Part 3: Combination Therapy|Disease Progression|2|||
37913655|NCT02393248|69600182|FG021|Part 3: Combination Therapy|Disease Progression|1|||
37913656|NCT02393248|69600183|FG022|Part 3: Combination Therapy|Disease Progression|0|||
37913657|NCT02393248|69600184|FG023|Part 3: Combination Therapy|Disease Progression|0|||
37913658|NCT02393248|69600185|FG024|Part 3: Combination Therapy|Disease Progression|0|||
37913659|NCT02393248|69600161|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
37913660|NCT02393248|69600162|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
37835705|NCT01658826|69520038|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
37835706|NCT01658826|69520039|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
37835707|NCT01658826|69520038|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
37835708|NCT01658826|69520039|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
37835709|NCT01186744|69520055|FG000|Overall Study|Lack of Efficacy|156|||
37835710|NCT01186744|69520056|FG001|Overall Study|Lack of Efficacy|99|||
37835711|NCT01186744|69520057|FG002|Overall Study|Lack of Efficacy|0|||
37835712|NCT01186744|69520058|FG003|Overall Study|Lack of Efficacy|2|||
37835713|NCT01186744|69520059|FG004|Overall Study|Lack of Efficacy|2|||
37913661|NCT02393248|69600163|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
37913662|NCT02393248|69600164|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
37913663|NCT02393248|69600165|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
37835714|NCT01186744|69520060|FG005|Overall Study|Lack of Efficacy|5|||
37835715|NCT01186744|69520055|FG000|Overall Study|Protocol Violation|1|||
37835716|NCT01186744|69520056|FG001|Overall Study|Protocol Violation|2|||
37835717|NCT01186744|69520057|FG002|Overall Study|Protocol Violation|0|||
37835718|NCT01186744|69520058|FG003|Overall Study|Protocol Violation|1|||
37835719|NCT01186744|69520059|FG004|Overall Study|Protocol Violation|1|||
37835720|NCT01186744|69520060|FG005|Overall Study|Protocol Violation|2|||
37913664|NCT02393248|69600166|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
37913665|NCT02393248|69600167|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
37913666|NCT02393248|69600168|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
37913667|NCT02393248|69600169|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
37913668|NCT02393248|69600170|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
37913669|NCT02393248|69600171|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
37913670|NCT02393248|69600172|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
37913671|NCT02393248|69600173|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
37913672|NCT02393248|69600174|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
37913673|NCT02393248|69600175|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
37913674|NCT02393248|69600176|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
37913675|NCT02393248|69600177|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
37913676|NCT02393248|69600178|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
37913677|NCT02393248|69600179|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
37913678|NCT02393248|69600180|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
37913679|NCT02393248|69600181|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
37913680|NCT02393248|69600182|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
37913681|NCT02393248|69600183|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
37913682|NCT02393248|69600184|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
37913683|NCT02393248|69600185|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
37913684|NCT02393248|69600161|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
37913685|NCT02393248|69600162|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
37913686|NCT02393248|69600163|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
37913687|NCT02393248|69600164|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
37913688|NCT02393248|69600165|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
37913689|NCT02393248|69600166|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
37913690|NCT02393248|69600167|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
37913691|NCT02393248|69600168|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
37913692|NCT02393248|69600169|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
37913693|NCT02393248|69600170|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
37913694|NCT02393248|69600171|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
37913695|NCT02393248|69600172|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
37913696|NCT02393248|69600173|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
37913697|NCT02393248|69600174|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
37913698|NCT02393248|69600175|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
37913699|NCT02393248|69600176|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
37913700|NCT02393248|69600177|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
37835721|NCT01186744|69520055|FG000|Overall Study|Lost to Follow-up|15|||
37835722|NCT01186744|69520056|FG001|Overall Study|Lost to Follow-up|16|||
37835723|NCT01186744|69520057|FG002|Overall Study|Lost to Follow-up|2|||
37913701|NCT02393248|69600178|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
37913702|NCT02393248|69600179|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
37913703|NCT02393248|69600180|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
38022891|NCT03129100|69705744|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
38022892|NCT03129100|69705719|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
38022893|NCT03129100|69705720|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
38022894|NCT03129100|69705721|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
38022895|NCT03129100|69705722|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
38022896|NCT03129100|69705723|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
38022897|NCT03129100|69705724|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
38022898|NCT03129100|69705725|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
38022899|NCT03129100|69705726|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
38022900|NCT03129100|69705727|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
38022901|NCT03129100|69705728|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
38022902|NCT03129100|69705729|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
38022903|NCT03129100|69705730|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
38022904|NCT03129100|69705731|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
38022905|NCT03129100|69705732|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
38022906|NCT03129100|69705733|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
38022907|NCT03129100|69705734|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
38022908|NCT03129100|69705735|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
38022909|NCT03129100|69705736|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
38022910|NCT03129100|69705737|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
38022911|NCT03129100|69705738|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
38022912|NCT03129100|69705739|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
38022913|NCT03129100|69705740|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
38022914|NCT03129100|69705741|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
38022915|NCT03129100|69705742|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
38022916|NCT03129100|69705743|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
38022917|NCT03129100|69705744|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
37913704|NCT02393248|69600181|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
37913705|NCT02393248|69600182|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
37913706|NCT02393248|69600183|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
37913707|NCT02393248|69600184|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
37913708|NCT02393248|69600185|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
37913709|NCT02393248|69600161|FG000|Part 3: Combination Therapy|Adverse Event|0|||
38022918|NCT03129100|69705719|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
38022919|NCT03129100|69705720|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
38022920|NCT03129100|69705721|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
38022921|NCT03129100|69705722|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
37700500|NCT02357147|69177573|FG001|Combination Treatment Phase|Sponsor Decision|12|||
37700501|NCT02357147|69177572|FG000|Combination Treatment Phase|Other|1|||
37700502|NCT02357147|69177573|FG001|Combination Treatment Phase|Other|0|||
37700503|NCT02357147|69177572|FG000|Combination Treatment Phase|Not treated|0|||
37835724|NCT01186744|69520058|FG003|Overall Study|Lost to Follow-up|1|||
37835725|NCT01186744|69520059|FG004|Overall Study|Lost to Follow-up|1|||
37835726|NCT01186744|69520060|FG005|Overall Study|Lost to Follow-up|4|||
37835727|NCT01186744|69520055|FG000|Overall Study|Screen failure|1|||
37835728|NCT01186744|69520056|FG001|Overall Study|Screen failure|1|||
37835729|NCT01186744|69520057|FG002|Overall Study|Screen failure|0|||
37835730|NCT01186744|69520058|FG003|Overall Study|Screen failure|1|||
37835731|NCT01186744|69520059|FG004|Overall Study|Screen failure|0|||
37835732|NCT01186744|69520060|FG005|Overall Study|Screen failure|0|||
37835733|NCT01186744|69520055|FG000|Overall Study|Withdrawal by Subject|14|||
37835734|NCT01186744|69520056|FG001|Overall Study|Withdrawal by Subject|10|||
37835735|NCT01186744|69520057|FG002|Overall Study|Withdrawal by Subject|2|||
37835736|NCT01186744|69520058|FG003|Overall Study|Withdrawal by Subject|5|||
37835737|NCT01186744|69520059|FG004|Overall Study|Withdrawal by Subject|0|||
37835738|NCT01186744|69520060|FG005|Overall Study|Withdrawal by Subject|6|||
37835739|NCT01186744|69520055|FG000|Overall Study|Study terminated by Sponsor|1|||
37835740|NCT01186744|69520056|FG001|Overall Study|Study terminated by Sponsor|0|||
37913710|NCT02393248|69600162|FG001|Part 3: Combination Therapy|Adverse Event|0|||
37913711|NCT02393248|69600163|FG002|Part 3: Combination Therapy|Adverse Event|0|||
37913712|NCT02393248|69600164|FG003|Part 3: Combination Therapy|Adverse Event|0|||
37913713|NCT02393248|69600165|FG004|Part 3: Combination Therapy|Adverse Event|0|||
37913714|NCT02393248|69600166|FG005|Part 3: Combination Therapy|Adverse Event|0|||
37913715|NCT02393248|69600167|FG006|Part 3: Combination Therapy|Adverse Event|0|||
37913716|NCT02393248|69600168|FG007|Part 3: Combination Therapy|Adverse Event|0|||
37913717|NCT02393248|69600169|FG008|Part 3: Combination Therapy|Adverse Event|0|||
37913718|NCT02393248|69600170|FG009|Part 3: Combination Therapy|Adverse Event|0|||
37913719|NCT02393248|69600171|FG010|Part 3: Combination Therapy|Adverse Event|0|||
37913720|NCT02393248|69600172|FG011|Part 3: Combination Therapy|Adverse Event|0|||
37913721|NCT02393248|69600173|FG012|Part 3: Combination Therapy|Adverse Event|0|||
37913722|NCT02393248|69600174|FG013|Part 3: Combination Therapy|Adverse Event|0|||
37913723|NCT02393248|69600175|FG014|Part 3: Combination Therapy|Adverse Event|0|||
37913724|NCT02393248|69600176|FG015|Part 3: Combination Therapy|Adverse Event|0|||
37913725|NCT02393248|69600177|FG016|Part 3: Combination Therapy|Adverse Event|0|||
37913726|NCT02393248|69600178|FG017|Part 3: Combination Therapy|Adverse Event|0|||
37913727|NCT02393248|69600179|FG018|Part 3: Combination Therapy|Adverse Event|0|||
37913728|NCT02393248|69600180|FG019|Part 3: Combination Therapy|Adverse Event|0|||
37913729|NCT02393248|69600181|FG020|Part 3: Combination Therapy|Adverse Event|0|||
37913730|NCT02393248|69600182|FG021|Part 3: Combination Therapy|Adverse Event|0|||
37913731|NCT02393248|69600183|FG022|Part 3: Combination Therapy|Adverse Event|0|||
37913732|NCT02393248|69600184|FG023|Part 3: Combination Therapy|Adverse Event|1|||
37913733|NCT02393248|69600185|FG024|Part 3: Combination Therapy|Adverse Event|0|||
37913734|NCT02393248|69600161|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
37913735|NCT02393248|69600162|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
37913736|NCT02393248|69600163|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
37913737|NCT02393248|69600164|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
37913738|NCT02393248|69600165|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
37913739|NCT02393248|69600166|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
37913740|NCT02393248|69600167|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
37913741|NCT02393248|69600168|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
37913742|NCT02393248|69600169|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
37913743|NCT02393248|69600170|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
37913744|NCT02393248|69600171|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
37913745|NCT02393248|69600172|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
37913746|NCT02393248|69600173|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
37913747|NCT02393248|69600174|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
37913748|NCT02393248|69600175|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
37913749|NCT02393248|69600176|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
37913750|NCT02393248|69600177|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
37913751|NCT02393248|69600178|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
37913752|NCT02393248|69600179|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
37913753|NCT02393248|69600180|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
37913754|NCT02393248|69600181|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
37913755|NCT02393248|69600182|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
37913756|NCT02393248|69600183|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
37913757|NCT02393248|69600184|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
37700504|NCT02357147|69177573|FG001|Combination Treatment Phase|Not treated|2|||
37700505|NCT02357147|69177572|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
37700506|NCT02357147|69177573|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
37700507|NCT02357147|69177572|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
37700508|NCT02357147|69177573|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
37700509|NCT02357147|69177572|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
37700510|NCT02357147|69177573|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
37700511|NCT02357147|69177572|FG000|Maintenance Treatment Phase|Adverse Event|0|||
37700512|NCT02357147|69177573|FG001|Maintenance Treatment Phase|Adverse Event|3|||
37700513|NCT02357147|69177572|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
37700514|NCT02357147|69177573|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
37700515|NCT02357147|69177572|FG000|Maintenance Treatment Phase|Not Treated|1|||
37700516|NCT02357147|69177573|FG001|Maintenance Treatment Phase|Not Treated|0|||
37700517|NCT02356211|69177585|FG000|Overall Study|Withdrawal by Subject|2|||
37700518|NCT02356211|69177586|FG001|Overall Study|Withdrawal by Subject|2|||
37700519|NCT02356211|69177585|FG000|Overall Study|ineligible|1|||
37700520|NCT02356211|69177586|FG001|Overall Study|ineligible|8|||
37700521|NCT02332655|69177592|FG000|Overall Study|Lack of Efficacy|1|||
37700522|NCT02388737|69177599|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
37700523|NCT02388737|69177600|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
37913758|NCT02393248|69600185|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
37913759|NCT00601484|69600248|FG000|Overall Study|Adverse Event|0|||
37913760|NCT00601484|69600249|FG001|Overall Study|Adverse Event|1|||
37913761|NCT00601484|69600248|FG000|Overall Study|Lost to Follow-up|4|||
37700524|NCT02388737|69177601|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
37700525|NCT02388737|69177599|FG000|Overall Study|Major Protocol Deviation|18|||
37913762|NCT00601484|69600249|FG001|Overall Study|Lost to Follow-up|3|||
37913763|NCT00601484|69600248|FG000|Overall Study|Lack of Efficacy|0|||
37913764|NCT00601484|69600249|FG001|Overall Study|Lack of Efficacy|2|||
37913765|NCT00601484|69600248|FG000|Overall Study|Withdrawal by Subject|1|||
37913766|NCT00601484|69600249|FG001|Overall Study|Withdrawal by Subject|1|||
37913767|NCT00601484|69600248|FG000|Overall Study|Randomized, but not treated|0|||
37913768|NCT00601484|69600249|FG001|Overall Study|Randomized, but not treated|1|||
37913769|NCT00883896|69600259|FG000|Overall Study|Lost to Follow-up|0|||
37913770|NCT00883896|69600260|FG001|Overall Study|Lost to Follow-up|0|||
37913771|NCT00883896|69600261|FG002|Overall Study|Lost to Follow-up|0|||
37913772|NCT00883896|69600262|FG003|Overall Study|Lost to Follow-up|2|||
38022922|NCT03129100|69705723|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
37700526|NCT02388737|69177600|FG001|Overall Study|Major Protocol Deviation|25|||
37700527|NCT02388737|69177601|FG002|Overall Study|Major Protocol Deviation|22|||
37835741|NCT01186744|69520057|FG002|Overall Study|Study terminated by Sponsor|0|||
37835742|NCT01186744|69520058|FG003|Overall Study|Study terminated by Sponsor|0|||
37835743|NCT01186744|69520059|FG004|Overall Study|Study terminated by Sponsor|0|||
37835744|NCT01186744|69520060|FG005|Overall Study|Study terminated by Sponsor|0|||
37913773|NCT00883896|69600259|FG000|Overall Study|Withdrawal by Subject|5|||
37913774|NCT00883896|69600260|FG001|Overall Study|Withdrawal by Subject|0|||
37913775|NCT00883896|69600261|FG002|Overall Study|Withdrawal by Subject|1|||
37913776|NCT00883896|69600262|FG003|Overall Study|Withdrawal by Subject|3|||
37913777|NCT00883896|69600259|FG000|Overall Study|Lack of Efficacy|0|||
37913778|NCT00883896|69600260|FG001|Overall Study|Lack of Efficacy|0|||
37913779|NCT00883896|69600261|FG002|Overall Study|Lack of Efficacy|0|||
37913780|NCT00883896|69600262|FG003|Overall Study|Lack of Efficacy|2|||
37913781|NCT00883896|69600259|FG000|Overall Study|Other|1|||
37913782|NCT00883896|69600260|FG001|Overall Study|Other|0|||
37913783|NCT00883896|69600261|FG002|Overall Study|Other|0|||
37913784|NCT00883896|69600262|FG003|Overall Study|Other|0|||
38022923|NCT03129100|69705724|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
38022924|NCT03129100|69705725|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
38022925|NCT03129100|69705726|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
38022926|NCT03129100|69705727|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
38022927|NCT03129100|69705728|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
38022928|NCT03129100|69705729|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
38022929|NCT03129100|69705730|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
38022930|NCT03129100|69705731|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
38022931|NCT03129100|69705732|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
38022932|NCT03129100|69705733|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
38022933|NCT03129100|69705734|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
38022934|NCT03129100|69705735|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
37913785|NCT00867009|69600272|FG000|Induction Period|Nonserious Adverse Event|5|||
38022935|NCT03129100|69705736|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
38022936|NCT03129100|69705737|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
38022937|NCT03129100|69705738|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
38022938|NCT03129100|69705739|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
38022939|NCT03129100|69705740|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
38022940|NCT03129100|69705741|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
38022941|NCT03129100|69705742|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
38022942|NCT03129100|69705743|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
38022943|NCT03129100|69705744|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
37913786|NCT00867009|69600272|FG000|Induction Period|Serious Adverse Event|10|||
37913787|NCT00867009|69600272|FG000|Induction Period|Death due to serious adverse event|6|||
37913788|NCT00867009|69600272|FG000|Induction Period|Death due to Study Disease|4|||
37913789|NCT00867009|69600272|FG000|Induction Period|Protocol Violation|1|||
37913790|NCT00867009|69600272|FG000|Induction Period|Withdrawal by Subject|8|||
38022944|NCT03129100|69705719|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
38022945|NCT03129100|69705720|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
38022946|NCT03129100|69705721|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
38022947|NCT03129100|69705722|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
38022948|NCT03129100|69705723|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
38022949|NCT03129100|69705724|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
38022950|NCT03129100|69705725|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
38022951|NCT03129100|69705726|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
38022952|NCT03129100|69705727|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
38022953|NCT03129100|69705728|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
38022954|NCT03129100|69705729|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
38022955|NCT03129100|69705730|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
38022956|NCT03129100|69705731|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
38022957|NCT03129100|69705732|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
38022958|NCT03129100|69705733|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
37835745|NCT01186744|69520055|FG000|Overall Study|Other|9|||
37835746|NCT01186744|69520056|FG001|Overall Study|Other|10|||
37835747|NCT01186744|69520057|FG002|Overall Study|Other|1|||
37835748|NCT01186744|69520058|FG003|Overall Study|Other|2|||
37835749|NCT01186744|69520059|FG004|Overall Study|Other|1|||
37835750|NCT01186744|69520060|FG005|Overall Study|Other|5|||
37835751|NCT01186744|69520055|FG000|Overall Study|Adverse Event|10|||
37835752|NCT01186744|69520056|FG001|Overall Study|Adverse Event|14|||
38022959|NCT03129100|69705734|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
37835753|NCT01186744|69520057|FG002|Overall Study|Adverse Event|1|||
38022960|NCT03129100|69705735|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
38022961|NCT03129100|69705736|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
37835754|NCT01186744|69520058|FG003|Overall Study|Adverse Event|0|||
37913791|NCT00867009|69600272|FG000|Induction Period|Physician Decision|3|||
37835755|NCT01186744|69520059|FG004|Overall Study|Adverse Event|1|||
37913792|NCT00867009|69600272|FG000|Induction Period|Progressive Disease (PD)|25|||
38022962|NCT03129100|69705737|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
38022963|NCT03129100|69705738|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
38022964|NCT03129100|69705739|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
38022965|NCT03129100|69705740|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
38022966|NCT03129100|69705741|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
38022967|NCT03129100|69705742|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
38022968|NCT03129100|69705743|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
38022969|NCT03129100|69705744|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
38022970|NCT03129100|69705719|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
38022971|NCT03129100|69705720|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
38022972|NCT03129100|69705721|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
38022973|NCT03129100|69705722|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
38022974|NCT03129100|69705723|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
38022975|NCT03129100|69705724|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
38022976|NCT03129100|69705725|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
37700528|NCT02388737|69177599|FG000|Overall Study|Lost to Follow-up|5|||
37913793|NCT00867009|69600272|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
37913794|NCT00601250|69600278|FG000|Overall Study|Adverse Event|3|||
37913795|NCT00601250|69600279|FG001|Overall Study|Adverse Event|9|||
37913796|NCT00601250|69600278|FG000|Overall Study|Protocol Violation|3|||
37913797|NCT00601250|69600279|FG001|Overall Study|Protocol Violation|2|||
37913798|NCT00601250|69600278|FG000|Overall Study|Lost to Follow-up|2|||
37913799|NCT00601250|69600279|FG001|Overall Study|Lost to Follow-up|6|||
37913800|NCT00601250|69600278|FG000|Overall Study|Withdrawal by Subject|4|||
37913801|NCT00601250|69600279|FG001|Overall Study|Withdrawal by Subject|13|||
37913802|NCT00601250|69600278|FG000|Overall Study|Other incl. lack of efficacy|2|||
37913803|NCT00601250|69600279|FG001|Overall Study|Other incl. lack of efficacy|9|||
37913804|NCT00866775|69600287|FG000|Overall Study|Adverse Event|5|||
37913805|NCT00866775|69600288|FG001|Overall Study|Adverse Event|19|||
37913806|NCT00866775|69600287|FG000|Overall Study|Death|1|||
37913807|NCT00866775|69600288|FG001|Overall Study|Death|0|||
37913808|NCT00866775|69600287|FG000|Overall Study|Lost to Follow-up|0|||
37913809|NCT00866775|69600288|FG001|Overall Study|Lost to Follow-up|4|||
37913810|NCT00866775|69600287|FG000|Overall Study|Physician Decision|0|||
37913811|NCT00866775|69600288|FG001|Overall Study|Physician Decision|3|||
37913812|NCT00866775|69600287|FG000|Overall Study|Protocol Violation|3|||
37913813|NCT00866775|69600288|FG001|Overall Study|Protocol Violation|4|||
37913814|NCT00866775|69600287|FG000|Overall Study|Withdrawal by Subject|4|||
37913815|NCT00866775|69600288|FG001|Overall Study|Withdrawal by Subject|4|||
37913816|NCT00866775|69600287|FG000|Overall Study|met exit criteria|23|||
37913817|NCT00866775|69600288|FG001|Overall Study|met exit criteria|17|||
37913818|NCT00866775|69600287|FG000|Overall Study|discontinued due to communication error|0|||
37913819|NCT00866775|69600288|FG001|Overall Study|discontinued due to communication error|1|||
37913820|NCT03265210|69600298|FG000|Overall Study|Withdrawal by Subject|7|||
37913821|NCT03265210|69600299|FG001|Overall Study|Withdrawal by Subject|9|||
37913822|NCT03265210|69600298|FG000|Overall Study|Lost to Follow-up|2|||
37700529|NCT02388737|69177600|FG001|Overall Study|Lost to Follow-up|1|||
37700530|NCT02388737|69177601|FG002|Overall Study|Lost to Follow-up|4|||
37700531|NCT02388737|69177599|FG000|Overall Study|Voluntary Withdrawal|10|||
37700532|NCT02388737|69177600|FG001|Overall Study|Voluntary Withdrawal|18|||
37700533|NCT02388737|69177601|FG002|Overall Study|Voluntary Withdrawal|17|||
37700534|NCT02388737|69177599|FG000|Overall Study|Lack of Efficacy|3|||
37835756|NCT01186744|69520060|FG005|Overall Study|Adverse Event|4|||
37835757|NCT01186744|69520055|FG000|Overall Study|Death|1|||
37835758|NCT01186744|69520056|FG001|Overall Study|Death|0|||
37835759|NCT01186744|69520057|FG002|Overall Study|Death|0|||
37835760|NCT01186744|69520058|FG003|Overall Study|Death|0|||
37835761|NCT01186744|69520059|FG004|Overall Study|Death|0|||
37835762|NCT01186744|69520060|FG005|Overall Study|Death|0|||
37835763|NCT01185964|69520098|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
37835764|NCT01185964|69520099|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
37835765|NCT01185964|69520100|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
37835766|NCT01185964|69520101|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
37700535|NCT02388737|69177600|FG001|Overall Study|Lack of Efficacy|0|||
37700536|NCT02388737|69177601|FG002|Overall Study|Lack of Efficacy|3|||
37700537|NCT02388737|69177599|FG000|Overall Study|Reason Not Specified|5|||
37700538|NCT02388737|69177600|FG001|Overall Study|Reason Not Specified|5|||
37835767|NCT01185964|69520098|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
37835768|NCT01185964|69520099|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
37835769|NCT01185964|69520100|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
37913823|NCT03265210|69600299|FG001|Overall Study|Lost to Follow-up|0|||
37913824|NCT03265210|69600298|FG000|Overall Study|Physician Decision|2|||
37913825|NCT03265210|69600299|FG001|Overall Study|Physician Decision|0|||
38022977|NCT03129100|69705726|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
38022978|NCT03129100|69705727|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
38022979|NCT03129100|69705728|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
38022980|NCT03129100|69705729|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
38022981|NCT03129100|69705730|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
38022982|NCT03129100|69705731|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
38022983|NCT03129100|69705732|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
38022984|NCT03129100|69705733|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
38022985|NCT03129100|69705734|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
38022986|NCT03129100|69705735|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
38022987|NCT03129100|69705736|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
38022988|NCT03129100|69705737|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
38022989|NCT03129100|69705738|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
38022990|NCT03129100|69705739|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
38022991|NCT03129100|69705740|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
38022992|NCT03129100|69705741|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
38022993|NCT03129100|69705742|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
38022994|NCT03129100|69705743|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
38022995|NCT03129100|69705744|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
38022996|NCT03129100|69705719|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
38022997|NCT03129100|69705720|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
38022998|NCT03129100|69705721|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
38022999|NCT03129100|69705722|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
38023000|NCT03129100|69705723|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
38023001|NCT03129100|69705724|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
38023002|NCT03129100|69705725|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
38023003|NCT03129100|69705726|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
38023004|NCT03129100|69705727|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
38023005|NCT03129100|69705728|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
38023006|NCT03129100|69705729|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
38023007|NCT03129100|69705730|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
38023008|NCT03129100|69705731|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
38023009|NCT03129100|69705732|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
38023010|NCT03129100|69705733|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
38023011|NCT03129100|69705734|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
38023012|NCT03129100|69705735|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
38023013|NCT03129100|69705736|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
38023014|NCT03129100|69705737|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
38023015|NCT03129100|69705738|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
38023016|NCT03129100|69705739|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
38023017|NCT03129100|69705740|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
38023018|NCT03129100|69705741|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
38023019|NCT03129100|69705742|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
38023020|NCT03129100|69705743|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
38023021|NCT03129100|69705744|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
38023022|NCT03129100|69705719|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
38023023|NCT03129100|69705720|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
38023024|NCT03129100|69705721|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
38023025|NCT03129100|69705722|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
38023026|NCT03129100|69705723|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
38023027|NCT03129100|69705724|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
38023028|NCT03129100|69705725|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
38023029|NCT03129100|69705726|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
38023030|NCT03129100|69705727|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
38023031|NCT03129100|69705728|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
38023032|NCT03129100|69705729|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
37835770|NCT01185964|69520101|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
37835771|NCT01185964|69520098|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
37835772|NCT01185964|69520099|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
37835773|NCT01185964|69520100|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
37835774|NCT01185964|69520101|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
37835775|NCT01185964|69520098|FG000|Phase 1b and Phase 2|Adverse Event|1|||
37835776|NCT01185964|69520099|FG001|Phase 1b and Phase 2|Adverse Event|0|||
37835777|NCT01185964|69520100|FG002|Phase 1b and Phase 2|Adverse Event|2|||
37913826|NCT03265210|69600298|FG000|Overall Study|Adverse Event|1|||
37913827|NCT03265210|69600299|FG001|Overall Study|Adverse Event|0|||
37913828|NCT00543985|69600305|FG000|Overall Study|Withdrawal by Subject|4|||
37913829|NCT00582556|69600320|FG000|Overall Study|Withdrawal by Subject|0|||
37913830|NCT00582556|69600321|FG001|Overall Study|Withdrawal by Subject|1|||
37913831|NCT00582556|69600322|FG002|Overall Study|Withdrawal by Subject|1|||
37913832|NCT00582556|69600320|FG000|Overall Study|Physician Decision|0|||
37913833|NCT00582556|69600321|FG001|Overall Study|Physician Decision|0|||
37913834|NCT00582556|69600322|FG002|Overall Study|Physician Decision|1|||
37913835|NCT00542269|69600334|FG000|Overall Study|Adverse Event|10|||
37913836|NCT00542269|69600335|FG001|Overall Study|Adverse Event|4|||
37913837|NCT00542269|69600336|FG002|Overall Study|Adverse Event|5|||
37913838|NCT00542269|69600334|FG000|Overall Study|Protocol Violation|1|||
37913839|NCT00542269|69600335|FG001|Overall Study|Protocol Violation|1|||
37913840|NCT00542269|69600336|FG002|Overall Study|Protocol Violation|0|||
37913841|NCT00542269|69600334|FG000|Overall Study|Withdrawal by Subject|1|||
37913842|NCT00542269|69600335|FG001|Overall Study|Withdrawal by Subject|0|||
37913843|NCT00542269|69600336|FG002|Overall Study|Withdrawal by Subject|0|||
37913844|NCT00542269|69600334|FG000|Overall Study|Administrative problems|1|||
37913845|NCT00542269|69600335|FG001|Overall Study|Administrative problems|1|||
37913846|NCT00542269|69600336|FG002|Overall Study|Administrative problems|1|||
37913847|NCT00866697|69600348|FG000|Overall Study|Study closed/terminated|156|||
37913848|NCT00866697|69600349|FG001|Overall Study|Study closed/terminated|138|||
37913849|NCT00866697|69600348|FG000|Overall Study|Lost to Follow-up|22|||
37913850|NCT00866697|69600349|FG001|Overall Study|Lost to Follow-up|28|||
37913851|NCT00866697|69600348|FG000|Overall Study|Physician Decision|3|||
37913852|NCT00866697|69600349|FG001|Overall Study|Physician Decision|5|||
37913853|NCT00866697|69600348|FG000|Overall Study|Withdrawal by Subject|33|||
37913854|NCT00866697|69600349|FG001|Overall Study|Withdrawal by Subject|57|||
37913855|NCT00542191|69600355|FG000|Overall Study|Death|3|||
37913856|NCT00600938|69600361|FG000|Core Study|Abnormal test procedure result(s)|3|||
37913857|NCT00600938|69600362|FG001|Core Study|Abnormal test procedure result(s)|2|||
37835778|NCT01185964|69520101|FG003|Phase 1b and Phase 2|Adverse Event|0|||
37835779|NCT01185964|69520098|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
37835780|NCT01185964|69520099|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
37835781|NCT01185964|69520100|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
37835782|NCT01185964|69520101|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
37913858|NCT00600938|69600363|FG002|Core Study|Abnormal test procedure result(s)|0|||
37913859|NCT00600938|69600364|FG003|Core Study|Abnormal test procedure result(s)|0|||
37913860|NCT00600938|69600361|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
37913861|NCT00600938|69600362|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
37913862|NCT00600938|69600363|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
37913863|NCT00600938|69600364|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
37913864|NCT00600938|69600361|FG000|Core Study|Patient withdrew consent|7|||
37913865|NCT00600938|69600362|FG001|Core Study|Patient withdrew consent|12|||
37835783|NCT01185964|69520098|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
37835784|NCT01185964|69520099|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
37835785|NCT01185964|69520100|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
37835786|NCT01185964|69520101|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
37835787|NCT01185964|69520098|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
37835788|NCT01185964|69520099|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
37835789|NCT01185964|69520100|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
37835790|NCT01185964|69520101|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
37835791|NCT01185964|69520098|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
37835792|NCT01185964|69520099|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
37835793|NCT01185964|69520100|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
37835794|NCT01185964|69520101|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
37835795|NCT01217476|69520119|FG000|Overall Study|Adverse Event|6|||
37835796|NCT01217476|69520120|FG001|Overall Study|Adverse Event|1|||
37835797|NCT01217476|69520119|FG000|Overall Study|Physician Decision|0|||
37835798|NCT01217476|69520120|FG001|Overall Study|Physician Decision|1|||
37835799|NCT01217476|69520119|FG000|Overall Study|Withdrawal by Subject|3|||
37835800|NCT01217476|69520120|FG001|Overall Study|Withdrawal by Subject|3|||
37913866|NCT00600938|69600363|FG002|Core Study|Patient withdrew consent|0|||
37913867|NCT00600938|69600364|FG003|Core Study|Patient withdrew consent|0|||
37913868|NCT00600938|69600361|FG000|Core Study|Lost to Follow-up|3|||
37913869|NCT00600938|69600362|FG001|Core Study|Lost to Follow-up|2|||
37913870|NCT00600938|69600363|FG002|Core Study|Lost to Follow-up|0|||
37913871|NCT00600938|69600364|FG003|Core Study|Lost to Follow-up|0|||
37913872|NCT00600938|69600361|FG000|Core Study|Death|1|||
37913873|NCT00600938|69600362|FG001|Core Study|Death|1|||
37913874|NCT00600938|69600363|FG002|Core Study|Death|0|||
37913875|NCT00600938|69600364|FG003|Core Study|Death|0|||
37913876|NCT00600938|69600361|FG000|Core Study|Protocol Violation|1|||
37835801|NCT01217476|69520119|FG000|Overall Study|Surgery on the Target Limb|0|||
37835802|NCT01217476|69520120|FG001|Overall Study|Surgery on the Target Limb|2|||
37835803|NCT01217476|69520119|FG000|Overall Study|Protocol Deviation|1|||
37835804|NCT01217476|69520120|FG001|Overall Study|Protocol Deviation|0|||
37835805|NCT01217476|69520119|FG000|Overall Study|Other|2|||
37835806|NCT01217476|69520120|FG001|Overall Study|Other|0|||
37835807|NCT01217437|69520141|FG000|Overall Study|Adverse Event|0|||
37835808|NCT01217437|69520142|FG001|Overall Study|Adverse Event|8|||
37835809|NCT01217437|69520141|FG000|Overall Study|Death|5|||
37913877|NCT00600938|69600362|FG001|Core Study|Protocol Violation|2|||
37913878|NCT00600938|69600363|FG002|Core Study|Protocol Violation|0|||
37913879|NCT00600938|69600364|FG003|Core Study|Protocol Violation|0|||
37913880|NCT00600938|69600361|FG000|Extension Study|Adverse Event|1|||
37913881|NCT00600938|69600362|FG001|Extension Study|Adverse Event|0|||
37835810|NCT01217437|69520142|FG001|Overall Study|Death|0|||
37835811|NCT01217437|69520141|FG000|Overall Study|Lack of Efficacy|29|||
37913882|NCT00600938|69600363|FG002|Extension Study|Adverse Event|2|||
37835812|NCT01217437|69520142|FG001|Overall Study|Lack of Efficacy|25|||
37835813|NCT01217437|69520141|FG000|Overall Study|Physician Decision|8|||
37835814|NCT01217437|69520142|FG001|Overall Study|Physician Decision|5|||
37835815|NCT01217437|69520141|FG000|Overall Study|Withdrawal by Subject|0|||
37835816|NCT01217437|69520142|FG001|Overall Study|Withdrawal by Subject|2|||
37835817|NCT01217437|69520141|FG000|Overall Study|Ineligible|1|||
37835818|NCT01217437|69520142|FG001|Overall Study|Ineligible|1|||
37913883|NCT00600938|69600364|FG003|Extension Study|Adverse Event|0|||
37913884|NCT00600938|69600361|FG000|Extension Study|Abnormal test procedure results|0|||
37913885|NCT00600938|69600362|FG001|Extension Study|Abnormal test procedure results|1|||
37913886|NCT00600938|69600363|FG002|Extension Study|Abnormal test procedure results|1|||
37913887|NCT00600938|69600364|FG003|Extension Study|Abnormal test procedure results|1|||
37913888|NCT00600938|69600361|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
37913889|NCT00600938|69600362|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
37913890|NCT00600938|69600363|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
37913891|NCT00600938|69600364|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
37913892|NCT00600938|69600361|FG000|Extension Study|Withdrawal by Subject|2|||
37913893|NCT00600938|69600362|FG001|Extension Study|Withdrawal by Subject|2|||
37913894|NCT00600938|69600363|FG002|Extension Study|Withdrawal by Subject|3|||
37913895|NCT00600938|69600364|FG003|Extension Study|Withdrawal by Subject|0|||
37913896|NCT00600938|69600361|FG000|Extension Study|Lost to Follow-up|1|||
37913897|NCT00600938|69600362|FG001|Extension Study|Lost to Follow-up|1|||
37913898|NCT00600938|69600363|FG002|Extension Study|Lost to Follow-up|2|||
37913899|NCT00600938|69600364|FG003|Extension Study|Lost to Follow-up|0|||
37913900|NCT00600938|69600361|FG000|Extension Study|Death|1|||
37913901|NCT00600938|69600362|FG001|Extension Study|Death|0|||
37913902|NCT00600938|69600363|FG002|Extension Study|Death|0|||
37913903|NCT00600938|69600364|FG003|Extension Study|Death|0|||
37913904|NCT00543439|69600405|FG000|Period 1|Adverse Event|0|||
37913905|NCT00543439|69600406|FG001|Period 1|Adverse Event|2|||
37913906|NCT00543439|69600407|FG002|Period 1|Adverse Event|1|||
37913907|NCT00543439|69600405|FG000|Period 1|Withdrawal by Subject|1|||
38023033|NCT03129100|69705730|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
38023034|NCT03129100|69705731|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
38023035|NCT03129100|69705732|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
38023036|NCT03129100|69705733|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
38023037|NCT03129100|69705734|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
38023038|NCT03129100|69705735|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
38023039|NCT03129100|69705736|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
38023040|NCT03129100|69705737|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
38023041|NCT03129100|69705738|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
38023042|NCT03129100|69705739|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
38023043|NCT03129100|69705740|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
38023044|NCT03129100|69705741|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
37835819|NCT01217047|69520152|FG000|Overall Study|Lost to Follow-up|0|||
37835820|NCT01217047|69520153|FG001|Overall Study|Lost to Follow-up|1|||
37835821|NCT01217047|69520154|FG002|Overall Study|Lost to Follow-up|0|||
37835822|NCT01185340|69520166|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
37835823|NCT01185340|69520167|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
37835824|NCT01185340|69520168|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
37835825|NCT01185340|69520169|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
37835826|NCT01185340|69520166|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
37835827|NCT01185340|69520167|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
37835828|NCT01185340|69520168|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
37835829|NCT01185340|69520169|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
37835830|NCT01185340|69520166|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
37835831|NCT01185340|69520167|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
37835832|NCT01185340|69520168|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
37835833|NCT01185340|69520169|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
37835834|NCT01185340|69520166|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
37835835|NCT01185340|69520167|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
38023045|NCT03129100|69705742|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
37835836|NCT01185340|69520168|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
37913908|NCT00543439|69600406|FG001|Period 1|Withdrawal by Subject|1|||
37913909|NCT00543439|69600407|FG002|Period 1|Withdrawal by Subject|0|||
37913910|NCT00543439|69600405|FG000|Period 1|Physician Decision|0|||
37913911|NCT00543439|69600406|FG001|Period 1|Physician Decision|0|||
37913912|NCT00543439|69600407|FG002|Period 1|Physician Decision|1|||
38023046|NCT03129100|69705743|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
38023047|NCT03129100|69705744|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
38023048|NCT03129100|69705719|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
37835837|NCT01185340|69520169|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
37835838|NCT01185340|69520166|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
37835839|NCT01185340|69520167|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
37835840|NCT01185340|69520168|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
37835841|NCT01185340|69520169|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
37835842|NCT01185340|69520166|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
37835843|NCT01185340|69520167|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
37835844|NCT01185340|69520168|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
37835845|NCT01185340|69520169|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
37835846|NCT01185340|69520166|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
38023049|NCT03129100|69705720|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
38023050|NCT03129100|69705721|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
37835847|NCT01185340|69520167|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
37835848|NCT01185340|69520168|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
37835849|NCT01185340|69520169|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
37835850|NCT01185340|69520166|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
37835851|NCT01185340|69520167|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
37835852|NCT01185340|69520168|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
37835853|NCT01185340|69520169|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
37835854|NCT01185340|69520166|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
38023051|NCT03129100|69705722|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
38023052|NCT03129100|69705723|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
37913913|NCT00543439|69600405|FG000|Period 2|Protocol Violation|1|||
37913914|NCT00543439|69600406|FG001|Period 2|Protocol Violation|0|||
37913915|NCT00543439|69600407|FG002|Period 2|Protocol Violation|1|||
37835855|NCT01185340|69520167|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
37835856|NCT01185340|69520168|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
37835857|NCT01185340|69520169|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
37835858|NCT01185340|69520166|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
37835859|NCT01185340|69520167|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
37835860|NCT01185340|69520168|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
38023053|NCT03129100|69705724|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
38023054|NCT03129100|69705725|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
38023055|NCT03129100|69705726|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
38023056|NCT03129100|69705727|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
38023057|NCT03129100|69705728|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
38023058|NCT03129100|69705729|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
38023059|NCT03129100|69705730|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
38023060|NCT03129100|69705731|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
38023061|NCT03129100|69705732|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
38023062|NCT03129100|69705733|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
38023063|NCT03129100|69705734|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
38023064|NCT03129100|69705735|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
38023065|NCT03129100|69705736|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
38023066|NCT03129100|69705737|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
38023067|NCT03129100|69705738|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
37835861|NCT01185340|69520169|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
37835862|NCT01185340|69520166|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
37835863|NCT01185340|69520167|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
37835864|NCT01185340|69520168|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
37835865|NCT01185340|69520169|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
37913916|NCT00543439|69600405|FG000|Period 2|Adverse Event|0|||
37913917|NCT00543439|69600406|FG001|Period 2|Adverse Event|1|||
37913918|NCT00543439|69600407|FG002|Period 2|Adverse Event|1|||
37913919|NCT00582166|69600424|FG000|Overall Study|Death|1|||
38023068|NCT03129100|69705739|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
38023069|NCT03129100|69705740|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
38023070|NCT03129100|69705741|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
38023071|NCT03129100|69705742|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
38023072|NCT03129100|69705743|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
38023073|NCT03129100|69705744|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
38023074|NCT03101020|69705783|FG000|Overall Study|Lack of time to participate|1|||
38023075|NCT03101020|69705784|FG001|Overall Study|Lack of time to participate|0|||
38023076|NCT03101020|69705783|FG000|Overall Study|Ran over by a car|0|||
38023077|NCT03101020|69705784|FG001|Overall Study|Ran over by a car|1|||
38023078|NCT03101020|69705783|FG000|Overall Study|Withdrawal by Subject|0|||
37913920|NCT00582166|69600424|FG000|Overall Study|Ineligible pathology|1|||
37913921|NCT00601172|69600430|FG000|Overall Study|Adverse Event|43|||
37913922|NCT00601172|69600431|FG001|Overall Study|Adverse Event|32|||
37913923|NCT00601172|69600430|FG000|Overall Study|Lack of Efficacy|11|||
37913924|NCT00601172|69600431|FG001|Overall Study|Lack of Efficacy|12|||
37913925|NCT00601172|69600430|FG000|Overall Study|Protocol Violation|2|||
37913926|NCT00601172|69600431|FG001|Overall Study|Protocol Violation|5|||
37913927|NCT00601172|69600430|FG000|Overall Study|Lost to Follow-up|4|||
37913928|NCT00601172|69600431|FG001|Overall Study|Lost to Follow-up|3|||
37913929|NCT00601172|69600430|FG000|Overall Study|Physician Decision|27|||
37913930|NCT00601172|69600431|FG001|Overall Study|Physician Decision|28|||
37913931|NCT00601172|69600430|FG000|Overall Study|Withdrawal by Subject|35|||
37913932|NCT00601172|69600431|FG001|Overall Study|Withdrawal by Subject|27|||
37913933|NCT00601172|69600430|FG000|Overall Study|Did not meet continuation criteria|19|||
37913934|NCT00601172|69600431|FG001|Overall Study|Did not meet continuation criteria|20|||
37913935|NCT00582010|69600440|FG000|Overall Study|Death|0|||
37913936|NCT00582010|69600441|FG001|Overall Study|Death|1|||
37913937|NCT00580840|69600451|FG000|Run-in|Adverse Event|17|||
37913938|NCT00580840|69600452|FG001|Run-in|Adverse Event|0|||
37913939|NCT00580840|69600453|FG002|Run-in|Adverse Event|0|||
37913940|NCT00580840|69600454|FG003|Run-in|Adverse Event|0|||
37913941|NCT00580840|69600451|FG000|Run-in|Lack of Efficacy|93|||
37913942|NCT00580840|69600452|FG001|Run-in|Lack of Efficacy|0|||
37913943|NCT00580840|69600453|FG002|Run-in|Lack of Efficacy|0|||
37913944|NCT00580840|69600454|FG003|Run-in|Lack of Efficacy|0|||
37913945|NCT00580840|69600451|FG000|Run-in|Loss of Efficacy|1|||
37913946|NCT00580840|69600452|FG001|Run-in|Loss of Efficacy|0|||
37913947|NCT00580840|69600453|FG002|Run-in|Loss of Efficacy|0|||
37913948|NCT00580840|69600454|FG003|Run-in|Loss of Efficacy|0|||
37913949|NCT00580840|69600451|FG000|Run-in|Lost to Follow-up|4|||
37913950|NCT00580840|69600452|FG001|Run-in|Lost to Follow-up|0|||
37913951|NCT00580840|69600453|FG002|Run-in|Lost to Follow-up|0|||
37913952|NCT00580840|69600454|FG003|Run-in|Lost to Follow-up|0|||
37913953|NCT00580840|69600451|FG000|Run-in|Withdrawal by Subject|5|||
37913954|NCT00580840|69600452|FG001|Run-in|Withdrawal by Subject|0|||
37913955|NCT00580840|69600453|FG002|Run-in|Withdrawal by Subject|0|||
37913956|NCT00580840|69600454|FG003|Run-in|Withdrawal by Subject|0|||
37913957|NCT00580840|69600451|FG000|Run-in|Other: Per Sponsor Request|2|||
37913958|NCT00580840|69600452|FG001|Run-in|Other: Per Sponsor Request|0|||
37913959|NCT00580840|69600453|FG002|Run-in|Other: Per Sponsor Request|0|||
37913960|NCT00580840|69600454|FG003|Run-in|Other: Per Sponsor Request|0|||
37913961|NCT00580840|69600451|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
38023079|NCT03101020|69705784|FG001|Overall Study|Withdrawal by Subject|2|||
38023080|NCT03100942|69705794|FG000|Randomized Treatment Period|Withdrew Consent|4|||
38023081|NCT03100942|69705795|FG001|Randomized Treatment Period|Withdrew Consent|5|||
38023082|NCT03100942|69705796|FG002|Randomized Treatment Period|Withdrew Consent|3|||
38023083|NCT03100942|69705797|FG003|Randomized Treatment Period|Withdrew Consent|3|||
37835866|NCT01185340|69520166|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
37835867|NCT01185340|69520167|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
37835868|NCT01185340|69520168|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
37835869|NCT01185340|69520169|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
37835870|NCT01185340|69520166|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
37835871|NCT01185340|69520167|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
37835872|NCT01185340|69520168|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
37835873|NCT01185340|69520169|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
37835874|NCT01185340|69520166|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
37835875|NCT01185340|69520167|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
37835876|NCT01185340|69520168|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
37835877|NCT01185340|69520169|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
37835878|NCT01216189|69520183|FG000|Overall Study|Lost to Follow-up|21|||
37835879|NCT01216189|69520184|FG001|Overall Study|Lost to Follow-up|3|||
37835880|NCT01216189|69520183|FG000|Overall Study|Death|4|||
37913962|NCT00580840|69600452|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
37913963|NCT00580840|69600453|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
37913964|NCT00580840|69600454|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
37913965|NCT00580840|69600451|FG000|Run-in|Other: Exclusionary Lab Value|1|||
37913966|NCT00580840|69600452|FG001|Run-in|Other: Exclusionary Lab Value|0|||
37913967|NCT00580840|69600453|FG002|Run-in|Other: Exclusionary Lab Value|0|||
38023084|NCT03100942|69705798|FG004|Randomized Treatment Period|Withdrew Consent|0|||
37913968|NCT00580840|69600454|FG003|Run-in|Other: Exclusionary Lab Value|0|||
37913969|NCT00580840|69600451|FG000|Double-Blind|Adverse Event|0|||
37913970|NCT00580840|69600452|FG001|Double-Blind|Adverse Event|3|||
37913971|NCT00580840|69600453|FG002|Double-Blind|Adverse Event|4|||
37913972|NCT00580840|69600454|FG003|Double-Blind|Adverse Event|1|||
37913973|NCT00580840|69600451|FG000|Double-Blind|Loss of Efficacy|0|||
37913974|NCT00580840|69600452|FG001|Double-Blind|Loss of Efficacy|1|||
37913975|NCT00580840|69600453|FG002|Double-Blind|Loss of Efficacy|2|||
38023085|NCT03100942|69705799|FG005|Randomized Treatment Period|Withdrew Consent|0|||
38023086|NCT03100942|69705800|FG006|Randomized Treatment Period|Withdrew Consent|0|||
38023087|NCT03100942|69705794|FG000|Randomized Treatment Period|Adverse Event|5|||
38023088|NCT03100942|69705795|FG001|Randomized Treatment Period|Adverse Event|2|||
38023089|NCT03100942|69705796|FG002|Randomized Treatment Period|Adverse Event|1|||
38023090|NCT03100942|69705797|FG003|Randomized Treatment Period|Adverse Event|0|||
38023091|NCT03100942|69705798|FG004|Randomized Treatment Period|Adverse Event|0|||
38023092|NCT03100942|69705799|FG005|Randomized Treatment Period|Adverse Event|0|||
38023093|NCT03100942|69705800|FG006|Randomized Treatment Period|Adverse Event|0|||
38023094|NCT03100942|69705794|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
38023095|NCT03100942|69705795|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
38023096|NCT03100942|69705796|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
38023097|NCT03100942|69705797|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
38023098|NCT03100942|69705798|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
38023099|NCT03100942|69705799|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
38023100|NCT03100942|69705800|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
38023101|NCT03100942|69705794|FG000|Randomized Treatment Period|Protocol Violation|0|||
38023102|NCT03100942|69705795|FG001|Randomized Treatment Period|Protocol Violation|1|||
38023103|NCT03100942|69705796|FG002|Randomized Treatment Period|Protocol Violation|1|||
38023104|NCT03100942|69705797|FG003|Randomized Treatment Period|Protocol Violation|1|||
38023105|NCT03100942|69705798|FG004|Randomized Treatment Period|Protocol Violation|0|||
38023106|NCT03100942|69705799|FG005|Randomized Treatment Period|Protocol Violation|0|||
38023107|NCT03100942|69705800|FG006|Randomized Treatment Period|Protocol Violation|0|||
38023108|NCT03100942|69705794|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
38023109|NCT03100942|69705795|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
38023110|NCT03100942|69705796|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
38023111|NCT03100942|69705797|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
38023112|NCT03100942|69705798|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
38023113|NCT03100942|69705799|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
37700539|NCT02388737|69177601|FG002|Overall Study|Reason Not Specified|4|||
38023114|NCT03100942|69705800|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
38023115|NCT03100942|69705794|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
38023116|NCT03100942|69705795|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
38023117|NCT03100942|69705796|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
38023118|NCT03100942|69705797|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
38023119|NCT03100942|69705798|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
38023120|NCT03100942|69705799|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
38023121|NCT03100942|69705800|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
38023122|NCT03100942|69705794|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
38023123|NCT03100942|69705795|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
38023124|NCT03100942|69705796|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
38023125|NCT03100942|69705797|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
38023126|NCT03100942|69705798|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
38023127|NCT03100942|69705799|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
38023128|NCT03100942|69705800|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
38023129|NCT03099694|69705815|FG000|Overall Study|Withdrawal by Subject|11|||
38023130|NCT03099694|69705816|FG001|Overall Study|Withdrawal by Subject|13|||
38023131|NCT03099694|69705815|FG000|Overall Study|Lost to Follow-up|9|||
38023132|NCT03099694|69705816|FG001|Overall Study|Lost to Follow-up|5|||
38023133|NCT03099538|69705823|FG000|Overall Study|Lack of Efficacy|3|||
38023134|NCT03099304|69705832|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
38023135|NCT03099304|69705833|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
38023136|NCT03099304|69705834|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
38023137|NCT03099304|69705835|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
38023138|NCT03099304|69705836|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
38023139|NCT03099304|69705837|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
38023140|NCT03099304|69705832|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
38023141|NCT03099304|69705833|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
38023142|NCT03099304|69705834|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
38023143|NCT03099304|69705835|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
38023144|NCT03099304|69705836|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
38023145|NCT03099304|69705837|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
38023146|NCT03099304|69705832|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
38023147|NCT03099304|69705833|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
38023148|NCT03099304|69705834|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
38023149|NCT03099304|69705835|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
38023150|NCT03099304|69705836|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
38023151|NCT03099304|69705837|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
38023152|NCT03099304|69705832|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
38023153|NCT03099304|69705833|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
38023154|NCT03099304|69705834|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
38023155|NCT03099304|69705835|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
38023156|NCT03099304|69705836|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
38023157|NCT03099304|69705837|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
38023158|NCT03099304|69705832|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
38023159|NCT03099304|69705833|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
38023160|NCT03099304|69705834|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
38023161|NCT03099304|69705835|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
38023162|NCT03099304|69705836|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
38023163|NCT03099304|69705837|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
38023164|NCT03099304|69705832|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
38023165|NCT03099304|69705833|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
37913976|NCT00580840|69600454|FG003|Double-Blind|Loss of Efficacy|10|||
37913977|NCT00580840|69600451|FG000|Double-Blind|Lost to Follow-up|0|||
37913978|NCT00580840|69600452|FG001|Double-Blind|Lost to Follow-up|1|||
37913979|NCT00580840|69600453|FG002|Double-Blind|Lost to Follow-up|0|||
37913980|NCT00580840|69600454|FG003|Double-Blind|Lost to Follow-up|2|||
37913981|NCT00580840|69600451|FG000|Double-Blind|Withdrawal by Subject|0|||
37913982|NCT00580840|69600452|FG001|Double-Blind|Withdrawal by Subject|1|||
37913983|NCT00580840|69600453|FG002|Double-Blind|Withdrawal by Subject|2|||
37913984|NCT00580840|69600454|FG003|Double-Blind|Withdrawal by Subject|2|||
37913985|NCT00580840|69600451|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
37913986|NCT00580840|69600452|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
37913987|NCT00580840|69600453|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
37913988|NCT00580840|69600454|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
37913989|NCT00580840|69600451|FG000|Double-Blind|Other: Forbidden Medication|0|||
37913990|NCT00580840|69600452|FG001|Double-Blind|Other: Forbidden Medication|0|||
37913991|NCT00580840|69600453|FG002|Double-Blind|Other: Forbidden Medication|1|||
38023166|NCT03099304|69705834|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
38023167|NCT03099304|69705835|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
38023168|NCT03099304|69705836|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
38023169|NCT03099304|69705837|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
38023170|NCT03099304|69705832|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
38023171|NCT03099304|69705833|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
37913992|NCT00580840|69600454|FG003|Double-Blind|Other: Forbidden Medication|0|||
37913993|NCT00879684|69600464|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
37913994|NCT00879684|69600465|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
37913995|NCT00879684|69600466|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
38023172|NCT03099304|69705834|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
37913996|NCT00879684|69600467|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
37913997|NCT00879684|69600468|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
37913998|NCT00879684|69600469|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
37913999|NCT00879684|69600470|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
37914000|NCT00879684|69600464|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
37914001|NCT00879684|69600465|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
37914002|NCT00879684|69600466|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
37914003|NCT00879684|69600467|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
37914004|NCT00879684|69600468|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
37914005|NCT00879684|69600469|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
37914006|NCT00879684|69600470|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
37914007|NCT00879684|69600464|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
37914008|NCT00879684|69600465|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
37914009|NCT00879684|69600466|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
37914010|NCT00879684|69600467|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
37914011|NCT00879684|69600468|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
37914012|NCT00879684|69600469|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
37914013|NCT00879684|69600470|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
37914014|NCT00879684|69600464|FG000|Stage 1: Dose Escalation|Death|0|||
37914015|NCT00879684|69600465|FG001|Stage 1: Dose Escalation|Death|0|||
37914016|NCT00879684|69600466|FG002|Stage 1: Dose Escalation|Death|1|||
37914017|NCT00879684|69600467|FG003|Stage 1: Dose Escalation|Death|0|||
37914018|NCT00879684|69600468|FG004|Stage 1: Dose Escalation|Death|0|||
37835881|NCT01216189|69520184|FG001|Overall Study|Death|2|||
37835882|NCT01185301|69520194|FG000|Overall Study|Adverse Event|3|||
37835883|NCT01185301|69520195|FG001|Overall Study|Adverse Event|0|||
37835884|NCT01185301|69520196|FG002|Overall Study|Adverse Event|2|||
37835885|NCT01185301|69520197|FG003|Overall Study|Adverse Event|3|||
37835886|NCT01185301|69520194|FG000|Overall Study|Withdrawal by Subject|7|||
37835887|NCT01185301|69520195|FG001|Overall Study|Withdrawal by Subject|5|||
37835888|NCT01185301|69520196|FG002|Overall Study|Withdrawal by Subject|2|||
37835889|NCT01185301|69520197|FG003|Overall Study|Withdrawal by Subject|3|||
37835890|NCT01185301|69520194|FG000|Overall Study|Lost to Follow-up|2|||
37835891|NCT01185301|69520195|FG001|Overall Study|Lost to Follow-up|0|||
37835892|NCT01185301|69520196|FG002|Overall Study|Lost to Follow-up|0|||
37835893|NCT01185301|69520197|FG003|Overall Study|Lost to Follow-up|1|||
37835894|NCT01185301|69520194|FG000|Overall Study|Other Reason|3|||
37835895|NCT01185301|69520195|FG001|Overall Study|Other Reason|2|||
37835896|NCT01185301|69520196|FG002|Overall Study|Other Reason|2|||
37835897|NCT01185301|69520197|FG003|Overall Study|Other Reason|2|||
37835898|NCT01216072|69520209|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
37835899|NCT01216072|69520210|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
37835900|NCT01216072|69520209|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
37835901|NCT01216072|69520210|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
37835902|NCT01216072|69520209|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
37835903|NCT01216072|69520210|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
37700540|NCT02355743|69177609|FG000|Overall Study|Withdrawal by Subject|1|||
37700541|NCT02355743|69177609|FG000|Overall Study|Lost to Follow-up|1|||
37700542|NCT02388347|69177618|FG000|Overall Study|Withdrawal by Subject|0|||
37700543|NCT02388347|69177619|FG001|Overall Study|Withdrawal by Subject|0|||
37700544|NCT02388347|69177620|FG002|Overall Study|Withdrawal by Subject|1|||
37700545|NCT02388347|69177621|FG003|Overall Study|Withdrawal by Subject|0|||
37835904|NCT01216072|69520209|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
37835905|NCT01216072|69520210|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
37835906|NCT01216072|69520209|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
37835907|NCT01216072|69520210|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
37835908|NCT01216072|69520209|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
37835909|NCT01216072|69520210|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
37835910|NCT01216072|69520209|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
37914019|NCT00879684|69600469|FG005|Stage 1: Dose Escalation|Death|0|||
38023173|NCT03099304|69705835|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
37700546|NCT02388347|69177622|FG004|Overall Study|Withdrawal by Subject|0|||
37700547|NCT02355665|69177640|FG000|Overall Study|Adverse Event|16|||
37700548|NCT02355665|69177641|FG001|Overall Study|Adverse Event|24|||
37700549|NCT02355665|69177640|FG000|Overall Study|Protocol Violation|2|||
37835911|NCT01216072|69520210|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
37835912|NCT01216072|69520209|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
37835913|NCT01216072|69520210|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
37914020|NCT00879684|69600470|FG006|Stage 1: Dose Escalation|Death|0|||
37835914|NCT01216072|69520209|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
37835915|NCT01216072|69520210|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
37835916|NCT01216072|69520209|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
37835917|NCT01216072|69520210|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
37835918|NCT01184989|69520219|FG000|Overall Study|Adverse Event|11|||
37835919|NCT01184989|69520219|FG000|Overall Study|Withdrawal by Subject|1|||
37835920|NCT01215955|69520227|FG000|Overall Study|Adverse Event|1|||
37835921|NCT01215955|69520228|FG001|Overall Study|Adverse Event|4|||
37835922|NCT01215955|69520229|FG002|Overall Study|Adverse Event|2|||
37835923|NCT01215955|69520230|FG003|Overall Study|Adverse Event|3|||
37835924|NCT01215955|69520227|FG000|Overall Study|Death|2|||
37835925|NCT01215955|69520228|FG001|Overall Study|Death|0|||
37835926|NCT01215955|69520229|FG002|Overall Study|Death|1|||
37835927|NCT01215955|69520230|FG003|Overall Study|Death|3|||
37835928|NCT01215955|69520227|FG000|Overall Study|Entry Criteria Not Met|1|||
37835929|NCT01215955|69520228|FG001|Overall Study|Entry Criteria Not Met|3|||
37835930|NCT01215955|69520229|FG002|Overall Study|Entry Criteria Not Met|4|||
37835931|NCT01215955|69520230|FG003|Overall Study|Entry Criteria Not Met|7|||
37835932|NCT01215955|69520227|FG000|Overall Study|Lack of Efficacy|1|||
37835933|NCT01215955|69520228|FG001|Overall Study|Lack of Efficacy|2|||
37835934|NCT01215955|69520229|FG002|Overall Study|Lack of Efficacy|1|||
37835935|NCT01215955|69520230|FG003|Overall Study|Lack of Efficacy|0|||
37835936|NCT01215955|69520227|FG000|Overall Study|Lost to Follow-up|4|||
37835937|NCT01215955|69520228|FG001|Overall Study|Lost to Follow-up|4|||
37835938|NCT01215955|69520229|FG002|Overall Study|Lost to Follow-up|8|||
37835939|NCT01215955|69520230|FG003|Overall Study|Lost to Follow-up|9|||
37835940|NCT01215955|69520227|FG000|Overall Study|Physician Decision|4|||
37835941|NCT01215955|69520228|FG001|Overall Study|Physician Decision|10|||
37835942|NCT01215955|69520229|FG002|Overall Study|Physician Decision|8|||
37835943|NCT01215955|69520230|FG003|Overall Study|Physician Decision|11|||
37835944|NCT01215955|69520227|FG000|Overall Study|Protocol Violation|17|||
37835945|NCT01215955|69520228|FG001|Overall Study|Protocol Violation|13|||
37835946|NCT01215955|69520229|FG002|Overall Study|Protocol Violation|8|||
37835947|NCT01215955|69520230|FG003|Overall Study|Protocol Violation|8|||
37835948|NCT01215955|69520227|FG000|Overall Study|Sponsor Decision|1|||
37835949|NCT01215955|69520228|FG001|Overall Study|Sponsor Decision|2|||
37914021|NCT00879684|69600464|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
37914022|NCT00879684|69600465|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
37914023|NCT00879684|69600466|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
37914024|NCT00879684|69600467|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
37914025|NCT00879684|69600468|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
37914026|NCT00879684|69600469|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
37914027|NCT00879684|69600470|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
37914028|NCT00879684|69600464|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
37914029|NCT00879684|69600465|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
37914030|NCT00879684|69600466|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
37914031|NCT00879684|69600467|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
37914032|NCT00879684|69600468|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
38023174|NCT03099304|69705836|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
38023175|NCT03099304|69705837|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
38023176|NCT03099304|69705832|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
38023177|NCT03099304|69705833|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
37914033|NCT00879684|69600469|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
37914034|NCT00879684|69600470|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
38023178|NCT03099304|69705834|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
38023179|NCT03099304|69705835|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
38023180|NCT03099304|69705836|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
37835950|NCT01215955|69520229|FG002|Overall Study|Sponsor Decision|0|||
37914035|NCT00879684|69600464|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
37914036|NCT00879684|69600465|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
37914037|NCT00879684|69600466|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
38023181|NCT03099304|69705837|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
37835951|NCT01215955|69520230|FG003|Overall Study|Sponsor Decision|1|||
37835952|NCT01215955|69520227|FG000|Overall Study|Withdrawal by Subject|14|||
37835953|NCT01215955|69520228|FG001|Overall Study|Withdrawal by Subject|15|||
37835954|NCT01215955|69520229|FG002|Overall Study|Withdrawal by Subject|13|||
37835955|NCT01215955|69520230|FG003|Overall Study|Withdrawal by Subject|9|||
37835956|NCT01215955|69520227|FG000|Overall Study|Quality Issues|0|||
37835957|NCT01215955|69520228|FG001|Overall Study|Quality Issues|0|||
37914038|NCT00879684|69600467|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
37914039|NCT00879684|69600468|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
37914040|NCT00879684|69600469|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
37914041|NCT00879684|69600470|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
37914042|NCT00581776|69600489|FG000|Overall Study|Disease progression or no response|3|||
37914043|NCT00883740|69600493|FG000|First Intervention|Lost to Follow-up|1|||
37914044|NCT00883740|69600494|FG001|First Intervention|Lost to Follow-up|0|||
37914045|NCT00883740|69600493|FG000|First Intervention|No longer willing to participate|2|||
37914046|NCT00883740|69600494|FG001|First Intervention|No longer willing to participate|0|||
37914047|NCT00883740|69600493|FG000|First Intervention|Protocol Violation|3|||
37914048|NCT00883740|69600494|FG001|First Intervention|Protocol Violation|6|||
37914049|NCT00883740|69600493|FG000|First Intervention|Adverse Event|1|||
37914050|NCT00883740|69600494|FG001|First Intervention|Adverse Event|2|||
37914051|NCT00883740|69600493|FG000|Second Intervention|Protocol Violation|1|||
37914052|NCT00883740|69600494|FG001|Second Intervention|Protocol Violation|0|||
37914053|NCT00883740|69600493|FG000|Second Intervention|No longer willing to participate|0|||
37914054|NCT00883740|69600494|FG001|Second Intervention|No longer willing to participate|1|||
37914055|NCT00597012|69600502|FG000|Overall Study|Death|1|||
37914056|NCT00597012|69600503|FG001|Overall Study|Death|1|||
37914057|NCT00597012|69600502|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
37914058|NCT00597012|69600503|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
37914059|NCT00597012|69600502|FG000|Overall Study|Withdrawal by Subject|7|||
37914060|NCT00597012|69600503|FG001|Overall Study|Withdrawal by Subject|4|||
37914061|NCT00597012|69600502|FG000|Overall Study|Ineligible|2|||
37914062|NCT00597012|69600503|FG001|Overall Study|Ineligible|0|||
37914063|NCT00597012|69600502|FG000|Overall Study|Lost to Follow-up|0|||
37914064|NCT00597012|69600503|FG001|Overall Study|Lost to Follow-up|2|||
37914065|NCT00542815|69600514|FG000|Overall Study|Adverse Event|19|||
37914066|NCT00542815|69600515|FG001|Overall Study|Adverse Event|6|||
37914067|NCT00542815|69600516|FG002|Overall Study|Adverse Event|9|||
37914068|NCT00542815|69600514|FG000|Overall Study|Death|10|||
37914069|NCT00542815|69600515|FG001|Overall Study|Death|7|||
37914070|NCT00542815|69600516|FG002|Overall Study|Death|3|||
37914071|NCT00542815|69600514|FG000|Overall Study|Lack of Efficacy|9|||
37914072|NCT00542815|69600515|FG001|Overall Study|Lack of Efficacy|2|||
37914073|NCT00542815|69600516|FG002|Overall Study|Lack of Efficacy|0|||
37914074|NCT00542815|69600514|FG000|Overall Study|Physician Decision|2|||
37914075|NCT00542815|69600515|FG001|Overall Study|Physician Decision|1|||
37914076|NCT00542815|69600516|FG002|Overall Study|Physician Decision|0|||
37914077|NCT00542815|69600514|FG000|Overall Study|Protocol Violation|1|||
37914078|NCT00542815|69600515|FG001|Overall Study|Protocol Violation|1|||
38023182|NCT03099304|69705832|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
38023183|NCT03099304|69705833|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
38023184|NCT03099304|69705834|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
38023185|NCT03099304|69705835|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
38023186|NCT03099304|69705836|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
38023187|NCT03099304|69705837|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
38023188|NCT03099304|69705832|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
38023189|NCT03099304|69705833|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
38023190|NCT03099304|69705834|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
38023191|NCT03099304|69705835|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
38023192|NCT03099304|69705836|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
38023193|NCT03099304|69705837|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
38023194|NCT03099304|69705832|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
38023195|NCT03099304|69705833|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
38023196|NCT03099304|69705834|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
38023197|NCT03099304|69705835|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
38023198|NCT03099304|69705836|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
37914079|NCT00542815|69600516|FG002|Overall Study|Protocol Violation|2|||
37914080|NCT00542815|69600514|FG000|Overall Study|Withdrawal by Subject|41|||
37914081|NCT00542815|69600515|FG001|Overall Study|Withdrawal by Subject|5|||
37914082|NCT00542815|69600516|FG002|Overall Study|Withdrawal by Subject|8|||
37914083|NCT00542815|69600514|FG000|Overall Study|Other reasons|24|||
37914084|NCT00542815|69600515|FG001|Overall Study|Other reasons|10|||
37914085|NCT00542815|69600516|FG002|Overall Study|Other reasons|10|||
37914086|NCT00542425|69600529|FG000|Initial 24 Weeks|Administrative reasons|0|||
37914087|NCT00542425|69600530|FG001|Initial 24 Weeks|Administrative reasons|0|||
38023199|NCT03099304|69705837|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
37914088|NCT00542425|69600531|FG002|Initial 24 Weeks|Administrative reasons|1|||
38023200|NCT03099304|69705832|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
38023201|NCT03099304|69705833|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
38023202|NCT03099304|69705834|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
38023203|NCT03099304|69705835|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
37914089|NCT00542425|69600532|FG003|Initial 24 Weeks|Administrative reasons|1|||
37914090|NCT00542425|69600533|FG004|Initial 24 Weeks|Administrative reasons|0|||
37914091|NCT00542425|69600529|FG000|Initial 24 Weeks|Adverse Event|0|||
37914092|NCT00542425|69600530|FG001|Initial 24 Weeks|Adverse Event|1|||
37914093|NCT00542425|69600531|FG002|Initial 24 Weeks|Adverse Event|1|||
37914094|NCT00542425|69600532|FG003|Initial 24 Weeks|Adverse Event|3|||
37914095|NCT00542425|69600533|FG004|Initial 24 Weeks|Adverse Event|2|||
37914096|NCT00542425|69600529|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
37914097|NCT00542425|69600530|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
37914098|NCT00542425|69600531|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
37914099|NCT00542425|69600532|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
37914100|NCT00542425|69600533|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
37914101|NCT00542425|69600529|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
37914102|NCT00542425|69600530|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
37914103|NCT00542425|69600531|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
37914104|NCT00542425|69600532|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
37914105|NCT00542425|69600533|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
37914106|NCT00542425|69600529|FG000|Initial 24 Weeks|Non-compliance|0|||
37914107|NCT00542425|69600530|FG001|Initial 24 Weeks|Non-compliance|0|||
37914108|NCT00542425|69600531|FG002|Initial 24 Weeks|Non-compliance|0|||
37914109|NCT00542425|69600532|FG003|Initial 24 Weeks|Non-compliance|1|||
37914110|NCT00542425|69600533|FG004|Initial 24 Weeks|Non-compliance|1|||
37914111|NCT00542425|69600529|FG000|Initial 24 Weeks|Protocol Violation|0|||
37914112|NCT00542425|69600530|FG001|Initial 24 Weeks|Protocol Violation|0|||
37914113|NCT00542425|69600531|FG002|Initial 24 Weeks|Protocol Violation|0|||
37914114|NCT00542425|69600532|FG003|Initial 24 Weeks|Protocol Violation|1|||
37914115|NCT00542425|69600533|FG004|Initial 24 Weeks|Protocol Violation|0|||
37914116|NCT00542425|69600529|FG000|Initial 24 Weeks|Refusal of treatment|2|||
37914117|NCT00542425|69600530|FG001|Initial 24 Weeks|Refusal of treatment|2|||
37914118|NCT00542425|69600531|FG002|Initial 24 Weeks|Refusal of treatment|1|||
37914119|NCT00542425|69600532|FG003|Initial 24 Weeks|Refusal of treatment|4|||
37914120|NCT00542425|69600533|FG004|Initial 24 Weeks|Refusal of treatment|1|||
37914121|NCT00542425|69600529|FG000|Initial 24 Weeks|Other|0|||
37914122|NCT00542425|69600530|FG001|Initial 24 Weeks|Other|2|||
37914123|NCT00542425|69600531|FG002|Initial 24 Weeks|Other|1|||
37914124|NCT00542425|69600532|FG003|Initial 24 Weeks|Other|0|||
37914125|NCT00542425|69600533|FG004|Initial 24 Weeks|Other|0|||
37914126|NCT00542425|69600529|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
37914127|NCT00542425|69600530|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
37914128|NCT00542425|69600531|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
37914129|NCT00542425|69600532|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
37914130|NCT00542425|69600533|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
37914131|NCT00542425|69600529|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
37914132|NCT00542425|69600530|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
37914133|NCT00542425|69600531|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
37914134|NCT00542425|69600532|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
37914135|NCT00542425|69600533|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
37914136|NCT00542425|69600529|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
37914137|NCT00542425|69600530|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
37914138|NCT00542425|69600531|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
37914139|NCT00542425|69600532|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
38023204|NCT03099304|69705836|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
38023205|NCT03099304|69705837|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
38023206|NCT03099304|69705832|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
38023207|NCT03099304|69705833|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
38023208|NCT03099304|69705834|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
38023209|NCT03099304|69705835|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
37914140|NCT00542425|69600533|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
37914141|NCT00542425|69600529|FG000|Extended 24 Weeks of Treatment|Other|1|||
37914142|NCT00542425|69600530|FG001|Extended 24 Weeks of Treatment|Other|1|||
37914143|NCT00542425|69600531|FG002|Extended 24 Weeks of Treatment|Other|0|||
37700550|NCT02355665|69177641|FG001|Overall Study|Protocol Violation|0|||
37914144|NCT00542425|69600532|FG003|Extended 24 Weeks of Treatment|Other|0|||
37914145|NCT00542425|69600533|FG004|Extended 24 Weeks of Treatment|Other|1|||
37914146|NCT00541099|69600545|FG000|Overall Study|Ineligible|3|||
37914147|NCT00580606|69600551|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
37914148|NCT00580606|69600552|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
37914149|NCT00580606|69600551|FG000|Open Label (OL)|Withdrawal by Subject|4|||
37914150|NCT00580606|69600552|FG001|Open Label (OL)|Withdrawal by Subject|6|||
37914151|NCT00580606|69600551|FG000|Open Label (OL)|Dosing Symptoms|0|||
37914152|NCT00580606|69600552|FG001|Open Label (OL)|Dosing Symptoms|1|||
37914153|NCT00580606|69600551|FG000|Open Label (OL)|Lost to Follow-up|0|||
37914154|NCT00580606|69600552|FG001|Open Label (OL)|Lost to Follow-up|1|||
37914155|NCT00580606|69600551|FG000|Open Label (OL)|Pregnancy|0|||
37914156|NCT00580606|69600552|FG001|Open Label (OL)|Pregnancy|1|||
37914157|NCT00580606|69600551|FG000|Open Label (OL)|Non-compliance|2|||
37914158|NCT00580606|69600552|FG001|Open Label (OL)|Non-compliance|0|||
37914159|NCT00580606|69600551|FG000|Open Label (OL)|Physician Decision|1|||
37914160|NCT00580606|69600552|FG001|Open Label (OL)|Physician Decision|1|||
37914161|NCT00580606|69600551|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
37914162|NCT00580606|69600552|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
37914163|NCT00579982|69600566|FG000|Overall Study|Adverse Event|4|||
37914164|NCT00579982|69600566|FG000|Overall Study|Protocol Violation|4|||
37914165|NCT00596466|69600570|FG000|Overall Study|Lack of Efficacy|5|||
37914166|NCT00596466|69600570|FG000|Overall Study|Adverse Event|4|||
37914167|NCT00596466|69600570|FG000|Overall Study|Withdrawal by Subject|2|||
37914168|NCT00596466|69600570|FG000|Overall Study|Protocol Violation|2|||
37914169|NCT00596466|69600570|FG000|Overall Study|Unpecified|2|||
37914170|NCT00596466|69600570|FG000|Overall Study|Enrolled, not treated|2|||
37914171|NCT00596934|69600574|FG000|Overall Study|Protocol Violation|1|||
37914172|NCT00596934|69600574|FG000|Overall Study|Withdrawal by Subject|1|||
37914173|NCT03911401|69600583|FG000|Overall Study|Adverse Event|1|||
37914174|NCT03911401|69600584|FG001|Overall Study|Adverse Event|2|||
37914175|NCT03911401|69600585|FG002|Overall Study|Adverse Event|5|||
37914176|NCT03911401|69600583|FG000|Overall Study|Lack of Efficacy|1|||
37914177|NCT03911401|69600584|FG001|Overall Study|Lack of Efficacy|1|||
37914178|NCT03911401|69600585|FG002|Overall Study|Lack of Efficacy|8|||
37914179|NCT03911401|69600583|FG000|Overall Study|Physician Decision|0|||
37914180|NCT03911401|69600584|FG001|Overall Study|Physician Decision|0|||
37914181|NCT03911401|69600585|FG002|Overall Study|Physician Decision|1|||
37914182|NCT03911401|69600583|FG000|Overall Study|Withdrawal by Subject|1|||
37914183|NCT03911401|69600584|FG001|Overall Study|Withdrawal by Subject|2|||
37914184|NCT03911401|69600585|FG002|Overall Study|Withdrawal by Subject|0|||
37914185|NCT03911401|69600583|FG000|Overall Study|Withdrawal by parent/guardian|4|||
37914186|NCT03911401|69600584|FG001|Overall Study|Withdrawal by parent/guardian|4|||
37914187|NCT03911401|69600585|FG002|Overall Study|Withdrawal by parent/guardian|11|||
37914188|NCT00579670|69600598|FG000|Overall Study|Death|1|||
37914189|NCT00579670|69600599|FG001|Overall Study|Death|0|||
37914190|NCT00579670|69600600|FG002|Overall Study|Death|0|||
37914191|NCT00579670|69600601|FG003|Overall Study|Death|0|||
37914192|NCT00579670|69600602|FG004|Overall Study|Death|0|||
37914193|NCT00579670|69600598|FG000|Overall Study|Adverse Event|1|||
37914194|NCT00579670|69600599|FG001|Overall Study|Adverse Event|0|||
37914195|NCT00579670|69600600|FG002|Overall Study|Adverse Event|1|||
37914196|NCT00579670|69600601|FG003|Overall Study|Adverse Event|2|||
37914197|NCT00579670|69600602|FG004|Overall Study|Adverse Event|0|||
37914198|NCT00579670|69600598|FG000|Overall Study|Lack of Efficacy|0|||
37914199|NCT00579670|69600599|FG001|Overall Study|Lack of Efficacy|0|||
37914200|NCT00579670|69600600|FG002|Overall Study|Lack of Efficacy|1|||
37914201|NCT00579670|69600601|FG003|Overall Study|Lack of Efficacy|14|||
37914202|NCT00579670|69600602|FG004|Overall Study|Lack of Efficacy|0|||
37914203|NCT00579670|69600598|FG000|Overall Study|Lost to Follow-up|0|||
37914204|NCT00579670|69600599|FG001|Overall Study|Lost to Follow-up|1|||
37914205|NCT00579670|69600600|FG002|Overall Study|Lost to Follow-up|0|||
37914206|NCT00579670|69600601|FG003|Overall Study|Lost to Follow-up|4|||
37914207|NCT00579670|69600602|FG004|Overall Study|Lost to Follow-up|0|||
37914208|NCT00579670|69600598|FG000|Overall Study|Other|0|||
37914209|NCT00579670|69600599|FG001|Overall Study|Other|0|||
37914210|NCT00579670|69600600|FG002|Overall Study|Other|1|||
37914211|NCT00579670|69600601|FG003|Overall Study|Other|2|||
37914212|NCT00579670|69600602|FG004|Overall Study|Other|0|||
37914213|NCT00579670|69600598|FG000|Overall Study|Withdrawal by Subject|0|||
37914214|NCT00579670|69600599|FG001|Overall Study|Withdrawal by Subject|0|||
37914215|NCT00579670|69600600|FG002|Overall Study|Withdrawal by Subject|1|||
37914216|NCT00579670|69600601|FG003|Overall Study|Withdrawal by Subject|0|||
37914217|NCT00579670|69600602|FG004|Overall Study|Withdrawal by Subject|0|||
37914218|NCT03909295|69600626|FG000|Overall Study|Adverse Event|2|||
37914219|NCT03909295|69600626|FG000|Overall Study|Study terminated by sponsor|50|||
37914220|NCT00599924|69600637|FG000|Overall Study|Lack of Efficacy|3|||
37914221|NCT00599924|69600638|FG001|Overall Study|Lack of Efficacy|5|||
37914222|NCT00599924|69600639|FG002|Overall Study|Lack of Efficacy|1|||
37914223|NCT00599924|69600640|FG003|Overall Study|Lack of Efficacy|2|||
37914224|NCT00599924|69600641|FG004|Overall Study|Lack of Efficacy|3|||
37914225|NCT00599924|69600642|FG005|Overall Study|Lack of Efficacy|2|||
37914226|NCT00599924|69600643|FG006|Overall Study|Lack of Efficacy|0|||
37914227|NCT00599924|69600637|FG000|Overall Study|Adverse Event|0|||
37914228|NCT00599924|69600638|FG001|Overall Study|Adverse Event|0|||
37914229|NCT00599924|69600639|FG002|Overall Study|Adverse Event|0|||
37914230|NCT00599924|69600640|FG003|Overall Study|Adverse Event|2|||
37914231|NCT00599924|69600641|FG004|Overall Study|Adverse Event|0|||
37914232|NCT00599924|69600642|FG005|Overall Study|Adverse Event|0|||
37914233|NCT00599924|69600643|FG006|Overall Study|Adverse Event|2|||
37914234|NCT00599924|69600637|FG000|Overall Study|Death|0|||
37914235|NCT00599924|69600638|FG001|Overall Study|Death|0|||
37914236|NCT00599924|69600639|FG002|Overall Study|Death|0|||
37914237|NCT00599924|69600640|FG003|Overall Study|Death|2|||
37914238|NCT00599924|69600641|FG004|Overall Study|Death|0|||
37914239|NCT00599924|69600642|FG005|Overall Study|Death|2|||
37914240|NCT00599924|69600643|FG006|Overall Study|Death|1|||
37914241|NCT00599924|69600637|FG000|Overall Study|Protocol Violation|0|||
37914242|NCT00599924|69600638|FG001|Overall Study|Protocol Violation|0|||
37914243|NCT00599924|69600639|FG002|Overall Study|Protocol Violation|0|||
37914244|NCT00599924|69600640|FG003|Overall Study|Protocol Violation|1|||
37914245|NCT00599924|69600641|FG004|Overall Study|Protocol Violation|0|||
37914246|NCT00599924|69600642|FG005|Overall Study|Protocol Violation|0|||
37914247|NCT00599924|69600643|FG006|Overall Study|Protocol Violation|0|||
37914248|NCT00599924|69600637|FG000|Overall Study|Withdrawal by Subject|0|||
37914249|NCT00599924|69600638|FG001|Overall Study|Withdrawal by Subject|0|||
37914250|NCT00599924|69600639|FG002|Overall Study|Withdrawal by Subject|1|||
37914251|NCT00599924|69600640|FG003|Overall Study|Withdrawal by Subject|0|||
37914252|NCT00599924|69600641|FG004|Overall Study|Withdrawal by Subject|1|||
37914253|NCT00599924|69600642|FG005|Overall Study|Withdrawal by Subject|0|||
37914254|NCT00599924|69600643|FG006|Overall Study|Withdrawal by Subject|0|||
37914255|NCT00599924|69600637|FG000|Overall Study|Other|0|||
37914256|NCT00599924|69600638|FG001|Overall Study|Other|0|||
37914257|NCT00599924|69600639|FG002|Overall Study|Other|0|||
37914258|NCT00599924|69600640|FG003|Overall Study|Other|1|||
37914259|NCT00599924|69600641|FG004|Overall Study|Other|2|||
37914260|NCT00599924|69600642|FG005|Overall Study|Other|0|||
37914261|NCT00599924|69600643|FG006|Overall Study|Other|2|||
37914262|NCT00581542|69600666|FG000|Overall Study|they met an exclusion criteria|2|||
37914263|NCT00581542|69600667|FG001|Overall Study|they met an exclusion criteria|2|||
37914264|NCT00581542|69600666|FG000|Overall Study|Lost to Follow-up|9|||
37914265|NCT00581542|69600667|FG001|Overall Study|Lost to Follow-up|21|||
37914266|NCT03912337|69600677|FG000|Overall Study|Withdrawal of Consent From Study|1|||
37914267|NCT03912337|69600678|FG001|Overall Study|Withdrawal of Consent From Study|0|||
37914268|NCT03912337|69600677|FG000|Overall Study|Lost to Follow-up|1|||
37914269|NCT03912337|69600678|FG001|Overall Study|Lost to Follow-up|1|||
37914270|NCT03912259|69600686|FG000|Overall Study|Adverse Event (AE)|2|||
37914271|NCT03912259|69600687|FG001|Overall Study|Adverse Event (AE)|4|||
37914272|NCT03912259|69600686|FG000|Overall Study|Lack of Efficacy|4|||
37914273|NCT03912259|69600687|FG001|Overall Study|Lack of Efficacy|1|||
37914274|NCT03912259|69600686|FG000|Overall Study|Withdrawal by Subject|11|||
37914275|NCT03912259|69600687|FG001|Overall Study|Withdrawal by Subject|1|||
37914276|NCT02121652|69600696|FG000|Overall Study|Lost to Follow-up|2|||
37914277|NCT02121652|69600697|FG001|Overall Study|Lost to Follow-up|1|||
37914278|NCT02121652|69600696|FG000|Overall Study|Death|1|||
37914279|NCT02121652|69600697|FG001|Overall Study|Death|0|||
37914280|NCT02121652|69600696|FG000|Overall Study|Withdrawal by Subject|3|||
37914281|NCT02121652|69600697|FG001|Overall Study|Withdrawal by Subject|3|||
37914282|NCT00595920|69600703|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
37914283|NCT00595764|69600709|FG000|Overall Study|Protocol Violation|24|||
37914284|NCT00595764|69600710|FG001|Overall Study|Protocol Violation|19|||
37914285|NCT00595764|69600709|FG000|Overall Study|Missed Medication >1 week|10|||
37914286|NCT00595764|69600710|FG001|Overall Study|Missed Medication >1 week|17|||
37914287|NCT00595764|69600709|FG000|Overall Study|Missed 3 PM visits|1|||
37914288|NCT00595764|69600710|FG001|Overall Study|Missed 3 PM visits|7|||
37914289|NCT00595764|69600709|FG000|Overall Study|Withdrawal by Subject|4|||
37914290|NCT00595764|69600710|FG001|Overall Study|Withdrawal by Subject|0|||
37914291|NCT00581308|69600730|FG000|Pre Discharge|Lost to Follow-up|1|||
37914292|NCT00581308|69600730|FG000|Pre Discharge|Device Removed|1|||
37914293|NCT00581308|69600730|FG000|Month 1|Lost to Follow-up|3|||
37914294|NCT00581308|69600730|FG000|Month 1|Withdrawal by Subject|2|||
37914295|NCT00581308|69600730|FG000|Month 1|Device Removed|2|||
37914296|NCT00581308|69600730|FG000|Month 1|Uknown|1|||
37914297|NCT00581308|69600730|FG000|Month 6|Lost to Follow-up|1|||
37914298|NCT00581308|69600730|FG000|Month 6|Withdrawal by Subject|2|||
37914299|NCT00581308|69600730|FG000|Month 12|Death|1|||
37914300|NCT00581308|69600730|FG000|Month 12|Lost to Follow-up|14|||
37914301|NCT00581308|69600730|FG000|Month 12|Withdrawal by Subject|3|||
37914302|NCT00581308|69600730|FG000|Month 12|Device Removed|1|||
37914303|NCT00581308|69600730|FG000|Month 12|Other|1|||
37914304|NCT00877890|69600739|FG000|Overall Study|Adverse Event|6|||
37914305|NCT00877890|69600740|FG001|Overall Study|Adverse Event|6|||
37914306|NCT00877890|69600739|FG000|Overall Study|Lost to Follow-up|5|||
37914307|NCT00877890|69600740|FG001|Overall Study|Lost to Follow-up|5|||
37914308|NCT00877890|69600739|FG000|Overall Study|Protocol Violation|0|||
37914309|NCT00877890|69600740|FG001|Overall Study|Protocol Violation|1|||
37914310|NCT00877890|69600739|FG000|Overall Study|Withdrawal of Consent|6|||
37914311|NCT00877890|69600740|FG001|Overall Study|Withdrawal of Consent|12|||
37914312|NCT00877890|69600739|FG000|Overall Study|Investigator Decision|0|||
37914313|NCT00877890|69600740|FG001|Overall Study|Investigator Decision|2|||
37914314|NCT00877890|69600739|FG000|Overall Study|Loss of Glucose Control|3|||
37914315|NCT00877890|69600740|FG001|Overall Study|Loss of Glucose Control|4|||
37914316|NCT03474679|69600750|FG000|Overall Study|Death|7|||
37914317|NCT03474679|69600750|FG000|Overall Study|Withdrawal by Subject|1|||
37914318|NCT03472885|69600754|FG000|Overall Study|Adverse Event|1|||
37914319|NCT03905863|69600760|FG000|Overall Study|Adverse Event|2|||
37914320|NCT03905863|69600761|FG001|Overall Study|Adverse Event|4|||
37914321|NCT03905863|69600760|FG000|Overall Study|Withdrawal by Subject|2|||
37914322|NCT03905863|69600761|FG001|Overall Study|Withdrawal by Subject|2|||
37914323|NCT03905863|69600760|FG000|Overall Study|Physician Decision|0|||
37914324|NCT03905863|69600761|FG001|Overall Study|Physician Decision|3|||
37914325|NCT03905863|69600760|FG000|Overall Study|Lost to Follow-up|1|||
37914326|NCT03905863|69600761|FG001|Overall Study|Lost to Follow-up|0|||
37914327|NCT03905863|69600760|FG000|Overall Study|Protocol Violation|0|||
37914328|NCT03905863|69600761|FG001|Overall Study|Protocol Violation|2|||
37914329|NCT03905863|69600760|FG000|Overall Study|Death|0|||
37914330|NCT03905863|69600761|FG001|Overall Study|Death|1|||
38023210|NCT03099304|69705836|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
38023211|NCT03099304|69705837|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
38023212|NCT03099304|69705832|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
38023213|NCT03099304|69705833|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
38023214|NCT03099304|69705834|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
38023215|NCT03099304|69705835|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
38023216|NCT03099304|69705836|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
37700551|NCT02355665|69177640|FG000|Overall Study|Withdrawal by Subject|90|||
37914331|NCT04067011|69600770|FG000|Overall Study|Not Treated|8|||
37914332|NCT04067011|69600771|FG001|Overall Study|Not Treated|7|||
37914333|NCT04067011|69600772|FG002|Overall Study|Not Treated|5|||
37914334|NCT04067011|69600770|FG000|Overall Study|Adverse Event|2|||
37914335|NCT04067011|69600771|FG001|Overall Study|Adverse Event|1|||
37914336|NCT04067011|69600772|FG002|Overall Study|Adverse Event|0|||
37700552|NCT02355665|69177641|FG001|Overall Study|Withdrawal by Subject|100|||
37914337|NCT04067011|69600770|FG000|Overall Study|Withdrawal by Subject|6|||
37914338|NCT04067011|69600771|FG001|Overall Study|Withdrawal by Subject|2|||
37914339|NCT04067011|69600772|FG002|Overall Study|Withdrawal by Subject|1|||
37914340|NCT04067011|69600770|FG000|Overall Study|Lost to Follow-up|0|||
37914341|NCT04067011|69600771|FG001|Overall Study|Lost to Follow-up|0|||
37914342|NCT04067011|69600772|FG002|Overall Study|Lost to Follow-up|1|||
37914343|NCT04067011|69600770|FG000|Overall Study|Physician Decision|1|||
37914344|NCT04067011|69600771|FG001|Overall Study|Physician Decision|1|||
37914345|NCT04067011|69600772|FG002|Overall Study|Physician Decision|0|||
37914346|NCT04067011|69600770|FG000|Overall Study|Other Reasons|2|||
37914347|NCT04067011|69600771|FG001|Overall Study|Other Reasons|0|||
37914348|NCT04067011|69600772|FG002|Overall Study|Other Reasons|1|||
37914349|NCT04067011|69600770|FG000|Overall Study|Missing|0|||
37914350|NCT04067011|69600771|FG001|Overall Study|Missing|2|||
37914351|NCT04067011|69600772|FG002|Overall Study|Missing|0|||
38023217|NCT03099304|69705837|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
38023218|NCT03099304|69705832|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
37914352|NCT00539305|69600816|FG000|Overall Study|Adverse Event|1|||
37914353|NCT00539305|69600817|FG001|Overall Study|Adverse Event|0|||
37914354|NCT00539305|69600816|FG000|Overall Study|Substance Use|0|||
37914355|NCT00539305|69600817|FG001|Overall Study|Substance Use|1|||
37914356|NCT00539305|69600816|FG000|Overall Study|Withdrawal by Subject|0|||
37914357|NCT00539305|69600817|FG001|Overall Study|Withdrawal by Subject|1|||
37914358|NCT04469465|69600844|FG000|Overall Study|Adverse Event|2|||
37914359|NCT04469465|69600845|FG001|Overall Study|Adverse Event|1|||
37914360|NCT04469465|69600844|FG000|Overall Study|Ongoing treatment|7|||
37914361|NCT04469465|69600845|FG001|Overall Study|Ongoing treatment|4|||
37914362|NCT04469465|69600844|FG000|Overall Study|Withdrawal by Subject|0|||
37914363|NCT04469465|69600845|FG001|Overall Study|Withdrawal by Subject|1|||
37914364|NCT00877032|69600858|FG000|Overall Study|Did not meet entrance criteria|0|||
37914365|NCT00877032|69600859|FG001|Overall Study|Did not meet entrance criteria|0|||
37914366|NCT00877032|69600860|FG002|Overall Study|Did not meet entrance criteria|0|||
37914367|NCT00877032|69600861|FG003|Overall Study|Did not meet entrance criteria|1|||
37914368|NCT00877032|69600862|FG004|Overall Study|Did not meet entrance criteria|0|||
37914369|NCT00877032|69600863|FG005|Overall Study|Did not meet entrance criteria|0|||
37914370|NCT00877032|69600864|FG006|Overall Study|Did not meet entrance criteria|2|||
37914371|NCT00538681|69600903|FG000|Overall Study|Progressive Disease|7|||
37914372|NCT00538681|69600904|FG001|Overall Study|Progressive Disease|0|||
37914373|NCT00538681|69600905|FG002|Overall Study|Progressive Disease|1|||
37914374|NCT00538681|69600906|FG003|Overall Study|Progressive Disease|0|||
37914375|NCT00538681|69600903|FG000|Overall Study|Sponsor Decision|1|||
37914376|NCT00538681|69600904|FG001|Overall Study|Sponsor Decision|3|||
37914377|NCT00538681|69600905|FG002|Overall Study|Sponsor Decision|8|||
37914378|NCT00538681|69600906|FG003|Overall Study|Sponsor Decision|9|||
37914379|NCT00538681|69600903|FG000|Overall Study|Adverse Event|1|||
37914380|NCT00538681|69600904|FG001|Overall Study|Adverse Event|1|||
38023219|NCT03099304|69705833|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
38023220|NCT03099304|69705834|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
38023221|NCT03099304|69705835|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
38023222|NCT03099304|69705836|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
38023223|NCT03099304|69705837|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
38023224|NCT03099304|69705832|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
37914381|NCT00538681|69600905|FG002|Overall Study|Adverse Event|1|||
37914382|NCT00538681|69600906|FG003|Overall Study|Adverse Event|0|||
38023225|NCT03099304|69705833|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
38023226|NCT03099304|69705834|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
37914383|NCT00538681|69600903|FG000|Overall Study|Death|0|||
37914384|NCT00538681|69600904|FG001|Overall Study|Death|0|||
37914385|NCT00538681|69600905|FG002|Overall Study|Death|1|||
37914386|NCT00538681|69600906|FG003|Overall Study|Death|1|||
37914387|NCT00538681|69600903|FG000|Overall Study|Investigator Decision|0|||
37914388|NCT00538681|69600904|FG001|Overall Study|Investigator Decision|0|||
37914389|NCT00538681|69600905|FG002|Overall Study|Investigator Decision|0|||
37914390|NCT00538681|69600906|FG003|Overall Study|Investigator Decision|1|||
37914391|NCT00876018|69600920|FG000|Overall Study|Lost to Follow-up|0|||
37914392|NCT00876018|69600921|FG001|Overall Study|Lost to Follow-up|1|||
38023227|NCT03099304|69705835|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
38023228|NCT03099304|69705836|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
38023229|NCT03099304|69705837|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
37914393|NCT00876018|69600922|FG002|Overall Study|Lost to Follow-up|1|||
37914394|NCT00876018|69600920|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
37914395|NCT00876018|69600921|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
37914396|NCT00876018|69600922|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
37914397|NCT03885934|69600947|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
37914398|NCT03885934|69600948|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
37914399|NCT03885934|69600949|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
37914400|NCT03885934|69600950|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
37914401|NCT03885934|69600951|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
37914402|NCT03885934|69600952|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
37914403|NCT00875706|69600969|FG000|Overall Study|Withdrawal by Subject|1|||
37914404|NCT00875706|69600970|FG001|Overall Study|Withdrawal by Subject|0|||
37914405|NCT00875706|69600971|FG002|Overall Study|Withdrawal by Subject|0|||
37914406|NCT04399889|69600982|FG000|Overall Study|Death|5|||
37914407|NCT04399889|69600983|FG001|Overall Study|Death|1|||
37914408|NCT04399889|69600984|FG002|Overall Study|Death|1|||
37914409|NCT00837265|69600999|FG000|Pilot Phase|Withdrawal by Subject|0|||
37914410|NCT00837265|69601000|FG001|Pilot Phase|Withdrawal by Subject|2|||
37914411|NCT00837265|69601001|FG002|Pilot Phase|Withdrawal by Subject|3|||
37914412|NCT00837265|69601002|FG003|Pilot Phase|Withdrawal by Subject|2|||
37914413|NCT00837265|69601003|FG004|Pilot Phase|Withdrawal by Subject|0|||
37914414|NCT00837265|69601004|FG005|Pilot Phase|Withdrawal by Subject|0|||
37914415|NCT00837265|69601005|FG006|Pilot Phase|Withdrawal by Subject|0|||
37914416|NCT00837265|69600999|FG000|Pilot Phase|Decision of the investigator|2|||
37914417|NCT00837265|69601000|FG001|Pilot Phase|Decision of the investigator|1|||
37914418|NCT00837265|69601001|FG002|Pilot Phase|Decision of the investigator|0|||
37914419|NCT00837265|69601002|FG003|Pilot Phase|Decision of the investigator|0|||
37914420|NCT00837265|69601003|FG004|Pilot Phase|Decision of the investigator|0|||
37914421|NCT00837265|69601004|FG005|Pilot Phase|Decision of the investigator|0|||
37914422|NCT00837265|69601005|FG006|Pilot Phase|Decision of the investigator|0|||
37914423|NCT00837265|69600999|FG000|Pilot Phase|Adverse Event|1|||
37914424|NCT00837265|69601000|FG001|Pilot Phase|Adverse Event|0|||
37914425|NCT00837265|69601001|FG002|Pilot Phase|Adverse Event|0|||
37914426|NCT00837265|69601002|FG003|Pilot Phase|Adverse Event|0|||
37914427|NCT00837265|69601003|FG004|Pilot Phase|Adverse Event|0|||
37914428|NCT00837265|69601004|FG005|Pilot Phase|Adverse Event|0|||
37914429|NCT00837265|69601005|FG006|Pilot Phase|Adverse Event|0|||
37914430|NCT00837265|69600999|FG000|Pilot Phase|Disease progression|0|||
37914431|NCT00837265|69601000|FG001|Pilot Phase|Disease progression|0|||
37914432|NCT00837265|69601001|FG002|Pilot Phase|Disease progression|0|||
37914433|NCT00837265|69601002|FG003|Pilot Phase|Disease progression|1|||
37914434|NCT00837265|69601003|FG004|Pilot Phase|Disease progression|0|||
37914435|NCT00837265|69601004|FG005|Pilot Phase|Disease progression|0|||
37914436|NCT00837265|69601005|FG006|Pilot Phase|Disease progression|0|||
37914437|NCT00837265|69600999|FG000|Pilot Phase|Participant left the city|0|||
37914438|NCT00837265|69601000|FG001|Pilot Phase|Participant left the city|0|||
37914439|NCT00837265|69601001|FG002|Pilot Phase|Participant left the city|0|||
37914440|NCT00837265|69601002|FG003|Pilot Phase|Participant left the city|1|||
37914441|NCT00837265|69601003|FG004|Pilot Phase|Participant left the city|0|||
37914442|NCT00837265|69601004|FG005|Pilot Phase|Participant left the city|0|||
37914443|NCT00837265|69601005|FG006|Pilot Phase|Participant left the city|0|||
37914444|NCT00837265|69600999|FG000|Main Phase|Withdrawal by Subject|0|||
37914445|NCT00837265|69601000|FG001|Main Phase|Withdrawal by Subject|0|||
37914446|NCT00837265|69601001|FG002|Main Phase|Withdrawal by Subject|0|||
37914447|NCT00837265|69601002|FG003|Main Phase|Withdrawal by Subject|0|||
37914448|NCT00837265|69601003|FG004|Main Phase|Withdrawal by Subject|4|||
37914449|NCT00837265|69601004|FG005|Main Phase|Withdrawal by Subject|2|||
37914450|NCT00837265|69601005|FG006|Main Phase|Withdrawal by Subject|1|||
37914451|NCT00837265|69600999|FG000|Main Phase|Decision of the investigator|0|||
37914452|NCT00837265|69601000|FG001|Main Phase|Decision of the investigator|0|||
37914453|NCT00837265|69601001|FG002|Main Phase|Decision of the investigator|0|||
37914454|NCT00837265|69601002|FG003|Main Phase|Decision of the investigator|0|||
37914455|NCT00837265|69601003|FG004|Main Phase|Decision of the investigator|0|||
37914456|NCT00837265|69601004|FG005|Main Phase|Decision of the investigator|2|||
37914457|NCT00837265|69601005|FG006|Main Phase|Decision of the investigator|1|||
37914458|NCT00837265|69600999|FG000|Main Phase|Adverse Event|0|||
37914459|NCT00837265|69601000|FG001|Main Phase|Adverse Event|0|||
37914460|NCT00837265|69601001|FG002|Main Phase|Adverse Event|0|||
37914461|NCT00837265|69601002|FG003|Main Phase|Adverse Event|0|||
37914462|NCT00837265|69601003|FG004|Main Phase|Adverse Event|0|||
37914463|NCT00837265|69601004|FG005|Main Phase|Adverse Event|1|||
37914464|NCT00837265|69601005|FG006|Main Phase|Adverse Event|0|||
37914465|NCT00837265|69600999|FG000|Main Phase|Death|0|||
37914466|NCT00837265|69601000|FG001|Main Phase|Death|0|||
37914467|NCT00837265|69601001|FG002|Main Phase|Death|0|||
37914468|NCT00837265|69601002|FG003|Main Phase|Death|0|||
37914469|NCT00837265|69601003|FG004|Main Phase|Death|2|||
37914470|NCT00837265|69601004|FG005|Main Phase|Death|0|||
37914471|NCT00837265|69601005|FG006|Main Phase|Death|1|||
37914472|NCT00837265|69600999|FG000|Main Phase|Lost to Follow-up|0|||
37914473|NCT00837265|69601000|FG001|Main Phase|Lost to Follow-up|0|||
37914474|NCT00837265|69601001|FG002|Main Phase|Lost to Follow-up|0|||
37914475|NCT00837265|69601002|FG003|Main Phase|Lost to Follow-up|0|||
37914476|NCT00837265|69601003|FG004|Main Phase|Lost to Follow-up|1|||
37914477|NCT00837265|69601004|FG005|Main Phase|Lost to Follow-up|0|||
37914478|NCT00837265|69601005|FG006|Main Phase|Lost to Follow-up|0|||
37914479|NCT00837265|69600999|FG000|Main Phase|Principal investigator resignation|0|||
37914480|NCT00837265|69601000|FG001|Main Phase|Principal investigator resignation|0|||
38023230|NCT03099304|69705832|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
38023231|NCT03099304|69705833|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
38023232|NCT03099304|69705834|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
38023233|NCT03099304|69705835|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
38023234|NCT03099304|69705836|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
38023235|NCT03099304|69705837|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
38023236|NCT03097588|69705864|FG000|Overall Study|Adverse Event|1|||
38023237|NCT01631214|69705870|FG000|Overall Study|Withdrawal by Subject|276|||
38023238|NCT01631214|69705871|FG001|Overall Study|Withdrawal by Subject|290|||
38023239|NCT01631214|69705870|FG000|Overall Study|Death|113|||
38023240|NCT01631214|69705871|FG001|Overall Study|Death|106|||
38023241|NCT01631214|69705870|FG000|Overall Study|Lost to Follow-up|54|||
38023242|NCT01631214|69705871|FG001|Overall Study|Lost to Follow-up|40|||
38023243|NCT01631214|69705870|FG000|Overall Study|Adverse Event|45|||
38023244|NCT01631214|69705871|FG001|Overall Study|Adverse Event|45|||
37914481|NCT00837265|69601001|FG002|Main Phase|Principal investigator resignation|0|||
37914482|NCT00837265|69601002|FG003|Main Phase|Principal investigator resignation|0|||
37914483|NCT00837265|69601003|FG004|Main Phase|Principal investigator resignation|2|||
37914484|NCT00837265|69601004|FG005|Main Phase|Principal investigator resignation|0|||
37914485|NCT00837265|69601005|FG006|Main Phase|Principal investigator resignation|0|||
37835958|NCT01215955|69520229|FG002|Overall Study|Quality Issues|3|||
37835959|NCT01215955|69520230|FG003|Overall Study|Quality Issues|2|||
37700553|NCT02355665|69177640|FG000|Overall Study|Lost to Follow-up|131|||
37700554|NCT02355665|69177641|FG001|Overall Study|Lost to Follow-up|103|||
37700555|NCT02355665|69177640|FG000|Overall Study|Death|4|||
37700556|NCT02355665|69177641|FG001|Overall Study|Death|2|||
37835960|NCT01215916|69520265|FG000|Overall Study|Progressive Disease|0|||
37835961|NCT01215916|69520266|FG001|Overall Study|Progressive Disease|2|||
37835962|NCT01215916|69520267|FG002|Overall Study|Progressive Disease|1|||
37835963|NCT01215916|69520268|FG003|Overall Study|Progressive Disease|2|||
37835964|NCT01215916|69520269|FG004|Overall Study|Progressive Disease|5|||
37835965|NCT01215916|69520270|FG005|Overall Study|Progressive Disease|4|||
37835966|NCT01215916|69520271|FG006|Overall Study|Progressive Disease|5|||
37835967|NCT01215916|69520272|FG007|Overall Study|Progressive Disease|3|||
37835968|NCT01215916|69520273|FG008|Overall Study|Progressive Disease|1|||
37835969|NCT01215916|69520265|FG000|Overall Study|Adverse Event|1|||
37835970|NCT01215916|69520266|FG001|Overall Study|Adverse Event|1|||
37835971|NCT01215916|69520267|FG002|Overall Study|Adverse Event|0|||
37835972|NCT01215916|69520268|FG003|Overall Study|Adverse Event|1|||
37835973|NCT01215916|69520269|FG004|Overall Study|Adverse Event|0|||
37835974|NCT01215916|69520270|FG005|Overall Study|Adverse Event|0|||
37700557|NCT02355665|69177640|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
37700558|NCT02355665|69177641|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
37700559|NCT02010255|69177661|FG000|Overall Study|Death|0|||
37700560|NCT02010255|69177662|FG001|Overall Study|Death|1|||
37700561|NCT02010255|69177663|FG002|Overall Study|Death|4|||
37700562|NCT02010255|69177664|FG003|Overall Study|Death|4|||
37835975|NCT01215916|69520271|FG006|Overall Study|Adverse Event|3|||
37835976|NCT01215916|69520272|FG007|Overall Study|Adverse Event|0|||
37914486|NCT00837265|69600999|FG000|Main Phase|Participant's personal reason|0|||
37914487|NCT00837265|69601000|FG001|Main Phase|Participant's personal reason|0|||
37914488|NCT00837265|69601001|FG002|Main Phase|Participant's personal reason|0|||
37700563|NCT02010255|69177665|FG004|Overall Study|Death|2|||
37835977|NCT01215916|69520273|FG008|Overall Study|Adverse Event|0|||
37835978|NCT01215916|69520265|FG000|Overall Study|Withdrawal by Subject|0|||
37835979|NCT01215916|69520266|FG001|Overall Study|Withdrawal by Subject|1|||
37914489|NCT00837265|69601002|FG003|Main Phase|Participant's personal reason|0|||
37914490|NCT00837265|69601003|FG004|Main Phase|Participant's personal reason|1|||
37700564|NCT02010255|69177666|FG005|Overall Study|Death|0|||
37835980|NCT01215916|69520267|FG002|Overall Study|Withdrawal by Subject|1|||
38023245|NCT01631214|69705870|FG000|Overall Study|Other|22|||
38023246|NCT01631214|69705871|FG001|Overall Study|Other|19|||
38023247|NCT01631214|69705870|FG000|Overall Study|Noncompliance|16|||
38023248|NCT01631214|69705871|FG001|Overall Study|Noncompliance|15|||
38023249|NCT01631214|69705870|FG000|Overall Study|Requirement for Alternative Therapy|8|||
38023250|NCT01631214|69705871|FG001|Overall Study|Requirement for Alternative Therapy|3|||
38023251|NCT01631214|69705870|FG000|Overall Study|Protocol Deviation|4|||
38023252|NCT01631214|69705871|FG001|Overall Study|Protocol Deviation|3|||
38023253|NCT01631214|69705870|FG000|Overall Study|Ineligibility determined|5|||
38023254|NCT01631214|69705871|FG001|Overall Study|Ineligibility determined|2|||
38023255|NCT01631214|69705870|FG000|Overall Study|Administrative Decision|1|||
37914491|NCT00837265|69601004|FG005|Main Phase|Participant's personal reason|0|||
37914492|NCT00837265|69601005|FG006|Main Phase|Participant's personal reason|0|||
37914493|NCT00594516|69601018|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
37914494|NCT00594516|69601019|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
37914495|NCT00594516|69601020|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
37914496|NCT00594516|69601018|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
37914497|NCT00594516|69601019|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
37914498|NCT00594516|69601020|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
37914499|NCT00594516|69601018|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
37914500|NCT00594516|69601019|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
37914501|NCT00594516|69601020|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
37914502|NCT00594516|69601018|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
38023256|NCT01631214|69705871|FG001|Overall Study|Administrative Decision|0|||
38023257|NCT03093454|69705881|FG000|Overall Study|Withdrawal by Subject|1|||
38023258|NCT03093454|69705882|FG001|Overall Study|Withdrawal by Subject|1|||
38023259|NCT03093454|69705881|FG000|Overall Study|Scheduling conflict|3|||
38023260|NCT03093454|69705882|FG001|Overall Study|Scheduling conflict|1|||
38023261|NCT03093454|69705881|FG000|Overall Study|Physician Decision|2|||
38023262|NCT03093454|69705882|FG001|Overall Study|Physician Decision|1|||
38023263|NCT00468130|69705903|FG000|Overall Study|Adverse Event|2|||
38023264|NCT00468130|69705904|FG001|Overall Study|Adverse Event|1|||
38023265|NCT00468130|69705903|FG000|Overall Study|Withdrawal by Subject|0|||
38023266|NCT00468130|69705904|FG001|Overall Study|Withdrawal by Subject|1|||
38023267|NCT00911820|69705914|FG000|Overall Study|RECIST progression|12|||
38023268|NCT00911820|69705915|FG001|Overall Study|RECIST progression|8|||
38023269|NCT00911820|69705914|FG000|Overall Study|Adverse Event|8|||
38023270|NCT00911820|69705915|FG001|Overall Study|Adverse Event|8|||
38023271|NCT00911820|69705914|FG000|Overall Study|Clinical Progression|7|||
38023272|NCT00911820|69705915|FG001|Overall Study|Clinical Progression|5|||
38023273|NCT00911820|69705914|FG000|Overall Study|Physician Decision|5|||
38023274|NCT00911820|69705915|FG001|Overall Study|Physician Decision|9|||
38023275|NCT00911820|69705914|FG000|Overall Study|Decline in Performance Status|4|||
38023276|NCT00911820|69705915|FG001|Overall Study|Decline in Performance Status|2|||
38023277|NCT00911820|69705914|FG000|Overall Study|Withdrawal by Subject|3|||
38023278|NCT00911820|69705915|FG001|Overall Study|Withdrawal by Subject|4|||
38023279|NCT00911820|69705914|FG000|Overall Study|Death|1|||
38023280|NCT00911820|69705915|FG001|Overall Study|Death|2|||
38023281|NCT00911820|69705914|FG000|Overall Study|Pursue surgery|1|||
38023282|NCT00911820|69705915|FG001|Overall Study|Pursue surgery|1|||
38023283|NCT00911820|69705914|FG000|Overall Study|Pursue Radiation|1|||
38023284|NCT00911820|69705915|FG001|Overall Study|Pursue Radiation|0|||
38023285|NCT00911820|69705914|FG000|Overall Study|Still on Therapy|2|||
38023286|NCT00911820|69705915|FG001|Overall Study|Still on Therapy|2|||
38023287|NCT00911820|69705914|FG000|Overall Study|Pathology Not Confirmed|1|||
38023288|NCT00911820|69705915|FG001|Overall Study|Pathology Not Confirmed|0|||
38023289|NCT00911820|69705914|FG000|Overall Study|Withdraw before Receive Treatment|0|||
38023290|NCT00911820|69705915|FG001|Overall Study|Withdraw before Receive Treatment|2|||
38023291|NCT00246324|69705930|FG000|Overall Study|Withdrawal by Subject|1|||
38023292|NCT04234984|69705936|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
38023293|NCT04234984|69705936|FG000|Follow-up at the Second Time Point|Death|1|||
38023294|NCT04234984|69705936|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
38023295|NCT03922750|69705950|FG000|Overall Study|Unclassified|0|||
38023296|NCT03922750|69705951|FG001|Overall Study|Unclassified|0|||
38023297|NCT03922750|69705952|FG002|Overall Study|Unclassified|1|||
38023298|NCT03922750|69705950|FG000|Overall Study|Adverse Event|0|||
38023299|NCT03922750|69705951|FG001|Overall Study|Adverse Event|1|||
38023300|NCT03922750|69705952|FG002|Overall Study|Adverse Event|0|||
38023301|NCT04634253|69705974|FG000|Overall Study|Adverse Event|1|||
38023302|NCT04634253|69705975|FG001|Overall Study|Adverse Event|1|||
37914503|NCT00594516|69601019|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
38023303|NCT04634253|69705976|FG002|Overall Study|Adverse Event|0|||
38023304|NCT04634253|69705974|FG000|Overall Study|Physician Decision|0|||
37914504|NCT00594516|69601020|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
37914505|NCT00594516|69601018|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
37914506|NCT00594516|69601019|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
37914507|NCT00594516|69601020|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
37914508|NCT00594516|69601018|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
37914509|NCT00594516|69601019|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
37914510|NCT00594516|69601020|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
37914511|NCT00594516|69601018|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
37914512|NCT00594516|69601019|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
37914513|NCT00594516|69601020|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
37914514|NCT00594516|69601018|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
37914515|NCT00594516|69601019|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
37914516|NCT00594516|69601020|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
37914517|NCT00594516|69601018|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
37914518|NCT00594516|69601019|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
37914519|NCT00594516|69601020|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
38023305|NCT04634253|69705975|FG001|Overall Study|Physician Decision|1|||
38023306|NCT04634253|69705976|FG002|Overall Study|Physician Decision|0|||
38023307|NCT04634253|69705974|FG000|Overall Study|Withdrawal by Subject|1|||
38023308|NCT04634253|69705975|FG001|Overall Study|Withdrawal by Subject|0|||
38023309|NCT04634253|69705976|FG002|Overall Study|Withdrawal by Subject|3|||
38023310|NCT04209634|69706043|FG000|Overall Study|Ongoing|10|||
38023311|NCT03915951|69706049|FG000|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|25|||
38023312|NCT03915951|69706050|FG001|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|8|||
38023313|NCT03915951|69706049|FG000|Overall Study|Adverse Event|12|||
38023314|NCT03915951|69706050|FG001|Overall Study|Adverse Event|6|||
38023315|NCT03915951|69706049|FG000|Overall Study|Disease progression (radiological)|17|||
38023316|NCT03915951|69706050|FG001|Overall Study|Disease progression (radiological)|15|||
38023317|NCT03915951|69706049|FG000|Overall Study|Disease progression (clinical)|4|||
38023318|NCT03915951|69706050|FG001|Overall Study|Disease progression (clinical)|1|||
38023319|NCT03915951|69706049|FG000|Overall Study|Patient decision|0|||
38023320|NCT03915951|69706050|FG001|Overall Study|Patient decision|4|||
38023321|NCT03915951|69706049|FG000|Overall Study|Investigator decision|0|||
38023322|NCT03915951|69706050|FG001|Overall Study|Investigator decision|1|||
38023323|NCT03915951|69706049|FG000|Overall Study|Consent withdrawn|1|||
37914520|NCT00538291|69601024|FG000|Overall Study|Adverse Event|2|||
37914521|NCT00538291|69601024|FG000|Overall Study|Withdrawal by Subject|1|||
37914522|NCT00594906|69601030|FG000|Overall Study|Physician Decision|1|||
37914523|NCT00594906|69601031|FG001|Overall Study|Physician Decision|0|||
37914524|NCT00594906|69601030|FG000|Overall Study|Physician Decision|0|||
37914525|NCT00594906|69601031|FG001|Overall Study|Physician Decision|1|||
37914526|NCT00594906|69601030|FG000|Overall Study|Death|0|||
37914527|NCT00594906|69601031|FG001|Overall Study|Death|1|||
37914528|NCT00537979|69601039|FG000|Overall Study|Adverse Event|2|||
37914529|NCT00537979|69601040|FG001|Overall Study|Adverse Event|2|||
37914530|NCT00537979|69601039|FG000|Overall Study|Withdrawal by Subject|1|||
37914531|NCT00537979|69601040|FG001|Overall Study|Withdrawal by Subject|4|||
37914532|NCT00537979|69601039|FG000|Overall Study|Lost to Follow-up|1|||
37914533|NCT00537979|69601040|FG001|Overall Study|Lost to Follow-up|4|||
37914534|NCT00537979|69601039|FG000|Overall Study|Lack of Efficacy|0|||
37914535|NCT00537979|69601040|FG001|Overall Study|Lack of Efficacy|1|||
37914536|NCT00537979|69601039|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
37914537|NCT00537979|69601040|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
37914538|NCT00537979|69601039|FG000|Overall Study|Death|0|||
37914539|NCT00537979|69601040|FG001|Overall Study|Death|3|||
37914540|NCT00537979|69601039|FG000|Overall Study|Kidney transplant|0|||
37914541|NCT00537979|69601040|FG001|Overall Study|Kidney transplant|3|||
37914542|NCT00537979|69601039|FG000|Overall Study|Heart failure|0|||
37914543|NCT00537979|69601040|FG001|Overall Study|Heart failure|1|||
37914544|NCT00537823|69601049|FG000|Overall Study|Adverse Event|2|||
37914545|NCT00537823|69601050|FG001|Overall Study|Adverse Event|0|||
37914546|NCT00537277|69601057|FG000|Overall Study|Adverse Event|1|||
37914547|NCT00537277|69601057|FG000|Overall Study|Lack of Efficacy|2|||
38023324|NCT03915951|69706050|FG001|Overall Study|Consent withdrawn|1|||
38023325|NCT03915951|69706049|FG000|Overall Study|Death|0|||
38023326|NCT03915951|69706050|FG001|Overall Study|Death|3|||
38023327|NCT03725982|69706097|FG000|First Intervention|Withdrawal by Subject|0|||
38023328|NCT03725982|69706098|FG001|First Intervention|Withdrawal by Subject|1|||
38023329|NCT03725982|69706097|FG000|First Intervention|Physician Decision|1|||
38023330|NCT03725982|69706098|FG001|First Intervention|Physician Decision|1|||
37914548|NCT00537277|69601057|FG000|Overall Study|Lost to Follow-up|12|||
37914549|NCT00537277|69601057|FG000|Overall Study|Protocol Violation|11|||
37914550|NCT00537277|69601057|FG000|Overall Study|Unclassified|4|||
37914551|NCT00537277|69601057|FG000|Overall Study|Inability to tolerate trial medication|4|||
38023331|NCT03354273|69706168|FG000|Overall Study|Adverse Event|5|||
38023332|NCT03354273|69706168|FG000|Overall Study|Screen Failure|21|||
38023333|NCT03354273|69706168|FG000|Overall Study|Withdrawal by Subject|34|||
37914552|NCT00537277|69601057|FG000|Overall Study|Non-compliance with trial procedures|15|||
37914553|NCT00537199|69601061|FG000|Overall Study|Study Terminated|1|||
37914554|NCT03898063|69601067|FG000|Overall Study|Withdrawal by Subject|10|||
37914555|NCT03898063|69601068|FG001|Overall Study|Withdrawal by Subject|8|||
37914556|NCT00873912|69601076|FG000|Overall Study|Withdrawal by Subject|1|||
37914557|NCT00873912|69601077|FG001|Overall Study|Withdrawal by Subject|0|||
37914558|NCT00873912|69601076|FG000|Overall Study|Lost to Follow-up|2|||
37914559|NCT00873912|69601077|FG001|Overall Study|Lost to Follow-up|0|||
37914560|NCT03823300|69601089|FG000|Overall Study|Withdrawal by Subject|16|||
37914561|NCT03823300|69601090|FG001|Overall Study|Withdrawal by Subject|22|||
37914562|NCT03823300|69601089|FG000|Overall Study|Death|10|||
37914563|NCT03823300|69601090|FG001|Overall Study|Death|14|||
37914564|NCT03823300|69601089|FG000|Overall Study|Adverse Event|3|||
37914565|NCT03823300|69601090|FG001|Overall Study|Adverse Event|5|||
37914566|NCT03823300|69601089|FG000|Overall Study|Physician Decision|1|||
37914567|NCT03823300|69601090|FG001|Overall Study|Physician Decision|7|||
37914568|NCT03823300|69601089|FG000|Overall Study|Lost to Follow-up|1|||
38023334|NCT03354273|69706168|FG000|Overall Study|Technical Problems|30|||
38023335|NCT03354273|69706168|FG000|Overall Study|Lost to Follow-up|4|||
38023336|NCT03354273|69706168|FG000|Overall Study|Investigator Decision|3|||
38023337|NCT03354273|69706168|FG000|Overall Study|Investigational Medicinal Product (IMP) Supply Issues|21|||
37700565|NCT02010255|69177667|FG006|Overall Study|Death|1|||
38023338|NCT03354273|69706168|FG000|Overall Study|Issues With Performing Invasive Coronary Angiography (ICA)|20|||
37835981|NCT01215916|69520268|FG003|Overall Study|Withdrawal by Subject|2|||
37835982|NCT01215916|69520269|FG004|Overall Study|Withdrawal by Subject|0|||
37835983|NCT01215916|69520270|FG005|Overall Study|Withdrawal by Subject|0|||
37835984|NCT01215916|69520271|FG006|Overall Study|Withdrawal by Subject|1|||
37835985|NCT01215916|69520272|FG007|Overall Study|Withdrawal by Subject|0|||
37835986|NCT01215916|69520273|FG008|Overall Study|Withdrawal by Subject|0|||
37835987|NCT01215916|69520265|FG000|Overall Study|Death|0|||
37835988|NCT01215916|69520266|FG001|Overall Study|Death|1|||
37835989|NCT01215916|69520267|FG002|Overall Study|Death|0|||
37835990|NCT01215916|69520268|FG003|Overall Study|Death|0|||
37835991|NCT01215916|69520269|FG004|Overall Study|Death|1|||
37835992|NCT01215916|69520270|FG005|Overall Study|Death|0|||
38023339|NCT03354273|69706168|FG000|Overall Study|COVID-19 Restrictions|9|||
38023340|NCT03354273|69706168|FG000|Overall Study|Other|5|||
38023341|NCT03282123|69706179|FG000|Overall Study|Withdrawal by Subject|5|||
37835993|NCT01215916|69520271|FG006|Overall Study|Death|0|||
38023342|NCT02759185|69706207|FG000|Stage 1|Adverse Event|0|||
38023343|NCT02759185|69706208|FG001|Stage 1|Adverse Event|1|||
38023344|NCT02759185|69706209|FG002|Stage 1|Adverse Event|3|||
38023345|NCT02759185|69706210|FG003|Stage 1|Adverse Event|0|||
38023346|NCT02759185|69706211|FG004|Stage 1|Adverse Event|0|||
38023347|NCT02759185|69706212|FG005|Stage 1|Adverse Event|0|||
38023348|NCT02759185|69706213|FG006|Stage 1|Adverse Event|0|||
38023349|NCT02759185|69706207|FG000|Stage 1|Withdrawal by Subject|1|||
38023350|NCT02759185|69706208|FG001|Stage 1|Withdrawal by Subject|0|||
38023351|NCT02759185|69706209|FG002|Stage 1|Withdrawal by Subject|0|||
38023352|NCT02759185|69706210|FG003|Stage 1|Withdrawal by Subject|0|||
38023353|NCT02759185|69706211|FG004|Stage 1|Withdrawal by Subject|0|||
37700566|NCT02010255|69177668|FG007|Overall Study|Death|1|||
37700567|NCT02010255|69177669|FG008|Overall Study|Death|1|||
37700568|NCT02010255|69177670|FG009|Overall Study|Death|0|||
37700569|NCT02010255|69177671|FG010|Overall Study|Death|1|||
37700570|NCT02010255|69177672|FG011|Overall Study|Death|1|||
37700571|NCT02010255|69177673|FG012|Overall Study|Death|0|||
37700572|NCT02010255|69177674|FG013|Overall Study|Death|0|||
37835994|NCT01215916|69520272|FG007|Overall Study|Death|0|||
37835995|NCT01215916|69520273|FG008|Overall Study|Death|1|||
37835996|NCT01215916|69520265|FG000|Overall Study|Physician Decision|0|||
37835997|NCT01215916|69520266|FG001|Overall Study|Physician Decision|0|||
37835998|NCT01215916|69520267|FG002|Overall Study|Physician Decision|1|||
37835999|NCT01215916|69520268|FG003|Overall Study|Physician Decision|1|||
37836000|NCT01215916|69520269|FG004|Overall Study|Physician Decision|0|||
37914569|NCT03823300|69601090|FG001|Overall Study|Lost to Follow-up|3|||
37914570|NCT03823300|69601089|FG000|Overall Study|Protocol Violation|1|||
37914571|NCT03823300|69601090|FG001|Overall Study|Protocol Violation|1|||
37914572|NCT03823300|69601089|FG000|Overall Study|Lack of Efficacy|1|||
37914573|NCT03823300|69601090|FG001|Overall Study|Lack of Efficacy|1|||
37836001|NCT01215916|69520270|FG005|Overall Study|Physician Decision|0|||
37914574|NCT03823300|69601089|FG000|Overall Study|Not Eligible|0|||
37914575|NCT03823300|69601090|FG001|Overall Study|Not Eligible|1|||
37914576|NCT03823300|69601089|FG000|Overall Study|Other|1|||
38023354|NCT02759185|69706212|FG005|Stage 1|Withdrawal by Subject|0|||
38023355|NCT02759185|69706213|FG006|Stage 1|Withdrawal by Subject|0|||
38023356|NCT02759185|69706207|FG000|Stage 2|Adverse Event|0|||
38023357|NCT02759185|69706208|FG001|Stage 2|Adverse Event|0|||
37700573|NCT02010255|69177661|FG000|Overall Study|Lack of Efficacy|4|||
37914577|NCT03823300|69601090|FG001|Overall Study|Other|0|||
38023358|NCT02759185|69706209|FG002|Stage 2|Adverse Event|0|||
37836002|NCT01215916|69520271|FG006|Overall Study|Physician Decision|0|||
37836003|NCT01215916|69520272|FG007|Overall Study|Physician Decision|0|||
37836004|NCT01215916|69520273|FG008|Overall Study|Physician Decision|0|||
37836005|NCT01184872|69520299|FG000|Overall Study|Adverse Event|3|||
37836006|NCT01184872|69520300|FG001|Overall Study|Adverse Event|4|||
37836007|NCT01184872|69520299|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
37836008|NCT01184872|69520300|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
37836009|NCT01184872|69520299|FG000|Overall Study|Withdrawal by Subject|2|||
37836010|NCT01184872|69520300|FG001|Overall Study|Withdrawal by Subject|0|||
37836011|NCT01184872|69520299|FG000|Overall Study|Lost to Follow-up|0|||
37836012|NCT01184872|69520300|FG001|Overall Study|Lost to Follow-up|1|||
37836013|NCT01184872|69520299|FG000|Overall Study|Administrative problems|1|||
37836014|NCT01184872|69520300|FG001|Overall Study|Administrative problems|1|||
37836015|NCT01184872|69520299|FG000|Overall Study|Protocol deviation|1|||
37836016|NCT01184872|69520300|FG001|Overall Study|Protocol deviation|0|||
37836017|NCT01215721|69520306|FG000|Overall Study|Adverse Event|2|||
37836018|NCT01184326|69520313|FG000|Overall Study|Adverse Event|1|||
37836019|NCT01184326|69520314|FG001|Overall Study|Adverse Event|2|||
37836020|NCT01184326|69520315|FG002|Overall Study|Adverse Event|0|||
37836021|NCT01184326|69520313|FG000|Overall Study|Death|0|||
37836022|NCT01184326|69520314|FG001|Overall Study|Death|0|||
37836023|NCT01184326|69520315|FG002|Overall Study|Death|1|||
37836024|NCT01184326|69520313|FG000|Overall Study|Withdrawal by Subject|0|||
37836025|NCT01184326|69520314|FG001|Overall Study|Withdrawal by Subject|0|||
37836026|NCT01184326|69520315|FG002|Overall Study|Withdrawal by Subject|1|||
37836027|NCT01184326|69520313|FG000|Overall Study|Physician Decision|1|||
37836028|NCT01184326|69520314|FG001|Overall Study|Physician Decision|1|||
37836029|NCT01184326|69520315|FG002|Overall Study|Physician Decision|0|||
37836030|NCT01184326|69520313|FG000|Overall Study|Disease Progression|1|||
37836031|NCT01184326|69520314|FG001|Overall Study|Disease Progression|3|||
37836032|NCT01184326|69520315|FG002|Overall Study|Disease Progression|12|||
37836033|NCT01215253|69520328|FG000|Overall Study|Withdrawal by Subject|57|||
37836034|NCT01215253|69520329|FG001|Overall Study|Withdrawal by Subject|35|||
37836035|NCT01215253|69520328|FG000|Overall Study|Physician Decision|9|||
37836036|NCT01215253|69520329|FG001|Overall Study|Physician Decision|12|||
37836037|NCT01215253|69520328|FG000|Overall Study|Lost to Follow-up|6|||
37836038|NCT01215253|69520329|FG001|Overall Study|Lost to Follow-up|4|||
37836039|NCT01215253|69520328|FG000|Overall Study|Other|14|||
37836040|NCT01215253|69520329|FG001|Overall Study|Other|12|||
37836041|NCT01184053|69520336|FG000|Overall Study|progression while on treatment|3|||
37836042|NCT01183975|69520341|FG000|Overall Study|Lost to Follow-up|73|||
37836043|NCT01183858|69520347|FG000|Overall Study|Death not related to Progressive Disease|5|||
37836044|NCT01183858|69520348|FG001|Overall Study|Death not related to Progressive Disease|6|||
37836045|NCT01183858|69520347|FG000|Overall Study|Adverse Event|14|||
37836046|NCT01183858|69520348|FG001|Overall Study|Adverse Event|11|||
37836047|NCT01183858|69520347|FG000|Overall Study|Investigator's Decision|0|||
37836048|NCT01183858|69520348|FG001|Overall Study|Investigator's Decision|3|||
37914578|NCT00537745|69601096|FG000|Overall Study|Did not meet eligibility criteria|2|||
37914579|NCT00537745|69601096|FG000|Overall Study|Withdrawal by Subject|2|||
37914580|NCT00537745|69601096|FG000|Overall Study|Subject unable to provide Interlock info|1|||
37914581|NCT00874848|69601103|FG000|Overall Study|Adverse Event|13|||
37914582|NCT00874848|69601104|FG001|Overall Study|Adverse Event|2|||
37914583|NCT00874848|69601103|FG000|Overall Study|Progressive neoplastic disease|38|||
37914584|NCT00874848|69601104|FG001|Overall Study|Progressive neoplastic disease|18|||
37914585|NCT00874848|69601103|FG000|Overall Study|Withdrawal by Subject|7|||
37914586|NCT00874848|69601104|FG001|Overall Study|Withdrawal by Subject|4|||
37914587|NCT00874848|69601103|FG000|Overall Study|Noncompliance|1|||
37914588|NCT00874848|69601104|FG001|Overall Study|Noncompliance|1|||
38023359|NCT02759185|69706210|FG003|Stage 2|Adverse Event|0|||
38023360|NCT02759185|69706211|FG004|Stage 2|Adverse Event|1|||
38023361|NCT02759185|69706212|FG005|Stage 2|Adverse Event|2|||
37836049|NCT01183858|69520347|FG000|Overall Study|Insufficient Therapeutic Response|2|||
37836050|NCT01183858|69520348|FG001|Overall Study|Insufficient Therapeutic Response|0|||
37836051|NCT01183858|69520347|FG000|Overall Study|Refused Treatment|1|||
37836052|NCT01183858|69520348|FG001|Overall Study|Refused Treatment|4|||
37836053|NCT01183858|69520347|FG000|Overall Study|Withdrew Consent|4|||
37836054|NCT01183858|69520348|FG001|Overall Study|Withdrew Consent|4|||
37836055|NCT01183858|69520347|FG000|Overall Study|Discontinued Smoking|3|||
37836056|NCT01183858|69520348|FG001|Overall Study|Discontinued Smoking|1|||
37836057|NCT01183858|69520347|FG000|Overall Study|Protocol Violation|1|||
37914589|NCT00874848|69601103|FG000|Overall Study|Failure to comply with protocol|0|||
37914590|NCT00874848|69601104|FG001|Overall Study|Failure to comply with protocol|1|||
37914591|NCT00874848|69601103|FG000|Overall Study|Physician Decision|0|||
37836058|NCT01183858|69520348|FG001|Overall Study|Protocol Violation|0|||
37836059|NCT01183858|69520347|FG000|Overall Study|Administrative/Other|6|||
38023362|NCT02759185|69706213|FG006|Stage 2|Adverse Event|0|||
37836060|NCT01183858|69520348|FG001|Overall Study|Administrative/Other|6|||
37836061|NCT01183858|69520347|FG000|Overall Study|Progressive Disease|112|||
37836062|NCT01183858|69520348|FG001|Overall Study|Progressive Disease|115|||
37836063|NCT01183858|69520347|FG000|Overall Study|Death related to Progressive Disease|4|||
37836064|NCT01183858|69520348|FG001|Overall Study|Death related to Progressive Disease|5|||
37836065|NCT01183858|69520347|FG000|Overall Study|Lost to Follow-up|1|||
37836066|NCT01183858|69520348|FG001|Overall Study|Lost to Follow-up|1|||
37836067|NCT01215175|69520359|FG000|Overall Study|Lost to Follow-up|0|||
37836068|NCT01215175|69520360|FG001|Overall Study|Lost to Follow-up|1|||
37836069|NCT01215175|69520361|FG002|Overall Study|Lost to Follow-up|0|||
37836070|NCT01215175|69520362|FG003|Overall Study|Lost to Follow-up|1|||
37836071|NCT01215175|69520363|FG004|Overall Study|Lost to Follow-up|0|||
37836072|NCT01215097|69520377|FG000|Overall Study|Adverse Event|1|||
37836073|NCT01215097|69520378|FG001|Overall Study|Adverse Event|3|||
37836074|NCT01215097|69520377|FG000|Overall Study|Protocol Violation|0|||
37836075|NCT01215097|69520378|FG001|Overall Study|Protocol Violation|2|||
37836076|NCT01215097|69520377|FG000|Overall Study|Lost to Follow-up|2|||
37836077|NCT01215097|69520378|FG001|Overall Study|Lost to Follow-up|0|||
37836078|NCT01215097|69520377|FG000|Overall Study|Withdrawal by Subject|6|||
37836079|NCT01215097|69520378|FG001|Overall Study|Withdrawal by Subject|3|||
37836080|NCT01215097|69520377|FG000|Overall Study|Lack of Efficacy|0|||
37836081|NCT01215097|69520378|FG001|Overall Study|Lack of Efficacy|3|||
37836082|NCT01215097|69520377|FG000|Overall Study|patient's refusal to come|2|||
37836083|NCT01215097|69520378|FG001|Overall Study|patient's refusal to come|2|||
37836084|NCT01215097|69520377|FG000|Overall Study|patient's private reason|1|||
37836085|NCT01215097|69520378|FG001|Overall Study|patient's private reason|1|||
37836086|NCT03303339|69520396|FG000|Overall Study|Death|2|||
37836087|NCT03303339|69520397|FG001|Overall Study|Death|2|||
37836088|NCT03303339|69520398|FG002|Overall Study|Death|2|||
37836089|NCT03303339|69520399|FG003|Overall Study|Death|1|||
37836090|NCT03303339|69520400|FG004|Overall Study|Death|4|||
37836091|NCT03303339|69520401|FG005|Overall Study|Death|2|||
37836092|NCT03303339|69520402|FG006|Overall Study|Death|2|||
37836093|NCT03303339|69520403|FG007|Overall Study|Death|2|||
37836094|NCT03303339|69520404|FG008|Overall Study|Death|3|||
37836095|NCT03303339|69520405|FG009|Overall Study|Death|3|||
37836096|NCT03303339|69520406|FG010|Overall Study|Death|4|||
37836097|NCT03303339|69520407|FG011|Overall Study|Death|24|||
37836098|NCT03303339|69520396|FG000|Overall Study|Study Terminated by Sponsor|0|||
37836099|NCT03303339|69520397|FG001|Overall Study|Study Terminated by Sponsor|0|||
37836100|NCT03303339|69520398|FG002|Overall Study|Study Terminated by Sponsor|0|||
37836101|NCT03303339|69520399|FG003|Overall Study|Study Terminated by Sponsor|0|||
37836102|NCT03303339|69520400|FG004|Overall Study|Study Terminated by Sponsor|0|||
37836103|NCT03303339|69520401|FG005|Overall Study|Study Terminated by Sponsor|0|||
37836104|NCT03303339|69520402|FG006|Overall Study|Study Terminated by Sponsor|0|||
37836105|NCT03303339|69520403|FG007|Overall Study|Study Terminated by Sponsor|0|||
37836106|NCT03303339|69520404|FG008|Overall Study|Study Terminated by Sponsor|1|||
37836107|NCT03303339|69520405|FG009|Overall Study|Study Terminated by Sponsor|0|||
37836108|NCT03303339|69520406|FG010|Overall Study|Study Terminated by Sponsor|1|||
37836109|NCT03303339|69520407|FG011|Overall Study|Study Terminated by Sponsor|1|||
37836110|NCT03303339|69520396|FG000|Overall Study|Withdrawal by Subject|1|||
37836111|NCT03303339|69520397|FG001|Overall Study|Withdrawal by Subject|0|||
37836112|NCT03303339|69520398|FG002|Overall Study|Withdrawal by Subject|0|||
37836113|NCT03303339|69520399|FG003|Overall Study|Withdrawal by Subject|0|||
37836114|NCT03303339|69520400|FG004|Overall Study|Withdrawal by Subject|0|||
37836115|NCT03303339|69520401|FG005|Overall Study|Withdrawal by Subject|1|||
37836116|NCT03303339|69520402|FG006|Overall Study|Withdrawal by Subject|1|||
37836117|NCT03303339|69520403|FG007|Overall Study|Withdrawal by Subject|0|||
37836118|NCT03303339|69520404|FG008|Overall Study|Withdrawal by Subject|0|||
37836119|NCT03303339|69520405|FG009|Overall Study|Withdrawal by Subject|0|||
38023363|NCT02759185|69706207|FG000|Stage 2|Withdrawal by Subject|0|||
38023364|NCT02759185|69706208|FG001|Stage 2|Withdrawal by Subject|0|||
37836120|NCT03303339|69520406|FG010|Overall Study|Withdrawal by Subject|0|||
37836121|NCT03303339|69520407|FG011|Overall Study|Withdrawal by Subject|2|||
37836122|NCT03303339|69520396|FG000|Overall Study|Physician Decision|0|||
37836123|NCT03303339|69520397|FG001|Overall Study|Physician Decision|0|||
37836124|NCT03303339|69520398|FG002|Overall Study|Physician Decision|0|||
37836125|NCT03303339|69520399|FG003|Overall Study|Physician Decision|0|||
37836126|NCT03303339|69520400|FG004|Overall Study|Physician Decision|1|||
37836127|NCT03303339|69520401|FG005|Overall Study|Physician Decision|0|||
37836128|NCT03303339|69520402|FG006|Overall Study|Physician Decision|0|||
37836129|NCT03303339|69520403|FG007|Overall Study|Physician Decision|0|||
37836130|NCT03303339|69520404|FG008|Overall Study|Physician Decision|0|||
37836131|NCT03303339|69520405|FG009|Overall Study|Physician Decision|0|||
37836132|NCT03303339|69520406|FG010|Overall Study|Physician Decision|0|||
37836133|NCT03303339|69520407|FG011|Overall Study|Physician Decision|0|||
37836134|NCT03303339|69520396|FG000|Overall Study|Safety/Non-compliance|0|||
37836135|NCT03303339|69520397|FG001|Overall Study|Safety/Non-compliance|0|||
37836136|NCT03303339|69520398|FG002|Overall Study|Safety/Non-compliance|0|||
37836137|NCT03303339|69520399|FG003|Overall Study|Safety/Non-compliance|0|||
37836138|NCT03303339|69520400|FG004|Overall Study|Safety/Non-compliance|0|||
37836139|NCT03303339|69520401|FG005|Overall Study|Safety/Non-compliance|0|||
37836140|NCT03303339|69520402|FG006|Overall Study|Safety/Non-compliance|0|||
37836141|NCT03303339|69520403|FG007|Overall Study|Safety/Non-compliance|0|||
37836142|NCT03303339|69520404|FG008|Overall Study|Safety/Non-compliance|0|||
37836143|NCT03303339|69520405|FG009|Overall Study|Safety/Non-compliance|0|||
37836144|NCT03303339|69520406|FG010|Overall Study|Safety/Non-compliance|0|||
37836145|NCT03303339|69520407|FG011|Overall Study|Safety/Non-compliance|1|||
37836146|NCT01183780|69520452|FG000|Overall Study|Withdrawal by Subject|25|||
37836147|NCT01183780|69520453|FG001|Overall Study|Withdrawal by Subject|14|||
37836148|NCT01183780|69520452|FG000|Overall Study|Lost to Follow-up|6|||
37836149|NCT01183780|69520453|FG001|Overall Study|Lost to Follow-up|11|||
37836150|NCT01183468|69520463|FG000|Overall Study|Lost to Follow-up|2|||
37836151|NCT01183468|69520464|FG001|Overall Study|Lost to Follow-up|1|||
37836152|NCT01183468|69520465|FG002|Overall Study|Lost to Follow-up|0|||
37836153|NCT01183468|69520466|FG003|Overall Study|Lost to Follow-up|0|||
37836154|NCT01183468|69520463|FG000|Overall Study|Physician Decision|1|||
37836155|NCT01183468|69520464|FG001|Overall Study|Physician Decision|0|||
37836156|NCT01183468|69520465|FG002|Overall Study|Physician Decision|0|||
37836157|NCT01183468|69520466|FG003|Overall Study|Physician Decision|0|||
37836158|NCT01183468|69520463|FG000|Overall Study|Withdrawal by Subject|0|||
37836159|NCT01183468|69520464|FG001|Overall Study|Withdrawal by Subject|1|||
37836160|NCT01183468|69520465|FG002|Overall Study|Withdrawal by Subject|0|||
37836161|NCT01183468|69520466|FG003|Overall Study|Withdrawal by Subject|0|||
37836162|NCT01183390|69520476|FG000|First Intervention|Adverse Event|0|||
37836163|NCT01183390|69520477|FG001|First Intervention|Adverse Event|1|||
37836164|NCT01214668|69520489|FG000|Overall Study|Adverse Event|0|||
37836165|NCT01214668|69520490|FG001|Overall Study|Adverse Event|1|||
37836166|NCT01214668|69520491|FG002|Overall Study|Adverse Event|0|||
37836167|NCT01214668|69520492|FG003|Overall Study|Adverse Event|2|||
37836168|NCT01214668|69520493|FG004|Overall Study|Adverse Event|1|||
37836169|NCT01214668|69520494|FG005|Overall Study|Adverse Event|1|||
37836170|NCT01214668|69520489|FG000|Overall Study|Death|0|||
37836171|NCT01214668|69520490|FG001|Overall Study|Death|0|||
37836172|NCT01214668|69520491|FG002|Overall Study|Death|1|||
37836173|NCT01214668|69520492|FG003|Overall Study|Death|0|||
37836174|NCT01214668|69520493|FG004|Overall Study|Death|0|||
37836175|NCT01214668|69520494|FG005|Overall Study|Death|0|||
37836176|NCT01214668|69520489|FG000|Overall Study|Progressive Disease|4|||
37836177|NCT01214668|69520490|FG001|Overall Study|Progressive Disease|2|||
37836178|NCT01214668|69520491|FG002|Overall Study|Progressive Disease|5|||
37914592|NCT00874848|69601104|FG001|Overall Study|Physician Decision|2|||
38023365|NCT02759185|69706209|FG002|Stage 2|Withdrawal by Subject|0|||
37836179|NCT01214668|69520492|FG003|Overall Study|Progressive Disease|4|||
37836180|NCT01214668|69520493|FG004|Overall Study|Progressive Disease|4|||
37836181|NCT01214668|69520494|FG005|Overall Study|Progressive Disease|5|||
37836182|NCT01214668|69520489|FG000|Overall Study|Withdrawal by Subject|0|||
37836183|NCT01214668|69520490|FG001|Overall Study|Withdrawal by Subject|0|||
37836184|NCT01214668|69520491|FG002|Overall Study|Withdrawal by Subject|0|||
37836185|NCT01214668|69520492|FG003|Overall Study|Withdrawal by Subject|0|||
37836186|NCT01214668|69520493|FG004|Overall Study|Withdrawal by Subject|1|||
37836187|NCT01214668|69520494|FG005|Overall Study|Withdrawal by Subject|0|||
37836188|NCT01191268|69520512|FG000|Overall Study|Withdrawal by Subject|19|||
37914593|NCT00578812|69601112|FG000|Overall Study|Not treated|6|||
37836189|NCT01191268|69520513|FG001|Overall Study|Withdrawal by Subject|25|||
37836190|NCT01191268|69520514|FG002|Overall Study|Withdrawal by Subject|21|||
37836191|NCT01191268|69520512|FG000|Overall Study|Adverse Event|21|||
37836192|NCT01191268|69520513|FG001|Overall Study|Adverse Event|13|||
37836193|NCT01191268|69520514|FG002|Overall Study|Adverse Event|8|||
37836194|NCT01191268|69520512|FG000|Overall Study|Physician Decision|6|||
37836195|NCT01191268|69520513|FG001|Overall Study|Physician Decision|8|||
37836196|NCT01191268|69520514|FG002|Overall Study|Physician Decision|9|||
37836197|NCT01191268|69520512|FG000|Overall Study|Lost to Follow-up|8|||
37836198|NCT01191268|69520513|FG001|Overall Study|Lost to Follow-up|5|||
37836199|NCT01191268|69520514|FG002|Overall Study|Lost to Follow-up|9|||
37836200|NCT01191268|69520512|FG000|Overall Study|Entry Criteria Not Met|3|||
37836201|NCT01191268|69520513|FG001|Overall Study|Entry Criteria Not Met|1|||
37836202|NCT01191268|69520514|FG002|Overall Study|Entry Criteria Not Met|1|||
37836203|NCT01191268|69520512|FG000|Overall Study|Death|0|||
37836204|NCT01191268|69520513|FG001|Overall Study|Death|1|||
37836205|NCT01191268|69520514|FG002|Overall Study|Death|3|||
37836206|NCT01191268|69520512|FG000|Overall Study|Protocol Violation|1|||
37836207|NCT01191268|69520513|FG001|Overall Study|Protocol Violation|0|||
37836208|NCT01191268|69520514|FG002|Overall Study|Protocol Violation|1|||
37836209|NCT01191268|69520512|FG000|Overall Study|Sponsor Decision|0|||
37836210|NCT01191268|69520513|FG001|Overall Study|Sponsor Decision|2|||
37836211|NCT01191268|69520514|FG002|Overall Study|Sponsor Decision|0|||
37836212|NCT01191190|69520523|FG000|Overall Study|Withdrawal by Subject|1|||
37836213|NCT05751629|69520527|FG000|Overall Study|Withdrawal by Subject|6|||
37836214|NCT05751629|69520527|FG000|Overall Study|Death|25|||
37836215|NCT05751629|69520527|FG000|Overall Study|Study Site Closed|9|||
37836216|NCT05751629|69520527|FG000|Overall Study|Physician Decision|1|||
37836217|NCT05306977|69520531|FG000|Overall Study|Withdrawal by Subject|1|||
37836218|NCT05086276|69520537|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
37836219|NCT05086276|69520538|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
37836220|NCT04870710|69520544|FG000|Overall Study|Lost to Follow-up|3|||
37836221|NCT04858802|69520550|FG000|Overall Study|Lost to Follow-up|1|||
37836222|NCT04858802|69520551|FG001|Overall Study|Lost to Follow-up|1|||
37836223|NCT04858802|69520550|FG000|Overall Study|Withdrawal by Subject|1|||
37836224|NCT04858802|69520551|FG001|Overall Study|Withdrawal by Subject|1|||
37836225|NCT04562090|69520569|FG000|Overall Study|Withdrawal by Subject|3|||
37836226|NCT04562090|69520570|FG001|Overall Study|Withdrawal by Subject|4|||
37836227|NCT04562090|69520569|FG000|Overall Study|Protocol Violation|2|||
37836228|NCT04562090|69520570|FG001|Overall Study|Protocol Violation|0|||
37836229|NCT04562090|69520569|FG000|Overall Study|Lack of Efficacy|0|||
37836230|NCT04562090|69520570|FG001|Overall Study|Lack of Efficacy|1|||
37836231|NCT04562090|69520569|FG000|Overall Study|Adverse Event|1|||
37836232|NCT04562090|69520570|FG001|Overall Study|Adverse Event|4|||
37836233|NCT04562090|69520569|FG000|Overall Study|Miscellaneous|0|||
37836234|NCT04562090|69520570|FG001|Overall Study|Miscellaneous|3|||
37836235|NCT04557189|69520581|FG000|Overall Study|Adverse Event|0|||
37836236|NCT04557189|69520582|FG001|Overall Study|Adverse Event|1|||
37836237|NCT04557189|69520581|FG000|Overall Study|Lost to Follow-up|1|||
37836238|NCT04557189|69520582|FG001|Overall Study|Lost to Follow-up|1|||
37836239|NCT04557189|69520581|FG000|Overall Study|Withdrawal by Subject|2|||
37836240|NCT04557189|69520582|FG001|Overall Study|Withdrawal by Subject|1|||
37836241|NCT04557189|69520581|FG000|Overall Study|Reason not Specified|3|||
37836242|NCT04557189|69520582|FG001|Overall Study|Reason not Specified|6|||
37836243|NCT04530838|69520595|FG000|Overall Study|Other|2|||
37836244|NCT04530838|69520596|FG001|Overall Study|Other|1|||
37836245|NCT04530838|69520597|FG002|Overall Study|Other|0|||
37914594|NCT00578812|69601113|FG001|Overall Study|Not treated|7|||
37914595|NCT04043806|69601120|FG000|Overall Study|Commercial drug is available for participants|13|||
37914596|NCT04043806|69601120|FG000|Overall Study|Physician Decision|2|||
37914597|NCT04043806|69601120|FG000|Overall Study|Other|12|||
37914598|NCT04043806|69601120|FG000|Overall Study|Adverse Event|2|||
37914599|NCT04043806|69601120|FG000|Overall Study|Lost to Follow-up|6|||
37836246|NCT04530838|69520595|FG000|Overall Study|Physician Decision|0|||
37836247|NCT04530838|69520596|FG001|Overall Study|Physician Decision|0|||
37700574|NCT02010255|69177662|FG001|Overall Study|Lack of Efficacy|1|||
37836248|NCT04530838|69520597|FG002|Overall Study|Physician Decision|1|||
37836249|NCT04530838|69520595|FG000|Overall Study|Death|0|||
37836250|NCT04530838|69520596|FG001|Overall Study|Death|0|||
37836251|NCT04530838|69520597|FG002|Overall Study|Death|1|||
37836252|NCT04530838|69520595|FG000|Overall Study|Adverse Event|0|||
37836253|NCT04530838|69520596|FG001|Overall Study|Adverse Event|1|||
37836254|NCT04530838|69520597|FG002|Overall Study|Adverse Event|0|||
37836255|NCT04530838|69520595|FG000|Overall Study|No longer meets eligibility criteria|1|||
37836256|NCT04530838|69520596|FG001|Overall Study|No longer meets eligibility criteria|0|||
37836257|NCT04530838|69520597|FG002|Overall Study|No longer meets eligibility criteria|2|||
37836258|NCT04530838|69520595|FG000|Overall Study|Withdrawal by parent/guardian|5|||
37836259|NCT04530838|69520596|FG001|Overall Study|Withdrawal by parent/guardian|2|||
37836260|NCT04530838|69520597|FG002|Overall Study|Withdrawal by parent/guardian|2|||
37836261|NCT04424901|69520611|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
37836262|NCT04424901|69520612|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
37836263|NCT04410445|69520620|FG000|Overall Study|Lost to Follow-up|3|||
37836264|NCT04410445|69520621|FG001|Overall Study|Lost to Follow-up|9|||
37836265|NCT04410445|69520620|FG000|Overall Study|Withdrawal by Subject|27|||
37836266|NCT04410445|69520621|FG001|Overall Study|Withdrawal by Subject|15|||
37836267|NCT04062448|69520645|FG000|Overall Study|Lost to Follow-up|1|||
37836268|NCT04062448|69520645|FG000|Overall Study|Withdrawal by Subject|1|||
37836269|NCT04062448|69520645|FG000|Overall Study|Ongoing|14|||
37836270|NCT03970733|69520652|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
37836271|NCT03970733|69520653|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
37836272|NCT03970733|69520654|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
37836273|NCT03970733|69520655|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
37836274|NCT03970733|69520656|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
37836275|NCT03970733|69520652|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
37836276|NCT03970733|69520653|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
37836277|NCT03970733|69520654|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
37836278|NCT03970733|69520655|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
37836279|NCT03970733|69520656|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
37836280|NCT03970733|69520652|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
37836281|NCT03970733|69520653|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
37836282|NCT03970733|69520654|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
37836283|NCT03970733|69520655|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
37836284|NCT03970733|69520656|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
37836285|NCT03970733|69520652|FG000|Main Study Phase (18 Months)|Other|1|||
37836286|NCT03970733|69520653|FG001|Main Study Phase (18 Months)|Other|1|||
37836287|NCT03970733|69520654|FG002|Main Study Phase (18 Months)|Other|0|||
37836288|NCT03970733|69520655|FG003|Main Study Phase (18 Months)|Other|0|||
37836289|NCT03970733|69520656|FG004|Main Study Phase (18 Months)|Other|0|||
37836290|NCT03970733|69520652|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
37836291|NCT03970733|69520653|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
37836292|NCT03970733|69520654|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
37836293|NCT03970733|69520655|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
37836294|NCT03970733|69520656|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
37836295|NCT03921411|69520668|FG000|Overall Study|Withdrawal by Subject|1|||
37836296|NCT03921411|69520668|FG000|Overall Study|Protocol Deviation|2|||
37836297|NCT03921411|69520668|FG000|Overall Study|Enrolled, but never treated|2|||
37836298|NCT03728582|69520672|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
37836299|NCT03728582|69520673|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
37836300|NCT03728582|69520672|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
37836301|NCT03728582|69520673|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
37836302|NCT03416179|69520692|FG000|Overall Study|Death|90|||
37836303|NCT03416179|69520693|FG001|Overall Study|Death|87|||
37836304|NCT03416179|69520694|FG002|Overall Study|Death|117|||
37836305|NCT03416179|69520695|FG003|Overall Study|Death|113|||
37836306|NCT03416179|69520692|FG000|Overall Study|Withdrawal by Subject|15|||
37836307|NCT03416179|69520693|FG001|Overall Study|Withdrawal by Subject|20|||
37836308|NCT03416179|69520694|FG002|Overall Study|Withdrawal by Subject|6|||
37836309|NCT03416179|69520695|FG003|Overall Study|Withdrawal by Subject|9|||
37836310|NCT03416179|69520692|FG000|Overall Study|Lost to Follow-up|1|||
37836311|NCT03416179|69520693|FG001|Overall Study|Lost to Follow-up|1|||
37836312|NCT03416179|69520694|FG002|Overall Study|Lost to Follow-up|0|||
37836313|NCT03416179|69520695|FG003|Overall Study|Lost to Follow-up|3|||
37836314|NCT03416179|69520692|FG000|Overall Study|Study participation terminated by Sponsor|93|||
37914600|NCT04043806|69601120|FG000|Overall Study|Other non-compliance|2|||
37914601|NCT04043806|69601120|FG000|Overall Study|Withdrawal of Consent (not due to AE)|8|||
37914602|NCT04043806|69601120|FG000|Overall Study|Never Dosed|1|||
37914603|NCT00536809|69601125|FG000|Phase II|Adverse Event|1|||
37836315|NCT03416179|69520693|FG001|Overall Study|Study participation terminated by Sponsor|91|||
37836316|NCT03416179|69520694|FG002|Overall Study|Study participation terminated by Sponsor|26|||
37836317|NCT03416179|69520695|FG003|Overall Study|Study participation terminated by Sponsor|31|||
37836318|NCT03416179|69520692|FG000|Overall Study|Other|2|||
37836319|NCT03416179|69520693|FG001|Overall Study|Other|3|||
37836320|NCT03416179|69520694|FG002|Overall Study|Other|1|||
37836321|NCT03416179|69520695|FG003|Overall Study|Other|0|||
37836322|NCT02932332|69520722|FG000|Overall Study|Withdrawal by Subject|1|||
37836323|NCT02932332|69520723|FG001|Overall Study|Withdrawal by Subject|1|||
37836324|NCT02932332|69520724|FG002|Overall Study|Withdrawal by Subject|0|||
37836325|NCT02932332|69520725|FG003|Overall Study|Withdrawal by Subject|1|||
37836326|NCT02932332|69520722|FG000|Overall Study|Chest pain|0|||
37914604|NCT00536809|69601125|FG000|Phase II|Referred for surgical resection|1|||
37836327|NCT02932332|69520723|FG001|Overall Study|Chest pain|0|||
37914605|NCT00536731|69601136|FG000|Overall Study|Adverse Event|3|||
37914606|NCT00536731|69601137|FG001|Overall Study|Adverse Event|2|||
37914607|NCT00536731|69601138|FG002|Overall Study|Adverse Event|3|||
37914608|NCT00536731|69601136|FG000|Overall Study|Withdrawal by Subject|0|||
37836328|NCT02932332|69520724|FG002|Overall Study|Chest pain|0|||
37836329|NCT02932332|69520725|FG003|Overall Study|Chest pain|1|||
37836330|NCT02932332|69520722|FG000|Overall Study|Not Dyspneic cough|1|||
37836331|NCT02932332|69520723|FG001|Overall Study|Not Dyspneic cough|2|||
37836332|NCT02932332|69520724|FG002|Overall Study|Not Dyspneic cough|1|||
37836333|NCT02932332|69520725|FG003|Overall Study|Not Dyspneic cough|0|||
37914609|NCT00536731|69601137|FG001|Overall Study|Withdrawal by Subject|2|||
37914610|NCT00536731|69601138|FG002|Overall Study|Withdrawal by Subject|0|||
37914611|NCT00536731|69601136|FG000|Overall Study|Intake of prohibited conc. medication|0|||
37914612|NCT00536731|69601137|FG001|Overall Study|Intake of prohibited conc. medication|0|||
37914613|NCT00536731|69601138|FG002|Overall Study|Intake of prohibited conc. medication|1|||
37914614|NCT00536731|69601136|FG000|Overall Study|Safety reasons|0|||
37914615|NCT00536731|69601137|FG001|Overall Study|Safety reasons|0|||
37914616|NCT00536731|69601138|FG002|Overall Study|Safety reasons|1|||
37914617|NCT00536731|69601136|FG000|Overall Study|Other|1|||
37914618|NCT00536731|69601137|FG001|Overall Study|Other|1|||
37914619|NCT00536731|69601138|FG002|Overall Study|Other|0|||
37914620|NCT00536575|69601146|FG000|Overall Study|Withdrawal by Subject|1|||
37914621|NCT00536575|69601146|FG000|Overall Study|Death|1|||
37914622|NCT03214250|69601157|FG000|Overall Study|Death|5|||
37914623|NCT03214250|69601158|FG001|Overall Study|Death|5|||
37914624|NCT03214250|69601159|FG002|Overall Study|Death|7|||
37914625|NCT03214250|69601160|FG003|Overall Study|Death|4|||
37914626|NCT03214250|69601161|FG004|Overall Study|Death|23|||
37914627|NCT03214250|69601162|FG005|Overall Study|Death|23|||
37914628|NCT03214250|69601163|FG006|Overall Study|Death|24|||
37914629|NCT03214250|69601157|FG000|Overall Study|Lost to Follow-up|0|||
37914630|NCT03214250|69601158|FG001|Overall Study|Lost to Follow-up|0|||
37914631|NCT03214250|69601159|FG002|Overall Study|Lost to Follow-up|0|||
37914632|NCT03214250|69601160|FG003|Overall Study|Lost to Follow-up|1|||
37914633|NCT03214250|69601161|FG004|Overall Study|Lost to Follow-up|1|||
37914634|NCT03214250|69601162|FG005|Overall Study|Lost to Follow-up|2|||
37914635|NCT03214250|69601163|FG006|Overall Study|Lost to Follow-up|0|||
37914636|NCT03214250|69601157|FG000|Overall Study|Other|0|||
37914637|NCT03214250|69601158|FG001|Overall Study|Other|0|||
37914638|NCT03214250|69601159|FG002|Overall Study|Other|0|||
37914639|NCT03214250|69601160|FG003|Overall Study|Other|0|||
37914640|NCT03214250|69601161|FG004|Overall Study|Other|1|||
37914641|NCT03214250|69601162|FG005|Overall Study|Other|1|||
37914642|NCT03214250|69601163|FG006|Overall Study|Other|2|||
37914643|NCT03214250|69601157|FG000|Overall Study|Remains on Study|2|||
37914644|NCT03214250|69601158|FG001|Overall Study|Remains on Study|2|||
37914645|NCT03214250|69601159|FG002|Overall Study|Remains on Study|0|||
37914646|NCT03214250|69601160|FG003|Overall Study|Remains on Study|1|||
37914647|NCT03214250|69601161|FG004|Overall Study|Remains on Study|7|||
37914648|NCT03214250|69601162|FG005|Overall Study|Remains on Study|5|||
37914649|NCT03214250|69601163|FG006|Overall Study|Remains on Study|3|||
37914650|NCT03214250|69601157|FG000|Overall Study|Withdrawal by Subject|0|||
37914651|NCT03214250|69601158|FG001|Overall Study|Withdrawal by Subject|0|||
37914652|NCT03214250|69601159|FG002|Overall Study|Withdrawal by Subject|1|||
37914653|NCT03214250|69601160|FG003|Overall Study|Withdrawal by Subject|2|||
37914654|NCT03214250|69601161|FG004|Overall Study|Withdrawal by Subject|5|||
37914655|NCT03214250|69601162|FG005|Overall Study|Withdrawal by Subject|0|||
37914656|NCT03214250|69601163|FG006|Overall Study|Withdrawal by Subject|2|||
37836334|NCT02820623|69520759|FG000|Overall Study|Withdrawal by Subject|1|||
37836335|NCT02820623|69520760|FG001|Overall Study|Withdrawal by Subject|3|||
37836336|NCT02820623|69520761|FG002|Overall Study|Withdrawal by Subject|3|||
37914657|NCT00874770|69601187|FG000|Overall Study|Lack of Efficacy|2|||
37914658|NCT00874770|69601188|FG001|Overall Study|Lack of Efficacy|0|||
37914659|NCT00874770|69601189|FG002|Overall Study|Lack of Efficacy|0|||
37914660|NCT00874770|69601190|FG003|Overall Study|Lack of Efficacy|2|||
37836337|NCT02820623|69520759|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
37836338|NCT02820623|69520760|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
37836339|NCT02820623|69520761|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
37836340|NCT02820623|69520759|FG000|Overall Study|Therapist unable to enroll clients|1|||
37914661|NCT00874770|69601187|FG000|Overall Study|Adverse Event|1|||
37914662|NCT00874770|69601188|FG001|Overall Study|Adverse Event|1|||
38023366|NCT02759185|69706210|FG003|Stage 2|Withdrawal by Subject|0|||
37914663|NCT00874770|69601189|FG002|Overall Study|Adverse Event|4|||
37914664|NCT00874770|69601190|FG003|Overall Study|Adverse Event|2|||
37914665|NCT00874770|69601187|FG000|Overall Study|Lost to Follow-up|1|||
37914666|NCT00874770|69601188|FG001|Overall Study|Lost to Follow-up|0|||
37914667|NCT00874770|69601189|FG002|Overall Study|Lost to Follow-up|0|||
37914668|NCT00874770|69601190|FG003|Overall Study|Lost to Follow-up|1|||
37836341|NCT02820623|69520760|FG001|Overall Study|Therapist unable to enroll clients|1|||
37836342|NCT02820623|69520761|FG002|Overall Study|Therapist unable to enroll clients|3|||
37836343|NCT02820623|69520759|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
37836344|NCT02820623|69520760|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
37836345|NCT02820623|69520761|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
37914669|NCT00874770|69601187|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
37836346|NCT02774005|69520769|FG000|Overall Study|Adverse Event|8|||
37836347|NCT02774005|69520769|FG000|Overall Study|Withdrawal by Subject|23|||
37836348|NCT02774005|69520769|FG000|Overall Study|Lost to Follow-up|7|||
37836349|NCT02774005|69520769|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
37836350|NCT02774005|69520769|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
37836351|NCT02774005|69520769|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
37836352|NCT02774005|69520769|FG000|Overall Study|Death|1|||
37836353|NCT02774005|69520769|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
37836354|NCT02774005|69520769|FG000|Overall Study|Lack of compliance with study medication|4|||
37836355|NCT02774005|69520769|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
37836356|NCT02774005|69520769|FG000|Overall Study|another study|1|||
37836357|NCT02774005|69520769|FG000|Overall Study|cardiologist imposed travel restriction|1|||
37836358|NCT01975428|69520799|FG000|Overall Study|Lost to Follow-up|17|||
37836359|NCT01975428|69520800|FG001|Overall Study|Lost to Follow-up|4|||
37836360|NCT01975428|69520799|FG000|Overall Study|Withdrawal by Subject|3|||
37836361|NCT01975428|69520800|FG001|Overall Study|Withdrawal by Subject|10|||
37836362|NCT01047540|69520841|FG000|Overall Study|Protocol Violation|1|||
37836363|NCT01047540|69520842|FG001|Overall Study|Protocol Violation|0|||
37836364|NCT01047540|69520843|FG002|Overall Study|Protocol Violation|0|||
37836365|NCT01047540|69520844|FG003|Overall Study|Protocol Violation|0|||
37836366|NCT01047540|69520845|FG004|Overall Study|Protocol Violation|0|||
37836367|NCT01047540|69520841|FG000|Overall Study|Lost to Follow-up|1|||
37836368|NCT01047540|69520842|FG001|Overall Study|Lost to Follow-up|0|||
37836369|NCT01047540|69520843|FG002|Overall Study|Lost to Follow-up|0|||
37836370|NCT01047540|69520844|FG003|Overall Study|Lost to Follow-up|0|||
37836371|NCT01047540|69520845|FG004|Overall Study|Lost to Follow-up|0|||
37836372|NCT01047540|69520841|FG000|Overall Study|Withdrawal by Subject|1|||
37836373|NCT01047540|69520842|FG001|Overall Study|Withdrawal by Subject|0|||
37836374|NCT01047540|69520843|FG002|Overall Study|Withdrawal by Subject|3|||
37836375|NCT01047540|69520844|FG003|Overall Study|Withdrawal by Subject|0|||
37836376|NCT01047540|69520845|FG004|Overall Study|Withdrawal by Subject|1|||
37836377|NCT01047540|69520841|FG000|Overall Study|Pregnancy|1|||
37836378|NCT01047540|69520842|FG001|Overall Study|Pregnancy|0|||
37836379|NCT01047540|69520843|FG002|Overall Study|Pregnancy|0|||
37836380|NCT01047540|69520844|FG003|Overall Study|Pregnancy|0|||
37836381|NCT01047540|69520845|FG004|Overall Study|Pregnancy|0|||
37836382|NCT01047540|69520841|FG000|Overall Study|Adverse Event|1|||
37836383|NCT01047540|69520842|FG001|Overall Study|Adverse Event|0|||
37836384|NCT01047540|69520843|FG002|Overall Study|Adverse Event|0|||
37836385|NCT01047540|69520844|FG003|Overall Study|Adverse Event|0|||
37836386|NCT01047540|69520845|FG004|Overall Study|Adverse Event|0|||
37836387|NCT00521222|69520861|FG000|Overall Study|Lost to Follow-up|0|||
37836388|NCT00521222|69520862|FG001|Overall Study|Lost to Follow-up|0|||
37836389|NCT00521222|69520863|FG002|Overall Study|Lost to Follow-up|1|||
37836390|NCT00521222|69520864|FG003|Overall Study|Lost to Follow-up|1|||
37836391|NCT00521222|69520861|FG000|Overall Study|Withdrawal by Subject|0|||
37836392|NCT00521222|69520862|FG001|Overall Study|Withdrawal by Subject|0|||
37836393|NCT00521222|69520863|FG002|Overall Study|Withdrawal by Subject|2|||
37836394|NCT00521222|69520864|FG003|Overall Study|Withdrawal by Subject|0|||
37836395|NCT00521222|69520861|FG000|Overall Study|Physician Decision|0|||
37836396|NCT00521222|69520862|FG001|Overall Study|Physician Decision|1|||
37836397|NCT00521222|69520863|FG002|Overall Study|Physician Decision|0|||
37836398|NCT00521222|69520864|FG003|Overall Study|Physician Decision|1|||
37836399|NCT01214629|69520898|FG000|Overall Study|Progressive Disease|1|||
37836400|NCT01214629|69520899|FG001|Overall Study|Progressive Disease|1|||
37836401|NCT01214629|69520900|FG002|Overall Study|Progressive Disease|0|||
37836402|NCT01214629|69520901|FG003|Overall Study|Progressive Disease|1|||
37914670|NCT00874770|69601188|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
37914671|NCT00874770|69601189|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
37836403|NCT01214629|69520902|FG004|Overall Study|Progressive Disease|2|||
37836404|NCT01214629|69520903|FG005|Overall Study|Progressive Disease|3|||
37836405|NCT01214629|69520904|FG006|Overall Study|Progressive Disease|1|||
37914672|NCT00874770|69601190|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
37836406|NCT01214629|69520905|FG007|Overall Study|Progressive Disease|1|||
37836407|NCT01214629|69520906|FG008|Overall Study|Progressive Disease|1|||
37836408|NCT01214629|69520907|FG009|Overall Study|Progressive Disease|5|||
37836409|NCT01214629|69520908|FG010|Overall Study|Progressive Disease|1|||
37836410|NCT01214629|69520898|FG000|Overall Study|Adverse Event|0|||
37836411|NCT01214629|69520899|FG001|Overall Study|Adverse Event|0|||
37836412|NCT01214629|69520900|FG002|Overall Study|Adverse Event|0|||
37836413|NCT01214629|69520901|FG003|Overall Study|Adverse Event|1|||
37836414|NCT01214629|69520902|FG004|Overall Study|Adverse Event|0|||
37836415|NCT01214629|69520903|FG005|Overall Study|Adverse Event|1|||
37836416|NCT01214629|69520904|FG006|Overall Study|Adverse Event|0|||
37836417|NCT01214629|69520905|FG007|Overall Study|Adverse Event|0|||
37836418|NCT01214629|69520906|FG008|Overall Study|Adverse Event|0|||
37836419|NCT01214629|69520907|FG009|Overall Study|Adverse Event|1|||
37836420|NCT01214629|69520908|FG010|Overall Study|Adverse Event|0|||
37836421|NCT01214629|69520898|FG000|Overall Study|Physician Decision|0|||
37836422|NCT01214629|69520899|FG001|Overall Study|Physician Decision|0|||
37836423|NCT01214629|69520900|FG002|Overall Study|Physician Decision|0|||
37836424|NCT01214629|69520901|FG003|Overall Study|Physician Decision|0|||
37836425|NCT01214629|69520902|FG004|Overall Study|Physician Decision|0|||
37914673|NCT00536263|69601213|FG000|Overall Study|Adverse Event|5|||
37914674|NCT00536263|69601214|FG001|Overall Study|Adverse Event|5|||
37914675|NCT00536263|69601215|FG002|Overall Study|Adverse Event|7|||
37914676|NCT00536263|69601213|FG000|Overall Study|Lost to Follow-up|3|||
37836426|NCT01214629|69520903|FG005|Overall Study|Physician Decision|0|||
37836427|NCT01214629|69520904|FG006|Overall Study|Physician Decision|0|||
37836428|NCT01214629|69520905|FG007|Overall Study|Physician Decision|0|||
37836429|NCT01214629|69520906|FG008|Overall Study|Physician Decision|0|||
37836430|NCT01214629|69520907|FG009|Overall Study|Physician Decision|0|||
37836431|NCT01214629|69520908|FG010|Overall Study|Physician Decision|1|||
37836432|NCT01214629|69520898|FG000|Overall Study|Withdrawal by Subject|0|||
37836433|NCT01214629|69520899|FG001|Overall Study|Withdrawal by Subject|0|||
37836434|NCT01214629|69520900|FG002|Overall Study|Withdrawal by Subject|0|||
37836435|NCT01214629|69520901|FG003|Overall Study|Withdrawal by Subject|0|||
37836436|NCT01214629|69520902|FG004|Overall Study|Withdrawal by Subject|0|||
37836437|NCT01214629|69520903|FG005|Overall Study|Withdrawal by Subject|0|||
37836438|NCT01214629|69520904|FG006|Overall Study|Withdrawal by Subject|0|||
37836439|NCT01214629|69520905|FG007|Overall Study|Withdrawal by Subject|0|||
37836440|NCT01214629|69520906|FG008|Overall Study|Withdrawal by Subject|0|||
37836441|NCT01214629|69520907|FG009|Overall Study|Withdrawal by Subject|1|||
37836442|NCT01214629|69520908|FG010|Overall Study|Withdrawal by Subject|0|||
37836443|NCT01214434|69520948|FG000|Overall Study|Withdrawal by Subject|1|||
37836444|NCT01214434|69520949|FG001|Overall Study|Withdrawal by Subject|0|||
37836445|NCT01214434|69520948|FG000|Overall Study|Lost to Follow-up|2|||
37836446|NCT01214434|69520949|FG001|Overall Study|Lost to Follow-up|2|||
37836447|NCT01214434|69520948|FG000|Overall Study|Site error|1|||
37836448|NCT01214434|69520949|FG001|Overall Study|Site error|0|||
37836449|NCT01214395|69520955|FG000|Overall Study|All patients had infection|5|||
37836450|NCT01214239|69520962|FG000|Overall Study|Adverse Event|3|||
37914677|NCT00536263|69601214|FG001|Overall Study|Lost to Follow-up|4|||
37914678|NCT00536263|69601215|FG002|Overall Study|Lost to Follow-up|4|||
38023367|NCT02759185|69706211|FG004|Stage 2|Withdrawal by Subject|1|||
38023368|NCT02759185|69706212|FG005|Stage 2|Withdrawal by Subject|1|||
38023369|NCT02759185|69706213|FG006|Stage 2|Withdrawal by Subject|1|||
38023370|NCT02008396|69706250|FG000|Overall Study|Protocol Violation|0|||
38023371|NCT02008396|69706251|FG001|Overall Study|Protocol Violation|1|||
37836451|NCT01214239|69520963|FG001|Overall Study|Adverse Event|4|||
37836452|NCT01214239|69520962|FG000|Overall Study|Protocol Violation|2|||
37914679|NCT00536263|69601213|FG000|Overall Study|Subject withdrew - not treatment related|2|||
37914680|NCT00536263|69601214|FG001|Overall Study|Subject withdrew - not treatment related|0|||
37914681|NCT00536263|69601215|FG002|Overall Study|Subject withdrew - not treatment related|5|||
37914682|NCT00536263|69601213|FG000|Overall Study|Subject withdrew - treatment related|0|||
38023372|NCT01844518|69706269|FG000|Overall Study|Adverse Event|7|||
38023373|NCT01844518|69706270|FG001|Overall Study|Adverse Event|1|||
38023374|NCT01844518|69706269|FG000|Overall Study|Lack of Efficacy|17|||
37836453|NCT01214239|69520963|FG001|Overall Study|Protocol Violation|1|||
37836454|NCT01214239|69520962|FG000|Overall Study|Lost to Follow-up|1|||
37836455|NCT01214239|69520963|FG001|Overall Study|Lost to Follow-up|1|||
37836456|NCT01214239|69520962|FG000|Overall Study|Withdrawal by Subject|4|||
37836457|NCT01214239|69520963|FG001|Overall Study|Withdrawal by Subject|9|||
37836458|NCT01214239|69520962|FG000|Overall Study|Lack of Efficacy|1|||
37836459|NCT01214239|69520963|FG001|Overall Study|Lack of Efficacy|2|||
37914683|NCT00536263|69601214|FG001|Overall Study|Subject withdrew - treatment related|3|||
38023375|NCT01844518|69706270|FG001|Overall Study|Lack of Efficacy|5|||
38023376|NCT01844518|69706269|FG000|Overall Study|Participant's request to discontinue|4|||
37836460|NCT01214239|69520962|FG000|Overall Study|patient's private reason|1|||
37836461|NCT01214239|69520963|FG001|Overall Study|patient's private reason|1|||
37836462|NCT01214200|69520969|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
37836463|NCT01214200|69520969|FG000|Overall Study|Withdrawal by Subject|2|||
37700575|NCT02010255|69177663|FG002|Overall Study|Lack of Efficacy|2|||
37700576|NCT02010255|69177664|FG003|Overall Study|Lack of Efficacy|1|||
37700577|NCT02010255|69177665|FG004|Overall Study|Lack of Efficacy|1|||
37700578|NCT02010255|69177666|FG005|Overall Study|Lack of Efficacy|0|||
37700579|NCT02010255|69177667|FG006|Overall Study|Lack of Efficacy|0|||
37700580|NCT02010255|69177668|FG007|Overall Study|Lack of Efficacy|0|||
37700581|NCT02010255|69177669|FG008|Overall Study|Lack of Efficacy|0|||
37700582|NCT02010255|69177670|FG009|Overall Study|Lack of Efficacy|0|||
37700583|NCT02010255|69177671|FG010|Overall Study|Lack of Efficacy|1|||
37700584|NCT02010255|69177672|FG011|Overall Study|Lack of Efficacy|0|||
37700585|NCT02010255|69177673|FG012|Overall Study|Lack of Efficacy|0|||
37700586|NCT02010255|69177674|FG013|Overall Study|Lack of Efficacy|0|||
37700587|NCT02010255|69177661|FG000|Overall Study|Withdrew Consent|1|||
37700588|NCT02010255|69177662|FG001|Overall Study|Withdrew Consent|0|||
37700589|NCT02010255|69177663|FG002|Overall Study|Withdrew Consent|0|||
37700590|NCT02010255|69177664|FG003|Overall Study|Withdrew Consent|1|||
37700591|NCT02010255|69177665|FG004|Overall Study|Withdrew Consent|0|||
37700592|NCT02010255|69177666|FG005|Overall Study|Withdrew Consent|0|||
37700593|NCT02010255|69177667|FG006|Overall Study|Withdrew Consent|0|||
37700594|NCT02010255|69177668|FG007|Overall Study|Withdrew Consent|0|||
37700595|NCT02010255|69177669|FG008|Overall Study|Withdrew Consent|0|||
37700596|NCT02010255|69177670|FG009|Overall Study|Withdrew Consent|0|||
37700597|NCT02010255|69177671|FG010|Overall Study|Withdrew Consent|0|||
37700598|NCT02010255|69177672|FG011|Overall Study|Withdrew Consent|0|||
37700599|NCT02010255|69177673|FG012|Overall Study|Withdrew Consent|0|||
37700600|NCT02010255|69177674|FG013|Overall Study|Withdrew Consent|0|||
37700601|NCT02010255|69177661|FG000|Overall Study|Adverse Event|1|||
37700602|NCT02010255|69177662|FG001|Overall Study|Adverse Event|0|||
37700603|NCT02010255|69177663|FG002|Overall Study|Adverse Event|0|||
37700604|NCT02010255|69177664|FG003|Overall Study|Adverse Event|0|||
37700605|NCT02010255|69177665|FG004|Overall Study|Adverse Event|0|||
37700606|NCT02010255|69177666|FG005|Overall Study|Adverse Event|0|||
37700607|NCT02010255|69177667|FG006|Overall Study|Adverse Event|0|||
37700608|NCT02010255|69177668|FG007|Overall Study|Adverse Event|0|||
37700609|NCT02010255|69177669|FG008|Overall Study|Adverse Event|0|||
37700610|NCT02010255|69177670|FG009|Overall Study|Adverse Event|0|||
37700611|NCT02010255|69177671|FG010|Overall Study|Adverse Event|0|||
37700612|NCT02010255|69177672|FG011|Overall Study|Adverse Event|0|||
37700613|NCT02010255|69177673|FG012|Overall Study|Adverse Event|0|||
37700614|NCT02010255|69177674|FG013|Overall Study|Adverse Event|0|||
37700615|NCT02010255|69177661|FG000|Overall Study|Lost to Follow-up|0|||
37700616|NCT02010255|69177662|FG001|Overall Study|Lost to Follow-up|0|||
37700617|NCT02010255|69177663|FG002|Overall Study|Lost to Follow-up|1|||
37700618|NCT02010255|69177664|FG003|Overall Study|Lost to Follow-up|0|||
37700619|NCT02010255|69177665|FG004|Overall Study|Lost to Follow-up|1|||
37700620|NCT02010255|69177666|FG005|Overall Study|Lost to Follow-up|0|||
37700621|NCT02010255|69177667|FG006|Overall Study|Lost to Follow-up|0|||
37700622|NCT02010255|69177668|FG007|Overall Study|Lost to Follow-up|0|||
37700623|NCT02010255|69177669|FG008|Overall Study|Lost to Follow-up|0|||
37700624|NCT02010255|69177670|FG009|Overall Study|Lost to Follow-up|0|||
37700625|NCT02010255|69177671|FG010|Overall Study|Lost to Follow-up|0|||
37700626|NCT02010255|69177672|FG011|Overall Study|Lost to Follow-up|0|||
37700627|NCT02010255|69177673|FG012|Overall Study|Lost to Follow-up|0|||
37700628|NCT02010255|69177674|FG013|Overall Study|Lost to Follow-up|0|||
37700629|NCT02010255|69177661|FG000|Overall Study|Randomized but Not Treated|0|||
37836464|NCT01214044|69520975|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
37700630|NCT02010255|69177662|FG001|Overall Study|Randomized but Not Treated|0|||
37700631|NCT02010255|69177663|FG002|Overall Study|Randomized but Not Treated|0|||
37700632|NCT02010255|69177664|FG003|Overall Study|Randomized but Not Treated|0|||
37700633|NCT02010255|69177665|FG004|Overall Study|Randomized but Not Treated|0|||
37700634|NCT02010255|69177666|FG005|Overall Study|Randomized but Not Treated|0|||
37700635|NCT02010255|69177667|FG006|Overall Study|Randomized but Not Treated|0|||
37700636|NCT02010255|69177668|FG007|Overall Study|Randomized but Not Treated|0|||
37700637|NCT02010255|69177669|FG008|Overall Study|Randomized but Not Treated|0|||
37700638|NCT02010255|69177670|FG009|Overall Study|Randomized but Not Treated|0|||
37700639|NCT02010255|69177671|FG010|Overall Study|Randomized but Not Treated|0|||
37700640|NCT02010255|69177672|FG011|Overall Study|Randomized but Not Treated|0|||
37700641|NCT02010255|69177673|FG012|Overall Study|Randomized but Not Treated|0|||
37700642|NCT02010255|69177674|FG013|Overall Study|Randomized but Not Treated|1|||
37700643|NCT02354417|69177729|FG000|Overall Study|Physician Decision|1|||
37700644|NCT02332187|69177735|FG000|Overall Study|Withdrawal by Subject|2|||
37700645|NCT02332187|69177736|FG001|Overall Study|Withdrawal by Subject|2|||
37700646|NCT02332187|69177735|FG000|Overall Study|Adverse Event|0|||
37700647|NCT02332187|69177736|FG001|Overall Study|Adverse Event|1|||
37700648|NCT02330549|69177744|FG000|Overall Study|Adverse Event|1|||
37700649|NCT02330549|69177745|FG001|Overall Study|Adverse Event|0|||
37700650|NCT02330549|69177744|FG000|Overall Study|Subject withdrew consent|2|||
37700651|NCT02330549|69177745|FG001|Overall Study|Subject withdrew consent|1|||
37700652|NCT02330549|69177744|FG000|Overall Study|Failure to meet randomization criteria|1|||
37700653|NCT02330549|69177745|FG001|Overall Study|Failure to meet randomization criteria|0|||
37700654|NCT02009865|69177753|FG000|Overall Study|Adverse Event|0|||
37700655|NCT02009865|69177754|FG001|Overall Study|Adverse Event|2|||
37700656|NCT02009865|69177753|FG000|Overall Study|Protocol Violation|0|||
37700657|NCT02009865|69177754|FG001|Overall Study|Protocol Violation|2|||
37700658|NCT02009865|69177753|FG000|Overall Study|Withdrawal by Subject|1|||
37700659|NCT02009865|69177754|FG001|Overall Study|Withdrawal by Subject|1|||
37700660|NCT01620177|69177760|FG000|Overall Study|Failure at Screening Visit|43|||
37700661|NCT01620177|69177760|FG000|Overall Study|Withdrawal by Subject|26|||
37700662|NCT01620177|69177760|FG000|Overall Study|Lost to Follow-up|7|||
37700663|NCT01620177|69177760|FG000|Overall Study|Physician Decision|2|||
37700664|NCT01620177|69177760|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
37700665|NCT02075541|69177779|FG000|Overall Study|Serious Adverse Event|1|||
37700666|NCT02075541|69177780|FG001|Overall Study|Serious Adverse Event|4|||
37700667|NCT02075541|69177779|FG000|Overall Study|Protocol Violation|1|||
37700668|NCT02075541|69177780|FG001|Overall Study|Protocol Violation|0|||
37700669|NCT02075541|69177779|FG000|Overall Study|Withdrawal by Subject|1|||
37700670|NCT02075541|69177780|FG001|Overall Study|Withdrawal by Subject|3|||
37700671|NCT02075541|69177779|FG000|Overall Study|Sponsor study termination|0|||
37700672|NCT02075541|69177780|FG001|Overall Study|Sponsor study termination|1|||
37700673|NCT02075541|69177779|FG000|Overall Study|Other- unable to perform study procedure|1|||
37700674|NCT02075541|69177780|FG001|Overall Study|Other- unable to perform study procedure|0|||
37700675|NCT02330081|69177786|FG000|Overall Study|Adverse Event|1|||
37700676|NCT02330081|69177786|FG000|Overall Study|Donation did not meet criteria|1|||
37700677|NCT02330081|69177786|FG000|Overall Study|Protocol Violation|6|||
37700678|NCT01986855|69177796|FG000|Overall Study|Adverse Event|1|||
37700679|NCT01986855|69177797|FG001|Overall Study|Adverse Event|0|||
37700680|NCT01986855|69177798|FG002|Overall Study|Adverse Event|0|||
37700681|NCT01986855|69177796|FG000|Overall Study|Death|3|||
37700682|NCT01986855|69177797|FG001|Overall Study|Death|4|||
37700683|NCT01986855|69177798|FG002|Overall Study|Death|4|||
37700684|NCT01986855|69177796|FG000|Overall Study|Lost to Follow-up|2|||
37700685|NCT01986855|69177797|FG001|Overall Study|Lost to Follow-up|1|||
37700686|NCT01986855|69177798|FG002|Overall Study|Lost to Follow-up|0|||
37700687|NCT01986855|69177796|FG000|Overall Study|Screen Failure|0|||
37700688|NCT01986855|69177797|FG001|Overall Study|Screen Failure|1|||
37700689|NCT01986855|69177798|FG002|Overall Study|Screen Failure|0|||
37700690|NCT01986855|69177796|FG000|Overall Study|Participant Moved|0|||
37700691|NCT01986855|69177797|FG001|Overall Study|Participant Moved|0|||
37700692|NCT01986855|69177798|FG002|Overall Study|Participant Moved|2|||
37700693|NCT01986855|69177796|FG000|Overall Study|Withdrawal by Subject|7|||
37700694|NCT01986855|69177797|FG001|Overall Study|Withdrawal by Subject|8|||
37700695|NCT01986855|69177798|FG002|Overall Study|Withdrawal by Subject|5|||
37700696|NCT02075463|69177806|FG000|Overall Study|Adverse Event|3|||
37700697|NCT02075463|69177806|FG000|Overall Study|Par. reached stopping criteria|4|||
37700698|NCT02075463|69177806|FG000|Overall Study|Withdrawal by Subject|1|||
37700699|NCT02353871|69177813|FG000|Overall Study|Protocol deviation|0|||
37836465|NCT01214044|69520975|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
37836466|NCT01214044|69520975|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
37836467|NCT01214044|69520975|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
37836468|NCT01214044|69520975|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
37836469|NCT01214044|69520975|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
37836470|NCT01213966|69520987|FG000|Overall Study|Protocol Violation|1|||
37836471|NCT01213966|69520988|FG001|Overall Study|Protocol Violation|0|||
37700700|NCT02353871|69177814|FG001|Overall Study|Protocol deviation|1|||
37700701|NCT02353871|69177813|FG000|Overall Study|Consent withdrawn|1|||
37700702|NCT02353871|69177814|FG001|Overall Study|Consent withdrawn|8|||
37700703|NCT02353871|69177813|FG000|Overall Study|Lost to Follow-up|2|||
37700704|NCT02353871|69177814|FG001|Overall Study|Lost to Follow-up|0|||
37700705|NCT02009397|69177820|FG000|Overall Study|Protocol Violation|6|||
37700706|NCT02009397|69177820|FG000|Overall Study|Death|8|||
37700707|NCT02009397|69177820|FG000|Overall Study|Lost to Follow-up|6|||
37700708|NCT02312219|69177826|FG000|Overall Study|Withdrawal by Subject|1|||
37700709|NCT02312219|69177827|FG001|Overall Study|Withdrawal by Subject|2|||
37700710|NCT02312219|69177826|FG000|Overall Study|could not schedule imaging in time|0|||
37700711|NCT02312219|69177827|FG001|Overall Study|could not schedule imaging in time|2|||
37700712|NCT02312219|69177826|FG000|Overall Study|Other|0|||
37700713|NCT02312219|69177827|FG001|Overall Study|Other|1|||
37700714|NCT02312219|69177826|FG000|Overall Study|Not randomized. Ineligible|0|||
37700715|NCT02312219|69177827|FG001|Overall Study|Not randomized. Ineligible|1|||
37836472|NCT01213966|69520989|FG002|Overall Study|Protocol Violation|3|||
37700716|NCT01986231|69177833|FG000|Overall Study|Adverse Event|1|||
38023377|NCT01844518|69706270|FG001|Overall Study|Participant's request to discontinue|1|||
38023378|NCT01844518|69706269|FG000|Overall Study|Poor/Non-compliance|1|||
38023379|NCT01844518|69706270|FG001|Overall Study|Poor/Non-compliance|0|||
38023380|NCT01844518|69706269|FG000|Overall Study|No Longer Met Study Criteria|2|||
38023381|NCT01844518|69706270|FG001|Overall Study|No Longer Met Study Criteria|0|||
38023382|NCT01844518|69706269|FG000|Overall Study|Withdrawal by Subject|9|||
38023383|NCT01844518|69706270|FG001|Overall Study|Withdrawal by Subject|0|||
38023384|NCT01844518|69706269|FG000|Overall Study|Pregnancy|1|||
38023385|NCT01844518|69706270|FG001|Overall Study|Pregnancy|0|||
38023386|NCT01793610|69706306|FG000|Overall Study|Withdrawal by Subject|1|||
38023387|NCT01793610|69706307|FG001|Overall Study|Withdrawal by Subject|0|||
38023388|NCT01793610|69706308|FG002|Overall Study|Withdrawal by Subject|1|||
37700717|NCT02312063|69177839|FG000|Overall Study|Withdrawal by Subject|0|||
37700718|NCT02312063|69177840|FG001|Overall Study|Withdrawal by Subject|1|||
37700719|NCT02353169|69177851|FG000|Overall Study|QTc > 450 msec|1|||
37700720|NCT02353169|69177852|FG001|Overall Study|QTc > 450 msec|1|||
37700721|NCT02353169|69177853|FG002|Overall Study|QTc > 450 msec|1|||
37700722|NCT02353169|69177854|FG003|Overall Study|QTc > 450 msec|1|||
37700723|NCT02353169|69177851|FG000|Overall Study|OR team declined|2|||
37700724|NCT02353169|69177852|FG001|Overall Study|OR team declined|0|||
37700725|NCT02353169|69177853|FG002|Overall Study|OR team declined|0|||
37700726|NCT02353169|69177854|FG003|Overall Study|OR team declined|0|||
37700727|NCT02353169|69177851|FG000|Overall Study|Inhalational induction|0|||
37700728|NCT02353169|69177852|FG001|Overall Study|Inhalational induction|2|||
37700729|NCT02353169|69177853|FG002|Overall Study|Inhalational induction|0|||
37700730|NCT02353169|69177854|FG003|Overall Study|Inhalational induction|0|||
37700731|NCT02353169|69177851|FG000|Overall Study|ECG data error|0|||
37700732|NCT02353169|69177852|FG001|Overall Study|ECG data error|3|||
37700733|NCT02353169|69177853|FG002|Overall Study|ECG data error|2|||
37700734|NCT02353169|69177854|FG003|Overall Study|ECG data error|2|||
37700735|NCT02353169|69177851|FG000|Overall Study|Pre-op medication|0|||
37700736|NCT02353169|69177852|FG001|Overall Study|Pre-op medication|0|||
37700737|NCT02353169|69177853|FG002|Overall Study|Pre-op medication|1|||
37700738|NCT02353169|69177854|FG003|Overall Study|Pre-op medication|0|||
37700739|NCT02009163|69177864|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
37700740|NCT02009163|69177865|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
37700741|NCT02009163|69177866|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
37700742|NCT02009163|69177864|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
37700743|NCT02009163|69177865|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
37700744|NCT02009163|69177866|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
37700745|NCT02009163|69177864|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
37700746|NCT02009163|69177865|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
37700747|NCT02009163|69177866|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
37700748|NCT02009163|69177864|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
37700749|NCT02009163|69177865|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
37700750|NCT02009163|69177866|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
37700751|NCT02009163|69177864|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
37700752|NCT02009163|69177865|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
37700753|NCT02009163|69177866|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
37700754|NCT02009163|69177864|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
37700755|NCT02009163|69177865|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
37700756|NCT02009163|69177866|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
37700757|NCT02009163|69177864|FG000|Open-label Period (Non-randomized)|Other|13|||
37700758|NCT02009163|69177865|FG001|Open-label Period (Non-randomized)|Other|0|||
37836473|NCT01213966|69520990|FG003|Overall Study|Protocol Violation|1|||
37836474|NCT01213264|69521003|FG000|Overall Study|Adverse Event|1|||
37700759|NCT02009163|69177866|FG002|Open-label Period (Non-randomized)|Other|0|||
37700760|NCT02009163|69177864|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
37700761|NCT02009163|69177865|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
37700762|NCT02009163|69177866|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
37700763|NCT02009163|69177864|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
37700764|NCT02009163|69177865|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
37700765|NCT02009163|69177866|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
37700766|NCT02009163|69177864|FG000|Randomized-withdrawal Period|Adverse Event|0|||
37700767|NCT02009163|69177865|FG001|Randomized-withdrawal Period|Adverse Event|0|||
37700768|NCT02009163|69177866|FG002|Randomized-withdrawal Period|Adverse Event|6|||
37700769|NCT02009163|69177864|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
37700770|NCT02009163|69177865|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
37700771|NCT02009163|69177866|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
37700772|NCT02009163|69177864|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
37700773|NCT02009163|69177865|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
37700774|NCT02009163|69177866|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
37700775|NCT02009163|69177864|FG000|Randomized-withdrawal Period|Pregnancy|0|||
37700776|NCT02009163|69177865|FG001|Randomized-withdrawal Period|Pregnancy|0|||
37700777|NCT02009163|69177866|FG002|Randomized-withdrawal Period|Pregnancy|2|||
37700778|NCT02009163|69177864|FG000|Randomized-withdrawal Period|Other|0|||
37700779|NCT02009163|69177865|FG001|Randomized-withdrawal Period|Other|9|||
37700780|NCT02009163|69177866|FG002|Randomized-withdrawal Period|Other|5|||
37700781|NCT01983969|69177879|FG000|Overall Study|Disease Progression|0|||
37700782|NCT01983969|69177880|FG001|Overall Study|Disease Progression|1|||
37700783|NCT01983969|69177881|FG002|Overall Study|Disease Progression|0|||
37700784|NCT02008773|69177897|FG000|Overall Study|Adverse Event|3|||
37700785|NCT02008773|69177898|FG001|Overall Study|Adverse Event|3|||
37700786|NCT02008773|69177899|FG002|Overall Study|Adverse Event|1|||
37700787|NCT02008773|69177900|FG003|Overall Study|Adverse Event|2|||
37700788|NCT02008773|69177897|FG000|Overall Study|Medication Non-compliance|2|||
37700789|NCT02008773|69177898|FG001|Overall Study|Medication Non-compliance|1|||
37700790|NCT02008773|69177899|FG002|Overall Study|Medication Non-compliance|3|||
37700791|NCT02008773|69177900|FG003|Overall Study|Medication Non-compliance|2|||
37700792|NCT02008773|69177897|FG000|Overall Study|Withdrawal by Subject|8|||
37700793|NCT02008773|69177898|FG001|Overall Study|Withdrawal by Subject|4|||
37700794|NCT02008773|69177899|FG002|Overall Study|Withdrawal by Subject|7|||
37700795|NCT02008773|69177900|FG003|Overall Study|Withdrawal by Subject|6|||
37700796|NCT02008773|69177897|FG000|Overall Study|Lost to Follow-up|0|||
37700797|NCT02008773|69177898|FG001|Overall Study|Lost to Follow-up|1|||
37700798|NCT02008773|69177899|FG002|Overall Study|Lost to Follow-up|3|||
37700799|NCT02008773|69177900|FG003|Overall Study|Lost to Follow-up|2|||
37700800|NCT02257567|69177919|FG000|Overall Study|Adverse Event|0|||
37700801|NCT02257567|69177920|FG001|Overall Study|Adverse Event|0|||
37700802|NCT02257567|69177921|FG002|Overall Study|Adverse Event|0|||
37700803|NCT02257567|69177922|FG003|Overall Study|Adverse Event|1|||
37700804|NCT02257567|69177923|FG004|Overall Study|Adverse Event|1|||
37700805|NCT02257567|69177924|FG005|Overall Study|Adverse Event|0|||
37700806|NCT02257567|69177925|FG006|Overall Study|Adverse Event|0|||
37700807|NCT02257567|69177926|FG007|Overall Study|Adverse Event|0|||
37700808|NCT02257567|69177927|FG008|Overall Study|Adverse Event|1|||
37700809|NCT02257567|69177928|FG009|Overall Study|Adverse Event|0|||
37700810|NCT02257567|69177929|FG010|Overall Study|Adverse Event|0|||
37700811|NCT02257567|69177919|FG000|Overall Study|Death|2|||
37700812|NCT02257567|69177920|FG001|Overall Study|Death|2|||
37700813|NCT02257567|69177921|FG002|Overall Study|Death|2|||
37700814|NCT02257567|69177922|FG003|Overall Study|Death|4|||
37700815|NCT02257567|69177923|FG004|Overall Study|Death|15|||
37700816|NCT02257567|69177924|FG005|Overall Study|Death|11|||
37700817|NCT02257567|69177925|FG006|Overall Study|Death|26|||
37836475|NCT01213264|69521004|FG001|Overall Study|Adverse Event|0|||
37836476|NCT01213264|69521005|FG002|Overall Study|Adverse Event|0|||
37836477|NCT01213264|69521003|FG000|Overall Study|Lost to Follow-up|1|||
37836478|NCT01213264|69521004|FG001|Overall Study|Lost to Follow-up|2|||
37836479|NCT01213264|69521005|FG002|Overall Study|Lost to Follow-up|6|||
37700818|NCT02257567|69177926|FG007|Overall Study|Death|30|||
37700819|NCT02257567|69177927|FG008|Overall Study|Death|2|||
37700820|NCT02257567|69177928|FG009|Overall Study|Death|18|||
37700821|NCT02257567|69177929|FG010|Overall Study|Death|65|||
37700822|NCT02257567|69177919|FG000|Overall Study|Lost to Follow-up|0|||
37700823|NCT02257567|69177920|FG001|Overall Study|Lost to Follow-up|0|||
37700824|NCT02257567|69177921|FG002|Overall Study|Lost to Follow-up|0|||
37700825|NCT02257567|69177922|FG003|Overall Study|Lost to Follow-up|0|||
37700826|NCT02257567|69177923|FG004|Overall Study|Lost to Follow-up|2|||
37700827|NCT02257567|69177924|FG005|Overall Study|Lost to Follow-up|2|||
37700828|NCT02257567|69177925|FG006|Overall Study|Lost to Follow-up|0|||
37700829|NCT02257567|69177926|FG007|Overall Study|Lost to Follow-up|0|||
37700830|NCT02257567|69177927|FG008|Overall Study|Lost to Follow-up|0|||
37700831|NCT02257567|69177928|FG009|Overall Study|Lost to Follow-up|1|||
37700832|NCT02257567|69177929|FG010|Overall Study|Lost to Follow-up|1|||
37836480|NCT01212991|69521018|FG000|Double-blind|Lost to Follow-up|8|||
37836481|NCT01212991|69521019|FG001|Double-blind|Lost to Follow-up|4|||
38023389|NCT01039584|69706356|FG000|Overall Study|Withdrawal by Subject|4|||
38023390|NCT01039584|69706357|FG001|Overall Study|Withdrawal by Subject|2|||
38023391|NCT01039584|69706358|FG002|Overall Study|Withdrawal by Subject|1|||
38023392|NCT01039584|69706356|FG000|Overall Study|Protocol Violation|10|||
38023393|NCT01039584|69706357|FG001|Overall Study|Protocol Violation|4|||
38023394|NCT01039584|69706358|FG002|Overall Study|Protocol Violation|6|||
38023395|NCT01039584|69706356|FG000|Overall Study|Lost to Follow-up|5|||
38023396|NCT01039584|69706357|FG001|Overall Study|Lost to Follow-up|3|||
38023397|NCT01039584|69706358|FG002|Overall Study|Lost to Follow-up|4|||
38023398|NCT01039584|69706356|FG000|Overall Study|Negative Baseline culture for Candida|59|||
38023399|NCT01039584|69706357|FG001|Overall Study|Negative Baseline culture for Candida|59|||
38023400|NCT01039584|69706358|FG002|Overall Study|Negative Baseline culture for Candida|24|||
38023401|NCT01039584|69706356|FG000|Overall Study|Lack of Efficacy|7|||
38023402|NCT01039584|69706357|FG001|Overall Study|Lack of Efficacy|6|||
38023403|NCT01039584|69706358|FG002|Overall Study|Lack of Efficacy|10|||
38023404|NCT01039584|69706356|FG000|Overall Study|other|1|||
38023405|NCT01039584|69706357|FG001|Overall Study|other|3|||
38023406|NCT01039584|69706358|FG002|Overall Study|other|1|||
38023407|NCT01039584|69706356|FG000|Overall Study|Pap smear with significant pathology|10|||
38023408|NCT01039584|69706357|FG001|Overall Study|Pap smear with significant pathology|10|||
38023409|NCT01039584|69706358|FG002|Overall Study|Pap smear with significant pathology|3|||
38023410|NCT01039584|69706356|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
38023411|NCT01039584|69706357|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
38023412|NCT01039584|69706358|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
38023413|NCT00920387|69706368|FG000|Stage 1|Adverse Event|1|||
38023414|NCT00920387|69706369|FG001|Stage 1|Adverse Event|0|||
38023415|NCT00920387|69706370|FG002|Stage 1|Adverse Event|0|||
38023416|NCT00679783|69706395|FG000|Overall Study|Adverse Event|0|||
38023417|NCT00679783|69706396|FG001|Overall Study|Adverse Event|0|||
38023418|NCT00679783|69706397|FG002|Overall Study|Adverse Event|0|||
38023419|NCT00679783|69706398|FG003|Overall Study|Adverse Event|3|||
38023420|NCT00679783|69706399|FG004|Overall Study|Adverse Event|0|||
38023421|NCT00679783|69706400|FG005|Overall Study|Adverse Event|0|||
38023422|NCT00679783|69706401|FG006|Overall Study|Adverse Event|1|||
38023423|NCT00679783|69706395|FG000|Overall Study|Lack of Efficacy|0|||
38023424|NCT00679783|69706396|FG001|Overall Study|Lack of Efficacy|1|||
38023425|NCT00679783|69706397|FG002|Overall Study|Lack of Efficacy|0|||
38023426|NCT00679783|69706398|FG003|Overall Study|Lack of Efficacy|2|||
38023427|NCT00679783|69706399|FG004|Overall Study|Lack of Efficacy|0|||
38023428|NCT00679783|69706400|FG005|Overall Study|Lack of Efficacy|0|||
38023429|NCT00679783|69706401|FG006|Overall Study|Lack of Efficacy|0|||
37836482|NCT01212991|69521020|FG002|Double-blind|Lost to Follow-up|0|||
37836483|NCT01212991|69521018|FG000|Double-blind|Death|699|||
37836484|NCT01212991|69521019|FG001|Double-blind|Death|550|||
37836485|NCT01212991|69521020|FG002|Double-blind|Death|0|||
37836486|NCT01212991|69521018|FG000|Double-blind|Withdrawal by Subject|16|||
37836487|NCT01212991|69521019|FG001|Double-blind|Withdrawal by Subject|19|||
37836488|NCT01212991|69521020|FG002|Double-blind|Withdrawal by Subject|0|||
38023430|NCT00679783|69706395|FG000|Overall Study|Withdrawal by Subject|0|||
37836489|NCT01212991|69521018|FG000|Double-blind|Other|7|||
37836490|NCT01212991|69521019|FG001|Double-blind|Other|0|||
37836491|NCT01212991|69521020|FG002|Double-blind|Other|0|||
38023431|NCT00679783|69706396|FG001|Overall Study|Withdrawal by Subject|0|||
38023432|NCT00679783|69706397|FG002|Overall Study|Withdrawal by Subject|1|||
38023433|NCT00679783|69706398|FG003|Overall Study|Withdrawal by Subject|1|||
38023434|NCT00679783|69706399|FG004|Overall Study|Withdrawal by Subject|0|||
37836492|NCT01212991|69521018|FG000|Double-blind|Sponsor decision|142|||
37700833|NCT02257567|69177919|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
37700834|NCT02257567|69177920|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
37700835|NCT02257567|69177921|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
37700836|NCT02257567|69177922|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
37700837|NCT02257567|69177923|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
37700838|NCT02257567|69177924|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
37700839|NCT02257567|69177925|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
37700840|NCT02257567|69177926|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
37700841|NCT02257567|69177927|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
37700842|NCT02257567|69177928|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
37700843|NCT02257567|69177929|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
37700844|NCT02257567|69177919|FG000|Overall Study|Physician Decision|0|||
37700845|NCT02257567|69177920|FG001|Overall Study|Physician Decision|0|||
37700846|NCT02257567|69177921|FG002|Overall Study|Physician Decision|0|||
37700847|NCT02257567|69177922|FG003|Overall Study|Physician Decision|0|||
37700848|NCT02257567|69177923|FG004|Overall Study|Physician Decision|0|||
37700849|NCT02257567|69177924|FG005|Overall Study|Physician Decision|0|||
37700850|NCT02257567|69177925|FG006|Overall Study|Physician Decision|0|||
37700851|NCT02257567|69177926|FG007|Overall Study|Physician Decision|2|||
37700852|NCT02257567|69177927|FG008|Overall Study|Physician Decision|0|||
37700853|NCT02257567|69177928|FG009|Overall Study|Physician Decision|1|||
37700854|NCT02257567|69177929|FG010|Overall Study|Physician Decision|0|||
37700855|NCT02257567|69177919|FG000|Overall Study|Withdrawal by Subject|0|||
37700856|NCT02257567|69177920|FG001|Overall Study|Withdrawal by Subject|0|||
37700857|NCT02257567|69177921|FG002|Overall Study|Withdrawal by Subject|2|||
37700858|NCT02257567|69177922|FG003|Overall Study|Withdrawal by Subject|0|||
37700859|NCT02257567|69177923|FG004|Overall Study|Withdrawal by Subject|0|||
37700860|NCT02257567|69177924|FG005|Overall Study|Withdrawal by Subject|6|||
37700861|NCT02257567|69177925|FG006|Overall Study|Withdrawal by Subject|6|||
37700862|NCT02257567|69177926|FG007|Overall Study|Withdrawal by Subject|6|||
37700863|NCT02257567|69177927|FG008|Overall Study|Withdrawal by Subject|1|||
37700864|NCT02257567|69177928|FG009|Overall Study|Withdrawal by Subject|1|||
37700865|NCT02257567|69177929|FG010|Overall Study|Withdrawal by Subject|10|||
37700866|NCT01642615|69177986|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
37700867|NCT01642615|69177987|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
37700868|NCT01642615|69177988|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
37700869|NCT01642615|69177986|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
37700870|NCT01642615|69177987|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
37700871|NCT01642615|69177988|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
37700872|NCT01642615|69177986|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
37700873|NCT01642615|69177987|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
37700874|NCT01642615|69177988|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
37700875|NCT01642615|69177986|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
37700876|NCT01642615|69177987|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
37700877|NCT01642615|69177988|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
37700878|NCT01642615|69177986|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
37700879|NCT01642615|69177987|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
37700880|NCT01642615|69177988|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
37700881|NCT01642615|69177986|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
37700882|NCT01642615|69177987|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
37700883|NCT01642615|69177988|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
37700884|NCT01642615|69177986|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
37700885|NCT01642615|69177987|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
37700886|NCT01642615|69177988|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
37914684|NCT00536263|69601215|FG002|Overall Study|Subject withdrew - treatment related|2|||
37914685|NCT00536263|69601213|FG000|Overall Study|Noncompliance with protocol|0|||
37914686|NCT00536263|69601214|FG001|Overall Study|Noncompliance with protocol|0|||
37914687|NCT00536263|69601215|FG002|Overall Study|Noncompliance with protocol|1|||
37914688|NCT00536263|69601213|FG000|Overall Study|Did not meet protocol eligibility|1|||
37914689|NCT00536263|69601214|FG001|Overall Study|Did not meet protocol eligibility|2|||
37914690|NCT00536263|69601215|FG002|Overall Study|Did not meet protocol eligibility|2|||
37914691|NCT00578344|69601223|FG000|Overall Study|Insurance problems|1|||
37914692|NCT00578344|69601223|FG000|Overall Study|Graft failure|1|||
37914693|NCT00873366|69601227|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
37914694|NCT00873366|69601227|FG000|Overall Study|Off tamoxifen due to side effects|2|||
37700887|NCT01642615|69177986|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
37700888|NCT01642615|69177987|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
37700889|NCT01642615|69177988|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
37700890|NCT01642615|69177986|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
37700891|NCT01642615|69177987|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
37700892|NCT01642615|69177988|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
37700893|NCT02311361|69178000|FG000|Overall Study|Did not receive treatment|0|||
37700894|NCT02311361|69178001|FG001|Overall Study|Did not receive treatment|1|||
37700895|NCT02311361|69178002|FG002|Overall Study|Did not receive treatment|0|||
37700896|NCT02311361|69178003|FG003|Overall Study|Did not receive treatment|1|||
37700897|NCT02352779|69178020|FG000|Overall Study|Personal Issues|1|||
37700898|NCT02352779|69178021|FG001|Overall Study|Personal Issues|1|||
37700899|NCT02352779|69178022|FG002|Overall Study|Personal Issues|0|||
37700900|NCT02352779|69178020|FG000|Overall Study|Too Many Forms|2|||
38023435|NCT00679783|69706400|FG005|Overall Study|Withdrawal by Subject|0|||
37700901|NCT02352779|69178021|FG001|Overall Study|Too Many Forms|0|||
37700902|NCT02352779|69178022|FG002|Overall Study|Too Many Forms|0|||
37700903|NCT02352779|69178020|FG000|Overall Study|Feeling Overwhelmed|1|||
37836493|NCT01212991|69521019|FG001|Double-blind|Sponsor decision|38|||
37836494|NCT01212991|69521020|FG002|Double-blind|Sponsor decision|0|||
37836495|NCT01212991|69521018|FG000|Open-label|Death|0|||
37836496|NCT01212991|69521019|FG001|Open-label|Death|0|||
37836497|NCT01212991|69521020|FG002|Open-label|Death|166|||
38023436|NCT00679783|69706401|FG006|Overall Study|Withdrawal by Subject|0|||
38023437|NCT00679783|69706395|FG000|Overall Study|Not Captured|0|||
38023438|NCT00679783|69706396|FG001|Overall Study|Not Captured|0|||
38023439|NCT00679783|69706397|FG002|Overall Study|Not Captured|0|||
38023440|NCT00679783|69706398|FG003|Overall Study|Not Captured|5|||
38023441|NCT00679783|69706399|FG004|Overall Study|Not Captured|0|||
38023442|NCT00679783|69706400|FG005|Overall Study|Not Captured|0|||
38023443|NCT00679783|69706401|FG006|Overall Study|Not Captured|0|||
38023444|NCT00679783|69706395|FG000|Overall Study|Ongoing at data cut-off|2|||
38023445|NCT00679783|69706396|FG001|Overall Study|Ongoing at data cut-off|2|||
37836498|NCT01212991|69521018|FG000|Open-label|Lost to Follow-up|0|||
37836499|NCT01212991|69521019|FG001|Open-label|Lost to Follow-up|0|||
37836500|NCT01212991|69521020|FG002|Open-label|Lost to Follow-up|5|||
37700904|NCT02352779|69178021|FG001|Overall Study|Feeling Overwhelmed|0|||
37700905|NCT02352779|69178022|FG002|Overall Study|Feeling Overwhelmed|0|||
37836501|NCT01212991|69521018|FG000|Open-label|Withdrawal by Subject|0|||
37914695|NCT00873366|69601227|FG000|Overall Study|Refused to continue DM-BT testing|3|||
37914696|NCT00536107|69601233|FG000|Overall Study|Death|5|||
37914697|NCT00536107|69601234|FG001|Overall Study|Death|1|||
38023446|NCT00679783|69706397|FG002|Overall Study|Ongoing at data cut-off|0|||
37700906|NCT02352779|69178020|FG000|Overall Study|Disliked Intervention|1|||
37836502|NCT01212991|69521019|FG001|Open-label|Withdrawal by Subject|0|||
37700907|NCT02352779|69178021|FG001|Overall Study|Disliked Intervention|0|||
37700908|NCT02352779|69178022|FG002|Overall Study|Disliked Intervention|0|||
37700909|NCT02352779|69178020|FG000|Overall Study|Changed Mind|1|||
37700910|NCT02352779|69178021|FG001|Overall Study|Changed Mind|0|||
37700911|NCT02352779|69178022|FG002|Overall Study|Changed Mind|0|||
37700912|NCT02352779|69178020|FG000|Overall Study|Study Related Symptoms|1|||
37700913|NCT02352779|69178021|FG001|Overall Study|Study Related Symptoms|0|||
37700914|NCT02352779|69178022|FG002|Overall Study|Study Related Symptoms|0|||
37700915|NCT02352779|69178020|FG000|Overall Study|Absence of Symptoms|1|||
37700916|NCT02352779|69178021|FG001|Overall Study|Absence of Symptoms|0|||
37700917|NCT02352779|69178022|FG002|Overall Study|Absence of Symptoms|0|||
37700918|NCT02352779|69178020|FG000|Overall Study|Other Medical Reason|0|||
37700919|NCT02352779|69178021|FG001|Overall Study|Other Medical Reason|0|||
37700920|NCT02352779|69178022|FG002|Overall Study|Other Medical Reason|1|||
37700921|NCT02352779|69178020|FG000|Overall Study|No Reason|0|||
37700922|NCT02352779|69178021|FG001|Overall Study|No Reason|0|||
37700923|NCT02352779|69178022|FG002|Overall Study|No Reason|1|||
37700924|NCT02257489|69178039|FG000|Overall Study|Withdrawal by Subject|0|||
37700925|NCT02257489|69178040|FG001|Overall Study|Withdrawal by Subject|0|||
37700926|NCT02257489|69178041|FG002|Overall Study|Withdrawal by Subject|0|||
37700927|NCT02257489|69178042|FG003|Overall Study|Withdrawal by Subject|1|||
37700928|NCT02257489|69178043|FG004|Overall Study|Withdrawal by Subject|0|||
37700929|NCT02257489|69178044|FG005|Overall Study|Withdrawal by Subject|0|||
37700930|NCT02257489|69178045|FG006|Overall Study|Withdrawal by Subject|0|||
37700931|NCT02257489|69178046|FG007|Overall Study|Withdrawal by Subject|0|||
37700932|NCT02257489|69178047|FG008|Overall Study|Withdrawal by Subject|0|||
37700933|NCT02329223|69178070|FG000|Overall Study|Withdrawal by Subject|1|||
37700934|NCT02329223|69178071|FG001|Overall Study|Withdrawal by Subject|2|||
37700935|NCT02329223|69178072|FG002|Overall Study|Withdrawal by Subject|5|||
37700936|NCT02329223|69178070|FG000|Overall Study|Physician Decision|0|||
37914698|NCT00536107|69601233|FG000|Overall Study|Incorrect enrolment|1|||
37914699|NCT00536107|69601234|FG001|Overall Study|Incorrect enrolment|0|||
37914700|NCT00536107|69601233|FG000|Overall Study|Withdrawal by Subject|0|||
37700937|NCT02329223|69178071|FG001|Overall Study|Physician Decision|0|||
37700938|NCT02329223|69178072|FG002|Overall Study|Physician Decision|1|||
37700939|NCT02329223|69178070|FG000|Overall Study|Adverse Event|0|||
37700940|NCT02329223|69178071|FG001|Overall Study|Adverse Event|1|||
37700941|NCT02329223|69178072|FG002|Overall Study|Adverse Event|0|||
37700942|NCT01641601|69178082|FG000|Overall Study|Study discontinued.|3|||
37700943|NCT01641601|69178083|FG001|Overall Study|Study discontinued.|5|||
37700944|NCT02350127|69178091|FG000|4-Month Assessment|Withdrawal by Subject|10|||
37700945|NCT02350127|69178092|FG001|4-Month Assessment|Withdrawal by Subject|9|||
37700946|NCT02350127|69178091|FG000|4-Month Assessment|Death|1|||
37700947|NCT02350127|69178092|FG001|4-Month Assessment|Death|0|||
37700948|NCT02350127|69178091|FG000|8-Month Assessment|Death|1|||
37700949|NCT02350127|69178092|FG001|8-Month Assessment|Death|1|||
37700950|NCT02350127|69178091|FG000|8-Month Assessment|Withdrawal by Subject|5|||
37700951|NCT02350127|69178092|FG001|8-Month Assessment|Withdrawal by Subject|8|||
38023447|NCT00679783|69706398|FG003|Overall Study|Ongoing at data cut-off|9|||
38023448|NCT00679783|69706399|FG004|Overall Study|Ongoing at data cut-off|1|||
38023449|NCT00679783|69706400|FG005|Overall Study|Ongoing at data cut-off|0|||
38023450|NCT00679783|69706401|FG006|Overall Study|Ongoing at data cut-off|0|||
38023451|NCT03896490|69706423|FG000|Overall Study|Withdrawal by Subject|1|||
38023452|NCT03896490|69706424|FG001|Overall Study|Withdrawal by Subject|1|||
38023453|NCT03617172|69706432|FG000|Overall Study|Lost to Follow-up|1|||
38023454|NCT03617172|69706433|FG001|Overall Study|Lost to Follow-up|0|||
38023455|NCT03760146|69706445|FG000|Overall Study|Adverse Event|11|||
38023456|NCT03760146|69706446|FG001|Overall Study|Adverse Event|8|||
38023457|NCT03760146|69706447|FG002|Overall Study|Adverse Event|0|||
38023458|NCT03760146|69706448|FG003|Overall Study|Adverse Event|0|||
38023459|NCT03760146|69706449|FG004|Overall Study|Adverse Event|0|||
38023460|NCT03760146|69706450|FG005|Overall Study|Adverse Event|0|||
38023461|NCT03760146|69706445|FG000|Overall Study|Death|1|||
38023462|NCT03760146|69706446|FG001|Overall Study|Death|0|||
37836503|NCT01212991|69521020|FG002|Open-label|Withdrawal by Subject|7|||
37836504|NCT01212991|69521018|FG000|Open-label|Sponsor decision|0|||
37836505|NCT01212991|69521019|FG001|Open-label|Sponsor decision|0|||
37836506|NCT01212991|69521020|FG002|Open-label|Sponsor decision|53|||
37836507|NCT01212991|69521018|FG000|Open-label|Other|0|||
37836508|NCT01212991|69521019|FG001|Open-label|Other|0|||
38023463|NCT03760146|69706447|FG002|Overall Study|Death|0|||
37700952|NCT02256553|69178099|FG000|Period I|Adverse Event|5|||
37836509|NCT01212991|69521020|FG002|Open-label|Other|3|||
37700953|NCT02256553|69178099|FG000|Period I|Protocol Violation|1|||
37700954|NCT02256553|69178099|FG000|Period II|Adverse Event|1|||
37836510|NCT01212757|69521031|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
38023464|NCT03760146|69706448|FG003|Overall Study|Death|0|||
38023465|NCT03760146|69706449|FG004|Overall Study|Death|0|||
38023466|NCT03760146|69706450|FG005|Overall Study|Death|0|||
37914701|NCT00536107|69601234|FG001|Overall Study|Withdrawal by Subject|1|||
37914702|NCT00536107|69601233|FG000|Overall Study|Study Termination|2|||
37914703|NCT00536107|69601234|FG001|Overall Study|Study Termination|4|||
37914704|NCT00885482|69601254|FG000|Overall Study|Pregnancy|1|||
37914705|NCT00885482|69601254|FG000|Overall Study|Lack of Efficacy|1|||
37914706|NCT00885482|69601254|FG000|Overall Study|Death|1|||
37914707|NCT00885482|69601254|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
37914708|NCT00885170|69601278|FG000|Overall Study|Adverse Event|12|||
37914709|NCT00885170|69601279|FG001|Overall Study|Adverse Event|4|||
37914710|NCT00885170|69601278|FG000|Overall Study|Excessive bone loss|6|||
37914711|NCT00885170|69601279|FG001|Overall Study|Excessive bone loss|3|||
37914712|NCT00885170|69601278|FG000|Overall Study|Lost to Follow-up|2|||
37914713|NCT00885170|69601279|FG001|Overall Study|Lost to Follow-up|1|||
37914714|NCT00885170|69601278|FG000|Overall Study|Physician Decision|2|||
37914715|NCT00885170|69601279|FG001|Overall Study|Physician Decision|1|||
37914716|NCT00885170|69601278|FG000|Overall Study|Protocol Violation|3|||
37914717|NCT00885170|69601279|FG001|Overall Study|Protocol Violation|1|||
37914718|NCT00885170|69601278|FG000|Overall Study|Withdrawal by Subject|13|||
37914719|NCT00885170|69601279|FG001|Overall Study|Withdrawal by Subject|13|||
37914720|NCT00866619|69601306|FG000|Overall Study|Adverse Event|112|||
37914721|NCT00866619|69601307|FG001|Overall Study|Adverse Event|106|||
37914722|NCT00866619|69601308|FG002|Overall Study|Adverse Event|47|||
37914723|NCT00866619|69601309|FG003|Overall Study|Adverse Event|44|||
37914724|NCT00866619|69601306|FG000|Overall Study|Protocol Violation|2|||
37914725|NCT00866619|69601307|FG001|Overall Study|Protocol Violation|39|||
37914726|NCT00866619|69601308|FG002|Overall Study|Protocol Violation|2|||
37914727|NCT00866619|69601309|FG003|Overall Study|Protocol Violation|17|||
37914728|NCT00866619|69601306|FG000|Overall Study|Withdrawal by Subject|587|||
37914729|NCT00866619|69601307|FG001|Overall Study|Withdrawal by Subject|295|||
37914730|NCT00866619|69601308|FG002|Overall Study|Withdrawal by Subject|272|||
37914731|NCT00866619|69601309|FG003|Overall Study|Withdrawal by Subject|144|||
37700955|NCT02256553|69178099|FG000|Period II|Subject Moved|1|||
37700956|NCT02256553|69178099|FG000|Period III|Adverse Event|3|||
37700957|NCT02349425|69178109|FG000|Period 1|Adverse Event|1|||
37700958|NCT02349425|69178110|FG001|Period 1|Adverse Event|1|||
37700959|NCT02349425|69178111|FG002|Period 1|Adverse Event|0|||
37700960|NCT02349425|69178112|FG003|Period 1|Adverse Event|0|||
37700961|NCT02349425|69178109|FG000|Period 2|Adverse Event|0|||
37700962|NCT02349425|69178110|FG001|Period 2|Adverse Event|1|||
37700963|NCT02349425|69178111|FG002|Period 2|Adverse Event|1|||
37700964|NCT02349425|69178112|FG003|Period 2|Adverse Event|0|||
37700965|NCT02310581|69178154|FG000|Overall Study|Adverse Event|1|||
37700966|NCT02310581|69178155|FG001|Overall Study|Adverse Event|1|||
37700967|NCT02310581|69178156|FG002|Overall Study|Adverse Event|1|||
37700968|NCT02310581|69178157|FG003|Overall Study|Adverse Event|0|||
37700969|NCT02310581|69178154|FG000|Overall Study|Withdrawal by Subject|2|||
37836511|NCT01212757|69521032|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
37836512|NCT01212757|69521033|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
37836513|NCT01212757|69521034|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
37836514|NCT01212757|69521035|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
37836515|NCT01212757|69521036|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
37836516|NCT01212757|69521037|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
37836517|NCT01212757|69521038|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
37914732|NCT00866619|69601306|FG000|Overall Study|Lost to Follow-up|1145|||
37914733|NCT00866619|69601307|FG001|Overall Study|Lost to Follow-up|830|||
37914734|NCT00866619|69601308|FG002|Overall Study|Lost to Follow-up|568|||
37914735|NCT00866619|69601309|FG003|Overall Study|Lost to Follow-up|425|||
37700970|NCT02310581|69178155|FG001|Overall Study|Withdrawal by Subject|1|||
37700971|NCT02310581|69178156|FG002|Overall Study|Withdrawal by Subject|0|||
37700972|NCT02310581|69178157|FG003|Overall Study|Withdrawal by Subject|1|||
37700973|NCT02309723|69178170|FG000|Overall Study|Withdrawal by Subject|24|||
37700974|NCT02309723|69178171|FG001|Overall Study|Withdrawal by Subject|23|||
37700975|NCT02309723|69178172|FG002|Overall Study|Withdrawal by Subject|24|||
37700976|NCT02309411|69178183|FG000|Overall Study|Physician Decision|1|||
37700977|NCT02309411|69178184|FG001|Overall Study|Physician Decision|0|||
37700978|NCT02309411|69178185|FG002|Overall Study|Physician Decision|0|||
37700979|NCT02309411|69178183|FG000|Overall Study|Withdrawal by Subject|1|||
37700980|NCT02309411|69178184|FG001|Overall Study|Withdrawal by Subject|1|||
37700981|NCT02309411|69178185|FG002|Overall Study|Withdrawal by Subject|0|||
37700982|NCT02008227|69178194|FG000|Overall Study|Lost to Follow-up|7|||
37700983|NCT02008227|69178195|FG001|Overall Study|Lost to Follow-up|9|||
37700984|NCT02008227|69178194|FG000|Overall Study|Death|494|||
37700985|NCT02008227|69178195|FG001|Overall Study|Death|485|||
37700986|NCT02008227|69178194|FG000|Overall Study|Withdrawal by Subject|67|||
37700987|NCT02008227|69178195|FG001|Overall Study|Withdrawal by Subject|36|||
37700988|NCT02008227|69178194|FG000|Overall Study|Study Terminated By Sponsor|44|||
37700989|NCT02008227|69178195|FG001|Overall Study|Study Terminated By Sponsor|83|||
37700990|NCT02006979|69178204|FG000|Overall Study|Withdrawal by Subject|1|||
37700991|NCT02006979|69178205|FG001|Overall Study|Withdrawal by Subject|1|||
37700992|NCT02006979|69178204|FG000|Overall Study|Protocol Violation|0|||
37700993|NCT02006979|69178205|FG001|Overall Study|Protocol Violation|1|||
37700994|NCT02348723|69178213|FG000|Overall Study|No ablation|21|||
37700995|NCT02348723|69178214|FG001|Overall Study|No ablation|20|||
37700996|NCT02348723|69178213|FG000|Overall Study|Non-compliant with Protocol|1|||
37700997|NCT02348723|69178214|FG001|Overall Study|Non-compliant with Protocol|0|||
37700998|NCT02348723|69178213|FG000|Overall Study|Lost to Follow-up|1|||
37700999|NCT02348723|69178214|FG001|Overall Study|Lost to Follow-up|1|||
37701000|NCT02348723|69178213|FG000|Overall Study|Consent withdrawn|1|||
37701001|NCT02348723|69178214|FG001|Overall Study|Consent withdrawn|3|||
37701002|NCT02348723|69178213|FG000|Overall Study|Reason other than specified|1|||
37701003|NCT02348723|69178214|FG001|Overall Study|Reason other than specified|1|||
37701004|NCT02348723|69178213|FG000|Overall Study|Adverse Event|3|||
37701005|NCT02348723|69178214|FG001|Overall Study|Adverse Event|1|||
37701006|NCT01967277|69178222|FG000|Overall Study|Lost to Follow-up|1|||
37701007|NCT01967277|69178223|FG001|Overall Study|Lost to Follow-up|2|||
37701008|NCT01967277|69178222|FG000|Overall Study|Unrelated illness|0|||
37701009|NCT01967277|69178223|FG001|Overall Study|Unrelated illness|1|||
37701010|NCT02326883|69178232|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
37701011|NCT02326883|69178233|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
37701012|NCT02326883|69178234|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
37701013|NCT02006667|69178242|FG000|Overall Study|Adverse Event|3|||
37701014|NCT02006667|69178242|FG000|Overall Study|Death|2|||
37701015|NCT02006667|69178242|FG000|Overall Study|Withdrawal by Subject|1|||
37701016|NCT01983111|69178248|FG000|Overall Study|Withdrawal by Subject|8|||
37701017|NCT01983111|69178249|FG001|Overall Study|Withdrawal by Subject|6|||
37701018|NCT01983111|69178248|FG000|Overall Study|Adverse Event|4|||
37701019|NCT01983111|69178249|FG001|Overall Study|Adverse Event|0|||
37701020|NCT01983111|69178248|FG000|Overall Study|Protocol Violation|0|||
37701021|NCT01983111|69178249|FG001|Overall Study|Protocol Violation|1|||
37701022|NCT02348489|69178257|FG000|Overall Study|Death|336|||
37701023|NCT02348489|69178258|FG001|Overall Study|Death|335|||
37701024|NCT02348489|69178257|FG000|Overall Study|Withdrawal by Subject|14|||
37701025|NCT02348489|69178258|FG001|Overall Study|Withdrawal by Subject|27|||
37701026|NCT02348489|69178257|FG000|Overall Study|Lost to Follow-up|3|||
37701027|NCT02348489|69178258|FG001|Overall Study|Lost to Follow-up|5|||
37701028|NCT02309099|69178268|FG000|Overall Study|Adverse Event|2|||
37701029|NCT02309099|69178269|FG001|Overall Study|Adverse Event|0|||
37701030|NCT01966107|69178277|FG000|Overall Study|excluded from FAS|21|||
37701031|NCT01966107|69178278|FG001|Overall Study|excluded from FAS|20|||
37701032|NCT01966107|69178277|FG000|Overall Study|discontinued treatment|345|||
37701033|NCT01966107|69178278|FG001|Overall Study|discontinued treatment|372|||
37701034|NCT01966107|69178277|FG000|Overall Study|due to study closure|164|||
37701035|NCT01966107|69178278|FG001|Overall Study|due to study closure|186|||
37836518|NCT01212757|69521039|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
38023467|NCT03760146|69706445|FG000|Overall Study|Lost to Follow-up|41|||
37701036|NCT01966107|69178277|FG000|Overall Study|withdrew from the study|272|||
37701037|NCT01966107|69178278|FG001|Overall Study|withdrew from the study|303|||
37701038|NCT02347943|69178287|FG000|Overall Study|Study was cancelled|140|||
37701039|NCT02347943|69178288|FG001|Overall Study|Study was cancelled|67|||
37701040|NCT02347943|69178289|FG002|Overall Study|Study was cancelled|45|||
37701041|NCT01982331|69178299|FG000|Received Vaccination 2|Adverse Event|1|||
37701042|NCT01982331|69178300|FG001|Received Vaccination 2|Adverse Event|2|||
38023468|NCT03760146|69706446|FG001|Overall Study|Lost to Follow-up|28|||
38023469|NCT03760146|69706447|FG002|Overall Study|Lost to Follow-up|9|||
38023470|NCT03760146|69706448|FG003|Overall Study|Lost to Follow-up|2|||
38023471|NCT03760146|69706449|FG004|Overall Study|Lost to Follow-up|14|||
38023472|NCT03760146|69706450|FG005|Overall Study|Lost to Follow-up|8|||
37701043|NCT01982331|69178299|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
37701044|NCT01982331|69178300|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
37701045|NCT01982331|69178299|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
37701046|NCT01982331|69178300|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
37701047|NCT02326025|69178308|FG000|Overall Study|Adverse Event|3|||
37701048|NCT02326025|69178309|FG001|Overall Study|Adverse Event|0|||
37701049|NCT02326025|69178308|FG000|Overall Study|Physician Decision|1|||
37701050|NCT02326025|69178309|FG001|Overall Study|Physician Decision|2|||
37701051|NCT02326025|69178308|FG000|Overall Study|Physician and Participant Decision|1|||
37701052|NCT02326025|69178309|FG001|Overall Study|Physician and Participant Decision|0|||
37701053|NCT02326025|69178308|FG000|Overall Study|Withdrawal by Subject|0|||
37701054|NCT02326025|69178309|FG001|Overall Study|Withdrawal by Subject|2|||
37701055|NCT02326025|69178308|FG000|Overall Study|Protocol Violation|0|||
37701056|NCT02326025|69178309|FG001|Overall Study|Protocol Violation|1|||
37701057|NCT01619865|69178328|FG000|Overall Study|Adverse Event|1|||
37701058|NCT01619865|69178328|FG000|Overall Study|Death|2|||
37701059|NCT01619865|69178328|FG000|Overall Study|subject not able to comply|1|||
37701060|NCT02006121|69178335|FG000|Double Blind Phase|Adverse Event|6|||
37701061|NCT02006121|69178336|FG001|Double Blind Phase|Adverse Event|0|||
37701062|NCT02006121|69178335|FG000|Double Blind Phase|Lack of Efficacy|1|||
37701063|NCT02006121|69178336|FG001|Double Blind Phase|Lack of Efficacy|16|||
37701064|NCT02006121|69178335|FG000|Double Blind Phase|Withdrawal by Subject|3|||
37701065|NCT02006121|69178336|FG001|Double Blind Phase|Withdrawal by Subject|4|||
37701066|NCT02006121|69178335|FG000|Double Blind Phase|Non-compliance with study drug|1|||
37701067|NCT02006121|69178336|FG001|Double Blind Phase|Non-compliance with study drug|3|||
37701068|NCT02006121|69178335|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
37701069|NCT02006121|69178336|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
37701070|NCT02006121|69178335|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
37701071|NCT02006121|69178336|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
37701072|NCT02006121|69178335|FG000|Open Label Phase|Adverse Event|15|||
37701073|NCT02006121|69178336|FG001|Open Label Phase|Adverse Event|0|||
37701074|NCT02006121|69178335|FG000|Open Label Phase|Lack of Efficacy|2|||
37701075|NCT02006121|69178336|FG001|Open Label Phase|Lack of Efficacy|0|||
37701076|NCT02006121|69178335|FG000|Open Label Phase|Protocol Violation|2|||
37701077|NCT02006121|69178336|FG001|Open Label Phase|Protocol Violation|0|||
37701078|NCT02006121|69178335|FG000|Open Label Phase|Withdrawal by Subject|3|||
37701079|NCT02006121|69178336|FG001|Open Label Phase|Withdrawal by Subject|0|||
37701080|NCT02006121|69178335|FG000|Open Label Phase|Non-compliance with study drug|3|||
37701081|NCT02006121|69178336|FG001|Open Label Phase|Non-compliance with study drug|0|||
37701082|NCT02005887|69178348|FG000|Overall Study|Protocol Violation|0|||
37701083|NCT02005887|69178349|FG001|Overall Study|Protocol Violation|2|||
37701084|NCT01982253|69178358|FG000|Overall Study|Withdrawal by Subject|1|||
37701085|NCT01982253|69178359|FG001|Overall Study|Withdrawal by Subject|0|||
37701086|NCT01982253|69178360|FG002|Overall Study|Withdrawal by Subject|0|||
37701087|NCT01982253|69178358|FG000|Overall Study|Study terminated by sponsor|1|||
37701088|NCT01982253|69178359|FG001|Overall Study|Study terminated by sponsor|4|||
37701089|NCT01982253|69178360|FG002|Overall Study|Study terminated by sponsor|4|||
37701090|NCT01619787|69178370|FG000|Overall Study|Lost to Follow-up|5|||
37701091|NCT01981473|69178379|FG000|Overall Study|Incorrect diagnosis of RA|0|||
37701092|NCT01981473|69178380|FG001|Overall Study|Incorrect diagnosis of RA|0|||
37701093|NCT01981473|69178381|FG002|Overall Study|Incorrect diagnosis of RA|1|||
37701094|NCT01981473|69178379|FG000|Overall Study|Received treatment for < 6 months|0|||
37701095|NCT01981473|69178380|FG001|Overall Study|Received treatment for < 6 months|0|||
37701096|NCT01981473|69178381|FG002|Overall Study|Received treatment for < 6 months|1|||
37701097|NCT01981473|69178379|FG000|Overall Study|Received treatment for >24 months|2|||
37701098|NCT01981473|69178380|FG001|Overall Study|Received treatment for >24 months|0|||
37701099|NCT01981473|69178381|FG002|Overall Study|Received treatment for >24 months|6|||
37914736|NCT00884390|69601356|FG000|Overall Study|Adverse Event|0|||
38023473|NCT03760146|69706445|FG000|Overall Study|No longer met eligibility criteria|3|||
38023474|NCT03760146|69706446|FG001|Overall Study|No longer met eligibility criteria|9|||
38023475|NCT03760146|69706447|FG002|Overall Study|No longer met eligibility criteria|0|||
38023476|NCT03760146|69706448|FG003|Overall Study|No longer met eligibility criteria|0|||
37701100|NCT02005029|69178394|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
37701101|NCT02005029|69178395|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
37701102|NCT02325791|69178423|FG000|Overall Study|Adverse Event|0|||
37701103|NCT02325791|69178424|FG001|Overall Study|Adverse Event|1|||
37701104|NCT02325791|69178425|FG002|Overall Study|Adverse Event|1|||
38023477|NCT03760146|69706449|FG004|Overall Study|No longer met eligibility criteria|1|||
37701105|NCT02325791|69178426|FG003|Overall Study|Adverse Event|0|||
37701106|NCT02325791|69178423|FG000|Overall Study|Death|0|||
37701107|NCT02325791|69178424|FG001|Overall Study|Death|3|||
37914737|NCT00884390|69601357|FG001|Overall Study|Adverse Event|1|||
37914738|NCT00884390|69601356|FG000|Overall Study|Lost to Follow-up|0|||
37914739|NCT00884390|69601357|FG001|Overall Study|Lost to Follow-up|1|||
37914740|NCT00884390|69601356|FG000|Overall Study|Physician Decision|2|||
37914741|NCT00884390|69601357|FG001|Overall Study|Physician Decision|1|||
37914742|NCT00884390|69601356|FG000|Overall Study|Protocol Violation|4|||
37914743|NCT00884390|69601357|FG001|Overall Study|Protocol Violation|1|||
37914744|NCT00884390|69601356|FG000|Overall Study|Withdrawal by Subject|4|||
37914745|NCT00884390|69601357|FG001|Overall Study|Withdrawal by Subject|1|||
37914746|NCT00884390|69601356|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
37914747|NCT00884390|69601357|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
37914748|NCT00884390|69601356|FG000|Overall Study|Other|11|||
37914749|NCT00884390|69601357|FG001|Overall Study|Other|1|||
37914750|NCT00872898|69601394|FG000|Part Two - Double Blind|Adverse Event|4|||
37914751|NCT00872898|69601395|FG001|Part Two - Double Blind|Adverse Event|3|||
37914752|NCT00872898|69601394|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
37914753|NCT00872898|69601395|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
37914754|NCT00872898|69601394|FG000|Part Two - Double Blind|Protocol Violation|1|||
37914755|NCT00872898|69601395|FG001|Part Two - Double Blind|Protocol Violation|0|||
37914756|NCT00872898|69601394|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
37914757|NCT00872898|69601395|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
37914758|NCT00872898|69601394|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
37914759|NCT00872898|69601395|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
37701108|NCT02325791|69178425|FG002|Overall Study|Death|0|||
37701109|NCT02325791|69178426|FG003|Overall Study|Death|1|||
37701110|NCT02325791|69178423|FG000|Overall Study|Lost to Follow-up|0|||
37836519|NCT01212757|69521031|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
37836520|NCT01212757|69521032|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
37836521|NCT01212757|69521033|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
37836522|NCT01212757|69521034|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
37836523|NCT01212757|69521035|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
37836524|NCT01212757|69521036|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
37836525|NCT01212757|69521037|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
37836526|NCT01212757|69521038|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
37914760|NCT00872898|69601394|FG000|Part Two - Double Blind|Other reasons|2|||
37914761|NCT00872898|69601395|FG001|Part Two - Double Blind|Other reasons|0|||
37914762|NCT00884312|69601406|FG000|Overall Study|Non-fatal Progressive Disease|0|||
37701111|NCT02325791|69178424|FG001|Overall Study|Lost to Follow-up|15|||
37701112|NCT02325791|69178425|FG002|Overall Study|Lost to Follow-up|14|||
37701113|NCT02325791|69178426|FG003|Overall Study|Lost to Follow-up|9|||
37701114|NCT02325791|69178423|FG000|Overall Study|Physician Decision|0|||
37701115|NCT02325791|69178424|FG001|Overall Study|Physician Decision|1|||
37701116|NCT02325791|69178425|FG002|Overall Study|Physician Decision|1|||
37701117|NCT02325791|69178426|FG003|Overall Study|Physician Decision|0|||
37701118|NCT02325791|69178423|FG000|Overall Study|Protocol Violation|0|||
37914763|NCT00884312|69601407|FG001|Overall Study|Non-fatal Progressive Disease|8|||
37914764|NCT00884312|69601406|FG000|Overall Study|Fatal Progressive Disease|0|||
37914765|NCT00884312|69601407|FG001|Overall Study|Fatal Progressive Disease|1|||
37914766|NCT00884312|69601406|FG000|Overall Study|Non-fatal Adverse Event|1|||
37914767|NCT00884312|69601407|FG001|Overall Study|Non-fatal Adverse Event|0|||
37914768|NCT00884312|69601406|FG000|Overall Study|Fatal Adverse Event|1|||
37914769|NCT00884312|69601407|FG001|Overall Study|Fatal Adverse Event|4|||
37914770|NCT00884312|69601406|FG000|Overall Study|Withdrawal by Subject|0|||
37914771|NCT00884312|69601407|FG001|Overall Study|Withdrawal by Subject|6|||
37914772|NCT00884312|69601406|FG000|Overall Study|Physician Decision|0|||
37914773|NCT00884312|69601407|FG001|Overall Study|Physician Decision|1|||
37914774|NCT00884312|69601406|FG000|Overall Study|Other|0|||
37914775|NCT00884312|69601407|FG001|Overall Study|Other|4|||
37914776|NCT00884312|69601406|FG000|Overall Study|Did Not Receive Study Drug|0|||
37914777|NCT00884312|69601407|FG001|Overall Study|Did Not Receive Study Drug|1|||
37914778|NCT00534313|69601417|FG000|Short-term Period|Adverse Event|1|||
37914779|NCT00534313|69601418|FG001|Short-term Period|Adverse Event|2|||
37914780|NCT00534313|69601419|FG002|Short-term Period|Adverse Event|1|||
37914781|NCT00534313|69601420|FG003|Short-term Period|Adverse Event|3|||
37914782|NCT00534313|69601417|FG000|Short-term Period|Lack of Efficacy|3|||
37914783|NCT00534313|69601418|FG001|Short-term Period|Lack of Efficacy|4|||
37914784|NCT00534313|69601419|FG002|Short-term Period|Lack of Efficacy|0|||
37914785|NCT00534313|69601420|FG003|Short-term Period|Lack of Efficacy|3|||
38023478|NCT03760146|69706450|FG005|Overall Study|No longer met eligibility criteria|0|||
38023479|NCT03760146|69706445|FG000|Overall Study|Protocol Violation|21|||
37914786|NCT00534313|69601417|FG000|Short-term Period|Participant not meeting study criteria|0|||
37914787|NCT00534313|69601418|FG001|Short-term Period|Participant not meeting study criteria|0|||
37914788|NCT00534313|69601419|FG002|Short-term Period|Participant not meeting study criteria|0|||
37914789|NCT00534313|69601420|FG003|Short-term Period|Participant not meeting study criteria|1|||
37914790|NCT00534313|69601417|FG000|Short-term Period|Participant withdrew consent|2|||
37914791|NCT00534313|69601418|FG001|Short-term Period|Participant withdrew consent|0|||
37914792|NCT00534313|69601419|FG002|Short-term Period|Participant withdrew consent|0|||
37914793|NCT00534313|69601420|FG003|Short-term Period|Participant withdrew consent|2|||
37914794|NCT00534313|69601417|FG000|Short-term Period|Pregnancy|0|||
37914795|NCT00534313|69601418|FG001|Short-term Period|Pregnancy|0|||
38023480|NCT03760146|69706446|FG001|Overall Study|Protocol Violation|13|||
37701119|NCT02325791|69178424|FG001|Overall Study|Protocol Violation|0|||
37701120|NCT02325791|69178425|FG002|Overall Study|Protocol Violation|1|||
37701121|NCT02325791|69178426|FG003|Overall Study|Protocol Violation|0|||
37701122|NCT02325791|69178423|FG000|Overall Study|Withdrawal by Subject|0|||
37701123|NCT02325791|69178424|FG001|Overall Study|Withdrawal by Subject|5|||
37701124|NCT02325791|69178425|FG002|Overall Study|Withdrawal by Subject|8|||
37701125|NCT02325791|69178426|FG003|Overall Study|Withdrawal by Subject|16|||
37701126|NCT02004873|69178439|FG000|Overall Study|Implant unsuccessful|6|||
37701127|NCT02004873|69178439|FG000|Overall Study|Awaiting 6-month visit|390|||
37701128|NCT02004873|69178439|FG000|Overall Study|Missed 6-month visit|4|||
37701129|NCT02004873|69178439|FG000|Overall Study|Death|23|||
37701130|NCT02004873|69178439|FG000|Overall Study|Withdrawal by Subject|1|||
37701131|NCT02347787|69178448|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
37701132|NCT02347787|69178449|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
37914796|NCT00534313|69601419|FG002|Short-term Period|Pregnancy|1|||
37914797|NCT00534313|69601420|FG003|Short-term Period|Pregnancy|0|||
37914798|NCT00534313|69601417|FG000|Long-term Period|Adverse Event|2|||
37914799|NCT00534313|69601418|FG001|Long-term Period|Adverse Event|1|||
37914800|NCT00534313|69601419|FG002|Long-term Period|Adverse Event|0|||
37914801|NCT00534313|69601420|FG003|Long-term Period|Adverse Event|1|||
37701133|NCT02347787|69178448|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
37701134|NCT02347787|69178449|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
37701135|NCT02347787|69178448|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
37701136|NCT02347787|69178449|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
37701137|NCT02347787|69178448|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
37701138|NCT02347787|69178449|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
37701139|NCT01979835|69178460|FG000|Primary Outcome SA Measurment|failed insertion|18|||
37701140|NCT01979835|69178460|FG000|Follow-up|Lost to Follow-up|32|||
37701141|NCT02282345|69178466|FG000|Overall Study|Progression|0|||
37701142|NCT02282345|69178467|FG001|Overall Study|Progression|1|||
37701143|NCT01732822|69178478|FG000|Overall Study|Withdrawal by Subject|123|||
37701144|NCT01732822|69178479|FG001|Overall Study|Withdrawal by Subject|113|||
37701145|NCT02004093|69178509|FG000|Overall Study|Death|2|||
37701146|NCT02004093|69178510|FG001|Overall Study|Death|1|||
37701147|NCT02004093|69178509|FG000|Overall Study|Lack of Efficacy|66|||
37701148|NCT02004093|69178510|FG001|Overall Study|Lack of Efficacy|62|||
37701149|NCT02004093|69178509|FG000|Overall Study|Protocol Violation|0|||
37701150|NCT02004093|69178510|FG001|Overall Study|Protocol Violation|1|||
37701151|NCT02004093|69178509|FG000|Overall Study|Lost to Follow-up|0|||
37701152|NCT02004093|69178510|FG001|Overall Study|Lost to Follow-up|1|||
37701153|NCT02004093|69178509|FG000|Overall Study|Withdrawal by Subject|3|||
37701154|NCT02004093|69178510|FG001|Overall Study|Withdrawal by Subject|7|||
37701155|NCT02004093|69178509|FG000|Overall Study|Other|3|||
37701156|NCT02004093|69178510|FG001|Overall Study|Other|1|||
37701157|NCT01641367|69178525|FG000|Cohorts|Death|18|||
37701158|NCT01641367|69178526|FG001|Cohorts|Death|1|||
37701159|NCT01641367|69178527|FG002|Cohorts|Death|2|||
37701160|NCT01641367|69178528|FG003|Cohorts|Death|0|||
37701161|NCT01641367|69178529|FG004|Cohorts|Death|1|||
37701162|NCT01641367|69178530|FG005|Cohorts|Death|1|||
37701163|NCT01641367|69178531|FG006|Cohorts|Death|0|||
37701164|NCT01641367|69178532|FG007|Cohorts|Death|0|||
37701165|NCT01641367|69178525|FG000|Cohorts|Lost to Follow-up|16|||
37701166|NCT01641367|69178526|FG001|Cohorts|Lost to Follow-up|0|||
37701167|NCT01641367|69178527|FG002|Cohorts|Lost to Follow-up|2|||
37701168|NCT01641367|69178528|FG003|Cohorts|Lost to Follow-up|0|||
37701169|NCT01641367|69178529|FG004|Cohorts|Lost to Follow-up|2|||
37701170|NCT01641367|69178530|FG005|Cohorts|Lost to Follow-up|0|||
37701171|NCT01641367|69178531|FG006|Cohorts|Lost to Follow-up|0|||
37701172|NCT01641367|69178532|FG007|Cohorts|Lost to Follow-up|0|||
37701173|NCT01641367|69178525|FG000|Randomized Adherence Intervention|Death|0|||
37701174|NCT01641367|69178526|FG001|Randomized Adherence Intervention|Death|0|||
38023481|NCT03760146|69706447|FG002|Overall Study|Protocol Violation|1|||
38023482|NCT03760146|69706448|FG003|Overall Study|Protocol Violation|0|||
38023483|NCT03760146|69706449|FG004|Overall Study|Protocol Violation|1|||
38023484|NCT03760146|69706450|FG005|Overall Study|Protocol Violation|0|||
38023485|NCT03760146|69706445|FG000|Overall Study|Withdrawal by Subject|19|||
38023486|NCT03760146|69706446|FG001|Overall Study|Withdrawal by Subject|20|||
38023487|NCT03760146|69706447|FG002|Overall Study|Withdrawal by Subject|1|||
38023488|NCT03760146|69706448|FG003|Overall Study|Withdrawal by Subject|0|||
38023489|NCT03760146|69706449|FG004|Overall Study|Withdrawal by Subject|1|||
38023490|NCT03760146|69706450|FG005|Overall Study|Withdrawal by Subject|0|||
38023491|NCT03877068|69706470|FG000|Overall Study|Physician Decision|9|||
38023492|NCT03877068|69706471|FG001|Overall Study|Physician Decision|3|||
38023493|NCT03760068|69706481|FG000|Overall Study|Withdrawal by Subject|7|||
38023494|NCT03760068|69706482|FG001|Overall Study|Withdrawal by Subject|8|||
38023495|NCT03760068|69706481|FG000|Overall Study|Adverse Event|1|||
38023496|NCT03760068|69706482|FG001|Overall Study|Adverse Event|2|||
37701175|NCT01641367|69178527|FG002|Randomized Adherence Intervention|Death|0|||
37701176|NCT01641367|69178528|FG003|Randomized Adherence Intervention|Death|0|||
38023497|NCT03760068|69706481|FG000|Overall Study|Administrative Decision by Sponsor|0|||
38023498|NCT03760068|69706482|FG001|Overall Study|Administrative Decision by Sponsor|2|||
38023499|NCT03760068|69706481|FG000|Overall Study|Physician Decision|1|||
37701177|NCT01641367|69178529|FG004|Randomized Adherence Intervention|Death|0|||
37701178|NCT01641367|69178530|FG005|Randomized Adherence Intervention|Death|0|||
38023500|NCT03760068|69706482|FG001|Overall Study|Physician Decision|2|||
38023501|NCT03760068|69706481|FG000|Overall Study|Lost to Follow-up|4|||
37701179|NCT01641367|69178531|FG006|Randomized Adherence Intervention|Death|11|||
37701180|NCT01641367|69178532|FG007|Randomized Adherence Intervention|Death|12|||
37701181|NCT01641367|69178525|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
37701182|NCT01641367|69178526|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
37701183|NCT01641367|69178527|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
37701184|NCT01641367|69178528|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
37701185|NCT01641367|69178529|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
38023502|NCT03760068|69706482|FG001|Overall Study|Lost to Follow-up|9|||
38023503|NCT03760068|69706481|FG000|Overall Study|Subject Moved Out of State|1|||
37701186|NCT01641367|69178530|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
37701187|NCT01641367|69178531|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
37836527|NCT01212757|69521039|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
37836528|NCT01212757|69521031|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
37836529|NCT01212757|69521032|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
37836530|NCT01212757|69521033|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
37836531|NCT01212757|69521034|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
37836532|NCT01212757|69521035|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
37836533|NCT01212757|69521036|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
37701188|NCT01641367|69178532|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
37914802|NCT00534313|69601417|FG000|Long-term Period|Lack of Efficacy|14|||
37701189|NCT02325713|69178571|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
37701190|NCT02325713|69178572|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
37701191|NCT02325713|69178573|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
37701192|NCT02325713|69178574|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
37701193|NCT02325713|69178575|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
37701194|NCT02325713|69178576|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
37701195|NCT02325713|69178577|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
37701196|NCT02325713|69178578|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
37701197|NCT02325713|69178579|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
37701198|NCT02325713|69178580|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
37701199|NCT02325713|69178581|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
37701200|NCT02325713|69178582|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
37701201|NCT02325713|69178583|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
37701202|NCT02325713|69178584|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
37701203|NCT02325713|69178585|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
37701204|NCT02325713|69178586|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
37701205|NCT02325713|69178571|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
37701206|NCT02325713|69178572|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
37701207|NCT02325713|69178573|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
37701208|NCT02325713|69178574|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
37701209|NCT02325713|69178575|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
37701210|NCT02325713|69178576|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
37701211|NCT02325713|69178577|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
37701212|NCT02325713|69178578|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
37701213|NCT02325713|69178579|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
37701214|NCT02325713|69178580|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
37701215|NCT02325713|69178581|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
37701216|NCT02325713|69178582|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
37701217|NCT02325713|69178583|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
37836534|NCT01212757|69521037|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
37836535|NCT01212757|69521038|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
37836536|NCT01212757|69521039|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
37701218|NCT02325713|69178584|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
37701219|NCT02325713|69178585|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
37836537|NCT01212757|69521031|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
37836538|NCT01212757|69521032|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
37836539|NCT01212757|69521033|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
37836540|NCT01212757|69521034|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
37836541|NCT01212757|69521035|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
37836542|NCT01212757|69521036|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
37836543|NCT01212757|69521037|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
37836544|NCT01212757|69521038|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
37836545|NCT01212757|69521039|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
37836546|NCT01212757|69521031|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
37836547|NCT01212757|69521032|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
37836548|NCT01212757|69521033|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
37836549|NCT01212757|69521034|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
37836550|NCT01212757|69521035|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
37914803|NCT00534313|69601418|FG001|Long-term Period|Lack of Efficacy|10|||
37701220|NCT02325713|69178586|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
37701221|NCT02325713|69178571|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
37701222|NCT02325713|69178572|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
37701223|NCT02325713|69178573|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
37701224|NCT02325713|69178574|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
37701225|NCT02325713|69178575|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
37701226|NCT02325713|69178576|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
37701227|NCT02325713|69178577|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
37701228|NCT02325713|69178578|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
37701229|NCT02325713|69178579|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
37701230|NCT02325713|69178580|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
37701231|NCT02325713|69178581|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
37701232|NCT02325713|69178582|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
37701233|NCT02325713|69178583|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
37701234|NCT02325713|69178584|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
37701235|NCT02325713|69178585|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
37701236|NCT02325713|69178586|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
37701237|NCT02325401|69178601|FG000|Overall Study|Withdrawal by Subject|0|||
37701238|NCT02325401|69178602|FG001|Overall Study|Withdrawal by Subject|1|||
37701239|NCT02325401|69178603|FG002|Overall Study|Withdrawal by Subject|1|||
37701240|NCT02324699|69178617|FG000|Overall Study|study terminated|1|||
37701241|NCT01764256|69178625|FG000|Received All Vaccinations|Adverse Event|1|||
37701242|NCT01764256|69178626|FG001|Received All Vaccinations|Adverse Event|1|||
37701243|NCT01764256|69178627|FG002|Received All Vaccinations|Adverse Event|0|||
37701244|NCT01764256|69178628|FG003|Received All Vaccinations|Adverse Event|0|||
37701245|NCT01764256|69178625|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
37701246|NCT01764256|69178626|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
37701247|NCT01764256|69178627|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
37701248|NCT01764256|69178628|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
37701249|NCT01764256|69178625|FG000|Received All Vaccinations|Lost to Follow-up|1|||
37701250|NCT01764256|69178626|FG001|Received All Vaccinations|Lost to Follow-up|0|||
37701251|NCT01764256|69178627|FG002|Received All Vaccinations|Lost to Follow-up|0|||
37701252|NCT01764256|69178628|FG003|Received All Vaccinations|Lost to Follow-up|0|||
37701253|NCT01764256|69178625|FG000|Completed Study|Lost to Follow-up|0|||
37701254|NCT01764256|69178626|FG001|Completed Study|Lost to Follow-up|0|||
37701255|NCT01764256|69178627|FG002|Completed Study|Lost to Follow-up|0|||
37701256|NCT01764256|69178628|FG003|Completed Study|Lost to Follow-up|1|||
37701257|NCT01979523|69178644|FG000|Overall Study|Withdrawal by Subject|1|||
37701258|NCT01979523|69178645|FG001|Overall Study|Withdrawal by Subject|0|||
37701259|NCT02255461|69178657|FG000|Overall Study|Adverse Event|0|||
37701260|NCT02255461|69178658|FG001|Overall Study|Adverse Event|1|||
37701261|NCT02255461|69178659|FG002|Overall Study|Adverse Event|0|||
37701262|NCT02255461|69178660|FG003|Overall Study|Adverse Event|0|||
37701263|NCT02255461|69178661|FG004|Overall Study|Adverse Event|1|||
37701264|NCT02255461|69178657|FG000|Overall Study|Withdrawal by Subject|0|||
37701265|NCT02255461|69178658|FG001|Overall Study|Withdrawal by Subject|0|||
37701266|NCT02255461|69178659|FG002|Overall Study|Withdrawal by Subject|1|||
37701267|NCT02255461|69178660|FG003|Overall Study|Withdrawal by Subject|0|||
37701268|NCT02255461|69178661|FG004|Overall Study|Withdrawal by Subject|1|||
37701269|NCT02255461|69178657|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
37701270|NCT02255461|69178658|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
37701271|NCT02255461|69178659|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
37701272|NCT02255461|69178660|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
37914804|NCT00534313|69601419|FG002|Long-term Period|Lack of Efficacy|14|||
37701273|NCT02255461|69178661|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
37701274|NCT01764022|69178680|FG000|Overall Study|Death|3|||
37701275|NCT01764022|69178681|FG001|Overall Study|Death|5|||
37701276|NCT01764022|69178680|FG000|Overall Study|Withdrawal by Subject|2|||
37701277|NCT01764022|69178681|FG001|Overall Study|Withdrawal by Subject|6|||
37701278|NCT01764022|69178680|FG000|Overall Study|Lack of Efficacy|0|||
37701279|NCT01764022|69178681|FG001|Overall Study|Lack of Efficacy|1|||
37914805|NCT00534313|69601420|FG003|Long-term Period|Lack of Efficacy|12|||
37914806|NCT00534313|69601417|FG000|Long-term Period|Lost to Follow-up|1|||
37701280|NCT01764022|69178680|FG000|Overall Study|Physician Decision|0|||
37701281|NCT01764022|69178681|FG001|Overall Study|Physician Decision|2|||
37701282|NCT01764022|69178680|FG000|Overall Study|Lost to Follow-up|2|||
37701283|NCT01764022|69178681|FG001|Overall Study|Lost to Follow-up|0|||
37701284|NCT01764022|69178680|FG000|Overall Study|Protocol Violation|1|||
37701285|NCT01764022|69178681|FG001|Overall Study|Protocol Violation|0|||
37701286|NCT02003391|69178691|FG000|Overall Study|Withdrawal by Subject|2|||
37701287|NCT02003391|69178692|FG001|Overall Study|Withdrawal by Subject|1|||
37701288|NCT02003391|69178691|FG000|Overall Study|Protocol Violation|0|||
37701289|NCT02003391|69178692|FG001|Overall Study|Protocol Violation|1|||
37701290|NCT02003391|69178691|FG000|Overall Study|Adverse Event|1|||
37701291|NCT02003391|69178692|FG001|Overall Study|Adverse Event|0|||
37701292|NCT02254681|69178698|FG000|Overall Study|Lack of Efficacy|6|||
37701293|NCT01965327|69178703|FG000|Overall Study|Physician Decision|2|||
37701294|NCT02002689|69178707|FG000|Overall Study|Disease Progression|7|||
37701295|NCT02002689|69178707|FG000|Overall Study|Adverse Event|3|||
37701296|NCT01639729|69178711|FG000|Overall Study|Withdrawal by Subject|1|||
37701297|NCT01639729|69178712|FG001|Overall Study|Withdrawal by Subject|0|||
37701298|NCT01639729|69178713|FG002|Overall Study|Withdrawal by Subject|1|||
37701299|NCT01639729|69178714|FG003|Overall Study|Withdrawal by Subject|1|||
37701300|NCT01639729|69178715|FG004|Overall Study|Withdrawal by Subject|0|||
37701301|NCT01639729|69178716|FG005|Overall Study|Withdrawal by Subject|0|||
37701302|NCT02002533|69178728|FG000|Overall Study|Withdrawal by Subject|6|||
37701303|NCT02002533|69178729|FG001|Overall Study|Withdrawal by Subject|13|||
37701304|NCT02002533|69178728|FG000|Overall Study|Protocol Violation|0|||
37701305|NCT02002533|69178729|FG001|Overall Study|Protocol Violation|1|||
37701306|NCT02002533|69178728|FG000|Overall Study|Adverse Event|0|||
37701307|NCT02002533|69178729|FG001|Overall Study|Adverse Event|3|||
37701308|NCT02002533|69178728|FG000|Overall Study|Lost to Follow-up|0|||
37701309|NCT02002533|69178729|FG001|Overall Study|Lost to Follow-up|1|||
37701310|NCT02002221|69178738|FG000|Overall Study|Adverse Event|2|||
37701311|NCT02002221|69178739|FG001|Overall Study|Adverse Event|1|||
37701312|NCT02002221|69178738|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
37701313|NCT02002221|69178739|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
37701314|NCT02002221|69178738|FG000|Overall Study|Patient withdrew consent|0|||
37701315|NCT02002221|69178739|FG001|Overall Study|Patient withdrew consent|1|||
37701316|NCT01639495|69178745|FG000|Overall Study|Lost to Follow-up|6|||
37701317|NCT01639495|69178745|FG000|Overall Study|Consented but didn't have study catheter|4|||
37701318|NCT01639495|69178745|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
37701319|NCT01639495|69178745|FG000|Overall Study|No radiofrequency energy applied|2|||
37701320|NCT02001987|69178749|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
37701321|NCT02001987|69178749|FG000|Core Study Period (24 Weeks)|Death|1|||
37701322|NCT02001987|69178749|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
37701323|NCT02001987|69178749|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
37701324|NCT02001987|69178749|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
37701325|NCT02001987|69178749|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
37701326|NCT02001987|69178749|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
37701327|NCT02001987|69178749|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
37701328|NCT02001987|69178749|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
37701329|NCT02001987|69178749|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
37914807|NCT00534313|69601418|FG001|Long-term Period|Lost to Follow-up|2|||
38023504|NCT03760068|69706482|FG001|Overall Study|Subject Moved Out of State|0|||
37701330|NCT02001987|69178749|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
37701331|NCT02001987|69178749|FG000|LTE Period (52 Weeks)|Other|3|||
37701332|NCT01363765|69178760|FG000|Overall Study|non-diagnostic|2621|||
37701333|NCT01363765|69178761|FG001|Overall Study|non-diagnostic|1124|||
37701334|NCT01363765|69178760|FG000|Overall Study|duplicate records|736|||
37701335|NCT01363765|69178761|FG001|Overall Study|duplicate records|3177|||
37701336|NCT01363765|69178760|FG000|Overall Study|non-resident|156|||
37701337|NCT01363765|69178761|FG001|Overall Study|non-resident|76|||
37914808|NCT00534313|69601419|FG002|Long-term Period|Lost to Follow-up|0|||
37701338|NCT01363765|69178760|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
37701339|NCT01363765|69178761|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
37701340|NCT01363765|69178760|FG000|Overall Study|smear during intervention|2170|||
37701341|NCT01363765|69178761|FG001|Overall Study|smear during intervention|0|||
37701342|NCT02001051|69178771|FG000|Overall Study|Deemed not eligible following enrollment|0|||
37701343|NCT02001051|69178772|FG001|Overall Study|Deemed not eligible following enrollment|1|||
37701344|NCT01763164|69178780|FG000|Treatment Phase|Participant/Guardian decision|26|||
37701345|NCT01763164|69178781|FG001|Treatment Phase|Participant/Guardian decision|14|||
37701346|NCT01763164|69178780|FG000|Treatment Phase|Protocol Violation|1|||
37701347|NCT01763164|69178781|FG001|Treatment Phase|Protocol Violation|1|||
37701348|NCT01763164|69178780|FG000|Treatment Phase|Progressive Disease|142|||
37701349|NCT01763164|69178781|FG001|Treatment Phase|Progressive Disease|76|||
37701350|NCT01763164|69178780|FG000|Treatment Phase|Physician Decision|24|||
37701351|NCT01763164|69178781|FG001|Treatment Phase|Physician Decision|13|||
37701352|NCT01763164|69178780|FG000|Treatment Phase|Death|10|||
37701353|NCT01763164|69178781|FG001|Treatment Phase|Death|1|||
37701354|NCT01763164|69178780|FG000|Treatment Phase|Adverse Event|66|||
37701355|NCT01763164|69178781|FG001|Treatment Phase|Adverse Event|8|||
37701356|NCT01763164|69178780|FG000|Treatment Phase|Randomized but not Treated|0|||
37701357|NCT01763164|69178781|FG001|Treatment Phase|Randomized but not Treated|19|||
37701358|NCT01763164|69178780|FG000|Treatment Phase|Other|0|||
37701359|NCT01763164|69178781|FG001|Treatment Phase|Other|1|||
37701360|NCT01763164|69178780|FG000|Follow up Phase|New therapy for study indication|12|||
37701361|NCT01763164|69178781|FG001|Follow up Phase|New therapy for study indication|3|||
37701362|NCT01763164|69178780|FG000|Follow up Phase|Death|21|||
37701363|NCT01763164|69178781|FG001|Follow up Phase|Death|4|||
37701364|NCT01763164|69178780|FG000|Follow up Phase|Subject/guardian decision|9|||
37701365|NCT01763164|69178781|FG001|Follow up Phase|Subject/guardian decision|2|||
37701366|NCT01763164|69178780|FG000|Follow up Phase|Progressive disease|127|||
37701367|NCT01763164|69178781|FG001|Follow up Phase|Progressive disease|62|||
37701368|NCT01763164|69178780|FG000|Follow up Phase|Physician Decision|10|||
37701369|NCT01763164|69178781|FG001|Follow up Phase|Physician Decision|3|||
37701370|NCT01763164|69178780|FG000|Follow up Phase|Lost to Follow-up|1|||
37701371|NCT01763164|69178781|FG001|Follow up Phase|Lost to Follow-up|0|||
37701372|NCT01763164|69178780|FG000|Follow up Phase|Adverse Event|17|||
37701373|NCT01763164|69178781|FG001|Follow up Phase|Adverse Event|1|||
37701374|NCT01782742|69178789|FG000|Double-blind Treatment Phase|Adverse Event|1|||
37701375|NCT01782742|69178790|FG001|Double-blind Treatment Phase|Adverse Event|0|||
37701376|NCT01782664|69178804|FG000|Overall Study|Adverse Event|2|||
37701377|NCT01782664|69178805|FG001|Overall Study|Adverse Event|2|||
37701378|NCT01782664|69178806|FG002|Overall Study|Adverse Event|2|||
37701379|NCT01782664|69178807|FG003|Overall Study|Adverse Event|2|||
37701380|NCT01782664|69178808|FG004|Overall Study|Adverse Event|0|||
37701381|NCT01782664|69178809|FG005|Overall Study|Adverse Event|0|||
37701382|NCT01782664|69178804|FG000|Overall Study|Lack of Efficacy|2|||
37701383|NCT01782664|69178805|FG001|Overall Study|Lack of Efficacy|0|||
37701384|NCT01782664|69178806|FG002|Overall Study|Lack of Efficacy|2|||
37701385|NCT01782664|69178807|FG003|Overall Study|Lack of Efficacy|2|||
37701386|NCT01782664|69178808|FG004|Overall Study|Lack of Efficacy|0|||
37701387|NCT01782664|69178809|FG005|Overall Study|Lack of Efficacy|0|||
37701388|NCT01782664|69178804|FG000|Overall Study|Protocol Violation|0|||
37836551|NCT01212757|69521036|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
37836552|NCT01212757|69521037|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
37836553|NCT01212757|69521038|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
37836554|NCT01212757|69521039|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
37836555|NCT01212757|69521031|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
37836556|NCT01212757|69521032|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
37701389|NCT01782664|69178805|FG001|Overall Study|Protocol Violation|1|||
37701390|NCT01782664|69178806|FG002|Overall Study|Protocol Violation|0|||
37701391|NCT01782664|69178807|FG003|Overall Study|Protocol Violation|1|||
37701392|NCT01782664|69178808|FG004|Overall Study|Protocol Violation|0|||
37701393|NCT01782664|69178809|FG005|Overall Study|Protocol Violation|0|||
37701394|NCT01782664|69178804|FG000|Overall Study|Withdrawal by Subject|2|||
37701395|NCT01782664|69178805|FG001|Overall Study|Withdrawal by Subject|2|||
37701396|NCT01782664|69178806|FG002|Overall Study|Withdrawal by Subject|0|||
37701397|NCT01782664|69178807|FG003|Overall Study|Withdrawal by Subject|0|||
37701398|NCT01782664|69178808|FG004|Overall Study|Withdrawal by Subject|0|||
37701399|NCT01782664|69178809|FG005|Overall Study|Withdrawal by Subject|0|||
37701400|NCT01732588|69178826|FG000|First Intervention (7 Days)|Adverse Event|0|||
37701401|NCT01732588|69178827|FG001|First Intervention (7 Days)|Adverse Event|1|||
37701402|NCT01732588|69178828|FG002|First Intervention (7 Days)|Adverse Event|0|||
37701403|NCT01781962|69178836|FG000|Overall Study|Other Miscellaneous Reasons|5|||
37701404|NCT01639339|69178842|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
37701405|NCT01639339|69178843|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
37701406|NCT01639339|69178842|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
37701407|NCT01639339|69178843|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
37701408|NCT01639339|69178842|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
37701409|NCT01639339|69178843|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
37701410|NCT01639339|69178842|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
37701411|NCT01639339|69178843|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
37914809|NCT00534313|69601420|FG003|Long-term Period|Lost to Follow-up|0|||
37914810|NCT00534313|69601417|FG000|Long-term Period|Withdrawal by Subject|2|||
37914811|NCT00534313|69601418|FG001|Long-term Period|Withdrawal by Subject|2|||
37914812|NCT00534313|69601419|FG002|Long-term Period|Withdrawal by Subject|0|||
37914813|NCT00534313|69601420|FG003|Long-term Period|Withdrawal by Subject|0|||
37914814|NCT00534313|69601417|FG000|Long-term Period|No longer meets study criteria|0|||
37914815|NCT00534313|69601418|FG001|Long-term Period|No longer meets study criteria|1|||
37914816|NCT00534313|69601419|FG002|Long-term Period|No longer meets study criteria|0|||
37914817|NCT00534313|69601420|FG003|Long-term Period|No longer meets study criteria|0|||
37914818|NCT00534313|69601417|FG000|Long-term Period|Poor compliance/noncompliance|0|||
37914819|NCT00534313|69601418|FG001|Long-term Period|Poor compliance/noncompliance|1|||
37701412|NCT01639339|69178842|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
37701413|NCT01639339|69178843|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
37701414|NCT01639339|69178842|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
37701415|NCT01639339|69178843|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
37701416|NCT01639339|69178842|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
37701417|NCT01639339|69178843|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
37701418|NCT01639339|69178842|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
37701419|NCT01639339|69178843|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
37701420|NCT01639339|69178842|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
37701421|NCT01639339|69178843|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
37701422|NCT01639339|69178842|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
37701423|NCT01639339|69178843|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
37701424|NCT02000817|69178857|FG000|Overall Study|Withdrawal by Subject|2|||
37701425|NCT02000817|69178858|FG001|Overall Study|Withdrawal by Subject|0|||
37701426|NCT02000817|69178859|FG002|Overall Study|Withdrawal by Subject|0|||
37701427|NCT02000817|69178860|FG003|Overall Study|Withdrawal by Subject|0|||
37701428|NCT02000817|69178857|FG000|Overall Study|Adverse Event|0|||
37701429|NCT02000817|69178858|FG001|Overall Study|Adverse Event|1|||
37701430|NCT02000817|69178859|FG002|Overall Study|Adverse Event|0|||
37701431|NCT02000817|69178860|FG003|Overall Study|Adverse Event|0|||
37836557|NCT01212757|69521033|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
37836558|NCT01212757|69521034|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
37836559|NCT01212757|69521035|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
37836560|NCT01212757|69521036|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
37836561|NCT01212757|69521037|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
37836562|NCT01212757|69521038|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
37836563|NCT01212757|69521039|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
37836564|NCT01212757|69521031|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
37836565|NCT01212757|69521032|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
37701432|NCT02000817|69178857|FG000|Overall Study|Lost to Follow-up|0|||
37701433|NCT02000817|69178858|FG001|Overall Study|Lost to Follow-up|0|||
37914820|NCT00534313|69601419|FG002|Long-term Period|Poor compliance/noncompliance|1|||
37914821|NCT00534313|69601420|FG003|Long-term Period|Poor compliance/noncompliance|0|||
37701434|NCT02000817|69178859|FG002|Overall Study|Lost to Follow-up|1|||
37701435|NCT02000817|69178860|FG003|Overall Study|Lost to Follow-up|0|||
37701436|NCT01641133|69178876|FG000|Overall Study|Protocol Violation|0|||
37701437|NCT01641133|69178877|FG001|Overall Study|Protocol Violation|1|||
37701438|NCT01641133|69178878|FG002|Overall Study|Protocol Violation|1|||
37701439|NCT01641133|69178876|FG000|Overall Study|Migrated/moved from study area|5|||
37701440|NCT01641133|69178877|FG001|Overall Study|Migrated/moved from study area|3|||
37701441|NCT01641133|69178878|FG002|Overall Study|Migrated/moved from study area|1|||
37701442|NCT01641133|69178876|FG000|Overall Study|Adverse Event|0|||
37701443|NCT01641133|69178877|FG001|Overall Study|Adverse Event|0|||
37701444|NCT01641133|69178878|FG002|Overall Study|Adverse Event|1|||
37701445|NCT01641133|69178876|FG000|Overall Study|Withdrawal by Subject|5|||
37701446|NCT01641133|69178877|FG001|Overall Study|Withdrawal by Subject|3|||
37701447|NCT01641133|69178878|FG002|Overall Study|Withdrawal by Subject|3|||
37701448|NCT01641133|69178876|FG000|Overall Study|Lost to Follow-up|0|||
37701449|NCT01641133|69178877|FG001|Overall Study|Lost to Follow-up|2|||
37701450|NCT01641133|69178878|FG002|Overall Study|Lost to Follow-up|2|||
37701451|NCT02000427|69178886|FG000|Overall Study|Death|22|||
37701452|NCT01600885|69178890|FG000|First Period|Adverse Event|1|||
37701453|NCT01600885|69178891|FG001|First Period|Adverse Event|1|||
37701454|NCT01600885|69178890|FG000|First Period|moved out of area|1|||
37701455|NCT01600885|69178891|FG001|First Period|moved out of area|0|||
37701456|NCT01732510|69178904|FG000|Overall Study|Adverse Event|0|||
37701457|NCT01732510|69178905|FG001|Overall Study|Adverse Event|1|||
37701458|NCT01732510|69178906|FG002|Overall Study|Adverse Event|1|||
37701459|NCT01732510|69178907|FG003|Overall Study|Adverse Event|0|||
37701460|NCT01732510|69178908|FG004|Overall Study|Adverse Event|0|||
37701461|NCT01732510|69178909|FG005|Overall Study|Adverse Event|0|||
37701462|NCT01732510|69178910|FG006|Overall Study|Adverse Event|1|||
37701463|NCT01732510|69178904|FG000|Overall Study|Protocol Violation|0|||
37701464|NCT01732510|69178905|FG001|Overall Study|Protocol Violation|0|||
37701465|NCT01732510|69178906|FG002|Overall Study|Protocol Violation|0|||
37701466|NCT01732510|69178907|FG003|Overall Study|Protocol Violation|1|||
37701467|NCT01732510|69178908|FG004|Overall Study|Protocol Violation|0|||
37701468|NCT01732510|69178909|FG005|Overall Study|Protocol Violation|0|||
37701469|NCT01732510|69178910|FG006|Overall Study|Protocol Violation|0|||
37701470|NCT01732510|69178904|FG000|Overall Study|Withdrawal by Subject|1|||
37701471|NCT01732510|69178905|FG001|Overall Study|Withdrawal by Subject|3|||
37701472|NCT01732510|69178906|FG002|Overall Study|Withdrawal by Subject|2|||
37701473|NCT01732510|69178907|FG003|Overall Study|Withdrawal by Subject|1|||
37701474|NCT01732510|69178908|FG004|Overall Study|Withdrawal by Subject|5|||
37701475|NCT01732510|69178909|FG005|Overall Study|Withdrawal by Subject|0|||
37701476|NCT01732510|69178910|FG006|Overall Study|Withdrawal by Subject|1|||
37701477|NCT01732510|69178904|FG000|Overall Study|Lost to Follow-up|0|||
37701478|NCT01732510|69178905|FG001|Overall Study|Lost to Follow-up|0|||
37701479|NCT01732510|69178906|FG002|Overall Study|Lost to Follow-up|1|||
37701480|NCT01732510|69178907|FG003|Overall Study|Lost to Follow-up|1|||
37701481|NCT01732510|69178908|FG004|Overall Study|Lost to Follow-up|0|||
37701482|NCT01732510|69178909|FG005|Overall Study|Lost to Follow-up|1|||
37701483|NCT01732510|69178910|FG006|Overall Study|Lost to Follow-up|0|||
37701484|NCT01732510|69178904|FG000|Overall Study|Physician Decision|0|||
37701485|NCT01732510|69178905|FG001|Overall Study|Physician Decision|1|||
37701486|NCT01732510|69178906|FG002|Overall Study|Physician Decision|0|||
37701487|NCT01732510|69178907|FG003|Overall Study|Physician Decision|0|||
37701488|NCT01732510|69178908|FG004|Overall Study|Physician Decision|0|||
37701489|NCT01732510|69178909|FG005|Overall Study|Physician Decision|0|||
37701490|NCT01732510|69178910|FG006|Overall Study|Physician Decision|0|||
37701491|NCT01732510|69178904|FG000|Overall Study|Pregnancy|0|||
37701492|NCT01732510|69178905|FG001|Overall Study|Pregnancy|0|||
37701493|NCT01732510|69178906|FG002|Overall Study|Pregnancy|0|||
37701494|NCT01732510|69178907|FG003|Overall Study|Pregnancy|1|||
37701495|NCT01732510|69178908|FG004|Overall Study|Pregnancy|0|||
37701496|NCT01732510|69178909|FG005|Overall Study|Pregnancy|0|||
37701497|NCT01732510|69178910|FG006|Overall Study|Pregnancy|0|||
37701498|NCT01732510|69178904|FG000|Overall Study|Study Terminated By Sponsor|0|||
37701499|NCT01732510|69178905|FG001|Overall Study|Study Terminated By Sponsor|0|||
37701500|NCT01732510|69178906|FG002|Overall Study|Study Terminated By Sponsor|0|||
37701501|NCT01732510|69178907|FG003|Overall Study|Study Terminated By Sponsor|1|||
37701502|NCT01732510|69178908|FG004|Overall Study|Study Terminated By Sponsor|0|||
37701503|NCT01732510|69178909|FG005|Overall Study|Study Terminated By Sponsor|12|||
37701504|NCT01732510|69178910|FG006|Overall Study|Study Terminated By Sponsor|6|||
37701505|NCT01637077|69178931|FG000|Overall Study|Cancel|1|||
37701506|NCT01637077|69178932|FG001|Overall Study|Cancel|1|||
37701507|NCT01637077|69178931|FG000|Overall Study|Withdrawal by Subject|1|||
37701508|NCT01637077|69178932|FG001|Overall Study|Withdrawal by Subject|0|||
37701509|NCT01637077|69178931|FG000|Overall Study|No cycle 1 questionnaire data|2|||
37701510|NCT01637077|69178932|FG001|Overall Study|No cycle 1 questionnaire data|0|||
37701511|NCT02308163|69178942|FG000|Overall Study|Not fulfill eligible criteria|1|||
37701512|NCT02308163|69178943|FG001|Overall Study|Not fulfill eligible criteria|2|||
37701513|NCT02308163|69178944|FG002|Overall Study|Not fulfill eligible criteria|0|||
37701514|NCT02308163|69178945|FG003|Overall Study|Not fulfill eligible criteria|1|||
37701515|NCT02308163|69178946|FG004|Overall Study|Not fulfill eligible criteria|1|||
37701516|NCT02308163|69178942|FG000|Overall Study|Adverse Event|9|||
37701517|NCT02308163|69178943|FG001|Overall Study|Adverse Event|5|||
37701518|NCT02308163|69178944|FG002|Overall Study|Adverse Event|2|||
37701519|NCT02308163|69178945|FG003|Overall Study|Adverse Event|2|||
37701520|NCT02308163|69178946|FG004|Overall Study|Adverse Event|11|||
37701521|NCT02308163|69178942|FG000|Overall Study|Lack of Efficacy|11|||
37701522|NCT02308163|69178943|FG001|Overall Study|Lack of Efficacy|3|||
37701523|NCT02308163|69178944|FG002|Overall Study|Lack of Efficacy|8|||
37701524|NCT02308163|69178945|FG003|Overall Study|Lack of Efficacy|4|||
37701525|NCT02308163|69178946|FG004|Overall Study|Lack of Efficacy|6|||
37701526|NCT02308163|69178942|FG000|Overall Study|Withdrawal of consent|2|||
37701527|NCT02308163|69178943|FG001|Overall Study|Withdrawal of consent|3|||
37701528|NCT02308163|69178944|FG002|Overall Study|Withdrawal of consent|0|||
37701529|NCT02308163|69178945|FG003|Overall Study|Withdrawal of consent|2|||
37701530|NCT02308163|69178946|FG004|Overall Study|Withdrawal of consent|6|||
37701531|NCT02308163|69178942|FG000|Overall Study|Protocol Violation|3|||
37701532|NCT02308163|69178943|FG001|Overall Study|Protocol Violation|3|||
37701533|NCT02308163|69178944|FG002|Overall Study|Protocol Violation|3|||
37701534|NCT02308163|69178945|FG003|Overall Study|Protocol Violation|2|||
37701535|NCT02308163|69178946|FG004|Overall Study|Protocol Violation|5|||
37701536|NCT02308163|69178942|FG000|Overall Study|Lab data met discontinuation criteria|3|||
37701537|NCT02308163|69178943|FG001|Overall Study|Lab data met discontinuation criteria|0|||
37701538|NCT02308163|69178944|FG002|Overall Study|Lab data met discontinuation criteria|0|||
37701539|NCT02308163|69178945|FG003|Overall Study|Lab data met discontinuation criteria|2|||
37701540|NCT02308163|69178946|FG004|Overall Study|Lab data met discontinuation criteria|0|||
37701541|NCT02308163|69178942|FG000|Overall Study|Miscellaneous|2|||
37701542|NCT02308163|69178943|FG001|Overall Study|Miscellaneous|2|||
37701543|NCT02308163|69178944|FG002|Overall Study|Miscellaneous|1|||
37701544|NCT02308163|69178945|FG003|Overall Study|Miscellaneous|0|||
37701545|NCT02308163|69178946|FG004|Overall Study|Miscellaneous|5|||
37701546|NCT01999335|69178978|FG000|Overall Study|Discontinued before receiving treatment|0|||
37701547|NCT01999335|69178979|FG001|Overall Study|Discontinued before receiving treatment|0|||
37701548|NCT01999335|69178980|FG002|Overall Study|Discontinued before receiving treatment|0|||
37701549|NCT01999335|69178981|FG003|Overall Study|Discontinued before receiving treatment|0|||
37701550|NCT01999335|69178982|FG004|Overall Study|Discontinued before receiving treatment|2|||
37701551|NCT01978119|69178997|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
37701552|NCT01978119|69178998|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
37701553|NCT01978119|69178997|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
37701554|NCT01978119|69178998|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
37701555|NCT01978119|69178997|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
37701556|NCT01978119|69178998|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
37701557|NCT01999179|69179004|FG000|Overall Study|Adverse Event|1|||
37701558|NCT01999179|69179004|FG000|Overall Study|Lost to Follow-up|1|||
37701559|NCT01999179|69179004|FG000|Overall Study|Change in Therapy|3|||
37701560|NCT01999179|69179004|FG000|Overall Study|New catheter|2|||
37701561|NCT01977729|69179008|FG000|Overall Study|Study terminated|1|||
37701562|NCT01998477|69179016|FG000|Overall Study|Lost to Follow-up|4|||
37701563|NCT01998477|69179017|FG001|Overall Study|Lost to Follow-up|5|||
37701564|NCT01998477|69179016|FG000|Overall Study|Withdrawal by Subject|6|||
37701565|NCT01998477|69179017|FG001|Overall Study|Withdrawal by Subject|0|||
37701566|NCT01998399|69179050|FG000|Overall Study|Lost to Follow-up|1|||
37701567|NCT01998399|69179051|FG001|Overall Study|Lost to Follow-up|3|||
37701568|NCT01998399|69179050|FG000|Overall Study|Death|4|||
37836566|NCT01212757|69521033|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
37836567|NCT01212757|69521034|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
37836568|NCT01212757|69521035|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
37836569|NCT01212757|69521036|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
37836570|NCT01212757|69521037|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
37836571|NCT01212757|69521038|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
38023505|NCT03759600|69706489|FG000|Overall Study|Ongoing at Data Cut-off|16|||
38023506|NCT03759600|69706489|FG000|Overall Study|Adverse Event|1|||
37701569|NCT01998399|69179051|FG001|Overall Study|Death|2|||
37701570|NCT01998399|69179050|FG000|Overall Study|Study stopped before dosing completed|3|||
37701571|NCT01998399|69179051|FG001|Overall Study|Study stopped before dosing completed|3|||
37701572|NCT01998399|69179050|FG000|Overall Study|Withdrawal by Subject|0|||
37701573|NCT01998399|69179051|FG001|Overall Study|Withdrawal by Subject|1|||
37701574|NCT01781572|69179068|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
37701575|NCT01781572|69179069|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
37836572|NCT01212757|69521039|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
37836573|NCT01212757|69521031|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
37701576|NCT01781572|69179070|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
37701577|NCT01781572|69179068|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
37701578|NCT01781572|69179069|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
37701579|NCT01781572|69179070|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
37701580|NCT01781572|69179068|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
37701581|NCT01781572|69179069|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
37701582|NCT01781572|69179070|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
37701583|NCT01781572|69179068|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
37701584|NCT01781572|69179069|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
37701585|NCT01781572|69179070|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
37701586|NCT01781572|69179068|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
37701587|NCT01781572|69179069|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
37701588|NCT01781572|69179070|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
37701589|NCT01781572|69179068|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
37701590|NCT01781572|69179069|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
37701591|NCT01781572|69179070|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
37701592|NCT01781572|69179068|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
37701593|NCT01781572|69179069|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
37701594|NCT01781572|69179070|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
37701595|NCT01781572|69179068|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
37701596|NCT01781572|69179069|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
37701597|NCT01781572|69179070|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
37701598|NCT01781572|69179068|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
37701599|NCT01781572|69179069|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
37701600|NCT01781572|69179070|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
37701601|NCT01781572|69179068|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
37701602|NCT01781572|69179069|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
37701603|NCT01781572|69179070|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
37701604|NCT01781572|69179068|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
37701605|NCT01781572|69179069|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
37701606|NCT01781572|69179070|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
37701607|NCT01781572|69179068|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
37701608|NCT01781572|69179069|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
37701609|NCT01781572|69179070|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
37701610|NCT01781572|69179068|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
37701611|NCT01781572|69179069|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
37701612|NCT01781572|69179070|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
37701613|NCT01781572|69179068|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
37701614|NCT01781572|69179069|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
37701615|NCT01781572|69179070|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
37701616|NCT01781572|69179068|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
37701617|NCT01781572|69179069|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
37701618|NCT01781572|69179070|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
37701619|NCT01781572|69179068|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
37701620|NCT01781572|69179069|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
37701621|NCT01781572|69179070|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
37701622|NCT01781572|69179068|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
37701623|NCT01781572|69179069|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
37701624|NCT01781572|69179070|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
37701625|NCT01781572|69179068|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
37701626|NCT01781572|69179069|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
37701627|NCT01781572|69179070|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
37701628|NCT01998243|69179101|FG000|Overall Study|Pregnancy|0|||
37701629|NCT01998243|69179102|FG001|Overall Study|Pregnancy|1|||
37701630|NCT01998243|69179101|FG000|Overall Study|Protocol Violation|5|||
37836574|NCT01212757|69521032|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
37836575|NCT01212757|69521033|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
37836576|NCT01212757|69521034|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
37836577|NCT01212757|69521035|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
37836578|NCT01212757|69521036|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
37836579|NCT01212757|69521037|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
38023507|NCT03759600|69706489|FG000|Overall Study|Progressive Disease|3|||
38023508|NCT04724733|69706496|FG000|Overall Study|Lost to Follow-up|1|||
38023509|NCT04724733|69706497|FG001|Overall Study|Lost to Follow-up|1|||
38023510|NCT04724733|69706498|FG002|Overall Study|Lost to Follow-up|1|||
38023511|NCT04635839|69706508|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
38023512|NCT04635839|69706509|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
38023513|NCT04493502|69706517|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
38023514|NCT04493502|69706518|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
38023515|NCT04493502|69706517|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
38023516|NCT04493502|69706518|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
38023517|NCT04493502|69706517|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
38023518|NCT04493502|69706518|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
38023519|NCT04493502|69706517|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
38023520|NCT04493502|69706518|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
38023521|NCT04493502|69706517|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
38023522|NCT04493502|69706518|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
38023523|NCT04493502|69706517|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
38023524|NCT04493502|69706518|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
38023525|NCT04493502|69706517|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
38023526|NCT04493502|69706518|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
38023527|NCT04493502|69706517|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
38023528|NCT04493502|69706518|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
38023529|NCT04493502|69706517|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
38023530|NCT04493502|69706518|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
38023531|NCT04493502|69706517|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
38023532|NCT04493502|69706518|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
38023533|NCT04493502|69706517|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
38023534|NCT04493502|69706518|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
38023535|NCT04493502|69706517|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
37701631|NCT01998243|69179102|FG001|Overall Study|Protocol Violation|2|||
37701632|NCT01998243|69179101|FG000|Overall Study|Withdrawal by Subject|3|||
37701633|NCT01998243|69179102|FG001|Overall Study|Withdrawal by Subject|4|||
37836580|NCT01212757|69521038|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
37836581|NCT01212757|69521039|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
37836582|NCT01212757|69521031|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
37836583|NCT01212757|69521032|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
37836584|NCT01212757|69521033|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
37701634|NCT01977573|69179114|FG000|Overall Study|Adverse Event|7|||
37701635|NCT01977573|69179115|FG001|Overall Study|Adverse Event|0|||
37701636|NCT01977573|69179116|FG002|Overall Study|Adverse Event|2|||
37701637|NCT01977573|69179117|FG003|Overall Study|Adverse Event|1|||
37701638|NCT01977573|69179114|FG000|Overall Study|Lost to Follow-up|1|||
37701639|NCT01977573|69179115|FG001|Overall Study|Lost to Follow-up|0|||
37701640|NCT01977573|69179116|FG002|Overall Study|Lost to Follow-up|0|||
37701641|NCT01977573|69179117|FG003|Overall Study|Lost to Follow-up|1|||
37701642|NCT01977573|69179114|FG000|Overall Study|Physician Decision|1|||
37701643|NCT01977573|69179115|FG001|Overall Study|Physician Decision|0|||
37701644|NCT01977573|69179116|FG002|Overall Study|Physician Decision|0|||
37701645|NCT01977573|69179117|FG003|Overall Study|Physician Decision|0|||
37701646|NCT01977573|69179114|FG000|Overall Study|Protocol Violation|3|||
37701647|NCT01977573|69179115|FG001|Overall Study|Protocol Violation|1|||
37701648|NCT01977573|69179116|FG002|Overall Study|Protocol Violation|0|||
37701649|NCT01977573|69179117|FG003|Overall Study|Protocol Violation|0|||
37701650|NCT01977573|69179114|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
37701651|NCT01977573|69179115|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
37701652|NCT01977573|69179116|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
37701653|NCT01977573|69179117|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
37701654|NCT01977573|69179114|FG000|Overall Study|Withdrawal by Subject|6|||
37701655|NCT01977573|69179115|FG001|Overall Study|Withdrawal by Subject|1|||
37701656|NCT01977573|69179116|FG002|Overall Study|Withdrawal by Subject|1|||
37701657|NCT01977573|69179117|FG003|Overall Study|Withdrawal by Subject|1|||
37701658|NCT01963767|69179130|FG000|Overall Study|Withdrawal by Subject|4|||
37701659|NCT01963767|69179131|FG001|Overall Study|Withdrawal by Subject|2|||
37701660|NCT01963767|69179130|FG000|Overall Study|Adverse Event|2|||
37701661|NCT01963767|69179131|FG001|Overall Study|Adverse Event|0|||
37701662|NCT01731886|69179139|FG000|Overall Study|Death|1|||
37701663|NCT01731886|69179140|FG001|Overall Study|Death|0|||
37701664|NCT01731886|69179139|FG000|Overall Study|Never started treatment|0|||
37701665|NCT01731886|69179140|FG001|Overall Study|Never started treatment|1|||
37701666|NCT01731886|69179139|FG000|Overall Study|Non-compliant|1|||
37701667|NCT01731886|69179140|FG001|Overall Study|Non-compliant|0|||
37701668|NCT01759420|69179147|FG000|Overall Study|Screen failure|5|||
37701669|NCT01759420|69179147|FG000|Overall Study|Inaccurate EKG machine readings|1|||
37701670|NCT01781026|69179151|FG000|Overall Study|Lack of Efficacy|2|||
37701671|NCT01607398|69179157|FG000|Overall Study|Adverse Event|0|||
37701672|NCT01607398|69179158|FG001|Overall Study|Adverse Event|2|||
37701673|NCT01607398|69179157|FG000|Overall Study|Severe COPD|2|||
37701674|NCT01607398|69179158|FG001|Overall Study|Severe COPD|0|||
37701675|NCT01779856|69179164|FG000|Overall Study|Withdrawal by Subject|15|||
37701676|NCT01779856|69179164|FG000|Overall Study|Death|3|||
37701677|NCT01779856|69179164|FG000|Overall Study|Physician Decision|1|||
37701678|NCT01779856|69179164|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
37701679|NCT01779856|69179164|FG000|Overall Study|Delays in scheduling implant|1|||
37701680|NCT01779856|69179164|FG000|Overall Study|Subject ineligible for Implant|2|||
37701681|NCT01729156|69179178|FG000|Overall Study|Withdrawal by Subject|1|||
37701682|NCT01729156|69179179|FG001|Overall Study|Withdrawal by Subject|0|||
37701683|NCT01729156|69179180|FG002|Overall Study|Withdrawal by Subject|0|||
37701684|NCT01779700|69179191|FG000|Overall Study|Adverse Event|4|||
37701685|NCT01779700|69179192|FG001|Overall Study|Adverse Event|3|||
37701686|NCT01779700|69179191|FG000|Overall Study|Withdrawal by Subject|0|||
37701687|NCT01779700|69179192|FG001|Overall Study|Withdrawal by Subject|2|||
37701688|NCT01778530|69179198|FG000|Overall Study|Progression on study|1|||
37701689|NCT01778530|69179198|FG000|Overall Study|Adverse event/side effect|1|||
37701690|NCT01778062|69179204|FG000|Overall Study|Adverse Event|1|||
37701691|NCT01778062|69179205|FG001|Overall Study|Adverse Event|3|||
37701692|NCT01778062|69179204|FG000|Overall Study|Consent Withdrawal|1|||
37701693|NCT01778062|69179205|FG001|Overall Study|Consent Withdrawal|5|||
37701694|NCT01778062|69179204|FG000|Overall Study|major protocol deviation|4|||
37701695|NCT01778062|69179205|FG001|Overall Study|major protocol deviation|3|||
37701696|NCT01759264|69179211|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
37701697|NCT01759264|69179211|FG000|Overall Study|Adverse Event|1|||
37836585|NCT01212757|69521034|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
37701698|NCT01759264|69179211|FG000|Overall Study|Other|2|||
37701699|NCT01759264|69179211|FG000|Overall Study|Lost to Follow-up|2|||
37701700|NCT01759264|69179211|FG000|Overall Study|Withdrawal by Subject|3|||
37701701|NCT01759264|69179211|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
37701702|NCT01757704|69179218|FG000|Overall Study|Protocol Violation|1|||
37701703|NCT01757704|69179219|FG001|Overall Study|Protocol Violation|3|||
37836586|NCT01212757|69521035|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
37701704|NCT01757392|69179225|FG000|Overall Study|Withdrawal by Subject|1|||
37701705|NCT01757392|69179225|FG000|Overall Study|Screen Fail|3|||
37701706|NCT01756846|69179231|FG000|Overall Study|Lost to Follow-up|5|||
37836587|NCT01212757|69521036|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
37701707|NCT01756846|69179232|FG001|Overall Study|Lost to Follow-up|10|||
37701708|NCT01756846|69179231|FG000|Overall Study|Withdrawal by Subject|1|||
37701709|NCT01756846|69179232|FG001|Overall Study|Withdrawal by Subject|2|||
37701710|NCT01963611|69179243|FG000|Overall Study|Adverse Event|1|||
37701711|NCT01963611|69179244|FG001|Overall Study|Adverse Event|1|||
37701712|NCT01963611|69179245|FG002|Overall Study|Adverse Event|3|||
37701713|NCT01963611|69179246|FG003|Overall Study|Adverse Event|4|||
37701714|NCT01963611|69179247|FG004|Overall Study|Adverse Event|3|||
37701715|NCT01963611|69179243|FG000|Overall Study|Protocol Violation|0|||
37701716|NCT01963611|69179244|FG001|Overall Study|Protocol Violation|0|||
37701717|NCT01963611|69179245|FG002|Overall Study|Protocol Violation|0|||
37701718|NCT01963611|69179246|FG003|Overall Study|Protocol Violation|1|||
37701719|NCT01963611|69179247|FG004|Overall Study|Protocol Violation|0|||
37701720|NCT01963611|69179243|FG000|Overall Study|Lack of Efficacy|0|||
37701721|NCT01963611|69179244|FG001|Overall Study|Lack of Efficacy|0|||
37914822|NCT00534313|69601417|FG000|Long-term Period|Administrative reason by sponsor|17|||
37914823|NCT00534313|69601418|FG001|Long-term Period|Administrative reason by sponsor|15|||
37914824|NCT00534313|69601419|FG002|Long-term Period|Administrative reason by sponsor|26|||
38023536|NCT04493502|69706518|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
38023537|NCT04493502|69706517|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
37701722|NCT01963611|69179245|FG002|Overall Study|Lack of Efficacy|0|||
37701723|NCT01963611|69179246|FG003|Overall Study|Lack of Efficacy|1|||
37701724|NCT01963611|69179247|FG004|Overall Study|Lack of Efficacy|0|||
37701725|NCT01963611|69179243|FG000|Overall Study|Withdrawal by Subject|3|||
37701726|NCT01963611|69179244|FG001|Overall Study|Withdrawal by Subject|2|||
37701727|NCT01963611|69179245|FG002|Overall Study|Withdrawal by Subject|1|||
37701728|NCT01963611|69179246|FG003|Overall Study|Withdrawal by Subject|1|||
37701729|NCT01963611|69179247|FG004|Overall Study|Withdrawal by Subject|3|||
37701730|NCT01963611|69179243|FG000|Overall Study|Other|47|||
37701731|NCT01963611|69179244|FG001|Overall Study|Other|46|||
37701732|NCT01963611|69179245|FG002|Overall Study|Other|48|||
37701733|NCT01963611|69179246|FG003|Overall Study|Other|45|||
37701734|NCT01963611|69179247|FG004|Overall Study|Other|45|||
37701735|NCT01975701|69179260|FG000|Overall Study|Lost to Follow-up|1|||
37701736|NCT01975701|69179260|FG000|Overall Study|Death|23|||
37701737|NCT01975701|69179260|FG000|Overall Study|Physician Decision|1|||
37701738|NCT01962987|69179267|FG000|Overall Study|Adverse Event|4|||
37701739|NCT01962987|69179268|FG001|Overall Study|Adverse Event|4|||
37701740|NCT01962987|69179269|FG002|Overall Study|Adverse Event|0|||
37701741|NCT01962987|69179267|FG000|Overall Study|Lost to Follow-up|0|||
37701742|NCT01962987|69179268|FG001|Overall Study|Lost to Follow-up|0|||
37701743|NCT01962987|69179269|FG002|Overall Study|Lost to Follow-up|1|||
37701744|NCT01962987|69179267|FG000|Overall Study|Non compliance with dosing requirements|4|||
37701745|NCT01962987|69179268|FG001|Overall Study|Non compliance with dosing requirements|2|||
37701746|NCT01962987|69179269|FG002|Overall Study|Non compliance with dosing requirements|0|||
37701747|NCT01962987|69179267|FG000|Overall Study|Miscellaneous|1|||
37701748|NCT01962987|69179268|FG001|Overall Study|Miscellaneous|9|||
37701749|NCT01962987|69179269|FG002|Overall Study|Miscellaneous|2|||
37701750|NCT01962987|69179267|FG000|Overall Study|Restricted medication|5|||
37701751|NCT01962987|69179268|FG001|Overall Study|Restricted medication|1|||
37701752|NCT01962987|69179269|FG002|Overall Study|Restricted medication|1|||
37701753|NCT01962987|69179267|FG000|Overall Study|Serious Adverse Event|1|||
37701754|NCT01962987|69179268|FG001|Overall Study|Serious Adverse Event|0|||
37701755|NCT01962987|69179269|FG002|Overall Study|Serious Adverse Event|0|||
37701756|NCT01962987|69179267|FG000|Overall Study|Withdrawal by Subject|11|||
37701757|NCT01962987|69179268|FG001|Overall Study|Withdrawal by Subject|10|||
37701758|NCT01962987|69179269|FG002|Overall Study|Withdrawal by Subject|6|||
37701759|NCT01962987|69179267|FG000|Overall Study|Randomized in Error|4|||
37701760|NCT01962987|69179268|FG001|Overall Study|Randomized in Error|2|||
37701761|NCT01962987|69179269|FG002|Overall Study|Randomized in Error|2|||
37701762|NCT01962441|69179280|FG000|Randomized Period|Randomized but Never Treated|4|||
37701763|NCT01962441|69179281|FG001|Randomized Period|Randomized but Never Treated|2|||
37701764|NCT01962441|69179282|FG002|Randomized Period|Randomized but Never Treated|3|||
37701765|NCT01962441|69179280|FG000|Randomized Period|Lost to Follow-up|2|||
37701766|NCT01962441|69179281|FG001|Randomized Period|Lost to Follow-up|4|||
37701767|NCT01962441|69179282|FG002|Randomized Period|Lost to Follow-up|4|||
37701768|NCT01962441|69179280|FG000|Randomized Period|Withdrew Consent|3|||
37701769|NCT01962441|69179281|FG001|Randomized Period|Withdrew Consent|3|||
37701770|NCT01962441|69179282|FG002|Randomized Period|Withdrew Consent|2|||
37701771|NCT01962441|69179280|FG000|Randomized Period|Adverse Event|1|||
37701772|NCT01962441|69179281|FG001|Randomized Period|Adverse Event|1|||
37701773|NCT01962441|69179282|FG002|Randomized Period|Adverse Event|0|||
37701774|NCT01962441|69179280|FG000|Randomized Period|Death|0|||
37701775|NCT01962441|69179281|FG001|Randomized Period|Death|0|||
37701776|NCT01962441|69179282|FG002|Randomized Period|Death|2|||
37701777|NCT01962441|69179280|FG000|Randomized Period|Protocol Violation|0|||
37701778|NCT01962441|69179281|FG001|Randomized Period|Protocol Violation|1|||
37701779|NCT01962441|69179282|FG002|Randomized Period|Protocol Violation|0|||
37701780|NCT01962441|69179280|FG000|Retreatment Substudy|Lack of Efficacy|1|||
37701781|NCT01962441|69179281|FG001|Retreatment Substudy|Lack of Efficacy|0|||
37701782|NCT01962441|69179282|FG002|Retreatment Substudy|Lack of Efficacy|0|||
37701783|NCT01962441|69179280|FG000|Retreatment Substudy|Lost to Follow-up|1|||
37701784|NCT01962441|69179281|FG001|Retreatment Substudy|Lost to Follow-up|0|||
37914825|NCT00534313|69601420|FG003|Long-term Period|Administrative reason by sponsor|18|||
37701785|NCT01962441|69179282|FG002|Retreatment Substudy|Lost to Follow-up|0|||
37701786|NCT01638013|69179294|FG000|Overall Study|Adverse Event|36|||
37836588|NCT01212757|69521037|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
37836589|NCT01212757|69521038|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
37836590|NCT01212757|69521039|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
37836591|NCT01212757|69521031|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
37836592|NCT01212757|69521032|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
37836593|NCT01212757|69521033|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
37836594|NCT01212757|69521034|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
37701787|NCT01638013|69179295|FG001|Overall Study|Adverse Event|29|||
37701788|NCT01638013|69179296|FG002|Overall Study|Adverse Event|48|||
37701789|NCT01638013|69179294|FG000|Overall Study|Lack of Efficacy|39|||
37701790|NCT01638013|69179295|FG001|Overall Study|Lack of Efficacy|11|||
37701791|NCT01638013|69179296|FG002|Overall Study|Lack of Efficacy|14|||
37701792|NCT01638013|69179294|FG000|Overall Study|Protocol Violation|10|||
37701793|NCT01638013|69179295|FG001|Overall Study|Protocol Violation|7|||
37701794|NCT01638013|69179296|FG002|Overall Study|Protocol Violation|11|||
37701795|NCT01638013|69179294|FG000|Overall Study|Met discontinuation criteria|4|||
37701796|NCT01638013|69179295|FG001|Overall Study|Met discontinuation criteria|0|||
37701797|NCT01638013|69179296|FG002|Overall Study|Met discontinuation criteria|7|||
37701798|NCT01638013|69179294|FG000|Overall Study|Subject Lost to Follow up|1|||
37701799|NCT01638013|69179295|FG001|Overall Study|Subject Lost to Follow up|0|||
37701800|NCT01638013|69179296|FG002|Overall Study|Subject Lost to Follow up|1|||
37701801|NCT01638013|69179294|FG000|Overall Study|Miscellaneous|25|||
37701802|NCT01638013|69179295|FG001|Overall Study|Miscellaneous|19|||
37701803|NCT01638013|69179296|FG002|Overall Study|Miscellaneous|23|||
37701804|NCT01638013|69179294|FG000|Overall Study|Withdrawal of Consent|16|||
37701805|NCT01638013|69179295|FG001|Overall Study|Withdrawal of Consent|12|||
37701806|NCT01638013|69179296|FG002|Overall Study|Withdrawal of Consent|16|||
37701807|NCT01638013|69179294|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
37701808|NCT01638013|69179295|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
37701809|NCT01638013|69179296|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
37701810|NCT01637623|69179311|FG000|Overall Study|Lost to Follow-up|0|||
37701811|NCT01637623|69179312|FG001|Overall Study|Lost to Follow-up|0|||
37701812|NCT01637623|69179313|FG002|Overall Study|Lost to Follow-up|2|||
37701813|NCT01637623|69179311|FG000|Overall Study|Physician Decision|1|||
37701814|NCT01637623|69179312|FG001|Overall Study|Physician Decision|0|||
37701815|NCT01637623|69179313|FG002|Overall Study|Physician Decision|1|||
37701816|NCT01962207|69179325|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
37701817|NCT01962207|69179326|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
37701818|NCT01962207|69179327|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
37701819|NCT01962207|69179328|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
37701820|NCT01962207|69179325|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
37701821|NCT01962207|69179326|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
37701822|NCT01962207|69179327|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
37701823|NCT01962207|69179328|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
37701824|NCT01962207|69179325|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
37701825|NCT01962207|69179326|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
37701826|NCT01962207|69179327|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
37701827|NCT01962207|69179328|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
37701828|NCT01962207|69179325|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
37701829|NCT01962207|69179326|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
37701830|NCT01962207|69179327|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
37701831|NCT01962207|69179328|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
37701832|NCT01962207|69179325|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
37701833|NCT01962207|69179326|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
37701834|NCT01962207|69179327|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
37701835|NCT01962207|69179328|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
37701836|NCT01962207|69179325|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
37701837|NCT01962207|69179326|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
37701838|NCT01962207|69179327|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
37701839|NCT01962207|69179328|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
37701840|NCT01995825|69179344|FG000|Overall Study|Withdrawal by Subject|1|||
37836595|NCT01212757|69521035|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
37836596|NCT01212757|69521036|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
37701841|NCT01995825|69179345|FG001|Overall Study|Withdrawal by Subject|0|||
37701842|NCT01995357|69179351|FG000|Period 5|Lack of Efficacy|1|||
37701843|NCT01995357|69179352|FG001|Period 5|Lack of Efficacy|0|||
37701844|NCT01995357|69179353|FG002|Period 5|Lack of Efficacy|0|||
37836597|NCT01212757|69521037|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
37701845|NCT01995357|69179354|FG003|Period 5|Lack of Efficacy|0|||
37701846|NCT01995357|69179355|FG004|Period 5|Lack of Efficacy|0|||
37701847|NCT01995357|69179356|FG005|Period 5|Lack of Efficacy|0|||
37701848|NCT01995357|69179351|FG000|Period 5|Adverse Event|1|||
37701849|NCT01995357|69179352|FG001|Period 5|Adverse Event|0|||
37701850|NCT01995357|69179353|FG002|Period 5|Adverse Event|1|||
37701851|NCT01995357|69179354|FG003|Period 5|Adverse Event|0|||
37701852|NCT01995357|69179355|FG004|Period 5|Adverse Event|0|||
37701853|NCT01995357|69179356|FG005|Period 5|Adverse Event|0|||
37701854|NCT01638559|69179372|FG000|Overall Study|Lost to Follow-up|1|||
37701855|NCT01638559|69179372|FG000|Overall Study|Withdrawal by Subject|1|||
37701856|NCT01638559|69179372|FG000|Overall Study|Subject declined to travel for biopsy|1|||
37701857|NCT01756456|69179393|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
37701858|NCT01756456|69179394|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
37701859|NCT01756456|69179395|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
37701860|NCT01756456|69179396|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
37701861|NCT01756456|69179397|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
37701862|NCT01756456|69179398|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
37701863|NCT01756456|69179393|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
37701864|NCT01756456|69179394|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
37701865|NCT01756456|69179395|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
37701866|NCT01756456|69179396|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
37701867|NCT01756456|69179397|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
37701868|NCT01756456|69179398|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
37701869|NCT01756456|69179393|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
37701870|NCT01756456|69179394|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
37701871|NCT01756456|69179395|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
37701872|NCT01756456|69179396|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
37701873|NCT01756456|69179397|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
37701874|NCT01756456|69179398|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
37701875|NCT01756456|69179393|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
37701876|NCT01756456|69179394|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
37701877|NCT01756456|69179395|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
37701878|NCT01756456|69179396|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
37701879|NCT01756456|69179397|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
37701880|NCT01756456|69179398|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
37701881|NCT01756456|69179393|FG000|Treatment Period: Phase I/II|Other causes|0|||
37701882|NCT01756456|69179394|FG001|Treatment Period: Phase I/II|Other causes|0|||
37701883|NCT01756456|69179395|FG002|Treatment Period: Phase I/II|Other causes|0|||
37701884|NCT01756456|69179396|FG003|Treatment Period: Phase I/II|Other causes|1|||
37701885|NCT01756456|69179397|FG004|Treatment Period: Phase I/II|Other causes|2|||
37701886|NCT01756456|69179398|FG005|Treatment Period: Phase I/II|Other causes|2|||
37701887|NCT01756456|69179393|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
37701888|NCT01756456|69179394|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
37701889|NCT01756456|69179395|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
37701890|NCT01756456|69179396|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
37701891|NCT01756456|69179397|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
37701892|NCT01756456|69179398|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
37701893|NCT01756456|69179393|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
37701894|NCT01756456|69179394|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
37701895|NCT01756456|69179395|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
37701896|NCT01756456|69179396|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
37701897|NCT01756456|69179397|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
37701898|NCT01756456|69179398|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
37701899|NCT01756456|69179393|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
37701900|NCT01756456|69179394|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
37701901|NCT01756456|69179395|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
37701902|NCT01756456|69179396|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
37701903|NCT01756456|69179397|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
37836598|NCT01212757|69521038|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
37701904|NCT01756456|69179398|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
37701905|NCT01756456|69179393|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
37836599|NCT01212757|69521039|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
37836600|NCT01212757|69521031|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
37701906|NCT01756456|69179394|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
37701907|NCT01756456|69179395|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
37701908|NCT01756456|69179396|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
37701909|NCT01756456|69179397|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
37701910|NCT01756456|69179398|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
37701911|NCT01756456|69179393|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
37701912|NCT01756456|69179394|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
37701913|NCT01756456|69179395|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
37701914|NCT01756456|69179396|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
37701915|NCT01756456|69179397|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
37701916|NCT01756456|69179398|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
37701917|NCT01756456|69179393|FG000|Follow Up Period Phase I/II|Other causes|0|||
37701918|NCT01756456|69179394|FG001|Follow Up Period Phase I/II|Other causes|0|||
37701919|NCT01756456|69179395|FG002|Follow Up Period Phase I/II|Other causes|0|||
37701920|NCT01756456|69179396|FG003|Follow Up Period Phase I/II|Other causes|1|||
37701921|NCT01756456|69179397|FG004|Follow Up Period Phase I/II|Other causes|3|||
37701922|NCT01756456|69179398|FG005|Follow Up Period Phase I/II|Other causes|5|||
37701923|NCT01756300|69179421|FG000|Overall Study|Death|1|||
37701924|NCT01756300|69179421|FG000|Overall Study|Withdrawal by Subject|1|||
37701925|NCT01995201|69179444|FG000|From Baseline Until Week 24|Adverse Event|4|||
37701926|NCT01995201|69179445|FG001|From Baseline Until Week 24|Adverse Event|15|||
37701927|NCT01995201|69179446|FG002|From Baseline Until Week 24|Adverse Event|0|||
37701928|NCT01995201|69179447|FG003|From Baseline Until Week 24|Adverse Event|0|||
37701929|NCT01995201|69179448|FG004|From Baseline Until Week 24|Adverse Event|0|||
37701930|NCT01995201|69179449|FG005|From Baseline Until Week 24|Adverse Event|0|||
37701931|NCT01995201|69179450|FG006|From Baseline Until Week 24|Adverse Event|0|||
37701932|NCT01995201|69179444|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
37701933|NCT01995201|69179445|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
37701934|NCT01995201|69179446|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
37701935|NCT01995201|69179447|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
37701936|NCT01995201|69179448|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
37701937|NCT01995201|69179449|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
37701938|NCT01995201|69179450|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
37701939|NCT01995201|69179444|FG000|From Baseline Until Week 24|Death|0|||
37701940|NCT01995201|69179445|FG001|From Baseline Until Week 24|Death|1|||
37701941|NCT01995201|69179446|FG002|From Baseline Until Week 24|Death|0|||
37701942|NCT01995201|69179447|FG003|From Baseline Until Week 24|Death|0|||
37701943|NCT01995201|69179448|FG004|From Baseline Until Week 24|Death|0|||
37701944|NCT01995201|69179449|FG005|From Baseline Until Week 24|Death|0|||
37701945|NCT01995201|69179450|FG006|From Baseline Until Week 24|Death|0|||
37701946|NCT01995201|69179444|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
37701947|NCT01995201|69179445|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
37701948|NCT01995201|69179446|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
37701949|NCT01995201|69179447|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
37701950|NCT01995201|69179448|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
37701951|NCT01995201|69179449|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
37701952|NCT01995201|69179450|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
37701953|NCT01995201|69179444|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
37701954|NCT01995201|69179445|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
37701955|NCT01995201|69179446|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
37701956|NCT01995201|69179447|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
37701957|NCT01995201|69179448|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
37701958|NCT01995201|69179449|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
37701959|NCT01995201|69179450|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
37701960|NCT01995201|69179444|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
37701961|NCT01995201|69179445|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
37701962|NCT01995201|69179446|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
37701963|NCT01995201|69179447|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
37701964|NCT01995201|69179448|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
37701965|NCT01995201|69179449|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
37701966|NCT01995201|69179450|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
37701967|NCT01995201|69179444|FG000|From Baseline Until Week 24|Physician Decision|0|||
37701968|NCT01995201|69179445|FG001|From Baseline Until Week 24|Physician Decision|2|||
37701969|NCT01995201|69179446|FG002|From Baseline Until Week 24|Physician Decision|0|||
37701970|NCT01995201|69179447|FG003|From Baseline Until Week 24|Physician Decision|0|||
37701971|NCT01995201|69179448|FG004|From Baseline Until Week 24|Physician Decision|0|||
37701972|NCT01995201|69179449|FG005|From Baseline Until Week 24|Physician Decision|0|||
37701973|NCT01995201|69179450|FG006|From Baseline Until Week 24|Physician Decision|0|||
37701974|NCT01995201|69179444|FG000|From Baseline Until Week 24|Protocol Violation|0|||
37701975|NCT01995201|69179445|FG001|From Baseline Until Week 24|Protocol Violation|9|||
37701976|NCT01995201|69179446|FG002|From Baseline Until Week 24|Protocol Violation|0|||
37701977|NCT01995201|69179447|FG003|From Baseline Until Week 24|Protocol Violation|0|||
37701978|NCT01995201|69179448|FG004|From Baseline Until Week 24|Protocol Violation|0|||
37701979|NCT01995201|69179449|FG005|From Baseline Until Week 24|Protocol Violation|0|||
37701980|NCT01995201|69179450|FG006|From Baseline Until Week 24|Protocol Violation|0|||
37701981|NCT01995201|69179444|FG000|From Week 24 Until Week 48|Adverse Event|0|||
37701982|NCT01995201|69179445|FG001|From Week 24 Until Week 48|Adverse Event|0|||
37701983|NCT01995201|69179446|FG002|From Week 24 Until Week 48|Adverse Event|2|||
37701984|NCT01995201|69179447|FG003|From Week 24 Until Week 48|Adverse Event|1|||
37701985|NCT01995201|69179448|FG004|From Week 24 Until Week 48|Adverse Event|1|||
37701986|NCT01995201|69179449|FG005|From Week 24 Until Week 48|Adverse Event|3|||
37701987|NCT01995201|69179450|FG006|From Week 24 Until Week 48|Adverse Event|1|||
37701988|NCT01995201|69179444|FG000|From Week 24 Until Week 48|Death|0|||
37701989|NCT01995201|69179445|FG001|From Week 24 Until Week 48|Death|0|||
37701990|NCT01995201|69179446|FG002|From Week 24 Until Week 48|Death|0|||
37701991|NCT01995201|69179447|FG003|From Week 24 Until Week 48|Death|0|||
37701992|NCT01995201|69179448|FG004|From Week 24 Until Week 48|Death|0|||
37701993|NCT01995201|69179449|FG005|From Week 24 Until Week 48|Death|2|||
37701994|NCT01995201|69179450|FG006|From Week 24 Until Week 48|Death|0|||
37701995|NCT01995201|69179444|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
37701996|NCT01995201|69179445|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
37701997|NCT01995201|69179446|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
37701998|NCT01995201|69179447|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
37701999|NCT01995201|69179448|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
37702000|NCT01995201|69179449|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
37702001|NCT01995201|69179450|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
37702002|NCT01995201|69179444|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
37702003|NCT01995201|69179445|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
37702004|NCT01995201|69179446|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
37702005|NCT01995201|69179447|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
37702006|NCT01995201|69179448|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
37702007|NCT01995201|69179449|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
37702008|NCT01995201|69179450|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
37702009|NCT01995201|69179444|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
37702010|NCT01995201|69179445|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
37702011|NCT01995201|69179446|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
37702012|NCT01995201|69179447|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
37702013|NCT01995201|69179448|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
37702014|NCT01995201|69179449|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
37702015|NCT01995201|69179450|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
37702016|NCT01995201|69179444|FG000|From Week 24 Until Week 48|Physician Decision|0|||
37702017|NCT01995201|69179445|FG001|From Week 24 Until Week 48|Physician Decision|0|||
37702018|NCT01995201|69179446|FG002|From Week 24 Until Week 48|Physician Decision|0|||
37702019|NCT01995201|69179447|FG003|From Week 24 Until Week 48|Physician Decision|0|||
37702020|NCT01995201|69179448|FG004|From Week 24 Until Week 48|Physician Decision|1|||
37702021|NCT01995201|69179449|FG005|From Week 24 Until Week 48|Physician Decision|0|||
37702022|NCT01995201|69179450|FG006|From Week 24 Until Week 48|Physician Decision|0|||
37702023|NCT01995201|69179444|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
37836601|NCT01212757|69521032|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
37836602|NCT01212757|69521033|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
37836603|NCT01212757|69521034|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
37702024|NCT01995201|69179445|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
37702025|NCT01995201|69179446|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
37702026|NCT01995201|69179447|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
37702027|NCT01995201|69179448|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
37702028|NCT01995201|69179449|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
37702029|NCT01995201|69179450|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
37702030|NCT01728454|69179474|FG000|Stage 1 and 2|Pregnancy|1|||
37702031|NCT01728454|69179475|FG001|Stage 1 and 2|Pregnancy|0|||
37702032|NCT01728454|69179476|FG002|Stage 1 and 2|Pregnancy|0|||
37702033|NCT01728454|69179474|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
37702034|NCT01728454|69179475|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
37702035|NCT01728454|69179476|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
37702036|NCT01728454|69179474|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
37702037|NCT01728454|69179475|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
37702038|NCT01728454|69179476|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
37702039|NCT01728454|69179474|FG000|Stage 1 and 2|Lost to Follow-up|1|||
37702040|NCT01728454|69179475|FG001|Stage 1 and 2|Lost to Follow-up|1|||
37914826|NCT00534313|69601417|FG000|Long-term Period|Other|1|||
37702041|NCT01728454|69179476|FG002|Stage 1 and 2|Lost to Follow-up|0|||
37702042|NCT01728454|69179474|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
37702043|NCT01728454|69179475|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
37702044|NCT01728454|69179476|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
37702045|NCT01728454|69179474|FG000|Stage 3|Reason Missing|0|||
37702046|NCT01728454|69179475|FG001|Stage 3|Reason Missing|0|||
37702047|NCT01728454|69179476|FG002|Stage 3|Reason Missing|1|||
37702048|NCT01728454|69179474|FG000|Stage 3|Subject Required Other Treatment|0|||
37702049|NCT01728454|69179475|FG001|Stage 3|Subject Required Other Treatment|1|||
37702050|NCT01728454|69179476|FG002|Stage 3|Subject Required Other Treatment|0|||
37702051|NCT01728454|69179474|FG000|Stage 3|Pregnancy|1|||
37702052|NCT01728454|69179475|FG001|Stage 3|Pregnancy|0|||
37702053|NCT01728454|69179476|FG002|Stage 3|Pregnancy|0|||
37702054|NCT01728454|69179474|FG000|Stage 3|Withdrew Consent|1|||
37702055|NCT01728454|69179475|FG001|Stage 3|Withdrew Consent|0|||
37702056|NCT01728454|69179476|FG002|Stage 3|Withdrew Consent|1|||
37702057|NCT01728454|69179474|FG000|Stage 3|Non-compliance with Protocol|0|||
37702058|NCT01728454|69179475|FG001|Stage 3|Non-compliance with Protocol|0|||
37702059|NCT01728454|69179476|FG002|Stage 3|Non-compliance with Protocol|1|||
37702060|NCT01728454|69179474|FG000|Stage 3|Lost to Follow-up|0|||
37702061|NCT01728454|69179475|FG001|Stage 3|Lost to Follow-up|3|||
37702062|NCT01728454|69179476|FG002|Stage 3|Lost to Follow-up|1|||
37702063|NCT01728454|69179474|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
37702064|NCT01728454|69179475|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
37702065|NCT01728454|69179476|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
37702066|NCT01636687|69179490|FG000|Induction Period|Withdrawal by Subject|1|||
37702067|NCT01636687|69179491|FG001|Induction Period|Withdrawal by Subject|0|||
37702068|NCT01636687|69179492|FG002|Induction Period|Withdrawal by Subject|0|||
37702069|NCT01636687|69179493|FG003|Induction Period|Withdrawal by Subject|0|||
37702070|NCT01636687|69179494|FG004|Induction Period|Withdrawal by Subject|0|||
37702071|NCT01636687|69179490|FG000|Induction Period|Adverse Event|1|||
37702072|NCT01636687|69179491|FG001|Induction Period|Adverse Event|0|||
37702073|NCT01636687|69179492|FG002|Induction Period|Adverse Event|0|||
37702074|NCT01636687|69179493|FG003|Induction Period|Adverse Event|0|||
37702075|NCT01636687|69179494|FG004|Induction Period|Adverse Event|1|||
37702076|NCT01636687|69179490|FG000|Induction Period|Lack of Efficacy|0|||
37702077|NCT01636687|69179491|FG001|Induction Period|Lack of Efficacy|0|||
37702078|NCT01636687|69179492|FG002|Induction Period|Lack of Efficacy|0|||
37702079|NCT01636687|69179493|FG003|Induction Period|Lack of Efficacy|0|||
37702080|NCT01636687|69179494|FG004|Induction Period|Lack of Efficacy|1|||
37702081|NCT01636687|69179490|FG000|Induction Period|Physician Decision|1|||
37702082|NCT01636687|69179491|FG001|Induction Period|Physician Decision|0|||
37702083|NCT01636687|69179492|FG002|Induction Period|Physician Decision|0|||
37702084|NCT01636687|69179493|FG003|Induction Period|Physician Decision|0|||
37702085|NCT01636687|69179494|FG004|Induction Period|Physician Decision|0|||
37702086|NCT01636687|69179490|FG000|Maintenance Period|Withdrawal by Subject|2|||
37702087|NCT01636687|69179491|FG001|Maintenance Period|Withdrawal by Subject|0|||
37702088|NCT01636687|69179492|FG002|Maintenance Period|Withdrawal by Subject|2|||
37702089|NCT01636687|69179493|FG003|Maintenance Period|Withdrawal by Subject|0|||
37702090|NCT01636687|69179494|FG004|Maintenance Period|Withdrawal by Subject|0|||
37702091|NCT01636687|69179490|FG000|Maintenance Period|Adverse Event|1|||
37702092|NCT01636687|69179491|FG001|Maintenance Period|Adverse Event|0|||
37702093|NCT01636687|69179492|FG002|Maintenance Period|Adverse Event|0|||
37702094|NCT01636687|69179493|FG003|Maintenance Period|Adverse Event|0|||
37702095|NCT01636687|69179494|FG004|Maintenance Period|Adverse Event|0|||
37702096|NCT01636687|69179490|FG000|Maintenance Period|Lack of Efficacy|4|||
37702097|NCT01636687|69179491|FG001|Maintenance Period|Lack of Efficacy|1|||
37702098|NCT01636687|69179492|FG002|Maintenance Period|Lack of Efficacy|0|||
37702099|NCT01636687|69179493|FG003|Maintenance Period|Lack of Efficacy|0|||
37702100|NCT01636687|69179494|FG004|Maintenance Period|Lack of Efficacy|0|||
37702101|NCT01636687|69179490|FG000|Maintenance Period|Lost to Follow-up|1|||
37702102|NCT01636687|69179491|FG001|Maintenance Period|Lost to Follow-up|1|||
37702103|NCT01636687|69179492|FG002|Maintenance Period|Lost to Follow-up|0|||
37702104|NCT01636687|69179493|FG003|Maintenance Period|Lost to Follow-up|0|||
37702105|NCT01636687|69179494|FG004|Maintenance Period|Lost to Follow-up|1|||
37702106|NCT01636687|69179490|FG000|Maintenance Period|Physician Decision|0|||
37702107|NCT01636687|69179491|FG001|Maintenance Period|Physician Decision|0|||
37702108|NCT01636687|69179492|FG002|Maintenance Period|Physician Decision|0|||
37702109|NCT01636687|69179493|FG003|Maintenance Period|Physician Decision|0|||
37702110|NCT01636687|69179494|FG004|Maintenance Period|Physician Decision|1|||
37702111|NCT01636687|69179490|FG000|Extension Period|technical problems|0|||
37702112|NCT01636687|69179491|FG001|Extension Period|technical problems|1|||
37702113|NCT01636687|69179492|FG002|Extension Period|technical problems|2|||
37702114|NCT01636687|69179493|FG003|Extension Period|technical problems|1|||
37702115|NCT01636687|69179494|FG004|Extension Period|technical problems|0|||
37702116|NCT01636687|69179490|FG000|Extension Period|Adverse Event|4|||
37914827|NCT00534313|69601418|FG001|Long-term Period|Other|2|||
37914828|NCT00534313|69601419|FG002|Long-term Period|Other|2|||
37914829|NCT00534313|69601420|FG003|Long-term Period|Other|2|||
37914830|NCT03888391|69601465|FG000|Overall Study|Lost to Follow-up|15|||
37914831|NCT00594204|69601471|FG000|Overall Study|Adverse Event|15|||
37914832|NCT00594204|69601472|FG001|Overall Study|Adverse Event|3|||
37914833|NCT00594204|69601471|FG000|Overall Study|Lost to Follow-up|9|||
37914834|NCT00594204|69601472|FG001|Overall Study|Lost to Follow-up|5|||
37914835|NCT00594204|69601471|FG000|Overall Study|Withdrawal by Subject|23|||
37914836|NCT00594204|69601472|FG001|Overall Study|Withdrawal by Subject|29|||
37914837|NCT00594204|69601471|FG000|Overall Study|Other|4|||
37914838|NCT00594204|69601472|FG001|Overall Study|Other|3|||
38023538|NCT04493502|69706518|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
38023539|NCT04147858|69706529|FG000|Overall Study|Adverse Event|6|||
38023540|NCT04147858|69706530|FG001|Overall Study|Adverse Event|6|||
37702117|NCT01636687|69179491|FG001|Extension Period|Adverse Event|3|||
38023541|NCT04147858|69706531|FG002|Overall Study|Adverse Event|6|||
38023542|NCT04147858|69706529|FG000|Overall Study|Lack of Efficacy|3|||
38023543|NCT04147858|69706530|FG001|Overall Study|Lack of Efficacy|3|||
38023544|NCT04147858|69706531|FG002|Overall Study|Lack of Efficacy|1|||
38023545|NCT04147858|69706529|FG000|Overall Study|Lost to Follow-up|1|||
38023546|NCT04147858|69706530|FG001|Overall Study|Lost to Follow-up|6|||
38023547|NCT04147858|69706531|FG002|Overall Study|Lost to Follow-up|2|||
38023548|NCT04147858|69706529|FG000|Overall Study|Withdrawal by Subject|3|||
38023549|NCT04147858|69706530|FG001|Overall Study|Withdrawal by Subject|4|||
38023550|NCT04147858|69706531|FG002|Overall Study|Withdrawal by Subject|10|||
37702118|NCT01636687|69179492|FG002|Extension Period|Adverse Event|2|||
37702119|NCT01636687|69179493|FG003|Extension Period|Adverse Event|1|||
37702120|NCT01636687|69179494|FG004|Extension Period|Adverse Event|0|||
37702121|NCT01636687|69179490|FG000|Extension Period|Lack of Efficacy|7|||
37836604|NCT01212757|69521035|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
37702122|NCT01636687|69179491|FG001|Extension Period|Lack of Efficacy|0|||
37836605|NCT01212757|69521036|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
37836606|NCT01212757|69521037|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
37836607|NCT01212757|69521038|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
37836608|NCT01212757|69521039|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
37836609|NCT01212757|69521031|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
37836610|NCT01212757|69521032|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
37836611|NCT01212757|69521033|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
37836612|NCT01212757|69521034|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
37914839|NCT00594204|69601471|FG000|Overall Study|Lack of Efficacy|3|||
38023551|NCT04147858|69706529|FG000|Overall Study|Subject Noncompliance, Other|4|||
37702123|NCT01636687|69179492|FG002|Extension Period|Lack of Efficacy|2|||
37702124|NCT01636687|69179493|FG003|Extension Period|Lack of Efficacy|1|||
37702125|NCT01636687|69179494|FG004|Extension Period|Lack of Efficacy|0|||
37702126|NCT01636687|69179490|FG000|Extension Period|Lost to Follow-up|1|||
37702127|NCT01636687|69179491|FG001|Extension Period|Lost to Follow-up|0|||
37914840|NCT00594204|69601472|FG001|Overall Study|Lack of Efficacy|4|||
37914841|NCT00594204|69601471|FG000|Overall Study|Randomized but not treated|4|||
37914842|NCT00594204|69601472|FG001|Overall Study|Randomized but not treated|1|||
38023552|NCT04147858|69706530|FG001|Overall Study|Subject Noncompliance, Other|3|||
37702128|NCT01636687|69179492|FG002|Extension Period|Lost to Follow-up|1|||
37702129|NCT01636687|69179493|FG003|Extension Period|Lost to Follow-up|0|||
37702130|NCT01636687|69179494|FG004|Extension Period|Lost to Follow-up|0|||
37702131|NCT01636687|69179490|FG000|Extension Period|Physician Decision|1|||
37702132|NCT01636687|69179491|FG001|Extension Period|Physician Decision|0|||
37702133|NCT01636687|69179492|FG002|Extension Period|Physician Decision|0|||
37702134|NCT01636687|69179493|FG003|Extension Period|Physician Decision|1|||
37702135|NCT01636687|69179494|FG004|Extension Period|Physician Decision|0|||
37702136|NCT01636687|69179490|FG000|Extension Period|study terminated by sponsor|33|||
37702137|NCT01636687|69179491|FG001|Extension Period|study terminated by sponsor|50|||
37702138|NCT01636687|69179492|FG002|Extension Period|study terminated by sponsor|17|||
37702139|NCT01636687|69179493|FG003|Extension Period|study terminated by sponsor|23|||
37702140|NCT01636687|69179494|FG004|Extension Period|study terminated by sponsor|0|||
37702141|NCT01636687|69179490|FG000|Extension Period|Withdrawal by Subject|1|||
37702142|NCT01636687|69179491|FG001|Extension Period|Withdrawal by Subject|0|||
37702143|NCT01636687|69179492|FG002|Extension Period|Withdrawal by Subject|1|||
37702144|NCT01636687|69179493|FG003|Extension Period|Withdrawal by Subject|1|||
37702145|NCT01636687|69179494|FG004|Extension Period|Withdrawal by Subject|0|||
37702146|NCT01636687|69179490|FG000|Follow-up Period|Withdrawal by Subject|1|||
37702147|NCT01636687|69179491|FG001|Follow-up Period|Withdrawal by Subject|0|||
37702148|NCT01636687|69179492|FG002|Follow-up Period|Withdrawal by Subject|0|||
37702149|NCT01636687|69179493|FG003|Follow-up Period|Withdrawal by Subject|0|||
37702150|NCT01636687|69179494|FG004|Follow-up Period|Withdrawal by Subject|1|||
37702151|NCT01634659|69179514|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
37702152|NCT01634659|69179515|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
37702153|NCT01634659|69179514|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
37702154|NCT01634659|69179515|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
37702155|NCT04863248|69179527|FG000|Overall Study|Sponsor Terminated|4|||
37702156|NCT04863248|69179528|FG001|Overall Study|Sponsor Terminated|1|||
37702157|NCT04863248|69179527|FG000|Overall Study|Death|0|||
37702158|NCT04863248|69179528|FG001|Overall Study|Death|1|||
37702159|NCT04863248|69179527|FG000|Overall Study|Withdrawal by Subject|0|||
37702160|NCT04863248|69179528|FG001|Overall Study|Withdrawal by Subject|1|||
37702161|NCT04285229|69179536|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
37702162|NCT04285229|69179537|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
37702163|NCT04285229|69179538|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
37702164|NCT04285229|69179539|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
37702165|NCT04285229|69179540|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
37702166|NCT04285229|69179541|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
37702167|NCT04285229|69179536|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
37702168|NCT04285229|69179537|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
37702169|NCT04285229|69179538|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
37702170|NCT04285229|69179539|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
37702171|NCT04285229|69179540|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
37702172|NCT04285229|69179541|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
37702173|NCT04285229|69179536|FG000|Extended Treatment Period|Adverse Event|0|||
37702174|NCT04285229|69179537|FG001|Extended Treatment Period|Adverse Event|0|||
37702175|NCT04285229|69179538|FG002|Extended Treatment Period|Adverse Event|0|||
37914843|NCT03888235|69601490|FG000|Overall Study|Lost to Follow-up|1|||
37914844|NCT03888235|69601491|FG001|Overall Study|Lost to Follow-up|1|||
37914845|NCT03888235|69601492|FG002|Overall Study|Lost to Follow-up|0|||
37836613|NCT01212757|69521035|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
37836614|NCT01212757|69521036|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
37836615|NCT01212757|69521037|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
37836616|NCT01212757|69521038|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
37836617|NCT01212757|69521039|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
37836618|NCT01212757|69521031|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
37836619|NCT01212757|69521032|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
37836620|NCT01212757|69521033|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
37836621|NCT01212757|69521034|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
37914846|NCT00866307|69601523|FG000|Induction|Adverse Event|5|||
37702176|NCT04285229|69179539|FG003|Extended Treatment Period|Adverse Event|1|||
37702177|NCT04285229|69179540|FG004|Extended Treatment Period|Adverse Event|0|||
37702178|NCT04285229|69179541|FG005|Extended Treatment Period|Adverse Event|0|||
37702179|NCT04285229|69179536|FG000|Extended Treatment Period|Physician Decision|0|||
37702180|NCT04285229|69179537|FG001|Extended Treatment Period|Physician Decision|0|||
37702181|NCT04285229|69179538|FG002|Extended Treatment Period|Physician Decision|1|||
37702182|NCT04285229|69179539|FG003|Extended Treatment Period|Physician Decision|0|||
37702183|NCT04285229|69179540|FG004|Extended Treatment Period|Physician Decision|0|||
37702184|NCT04285229|69179541|FG005|Extended Treatment Period|Physician Decision|0|||
37702185|NCT04285229|69179536|FG000|Follow-up Period|Adverse Event|0|||
37702186|NCT04285229|69179537|FG001|Follow-up Period|Adverse Event|0|||
37702187|NCT04285229|69179538|FG002|Follow-up Period|Adverse Event|0|||
37702188|NCT04285229|69179539|FG003|Follow-up Period|Adverse Event|0|||
37702189|NCT04285229|69179540|FG004|Follow-up Period|Adverse Event|1|||
37702190|NCT04285229|69179541|FG005|Follow-up Period|Adverse Event|4|||
37702191|NCT04285229|69179536|FG000|Follow-up Period|Withdrawal by Subject|0|||
37702192|NCT04285229|69179537|FG001|Follow-up Period|Withdrawal by Subject|0|||
37702193|NCT04285229|69179538|FG002|Follow-up Period|Withdrawal by Subject|0|||
37702194|NCT04285229|69179539|FG003|Follow-up Period|Withdrawal by Subject|0|||
37702195|NCT04285229|69179540|FG004|Follow-up Period|Withdrawal by Subject|0|||
37702196|NCT04285229|69179541|FG005|Follow-up Period|Withdrawal by Subject|5|||
37702197|NCT04285229|69179536|FG000|Follow-up Period|Covid-19|0|||
37702198|NCT04285229|69179537|FG001|Follow-up Period|Covid-19|0|||
37702199|NCT04285229|69179538|FG002|Follow-up Period|Covid-19|0|||
37702200|NCT04285229|69179539|FG003|Follow-up Period|Covid-19|0|||
37702201|NCT04285229|69179540|FG004|Follow-up Period|Covid-19|0|||
37702202|NCT04285229|69179541|FG005|Follow-up Period|Covid-19|2|||
37702203|NCT04285229|69179536|FG000|Follow-up Period|Physician Decision|0|||
37702204|NCT04285229|69179537|FG001|Follow-up Period|Physician Decision|0|||
37702205|NCT04285229|69179538|FG002|Follow-up Period|Physician Decision|0|||
37702206|NCT04285229|69179539|FG003|Follow-up Period|Physician Decision|0|||
37702207|NCT04285229|69179540|FG004|Follow-up Period|Physician Decision|0|||
37702208|NCT04285229|69179541|FG005|Follow-up Period|Physician Decision|1|||
37702209|NCT04263454|69179558|FG000|Overall Study|Adverse Event|0|||
37702210|NCT04263454|69179559|FG001|Overall Study|Adverse Event|2|||
37702211|NCT04263454|69179558|FG000|Overall Study|Physician Decision|3|||
37702212|NCT04263454|69179559|FG001|Overall Study|Physician Decision|5|||
37702213|NCT04263454|69179558|FG000|Overall Study|Poor Data Quality|0|||
37702214|NCT04263454|69179559|FG001|Overall Study|Poor Data Quality|1|||
37702215|NCT04155463|69179569|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
37702216|NCT04155463|69179570|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
37702217|NCT04056611|69179576|FG000|Overall Study|Physician Decision|1|||
37836622|NCT01212757|69521035|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
37836623|NCT01212757|69521036|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
37836624|NCT01212757|69521037|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
37836625|NCT01212757|69521038|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
37836626|NCT01212757|69521039|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
37836627|NCT01212757|69521031|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
37836628|NCT01212757|69521032|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
37914847|NCT00866307|69601524|FG001|Induction|Adverse Event|0|||
37914848|NCT00866307|69601525|FG002|Induction|Adverse Event|0|||
37914849|NCT00866307|69601523|FG000|Induction|Death|2|||
37914850|NCT00866307|69601524|FG001|Induction|Death|0|||
37914851|NCT00866307|69601525|FG002|Induction|Death|0|||
37914852|NCT00866307|69601523|FG000|Induction|Physician Decision|5|||
37914853|NCT00866307|69601524|FG001|Induction|Physician Decision|0|||
37702218|NCT04001803|69179580|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
37836629|NCT01212757|69521033|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
37836630|NCT01212757|69521034|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
37836631|NCT01212757|69521035|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
37702219|NCT04001803|69179580|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
37836632|NCT01212757|69521036|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
37836633|NCT01212757|69521037|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
37702220|NCT04001803|69179580|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
37702221|NCT04001803|69179580|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
37702222|NCT04001803|69179580|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
37702223|NCT04001803|69179580|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
37702224|NCT04001803|69179580|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
37702225|NCT04001803|69179580|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
37914854|NCT00866307|69601525|FG002|Induction|Physician Decision|0|||
37914855|NCT00866307|69601523|FG000|Induction|Progressive Disease|1|||
38023553|NCT04147858|69706531|FG002|Overall Study|Subject Noncompliance, Other|1|||
38023554|NCT04146896|69706541|FG000|Overall Study|Adverse Event|5|||
38023555|NCT04146896|69706542|FG001|Overall Study|Adverse Event|8|||
38023556|NCT04146896|69706541|FG000|Overall Study|Lack of Efficacy|3|||
38023557|NCT04146896|69706542|FG001|Overall Study|Lack of Efficacy|2|||
38023558|NCT04146896|69706541|FG000|Overall Study|Lost to Follow-up|0|||
38023559|NCT04146896|69706542|FG001|Overall Study|Lost to Follow-up|1|||
38023560|NCT04146896|69706541|FG000|Overall Study|Non-compliance|5|||
38023561|NCT04146896|69706542|FG001|Overall Study|Non-compliance|4|||
38023562|NCT04146896|69706541|FG000|Overall Study|Withdrawal by Subject|3|||
38023563|NCT04146896|69706542|FG001|Overall Study|Withdrawal by Subject|5|||
38023564|NCT04146896|69706541|FG000|Overall Study|Randomized in error|1|||
38023565|NCT04146896|69706542|FG001|Overall Study|Randomized in error|2|||
38023566|NCT04072887|69706554|FG000|Overall Study|Withdrawal by Subject|3|||
38023567|NCT04072887|69706555|FG001|Overall Study|Withdrawal by Subject|8|||
38023568|NCT04072887|69706556|FG002|Overall Study|Withdrawal by Subject|1|||
38023569|NCT04072887|69706557|FG003|Overall Study|Withdrawal by Subject|3|||
37914856|NCT00866307|69601524|FG001|Induction|Progressive Disease|0|||
37914857|NCT00866307|69601525|FG002|Induction|Progressive Disease|0|||
38023570|NCT04072887|69706558|FG004|Overall Study|Withdrawal by Subject|3|||
38023571|NCT04072887|69706559|FG005|Overall Study|Withdrawal by Subject|13|||
38023572|NCT04072887|69706554|FG000|Overall Study|Adverse Event|2|||
38023573|NCT04072887|69706555|FG001|Overall Study|Adverse Event|4|||
37836634|NCT01212757|69521038|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
37836635|NCT01212757|69521039|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
37836636|NCT01212757|69521031|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
37836637|NCT01212757|69521032|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
37836638|NCT01212757|69521033|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
37836639|NCT01212757|69521034|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
37836640|NCT01212757|69521035|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
37836641|NCT01212757|69521036|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
37836642|NCT01212757|69521037|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
37836643|NCT01212757|69521038|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
37836644|NCT01212757|69521039|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
37836645|NCT01212757|69521031|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
37836646|NCT01212757|69521032|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
37836647|NCT01212757|69521033|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
37836648|NCT01212757|69521034|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
37836649|NCT01212757|69521035|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
37836650|NCT01212757|69521036|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
37836651|NCT01212757|69521037|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
37836652|NCT01212757|69521038|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
37836653|NCT01212757|69521039|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
37836654|NCT01212757|69521031|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
37836655|NCT01212757|69521032|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
37914858|NCT00866307|69601523|FG000|Induction|Identification of Patients with Day 29 M|3|||
37914859|NCT00866307|69601524|FG001|Induction|Identification of Patients with Day 29 M|0|||
37914860|NCT00866307|69601525|FG002|Induction|Identification of Patients with Day 29 M|0|||
37914861|NCT00866307|69601523|FG000|Induction|Inadequate cytognetic samples th|1|||
37914862|NCT00866307|69601524|FG001|Induction|Inadequate cytognetic samples th|0|||
37914863|NCT00866307|69601525|FG002|Induction|Inadequate cytognetic samples th|0|||
37914864|NCT00866307|69601523|FG000|Induction|Improper post-induction consent|2|||
37914865|NCT00866307|69601524|FG001|Induction|Improper post-induction consent|0|||
37914866|NCT00866307|69601525|FG002|Induction|Improper post-induction consent|0|||
37914867|NCT00866307|69601523|FG000|Induction|Study was closed at the time|1|||
37914868|NCT00866307|69601524|FG001|Induction|Study was closed at the time|0|||
37914869|NCT00866307|69601525|FG002|Induction|Study was closed at the time|0|||
37836656|NCT01212757|69521033|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
37836657|NCT01212757|69521034|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
37914870|NCT00866307|69601523|FG000|Consolidation/Maintenance|Adverse Event|0|||
37914871|NCT00866307|69601524|FG001|Consolidation/Maintenance|Adverse Event|0|||
37914872|NCT00866307|69601525|FG002|Consolidation/Maintenance|Adverse Event|8|||
38023574|NCT04072887|69706556|FG002|Overall Study|Adverse Event|1|||
38023575|NCT04072887|69706557|FG003|Overall Study|Adverse Event|4|||
38023576|NCT04072887|69706558|FG004|Overall Study|Adverse Event|0|||
38023577|NCT04072887|69706559|FG005|Overall Study|Adverse Event|1|||
38023578|NCT04072887|69706554|FG000|Overall Study|Physician Decision|2|||
38023579|NCT04072887|69706555|FG001|Overall Study|Physician Decision|0|||
38023580|NCT04072887|69706556|FG002|Overall Study|Physician Decision|0|||
38023581|NCT04072887|69706557|FG003|Overall Study|Physician Decision|0|||
38023582|NCT04072887|69706558|FG004|Overall Study|Physician Decision|0|||
38023583|NCT04072887|69706559|FG005|Overall Study|Physician Decision|1|||
38023584|NCT04072887|69706554|FG000|Overall Study|Lost to Follow-up|1|||
37702226|NCT04001803|69179580|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
37702227|NCT04001803|69179580|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
37702228|NCT03768427|69179589|FG000|Overall Study|Death|0|||
37702229|NCT03768427|69179590|FG001|Overall Study|Death|0|||
37702230|NCT03768427|69179591|FG002|Overall Study|Death|1|||
37702231|NCT03768427|69179592|FG003|Overall Study|Death|0|||
37702232|NCT03768427|69179589|FG000|Overall Study|Lost to Follow-up|2|||
37702233|NCT03768427|69179590|FG001|Overall Study|Lost to Follow-up|0|||
37702234|NCT03768427|69179591|FG002|Overall Study|Lost to Follow-up|0|||
37702235|NCT03768427|69179592|FG003|Overall Study|Lost to Follow-up|0|||
37702236|NCT03768427|69179589|FG000|Overall Study|Physician Decision|3|||
37702237|NCT03768427|69179590|FG001|Overall Study|Physician Decision|2|||
37702238|NCT03768427|69179591|FG002|Overall Study|Physician Decision|4|||
37702239|NCT03768427|69179592|FG003|Overall Study|Physician Decision|4|||
37702240|NCT03768427|69179589|FG000|Overall Study|Withdrawal by Subject|7|||
37702241|NCT03768427|69179590|FG001|Overall Study|Withdrawal by Subject|2|||
37702242|NCT03768427|69179591|FG002|Overall Study|Withdrawal by Subject|6|||
37702243|NCT03768427|69179592|FG003|Overall Study|Withdrawal by Subject|7|||
37702244|NCT03595228|69179606|FG000|Overall Study|Death|2|||
37702245|NCT03595228|69179606|FG000|Overall Study|Lack of Efficacy|13|||
37702246|NCT03595228|69179606|FG000|Overall Study|Withdrawal by Subject|3|||
37702247|NCT03595228|69179606|FG000|Overall Study|Withdrawal by Sponsor|1|||
37702248|NCT03572933|69179612|FG000|Overall Study|Adverse Event|4|||
38023585|NCT04072887|69706555|FG001|Overall Study|Lost to Follow-up|3|||
38023586|NCT04072887|69706556|FG002|Overall Study|Lost to Follow-up|0|||
38023587|NCT04072887|69706557|FG003|Overall Study|Lost to Follow-up|0|||
38023588|NCT04072887|69706558|FG004|Overall Study|Lost to Follow-up|0|||
38023589|NCT04072887|69706559|FG005|Overall Study|Lost to Follow-up|0|||
38023590|NCT04072887|69706554|FG000|Overall Study|Death|0|||
38023591|NCT04072887|69706555|FG001|Overall Study|Death|2|||
38023592|NCT04072887|69706556|FG002|Overall Study|Death|0|||
37702249|NCT03572933|69179613|FG001|Overall Study|Adverse Event|1|||
37702250|NCT03572933|69179612|FG000|Overall Study|Withdrawal by Subject|0|||
37702251|NCT03572933|69179613|FG001|Overall Study|Withdrawal by Subject|1|||
37702252|NCT03558152|69179624|FG000|Overall Study|Adverse Event|0|||
37702253|NCT03558152|69179625|FG001|Overall Study|Adverse Event|0|||
37702254|NCT03558152|69179626|FG002|Overall Study|Adverse Event|1|||
37702255|NCT03558152|69179627|FG003|Overall Study|Adverse Event|1|||
37702256|NCT03558152|69179628|FG004|Overall Study|Adverse Event|2|||
37702257|NCT03558152|69179629|FG005|Overall Study|Adverse Event|1|||
37702258|NCT03558152|69179630|FG006|Overall Study|Adverse Event|1|||
37702259|NCT03558152|69179631|FG007|Overall Study|Adverse Event|0|||
37702260|NCT03558152|69179624|FG000|Overall Study|Death|0|||
37702261|NCT03558152|69179625|FG001|Overall Study|Death|0|||
37702262|NCT03558152|69179626|FG002|Overall Study|Death|0|||
37702263|NCT03558152|69179627|FG003|Overall Study|Death|0|||
37702264|NCT03558152|69179628|FG004|Overall Study|Death|1|||
37914873|NCT00866307|69601523|FG000|Consolidation/Maintenance|Death|0|||
37702265|NCT03558152|69179629|FG005|Overall Study|Death|0|||
37702266|NCT03558152|69179630|FG006|Overall Study|Death|0|||
37702267|NCT03558152|69179631|FG007|Overall Study|Death|0|||
37702268|NCT03558152|69179624|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
37702269|NCT03558152|69179625|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
37914874|NCT00866307|69601524|FG001|Consolidation/Maintenance|Death|0|||
38023593|NCT04072887|69706557|FG003|Overall Study|Death|2|||
38023594|NCT04072887|69706558|FG004|Overall Study|Death|3|||
38023595|NCT04072887|69706559|FG005|Overall Study|Death|0|||
37702270|NCT03558152|69179626|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
37702271|NCT03558152|69179627|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
37702272|NCT03558152|69179628|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
37702273|NCT03558152|69179629|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
37702274|NCT03558152|69179630|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
37702275|NCT03558152|69179631|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
37702276|NCT03558152|69179624|FG000|Overall Study|Miscalculation in mmcs|0|||
37702277|NCT03558152|69179625|FG001|Overall Study|Miscalculation in mmcs|0|||
37702278|NCT03558152|69179626|FG002|Overall Study|Miscalculation in mmcs|0|||
37702279|NCT03558152|69179627|FG003|Overall Study|Miscalculation in mmcs|0|||
37702280|NCT03558152|69179628|FG004|Overall Study|Miscalculation in mmcs|0|||
37702281|NCT03558152|69179629|FG005|Overall Study|Miscalculation in mmcs|0|||
37702282|NCT03558152|69179630|FG006|Overall Study|Miscalculation in mmcs|1|||
37702283|NCT03558152|69179631|FG007|Overall Study|Miscalculation in mmcs|0|||
37702284|NCT03558152|69179624|FG000|Overall Study|Mistake in calculation|0|||
37702285|NCT03558152|69179625|FG001|Overall Study|Mistake in calculation|0|||
37702286|NCT03558152|69179626|FG002|Overall Study|Mistake in calculation|0|||
37702287|NCT03558152|69179627|FG003|Overall Study|Mistake in calculation|1|||
37702288|NCT03558152|69179628|FG004|Overall Study|Mistake in calculation|0|||
37702289|NCT03558152|69179629|FG005|Overall Study|Mistake in calculation|0|||
37702290|NCT03558152|69179630|FG006|Overall Study|Mistake in calculation|0|||
37702291|NCT03558152|69179631|FG007|Overall Study|Mistake in calculation|0|||
37702292|NCT03558152|69179624|FG000|Overall Study|Mistake in evaluation of disease status|0|||
37702293|NCT03558152|69179625|FG001|Overall Study|Mistake in evaluation of disease status|0|||
37702294|NCT03558152|69179626|FG002|Overall Study|Mistake in evaluation of disease status|0|||
37702295|NCT03558152|69179627|FG003|Overall Study|Mistake in evaluation of disease status|0|||
37702296|NCT03558152|69179628|FG004|Overall Study|Mistake in evaluation of disease status|0|||
37702297|NCT03558152|69179629|FG005|Overall Study|Mistake in evaluation of disease status|0|||
37702298|NCT03558152|69179630|FG006|Overall Study|Mistake in evaluation of disease status|0|||
37702299|NCT03558152|69179631|FG007|Overall Study|Mistake in evaluation of disease status|1|||
37702300|NCT03558152|69179624|FG000|Overall Study|Physician Decision|0|||
37702301|NCT03558152|69179625|FG001|Overall Study|Physician Decision|0|||
37702302|NCT03558152|69179626|FG002|Overall Study|Physician Decision|0|||
37702303|NCT03558152|69179627|FG003|Overall Study|Physician Decision|0|||
37702304|NCT03558152|69179628|FG004|Overall Study|Physician Decision|0|||
37702305|NCT03558152|69179629|FG005|Overall Study|Physician Decision|0|||
37702306|NCT03558152|69179630|FG006|Overall Study|Physician Decision|1|||
37702307|NCT03558152|69179631|FG007|Overall Study|Physician Decision|0|||
37702308|NCT03558152|69179624|FG000|Overall Study|Withdrawal by Subject|2|||
37702309|NCT03558152|69179625|FG001|Overall Study|Withdrawal by Subject|3|||
37702310|NCT03558152|69179626|FG002|Overall Study|Withdrawal by Subject|2|||
37702311|NCT03558152|69179627|FG003|Overall Study|Withdrawal by Subject|1|||
37702312|NCT03558152|69179628|FG004|Overall Study|Withdrawal by Subject|1|||
37702313|NCT03558152|69179629|FG005|Overall Study|Withdrawal by Subject|1|||
37702314|NCT03558152|69179630|FG006|Overall Study|Withdrawal by Subject|3|||
37702315|NCT03558152|69179631|FG007|Overall Study|Withdrawal by Subject|2|||
37702316|NCT03558152|69179624|FG000|Overall Study|Lack of Efficacy|11|||
37702317|NCT03558152|69179625|FG001|Overall Study|Lack of Efficacy|11|||
37702318|NCT03558152|69179626|FG002|Overall Study|Lack of Efficacy|10|||
37702319|NCT03558152|69179627|FG003|Overall Study|Lack of Efficacy|11|||
37702320|NCT03558152|69179628|FG004|Overall Study|Lack of Efficacy|14|||
37702321|NCT03558152|69179629|FG005|Overall Study|Lack of Efficacy|12|||
37702322|NCT03558152|69179630|FG006|Overall Study|Lack of Efficacy|14|||
37702323|NCT03558152|69179631|FG007|Overall Study|Lack of Efficacy|13|||
37702324|NCT03558152|69179624|FG000|Overall Study|Protocol Violation|1|||
37836658|NCT01212757|69521035|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
37836659|NCT01212757|69521036|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
37836660|NCT01212757|69521037|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
37836661|NCT01212757|69521038|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
37836662|NCT01212757|69521039|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
37836663|NCT01212757|69521031|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
38023596|NCT03516812|69706652|FG000|Overall Study|Adverse Event|4|||
38023597|NCT03516812|69706652|FG000|Overall Study|Lack of Efficacy|2|||
38023598|NCT03440047|69706656|FG000|Overall Study|Withdrawal by Subject|2|||
38023599|NCT03122119|69706687|FG000|Overall Study|Did not meet eligibility critria|1|||
37702325|NCT03558152|69179625|FG001|Overall Study|Protocol Violation|1|||
37702326|NCT03558152|69179626|FG002|Overall Study|Protocol Violation|0|||
37702327|NCT03558152|69179627|FG003|Overall Study|Protocol Violation|1|||
37702328|NCT03558152|69179628|FG004|Overall Study|Protocol Violation|1|||
37702329|NCT03558152|69179629|FG005|Overall Study|Protocol Violation|0|||
37702330|NCT03558152|69179630|FG006|Overall Study|Protocol Violation|2|||
37702331|NCT03558152|69179631|FG007|Overall Study|Protocol Violation|0|||
37702332|NCT03461406|69179671|FG000|Overall Study|Death|1|||
37702333|NCT03461406|69179672|FG001|Overall Study|Death|2|||
37702334|NCT03461406|69179671|FG000|Overall Study|Consent Withdrawn by Participant|0|||
37702335|NCT03461406|69179672|FG001|Overall Study|Consent Withdrawn by Participant|1|||
37702336|NCT03461406|69179671|FG000|Overall Study|Screen Failure|3|||
37702337|NCT03461406|69179672|FG001|Overall Study|Screen Failure|1|||
37702338|NCT03461406|69179671|FG000|Overall Study|Reason not Specified|1|||
37702339|NCT03461406|69179672|FG001|Overall Study|Reason not Specified|3|||
37702340|NCT03461406|69179671|FG000|Overall Study|Lost to Follow-up|3|||
37702341|NCT03461406|69179672|FG001|Overall Study|Lost to Follow-up|0|||
37702342|NCT03408899|69179687|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
37702343|NCT02528643|69179708|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
37702344|NCT02528643|69179709|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
37702345|NCT02528643|69179708|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
37702346|NCT02528643|69179709|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
37702347|NCT02528643|69179708|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
37702348|NCT02528643|69179709|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
37702349|NCT02528643|69179708|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
37702350|NCT02528643|69179709|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
37702351|NCT02528643|69179708|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
37702352|NCT02528643|69179709|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
37702353|NCT02528643|69179708|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
37702354|NCT02528643|69179709|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
37702355|NCT02528643|69179708|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
37702356|NCT02528643|69179709|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
37702357|NCT02175680|69179730|FG000|Overall Study|non-compliance|1|||
37702358|NCT02175680|69179730|FG000|Overall Study|other non-medical reason|1|||
37702359|NCT01983462|69179744|FG000|Overall Study|Adverse Event|1|||
37702360|NCT01983462|69179745|FG001|Overall Study|Adverse Event|0|||
37702361|NCT01983462|69179746|FG002|Overall Study|Adverse Event|0|||
37702362|NCT01559935|69179777|FG000|Car Phase|Toxicity|4|||
37702363|NCT01559935|69179777|FG000|Car Phase|Death|1|||
37702364|NCT01559935|69179777|FG000|Car Phase|Lack of Efficacy|2|||
37702365|NCT01559935|69179777|FG000|Car Phase|Lost to Follow-up|1|||
37702366|NCT01559935|69179777|FG000|Car Phase|Physician Decision|1|||
37702367|NCT01559935|69179777|FG000|Car Phase|Withdrawal by Subject|2|||
38023600|NCT02613169|69706693|FG000|Overall Study|Withdrawal by Subject|4|||
38023601|NCT02613169|69706694|FG001|Overall Study|Withdrawal by Subject|1|||
38023602|NCT02613169|69706693|FG000|Overall Study|Lost to Follow-up|0|||
38023603|NCT02613169|69706694|FG001|Overall Study|Lost to Follow-up|5|||
38023604|NCT02613169|69706693|FG000|Overall Study|HIV|0|||
38023605|NCT02613169|69706694|FG001|Overall Study|HIV|2|||
38023606|NCT02613169|69706693|FG000|Overall Study|No TB infection endpoint|14|||
38023607|NCT02613169|69706694|FG001|Overall Study|No TB infection endpoint|9|||
38023608|NCT01974765|69706700|FG000|Overall Study|Withdrawal by Subject|1|||
38023609|NCT01974765|69706700|FG000|Overall Study|Death|1|||
38023610|NCT01974765|69706700|FG000|Overall Study|Adverse Event|2|||
38023611|NCT01725217|69706707|FG000|Overall Study|Withdrawal by Subject|1|||
38023612|NCT01725217|69706708|FG001|Overall Study|Withdrawal by Subject|0|||
38023613|NCT01725217|69706709|FG002|Overall Study|Withdrawal by Subject|0|||
38023614|NCT01344057|69706735|FG000|Overall Study|Premature Withdrawal|1|||
38023615|NCT00886782|69706742|FG000|Overall Study|Disease progression|3|||
38023616|NCT00886782|69706743|FG001|Overall Study|Disease progression|3|||
38023617|NCT00886782|69706744|FG002|Overall Study|Disease progression|3|||
38023618|NCT00886782|69706742|FG000|Overall Study|Study drug toxicity|0|||
38023619|NCT00886782|69706743|FG001|Overall Study|Study drug toxicity|0|||
37702368|NCT01559935|69179777|FG000|Car Phase|Per protocol|1|||
37702369|NCT01559935|69179777|FG000|Car Phase|Insurance|1|||
37702370|NCT01559935|69179777|FG000|Car Phase|non-compliance|1|||
37702371|NCT01559935|69179777|FG000|BiRD Phase|Toxicity|1|||
37702372|NCT01559935|69179777|FG000|BiRD Phase|Lack of Efficacy|1|||
37836664|NCT01212757|69521032|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
37836665|NCT01212757|69521033|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
38023620|NCT00886782|69706744|FG002|Overall Study|Study drug toxicity|1|||
37702373|NCT01559935|69179777|FG000|BiRD Phase|Withdrawal by Subject|2|||
38023621|NCT00886782|69706742|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
37702374|NCT01559935|69179777|FG000|Maintenance Phase|Remains on study|28|||
37702375|NCT01559935|69179777|FG000|Maintenance Phase|Toxicity|1|||
37702376|NCT01559935|69179777|FG000|Maintenance Phase|Lack of Efficacy|18|||
37702377|NCT01559935|69179777|FG000|Maintenance Phase|Withdrawal by Subject|5|||
37702378|NCT01559935|69179777|FG000|Maintenance Phase|Non-compliance|2|||
37702379|NCT00981058|69179783|FG000|Overall Study|Adverse Event|1|||
37702380|NCT00981058|69179784|FG001|Overall Study|Adverse Event|1|||
37702381|NCT00981058|69179783|FG000|Overall Study|Progressive Disease|61|||
37702382|NCT00981058|69179784|FG001|Overall Study|Progressive Disease|49|||
37702383|NCT00981058|69179783|FG000|Overall Study|Lost to Follow-up|16|||
37702384|NCT00981058|69179784|FG001|Overall Study|Lost to Follow-up|15|||
37702385|NCT00981058|69179783|FG000|Overall Study|New Anticancer Therapy|6|||
37702386|NCT00981058|69179784|FG001|Overall Study|New Anticancer Therapy|6|||
37702387|NCT00981058|69179783|FG000|Overall Study|Noncompliance|1|||
37702388|NCT00981058|69179784|FG001|Overall Study|Noncompliance|0|||
37702389|NCT00981058|69179783|FG000|Overall Study|Radiologist Error|0|||
37702390|NCT00981058|69179784|FG001|Overall Study|Radiologist Error|1|||
37702391|NCT00981058|69179783|FG000|Overall Study|Randomization Error|1|||
37702392|NCT00981058|69179784|FG001|Overall Study|Randomization Error|2|||
37702393|NCT00981058|69179783|FG000|Overall Study|Withdrawal by Subject|25|||
37702394|NCT00981058|69179784|FG001|Overall Study|Withdrawal by Subject|23|||
37702395|NCT00981058|69179783|FG000|Overall Study|On study treatment at conclusion|9|||
38023622|NCT00886782|69706743|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
38023623|NCT00886782|69706744|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
38023624|NCT00583024|69706752|FG000|Overall Study|Lost to Follow-up|4|||
38023625|NCT03435640|69706767|FG000|Overall Study|Withdrawal by Subject|0|||
38023626|NCT03435640|69706768|FG001|Overall Study|Withdrawal by Subject|1|||
38023627|NCT03435640|69706769|FG002|Overall Study|Withdrawal by Subject|0|||
38023628|NCT03435640|69706770|FG003|Overall Study|Withdrawal by Subject|2|||
38023629|NCT03435640|69706771|FG004|Overall Study|Withdrawal by Subject|0|||
38023630|NCT03435640|69706772|FG005|Overall Study|Withdrawal by Subject|0|||
37702396|NCT00981058|69179784|FG001|Overall Study|On study treatment at conclusion|0|||
37702397|NCT00565851|69179798|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
37702398|NCT00565851|69179799|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
37702399|NCT00565851|69179800|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
38023631|NCT03435640|69706773|FG006|Overall Study|Withdrawal by Subject|3|||
38023632|NCT03435640|69706774|FG007|Overall Study|Withdrawal by Subject|0|||
38023633|NCT03435640|69706775|FG008|Overall Study|Withdrawal by Subject|0|||
38023634|NCT03435640|69706776|FG009|Overall Study|Withdrawal by Subject|2|||
38023635|NCT03435640|69706777|FG010|Overall Study|Withdrawal by Subject|3|||
38023636|NCT03435640|69706767|FG000|Overall Study|Lost to Follow-up|0|||
37702400|NCT00565851|69179801|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
37702401|NCT00565851|69179802|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
37702402|NCT00565851|69179803|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
37702403|NCT00565851|69179804|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
37702404|NCT00565851|69179805|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
37702405|NCT00565851|69179798|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
37702406|NCT00565851|69179799|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
37702407|NCT00565851|69179800|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
37702408|NCT00565851|69179801|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
37702409|NCT00565851|69179802|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
37702410|NCT00565851|69179803|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
37702411|NCT00565851|69179804|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
37702412|NCT00565851|69179805|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
37702413|NCT00305227|69179829|FG000|Overall Study|Lost to Follow-up|7|||
37702414|NCT00305227|69179830|FG001|Overall Study|Lost to Follow-up|6|||
37702415|NCT01599793|69179838|FG000|Overall Study|Adverse Event|2|||
37702416|NCT01755598|69179853|FG000|Overall Study|Other|109|||
37702417|NCT01755598|69179854|FG001|Overall Study|Other|109|||
37702418|NCT01755598|69179853|FG000|Overall Study|Lost to Follow-up|32|||
37702419|NCT01755598|69179854|FG001|Overall Study|Lost to Follow-up|43|||
37702420|NCT01755598|69179853|FG000|Overall Study|Migrated/moved from study area|76|||
37702421|NCT01755598|69179854|FG001|Overall Study|Migrated/moved from study area|65|||
37702422|NCT01755598|69179853|FG000|Overall Study|Withdrawal by Subject|22|||
37702423|NCT01755598|69179854|FG001|Overall Study|Withdrawal by Subject|31|||
37702424|NCT01755598|69179853|FG000|Overall Study|Protocol Violation|7|||
37702425|NCT01755598|69179854|FG001|Overall Study|Protocol Violation|7|||
37702426|NCT01755598|69179853|FG000|Overall Study|Adverse Event|19|||
37702427|NCT01755598|69179854|FG001|Overall Study|Adverse Event|28|||
37702428|NCT01606306|69179866|FG000|Overall Study|Lack of Efficacy|2|||
37702429|NCT01606306|69179867|FG001|Overall Study|Lack of Efficacy|1|||
37702430|NCT01606306|69179868|FG002|Overall Study|Lack of Efficacy|4|||
37702431|NCT01606306|69179869|FG003|Overall Study|Lack of Efficacy|4|||
37702432|NCT01606306|69179870|FG004|Overall Study|Lack of Efficacy|1|||
37702433|NCT01606306|69179871|FG005|Overall Study|Lack of Efficacy|2|||
37702434|NCT01606306|69179866|FG000|Overall Study|Adverse Event|1|||
37702435|NCT01606306|69179867|FG001|Overall Study|Adverse Event|0|||
37702436|NCT01606306|69179868|FG002|Overall Study|Adverse Event|1|||
37702437|NCT01606306|69179869|FG003|Overall Study|Adverse Event|1|||
37702438|NCT01606306|69179870|FG004|Overall Study|Adverse Event|2|||
37702439|NCT01606306|69179871|FG005|Overall Study|Adverse Event|0|||
37702440|NCT01606306|69179866|FG000|Overall Study|Lost to Follow-up|7|||
37702441|NCT01606306|69179867|FG001|Overall Study|Lost to Follow-up|4|||
37702442|NCT01606306|69179868|FG002|Overall Study|Lost to Follow-up|5|||
37702443|NCT01606306|69179869|FG003|Overall Study|Lost to Follow-up|4|||
37702444|NCT01606306|69179870|FG004|Overall Study|Lost to Follow-up|3|||
37836666|NCT01212757|69521034|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
37836667|NCT01212757|69521035|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
37836668|NCT01212757|69521036|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
37836669|NCT01212757|69521037|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
37914875|NCT00866307|69601525|FG002|Consolidation/Maintenance|Death|1|||
37702445|NCT01606306|69179871|FG005|Overall Study|Lost to Follow-up|5|||
37702446|NCT01606306|69179866|FG000|Overall Study|Withdrawal by Subject|4|||
37702447|NCT01606306|69179867|FG001|Overall Study|Withdrawal by Subject|3|||
37702448|NCT01606306|69179868|FG002|Overall Study|Withdrawal by Subject|4|||
38023637|NCT03435640|69706768|FG001|Overall Study|Lost to Follow-up|0|||
38023638|NCT03435640|69706769|FG002|Overall Study|Lost to Follow-up|1|||
38023639|NCT03435640|69706770|FG003|Overall Study|Lost to Follow-up|0|||
38023640|NCT03435640|69706771|FG004|Overall Study|Lost to Follow-up|0|||
38023641|NCT03435640|69706772|FG005|Overall Study|Lost to Follow-up|0|||
38023642|NCT03435640|69706773|FG006|Overall Study|Lost to Follow-up|0|||
38023643|NCT03435640|69706774|FG007|Overall Study|Lost to Follow-up|0|||
37702449|NCT01606306|69179869|FG003|Overall Study|Withdrawal by Subject|4|||
37702450|NCT01606306|69179870|FG004|Overall Study|Withdrawal by Subject|5|||
37702451|NCT01606306|69179871|FG005|Overall Study|Withdrawal by Subject|4|||
37702452|NCT01606306|69179866|FG000|Overall Study|Physician Decision|1|||
37702453|NCT01606306|69179867|FG001|Overall Study|Physician Decision|2|||
37702454|NCT01606306|69179868|FG002|Overall Study|Physician Decision|0|||
37702455|NCT01606306|69179869|FG003|Overall Study|Physician Decision|0|||
37702456|NCT01606306|69179870|FG004|Overall Study|Physician Decision|0|||
37702457|NCT01606306|69179871|FG005|Overall Study|Physician Decision|0|||
37702458|NCT01754194|69179879|FG000|Overall Study|Lost to Follow-up|39|||
37702459|NCT01754194|69179880|FG001|Overall Study|Lost to Follow-up|14|||
37702460|NCT01754194|69179879|FG000|Overall Study|Withdrawal by Subject|4|||
37702461|NCT01754194|69179880|FG001|Overall Study|Withdrawal by Subject|5|||
37702462|NCT01754194|69179879|FG000|Overall Study|Other|9|||
37702463|NCT01754194|69179880|FG001|Overall Study|Other|8|||
37702464|NCT01753570|69179891|FG000|Overall Study|Adverse Event|1|||
37702465|NCT01753570|69179892|FG001|Overall Study|Adverse Event|0|||
37702466|NCT01753570|69179893|FG002|Overall Study|Adverse Event|1|||
37702467|NCT01753570|69179891|FG000|Overall Study|Physician Decision|0|||
37702468|NCT01753570|69179892|FG001|Overall Study|Physician Decision|1|||
37702469|NCT01753570|69179893|FG002|Overall Study|Physician Decision|0|||
37702470|NCT01753570|69179891|FG000|Overall Study|Withdrawal by Subject|1|||
37702471|NCT01753570|69179892|FG001|Overall Study|Withdrawal by Subject|4|||
37702472|NCT01753570|69179893|FG002|Overall Study|Withdrawal by Subject|0|||
37702473|NCT01753336|69179902|FG000|Overall Study|Patient decision|12|||
37702474|NCT01753336|69179902|FG000|Overall Study|Lost to Follow-up|3|||
37702475|NCT01753336|69179902|FG000|Overall Study|Physician Decision|2|||
37702476|NCT01753336|69179902|FG000|Overall Study|Sponsor's decision|2|||
37702477|NCT01753336|69179902|FG000|Overall Study|Withdrawal by Subject|1|||
37702478|NCT01777282|69179911|FG000|Overall Study|Persistent Hyperglycemia|0|||
37702479|NCT01777282|69179912|FG001|Overall Study|Persistent Hyperglycemia|0|||
37836670|NCT01212757|69521038|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
37836671|NCT01212757|69521039|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
37836672|NCT01212757|69521031|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
38023644|NCT03435640|69706775|FG008|Overall Study|Lost to Follow-up|0|||
38023645|NCT03435640|69706776|FG009|Overall Study|Lost to Follow-up|0|||
38023646|NCT03435640|69706777|FG010|Overall Study|Lost to Follow-up|0|||
38023647|NCT00655876|69706805|FG000|Overall Study|Protocol Violation|9|||
38023648|NCT00655876|69706806|FG001|Overall Study|Protocol Violation|7|||
37836673|NCT01212757|69521032|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
38023649|NCT03092752|69706812|FG000|Overall Study|Aged <40 years|14209|||
38023650|NCT03092752|69706812|FG000|Overall Study|At least one claim with T2DM|61299|||
38023651|NCT03092752|69706812|FG000|Overall Study|Having no claim of study drugs|29282|||
38023652|NCT03092752|69706812|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
38023653|NCT03092752|69706812|FG000|Overall Study|<6 month history|245900|||
38023654|NCT03750552|69706835|FG000|Overall Study|Adverse Event|5|||
37702480|NCT01777282|69179913|FG002|Overall Study|Persistent Hyperglycemia|1|||
37836674|NCT01212757|69521033|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
37836675|NCT01212757|69521034|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
38023655|NCT03750552|69706836|FG001|Overall Study|Adverse Event|1|||
38023656|NCT03750552|69706835|FG000|Overall Study|Withdrawal by Subject|1|||
38023657|NCT03750552|69706836|FG001|Overall Study|Withdrawal by Subject|1|||
38023658|NCT03750552|69706835|FG000|Overall Study|Other|2|||
38023659|NCT03750552|69706836|FG001|Overall Study|Other|0|||
37702481|NCT01777282|69179914|FG003|Overall Study|Persistent Hyperglycemia|0|||
37702482|NCT01777282|69179915|FG004|Overall Study|Persistent Hyperglycemia|0|||
37702483|NCT01777282|69179911|FG000|Overall Study|New Antidiabetic Medication|0|||
37702484|NCT01777282|69179912|FG001|Overall Study|New Antidiabetic Medication|0|||
37702485|NCT01777282|69179913|FG002|Overall Study|New Antidiabetic Medication|1|||
37702486|NCT01777282|69179914|FG003|Overall Study|New Antidiabetic Medication|0|||
38023660|NCT03750240|69706843|FG000|Overall Study|Technical Difficulties|2|||
37836676|NCT01212757|69521035|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
37836677|NCT01212757|69521036|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
37836678|NCT01212757|69521037|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
37836679|NCT01212757|69521038|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
37836680|NCT01212757|69521039|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
37836681|NCT01212757|69521031|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
37836682|NCT01212757|69521032|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
37836683|NCT01212757|69521033|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
37836684|NCT01212757|69521034|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
37836685|NCT01212757|69521035|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
37836686|NCT01212757|69521036|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
37914876|NCT00866307|69601523|FG000|Consolidation/Maintenance|Physician Decision|0|||
37914877|NCT00866307|69601524|FG001|Consolidation/Maintenance|Physician Decision|3|||
37914878|NCT00866307|69601525|FG002|Consolidation/Maintenance|Physician Decision|2|||
37914879|NCT00866307|69601523|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
37914880|NCT00866307|69601524|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
37836687|NCT01212757|69521037|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
37914881|NCT00866307|69601525|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
37914882|NCT00866307|69601523|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
37914883|NCT00866307|69601524|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
37914884|NCT00866307|69601525|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
37914885|NCT00866307|69601523|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
37914886|NCT00866307|69601524|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
37836688|NCT01212757|69521038|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
37836689|NCT01212757|69521039|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
37836690|NCT01212757|69521031|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
37702487|NCT01777282|69179915|FG004|Overall Study|New Antidiabetic Medication|0|||
37702488|NCT01777282|69179911|FG000|Overall Study|Adverse Event|4|||
37702489|NCT01777282|69179912|FG001|Overall Study|Adverse Event|4|||
37702490|NCT01777282|69179913|FG002|Overall Study|Adverse Event|2|||
37702491|NCT01777282|69179914|FG003|Overall Study|Adverse Event|1|||
37702492|NCT01777282|69179915|FG004|Overall Study|Adverse Event|3|||
37702493|NCT01777282|69179911|FG000|Overall Study|Withdrawal by Subject|4|||
37702494|NCT01777282|69179912|FG001|Overall Study|Withdrawal by Subject|0|||
37702495|NCT01777282|69179913|FG002|Overall Study|Withdrawal by Subject|0|||
37702496|NCT01777282|69179914|FG003|Overall Study|Withdrawal by Subject|1|||
37702497|NCT01777282|69179915|FG004|Overall Study|Withdrawal by Subject|2|||
37702498|NCT01777282|69179911|FG000|Overall Study|Protocol Violation|2|||
37702499|NCT01777282|69179912|FG001|Overall Study|Protocol Violation|0|||
37702500|NCT01777282|69179913|FG002|Overall Study|Protocol Violation|1|||
37702501|NCT01777282|69179914|FG003|Overall Study|Protocol Violation|0|||
37702502|NCT01777282|69179915|FG004|Overall Study|Protocol Violation|2|||
37702503|NCT01777282|69179911|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
37702504|NCT01777282|69179912|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
37702505|NCT01777282|69179913|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
37836691|NCT01212757|69521032|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
37836692|NCT01212757|69521033|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
37836693|NCT01212757|69521034|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
37702506|NCT01777282|69179914|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
37702507|NCT01777282|69179915|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
37702508|NCT01975389|69179929|FG000|Overall Study|Adverse Event|10|||
37702509|NCT01975389|69179930|FG001|Overall Study|Adverse Event|6|||
37702510|NCT01975389|69179929|FG000|Overall Study|Death|61|||
37702511|NCT01975389|69179930|FG001|Overall Study|Death|54|||
37702512|NCT01975389|69179929|FG000|Overall Study|Lost to Follow-up|81|||
37702513|NCT01975389|69179930|FG001|Overall Study|Lost to Follow-up|86|||
37702514|NCT01975389|69179929|FG000|Overall Study|Withdrawal by Subject|90|||
37702515|NCT01975389|69179930|FG001|Overall Study|Withdrawal by Subject|76|||
37702516|NCT01975389|69179929|FG000|Overall Study|Other|6|||
37702517|NCT01975389|69179930|FG001|Overall Study|Other|9|||
37702518|NCT01975389|69179929|FG000|Overall Study|Randomized, not treated|4|||
37702519|NCT01975389|69179930|FG001|Overall Study|Randomized, not treated|5|||
37702520|NCT01974141|69179938|FG000|Overall Study|Other Reasons|28|||
37702521|NCT01974141|69179939|FG001|Overall Study|Other Reasons|18|||
37702522|NCT01974141|69179938|FG000|Overall Study|Protocol Violation|2|||
37702523|NCT01974141|69179939|FG001|Overall Study|Protocol Violation|6|||
37702524|NCT01974141|69179938|FG000|Overall Study|Personal Reasons|21|||
37702525|NCT01974141|69179939|FG001|Overall Study|Personal Reasons|20|||
37702526|NCT01974141|69179938|FG000|Overall Study|Lost to Follow-up|38|||
37702527|NCT01974141|69179939|FG001|Overall Study|Lost to Follow-up|29|||
37702528|NCT01974141|69179938|FG000|Overall Study|Pregnancy|3|||
37702529|NCT01974141|69179939|FG001|Overall Study|Pregnancy|3|||
37702530|NCT01974141|69179938|FG000|Overall Study|Lack of Efficacy|0|||
37836694|NCT01212757|69521035|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
37836695|NCT01212757|69521036|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
37836696|NCT01212757|69521037|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
37836697|NCT01212757|69521038|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
37702531|NCT01974141|69179939|FG001|Overall Study|Lack of Efficacy|1|||
37702532|NCT01974141|69179938|FG000|Overall Study|Adverse Event|4|||
37702533|NCT01974141|69179939|FG001|Overall Study|Adverse Event|5|||
37702534|NCT01945593|69179949|FG000|Overall Study|Adverse Event|0|||
37702535|NCT01945593|69179950|FG001|Overall Study|Adverse Event|0|||
37702536|NCT01945593|69179951|FG002|Overall Study|Adverse Event|0|||
37702537|NCT01945593|69179952|FG003|Overall Study|Adverse Event|5|||
37702538|NCT01945593|69179949|FG000|Overall Study|Physician Decision|0|||
37702539|NCT01945593|69179950|FG001|Overall Study|Physician Decision|0|||
37702540|NCT01945593|69179951|FG002|Overall Study|Physician Decision|1|||
37702541|NCT01945593|69179952|FG003|Overall Study|Physician Decision|1|||
37702542|NCT01945593|69179949|FG000|Overall Study|Withdrawal by Subject|0|||
37702543|NCT01945593|69179950|FG001|Overall Study|Withdrawal by Subject|2|||
37702544|NCT01945593|69179951|FG002|Overall Study|Withdrawal by Subject|0|||
37702545|NCT01945593|69179952|FG003|Overall Study|Withdrawal by Subject|4|||
37702546|NCT01945593|69179949|FG000|Overall Study|Protocol Violation|0|||
37702547|NCT01945593|69179950|FG001|Overall Study|Protocol Violation|2|||
37702548|NCT01945593|69179951|FG002|Overall Study|Protocol Violation|1|||
37702549|NCT01945593|69179952|FG003|Overall Study|Protocol Violation|3|||
37702550|NCT01945593|69179949|FG000|Overall Study|Death|0|||
37702551|NCT01945593|69179950|FG001|Overall Study|Death|0|||
37702552|NCT01945593|69179951|FG002|Overall Study|Death|1|||
37702553|NCT01945593|69179952|FG003|Overall Study|Death|0|||
37702554|NCT01945593|69179949|FG000|Overall Study|Other: Terminated|0|||
37702555|NCT01945593|69179950|FG001|Overall Study|Other: Terminated|0|||
37702556|NCT01945593|69179951|FG002|Overall Study|Other: Terminated|0|||
37702557|NCT01945593|69179952|FG003|Overall Study|Other: Terminated|1|||
37702558|NCT01945593|69179949|FG000|Overall Study|Other: Surgical Procedure|0|||
37702559|NCT01945593|69179950|FG001|Overall Study|Other: Surgical Procedure|2|||
37702560|NCT01945593|69179951|FG002|Overall Study|Other: Surgical Procedure|0|||
37702561|NCT01945593|69179952|FG003|Overall Study|Other: Surgical Procedure|6|||
37702562|NCT01945593|69179949|FG000|Overall Study|Other: Screen Failure|0|||
37702563|NCT01945593|69179950|FG001|Overall Study|Other: Screen Failure|2|||
37702564|NCT01945593|69179951|FG002|Overall Study|Other: Screen Failure|0|||
37702565|NCT01945593|69179952|FG003|Overall Study|Other: Screen Failure|0|||
37702566|NCT01945281|69179969|FG000|Overall Study|Adverse Event|1|||
37702567|NCT01945281|69179970|FG001|Overall Study|Adverse Event|0|||
37702568|NCT01945281|69179969|FG000|Overall Study|Death|3|||
37702569|NCT01945281|69179970|FG001|Overall Study|Death|3|||
37702570|NCT01945281|69179969|FG000|Overall Study|Physician Decision|1|||
37702571|NCT01945281|69179970|FG001|Overall Study|Physician Decision|1|||
37702572|NCT01945281|69179969|FG000|Overall Study|Technical Problems|1|||
37702573|NCT01945281|69179970|FG001|Overall Study|Technical Problems|0|||
37702574|NCT01961349|69179979|FG000|Overall Study|Withdrawal by Subject|1|||
37702575|NCT01961349|69179980|FG001|Overall Study|Withdrawal by Subject|4|||
37702576|NCT01961349|69179981|FG002|Overall Study|Withdrawal by Subject|0|||
37702577|NCT01961349|69179979|FG000|Overall Study|Adverse Event|0|||
37702578|NCT01961349|69179980|FG001|Overall Study|Adverse Event|0|||
37702579|NCT01961349|69179981|FG002|Overall Study|Adverse Event|1|||
37702580|NCT01961349|69179979|FG000|Overall Study|registration error, personal reason etc|2|||
37702581|NCT01961349|69179980|FG001|Overall Study|registration error, personal reason etc|2|||
37702582|NCT01961349|69179981|FG002|Overall Study|registration error, personal reason etc|1|||
37836698|NCT01212757|69521039|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
37836699|NCT01212757|69521031|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
37836700|NCT01212757|69521032|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
37702583|NCT01973595|69179993|FG000|Washout|Withdrawal by Subject|1|||
37702584|NCT01973595|69179994|FG001|Washout|Withdrawal by Subject|0|||
37702585|NCT01973595|69179995|FG002|Washout|Withdrawal by Subject|1|||
37702586|NCT01973595|69179996|FG003|Washout|Withdrawal by Subject|0|||
37702587|NCT01944969|69180007|FG000|Overall Study|Adverse Event|1|||
37702588|NCT01944969|69180007|FG000|Overall Study|Lack of Efficacy|1|||
37702589|NCT01944969|69180007|FG000|Overall Study|Non-compliance with IMP|1|||
37702590|NCT01944969|69180007|FG000|Overall Study|Administrative or other reasons|23|||
37702591|NCT01961115|69180016|FG000|Overall Study|Disease Progression|1|||
37702592|NCT01961115|69180017|FG001|Overall Study|Disease Progression|0|||
37702593|NCT01961115|69180018|FG002|Overall Study|Disease Progression|3|||
37702594|NCT01961115|69180016|FG000|Overall Study|Adverse Event|1|||
37702595|NCT01961115|69180017|FG001|Overall Study|Adverse Event|0|||
37702596|NCT01961115|69180018|FG002|Overall Study|Adverse Event|1|||
37702597|NCT01973439|69180026|FG000|Overall Study|Lost samples from one PK Day|2|||
37702598|NCT01973439|69180026|FG000|Overall Study|Vomiting after commencing once daily|1|||
37702599|NCT01973439|69180026|FG000|Overall Study|PK curve incomplete|2|||
37702600|NCT01973283|69180030|FG000|Overall Study|Lost to Follow-up|4|||
37702601|NCT01943799|69180040|FG000|Overall Study|Lost to Follow-up|0|||
37702602|NCT01943799|69180041|FG001|Overall Study|Lost to Follow-up|1|||
37702603|NCT01943799|69180042|FG002|Overall Study|Lost to Follow-up|1|||
37702604|NCT01943799|69180043|FG003|Overall Study|Lost to Follow-up|0|||
37702605|NCT01943799|69180040|FG000|Overall Study|Protocol Violation|1|||
37702606|NCT01943799|69180041|FG001|Overall Study|Protocol Violation|0|||
37702607|NCT01943799|69180042|FG002|Overall Study|Protocol Violation|0|||
37702608|NCT01943799|69180043|FG003|Overall Study|Protocol Violation|0|||
37702609|NCT01943799|69180040|FG000|Overall Study|Withdrawal by Subject|4|||
37702610|NCT01943799|69180041|FG001|Overall Study|Withdrawal by Subject|2|||
37702611|NCT01943799|69180042|FG002|Overall Study|Withdrawal by Subject|1|||
37702612|NCT01943799|69180043|FG003|Overall Study|Withdrawal by Subject|0|||
37702613|NCT01972659|69180055|FG000|Overall Study|Protocol Violation|2|||
37702614|NCT01972659|69180056|FG001|Overall Study|Protocol Violation|2|||
37702615|NCT01972659|69180055|FG000|Overall Study|problems realted to acceleromyograph|2|||
37702616|NCT01972659|69180056|FG001|Overall Study|problems realted to acceleromyograph|1|||
37702617|NCT01971723|69180064|FG000|Overall Study|Withdrawal by Subject|1|||
37702618|NCT01971723|69180065|FG001|Overall Study|Withdrawal by Subject|1|||
37702619|NCT01971723|69180064|FG000|Overall Study|Protocol Violation|1|||
37702620|NCT01971723|69180065|FG001|Overall Study|Protocol Violation|2|||
37914887|NCT00866307|69601525|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
37914888|NCT00866307|69601523|FG000|Consolidation/Maintenance|Therapy error|0|||
37914889|NCT00866307|69601524|FG001|Consolidation/Maintenance|Therapy error|1|||
37914890|NCT00866307|69601525|FG002|Consolidation/Maintenance|Therapy error|0|||
37914891|NCT00866307|69601523|FG000|Consolidation/Maintenance|Non-compliance|0|||
37914892|NCT00866307|69601524|FG001|Consolidation/Maintenance|Non-compliance|0|||
37914893|NCT00866307|69601525|FG002|Consolidation/Maintenance|Non-compliance|1|||
37914894|NCT00866307|69601523|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
37914895|NCT00866307|69601524|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
37914896|NCT00866307|69601525|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
37914897|NCT00531427|69601533|FG000|Overall Study|Withdrawal by Subject|7|||
37914898|NCT00531427|69601534|FG001|Overall Study|Withdrawal by Subject|13|||
37914899|NCT00531427|69601533|FG000|Overall Study|Adverse Event|44|||
37914900|NCT00531427|69601534|FG001|Overall Study|Adverse Event|30|||
37914901|NCT00531427|69601533|FG000|Overall Study|Lost to Follow-up|4|||
37914902|NCT00531427|69601534|FG001|Overall Study|Lost to Follow-up|3|||
37914903|NCT00531427|69601533|FG000|Overall Study|Lack of Efficacy|14|||
37914904|NCT00531427|69601534|FG001|Overall Study|Lack of Efficacy|39|||
37914905|NCT00531427|69601533|FG000|Overall Study|Administrative|4|||
38023661|NCT03091738|69706847|FG000|Overall Study|Adverse Event|1|||
37914906|NCT00531427|69601534|FG001|Overall Study|Administrative|9|||
37914907|NCT00871728|69601541|FG000|Overall Study|Adverse Event|1|||
38023662|NCT03091738|69706847|FG000|Overall Study|Lost to Follow-up|1|||
38023663|NCT03193216|69706853|FG000|Overall Study|Lost to Follow-up|1|||
38023664|NCT03193216|69706854|FG001|Overall Study|Lost to Follow-up|0|||
38023665|NCT03193216|69706853|FG000|Overall Study|Withdrawal by Subject|5|||
38023666|NCT03193216|69706854|FG001|Overall Study|Withdrawal by Subject|0|||
37702621|NCT01942785|69180071|FG000|Overall Study|Adverse Event|2|||
37702622|NCT01942785|69180071|FG000|Overall Study|Withdrawal by Subject|1|||
37702623|NCT01942785|69180071|FG000|Overall Study|Protocol Violation|1|||
37702624|NCT01774786|69180079|FG000|Overall Study|Death|300|||
37702625|NCT01774786|69180080|FG001|Overall Study|Death|319|||
37702626|NCT01774786|69180079|FG000|Overall Study|Lost to Follow-up|6|||
37702627|NCT01774786|69180080|FG001|Overall Study|Lost to Follow-up|7|||
37914908|NCT00871728|69601541|FG000|Overall Study|Protocol Violation|7|||
37914909|NCT00871728|69601541|FG000|Overall Study|Lost to Follow-up|2|||
37702628|NCT01774786|69180079|FG000|Overall Study|Withdrawal by Subject|18|||
37702629|NCT01774786|69180080|FG001|Overall Study|Withdrawal by Subject|14|||
37702630|NCT01774786|69180079|FG000|Overall Study|Physician Decision|2|||
37702631|NCT01774786|69180080|FG001|Overall Study|Physician Decision|0|||
37702632|NCT01774786|69180079|FG000|Overall Study|Non-compliance|0|||
37702633|NCT01774786|69180080|FG001|Overall Study|Non-compliance|1|||
37702634|NCT01774786|69180079|FG000|Overall Study|Reason Not Specified|2|||
37702635|NCT01774786|69180080|FG001|Overall Study|Reason Not Specified|5|||
37702636|NCT01960725|69180088|FG000|Overall Study|Lost to Follow-up|4|||
37702637|NCT01960725|69180089|FG001|Overall Study|Lost to Follow-up|3|||
37702638|NCT01960725|69180088|FG000|Overall Study|Withdrawal by Subject|1|||
37702639|NCT01960725|69180089|FG001|Overall Study|Withdrawal by Subject|0|||
37702640|NCT01960725|69180088|FG000|Overall Study|unable to obtain blood sample|1|||
37702641|NCT01960725|69180089|FG001|Overall Study|unable to obtain blood sample|2|||
37702642|NCT01942161|69180098|FG000|Overall Study|Adverse Event|1|||
37702643|NCT01942161|69180099|FG001|Overall Study|Adverse Event|2|||
37702644|NCT01942161|69180100|FG002|Overall Study|Adverse Event|5|||
37702645|NCT01942161|69180098|FG000|Overall Study|Physician Decision|3|||
37702646|NCT01942161|69180099|FG001|Overall Study|Physician Decision|1|||
37702647|NCT01942161|69180100|FG002|Overall Study|Physician Decision|0|||
37836701|NCT01212757|69521033|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
37702648|NCT01942161|69180098|FG000|Overall Study|Protocol Violation|1|||
37702649|NCT01942161|69180099|FG001|Overall Study|Protocol Violation|0|||
37702650|NCT01942161|69180100|FG002|Overall Study|Protocol Violation|0|||
37702651|NCT01942161|69180098|FG000|Overall Study|Withdrawal by Subject|3|||
37836702|NCT01212757|69521034|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
37836703|NCT01212757|69521035|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
37836704|NCT01212757|69521036|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
37836705|NCT01212757|69521037|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
37702652|NCT01942161|69180099|FG001|Overall Study|Withdrawal by Subject|3|||
37702653|NCT01942161|69180100|FG002|Overall Study|Withdrawal by Subject|1|||
37702654|NCT01971645|69180111|FG000|Overall Study|Adverse Event|1|||
37702655|NCT01971645|69180112|FG001|Overall Study|Adverse Event|0|||
37702656|NCT01971645|69180113|FG002|Overall Study|Adverse Event|0|||
37702657|NCT01971645|69180111|FG000|Overall Study|Lost to Follow-up|1|||
37702658|NCT01971645|69180112|FG001|Overall Study|Lost to Follow-up|0|||
37702659|NCT01971645|69180113|FG002|Overall Study|Lost to Follow-up|1|||
37702660|NCT01971645|69180111|FG000|Overall Study|Protocol Violation|0|||
37702661|NCT01971645|69180112|FG001|Overall Study|Protocol Violation|0|||
37702662|NCT01971645|69180113|FG002|Overall Study|Protocol Violation|1|||
37702663|NCT01941537|69180123|FG000|Overall Study|Lack of Efficacy|1|||
37702664|NCT01941537|69180124|FG001|Overall Study|Lack of Efficacy|2|||
37702665|NCT01941537|69180123|FG000|Overall Study|Lost to Follow-up|1|||
37702666|NCT01941537|69180124|FG001|Overall Study|Lost to Follow-up|0|||
37702667|NCT01941537|69180123|FG000|Overall Study|Pregnancy|1|||
37702668|NCT01941537|69180124|FG001|Overall Study|Pregnancy|0|||
37702669|NCT01941537|69180123|FG000|Overall Study|Adverse Event|1|||
37702670|NCT01941537|69180124|FG001|Overall Study|Adverse Event|0|||
37702671|NCT01941537|69180123|FG000|Overall Study|Withdrawal by Subject|0|||
37702672|NCT01941537|69180124|FG001|Overall Study|Withdrawal by Subject|1|||
37702673|NCT01971567|69180133|FG000|Overall Study|Withdrawal by Subject|3|||
37702674|NCT01971567|69180134|FG001|Overall Study|Withdrawal by Subject|2|||
37702675|NCT01971567|69180133|FG000|Overall Study|Lost to Follow-up|1|||
37702676|NCT01971567|69180134|FG001|Overall Study|Lost to Follow-up|0|||
37702677|NCT01960413|69180142|FG000|Overall Study|Withdrawal by Subject|1|||
37702678|NCT01960413|69180143|FG001|Overall Study|Withdrawal by Subject|1|||
37702679|NCT01960413|69180142|FG000|Overall Study|Physician Decision|1|||
37702680|NCT01960413|69180143|FG001|Overall Study|Physician Decision|0|||
37702681|NCT01960413|69180142|FG000|Overall Study|Lost to Follow-up|2|||
37702682|NCT01960413|69180143|FG001|Overall Study|Lost to Follow-up|0|||
37702683|NCT01970475|69180151|FG000|Overall Study|Withdrawal by Subject|11|||
37702684|NCT01970475|69180152|FG001|Overall Study|Withdrawal by Subject|6|||
37702685|NCT01970475|69180151|FG000|Overall Study|Adverse Event|7|||
37702686|NCT01970475|69180152|FG001|Overall Study|Adverse Event|3|||
37702687|NCT01970475|69180151|FG000|Overall Study|Lost to Follow-up|2|||
37702688|NCT01970475|69180152|FG001|Overall Study|Lost to Follow-up|2|||
37702689|NCT01970475|69180151|FG000|Overall Study|Protocol Violation|1|||
37702690|NCT01970475|69180152|FG001|Overall Study|Protocol Violation|0|||
37702691|NCT01939977|69180160|FG000|Overall Study|Adverse Event|4|||
37702692|NCT01939977|69180161|FG001|Overall Study|Adverse Event|3|||
37702693|NCT01939977|69180160|FG000|Overall Study|Lack of Efficacy|3|||
37702694|NCT01939977|69180161|FG001|Overall Study|Lack of Efficacy|0|||
37702695|NCT01939977|69180160|FG000|Overall Study|Physician Decision|1|||
37702696|NCT01939977|69180161|FG001|Overall Study|Physician Decision|1|||
37702697|NCT01939977|69180160|FG000|Overall Study|Withdrawal by Subject|0|||
37702698|NCT01939977|69180161|FG001|Overall Study|Withdrawal by Subject|2|||
37702699|NCT01939977|69180160|FG000|Overall Study|Did not meet inclusion criteria|1|||
37702700|NCT01939977|69180161|FG001|Overall Study|Did not meet inclusion criteria|0|||
37702701|NCT01939977|69180160|FG000|Overall Study|Did not receive study medication|0|||
37702702|NCT01939977|69180161|FG001|Overall Study|Did not receive study medication|1|||
37702703|NCT01939899|69180172|FG000|Lead-in Dose Finding Phase|Death|0|||
37702704|NCT01939899|69180173|FG001|Lead-in Dose Finding Phase|Death|3|||
37702705|NCT01939899|69180174|FG002|Lead-in Dose Finding Phase|Death|1|||
37702706|NCT01939899|69180175|FG003|Lead-in Dose Finding Phase|Death|0|||
37702707|NCT01939899|69180176|FG004|Lead-in Dose Finding Phase|Death|0|||
37702708|NCT01939899|69180172|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
37702709|NCT01939899|69180173|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
37702710|NCT01939899|69180174|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
37702711|NCT01939899|69180175|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
37702712|NCT01939899|69180176|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
37702713|NCT01939899|69180172|FG000|Lead-in Dose Finding Phase|Other|0|||
37702714|NCT01939899|69180173|FG001|Lead-in Dose Finding Phase|Other|0|||
37702715|NCT01939899|69180174|FG002|Lead-in Dose Finding Phase|Other|1|||
37702716|NCT01939899|69180175|FG003|Lead-in Dose Finding Phase|Other|0|||
37702717|NCT01939899|69180176|FG004|Lead-in Dose Finding Phase|Other|0|||
37702718|NCT01939899|69180172|FG000|Phase 2|Withdrawal by Subject|0|||
37702719|NCT01939899|69180173|FG001|Phase 2|Withdrawal by Subject|0|||
37702720|NCT01939899|69180174|FG002|Phase 2|Withdrawal by Subject|0|||
37702721|NCT01939899|69180175|FG003|Phase 2|Withdrawal by Subject|2|||
37702722|NCT01939899|69180176|FG004|Phase 2|Withdrawal by Subject|0|||
37702723|NCT01939899|69180172|FG000|Phase 2|Disease Progression|0|||
37702724|NCT01939899|69180173|FG001|Phase 2|Disease Progression|0|||
37702725|NCT01939899|69180174|FG002|Phase 2|Disease Progression|0|||
37702726|NCT01939899|69180175|FG003|Phase 2|Disease Progression|9|||
37702727|NCT01939899|69180176|FG004|Phase 2|Disease Progression|1|||
37702728|NCT01970397|69180196|FG000|Overall Study|Adverse Event|0|||
37702729|NCT01970397|69180197|FG001|Overall Study|Adverse Event|1|||
37702730|NCT01970397|69180196|FG000|Overall Study|Lost to Follow-up|0|||
37702731|NCT01970397|69180197|FG001|Overall Study|Lost to Follow-up|1|||
37702732|NCT01970397|69180196|FG000|Overall Study|Personal Reasons|1|||
37702733|NCT01970397|69180197|FG001|Overall Study|Personal Reasons|2|||
37702734|NCT01970397|69180196|FG000|Overall Study|Protocol Violation|1|||
37702735|NCT01970397|69180197|FG001|Overall Study|Protocol Violation|1|||
37702736|NCT01970241|69180205|FG000|Overall Study|Withdrawal by Subject|2|||
37702737|NCT01970241|69180206|FG001|Overall Study|Withdrawal by Subject|0|||
37702738|NCT01970241|69180205|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
37702739|NCT01970241|69180206|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
37702740|NCT01939353|69180214|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
37702741|NCT01939353|69180214|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
37702742|NCT01939353|69180214|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
37702743|NCT01939353|69180214|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
37702744|NCT01939353|69180214|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
37702745|NCT01970007|69180218|FG000|Overall Study|Death|5|||
37702746|NCT01970007|69180218|FG000|Overall Study|Withdrawal by Subject|23|||
37702747|NCT01970007|69180218|FG000|Overall Study|Lost to Follow-up|24|||
37702748|NCT01970007|69180218|FG000|Overall Study|"Other endpoint"|3|||
37702749|NCT01728376|69180228|FG000|Overall Study|Adverse Event|1|||
37702750|NCT01728376|69180229|FG001|Overall Study|Adverse Event|1|||
37702751|NCT01728376|69180230|FG002|Overall Study|Adverse Event|1|||
37702752|NCT01728376|69180231|FG003|Overall Study|Adverse Event|1|||
37702753|NCT01728376|69180232|FG004|Overall Study|Adverse Event|1|||
37702754|NCT01728376|69180233|FG005|Overall Study|Adverse Event|0|||
37702755|NCT01728376|69180228|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
37702756|NCT01728376|69180229|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
37702757|NCT01728376|69180230|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
37702758|NCT01728376|69180231|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
37702759|NCT01728376|69180232|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
37702760|NCT01728376|69180233|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
37702761|NCT01728376|69180228|FG000|Overall Study|No relevant bacteria|2|||
37702762|NCT01728376|69180229|FG001|Overall Study|No relevant bacteria|0|||
37702763|NCT01728376|69180230|FG002|Overall Study|No relevant bacteria|0|||
37702764|NCT01728376|69180231|FG003|Overall Study|No relevant bacteria|0|||
37702765|NCT01728376|69180232|FG004|Overall Study|No relevant bacteria|1|||
37702766|NCT01728376|69180233|FG005|Overall Study|No relevant bacteria|1|||
37702767|NCT01728376|69180228|FG000|Overall Study|Did not receive treatment|0|||
37702768|NCT01728376|69180229|FG001|Overall Study|Did not receive treatment|1|||
38023667|NCT03193216|69706853|FG000|Overall Study|Physician Decision|4|||
37702769|NCT01728376|69180230|FG002|Overall Study|Did not receive treatment|0|||
37702770|NCT01728376|69180231|FG003|Overall Study|Did not receive treatment|0|||
37702771|NCT01728376|69180232|FG004|Overall Study|Did not receive treatment|0|||
37702772|NCT01728376|69180233|FG005|Overall Study|Did not receive treatment|0|||
37702773|NCT01728376|69180228|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
37702774|NCT01728376|69180229|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
37702775|NCT01728376|69180230|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
37702776|NCT01728376|69180231|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
37702777|NCT01728376|69180232|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
37702778|NCT01728376|69180233|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
37702779|NCT01708174|69180250|FG000|Treatment Period|Withdrawal by Subject|1|||
37702780|NCT01708174|69180251|FG001|Treatment Period|Withdrawal by Subject|0|||
37702781|NCT01708174|69180252|FG002|Treatment Period|Withdrawal by Subject|0|||
37702782|NCT01708174|69180250|FG000|Treatment Period|Progressive disease|0|||
37702783|NCT01708174|69180251|FG001|Treatment Period|Progressive disease|1|||
37702784|NCT01708174|69180252|FG002|Treatment Period|Progressive disease|0|||
37702785|NCT01708174|69180250|FG000|Treatment Period|Death|0|||
37702786|NCT01708174|69180251|FG001|Treatment Period|Death|0|||
37702787|NCT01708174|69180252|FG002|Treatment Period|Death|1|||
37702788|NCT01708174|69180250|FG000|Treatment Period|Adverse Event|0|||
37702789|NCT01708174|69180251|FG001|Treatment Period|Adverse Event|1|||
37702790|NCT01708174|69180252|FG002|Treatment Period|Adverse Event|0|||
37702791|NCT01605916|69180266|FG000|Overall Study|Adverse Event|1|||
37702792|NCT01605916|69180267|FG001|Overall Study|Adverse Event|0|||
37702793|NCT01605916|69180268|FG002|Overall Study|Adverse Event|0|||
37702794|NCT01605916|69180269|FG003|Overall Study|Adverse Event|1|||
37702795|NCT01605916|69180270|FG004|Overall Study|Adverse Event|0|||
37702796|NCT01605916|69180266|FG000|Overall Study|Lack of Efficacy|2|||
37702797|NCT01605916|69180267|FG001|Overall Study|Lack of Efficacy|3|||
37702798|NCT01605916|69180268|FG002|Overall Study|Lack of Efficacy|3|||
37702799|NCT01605916|69180269|FG003|Overall Study|Lack of Efficacy|5|||
37702800|NCT01605916|69180270|FG004|Overall Study|Lack of Efficacy|4|||
37702801|NCT01605916|69180266|FG000|Overall Study|Withdrawal by Subject|1|||
37702802|NCT01605916|69180267|FG001|Overall Study|Withdrawal by Subject|1|||
37702803|NCT01605916|69180268|FG002|Overall Study|Withdrawal by Subject|0|||
37836706|NCT01212757|69521038|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
37836707|NCT01212757|69521039|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
37702804|NCT01605916|69180269|FG003|Overall Study|Withdrawal by Subject|0|||
37702805|NCT01605916|69180270|FG004|Overall Study|Withdrawal by Subject|2|||
37702806|NCT01635283|69180283|FG000|Overall Study|Tumor Progression|3|||
37702807|NCT01635283|69180283|FG000|Overall Study|Lost to Follow-up|1|||
37836708|NCT01212757|69521031|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
37836709|NCT01212757|69521032|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
37702808|NCT01707004|69180290|FG000|Overall Study|Physician Decision|3|||
37702809|NCT01939197|69180302|FG000|Overall Study|Withdrawal by Subject|1|||
37702810|NCT01939197|69180303|FG001|Overall Study|Withdrawal by Subject|0|||
37702811|NCT01939197|69180304|FG002|Overall Study|Withdrawal by Subject|0|||
37702812|NCT01939197|69180305|FG003|Overall Study|Withdrawal by Subject|0|||
37702813|NCT01939197|69180306|FG004|Overall Study|Withdrawal by Subject|1|||
37702814|NCT01939197|69180307|FG005|Overall Study|Withdrawal by Subject|0|||
37702815|NCT01939197|69180308|FG006|Overall Study|Withdrawal by Subject|0|||
37702816|NCT01939197|69180302|FG000|Overall Study|Lost to Follow-up|0|||
37702817|NCT01939197|69180303|FG001|Overall Study|Lost to Follow-up|1|||
37702818|NCT01939197|69180304|FG002|Overall Study|Lost to Follow-up|0|||
37702819|NCT01939197|69180305|FG003|Overall Study|Lost to Follow-up|1|||
37702820|NCT01939197|69180306|FG004|Overall Study|Lost to Follow-up|3|||
37702821|NCT01939197|69180307|FG005|Overall Study|Lost to Follow-up|1|||
37702822|NCT01939197|69180308|FG006|Overall Study|Lost to Follow-up|2|||
37702823|NCT01969851|69180341|FG000|Overall Study|Adverse Event|0|||
37702824|NCT01969851|69180342|FG001|Overall Study|Adverse Event|0|||
37702825|NCT01969851|69180343|FG002|Overall Study|Adverse Event|3|||
37702826|NCT01969851|69180341|FG000|Overall Study|Lack of Efficacy|0|||
37702827|NCT01969851|69180342|FG001|Overall Study|Lack of Efficacy|3|||
37702828|NCT01969851|69180343|FG002|Overall Study|Lack of Efficacy|1|||
37702829|NCT01969851|69180341|FG000|Overall Study|Withdrawal by Subject|1|||
37702830|NCT01969851|69180342|FG001|Overall Study|Withdrawal by Subject|0|||
37702831|NCT01969851|69180343|FG002|Overall Study|Withdrawal by Subject|1|||
37702832|NCT01969851|69180341|FG000|Overall Study|No effective dose in Titration period|0|||
37702833|NCT01969851|69180342|FG001|Overall Study|No effective dose in Titration period|0|||
37702834|NCT01969851|69180343|FG002|Overall Study|No effective dose in Titration period|1|||
37702835|NCT01969851|69180341|FG000|Overall Study|Sponsor decision|0|||
37702836|NCT01969851|69180342|FG001|Overall Study|Sponsor decision|0|||
37702837|NCT01969851|69180343|FG002|Overall Study|Sponsor decision|1|||
37702838|NCT01938573|69180351|FG000|Overall Study|Lack of Efficacy|1|||
37702839|NCT01938573|69180352|FG001|Overall Study|Lack of Efficacy|0|||
37702840|NCT01938573|69180351|FG000|Overall Study|Operation at other hospital|1|||
37702841|NCT01938573|69180352|FG001|Overall Study|Operation at other hospital|0|||
37702842|NCT01937871|69180360|FG000|Overall Study|Adverse Event|6|||
37702843|NCT01937871|69180361|FG001|Overall Study|Adverse Event|6|||
37702844|NCT01937871|69180362|FG002|Overall Study|Adverse Event|2|||
37702845|NCT01937871|69180360|FG000|Overall Study|Lost to Follow-up|8|||
37702846|NCT01937871|69180361|FG001|Overall Study|Lost to Follow-up|2|||
37702847|NCT01937871|69180362|FG002|Overall Study|Lost to Follow-up|4|||
37702848|NCT01937871|69180360|FG000|Overall Study|Withdrawal by Subject|9|||
37702849|NCT01937871|69180361|FG001|Overall Study|Withdrawal by Subject|6|||
37702850|NCT01937871|69180362|FG002|Overall Study|Withdrawal by Subject|4|||
37702851|NCT01937871|69180360|FG000|Overall Study|Physician Decision|0|||
37702852|NCT01937871|69180361|FG001|Overall Study|Physician Decision|1|||
37702853|NCT01937871|69180362|FG002|Overall Study|Physician Decision|0|||
37702854|NCT01937871|69180360|FG000|Overall Study|Entry Criteria Not Met|1|||
37702855|NCT01937871|69180361|FG001|Overall Study|Entry Criteria Not Met|2|||
37702856|NCT01937871|69180362|FG002|Overall Study|Entry Criteria Not Met|1|||
37702857|NCT01269463|69180373|FG000|First Intervention|Withdrawal by Subject|1|||
37702858|NCT01269463|69180374|FG001|First Intervention|Withdrawal by Subject|0|||
37702859|NCT01269463|69180373|FG000|First Intervention|Adverse Event|1|||
37702860|NCT01269463|69180374|FG001|First Intervention|Adverse Event|0|||
37702861|NCT01269463|69180373|FG000|First Intervention|Lack of Efficacy|0|||
37702862|NCT01269463|69180374|FG001|First Intervention|Lack of Efficacy|1|||
37702863|NCT01269463|69180373|FG000|First Intervention|Physician Decision|0|||
37702864|NCT01269463|69180374|FG001|First Intervention|Physician Decision|1|||
37702865|NCT01706926|69180389|FG000|Overall Study|Lost to Follow-up|0|||
37702866|NCT01706926|69180390|FG001|Overall Study|Lost to Follow-up|0|||
37702867|NCT01706926|69180391|FG002|Overall Study|Lost to Follow-up|1|||
37702868|NCT01706926|69180392|FG003|Overall Study|Lost to Follow-up|0|||
37702869|NCT01706926|69180389|FG000|Overall Study|Withdrawal by Subject|2|||
37702870|NCT01706926|69180390|FG001|Overall Study|Withdrawal by Subject|0|||
37702871|NCT01706926|69180391|FG002|Overall Study|Withdrawal by Subject|1|||
37702872|NCT01706926|69180392|FG003|Overall Study|Withdrawal by Subject|2|||
37702873|NCT01706926|69180389|FG000|Overall Study|Other|4|||
37702874|NCT01706926|69180390|FG001|Overall Study|Other|4|||
37702875|NCT01706926|69180391|FG002|Overall Study|Other|4|||
37702876|NCT01706926|69180392|FG003|Overall Study|Other|3|||
37702877|NCT01634113|69180408|FG000|Overall Study|Not treated|0|||
37702878|NCT01634113|69180409|FG001|Overall Study|Not treated|0|||
37702879|NCT01634113|69180410|FG002|Overall Study|Not treated|1|||
37702880|NCT01706770|69180420|FG000|Overall Study|Lost to Follow-up|1|||
37702881|NCT01706770|69180421|FG001|Overall Study|Lost to Follow-up|0|||
37702882|NCT01706770|69180420|FG000|Overall Study|Physician Decision|1|||
37702883|NCT01706770|69180421|FG001|Overall Study|Physician Decision|0|||
37702884|NCT01937715|69180432|FG000|Overall Study|Death|0|||
37702885|NCT01937715|69180433|FG001|Overall Study|Death|0|||
37702886|NCT01937715|69180434|FG002|Overall Study|Death|0|||
37702887|NCT01937715|69180435|FG003|Overall Study|Death|1|||
37702888|NCT01937715|69180436|FG004|Overall Study|Death|0|||
37702889|NCT01937715|69180432|FG000|Overall Study|Withdrawal by Subject|0|||
37702890|NCT01937715|69180433|FG001|Overall Study|Withdrawal by Subject|1|||
37702891|NCT01937715|69180434|FG002|Overall Study|Withdrawal by Subject|0|||
37702892|NCT01937715|69180435|FG003|Overall Study|Withdrawal by Subject|0|||
37702893|NCT01937715|69180436|FG004|Overall Study|Withdrawal by Subject|2|||
37702894|NCT01937715|69180432|FG000|Overall Study|Other|0|||
37702895|NCT01937715|69180433|FG001|Overall Study|Other|0|||
37702896|NCT01937715|69180434|FG002|Overall Study|Other|0|||
37702897|NCT01937715|69180435|FG003|Overall Study|Other|3|||
37702898|NCT01937715|69180436|FG004|Overall Study|Other|0|||
37702899|NCT01937559|69180451|FG000|Overall Study|Physician Decision|3|||
37702900|NCT01937559|69180452|FG001|Overall Study|Physician Decision|3|||
37702901|NCT01937559|69180453|FG002|Overall Study|Physician Decision|0|||
37702902|NCT01937559|69180451|FG000|Overall Study|Withdrawal by Subject|6|||
37702903|NCT01937559|69180452|FG001|Overall Study|Withdrawal by Subject|4|||
37702904|NCT01937559|69180453|FG002|Overall Study|Withdrawal by Subject|0|||
37702905|NCT01937559|69180451|FG000|Overall Study|screen fail|2|||
37702906|NCT01937559|69180452|FG001|Overall Study|screen fail|4|||
37702907|NCT01937559|69180453|FG002|Overall Study|screen fail|0|||
37702908|NCT01960257|69180465|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
37702909|NCT01960257|69180466|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
37702910|NCT01960257|69180467|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
37836710|NCT01212757|69521033|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
37836711|NCT01212757|69521034|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
37702911|NCT01960257|69180465|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
37702912|NCT01960257|69180466|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
37836712|NCT01212757|69521035|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
37836713|NCT01212757|69521036|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
37836714|NCT01212757|69521037|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
37836715|NCT01212757|69521038|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
37836716|NCT01212757|69521039|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
37836717|NCT01212757|69521031|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
37836718|NCT01212757|69521032|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
37836719|NCT01212757|69521033|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
37836720|NCT01212757|69521034|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
37836721|NCT01212757|69521035|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
37914910|NCT00871728|69601541|FG000|Overall Study|Failed to Visit Hospital|4|||
37914911|NCT00871728|69601541|FG000|Overall Study|Participant Non-compliance|1|||
37914912|NCT00871728|69601541|FG000|Overall Study|Withdrawal of Informed Consent|5|||
37914913|NCT00868998|69601545|FG000|Overall Study|Screen Failure|1|||
37914914|NCT00868998|69601545|FG000|Overall Study|Withdrawal by Subject|1|||
37914915|NCT00868998|69601545|FG000|Overall Study|Progression of disease|2|||
37914916|NCT00868998|69601545|FG000|Overall Study|Death|1|||
38023668|NCT03193216|69706854|FG001|Overall Study|Physician Decision|0|||
37702913|NCT01960257|69180467|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
37702914|NCT01960257|69180465|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
37702915|NCT01960257|69180466|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
37702916|NCT01960257|69180467|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
37702917|NCT01918371|69180479|FG000|Overall Study|Missing Data|1|||
37702918|NCT01918371|69180480|FG001|Overall Study|Missing Data|1|||
37702919|NCT01917747|69180488|FG000|Overall Study|Withdrawal by Subject|1|||
37836722|NCT01212757|69521036|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
37836723|NCT01212757|69521037|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
37836724|NCT01212757|69521038|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
37914917|NCT00533845|69601560|FG000|Overall Study|Physician Decision|1|||
37914918|NCT00533845|69601561|FG001|Overall Study|Physician Decision|0|||
37914919|NCT00857649|69601569|FG000|Overall Study|Adverse Event|15|||
38023669|NCT03091348|69706862|FG000|Overall Study|Lost to Follow-up|2|||
38023670|NCT03091348|69706863|FG001|Overall Study|Lost to Follow-up|1|||
37702920|NCT01917747|69180489|FG001|Overall Study|Withdrawal by Subject|2|||
37702921|NCT01917747|69180488|FG000|Overall Study|Lost to Follow-up|18|||
37836725|NCT01212757|69521039|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
37836726|NCT01212757|69521031|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
37836727|NCT01212757|69521032|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
37836728|NCT01212757|69521033|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
37836729|NCT01212757|69521034|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
37836730|NCT01212757|69521035|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
37836731|NCT01212757|69521036|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
37702922|NCT01917747|69180489|FG001|Overall Study|Lost to Follow-up|9|||
37702923|NCT01597791|69180501|FG000|Overall Study|Physician Decision|2|||
37702924|NCT01597791|69180502|FG001|Overall Study|Physician Decision|1|||
37702925|NCT01597791|69180501|FG000|Overall Study|Cesarean Section|6|||
37702926|NCT01597791|69180502|FG001|Overall Study|Cesarean Section|7|||
37702927|NCT01597791|69180501|FG000|Overall Study|Subject withdrawal|0|||
37702928|NCT01597791|69180502|FG001|Overall Study|Subject withdrawal|1|||
37702929|NCT01597791|69180501|FG000|Overall Study|Protocol Violation|0|||
37702930|NCT01597791|69180502|FG001|Overall Study|Protocol Violation|1|||
37702931|NCT01916967|69180511|FG000|Overall Study|Adverse Event|0|||
37702932|NCT01916967|69180512|FG001|Overall Study|Adverse Event|0|||
37702933|NCT01916967|69180513|FG002|Overall Study|Adverse Event|2|||
37702934|NCT01916967|69180511|FG000|Overall Study|Lack of Efficacy|0|||
37702935|NCT01916967|69180512|FG001|Overall Study|Lack of Efficacy|0|||
37702936|NCT01916967|69180513|FG002|Overall Study|Lack of Efficacy|6|||
37702937|NCT01916967|69180511|FG000|Overall Study|Physician Decision|0|||
37702938|NCT01916967|69180512|FG001|Overall Study|Physician Decision|0|||
37702939|NCT01916967|69180513|FG002|Overall Study|Physician Decision|1|||
37702940|NCT01916967|69180511|FG000|Overall Study|Protocol Violation|0|||
37702941|NCT01916967|69180512|FG001|Overall Study|Protocol Violation|1|||
37702942|NCT01916967|69180513|FG002|Overall Study|Protocol Violation|0|||
37702943|NCT01936623|69180525|FG000|Overall Study|Lost to Follow-up|0|||
37702944|NCT01936623|69180526|FG001|Overall Study|Lost to Follow-up|5|||
37702945|NCT01959243|69180534|FG000|Overall Study|Investigator Decision|3|||
37702946|NCT01959243|69180535|FG001|Overall Study|Investigator Decision|0|||
37702947|NCT01959243|69180534|FG000|Overall Study|Adverse Event|5|||
37702948|NCT01959243|69180535|FG001|Overall Study|Adverse Event|2|||
37702949|NCT01959243|69180534|FG000|Overall Study|Administrative reasons|2|||
37702950|NCT01959243|69180535|FG001|Overall Study|Administrative reasons|1|||
37702951|NCT01959243|69180534|FG000|Overall Study|Lost to Follow-up|3|||
37702952|NCT01959243|69180535|FG001|Overall Study|Lost to Follow-up|1|||
37702953|NCT01959165|69180545|FG000|Overall Study|Adverse Event|0|||
37702954|NCT01959165|69180546|FG001|Overall Study|Adverse Event|0|||
37836732|NCT01212757|69521037|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
37836733|NCT01212757|69521038|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
37914920|NCT00857649|69601570|FG001|Overall Study|Adverse Event|10|||
37914921|NCT00857649|69601569|FG000|Overall Study|Non-compliance|1|||
37914922|NCT00857649|69601570|FG001|Overall Study|Non-compliance|1|||
37702955|NCT01959165|69180547|FG002|Overall Study|Adverse Event|0|||
37702956|NCT01959165|69180548|FG003|Overall Study|Adverse Event|1|||
37702957|NCT01959165|69180545|FG000|Overall Study|Lack of Efficacy|1|||
37702958|NCT01959165|69180546|FG001|Overall Study|Lack of Efficacy|0|||
37702959|NCT01959165|69180547|FG002|Overall Study|Lack of Efficacy|0|||
37836734|NCT01212757|69521039|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
37836735|NCT01212757|69521031|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
37836736|NCT01212757|69521032|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
37836737|NCT01212757|69521033|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
37836738|NCT01212757|69521034|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
37836739|NCT01212757|69521035|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
37836740|NCT01212757|69521036|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
37836741|NCT01212757|69521037|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
37836742|NCT01212757|69521038|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
37836743|NCT01212757|69521039|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
37836744|NCT01212757|69521031|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
37836745|NCT01212757|69521032|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
37836746|NCT01212757|69521033|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
37836747|NCT01212757|69521034|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
37914923|NCT00857649|69601569|FG000|Overall Study|Protocol Violation|2|||
37702960|NCT01959165|69180548|FG003|Overall Study|Lack of Efficacy|0|||
37702961|NCT01959165|69180545|FG000|Overall Study|overdose|0|||
37702962|NCT01959165|69180546|FG001|Overall Study|overdose|0|||
37702963|NCT01959165|69180547|FG002|Overall Study|overdose|0|||
37702964|NCT01959165|69180548|FG003|Overall Study|overdose|1|||
37702965|NCT01959165|69180545|FG000|Overall Study|Welfare recipient|0|||
37702966|NCT01959165|69180546|FG001|Overall Study|Welfare recipient|1|||
37702967|NCT01959165|69180547|FG002|Overall Study|Welfare recipient|0|||
37702968|NCT01959165|69180548|FG003|Overall Study|Welfare recipient|0|||
37702969|NCT01916109|69180558|FG000|Overall Study|Withdrawal by Subject|1|||
37702970|NCT01915095|69180569|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
37702971|NCT01915095|69180570|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
37702972|NCT01915095|69180571|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
37702973|NCT01915095|69180572|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
37702974|NCT01915095|69180573|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
37702975|NCT01958619|69180598|FG000|Overall Study|Protocol Violation|2|||
37702976|NCT01958619|69180599|FG001|Overall Study|Protocol Violation|0|||
37702977|NCT01958619|69180600|FG002|Overall Study|Protocol Violation|1|||
37702978|NCT01958619|69180601|FG003|Overall Study|Protocol Violation|0|||
37702979|NCT01752634|69180617|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
37702980|NCT01752634|69180618|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
37702981|NCT01752634|69180619|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
37702982|NCT01752634|69180620|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
37702983|NCT01752634|69180621|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
37702984|NCT01752634|69180622|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
37702985|NCT01752634|69180617|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
37702986|NCT01752634|69180618|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
37702987|NCT01752634|69180619|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
37702988|NCT01752634|69180620|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
37702989|NCT01752634|69180621|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
37702990|NCT01752634|69180622|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
37914924|NCT00857649|69601570|FG001|Overall Study|Protocol Violation|2|||
37914925|NCT00857649|69601569|FG000|Overall Study|Withdrawal of Consent|10|||
37836748|NCT01212757|69521035|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
37836749|NCT01212757|69521036|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
37836750|NCT01212757|69521037|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
37836751|NCT01212757|69521038|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
37836752|NCT01212757|69521039|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
37836753|NCT01212757|69521031|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
37836754|NCT01212757|69521032|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
37836755|NCT01212757|69521033|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
37836756|NCT01212757|69521034|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
37836757|NCT01212757|69521035|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
37836758|NCT01212757|69521036|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
37836759|NCT01212757|69521037|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
37836760|NCT01212757|69521038|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
37836761|NCT01212757|69521039|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
37836762|NCT01212757|69521031|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
37836763|NCT01212757|69521032|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
37836764|NCT01212757|69521033|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
37702991|NCT01752634|69180617|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
37702992|NCT01752634|69180618|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
37836765|NCT01212757|69521034|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
37836766|NCT01212757|69521035|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
37836767|NCT01212757|69521036|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
37836768|NCT01212757|69521037|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
37836769|NCT01212757|69521038|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
37836770|NCT01212757|69521039|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
37836771|NCT01212757|69521031|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
37836772|NCT01212757|69521032|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
37836773|NCT01212757|69521033|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
37836774|NCT01212757|69521034|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
37836775|NCT01212757|69521035|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
37836776|NCT01212757|69521036|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
37836777|NCT01212757|69521037|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
37836778|NCT01212757|69521038|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
37836779|NCT01212757|69521039|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
37836780|NCT01212757|69521031|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
37836781|NCT01212757|69521032|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
37836782|NCT01212757|69521033|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
37836783|NCT01212757|69521034|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
37702993|NCT01752634|69180619|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
37702994|NCT01752634|69180620|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
37702995|NCT01752634|69180621|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
37702996|NCT01752634|69180622|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
37702997|NCT01752634|69180617|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
37702998|NCT01752634|69180618|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
37702999|NCT01752634|69180619|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
37914926|NCT00857649|69601570|FG001|Overall Study|Withdrawal of Consent|7|||
37914927|NCT00857649|69601569|FG000|Overall Study|Nursing Home Placement|2|||
37914928|NCT00857649|69601570|FG001|Overall Study|Nursing Home Placement|9|||
37914929|NCT00857649|69601569|FG000|Overall Study|Other Reasons|1|||
37703000|NCT01752634|69180620|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
37836784|NCT01212757|69521035|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
37703001|NCT01752634|69180621|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
37914930|NCT00857649|69601570|FG001|Overall Study|Other Reasons|3|||
37836785|NCT01212757|69521036|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
37836786|NCT01212757|69521037|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
37836787|NCT01212757|69521038|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
37836788|NCT01212757|69521039|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
37836789|NCT01212757|69521031|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
37836790|NCT01212757|69521032|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
37836791|NCT01212757|69521033|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
37836792|NCT01212757|69521034|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
37703002|NCT01752634|69180622|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
37703003|NCT01752634|69180617|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
37703004|NCT01752634|69180618|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
37703005|NCT01752634|69180619|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
37703006|NCT01752634|69180620|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
37703007|NCT01752634|69180621|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
37703008|NCT01752634|69180622|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
37703009|NCT01752634|69180617|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
37914931|NCT00857415|69601578|FG000|Overall Study|Image acquisition failure|2|||
37914932|NCT00857415|69601579|FG001|Overall Study|Image acquisition failure|0|||
37914933|NCT00857415|69601578|FG000|Overall Study|Invalid image or not imaged|3|||
37914934|NCT00857415|69601579|FG001|Overall Study|Invalid image or not imaged|0|||
37914935|NCT00857415|69601578|FG000|Overall Study|Subject still living at end of study|110|||
37914936|NCT00857415|69601579|FG001|Overall Study|Subject still living at end of study|0|||
37914937|NCT00857415|69601578|FG000|Overall Study|Deceased with no autopsy|2|||
38023671|NCT03751098|69706870|FG000|Overall Study|Withdrawal by Subject|0|||
38023672|NCT03751098|69706871|FG001|Overall Study|Withdrawal by Subject|1|||
38023673|NCT03751020|69706882|FG000|Overall Study|Withdrawal by Subject|2|||
38023674|NCT03751020|69706883|FG001|Overall Study|Withdrawal by Subject|0|||
37703010|NCT01752634|69180618|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
37703011|NCT01752634|69180619|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
37703012|NCT01752634|69180620|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
37703013|NCT01752634|69180621|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
37703014|NCT01752634|69180622|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
37703015|NCT01752634|69180617|FG000|Week 24 to Week 260|Physician Decision|1|||
37703016|NCT01752634|69180618|FG001|Week 24 to Week 260|Physician Decision|2|||
37703017|NCT01752634|69180619|FG002|Week 24 to Week 260|Physician Decision|4|||
37703018|NCT01752634|69180620|FG003|Week 24 to Week 260|Physician Decision|2|||
37703019|NCT01752634|69180621|FG004|Week 24 to Week 260|Physician Decision|1|||
37703020|NCT01752634|69180622|FG005|Week 24 to Week 260|Physician Decision|0|||
37703021|NCT01752634|69180617|FG000|Week 24 to Week 260|Death|0|||
37703022|NCT01752634|69180618|FG001|Week 24 to Week 260|Death|1|||
37703023|NCT01752634|69180619|FG002|Week 24 to Week 260|Death|0|||
37703024|NCT01752634|69180620|FG003|Week 24 to Week 260|Death|0|||
37703025|NCT01752634|69180621|FG004|Week 24 to Week 260|Death|0|||
37836793|NCT01212757|69521035|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
37836794|NCT01212757|69521036|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
37836795|NCT01212757|69521037|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
37836796|NCT01212757|69521038|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
37836797|NCT01212757|69521039|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
37836798|NCT01212757|69521031|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
37836799|NCT01212757|69521032|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
37914938|NCT00857415|69601579|FG001|Overall Study|Deceased with no autopsy|0|||
38023675|NCT03751020|69706884|FG002|Overall Study|Withdrawal by Subject|0|||
37703026|NCT01752634|69180622|FG005|Week 24 to Week 260|Death|0|||
37703027|NCT01752634|69180617|FG000|Week 24 to Week 260|Pregnancy|0|||
37703028|NCT01752634|69180618|FG001|Week 24 to Week 260|Pregnancy|0|||
37836800|NCT01212757|69521033|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
37703029|NCT01752634|69180619|FG002|Week 24 to Week 260|Pregnancy|1|||
37703030|NCT01752634|69180620|FG003|Week 24 to Week 260|Pregnancy|0|||
37703031|NCT01752634|69180621|FG004|Week 24 to Week 260|Pregnancy|0|||
37703032|NCT01752634|69180622|FG005|Week 24 to Week 260|Pregnancy|0|||
37703033|NCT01752634|69180617|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
37703034|NCT01752634|69180618|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
37703035|NCT01752634|69180619|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
37703036|NCT01752634|69180620|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
37703037|NCT01752634|69180621|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
37703038|NCT01752634|69180622|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
37703039|NCT01752634|69180617|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
37703040|NCT01752634|69180618|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
37703041|NCT01752634|69180619|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
37703042|NCT01752634|69180620|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
37703043|NCT01752634|69180621|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
37703044|NCT01752634|69180622|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
37703045|NCT01752634|69180617|FG000|Week 24 to Week 260|Adverse Event|4|||
37703046|NCT01752634|69180618|FG001|Week 24 to Week 260|Adverse Event|8|||
37703047|NCT01752634|69180619|FG002|Week 24 to Week 260|Adverse Event|8|||
37703048|NCT01752634|69180620|FG003|Week 24 to Week 260|Adverse Event|4|||
37703049|NCT01752634|69180621|FG004|Week 24 to Week 260|Adverse Event|2|||
37703050|NCT01752634|69180622|FG005|Week 24 to Week 260|Adverse Event|0|||
37703051|NCT01933113|69180632|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
37703052|NCT01726270|69180636|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
37703053|NCT01726270|69180636|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
37703054|NCT01726270|69180636|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
37703055|NCT01726270|69180636|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
37703056|NCT01726270|69180636|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
37703057|NCT01726270|69180636|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
37703058|NCT01914393|69180645|FG000|Overall Study|Protocol Violation|11|||
37703059|NCT01914393|69180646|FG001|Overall Study|Protocol Violation|3|||
37703060|NCT01914393|69180647|FG002|Overall Study|Protocol Violation|19|||
37703061|NCT01914393|69180645|FG000|Overall Study|Lack of Efficacy|11|||
37703062|NCT01914393|69180646|FG001|Overall Study|Lack of Efficacy|16|||
37703063|NCT01914393|69180647|FG002|Overall Study|Lack of Efficacy|5|||
37703064|NCT01914393|69180645|FG000|Overall Study|no reason given|14|||
37703065|NCT01914393|69180646|FG001|Overall Study|no reason given|8|||
37703066|NCT01914393|69180647|FG002|Overall Study|no reason given|16|||
37703067|NCT01914393|69180645|FG000|Overall Study|Adverse Event|29|||
37703068|NCT01914393|69180646|FG001|Overall Study|Adverse Event|18|||
37703069|NCT01914393|69180647|FG002|Overall Study|Adverse Event|31|||
37914939|NCT00532441|69601585|FG000|Overall Study|Death|1|||
37703070|NCT01914393|69180645|FG000|Overall Study|Withdrawal by Subject|38|||
37703071|NCT01914393|69180646|FG001|Overall Study|Withdrawal by Subject|20|||
37703072|NCT01914393|69180647|FG002|Overall Study|Withdrawal by Subject|47|||
37703073|NCT01914393|69180645|FG000|Overall Study|Lost to Follow-up|12|||
37703074|NCT01914393|69180646|FG001|Overall Study|Lost to Follow-up|6|||
37703075|NCT01914393|69180647|FG002|Overall Study|Lost to Follow-up|19|||
37914940|NCT00532441|69601586|FG001|Overall Study|Death|0|||
37703076|NCT01914393|69180645|FG000|Overall Study|subject never dosed|0|||
37703077|NCT01914393|69180646|FG001|Overall Study|subject never dosed|0|||
37703078|NCT01914393|69180647|FG002|Overall Study|subject never dosed|1|||
37703079|NCT01931865|69180659|FG000|Overall Study|Lost to Follow-up|2|||
37703080|NCT01931865|69180659|FG000|Overall Study|Withdrawal by Subject|2|||
37703081|NCT01617447|69180666|FG000|Overall Study|Adverse Event|0|||
37703082|NCT01617447|69180667|FG001|Overall Study|Adverse Event|1|||
37914941|NCT00857259|69601607|FG000|Overall Study|Protocol Violation|1|||
37914942|NCT00857259|69601608|FG001|Overall Study|Protocol Violation|0|||
37914943|NCT00857259|69601609|FG002|Overall Study|Protocol Violation|1|||
37703083|NCT01617447|69180666|FG000|Overall Study|Physician Decision|0|||
37914944|NCT00868608|69601622|FG000|Overall Study|Withdrawal by Subject|3|||
37914945|NCT00868608|69601623|FG001|Overall Study|Withdrawal by Subject|1|||
37703084|NCT01617447|69180667|FG001|Overall Study|Physician Decision|2|||
37703085|NCT00432679|69180675|FG000|Overall Study|Adverse Event|2|||
37703086|NCT00432679|69180676|FG001|Overall Study|Adverse Event|1|||
37703087|NCT00432679|69180675|FG000|Overall Study|Withdrawal by Subject|3|||
37703088|NCT00432679|69180676|FG001|Overall Study|Withdrawal by Subject|2|||
37703089|NCT01600105|69180684|FG000|Total Participants|Withdrawal by Subject|1|||
37703090|NCT01600105|69180685|FG001|Total Participants|Withdrawal by Subject|0|||
37703091|NCT01600105|69180684|FG000|Total Participants|No images in PACS|10|||
37703092|NCT01600105|69180685|FG001|Total Participants|No images in PACS|0|||
37703093|NCT01600105|69180684|FG000|Total Participants|Insufficient image quality|30|||
37703094|NCT01600105|69180685|FG001|Total Participants|Insufficient image quality|10|||
37703095|NCT01600105|69180684|FG000|Sub Study I|Insufficient image quality|0|||
37703096|NCT01600105|69180685|FG001|Sub Study I|Insufficient image quality|10|||
37703097|NCT01600105|69180684|FG000|Sub Study II|Withdrawal by Subject|1|||
37703098|NCT01600105|69180685|FG001|Sub Study II|Withdrawal by Subject|0|||
37703099|NCT01600105|69180684|FG000|Sub Study II|No images in PACS|1|||
37703100|NCT01600105|69180685|FG001|Sub Study II|No images in PACS|0|||
37703101|NCT01600105|69180684|FG000|Sub Study II|Insufficient image quality|3|||
37703102|NCT01600105|69180685|FG001|Sub Study II|Insufficient image quality|0|||
37703103|NCT01600105|69180684|FG000|Sub Study III|Insufficient image quality|5|||
37703104|NCT01600105|69180685|FG001|Sub Study III|Insufficient image quality|0|||
37703105|NCT01600105|69180684|FG000|Sub Study V|Poor Image Quality|2|||
37703106|NCT01600105|69180685|FG001|Sub Study V|Poor Image Quality|0|||
37703107|NCT02246647|69180697|FG000|Overall Study|Withdrawal by Subject|1|||
37703108|NCT02246647|69180698|FG001|Overall Study|Withdrawal by Subject|1|||
37703109|NCT02244619|69180720|FG000|Overall Study|Did not receive study intervention|8|||
37703110|NCT02244619|69180721|FG001|Overall Study|Did not receive study intervention|21|||
37703111|NCT02243371|69180729|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
37703112|NCT02243371|69180730|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
37703113|NCT02243371|69180729|FG000|Overall Study|Death (unrelated)|2|||
37703114|NCT02243371|69180730|FG001|Overall Study|Death (unrelated)|4|||
37703115|NCT02243371|69180729|FG000|Overall Study|Adverse Event (unrelated)|0|||
37703116|NCT02243371|69180730|FG001|Overall Study|Adverse Event (unrelated)|1|||
37703117|NCT02243371|69180729|FG000|Overall Study|Lack of Clinical Benefit|0|||
37703118|NCT02243371|69180730|FG001|Overall Study|Lack of Clinical Benefit|1|||
37703119|NCT02243371|69180729|FG000|Overall Study|Withdrawal by Subject|0|||
37703120|NCT02243371|69180730|FG001|Overall Study|Withdrawal by Subject|2|||
37703121|NCT01931475|69180738|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
37703122|NCT01931475|69180739|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
37703123|NCT01931475|69180738|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
37703124|NCT01931475|69180739|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
37703125|NCT01931475|69180738|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
37703126|NCT01931475|69180739|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
37703127|NCT01931475|69180738|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
37703128|NCT01931475|69180739|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
37703129|NCT01931475|69180738|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
37703130|NCT01931475|69180739|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
37703131|NCT01931475|69180738|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
37703132|NCT01931475|69180739|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
37703133|NCT01931475|69180738|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
37703134|NCT01931475|69180739|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
37703135|NCT01931475|69180738|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
37703136|NCT01931475|69180739|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
37703137|NCT01931475|69180738|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
37703138|NCT01931475|69180739|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
37703139|NCT01931475|69180738|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
37703140|NCT01931475|69180739|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
37703141|NCT01931475|69180738|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
37703142|NCT01931475|69180739|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
37703143|NCT01931397|69180750|FG000|Overall Study|Physician Decision|2|||
37703144|NCT01931397|69180750|FG000|Overall Study|Withdrawal by Subject|8|||
37703145|NCT01931397|69180750|FG000|Overall Study|moved out of state|1|||
37703146|NCT01929993|69180760|FG000|Overall Study|Protocol Violation|4|||
37703147|NCT01929993|69180761|FG001|Overall Study|Protocol Violation|6|||
37703148|NCT01929993|69180760|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
37703149|NCT01929993|69180761|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
37703150|NCT01912599|69180769|FG000|Overall Study|Withdrawal by Subject|0|||
37703151|NCT01912599|69180770|FG001|Overall Study|Withdrawal by Subject|1|||
37703152|NCT01929681|69180778|FG000|Overall Study|Withdrawal by Subject|1|||
37703153|NCT01929681|69180779|FG001|Overall Study|Withdrawal by Subject|0|||
37836801|NCT01212757|69521034|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
37836802|NCT01212757|69521035|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
37836803|NCT01212757|69521036|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
37836804|NCT01212757|69521037|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
37836805|NCT01212757|69521038|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
37836806|NCT01212757|69521039|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
37836807|NCT01212757|69521031|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
37836808|NCT01212757|69521032|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
37836809|NCT01212757|69521033|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
37836810|NCT01212757|69521034|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
37836811|NCT01212757|69521035|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
37836812|NCT01212757|69521036|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
37836813|NCT01212757|69521037|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
37836814|NCT01212757|69521038|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
37836815|NCT01212757|69521039|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
37836816|NCT01212757|69521031|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
37836817|NCT01212757|69521032|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
37836818|NCT01212757|69521033|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
37836819|NCT01212757|69521034|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
37836820|NCT01212757|69521035|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
37836821|NCT01212757|69521036|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
37836822|NCT01212757|69521037|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
37836823|NCT01212757|69521038|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
37836824|NCT01212757|69521039|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
37836825|NCT01212757|69521031|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
37836826|NCT01212757|69521032|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
37836827|NCT01212757|69521033|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
37836828|NCT01212757|69521034|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
37836829|NCT01212757|69521035|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
37836830|NCT01212757|69521036|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
37836831|NCT01212757|69521037|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
37836832|NCT01212757|69521038|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
37836833|NCT01212757|69521039|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
37836834|NCT01190410|69521059|FG000|Overall Study|Adverse Event|0|||
37836835|NCT01190410|69521060|FG001|Overall Study|Adverse Event|3|||
37836836|NCT01190410|69521059|FG000|Overall Study|Lack of Efficacy|0|||
37914946|NCT00868608|69601624|FG002|Overall Study|Withdrawal by Subject|0|||
37914947|NCT00868608|69601622|FG000|Overall Study|Lost to Follow-up|3|||
37914948|NCT00868608|69601623|FG001|Overall Study|Lost to Follow-up|0|||
37914949|NCT00868608|69601624|FG002|Overall Study|Lost to Follow-up|1|||
38023676|NCT03751020|69706882|FG000|Overall Study|Lost to Follow-up|7|||
37703154|NCT01929681|69180778|FG000|Overall Study|Physician Decision|1|||
37703155|NCT01929681|69180779|FG001|Overall Study|Physician Decision|1|||
37836837|NCT01190410|69521060|FG001|Overall Study|Lack of Efficacy|2|||
37836838|NCT01190410|69521059|FG000|Overall Study|Withdrawal by Subject|0|||
37836839|NCT01190410|69521060|FG001|Overall Study|Withdrawal by Subject|2|||
37836840|NCT01190410|69521059|FG000|Overall Study|Administrative decision|1|||
37836841|NCT01190410|69521060|FG001|Overall Study|Administrative decision|0|||
37836842|NCT01190410|69521059|FG000|Overall Study|PI discretion|0|||
37836843|NCT01190410|69521060|FG001|Overall Study|PI discretion|2|||
37836844|NCT01190254|69521075|FG000|Overall Study|Adverse Event|3|||
37836845|NCT01190254|69521076|FG001|Overall Study|Adverse Event|6|||
37836846|NCT01190254|69521077|FG002|Overall Study|Adverse Event|8|||
37836847|NCT01190254|69521075|FG000|Overall Study|Lack of Efficacy|7|||
38023677|NCT03751020|69706883|FG001|Overall Study|Lost to Follow-up|4|||
37703156|NCT01646177|69180789|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
37703157|NCT01646177|69180790|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
37703158|NCT01646177|69180791|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
37703159|NCT01646177|69180792|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
37703160|NCT01646177|69180793|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
37703161|NCT01646177|69180794|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
37703162|NCT01646177|69180795|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
37703163|NCT01646177|69180796|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
37703164|NCT01646177|69180797|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
37703165|NCT01646177|69180798|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
37703166|NCT01646177|69180799|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
37703167|NCT01646177|69180800|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
37703168|NCT01646177|69180789|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
37703169|NCT01646177|69180790|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
37703170|NCT01646177|69180791|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
37703171|NCT01646177|69180792|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
37703172|NCT01646177|69180793|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
37703173|NCT01646177|69180794|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
37703174|NCT01646177|69180795|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
37703175|NCT01646177|69180796|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
37703176|NCT01646177|69180797|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
37703177|NCT01646177|69180798|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
37703178|NCT01646177|69180799|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
37703179|NCT01646177|69180800|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
37703180|NCT01646177|69180789|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
37703181|NCT01646177|69180790|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
37836848|NCT01190254|69521076|FG001|Overall Study|Lack of Efficacy|4|||
38023678|NCT03751020|69706884|FG002|Overall Study|Lost to Follow-up|10|||
38023679|NCT03090100|69706894|FG000|Overall Study|Adverse Event|9|||
38023680|NCT03090100|69706895|FG001|Overall Study|Adverse Event|11|||
38023681|NCT03090100|69706894|FG000|Overall Study|Pregnancy|1|||
38023682|NCT03090100|69706895|FG001|Overall Study|Pregnancy|1|||
38023683|NCT03090100|69706894|FG000|Overall Study|Lack of Efficacy|2|||
38023684|NCT03090100|69706895|FG001|Overall Study|Lack of Efficacy|7|||
38023685|NCT03090100|69706894|FG000|Overall Study|Lost to Follow-up|2|||
38023686|NCT03090100|69706895|FG001|Overall Study|Lost to Follow-up|2|||
38023687|NCT03090100|69706894|FG000|Overall Study|Withdrawal by Subject|7|||
38023688|NCT03090100|69706895|FG001|Overall Study|Withdrawal by Subject|19|||
38023689|NCT03090100|69706894|FG000|Overall Study|Protocol Violation|2|||
38023690|NCT03090100|69706895|FG001|Overall Study|Protocol Violation|6|||
38023691|NCT03090100|69706894|FG000|Overall Study|Non-compliance|2|||
38023692|NCT03090100|69706895|FG001|Overall Study|Non-compliance|0|||
38023693|NCT03090100|69706894|FG000|Overall Study|Other|2|||
38023694|NCT03090100|69706895|FG001|Overall Study|Other|2|||
38023695|NCT03089944|69706901|FG000|Overall Study|Lost to Follow-up|8|||
38023696|NCT03089944|69706901|FG000|Overall Study|Withdrew Consent|2|||
37836849|NCT01190254|69521077|FG002|Overall Study|Lack of Efficacy|5|||
37836850|NCT01190254|69521075|FG000|Overall Study|Lost to Follow-up|4|||
38023697|NCT03089944|69706901|FG000|Overall Study|Adverse Event|1|||
38023698|NCT03089944|69706901|FG000|Overall Study|Other|1|||
38023699|NCT03739866|69706924|FG000|Overall Study|Lost to Follow-up|0|||
38023700|NCT03739866|69706925|FG001|Overall Study|Lost to Follow-up|0|||
37836851|NCT01190254|69521076|FG001|Overall Study|Lost to Follow-up|2|||
38023701|NCT03739866|69706926|FG002|Overall Study|Lost to Follow-up|0|||
38023702|NCT03739866|69706927|FG003|Overall Study|Lost to Follow-up|1|||
37836852|NCT01190254|69521077|FG002|Overall Study|Lost to Follow-up|0|||
37836853|NCT01190254|69521075|FG000|Overall Study|Withdrawal by Subject|4|||
37836854|NCT01190254|69521076|FG001|Overall Study|Withdrawal by Subject|5|||
37836855|NCT01190254|69521077|FG002|Overall Study|Withdrawal by Subject|7|||
37836856|NCT01190254|69521075|FG000|Overall Study|Protocol Violation|2|||
38023703|NCT03739866|69706928|FG004|Overall Study|Lost to Follow-up|0|||
37836857|NCT01190254|69521076|FG001|Overall Study|Protocol Violation|0|||
38023704|NCT03739866|69706929|FG005|Overall Study|Lost to Follow-up|0|||
37703182|NCT01646177|69180791|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
37703183|NCT01646177|69180792|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
37703184|NCT01646177|69180793|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
37703185|NCT01646177|69180794|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
37703186|NCT01646177|69180795|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
37703187|NCT01646177|69180796|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
37703188|NCT01646177|69180797|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
37703189|NCT01646177|69180798|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
37703190|NCT01646177|69180799|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
37703191|NCT01646177|69180800|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
37703192|NCT01646177|69180789|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
37703193|NCT01646177|69180790|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
37703194|NCT01646177|69180791|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
37703195|NCT01646177|69180792|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
37703196|NCT01646177|69180793|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
37703197|NCT01646177|69180794|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
37703198|NCT01646177|69180795|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
37703199|NCT01646177|69180796|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
37703200|NCT01646177|69180797|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
37703201|NCT01646177|69180798|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
37703202|NCT01646177|69180799|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
37703203|NCT01646177|69180800|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
37703204|NCT01646177|69180789|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
37703205|NCT01646177|69180790|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
37703206|NCT01646177|69180791|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
37703207|NCT01646177|69180792|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
37703208|NCT01646177|69180793|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
37703209|NCT01646177|69180794|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
37703210|NCT01646177|69180795|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
37703211|NCT01646177|69180796|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
37703212|NCT01646177|69180797|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
37703213|NCT01646177|69180798|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
37703214|NCT01646177|69180799|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
37703215|NCT01646177|69180800|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
37703216|NCT01646177|69180789|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
37703217|NCT01646177|69180790|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
37703218|NCT01646177|69180791|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
37703219|NCT01646177|69180792|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
37703220|NCT01646177|69180793|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
37836858|NCT01190254|69521077|FG002|Overall Study|Protocol Violation|2|||
37836859|NCT01190254|69521075|FG000|Overall Study|Did not meet protocol eligibility|1|||
37836860|NCT01190254|69521076|FG001|Overall Study|Did not meet protocol eligibility|0|||
37836861|NCT01190254|69521077|FG002|Overall Study|Did not meet protocol eligibility|0|||
37836862|NCT01190839|69521087|FG000|Overall Study|Adverse Event|32|||
38023705|NCT03739866|69706930|FG006|Overall Study|Lost to Follow-up|0|||
38023706|NCT03739866|69706931|FG007|Overall Study|Lost to Follow-up|0|||
37836863|NCT01190839|69521088|FG001|Overall Study|Adverse Event|41|||
37836864|NCT01190839|69521087|FG000|Overall Study|Protocol Violation|2|||
37836865|NCT01190839|69521088|FG001|Overall Study|Protocol Violation|2|||
37836866|NCT01190839|69521087|FG000|Overall Study|Lost to Follow-up|7|||
37836867|NCT01190839|69521088|FG001|Overall Study|Lost to Follow-up|1|||
37836868|NCT01190839|69521087|FG000|Overall Study|Death|1|||
37836869|NCT01190839|69521088|FG001|Overall Study|Death|0|||
37914950|NCT00868608|69601622|FG000|Overall Study|Death|16|||
37914951|NCT00868608|69601623|FG001|Overall Study|Death|2|||
37836870|NCT01190839|69521087|FG000|Overall Study|Trial stopped by Sponsor|71|||
37836871|NCT01190839|69521088|FG001|Overall Study|Trial stopped by Sponsor|68|||
37836872|NCT01190839|69521087|FG000|Overall Study|Undefined|35|||
37836873|NCT01190839|69521088|FG001|Overall Study|Undefined|31|||
37836874|NCT01190839|69521087|FG000|Overall Study|Randomized but not treated|2|||
37836875|NCT01190839|69521088|FG001|Overall Study|Randomized but not treated|4|||
37836876|NCT01190215|69521098|FG000|Up to Month 6|Lost to Follow-up|2|||
37836877|NCT01190215|69521099|FG001|Up to Month 6|Lost to Follow-up|0|||
37836878|NCT01190449|69521107|FG000|Overall Study|Ineligible|0|||
37836879|NCT01190449|69521108|FG001|Overall Study|Ineligible|4|||
37836880|NCT01190176|69521114|FG000|Overall Study|Withdrawal by Subject|1|||
37836881|NCT01190176|69521114|FG000|Overall Study|Lost to Follow-up|1|||
37836882|NCT01190098|69521120|FG000|Overall Study|Adverse Event|2|||
37836883|NCT01190098|69521121|FG001|Overall Study|Adverse Event|0|||
37836884|NCT01190098|69521120|FG000|Overall Study|Patient coomorbidity|0|||
37836885|NCT01190098|69521121|FG001|Overall Study|Patient coomorbidity|1|||
37836886|NCT01190098|69521120|FG000|Overall Study|Lack of transportation|1|||
37836887|NCT01190098|69521121|FG001|Overall Study|Lack of transportation|0|||
37836888|NCT01190098|69521120|FG000|Overall Study|Other|0|||
37836889|NCT01190098|69521121|FG001|Overall Study|Other|1|||
37836890|NCT01190020|69521129|FG000|Overall Study|Adverse Event|2|||
37836891|NCT01190020|69521130|FG001|Overall Study|Adverse Event|0|||
37836892|NCT01190020|69521129|FG000|Overall Study|Lost to Follow-up|2|||
37836893|NCT01190020|69521130|FG001|Overall Study|Lost to Follow-up|0|||
37836894|NCT01190020|69521129|FG000|Overall Study|Withdrawal by Subject|3|||
37836895|NCT01190020|69521130|FG001|Overall Study|Withdrawal by Subject|0|||
37836896|NCT01189435|69521136|FG000|Overall Study|Withdrawal by Subject|1|||
37836897|NCT01189435|69521136|FG000|Overall Study|Physician Decision|1|||
37836898|NCT01165996|69521140|FG000|Overall Study|Death|1|||
37836899|NCT01165996|69521140|FG000|Overall Study|Physician Decision|1|||
37836900|NCT01165684|69521147|FG000|Overall Study|Adverse Event|1|||
37836901|NCT01165684|69521148|FG001|Overall Study|Adverse Event|1|||
37836902|NCT01165684|69521147|FG000|Overall Study|Lack of Efficacy|2|||
37836903|NCT01165684|69521148|FG001|Overall Study|Lack of Efficacy|1|||
37836904|NCT01165684|69521147|FG000|Overall Study|Protocol Violation|7|||
37836905|NCT01165684|69521148|FG001|Overall Study|Protocol Violation|15|||
37836906|NCT01165684|69521147|FG000|Overall Study|Withdrawal Criteria|2|||
37836907|NCT01165684|69521148|FG001|Overall Study|Withdrawal Criteria|13|||
37836908|NCT01165684|69521147|FG000|Overall Study|Unclassified|16|||
37836909|NCT01165684|69521148|FG001|Overall Study|Unclassified|22|||
37836910|NCT01189201|69521154|FG000|Overall Study|Adverse Event|1|||
37836911|NCT01188967|69521171|FG000|Overall Study|Withdrawal by Subject|1|||
37836912|NCT01188967|69521172|FG001|Overall Study|Withdrawal by Subject|1|||
37836913|NCT01188967|69521171|FG000|Overall Study|Physician Decision|1|||
37836914|NCT01188967|69521172|FG001|Overall Study|Physician Decision|1|||
37836915|NCT01188967|69521171|FG000|Overall Study|Lost to Follow-up|3|||
37836916|NCT01188967|69521172|FG001|Overall Study|Lost to Follow-up|2|||
37836917|NCT01188811|69521182|FG000|Overall Study|Withdrawal by Subject|0|||
37836918|NCT01188811|69521183|FG001|Overall Study|Withdrawal by Subject|2|||
37836919|NCT01188811|69521182|FG000|Overall Study|Adverse Event|6|||
37836920|NCT01188811|69521183|FG001|Overall Study|Adverse Event|0|||
37836921|NCT01183234|69521191|FG000|First Intervention|Adverse Event|1|||
37836922|NCT01183234|69521192|FG001|First Intervention|Adverse Event|0|||
37836923|NCT01165216|69521200|FG000|Overall Study|Adverse Event|6|||
38023707|NCT03739866|69706924|FG000|Overall Study|Enrolled but not treated|0|||
37836924|NCT01165216|69521201|FG001|Overall Study|Adverse Event|3|||
37914952|NCT00868608|69601624|FG002|Overall Study|Death|4|||
37836925|NCT01165216|69521200|FG000|Overall Study|Withdrawal by Subject|1|||
37836926|NCT01165216|69521201|FG001|Overall Study|Withdrawal by Subject|1|||
37836927|NCT01165216|69521200|FG000|Overall Study|Disease progression|1|||
37836928|NCT01165216|69521201|FG001|Overall Study|Disease progression|3|||
37836929|NCT04545476|69521226|FG000|Overall Study|Lost to Follow-up|1|||
37836930|NCT04545476|69521227|FG001|Overall Study|Lost to Follow-up|1|||
37836931|NCT04545476|69521228|FG002|Overall Study|Lost to Follow-up|0|||
37836932|NCT04545476|69521229|FG003|Overall Study|Lost to Follow-up|0|||
37836933|NCT01969838|69521244|FG000|Double-blind Phase|Adverse Event|10|||
37914953|NCT00868608|69601622|FG000|Overall Study|Other - Unspecified|1|||
37703221|NCT01646177|69180794|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
37703222|NCT01646177|69180795|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
37703223|NCT01646177|69180796|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
37703224|NCT01646177|69180797|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
37703225|NCT01646177|69180798|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
37703226|NCT01646177|69180799|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
37703227|NCT01646177|69180800|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
37703228|NCT01646177|69180789|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
37703229|NCT01646177|69180790|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
37703230|NCT01646177|69180791|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
37703231|NCT01646177|69180792|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
37703232|NCT01646177|69180793|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
37703233|NCT01646177|69180794|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
37703234|NCT01646177|69180795|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
37703235|NCT01646177|69180796|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
37703236|NCT01646177|69180797|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
37703237|NCT01646177|69180798|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
37703238|NCT01646177|69180799|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
37703239|NCT01646177|69180800|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
37703240|NCT01646177|69180789|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
37836934|NCT01969838|69521245|FG001|Double-blind Phase|Adverse Event|4|||
37836935|NCT01969838|69521246|FG002|Double-blind Phase|Adverse Event|0|||
37836936|NCT01969838|69521247|FG003|Double-blind Phase|Adverse Event|0|||
37836937|NCT01969838|69521244|FG000|Double-blind Phase|Death|5|||
37836938|NCT01969838|69521245|FG001|Double-blind Phase|Death|2|||
37836939|NCT01969838|69521246|FG002|Double-blind Phase|Death|0|||
37836940|NCT01969838|69521247|FG003|Double-blind Phase|Death|0|||
37836941|NCT01969838|69521244|FG000|Double-blind Phase|Physician Decision|5|||
37836942|NCT01969838|69521245|FG001|Double-blind Phase|Physician Decision|1|||
37836943|NCT01969838|69521246|FG002|Double-blind Phase|Physician Decision|0|||
37836944|NCT01969838|69521247|FG003|Double-blind Phase|Physician Decision|0|||
37836945|NCT01969838|69521244|FG000|Double-blind Phase|Subject Decision|4|||
37836946|NCT01969838|69521245|FG001|Double-blind Phase|Subject Decision|2|||
37836947|NCT01969838|69521246|FG002|Double-blind Phase|Subject Decision|0|||
37836948|NCT01969838|69521247|FG003|Double-blind Phase|Subject Decision|0|||
37836949|NCT01969838|69521244|FG000|Double-blind Phase|Disease Progression|2|||
37836950|NCT01969838|69521245|FG001|Double-blind Phase|Disease Progression|0|||
37836951|NCT01969838|69521246|FG002|Double-blind Phase|Disease Progression|0|||
37836952|NCT01969838|69521247|FG003|Double-blind Phase|Disease Progression|0|||
37836953|NCT01969838|69521244|FG000|Double-blind Phase|Symptomatic Spleen Growth|1|||
37836954|NCT01969838|69521245|FG001|Double-blind Phase|Symptomatic Spleen Growth|0|||
37836955|NCT01969838|69521246|FG002|Double-blind Phase|Symptomatic Spleen Growth|0|||
37836956|NCT01969838|69521247|FG003|Double-blind Phase|Symptomatic Spleen Growth|0|||
37836957|NCT01969838|69521244|FG000|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
37836958|NCT01969838|69521245|FG001|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
37836959|NCT01969838|69521246|FG002|Open-label Phase|Transferred to study SRA-MMB-4365|52|||
37836960|NCT01969838|69521247|FG003|Open-label Phase|Transferred to study SRA-MMB-4365|62|||
37836961|NCT01969838|69521244|FG000|Open-label Phase|Adverse Event|0|||
37836962|NCT01969838|69521245|FG001|Open-label Phase|Adverse Event|0|||
37836963|NCT01969838|69521246|FG002|Open-label Phase|Adverse Event|37|||
37836964|NCT01969838|69521247|FG003|Open-label Phase|Adverse Event|49|||
37836965|NCT01969838|69521244|FG000|Open-label Phase|Disease Progression|0|||
37836966|NCT01969838|69521245|FG001|Open-label Phase|Disease Progression|0|||
37836967|NCT01969838|69521246|FG002|Open-label Phase|Disease Progression|26|||
37836968|NCT01969838|69521247|FG003|Open-label Phase|Disease Progression|27|||
37836969|NCT01969838|69521244|FG000|Open-label Phase|Lack of Efficacy|0|||
37836970|NCT01969838|69521245|FG001|Open-label Phase|Lack of Efficacy|0|||
37836971|NCT01969838|69521246|FG002|Open-label Phase|Lack of Efficacy|17|||
37836972|NCT01969838|69521247|FG003|Open-label Phase|Lack of Efficacy|19|||
37836973|NCT01969838|69521244|FG000|Open-label Phase|Subject Decision|0|||
37703241|NCT01646177|69180790|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
37703242|NCT01646177|69180791|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
37703243|NCT01646177|69180792|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
37836974|NCT01969838|69521245|FG001|Open-label Phase|Subject Decision|0|||
37836975|NCT01969838|69521246|FG002|Open-label Phase|Subject Decision|14|||
37836976|NCT01969838|69521247|FG003|Open-label Phase|Subject Decision|15|||
37836977|NCT01969838|69521244|FG000|Open-label Phase|Death|0|||
37836978|NCT01969838|69521245|FG001|Open-label Phase|Death|0|||
37836979|NCT01969838|69521246|FG002|Open-label Phase|Death|13|||
37836980|NCT01969838|69521247|FG003|Open-label Phase|Death|11|||
37836981|NCT01969838|69521244|FG000|Open-label Phase|Physician Decision|0|||
37836982|NCT01969838|69521245|FG001|Open-label Phase|Physician Decision|0|||
37836983|NCT01969838|69521246|FG002|Open-label Phase|Physician Decision|9|||
37836984|NCT01969838|69521247|FG003|Open-label Phase|Physician Decision|14|||
37836985|NCT01969838|69521244|FG000|Open-label Phase|Non-compliance with Study Drug|0|||
37836986|NCT01969838|69521245|FG001|Open-label Phase|Non-compliance with Study Drug|0|||
37836987|NCT01969838|69521246|FG002|Open-label Phase|Non-compliance with Study Drug|2|||
37836988|NCT01969838|69521247|FG003|Open-label Phase|Non-compliance with Study Drug|0|||
37836989|NCT01165177|69521258|FG000|Overall Study|Serious Adverse Event|227|||
37836990|NCT01165177|69521259|FG001|Overall Study|Serious Adverse Event|235|||
37836991|NCT01165177|69521258|FG000|Overall Study|Withdrawal by Subject|368|||
37836992|NCT01165177|69521259|FG001|Overall Study|Withdrawal by Subject|354|||
37836993|NCT01165177|69521258|FG000|Overall Study|Protocol Violation|19|||
37836994|NCT01165177|69521259|FG001|Overall Study|Protocol Violation|21|||
37836995|NCT01165177|69521258|FG000|Overall Study|Non-serious adverse event|30|||
37836996|NCT01165177|69521259|FG001|Overall Study|Non-serious adverse event|18|||
37836997|NCT01165177|69521258|FG000|Overall Study|Other unspecified reasons|47|||
37836998|NCT01165177|69521259|FG001|Overall Study|Other unspecified reasons|35|||
37836999|NCT01165177|69521258|FG000|Overall Study|Suspected HZ episode|0|||
37837000|NCT01165177|69521259|FG001|Overall Study|Suspected HZ episode|2|||
37837001|NCT01165177|69521258|FG000|Overall Study|Lost to Follow-up|183|||
37837002|NCT01165177|69521259|FG001|Overall Study|Lost to Follow-up|194|||
37837003|NCT01165177|69521258|FG000|Overall Study|Migrated/ moved from study area|48|||
37837004|NCT01165177|69521259|FG001|Overall Study|Migrated/ moved from study area|43|||
37914954|NCT00868608|69601623|FG001|Overall Study|Other - Unspecified|0|||
37914955|NCT00868608|69601624|FG002|Overall Study|Other - Unspecified|0|||
37914956|NCT00856635|69601634|FG000|Overall Study|Lost to Follow-up|2|||
38023708|NCT03739866|69706925|FG001|Overall Study|Enrolled but not treated|0|||
38023709|NCT03739866|69706926|FG002|Overall Study|Enrolled but not treated|1|||
38023710|NCT03739866|69706927|FG003|Overall Study|Enrolled but not treated|0|||
38023711|NCT03739866|69706928|FG004|Overall Study|Enrolled but not treated|1|||
38023712|NCT03739866|69706929|FG005|Overall Study|Enrolled but not treated|0|||
38023713|NCT03739866|69706930|FG006|Overall Study|Enrolled but not treated|0|||
38023714|NCT03739866|69706931|FG007|Overall Study|Enrolled but not treated|0|||
38023715|NCT03739242|69706955|FG000|Overall Study|Withdrawal by Subject|1|||
38023716|NCT03739242|69706956|FG001|Overall Study|Withdrawal by Subject|1|||
38023717|NCT03739242|69706955|FG000|Overall Study|Protocol Violation|0|||
38023718|NCT03739242|69706956|FG001|Overall Study|Protocol Violation|1|||
38023719|NCT02849626|69707013|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
38023720|NCT02849626|69707014|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
38023721|NCT02849626|69707015|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
38023722|NCT02849626|69707016|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
38023723|NCT02849626|69707013|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
38023724|NCT02849626|69707014|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
38023725|NCT02849626|69707015|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
38023726|NCT02849626|69707016|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
38023727|NCT02849626|69707013|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
38023728|NCT02849626|69707014|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
38023729|NCT02849626|69707015|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
38023730|NCT02849626|69707016|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
38023731|NCT02849626|69707013|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
38023732|NCT02849626|69707014|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
38023733|NCT02849626|69707015|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
38023734|NCT02849626|69707016|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
37703244|NCT01646177|69180793|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
37703245|NCT01646177|69180794|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
37837005|NCT01165138|69521276|FG000|Overall Study|Adverse Event|0|||
37837006|NCT01165138|69521277|FG001|Overall Study|Adverse Event|1|||
37837007|NCT01165138|69521278|FG002|Overall Study|Adverse Event|0|||
37914957|NCT00856635|69601635|FG001|Overall Study|Lost to Follow-up|5|||
37914958|NCT00856635|69601634|FG000|Overall Study|Pregnancy|1|||
37914959|NCT00856635|69601635|FG001|Overall Study|Pregnancy|0|||
37914960|NCT00856635|69601634|FG000|Overall Study|Withdrawal by Subject|3|||
38023735|NCT02849626|69707013|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
38023736|NCT02849626|69707014|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
38023737|NCT02849626|69707015|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
38023738|NCT02849626|69707016|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
38023739|NCT02849626|69707013|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
38023740|NCT02849626|69707014|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
38023741|NCT02849626|69707015|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
38023742|NCT02849626|69707016|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
37837008|NCT01165138|69521279|FG003|Overall Study|Adverse Event|2|||
37837009|NCT01165138|69521276|FG000|Overall Study|Lack of Efficacy|0|||
37914961|NCT00856635|69601635|FG001|Overall Study|Withdrawal by Subject|1|||
37837010|NCT01165138|69521277|FG001|Overall Study|Lack of Efficacy|32|||
37914962|NCT00856635|69601634|FG000|Overall Study|Serious Adverse Event|1|||
37837011|NCT01165138|69521278|FG002|Overall Study|Lack of Efficacy|6|||
37837012|NCT01165138|69521279|FG003|Overall Study|Lack of Efficacy|7|||
37837013|NCT01165138|69521276|FG000|Overall Study|Protocol Violation|0|||
37837014|NCT01165138|69521277|FG001|Overall Study|Protocol Violation|7|||
37837015|NCT01165138|69521278|FG002|Overall Study|Protocol Violation|0|||
37837016|NCT01165138|69521279|FG003|Overall Study|Protocol Violation|2|||
37837017|NCT01165138|69521276|FG000|Overall Study|Lost to Follow-up|0|||
37837018|NCT01165138|69521277|FG001|Overall Study|Lost to Follow-up|0|||
37837019|NCT01165138|69521278|FG002|Overall Study|Lost to Follow-up|1|||
38023743|NCT02849626|69707013|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
37914963|NCT00856635|69601635|FG001|Overall Study|Serious Adverse Event|0|||
37914964|NCT00856635|69601634|FG000|Overall Study|Other|1|||
37914965|NCT00856635|69601635|FG001|Overall Study|Other|0|||
37914966|NCT00856635|69601634|FG000|Overall Study|Discontinued at Randomization|2|||
37914967|NCT00856635|69601635|FG001|Overall Study|Discontinued at Randomization|2|||
37914968|NCT00856557|69601645|FG000|Overall Study|No patients with contextual flags|12|||
37914969|NCT00856557|69601646|FG001|Overall Study|No patients with contextual flags|16|||
37914970|NCT00856323|69601652|FG000|Overall Study|Withdrawal by Subject|2|||
37914971|NCT00856245|69601660|FG000|Overall Study|Was not transplanted|5|||
37914972|NCT00855933|69601666|FG000|Overall Study|Withdrawal by Subject|0|||
37914973|NCT00855933|69601667|FG001|Overall Study|Withdrawal by Subject|1|||
37914974|NCT00871572|69601677|FG000|Overall Study|Adverse Event|0|||
37914975|NCT00871572|69601678|FG001|Overall Study|Adverse Event|2|||
37914976|NCT00871572|69601679|FG002|Overall Study|Adverse Event|0|||
37914977|NCT00871572|69601680|FG003|Overall Study|Adverse Event|3|||
37914978|NCT00871572|69601677|FG000|Overall Study|Investigator Decision|0|||
37914979|NCT00871572|69601678|FG001|Overall Study|Investigator Decision|1|||
37914980|NCT00871572|69601679|FG002|Overall Study|Investigator Decision|0|||
37914981|NCT00871572|69601680|FG003|Overall Study|Investigator Decision|1|||
37914982|NCT00871572|69601677|FG000|Overall Study|Lost to Follow-up|0|||
37914983|NCT00871572|69601678|FG001|Overall Study|Lost to Follow-up|1|||
37914984|NCT00871572|69601679|FG002|Overall Study|Lost to Follow-up|0|||
37914985|NCT00871572|69601680|FG003|Overall Study|Lost to Follow-up|1|||
37914986|NCT00871572|69601677|FG000|Overall Study|Protocol Violation|0|||
37914987|NCT00871572|69601678|FG001|Overall Study|Protocol Violation|0|||
37914988|NCT00871572|69601679|FG002|Overall Study|Protocol Violation|1|||
38023744|NCT02849626|69707014|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
38023745|NCT02849626|69707015|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
38023746|NCT02849626|69707016|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
37837020|NCT01165138|69521279|FG003|Overall Study|Lost to Follow-up|2|||
37837021|NCT01165138|69521276|FG000|Overall Study|Physician Decision|0|||
37837022|NCT01165138|69521277|FG001|Overall Study|Physician Decision|6|||
37837023|NCT01165138|69521278|FG002|Overall Study|Physician Decision|7|||
37837024|NCT01165138|69521279|FG003|Overall Study|Physician Decision|6|||
37837025|NCT01165138|69521276|FG000|Overall Study|Withdrawal by Subject|0|||
37837026|NCT01165138|69521277|FG001|Overall Study|Withdrawal by Subject|6|||
37837027|NCT01165138|69521278|FG002|Overall Study|Withdrawal by Subject|6|||
37837028|NCT01165138|69521279|FG003|Overall Study|Withdrawal by Subject|3|||
37837029|NCT01165021|69521287|FG000|Overall Study|Death|1|||
37837030|NCT01182844|69521293|FG000|Overall Study|Withdrawal by Subject|0|||
37837031|NCT01182844|69521294|FG001|Overall Study|Withdrawal by Subject|2|||
37837032|NCT01164865|69521302|FG000|Overall Study|Lost to Follow-up|2|||
37837033|NCT01164865|69521303|FG001|Overall Study|Lost to Follow-up|1|||
37837034|NCT01164475|69521311|FG000|Overall Study|Lack of Efficacy|1|||
37837035|NCT01164475|69521312|FG001|Overall Study|Lack of Efficacy|0|||
37837036|NCT01164475|69521311|FG000|Overall Study|Other|0|||
37837037|NCT01164475|69521312|FG001|Overall Study|Other|1|||
37837038|NCT01164475|69521311|FG000|Overall Study|Progressive disease|0|||
37837039|NCT01164475|69521312|FG001|Overall Study|Progressive disease|1|||
37837040|NCT01164475|69521311|FG000|Overall Study|Protocol Violation|1|||
37837041|NCT01164475|69521312|FG001|Overall Study|Protocol Violation|0|||
37837042|NCT01164007|69521318|FG000|Overall Study|Adverse Event|5|||
37837043|NCT01164007|69521318|FG000|Overall Study|Progression of Disease|30|||
37837044|NCT01164007|69521318|FG000|Overall Study|Protocol Violation|1|||
37914989|NCT00871572|69601680|FG003|Overall Study|Protocol Violation|1|||
37914990|NCT00871572|69601677|FG000|Overall Study|Sponsor Decision|1|||
37914991|NCT00871572|69601678|FG001|Overall Study|Sponsor Decision|0|||
37914992|NCT00871572|69601679|FG002|Overall Study|Sponsor Decision|0|||
37914993|NCT00871572|69601680|FG003|Overall Study|Sponsor Decision|0|||
37914994|NCT00871572|69601677|FG000|Overall Study|Withdrawal by Subject|1|||
37837045|NCT01164007|69521318|FG000|Overall Study|Withdrawal by Subject|1|||
37837046|NCT01164007|69521318|FG000|Overall Study|Medical Decision|3|||
37837047|NCT01163851|69521324|FG000|Overall Study|Site Closure|0|||
37837048|NCT01163851|69521325|FG001|Overall Study|Site Closure|1|||
37837049|NCT01163851|69521324|FG000|Overall Study|Enrolled but not treated|1|||
37837050|NCT01163851|69521325|FG001|Overall Study|Enrolled but not treated|0|||
37914995|NCT00871572|69601678|FG001|Overall Study|Withdrawal by Subject|2|||
37837051|NCT01163617|69521331|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
37837052|NCT01163617|69521332|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
37837053|NCT01163617|69521333|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
37914996|NCT00871572|69601679|FG002|Overall Study|Withdrawal by Subject|3|||
37914997|NCT00871572|69601680|FG003|Overall Study|Withdrawal by Subject|1|||
37914998|NCT03885661|69601692|FG000|Overall Study|Withdrawal by Subject|0|||
37914999|NCT03885661|69601693|FG001|Overall Study|Withdrawal by Subject|1|||
37915000|NCT03885661|69601692|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
37915001|NCT03885661|69601693|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
37915002|NCT00868530|69601699|FG000|Overall Study|Adverse Event|3|||
37915003|NCT00868530|69601699|FG000|Overall Study|Lost to Follow-up|1|||
37915004|NCT00598442|69601706|FG000|Overall Study|Adverse Event|3|||
37915005|NCT00598442|69601707|FG001|Overall Study|Adverse Event|0|||
37915006|NCT00598442|69601708|FG002|Overall Study|Adverse Event|0|||
37915007|NCT00598442|69601706|FG000|Overall Study|Death|19|||
37915008|NCT00598442|69601707|FG001|Overall Study|Death|11|||
37915009|NCT00598442|69601708|FG002|Overall Study|Death|11|||
37915010|NCT00598442|69601706|FG000|Overall Study|Lost to Follow-up|4|||
37915011|NCT00598442|69601707|FG001|Overall Study|Lost to Follow-up|3|||
37915012|NCT00598442|69601708|FG002|Overall Study|Lost to Follow-up|3|||
37915013|NCT00598442|69601706|FG000|Overall Study|Physician Decision|2|||
37915014|NCT00598442|69601707|FG001|Overall Study|Physician Decision|1|||
37915015|NCT00598442|69601708|FG002|Overall Study|Physician Decision|1|||
37915016|NCT00598442|69601706|FG000|Overall Study|Withdrawal by Subject|8|||
37915017|NCT00598442|69601707|FG001|Overall Study|Withdrawal by Subject|16|||
37915018|NCT00598442|69601708|FG002|Overall Study|Withdrawal by Subject|6|||
38023747|NCT02849626|69707013|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
38023748|NCT02849626|69707014|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
37837054|NCT01163617|69521334|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
37837055|NCT01163617|69521335|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
37837056|NCT01163617|69521336|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
37837057|NCT01163617|69521337|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
37837058|NCT01163617|69521338|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
37837059|NCT01163617|69521331|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
37837060|NCT01163617|69521332|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
37837061|NCT01163617|69521333|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
37837062|NCT01163617|69521334|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
37837063|NCT01163617|69521335|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
37837064|NCT01163617|69521336|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
37837065|NCT01163617|69521337|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
37837066|NCT01163617|69521338|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
37837067|NCT01163617|69521331|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
37837068|NCT01163617|69521332|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
37837069|NCT01163617|69521333|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
37837070|NCT01163617|69521334|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
37837071|NCT01163617|69521335|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
37837072|NCT01163617|69521336|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
37837073|NCT01163617|69521337|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
37837074|NCT01163617|69521338|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
37837075|NCT01182337|69521360|FG000|Overall Study|Withdrawal by Subject|3|||
37915019|NCT00598442|69601706|FG000|Overall Study|Noncompliance|0|||
37915020|NCT00598442|69601707|FG001|Overall Study|Noncompliance|2|||
37915021|NCT00598442|69601708|FG002|Overall Study|Noncompliance|1|||
37915022|NCT00598442|69601706|FG000|Overall Study|Relocation|1|||
38023749|NCT02849626|69707015|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
38023750|NCT02849626|69707016|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
37915023|NCT00598442|69601707|FG001|Overall Study|Relocation|4|||
37915024|NCT00598442|69601708|FG002|Overall Study|Relocation|0|||
38023751|NCT02849626|69707013|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
37703246|NCT01646177|69180795|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
37837076|NCT01182337|69521361|FG001|Overall Study|Withdrawal by Subject|1|||
37837077|NCT01182337|69521360|FG000|Overall Study|Lost to Follow-up|0|||
37837078|NCT01182337|69521361|FG001|Overall Study|Lost to Follow-up|1|||
38023752|NCT02849626|69707014|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
38023753|NCT02849626|69707015|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
38023754|NCT02849626|69707016|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
38023755|NCT02849626|69707013|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
38023756|NCT02849626|69707014|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
38023757|NCT02849626|69707015|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
38023758|NCT02849626|69707016|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
38023759|NCT02849626|69707013|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
38023760|NCT02849626|69707014|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
38023761|NCT02849626|69707015|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
38023762|NCT02849626|69707016|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
38023763|NCT03735498|69707034|FG000|Overall Study|Withdrawal by Subject|5|||
38023764|NCT03735498|69707034|FG000|Overall Study|one participant only completed 5 of 6 sessions|1|||
38023765|NCT02659540|69707040|FG000|Overall Study|Adverse Event|3|||
38023766|NCT02659540|69707041|FG001|Overall Study|Adverse Event|2|||
38023767|NCT02659540|69707040|FG000|Overall Study|Death|1|||
38023768|NCT02659540|69707041|FG001|Overall Study|Death|0|||
38023769|NCT02659540|69707040|FG000|Overall Study|Progressive disease|2|||
38023770|NCT02659540|69707041|FG001|Overall Study|Progressive disease|6|||
38023771|NCT01097746|69707047|FG000|Overall Study|Adverse Event|4|||
38023772|NCT01097746|69707047|FG000|Overall Study|taken off study before any treatment given|1|||
38023773|NCT03733470|69707077|FG000|Overall Study|PI Decision|1|||
38023774|NCT03733470|69707078|FG001|Overall Study|PI Decision|1|||
38023775|NCT03732534|69707084|FG000|Overall Study|Study terminated by Sponsor|6|||
38023776|NCT03087058|69707090|FG000|Overall Study|Withdrawal by Subject|2|||
38023777|NCT03087058|69707091|FG001|Overall Study|Withdrawal by Subject|0|||
38023778|NCT03087058|69707092|FG002|Overall Study|Withdrawal by Subject|0|||
38023779|NCT03726996|69707099|FG000|Overall Study|Parent's decision|2|||
38023780|NCT03726996|69707099|FG000|Overall Study|Study early termination|2|||
38023781|NCT03882970|69707107|FG000|Overall Study|Adverse Event|5|||
38023782|NCT03882970|69707108|FG001|Overall Study|Adverse Event|7|||
37837079|NCT01182298|69521368|FG000|Overall Study|Lack of Efficacy|4|||
37837080|NCT01182298|69521368|FG000|Overall Study|Withdrawal by Subject|2|||
37837081|NCT01163266|69521375|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
37837082|NCT01163266|69521376|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
37837083|NCT01163266|69521377|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
37837084|NCT01163266|69521375|FG000|Overall Study|Lack of Efficacy|1|||
37837085|NCT01163266|69521376|FG001|Overall Study|Lack of Efficacy|3|||
38023783|NCT03882970|69707109|FG002|Overall Study|Adverse Event|3|||
38023784|NCT03882970|69707110|FG003|Overall Study|Adverse Event|1|||
38023785|NCT03882970|69707107|FG000|Overall Study|Death|1|||
38023786|NCT03882970|69707108|FG001|Overall Study|Death|2|||
38023787|NCT03882970|69707109|FG002|Overall Study|Death|1|||
38023788|NCT03882970|69707110|FG003|Overall Study|Death|1|||
38023789|NCT03882970|69707107|FG000|Overall Study|Lost to Follow-up|8|||
38023790|NCT03882970|69707108|FG001|Overall Study|Lost to Follow-up|9|||
38023791|NCT03882970|69707109|FG002|Overall Study|Lost to Follow-up|5|||
38023792|NCT03882970|69707110|FG003|Overall Study|Lost to Follow-up|5|||
38023793|NCT03882970|69707107|FG000|Overall Study|Physician Decision|0|||
38023794|NCT03882970|69707108|FG001|Overall Study|Physician Decision|2|||
38023795|NCT03882970|69707109|FG002|Overall Study|Physician Decision|2|||
38023796|NCT03882970|69707110|FG003|Overall Study|Physician Decision|2|||
38023797|NCT03882970|69707107|FG000|Overall Study|Protocol Violation|2|||
38023798|NCT03882970|69707108|FG001|Overall Study|Protocol Violation|0|||
38023799|NCT03882970|69707109|FG002|Overall Study|Protocol Violation|0|||
38023800|NCT03882970|69707110|FG003|Overall Study|Protocol Violation|0|||
38023801|NCT03882970|69707107|FG000|Overall Study|Withdrawal by Subject|8|||
38023802|NCT03882970|69707108|FG001|Overall Study|Withdrawal by Subject|17|||
38023803|NCT03882970|69707109|FG002|Overall Study|Withdrawal by Subject|7|||
37837086|NCT01163266|69521377|FG002|Overall Study|Lack of Efficacy|1|||
37837087|NCT01163266|69521375|FG000|Overall Study|Noncompliance with Study Drug|0|||
37837088|NCT01163266|69521376|FG001|Overall Study|Noncompliance with Study Drug|2|||
37837089|NCT01163266|69521377|FG002|Overall Study|Noncompliance with Study Drug|0|||
37837090|NCT01163266|69521375|FG000|Overall Study|Protocol Deviations|2|||
37837091|NCT01163266|69521376|FG001|Overall Study|Protocol Deviations|2|||
37837092|NCT01163266|69521377|FG002|Overall Study|Protocol Deviations|5|||
37837093|NCT01163266|69521375|FG000|Overall Study|Withdrawal of Consent|5|||
37837094|NCT01163266|69521376|FG001|Overall Study|Withdrawal of Consent|7|||
37837095|NCT01163266|69521377|FG002|Overall Study|Withdrawal of Consent|3|||
37837096|NCT01163266|69521375|FG000|Overall Study|Lost to Follow-up|7|||
37837097|NCT01163266|69521376|FG001|Overall Study|Lost to Follow-up|7|||
37837098|NCT01163266|69521377|FG002|Overall Study|Lost to Follow-up|10|||
37837099|NCT01163266|69521375|FG000|Overall Study|Other|1|||
37837100|NCT01163266|69521376|FG001|Overall Study|Other|1|||
37837101|NCT01163266|69521377|FG002|Overall Study|Other|2|||
37837102|NCT01163149|69521435|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
37837103|NCT01163149|69521436|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
37837104|NCT01163149|69521437|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
37837105|NCT01163149|69521435|FG000|Extension Treatment Period|Adverse Event|0|||
37837106|NCT01163149|69521436|FG001|Extension Treatment Period|Adverse Event|1|||
37837107|NCT01163149|69521437|FG002|Extension Treatment Period|Adverse Event|0|||
37837108|NCT01163149|69521435|FG000|Extension Treatment Period|Noncompliance|0|||
37837109|NCT01163149|69521436|FG001|Extension Treatment Period|Noncompliance|0|||
37837110|NCT01163149|69521437|FG002|Extension Treatment Period|Noncompliance|1|||
37837111|NCT01163032|69521462|FG000|Randomization Phase|Withdrawal by Subject|2|||
37837112|NCT01163032|69521463|FG001|Randomization Phase|Withdrawal by Subject|3|||
37837113|NCT01163032|69521464|FG002|Randomization Phase|Withdrawal by Subject|0|||
37837114|NCT01163032|69521462|FG000|Randomization Phase|Adverse Event|3|||
37837115|NCT01163032|69521463|FG001|Randomization Phase|Adverse Event|3|||
37837116|NCT01163032|69521464|FG002|Randomization Phase|Adverse Event|0|||
37837117|NCT01163032|69521462|FG000|Randomization Phase|Protocol Violation|0|||
37837118|NCT01163032|69521463|FG001|Randomization Phase|Protocol Violation|1|||
37837119|NCT01163032|69521464|FG002|Randomization Phase|Protocol Violation|0|||
37837120|NCT01163032|69521462|FG000|Randomization Phase|Various*|5|||
37837121|NCT01163032|69521463|FG001|Randomization Phase|Various*|4|||
37837122|NCT01163032|69521464|FG002|Randomization Phase|Various*|0|||
37837123|NCT01163032|69521462|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
37837124|NCT01163032|69521463|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
37837125|NCT01163032|69521464|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
37837126|NCT01163032|69521462|FG000|Open Label Extension Phase|Adverse Event|0|||
37837127|NCT01163032|69521463|FG001|Open Label Extension Phase|Adverse Event|0|||
37837128|NCT01163032|69521464|FG002|Open Label Extension Phase|Adverse Event|3|||
37837129|NCT01163032|69521462|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
37837130|NCT01163032|69521463|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
37837131|NCT01163032|69521464|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
37837132|NCT01163032|69521462|FG000|Open Label Extension Phase|Protocol Violation|0|||
37837133|NCT01163032|69521463|FG001|Open Label Extension Phase|Protocol Violation|0|||
37837134|NCT01163032|69521464|FG002|Open Label Extension Phase|Protocol Violation|1|||
37837135|NCT01163032|69521462|FG000|Open Label Extension Phase|Study Termination|0|||
37837136|NCT01163032|69521463|FG001|Open Label Extension Phase|Study Termination|0|||
37837137|NCT01163032|69521464|FG002|Open Label Extension Phase|Study Termination|7|||
37837138|NCT01163032|69521462|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
37837139|NCT01163032|69521463|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
37837140|NCT01163032|69521464|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
37837141|NCT01162486|69521477|FG000|Overall Study|low ANC|1|||
37837142|NCT01162486|69521478|FG001|Overall Study|low ANC|0|||
37837143|NCT01162486|69521479|FG002|Overall Study|low ANC|0|||
37837144|NCT01162486|69521480|FG003|Overall Study|low ANC|0|||
37837145|NCT01162486|69521481|FG004|Overall Study|low ANC|0|||
37837146|NCT01162486|69521477|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
37837147|NCT01162486|69521478|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
37837148|NCT01162486|69521479|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
37837149|NCT01162486|69521480|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
37837150|NCT01162486|69521481|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
37837151|NCT01162486|69521477|FG000|Overall Study|elevated LFTs|0|||
37837152|NCT01162486|69521478|FG001|Overall Study|elevated LFTs|0|||
37837153|NCT01162486|69521479|FG002|Overall Study|elevated LFTs|1|||
37837154|NCT01162486|69521480|FG003|Overall Study|elevated LFTs|0|||
37837155|NCT01162486|69521481|FG004|Overall Study|elevated LFTs|0|||
37837156|NCT01162486|69521477|FG000|Overall Study|Pregnancy|0|||
37837157|NCT01162486|69521478|FG001|Overall Study|Pregnancy|0|||
37837158|NCT01162486|69521479|FG002|Overall Study|Pregnancy|0|||
37837159|NCT01162486|69521480|FG003|Overall Study|Pregnancy|1|||
37837160|NCT01162486|69521481|FG004|Overall Study|Pregnancy|0|||
37915025|NCT00598442|69601706|FG000|Overall Study|Renal transplant|0|||
37837161|NCT01162135|69521497|FG000|Overall Study|Withdrawal by Subject|1|||
37837162|NCT01162135|69521497|FG000|Overall Study|Severe back pain|1|||
37837163|NCT01162135|69521497|FG000|Overall Study|Ineligible|1|||
37837164|NCT01161628|69521501|FG000|Overall Study|Death|6|||
37837165|NCT01161628|69521501|FG000|Overall Study|Lack of Efficacy|2|||
37837166|NCT01161472|69521505|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
37837167|NCT01161472|69521506|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
37837168|NCT01161472|69521507|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
37837169|NCT01161472|69521508|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
37837170|NCT01161043|69521518|FG000|Overall Study|Withdrawal by Subject|3|||
37837171|NCT01160770|69521522|FG000|Overall Study|Adverse Event|10|||
37837172|NCT01160770|69521522|FG000|Overall Study|Protocol Violation|2|||
37837173|NCT01160770|69521522|FG000|Overall Study|Subject/parent/caregiver request|33|||
37837174|NCT01160770|69521522|FG000|Overall Study|Physician Decision|1|||
37837175|NCT01160770|69521522|FG000|Overall Study|Lost to Follow-up|7|||
37837176|NCT01160770|69521522|FG000|Overall Study|Study termination or sponsor request|1|||
37837177|NCT01160770|69521522|FG000|Overall Study|Death|9|||
37837178|NCT01160770|69521522|FG000|Overall Study|Lack of Efficacy|15|||
37837179|NCT01160770|69521522|FG000|Overall Study|Other Reasons|1|||
37837180|NCT01160614|69521528|FG000|Overall Study|Withdrawal by Subject|0|||
37837181|NCT01160614|69521529|FG001|Overall Study|Withdrawal by Subject|2|||
37915026|NCT00598442|69601707|FG001|Overall Study|Renal transplant|0|||
37915027|NCT00598442|69601708|FG002|Overall Study|Renal transplant|1|||
37915028|NCT00598442|69601706|FG000|Overall Study|Site closed by sponsor|5|||
37915029|NCT00598442|69601707|FG001|Overall Study|Site closed by sponsor|2|||
37915030|NCT00598442|69601708|FG002|Overall Study|Site closed by sponsor|1|||
37915031|NCT00598442|69601706|FG000|Overall Study|Started dialysis|1|||
37915032|NCT00598442|69601707|FG001|Overall Study|Started dialysis|0|||
37915033|NCT00598442|69601708|FG002|Overall Study|Started dialysis|0|||
37915034|NCT00593814|69601718|FG000|Overall Study|Death|7|||
37915035|NCT00593814|69601719|FG001|Overall Study|Death|0|||
37915036|NCT00593814|69601718|FG000|Overall Study|Withdrawal by Subject|7|||
37915037|NCT00593814|69601719|FG001|Overall Study|Withdrawal by Subject|0|||
37915038|NCT00593814|69601718|FG000|Overall Study|Lost to Follow-up|7|||
37915039|NCT00593814|69601719|FG001|Overall Study|Lost to Follow-up|0|||
37915040|NCT00593814|69601718|FG000|Overall Study|Physician Decision|3|||
37915041|NCT00593814|69601719|FG001|Overall Study|Physician Decision|0|||
37915042|NCT00855309|69601727|FG000|Overall Study|patient never recieved drug|1|||
37915043|NCT00855309|69601728|FG001|Overall Study|patient never recieved drug|0|||
37915044|NCT00532129|69601734|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
37915045|NCT00532129|69601734|FG000|Treatment Period|Physician Decision|15|||
37915046|NCT00532129|69601734|FG000|Treatment Period|Disease progression|3|||
37915047|NCT00532129|69601734|FG000|Treatment Period|Protocol Violation|1|||
37915048|NCT00532129|69601734|FG000|Treatment Period|Other|5|||
37915049|NCT00532129|69601734|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
37837182|NCT01159912|69521556|FG000|Overall Study|Adverse Event|2|||
37837183|NCT01159912|69521557|FG001|Overall Study|Adverse Event|2|||
37837184|NCT01159912|69521558|FG002|Overall Study|Adverse Event|3|||
37837185|NCT01159912|69521556|FG000|Overall Study|Lack of Efficacy|23|||
37837186|NCT01159912|69521557|FG001|Overall Study|Lack of Efficacy|15|||
37837187|NCT01159912|69521558|FG002|Overall Study|Lack of Efficacy|14|||
37837188|NCT01159912|69521556|FG000|Overall Study|Protocol Violation|1|||
37837189|NCT01159912|69521557|FG001|Overall Study|Protocol Violation|2|||
37837190|NCT01159912|69521558|FG002|Overall Study|Protocol Violation|3|||
37837191|NCT01159912|69521556|FG000|Overall Study|Lost to Follow-up|4|||
37837192|NCT01159912|69521557|FG001|Overall Study|Lost to Follow-up|0|||
37837193|NCT01159912|69521558|FG002|Overall Study|Lost to Follow-up|0|||
37837194|NCT01159912|69521556|FG000|Overall Study|Physician Decision|0|||
37837195|NCT01159912|69521557|FG001|Overall Study|Physician Decision|0|||
37837196|NCT01159912|69521558|FG002|Overall Study|Physician Decision|3|||
37837197|NCT01159912|69521556|FG000|Overall Study|Withdrawal by Subject|10|||
37837198|NCT01159912|69521557|FG001|Overall Study|Withdrawal by Subject|3|||
37915050|NCT00532129|69601734|FG000|Follow-up Period|Disease progression|57|||
37915051|NCT00532129|69601734|FG000|Follow-up Period|Lost to Follow-up|1|||
37915052|NCT00532129|69601734|FG000|Follow-up Period|Other|6|||
37915053|NCT00854607|69601738|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
37915054|NCT00854373|69601751|FG000|Overall Study|Withdrawal by Subject|1|||
37915055|NCT00854373|69601752|FG001|Overall Study|Withdrawal by Subject|3|||
37915056|NCT00854373|69601751|FG000|Overall Study|Forgot to take study drug|1|||
37837199|NCT01159912|69521558|FG002|Overall Study|Withdrawal by Subject|3|||
37837200|NCT01159600|69521574|FG000|Overall Study|Not treated|0|||
37837201|NCT01159600|69521575|FG001|Overall Study|Not treated|0|||
37837202|NCT01159600|69521576|FG002|Overall Study|Not treated|1|||
37915057|NCT00854373|69601752|FG001|Overall Study|Forgot to take study drug|1|||
37915058|NCT00853905|69601760|FG000|Overall Study|Lost to Follow-up|1|||
37837203|NCT01159600|69521577|FG003|Overall Study|Not treated|0|||
37837204|NCT01159600|69521578|FG004|Overall Study|Not treated|0|||
37915059|NCT00853905|69601761|FG001|Overall Study|Lost to Follow-up|3|||
37915060|NCT00853905|69601760|FG000|Overall Study|Withdrawal by Subject|0|||
37915061|NCT00853905|69601761|FG001|Overall Study|Withdrawal by Subject|1|||
37915062|NCT00853905|69601760|FG000|Overall Study|never had surgery|1|||
37915063|NCT00853905|69601761|FG001|Overall Study|never had surgery|0|||
37837205|NCT01159600|69521579|FG005|Overall Study|Not treated|1|||
37837206|NCT01159600|69521580|FG006|Overall Study|Not treated|2|||
37837207|NCT01159600|69521581|FG007|Overall Study|Not treated|2|||
37837208|NCT01159600|69521574|FG000|Overall Study|Adverse Event|7|||
37837209|NCT01159600|69521575|FG001|Overall Study|Adverse Event|2|||
37837210|NCT01159600|69521576|FG002|Overall Study|Adverse Event|5|||
37837211|NCT01159600|69521577|FG003|Overall Study|Adverse Event|1|||
37837212|NCT01159600|69521578|FG004|Overall Study|Adverse Event|8|||
37837213|NCT01159600|69521579|FG005|Overall Study|Adverse Event|6|||
37837214|NCT01159600|69521580|FG006|Overall Study|Adverse Event|7|||
37837215|NCT01159600|69521581|FG007|Overall Study|Adverse Event|5|||
37837216|NCT01159600|69521574|FG000|Overall Study|Lack of Efficacy|0|||
37837217|NCT01159600|69521575|FG001|Overall Study|Lack of Efficacy|0|||
37915064|NCT00868296|69601772|FG000|Overall Study|Adverse Event|0|||
37915065|NCT00868296|69601773|FG001|Overall Study|Adverse Event|2|||
37915066|NCT00868296|69601772|FG000|Overall Study|Withdrawal by Subject|0|||
37915067|NCT00868296|69601773|FG001|Overall Study|Withdrawal by Subject|1|||
37915068|NCT00867360|69601781|FG000|Overall Study|Withdrawal by Subject|1|||
37915069|NCT00867360|69601782|FG001|Overall Study|Withdrawal by Subject|0|||
38023804|NCT03882970|69707110|FG003|Overall Study|Withdrawal by Subject|22|||
38023805|NCT03882970|69707107|FG000|Overall Study|Personal Reason|2|||
37703247|NCT01646177|69180796|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
37703248|NCT01646177|69180797|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
37703249|NCT01646177|69180798|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
37703250|NCT01646177|69180799|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
37703251|NCT01646177|69180800|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
37703252|NCT01646177|69180789|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
37703253|NCT01646177|69180790|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
37703254|NCT01646177|69180791|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
37703255|NCT01646177|69180792|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
37703256|NCT01646177|69180793|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
37703257|NCT01646177|69180794|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
37703258|NCT01646177|69180795|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
37837218|NCT01159600|69521576|FG002|Overall Study|Lack of Efficacy|0|||
37837219|NCT01159600|69521577|FG003|Overall Study|Lack of Efficacy|0|||
37837220|NCT01159600|69521578|FG004|Overall Study|Lack of Efficacy|2|||
37837221|NCT01159600|69521579|FG005|Overall Study|Lack of Efficacy|0|||
37837222|NCT01159600|69521580|FG006|Overall Study|Lack of Efficacy|0|||
37837223|NCT01159600|69521581|FG007|Overall Study|Lack of Efficacy|1|||
37837224|NCT01159600|69521574|FG000|Overall Study|Non compliant with protocol|2|||
37837225|NCT01159600|69521575|FG001|Overall Study|Non compliant with protocol|1|||
37837226|NCT01159600|69521576|FG002|Overall Study|Non compliant with protocol|0|||
37837227|NCT01159600|69521577|FG003|Overall Study|Non compliant with protocol|0|||
37837228|NCT01159600|69521578|FG004|Overall Study|Non compliant with protocol|2|||
37837229|NCT01159600|69521579|FG005|Overall Study|Non compliant with protocol|0|||
37837230|NCT01159600|69521580|FG006|Overall Study|Non compliant with protocol|2|||
37837231|NCT01159600|69521581|FG007|Overall Study|Non compliant with protocol|0|||
37837232|NCT01159600|69521574|FG000|Overall Study|Lost to Follow-up|2|||
37837233|NCT01159600|69521575|FG001|Overall Study|Lost to Follow-up|3|||
37837234|NCT01159600|69521576|FG002|Overall Study|Lost to Follow-up|4|||
37837235|NCT01159600|69521577|FG003|Overall Study|Lost to Follow-up|3|||
37837236|NCT01159600|69521578|FG004|Overall Study|Lost to Follow-up|3|||
37837237|NCT01159600|69521579|FG005|Overall Study|Lost to Follow-up|0|||
37837238|NCT01159600|69521580|FG006|Overall Study|Lost to Follow-up|3|||
37837239|NCT01159600|69521581|FG007|Overall Study|Lost to Follow-up|2|||
37837240|NCT01159600|69521574|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
37837241|NCT01159600|69521575|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
37837242|NCT01159600|69521576|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
37837243|NCT01159600|69521577|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
37915070|NCT00867360|69601781|FG000|Overall Study|Physician Decision|0|||
37837244|NCT01159600|69521578|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
37837245|NCT01159600|69521579|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
37837246|NCT01159600|69521580|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
37837247|NCT01159600|69521581|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
37837248|NCT01159600|69521574|FG000|Overall Study|Other reason not defined above|3|||
38023806|NCT03882970|69707108|FG001|Overall Study|Personal Reason|3|||
37915071|NCT00867360|69601782|FG001|Overall Study|Physician Decision|1|||
37915072|NCT00593736|69601793|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
37915073|NCT00593736|69601794|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
37703259|NCT01646177|69180796|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
37703260|NCT01646177|69180797|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
37703261|NCT01646177|69180798|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
37703262|NCT01646177|69180799|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
37703263|NCT01646177|69180800|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
37703264|NCT01646177|69180789|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
37703265|NCT01646177|69180790|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
37703266|NCT01646177|69180791|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
37703267|NCT01646177|69180792|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
37703268|NCT01646177|69180793|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
37703269|NCT01646177|69180794|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
37703270|NCT01646177|69180795|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
37703271|NCT01646177|69180796|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
37703272|NCT01646177|69180797|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
37703273|NCT01646177|69180798|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
37703274|NCT01646177|69180799|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
37703275|NCT01646177|69180800|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
38023807|NCT03882970|69707109|FG002|Overall Study|Personal Reason|1|||
37837249|NCT01159600|69521575|FG001|Overall Study|Other reason not defined above|0|||
38023808|NCT03882970|69707110|FG003|Overall Study|Personal Reason|3|||
37703276|NCT01646177|69180789|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
37703277|NCT01646177|69180790|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
37703278|NCT01646177|69180791|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
37703279|NCT01646177|69180792|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
37703280|NCT01646177|69180793|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
37703281|NCT01646177|69180794|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
37703282|NCT01646177|69180795|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
37703283|NCT01646177|69180796|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
37703284|NCT01646177|69180797|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
37703285|NCT01646177|69180798|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
37703286|NCT01646177|69180799|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
37703287|NCT01646177|69180800|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
37703288|NCT01646177|69180789|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
37703289|NCT01646177|69180790|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
37703290|NCT01646177|69180791|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
37703291|NCT01646177|69180792|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
37703292|NCT01646177|69180793|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
37703293|NCT01646177|69180794|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
37703294|NCT01646177|69180795|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
37703295|NCT01646177|69180796|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
37703296|NCT01646177|69180797|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
37703297|NCT01646177|69180798|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
37703298|NCT01646177|69180799|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
37703299|NCT01646177|69180800|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
37703300|NCT01646177|69180789|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
37837250|NCT01159600|69521576|FG002|Overall Study|Other reason not defined above|4|||
37837251|NCT01159600|69521577|FG003|Overall Study|Other reason not defined above|2|||
38023809|NCT03730480|69707124|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
38023810|NCT03674112|69707131|FG000|Overall Study|Adverse Event|1|||
37837252|NCT01159600|69521578|FG004|Overall Study|Other reason not defined above|5|||
38023811|NCT03674112|69707132|FG001|Overall Study|Adverse Event|0|||
37837253|NCT01159600|69521579|FG005|Overall Study|Other reason not defined above|7|||
37837254|NCT01159600|69521580|FG006|Overall Study|Other reason not defined above|3|||
37837255|NCT01159600|69521581|FG007|Overall Study|Other reason not defined above|3|||
37837256|NCT01159171|69521600|FG000|Overall Study|Adverse Event|11|||
37837257|NCT01159171|69521600|FG000|Overall Study|Progression of Disease|28|||
37837258|NCT01159171|69521600|FG000|Overall Study|Protocol Violation|1|||
37837259|NCT01159171|69521600|FG000|Overall Study|Need for Surgery|5|||
37837260|NCT01159171|69521600|FG000|Overall Study|Medical Decision|4|||
37837261|NCT01159171|69521600|FG000|Overall Study|Death|1|||
37837262|NCT01158118|69521607|FG000|Overall Study|Screen failure|1|||
37837263|NCT01158118|69521608|FG001|Overall Study|Screen failure|0|||
37837264|NCT01158118|69521607|FG000|Overall Study|Donor match was a screen failure|0|||
37837265|NCT01158118|69521608|FG001|Overall Study|Donor match was a screen failure|1|||
37837266|NCT01158118|69521607|FG000|Overall Study|Suffered stroke prior to transplant|0|||
37837267|NCT01158118|69521608|FG001|Overall Study|Suffered stroke prior to transplant|1|||
37837268|NCT01158118|69521607|FG000|Overall Study|Death|0|||
37837269|NCT01158118|69521608|FG001|Overall Study|Death|1|||
37837270|NCT01157845|69521614|FG000|Overall Study|Lost to Follow-up|5|||
37837271|NCT01157845|69521614|FG000|Overall Study|Withdrawal by Subject|12|||
37837272|NCT01157845|69521614|FG000|Overall Study|Physician Decision|3|||
37837273|NCT01157845|69521614|FG000|Overall Study|Protocol Violation|13|||
37837274|NCT01157845|69521614|FG000|Overall Study|Study was ended|1|||
37837275|NCT01157845|69521614|FG000|Overall Study|Device malfunction|1|||
37837276|NCT01157377|69521625|FG000|Overall Study|Lost to Follow-up|0|||
37837277|NCT01157377|69521626|FG001|Overall Study|Lost to Follow-up|0|||
37837278|NCT01157377|69521627|FG002|Overall Study|Lost to Follow-up|1|||
37837279|NCT01157377|69521628|FG003|Overall Study|Lost to Follow-up|0|||
37837280|NCT01157377|69521629|FG004|Overall Study|Lost to Follow-up|1|||
37837281|NCT01157377|69521630|FG005|Overall Study|Lost to Follow-up|1|||
37837282|NCT01157377|69521631|FG006|Overall Study|Lost to Follow-up|0|||
37837283|NCT01157377|69521625|FG000|Overall Study|Personal Reasons|2|||
37837284|NCT01157377|69521626|FG001|Overall Study|Personal Reasons|1|||
37837285|NCT01157377|69521627|FG002|Overall Study|Personal Reasons|0|||
37837286|NCT01157377|69521628|FG003|Overall Study|Personal Reasons|1|||
37837287|NCT01157377|69521629|FG004|Overall Study|Personal Reasons|0|||
37837288|NCT01157377|69521630|FG005|Overall Study|Personal Reasons|0|||
37837289|NCT01157377|69521631|FG006|Overall Study|Personal Reasons|0|||
37837290|NCT01157377|69521625|FG000|Overall Study|Protocol Violation|0|||
37837291|NCT01157377|69521626|FG001|Overall Study|Protocol Violation|0|||
37837292|NCT01157377|69521627|FG002|Overall Study|Protocol Violation|0|||
37837293|NCT01157377|69521628|FG003|Overall Study|Protocol Violation|0|||
37837294|NCT01157377|69521629|FG004|Overall Study|Protocol Violation|0|||
37837295|NCT01157377|69521630|FG005|Overall Study|Protocol Violation|1|||
37837296|NCT01157377|69521631|FG006|Overall Study|Protocol Violation|0|||
37837297|NCT01157377|69521625|FG000|Overall Study|Lack of Efficacy|0|||
37837298|NCT01157377|69521626|FG001|Overall Study|Lack of Efficacy|0|||
37837299|NCT01157377|69521627|FG002|Overall Study|Lack of Efficacy|0|||
37837300|NCT01157377|69521628|FG003|Overall Study|Lack of Efficacy|0|||
37837301|NCT01157377|69521629|FG004|Overall Study|Lack of Efficacy|0|||
37837302|NCT01157377|69521630|FG005|Overall Study|Lack of Efficacy|0|||
37837303|NCT01157377|69521631|FG006|Overall Study|Lack of Efficacy|1|||
37837304|NCT01157377|69521625|FG000|Overall Study|Other Miscellaneous Reasons|0|||
37837305|NCT01157377|69521626|FG001|Overall Study|Other Miscellaneous Reasons|2|||
37837306|NCT01157377|69521627|FG002|Overall Study|Other Miscellaneous Reasons|0|||
37703301|NCT01646177|69180790|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
37703302|NCT01646177|69180791|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
37703303|NCT01646177|69180792|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
37703304|NCT01646177|69180793|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
37703305|NCT01646177|69180794|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
37703306|NCT01646177|69180795|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
37703307|NCT01646177|69180796|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
37703308|NCT01646177|69180797|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
37703309|NCT01646177|69180798|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
37703310|NCT01646177|69180799|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
37837307|NCT01157377|69521628|FG003|Overall Study|Other Miscellaneous Reasons|0|||
37837308|NCT01157377|69521629|FG004|Overall Study|Other Miscellaneous Reasons|1|||
37837309|NCT01157377|69521630|FG005|Overall Study|Other Miscellaneous Reasons|1|||
37837310|NCT01157377|69521631|FG006|Overall Study|Other Miscellaneous Reasons|1|||
37837311|NCT01157182|69521649|FG000|Washout of 28 Days|Adverse Event|2|||
37837312|NCT01157182|69521650|FG001|Washout of 28 Days|Adverse Event|0|||
37837313|NCT01157065|69521658|FG000|Overall Study|Death|0|||
37837314|NCT01157065|69521659|FG001|Overall Study|Death|1|||
37837315|NCT01156792|69521665|FG000|Overall Study|Adverse Event|1|||
37837316|NCT01156792|69521665|FG000|Overall Study|Lack of Efficacy|36|||
37837317|NCT01156792|69521665|FG000|Overall Study|Protocol Violation|6|||
37837318|NCT01156792|69521665|FG000|Overall Study|Lost to Follow-up|3|||
37837319|NCT01156792|69521665|FG000|Overall Study|Physician Decision|3|||
37837320|NCT01156792|69521665|FG000|Overall Study|Withdrawal by Subject|9|||
37837321|NCT01156792|69521665|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
37837322|NCT01156714|69521683|FG000|Overall Study|Withdrawal by Subject|9|||
37837323|NCT01156714|69521684|FG001|Overall Study|Withdrawal by Subject|4|||
37837324|NCT01156714|69521685|FG002|Overall Study|Withdrawal by Subject|3|||
37837325|NCT01156675|69521699|FG000|Overall Study|Death|5|||
37915074|NCT00593736|69601795|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
37915075|NCT00593736|69601796|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
37915076|NCT00593736|69601793|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
37837326|NCT01156675|69521700|FG001|Overall Study|Death|3|||
37837327|NCT01156675|69521701|FG002|Overall Study|Death|0|||
37837328|NCT01156675|69521699|FG000|Overall Study|No data|29|||
37837329|NCT01156675|69521700|FG001|Overall Study|No data|22|||
37837330|NCT01156675|69521701|FG002|Overall Study|No data|2|||
37837331|NCT01156480|69521712|FG000|Overall Study|change in diagnosis|0|||
37837332|NCT01156480|69521713|FG001|Overall Study|change in diagnosis|1|||
37837333|NCT01156363|69521721|FG000|Overall Study|Adverse Event|6|||
37837334|NCT01156363|69521721|FG000|Overall Study|Insufficient Therapeutic Response|5|||
37837335|NCT01156363|69521721|FG000|Overall Study|Failure to Return|1|||
37837336|NCT01156363|69521721|FG000|Overall Study|Refused Treatment|4|||
37837337|NCT01156363|69521721|FG000|Overall Study|Other|6|||
37837338|NCT01156051|69521734|FG000|Overall Study|Lost to Follow-up|1|||
37837339|NCT01156051|69521735|FG001|Overall Study|Lost to Follow-up|0|||
37837340|NCT01156051|69521734|FG000|Overall Study|patient not compliant with protocol|0|||
37837341|NCT01156051|69521735|FG001|Overall Study|patient not compliant with protocol|1|||
37837342|NCT01156012|69521743|FG000|Overall Study|Adverse Event|3|||
37837343|NCT01156012|69521744|FG001|Overall Study|Adverse Event|1|||
37837344|NCT01156012|69521743|FG000|Overall Study|Lost to Follow-up|1|||
37837345|NCT01156012|69521744|FG001|Overall Study|Lost to Follow-up|0|||
37837346|NCT01156012|69521743|FG000|Overall Study|Withdrawal by Subject|1|||
37837347|NCT01156012|69521744|FG001|Overall Study|Withdrawal by Subject|0|||
37837348|NCT01156012|69521743|FG000|Overall Study|use of commercial drug instead of study|0|||
37837349|NCT01156012|69521744|FG001|Overall Study|use of commercial drug instead of study|1|||
37837350|NCT01156012|69521743|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
37837351|NCT01156012|69521744|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
37837352|NCT01155661|69521750|FG000|Overall Study|Adverse Event|101|||
37915077|NCT00593736|69601794|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
37915078|NCT00593736|69601795|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
37915079|NCT00593736|69601796|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
38023812|NCT03674112|69707131|FG000|Overall Study|Ongoing in the Study|79|||
38023813|NCT03674112|69707132|FG001|Overall Study|Ongoing in the Study|80|||
38023814|NCT03668808|69707158|FG000|First Intervention|Withdrawal by Subject|2|||
38023815|NCT03668808|69707159|FG001|First Intervention|Withdrawal by Subject|2|||
38023816|NCT02982954|69707171|FG000|Overall Study|Death|55|||
38023817|NCT02982954|69707172|FG001|Overall Study|Death|29|||
38023818|NCT02982954|69707173|FG002|Overall Study|Death|15|||
38023819|NCT02982954|69707174|FG003|Overall Study|Death|20|||
37837353|NCT01155661|69521750|FG000|Overall Study|Death|1|||
37837354|NCT01155661|69521750|FG000|Overall Study|Lack of Efficacy|32|||
38023820|NCT02982954|69707171|FG000|Overall Study|Lost to Follow-up|2|||
37837355|NCT01155661|69521750|FG000|Overall Study|Lost to Follow-up|22|||
37837356|NCT01155661|69521750|FG000|Overall Study|Physician Decision|3|||
37837357|NCT01155661|69521750|FG000|Overall Study|Protocol Violation|35|||
37837358|NCT01155661|69521750|FG000|Overall Study|Withdrawal by Subject|73|||
37837359|NCT01155661|69521750|FG000|Overall Study|Sponsor Decision|13|||
37837360|NCT01155583|69521765|FG000|Phase I|Screen failure - did not start treatment|0|||
37837361|NCT01155583|69521766|FG001|Phase I|Screen failure - did not start treatment|0|||
37837362|NCT01155583|69521767|FG002|Phase I|Screen failure - did not start treatment|0|||
37837363|NCT01155583|69521768|FG003|Phase I|Screen failure - did not start treatment|0|||
37837364|NCT01155583|69521769|FG004|Phase I|Screen failure - did not start treatment|1|||
37837365|NCT01155583|69521770|FG005|Phase I|Screen failure - did not start treatment|0|||
37837366|NCT01155583|69521771|FG006|Phase I|Screen failure - did not start treatment|0|||
37837367|NCT01155583|69521772|FG007|Phase I|Screen failure - did not start treatment|2|||
37837368|NCT01155583|69521773|FG008|Phase I|Screen failure - did not start treatment|0|||
37837369|NCT01155583|69521765|FG000|Phase I|Withdrawal by Subject|0|||
37837370|NCT01155583|69521766|FG001|Phase I|Withdrawal by Subject|0|||
37837371|NCT01155583|69521767|FG002|Phase I|Withdrawal by Subject|0|||
37837372|NCT01155583|69521768|FG003|Phase I|Withdrawal by Subject|0|||
37837373|NCT01155583|69521769|FG004|Phase I|Withdrawal by Subject|0|||
37837374|NCT01155583|69521770|FG005|Phase I|Withdrawal by Subject|0|||
38023821|NCT02982954|69707172|FG001|Overall Study|Lost to Follow-up|1|||
38023822|NCT02982954|69707173|FG002|Overall Study|Lost to Follow-up|0|||
37703311|NCT01646177|69180800|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
37703312|NCT01646177|69180789|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
37703313|NCT01646177|69180790|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
37703314|NCT01646177|69180791|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
37703315|NCT01646177|69180792|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
37703316|NCT01646177|69180793|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
37703317|NCT01646177|69180794|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
37703318|NCT01646177|69180795|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
37703319|NCT01646177|69180796|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
37703320|NCT01646177|69180797|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
37703321|NCT01646177|69180798|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
37703322|NCT01646177|69180799|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
37703323|NCT01646177|69180800|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
37703324|NCT01646177|69180789|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
37703325|NCT01646177|69180790|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
37703326|NCT01646177|69180791|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
37703327|NCT01646177|69180792|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
37703328|NCT01646177|69180793|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
37703329|NCT01646177|69180794|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
37703330|NCT01646177|69180795|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
37703331|NCT01646177|69180796|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
37703332|NCT01646177|69180797|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
37703333|NCT01646177|69180798|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
37703334|NCT01646177|69180799|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
37703335|NCT01646177|69180800|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
37837375|NCT01155583|69521771|FG006|Phase I|Withdrawal by Subject|0|||
37837376|NCT01155583|69521772|FG007|Phase I|Withdrawal by Subject|1|||
37837377|NCT01155583|69521773|FG008|Phase I|Withdrawal by Subject|0|||
37837378|NCT01155466|69521794|FG000|Overall Study|Adverse Event|13|||
38023823|NCT02982954|69707174|FG003|Overall Study|Lost to Follow-up|0|||
38023824|NCT02982954|69707171|FG000|Overall Study|Participant withdrew consent|7|||
38023825|NCT02982954|69707172|FG001|Overall Study|Participant withdrew consent|5|||
38023826|NCT02982954|69707173|FG002|Overall Study|Participant withdrew consent|1|||
38023827|NCT02982954|69707174|FG003|Overall Study|Participant withdrew consent|1|||
38023828|NCT02982954|69707171|FG000|Overall Study|Other reasons|42|||
38023829|NCT02982954|69707172|FG001|Overall Study|Other reasons|17|||
38023830|NCT02982954|69707173|FG002|Overall Study|Other reasons|12|||
38023831|NCT02982954|69707174|FG003|Overall Study|Other reasons|3|||
38023832|NCT02982954|69707171|FG000|Overall Study|Premature site closure|0|||
38023833|NCT02982954|69707172|FG001|Overall Study|Premature site closure|0|||
38023834|NCT02982954|69707173|FG002|Overall Study|Premature site closure|0|||
38023835|NCT02982954|69707174|FG003|Overall Study|Premature site closure|1|||
38023836|NCT03724968|69707186|FG000|Overall Study|Insurance issues|0|||
38023837|NCT03724968|69707187|FG001|Overall Study|Insurance issues|1|||
38023838|NCT03724968|69707186|FG000|Overall Study|Study closed|0|||
38023839|NCT03724968|69707187|FG001|Overall Study|Study closed|1|||
38023840|NCT03724812|69707193|FG000|Overall Study|Missed Visit|1|||
38023841|NCT03724812|69707193|FG000|Overall Study|Death|2|||
38023842|NCT03724812|69707193|FG000|Overall Study|Withdrawal by Subject|1|||
38023843|NCT03722784|69707200|FG000|Overall Study|Withdrawal by Subject|1|||
38023844|NCT03722784|69707201|FG001|Overall Study|Withdrawal by Subject|0|||
38023845|NCT03722784|69707200|FG000|Overall Study|Physician Decision|1|||
38023846|NCT03722784|69707201|FG001|Overall Study|Physician Decision|1|||
38023847|NCT03722784|69707200|FG000|Overall Study|Protocol Violation|0|||
38023848|NCT03722784|69707201|FG001|Overall Study|Protocol Violation|1|||
38023849|NCT03722238|69707210|FG000|Overall Study|Protocol Violation|1|||
38023850|NCT03722238|69707211|FG001|Overall Study|Protocol Violation|0|||
38023851|NCT03722238|69707210|FG000|Overall Study|Physician Decision|1|||
38023852|NCT03722238|69707211|FG001|Overall Study|Physician Decision|0|||
38023853|NCT03722238|69707210|FG000|Overall Study|Death|1|||
38023854|NCT03722238|69707211|FG001|Overall Study|Death|0|||
38023855|NCT03722238|69707210|FG000|Overall Study|Lost to Follow-up|6|||
38023856|NCT03722238|69707211|FG001|Overall Study|Lost to Follow-up|0|||
38023857|NCT03722238|69707210|FG000|Overall Study|Partial missing data|44|||
37703336|NCT01646177|69180789|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
38023858|NCT03722238|69707211|FG001|Overall Study|Partial missing data|1|||
38023859|NCT03722238|69707210|FG000|Overall Study|Withdrawal by Subject|2|||
38023860|NCT03722238|69707211|FG001|Overall Study|Withdrawal by Subject|0|||
38023861|NCT03722238|69707210|FG000|Overall Study|Other|4|||
38023862|NCT03722238|69707211|FG001|Overall Study|Other|0|||
38023863|NCT03722238|69707210|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
37703337|NCT01646177|69180790|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
37703338|NCT01646177|69180791|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
37703339|NCT01646177|69180792|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
37703340|NCT01646177|69180793|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
37703341|NCT01646177|69180794|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
37703342|NCT01646177|69180795|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
37703343|NCT01646177|69180796|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
37703344|NCT01646177|69180797|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
37703345|NCT01646177|69180798|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
37703346|NCT01646177|69180799|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
37703347|NCT01646177|69180800|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
37703348|NCT01646177|69180789|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
37703349|NCT01646177|69180790|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
37703350|NCT01646177|69180791|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
37703351|NCT01646177|69180792|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
37703352|NCT01646177|69180793|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
37703353|NCT01646177|69180794|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
37703354|NCT01646177|69180795|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
37703355|NCT01646177|69180796|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
37703356|NCT01646177|69180797|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
37703357|NCT01646177|69180798|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
37703358|NCT01646177|69180799|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
37703359|NCT01646177|69180800|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
37703360|NCT01646177|69180789|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
37703361|NCT01646177|69180790|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
37703362|NCT01646177|69180791|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
37703363|NCT01646177|69180792|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
37703364|NCT01646177|69180793|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
37703365|NCT01646177|69180794|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
37703366|NCT01646177|69180795|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
37703367|NCT01646177|69180796|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
37703368|NCT01646177|69180797|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
37703369|NCT01646177|69180798|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
37703370|NCT01646177|69180799|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
37703371|NCT01646177|69180800|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
37703372|NCT01646177|69180789|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
37703373|NCT01646177|69180790|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
37703374|NCT01646177|69180791|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
37703375|NCT01646177|69180792|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
37703376|NCT01646177|69180793|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
37703377|NCT01646177|69180794|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
37703378|NCT01646177|69180795|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
37703379|NCT01646177|69180796|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
37703380|NCT01646177|69180797|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
37703381|NCT01646177|69180798|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
37703382|NCT01646177|69180799|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
37703383|NCT01646177|69180800|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
37703384|NCT01646177|69180789|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
37703385|NCT01646177|69180790|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
37703386|NCT01646177|69180791|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
37703387|NCT01646177|69180792|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
37703388|NCT01646177|69180793|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
37703389|NCT01646177|69180794|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
37703390|NCT01646177|69180795|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
37703391|NCT01646177|69180796|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
37703392|NCT01646177|69180797|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
37703393|NCT01646177|69180798|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
37703394|NCT01646177|69180799|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
37703395|NCT01646177|69180800|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
37703396|NCT01646177|69180789|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
37703397|NCT01646177|69180790|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
37703398|NCT01646177|69180791|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
37837379|NCT01155466|69521795|FG001|Overall Study|Adverse Event|15|||
37703399|NCT01646177|69180792|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
37703400|NCT01646177|69180793|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
37703401|NCT01646177|69180794|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
37703402|NCT01646177|69180795|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
37915080|NCT00593736|69601793|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
37915081|NCT00593736|69601794|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
37915082|NCT00593736|69601795|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
37915083|NCT00593736|69601796|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
37915084|NCT00593736|69601793|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
37915085|NCT00593736|69601794|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
37915086|NCT00593736|69601795|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
37915087|NCT00593736|69601796|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
37915088|NCT00593736|69601793|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
37915089|NCT00593736|69601794|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
37915090|NCT00593736|69601795|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
37915091|NCT00593736|69601796|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
37915092|NCT00593736|69601793|FG000|Screening Period and Placebo Run-in|Various|0|||
37915093|NCT00593736|69601794|FG001|Screening Period and Placebo Run-in|Various|0|||
37915094|NCT00593736|69601795|FG002|Screening Period and Placebo Run-in|Various|0|||
37915095|NCT00593736|69601796|FG003|Screening Period and Placebo Run-in|Various|25|||
37915096|NCT00593736|69601793|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
37703403|NCT01646177|69180796|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
37703404|NCT01646177|69180797|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
37703405|NCT01646177|69180798|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
37703406|NCT01646177|69180799|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
37703407|NCT01646177|69180800|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
37703408|NCT01646177|69180789|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
37703409|NCT01646177|69180790|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
37703410|NCT01646177|69180791|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
37703411|NCT01646177|69180792|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
37703412|NCT01646177|69180793|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
37703413|NCT01646177|69180794|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
37703414|NCT01646177|69180795|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
37703415|NCT01646177|69180796|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
37703416|NCT01646177|69180797|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
37703417|NCT01646177|69180798|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
37703418|NCT01646177|69180799|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
37703419|NCT01646177|69180800|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
37703420|NCT01646177|69180789|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
37703421|NCT01646177|69180790|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
37703422|NCT01646177|69180791|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
37703423|NCT01646177|69180792|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
37703424|NCT01646177|69180793|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
37703425|NCT01646177|69180794|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
37703426|NCT01646177|69180795|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
37703427|NCT01646177|69180796|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
37703428|NCT01646177|69180797|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
37703429|NCT01646177|69180798|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
37703430|NCT01646177|69180799|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
37703431|NCT01646177|69180800|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
37703432|NCT01646177|69180789|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
37703433|NCT01646177|69180790|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
37703434|NCT01646177|69180791|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
37703435|NCT01646177|69180792|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
37703436|NCT01646177|69180793|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
37703437|NCT01646177|69180794|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
37703438|NCT01646177|69180795|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
37703439|NCT01646177|69180796|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
37703440|NCT01646177|69180797|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
37703441|NCT01646177|69180798|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
37703442|NCT01646177|69180799|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
37703443|NCT01646177|69180800|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
37703444|NCT01646177|69180789|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
37703445|NCT01646177|69180790|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
37703446|NCT01646177|69180791|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
37703447|NCT01646177|69180792|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
37703448|NCT01646177|69180793|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
37703449|NCT01646177|69180794|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
37703450|NCT01646177|69180795|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
37703451|NCT01646177|69180796|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
37703452|NCT01646177|69180797|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
37703453|NCT01646177|69180798|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
37703454|NCT01646177|69180799|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
37703455|NCT01646177|69180800|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
37703456|NCT01646177|69180789|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
37915097|NCT00593736|69601794|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
37915098|NCT00593736|69601795|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
37703457|NCT01646177|69180790|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
37915099|NCT00593736|69601796|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
37703458|NCT01646177|69180791|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
37703459|NCT01646177|69180792|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
37703460|NCT01646177|69180793|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
37703461|NCT01646177|69180794|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
37703462|NCT01646177|69180795|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
37837380|NCT01155466|69521796|FG002|Overall Study|Adverse Event|6|||
37837381|NCT01155466|69521797|FG003|Overall Study|Adverse Event|17|||
37837382|NCT01155466|69521798|FG004|Overall Study|Adverse Event|18|||
37837383|NCT01155466|69521794|FG000|Overall Study|Lost to Follow-up|0|||
37837384|NCT01155466|69521795|FG001|Overall Study|Lost to Follow-up|0|||
37837385|NCT01155466|69521796|FG002|Overall Study|Lost to Follow-up|0|||
37837386|NCT01155466|69521797|FG003|Overall Study|Lost to Follow-up|0|||
37703463|NCT01646177|69180796|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
37703464|NCT01646177|69180797|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
37837387|NCT01155466|69521798|FG004|Overall Study|Lost to Follow-up|2|||
37703465|NCT01646177|69180798|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
37703466|NCT01646177|69180799|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
37703467|NCT01646177|69180800|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
37703468|NCT01646177|69180789|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
37703469|NCT01646177|69180790|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
37703470|NCT01646177|69180791|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
37703471|NCT01646177|69180792|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
37703472|NCT01646177|69180793|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
37703473|NCT01646177|69180794|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
37703474|NCT01646177|69180795|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
37703475|NCT01646177|69180796|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
37703476|NCT01646177|69180797|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
37703477|NCT01646177|69180798|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
37703478|NCT01646177|69180799|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
37703479|NCT01646177|69180800|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
37703480|NCT01912287|69180823|FG000|Overall Study|Ineligible|1|||
37703481|NCT01912287|69180824|FG001|Overall Study|Ineligible|0|||
37703482|NCT01912287|69180825|FG002|Overall Study|Ineligible|1|||
37703483|NCT01912287|69180823|FG000|Overall Study|No-show|0|||
37703484|NCT01912287|69180824|FG001|Overall Study|No-show|0|||
37703485|NCT01912287|69180825|FG002|Overall Study|No-show|1|||
37703486|NCT01912287|69180823|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
37703487|NCT01912287|69180824|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
37703488|NCT01912287|69180825|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
37703489|NCT01912287|69180823|FG000|Overall Study|Felt treatment no longer needed|0|||
37703490|NCT01912287|69180824|FG001|Overall Study|Felt treatment no longer needed|1|||
37703491|NCT01912287|69180825|FG002|Overall Study|Felt treatment no longer needed|0|||
37703492|NCT01912287|69180823|FG000|Overall Study|Life circumstances|4|||
37703493|NCT01912287|69180824|FG001|Overall Study|Life circumstances|2|||
37703494|NCT01912287|69180825|FG002|Overall Study|Life circumstances|0|||
37703495|NCT01912287|69180823|FG000|Overall Study|Lost Interest|1|||
37703496|NCT01912287|69180824|FG001|Overall Study|Lost Interest|0|||
37703497|NCT01912287|69180825|FG002|Overall Study|Lost Interest|0|||
37703498|NCT01912287|69180823|FG000|Overall Study|Uknown reason - subject drop out|5|||
37703499|NCT01912287|69180824|FG001|Overall Study|Uknown reason - subject drop out|7|||
37703500|NCT01912287|69180825|FG002|Overall Study|Uknown reason - subject drop out|3|||
37703501|NCT01912287|69180823|FG000|Overall Study|Missed Assesment|1|||
37703502|NCT01912287|69180824|FG001|Overall Study|Missed Assesment|1|||
37703503|NCT01912287|69180825|FG002|Overall Study|Missed Assesment|1|||
37703504|NCT01912287|69180823|FG000|Overall Study|Scheduling/change in availability|17|||
37703505|NCT01912287|69180824|FG001|Overall Study|Scheduling/change in availability|10|||
37703506|NCT01912287|69180825|FG002|Overall Study|Scheduling/change in availability|8|||
37703507|NCT01929135|69180835|FG000|Overall Study|Lost to Follow-up|1|||
37703508|NCT01929135|69180836|FG001|Overall Study|Lost to Follow-up|1|||
37703509|NCT01911819|69180847|FG000|Overall Study|Adverse Event|0|||
37703510|NCT01911819|69180848|FG001|Overall Study|Adverse Event|1|||
37703511|NCT01911819|69180849|FG002|Overall Study|Adverse Event|0|||
37703512|NCT01911819|69180847|FG000|Overall Study|Withdrawal by Subject|1|||
37703513|NCT01911819|69180848|FG001|Overall Study|Withdrawal by Subject|1|||
37703514|NCT01911819|69180849|FG002|Overall Study|Withdrawal by Subject|0|||
37703515|NCT02280863|69180859|FG000|Integrated Platform|Met stopping criteria|0|||
37703516|NCT02280863|69180860|FG001|Integrated Platform|Met stopping criteria|1|||
38023864|NCT03722238|69707211|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
38023865|NCT03722238|69707210|FG000|Overall Study|Did not meet risk classification group criteria|90|||
37703517|NCT01911429|69180873|FG000|Overall Study|Adverse Event|5|||
37703518|NCT01911429|69180874|FG001|Overall Study|Adverse Event|3|||
37703519|NCT01911429|69180875|FG002|Overall Study|Adverse Event|9|||
37703520|NCT01911429|69180873|FG000|Overall Study|Lack of Efficacy|1|||
37703521|NCT01911429|69180874|FG001|Overall Study|Lack of Efficacy|2|||
37703522|NCT01911429|69180875|FG002|Overall Study|Lack of Efficacy|4|||
37703523|NCT01911429|69180873|FG000|Overall Study|Lost to Follow-up|0|||
37703524|NCT01911429|69180874|FG001|Overall Study|Lost to Follow-up|0|||
37703525|NCT01911429|69180875|FG002|Overall Study|Lost to Follow-up|1|||
37703526|NCT01911429|69180873|FG000|Overall Study|Protocol Violation|0|||
37703527|NCT01911429|69180874|FG001|Overall Study|Protocol Violation|0|||
37703528|NCT01911429|69180875|FG002|Overall Study|Protocol Violation|1|||
37703529|NCT01911429|69180873|FG000|Overall Study|Withdrawal by Subject|5|||
37703530|NCT01911429|69180874|FG001|Overall Study|Withdrawal by Subject|5|||
37703531|NCT01911429|69180875|FG002|Overall Study|Withdrawal by Subject|4|||
37703532|NCT01911429|69180873|FG000|Overall Study|Accidental randomization|0|||
37703533|NCT01911429|69180874|FG001|Overall Study|Accidental randomization|0|||
37703534|NCT01911429|69180875|FG002|Overall Study|Accidental randomization|1|||
38023866|NCT03722238|69707211|FG001|Overall Study|Did not meet risk classification group criteria|0|||
38023867|NCT03722238|69707210|FG000|Overall Study|Did not sign consent|17|||
38023868|NCT03722238|69707211|FG001|Overall Study|Did not sign consent|0|||
38023869|NCT03722238|69707210|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
38023870|NCT03722238|69707211|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
38023871|NCT03722238|69707210|FG000|Overall Study|Not willing to purchase study medication|142|||
38023872|NCT03722238|69707211|FG001|Overall Study|Not willing to purchase study medication|0|||
38023873|NCT03722238|69707210|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
38023874|NCT03722238|69707211|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
38023875|NCT02927080|69707227|FG000|Overall Study|Withdrawal by Subject|0|||
38023876|NCT02927080|69707228|FG001|Overall Study|Withdrawal by Subject|0|||
38023877|NCT02927080|69707229|FG002|Overall Study|Withdrawal by Subject|0|||
38023878|NCT02927080|69707230|FG003|Overall Study|Withdrawal by Subject|0|||
38023879|NCT02927080|69707231|FG004|Overall Study|Withdrawal by Subject|1|||
38023880|NCT02927080|69707232|FG005|Overall Study|Withdrawal by Subject|0|||
38023881|NCT02927080|69707233|FG006|Overall Study|Withdrawal by Subject|1|||
38023882|NCT02927080|69707234|FG007|Overall Study|Withdrawal by Subject|1|||
37703535|NCT01911429|69180873|FG000|Overall Study|subject left study|1|||
37703536|NCT01911429|69180874|FG001|Overall Study|subject left study|0|||
37703537|NCT01911429|69180875|FG002|Overall Study|subject left study|0|||
37703538|NCT02324465|69180885|FG000|Overall Study|device failure|0|||
37703539|NCT02324465|69180886|FG001|Overall Study|device failure|1|||
37703540|NCT02324153|69180894|FG000|Overall Study|Withdrawal by Subject|4|||
37703541|NCT02324153|69180895|FG001|Overall Study|Withdrawal by Subject|1|||
37703542|NCT02324153|69180894|FG000|Overall Study|Surgery postponed after randomization|3|||
37703543|NCT02324153|69180895|FG001|Overall Study|Surgery postponed after randomization|0|||
37703544|NCT02324153|69180894|FG000|Overall Study|Developed delirium preoperatively|1|||
37703545|NCT02324153|69180895|FG001|Overall Study|Developed delirium preoperatively|0|||
37703546|NCT02280473|69180903|FG000|Overall Study|Adverse Event|1|||
37703547|NCT02280473|69180904|FG001|Overall Study|Adverse Event|1|||
37703548|NCT02280473|69180903|FG000|Overall Study|Lack of Efficacy|0|||
37703549|NCT02280473|69180904|FG001|Overall Study|Lack of Efficacy|1|||
37703550|NCT02280473|69180903|FG000|Overall Study|Lost to Follow-up|0|||
37703551|NCT02280473|69180904|FG001|Overall Study|Lost to Follow-up|1|||
37703552|NCT01911273|69180912|FG000|Overall Study|Progression of Disease|1|||
37703553|NCT01911273|69180913|FG001|Overall Study|Progression of Disease|0|||
37703554|NCT01911273|69180912|FG000|Overall Study|Withdrawal by Subject|0|||
37703555|NCT01911273|69180913|FG001|Overall Study|Withdrawal by Subject|2|||
37703556|NCT02308007|69180922|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
37703557|NCT02308007|69180923|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
37703558|NCT02308007|69180924|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
37703559|NCT02308007|69180922|FG000|Overall Study|Positive for STD at Baseline|7|||
37703560|NCT02308007|69180923|FG001|Overall Study|Positive for STD at Baseline|11|||
37703561|NCT02308007|69180924|FG002|Overall Study|Positive for STD at Baseline|7|||
37703562|NCT02308007|69180922|FG000|Overall Study|Lost to Follow-up|3|||
37703563|NCT02308007|69180923|FG001|Overall Study|Lost to Follow-up|0|||
37703564|NCT02308007|69180924|FG002|Overall Study|Lost to Follow-up|1|||
37703565|NCT02278367|69180934|FG000|Overall Study|Physician Decision|5|||
37703566|NCT02278367|69180935|FG001|Overall Study|Physician Decision|0|||
37703567|NCT02278367|69180934|FG000|Overall Study|Withdrawal by Subject|5|||
37703568|NCT02278367|69180935|FG001|Overall Study|Withdrawal by Subject|0|||
37837388|NCT01155466|69521794|FG000|Overall Study|Withdrawal by Subject|7|||
38023883|NCT02927080|69707235|FG008|Overall Study|Withdrawal by Subject|0|||
38023884|NCT02927080|69707236|FG009|Overall Study|Withdrawal by Subject|2|||
38023885|NCT02927080|69707227|FG000|Overall Study|Willingness to comply with protocol|0|||
37837389|NCT01155466|69521795|FG001|Overall Study|Withdrawal by Subject|5|||
37837390|NCT01155466|69521796|FG002|Overall Study|Withdrawal by Subject|9|||
37837391|NCT01155466|69521797|FG003|Overall Study|Withdrawal by Subject|4|||
37837392|NCT01155466|69521798|FG004|Overall Study|Withdrawal by Subject|4|||
37837393|NCT01155466|69521794|FG000|Overall Study|Protocol Violation|0|||
37837394|NCT01155466|69521795|FG001|Overall Study|Protocol Violation|0|||
37837395|NCT01155466|69521796|FG002|Overall Study|Protocol Violation|2|||
37837396|NCT01155466|69521797|FG003|Overall Study|Protocol Violation|0|||
37703569|NCT01910181|69180941|FG000|Overall Study|Death|37|||
37703570|NCT01910181|69180941|FG000|Overall Study|Lost to Follow-up|3|||
37703571|NCT01910181|69180941|FG000|Overall Study|Study Terminated by Sponsor|6|||
37703572|NCT01957215|69180948|FG000|Overall Study|Adverse Event|2|||
37703573|NCT01957215|69180949|FG001|Overall Study|Adverse Event|2|||
37703574|NCT01957215|69180948|FG000|Overall Study|Lost to Follow-up|3|||
37703575|NCT01957215|69180949|FG001|Overall Study|Lost to Follow-up|3|||
37703576|NCT01957215|69180948|FG000|Overall Study|Protocol Violation|1|||
37703577|NCT01957215|69180949|FG001|Overall Study|Protocol Violation|2|||
37703578|NCT01957215|69180948|FG000|Overall Study|Withdrawal by Subject|7|||
37703579|NCT01957215|69180949|FG001|Overall Study|Withdrawal by Subject|5|||
37703580|NCT02322749|69180959|FG000|Period 2|Adverse Event|0|||
37703581|NCT02322749|69180960|FG001|Period 2|Adverse Event|0|||
37703582|NCT02322749|69180961|FG002|Period 2|Adverse Event|0|||
37703583|NCT02322749|69180962|FG003|Period 2|Adverse Event|1|||
37703584|NCT02322749|69180963|FG004|Period 2|Adverse Event|0|||
37703585|NCT02322749|69180964|FG005|Period 2|Adverse Event|0|||
37703586|NCT02322749|69180959|FG000|Period 2|Withdrawal by Subject|0|||
37703587|NCT02322749|69180960|FG001|Period 2|Withdrawal by Subject|0|||
37703588|NCT02322749|69180961|FG002|Period 2|Withdrawal by Subject|0|||
37703589|NCT02322749|69180962|FG003|Period 2|Withdrawal by Subject|1|||
37703590|NCT02322749|69180963|FG004|Period 2|Withdrawal by Subject|0|||
37703591|NCT02322749|69180964|FG005|Period 2|Withdrawal by Subject|0|||
37703592|NCT02322749|69180959|FG000|Period 3|Withdrawal by Subject|0|||
37703593|NCT02322749|69180960|FG001|Period 3|Withdrawal by Subject|0|||
37915100|NCT00593736|69601793|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
37915101|NCT00593736|69601794|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
37915102|NCT00593736|69601795|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
37915103|NCT00593736|69601796|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
37915104|NCT00593736|69601793|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
37915105|NCT00593736|69601794|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
37915106|NCT00593736|69601795|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
37915107|NCT00593736|69601796|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
37915108|NCT00593736|69601793|FG000|Treatment Period and Placebo Run-out|Various|1|||
37915109|NCT00593736|69601794|FG001|Treatment Period and Placebo Run-out|Various|1|||
37915110|NCT00593736|69601795|FG002|Treatment Period and Placebo Run-out|Various|1|||
37915111|NCT00593736|69601796|FG003|Treatment Period and Placebo Run-out|Various|0|||
37915112|NCT00883688|69601806|FG000|Overall Study|Ineligible|2|||
37915113|NCT03883477|69601812|FG000|Overall Study|Death|1|||
37915114|NCT03883477|69601813|FG001|Overall Study|Death|0|||
37915115|NCT03883477|69601812|FG000|Overall Study|Protocol Violation|0|||
37915116|NCT03883477|69601813|FG001|Overall Study|Protocol Violation|1|||
37915117|NCT00853827|69601821|FG000|Single Blind Period (1 Week)|Other|4|||
37915118|NCT00853827|69601822|FG001|Single Blind Period (1 Week)|Other|0|||
37915119|NCT00853827|69601821|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
37915120|NCT00853827|69601822|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
37915121|NCT00853827|69601821|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
37915122|NCT00853827|69601822|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
37915123|NCT00853827|69601821|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
37915124|NCT00853827|69601822|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
37915125|NCT00853827|69601821|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
37915126|NCT00853827|69601822|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
37915127|NCT00853827|69601821|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
37915128|NCT00853827|69601822|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
37703594|NCT02322749|69180961|FG002|Period 3|Withdrawal by Subject|1|||
37703595|NCT02322749|69180962|FG003|Period 3|Withdrawal by Subject|0|||
37703596|NCT02322749|69180963|FG004|Period 3|Withdrawal by Subject|0|||
37703597|NCT02322749|69180964|FG005|Period 3|Withdrawal by Subject|0|||
37703598|NCT01957137|69180973|FG000|Randomized Portion|Adverse Event|1|||
37703599|NCT01957137|69180973|FG000|Randomized Portion|Withdrawal by Subject|1|||
37703600|NCT01928433|69180988|FG000|Overall Study|Adverse Event|5|||
37703601|NCT01928433|69180989|FG001|Overall Study|Adverse Event|2|||
37703602|NCT01928433|69180990|FG002|Overall Study|Adverse Event|5|||
37703603|NCT01928433|69180988|FG000|Overall Study|Protocol Violation|0|||
37703604|NCT01928433|69180989|FG001|Overall Study|Protocol Violation|0|||
37703605|NCT01928433|69180990|FG002|Overall Study|Protocol Violation|2|||
37703606|NCT01928433|69180988|FG000|Overall Study|Lack of Efficacy|5|||
37703607|NCT01928433|69180989|FG001|Overall Study|Lack of Efficacy|4|||
37703608|NCT01928433|69180990|FG002|Overall Study|Lack of Efficacy|4|||
37703609|NCT01928433|69180988|FG000|Overall Study|Withdrawal by Subject|0|||
37703610|NCT01928433|69180989|FG001|Overall Study|Withdrawal by Subject|4|||
37703611|NCT01928433|69180990|FG002|Overall Study|Withdrawal by Subject|0|||
37703612|NCT01928433|69180988|FG000|Overall Study|Negative screening urine culture|7|||
37703613|NCT01928433|69180989|FG001|Overall Study|Negative screening urine culture|6|||
37703614|NCT01928433|69180990|FG002|Overall Study|Negative screening urine culture|10|||
37915129|NCT00853827|69601821|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
37703615|NCT01928433|69180988|FG000|Overall Study|Lost to Follow-up|0|||
37703616|NCT01928433|69180989|FG001|Overall Study|Lost to Follow-up|2|||
37703617|NCT01928433|69180990|FG002|Overall Study|Lost to Follow-up|3|||
37703618|NCT01928433|69180988|FG000|Overall Study|Other reasons|3|||
37703619|NCT01928433|69180989|FG001|Overall Study|Other reasons|3|||
37703620|NCT01928433|69180990|FG002|Overall Study|Other reasons|4|||
37703621|NCT02322281|69181004|FG000|Overall Study|Progressive Disease|42|||
37703622|NCT02322281|69181005|FG001|Overall Study|Progressive Disease|14|||
37703623|NCT02322281|69181006|FG002|Overall Study|Progressive Disease|49|||
37703624|NCT02322281|69181004|FG000|Overall Study|Adverse Event|3|||
37703625|NCT02322281|69181005|FG001|Overall Study|Adverse Event|4|||
37703626|NCT02322281|69181006|FG002|Overall Study|Adverse Event|6|||
37703627|NCT02322281|69181004|FG000|Overall Study|Death|3|||
37703628|NCT02322281|69181005|FG001|Overall Study|Death|3|||
37703629|NCT02322281|69181006|FG002|Overall Study|Death|3|||
37703630|NCT02322281|69181004|FG000|Overall Study|Withdrawal by Subject|1|||
37703631|NCT02322281|69181005|FG001|Overall Study|Withdrawal by Subject|1|||
37703632|NCT02322281|69181006|FG002|Overall Study|Withdrawal by Subject|6|||
37703633|NCT02322281|69181004|FG000|Overall Study|Physician Decision|2|||
37703634|NCT02322281|69181005|FG001|Overall Study|Physician Decision|0|||
37703635|NCT02322281|69181006|FG002|Overall Study|Physician Decision|5|||
37703636|NCT02322281|69181004|FG000|Overall Study|Study Terminated by Sponsor|2|||
37703637|NCT02322281|69181005|FG001|Overall Study|Study Terminated by Sponsor|0|||
37703638|NCT02322281|69181006|FG002|Overall Study|Study Terminated by Sponsor|0|||
37703639|NCT02322281|69181004|FG000|Overall Study|Missing|0|||
37703640|NCT02322281|69181005|FG001|Overall Study|Missing|0|||
37703641|NCT02322281|69181006|FG002|Overall Study|Missing|1|||
37703642|NCT02322281|69181004|FG000|Overall Study|Miscellaneous|0|||
37703643|NCT02322281|69181005|FG001|Overall Study|Miscellaneous|0|||
37703644|NCT02322281|69181006|FG002|Overall Study|Miscellaneous|4|||
37915130|NCT00853827|69601822|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
37703645|NCT02322125|69181016|FG000|Overall Study|Withdrawal by Subject|2|||
37703646|NCT02243293|69181037|FG000|Overall Study|Adverse Event|1|||
37703647|NCT02243293|69181038|FG001|Overall Study|Adverse Event|0|||
37703648|NCT02243293|69181039|FG002|Overall Study|Adverse Event|0|||
37703649|NCT02243293|69181040|FG003|Overall Study|Adverse Event|0|||
37703650|NCT02243293|69181041|FG004|Overall Study|Adverse Event|0|||
37703651|NCT02243293|69181042|FG005|Overall Study|Adverse Event|0|||
37703652|NCT02243293|69181043|FG006|Overall Study|Adverse Event|0|||
37703653|NCT02243293|69181044|FG007|Overall Study|Adverse Event|0|||
37703654|NCT02243293|69181045|FG008|Overall Study|Adverse Event|0|||
37703655|NCT02243293|69181046|FG009|Overall Study|Adverse Event|0|||
37703656|NCT02243293|69181047|FG010|Overall Study|Adverse Event|0|||
37703657|NCT02243293|69181048|FG011|Overall Study|Adverse Event|0|||
37703658|NCT02243293|69181049|FG012|Overall Study|Adverse Event|0|||
37703659|NCT02243293|69181050|FG013|Overall Study|Adverse Event|0|||
37703660|NCT02243293|69181051|FG014|Overall Study|Adverse Event|0|||
37703661|NCT02243293|69181052|FG015|Overall Study|Adverse Event|1|||
37703662|NCT02243293|69181053|FG016|Overall Study|Adverse Event|0|||
37703663|NCT02243293|69181054|FG017|Overall Study|Adverse Event|0|||
37703664|NCT02243293|69181055|FG018|Overall Study|Adverse Event|0|||
37703665|NCT02243293|69181056|FG019|Overall Study|Adverse Event|0|||
37703666|NCT02243293|69181057|FG020|Overall Study|Adverse Event|1|||
37703667|NCT02243293|69181058|FG021|Overall Study|Adverse Event|0|||
37703668|NCT02243293|69181037|FG000|Overall Study|Withdrawal by Subject|1|||
37703669|NCT02243293|69181038|FG001|Overall Study|Withdrawal by Subject|0|||
37703670|NCT02243293|69181039|FG002|Overall Study|Withdrawal by Subject|0|||
37703671|NCT02243293|69181040|FG003|Overall Study|Withdrawal by Subject|0|||
37703672|NCT02243293|69181041|FG004|Overall Study|Withdrawal by Subject|0|||
37703673|NCT02243293|69181042|FG005|Overall Study|Withdrawal by Subject|0|||
37703674|NCT02243293|69181043|FG006|Overall Study|Withdrawal by Subject|0|||
37703675|NCT02243293|69181044|FG007|Overall Study|Withdrawal by Subject|0|||
37703676|NCT02243293|69181045|FG008|Overall Study|Withdrawal by Subject|0|||
37703677|NCT02243293|69181046|FG009|Overall Study|Withdrawal by Subject|1|||
37703678|NCT02243293|69181047|FG010|Overall Study|Withdrawal by Subject|0|||
37703679|NCT02243293|69181048|FG011|Overall Study|Withdrawal by Subject|1|||
37703680|NCT02243293|69181049|FG012|Overall Study|Withdrawal by Subject|0|||
37703681|NCT02243293|69181050|FG013|Overall Study|Withdrawal by Subject|0|||
37703682|NCT02243293|69181051|FG014|Overall Study|Withdrawal by Subject|0|||
37703683|NCT02243293|69181052|FG015|Overall Study|Withdrawal by Subject|0|||
37703684|NCT02243293|69181053|FG016|Overall Study|Withdrawal by Subject|0|||
37703685|NCT02243293|69181054|FG017|Overall Study|Withdrawal by Subject|0|||
37703686|NCT02243293|69181055|FG018|Overall Study|Withdrawal by Subject|0|||
37703687|NCT02243293|69181056|FG019|Overall Study|Withdrawal by Subject|0|||
37703688|NCT02243293|69181057|FG020|Overall Study|Withdrawal by Subject|0|||
37703689|NCT02243293|69181058|FG021|Overall Study|Withdrawal by Subject|1|||
37703690|NCT02243293|69181037|FG000|Overall Study|Lost to Follow-up|0|||
37703691|NCT02243293|69181038|FG001|Overall Study|Lost to Follow-up|1|||
37703692|NCT02243293|69181039|FG002|Overall Study|Lost to Follow-up|1|||
37703693|NCT02243293|69181040|FG003|Overall Study|Lost to Follow-up|1|||
37837397|NCT01155466|69521798|FG004|Overall Study|Protocol Violation|1|||
37837398|NCT01155466|69521794|FG000|Overall Study|Administrative|0|||
37837399|NCT01155466|69521795|FG001|Overall Study|Administrative|3|||
38023886|NCT02927080|69707228|FG001|Overall Study|Willingness to comply with protocol|0|||
37703694|NCT02243293|69181041|FG004|Overall Study|Lost to Follow-up|0|||
37703695|NCT02243293|69181042|FG005|Overall Study|Lost to Follow-up|0|||
37703696|NCT02243293|69181043|FG006|Overall Study|Lost to Follow-up|3|||
37703697|NCT02243293|69181044|FG007|Overall Study|Lost to Follow-up|0|||
37703698|NCT02243293|69181045|FG008|Overall Study|Lost to Follow-up|0|||
37703699|NCT02243293|69181046|FG009|Overall Study|Lost to Follow-up|0|||
37703700|NCT02243293|69181047|FG010|Overall Study|Lost to Follow-up|0|||
37703701|NCT02243293|69181048|FG011|Overall Study|Lost to Follow-up|2|||
37703702|NCT02243293|69181049|FG012|Overall Study|Lost to Follow-up|0|||
37703703|NCT02243293|69181050|FG013|Overall Study|Lost to Follow-up|0|||
37703704|NCT02243293|69181051|FG014|Overall Study|Lost to Follow-up|0|||
37703705|NCT02243293|69181052|FG015|Overall Study|Lost to Follow-up|0|||
37703706|NCT02243293|69181053|FG016|Overall Study|Lost to Follow-up|3|||
37703707|NCT02243293|69181054|FG017|Overall Study|Lost to Follow-up|1|||
37703708|NCT02243293|69181055|FG018|Overall Study|Lost to Follow-up|0|||
37703709|NCT02243293|69181056|FG019|Overall Study|Lost to Follow-up|0|||
37703710|NCT02243293|69181057|FG020|Overall Study|Lost to Follow-up|1|||
37703711|NCT02243293|69181058|FG021|Overall Study|Lost to Follow-up|2|||
37703712|NCT02243293|69181037|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
37703713|NCT02243293|69181038|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
37703714|NCT02243293|69181039|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
37703715|NCT02243293|69181040|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
37703716|NCT02243293|69181041|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
37703717|NCT02243293|69181042|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
37703718|NCT02243293|69181043|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
37703719|NCT02243293|69181044|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
37703720|NCT02243293|69181045|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
37703721|NCT02243293|69181046|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
37703722|NCT02243293|69181047|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
37703723|NCT02243293|69181048|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
37703724|NCT02243293|69181049|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
37703725|NCT02243293|69181050|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
37703726|NCT02243293|69181051|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
37703727|NCT02243293|69181052|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
37703728|NCT02243293|69181053|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
37703729|NCT02243293|69181054|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
37703730|NCT02243293|69181055|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
37703731|NCT02243293|69181056|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
37703732|NCT02243293|69181057|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
37703733|NCT02243293|69181058|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
37703734|NCT02243293|69181037|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
37703735|NCT02243293|69181038|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
37703736|NCT02243293|69181039|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
37703737|NCT02243293|69181040|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
37703738|NCT02243293|69181041|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
37703739|NCT02243293|69181042|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
37915131|NCT00853827|69601821|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
37915132|NCT00853827|69601822|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
37703740|NCT02243293|69181043|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
37703741|NCT02243293|69181044|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
37703742|NCT02243293|69181045|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
37703743|NCT02243293|69181046|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
37703744|NCT02243293|69181047|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
37703745|NCT02243293|69181048|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
37703746|NCT02243293|69181049|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
37703747|NCT02243293|69181050|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
37703748|NCT02243293|69181051|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
37703749|NCT02243293|69181052|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
37703750|NCT02243293|69181053|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
37703751|NCT02243293|69181054|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
37703752|NCT02243293|69181055|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
37703753|NCT02243293|69181056|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
37703754|NCT02243293|69181057|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
37703755|NCT02243293|69181058|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
37703756|NCT02322047|69181099|FG000|Overall Study|Physician Decision|1|||
37703757|NCT02322047|69181100|FG001|Overall Study|Physician Decision|0|||
37703758|NCT02322047|69181101|FG002|Overall Study|Physician Decision|0|||
37703759|NCT02322047|69181102|FG003|Overall Study|Physician Decision|0|||
37703760|NCT02322047|69181099|FG000|Overall Study|Withdrawal by Subject|1|||
37703761|NCT02322047|69181100|FG001|Overall Study|Withdrawal by Subject|0|||
37703762|NCT02322047|69181101|FG002|Overall Study|Withdrawal by Subject|0|||
37703763|NCT02322047|69181102|FG003|Overall Study|Withdrawal by Subject|1|||
37703764|NCT02322047|69181099|FG000|Overall Study|Adverse Event|0|||
37703765|NCT02322047|69181100|FG001|Overall Study|Adverse Event|1|||
37703766|NCT02322047|69181101|FG002|Overall Study|Adverse Event|0|||
37703767|NCT02322047|69181102|FG003|Overall Study|Adverse Event|0|||
37703768|NCT02322047|69181099|FG000|Overall Study|Lost to Follow-up|0|||
37703769|NCT02322047|69181100|FG001|Overall Study|Lost to Follow-up|0|||
37703770|NCT02322047|69181101|FG002|Overall Study|Lost to Follow-up|1|||
37703771|NCT02322047|69181102|FG003|Overall Study|Lost to Follow-up|1|||
37703772|NCT02254291|69181115|FG000|Overall Study|Withdrawal by Subject|0|||
37703773|NCT02254291|69181116|FG001|Overall Study|Withdrawal by Subject|3|||
37703774|NCT02254291|69181117|FG002|Overall Study|Withdrawal by Subject|1|||
37703775|NCT02254291|69181115|FG000|Overall Study|Missing follow-up information|0|||
37703776|NCT02254291|69181116|FG001|Overall Study|Missing follow-up information|0|||
37703777|NCT02254291|69181117|FG002|Overall Study|Missing follow-up information|1|||
37703778|NCT02253433|69181127|FG000|Overall Study|Unable to Contact|9|||
37703779|NCT02253433|69181128|FG001|Overall Study|Unable to Contact|16|||
37703780|NCT02253433|69181127|FG000|Overall Study|Death|1|||
37703781|NCT02253433|69181128|FG001|Overall Study|Death|1|||
37703782|NCT02253433|69181127|FG000|Overall Study|No Longer Interested|3|||
37703783|NCT02253433|69181128|FG001|Overall Study|No Longer Interested|15|||
37703784|NCT02253433|69181127|FG000|Overall Study|Out of Study Area|2|||
37703785|NCT02253433|69181128|FG001|Overall Study|Out of Study Area|7|||
37703786|NCT02253433|69181127|FG000|Overall Study|Uncomfortable with home visitors|0|||
37703787|NCT02253433|69181128|FG001|Overall Study|Uncomfortable with home visitors|3|||
37703788|NCT02253433|69181127|FG000|Overall Study|Unstable Housing/Homeless|0|||
37703789|NCT02253433|69181128|FG001|Overall Study|Unstable Housing/Homeless|7|||
37703790|NCT02253433|69181127|FG000|Overall Study|Too Busy|0|||
37703791|NCT02253433|69181128|FG001|Overall Study|Too Busy|4|||
37703792|NCT02253433|69181127|FG000|Overall Study|Medical or Other Concerns|1|||
37703793|NCT02253433|69181128|FG001|Overall Study|Medical or Other Concerns|2|||
37703794|NCT02242981|69181135|FG000|Overall Study|Withdrawal by Subject|1|||
37837400|NCT01155466|69521796|FG002|Overall Study|Administrative|0|||
37837401|NCT01155466|69521797|FG003|Overall Study|Administrative|0|||
37837402|NCT01155466|69521798|FG004|Overall Study|Administrative|0|||
37703795|NCT02277743|69181142|FG000|Overall Study|Protocol Violation|1|||
37703796|NCT02277743|69181143|FG001|Overall Study|Protocol Violation|1|||
37703797|NCT02277743|69181144|FG002|Overall Study|Protocol Violation|1|||
37703798|NCT02277743|69181142|FG000|Overall Study|Adverse Event|10|||
37837403|NCT01155466|69521794|FG000|Overall Study|Randomized not treated|2|||
37837404|NCT01155466|69521795|FG001|Overall Study|Randomized not treated|2|||
37837405|NCT01155466|69521796|FG002|Overall Study|Randomized not treated|3|||
37837406|NCT01155466|69521797|FG003|Overall Study|Randomized not treated|0|||
37837407|NCT01155466|69521798|FG004|Overall Study|Randomized not treated|2|||
37837408|NCT01155388|69521812|FG000|Overall Study|Adverse Event|1|||
37703799|NCT02277743|69181143|FG001|Overall Study|Adverse Event|6|||
37703800|NCT02277743|69181144|FG002|Overall Study|Adverse Event|6|||
37837409|NCT01155388|69521813|FG001|Overall Study|Adverse Event|0|||
37837410|NCT01154452|69521824|FG000|Phase Ib|Not Treated|1|||
37837411|NCT01154452|69521825|FG001|Phase Ib|Not Treated|0|||
37677364|NCT01659255|69152298|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
37677365|NCT01659255|69152299|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
37677366|NCT01659255|69152300|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
37677367|NCT01659255|69152301|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
37677368|NCT01659255|69152302|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
37677369|NCT01659255|69152303|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
37677370|NCT01659255|69152304|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
37677371|NCT01659255|69152288|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
37677372|NCT01659255|69152289|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
37703801|NCT02277743|69181142|FG000|Overall Study|Lack of Efficacy|11|||
37703802|NCT02277743|69181143|FG001|Overall Study|Lack of Efficacy|4|||
37703803|NCT02277743|69181144|FG002|Overall Study|Lack of Efficacy|3|||
37703804|NCT02277743|69181142|FG000|Overall Study|Other than specified above|18|||
37703805|NCT02277743|69181143|FG001|Overall Study|Other than specified above|5|||
37703806|NCT02277743|69181144|FG002|Overall Study|Other than specified above|16|||
37703807|NCT02242903|69181159|FG000|Overall Study|Withdrawal by Subject|1|||
37703808|NCT02242903|69181160|FG001|Overall Study|Withdrawal by Subject|0|||
37703809|NCT02242903|69181161|FG002|Overall Study|Withdrawal by Subject|0|||
37703810|NCT02242903|69181162|FG003|Overall Study|Withdrawal by Subject|0|||
37703811|NCT02242903|69181163|FG004|Overall Study|Withdrawal by Subject|0|||
37703812|NCT02242903|69181164|FG005|Overall Study|Withdrawal by Subject|0|||
37703813|NCT02242903|69181165|FG006|Overall Study|Withdrawal by Subject|0|||
37703814|NCT02320721|69181189|FG000|Overall Study|Adverse Event|6|||
37703815|NCT02320721|69181190|FG001|Overall Study|Adverse Event|6|||
37703816|NCT02320721|69181189|FG000|Overall Study|Lack of Efficacy|2|||
37703817|NCT02320721|69181190|FG001|Overall Study|Lack of Efficacy|0|||
37703818|NCT02320721|69181189|FG000|Overall Study|Poor compliance to protocol|3|||
37703819|NCT02320721|69181190|FG001|Overall Study|Poor compliance to protocol|7|||
37703820|NCT02320721|69181189|FG000|Overall Study|Randomized but not treated|0|||
37703821|NCT02320721|69181190|FG001|Overall Study|Randomized but not treated|1|||
37703822|NCT02320721|69181189|FG000|Overall Study|Hypoglycemia|1|||
37703823|NCT02320721|69181190|FG001|Overall Study|Hypoglycemia|0|||
37703824|NCT02320721|69181189|FG000|Overall Study|Other than specified above|15|||
37703825|NCT02320721|69181190|FG001|Overall Study|Other than specified above|20|||
37703826|NCT02320487|69181196|FG000|Overall Study|Reason not Specified|1|||
37703827|NCT02320487|69181196|FG000|Overall Study|Physician Decision|5|||
37703828|NCT02320487|69181196|FG000|Overall Study|Withdrawal by Subject|1|||
37703829|NCT02320487|69181196|FG000|Overall Study|Death|3|||
37703830|NCT02320487|69181196|FG000|Overall Study|Adverse Event|11|||
37703831|NCT02277119|69181203|FG000|Overall Study|Lack of Efficacy|1|||
37703832|NCT02277119|69181204|FG001|Overall Study|Lack of Efficacy|1|||
37703833|NCT02277119|69181205|FG002|Overall Study|Lack of Efficacy|1|||
37703834|NCT02277119|69181203|FG000|Overall Study|Protocol Violation|2|||
37703835|NCT02277119|69181204|FG001|Overall Study|Protocol Violation|3|||
37703836|NCT02277119|69181205|FG002|Overall Study|Protocol Violation|7|||
37703837|NCT02320253|69181216|FG000|Overall Study|Withdrawal by Subject|3|||
37703838|NCT02320253|69181217|FG001|Overall Study|Withdrawal by Subject|0|||
37703839|NCT02320253|69181218|FG002|Overall Study|Withdrawal by Subject|0|||
37703840|NCT02320253|69181216|FG000|Overall Study|Lost to Follow-up|2|||
37703841|NCT02320253|69181217|FG001|Overall Study|Lost to Follow-up|2|||
37703842|NCT02320253|69181218|FG002|Overall Study|Lost to Follow-up|1|||
37703843|NCT02320253|69181216|FG000|Overall Study|Death|1|||
37703844|NCT02320253|69181217|FG001|Overall Study|Death|0|||
37703845|NCT02320253|69181218|FG002|Overall Study|Death|1|||
37703846|NCT02276807|69181228|FG000|Overall Study|Withdrawal by Subject|8|||
37703847|NCT02276807|69181229|FG001|Overall Study|Withdrawal by Subject|7|||
37703848|NCT02276807|69181228|FG000|Overall Study|Lost to Follow-up|10|||
37703849|NCT02276807|69181229|FG001|Overall Study|Lost to Follow-up|10|||
37703850|NCT02252965|69181237|FG000|Overall Study|Adverse Event|9|||
37703851|NCT02252965|69181238|FG001|Overall Study|Adverse Event|14|||
37703852|NCT02252965|69181237|FG000|Overall Study|Lost to Follow-up|16|||
37703853|NCT02252965|69181238|FG001|Overall Study|Lost to Follow-up|8|||
37703854|NCT02252965|69181237|FG000|Overall Study|Protocol Violation|4|||
37703855|NCT02252965|69181238|FG001|Overall Study|Protocol Violation|5|||
37703856|NCT02252965|69181237|FG000|Overall Study|Lack of Efficacy|0|||
37703857|NCT02252965|69181238|FG001|Overall Study|Lack of Efficacy|2|||
37703858|NCT02252965|69181237|FG000|Overall Study|Withdrawal by Subject|7|||
37703859|NCT02252965|69181238|FG001|Overall Study|Withdrawal by Subject|9|||
37703860|NCT02252965|69181237|FG000|Overall Study|Other|4|||
37703861|NCT02252965|69181238|FG001|Overall Study|Other|5|||
37703862|NCT02242435|69181248|FG000|Overall Study|Lost to Follow-up|3|||
37703863|NCT02242435|69181249|FG001|Overall Study|Lost to Follow-up|4|||
37703864|NCT02242435|69181248|FG000|Overall Study|Adverse Event|3|||
37703865|NCT02242435|69181249|FG001|Overall Study|Adverse Event|2|||
37703866|NCT02242435|69181248|FG000|Overall Study|Withdrawal by Subject|13|||
37703867|NCT02242435|69181249|FG001|Overall Study|Withdrawal by Subject|8|||
37703868|NCT02242435|69181248|FG000|Overall Study|Death|0|||
37703869|NCT02242435|69181249|FG001|Overall Study|Death|1|||
37703870|NCT02242435|69181248|FG000|Overall Study|Protocol Violation|1|||
37703871|NCT02242435|69181249|FG001|Overall Study|Protocol Violation|0|||
37703872|NCT02242435|69181248|FG000|Overall Study|Physician Decision|0|||
37703873|NCT02242435|69181249|FG001|Overall Study|Physician Decision|1|||
37703874|NCT02251717|69181257|FG000|Overall Study|Adverse Event|0|||
37703875|NCT02251717|69181258|FG001|Overall Study|Adverse Event|1|||
37703876|NCT02251717|69181257|FG000|Overall Study|Withdrew Consent|1|||
37703877|NCT02251717|69181258|FG001|Overall Study|Withdrew Consent|0|||
37703878|NCT02242201|69181267|FG000|Overall Study|preoperative identified neuropathy|2|||
37703879|NCT02242201|69181268|FG001|Overall Study|preoperative identified neuropathy|0|||
37703880|NCT02242201|69181269|FG002|Overall Study|preoperative identified neuropathy|0|||
37703881|NCT02242201|69181267|FG000|Overall Study|planned post-op anticoagulation|1|||
37703882|NCT02242201|69181268|FG001|Overall Study|planned post-op anticoagulation|0|||
37703883|NCT02242201|69181269|FG002|Overall Study|planned post-op anticoagulation|0|||
37703884|NCT02242201|69181267|FG000|Overall Study|changed surgical procedure|1|||
37703885|NCT02242201|69181268|FG001|Overall Study|changed surgical procedure|0|||
37703886|NCT02242201|69181269|FG002|Overall Study|changed surgical procedure|0|||
37703887|NCT02242201|69181267|FG000|Overall Study|postponed surgery|0|||
37703888|NCT02242201|69181268|FG001|Overall Study|postponed surgery|0|||
37703889|NCT02242201|69181269|FG002|Overall Study|postponed surgery|1|||
37703890|NCT02242201|69181267|FG000|Overall Study|preoperative opioid consumption|0|||
37703891|NCT02242201|69181268|FG001|Overall Study|preoperative opioid consumption|1|||
37703892|NCT02242201|69181269|FG002|Overall Study|preoperative opioid consumption|0|||
37703893|NCT02242045|69181277|FG000|Overall Study|Investigator's Discretion|1|||
37703894|NCT02242045|69181277|FG000|Overall Study|Progressive Disease|2|||
37703895|NCT02242045|69181277|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
37703896|NCT02242045|69181277|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
37703897|NCT02241889|69181281|FG000|Overall Study|device issues|0|||
37703898|NCT02241889|69181282|FG001|Overall Study|device issues|0|||
37703899|NCT02241889|69181283|FG002|Overall Study|device issues|1|||
37703900|NCT02241889|69181284|FG003|Overall Study|device issues|0|||
37703901|NCT02241889|69181285|FG004|Overall Study|device issues|0|||
37703902|NCT02241889|69181286|FG005|Overall Study|device issues|0|||
37703903|NCT02241889|69181281|FG000|Overall Study|Withdrawal by Subject|0|||
37703904|NCT02241889|69181282|FG001|Overall Study|Withdrawal by Subject|0|||
37703905|NCT02241889|69181283|FG002|Overall Study|Withdrawal by Subject|0|||
37703906|NCT02241889|69181284|FG003|Overall Study|Withdrawal by Subject|0|||
37703907|NCT02241889|69181285|FG004|Overall Study|Withdrawal by Subject|0|||
37703908|NCT02241889|69181286|FG005|Overall Study|Withdrawal by Subject|1|||
37703909|NCT02241733|69181296|FG000|Overall Study|Lost to Follow-up|9|||
37703910|NCT02241733|69181297|FG001|Overall Study|Lost to Follow-up|4|||
37703911|NCT02241733|69181296|FG000|Overall Study|Physician Decision|6|||
37703912|NCT02241733|69181297|FG001|Overall Study|Physician Decision|2|||
37703913|NCT02241733|69181296|FG000|Overall Study|Withdrawal by Subject|0|||
37703914|NCT02241733|69181297|FG001|Overall Study|Withdrawal by Subject|2|||
37703915|NCT02241733|69181296|FG000|Overall Study|Death|0|||
37703916|NCT02241733|69181297|FG001|Overall Study|Death|2|||
37703917|NCT02241343|69181303|FG000|Overall Study|Adverse Event|1|||
37703918|NCT02241187|69181308|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
37703919|NCT02249767|69181315|FG000|Overall Study|Did not use medication|8|||
37703920|NCT02249767|69181316|FG001|Overall Study|Did not use medication|9|||
37703921|NCT02249767|69181317|FG002|Overall Study|Did not use medication|8|||
37703922|NCT02239939|69181327|FG000|Overall Study|Adverse Event|1|||
37703923|NCT02239939|69181328|FG001|Overall Study|Adverse Event|0|||
37703924|NCT02239939|69181327|FG000|Overall Study|Withdrawal by Subject|1|||
37703925|NCT02239939|69181328|FG001|Overall Study|Withdrawal by Subject|1|||
37837412|NCT01154452|69521826|FG002|Phase Ib|Not Treated|0|||
37837413|NCT01154452|69521827|FG003|Phase Ib|Not Treated|0|||
37837414|NCT01154452|69521824|FG000|Phase Ib|Adverse Event|2|||
37837415|NCT01154452|69521825|FG001|Phase Ib|Adverse Event|1|||
37703926|NCT02239939|69181327|FG000|Overall Study|Lost to Follow-up|0|||
37703927|NCT02239939|69181328|FG001|Overall Study|Lost to Follow-up|1|||
37703928|NCT02248675|69181338|FG000|Overall Study|Lost to Follow-up|3|||
37703929|NCT02248675|69181339|FG001|Overall Study|Lost to Follow-up|1|||
37703930|NCT02238379|69181347|FG000|Overall Study|Lost to Follow-up|1|||
37703931|NCT02238379|69181348|FG001|Overall Study|Lost to Follow-up|0|||
37703932|NCT02238067|69181354|FG000|Overall Study|Not completed survey at Month 6|45|||
37703933|NCT02237911|69181361|FG000|Overall Study|Withdrawal by Subject|4|||
37703934|NCT02237911|69181362|FG001|Overall Study|Withdrawal by Subject|7|||
37703935|NCT02237911|69181363|FG002|Overall Study|Withdrawal by Subject|2|||
37703936|NCT02237911|69181361|FG000|Overall Study|Lost to Follow-up|3|||
37703937|NCT02237911|69181362|FG001|Overall Study|Lost to Follow-up|1|||
37703938|NCT02237911|69181363|FG002|Overall Study|Lost to Follow-up|1|||
37837416|NCT01154452|69521826|FG002|Phase Ib|Adverse Event|0|||
37703939|NCT02234479|69181373|FG000|Overall Study|Withdrawal by Subject|1|||
37703940|NCT02234479|69181374|FG001|Overall Study|Withdrawal by Subject|3|||
37703941|NCT02207491|69181382|FG000|Overall Study|Adverse Event|20|||
37703942|NCT02207491|69181383|FG001|Overall Study|Adverse Event|4|||
37703943|NCT02207491|69181382|FG000|Overall Study|Withdrawal by Subject|3|||
37703944|NCT02207491|69181383|FG001|Overall Study|Withdrawal by Subject|2|||
37703945|NCT02207491|69181382|FG000|Overall Study|Non-compliant|0|||
37703946|NCT02207491|69181383|FG001|Overall Study|Non-compliant|1|||
37703947|NCT02207491|69181382|FG000|Overall Study|Lost to Follow-up|0|||
37703948|NCT02207491|69181383|FG001|Overall Study|Lost to Follow-up|1|||
37703949|NCT02207491|69181382|FG000|Overall Study|Lack of Efficacy|3|||
37703950|NCT02207491|69181383|FG001|Overall Study|Lack of Efficacy|0|||
37703951|NCT02207491|69181382|FG000|Overall Study|Physician Decision|2|||
37703952|NCT02207491|69181383|FG001|Overall Study|Physician Decision|0|||
37703953|NCT02207491|69181382|FG000|Overall Study|Protocol Violation|3|||
37703954|NCT02207491|69181383|FG001|Overall Study|Protocol Violation|5|||
37703955|NCT02315066|69181403|FG000|Overall Study|Lost to Follow-up|0|||
37703956|NCT02315066|69181404|FG001|Overall Study|Lost to Follow-up|1|||
37703957|NCT02315066|69181405|FG002|Overall Study|Lost to Follow-up|1|||
37703958|NCT02315066|69181406|FG003|Overall Study|Lost to Follow-up|0|||
37703959|NCT02315066|69181407|FG004|Overall Study|Lost to Follow-up|1|||
37703960|NCT02315066|69181408|FG005|Overall Study|Lost to Follow-up|0|||
37703961|NCT02315066|69181409|FG006|Overall Study|Lost to Follow-up|2|||
37703962|NCT02315066|69181410|FG007|Overall Study|Lost to Follow-up|1|||
37703963|NCT02315066|69181411|FG008|Overall Study|Lost to Follow-up|0|||
37703964|NCT02315066|69181412|FG009|Overall Study|Lost to Follow-up|0|||
37703965|NCT02315066|69181413|FG010|Overall Study|Lost to Follow-up|1|||
37703966|NCT02315066|69181414|FG011|Overall Study|Lost to Follow-up|2|||
37703967|NCT02315066|69181415|FG012|Overall Study|Lost to Follow-up|0|||
37703968|NCT02315066|69181416|FG013|Overall Study|Lost to Follow-up|4|||
37703969|NCT02315066|69181403|FG000|Overall Study|Death|2|||
37703970|NCT02315066|69181404|FG001|Overall Study|Death|7|||
37703971|NCT02315066|69181405|FG002|Overall Study|Death|6|||
37703972|NCT02315066|69181406|FG003|Overall Study|Death|11|||
37703973|NCT02315066|69181407|FG004|Overall Study|Death|10|||
37703974|NCT02315066|69181408|FG005|Overall Study|Death|3|||
37703975|NCT02315066|69181409|FG006|Overall Study|Death|9|||
37703976|NCT02315066|69181410|FG007|Overall Study|Death|9|||
37703977|NCT02315066|69181411|FG008|Overall Study|Death|10|||
37703978|NCT02315066|69181412|FG009|Overall Study|Death|8|||
37703979|NCT02315066|69181413|FG010|Overall Study|Death|10|||
37703980|NCT02315066|69181414|FG011|Overall Study|Death|7|||
37703981|NCT02315066|69181415|FG012|Overall Study|Death|8|||
37703982|NCT02315066|69181416|FG013|Overall Study|Death|21|||
37703983|NCT02315066|69181403|FG000|Overall Study|Other|0|||
37703984|NCT02315066|69181404|FG001|Overall Study|Other|0|||
37703985|NCT02315066|69181405|FG002|Overall Study|Other|0|||
37703986|NCT02315066|69181406|FG003|Overall Study|Other|0|||
37703987|NCT02315066|69181407|FG004|Overall Study|Other|0|||
37703988|NCT02315066|69181408|FG005|Overall Study|Other|0|||
37703989|NCT02315066|69181409|FG006|Overall Study|Other|0|||
37703990|NCT02315066|69181410|FG007|Overall Study|Other|1|||
37703991|NCT02315066|69181411|FG008|Overall Study|Other|1|||
37703992|NCT02315066|69181412|FG009|Overall Study|Other|2|||
37703993|NCT02315066|69181413|FG010|Overall Study|Other|0|||
37703994|NCT02315066|69181414|FG011|Overall Study|Other|0|||
37703995|NCT02315066|69181415|FG012|Overall Study|Other|0|||
37703996|NCT02315066|69181416|FG013|Overall Study|Other|0|||
37703997|NCT02315066|69181403|FG000|Overall Study|Subject refused further follow-up|0|||
37703998|NCT02315066|69181404|FG001|Overall Study|Subject refused further follow-up|2|||
37703999|NCT02315066|69181405|FG002|Overall Study|Subject refused further follow-up|2|||
37704000|NCT02315066|69181406|FG003|Overall Study|Subject refused further follow-up|0|||
37704001|NCT02315066|69181407|FG004|Overall Study|Subject refused further follow-up|0|||
37704002|NCT02315066|69181408|FG005|Overall Study|Subject refused further follow-up|0|||
37704003|NCT02315066|69181409|FG006|Overall Study|Subject refused further follow-up|2|||
37704004|NCT02315066|69181410|FG007|Overall Study|Subject refused further follow-up|3|||
37704005|NCT02315066|69181411|FG008|Overall Study|Subject refused further follow-up|0|||
37704006|NCT02315066|69181412|FG009|Overall Study|Subject refused further follow-up|1|||
37704007|NCT02315066|69181413|FG010|Overall Study|Subject refused further follow-up|1|||
37704008|NCT02315066|69181414|FG011|Overall Study|Subject refused further follow-up|2|||
37704009|NCT02315066|69181415|FG012|Overall Study|Subject refused further follow-up|2|||
37704010|NCT02315066|69181416|FG013|Overall Study|Subject refused further follow-up|4|||
37704011|NCT02315066|69181403|FG000|Overall Study|Study ongoing at date of cut-off|0|||
37704012|NCT02315066|69181404|FG001|Overall Study|Study ongoing at date of cut-off|0|||
37704013|NCT02315066|69181405|FG002|Overall Study|Study ongoing at date of cut-off|0|||
37704014|NCT02315066|69181406|FG003|Overall Study|Study ongoing at date of cut-off|0|||
37704015|NCT02315066|69181407|FG004|Overall Study|Study ongoing at date of cut-off|0|||
37704016|NCT02315066|69181408|FG005|Overall Study|Study ongoing at date of cut-off|0|||
37704017|NCT02315066|69181409|FG006|Overall Study|Study ongoing at date of cut-off|0|||
37704018|NCT02315066|69181410|FG007|Overall Study|Study ongoing at date of cut-off|0|||
37704019|NCT02315066|69181411|FG008|Overall Study|Study ongoing at date of cut-off|0|||
37704020|NCT02315066|69181412|FG009|Overall Study|Study ongoing at date of cut-off|0|||
37704021|NCT02315066|69181413|FG010|Overall Study|Study ongoing at date of cut-off|0|||
37704022|NCT02315066|69181414|FG011|Overall Study|Study ongoing at date of cut-off|0|||
37704023|NCT02315066|69181415|FG012|Overall Study|Study ongoing at date of cut-off|0|||
37704024|NCT02315066|69181416|FG013|Overall Study|Study ongoing at date of cut-off|1|||
37704025|NCT02207413|69181452|FG000|Overall Study|Withdrawal by Subject|1|||
37704026|NCT02207413|69181453|FG001|Overall Study|Withdrawal by Subject|0|||
37704027|NCT02207413|69181454|FG002|Overall Study|Withdrawal by Subject|0|||
37704028|NCT02207413|69181455|FG003|Overall Study|Withdrawal by Subject|0|||
37704029|NCT02207413|69181456|FG004|Overall Study|Withdrawal by Subject|3|||
37704030|NCT02207413|69181457|FG005|Overall Study|Withdrawal by Subject|7|||
37704031|NCT02207413|69181452|FG000|Overall Study|Lost to Follow-up|0|||
37704032|NCT02207413|69181453|FG001|Overall Study|Lost to Follow-up|0|||
37704033|NCT02207413|69181454|FG002|Overall Study|Lost to Follow-up|0|||
37704034|NCT02207413|69181455|FG003|Overall Study|Lost to Follow-up|1|||
37704035|NCT02207413|69181456|FG004|Overall Study|Lost to Follow-up|1|||
37704036|NCT02207413|69181457|FG005|Overall Study|Lost to Follow-up|5|||
37704037|NCT02207413|69181452|FG000|Overall Study|Adverse Event|0|||
37704038|NCT02207413|69181453|FG001|Overall Study|Adverse Event|0|||
37704039|NCT02207413|69181454|FG002|Overall Study|Adverse Event|0|||
37704040|NCT02207413|69181455|FG003|Overall Study|Adverse Event|0|||
37704041|NCT02207413|69181456|FG004|Overall Study|Adverse Event|2|||
37704042|NCT02207413|69181457|FG005|Overall Study|Adverse Event|1|||
37704043|NCT02207413|69181452|FG000|Overall Study|Migrated/moved from study area|0|||
37704044|NCT02207413|69181453|FG001|Overall Study|Migrated/moved from study area|0|||
37704045|NCT02207413|69181454|FG002|Overall Study|Migrated/moved from study area|0|||
37704046|NCT02207413|69181455|FG003|Overall Study|Migrated/moved from study area|0|||
37704047|NCT02207413|69181456|FG004|Overall Study|Migrated/moved from study area|1|||
37704048|NCT02207413|69181457|FG005|Overall Study|Migrated/moved from study area|0|||
37704049|NCT02309372|69181479|FG000|Overall Study|Lost to Follow-up|3|||
37704050|NCT02309372|69181480|FG001|Overall Study|Lost to Follow-up|2|||
37704051|NCT02276027|69181490|FG000|Overall Study|Death|1|||
37704052|NCT02276027|69181491|FG001|Overall Study|Death|0|||
37704053|NCT02276027|69181492|FG002|Overall Study|Death|0|||
37704054|NCT02276027|69181493|FG003|Overall Study|Death|2|||
37704055|NCT02276027|69181490|FG000|Overall Study|Physician Decision|0|||
37704056|NCT02276027|69181491|FG001|Overall Study|Physician Decision|0|||
37704057|NCT02276027|69181492|FG002|Overall Study|Physician Decision|0|||
37704058|NCT02276027|69181493|FG003|Overall Study|Physician Decision|1|||
37704059|NCT02276027|69181490|FG000|Overall Study|Progressive disease|1|||
37704060|NCT02276027|69181491|FG001|Overall Study|Progressive disease|13|||
37704061|NCT02276027|69181492|FG002|Overall Study|Progressive disease|12|||
37704062|NCT02276027|69181493|FG003|Overall Study|Progressive disease|14|||
37704063|NCT02276027|69181490|FG000|Overall Study|Subject/guardian decision|0|||
37704064|NCT02276027|69181491|FG001|Overall Study|Subject/guardian decision|1|||
37704065|NCT02276027|69181492|FG002|Overall Study|Subject/guardian decision|0|||
37704066|NCT02276027|69181493|FG003|Overall Study|Subject/guardian decision|3|||
37704067|NCT02276027|69181490|FG000|Overall Study|Adverse Event|0|||
37704068|NCT02276027|69181491|FG001|Overall Study|Adverse Event|2|||
37704069|NCT02276027|69181492|FG002|Overall Study|Adverse Event|8|||
37704070|NCT02276027|69181493|FG003|Overall Study|Adverse Event|2|||
37704071|NCT02309294|69181503|FG000|Overall Study|Withdrawal by Subject|2|||
37704072|NCT02233543|69181507|FG000|Period 1|Withdrawal by Subject|1|||
37704073|NCT02233543|69181508|FG001|Period 1|Withdrawal by Subject|0|||
37704074|NCT02233543|69181507|FG000|Period 1|Participants required other treatment.|2|||
37704075|NCT02233543|69181508|FG001|Period 1|Participants required other treatment.|3|||
37704076|NCT02233543|69181507|FG000|Period 2|Adverse Event|1|||
37704077|NCT02233543|69181508|FG001|Period 2|Adverse Event|0|||
37704078|NCT02233543|69181507|FG000|Period 2|Participant required other treatment.|0|||
37704079|NCT02233543|69181508|FG001|Period 2|Participant required other treatment.|1|||
37704080|NCT02233543|69181507|FG000|Period 2|COPD exacerbation|1|||
37704081|NCT02233543|69181508|FG001|Period 2|COPD exacerbation|0|||
37704082|NCT02309138|69181516|FG000|Overall Study|Withdrawal by Subject|44|||
37704083|NCT02309138|69181517|FG001|Overall Study|Withdrawal by Subject|15|||
37704084|NCT02309138|69181516|FG000|Overall Study|Protocol Violation|4|||
37704085|NCT02309138|69181517|FG001|Overall Study|Protocol Violation|2|||
37704086|NCT02309138|69181516|FG000|Overall Study|delivered before visit 2|0|||
37704087|NCT02309138|69181517|FG001|Overall Study|delivered before visit 2|1|||
37704088|NCT02233309|69181533|FG000|Overall Study|Physician Decision|5|||
37704089|NCT02204917|69181537|FG000|Overall Study|Protocol Violation|1|||
37704090|NCT02280044|69181546|FG000|Overall Study|Planned alternate|0|||
37704091|NCT02280044|69181547|FG001|Overall Study|Planned alternate|2|||
37704092|NCT02308748|69181553|FG000|Period 1|Withdrawal by Subject|0|||
37704093|NCT02308748|69181554|FG001|Period 1|Withdrawal by Subject|0|||
37704094|NCT02308748|69181555|FG002|Period 1|Withdrawal by Subject|1|||
37704095|NCT02308748|69181556|FG003|Period 1|Withdrawal by Subject|0|||
37704096|NCT02308748|69181557|FG004|Period 1|Withdrawal by Subject|0|||
37704097|NCT02308748|69181558|FG005|Period 1|Withdrawal by Subject|0|||
37704098|NCT02308748|69181559|FG006|Period 1|Withdrawal by Subject|0|||
37704099|NCT02308748|69181560|FG007|Period 1|Withdrawal by Subject|0|||
37704100|NCT02308748|69181561|FG008|Period 1|Withdrawal by Subject|0|||
37704101|NCT02308748|69181562|FG009|Period 1|Withdrawal by Subject|0|||
37704102|NCT02308748|69181553|FG000|Period 2|Adverse Event|0|||
37704103|NCT02308748|69181554|FG001|Period 2|Adverse Event|0|||
37704104|NCT02308748|69181555|FG002|Period 2|Adverse Event|0|||
37704105|NCT02308748|69181556|FG003|Period 2|Adverse Event|0|||
37704106|NCT02308748|69181557|FG004|Period 2|Adverse Event|0|||
37704107|NCT02308748|69181558|FG005|Period 2|Adverse Event|0|||
37704108|NCT02308748|69181559|FG006|Period 2|Adverse Event|0|||
37704109|NCT02308748|69181560|FG007|Period 2|Adverse Event|1|||
37704110|NCT02308748|69181561|FG008|Period 2|Adverse Event|0|||
37704111|NCT02308748|69181562|FG009|Period 2|Adverse Event|0|||
37704112|NCT02308748|69181553|FG000|Period 3|Protocol Violation|0|||
37704113|NCT02308748|69181554|FG001|Period 3|Protocol Violation|0|||
37704114|NCT02308748|69181555|FG002|Period 3|Protocol Violation|0|||
37704115|NCT02308748|69181556|FG003|Period 3|Protocol Violation|0|||
37704116|NCT02308748|69181557|FG004|Period 3|Protocol Violation|0|||
37704117|NCT02308748|69181558|FG005|Period 3|Protocol Violation|0|||
37704118|NCT02308748|69181559|FG006|Period 3|Protocol Violation|0|||
37704119|NCT02308748|69181560|FG007|Period 3|Protocol Violation|0|||
37704120|NCT02308748|69181561|FG008|Period 3|Protocol Violation|0|||
37704121|NCT02308748|69181562|FG009|Period 3|Protocol Violation|1|||
37704122|NCT02308748|69181553|FG000|Period 5|Adverse Event|1|||
37704123|NCT02308748|69181554|FG001|Period 5|Adverse Event|0|||
37704124|NCT02308748|69181555|FG002|Period 5|Adverse Event|0|||
37704125|NCT02308748|69181556|FG003|Period 5|Adverse Event|0|||
37704126|NCT02308748|69181557|FG004|Period 5|Adverse Event|0|||
37704127|NCT02308748|69181558|FG005|Period 5|Adverse Event|0|||
37704128|NCT02308748|69181559|FG006|Period 5|Adverse Event|0|||
37704129|NCT02308748|69181560|FG007|Period 5|Adverse Event|0|||
37704130|NCT02308748|69181561|FG008|Period 5|Adverse Event|1|||
37704131|NCT02308748|69181562|FG009|Period 5|Adverse Event|0|||
37704132|NCT01646216|69181576|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
37704133|NCT01646216|69181577|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
37704134|NCT01646216|69181576|FG000|Overall Study|Did not complete training|0|||
37704135|NCT01646216|69181577|FG001|Overall Study|Did not complete training|2|||
37837417|NCT01154452|69521827|FG003|Phase Ib|Adverse Event|0|||
37837418|NCT01154452|69521824|FG000|Phase II|Withdrawal by Subject|0|||
37837419|NCT01154452|69521825|FG001|Phase II|Withdrawal by Subject|0|||
37704136|NCT01646216|69181576|FG000|Overall Study|Investigator decision|1|||
37837420|NCT01154452|69521826|FG002|Phase II|Withdrawal by Subject|1|||
37704137|NCT01646216|69181577|FG001|Overall Study|Investigator decision|1|||
37704138|NCT02308124|69181590|FG000|Overall Study|Lost to Follow-up|6|||
37704139|NCT02308124|69181591|FG001|Overall Study|Lost to Follow-up|6|||
37704140|NCT02308124|69181592|FG002|Overall Study|Lost to Follow-up|6|||
37704141|NCT02308124|69181590|FG000|Overall Study|Adverse Event|0|||
37704142|NCT02308124|69181591|FG001|Overall Study|Adverse Event|2|||
37704143|NCT02308124|69181592|FG002|Overall Study|Adverse Event|2|||
37704144|NCT02232061|69181600|FG000|Overall Study|Administrative problems|1|||
37704145|NCT02232061|69181600|FG000|Overall Study|Withdrawal by Subject|1|||
37704146|NCT02275481|69181606|FG000|Overall Study|Death|2|||
37704147|NCT02275481|69181607|FG001|Overall Study|Death|1|||
37704148|NCT02275481|69181606|FG000|Overall Study|Lost to Follow-up|2|||
37704149|NCT02275481|69181607|FG001|Overall Study|Lost to Follow-up|0|||
37704150|NCT02275481|69181606|FG000|Overall Study|Withdrawal by Subject|3|||
37704151|NCT02275481|69181607|FG001|Overall Study|Withdrawal by Subject|0|||
37704152|NCT02275481|69181606|FG000|Overall Study|all other reasons combined|2|||
37704153|NCT02275481|69181607|FG001|Overall Study|all other reasons combined|1|||
37704154|NCT02275481|69181606|FG000|Overall Study|Physician Decision|0|||
37704155|NCT02275481|69181607|FG001|Overall Study|Physician Decision|1|||
37704156|NCT02204449|69181615|FG000|Overall Study|Lost to Follow-up|7|||
37704157|NCT02204449|69181616|FG001|Overall Study|Lost to Follow-up|9|||
37704158|NCT02204449|69181615|FG000|Overall Study|Death|0|||
37704159|NCT02204449|69181616|FG001|Overall Study|Death|1|||
37704160|NCT02204449|69181615|FG000|Overall Study|Withdrawal by Subject|0|||
37704161|NCT02204449|69181616|FG001|Overall Study|Withdrawal by Subject|1|||
37704162|NCT02308046|69181624|FG000|Overall Study|Negative yeast culture at Baseline|32|||
37704163|NCT02308046|69181625|FG001|Overall Study|Negative yeast culture at Baseline|33|||
37704164|NCT02308046|69181624|FG000|Overall Study|Positive for STD at Baseline|1|||
37704165|NCT02308046|69181625|FG001|Overall Study|Positive for STD at Baseline|2|||
37704166|NCT02308046|69181624|FG000|Overall Study|Lost to Follow-up|1|||
37704167|NCT02308046|69181625|FG001|Overall Study|Lost to Follow-up|3|||
37704168|NCT02318693|69181633|FG000|Overall Study|Protocol Violation|0|||
37704169|NCT02318693|69181634|FG001|Overall Study|Protocol Violation|1|||
37704170|NCT02230891|69181643|FG000|Baseline|Did not meet inclusion|0|||
37704171|NCT02230891|69181644|FG001|Baseline|Did not meet inclusion|1|||
37704172|NCT02230891|69181645|FG002|Baseline|Did not meet inclusion|1|||
37704173|NCT02230891|69181643|FG000|2 Week|Withdrawal by Subject|2|||
37704174|NCT02230891|69181644|FG001|2 Week|Withdrawal by Subject|2|||
37704175|NCT02230891|69181645|FG002|2 Week|Withdrawal by Subject|0|||
37704176|NCT02230891|69181643|FG000|2 Week|Consent withdrawn|1|||
37704177|NCT02230891|69181644|FG001|2 Week|Consent withdrawn|0|||
37704178|NCT02230891|69181645|FG002|2 Week|Consent withdrawn|0|||
37704179|NCT02230891|69181643|FG000|6 Month|Withdrawal by Subject|1|||
37704180|NCT02230891|69181644|FG001|6 Month|Withdrawal by Subject|1|||
37704181|NCT02230891|69181645|FG002|6 Month|Withdrawal by Subject|1|||
37704182|NCT02230891|69181643|FG000|6 Month|Physician Decision|0|||
37704183|NCT02230891|69181644|FG001|6 Month|Physician Decision|2|||
37704184|NCT02230891|69181645|FG002|6 Month|Physician Decision|0|||
37704185|NCT02230891|69181643|FG000|12 Month|Death|1|||
37704186|NCT02230891|69181644|FG001|12 Month|Death|0|||
37704187|NCT02230891|69181645|FG002|12 Month|Death|0|||
37704188|NCT02230891|69181643|FG000|12 Month|Lost to Follow-up|0|||
37704189|NCT02230891|69181644|FG001|12 Month|Lost to Follow-up|1|||
37704190|NCT02230891|69181645|FG002|12 Month|Lost to Follow-up|0|||
37704191|NCT02230891|69181643|FG000|12 Month|Withdrawal by Subject|0|||
37704192|NCT02230891|69181644|FG001|12 Month|Withdrawal by Subject|2|||
37704193|NCT02230891|69181645|FG002|12 Month|Withdrawal by Subject|0|||
37704194|NCT02230891|69181643|FG000|18 Month End of Study|Death|0|||
37704195|NCT02230891|69181644|FG001|18 Month End of Study|Death|0|||
37704196|NCT02230891|69181645|FG002|18 Month End of Study|Death|1|||
37704197|NCT02230891|69181643|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
37704198|NCT02230891|69181644|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
37704199|NCT02230891|69181645|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
37704200|NCT01646138|69181660|FG000|Overall Study|Lost to Follow-up|0|||
37704201|NCT01646138|69181661|FG001|Overall Study|Lost to Follow-up|0|||
37704202|NCT01646138|69181662|FG002|Overall Study|Lost to Follow-up|0|||
37704203|NCT01646138|69181663|FG003|Overall Study|Lost to Follow-up|0|||
37704204|NCT01646138|69181664|FG004|Overall Study|Lost to Follow-up|2|||
37704205|NCT02204371|69181676|FG000|Overall Study|Adverse Event|1|||
37704206|NCT02274857|69181682|FG000|Overall Study|Adverse Event|1|||
37704207|NCT02274857|69181683|FG001|Overall Study|Adverse Event|0|||
37704208|NCT02274857|69181682|FG000|Overall Study|Death|1|||
37704209|NCT02274857|69181683|FG001|Overall Study|Death|2|||
37704210|NCT02274857|69181682|FG000|Overall Study|Lost to Follow-up|3|||
37704211|NCT02274857|69181683|FG001|Overall Study|Lost to Follow-up|0|||
37704212|NCT02274857|69181682|FG000|Overall Study|Physician Decision|2|||
37704213|NCT02274857|69181683|FG001|Overall Study|Physician Decision|0|||
37704214|NCT02274857|69181682|FG000|Overall Study|Trial screen failure|0|||
37704215|NCT02274857|69181683|FG001|Overall Study|Trial screen failure|2|||
37704216|NCT02274857|69181682|FG000|Overall Study|Withdrawal by Subject|11|||
37704217|NCT02274857|69181683|FG001|Overall Study|Withdrawal by Subject|2|||
37704218|NCT02274857|69181682|FG000|Overall Study|Other|2|||
37704219|NCT02274857|69181683|FG001|Overall Study|Other|0|||
37704220|NCT02302859|69181692|FG000|Overall Study|Lost Phone|1|||
37704221|NCT02302859|69181693|FG001|Overall Study|Lost Phone|1|||
37704222|NCT02302859|69181692|FG000|Overall Study|Withdrawal by Subject|0|||
37704223|NCT02302859|69181693|FG001|Overall Study|Withdrawal by Subject|1|||
37704224|NCT02274311|69181699|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
37704225|NCT02316353|69181707|FG000|Overall Study|Pregnancy|1|||
37704226|NCT02316353|69181708|FG001|Overall Study|Pregnancy|3|||
37704227|NCT02316353|69181707|FG000|Overall Study|Adverse Event|1|||
37704228|NCT02316353|69181708|FG001|Overall Study|Adverse Event|3|||
37704229|NCT02316353|69181707|FG000|Overall Study|Withdrawal by Subject|6|||
37704230|NCT02316353|69181708|FG001|Overall Study|Withdrawal by Subject|2|||
37704231|NCT02273141|69181719|FG000|Overall Study|Adverse Event|0|||
37704232|NCT02273141|69181720|FG001|Overall Study|Adverse Event|1|||
37704233|NCT02273141|69181719|FG000|Overall Study|Lost to Follow-up|1|||
38023887|NCT02927080|69707229|FG002|Overall Study|Willingness to comply with protocol|0|||
38023888|NCT02927080|69707230|FG003|Overall Study|Willingness to comply with protocol|0|||
37704234|NCT02273141|69181720|FG001|Overall Study|Lost to Follow-up|3|||
37704235|NCT02273141|69181719|FG000|Overall Study|Withdrawal by Subject|10|||
37704236|NCT02273141|69181720|FG001|Overall Study|Withdrawal by Subject|15|||
37704237|NCT02273141|69181719|FG000|Overall Study|Various|6|||
37704238|NCT02273141|69181720|FG001|Overall Study|Various|6|||
38023889|NCT02927080|69707231|FG004|Overall Study|Willingness to comply with protocol|0|||
38023890|NCT02927080|69707232|FG005|Overall Study|Willingness to comply with protocol|0|||
38023891|NCT02927080|69707233|FG006|Overall Study|Willingness to comply with protocol|0|||
38023892|NCT02927080|69707234|FG007|Overall Study|Willingness to comply with protocol|0|||
38023893|NCT02927080|69707235|FG008|Overall Study|Willingness to comply with protocol|0|||
38023894|NCT02927080|69707236|FG009|Overall Study|Willingness to comply with protocol|1|||
38023895|NCT02927080|69707227|FG000|Overall Study|Study terminated by Sponsor|0|||
37704239|NCT02314052|69181726|FG000|Cycle One|Adverse Event|0|||
37704240|NCT02314052|69181727|FG001|Cycle One|Adverse Event|0|||
37704241|NCT02314052|69181728|FG002|Cycle One|Adverse Event|0|||
37704242|NCT02314052|69181729|FG003|Cycle One|Adverse Event|1|||
37704243|NCT02314052|69181730|FG004|Cycle One|Adverse Event|0|||
37704244|NCT02314052|69181731|FG005|Cycle One|Adverse Event|0|||
37704245|NCT02279732|69181747|FG000|Overall Study|Death|23|||
37704246|NCT02279732|69181748|FG001|Overall Study|Death|20|||
37704247|NCT02279732|69181747|FG000|Overall Study|Disease Progression|13|||
37704248|NCT02279732|69181748|FG001|Overall Study|Disease Progression|3|||
37704249|NCT02279732|69181747|FG000|Overall Study|Withdrawal by Subject|2|||
37704250|NCT02279732|69181748|FG001|Overall Study|Withdrawal by Subject|7|||
37704251|NCT02279732|69181747|FG000|Overall Study|Adverse Event|1|||
37704252|NCT02279732|69181748|FG001|Overall Study|Adverse Event|2|||
37704253|NCT02279732|69181747|FG000|Overall Study|Administrative Reason By Sponsor|0|||
37704254|NCT02279732|69181748|FG001|Overall Study|Administrative Reason By Sponsor|2|||
37704255|NCT02279732|69181747|FG000|Overall Study|Study Drug Toxicity|2|||
37704256|NCT02279732|69181748|FG001|Overall Study|Study Drug Toxicity|0|||
37704257|NCT02279732|69181747|FG000|Overall Study|Lost to Follow-up|0|||
37704258|NCT02279732|69181748|FG001|Overall Study|Lost to Follow-up|1|||
37704259|NCT02279732|69181747|FG000|Overall Study|Maximum Clinical Benefit|1|||
37704260|NCT02279732|69181748|FG001|Overall Study|Maximum Clinical Benefit|0|||
37704261|NCT02279732|69181747|FG000|Overall Study|Subject Requested to Discontinue|0|||
37704262|NCT02279732|69181748|FG001|Overall Study|Subject Requested to Discontinue|1|||
37704263|NCT02279732|69181747|FG000|Overall Study|Other|53|||
37704264|NCT02279732|69181748|FG001|Overall Study|Other|67|||
37704265|NCT02279732|69181747|FG000|Overall Study|Other|3|||
37704266|NCT02279732|69181748|FG001|Overall Study|Other|3|||
37704267|NCT02279498|69181756|FG000|Overall Study|Adverse Event|3|||
37704268|NCT02279498|69181757|FG001|Overall Study|Adverse Event|0|||
37704269|NCT02279498|69181756|FG000|Overall Study|Lack of Efficacy|4|||
37704270|NCT02279498|69181757|FG001|Overall Study|Lack of Efficacy|0|||
37704271|NCT02279498|69181756|FG000|Overall Study|Lost to Follow-up|0|||
37704272|NCT02279498|69181757|FG001|Overall Study|Lost to Follow-up|1|||
37704273|NCT02279498|69181756|FG000|Overall Study|Withdrawal by Subject|9|||
37704274|NCT02279498|69181757|FG001|Overall Study|Withdrawal by Subject|2|||
37704275|NCT02279498|69181756|FG000|Overall Study|Undefined|2|||
37704276|NCT02279498|69181757|FG001|Overall Study|Undefined|1|||
37704277|NCT02307266|69181767|FG000|Overall Study|Adverse Event|3|||
37704278|NCT02307266|69181768|FG001|Overall Study|Adverse Event|1|||
37704279|NCT02307266|69181769|FG002|Overall Study|Adverse Event|5|||
37704280|NCT02307266|69181767|FG000|Overall Study|Withdrawal by Subject|2|||
37704281|NCT02307266|69181768|FG001|Overall Study|Withdrawal by Subject|0|||
37704282|NCT02307266|69181769|FG002|Overall Study|Withdrawal by Subject|1|||
37704283|NCT02307266|69181767|FG000|Overall Study|Lost to Follow-up|3|||
37704284|NCT02307266|69181768|FG001|Overall Study|Lost to Follow-up|0|||
37704285|NCT02307266|69181769|FG002|Overall Study|Lost to Follow-up|0|||
37704286|NCT02279420|69181777|FG000|Overall Study|Lost to Follow-up|23|||
37704287|NCT02278952|69181781|FG000|Overall Study|Insufficient Sample|6|||
37704288|NCT02278328|69181791|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
37704289|NCT02278328|69181792|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
37704290|NCT02278328|69181793|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
37704291|NCT02278328|69181791|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
37704292|NCT02278328|69181792|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
37837421|NCT01154452|69521827|FG003|Phase II|Withdrawal by Subject|2|||
37837422|NCT01154452|69521824|FG000|Phase II|Adverse Event|0|||
37704293|NCT02278328|69181793|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
37704294|NCT02278328|69181791|FG000|Neuropsych Screening|incomplete consent|0|||
37704295|NCT02278328|69181792|FG001|Neuropsych Screening|incomplete consent|0|||
37704296|NCT02278328|69181793|FG002|Neuropsych Screening|incomplete consent|2|||
37704297|NCT02314637|69181801|FG000|Overall Study|Adverse Event|4|||
37704298|NCT02314637|69181802|FG001|Overall Study|Adverse Event|8|||
37704299|NCT02314637|69181801|FG000|Overall Study|Lack of Efficacy|1|||
37704300|NCT02314637|69181802|FG001|Overall Study|Lack of Efficacy|0|||
37704301|NCT02314637|69181801|FG000|Overall Study|Physician Decision|5|||
37704302|NCT02314637|69181802|FG001|Overall Study|Physician Decision|2|||
37704303|NCT02314637|69181801|FG000|Overall Study|Withdrawal by Subject|5|||
37704304|NCT02314637|69181802|FG001|Overall Study|Withdrawal by Subject|4|||
37704305|NCT02314637|69181801|FG000|Overall Study|Other Reason|1|||
37704306|NCT02314637|69181802|FG001|Overall Study|Other Reason|0|||
37704307|NCT01646645|69181808|FG000|Overall Study|No Treated|1|||
37837423|NCT01154452|69521825|FG001|Phase II|Adverse Event|0|||
37704308|NCT01646645|69181808|FG000|Overall Study|Inevaluable Donor|29|||
37704309|NCT02272985|69181812|FG000|Overall Study|Withdrawal by Subject|1|||
37704310|NCT02272985|69181812|FG000|Overall Study|hip fracture|1|||
37704311|NCT02272985|69181812|FG000|Overall Study|kidney transplantation|1|||
37704312|NCT01644149|69181819|FG000|Overall Study|Withdrawal by Subject|1|||
37704313|NCT01644149|69181820|FG001|Overall Study|Withdrawal by Subject|0|||
37704314|NCT01644149|69181819|FG000|Overall Study|Lost to Follow-up|3|||
37704315|NCT01644149|69181820|FG001|Overall Study|Lost to Follow-up|1|||
37704316|NCT02313233|69181829|FG000|Overall Study|Withdrawal by Subject|1|||
37704317|NCT02313233|69181830|FG001|Overall Study|Withdrawal by Subject|2|||
37704318|NCT02313233|69181829|FG000|Overall Study|Administrative reason|1|||
37704319|NCT02313233|69181830|FG001|Overall Study|Administrative reason|1|||
37704320|NCT02313155|69181840|FG000|Overall Study|Lost to Follow-up|0|||
37704321|NCT02313155|69181841|FG001|Overall Study|Lost to Follow-up|1|||
37704322|NCT02204293|69181849|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
37704323|NCT02204293|69181850|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
37704324|NCT02204293|69181851|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
37704325|NCT02204293|69181852|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
37704326|NCT02204293|69181853|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
37704327|NCT02204293|69181854|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
37704328|NCT02204293|69181849|FG000|Core Study Part I|Adverse Event|1|||
37704329|NCT02204293|69181850|FG001|Core Study Part I|Adverse Event|0|||
37704330|NCT02204293|69181851|FG002|Core Study Part I|Adverse Event|0|||
37704331|NCT02204293|69181852|FG003|Core Study Part I|Adverse Event|0|||
37704332|NCT02204293|69181853|FG004|Core Study Part I|Adverse Event|0|||
37704333|NCT02204293|69181854|FG005|Core Study Part I|Adverse Event|0|||
37704334|NCT02204293|69181849|FG000|Core Study Part I|Physician Decision|0|||
37704335|NCT02204293|69181850|FG001|Core Study Part I|Physician Decision|3|||
37704336|NCT02204293|69181851|FG002|Core Study Part I|Physician Decision|0|||
37704337|NCT02204293|69181852|FG003|Core Study Part I|Physician Decision|0|||
37704338|NCT02204293|69181853|FG004|Core Study Part I|Physician Decision|0|||
37704339|NCT02204293|69181854|FG005|Core Study Part I|Physician Decision|0|||
37704340|NCT02204293|69181849|FG000|LTE Phase|Study Suspended|0|||
37704341|NCT02204293|69181850|FG001|LTE Phase|Study Suspended|0|||
37704342|NCT02204293|69181851|FG002|LTE Phase|Study Suspended|0|||
37704343|NCT02204293|69181852|FG003|LTE Phase|Study Suspended|0|||
37704344|NCT02204293|69181853|FG004|LTE Phase|Study Suspended|0|||
37704345|NCT02204293|69181854|FG005|LTE Phase|Study Suspended|7|||
37704346|NCT02304926|69181870|FG000|Overall Study|Lost to Follow-up|2|||
37704347|NCT02304926|69181871|FG001|Overall Study|Lost to Follow-up|1|||
37704348|NCT01646255|69181881|FG000|Overall Study|Adverse Event|7|||
37704349|NCT01646255|69181882|FG001|Overall Study|Adverse Event|8|||
37704350|NCT01646255|69181881|FG000|Overall Study|Lack of Efficacy|2|||
37704351|NCT01646255|69181882|FG001|Overall Study|Lack of Efficacy|0|||
37704352|NCT01646255|69181881|FG000|Overall Study|Withdrawal by Subject|10|||
37704353|NCT01646255|69181882|FG001|Overall Study|Withdrawal by Subject|6|||
37704354|NCT01646255|69181881|FG000|Overall Study|Compliance is not well|1|||
37704355|NCT01646255|69181882|FG001|Overall Study|Compliance is not well|0|||
37704356|NCT01646255|69181881|FG000|Overall Study|Inclusion Criteria Deviation|1|||
37704357|NCT01646255|69181882|FG001|Overall Study|Inclusion Criteria Deviation|0|||
37704358|NCT02304380|69181895|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
37704359|NCT02304380|69181896|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
37704360|NCT02304380|69181897|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
37704361|NCT02304380|69181898|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
38023896|NCT02927080|69707228|FG001|Overall Study|Study terminated by Sponsor|0|||
37704362|NCT02304380|69181899|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
38023897|NCT02927080|69707229|FG002|Overall Study|Study terminated by Sponsor|0|||
38023898|NCT02927080|69707230|FG003|Overall Study|Study terminated by Sponsor|0|||
37704363|NCT02304380|69181900|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
37704364|NCT02203591|69181922|FG000|Overall Study|Did not meet treatment day baseline|147|||
37704365|NCT02203591|69181923|FG001|Overall Study|Did not meet treatment day baseline|141|||
37704366|NCT02203591|69181924|FG002|Overall Study|Did not meet treatment day baseline|150|||
37704367|NCT02203591|69181925|FG003|Overall Study|Did not meet treatment day baseline|45|||
37704368|NCT02203591|69181926|FG004|Overall Study|Did not meet treatment day baseline|33|||
37704369|NCT02203591|69181927|FG005|Overall Study|Did not meet treatment day baseline|35|||
37704370|NCT02203591|69181928|FG006|Overall Study|Did not meet treatment day baseline|29|||
37704371|NCT02203591|69181929|FG007|Overall Study|Did not meet treatment day baseline|12|||
37704372|NCT02203591|69181922|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
37704373|NCT02203591|69181923|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
37704374|NCT02203591|69181924|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
37837424|NCT01154452|69521826|FG002|Phase II|Adverse Event|4|||
37837425|NCT01154452|69521827|FG003|Phase II|Adverse Event|4|||
37837426|NCT01154296|69521842|FG000|Randomization and Intervention|Decided to decline|1|||
37837427|NCT01154296|69521843|FG001|Randomization and Intervention|Decided to decline|1|||
37837428|NCT01154296|69521842|FG000|Randomization and Intervention|Declined by staff|1|||
37837429|NCT01154296|69521843|FG001|Randomization and Intervention|Declined by staff|0|||
37837430|NCT01154296|69521842|FG000|Randomization and Intervention|Did not return|1|||
37915133|NCT00853827|69601821|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
37837431|NCT01154296|69521843|FG001|Randomization and Intervention|Did not return|0|||
37837432|NCT01154296|69521842|FG000|Randomization and Intervention|Left before test|0|||
37837433|NCT01154296|69521843|FG001|Randomization and Intervention|Left before test|1|||
37837434|NCT01154296|69521842|FG000|Randomization and Intervention|Left clinic early|2|||
37915134|NCT00853827|69601822|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
37837435|NCT01154296|69521843|FG001|Randomization and Intervention|Left clinic early|0|||
37837436|NCT01154296|69521842|FG000|6-month Follow-up|Lost contact|269|||
37837437|NCT01154296|69521843|FG001|6-month Follow-up|Lost contact|275|||
37837438|NCT01154296|69521842|FG000|6-month Follow-up|Incarcerated|37|||
37837439|NCT01154296|69521843|FG001|6-month Follow-up|Incarcerated|32|||
37837440|NCT01154296|69521842|FG000|6-month Follow-up|Withdrew consent|14|||
37837441|NCT01154296|69521843|FG001|6-month Follow-up|Withdrew consent|15|||
37837442|NCT01154296|69521842|FG000|6-month Follow-up|Death|3|||
37837443|NCT01154296|69521843|FG001|6-month Follow-up|Death|2|||
37704375|NCT02203591|69181925|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
37837444|NCT01154296|69521842|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
37704376|NCT02203591|69181926|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
37704377|NCT02203591|69181927|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
37704378|NCT02203591|69181928|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
37704379|NCT02203591|69181929|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
37704380|NCT01642277|69181953|FG000|Overall Study|Adverse Event|10|||
37704381|NCT01642277|69181954|FG001|Overall Study|Adverse Event|0|||
37704382|NCT01642277|69181953|FG000|Overall Study|Physician Decision|2|||
37704383|NCT01642277|69181954|FG001|Overall Study|Physician Decision|0|||
37704384|NCT01642277|69181953|FG000|Overall Study|Protocol Violation|1|||
37704385|NCT01642277|69181954|FG001|Overall Study|Protocol Violation|0|||
37704386|NCT01642277|69181953|FG000|Overall Study|Withdrawal by Subject|11|||
37704387|NCT01642277|69181954|FG001|Overall Study|Withdrawal by Subject|0|||
37704388|NCT02230189|69181964|FG000|Overall Study|Withdrawal by Subject|3|||
37704389|NCT02230189|69181965|FG001|Overall Study|Withdrawal by Subject|0|||
37704390|NCT02230189|69181966|FG002|Overall Study|Withdrawal by Subject|1|||
37704391|NCT02230189|69181964|FG000|Overall Study|Lost to Follow-up|1|||
37704392|NCT02230189|69181965|FG001|Overall Study|Lost to Follow-up|0|||
37704393|NCT02230189|69181966|FG002|Overall Study|Lost to Follow-up|0|||
37704394|NCT02230189|69181964|FG000|Overall Study|Physician Decision|1|||
37704395|NCT02230189|69181965|FG001|Overall Study|Physician Decision|0|||
37704396|NCT02230189|69181966|FG002|Overall Study|Physician Decision|0|||
37704397|NCT02304302|69181977|FG000|Overall Study|Adverse Event|2|||
37704398|NCT02304302|69181978|FG001|Overall Study|Adverse Event|3|||
37704399|NCT02304302|69181977|FG000|Overall Study|Lost to Follow-up|1|||
37704400|NCT02304302|69181978|FG001|Overall Study|Lost to Follow-up|4|||
37704401|NCT02304302|69181977|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
37704402|NCT02304302|69181978|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
37704403|NCT02276612|69181990|FG000|Overall Study|Death|1|||
37704404|NCT02276612|69181991|FG001|Overall Study|Death|0|||
37704405|NCT02276612|69181990|FG000|Overall Study|Pregnancy|1|||
37704406|NCT02276612|69181991|FG001|Overall Study|Pregnancy|0|||
37704407|NCT02276612|69181990|FG000|Overall Study|Withdrew Consent|1|||
37704408|NCT02276612|69181991|FG001|Overall Study|Withdrew Consent|0|||
37704409|NCT02276612|69181990|FG000|Overall Study|Lost to Follow-up|1|||
37704410|NCT02276612|69181991|FG001|Overall Study|Lost to Follow-up|0|||
37704411|NCT02301143|69181997|FG000|Induction Period|Enrolled But Not Treated|1|||
37704412|NCT02301143|69181998|FG001|Induction Period|Enrolled But Not Treated|0|||
37704413|NCT02301143|69181997|FG000|Induction Period|Death|1|||
37704414|NCT02301143|69181998|FG001|Induction Period|Death|0|||
37704415|NCT02301143|69181997|FG000|Induction Period|Adverse Event|22|||
37704416|NCT02301143|69181998|FG001|Induction Period|Adverse Event|0|||
37704417|NCT02301143|69181997|FG000|Induction Period|Progressive Disease|8|||
37704418|NCT02301143|69181998|FG001|Induction Period|Progressive Disease|0|||
37704419|NCT02301143|69181997|FG000|Induction Period|Withdrawal by Subject|3|||
37704420|NCT02301143|69181998|FG001|Induction Period|Withdrawal by Subject|0|||
37704421|NCT02301143|69181997|FG000|Induction Period|Noncompliance with Study Drug|1|||
37704422|NCT02301143|69181998|FG001|Induction Period|Noncompliance with Study Drug|0|||
37704423|NCT02301143|69181997|FG000|Induction Period|Physician Decision|4|||
37704424|NCT02301143|69181998|FG001|Induction Period|Physician Decision|0|||
37704425|NCT02301143|69181997|FG000|Induction Period|Symptomatic Deterioration|2|||
37704426|NCT02301143|69181998|FG001|Induction Period|Symptomatic Deterioration|0|||
37704427|NCT02301143|69181997|FG000|Induction Period|Protocol Violation|2|||
37704428|NCT02301143|69181998|FG001|Induction Period|Protocol Violation|0|||
37704429|NCT02301143|69181997|FG000|Induction Period|Other|1|||
37704430|NCT02301143|69181998|FG001|Induction Period|Other|0|||
37704431|NCT02301143|69181997|FG000|Investigator's Choice|Adverse Event|0|||
37704432|NCT02301143|69181998|FG001|Investigator's Choice|Adverse Event|3|||
37704433|NCT02301143|69181997|FG000|Investigator's Choice|Progressive Disease|0|||
37704434|NCT02301143|69181998|FG001|Investigator's Choice|Progressive Disease|3|||
37704435|NCT02301143|69181997|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
37704436|NCT02301143|69181998|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
37704437|NCT02301143|69181997|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
37704438|NCT02301143|69181998|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
37704439|NCT02301143|69181997|FG000|Investigator's Choice|Other|0|||
37704440|NCT02301143|69181998|FG001|Investigator's Choice|Other|1|||
37704441|NCT02301143|69181997|FG000|Investigator's Choice|Unresectable Surgery|0|||
37704442|NCT02301143|69181998|FG001|Investigator's Choice|Unresectable Surgery|1|||
37704443|NCT02276222|69182011|FG000|Overall Study|Adverse Event|62|||
37704444|NCT02276222|69182012|FG001|Overall Study|Adverse Event|11|||
37704445|NCT02276222|69182011|FG000|Overall Study|Death|3|||
37704446|NCT02276222|69182012|FG001|Overall Study|Death|4|||
37704447|NCT02276222|69182011|FG000|Overall Study|Lack of Efficacy|13|||
37704448|NCT02276222|69182012|FG001|Overall Study|Lack of Efficacy|3|||
37704449|NCT02276222|69182011|FG000|Overall Study|Protocol Violation|3|||
37704450|NCT02276222|69182012|FG001|Overall Study|Protocol Violation|2|||
37704451|NCT02276222|69182011|FG000|Overall Study|Withdrawal by Subject|79|||
37704452|NCT02276222|69182012|FG001|Overall Study|Withdrawal by Subject|33|||
37704453|NCT02276222|69182011|FG000|Overall Study|non compliance with study medication|6|||
37704454|NCT02276222|69182012|FG001|Overall Study|non compliance with study medication|2|||
37704455|NCT02276222|69182011|FG000|Overall Study|sponsor decision|0|||
37704456|NCT02276222|69182012|FG001|Overall Study|sponsor decision|3|||
37704457|NCT02276222|69182011|FG000|Overall Study|Lost to Follow-up|15|||
37704458|NCT02276222|69182012|FG001|Overall Study|Lost to Follow-up|5|||
37704459|NCT02276222|69182011|FG000|Overall Study|Physician Decision|2|||
37704460|NCT02276222|69182012|FG001|Overall Study|Physician Decision|1|||
37704461|NCT02276222|69182011|FG000|Overall Study|sheduling conflict|1|||
37704462|NCT02276222|69182012|FG001|Overall Study|sheduling conflict|0|||
37704463|NCT02276222|69182011|FG000|Overall Study|subject withdrew after randomization|1|||
37704464|NCT02276222|69182012|FG001|Overall Study|subject withdrew after randomization|0|||
37837445|NCT01154296|69521843|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
37837446|NCT01154218|69521849|FG000|Third Intervention Period|Adverse Event|0|||
37837447|NCT01154218|69521850|FG001|Third Intervention Period|Adverse Event|1|||
37837448|NCT01154218|69521851|FG002|Third Intervention Period|Adverse Event|0|||
37837449|NCT01154218|69521852|FG003|Third Intervention Period|Adverse Event|0|||
37704465|NCT02275364|69182018|FG000|Period 1|Withdrawal by Subject|1|||
37704466|NCT02275364|69182019|FG001|Period 1|Withdrawal by Subject|0|||
37704467|NCT02275364|69182018|FG000|Period 1|Other reason|1|||
37704468|NCT02275364|69182019|FG001|Period 1|Other reason|0|||
37704469|NCT02275052|69182036|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
37704470|NCT02275052|69182037|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
37704471|NCT02275052|69182038|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
37704472|NCT02275052|69182039|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
37704473|NCT02275052|69182036|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
37704474|NCT02275052|69182037|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
37704475|NCT02275052|69182038|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
37704476|NCT02275052|69182039|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
37704477|NCT02275052|69182036|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
37704478|NCT02275052|69182037|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
37704479|NCT02275052|69182038|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
37704480|NCT02275052|69182039|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
37704481|NCT02275052|69182036|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
37704482|NCT02275052|69182037|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
37704483|NCT02275052|69182038|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
37704484|NCT02275052|69182039|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
37704485|NCT02275052|69182036|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
37704486|NCT02275052|69182037|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
37704487|NCT02275052|69182038|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
37704488|NCT02275052|69182039|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
37704489|NCT02275052|69182036|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
37704490|NCT02275052|69182037|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
37704491|NCT02275052|69182038|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
37704492|NCT02275052|69182039|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
37704493|NCT02275052|69182036|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
37704494|NCT02275052|69182037|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
37704495|NCT02275052|69182038|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
37704496|NCT02275052|69182039|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
37704497|NCT02275052|69182036|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
37704498|NCT02275052|69182037|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
37704499|NCT02275052|69182038|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
37704500|NCT02275052|69182039|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
37704501|NCT02275052|69182036|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
37704502|NCT02275052|69182037|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
37704503|NCT02275052|69182038|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
37704504|NCT02275052|69182039|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
37704505|NCT02275052|69182036|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
37704506|NCT02275052|69182037|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
37704507|NCT02275052|69182038|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
37704508|NCT02275052|69182039|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
37704509|NCT02275052|69182036|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
37704510|NCT02275052|69182037|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
37704511|NCT02275052|69182038|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
37704512|NCT02275052|69182039|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
37704513|NCT02274038|69182045|FG000|Overall Study|Death|1|||
37704514|NCT02300558|69182051|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
37704515|NCT02300558|69182051|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
37704516|NCT02300558|69182051|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
37704517|NCT02300558|69182051|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
37704518|NCT02273960|69182063|FG000|Short Term Period|Lost to Follow-up|1|||
37704519|NCT02273960|69182064|FG001|Short Term Period|Lost to Follow-up|0|||
37704520|NCT02273960|69182065|FG002|Short Term Period|Lost to Follow-up|0|||
37704521|NCT02273960|69182066|FG003|Short Term Period|Lost to Follow-up|0|||
37704522|NCT02273960|69182063|FG000|Short Term Period|Lack of Efficacy|0|||
37704523|NCT02273960|69182064|FG001|Short Term Period|Lack of Efficacy|0|||
37704524|NCT02273960|69182065|FG002|Short Term Period|Lack of Efficacy|0|||
37704525|NCT02273960|69182066|FG003|Short Term Period|Lack of Efficacy|1|||
37704526|NCT02273960|69182063|FG000|Short Term Period|ST complete, not entering LTE|4|||
37704527|NCT02273960|69182064|FG001|Short Term Period|ST complete, not entering LTE|6|||
37704528|NCT02273960|69182065|FG002|Short Term Period|ST complete, not entering LTE|4|||
37704529|NCT02273960|69182066|FG003|Short Term Period|ST complete, not entering LTE|5|||
37704530|NCT02273960|69182063|FG000|Long Term Extension|Death|0|||
37704531|NCT02273960|69182064|FG001|Long Term Extension|Death|0|||
37704532|NCT02273960|69182065|FG002|Long Term Extension|Death|0|||
37704533|NCT02273960|69182066|FG003|Long Term Extension|Death|1|||
37704534|NCT01646021|69182078|FG000|Overall Study|Death|77|||
37704535|NCT01646021|69182079|FG001|Overall Study|Death|83|||
37704536|NCT01646021|69182078|FG000|Overall Study|Study Terminated by Sponsor|50|||
37704537|NCT01646021|69182079|FG001|Overall Study|Study Terminated by Sponsor|41|||
37704538|NCT01646021|69182078|FG000|Overall Study|Lost to Follow-up|2|||
37704539|NCT01646021|69182079|FG001|Overall Study|Lost to Follow-up|2|||
37704540|NCT01646021|69182078|FG000|Overall Study|Withdrawal by Subject|10|||
37704541|NCT01646021|69182079|FG001|Overall Study|Withdrawal by Subject|15|||
37704542|NCT01750918|69182096|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
37704543|NCT01750918|69182097|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
37704544|NCT01750918|69182098|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
37704545|NCT01750918|69182099|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
37704546|NCT01750918|69182100|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
37704547|NCT01750918|69182101|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
37704548|NCT01750918|69182102|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
37704549|NCT01750918|69182103|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
37704550|NCT01750918|69182096|FG000|Overall Study|Lost to Follow-up|0|||
37704551|NCT01750918|69182097|FG001|Overall Study|Lost to Follow-up|0|||
37704552|NCT01750918|69182098|FG002|Overall Study|Lost to Follow-up|2|||
37704553|NCT01750918|69182099|FG003|Overall Study|Lost to Follow-up|2|||
37704554|NCT01750918|69182100|FG004|Overall Study|Lost to Follow-up|0|||
37704555|NCT01750918|69182101|FG005|Overall Study|Lost to Follow-up|0|||
37704556|NCT01750918|69182102|FG006|Overall Study|Lost to Follow-up|0|||
37704557|NCT01750918|69182103|FG007|Overall Study|Lost to Follow-up|1|||
37704558|NCT01750918|69182096|FG000|Overall Study|Withdrawal by Subject|0|||
37704559|NCT01750918|69182097|FG001|Overall Study|Withdrawal by Subject|0|||
37704560|NCT01750918|69182098|FG002|Overall Study|Withdrawal by Subject|1|||
37704561|NCT01750918|69182099|FG003|Overall Study|Withdrawal by Subject|2|||
37704562|NCT01750918|69182100|FG004|Overall Study|Withdrawal by Subject|1|||
37704563|NCT01750918|69182101|FG005|Overall Study|Withdrawal by Subject|1|||
37704564|NCT01750918|69182102|FG006|Overall Study|Withdrawal by Subject|2|||
37704565|NCT01750918|69182103|FG007|Overall Study|Withdrawal by Subject|2|||
37704566|NCT02300987|69182135|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
37704567|NCT02300987|69182136|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
37704568|NCT02300987|69182135|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
37704569|NCT02300987|69182136|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
37704570|NCT02300987|69182135|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
37704571|NCT02300987|69182136|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
37704572|NCT02300987|69182135|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
37704573|NCT02300987|69182136|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
37704574|NCT02300987|69182135|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
37704575|NCT02300987|69182136|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
37704576|NCT01750840|69182143|FG000|Overall Study|Lost to Follow-up|4|||
37704577|NCT01606228|69182148|FG000|Overall Study|Lost to Follow-up|20|||
37704578|NCT01606228|69182148|FG000|Overall Study|Withdrawal by Subject|3|||
37704579|NCT01606228|69182148|FG000|Overall Study|Non-compliant|3|||
37704580|NCT01606228|69182148|FG000|Overall Study|Lack of Efficacy|2|||
37704581|NCT01606228|69182148|FG000|Overall Study|Adverse Event|1|||
37704582|NCT01706536|69182157|FG000|Overall Study|Withdrawal by Subject|1|||
37704583|NCT01706536|69182158|FG001|Overall Study|Withdrawal by Subject|0|||
37704584|NCT01706536|69182159|FG002|Overall Study|Withdrawal by Subject|1|||
37704585|NCT01706536|69182160|FG003|Overall Study|Withdrawal by Subject|0|||
37704586|NCT01706536|69182161|FG004|Overall Study|Withdrawal by Subject|0|||
37704587|NCT01706536|69182157|FG000|Overall Study|Adverse Event|2|||
37704588|NCT01706536|69182158|FG001|Overall Study|Adverse Event|3|||
37704589|NCT01706536|69182159|FG002|Overall Study|Adverse Event|4|||
37704590|NCT01706536|69182160|FG003|Overall Study|Adverse Event|3|||
37704591|NCT01706536|69182161|FG004|Overall Study|Adverse Event|2|||
37704592|NCT01706536|69182157|FG000|Overall Study|Lack of Efficacy|1|||
37704593|NCT01706536|69182158|FG001|Overall Study|Lack of Efficacy|0|||
37704594|NCT01706536|69182159|FG002|Overall Study|Lack of Efficacy|0|||
37704595|NCT01706536|69182160|FG003|Overall Study|Lack of Efficacy|1|||
37704596|NCT01706536|69182161|FG004|Overall Study|Lack of Efficacy|0|||
37704597|NCT01706536|69182157|FG000|Overall Study|non compliance|0|||
37704598|NCT01706536|69182158|FG001|Overall Study|non compliance|1|||
37704599|NCT01706536|69182159|FG002|Overall Study|non compliance|0|||
37704600|NCT01706536|69182160|FG003|Overall Study|non compliance|0|||
37704601|NCT01706536|69182161|FG004|Overall Study|non compliance|0|||
37704602|NCT02269943|69182176|FG000|Treatment Period|Death|0|||
37704603|NCT02269943|69182177|FG001|Treatment Period|Death|1|||
37704604|NCT02269943|69182176|FG000|Treatment Period|Adverse Event|1|||
37704605|NCT02269943|69182177|FG001|Treatment Period|Adverse Event|10|||
37704606|NCT02269943|69182176|FG000|Treatment Period|Progressive Disease|5|||
37704607|NCT02269943|69182177|FG001|Treatment Period|Progressive Disease|17|||
37704608|NCT02269943|69182176|FG000|Treatment Period|Symptomatic Deterioration|0|||
37704609|NCT02269943|69182177|FG001|Treatment Period|Symptomatic Deterioration|2|||
37704610|NCT02269943|69182176|FG000|Follow-Up Survival Period|Death|3|||
37704611|NCT02269943|69182177|FG001|Follow-Up Survival Period|Death|16|||
37704612|NCT02269943|69182176|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
37704613|NCT02269943|69182177|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
37704614|NCT02269943|69182176|FG000|Follow-Up Survival Period|Alive|2|||
37704615|NCT02269943|69182177|FG001|Follow-Up Survival Period|Alive|8|||
37704616|NCT01706458|69182185|FG000|Overall Study|Physician Decision|3|||
37704617|NCT01706458|69182186|FG001|Overall Study|Physician Decision|4|||
37704618|NCT02269787|69182194|FG000|Overall Study|Lost to Follow-up|20|||
37704619|NCT02269787|69182195|FG001|Overall Study|Lost to Follow-up|6|||
37704620|NCT02269787|69182194|FG000|Overall Study|Death|2|||
37704621|NCT02269787|69182195|FG001|Overall Study|Death|3|||
37704622|NCT02269787|69182194|FG000|Overall Study|Incapacitated|0|||
37704623|NCT02269787|69182195|FG001|Overall Study|Incapacitated|1|||
37704624|NCT01605370|69182203|FG000|Overall Study|Adverse Event|1|||
37704625|NCT01605370|69182204|FG001|Overall Study|Adverse Event|0|||
37704626|NCT02269709|69182210|FG000|Time of Enrollment|Withdrawal by Subject|3|||
37704627|NCT02269709|69182210|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
37704628|NCT02269709|69182210|FG000|Six Month Follow-up|Lost to Follow-up|12|||
37704629|NCT02269475|69182217|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
37704630|NCT02269475|69182218|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
37704631|NCT02269475|69182217|FG000|Overall Study|Withdrawal by Subject|0|||
37704632|NCT02269475|69182218|FG001|Overall Study|Withdrawal by Subject|1|||
37704633|NCT01605136|69182227|FG000|Study Period|Withdrawal by Subject|2|||
37704634|NCT01605136|69182228|FG001|Study Period|Withdrawal by Subject|0|||
37704635|NCT01605136|69182227|FG000|Study Period|Physician Decision|1|||
37704636|NCT01605136|69182228|FG001|Study Period|Physician Decision|1|||
37704637|NCT01605136|69182227|FG000|Study Period|Lost to Follow-up|0|||
37704638|NCT01605136|69182228|FG001|Study Period|Lost to Follow-up|2|||
37704639|NCT01605136|69182227|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
37704640|NCT01605136|69182228|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
37704641|NCT01706146|69182234|FG000|Overall Study|Withdrawal by Subject|1|||
37704642|NCT01706146|69182234|FG000|Overall Study|Adverse Event|3|||
37704643|NCT01706146|69182234|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
37704644|NCT02269241|69182238|FG000|Overall Study|Lost to Follow-up|269|||
37704645|NCT02269241|69182238|FG000|Overall Study|Withdrawal by Subject|155|||
37704646|NCT02269241|69182238|FG000|Overall Study|Protocol Violation|1|||
37704647|NCT02269241|69182238|FG000|Overall Study|Physician Decision|7|||
37704648|NCT02269241|69182238|FG000|Overall Study|Pregnancy|15|||
37704649|NCT02269241|69182238|FG000|Overall Study|Wish for pregnancy|5|||
37704650|NCT02269241|69182238|FG000|Overall Study|Development of an exclusion criteria|16|||
37704651|NCT02269241|69182238|FG000|Overall Study|Adverse Event|113|||
37704652|NCT02269241|69182238|FG000|Overall Study|At the specific request of the sponsor|20|||
37704653|NCT02269241|69182238|FG000|Overall Study|Several reasons not classified|53|||
37704654|NCT02269241|69182238|FG000|Overall Study|Screening failures|546|||
37704655|NCT01750684|69182245|FG000|Overall Study|Death|1|||
37704656|NCT01750684|69182246|FG001|Overall Study|Death|0|||
37704657|NCT01750684|69182245|FG000|Overall Study|Non-compliance with Study Drug|0|||
37704658|NCT01750684|69182246|FG001|Overall Study|Non-compliance with Study Drug|1|||
37704659|NCT01750684|69182245|FG000|Overall Study|Withdrawn by Sponsor|0|||
37704660|NCT01750684|69182246|FG001|Overall Study|Withdrawn by Sponsor|1|||
37704661|NCT01750684|69182245|FG000|Overall Study|Protocol Violation|1|||
37704662|NCT01750684|69182246|FG001|Overall Study|Protocol Violation|0|||
37704663|NCT01750294|69182253|FG000|Overall Study|Withdrawal by Subject|1|||
37837450|NCT01154218|69521849|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
37704664|NCT01750294|69182253|FG000|Overall Study|Safety Endpoint|1|||
37704665|NCT01749982|69182261|FG000|Overall Study|Physician Decision|0|||
37704666|NCT01749982|69182262|FG001|Overall Study|Physician Decision|0|||
37704667|NCT01749982|69182263|FG002|Overall Study|Physician Decision|0|||
37704668|NCT01749982|69182264|FG003|Overall Study|Physician Decision|1|||
37704669|NCT01749982|69182261|FG000|Overall Study|Lost to Follow-up|0|||
37704670|NCT01749982|69182262|FG001|Overall Study|Lost to Follow-up|0|||
37704671|NCT01749982|69182263|FG002|Overall Study|Lost to Follow-up|0|||
37704672|NCT01749982|69182264|FG003|Overall Study|Lost to Follow-up|1|||
37704673|NCT01749982|69182261|FG000|Overall Study|Withdrawal by Subject|0|||
37704674|NCT01749982|69182262|FG001|Overall Study|Withdrawal by Subject|0|||
37704675|NCT01749982|69182263|FG002|Overall Study|Withdrawal by Subject|0|||
37704676|NCT01749982|69182264|FG003|Overall Study|Withdrawal by Subject|1|||
37704677|NCT02269163|69182276|FG000|Overall Study|Lost to Follow-up|1|||
37704678|NCT02269163|69182277|FG001|Overall Study|Lost to Follow-up|0|||
37704679|NCT02269163|69182276|FG000|Overall Study|Major protocol violation|0|||
37704680|NCT02269163|69182277|FG001|Overall Study|Major protocol violation|1|||
37704681|NCT02269163|69182276|FG000|Overall Study|Other|2|||
37704682|NCT02269163|69182277|FG001|Overall Study|Other|2|||
37704683|NCT02269163|69182276|FG000|Overall Study|Withdrawal by Subject|0|||
37704684|NCT02269163|69182277|FG001|Overall Study|Withdrawal by Subject|3|||
37704685|NCT02269163|69182276|FG000|Overall Study|Physician Decision|0|||
37704686|NCT02269163|69182277|FG001|Overall Study|Physician Decision|1|||
37704687|NCT01749826|69182287|FG000|Overall Study|Study Terminated|20|||
37704688|NCT01749826|69182288|FG001|Overall Study|Study Terminated|0|||
37704689|NCT02300129|69182294|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
37704690|NCT02300129|69182295|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
37704691|NCT02300129|69182296|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
37704692|NCT02300129|69182297|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
37704693|NCT02300129|69182294|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
37704694|NCT02300129|69182295|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
37704695|NCT02300129|69182296|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
37704696|NCT02300129|69182297|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
37704697|NCT02300129|69182294|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
37704698|NCT02300129|69182295|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
37704699|NCT02300129|69182296|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
37704700|NCT02300129|69182297|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
37704701|NCT02267135|69182309|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
37704702|NCT02267135|69182310|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
37704703|NCT02267135|69182309|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
37704704|NCT02267135|69182310|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
37704705|NCT02267135|69182309|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
37704706|NCT02267135|69182310|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
37704707|NCT02267135|69182309|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
37704708|NCT02267135|69182310|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
37704709|NCT02267135|69182309|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
37704710|NCT02267135|69182310|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
37704711|NCT02299427|69182321|FG000|Overall Study|Withdrawal by Subject|1|||
37704712|NCT02299427|69182322|FG001|Overall Study|Withdrawal by Subject|0|||
37704713|NCT02299427|69182321|FG000|Overall Study|Lost to Follow-up|1|||
37704714|NCT02299427|69182322|FG001|Overall Study|Lost to Follow-up|3|||
37704715|NCT02299427|69182321|FG000|Overall Study|not adherent to dog website use|21|||
37704716|NCT02299427|69182322|FG001|Overall Study|not adherent to dog website use|0|||
37704717|NCT01724866|69182332|FG000|Overall Study|Adverse Event|0|||
37704718|NCT01724866|69182333|FG001|Overall Study|Adverse Event|0|||
37704719|NCT01724866|69182334|FG002|Overall Study|Adverse Event|1|||
37704720|NCT01724866|69182335|FG003|Overall Study|Adverse Event|1|||
37704721|NCT01724866|69182332|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
37704722|NCT01724866|69182333|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
37704723|NCT01724866|69182334|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
37704724|NCT01724866|69182335|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
37704725|NCT01724866|69182332|FG000|Overall Study|Investigator's Discretion|0|||
37704726|NCT01724866|69182333|FG001|Overall Study|Investigator's Discretion|1|||
37704727|NCT01724866|69182334|FG002|Overall Study|Investigator's Discretion|1|||
37704728|NCT01724866|69182335|FG003|Overall Study|Investigator's Discretion|0|||
37704729|NCT01724866|69182332|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
37704730|NCT01724866|69182333|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
37704731|NCT01724866|69182334|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
37704732|NCT01724866|69182335|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
37704733|NCT01724866|69182332|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
37837451|NCT01154218|69521850|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
37704734|NCT01724866|69182333|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
37704735|NCT01724866|69182334|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
37704736|NCT01724866|69182335|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
37704737|NCT02266433|69182347|FG000|Overall Study|Lost to Follow-up|54|||
37704738|NCT02266433|69182348|FG001|Overall Study|Lost to Follow-up|46|||
37704739|NCT02266433|69182347|FG000|Overall Study|Withdrawal by Subject|5|||
37704740|NCT02266433|69182348|FG001|Overall Study|Withdrawal by Subject|7|||
37704741|NCT01748890|69182355|FG000|Overall Study|Insufficient recruitment for analysis|4|||
37704742|NCT01747876|69182362|FG000|Overall Study|Adverse Event|1|||
37704743|NCT01747876|69182363|FG001|Overall Study|Adverse Event|0|||
37704744|NCT01747876|69182364|FG002|Overall Study|Adverse Event|2|||
37704745|NCT01747876|69182362|FG000|Overall Study|Withdrawal by Subject|0|||
37704746|NCT01747876|69182363|FG001|Overall Study|Withdrawal by Subject|1|||
37704747|NCT01747876|69182364|FG002|Overall Study|Withdrawal by Subject|1|||
37704748|NCT01747876|69182362|FG000|Overall Study|Disease progression|4|||
37704749|NCT01747876|69182363|FG001|Overall Study|Disease progression|13|||
37704750|NCT01747876|69182364|FG002|Overall Study|Disease progression|8|||
37704751|NCT01747876|69182362|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
37704752|NCT01747876|69182363|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
37704753|NCT01747876|69182364|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
37704754|NCT02273726|69182377|FG000|Overall Study|Death|70|||
37704755|NCT02273726|69182378|FG001|Overall Study|Death|62|||
37704756|NCT02273726|69182377|FG000|Overall Study|Withdrawal by Subject|41|||
37704757|NCT02273726|69182378|FG001|Overall Study|Withdrawal by Subject|29|||
37704758|NCT02273726|69182377|FG000|Overall Study|Kidney transplant|31|||
37704759|NCT02273726|69182378|FG001|Overall Study|Kidney transplant|39|||
37704760|NCT02273726|69182377|FG000|Overall Study|Physician Decision|30|||
37704761|NCT02273726|69182378|FG001|Overall Study|Physician Decision|15|||
37704762|NCT02273726|69182377|FG000|Overall Study|Adverse Event|27|||
37704763|NCT02273726|69182378|FG001|Overall Study|Adverse Event|9|||
37704764|NCT02273726|69182377|FG000|Overall Study|Lost to Follow-up|6|||
37704765|NCT02273726|69182378|FG001|Overall Study|Lost to Follow-up|3|||
37704766|NCT02273726|69182377|FG000|Overall Study|Lack of Efficacy|6|||
37704767|NCT02273726|69182378|FG001|Overall Study|Lack of Efficacy|1|||
37704768|NCT02273726|69182377|FG000|Overall Study|Protocol Violation|4|||
37704769|NCT02273726|69182378|FG001|Overall Study|Protocol Violation|0|||
37704770|NCT02273726|69182377|FG000|Overall Study|Other than specified|28|||
37704771|NCT02273726|69182378|FG001|Overall Study|Other than specified|30|||
37704772|NCT01723228|69182386|FG000|Overall Study|Adverse Event|2|||
37704773|NCT01723228|69182387|FG001|Overall Study|Adverse Event|6|||
37704774|NCT01723228|69182386|FG000|Overall Study|Withdrawal by Subject|2|||
37704775|NCT01723228|69182387|FG001|Overall Study|Withdrawal by Subject|1|||
37704776|NCT01723228|69182386|FG000|Overall Study|Protocol Violation|0|||
37704777|NCT01723228|69182387|FG001|Overall Study|Protocol Violation|2|||
37704778|NCT01723228|69182386|FG000|Overall Study|Lost to Follow-up|2|||
37704779|NCT01723228|69182387|FG001|Overall Study|Lost to Follow-up|1|||
37704780|NCT01723228|69182386|FG000|Overall Study|Other|2|||
37704781|NCT01723228|69182387|FG001|Overall Study|Other|1|||
37704782|NCT02273180|69182395|FG000|Overall Study|Adverse Event|2|||
37704783|NCT02273180|69182396|FG001|Overall Study|Adverse Event|2|||
37704784|NCT02273180|69182395|FG000|Overall Study|Lack of Efficacy|1|||
37704785|NCT02273180|69182396|FG001|Overall Study|Lack of Efficacy|0|||
37704786|NCT02273180|69182395|FG000|Overall Study|Protocol Violation|1|||
37704787|NCT02273180|69182396|FG001|Overall Study|Protocol Violation|7|||
37704788|NCT02273180|69182395|FG000|Overall Study|Randomized but not treated|1|||
37704789|NCT02273180|69182396|FG001|Overall Study|Randomized but not treated|0|||
37704790|NCT02273180|69182395|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
37837452|NCT01154218|69521851|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
37704791|NCT02273180|69182396|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
37704792|NCT02273180|69182395|FG000|Overall Study|Other than specified above|21|||
37704793|NCT02273180|69182396|FG001|Overall Study|Other than specified above|10|||
37704794|NCT01746862|69182404|FG000|Overall Study|Withdrawal by Subject|1|||
37837453|NCT01154218|69521852|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
37837454|NCT01154218|69521849|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
37837455|NCT01154218|69521850|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
37704795|NCT01746862|69182405|FG001|Overall Study|Withdrawal by Subject|1|||
37704796|NCT01746862|69182404|FG000|Overall Study|Protocol Violation|1|||
37837456|NCT01154218|69521851|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
37837457|NCT01154218|69521852|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
37704797|NCT01746862|69182405|FG001|Overall Study|Protocol Violation|0|||
37704798|NCT01746862|69182404|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
37704799|NCT01746862|69182405|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
37704800|NCT01746862|69182404|FG000|Overall Study|Entered puberty during the study|1|||
37704801|NCT01746862|69182405|FG001|Overall Study|Entered puberty during the study|0|||
37704802|NCT01745848|69182412|FG000|Overall Study|Adverse Event|6|||
37837458|NCT01154140|69521877|FG000|Overall Study|Death|71|||
37704803|NCT01745380|69182418|FG000|Overall Study|Lost to Follow-up|1|||
37704804|NCT01745380|69182419|FG001|Overall Study|Lost to Follow-up|0|||
37704805|NCT01745380|69182418|FG000|Overall Study|Lack of Efficacy|0|||
37704806|NCT01745380|69182419|FG001|Overall Study|Lack of Efficacy|1|||
37704807|NCT01745146|69182427|FG000|Overall Study|Withdrawal by Subject|1|||
37704808|NCT01745146|69182428|FG001|Overall Study|Withdrawal by Subject|3|||
37704809|NCT01745146|69182427|FG000|Overall Study|Lost to Follow-up|2|||
37704810|NCT01745146|69182428|FG001|Overall Study|Lost to Follow-up|0|||
37704811|NCT02203513|69182440|FG000|Overall Study|Refused further treatment|2|||
37704812|NCT02203513|69182441|FG001|Overall Study|Refused further treatment|0|||
37704813|NCT02203513|69182442|FG002|Overall Study|Refused further treatment|1|||
37704814|NCT02203513|69182443|FG003|Overall Study|Refused further treatment|0|||
37704815|NCT02203513|69182444|FG004|Overall Study|Refused further treatment|0|||
37704816|NCT02203513|69182440|FG000|Overall Study|Switched to alternative treatment|3|||
37704817|NCT02203513|69182441|FG001|Overall Study|Switched to alternative treatment|4|||
37704818|NCT02203513|69182442|FG002|Overall Study|Switched to alternative treatment|0|||
37704819|NCT02203513|69182443|FG003|Overall Study|Switched to alternative treatment|0|||
37704820|NCT02203513|69182444|FG004|Overall Study|Switched to alternative treatment|4|||
37704821|NCT02203513|69182440|FG000|Overall Study|Did not receive investigational product (IP)|0|||
37704822|NCT02203513|69182441|FG001|Overall Study|Did not receive investigational product (IP)|1|||
37704823|NCT02203513|69182442|FG002|Overall Study|Did not receive investigational product (IP)|0|||
37704824|NCT02203513|69182443|FG003|Overall Study|Did not receive investigational product (IP)|0|||
37704825|NCT02203513|69182444|FG004|Overall Study|Did not receive investigational product (IP)|0|||
37704826|NCT02203513|69182440|FG000|Overall Study|Death (unrelated to study therapy)|1|||
37704827|NCT02203513|69182441|FG001|Overall Study|Death (unrelated to study therapy)|3|||
37704828|NCT02203513|69182442|FG002|Overall Study|Death (unrelated to study therapy)|1|||
37704829|NCT02203513|69182443|FG003|Overall Study|Death (unrelated to study therapy)|0|||
37704830|NCT02203513|69182444|FG004|Overall Study|Death (unrelated to study therapy)|2|||
37704831|NCT02203513|69182440|FG000|Overall Study|Lost to Follow-up|0|||
37704832|NCT02203513|69182441|FG001|Overall Study|Lost to Follow-up|0|||
37704833|NCT02203513|69182442|FG002|Overall Study|Lost to Follow-up|1|||
37704834|NCT02203513|69182443|FG003|Overall Study|Lost to Follow-up|1|||
37704835|NCT02203513|69182444|FG004|Overall Study|Lost to Follow-up|0|||
37704836|NCT02299934|69182458|FG000|Overall Study|Termination of study|13|||
37704837|NCT01703260|69182465|FG000|Overall Study|Adverse Event|1|||
37704838|NCT01703260|69182466|FG001|Overall Study|Adverse Event|2|||
37704839|NCT01703260|69182467|FG002|Overall Study|Adverse Event|2|||
37704840|NCT01703260|69182465|FG000|Overall Study|Lost to Follow-up|1|||
37704841|NCT01703260|69182466|FG001|Overall Study|Lost to Follow-up|0|||
37704842|NCT01703260|69182467|FG002|Overall Study|Lost to Follow-up|0|||
37704843|NCT01703260|69182465|FG000|Overall Study|Withdrawal by Subject|0|||
37704844|NCT01703260|69182466|FG001|Overall Study|Withdrawal by Subject|0|||
37704845|NCT01703260|69182467|FG002|Overall Study|Withdrawal by Subject|1|||
37704846|NCT01703260|69182465|FG000|Overall Study|Study Termination|1|||
37704847|NCT01703260|69182466|FG001|Overall Study|Study Termination|2|||
37704848|NCT01703260|69182467|FG002|Overall Study|Study Termination|0|||
37704849|NCT02203357|69182478|FG000|Overall Study|Lost to Follow-up|58|||
37704850|NCT02203357|69182479|FG001|Overall Study|Lost to Follow-up|66|||
37704851|NCT02203357|69182480|FG002|Overall Study|Lost to Follow-up|70|||
37704852|NCT02299388|69182493|FG000|Overall Study|Withdrawal by Subject|0|||
37704853|NCT02299388|69182494|FG001|Overall Study|Withdrawal by Subject|1|||
37704854|NCT02202577|69182502|FG000|Overall Study|Lost to Follow-up|6|||
37704855|NCT02202577|69182503|FG001|Overall Study|Lost to Follow-up|16|||
37704856|NCT02202577|69182502|FG000|Overall Study|Protocol Violation|7|||
37704857|NCT02202577|69182503|FG001|Overall Study|Protocol Violation|3|||
37704858|NCT02299076|69182511|FG000|Overall Study|Fraudulent Entries|20|||
37704859|NCT02299076|69182512|FG001|Overall Study|Fraudulent Entries|14|||
37704860|NCT01723072|69182520|FG000|Overall Study|Withdrawal by Subject|7|||
37837459|NCT01154140|69521878|FG001|Overall Study|Death|81|||
37837460|NCT01154140|69521877|FG000|Overall Study|Lost to Follow-up|4|||
37837461|NCT01154140|69521878|FG001|Overall Study|Lost to Follow-up|5|||
37837462|NCT01154140|69521877|FG000|Overall Study|Withdrawal by Subject|12|||
37837463|NCT01154140|69521878|FG001|Overall Study|Withdrawal by Subject|13|||
37837464|NCT01154140|69521877|FG000|Overall Study|Other|3|||
37837465|NCT01154140|69521878|FG001|Overall Study|Other|1|||
37837466|NCT01154140|69521877|FG000|Overall Study|Randomized but not treated|1|||
37837467|NCT01154140|69521878|FG001|Overall Study|Randomized but not treated|2|||
37837468|NCT01154101|69521889|FG000|Overall Study|Adverse Event|0|||
37837469|NCT01154101|69521890|FG001|Overall Study|Adverse Event|2|||
37704861|NCT01723072|69182521|FG001|Overall Study|Withdrawal by Subject|13|||
37704862|NCT01723072|69182520|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
37704863|NCT01723072|69182521|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
37704864|NCT01723072|69182520|FG000|Overall Study|Other|4|||
37704865|NCT01723072|69182521|FG001|Overall Study|Other|3|||
37704866|NCT01722994|69182529|FG000|Overall Study|Missing data|25|||
37837470|NCT01154101|69521891|FG002|Overall Study|Adverse Event|1|||
37915135|NCT00853827|69601821|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
37704867|NCT01722994|69182530|FG001|Overall Study|Missing data|17|||
37704868|NCT02228395|69182538|FG000|First Intervention Period|No longer willing to participate|1|||
37704869|NCT02228395|69182539|FG001|First Intervention Period|No longer willing to participate|0|||
37704870|NCT02228395|69182540|FG002|First Intervention Period|No longer willing to participate|0|||
37704871|NCT02228395|69182538|FG000|First Intervention Period|Unable to comply with study dates|0|||
37704872|NCT02228395|69182539|FG001|First Intervention Period|Unable to comply with study dates|1|||
37704873|NCT02228395|69182540|FG002|First Intervention Period|Unable to comply with study dates|1|||
37704874|NCT02170051|69182552|FG000|Overall Study|Withdrawal by Subject|10|||
37704875|NCT02170051|69182553|FG001|Overall Study|Withdrawal by Subject|10|||
37704876|NCT02170051|69182552|FG000|Overall Study|Lost to Follow-up|1|||
37704877|NCT02170051|69182553|FG001|Overall Study|Lost to Follow-up|3|||
37704878|NCT02169739|69182561|FG000|Overall Study|Lost to Follow-up|0|||
37704879|NCT02169739|69182562|FG001|Overall Study|Lost to Follow-up|4|||
37704880|NCT02169505|69182569|FG000|Overall Study|Withdrawal by Subject|1|||
37704881|NCT01909791|69182576|FG000|Overall Study|Death|9|||
37704882|NCT01909791|69182577|FG001|Overall Study|Death|8|||
37704883|NCT01909791|69182578|FG002|Overall Study|Death|4|||
37704884|NCT01909791|69182576|FG000|Overall Study|Withdrawal by Subject|5|||
37704885|NCT01909791|69182577|FG001|Overall Study|Withdrawal by Subject|9|||
37704886|NCT01909791|69182578|FG002|Overall Study|Withdrawal by Subject|13|||
37704887|NCT01909791|69182576|FG000|Overall Study|Lost to Follow-up|5|||
37704888|NCT01909791|69182577|FG001|Overall Study|Lost to Follow-up|11|||
37704889|NCT01909791|69182578|FG002|Overall Study|Lost to Follow-up|10|||
37704890|NCT01909791|69182576|FG000|Overall Study|Missed Visit|2|||
37704891|NCT01909791|69182577|FG001|Overall Study|Missed Visit|0|||
37704892|NCT01909791|69182578|FG002|Overall Study|Missed Visit|1|||
37704893|NCT02202499|69182594|FG000|Overall Study|Cancer diagnosis|0|||
37704894|NCT02202499|69182595|FG001|Overall Study|Cancer diagnosis|0|||
37704895|NCT02202499|69182596|FG002|Overall Study|Cancer diagnosis|1|||
37704896|NCT02202499|69182594|FG000|Overall Study|Moved from area|0|||
37704897|NCT02202499|69182595|FG001|Overall Study|Moved from area|0|||
37704898|NCT02202499|69182596|FG002|Overall Study|Moved from area|1|||
37704899|NCT02202499|69182594|FG000|Overall Study|Declined before randomization|1|||
37704900|NCT02202499|69182595|FG001|Overall Study|Declined before randomization|0|||
37704901|NCT02202499|69182596|FG002|Overall Study|Declined before randomization|0|||
37704902|NCT02202499|69182594|FG000|Overall Study|Auto accident|1|||
37704903|NCT02202499|69182595|FG001|Overall Study|Auto accident|0|||
37704904|NCT02202499|69182596|FG002|Overall Study|Auto accident|0|||
37704905|NCT02202109|69182611|FG000|Overall Study|Lost to Follow-up|88|||
37704906|NCT02202109|69182612|FG001|Overall Study|Lost to Follow-up|87|||
37704907|NCT02202109|69182611|FG000|Overall Study|Withdrawal by Subject|2|||
37704908|NCT02202109|69182612|FG001|Overall Study|Withdrawal by Subject|0|||
37704909|NCT02227849|69182618|FG000|Overall Study|Adverse Event|4|||
37704910|NCT02227849|69182618|FG000|Overall Study|Physician Decision|1|||
37704911|NCT02227849|69182618|FG000|Overall Study|Withdrawal by Subject|3|||
37704912|NCT01927497|69182624|FG000|Overall Study|Death|0|||
37704913|NCT01927497|69182625|FG001|Overall Study|Death|1|||
37704914|NCT01927497|69182624|FG000|Overall Study|Protocol Violation|2|||
37704915|NCT01927497|69182625|FG001|Overall Study|Protocol Violation|0|||
37704916|NCT02169271|69182633|FG000|Overall Study|Protocol Violation|1|||
37704917|NCT02169271|69182634|FG001|Overall Study|Protocol Violation|2|||
37704918|NCT02202031|69182642|FG000|Overall Study|Lost to Follow-up|1|||
37704919|NCT02202031|69182643|FG001|Overall Study|Lost to Follow-up|0|||
37704920|NCT02202031|69182642|FG000|Overall Study|Too Busy|1|||
37704921|NCT02202031|69182643|FG001|Overall Study|Too Busy|3|||
37704922|NCT02202031|69182642|FG000|Overall Study|Illness/Medical Reason|0|||
37704923|NCT02202031|69182643|FG001|Overall Study|Illness/Medical Reason|2|||
37704924|NCT02202031|69182642|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
37704925|NCT02202031|69182643|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
37704926|NCT01644188|69182651|FG000|Overall Study|Adverse Event|44|||
37704927|NCT01644188|69182652|FG001|Overall Study|Adverse Event|20|||
37704928|NCT01644188|69182651|FG000|Overall Study|Poor compliance to protocol|26|||
37704929|NCT01644188|69182652|FG001|Overall Study|Poor compliance to protocol|14|||
37704930|NCT01644188|69182651|FG000|Overall Study|Physician Decision|1|||
37704931|NCT01644188|69182652|FG001|Overall Study|Physician Decision|3|||
37704932|NCT01644188|69182651|FG000|Overall Study|Participant moved|7|||
37837471|NCT01154101|69521892|FG003|Overall Study|Adverse Event|1|||
37704933|NCT01644188|69182652|FG001|Overall Study|Participant moved|2|||
37704934|NCT01644188|69182651|FG000|Overall Study|Related to auto-injector administration|2|||
37704935|NCT01644188|69182652|FG001|Overall Study|Related to auto-injector administration|2|||
37704936|NCT01644188|69182651|FG000|Overall Study|Consent withdrawn by participant|14|||
37704937|NCT01644188|69182652|FG001|Overall Study|Consent withdrawn by participant|7|||
37704938|NCT01644188|69182651|FG000|Overall Study|Selection criteria finally not met|2|||
37704939|NCT01644188|69182652|FG001|Overall Study|Selection criteria finally not met|0|||
37704940|NCT01644188|69182651|FG000|Overall Study|Lost to Follow-up|1|||
37704941|NCT01644188|69182652|FG001|Overall Study|Lost to Follow-up|0|||
37704942|NCT01644188|69182651|FG000|Overall Study|Death|4|||
37704943|NCT01644188|69182652|FG001|Overall Study|Death|3|||
37704944|NCT01644188|69182651|FG000|Overall Study|Last visit outside protocol visit window|14|||
37704945|NCT01644188|69182652|FG001|Overall Study|Last visit outside protocol visit window|16|||
37704946|NCT01644188|69182651|FG000|Overall Study|Site closure|1|||
37704947|NCT01644188|69182652|FG001|Overall Study|Site closure|1|||
37704948|NCT01644188|69182651|FG000|Overall Study|Other than specified above|6|||
37704949|NCT01644188|69182652|FG001|Overall Study|Other than specified above|7|||
37704950|NCT02201953|69182660|FG000|Overall Study|Randomized but Never Treated|1|||
37704951|NCT02201953|69182661|FG001|Overall Study|Randomized but Never Treated|5|||
37704952|NCT02201953|69182660|FG000|Overall Study|Lack of Efficacy|9|||
37704953|NCT02201953|69182661|FG001|Overall Study|Lack of Efficacy|30|||
37704954|NCT02201953|69182660|FG000|Overall Study|Lost to Follow-up|8|||
37704955|NCT02201953|69182661|FG001|Overall Study|Lost to Follow-up|8|||
37704956|NCT02201953|69182660|FG000|Overall Study|Withdrew Consent|2|||
37704957|NCT02201953|69182661|FG001|Overall Study|Withdrew Consent|5|||
37704958|NCT02201953|69182660|FG000|Overall Study|Adverse Event|0|||
37704959|NCT02201953|69182661|FG001|Overall Study|Adverse Event|5|||
37704960|NCT02201953|69182660|FG000|Overall Study|Death|0|||
37704961|NCT02201953|69182661|FG001|Overall Study|Death|3|||
37704962|NCT02271854|69182667|FG000|Overall Study|Withdrawal by Subject|2|||
37704963|NCT02271854|69182667|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
37704964|NCT02271854|69182667|FG000|Overall Study|Lost to Follow-up|1|||
37704965|NCT02296892|69182675|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
37704966|NCT02296892|69182676|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
37704967|NCT02296892|69182677|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
37704968|NCT02296892|69182675|FG000|Overall Study|Lost to Follow-up|5|||
37704969|NCT02296892|69182676|FG001|Overall Study|Lost to Follow-up|0|||
37704970|NCT02296892|69182677|FG002|Overall Study|Lost to Follow-up|1|||
37704971|NCT02270684|69182687|FG000|Overall Study|Lost to Follow-up|0|||
37704972|NCT02270684|69182688|FG001|Overall Study|Lost to Follow-up|3|||
37704973|NCT02270684|69182687|FG000|Overall Study|Study terminated|1|||
37704974|NCT02270684|69182688|FG001|Overall Study|Study terminated|0|||
37704975|NCT02168803|69182697|FG000|Overall Study|Lost to Follow-up|1|||
37704976|NCT02168803|69182698|FG001|Overall Study|Lost to Follow-up|0|||
37704977|NCT02168803|69182699|FG002|Overall Study|Lost to Follow-up|1|||
37704978|NCT02168803|69182697|FG000|Overall Study|Withdrawal by Subject|1|||
37704979|NCT02168803|69182698|FG001|Overall Study|Withdrawal by Subject|1|||
37704980|NCT02168803|69182699|FG002|Overall Study|Withdrawal by Subject|2|||
37704981|NCT02168803|69182697|FG000|Overall Study|Physician Decision|0|||
37704982|NCT02168803|69182698|FG001|Overall Study|Physician Decision|1|||
37704983|NCT02168803|69182699|FG002|Overall Study|Physician Decision|0|||
37704984|NCT02168803|69182697|FG000|Overall Study|Adverse Event|0|||
37704985|NCT02168803|69182698|FG001|Overall Study|Adverse Event|1|||
37704986|NCT02168803|69182699|FG002|Overall Study|Adverse Event|1|||
37704987|NCT02168803|69182697|FG000|Overall Study|Death|0|||
37704988|NCT02168803|69182698|FG001|Overall Study|Death|0|||
37704989|NCT02168803|69182699|FG002|Overall Study|Death|1|||
37704990|NCT02168803|69182697|FG000|Overall Study|Sponsor Decision|0|||
37704991|NCT02168803|69182698|FG001|Overall Study|Sponsor Decision|0|||
37837472|NCT01154101|69521893|FG004|Overall Study|Adverse Event|0|||
37837473|NCT01154101|69521889|FG000|Overall Study|Lost to Follow-up|0|||
37837474|NCT01154101|69521890|FG001|Overall Study|Lost to Follow-up|1|||
37837475|NCT01154101|69521891|FG002|Overall Study|Lost to Follow-up|0|||
37704992|NCT02168803|69182699|FG002|Overall Study|Sponsor Decision|1|||
37704993|NCT02201329|69182714|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
37704994|NCT02201329|69182714|FG000|Overall Study|Withdrawal by Subject|2|||
37704995|NCT01927419|69182720|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
37704996|NCT01927419|69182721|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
37704997|NCT01927419|69182720|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
37704998|NCT01927419|69182721|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
37704999|NCT01927419|69182720|FG000|Treatment Period|Disease progression|17|||
37705000|NCT01927419|69182721|FG001|Treatment Period|Disease progression|20|||
37705001|NCT01927419|69182720|FG000|Treatment Period|Study drug toxicity|48|||
37705002|NCT01927419|69182721|FG001|Treatment Period|Study drug toxicity|10|||
37705003|NCT01927419|69182720|FG000|Treatment Period|Death|0|||
37705004|NCT01927419|69182721|FG001|Treatment Period|Death|1|||
37705005|NCT01927419|69182720|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
37705006|NCT01927419|69182721|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
37705007|NCT01927419|69182720|FG000|Treatment Period|Participant request to discontinue|12|||
37705008|NCT01927419|69182721|FG001|Treatment Period|Participant request to discontinue|4|||
37705009|NCT01927419|69182720|FG000|Treatment Period|Withdrawal by Subject|1|||
37705010|NCT01927419|69182721|FG001|Treatment Period|Withdrawal by Subject|1|||
37705011|NCT01927419|69182720|FG000|Treatment Period|Maximum Clinical Benefit|6|||
37705012|NCT01927419|69182721|FG001|Treatment Period|Maximum Clinical Benefit|2|||
37705013|NCT01927419|69182720|FG000|Treatment Period|Other reasons|3|||
37705014|NCT01927419|69182721|FG001|Treatment Period|Other reasons|4|||
37705015|NCT01927419|69182720|FG000|Treatment Period|Not Reported|1|||
37705016|NCT01927419|69182721|FG001|Treatment Period|Not Reported|1|||
37705017|NCT02168491|69182727|FG000|Overall Study|Withdrawal by Subject|1|||
37705018|NCT02225743|69182731|FG000|Overall Study|Withdrawal by Subject|18|||
37705019|NCT01721746|69182737|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
37705020|NCT01721746|69182738|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
37705021|NCT01721746|69182737|FG000|Pre-Treatment|Withdrawal by Subject|1|||
37705022|NCT01721746|69182738|FG001|Pre-Treatment|Withdrawal by Subject|16|||
37705023|NCT01721746|69182737|FG000|Pre-Treatment|Poor/Non-compliance|1|||
37705024|NCT01721746|69182738|FG001|Pre-Treatment|Poor/Non-compliance|0|||
37705025|NCT01721746|69182737|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
37705026|NCT01721746|69182738|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
37705027|NCT01721746|69182737|FG000|Treatment|Disease Progression|192|||
37705028|NCT01721746|69182738|FG001|Treatment|Disease Progression|74|||
37837476|NCT01154101|69521892|FG003|Overall Study|Lost to Follow-up|1|||
37915136|NCT00853827|69601822|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
37915137|NCT00853827|69601821|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
37915138|NCT00853827|69601822|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
37915139|NCT00853827|69601821|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
37915140|NCT00853827|69601822|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
37915141|NCT00853827|69601821|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
37915142|NCT00853827|69601822|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
37915143|NCT00853827|69601821|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
37915144|NCT00853827|69601822|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
37915145|NCT00853827|69601821|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
37915146|NCT00853827|69601822|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
37915147|NCT00853827|69601821|FG000|Double Blind Period (103 Weeks)|Death|1|||
37915148|NCT00853827|69601822|FG001|Double Blind Period (103 Weeks)|Death|6|||
38023899|NCT02927080|69707231|FG004|Overall Study|Study terminated by Sponsor|0|||
37705029|NCT01721746|69182737|FG000|Treatment|Study Drug Toxicity|19|||
37705030|NCT01721746|69182738|FG001|Treatment|Study Drug Toxicity|11|||
37705031|NCT01721746|69182737|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
37705032|NCT01721746|69182738|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
37837477|NCT01154101|69521893|FG004|Overall Study|Lost to Follow-up|0|||
37837478|NCT01154101|69521889|FG000|Overall Study|Withdrawal by Subject|0|||
37837479|NCT01154101|69521890|FG001|Overall Study|Withdrawal by Subject|1|||
37837480|NCT01154101|69521891|FG002|Overall Study|Withdrawal by Subject|2|||
37837481|NCT01154101|69521892|FG003|Overall Study|Withdrawal by Subject|0|||
37837482|NCT01154101|69521893|FG004|Overall Study|Withdrawal by Subject|1|||
37837483|NCT01153984|69521910|FG000|Overall Study|Withdrawal by Subject|1|||
37837484|NCT01153984|69521910|FG000|Overall Study|Adverse Event|1|||
37837485|NCT01153633|69521916|FG000|Overall Study|Protocol Violation|1|||
37837486|NCT01153633|69521917|FG001|Overall Study|Protocol Violation|1|||
37837487|NCT01153633|69521916|FG000|Overall Study|Therapeutic failure|3|||
37837488|NCT01153633|69521917|FG001|Overall Study|Therapeutic failure|3|||
37837489|NCT01153516|69521927|FG000|Overall Study|Both subjects refused surgery|2|||
37837490|NCT01153516|69521928|FG001|Overall Study|Both subjects refused surgery|0|||
37837491|NCT01153321|69521936|FG000|Overall Study|Development of study withdrawal criteria|0|||
37837492|NCT01153321|69521937|FG001|Overall Study|Development of study withdrawal criteria|1|||
37837493|NCT01153321|69521936|FG000|Overall Study|Withdrawal by Subject|0|||
37705033|NCT01721746|69182737|FG000|Treatment|Participant request to discontinue Study treatment|26|||
37837494|NCT01153321|69521937|FG001|Overall Study|Withdrawal by Subject|1|||
37915149|NCT00853749|69601830|FG000|Overall Study|Lost to Follow-up|0|||
37705034|NCT01721746|69182738|FG001|Treatment|Participant request to discontinue Study treatment|7|||
37705035|NCT01721746|69182737|FG000|Treatment|Participant withdrew consent|4|||
37705036|NCT01721746|69182738|FG001|Treatment|Participant withdrew consent|2|||
37705037|NCT01721746|69182737|FG000|Treatment|Maximum Clinical Benefit|9|||
37705038|NCT01721746|69182738|FG001|Treatment|Maximum Clinical Benefit|3|||
37705039|NCT01721746|69182737|FG000|Treatment|Poor/Non-compliance|2|||
37705040|NCT01721746|69182738|FG001|Treatment|Poor/Non-compliance|0|||
37705041|NCT01721746|69182737|FG000|Treatment|Participant no longer met Study criteria|4|||
37705042|NCT01721746|69182738|FG001|Treatment|Participant no longer met Study criteria|0|||
37705043|NCT01721746|69182737|FG000|Treatment|Other reasons|6|||
37705044|NCT01721746|69182738|FG001|Treatment|Other reasons|2|||
37705045|NCT02225665|69182747|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
37705046|NCT02225665|69182748|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
37705047|NCT02225665|69182747|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
37705048|NCT02225665|69182748|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
37705049|NCT01721200|69182756|FG000|Overall Study|Lost to Follow-up|3|||
37705050|NCT01721200|69182757|FG001|Overall Study|Lost to Follow-up|5|||
37705051|NCT02225587|69182770|FG000|Overall Study|Adverse Event|5|||
37705052|NCT02225587|69182771|FG001|Overall Study|Adverse Event|5|||
37705053|NCT02225587|69182770|FG000|Overall Study|Lost to Follow-up|5|||
37705054|NCT02225587|69182771|FG001|Overall Study|Lost to Follow-up|5|||
37705055|NCT02225587|69182770|FG000|Overall Study|Non-Compliance With Study Drug|1|||
37705056|NCT02225587|69182771|FG001|Overall Study|Non-Compliance With Study Drug|0|||
37705057|NCT02225587|69182770|FG000|Overall Study|Physician Decision|2|||
37705058|NCT02225587|69182771|FG001|Overall Study|Physician Decision|0|||
37705059|NCT02225587|69182770|FG000|Overall Study|Protocol Violation|1|||
37705060|NCT02225587|69182771|FG001|Overall Study|Protocol Violation|0|||
37705061|NCT02225587|69182770|FG000|Overall Study|Participant Moved|1|||
37705062|NCT02225587|69182771|FG001|Overall Study|Participant Moved|0|||
37705063|NCT02225587|69182770|FG000|Overall Study|Withdrawal by Subject|13|||
37705064|NCT02225587|69182771|FG001|Overall Study|Withdrawal by Subject|28|||
37837495|NCT01153321|69521936|FG000|Overall Study|Adverse Event|1|||
37837496|NCT01153321|69521937|FG001|Overall Study|Adverse Event|1|||
37837497|NCT01153009|69521947|FG000|Overall Study|Adverse Event|4|||
37837498|NCT01153009|69521948|FG001|Overall Study|Adverse Event|14|||
37837499|NCT01153009|69521949|FG002|Overall Study|Adverse Event|14|||
37837500|NCT01153009|69521950|FG003|Overall Study|Adverse Event|10|||
37837501|NCT01153009|69521947|FG000|Overall Study|Lack of Efficacy|9|||
37837502|NCT01153009|69521948|FG001|Overall Study|Lack of Efficacy|0|||
37837503|NCT01153009|69521949|FG002|Overall Study|Lack of Efficacy|2|||
37837504|NCT01153009|69521950|FG003|Overall Study|Lack of Efficacy|1|||
37837505|NCT01153009|69521947|FG000|Overall Study|Noncompliance with Study Medication|1|||
37837506|NCT01153009|69521948|FG001|Overall Study|Noncompliance with Study Medication|3|||
37837507|NCT01153009|69521949|FG002|Overall Study|Noncompliance with Study Medication|4|||
37837508|NCT01153009|69521950|FG003|Overall Study|Noncompliance with Study Medication|1|||
37837509|NCT01153009|69521947|FG000|Overall Study|Protocol Deviations|4|||
37837510|NCT01153009|69521948|FG001|Overall Study|Protocol Deviations|3|||
37837511|NCT01153009|69521949|FG002|Overall Study|Protocol Deviations|3|||
37705065|NCT02296424|69182779|FG000|Part 1|New therapy for study indication|0|||
37705066|NCT02296424|69182780|FG001|Part 1|New therapy for study indication|1|||
37705067|NCT02296424|69182781|FG002|Part 1|New therapy for study indication|0|||
37705068|NCT02296424|69182782|FG003|Part 1|New therapy for study indication|0|||
37837512|NCT01153009|69521950|FG003|Overall Study|Protocol Deviations|2|||
37705069|NCT02296424|69182779|FG000|Part 1|Protocol Violation|0|||
37705070|NCT02296424|69182780|FG001|Part 1|Protocol Violation|1|||
37705071|NCT02296424|69182781|FG002|Part 1|Protocol Violation|0|||
38023900|NCT02927080|69707232|FG005|Overall Study|Study terminated by Sponsor|0|||
38023901|NCT02927080|69707233|FG006|Overall Study|Study terminated by Sponsor|6|||
38023902|NCT02927080|69707234|FG007|Overall Study|Study terminated by Sponsor|7|||
38023903|NCT02927080|69707235|FG008|Overall Study|Study terminated by Sponsor|2|||
38023904|NCT02927080|69707236|FG009|Overall Study|Study terminated by Sponsor|3|||
38023905|NCT02927080|69707227|FG000|Overall Study|Adverse Event|0|||
38023906|NCT02927080|69707228|FG001|Overall Study|Adverse Event|1|||
38023907|NCT02927080|69707229|FG002|Overall Study|Adverse Event|0|||
38023908|NCT02927080|69707230|FG003|Overall Study|Adverse Event|0|||
38023909|NCT02927080|69707231|FG004|Overall Study|Adverse Event|0|||
38023910|NCT02927080|69707232|FG005|Overall Study|Adverse Event|0|||
38023911|NCT02927080|69707233|FG006|Overall Study|Adverse Event|0|||
38023912|NCT02927080|69707234|FG007|Overall Study|Adverse Event|1|||
38023913|NCT02927080|69707235|FG008|Overall Study|Adverse Event|0|||
38023914|NCT02927080|69707236|FG009|Overall Study|Adverse Event|1|||
38023915|NCT02927080|69707227|FG000|Overall Study|Other|0|||
38023916|NCT02927080|69707228|FG001|Overall Study|Other|0|||
38023917|NCT02927080|69707229|FG002|Overall Study|Other|0|||
38023918|NCT02927080|69707230|FG003|Overall Study|Other|0|||
38023919|NCT02927080|69707231|FG004|Overall Study|Other|0|||
38023920|NCT02927080|69707232|FG005|Overall Study|Other|0|||
38023921|NCT02927080|69707233|FG006|Overall Study|Other|1|||
38023922|NCT02927080|69707234|FG007|Overall Study|Other|0|||
38023923|NCT02927080|69707235|FG008|Overall Study|Other|1|||
38023924|NCT02927080|69707236|FG009|Overall Study|Other|0|||
38023925|NCT02374476|69707283|FG000|VT Induced Ablation|Screening Failures|36|||
38023926|NCT02374476|69707284|FG001|VT Induced Ablation|Screening Failures|0|||
38023927|NCT02374476|69707285|FG002|VT Induced Ablation|Screening Failures|0|||
38023928|NCT02374476|69707283|FG000|Arm Assignment|Withdrawal by Subject|0|||
38023929|NCT02374476|69707284|FG001|Arm Assignment|Withdrawal by Subject|0|||
38023930|NCT02374476|69707285|FG002|Arm Assignment|Withdrawal by Subject|1|||
38023931|NCT02918292|69707292|FG000|Study Enrollment Prior to Transplant|Death|1|||
38023932|NCT02918292|69707292|FG000|Study Follow up After Transplant|Death|6|||
38023933|NCT03720210|69707296|FG000|Overall Study|Lost to Follow-up|1|||
38023934|NCT03719586|69707304|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
38023935|NCT03719586|69707305|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
38023936|NCT03719586|69707306|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
38023937|NCT03719586|69707307|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
38023938|NCT03353350|69707333|FG000|30-week Core Treatment Period|Protocol Violation|1|||
38023939|NCT03353350|69707334|FG001|30-week Core Treatment Period|Protocol Violation|1|||
38023940|NCT03353350|69707335|FG002|30-week Core Treatment Period|Protocol Violation|1|||
38023941|NCT03353350|69707336|FG003|30-week Core Treatment Period|Protocol Violation|0|||
38023942|NCT03353350|69707333|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
38023943|NCT03353350|69707334|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
38023944|NCT03353350|69707335|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
38023945|NCT03353350|69707336|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
38023946|NCT03353350|69707333|FG000|30-week Core Treatment Period|Adverse Event|0|||
38023947|NCT03353350|69707334|FG001|30-week Core Treatment Period|Adverse Event|4|||
38023948|NCT03353350|69707335|FG002|30-week Core Treatment Period|Adverse Event|2|||
37705072|NCT02296424|69182782|FG003|Part 1|Protocol Violation|0|||
38023949|NCT03353350|69707336|FG003|30-week Core Treatment Period|Adverse Event|3|||
38023950|NCT03353350|69707333|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
38023951|NCT03353350|69707334|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
38023952|NCT03353350|69707335|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
38023953|NCT03353350|69707336|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
38023954|NCT03353350|69707333|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
38023955|NCT03353350|69707334|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
38023956|NCT03353350|69707335|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
38023957|NCT03353350|69707336|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
38023958|NCT03353350|69707333|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
38023959|NCT03353350|69707334|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
38023960|NCT03353350|69707335|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
38023961|NCT03353350|69707336|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
38023962|NCT03353350|69707333|FG000|26-week Treatment Extension Period|Adverse Event|1|||
38023963|NCT03353350|69707334|FG001|26-week Treatment Extension Period|Adverse Event|0|||
38023964|NCT03353350|69707335|FG002|26-week Treatment Extension Period|Adverse Event|0|||
38023965|NCT03353350|69707336|FG003|26-week Treatment Extension Period|Adverse Event|1|||
38023966|NCT03353350|69707333|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
38023967|NCT03353350|69707334|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
37705073|NCT02296424|69182779|FG000|Part 1|Withdrawal by Subject|0|||
37705074|NCT02296424|69182780|FG001|Part 1|Withdrawal by Subject|2|||
37705075|NCT02296424|69182781|FG002|Part 1|Withdrawal by Subject|0|||
37705076|NCT02296424|69182782|FG003|Part 1|Withdrawal by Subject|0|||
37705077|NCT02296424|69182779|FG000|Part 1|Study terminated by sponsor|0|||
37705078|NCT02296424|69182780|FG001|Part 1|Study terminated by sponsor|1|||
37705079|NCT02296424|69182781|FG002|Part 1|Study terminated by sponsor|0|||
37705080|NCT02296424|69182782|FG003|Part 1|Study terminated by sponsor|0|||
37705081|NCT02296424|69182779|FG000|Part 1|Adverse Event|2|||
37705082|NCT02296424|69182780|FG001|Part 1|Adverse Event|11|||
37705083|NCT02296424|69182781|FG002|Part 1|Adverse Event|0|||
37705084|NCT02296424|69182782|FG003|Part 1|Adverse Event|0|||
37705085|NCT02296424|69182779|FG000|Part 1|Lack of Efficacy|5|||
37705086|NCT02296424|69182780|FG001|Part 1|Lack of Efficacy|17|||
37705087|NCT02296424|69182781|FG002|Part 1|Lack of Efficacy|0|||
37705088|NCT02296424|69182782|FG003|Part 1|Lack of Efficacy|0|||
37705089|NCT02296424|69182779|FG000|Part 1|16 directly started part II|16|||
37705090|NCT02296424|69182780|FG001|Part 1|16 directly started part II|0|||
37705091|NCT02296424|69182781|FG002|Part 1|16 directly started part II|0|||
37705092|NCT02296424|69182782|FG003|Part 1|16 directly started part II|0|||
37705093|NCT02296424|69182779|FG000|Part 2|Lack of Efficacy|0|||
37705094|NCT02296424|69182780|FG001|Part 2|Lack of Efficacy|0|||
37705095|NCT02296424|69182781|FG002|Part 2|Lack of Efficacy|1|||
37705096|NCT02296424|69182782|FG003|Part 2|Lack of Efficacy|0|||
37705097|NCT02296424|69182779|FG000|Part 2|Adverse Event|0|||
37705098|NCT02296424|69182780|FG001|Part 2|Adverse Event|0|||
37705099|NCT02296424|69182781|FG002|Part 2|Adverse Event|1|||
37705100|NCT02296424|69182782|FG003|Part 2|Adverse Event|0|||
37705101|NCT02296424|69182779|FG000|Part 2|Lost to Follow-up|0|||
37705102|NCT02296424|69182780|FG001|Part 2|Lost to Follow-up|0|||
37705103|NCT02296424|69182781|FG002|Part 2|Lost to Follow-up|1|||
37705104|NCT02296424|69182782|FG003|Part 2|Lost to Follow-up|0|||
37705105|NCT02296190|69182796|FG000|Overall Study|Lost to Follow-up|0|||
37705106|NCT02296190|69182797|FG001|Overall Study|Lost to Follow-up|0|||
37705107|NCT02296190|69182798|FG002|Overall Study|Lost to Follow-up|0|||
37705108|NCT02296190|69182799|FG003|Overall Study|Lost to Follow-up|0|||
37705109|NCT02296190|69182800|FG004|Overall Study|Lost to Follow-up|1|||
37705110|NCT02296190|69182801|FG005|Overall Study|Lost to Follow-up|0|||
37705111|NCT02296190|69182796|FG000|Overall Study|Failure to induce PSVT|6|||
37705112|NCT02296190|69182797|FG001|Overall Study|Failure to induce PSVT|10|||
37705113|NCT02296190|69182798|FG002|Overall Study|Failure to induce PSVT|5|||
37705114|NCT02296190|69182799|FG003|Overall Study|Failure to induce PSVT|13|||
37705115|NCT02296190|69182800|FG004|Overall Study|Failure to induce PSVT|8|||
37705116|NCT02296190|69182801|FG005|Overall Study|Failure to induce PSVT|0|||
37705117|NCT02296190|69182796|FG000|Overall Study|Physician Decision|1|||
37705118|NCT02296190|69182797|FG001|Overall Study|Physician Decision|1|||
37705119|NCT02296190|69182798|FG002|Overall Study|Physician Decision|0|||
37705120|NCT02296190|69182799|FG003|Overall Study|Physician Decision|1|||
37705121|NCT02296190|69182800|FG004|Overall Study|Physician Decision|2|||
37705122|NCT02296190|69182801|FG005|Overall Study|Physician Decision|0|||
37705123|NCT02296190|69182796|FG000|Overall Study|Withdrawal by Subject|0|||
37705124|NCT02296190|69182797|FG001|Overall Study|Withdrawal by Subject|1|||
37705125|NCT02296190|69182798|FG002|Overall Study|Withdrawal by Subject|0|||
37705126|NCT02296190|69182799|FG003|Overall Study|Withdrawal by Subject|0|||
37705127|NCT02296190|69182800|FG004|Overall Study|Withdrawal by Subject|0|||
37705128|NCT02296190|69182801|FG005|Overall Study|Withdrawal by Subject|0|||
37705129|NCT02296190|69182796|FG000|Overall Study|PSVT < 5 minutes|5|||
37705130|NCT02296190|69182797|FG001|Overall Study|PSVT < 5 minutes|6|||
37705131|NCT02296190|69182798|FG002|Overall Study|PSVT < 5 minutes|6|||
37705132|NCT02296190|69182799|FG003|Overall Study|PSVT < 5 minutes|6|||
37705133|NCT02296190|69182800|FG004|Overall Study|PSVT < 5 minutes|5|||
37705134|NCT02296190|69182801|FG005|Overall Study|PSVT < 5 minutes|0|||
37705135|NCT02296190|69182796|FG000|Overall Study|Patient was given Propofol|0|||
37705136|NCT02296190|69182797|FG001|Overall Study|Patient was given Propofol|1|||
37705137|NCT02296190|69182798|FG002|Overall Study|Patient was given Propofol|0|||
37705138|NCT02296190|69182799|FG003|Overall Study|Patient was given Propofol|1|||
37705139|NCT02296190|69182800|FG004|Overall Study|Patient was given Propofol|0|||
37705140|NCT02296190|69182801|FG005|Overall Study|Patient was given Propofol|0|||
37705141|NCT02296190|69182796|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
37705142|NCT02296190|69182797|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
37705143|NCT02296190|69182798|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
37705144|NCT02296190|69182799|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
37705145|NCT02296190|69182800|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
37705146|NCT02296190|69182801|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
37705147|NCT02296190|69182796|FG000|Overall Study|Blood pressure <100 after sedation|0|||
37705148|NCT02296190|69182797|FG001|Overall Study|Blood pressure <100 after sedation|0|||
37705149|NCT02296190|69182798|FG002|Overall Study|Blood pressure <100 after sedation|0|||
37705150|NCT02296190|69182799|FG003|Overall Study|Blood pressure <100 after sedation|1|||
37705151|NCT02296190|69182800|FG004|Overall Study|Blood pressure <100 after sedation|0|||
37705152|NCT02296190|69182801|FG005|Overall Study|Blood pressure <100 after sedation|0|||
37705153|NCT02296190|69182796|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
37705154|NCT02296190|69182797|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
37705155|NCT02296190|69182798|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
37705156|NCT02296190|69182799|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
37705157|NCT02296190|69182800|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
37705158|NCT02296190|69182801|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
37705159|NCT02296190|69182796|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
37705160|NCT02296190|69182797|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
37705161|NCT02296190|69182798|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
37705162|NCT02296190|69182799|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
37705163|NCT02296190|69182800|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
37705164|NCT02296190|69182801|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
37705165|NCT02296190|69182796|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
37705166|NCT02296190|69182797|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
37705167|NCT02296190|69182798|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
37705168|NCT02296190|69182799|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
37705169|NCT02296190|69182800|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
37705170|NCT02296190|69182801|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
37705171|NCT02296190|69182796|FG000|Overall Study|Lab result not available in time|1|||
37705172|NCT02296190|69182797|FG001|Overall Study|Lab result not available in time|0|||
37705173|NCT02296190|69182798|FG002|Overall Study|Lab result not available in time|0|||
37705174|NCT02296190|69182799|FG003|Overall Study|Lab result not available in time|0|||
37705175|NCT02296190|69182800|FG004|Overall Study|Lab result not available in time|0|||
37705176|NCT02296190|69182801|FG005|Overall Study|Lab result not available in time|0|||
37705177|NCT02296112|69182814|FG000|Overall Study|Disease progression|7|||
37705178|NCT02296112|69182814|FG000|Overall Study|Toxicity|1|||
37705179|NCT02296112|69182814|FG000|Overall Study|Began an alternate therapy|1|||
37705180|NCT02295644|69182827|FG000|Overall Study|Did not meet inclusion criterion|0|||
37705181|NCT02295644|69182828|FG001|Overall Study|Did not meet inclusion criterion|0|||
37705182|NCT02295644|69182829|FG002|Overall Study|Did not meet inclusion criterion|1|||
37837513|NCT01153009|69521947|FG000|Overall Study|Withdrawal of Consent|5|||
37837514|NCT01153009|69521948|FG001|Overall Study|Withdrawal of Consent|5|||
37837515|NCT01153009|69521949|FG002|Overall Study|Withdrawal of Consent|4|||
37705183|NCT02295644|69182830|FG003|Overall Study|Did not meet inclusion criterion|2|||
37705184|NCT02269670|69182840|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
37705185|NCT02225353|69182847|FG000|Overall Study|Lost to Follow-up|0|||
37705186|NCT02225353|69182848|FG001|Overall Study|Lost to Follow-up|1|||
37705187|NCT02225353|69182849|FG002|Overall Study|Lost to Follow-up|3|||
37705188|NCT02225353|69182847|FG000|Overall Study|Protocol Violation|4|||
37705189|NCT02225353|69182848|FG001|Overall Study|Protocol Violation|5|||
37705190|NCT02225353|69182849|FG002|Overall Study|Protocol Violation|12|||
37705191|NCT01641926|69182864|FG000|Overall Study|Adverse Event|5|||
37705192|NCT01641926|69182865|FG001|Overall Study|Adverse Event|2|||
37705193|NCT01641926|69182866|FG002|Overall Study|Adverse Event|3|||
37705194|NCT01641926|69182867|FG003|Overall Study|Adverse Event|1|||
37705195|NCT01641926|69182864|FG000|Overall Study|Lost to Follow-up|2|||
37705196|NCT01641926|69182865|FG001|Overall Study|Lost to Follow-up|2|||
37705197|NCT01641926|69182866|FG002|Overall Study|Lost to Follow-up|1|||
37705198|NCT01641926|69182867|FG003|Overall Study|Lost to Follow-up|0|||
37705199|NCT01641926|69182864|FG000|Overall Study|Physician Decision|6|||
37705200|NCT01641926|69182865|FG001|Overall Study|Physician Decision|5|||
37705201|NCT01641926|69182866|FG002|Overall Study|Physician Decision|0|||
37705202|NCT01641926|69182867|FG003|Overall Study|Physician Decision|1|||
37705203|NCT01641926|69182864|FG000|Overall Study|Protocol Violation|1|||
37705204|NCT01641926|69182865|FG001|Overall Study|Protocol Violation|0|||
37705205|NCT01641926|69182866|FG002|Overall Study|Protocol Violation|0|||
37705206|NCT01641926|69182867|FG003|Overall Study|Protocol Violation|1|||
37705207|NCT01641926|69182864|FG000|Overall Study|Withdrawal by Subject|13|||
37705208|NCT01641926|69182865|FG001|Overall Study|Withdrawal by Subject|5|||
37705209|NCT01641926|69182866|FG002|Overall Study|Withdrawal by Subject|6|||
37705210|NCT01641926|69182867|FG003|Overall Study|Withdrawal by Subject|1|||
37705211|NCT01641926|69182864|FG000|Overall Study|Not Treated|1|||
37705212|NCT01641926|69182865|FG001|Overall Study|Not Treated|1|||
37705213|NCT01641926|69182866|FG002|Overall Study|Not Treated|1|||
37705214|NCT01641926|69182867|FG003|Overall Study|Not Treated|0|||
37705215|NCT02295020|69182879|FG000|Overall Study|Adverse Event|0|||
37705216|NCT02295020|69182880|FG001|Overall Study|Adverse Event|1|||
37705217|NCT02295020|69182879|FG000|Overall Study|Withdrawal by Subject|3|||
37705218|NCT02295020|69182880|FG001|Overall Study|Withdrawal by Subject|2|||
37705219|NCT02200939|69182894|FG000|Overall Study|Participant withdrew consent|0|||
37705220|NCT02200939|69182895|FG001|Overall Study|Participant withdrew consent|1|||
37705221|NCT02200939|69182894|FG000|Overall Study|Lost to Follow-up|2|||
37705222|NCT02200939|69182895|FG001|Overall Study|Lost to Follow-up|9|||
37705223|NCT02200939|69182894|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
37705224|NCT02200939|69182895|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
37705225|NCT02294786|69182907|FG000|Overall Study|Withdrawal by Subject|0|||
37705226|NCT02294786|69182908|FG001|Overall Study|Withdrawal by Subject|1|||
37705227|NCT02294786|69182907|FG000|Overall Study|Physician Decision|6|||
37705228|NCT02294786|69182908|FG001|Overall Study|Physician Decision|7|||
37705229|NCT02294786|69182907|FG000|Overall Study|Lost to Follow-up|1|||
37705230|NCT02294786|69182908|FG001|Overall Study|Lost to Follow-up|2|||
37705231|NCT02294786|69182907|FG000|Overall Study|Protocol Violation|1|||
37705232|NCT02294786|69182908|FG001|Overall Study|Protocol Violation|0|||
37705233|NCT02294786|69182907|FG000|Overall Study|Adverse Event|1|||
37705234|NCT02294786|69182908|FG001|Overall Study|Adverse Event|1|||
37705235|NCT02294786|69182907|FG000|Overall Study|Death|2|||
37705236|NCT02294786|69182908|FG001|Overall Study|Death|3|||
37705237|NCT02269124|69182917|FG000|Overall Study|Lost to Follow-up|1|||
37705238|NCT02269124|69182918|FG001|Overall Study|Lost to Follow-up|0|||
37705239|NCT02269124|69182917|FG000|Overall Study|Withdrawal by Subject|0|||
37705240|NCT02269124|69182918|FG001|Overall Study|Withdrawal by Subject|2|||
37705241|NCT01927341|69182930|FG000|Phase 1b|Lost to Follow-up|1|||
37705242|NCT01927341|69182931|FG001|Phase 1b|Lost to Follow-up|0|||
38023968|NCT03353350|69707335|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
37705243|NCT01927341|69182932|FG002|Phase 1b|Lost to Follow-up|0|||
37705244|NCT01927341|69182933|FG003|Phase 1b|Lost to Follow-up|0|||
37705245|NCT01927341|69182934|FG004|Phase 1b|Lost to Follow-up|0|||
37705246|NCT01927341|69182930|FG000|Phase 1b|Death|2|||
37705247|NCT01927341|69182931|FG001|Phase 1b|Death|0|||
37705248|NCT01927341|69182932|FG002|Phase 1b|Death|0|||
37705249|NCT01927341|69182933|FG003|Phase 1b|Death|0|||
37705250|NCT01927341|69182934|FG004|Phase 1b|Death|0|||
37705251|NCT01927341|69182930|FG000|Phase 1b|Follow-up completed|7|||
37705252|NCT01927341|69182931|FG001|Phase 1b|Follow-up completed|0|||
37705253|NCT01927341|69182932|FG002|Phase 1b|Follow-up completed|0|||
37705254|NCT01927341|69182933|FG003|Phase 1b|Follow-up completed|0|||
37705255|NCT01927341|69182934|FG004|Phase 1b|Follow-up completed|0|||
37705256|NCT01927341|69182930|FG000|Phase 2|Lost to Follow-up|0|||
37705257|NCT01927341|69182931|FG001|Phase 2|Lost to Follow-up|1|||
37705258|NCT01927341|69182932|FG002|Phase 2|Lost to Follow-up|0|||
37705259|NCT01927341|69182933|FG003|Phase 2|Lost to Follow-up|0|||
37705260|NCT01927341|69182934|FG004|Phase 2|Lost to Follow-up|0|||
37705261|NCT01927341|69182930|FG000|Phase 2|Participant withdrew consent|0|||
37705262|NCT01927341|69182931|FG001|Phase 2|Participant withdrew consent|2|||
37705263|NCT01927341|69182932|FG002|Phase 2|Participant withdrew consent|1|||
37705264|NCT01927341|69182933|FG003|Phase 2|Participant withdrew consent|2|||
37705265|NCT01927341|69182934|FG004|Phase 2|Participant withdrew consent|3|||
37705266|NCT01927341|69182930|FG000|Phase 2|Death|0|||
37705267|NCT01927341|69182931|FG001|Phase 2|Death|4|||
37705268|NCT01927341|69182932|FG002|Phase 2|Death|0|||
37705269|NCT01927341|69182933|FG003|Phase 2|Death|3|||
37705270|NCT01927341|69182934|FG004|Phase 2|Death|2|||
37705271|NCT01927341|69182930|FG000|Phase 2|New cancer therapy|0|||
37705272|NCT01927341|69182931|FG001|Phase 2|New cancer therapy|1|||
37705273|NCT01927341|69182932|FG002|Phase 2|New cancer therapy|0|||
37705274|NCT01927341|69182933|FG003|Phase 2|New cancer therapy|4|||
37705275|NCT01927341|69182934|FG004|Phase 2|New cancer therapy|1|||
37705276|NCT01927341|69182930|FG000|Phase 2|Disease progression|0|||
37705277|NCT01927341|69182931|FG001|Phase 2|Disease progression|1|||
37705278|NCT01927341|69182932|FG002|Phase 2|Disease progression|1|||
37705279|NCT01927341|69182933|FG003|Phase 2|Disease progression|1|||
37705280|NCT01927341|69182934|FG004|Phase 2|Disease progression|0|||
37705281|NCT01927341|69182930|FG000|Phase 2|Follow-up completed|0|||
37705282|NCT01927341|69182931|FG001|Phase 2|Follow-up completed|6|||
37705283|NCT01927341|69182932|FG002|Phase 2|Follow-up completed|3|||
37705284|NCT01927341|69182933|FG003|Phase 2|Follow-up completed|5|||
37705285|NCT01927341|69182934|FG004|Phase 2|Follow-up completed|2|||
37705286|NCT02294474|69182952|FG000|Overall Study|Adverse Event|7|||
37705287|NCT02294474|69182953|FG001|Overall Study|Adverse Event|7|||
37705288|NCT02294474|69182952|FG000|Overall Study|Lack of Efficacy|2|||
37705289|NCT02294474|69182953|FG001|Overall Study|Lack of Efficacy|1|||
37705290|NCT02294474|69182952|FG000|Overall Study|Protocol Violation|4|||
37705291|NCT02294474|69182953|FG001|Overall Study|Protocol Violation|2|||
37705292|NCT02294474|69182952|FG000|Overall Study|Other than specified above|12|||
37705293|NCT02294474|69182953|FG001|Overall Study|Other than specified above|12|||
37705294|NCT02168101|69182963|FG000|Overall Study|Death|2|||
37705295|NCT02168101|69182964|FG001|Overall Study|Death|2|||
37705296|NCT02168101|69182965|FG002|Overall Study|Death|1|||
37705297|NCT02298179|69182986|FG000|Overall Study|Lost to Follow-up|0|||
37705298|NCT02298179|69182987|FG001|Overall Study|Lost to Follow-up|0|||
37705299|NCT02298179|69182988|FG002|Overall Study|Lost to Follow-up|1|||
37705300|NCT02298179|69182989|FG003|Overall Study|Lost to Follow-up|0|||
37705301|NCT02298179|69182990|FG004|Overall Study|Lost to Follow-up|0|||
37705302|NCT02298179|69182991|FG005|Overall Study|Lost to Follow-up|0|||
37705303|NCT02298179|69182992|FG006|Overall Study|Lost to Follow-up|0|||
37705304|NCT02298179|69182993|FG007|Overall Study|Lost to Follow-up|1|||
37705305|NCT02298179|69182994|FG008|Overall Study|Lost to Follow-up|0|||
37705306|NCT02298179|69182995|FG009|Overall Study|Lost to Follow-up|0|||
37705307|NCT02298179|69182996|FG010|Overall Study|Lost to Follow-up|0|||
37705308|NCT02298179|69182997|FG011|Overall Study|Lost to Follow-up|0|||
37705309|NCT02298023|69183026|FG000|Overall Study|Withdrawal by Subject|1|||
37705310|NCT02298023|69183027|FG001|Overall Study|Withdrawal by Subject|0|||
37705311|NCT02298023|69183028|FG002|Overall Study|Withdrawal by Subject|0|||
37705312|NCT02296931|69183041|FG000|Overall Study|Protocol Violation|0|||
37837516|NCT01153009|69521950|FG003|Overall Study|Withdrawal of Consent|6|||
37705313|NCT02296931|69183042|FG001|Overall Study|Protocol Violation|2|||
37705314|NCT02166697|69183048|FG000|Overall Study|Protocol Violation|347|||
37705315|NCT01909479|69183054|FG000|From Baseline to Week 26|Adverse Event|3|||
37705316|NCT01909479|69183055|FG001|From Baseline to Week 26|Adverse Event|2|||
37705317|NCT01909479|69183054|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
37705318|NCT01909479|69183055|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
37705319|NCT01909479|69183054|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
37705320|NCT01909479|69183055|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
37705321|NCT01909479|69183054|FG000|26 - 52 Weeks|Adverse Event|0|||
37705322|NCT01909479|69183055|FG001|26 - 52 Weeks|Adverse Event|1|||
37705323|NCT01909479|69183054|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
38023969|NCT03353350|69707336|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
37705324|NCT01909479|69183055|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
37705325|NCT01909479|69183054|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
37705326|NCT01909479|69183055|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
37705327|NCT01909479|69183054|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
37705328|NCT01909479|69183055|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
37705329|NCT01909479|69183054|FG000|52 Weeks to End of Study|Adverse Event|2|||
37705330|NCT01909479|69183055|FG001|52 Weeks to End of Study|Adverse Event|1|||
37705331|NCT01909479|69183054|FG000|52 Weeks to End of Study|Death|0|||
37705332|NCT01909479|69183055|FG001|52 Weeks to End of Study|Death|1|||
37705333|NCT01909479|69183054|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
37705334|NCT01909479|69183055|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
37705335|NCT01909479|69183054|FG000|52 Weeks to End of Study|Protocol Violation|1|||
37705336|NCT01909479|69183055|FG001|52 Weeks to End of Study|Protocol Violation|0|||
37705337|NCT01909479|69183054|FG000|52 Weeks to End of Study|Progressive disease|1|||
37705338|NCT01909479|69183055|FG001|52 Weeks to End of Study|Progressive disease|1|||
37705339|NCT01909479|69183054|FG000|52 Weeks to End of Study|Personal reasons|2|||
37705340|NCT01909479|69183055|FG001|52 Weeks to End of Study|Personal reasons|1|||
37705341|NCT01909479|69183054|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
37705342|NCT01909479|69183055|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
37705343|NCT01909479|69183054|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
37705344|NCT01909479|69183055|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
37705345|NCT01909479|69183054|FG000|52 Weeks to End of Study|Lack of contact|1|||
37705346|NCT01909479|69183055|FG001|52 Weeks to End of Study|Lack of contact|0|||
37705347|NCT01909479|69183054|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
37705348|NCT01909479|69183055|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
37705349|NCT01909479|69183054|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
37705350|NCT01909479|69183055|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
37705351|NCT01955733|69183068|FG000|Period 1|Lost to Follow-up|1|||
37705352|NCT01955733|69183069|FG001|Period 1|Lost to Follow-up|0|||
37705353|NCT01955733|69183070|FG002|Period 1|Lost to Follow-up|0|||
37705354|NCT01955733|69183068|FG000|Period 2|Adverse Event|1|||
37705355|NCT01955733|69183069|FG001|Period 2|Adverse Event|0|||
37705356|NCT01955733|69183070|FG002|Period 2|Adverse Event|0|||
37705357|NCT01955733|69183068|FG000|Period 2|Physician Decision|0|||
37705358|NCT01955733|69183069|FG001|Period 2|Physician Decision|0|||
37705359|NCT01955733|69183070|FG002|Period 2|Physician Decision|1|||
37705360|NCT01955733|69183068|FG000|Period 2|Withdrawal by Subject|1|||
37705361|NCT01955733|69183069|FG001|Period 2|Withdrawal by Subject|3|||
37837517|NCT01153009|69521947|FG000|Overall Study|Lost to Follow-up|8|||
37837518|NCT01153009|69521948|FG001|Overall Study|Lost to Follow-up|8|||
37837519|NCT01153009|69521949|FG002|Overall Study|Lost to Follow-up|11|||
37837520|NCT01153009|69521950|FG003|Overall Study|Lost to Follow-up|15|||
37837521|NCT01153009|69521947|FG000|Overall Study|Other|1|||
37705362|NCT01955733|69183070|FG002|Period 2|Withdrawal by Subject|2|||
37705363|NCT01955733|69183068|FG000|Period 2|Study terminated by sponsor|8|||
37705364|NCT01955733|69183069|FG001|Period 2|Study terminated by sponsor|14|||
37705365|NCT01955733|69183070|FG002|Period 2|Study terminated by sponsor|16|||
37705366|NCT01955733|69183068|FG000|Period 2|Lost to Follow-up|2|||
37705367|NCT01955733|69183069|FG001|Period 2|Lost to Follow-up|0|||
37705368|NCT01955733|69183070|FG002|Period 2|Lost to Follow-up|0|||
37705369|NCT01955733|69183068|FG000|Period 2|Other not defined above|0|||
37705370|NCT01955733|69183069|FG001|Period 2|Other not defined above|2|||
37705371|NCT01955733|69183070|FG002|Period 2|Other not defined above|2|||
37705372|NCT02197897|69183078|FG000|Overall Study|not eligible|1|||
37705373|NCT02223793|69183085|FG000|Overall Study|Lost to Follow-up|10|||
37705374|NCT02223793|69183086|FG001|Overall Study|Lost to Follow-up|1|||
37705375|NCT02223793|69183087|FG002|Overall Study|Lost to Follow-up|2|||
37705376|NCT02223793|69183085|FG000|Overall Study|Withdrawal by Subject|3|||
37705377|NCT02223793|69183086|FG001|Overall Study|Withdrawal by Subject|2|||
37705378|NCT02223793|69183087|FG002|Overall Study|Withdrawal by Subject|3|||
37705379|NCT02223793|69183085|FG000|Overall Study|Moved/studycenter unable to participate|4|||
37705380|NCT02223793|69183086|FG001|Overall Study|Moved/studycenter unable to participate|6|||
37705381|NCT02223793|69183087|FG002|Overall Study|Moved/studycenter unable to participate|8|||
37705382|NCT01926015|69183097|FG000|Overall Study|Withdrawal by parent/guardian|0|||
37705383|NCT01926015|69183098|FG001|Overall Study|Withdrawal by parent/guardian|1|||
37705384|NCT01926015|69183097|FG000|Overall Study|Randomized not treated|2|||
37705385|NCT01926015|69183098|FG001|Overall Study|Randomized not treated|0|||
37705386|NCT02223715|69183104|FG000|Overall Study|Death|31|||
37705387|NCT02223715|69183104|FG000|Overall Study|Lost to Follow-up|73|||
37705388|NCT02196259|69183114|FG000|Overall Study|Researcher choice|0|||
37705389|NCT02196259|69183115|FG001|Overall Study|Researcher choice|0|||
37705390|NCT02196259|69183116|FG002|Overall Study|Researcher choice|1|||
37837522|NCT01153009|69521948|FG001|Overall Study|Other|1|||
37705391|NCT02196259|69183114|FG000|Overall Study|Partial data analysis|0|||
37705392|NCT02196259|69183115|FG001|Overall Study|Partial data analysis|3|||
37705393|NCT02196259|69183116|FG002|Overall Study|Partial data analysis|0|||
37705394|NCT02294396|69183127|FG000|Overall Study|Adverse Event|26|||
37705395|NCT02294396|69183128|FG001|Overall Study|Adverse Event|25|||
37705396|NCT02294396|69183129|FG002|Overall Study|Adverse Event|21|||
37705397|NCT02294396|69183130|FG003|Overall Study|Adverse Event|24|||
37705398|NCT02294396|69183127|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
37705399|NCT02294396|69183128|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
37705400|NCT02294396|69183129|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
37705401|NCT02294396|69183130|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
37705402|NCT02294396|69183127|FG000|Overall Study|Withdrawal by Subject|8|||
37705403|NCT02294396|69183128|FG001|Overall Study|Withdrawal by Subject|6|||
37705404|NCT02294396|69183129|FG002|Overall Study|Withdrawal by Subject|6|||
37705405|NCT02294396|69183130|FG003|Overall Study|Withdrawal by Subject|8|||
37705406|NCT02294396|69183127|FG000|Overall Study|Lost to Follow-up|0|||
37705407|NCT02294396|69183128|FG001|Overall Study|Lost to Follow-up|0|||
37705408|NCT02294396|69183129|FG002|Overall Study|Lost to Follow-up|1|||
37705409|NCT02294396|69183130|FG003|Overall Study|Lost to Follow-up|1|||
37705410|NCT02294396|69183127|FG000|Overall Study|Protocol Deviation|3|||
37705411|NCT02294396|69183128|FG001|Overall Study|Protocol Deviation|2|||
37705412|NCT02294396|69183129|FG002|Overall Study|Protocol Deviation|2|||
37705413|NCT02294396|69183130|FG003|Overall Study|Protocol Deviation|1|||
37705414|NCT02294396|69183127|FG000|Overall Study|Miscellaneous|2|||
37705415|NCT02294396|69183128|FG001|Overall Study|Miscellaneous|0|||
37705416|NCT02294396|69183129|FG002|Overall Study|Miscellaneous|5|||
37705417|NCT02294396|69183130|FG003|Overall Study|Miscellaneous|2|||
37705418|NCT01721044|69183143|FG000|Treatment Period|Adverse Event|7|||
37705419|NCT01721044|69183144|FG001|Treatment Period|Adverse Event|7|||
37705420|NCT01721044|69183145|FG002|Treatment Period|Adverse Event|10|||
37705421|NCT01721044|69183143|FG000|Treatment Period|Death|0|||
37705422|NCT01721044|69183144|FG001|Treatment Period|Death|0|||
37705423|NCT01721044|69183145|FG002|Treatment Period|Death|1|||
37705424|NCT01721044|69183143|FG000|Treatment Period|Lack of Efficacy|16|||
37705425|NCT01721044|69183144|FG001|Treatment Period|Lack of Efficacy|4|||
37705426|NCT01721044|69183145|FG002|Treatment Period|Lack of Efficacy|4|||
37705427|NCT01721044|69183143|FG000|Treatment Period|Lost to Follow-up|0|||
37705428|NCT01721044|69183144|FG001|Treatment Period|Lost to Follow-up|0|||
37705429|NCT01721044|69183145|FG002|Treatment Period|Lost to Follow-up|1|||
37705430|NCT01721044|69183143|FG000|Treatment Period|Physician Decision|1|||
37705431|NCT01721044|69183144|FG001|Treatment Period|Physician Decision|0|||
37705432|NCT01721044|69183145|FG002|Treatment Period|Physician Decision|2|||
37705433|NCT01721044|69183143|FG000|Treatment Period|Protocol Violation|1|||
37705434|NCT01721044|69183144|FG001|Treatment Period|Protocol Violation|0|||
37705435|NCT01721044|69183145|FG002|Treatment Period|Protocol Violation|0|||
37705436|NCT01721044|69183143|FG000|Treatment Period|Withdrawal by Subject|7|||
37705437|NCT01721044|69183144|FG001|Treatment Period|Withdrawal by Subject|6|||
37705438|NCT01721044|69183145|FG002|Treatment Period|Withdrawal by Subject|1|||
37705439|NCT02164981|69183167|FG000|Started|Withdrawal by Subject|2|||
37705440|NCT02164981|69183168|FG001|Started|Withdrawal by Subject|1|||
37705441|NCT02164981|69183169|FG002|Started|Withdrawal by Subject|0|||
37705442|NCT02164981|69183167|FG000|Started|Protocol Violation|2|||
37705443|NCT02164981|69183168|FG001|Started|Protocol Violation|0|||
37837523|NCT01153009|69521949|FG002|Overall Study|Other|3|||
37837524|NCT01153009|69521950|FG003|Overall Study|Other|2|||
37837525|NCT01152814|69521960|FG000|Overall Study|Lost to Follow-up|2|||
37705444|NCT02164981|69183169|FG002|Started|Protocol Violation|0|||
37705445|NCT02164981|69183167|FG000|Started|Adverse Event|1|||
37705446|NCT02164981|69183168|FG001|Started|Adverse Event|2|||
37705447|NCT02164981|69183169|FG002|Started|Adverse Event|0|||
37705448|NCT02164981|69183167|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
37705449|NCT02164981|69183168|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
37705450|NCT02164981|69183169|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
37705451|NCT02164981|69183167|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
37705452|NCT02164981|69183168|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
37837526|NCT01152580|69521966|FG000|Overall Study|Withdrawal by Subject|0|||
37705453|NCT02164981|69183169|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
37705454|NCT02164981|69183167|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
37705455|NCT02164981|69183168|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
37705456|NCT02164981|69183169|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
37705457|NCT02195869|69183190|FG000|Overall Study|cGVHD Progression|5|||
37705458|NCT02195869|69183190|FG000|Overall Study|Malignancy Progression/relapse|2|||
37705459|NCT02195869|69183190|FG000|Overall Study|Adverse Event|15|||
37705460|NCT02195869|69183190|FG000|Overall Study|Withdrawal by Subject|7|||
37705461|NCT02195869|69183190|FG000|Overall Study|Physician Decision|4|||
37705462|NCT02195869|69183190|FG000|Overall Study|Study Terminated by Sponsor|7|||
37705463|NCT02195869|69183190|FG000|Overall Study|Noncompliance with study drug|2|||
37705464|NCT01908699|69183199|FG000|Overall Study|Adverse Event|8|||
37705465|NCT01908699|69183200|FG001|Overall Study|Adverse Event|12|||
37705466|NCT01908699|69183199|FG000|Overall Study|Lack of Efficacy|2|||
37705467|NCT01908699|69183200|FG001|Overall Study|Lack of Efficacy|2|||
37705468|NCT01908699|69183199|FG000|Overall Study|Lost to Follow-up|2|||
37705469|NCT01908699|69183200|FG001|Overall Study|Lost to Follow-up|4|||
37705470|NCT01908699|69183199|FG000|Overall Study|Physician Decision|8|||
37705471|NCT01908699|69183200|FG001|Overall Study|Physician Decision|8|||
37705472|NCT01908699|69183199|FG000|Overall Study|Withdrawal by Subject|15|||
37705473|NCT01908699|69183200|FG001|Overall Study|Withdrawal by Subject|10|||
37705474|NCT01908699|69183199|FG000|Overall Study|Pregnancy|0|||
37705475|NCT01908699|69183200|FG001|Overall Study|Pregnancy|1|||
37705476|NCT01908699|69183199|FG000|Overall Study|Randomized in Error|1|||
37705477|NCT01908699|69183200|FG001|Overall Study|Randomized in Error|0|||
37705478|NCT01908699|69183199|FG000|Overall Study|Death|9|||
37705479|NCT01908699|69183200|FG001|Overall Study|Death|12|||
37705480|NCT01908699|69183199|FG000|Overall Study|Progressive Disease|30|||
37705481|NCT01908699|69183200|FG001|Overall Study|Progressive Disease|29|||
37705482|NCT01599637|69183209|FG000|Overall Study|administrative problems|0|||
37705483|NCT01599637|69183210|FG001|Overall Study|administrative problems|2|||
37705484|NCT01599637|69183211|FG002|Overall Study|administrative problems|0|||
37705485|NCT01599637|69183209|FG000|Overall Study|Adverse Event|1|||
37705486|NCT01599637|69183210|FG001|Overall Study|Adverse Event|0|||
37705487|NCT01599637|69183211|FG002|Overall Study|Adverse Event|0|||
37705488|NCT02264639|69183226|FG000|Overall Study|Death (after completing single-dose phase)|1|||
37705489|NCT02264639|69183227|FG001|Overall Study|Death (after completing single-dose phase)|0|||
37705490|NCT02264639|69183228|FG002|Overall Study|Death (after completing single-dose phase)|0|||
37705491|NCT02264639|69183229|FG003|Overall Study|Death (after completing single-dose phase)|0|||
37705492|NCT02264639|69183230|FG004|Overall Study|Death (after completing single-dose phase)|0|||
37705493|NCT02264639|69183226|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
37705494|NCT02264639|69183227|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
37705495|NCT02264639|69183228|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
37705496|NCT02264639|69183229|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
37705497|NCT02264639|69183230|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
37705498|NCT02264639|69183226|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
37705499|NCT02264639|69183227|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
37705500|NCT02264639|69183228|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
37705501|NCT02264639|69183229|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
37705502|NCT02264639|69183230|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
37705503|NCT02264639|69183226|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
37837527|NCT01152580|69521967|FG001|Overall Study|Withdrawal by Subject|1|||
37837528|NCT01152385|69521977|FG000|Overall Study|Withdrawal by Subject|3|||
37705504|NCT02264639|69183227|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
37705505|NCT02264639|69183228|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
37705506|NCT02264639|69183229|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
37705507|NCT02264639|69183230|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
37705508|NCT01363011|69183247|FG000|Main Study|Adverse Event|2|||
37705509|NCT01363011|69183248|FG001|Main Study|Adverse Event|3|||
37705510|NCT01363011|69183247|FG000|Main Study|Investigator's Discretion|1|||
37705511|NCT01363011|69183248|FG001|Main Study|Investigator's Discretion|1|||
37705512|NCT01363011|69183247|FG000|Main Study|Withdrew Consent|1|||
37705513|NCT01363011|69183248|FG001|Main Study|Withdrew Consent|4|||
37705514|NCT01363011|69183247|FG000|Main Study|Protocol Violation|0|||
37705515|NCT01363011|69183248|FG001|Main Study|Protocol Violation|1|||
37705516|NCT01363011|69183247|FG000|Extension Phase|Adverse Event|1|||
37705517|NCT01363011|69183248|FG001|Extension Phase|Adverse Event|1|||
37705518|NCT01363011|69183247|FG000|Extension Phase|Lack of Efficacy|0|||
37705519|NCT01363011|69183248|FG001|Extension Phase|Lack of Efficacy|1|||
37705520|NCT01363011|69183247|FG000|Extension Phase|Investigator's Discretion|2|||
37705521|NCT01363011|69183248|FG001|Extension Phase|Investigator's Discretion|2|||
37705522|NCT01363011|69183247|FG000|Extension Phase|Withdrew Consent|0|||
37705523|NCT01363011|69183248|FG001|Extension Phase|Withdrew Consent|1|||
37915150|NCT00853749|69601831|FG001|Overall Study|Lost to Follow-up|1|||
37705524|NCT01363011|69183247|FG000|Extension Phase|Lost to Follow-up|0|||
37705525|NCT01363011|69183248|FG001|Extension Phase|Lost to Follow-up|2|||
37705526|NCT01363011|69183247|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
37705527|NCT01363011|69183248|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
37705528|NCT02263547|69183254|FG000|Overall Study|Adverse Event|1|||
37705529|NCT02263547|69183254|FG000|Overall Study|Lost to Follow-up|2|||
37705530|NCT01925703|69183258|FG000|Overall Study|Physician Decision|1|||
37705531|NCT01925703|69183258|FG000|Overall Study|Lost to Follow-up|2|||
37705532|NCT01925703|69183258|FG000|Overall Study|Discharge prior to full iron repletion|1|||
37705533|NCT02195011|69183264|FG000|Overall Study|Adverse Event|4|||
37705534|NCT02195011|69183265|FG001|Overall Study|Adverse Event|0|||
37705535|NCT02195011|69183264|FG000|Overall Study|Progressive Disease|18|||
37705536|NCT02195011|69183265|FG001|Overall Study|Progressive Disease|1|||
37705537|NCT02195011|69183264|FG000|Overall Study|Withdrawal by Subject|3|||
37705538|NCT02195011|69183265|FG001|Overall Study|Withdrawal by Subject|0|||
37705539|NCT01617681|69183275|FG000|Period 1 Double Blind|Adverse Event|2|||
37705540|NCT01617681|69183276|FG001|Period 1 Double Blind|Adverse Event|0|||
37705541|NCT01617681|69183277|FG002|Period 1 Double Blind|Adverse Event|0|||
37705542|NCT01617681|69183278|FG003|Period 1 Double Blind|Adverse Event|2|||
37705543|NCT01617681|69183279|FG004|Period 1 Double Blind|Adverse Event|0|||
37705544|NCT01617681|69183275|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
37705545|NCT01617681|69183276|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
37705546|NCT01617681|69183277|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
37705547|NCT01617681|69183278|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
37705548|NCT01617681|69183279|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
37705549|NCT01617681|69183275|FG000|Period 2 Open Label|Adverse Event|0|||
37705550|NCT01617681|69183276|FG001|Period 2 Open Label|Adverse Event|0|||
37705551|NCT01617681|69183277|FG002|Period 2 Open Label|Adverse Event|0|||
37705552|NCT01617681|69183278|FG003|Period 2 Open Label|Adverse Event|0|||
37705553|NCT01617681|69183279|FG004|Period 2 Open Label|Adverse Event|3|||
37705554|NCT01617681|69183275|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
37705555|NCT01617681|69183276|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
37705556|NCT01617681|69183277|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
37705557|NCT01617681|69183278|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
37705558|NCT01617681|69183279|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
37705559|NCT02263079|69183291|FG000|Overall Study|Physician Decision|1|||
37705560|NCT02263079|69183292|FG001|Overall Study|Physician Decision|0|||
37705561|NCT02263079|69183293|FG002|Overall Study|Physician Decision|0|||
37705562|NCT02263079|69183291|FG000|Overall Study|Withdrawal by Subject|2|||
37705563|NCT02263079|69183292|FG001|Overall Study|Withdrawal by Subject|8|||
37705564|NCT02263079|69183293|FG002|Overall Study|Withdrawal by Subject|0|||
37705565|NCT02295995|69183303|FG000|Overall Study|Lost to Follow-up|5|||
37705566|NCT02295995|69183304|FG001|Overall Study|Lost to Follow-up|1|||
37705567|NCT02294981|69183311|FG000|Overall Study|Lost to Follow-up|1|||
37705568|NCT02262377|69183317|FG000|Overall Study|Lost to Follow-up|5|||
37705569|NCT02262377|69183318|FG001|Overall Study|Lost to Follow-up|6|||
37705570|NCT02262377|69183317|FG000|Overall Study|Found ineligible after enrollment|3|||
37705571|NCT02262377|69183318|FG001|Overall Study|Found ineligible after enrollment|0|||
37705572|NCT02262377|69183317|FG000|Overall Study|Withdrawal by Subject|4|||
37705573|NCT02262377|69183318|FG001|Overall Study|Withdrawal by Subject|0|||
37705574|NCT02260817|69183327|FG000|Overall Study|Lost to Follow-up|0|||
37705575|NCT02260817|69183328|FG001|Overall Study|Lost to Follow-up|14|||
37705576|NCT02260817|69183327|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
37705577|NCT02260817|69183328|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
37705578|NCT02260817|69183327|FG000|Overall Study|Observation, no biopsy|0|||
37705579|NCT02260817|69183328|FG001|Overall Study|Observation, no biopsy|1|||
37705580|NCT02260817|69183327|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
37705581|NCT02260817|69183328|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
37705582|NCT02260817|69183327|FG000|Overall Study|Protocol Violation|0|||
37705583|NCT02260817|69183328|FG001|Overall Study|Protocol Violation|14|||
37705584|NCT01642589|69183336|FG000|Overall Study|Withdrawal by Subject|1|||
37705585|NCT01642589|69183337|FG001|Overall Study|Withdrawal by Subject|1|||
37705586|NCT02268812|69183347|FG000|Overall Study|Adverse Event|8|||
37705587|NCT02268812|69183348|FG001|Overall Study|Adverse Event|26|||
37705588|NCT02268812|69183349|FG002|Overall Study|Adverse Event|7|||
37705589|NCT02268812|69183350|FG003|Overall Study|Adverse Event|10|||
37705590|NCT02268812|69183347|FG000|Overall Study|Protocol deviation|0|||
37705591|NCT02268812|69183348|FG001|Overall Study|Protocol deviation|0|||
37705592|NCT02268812|69183349|FG002|Overall Study|Protocol deviation|1|||
37705593|NCT02268812|69183350|FG003|Overall Study|Protocol deviation|0|||
37705594|NCT02268812|69183347|FG000|Overall Study|Withdrawal by Subject|0|||
37705595|NCT02268812|69183348|FG001|Overall Study|Withdrawal by Subject|1|||
37837529|NCT01152385|69521978|FG001|Overall Study|Withdrawal by Subject|1|||
37837530|NCT01152385|69521979|FG002|Overall Study|Withdrawal by Subject|1|||
37705596|NCT02268812|69183349|FG002|Overall Study|Withdrawal by Subject|0|||
37705597|NCT02268812|69183350|FG003|Overall Study|Withdrawal by Subject|0|||
37705598|NCT02268812|69183347|FG000|Overall Study|Physician Decision|3|||
37705599|NCT02268812|69183348|FG001|Overall Study|Physician Decision|1|||
37705600|NCT02268812|69183349|FG002|Overall Study|Physician Decision|0|||
37705601|NCT02268812|69183350|FG003|Overall Study|Physician Decision|1|||
37705602|NCT02268812|69183347|FG000|Overall Study|Other|5|||
37705603|NCT02268812|69183348|FG001|Overall Study|Other|4|||
37705604|NCT02268812|69183349|FG002|Overall Study|Other|1|||
37705605|NCT02268812|69183350|FG003|Overall Study|Other|3|||
37705606|NCT01954251|69183362|FG000|Overall Study|Adverse Event|5|||
37705607|NCT01954251|69183363|FG001|Overall Study|Adverse Event|7|||
37705608|NCT01954251|69183362|FG000|Overall Study|Lost to Follow-up|6|||
37705609|NCT01954251|69183363|FG001|Overall Study|Lost to Follow-up|6|||
37705610|NCT01954251|69183362|FG000|Overall Study|Withdrawal by Subject|2|||
37705611|NCT01954251|69183363|FG001|Overall Study|Withdrawal by Subject|6|||
37705612|NCT01644617|69183373|FG000|Overall Study|Withdrawal by Subject|3|||
37705613|NCT01644617|69183374|FG001|Overall Study|Withdrawal by Subject|4|||
37705614|NCT01644617|69183375|FG002|Overall Study|Withdrawal by Subject|1|||
37705615|NCT01644617|69183373|FG000|Overall Study|Lost to Follow-up|0|||
37705616|NCT01644617|69183374|FG001|Overall Study|Lost to Follow-up|1|||
37705617|NCT01644617|69183375|FG002|Overall Study|Lost to Follow-up|0|||
37705618|NCT01644617|69183373|FG000|Overall Study|Adverse Event|3|||
37705619|NCT01644617|69183374|FG001|Overall Study|Adverse Event|0|||
37705620|NCT01644617|69183375|FG002|Overall Study|Adverse Event|6|||
37705621|NCT02294318|69183385|FG000|Overall Study|Worsening of drinking|3|||
37705622|NCT02294318|69183386|FG001|Overall Study|Worsening of drinking|0|||
37705623|NCT02294318|69183385|FG000|Overall Study|Not exposed to intervention|0|||
37705624|NCT02294318|69183386|FG001|Overall Study|Not exposed to intervention|2|||
37705625|NCT02293499|69183395|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
37705626|NCT02293499|69183396|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
37705627|NCT02293499|69183397|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
37705628|NCT02293499|69183395|FG000|Intervention - Camp|Withdrawal by Subject|3|||
37705629|NCT02293499|69183396|FG001|Intervention - Camp|Withdrawal by Subject|6|||
37705630|NCT02293499|69183397|FG002|Intervention - Camp|Withdrawal by Subject|2|||
37705631|NCT02293499|69183395|FG000|Intervention - Camp|these are those not showing up at camp|24|||
37705632|NCT02293499|69183396|FG001|Intervention - Camp|these are those not showing up at camp|28|||
37705633|NCT02293499|69183397|FG002|Intervention - Camp|these are those not showing up at camp|4|||
37705634|NCT02293499|69183395|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
37705635|NCT02293499|69183396|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
37705636|NCT02293499|69183397|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
37705637|NCT02293499|69183395|FG000|3 Month Follow Up|Lost to Follow-up|14|||
37705638|NCT02293499|69183396|FG001|3 Month Follow Up|Lost to Follow-up|15|||
37705639|NCT02293499|69183397|FG002|3 Month Follow Up|Lost to Follow-up|6|||
37705640|NCT02293499|69183395|FG000|6 Month Follow Up|Lost to Follow-up|17|||
37705641|NCT02293499|69183396|FG001|6 Month Follow Up|Lost to Follow-up|27|||
37705642|NCT02293499|69183397|FG002|6 Month Follow Up|Lost to Follow-up|6|||
37705643|NCT02293499|69183395|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
37705644|NCT02293499|69183396|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
37705645|NCT02293499|69183397|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
37705646|NCT02293499|69183395|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
37705647|NCT02293499|69183396|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
37705648|NCT02293499|69183397|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
37705649|NCT02293499|69183395|FG000|9 Month Follow Up|Lost to Follow-up|24|||
37705650|NCT02293499|69183396|FG001|9 Month Follow Up|Lost to Follow-up|28|||
37705651|NCT02293499|69183397|FG002|9 Month Follow Up|Lost to Follow-up|4|||
37705652|NCT02293499|69183395|FG000|12 Month Follow Up|Lost to Follow-up|26|||
37705653|NCT02293499|69183396|FG001|12 Month Follow Up|Lost to Follow-up|25|||
37705654|NCT02293499|69183397|FG002|12 Month Follow Up|Lost to Follow-up|6|||
37705655|NCT02293499|69183395|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
37705656|NCT02293499|69183396|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
37705657|NCT02293499|69183397|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
37705658|NCT02293499|69183395|FG000|15 Month Follow Up|Lost to Follow-up|22|||
37705659|NCT02293499|69183396|FG001|15 Month Follow Up|Lost to Follow-up|22|||
37705660|NCT02293499|69183397|FG002|15 Month Follow Up|Lost to Follow-up|7|||
37705661|NCT02257385|69183408|FG000|Overall Study|Adverse Event|12|||
37705662|NCT02257385|69183409|FG001|Overall Study|Adverse Event|8|||
37705663|NCT02257385|69183408|FG000|Overall Study|Lack of Efficacy|1|||
37705664|NCT02257385|69183409|FG001|Overall Study|Lack of Efficacy|2|||
37705665|NCT02257385|69183408|FG000|Overall Study|Protocol Violation|5|||
37705666|NCT02257385|69183409|FG001|Overall Study|Protocol Violation|7|||
37705667|NCT02257385|69183408|FG000|Overall Study|Lost to Follow-up|0|||
37705668|NCT02257385|69183409|FG001|Overall Study|Lost to Follow-up|1|||
37705669|NCT02257385|69183408|FG000|Overall Study|Withdrawal by Subject|4|||
37705670|NCT02257385|69183409|FG001|Overall Study|Withdrawal by Subject|4|||
37705671|NCT01629667|69183418|FG000|Overall Study|Lost to Follow-up|0|||
37705672|NCT01629667|69183419|FG001|Overall Study|Lost to Follow-up|1|||
37705673|NCT01629667|69183420|FG002|Overall Study|Lost to Follow-up|1|||
37705674|NCT01629667|69183418|FG000|Overall Study|Withdrawal by Subject|31|||
37705675|NCT01629667|69183419|FG001|Overall Study|Withdrawal by Subject|20|||
37705676|NCT01629667|69183420|FG002|Overall Study|Withdrawal by Subject|28|||
37705677|NCT01629667|69183418|FG000|Overall Study|Death|1|||
37705678|NCT01629667|69183419|FG001|Overall Study|Death|5|||
37705679|NCT01629667|69183420|FG002|Overall Study|Death|3|||
37705680|NCT01629667|69183418|FG000|Overall Study|Randomized, not treated|2|||
37705681|NCT01629667|69183419|FG001|Overall Study|Randomized, not treated|1|||
37705682|NCT01629667|69183420|FG002|Overall Study|Randomized, not treated|0|||
37705683|NCT01629667|69183418|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
37705684|NCT01629667|69183419|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
37705685|NCT01629667|69183420|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
37705686|NCT01629667|69183418|FG000|Overall Study|Requiring lung transplant|2|||
37705687|NCT01629667|69183419|FG001|Overall Study|Requiring lung transplant|1|||
37705688|NCT01629667|69183420|FG002|Overall Study|Requiring lung transplant|3|||
37705689|NCT01629667|69183418|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
37705690|NCT01629667|69183419|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
37705691|NCT01629667|69183420|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
37705692|NCT01629667|69183418|FG000|Overall Study|Started other medicine|1|||
37705693|NCT01629667|69183419|FG001|Overall Study|Started other medicine|0|||
37705694|NCT01629667|69183420|FG002|Overall Study|Started other medicine|1|||
37705695|NCT01629667|69183418|FG000|Overall Study|Site error in safety follow-up|0|||
37705696|NCT01629667|69183419|FG001|Overall Study|Site error in safety follow-up|0|||
37705697|NCT01629667|69183420|FG002|Overall Study|Site error in safety follow-up|1|||
37705698|NCT01629667|69183418|FG000|Overall Study|Enrolled in another clinical study|0|||
37705699|NCT01629667|69183419|FG001|Overall Study|Enrolled in another clinical study|1|||
37705700|NCT01629667|69183420|FG002|Overall Study|Enrolled in another clinical study|0|||
37705701|NCT01629667|69183418|FG000|Overall Study|Code break|1|||
37705702|NCT01629667|69183419|FG001|Overall Study|Code break|0|||
37705703|NCT01629667|69183420|FG002|Overall Study|Code break|0|||
37705704|NCT01645280|69183435|FG000|Overall Study|Death|0|||
37705705|NCT01645280|69183436|FG001|Overall Study|Death|1|||
37705706|NCT01645280|69183437|FG002|Overall Study|Death|0|||
37705707|NCT01645280|69183438|FG003|Overall Study|Death|0|||
37705708|NCT01645280|69183439|FG004|Overall Study|Death|0|||
37705709|NCT01645280|69183435|FG000|Overall Study|Withdrawal by Subject|4|||
37705710|NCT01645280|69183436|FG001|Overall Study|Withdrawal by Subject|0|||
37705711|NCT01645280|69183437|FG002|Overall Study|Withdrawal by Subject|2|||
37705712|NCT01645280|69183438|FG003|Overall Study|Withdrawal by Subject|4|||
37705713|NCT01645280|69183439|FG004|Overall Study|Withdrawal by Subject|5|||
37705714|NCT01645280|69183435|FG000|Overall Study|Lost to Follow-up|0|||
37705715|NCT01645280|69183436|FG001|Overall Study|Lost to Follow-up|0|||
37705716|NCT01645280|69183437|FG002|Overall Study|Lost to Follow-up|0|||
37705717|NCT01645280|69183438|FG003|Overall Study|Lost to Follow-up|2|||
37705718|NCT01645280|69183439|FG004|Overall Study|Lost to Follow-up|1|||
37705719|NCT01645280|69183435|FG000|Overall Study|Other|1|||
37705720|NCT01645280|69183436|FG001|Overall Study|Other|1|||
37705721|NCT01645280|69183437|FG002|Overall Study|Other|2|||
37705722|NCT01645280|69183438|FG003|Overall Study|Other|0|||
37705723|NCT01645280|69183439|FG004|Overall Study|Other|0|||
37705724|NCT01645280|69183435|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
37705725|NCT01645280|69183436|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
37705726|NCT01645280|69183437|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
37705727|NCT01645280|69183438|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
37705728|NCT01645280|69183439|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
37705729|NCT02256917|69183452|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
37705730|NCT02256917|69183452|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
37705731|NCT02256917|69183452|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
37705732|NCT02256917|69183452|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
37705733|NCT02256917|69183452|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
37705734|NCT01629589|69183465|FG000|Overall Study|Protocol Violation|4|||
37705735|NCT01629589|69183466|FG001|Overall Study|Protocol Violation|2|||
37705736|NCT01629589|69183465|FG000|Overall Study|Lost to Follow-up|2|||
37705737|NCT01629589|69183466|FG001|Overall Study|Lost to Follow-up|1|||
37705738|NCT01629589|69183465|FG000|Overall Study|Withdrawal by Subject|2|||
37705739|NCT01629589|69183466|FG001|Overall Study|Withdrawal by Subject|3|||
37705740|NCT01629589|69183465|FG000|Overall Study|Did not receive study vaccine|0|||
37705741|NCT01629589|69183466|FG001|Overall Study|Did not receive study vaccine|1|||
37705742|NCT02256839|69183474|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
37705743|NCT02256839|69183475|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
37705744|NCT02220907|69183481|FG000|Overall Study|Adverse Event|7|||
37705745|NCT02220907|69183481|FG000|Overall Study|Physician Decision|1|||
37705746|NCT02220907|69183481|FG000|Overall Study|Withdrawal by Subject|2|||
37705747|NCT02220907|69183481|FG000|Overall Study|Conflict with the stopping criteria|1|||
37705748|NCT02255981|69183485|FG000|Overall Study|Lost to Follow-up|3|||
37705749|NCT02255981|69183485|FG000|Overall Study|Withdrawal by Subject|1|||
37705750|NCT01601873|69183497|FG000|Overall Study|Lost to Follow-up|2|||
37705751|NCT01601873|69183498|FG001|Overall Study|Lost to Follow-up|3|||
37705752|NCT02194933|69183506|FG000|Overall Study|Lost to Follow-up|1|||
37705753|NCT02194933|69183507|FG001|Overall Study|Lost to Follow-up|2|||
37705754|NCT02194933|69183506|FG000|Overall Study|Participant met withdrawal criteria|1|||
37705755|NCT02194933|69183507|FG001|Overall Study|Participant met withdrawal criteria|3|||
37705756|NCT02194933|69183506|FG000|Overall Study|Withdrawal by Subject|0|||
37705757|NCT02194933|69183507|FG001|Overall Study|Withdrawal by Subject|2|||
37705758|NCT02194933|69183506|FG000|Overall Study|Lack of Efficacy|1|||
37705759|NCT02194933|69183507|FG001|Overall Study|Lack of Efficacy|2|||
37705760|NCT01644890|69183517|FG000|Overall Study|Adverse Event|7|||
37705761|NCT01644890|69183518|FG001|Overall Study|Adverse Event|20|||
37705762|NCT01644890|69183517|FG000|Overall Study|Death|1|||
37705763|NCT01644890|69183518|FG001|Overall Study|Death|3|||
37705764|NCT01644890|69183517|FG000|Overall Study|Physician Decision|3|||
37705765|NCT01644890|69183518|FG001|Overall Study|Physician Decision|9|||
37705766|NCT01644890|69183517|FG000|Overall Study|Protocol Violation|6|||
37705767|NCT01644890|69183518|FG001|Overall Study|Protocol Violation|7|||
37705768|NCT01644890|69183517|FG000|Overall Study|Withdrawal by Subject|19|||
37705769|NCT01644890|69183518|FG001|Overall Study|Withdrawal by Subject|27|||
37705770|NCT01644890|69183517|FG000|Overall Study|Progression Disease|160|||
37705771|NCT01644890|69183518|FG001|Overall Study|Progression Disease|131|||
37705772|NCT01644890|69183517|FG000|Overall Study|Clinical Progression|6|||
37705773|NCT01644890|69183518|FG001|Overall Study|Clinical Progression|6|||
37705774|NCT01644890|69183517|FG000|Overall Study|> 28 days since last dose of study drug|6|||
37915151|NCT00592839|69601840|FG000|Overall Study|Withdrawal by Subject|1|||
37915152|NCT00592839|69601841|FG001|Overall Study|Withdrawal by Subject|1|||
37705775|NCT01644890|69183518|FG001|Overall Study|> 28 days since last dose of study drug|3|||
37705776|NCT01644890|69183517|FG000|Overall Study|Other|8|||
37705777|NCT01644890|69183518|FG001|Overall Study|Other|9|||
37705778|NCT01628965|69183524|FG000|Overall Study|Adverse Event|30|||
37705779|NCT01628965|69183524|FG000|Overall Study|Lack of Efficacy|7|||
37705780|NCT01628965|69183524|FG000|Overall Study|Withdrawal by Subject|3|||
37705781|NCT01628965|69183524|FG000|Overall Study|Lost to Follow-up|1|||
37705782|NCT01628965|69183524|FG000|Overall Study|Discontinuation criteria|8|||
37705783|NCT01644734|69183528|FG000|Overall Study|Adverse Event|4|||
37705784|NCT01644734|69183528|FG000|Overall Study|Lost to Follow-up|17|||
37705785|NCT01644734|69183528|FG000|Overall Study|Reasons other than stated above|7|||
37705786|NCT01644734|69183528|FG000|Overall Study|Missing documentation|238|||
37705787|NCT02255279|69183534|FG000|Overall Study|Lost to Follow-up|2|||
37705788|NCT02255279|69183535|FG001|Overall Study|Lost to Follow-up|2|||
37705789|NCT02255279|69183534|FG000|Overall Study|Protocol Violation|0|||
37705790|NCT02255279|69183535|FG001|Overall Study|Protocol Violation|1|||
37705791|NCT02255279|69183534|FG000|Overall Study|Withdrawal by Subject|3|||
37705792|NCT02255279|69183535|FG001|Overall Study|Withdrawal by Subject|6|||
37705793|NCT01643798|69183555|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
37705794|NCT01643798|69183556|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
37705795|NCT02194699|69183569|FG000|Randomised|Did not receive treatment|1|||
37705796|NCT02194699|69183570|FG001|Randomised|Did not receive treatment|5|||
37705797|NCT02194699|69183569|FG000|Randomised|Without potential for 52 weeks of IP|5|||
37705798|NCT02194699|69183570|FG001|Randomised|Without potential for 52 weeks of IP|5|||
37705799|NCT02194699|69183569|FG000|Randomised|Duplicate patient|2|||
37705800|NCT02194699|69183570|FG001|Randomised|Duplicate patient|1|||
37705801|NCT02194699|69183569|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
37705802|NCT02194699|69183570|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
37705803|NCT02194699|69183569|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
37705804|NCT02194699|69183570|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
37705805|NCT02194699|69183569|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
37705806|NCT02194699|69183570|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
37705807|NCT02194699|69183569|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
37705808|NCT02194699|69183570|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
37705809|NCT02194699|69183569|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
37705810|NCT02194699|69183570|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
37705811|NCT02194699|69183569|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
37705812|NCT02194699|69183570|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
37705813|NCT02293538|69183586|FG000|Overall Study|Adverse Event|0|||
37705814|NCT02293538|69183587|FG001|Overall Study|Adverse Event|1|||
37705815|NCT02293538|69183586|FG000|Overall Study|Lost to Follow-up|1|||
37705816|NCT02293538|69183587|FG001|Overall Study|Lost to Follow-up|0|||
37705817|NCT02293538|69183586|FG000|Overall Study|Withdrawal by Subject|0|||
37705818|NCT02293538|69183587|FG001|Overall Study|Withdrawal by Subject|1|||
37705819|NCT02194621|69183597|FG000|Overall Study|6 withdrew prior to randomization|2|||
37705820|NCT02194621|69183598|FG001|Overall Study|6 withdrew prior to randomization|2|||
37705821|NCT02194621|69183599|FG002|Overall Study|6 withdrew prior to randomization|2|||
37705822|NCT02194621|69183597|FG000|Overall Study|Withdrawal by Subject|4|||
37705823|NCT02194621|69183598|FG001|Overall Study|Withdrawal by Subject|4|||
37705824|NCT02194621|69183599|FG002|Overall Study|Withdrawal by Subject|7|||
37705825|NCT02220205|69183609|FG000|Overall Study|Withdrawal by Subject|1|||
37705826|NCT02220205|69183610|FG001|Overall Study|Withdrawal by Subject|0|||
37705827|NCT02266706|69183625|FG000|Overall Study|Withdrawal by Subject|0|||
37705828|NCT02266706|69183626|FG001|Overall Study|Withdrawal by Subject|1|||
37705829|NCT02266706|69183627|FG002|Overall Study|Withdrawal by Subject|1|||
37705830|NCT02266706|69183628|FG003|Overall Study|Withdrawal by Subject|0|||
37705831|NCT02266706|69183629|FG004|Overall Study|Withdrawal by Subject|0|||
37705832|NCT02266706|69183630|FG005|Overall Study|Withdrawal by Subject|1|||
37705833|NCT02266706|69183631|FG006|Overall Study|Withdrawal by Subject|0|||
37915153|NCT00592839|69601842|FG002|Overall Study|Withdrawal by Subject|3|||
37705834|NCT02266706|69183632|FG007|Overall Study|Withdrawal by Subject|0|||
37705835|NCT02266706|69183633|FG008|Overall Study|Withdrawal by Subject|0|||
37705836|NCT02266706|69183625|FG000|Overall Study|Screen failure|0|||
37705837|NCT02266706|69183626|FG001|Overall Study|Screen failure|0|||
37705838|NCT02266706|69183627|FG002|Overall Study|Screen failure|0|||
37705839|NCT02266706|69183628|FG003|Overall Study|Screen failure|0|||
37705840|NCT02266706|69183629|FG004|Overall Study|Screen failure|0|||
37705841|NCT02266706|69183630|FG005|Overall Study|Screen failure|1|||
37705842|NCT02266706|69183631|FG006|Overall Study|Screen failure|1|||
37705843|NCT02266706|69183632|FG007|Overall Study|Screen failure|0|||
37705844|NCT02266706|69183633|FG008|Overall Study|Screen failure|0|||
37705845|NCT02266706|69183625|FG000|Overall Study|Enrollment in another study|0|||
37705846|NCT02266706|69183626|FG001|Overall Study|Enrollment in another study|0|||
37705847|NCT02266706|69183627|FG002|Overall Study|Enrollment in another study|0|||
37705848|NCT02266706|69183628|FG003|Overall Study|Enrollment in another study|1|||
37705849|NCT02266706|69183629|FG004|Overall Study|Enrollment in another study|0|||
37705850|NCT02266706|69183630|FG005|Overall Study|Enrollment in another study|0|||
37705851|NCT02266706|69183631|FG006|Overall Study|Enrollment in another study|0|||
37705852|NCT02266706|69183632|FG007|Overall Study|Enrollment in another study|0|||
37705853|NCT02266706|69183633|FG008|Overall Study|Enrollment in another study|0|||
37705854|NCT02293460|69183653|FG000|Overall Study|Protocol Violation|1|||
37705855|NCT02293460|69183653|FG000|Overall Study|Lack of Efficacy|2|||
37705856|NCT02293460|69183653|FG000|Overall Study|Adverse Event|2|||
37705857|NCT02293460|69183653|FG000|Overall Study|Withdrawal by Subject|1|||
37705858|NCT02266004|69183657|FG000|Overall Study|unrelated adverse event|1|||
37705859|NCT02266004|69183657|FG000|Overall Study|Physician Decision|1|||
37705860|NCT02292719|69183667|FG000|Overall Study|Withdrawal by Subject|0|||
37705861|NCT02292719|69183668|FG001|Overall Study|Withdrawal by Subject|0|||
37705862|NCT02292719|69183669|FG002|Overall Study|Withdrawal by Subject|0|||
37705863|NCT02292719|69183670|FG003|Overall Study|Withdrawal by Subject|1|||
37705864|NCT02292719|69183671|FG004|Overall Study|Withdrawal by Subject|1|||
37705865|NCT02292719|69183672|FG005|Overall Study|Withdrawal by Subject|0|||
37705866|NCT02292719|69183667|FG000|Overall Study|Subject enrolled in new study.|0|||
37705867|NCT02292719|69183668|FG001|Overall Study|Subject enrolled in new study.|0|||
37705868|NCT02292719|69183669|FG002|Overall Study|Subject enrolled in new study.|1|||
37705869|NCT02292719|69183670|FG003|Overall Study|Subject enrolled in new study.|0|||
37705870|NCT02292719|69183671|FG004|Overall Study|Subject enrolled in new study.|0|||
37705871|NCT02292719|69183672|FG005|Overall Study|Subject enrolled in new study.|0|||
37705872|NCT02291861|69183690|FG000|Overall Study|Adverse Event|2|||
37705873|NCT02291861|69183691|FG001|Overall Study|Adverse Event|4|||
37705874|NCT02291861|69183692|FG002|Overall Study|Adverse Event|1|||
37705875|NCT02291861|69183693|FG003|Overall Study|Adverse Event|2|||
37705876|NCT02291861|69183690|FG000|Overall Study|Death|0|||
37705877|NCT02291861|69183691|FG001|Overall Study|Death|0|||
37705878|NCT02291861|69183692|FG002|Overall Study|Death|1|||
37705879|NCT02291861|69183693|FG003|Overall Study|Death|1|||
37705880|NCT02291861|69183690|FG000|Overall Study|Protocol Violation|1|||
37705881|NCT02291861|69183691|FG001|Overall Study|Protocol Violation|0|||
37705882|NCT02291861|69183692|FG002|Overall Study|Protocol Violation|0|||
37705883|NCT02291861|69183693|FG003|Overall Study|Protocol Violation|1|||
37705884|NCT02291861|69183690|FG000|Overall Study|Withdrawal by Subject|1|||
37705885|NCT02291861|69183691|FG001|Overall Study|Withdrawal by Subject|2|||
37705886|NCT02291861|69183692|FG002|Overall Study|Withdrawal by Subject|1|||
37705887|NCT02291861|69183693|FG003|Overall Study|Withdrawal by Subject|4|||
37705888|NCT02291861|69183690|FG000|Overall Study|Noncompliance|1|||
37705889|NCT02291861|69183691|FG001|Overall Study|Noncompliance|1|||
37705890|NCT02291861|69183692|FG002|Overall Study|Noncompliance|2|||
37705891|NCT02291861|69183693|FG003|Overall Study|Noncompliance|1|||
37705892|NCT02291861|69183690|FG000|Overall Study|Lost to Follow-up|2|||
37915154|NCT00592839|69601840|FG000|Overall Study|Protocol Violation|1|||
37705893|NCT02291861|69183691|FG001|Overall Study|Lost to Follow-up|1|||
37705894|NCT02291861|69183692|FG002|Overall Study|Lost to Follow-up|4|||
37705895|NCT02291861|69183693|FG003|Overall Study|Lost to Follow-up|0|||
37705896|NCT02291861|69183690|FG000|Overall Study|Other|0|||
37705897|NCT02291861|69183691|FG001|Overall Study|Other|0|||
37705898|NCT02291861|69183692|FG002|Overall Study|Other|0|||
37705899|NCT02291861|69183693|FG003|Overall Study|Other|1|||
37705900|NCT02291549|69183705|FG000|Overall Study|Lost to Follow-up|1|||
37705901|NCT02291549|69183706|FG001|Overall Study|Lost to Follow-up|0|||
37705902|NCT02291549|69183705|FG000|Overall Study|Withdrawal by Subject|0|||
37705903|NCT02291549|69183706|FG001|Overall Study|Withdrawal by Subject|1|||
37705904|NCT02264990|69183716|FG000|Overall Study|Death|255|||
37705905|NCT02264990|69183717|FG001|Overall Study|Death|250|||
37705906|NCT02264990|69183716|FG000|Overall Study|Withdrawal by Subject|4|||
37705907|NCT02264990|69183717|FG001|Overall Study|Withdrawal by Subject|5|||
37705908|NCT02264990|69183716|FG000|Overall Study|Lost to Follow-up|1|||
37705909|NCT02264990|69183717|FG001|Overall Study|Lost to Follow-up|3|||
37705910|NCT02264990|69183716|FG000|Overall Study|Other|0|||
37705911|NCT02264990|69183717|FG001|Overall Study|Other|1|||
37705912|NCT02291237|69183726|FG000|Overall Study|Study Terminated by Sponsor|72|||
37705913|NCT02291237|69183727|FG001|Overall Study|Study Terminated by Sponsor|67|||
37705914|NCT02291237|69183726|FG000|Overall Study|Adverse Event|1|||
37705915|NCT02291237|69183727|FG001|Overall Study|Adverse Event|3|||
37705916|NCT02291237|69183726|FG000|Overall Study|Investigator's Discretion|0|||
37705917|NCT02291237|69183727|FG001|Overall Study|Investigator's Discretion|3|||
37705918|NCT02291237|69183726|FG000|Overall Study|Withdrew Consent|11|||
37705919|NCT02291237|69183727|FG001|Overall Study|Withdrew Consent|11|||
37705920|NCT02291237|69183726|FG000|Overall Study|Lost to Follow-up|0|||
37705921|NCT02291237|69183727|FG001|Overall Study|Lost to Follow-up|2|||
37705922|NCT02291237|69183726|FG000|Overall Study|Subject Required Prohibited Medication|2|||
37705923|NCT02291237|69183727|FG001|Overall Study|Subject Required Prohibited Medication|0|||
37705924|NCT02292446|69183733|FG000|Overall Study|Adverse Event|12|||
37705925|NCT02292446|69183733|FG000|Overall Study|Death|1|||
37705926|NCT02292446|69183733|FG000|Overall Study|Disease progression|2|||
37705927|NCT02292446|69183733|FG000|Overall Study|Subject/guardian decision|2|||
37705928|NCT02292446|69183733|FG000|Overall Study|Withdrawal by Subject|3|||
37705929|NCT02290925|69183742|FG000|First Period of Three Months|Lost to Follow-up|2|||
37705930|NCT02290925|69183743|FG001|First Period of Three Months|Lost to Follow-up|1|||
37705931|NCT02290925|69183742|FG000|First Period of Three Months|Death|1|||
37705932|NCT02290925|69183743|FG001|First Period of Three Months|Death|0|||
37705933|NCT02290925|69183742|FG000|First Period of Three Months|Insulin Started|1|||
37705934|NCT02290925|69183743|FG001|First Period of Three Months|Insulin Started|1|||
37705935|NCT02290925|69183742|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
37705936|NCT02290925|69183743|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
37705937|NCT02290925|69183742|FG000|Second Period of 3 Months|insulin started|0|||
37705938|NCT02290925|69183743|FG001|Second Period of 3 Months|insulin started|1|||
37705939|NCT02290691|69183753|FG000|Overall Study|Noncompliance|0|||
37705940|NCT02290691|69183754|FG001|Overall Study|Noncompliance|1|||
37705941|NCT02290691|69183753|FG000|Overall Study|Withdrawal by Subject|1|||
37705942|NCT02290691|69183754|FG001|Overall Study|Withdrawal by Subject|1|||
37705943|NCT02290691|69183753|FG000|Overall Study|Lost to Follow-up|7|||
37705944|NCT02290691|69183754|FG001|Overall Study|Lost to Follow-up|7|||
37705945|NCT02292212|69183760|FG000|ViE Phase|Withdrawal by Subject|1|||
37705946|NCT02292212|69183760|FG000|ViE Phase|Protocol Violation|2|||
37705947|NCT02291510|69183775|FG000|Overall Study|Adverse Event|0|||
37705948|NCT02291510|69183776|FG001|Overall Study|Adverse Event|0|||
37705949|NCT02291510|69183777|FG002|Overall Study|Adverse Event|0|||
37705950|NCT02291510|69183778|FG003|Overall Study|Adverse Event|1|||
37705951|NCT02290223|69183790|FG000|6 Months|Lost to Follow-up|9|||
37705952|NCT02290223|69183791|FG001|6 Months|Lost to Follow-up|6|||
37705953|NCT02290223|69183790|FG000|6 Months|Withdrawal by Subject|5|||
37705954|NCT02290223|69183791|FG001|6 Months|Withdrawal by Subject|0|||
37705955|NCT02290223|69183790|FG000|6 Months|deceased (not related to study)|2|||
37705956|NCT02290223|69183791|FG001|6 Months|deceased (not related to study)|0|||
37705957|NCT02290223|69183790|FG000|12 Months|Lost to Follow-up|16|||
37705958|NCT02290223|69183791|FG001|12 Months|Lost to Follow-up|10|||
37705959|NCT02290223|69183790|FG000|12 Months|Refusal|0|||
37705960|NCT02290223|69183791|FG001|12 Months|Refusal|1|||
37705961|NCT02289833|69183799|FG000|Overall Study|Study discontinuation|0|||
37705962|NCT02289833|69183800|FG001|Overall Study|Study discontinuation|1|||
37705963|NCT02289833|69183799|FG000|Overall Study|Lost to Follow-up|4|||
37705964|NCT02289833|69183800|FG001|Overall Study|Lost to Follow-up|0|||
37705965|NCT02289833|69183799|FG000|Overall Study|Death|23|||
37705966|NCT02289833|69183800|FG001|Overall Study|Death|16|||
37705967|NCT01702558|69183813|FG000|Overall Study|Withdrawal by Subject|0|||
37705968|NCT01702558|69183814|FG001|Overall Study|Withdrawal by Subject|0|||
37705969|NCT01702558|69183815|FG002|Overall Study|Withdrawal by Subject|0|||
37705970|NCT01702558|69183816|FG003|Overall Study|Withdrawal by Subject|12|||
37705971|NCT01702558|69183817|FG004|Overall Study|Withdrawal by Subject|4|||
37705972|NCT01702558|69183813|FG000|Overall Study|Lost to Follow-up|0|||
37705973|NCT01702558|69183814|FG001|Overall Study|Lost to Follow-up|0|||
37705974|NCT01702558|69183815|FG002|Overall Study|Lost to Follow-up|0|||
37705975|NCT01702558|69183816|FG003|Overall Study|Lost to Follow-up|3|||
37705976|NCT01702558|69183817|FG004|Overall Study|Lost to Follow-up|0|||
37705977|NCT01702558|69183813|FG000|Overall Study|Death|4|||
37705978|NCT01702558|69183814|FG001|Overall Study|Death|3|||
37705979|NCT01702558|69183815|FG002|Overall Study|Death|3|||
37705980|NCT01702558|69183816|FG003|Overall Study|Death|16|||
37705981|NCT01702558|69183817|FG004|Overall Study|Death|20|||
37705982|NCT01702558|69183813|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
37915155|NCT00592839|69601841|FG001|Overall Study|Protocol Violation|1|||
37705983|NCT01702558|69183814|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
37705984|NCT01702558|69183815|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
37705985|NCT01702558|69183816|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
37705986|NCT01702558|69183817|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
37705987|NCT01702558|69183813|FG000|Overall Study|Study Terminated by Sponsor|0|||
37705988|NCT01702558|69183814|FG001|Overall Study|Study Terminated by Sponsor|1|||
37705989|NCT01702558|69183815|FG002|Overall Study|Study Terminated by Sponsor|0|||
37705990|NCT01702558|69183816|FG003|Overall Study|Study Terminated by Sponsor|0|||
37705991|NCT01702558|69183817|FG004|Overall Study|Study Terminated by Sponsor|1|||
37705992|NCT01702558|69183813|FG000|Overall Study|Other|0|||
37705993|NCT01702558|69183814|FG001|Overall Study|Other|0|||
37705994|NCT01702558|69183815|FG002|Overall Study|Other|0|||
37705995|NCT01702558|69183816|FG003|Overall Study|Other|16|||
37705996|NCT01702558|69183817|FG004|Overall Study|Other|17|||
37705997|NCT02287883|69183832|FG000|Overall Study|Death|8|||
37705998|NCT02287883|69183833|FG001|Overall Study|Death|7|||
37705999|NCT02287883|69183832|FG000|Overall Study|No longer eligible|222|||
37706000|NCT02287883|69183833|FG001|Overall Study|No longer eligible|182|||
37706001|NCT02287883|69183832|FG000|Overall Study|Non-response to survey|229|||
37706002|NCT02287883|69183833|FG001|Overall Study|Non-response to survey|237|||
37706003|NCT01743040|69183839|FG000|Overall Study|Death|1|||
37706004|NCT01743040|69183839|FG000|Overall Study|Lost to Follow-up|66|||
37706005|NCT01743040|69183839|FG000|Overall Study|Physician Decision|40|||
37706006|NCT01743040|69183839|FG000|Overall Study|Protocol Violation|1|||
37706007|NCT01743040|69183839|FG000|Overall Study|Withdrawal by Subject|121|||
37706008|NCT02194465|69183850|FG000|Overall Study|Adverse Event|6|||
37706009|NCT02194465|69183851|FG001|Overall Study|Adverse Event|1|||
37706010|NCT02194465|69183852|FG002|Overall Study|Adverse Event|4|||
37706011|NCT02194465|69183853|FG003|Overall Study|Adverse Event|4|||
37706012|NCT02194465|69183854|FG004|Overall Study|Adverse Event|4|||
37706013|NCT02194465|69183855|FG005|Overall Study|Adverse Event|2|||
37706014|NCT02194465|69183856|FG006|Overall Study|Adverse Event|0|||
37706015|NCT02194465|69183850|FG000|Overall Study|Lost to Follow-up|0|||
37706016|NCT02194465|69183851|FG001|Overall Study|Lost to Follow-up|0|||
37706017|NCT02194465|69183852|FG002|Overall Study|Lost to Follow-up|0|||
37706018|NCT02194465|69183853|FG003|Overall Study|Lost to Follow-up|1|||
37706019|NCT02194465|69183854|FG004|Overall Study|Lost to Follow-up|0|||
37706020|NCT02194465|69183855|FG005|Overall Study|Lost to Follow-up|1|||
37706021|NCT02194465|69183856|FG006|Overall Study|Lost to Follow-up|0|||
37706022|NCT02194465|69183850|FG000|Overall Study|Physician Decision|1|||
37706023|NCT02194465|69183851|FG001|Overall Study|Physician Decision|0|||
37706024|NCT02194465|69183852|FG002|Overall Study|Physician Decision|0|||
37706025|NCT02194465|69183853|FG003|Overall Study|Physician Decision|0|||
37706026|NCT02194465|69183854|FG004|Overall Study|Physician Decision|0|||
37706027|NCT02194465|69183855|FG005|Overall Study|Physician Decision|0|||
37706028|NCT02194465|69183856|FG006|Overall Study|Physician Decision|0|||
37706029|NCT02194465|69183850|FG000|Overall Study|Protocol Violation|1|||
37706030|NCT02194465|69183851|FG001|Overall Study|Protocol Violation|1|||
37706031|NCT02194465|69183852|FG002|Overall Study|Protocol Violation|2|||
37706032|NCT02194465|69183853|FG003|Overall Study|Protocol Violation|1|||
37706033|NCT02194465|69183854|FG004|Overall Study|Protocol Violation|1|||
37706034|NCT02194465|69183855|FG005|Overall Study|Protocol Violation|0|||
37915156|NCT00592839|69601842|FG002|Overall Study|Protocol Violation|2|||
37915157|NCT00592839|69601840|FG000|Overall Study|Adverse Event|0|||
37706035|NCT02194465|69183856|FG006|Overall Study|Protocol Violation|0|||
37706036|NCT02194465|69183850|FG000|Overall Study|Withdrawal by Subject|1|||
37706037|NCT02194465|69183851|FG001|Overall Study|Withdrawal by Subject|3|||
37706038|NCT02194465|69183852|FG002|Overall Study|Withdrawal by Subject|1|||
37706039|NCT02194465|69183853|FG003|Overall Study|Withdrawal by Subject|2|||
37706040|NCT02194465|69183854|FG004|Overall Study|Withdrawal by Subject|2|||
37706041|NCT02194465|69183855|FG005|Overall Study|Withdrawal by Subject|1|||
37706042|NCT02194465|69183856|FG006|Overall Study|Withdrawal by Subject|2|||
37706043|NCT02194465|69183850|FG000|Overall Study|Discontinued follow-up period|0|||
37915158|NCT00592839|69601841|FG001|Overall Study|Adverse Event|1|||
37706044|NCT02194465|69183851|FG001|Overall Study|Discontinued follow-up period|2|||
37706045|NCT02194465|69183852|FG002|Overall Study|Discontinued follow-up period|1|||
37706046|NCT02194465|69183853|FG003|Overall Study|Discontinued follow-up period|0|||
37706047|NCT02194465|69183854|FG004|Overall Study|Discontinued follow-up period|2|||
37706048|NCT02194465|69183855|FG005|Overall Study|Discontinued follow-up period|0|||
37706049|NCT02194465|69183856|FG006|Overall Study|Discontinued follow-up period|0|||
37706050|NCT02287025|69183878|FG000|Overall Study|Not treated|2|||
37706051|NCT02287025|69183879|FG001|Overall Study|Not treated|0|||
37706052|NCT02287025|69183878|FG000|Overall Study|Progression of disease|3|||
37706053|NCT02287025|69183879|FG001|Overall Study|Progression of disease|2|||
37706054|NCT02287025|69183878|FG000|Overall Study|Adverse Event|2|||
37706055|NCT02287025|69183879|FG001|Overall Study|Adverse Event|4|||
37706056|NCT02287025|69183878|FG000|Overall Study|Withdrawal by Subject|2|||
37706057|NCT02287025|69183879|FG001|Overall Study|Withdrawal by Subject|2|||
37706058|NCT02287025|69183878|FG000|Overall Study|Screening failed|1|||
37706059|NCT02287025|69183879|FG001|Overall Study|Screening failed|1|||
37706060|NCT01720264|69183883|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
37706061|NCT01720264|69183883|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
37706062|NCT01720264|69183883|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
37706063|NCT01702246|69183887|FG000|Overall Study|Lost to Follow-up|2|||
37706064|NCT01702246|69183887|FG000|Overall Study|Withdrawal by Subject|2|||
37706065|NCT01702246|69183887|FG000|Overall Study|Physician Decision|1|||
37706066|NCT01631227|69183896|FG000|Overall Study|withdrawn consent|27|||
37706067|NCT01631227|69183897|FG001|Overall Study|withdrawn consent|21|||
37706068|NCT01631227|69183896|FG000|Overall Study|Adverse Event|1|||
37706069|NCT01631227|69183897|FG001|Overall Study|Adverse Event|0|||
37706070|NCT01631227|69183896|FG000|Overall Study|administrative|2|||
37706071|NCT01631227|69183897|FG001|Overall Study|administrative|1|||
37706072|NCT01719172|69183903|FG000|Overall Study|Lost to Follow-up|1|||
37706073|NCT01719172|69183903|FG000|Overall Study|Death|1|||
37706074|NCT02286947|69183907|FG000|Overall Study|Withdrawal by Subject|2|||
37706075|NCT02286713|69183915|FG000|One Week Follow-Up|Death|1|||
37706076|NCT02286713|69183916|FG001|One Week Follow-Up|Death|0|||
37706077|NCT02286713|69183915|FG000|One Week Follow-Up|Lost to Follow-up|17|||
37706078|NCT02286713|69183916|FG001|One Week Follow-Up|Lost to Follow-up|21|||
37706079|NCT02286713|69183915|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
37706080|NCT02286713|69183916|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
37706081|NCT02286713|69183915|FG000|Three Month Follow-Up|Death|1|||
37706082|NCT02286713|69183916|FG001|Three Month Follow-Up|Death|1|||
37706083|NCT02286713|69183915|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
37706084|NCT02286713|69183916|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
37706085|NCT02286713|69183915|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
37706086|NCT02286713|69183916|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
37706087|NCT02286713|69183915|FG000|Six Month Follow-Up|Death|2|||
37706088|NCT02286713|69183916|FG001|Six Month Follow-Up|Death|0|||
37706089|NCT02286713|69183915|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
37706090|NCT02286713|69183916|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
37706091|NCT02285855|69183924|FG000|Overall Study|Withdrawal by Subject|2|||
37706092|NCT02285855|69183925|FG001|Overall Study|Withdrawal by Subject|1|||
37706093|NCT02285777|69183933|FG000|Overall Study|Withdrawal by Subject|1|||
37706094|NCT02285777|69183934|FG001|Overall Study|Withdrawal by Subject|1|||
37706095|NCT02285777|69183933|FG000|Overall Study|Lost to Follow-up|4|||
37706096|NCT02285777|69183934|FG001|Overall Study|Lost to Follow-up|2|||
37706097|NCT02285153|69183942|FG000|Overall Study|Adverse Event|1|||
37706098|NCT02285153|69183943|FG001|Overall Study|Adverse Event|0|||
37706099|NCT02284373|69183952|FG000|Overall Study|Withdrawal by Subject|0|||
37837531|NCT01152385|69521980|FG003|Overall Study|Withdrawal by Subject|1|||
37837532|NCT01152385|69521977|FG000|Overall Study|Protocol Violation|0|||
37837533|NCT01152385|69521978|FG001|Overall Study|Protocol Violation|0|||
37837534|NCT01152385|69521979|FG002|Overall Study|Protocol Violation|0|||
37837535|NCT01152385|69521980|FG003|Overall Study|Protocol Violation|1|||
37837536|NCT01152385|69521977|FG000|Overall Study|Adverse Event|1|||
37837537|NCT01152385|69521978|FG001|Overall Study|Adverse Event|1|||
37837538|NCT01152385|69521979|FG002|Overall Study|Adverse Event|0|||
37837539|NCT01152385|69521980|FG003|Overall Study|Adverse Event|0|||
37837540|NCT01152385|69521977|FG000|Overall Study|Study-specific withdrawal criteria|1|||
37837541|NCT01152385|69521978|FG001|Overall Study|Study-specific withdrawal criteria|1|||
37837542|NCT01152385|69521979|FG002|Overall Study|Study-specific withdrawal criteria|2|||
37837543|NCT01152385|69521980|FG003|Overall Study|Study-specific withdrawal criteria|0|||
37837544|NCT01152385|69521977|FG000|Overall Study|Other|4|||
37837545|NCT01152385|69521978|FG001|Overall Study|Other|3|||
37706100|NCT02284373|69183953|FG001|Overall Study|Withdrawal by Subject|1|||
37706101|NCT02284373|69183954|FG002|Overall Study|Withdrawal by Subject|0|||
37706102|NCT02284373|69183952|FG000|Overall Study|Other|0|||
37837546|NCT01152385|69521979|FG002|Overall Study|Other|2|||
37837547|NCT01152385|69521980|FG003|Overall Study|Other|3|||
37915159|NCT00592839|69601842|FG002|Overall Study|Adverse Event|0|||
37915160|NCT00592839|69601840|FG000|Overall Study|Lost to Follow-up|0|||
37915161|NCT00592839|69601841|FG001|Overall Study|Lost to Follow-up|1|||
37915162|NCT00592839|69601842|FG002|Overall Study|Lost to Follow-up|1|||
37915163|NCT00598832|69601852|FG000|Overall Study|Lack of Efficacy|3|||
37915164|NCT00598832|69601853|FG001|Overall Study|Lack of Efficacy|7|||
37915165|NCT00598832|69601852|FG000|Overall Study|Adverse Event|6|||
37915166|NCT00598832|69601853|FG001|Overall Study|Adverse Event|2|||
37915167|NCT00598832|69601852|FG000|Overall Study|Withdrawal by Subject|25|||
37915168|NCT00598832|69601853|FG001|Overall Study|Withdrawal by Subject|36|||
38023970|NCT03032068|69707350|FG000|Overall Study|Adverse Event|1|||
38023971|NCT02674516|69707370|FG000|Overall Study|Lost to Follow-up|3|||
38023972|NCT02674516|69707371|FG001|Overall Study|Lost to Follow-up|0|||
38023973|NCT02674516|69707370|FG000|Overall Study|Protocol Violation|0|||
38023974|NCT02674516|69707371|FG001|Overall Study|Protocol Violation|4|||
38023975|NCT02674516|69707370|FG000|Overall Study|Knowledge of study hypothesis|1|||
38023976|NCT02674516|69707371|FG001|Overall Study|Knowledge of study hypothesis|0|||
38023977|NCT02463448|69707377|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
38023978|NCT02463448|69707377|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
38023979|NCT02463448|69707377|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
38023980|NCT02463448|69707377|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
38023981|NCT03794544|69707385|FG000|Overall Study|Withdrawal by Subject|1|||
38023982|NCT03794544|69707386|FG001|Overall Study|Withdrawal by Subject|1|||
38023983|NCT03794544|69707387|FG002|Overall Study|Withdrawal by Subject|0|||
38023984|NCT03794544|69707388|FG003|Overall Study|Withdrawal by Subject|0|||
38023985|NCT03794544|69707385|FG000|Overall Study|Death|0|||
38023986|NCT03794544|69707386|FG001|Overall Study|Death|0|||
38023987|NCT03794544|69707387|FG002|Overall Study|Death|0|||
38023988|NCT03794544|69707388|FG003|Overall Study|Death|1|||
38023989|NCT03794544|69707385|FG000|Overall Study|Lost to Follow-up|0|||
38023990|NCT03794544|69707386|FG001|Overall Study|Lost to Follow-up|1|||
38023991|NCT03794544|69707387|FG002|Overall Study|Lost to Follow-up|1|||
38023992|NCT03794544|69707388|FG003|Overall Study|Lost to Follow-up|0|||
38023993|NCT03794544|69707385|FG000|Overall Study|Other|0|||
38023994|NCT03794544|69707386|FG001|Overall Study|Other|1|||
38023995|NCT03794544|69707387|FG002|Overall Study|Other|0|||
38023996|NCT03794544|69707388|FG003|Overall Study|Other|0|||
38023997|NCT01804270|69707400|FG000|Overall Study|Withdrawal by Subject|1|||
38023998|NCT01804270|69707401|FG001|Overall Study|Withdrawal by Subject|1|||
38023999|NCT03107026|69707410|FG000|Overall Study|Adverse Event|2|||
38024000|NCT03107026|69707411|FG001|Overall Study|Adverse Event|14|||
38024001|NCT03107026|69707412|FG002|Overall Study|Adverse Event|23|||
38024002|NCT03107026|69707410|FG000|Overall Study|Lost to Follow-up|12|||
38024003|NCT03107026|69707411|FG001|Overall Study|Lost to Follow-up|12|||
38024004|NCT03107026|69707412|FG002|Overall Study|Lost to Follow-up|13|||
38024005|NCT03107026|69707410|FG000|Overall Study|Protocol Violation|1|||
38024006|NCT03107026|69707411|FG001|Overall Study|Protocol Violation|2|||
38024007|NCT03107026|69707412|FG002|Overall Study|Protocol Violation|0|||
38024008|NCT03107026|69707410|FG000|Overall Study|Pregnancy|1|||
38024009|NCT03107026|69707411|FG001|Overall Study|Pregnancy|0|||
38024010|NCT03107026|69707412|FG002|Overall Study|Pregnancy|0|||
38024011|NCT03107026|69707410|FG000|Overall Study|Withdrawal by Subject|13|||
38024012|NCT03107026|69707411|FG001|Overall Study|Withdrawal by Subject|5|||
38024013|NCT03107026|69707412|FG002|Overall Study|Withdrawal by Subject|17|||
38024014|NCT03107026|69707410|FG000|Overall Study|non compliance with study visits|1|||
38024015|NCT03107026|69707411|FG001|Overall Study|non compliance with study visits|2|||
38024016|NCT03107026|69707412|FG002|Overall Study|non compliance with study visits|0|||
38024017|NCT03107026|69707410|FG000|Overall Study|non-compliance with study drug|2|||
38024018|NCT03107026|69707411|FG001|Overall Study|non-compliance with study drug|2|||
38024019|NCT03107026|69707412|FG002|Overall Study|non-compliance with study drug|3|||
38024020|NCT03107026|69707410|FG000|Overall Study|Physician Decision|0|||
38024021|NCT03107026|69707411|FG001|Overall Study|Physician Decision|1|||
37915169|NCT00598832|69601852|FG000|Overall Study|Protocol Violation|0|||
38024022|NCT03107026|69707412|FG002|Overall Study|Physician Decision|0|||
38024023|NCT03717480|69707420|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
38024024|NCT00005044|69707426|FG000|Overall Study|Protocol Violation|37|||
38024025|NCT00005044|69707427|FG001|Overall Study|Protocol Violation|46|||
38024026|NCT00005044|69707426|FG000|Overall Study|Withdrawal by Subject|1|||
38024027|NCT00005044|69707427|FG001|Overall Study|Withdrawal by Subject|5|||
38024028|NCT00005044|69707426|FG000|Overall Study|No protocol treatment|0|||
38024029|NCT00005044|69707427|FG001|Overall Study|No protocol treatment|1|||
38024030|NCT03084796|69707439|FG000|Overall Study|Adverse Event|4|||
38024031|NCT03084796|69707440|FG001|Overall Study|Adverse Event|5|||
38024032|NCT03084796|69707441|FG002|Overall Study|Adverse Event|6|||
37915170|NCT00598832|69601853|FG001|Overall Study|Protocol Violation|2|||
37915171|NCT00598832|69601852|FG000|Overall Study|Lost to Follow-up|24|||
38024033|NCT03084796|69707442|FG003|Overall Study|Adverse Event|2|||
37915172|NCT00598832|69601853|FG001|Overall Study|Lost to Follow-up|29|||
37706103|NCT02284373|69183953|FG001|Overall Study|Other|1|||
37706104|NCT02284373|69183954|FG002|Overall Study|Other|0|||
37706105|NCT02284373|69183952|FG000|Overall Study|Lost to Follow-up|0|||
37706106|NCT02284373|69183953|FG001|Overall Study|Lost to Follow-up|1|||
37706107|NCT02284373|69183954|FG002|Overall Study|Lost to Follow-up|0|||
37706108|NCT01632241|69183964|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
37706109|NCT01632241|69183965|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
37706110|NCT01632241|69183964|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
37706111|NCT01632241|69183965|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
37706112|NCT01632241|69183964|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
37706113|NCT01632241|69183965|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
37706114|NCT01632241|69183964|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
37706115|NCT01632241|69183965|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
37706116|NCT01632241|69183964|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
37706117|NCT01632241|69183965|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
37706118|NCT01632241|69183964|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
37706119|NCT01632241|69183965|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
37706120|NCT01632241|69183964|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
37706121|NCT01632241|69183965|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
37706122|NCT01632241|69183964|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
37706123|NCT01632241|69183965|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
37706124|NCT01632241|69183964|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
37706125|NCT01632241|69183965|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
37706126|NCT01632241|69183964|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
37706127|NCT01632241|69183965|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
37706128|NCT01632241|69183964|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
37706129|NCT01632241|69183965|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
37706130|NCT01632241|69183964|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
37706131|NCT01632241|69183965|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
37706132|NCT01632241|69183964|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
37706133|NCT01632241|69183965|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
37706134|NCT01632241|69183964|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
37706135|NCT01632241|69183965|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
37706136|NCT02263508|69183980|FG000|Overall Study|Withdrawal by Subject|1|||
37706137|NCT02263508|69183981|FG001|Overall Study|Withdrawal by Subject|23|||
37706138|NCT02263508|69183982|FG002|Overall Study|Withdrawal by Subject|17|||
37706139|NCT02263508|69183980|FG000|Overall Study|Sponsor Decision|12|||
37706140|NCT02263508|69183981|FG001|Overall Study|Sponsor Decision|165|||
37706141|NCT02263508|69183982|FG002|Overall Study|Sponsor Decision|182|||
37706142|NCT02263508|69183980|FG000|Overall Study|Lost to Follow-up|2|||
37706143|NCT02263508|69183981|FG001|Overall Study|Lost to Follow-up|7|||
37706144|NCT02263508|69183982|FG002|Overall Study|Lost to Follow-up|7|||
37706145|NCT02263508|69183980|FG000|Overall Study|Death|6|||
37706146|NCT02263508|69183981|FG001|Overall Study|Death|151|||
37706147|NCT02263508|69183982|FG002|Overall Study|Death|140|||
37706148|NCT02291432|69183993|FG000|Overall Study|Withdrawal by Subject|2|||
37706149|NCT02290340|69184001|FG000|Overall Study|Lost to Follow-up|0|||
37706150|NCT02290340|69184002|FG001|Overall Study|Lost to Follow-up|0|||
37706151|NCT02290340|69184003|FG002|Overall Study|Lost to Follow-up|0|||
37706152|NCT02290340|69184004|FG003|Overall Study|Lost to Follow-up|1|||
37706153|NCT02290340|69184001|FG000|Overall Study|Withdrawal by Subject|1|||
37706154|NCT02290340|69184002|FG001|Overall Study|Withdrawal by Subject|0|||
37706155|NCT02290340|69184003|FG002|Overall Study|Withdrawal by Subject|0|||
37706156|NCT02290340|69184004|FG003|Overall Study|Withdrawal by Subject|0|||
37706157|NCT02290340|69184001|FG000|Overall Study|Other|1|||
37706158|NCT02290340|69184002|FG001|Overall Study|Other|0|||
37706159|NCT02290340|69184003|FG002|Overall Study|Other|0|||
37915173|NCT00598832|69601852|FG000|Overall Study|Pregnancy|2|||
38024034|NCT03084796|69707443|FG004|Overall Study|Adverse Event|3|||
37706160|NCT02290340|69184004|FG003|Overall Study|Other|1|||
37706161|NCT02290028|69184017|FG000|Overall Study|Death|217|||
37706162|NCT02290028|69184017|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
37706163|NCT02290028|69184017|FG000|Overall Study|No longer under care of study physician|76|||
37706164|NCT02290028|69184017|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
37706165|NCT02290028|69184017|FG000|Overall Study|Withdrawal by Subject|52|||
37706166|NCT02290028|69184017|FG000|Overall Study|Study site closure|44|||
37706167|NCT02290028|69184017|FG000|Overall Study|Lost to Follow-up|34|||
37706168|NCT02290028|69184017|FG000|Overall Study|Miscellaneous|10|||
37706169|NCT02290028|69184017|FG000|Overall Study|Transition to EP PASSION|1295|||
37706170|NCT02290028|69184017|FG000|Overall Study|Planned study completion at 12 months|257|||
37706171|NCT01741792|69184027|FG000|Overall Study|Death|6|||
37706172|NCT01741792|69184028|FG001|Overall Study|Death|1|||
37706173|NCT01741792|69184029|FG002|Overall Study|Death|12|||
37837548|NCT01152190|69521996|FG000|Overall Study|Adverse Event|2|||
37706174|NCT02289950|69184045|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
37706175|NCT02289950|69184046|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
37706176|NCT02289950|69184045|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
37706177|NCT02289950|69184046|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
37706178|NCT02289950|69184045|FG000|Overall Study|Lost to Follow-up|1|||
37706179|NCT02289950|69184046|FG001|Overall Study|Lost to Follow-up|0|||
37706180|NCT02289950|69184045|FG000|Overall Study|Physician Decision|9|||
37706181|NCT02289950|69184046|FG001|Overall Study|Physician Decision|3|||
37706182|NCT02289950|69184045|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
37706183|NCT02289950|69184046|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
37706184|NCT02289950|69184045|FG000|Overall Study|Withdrawal by Subject|1|||
37706185|NCT02289950|69184046|FG001|Overall Study|Withdrawal by Subject|3|||
37706186|NCT02289950|69184045|FG000|Overall Study|Test article held for greater than 28 days|0|||
37706187|NCT02289950|69184046|FG001|Overall Study|Test article held for greater than 28 days|1|||
37706188|NCT02289950|69184045|FG000|Overall Study|Adverse Event|11|||
37706189|NCT02289950|69184046|FG001|Overall Study|Adverse Event|3|||
37706190|NCT02289950|69184045|FG000|Overall Study|Death|1|||
37706191|NCT02289950|69184046|FG001|Overall Study|Death|1|||
37706192|NCT02289950|69184045|FG000|Overall Study|Other|5|||
37706193|NCT02289950|69184046|FG001|Overall Study|Other|2|||
37706194|NCT02289950|69184045|FG000|Overall Study|Not Treated|2|||
37706195|NCT02289950|69184046|FG001|Overall Study|Not Treated|1|||
37706196|NCT01741012|69184052|FG000|Overall Study|Lost to Follow-up|1|||
37706197|NCT01741012|69184052|FG000|Overall Study|Withdrawal by Subject|2|||
37706198|NCT02288312|69184060|FG000|Overall Study|Pregnancy|1|||
37706199|NCT02288312|69184061|FG001|Overall Study|Pregnancy|0|||
37706200|NCT02288312|69184062|FG002|Overall Study|Pregnancy|0|||
37706201|NCT01740388|69184072|FG000|Overall Study|Withdrawal by Subject|1|||
37706202|NCT01740388|69184073|FG001|Overall Study|Withdrawal by Subject|2|||
37706203|NCT01740388|69184072|FG000|Overall Study|Lost to Follow-up|2|||
37706204|NCT01740388|69184073|FG001|Overall Study|Lost to Follow-up|0|||
37706205|NCT01740388|69184072|FG000|Overall Study|Physician Decision|2|||
37706206|NCT01740388|69184073|FG001|Overall Study|Physician Decision|6|||
37706207|NCT01740388|69184072|FG000|Overall Study|Subjects missing data, completed|41|||
37706208|NCT01740388|69184073|FG001|Overall Study|Subjects missing data, completed|36|||
37706209|NCT01740154|69184079|FG000|Overall Study|Adverse Event|1|||
37706210|NCT02287922|69184087|FG000|Overall Study|Adverse Event|1|||
37706211|NCT02287922|69184088|FG001|Overall Study|Adverse Event|1|||
37706212|NCT02287922|69184089|FG002|Overall Study|Adverse Event|3|||
37706213|NCT02287922|69184090|FG003|Overall Study|Adverse Event|4|||
37706214|NCT02287922|69184087|FG000|Overall Study|Withdrawal by Subject|1|||
37706215|NCT02287922|69184088|FG001|Overall Study|Withdrawal by Subject|1|||
37706216|NCT02287922|69184089|FG002|Overall Study|Withdrawal by Subject|1|||
37706217|NCT02287922|69184090|FG003|Overall Study|Withdrawal by Subject|2|||
37706218|NCT02287922|69184087|FG000|Overall Study|Lost to Follow-up|0|||
37706219|NCT02287922|69184088|FG001|Overall Study|Lost to Follow-up|0|||
37706220|NCT02287922|69184089|FG002|Overall Study|Lost to Follow-up|1|||
37706221|NCT02287922|69184090|FG003|Overall Study|Lost to Follow-up|0|||
37706222|NCT02287922|69184087|FG000|Overall Study|Sponsor's decision|0|||
37706223|NCT02287922|69184088|FG001|Overall Study|Sponsor's decision|0|||
37706224|NCT02287922|69184089|FG002|Overall Study|Sponsor's decision|0|||
37706225|NCT02287922|69184090|FG003|Overall Study|Sponsor's decision|1|||
37706226|NCT02287922|69184087|FG000|Overall Study|Other|1|||
37706227|NCT02287922|69184088|FG001|Overall Study|Other|0|||
37706228|NCT02287922|69184089|FG002|Overall Study|Other|2|||
37706229|NCT02287922|69184090|FG003|Overall Study|Other|0|||
37706230|NCT02287610|69184101|FG000|Overall Study|Lost to Follow-up|3|||
37706231|NCT02287610|69184101|FG000|Overall Study|Withdrawal by Subject|8|||
37706232|NCT02287610|69184101|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
37706233|NCT02262728|69184107|FG000|Follow-up Phase (3 Years)|Death|0|||
37706234|NCT02262728|69184108|FG001|Follow-up Phase (3 Years)|Death|1|||
37706235|NCT02262728|69184107|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
37706236|NCT02262728|69184108|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
37706237|NCT02262728|69184107|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
37706238|NCT02262728|69184108|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
37706239|NCT02262260|69184116|FG000|Overall Study|Adverse Event|4|||
37706240|NCT02262260|69184117|FG001|Overall Study|Adverse Event|1|||
37706241|NCT02262260|69184116|FG000|Overall Study|Withdrawal of consent|4|||
37706242|NCT02262260|69184117|FG001|Overall Study|Withdrawal of consent|2|||
37706243|NCT02262260|69184116|FG000|Overall Study|Lost to Follow-up|1|||
37706244|NCT02262260|69184117|FG001|Overall Study|Lost to Follow-up|2|||
37706245|NCT02262260|69184116|FG000|Overall Study|Protocol deviation|2|||
37706246|NCT02262260|69184117|FG001|Overall Study|Protocol deviation|5|||
37706247|NCT02285270|69184123|FG000|Overall Study|Lost to Follow-up|1|||
37706248|NCT02285270|69184123|FG000|Overall Study|Physician Decision|3|||
37706249|NCT02285270|69184123|FG000|Overall Study|Determined to be ineligible|1|||
37706250|NCT01717768|69184137|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
37706251|NCT01717768|69184138|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
37706252|NCT01717768|69184139|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
37706253|NCT01717768|69184140|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
37706254|NCT01717768|69184141|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
37706255|NCT01717768|69184142|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
37706256|NCT01717768|69184143|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
37706257|NCT01717768|69184144|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
37706258|NCT01717768|69184145|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
37706259|NCT01717768|69184146|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
37706260|NCT01717768|69184147|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
37706261|NCT01717768|69184148|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
37837549|NCT01152190|69521997|FG001|Overall Study|Adverse Event|4|||
37837550|NCT01152190|69521996|FG000|Overall Study|Death|1|||
37915174|NCT00598832|69601853|FG001|Overall Study|Pregnancy|2|||
37915175|NCT00598832|69601852|FG000|Overall Study|Physician Decision|1|||
37915176|NCT00598832|69601853|FG001|Overall Study|Physician Decision|4|||
37915177|NCT00598832|69601852|FG000|Overall Study|Non compliance|1|||
37915178|NCT00598832|69601853|FG001|Overall Study|Non compliance|0|||
37915179|NCT00853593|69601859|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
37915180|NCT00853593|69601859|FG000|Overall Study|Model 4396 lead not attempted|29|||
37915181|NCT00853593|69601859|FG000|Overall Study|Implant not attempted|4|||
37915182|NCT00853125|69601880|FG000|Overall Study|Study participant's donor was CMV +|1|||
37915183|NCT00530023|69601887|FG000|Overall Study|Withdrawal by Subject|0|||
37915184|NCT00530023|69601888|FG001|Overall Study|Withdrawal by Subject|1|||
37915185|NCT00529087|69601897|FG000|Overall Study|Adverse Event|10|||
37837551|NCT01152190|69521997|FG001|Overall Study|Death|0|||
37837552|NCT01152190|69521996|FG000|Overall Study|Protocol Violation|1|||
37915186|NCT00529087|69601898|FG001|Overall Study|Adverse Event|13|||
37915187|NCT00529087|69601899|FG002|Overall Study|Adverse Event|4|||
37837553|NCT01152190|69521997|FG001|Overall Study|Protocol Violation|1|||
37837554|NCT01152190|69521996|FG000|Overall Study|Withdrawal by Subject|1|||
37837555|NCT01152190|69521997|FG001|Overall Study|Withdrawal by Subject|3|||
37837556|NCT01151410|69522005|FG000|Overall Study|Withdrawal by Subject|3|||
37837557|NCT01151410|69522006|FG001|Overall Study|Withdrawal by Subject|5|||
37837558|NCT01151410|69522005|FG000|Overall Study|Lost to Follow-up|3|||
37706262|NCT01717768|69184137|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
37706263|NCT01717768|69184138|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
37706264|NCT01717768|69184139|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
37706265|NCT01717768|69184140|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
37706266|NCT01717768|69184141|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
37837559|NCT01151410|69522006|FG001|Overall Study|Lost to Follow-up|4|||
37837560|NCT01151410|69522005|FG000|Overall Study|Adverse Event|1|||
37915188|NCT00529087|69601897|FG000|Overall Study|Lost to Follow-up|6|||
37915189|NCT00529087|69601898|FG001|Overall Study|Lost to Follow-up|4|||
37915190|NCT00529087|69601899|FG002|Overall Study|Lost to Follow-up|1|||
37915191|NCT00529087|69601897|FG000|Overall Study|Protocol Violation|8|||
37915192|NCT00529087|69601898|FG001|Overall Study|Protocol Violation|7|||
37915193|NCT00529087|69601899|FG002|Overall Study|Protocol Violation|6|||
37915194|NCT00529087|69601897|FG000|Overall Study|Withdrawal by Subject|3|||
37915195|NCT00529087|69601898|FG001|Overall Study|Withdrawal by Subject|3|||
37915196|NCT00529087|69601899|FG002|Overall Study|Withdrawal by Subject|3|||
37915197|NCT00529087|69601897|FG000|Overall Study|Protocol deviation|1|||
37915198|NCT00529087|69601898|FG001|Overall Study|Protocol deviation|1|||
37915199|NCT00529087|69601899|FG002|Overall Study|Protocol deviation|2|||
37915200|NCT00870870|69601934|FG000|Overall Study|Withdrawal by Subject|0|||
37915201|NCT00870870|69601935|FG001|Overall Study|Withdrawal by Subject|1|||
37915202|NCT00870870|69601936|FG002|Overall Study|Withdrawal by Subject|1|||
37915203|NCT00870870|69601937|FG003|Overall Study|Withdrawal by Subject|3|||
37915204|NCT00870870|69601934|FG000|Overall Study|Adverse Event|0|||
37915205|NCT00870870|69601935|FG001|Overall Study|Adverse Event|0|||
37915206|NCT00870870|69601936|FG002|Overall Study|Adverse Event|2|||
37915207|NCT00870870|69601937|FG003|Overall Study|Adverse Event|2|||
37915208|NCT03877237|69601954|FG000|Overall Study|Adverse Event|1|||
37915209|NCT03877237|69601955|FG001|Overall Study|Adverse Event|2|||
37915210|NCT03877237|69601954|FG000|Overall Study|Death|3|||
37915211|NCT03877237|69601955|FG001|Overall Study|Death|2|||
37915212|NCT03877237|69601954|FG000|Overall Study|Physician Decision|1|||
37915213|NCT03877237|69601955|FG001|Overall Study|Physician Decision|0|||
37915214|NCT03877237|69601954|FG000|Overall Study|Withdrawal by Subject|0|||
37915215|NCT03877237|69601955|FG001|Overall Study|Withdrawal by Subject|2|||
37915216|NCT00528931|69601961|FG000|Overall Study|Lost to Follow-up|1|||
37915217|NCT00866814|69601966|FG000|Overall Study|Lost to Follow-up|12|||
37915218|NCT00866814|69601966|FG000|Overall Study|Adverse Event|2|||
37915219|NCT00866814|69601966|FG000|Overall Study|Physician Decision|1|||
37915220|NCT00866814|69601966|FG000|Overall Study|Death|1|||
37915221|NCT00866814|69601966|FG000|Overall Study|No longer wished to participate|1|||
37915222|NCT00866814|69601966|FG000|Overall Study|Unable to meet follow-up requirements|2|||
37915223|NCT00866814|69601966|FG000|Overall Study|Moved to area without study site|1|||
37915224|NCT00871494|69601970|FG000|Overall Study|Protocol Violation|5|||
37915225|NCT00871494|69601970|FG000|Overall Study|Lack of Efficacy|4|||
37915226|NCT00871494|69601970|FG000|Overall Study|Adverse Event|4|||
37915227|NCT00871494|69601970|FG000|Overall Study|Lost to Follow-up|1|||
37915228|NCT00529789|69601974|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
37915229|NCT00529789|69601974|FG000|Study Period II/III|Adverse Event|3|||
37915230|NCT00529789|69601974|FG000|Study Period II/III|Lack of Efficacy|2|||
37915231|NCT00529789|69601974|FG000|Study Period II/III|Withdrawal by Subject|1|||
37915232|NCT00529789|69601974|FG000|Study Period II/III|Protocol Violation|3|||
37915233|NCT00529789|69601974|FG000|Study Period II/III|Physician Decision|3|||
37915234|NCT00529789|69601974|FG000|Study Period II/III|Lost to Follow-up|3|||
37915235|NCT00529789|69601974|FG000|Study Period IV|Parent/Caregiver Decision|1|||
37915236|NCT00529789|69601974|FG000|Study Period IV|Adverse Event|1|||
37915237|NCT00529789|69601974|FG000|Study Period IV|Lack of Efficacy|1|||
37915238|NCT00529789|69601974|FG000|Study Period IV|Lost to Follow-up|3|||
37915239|NCT00577642|69601984|FG000|Overall Study|Clinical Disease Progression|1|||
37915240|NCT00866658|69601990|FG000|Overall Study|Adverse Event|5|||
38024035|NCT03084796|69707444|FG005|Overall Study|Adverse Event|5|||
38024036|NCT03084796|69707439|FG000|Overall Study|Withdrawal by Subject|3|||
38024037|NCT03084796|69707440|FG001|Overall Study|Withdrawal by Subject|5|||
38024038|NCT03084796|69707441|FG002|Overall Study|Withdrawal by Subject|2|||
37837561|NCT01151410|69522006|FG001|Overall Study|Adverse Event|2|||
37837562|NCT01151410|69522005|FG000|Overall Study|Protocol deviation|2|||
37837563|NCT01151410|69522006|FG001|Overall Study|Protocol deviation|1|||
37837564|NCT01151410|69522005|FG000|Overall Study|Administrative problems|1|||
37837565|NCT01151410|69522006|FG001|Overall Study|Administrative problems|1|||
37837566|NCT01151410|69522005|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
37837567|NCT01151410|69522006|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
37837568|NCT01151410|69522005|FG000|Overall Study|Abnormal laboratory value(s)|0|||
37837569|NCT01151410|69522006|FG001|Overall Study|Abnormal laboratory value(s)|1|||
37915241|NCT00866658|69601991|FG001|Overall Study|Adverse Event|14|||
38024039|NCT03084796|69707442|FG003|Overall Study|Withdrawal by Subject|1|||
38024040|NCT03084796|69707443|FG004|Overall Study|Withdrawal by Subject|3|||
37915242|NCT00866658|69601990|FG000|Overall Study|Lack of Efficacy|2|||
37915243|NCT00866658|69601991|FG001|Overall Study|Lack of Efficacy|1|||
37915244|NCT00866658|69601990|FG000|Overall Study|Withdrawal by Subject|1|||
37915245|NCT00866658|69601991|FG001|Overall Study|Withdrawal by Subject|0|||
37915246|NCT00866658|69601990|FG000|Overall Study|Protocol Violation|1|||
37915247|NCT00866658|69601991|FG001|Overall Study|Protocol Violation|1|||
37915248|NCT00866658|69601990|FG000|Overall Study|Familial and Personal Reasons|4|||
37915249|NCT00866658|69601991|FG001|Overall Study|Familial and Personal Reasons|5|||
37915250|NCT00597584|69601999|FG000|Overall Study|Adverse Event|4|||
37915251|NCT00597584|69602000|FG001|Overall Study|Adverse Event|2|||
37915252|NCT00597584|69601999|FG000|Overall Study|Death|53|||
37706267|NCT01717768|69184142|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
37706268|NCT01717768|69184143|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
37706269|NCT01717768|69184144|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
37706270|NCT01717768|69184145|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
37706271|NCT01717768|69184146|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
37706272|NCT01717768|69184147|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
37706273|NCT01717768|69184148|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
37706274|NCT01717768|69184137|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
37706275|NCT01717768|69184138|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
37706276|NCT01717768|69184139|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
37706277|NCT01717768|69184140|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
37706278|NCT01717768|69184141|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
37706279|NCT01717768|69184142|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
37706280|NCT01717768|69184143|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
37706281|NCT01717768|69184144|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
37706282|NCT01717768|69184145|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
37706283|NCT01717768|69184146|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
37706284|NCT01717768|69184147|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
37706285|NCT01717768|69184148|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
37706286|NCT01717768|69184137|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
37706287|NCT01717768|69184138|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
37706288|NCT01717768|69184139|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
37706289|NCT01717768|69184140|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
37706290|NCT01717768|69184141|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
37706291|NCT01717768|69184142|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
37706292|NCT01717768|69184143|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
37706293|NCT01717768|69184144|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
37706294|NCT01717768|69184145|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
37706295|NCT01717768|69184146|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
37915253|NCT00597584|69602000|FG001|Overall Study|Death|30|||
37706296|NCT01717768|69184147|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
37706297|NCT01717768|69184148|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
37706298|NCT02260934|69184176|FG000|Overall Study|Lost to Follow-up|2|||
37706299|NCT02260934|69184177|FG001|Overall Study|Lost to Follow-up|1|||
37706300|NCT02260934|69184176|FG000|Overall Study|Withdrawal by Subject|0|||
37706301|NCT02260934|69184177|FG001|Overall Study|Withdrawal by Subject|2|||
37706302|NCT02260934|69184176|FG000|Overall Study|Participant Relocated|1|||
37706303|NCT02260934|69184177|FG001|Overall Study|Participant Relocated|0|||
37706304|NCT02260934|69184176|FG000|Overall Study|Site error|0|||
37706305|NCT02260934|69184177|FG001|Overall Study|Site error|1|||
37706306|NCT02260388|69184194|FG000|Overall Study|Lost to Follow-up|2|||
37706307|NCT02260388|69184195|FG001|Overall Study|Lost to Follow-up|8|||
37706308|NCT02260388|69184196|FG002|Overall Study|Lost to Follow-up|3|||
37706309|NCT02260388|69184197|FG003|Overall Study|Lost to Follow-up|4|||
37706310|NCT02260154|69184207|FG000|Overall Study|Screening failure|2|||
37706311|NCT02284178|69184214|FG000|Overall Study|Met exclusion criteria|49|||
37706312|NCT02284178|69184215|FG001|Overall Study|Met exclusion criteria|54|||
37706313|NCT01643408|69184221|FG000|Overall Study|Adverse Event|12|||
37706314|NCT01643408|69184221|FG000|Overall Study|Other|2|||
37706315|NCT02283788|69184229|FG000|Overall Study|Adverse Event|1|||
37706316|NCT02283788|69184230|FG001|Overall Study|Adverse Event|3|||
37706317|NCT02283788|69184231|FG002|Overall Study|Adverse Event|5|||
37706318|NCT02283788|69184232|FG003|Overall Study|Adverse Event|1|||
37706319|NCT02283788|69184229|FG000|Overall Study|Withdrawal by Subject|0|||
37706320|NCT02283788|69184230|FG001|Overall Study|Withdrawal by Subject|1|||
37706321|NCT02283788|69184231|FG002|Overall Study|Withdrawal by Subject|0|||
37706322|NCT02283788|69184232|FG003|Overall Study|Withdrawal by Subject|1|||
37706323|NCT01739764|69184245|FG000|Overall Study|Adverse Event|0|||
37706324|NCT01739764|69184246|FG001|Overall Study|Adverse Event|3|||
37706325|NCT01739764|69184247|FG002|Overall Study|Adverse Event|4|||
37706326|NCT01739764|69184245|FG000|Overall Study|Death|4|||
37706327|NCT01739764|69184246|FG001|Overall Study|Death|6|||
37706328|NCT01739764|69184247|FG002|Overall Study|Death|38|||
37706329|NCT01739764|69184245|FG000|Overall Study|Lost to Follow-up|0|||
37706330|NCT01739764|69184246|FG001|Overall Study|Lost to Follow-up|0|||
37706331|NCT01739764|69184247|FG002|Overall Study|Lost to Follow-up|5|||
37706332|NCT01739764|69184245|FG000|Overall Study|Non-Compliance|0|||
37706333|NCT01739764|69184246|FG001|Overall Study|Non-Compliance|0|||
37706334|NCT01739764|69184247|FG002|Overall Study|Non-Compliance|1|||
37706335|NCT01739764|69184245|FG000|Overall Study|Multiple Reasons|3|||
37706336|NCT01739764|69184246|FG001|Overall Study|Multiple Reasons|2|||
37706337|NCT01739764|69184247|FG002|Overall Study|Multiple Reasons|3|||
37706338|NCT01739764|69184245|FG000|Overall Study|Physician Decision|2|||
37706339|NCT01739764|69184246|FG001|Overall Study|Physician Decision|2|||
37706340|NCT01739764|69184247|FG002|Overall Study|Physician Decision|4|||
37706341|NCT01739764|69184245|FG000|Overall Study|Progressive Disease|3|||
37706342|NCT01739764|69184246|FG001|Overall Study|Progressive Disease|5|||
37706343|NCT01739764|69184247|FG002|Overall Study|Progressive Disease|16|||
37706344|NCT01739764|69184245|FG000|Overall Study|Protocol Violation|0|||
37706345|NCT01739764|69184246|FG001|Overall Study|Protocol Violation|0|||
37706346|NCT01739764|69184247|FG002|Overall Study|Protocol Violation|2|||
37706347|NCT01739764|69184245|FG000|Overall Study|Study Terminated by Sponsor|8|||
37706348|NCT01739764|69184246|FG001|Overall Study|Study Terminated by Sponsor|13|||
37706349|NCT01739764|69184247|FG002|Overall Study|Study Terminated by Sponsor|26|||
37706350|NCT01739764|69184245|FG000|Overall Study|Withdrawal by Subject|6|||
37706351|NCT01739764|69184246|FG001|Overall Study|Withdrawal by Subject|5|||
37706352|NCT01739764|69184247|FG002|Overall Study|Withdrawal by Subject|27|||
37706353|NCT01700530|69184258|FG000|Overall Study|Withdrawal by Subject|0|||
37706354|NCT01700530|69184259|FG001|Overall Study|Withdrawal by Subject|3|||
37706355|NCT01700530|69184260|FG002|Overall Study|Withdrawal by Subject|1|||
37837570|NCT01151215|69522015|FG000|Overall Study|Worsening of condition under study|1|||
37837571|NCT01151215|69522016|FG001|Overall Study|Worsening of condition under study|1|||
37706356|NCT01700140|69184271|FG000|Overall Study|Use of rescue drugs|3|||
37706357|NCT01700140|69184272|FG001|Overall Study|Use of rescue drugs|3|||
37837572|NCT01151215|69522017|FG002|Overall Study|Worsening of condition under study|1|||
37837573|NCT01151215|69522015|FG000|Overall Study|Death|16|||
37706358|NCT01700140|69184273|FG002|Overall Study|Use of rescue drugs|1|||
37706359|NCT01700140|69184271|FG000|Overall Study|Discontinuation of radiotherapy|1|||
37706360|NCT01700140|69184272|FG001|Overall Study|Discontinuation of radiotherapy|0|||
37706361|NCT01700140|69184273|FG002|Overall Study|Discontinuation of radiotherapy|0|||
37706362|NCT01700140|69184271|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
37706363|NCT01700140|69184272|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
37706364|NCT01700140|69184273|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
37706365|NCT01700140|69184271|FG000|Overall Study|Aggravation of symptoms|1|||
37706366|NCT01700140|69184272|FG001|Overall Study|Aggravation of symptoms|0|||
37837574|NCT01151215|69522016|FG001|Overall Study|Death|20|||
37706367|NCT01700140|69184273|FG002|Overall Study|Aggravation of symptoms|0|||
37706368|NCT01700140|69184271|FG000|Overall Study|Adverse Event|0|||
37706369|NCT01700140|69184272|FG001|Overall Study|Adverse Event|1|||
37706370|NCT01700140|69184273|FG002|Overall Study|Adverse Event|0|||
37706371|NCT01700140|69184271|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
37706372|NCT01700140|69184272|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
37706373|NCT01700140|69184273|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
37706374|NCT01717456|69184286|FG000|End of Treatment|Physician Decision|0|||
37706375|NCT01717456|69184287|FG001|End of Treatment|Physician Decision|1|||
37706376|NCT01717456|69184286|FG000|End of Treatment|Lost to Follow-up|0|||
37706377|NCT01717456|69184287|FG001|End of Treatment|Lost to Follow-up|1|||
37706378|NCT01717456|69184286|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
37706379|NCT01717456|69184287|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
37706380|NCT01699750|69184296|FG000|Overall Study|Withdrew Consent|0|||
37706381|NCT01699750|69184297|FG001|Overall Study|Withdrew Consent|1|||
37706382|NCT01699750|69184296|FG000|Overall Study|Other|0|||
37706383|NCT01699750|69184297|FG001|Overall Study|Other|2|||
37706384|NCT01716754|69184311|FG000|Overall Study|Death|0|||
37706385|NCT01716754|69184312|FG001|Overall Study|Death|0|||
37706386|NCT01716754|69184313|FG002|Overall Study|Death|0|||
37706387|NCT01716754|69184314|FG003|Overall Study|Death|1|||
37706388|NCT01716754|69184311|FG000|Overall Study|Protocol deviation|0|||
37706389|NCT01716754|69184312|FG001|Overall Study|Protocol deviation|2|||
37706390|NCT01716754|69184313|FG002|Overall Study|Protocol deviation|7|||
37706391|NCT01716754|69184314|FG003|Overall Study|Protocol deviation|2|||
37706392|NCT01716754|69184311|FG000|Overall Study|Non-compliance with study treatment|0|||
37706393|NCT01716754|69184312|FG001|Overall Study|Non-compliance with study treatment|0|||
37706394|NCT01716754|69184313|FG002|Overall Study|Non-compliance with study treatment|1|||
37706395|NCT01716754|69184314|FG003|Overall Study|Non-compliance with study treatment|0|||
37706396|NCT01716754|69184311|FG000|Overall Study|Physician Decision|1|||
37706397|NCT01716754|69184312|FG001|Overall Study|Physician Decision|0|||
37706398|NCT01716754|69184313|FG002|Overall Study|Physician Decision|0|||
37706399|NCT01716754|69184314|FG003|Overall Study|Physician Decision|0|||
37706400|NCT01716754|69184311|FG000|Overall Study|Lost to Follow-up|1|||
37706401|NCT01716754|69184312|FG001|Overall Study|Lost to Follow-up|0|||
37706402|NCT01716754|69184313|FG002|Overall Study|Lost to Follow-up|0|||
37706403|NCT01716754|69184314|FG003|Overall Study|Lost to Follow-up|1|||
37706404|NCT01716754|69184311|FG000|Overall Study|Adverse Event|4|||
37706405|NCT01716754|69184312|FG001|Overall Study|Adverse Event|2|||
37706406|NCT01716754|69184313|FG002|Overall Study|Adverse Event|2|||
37706407|NCT01716754|69184314|FG003|Overall Study|Adverse Event|1|||
37706408|NCT01716754|69184311|FG000|Overall Study|Withdrawal by Subject|5|||
37706409|NCT01716754|69184312|FG001|Overall Study|Withdrawal by Subject|0|||
37706410|NCT01716754|69184313|FG002|Overall Study|Withdrawal by Subject|4|||
37706411|NCT01716754|69184314|FG003|Overall Study|Withdrawal by Subject|3|||
37706412|NCT01698814|69184325|FG000|Overall Study|Adverse Event|0|||
37706413|NCT01698814|69184326|FG001|Overall Study|Adverse Event|2|||
37706414|NCT01698814|69184325|FG000|Overall Study|Lost to Follow-up|0|||
37706415|NCT01698814|69184326|FG001|Overall Study|Lost to Follow-up|1|||
37706416|NCT01698814|69184325|FG000|Overall Study|Pregnancy|1|||
37706417|NCT01698814|69184326|FG001|Overall Study|Pregnancy|0|||
37706418|NCT01698814|69184325|FG000|Overall Study|Randomized in error|1|||
37706419|NCT01698814|69184326|FG001|Overall Study|Randomized in error|0|||
37706420|NCT01738984|69184334|FG000|Overall Study|Pregnancy|4|||
37706421|NCT01738984|69184335|FG001|Overall Study|Pregnancy|0|||
37706422|NCT01738984|69184334|FG000|Overall Study|Withdrawal by Subject|1|||
37706423|NCT01738984|69184335|FG001|Overall Study|Withdrawal by Subject|0|||
37706424|NCT01738984|69184334|FG000|Overall Study|Lost to Follow-up|59|||
37706425|NCT01738984|69184335|FG001|Overall Study|Lost to Follow-up|39|||
37706426|NCT01738594|69184344|FG000|Registration and Treatment Start|Adverse Event|0|||
37706427|NCT01738594|69184345|FG001|Registration and Treatment Start|Adverse Event|1|||
37706428|NCT01738594|69184346|FG002|Registration and Treatment Start|Adverse Event|0|||
38024041|NCT03084796|69707444|FG005|Overall Study|Withdrawal by Subject|0|||
37706429|NCT01738594|69184347|FG003|Registration and Treatment Start|Adverse Event|0|||
37706430|NCT01738594|69184348|FG004|Registration and Treatment Start|Adverse Event|0|||
38024042|NCT03084796|69707439|FG000|Overall Study|Protocol Violation|0|||
38024043|NCT03084796|69707440|FG001|Overall Study|Protocol Violation|0|||
38024044|NCT03084796|69707441|FG002|Overall Study|Protocol Violation|1|||
37706431|NCT01738594|69184349|FG005|Registration and Treatment Start|Adverse Event|0|||
37706432|NCT01738594|69184350|FG006|Registration and Treatment Start|Adverse Event|0|||
37706433|NCT01738594|69184351|FG007|Registration and Treatment Start|Adverse Event|0|||
37706434|NCT01738594|69184344|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
37706435|NCT01738594|69184345|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
37706436|NCT01738594|69184346|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
37706437|NCT01738594|69184347|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
37837575|NCT01151215|69522017|FG002|Overall Study|Death|11|||
37706438|NCT01738594|69184348|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
37706439|NCT01738594|69184349|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
37706440|NCT01738594|69184350|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
37706441|NCT01738594|69184351|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
37706442|NCT01738594|69184344|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
37837576|NCT01151215|69522015|FG000|Overall Study|Lost to Follow-up|0|||
37837577|NCT01151215|69522016|FG001|Overall Study|Lost to Follow-up|0|||
37837578|NCT01151215|69522017|FG002|Overall Study|Lost to Follow-up|3|||
37837579|NCT01151215|69522015|FG000|Overall Study|Withdrawal by Subject|3|||
37837580|NCT01151215|69522016|FG001|Overall Study|Withdrawal by Subject|1|||
37837581|NCT01151215|69522017|FG002|Overall Study|Withdrawal by Subject|2|||
37837582|NCT01151215|69522015|FG000|Overall Study|Disease progression|0|||
37837583|NCT01151215|69522016|FG001|Overall Study|Disease progression|1|||
37837584|NCT01151215|69522017|FG002|Overall Study|Disease progression|1|||
37837585|NCT01151215|69522015|FG000|Overall Study|Safety as judged by the investigator|0|||
37837586|NCT01151215|69522016|FG001|Overall Study|Safety as judged by the investigator|0|||
37837587|NCT01151215|69522017|FG002|Overall Study|Safety as judged by the investigator|1|||
37837588|NCT01151137|69522027|FG000|Overall Study|Death|15|||
37837589|NCT01151137|69522028|FG001|Overall Study|Death|27|||
37837590|NCT01151137|69522027|FG000|Overall Study|Lost to Follow-up|1|||
37837591|NCT01151137|69522028|FG001|Overall Study|Lost to Follow-up|1|||
37837592|NCT01151098|69522034|FG000|Overall Study|Adverse Event|82|||
37837593|NCT01151098|69522034|FG000|Overall Study|Lost to Follow-up|6|||
37837594|NCT01151098|69522034|FG000|Overall Study|Lack of Efficacy|15|||
37837595|NCT01151098|69522034|FG000|Overall Study|Protocol Violation|1|||
37837596|NCT01151098|69522034|FG000|Overall Study|Miscellaneous|13|||
37837597|NCT01151020|69522038|FG000|Overall Study|Death|25|||
37837598|NCT01151020|69522038|FG000|Overall Study|Conversion to open repair|1|||
37837599|NCT01151020|69522038|FG000|Overall Study|Lost to Follow-up|4|||
37837600|NCT01151020|69522038|FG000|Overall Study|Withdrawal by Subject|22|||
37837601|NCT01151020|69522038|FG000|Overall Study|Patients did not receive the device|2|||
37837602|NCT01150474|69522044|FG000|Overall Study|Withdrawal by Subject|5|||
37837603|NCT01150474|69522045|FG001|Overall Study|Withdrawal by Subject|2|||
37837604|NCT01150474|69522044|FG000|Overall Study|Cancer found|1|||
37837605|NCT01150474|69522045|FG001|Overall Study|Cancer found|0|||
37837606|NCT01150474|69522044|FG000|Overall Study|Multiple Studies|0|||
37837607|NCT01150474|69522045|FG001|Overall Study|Multiple Studies|1|||
37837608|NCT01150474|69522044|FG000|Overall Study|Rectotomy|1|||
37837609|NCT01150474|69522045|FG001|Overall Study|Rectotomy|0|||
37837610|NCT01150474|69522044|FG000|Overall Study|Drug did not arrive in time|1|||
37837611|NCT01150474|69522045|FG001|Overall Study|Drug did not arrive in time|0|||
37837612|NCT01150474|69522044|FG000|Overall Study|Drug not administered|1|||
37837613|NCT01150474|69522045|FG001|Overall Study|Drug not administered|0|||
37837614|NCT01150474|69522044|FG000|Overall Study|Surgery Changed|1|||
37837615|NCT01150474|69522045|FG001|Overall Study|Surgery Changed|0|||
37837616|NCT01150357|69522054|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
37837617|NCT01150357|69522055|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
37837618|NCT01150357|69522056|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
37837619|NCT01150357|69522054|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
37837620|NCT01150357|69522055|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
37837621|NCT01150357|69522056|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
37837622|NCT01150357|69522054|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
37837623|NCT01150357|69522055|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
37837624|NCT01150357|69522056|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
37837625|NCT01150357|69522054|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
37837626|NCT01150357|69522055|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
37837627|NCT01150357|69522056|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
37837628|NCT01150357|69522054|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
37837629|NCT01150357|69522055|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
37837630|NCT01150357|69522056|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
37837631|NCT01150357|69522054|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
38024045|NCT03084796|69707442|FG003|Overall Study|Protocol Violation|0|||
38024046|NCT03084796|69707443|FG004|Overall Study|Protocol Violation|1|||
37706443|NCT01738594|69184345|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
37837632|NCT01150357|69522055|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
37837633|NCT01150357|69522056|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
37837634|NCT01150357|69522054|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
37837635|NCT01150357|69522055|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
37837636|NCT01150357|69522056|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
37837637|NCT01150123|69522106|FG000|Overall Study|Withdrawal by Subject|1|||
37837638|NCT01150123|69522107|FG001|Overall Study|Withdrawal by Subject|1|||
37706444|NCT01738594|69184346|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
37706445|NCT01738594|69184347|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
37706446|NCT01738594|69184348|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
37706447|NCT01738594|69184349|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
37706448|NCT01738594|69184350|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
37706449|NCT01738594|69184351|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
37706450|NCT01738594|69184344|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
37706451|NCT01738594|69184345|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
37706452|NCT01738594|69184346|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
37706453|NCT01738594|69184347|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
37706454|NCT01738594|69184348|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
37706455|NCT01738594|69184349|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
37706456|NCT01738594|69184350|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
37706457|NCT01738594|69184351|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
37706458|NCT01738594|69184344|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
37706459|NCT01738594|69184345|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
37706460|NCT01738594|69184346|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
37706461|NCT01738594|69184347|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
37706462|NCT01738594|69184348|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
37706463|NCT01738594|69184349|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
37706464|NCT01738594|69184350|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
37706465|NCT01738594|69184351|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
37706466|NCT01738594|69184344|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
37706467|NCT01738594|69184345|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
37706468|NCT01738594|69184346|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
37706469|NCT01738594|69184347|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
37706470|NCT01738594|69184348|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
37706471|NCT01738594|69184349|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
37706472|NCT01738594|69184350|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
37706473|NCT01738594|69184351|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
37706474|NCT01738594|69184344|FG000|Follow up for 1 Year|Death|0|||
37706475|NCT01738594|69184345|FG001|Follow up for 1 Year|Death|0|||
37706476|NCT01738594|69184346|FG002|Follow up for 1 Year|Death|0|||
37706477|NCT01738594|69184347|FG003|Follow up for 1 Year|Death|0|||
37706478|NCT01738594|69184348|FG004|Follow up for 1 Year|Death|0|||
37706479|NCT01738594|69184349|FG005|Follow up for 1 Year|Death|1|||
37706480|NCT01738594|69184350|FG006|Follow up for 1 Year|Death|0|||
37706481|NCT01738594|69184351|FG007|Follow up for 1 Year|Death|0|||
37706482|NCT01738594|69184344|FG000|Follow up for 1 Year|Other|0|||
37706483|NCT01738594|69184345|FG001|Follow up for 1 Year|Other|0|||
37706484|NCT01738594|69184346|FG002|Follow up for 1 Year|Other|0|||
37706485|NCT01738594|69184347|FG003|Follow up for 1 Year|Other|0|||
37706486|NCT01738594|69184348|FG004|Follow up for 1 Year|Other|0|||
37706487|NCT01738594|69184349|FG005|Follow up for 1 Year|Other|2|||
37706488|NCT01738594|69184350|FG006|Follow up for 1 Year|Other|0|||
37706489|NCT01738594|69184351|FG007|Follow up for 1 Year|Other|0|||
37706490|NCT01738438|69184361|FG000|Overall Study|Disease Progression|32|||
37706491|NCT01738438|69184361|FG000|Overall Study|Adverse Event|3|||
37706492|NCT01716520|69184365|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
37706493|NCT01716520|69184366|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
37706494|NCT01716520|69184367|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
37706495|NCT01716520|69184368|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
37706496|NCT01716520|69184369|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
37706497|NCT01716520|69184370|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
37706498|NCT01716520|69184365|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
37706499|NCT01716520|69184366|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
37706500|NCT01716520|69184367|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
37706501|NCT01716520|69184368|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
37706502|NCT01716520|69184369|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
37706503|NCT01716520|69184370|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
37706504|NCT01716520|69184365|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
37706505|NCT01716520|69184366|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
37706506|NCT01716520|69184367|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
37706507|NCT01716520|69184368|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
37706508|NCT01716520|69184369|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
37706509|NCT01716520|69184370|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
37706510|NCT01716520|69184365|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
37706511|NCT01716520|69184366|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
37706512|NCT01716520|69184367|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
37706513|NCT01716520|69184368|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
37706514|NCT01716520|69184369|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
37706515|NCT01716520|69184370|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
37706516|NCT01716520|69184365|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
37706517|NCT01716520|69184366|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
37706518|NCT01716520|69184367|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
37706519|NCT01716520|69184368|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
37706520|NCT01716520|69184369|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
37706521|NCT01716520|69184370|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
37706522|NCT01716520|69184365|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
37706523|NCT01716520|69184366|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
37706524|NCT01716520|69184367|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
37706525|NCT01716520|69184368|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
37706526|NCT01716520|69184369|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
37706527|NCT01716520|69184370|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
37706528|NCT01716520|69184365|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
37706529|NCT01716520|69184366|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
37706530|NCT01716520|69184367|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
37706531|NCT01716520|69184368|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
37706532|NCT01716520|69184369|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
37706533|NCT01716520|69184370|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
37706534|NCT01716520|69184365|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
37706535|NCT01716520|69184366|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
37706536|NCT01716520|69184367|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
37706537|NCT01716520|69184368|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
37706538|NCT01716520|69184369|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
37706539|NCT01716520|69184370|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
37706540|NCT01716520|69184365|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
37706541|NCT01716520|69184366|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
37706542|NCT01716520|69184367|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
37706543|NCT01716520|69184368|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
37706544|NCT01716520|69184369|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
37706545|NCT01716520|69184370|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
37706546|NCT01716520|69184365|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
37706547|NCT01716520|69184366|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
37706548|NCT01716520|69184367|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
37706549|NCT01716520|69184368|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
37706550|NCT01716520|69184369|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
37706551|NCT01716520|69184370|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
37706552|NCT01716520|69184365|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
37706553|NCT01716520|69184366|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
37706554|NCT01716520|69184367|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
37706555|NCT01716520|69184368|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
37706556|NCT01716520|69184369|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
37706557|NCT01716520|69184370|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
37837639|NCT01150123|69522108|FG002|Overall Study|Withdrawal by Subject|2|||
37706558|NCT01716520|69184365|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
37706559|NCT01716520|69184366|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
37706560|NCT01716520|69184367|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
37706561|NCT01716520|69184368|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
37706562|NCT01716520|69184369|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
37706563|NCT01716520|69184370|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
37706564|NCT01716520|69184365|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
37706565|NCT01716520|69184366|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
37706566|NCT01716520|69184367|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
37706567|NCT01716520|69184368|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
37706568|NCT01716520|69184369|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
37706569|NCT01716520|69184370|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
37706570|NCT01716520|69184365|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
37706571|NCT01716520|69184366|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
37706572|NCT01716520|69184367|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
37706573|NCT01716520|69184368|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
37706574|NCT01716520|69184369|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
37706575|NCT01716520|69184370|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
37706576|NCT01716520|69184365|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
37706577|NCT01716520|69184366|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
37706578|NCT01716520|69184367|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
37706579|NCT01716520|69184368|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
37706580|NCT01716520|69184369|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
37706581|NCT01716520|69184370|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
37706582|NCT01698268|69184380|FG000|Overall Study|Physician Decision|2|||
37706583|NCT01698268|69184381|FG001|Overall Study|Physician Decision|1|||
37706584|NCT01697956|69184389|FG000|Overall Study|Protocol Violation|1|||
37706585|NCT01697956|69184390|FG001|Overall Study|Protocol Violation|1|||
37706586|NCT01697800|69184404|FG000|Overall Study|Death|0|||
37706587|NCT01697800|69184405|FG001|Overall Study|Death|1|||
37706588|NCT01644500|69184414|FG000|Overall Study|Adverse Event|6|||
37706589|NCT01644500|69184415|FG001|Overall Study|Adverse Event|1|||
37706590|NCT01644500|69184416|FG002|Overall Study|Adverse Event|2|||
37706591|NCT01644500|69184414|FG000|Overall Study|Death|0|||
37706592|NCT01644500|69184415|FG001|Overall Study|Death|1|||
37706593|NCT01644500|69184416|FG002|Overall Study|Death|0|||
37706594|NCT01644500|69184414|FG000|Overall Study|Lost to Follow-up|3|||
37706595|NCT01644500|69184415|FG001|Overall Study|Lost to Follow-up|8|||
37706596|NCT01644500|69184416|FG002|Overall Study|Lost to Follow-up|0|||
37706597|NCT01644500|69184414|FG000|Overall Study|Protocol Violation|1|||
37706598|NCT01644500|69184415|FG001|Overall Study|Protocol Violation|1|||
37706599|NCT01644500|69184416|FG002|Overall Study|Protocol Violation|0|||
37706600|NCT01644500|69184414|FG000|Overall Study|Withdrawal by Subject|11|||
37706601|NCT01644500|69184415|FG001|Overall Study|Withdrawal by Subject|12|||
37706602|NCT01644500|69184416|FG002|Overall Study|Withdrawal by Subject|12|||
37706603|NCT01644500|69184414|FG000|Overall Study|Physician Decision|1|||
37706604|NCT01644500|69184415|FG001|Overall Study|Physician Decision|1|||
37706605|NCT01644500|69184416|FG002|Overall Study|Physician Decision|1|||
37706606|NCT01604824|69184428|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
37706607|NCT01604824|69184429|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
37706608|NCT01604824|69184430|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
37706609|NCT01604824|69184431|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
37706610|NCT01604824|69184432|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
37706611|NCT01604824|69184433|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
37706612|NCT01604824|69184428|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
37706613|NCT01604824|69184429|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
37706614|NCT01604824|69184430|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
37706615|NCT01604824|69184431|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
37706616|NCT01604824|69184432|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
37706617|NCT01604824|69184433|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
37837640|NCT01150123|69522109|FG003|Overall Study|Withdrawal by Subject|1|||
37706618|NCT01716052|69184447|FG000|Overall Study|Withdrawal of funding|1|||
37706619|NCT01716052|69184448|FG001|Overall Study|Withdrawal of funding|1|||
37837641|NCT01150123|69522110|FG004|Overall Study|Withdrawal by Subject|1|||
37837642|NCT01150123|69522111|FG005|Overall Study|Withdrawal by Subject|1|||
37706620|NCT01641692|69184454|FG000|Treatment Period 1|Adverse Event|1|||
37706621|NCT01641692|69184455|FG001|Treatment Period 1|Adverse Event|0|||
37706622|NCT01641692|69184456|FG002|Treatment Period 1|Adverse Event|0|||
37706623|NCT01641692|69184457|FG003|Treatment Period 1|Adverse Event|0|||
37706624|NCT01641692|69184458|FG004|Treatment Period 1|Adverse Event|0|||
37706625|NCT01641692|69184459|FG005|Treatment Period 1|Adverse Event|0|||
37706626|NCT01641692|69184460|FG006|Treatment Period 1|Adverse Event|0|||
37706627|NCT01641692|69184461|FG007|Treatment Period 1|Adverse Event|0|||
37706628|NCT01641692|69184454|FG000|Treatment Period 1|Lack of Efficacy|0|||
37706629|NCT01641692|69184455|FG001|Treatment Period 1|Lack of Efficacy|0|||
37706630|NCT01641692|69184456|FG002|Treatment Period 1|Lack of Efficacy|0|||
37706631|NCT01641692|69184457|FG003|Treatment Period 1|Lack of Efficacy|0|||
37706632|NCT01641692|69184458|FG004|Treatment Period 1|Lack of Efficacy|0|||
37706633|NCT01641692|69184459|FG005|Treatment Period 1|Lack of Efficacy|0|||
37706634|NCT01641692|69184460|FG006|Treatment Period 1|Lack of Efficacy|0|||
37706635|NCT01641692|69184461|FG007|Treatment Period 1|Lack of Efficacy|1|||
37706636|NCT01641692|69184454|FG000|Treatment Period 1|Protocol Violation|1|||
37706637|NCT01641692|69184455|FG001|Treatment Period 1|Protocol Violation|0|||
37706638|NCT01641692|69184456|FG002|Treatment Period 1|Protocol Violation|0|||
37706639|NCT01641692|69184457|FG003|Treatment Period 1|Protocol Violation|0|||
37706640|NCT01641692|69184458|FG004|Treatment Period 1|Protocol Violation|2|||
37706641|NCT01641692|69184459|FG005|Treatment Period 1|Protocol Violation|0|||
37706642|NCT01641692|69184460|FG006|Treatment Period 1|Protocol Violation|0|||
37706643|NCT01641692|69184461|FG007|Treatment Period 1|Protocol Violation|0|||
37706644|NCT01641692|69184454|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
37706645|NCT01641692|69184455|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
37706646|NCT01641692|69184456|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
37706647|NCT01641692|69184457|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
37706648|NCT01641692|69184458|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
37706649|NCT01641692|69184459|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
37706650|NCT01641692|69184460|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
37706651|NCT01641692|69184461|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
37706652|NCT01641692|69184454|FG000|Treatment Period 1|Lost to Follow-up|0|||
37706653|NCT01641692|69184455|FG001|Treatment Period 1|Lost to Follow-up|0|||
37706654|NCT01641692|69184456|FG002|Treatment Period 1|Lost to Follow-up|1|||
37706655|NCT01641692|69184457|FG003|Treatment Period 1|Lost to Follow-up|0|||
37706656|NCT01641692|69184458|FG004|Treatment Period 1|Lost to Follow-up|0|||
37706657|NCT01641692|69184459|FG005|Treatment Period 1|Lost to Follow-up|0|||
37706658|NCT01641692|69184460|FG006|Treatment Period 1|Lost to Follow-up|0|||
37706659|NCT01641692|69184461|FG007|Treatment Period 1|Lost to Follow-up|0|||
37706660|NCT01641692|69184454|FG000|Treatment Period 1|Physician Decision|0|||
37706661|NCT01641692|69184455|FG001|Treatment Period 1|Physician Decision|0|||
37706662|NCT01641692|69184456|FG002|Treatment Period 1|Physician Decision|0|||
37706663|NCT01641692|69184457|FG003|Treatment Period 1|Physician Decision|0|||
37706664|NCT01641692|69184458|FG004|Treatment Period 1|Physician Decision|1|||
37706665|NCT01641692|69184459|FG005|Treatment Period 1|Physician Decision|0|||
37706666|NCT01641692|69184460|FG006|Treatment Period 1|Physician Decision|0|||
37706667|NCT01641692|69184461|FG007|Treatment Period 1|Physician Decision|0|||
37706668|NCT01641692|69184454|FG000|Treatment Period 1|Withdrawal by Subject|0|||
37706669|NCT01641692|69184455|FG001|Treatment Period 1|Withdrawal by Subject|0|||
37706670|NCT01641692|69184456|FG002|Treatment Period 1|Withdrawal by Subject|0|||
37706671|NCT01641692|69184457|FG003|Treatment Period 1|Withdrawal by Subject|0|||
37706672|NCT01641692|69184458|FG004|Treatment Period 1|Withdrawal by Subject|0|||
37706673|NCT01641692|69184459|FG005|Treatment Period 1|Withdrawal by Subject|2|||
37706674|NCT01641692|69184460|FG006|Treatment Period 1|Withdrawal by Subject|0|||
37706675|NCT01641692|69184461|FG007|Treatment Period 1|Withdrawal by Subject|1|||
37706676|NCT01641692|69184454|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
37706677|NCT01641692|69184455|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
37706678|NCT01641692|69184456|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
37706679|NCT01641692|69184457|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
37706680|NCT01641692|69184458|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
37706681|NCT01641692|69184459|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
37706682|NCT01641692|69184460|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
37706683|NCT01641692|69184461|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
37706684|NCT01641692|69184454|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
37706685|NCT01641692|69184455|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
37706686|NCT01641692|69184456|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
37706687|NCT01641692|69184457|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
37706688|NCT01641692|69184458|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
37706689|NCT01641692|69184459|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
37706690|NCT01641692|69184460|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
37706691|NCT01641692|69184461|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
37706692|NCT01641692|69184454|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
37706693|NCT01641692|69184455|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
37706694|NCT01641692|69184456|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
37706695|NCT01641692|69184457|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
37706696|NCT01641692|69184458|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
37706697|NCT01641692|69184459|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
37706698|NCT01641692|69184460|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
37706699|NCT01641692|69184461|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
37706700|NCT01641692|69184454|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
37706701|NCT01641692|69184455|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
37706702|NCT01641692|69184456|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
37706703|NCT01641692|69184457|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
37706704|NCT01641692|69184458|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
37706705|NCT01641692|69184459|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
37706706|NCT01641692|69184460|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
37706707|NCT01641692|69184461|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
37706708|NCT01641692|69184454|FG000|Treatment Period 2|Lack of Efficacy|1|||
37706709|NCT01641692|69184455|FG001|Treatment Period 2|Lack of Efficacy|0|||
37706710|NCT01641692|69184456|FG002|Treatment Period 2|Lack of Efficacy|0|||
37706711|NCT01641692|69184457|FG003|Treatment Period 2|Lack of Efficacy|0|||
37706712|NCT01641692|69184458|FG004|Treatment Period 2|Lack of Efficacy|0|||
37706713|NCT01641692|69184459|FG005|Treatment Period 2|Lack of Efficacy|0|||
37706714|NCT01641692|69184460|FG006|Treatment Period 2|Lack of Efficacy|0|||
37706715|NCT01641692|69184461|FG007|Treatment Period 2|Lack of Efficacy|0|||
37706716|NCT01641692|69184454|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
37706717|NCT01641692|69184455|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
37706718|NCT01641692|69184456|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
37706719|NCT01641692|69184457|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
37706720|NCT01641692|69184458|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
37706721|NCT01641692|69184459|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
37706722|NCT01641692|69184460|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
37706723|NCT01641692|69184461|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
37706724|NCT01641692|69184454|FG000|Treatment Period 2|Lost to Follow-up|0|||
37706725|NCT01641692|69184455|FG001|Treatment Period 2|Lost to Follow-up|0|||
37706726|NCT01641692|69184456|FG002|Treatment Period 2|Lost to Follow-up|0|||
37706727|NCT01641692|69184457|FG003|Treatment Period 2|Lost to Follow-up|0|||
37706728|NCT01641692|69184458|FG004|Treatment Period 2|Lost to Follow-up|0|||
37706729|NCT01641692|69184459|FG005|Treatment Period 2|Lost to Follow-up|1|||
37706730|NCT01641692|69184460|FG006|Treatment Period 2|Lost to Follow-up|0|||
37706731|NCT01641692|69184461|FG007|Treatment Period 2|Lost to Follow-up|0|||
37706732|NCT01641692|69184454|FG000|Treatment Period 2|Withdrawal by Subject|1|||
37706733|NCT01641692|69184455|FG001|Treatment Period 2|Withdrawal by Subject|0|||
37706734|NCT01641692|69184456|FG002|Treatment Period 2|Withdrawal by Subject|0|||
37706735|NCT01641692|69184457|FG003|Treatment Period 2|Withdrawal by Subject|0|||
37706736|NCT01641692|69184458|FG004|Treatment Period 2|Withdrawal by Subject|0|||
37706737|NCT01641692|69184459|FG005|Treatment Period 2|Withdrawal by Subject|1|||
37706738|NCT01641692|69184460|FG006|Treatment Period 2|Withdrawal by Subject|0|||
37706739|NCT01641692|69184461|FG007|Treatment Period 2|Withdrawal by Subject|1|||
37706740|NCT01641692|69184454|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
37706741|NCT01641692|69184455|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
37706742|NCT01641692|69184456|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
37706743|NCT01641692|69184457|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
37706744|NCT01641692|69184458|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
37706745|NCT01641692|69184459|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
37706746|NCT01641692|69184460|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
37706747|NCT01641692|69184461|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
37706748|NCT01641692|69184454|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
37706749|NCT01641692|69184455|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
37706750|NCT01641692|69184456|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
37706751|NCT01641692|69184457|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
37706752|NCT01641692|69184458|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
37706753|NCT01641692|69184459|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
37706754|NCT01641692|69184460|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
37706755|NCT01641692|69184461|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
37706756|NCT01641692|69184454|FG000|Treatment Period 3|Adverse Event|0|||
37706757|NCT01641692|69184455|FG001|Treatment Period 3|Adverse Event|0|||
37706758|NCT01641692|69184456|FG002|Treatment Period 3|Adverse Event|0|||
37706759|NCT01641692|69184457|FG003|Treatment Period 3|Adverse Event|0|||
37706760|NCT01641692|69184458|FG004|Treatment Period 3|Adverse Event|0|||
37706761|NCT01641692|69184459|FG005|Treatment Period 3|Adverse Event|0|||
37706762|NCT01641692|69184460|FG006|Treatment Period 3|Adverse Event|1|||
37706763|NCT01641692|69184461|FG007|Treatment Period 3|Adverse Event|0|||
37706764|NCT01641692|69184454|FG000|Treatment Period 3|Protocol Violation|0|||
37706765|NCT01641692|69184455|FG001|Treatment Period 3|Protocol Violation|0|||
37706766|NCT01641692|69184456|FG002|Treatment Period 3|Protocol Violation|1|||
37706767|NCT01641692|69184457|FG003|Treatment Period 3|Protocol Violation|0|||
37706768|NCT01641692|69184458|FG004|Treatment Period 3|Protocol Violation|0|||
37706769|NCT01641692|69184459|FG005|Treatment Period 3|Protocol Violation|0|||
37706770|NCT01641692|69184460|FG006|Treatment Period 3|Protocol Violation|0|||
37706771|NCT01641692|69184461|FG007|Treatment Period 3|Protocol Violation|0|||
37706772|NCT01641692|69184454|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
37706773|NCT01641692|69184455|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
37706774|NCT01641692|69184456|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
37706775|NCT01641692|69184457|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
37706776|NCT01641692|69184458|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
37706777|NCT01641692|69184459|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
37706778|NCT01641692|69184460|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
37706779|NCT01641692|69184461|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
37706780|NCT01641692|69184454|FG000|Treatment Period 3|Lost to Follow-up|0|||
37706781|NCT01641692|69184455|FG001|Treatment Period 3|Lost to Follow-up|1|||
37706782|NCT01641692|69184456|FG002|Treatment Period 3|Lost to Follow-up|0|||
37706783|NCT01641692|69184457|FG003|Treatment Period 3|Lost to Follow-up|0|||
37706784|NCT01641692|69184458|FG004|Treatment Period 3|Lost to Follow-up|0|||
37706785|NCT01641692|69184459|FG005|Treatment Period 3|Lost to Follow-up|0|||
37706786|NCT01641692|69184460|FG006|Treatment Period 3|Lost to Follow-up|0|||
37706787|NCT01641692|69184461|FG007|Treatment Period 3|Lost to Follow-up|0|||
37706788|NCT01641692|69184454|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
37706789|NCT01641692|69184455|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
37706790|NCT01641692|69184456|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
37706791|NCT01641692|69184457|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
37706792|NCT01641692|69184458|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
37706793|NCT01641692|69184459|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
37706794|NCT01641692|69184460|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
37706795|NCT01641692|69184461|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
37706796|NCT01641692|69184454|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
37706797|NCT01641692|69184455|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
37706798|NCT01641692|69184456|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
37706799|NCT01641692|69184457|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
37706800|NCT01641692|69184458|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
37706801|NCT01641692|69184459|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
37837643|NCT01150123|69522112|FG006|Overall Study|Withdrawal by Subject|0|||
37837644|NCT01150123|69522113|FG007|Overall Study|Withdrawal by Subject|3|||
37837645|NCT01150123|69522114|FG008|Overall Study|Withdrawal by Subject|2|||
37837646|NCT01150123|69522115|FG009|Overall Study|Withdrawal by Subject|0|||
37706802|NCT01641692|69184460|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
37837647|NCT01150123|69522116|FG010|Overall Study|Withdrawal by Subject|1|||
37706803|NCT01641692|69184461|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
37706804|NCT01682512|69184483|FG000|Overall Study|Adverse Event|6|||
37706805|NCT01682512|69184484|FG001|Overall Study|Adverse Event|5|||
37706806|NCT01682512|69184485|FG002|Overall Study|Adverse Event|2|||
37706807|NCT01682512|69184483|FG000|Overall Study|Withdrawal by Subject|2|||
37706808|NCT01682512|69184484|FG001|Overall Study|Withdrawal by Subject|6|||
37706809|NCT01682512|69184485|FG002|Overall Study|Withdrawal by Subject|3|||
37706810|NCT01682512|69184483|FG000|Overall Study|Physician Decision|0|||
37706811|NCT01682512|69184484|FG001|Overall Study|Physician Decision|2|||
37706812|NCT01682512|69184485|FG002|Overall Study|Physician Decision|0|||
37706813|NCT01682512|69184483|FG000|Overall Study|Study terminated by sponsor|46|||
37706814|NCT01682512|69184484|FG001|Overall Study|Study terminated by sponsor|43|||
37706815|NCT01682512|69184485|FG002|Overall Study|Study terminated by sponsor|0|||
37706816|NCT01682512|69184483|FG000|Overall Study|Lost to Follow-up|3|||
37706817|NCT01682512|69184484|FG001|Overall Study|Lost to Follow-up|0|||
37706818|NCT01682512|69184485|FG002|Overall Study|Lost to Follow-up|2|||
37706819|NCT01682512|69184483|FG000|Overall Study|Protocol Violation|2|||
37706820|NCT01682512|69184484|FG001|Overall Study|Protocol Violation|3|||
37706821|NCT01682512|69184485|FG002|Overall Study|Protocol Violation|2|||
37706822|NCT01682512|69184483|FG000|Overall Study|Primary lack of efficacy|10|||
37706823|NCT01682512|69184484|FG001|Overall Study|Primary lack of efficacy|7|||
37706824|NCT01682512|69184485|FG002|Overall Study|Primary lack of efficacy|7|||
37706825|NCT01682512|69184483|FG000|Overall Study|Secondary lack of efficacy|1|||
37706826|NCT01682512|69184484|FG001|Overall Study|Secondary lack of efficacy|1|||
37706827|NCT01682512|69184485|FG002|Overall Study|Secondary lack of efficacy|0|||
37706828|NCT01682512|69184483|FG000|Overall Study|Other than stated above|2|||
37706829|NCT01682512|69184484|FG001|Overall Study|Other than stated above|4|||
37706830|NCT01682512|69184485|FG002|Overall Study|Other than stated above|2|||
37706831|NCT02256488|69184497|FG000|Overall Study|Lost to Follow-up|6|||
37706832|NCT02256488|69184498|FG001|Overall Study|Lost to Follow-up|6|||
37706833|NCT02256488|69184499|FG002|Overall Study|Lost to Follow-up|9|||
37706834|NCT02256488|69184500|FG003|Overall Study|Lost to Follow-up|3|||
37706835|NCT02256488|69184497|FG000|Overall Study|OTHER|1|||
37706836|NCT02256488|69184498|FG001|Overall Study|OTHER|0|||
37706837|NCT02256488|69184499|FG002|Overall Study|OTHER|1|||
37706838|NCT02256488|69184500|FG003|Overall Study|OTHER|1|||
37706839|NCT02256488|69184497|FG000|Overall Study|Withdrawal by Subject|1|||
37706840|NCT02256488|69184498|FG001|Overall Study|Withdrawal by Subject|0|||
37706841|NCT02256488|69184499|FG002|Overall Study|Withdrawal by Subject|0|||
37706842|NCT02256488|69184500|FG003|Overall Study|Withdrawal by Subject|2|||
37706843|NCT01715896|69184513|FG000|Overall Study|Lost to Follow-up|0|||
37706844|NCT01715896|69184514|FG001|Overall Study|Lost to Follow-up|2|||
37706845|NCT01715896|69184513|FG000|Overall Study|Withdrawal by Subject|1|||
37706846|NCT01715896|69184514|FG001|Overall Study|Withdrawal by Subject|4|||
37706847|NCT01715896|69184513|FG000|Overall Study|Other|2|||
37706848|NCT01715896|69184514|FG001|Overall Study|Other|5|||
37706849|NCT02255552|69184523|FG000|Overall Study|Participants enrolled into another study|0|||
37706850|NCT02255552|69184524|FG001|Overall Study|Participants enrolled into another study|11|||
37706851|NCT02255552|69184523|FG000|Overall Study|Withdrawal by Subject|1|||
37706852|NCT02255552|69184524|FG001|Overall Study|Withdrawal by Subject|4|||
37706853|NCT01714726|69184532|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
37706854|NCT01714726|69184533|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
37706855|NCT01714726|69184534|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
37706856|NCT01714726|69184535|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
37706857|NCT01714726|69184532|FG000|Double-Blinded Induction Period|Adverse Event|0|||
37706858|NCT01714726|69184533|FG001|Double-Blinded Induction Period|Adverse Event|1|||
37706859|NCT01714726|69184534|FG002|Double-Blinded Induction Period|Adverse Event|0|||
37706860|NCT01714726|69184535|FG003|Double-Blinded Induction Period|Adverse Event|0|||
37706861|NCT01714726|69184532|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
37706862|NCT01714726|69184533|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
37706863|NCT01714726|69184534|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
37706864|NCT01714726|69184535|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
37706865|NCT01714726|69184532|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
37706866|NCT01714726|69184533|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
37706867|NCT01714726|69184534|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
37706868|NCT01714726|69184535|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
37706869|NCT01714726|69184532|FG000|Open-Label Period|Other|0|||
37706870|NCT01714726|69184533|FG001|Open-Label Period|Other|0|||
37706871|NCT01714726|69184534|FG002|Open-Label Period|Other|1|||
37706872|NCT01714726|69184535|FG003|Open-Label Period|Other|3|||
37706873|NCT01714726|69184532|FG000|Open-Label Period|Adverse Event|0|||
37706874|NCT01714726|69184533|FG001|Open-Label Period|Adverse Event|0|||
37706875|NCT01714726|69184534|FG002|Open-Label Period|Adverse Event|1|||
37706876|NCT01714726|69184535|FG003|Open-Label Period|Adverse Event|0|||
37706877|NCT01714726|69184532|FG000|Open-Label Period|Withdrawal by Subject|0|||
37706878|NCT01714726|69184533|FG001|Open-Label Period|Withdrawal by Subject|0|||
37706879|NCT01714726|69184534|FG002|Open-Label Period|Withdrawal by Subject|9|||
37706880|NCT01714726|69184535|FG003|Open-Label Period|Withdrawal by Subject|19|||
37706881|NCT01714726|69184532|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
37706882|NCT01714726|69184533|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
37706883|NCT01714726|69184534|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
37706884|NCT01714726|69184535|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
37706885|NCT01714726|69184532|FG000|Open-Label Period|Lost to Follow-up|0|||
37706886|NCT01714726|69184533|FG001|Open-Label Period|Lost to Follow-up|0|||
37706887|NCT01714726|69184534|FG002|Open-Label Period|Lost to Follow-up|3|||
37706888|NCT01714726|69184535|FG003|Open-Label Period|Lost to Follow-up|4|||
37706889|NCT02255474|69184548|FG000|Overall Study|Lost to Follow-up|1|||
37706890|NCT02255474|69184549|FG001|Overall Study|Lost to Follow-up|1|||
37706891|NCT02255474|69184550|FG002|Overall Study|Lost to Follow-up|3|||
37706892|NCT02255474|69184548|FG000|Overall Study|Withdrawal by Subject|1|||
37706893|NCT02255474|69184549|FG001|Overall Study|Withdrawal by Subject|1|||
37706894|NCT02255474|69184550|FG002|Overall Study|Withdrawal by Subject|0|||
37706895|NCT02254772|69184559|FG000|Overall Study|Ineligible|1|||
37706896|NCT02254772|69184559|FG000|Overall Study|Withdrawal by Subject|1|||
37706897|NCT02254460|69184563|FG000|Overall Study|Adverse Event|1|||
37706898|NCT02254460|69184564|FG001|Overall Study|Adverse Event|0|||
37706899|NCT01682044|69184570|FG000|Overall Study|Death|1|||
37706900|NCT01682044|69184570|FG000|Overall Study|Progression|3|||
37706901|NCT01696942|69184576|FG000|Overall Study|Withdrawal by Subject|1|||
37706902|NCT01696942|69184577|FG001|Overall Study|Withdrawal by Subject|0|||
37706903|NCT01696942|69184576|FG000|Overall Study|Protocol Violation|1|||
37706904|NCT01696942|69184577|FG001|Overall Study|Protocol Violation|2|||
37706905|NCT01696942|69184576|FG000|Overall Study|screen failure|0|||
37706906|NCT01696942|69184577|FG001|Overall Study|screen failure|1|||
37706907|NCT01640366|69184583|FG000|Overall Study|Withdrawal by Subject|1|||
37706908|NCT01640366|69184583|FG000|Overall Study|Protocol Violation|16|||
37706909|NCT01640366|69184583|FG000|Overall Study|Lost to Follow-up|5|||
37706910|NCT01640288|69184591|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
37706911|NCT01640288|69184592|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
37706912|NCT01640288|69184591|FG000|Overall Study|Screen Failure|20|||
37706913|NCT01640288|69184592|FG001|Overall Study|Screen Failure|18|||
37706914|NCT01640288|69184591|FG000|Overall Study|Withdrawn by PI|5|||
37706915|NCT01640288|69184592|FG001|Overall Study|Withdrawn by PI|0|||
37915254|NCT00597584|69601999|FG000|Overall Study|Lack of Efficacy|1|||
37915255|NCT00597584|69602000|FG001|Overall Study|Lack of Efficacy|0|||
37915256|NCT00597584|69601999|FG000|Overall Study|Lost to Follow-up|2|||
37706916|NCT01640288|69184591|FG000|Overall Study|Withdrawal by Subject|1|||
37706917|NCT01640288|69184592|FG001|Overall Study|Withdrawal by Subject|0|||
37706918|NCT01639040|69184601|FG000|Overall Study|Adverse Event|1|||
37706919|NCT01639040|69184602|FG001|Overall Study|Adverse Event|0|||
37706920|NCT01640054|69184611|FG000|Overall Study|Study-specific disc criteria|1|||
37706921|NCT01640054|69184611|FG000|Overall Study|Lack of Efficacy|3|||
37915257|NCT00597584|69602000|FG001|Overall Study|Lost to Follow-up|4|||
37706922|NCT01640054|69184611|FG000|Overall Study|Adverse Event|2|||
37837648|NCT01150123|69522117|FG011|Overall Study|Withdrawal by Subject|0|||
37837649|NCT01150123|69522118|FG012|Overall Study|Withdrawal by Subject|1|||
37837650|NCT01150123|69522119|FG013|Overall Study|Withdrawal by Subject|0|||
37837651|NCT01150123|69522120|FG014|Overall Study|Withdrawal by Subject|0|||
37837652|NCT01150123|69522121|FG015|Overall Study|Withdrawal by Subject|1|||
37837653|NCT01150123|69522122|FG016|Overall Study|Withdrawal by Subject|0|||
37837654|NCT01150123|69522123|FG017|Overall Study|Withdrawal by Subject|1|||
37837655|NCT01150123|69522106|FG000|Overall Study|Lost to Follow-up|2|||
37837656|NCT01150123|69522107|FG001|Overall Study|Lost to Follow-up|1|||
37837657|NCT01150123|69522108|FG002|Overall Study|Lost to Follow-up|2|||
37837658|NCT01150123|69522109|FG003|Overall Study|Lost to Follow-up|2|||
37837659|NCT01150123|69522110|FG004|Overall Study|Lost to Follow-up|2|||
37837660|NCT01150123|69522111|FG005|Overall Study|Lost to Follow-up|5|||
37837661|NCT01150123|69522112|FG006|Overall Study|Lost to Follow-up|0|||
37837662|NCT01150123|69522113|FG007|Overall Study|Lost to Follow-up|0|||
37837663|NCT01150123|69522114|FG008|Overall Study|Lost to Follow-up|3|||
37837664|NCT01150123|69522115|FG009|Overall Study|Lost to Follow-up|1|||
37837665|NCT01150123|69522116|FG010|Overall Study|Lost to Follow-up|1|||
37837666|NCT01150123|69522117|FG011|Overall Study|Lost to Follow-up|1|||
37837667|NCT01150123|69522118|FG012|Overall Study|Lost to Follow-up|2|||
37837668|NCT01150123|69522119|FG013|Overall Study|Lost to Follow-up|0|||
37837669|NCT01150123|69522120|FG014|Overall Study|Lost to Follow-up|0|||
37837670|NCT01150123|69522121|FG015|Overall Study|Lost to Follow-up|0|||
37837671|NCT01150123|69522122|FG016|Overall Study|Lost to Follow-up|0|||
37837672|NCT01150123|69522123|FG017|Overall Study|Lost to Follow-up|0|||
37837673|NCT01149655|69522182|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
37837674|NCT01149655|69522183|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
37837675|NCT01149655|69522184|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
37837676|NCT01149655|69522185|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
37837677|NCT01149655|69522182|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
37837678|NCT01149655|69522183|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
37837679|NCT01149655|69522184|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
37837680|NCT01149655|69522185|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
37837681|NCT01149655|69522182|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
37837682|NCT01149655|69522183|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
37837683|NCT01149655|69522184|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
37837684|NCT01149655|69522185|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
37837685|NCT01149655|69522182|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
37837686|NCT01149655|69522183|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
37837687|NCT01149655|69522184|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
37837688|NCT01149655|69522185|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
37837689|NCT01149655|69522182|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
37837690|NCT01149655|69522183|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
37837691|NCT01149655|69522184|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
37837692|NCT01149655|69522185|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
37837693|NCT01149655|69522182|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
37837694|NCT01149655|69522183|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
37837695|NCT01149655|69522184|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
37837696|NCT01149655|69522185|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
37837697|NCT01149655|69522182|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
37837698|NCT01149655|69522183|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
38024047|NCT03084796|69707444|FG005|Overall Study|Protocol Violation|1|||
37706923|NCT01600586|69184617|FG000|Overall Study|Physician Decision|3|||
37837699|NCT01149655|69522184|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
37837700|NCT01149655|69522185|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
37837701|NCT01149655|69522182|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
37837702|NCT01149655|69522183|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
37837703|NCT01149655|69522184|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
37915258|NCT00597584|69601999|FG000|Overall Study|Physician Decision|3|||
37706924|NCT01600586|69184618|FG001|Overall Study|Physician Decision|3|||
37706925|NCT01639742|69184631|FG000|Overall Study|Study Ongoing|17|||
37706926|NCT01639742|69184631|FG000|Overall Study|Lost to Follow-up|1|||
37706927|NCT02164513|69184638|FG000|Overall Study|Adverse Event|162|||
37706928|NCT02164513|69184639|FG001|Overall Study|Adverse Event|180|||
37706929|NCT02164513|69184640|FG002|Overall Study|Adverse Event|111|||
37706930|NCT02164513|69184638|FG000|Overall Study|Other: Study Closed or terminated|5|||
37706931|NCT02164513|69184639|FG001|Overall Study|Other: Study Closed or terminated|2|||
37706932|NCT02164513|69184640|FG002|Overall Study|Other: Study Closed or terminated|4|||
37706933|NCT02164513|69184638|FG000|Overall Study|Lost to Follow-up|30|||
37706934|NCT02164513|69184639|FG001|Overall Study|Lost to Follow-up|36|||
37706935|NCT02164513|69184640|FG002|Overall Study|Lost to Follow-up|22|||
37706936|NCT02164513|69184638|FG000|Overall Study|Physician Decision|47|||
37706937|NCT02164513|69184639|FG001|Overall Study|Physician Decision|57|||
37706938|NCT02164513|69184640|FG002|Overall Study|Physician Decision|28|||
37706939|NCT02164513|69184638|FG000|Overall Study|Withdrawal by Subject|192|||
37706940|NCT02164513|69184639|FG001|Overall Study|Withdrawal by Subject|261|||
37706941|NCT02164513|69184640|FG002|Overall Study|Withdrawal by Subject|130|||
37706942|NCT02164513|69184638|FG000|Overall Study|Other: Reason not provided by site|1|||
37706943|NCT02164513|69184639|FG001|Overall Study|Other: Reason not provided by site|0|||
37706944|NCT02164513|69184640|FG002|Overall Study|Other: Reason not provided by site|0|||
37706945|NCT02218489|69184660|FG000|Overall Study|Withdrawal by Subject|4|||
37706946|NCT02218489|69184661|FG001|Overall Study|Withdrawal by Subject|3|||
37706947|NCT02218489|69184660|FG000|Overall Study|Lost to Follow-up|1|||
37706948|NCT02218489|69184661|FG001|Overall Study|Lost to Follow-up|0|||
37706949|NCT02192905|69184668|FG000|Overall Study|Lost to Follow-up|1|||
37706950|NCT01713946|69184676|FG000|Overall Study|Death|0|||
37706951|NCT01713946|69184677|FG001|Overall Study|Death|2|||
37706952|NCT01713946|69184678|FG002|Overall Study|Death|2|||
37706953|NCT01713946|69184676|FG000|Overall Study|Adverse Event|19|||
38024048|NCT03084796|69707439|FG000|Overall Study|Lack of Efficacy|0|||
38024049|NCT03084796|69707440|FG001|Overall Study|Lack of Efficacy|0|||
38024050|NCT03084796|69707441|FG002|Overall Study|Lack of Efficacy|1|||
37706954|NCT01713946|69184677|FG001|Overall Study|Adverse Event|14|||
37706955|NCT01713946|69184678|FG002|Overall Study|Adverse Event|13|||
37706956|NCT01713946|69184676|FG000|Overall Study|Withdrawal by Subject|12|||
37706957|NCT01713946|69184677|FG001|Overall Study|Withdrawal by Subject|12|||
37706958|NCT01713946|69184678|FG002|Overall Study|Withdrawal by Subject|8|||
38024051|NCT03084796|69707442|FG003|Overall Study|Lack of Efficacy|0|||
38024052|NCT03084796|69707443|FG004|Overall Study|Lack of Efficacy|1|||
37706959|NCT01713946|69184676|FG000|Overall Study|Lack of Efficacy|8|||
37706960|NCT01713946|69184677|FG001|Overall Study|Lack of Efficacy|8|||
37706961|NCT01713946|69184678|FG002|Overall Study|Lack of Efficacy|14|||
37706962|NCT01713946|69184676|FG000|Overall Study|Protocol Violation|2|||
37706963|NCT01713946|69184677|FG001|Overall Study|Protocol Violation|4|||
37706964|NCT01713946|69184678|FG002|Overall Study|Protocol Violation|1|||
37706965|NCT01713946|69184676|FG000|Overall Study|Lost to Follow-up|0|||
37706966|NCT01713946|69184677|FG001|Overall Study|Lost to Follow-up|0|||
37706967|NCT01713946|69184678|FG002|Overall Study|Lost to Follow-up|1|||
37706968|NCT01713946|69184676|FG000|Overall Study|Administrative problems|1|||
37706969|NCT01713946|69184677|FG001|Overall Study|Administrative problems|0|||
37706970|NCT01713946|69184678|FG002|Overall Study|Administrative problems|0|||
37706971|NCT01713946|69184676|FG000|Overall Study|Did not continue in Ext|0|||
37706972|NCT01713946|69184677|FG001|Overall Study|Did not continue in Ext|3|||
37706973|NCT01713946|69184678|FG002|Overall Study|Did not continue in Ext|0|||
37706974|NCT01713946|69184676|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
37706975|NCT01713946|69184677|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
37706976|NCT01713946|69184678|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
37706977|NCT01713946|69184676|FG000|Overall Study|Patients never switched to everolimus|0|||
37837704|NCT01149655|69522185|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
37837705|NCT01149655|69522182|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
37837706|NCT01149655|69522183|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
37837707|NCT01149655|69522184|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
37837708|NCT01149655|69522185|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
37837709|NCT01149655|69522182|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
37837710|NCT01149655|69522183|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
37837711|NCT01149655|69522184|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
37837712|NCT01149655|69522185|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
37837713|NCT01149655|69522182|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
37837714|NCT01149655|69522183|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
37837715|NCT01149655|69522184|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
37837716|NCT01149655|69522185|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
37837717|NCT01149655|69522182|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
37837718|NCT01149655|69522183|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
37837719|NCT01149655|69522184|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
37837720|NCT01149655|69522185|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
37837721|NCT01149655|69522182|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
37837722|NCT01149655|69522183|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
37837723|NCT01149655|69522184|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
37837724|NCT01149655|69522185|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
37837725|NCT01149655|69522182|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
37837726|NCT01149655|69522183|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
37837727|NCT01149655|69522184|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
37837728|NCT01149655|69522185|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
37837729|NCT01149655|69522182|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
37837730|NCT01149655|69522183|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
37837731|NCT01149655|69522184|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
37837732|NCT01149655|69522185|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
37837733|NCT01149655|69522182|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
37837734|NCT01149655|69522183|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
37837735|NCT01149655|69522184|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
37837736|NCT01149655|69522185|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
37837737|NCT01149538|69522195|FG000|Overall Study|Lost to Follow-up|0|||
37837738|NCT01149538|69522196|FG001|Overall Study|Lost to Follow-up|1|||
37837739|NCT01149538|69522195|FG000|Overall Study|Withdrawal by Subject|5|||
37837740|NCT01149538|69522196|FG001|Overall Study|Withdrawal by Subject|3|||
37837741|NCT01149460|69522204|FG000|Overall Study|Withdrawal by Subject|0|||
37837742|NCT01149460|69522205|FG001|Overall Study|Withdrawal by Subject|2|||
37837743|NCT01149421|69522214|FG000|Overall Study|Adverse Event|22|||
38024053|NCT03084796|69707444|FG005|Overall Study|Lack of Efficacy|0|||
38024054|NCT03084796|69707439|FG000|Overall Study|Lost to Follow-up|0|||
37706978|NCT01713946|69184677|FG001|Overall Study|Patients never switched to everolimus|0|||
37706979|NCT01713946|69184678|FG002|Overall Study|Patients never switched to everolimus|5|||
37706980|NCT02163499|69184704|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
37837744|NCT01149421|69522215|FG001|Overall Study|Adverse Event|6|||
37837745|NCT01149421|69522216|FG002|Overall Study|Adverse Event|11|||
37837746|NCT01149421|69522214|FG000|Overall Study|Withdrawal by Subject|20|||
37837747|NCT01149421|69522215|FG001|Overall Study|Withdrawal by Subject|12|||
37837748|NCT01149421|69522216|FG002|Overall Study|Withdrawal by Subject|13|||
37706981|NCT02163499|69184704|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
37706982|NCT02163499|69184704|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
37837749|NCT01149421|69522214|FG000|Overall Study|Sponsor Decision|0|||
37837750|NCT01149421|69522215|FG001|Overall Study|Sponsor Decision|1|||
37837751|NCT01149421|69522216|FG002|Overall Study|Sponsor Decision|1|||
37837752|NCT01149421|69522214|FG000|Overall Study|Lost to Follow-up|2|||
37837753|NCT01149421|69522215|FG001|Overall Study|Lost to Follow-up|4|||
37837754|NCT01149421|69522216|FG002|Overall Study|Lost to Follow-up|5|||
37837755|NCT01149421|69522214|FG000|Overall Study|Physician Decision|5|||
37837756|NCT01149421|69522215|FG001|Overall Study|Physician Decision|3|||
37837757|NCT01149421|69522216|FG002|Overall Study|Physician Decision|6|||
37837758|NCT01149421|69522214|FG000|Overall Study|Entry Criteria Not Met|1|||
37837759|NCT01149421|69522215|FG001|Overall Study|Entry Criteria Not Met|1|||
37837760|NCT01149421|69522216|FG002|Overall Study|Entry Criteria Not Met|2|||
37915259|NCT00597584|69602000|FG001|Overall Study|Physician Decision|0|||
37915260|NCT00597584|69601999|FG000|Overall Study|Pregnancy|2|||
37915261|NCT00597584|69602000|FG001|Overall Study|Pregnancy|0|||
37915262|NCT00597584|69601999|FG000|Overall Study|Withdrawal by Subject|44|||
37915263|NCT00597584|69602000|FG001|Overall Study|Withdrawal by Subject|12|||
37915264|NCT00597584|69601999|FG000|Overall Study|Discontinued Dialysis|0|||
37915265|NCT00597584|69602000|FG001|Overall Study|Discontinued Dialysis|1|||
37915266|NCT00597584|69601999|FG000|Overall Study|Lost ability to consent|1|||
37915267|NCT00597584|69602000|FG001|Overall Study|Lost ability to consent|1|||
37915268|NCT00597584|69601999|FG000|Overall Study|Never dosed|1|||
37915269|NCT00597584|69602000|FG001|Overall Study|Never dosed|0|||
37915270|NCT00597584|69601999|FG000|Overall Study|Relocation|8|||
37915271|NCT00597584|69602000|FG001|Overall Study|Relocation|6|||
37915272|NCT00597584|69601999|FG000|Overall Study|Renal transplant|9|||
37915273|NCT00597584|69602000|FG001|Overall Study|Renal transplant|7|||
37915274|NCT00529633|69602008|FG000|Overall Study|Withdrawal by Subject|1|||
37915275|NCT00529633|69602009|FG001|Overall Study|Withdrawal by Subject|1|||
37915276|NCT00530335|69602015|FG000|Overall Study|Adverse Event|3|||
37915277|NCT00530335|69602015|FG000|Overall Study|Protocol Violation|1|||
37915278|NCT00530335|69602015|FG000|Overall Study|Withdrawal by Subject|1|||
37915279|NCT00530335|69602015|FG000|Overall Study|Physician Decision|1|||
37915280|NCT00712270|69602022|FG000|Overall Study|Withdrawal by Subject|11|||
37915281|NCT00712270|69602022|FG000|Overall Study|Screen Failure|3|||
37915282|NCT00530257|69602048|FG000|Overall Study|Lost to Follow-up|1|||
37915283|NCT00869778|69602058|FG000|Overall Study|Adverse Event|2|||
37915284|NCT00869778|69602059|FG001|Overall Study|Adverse Event|0|||
37915285|NCT00869778|69602060|FG002|Overall Study|Adverse Event|0|||
37915286|NCT00869778|69602058|FG000|Overall Study|Withdrawal by Subject|3|||
37915287|NCT00869778|69602059|FG001|Overall Study|Withdrawal by Subject|4|||
37915288|NCT00869778|69602060|FG002|Overall Study|Withdrawal by Subject|5|||
37915289|NCT00869778|69602058|FG000|Overall Study|Pregnancy|1|||
37915290|NCT00869778|69602059|FG001|Overall Study|Pregnancy|0|||
37915291|NCT00869778|69602060|FG002|Overall Study|Pregnancy|0|||
37915292|NCT00869778|69602058|FG000|Overall Study|Protocol Violation|5|||
37915293|NCT00869778|69602059|FG001|Overall Study|Protocol Violation|3|||
37915294|NCT00869778|69602060|FG002|Overall Study|Protocol Violation|5|||
37915295|NCT00869778|69602058|FG000|Overall Study|Unblinding|1|||
37915296|NCT00869778|69602059|FG001|Overall Study|Unblinding|0|||
37915297|NCT00869778|69602060|FG002|Overall Study|Unblinding|0|||
37915298|NCT00711958|69602091|FG000|Overall Study|Withdrawal by Subject|6|||
37915299|NCT00711958|69602092|FG001|Overall Study|Withdrawal by Subject|8|||
37706983|NCT02163499|69184704|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
37706984|NCT02163499|69184704|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
37706985|NCT02163499|69184704|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
37706986|NCT02163499|69184704|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
37706987|NCT02163499|69184704|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
37706988|NCT02163499|69184704|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
37706989|NCT02163499|69184704|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
37706990|NCT02163499|69184704|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
37706991|NCT02163499|69184704|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
37706992|NCT02163499|69184704|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
37706993|NCT02163499|69184704|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
37706994|NCT02163499|69184704|FG000|Extended Dosing Phase: ZS|Death|8|||
37837761|NCT01149421|69522214|FG000|Overall Study|Protocol Violation|2|||
38024055|NCT03084796|69707440|FG001|Overall Study|Lost to Follow-up|0|||
38024056|NCT03084796|69707441|FG002|Overall Study|Lost to Follow-up|1|||
38024057|NCT03084796|69707442|FG003|Overall Study|Lost to Follow-up|1|||
38024058|NCT03084796|69707443|FG004|Overall Study|Lost to Follow-up|3|||
38024059|NCT03084796|69707444|FG005|Overall Study|Lost to Follow-up|1|||
38024060|NCT03084796|69707439|FG000|Overall Study|Randomization error|0|||
38024061|NCT03084796|69707440|FG001|Overall Study|Randomization error|0|||
38024062|NCT03084796|69707441|FG002|Overall Study|Randomization error|1|||
38024063|NCT03084796|69707442|FG003|Overall Study|Randomization error|0|||
38024064|NCT03084796|69707443|FG004|Overall Study|Randomization error|0|||
38024065|NCT03084796|69707444|FG005|Overall Study|Randomization error|0|||
38024066|NCT03717012|69707460|FG000|Overall Study|Due to trial termination|1|||
38024067|NCT03717012|69707461|FG001|Overall Study|Due to trial termination|2|||
38024068|NCT03717012|69707460|FG000|Overall Study|Protocol Violation|0|||
38024069|NCT03717012|69707461|FG001|Overall Study|Protocol Violation|2|||
38024070|NCT03717012|69707460|FG000|Overall Study|Adverse Event|0|||
38024071|NCT03717012|69707461|FG001|Overall Study|Adverse Event|1|||
38024072|NCT03717012|69707460|FG000|Overall Study|Lung transplant|0|||
38024073|NCT03717012|69707461|FG001|Overall Study|Lung transplant|1|||
38024074|NCT03078556|69707474|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
38024075|NCT03078556|69707475|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
38024076|NCT03078556|69707476|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
38024077|NCT03078556|69707477|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
38024078|NCT03078556|69707474|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
38024079|NCT03078556|69707475|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
38024080|NCT03078556|69707476|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
38024081|NCT03078556|69707477|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
38024082|NCT03078556|69707474|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
38024083|NCT03078556|69707475|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
38024084|NCT03078556|69707476|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
38024085|NCT03078556|69707477|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
38024086|NCT03078556|69707474|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
38024087|NCT03078556|69707475|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
38024088|NCT03078556|69707476|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
38024089|NCT03078556|69707477|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
38024090|NCT03714672|69707506|FG000|Overall Study|Adverse Event|0|||
38024091|NCT03714672|69707507|FG001|Overall Study|Adverse Event|0|||
38024092|NCT03714672|69707508|FG002|Overall Study|Adverse Event|3|||
38024093|NCT03714672|69707509|FG003|Overall Study|Adverse Event|0|||
38024094|NCT03714672|69707506|FG000|Overall Study|Physician Decision|0|||
38024095|NCT03714672|69707507|FG001|Overall Study|Physician Decision|1|||
38024096|NCT03714672|69707508|FG002|Overall Study|Physician Decision|0|||
38024097|NCT03714672|69707509|FG003|Overall Study|Physician Decision|0|||
38024098|NCT03714672|69707506|FG000|Overall Study|Other Reason|1|||
38024099|NCT03714672|69707507|FG001|Overall Study|Other Reason|2|||
38024100|NCT03714672|69707508|FG002|Overall Study|Other Reason|1|||
38024101|NCT03714672|69707509|FG003|Overall Study|Other Reason|1|||
38024102|NCT03714672|69707506|FG000|Overall Study|Lost to Follow-up|1|||
38024103|NCT03714672|69707507|FG001|Overall Study|Lost to Follow-up|1|||
38024104|NCT03714672|69707508|FG002|Overall Study|Lost to Follow-up|0|||
38024105|NCT03714672|69707509|FG003|Overall Study|Lost to Follow-up|0|||
38024106|NCT03083470|69707525|FG000|Overall Study|Lost to Follow-up|0|||
38024107|NCT03083470|69707526|FG001|Overall Study|Lost to Follow-up|0|||
38024108|NCT03083470|69707527|FG002|Overall Study|Lost to Follow-up|0|||
38024109|NCT03083470|69707528|FG003|Overall Study|Lost to Follow-up|0|||
38024110|NCT03083470|69707529|FG004|Overall Study|Lost to Follow-up|1|||
38024111|NCT03083470|69707525|FG000|Overall Study|Withdrawal by Subject|0|||
38024112|NCT03083470|69707526|FG001|Overall Study|Withdrawal by Subject|0|||
38024113|NCT03083470|69707527|FG002|Overall Study|Withdrawal by Subject|0|||
38024114|NCT03083470|69707528|FG003|Overall Study|Withdrawal by Subject|0|||
38024115|NCT03083470|69707529|FG004|Overall Study|Withdrawal by Subject|1|||
38024116|NCT05405244|69707541|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
38024117|NCT05405244|69707542|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
38024118|NCT05405244|69707541|FG000|Washout (2 Weeks)|Adverse Event|2|||
38024119|NCT05405244|69707542|FG001|Washout (2 Weeks)|Adverse Event|0|||
38024120|NCT05405244|69707541|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
38024121|NCT05405244|69707542|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
38024122|NCT03074500|69707555|FG000|Overall Study|Lost to Follow-up|1|||
38024123|NCT03074500|69707556|FG001|Overall Study|Lost to Follow-up|0|||
38024124|NCT03074500|69707557|FG002|Overall Study|Lost to Follow-up|0|||
38024125|NCT03074500|69707555|FG000|Overall Study|Lack of Efficacy|0|||
38024126|NCT03074500|69707556|FG001|Overall Study|Lack of Efficacy|1|||
38024127|NCT03074500|69707557|FG002|Overall Study|Lack of Efficacy|0|||
38024128|NCT03074500|69707555|FG000|Overall Study|Adverse Event|0|||
38024129|NCT03074500|69707556|FG001|Overall Study|Adverse Event|0|||
37706995|NCT02163499|69184704|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
37706996|NCT02163499|69184704|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
37706997|NCT02163499|69184704|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
37706998|NCT02163187|69184714|FG000|Overall Study|Device removed|1|||
37706999|NCT02163187|69184715|FG001|Overall Study|Device removed|0|||
37707000|NCT02163187|69184714|FG000|Overall Study|Progressive disease|1|||
37707001|NCT02163187|69184715|FG001|Overall Study|Progressive disease|0|||
37707002|NCT02191579|69184723|FG000|Treatment 1|Multiple Reasons Specified|27|||
37707003|NCT02191579|69184724|FG001|Treatment 1|Multiple Reasons Specified|58|||
37707004|NCT02191579|69184723|FG000|Treatment 2|Multiple Reasons Specified|0|||
37707005|NCT02191579|69184724|FG001|Treatment 2|Multiple Reasons Specified|25|||
37707006|NCT01363700|69184733|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
37707007|NCT01363700|69184734|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
37707008|NCT01363700|69184735|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
37707009|NCT01363700|69184736|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
37707010|NCT01363700|69184737|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
37707011|NCT01637402|69184748|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
37707012|NCT01637402|69184749|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
37707013|NCT01637402|69184748|FG000|Standard Dose Regimen|Adverse Event|1|||
37707014|NCT01637402|69184749|FG001|Standard Dose Regimen|Adverse Event|0|||
37707015|NCT01637402|69184748|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
37707016|NCT01637402|69184749|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
37707017|NCT01637402|69184748|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
37707018|NCT01637402|69184749|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
37707019|NCT01637402|69184748|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
37707020|NCT01637402|69184749|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
37707021|NCT01637402|69184748|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
37707022|NCT01637402|69184749|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
37707023|NCT02217475|69184777|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
37707024|NCT02217475|69184778|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
37707025|NCT02217475|69184779|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
37707026|NCT02217475|69184777|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
37707027|NCT02217475|69184778|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
37707028|NCT02217475|69184779|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
37707029|NCT02217475|69184777|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
37707030|NCT02217475|69184778|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
37707031|NCT02217475|69184779|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
37707032|NCT02217475|69184777|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
37707033|NCT02217475|69184778|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
37707034|NCT02217475|69184779|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
37707035|NCT02217475|69184777|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
37707036|NCT02217475|69184778|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
37707037|NCT02217475|69184779|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
37707038|NCT02217475|69184777|FG000|Discontinued After Period 1|Adverse Event|1|||
37707039|NCT02217475|69184778|FG001|Discontinued After Period 1|Adverse Event|2|||
37707040|NCT02217475|69184779|FG002|Discontinued After Period 1|Adverse Event|0|||
37707041|NCT02217475|69184777|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
37707042|NCT02217475|69184778|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
37707043|NCT02217475|69184779|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
37707044|NCT02217475|69184777|FG000|Discontinued After Period 1|Physician Decision|0|||
37707045|NCT02217475|69184778|FG001|Discontinued After Period 1|Physician Decision|0|||
37707046|NCT02217475|69184779|FG002|Discontinued After Period 1|Physician Decision|1|||
37707047|NCT02217475|69184777|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
37707048|NCT02217475|69184778|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
37707049|NCT02217475|69184779|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
37707050|NCT02217475|69184777|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
37707051|NCT02217475|69184778|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
37707052|NCT02217475|69184779|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
37707053|NCT02217475|69184777|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
37707054|NCT02217475|69184778|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
37707055|NCT02217475|69184779|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
37707056|NCT02217475|69184777|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
37707057|NCT02217475|69184778|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
37707058|NCT02217475|69184779|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
37707059|NCT02217475|69184777|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
37837762|NCT01149421|69522215|FG001|Overall Study|Protocol Violation|2|||
37837763|NCT01149421|69522216|FG002|Overall Study|Protocol Violation|6|||
37837764|NCT01149343|69522234|FG000|Overall Study|Withdrawal by Subject|1|||
37915300|NCT00711958|69602091|FG000|Overall Study|Lack of Efficacy|3|||
37707060|NCT02217475|69184778|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
37707061|NCT02217475|69184779|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
37707062|NCT02191267|69184799|FG000|Overall Study|Withdrawal by Subject|1|||
37707063|NCT02191267|69184800|FG001|Overall Study|Withdrawal by Subject|0|||
37707064|NCT02191267|69184801|FG002|Overall Study|Withdrawal by Subject|0|||
37707065|NCT02189941|69184809|FG000|Overall Study|Non-compliance|0|||
37707066|NCT02189941|69184810|FG001|Overall Study|Non-compliance|0|||
37707067|NCT02189941|69184811|FG002|Overall Study|Non-compliance|1|||
37707068|NCT02216773|69184821|FG000|Overall Study|Disease progression|4|||
37707069|NCT02216773|69184822|FG001|Overall Study|Disease progression|2|||
37707070|NCT02216773|69184821|FG000|Overall Study|Insufficient FLRV|4|||
37707071|NCT02216773|69184822|FG001|Overall Study|Insufficient FLRV|0|||
37707072|NCT02216773|69184821|FG000|Overall Study|Abandoned|4|||
37707073|NCT02216773|69184822|FG001|Overall Study|Abandoned|3|||
37707074|NCT01601132|69184828|FG000|Overall Study|Patient withdrew consent|1|||
37707075|NCT01601132|69184828|FG000|Overall Study|Protocol deviation|1|||
37707076|NCT02162719|69184837|FG000|Overall Study|Death|41|||
37707077|NCT02162719|69184838|FG001|Overall Study|Death|46|||
37707078|NCT02162719|69184837|FG000|Overall Study|Lost to Follow-up|1|||
37707079|NCT02162719|69184838|FG001|Overall Study|Lost to Follow-up|3|||
37707080|NCT02162719|69184837|FG000|Overall Study|Disease Progression|2|||
37707081|NCT02162719|69184838|FG001|Overall Study|Disease Progression|1|||
37707082|NCT02162719|69184837|FG000|Overall Study|Withdrawal by Subject|8|||
37707083|NCT02162719|69184838|FG001|Overall Study|Withdrawal by Subject|2|||
37707084|NCT02162719|69184837|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
37707085|NCT02162719|69184838|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
37707086|NCT02161549|69184846|FG000|Overall Study|Physician Decision|6|||
37707087|NCT02161549|69184847|FG001|Overall Study|Physician Decision|2|||
37707088|NCT02189863|69184853|FG000|First 2 Weeks|Motion Sickness|4|||
37707089|NCT02189863|69184854|FG001|First 2 Weeks|Motion Sickness|2|||
37707090|NCT02189473|69184865|FG000|Overall Study|Death|22|||
37707091|NCT02189473|69184866|FG001|Overall Study|Death|23|||
37707092|NCT02189473|69184865|FG000|Overall Study|Lost to Follow-up|1|||
37707093|NCT02189473|69184866|FG001|Overall Study|Lost to Follow-up|2|||
37707094|NCT02188849|69184874|FG000|Overall Study|Lost to Follow-up|3|||
37707095|NCT02188849|69184875|FG001|Overall Study|Lost to Follow-up|8|||
37707096|NCT01636076|69184883|FG000|Overall Study|Terminated by sponsor|1|||
37707097|NCT01636076|69184884|FG001|Overall Study|Terminated by sponsor|1|||
37707098|NCT01636076|69184883|FG000|Overall Study|Lack of Efficacy|0|||
37707099|NCT01636076|69184884|FG001|Overall Study|Lack of Efficacy|1|||
37707100|NCT01636076|69184883|FG000|Overall Study|Lost to Follow-up|1|||
37707101|NCT01636076|69184884|FG001|Overall Study|Lost to Follow-up|0|||
37707102|NCT01636076|69184883|FG000|Overall Study|Physician Decision|1|||
37707103|NCT01636076|69184884|FG001|Overall Study|Physician Decision|1|||
37707104|NCT01636076|69184883|FG000|Overall Study|Non-compliance with study treatment|1|||
37707105|NCT01636076|69184884|FG001|Overall Study|Non-compliance with study treatment|1|||
37707106|NCT01636076|69184883|FG000|Overall Study|Adverse Event|6|||
37707107|NCT01636076|69184884|FG001|Overall Study|Adverse Event|11|||
37707108|NCT01636076|69184883|FG000|Overall Study|Withdrawal by Subject|7|||
37707109|NCT01636076|69184884|FG001|Overall Study|Withdrawal by Subject|10|||
37707110|NCT01635998|69184899|FG000|Overall Study|Death|1|||
37707111|NCT01635998|69184900|FG001|Overall Study|Death|1|||
37707112|NCT01635998|69184899|FG000|Overall Study|Lost to Follow-up|2|||
37707113|NCT01635998|69184900|FG001|Overall Study|Lost to Follow-up|1|||
37707114|NCT01635998|69184899|FG000|Overall Study|Withdrawal by Subject|1|||
37707115|NCT01635998|69184900|FG001|Overall Study|Withdrawal by Subject|5|||
37707116|NCT01635920|69184908|FG000|Overall Study|Adverse Event|1|||
37707117|NCT01635920|69184909|FG001|Overall Study|Adverse Event|0|||
37707118|NCT01635920|69184908|FG000|Overall Study|Lost to Follow-up|0|||
37707119|NCT01635920|69184909|FG001|Overall Study|Lost to Follow-up|1|||
37707120|NCT01635920|69184908|FG000|Overall Study|Subject decision|2|||
37707121|NCT01635920|69184909|FG001|Overall Study|Subject decision|0|||
37707122|NCT02160145|69184926|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
37707123|NCT02160145|69184927|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
37707124|NCT02160145|69184928|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
37707125|NCT02160145|69184926|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
37707126|NCT02160145|69184927|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
37707127|NCT02160145|69184928|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
37707128|NCT02160145|69184926|FG000|Randomized Double-blind Period|Subject decision|0|||
37707129|NCT02160145|69184927|FG001|Randomized Double-blind Period|Subject decision|21|||
37707130|NCT02160145|69184928|FG002|Randomized Double-blind Period|Subject decision|20|||
37707131|NCT02160145|69184926|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
37707132|NCT02160145|69184927|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
37707133|NCT02160145|69184928|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
37707134|NCT02160145|69184926|FG000|Randomized Double-blind Period|Physician Decision|0|||
37707135|NCT02160145|69184927|FG001|Randomized Double-blind Period|Physician Decision|7|||
37707136|NCT02160145|69184928|FG002|Randomized Double-blind Period|Physician Decision|5|||
37707137|NCT01696396|69184939|FG000|Overall Study|Withdrawal by Subject|19|||
37707138|NCT01696396|69184940|FG001|Overall Study|Withdrawal by Subject|5|||
37707139|NCT01696396|69184941|FG002|Overall Study|Withdrawal by Subject|19|||
37707140|NCT01696396|69184942|FG003|Overall Study|Withdrawal by Subject|11|||
37707141|NCT01696396|69184939|FG000|Overall Study|Decision by Sponsor|3|||
37707142|NCT01696396|69184940|FG001|Overall Study|Decision by Sponsor|1|||
37707143|NCT01696396|69184941|FG002|Overall Study|Decision by Sponsor|2|||
37707144|NCT01696396|69184942|FG003|Overall Study|Decision by Sponsor|2|||
37707145|NCT01696396|69184939|FG000|Overall Study|Lost to Follow-up|9|||
37707146|NCT01696396|69184940|FG001|Overall Study|Lost to Follow-up|1|||
37707147|NCT01696396|69184941|FG002|Overall Study|Lost to Follow-up|4|||
37707148|NCT01696396|69184942|FG003|Overall Study|Lost to Follow-up|1|||
37707149|NCT01696396|69184939|FG000|Overall Study|Death|0|||
37707150|NCT01696396|69184940|FG001|Overall Study|Death|0|||
37707151|NCT01696396|69184941|FG002|Overall Study|Death|1|||
37707152|NCT01696396|69184942|FG003|Overall Study|Death|0|||
37707153|NCT02216071|69184958|FG000|Overall Study|Withdrawal by Subject|7|||
37707154|NCT02216071|69184959|FG001|Overall Study|Withdrawal by Subject|2|||
37707155|NCT02216071|69184958|FG000|Overall Study|Lost to Follow-up|3|||
37707156|NCT02216071|69184959|FG001|Overall Study|Lost to Follow-up|3|||
37707157|NCT02216071|69184958|FG000|Overall Study|Protocol Violation|3|||
37707158|NCT02216071|69184959|FG001|Overall Study|Protocol Violation|5|||
37707159|NCT02216071|69184958|FG000|Overall Study|Other|2|||
37707160|NCT02216071|69184959|FG001|Overall Study|Other|2|||
37707161|NCT01681576|69184967|FG000|Period 1|Adverse Event|1|||
37707162|NCT01681576|69184968|FG001|Period 1|Adverse Event|0|||
37707163|NCT01681576|69184967|FG000|Period 1|Protocol Deviation|1|||
37707164|NCT01681576|69184968|FG001|Period 1|Protocol Deviation|0|||
37707165|NCT01681576|69184967|FG000|Period 2|subject/guardian decision|3|||
37707166|NCT01681576|69184968|FG001|Period 2|subject/guardian decision|1|||
37707167|NCT01681576|69184967|FG000|Period 2|Non-compliance with study treatment|1|||
37707168|NCT01681576|69184968|FG001|Period 2|Non-compliance with study treatment|0|||
37707169|NCT02188459|69184978|FG000|Overall Study|Lost to Follow-up|3|||
37707170|NCT02188459|69184979|FG001|Overall Study|Lost to Follow-up|4|||
37707171|NCT02188459|69184978|FG000|Overall Study|Early Termination|0|||
37707172|NCT02188459|69184979|FG001|Overall Study|Early Termination|3|||
37707173|NCT02214121|69185001|FG000|Part A|Patient decision|2|||
37707174|NCT02214121|69185002|FG001|Part A|Patient decision|0|||
37707175|NCT02214121|69185003|FG002|Part A|Patient decision|0|||
37707176|NCT02214121|69185001|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
37707177|NCT02214121|69185002|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
37707178|NCT02214121|69185003|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
37707179|NCT02214121|69185001|FG000|Part A|Other|1|||
37707180|NCT02214121|69185002|FG001|Part A|Other|0|||
37707181|NCT02214121|69185003|FG002|Part A|Other|0|||
37707182|NCT02214121|69185001|FG000|Part B|Patient decision|0|||
37707183|NCT02214121|69185002|FG001|Part B|Patient decision|1|||
37707184|NCT02214121|69185003|FG002|Part B|Patient decision|0|||
37707185|NCT02214121|69185001|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
37707186|NCT02214121|69185002|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
37707187|NCT02214121|69185003|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
37707188|NCT02214121|69185001|FG000|Part B|Lost to Follow-up|0|||
37707189|NCT02214121|69185002|FG001|Part B|Lost to Follow-up|0|||
37707190|NCT02214121|69185003|FG002|Part B|Lost to Follow-up|1|||
37707191|NCT01681186|69185031|FG000|Washout Period From Second Intervention|Adverse Event|0|||
37707192|NCT01681186|69185032|FG001|Washout Period From Second Intervention|Adverse Event|0|||
37707193|NCT01681186|69185033|FG002|Washout Period From Second Intervention|Adverse Event|0|||
37707194|NCT01681186|69185034|FG003|Washout Period From Second Intervention|Adverse Event|0|||
37707195|NCT01681186|69185035|FG004|Washout Period From Second Intervention|Adverse Event|0|||
37707196|NCT01681186|69185036|FG005|Washout Period From Second Intervention|Adverse Event|0|||
37707197|NCT01681186|69185037|FG006|Washout Period From Second Intervention|Adverse Event|1|||
37707198|NCT01681186|69185038|FG007|Washout Period From Second Intervention|Adverse Event|0|||
37707199|NCT01681186|69185031|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
37707200|NCT01681186|69185032|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
37707201|NCT01681186|69185033|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
37707202|NCT01681186|69185034|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
37707203|NCT01681186|69185035|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
37707204|NCT01681186|69185036|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
37707205|NCT01681186|69185037|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
37707206|NCT01681186|69185038|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
37707207|NCT01681186|69185031|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
37707208|NCT01681186|69185032|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
37707209|NCT01681186|69185033|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
37707210|NCT01681186|69185034|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
37915301|NCT00711958|69602092|FG001|Overall Study|Lack of Efficacy|1|||
37707211|NCT01681186|69185035|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
37707212|NCT01681186|69185036|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
37707213|NCT01681186|69185037|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
37707214|NCT01681186|69185038|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
37707215|NCT01681186|69185031|FG000|Fourth Intervention|Protocol Violation|0|||
37707216|NCT01681186|69185032|FG001|Fourth Intervention|Protocol Violation|0|||
37707217|NCT01681186|69185033|FG002|Fourth Intervention|Protocol Violation|0|||
37707218|NCT01681186|69185034|FG003|Fourth Intervention|Protocol Violation|0|||
37707219|NCT01681186|69185035|FG004|Fourth Intervention|Protocol Violation|0|||
37707220|NCT01681186|69185036|FG005|Fourth Intervention|Protocol Violation|0|||
37707221|NCT01681186|69185037|FG006|Fourth Intervention|Protocol Violation|0|||
37707222|NCT01681186|69185038|FG007|Fourth Intervention|Protocol Violation|1|||
37707223|NCT03597464|69185070|FG000|Overall Study|Withdrawal by Subject|4|||
37707224|NCT03597464|69185071|FG001|Overall Study|Withdrawal by Subject|5|||
37707225|NCT03597464|69185070|FG000|Overall Study|Lost to Follow-up|3|||
37707226|NCT03597464|69185071|FG001|Overall Study|Lost to Follow-up|1|||
37707227|NCT03597464|69185070|FG000|Overall Study|Pregnancy|3|||
37707228|NCT03597464|69185071|FG001|Overall Study|Pregnancy|1|||
37707229|NCT03597464|69185070|FG000|Overall Study|Lack of Efficacy|2|||
37707230|NCT03597464|69185071|FG001|Overall Study|Lack of Efficacy|0|||
37707231|NCT03597464|69185070|FG000|Overall Study|Physician Decision|2|||
37707232|NCT03597464|69185071|FG001|Overall Study|Physician Decision|2|||
37707233|NCT03597464|69185070|FG000|Overall Study|Protocol Violation|1|||
37707234|NCT03597464|69185071|FG001|Overall Study|Protocol Violation|1|||
37707235|NCT03597464|69185070|FG000|Overall Study|Adverse Event|0|||
37707236|NCT03597464|69185071|FG001|Overall Study|Adverse Event|2|||
37707237|NCT03597464|69185070|FG000|Overall Study|Death|0|||
37707238|NCT03597464|69185071|FG001|Overall Study|Death|3|||
37707239|NCT01695772|69185079|FG000|Overall Study|Withdrawal by Subject|18|||
37707240|NCT01695772|69185079|FG000|Overall Study|Progressive Disease|8|||
37707241|NCT01695772|69185079|FG000|Overall Study|Investigator Decision|5|||
37707242|NCT01695772|69185079|FG000|Overall Study|Lost to Follow-up|4|||
37707243|NCT01695772|69185079|FG000|Overall Study|Protocol Violation|2|||
37707244|NCT01695772|69185079|FG000|Overall Study|Unspecified Reason|1|||
37707245|NCT02159521|69185083|FG000|Overall Study|Enrolled but not treated|3|||
37707246|NCT02159521|69185083|FG000|Overall Study|Withdrawal by Subject|7|||
37707247|NCT02159521|69185083|FG000|Overall Study|Lost to Follow-up|6|||
37707248|NCT02159521|69185083|FG000|Overall Study|Death|1|||
37707249|NCT02159521|69185083|FG000|Overall Study|Other than specified|1|||
37707250|NCT01636934|69185089|FG000|Overall Study|Withdrawal by Subject|3|||
37707251|NCT01636934|69185090|FG001|Overall Study|Withdrawal by Subject|2|||
37707252|NCT01636934|69185089|FG000|Overall Study|Chemo cancel|1|||
37707253|NCT01636934|69185090|FG001|Overall Study|Chemo cancel|0|||
37707254|NCT01636934|69185089|FG000|Overall Study|Too ill to continue|1|||
37707255|NCT01636934|69185090|FG001|Overall Study|Too ill to continue|0|||
37707256|NCT01636934|69185089|FG000|Overall Study|Never started study medication|1|||
37707257|NCT01636934|69185090|FG001|Overall Study|Never started study medication|1|||
37707258|NCT01712854|69185096|FG000|Overall Study|Physician Decision|1|||
37707259|NCT01693120|69185100|FG000|Enrollment|Lost to Follow-up|1|||
37707260|NCT01693120|69185100|FG000|Enrollment|Withdrawal by Subject|10|||
37707261|NCT01693120|69185100|FG000|Enrollment|Protocol Violation|46|||
37707262|NCT01693120|69185100|FG000|Enrollment|Physician Decision|3|||
37707263|NCT01693120|69185100|FG000|Enrollment|Adverse Event|1|||
37707264|NCT01693120|69185100|FG000|Enrollment|Study closed|8|||
37707265|NCT01693120|69185100|FG000|Enrollment|Other|1|||
37707266|NCT01693120|69185100|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
37707267|NCT01693120|69185100|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
37707268|NCT01693120|69185100|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
37707269|NCT01693120|69185100|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
37707270|NCT01693120|69185100|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
37707271|NCT02159365|69185104|FG000|Overall Study|Disease Progression|23|||
37707272|NCT02159365|69185104|FG000|Overall Study|Other reasons|11|||
38024130|NCT03074500|69707557|FG002|Overall Study|Adverse Event|1|||
38024131|NCT03715530|69707570|FG000|Overall Study|Lost to Follow-up|3|||
38024132|NCT03715530|69707571|FG001|Overall Study|Lost to Follow-up|1|||
38024133|NCT03715530|69707572|FG002|Overall Study|Lost to Follow-up|2|||
38024134|NCT03077698|69707582|FG000|Progestin Monotherapy|Stable Disease|8|||
37707273|NCT02159365|69185104|FG000|Overall Study|Administrative reason by Sponsor|9|||
37707274|NCT02159365|69185104|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
37707275|NCT02159365|69185104|FG000|Overall Study|Study drug toxicity|7|||
37707276|NCT02159365|69185104|FG000|Overall Study|Maximum clinical benefit|3|||
37707277|NCT02159365|69185104|FG000|Overall Study|Subject request to discontinue treatment|3|||
37707278|NCT02159365|69185104|FG000|Overall Study|Subject withdrew consent|3|||
37707279|NCT02159365|69185104|FG000|Overall Study|Death|1|||
37707280|NCT02159365|69185104|FG000|Overall Study|Lost to Follow-up|1|||
37707281|NCT01712074|69185111|FG000|Placebo Run-in Period|Adverse Event|2|||
37707282|NCT01712074|69185112|FG001|Placebo Run-in Period|Adverse Event|0|||
37707283|NCT01712074|69185113|FG002|Placebo Run-in Period|Adverse Event|0|||
37707284|NCT01712074|69185111|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
37707285|NCT01712074|69185112|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
37707286|NCT01712074|69185113|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
37707287|NCT01712074|69185111|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
37707288|NCT01712074|69185112|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
37707289|NCT01712074|69185113|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
37707290|NCT01712074|69185111|FG000|Placebo Run-in Period|Other|1|||
37707291|NCT01712074|69185112|FG001|Placebo Run-in Period|Other|0|||
37707292|NCT01712074|69185113|FG002|Placebo Run-in Period|Other|0|||
37707293|NCT01712074|69185111|FG000|Placebo Run-in Period|No longer willing to participate|1|||
37707294|NCT01712074|69185112|FG001|Placebo Run-in Period|No longer willing to participate|0|||
37707295|NCT01712074|69185113|FG002|Placebo Run-in Period|No longer willing to participate|0|||
37707296|NCT01712074|69185111|FG000|Double Blind Period|Adverse Event|0|||
37707297|NCT01712074|69185112|FG001|Double Blind Period|Adverse Event|2|||
37707298|NCT01712074|69185113|FG002|Double Blind Period|Adverse Event|1|||
37707299|NCT01712074|69185111|FG000|Double Blind Period|No longer willing to participate|0|||
37707300|NCT01712074|69185112|FG001|Double Blind Period|No longer willing to participate|2|||
37707301|NCT01712074|69185113|FG002|Double Blind Period|No longer willing to participate|4|||
37707302|NCT01712074|69185111|FG000|Double Blind Period|Death|0|||
37707303|NCT01712074|69185112|FG001|Double Blind Period|Death|1|||
37707304|NCT01712074|69185113|FG002|Double Blind Period|Death|0|||
37707305|NCT01712074|69185111|FG000|Double Blind Period|Lost to Follow-up|0|||
37707306|NCT01712074|69185112|FG001|Double Blind Period|Lost to Follow-up|2|||
37707307|NCT01712074|69185113|FG002|Double Blind Period|Lost to Follow-up|1|||
37707308|NCT01712074|69185111|FG000|Double Blind Period|Other|0|||
37707309|NCT01712074|69185112|FG001|Double Blind Period|Other|4|||
37707310|NCT01712074|69185113|FG002|Double Blind Period|Other|1|||
37707311|NCT01712074|69185111|FG000|Double Blind Period|Protocol Violation|0|||
37707312|NCT01712074|69185112|FG001|Double Blind Period|Protocol Violation|0|||
37707313|NCT01712074|69185113|FG002|Double Blind Period|Protocol Violation|1|||
37707314|NCT01712074|69185111|FG000|Double Blind Period|No longer met eligibility criteria|0|||
37707315|NCT01712074|69185112|FG001|Double Blind Period|No longer met eligibility criteria|3|||
37707316|NCT01712074|69185113|FG002|Double Blind Period|No longer met eligibility criteria|0|||
37707317|NCT01711216|69185128|FG000|Overall Study|Adverse Event|4|||
37707318|NCT01711216|69185128|FG000|Overall Study|Pregnancy|56|||
37707319|NCT01711216|69185128|FG000|Overall Study|Withdrawal by Subject|6|||
37707320|NCT01711216|69185128|FG000|Overall Study|Lost to Follow-up|46|||
37707321|NCT01711216|69185128|FG000|Overall Study|variety of other minor reasons|83|||
37707322|NCT01711216|69185128|FG000|Overall Study|no reason specified|22|||
37707323|NCT01692730|69185138|FG000|Overall Study|Lost to Follow-up|225|||
37707324|NCT01692730|69185139|FG001|Overall Study|Lost to Follow-up|227|||
37707325|NCT01691794|69185148|FG000|Overall Study|Poor/Non-Compliance|1|||
37707326|NCT01691794|69185149|FG001|Overall Study|Poor/Non-Compliance|4|||
37707327|NCT01691794|69185150|FG002|Overall Study|Poor/Non-Compliance|1|||
37707328|NCT01691794|69185148|FG000|Overall Study|Death|0|||
37707329|NCT01691794|69185149|FG001|Overall Study|Death|0|||
37707330|NCT01691794|69185150|FG002|Overall Study|Death|1|||
37707331|NCT01691794|69185148|FG000|Overall Study|Lack of Efficacy|0|||
37707332|NCT01691794|69185149|FG001|Overall Study|Lack of Efficacy|7|||
37707333|NCT01691794|69185150|FG002|Overall Study|Lack of Efficacy|1|||
37707334|NCT01691794|69185148|FG000|Overall Study|Participant request to discontinue|0|||
37707335|NCT01691794|69185149|FG001|Overall Study|Participant request to discontinue|1|||
37707336|NCT01691794|69185150|FG002|Overall Study|Participant request to discontinue|0|||
37707337|NCT01691794|69185148|FG000|Overall Study|Adverse Event|0|||
37707338|NCT01691794|69185149|FG001|Overall Study|Adverse Event|1|||
37707339|NCT01691794|69185150|FG002|Overall Study|Adverse Event|1|||
37707340|NCT01691794|69185148|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
37707341|NCT01691794|69185149|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
37707342|NCT01691794|69185150|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
37707343|NCT01691794|69185148|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
37707344|NCT01691794|69185149|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
37707345|NCT01691794|69185150|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
37707346|NCT01710514|69185160|FG000|Overall Study|Adverse Event|6|||
37707347|NCT01710514|69185161|FG001|Overall Study|Adverse Event|7|||
37707348|NCT01710514|69185160|FG000|Overall Study|Withdrawal by Subject|1|||
37707349|NCT01710514|69185161|FG001|Overall Study|Withdrawal by Subject|0|||
37707350|NCT01592344|69185172|FG000|Overall Study|Adverse Event|1|||
37707351|NCT01592344|69185173|FG001|Overall Study|Adverse Event|1|||
37707352|NCT01592344|69185172|FG000|Overall Study|Lack of Efficacy|1|||
37707353|NCT01592344|69185173|FG001|Overall Study|Lack of Efficacy|0|||
37707354|NCT01592344|69185172|FG000|Overall Study|not available at primary outcome visit|2|||
37707355|NCT01592344|69185173|FG001|Overall Study|not available at primary outcome visit|4|||
37707356|NCT01636778|69185179|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
37707357|NCT01636778|69185180|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
37707358|NCT01636778|69185181|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
37707359|NCT01636778|69185179|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
37707360|NCT01636778|69185180|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
37707361|NCT01636778|69185181|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
37707362|NCT01636778|69185179|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
37707363|NCT01636778|69185180|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
37707364|NCT01636778|69185181|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
37707365|NCT01636778|69185179|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
37707366|NCT01636778|69185180|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
37707367|NCT01636778|69185181|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
37707368|NCT01636778|69185179|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
37707369|NCT01636778|69185180|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
37707370|NCT01636778|69185181|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
37707371|NCT01636778|69185179|FG000|Follow-up Period After Part 2|Other|0|||
37707372|NCT01636778|69185180|FG001|Follow-up Period After Part 2|Other|0|||
37707373|NCT01636778|69185181|FG002|Follow-up Period After Part 2|Other|1|||
37707374|NCT01636778|69185179|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
37707375|NCT01636778|69185180|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
37707376|NCT01636778|69185181|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
37707377|NCT01636778|69185179|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
37707378|NCT01636778|69185180|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
37707379|NCT01636778|69185181|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
37707380|NCT02159053|69185192|FG000|Overall Study|Death|2|||
37707381|NCT02159053|69185193|FG001|Overall Study|Death|0|||
37707382|NCT02159053|69185194|FG002|Overall Study|Death|1|||
37707383|NCT02159053|69185192|FG000|Overall Study|Physician Decision|0|||
37707384|NCT02159053|69185193|FG001|Overall Study|Physician Decision|1|||
37707385|NCT02159053|69185194|FG002|Overall Study|Physician Decision|1|||
37707386|NCT02159053|69185192|FG000|Overall Study|Lack of Efficacy|3|||
37707387|NCT02159053|69185193|FG001|Overall Study|Lack of Efficacy|4|||
37707388|NCT02159053|69185194|FG002|Overall Study|Lack of Efficacy|7|||
37707389|NCT02159053|69185192|FG000|Overall Study|Adverse Event|7|||
37707390|NCT02159053|69185193|FG001|Overall Study|Adverse Event|6|||
37707391|NCT02159053|69185194|FG002|Overall Study|Adverse Event|5|||
37707392|NCT02159053|69185192|FG000|Overall Study|Participants/guardian decision|8|||
37837765|NCT01149343|69522235|FG001|Overall Study|Withdrawal by Subject|1|||
37837766|NCT01149343|69522236|FG002|Overall Study|Withdrawal by Subject|1|||
37837767|NCT01149343|69522237|FG003|Overall Study|Withdrawal by Subject|5|||
37707393|NCT02159053|69185193|FG001|Overall Study|Participants/guardian decision|10|||
37707394|NCT02159053|69185194|FG002|Overall Study|Participants/guardian decision|6|||
37707395|NCT02158975|69185204|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
37707396|NCT02158663|69185211|FG000|Overall Study|Withdrawal by Subject|5|||
37707397|NCT02158663|69185212|FG001|Overall Study|Withdrawal by Subject|4|||
37707398|NCT02158039|69185220|FG000|Overall Study|Withdrawal by Subject|1|||
37707399|NCT02158039|69185220|FG000|Overall Study|Screen Failure|9|||
37707400|NCT01635764|69185238|FG000|Overall Study|Adverse Event|46|||
37707401|NCT01635764|69185238|FG000|Overall Study|Lack of Efficacy|76|||
37707402|NCT01635764|69185238|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
37707403|NCT01635764|69185238|FG000|Overall Study|Protocol Deviation|1|||
37707404|NCT01635764|69185238|FG000|Overall Study|Withdrew Consent|67|||
37707405|NCT01635764|69185238|FG000|Overall Study|Lost to Follow-up|53|||
37707406|NCT01635764|69185238|FG000|Overall Study|Other|28|||
37707407|NCT03432260|69185254|FG000|Overall Study|Lost to Follow-up|1|||
37707408|NCT03432260|69185255|FG001|Overall Study|Lost to Follow-up|1|||
37707409|NCT03432260|69185256|FG002|Overall Study|Lost to Follow-up|0|||
37707410|NCT03432260|69185257|FG003|Overall Study|Lost to Follow-up|0|||
37707411|NCT03432260|69185258|FG004|Overall Study|Lost to Follow-up|1|||
37707412|NCT01634360|69185272|FG000|Overall Study|Adverse Event|10|||
37707413|NCT01634360|69185273|FG001|Overall Study|Adverse Event|34|||
37707414|NCT01634360|69185272|FG000|Overall Study|subject withdrew consent|13|||
37707415|NCT01634360|69185273|FG001|Overall Study|subject withdrew consent|23|||
37707416|NCT01634360|69185272|FG000|Overall Study|Protocol Violation|1|||
37707417|NCT01634360|69185273|FG001|Overall Study|Protocol Violation|1|||
37707418|NCT01634360|69185272|FG000|Overall Study|Lack of Efficacy|4|||
37707419|NCT01634360|69185273|FG001|Overall Study|Lack of Efficacy|14|||
37707420|NCT01634360|69185272|FG000|Overall Study|Other|3|||
37707421|NCT01634360|69185273|FG001|Overall Study|Other|20|||
37707422|NCT01634360|69185272|FG000|Overall Study|Study termination by sponsor|18|||
37707423|NCT01634360|69185273|FG001|Overall Study|Study termination by sponsor|44|||
37707424|NCT01635218|69185290|FG000|Overall Study|Lost to Follow-up|3|||
37837768|NCT01149343|69522234|FG000|Overall Study|Death|10|||
37837769|NCT01149343|69522235|FG001|Overall Study|Death|13|||
37837770|NCT01149343|69522236|FG002|Overall Study|Death|18|||
37837771|NCT01149343|69522237|FG003|Overall Study|Death|18|||
37837772|NCT01149343|69522234|FG000|Overall Study|Lost to Follow-up|1|||
37837773|NCT01149343|69522235|FG001|Overall Study|Lost to Follow-up|0|||
37837774|NCT01149343|69522236|FG002|Overall Study|Lost to Follow-up|0|||
37837775|NCT01149343|69522237|FG003|Overall Study|Lost to Follow-up|1|||
37837776|NCT01149343|69522234|FG000|Overall Study|Other|8|||
37837777|NCT01149343|69522235|FG001|Overall Study|Other|10|||
37837778|NCT01149343|69522236|FG002|Overall Study|Other|2|||
37837779|NCT01149343|69522237|FG003|Overall Study|Other|14|||
37837780|NCT01149343|69522234|FG000|Overall Study|Sponsor study termination|0|||
37837781|NCT01149343|69522235|FG001|Overall Study|Sponsor study termination|0|||
37837782|NCT01149343|69522236|FG002|Overall Study|Sponsor study termination|0|||
37837783|NCT01149343|69522237|FG003|Overall Study|Sponsor study termination|2|||
37837784|NCT01149343|69522234|FG000|Overall Study|Recurrence / Progressive disease|0|||
37837785|NCT01149343|69522235|FG001|Overall Study|Recurrence / Progressive disease|0|||
37837786|NCT01149343|69522236|FG002|Overall Study|Recurrence / Progressive disease|1|||
37837787|NCT01149343|69522237|FG003|Overall Study|Recurrence / Progressive disease|0|||
37837788|NCT01149148|69522253|FG000|Overall Study|Lost to Follow-up|1|||
37837789|NCT01149148|69522254|FG001|Overall Study|Lost to Follow-up|2|||
37837790|NCT01149148|69522253|FG000|Overall Study|Death|1|||
37837791|NCT01149148|69522254|FG001|Overall Study|Death|0|||
37837792|NCT01148017|69522265|FG000|Overall Study|Withdrawal by Subject|31|||
37837793|NCT01148017|69522266|FG001|Overall Study|Withdrawal by Subject|14|||
37837794|NCT01148017|69522267|FG002|Overall Study|Withdrawal by Subject|0|||
37837795|NCT01148017|69522268|FG003|Overall Study|Withdrawal by Subject|0|||
37837796|NCT01148017|69522265|FG000|Overall Study|Lost to Follow-up|23|||
37837797|NCT01148017|69522266|FG001|Overall Study|Lost to Follow-up|10|||
37837798|NCT01148017|69522267|FG002|Overall Study|Lost to Follow-up|0|||
38024135|NCT03077698|69707583|FG001|Progestin Monotherapy|Stable Disease|0|||
38024136|NCT03077698|69707582|FG000|Progestin Monotherapy|Adverse Event|1|||
37837799|NCT01148017|69522268|FG003|Overall Study|Lost to Follow-up|0|||
37837800|NCT01148017|69522265|FG000|Overall Study|Inappropriate enrollment|1|||
37837801|NCT01148017|69522266|FG001|Overall Study|Inappropriate enrollment|0|||
37837802|NCT01148017|69522267|FG002|Overall Study|Inappropriate enrollment|0|||
38024137|NCT03077698|69707583|FG001|Progestin Monotherapy|Adverse Event|0|||
37837803|NCT01148017|69522268|FG003|Overall Study|Inappropriate enrollment|0|||
37837804|NCT01148017|69522265|FG000|Overall Study|Administrative reason|22|||
37707425|NCT01635218|69185291|FG001|Overall Study|Lost to Follow-up|7|||
37707426|NCT01635218|69185292|FG002|Overall Study|Lost to Follow-up|6|||
37707427|NCT02049866|69185300|FG000|Overall Study|Withdrawal by Subject|1|||
37707428|NCT04307186|69185304|FG000|Period 1 - Gadobutrol|Withdrawal by Subject|1|||
37837805|NCT01148017|69522266|FG001|Overall Study|Administrative reason|9|||
37837806|NCT01148017|69522267|FG002|Overall Study|Administrative reason|0|||
38024138|NCT03077698|69707582|FG000|Progestin Monotherapy|Death|1|||
38024139|NCT03077698|69707583|FG001|Progestin Monotherapy|Death|0|||
38024140|NCT03077698|69707582|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
38024141|NCT03077698|69707583|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
38024142|NCT03077698|69707582|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
38024143|NCT03077698|69707583|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
38024144|NCT03077698|69707582|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
38024145|NCT03077698|69707583|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
38024146|NCT03077698|69707582|FG000|Safety Follow Up|Withdrawal by Subject|2|||
38024147|NCT03077698|69707583|FG001|Safety Follow Up|Withdrawal by Subject|1|||
38024148|NCT03077698|69707582|FG000|Safety Follow Up|Transfer of care to hospice|1|||
38024149|NCT03077698|69707583|FG001|Safety Follow Up|Transfer of care to hospice|0|||
38024150|NCT03079102|69707601|FG000|Overall Study|Physician Decision|0|||
38024151|NCT03079102|69707602|FG001|Overall Study|Physician Decision|1|||
38024152|NCT02434354|69707608|FG000|Overall Study|screen fail|3|||
37707429|NCT04307186|69185304|FG000|Washout 3-14 Days|Withdrawal by Subject|1|||
37707430|NCT04307186|69185304|FG000|Washout 3-14 Days|Progressive disease|1|||
37707431|NCT04307186|69185304|FG000|Washout 3-14 Days|Pre-specified withdrawal criterion met|1|||
37837807|NCT01148017|69522268|FG003|Overall Study|Administrative reason|0|||
37837808|NCT01148017|69522265|FG000|Overall Study|Unable to classify|3|||
37837809|NCT01148017|69522266|FG001|Overall Study|Unable to classify|1|||
37837810|NCT01148017|69522267|FG002|Overall Study|Unable to classify|0|||
37837811|NCT01148017|69522268|FG003|Overall Study|Unable to classify|0|||
37837812|NCT01147900|69522282|FG000|At Year 10|Lost to Follow-up|0|||
37837813|NCT01147900|69522283|FG001|At Year 10|Lost to Follow-up|1|||
37837814|NCT01147900|69522284|FG002|At Year 10|Lost to Follow-up|0|||
37837815|NCT01147744|69522299|FG000|Overall Study|Protocol Violation|1|||
37837816|NCT01147744|69522300|FG001|Overall Study|Protocol Violation|0|||
37837817|NCT01147744|69522301|FG002|Overall Study|Protocol Violation|1|||
37837818|NCT01147744|69522302|FG003|Overall Study|Protocol Violation|0|||
37837819|NCT01147744|69522303|FG004|Overall Study|Protocol Violation|1|||
37837820|NCT01147744|69522304|FG005|Overall Study|Protocol Violation|3|||
37837821|NCT01147744|69522305|FG006|Overall Study|Protocol Violation|1|||
37837822|NCT01147744|69522299|FG000|Overall Study|Physician Decision|0|||
37837823|NCT01147744|69522300|FG001|Overall Study|Physician Decision|1|||
37837824|NCT01147744|69522301|FG002|Overall Study|Physician Decision|1|||
37837825|NCT01147744|69522302|FG003|Overall Study|Physician Decision|0|||
37837826|NCT01147744|69522303|FG004|Overall Study|Physician Decision|0|||
37837827|NCT01147744|69522304|FG005|Overall Study|Physician Decision|0|||
37837828|NCT01147744|69522305|FG006|Overall Study|Physician Decision|1|||
37837829|NCT01147744|69522299|FG000|Overall Study|Lack of Efficacy|11|||
37837830|NCT01147744|69522300|FG001|Overall Study|Lack of Efficacy|11|||
37837831|NCT01147744|69522301|FG002|Overall Study|Lack of Efficacy|9|||
37837832|NCT01147744|69522302|FG003|Overall Study|Lack of Efficacy|11|||
37837833|NCT01147744|69522303|FG004|Overall Study|Lack of Efficacy|13|||
37837834|NCT01147744|69522304|FG005|Overall Study|Lack of Efficacy|8|||
37837835|NCT01147744|69522305|FG006|Overall Study|Lack of Efficacy|7|||
37837836|NCT01147744|69522299|FG000|Overall Study|Adverse Event|1|||
37837837|NCT01147744|69522300|FG001|Overall Study|Adverse Event|2|||
37837838|NCT01147744|69522301|FG002|Overall Study|Adverse Event|3|||
37837839|NCT01147744|69522302|FG003|Overall Study|Adverse Event|0|||
37837840|NCT01147744|69522303|FG004|Overall Study|Adverse Event|2|||
37837841|NCT01147744|69522304|FG005|Overall Study|Adverse Event|1|||
37837842|NCT01147744|69522305|FG006|Overall Study|Adverse Event|2|||
37837843|NCT01147744|69522299|FG000|Overall Study|Withdrawal by Subject|8|||
37837844|NCT01147744|69522300|FG001|Overall Study|Withdrawal by Subject|4|||
37837845|NCT01147744|69522301|FG002|Overall Study|Withdrawal by Subject|2|||
37837846|NCT01147744|69522302|FG003|Overall Study|Withdrawal by Subject|2|||
37837847|NCT01147744|69522303|FG004|Overall Study|Withdrawal by Subject|2|||
37837848|NCT01147744|69522304|FG005|Overall Study|Withdrawal by Subject|5|||
37837849|NCT01147744|69522305|FG006|Overall Study|Withdrawal by Subject|2|||
37837850|NCT01147744|69522299|FG000|Overall Study|Lost to Follow-up|0|||
37707432|NCT04307186|69185304|FG000|Period 2 - Gadoquatrane|Protocol Violation|1|||
37707433|NCT04274894|69185316|FG000|Overall Study|Adverse Event|7|||
37837851|NCT01147744|69522300|FG001|Overall Study|Lost to Follow-up|1|||
37837852|NCT01147744|69522301|FG002|Overall Study|Lost to Follow-up|0|||
37837853|NCT01147744|69522302|FG003|Overall Study|Lost to Follow-up|0|||
37837854|NCT01147744|69522303|FG004|Overall Study|Lost to Follow-up|0|||
37837855|NCT01147744|69522304|FG005|Overall Study|Lost to Follow-up|0|||
37837856|NCT01147744|69522305|FG006|Overall Study|Lost to Follow-up|0|||
37837857|NCT01147744|69522299|FG000|Overall Study|Sponsor decision to amend protocol|7|||
38024153|NCT03076996|69707612|FG000|Overall Study|Withdrawal by Subject|2|||
38024154|NCT03076996|69707612|FG000|Overall Study|Lost to Follow-up|3|||
37837858|NCT01147744|69522300|FG001|Overall Study|Sponsor decision to amend protocol|4|||
37837859|NCT01147744|69522301|FG002|Overall Study|Sponsor decision to amend protocol|2|||
37837860|NCT01147744|69522302|FG003|Overall Study|Sponsor decision to amend protocol|5|||
37837861|NCT01147744|69522303|FG004|Overall Study|Sponsor decision to amend protocol|7|||
37707434|NCT04274894|69185316|FG000|Overall Study|Withdrew consent|5|||
37707435|NCT04274894|69185316|FG000|Overall Study|Lost to Follow-up|9|||
37707436|NCT04274894|69185316|FG000|Overall Study|COVID-19 infection|1|||
37707437|NCT04274894|69185316|FG000|Overall Study|Other, not specified|20|||
37707438|NCT02213263|69185322|FG000|Overall Study|Insufficient clinical response|4|||
37707439|NCT02213263|69185323|FG001|Overall Study|Insufficient clinical response|3|||
37707440|NCT02213263|69185322|FG000|Overall Study|Lost to Follow-up|0|||
37707441|NCT02213263|69185323|FG001|Overall Study|Lost to Follow-up|1|||
37707442|NCT02213263|69185322|FG000|Overall Study|No longer willing to participate|3|||
37707443|NCT02213263|69185323|FG001|Overall Study|No longer willing to participate|4|||
37707444|NCT02213263|69185322|FG000|Overall Study|Progressive disease|20|||
37707445|NCT02213263|69185323|FG001|Overall Study|Progressive disease|14|||
37707446|NCT02213263|69185322|FG000|Overall Study|Protocol Violation|0|||
37707447|NCT02213263|69185323|FG001|Overall Study|Protocol Violation|1|||
37707448|NCT02213263|69185322|FG000|Overall Study|Adverse Event|1|||
37707449|NCT02213263|69185323|FG001|Overall Study|Adverse Event|3|||
37707450|NCT02211313|69185331|FG000|Overall Study|Treatment Failure|5|||
37707451|NCT02211313|69185332|FG001|Overall Study|Treatment Failure|2|||
37707452|NCT02211313|69185331|FG000|Overall Study|No Follow up Questionnaires|1|||
37707453|NCT02211313|69185332|FG001|Overall Study|No Follow up Questionnaires|1|||
37707454|NCT02210689|69185341|FG000|Overall Study|Withdrawal by Subject|7|||
37707455|NCT02210689|69185342|FG001|Overall Study|Withdrawal by Subject|4|||
37707456|NCT02210689|69185343|FG002|Overall Study|Withdrawal by Subject|2|||
37707457|NCT02210689|69185341|FG000|Overall Study|Adverse Event|0|||
37707458|NCT02210689|69185342|FG001|Overall Study|Adverse Event|1|||
37707459|NCT02210689|69185343|FG002|Overall Study|Adverse Event|0|||
37707460|NCT02210689|69185341|FG000|Overall Study|Protocol Violation|1|||
37707461|NCT02210689|69185342|FG001|Overall Study|Protocol Violation|0|||
37707462|NCT02210689|69185343|FG002|Overall Study|Protocol Violation|0|||
37707463|NCT02210689|69185341|FG000|Overall Study|Lost to Follow-up|11|||
37707464|NCT02210689|69185342|FG001|Overall Study|Lost to Follow-up|9|||
37707465|NCT02210689|69185343|FG002|Overall Study|Lost to Follow-up|5|||
37707466|NCT02210689|69185341|FG000|Overall Study|Pregnancy|0|||
37707467|NCT02210689|69185342|FG001|Overall Study|Pregnancy|1|||
37707468|NCT02210689|69185343|FG002|Overall Study|Pregnancy|0|||
37707469|NCT02210689|69185341|FG000|Overall Study|Lack of Efficacy|0|||
37707470|NCT02210689|69185342|FG001|Overall Study|Lack of Efficacy|1|||
37707471|NCT02210689|69185343|FG002|Overall Study|Lack of Efficacy|5|||
37707472|NCT02210689|69185341|FG000|Overall Study|Prohibited medication|2|||
37707473|NCT02210689|69185342|FG001|Overall Study|Prohibited medication|8|||
37707474|NCT02210689|69185343|FG002|Overall Study|Prohibited medication|1|||
37707475|NCT02210689|69185341|FG000|Overall Study|Negative Nugent score at baseline|6|||
37707476|NCT02210689|69185342|FG001|Overall Study|Negative Nugent score at baseline|2|||
37707477|NCT02210689|69185343|FG002|Overall Study|Negative Nugent score at baseline|2|||
37707478|NCT02210689|69185341|FG000|Overall Study|Other|25|||
37707479|NCT02210689|69185342|FG001|Overall Study|Other|21|||
37707480|NCT02210689|69185343|FG002|Overall Study|Other|8|||
37707481|NCT02209597|69185351|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
37707482|NCT02209597|69185351|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
37707483|NCT02209597|69185351|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
37707484|NCT02209597|69185351|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
37707485|NCT02188303|69185380|FG000|Overall Study|Adverse Event|0|||
37707486|NCT02188303|69185381|FG001|Overall Study|Adverse Event|0|||
37707487|NCT02188303|69185382|FG002|Overall Study|Adverse Event|0|||
37707488|NCT02188303|69185383|FG003|Overall Study|Adverse Event|0|||
37707489|NCT02188303|69185384|FG004|Overall Study|Adverse Event|0|||
37707490|NCT02188303|69185385|FG005|Overall Study|Adverse Event|2|||
37707491|NCT02188303|69185386|FG006|Overall Study|Adverse Event|0|||
38024155|NCT03076996|69707612|FG000|Overall Study|Literacy precluded participation|1|||
38024156|NCT03078868|69707616|FG000|Overall Study|Physician Decision|3|||
38024157|NCT04524598|69707624|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
38024158|NCT04524598|69707625|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
38024159|NCT04524598|69707626|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
37707492|NCT02188303|69185387|FG007|Overall Study|Adverse Event|2|||
37707493|NCT02188303|69185380|FG000|Overall Study|Dose Termination Criteria Met|0|||
37707494|NCT02188303|69185381|FG001|Overall Study|Dose Termination Criteria Met|0|||
37707495|NCT02188303|69185382|FG002|Overall Study|Dose Termination Criteria Met|0|||
37707496|NCT02188303|69185383|FG003|Overall Study|Dose Termination Criteria Met|0|||
37707497|NCT02188303|69185384|FG004|Overall Study|Dose Termination Criteria Met|0|||
37707498|NCT02188303|69185385|FG005|Overall Study|Dose Termination Criteria Met|0|||
37707499|NCT02188303|69185386|FG006|Overall Study|Dose Termination Criteria Met|2|||
37707500|NCT02188303|69185387|FG007|Overall Study|Dose Termination Criteria Met|4|||
37707501|NCT04867382|69185423|FG000|Overall Study|Did not complete the survey|2|||
37707502|NCT04867382|69185424|FG001|Overall Study|Did not complete the survey|1|||
37707503|NCT02187055|69185433|FG000|Overall Study|Lack of Efficacy|10|||
37707504|NCT02187055|69185434|FG001|Overall Study|Lack of Efficacy|3|||
37707505|NCT02187055|69185435|FG002|Overall Study|Lack of Efficacy|7|||
37707506|NCT02187055|69185433|FG000|Overall Study|Lost to Follow-up|2|||
37707507|NCT02187055|69185434|FG001|Overall Study|Lost to Follow-up|7|||
37707508|NCT02187055|69185435|FG002|Overall Study|Lost to Follow-up|3|||
37707509|NCT02187055|69185433|FG000|Overall Study|No longer meets eligibility criteria|0|||
37707510|NCT02187055|69185434|FG001|Overall Study|No longer meets eligibility criteria|2|||
37707511|NCT02187055|69185435|FG002|Overall Study|No longer meets eligibility criteria|0|||
37707512|NCT02187055|69185433|FG000|Overall Study|No longer willing to participate|6|||
37707513|NCT02187055|69185434|FG001|Overall Study|No longer willing to participate|8|||
37707514|NCT02187055|69185435|FG002|Overall Study|No longer willing to participate|10|||
37707515|NCT02187055|69185433|FG000|Overall Study|Other|5|||
37707516|NCT02187055|69185434|FG001|Overall Study|Other|6|||
37707517|NCT02187055|69185435|FG002|Overall Study|Other|3|||
37707518|NCT02187055|69185433|FG000|Overall Study|Protocol Violation|9|||
37707519|NCT02187055|69185434|FG001|Overall Study|Protocol Violation|9|||
37707520|NCT02187055|69185435|FG002|Overall Study|Protocol Violation|4|||
37707521|NCT02187055|69185433|FG000|Overall Study|Pregnancy|3|||
37707522|NCT02187055|69185434|FG001|Overall Study|Pregnancy|1|||
37707523|NCT02187055|69185435|FG002|Overall Study|Pregnancy|0|||
37707524|NCT02187055|69185433|FG000|Overall Study|Withdrawal by Subject|11|||
37707525|NCT02187055|69185434|FG001|Overall Study|Withdrawal by Subject|11|||
37707526|NCT02187055|69185435|FG002|Overall Study|Withdrawal by Subject|11|||
37707527|NCT02187055|69185433|FG000|Overall Study|Adverse Event|21|||
37707528|NCT02187055|69185434|FG001|Overall Study|Adverse Event|26|||
37707529|NCT02187055|69185435|FG002|Overall Study|Adverse Event|36|||
37707530|NCT02187055|69185433|FG000|Overall Study|Death|2|||
37707531|NCT02187055|69185434|FG001|Overall Study|Death|0|||
37707532|NCT02187055|69185435|FG002|Overall Study|Death|0|||
37707533|NCT02246660|69185475|FG000|Overall Study|Withdrawal by Subject|0|||
37707534|NCT02246660|69185476|FG001|Overall Study|Withdrawal by Subject|1|||
37707535|NCT02246660|69185477|FG002|Overall Study|Withdrawal by Subject|0|||
37707536|NCT02246660|69185475|FG000|Overall Study|Death|0|||
37707537|NCT02246660|69185476|FG001|Overall Study|Death|0|||
37707538|NCT02246660|69185477|FG002|Overall Study|Death|1|||
37707539|NCT02246582|69185485|FG000|Overall Study|Withdrawal by Subject|3|||
37707540|NCT02246582|69185486|FG001|Overall Study|Withdrawal by Subject|4|||
37707541|NCT02137369|69185492|FG000|Overall Study|Withdrawal by Subject|3|||
37707542|NCT02137369|69185493|FG001|Overall Study|Withdrawal by Subject|2|||
37707543|NCT02137369|69185492|FG000|Overall Study|Adverse Event|2|||
37707544|NCT02137369|69185493|FG001|Overall Study|Adverse Event|0|||
37707545|NCT02137369|69185492|FG000|Overall Study|Lost to Follow-up|1|||
37707546|NCT02137369|69185493|FG001|Overall Study|Lost to Follow-up|0|||
37707547|NCT02137369|69185492|FG000|Overall Study|Moved away|2|||
37707548|NCT02137369|69185493|FG001|Overall Study|Moved away|0|||
37707549|NCT02155309|69185502|FG000|Overall Study|Protocol Violation|0|||
37707550|NCT02155309|69185503|FG001|Overall Study|Protocol Violation|0|||
37707551|NCT02155309|69185504|FG002|Overall Study|Protocol Violation|1|||
37707552|NCT02186821|69185511|FG000|Overall Study|Adverse Event|9|||
37707553|NCT02186821|69185511|FG000|Overall Study|Death|2|||
37707554|NCT02186821|69185511|FG000|Overall Study|Disease progression|32|||
37707555|NCT02186821|69185511|FG000|Overall Study|Protocol Violation|1|||
37707556|NCT02186821|69185511|FG000|Overall Study|Physician Decision|1|||
37707557|NCT02186821|69185511|FG000|Overall Study|Study terminated by sponsor|2|||
37707558|NCT01710358|69185518|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
37707559|NCT01710358|69185519|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
37707560|NCT01710358|69185520|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
37707561|NCT01710358|69185518|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
37707562|NCT01710358|69185519|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
37707563|NCT01710358|69185520|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
37707564|NCT01710358|69185518|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
37707565|NCT01710358|69185519|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
37707566|NCT01710358|69185520|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
37707567|NCT01710358|69185518|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
37707568|NCT01710358|69185519|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
38024160|NCT04524598|69707627|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
37707569|NCT01710358|69185520|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
37707570|NCT01710358|69185518|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
37707571|NCT01710358|69185519|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
37707572|NCT01710358|69185520|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
37707573|NCT01710358|69185518|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
37707574|NCT01710358|69185519|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
37707575|NCT01710358|69185520|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
37707576|NCT01710358|69185518|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
37707577|NCT01710358|69185519|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
37707578|NCT01710358|69185520|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
37707579|NCT01710358|69185518|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
37707580|NCT01710358|69185519|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
37707581|NCT01710358|69185520|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
37707582|NCT01710358|69185518|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
37707583|NCT01710358|69185519|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
37707584|NCT01710358|69185520|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
37707585|NCT01710358|69185518|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
37707586|NCT01710358|69185519|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
37707587|NCT01710358|69185520|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
37707588|NCT01710358|69185518|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
37707589|NCT01710358|69185519|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
37707590|NCT01710358|69185520|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
37707591|NCT01710358|69185518|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
37707592|NCT01710358|69185519|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
37707593|NCT01710358|69185520|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
37707594|NCT01710358|69185518|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
37707595|NCT01710358|69185519|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
37707596|NCT01710358|69185520|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
37707597|NCT01710358|69185518|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
37707598|NCT01710358|69185519|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
37707599|NCT01710358|69185520|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
37707600|NCT01710358|69185518|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
37707601|NCT01710358|69185519|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
37707602|NCT01710358|69185520|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
37707603|NCT01710358|69185518|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
37707604|NCT01710358|69185519|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
37707605|NCT01710358|69185520|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
37707606|NCT01710358|69185518|FG000|Rescue Period|Adverse Event|0|||
37707607|NCT01710358|69185519|FG001|Rescue Period|Adverse Event|15|||
37707608|NCT01710358|69185520|FG002|Rescue Period|Adverse Event|0|||
37707609|NCT01710358|69185518|FG000|Rescue Period|Death|0|||
37707610|NCT01710358|69185519|FG001|Rescue Period|Death|1|||
37707611|NCT01710358|69185520|FG002|Rescue Period|Death|0|||
37707612|NCT01710358|69185518|FG000|Rescue Period|Lack of Efficacy|0|||
37707613|NCT01710358|69185519|FG001|Rescue Period|Lack of Efficacy|7|||
37707614|NCT01710358|69185520|FG002|Rescue Period|Lack of Efficacy|0|||
37707615|NCT01710358|69185518|FG000|Rescue Period|Withdrawal by Subject|0|||
37707616|NCT01710358|69185519|FG001|Rescue Period|Withdrawal by Subject|8|||
37707617|NCT01710358|69185520|FG002|Rescue Period|Withdrawal by Subject|0|||
37707618|NCT01633112|69185544|FG000|Overall Study|Lack of Efficacy|1|||
37707619|NCT01633112|69185545|FG001|Overall Study|Lack of Efficacy|6|||
37707620|NCT01633112|69185546|FG002|Overall Study|Lack of Efficacy|13|||
37707621|NCT01633112|69185544|FG000|Overall Study|Abnormal laboratory value(s)|3|||
37707622|NCT01633112|69185545|FG001|Overall Study|Abnormal laboratory value(s)|1|||
37707623|NCT01633112|69185546|FG002|Overall Study|Abnormal laboratory value(s)|0|||
37707624|NCT01633112|69185544|FG000|Overall Study|Abnormal test procedure result(s)|0|||
37707625|NCT01633112|69185545|FG001|Overall Study|Abnormal test procedure result(s)|1|||
37707626|NCT01633112|69185546|FG002|Overall Study|Abnormal test procedure result(s)|0|||
37707627|NCT01633112|69185544|FG000|Overall Study|Administrative problems|1|||
37707628|NCT01633112|69185545|FG001|Overall Study|Administrative problems|2|||
37707629|NCT01633112|69185546|FG002|Overall Study|Administrative problems|5|||
37707630|NCT01633112|69185544|FG000|Overall Study|Adverse Event|16|||
37707631|NCT01633112|69185545|FG001|Overall Study|Adverse Event|18|||
37707632|NCT01633112|69185546|FG002|Overall Study|Adverse Event|20|||
37707633|NCT01633112|69185544|FG000|Overall Study|Lost to Follow-up|7|||
37707634|NCT01633112|69185545|FG001|Overall Study|Lost to Follow-up|19|||
37707635|NCT01633112|69185546|FG002|Overall Study|Lost to Follow-up|6|||
37707636|NCT01633112|69185544|FG000|Overall Study|Protocol Violation|4|||
37707637|NCT01633112|69185545|FG001|Overall Study|Protocol Violation|0|||
37707638|NCT01633112|69185546|FG002|Overall Study|Protocol Violation|2|||
38024161|NCT04524598|69707628|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
37707639|NCT01633112|69185544|FG000|Overall Study|Subject no longer requires study drug|0|||
37707640|NCT01633112|69185545|FG001|Overall Study|Subject no longer requires study drug|0|||
37707641|NCT01633112|69185546|FG002|Overall Study|Subject no longer requires study drug|1|||
37707642|NCT01633112|69185544|FG000|Overall Study|Withdrawal by Subject|20|||
37707643|NCT01633112|69185545|FG001|Overall Study|Withdrawal by Subject|12|||
37707644|NCT01633112|69185546|FG002|Overall Study|Withdrawal by Subject|41|||
37707645|NCT01633112|69185544|FG000|Overall Study|missing Study Completion CRF|1|||
37707646|NCT01633112|69185545|FG001|Overall Study|missing Study Completion CRF|1|||
37707647|NCT01633112|69185546|FG002|Overall Study|missing Study Completion CRF|4|||
37707648|NCT01691482|69185555|FG000|Treatment Period 2|Adverse Event|0|||
37707649|NCT01691482|69185556|FG001|Treatment Period 2|Adverse Event|1|||
37707650|NCT01691482|69185555|FG000|Treatment Period 2|Protocol Violation|1|||
37707651|NCT01691482|69185556|FG001|Treatment Period 2|Protocol Violation|1|||
37707652|NCT02246114|69185565|FG000|Overall Study|miscarriage|1|||
37707653|NCT02246114|69185566|FG001|Overall Study|miscarriage|0|||
37707654|NCT01710046|69185574|FG000|Overall Study|Lost to Follow-up|1|||
37707655|NCT01710046|69185575|FG001|Overall Study|Lost to Follow-up|0|||
37707656|NCT02154529|69185585|FG000|Overall Study|Death|1|||
37707657|NCT02154529|69185586|FG001|Overall Study|Death|1|||
37707658|NCT02154529|69185587|FG002|Overall Study|Death|5|||
37707659|NCT02154529|69185588|FG003|Overall Study|Death|1|||
37707660|NCT02154529|69185585|FG000|Overall Study|Termination of study by sponsor|2|||
37707661|NCT02154529|69185586|FG001|Overall Study|Termination of study by sponsor|2|||
37707662|NCT02154529|69185587|FG002|Overall Study|Termination of study by sponsor|3|||
37707663|NCT02154529|69185588|FG003|Overall Study|Termination of study by sponsor|1|||
37707664|NCT02154529|69185585|FG000|Overall Study|Lost to Follow-up|1|||
37707665|NCT02154529|69185586|FG001|Overall Study|Lost to Follow-up|0|||
37707666|NCT02154529|69185587|FG002|Overall Study|Lost to Follow-up|0|||
37707667|NCT02154529|69185588|FG003|Overall Study|Lost to Follow-up|0|||
37707668|NCT01954017|69185603|FG000|Overall Study|Adverse Event|0|||
37707669|NCT01954017|69185604|FG001|Overall Study|Adverse Event|0|||
37707670|NCT01954017|69185605|FG002|Overall Study|Adverse Event|1|||
37707671|NCT01954017|69185603|FG000|Overall Study|Death|2|||
37707672|NCT01954017|69185604|FG001|Overall Study|Death|1|||
37707673|NCT01954017|69185605|FG002|Overall Study|Death|1|||
37707674|NCT01954017|69185603|FG000|Overall Study|Withdrawal by Subject|0|||
37707675|NCT01954017|69185604|FG001|Overall Study|Withdrawal by Subject|1|||
37707676|NCT01954017|69185605|FG002|Overall Study|Withdrawal by Subject|0|||
37707677|NCT01954017|69185603|FG000|Overall Study|Protocol Violation|0|||
37707678|NCT01954017|69185604|FG001|Overall Study|Protocol Violation|3|||
37707679|NCT01954017|69185605|FG002|Overall Study|Protocol Violation|2|||
37707680|NCT01954017|69185603|FG000|Overall Study|Necrotizing enterocolitis|1|||
37707681|NCT01954017|69185604|FG001|Overall Study|Necrotizing enterocolitis|0|||
37707682|NCT01954017|69185605|FG002|Overall Study|Necrotizing enterocolitis|1|||
37707683|NCT01954017|69185603|FG000|Overall Study|Enteral intake stopped >7 days|0|||
37707684|NCT01954017|69185604|FG001|Overall Study|Enteral intake stopped >7 days|1|||
37707685|NCT01954017|69185605|FG002|Overall Study|Enteral intake stopped >7 days|1|||
37707686|NCT01954017|69185603|FG000|Overall Study|All other reasons|2|||
37707687|NCT01954017|69185604|FG001|Overall Study|All other reasons|2|||
37707688|NCT01954017|69185605|FG002|Overall Study|All other reasons|7|||
37707689|NCT02154139|69185639|FG000|Overall Study|Injection not administered|2|||
37707690|NCT02154139|69185639|FG000|Overall Study|Other|2|||
37707691|NCT02154139|69185639|FG000|Overall Study|Investigator transferred|3|||
37707692|NCT02245568|69185643|FG000|Overall Study|Study terminated by Sponsor|346|||
37707693|NCT02245568|69185643|FG000|Overall Study|Adverse Event|144|||
37707694|NCT02245568|69185643|FG000|Overall Study|Lack of Efficacy|98|||
37707695|NCT02245568|69185643|FG000|Overall Study|Withdrawal by Caregiver|85|||
37707696|NCT02245568|69185643|FG000|Overall Study|Withdrawal by Subject|77|||
37707697|NCT02245568|69185643|FG000|Overall Study|Withdrawal by Legal Representative|31|||
37707698|NCT02245568|69185643|FG000|Overall Study|Missing (Site closure)|16|||
37707699|NCT02245568|69185643|FG000|Overall Study|Physician Decision|14|||
37707700|NCT02245568|69185643|FG000|Overall Study|Non-compliance with study drug|11|||
37707701|NCT02245568|69185643|FG000|Overall Study|Death|9|||
38024162|NCT04524598|69707624|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
37707702|NCT02245568|69185643|FG000|Overall Study|Blue staining|6|||
37707703|NCT02245568|69185643|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
37707704|NCT02245568|69185643|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
37707705|NCT02245568|69185643|FG000|Overall Study|Lost to Follow-up|5|||
37707706|NCT02154061|69185649|FG000|Overall Study|Pregnancy|1|||
37707707|NCT02154061|69185650|FG001|Overall Study|Pregnancy|0|||
37837862|NCT01147744|69522304|FG005|Overall Study|Sponsor decision to amend protocol|2|||
37837863|NCT01147744|69522305|FG006|Overall Study|Sponsor decision to amend protocol|6|||
37837864|NCT01147744|69522299|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
37707708|NCT02154061|69185649|FG000|Overall Study|enrolled but not vaccinated|1|||
37707709|NCT02154061|69185650|FG001|Overall Study|enrolled but not vaccinated|0|||
37707710|NCT01907217|69185658|FG000|Overall Study|Withdrawal by Subject|0|||
37707711|NCT01907217|69185659|FG001|Overall Study|Withdrawal by Subject|2|||
37707712|NCT01953783|69185667|FG000|Overall Study|Progressive disease|2|||
37707713|NCT02134015|69185673|FG000|Overall Study|Protocol Violation|0|||
37707714|NCT02134015|69185674|FG001|Overall Study|Protocol Violation|1|||
37707715|NCT02134015|69185673|FG000|Overall Study|Death|2|||
37707716|NCT02134015|69185674|FG001|Overall Study|Death|1|||
37707717|NCT02134015|69185673|FG000|Overall Study|Reason not provided|1|||
37707718|NCT02134015|69185674|FG001|Overall Study|Reason not provided|2|||
37707719|NCT02134015|69185673|FG000|Overall Study|Clinical progression|14|||
37707720|NCT02134015|69185674|FG001|Overall Study|Clinical progression|7|||
37707721|NCT02134015|69185673|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
37707722|NCT02134015|69185674|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
37707723|NCT02134015|69185673|FG000|Overall Study|Study terminated by sponsor|2|||
37707724|NCT02134015|69185674|FG001|Overall Study|Study terminated by sponsor|3|||
37707725|NCT02134015|69185673|FG000|Overall Study|Adverse Event|9|||
37707726|NCT02134015|69185674|FG001|Overall Study|Adverse Event|10|||
37707727|NCT02134015|69185673|FG000|Overall Study|Withdrawal by Subject|3|||
37707728|NCT02134015|69185674|FG001|Overall Study|Withdrawal by Subject|7|||
37707729|NCT01924845|69185680|FG000|Overall Study|Adverse Event|3|||
37707730|NCT01924845|69185680|FG000|Overall Study|Withdrawal by Subject|2|||
37707731|NCT01924845|69185680|FG000|Overall Study|Protocol Violation|1|||
37707732|NCT01630135|69185686|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
37707733|NCT01630135|69185687|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
37707734|NCT01691248|69185695|FG000|Overall Study|Protocol Violation|43|||
37707735|NCT01691248|69185696|FG001|Overall Study|Protocol Violation|27|||
37707736|NCT01691248|69185695|FG000|Overall Study|Adverse Event|24|||
37707737|NCT01691248|69185696|FG001|Overall Study|Adverse Event|22|||
37707738|NCT01691248|69185695|FG000|Overall Study|Withdrawal by Subject|20|||
37707739|NCT01691248|69185696|FG001|Overall Study|Withdrawal by Subject|18|||
37707740|NCT01691248|69185695|FG000|Overall Study|Confirmed CDAD|14|||
37707741|NCT01691248|69185696|FG001|Overall Study|Confirmed CDAD|31|||
37707742|NCT01691248|69185695|FG000|Overall Study|Lost to Follow-up|2|||
37707743|NCT01691248|69185696|FG001|Overall Study|Lost to Follow-up|5|||
37707744|NCT01691248|69185695|FG000|Overall Study|Reason not provided|4|||
37707745|NCT01691248|69185696|FG001|Overall Study|Reason not provided|4|||
37707746|NCT01691248|69185695|FG000|Overall Study|Not Treated|4|||
37707747|NCT01691248|69185696|FG001|Overall Study|Not Treated|7|||
37707748|NCT01924767|69185707|FG000|Overall Study|Adverse Event|1|||
37707749|NCT01924767|69185708|FG001|Overall Study|Adverse Event|0|||
37707750|NCT01924767|69185709|FG002|Overall Study|Adverse Event|1|||
37707751|NCT01924767|69185710|FG003|Overall Study|Adverse Event|0|||
37707752|NCT01924767|69185711|FG004|Overall Study|Adverse Event|0|||
37707753|NCT01691092|69185728|FG000|Overall Study|Lost to Follow-up|10|||
37707754|NCT01691092|69185728|FG000|Overall Study|Physician Decision|4|||
37707755|NCT01691092|69185728|FG000|Overall Study|Withdrawal by Subject|3|||
37707756|NCT01691092|69185728|FG000|Overall Study|non-compliance|3|||
37707757|NCT01691092|69185728|FG000|Overall Study|used for different study|2|||
37707758|NCT01691092|69185728|FG000|Overall Study|screen fail|19|||
37707759|NCT02133001|69185734|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
37707760|NCT02133001|69185735|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
37707761|NCT02133001|69185734|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
37707762|NCT02133001|69185735|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
37707763|NCT02133001|69185734|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
37915302|NCT00711958|69602091|FG000|Overall Study|Clinical deterioration|1|||
37915303|NCT00711958|69602092|FG001|Overall Study|Clinical deterioration|0|||
37915304|NCT00711958|69602091|FG000|Overall Study|Adverse Event|9|||
37915305|NCT00711958|69602092|FG001|Overall Study|Adverse Event|7|||
37915306|NCT00711958|69602091|FG000|Overall Study|Protocol Violation|1|||
37915307|NCT00711958|69602092|FG001|Overall Study|Protocol Violation|0|||
37707764|NCT02133001|69185735|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
37915308|NCT00711958|69602091|FG000|Overall Study|Lost to Follow-up|2|||
38024163|NCT04524598|69707625|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
37707765|NCT02133001|69185734|FG000|Double Blind (Day 1-25)|Other|2|||
37707766|NCT02133001|69185735|FG001|Double Blind (Day 1-25)|Other|2|||
37707767|NCT02133001|69185734|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
37707768|NCT02133001|69185735|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
37707769|NCT02133001|69185734|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
37707770|NCT02133001|69185735|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
37707771|NCT02133001|69185734|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
37707772|NCT02133001|69185735|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
37707773|NCT02133001|69185734|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
37707774|NCT02133001|69185735|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
37707775|NCT01709578|69185746|FG000|Overall Study|Rescued and entered in long term safety|63|||
37707776|NCT01709578|69185747|FG001|Overall Study|Rescued and entered in long term safety|25|||
37707777|NCT01709578|69185748|FG002|Overall Study|Rescued and entered in long term safety|26|||
37707778|NCT01709578|69185746|FG000|Overall Study|Adverse Event|9|||
37707779|NCT01709578|69185747|FG001|Overall Study|Adverse Event|18|||
37707780|NCT01709578|69185748|FG002|Overall Study|Adverse Event|17|||
37707781|NCT01709578|69185746|FG000|Overall Study|Lack of Efficacy|5|||
37707782|NCT01709578|69185747|FG001|Overall Study|Lack of Efficacy|4|||
37707783|NCT01709578|69185748|FG002|Overall Study|Lack of Efficacy|2|||
37707784|NCT01709578|69185746|FG000|Overall Study|Poor compliance to protocol|1|||
37707785|NCT01709578|69185747|FG001|Overall Study|Poor compliance to protocol|2|||
37707786|NCT01709578|69185748|FG002|Overall Study|Poor compliance to protocol|1|||
37707787|NCT01709578|69185746|FG000|Overall Study|Other, not related to safety or efficacy|2|||
37707788|NCT01709578|69185747|FG001|Overall Study|Other, not related to safety or efficacy|7|||
37707789|NCT01709578|69185748|FG002|Overall Study|Other, not related to safety or efficacy|5|||
37707790|NCT02132767|69185758|FG000|Overall Study|Death|3|||
37707791|NCT02132767|69185759|FG001|Overall Study|Death|2|||
37707792|NCT02132767|69185758|FG000|Overall Study|Withdrawal by Subject|10|||
37707793|NCT02132767|69185759|FG001|Overall Study|Withdrawal by Subject|9|||
37707794|NCT02132767|69185758|FG000|Overall Study|Lost to Follow-up|4|||
37707795|NCT02132767|69185759|FG001|Overall Study|Lost to Follow-up|4|||
37707796|NCT02153905|69185767|FG000|Overall Study|Death|1|||
37707797|NCT02153905|69185768|FG001|Overall Study|Death|0|||
37707798|NCT02153827|69185776|FG000|Overall Study|Lost to Follow-up|3|||
37707799|NCT02153827|69185777|FG001|Overall Study|Lost to Follow-up|9|||
37707800|NCT02153359|69185783|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
37707801|NCT02153359|69185784|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
37707802|NCT01691014|69185797|FG000|Overall Study|Premature Termination|1|||
37707803|NCT01691014|69185798|FG001|Overall Study|Premature Termination|6|||
37707804|NCT01691014|69185799|FG002|Overall Study|Premature Termination|0|||
37707805|NCT01691014|69185800|FG003|Overall Study|Premature Termination|3|||
37707806|NCT01691014|69185797|FG000|Overall Study|Other|0|||
37707807|NCT01691014|69185798|FG001|Overall Study|Other|0|||
37707808|NCT01691014|69185799|FG002|Overall Study|Other|2|||
37707809|NCT01691014|69185800|FG003|Overall Study|Other|0|||
37707810|NCT01691014|69185797|FG000|Overall Study|Withdrawal by Subject|0|||
37707811|NCT01691014|69185798|FG001|Overall Study|Withdrawal by Subject|1|||
37837865|NCT01147744|69522300|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
37915309|NCT00711958|69602092|FG001|Overall Study|Lost to Follow-up|2|||
38024164|NCT04524598|69707626|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
38024165|NCT04524598|69707627|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
38024166|NCT04524598|69707628|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
38024167|NCT04524598|69707624|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
38024168|NCT04524598|69707625|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
38024169|NCT04524598|69707626|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
38024170|NCT04524598|69707627|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
38024171|NCT04524598|69707628|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
38024172|NCT04524598|69707624|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
38024173|NCT04524598|69707625|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
38024174|NCT04524598|69707626|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
38024175|NCT04524598|69707627|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
38024176|NCT04524598|69707628|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
38024177|NCT04524598|69707624|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
38024178|NCT04524598|69707625|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
38024179|NCT04524598|69707626|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
38024180|NCT04524598|69707627|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
38024181|NCT04524598|69707628|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
38024182|NCT04524598|69707624|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
38024183|NCT04524598|69707625|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
38024184|NCT04524598|69707626|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
37707812|NCT01691014|69185799|FG002|Overall Study|Withdrawal by Subject|1|||
37707813|NCT01691014|69185800|FG003|Overall Study|Withdrawal by Subject|1|||
37707814|NCT01691014|69185797|FG000|Overall Study|Adverse Event|0|||
37707815|NCT01691014|69185798|FG001|Overall Study|Adverse Event|5|||
37707816|NCT01691014|69185799|FG002|Overall Study|Adverse Event|1|||
37707817|NCT01691014|69185800|FG003|Overall Study|Adverse Event|1|||
37707818|NCT01691014|69185797|FG000|Overall Study|Lack of Efficacy|2|||
37707819|NCT01691014|69185798|FG001|Overall Study|Lack of Efficacy|3|||
37707820|NCT01691014|69185799|FG002|Overall Study|Lack of Efficacy|7|||
37707821|NCT01691014|69185800|FG003|Overall Study|Lack of Efficacy|0|||
37707822|NCT02245412|69185813|FG000|Treatment Period|Death|1|||
37707823|NCT02245412|69185814|FG001|Treatment Period|Death|1|||
37707824|NCT02245412|69185815|FG002|Treatment Period|Death|0|||
37707825|NCT02245412|69185813|FG000|Treatment Period|Physician Decision|1|||
37707826|NCT02245412|69185814|FG001|Treatment Period|Physician Decision|1|||
37707827|NCT02245412|69185815|FG002|Treatment Period|Physician Decision|0|||
37707828|NCT02245412|69185813|FG000|Treatment Period|Withdrawal by Subject|2|||
37707829|NCT02245412|69185814|FG001|Treatment Period|Withdrawal by Subject|1|||
37707830|NCT02245412|69185815|FG002|Treatment Period|Withdrawal by Subject|0|||
37707831|NCT02245412|69185813|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
38024185|NCT04524598|69707627|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
38024186|NCT04524598|69707628|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
38024187|NCT04524598|69707624|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
38024188|NCT04524598|69707625|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
38024189|NCT04524598|69707626|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
38024190|NCT04524598|69707627|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
38024191|NCT04524598|69707628|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
38024192|NCT03075904|69707642|FG000|Overall Study|Physician Decision|3|||
38024193|NCT03075904|69707642|FG000|Overall Study|Need for Medication not Permitted|1|||
38024194|NCT03073798|69707646|FG000|Overall Study|Adverse Event|1|||
38024195|NCT03073798|69707646|FG000|Overall Study|Withdrawal by Subject|1|||
38024196|NCT03075826|69707651|FG000|Overall Study|Withdrawal by Subject|1|||
38024197|NCT03075826|69707651|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
38024198|NCT02865850|69707666|FG000|Overall Study|Death|15|||
38024199|NCT02865850|69707667|FG001|Overall Study|Death|19|||
38024200|NCT02865850|69707666|FG000|Overall Study|Withdrawal by Subject|3|||
38024201|NCT02865850|69707667|FG001|Overall Study|Withdrawal by Subject|2|||
38024202|NCT02865850|69707666|FG000|Overall Study|Lost to Follow-up|3|||
38024203|NCT02865850|69707667|FG001|Overall Study|Lost to Follow-up|2|||
38024204|NCT03711162|69707676|FG000|Overall Study|Adverse Event|5|||
38024205|NCT03711162|69707677|FG001|Overall Study|Adverse Event|2|||
38024206|NCT03711162|69707678|FG002|Overall Study|Adverse Event|4|||
38024207|NCT03711162|69707676|FG000|Overall Study|Death|11|||
38024208|NCT03711162|69707677|FG001|Overall Study|Death|7|||
38024209|NCT03711162|69707678|FG002|Overall Study|Death|8|||
38024210|NCT03711162|69707676|FG000|Overall Study|Lost to Follow-up|1|||
38024211|NCT03711162|69707677|FG001|Overall Study|Lost to Follow-up|0|||
38024212|NCT03711162|69707678|FG002|Overall Study|Lost to Follow-up|1|||
38024213|NCT03711162|69707676|FG000|Overall Study|Study Terminated by Sponsor|139|||
38024214|NCT03711162|69707677|FG001|Overall Study|Study Terminated by Sponsor|152|||
38024215|NCT03711162|69707678|FG002|Overall Study|Study Terminated by Sponsor|146|||
38024216|NCT03711162|69707676|FG000|Overall Study|Withdrawal by Subject|17|||
38024217|NCT03711162|69707677|FG001|Overall Study|Withdrawal by Subject|10|||
38024218|NCT03711162|69707678|FG002|Overall Study|Withdrawal by Subject|10|||
38024219|NCT03711162|69707676|FG000|Overall Study|Miscellaneous|1|||
38024220|NCT03711162|69707677|FG001|Overall Study|Miscellaneous|2|||
38024221|NCT03711162|69707678|FG002|Overall Study|Miscellaneous|2|||
38024222|NCT03711162|69707676|FG000|Overall Study|Not Treated|1|||
38024223|NCT03711162|69707677|FG001|Overall Study|Not Treated|0|||
38024224|NCT03711162|69707678|FG002|Overall Study|Not Treated|1|||
38024225|NCT03711162|69707676|FG000|Overall Study|Physician Decision|0|||
38024226|NCT03711162|69707677|FG001|Overall Study|Physician Decision|2|||
38024227|NCT03711162|69707678|FG002|Overall Study|Physician Decision|0|||
38024228|NCT03711162|69707676|FG000|Overall Study|Lack of Efficacy|0|||
38024229|NCT03711162|69707677|FG001|Overall Study|Lack of Efficacy|0|||
38024230|NCT03711162|69707678|FG002|Overall Study|Lack of Efficacy|2|||
38024231|NCT03711162|69707676|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
38024232|NCT03711162|69707677|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
38024233|NCT03711162|69707678|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
38024234|NCT03072160|69707694|FG000|Overall Study|Adverse Event|3|||
38024235|NCT03072160|69707695|FG001|Overall Study|Adverse Event|1|||
38024236|NCT03072160|69707694|FG000|Overall Study|Refused further treatment|6|||
38024237|NCT03072160|69707695|FG001|Overall Study|Refused further treatment|1|||
38024238|NCT03072160|69707694|FG000|Overall Study|Physician Decision|1|||
38024239|NCT03072160|69707695|FG001|Overall Study|Physician Decision|0|||
38024240|NCT03072160|69707694|FG000|Overall Study|Disease progression on study|1|||
38024241|NCT03072160|69707695|FG001|Overall Study|Disease progression on study|1|||
38024242|NCT03072160|69707694|FG000|Overall Study|No contact|0|||
38024243|NCT03072160|69707695|FG001|Overall Study|No contact|1|||
38024244|NCT00407602|69707733|FG000|Overall Study|Death - unrelated to device|1|||
38024245|NCT00407602|69707733|FG000|Overall Study|Device explanted|5|||
38024246|NCT00407602|69707733|FG000|Overall Study|Withdrawal by Subject|1|||
37707832|NCT02245412|69185814|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
37707833|NCT02245412|69185815|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
37707834|NCT02245412|69185813|FG000|Follow-Up Period|Death|4|||
37707835|NCT02245412|69185814|FG001|Follow-Up Period|Death|2|||
37837866|NCT01147744|69522301|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
37837867|NCT01147744|69522302|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
37837868|NCT01147744|69522303|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
37837869|NCT01147744|69522304|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
37837870|NCT01147744|69522305|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
37837871|NCT01147471|69522329|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
37837872|NCT01147471|69522330|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
37837873|NCT01147471|69522329|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
37837874|NCT01147471|69522330|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
37837875|NCT01147471|69522329|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
37837876|NCT01147471|69522330|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
37837877|NCT01147471|69522329|FG000|3 Month Follow Up|Lost to Follow-up|1|||
37837878|NCT01147471|69522330|FG001|3 Month Follow Up|Lost to Follow-up|1|||
37837879|NCT01147471|69522329|FG000|3 Month Follow Up|Physician Decision|0|||
37837880|NCT01147471|69522330|FG001|3 Month Follow Up|Physician Decision|1|||
37837881|NCT01147471|69522329|FG000|6 Month Follow Up|Lost to Follow-up|4|||
37837882|NCT01147471|69522330|FG001|6 Month Follow Up|Lost to Follow-up|2|||
37837883|NCT01147393|69522336|FG000|Dose Level 1|Dose limiting Toxicity|2|||
37915310|NCT00711958|69602091|FG000|Overall Study|Death|10|||
37915311|NCT00711958|69602092|FG001|Overall Study|Death|5|||
37915312|NCT00711958|69602091|FG000|Overall Study|Progression of disease|1|||
37915313|NCT00711958|69602092|FG001|Overall Study|Progression of disease|0|||
37915314|NCT00711880|69602100|FG000|Overall Study|Adverse Event|11|||
37915315|NCT00711880|69602101|FG001|Overall Study|Adverse Event|2|||
37915316|NCT00711880|69602100|FG000|Overall Study|Patient non-compliance|1|||
37915317|NCT00711880|69602101|FG001|Overall Study|Patient non-compliance|0|||
37915318|NCT00711880|69602100|FG000|Overall Study|Lack of Efficacy|1|||
37915319|NCT00711880|69602101|FG001|Overall Study|Lack of Efficacy|5|||
37837884|NCT01147393|69522336|FG000|Dose Level -1|Dose Limited Toxicity|1|||
37837885|NCT01146652|69522343|FG000|Overall Study|Adverse Event|506|||
37837886|NCT01146652|69522344|FG001|Overall Study|Adverse Event|15|||
37837887|NCT01146652|69522343|FG000|Overall Study|Lack of Efficacy|91|||
38024247|NCT03057496|69707740|FG000|Overall Study|Withdrawal by Subject|8|||
37837888|NCT01146652|69522344|FG001|Overall Study|Lack of Efficacy|7|||
37837889|NCT01146652|69522343|FG000|Overall Study|Poor compliance to protocol|38|||
37837890|NCT01146652|69522344|FG001|Overall Study|Poor compliance to protocol|1|||
37837891|NCT01146652|69522343|FG000|Overall Study|Other unspecified reasons|314|||
37837892|NCT01146652|69522344|FG001|Overall Study|Other unspecified reasons|22|||
37915320|NCT00528775|69602107|FG000|Overall Study|Other not specified|1|||
37915321|NCT00529399|69602114|FG000|Overall Study|Lost to Follow-up|1|||
37915322|NCT00529399|69602115|FG001|Overall Study|Lost to Follow-up|0|||
38024248|NCT03057496|69707740|FG000|Overall Study|Lost to Follow-up|5|||
38024249|NCT03057496|69707740|FG000|Overall Study|Did not use device during home trial|3|||
37915323|NCT00529399|69602116|FG002|Overall Study|Lost to Follow-up|1|||
37915324|NCT00529399|69602114|FG000|Overall Study|Withdrawal by Subject|1|||
37915325|NCT00529399|69602115|FG001|Overall Study|Withdrawal by Subject|0|||
37707836|NCT02245412|69185815|FG002|Follow-Up Period|Death|1|||
37837893|NCT01146652|69522343|FG000|Overall Study|Enrolled but not treated|2|||
37837894|NCT01146652|69522344|FG001|Overall Study|Enrolled but not treated|0|||
37837895|NCT01146613|69522359|FG000|Overall Study|Lost to Follow-up|3|||
37837896|NCT01146613|69522360|FG001|Overall Study|Lost to Follow-up|8|||
37837897|NCT01146613|69522359|FG000|Overall Study|Lack of Efficacy|0|||
37837898|NCT01146613|69522360|FG001|Overall Study|Lack of Efficacy|1|||
37837899|NCT01146613|69522359|FG000|Overall Study|Death|1|||
37837900|NCT01146613|69522360|FG001|Overall Study|Death|0|||
37837901|NCT01146613|69522359|FG000|Overall Study|Physician Decision|1|||
37837902|NCT01146613|69522360|FG001|Overall Study|Physician Decision|0|||
37837903|NCT01146613|69522359|FG000|Overall Study|Withdrawal by Subject|0|||
37837904|NCT01146613|69522360|FG001|Overall Study|Withdrawal by Subject|3|||
37837905|NCT01146613|69522359|FG000|Overall Study|schedule conflict|1|||
37837906|NCT01146613|69522360|FG001|Overall Study|schedule conflict|0|||
37837907|NCT01146613|69522359|FG000|Overall Study|Outpatient detox|1|||
37837908|NCT01146613|69522360|FG001|Overall Study|Outpatient detox|0|||
37837909|NCT01145755|69522369|FG000|Overall Study|Adverse Event|2|||
37837910|NCT01145755|69522370|FG001|Overall Study|Adverse Event|4|||
37837911|NCT01145755|69522371|FG002|Overall Study|Adverse Event|2|||
37837912|NCT01145755|69522369|FG000|Overall Study|Withdrawal by Subject|2|||
37837913|NCT01145755|69522370|FG001|Overall Study|Withdrawal by Subject|2|||
37837914|NCT01145755|69522371|FG002|Overall Study|Withdrawal by Subject|2|||
37837915|NCT01145755|69522369|FG000|Overall Study|Lost to Follow-up|2|||
37837916|NCT01145755|69522370|FG001|Overall Study|Lost to Follow-up|3|||
37837917|NCT01145755|69522371|FG002|Overall Study|Lost to Follow-up|1|||
37837918|NCT01145755|69522369|FG000|Overall Study|Protocol Violation|0|||
37837919|NCT01145755|69522370|FG001|Overall Study|Protocol Violation|3|||
37837920|NCT01145755|69522371|FG002|Overall Study|Protocol Violation|1|||
37837921|NCT01145755|69522369|FG000|Overall Study|Study Closure|14|||
37837922|NCT01145755|69522370|FG001|Overall Study|Study Closure|14|||
37837923|NCT01145755|69522371|FG002|Overall Study|Study Closure|17|||
37837924|NCT01145755|69522369|FG000|Overall Study|Lack of Efficacy|0|||
37707837|NCT02245412|69185813|FG000|Follow-Up Period|Physician Decision|1|||
37707838|NCT02245412|69185814|FG001|Follow-Up Period|Physician Decision|0|||
37707839|NCT02245412|69185815|FG002|Follow-Up Period|Physician Decision|0|||
37707840|NCT02245412|69185813|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
37837925|NCT01145755|69522370|FG001|Overall Study|Lack of Efficacy|1|||
37837926|NCT01145755|69522371|FG002|Overall Study|Lack of Efficacy|0|||
37837927|NCT01145755|69522369|FG000|Overall Study|Patient could not swollow medication|0|||
37837928|NCT01145755|69522370|FG001|Overall Study|Patient could not swollow medication|0|||
37837929|NCT01145755|69522371|FG002|Overall Study|Patient could not swollow medication|1|||
37837930|NCT01145755|69522369|FG000|Overall Study|Withdrawal by Subject|0|||
37837931|NCT01145755|69522370|FG001|Overall Study|Withdrawal by Subject|0|||
37837932|NCT01145755|69522371|FG002|Overall Study|Withdrawal by Subject|1|||
37837933|NCT01145755|69522369|FG000|Overall Study|Positive urine ethanol|0|||
37837934|NCT01145755|69522370|FG001|Overall Study|Positive urine ethanol|1|||
37837935|NCT01145755|69522371|FG002|Overall Study|Positive urine ethanol|0|||
37837936|NCT01145560|69522382|FG000|Overall Study|Withdrawal by Subject|2|||
37837937|NCT01145560|69522383|FG001|Overall Study|Withdrawal by Subject|1|||
37837938|NCT01145560|69522384|FG002|Overall Study|Withdrawal by Subject|0|||
37837939|NCT01145560|69522382|FG000|Overall Study|Lost to Follow-up|1|||
37837940|NCT01145560|69522383|FG001|Overall Study|Lost to Follow-up|1|||
37837941|NCT01145560|69522384|FG002|Overall Study|Lost to Follow-up|1|||
37837942|NCT01145560|69522382|FG000|Overall Study|No study drug by 24h after organ failure|1|||
37837943|NCT01145560|69522383|FG001|Overall Study|No study drug by 24h after organ failure|0|||
37837944|NCT01145560|69522384|FG002|Overall Study|No study drug by 24h after organ failure|0|||
37837945|NCT01145560|69522382|FG000|Overall Study|Accidental unblinding of study treatment|0|||
37837946|NCT01145560|69522383|FG001|Overall Study|Accidental unblinding of study treatment|1|||
37837947|NCT01145560|69522384|FG002|Overall Study|Accidental unblinding of study treatment|0|||
37837948|NCT01145560|69522382|FG000|Overall Study|False insurance information|0|||
37837949|NCT01145560|69522383|FG001|Overall Study|False insurance information|1|||
37837950|NCT01145560|69522384|FG002|Overall Study|False insurance information|0|||
37837951|NCT01145560|69522382|FG000|Overall Study|Withdrawal of therapy|0|||
37707841|NCT02245412|69185814|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
37707842|NCT02245412|69185815|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
37707843|NCT02244944|69185823|FG000|Overall Study|Withdrawal by Subject|1|||
37837952|NCT01145560|69522383|FG001|Overall Study|Withdrawal of therapy|0|||
37707844|NCT02244944|69185823|FG000|Overall Study|Study Terminated|1|||
37707845|NCT01689532|69185829|FG000|Overall Study|Adverse Event|9|||
37837953|NCT01145560|69522384|FG002|Overall Study|Withdrawal of therapy|1|||
37837954|NCT01145482|69522394|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
37837955|NCT01145482|69522395|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
37837956|NCT01145053|69522401|FG000|Overall Study|Adverse Event|22|||
37707846|NCT01689532|69185830|FG001|Overall Study|Adverse Event|5|||
37837957|NCT01145053|69522401|FG000|Overall Study|Lost to Follow-up|28|||
37837958|NCT01145053|69522401|FG000|Overall Study|Withdrawal by Subject|25|||
37707847|NCT01689532|69185829|FG000|Overall Study|Lack of Efficacy|2|||
37707848|NCT01689532|69185830|FG001|Overall Study|Lack of Efficacy|2|||
37707849|NCT01689532|69185829|FG000|Overall Study|Withdrawal by Subject|1|||
37707850|NCT01689532|69185830|FG001|Overall Study|Withdrawal by Subject|2|||
37707851|NCT01689532|69185829|FG000|Overall Study|Physician Decision|2|||
37707852|NCT01689532|69185830|FG001|Overall Study|Physician Decision|0|||
37707853|NCT01924689|69185842|FG000|Overall Study|Death|0|||
37707854|NCT01924689|69185843|FG001|Overall Study|Death|1|||
37707855|NCT01924689|69185844|FG002|Overall Study|Death|0|||
37707856|NCT01924689|69185845|FG003|Overall Study|Death|1|||
37707857|NCT01924689|69185846|FG004|Overall Study|Death|0|||
37707858|NCT01924689|69185847|FG005|Overall Study|Death|0|||
37707859|NCT01924689|69185842|FG000|Overall Study|Disease progression|0|||
37707860|NCT01924689|69185843|FG001|Overall Study|Disease progression|0|||
37707861|NCT01924689|69185844|FG002|Overall Study|Disease progression|2|||
37707862|NCT01924689|69185845|FG003|Overall Study|Disease progression|0|||
37707863|NCT01924689|69185846|FG004|Overall Study|Disease progression|3|||
37707864|NCT01924689|69185847|FG005|Overall Study|Disease progression|2|||
37707865|NCT01924689|69185842|FG000|Overall Study|New therapy or study|3|||
37707866|NCT01924689|69185843|FG001|Overall Study|New therapy or study|2|||
37707867|NCT01924689|69185844|FG002|Overall Study|New therapy or study|1|||
37707868|NCT01924689|69185845|FG003|Overall Study|New therapy or study|4|||
37707869|NCT01924689|69185846|FG004|Overall Study|New therapy or study|2|||
37707870|NCT01924689|69185847|FG005|Overall Study|New therapy or study|0|||
37707871|NCT01924689|69185842|FG000|Overall Study|Withdrawal of consent|0|||
37707872|NCT01924689|69185843|FG001|Overall Study|Withdrawal of consent|0|||
37707873|NCT01924689|69185844|FG002|Overall Study|Withdrawal of consent|1|||
37707874|NCT01924689|69185845|FG003|Overall Study|Withdrawal of consent|1|||
37707875|NCT01924689|69185846|FG004|Overall Study|Withdrawal of consent|0|||
37707876|NCT01924689|69185847|FG005|Overall Study|Withdrawal of consent|0|||
37707877|NCT01924689|69185842|FG000|Overall Study|Other|0|||
37707878|NCT01924689|69185843|FG001|Overall Study|Other|0|||
37707879|NCT01924689|69185844|FG002|Overall Study|Other|0|||
37707880|NCT01924689|69185845|FG003|Overall Study|Other|0|||
37707881|NCT01924689|69185846|FG004|Overall Study|Other|1|||
37707882|NCT01924689|69185847|FG005|Overall Study|Other|0|||
37707883|NCT01591330|69185865|FG000|Period 1|Adverse Event|1|||
37707884|NCT01591330|69185866|FG001|Period 1|Adverse Event|0|||
37707885|NCT01591330|69185867|FG002|Period 1|Adverse Event|0|||
37707886|NCT01591330|69185868|FG003|Period 1|Adverse Event|0|||
37707887|NCT01591330|69185865|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
37707888|NCT01591330|69185866|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
37707889|NCT01591330|69185867|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
37707890|NCT01591330|69185868|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
37707891|NCT01591330|69185865|FG000|Period 2|Adverse Event|1|||
37707892|NCT01591330|69185866|FG001|Period 2|Adverse Event|0|||
37707893|NCT01591330|69185867|FG002|Period 2|Adverse Event|0|||
37707894|NCT01591330|69185868|FG003|Period 2|Adverse Event|0|||
37707895|NCT01591096|69185878|FG000|Overall Study|Adverse Event|1|||
37707896|NCT01953003|69185884|FG000|Overall Study|Not treated|0|||
37707897|NCT01953003|69185885|FG001|Overall Study|Not treated|1|||
37707898|NCT01953003|69185884|FG000|Overall Study|Progressive disease|35|||
37707899|NCT01953003|69185885|FG001|Overall Study|Progressive disease|45|||
37707900|NCT01953003|69185884|FG000|Overall Study|Related Adverse events|7|||
37707901|NCT01953003|69185885|FG001|Overall Study|Related Adverse events|2|||
37707902|NCT01953003|69185884|FG000|Overall Study|Non-related adverse events|0|||
37707903|NCT01953003|69185885|FG001|Overall Study|Non-related adverse events|2|||
37707904|NCT01953003|69185884|FG000|Overall Study|Protocol Violation|0|||
37707905|NCT01953003|69185885|FG001|Overall Study|Protocol Violation|1|||
37707906|NCT01953003|69185884|FG000|Overall Study|Withdrawal by Subject|14|||
37915326|NCT00529399|69602116|FG002|Overall Study|Withdrawal by Subject|1|||
37707907|NCT01953003|69185885|FG001|Overall Study|Withdrawal by Subject|4|||
37707908|NCT01952691|69185891|FG000|Overall Study|Lost to Follow-up|2|||
37707909|NCT01709500|69185897|FG000|Overall Study|Randomized but not treated|0|||
37707910|NCT01709500|69185898|FG001|Overall Study|Randomized but not treated|1|||
37707911|NCT01709500|69185897|FG000|Overall Study|Adverse Event|5|||
37707912|NCT01709500|69185898|FG001|Overall Study|Adverse Event|1|||
37707913|NCT01709500|69185897|FG000|Overall Study|Poor compliance to protocol|2|||
37707914|NCT01709500|69185898|FG001|Overall Study|Poor compliance to protocol|1|||
37707915|NCT01709500|69185897|FG000|Overall Study|Other|3|||
37707916|NCT01709500|69185898|FG001|Overall Study|Other|1|||
37707917|NCT01709500|69185897|FG000|Overall Study|Related to IMP administration|1|||
37707918|NCT01709500|69185898|FG001|Overall Study|Related to IMP administration|0|||
37707919|NCT01709500|69185897|FG000|Overall Study|Treatment ongoing|156|||
37707920|NCT01709500|69185898|FG001|Overall Study|Treatment ongoing|78|||
37707921|NCT01599806|69185906|FG000|Overall Study|Lost to Follow-up|20|||
37707922|NCT01599806|69185907|FG001|Overall Study|Lost to Follow-up|20|||
37707923|NCT01599806|69185906|FG000|Overall Study|Withdrawal by Subject|12|||
37707924|NCT01599806|69185907|FG001|Overall Study|Withdrawal by Subject|12|||
37707925|NCT01599806|69185906|FG000|Overall Study|Other Eligibility criteria|11|||
37707926|NCT01599806|69185907|FG001|Overall Study|Other Eligibility criteria|9|||
37707927|NCT01599325|69185913|FG000|Primary Parent Phase|Adverse Event|5|||
37707928|NCT01599325|69185913|FG000|Primary Parent Phase|Disease Progression|7|||
37707929|NCT01599325|69185913|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
37707930|NCT01599325|69185913|FG000|Primary Parent Phase|Death|13|||
37707931|NCT01599325|69185913|FG000|Primary Parent Phase|Protocol Violation|1|||
37707932|NCT01599325|69185913|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
37707933|NCT01599325|69185913|FG000|Primary Parent Phase|Other|2|||
37837959|NCT01145053|69522401|FG000|Overall Study|Other|18|||
37837960|NCT01144663|69522409|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
37837961|NCT01144663|69522410|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
37837962|NCT01144663|69522411|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
37837963|NCT01144663|69522412|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
37837964|NCT01144663|69522409|FG000|Primary Vaccination Phase|Adverse Event|1|||
37837965|NCT01144663|69522410|FG001|Primary Vaccination Phase|Adverse Event|0|||
37837966|NCT01144663|69522411|FG002|Primary Vaccination Phase|Adverse Event|0|||
37837967|NCT01144663|69522412|FG003|Primary Vaccination Phase|Adverse Event|1|||
37837968|NCT01144663|69522409|FG000|Primary Vaccination Phase|Protocol Violation|2|||
37837969|NCT01144663|69522410|FG001|Primary Vaccination Phase|Protocol Violation|0|||
37915327|NCT00529399|69602114|FG000|Overall Study|Non-compliant|0|||
37707934|NCT01599325|69185913|FG000|Extension Phase|Study Closure|1|||
37707935|NCT01599325|69185913|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
37707936|NCT01599325|69185913|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
37707937|NCT01599325|69185913|FG000|Extension Phase|Disease Progression|1|||
37707938|NCT01599325|69185913|FG000|Extension Phase|Withdrawal by Subject|8|||
37707939|NCT01924299|69185920|FG000|Period 2|Withdrawal by Subject|1|||
37707940|NCT01924299|69185921|FG001|Period 2|Withdrawal by Subject|0|||
37707941|NCT01924299|69185920|FG000|Period 2|Adverse Event|0|||
37707942|NCT01924299|69185921|FG001|Period 2|Adverse Event|1|||
37707943|NCT02182999|69185935|FG000|Overall Study|Adverse Event|4|||
37707944|NCT02182999|69185936|FG001|Overall Study|Adverse Event|3|||
37707945|NCT02182999|69185935|FG000|Overall Study|Physician Decision|1|||
37707946|NCT02182999|69185936|FG001|Overall Study|Physician Decision|0|||
37707947|NCT02243696|69185942|FG000|Overall Study|Death|282|||
37707948|NCT02243696|69185942|FG000|Overall Study|Withdrawal by Subject|79|||
37707949|NCT02243696|69185942|FG000|Overall Study|Lost to Follow-up|57|||
37707950|NCT02243696|69185942|FG000|Overall Study|Subject No Longer has Study System|42|||
37707951|NCT02243696|69185942|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
37707952|NCT02243696|69185942|FG000|Overall Study|Study Terminated for EP PASSION|961|||
37707953|NCT01598311|69185948|FG000|Overall Study|Physician Decision|4|||
37707954|NCT01598311|69185949|FG001|Overall Study|Physician Decision|5|||
37707955|NCT01598311|69185948|FG000|Overall Study|Adverse Event|9|||
37707956|NCT01598311|69185949|FG001|Overall Study|Adverse Event|13|||
37707957|NCT01598311|69185948|FG000|Overall Study|Lost to Follow-up|7|||
37707958|NCT01598311|69185949|FG001|Overall Study|Lost to Follow-up|12|||
37707959|NCT01598311|69185948|FG000|Overall Study|Withdrawal by Subject|9|||
37707960|NCT01598311|69185949|FG001|Overall Study|Withdrawal by Subject|13|||
37707961|NCT01598311|69185948|FG000|Overall Study|No reason provided.|0|||
37707962|NCT01598311|69185949|FG001|Overall Study|No reason provided.|5|||
37707963|NCT01598311|69185948|FG000|Overall Study|Randomized but never treated|8|||
37707964|NCT01598311|69185949|FG001|Overall Study|Randomized but never treated|5|||
37707965|NCT01598311|69185948|FG000|Overall Study|Treated but no confirmed CDAD|9|||
37707966|NCT01598311|69185949|FG001|Overall Study|Treated but no confirmed CDAD|8|||
37707967|NCT01598311|69185948|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
37707968|NCT01598311|69185949|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
37707969|NCT02182843|69185955|FG000|Overall Study|Withdrawal by Subject|7|||
37707970|NCT02182843|69185955|FG000|Overall Study|Lost to Follow-up|2|||
37707971|NCT02182843|69185955|FG000|Overall Study|Adverse Event|1|||
37707972|NCT02208050|69185961|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
37707973|NCT02208050|69185962|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
37707974|NCT02978222|69185984|FG000|Overall Study|Withdrawal by Subject|2|||
37707975|NCT02978222|69185985|FG001|Overall Study|Withdrawal by Subject|2|||
37707976|NCT02978222|69185984|FG000|Overall Study|Physician Decision|2|||
37707977|NCT02978222|69185985|FG001|Overall Study|Physician Decision|0|||
37707978|NCT02978222|69185984|FG000|Overall Study|Adverse Event|0|||
37707979|NCT02978222|69185985|FG001|Overall Study|Adverse Event|1|||
37707980|NCT02978222|69185984|FG000|Overall Study|Death|1|||
37707981|NCT02978222|69185985|FG001|Overall Study|Death|0|||
37707982|NCT02978222|69185984|FG000|Overall Study|Disease Progression|32|||
37707983|NCT02978222|69185985|FG001|Overall Study|Disease Progression|32|||
37707984|NCT02978222|69185984|FG000|Overall Study|Early Study Termination|24|||
37707985|NCT02978222|69185985|FG001|Overall Study|Early Study Termination|21|||
37707986|NCT02181673|69185993|FG000|Up to Week 24|Adverse Event|2|||
37707987|NCT02181673|69185994|FG001|Up to Week 24|Adverse Event|0|||
37707988|NCT02181673|69185995|FG002|Up to Week 24|Adverse Event|3|||
37707989|NCT02181673|69185993|FG000|Up to Week 24|Death|1|||
37707990|NCT02181673|69185994|FG001|Up to Week 24|Death|0|||
37707991|NCT02181673|69185995|FG002|Up to Week 24|Death|0|||
37707992|NCT02181673|69185993|FG000|Up to Week 24|Lack of Efficacy|1|||
37707993|NCT02181673|69185994|FG001|Up to Week 24|Lack of Efficacy|0|||
37707994|NCT02181673|69185995|FG002|Up to Week 24|Lack of Efficacy|0|||
37707995|NCT02181673|69185993|FG000|Up to Week 24|Lost to Follow-up|1|||
37707996|NCT02181673|69185994|FG001|Up to Week 24|Lost to Follow-up|0|||
37707997|NCT02181673|69185995|FG002|Up to Week 24|Lost to Follow-up|0|||
37707998|NCT02181673|69185993|FG000|Up to Week 24|Physician Decision|0|||
37707999|NCT02181673|69185994|FG001|Up to Week 24|Physician Decision|0|||
37708000|NCT02181673|69185995|FG002|Up to Week 24|Physician Decision|3|||
37708001|NCT02181673|69185993|FG000|Up to Week 24|Withdrawal by Subject|10|||
37708002|NCT02181673|69185994|FG001|Up to Week 24|Withdrawal by Subject|0|||
37708003|NCT02181673|69185995|FG002|Up to Week 24|Withdrawal by Subject|1|||
37708004|NCT02181673|69185993|FG000|Up to Week 24|Other|2|||
37708005|NCT02181673|69185994|FG001|Up to Week 24|Other|0|||
37915328|NCT00529399|69602115|FG001|Overall Study|Non-compliant|1|||
37708006|NCT02181673|69185995|FG002|Up to Week 24|Other|3|||
37708007|NCT02181673|69185993|FG000|Up to Week 24|Randomized not Treated|0|||
37708008|NCT02181673|69185994|FG001|Up to Week 24|Randomized not Treated|0|||
37708009|NCT02181673|69185995|FG002|Up to Week 24|Randomized not Treated|1|||
37708010|NCT02181673|69185993|FG000|Week 24-Week 60|Adverse Event|0|||
37708011|NCT02181673|69185994|FG001|Week 24-Week 60|Adverse Event|4|||
37708012|NCT02181673|69185995|FG002|Week 24-Week 60|Adverse Event|10|||
37708013|NCT02181673|69185993|FG000|Week 24-Week 60|Other|0|||
37708014|NCT02181673|69185994|FG001|Week 24-Week 60|Other|2|||
37708015|NCT02181673|69185995|FG002|Week 24-Week 60|Other|1|||
37708016|NCT02181673|69185993|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
37708017|NCT02181673|69185994|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
37708018|NCT02181673|69185995|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
37708019|NCT02181673|69185993|FG000|Week 24-Week 60|Pregnancy|0|||
37708020|NCT02181673|69185994|FG001|Week 24-Week 60|Pregnancy|0|||
37708021|NCT02181673|69185995|FG002|Week 24-Week 60|Pregnancy|1|||
37708022|NCT02181673|69185993|FG000|Week 24-Week 60|Lack of Efficacy|0|||
37708023|NCT02181673|69185994|FG001|Week 24-Week 60|Lack of Efficacy|0|||
37708024|NCT02181673|69185995|FG002|Week 24-Week 60|Lack of Efficacy|1|||
37708025|NCT02181673|69185993|FG000|Week 24-Week 60|Lost to Follow-up|0|||
37708026|NCT02181673|69185994|FG001|Week 24-Week 60|Lost to Follow-up|0|||
37708027|NCT02181673|69185995|FG002|Week 24-Week 60|Lost to Follow-up|1|||
37708028|NCT02181673|69185993|FG000|Week 24-Week 60|Physician Decision|0|||
37708029|NCT02181673|69185994|FG001|Week 24-Week 60|Physician Decision|0|||
37708030|NCT02181673|69185995|FG002|Week 24-Week 60|Physician Decision|1|||
37708031|NCT02131129|69186004|FG000|Overall Study|Withdrawal by Subject|1|||
37708032|NCT02131129|69186005|FG001|Overall Study|Withdrawal by Subject|0|||
37708033|NCT02152345|69186013|FG000|Overall Study|Case Cancellations|2|||
37708034|NCT02152345|69186014|FG001|Overall Study|Case Cancellations|4|||
37708035|NCT02152345|69186013|FG000|Overall Study|Withdrawal by Subject|2|||
37708036|NCT02152345|69186014|FG001|Overall Study|Withdrawal by Subject|1|||
37708037|NCT02180659|69186022|FG000|Overall Study|Adverse Event|1|||
37708038|NCT02180659|69186023|FG001|Overall Study|Adverse Event|0|||
37708039|NCT02180659|69186022|FG000|Overall Study|Lost to Follow-up|4|||
37708040|NCT02180659|69186023|FG001|Overall Study|Lost to Follow-up|2|||
37708041|NCT02180659|69186022|FG000|Overall Study|Subject incarcerated during conduct|1|||
37708042|NCT02180659|69186023|FG001|Overall Study|Subject incarcerated during conduct|0|||
37708043|NCT02180659|69186022|FG000|Overall Study|Withdrawal by Subject|0|||
37708044|NCT02180659|69186023|FG001|Overall Study|Withdrawal by Subject|2|||
37708045|NCT02180659|69186022|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
37708046|NCT02180659|69186023|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
37708047|NCT02130427|69186029|FG000|Overall Study|Imaging results not interpretable|30|||
37708048|NCT02207816|69186036|FG000|Overall Study|Serious Adverse Event|0|||
37708049|NCT02207816|69186037|FG001|Overall Study|Serious Adverse Event|5|||
37708050|NCT02207816|69186038|FG002|Overall Study|Serious Adverse Event|2|||
37708051|NCT02207816|69186036|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
37708052|NCT02207816|69186037|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
37708053|NCT02207816|69186038|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
37708054|NCT02207816|69186036|FG000|Overall Study|Withdrawal by Subject|4|||
37708055|NCT02207816|69186037|FG001|Overall Study|Withdrawal by Subject|9|||
37708056|NCT02207816|69186038|FG002|Overall Study|Withdrawal by Subject|7|||
37708057|NCT02207816|69186036|FG000|Overall Study|Migrated/Moved From Study Area|41|||
37708058|NCT02207816|69186037|FG001|Overall Study|Migrated/Moved From Study Area|60|||
37708059|NCT02207816|69186038|FG002|Overall Study|Migrated/Moved From Study Area|51|||
37708060|NCT02207816|69186036|FG000|Overall Study|Lost to Follow-up|3|||
37708061|NCT02207816|69186037|FG001|Overall Study|Lost to Follow-up|9|||
37708062|NCT02207816|69186038|FG002|Overall Study|Lost to Follow-up|1|||
37708063|NCT02207816|69186036|FG000|Overall Study|Other|1|||
37708064|NCT02207816|69186037|FG001|Overall Study|Other|2|||
37708065|NCT02207816|69186038|FG002|Overall Study|Other|4|||
37708066|NCT02241512|69186051|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
37708067|NCT02241512|69186052|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
37708068|NCT02205476|69186060|FG000|Overall Study|Study termination by Sponsor|7|||
37708069|NCT02205476|69186061|FG001|Overall Study|Study termination by Sponsor|3|||
37708070|NCT01709110|69186075|FG000|Overall Study|Adverse Event|56|||
37708071|NCT01709110|69186076|FG001|Overall Study|Adverse Event|48|||
37708072|NCT01709110|69186075|FG000|Overall Study|Death|14|||
37708073|NCT01709110|69186076|FG001|Overall Study|Death|6|||
37708074|NCT01709110|69186075|FG000|Overall Study|Lost to Follow-up|7|||
37708075|NCT01709110|69186076|FG001|Overall Study|Lost to Follow-up|5|||
37708076|NCT01709110|69186075|FG000|Overall Study|Protocol Violation|4|||
37708077|NCT01709110|69186076|FG001|Overall Study|Protocol Violation|6|||
37708078|NCT01709110|69186075|FG000|Overall Study|Withdrawal by Subject|96|||
37708079|NCT01709110|69186076|FG001|Overall Study|Withdrawal by Subject|89|||
37708080|NCT01709110|69186075|FG000|Overall Study|Physician Decision|4|||
37708081|NCT01709110|69186076|FG001|Overall Study|Physician Decision|10|||
37708082|NCT01709110|69186075|FG000|Overall Study|Sponsor Decision|2|||
37708083|NCT01709110|69186076|FG001|Overall Study|Sponsor Decision|2|||
37708084|NCT01709110|69186075|FG000|Overall Study|Lack of Efficacy|1|||
37708085|NCT01709110|69186076|FG001|Overall Study|Lack of Efficacy|1|||
37708086|NCT01709110|69186075|FG000|Overall Study|Caregiver Decision|1|||
37708087|NCT01709110|69186076|FG001|Overall Study|Caregiver Decision|1|||
37708088|NCT02240108|69186084|FG000|Overall Study|Other than specified|8|||
37708089|NCT02240108|69186085|FG001|Overall Study|Other than specified|6|||
37708090|NCT02240108|69186084|FG000|Overall Study|Adverse Event|1|||
37708091|NCT02240108|69186085|FG001|Overall Study|Adverse Event|9|||
37708092|NCT02240108|69186084|FG000|Overall Study|Pregnancy|1|||
37708093|NCT02240108|69186085|FG001|Overall Study|Pregnancy|0|||
37708094|NCT02240108|69186084|FG000|Overall Study|Withdrawal by Subject|4|||
37708095|NCT02240108|69186085|FG001|Overall Study|Withdrawal by Subject|9|||
37708096|NCT02240108|69186084|FG000|Overall Study|StudyTerminated by Sponsor|0|||
37708097|NCT02240108|69186085|FG001|Overall Study|StudyTerminated by Sponsor|1|||
37837970|NCT01144663|69522411|FG002|Primary Vaccination Phase|Protocol Violation|1|||
37837971|NCT01144663|69522412|FG003|Primary Vaccination Phase|Protocol Violation|0|||
37837972|NCT01144663|69522409|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
37837973|NCT01144663|69522410|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
37837974|NCT01144663|69522411|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
37837975|NCT01144663|69522412|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
37708098|NCT02239640|69186091|FG000|Overall Study|Withdrawal by Subject|3|||
37708099|NCT02239640|69186091|FG000|Overall Study|Lost to Follow-up|72|||
37708100|NCT02239640|69186091|FG000|Overall Study|Death|142|||
37708101|NCT01590628|69186103|FG000|Overall Study|Death|2|||
37708102|NCT01590628|69186104|FG001|Overall Study|Death|0|||
37708103|NCT02130193|69186116|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
37708104|NCT02130193|69186117|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
37708105|NCT02130193|69186118|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
37708106|NCT02130193|69186116|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
37708107|NCT02130193|69186117|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
37708108|NCT02130193|69186118|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
37708109|NCT02130193|69186116|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
37708110|NCT02130193|69186117|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
37708111|NCT02130193|69186118|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
37708112|NCT02130193|69186116|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
37708113|NCT02130193|69186117|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
37708114|NCT02130193|69186118|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
37708115|NCT01590082|69186129|FG000|Overall Study|Withdrawal by Subject|1|||
37708116|NCT01590082|69186130|FG001|Overall Study|Withdrawal by Subject|0|||
37708117|NCT01590082|69186129|FG000|Overall Study|Ineligible|1|||
37708118|NCT01590082|69186130|FG001|Overall Study|Ineligible|0|||
37708119|NCT01631474|69186141|FG000|Overall Study|Lost to Follow-up|8|||
37708120|NCT01631474|69186142|FG001|Overall Study|Lost to Follow-up|5|||
37708121|NCT01631474|69186143|FG002|Overall Study|Lost to Follow-up|7|||
37708122|NCT01631474|69186144|FG003|Overall Study|Lost to Follow-up|5|||
37708123|NCT01631474|69186145|FG004|Overall Study|Lost to Follow-up|5|||
37708124|NCT01631474|69186141|FG000|Overall Study|Withdrawal by Subject|4|||
37708125|NCT01631474|69186142|FG001|Overall Study|Withdrawal by Subject|4|||
37708126|NCT01631474|69186143|FG002|Overall Study|Withdrawal by Subject|2|||
37708127|NCT01631474|69186144|FG003|Overall Study|Withdrawal by Subject|6|||
37708128|NCT01631474|69186145|FG004|Overall Study|Withdrawal by Subject|5|||
37708129|NCT01631474|69186141|FG000|Overall Study|Lack of Efficacy|2|||
37708130|NCT01631474|69186142|FG001|Overall Study|Lack of Efficacy|2|||
37708131|NCT01631474|69186143|FG002|Overall Study|Lack of Efficacy|0|||
37708132|NCT01631474|69186144|FG003|Overall Study|Lack of Efficacy|0|||
37708133|NCT01631474|69186145|FG004|Overall Study|Lack of Efficacy|2|||
37708134|NCT01631474|69186141|FG000|Overall Study|Noncompliance with Study Drug|0|||
37708135|NCT01631474|69186142|FG001|Overall Study|Noncompliance with Study Drug|0|||
37708136|NCT01631474|69186143|FG002|Overall Study|Noncompliance with Study Drug|0|||
37708137|NCT01631474|69186144|FG003|Overall Study|Noncompliance with Study Drug|0|||
37708138|NCT01631474|69186145|FG004|Overall Study|Noncompliance with Study Drug|1|||
37708139|NCT01631474|69186141|FG000|Overall Study|Adverse Event|0|||
37708140|NCT01631474|69186142|FG001|Overall Study|Adverse Event|1|||
37708141|NCT01631474|69186143|FG002|Overall Study|Adverse Event|0|||
37708142|NCT01631474|69186144|FG003|Overall Study|Adverse Event|0|||
37708143|NCT01631474|69186145|FG004|Overall Study|Adverse Event|0|||
37837976|NCT01144663|69522409|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
37837977|NCT01144663|69522410|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
37837978|NCT01144663|69522411|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
37708144|NCT02203916|69186160|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
37708145|NCT02203916|69186161|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
37837979|NCT01144663|69522412|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
37708146|NCT02203916|69186162|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
37708147|NCT02203916|69186160|FG000|Overall Study|Major Protocol Deviation|1|||
37708148|NCT02203916|69186161|FG001|Overall Study|Major Protocol Deviation|1|||
37708149|NCT02203916|69186162|FG002|Overall Study|Major Protocol Deviation|0|||
37708150|NCT02203916|69186160|FG000|Overall Study|Lost to Follow-up|0|||
37837980|NCT01144663|69522409|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
37708151|NCT02203916|69186161|FG001|Overall Study|Lost to Follow-up|1|||
37708152|NCT02203916|69186162|FG002|Overall Study|Lost to Follow-up|0|||
37708153|NCT02203916|69186160|FG000|Overall Study|Voluntary Withdrawal|3|||
37708154|NCT02203916|69186161|FG001|Overall Study|Voluntary Withdrawal|3|||
37708155|NCT02203916|69186162|FG002|Overall Study|Voluntary Withdrawal|8|||
37708156|NCT02203916|69186160|FG000|Overall Study|Lack of Efficacy|3|||
37708157|NCT02203916|69186161|FG001|Overall Study|Lack of Efficacy|0|||
37708158|NCT02203916|69186162|FG002|Overall Study|Lack of Efficacy|0|||
37708159|NCT02203916|69186160|FG000|Overall Study|Reason Not Specified|0|||
37708160|NCT02203916|69186161|FG001|Overall Study|Reason Not Specified|2|||
37708161|NCT02203916|69186162|FG002|Overall Study|Reason Not Specified|1|||
37708162|NCT02179177|69186186|FG000|Overall Study|Lost to Follow-up|1|||
37708163|NCT02179177|69186187|FG001|Overall Study|Lost to Follow-up|1|||
37708164|NCT02179177|69186186|FG000|Overall Study|Withdrawal by Subject|1|||
37708165|NCT02179177|69186187|FG001|Overall Study|Withdrawal by Subject|1|||
37708166|NCT02239328|69186193|FG000|Overall Study|Benign disease noted at time of surgery|6|||
37708167|NCT02239328|69186193|FG000|Overall Study|Equipment or website malfunction|2|||
37708168|NCT02129803|69186199|FG000|Overall Study|Protocol Violation|4|||
37708169|NCT02129803|69186200|FG001|Overall Study|Protocol Violation|0|||
37708170|NCT02129803|69186199|FG000|Overall Study|Physician Decision|0|||
37708171|NCT02129803|69186200|FG001|Overall Study|Physician Decision|1|||
37708172|NCT02129803|69186199|FG000|Overall Study|Difficulty sleeping|1|||
37708173|NCT02129803|69186200|FG001|Overall Study|Difficulty sleeping|0|||
37708174|NCT02129803|69186199|FG000|Overall Study|Morning headache|0|||
37708175|NCT02129803|69186200|FG001|Overall Study|Morning headache|1|||
37708176|NCT02129803|69186199|FG000|Overall Study|Withdrawal by Subject|1|||
37708177|NCT02129803|69186200|FG001|Overall Study|Withdrawal by Subject|1|||
37708178|NCT02239094|69186206|FG000|Overall Study|Withdrawal by Subject|1|||
37708179|NCT02239094|69186206|FG000|Overall Study|Remitted before started|1|||
37708180|NCT02129647|69186210|FG000|Overall Study|Adverse Event|2|||
37708181|NCT02129647|69186210|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
37708182|NCT02238626|69186218|FG000|Overall Study|Adverse Event|3|||
37708183|NCT02238626|69186219|FG001|Overall Study|Adverse Event|5|||
37708184|NCT02238626|69186220|FG002|Overall Study|Adverse Event|0|||
37708185|NCT02238626|69186221|FG003|Overall Study|Adverse Event|3|||
37708186|NCT02238626|69186218|FG000|Overall Study|Lost to Follow-up|2|||
37708187|NCT02238626|69186219|FG001|Overall Study|Lost to Follow-up|4|||
37708188|NCT02238626|69186220|FG002|Overall Study|Lost to Follow-up|2|||
37708189|NCT02238626|69186221|FG003|Overall Study|Lost to Follow-up|2|||
37708190|NCT02238626|69186218|FG000|Overall Study|Withdrawal by Subject|0|||
37708191|NCT02238626|69186219|FG001|Overall Study|Withdrawal by Subject|3|||
37708192|NCT02238626|69186220|FG002|Overall Study|Withdrawal by Subject|0|||
37708193|NCT02238626|69186221|FG003|Overall Study|Withdrawal by Subject|1|||
37708194|NCT02238626|69186218|FG000|Overall Study|Death|0|||
37708195|NCT02238626|69186219|FG001|Overall Study|Death|0|||
37708196|NCT02238626|69186220|FG002|Overall Study|Death|1|||
37837981|NCT01144663|69522410|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
37837982|NCT01144663|69522411|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
37837983|NCT01144663|69522412|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
37837984|NCT01144663|69522409|FG000|Primary Vaccination Phase|Other|0|||
37837985|NCT01144663|69522410|FG001|Primary Vaccination Phase|Other|1|||
37837986|NCT01144663|69522411|FG002|Primary Vaccination Phase|Other|0|||
37837987|NCT01144663|69522412|FG003|Primary Vaccination Phase|Other|2|||
37837988|NCT01144663|69522409|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
37837989|NCT01144663|69522410|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
37837990|NCT01144663|69522411|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
37837991|NCT01144663|69522412|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
37837992|NCT01144663|69522409|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
37837993|NCT01144663|69522410|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
37837994|NCT01144663|69522411|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
37837995|NCT01144663|69522412|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
37837996|NCT01144663|69522409|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
37837997|NCT01144663|69522410|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
37708197|NCT02238626|69186221|FG003|Overall Study|Death|1|||
37708198|NCT02238626|69186218|FG000|Overall Study|Other|0|||
37837998|NCT01144663|69522411|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
37708199|NCT02238626|69186219|FG001|Overall Study|Other|2|||
37837999|NCT01144663|69522412|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
38024250|NCT03057496|69707740|FG000|Overall Study|Device failure|2|||
37708200|NCT02238626|69186220|FG002|Overall Study|Other|0|||
37838000|NCT01144663|69522409|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
37838001|NCT01144663|69522410|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
37838002|NCT01144663|69522411|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
38024251|NCT03708744|69707750|FG000|Overall Study|Withdrawal by Subject|0|||
37708201|NCT02238626|69186221|FG003|Overall Study|Other|0|||
37708202|NCT02151643|69186247|FG000|Overall Study|Adverse Event|2|||
37708203|NCT02151643|69186248|FG001|Overall Study|Adverse Event|0|||
37708204|NCT02151643|69186249|FG002|Overall Study|Adverse Event|1|||
37708205|NCT02151643|69186250|FG003|Overall Study|Adverse Event|4|||
37708206|NCT02151643|69186251|FG004|Overall Study|Adverse Event|0|||
37708207|NCT02151643|69186247|FG000|Overall Study|Withdrawal by Subject|0|||
37708208|NCT02151643|69186248|FG001|Overall Study|Withdrawal by Subject|1|||
37708209|NCT02151643|69186249|FG002|Overall Study|Withdrawal by Subject|1|||
37708210|NCT02151643|69186250|FG003|Overall Study|Withdrawal by Subject|1|||
37708211|NCT02151643|69186251|FG004|Overall Study|Withdrawal by Subject|1|||
37708212|NCT02151643|69186247|FG000|Overall Study|Hyperphosphataemia|1|||
37708213|NCT02151643|69186248|FG001|Overall Study|Hyperphosphataemia|0|||
37708214|NCT02151643|69186249|FG002|Overall Study|Hyperphosphataemia|0|||
37708215|NCT02151643|69186250|FG003|Overall Study|Hyperphosphataemia|0|||
37708216|NCT02151643|69186251|FG004|Overall Study|Hyperphosphataemia|1|||
37708217|NCT02151643|69186247|FG000|Overall Study|High Ferritin levels|3|||
37708218|NCT02151643|69186248|FG001|Overall Study|High Ferritin levels|3|||
37708219|NCT02151643|69186249|FG002|Overall Study|High Ferritin levels|2|||
37708220|NCT02151643|69186250|FG003|Overall Study|High Ferritin levels|2|||
37708221|NCT02151643|69186251|FG004|Overall Study|High Ferritin levels|1|||
37708222|NCT02203838|69186267|FG000|Overall Study|Lack of Efficacy|7|||
37708223|NCT02203838|69186268|FG001|Overall Study|Lack of Efficacy|0|||
37708224|NCT02203838|69186269|FG002|Overall Study|Lack of Efficacy|1|||
37708225|NCT02203838|69186270|FG003|Overall Study|Lack of Efficacy|1|||
37708226|NCT02203838|69186267|FG000|Overall Study|Adverse Event|46|||
37708227|NCT02203838|69186268|FG001|Overall Study|Adverse Event|6|||
37708228|NCT02203838|69186269|FG002|Overall Study|Adverse Event|3|||
37708229|NCT02203838|69186270|FG003|Overall Study|Adverse Event|2|||
37708230|NCT02203838|69186267|FG000|Overall Study|Lost to Follow-up|39|||
37708231|NCT02203838|69186268|FG001|Overall Study|Lost to Follow-up|3|||
37708232|NCT02203838|69186269|FG002|Overall Study|Lost to Follow-up|2|||
37708233|NCT02203838|69186270|FG003|Overall Study|Lost to Follow-up|1|||
37708234|NCT02203838|69186267|FG000|Overall Study|Protocol Violation|7|||
37708235|NCT02203838|69186268|FG001|Overall Study|Protocol Violation|3|||
37708236|NCT02203838|69186269|FG002|Overall Study|Protocol Violation|0|||
37708237|NCT02203838|69186270|FG003|Overall Study|Protocol Violation|0|||
37708238|NCT02203838|69186267|FG000|Overall Study|Withdrawal by Subject|83|||
37708239|NCT02203838|69186268|FG001|Overall Study|Withdrawal by Subject|10|||
37708240|NCT02203838|69186269|FG002|Overall Study|Withdrawal by Subject|8|||
37708241|NCT02203838|69186270|FG003|Overall Study|Withdrawal by Subject|11|||
37708242|NCT02203838|69186267|FG000|Overall Study|Physician Decision|27|||
37708243|NCT02203838|69186268|FG001|Overall Study|Physician Decision|0|||
37708244|NCT02203838|69186269|FG002|Overall Study|Physician Decision|2|||
37708245|NCT02203838|69186270|FG003|Overall Study|Physician Decision|3|||
37708246|NCT02203838|69186267|FG000|Overall Study|Other|1|||
37708247|NCT02203838|69186268|FG001|Overall Study|Other|0|||
37708248|NCT02203838|69186269|FG002|Overall Study|Other|0|||
37708249|NCT02203838|69186270|FG003|Overall Study|Other|0|||
37708250|NCT02178787|69186282|FG000|Overall Study|Lost to Follow-up|1|||
37708251|NCT02178787|69186283|FG001|Overall Study|Lost to Follow-up|0|||
37708252|NCT02178787|69186282|FG000|Overall Study|Withdrawal by Subject|0|||
37708253|NCT02178787|69186283|FG001|Overall Study|Withdrawal by Subject|2|||
37708254|NCT02178787|69186282|FG000|Overall Study|No TCD window|3|||
37708255|NCT02178787|69186283|FG001|Overall Study|No TCD window|7|||
37708256|NCT02178787|69186282|FG000|Overall Study|Physician Decision|1|||
37708257|NCT02178787|69186283|FG001|Overall Study|Physician Decision|0|||
37708258|NCT02178709|69186291|FG000|Overall Study|Adverse Event|5|||
37838003|NCT01144663|69522412|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
37838004|NCT01144663|69522409|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
37838005|NCT01144663|69522410|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
37838006|NCT01144663|69522411|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
37838007|NCT01144663|69522412|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
37838008|NCT01144663|69522409|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
37838009|NCT01144663|69522410|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
37838010|NCT01144663|69522411|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
37838011|NCT01144663|69522412|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
37838012|NCT01143337|69522424|FG000|Overall Study|Adverse Event|3|||
37708259|NCT02178709|69186291|FG000|Overall Study|Death|2|||
37708260|NCT02178709|69186291|FG000|Overall Study|Withdrawal by Subject|2|||
37708261|NCT02178709|69186291|FG000|Overall Study|Physician Decision|2|||
37708262|NCT02178709|69186291|FG000|Overall Study|Disease Progression|5|||
37708263|NCT02238080|69186295|FG000|Overall Study|Death|13|||
37708264|NCT02238080|69186295|FG000|Overall Study|Treatment interrupted|6|||
37708265|NCT02238080|69186295|FG000|Overall Study|Withdrawal by Subject|2|||
37708266|NCT02238080|69186295|FG000|Overall Study|Other|4|||
37838013|NCT01143337|69522425|FG001|Overall Study|Adverse Event|9|||
37708267|NCT02150863|69186302|FG000|Overall Study|Lost to Follow-up|0|||
37708268|NCT02150863|69186303|FG001|Overall Study|Lost to Follow-up|1|||
37708269|NCT02150863|69186304|FG002|Overall Study|Lost to Follow-up|0|||
37708270|NCT02178553|69186314|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
37708271|NCT02178553|69186315|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
37838014|NCT01143337|69522426|FG002|Overall Study|Adverse Event|5|||
37838015|NCT01143337|69522424|FG000|Overall Study|Lack of Efficacy|6|||
37838016|NCT01143337|69522425|FG001|Overall Study|Lack of Efficacy|2|||
37838017|NCT01143337|69522426|FG002|Overall Study|Lack of Efficacy|1|||
37838018|NCT01143337|69522424|FG000|Overall Study|Protocol Violation|1|||
37838019|NCT01143337|69522425|FG001|Overall Study|Protocol Violation|0|||
37838020|NCT01143337|69522426|FG002|Overall Study|Protocol Violation|0|||
37838021|NCT01143337|69522424|FG000|Overall Study|Withdrawal by Subject|0|||
37838022|NCT01143337|69522425|FG001|Overall Study|Withdrawal by Subject|0|||
37838023|NCT01143337|69522426|FG002|Overall Study|Withdrawal by Subject|1|||
37838024|NCT01143337|69522424|FG000|Overall Study|Other reason|0|||
37838025|NCT01143337|69522425|FG001|Overall Study|Other reason|0|||
37838026|NCT01143337|69522426|FG002|Overall Study|Other reason|5|||
37838027|NCT01143259|69522443|FG000|Overall Study|Withdrawal by Subject|3|||
37838028|NCT01143259|69522444|FG001|Overall Study|Withdrawal by Subject|2|||
37838029|NCT01143259|69522443|FG000|Overall Study|Protocol Violation|13|||
37838030|NCT01143259|69522444|FG001|Overall Study|Protocol Violation|9|||
37838031|NCT01143259|69522443|FG000|Overall Study|Screen Failure|7|||
37838032|NCT01143259|69522444|FG001|Overall Study|Screen Failure|9|||
37838033|NCT01142791|69522450|FG000|Overall Study|Alternative Treatment|1|||
37838034|NCT01142791|69522451|FG001|Overall Study|Alternative Treatment|0|||
37838035|NCT01142791|69522450|FG000|Overall Study|Lost to Follow-up|1|||
37838036|NCT01142791|69522451|FG001|Overall Study|Lost to Follow-up|0|||
37838037|NCT01142791|69522450|FG000|Overall Study|Withdrawal by Subject|5|||
37838038|NCT01142791|69522451|FG001|Overall Study|Withdrawal by Subject|0|||
37838039|NCT01142791|69522450|FG000|Overall Study|Received only 1 sonication|0|||
37838040|NCT01142791|69522451|FG001|Overall Study|Received only 1 sonication|6|||
37838041|NCT01142596|69522457|FG000|Overall Study|Withdrawal by Subject|9|||
37838042|NCT01142596|69522458|FG001|Overall Study|Withdrawal by Subject|35|||
37838043|NCT01142596|69522457|FG000|Overall Study|Adverse Event|8|||
37838044|NCT01142596|69522458|FG001|Overall Study|Adverse Event|35|||
37838045|NCT01142596|69522457|FG000|Overall Study|Lack of Efficacy|5|||
37838046|NCT01142596|69522458|FG001|Overall Study|Lack of Efficacy|9|||
37838047|NCT01142596|69522457|FG000|Overall Study|Lost to Follow-up|2|||
37838048|NCT01142596|69522458|FG001|Overall Study|Lost to Follow-up|3|||
37838049|NCT01142596|69522457|FG000|Overall Study|Other reason (not specified)|5|||
37838050|NCT01142596|69522458|FG001|Overall Study|Other reason (not specified)|4|||
37838051|NCT01142128|69522468|FG000|Overall Study|Physician Decision|1|||
37838052|NCT01142128|69522468|FG000|Overall Study|Lost to Follow-up|1|||
37838053|NCT01142128|69522468|FG000|Overall Study|Withdrawal by Subject|2|||
37838054|NCT01142089|69522480|FG000|Overall Study|Physician Decision|1|||
37838055|NCT01142089|69522481|FG001|Overall Study|Physician Decision|0|||
37838056|NCT01142089|69522480|FG000|Overall Study|Withdrawal by Subject|1|||
37838057|NCT01142089|69522481|FG001|Overall Study|Withdrawal by Subject|2|||
37838058|NCT01142089|69522480|FG000|Overall Study|Use of prohibited medications|0|||
37838059|NCT01142089|69522481|FG001|Overall Study|Use of prohibited medications|1|||
37838060|NCT01142089|69522480|FG000|Overall Study|Noncompliance with study procedures|2|||
37838061|NCT01142089|69522481|FG001|Overall Study|Noncompliance with study procedures|1|||
37838062|NCT01142089|69522480|FG000|Overall Study|Patient required rescue medication|8|||
37838063|NCT01142089|69522481|FG001|Overall Study|Patient required rescue medication|17|||
37838064|NCT01141660|69522489|FG000|Overall Study|Physician Decision|0|||
37838065|NCT01141660|69522490|FG001|Overall Study|Physician Decision|12|||
37838066|NCT01140880|69522498|FG000|Overall Study|Death|0|||
37838067|NCT01140880|69522499|FG001|Overall Study|Death|1|||
37838068|NCT01140880|69522498|FG000|Overall Study|Withdrawal by Subject|6|||
37838069|NCT01140880|69522499|FG001|Overall Study|Withdrawal by Subject|3|||
37838070|NCT01140880|69522498|FG000|Overall Study|Lost to Follow-up|8|||
37838071|NCT01140880|69522499|FG001|Overall Study|Lost to Follow-up|10|||
37838072|NCT01140880|69522498|FG000|Overall Study|Protocol Violation|0|||
37838073|NCT01140880|69522499|FG001|Overall Study|Protocol Violation|30|||
37838074|NCT01140646|69522505|FG000|Overall Study|Adverse Event|4|||
37838075|NCT01140646|69522505|FG000|Overall Study|Refused Further Treatment|5|||
37838076|NCT01140568|69522509|FG000|Overall Study|disease progression|31|||
37838077|NCT01140568|69522509|FG000|Overall Study|Withdrawal by Subject|1|||
37708272|NCT02178553|69186314|FG000|Overall Study|Physician Decision|0|||
37838078|NCT01140568|69522509|FG000|Overall Study|Screen Fail|4|||
37708273|NCT02178553|69186315|FG001|Overall Study|Physician Decision|4|||
37708274|NCT02178553|69186314|FG000|Overall Study|Technical problem with injection|1|||
37838079|NCT01140451|69522515|FG000|Overall Study|Withdrawal by Subject|26|||
37838080|NCT01140451|69522516|FG001|Overall Study|Withdrawal by Subject|33|||
37708275|NCT02178553|69186315|FG001|Overall Study|Technical problem with injection|3|||
37708276|NCT01627327|69186323|FG000|Overall Study|Adverse Event|6|||
37708277|NCT01627327|69186324|FG001|Overall Study|Adverse Event|12|||
37708278|NCT01627327|69186323|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
37708279|NCT01627327|69186324|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
37708280|NCT01627327|69186323|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
37708281|NCT01627327|69186324|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
37708282|NCT01627327|69186323|FG000|Overall Study|Protocol Violation|4|||
37708283|NCT01627327|69186324|FG001|Overall Study|Protocol Violation|10|||
37708284|NCT01627327|69186323|FG000|Overall Study|Lost to Follow-up|1|||
37708285|NCT01627327|69186324|FG001|Overall Study|Lost to Follow-up|3|||
37708286|NCT01627327|69186323|FG000|Overall Study|Physician Decision|1|||
37708287|NCT01627327|69186324|FG001|Overall Study|Physician Decision|0|||
37708288|NCT01627327|69186323|FG000|Overall Study|Withdrawal by Subject|3|||
37708289|NCT01627327|69186324|FG001|Overall Study|Withdrawal by Subject|3|||
37708290|NCT01627249|69186333|FG000|Overall Study|Death|3|||
37708291|NCT01627249|69186334|FG001|Overall Study|Death|5|||
37708292|NCT01627249|69186335|FG002|Overall Study|Death|3|||
37708293|NCT01627249|69186333|FG000|Overall Study|Withdrawal by Subject|12|||
37708294|NCT01627249|69186334|FG001|Overall Study|Withdrawal by Subject|6|||
37708295|NCT01627249|69186335|FG002|Overall Study|Withdrawal by Subject|9|||
37708296|NCT01627249|69186333|FG000|Overall Study|Missed Visit|1|||
37708297|NCT01627249|69186334|FG001|Overall Study|Missed Visit|1|||
37838081|NCT01140451|69522515|FG000|Overall Study|Adverse Event|2|||
37708298|NCT01627249|69186335|FG002|Overall Study|Missed Visit|0|||
37708299|NCT01688830|69186364|FG000|Overall Study|Lost to Follow-up|0|||
37708300|NCT01688830|69186365|FG001|Overall Study|Lost to Follow-up|0|||
37708301|NCT01688830|69186366|FG002|Overall Study|Lost to Follow-up|0|||
37708302|NCT01688830|69186367|FG003|Overall Study|Lost to Follow-up|0|||
37708303|NCT01688830|69186368|FG004|Overall Study|Lost to Follow-up|0|||
37708304|NCT01688830|69186369|FG005|Overall Study|Lost to Follow-up|0|||
37708305|NCT01688830|69186370|FG006|Overall Study|Lost to Follow-up|0|||
37708306|NCT01688830|69186371|FG007|Overall Study|Lost to Follow-up|0|||
37708307|NCT01688830|69186372|FG008|Overall Study|Lost to Follow-up|0|||
37708308|NCT01688830|69186373|FG009|Overall Study|Lost to Follow-up|0|||
37708309|NCT01688830|69186374|FG010|Overall Study|Lost to Follow-up|1|||
37708310|NCT01688830|69186375|FG011|Overall Study|Lost to Follow-up|0|||
37708311|NCT01688830|69186376|FG012|Overall Study|Lost to Follow-up|0|||
37708312|NCT01688830|69186377|FG013|Overall Study|Lost to Follow-up|0|||
37708313|NCT01688830|69186378|FG014|Overall Study|Lost to Follow-up|0|||
37708314|NCT01688830|69186379|FG015|Overall Study|Lost to Follow-up|0|||
37708315|NCT01688830|69186380|FG016|Overall Study|Lost to Follow-up|0|||
37708316|NCT01688830|69186381|FG017|Overall Study|Lost to Follow-up|0|||
37708317|NCT01688830|69186382|FG018|Overall Study|Lost to Follow-up|0|||
37708318|NCT01688830|69186383|FG019|Overall Study|Lost to Follow-up|0|||
37708319|NCT01688830|69186384|FG020|Overall Study|Lost to Follow-up|0|||
37708320|NCT02178475|69186468|FG000|Overall Study|Withdrawal by Subject|7|||
37708321|NCT02178475|69186468|FG000|Overall Study|Lost to Follow-up|10|||
37708322|NCT02178475|69186468|FG000|Overall Study|Death|13|||
37708323|NCT02178475|69186468|FG000|Overall Study|Protocol-specified Criteria|99|||
37708324|NCT01569022|69186472|FG000|First Intervention|Lost to Follow-up|2|||
37708325|NCT01569022|69186473|FG001|First Intervention|Lost to Follow-up|1|||
37708326|NCT01569022|69186472|FG000|Second Intervention|Lost to Follow-up|2|||
37708327|NCT01569022|69186473|FG001|Second Intervention|Lost to Follow-up|2|||
37708328|NCT01629823|69186484|FG000|Trial Period|Missed visit|11|||
37708329|NCT01629823|69186485|FG001|Trial Period|Missed visit|9|||
37708330|NCT01629823|69186486|FG002|Trial Period|Missed visit|8|||
37708331|NCT01629823|69186484|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
37708332|NCT01629823|69186485|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
37708333|NCT01629823|69186486|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
37708334|NCT01629823|69186484|FG000|Trial Period|Pregnancy|1|||
37708335|NCT01629823|69186485|FG001|Trial Period|Pregnancy|0|||
37708336|NCT01629823|69186486|FG002|Trial Period|Pregnancy|0|||
37708337|NCT01629823|69186484|FG000|Trial Period|Adverse Event|0|||
37708338|NCT01629823|69186485|FG001|Trial Period|Adverse Event|1|||
37708339|NCT01629823|69186486|FG002|Trial Period|Adverse Event|0|||
37708340|NCT01629823|69186484|FG000|Trial Period|Out-of-window visit|0|||
37708341|NCT01629823|69186485|FG001|Trial Period|Out-of-window visit|2|||
37708342|NCT01629823|69186486|FG002|Trial Period|Out-of-window visit|0|||
37708343|NCT01629823|69186484|FG000|Trial Period|Failed to hold medication|0|||
37708344|NCT01629823|69186485|FG001|Trial Period|Failed to hold medication|0|||
37708345|NCT01629823|69186486|FG002|Trial Period|Failed to hold medication|1|||
37708346|NCT01629823|69186484|FG000|Washout Period|Safety|2|||
37708347|NCT01629823|69186485|FG001|Washout Period|Safety|5|||
37708348|NCT01629823|69186486|FG002|Washout Period|Safety|0|||
37708349|NCT01629823|69186484|FG000|Washout Period|Pregnancy|1|||
37838082|NCT01140451|69522516|FG001|Overall Study|Adverse Event|6|||
37838083|NCT01140451|69522515|FG000|Overall Study|Physician Decision|5|||
37838084|NCT01140451|69522516|FG001|Overall Study|Physician Decision|3|||
37838085|NCT01140451|69522515|FG000|Overall Study|Lost to Follow-up|2|||
37838086|NCT01140451|69522516|FG001|Overall Study|Lost to Follow-up|0|||
37915329|NCT00529399|69602116|FG002|Overall Study|Non-compliant|0|||
37915330|NCT00852969|69602126|FG000|Overall Study|Adverse Event|0|||
37708350|NCT01629823|69186485|FG001|Washout Period|Pregnancy|0|||
37838087|NCT01140451|69522515|FG000|Overall Study|Participants Planning Pregnancy|3|||
37838088|NCT01140451|69522516|FG001|Overall Study|Participants Planning Pregnancy|0|||
37708351|NCT01629823|69186486|FG002|Washout Period|Pregnancy|0|||
37708352|NCT01629823|69186484|FG000|Washout Period|Protocol Violation|0|||
37838089|NCT01140061|69522533|FG000|Part I|Adverse Event|1|||
37838090|NCT01140061|69522534|FG001|Part I|Adverse Event|0|||
37838091|NCT01140061|69522535|FG002|Part I|Adverse Event|0|||
37838092|NCT01140061|69522536|FG003|Part I|Adverse Event|0|||
37838093|NCT01140061|69522537|FG004|Part I|Adverse Event|0|||
37838094|NCT01140061|69522538|FG005|Part I|Adverse Event|0|||
38024252|NCT03708744|69707751|FG001|Overall Study|Withdrawal by Subject|0|||
37708353|NCT01629823|69186485|FG001|Washout Period|Protocol Violation|1|||
37708354|NCT01629823|69186486|FG002|Washout Period|Protocol Violation|0|||
37708355|NCT01688050|69186494|FG000|Overall Study|Death|7|||
37708356|NCT01688050|69186494|FG000|Overall Study|Conversion to open repair|1|||
37708357|NCT01688050|69186494|FG000|Overall Study|Lost to Follow-up|13|||
37708358|NCT01688050|69186494|FG000|Overall Study|Withdrawal by Subject|10|||
37708359|NCT01604278|69186500|FG000|Overall Study|Lack of Efficacy|0|||
37708360|NCT01604278|69186501|FG001|Overall Study|Lack of Efficacy|1|||
37708361|NCT01604278|69186500|FG000|Overall Study|Lost to Follow-up|1|||
37708362|NCT01604278|69186501|FG001|Overall Study|Lost to Follow-up|0|||
37838095|NCT01140061|69522539|FG006|Part I|Adverse Event|0|||
37915331|NCT00852969|69602127|FG001|Overall Study|Adverse Event|1|||
37708363|NCT01604278|69186500|FG000|Overall Study|Administrative problems|2|||
37708364|NCT01604278|69186501|FG001|Overall Study|Administrative problems|1|||
37708365|NCT01604278|69186500|FG000|Overall Study|Withdrawal by Subject|3|||
37708366|NCT01604278|69186501|FG001|Overall Study|Withdrawal by Subject|3|||
37708367|NCT01604278|69186500|FG000|Overall Study|Adverse Event|3|||
37708368|NCT01604278|69186501|FG001|Overall Study|Adverse Event|5|||
37708369|NCT01604278|69186500|FG000|Overall Study|Protocol Deviation|5|||
37708370|NCT01604278|69186501|FG001|Overall Study|Protocol Deviation|3|||
37708371|NCT01687270|69186507|FG000|Overall Study|Lack of Efficacy|11|||
37708372|NCT01687270|69186507|FG000|Overall Study|Lost to Follow-up|1|||
37708373|NCT01589770|69186513|FG000|Overall Study|EGFR <60ml/min|6|||
37708374|NCT01589770|69186514|FG001|Overall Study|EGFR <60ml/min|4|||
37708375|NCT01589770|69186513|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
37708376|NCT01589770|69186514|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
37708377|NCT01588990|69186520|FG000|Phase A|Withdrawal by Subject|5|||
37708378|NCT01588990|69186520|FG000|Phase A|Physician Decision|11|||
37708379|NCT01588990|69186520|FG000|Phase A|Other|14|||
37708380|NCT01588990|69186520|FG000|Phase A|Lost to Follow-up|1|||
37708381|NCT01588990|69186520|FG000|Phase A|Death|5|||
37708382|NCT01588990|69186520|FG000|Phase A|Adverse Event|28|||
37708383|NCT01588990|69186520|FG000|Phase A|Still on therapy at end of study|6|||
37708384|NCT01588990|69186520|FG000|Phase B|Adverse Event|2|||
37708385|NCT01588990|69186520|FG000|Phase B|Still on therapy at end of study|5|||
37708386|NCT01588990|69186520|FG000|Phase B|Withdrawal by Subject|3|||
37708387|NCT01588990|69186520|FG000|Phase B|Physician Decision|4|||
37708388|NCT01588990|69186520|FG000|Phase B|Other|2|||
37708389|NCT02176525|69186536|FG000|Overall Study|Adverse Event|0|||
37708390|NCT02176525|69186537|FG001|Overall Study|Adverse Event|0|||
37708391|NCT02176525|69186538|FG002|Overall Study|Adverse Event|0|||
37708392|NCT02176525|69186539|FG003|Overall Study|Adverse Event|1|||
37708393|NCT02176525|69186540|FG004|Overall Study|Adverse Event|1|||
37708394|NCT02176525|69186541|FG005|Overall Study|Adverse Event|0|||
37708395|NCT02176525|69186542|FG006|Overall Study|Adverse Event|1|||
37708396|NCT02176525|69186543|FG007|Overall Study|Adverse Event|0|||
37708397|NCT02176525|69186536|FG000|Overall Study|not treated|1|||
37708398|NCT02176525|69186537|FG001|Overall Study|not treated|0|||
37708399|NCT02176525|69186538|FG002|Overall Study|not treated|0|||
37708400|NCT02176525|69186539|FG003|Overall Study|not treated|0|||
37708401|NCT02176525|69186540|FG004|Overall Study|not treated|0|||
37708402|NCT02176525|69186541|FG005|Overall Study|not treated|1|||
37708403|NCT02176525|69186542|FG006|Overall Study|not treated|0|||
37708404|NCT02176525|69186543|FG007|Overall Study|not treated|0|||
37708405|NCT02127931|69186569|FG000|Overall Study|Glitch in Game|1|||
37708406|NCT02127307|69186574|FG000|Overall Study|Protocol Violation|36|||
37708407|NCT02127307|69186574|FG000|Overall Study|Lost to Follow-up|2|||
37708408|NCT02127307|69186574|FG000|Overall Study|Death|101|||
37708409|NCT02127307|69186574|FG000|Overall Study|Other than specified above|169|||
37708410|NCT02126839|69186580|FG000|Overall Study|Adverse Event|0|||
37708411|NCT02126839|69186581|FG001|Overall Study|Adverse Event|1|||
37708412|NCT02126839|69186580|FG000|Overall Study|Withdrawal by Subject|1|||
37708413|NCT02126839|69186581|FG001|Overall Study|Withdrawal by Subject|0|||
37708414|NCT02126839|69186580|FG000|Overall Study|Withdrawal by parent/guardian|1|||
37708415|NCT02126839|69186581|FG001|Overall Study|Withdrawal by parent/guardian|0|||
37708416|NCT02126839|69186580|FG000|Overall Study|Protocol Violation|2|||
37708417|NCT02126839|69186581|FG001|Overall Study|Protocol Violation|3|||
37708418|NCT02126839|69186580|FG000|Overall Study|Sponsor request|0|||
37708419|NCT02126839|69186581|FG001|Overall Study|Sponsor request|1|||
37708420|NCT02126839|69186580|FG000|Overall Study|Lost to Follow-up|1|||
37708421|NCT02126839|69186581|FG001|Overall Study|Lost to Follow-up|4|||
37708422|NCT02126839|69186580|FG000|Overall Study|Other|5|||
37708423|NCT02126839|69186581|FG001|Overall Study|Other|5|||
37708424|NCT02125279|69186587|FG000|Overall Study|Lack of Efficacy|2|||
37708425|NCT02125279|69186587|FG000|Overall Study|Withdrawal by Subject|6|||
37708426|NCT02125279|69186587|FG000|Overall Study|Protocol Violation|1|||
37708427|NCT02125279|69186587|FG000|Overall Study|Lost to Follow-up|4|||
37708428|NCT02124811|69186595|FG000|Overall Study|Early termination|2|||
37708429|NCT02124811|69186596|FG001|Overall Study|Early termination|2|||
37708430|NCT02124811|69186595|FG000|Overall Study|Withdrawal by Subject|1|||
37708431|NCT02124811|69186596|FG001|Overall Study|Withdrawal by Subject|0|||
37708432|NCT02148445|69186604|FG000|Overall Study|Death|1|||
37708433|NCT02148445|69186605|FG001|Overall Study|Death|3|||
37708434|NCT02148211|69186613|FG000|Overall Study|Lost to Follow-up|352|||
37708435|NCT02147587|69186619|FG000|Overall Study|Adverse Event|9|||
37708436|NCT02147587|69186620|FG001|Overall Study|Adverse Event|4|||
37708437|NCT02147587|69186619|FG000|Overall Study|Lack of Efficacy|2|||
38024253|NCT03708744|69707752|FG002|Overall Study|Withdrawal by Subject|1|||
37708438|NCT02147587|69186620|FG001|Overall Study|Lack of Efficacy|1|||
37708439|NCT02147353|69186628|FG000|Overall Study|Lost to Follow-up|2|||
37708440|NCT02147353|69186629|FG001|Overall Study|Lost to Follow-up|0|||
37708441|NCT02147353|69186628|FG000|Overall Study|unable to make visits|4|||
37708442|NCT02147353|69186629|FG001|Overall Study|unable to make visits|0|||
37708443|NCT02147353|69186628|FG000|Overall Study|medication noncompliance|3|||
37708444|NCT02147353|69186629|FG001|Overall Study|medication noncompliance|0|||
37708445|NCT02147197|69186638|FG000|Overall Study|Adverse Event|1|||
37708446|NCT02147197|69186639|FG001|Overall Study|Adverse Event|0|||
37708447|NCT02147197|69186640|FG002|Overall Study|Adverse Event|0|||
37708448|NCT02147197|69186638|FG000|Overall Study|Withdrawal of Consent|4|||
37708449|NCT02147197|69186639|FG001|Overall Study|Withdrawal of Consent|3|||
37708450|NCT02147197|69186640|FG002|Overall Study|Withdrawal of Consent|2|||
37708451|NCT02147197|69186638|FG000|Overall Study|Lost to Follow-up|2|||
37708452|NCT02147197|69186639|FG001|Overall Study|Lost to Follow-up|3|||
37708453|NCT02147197|69186640|FG002|Overall Study|Lost to Follow-up|1|||
37708454|NCT02147197|69186638|FG000|Overall Study|Protocol Violation|1|||
37708455|NCT02147197|69186639|FG001|Overall Study|Protocol Violation|0|||
37708456|NCT02147197|69186640|FG002|Overall Study|Protocol Violation|3|||
37708457|NCT02147197|69186638|FG000|Overall Study|Other Miscellaneous Reasons|1|||
37708458|NCT02147197|69186639|FG001|Overall Study|Other Miscellaneous Reasons|0|||
37708459|NCT02147197|69186640|FG002|Overall Study|Other Miscellaneous Reasons|3|||
37708460|NCT02176291|69186650|FG000|Overall Study|Death|1|||
37708461|NCT02176291|69186651|FG001|Overall Study|Death|0|||
37708462|NCT02176291|69186650|FG000|Overall Study|non compliance with protocol|2|||
37708463|NCT02176291|69186651|FG001|Overall Study|non compliance with protocol|0|||
37708464|NCT02176291|69186650|FG000|Overall Study|Withdrawal by Subject|2|||
37708465|NCT02176291|69186651|FG001|Overall Study|Withdrawal by Subject|0|||
37708466|NCT02175745|69186657|FG000|Overall Study|Not Eligible|1|||
37708467|NCT02175277|69186661|FG000|Overall Study|Protocol-specified Criteria|1|||
37708468|NCT02124265|69186665|FG000|Overall Study|Adverse Event|1|||
37708469|NCT02146105|69186669|FG000|Overall Study|Adverse Event|1|||
37708470|NCT02146105|69186669|FG000|Overall Study|Withdrawal by Subject|5|||
37708471|NCT02175199|69186675|FG000|Overall Study|Withdrawal by Subject|1|||
37708472|NCT02175199|69186676|FG001|Overall Study|Withdrawal by Subject|5|||
37708473|NCT02175199|69186675|FG000|Overall Study|Randomized in Error|1|||
37708474|NCT02175199|69186676|FG001|Overall Study|Randomized in Error|0|||
37708475|NCT02175199|69186675|FG000|Overall Study|Sponsor Decision|1|||
37708476|NCT02175199|69186676|FG001|Overall Study|Sponsor Decision|0|||
37708477|NCT02123797|69186685|FG000|Baseline Intervention|Death|9|||
37708478|NCT02123797|69186686|FG001|Baseline Intervention|Death|16|||
37708479|NCT02123797|69186687|FG002|Baseline Intervention|Death|0|||
37708480|NCT02123797|69186688|FG003|Baseline Intervention|Death|0|||
37708481|NCT02123797|69186689|FG004|Baseline Intervention|Death|0|||
37708482|NCT02123797|69186685|FG000|Baseline Intervention|Withdrawal by Subject|2|||
37708483|NCT02123797|69186686|FG001|Baseline Intervention|Withdrawal by Subject|8|||
37708484|NCT02123797|69186687|FG002|Baseline Intervention|Withdrawal by Subject|0|||
37708485|NCT02123797|69186688|FG003|Baseline Intervention|Withdrawal by Subject|0|||
37708486|NCT02123797|69186689|FG004|Baseline Intervention|Withdrawal by Subject|0|||
37708487|NCT02123797|69186685|FG000|Baseline Intervention|Relocation|2|||
37708488|NCT02123797|69186686|FG001|Baseline Intervention|Relocation|0|||
37838096|NCT01140061|69522540|FG007|Part I|Adverse Event|0|||
37838097|NCT01140061|69522541|FG008|Part I|Adverse Event|0|||
37838098|NCT01140061|69522542|FG009|Part I|Adverse Event|0|||
37838099|NCT01140061|69522533|FG000|Extension|Laboratory Adverse Event|0|||
37838100|NCT01140061|69522534|FG001|Extension|Laboratory Adverse Event|0|||
37838101|NCT01140061|69522535|FG002|Extension|Laboratory Adverse Event|0|||
37838102|NCT01140061|69522536|FG003|Extension|Laboratory Adverse Event|0|||
37838103|NCT01140061|69522537|FG004|Extension|Laboratory Adverse Event|0|||
37838104|NCT01140061|69522538|FG005|Extension|Laboratory Adverse Event|0|||
37838105|NCT01140061|69522539|FG006|Extension|Laboratory Adverse Event|0|||
37838106|NCT01140061|69522540|FG007|Extension|Laboratory Adverse Event|0|||
37708489|NCT02123797|69186687|FG002|Baseline Intervention|Relocation|0|||
37708490|NCT02123797|69186688|FG003|Baseline Intervention|Relocation|0|||
37708491|NCT02123797|69186689|FG004|Baseline Intervention|Relocation|0|||
37708492|NCT02123797|69186685|FG000|Baseline Intervention|Out of window for initial survey|6|||
37708493|NCT02123797|69186686|FG001|Baseline Intervention|Out of window for initial survey|13|||
37708494|NCT02123797|69186687|FG002|Baseline Intervention|Out of window for initial survey|0|||
37838107|NCT01140061|69522541|FG008|Extension|Laboratory Adverse Event|0|||
37838108|NCT01140061|69522542|FG009|Extension|Laboratory Adverse Event|1|||
37708495|NCT02123797|69186688|FG003|Baseline Intervention|Out of window for initial survey|0|||
37708496|NCT02123797|69186689|FG004|Baseline Intervention|Out of window for initial survey|0|||
37708497|NCT02123797|69186685|FG000|Baseline Intervention|Lost to Follow-up|0|||
37838109|NCT01139164|69522560|FG000|Overall Study|Withdrawn prior to study start|0|||
37838110|NCT01139164|69522561|FG001|Overall Study|Withdrawn prior to study start|2|||
37708498|NCT02123797|69186686|FG001|Baseline Intervention|Lost to Follow-up|5|||
37708499|NCT02123797|69186687|FG002|Baseline Intervention|Lost to Follow-up|0|||
37708500|NCT02123797|69186688|FG003|Baseline Intervention|Lost to Follow-up|0|||
37838111|NCT01139164|69522562|FG002|Overall Study|Withdrawn prior to study start|0|||
37838112|NCT01139125|69522570|FG000|Overall Study|Withdrawal by Subject|1|||
37838113|NCT01139047|69522574|FG000|Overall Study|Withdrawal by Subject|1|||
37838114|NCT01139008|69522581|FG000|Overall Study|Withdrawal by Subject|5|||
37838115|NCT01139008|69522581|FG000|Overall Study|Non-compliant, lost product|1|||
37838116|NCT01138657|69522590|FG000|Overall Study|Adverse Event|3|||
37838117|NCT01138657|69522591|FG001|Overall Study|Adverse Event|10|||
37838118|NCT01138657|69522590|FG000|Overall Study|Lack of Efficacy|2|||
37838119|NCT01138657|69522591|FG001|Overall Study|Lack of Efficacy|1|||
37838120|NCT01138657|69522590|FG000|Overall Study|Lost to Follow-up|0|||
37838121|NCT01138657|69522591|FG001|Overall Study|Lost to Follow-up|3|||
37838122|NCT01138657|69522590|FG000|Overall Study|Miscellaneous Reasons|3|||
37838123|NCT01138657|69522591|FG001|Overall Study|Miscellaneous Reasons|4|||
37838124|NCT01138501|69522599|FG000|Overall Study|Protocol Violation|2|||
37838125|NCT01138501|69522599|FG000|Overall Study|Withdrawal by Subject|3|||
37838126|NCT01138150|69522605|FG000|Overall Study|blood unable to be processed|0|||
37838127|NCT01138150|69522606|FG001|Overall Study|blood unable to be processed|1|||
37838128|NCT01138150|69522605|FG000|Overall Study|Physician Decision|1|||
37838129|NCT01138150|69522606|FG001|Overall Study|Physician Decision|0|||
37838130|NCT01138111|69522622|FG000|Overall Study|Withdrawal by Subject|5|||
37838131|NCT01138111|69522622|FG000|Overall Study|Adverse Event|1|||
37838132|NCT01138111|69522622|FG000|Overall Study|Death|1|||
37838133|NCT01138111|69522622|FG000|Overall Study|Lost to Follow-up|2|||
37838134|NCT01137955|69522653|FG000|Overall Study|Withdrawal by Subject|5|||
37838135|NCT01137955|69522654|FG001|Overall Study|Withdrawal by Subject|4|||
37838136|NCT01137682|69522664|FG000|Overall Study|Adverse Event-CORE|2|||
37838137|NCT01137682|69522665|FG001|Overall Study|Adverse Event-CORE|4|||
37838138|NCT01137682|69522666|FG002|Overall Study|Adverse Event-CORE|0|||
37838139|NCT01137682|69522664|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
37838140|NCT01137682|69522665|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
37838141|NCT01137682|69522666|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
37838142|NCT01137682|69522664|FG000|Overall Study|Administrative problems-CORE|2|||
37838143|NCT01137682|69522665|FG001|Overall Study|Administrative problems-CORE|1|||
37838144|NCT01137682|69522666|FG002|Overall Study|Administrative problems-CORE|0|||
37838145|NCT01137682|69522664|FG000|Overall Study|Protocol Violation-CORE|0|||
37838146|NCT01137682|69522665|FG001|Overall Study|Protocol Violation-CORE|1|||
37915332|NCT00852969|69602126|FG000|Overall Study|Lost to Follow-up|0|||
37838147|NCT01137682|69522666|FG002|Overall Study|Protocol Violation-CORE|1|||
37838148|NCT01137682|69522664|FG000|Overall Study|Adverse Event-Extension|4|||
37838149|NCT01137682|69522665|FG001|Overall Study|Adverse Event-Extension|8|||
37838150|NCT01137682|69522666|FG002|Overall Study|Adverse Event-Extension|7|||
37838151|NCT01137682|69522664|FG000|Overall Study|Lack of Efficacy-Extension|15|||
37838152|NCT01137682|69522665|FG001|Overall Study|Lack of Efficacy-Extension|9|||
37915333|NCT00852969|69602127|FG001|Overall Study|Lost to Follow-up|1|||
37915334|NCT03870997|69602139|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
37915335|NCT03870997|69602140|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
37915336|NCT03870997|69602141|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
37915337|NCT03870997|69602142|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
37915338|NCT03870997|69602143|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
37915339|NCT03870997|69602144|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
37915340|NCT00521365|69602153|FG000|Overall Study|Adverse Event|3|||
37915341|NCT00521365|69602153|FG000|Overall Study|Lost to Follow-up|6|||
37915342|NCT00521365|69602153|FG000|Overall Study|Protocol deviation|2|||
37915343|NCT00521365|69602153|FG000|Overall Study|Drug compliance|3|||
37915344|NCT00521365|69602153|FG000|Overall Study|Usage of not allowed drugs|6|||
37915345|NCT00711802|69602165|FG000|Overall Study|Not treated (no further detail)|2|||
37915346|NCT00711802|69602166|FG001|Overall Study|Not treated (no further detail)|1|||
37915347|NCT00711802|69602167|FG002|Overall Study|Not treated (no further detail)|2|||
37915348|NCT00711802|69602168|FG003|Overall Study|Not treated (no further detail)|0|||
37915349|NCT00711802|69602169|FG004|Overall Study|Not treated (no further detail)|2|||
37915350|NCT00711802|69602170|FG005|Overall Study|Not treated (no further detail)|0|||
37915351|NCT00711802|69602171|FG006|Overall Study|Not treated (no further detail)|0|||
37915352|NCT00711802|69602172|FG007|Overall Study|Not treated (no further detail)|0|||
37915353|NCT00711802|69602165|FG000|Overall Study|Adverse Event|0|||
37915354|NCT00711802|69602166|FG001|Overall Study|Adverse Event|0|||
37915355|NCT00711802|69602167|FG002|Overall Study|Adverse Event|0|||
37915356|NCT00711802|69602168|FG003|Overall Study|Adverse Event|0|||
37915357|NCT00711802|69602169|FG004|Overall Study|Adverse Event|1|||
37915358|NCT00711802|69602170|FG005|Overall Study|Adverse Event|1|||
37915359|NCT00711802|69602171|FG006|Overall Study|Adverse Event|0|||
37915360|NCT00711802|69602172|FG007|Overall Study|Adverse Event|0|||
37838153|NCT01137682|69522666|FG002|Overall Study|Lack of Efficacy-Extension|13|||
37838154|NCT01137682|69522664|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
37838155|NCT01137682|69522665|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
37838156|NCT01137682|69522666|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
37838157|NCT01137682|69522664|FG000|Overall Study|Lost to Follow Up-Extension|0|||
37838158|NCT01137682|69522665|FG001|Overall Study|Lost to Follow Up-Extension|1|||
37838159|NCT01137682|69522666|FG002|Overall Study|Lost to Follow Up-Extension|0|||
37838160|NCT01137682|69522664|FG000|Overall Study|Administrative problems-Extension|0|||
37838161|NCT01137682|69522665|FG001|Overall Study|Administrative problems-Extension|2|||
37838162|NCT01137682|69522666|FG002|Overall Study|Administrative problems-Extension|0|||
37838163|NCT01137682|69522664|FG000|Overall Study|Death-Extension|2|||
37838164|NCT01137682|69522665|FG001|Overall Study|Death-Extension|0|||
37838165|NCT01137682|69522666|FG002|Overall Study|Death-Extension|0|||
37838166|NCT01137682|69522664|FG000|Overall Study|Protocol Violation-Extension|2|||
37838167|NCT01137682|69522665|FG001|Overall Study|Protocol Violation-Extension|1|||
37838168|NCT01137682|69522666|FG002|Overall Study|Protocol Violation-Extension|0|||
37838169|NCT01137682|69522664|FG000|Overall Study|Did not enter extension|2|||
37838170|NCT01137682|69522665|FG001|Overall Study|Did not enter extension|3|||
37838171|NCT01137682|69522666|FG002|Overall Study|Did not enter extension|2|||
37838172|NCT01137682|69522664|FG000|Overall Study|Did not receive treatment in extension|0|||
37838173|NCT01137682|69522665|FG001|Overall Study|Did not receive treatment in extension|0|||
37838174|NCT01137682|69522666|FG002|Overall Study|Did not receive treatment in extension|1|||
37838175|NCT03452397|69522682|FG000|Overall Study|Adverse Event|1|||
37838176|NCT03452397|69522683|FG001|Overall Study|Adverse Event|0|||
37838177|NCT03452397|69522684|FG002|Overall Study|Adverse Event|0|||
37838178|NCT03452397|69522685|FG003|Overall Study|Adverse Event|0|||
37838179|NCT03452397|69522682|FG000|Overall Study|Administrative reason|0|||
37838180|NCT03452397|69522683|FG001|Overall Study|Administrative reason|0|||
37838181|NCT03452397|69522684|FG002|Overall Study|Administrative reason|1|||
37838182|NCT03452397|69522685|FG003|Overall Study|Administrative reason|1|||
37838183|NCT03452397|69522682|FG000|Overall Study|Withdrawal by Subject|0|||
37838184|NCT03452397|69522683|FG001|Overall Study|Withdrawal by Subject|0|||
37838185|NCT03452397|69522684|FG002|Overall Study|Withdrawal by Subject|1|||
37838186|NCT03452397|69522685|FG003|Overall Study|Withdrawal by Subject|0|||
37838187|NCT00199875|69522719|FG000|Overall Study|Withdrawal by Subject|0|||
37838188|NCT00199875|69522720|FG001|Overall Study|Withdrawal by Subject|0|||
37838189|NCT00199875|69522721|FG002|Overall Study|Withdrawal by Subject|0|||
37838190|NCT00199875|69522722|FG003|Overall Study|Withdrawal by Subject|0|||
37838191|NCT00199875|69522723|FG004|Overall Study|Withdrawal by Subject|1|||
37838192|NCT00199836|69522735|FG000|Overall Study|Progressive Disease|5|||
37838193|NCT00199836|69522735|FG000|Overall Study|Death|1|||
37838194|NCT00199797|69522740|FG000|Overall Study|Progressive Disease|1|||
37838195|NCT00199797|69522740|FG000|Overall Study|Adverse Event|1|||
37838196|NCT00199797|69522740|FG000|Overall Study|Physician Decision|1|||
37838197|NCT01137604|69522749|FG000|Overall Study|Adverse Event|3|||
37838198|NCT01137604|69522750|FG001|Overall Study|Adverse Event|6|||
37838199|NCT01137604|69522751|FG002|Overall Study|Adverse Event|9|||
37708501|NCT02123797|69186689|FG004|Baseline Intervention|Lost to Follow-up|0|||
37708502|NCT02123797|69186685|FG000|Baseline Intervention|Other Disease|3|||
37708503|NCT02123797|69186686|FG001|Baseline Intervention|Other Disease|0|||
37708504|NCT02123797|69186687|FG002|Baseline Intervention|Other Disease|0|||
37838200|NCT01137604|69522752|FG003|Overall Study|Adverse Event|9|||
37838201|NCT01137604|69522749|FG000|Overall Study|Participant Choice|0|||
37838202|NCT01137604|69522750|FG001|Overall Study|Participant Choice|2|||
37838203|NCT01137604|69522751|FG002|Overall Study|Participant Choice|2|||
37838204|NCT01137604|69522752|FG003|Overall Study|Participant Choice|0|||
37838205|NCT01137604|69522749|FG000|Overall Study|Withdrawal of consent|0|||
37838206|NCT01137604|69522750|FG001|Overall Study|Withdrawal of consent|0|||
37838207|NCT01137604|69522751|FG002|Overall Study|Withdrawal of consent|0|||
37838208|NCT01137604|69522752|FG003|Overall Study|Withdrawal of consent|2|||
37838209|NCT01137604|69522749|FG000|Overall Study|Clinical progression/deterioration|1|||
37838210|NCT01137604|69522750|FG001|Overall Study|Clinical progression/deterioration|2|||
37838211|NCT01137604|69522751|FG002|Overall Study|Clinical progression/deterioration|2|||
37838212|NCT01137604|69522752|FG003|Overall Study|Clinical progression/deterioration|0|||
37838213|NCT00198822|69522765|FG000|Overall Study|Lost to Follow-up|14|||
37838214|NCT00198822|69522766|FG001|Overall Study|Lost to Follow-up|20|||
37838215|NCT00198822|69522767|FG002|Overall Study|Lost to Follow-up|21|||
37838216|NCT01137292|69522775|FG000|Overall Study|Death|30|||
37838217|NCT01137292|69522775|FG000|Overall Study|Adverse Event|3|||
37708505|NCT02123797|69186688|FG003|Baseline Intervention|Other Disease|0|||
37708506|NCT02123797|69186689|FG004|Baseline Intervention|Other Disease|0|||
37708507|NCT02123797|69186685|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
37838218|NCT01137292|69522775|FG000|Overall Study|Lack of Efficacy|13|||
37838219|NCT01137292|69522775|FG000|Overall Study|Lost to Follow-up|1|||
37838220|NCT01137292|69522775|FG000|Overall Study|Other|7|||
37708508|NCT02123797|69186686|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
37838221|NCT00197496|69522781|FG000|Baseline to Discharge|not interested|1|||
37708509|NCT02123797|69186687|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
37708510|NCT02123797|69186688|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
37708511|NCT02123797|69186689|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
37708512|NCT02123797|69186685|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
37708513|NCT02123797|69186686|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
37708514|NCT02123797|69186687|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
37708515|NCT02123797|69186688|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
37708516|NCT02123797|69186689|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
37708517|NCT02123797|69186685|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
37708518|NCT02123797|69186686|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
37708519|NCT02123797|69186687|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
37708520|NCT02123797|69186688|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
37708521|NCT02123797|69186689|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
37708522|NCT02123797|69186685|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
37708523|NCT02123797|69186686|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
37708524|NCT02123797|69186687|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
37708525|NCT02123797|69186688|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
37708526|NCT02123797|69186689|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
37708527|NCT02123797|69186685|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
37708528|NCT02123797|69186686|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
37708529|NCT02123797|69186687|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
37708530|NCT02123797|69186688|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
37708531|NCT02123797|69186689|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
37708532|NCT02123797|69186685|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
37708533|NCT02123797|69186686|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
37708534|NCT02123797|69186687|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
37708535|NCT02123797|69186688|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
37708536|NCT02123797|69186689|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
37838222|NCT00197496|69522782|FG001|Baseline to Discharge|not interested|0|||
37838223|NCT00197496|69522781|FG000|Baseline to Discharge|MRSA|1|||
37838224|NCT00197496|69522782|FG001|Baseline to Discharge|MRSA|0|||
37838225|NCT00197496|69522781|FG000|Baseline to Discharge|Physician Decision|0|||
37838226|NCT00197496|69522782|FG001|Baseline to Discharge|Physician Decision|1|||
37838227|NCT00197496|69522781|FG000|Baseline to Discharge|Protocol Violation|0|||
37838228|NCT00197496|69522782|FG001|Baseline to Discharge|Protocol Violation|1|||
37838229|NCT00197496|69522781|FG000|Follow-up|Lost to Follow-up|2|||
37838230|NCT00197496|69522782|FG001|Follow-up|Lost to Follow-up|1|||
37838231|NCT00197145|69522790|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
37838232|NCT00197145|69522791|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
37838233|NCT00197145|69522790|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
37838234|NCT00197145|69522791|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
37838235|NCT00197145|69522790|FG000|Period 1: Randomized Treatment Phase|Other|2|||
37838236|NCT00197145|69522791|FG001|Period 1: Randomized Treatment Phase|Other|2|||
37838237|NCT00197145|69522790|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
37838238|NCT00197145|69522791|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
37838239|NCT00197145|69522790|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
37838240|NCT00197145|69522791|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
37838241|NCT00197145|69522790|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
37838242|NCT00197145|69522791|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
37838243|NCT00197145|69522790|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
37838244|NCT00197145|69522791|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
37838245|NCT00197145|69522790|FG000|Period 2 : Open Label Phase|Other|1|||
37838246|NCT00197145|69522791|FG001|Period 2 : Open Label Phase|Other|0|||
37838247|NCT01136785|69522800|FG000|Overall Study|Protocol Violation|2|||
37838248|NCT01136785|69522801|FG001|Overall Study|Protocol Violation|1|||
37838249|NCT00197106|69522813|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
37838250|NCT00197106|69522814|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
37838251|NCT00197106|69522815|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
37838252|NCT00197106|69522813|FG000|Overall Treatment Period|Lack of Efficacy|0|||
37838253|NCT00197106|69522814|FG001|Overall Treatment Period|Lack of Efficacy|1|||
37838254|NCT00197106|69522815|FG002|Overall Treatment Period|Lack of Efficacy|0|||
37708537|NCT02123797|69186685|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
37708538|NCT02123797|69186686|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
37708539|NCT02123797|69186687|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
37708540|NCT02123797|69186688|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
37838255|NCT00197106|69522813|FG000|Overall Treatment Period|Lost to Follow-up|0|||
37838256|NCT00197106|69522814|FG001|Overall Treatment Period|Lost to Follow-up|0|||
37838257|NCT00197106|69522815|FG002|Overall Treatment Period|Lost to Follow-up|2|||
37708541|NCT02123797|69186689|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
37708542|NCT02123797|69186685|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
37708543|NCT02123797|69186686|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
37708544|NCT02123797|69186687|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
37708545|NCT02123797|69186688|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
37708546|NCT02123797|69186689|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
37708547|NCT02123797|69186685|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
37708548|NCT02123797|69186686|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
37708549|NCT02123797|69186687|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
37708550|NCT02123797|69186688|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
37708551|NCT02123797|69186689|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
37708552|NCT02175121|69186714|FG000|Overall Study|Lack of Efficacy|1|||
37708553|NCT02175121|69186715|FG001|Overall Study|Lack of Efficacy|0|||
37708554|NCT02175121|69186716|FG002|Overall Study|Lack of Efficacy|0|||
37708555|NCT02175121|69186717|FG003|Overall Study|Lack of Efficacy|0|||
37708556|NCT02175121|69186718|FG004|Overall Study|Lack of Efficacy|0|||
37708557|NCT02175121|69186714|FG000|Overall Study|Lost to Follow-up|0|||
37708558|NCT02175121|69186715|FG001|Overall Study|Lost to Follow-up|1|||
37708559|NCT02175121|69186716|FG002|Overall Study|Lost to Follow-up|0|||
37708560|NCT02175121|69186717|FG003|Overall Study|Lost to Follow-up|1|||
37708561|NCT02175121|69186718|FG004|Overall Study|Lost to Follow-up|0|||
37708562|NCT02175121|69186714|FG000|Overall Study|Personal emergency|0|||
37708563|NCT02175121|69186715|FG001|Overall Study|Personal emergency|0|||
37708564|NCT02175121|69186716|FG002|Overall Study|Personal emergency|0|||
37708565|NCT02175121|69186717|FG003|Overall Study|Personal emergency|0|||
37708566|NCT02175121|69186718|FG004|Overall Study|Personal emergency|1|||
37708567|NCT02175121|69186714|FG000|Overall Study|Schedule conflict|0|||
37708568|NCT02175121|69186715|FG001|Overall Study|Schedule conflict|0|||
37708569|NCT02175121|69186716|FG002|Overall Study|Schedule conflict|1|||
37708570|NCT02175121|69186717|FG003|Overall Study|Schedule conflict|0|||
37708571|NCT02175121|69186718|FG004|Overall Study|Schedule conflict|0|||
37708572|NCT02175121|69186714|FG000|Overall Study|Time issues|0|||
37708573|NCT02175121|69186715|FG001|Overall Study|Time issues|0|||
37708574|NCT02175121|69186716|FG002|Overall Study|Time issues|1|||
37708575|NCT02175121|69186717|FG003|Overall Study|Time issues|0|||
37708576|NCT02175121|69186718|FG004|Overall Study|Time issues|0|||
37708577|NCT01568866|69186736|FG000|Overall Study|Disease Progression|208|||
37708578|NCT01568866|69186737|FG001|Overall Study|Disease Progression|183|||
37708579|NCT01568866|69186736|FG000|Overall Study|Adverse Event|94|||
37708580|NCT01568866|69186737|FG001|Overall Study|Adverse Event|96|||
37708581|NCT01568866|69186736|FG000|Overall Study|Patient Request|55|||
37708582|NCT01568866|69186737|FG001|Overall Study|Patient Request|71|||
37708583|NCT01568866|69186736|FG000|Overall Study|Physician Decision|40|||
37708584|NCT01568866|69186737|FG001|Overall Study|Physician Decision|32|||
37708585|NCT01568866|69186736|FG000|Overall Study|Withdrawal by Subject|19|||
37708586|NCT01568866|69186737|FG001|Overall Study|Withdrawal by Subject|11|||
37708587|NCT01568866|69186736|FG000|Overall Study|Death|10|||
37708588|NCT01568866|69186737|FG001|Overall Study|Death|18|||
37708589|NCT01568866|69186736|FG000|Overall Study|Protocol Non-compliance|2|||
37708590|NCT01568866|69186737|FG001|Overall Study|Protocol Non-compliance|4|||
37708591|NCT01568866|69186736|FG000|Overall Study|Lost to Follow-up|1|||
37708592|NCT01568866|69186737|FG001|Overall Study|Lost to Follow-up|0|||
37708593|NCT01568866|69186736|FG000|Overall Study|Randomized but Not Dosed|9|||
37708594|NCT01568866|69186737|FG001|Overall Study|Randomized but Not Dosed|1|||
37708595|NCT01568320|69186743|FG000|Overall Study|Death|20|||
37708596|NCT01568320|69186743|FG000|Overall Study|Lost to Follow-up|9|||
37708597|NCT01568320|69186743|FG000|Overall Study|Withdrawal by Subject|10|||
37708598|NCT01568320|69186743|FG000|Overall Study|Conversion to open repair|1|||
37708599|NCT01568320|69186743|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
37708600|NCT01567852|69186749|FG000|Overall Study|Withdrawal by Subject|3|||
37708601|NCT01567852|69186750|FG001|Overall Study|Withdrawal by Subject|6|||
37708602|NCT01567852|69186749|FG000|Overall Study|ECT discontinued|1|||
37708603|NCT01567852|69186750|FG001|Overall Study|ECT discontinued|1|||
37708604|NCT01588366|69186761|FG000|Overall Study|Adverse Event|0|||
37708605|NCT01588366|69186762|FG001|Overall Study|Adverse Event|1|||
37708606|NCT01588366|69186763|FG002|Overall Study|Adverse Event|0|||
37708607|NCT01588366|69186764|FG003|Overall Study|Adverse Event|1|||
37708608|NCT01588366|69186765|FG004|Overall Study|Adverse Event|0|||
37838258|NCT00197106|69522813|FG000|Overall Treatment Period|Protocol Violation|0|||
37708609|NCT01588366|69186766|FG005|Overall Study|Adverse Event|2|||
37708610|NCT01686958|69186782|FG000|Overall Study|Withdrawal by Subject|1|||
37708611|NCT01686568|69186789|FG000|Main Study|Withdrawal by Subject|1|||
37708612|NCT01686568|69186790|FG001|Main Study|Withdrawal by Subject|3|||
37708613|NCT01686568|69186789|FG000|Main Study|Noncompliance with protocol|0|||
37708614|NCT01686568|69186790|FG001|Main Study|Noncompliance with protocol|1|||
37708615|NCT01686568|69186789|FG000|Main Study|Liver enzymes above range of exclusion|1|||
37708616|NCT01686568|69186790|FG001|Main Study|Liver enzymes above range of exclusion|0|||
37708617|NCT01686568|69186789|FG000|Sub-Study|Not consented for sub-study|2|||
37708618|NCT01686568|69186790|FG001|Sub-Study|Not consented for sub-study|2|||
37708619|NCT01567462|69186798|FG000|Overall Study|Withdrawal by Subject|4|||
37708620|NCT01567462|69186799|FG001|Overall Study|Withdrawal by Subject|7|||
37708621|NCT01587898|69186809|FG000|Overall Study|Adverse Event|1|||
37708622|NCT01587898|69186810|FG001|Overall Study|Adverse Event|1|||
37708623|NCT01587898|69186811|FG002|Overall Study|Adverse Event|0|||
37708624|NCT01587898|69186812|FG003|Overall Study|Adverse Event|0|||
37708625|NCT01587898|69186809|FG000|Overall Study|Protocol Violation|0|||
37708626|NCT01587898|69186810|FG001|Overall Study|Protocol Violation|2|||
37708627|NCT01587898|69186811|FG002|Overall Study|Protocol Violation|1|||
37708628|NCT01587898|69186812|FG003|Overall Study|Protocol Violation|1|||
37708629|NCT01587898|69186809|FG000|Overall Study|Lost to Follow-up|0|||
37708630|NCT01587898|69186810|FG001|Overall Study|Lost to Follow-up|0|||
37708631|NCT01587898|69186811|FG002|Overall Study|Lost to Follow-up|0|||
37708632|NCT01587898|69186812|FG003|Overall Study|Lost to Follow-up|1|||
37708633|NCT01587898|69186809|FG000|Overall Study|Withdrawal by Subject|2|||
37708634|NCT01587898|69186810|FG001|Overall Study|Withdrawal by Subject|1|||
37708635|NCT01587898|69186811|FG002|Overall Study|Withdrawal by Subject|0|||
37708636|NCT01587898|69186812|FG003|Overall Study|Withdrawal by Subject|0|||
37708637|NCT01587898|69186809|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
37708638|NCT01587898|69186810|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
37708639|NCT01587898|69186811|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
37708640|NCT01587898|69186812|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
37708641|NCT01567306|69186831|FG000|Overall Study|Protocol Violation|2|||
37708642|NCT01567306|69186832|FG001|Overall Study|Protocol Violation|2|||
37708643|NCT01567306|69186833|FG002|Overall Study|Protocol Violation|0|||
37708644|NCT01567306|69186834|FG003|Overall Study|Protocol Violation|3|||
37708645|NCT01567306|69186835|FG004|Overall Study|Protocol Violation|1|||
37708646|NCT01567306|69186836|FG005|Overall Study|Protocol Violation|1|||
37708647|NCT01567306|69186831|FG000|Overall Study|Change site living|1|||
37915361|NCT00711802|69602165|FG000|Overall Study|Microbiological failure|0|||
37708648|NCT01567306|69186832|FG001|Overall Study|Change site living|0|||
37708649|NCT01567306|69186833|FG002|Overall Study|Change site living|0|||
37708650|NCT01567306|69186834|FG003|Overall Study|Change site living|0|||
37708651|NCT01567306|69186835|FG004|Overall Study|Change site living|0|||
37708652|NCT01567306|69186836|FG005|Overall Study|Change site living|0|||
37708653|NCT01567306|69186831|FG000|Overall Study|Adverse Event|0|||
37708654|NCT01567306|69186832|FG001|Overall Study|Adverse Event|0|||
37708655|NCT01567306|69186833|FG002|Overall Study|Adverse Event|0|||
37708656|NCT01567306|69186834|FG003|Overall Study|Adverse Event|2|||
37708657|NCT01567306|69186835|FG004|Overall Study|Adverse Event|4|||
37708658|NCT01567306|69186836|FG005|Overall Study|Adverse Event|1|||
37708659|NCT01567306|69186831|FG000|Overall Study|Lost to Follow-up|0|||
37708660|NCT01567306|69186832|FG001|Overall Study|Lost to Follow-up|0|||
37708661|NCT01567306|69186833|FG002|Overall Study|Lost to Follow-up|0|||
37708662|NCT01567306|69186834|FG003|Overall Study|Lost to Follow-up|0|||
37708663|NCT01567306|69186835|FG004|Overall Study|Lost to Follow-up|2|||
37708664|NCT01567306|69186836|FG005|Overall Study|Lost to Follow-up|0|||
37708665|NCT01567306|69186831|FG000|Overall Study|Withdrawal by Subject|0|||
37708666|NCT01567306|69186832|FG001|Overall Study|Withdrawal by Subject|0|||
37708667|NCT01567306|69186833|FG002|Overall Study|Withdrawal by Subject|0|||
37708668|NCT01567306|69186834|FG003|Overall Study|Withdrawal by Subject|0|||
37708669|NCT01567306|69186835|FG004|Overall Study|Withdrawal by Subject|0|||
37708670|NCT01567306|69186836|FG005|Overall Study|Withdrawal by Subject|1|||
37708671|NCT01587274|69186853|FG000|Overall Study|Lost to Follow-up|4|||
37708672|NCT01587274|69186854|FG001|Overall Study|Lost to Follow-up|5|||
37708673|NCT01587274|69186855|FG002|Overall Study|Lost to Follow-up|3|||
37708674|NCT01587118|69186863|FG000|Overall Study|Adverse Event|3|||
37708675|NCT01587118|69186863|FG000|Overall Study|Lost to Follow-up|2|||
37708676|NCT01587118|69186863|FG000|Overall Study|Relocation|1|||
37708677|NCT01587118|69186863|FG000|Overall Study|nonresponse|1|||
37708678|NCT01905657|69186870|FG000|Overall Study|Adverse Event|23|||
37708679|NCT01905657|69186871|FG001|Overall Study|Adverse Event|17|||
37708680|NCT01905657|69186872|FG002|Overall Study|Adverse Event|18|||
37838259|NCT00197106|69522814|FG001|Overall Treatment Period|Protocol Violation|0|||
37838260|NCT00197106|69522815|FG002|Overall Treatment Period|Protocol Violation|2|||
37838261|NCT00197106|69522813|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
37838262|NCT00197106|69522814|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
37838263|NCT00197106|69522815|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
37838264|NCT01136746|69522823|FG000|Overall Study|Lost to Follow-up|0|||
37838265|NCT01136746|69522824|FG001|Overall Study|Lost to Follow-up|2|||
37708681|NCT01905657|69186870|FG000|Overall Study|Clinical Progression|103|||
37838266|NCT01136746|69522823|FG000|Overall Study|Protocol Violation|2|||
37708682|NCT01905657|69186871|FG001|Overall Study|Clinical Progression|78|||
37708683|NCT01905657|69186872|FG002|Overall Study|Clinical Progression|59|||
37708684|NCT01905657|69186870|FG000|Overall Study|Death|40|||
37708685|NCT01905657|69186871|FG001|Overall Study|Death|43|||
37708686|NCT01905657|69186872|FG002|Overall Study|Death|47|||
37708687|NCT01905657|69186870|FG000|Overall Study|Excluded Medication|13|||
37708688|NCT01905657|69186871|FG001|Overall Study|Excluded Medication|16|||
37708689|NCT01905657|69186872|FG002|Overall Study|Excluded Medication|9|||
37708690|NCT01905657|69186870|FG000|Overall Study|Lost to Follow-up|1|||
37708691|NCT01905657|69186871|FG001|Overall Study|Lost to Follow-up|2|||
37708692|NCT01905657|69186872|FG002|Overall Study|Lost to Follow-up|1|||
37708693|NCT01905657|69186870|FG000|Overall Study|Physician Decision|5|||
37708694|NCT01905657|69186871|FG001|Overall Study|Physician Decision|8|||
37708695|NCT01905657|69186872|FG002|Overall Study|Physician Decision|12|||
37708696|NCT01905657|69186870|FG000|Overall Study|Protocol Violation|2|||
37708697|NCT01905657|69186871|FG001|Overall Study|Protocol Violation|1|||
37708698|NCT01905657|69186872|FG002|Overall Study|Protocol Violation|1|||
37708699|NCT01905657|69186870|FG000|Overall Study|Screen Failure|0|||
37708700|NCT01905657|69186871|FG001|Overall Study|Screen Failure|1|||
37708701|NCT01905657|69186872|FG002|Overall Study|Screen Failure|0|||
37708702|NCT01905657|69186870|FG000|Overall Study|Withdrawal by Subject|15|||
37708703|NCT01905657|69186871|FG001|Overall Study|Withdrawal by Subject|21|||
37708704|NCT01905657|69186872|FG002|Overall Study|Withdrawal by Subject|53|||
37708705|NCT01905657|69186870|FG000|Overall Study|Sponsor Decision|1|||
37708706|NCT01905657|69186871|FG001|Overall Study|Sponsor Decision|0|||
37708707|NCT01905657|69186872|FG002|Overall Study|Sponsor Decision|0|||
37708708|NCT02202980|69186897|FG000|Overall Study|Lack of Efficacy|1|||
37708709|NCT02202980|69186898|FG001|Overall Study|Lack of Efficacy|0|||
37708710|NCT02202980|69186899|FG002|Overall Study|Lack of Efficacy|7|||
37708711|NCT02202980|69186900|FG003|Overall Study|Lack of Efficacy|0|||
37708712|NCT02202980|69186901|FG004|Overall Study|Lack of Efficacy|3|||
37708713|NCT02202980|69186902|FG005|Overall Study|Lack of Efficacy|1|||
37708714|NCT02202980|69186903|FG006|Overall Study|Lack of Efficacy|11|||
37708715|NCT02202980|69186904|FG007|Overall Study|Lack of Efficacy|2|||
37708716|NCT02202980|69186905|FG008|Overall Study|Lack of Efficacy|2|||
37708717|NCT02202980|69186906|FG009|Overall Study|Lack of Efficacy|0|||
37708718|NCT02202980|69186907|FG010|Overall Study|Lack of Efficacy|0|||
37708719|NCT02202980|69186908|FG011|Overall Study|Lack of Efficacy|3|||
37708720|NCT02202980|69186909|FG012|Overall Study|Lack of Efficacy|10|||
37708721|NCT02202980|69186910|FG013|Overall Study|Lack of Efficacy|0|||
37708722|NCT02202980|69186897|FG000|Overall Study|Protocol Violation|0|||
37708723|NCT02202980|69186898|FG001|Overall Study|Protocol Violation|0|||
37708724|NCT02202980|69186899|FG002|Overall Study|Protocol Violation|0|||
37708725|NCT02202980|69186900|FG003|Overall Study|Protocol Violation|3|||
37708726|NCT02202980|69186901|FG004|Overall Study|Protocol Violation|3|||
37708727|NCT02202980|69186902|FG005|Overall Study|Protocol Violation|0|||
37838267|NCT01136746|69522824|FG001|Overall Study|Protocol Violation|1|||
37838268|NCT01136746|69522823|FG000|Overall Study|Death|1|||
37838269|NCT01136746|69522824|FG001|Overall Study|Death|0|||
37708728|NCT02202980|69186903|FG006|Overall Study|Protocol Violation|0|||
37708729|NCT02202980|69186904|FG007|Overall Study|Protocol Violation|0|||
37708730|NCT02202980|69186905|FG008|Overall Study|Protocol Violation|0|||
37708731|NCT02202980|69186906|FG009|Overall Study|Protocol Violation|0|||
37708732|NCT02202980|69186907|FG010|Overall Study|Protocol Violation|0|||
37708733|NCT02202980|69186908|FG011|Overall Study|Protocol Violation|0|||
37708734|NCT02202980|69186909|FG012|Overall Study|Protocol Violation|0|||
37708735|NCT02202980|69186910|FG013|Overall Study|Protocol Violation|0|||
37708736|NCT02202980|69186897|FG000|Overall Study|Lost to Follow-up|0|||
37708737|NCT02202980|69186898|FG001|Overall Study|Lost to Follow-up|1|||
37708738|NCT02202980|69186899|FG002|Overall Study|Lost to Follow-up|1|||
37708739|NCT02202980|69186900|FG003|Overall Study|Lost to Follow-up|1|||
37708740|NCT02202980|69186901|FG004|Overall Study|Lost to Follow-up|0|||
37708741|NCT02202980|69186902|FG005|Overall Study|Lost to Follow-up|0|||
37708742|NCT02202980|69186903|FG006|Overall Study|Lost to Follow-up|0|||
37708743|NCT02202980|69186904|FG007|Overall Study|Lost to Follow-up|1|||
37708744|NCT02202980|69186905|FG008|Overall Study|Lost to Follow-up|1|||
37708745|NCT02202980|69186906|FG009|Overall Study|Lost to Follow-up|0|||
37708746|NCT02202980|69186907|FG010|Overall Study|Lost to Follow-up|0|||
37708747|NCT02202980|69186908|FG011|Overall Study|Lost to Follow-up|0|||
37708748|NCT02202980|69186909|FG012|Overall Study|Lost to Follow-up|1|||
37708749|NCT02202980|69186910|FG013|Overall Study|Lost to Follow-up|0|||
37708750|NCT02202980|69186897|FG000|Overall Study|Withdrew Consent|0|||
37708751|NCT02202980|69186898|FG001|Overall Study|Withdrew Consent|1|||
37708752|NCT02202980|69186899|FG002|Overall Study|Withdrew Consent|2|||
37708753|NCT02202980|69186900|FG003|Overall Study|Withdrew Consent|0|||
37708754|NCT02202980|69186901|FG004|Overall Study|Withdrew Consent|0|||
37708755|NCT02202980|69186902|FG005|Overall Study|Withdrew Consent|0|||
37708756|NCT02202980|69186903|FG006|Overall Study|Withdrew Consent|0|||
37708757|NCT02202980|69186904|FG007|Overall Study|Withdrew Consent|0|||
37708758|NCT02202980|69186905|FG008|Overall Study|Withdrew Consent|1|||
37708759|NCT02202980|69186906|FG009|Overall Study|Withdrew Consent|0|||
37708760|NCT02202980|69186907|FG010|Overall Study|Withdrew Consent|0|||
37708761|NCT02202980|69186908|FG011|Overall Study|Withdrew Consent|0|||
37708762|NCT02202980|69186909|FG012|Overall Study|Withdrew Consent|0|||
37708763|NCT02202980|69186910|FG013|Overall Study|Withdrew Consent|0|||
37708764|NCT01952145|69186942|FG000|Overall Study|Protocol Violation|2|||
37708765|NCT01952145|69186943|FG001|Overall Study|Protocol Violation|1|||
37708766|NCT01952145|69186942|FG000|Overall Study|Death|0|||
37708767|NCT01952145|69186943|FG001|Overall Study|Death|1|||
37708768|NCT01952145|69186942|FG000|Overall Study|Adverse Event|9|||
37708769|NCT01952145|69186943|FG001|Overall Study|Adverse Event|0|||
37708770|NCT01952145|69186942|FG000|Overall Study|Withdrawal Criteria|16|||
37708771|NCT01952145|69186943|FG001|Overall Study|Withdrawal Criteria|11|||
37708772|NCT01952145|69186942|FG000|Overall Study|Unclassified|1|||
37708773|NCT01952145|69186943|FG001|Overall Study|Unclassified|1|||
37708774|NCT01923363|69186949|FG000|Overall Study|Protocol Violation|1|||
37708775|NCT01905267|69186955|FG000|Overall Study|Physician Decision|2|||
37708776|NCT01905267|69186956|FG001|Overall Study|Physician Decision|2|||
37708777|NCT01923285|69186964|FG000|Overall Study|Withdrawal by Subject|7|||
37708778|NCT01923285|69186965|FG001|Overall Study|Withdrawal by Subject|6|||
37708779|NCT01904721|69186978|FG000|Overall Study|Other Reasons|0|||
37708780|NCT01904721|69186979|FG001|Overall Study|Other Reasons|0|||
37708781|NCT01904721|69186980|FG002|Overall Study|Other Reasons|1|||
37708782|NCT01904721|69186981|FG003|Overall Study|Other Reasons|1|||
37708783|NCT01904721|69186982|FG004|Overall Study|Other Reasons|2|||
37708784|NCT01904721|69186983|FG005|Overall Study|Other Reasons|2|||
37708785|NCT01904721|69186984|FG006|Overall Study|Other Reasons|2|||
37708786|NCT01904721|69186978|FG000|Overall Study|Personal Reasons|0|||
37708787|NCT01904721|69186979|FG001|Overall Study|Personal Reasons|0|||
37708788|NCT01904721|69186980|FG002|Overall Study|Personal Reasons|0|||
37838270|NCT01136356|69522830|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
37838271|NCT01136356|69522831|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
37838272|NCT01136356|69522830|FG000|First 18-day Withdrawal|Physician Decision|1|||
37838273|NCT01136356|69522831|FG001|First 18-day Withdrawal|Physician Decision|0|||
37838274|NCT01136356|69522830|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
37838275|NCT01136356|69522831|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
37838276|NCT00196326|69522836|FG000|Overall Study|Did not meet protocol requirements|64|||
37838277|NCT00196326|69522836|FG000|Overall Study|Non-compliance with the protocol|81|||
38024254|NCT03708744|69707753|FG003|Overall Study|Withdrawal by Subject|0|||
38024255|NCT02574286|69707767|FG000|Overall Study|Adverse Event|3|||
38024256|NCT02574286|69707767|FG000|Overall Study|Withdrawal by Subject|2|||
38024257|NCT02083354|69707775|FG000|Overall Study|Withdrawal by Subject|9|||
38024258|NCT02083354|69707775|FG000|Overall Study|Lost to Follow-up|1|||
38024259|NCT02083354|69707775|FG000|Overall Study|Adverse Event|3|||
38024260|NCT02083354|69707775|FG000|Overall Study|Disease progression|46|||
38024261|NCT02083354|69707775|FG000|Overall Study|Study closed/terminated|5|||
38024262|NCT04230486|69707779|FG000|Overall Study|Screen Failure|1|||
37708789|NCT01904721|69186981|FG003|Overall Study|Personal Reasons|0|||
37708790|NCT01904721|69186982|FG004|Overall Study|Personal Reasons|2|||
37708791|NCT01904721|69186983|FG005|Overall Study|Personal Reasons|3|||
37708792|NCT01904721|69186984|FG006|Overall Study|Personal Reasons|3|||
37708793|NCT01904721|69186978|FG000|Overall Study|Lost to Follow-up|0|||
37708794|NCT01904721|69186979|FG001|Overall Study|Lost to Follow-up|0|||
37838278|NCT00196326|69522836|FG000|Overall Study|Physician Decision|3|||
38024263|NCT01399918|69707785|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
37708795|NCT01904721|69186980|FG002|Overall Study|Lost to Follow-up|0|||
37708796|NCT01904721|69186981|FG003|Overall Study|Lost to Follow-up|0|||
37838279|NCT00196326|69522836|FG000|Overall Study|Withdrawal by Subject|225|||
37708797|NCT01904721|69186982|FG004|Overall Study|Lost to Follow-up|1|||
37708798|NCT01904721|69186983|FG005|Overall Study|Lost to Follow-up|3|||
37708799|NCT01904721|69186984|FG006|Overall Study|Lost to Follow-up|1|||
37708800|NCT01904721|69186978|FG000|Overall Study|Lack of Efficacy|0|||
37708801|NCT01904721|69186979|FG001|Overall Study|Lack of Efficacy|0|||
37708802|NCT01904721|69186980|FG002|Overall Study|Lack of Efficacy|0|||
37708803|NCT01904721|69186981|FG003|Overall Study|Lack of Efficacy|0|||
37708804|NCT01904721|69186982|FG004|Overall Study|Lack of Efficacy|0|||
37708805|NCT01904721|69186983|FG005|Overall Study|Lack of Efficacy|0|||
37708806|NCT01904721|69186984|FG006|Overall Study|Lack of Efficacy|1|||
37708807|NCT01904721|69186978|FG000|Overall Study|Adverse Event|0|||
37708808|NCT01904721|69186979|FG001|Overall Study|Adverse Event|0|||
37708809|NCT01904721|69186980|FG002|Overall Study|Adverse Event|0|||
37708810|NCT01904721|69186981|FG003|Overall Study|Adverse Event|0|||
37708811|NCT01904721|69186982|FG004|Overall Study|Adverse Event|3|||
37708812|NCT01904721|69186983|FG005|Overall Study|Adverse Event|1|||
37708813|NCT01904721|69186984|FG006|Overall Study|Adverse Event|0|||
37708814|NCT01904019|69186996|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
37708815|NCT01904019|69186996|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
37708816|NCT01904019|69186996|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
37708817|NCT01904019|69186996|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
37708818|NCT01904019|69186996|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
37708819|NCT01904019|69186996|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
37708820|NCT01922895|69187002|FG000|Overall Study|Death|0|||
37708821|NCT01922895|69187003|FG001|Overall Study|Death|1|||
37708822|NCT01922895|69187002|FG000|Overall Study|Withdrawal by Subject|1|||
37708823|NCT01922895|69187003|FG001|Overall Study|Withdrawal by Subject|2|||
37708824|NCT01922895|69187002|FG000|Overall Study|Lost to Follow-up|5|||
37708825|NCT01922895|69187003|FG001|Overall Study|Lost to Follow-up|11|||
37708826|NCT01922739|69187011|FG000|Titration/Adjustment Period|Adverse Event|3|||
37708827|NCT01922739|69187011|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
37708828|NCT01922739|69187011|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
37708829|NCT01922739|69187011|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
37708830|NCT01922739|69187011|FG000|Open-label Treatment Period|Adverse Event|6|||
37708831|NCT01922739|69187011|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
37708832|NCT01922739|69187011|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
37708833|NCT01922739|69187011|FG000|Open-label Treatment Period|Protocol Violation|5|||
37708834|NCT01922739|69187011|FG000|Open-label Treatment Period|Pregnancy|1|||
37708835|NCT01922739|69187011|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
37708836|NCT01922739|69187011|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
37708837|NCT01922739|69187011|FG000|Open-label Treatment Period|Physician Decision|1|||
37708838|NCT01922739|69187011|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
37708839|NCT02236988|69187031|FG000|Overall Study|Lost to Follow-up|0|||
37708840|NCT02236988|69187032|FG001|Overall Study|Lost to Follow-up|0|||
37708841|NCT02236988|69187033|FG002|Overall Study|Lost to Follow-up|0|||
37708842|NCT02236988|69187034|FG003|Overall Study|Lost to Follow-up|1|||
37708843|NCT02236988|69187031|FG000|Overall Study|Unable to Comply with Study Visits|0|||
37708844|NCT02236988|69187032|FG001|Overall Study|Unable to Comply with Study Visits|0|||
37708845|NCT02236988|69187033|FG002|Overall Study|Unable to Comply with Study Visits|0|||
37708846|NCT02236988|69187034|FG003|Overall Study|Unable to Comply with Study Visits|2|||
37708847|NCT02236598|69187087|FG000|Overall Study|Adverse Event|0|||
37708848|NCT02236598|69187088|FG001|Overall Study|Adverse Event|1|||
37708849|NCT02236598|69187087|FG000|Overall Study|Withdrawal by Subject|0|||
37708850|NCT02236598|69187088|FG001|Overall Study|Withdrawal by Subject|1|||
37708851|NCT01922349|69187098|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
37708852|NCT01922349|69187099|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
37708853|NCT01922349|69187100|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
37708854|NCT01922349|69187101|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
37708855|NCT02236520|69187139|FG000|Overall Study|Physician Decision|0|||
37708856|NCT02236520|69187140|FG001|Overall Study|Physician Decision|5|||
37708857|NCT02236520|69187141|FG002|Overall Study|Physician Decision|0|||
37708858|NCT02236520|69187142|FG003|Overall Study|Physician Decision|0|||
37708859|NCT02236520|69187139|FG000|Overall Study|Withdrawal by Subject|1|||
37708860|NCT02236520|69187140|FG001|Overall Study|Withdrawal by Subject|0|||
37708861|NCT02236520|69187141|FG002|Overall Study|Withdrawal by Subject|0|||
37708862|NCT02236520|69187142|FG003|Overall Study|Withdrawal by Subject|1|||
37708863|NCT02236520|69187139|FG000|Overall Study|Pregnancy|1|||
37708864|NCT02236520|69187140|FG001|Overall Study|Pregnancy|0|||
37708865|NCT02236520|69187141|FG002|Overall Study|Pregnancy|0|||
37708866|NCT02236520|69187142|FG003|Overall Study|Pregnancy|0|||
37708867|NCT01922271|69187154|FG000|WASHOUT Period|Withdrawal by Subject|1|||
37708868|NCT01922271|69187155|FG001|WASHOUT Period|Withdrawal by Subject|0|||
37708869|NCT02236130|69187163|FG000|Overall Study|Lost to Follow-up|7|||
37708870|NCT02236130|69187164|FG001|Overall Study|Lost to Follow-up|12|||
37708871|NCT02233946|69187172|FG000|Baseline|Withdrawal by Subject|2|||
37708872|NCT02233946|69187173|FG001|Baseline|Withdrawal by Subject|0|||
37708873|NCT02233946|69187172|FG000|3-months Follow-up|Lost to Follow-up|53|||
37708874|NCT02233946|69187173|FG001|3-months Follow-up|Lost to Follow-up|29|||
37708875|NCT02233946|69187172|FG000|6-months Follow-up|Lost to Follow-up|21|||
37708876|NCT02233946|69187173|FG001|6-months Follow-up|Lost to Follow-up|2|||
37708877|NCT02233946|69187172|FG000|9-month Follow-up|Lost to Follow-up|20|||
37708878|NCT02233946|69187173|FG001|9-month Follow-up|Lost to Follow-up|11|||
37708879|NCT02233946|69187172|FG000|12-month Follow-up|Lost to Follow-up|28|||
37708880|NCT02233946|69187173|FG001|12-month Follow-up|Lost to Follow-up|11|||
37708881|NCT02232698|69187181|FG000|Overall Study|Pregnancy|1|||
37708882|NCT02232698|69187182|FG001|Overall Study|Pregnancy|1|||
37708883|NCT02232698|69187181|FG000|Overall Study|Met exclusion criteria|1|||
37708884|NCT02232698|69187182|FG001|Overall Study|Met exclusion criteria|1|||
37708885|NCT02232698|69187181|FG000|Overall Study|Had device-associated symptoms|7|||
37708886|NCT02232698|69187182|FG001|Overall Study|Had device-associated symptoms|0|||
37708887|NCT02232698|69187181|FG000|Overall Study|Non-compliance with study device|1|||
37708888|NCT02232698|69187182|FG001|Overall Study|Non-compliance with study device|4|||
37708889|NCT02232698|69187181|FG000|Overall Study|Allocated to control group|0|||
37708890|NCT02232698|69187182|FG001|Overall Study|Allocated to control group|3|||
37708891|NCT02232698|69187181|FG000|Overall Study|Withdrawal by Subject|0|||
37708892|NCT02232698|69187182|FG001|Overall Study|Withdrawal by Subject|11|||
37708893|NCT01632878|69187190|FG000|Screening|Physician Decision|268|||
37708894|NCT01632878|69187190|FG000|Treatment|Lost to Follow-up|41|||
37708895|NCT01632878|69187190|FG000|Treatment|Withdrawal by Subject|36|||
37708896|NCT01632878|69187190|FG000|Treatment|Physician Decision|34|||
37708897|NCT01632878|69187190|FG000|Treatment|missing information|4|||
37708898|NCT01632878|69187190|FG000|Treatment|no information on study completion|43|||
37708899|NCT01632800|69187194|FG000|Overall Study|Subject did not fit in apparatus|1|||
37708900|NCT01641809|69187202|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
37708901|NCT01641809|69187203|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
37708902|NCT01641809|69187204|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
37708903|NCT01641809|69187205|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
37708904|NCT01641809|69187202|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
37708905|NCT01641809|69187203|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
37708906|NCT01641809|69187204|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
37708907|NCT01641809|69187205|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
37708908|NCT01641809|69187202|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
37708909|NCT01641809|69187203|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
37708910|NCT01641809|69187204|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
37708911|NCT01641809|69187205|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
37708912|NCT01641809|69187202|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
37708913|NCT01641809|69187203|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
37708914|NCT01641809|69187204|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
37838280|NCT00196326|69522836|FG000|Overall Study|Adverse Event|253|||
37838281|NCT00196326|69522836|FG000|Overall Study|Pregnancy|34|||
37838282|NCT00196326|69522836|FG000|Overall Study|Lost to Follow-up|304|||
37838283|NCT00196326|69522836|FG000|Overall Study|Other|22|||
37838284|NCT00195663|69522843|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
37838285|NCT00195663|69522844|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
37838286|NCT00195663|69522845|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
37838287|NCT00195663|69522843|FG000|2-year Double-blind Treatment Period|Death|0|||
37838288|NCT00195663|69522844|FG001|2-year Double-blind Treatment Period|Death|2|||
37838289|NCT00195663|69522845|FG002|2-year Double-blind Treatment Period|Death|0|||
37838290|NCT00195663|69522843|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
37838291|NCT00195663|69522844|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
37838292|NCT00195663|69522845|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
37838293|NCT00195663|69522843|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
37838294|NCT00195663|69522844|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
37838295|NCT00195663|69522845|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
37838296|NCT00195663|69522843|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
37838297|NCT00195663|69522844|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
37708915|NCT01641809|69187205|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
37708916|NCT01641809|69187202|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
37708917|NCT01641809|69187203|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
37708918|NCT01641809|69187204|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
37708919|NCT01641809|69187205|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
37708920|NCT01641809|69187202|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
37708921|NCT01641809|69187203|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
37708922|NCT01641809|69187204|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
37708923|NCT01641809|69187205|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
37708924|NCT01641809|69187202|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
37708925|NCT01641809|69187203|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
37838298|NCT00195663|69522845|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
37838299|NCT00195663|69522843|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
37708926|NCT01641809|69187204|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
37708927|NCT01641809|69187205|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
37708928|NCT01641809|69187202|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
37708929|NCT01641809|69187203|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
37708930|NCT01641809|69187204|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
37708931|NCT01641809|69187205|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
37708932|NCT01641809|69187202|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
37708933|NCT01641809|69187203|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
37708934|NCT01641809|69187204|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
37708935|NCT01641809|69187205|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
37708936|NCT01641809|69187202|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
37708937|NCT01641809|69187203|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
37708938|NCT01641809|69187204|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
37708939|NCT01641809|69187205|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
37708940|NCT01641809|69187202|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
37708941|NCT01641809|69187203|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
37708942|NCT01641809|69187204|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
37708943|NCT01641809|69187205|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
37708944|NCT01641809|69187202|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
37708945|NCT01641809|69187203|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
37708946|NCT01641809|69187204|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
37708947|NCT01641809|69187205|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
37708948|NCT01641809|69187202|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
37708949|NCT01641809|69187203|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
37708950|NCT01641809|69187204|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
37708951|NCT01641809|69187205|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
37708952|NCT01641809|69187202|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
37708953|NCT01641809|69187203|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
37708954|NCT01641809|69187204|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
37708955|NCT01641809|69187205|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
37708956|NCT01641809|69187202|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
37708957|NCT01641809|69187203|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
37708958|NCT01641809|69187204|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
37708959|NCT01641809|69187205|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
37708960|NCT01641809|69187202|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
37708961|NCT01641809|69187203|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
37708962|NCT01641809|69187204|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
37708963|NCT01641809|69187205|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
37708964|NCT01641809|69187202|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
37708965|NCT01641809|69187203|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
37708966|NCT01641809|69187204|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
37708967|NCT01641809|69187205|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
37708968|NCT01641809|69187202|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
37708969|NCT01641809|69187203|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
37708970|NCT01641809|69187204|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
37708971|NCT01641809|69187205|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
37708972|NCT01632566|69187228|FG000|Overall Study|Withdrawal by Subject|0|||
37708973|NCT01632566|69187229|FG001|Overall Study|Withdrawal by Subject|1|||
37708974|NCT01632566|69187230|FG002|Overall Study|Withdrawal by Subject|0|||
37708975|NCT01632566|69187231|FG003|Overall Study|Withdrawal by Subject|0|||
37708976|NCT01632566|69187232|FG004|Overall Study|Withdrawal by Subject|0|||
37708977|NCT01632566|69187228|FG000|Overall Study|Sponsor Decision|0|||
37708978|NCT01632566|69187229|FG001|Overall Study|Sponsor Decision|2|||
37708979|NCT01632566|69187230|FG002|Overall Study|Sponsor Decision|9|||
37708980|NCT01632566|69187231|FG003|Overall Study|Sponsor Decision|2|||
37708981|NCT01632566|69187232|FG004|Overall Study|Sponsor Decision|2|||
37708982|NCT02254304|69187250|FG000|Overall Study|Adverse Event|2|||
37708983|NCT02254304|69187251|FG001|Overall Study|Adverse Event|1|||
37708984|NCT02254304|69187250|FG000|Overall Study|Lost to Follow-up|2|||
37708985|NCT02254304|69187251|FG001|Overall Study|Lost to Follow-up|2|||
37708986|NCT02254304|69187250|FG000|Overall Study|Protocol Violation|1|||
37708987|NCT02254304|69187251|FG001|Overall Study|Protocol Violation|0|||
37708988|NCT02254304|69187250|FG000|Overall Study|Withdrawal by Subject|3|||
37708989|NCT02254304|69187251|FG001|Overall Study|Withdrawal by Subject|0|||
37708990|NCT02254304|69187250|FG000|Overall Study|Injection site pain and Injection fear|1|||
37708991|NCT02254304|69187251|FG001|Overall Study|Injection site pain and Injection fear|0|||
37708992|NCT02254304|69187250|FG000|Overall Study|Personal causes|4|||
37708993|NCT02254304|69187251|FG001|Overall Study|Personal causes|1|||
37708994|NCT02254304|69187250|FG000|Overall Study|Personal decision|1|||
37708995|NCT02254304|69187251|FG001|Overall Study|Personal decision|0|||
37708996|NCT02174731|69187261|FG000|Overall Study|Participant decision|67|||
37708997|NCT02174731|69187262|FG001|Overall Study|Participant decision|64|||
37708998|NCT02174731|69187261|FG000|Overall Study|Incorrect enrolment before randomization|0|||
37708999|NCT02174731|69187262|FG001|Overall Study|Incorrect enrolment before randomization|1|||
37709000|NCT02174731|69187261|FG000|Overall Study|Missing|2|||
37709001|NCT02174731|69187262|FG001|Overall Study|Missing|0|||
37709002|NCT01922037|69187270|FG000|Overall Study|Withdrawal by Subject|2|||
37709003|NCT01922037|69187271|FG001|Overall Study|Withdrawal by Subject|44|||
37709004|NCT01922037|69187270|FG000|Overall Study|Adverse Event|1|||
37709005|NCT01922037|69187271|FG001|Overall Study|Adverse Event|7|||
37709006|NCT01922037|69187270|FG000|Overall Study|Death|0|||
37709007|NCT01922037|69187271|FG001|Overall Study|Death|5|||
37709008|NCT01922037|69187270|FG000|Overall Study|Pregnancy|0|||
37709009|NCT01922037|69187271|FG001|Overall Study|Pregnancy|2|||
37709010|NCT01922037|69187270|FG000|Overall Study|Participant non-compliance|4|||
37709011|NCT01922037|69187271|FG001|Overall Study|Participant non-compliance|46|||
37709012|NCT01922037|69187270|FG000|Overall Study|Investigator/Sponsor decision|1|||
37709013|NCT01922037|69187271|FG001|Overall Study|Investigator/Sponsor decision|4|||
37709014|NCT01922037|69187270|FG000|Overall Study|Other unspecified|2|||
37709015|NCT01922037|69187271|FG001|Overall Study|Other unspecified|66|||
37709016|NCT02282813|69187282|FG000|Overall Study|Withdrawal by Subject|4|||
37709017|NCT02282813|69187283|FG001|Overall Study|Withdrawal by Subject|5|||
37709018|NCT02282813|69187284|FG002|Overall Study|Withdrawal by Subject|0|||
37709019|NCT02282813|69187282|FG000|Overall Study|Adverse Event|3|||
37709020|NCT02282813|69187283|FG001|Overall Study|Adverse Event|10|||
37709021|NCT02282813|69187284|FG002|Overall Study|Adverse Event|1|||
37709022|NCT02282813|69187282|FG000|Overall Study|Subject non-compliance|1|||
37709023|NCT02282813|69187283|FG001|Overall Study|Subject non-compliance|4|||
37709024|NCT02282813|69187284|FG002|Overall Study|Subject non-compliance|0|||
37709025|NCT02282813|69187282|FG000|Overall Study|Physician Decision|0|||
37709026|NCT02282813|69187283|FG001|Overall Study|Physician Decision|3|||
37709027|NCT02282813|69187284|FG002|Overall Study|Physician Decision|1|||
37709028|NCT02282813|69187282|FG000|Overall Study|Lost to Follow-up|2|||
38024264|NCT00112840|69707792|FG000|Overall Study|Physician Decision|1|||
38024265|NCT00112840|69707793|FG001|Overall Study|Physician Decision|0|||
38024266|NCT00112840|69707794|FG002|Overall Study|Physician Decision|0|||
37709029|NCT02282813|69187283|FG001|Overall Study|Lost to Follow-up|0|||
37709030|NCT02282813|69187284|FG002|Overall Study|Lost to Follow-up|1|||
37709031|NCT02282813|69187282|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
37709032|NCT02282813|69187283|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
37709033|NCT02282813|69187284|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
37709034|NCT02282813|69187282|FG000|Overall Study|Lack of Efficacy|1|||
37709035|NCT02282813|69187283|FG001|Overall Study|Lack of Efficacy|0|||
37709036|NCT02282813|69187284|FG002|Overall Study|Lack of Efficacy|0|||
37709037|NCT02282813|69187282|FG000|Overall Study|Administrative reasons|0|||
37709038|NCT02282813|69187283|FG001|Overall Study|Administrative reasons|1|||
37709039|NCT02282813|69187284|FG002|Overall Study|Administrative reasons|0|||
37709040|NCT01903863|69187296|FG000|Overall Study|Physician Decision|2|||
37709041|NCT01903863|69187297|FG001|Overall Study|Physician Decision|0|||
37709042|NCT02123251|69187305|FG000|Overall Study|Death|1|||
37709043|NCT02123251|69187306|FG001|Overall Study|Death|1|||
37709044|NCT02123251|69187305|FG000|Overall Study|Withdrawal by Subject|0|||
37709045|NCT02123251|69187306|FG001|Overall Study|Withdrawal by Subject|3|||
37709046|NCT02123251|69187305|FG000|Overall Study|Lost Medicaid eligibility|29|||
37709047|NCT02123251|69187306|FG001|Overall Study|Lost Medicaid eligibility|22|||
37709048|NCT02123251|69187305|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
37709049|NCT02123251|69187306|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
37709050|NCT01902303|69187315|FG000|Overall Study|Adverse Event|0|||
37709051|NCT01902303|69187316|FG001|Overall Study|Adverse Event|1|||
37709052|NCT01902303|69187315|FG000|Overall Study|Lost to Follow-up|0|||
37709053|NCT01902303|69187316|FG001|Overall Study|Lost to Follow-up|1|||
37709054|NCT01902303|69187315|FG000|Overall Study|Protocol Violation|2|||
37709055|NCT01902303|69187316|FG001|Overall Study|Protocol Violation|2|||
37709056|NCT01902303|69187315|FG000|Overall Study|subject lost investigational product|0|||
37709057|NCT01902303|69187316|FG001|Overall Study|subject lost investigational product|1|||
37709058|NCT01902303|69187315|FG000|Overall Study|Did not develop a cold sore|21|||
37709059|NCT01902303|69187316|FG001|Overall Study|Did not develop a cold sore|19|||
37709060|NCT02122783|69187326|FG000|Overall Study|Adverse Event|0|||
37709061|NCT02122783|69187327|FG001|Overall Study|Adverse Event|1|||
37709062|NCT01921257|69187336|FG000|Overall Study|Adverse Event|1|||
37709063|NCT01921257|69187336|FG000|Overall Study|Protocol Violation|1|||
37709064|NCT01921257|69187336|FG000|Overall Study|Withdrawal by Subject|1|||
37709065|NCT02121847|69187341|FG000|Overall Study|Administrative Reasons|1|||
37709066|NCT02121847|69187341|FG000|Overall Study|Adverse Event|2|||
37709067|NCT01921179|69187347|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
37709068|NCT01921179|69187348|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
37709069|NCT01921179|69187347|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
37709070|NCT01921179|69187348|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
37709071|NCT01587040|69187359|FG000|Overall Study|Protocol Violation|0|||
37709072|NCT01587040|69187360|FG001|Overall Study|Protocol Violation|0|||
37709073|NCT01587040|69187361|FG002|Overall Study|Protocol Violation|1|||
37709074|NCT01587040|69187362|FG003|Overall Study|Protocol Violation|0|||
37709075|NCT01587040|69187359|FG000|Overall Study|Adverse Event|0|||
37709076|NCT01587040|69187360|FG001|Overall Study|Adverse Event|1|||
37709077|NCT01587040|69187361|FG002|Overall Study|Adverse Event|10|||
37709078|NCT01587040|69187362|FG003|Overall Study|Adverse Event|0|||
37709079|NCT01587040|69187359|FG000|Overall Study|Disease progression|12|||
37709080|NCT01587040|69187360|FG001|Overall Study|Disease progression|1|||
37709081|NCT01587040|69187361|FG002|Overall Study|Disease progression|15|||
37709082|NCT01587040|69187362|FG003|Overall Study|Disease progression|3|||
37709083|NCT01587040|69187359|FG000|Overall Study|Other than specified|5|||
37709084|NCT01587040|69187360|FG001|Overall Study|Other than specified|1|||
37709085|NCT01587040|69187361|FG002|Overall Study|Other than specified|11|||
37709086|NCT01587040|69187362|FG003|Overall Study|Other than specified|1|||
37709087|NCT02144701|69187374|FG000|Overall Study|development of relapse, GVHD or death|9|||
37709088|NCT02144701|69187375|FG001|Overall Study|development of relapse, GVHD or death|3|||
37709089|NCT01921101|69187383|FG000|Overall Study|Death|16|||
37709090|NCT01921101|69187384|FG001|Overall Study|Death|6|||
37709091|NCT01586806|69187393|FG000|Overall Study|Protocol Violation|0|||
37709092|NCT01586806|69187394|FG001|Overall Study|Protocol Violation|1|||
37709093|NCT01586806|69187395|FG002|Overall Study|Protocol Violation|0|||
37709094|NCT01586806|69187393|FG000|Overall Study|Withdrawal by Subject|1|||
37709095|NCT01586806|69187394|FG001|Overall Study|Withdrawal by Subject|0|||
37709096|NCT01586806|69187395|FG002|Overall Study|Withdrawal by Subject|0|||
37709097|NCT01586806|69187393|FG000|Overall Study|Lost to Follow-up|2|||
37838300|NCT00195663|69522844|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
37838301|NCT00195663|69522845|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
37838302|NCT00195663|69522843|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
37838303|NCT00195663|69522844|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
37838304|NCT00195663|69522845|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
37838305|NCT00195663|69522843|FG000|2-year Double-blind Treatment Period|Recovery|1|||
37838306|NCT00195663|69522844|FG001|2-year Double-blind Treatment Period|Recovery|0|||
37838307|NCT00195663|69522845|FG002|2-year Double-blind Treatment Period|Recovery|1|||
37838308|NCT00195663|69522843|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
37838309|NCT00195663|69522844|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
37838310|NCT00195663|69522845|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
37838311|NCT00195663|69522843|FG000|Open-Label Extension Period|Adverse Event|21|||
37838312|NCT00195663|69522844|FG001|Open-Label Extension Period|Adverse Event|32|||
37838313|NCT00195663|69522845|FG002|Open-Label Extension Period|Adverse Event|36|||
37838314|NCT00195663|69522843|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
37838315|NCT00195663|69522844|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
37838316|NCT00195663|69522845|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
37838317|NCT00195663|69522843|FG000|Open-Label Extension Period|Recovery|0|||
37838318|NCT00195663|69522844|FG001|Open-Label Extension Period|Recovery|2|||
37838319|NCT00195663|69522845|FG002|Open-Label Extension Period|Recovery|2|||
37838320|NCT00195663|69522843|FG000|Open-Label Extension Period|Protocol Violation|3|||
37838321|NCT00195663|69522844|FG001|Open-Label Extension Period|Protocol Violation|4|||
37838322|NCT00195663|69522845|FG002|Open-Label Extension Period|Protocol Violation|4|||
37838323|NCT00195663|69522843|FG000|Open-Label Extension Period|Death|2|||
37838324|NCT00195663|69522844|FG001|Open-Label Extension Period|Death|2|||
37838325|NCT00195663|69522845|FG002|Open-Label Extension Period|Death|2|||
37838326|NCT00195663|69522843|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
37838327|NCT00195663|69522844|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
37838328|NCT00195663|69522845|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
37838329|NCT00195663|69522843|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
37838330|NCT00195663|69522844|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
37838331|NCT00195663|69522845|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
37709098|NCT01586806|69187394|FG001|Overall Study|Lost to Follow-up|3|||
37709099|NCT01586806|69187395|FG002|Overall Study|Lost to Follow-up|2|||
37838332|NCT00195663|69522843|FG000|Open-Label Extension Period|Administrative reasons|11|||
37709100|NCT02144077|69187405|FG000|Overall Study|Withdrawal by Subject|3|||
37709101|NCT02144077|69187406|FG001|Overall Study|Withdrawal by Subject|3|||
37838333|NCT00195663|69522844|FG001|Open-Label Extension Period|Administrative reasons|11|||
37709102|NCT02144077|69187405|FG000|Overall Study|Adverse Event|2|||
37709103|NCT02144077|69187406|FG001|Overall Study|Adverse Event|3|||
37838334|NCT00195663|69522845|FG002|Open-Label Extension Period|Administrative reasons|13|||
37838335|NCT01135498|69522863|FG000|Overall Study|Adverse Event|20|||
37838336|NCT01135498|69522863|FG000|Overall Study|Progressive disease|38|||
37838337|NCT01135498|69522863|FG000|Overall Study|Investigator judgement|25|||
37838338|NCT01135498|69522863|FG000|Overall Study|Withdrawal by Subject|4|||
37838339|NCT01135498|69522863|FG000|Overall Study|Death|1|||
37838340|NCT01135498|69522863|FG000|Overall Study|Ongoing at time of analysis|2|||
37838341|NCT00195507|69522870|FG000|Overall Study|Adverse Event|24|||
37838342|NCT00195507|69522871|FG001|Overall Study|Adverse Event|13|||
37838343|NCT00195507|69522870|FG000|Overall Study|Death|0|||
37838344|NCT00195507|69522871|FG001|Overall Study|Death|1|||
37838345|NCT00195507|69522870|FG000|Overall Study|Failed to Return|4|||
37838346|NCT00195507|69522871|FG001|Overall Study|Failed to Return|3|||
37838347|NCT00195507|69522870|FG000|Overall Study|Physician Decision|1|||
37838348|NCT00195507|69522871|FG001|Overall Study|Physician Decision|2|||
37838349|NCT00195507|69522870|FG000|Overall Study|Lost to Follow-up|3|||
37838350|NCT00195507|69522871|FG001|Overall Study|Lost to Follow-up|2|||
37838351|NCT00195507|69522870|FG000|Overall Study|Protocol Violation|5|||
37838352|NCT00195507|69522871|FG001|Overall Study|Protocol Violation|4|||
37838353|NCT00195507|69522870|FG000|Overall Study|Lack of Efficacy|40|||
37838354|NCT00195507|69522871|FG001|Overall Study|Lack of Efficacy|67|||
37838355|NCT00195507|69522870|FG000|Overall Study|Withdrawal by Subject|16|||
37838356|NCT00195507|69522871|FG001|Overall Study|Withdrawal by Subject|23|||
37838357|NCT00195507|69522870|FG000|Overall Study|Protocol Deviation|6|||
37838358|NCT00195507|69522871|FG001|Overall Study|Protocol Deviation|3|||
37838359|NCT01134562|69522882|FG000|Overall Study|Adverse Event|0|||
37838360|NCT01134562|69522883|FG001|Overall Study|Adverse Event|1|||
37838361|NCT01134562|69522884|FG002|Overall Study|Adverse Event|0|||
37838362|NCT01134562|69522885|FG003|Overall Study|Adverse Event|0|||
37838363|NCT01134562|69522886|FG004|Overall Study|Adverse Event|0|||
37838364|NCT00195429|69522913|FG000|Overall Study|Adverse Event|2|||
37838365|NCT00195429|69522914|FG001|Overall Study|Adverse Event|4|||
37838366|NCT00195429|69522913|FG000|Overall Study|Lack of Efficacy|2|||
37838367|NCT00195429|69522914|FG001|Overall Study|Lack of Efficacy|1|||
37838368|NCT00195429|69522913|FG000|Overall Study|Lost to Follow-up|1|||
37838369|NCT00195429|69522914|FG001|Overall Study|Lost to Follow-up|0|||
37838370|NCT00195351|69522922|FG000|Overall Study|Lost to Follow-up|9|||
37838371|NCT00195351|69522923|FG001|Overall Study|Lost to Follow-up|9|||
37838372|NCT00195351|69522922|FG000|Overall Study|Withdrawal by Subject|6|||
37838373|NCT00195351|69522923|FG001|Overall Study|Withdrawal by Subject|3|||
37838374|NCT00195351|69522922|FG000|Overall Study|Protocol Deviation|3|||
37838375|NCT00195351|69522923|FG001|Overall Study|Protocol Deviation|2|||
37838376|NCT00195351|69522922|FG000|Overall Study|Death|3|||
37838377|NCT00195351|69522923|FG001|Overall Study|Death|1|||
37838378|NCT00195351|69522922|FG000|Overall Study|Lack of Efficacy|0|||
37838379|NCT00195351|69522923|FG001|Overall Study|Lack of Efficacy|1|||
37838380|NCT00195273|69522931|FG000|Overall Study|Adverse Event|9|||
37838381|NCT00195273|69522932|FG001|Overall Study|Adverse Event|9|||
37838382|NCT00195273|69522931|FG000|Overall Study|Protocol deviation|0|||
37838383|NCT00195273|69522932|FG001|Overall Study|Protocol deviation|1|||
37838384|NCT00195273|69522931|FG000|Overall Study|Lack of Efficacy|3|||
37709104|NCT02144077|69187405|FG000|Overall Study|Lost to Follow-up|2|||
37709105|NCT02144077|69187406|FG001|Overall Study|Lost to Follow-up|2|||
37709106|NCT02144077|69187405|FG000|Overall Study|Protocol Violation|1|||
37709107|NCT02144077|69187406|FG001|Overall Study|Protocol Violation|2|||
37709108|NCT02144077|69187405|FG000|Overall Study|Death|0|||
37709109|NCT02144077|69187406|FG001|Overall Study|Death|1|||
37709110|NCT02144077|69187405|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
37838385|NCT00195273|69522932|FG001|Overall Study|Lack of Efficacy|1|||
37838386|NCT00195273|69522931|FG000|Overall Study|Procedural complications|9|||
37838387|NCT00195273|69522932|FG001|Overall Study|Procedural complications|3|||
37838388|NCT00193479|69522938|FG000|Induction Chemotherapy|Adverse Event|2|||
37838389|NCT00193479|69522938|FG000|Induction Chemotherapy|Disease Progression|1|||
37838390|NCT00193479|69522938|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
37838391|NCT00193479|69522938|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
37915362|NCT00711802|69602166|FG001|Overall Study|Microbiological failure|1|||
37709111|NCT02144077|69187406|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
37709112|NCT02172625|69187414|FG000|Overall Study|Adverse Event|0|||
37838392|NCT00193206|69522942|FG000|Preoperative Therapy|Lack of Efficacy|2|||
37838393|NCT00193206|69522942|FG000|Preoperative Therapy|Adverse Event|2|||
37838394|NCT00193206|69522942|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
37838395|NCT00193206|69522942|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
37838396|NCT00193206|69522942|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
37838397|NCT00193206|69522942|FG000|Postoperative Therapy|Physician Decision|3|||
37838398|NCT00193206|69522942|FG000|Postoperative Therapy|Intercurrent Illness|2|||
37838399|NCT00193206|69522942|FG000|Postoperative Therapy|Lack of Efficacy|1|||
37838400|NCT00193206|69522942|FG000|Postoperative Therapy|Protocol Violation|1|||
37838401|NCT00193050|69522946|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
37709113|NCT02172625|69187415|FG001|Overall Study|Adverse Event|1|||
37709114|NCT02172625|69187414|FG000|Overall Study|Pregnancy|0|||
37709115|NCT02172625|69187415|FG001|Overall Study|Pregnancy|1|||
37709116|NCT02172625|69187414|FG000|Overall Study|car accident|0|||
37709117|NCT02172625|69187415|FG001|Overall Study|car accident|1|||
37709118|NCT02143843|69187425|FG000|Overall Study|Adverse Event|8|||
37709119|NCT02143843|69187425|FG000|Overall Study|Lack of Efficacy|2|||
37709120|NCT02143843|69187425|FG000|Overall Study|Withdrawal by Subject|2|||
37709121|NCT02121535|69187431|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
37709122|NCT02121535|69187432|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
37709123|NCT02121535|69187431|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
37709124|NCT02121535|69187432|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
37709125|NCT01586338|69187439|FG000|Overall Study|Adverse Event|3|||
37709126|NCT01586338|69187439|FG000|Overall Study|Lost to Follow-up|1|||
37709127|NCT01586338|69187439|FG000|Overall Study|Withdrawal by participant|3|||
37709128|NCT01586338|69187439|FG000|Overall Study|Other|1|||
37709129|NCT02143141|69187445|FG000|Overall Study|pain scores at 24 hours not collected|1|||
37709130|NCT02143141|69187446|FG001|Overall Study|pain scores at 24 hours not collected|0|||
37709131|NCT02171065|69187455|FG000|Overall Study|Withdrawal by Subject|1|||
37709132|NCT02171065|69187456|FG001|Overall Study|Withdrawal by Subject|0|||
37709133|NCT02171065|69187457|FG002|Overall Study|Withdrawal by Subject|0|||
37709134|NCT02171065|69187455|FG000|Overall Study|Lost to Follow-up|0|||
37709135|NCT02171065|69187456|FG001|Overall Study|Lost to Follow-up|0|||
37709136|NCT02171065|69187457|FG002|Overall Study|Lost to Follow-up|1|||
37709137|NCT01566604|69187469|FG000|Overall Study|Patient's inability to use the device|1|||
37709138|NCT01566604|69187470|FG001|Overall Study|Patient's inability to use the device|0|||
37709139|NCT01566604|69187469|FG000|Overall Study|Administrative problems|1|||
37709140|NCT01566604|69187470|FG001|Overall Study|Administrative problems|0|||
37709141|NCT01566604|69187469|FG000|Overall Study|Lack of Efficacy|1|||
37709142|NCT01566604|69187470|FG001|Overall Study|Lack of Efficacy|2|||
37709143|NCT01566604|69187469|FG000|Overall Study|Protocol deviation|2|||
37709144|NCT01566604|69187470|FG001|Overall Study|Protocol deviation|0|||
37709145|NCT01566604|69187469|FG000|Overall Study|Abnormal laboratory value|2|||
37709146|NCT01566604|69187470|FG001|Overall Study|Abnormal laboratory value|0|||
37709147|NCT01566604|69187469|FG000|Overall Study|Death|4|||
37709148|NCT01566604|69187470|FG001|Overall Study|Death|1|||
37709149|NCT01566604|69187469|FG000|Overall Study|Adverse Event|4|||
37709150|NCT01566604|69187470|FG001|Overall Study|Adverse Event|2|||
37709151|NCT01566604|69187469|FG000|Overall Study|Withdrawal by Subject|9|||
37709152|NCT01566604|69187470|FG001|Overall Study|Withdrawal by Subject|6|||
37709153|NCT01684930|69187478|FG000|Overall Study|Withdrawal by Subject|3|||
37709154|NCT01684930|69187479|FG001|Overall Study|Withdrawal by Subject|1|||
37709155|NCT01566214|69187487|FG000|Overall Study|Lost to Follow-up|3|||
37709156|NCT01566214|69187488|FG001|Overall Study|Lost to Follow-up|0|||
37709157|NCT02253992|69187497|FG000|Overall Study|Study drug toxicity|1|||
37709158|NCT02253992|69187498|FG001|Overall Study|Study drug toxicity|0|||
37709159|NCT02253992|69187499|FG002|Overall Study|Study drug toxicity|10|||
37709160|NCT02253992|69187497|FG000|Overall Study|Disease progression|4|||
37709161|NCT02253992|69187498|FG001|Overall Study|Disease progression|3|||
37709162|NCT02253992|69187499|FG002|Overall Study|Disease progression|98|||
37709163|NCT02253992|69187497|FG000|Overall Study|Withdrawal by Subject|0|||
37709164|NCT02253992|69187498|FG001|Overall Study|Withdrawal by Subject|0|||
37709165|NCT02253992|69187499|FG002|Overall Study|Withdrawal by Subject|3|||
37709166|NCT02253992|69187497|FG000|Overall Study|Adverse Event|0|||
37709167|NCT02253992|69187498|FG001|Overall Study|Adverse Event|0|||
37709168|NCT02253992|69187499|FG002|Overall Study|Adverse Event|8|||
37709169|NCT02253992|69187497|FG000|Overall Study|Death|0|||
37709170|NCT02253992|69187498|FG001|Overall Study|Death|0|||
37709171|NCT02253992|69187499|FG002|Overall Study|Death|1|||
37709172|NCT02253992|69187497|FG000|Overall Study|Subject discontinued study drug|1|||
37709173|NCT02253992|69187498|FG001|Overall Study|Subject discontinued study drug|0|||
37709174|NCT02253992|69187499|FG002|Overall Study|Subject discontinued study drug|1|||
37709175|NCT02253992|69187497|FG000|Overall Study|Completed treatment as per protocol|0|||
37709176|NCT02253992|69187498|FG001|Overall Study|Completed treatment as per protocol|1|||
37709177|NCT02253992|69187499|FG002|Overall Study|Completed treatment as per protocol|22|||
37709178|NCT02253992|69187497|FG000|Overall Study|Other|0|||
37709179|NCT02253992|69187498|FG001|Overall Study|Other|0|||
37709180|NCT02253992|69187499|FG002|Overall Study|Other|1|||
37709181|NCT02252588|69187523|FG000|Overall Study|Withdrawal by Subject|4|||
37709182|NCT02252588|69187524|FG001|Overall Study|Withdrawal by Subject|0|||
37709183|NCT01585558|69187533|FG000|Overall Study|Withdrawal by Subject|4|||
37709184|NCT01585558|69187534|FG001|Overall Study|Withdrawal by Subject|5|||
37709185|NCT01585558|69187535|FG002|Overall Study|Withdrawal by Subject|8|||
37709186|NCT01585558|69187533|FG000|Overall Study|Lost to Follow-up|2|||
37709187|NCT01585558|69187534|FG001|Overall Study|Lost to Follow-up|0|||
37709188|NCT01585558|69187535|FG002|Overall Study|Lost to Follow-up|3|||
37709189|NCT01585558|69187533|FG000|Overall Study|Adverse Event|3|||
37709190|NCT01585558|69187534|FG001|Overall Study|Adverse Event|4|||
37709191|NCT01585558|69187535|FG002|Overall Study|Adverse Event|1|||
37709192|NCT01585558|69187533|FG000|Overall Study|Protocol Violation|4|||
37709193|NCT01585558|69187534|FG001|Overall Study|Protocol Violation|3|||
37709194|NCT01585558|69187535|FG002|Overall Study|Protocol Violation|2|||
37709195|NCT01585558|69187533|FG000|Overall Study|Lack of Efficacy|0|||
37709196|NCT01585558|69187534|FG001|Overall Study|Lack of Efficacy|0|||
37709197|NCT01585558|69187535|FG002|Overall Study|Lack of Efficacy|1|||
37709198|NCT01565980|69187545|FG000|Overall Study|Death|1|||
37709199|NCT01565980|69187546|FG001|Overall Study|Death|0|||
37709200|NCT01565980|69187545|FG000|Overall Study|Lost to Follow-up|1|||
37709201|NCT01565980|69187546|FG001|Overall Study|Lost to Follow-up|0|||
37709202|NCT01565980|69187545|FG000|Overall Study|health complications|1|||
37709203|NCT01565980|69187546|FG001|Overall Study|health complications|1|||
37709204|NCT01565980|69187545|FG000|Overall Study|stopped medical treatment|1|||
37709205|NCT01565980|69187546|FG001|Overall Study|stopped medical treatment|0|||
37709206|NCT01565980|69187545|FG000|Overall Study|Withdrawal by Subject|0|||
37709207|NCT01565980|69187546|FG001|Overall Study|Withdrawal by Subject|3|||
37709208|NCT01585246|69187561|FG000|Overall Study|Lost to Follow-up|0|||
37709209|NCT01585246|69187562|FG001|Overall Study|Lost to Follow-up|0|||
37709210|NCT01585246|69187563|FG002|Overall Study|Lost to Follow-up|2|||
37709211|NCT01585246|69187564|FG003|Overall Study|Lost to Follow-up|1|||
37709212|NCT01585246|69187565|FG004|Overall Study|Lost to Follow-up|0|||
37709213|NCT01585246|69187561|FG000|Overall Study|Protocol Violation|0|||
37709214|NCT01585246|69187562|FG001|Overall Study|Protocol Violation|0|||
37709215|NCT01585246|69187563|FG002|Overall Study|Protocol Violation|0|||
37709216|NCT01585246|69187564|FG003|Overall Study|Protocol Violation|0|||
37709217|NCT01585246|69187565|FG004|Overall Study|Protocol Violation|1|||
37709218|NCT01585246|69187561|FG000|Overall Study|Withdrawal by Subject|0|||
37709219|NCT01585246|69187562|FG001|Overall Study|Withdrawal by Subject|0|||
37709220|NCT01585246|69187563|FG002|Overall Study|Withdrawal by Subject|1|||
37709221|NCT01585246|69187564|FG003|Overall Study|Withdrawal by Subject|2|||
37709222|NCT01585246|69187565|FG004|Overall Study|Withdrawal by Subject|1|||
37709223|NCT01585246|69187561|FG000|Overall Study|Other|0|||
37709224|NCT01585246|69187562|FG001|Overall Study|Other|1|||
37709225|NCT01585246|69187563|FG002|Overall Study|Other|1|||
37709226|NCT01585246|69187564|FG003|Overall Study|Other|1|||
37709227|NCT01585246|69187565|FG004|Overall Study|Other|0|||
37709228|NCT01585168|69187582|FG000|Overall Study|Lost to Follow-up|3|||
37709229|NCT01585168|69187583|FG001|Overall Study|Lost to Follow-up|1|||
37709230|NCT01585168|69187584|FG002|Overall Study|Lost to Follow-up|1|||
37709231|NCT01585168|69187585|FG003|Overall Study|Lost to Follow-up|1|||
37709232|NCT02232074|69187595|FG000|Overall Study|Withdrawal by Subject|5|||
37709233|NCT02232074|69187596|FG001|Overall Study|Withdrawal by Subject|3|||
37709234|NCT02232074|69187595|FG000|Overall Study|No legal concerns at baseline|36|||
37709235|NCT02232074|69187596|FG001|Overall Study|No legal concerns at baseline|41|||
37709236|NCT02232074|69187595|FG000|Overall Study|deemed ineligible|0|||
37709237|NCT02232074|69187596|FG001|Overall Study|deemed ineligible|1|||
37709238|NCT02142283|69187610|FG000|Overall Study|Death|20|||
37709239|NCT02142283|69187611|FG001|Overall Study|Death|18|||
37709240|NCT02142283|69187610|FG000|Overall Study|Withdrawal by Subject|1|||
37709241|NCT02142283|69187611|FG001|Overall Study|Withdrawal by Subject|3|||
37709242|NCT02231918|69187620|FG000|Overall Study|Withdrawal by Subject|0|||
37709243|NCT02231918|69187621|FG001|Overall Study|Withdrawal by Subject|1|||
37709244|NCT02231918|69187622|FG002|Overall Study|Withdrawal by Subject|0|||
37838402|NCT00193050|69522946|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
37838403|NCT00193050|69522946|FG000|Neoadjuvant Treatment|Physician Decision|2|||
37838404|NCT00193050|69522946|FG000|Neoadjuvant Treatment|Adverse Event|2|||
37838405|NCT00193050|69522946|FG000|Adjuvant|Physician Decision|5|||
37838406|NCT00193050|69522946|FG000|Adjuvant|Intercurrent Hospitalization|3|||
37838407|NCT00193050|69522946|FG000|Adjuvant|Lack of Efficacy|2|||
37709245|NCT02231918|69187620|FG000|Overall Study|Adverse Event|0|||
37709246|NCT02231918|69187621|FG001|Overall Study|Adverse Event|0|||
37709247|NCT02231918|69187622|FG002|Overall Study|Adverse Event|1|||
37709248|NCT02199314|69187630|FG000|Overall Study|Withdrawal by Subject|6|||
37709249|NCT02199314|69187630|FG000|Overall Study|Physician Decision|10|||
37709250|NCT02251652|69187634|FG000|Overall Study|Withdrawal by Subject|1|||
37709251|NCT02197520|69187640|FG000|Period 1|Withdrawal by Subject|1|||
37709252|NCT02197520|69187641|FG001|Period 1|Withdrawal by Subject|0|||
37709253|NCT02197520|69187640|FG000|Period 2|Adverse Event|0|||
37709254|NCT02197520|69187641|FG001|Period 2|Adverse Event|2|||
37709255|NCT02197520|69187640|FG000|Period 2|Withdrawal by Subject|1|||
37709256|NCT02197520|69187641|FG001|Period 2|Withdrawal by Subject|0|||
37838408|NCT00192504|69522955|FG000|Overall Study|Lost to Follow-up|1|||
37709257|NCT02230904|69187651|FG000|Overall Study|Safety follow up could not take place|0|||
37709258|NCT02230904|69187652|FG001|Overall Study|Safety follow up could not take place|1|||
37709259|NCT02230670|69187662|FG000|Overall Study|Adverse Event|1|||
37709260|NCT02230670|69187663|FG001|Overall Study|Adverse Event|2|||
37709261|NCT02230670|69187662|FG000|Overall Study|Withdrawal by Subject|2|||
37709262|NCT02230670|69187663|FG001|Overall Study|Withdrawal by Subject|2|||
37709263|NCT02230670|69187662|FG000|Overall Study|Physician Decision|0|||
37709264|NCT02230670|69187663|FG001|Overall Study|Physician Decision|1|||
37709265|NCT02230670|69187662|FG000|Overall Study|Protocol Violation|0|||
37709266|NCT02230670|69187663|FG001|Overall Study|Protocol Violation|1|||
37709267|NCT02230670|69187662|FG000|Overall Study|Progression to Child-Pugh C|1|||
37709268|NCT02230670|69187663|FG001|Overall Study|Progression to Child-Pugh C|2|||
37709269|NCT02197130|69187672|FG000|Overall Study|Adverse Event|13|||
37709270|NCT02197130|69187673|FG001|Overall Study|Adverse Event|4|||
37709271|NCT02197130|69187674|FG002|Overall Study|Adverse Event|23|||
37709272|NCT02197130|69187672|FG000|Overall Study|Death|0|||
37709273|NCT02197130|69187673|FG001|Overall Study|Death|1|||
37709274|NCT02197130|69187674|FG002|Overall Study|Death|0|||
37709275|NCT02197130|69187672|FG000|Overall Study|Lost to Follow-up|2|||
37709276|NCT02197130|69187673|FG001|Overall Study|Lost to Follow-up|0|||
37709277|NCT02197130|69187674|FG002|Overall Study|Lost to Follow-up|1|||
37709278|NCT02197130|69187672|FG000|Overall Study|Does not meet entrance criteria|0|||
37709279|NCT02197130|69187673|FG001|Overall Study|Does not meet entrance criteria|0|||
37709280|NCT02197130|69187674|FG002|Overall Study|Does not meet entrance criteria|1|||
37709281|NCT02197130|69187672|FG000|Overall Study|Withdrawal by Subject|0|||
37709282|NCT02197130|69187673|FG001|Overall Study|Withdrawal by Subject|3|||
37709283|NCT02197130|69187674|FG002|Overall Study|Withdrawal by Subject|4|||
37709284|NCT02197130|69187672|FG000|Overall Study|Other|1|||
37709285|NCT02197130|69187673|FG001|Overall Study|Other|0|||
37709286|NCT02197130|69187674|FG002|Overall Study|Other|3|||
37709287|NCT02196506|69187684|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
37709288|NCT02196506|69187685|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
37709289|NCT02196506|69187686|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
37709290|NCT02196506|69187687|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
37709291|NCT02196506|69187684|FG000|Phase A|Withdrawal by Subject|34|||
37709292|NCT02196506|69187685|FG001|Phase A|Withdrawal by Subject|0|||
37709293|NCT02196506|69187686|FG002|Phase A|Withdrawal by Subject|0|||
37709294|NCT02196506|69187687|FG003|Phase A|Withdrawal by Subject|0|||
37709295|NCT02196506|69187684|FG000|Phase A|Adverse Event|22|||
37709296|NCT02196506|69187685|FG001|Phase A|Adverse Event|0|||
37709297|NCT02196506|69187686|FG002|Phase A|Adverse Event|0|||
37709298|NCT02196506|69187687|FG003|Phase A|Adverse Event|0|||
37709299|NCT02196506|69187684|FG000|Phase A|Lost to Follow-up|9|||
37709300|NCT02196506|69187685|FG001|Phase A|Lost to Follow-up|0|||
37709301|NCT02196506|69187686|FG002|Phase A|Lost to Follow-up|0|||
37709302|NCT02196506|69187687|FG003|Phase A|Lost to Follow-up|0|||
37709303|NCT02196506|69187684|FG000|Phase A|Protocol deviation|12|||
37709304|NCT02196506|69187685|FG001|Phase A|Protocol deviation|0|||
37709305|NCT02196506|69187686|FG002|Phase A|Protocol deviation|0|||
37709306|NCT02196506|69187687|FG003|Phase A|Protocol deviation|0|||
37709307|NCT02196506|69187684|FG000|Phase A|Participant withdrawn by investigator|10|||
37709308|NCT02196506|69187685|FG001|Phase A|Participant withdrawn by investigator|0|||
37709309|NCT02196506|69187686|FG002|Phase A|Participant withdrawn by investigator|0|||
37709310|NCT02196506|69187687|FG003|Phase A|Participant withdrawn by investigator|0|||
37709311|NCT02196506|69187684|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
37709312|NCT02196506|69187685|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
37709313|NCT02196506|69187686|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
37709314|NCT02196506|69187687|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
37709315|NCT02196506|69187684|FG000|Phase B|Lack of Efficacy|0|||
37709316|NCT02196506|69187685|FG001|Phase B|Lack of Efficacy|1|||
37709317|NCT02196506|69187686|FG002|Phase B|Lack of Efficacy|2|||
37709318|NCT02196506|69187687|FG003|Phase B|Lack of Efficacy|0|||
37709319|NCT02196506|69187684|FG000|Phase B|Withdrawal by Participant|0|||
37709320|NCT02196506|69187685|FG001|Phase B|Withdrawal by Participant|8|||
37709321|NCT02196506|69187686|FG002|Phase B|Withdrawal by Participant|1|||
37709322|NCT02196506|69187687|FG003|Phase B|Withdrawal by Participant|0|||
37709323|NCT02196506|69187684|FG000|Phase B|Adverse Event|0|||
37709324|NCT02196506|69187685|FG001|Phase B|Adverse Event|4|||
37709325|NCT02196506|69187686|FG002|Phase B|Adverse Event|1|||
37709326|NCT02196506|69187687|FG003|Phase B|Adverse Event|0|||
37709327|NCT02196506|69187684|FG000|Phase B|Lost to Follow-up|0|||
37709328|NCT02196506|69187685|FG001|Phase B|Lost to Follow-up|2|||
37709329|NCT02196506|69187686|FG002|Phase B|Lost to Follow-up|1|||
37709330|NCT02196506|69187687|FG003|Phase B|Lost to Follow-up|0|||
37709331|NCT02196506|69187684|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
37709332|NCT02196506|69187685|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
37709333|NCT02196506|69187686|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
37709334|NCT02196506|69187687|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
37709335|NCT02196506|69187684|FG000|Phase A+|Withdrawal by Participant|0|||
37709336|NCT02196506|69187685|FG001|Phase A+|Withdrawal by Participant|0|||
37709337|NCT02196506|69187686|FG002|Phase A+|Withdrawal by Participant|0|||
37709338|NCT02196506|69187687|FG003|Phase A+|Withdrawal by Participant|5|||
37709339|NCT02196506|69187684|FG000|Phase A+|Adverse Event|0|||
37709340|NCT02196506|69187685|FG001|Phase A+|Adverse Event|0|||
37709341|NCT02196506|69187686|FG002|Phase A+|Adverse Event|0|||
37709342|NCT02196506|69187687|FG003|Phase A+|Adverse Event|1|||
37709343|NCT02196506|69187684|FG000|Phase A+|Lost to Follow-up|0|||
37709344|NCT02196506|69187685|FG001|Phase A+|Lost to Follow-up|0|||
37709345|NCT02196506|69187686|FG002|Phase A+|Lost to Follow-up|0|||
37709346|NCT02196506|69187687|FG003|Phase A+|Lost to Follow-up|6|||
37709347|NCT02196506|69187684|FG000|Phase A+|Participant withdrawn by investigator|0|||
37709348|NCT02196506|69187685|FG001|Phase A+|Participant withdrawn by investigator|0|||
37709349|NCT02196506|69187686|FG002|Phase A+|Participant withdrawn by investigator|0|||
37709350|NCT02196506|69187687|FG003|Phase A+|Participant withdrawn by investigator|1|||
37709351|NCT02228720|69187693|FG000|Open Label - Day 30|Lost to Follow-up|1|||
37709352|NCT02228564|69187697|FG000|Overall Study|Withdrawal by Subject|10|||
37709353|NCT02228564|69187697|FG000|Overall Study|Death|11|||
37709354|NCT02228564|69187697|FG000|Overall Study|Physician Decision|5|||
37709355|NCT02228564|69187697|FG000|Overall Study|Lost to Follow-up|17|||
37709356|NCT02228564|69187697|FG000|Overall Study|Other|6|||
37709357|NCT01640951|69187709|FG000|Overall Study|Adverse Event|8|||
37709358|NCT01640951|69187710|FG001|Overall Study|Adverse Event|3|||
37709359|NCT01640951|69187711|FG002|Overall Study|Adverse Event|10|||
37709360|NCT01640951|69187712|FG003|Overall Study|Adverse Event|6|||
37709361|NCT01640951|69187713|FG004|Overall Study|Adverse Event|1|||
37709362|NCT01640951|69187714|FG005|Overall Study|Adverse Event|11|||
37709363|NCT01640951|69187715|FG006|Overall Study|Adverse Event|1|||
37709364|NCT01640951|69187716|FG007|Overall Study|Adverse Event|3|||
37709365|NCT01640951|69187709|FG000|Overall Study|Lack of Efficacy|20|||
37709366|NCT01640951|69187710|FG001|Overall Study|Lack of Efficacy|1|||
37709367|NCT01640951|69187711|FG002|Overall Study|Lack of Efficacy|7|||
37709368|NCT01640951|69187712|FG003|Overall Study|Lack of Efficacy|14|||
37709369|NCT01640951|69187713|FG004|Overall Study|Lack of Efficacy|0|||
37709370|NCT01640951|69187714|FG005|Overall Study|Lack of Efficacy|6|||
37709371|NCT01640951|69187715|FG006|Overall Study|Lack of Efficacy|5|||
37709372|NCT01640951|69187716|FG007|Overall Study|Lack of Efficacy|6|||
37709373|NCT01640951|69187709|FG000|Overall Study|Lost to Follow-up|1|||
37709374|NCT01640951|69187710|FG001|Overall Study|Lost to Follow-up|0|||
37709375|NCT01640951|69187711|FG002|Overall Study|Lost to Follow-up|6|||
37709376|NCT01640951|69187712|FG003|Overall Study|Lost to Follow-up|2|||
37709377|NCT01640951|69187713|FG004|Overall Study|Lost to Follow-up|2|||
37709378|NCT01640951|69187714|FG005|Overall Study|Lost to Follow-up|3|||
37709379|NCT01640951|69187715|FG006|Overall Study|Lost to Follow-up|1|||
37709380|NCT01640951|69187716|FG007|Overall Study|Lost to Follow-up|1|||
37709381|NCT01640951|69187709|FG000|Overall Study|Non-compliance with study treatment|0|||
37709382|NCT01640951|69187710|FG001|Overall Study|Non-compliance with study treatment|0|||
37709383|NCT01640951|69187711|FG002|Overall Study|Non-compliance with study treatment|1|||
37709384|NCT01640951|69187712|FG003|Overall Study|Non-compliance with study treatment|1|||
37709385|NCT01640951|69187713|FG004|Overall Study|Non-compliance with study treatment|1|||
37709386|NCT01640951|69187714|FG005|Overall Study|Non-compliance with study treatment|4|||
37709387|NCT01640951|69187715|FG006|Overall Study|Non-compliance with study treatment|1|||
37709388|NCT01640951|69187716|FG007|Overall Study|Non-compliance with study treatment|0|||
37709389|NCT01640951|69187709|FG000|Overall Study|Physician Decision|2|||
37709390|NCT01640951|69187710|FG001|Overall Study|Physician Decision|5|||
37709391|NCT01640951|69187711|FG002|Overall Study|Physician Decision|2|||
37709392|NCT01640951|69187712|FG003|Overall Study|Physician Decision|2|||
37709393|NCT01640951|69187713|FG004|Overall Study|Physician Decision|2|||
37709394|NCT01640951|69187714|FG005|Overall Study|Physician Decision|3|||
37709395|NCT01640951|69187715|FG006|Overall Study|Physician Decision|3|||
37709396|NCT01640951|69187716|FG007|Overall Study|Physician Decision|0|||
37709397|NCT01640951|69187709|FG000|Overall Study|Pregnancy|3|||
37709398|NCT01640951|69187710|FG001|Overall Study|Pregnancy|0|||
37709399|NCT01640951|69187711|FG002|Overall Study|Pregnancy|0|||
37709400|NCT01640951|69187712|FG003|Overall Study|Pregnancy|4|||
37709401|NCT01640951|69187713|FG004|Overall Study|Pregnancy|0|||
37709402|NCT01640951|69187714|FG005|Overall Study|Pregnancy|0|||
37915363|NCT00711802|69602167|FG002|Overall Study|Microbiological failure|0|||
37915364|NCT00711802|69602168|FG003|Overall Study|Microbiological failure|0|||
37709403|NCT01640951|69187715|FG006|Overall Study|Pregnancy|2|||
37709404|NCT01640951|69187716|FG007|Overall Study|Pregnancy|0|||
37709405|NCT01640951|69187709|FG000|Overall Study|Protocol Deviation|0|||
37709406|NCT01640951|69187710|FG001|Overall Study|Protocol Deviation|1|||
37709407|NCT01640951|69187711|FG002|Overall Study|Protocol Deviation|2|||
37709408|NCT01640951|69187712|FG003|Overall Study|Protocol Deviation|1|||
37709409|NCT01640951|69187713|FG004|Overall Study|Protocol Deviation|0|||
37709410|NCT01640951|69187714|FG005|Overall Study|Protocol Deviation|1|||
37709411|NCT01640951|69187715|FG006|Overall Study|Protocol Deviation|0|||
37709412|NCT01640951|69187716|FG007|Overall Study|Protocol Deviation|0|||
37709413|NCT01640951|69187709|FG000|Overall Study|Subject/Guardian decision|12|||
37709414|NCT01640951|69187710|FG001|Overall Study|Subject/Guardian decision|4|||
37709415|NCT01640951|69187711|FG002|Overall Study|Subject/Guardian decision|13|||
37709416|NCT01640951|69187712|FG003|Overall Study|Subject/Guardian decision|15|||
37709417|NCT01640951|69187713|FG004|Overall Study|Subject/Guardian decision|7|||
37709418|NCT01640951|69187714|FG005|Overall Study|Subject/Guardian decision|19|||
37709419|NCT01640951|69187715|FG006|Overall Study|Subject/Guardian decision|5|||
37709420|NCT01640951|69187716|FG007|Overall Study|Subject/Guardian decision|4|||
37709421|NCT01640951|69187709|FG000|Overall Study|Death|0|||
37709422|NCT01640951|69187710|FG001|Overall Study|Death|1|||
37709423|NCT01640951|69187711|FG002|Overall Study|Death|1|||
37709424|NCT01640951|69187712|FG003|Overall Study|Death|0|||
37709425|NCT01640951|69187713|FG004|Overall Study|Death|0|||
37709426|NCT01640951|69187714|FG005|Overall Study|Death|0|||
37709427|NCT01640951|69187715|FG006|Overall Study|Death|0|||
37709428|NCT01640951|69187716|FG007|Overall Study|Death|2|||
37709429|NCT02228096|69187738|FG000|Overall Study|Study terminated by Sponsor|24|||
37709430|NCT02228096|69187738|FG000|Overall Study|Lack of Efficacy|18|||
37709431|NCT02228096|69187738|FG000|Overall Study|Death|12|||
37709432|NCT02228096|69187738|FG000|Overall Study|Physician Decision|3|||
37709433|NCT02228096|69187738|FG000|Overall Study|Subject/guardian decision|2|||
37709434|NCT02228096|69187738|FG000|Overall Study|New therapy for study indication|1|||
37709435|NCT02228096|69187738|FG000|Overall Study|Enrolled, not infused|11|||
37709436|NCT01640873|69187758|FG000|Overall Study|Protocol Violation|2|||
37709437|NCT01640873|69187759|FG001|Overall Study|Protocol Violation|1|||
37709438|NCT01683994|69187770|FG000|Overall Study|Withdrawal by Subject|1|||
37709439|NCT01683994|69187771|FG001|Overall Study|Withdrawal by Subject|0|||
37709440|NCT01683994|69187772|FG002|Overall Study|Withdrawal by Subject|0|||
37709441|NCT01683994|69187773|FG003|Overall Study|Withdrawal by Subject|1|||
37838409|NCT00192504|69522956|FG001|Overall Study|Lost to Follow-up|0|||
37838410|NCT00192504|69522957|FG002|Overall Study|Lost to Follow-up|0|||
37838411|NCT00192504|69522958|FG003|Overall Study|Lost to Follow-up|0|||
37838412|NCT00192504|69522955|FG000|Overall Study|Dosing window missed|0|||
37838413|NCT00192504|69522956|FG001|Overall Study|Dosing window missed|0|||
37838414|NCT00192504|69522957|FG002|Overall Study|Dosing window missed|1|||
37838415|NCT00192504|69522958|FG003|Overall Study|Dosing window missed|0|||
37915365|NCT00711802|69602169|FG004|Overall Study|Microbiological failure|0|||
37915366|NCT00711802|69602170|FG005|Overall Study|Microbiological failure|1|||
37915367|NCT00711802|69602171|FG006|Overall Study|Microbiological failure|0|||
37915368|NCT00711802|69602172|FG007|Overall Study|Microbiological failure|0|||
37838416|NCT00192114|69522968|FG000|Overall Study|Objective Tumor Progression|19|||
37838417|NCT00192114|69522968|FG000|Overall Study|Adverse Event|2|||
37838418|NCT00192114|69522968|FG000|Overall Study|Clinical Progression|2|||
37838419|NCT00192114|69522968|FG000|Overall Study|Death|1|||
37838420|NCT00192075|69522974|FG000|Overall Study|Disease Progression|23|||
37838421|NCT00192075|69522975|FG001|Overall Study|Disease Progression|6|||
37838422|NCT00192075|69522974|FG000|Overall Study|Adverse Event|1|||
37838423|NCT00192075|69522975|FG001|Overall Study|Adverse Event|3|||
37838424|NCT00192075|69522974|FG000|Overall Study|Death|0|||
38024267|NCT00112840|69707792|FG000|Overall Study|Withdrawal by Subject|1|||
38024268|NCT00112840|69707793|FG001|Overall Study|Withdrawal by Subject|0|||
37709442|NCT01683994|69187774|FG004|Overall Study|Withdrawal by Subject|0|||
37709443|NCT01683994|69187770|FG000|Overall Study|Intercurrent illness|0|||
37709444|NCT01683994|69187771|FG001|Overall Study|Intercurrent illness|0|||
37709445|NCT01683994|69187772|FG002|Overall Study|Intercurrent illness|0|||
37709446|NCT01683994|69187773|FG003|Overall Study|Intercurrent illness|2|||
37709447|NCT01683994|69187774|FG004|Overall Study|Intercurrent illness|1|||
37709448|NCT02247440|69187792|FG000|Overall Study|Withdrawal by Subject|1|||
37709449|NCT02247440|69187792|FG000|Overall Study|Lack of Efficacy|3|||
37709450|NCT01683838|69187798|FG000|Overall Study|Adverse Event|12|||
37709451|NCT01683838|69187799|FG001|Overall Study|Adverse Event|2|||
37709452|NCT01683838|69187798|FG000|Overall Study|Protocol Violation|3|||
37838425|NCT00192075|69522975|FG001|Overall Study|Death|1|||
37838426|NCT00192075|69522974|FG000|Overall Study|Lack of Efficacy|0|||
37838427|NCT00192075|69522975|FG001|Overall Study|Lack of Efficacy|0|||
37915369|NCT00711802|69602165|FG000|Overall Study|Protocol Violation|0|||
37915370|NCT00711802|69602166|FG001|Overall Study|Protocol Violation|0|||
37709453|NCT01683838|69187799|FG001|Overall Study|Protocol Violation|1|||
37838428|NCT00192075|69522974|FG000|Overall Study|Physician Decision|3|||
37838429|NCT00192075|69522975|FG001|Overall Study|Physician Decision|0|||
37838430|NCT00192075|69522974|FG000|Overall Study|Withdrawal by Subject|5|||
37838431|NCT00192075|69522975|FG001|Overall Study|Withdrawal by Subject|5|||
37838432|NCT00192075|69522974|FG000|Overall Study|Patient Non-Compliance|0|||
37838433|NCT00192075|69522975|FG001|Overall Study|Patient Non-Compliance|1|||
38024269|NCT00112840|69707794|FG002|Overall Study|Withdrawal by Subject|1|||
37709454|NCT01683838|69187798|FG000|Overall Study|Withdrawal by Subject|6|||
37709455|NCT01683838|69187799|FG001|Overall Study|Withdrawal by Subject|5|||
37709456|NCT01683838|69187798|FG000|Overall Study|Lost to Follow-up|1|||
37838434|NCT00192075|69522974|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
37915371|NCT00711802|69602167|FG002|Overall Study|Protocol Violation|0|||
37709457|NCT01683838|69187799|FG001|Overall Study|Lost to Follow-up|1|||
37709458|NCT01683838|69187798|FG000|Overall Study|Other|4|||
37709459|NCT01683838|69187799|FG001|Overall Study|Other|3|||
37709460|NCT01683604|69187805|FG000|Overall Study|Adverse Event|2|||
37709461|NCT01683604|69187805|FG000|Overall Study|Lack of Efficacy|1|||
37709462|NCT01683604|69187805|FG000|Overall Study|Other|2|||
37709463|NCT02196038|69187816|FG000|Overall Study|Death|16|||
37709464|NCT02196038|69187817|FG001|Overall Study|Death|21|||
37709465|NCT02196038|69187816|FG000|Overall Study|Withdrawal by Subject|0|||
37709466|NCT02196038|69187817|FG001|Overall Study|Withdrawal by Subject|1|||
37709467|NCT02196038|69187816|FG000|Overall Study|Lost to Follow-up|1|||
37709468|NCT02196038|69187817|FG001|Overall Study|Lost to Follow-up|0|||
37709469|NCT02141659|69187829|FG000|Overall Study|Major Protocol Deviation|0|||
37709470|NCT02141659|69187830|FG001|Overall Study|Major Protocol Deviation|1|||
37709471|NCT02141659|69187831|FG002|Overall Study|Major Protocol Deviation|0|||
37709472|NCT02141659|69187832|FG003|Overall Study|Major Protocol Deviation|0|||
37709473|NCT02141659|69187833|FG004|Overall Study|Major Protocol Deviation|0|||
37709474|NCT02141659|69187834|FG005|Overall Study|Major Protocol Deviation|0|||
37709475|NCT02141659|69187829|FG000|Overall Study|Lack of Efficacy|0|||
37709476|NCT02141659|69187830|FG001|Overall Study|Lack of Efficacy|0|||
37709477|NCT02141659|69187831|FG002|Overall Study|Lack of Efficacy|0|||
37709478|NCT02141659|69187832|FG003|Overall Study|Lack of Efficacy|0|||
37709479|NCT02141659|69187833|FG004|Overall Study|Lack of Efficacy|0|||
37709480|NCT02141659|69187834|FG005|Overall Study|Lack of Efficacy|1|||
37709481|NCT02141659|69187829|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
37709482|NCT02141659|69187830|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
37709483|NCT02141659|69187831|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
37709484|NCT02141659|69187832|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
37709485|NCT02141659|69187833|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
37709486|NCT02141659|69187834|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
37709487|NCT01640249|69187855|FG000|Period 1|Withdrawal by Subject|1|||
37709488|NCT01640249|69187856|FG001|Period 1|Withdrawal by Subject|0|||
37709489|NCT01640249|69187857|FG002|Period 1|Withdrawal by Subject|0|||
37709490|NCT01640249|69187858|FG003|Period 1|Withdrawal by Subject|0|||
37709491|NCT01640249|69187859|FG004|Period 1|Withdrawal by Subject|0|||
37709492|NCT01640249|69187860|FG005|Period 1|Withdrawal by Subject|1|||
37709493|NCT01640249|69187861|FG006|Period 1|Withdrawal by Subject|0|||
37709494|NCT02121301|69187883|FG000|Overall Study|Protocol Violation|1|||
37709495|NCT02121301|69187884|FG001|Overall Study|Protocol Violation|4|||
37709496|NCT02121301|69187885|FG002|Overall Study|Protocol Violation|1|||
37709497|NCT02227862|69187895|FG000|Overall Study|Protocol Violation|7|||
37709498|NCT02227862|69187896|FG001|Overall Study|Protocol Violation|9|||
37709499|NCT02227862|69187895|FG000|Overall Study|Other|0|||
37709500|NCT02227862|69187896|FG001|Overall Study|Other|2|||
37709501|NCT02227862|69187895|FG000|Overall Study|Adverse Event|4|||
37709502|NCT02227862|69187896|FG001|Overall Study|Adverse Event|3|||
37709503|NCT02227862|69187895|FG000|Overall Study|Withdrawal by Subject|7|||
37709504|NCT02227862|69187896|FG001|Overall Study|Withdrawal by Subject|6|||
37709505|NCT02227862|69187895|FG000|Overall Study|Lost to Follow-up|1|||
37709506|NCT02227862|69187896|FG001|Overall Study|Lost to Follow-up|2|||
37709507|NCT02120833|69187904|FG000|Overall Study|Adverse Event|1|||
37709508|NCT02120833|69187905|FG001|Overall Study|Adverse Event|0|||
37709509|NCT02120833|69187904|FG000|Overall Study|Withdrawal by Subject|2|||
37709510|NCT02120833|69187905|FG001|Overall Study|Withdrawal by Subject|0|||
37709511|NCT02120833|69187904|FG000|Overall Study|Lost to Follow-up|1|||
37709512|NCT02120833|69187905|FG001|Overall Study|Lost to Follow-up|1|||
37709513|NCT02170207|69187911|FG000|Overall Study|Case report forms unavailable|5|||
37709514|NCT02227784|69187919|FG000|Double-Blind Phase|Adverse Event|3|||
37709515|NCT02227784|69187920|FG001|Double-Blind Phase|Adverse Event|2|||
37709516|NCT02227784|69187921|FG002|Double-Blind Phase|Adverse Event|1|||
37709517|NCT02227784|69187922|FG003|Double-Blind Phase|Adverse Event|3|||
37709518|NCT02227784|69187923|FG004|Double-Blind Phase|Adverse Event|0|||
37709519|NCT02227784|69187919|FG000|Double-Blind Phase|Physician Decision|1|||
37709520|NCT02227784|69187920|FG001|Double-Blind Phase|Physician Decision|0|||
37709521|NCT02227784|69187921|FG002|Double-Blind Phase|Physician Decision|0|||
37838435|NCT00192075|69522975|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
37838436|NCT00192075|69522974|FG000|Overall Study|Other|5|||
37709522|NCT02227784|69187922|FG003|Double-Blind Phase|Physician Decision|1|||
37709523|NCT02227784|69187923|FG004|Double-Blind Phase|Physician Decision|0|||
37709524|NCT02227784|69187919|FG000|Double-Blind Phase|Protocol Violation|0|||
37709525|NCT02227784|69187920|FG001|Double-Blind Phase|Protocol Violation|0|||
37709526|NCT02227784|69187921|FG002|Double-Blind Phase|Protocol Violation|1|||
37838437|NCT00192075|69522975|FG001|Overall Study|Other|2|||
37709527|NCT02227784|69187922|FG003|Double-Blind Phase|Protocol Violation|1|||
37838438|NCT00192036|69522986|FG000|Overall Study|Protocol Violation|3|||
37709528|NCT02227784|69187923|FG004|Double-Blind Phase|Protocol Violation|0|||
37709529|NCT02227784|69187919|FG000|Double-Blind Phase|Sponsor Decision|34|||
37709530|NCT02227784|69187920|FG001|Double-Blind Phase|Sponsor Decision|15|||
37838439|NCT00192036|69522986|FG000|Overall Study|Adverse Event|6|||
37709531|NCT02227784|69187921|FG002|Double-Blind Phase|Sponsor Decision|14|||
37709532|NCT02227784|69187922|FG003|Double-Blind Phase|Sponsor Decision|32|||
37709533|NCT02227784|69187923|FG004|Double-Blind Phase|Sponsor Decision|0|||
37709534|NCT02227784|69187919|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
37709535|NCT02227784|69187920|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
37709536|NCT02227784|69187921|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
37709537|NCT02227784|69187922|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
37709538|NCT02227784|69187923|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
37709539|NCT02227784|69187919|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
37709540|NCT02227784|69187920|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
37709541|NCT02227784|69187921|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
37709542|NCT02227784|69187922|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
37709543|NCT02227784|69187923|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
37709544|NCT02227784|69187919|FG000|Open-Label Extension Phase (OLE)|Death|0|||
37709545|NCT02227784|69187920|FG001|Open-Label Extension Phase (OLE)|Death|0|||
37709546|NCT02227784|69187921|FG002|Open-Label Extension Phase (OLE)|Death|0|||
37709547|NCT02227784|69187922|FG003|Open-Label Extension Phase (OLE)|Death|0|||
37709548|NCT02227784|69187923|FG004|Open-Label Extension Phase (OLE)|Death|1|||
37709549|NCT02227784|69187919|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
37709550|NCT02227784|69187920|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
37709551|NCT02227784|69187921|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
37709552|NCT02227784|69187922|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
37709553|NCT02227784|69187923|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
37709554|NCT02227784|69187919|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
37709555|NCT02227784|69187920|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
37709556|NCT02227784|69187921|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
37709557|NCT02227784|69187922|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
37709558|NCT02227784|69187923|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
37709559|NCT01565668|69187938|FG000|Overall Study|Death|2|||
37709560|NCT01565668|69187939|FG001|Overall Study|Death|1|||
37709561|NCT01565668|69187938|FG000|Overall Study|Lack of Efficacy|4|||
37709562|NCT01565668|69187939|FG001|Overall Study|Lack of Efficacy|2|||
37709563|NCT01565668|69187938|FG000|Overall Study|Participant went on Hospice Care|1|||
37709564|NCT01565668|69187939|FG001|Overall Study|Participant went on Hospice Care|0|||
37709565|NCT01565668|69187938|FG000|Overall Study|Adverse Event|6|||
37709566|NCT01565668|69187939|FG001|Overall Study|Adverse Event|1|||
37709567|NCT01565668|69187938|FG000|Overall Study|Randomized, but never received drug|0|||
37709568|NCT01565668|69187939|FG001|Overall Study|Randomized, but never received drug|2|||
37709569|NCT01565668|69187938|FG000|Overall Study|Progressive disease|13|||
37709570|NCT01565668|69187939|FG001|Overall Study|Progressive disease|14|||
37709571|NCT01565668|69187938|FG000|Overall Study|Withdrawal by Subject|1|||
37709572|NCT01565668|69187939|FG001|Overall Study|Withdrawal by Subject|3|||
37709573|NCT01565668|69187938|FG000|Overall Study|HSCT Transplant|11|||
37709574|NCT01565668|69187939|FG001|Overall Study|HSCT Transplant|15|||
37709575|NCT01683058|69187945|FG000|Overall Study|Lost to Follow-up|9|||
37709576|NCT01683058|69187945|FG000|Overall Study|Adverse Event|6|||
37709577|NCT01683058|69187945|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
37709578|NCT01683058|69187945|FG000|Overall Study|Withdrawal by Subject|7|||
37709579|NCT01683058|69187945|FG000|Overall Study|Lack of Efficacy|2|||
37709580|NCT01626859|69187953|FG000|Overall Study|Adverse Event|1|||
37709581|NCT01626859|69187954|FG001|Overall Study|Adverse Event|3|||
37709582|NCT01626859|69187955|FG002|Overall Study|Adverse Event|2|||
37709583|NCT01626859|69187953|FG000|Overall Study|Physician Decision|0|||
37709584|NCT01626859|69187954|FG001|Overall Study|Physician Decision|1|||
37709585|NCT01626859|69187955|FG002|Overall Study|Physician Decision|0|||
37709586|NCT01626859|69187953|FG000|Overall Study|Withdrawal by Subject|1|||
37709587|NCT01626859|69187954|FG001|Overall Study|Withdrawal by Subject|4|||
37709588|NCT01626859|69187955|FG002|Overall Study|Withdrawal by Subject|2|||
37709589|NCT02193776|69187967|FG000|Overall Study|Consent withdrawn|1|||
37709590|NCT02193776|69187968|FG001|Overall Study|Consent withdrawn|0|||
37838440|NCT00192036|69522986|FG000|Overall Study|Patient/Physician Perception|1|||
37838441|NCT00192036|69522986|FG000|Overall Study|Objective Tumor Progression|4|||
37709591|NCT02193776|69187969|FG002|Overall Study|Consent withdrawn|0|||
37709592|NCT02193776|69187970|FG003|Overall Study|Consent withdrawn|0|||
37709593|NCT02193776|69187967|FG000|Overall Study|Failure to comply with protocol|0|||
37709594|NCT02193776|69187968|FG001|Overall Study|Failure to comply with protocol|1|||
37709595|NCT02193776|69187969|FG002|Overall Study|Failure to comply with protocol|0|||
37709596|NCT02193776|69187970|FG003|Overall Study|Failure to comply with protocol|0|||
37709597|NCT02193776|69187967|FG000|Overall Study|Investigator/Sponsor decision|1|||
37709598|NCT02193776|69187968|FG001|Overall Study|Investigator/Sponsor decision|1|||
37709599|NCT02193776|69187969|FG002|Overall Study|Investigator/Sponsor decision|0|||
37838442|NCT00192036|69522986|FG000|Overall Study|Clinical Disease Progression|1|||
37838443|NCT00192036|69522986|FG000|Overall Study|Death|1|||
38024270|NCT00112840|69707792|FG000|Overall Study|Protocol Violation|0|||
38024271|NCT00112840|69707793|FG001|Overall Study|Protocol Violation|0|||
37709600|NCT02193776|69187970|FG003|Overall Study|Investigator/Sponsor decision|0|||
37709601|NCT02193776|69187967|FG000|Overall Study|Death|1|||
37709602|NCT02193776|69187968|FG001|Overall Study|Death|0|||
37709603|NCT02193776|69187969|FG002|Overall Study|Death|0|||
37709604|NCT02193776|69187970|FG003|Overall Study|Death|0|||
37709605|NCT02193776|69187967|FG000|Overall Study|Adverse event/Specific toxicity|5|||
37709606|NCT02193776|69187968|FG001|Overall Study|Adverse event/Specific toxicity|5|||
37709607|NCT02193776|69187969|FG002|Overall Study|Adverse event/Specific toxicity|2|||
37709608|NCT02193776|69187970|FG003|Overall Study|Adverse event/Specific toxicity|2|||
37709609|NCT02170064|69187983|FG000|Overall Study|Withdrawal by Subject|5|||
37709610|NCT02170064|69187984|FG001|Overall Study|Withdrawal by Subject|1|||
37709611|NCT02170064|69187985|FG002|Overall Study|Withdrawal by Subject|1|||
37709612|NCT02170064|69187983|FG000|Overall Study|Physician Decision|1|||
37709613|NCT02170064|69187984|FG001|Overall Study|Physician Decision|1|||
37709614|NCT02170064|69187985|FG002|Overall Study|Physician Decision|0|||
37709615|NCT02169830|69187996|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
37709616|NCT02169830|69187997|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
37709617|NCT02169830|69187998|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
37709618|NCT02169830|69187996|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
37709619|NCT02169830|69187997|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
37709620|NCT02169830|69187998|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
37709621|NCT02169830|69187996|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
37709622|NCT02169830|69187997|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
37709623|NCT02169830|69187998|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
37709624|NCT02169830|69187996|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
37709625|NCT02169830|69187997|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
37709626|NCT02169830|69187998|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
37709627|NCT02169830|69187996|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
37709628|NCT02169830|69187997|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
37709629|NCT02169830|69187998|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
37709630|NCT02169674|69188008|FG000|Overall Study|Withdrawal by Subject|2|||
37709631|NCT02169674|69188009|FG001|Overall Study|Withdrawal by Subject|1|||
37709632|NCT02169674|69188008|FG000|Overall Study|Seroprotected|30|||
37709633|NCT02169674|69188009|FG001|Overall Study|Seroprotected|76|||
37709634|NCT02169674|69188008|FG000|Overall Study|Lost to Follow-up|0|||
37709635|NCT02169674|69188009|FG001|Overall Study|Lost to Follow-up|1|||
37709636|NCT02169284|69188017|FG000|Overall Study|Physician Decision|0|||
37709637|NCT02169284|69188018|FG001|Overall Study|Physician Decision|1|||
37709638|NCT02119819|69188032|FG000|Overall Study|Adverse Event|3|||
37709639|NCT02119819|69188033|FG001|Overall Study|Adverse Event|1|||
37709640|NCT02119819|69188034|FG002|Overall Study|Adverse Event|2|||
37709641|NCT02119819|69188035|FG003|Overall Study|Adverse Event|3|||
37709642|NCT02119819|69188036|FG004|Overall Study|Adverse Event|0|||
37709643|NCT02119819|69188037|FG005|Overall Study|Adverse Event|1|||
37709644|NCT02119819|69188032|FG000|Overall Study|Lack of Efficacy|0|||
37709645|NCT02119819|69188033|FG001|Overall Study|Lack of Efficacy|0|||
37709646|NCT02119819|69188034|FG002|Overall Study|Lack of Efficacy|0|||
37709647|NCT02119819|69188035|FG003|Overall Study|Lack of Efficacy|0|||
37709648|NCT02119819|69188036|FG004|Overall Study|Lack of Efficacy|0|||
37709649|NCT02119819|69188037|FG005|Overall Study|Lack of Efficacy|1|||
37709650|NCT02119819|69188032|FG000|Overall Study|Lost to Follow-up|0|||
37709651|NCT02119819|69188033|FG001|Overall Study|Lost to Follow-up|0|||
37709652|NCT02119819|69188034|FG002|Overall Study|Lost to Follow-up|1|||
37709653|NCT02119819|69188035|FG003|Overall Study|Lost to Follow-up|2|||
37709654|NCT02119819|69188036|FG004|Overall Study|Lost to Follow-up|1|||
37709655|NCT02119819|69188037|FG005|Overall Study|Lost to Follow-up|2|||
37709656|NCT02119819|69188032|FG000|Overall Study|Physician Decision|1|||
37709657|NCT02119819|69188033|FG001|Overall Study|Physician Decision|1|||
37709658|NCT02119819|69188034|FG002|Overall Study|Physician Decision|0|||
37709659|NCT02119819|69188035|FG003|Overall Study|Physician Decision|0|||
37709660|NCT02119819|69188036|FG004|Overall Study|Physician Decision|0|||
37709661|NCT02119819|69188037|FG005|Overall Study|Physician Decision|1|||
37709662|NCT02119819|69188032|FG000|Overall Study|Withdrawal by Subject|5|||
37709663|NCT02119819|69188033|FG001|Overall Study|Withdrawal by Subject|3|||
37709664|NCT02119819|69188034|FG002|Overall Study|Withdrawal by Subject|0|||
37709665|NCT02119819|69188035|FG003|Overall Study|Withdrawal by Subject|0|||
37709666|NCT02119819|69188036|FG004|Overall Study|Withdrawal by Subject|6|||
37709667|NCT02119819|69188037|FG005|Overall Study|Withdrawal by Subject|10|||
38024272|NCT00112840|69707794|FG002|Overall Study|Protocol Violation|5|||
38024273|NCT02197572|69707807|FG000|Overall Study|Progressive Disease|28|||
37709668|NCT02119819|69188032|FG000|Overall Study|Jury Duty|0|||
37709669|NCT02119819|69188033|FG001|Overall Study|Jury Duty|0|||
37709670|NCT02119819|69188034|FG002|Overall Study|Jury Duty|1|||
37709671|NCT02119819|69188035|FG003|Overall Study|Jury Duty|0|||
37709672|NCT02119819|69188036|FG004|Overall Study|Jury Duty|0|||
37709673|NCT02119819|69188037|FG005|Overall Study|Jury Duty|0|||
37709674|NCT02119819|69188032|FG000|Overall Study|Protocol Violation|0|||
37709675|NCT02119819|69188033|FG001|Overall Study|Protocol Violation|0|||
37709676|NCT02119819|69188034|FG002|Overall Study|Protocol Violation|0|||
37709677|NCT02119819|69188035|FG003|Overall Study|Protocol Violation|1|||
37709678|NCT02119819|69188036|FG004|Overall Study|Protocol Violation|0|||
37709679|NCT02119819|69188037|FG005|Overall Study|Protocol Violation|0|||
37709680|NCT02119819|69188032|FG000|Overall Study|Left the city to get a job|0|||
37709681|NCT02119819|69188033|FG001|Overall Study|Left the city to get a job|0|||
37709682|NCT02119819|69188034|FG002|Overall Study|Left the city to get a job|0|||
37709683|NCT02119819|69188035|FG003|Overall Study|Left the city to get a job|1|||
37709684|NCT02119819|69188036|FG004|Overall Study|Left the city to get a job|0|||
37709685|NCT02119819|69188037|FG005|Overall Study|Left the city to get a job|0|||
37709686|NCT02168816|69188053|FG000|Overall Study|Lost to Follow-up|2|||
37709687|NCT02168816|69188054|FG001|Overall Study|Lost to Follow-up|2|||
37709688|NCT01584232|69188062|FG000|Overall Study|Adverse Event|3|||
37709689|NCT01584232|69188063|FG001|Overall Study|Adverse Event|1|||
37709690|NCT01584232|69188062|FG000|Overall Study|Withdrawal by Subject|2|||
37709691|NCT01584232|69188063|FG001|Overall Study|Withdrawal by Subject|1|||
37709692|NCT01584232|69188062|FG000|Overall Study|Physician Decision|2|||
37709693|NCT01584232|69188063|FG001|Overall Study|Physician Decision|1|||
37709694|NCT01584232|69188062|FG000|Overall Study|Lost to Follow-up|1|||
37709695|NCT01584232|69188063|FG001|Overall Study|Lost to Follow-up|0|||
37709696|NCT01639703|69188069|FG000|Overall Study|Withdrawal by Subject|5|||
37709697|NCT01639703|69188069|FG000|Overall Study|Other reason|7|||
37709698|NCT02119663|69188087|FG000|Overall Study|Disease progression|26|||
37709699|NCT02119663|69188088|FG001|Overall Study|Disease progression|27|||
37709700|NCT02119663|69188087|FG000|Overall Study|Adverse Event|5|||
37709701|NCT02119663|69188088|FG001|Overall Study|Adverse Event|5|||
37709702|NCT02119663|69188087|FG000|Overall Study|Death|3|||
37709703|NCT02119663|69188088|FG001|Overall Study|Death|2|||
37709704|NCT02119663|69188087|FG000|Overall Study|Physician Decision|1|||
37709705|NCT02119663|69188088|FG001|Overall Study|Physician Decision|2|||
37709706|NCT02119663|69188087|FG000|Overall Study|Other unspecified|2|||
37709707|NCT02119663|69188088|FG001|Overall Study|Other unspecified|0|||
37709708|NCT02119663|69188087|FG000|Overall Study|Subject decision|0|||
37709709|NCT02119663|69188088|FG001|Overall Study|Subject decision|1|||
37709710|NCT02119663|69188087|FG000|Overall Study|Study Terminated by the Sponsor|3|||
37709711|NCT02119663|69188088|FG001|Overall Study|Study Terminated by the Sponsor|4|||
37709712|NCT01639469|69188096|FG000|Overall Study|Death|4|||
37709713|NCT01639469|69188097|FG001|Overall Study|Death|2|||
37709714|NCT01639469|69188096|FG000|Overall Study|Lost to Follow-up|1|||
37709715|NCT01639469|69188097|FG001|Overall Study|Lost to Follow-up|1|||
37709716|NCT02193074|69188105|FG000|Overall Study|Withdrawal by Subject|1|||
37709717|NCT02193074|69188106|FG001|Overall Study|Withdrawal by Subject|2|||
37709718|NCT02193074|69188105|FG000|Overall Study|Adverse Event|16|||
37709719|NCT02193074|69188106|FG001|Overall Study|Adverse Event|13|||
37709720|NCT02192606|69188114|FG000|Overall Study|surgery type was changed|1|||
37709721|NCT02192606|69188115|FG001|Overall Study|surgery type was changed|1|||
37709722|NCT02192606|69188114|FG000|Overall Study|Physician Decision|1|||
37709723|NCT02192606|69188115|FG001|Overall Study|Physician Decision|2|||
37709724|NCT02192606|69188114|FG000|Overall Study|3D equipment rep unable to join|0|||
37709725|NCT02192606|69188115|FG001|Overall Study|3D equipment rep unable to join|1|||
37709726|NCT01628107|69188121|FG000|Overall Study|Withdrawal by Subject|17|||
37709727|NCT01628107|69188121|FG000|Overall Study|Lost to Follow-up|4|||
37709728|NCT01628107|69188121|FG000|Overall Study|Adverse Event|33|||
37709729|NCT01628107|69188121|FG000|Overall Study|Physician Decision|2|||
37709730|NCT01628107|69188121|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
37709731|NCT01628107|69188121|FG000|Overall Study|Non-compliant with Study Procedures|10|||
37709732|NCT01628107|69188121|FG000|Overall Study|Not Treated|8|||
37709733|NCT01628107|69188121|FG000|Overall Study|Sponsor Decision|11|||
37709734|NCT01628107|69188121|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
37709735|NCT01628107|69188121|FG000|Overall Study|Relocated|8|||
37709736|NCT01628107|69188121|FG000|Overall Study|Kidney Transplant|9|||
37709737|NCT01628107|69188121|FG000|Overall Study|Use of Standard of Care|9|||
37709738|NCT01583530|69188131|FG000|Overall Study|Adverse Event|0|||
37709739|NCT01583530|69188132|FG001|Overall Study|Adverse Event|0|||
37709740|NCT01583530|69188133|FG002|Overall Study|Adverse Event|0|||
37709741|NCT01583530|69188134|FG003|Overall Study|Adverse Event|0|||
37709742|NCT01583530|69188135|FG004|Overall Study|Adverse Event|0|||
37709743|NCT01583530|69188136|FG005|Overall Study|Adverse Event|1|||
37709744|NCT01583530|69188131|FG000|Overall Study|Withdrawal by Subject|0|||
37709745|NCT01583530|69188132|FG001|Overall Study|Withdrawal by Subject|3|||
37709746|NCT01583530|69188133|FG002|Overall Study|Withdrawal by Subject|0|||
37709747|NCT01583530|69188134|FG003|Overall Study|Withdrawal by Subject|1|||
37709748|NCT01583530|69188135|FG004|Overall Study|Withdrawal by Subject|1|||
37709749|NCT01583530|69188136|FG005|Overall Study|Withdrawal by Subject|2|||
37709750|NCT01583530|69188131|FG000|Overall Study|Lost to Follow-up|0|||
37709751|NCT01583530|69188132|FG001|Overall Study|Lost to Follow-up|0|||
37709752|NCT01583530|69188133|FG002|Overall Study|Lost to Follow-up|0|||
37709753|NCT01583530|69188134|FG003|Overall Study|Lost to Follow-up|0|||
37709754|NCT01583530|69188135|FG004|Overall Study|Lost to Follow-up|3|||
37709755|NCT01583530|69188136|FG005|Overall Study|Lost to Follow-up|0|||
37709756|NCT01583530|69188131|FG000|Overall Study|Lack of compliance|0|||
37709757|NCT01583530|69188132|FG001|Overall Study|Lack of compliance|0|||
37709758|NCT01583530|69188133|FG002|Overall Study|Lack of compliance|0|||
37709759|NCT01583530|69188134|FG003|Overall Study|Lack of compliance|0|||
37709760|NCT01583530|69188135|FG004|Overall Study|Lack of compliance|1|||
37709761|NCT01583530|69188136|FG005|Overall Study|Lack of compliance|0|||
37709762|NCT01639001|69188155|FG000|Overall Study|Refused further follow-up|9|||
37709763|NCT01639001|69188156|FG001|Overall Study|Refused further follow-up|12|||
37709764|NCT01639001|69188155|FG000|Overall Study|Lost to Follow-up|3|||
37709765|NCT01639001|69188156|FG001|Overall Study|Lost to Follow-up|0|||
37709766|NCT01639001|69188155|FG000|Overall Study|Death|62|||
37709767|NCT01639001|69188156|FG001|Overall Study|Death|61|||
37709768|NCT01639001|69188155|FG000|Overall Study|Randomized but not treated|0|||
37709769|NCT01639001|69188156|FG001|Overall Study|Randomized but not treated|2|||
37709770|NCT01639001|69188155|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
37709771|NCT01639001|69188156|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
37709772|NCT02224664|69188164|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
37709773|NCT02224664|69188165|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
37709774|NCT02224664|69188166|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
37709775|NCT02224664|69188167|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
37709776|NCT02224664|69188168|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
37709777|NCT02224664|69188164|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
37709778|NCT02224664|69188165|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
37709779|NCT02224664|69188166|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
37709780|NCT02224664|69188167|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
37709781|NCT02224664|69188168|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
37709782|NCT02224664|69188164|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
37709783|NCT02224664|69188165|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
37709784|NCT02224664|69188166|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
37709785|NCT02224664|69188167|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
37709786|NCT02224664|69188168|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
37915372|NCT00711802|69602168|FG003|Overall Study|Protocol Violation|1|||
37709788|NCT02167256|69188190|FG000|Overall Study|Adverse Event|13|||
37709789|NCT02167256|69188191|FG001|Overall Study|Adverse Event|6|||
37709790|NCT02167256|69188190|FG000|Overall Study|Withdrawal by Subject|4|||
37709791|NCT02167256|69188191|FG001|Overall Study|Withdrawal by Subject|4|||
37709792|NCT02167256|69188190|FG000|Overall Study|non-compliance|3|||
37709793|NCT02167256|69188191|FG001|Overall Study|non-compliance|0|||
37709794|NCT02167256|69188190|FG000|Overall Study|Study partner unable to participate|1|||
37709795|NCT02167256|69188191|FG001|Overall Study|Study partner unable to participate|0|||
37709796|NCT02191046|69188199|FG000|Overall Study|low compliance|5|||
37709797|NCT02191046|69188200|FG001|Overall Study|low compliance|1|||
37709798|NCT02166476|69188208|FG000|Overall Study|Withdrawal by Subject|5|||
37709799|NCT02166476|69188209|FG001|Overall Study|Withdrawal by Subject|7|||
37709800|NCT02166476|69188208|FG000|Overall Study|Adverse Event|3|||
37709801|NCT02166476|69188209|FG001|Overall Study|Adverse Event|3|||
37709802|NCT02166476|69188208|FG000|Overall Study|Lost to Follow-up|5|||
37709803|NCT02166476|69188209|FG001|Overall Study|Lost to Follow-up|10|||
37838444|NCT00192036|69522986|FG000|Overall Study|Unknown or Not Specified|5|||
37838445|NCT00191724|69522995|FG000|Overall Study|Adverse Event|0|||
37709804|NCT02166476|69188208|FG000|Overall Study|Physician Decision|1|||
37709805|NCT02166476|69188209|FG001|Overall Study|Physician Decision|0|||
37709806|NCT02166476|69188208|FG000|Overall Study|Unable to Come for Visit|0|||
37709807|NCT02166476|69188209|FG001|Overall Study|Unable to Come for Visit|3|||
37709808|NCT02224274|69188220|FG000|Overall Study|Death|1|||
37838446|NCT00191724|69522996|FG001|Overall Study|Adverse Event|0|||
37838447|NCT00191724|69522997|FG002|Overall Study|Adverse Event|1|||
37838448|NCT00191724|69522998|FG003|Overall Study|Adverse Event|0|||
37838449|NCT00191724|69522999|FG004|Overall Study|Adverse Event|0|||
37709809|NCT02224274|69188221|FG001|Overall Study|Death|0|||
37709810|NCT02189252|69188235|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
37709811|NCT02189252|69188236|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
37709812|NCT02189252|69188237|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
37709813|NCT02189252|69188238|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
37709814|NCT02189252|69188235|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
37709815|NCT02189252|69188236|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
37709816|NCT02189252|69188237|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
37709817|NCT02189252|69188238|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
37838450|NCT00191724|69522995|FG000|Overall Study|Lost to Follow-up|1|||
37838451|NCT00191724|69522996|FG001|Overall Study|Lost to Follow-up|1|||
37838452|NCT00191724|69522997|FG002|Overall Study|Lost to Follow-up|0|||
37838453|NCT00191724|69522998|FG003|Overall Study|Lost to Follow-up|2|||
37709818|NCT01583374|69188252|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
37709819|NCT01583374|69188253|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
37709820|NCT01583374|69188254|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
37709821|NCT01583374|69188255|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
37709822|NCT01583374|69188256|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
37709823|NCT01583374|69188257|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
37709824|NCT01583374|69188258|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
37709825|NCT01583374|69188259|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
37709826|NCT01583374|69188260|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
37709827|NCT01583374|69188252|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
37709828|NCT01583374|69188253|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
37709829|NCT01583374|69188254|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
37709830|NCT01583374|69188255|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
37709831|NCT01583374|69188256|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
37709832|NCT01583374|69188257|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
37709833|NCT01583374|69188258|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
37709834|NCT01583374|69188259|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
38024274|NCT02197572|69707807|FG000|Overall Study|Withdrawal by Subject|9|||
38024275|NCT02197572|69707807|FG000|Overall Study|Adverse Event|3|||
38024276|NCT02197572|69707807|FG000|Overall Study|Reason Not Specified|4|||
38024277|NCT03176784|69707815|FG000|Overall Study|Lost to Follow-up|77|||
38024278|NCT03176784|69707816|FG001|Overall Study|Lost to Follow-up|79|||
38024279|NCT03176784|69707817|FG002|Overall Study|Lost to Follow-up|79|||
38024280|NCT03176784|69707818|FG003|Overall Study|Lost to Follow-up|49|||
38024281|NCT03176784|69707815|FG000|Overall Study|Withdrawal by Subject|28|||
38024282|NCT03176784|69707816|FG001|Overall Study|Withdrawal by Subject|34|||
38024283|NCT03176784|69707817|FG002|Overall Study|Withdrawal by Subject|34|||
38024284|NCT03176784|69707818|FG003|Overall Study|Withdrawal by Subject|21|||
38024285|NCT03049852|69707831|FG000|Overall Study|Lost to Follow-up|0|||
38024286|NCT03049852|69707832|FG001|Overall Study|Lost to Follow-up|1|||
38024287|NCT03049852|69707833|FG002|Overall Study|Lost to Follow-up|0|||
38024288|NCT05091528|69707845|FG000|Overall Study|Study Termination by Sponsor|0|||
38024289|NCT05091528|69707846|FG001|Overall Study|Study Termination by Sponsor|1|||
38024290|NCT05091528|69707847|FG002|Overall Study|Study Termination by Sponsor|0|||
38024291|NCT05091528|69707848|FG003|Overall Study|Study Termination by Sponsor|1|||
38024292|NCT01317004|69707871|FG000|Overall Study|Withdrawal by Subject|1|||
38024293|NCT01317004|69707872|FG001|Overall Study|Withdrawal by Subject|4|||
38024294|NCT01317004|69707871|FG000|Overall Study|Protocol Violation|0|||
38024295|NCT01317004|69707872|FG001|Overall Study|Protocol Violation|2|||
38024296|NCT01317004|69707871|FG000|Overall Study|Adverse Event|3|||
38024297|NCT01317004|69707872|FG001|Overall Study|Adverse Event|3|||
38024298|NCT01343056|69707882|FG000|Overall Study|Lost to Follow-up|7|||
38024299|NCT01343056|69707883|FG001|Overall Study|Lost to Follow-up|5|||
38024300|NCT01343056|69707884|FG002|Overall Study|Lost to Follow-up|3|||
38024301|NCT01343056|69707885|FG003|Overall Study|Lost to Follow-up|9|||
38024302|NCT01316692|69707899|FG000|Overall Study|Adverse Event|5|||
38024303|NCT01316692|69707899|FG000|Overall Study|Disease Progression|7|||
38024304|NCT01316380|69707906|FG000|Overall Study|Adverse Event|0|||
38024305|NCT01316380|69707907|FG001|Overall Study|Adverse Event|2|||
38024306|NCT01316380|69707908|FG002|Overall Study|Adverse Event|1|||
38024307|NCT01316380|69707906|FG000|Overall Study|Protocol Violation|0|||
38024308|NCT01316380|69707907|FG001|Overall Study|Protocol Violation|0|||
38024309|NCT01316380|69707908|FG002|Overall Study|Protocol Violation|1|||
38024310|NCT01316380|69707906|FG000|Overall Study|Withdrawal by Subject|1|||
38024311|NCT01316380|69707907|FG001|Overall Study|Withdrawal by Subject|2|||
38024312|NCT01316380|69707908|FG002|Overall Study|Withdrawal by Subject|0|||
38024313|NCT01316380|69707906|FG000|Overall Study|Other|0|||
38024314|NCT01316380|69707907|FG001|Overall Study|Other|1|||
38024315|NCT01316380|69707908|FG002|Overall Study|Other|1|||
38024316|NCT01316380|69707906|FG000|Overall Study|Not treated|1|||
38024317|NCT01316380|69707907|FG001|Overall Study|Not treated|0|||
38024318|NCT01316380|69707908|FG002|Overall Study|Not treated|0|||
38024319|NCT01316224|69707916|FG000|Overall Study|Protocol Violation|3|||
37709835|NCT01583374|69188260|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
37838454|NCT00191724|69522999|FG004|Overall Study|Lost to Follow-up|3|||
38024320|NCT01316224|69707916|FG000|Overall Study|Adverse Event|3|||
38024321|NCT01316224|69707916|FG000|Overall Study|Lack of Efficacy|1|||
38024322|NCT01316224|69707916|FG000|Overall Study|Withdrawal by Subject|1|||
38024323|NCT01316224|69707916|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
38024324|NCT01316224|69707916|FG000|Overall Study|Other|1|||
38024325|NCT04315298|69707939|FG000|Overall Study|Withdrawal by Subject|0|||
38024326|NCT04315298|69707940|FG001|Overall Study|Withdrawal by Subject|0|||
38024327|NCT04315298|69707941|FG002|Overall Study|Withdrawal by Subject|0|||
38024328|NCT04315298|69707942|FG003|Overall Study|Withdrawal by Subject|2|||
38024329|NCT04315298|69707943|FG004|Overall Study|Withdrawal by Subject|2|||
37709836|NCT01583374|69188252|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
37709837|NCT01583374|69188253|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
37709838|NCT01583374|69188254|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
37709839|NCT01583374|69188255|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
37709840|NCT01583374|69188256|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
37709841|NCT01583374|69188257|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
37709842|NCT01583374|69188258|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
37709843|NCT01583374|69188259|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
37709844|NCT01583374|69188260|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
37709845|NCT01583374|69188252|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
37709846|NCT01583374|69188253|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
37709847|NCT01583374|69188254|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
37709848|NCT01583374|69188255|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
37709849|NCT01583374|69188256|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
37709850|NCT01583374|69188257|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
37709851|NCT01583374|69188258|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
37709852|NCT01583374|69188259|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
37709853|NCT01583374|69188260|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
37709854|NCT01583374|69188252|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
37709855|NCT01583374|69188253|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
37709856|NCT01583374|69188254|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
37709857|NCT01583374|69188255|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
37709858|NCT01583374|69188256|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
37709859|NCT01583374|69188257|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
37709860|NCT01583374|69188258|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
37709861|NCT01583374|69188259|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
37709862|NCT01583374|69188260|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
37709863|NCT01583374|69188252|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
37709864|NCT01583374|69188253|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
37709865|NCT01583374|69188254|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
37709866|NCT01583374|69188255|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
37709867|NCT01583374|69188256|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
37709868|NCT01583374|69188257|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
37709869|NCT01583374|69188258|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
37709870|NCT01583374|69188259|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
37709871|NCT01583374|69188260|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
37709872|NCT01583374|69188252|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
37709873|NCT01583374|69188253|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
37709874|NCT01583374|69188254|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
37709875|NCT01583374|69188255|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
37709876|NCT01583374|69188256|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
37709877|NCT01583374|69188257|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
37709878|NCT01583374|69188258|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
37709879|NCT01583374|69188259|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
37709880|NCT01583374|69188260|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
37709881|NCT01583374|69188252|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
37709882|NCT01583374|69188253|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
37709883|NCT01583374|69188254|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
37709884|NCT01583374|69188255|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
37709885|NCT01583374|69188256|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
37709886|NCT01583374|69188257|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
37709887|NCT01583374|69188258|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
37709888|NCT01583374|69188259|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
37709889|NCT01583374|69188260|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
37709890|NCT01583374|69188252|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
37709891|NCT01583374|69188253|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
37709892|NCT01583374|69188254|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
37709893|NCT01583374|69188255|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
37709894|NCT01583374|69188256|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
37709895|NCT01583374|69188257|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
37709896|NCT01583374|69188258|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
37709897|NCT01583374|69188259|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
37709898|NCT01583374|69188260|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
37709899|NCT01583374|69188252|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
37709900|NCT01583374|69188253|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
37709901|NCT01583374|69188254|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
37709902|NCT01583374|69188255|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
37709903|NCT01583374|69188256|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
37709904|NCT01583374|69188257|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
37709905|NCT01583374|69188258|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
37709906|NCT01583374|69188259|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
37709907|NCT01583374|69188260|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
37709908|NCT01583374|69188252|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
37709909|NCT01583374|69188253|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
37709910|NCT01583374|69188254|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
37709911|NCT01583374|69188255|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
37709912|NCT01583374|69188256|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
37709913|NCT01583374|69188257|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
37709914|NCT01583374|69188258|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
37709915|NCT01583374|69188259|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
37709916|NCT01583374|69188260|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
37709917|NCT01583374|69188252|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
37709918|NCT01583374|69188253|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
37709919|NCT01583374|69188254|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
37709920|NCT01583374|69188255|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
37709921|NCT01583374|69188256|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
37709922|NCT01583374|69188257|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
37709923|NCT01583374|69188258|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
37709924|NCT01583374|69188259|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
37709925|NCT01583374|69188260|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
37709926|NCT01583374|69188252|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
37709927|NCT01583374|69188253|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
37709928|NCT01583374|69188254|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
37709929|NCT01583374|69188255|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
37709930|NCT01583374|69188256|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
37709931|NCT01583374|69188257|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
37709932|NCT01583374|69188258|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
37709933|NCT01583374|69188259|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
37709934|NCT01583374|69188260|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
37709935|NCT01583374|69188252|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
37709936|NCT01583374|69188253|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
37709937|NCT01583374|69188254|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
37709938|NCT01583374|69188255|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
37709939|NCT01583374|69188256|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
37709940|NCT01583374|69188257|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
37709941|NCT01583374|69188258|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
37709942|NCT01583374|69188259|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
37709943|NCT01583374|69188260|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
37709944|NCT01583374|69188252|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
37709945|NCT01583374|69188253|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
37709946|NCT01583374|69188254|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
37709947|NCT01583374|69188255|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
37709948|NCT01583374|69188256|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
37709949|NCT01583374|69188257|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
37709950|NCT01583374|69188258|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
37709951|NCT01583374|69188259|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
37915373|NCT00711802|69602169|FG004|Overall Study|Protocol Violation|0|||
37709952|NCT01583374|69188260|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
37709953|NCT01583374|69188252|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
37709954|NCT01583374|69188253|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
37709955|NCT01583374|69188254|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
37709956|NCT01583374|69188255|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
37709957|NCT01583374|69188256|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
37709958|NCT01583374|69188257|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
37709959|NCT01583374|69188258|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
37709960|NCT01583374|69188259|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
37709961|NCT01583374|69188260|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
37709962|NCT01583374|69188252|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
37709963|NCT01583374|69188253|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
37709964|NCT01583374|69188254|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
37709965|NCT01583374|69188255|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
37709966|NCT01583374|69188256|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
37709967|NCT01583374|69188257|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
37709968|NCT01583374|69188258|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
37709969|NCT01583374|69188259|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
37709970|NCT01583374|69188260|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
37709971|NCT01583374|69188252|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
37709972|NCT01583374|69188253|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
37709973|NCT01583374|69188254|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
37709974|NCT01583374|69188255|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
37709975|NCT01583374|69188256|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
37709976|NCT01583374|69188257|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
37709977|NCT01583374|69188258|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
37709978|NCT01583374|69188259|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
37709979|NCT01583374|69188260|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
37709980|NCT01583374|69188252|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
37709981|NCT01583374|69188253|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
37709982|NCT01583374|69188254|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
37709983|NCT01583374|69188255|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
37709984|NCT01583374|69188256|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
37709985|NCT01583374|69188257|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
37709986|NCT01583374|69188258|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
37709987|NCT01583374|69188259|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
37709988|NCT01583374|69188260|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
37709989|NCT01583296|69188281|FG000|Overall Study|Withdrawal by Subject|11|||
37709990|NCT01583296|69188282|FG001|Overall Study|Withdrawal by Subject|10|||
37709991|NCT02222714|69188293|FG000|Overall Study|Death|0|||
37838455|NCT00191724|69522995|FG000|Overall Study|Withdrawal by Subject|0|||
37838456|NCT00191724|69522996|FG001|Overall Study|Withdrawal by Subject|0|||
37838457|NCT00191724|69522997|FG002|Overall Study|Withdrawal by Subject|0|||
37838458|NCT00191724|69522998|FG003|Overall Study|Withdrawal by Subject|1|||
37838459|NCT00191724|69522999|FG004|Overall Study|Withdrawal by Subject|0|||
37838460|NCT00191646|69523013|FG000|Overall Study|Toxicity|26|||
37838461|NCT00191646|69523014|FG001|Overall Study|Toxicity|37|||
37838462|NCT00191646|69523013|FG000|Overall Study|Disease Progression|5|||
37838463|NCT00191646|69523014|FG001|Overall Study|Disease Progression|6|||
37838464|NCT00191646|69523013|FG000|Overall Study|Physician Decision|20|||
37838465|NCT00191646|69523014|FG001|Overall Study|Physician Decision|11|||
37838466|NCT00191646|69523013|FG000|Overall Study|Withdrawal by Subject|58|||
37838467|NCT00191646|69523014|FG001|Overall Study|Withdrawal by Subject|39|||
37838468|NCT00191646|69523013|FG000|Overall Study|Protocol Violation|5|||
37838469|NCT00191646|69523014|FG001|Overall Study|Protocol Violation|7|||
37838470|NCT00191646|69523013|FG000|Overall Study|Death|6|||
37838471|NCT00191646|69523014|FG001|Overall Study|Death|8|||
37838472|NCT00191646|69523013|FG000|Overall Study|Other|33|||
37838473|NCT00191646|69523014|FG001|Overall Study|Other|34|||
37838474|NCT00191646|69523013|FG000|Overall Study|Missing Data|18|||
37838475|NCT00191646|69523014|FG001|Overall Study|Missing Data|11|||
37709992|NCT02222714|69188294|FG001|Overall Study|Death|2|||
37838476|NCT00191451|69523031|FG000|Overall Study|Withdrawal by Subject|2|||
37838477|NCT00191451|69523032|FG001|Overall Study|Withdrawal by Subject|3|||
37838478|NCT00191451|69523033|FG002|Overall Study|Withdrawal by Subject|5|||
37838479|NCT00191451|69523031|FG000|Overall Study|Physician Decision|2|||
37838480|NCT00191451|69523032|FG001|Overall Study|Physician Decision|9|||
37838481|NCT00191451|69523033|FG002|Overall Study|Physician Decision|6|||
37838482|NCT00191451|69523031|FG000|Overall Study|Sponsor Decision|1|||
37838483|NCT00191451|69523032|FG001|Overall Study|Sponsor Decision|0|||
37838484|NCT00191451|69523033|FG002|Overall Study|Sponsor Decision|0|||
37838485|NCT00191451|69523031|FG000|Overall Study|Ineligible|0|||
37709993|NCT02222714|69188295|FG002|Overall Study|Death|3|||
37709994|NCT02222714|69188296|FG003|Overall Study|Death|4|||
37709995|NCT02222714|69188297|FG004|Overall Study|Death|6|||
37838486|NCT00191451|69523032|FG001|Overall Study|Ineligible|1|||
37838487|NCT00191451|69523033|FG002|Overall Study|Ineligible|0|||
37838488|NCT00191451|69523031|FG000|Overall Study|Reason Not Specified|2|||
37838489|NCT00191451|69523032|FG001|Overall Study|Reason Not Specified|1|||
37838490|NCT00191451|69523033|FG002|Overall Study|Reason Not Specified|3|||
37838491|NCT00191334|69523041|FG000|Overall Study|Adverse Event|4|||
37838492|NCT00191334|69523041|FG000|Overall Study|Disease Progression or Relapse|8|||
37838493|NCT00191334|69523041|FG000|Overall Study|Physician Decision|1|||
37838494|NCT00191334|69523041|FG000|Overall Study|Withdrawal by Subject|4|||
37838495|NCT00191139|69523047|FG000|Overall Study|Adverse Event|2|||
37838496|NCT00191139|69523048|FG001|Overall Study|Adverse Event|6|||
37838497|NCT00191139|69523047|FG000|Overall Study|Death|2|||
37838498|NCT00191139|69523048|FG001|Overall Study|Death|0|||
37838499|NCT00191139|69523047|FG000|Overall Study|Withdrawal by Subject|0|||
37838500|NCT00191139|69523048|FG001|Overall Study|Withdrawal by Subject|3|||
37838501|NCT00191139|69523047|FG000|Overall Study|Disease Progression|0|||
37838502|NCT00191139|69523048|FG001|Overall Study|Disease Progression|1|||
37838503|NCT00191139|69523047|FG000|Overall Study|Other|1|||
37838504|NCT00191139|69523048|FG001|Overall Study|Other|2|||
37838505|NCT00190983|69523054|FG000|Overall Study|Inevaluable (never treated)|2|||
37838506|NCT00190749|69523060|FG000|Overall Study|Lost to Follow-up|8|||
37838507|NCT00190749|69523061|FG001|Overall Study|Lost to Follow-up|11|||
37838508|NCT00190749|69523060|FG000|Overall Study|Withdrawal by Subject|10|||
37838509|NCT00190749|69523061|FG001|Overall Study|Withdrawal by Subject|6|||
37838510|NCT00190749|69523060|FG000|Overall Study|Protocol Violation|5|||
37838511|NCT00190749|69523061|FG001|Overall Study|Protocol Violation|4|||
37838512|NCT00190749|69523060|FG000|Overall Study|Adverse Event|0|||
38024330|NCT04315298|69707944|FG005|Overall Study|Withdrawal by Subject|2|||
38024331|NCT04315298|69707945|FG006|Overall Study|Withdrawal by Subject|0|||
37838513|NCT00190749|69523061|FG001|Overall Study|Adverse Event|5|||
37838514|NCT00190749|69523060|FG000|Overall Study|Lack of Efficacy|2|||
37838515|NCT00190749|69523061|FG001|Overall Study|Lack of Efficacy|3|||
37838516|NCT00190749|69523060|FG000|Overall Study|Reason Not Specified|0|||
37838517|NCT00190749|69523061|FG001|Overall Study|Reason Not Specified|2|||
37838518|NCT00190749|69523060|FG000|Overall Study|Sponsor Decision|1|||
37838519|NCT00190749|69523061|FG001|Overall Study|Sponsor Decision|0|||
37838520|NCT00190671|69523069|FG000|Overall Study|Satisfactory Response|4|||
37838521|NCT00190671|69523070|FG001|Overall Study|Satisfactory Response|7|||
37838522|NCT00190671|69523069|FG000|Overall Study|Lack of Efficacy|19|||
37838523|NCT00190671|69523070|FG001|Overall Study|Lack of Efficacy|24|||
37838524|NCT00190671|69523069|FG000|Overall Study|Death from Study Disease|1|||
37838525|NCT00190671|69523070|FG001|Overall Study|Death from Study Disease|1|||
38024332|NCT04315298|69707946|FG007|Overall Study|Withdrawal by Subject|1|||
37709996|NCT02222714|69188293|FG000|Overall Study|Withdrawal by Subject|0|||
37709997|NCT02222714|69188294|FG001|Overall Study|Withdrawal by Subject|0|||
37709998|NCT02222714|69188295|FG002|Overall Study|Withdrawal by Subject|1|||
37709999|NCT02222714|69188296|FG003|Overall Study|Withdrawal by Subject|0|||
37710000|NCT02222714|69188297|FG004|Overall Study|Withdrawal by Subject|1|||
37710001|NCT02164916|69188314|FG000|Overall Study|Adverse Event|3|||
37710002|NCT02164916|69188315|FG001|Overall Study|Adverse Event|8|||
37710003|NCT02164916|69188314|FG000|Overall Study|Death|1|||
37710004|NCT02164916|69188315|FG001|Overall Study|Death|1|||
37710005|NCT02164916|69188314|FG000|Overall Study|Refusal unrelated to adverse event|3|||
37710006|NCT02164916|69188315|FG001|Overall Study|Refusal unrelated to adverse event|7|||
37710007|NCT02164916|69188314|FG000|Overall Study|Progression|37|||
37710008|NCT02164916|69188315|FG001|Overall Study|Progression|26|||
37710009|NCT02164916|69188314|FG000|Overall Study|Not protocol specified|5|||
38024333|NCT04315298|69707947|FG008|Overall Study|Withdrawal by Subject|1|||
37710010|NCT02164916|69188315|FG001|Overall Study|Not protocol specified|1|||
37710011|NCT02164916|69188314|FG000|Overall Study|Reason under review|1|||
37710012|NCT02164916|69188315|FG001|Overall Study|Reason under review|6|||
37710013|NCT02164916|69188314|FG000|Overall Study|Not eligible|2|||
37710014|NCT02164916|69188315|FG001|Overall Study|Not eligible|5|||
37710015|NCT02222558|69188326|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
37710016|NCT02222558|69188327|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
37710017|NCT02222558|69188328|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
37710018|NCT02222558|69188329|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
37710019|NCT02222558|69188330|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
37710020|NCT02222558|69188331|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
37710021|NCT02222558|69188326|FG000|Period 3|Withdrawal by Subject|0|||
37710022|NCT02222558|69188327|FG001|Period 3|Withdrawal by Subject|0|||
37710023|NCT02222558|69188328|FG002|Period 3|Withdrawal by Subject|0|||
37710024|NCT02222558|69188329|FG003|Period 3|Withdrawal by Subject|0|||
37710025|NCT02222558|69188330|FG004|Period 3|Withdrawal by Subject|0|||
37710026|NCT02222558|69188331|FG005|Period 3|Withdrawal by Subject|1|||
37710027|NCT02188784|69188347|FG000|Overall Study|Death|3|||
37710028|NCT02188784|69188348|FG001|Overall Study|Death|1|||
37710029|NCT02188784|69188347|FG000|Overall Study|Lost to Follow-up|1|||
37710030|NCT02188784|69188348|FG001|Overall Study|Lost to Follow-up|0|||
37710031|NCT02188784|69188347|FG000|Overall Study|Withdrawal by Subject|3|||
37710032|NCT02188784|69188348|FG001|Overall Study|Withdrawal by Subject|9|||
37710033|NCT02188784|69188347|FG000|Overall Study|Physician Decision|2|||
37710034|NCT02188784|69188348|FG001|Overall Study|Physician Decision|3|||
37710035|NCT02222246|69188371|FG000|Overall Study|No Emergency Department Visits|27|||
37710036|NCT02222246|69188372|FG001|Overall Study|No Emergency Department Visits|26|||
37710037|NCT02222246|69188371|FG000|Overall Study|Physician Decision|0|||
37710038|NCT02222246|69188372|FG001|Overall Study|Physician Decision|1|||
37710039|NCT02188160|69188382|FG000|Overall Study|Adverse Event|1|||
37710040|NCT02188160|69188383|FG001|Overall Study|Adverse Event|0|||
37710041|NCT02188160|69188382|FG000|Overall Study|Use of an excluded medication|0|||
37710042|NCT02188160|69188383|FG001|Overall Study|Use of an excluded medication|1|||
37710043|NCT02220998|69188391|FG000|Overall Study|Randomized but Never Treated|1|||
37710044|NCT02220998|69188392|FG001|Overall Study|Randomized but Never Treated|2|||
37710045|NCT02220998|69188391|FG000|Overall Study|Death|2|||
37710046|NCT02220998|69188392|FG001|Overall Study|Death|0|||
37710047|NCT02220998|69188391|FG000|Overall Study|Lack of Efficacy|0|||
37710048|NCT02220998|69188392|FG001|Overall Study|Lack of Efficacy|5|||
37710049|NCT02220998|69188391|FG000|Overall Study|Lost to Follow-up|4|||
37710050|NCT02220998|69188392|FG001|Overall Study|Lost to Follow-up|4|||
37710051|NCT02220920|69188400|FG000|Overall Study|Adverse Event|1|||
37710052|NCT02220920|69188401|FG001|Overall Study|Adverse Event|0|||
37710053|NCT02220920|69188400|FG000|Overall Study|Lack of Efficacy|0|||
37838526|NCT00190671|69523069|FG000|Overall Study|Adverse Event|3|||
37710054|NCT02220920|69188401|FG001|Overall Study|Lack of Efficacy|1|||
37710055|NCT02220920|69188400|FG000|Overall Study|Withdrawal by Subject|1|||
37710056|NCT02220920|69188401|FG001|Overall Study|Withdrawal by Subject|0|||
37710057|NCT02220920|69188400|FG000|Overall Study|Conflict with the stopping criteria|1|||
37710058|NCT02220920|69188401|FG001|Overall Study|Conflict with the stopping criteria|2|||
37710059|NCT03966053|69188407|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
37710060|NCT01634555|69188420|FG000|Overall Study|Adverse Event|3|||
37710061|NCT01634555|69188420|FG000|Overall Study|Physician Decision|1|||
37710062|NCT01634243|69188427|FG000|Overall Study|Adverse Event|5|||
37710063|NCT01634243|69188428|FG001|Overall Study|Adverse Event|5|||
37710064|NCT01634243|69188427|FG000|Overall Study|Lack of Efficacy|1|||
37838527|NCT00190671|69523070|FG001|Overall Study|Adverse Event|2|||
37710065|NCT01634243|69188428|FG001|Overall Study|Lack of Efficacy|0|||
37710066|NCT01542034|69188445|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
37710067|NCT01542034|69188446|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
37710068|NCT01542034|69188445|FG000|Overall Study|Administrative decision|0|||
37710069|NCT01542034|69188446|FG001|Overall Study|Administrative decision|3|||
37710070|NCT01542034|69188445|FG000|Overall Study|Subject Noncompliance|1|||
37710071|NCT01542034|69188446|FG001|Overall Study|Subject Noncompliance|0|||
37710072|NCT01542034|69188445|FG000|Overall Study|Adverse Event|2|||
37710073|NCT01542034|69188446|FG001|Overall Study|Adverse Event|2|||
37710074|NCT01542034|69188445|FG000|Overall Study|Lost to Follow-up|7|||
37710075|NCT01542034|69188446|FG001|Overall Study|Lost to Follow-up|6|||
37710076|NCT01564732|69188454|FG000|Overall Study|Early termination by the study sponsor|6|||
37710077|NCT01564732|69188455|FG001|Overall Study|Early termination by the study sponsor|5|||
37710078|NCT01541644|69188461|FG000|Overall Study|Withdrawal by Subject|3|||
37710079|NCT01582282|69188468|FG000|Overall Study|Adverse Event|1|||
37710080|NCT01582282|69188469|FG001|Overall Study|Adverse Event|1|||
37710081|NCT01582282|69188470|FG002|Overall Study|Adverse Event|0|||
37710082|NCT01582282|69188468|FG000|Overall Study|Lost to Follow-up|1|||
37710083|NCT01582282|69188469|FG001|Overall Study|Lost to Follow-up|0|||
37710084|NCT01582282|69188470|FG002|Overall Study|Lost to Follow-up|0|||
37710085|NCT01582282|69188468|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
37710086|NCT01582282|69188469|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
37710087|NCT01582282|69188470|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
37710088|NCT01599650|69188481|FG000|Overall Study|Administrative issue|1|||
37710089|NCT01599650|69188482|FG001|Overall Study|Administrative issue|0|||
37710090|NCT01599650|69188483|FG002|Overall Study|Administrative issue|1|||
37710091|NCT01599650|69188481|FG000|Overall Study|Physician Decision|2|||
37710092|NCT01599650|69188482|FG001|Overall Study|Physician Decision|0|||
37710093|NCT01599650|69188483|FG002|Overall Study|Physician Decision|7|||
37710094|NCT01599650|69188481|FG000|Overall Study|Protocol Violation|0|||
37710095|NCT01599650|69188482|FG001|Overall Study|Protocol Violation|3|||
37710096|NCT01599650|69188483|FG002|Overall Study|Protocol Violation|0|||
37710097|NCT01599650|69188481|FG000|Overall Study|Death|2|||
37710098|NCT01599650|69188482|FG001|Overall Study|Death|1|||
37710099|NCT01599650|69188483|FG002|Overall Study|Death|2|||
37710100|NCT01599650|69188481|FG000|Overall Study|Lost to Follow-up|3|||
37710101|NCT01599650|69188482|FG001|Overall Study|Lost to Follow-up|3|||
37710102|NCT01599650|69188483|FG002|Overall Study|Lost to Follow-up|3|||
37710103|NCT01599650|69188481|FG000|Overall Study|Withdrawal by Subject|11|||
37710104|NCT01599650|69188482|FG001|Overall Study|Withdrawal by Subject|11|||
37710105|NCT01599650|69188483|FG002|Overall Study|Withdrawal by Subject|10|||
37710106|NCT01599650|69188481|FG000|Overall Study|Adverse Event|3|||
37710107|NCT01599650|69188482|FG001|Overall Study|Adverse Event|8|||
37710108|NCT01599650|69188483|FG002|Overall Study|Adverse Event|4|||
37710109|NCT01541254|69188493|FG000|Overall Study|Withdrawal by Subject|1|||
37710110|NCT01541254|69188493|FG000|Overall Study|excluded - metal allergy|1|||
37710111|NCT01541254|69188493|FG000|Overall Study|enrolled after study closed|1|||
37710112|NCT01541254|69188493|FG000|Overall Study|GI bleed prior to procedure|1|||
37710113|NCT01541254|69188493|FG000|Overall Study|stent not required|1|||
37710114|NCT01541254|69188493|FG000|Overall Study|alternate stent used|1|||
37710115|NCT02163902|69188499|FG000|Overall Study|Subject's Request|3|||
37838528|NCT00190671|69523069|FG000|Overall Study|Clinical Relapse|0|||
37838529|NCT00190671|69523070|FG001|Overall Study|Clinical Relapse|1|||
37838530|NCT00190671|69523069|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
37838531|NCT00190671|69523070|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
37838532|NCT00190671|69523069|FG000|Overall Study|Death from Other Causes|0|||
37838533|NCT00190671|69523070|FG001|Overall Study|Death from Other Causes|2|||
37838534|NCT00190671|69523069|FG000|Overall Study|Protocol Violation|0|||
37838535|NCT00190671|69523070|FG001|Overall Study|Protocol Violation|1|||
37838536|NCT00190671|69523069|FG000|Overall Study|Withdrawal by Subject|0|||
37838537|NCT00190671|69523070|FG001|Overall Study|Withdrawal by Subject|2|||
38024334|NCT04315298|69707948|FG009|Overall Study|Withdrawal by Subject|1|||
37710116|NCT02163902|69188500|FG001|Overall Study|Subject's Request|4|||
37710117|NCT02163902|69188499|FG000|Overall Study|Lost to Follow-up|6|||
37710118|NCT02163902|69188500|FG001|Overall Study|Lost to Follow-up|7|||
37710119|NCT02163902|69188499|FG000|Overall Study|Administrative Decision|2|||
37710120|NCT02163902|69188500|FG001|Overall Study|Administrative Decision|2|||
37710121|NCT01630616|69188512|FG000|Overall Study|Adverse Event|0|||
37710122|NCT01630616|69188513|FG001|Overall Study|Adverse Event|0|||
37710123|NCT01630616|69188514|FG002|Overall Study|Adverse Event|0|||
37710124|NCT01630616|69188515|FG003|Overall Study|Adverse Event|1|||
37710125|NCT01630616|69188516|FG004|Overall Study|Adverse Event|0|||
37710126|NCT01630616|69188517|FG005|Overall Study|Adverse Event|0|||
37710127|NCT01630616|69188512|FG000|Overall Study|Withdrawal by Subject|0|||
37838538|NCT00477165|69523092|FG000|Overall Study|Adverse Event|7|||
37838539|NCT00477165|69523093|FG001|Overall Study|Adverse Event|2|||
37838540|NCT00476229|69523099|FG000|Overall Study|Progressive shortness of breath|1|||
37710128|NCT01630616|69188513|FG001|Overall Study|Withdrawal by Subject|0|||
37710129|NCT01630616|69188514|FG002|Overall Study|Withdrawal by Subject|0|||
37710130|NCT01630616|69188515|FG003|Overall Study|Withdrawal by Subject|2|||
37710131|NCT01630616|69188516|FG004|Overall Study|Withdrawal by Subject|0|||
37710132|NCT01630616|69188517|FG005|Overall Study|Withdrawal by Subject|0|||
37710133|NCT03774875|69188536|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
37710134|NCT03774875|69188537|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
37838541|NCT00476151|69523105|FG000|Overall Study|Adverse Event|0|||
37838542|NCT00476151|69523106|FG001|Overall Study|Adverse Event|2|||
37838543|NCT00476151|69523105|FG000|Overall Study|Protocol Violation|1|||
37838544|NCT00476151|69523106|FG001|Overall Study|Protocol Violation|3|||
37838545|NCT00476151|69523105|FG000|Overall Study|Withdrawal by Subject|2|||
37838546|NCT00476151|69523106|FG001|Overall Study|Withdrawal by Subject|0|||
37838547|NCT00476151|69523105|FG000|Overall Study|Physician Decision|0|||
37838548|NCT00476151|69523106|FG001|Overall Study|Physician Decision|2|||
37838549|NCT00475644|69523112|FG000|Overall Study|Protocol Violation|13|||
37838550|NCT00474903|69523119|FG000|Overall Study|Protocol Violation|1|||
37838551|NCT00474903|69523120|FG001|Overall Study|Protocol Violation|5|||
37838552|NCT00474903|69523121|FG002|Overall Study|Protocol Violation|2|||
37710135|NCT03774875|69188536|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
37710136|NCT03774875|69188537|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
37710137|NCT03774875|69188536|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
37710138|NCT03774875|69188537|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
37710139|NCT03774875|69188536|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
37710140|NCT03774875|69188537|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
37710141|NCT03774875|69188536|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
37710142|NCT03774875|69188537|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
37710143|NCT03774875|69188536|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
37710144|NCT03774875|69188537|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
37710145|NCT03774875|69188536|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
37710146|NCT03774875|69188537|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
37710147|NCT03774875|69188536|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
37710148|NCT03774875|69188537|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
37710149|NCT03774875|69188536|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
37710150|NCT03774875|69188537|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
37710151|NCT03774875|69188536|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
37710152|NCT03774875|69188537|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
37710153|NCT03774875|69188536|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
37710154|NCT03774875|69188537|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
37710155|NCT03774875|69188536|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
37710156|NCT03774875|69188537|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
37710157|NCT03774875|69188536|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
37710158|NCT03774875|69188537|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
37710159|NCT02220764|69188550|FG000|Overall Study|Lost to Follow-up|3|||
37710160|NCT02220764|69188551|FG001|Overall Study|Lost to Follow-up|1|||
37710161|NCT02220764|69188550|FG000|Overall Study|Death|1|||
37710162|NCT02220764|69188551|FG001|Overall Study|Death|0|||
37710163|NCT01563172|69188557|FG000|Overall Study|Adverse Event|5|||
37710164|NCT01563172|69188557|FG000|Overall Study|Lost to Follow-up|2|||
37710165|NCT01563172|69188557|FG000|Overall Study|Other (Protocol deviation)|5|||
37710166|NCT01563172|69188557|FG000|Overall Study|Other (Not specified)|1|||
37710167|NCT02161718|69188574|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
37710168|NCT02161718|69188575|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
37710169|NCT02161718|69188576|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
37710170|NCT02161718|69188574|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
37710171|NCT02161718|69188575|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
37710172|NCT02161718|69188576|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
37710173|NCT02161718|69188574|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
37710174|NCT02161718|69188575|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
37710175|NCT02161718|69188576|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
37710176|NCT02161718|69188574|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
37710177|NCT02161718|69188575|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
37710178|NCT02161718|69188576|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
37710179|NCT02161718|69188574|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
37838553|NCT01134055|69523136|FG000|Overall Study|Adverse Event|5|||
37838554|NCT01134055|69523137|FG001|Overall Study|Adverse Event|2|||
37710180|NCT02161718|69188575|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
37838555|NCT01134055|69523138|FG002|Overall Study|Adverse Event|2|||
37838556|NCT01134055|69523139|FG003|Overall Study|Adverse Event|2|||
37838557|NCT01134055|69523140|FG004|Overall Study|Adverse Event|5|||
37838558|NCT01134055|69523141|FG005|Overall Study|Adverse Event|7|||
37915374|NCT00711802|69602170|FG005|Overall Study|Protocol Violation|0|||
37915375|NCT00711802|69602171|FG006|Overall Study|Protocol Violation|0|||
37915376|NCT00711802|69602172|FG007|Overall Study|Protocol Violation|0|||
37838559|NCT01134055|69523142|FG006|Overall Study|Adverse Event|2|||
37838560|NCT01134055|69523136|FG000|Overall Study|Lost to Follow-up|0|||
37838561|NCT01134055|69523137|FG001|Overall Study|Lost to Follow-up|1|||
37838562|NCT01134055|69523138|FG002|Overall Study|Lost to Follow-up|0|||
37838563|NCT01134055|69523139|FG003|Overall Study|Lost to Follow-up|1|||
37838564|NCT01134055|69523140|FG004|Overall Study|Lost to Follow-up|0|||
37838565|NCT01134055|69523141|FG005|Overall Study|Lost to Follow-up|0|||
37838566|NCT01134055|69523142|FG006|Overall Study|Lost to Follow-up|0|||
37838567|NCT01134055|69523136|FG000|Overall Study|Withdrawal by Subject|3|||
37838568|NCT01134055|69523137|FG001|Overall Study|Withdrawal by Subject|3|||
37838569|NCT01134055|69523138|FG002|Overall Study|Withdrawal by Subject|1|||
37838570|NCT01134055|69523139|FG003|Overall Study|Withdrawal by Subject|2|||
37838571|NCT01134055|69523140|FG004|Overall Study|Withdrawal by Subject|0|||
37838572|NCT01134055|69523141|FG005|Overall Study|Withdrawal by Subject|0|||
37838573|NCT01134055|69523142|FG006|Overall Study|Withdrawal by Subject|8|||
37838574|NCT01134055|69523136|FG000|Overall Study|Protocol Violation|0|||
37838575|NCT01134055|69523137|FG001|Overall Study|Protocol Violation|0|||
37838576|NCT01134055|69523138|FG002|Overall Study|Protocol Violation|0|||
37915377|NCT00711802|69602165|FG000|Overall Study|Physician Decision|0|||
37915378|NCT00711802|69602166|FG001|Overall Study|Physician Decision|2|||
37915379|NCT00711802|69602167|FG002|Overall Study|Physician Decision|0|||
38024335|NCT04315298|69707949|FG010|Overall Study|Withdrawal by Subject|0|||
37915380|NCT00711802|69602168|FG003|Overall Study|Physician Decision|0|||
37915381|NCT00711802|69602169|FG004|Overall Study|Physician Decision|0|||
37915382|NCT00711802|69602170|FG005|Overall Study|Physician Decision|0|||
37915383|NCT00711802|69602171|FG006|Overall Study|Physician Decision|0|||
37915384|NCT00711802|69602172|FG007|Overall Study|Physician Decision|0|||
37915385|NCT00711802|69602165|FG000|Overall Study|Withdrawal by Subject|0|||
37915386|NCT00711802|69602166|FG001|Overall Study|Withdrawal by Subject|1|||
37915387|NCT00711802|69602167|FG002|Overall Study|Withdrawal by Subject|0|||
37915388|NCT00711802|69602168|FG003|Overall Study|Withdrawal by Subject|1|||
37915389|NCT00711802|69602169|FG004|Overall Study|Withdrawal by Subject|0|||
37915390|NCT00711802|69602170|FG005|Overall Study|Withdrawal by Subject|0|||
37915391|NCT00711802|69602171|FG006|Overall Study|Withdrawal by Subject|0|||
37915392|NCT00711802|69602172|FG007|Overall Study|Withdrawal by Subject|0|||
38024336|NCT04315298|69707950|FG011|Overall Study|Withdrawal by Subject|0|||
38024337|NCT04315298|69707951|FG012|Overall Study|Withdrawal by Subject|0|||
38024338|NCT04315298|69707952|FG013|Overall Study|Withdrawal by Subject|0|||
37710181|NCT02161718|69188576|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
37710182|NCT02161718|69188574|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
37710183|NCT02161718|69188575|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
37710184|NCT02161718|69188576|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
37710185|NCT02161718|69188574|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
37710186|NCT02161718|69188575|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
37710187|NCT02161718|69188576|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
37710188|NCT02161718|69188574|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
37710189|NCT02161718|69188575|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
37710190|NCT02161718|69188576|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
37710191|NCT02161718|69188574|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
37710192|NCT02161718|69188575|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
37710193|NCT02161718|69188576|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
37710194|NCT02161718|69188574|FG000|Post- Randomization Period|Lost to Follow-up|0|||
37838577|NCT01134055|69523139|FG003|Overall Study|Protocol Violation|1|||
37838578|NCT01134055|69523140|FG004|Overall Study|Protocol Violation|1|||
37915393|NCT00711802|69602165|FG000|Overall Study|Lost to Follow-up|0|||
37710195|NCT02161718|69188575|FG001|Post- Randomization Period|Lost to Follow-up|9|||
37710196|NCT02161718|69188576|FG002|Post- Randomization Period|Lost to Follow-up|15|||
37710197|NCT02161718|69188574|FG000|Post- Randomization Period|Adverse Event|0|||
37710198|NCT02161718|69188575|FG001|Post- Randomization Period|Adverse Event|9|||
37710199|NCT02161718|69188576|FG002|Post- Randomization Period|Adverse Event|10|||
37710200|NCT02161718|69188574|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
37710201|NCT02161718|69188575|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
37710202|NCT02161718|69188576|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
37710203|NCT02161718|69188574|FG000|Post- Randomization Period|Physician Decision|0|||
37710204|NCT02161718|69188575|FG001|Post- Randomization Period|Physician Decision|2|||
37710205|NCT02161718|69188576|FG002|Post- Randomization Period|Physician Decision|4|||
37710206|NCT02161718|69188574|FG000|Post- Randomization Period|Protocol Violation|0|||
37710207|NCT02161718|69188575|FG001|Post- Randomization Period|Protocol Violation|2|||
37710208|NCT02161718|69188576|FG002|Post- Randomization Period|Protocol Violation|3|||
37710209|NCT02161718|69188574|FG000|Post- Randomization Period|Lack of Efficacy|0|||
37710210|NCT02161718|69188575|FG001|Post- Randomization Period|Lack of Efficacy|0|||
37710211|NCT02161718|69188576|FG002|Post- Randomization Period|Lack of Efficacy|1|||
37710212|NCT02161718|69188574|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
37710213|NCT02161718|69188575|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
37710214|NCT02161718|69188576|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
37710215|NCT02161718|69188574|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
37710216|NCT02161718|69188575|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
37710217|NCT02161718|69188576|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
37710218|NCT02161718|69188574|FG000|Post- Randomization Period|Relocation|0|||
37710219|NCT02161718|69188575|FG001|Post- Randomization Period|Relocation|3|||
37710220|NCT02161718|69188576|FG002|Post- Randomization Period|Relocation|0|||
37710221|NCT02219048|69188585|FG000|Overall Study|Adverse Event|2|||
37710222|NCT02219048|69188586|FG001|Overall Study|Adverse Event|5|||
37710223|NCT02219048|69188585|FG000|Overall Study|No longer meets eligibility criteria|1|||
37710224|NCT02219048|69188586|FG001|Overall Study|No longer meets eligibility criteria|0|||
37710225|NCT02219048|69188585|FG000|Overall Study|Study terminated by sponsor|16|||
37710226|NCT02219048|69188586|FG001|Overall Study|Study terminated by sponsor|15|||
37710227|NCT02219048|69188585|FG000|Overall Study|Withdrawal by Subject|2|||
37710228|NCT02219048|69188586|FG001|Overall Study|Withdrawal by Subject|0|||
37710229|NCT02219048|69188585|FG000|Overall Study|Other|0|||
37710230|NCT02219048|69188586|FG001|Overall Study|Other|1|||
37710231|NCT02218736|69188594|FG000|Overall Study|Withdrawal by Subject|10|||
37710232|NCT02218736|69188595|FG001|Overall Study|Withdrawal by Subject|9|||
37710233|NCT02218736|69188594|FG000|Overall Study|Protocol Violation|2|||
37710234|NCT02218736|69188595|FG001|Overall Study|Protocol Violation|0|||
37710235|NCT01540474|69188605|FG000|Vaccination Period|Lost to Follow-up|0|||
37710236|NCT01540474|69188606|FG001|Vaccination Period|Lost to Follow-up|1|||
37710237|NCT01540474|69188607|FG002|Vaccination Period|Lost to Follow-up|0|||
37710238|NCT01540474|69188608|FG003|Vaccination Period|Lost to Follow-up|0|||
37710239|NCT01580488|69188619|FG000|Overall Study|Withdrawal by Subject|1|||
37710240|NCT01580020|69188635|FG000|Overall Study|Lack of Efficacy|0|||
37710241|NCT01580020|69188636|FG001|Overall Study|Lack of Efficacy|5|||
37710242|NCT01580020|69188637|FG002|Overall Study|Lack of Efficacy|0|||
37710243|NCT01580020|69188638|FG003|Overall Study|Lack of Efficacy|1|||
37710244|NCT01580020|69188635|FG000|Overall Study|Withdrawal by Subject|0|||
37710245|NCT01580020|69188636|FG001|Overall Study|Withdrawal by Subject|1|||
37710246|NCT01580020|69188637|FG002|Overall Study|Withdrawal by Subject|1|||
37710247|NCT01580020|69188638|FG003|Overall Study|Withdrawal by Subject|0|||
37710248|NCT01580020|69188635|FG000|Overall Study|Adverse Event|1|||
37710249|NCT01580020|69188636|FG001|Overall Study|Adverse Event|1|||
37710250|NCT01580020|69188637|FG002|Overall Study|Adverse Event|1|||
37710251|NCT01580020|69188638|FG003|Overall Study|Adverse Event|1|||
37710252|NCT01580020|69188635|FG000|Overall Study|Administrative Problems|0|||
37710253|NCT01580020|69188636|FG001|Overall Study|Administrative Problems|0|||
37710254|NCT01580020|69188637|FG002|Overall Study|Administrative Problems|1|||
37710255|NCT01580020|69188638|FG003|Overall Study|Administrative Problems|0|||
37710256|NCT01580020|69188635|FG000|Overall Study|Lost to Follow-up|0|||
37710257|NCT01580020|69188636|FG001|Overall Study|Lost to Follow-up|0|||
37710258|NCT01580020|69188637|FG002|Overall Study|Lost to Follow-up|1|||
37710259|NCT01580020|69188638|FG003|Overall Study|Lost to Follow-up|0|||
37710260|NCT01579474|69188654|FG000|Overall Study|Adverse Event|1|||
37710261|NCT01579474|69188655|FG001|Overall Study|Adverse Event|13|||
37710262|NCT01579474|69188656|FG002|Overall Study|Adverse Event|2|||
37710263|NCT01579474|69188657|FG003|Overall Study|Adverse Event|0|||
37710264|NCT01579474|69188658|FG004|Overall Study|Adverse Event|0|||
37710265|NCT01579474|69188659|FG005|Overall Study|Adverse Event|1|||
37710266|NCT01579474|69188654|FG000|Overall Study|Lack of Efficacy|1|||
37710267|NCT01579474|69188655|FG001|Overall Study|Lack of Efficacy|0|||
37710268|NCT01579474|69188656|FG002|Overall Study|Lack of Efficacy|0|||
37710269|NCT01579474|69188657|FG003|Overall Study|Lack of Efficacy|0|||
37710270|NCT01579474|69188658|FG004|Overall Study|Lack of Efficacy|1|||
37710271|NCT01579474|69188659|FG005|Overall Study|Lack of Efficacy|0|||
37710272|NCT01579474|69188654|FG000|Overall Study|Withdrawal by Subject|1|||
37710273|NCT01579474|69188655|FG001|Overall Study|Withdrawal by Subject|0|||
37710274|NCT01579474|69188656|FG002|Overall Study|Withdrawal by Subject|0|||
37710275|NCT01579474|69188657|FG003|Overall Study|Withdrawal by Subject|0|||
37710276|NCT01579474|69188658|FG004|Overall Study|Withdrawal by Subject|0|||
37710277|NCT01579474|69188659|FG005|Overall Study|Withdrawal by Subject|0|||
38024339|NCT04315298|69707953|FG014|Overall Study|Withdrawal by Subject|0|||
38024340|NCT04315298|69707954|FG015|Overall Study|Withdrawal by Subject|0|||
38024341|NCT04315298|69707955|FG016|Overall Study|Withdrawal by Subject|0|||
38024342|NCT04315298|69707956|FG017|Overall Study|Withdrawal by Subject|0|||
38024343|NCT04315298|69707957|FG018|Overall Study|Withdrawal by Subject|0|||
38024344|NCT04315298|69707939|FG000|Overall Study|Physician Decision|0|||
38024345|NCT04315298|69707940|FG001|Overall Study|Physician Decision|0|||
37710278|NCT01579318|69188672|FG000|Overall Study|Disease Progression|1|||
37710279|NCT01562782|69188678|FG000|Overall Study|Withdrawal by Subject|3|||
37710280|NCT01562782|69188679|FG001|Overall Study|Withdrawal by Subject|3|||
37710281|NCT01562782|69188678|FG000|Overall Study|screen failure|1|||
37710282|NCT01562782|69188679|FG001|Overall Study|screen failure|2|||
37710283|NCT01579006|69188685|FG000|Overall Study|Lack of Efficacy|10|||
37710284|NCT01579006|69188685|FG000|Overall Study|Adverse Event|13|||
37710285|NCT01579006|69188685|FG000|Overall Study|Withdrawal by Subject|5|||
37710286|NCT01579006|69188685|FG000|Overall Study|Non-compliance|3|||
37710287|NCT01579006|69188685|FG000|Overall Study|Due to participant's health fund|1|||
37838579|NCT01134055|69523141|FG005|Overall Study|Protocol Violation|0|||
37838580|NCT01134055|69523142|FG006|Overall Study|Protocol Violation|0|||
37838581|NCT01134055|69523136|FG000|Overall Study|Physician Decision|0|||
38024346|NCT04315298|69707941|FG002|Overall Study|Physician Decision|0|||
38024347|NCT04315298|69707942|FG003|Overall Study|Physician Decision|0|||
38024348|NCT04315298|69707943|FG004|Overall Study|Physician Decision|1|||
38024349|NCT04315298|69707944|FG005|Overall Study|Physician Decision|0|||
37710288|NCT01579006|69188685|FG000|Overall Study|Scheduled surgery|1|||
37710289|NCT01578850|69188691|FG000|Period 1|Insufficient Clinical Response|1|||
37710290|NCT01578850|69188692|FG001|Period 1|Insufficient Clinical Response|0|||
37710291|NCT01578850|69188693|FG002|Period 1|Insufficient Clinical Response|0|||
37710292|NCT01578850|69188691|FG000|Period 1|Adverse Event|11|||
37710293|NCT01578850|69188692|FG001|Period 1|Adverse Event|0|||
37710294|NCT01578850|69188693|FG002|Period 1|Adverse Event|0|||
37710295|NCT01578850|69188691|FG000|Period 1|Death|1|||
37710296|NCT01578850|69188692|FG001|Period 1|Death|0|||
37710297|NCT01578850|69188693|FG002|Period 1|Death|0|||
37710298|NCT01578850|69188691|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
37710299|NCT01578850|69188692|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
37710300|NCT01578850|69188693|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
37710301|NCT01578850|69188691|FG000|Period 1|Withdrawal by Subject|9|||
37710302|NCT01578850|69188692|FG001|Period 1|Withdrawal by Subject|0|||
37710303|NCT01578850|69188693|FG002|Period 1|Withdrawal by Subject|0|||
37710304|NCT01578850|69188691|FG000|Period 1|Study Terminated by Sponsor|3|||
37710305|NCT01578850|69188692|FG001|Period 1|Study Terminated by Sponsor|0|||
37710306|NCT01578850|69188693|FG002|Period 1|Study Terminated by Sponsor|0|||
37710307|NCT01578850|69188691|FG000|Period 2|Insufficient Clinical Response|0|||
37710308|NCT01578850|69188692|FG001|Period 2|Insufficient Clinical Response|1|||
37710309|NCT01578850|69188693|FG002|Period 2|Insufficient Clinical Response|0|||
37710310|NCT01578850|69188691|FG000|Period 2|Adverse Event|0|||
37710311|NCT01578850|69188692|FG001|Period 2|Adverse Event|3|||
37710312|NCT01578850|69188693|FG002|Period 2|Adverse Event|6|||
37710313|NCT01578850|69188691|FG000|Period 2|Lost to Follow-up|0|||
37710314|NCT01578850|69188692|FG001|Period 2|Lost to Follow-up|1|||
37710315|NCT01578850|69188693|FG002|Period 2|Lost to Follow-up|2|||
37710316|NCT01578850|69188691|FG000|Period 2|Withdrawal by Subject|0|||
37710317|NCT01578850|69188692|FG001|Period 2|Withdrawal by Subject|2|||
37710318|NCT01578850|69188693|FG002|Period 2|Withdrawal by Subject|2|||
37710319|NCT01578850|69188691|FG000|Period 2|Study Terminated by Sponsor|0|||
37710320|NCT01578850|69188692|FG001|Period 2|Study Terminated by Sponsor|5|||
37710321|NCT01578850|69188693|FG002|Period 2|Study Terminated by Sponsor|4|||
37710322|NCT01578850|69188691|FG000|Period 2|Unspecified Reasons|0|||
37710323|NCT01578850|69188692|FG001|Period 2|Unspecified Reasons|1|||
37710324|NCT01578850|69188693|FG002|Period 2|Unspecified Reasons|0|||
37710325|NCT01539538|69188703|FG000|Overall Study|Adverse Event|13|||
37710326|NCT01539538|69188704|FG001|Overall Study|Adverse Event|18|||
37710327|NCT01539538|69188703|FG000|Overall Study|Lack of Efficacy|13|||
37710328|NCT01539538|69188704|FG001|Overall Study|Lack of Efficacy|16|||
37710329|NCT01539538|69188703|FG000|Overall Study|Withdrawal by Subject|2|||
37710330|NCT01539538|69188704|FG001|Overall Study|Withdrawal by Subject|3|||
37710331|NCT01539538|69188703|FG000|Overall Study|PCA no longer required or PCA problem|3|||
37710332|NCT01539538|69188704|FG001|Overall Study|PCA no longer required or PCA problem|7|||
37710333|NCT01562548|69188714|FG000|Overall Study|Lost to Follow-up|0|||
37710334|NCT01562548|69188715|FG001|Overall Study|Lost to Follow-up|0|||
37710335|NCT01562548|69188716|FG002|Overall Study|Lost to Follow-up|1|||
37710336|NCT01562548|69188717|FG003|Overall Study|Lost to Follow-up|0|||
37710337|NCT01562314|69188731|FG000|Overall Study|Adverse Event|10|||
37710338|NCT01562314|69188732|FG001|Overall Study|Adverse Event|5|||
37710339|NCT01562314|69188731|FG000|Overall Study|Met Withdrawal Criteria|3|||
37710340|NCT01562314|69188732|FG001|Overall Study|Met Withdrawal Criteria|2|||
37710341|NCT01562314|69188731|FG000|Overall Study|Withdrawal by Subject|0|||
37710342|NCT01562314|69188732|FG001|Overall Study|Withdrawal by Subject|1|||
37710343|NCT01539226|69188740|FG000|Overall Study|Withdrawal by Subject|24|||
37710344|NCT01539226|69188741|FG001|Overall Study|Withdrawal by Subject|54|||
37710345|NCT01539226|69188740|FG000|Overall Study|Lost to Follow-up|20|||
37710346|NCT01539226|69188741|FG001|Overall Study|Lost to Follow-up|54|||
37710347|NCT01539226|69188740|FG000|Overall Study|Death|1|||
37710348|NCT01539226|69188741|FG001|Overall Study|Death|2|||
37710349|NCT01539226|69188740|FG000|Overall Study|Adverse Event|2|||
37710350|NCT01539226|69188741|FG001|Overall Study|Adverse Event|0|||
37710351|NCT01539226|69188740|FG000|Overall Study|Pregnancy|13|||
37710352|NCT01539226|69188741|FG001|Overall Study|Pregnancy|29|||
37710353|NCT01539226|69188740|FG000|Overall Study|inappropriate enrollment|0|||
37710354|NCT01539226|69188741|FG001|Overall Study|inappropriate enrollment|1|||
38024350|NCT04315298|69707945|FG006|Overall Study|Physician Decision|0|||
37710355|NCT01539226|69188740|FG000|Overall Study|Multiple Reasons|3|||
37710356|NCT01539226|69188741|FG001|Overall Study|Multiple Reasons|1|||
37710357|NCT01539226|69188740|FG000|Overall Study|not HIV seroconversion-related|93|||
37710358|NCT01539226|69188741|FG001|Overall Study|not HIV seroconversion-related|176|||
37710359|NCT01539226|69188740|FG000|Overall Study|HIV seroconversion-related|55|||
37710360|NCT01539226|69188741|FG001|Overall Study|HIV seroconversion-related|80|||
37710361|NCT01539226|69188740|FG000|Overall Study|Non-compliance|6|||
37710362|NCT01539226|69188741|FG001|Overall Study|Non-compliance|8|||
37710363|NCT01577758|69188747|FG000|Dose Escalation Phase|Adverse Event|0|||
37710364|NCT01577758|69188748|FG001|Dose Escalation Phase|Adverse Event|0|||
37710365|NCT01577758|69188749|FG002|Dose Escalation Phase|Adverse Event|0|||
37710366|NCT01577758|69188750|FG003|Dose Escalation Phase|Adverse Event|0|||
37710367|NCT01577758|69188751|FG004|Dose Escalation Phase|Adverse Event|0|||
37710368|NCT01577758|69188752|FG005|Dose Escalation Phase|Adverse Event|2|||
37710369|NCT01577758|69188753|FG006|Dose Escalation Phase|Adverse Event|1|||
37710370|NCT01577758|69188754|FG007|Dose Escalation Phase|Adverse Event|0|||
37710371|NCT01577758|69188747|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
37710372|NCT01577758|69188748|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
37710373|NCT01577758|69188749|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
37710374|NCT01577758|69188750|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
37710375|NCT01577758|69188751|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
37710376|NCT01577758|69188752|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
37710377|NCT01577758|69188753|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
37710378|NCT01577758|69188754|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
37710379|NCT01577758|69188747|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
37710380|NCT01577758|69188748|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
37710381|NCT01577758|69188749|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
37710382|NCT01577758|69188750|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
37710383|NCT01577758|69188751|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
37710384|NCT01577758|69188752|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
37710385|NCT01577758|69188753|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
37710386|NCT01577758|69188754|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
37710387|NCT01577758|69188747|FG000|Dose Escalation Phase|Progression Disease|2|||
37710388|NCT01577758|69188748|FG001|Dose Escalation Phase|Progression Disease|2|||
37710389|NCT01577758|69188749|FG002|Dose Escalation Phase|Progression Disease|1|||
37710390|NCT01577758|69188750|FG003|Dose Escalation Phase|Progression Disease|2|||
37710391|NCT01577758|69188751|FG004|Dose Escalation Phase|Progression Disease|5|||
37710392|NCT01577758|69188752|FG005|Dose Escalation Phase|Progression Disease|0|||
37710393|NCT01577758|69188753|FG006|Dose Escalation Phase|Progression Disease|0|||
37710394|NCT01577758|69188754|FG007|Dose Escalation Phase|Progression Disease|0|||
37710395|NCT01577758|69188747|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
37710396|NCT01577758|69188748|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
37710397|NCT01577758|69188749|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
37710398|NCT01577758|69188750|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
37710399|NCT01577758|69188751|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
37710400|NCT01577758|69188752|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
37710401|NCT01577758|69188753|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
37710402|NCT01577758|69188754|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
37710403|NCT01577758|69188747|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
37710404|NCT01577758|69188748|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
37710405|NCT01577758|69188749|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
37710406|NCT01577758|69188750|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
37710407|NCT01577758|69188751|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
37710408|NCT01577758|69188752|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
37710409|NCT01577758|69188753|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
37710410|NCT01577758|69188754|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
37710411|NCT01577758|69188747|FG000|mCRC Expansion Phase|Progression Disease|0|||
37710412|NCT01577758|69188748|FG001|mCRC Expansion Phase|Progression Disease|0|||
37710413|NCT01577758|69188749|FG002|mCRC Expansion Phase|Progression Disease|0|||
37710414|NCT01577758|69188750|FG003|mCRC Expansion Phase|Progression Disease|0|||
37710415|NCT01577758|69188751|FG004|mCRC Expansion Phase|Progression Disease|0|||
37710416|NCT01577758|69188752|FG005|mCRC Expansion Phase|Progression Disease|0|||
37710417|NCT01577758|69188753|FG006|mCRC Expansion Phase|Progression Disease|0|||
37710418|NCT01577758|69188754|FG007|mCRC Expansion Phase|Progression Disease|19|||
37710419|NCT01537432|69188776|FG000|Overall Study|Lost to Follow-up|3|||
37710420|NCT01537432|69188777|FG001|Overall Study|Lost to Follow-up|1|||
37710421|NCT01537432|69188776|FG000|Overall Study|Withdrawal by Subject|0|||
37710422|NCT01537432|69188777|FG001|Overall Study|Withdrawal by Subject|1|||
37710423|NCT01537432|69188776|FG000|Overall Study|Administrative problems|1|||
37710424|NCT01537432|69188777|FG001|Overall Study|Administrative problems|0|||
37710425|NCT01537432|69188776|FG000|Overall Study|Adverse Event|1|||
37710426|NCT01537432|69188777|FG001|Overall Study|Adverse Event|0|||
37710427|NCT01537432|69188776|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
37710428|NCT01537432|69188777|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
37710429|NCT01537198|69188783|FG000|Overall Study|RSV infection|2|||
37710430|NCT01537198|69188783|FG000|Overall Study|Adverse Event|4|||
37710431|NCT01537198|69188783|FG000|Overall Study|No Further Visits to the Clinic|37|||
37710432|NCT01537198|69188783|FG000|Overall Study|Other|111|||
37710433|NCT01537120|69188787|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
37710434|NCT01537120|69188787|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
37710435|NCT01537042|69188795|FG000|Overall Study|Adverse Event|0|||
37710436|NCT01537042|69188796|FG001|Overall Study|Adverse Event|2|||
37710437|NCT01537042|69188795|FG000|Overall Study|Lack of Efficacy|0|||
37710438|NCT01537042|69188796|FG001|Overall Study|Lack of Efficacy|1|||
37710439|NCT01537042|69188795|FG000|Overall Study|Protocol Violation|0|||
37710440|NCT01537042|69188796|FG001|Overall Study|Protocol Violation|1|||
37710441|NCT01537042|69188795|FG000|Overall Study|Other|0|||
37710442|NCT01537042|69188796|FG001|Overall Study|Other|1|||
37710443|NCT01536574|69188817|FG000|Overall Study|Adverse Event|4|||
37710444|NCT01536574|69188818|FG001|Overall Study|Adverse Event|5|||
37710445|NCT01536574|69188817|FG000|Overall Study|Withdrawal by Subject|1|||
37710446|NCT01536574|69188818|FG001|Overall Study|Withdrawal by Subject|2|||
37915394|NCT00711802|69602166|FG001|Overall Study|Lost to Follow-up|0|||
37915395|NCT00711802|69602167|FG002|Overall Study|Lost to Follow-up|3|||
37710447|NCT01536574|69188817|FG000|Overall Study|Lack of Efficacy|1|||
37710448|NCT01536574|69188818|FG001|Overall Study|Lack of Efficacy|0|||
37710449|NCT01536418|69188826|FG000|Overall Study|Protocol Violation|2|||
37710450|NCT01536418|69188827|FG001|Overall Study|Protocol Violation|3|||
37915396|NCT00711802|69602168|FG003|Overall Study|Lost to Follow-up|1|||
37710451|NCT01536418|69188826|FG000|Overall Study|Physician Decision|1|||
37710452|NCT01536418|69188827|FG001|Overall Study|Physician Decision|3|||
37710453|NCT01536418|69188826|FG000|Overall Study|Study closed/terminated|41|||
37710454|NCT01536418|69188827|FG001|Overall Study|Study closed/terminated|37|||
37710455|NCT01536418|69188826|FG000|Overall Study|Lack of Efficacy|10|||
37710456|NCT01536418|69188827|FG001|Overall Study|Lack of Efficacy|16|||
37710457|NCT01536418|69188826|FG000|Overall Study|Adverse Event|9|||
37710458|NCT01536418|69188827|FG001|Overall Study|Adverse Event|4|||
37710459|NCT01536418|69188826|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
37710460|NCT01536418|69188827|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
37710461|NCT01536418|69188826|FG000|Overall Study|Withdrawal by Subject|5|||
37710462|NCT01536418|69188827|FG001|Overall Study|Withdrawal by Subject|3|||
37710463|NCT01576042|69188836|FG000|Overall Study|Physician Decision|2|||
37710464|NCT01576042|69188837|FG001|Overall Study|Physician Decision|0|||
37710465|NCT01561300|69188843|FG000|Run in on Placebo|Adverse Event|1|||
37710466|NCT01561300|69188844|FG001|Run in on Placebo|Adverse Event|0|||
37710467|NCT01536262|69188854|FG000|Overall Study|Adverse Event|6|||
37710468|NCT01536262|69188855|FG001|Overall Study|Adverse Event|1|||
37710469|NCT01536262|69188856|FG002|Overall Study|Adverse Event|2|||
37710470|NCT01536262|69188854|FG000|Overall Study|Withdrawal by Subject|1|||
37710471|NCT01536262|69188855|FG001|Overall Study|Withdrawal by Subject|1|||
37710472|NCT01536262|69188856|FG002|Overall Study|Withdrawal by Subject|0|||
37710473|NCT01536262|69188854|FG000|Overall Study|Other than stated above|1|||
37710474|NCT01536262|69188855|FG001|Overall Study|Other than stated above|0|||
37710475|NCT01536262|69188856|FG002|Overall Study|Other than stated above|0|||
37710476|NCT01560988|69188865|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
37710477|NCT01560988|69188866|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
37710478|NCT01560988|69188865|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
37710479|NCT01560988|69188866|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
37710480|NCT01560988|69188865|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
37710481|NCT01560988|69188866|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
37710482|NCT01535638|69188877|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
37710483|NCT01535638|69188878|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
37710484|NCT01535638|69188879|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
37710485|NCT01535638|69188880|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
37710486|NCT01535638|69188881|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
37710487|NCT01535638|69188882|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
37710488|NCT01535638|69188877|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
37710489|NCT01535638|69188878|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
37710490|NCT01535638|69188879|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
37710491|NCT01535638|69188880|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
37710492|NCT01535638|69188881|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
37710493|NCT01535638|69188882|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
37710494|NCT01535560|69188893|FG000|Overall Study|Adverse Event|12|||
37710495|NCT01535560|69188894|FG001|Overall Study|Adverse Event|7|||
37710496|NCT01535560|69188893|FG000|Overall Study|Lost to Follow-up|1|||
37710497|NCT01535560|69188894|FG001|Overall Study|Lost to Follow-up|3|||
37710498|NCT01535560|69188893|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
37710499|NCT01535560|69188894|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
37710500|NCT01535560|69188893|FG000|Overall Study|Treatment Failure|21|||
37710501|NCT01535560|69188894|FG001|Overall Study|Treatment Failure|83|||
37710502|NCT01535560|69188893|FG000|Overall Study|Other|0|||
37710503|NCT01535560|69188894|FG001|Overall Study|Other|1|||
37710504|NCT01535560|69188893|FG000|Overall Study|Randomized in Error|0|||
37710505|NCT01535560|69188894|FG001|Overall Study|Randomized in Error|1|||
37710506|NCT01575028|69188902|FG000|Overall Study|Physician Decision|0|||
37710507|NCT01575028|69188903|FG001|Overall Study|Physician Decision|1|||
37710508|NCT01574716|69188928|FG000|Part 1|Death|3|||
37710509|NCT01574716|69188929|FG001|Part 1|Death|1|||
37710510|NCT01574716|69188930|FG002|Part 1|Death|8|||
37710511|NCT01574716|69188931|FG003|Part 1|Death|0|||
37710512|NCT01574716|69188932|FG004|Part 1|Death|0|||
37710513|NCT01574716|69188928|FG000|Part 1|Discontinuation of study by sponsor|0|||
37710514|NCT01574716|69188929|FG001|Part 1|Discontinuation of study by sponsor|0|||
37710515|NCT01574716|69188930|FG002|Part 1|Discontinuation of study by sponsor|1|||
37710516|NCT01574716|69188931|FG003|Part 1|Discontinuation of study by sponsor|0|||
37710517|NCT01574716|69188932|FG004|Part 1|Discontinuation of study by sponsor|0|||
37710518|NCT01574716|69188928|FG000|Part 1|Withdrawal by Subject|0|||
37710519|NCT01574716|69188929|FG001|Part 1|Withdrawal by Subject|2|||
37710520|NCT01574716|69188930|FG002|Part 1|Withdrawal by Subject|0|||
37710521|NCT01574716|69188931|FG003|Part 1|Withdrawal by Subject|0|||
37710522|NCT01574716|69188932|FG004|Part 1|Withdrawal by Subject|0|||
37710523|NCT01574716|69188928|FG000|Part 1|Lost to Follow-up|0|||
37710524|NCT01574716|69188929|FG001|Part 1|Lost to Follow-up|1|||
37710525|NCT01574716|69188930|FG002|Part 1|Lost to Follow-up|0|||
37710526|NCT01574716|69188931|FG003|Part 1|Lost to Follow-up|0|||
37710527|NCT01574716|69188932|FG004|Part 1|Lost to Follow-up|0|||
37710528|NCT01574716|69188928|FG000|Part 2|Progressive disease|0|||
37710529|NCT01574716|69188929|FG001|Part 2|Progressive disease|0|||
37710530|NCT01574716|69188930|FG002|Part 2|Progressive disease|0|||
37710531|NCT01574716|69188931|FG003|Part 2|Progressive disease|1|||
37710532|NCT01574716|69188932|FG004|Part 2|Progressive disease|0|||
37710533|NCT01574716|69188928|FG000|Part 2|Death|0|||
37710534|NCT01574716|69188929|FG001|Part 2|Death|0|||
37710535|NCT01574716|69188930|FG002|Part 2|Death|0|||
37710536|NCT01574716|69188931|FG003|Part 2|Death|76|||
37710537|NCT01574716|69188932|FG004|Part 2|Death|35|||
37710538|NCT01574716|69188928|FG000|Part 2|Discontinuation of study by sponsor|0|||
37710539|NCT01574716|69188929|FG001|Part 2|Discontinuation of study by sponsor|0|||
37710540|NCT01574716|69188930|FG002|Part 2|Discontinuation of study by sponsor|0|||
37710541|NCT01574716|69188931|FG003|Part 2|Discontinuation of study by sponsor|51|||
37710542|NCT01574716|69188932|FG004|Part 2|Discontinuation of study by sponsor|31|||
37710543|NCT01574716|69188928|FG000|Part 2|Withdrawal by Subject|0|||
37710544|NCT01574716|69188929|FG001|Part 2|Withdrawal by Subject|0|||
37710545|NCT01574716|69188930|FG002|Part 2|Withdrawal by Subject|0|||
37710546|NCT01574716|69188931|FG003|Part 2|Withdrawal by Subject|5|||
37710547|NCT01574716|69188932|FG004|Part 2|Withdrawal by Subject|4|||
37710548|NCT01574716|69188928|FG000|Part 2|Brain metastases|0|||
37710549|NCT01574716|69188929|FG001|Part 2|Brain metastases|0|||
37710550|NCT01574716|69188930|FG002|Part 2|Brain metastases|0|||
37710551|NCT01574716|69188931|FG003|Part 2|Brain metastases|1|||
37710552|NCT01574716|69188932|FG004|Part 2|Brain metastases|0|||
37710553|NCT01574716|69188928|FG000|Part 2|Lost to Follow-up|0|||
37710554|NCT01574716|69188929|FG001|Part 2|Lost to Follow-up|0|||
37710555|NCT01574716|69188930|FG002|Part 2|Lost to Follow-up|0|||
37710556|NCT01574716|69188931|FG003|Part 2|Lost to Follow-up|3|||
37710557|NCT01574716|69188932|FG004|Part 2|Lost to Follow-up|0|||
37710558|NCT02161562|69188943|FG000|Overall Study|Withdrawal by Subject|5|||
37710559|NCT02161562|69188944|FG001|Overall Study|Withdrawal by Subject|8|||
37710560|NCT02161562|69188943|FG000|Overall Study|Protocol Violation|9|||
37710561|NCT02161562|69188944|FG001|Overall Study|Protocol Violation|4|||
37710562|NCT02161562|69188943|FG000|Overall Study|Pregnancy|1|||
37710563|NCT02161562|69188944|FG001|Overall Study|Pregnancy|2|||
37710564|NCT02161562|69188943|FG000|Overall Study|Lost to Follow-up|3|||
37710565|NCT02161562|69188944|FG001|Overall Study|Lost to Follow-up|1|||
37710566|NCT02161562|69188943|FG000|Overall Study|Lack of Efficacy|4|||
37710567|NCT02161562|69188944|FG001|Overall Study|Lack of Efficacy|1|||
37710568|NCT02161562|69188943|FG000|Overall Study|Adverse Event|1|||
37710569|NCT02161562|69188944|FG001|Overall Study|Adverse Event|1|||
37710570|NCT02161562|69188943|FG000|Overall Study|Participant moved back to home country|1|||
37710571|NCT02161562|69188944|FG001|Overall Study|Participant moved back to home country|0|||
37710572|NCT02161562|69188943|FG000|Overall Study|Withdrew due to being out of the country|1|||
37710573|NCT02161562|69188944|FG001|Overall Study|Withdrew due to being out of the country|0|||
37710574|NCT02161562|69188943|FG000|Overall Study|Participant moved out of province|1|||
37710575|NCT02161562|69188944|FG001|Overall Study|Participant moved out of province|0|||
37710576|NCT01559116|69188963|FG000|Overall Study|Adverse Event|10|||
37710577|NCT01559116|69188963|FG000|Overall Study|Lack of Efficacy|1|||
37710578|NCT01559116|69188963|FG000|Overall Study|Lost to Follow-up|1|||
37710579|NCT01559116|69188963|FG000|Overall Study|Protocol Violation|1|||
37710580|NCT01559116|69188963|FG000|Overall Study|Withdrawal by Subject|4|||
37710581|NCT01559116|69188963|FG000|Overall Study|other than stated above|9|||
37710582|NCT01574326|69188982|FG000|Overall Study|Randomized but not treated|0|||
37710583|NCT01574326|69188983|FG001|Overall Study|Randomized but not treated|1|||
37710584|NCT01574326|69188982|FG000|Overall Study|Withdrawal by Participant|2|||
37710585|NCT01574326|69188983|FG001|Overall Study|Withdrawal by Participant|4|||
37710586|NCT01574326|69188982|FG000|Overall Study|Physician Decision|5|||
37710587|NCT01574326|69188983|FG001|Overall Study|Physician Decision|3|||
37710588|NCT01574326|69188982|FG000|Overall Study|Adverse Event|1|||
37710589|NCT01574326|69188983|FG001|Overall Study|Adverse Event|3|||
37710590|NCT01574326|69188982|FG000|Overall Study|Other: Mainly kidney transplant|8|||
37710591|NCT01574326|69188983|FG001|Overall Study|Other: Mainly kidney transplant|8|||
37710592|NCT01574248|69188996|FG000|Overall Study|Withdrawal by Subject|2|||
37710593|NCT01574248|69188997|FG001|Overall Study|Withdrawal by Subject|0|||
37710594|NCT01574248|69188996|FG000|Overall Study|Missing primary endpoint data|1|||
37710595|NCT01574248|69188997|FG001|Overall Study|Missing primary endpoint data|0|||
37710596|NCT01573624|69189003|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
37710597|NCT01573624|69189004|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
37710598|NCT01573624|69189005|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
37710599|NCT01573624|69189006|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
37710600|NCT01573624|69189007|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
37838582|NCT01134055|69523137|FG001|Overall Study|Physician Decision|0|||
37710601|NCT01573624|69189008|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
37838583|NCT01134055|69523138|FG002|Overall Study|Physician Decision|0|||
37710602|NCT01573624|69189009|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
37710603|NCT01573624|69189003|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
37710604|NCT01573624|69189004|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
37710605|NCT01573624|69189005|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
37710606|NCT01573624|69189006|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
37838584|NCT01134055|69523139|FG003|Overall Study|Physician Decision|0|||
37838585|NCT01134055|69523140|FG004|Overall Study|Physician Decision|0|||
37710607|NCT01573624|69189007|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
37710608|NCT01573624|69189008|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
37710609|NCT01573624|69189009|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
37838586|NCT01134055|69523141|FG005|Overall Study|Physician Decision|0|||
37838587|NCT01134055|69523142|FG006|Overall Study|Physician Decision|1|||
37710610|NCT01573624|69189003|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
37710611|NCT01573624|69189004|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
37710612|NCT01573624|69189005|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
37710613|NCT01573624|69189006|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
37710614|NCT01573624|69189007|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
37710615|NCT01573624|69189008|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
37710616|NCT01573624|69189009|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
37710617|NCT01573624|69189003|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
37710618|NCT01573624|69189004|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
37710619|NCT01573624|69189005|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
37710620|NCT01573624|69189006|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
37710621|NCT01573624|69189007|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
37710622|NCT01573624|69189008|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
37710623|NCT01573624|69189009|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
37710624|NCT01573624|69189003|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
37710625|NCT01573624|69189004|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
37710626|NCT01573624|69189005|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
37710627|NCT01573624|69189006|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
37710628|NCT01573624|69189007|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
37710629|NCT01573624|69189008|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
37710630|NCT01573624|69189009|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
37710631|NCT01573624|69189003|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
37710632|NCT01573624|69189004|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
37710633|NCT01573624|69189005|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
37710634|NCT01573624|69189006|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
37710635|NCT01573624|69189007|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
37710636|NCT01573624|69189008|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
37710637|NCT01573624|69189009|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
37710638|NCT01573624|69189003|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
37710639|NCT01573624|69189004|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
37710640|NCT01573624|69189005|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
37710641|NCT01573624|69189006|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
37710642|NCT01573624|69189007|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
37710643|NCT01573624|69189008|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
37710644|NCT01573624|69189009|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
37710645|NCT01573624|69189003|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
37838588|NCT00474708|69523166|FG000|Overall Study|Lack of Efficacy|11|||
37838589|NCT00474708|69523167|FG001|Overall Study|Lack of Efficacy|5|||
37838590|NCT00474708|69523166|FG000|Overall Study|Suicide ideation/behavior|0|||
37838591|NCT00474708|69523167|FG001|Overall Study|Suicide ideation/behavior|1|||
37838592|NCT00474708|69523166|FG000|Overall Study|Withdrawal by Subject|7|||
37838593|NCT00474708|69523167|FG001|Overall Study|Withdrawal by Subject|0|||
37838594|NCT00474708|69523166|FG000|Overall Study|Lack of compliance|12|||
37838595|NCT00474708|69523167|FG001|Overall Study|Lack of compliance|4|||
37838596|NCT00474708|69523166|FG000|Overall Study|Lost to Follow-up|18|||
37838597|NCT00474708|69523167|FG001|Overall Study|Lost to Follow-up|9|||
37838598|NCT00474708|69523166|FG000|Overall Study|Physician Decision|9|||
37838599|NCT00474708|69523167|FG001|Overall Study|Physician Decision|6|||
37838600|NCT00474240|69523179|FG000|Overall Study|Withdrawal by Subject|1|||
37838601|NCT00474240|69523180|FG001|Overall Study|Withdrawal by Subject|1|||
37838602|NCT00474240|69523181|FG002|Overall Study|Withdrawal by Subject|0|||
37838603|NCT00474240|69523182|FG003|Overall Study|Withdrawal by Subject|2|||
37838604|NCT00474240|69523183|FG004|Overall Study|Withdrawal by Subject|3|||
37838605|NCT00474240|69523184|FG005|Overall Study|Withdrawal by Subject|1|||
37838606|NCT00474240|69523179|FG000|Overall Study|Adverse Event|0|||
37838607|NCT00474240|69523180|FG001|Overall Study|Adverse Event|0|||
38024351|NCT04315298|69707946|FG007|Overall Study|Physician Decision|0|||
38024352|NCT04315298|69707947|FG008|Overall Study|Physician Decision|0|||
38024353|NCT04315298|69707948|FG009|Overall Study|Physician Decision|0|||
38024354|NCT04315298|69707949|FG010|Overall Study|Physician Decision|0|||
38024355|NCT04315298|69707950|FG011|Overall Study|Physician Decision|0|||
38024356|NCT04315298|69707951|FG012|Overall Study|Physician Decision|0|||
37838608|NCT00474240|69523181|FG002|Overall Study|Adverse Event|9|||
38024357|NCT04315298|69707952|FG013|Overall Study|Physician Decision|0|||
38024358|NCT04315298|69707953|FG014|Overall Study|Physician Decision|0|||
38024359|NCT04315298|69707954|FG015|Overall Study|Physician Decision|0|||
37838609|NCT00474240|69523182|FG003|Overall Study|Adverse Event|14|||
38024360|NCT04315298|69707955|FG016|Overall Study|Physician Decision|0|||
37710646|NCT01573624|69189004|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
37710647|NCT01573624|69189005|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
37710648|NCT01573624|69189006|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
37710649|NCT01573624|69189007|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
37710650|NCT01573624|69189008|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
37710651|NCT01573624|69189009|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
37710652|NCT01573624|69189003|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
37710653|NCT01573624|69189004|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
37710654|NCT01573624|69189005|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
37710655|NCT01573624|69189006|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
37710656|NCT01573624|69189007|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
37710657|NCT01573624|69189008|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
37710658|NCT01573624|69189009|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
37710659|NCT01573624|69189003|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
37710660|NCT01573624|69189004|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
37710661|NCT01573624|69189005|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
37710662|NCT01573624|69189006|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
37710663|NCT01573624|69189007|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
37710664|NCT01573624|69189008|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
37710665|NCT01573624|69189009|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
37710666|NCT01573624|69189003|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
37710667|NCT01573624|69189004|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
37710668|NCT01573624|69189005|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
37710669|NCT01573624|69189006|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
37710670|NCT01573624|69189007|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
37710671|NCT01573624|69189008|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
37710672|NCT01573624|69189009|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
37710673|NCT01573624|69189003|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
37710674|NCT01573624|69189004|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
37710675|NCT01573624|69189005|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
37710676|NCT01573624|69189006|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
37710677|NCT01573624|69189007|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
37710678|NCT01573624|69189008|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
37710679|NCT01573624|69189009|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
37710680|NCT01573624|69189003|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
37710681|NCT01573624|69189004|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
37710682|NCT01573624|69189005|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
37710683|NCT01573624|69189006|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
37710684|NCT01573624|69189007|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
37710685|NCT01573624|69189008|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
37710686|NCT01573624|69189009|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
37710687|NCT01573624|69189003|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
37710688|NCT01573624|69189004|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
37710689|NCT01573624|69189005|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
37710690|NCT01573624|69189006|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
37710691|NCT01573624|69189007|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
37710692|NCT01573624|69189008|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
37710693|NCT01573624|69189009|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
37710694|NCT01573624|69189003|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
37710695|NCT01573624|69189004|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
37710696|NCT01573624|69189005|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
37710697|NCT01573624|69189006|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
37710698|NCT01573624|69189007|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
37710699|NCT01573624|69189008|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
37710700|NCT01573624|69189009|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
37710701|NCT01573624|69189003|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
37838610|NCT00474240|69523183|FG004|Overall Study|Adverse Event|5|||
37710702|NCT01573624|69189004|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
37710703|NCT01573624|69189005|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
37710704|NCT01573624|69189006|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
37710705|NCT01573624|69189007|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
37710706|NCT01573624|69189008|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
37710707|NCT01573624|69189009|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
37710708|NCT01573624|69189003|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
37710709|NCT01573624|69189004|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
37710710|NCT01573624|69189005|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
37710711|NCT01573624|69189006|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
37710712|NCT01573624|69189007|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
37710713|NCT01573624|69189008|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
37710714|NCT01573624|69189009|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
37710715|NCT01573624|69189003|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
37710716|NCT01573624|69189004|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
37710717|NCT01573624|69189005|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
37710718|NCT01573624|69189006|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
37710719|NCT01573624|69189007|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
37710720|NCT01573624|69189008|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
37710721|NCT01573624|69189009|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
37710722|NCT01573624|69189003|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
37710723|NCT01573624|69189004|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
37710724|NCT01573624|69189005|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
37710725|NCT01573624|69189006|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
37710726|NCT01573624|69189007|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
37710727|NCT01573624|69189008|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
37710728|NCT01573624|69189009|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
37710729|NCT01573624|69189003|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
37710730|NCT01573624|69189004|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
37710731|NCT01573624|69189005|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
37838611|NCT00474240|69523184|FG005|Overall Study|Adverse Event|16|||
37838612|NCT00474240|69523179|FG000|Overall Study|Removed due to lab value|0|||
37838613|NCT00474240|69523180|FG001|Overall Study|Removed due to lab value|0|||
37838614|NCT00474240|69523181|FG002|Overall Study|Removed due to lab value|0|||
37838615|NCT00474240|69523182|FG003|Overall Study|Removed due to lab value|0|||
37838616|NCT00474240|69523183|FG004|Overall Study|Removed due to lab value|0|||
37838617|NCT00474240|69523184|FG005|Overall Study|Removed due to lab value|1|||
37838618|NCT00473889|69523200|FG000|Overall Study|Did not receive study medication|1|||
37838619|NCT00473889|69523201|FG001|Overall Study|Did not receive study medication|4|||
37838620|NCT00473889|69523200|FG000|Overall Study|Adverse Event|30|||
37838621|NCT00473889|69523201|FG001|Overall Study|Adverse Event|17|||
37838622|NCT00473889|69523200|FG000|Overall Study|Protocol Violation|4|||
37838623|NCT00473889|69523201|FG001|Overall Study|Protocol Violation|2|||
37838624|NCT00473889|69523200|FG000|Overall Study|Lack of Efficacy|28|||
37838625|NCT00473889|69523201|FG001|Overall Study|Lack of Efficacy|29|||
37838626|NCT00473889|69523200|FG000|Overall Study|Lost to Follow-up|2|||
37838627|NCT00473889|69523201|FG001|Overall Study|Lost to Follow-up|1|||
37838628|NCT00473889|69523200|FG000|Overall Study|Physician Decision|10|||
37838629|NCT00473889|69523201|FG001|Overall Study|Physician Decision|5|||
37838630|NCT00473889|69523200|FG000|Overall Study|Trial Terminated|3|||
37838631|NCT00473889|69523201|FG001|Overall Study|Trial Terminated|6|||
37838632|NCT00473889|69523200|FG000|Overall Study|Withdrawal by Subject|5|||
37838633|NCT00473889|69523201|FG001|Overall Study|Withdrawal by Subject|0|||
37838634|NCT00473694|69523211|FG000|Overall Study|Adverse Event|0|||
37838635|NCT00473694|69523212|FG001|Overall Study|Adverse Event|1|||
37838636|NCT00473694|69523213|FG002|Overall Study|Adverse Event|0|||
37838637|NCT00473694|69523214|FG003|Overall Study|Adverse Event|0|||
37838638|NCT00473694|69523211|FG000|Overall Study|Participants did not receive treatment|11|||
37838639|NCT00473694|69523212|FG001|Overall Study|Participants did not receive treatment|3|||
37838640|NCT00473694|69523213|FG002|Overall Study|Participants did not receive treatment|5|||
37838641|NCT00473694|69523214|FG003|Overall Study|Participants did not receive treatment|6|||
37838642|NCT00473694|69523211|FG000|Overall Study|Lost to Follow-up|0|||
37838643|NCT00473694|69523212|FG001|Overall Study|Lost to Follow-up|0|||
37838644|NCT00473694|69523213|FG002|Overall Study|Lost to Follow-up|0|||
37838645|NCT00473694|69523214|FG003|Overall Study|Lost to Follow-up|1|||
37838646|NCT00473655|69523230|FG000|Overall Study|Lost to Follow-up|9|||
37838647|NCT00473655|69523231|FG001|Overall Study|Lost to Follow-up|5|||
37838648|NCT00473655|69523232|FG002|Overall Study|Lost to Follow-up|8|||
37838649|NCT00473382|69523243|FG000|Core Study|Adverse Event|3|||
37838650|NCT00473382|69523244|FG001|Core Study|Adverse Event|1|||
37710732|NCT01573624|69189006|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
37710733|NCT01573624|69189007|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
37710734|NCT01573624|69189008|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
37710735|NCT01573624|69189009|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
37710736|NCT01573624|69189003|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
37710737|NCT01573624|69189004|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
37710738|NCT01573624|69189005|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
37710739|NCT01573624|69189006|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
37710740|NCT01573624|69189007|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
37710741|NCT01573624|69189008|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
37710742|NCT01573624|69189009|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
37710743|NCT01573624|69189003|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
37710744|NCT01573624|69189004|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
37710745|NCT01573624|69189005|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
37710746|NCT01573624|69189006|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
37710747|NCT01573624|69189007|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
37710748|NCT01573624|69189008|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
37710749|NCT01573624|69189009|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
37710750|NCT01573624|69189003|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
37710751|NCT01573624|69189004|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
37710752|NCT01573624|69189005|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
37710753|NCT01573624|69189006|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
37710754|NCT01573624|69189007|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
37710755|NCT01573624|69189008|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
37710756|NCT01573624|69189009|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
37710757|NCT01573624|69189003|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
37710758|NCT01573624|69189004|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
37710759|NCT01573624|69189005|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
37710760|NCT01573624|69189006|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
37710761|NCT01573624|69189007|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
37710762|NCT01573624|69189008|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
37710763|NCT01573624|69189009|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
37710764|NCT01573624|69189003|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
37710765|NCT01573624|69189004|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
37710766|NCT01573624|69189005|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
37710767|NCT01573624|69189006|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
37710768|NCT01573624|69189007|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
37710769|NCT01573624|69189008|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
37710770|NCT01573624|69189009|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
37710771|NCT01573624|69189003|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
37710772|NCT01573624|69189004|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
37710773|NCT01573624|69189005|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
37710774|NCT01573624|69189006|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
37710775|NCT01573624|69189007|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
37710776|NCT01573624|69189008|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
37710777|NCT01573624|69189009|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
37710778|NCT01573624|69189003|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
37710779|NCT01573624|69189004|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
37710780|NCT01573624|69189005|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
37710781|NCT01573624|69189006|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
37710782|NCT01573624|69189007|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
37710783|NCT01573624|69189008|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
37710784|NCT01573624|69189009|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
37710785|NCT01557946|69189033|FG000|Overall Study|Adverse Event|3|||
37710786|NCT01557946|69189034|FG001|Overall Study|Adverse Event|0|||
37710787|NCT01534078|69189039|FG000|Overall Study|Death|1|||
37710788|NCT01534078|69189039|FG000|Overall Study|Withdrawal by Subject|1|||
37710789|NCT02185040|69189048|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
37710790|NCT02185040|69189049|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
37710791|NCT02185040|69189050|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
37710792|NCT02185040|69189051|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
37710793|NCT02185040|69189052|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
37838651|NCT00473382|69523245|FG002|Core Study|Adverse Event|1|||
37838652|NCT00473382|69523243|FG000|Core Study|Death|3|||
37838653|NCT00473382|69523244|FG001|Core Study|Death|5|||
37838654|NCT00473382|69523245|FG002|Core Study|Death|10|||
37710794|NCT02185040|69189053|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
37710795|NCT02185040|69189054|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
37710796|NCT02185040|69189048|FG000|Part 1 Treatment Phase|Adverse Event|1|||
37710797|NCT02185040|69189049|FG001|Part 1 Treatment Phase|Adverse Event|0|||
37710798|NCT02185040|69189050|FG002|Part 1 Treatment Phase|Adverse Event|0|||
37710799|NCT02185040|69189051|FG003|Part 1 Treatment Phase|Adverse Event|2|||
37710800|NCT02185040|69189052|FG004|Part 1 Treatment Phase|Adverse Event|3|||
37710801|NCT02185040|69189053|FG005|Part 1 Treatment Phase|Adverse Event|0|||
37710802|NCT02185040|69189054|FG006|Part 1 Treatment Phase|Adverse Event|0|||
37710803|NCT02185040|69189048|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
37710804|NCT02185040|69189049|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
37710805|NCT02185040|69189050|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
37710806|NCT02185040|69189051|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
37710807|NCT02185040|69189052|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
37710808|NCT02185040|69189053|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
37710809|NCT02185040|69189054|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
37710810|NCT02185040|69189048|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
37710811|NCT02185040|69189049|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
37710812|NCT02185040|69189050|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
37710813|NCT02185040|69189051|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
37710814|NCT02185040|69189052|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
37710815|NCT02185040|69189053|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
37710816|NCT02185040|69189054|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
37710817|NCT02185040|69189048|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
37710818|NCT02185040|69189049|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
37710819|NCT02185040|69189050|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
37710820|NCT02185040|69189051|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
37710821|NCT02185040|69189052|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
37710822|NCT02185040|69189053|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
37710823|NCT02185040|69189054|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
37710824|NCT02185040|69189048|FG000|Active Treatment Extension Phase|Adverse Event|0|||
37710825|NCT02185040|69189049|FG001|Active Treatment Extension Phase|Adverse Event|0|||
37710826|NCT02185040|69189050|FG002|Active Treatment Extension Phase|Adverse Event|0|||
37710827|NCT02185040|69189051|FG003|Active Treatment Extension Phase|Adverse Event|0|||
37710828|NCT02185040|69189052|FG004|Active Treatment Extension Phase|Adverse Event|0|||
37710829|NCT02185040|69189053|FG005|Active Treatment Extension Phase|Adverse Event|1|||
37710830|NCT02185040|69189054|FG006|Active Treatment Extension Phase|Adverse Event|4|||
37710831|NCT02185040|69189048|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
37710832|NCT02185040|69189049|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
37710833|NCT02185040|69189050|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
37710834|NCT02185040|69189051|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
37710835|NCT02185040|69189052|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
37710836|NCT02185040|69189053|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
37710837|NCT02185040|69189054|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
37710838|NCT02185040|69189048|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
37710839|NCT02185040|69189049|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
37710840|NCT02185040|69189050|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
37710841|NCT02185040|69189051|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
37710842|NCT02185040|69189052|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
37710843|NCT02185040|69189053|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
37710844|NCT02185040|69189054|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
37710845|NCT02161406|69189076|FG000|Overall Study|Death|2|||
37710846|NCT02161406|69189077|FG001|Overall Study|Death|1|||
37710847|NCT02161406|69189076|FG000|Overall Study|Lost to Follow-up|2|||
37710848|NCT02161406|69189077|FG001|Overall Study|Lost to Follow-up|1|||
37710849|NCT02161406|69189076|FG000|Overall Study|Withdrawal by Subject|2|||
37710850|NCT02161406|69189077|FG001|Overall Study|Withdrawal by Subject|4|||
37710851|NCT02161406|69189076|FG000|Overall Study|investigator withdrew subject|3|||
37710852|NCT02161406|69189077|FG001|Overall Study|investigator withdrew subject|1|||
37710853|NCT02161406|69189076|FG000|Overall Study|Lack of Efficacy|1|||
37710854|NCT02161406|69189077|FG001|Overall Study|Lack of Efficacy|1|||
37710855|NCT02161406|69189076|FG000|Overall Study|relocation|0|||
37710856|NCT02161406|69189077|FG001|Overall Study|relocation|1|||
37710857|NCT02161016|69189083|FG000|Overall Study|withdrawn by IRB|1|||
37710858|NCT01573000|69189089|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
37838655|NCT00473382|69523243|FG000|Core Study|Lost to Follow-up|3|||
37838656|NCT00473382|69523244|FG001|Core Study|Lost to Follow-up|3|||
37710859|NCT01573000|69189090|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
37710860|NCT01573000|69189089|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
37710861|NCT01573000|69189090|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
37710862|NCT01573000|69189089|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
37710863|NCT01573000|69189090|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
37710864|NCT01573000|69189089|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
37710865|NCT01573000|69189090|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
37710866|NCT01573000|69189089|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
37710867|NCT01573000|69189090|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
37710868|NCT01573000|69189089|FG000|Crossover Phase|Lack of Efficacy|0|||
37710869|NCT01573000|69189090|FG001|Crossover Phase|Lack of Efficacy|13|||
37710870|NCT01573000|69189089|FG000|Crossover Phase|Lost to Follow-up|0|||
37710871|NCT01573000|69189090|FG001|Crossover Phase|Lost to Follow-up|2|||
37710872|NCT01573000|69189089|FG000|Crossover Phase|Death|0|||
37710873|NCT01573000|69189090|FG001|Crossover Phase|Death|3|||
37710874|NCT01573000|69189089|FG000|Long-Term Follow-Up|Death|3|||
37710875|NCT01573000|69189090|FG001|Long-Term Follow-Up|Death|0|||
37710876|NCT01573000|69189089|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
37915397|NCT00711802|69602169|FG004|Overall Study|Lost to Follow-up|10|||
37915398|NCT00711802|69602170|FG005|Overall Study|Lost to Follow-up|6|||
37915399|NCT00711802|69602171|FG006|Overall Study|Lost to Follow-up|4|||
37915400|NCT00711802|69602172|FG007|Overall Study|Lost to Follow-up|2|||
38024361|NCT04315298|69707956|FG017|Overall Study|Physician Decision|0|||
37710877|NCT01573000|69189090|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
37710878|NCT01572922|69189100|FG000|Overall Study|Adverse Event|1|||
37710879|NCT01572922|69189100|FG000|Overall Study|Protocol Violation|1|||
37710880|NCT01572922|69189100|FG000|Overall Study|Death|1|||
37710881|NCT01572844|69189109|FG000|Overall Study|Physician Decision|1|||
37710882|NCT01572844|69189110|FG001|Overall Study|Physician Decision|1|||
37710883|NCT01557400|69189119|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
37710884|NCT01557400|69189119|FG000|Overall Study|Adverse Event|3|||
37710885|NCT01557400|69189119|FG000|Overall Study|Lost to Follow-up|5|||
38024362|NCT04315298|69707957|FG018|Overall Study|Physician Decision|0|||
37710886|NCT01557400|69189119|FG000|Overall Study|Withdrawal by Subject|9|||
37710887|NCT01533922|69189123|FG000|Overall Study|Adverse Event|5|||
37710888|NCT01533922|69189124|FG001|Overall Study|Adverse Event|8|||
37710889|NCT01533922|69189125|FG002|Overall Study|Adverse Event|6|||
37710890|NCT01533922|69189126|FG003|Overall Study|Adverse Event|3|||
37710891|NCT01533922|69189127|FG004|Overall Study|Adverse Event|4|||
37710892|NCT01533922|69189123|FG000|Overall Study|Lack of Efficacy|0|||
37710893|NCT01533922|69189124|FG001|Overall Study|Lack of Efficacy|0|||
37710894|NCT01533922|69189125|FG002|Overall Study|Lack of Efficacy|1|||
37710895|NCT01533922|69189126|FG003|Overall Study|Lack of Efficacy|0|||
37710896|NCT01533922|69189127|FG004|Overall Study|Lack of Efficacy|0|||
37710897|NCT01533922|69189123|FG000|Overall Study|Protocol Violation|0|||
37710898|NCT01533922|69189124|FG001|Overall Study|Protocol Violation|3|||
37710899|NCT01533922|69189125|FG002|Overall Study|Protocol Violation|0|||
37710900|NCT01533922|69189126|FG003|Overall Study|Protocol Violation|0|||
37710901|NCT01533922|69189127|FG004|Overall Study|Protocol Violation|1|||
37710902|NCT01533922|69189123|FG000|Overall Study|Withdrawal by Subject|3|||
37710903|NCT01533922|69189124|FG001|Overall Study|Withdrawal by Subject|1|||
37710904|NCT01533922|69189125|FG002|Overall Study|Withdrawal by Subject|2|||
37710905|NCT01533922|69189126|FG003|Overall Study|Withdrawal by Subject|2|||
37710906|NCT01533922|69189127|FG004|Overall Study|Withdrawal by Subject|1|||
37710907|NCT01533922|69189123|FG000|Overall Study|Other reason not defined above|2|||
37710908|NCT01533922|69189124|FG001|Overall Study|Other reason not defined above|0|||
37710909|NCT01533922|69189125|FG002|Overall Study|Other reason not defined above|1|||
37710910|NCT01533922|69189126|FG003|Overall Study|Other reason not defined above|0|||
37710911|NCT01533922|69189127|FG004|Overall Study|Other reason not defined above|0|||
37710912|NCT01533688|69189142|FG000|Overall Study|Withdrawal by Subject|5|||
37710913|NCT01533688|69189143|FG001|Overall Study|Withdrawal by Subject|4|||
37710914|NCT01533688|69189144|FG002|Overall Study|Withdrawal by Subject|3|||
37710915|NCT01533688|69189142|FG000|Overall Study|Medically unstable|1|||
37710916|NCT01533688|69189143|FG001|Overall Study|Medically unstable|3|||
37915401|NCT00711802|69602165|FG000|Overall Study|Reason not reported|0|||
37915402|NCT00711802|69602166|FG001|Overall Study|Reason not reported|1|||
37915403|NCT00711802|69602167|FG002|Overall Study|Reason not reported|1|||
38024363|NCT04315298|69707939|FG000|Overall Study|Lost to Follow-up|5|||
37710917|NCT01533688|69189144|FG002|Overall Study|Medically unstable|3|||
37710918|NCT01533688|69189142|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
37710919|NCT01533688|69189143|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
37710920|NCT01533688|69189144|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
37710921|NCT01532986|69189156|FG000|Overall Study|Death|9|||
37710922|NCT01532986|69189157|FG001|Overall Study|Death|9|||
37915404|NCT00711802|69602168|FG003|Overall Study|Reason not reported|0|||
37915405|NCT00711802|69602169|FG004|Overall Study|Reason not reported|1|||
38024364|NCT04315298|69707940|FG001|Overall Study|Lost to Follow-up|10|||
37710923|NCT01532986|69189156|FG000|Overall Study|Withdrawal by Subject|7|||
37710924|NCT01532986|69189157|FG001|Overall Study|Withdrawal by Subject|10|||
37710925|NCT01532986|69189156|FG000|Overall Study|Physician Decision|7|||
37710926|NCT01532986|69189157|FG001|Overall Study|Physician Decision|5|||
37710927|NCT01532908|69189166|FG000|Overall Study|Not Transplanted|1|||
37710928|NCT01532908|69189167|FG001|Overall Study|Not Transplanted|0|||
37710929|NCT02160782|69189173|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
37710930|NCT02160782|69189174|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
37710931|NCT02160782|69189175|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
37710932|NCT02160782|69189176|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
37710933|NCT02160782|69189177|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
37710934|NCT02160782|69189173|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
37710935|NCT02160782|69189174|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
37710936|NCT02160782|69189175|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
37710937|NCT02160782|69189176|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
37710938|NCT02160782|69189177|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
37710939|NCT02160782|69189173|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
37710940|NCT02160782|69189174|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
37710941|NCT02160782|69189175|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
37710942|NCT02160782|69189176|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
37710943|NCT02160782|69189177|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
37710944|NCT02160782|69189173|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
37710945|NCT02160782|69189174|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
37710946|NCT02160782|69189175|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
37710947|NCT02160782|69189176|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
37710948|NCT02160782|69189177|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
37710949|NCT02160782|69189173|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
37710950|NCT02160782|69189174|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
37710951|NCT02160782|69189175|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
37710952|NCT02160782|69189176|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
37710953|NCT02160782|69189177|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
37710954|NCT02160782|69189173|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
37710955|NCT02160782|69189174|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
37710956|NCT02160782|69189175|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
37710957|NCT02160782|69189176|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
37710958|NCT02160782|69189177|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
37710959|NCT02160782|69189173|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
37710960|NCT02160782|69189174|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
37710961|NCT02160782|69189175|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
37710962|NCT02160782|69189176|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
37710963|NCT02160782|69189177|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
37710964|NCT02160626|69189204|FG000|Overall Study|Adverse Event|1|||
37710965|NCT02160626|69189205|FG001|Overall Study|Adverse Event|0|||
37710966|NCT02160626|69189206|FG002|Overall Study|Adverse Event|0|||
37710967|NCT02160626|69189204|FG000|Overall Study|Schedule not conducive to study visits|0|||
37710968|NCT02160626|69189205|FG001|Overall Study|Schedule not conducive to study visits|0|||
37710969|NCT02160626|69189206|FG002|Overall Study|Schedule not conducive to study visits|1|||
37710970|NCT02160626|69189204|FG000|Overall Study|Withdrawal by Subject|0|||
37710971|NCT02160626|69189205|FG001|Overall Study|Withdrawal by Subject|1|||
37710972|NCT02160626|69189206|FG002|Overall Study|Withdrawal by Subject|0|||
37710973|NCT02160314|69189218|FG000|Overall Study|Adverse Event|0|||
37710974|NCT02160314|69189219|FG001|Overall Study|Adverse Event|6|||
37710975|NCT02160314|69189218|FG000|Overall Study|Protocol Violation|0|||
37710976|NCT02160314|69189219|FG001|Overall Study|Protocol Violation|4|||
37710977|NCT02160314|69189218|FG000|Overall Study|Withdrawal by Subject|1|||
37710978|NCT02160314|69189219|FG001|Overall Study|Withdrawal by Subject|2|||
37710979|NCT02160314|69189218|FG000|Overall Study|Lost to Follow-up|0|||
37710980|NCT02160314|69189219|FG001|Overall Study|Lost to Follow-up|1|||
37710981|NCT02160002|69189227|FG000|Overall Study|Withdrawal by Subject|2|||
37710982|NCT02160002|69189228|FG001|Overall Study|Withdrawal by Subject|1|||
37710983|NCT02218268|69189234|FG000|24 Hour Washout|Physician Decision|11|||
37710984|NCT02218268|69189235|FG001|24 Hour Washout|Physician Decision|9|||
37710985|NCT02217878|69189243|FG000|Overall Study|required morphine due to chest pain|1|||
37710986|NCT02217878|69189244|FG001|Overall Study|required morphine due to chest pain|2|||
37710987|NCT02217878|69189243|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
37710988|NCT02217878|69189244|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
37710989|NCT02217566|69189250|FG000|Overall Study|Lost to Follow-up|2|||
37710990|NCT02217566|69189250|FG000|Overall Study|Death|3|||
37710991|NCT02217566|69189250|FG000|Overall Study|Early study termination|6|||
37710992|NCT02217410|69189257|FG000|Overall Study|Graft Loss|0|||
37710993|NCT02217410|69189258|FG001|Overall Study|Graft Loss|0|||
37710994|NCT02217410|69189259|FG002|Overall Study|Graft Loss|2|||
37710995|NCT02217410|69189257|FG000|Overall Study|Withdrawal by Subject|0|||
37710996|NCT02217410|69189258|FG001|Overall Study|Withdrawal by Subject|0|||
37710997|NCT02217410|69189259|FG002|Overall Study|Withdrawal by Subject|2|||
37710998|NCT02217410|69189257|FG000|Overall Study|Lost to Follow-up|0|||
37710999|NCT02217410|69189258|FG001|Overall Study|Lost to Follow-up|0|||
37711000|NCT02217410|69189259|FG002|Overall Study|Lost to Follow-up|1|||
37711001|NCT02217410|69189257|FG000|Overall Study|Lack of Efficacy|0|||
37711002|NCT02217410|69189258|FG001|Overall Study|Lack of Efficacy|1|||
37711003|NCT02217410|69189259|FG002|Overall Study|Lack of Efficacy|0|||
37711004|NCT02217410|69189257|FG000|Overall Study|Physician Decision|1|||
37711005|NCT02217410|69189258|FG001|Overall Study|Physician Decision|3|||
37711006|NCT02217410|69189259|FG002|Overall Study|Physician Decision|0|||
37711007|NCT02217332|69189272|FG000|Overall Study|Adverse Event|3|||
37711008|NCT02217332|69189272|FG000|Overall Study|Dose interruption >1 month|1|||
37711009|NCT02217332|69189272|FG000|Overall Study|Protocol Violation (eligibility)|1|||
37711010|NCT02217332|69189272|FG000|Overall Study|Withdrawal by Subject|1|||
37711011|NCT02217332|69189272|FG000|Overall Study|Lost to Follow-up|1|||
37711012|NCT02184572|69189278|FG000|Overall Study|Lost to Follow-up|29|||
37711013|NCT02184572|69189279|FG001|Overall Study|Lost to Follow-up|21|||
37711014|NCT02184572|69189278|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
37711015|NCT02184572|69189279|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
37711016|NCT02184572|69189278|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
37711017|NCT02184572|69189279|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
37711018|NCT02184572|69189278|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
37711019|NCT02184572|69189279|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
37711020|NCT02184572|69189278|FG000|Overall Study|Traveling Outside The Country|1|||
37711021|NCT02184572|69189279|FG001|Overall Study|Traveling Outside The Country|0|||
37711022|NCT02184572|69189278|FG000|Overall Study|Withdrawal by Subject|14|||
37711023|NCT02184572|69189279|FG001|Overall Study|Withdrawal by Subject|9|||
37711024|NCT02181842|69189287|FG000|Overall Study|Case Report Forms Uncollected|2|||
37711025|NCT01632020|69189293|FG000|Overall Study|Withdrawal by Subject|1|||
37711026|NCT01632020|69189294|FG001|Overall Study|Withdrawal by Subject|0|||
37711027|NCT01632020|69189293|FG000|Overall Study|Adverse Event|1|||
37711028|NCT01632020|69189294|FG001|Overall Study|Adverse Event|0|||
37711029|NCT02181296|69189302|FG000|Overall Study|Lost to Follow-up|7|||
37711030|NCT02181296|69189303|FG001|Overall Study|Lost to Follow-up|6|||
37711031|NCT02215616|69189313|FG000|Overall Study|Sponsor requested to stop study drug|0|||
38024365|NCT04315298|69707941|FG002|Overall Study|Lost to Follow-up|6|||
38024366|NCT04315298|69707942|FG003|Overall Study|Lost to Follow-up|8|||
38024367|NCT04315298|69707943|FG004|Overall Study|Lost to Follow-up|12|||
38024368|NCT04315298|69707944|FG005|Overall Study|Lost to Follow-up|13|||
38024369|NCT04315298|69707945|FG006|Overall Study|Lost to Follow-up|9|||
38024370|NCT04315298|69707946|FG007|Overall Study|Lost to Follow-up|16|||
38024371|NCT04315298|69707947|FG008|Overall Study|Lost to Follow-up|14|||
38024372|NCT04315298|69707948|FG009|Overall Study|Lost to Follow-up|0|||
38024373|NCT04315298|69707949|FG010|Overall Study|Lost to Follow-up|2|||
38024374|NCT04315298|69707950|FG011|Overall Study|Lost to Follow-up|1|||
38024375|NCT04315298|69707951|FG012|Overall Study|Lost to Follow-up|0|||
38024376|NCT04315298|69707952|FG013|Overall Study|Lost to Follow-up|0|||
38024377|NCT04315298|69707953|FG014|Overall Study|Lost to Follow-up|0|||
38024378|NCT04315298|69707954|FG015|Overall Study|Lost to Follow-up|2|||
37711032|NCT02215616|69189314|FG001|Overall Study|Sponsor requested to stop study drug|0|||
37711033|NCT02215616|69189315|FG002|Overall Study|Sponsor requested to stop study drug|1|||
37711034|NCT02215616|69189316|FG003|Overall Study|Sponsor requested to stop study drug|4|||
37711035|NCT02215616|69189313|FG000|Overall Study|Death|1|||
38024379|NCT04315298|69707955|FG016|Overall Study|Lost to Follow-up|0|||
38024380|NCT04315298|69707956|FG017|Overall Study|Lost to Follow-up|0|||
38024381|NCT04315298|69707957|FG018|Overall Study|Lost to Follow-up|0|||
38024382|NCT04315298|69707939|FG000|Overall Study|Death|24|||
38024383|NCT04315298|69707940|FG001|Overall Study|Death|60|||
37711036|NCT02215616|69189314|FG001|Overall Study|Death|0|||
38024384|NCT04315298|69707941|FG002|Overall Study|Death|49|||
37711037|NCT02215616|69189315|FG002|Overall Study|Death|0|||
37711038|NCT02215616|69189316|FG003|Overall Study|Death|0|||
37711039|NCT02215616|69189313|FG000|Overall Study|Adverse Event|7|||
37711040|NCT02215616|69189314|FG001|Overall Study|Adverse Event|4|||
37711041|NCT02215616|69189315|FG002|Overall Study|Adverse Event|9|||
37711042|NCT02215616|69189316|FG003|Overall Study|Adverse Event|2|||
37711043|NCT02215616|69189313|FG000|Overall Study|Withdrawal by Subject|1|||
37711044|NCT02215616|69189314|FG001|Overall Study|Withdrawal by Subject|8|||
37711045|NCT02215616|69189315|FG002|Overall Study|Withdrawal by Subject|2|||
37711046|NCT02215616|69189316|FG003|Overall Study|Withdrawal by Subject|5|||
37711047|NCT02215616|69189313|FG000|Overall Study|Non-compliance|0|||
37711048|NCT02215616|69189314|FG001|Overall Study|Non-compliance|2|||
37711049|NCT02215616|69189315|FG002|Overall Study|Non-compliance|1|||
37711050|NCT02215616|69189316|FG003|Overall Study|Non-compliance|0|||
37711051|NCT02215616|69189313|FG000|Overall Study|Protocol Violation|0|||
37711052|NCT02215616|69189314|FG001|Overall Study|Protocol Violation|2|||
37711053|NCT02215616|69189315|FG002|Overall Study|Protocol Violation|0|||
37711054|NCT02215616|69189316|FG003|Overall Study|Protocol Violation|0|||
37711055|NCT02215616|69189313|FG000|Overall Study|Lost to Follow-up|1|||
37711056|NCT02215616|69189314|FG001|Overall Study|Lost to Follow-up|1|||
37711057|NCT02215616|69189315|FG002|Overall Study|Lost to Follow-up|0|||
37711058|NCT02215616|69189316|FG003|Overall Study|Lost to Follow-up|1|||
37711059|NCT02215616|69189313|FG000|Overall Study|Other than specified|1|||
37711060|NCT02215616|69189314|FG001|Overall Study|Other than specified|0|||
37711061|NCT02215616|69189315|FG002|Overall Study|Other than specified|1|||
37711062|NCT02215616|69189316|FG003|Overall Study|Other than specified|1|||
37711063|NCT02213666|69189326|FG000|Overall Study|Withdrawal by Subject|1|||
37711064|NCT02213510|69189332|FG000|Overall Study|Death|0|||
37711065|NCT02213510|69189333|FG001|Overall Study|Death|1|||
37711066|NCT02213510|69189332|FG000|Overall Study|Lost to Follow-up|1|||
37711067|NCT02213510|69189333|FG001|Overall Study|Lost to Follow-up|0|||
37711068|NCT02158442|69189341|FG000|Overall Study|Withdrawal by Subject|1|||
37711069|NCT02158442|69189342|FG001|Overall Study|Withdrawal by Subject|0|||
37711070|NCT02158442|69189341|FG000|Overall Study|Perfusion staff not available|1|||
37711071|NCT02158442|69189342|FG001|Overall Study|Perfusion staff not available|0|||
37711072|NCT02158364|69189348|FG000|Overall Study|Case report forms uncollected|10|||
37711073|NCT02158364|69189348|FG000|Overall Study|Protocol Deviation|50|||
37711074|NCT02180672|69189354|FG000|Overall Study|Lost to Follow-up|5|||
37711075|NCT02180672|69189355|FG001|Overall Study|Lost to Follow-up|7|||
37711076|NCT02213198|69189363|FG000|Baseline|No show for intake|7|||
37711077|NCT02213198|69189364|FG001|Baseline|No show for intake|9|||
37711078|NCT02213198|69189363|FG000|Baseline|Withdrawal by Subject|34|||
37711079|NCT02213198|69189364|FG001|Baseline|Withdrawal by Subject|11|||
37711080|NCT02213198|69189363|FG000|Baseline|transferred out of clinic|7|||
37711081|NCT02213198|69189364|FG001|Baseline|transferred out of clinic|9|||
37711082|NCT02213198|69189363|FG000|Baseline|Lost to Follow-up|40|||
37711083|NCT02213198|69189364|FG001|Baseline|Lost to Follow-up|21|||
37711084|NCT02213198|69189363|FG000|Baseline|incarcerated,violent|0|||
37711085|NCT02213198|69189364|FG001|Baseline|incarcerated,violent|1|||
37711086|NCT02213198|69189363|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
37711087|NCT02213198|69189364|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
37711088|NCT02213198|69189363|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
37711089|NCT02213198|69189364|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
37711090|NCT02213198|69189363|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
37711091|NCT02213198|69189364|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
37711092|NCT02213198|69189363|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
37711093|NCT02213198|69189364|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
37711094|NCT02213198|69189363|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
37711095|NCT02213198|69189364|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
37711096|NCT02213198|69189363|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
37711097|NCT02213198|69189364|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
37711098|NCT02157506|69189375|FG000|Overall Study|Adverse Event|0|||
37711099|NCT02157506|69189376|FG001|Overall Study|Adverse Event|1|||
37711100|NCT02157506|69189377|FG002|Overall Study|Adverse Event|0|||
37711101|NCT02157506|69189378|FG003|Overall Study|Adverse Event|0|||
37711102|NCT02157506|69189379|FG004|Overall Study|Adverse Event|0|||
37711103|NCT02157506|69189375|FG000|Overall Study|Lost to Follow-up|0|||
37711104|NCT02157506|69189376|FG001|Overall Study|Lost to Follow-up|0|||
37711105|NCT02157506|69189377|FG002|Overall Study|Lost to Follow-up|1|||
37711106|NCT02157506|69189378|FG003|Overall Study|Lost to Follow-up|0|||
37711107|NCT02157506|69189379|FG004|Overall Study|Lost to Follow-up|0|||
37711108|NCT01920711|69189393|FG000|Overall Study|Death|347|||
37711109|NCT01920711|69189394|FG001|Overall Study|Death|356|||
37711110|NCT01920711|69189393|FG000|Overall Study|Lost to Follow-up|13|||
37711111|NCT01920711|69189394|FG001|Overall Study|Lost to Follow-up|14|||
37711112|NCT01920711|69189393|FG000|Overall Study|Withdrawal by Subject|4|||
37711113|NCT01920711|69189394|FG001|Overall Study|Withdrawal by Subject|3|||
37711114|NCT02180438|69189401|FG000|Overall Study|Lost to Follow-up|1|||
37711115|NCT02179190|69189405|FG000|Enrollment|Exit Prior to Device Attempt|11|||
37711116|NCT02179190|69189405|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
37711117|NCT02179190|69189405|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
37711118|NCT02179190|69189405|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
37711119|NCT02179190|69189405|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
37711120|NCT02179190|69189405|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
37711121|NCT02157116|69189409|FG000|Overall Study|Withdrawal by Subject|4|||
37711122|NCT02157116|69189409|FG000|Overall Study|Physician Decision|3|||
37711123|NCT02157116|69189409|FG000|Overall Study|Failed Screening|2|||
37711124|NCT01920555|69189418|FG000|Overall Study|Physician Decision|1|||
37711125|NCT01920555|69189419|FG001|Overall Study|Physician Decision|2|||
37711126|NCT01920555|69189420|FG002|Overall Study|Physician Decision|1|||
37711127|NCT01920555|69189421|FG003|Overall Study|Physician Decision|2|||
37711128|NCT01920555|69189422|FG004|Overall Study|Physician Decision|0|||
37711129|NCT01920555|69189418|FG000|Overall Study|Lack of Efficacy|2|||
37711130|NCT01920555|69189419|FG001|Overall Study|Lack of Efficacy|0|||
37711131|NCT01920555|69189420|FG002|Overall Study|Lack of Efficacy|0|||
37711132|NCT01920555|69189421|FG003|Overall Study|Lack of Efficacy|0|||
37711133|NCT01920555|69189422|FG004|Overall Study|Lack of Efficacy|0|||
37711134|NCT01920555|69189418|FG000|Overall Study|Travel Difficulties|1|||
37711135|NCT01920555|69189419|FG001|Overall Study|Travel Difficulties|1|||
37711136|NCT01920555|69189420|FG002|Overall Study|Travel Difficulties|0|||
37711137|NCT01920555|69189421|FG003|Overall Study|Travel Difficulties|0|||
37711138|NCT01920555|69189422|FG004|Overall Study|Travel Difficulties|1|||
37711139|NCT01920555|69189418|FG000|Overall Study|Lost to Follow-up|0|||
37711140|NCT01920555|69189419|FG001|Overall Study|Lost to Follow-up|1|||
37711141|NCT01920555|69189420|FG002|Overall Study|Lost to Follow-up|0|||
37711142|NCT01920555|69189421|FG003|Overall Study|Lost to Follow-up|1|||
37711143|NCT01920555|69189422|FG004|Overall Study|Lost to Follow-up|0|||
37711144|NCT02156804|69189434|FG000|Overall Study|Withdrawal by Subject|1|||
37711145|NCT02156492|69189441|FG000|Period 1|No Reason Given|0|||
37711146|NCT02156492|69189442|FG001|Period 1|No Reason Given|1|||
37711147|NCT02156492|69189443|FG002|Period 1|No Reason Given|0|||
37711148|NCT02156492|69189441|FG000|Period 3|Adverse Event|0|||
37711149|NCT02156492|69189442|FG001|Period 3|Adverse Event|1|||
37711150|NCT02156492|69189443|FG002|Period 3|Adverse Event|0|||
37711151|NCT01920477|69189463|FG000|Overall Study|Adverse Event|0|||
37711152|NCT01920477|69189464|FG001|Overall Study|Adverse Event|1|||
37711153|NCT01920477|69189463|FG000|Overall Study|Lack of Efficacy|1|||
37711154|NCT01920477|69189464|FG001|Overall Study|Lack of Efficacy|0|||
37711155|NCT01920477|69189463|FG000|Overall Study|Study closed/terminated|14|||
37711156|NCT01920477|69189464|FG001|Overall Study|Study closed/terminated|15|||
37711157|NCT01920477|69189463|FG000|Overall Study|Withdrawal by Subject|0|||
37711158|NCT01920477|69189464|FG001|Overall Study|Withdrawal by Subject|1|||
37711159|NCT02213042|69189473|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
37711160|NCT02213042|69189474|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
37711161|NCT02213042|69189475|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
37711162|NCT02213042|69189473|FG000|Overall Study|Adverse Event|2|||
37711163|NCT02213042|69189474|FG001|Overall Study|Adverse Event|1|||
37711164|NCT02213042|69189475|FG002|Overall Study|Adverse Event|0|||
37711165|NCT02213042|69189473|FG000|Overall Study|Withdrawal by Subject|0|||
37711166|NCT02213042|69189474|FG001|Overall Study|Withdrawal by Subject|1|||
37711167|NCT02213042|69189475|FG002|Overall Study|Withdrawal by Subject|1|||
37711168|NCT02213042|69189473|FG000|Overall Study|Protocol Violation|1|||
37711169|NCT02213042|69189474|FG001|Overall Study|Protocol Violation|0|||
37711170|NCT02213042|69189475|FG002|Overall Study|Protocol Violation|0|||
37915406|NCT00711802|69602170|FG005|Overall Study|Reason not reported|0|||
37711171|NCT02213042|69189473|FG000|Overall Study|Investigator discretion|0|||
37711172|NCT02213042|69189474|FG001|Overall Study|Investigator discretion|0|||
37711173|NCT02213042|69189475|FG002|Overall Study|Investigator discretion|1|||
37711174|NCT02212730|69189487|FG000|Overall Study|Tumor not of the required cell histology|1|||
37711175|NCT02212730|69189488|FG001|Overall Study|Tumor not of the required cell histology|0|||
37711176|NCT02212730|69189487|FG000|Overall Study|Withdrawal by Subject|1|||
37711177|NCT02212730|69189488|FG001|Overall Study|Withdrawal by Subject|0|||
37711178|NCT02212730|69189487|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
37915407|NCT00711802|69602171|FG006|Overall Study|Reason not reported|1|||
37915408|NCT00711802|69602172|FG007|Overall Study|Reason not reported|0|||
37711179|NCT02212730|69189488|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
37711180|NCT02178956|69189498|FG000|Overall Study|Lost to Follow-up|4|||
37711181|NCT02178956|69189499|FG001|Overall Study|Lost to Follow-up|4|||
37711182|NCT02178956|69189498|FG000|Overall Study|Sponsor terminated study|49|||
37711183|NCT02178956|69189499|FG001|Overall Study|Sponsor terminated study|58|||
37711184|NCT02178956|69189498|FG000|Overall Study|Withdrawal by Subject|15|||
37711185|NCT02178956|69189499|FG001|Overall Study|Withdrawal by Subject|11|||
37711186|NCT02178956|69189498|FG000|Overall Study|Various Reasons|3|||
37711187|NCT02178956|69189499|FG001|Overall Study|Various Reasons|5|||
37711188|NCT02211638|69189509|FG000|Overall Study|Case Report Forms Uncollected|291|||
37711189|NCT02211638|69189509|FG000|Overall Study|Protocol Violation|692|||
37711190|NCT02178566|69189515|FG000|Overall Study|patient did not complete due to noncompliance|0|||
37711191|NCT02178566|69189516|FG001|Overall Study|patient did not complete due to noncompliance|1|||
37711192|NCT02211014|69189524|FG000|Overall Study|Adverse Event|0|||
37711193|NCT02211014|69189525|FG001|Overall Study|Adverse Event|2|||
37711194|NCT02211014|69189524|FG000|Overall Study|Physician Decision|1|||
37711195|NCT02211014|69189525|FG001|Overall Study|Physician Decision|2|||
37711196|NCT02211014|69189524|FG000|Overall Study|Started another cancer therapy|1|||
37711197|NCT02211014|69189525|FG001|Overall Study|Started another cancer therapy|0|||
37711198|NCT02211014|69189524|FG000|Overall Study|Withdrawal by Subject|0|||
37711199|NCT02211014|69189525|FG001|Overall Study|Withdrawal by Subject|1|||
37711200|NCT02211014|69189524|FG000|Overall Study|In agreement with patient, no benefit|0|||
37711201|NCT02211014|69189525|FG001|Overall Study|In agreement with patient, no benefit|1|||
37711202|NCT01631864|69189549|FG000|Overall Study|Withdrawal by Subject|0|||
37711203|NCT01631864|69189550|FG001|Overall Study|Withdrawal by Subject|1|||
37711204|NCT01631864|69189549|FG000|Overall Study|Adverse Event|2|||
37711205|NCT01631864|69189550|FG001|Overall Study|Adverse Event|3|||
37711206|NCT02210780|69189558|FG000|Overall Study|Adverse Event|0|||
37711207|NCT02210780|69189559|FG001|Overall Study|Adverse Event|5|||
37711208|NCT02210780|69189558|FG000|Overall Study|Lost to Follow-up|2|||
37711209|NCT02210780|69189559|FG001|Overall Study|Lost to Follow-up|1|||
37711210|NCT02210780|69189558|FG000|Overall Study|Withdrawal by Subject|1|||
37711211|NCT02210780|69189559|FG001|Overall Study|Withdrawal by Subject|1|||
37711212|NCT02210780|69189558|FG000|Overall Study|Physician Decision|1|||
37711213|NCT02210780|69189559|FG001|Overall Study|Physician Decision|0|||
37711214|NCT02210780|69189558|FG000|Overall Study|Protocol Violation|1|||
37711215|NCT02210780|69189559|FG001|Overall Study|Protocol Violation|0|||
37711216|NCT02210780|69189558|FG000|Overall Study|Other than specified above|0|||
37711217|NCT02210780|69189559|FG001|Overall Study|Other than specified above|1|||
37711218|NCT01557244|69189570|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
37711219|NCT01557244|69189571|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
37711220|NCT01557244|69189572|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
37711221|NCT01557244|69189573|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
37711222|NCT01557244|69189574|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
37711223|NCT01557244|69189575|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
37711224|NCT01557244|69189576|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
37711225|NCT01557244|69189570|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
37711226|NCT01557244|69189571|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
37711227|NCT01557244|69189572|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
37711228|NCT01557244|69189573|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
37711229|NCT01557244|69189574|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
37711230|NCT01557244|69189575|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
37711231|NCT01557244|69189576|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
37711232|NCT01557244|69189570|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
37711233|NCT01557244|69189571|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
37711234|NCT01557244|69189572|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
37711235|NCT01557244|69189573|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
37711236|NCT01557244|69189574|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
37711237|NCT01557244|69189575|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
37711238|NCT01557244|69189576|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
37711239|NCT01557244|69189570|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
37711240|NCT01557244|69189571|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
37838657|NCT00473382|69523245|FG002|Core Study|Lost to Follow-up|3|||
37711241|NCT01557244|69189572|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
37711242|NCT01557244|69189573|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
37711243|NCT01557244|69189574|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
37838658|NCT00473382|69523243|FG000|Core Study|Physician Decision|1|||
37838659|NCT00473382|69523244|FG001|Core Study|Physician Decision|2|||
37711244|NCT01557244|69189575|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
37711245|NCT01557244|69189576|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
37711246|NCT01557244|69189570|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
37711247|NCT01557244|69189571|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
37711248|NCT01557244|69189572|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
37711249|NCT01557244|69189573|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
37711250|NCT01557244|69189574|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
37711251|NCT01557244|69189575|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
37711252|NCT01557244|69189576|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
37711253|NCT01557244|69189570|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
37711254|NCT01557244|69189571|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
37711255|NCT01557244|69189572|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
37711256|NCT01557244|69189573|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
37711257|NCT01557244|69189574|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
37711258|NCT01557244|69189575|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
37711259|NCT01557244|69189576|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
37711260|NCT01557244|69189570|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
37711261|NCT01557244|69189571|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
37711262|NCT01557244|69189572|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
37711263|NCT01557244|69189573|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
37711264|NCT01557244|69189574|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
37711265|NCT01557244|69189575|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
37711266|NCT01557244|69189576|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
37711267|NCT01557244|69189570|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
37711268|NCT01557244|69189571|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
37711269|NCT01557244|69189572|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
37711270|NCT01557244|69189573|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
37838660|NCT00473382|69523245|FG002|Core Study|Physician Decision|2|||
37838661|NCT00473382|69523243|FG000|Core Study|Subject non-compliance|5|||
37838662|NCT00473382|69523244|FG001|Core Study|Subject non-compliance|2|||
37838663|NCT00473382|69523245|FG002|Core Study|Subject non-compliance|1|||
37838664|NCT00473382|69523243|FG000|Core Study|Subject needed other treatment|1|||
38024385|NCT04315298|69707942|FG003|Overall Study|Death|59|||
38024386|NCT04315298|69707943|FG004|Overall Study|Death|70|||
37838665|NCT00473382|69523244|FG001|Core Study|Subject needed other treatment|3|||
37838666|NCT00473382|69523245|FG002|Core Study|Subject needed other treatment|2|||
37838667|NCT00473382|69523243|FG000|Core Study|Subject's decision|12|||
38024387|NCT04315298|69707944|FG005|Overall Study|Death|114|||
37711271|NCT01557244|69189574|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
37711272|NCT01557244|69189575|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
37711273|NCT01557244|69189576|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
37711274|NCT01557244|69189570|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
37711275|NCT01557244|69189571|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
37711276|NCT01557244|69189572|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
37711277|NCT01557244|69189573|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
37711278|NCT01557244|69189574|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
37711279|NCT01557244|69189575|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
37711280|NCT01557244|69189576|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
37711281|NCT01557244|69189570|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
37711282|NCT01557244|69189571|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
37711283|NCT01557244|69189572|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
37711284|NCT01557244|69189573|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
37711285|NCT01557244|69189574|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
37711286|NCT01557244|69189575|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
37711287|NCT01557244|69189576|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
37711288|NCT01557244|69189570|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
37711289|NCT01557244|69189571|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
37711290|NCT01557244|69189572|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
37711291|NCT01557244|69189573|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
37711292|NCT01557244|69189574|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
37711293|NCT01557244|69189575|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
37711294|NCT01557244|69189576|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
37711295|NCT01557244|69189570|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
37711296|NCT01557244|69189571|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
37711297|NCT01557244|69189572|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
37711298|NCT01557244|69189573|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
37711299|NCT01557244|69189574|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
37711300|NCT01557244|69189575|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
37711301|NCT01557244|69189576|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
37711302|NCT02177942|69189606|FG000|Overall Study|Adverse Event|1|||
37711303|NCT02177942|69189607|FG001|Overall Study|Adverse Event|0|||
37711304|NCT02177942|69189606|FG000|Overall Study|Lost to Follow-up|1|||
37711305|NCT02177942|69189607|FG001|Overall Study|Lost to Follow-up|1|||
37711306|NCT02177942|69189606|FG000|Overall Study|Protocol Violation|4|||
37711307|NCT02177942|69189607|FG001|Overall Study|Protocol Violation|6|||
37711308|NCT02177942|69189606|FG000|Overall Study|Withdrawal by Subject|71|||
37711309|NCT02177942|69189607|FG001|Overall Study|Withdrawal by Subject|81|||
37711310|NCT02155322|69189617|FG000|Overall Study|Adverse Event|1|||
37711311|NCT02155322|69189617|FG000|Overall Study|Physician Decision|1|||
37711312|NCT02155322|69189617|FG000|Overall Study|Relapse/Recurrence|8|||
37711313|NCT02155322|69189617|FG000|Overall Study|Withdrawal by Subject|4|||
37711314|NCT02210000|69189623|FG000|Overall Study|Study Terminated|11|||
37711315|NCT02210000|69189624|FG001|Overall Study|Study Terminated|12|||
37711316|NCT02210000|69189623|FG000|Overall Study|Withdrawal by Subject|7|||
37711317|NCT02210000|69189624|FG001|Overall Study|Withdrawal by Subject|1|||
37711318|NCT02210000|69189623|FG000|Overall Study|Adverse Event|1|||
37711319|NCT02210000|69189624|FG001|Overall Study|Adverse Event|5|||
37711320|NCT02210000|69189623|FG000|Overall Study|Lost to Follow-up|0|||
37711321|NCT02210000|69189624|FG001|Overall Study|Lost to Follow-up|2|||
37711322|NCT02210000|69189623|FG000|Overall Study|Physician Decision|0|||
37711323|NCT02210000|69189624|FG001|Overall Study|Physician Decision|1|||
37711324|NCT01531894|69189630|FG000|Overall Study|Physician Decision|8|||
37711325|NCT01531894|69189630|FG000|Overall Study|Death|1|||
37711326|NCT02209766|69189638|FG000|Overall Study|Withdrawal by Subject|0|||
37711327|NCT02209766|69189639|FG001|Overall Study|Withdrawal by Subject|0|||
37711328|NCT02209766|69189640|FG002|Overall Study|Withdrawal by Subject|0|||
37711329|NCT02209766|69189641|FG003|Overall Study|Withdrawal by Subject|1|||
37838668|NCT00473382|69523244|FG001|Core Study|Subject's decision|11|||
37711330|NCT02209766|69189642|FG004|Overall Study|Withdrawal by Subject|0|||
37711331|NCT02209454|69189652|FG000|Second Period|Adverse Event|1|||
37711332|NCT02209454|69189653|FG001|Second Period|Adverse Event|0|||
37711333|NCT01571596|69189662|FG000|Overall Study|Adverse Event|2|||
37711334|NCT01571596|69189663|FG001|Overall Study|Adverse Event|0|||
37711335|NCT01571596|69189664|FG002|Overall Study|Adverse Event|0|||
37711336|NCT01571596|69189662|FG000|Overall Study|Study Terminated by the Sponsor|0|||
37711337|NCT01571596|69189663|FG001|Overall Study|Study Terminated by the Sponsor|1|||
37711338|NCT01571596|69189664|FG002|Overall Study|Study Terminated by the Sponsor|1|||
37711339|NCT01557166|69189676|FG000|Overall Study|Adverse Event|20|||
37711340|NCT01557166|69189677|FG001|Overall Study|Adverse Event|6|||
37711341|NCT01557166|69189676|FG000|Overall Study|Lack of Efficacy|2|||
37711342|NCT01557166|69189677|FG001|Overall Study|Lack of Efficacy|1|||
37711343|NCT01557166|69189676|FG000|Overall Study|Protocol Violation|8|||
37711344|NCT01557166|69189677|FG001|Overall Study|Protocol Violation|5|||
37711345|NCT01557166|69189676|FG000|Overall Study|Withdrawn consent|12|||
37711346|NCT01557166|69189677|FG001|Overall Study|Withdrawn consent|20|||
37711347|NCT01557166|69189676|FG000|Overall Study|Target dose not tolerated|1|||
37711348|NCT01557166|69189677|FG001|Overall Study|Target dose not tolerated|0|||
37711349|NCT01557166|69189676|FG000|Overall Study|Psychiatric disorder|1|||
37711350|NCT01557166|69189677|FG001|Overall Study|Psychiatric disorder|0|||
37711351|NCT01557166|69189676|FG000|Overall Study|Unclassified|2|||
37711352|NCT01557166|69189677|FG001|Overall Study|Unclassified|5|||
37711353|NCT01556932|69189683|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
37711354|NCT01556932|69189684|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
37711355|NCT02177786|69189693|FG000|Overall Study|Withdrew Consent|2|||
37711356|NCT02177786|69189694|FG001|Overall Study|Withdrew Consent|6|||
37711357|NCT02177786|69189695|FG002|Overall Study|Withdrew Consent|9|||
37711358|NCT02177786|69189696|FG003|Overall Study|Withdrew Consent|5|||
37711359|NCT02177786|69189693|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
37711360|NCT02177786|69189694|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
37711361|NCT02177786|69189695|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
37711362|NCT02177786|69189696|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
37711363|NCT02177786|69189693|FG000|Overall Study|Adverse Event|1|||
37711364|NCT02177786|69189694|FG001|Overall Study|Adverse Event|1|||
37711365|NCT02177786|69189695|FG002|Overall Study|Adverse Event|2|||
37711366|NCT02177786|69189696|FG003|Overall Study|Adverse Event|3|||
37711367|NCT02177786|69189693|FG000|Overall Study|Death|1|||
37711368|NCT02177786|69189694|FG001|Overall Study|Death|1|||
37711369|NCT02177786|69189695|FG002|Overall Study|Death|1|||
37711370|NCT02177786|69189696|FG003|Overall Study|Death|1|||
37711371|NCT02177786|69189693|FG000|Overall Study|Lost to Follow-up|0|||
37711372|NCT02177786|69189694|FG001|Overall Study|Lost to Follow-up|0|||
37711373|NCT02177786|69189695|FG002|Overall Study|Lost to Follow-up|2|||
37711374|NCT02177786|69189696|FG003|Overall Study|Lost to Follow-up|2|||
37711375|NCT02177786|69189693|FG000|Overall Study|Non-Compliance with Study Drug|0|||
37711376|NCT02177786|69189694|FG001|Overall Study|Non-Compliance with Study Drug|1|||
37711377|NCT02177786|69189695|FG002|Overall Study|Non-Compliance with Study Drug|0|||
37711378|NCT02177786|69189696|FG003|Overall Study|Non-Compliance with Study Drug|1|||
37711379|NCT02177786|69189693|FG000|Overall Study|Protocol Violation|0|||
37711380|NCT02177786|69189694|FG001|Overall Study|Protocol Violation|0|||
37711381|NCT02177786|69189695|FG002|Overall Study|Protocol Violation|2|||
37711382|NCT02177786|69189696|FG003|Overall Study|Protocol Violation|0|||
37711383|NCT02177786|69189693|FG000|Overall Study|Progressive Disease|0|||
37711384|NCT02177786|69189694|FG001|Overall Study|Progressive Disease|1|||
37711385|NCT02177786|69189695|FG002|Overall Study|Progressive Disease|0|||
37711386|NCT02177786|69189696|FG003|Overall Study|Progressive Disease|0|||
37711387|NCT02177786|69189693|FG000|Overall Study|Missing study completion status|0|||
37711388|NCT02177786|69189694|FG001|Overall Study|Missing study completion status|1|||
37711389|NCT02177786|69189695|FG002|Overall Study|Missing study completion status|0|||
37711390|NCT02177786|69189696|FG003|Overall Study|Missing study completion status|0|||
37711391|NCT01555762|69189706|FG000|Overall Study|No information on Bevacizumab intake|11|||
37711392|NCT01555762|69189706|FG000|Overall Study|Missing start date of infusion|8|||
37711393|NCT01555762|69189706|FG000|Overall Study|75 years old or more ticked No|1|||
37711394|NCT01555762|69189706|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
37711395|NCT01555762|69189706|FG000|Overall Study|Death linked to progression of disease|165|||
37711396|NCT01555762|69189706|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
37711397|NCT01555762|69189706|FG000|Overall Study|Investigator's decision|10|||
37838669|NCT00473382|69523245|FG002|Core Study|Subject's decision|10|||
37838670|NCT00473382|69523243|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
37711398|NCT01555762|69189706|FG000|Overall Study|Participant not wishing to continue|5|||
37711399|NCT01555762|69189706|FG000|Overall Study|Missing data|1|||
37711400|NCT01555762|69189706|FG000|Overall Study|Death linked to an adverse event|14|||
37711401|NCT02153918|69189710|FG000|Overall Study|Refused further treatment|1|||
37711402|NCT02176928|69189716|FG000|Overall Study|Lost to Follow-up|2|||
37711403|NCT02176928|69189717|FG001|Overall Study|Lost to Follow-up|4|||
37711404|NCT01628510|69189725|FG000|Overall Study|Withdrawal by Subject|0|||
37711405|NCT01628510|69189726|FG001|Overall Study|Withdrawal by Subject|4|||
37711406|NCT01628510|69189725|FG000|Overall Study|Death|3|||
37711407|NCT01628510|69189726|FG001|Overall Study|Death|1|||
37711408|NCT01571362|69189734|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
37711409|NCT01571362|69189735|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
37711410|NCT01571362|69189736|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
37711411|NCT01571362|69189734|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
37711412|NCT01571362|69189735|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
37711413|NCT01571362|69189736|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
37711414|NCT01571362|69189734|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
37711415|NCT01571362|69189735|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
37711416|NCT01571362|69189736|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
37711417|NCT01571362|69189734|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
37711418|NCT01571362|69189735|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
37711419|NCT01571362|69189736|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
37711420|NCT01571362|69189734|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
37711421|NCT01571362|69189735|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
37711422|NCT01571362|69189736|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
37711423|NCT01571362|69189734|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
37838671|NCT00473382|69523244|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
37711424|NCT01571362|69189735|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
37711425|NCT01571362|69189736|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
37711426|NCT01571362|69189734|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
37711427|NCT01571362|69189735|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
37711428|NCT01571362|69189736|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
37711429|NCT01571362|69189734|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
37711430|NCT01571362|69189735|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
37711431|NCT01571362|69189736|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
37711432|NCT01571362|69189734|FG000|Double-Blind Treatment Period|Adverse Event|0|||
37711433|NCT01571362|69189735|FG001|Double-Blind Treatment Period|Adverse Event|9|||
37711434|NCT01571362|69189736|FG002|Double-Blind Treatment Period|Adverse Event|14|||
37711435|NCT01571362|69189734|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
37711436|NCT01571362|69189735|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
37711437|NCT01571362|69189736|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
37711438|NCT01571362|69189734|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
37711439|NCT01571362|69189735|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
37711440|NCT01571362|69189736|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
37711441|NCT01571362|69189734|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
37711442|NCT01571362|69189735|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
37711443|NCT01571362|69189736|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
37711444|NCT01571284|69189744|FG000|Overall Study|Participant's decision|84|||
37711445|NCT01571284|69189744|FG000|Overall Study|Lost to Follow-up|3|||
37711446|NCT01571284|69189744|FG000|Overall Study|Enrolled but not treated|2|||
37711447|NCT01571284|69189744|FG000|Overall Study|Other than specified above|80|||
37711448|NCT02137772|69189750|FG000|Overall Study|Adverse Event|6|||
37711449|NCT02137772|69189751|FG001|Overall Study|Adverse Event|3|||
37711450|NCT02137772|69189750|FG000|Overall Study|Death|71|||
37711451|NCT02137772|69189751|FG001|Overall Study|Death|44|||
37711452|NCT02137772|69189750|FG000|Overall Study|Lost to Follow-up|8|||
37711453|NCT02137772|69189751|FG001|Overall Study|Lost to Follow-up|4|||
37711454|NCT02137772|69189750|FG000|Overall Study|Physician Decision|15|||
37711455|NCT02137772|69189751|FG001|Overall Study|Physician Decision|5|||
37711456|NCT02137772|69189750|FG000|Overall Study|Withdrawal by Subject|28|||
37711457|NCT02137772|69189751|FG001|Overall Study|Withdrawal by Subject|17|||
37711458|NCT02137772|69189750|FG000|Overall Study|Non-compliance with study drug|1|||
37711459|NCT02137772|69189751|FG001|Overall Study|Non-compliance with study drug|0|||
37711460|NCT02137772|69189750|FG000|Overall Study|Not treated|3|||
37711461|NCT02137772|69189751|FG001|Overall Study|Not treated|2|||
37711462|NCT01555138|69189759|FG000|Overall Study|Death|0|||
37711463|NCT01555138|69189760|FG001|Overall Study|Death|1|||
37711464|NCT01555138|69189759|FG000|Overall Study|Lost to Follow-up|1|||
37711465|NCT01555138|69189760|FG001|Overall Study|Lost to Follow-up|0|||
37711466|NCT01555138|69189759|FG000|Overall Study|Abnormal Lab reults|1|||
37711467|NCT01555138|69189760|FG001|Overall Study|Abnormal Lab reults|3|||
37711468|NCT01555138|69189759|FG000|Overall Study|Lack of Efficacy|2|||
37711469|NCT01555138|69189760|FG001|Overall Study|Lack of Efficacy|2|||
37711470|NCT01555138|69189759|FG000|Overall Study|Protocol Violation|5|||
37711471|NCT01555138|69189760|FG001|Overall Study|Protocol Violation|3|||
37711472|NCT01555138|69189759|FG000|Overall Study|Administrative problems|8|||
37711473|NCT01555138|69189760|FG001|Overall Study|Administrative problems|0|||
37711474|NCT01555138|69189759|FG000|Overall Study|Withdrawal by Subject|16|||
37711475|NCT01555138|69189760|FG001|Overall Study|Withdrawal by Subject|15|||
37711476|NCT01555138|69189759|FG000|Overall Study|Adverse Event|14|||
37711477|NCT01555138|69189760|FG001|Overall Study|Adverse Event|14|||
37711478|NCT02137226|69189768|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
37711479|NCT02137226|69189769|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
37711480|NCT02137226|69189770|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
37711481|NCT02137226|69189771|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
37711482|NCT02137226|69189772|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
37711483|NCT02137226|69189768|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
37838672|NCT00473382|69523245|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
37838673|NCT00473382|69523243|FG000|Open-label Extension Through Month 48|Death|1|||
37711484|NCT02137226|69189769|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
37711485|NCT02137226|69189770|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
37711486|NCT02137226|69189771|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
37711487|NCT02137226|69189772|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
37711488|NCT02137226|69189768|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
37711489|NCT02137226|69189769|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
37711490|NCT02137226|69189770|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
37711491|NCT02137226|69189771|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
37711492|NCT02137226|69189772|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
37711493|NCT02137226|69189768|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
37711494|NCT02137226|69189769|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
37711495|NCT02137226|69189770|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
37711496|NCT02137226|69189771|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
37711497|NCT02137226|69189772|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
37711498|NCT02137226|69189768|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
37711499|NCT02137226|69189769|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
37711500|NCT02137226|69189770|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
37711501|NCT02137226|69189771|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
37711502|NCT02137226|69189772|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
37711503|NCT02137226|69189768|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
37711504|NCT02137226|69189769|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
37711505|NCT02137226|69189770|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
37711506|NCT02137226|69189771|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
37711507|NCT02137226|69189772|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
37711508|NCT02137226|69189768|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
37711509|NCT02137226|69189769|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
37711510|NCT02137226|69189770|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
37711511|NCT02137226|69189771|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
37711512|NCT02137226|69189772|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
37711513|NCT02137226|69189768|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
37711514|NCT02137226|69189769|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
37711515|NCT02137226|69189770|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
37711516|NCT02137226|69189771|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
37711517|NCT02137226|69189772|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
37711518|NCT02137226|69189768|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
37711519|NCT02137226|69189769|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
37711520|NCT02137226|69189770|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
37711521|NCT02137226|69189771|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
37711522|NCT02137226|69189772|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
37711523|NCT02137226|69189768|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
37711524|NCT02137226|69189769|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
37711525|NCT02137226|69189770|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
37711526|NCT02137226|69189771|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
37711527|NCT02137226|69189772|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
37711528|NCT02137226|69189768|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
37711529|NCT02137226|69189769|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
37711530|NCT02137226|69189770|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
37711531|NCT02137226|69189771|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
37711532|NCT02137226|69189772|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
37711533|NCT02137226|69189768|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
37711534|NCT02137226|69189769|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
37711535|NCT02137226|69189770|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
37711536|NCT02137226|69189771|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
37711537|NCT02137226|69189772|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
37711538|NCT01530334|69189780|FG000|Overall Study|Adverse Event|3|||
37711539|NCT01530334|69189780|FG000|Overall Study|unknown reason|1|||
37711540|NCT01530334|69189780|FG000|Overall Study|Progressive disease|47|||
37711541|NCT01570192|69189786|FG000|Overall Study|no qualifying organism|6|||
37711542|NCT01570192|69189787|FG001|Overall Study|no qualifying organism|12|||
37711543|NCT01570192|69189786|FG000|Overall Study|changed to palliative care|1|||
37711544|NCT01570192|69189787|FG001|Overall Study|changed to palliative care|0|||
37711545|NCT01570192|69189786|FG000|Overall Study|Physician Decision|0|||
37711546|NCT01570192|69189787|FG001|Overall Study|Physician Decision|1|||
37711547|NCT02136914|69189800|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
37711548|NCT02136914|69189801|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
37711549|NCT02136914|69189800|FG000|Overall Study|Withdrawal by Subject|3|||
37838674|NCT00473382|69523244|FG001|Open-label Extension Through Month 48|Death|3|||
37711550|NCT02136914|69189801|FG001|Overall Study|Withdrawal by Subject|10|||
37711551|NCT02136914|69189800|FG000|Overall Study|Subject Unwilling to Proceed|7|||
37711552|NCT02136914|69189801|FG001|Overall Study|Subject Unwilling to Proceed|2|||
37915409|NCT00851877|69602193|FG000|Phase I-1|Death|1|||
37711553|NCT02136914|69189800|FG000|Overall Study|Lost to Follow-up|1|||
37711554|NCT02136914|69189801|FG001|Overall Study|Lost to Follow-up|1|||
37711555|NCT02136914|69189800|FG000|Overall Study|Did Not Receive Study Drug|2|||
37711556|NCT02136914|69189801|FG001|Overall Study|Did Not Receive Study Drug|0|||
37711557|NCT02136914|69189800|FG000|Overall Study|Lack of Efficacy|1|||
37711558|NCT02136914|69189801|FG001|Overall Study|Lack of Efficacy|0|||
37711559|NCT02136914|69189800|FG000|Overall Study|Death|0|||
37711560|NCT02136914|69189801|FG001|Overall Study|Death|1|||
37711561|NCT01530256|69189807|FG000|Overall Study|Death|2|||
37711562|NCT01554904|69189811|FG000|Overall Study|Withdrawal by Subject|3|||
37711563|NCT01554904|69189811|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
37711564|NCT01529632|69189817|FG000|Overall Study|Administrative problem|2|||
37711565|NCT01529632|69189818|FG001|Overall Study|Administrative problem|1|||
37711566|NCT01529632|69189817|FG000|Overall Study|Protocol Violation|0|||
37711567|NCT01529632|69189818|FG001|Overall Study|Protocol Violation|1|||
37711568|NCT01529632|69189817|FG000|Overall Study|Adverse Event|1|||
37711569|NCT01529632|69189818|FG001|Overall Study|Adverse Event|1|||
37711570|NCT01554514|69189824|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
37711571|NCT01554514|69189824|FG000|Overall Study|Physician Decision|1|||
37711572|NCT01553188|69189832|FG000|Overall Study|Patient choice|1|||
37711573|NCT01553188|69189833|FG001|Overall Study|Patient choice|0|||
37711574|NCT01553188|69189834|FG002|Overall Study|Patient choice|0|||
37711575|NCT01553188|69189835|FG003|Overall Study|Patient choice|0|||
37711576|NCT01553188|69189832|FG000|Overall Study|Intercurrent illness and adverse event|0|||
37711577|NCT01553188|69189833|FG001|Overall Study|Intercurrent illness and adverse event|1|||
37711578|NCT01553188|69189834|FG002|Overall Study|Intercurrent illness and adverse event|2|||
37711579|NCT01553188|69189835|FG003|Overall Study|Intercurrent illness and adverse event|0|||
37711580|NCT02175758|69189854|FG000|Treatment Phase|Lost to Follow-up|0|||
37711581|NCT02175758|69189855|FG001|Treatment Phase|Lost to Follow-up|1|||
37711582|NCT02175758|69189856|FG002|Treatment Phase|Lost to Follow-up|0|||
37711583|NCT02175758|69189857|FG003|Treatment Phase|Lost to Follow-up|0|||
37711584|NCT02175758|69189858|FG004|Treatment Phase|Lost to Follow-up|0|||
37711585|NCT02175758|69189859|FG005|Treatment Phase|Lost to Follow-up|0|||
37711586|NCT02175758|69189854|FG000|Treatment Phase|Adverse Event|0|||
37711587|NCT02175758|69189855|FG001|Treatment Phase|Adverse Event|0|||
37711588|NCT02175758|69189856|FG002|Treatment Phase|Adverse Event|0|||
37711589|NCT02175758|69189857|FG003|Treatment Phase|Adverse Event|0|||
37711590|NCT02175758|69189858|FG004|Treatment Phase|Adverse Event|1|||
37711591|NCT02175758|69189859|FG005|Treatment Phase|Adverse Event|0|||
37711592|NCT01529008|69189901|FG000|Bone Marrow Harvesting|Physician Decision|1|||
37711593|NCT01529008|69189902|FG001|Bone Marrow Harvesting|Physician Decision|1|||
37711594|NCT01529008|69189901|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
37711595|NCT01529008|69189902|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
37711596|NCT01529008|69189901|FG000|Treatment|Adverse Event|6|||
37711597|NCT01529008|69189902|FG001|Treatment|Adverse Event|0|||
37711598|NCT01529008|69189901|FG000|Treatment|Other|3|||
37711599|NCT01529008|69189902|FG001|Treatment|Other|1|||
37711600|NCT01529008|69189901|FG000|Efficacy Analysis|Protocol Violation|2|||
37711601|NCT01529008|69189902|FG001|Efficacy Analysis|Protocol Violation|0|||
37711602|NCT01529008|69189901|FG000|Efficacy Analysis|Physician Decision|0|||
37711603|NCT01529008|69189902|FG001|Efficacy Analysis|Physician Decision|1|||
37711604|NCT01529008|69189901|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
37711605|NCT01529008|69189902|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
37711606|NCT01599104|69189911|FG000|Overall Study|Withdrawal by Subject|1|||
37711607|NCT01599104|69189912|FG001|Overall Study|Withdrawal by Subject|1|||
37711608|NCT01599104|69189913|FG002|Overall Study|Withdrawal by Subject|2|||
37711609|NCT01599104|69189911|FG000|Overall Study|Technical Problems|1|||
37711610|NCT01599104|69189912|FG001|Overall Study|Technical Problems|0|||
37711611|NCT01599104|69189913|FG002|Overall Study|Technical Problems|0|||
37711612|NCT01599104|69189911|FG000|Overall Study|Physician Decision|3|||
37711613|NCT01599104|69189912|FG001|Overall Study|Physician Decision|2|||
37838675|NCT00473382|69523245|FG002|Open-label Extension Through Month 48|Death|3|||
37915410|NCT00851877|69602194|FG001|Phase I-1|Death|0|||
37711614|NCT01599104|69189913|FG002|Overall Study|Physician Decision|2|||
37711615|NCT01599104|69189911|FG000|Overall Study|Non-compliance with study treatment|0|||
37711616|NCT01599104|69189912|FG001|Overall Study|Non-compliance with study treatment|1|||
37711617|NCT01599104|69189913|FG002|Overall Study|Non-compliance with study treatment|0|||
37711618|NCT01599104|69189911|FG000|Overall Study|Lack of Efficacy|4|||
37711619|NCT01599104|69189912|FG001|Overall Study|Lack of Efficacy|4|||
37711620|NCT01599104|69189913|FG002|Overall Study|Lack of Efficacy|10|||
37711621|NCT01599104|69189911|FG000|Overall Study|Adverse Event|7|||
37711622|NCT01599104|69189912|FG001|Overall Study|Adverse Event|6|||
37711623|NCT01599104|69189913|FG002|Overall Study|Adverse Event|12|||
37711624|NCT01569568|69189923|FG000|Overall Study|Physician Decision|0|||
37711625|NCT01569568|69189924|FG001|Overall Study|Physician Decision|2|||
37711626|NCT02136680|69189932|FG000|Overall Study|No Longer Interested|1|||
37711627|NCT02136680|69189933|FG001|Overall Study|No Longer Interested|1|||
37711628|NCT02136680|69189932|FG000|Overall Study|No longer receiving care at clinic|3|||
37711629|NCT02136680|69189933|FG001|Overall Study|No longer receiving care at clinic|5|||
37711630|NCT02136680|69189932|FG000|Overall Study|Moved away|5|||
37711631|NCT02136680|69189933|FG001|Overall Study|Moved away|4|||
37711632|NCT02136680|69189932|FG000|Overall Study|Unable to schedule|17|||
37711633|NCT02136680|69189933|FG001|Overall Study|Unable to schedule|16|||
37711634|NCT02136680|69189932|FG000|Overall Study|Study ended before interview due|6|||
37711635|NCT02136680|69189933|FG001|Overall Study|Study ended before interview due|3|||
37711636|NCT01552954|69189941|FG000|Overall Study|Adverse Event|1|||
37711637|NCT01552954|69189942|FG001|Overall Study|Adverse Event|2|||
37711638|NCT01552954|69189941|FG000|Overall Study|Lost to Follow-up|1|||
37711639|NCT01552954|69189942|FG001|Overall Study|Lost to Follow-up|1|||
37711640|NCT01552954|69189941|FG000|Overall Study|Withdrawal by Subject|1|||
37711641|NCT01552954|69189942|FG001|Overall Study|Withdrawal by Subject|1|||
37711642|NCT01552954|69189941|FG000|Overall Study|Protocol Violation|1|||
37711643|NCT01552954|69189942|FG001|Overall Study|Protocol Violation|2|||
37711644|NCT01552954|69189941|FG000|Overall Study|diagnosed DM|1|||
37711645|NCT01552954|69189942|FG001|Overall Study|diagnosed DM|0|||
37711646|NCT02175368|69189948|FG000|Overall Study|Lost to Follow-up|1|||
37711647|NCT01518244|69189952|FG000|Overall Study|Adverse Event|3|||
37711648|NCT01552408|69189958|FG000|Overall Study|Lost to Follow-up|2|||
37711649|NCT01552408|69189959|FG001|Overall Study|Lost to Follow-up|0|||
37711650|NCT01552408|69189958|FG000|Overall Study|Relocation|0|||
37711651|NCT01552408|69189959|FG001|Overall Study|Relocation|1|||
37711652|NCT01552408|69189958|FG000|Overall Study|Withdrawal by Subject|2|||
37711653|NCT01552408|69189959|FG001|Overall Study|Withdrawal by Subject|1|||
37711654|NCT01528696|69189968|FG000|Overall Study|See detailed description|18|||
37711655|NCT01528696|69189969|FG001|Overall Study|See detailed description|19|||
37711656|NCT02174276|69189979|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
37711657|NCT02174276|69189980|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
37711658|NCT02174276|69189981|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
37711659|NCT02174276|69189982|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
37711660|NCT02174276|69189979|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
37711661|NCT02174276|69189980|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
37711662|NCT02174276|69189981|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
37711663|NCT02174276|69189982|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
37711664|NCT02174276|69189979|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
37711665|NCT02174276|69189980|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
37711666|NCT02174276|69189981|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
37711667|NCT02174276|69189982|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
37711668|NCT02174276|69189979|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
37711669|NCT02174276|69189980|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
37711670|NCT02174276|69189981|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
37711671|NCT02174276|69189982|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
37711672|NCT02174276|69189979|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
37711673|NCT02174276|69189980|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
37711674|NCT02174276|69189981|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
37711675|NCT02174276|69189982|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
37711676|NCT02174276|69189979|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
37711677|NCT02174276|69189980|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
37711678|NCT02174276|69189981|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
37711679|NCT02174276|69189982|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
37711680|NCT01528072|69189992|FG000|Overall Study|Withdrawal by Subject|5|||
37711681|NCT01528072|69189992|FG000|Overall Study|Physician Decision|1|||
37711682|NCT01528072|69189992|FG000|Overall Study|Determined not eligible by AEAC|1|||
37711683|NCT01528072|69189992|FG000|Overall Study|Missed Visit|2|||
37711684|NCT01528072|69189992|FG000|Overall Study|Lost to Follow-up|5|||
37915411|NCT00851877|69602195|FG002|Phase I-1|Death|0|||
37915412|NCT00851877|69602193|FG000|Phase II|Withdrawal by Subject|0|||
37711685|NCT01528072|69189992|FG000|Overall Study|Explanted|2|||
37711686|NCT01528072|69189992|FG000|Overall Study|Site Closure|4|||
37711687|NCT01528072|69189992|FG000|Overall Study|Death|2|||
37711688|NCT01528072|69189992|FG000|Overall Study|Early Termination of Study|52|||
37711689|NCT01527682|69189996|FG000|Overall Study|Protocol Violation|8|||
37711690|NCT01527370|69190000|FG000|Overall Study|Withdrawal by Subject|4|||
37711691|NCT01527370|69190000|FG000|Overall Study|Physician Decision|1|||
37711692|NCT01527370|69190000|FG000|Overall Study|Death|1|||
37711693|NCT01527292|69190006|FG000|Overall Study|Physician Decision|0|||
37711694|NCT01527292|69190007|FG001|Overall Study|Physician Decision|3|||
37711695|NCT01516216|69190015|FG000|Overall Study|Adverse Event|2|||
37711696|NCT01516216|69190016|FG001|Overall Study|Adverse Event|4|||
37711697|NCT01516216|69190015|FG000|Overall Study|Disease Progression|38|||
37711698|NCT01516216|69190016|FG001|Overall Study|Disease Progression|34|||
37711699|NCT01516216|69190015|FG000|Overall Study|Withdrawal by Subject|9|||
37711700|NCT01516216|69190016|FG001|Overall Study|Withdrawal by Subject|11|||
37711701|NCT01516216|69190015|FG000|Overall Study|Potentially Curative Resection|6|||
37711702|NCT01516216|69190016|FG001|Overall Study|Potentially Curative Resection|12|||
37711703|NCT01516216|69190015|FG000|Overall Study|Nonadherence|2|||
37711704|NCT01516216|69190016|FG001|Overall Study|Nonadherence|3|||
37711705|NCT01516216|69190015|FG000|Overall Study|Physician Decision|6|||
37711706|NCT01516216|69190016|FG001|Overall Study|Physician Decision|3|||
37711707|NCT01516216|69190015|FG000|Overall Study|Prolonged Treatment Delay|5|||
37711708|NCT01516216|69190016|FG001|Overall Study|Prolonged Treatment Delay|1|||
37711709|NCT01516216|69190015|FG000|Overall Study|Intercurrent Illness|1|||
37711710|NCT01516216|69190016|FG001|Overall Study|Intercurrent Illness|0|||
37711711|NCT01516216|69190015|FG000|Overall Study|Death|1|||
37711712|NCT01516216|69190016|FG001|Overall Study|Death|1|||
37711713|NCT01950819|69190026|FG000|Overall Study|Graft Loss|35|||
37711714|NCT01950819|69190027|FG001|Overall Study|Graft Loss|30|||
37711715|NCT01950819|69190026|FG000|Overall Study|Death|29|||
37711716|NCT01950819|69190027|FG001|Overall Study|Death|34|||
37711717|NCT01950819|69190026|FG000|Overall Study|Subject / Gardian decision|54|||
37711718|NCT01950819|69190027|FG001|Overall Study|Subject / Gardian decision|51|||
37711719|NCT01950819|69190026|FG000|Overall Study|technical problems|2|||
37711720|NCT01950819|69190027|FG001|Overall Study|technical problems|0|||
37711721|NCT01950819|69190026|FG000|Overall Study|Pregnancy|0|||
37711722|NCT01950819|69190027|FG001|Overall Study|Pregnancy|2|||
37711723|NCT01950819|69190026|FG000|Overall Study|Lost to Follow-up|9|||
37711724|NCT01950819|69190027|FG001|Overall Study|Lost to Follow-up|17|||
37711725|NCT01514422|69190033|FG000|Overall Study|Lost to Follow-up|1|||
37711726|NCT01513330|69190037|FG000|SenSura Mio First,|Adverse Event|2|||
37711727|NCT01513330|69190038|FG001|SenSura Mio First,|Adverse Event|0|||
37711728|NCT01513330|69190037|FG000|SenSura Mio First,|Lack of Efficacy|0|||
37711729|NCT01513330|69190038|FG001|SenSura Mio First,|Lack of Efficacy|1|||
37711730|NCT01513330|69190037|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
37711731|NCT01513330|69190038|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
37711732|NCT01513330|69190037|FG000|SenSura Mio First,|Other|1|||
37711733|NCT01513330|69190038|FG001|SenSura Mio First,|Other|0|||
37711734|NCT01513330|69190037|FG000|Standard Care First,|Lack of Efficacy|2|||
37711735|NCT01513330|69190038|FG001|Standard Care First,|Lack of Efficacy|2|||
37711736|NCT01513330|69190037|FG000|Standard Care First,|Withdrawal by Subject|1|||
37711737|NCT01513330|69190038|FG001|Standard Care First,|Withdrawal by Subject|2|||
37711738|NCT01513330|69190037|FG000|Standard Care First,|Other|1|||
37711739|NCT01513330|69190038|FG001|Standard Care First,|Other|0|||
37711740|NCT01524796|69190044|FG000|Overall Study|Adverse Event|13|||
37711741|NCT01524796|69190044|FG000|Overall Study|Lack of Efficacy|3|||
37711742|NCT01524796|69190044|FG000|Overall Study|Lost to Follow-up|1|||
37711743|NCT01524796|69190044|FG000|Overall Study|The price|1|||
37711744|NCT01524796|69190044|FG000|Overall Study|Withdrawal by Subject|4|||
37711745|NCT01524796|69190044|FG000|Overall Study|Move|1|||
37711746|NCT01524796|69190044|FG000|Overall Study|Deterioration of pains|1|||
37711747|NCT01524796|69190044|FG000|Overall Study|Gall stone surgery|1|||
37711748|NCT01524796|69190044|FG000|Overall Study|Nervous about confidentiality|1|||
37711749|NCT01524796|69190044|FG000|Overall Study|Switch to carbamazapine|1|||
37711750|NCT01524796|69190044|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
37711751|NCT01547728|69190048|FG000|Overall Study|Change in procedure and equipment|1|||
37711752|NCT01547728|69190048|FG000|Overall Study|Drug not ready for subject|1|||
37711753|NCT01547728|69190048|FG000|Overall Study|Screen failure|39|||
37711754|NCT01523392|69190054|FG000|Treatment Period 1|Withdrawal by Subject|2|||
37711755|NCT01523392|69190055|FG001|Treatment Period 1|Withdrawal by Subject|0|||
37711756|NCT01523392|69190054|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
37711757|NCT01523392|69190055|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
37711758|NCT01523392|69190054|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
37711759|NCT01523392|69190055|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
37711760|NCT01512160|69190067|FG000|Overall Study|Lost to Follow-up|1|||
37711761|NCT01512160|69190068|FG001|Overall Study|Lost to Follow-up|0|||
37711762|NCT01512160|69190069|FG002|Overall Study|Lost to Follow-up|0|||
37711763|NCT01512160|69190070|FG003|Overall Study|Lost to Follow-up|0|||
37711764|NCT01512160|69190067|FG000|Overall Study|Withdrawal by Subject|1|||
37711765|NCT01512160|69190068|FG001|Overall Study|Withdrawal by Subject|0|||
37915413|NCT00851877|69602194|FG001|Phase II|Withdrawal by Subject|0|||
37711766|NCT01512160|69190069|FG002|Overall Study|Withdrawal by Subject|0|||
37711767|NCT01512160|69190070|FG003|Overall Study|Withdrawal by Subject|1|||
37711768|NCT01546168|69190083|FG000|Overall Study|Lost to Follow-up|1|||
37711769|NCT01546168|69190084|FG001|Overall Study|Lost to Follow-up|0|||
37711770|NCT01546168|69190083|FG000|Overall Study|Withdrawal by Subject|1|||
37711771|NCT01546168|69190084|FG001|Overall Study|Withdrawal by Subject|0|||
37711772|NCT01546168|69190083|FG000|Overall Study|ineligible after signing consent|2|||
37711773|NCT01546168|69190084|FG001|Overall Study|ineligible after signing consent|0|||
37711774|NCT01901289|69190090|FG000|Overall Study|Death|32|||
37711775|NCT01901289|69190090|FG000|Overall Study|Lost to Follow-up|16|||
37711776|NCT01901289|69190090|FG000|Overall Study|Withdrawal by Subject|35|||
37711777|NCT01901289|69190090|FG000|Overall Study|Other type of endpoint met|2|||
37711778|NCT01950741|69190094|FG000|Overall Study|Lost to Follow-up|1|||
37711779|NCT01950741|69190094|FG000|Overall Study|Death|1|||
37711780|NCT01950741|69190094|FG000|Overall Study|Withdrawal by Subject|1|||
37711781|NCT01950273|69190100|FG000|Overall Study|Protocol Violation|1|||
37711782|NCT01950273|69190101|FG001|Overall Study|Protocol Violation|0|||
37711783|NCT01950273|69190100|FG000|Overall Study|Withdrawal by Subject|2|||
37711784|NCT01950273|69190101|FG001|Overall Study|Withdrawal by Subject|0|||
37711785|NCT01950273|69190100|FG000|Overall Study|Other not defined above|1|||
37711786|NCT01950273|69190101|FG001|Overall Study|Other not defined above|0|||
37711787|NCT01919307|69190107|FG000|Overall Study|Withdrawal by Subject|9|||
37711788|NCT01919229|69190114|FG000|Overall Study|Subject/guardian decision|0|||
37711789|NCT01919229|69190115|FG001|Overall Study|Subject/guardian decision|0|||
37711790|NCT01919229|69190116|FG002|Overall Study|Subject/guardian decision|1|||
37711791|NCT01901055|69190126|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
37711792|NCT01901055|69190127|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
37711793|NCT01901055|69190126|FG000|Randomization But Not Titrated|Physician Decision|0|||
37711794|NCT01901055|69190127|FG001|Randomization But Not Titrated|Physician Decision|1|||
37711795|NCT01901055|69190126|FG000|Started Protocol to Week 6|Physician Decision|2|||
37711796|NCT01901055|69190127|FG001|Started Protocol to Week 6|Physician Decision|1|||
37711797|NCT01901055|69190126|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
37711798|NCT01901055|69190127|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
37711799|NCT01901055|69190126|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
37711800|NCT01901055|69190127|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
37711801|NCT01901055|69190126|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
37711802|NCT01901055|69190127|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
37711803|NCT01901055|69190126|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
37711804|NCT01901055|69190127|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
37711805|NCT01901055|69190126|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
37711806|NCT01901055|69190127|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
37711807|NCT01901055|69190126|FG000|Week 24|Withdrawal by Subject|13|||
37711808|NCT01901055|69190127|FG001|Week 24|Withdrawal by Subject|19|||
37711809|NCT01901055|69190126|FG000|Week 24|Physician Decision|1|||
37711810|NCT01901055|69190127|FG001|Week 24|Physician Decision|0|||
37711811|NCT01901055|69190126|FG000|Week 36|Withdrawal by Subject|0|||
37711812|NCT01901055|69190127|FG001|Week 36|Withdrawal by Subject|5|||
37711813|NCT01511536|69190139|FG000|Phase 1|Other|0|||
37711814|NCT01511536|69190140|FG001|Phase 1|Other|1|||
37711815|NCT01511536|69190141|FG002|Phase 1|Other|0|||
37711816|NCT01511536|69190139|FG000|Phase 2|Other|0|||
37711817|NCT01511536|69190140|FG001|Phase 2|Other|0|||
37711818|NCT01511536|69190141|FG002|Phase 2|Other|9|||
37711819|NCT01890759|69190151|FG000|Overall Study|Protocol Violation|0|||
37711820|NCT01890759|69190152|FG001|Overall Study|Protocol Violation|2|||
37711821|NCT01890759|69190151|FG000|Overall Study|Lost to Follow-up|0|||
37711822|NCT01890759|69190152|FG001|Overall Study|Lost to Follow-up|2|||
37711823|NCT01890759|69190151|FG000|Overall Study|Withdrawal by Subject|2|||
37711824|NCT01890759|69190152|FG001|Overall Study|Withdrawal by Subject|8|||
37711825|NCT01900899|69190160|FG000|Overall Study|Withdrawal by Subject|7|||
37711826|NCT01900899|69190161|FG001|Overall Study|Withdrawal by Subject|1|||
37711827|NCT01900899|69190160|FG000|Overall Study|Migrated from study area|2|||
37711828|NCT01900899|69190161|FG001|Overall Study|Migrated from study area|0|||
37711829|NCT01510912|69190167|FG000|Overall Study|Adverse Event|99|||
37711830|NCT01510912|69190167|FG000|Overall Study|Lack of Efficacy|12|||
37711831|NCT01510912|69190167|FG000|Overall Study|Non-compliance with trial drug|23|||
37711832|NCT01510912|69190167|FG000|Overall Study|Withdrawal by Subject|49|||
37711833|NCT01510912|69190167|FG000|Overall Study|Physician Decision|1|||
37711834|NCT01510912|69190167|FG000|Overall Study|Protocol Violation|27|||
37711835|NCT01510912|69190167|FG000|Overall Study|Lost to Follow-up|26|||
37711836|NCT01510912|69190167|FG000|Overall Study|Other, including joint replacement|5|||
37711837|NCT01510756|69190171|FG000|Overall Study|Death|1|||
37711838|NCT01510756|69190171|FG000|Overall Study|Lack of Efficacy|2|||
37711839|NCT01510756|69190171|FG000|Overall Study|Physician Decision|1|||
37711840|NCT01522456|69190175|FG000|Overall Study|Adverse Event|2|||
37711841|NCT01522456|69190175|FG000|Overall Study|Lost to Follow-up|2|||
37711842|NCT01522456|69190175|FG000|Overall Study|Withdrawal by Subject|2|||
37711843|NCT01522456|69190175|FG000|Overall Study|Pregnancy|1|||
37711844|NCT01522456|69190175|FG000|Overall Study|Tolerability Assessment|1|||
37711845|NCT01545934|69190188|FG000|Overall Study|Withdrawal by Subject|4|||
37711846|NCT01545934|69190189|FG001|Overall Study|Withdrawal by Subject|3|||
37711847|NCT01545934|69190188|FG000|Overall Study|Lost to Follow-up|1|||
37711848|NCT01545934|69190189|FG001|Overall Study|Lost to Follow-up|0|||
37711849|NCT01521364|69190196|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
37711850|NCT01521364|69190196|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
37711851|NCT01545388|69190210|FG000|Overall Study|Adverse Event|2|||
37711852|NCT01545388|69190211|FG001|Overall Study|Adverse Event|4|||
37711853|NCT01545388|69190212|FG002|Overall Study|Adverse Event|1|||
37711854|NCT01545388|69190210|FG000|Overall Study|Lack of Efficacy|3|||
37711855|NCT01545388|69190211|FG001|Overall Study|Lack of Efficacy|2|||
37711856|NCT01545388|69190212|FG002|Overall Study|Lack of Efficacy|5|||
37711857|NCT01545388|69190210|FG000|Overall Study|Participant moved or relocated|1|||
37711858|NCT01545388|69190211|FG001|Overall Study|Participant moved or relocated|0|||
37711859|NCT01545388|69190212|FG002|Overall Study|Participant moved or relocated|0|||
37838676|NCT00473382|69523243|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
37838677|NCT00473382|69523244|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
37838678|NCT00473382|69523245|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
37838679|NCT00473382|69523243|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
37838680|NCT00473382|69523244|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
37838681|NCT00473382|69523245|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
37838682|NCT00473382|69523243|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
37838683|NCT00473382|69523244|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
37838684|NCT00473382|69523245|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
37838685|NCT00473382|69523243|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
37838686|NCT00473382|69523244|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
37838687|NCT00473382|69523245|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
37838688|NCT00473382|69523243|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
37838689|NCT00473382|69523244|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
37838690|NCT00473382|69523245|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
37838691|NCT00473382|69523243|FG000|Open-label Extension Through Month 60|Death|1|||
37838692|NCT00473382|69523244|FG001|Open-label Extension Through Month 60|Death|7|||
37838693|NCT00473382|69523245|FG002|Open-label Extension Through Month 60|Death|4|||
37838694|NCT00473382|69523243|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
37838695|NCT00473382|69523244|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
37838696|NCT00473382|69523245|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
37838697|NCT00473382|69523243|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
37838698|NCT00473382|69523244|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
37838699|NCT00473382|69523245|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
37838700|NCT00473382|69523243|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
37838701|NCT00473382|69523244|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
37838702|NCT00473382|69523245|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
37838703|NCT00473382|69523243|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
37838704|NCT00473382|69523244|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
37838705|NCT00473382|69523245|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
37838706|NCT00473265|69523271|FG000|Overall Study|Unrelated adverse event|5|||
37838707|NCT00473265|69523271|FG000|Overall Study|Off treatment early|15|||
37838708|NCT00472641|69523275|FG000|Overall Study|Lack of Efficacy|3|||
37711860|NCT01545388|69190210|FG000|Overall Study|Withdrawal by Subject|1|||
37711861|NCT01545388|69190211|FG001|Overall Study|Withdrawal by Subject|4|||
37711862|NCT01545388|69190212|FG002|Overall Study|Withdrawal by Subject|2|||
37711863|NCT01545388|69190210|FG000|Overall Study|Other|1|||
37711864|NCT01545388|69190211|FG001|Overall Study|Other|1|||
37711865|NCT01545388|69190212|FG002|Overall Study|Other|0|||
37711866|NCT01545076|69190220|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
37711867|NCT01545076|69190221|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
37711868|NCT01545076|69190222|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
37711869|NCT01545076|69190223|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
37711870|NCT01545076|69190224|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
37711871|NCT01545076|69190220|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
37711872|NCT01545076|69190221|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
37711873|NCT01545076|69190222|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
37711874|NCT01545076|69190223|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
37711875|NCT01545076|69190224|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
37711876|NCT01545076|69190220|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
37711877|NCT01545076|69190221|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
37711878|NCT01545076|69190222|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
37711879|NCT01545076|69190223|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
37711880|NCT01545076|69190224|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
37711881|NCT01545076|69190220|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
37711882|NCT01545076|69190221|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
37711883|NCT01545076|69190222|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
37711884|NCT01545076|69190223|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
37711885|NCT01545076|69190224|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
37711886|NCT01545076|69190220|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
37711887|NCT01545076|69190221|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
37711888|NCT01545076|69190222|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
37711889|NCT01545076|69190223|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
37711890|NCT01545076|69190224|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
37711891|NCT01545076|69190220|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
37711892|NCT01545076|69190221|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
37711893|NCT01545076|69190222|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
37711894|NCT01545076|69190223|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
37711895|NCT01545076|69190224|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
37711896|NCT01545076|69190220|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
37711897|NCT01545076|69190221|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
37711898|NCT01545076|69190222|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
37711899|NCT01545076|69190223|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
37711900|NCT01545076|69190224|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
37711901|NCT01545076|69190220|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
37711902|NCT01545076|69190221|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
37711903|NCT01545076|69190222|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
37711904|NCT01545076|69190223|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
37711905|NCT01545076|69190224|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
37711906|NCT01545076|69190220|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
37711907|NCT01545076|69190221|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
37711908|NCT01545076|69190222|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
37711909|NCT01545076|69190223|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
37711910|NCT01545076|69190224|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
37711911|NCT01544920|69190239|FG000|Overall Study|Adverse Event|0|||
37711912|NCT01544920|69190240|FG001|Overall Study|Adverse Event|3|||
37711913|NCT01544920|69190239|FG000|Overall Study|Death|0|||
37711914|NCT01544920|69190240|FG001|Overall Study|Death|1|||
37711915|NCT01544920|69190239|FG000|Overall Study|Lost to Follow-up|11|||
37711916|NCT01544920|69190240|FG001|Overall Study|Lost to Follow-up|12|||
37711917|NCT01544920|69190239|FG000|Overall Study|Protocol Violation|0|||
37711918|NCT01544920|69190240|FG001|Overall Study|Protocol Violation|2|||
37711919|NCT01544920|69190239|FG000|Overall Study|Physician Decision|4|||
37711920|NCT01544920|69190240|FG001|Overall Study|Physician Decision|1|||
37711921|NCT01544920|69190239|FG000|Overall Study|Withdrawal by Subject|4|||
37711922|NCT01544920|69190240|FG001|Overall Study|Withdrawal by Subject|4|||
37711923|NCT01509664|69190250|FG000|Overall Study|Lost to Follow-up|15|||
37711924|NCT01509664|69190251|FG001|Overall Study|Lost to Follow-up|21|||
37711925|NCT01543828|69190259|FG000|Treatment 2|Lost to Follow-up|1|||
37711926|NCT01543828|69190260|FG001|Treatment 2|Lost to Follow-up|0|||
37711927|NCT01520506|69190268|FG000|Overall Study|Missed Visit|4|||
37915414|NCT00851877|69602195|FG002|Phase II|Withdrawal by Subject|3|||
37915415|NCT00882908|69602206|FG000|Overall Study|Adverse Event|0|||
37711928|NCT01520506|69190268|FG000|Overall Study|Lost to Follow-up|1|||
37711929|NCT01520506|69190268|FG000|Overall Study|Withdrawal by Subject|1|||
37711930|NCT01519960|69190275|FG000|Overall Study|Withdrawal from the study|26|||
37711931|NCT01519960|69190276|FG001|Overall Study|Withdrawal from the study|22|||
37711932|NCT01519960|69190277|FG002|Overall Study|Withdrawal from the study|5|||
37711933|NCT01543204|69190293|FG000|Overall Study|Non-compliance|1|||
37711934|NCT01543204|69190293|FG000|Overall Study|Adverse Event|1|||
37711935|NCT01543204|69190293|FG000|Overall Study|Withdrawal by Subject|4|||
37711936|NCT01543204|69190293|FG000|Overall Study|Requirement for Alternative Therapy|1|||
37711937|NCT01543204|69190293|FG000|Overall Study|Lost to Follow-up|1|||
37711938|NCT01488994|69190303|FG000|Overall Study|Withdrawal by Subject|0|||
37711939|NCT01488994|69190304|FG001|Overall Study|Withdrawal by Subject|1|||
37711940|NCT01508650|69190317|FG000|Overall Study|Lost to Follow-up|0|||
37711941|NCT01508650|69190318|FG001|Overall Study|Lost to Follow-up|3|||
37711942|NCT01488448|69190326|FG000|Overall Study|Withdrawal by Subject|3|||
37711943|NCT01488448|69190327|FG001|Overall Study|Withdrawal by Subject|1|||
37711944|NCT01488448|69190326|FG000|Overall Study|Adverse Event|9|||
37711945|NCT01488448|69190327|FG001|Overall Study|Adverse Event|4|||
37711946|NCT01488448|69190326|FG000|Overall Study|Physician Decision|4|||
37711947|NCT01488448|69190327|FG001|Overall Study|Physician Decision|9|||
37711948|NCT01488448|69190326|FG000|Overall Study|Protocol Violation|4|||
37711949|NCT01488448|69190327|FG001|Overall Study|Protocol Violation|3|||
37711950|NCT01518946|69190337|FG000|Open-label Phase|Other|4|||
37711951|NCT01518946|69190338|FG001|Open-label Phase|Other|0|||
37711952|NCT01518946|69190339|FG002|Open-label Phase|Other|0|||
37711953|NCT01518946|69190337|FG000|Randomized Phase (First Intervention)|Other|0|||
37711954|NCT01518946|69190338|FG001|Randomized Phase (First Intervention)|Other|1|||
37711955|NCT01518946|69190339|FG002|Randomized Phase (First Intervention)|Other|0|||
37711956|NCT01488370|69190349|FG000|Overall Study|Protocol Violation|0|||
37711957|NCT01488370|69190350|FG001|Overall Study|Protocol Violation|1|||
37711958|NCT01488370|69190351|FG002|Overall Study|Protocol Violation|1|||
37711959|NCT01518322|69190359|FG000|Overall Study|FeNO measurement was missing|13|||
37711960|NCT01507246|69190370|FG000|Overall Study|Required different surgical procedures|2|||
37711961|NCT01507246|69190371|FG001|Overall Study|Required different surgical procedures|1|||
37711962|NCT01507090|69190380|FG000|Overall Study|incomplete dataset|18|||
37711963|NCT01464346|69190394|FG000|Overall Study|Withdrawal by Subject|0|||
37711964|NCT01464346|69190395|FG001|Overall Study|Withdrawal by Subject|0|||
37711965|NCT01464346|69190396|FG002|Overall Study|Withdrawal by Subject|1|||
37711966|NCT01487200|69190423|FG000|Overall Study|Withdrawal by Subject|0|||
37711967|NCT01487200|69190424|FG001|Overall Study|Withdrawal by Subject|1|||
37711968|NCT01487200|69190425|FG002|Overall Study|Withdrawal by Subject|0|||
37711969|NCT01487200|69190426|FG003|Overall Study|Withdrawal by Subject|0|||
37711970|NCT01463878|69190439|FG000|Overall Study|no longer met criteria for tube feed|2|||
37711971|NCT01463878|69190440|FG001|Overall Study|no longer met criteria for tube feed|2|||
37711972|NCT01486966|69190448|FG000|Overall Study|Adverse Event|0|||
37711973|NCT01486966|69190449|FG001|Overall Study|Adverse Event|1|||
37711974|NCT01486966|69190448|FG000|Overall Study|Withdrawal by Subject|0|||
37711975|NCT01486966|69190449|FG001|Overall Study|Withdrawal by Subject|1|||
37711976|NCT01900665|69190457|FG000|Placebo Controlled Period|Death|9|||
37711977|NCT01900665|69190458|FG001|Placebo Controlled Period|Death|16|||
37711978|NCT01900665|69190457|FG000|Placebo Controlled Period|Adverse Event|48|||
37711979|NCT01900665|69190458|FG001|Placebo Controlled Period|Adverse Event|39|||
37711980|NCT01900665|69190457|FG000|Placebo Controlled Period|Protocol Violation|1|||
37711981|NCT01900665|69190458|FG001|Placebo Controlled Period|Protocol Violation|7|||
37711982|NCT01900665|69190457|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
37711983|NCT01900665|69190458|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
37711984|NCT01900665|69190457|FG000|Placebo Controlled Period|Physician Decision|11|||
37711985|NCT01900665|69190458|FG001|Placebo Controlled Period|Physician Decision|7|||
37711986|NCT01900665|69190457|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
37711987|NCT01900665|69190458|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
37711988|NCT01900665|69190457|FG000|Placebo Controlled Period|Caregiver Decision|33|||
37711989|NCT01900665|69190458|FG001|Placebo Controlled Period|Caregiver Decision|41|||
37711990|NCT01900665|69190457|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
37711991|NCT01900665|69190458|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
37711992|NCT01900665|69190457|FG000|Open Label Period|Adverse Event|16|||
37711993|NCT01900665|69190458|FG001|Open Label Period|Adverse Event|20|||
37711994|NCT01900665|69190457|FG000|Open Label Period|Death|5|||
37711995|NCT01900665|69190458|FG001|Open Label Period|Death|6|||
37711996|NCT01900665|69190457|FG000|Open Label Period|Lost to Follow-up|1|||
37711997|NCT01900665|69190458|FG001|Open Label Period|Lost to Follow-up|1|||
37711998|NCT01900665|69190457|FG000|Open Label Period|Parent/Caregiver Decision|33|||
37711999|NCT01900665|69190458|FG001|Open Label Period|Parent/Caregiver Decision|34|||
37838709|NCT00472641|69523275|FG000|Overall Study|Adverse Event|3|||
37712000|NCT01900665|69190457|FG000|Open Label Period|Physician Decision|4|||
37712001|NCT01900665|69190458|FG001|Open Label Period|Physician Decision|4|||
37712002|NCT01900665|69190457|FG000|Open Label Period|Protocol Violation|0|||
37712003|NCT01900665|69190458|FG001|Open Label Period|Protocol Violation|1|||
37712004|NCT01900665|69190457|FG000|Open Label Period|Sponsor Decision|802|||
37712005|NCT01900665|69190458|FG001|Open Label Period|Sponsor Decision|765|||
37712006|NCT01900665|69190457|FG000|Open Label Period|Withdrawal by Subject|20|||
37712007|NCT01900665|69190458|FG001|Open Label Period|Withdrawal by Subject|28|||
37712008|NCT01900431|69190469|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
37712009|NCT01900431|69190470|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
37712010|NCT01900431|69190471|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
37712011|NCT01900431|69190469|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
37712012|NCT01900431|69190470|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
37712013|NCT01900431|69190471|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
37712014|NCT01900431|69190469|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
37712015|NCT01900431|69190470|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
37712016|NCT01900431|69190471|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
37712017|NCT01900431|69190469|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
37712018|NCT01900431|69190470|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
37712019|NCT01900431|69190471|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
37712020|NCT01900431|69190469|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
37712021|NCT01900431|69190470|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
37712022|NCT01900431|69190471|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
37712023|NCT01900431|69190469|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
37712024|NCT01900431|69190470|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
37712025|NCT01900431|69190471|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
37712026|NCT01900431|69190469|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
37712027|NCT01900431|69190470|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
37712028|NCT01900431|69190471|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
37712029|NCT01900431|69190469|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
37712030|NCT01900431|69190470|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
37712031|NCT01900431|69190471|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
37712032|NCT01900431|69190469|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
37712033|NCT01900431|69190470|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
37712034|NCT01900431|69190471|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
37712035|NCT01948791|69190479|FG000|Overall Study|Adverse Event|12|||
37712036|NCT01948791|69190479|FG000|Overall Study|Lack of Efficacy|3|||
37712037|NCT01948791|69190479|FG000|Overall Study|Protocol Violation|2|||
37712038|NCT01948791|69190479|FG000|Overall Study|Withdrawal by Subject|5|||
37712039|NCT01948791|69190479|FG000|Overall Study|Lost to Follow-up|6|||
37712040|NCT01948791|69190479|FG000|Overall Study|Management issues|1|||
37712041|NCT01948791|69190479|FG000|Overall Study|Others|7|||
37712042|NCT01948791|69190479|FG000|Overall Study|Screening failure|35|||
37712043|NCT01899729|69190488|FG000|Overall Study|Adverse Event|1|||
37712044|NCT01899729|69190489|FG001|Overall Study|Adverse Event|0|||
37712045|NCT01899729|69190490|FG002|Overall Study|Adverse Event|0|||
37712046|NCT01899729|69190491|FG003|Overall Study|Adverse Event|0|||
37712047|NCT01899729|69190492|FG004|Overall Study|Adverse Event|1|||
37712048|NCT01899729|69190488|FG000|Overall Study|Withdrawal by Subject|1|||
37712049|NCT01899729|69190489|FG001|Overall Study|Withdrawal by Subject|2|||
37712050|NCT01899729|69190490|FG002|Overall Study|Withdrawal by Subject|0|||
37712051|NCT01899729|69190491|FG003|Overall Study|Withdrawal by Subject|0|||
37712052|NCT01899729|69190492|FG004|Overall Study|Withdrawal by Subject|0|||
37712053|NCT01899729|69190488|FG000|Overall Study|Lack of Efficacy|0|||
37712054|NCT01899729|69190489|FG001|Overall Study|Lack of Efficacy|0|||
37712055|NCT01899729|69190490|FG002|Overall Study|Lack of Efficacy|2|||
37712056|NCT01899729|69190491|FG003|Overall Study|Lack of Efficacy|0|||
37712057|NCT01899729|69190492|FG004|Overall Study|Lack of Efficacy|1|||
37712058|NCT01898091|69190506|FG000|Overall Study|Lost to Follow-up|1|||
37915416|NCT00882908|69602207|FG001|Overall Study|Adverse Event|0|||
37915417|NCT00882908|69602208|FG002|Overall Study|Adverse Event|1|||
37712059|NCT01898091|69190507|FG001|Overall Study|Lost to Follow-up|1|||
37712060|NCT01898091|69190506|FG000|Overall Study|Withdrawal by Subject|1|||
37712061|NCT01898091|69190507|FG001|Overall Study|Withdrawal by Subject|5|||
37712062|NCT01947855|69190516|FG000|Overall Study|Withdrawal by Subject|1|||
37712063|NCT01947855|69190517|FG001|Overall Study|Withdrawal by Subject|0|||
37712064|NCT01947855|69190518|FG002|Overall Study|Withdrawal by Subject|0|||
37712065|NCT01888965|69190526|FG000|Overall Study|Adverse Event|5|||
37712066|NCT01888965|69190526|FG000|Overall Study|Lack of Efficacy|4|||
37712067|NCT01888497|69190530|FG000|Washout Period 1|Withdrawal by Subject|0|||
37712068|NCT01888497|69190531|FG001|Washout Period 1|Withdrawal by Subject|0|||
37915418|NCT00882908|69602209|FG003|Overall Study|Adverse Event|0|||
37915419|NCT00882908|69602210|FG004|Overall Study|Adverse Event|1|||
37712069|NCT01888497|69190532|FG002|Washout Period 1|Withdrawal by Subject|1|||
37712070|NCT01888497|69190533|FG003|Washout Period 1|Withdrawal by Subject|1|||
37712071|NCT01888497|69190530|FG000|Washout Period 2|Adverse Event|0|||
37712072|NCT01888497|69190531|FG001|Washout Period 2|Adverse Event|0|||
37712073|NCT01888497|69190532|FG002|Washout Period 2|Adverse Event|0|||
37712074|NCT01888497|69190533|FG003|Washout Period 2|Adverse Event|1|||
37712075|NCT01888497|69190530|FG000|Washout Period 2|Withdrawal by Subject|0|||
37712076|NCT01888497|69190531|FG001|Washout Period 2|Withdrawal by Subject|0|||
37712077|NCT01888497|69190532|FG002|Washout Period 2|Withdrawal by Subject|0|||
37712078|NCT01888497|69190533|FG003|Washout Period 2|Withdrawal by Subject|1|||
37712079|NCT01505530|69190546|FG000|Overall Study|Progressive Disease|19|||
37712080|NCT01505530|69190547|FG001|Overall Study|Progressive Disease|17|||
37712081|NCT01505530|69190548|FG002|Overall Study|Progressive Disease|18|||
37712082|NCT01505530|69190546|FG000|Overall Study|Adverse Event|1|||
37712083|NCT01505530|69190547|FG001|Overall Study|Adverse Event|1|||
37712084|NCT01505530|69190548|FG002|Overall Study|Adverse Event|0|||
37712085|NCT01505530|69190546|FG000|Overall Study|Withdrawal by Subject|7|||
37712086|NCT01505530|69190547|FG001|Overall Study|Withdrawal by Subject|8|||
37712087|NCT01505530|69190548|FG002|Overall Study|Withdrawal by Subject|6|||
37712088|NCT01505530|69190546|FG000|Overall Study|Physician Decision|6|||
37712089|NCT01505530|69190547|FG001|Overall Study|Physician Decision|2|||
37712090|NCT01505530|69190548|FG002|Overall Study|Physician Decision|5|||
37712091|NCT01505530|69190546|FG000|Overall Study|Sponsor Decision|1|||
37712092|NCT01505530|69190547|FG001|Overall Study|Sponsor Decision|8|||
37712093|NCT01505530|69190548|FG002|Overall Study|Sponsor Decision|7|||
37712094|NCT01505530|69190546|FG000|Overall Study|Death|7|||
37712095|NCT01505530|69190547|FG001|Overall Study|Death|6|||
37712096|NCT01505530|69190548|FG002|Overall Study|Death|5|||
37712097|NCT01505530|69190546|FG000|Overall Study|entry criteria not met|0|||
37712098|NCT01505530|69190547|FG001|Overall Study|entry criteria not met|1|||
37712099|NCT01505530|69190548|FG002|Overall Study|entry criteria not met|0|||
37712100|NCT01485796|69190556|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
37712101|NCT01485796|69190556|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
37712102|NCT01485796|69190556|FG000|Period 2: Epoch 2|Adverse Event|3|||
37712103|NCT01485796|69190556|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
37712104|NCT01485796|69190556|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
37712105|NCT01485796|69190556|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
37712106|NCT01485796|69190556|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
37712107|NCT01485796|69190556|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
37712108|NCT01505374|69190564|FG000|Overall Study|Lost to Follow-up|1|||
37712109|NCT01505374|69190565|FG001|Overall Study|Lost to Follow-up|0|||
37712110|NCT01897233|69190572|FG000|Part B (24 Weeks)|Adverse Event|1|||
37712111|NCT01897233|69190572|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
37712112|NCT01897233|69190572|FG000|Part B (24 Weeks)|Physician Decision|1|||
37712113|NCT01887717|69190582|FG000|Overall Study|Withdrawal by Subject|1|||
37712114|NCT01887717|69190583|FG001|Overall Study|Withdrawal by Subject|7|||
37712115|NCT01887717|69190582|FG000|Overall Study|Physician Decision|0|||
37712116|NCT01887717|69190583|FG001|Overall Study|Physician Decision|2|||
37712117|NCT01887717|69190582|FG000|Overall Study|Administrative reasons|5|||
37712118|NCT01887717|69190583|FG001|Overall Study|Administrative reasons|2|||
37712119|NCT01886781|69190591|FG000|Overall Study|Protocol Violation|5|||
37712120|NCT01886781|69190592|FG001|Overall Study|Protocol Violation|0|||
37712121|NCT01886781|69190591|FG000|Overall Study|Adverse Event|1|||
37712122|NCT01886781|69190592|FG001|Overall Study|Adverse Event|0|||
37712123|NCT01886781|69190591|FG000|Overall Study|Lost to Follow-up|5|||
37712124|NCT01886781|69190592|FG001|Overall Study|Lost to Follow-up|0|||
37712125|NCT01886781|69190591|FG000|Overall Study|Withdrawal by Subject|2|||
37712126|NCT01886781|69190592|FG001|Overall Study|Withdrawal by Subject|1|||
37712127|NCT01886781|69190591|FG000|Overall Study|Worsening of symptoms|1|||
37915420|NCT00882908|69602206|FG000|Overall Study|Lost to Follow-up|3|||
37915421|NCT00882908|69602207|FG001|Overall Study|Lost to Follow-up|5|||
37712128|NCT01886781|69190592|FG001|Overall Study|Worsening of symptoms|1|||
37712129|NCT01463098|69190612|FG000|Part A (11 Days)|Participant Choice|2|||
37712130|NCT01463098|69190613|FG001|Part A (11 Days)|Participant Choice|0|||
37712131|NCT01463098|69190614|FG002|Part A (11 Days)|Participant Choice|0|||
37712132|NCT01463098|69190615|FG003|Part A (11 Days)|Participant Choice|0|||
37712133|NCT01463098|69190616|FG004|Part A (11 Days)|Participant Choice|0|||
37712134|NCT01463098|69190617|FG005|Part A (11 Days)|Participant Choice|0|||
37712135|NCT01463098|69190618|FG006|Part A (11 Days)|Participant Choice|0|||
37712136|NCT01463098|69190619|FG007|Part A (11 Days)|Participant Choice|0|||
37712137|NCT01463098|69190620|FG008|Part A (11 Days)|Participant Choice|1|||
37712138|NCT01463098|69190621|FG009|Part A (11 Days)|Participant Choice|0|||
37712139|NCT01463098|69190622|FG010|Part A (11 Days)|Participant Choice|0|||
37915422|NCT00882908|69602208|FG002|Overall Study|Lost to Follow-up|3|||
37712140|NCT01463098|69190623|FG011|Part A (11 Days)|Participant Choice|0|||
37712141|NCT01463098|69190624|FG012|Part A (11 Days)|Participant Choice|0|||
37915423|NCT00882908|69602209|FG003|Overall Study|Lost to Follow-up|1|||
37712142|NCT01463098|69190625|FG013|Part A (11 Days)|Participant Choice|0|||
37712143|NCT01463098|69190612|FG000|Part A (11 Days)|Lost to Follow-up|0|||
37712144|NCT01463098|69190613|FG001|Part A (11 Days)|Lost to Follow-up|0|||
37712145|NCT01463098|69190614|FG002|Part A (11 Days)|Lost to Follow-up|0|||
37712146|NCT01463098|69190615|FG003|Part A (11 Days)|Lost to Follow-up|0|||
37712147|NCT01463098|69190616|FG004|Part A (11 Days)|Lost to Follow-up|1|||
37712148|NCT01463098|69190617|FG005|Part A (11 Days)|Lost to Follow-up|0|||
37712149|NCT01463098|69190618|FG006|Part A (11 Days)|Lost to Follow-up|0|||
37712150|NCT01463098|69190619|FG007|Part A (11 Days)|Lost to Follow-up|0|||
37712151|NCT01463098|69190620|FG008|Part A (11 Days)|Lost to Follow-up|0|||
37712152|NCT01463098|69190621|FG009|Part A (11 Days)|Lost to Follow-up|0|||
37712153|NCT01463098|69190622|FG010|Part A (11 Days)|Lost to Follow-up|0|||
38024388|NCT04315298|69707945|FG006|Overall Study|Death|9|||
38024389|NCT04315298|69707946|FG007|Overall Study|Death|12|||
38024390|NCT04315298|69707947|FG008|Overall Study|Death|21|||
38024391|NCT04315298|69707948|FG009|Overall Study|Death|16|||
38024392|NCT04315298|69707949|FG010|Overall Study|Death|40|||
38024393|NCT04315298|69707950|FG011|Overall Study|Death|40|||
38024394|NCT04315298|69707951|FG012|Overall Study|Death|3|||
38024395|NCT04315298|69707952|FG013|Overall Study|Death|4|||
38024396|NCT04315298|69707953|FG014|Overall Study|Death|6|||
38024397|NCT04315298|69707954|FG015|Overall Study|Death|4|||
38024398|NCT04315298|69707955|FG016|Overall Study|Death|3|||
38024399|NCT04315298|69707956|FG017|Overall Study|Death|1|||
38024400|NCT04315298|69707957|FG018|Overall Study|Death|0|||
38024401|NCT04308668|69708026|FG000|Overall Study|Lost to Follow-up|32|||
38024402|NCT04308668|69708027|FG001|Overall Study|Lost to Follow-up|38|||
38024403|NCT04308668|69708026|FG000|Overall Study|Withdrawal by Subject|4|||
38024404|NCT04308668|69708027|FG001|Overall Study|Withdrawal by Subject|4|||
38024405|NCT04451330|69708035|FG000|Overall Study|Adverse Event|1|||
38024406|NCT04451330|69708036|FG001|Overall Study|Adverse Event|2|||
38024407|NCT04451330|69708035|FG000|Overall Study|Lost to Follow-up|5|||
38024408|NCT04451330|69708036|FG001|Overall Study|Lost to Follow-up|0|||
38024409|NCT04451330|69708035|FG000|Overall Study|Withdrawal by Subject|3|||
38024410|NCT04451330|69708036|FG001|Overall Study|Withdrawal by Subject|1|||
38024411|NCT04451330|69708035|FG000|Overall Study|Withdrawal by parent/guardian|1|||
38024412|NCT04451330|69708036|FG001|Overall Study|Withdrawal by parent/guardian|0|||
38024413|NCT04451330|69708035|FG000|Overall Study|Other than specified|0|||
38024414|NCT04451330|69708036|FG001|Overall Study|Other than specified|1|||
38024415|NCT02493426|69708042|FG000|Overall Study|Withdrawal by Subject|0|||
38024416|NCT02493426|69708043|FG001|Overall Study|Withdrawal by Subject|1|||
38024417|NCT04448756|69708052|FG000|Overall Study|Adverse Event|0|||
38024418|NCT04448756|69708053|FG001|Overall Study|Adverse Event|1|||
38024419|NCT04448756|69708054|FG002|Overall Study|Adverse Event|0|||
38024420|NCT04448756|69708052|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
38024421|NCT04448756|69708053|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
38024422|NCT04448756|69708054|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
38024423|NCT04448756|69708052|FG000|Overall Study|Withdrawal by Subject|0|||
38024424|NCT04448756|69708053|FG001|Overall Study|Withdrawal by Subject|3|||
38024425|NCT04448756|69708054|FG002|Overall Study|Withdrawal by Subject|1|||
38024426|NCT04448756|69708052|FG000|Overall Study|Death|2|||
38024427|NCT04448756|69708053|FG001|Overall Study|Death|1|||
38024428|NCT04448756|69708054|FG002|Overall Study|Death|0|||
38024429|NCT04274192|69708064|FG000|Overall Study|Protocol Violation|1|||
38024430|NCT04274192|69708065|FG001|Overall Study|Protocol Violation|0|||
38024431|NCT04387136|69708075|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
38024432|NCT04387136|69708076|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
38024433|NCT04252586|69708082|FG000|Overall Study|Withdrawal by parent/guardian|3|||
38024434|NCT04252586|69708082|FG000|Overall Study|Adverse Event|1|||
38024435|NCT04252586|69708082|FG000|Overall Study|Death|2|||
38024436|NCT04252586|69708082|FG000|Overall Study|Study terminated by sponsor|4|||
38024437|NCT04252586|69708082|FG000|Overall Study|Sponsor request|10|||
37712154|NCT01463098|69190623|FG011|Part A (11 Days)|Lost to Follow-up|0|||
37712155|NCT01463098|69190624|FG012|Part A (11 Days)|Lost to Follow-up|0|||
37712156|NCT01463098|69190625|FG013|Part A (11 Days)|Lost to Follow-up|0|||
37712157|NCT01463098|69190612|FG000|Part B (11 Days)|Participant Choice|0|||
38024438|NCT04252586|69708082|FG000|Overall Study|Did not complete treatment period|1|||
38024439|NCT04247828|69708087|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
38024440|NCT04507776|69708091|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
38024441|NCT04386902|69708100|FG000|Overall Study|Withdrawal by Subject|5|||
38024442|NCT04386902|69708100|FG000|Overall Study|Technical problems in the recording|5|||
38024443|NCT04232540|69708106|FG000|Overall Study|Lost to Follow-up|1|||
38024444|NCT04232540|69708107|FG001|Overall Study|Lost to Follow-up|0|||
38024445|NCT04504032|69708115|FG000|Overall Study|Adverse Event|1|||
38024446|NCT04504032|69708116|FG001|Overall Study|Adverse Event|2|||
38024447|NCT04504032|69708115|FG000|Overall Study|Lost to Follow-up|6|||
38024448|NCT04504032|69708116|FG001|Overall Study|Lost to Follow-up|9|||
37712158|NCT01463098|69190613|FG001|Part B (11 Days)|Participant Choice|0|||
37712159|NCT01463098|69190614|FG002|Part B (11 Days)|Participant Choice|0|||
37712160|NCT01463098|69190615|FG003|Part B (11 Days)|Participant Choice|0|||
37712161|NCT01463098|69190616|FG004|Part B (11 Days)|Participant Choice|0|||
37712162|NCT01463098|69190617|FG005|Part B (11 Days)|Participant Choice|0|||
37712163|NCT01463098|69190618|FG006|Part B (11 Days)|Participant Choice|0|||
37712164|NCT01463098|69190619|FG007|Part B (11 Days)|Participant Choice|0|||
37712165|NCT01463098|69190620|FG008|Part B (11 Days)|Participant Choice|0|||
37712166|NCT01463098|69190621|FG009|Part B (11 Days)|Participant Choice|0|||
37712167|NCT01463098|69190622|FG010|Part B (11 Days)|Participant Choice|0|||
37712168|NCT01463098|69190623|FG011|Part B (11 Days)|Participant Choice|1|||
37712169|NCT01463098|69190624|FG012|Part B (11 Days)|Participant Choice|0|||
37712170|NCT01463098|69190625|FG013|Part B (11 Days)|Participant Choice|0|||
38024449|NCT04504032|69708115|FG000|Overall Study|Protocol Violation|2|||
38024450|NCT04504032|69708116|FG001|Overall Study|Protocol Violation|0|||
38024451|NCT04504032|69708115|FG000|Overall Study|Study terminated by sponsor|1|||
38024452|NCT04504032|69708116|FG001|Overall Study|Study terminated by sponsor|2|||
38024453|NCT04504032|69708115|FG000|Overall Study|Withdrawal by Subject|9|||
38024454|NCT04504032|69708116|FG001|Overall Study|Withdrawal by Subject|11|||
38024455|NCT04504032|69708115|FG000|Overall Study|Disease progression prior to dosing|15|||
38024456|NCT04504032|69708116|FG001|Overall Study|Disease progression prior to dosing|3|||
38024457|NCT04504032|69708115|FG000|Overall Study|Drug supply issues|1|||
38024458|NCT04504032|69708116|FG001|Overall Study|Drug supply issues|1|||
38024459|NCT04504032|69708115|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
38024460|NCT04504032|69708116|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
37712183|NCT01462942|69190695|FG000|Overall Study|Adverse Event|7|||
37712184|NCT01462942|69190696|FG001|Overall Study|Adverse Event|12|||
37712185|NCT01462942|69190697|FG002|Overall Study|Adverse Event|10|||
37712186|NCT01462942|69190698|FG003|Overall Study|Adverse Event|11|||
37712187|NCT01462942|69190699|FG004|Overall Study|Adverse Event|11|||
37712188|NCT01462942|69190695|FG000|Overall Study|Other, including COPD exacerbation|3|||
37712189|NCT01462942|69190696|FG001|Overall Study|Other, including COPD exacerbation|5|||
37712190|NCT01462942|69190697|FG002|Overall Study|Other, including COPD exacerbation|2|||
37712191|NCT01462942|69190698|FG003|Overall Study|Other, including COPD exacerbation|8|||
37712192|NCT01462942|69190699|FG004|Overall Study|Other, including COPD exacerbation|5|||
37712193|NCT01462942|69190695|FG000|Overall Study|Withdrawal by Subject|14|||
37712194|NCT01462942|69190696|FG001|Overall Study|Withdrawal by Subject|10|||
37712195|NCT01462942|69190697|FG002|Overall Study|Withdrawal by Subject|14|||
37712196|NCT01462942|69190698|FG003|Overall Study|Withdrawal by Subject|16|||
37712197|NCT01462942|69190699|FG004|Overall Study|Withdrawal by Subject|19|||
37712198|NCT01462942|69190695|FG000|Overall Study|Lack of Efficacy|6|||
37712199|NCT01462942|69190696|FG001|Overall Study|Lack of Efficacy|0|||
37712200|NCT01462942|69190697|FG002|Overall Study|Lack of Efficacy|4|||
37712201|NCT01462942|69190698|FG003|Overall Study|Lack of Efficacy|5|||
37712202|NCT01462942|69190699|FG004|Overall Study|Lack of Efficacy|3|||
37712203|NCT01462942|69190695|FG000|Overall Study|Lost to Follow-up|0|||
37712204|NCT01462942|69190696|FG001|Overall Study|Lost to Follow-up|1|||
37712205|NCT01462942|69190697|FG002|Overall Study|Lost to Follow-up|1|||
37712206|NCT01462942|69190698|FG003|Overall Study|Lost to Follow-up|1|||
37712207|NCT01462942|69190699|FG004|Overall Study|Lost to Follow-up|1|||
37712208|NCT01462942|69190695|FG000|Overall Study|Protocol Violation|4|||
37712209|NCT01462942|69190696|FG001|Overall Study|Protocol Violation|6|||
37712210|NCT01462942|69190697|FG002|Overall Study|Protocol Violation|9|||
37712211|NCT01462942|69190698|FG003|Overall Study|Protocol Violation|9|||
37712212|NCT01462942|69190699|FG004|Overall Study|Protocol Violation|6|||
37712213|NCT01462630|69190711|FG000|Overall Study|Did not initiate therapy|3|||
37712214|NCT01462630|69190711|FG000|Overall Study|Death|1|||
37712215|NCT01462630|69190711|FG000|Overall Study|Protocol Violation|2|||
37712216|NCT01462630|69190711|FG000|Overall Study|Adverse Event|1|||
37712217|NCT01504204|69190717|FG000|Overall Study|Lost to Follow-up|1|||
37712218|NCT01504204|69190718|FG001|Overall Study|Lost to Follow-up|1|||
37712219|NCT01485640|69190724|FG000|Overall Study|Adverse Event|10|||
37712220|NCT01485640|69190724|FG000|Overall Study|Lack of Efficacy|2|||
37712221|NCT01485640|69190724|FG000|Overall Study|Protocol Violation|1|||
37712222|NCT01485640|69190724|FG000|Overall Study|Withdrawal by Subject|14|||
37712223|NCT01485640|69190724|FG000|Overall Study|Terminated by Sponsor|95|||
37712224|NCT02118961|69190730|FG000|Overall Study|Withdrawal by Subject|1|||
37712225|NCT02118961|69190731|FG001|Overall Study|Withdrawal by Subject|0|||
37712226|NCT02140645|69190743|FG000|Overall Study|Not linked|5489|||
37712227|NCT02140645|69190744|FG001|Overall Study|Not linked|61654|||
37712228|NCT02140645|69190745|FG002|Overall Study|Not linked|4236|||
37712229|NCT02140645|69190746|FG003|Overall Study|Not linked|13833|||
37712230|NCT02140645|69190747|FG004|Overall Study|Not linked|3286|||
37712231|NCT02140645|69190748|FG005|Overall Study|Not linked|70896|||
37712232|NCT02140567|69190757|FG000|Overall Study|Problems with recording equipment|6|||
37712233|NCT02140411|69190762|FG000|Overall Study|Adverse Event|1|||
37712234|NCT02139943|69190769|FG000|Overall Study|Adverse Event|0|||
37712235|NCT02139943|69190770|FG001|Overall Study|Adverse Event|1|||
37712236|NCT02139943|69190771|FG002|Overall Study|Adverse Event|2|||
37712237|NCT02139943|69190769|FG000|Overall Study|Lost to Follow-up|3|||
37712238|NCT02139943|69190770|FG001|Overall Study|Lost to Follow-up|2|||
37712239|NCT02139943|69190771|FG002|Overall Study|Lost to Follow-up|2|||
37712240|NCT02139943|69190769|FG000|Overall Study|Withdrawal by Subject|4|||
37712241|NCT02139943|69190770|FG001|Overall Study|Withdrawal by Subject|3|||
37712242|NCT02139943|69190771|FG002|Overall Study|Withdrawal by Subject|0|||
37712243|NCT02139943|69190769|FG000|Overall Study|Other|0|||
37712244|NCT02139943|69190770|FG001|Overall Study|Other|0|||
37712245|NCT02139943|69190771|FG002|Overall Study|Other|1|||
37712246|NCT02139943|69190769|FG000|Overall Study|Participant wishes to discontinue|2|||
37712247|NCT02139943|69190770|FG001|Overall Study|Participant wishes to discontinue|0|||
37712248|NCT02139943|69190771|FG002|Overall Study|Participant wishes to discontinue|0|||
37712249|NCT02139943|69190769|FG000|Overall Study|Participant in Poor Compliance|1|||
37712250|NCT02139943|69190770|FG001|Overall Study|Participant in Poor Compliance|0|||
37712251|NCT02139943|69190771|FG002|Overall Study|Participant in Poor Compliance|1|||
37712252|NCT02139943|69190769|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
37712253|NCT02139943|69190770|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
37712254|NCT02139943|69190771|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
37712255|NCT01485172|69190785|FG000|Overall Study|Adverse Event|2|||
37712256|NCT01485172|69190786|FG001|Overall Study|Adverse Event|1|||
37712257|NCT01485172|69190787|FG002|Overall Study|Adverse Event|2|||
37712258|NCT01485172|69190788|FG003|Overall Study|Adverse Event|2|||
37712259|NCT01485172|69190789|FG004|Overall Study|Adverse Event|1|||
37712260|NCT01485172|69190790|FG005|Overall Study|Adverse Event|2|||
37712261|NCT01485172|69190785|FG000|Overall Study|Lack of Efficacy|2|||
37712262|NCT01485172|69190786|FG001|Overall Study|Lack of Efficacy|0|||
37712263|NCT01485172|69190787|FG002|Overall Study|Lack of Efficacy|0|||
37712264|NCT01485172|69190788|FG003|Overall Study|Lack of Efficacy|0|||
38024461|NCT04439240|69708122|FG000|Overall Study|Ineligible|2|||
38024462|NCT04439240|69708122|FG000|Overall Study|Never started treatment|2|||
38024463|NCT04439240|69708122|FG000|Overall Study|Adverse Event|12|||
37712265|NCT01485172|69190789|FG004|Overall Study|Lack of Efficacy|0|||
37712266|NCT01485172|69190790|FG005|Overall Study|Lack of Efficacy|0|||
38024464|NCT04439240|69708122|FG000|Overall Study|Death|2|||
37712267|NCT01485172|69190785|FG000|Overall Study|Protocol Violation|0|||
37712268|NCT01485172|69190786|FG001|Overall Study|Protocol Violation|0|||
37712269|NCT01485172|69190787|FG002|Overall Study|Protocol Violation|4|||
37712270|NCT01485172|69190788|FG003|Overall Study|Protocol Violation|5|||
37712271|NCT01485172|69190789|FG004|Overall Study|Protocol Violation|1|||
37712272|NCT01485172|69190790|FG005|Overall Study|Protocol Violation|0|||
37712273|NCT01485172|69190785|FG000|Overall Study|Protocol defined stopping criteria|1|||
37712274|NCT01485172|69190786|FG001|Overall Study|Protocol defined stopping criteria|0|||
37712275|NCT01485172|69190787|FG002|Overall Study|Protocol defined stopping criteria|0|||
37712276|NCT01485172|69190788|FG003|Overall Study|Protocol defined stopping criteria|0|||
37712277|NCT01485172|69190789|FG004|Overall Study|Protocol defined stopping criteria|1|||
37712278|NCT01485172|69190790|FG005|Overall Study|Protocol defined stopping criteria|0|||
37712279|NCT01485172|69190785|FG000|Overall Study|Lost to Follow-up|0|||
37712280|NCT01485172|69190786|FG001|Overall Study|Lost to Follow-up|0|||
37712281|NCT01485172|69190787|FG002|Overall Study|Lost to Follow-up|1|||
37712282|NCT01485172|69190788|FG003|Overall Study|Lost to Follow-up|0|||
37712283|NCT01485172|69190789|FG004|Overall Study|Lost to Follow-up|0|||
37712284|NCT01485172|69190790|FG005|Overall Study|Lost to Follow-up|1|||
37712285|NCT01485172|69190785|FG000|Overall Study|Physician Decision|0|||
37712286|NCT01485172|69190786|FG001|Overall Study|Physician Decision|0|||
37712287|NCT01485172|69190787|FG002|Overall Study|Physician Decision|0|||
37712288|NCT01485172|69190788|FG003|Overall Study|Physician Decision|0|||
37712289|NCT01485172|69190789|FG004|Overall Study|Physician Decision|1|||
37712290|NCT01485172|69190790|FG005|Overall Study|Physician Decision|0|||
37712291|NCT01485172|69190785|FG000|Overall Study|Withdrawal by Subject|2|||
37712292|NCT01485172|69190786|FG001|Overall Study|Withdrawal by Subject|0|||
37712293|NCT01485172|69190787|FG002|Overall Study|Withdrawal by Subject|0|||
37712294|NCT01485172|69190788|FG003|Overall Study|Withdrawal by Subject|1|||
37712295|NCT01485172|69190789|FG004|Overall Study|Withdrawal by Subject|1|||
37712296|NCT01485172|69190790|FG005|Overall Study|Withdrawal by Subject|1|||
37712297|NCT02105701|69190808|FG000|Overall Study|Lost to Follow-up|1|||
37712298|NCT02105701|69190809|FG001|Overall Study|Lost to Follow-up|0|||
37712299|NCT02105701|69190810|FG002|Overall Study|Lost to Follow-up|2|||
37712300|NCT02105701|69190811|FG003|Overall Study|Lost to Follow-up|1|||
37712301|NCT02105701|69190808|FG000|Overall Study|Protocol Violation|0|||
37712302|NCT02105701|69190809|FG001|Overall Study|Protocol Violation|0|||
37712303|NCT02105701|69190810|FG002|Overall Study|Protocol Violation|1|||
37712304|NCT02105701|69190811|FG003|Overall Study|Protocol Violation|0|||
37712305|NCT02105701|69190808|FG000|Overall Study|Withdrawal by Subject|2|||
37712306|NCT02105701|69190809|FG001|Overall Study|Withdrawal by Subject|1|||
37712307|NCT02105701|69190810|FG002|Overall Study|Withdrawal by Subject|0|||
37712308|NCT02105701|69190811|FG003|Overall Study|Withdrawal by Subject|1|||
37712309|NCT02105701|69190808|FG000|Overall Study|Death|1|||
37712310|NCT02105701|69190809|FG001|Overall Study|Death|0|||
37712311|NCT02105701|69190810|FG002|Overall Study|Death|0|||
37712312|NCT02105701|69190811|FG003|Overall Study|Death|0|||
37712313|NCT01502956|69190823|FG000|Overall Study|Death|0|||
37712314|NCT01502956|69190824|FG001|Overall Study|Death|2|||
37712315|NCT01502956|69190823|FG000|Overall Study|Lost to Follow-up|14|||
37712316|NCT01502956|69190824|FG001|Overall Study|Lost to Follow-up|11|||
37712317|NCT01502956|69190823|FG000|Overall Study|Physician Decision|2|||
37712318|NCT01502956|69190824|FG001|Overall Study|Physician Decision|3|||
37712319|NCT01502956|69190823|FG000|Overall Study|Withdrawal by Subject|8|||
37712320|NCT01502956|69190824|FG001|Overall Study|Withdrawal by Subject|10|||
37712321|NCT01502644|69190833|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
37712322|NCT01502644|69190834|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
37712323|NCT01502644|69190835|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
37712324|NCT01502644|69190836|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
37712325|NCT01502644|69190833|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
37712326|NCT01502644|69190834|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
37712327|NCT01502644|69190835|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
37712328|NCT01502644|69190836|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
37712329|NCT01502644|69190833|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
37712330|NCT01502644|69190834|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
37712331|NCT01502644|69190835|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
37712332|NCT01502644|69190836|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
37712333|NCT01502644|69190833|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
37712334|NCT01502644|69190834|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
37712335|NCT01502644|69190835|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
37712336|NCT01502644|69190836|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
37712337|NCT01502644|69190833|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
37712338|NCT01502644|69190834|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
37712339|NCT01502644|69190835|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
37712340|NCT01502644|69190836|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
37712341|NCT01462318|69190846|FG000|Main Study / TP-DI Study|Other|2|||
37712342|NCT01462318|69190847|FG001|Main Study / TP-DI Study|Other|0|||
37712343|NCT01462318|69190848|FG002|Main Study / TP-DI Study|Other|0|||
37712344|NCT01462318|69190846|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
37712345|NCT01462318|69190847|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
37712346|NCT01462318|69190848|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
37712347|NCT01462318|69190846|FG000|Main Study / TP-DI Study|Adverse Event|4|||
37712348|NCT01462318|69190847|FG001|Main Study / TP-DI Study|Adverse Event|0|||
37712349|NCT01462318|69190848|FG002|Main Study / TP-DI Study|Adverse Event|0|||
37712350|NCT01462318|69190846|FG000|Extension Phase|Lost to Follow-up|0|||
37712351|NCT01462318|69190847|FG001|Extension Phase|Lost to Follow-up|0|||
37712352|NCT01462318|69190848|FG002|Extension Phase|Lost to Follow-up|1|||
37712353|NCT01462318|69190846|FG000|Extension Phase|Other|0|||
37712354|NCT01462318|69190847|FG001|Extension Phase|Other|0|||
37712355|NCT01462318|69190848|FG002|Extension Phase|Other|1|||
37712356|NCT01462318|69190846|FG000|Extension Phase|Disease Progression|0|||
37712357|NCT01462318|69190847|FG001|Extension Phase|Disease Progression|0|||
37712358|NCT01462318|69190848|FG002|Extension Phase|Disease Progression|1|||
37712359|NCT01462318|69190846|FG000|Extension Phase|Withdrawal by Subject|0|||
37712360|NCT01462318|69190847|FG001|Extension Phase|Withdrawal by Subject|0|||
37712361|NCT01462318|69190848|FG002|Extension Phase|Withdrawal by Subject|15|||
37712362|NCT01462318|69190846|FG000|Extension Phase|Investigator Decision|0|||
37712363|NCT01462318|69190847|FG001|Extension Phase|Investigator Decision|0|||
37712364|NCT01462318|69190848|FG002|Extension Phase|Investigator Decision|5|||
37712365|NCT01462318|69190846|FG000|Extension Phase|Adverse Event|0|||
37712366|NCT01462318|69190847|FG001|Extension Phase|Adverse Event|0|||
37712367|NCT01462318|69190848|FG002|Extension Phase|Adverse Event|22|||
37712368|NCT01485094|69190856|FG000|Overall Study|Adverse Event|1|||
37712369|NCT01485094|69190857|FG001|Overall Study|Adverse Event|1|||
37712370|NCT01485094|69190858|FG002|Overall Study|Adverse Event|1|||
37712371|NCT01485094|69190856|FG000|Overall Study|Lost to Follow-up|1|||
37712372|NCT01485094|69190857|FG001|Overall Study|Lost to Follow-up|0|||
37712373|NCT01485094|69190858|FG002|Overall Study|Lost to Follow-up|0|||
37712374|NCT01485094|69190856|FG000|Overall Study|Withdrawal by Subject|1|||
37712375|NCT01485094|69190857|FG001|Overall Study|Withdrawal by Subject|1|||
37712376|NCT01485094|69190858|FG002|Overall Study|Withdrawal by Subject|0|||
37712377|NCT01484938|69190866|FG000|Overall Study|Adverse Event|2|||
37712378|NCT01484938|69190866|FG000|Overall Study|Lost to Follow-up|1|||
37712379|NCT01484938|69190866|FG000|Overall Study|Noncompliance|1|||
37712380|NCT01502410|69190874|FG000|Overall Study|Adverse Event|1|||
37712381|NCT01502410|69190875|FG001|Overall Study|Adverse Event|2|||
37712382|NCT01502410|69190876|FG002|Overall Study|Adverse Event|0|||
37712383|NCT01502410|69190877|FG003|Overall Study|Adverse Event|0|||
37712384|NCT01502410|69190874|FG000|Overall Study|Lack of Efficacy|7|||
37712385|NCT01502410|69190875|FG001|Overall Study|Lack of Efficacy|7|||
37712386|NCT01502410|69190876|FG002|Overall Study|Lack of Efficacy|0|||
37712387|NCT01502410|69190877|FG003|Overall Study|Lack of Efficacy|0|||
37712388|NCT01502410|69190874|FG000|Overall Study|Physician Decision|0|||
37712389|NCT01502410|69190875|FG001|Overall Study|Physician Decision|1|||
37712390|NCT01502410|69190876|FG002|Overall Study|Physician Decision|0|||
37712391|NCT01502410|69190877|FG003|Overall Study|Physician Decision|0|||
37712392|NCT01502410|69190874|FG000|Overall Study|Withdrawal by Subject|2|||
37712393|NCT01502410|69190875|FG001|Overall Study|Withdrawal by Subject|0|||
37712394|NCT01502410|69190876|FG002|Overall Study|Withdrawal by Subject|0|||
37712395|NCT01502410|69190877|FG003|Overall Study|Withdrawal by Subject|0|||
37712396|NCT01462162|69190886|FG000|Overall Study|Adverse Event|5|||
37712397|NCT01462162|69190886|FG000|Overall Study|Lack of Efficacy|4|||
37712398|NCT01462162|69190886|FG000|Overall Study|Abnormal laboratory parameters|1|||
37712399|NCT01462162|69190886|FG000|Overall Study|Other|2|||
37712400|NCT01483924|69190896|FG000|Overall Study|Withdrawal by Subject|2|||
37712401|NCT01483924|69190897|FG001|Overall Study|Withdrawal by Subject|0|||
37712402|NCT01483924|69190898|FG002|Overall Study|Withdrawal by Subject|0|||
37712403|NCT01483924|69190899|FG003|Overall Study|Withdrawal by Subject|1|||
38024465|NCT04439240|69708122|FG000|Overall Study|Disease progression|25|||
38024466|NCT04439240|69708122|FG000|Overall Study|Other diseases|2|||
38024467|NCT04439240|69708122|FG000|Overall Study|Withdrawal by Subject|3|||
38024468|NCT04439240|69708122|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
38024469|NCT04439240|69708122|FG000|Overall Study|Symptomatic decline|1|||
38024470|NCT04439240|69708122|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
38024471|NCT04439240|69708122|FG000|Overall Study|Clinical progression|1|||
38024472|NCT04605588|69708128|FG000|Overall Study|Withdrawal by Subject|1|||
38024473|NCT04605588|69708129|FG001|Overall Study|Withdrawal by Subject|0|||
38024474|NCT04885296|69708135|FG000|Period 1|Covid-19 Related|1|||
38024475|NCT04885296|69708136|FG001|Period 1|Covid-19 Related|0|||
38024476|NCT04885296|69708135|FG000|Period 1|Adverse Event|0|||
38024477|NCT04885296|69708136|FG001|Period 1|Adverse Event|1|||
38024478|NCT04885296|69708135|FG000|Period 1|Withdrawal by Subject|1|||
38024479|NCT04885296|69708136|FG001|Period 1|Withdrawal by Subject|1|||
38024480|NCT04885296|69708135|FG000|Period 1|Test Article No Longer Available|1|||
38024481|NCT04885296|69708136|FG001|Period 1|Test Article No Longer Available|0|||
38024482|NCT04885296|69708135|FG000|Period 1|Dispensed Study lens in Error|1|||
38024483|NCT04885296|69708136|FG001|Period 1|Dispensed Study lens in Error|0|||
38024484|NCT04885296|69708135|FG000|Period 1|Lost to Follow-up|1|||
38024485|NCT04885296|69708136|FG001|Period 1|Lost to Follow-up|0|||
38024486|NCT04885296|69708135|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
38024487|NCT04885296|69708136|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
38024488|NCT04602000|69708147|FG000|Overall Study|Withdrawal by Subject|3|||
38024489|NCT04602000|69708148|FG001|Overall Study|Withdrawal by Subject|6|||
38024490|NCT04602000|69708149|FG002|Overall Study|Withdrawal by Subject|3|||
38024491|NCT04602000|69708150|FG003|Overall Study|Withdrawal by Subject|27|||
38024492|NCT04602000|69708151|FG004|Overall Study|Withdrawal by Subject|39|||
38024493|NCT04602000|69708147|FG000|Overall Study|Physician Decision|1|||
38024494|NCT04602000|69708148|FG001|Overall Study|Physician Decision|0|||
37712404|NCT01483924|69190900|FG004|Overall Study|Withdrawal by Subject|1|||
37712405|NCT01483924|69190896|FG000|Overall Study|Adverse Event|0|||
37712406|NCT01483924|69190897|FG001|Overall Study|Adverse Event|0|||
37712407|NCT01483924|69190898|FG002|Overall Study|Adverse Event|1|||
38024495|NCT04602000|69708149|FG002|Overall Study|Physician Decision|0|||
38024496|NCT04602000|69708150|FG003|Overall Study|Physician Decision|2|||
38024497|NCT04602000|69708151|FG004|Overall Study|Physician Decision|2|||
38024498|NCT04602000|69708147|FG000|Overall Study|Death|0|||
38024499|NCT04602000|69708148|FG001|Overall Study|Death|1|||
38024500|NCT04602000|69708149|FG002|Overall Study|Death|0|||
37712408|NCT01483924|69190899|FG003|Overall Study|Adverse Event|1|||
37712409|NCT01483924|69190900|FG004|Overall Study|Adverse Event|0|||
38024501|NCT04602000|69708150|FG003|Overall Study|Death|1|||
38024502|NCT04602000|69708151|FG004|Overall Study|Death|2|||
38024503|NCT04602000|69708147|FG000|Overall Study|Lost to Follow-up|0|||
38024504|NCT04602000|69708148|FG001|Overall Study|Lost to Follow-up|0|||
38024505|NCT04602000|69708149|FG002|Overall Study|Lost to Follow-up|0|||
38024506|NCT04602000|69708150|FG003|Overall Study|Lost to Follow-up|3|||
38024507|NCT04602000|69708151|FG004|Overall Study|Lost to Follow-up|4|||
38024508|NCT04602000|69708147|FG000|Overall Study|Other|4|||
38024509|NCT04602000|69708148|FG001|Overall Study|Other|1|||
38024510|NCT04602000|69708149|FG002|Overall Study|Other|2|||
38024511|NCT04602000|69708150|FG003|Overall Study|Other|5|||
38024512|NCT04602000|69708151|FG004|Overall Study|Other|4|||
38024513|NCT04602000|69708147|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
38024514|NCT04602000|69708148|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
38024515|NCT04602000|69708149|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
38024516|NCT04602000|69708150|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
38024517|NCT04602000|69708151|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
38024518|NCT03041116|69708167|FG000|Double-blind|Death|0|||
38024519|NCT03041116|69708168|FG001|Double-blind|Death|2|||
38024520|NCT03041116|69708167|FG000|Double-blind|Withdrawal by Subject|0|||
38024521|NCT03041116|69708168|FG001|Double-blind|Withdrawal by Subject|4|||
38024522|NCT03041116|69708167|FG000|Open-label|Death|1|||
38024523|NCT03041116|69708168|FG001|Open-label|Death|0|||
38024524|NCT03041116|69708167|FG000|Open-label|Termination of the study by Sponsor|39|||
38024525|NCT03041116|69708168|FG001|Open-label|Termination of the study by Sponsor|37|||
37712410|NCT01483924|69190896|FG000|Overall Study|Non-compliance|0|||
37712411|NCT01483924|69190897|FG001|Overall Study|Non-compliance|0|||
37712412|NCT01483924|69190898|FG002|Overall Study|Non-compliance|0|||
37712413|NCT01483924|69190899|FG003|Overall Study|Non-compliance|1|||
37712414|NCT01483924|69190900|FG004|Overall Study|Non-compliance|1|||
37712415|NCT01483924|69190896|FG000|Overall Study|Sponsor concern over ECG result|0|||
37712416|NCT01483924|69190897|FG001|Overall Study|Sponsor concern over ECG result|0|||
37712417|NCT01483924|69190898|FG002|Overall Study|Sponsor concern over ECG result|0|||
37712418|NCT01483924|69190899|FG003|Overall Study|Sponsor concern over ECG result|1|||
37712419|NCT01483924|69190900|FG004|Overall Study|Sponsor concern over ECG result|0|||
37712420|NCT01462084|69190921|FG000|Overall Study|Withdrawal by Subject|1|||
37712421|NCT01462084|69190922|FG001|Overall Study|Withdrawal by Subject|0|||
37712422|NCT01462084|69190921|FG000|Overall Study|Protocol Violation|1|||
37712423|NCT01462084|69190922|FG001|Overall Study|Protocol Violation|1|||
37712424|NCT02134028|69190937|FG000|Overall Study|Lack of Efficacy|1|||
37712425|NCT02134028|69190938|FG001|Overall Study|Lack of Efficacy|0|||
37712426|NCT02134028|69190939|FG002|Overall Study|Lack of Efficacy|3|||
37712427|NCT02134028|69190940|FG003|Overall Study|Lack of Efficacy|2|||
37712428|NCT02134028|69190941|FG004|Overall Study|Lack of Efficacy|1|||
37712429|NCT02134028|69190942|FG005|Overall Study|Lack of Efficacy|2|||
37712430|NCT02134028|69190943|FG006|Overall Study|Lack of Efficacy|1|||
37712431|NCT02134028|69190944|FG007|Overall Study|Lack of Efficacy|0|||
37712432|NCT02134028|69190937|FG000|Overall Study|Poor compliance to protocol|1|||
37712433|NCT02134028|69190938|FG001|Overall Study|Poor compliance to protocol|1|||
37712434|NCT02134028|69190939|FG002|Overall Study|Poor compliance to protocol|3|||
37712435|NCT02134028|69190940|FG003|Overall Study|Poor compliance to protocol|7|||
37712436|NCT02134028|69190941|FG004|Overall Study|Poor compliance to protocol|1|||
37712437|NCT02134028|69190942|FG005|Overall Study|Poor compliance to protocol|1|||
37712438|NCT02134028|69190943|FG006|Overall Study|Poor compliance to protocol|0|||
37712439|NCT02134028|69190944|FG007|Overall Study|Poor compliance to protocol|0|||
37712440|NCT02134028|69190937|FG000|Overall Study|Other unspecified|4|||
37712441|NCT02134028|69190938|FG001|Overall Study|Other unspecified|22|||
37712442|NCT02134028|69190939|FG002|Overall Study|Other unspecified|33|||
37712443|NCT02134028|69190940|FG003|Overall Study|Other unspecified|64|||
37712444|NCT02134028|69190941|FG004|Overall Study|Other unspecified|8|||
37712445|NCT02134028|69190942|FG005|Overall Study|Other unspecified|6|||
37712446|NCT02134028|69190943|FG006|Overall Study|Other unspecified|2|||
38024526|NCT03041116|69708167|FG000|Open-label|Withdrawal by Subject|1|||
38024527|NCT03041116|69708168|FG001|Open-label|Withdrawal by Subject|0|||
38024528|NCT04860258|69708185|FG000|Overall Study|Withdrawal by Subject|0|||
38024529|NCT04860258|69708186|FG001|Overall Study|Withdrawal by Subject|0|||
38024530|NCT04860258|69708187|FG002|Overall Study|Withdrawal by Subject|4|||
37712447|NCT02134028|69190944|FG007|Overall Study|Other unspecified|1|||
37712448|NCT02134028|69190937|FG000|Overall Study|Adverse Event|3|||
37712449|NCT02134028|69190938|FG001|Overall Study|Adverse Event|19|||
37838710|NCT00472641|69523275|FG000|Overall Study|Lost to Follow-up|1|||
37712450|NCT02134028|69190939|FG002|Overall Study|Adverse Event|13|||
37712451|NCT02134028|69190940|FG003|Overall Study|Adverse Event|32|||
37712452|NCT02134028|69190941|FG004|Overall Study|Adverse Event|4|||
37712453|NCT02134028|69190942|FG005|Overall Study|Adverse Event|5|||
37712454|NCT02134028|69190943|FG006|Overall Study|Adverse Event|1|||
37838711|NCT01133977|69523284|FG000|Overall Study|Adverse Event|0|||
38024531|NCT04860258|69708188|FG003|Overall Study|Withdrawal by Subject|1|||
37712455|NCT02134028|69190944|FG007|Overall Study|Adverse Event|2|||
37712456|NCT02172950|69190966|FG000|Overall Study|Physician Decision|3|||
37712457|NCT02172950|69190967|FG001|Overall Study|Physician Decision|3|||
37712458|NCT02172950|69190966|FG000|Overall Study|Lack of Efficacy|1|||
37838712|NCT01133977|69523285|FG001|Overall Study|Adverse Event|0|||
37838713|NCT01133977|69523286|FG002|Overall Study|Adverse Event|1|||
37838714|NCT01133977|69523287|FG003|Overall Study|Adverse Event|0|||
37838715|NCT01133977|69523288|FG004|Overall Study|Adverse Event|0|||
37838716|NCT01133977|69523284|FG000|Overall Study|Death|1|||
37838717|NCT01133977|69523285|FG001|Overall Study|Death|1|||
37838718|NCT01133977|69523286|FG002|Overall Study|Death|1|||
37838719|NCT01133977|69523287|FG003|Overall Study|Death|7|||
37838720|NCT01133977|69523288|FG004|Overall Study|Death|3|||
37838721|NCT01133977|69523284|FG000|Overall Study|Started a New Line of Therapy|2|||
37838722|NCT01133977|69523285|FG001|Overall Study|Started a New Line of Therapy|6|||
37838723|NCT01133977|69523286|FG002|Overall Study|Started a New Line of Therapy|4|||
37838724|NCT01133977|69523287|FG003|Overall Study|Started a New Line of Therapy|25|||
37838725|NCT01133977|69523288|FG004|Overall Study|Started a New Line of Therapy|33|||
37838726|NCT01133977|69523284|FG000|Overall Study|Lost to Follow-up|0|||
37838727|NCT01133977|69523285|FG001|Overall Study|Lost to Follow-up|0|||
37838728|NCT01133977|69523286|FG002|Overall Study|Lost to Follow-up|0|||
37838729|NCT01133977|69523287|FG003|Overall Study|Lost to Follow-up|2|||
37838730|NCT01133977|69523288|FG004|Overall Study|Lost to Follow-up|1|||
37838731|NCT01133977|69523284|FG000|Overall Study|Withdrawal by Subject|0|||
37838732|NCT01133977|69523285|FG001|Overall Study|Withdrawal by Subject|0|||
37838733|NCT01133977|69523286|FG002|Overall Study|Withdrawal by Subject|0|||
37712459|NCT02172950|69190967|FG001|Overall Study|Lack of Efficacy|0|||
37838734|NCT01133977|69523287|FG003|Overall Study|Withdrawal by Subject|5|||
37838735|NCT01133977|69523288|FG004|Overall Study|Withdrawal by Subject|1|||
37838736|NCT01133821|69523305|FG000|Overall Study|Lost to Follow-up|8|||
37712460|NCT02172950|69190966|FG000|Overall Study|Adverse Event|4|||
37712461|NCT02172950|69190967|FG001|Overall Study|Adverse Event|1|||
37712462|NCT02172950|69190966|FG000|Overall Study|Withdrawal by Subject|10|||
37712463|NCT02172950|69190967|FG001|Overall Study|Withdrawal by Subject|0|||
37712464|NCT02172950|69190966|FG000|Overall Study|Protocol Violation|1|||
37712465|NCT02172950|69190967|FG001|Overall Study|Protocol Violation|0|||
37712466|NCT02172950|69190966|FG000|Overall Study|Lost to Follow-up|1|||
37712467|NCT02172950|69190967|FG001|Overall Study|Lost to Follow-up|0|||
37712468|NCT02172950|69190966|FG000|Overall Study|Death|1|||
37712469|NCT02172950|69190967|FG001|Overall Study|Death|0|||
37712470|NCT02172950|69190966|FG000|Overall Study|Patient traveling|1|||
37712471|NCT02172950|69190967|FG001|Overall Study|Patient traveling|0|||
37712472|NCT02172950|69190966|FG000|Overall Study|Patient went to other country|1|||
37712473|NCT02172950|69190967|FG001|Overall Study|Patient went to other country|0|||
37712474|NCT02172950|69190966|FG000|Overall Study|Patient relocated overseas|1|||
37712475|NCT02172950|69190967|FG001|Overall Study|Patient relocated overseas|1|||
37712476|NCT02172950|69190966|FG000|Overall Study|Patient moving|1|||
37712477|NCT02172950|69190967|FG001|Overall Study|Patient moving|0|||
37712478|NCT02151266|69190977|FG000|Overall Study|Lost to Follow-up|1|||
37712479|NCT02151266|69190978|FG001|Overall Study|Lost to Follow-up|4|||
37712480|NCT02151266|69190979|FG002|Overall Study|Lost to Follow-up|1|||
37712481|NCT02151266|69190977|FG000|Overall Study|Did NOT receive intervention|3|||
37712482|NCT02151266|69190978|FG001|Overall Study|Did NOT receive intervention|6|||
37712483|NCT02151266|69190979|FG002|Overall Study|Did NOT receive intervention|2|||
37712484|NCT02151266|69190977|FG000|Overall Study|Not able to exercise|4|||
37712485|NCT02151266|69190978|FG001|Overall Study|Not able to exercise|5|||
37712486|NCT02151266|69190979|FG002|Overall Study|Not able to exercise|4|||
37712487|NCT02151110|69190995|FG000|Overall Study|Withdrawal by Subject|0|||
37712488|NCT02151110|69190996|FG001|Overall Study|Withdrawal by Subject|0|||
37712489|NCT02151110|69190997|FG002|Overall Study|Withdrawal by Subject|0|||
37712490|NCT02151110|69190998|FG003|Overall Study|Withdrawal by Subject|0|||
37712491|NCT02151110|69190999|FG004|Overall Study|Withdrawal by Subject|0|||
37712492|NCT02151110|69191000|FG005|Overall Study|Withdrawal by Subject|0|||
37712493|NCT02151110|69191001|FG006|Overall Study|Withdrawal by Subject|0|||
37712494|NCT02151110|69191002|FG007|Overall Study|Withdrawal by Subject|1|||
37712495|NCT02151110|69190995|FG000|Overall Study|Lost to Follow-up|0|||
37712496|NCT02151110|69190996|FG001|Overall Study|Lost to Follow-up|0|||
37712497|NCT02151110|69190997|FG002|Overall Study|Lost to Follow-up|0|||
37712498|NCT02151110|69190998|FG003|Overall Study|Lost to Follow-up|0|||
37712499|NCT02151110|69190999|FG004|Overall Study|Lost to Follow-up|0|||
37712500|NCT02151110|69191000|FG005|Overall Study|Lost to Follow-up|0|||
37712501|NCT02151110|69191001|FG006|Overall Study|Lost to Follow-up|0|||
37712502|NCT02151110|69191002|FG007|Overall Study|Lost to Follow-up|2|||
37712503|NCT02132312|69191029|FG000|Overall Study|Adverse Event|2|||
37712504|NCT02132312|69191030|FG001|Overall Study|Adverse Event|0|||
37712505|NCT02132312|69191029|FG000|Overall Study|Physician Decision|1|||
37712506|NCT02132312|69191030|FG001|Overall Study|Physician Decision|1|||
37712507|NCT02132312|69191029|FG000|Overall Study|Protocol Violation|0|||
37712508|NCT02132312|69191030|FG001|Overall Study|Protocol Violation|1|||
37712509|NCT02132312|69191029|FG000|Overall Study|Withdrawal by Subject|1|||
37712510|NCT02132312|69191030|FG001|Overall Study|Withdrawal by Subject|0|||
37712511|NCT02132312|69191029|FG000|Overall Study|Lost to Follow-up|2|||
37712512|NCT02132312|69191030|FG001|Overall Study|Lost to Follow-up|1|||
37712513|NCT02131766|69191036|FG000|Overall Study|Withdrawal by Subject|4|||
37838737|NCT01133821|69523306|FG001|Overall Study|Lost to Follow-up|11|||
38024532|NCT04860258|69708189|FG004|Overall Study|Withdrawal by Subject|4|||
38024533|NCT04860258|69708190|FG005|Overall Study|Withdrawal by Subject|1|||
38024534|NCT04860258|69708191|FG006|Overall Study|Withdrawal by Subject|0|||
38024535|NCT03041038|69708209|FG000|Overall Study|Withdrawal by Subject|4|||
38024536|NCT03041038|69708210|FG001|Overall Study|Withdrawal by Subject|0|||
38024537|NCT03041038|69708209|FG000|Overall Study|Lost to Follow-up|1|||
38024538|NCT03041038|69708210|FG001|Overall Study|Lost to Follow-up|1|||
37838738|NCT01133821|69523305|FG000|Overall Study|Withdrawal by Subject|8|||
38024539|NCT03041038|69708209|FG000|Overall Study|Protocol Violation|1|||
37712514|NCT02150954|69191045|FG000|Overall Study|Protocol Violation|1|||
37712515|NCT02150954|69191046|FG001|Overall Study|Protocol Violation|0|||
37712516|NCT02131532|69191052|FG000|Overall Study|Withdrawal by Subject|1|||
37712517|NCT02131532|69191052|FG000|Overall Study|Physician Decision|1|||
37712518|NCT02131532|69191052|FG000|Overall Study|Other health conditions|2|||
37712519|NCT02170688|69191066|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
37712520|NCT02170688|69191067|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
37712521|NCT02170688|69191068|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
37712522|NCT02170688|69191069|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
37712523|NCT02170688|69191070|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
37712524|NCT02170688|69191066|FG000|Overall Study|Full dose not received|0|||
37838739|NCT01133821|69523306|FG001|Overall Study|Withdrawal by Subject|3|||
38024540|NCT03041038|69708210|FG001|Overall Study|Protocol Violation|1|||
38024541|NCT04382066|69708221|FG000|Overall Study|Adverse Event|1|||
37712525|NCT02170688|69191067|FG001|Overall Study|Full dose not received|1|||
37712526|NCT02170688|69191068|FG002|Overall Study|Full dose not received|0|||
37712527|NCT02170688|69191069|FG003|Overall Study|Full dose not received|0|||
37712528|NCT02170688|69191070|FG004|Overall Study|Full dose not received|0|||
37712529|NCT02170688|69191066|FG000|Overall Study|Physician Decision|0|||
37712530|NCT02170688|69191067|FG001|Overall Study|Physician Decision|0|||
37712531|NCT02170688|69191068|FG002|Overall Study|Physician Decision|1|||
37712532|NCT02170688|69191069|FG003|Overall Study|Physician Decision|0|||
37712533|NCT02170688|69191070|FG004|Overall Study|Physician Decision|0|||
37712534|NCT02170298|69191084|FG000|Overall Study|Withdrawal by Subject|0|||
37712535|NCT02170298|69191085|FG001|Overall Study|Withdrawal by Subject|1|||
37712536|NCT02170298|69191084|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
37712537|NCT02170298|69191085|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
37712538|NCT02131064|69191093|FG000|Overall Study|Death|5|||
37712539|NCT02131064|69191094|FG001|Overall Study|Death|6|||
37712540|NCT02131064|69191093|FG000|Overall Study|Lost to Follow-up|4|||
37712541|NCT02131064|69191094|FG001|Overall Study|Lost to Follow-up|8|||
37712542|NCT02131064|69191093|FG000|Overall Study|Withdrawal by Subject|14|||
37712543|NCT02131064|69191094|FG001|Overall Study|Withdrawal by Subject|18|||
37712544|NCT02131064|69191093|FG000|Overall Study|Other|2|||
37712545|NCT02131064|69191094|FG001|Overall Study|Other|2|||
37712546|NCT02130986|69191103|FG000|Overall Study|Withdrawal by Subject|4|||
37712547|NCT02130986|69191104|FG001|Overall Study|Withdrawal by Subject|4|||
37712548|NCT02130986|69191103|FG000|Overall Study|Lost to Follow-up|151|||
37712549|NCT02130986|69191104|FG001|Overall Study|Lost to Follow-up|160|||
37712550|NCT02130284|69191112|FG000|Overall Study|Withdrawal by Subject|3|||
37712551|NCT02130284|69191112|FG000|Overall Study|Subject Withdrew Consent|1|||
37712552|NCT02130284|69191112|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
37712553|NCT02130284|69191112|FG000|Overall Study|Subject was screened as backup for study|3|||
37712554|NCT02130284|69191112|FG000|Overall Study|Screen Failure|1|||
37712555|NCT02147288|69191118|FG000|Overall Study|post-operative hematoma|1|||
37712556|NCT02147288|69191119|FG001|Overall Study|post-operative hematoma|1|||
37712557|NCT02147288|69191120|FG002|Overall Study|post-operative hematoma|0|||
37712558|NCT02147288|69191121|FG003|Overall Study|post-operative hematoma|0|||
37712559|NCT02147288|69191122|FG004|Overall Study|post-operative hematoma|0|||
37712560|NCT02147288|69191123|FG005|Overall Study|post-operative hematoma|0|||
37712561|NCT02147288|69191124|FG006|Overall Study|post-operative hematoma|0|||
37712562|NCT02147288|69191125|FG007|Overall Study|post-operative hematoma|0|||
37712563|NCT02147288|69191126|FG008|Overall Study|post-operative hematoma|0|||
37712564|NCT02147288|69191127|FG009|Overall Study|post-operative hematoma|0|||
37712565|NCT02147288|69191118|FG000|Overall Study|complications from concurrent hernia rep|0|||
37712566|NCT02147288|69191119|FG001|Overall Study|complications from concurrent hernia rep|1|||
37712567|NCT02147288|69191120|FG002|Overall Study|complications from concurrent hernia rep|0|||
37712568|NCT02147288|69191121|FG003|Overall Study|complications from concurrent hernia rep|0|||
37712569|NCT02147288|69191122|FG004|Overall Study|complications from concurrent hernia rep|0|||
37712570|NCT02147288|69191123|FG005|Overall Study|complications from concurrent hernia rep|0|||
37712571|NCT02147288|69191124|FG006|Overall Study|complications from concurrent hernia rep|0|||
37712572|NCT02147288|69191125|FG007|Overall Study|complications from concurrent hernia rep|0|||
37712573|NCT02147288|69191126|FG008|Overall Study|complications from concurrent hernia rep|0|||
37712574|NCT02147288|69191127|FG009|Overall Study|complications from concurrent hernia rep|0|||
37712575|NCT02147132|69191133|FG000|Overall Study|Lost to Follow-up|1|||
37712576|NCT02147132|69191134|FG001|Overall Study|Lost to Follow-up|0|||
37712577|NCT02147132|69191135|FG002|Overall Study|Lost to Follow-up|0|||
37712578|NCT02147132|69191136|FG003|Overall Study|Lost to Follow-up|0|||
37712579|NCT02146430|69191150|FG000|Overall Study|Protocol Violation|5|||
37712580|NCT02146430|69191151|FG001|Overall Study|Protocol Violation|4|||
37712581|NCT02146430|69191152|FG002|Overall Study|Protocol Violation|8|||
37712582|NCT02146430|69191153|FG003|Overall Study|Protocol Violation|6|||
37712583|NCT02146430|69191150|FG000|Overall Study|Lack of Efficacy|13|||
37712584|NCT02146430|69191151|FG001|Overall Study|Lack of Efficacy|11|||
37712585|NCT02146430|69191152|FG002|Overall Study|Lack of Efficacy|8|||
37712586|NCT02146430|69191153|FG003|Overall Study|Lack of Efficacy|5|||
37712587|NCT02146430|69191150|FG000|Overall Study|Adverse Event|20|||
37712588|NCT02146430|69191151|FG001|Overall Study|Adverse Event|40|||
37712589|NCT02146430|69191152|FG002|Overall Study|Adverse Event|32|||
37712590|NCT02146430|69191153|FG003|Overall Study|Adverse Event|49|||
37712591|NCT02146430|69191150|FG000|Overall Study|Reason missing or not reported|2|||
37712592|NCT02146430|69191151|FG001|Overall Study|Reason missing or not reported|3|||
37712593|NCT02146430|69191152|FG002|Overall Study|Reason missing or not reported|4|||
37712594|NCT02146430|69191153|FG003|Overall Study|Reason missing or not reported|5|||
37712595|NCT02146430|69191150|FG000|Overall Study|Withdrawal by Subject|27|||
38024542|NCT04382066|69708222|FG001|Overall Study|Adverse Event|0|||
37712596|NCT02146430|69191151|FG001|Overall Study|Withdrawal by Subject|29|||
37712597|NCT02146430|69191152|FG002|Overall Study|Withdrawal by Subject|30|||
37712598|NCT02146430|69191153|FG003|Overall Study|Withdrawal by Subject|34|||
37712599|NCT02129192|69191169|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
37712600|NCT02129192|69191170|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
37712601|NCT02105948|69191183|FG000|Overall Study|Adverse Event|10|||
37712602|NCT02105948|69191184|FG001|Overall Study|Adverse Event|7|||
37712603|NCT02105948|69191185|FG002|Overall Study|Adverse Event|11|||
37712604|NCT02105948|69191186|FG003|Overall Study|Adverse Event|11|||
37712605|NCT02105948|69191183|FG000|Overall Study|Lack of Efficacy|0|||
37712606|NCT02105948|69191184|FG001|Overall Study|Lack of Efficacy|1|||
37712607|NCT02105948|69191185|FG002|Overall Study|Lack of Efficacy|3|||
37712608|NCT02105948|69191186|FG003|Overall Study|Lack of Efficacy|2|||
37712609|NCT02105948|69191183|FG000|Overall Study|Lost to Follow-up|0|||
37712610|NCT02105948|69191184|FG001|Overall Study|Lost to Follow-up|0|||
37712611|NCT02105948|69191185|FG002|Overall Study|Lost to Follow-up|2|||
37712612|NCT02105948|69191186|FG003|Overall Study|Lost to Follow-up|1|||
37712613|NCT02105948|69191183|FG000|Overall Study|Physician Decision|2|||
37712614|NCT02105948|69191184|FG001|Overall Study|Physician Decision|2|||
37712615|NCT02105948|69191185|FG002|Overall Study|Physician Decision|2|||
37712616|NCT02105948|69191186|FG003|Overall Study|Physician Decision|2|||
37712617|NCT02105948|69191183|FG000|Overall Study|Withdrawal by Subject|15|||
37712618|NCT02105948|69191184|FG001|Overall Study|Withdrawal by Subject|10|||
37712619|NCT02105948|69191185|FG002|Overall Study|Withdrawal by Subject|10|||
37712620|NCT02105948|69191186|FG003|Overall Study|Withdrawal by Subject|11|||
37712621|NCT02128724|69191201|FG000|Overall Study|Death|1|||
37712622|NCT02128724|69191202|FG001|Overall Study|Death|0|||
37712623|NCT02128724|69191203|FG002|Overall Study|Death|0|||
37712624|NCT02128724|69191204|FG003|Overall Study|Death|0|||
37712625|NCT02128724|69191201|FG000|Overall Study|Adverse Event|0|||
37712626|NCT02128724|69191202|FG001|Overall Study|Adverse Event|1|||
37712627|NCT02128724|69191203|FG002|Overall Study|Adverse Event|0|||
37712628|NCT02128724|69191204|FG003|Overall Study|Adverse Event|0|||
37712629|NCT02128724|69191201|FG000|Overall Study|Physician Decision|0|||
37712630|NCT02128724|69191202|FG001|Overall Study|Physician Decision|0|||
37712631|NCT02128724|69191203|FG002|Overall Study|Physician Decision|0|||
37712632|NCT02128724|69191204|FG003|Overall Study|Physician Decision|2|||
37712633|NCT02128724|69191201|FG000|Overall Study|Withdrawal by Subject|0|||
37712634|NCT02128724|69191202|FG001|Overall Study|Withdrawal by Subject|0|||
37712635|NCT02128724|69191203|FG002|Overall Study|Withdrawal by Subject|0|||
37712636|NCT02128724|69191204|FG003|Overall Study|Withdrawal by Subject|1|||
37712637|NCT02128490|69191218|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
37712638|NCT02128490|69191219|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
37712639|NCT02128490|69191220|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
37712640|NCT02128490|69191221|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
37712641|NCT02128490|69191222|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
37712642|NCT02128490|69191218|FG000|Overall Study|Major Protocol Deviation|1|||
37712643|NCT02128490|69191219|FG001|Overall Study|Major Protocol Deviation|2|||
37712644|NCT02128490|69191220|FG002|Overall Study|Major Protocol Deviation|0|||
37712645|NCT02128490|69191221|FG003|Overall Study|Major Protocol Deviation|2|||
37712646|NCT02128490|69191222|FG004|Overall Study|Major Protocol Deviation|2|||
37712647|NCT02128490|69191218|FG000|Overall Study|Lost to Follow-up|0|||
37712648|NCT02128490|69191219|FG001|Overall Study|Lost to Follow-up|0|||
37712649|NCT02128490|69191220|FG002|Overall Study|Lost to Follow-up|1|||
37712650|NCT02128490|69191221|FG003|Overall Study|Lost to Follow-up|1|||
37712651|NCT02128490|69191222|FG004|Overall Study|Lost to Follow-up|1|||
37712652|NCT02128490|69191218|FG000|Overall Study|Voluntary Withdrawal|3|||
37712653|NCT02128490|69191219|FG001|Overall Study|Voluntary Withdrawal|3|||
37712654|NCT02128490|69191220|FG002|Overall Study|Voluntary Withdrawal|1|||
37712655|NCT02128490|69191221|FG003|Overall Study|Voluntary Withdrawal|1|||
37712656|NCT02128490|69191222|FG004|Overall Study|Voluntary Withdrawal|2|||
37712657|NCT02128490|69191218|FG000|Overall Study|Lack of Efficacy|0|||
37712658|NCT02128490|69191219|FG001|Overall Study|Lack of Efficacy|1|||
37712659|NCT02128490|69191220|FG002|Overall Study|Lack of Efficacy|0|||
38024543|NCT04382066|69708223|FG002|Overall Study|Adverse Event|0|||
38024544|NCT04382066|69708221|FG000|Overall Study|Death|1|||
38024545|NCT04382066|69708222|FG001|Overall Study|Death|0|||
37712660|NCT02128490|69191221|FG003|Overall Study|Lack of Efficacy|0|||
37712661|NCT02128490|69191222|FG004|Overall Study|Lack of Efficacy|0|||
37712662|NCT02128490|69191218|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
37712663|NCT02128490|69191219|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
37712664|NCT02128490|69191220|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
37712665|NCT02128490|69191221|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
37712666|NCT02128490|69191222|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
37712667|NCT02128490|69191218|FG000|Overall Study|Other Miscellaneous Reasons|0|||
37712668|NCT02128490|69191219|FG001|Overall Study|Other Miscellaneous Reasons|0|||
38024546|NCT04382066|69708223|FG002|Overall Study|Death|1|||
37712669|NCT02128490|69191220|FG002|Overall Study|Other Miscellaneous Reasons|2|||
37712670|NCT02128490|69191221|FG003|Overall Study|Other Miscellaneous Reasons|1|||
37712671|NCT02128490|69191222|FG004|Overall Study|Other Miscellaneous Reasons|1|||
37712672|NCT02146352|69191234|FG000|Overall Study|Death|1|||
37712673|NCT02146352|69191234|FG000|Overall Study|Patient entered hospice care|1|||
37712674|NCT02146274|69191238|FG000|Overall Study|Protocol Violation|73|||
37712675|NCT02105636|69191247|FG000|Pre-Treatment|Disease Progression|1|||
37712676|NCT02105636|69191248|FG001|Pre-Treatment|Disease Progression|0|||
37712677|NCT02105636|69191247|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
37712678|NCT02105636|69191248|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
37712679|NCT02105636|69191247|FG000|Pre-Treatment|Participant withdrew consent|0|||
37712680|NCT02105636|69191248|FG001|Pre-Treatment|Participant withdrew consent|6|||
37712681|NCT02105636|69191247|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
37712682|NCT02105636|69191248|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
37712683|NCT02105636|69191247|FG000|Treatment|Study Drug Toxicity|14|||
37712684|NCT02105636|69191248|FG001|Treatment|Study Drug Toxicity|10|||
37712685|NCT02105636|69191247|FG000|Treatment|Adverse event unrelated to study drug|19|||
37712686|NCT02105636|69191248|FG001|Treatment|Adverse event unrelated to study drug|3|||
37712687|NCT02105636|69191247|FG000|Treatment|Participant request to discontinue study treatment|8|||
37712688|NCT02105636|69191248|FG001|Treatment|Participant request to discontinue study treatment|6|||
37712689|NCT02105636|69191247|FG000|Treatment|Participant withdrew consent|5|||
37712690|NCT02105636|69191248|FG001|Treatment|Participant withdrew consent|1|||
37712691|NCT02105636|69191247|FG000|Treatment|Lost to Follow-up|1|||
37712692|NCT02105636|69191248|FG001|Treatment|Lost to Follow-up|0|||
37712693|NCT02105636|69191247|FG000|Treatment|Maximum Clinical Benefit|1|||
37712694|NCT02105636|69191248|FG001|Treatment|Maximum Clinical Benefit|3|||
37712695|NCT02105636|69191247|FG000|Treatment|Poor/Non-compliance|0|||
37712696|NCT02105636|69191248|FG001|Treatment|Poor/Non-compliance|1|||
37712697|NCT02105636|69191247|FG000|Treatment|Participant no longer meets study criteria|1|||
37712698|NCT02105636|69191248|FG001|Treatment|Participant no longer meets study criteria|0|||
37712699|NCT02105636|69191247|FG000|Treatment|Other reasons|1|||
37712700|NCT02105636|69191248|FG001|Treatment|Other reasons|0|||
37712701|NCT02105636|69191247|FG000|Treatment|Disease Progression|185|||
37712702|NCT02105636|69191248|FG001|Treatment|Disease Progression|87|||
37712703|NCT01626872|69191257|FG000|Overall Study|Physician Decision|13|||
37712704|NCT01626872|69191258|FG001|Overall Study|Physician Decision|9|||
37712705|NCT01626872|69191259|FG002|Overall Study|Physician Decision|6|||
37712706|NCT01626872|69191257|FG000|Overall Study|Withdrawal by Subject|19|||
37712707|NCT01626872|69191258|FG001|Overall Study|Withdrawal by Subject|27|||
37712708|NCT01626872|69191259|FG002|Overall Study|Withdrawal by Subject|8|||
37712709|NCT01626872|69191257|FG000|Overall Study|Adverse Event (including Death)|20|||
37712710|NCT01626872|69191258|FG001|Overall Study|Adverse Event (including Death)|28|||
37712711|NCT01626872|69191259|FG002|Overall Study|Adverse Event (including Death)|8|||
37712712|NCT01626872|69191257|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
37712713|NCT01626872|69191258|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
37712714|NCT01626872|69191259|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
37712715|NCT01598090|69191270|FG000|Treatment Period|Poor/non-compliance|0|||
37712716|NCT01598090|69191271|FG001|Treatment Period|Poor/non-compliance|2|||
37712717|NCT01598090|69191272|FG002|Treatment Period|Poor/non-compliance|0|||
37712718|NCT01598090|69191270|FG000|Treatment Period|No longer meet study criteria|0|||
37712719|NCT01598090|69191271|FG001|Treatment Period|No longer meet study criteria|1|||
37712720|NCT01598090|69191272|FG002|Treatment Period|No longer meet study criteria|0|||
37712721|NCT01598090|69191270|FG000|Treatment Period|Lack of Efficacy|5|||
37712722|NCT01598090|69191271|FG001|Treatment Period|Lack of Efficacy|14|||
37712723|NCT01598090|69191272|FG002|Treatment Period|Lack of Efficacy|6|||
37712724|NCT01598090|69191270|FG000|Treatment Period|Adverse Event|2|||
37712725|NCT01598090|69191271|FG001|Treatment Period|Adverse Event|33|||
37712726|NCT01598090|69191272|FG002|Treatment Period|Adverse Event|17|||
37712727|NCT01598090|69191270|FG000|Treatment Period|Other reasons|0|||
37712728|NCT01598090|69191271|FG001|Treatment Period|Other reasons|4|||
37712729|NCT01598090|69191272|FG002|Treatment Period|Other reasons|1|||
37712730|NCT01598090|69191270|FG000|Treatment Period|Withdrawal by Subject|3|||
37712731|NCT01598090|69191271|FG001|Treatment Period|Withdrawal by Subject|13|||
37712732|NCT01598090|69191272|FG002|Treatment Period|Withdrawal by Subject|10|||
37712733|NCT01598090|69191270|FG000|Treatment Period|Lost to Follow-up|1|||
37712734|NCT01598090|69191271|FG001|Treatment Period|Lost to Follow-up|5|||
37712735|NCT01598090|69191272|FG002|Treatment Period|Lost to Follow-up|1|||
37712736|NCT01598090|69191270|FG000|Follow-up Period|Death|0|||
37712737|NCT01598090|69191271|FG001|Follow-up Period|Death|1|||
37712738|NCT01598090|69191272|FG002|Follow-up Period|Death|0|||
37712739|NCT01598090|69191270|FG000|Follow-up Period|No longer required per protocol|1|||
37712740|NCT01598090|69191271|FG001|Follow-up Period|No longer required per protocol|3|||
37712741|NCT01598090|69191272|FG002|Follow-up Period|No longer required per protocol|2|||
37712742|NCT01598090|69191270|FG000|Follow-up Period|Not reported|0|||
37712743|NCT01598090|69191271|FG001|Follow-up Period|Not reported|10|||
37712744|NCT01598090|69191272|FG002|Follow-up Period|Not reported|4|||
37712745|NCT01598090|69191270|FG000|Follow-up Period|Withdrawal by Subject|0|||
37712746|NCT01598090|69191271|FG001|Follow-up Period|Withdrawal by Subject|3|||
37712747|NCT01598090|69191272|FG002|Follow-up Period|Withdrawal by Subject|2|||
37712748|NCT01598090|69191270|FG000|Follow-up Period|Other reasons|2|||
37712749|NCT01598090|69191271|FG001|Follow-up Period|Other reasons|8|||
37712750|NCT01598090|69191272|FG002|Follow-up Period|Other reasons|8|||
37712751|NCT01598090|69191270|FG000|Follow-up Period|Lost to Follow-up|2|||
37712752|NCT01598090|69191271|FG001|Follow-up Period|Lost to Follow-up|10|||
37712753|NCT01598090|69191272|FG002|Follow-up Period|Lost to Follow-up|12|||
37712754|NCT02105012|69191283|FG000|Overall Study|Withdrawal by Subject|11|||
37712755|NCT02105012|69191283|FG000|Overall Study|Protocol Specified Criteria|9|||
37712756|NCT02105012|69191283|FG000|Overall Study|Lost to Follow-up|4|||
37712757|NCT02105012|69191283|FG000|Overall Study|Protocol Violation|4|||
37712758|NCT02105012|69191283|FG000|Overall Study|Physician Decision|3|||
37712759|NCT02105012|69191283|FG000|Overall Study|Adverse Event|1|||
37712760|NCT02105012|69191283|FG000|Overall Study|Lack of Efficacy|1|||
37712761|NCT02145182|69191297|FG000|Overall Study|Adverse Event|4|||
37712762|NCT02145182|69191298|FG001|Overall Study|Adverse Event|1|||
37712763|NCT02145182|69191297|FG000|Overall Study|Death|7|||
37712764|NCT02145182|69191298|FG001|Overall Study|Death|7|||
37712765|NCT02145182|69191297|FG000|Overall Study|Lost to Follow-up|2|||
37712766|NCT02145182|69191298|FG001|Overall Study|Lost to Follow-up|2|||
37712767|NCT02145182|69191297|FG000|Overall Study|Pre-transplant Withdrawal|0|||
37712768|NCT02145182|69191298|FG001|Overall Study|Pre-transplant Withdrawal|2|||
37712769|NCT02145182|69191297|FG000|Overall Study|Withdrawal by Subject|5|||
37712770|NCT02145182|69191298|FG001|Overall Study|Withdrawal by Subject|4|||
37712771|NCT02145026|69191304|FG000|Overall Study|Adverse Event|2|||
37712772|NCT02145026|69191304|FG000|Overall Study|Death|4|||
37712773|NCT02145026|69191304|FG000|Overall Study|Withdrawal by Subject|2|||
37712774|NCT02145026|69191304|FG000|Overall Study|Physician Decision|4|||
37712775|NCT02144012|69191310|FG000|Overall Study|Adverse Event|1|||
37712776|NCT02144012|69191311|FG001|Overall Study|Adverse Event|0|||
37712777|NCT02144012|69191310|FG000|Overall Study|Death|1|||
37712778|NCT02144012|69191311|FG001|Overall Study|Death|0|||
37712779|NCT02144012|69191310|FG000|Overall Study|Withdrawal by Subject|11|||
37712780|NCT02144012|69191311|FG001|Overall Study|Withdrawal by Subject|3|||
37712781|NCT02144012|69191310|FG000|Overall Study|Study Terminated by Sponsor|18|||
37712782|NCT02144012|69191311|FG001|Overall Study|Study Terminated by Sponsor|12|||
37712783|NCT02144012|69191310|FG000|Overall Study|Other|3|||
37712784|NCT02144012|69191311|FG001|Overall Study|Other|0|||
37712785|NCT02103062|69191319|FG000|Overall Study|Adverse Event|1|||
37712786|NCT02103062|69191320|FG001|Overall Study|Adverse Event|2|||
37712787|NCT02103062|69191319|FG000|Overall Study|Progressive Disease|17|||
37712788|NCT02103062|69191320|FG001|Overall Study|Progressive Disease|20|||
37712789|NCT02103062|69191319|FG000|Overall Study|Death|0|||
37712790|NCT02103062|69191320|FG001|Overall Study|Death|1|||
37712791|NCT02141984|69191328|FG000|Overall Study|Lack of Efficacy|2|||
37712792|NCT02141672|69191335|FG000|Overall Study|Adverse Event|0|||
37712793|NCT02141672|69191336|FG001|Overall Study|Adverse Event|1|||
37712794|NCT02141672|69191337|FG002|Overall Study|Adverse Event|0|||
37712795|NCT02141672|69191335|FG000|Overall Study|Death|10|||
37712796|NCT02141672|69191336|FG001|Overall Study|Death|2|||
37712797|NCT02141672|69191337|FG002|Overall Study|Death|1|||
37712798|NCT02141672|69191335|FG000|Overall Study|Lack of Efficacy|0|||
37712799|NCT02141672|69191336|FG001|Overall Study|Lack of Efficacy|0|||
37712800|NCT02141672|69191337|FG002|Overall Study|Lack of Efficacy|2|||
37712801|NCT02141672|69191335|FG000|Overall Study|Lost to Follow-up|1|||
37712802|NCT02141672|69191336|FG001|Overall Study|Lost to Follow-up|1|||
37712803|NCT02141672|69191337|FG002|Overall Study|Lost to Follow-up|3|||
37712804|NCT02141672|69191335|FG000|Overall Study|Physician Decision|1|||
37712805|NCT02141672|69191336|FG001|Overall Study|Physician Decision|2|||
37712806|NCT02141672|69191337|FG002|Overall Study|Physician Decision|5|||
37712807|NCT02141672|69191335|FG000|Overall Study|Protocol Violation|0|||
37712808|NCT02141672|69191336|FG001|Overall Study|Protocol Violation|0|||
37712809|NCT02141672|69191337|FG002|Overall Study|Protocol Violation|1|||
37712810|NCT02141672|69191335|FG000|Overall Study|Withdrawal by Subject|3|||
37712811|NCT02141672|69191336|FG001|Overall Study|Withdrawal by Subject|2|||
37712812|NCT02141672|69191337|FG002|Overall Study|Withdrawal by Subject|5|||
37712813|NCT02141672|69191335|FG000|Overall Study|refused to follow-up|1|||
37712814|NCT02141672|69191336|FG001|Overall Study|refused to follow-up|0|||
37712815|NCT02141672|69191337|FG002|Overall Study|refused to follow-up|1|||
37712816|NCT02141516|69191348|FG000|Overall Study|Adverse Event|0|||
37712817|NCT02141516|69191349|FG001|Overall Study|Adverse Event|1|||
37712818|NCT02141516|69191350|FG002|Overall Study|Adverse Event|0|||
37712819|NCT02141516|69191348|FG000|Overall Study|Lost to Follow-up|0|||
37712820|NCT02141516|69191349|FG001|Overall Study|Lost to Follow-up|1|||
37712821|NCT02141516|69191350|FG002|Overall Study|Lost to Follow-up|0|||
37712822|NCT02141516|69191348|FG000|Overall Study|Other|0|||
37712823|NCT02141516|69191349|FG001|Overall Study|Other|3|||
37712824|NCT02141516|69191350|FG002|Overall Study|Other|0|||
37712825|NCT02141360|69191364|FG000|Overall Study|Withdrawal by Subject|6|||
37712826|NCT02141360|69191365|FG001|Overall Study|Withdrawal by Subject|0|||
37712827|NCT02141360|69191366|FG002|Overall Study|Withdrawal by Subject|0|||
37712828|NCT02141360|69191364|FG000|Overall Study|Study Terminated before Visit|1|||
37712829|NCT02141360|69191365|FG001|Overall Study|Study Terminated before Visit|0|||
37712830|NCT02141360|69191366|FG002|Overall Study|Study Terminated before Visit|0|||
37712831|NCT01628198|69191374|FG000|Overall Study|Lost to Follow-up|7|||
37712832|NCT01628198|69191374|FG000|Overall Study|Withdrawal by Subject|10|||
37712833|NCT01628198|69191374|FG000|Overall Study|Screen failure|1|||
37712834|NCT01628120|69191378|FG000|Overall Study|Withdrawal by Subject|7|||
37712835|NCT01628120|69191378|FG000|Overall Study|Adverse Event|12|||
37712836|NCT01628120|69191378|FG000|Overall Study|Lost to Follow-up|1|||
37712837|NCT01628120|69191378|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
37712838|NCT01628120|69191378|FG000|Overall Study|Non-compliant with Study Procedures|1|||
37712839|NCT01628120|69191378|FG000|Overall Study|Not Treated|3|||
37712840|NCT01628120|69191378|FG000|Overall Study|Sponsor Decision|5|||
37712841|NCT01628120|69191378|FG000|Overall Study|Switched Dialysis Method|2|||
37712842|NCT01628120|69191378|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
37712843|NCT01628120|69191378|FG000|Overall Study|Moved or Relocated|5|||
37712844|NCT01628120|69191378|FG000|Overall Study|Kidney Transplant|2|||
37712845|NCT01628120|69191378|FG000|Overall Study|Use of Standard of Care|1|||
37712846|NCT01627340|69191384|FG000|Overall Study|Adverse Event|1|||
37712847|NCT01627340|69191385|FG001|Overall Study|Adverse Event|0|||
37712848|NCT01627340|69191384|FG000|Overall Study|Lost to Follow-up|8|||
37712849|NCT01627340|69191385|FG001|Overall Study|Lost to Follow-up|4|||
37712850|NCT01627340|69191384|FG000|Overall Study|Pregnancy|1|||
37712851|NCT01627340|69191385|FG001|Overall Study|Pregnancy|0|||
37712852|NCT01627340|69191384|FG000|Overall Study|Withdrawal by Subject|2|||
37712853|NCT01627340|69191385|FG001|Overall Study|Withdrawal by Subject|0|||
37712854|NCT02125838|69191395|FG000|Overall Study|Lost to Follow-up|4|||
37712855|NCT02125838|69191396|FG001|Overall Study|Lost to Follow-up|4|||
37712856|NCT02125604|69191402|FG000|Overall Study|Other|4|||
37712857|NCT02125604|69191402|FG000|Overall Study|Investigator Decision|1|||
37712858|NCT02125604|69191402|FG000|Overall Study|Lost to Follow-up|2|||
37712859|NCT02125604|69191402|FG000|Overall Study|Consent Withdrawn|4|||
37712860|NCT02125604|69191402|FG000|Overall Study|Adverse Event|20|||
37712861|NCT02124746|69191409|FG000|Overall Study|Adverse Event|2|||
37712862|NCT02124746|69191410|FG001|Overall Study|Adverse Event|1|||
37712863|NCT02124746|69191411|FG002|Overall Study|Adverse Event|2|||
37712864|NCT02124746|69191409|FG000|Overall Study|Death|2|||
37712865|NCT02124746|69191410|FG001|Overall Study|Death|1|||
37712866|NCT02124746|69191411|FG002|Overall Study|Death|3|||
37712867|NCT02124746|69191409|FG000|Overall Study|Lack of Efficacy|3|||
37712868|NCT02124746|69191410|FG001|Overall Study|Lack of Efficacy|2|||
37712869|NCT02124746|69191411|FG002|Overall Study|Lack of Efficacy|2|||
37712870|NCT02124746|69191409|FG000|Overall Study|Physician Decision|6|||
37712871|NCT02124746|69191410|FG001|Overall Study|Physician Decision|4|||
37712872|NCT02124746|69191411|FG002|Overall Study|Physician Decision|5|||
37712873|NCT02124746|69191409|FG000|Overall Study|Non-Compliance with Study Drug|0|||
37712874|NCT02124746|69191410|FG001|Overall Study|Non-Compliance with Study Drug|1|||
37712875|NCT02124746|69191411|FG002|Overall Study|Non-Compliance with Study Drug|0|||
37712876|NCT02124746|69191409|FG000|Overall Study|Withdrawal by Subject|3|||
37712877|NCT02124746|69191410|FG001|Overall Study|Withdrawal by Subject|3|||
37712878|NCT02124746|69191411|FG002|Overall Study|Withdrawal by Subject|0|||
37712879|NCT02124746|69191409|FG000|Overall Study|Study Terminated by Sponsor|0|||
37712880|NCT02124746|69191410|FG001|Overall Study|Study Terminated by Sponsor|0|||
37712881|NCT02124746|69191411|FG002|Overall Study|Study Terminated by Sponsor|6|||
37712882|NCT02124746|69191409|FG000|Overall Study|Disease Progression|3|||
37712883|NCT02124746|69191410|FG001|Overall Study|Disease Progression|6|||
37712884|NCT02124746|69191411|FG002|Overall Study|Disease Progression|4|||
37712885|NCT02123966|69191419|FG000|Overall Study|Intercurrent Illness|1|||
37712886|NCT02123576|69191425|FG000|Overall Study|Adverse Event|1|||
37712887|NCT02123576|69191426|FG001|Overall Study|Adverse Event|0|||
37712888|NCT01177397|69191444|FG000|Overall Study|Protocol Violation|0|||
37712889|NCT01177397|69191445|FG001|Overall Study|Protocol Violation|0|||
37712890|NCT01177397|69191446|FG002|Overall Study|Protocol Violation|0|||
37712891|NCT01177397|69191447|FG003|Overall Study|Protocol Violation|0|||
37712892|NCT01177397|69191448|FG004|Overall Study|Protocol Violation|0|||
37712893|NCT01177397|69191449|FG005|Overall Study|Protocol Violation|1|||
37712894|NCT01177397|69191450|FG006|Overall Study|Protocol Violation|0|||
37712895|NCT01177397|69191451|FG007|Overall Study|Protocol Violation|0|||
37712896|NCT01177397|69191452|FG008|Overall Study|Protocol Violation|0|||
37712897|NCT01177397|69191453|FG009|Overall Study|Protocol Violation|0|||
37712898|NCT01177397|69191454|FG010|Overall Study|Protocol Violation|0|||
37712899|NCT01177397|69191455|FG011|Overall Study|Protocol Violation|0|||
37712900|NCT01177397|69191444|FG000|Overall Study|Lost to Follow-up|0|||
37712901|NCT01177397|69191445|FG001|Overall Study|Lost to Follow-up|0|||
37712902|NCT01177397|69191446|FG002|Overall Study|Lost to Follow-up|0|||
37712903|NCT01177397|69191447|FG003|Overall Study|Lost to Follow-up|0|||
37712904|NCT01177397|69191448|FG004|Overall Study|Lost to Follow-up|1|||
37712905|NCT01177397|69191449|FG005|Overall Study|Lost to Follow-up|0|||
37712906|NCT01177397|69191450|FG006|Overall Study|Lost to Follow-up|0|||
37712907|NCT01177397|69191451|FG007|Overall Study|Lost to Follow-up|2|||
37712908|NCT01177397|69191452|FG008|Overall Study|Lost to Follow-up|0|||
37712909|NCT01177397|69191453|FG009|Overall Study|Lost to Follow-up|0|||
37712910|NCT01177397|69191454|FG010|Overall Study|Lost to Follow-up|0|||
37712911|NCT01177397|69191455|FG011|Overall Study|Lost to Follow-up|0|||
37712912|NCT01177397|69191444|FG000|Overall Study|Death|0|||
37712913|NCT01177397|69191445|FG001|Overall Study|Death|0|||
37712914|NCT01177397|69191446|FG002|Overall Study|Death|1|||
37712915|NCT01177397|69191447|FG003|Overall Study|Death|1|||
37712916|NCT01177397|69191448|FG004|Overall Study|Death|0|||
37712917|NCT01177397|69191449|FG005|Overall Study|Death|0|||
37712918|NCT01177397|69191450|FG006|Overall Study|Death|0|||
37712919|NCT01177397|69191451|FG007|Overall Study|Death|5|||
37712920|NCT01177397|69191452|FG008|Overall Study|Death|2|||
37712921|NCT01177397|69191453|FG009|Overall Study|Death|1|||
37712922|NCT01177397|69191454|FG010|Overall Study|Death|0|||
37712923|NCT01177397|69191455|FG011|Overall Study|Death|0|||
37712924|NCT01177397|69191444|FG000|Overall Study|Withdrawal by Subject|0|||
37712925|NCT01177397|69191445|FG001|Overall Study|Withdrawal by Subject|0|||
37712926|NCT01177397|69191446|FG002|Overall Study|Withdrawal by Subject|1|||
37712927|NCT01177397|69191447|FG003|Overall Study|Withdrawal by Subject|1|||
37712928|NCT01177397|69191448|FG004|Overall Study|Withdrawal by Subject|1|||
37712929|NCT01177397|69191449|FG005|Overall Study|Withdrawal by Subject|2|||
37712930|NCT01177397|69191450|FG006|Overall Study|Withdrawal by Subject|0|||
37712931|NCT01177397|69191451|FG007|Overall Study|Withdrawal by Subject|5|||
37712932|NCT01177397|69191452|FG008|Overall Study|Withdrawal by Subject|9|||
37712933|NCT01177397|69191453|FG009|Overall Study|Withdrawal by Subject|1|||
37712934|NCT01177397|69191454|FG010|Overall Study|Withdrawal by Subject|1|||
37838740|NCT01133821|69523305|FG000|Overall Study|preferred other treatment|1|||
38024547|NCT04435184|69708239|FG000|Overall Study|follow-up blood draws missing|3|||
37712935|NCT01177397|69191455|FG011|Overall Study|Withdrawal by Subject|0|||
37712936|NCT01177397|69191444|FG000|Overall Study|Adverse Event|0|||
37712937|NCT01177397|69191445|FG001|Overall Study|Adverse Event|0|||
37712938|NCT01177397|69191446|FG002|Overall Study|Adverse Event|1|||
37712939|NCT01177397|69191447|FG003|Overall Study|Adverse Event|2|||
37712940|NCT01177397|69191448|FG004|Overall Study|Adverse Event|0|||
37712941|NCT01177397|69191449|FG005|Overall Study|Adverse Event|12|||
37712942|NCT01177397|69191450|FG006|Overall Study|Adverse Event|1|||
37712943|NCT01177397|69191451|FG007|Overall Study|Adverse Event|14|||
37712944|NCT01177397|69191452|FG008|Overall Study|Adverse Event|8|||
37712945|NCT01177397|69191453|FG009|Overall Study|Adverse Event|6|||
37712946|NCT01177397|69191454|FG010|Overall Study|Adverse Event|3|||
37712947|NCT01177397|69191455|FG011|Overall Study|Adverse Event|7|||
37712948|NCT01177397|69191444|FG000|Overall Study|Disease progression|1|||
37712949|NCT01177397|69191445|FG001|Overall Study|Disease progression|2|||
37712950|NCT01177397|69191446|FG002|Overall Study|Disease progression|5|||
37712951|NCT01177397|69191447|FG003|Overall Study|Disease progression|5|||
37712952|NCT01177397|69191448|FG004|Overall Study|Disease progression|4|||
37712953|NCT01177397|69191449|FG005|Overall Study|Disease progression|10|||
37712954|NCT01177397|69191450|FG006|Overall Study|Disease progression|10|||
37712955|NCT01177397|69191451|FG007|Overall Study|Disease progression|21|||
37712956|NCT01177397|69191452|FG008|Overall Study|Disease progression|18|||
37712957|NCT01177397|69191453|FG009|Overall Study|Disease progression|12|||
37712958|NCT01177397|69191454|FG010|Overall Study|Disease progression|10|||
37712959|NCT01177397|69191455|FG011|Overall Study|Disease progression|8|||
37712960|NCT01177397|69191444|FG000|Overall Study|Other reasons|0|||
37712961|NCT01177397|69191445|FG001|Overall Study|Other reasons|0|||
37712962|NCT01177397|69191446|FG002|Overall Study|Other reasons|1|||
37712963|NCT01177397|69191447|FG003|Overall Study|Other reasons|0|||
37712964|NCT01177397|69191448|FG004|Overall Study|Other reasons|1|||
37712965|NCT01177397|69191449|FG005|Overall Study|Other reasons|1|||
37712966|NCT01177397|69191450|FG006|Overall Study|Other reasons|2|||
37712967|NCT01177397|69191451|FG007|Overall Study|Other reasons|6|||
37712968|NCT01177397|69191452|FG008|Overall Study|Other reasons|10|||
37712969|NCT01177397|69191453|FG009|Overall Study|Other reasons|8|||
37712970|NCT01177397|69191454|FG010|Overall Study|Other reasons|0|||
37712971|NCT01177397|69191455|FG011|Overall Study|Other reasons|2|||
37712972|NCT00864227|69191496|FG000|Overall Study|Withdrawal by Subject|1|||
37712973|NCT00864227|69191496|FG000|Overall Study|Disease Relapse/Progression|3|||
37712974|NCT02102204|69191500|FG000|Overall Study|Withdrawal by Subject|137|||
37712975|NCT02102204|69191500|FG000|Overall Study|Death|92|||
37712976|NCT02102204|69191500|FG000|Overall Study|Lost to Follow-up|65|||
37712977|NCT02102204|69191500|FG000|Overall Study|Sponsor Decision|5|||
37712978|NCT02102204|69191500|FG000|Overall Study|Ongoing|5|||
37712979|NCT02141204|69191506|FG000|Overall Study|Lost to Follow-up|2|||
37712980|NCT02141204|69191507|FG001|Overall Study|Lost to Follow-up|1|||
37712981|NCT02141204|69191506|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
37712982|NCT02141204|69191507|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
37712983|NCT02141204|69191506|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
37712984|NCT02141204|69191507|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
37712985|NCT02141204|69191506|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
37712986|NCT02141204|69191507|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
37712987|NCT02140970|69191515|FG000|Overall Study|Lost to Follow-up|1|||
37712988|NCT02140970|69191516|FG001|Overall Study|Lost to Follow-up|2|||
37712989|NCT02140970|69191515|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
37712990|NCT02140970|69191516|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
37712991|NCT02140970|69191515|FG000|Overall Study|Did not meet inclusion criteria|0|||
37712992|NCT02140970|69191516|FG001|Overall Study|Did not meet inclusion criteria|1|||
37712993|NCT02101112|69191522|FG000|Overall Study|Adverse Event|0|||
37712994|NCT02101112|69191523|FG001|Overall Study|Adverse Event|0|||
37712995|NCT02101112|69191524|FG002|Overall Study|Adverse Event|1|||
37712996|NCT02101112|69191525|FG003|Overall Study|Adverse Event|0|||
37712997|NCT02101112|69191526|FG004|Overall Study|Adverse Event|0|||
37712998|NCT02101112|69191527|FG005|Overall Study|Adverse Event|0|||
37712999|NCT02101112|69191522|FG000|Overall Study|Withdrawal by Subject|0|||
37713000|NCT02101112|69191523|FG001|Overall Study|Withdrawal by Subject|0|||
37713001|NCT02101112|69191524|FG002|Overall Study|Withdrawal by Subject|0|||
37713002|NCT02101112|69191525|FG003|Overall Study|Withdrawal by Subject|0|||
37713003|NCT02101112|69191526|FG004|Overall Study|Withdrawal by Subject|1|||
37713004|NCT02101112|69191527|FG005|Overall Study|Withdrawal by Subject|0|||
37713005|NCT02139644|69191542|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
37838741|NCT01133821|69523306|FG001|Overall Study|preferred other treatment|1|||
37713006|NCT02139644|69191543|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
37713007|NCT02139644|69191544|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
37713008|NCT02139644|69191545|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
37713009|NCT02139644|69191546|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
37713010|NCT02139644|69191547|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
37713011|NCT02139644|69191542|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
37713012|NCT02139644|69191543|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
37713013|NCT02139644|69191544|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
37713014|NCT02139644|69191545|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
37713015|NCT02139644|69191546|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
37713016|NCT02139644|69191547|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
37713017|NCT02139644|69191542|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
37713018|NCT02139644|69191543|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
37713019|NCT02139644|69191544|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
37713020|NCT02139644|69191545|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
37713021|NCT02139644|69191546|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
37713022|NCT02139644|69191547|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
37713023|NCT02139644|69191542|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
37713024|NCT02139644|69191543|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
37713025|NCT02139644|69191544|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
37713026|NCT02139644|69191545|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
37713027|NCT02139644|69191546|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
37713028|NCT02139644|69191547|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
37713029|NCT02139644|69191542|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
37713030|NCT02139644|69191543|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
37713031|NCT02139644|69191544|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
37713032|NCT02139644|69191545|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
37713033|NCT02139644|69191546|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
37713034|NCT02139644|69191547|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
37713035|NCT02139644|69191542|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
37713036|NCT02139644|69191543|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
37713037|NCT02139644|69191544|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
37713038|NCT02139644|69191545|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
37713039|NCT02139644|69191546|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
37713040|NCT02139644|69191547|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
37713041|NCT02139644|69191542|FG000|Run-In Period (Pre-assignment)|Other|6|||
37713042|NCT02139644|69191543|FG001|Run-In Period (Pre-assignment)|Other|0|||
37713043|NCT02139644|69191544|FG002|Run-In Period (Pre-assignment)|Other|0|||
37713044|NCT02139644|69191545|FG003|Run-In Period (Pre-assignment)|Other|0|||
37713045|NCT02139644|69191546|FG004|Run-In Period (Pre-assignment)|Other|0|||
37713046|NCT02139644|69191547|FG005|Run-In Period (Pre-assignment)|Other|0|||
37713047|NCT02139644|69191542|FG000|Treatment Period|Adverse Event|0|||
37713048|NCT02139644|69191543|FG001|Treatment Period|Adverse Event|0|||
37713049|NCT02139644|69191544|FG002|Treatment Period|Adverse Event|3|||
37713050|NCT02139644|69191545|FG003|Treatment Period|Adverse Event|2|||
37713051|NCT02139644|69191546|FG004|Treatment Period|Adverse Event|1|||
37713052|NCT02139644|69191547|FG005|Treatment Period|Adverse Event|6|||
37713053|NCT02139644|69191542|FG000|Treatment Period|Withdrawal by Subject|0|||
37713054|NCT02139644|69191543|FG001|Treatment Period|Withdrawal by Subject|0|||
37713055|NCT02139644|69191544|FG002|Treatment Period|Withdrawal by Subject|2|||
37713056|NCT02139644|69191545|FG003|Treatment Period|Withdrawal by Subject|2|||
37713057|NCT02139644|69191546|FG004|Treatment Period|Withdrawal by Subject|3|||
37713058|NCT02139644|69191547|FG005|Treatment Period|Withdrawal by Subject|2|||
37713059|NCT02139644|69191542|FG000|Treatment Period|Non-compliance|0|||
37713060|NCT02139644|69191543|FG001|Treatment Period|Non-compliance|0|||
37838742|NCT01133821|69523305|FG000|Overall Study|Protocol Violation|0|||
37838743|NCT01133821|69523306|FG001|Overall Study|Protocol Violation|1|||
37838744|NCT01133821|69523305|FG000|Overall Study|Refused participation|1|||
37838745|NCT01133821|69523306|FG001|Overall Study|Refused participation|3|||
37838746|NCT00472446|69523316|FG000|Overall Study|Protocol Violation|0|||
37838747|NCT00472446|69523317|FG001|Overall Study|Protocol Violation|0|||
37838748|NCT00472446|69523318|FG002|Overall Study|Protocol Violation|0|||
37838749|NCT00472446|69523319|FG003|Overall Study|Protocol Violation|1|||
37838750|NCT00472446|69523316|FG000|Overall Study|Reintervention|0|||
37838751|NCT00472446|69523317|FG001|Overall Study|Reintervention|0|||
37838752|NCT00472446|69523318|FG002|Overall Study|Reintervention|1|||
37838753|NCT00472446|69523319|FG003|Overall Study|Reintervention|1|||
37838754|NCT00472446|69523316|FG000|Overall Study|Questionnaires not returned|5|||
37838755|NCT00472446|69523317|FG001|Overall Study|Questionnaires not returned|6|||
37838756|NCT00472446|69523318|FG002|Overall Study|Questionnaires not returned|6|||
37713061|NCT02139644|69191544|FG002|Treatment Period|Non-compliance|0|||
37713062|NCT02139644|69191545|FG003|Treatment Period|Non-compliance|1|||
37713063|NCT02139644|69191546|FG004|Treatment Period|Non-compliance|0|||
37713064|NCT02139644|69191547|FG005|Treatment Period|Non-compliance|0|||
37713065|NCT02139644|69191542|FG000|Treatment Period|Protocol Violation|0|||
37713066|NCT02139644|69191543|FG001|Treatment Period|Protocol Violation|0|||
37713067|NCT02139644|69191544|FG002|Treatment Period|Protocol Violation|0|||
37713068|NCT02139644|69191545|FG003|Treatment Period|Protocol Violation|1|||
37713069|NCT02139644|69191546|FG004|Treatment Period|Protocol Violation|1|||
37713070|NCT02139644|69191547|FG005|Treatment Period|Protocol Violation|1|||
37713071|NCT02139644|69191542|FG000|Treatment Period|Disease progression|0|||
37713072|NCT02139644|69191543|FG001|Treatment Period|Disease progression|0|||
37713073|NCT02139644|69191544|FG002|Treatment Period|Disease progression|0|||
37713074|NCT02139644|69191545|FG003|Treatment Period|Disease progression|1|||
37713075|NCT02139644|69191546|FG004|Treatment Period|Disease progression|1|||
37713076|NCT02139644|69191547|FG005|Treatment Period|Disease progression|2|||
37713077|NCT02139644|69191542|FG000|Treatment Period|Lost to Follow-up|0|||
37713078|NCT02139644|69191543|FG001|Treatment Period|Lost to Follow-up|0|||
37713079|NCT02139644|69191544|FG002|Treatment Period|Lost to Follow-up|1|||
37713080|NCT02139644|69191545|FG003|Treatment Period|Lost to Follow-up|1|||
37713081|NCT02139644|69191546|FG004|Treatment Period|Lost to Follow-up|1|||
37713082|NCT02139644|69191547|FG005|Treatment Period|Lost to Follow-up|1|||
37713083|NCT02139644|69191542|FG000|Treatment Period|Lack of Efficacy|0|||
37713084|NCT02139644|69191543|FG001|Treatment Period|Lack of Efficacy|0|||
37713085|NCT02139644|69191544|FG002|Treatment Period|Lack of Efficacy|1|||
37713086|NCT02139644|69191545|FG003|Treatment Period|Lack of Efficacy|0|||
37713087|NCT02139644|69191546|FG004|Treatment Period|Lack of Efficacy|1|||
37713088|NCT02139644|69191547|FG005|Treatment Period|Lack of Efficacy|4|||
37713089|NCT02139644|69191542|FG000|Treatment Period|Other|0|||
37713090|NCT02139644|69191543|FG001|Treatment Period|Other|3|||
37713091|NCT02139644|69191544|FG002|Treatment Period|Other|1|||
37713092|NCT02139644|69191545|FG003|Treatment Period|Other|1|||
37713093|NCT02139644|69191546|FG004|Treatment Period|Other|0|||
37713094|NCT02139644|69191547|FG005|Treatment Period|Other|1|||
37713095|NCT02100644|69191559|FG000|LTG Escalation Phase|Adverse Event|9|||
37713096|NCT02100644|69191560|FG001|LTG Escalation Phase|Adverse Event|0|||
37713097|NCT02100644|69191561|FG002|LTG Escalation Phase|Adverse Event|0|||
37713098|NCT02100644|69191559|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
37713099|NCT02100644|69191560|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
37713100|NCT02100644|69191561|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
37713101|NCT02100644|69191559|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
37713102|NCT02100644|69191560|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
37713103|NCT02100644|69191561|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
37713104|NCT02074982|69191567|FG000|Overall Study|Adverse Event|15|||
37713105|NCT02074982|69191568|FG001|Overall Study|Adverse Event|7|||
37713106|NCT02074982|69191567|FG000|Overall Study|Lack of Efficacy|6|||
37713107|NCT02074982|69191568|FG001|Overall Study|Lack of Efficacy|1|||
37713108|NCT02074982|69191567|FG000|Overall Study|Lost to Follow-up|9|||
37713109|NCT02074982|69191568|FG001|Overall Study|Lost to Follow-up|10|||
37713110|NCT02074982|69191567|FG000|Overall Study|Non-compliance with study treatment|0|||
37713111|NCT02074982|69191568|FG001|Overall Study|Non-compliance with study treatment|2|||
37713112|NCT02074982|69191567|FG000|Overall Study|Physician Decision|1|||
37713113|NCT02074982|69191568|FG001|Overall Study|Physician Decision|1|||
37713114|NCT02074982|69191567|FG000|Overall Study|Pregnancy|1|||
37713115|NCT02074982|69191568|FG001|Overall Study|Pregnancy|2|||
37713116|NCT02074982|69191567|FG000|Overall Study|Protocol deviation|4|||
37713117|NCT02074982|69191568|FG001|Overall Study|Protocol deviation|3|||
37713118|NCT02074982|69191567|FG000|Overall Study|Technical problems|0|||
37713119|NCT02074982|69191568|FG001|Overall Study|Technical problems|2|||
37713120|NCT02074982|69191567|FG000|Overall Study|Subject/guardian decision|15|||
37713121|NCT02074982|69191568|FG001|Overall Study|Subject/guardian decision|24|||
37713122|NCT02074982|69191567|FG000|Overall Study|Death|0|||
37713123|NCT02074982|69191568|FG001|Overall Study|Death|2|||
37713124|NCT02074514|69191578|FG000|Overall Study|Lack of Efficacy|3|||
37713125|NCT02074514|69191579|FG001|Overall Study|Lack of Efficacy|2|||
37713126|NCT02074514|69191578|FG000|Overall Study|Lost to Follow-up|0|||
37713127|NCT02074514|69191579|FG001|Overall Study|Lost to Follow-up|1|||
37838757|NCT00472446|69523319|FG003|Overall Study|Questionnaires not returned|4|||
37713128|NCT02074514|69191578|FG000|Overall Study|Withdrew Consent|0|||
37713129|NCT02074514|69191579|FG001|Overall Study|Withdrew Consent|1|||
37713130|NCT02099708|69191589|FG000|Overall Study|Data Not Available|30|||
37713131|NCT02099708|69191589|FG000|Overall Study|Lost to Follow-up|141|||
37713132|NCT02099708|69191589|FG000|Overall Study|Other|29|||
37713133|NCT02073656|69191593|FG000|Primary Study|Lost to Follow-up|6|||
37713134|NCT02073656|69191593|FG000|Primary Study|Death|1|||
37713135|NCT02073656|69191593|FG000|Primary Study|Withdrew Consent|1|||
37713136|NCT02242643|69191601|FG000|Overall Study|Protocol Violation|1|||
37713137|NCT02242643|69191602|FG001|Overall Study|Protocol Violation|2|||
37713138|NCT02242643|69191601|FG000|Overall Study|Withdrawal by Subject|15|||
37713139|NCT02242643|69191602|FG001|Overall Study|Withdrawal by Subject|10|||
37713140|NCT02242643|69191601|FG000|Overall Study|Migrated/moved from study area|1|||
37713141|NCT02242643|69191602|FG001|Overall Study|Migrated/moved from study area|3|||
37713142|NCT02242643|69191601|FG000|Overall Study|Lost to Follow-up|54|||
37713143|NCT02242643|69191602|FG001|Overall Study|Lost to Follow-up|61|||
37713144|NCT02242643|69191601|FG000|Overall Study|Child placed in foster care by family|0|||
37713145|NCT02242643|69191602|FG001|Overall Study|Child placed in foster care by family|1|||
37713146|NCT02242643|69191601|FG000|Overall Study|Non-compliance|1|||
37713147|NCT02242643|69191602|FG001|Overall Study|Non-compliance|0|||
37713148|NCT02242643|69191601|FG000|Overall Study|Consent withdrawal by parent|1|||
37713149|NCT02242643|69191602|FG001|Overall Study|Consent withdrawal by parent|0|||
37713150|NCT02242643|69191601|FG000|Overall Study|Protocol requirements not followed|1|||
37713151|NCT02242643|69191602|FG001|Overall Study|Protocol requirements not followed|0|||
37713152|NCT02242643|69191601|FG000|Overall Study|Language barrier|1|||
37713153|NCT02242643|69191602|FG001|Overall Study|Language barrier|0|||
37713154|NCT02242643|69191601|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
37713155|NCT02242643|69191602|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
37713156|NCT02097290|69191610|FG000|Overall Study|Death|6|||
37713157|NCT02097290|69191610|FG000|Overall Study|Total Withdrawals|3|||
37713158|NCT02097290|69191610|FG000|Overall Study|Attempt|8|||
37713159|NCT02072174|69191616|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
37713160|NCT02072174|69191617|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
37713161|NCT02072174|69191616|FG000|Overall Study|Protocol Violation|16|||
37713162|NCT02072174|69191617|FG001|Overall Study|Protocol Violation|23|||
37713163|NCT02072174|69191616|FG000|Overall Study|Physician Decision|0|||
37713164|NCT02072174|69191617|FG001|Overall Study|Physician Decision|1|||
37713165|NCT02072174|69191616|FG000|Overall Study|Non-compliance with protocol requirement|2|||
37713166|NCT02072174|69191617|FG001|Overall Study|Non-compliance with protocol requirement|0|||
37713167|NCT02209181|69191629|FG000|Overall Study|Adverse Event|1|||
37713168|NCT02209181|69191630|FG001|Overall Study|Adverse Event|0|||
37713169|NCT02209181|69191631|FG002|Overall Study|Adverse Event|1|||
37713170|NCT02209181|69191632|FG003|Overall Study|Adverse Event|0|||
37713171|NCT02209181|69191629|FG000|Overall Study|Withdrawal by Subject|0|||
37713172|NCT02209181|69191630|FG001|Overall Study|Withdrawal by Subject|1|||
37713173|NCT02209181|69191631|FG002|Overall Study|Withdrawal by Subject|0|||
37713174|NCT02209181|69191632|FG003|Overall Study|Withdrawal by Subject|0|||
37713175|NCT02208089|69191644|FG000|Overall Study|Withdrawal by Subject|1|||
37713176|NCT02208089|69191645|FG001|Overall Study|Withdrawal by Subject|0|||
37713177|NCT02208089|69191644|FG000|Overall Study|Lost to Follow-up|6|||
37713178|NCT02208089|69191645|FG001|Overall Study|Lost to Follow-up|0|||
37713179|NCT02242487|69191654|FG000|Overall Study|Adverse Event|13|||
37713180|NCT02242487|69191655|FG001|Overall Study|Adverse Event|15|||
37713181|NCT02242487|69191654|FG000|Overall Study|Lack of Efficacy|4|||
37713182|NCT02242487|69191655|FG001|Overall Study|Lack of Efficacy|6|||
37713183|NCT02242487|69191654|FG000|Overall Study|Protocol Violation|2|||
37713184|NCT02242487|69191655|FG001|Overall Study|Protocol Violation|0|||
37713185|NCT02242487|69191654|FG000|Overall Study|Lost to Follow-up|2|||
37713186|NCT02242487|69191655|FG001|Overall Study|Lost to Follow-up|1|||
37713187|NCT02242487|69191654|FG000|Overall Study|Other - Miscellaneous|4|||
37713188|NCT02242487|69191655|FG001|Overall Study|Other - Miscellaneous|6|||
37713189|NCT02242487|69191654|FG000|Overall Study|Withdrawal by Subject|37|||
37713190|NCT02242487|69191655|FG001|Overall Study|Withdrawal by Subject|19|||
37713191|NCT02241785|69191663|FG000|Overall Study|Sponsor Termination|43|||
37713192|NCT02241785|69191663|FG000|Overall Study|Withdrawal by Subject|1|||
37713193|NCT02241785|69191663|FG000|Overall Study|Lost to Follow-up|2|||
37713194|NCT02241785|69191663|FG000|Overall Study|Adverse Event|1|||
37713195|NCT02241551|69191669|FG000|Overall Study|Adverse Event|1|||
37713196|NCT02241551|69191670|FG001|Overall Study|Adverse Event|0|||
37713197|NCT02207621|69191681|FG000|Overall Study|Adverse Event|71|||
37915424|NCT00882908|69602210|FG004|Overall Study|Lost to Follow-up|2|||
37713198|NCT02207621|69191682|FG001|Overall Study|Adverse Event|15|||
37713199|NCT02207621|69191683|FG002|Overall Study|Adverse Event|132|||
37713200|NCT02207621|69191681|FG000|Overall Study|Withdrawal by Subject|9|||
37713201|NCT02207621|69191682|FG001|Overall Study|Withdrawal by Subject|9|||
37713202|NCT02207621|69191683|FG002|Overall Study|Withdrawal by Subject|13|||
37713203|NCT02207621|69191681|FG000|Overall Study|Non-Compliant|3|||
37713204|NCT02207621|69191682|FG001|Overall Study|Non-Compliant|3|||
37915425|NCT00882908|69602206|FG000|Overall Study|Protocol Violation|0|||
37713205|NCT02207621|69191683|FG002|Overall Study|Non-Compliant|1|||
37713206|NCT02207621|69191681|FG000|Overall Study|Lost to Follow-up|1|||
37713207|NCT02207621|69191682|FG001|Overall Study|Lost to Follow-up|0|||
37713208|NCT02207621|69191683|FG002|Overall Study|Lost to Follow-up|3|||
37713209|NCT02207621|69191681|FG000|Overall Study|Lack of Efficacy|10|||
37713210|NCT02207621|69191682|FG001|Overall Study|Lack of Efficacy|2|||
37713211|NCT02207621|69191683|FG002|Overall Study|Lack of Efficacy|4|||
37915426|NCT00882908|69602207|FG001|Overall Study|Protocol Violation|1|||
38024548|NCT04435184|69708240|FG001|Overall Study|follow-up blood draws missing|5|||
38024549|NCT04432376|69708249|FG000|Double-blind Treatment Period|Adverse Event|2|||
38024550|NCT04432376|69708250|FG001|Double-blind Treatment Period|Adverse Event|6|||
38024551|NCT04432376|69708251|FG002|Double-blind Treatment Period|Adverse Event|0|||
38024552|NCT04432376|69708249|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
38024553|NCT04432376|69708250|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
38024554|NCT04432376|69708251|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
38024555|NCT04432376|69708249|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
38024556|NCT04432376|69708250|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
38024557|NCT04432376|69708251|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
38024558|NCT04432376|69708249|FG000|Double-blind Treatment Period|Protocol Violation|0|||
38024559|NCT04432376|69708250|FG001|Double-blind Treatment Period|Protocol Violation|1|||
38024560|NCT04432376|69708251|FG002|Double-blind Treatment Period|Protocol Violation|0|||
38024561|NCT04432376|69708249|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
38024562|NCT04432376|69708250|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
38024563|NCT04432376|69708251|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
38024564|NCT03693404|69708260|FG000|Overall Study|Withdrawal by Subject|1|||
38024565|NCT03693404|69708261|FG001|Overall Study|Withdrawal by Subject|0|||
38024566|NCT03693404|69708260|FG000|Overall Study|Lost to Follow-up|0|||
38024567|NCT03693404|69708261|FG001|Overall Study|Lost to Follow-up|5|||
38024568|NCT03693404|69708260|FG000|Overall Study|Excluded from Analysis|0|||
38024569|NCT03693404|69708261|FG001|Overall Study|Excluded from Analysis|1|||
38024570|NCT03696108|69708269|FG000|Overall Study|Physician Decision|1|||
38024571|NCT03696108|69708270|FG001|Overall Study|Physician Decision|0|||
38024572|NCT03696108|69708269|FG000|Overall Study|Withdrawal by Subject|3|||
38024573|NCT03696108|69708270|FG001|Overall Study|Withdrawal by Subject|6|||
38024574|NCT04218110|69708280|FG000|Overall Study|Withdrawal by Subject|0|||
38024575|NCT04218110|69708281|FG001|Overall Study|Withdrawal by Subject|0|||
38024576|NCT04218110|69708282|FG002|Overall Study|Withdrawal by Subject|0|||
38024577|NCT04218110|69708283|FG003|Overall Study|Withdrawal by Subject|1|||
38024578|NCT04214600|69708295|FG000|Overall Study|Lost to Follow-up|9|||
38024579|NCT04214600|69708296|FG001|Overall Study|Lost to Follow-up|14|||
38024580|NCT04210310|69708305|FG000|Overall Study|Lost to Follow-up|32|||
38024581|NCT04210310|69708306|FG001|Overall Study|Lost to Follow-up|1|||
38043465|NCT03737994|69731600|FG006|Overall Study|Withdrawal by Subject|1|||
38043466|NCT03698019|69731622|FG000|Step 1: Registration|Still receiving protocol therapy|0|||
38043467|NCT03698019|69731623|FG001|Step 1: Registration|Still receiving protocol therapy|10|||
38043468|NCT03698019|69731622|FG000|Step 1: Registration|Withdrawal by Subject|7|||
38043469|NCT03698019|69731623|FG001|Step 1: Registration|Withdrawal by Subject|2|||
38043470|NCT03698019|69731622|FG000|Step 1: Registration|Toxicity|0|||
38043471|NCT03698019|69731623|FG001|Step 1: Registration|Toxicity|1|||
38043472|NCT03698019|69731622|FG000|Step 1: Registration|Disease Progression|0|||
38043473|NCT03698019|69731623|FG001|Step 1: Registration|Disease Progression|12|||
38043474|NCT03698019|69731622|FG000|Step 1: Registration|Co-morbidities|0|||
38043475|NCT03698019|69731623|FG001|Step 1: Registration|Co-morbidities|1|||
38043476|NCT03698019|69731622|FG000|Step 1: Registration|Scheduling Issues|1|||
38043477|NCT03698019|69731623|FG001|Step 1: Registration|Scheduling Issues|0|||
38043478|NCT03698019|69731622|FG000|Step 1: Registration|Participant Refusal|0|||
38043479|NCT03698019|69731623|FG001|Step 1: Registration|Participant Refusal|1|||
38043480|NCT03698019|69731622|FG000|Step 2: Surgery|Participant Refusal|2|||
38043481|NCT03698019|69731623|FG001|Step 2: Surgery|Participant Refusal|1|||
38043482|NCT03698019|69731622|FG000|Step 2: Surgery|Neoadjuvant Toxicity|0|||
38043483|NCT03698019|69731623|FG001|Step 2: Surgery|Neoadjuvant Toxicity|3|||
38043484|NCT03698019|69731622|FG000|Step 2: Surgery|Metastatic Disease|16|||
38043485|NCT03698019|69731623|FG001|Step 2: Surgery|Metastatic Disease|9|||
38043486|NCT03698019|69731622|FG000|Step 2: Surgery|Residual Disease|2|||
38043487|NCT03698019|69731623|FG001|Step 2: Surgery|Residual Disease|1|||
38043488|NCT03698019|69731622|FG000|Step 2: Surgery|Trial Closed due to Covid-19|0|||
38043489|NCT03698019|69731623|FG001|Step 2: Surgery|Trial Closed due to Covid-19|1|||
38043490|NCT03698019|69731622|FG000|Step 2: Surgery|Concerns about Exposure to Covid-19|0|||
38043491|NCT03698019|69731623|FG001|Step 2: Surgery|Concerns about Exposure to Covid-19|1|||
38043492|NCT03698019|69731622|FG000|Step 2: Surgery|Disease other than melanoma identified at surgery|0|||
38043493|NCT03698019|69731623|FG001|Step 2: Surgery|Disease other than melanoma identified at surgery|2|||
38043494|NCT03698019|69731622|FG000|Step 2: Surgery|Radiotherapy-related Delays|1|||
38043495|NCT03698019|69731623|FG001|Step 2: Surgery|Radiotherapy-related Delays|0|||
38043496|NCT03698019|69731622|FG000|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|41|||
38043497|NCT03698019|69731623|FG001|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|33|||
38043498|NCT03698019|69731622|FG000|Step 3: Adjuvant Pembrolizumab|Disease Progression|41|||
38043499|NCT03698019|69731623|FG001|Step 3: Adjuvant Pembrolizumab|Disease Progression|9|||
38043500|NCT03698019|69731622|FG000|Step 3: Adjuvant Pembrolizumab|Death|4|||
38043501|NCT03698019|69731623|FG001|Step 3: Adjuvant Pembrolizumab|Death|1|||
37713212|NCT02207621|69191681|FG000|Overall Study|Disallowed Concurrent Medication|2|||
37713213|NCT02207621|69191682|FG001|Overall Study|Disallowed Concurrent Medication|5|||
37713214|NCT02207621|69191683|FG002|Overall Study|Disallowed Concurrent Medication|2|||
37713215|NCT02207621|69191681|FG000|Overall Study|Physician Decision|1|||
37713216|NCT02207621|69191682|FG001|Overall Study|Physician Decision|2|||
37713217|NCT02207621|69191683|FG002|Overall Study|Physician Decision|2|||
37713218|NCT02207621|69191681|FG000|Overall Study|Protocol Violation|4|||
37713219|NCT02207621|69191682|FG001|Overall Study|Protocol Violation|10|||
37713220|NCT02207621|69191683|FG002|Overall Study|Protocol Violation|6|||
37713221|NCT02207621|69191681|FG000|Overall Study|Death|2|||
37713222|NCT02207621|69191682|FG001|Overall Study|Death|0|||
37713223|NCT02207621|69191683|FG002|Overall Study|Death|0|||
37713224|NCT02207621|69191681|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
37713225|NCT02207621|69191682|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
37713226|NCT02207621|69191683|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
37713227|NCT02240693|69191697|FG000|Overall Study|Adverse Event|0|||
37713228|NCT02240693|69191698|FG001|Overall Study|Adverse Event|0|||
37713229|NCT02240693|69191699|FG002|Overall Study|Adverse Event|0|||
37713230|NCT02240693|69191700|FG003|Overall Study|Adverse Event|0|||
37713231|NCT02240693|69191701|FG004|Overall Study|Adverse Event|1|||
37713232|NCT02240693|69191697|FG000|Overall Study|Withdrawal by Subject|0|||
37713233|NCT02240693|69191698|FG001|Overall Study|Withdrawal by Subject|0|||
37713234|NCT02240693|69191699|FG002|Overall Study|Withdrawal by Subject|2|||
37713235|NCT02240693|69191700|FG003|Overall Study|Withdrawal by Subject|1|||
37713236|NCT02240693|69191701|FG004|Overall Study|Withdrawal by Subject|0|||
37713237|NCT02240693|69191697|FG000|Overall Study|Other than specified|0|||
37713238|NCT02240693|69191698|FG001|Overall Study|Other than specified|0|||
37713239|NCT02240693|69191699|FG002|Overall Study|Other than specified|2|||
37713240|NCT02240693|69191700|FG003|Overall Study|Other than specified|0|||
37713241|NCT02240693|69191701|FG004|Overall Study|Other than specified|0|||
37713242|NCT02239679|69191718|FG000|Overall Study|Lost to Follow-up|1|||
37713243|NCT02239679|69191719|FG001|Overall Study|Lost to Follow-up|0|||
37713244|NCT02239679|69191720|FG002|Overall Study|Lost to Follow-up|0|||
37713245|NCT02239679|69191718|FG000|Overall Study|Withdrawal by Subject|2|||
37713246|NCT02239679|69191719|FG001|Overall Study|Withdrawal by Subject|3|||
37713247|NCT02239679|69191720|FG002|Overall Study|Withdrawal by Subject|1|||
37713248|NCT02072096|69191730|FG000|Overall Study|Lack of Efficacy|18|||
37713249|NCT02072096|69191731|FG001|Overall Study|Lack of Efficacy|29|||
37713250|NCT02072096|69191730|FG000|Overall Study|Protocol Violation|7|||
37713251|NCT02072096|69191731|FG001|Overall Study|Protocol Violation|7|||
37713252|NCT02072096|69191730|FG000|Overall Study|Withdrawal by Subject|5|||
37713253|NCT02072096|69191731|FG001|Overall Study|Withdrawal by Subject|7|||
37713254|NCT02072096|69191730|FG000|Overall Study|Adverse Event|5|||
37713255|NCT02072096|69191731|FG001|Overall Study|Adverse Event|2|||
37713256|NCT02072096|69191730|FG000|Overall Study|No Reason Provided|4|||
37713257|NCT02072096|69191731|FG001|Overall Study|No Reason Provided|2|||
37713258|NCT02072096|69191730|FG000|Overall Study|Death|2|||
37713259|NCT02072096|69191731|FG001|Overall Study|Death|0|||
37713260|NCT02072096|69191730|FG000|Overall Study|Physician Decision|0|||
37713261|NCT02072096|69191731|FG001|Overall Study|Physician Decision|1|||
37713262|NCT02072096|69191730|FG000|Overall Study|Study Terminated by Sponsor|43|||
37713263|NCT02072096|69191731|FG001|Overall Study|Study Terminated by Sponsor|30|||
37713264|NCT02072096|69191730|FG000|Overall Study|Lost to Follow-up|1|||
37713265|NCT02072096|69191731|FG001|Overall Study|Lost to Follow-up|0|||
37713266|NCT02071706|69191738|FG000|Overall Study|Adverse Event|1|||
37713267|NCT02071706|69191738|FG000|Overall Study|Withdrawal by Subject|2|||
37713268|NCT01631825|69191742|FG000|Overall Study|Adverse Event|42|||
37713269|NCT01631825|69191742|FG000|Overall Study|Lack of Efficacy|7|||
37713270|NCT01631825|69191742|FG000|Overall Study|Withdrawal by Subject|9|||
37713271|NCT01631825|69191742|FG000|Overall Study|Protocol Violation|4|||
37713272|NCT01631825|69191742|FG000|Overall Study|Discontinuation criteria|1|||
37713273|NCT01631825|69191742|FG000|Overall Study|Physician Decision|2|||
37713274|NCT02071082|69191748|FG000|Overall Study|Enrolled and Never Treated|1|||
37915427|NCT00882908|69602208|FG002|Overall Study|Protocol Violation|0|||
37713275|NCT02071082|69191749|FG001|Overall Study|Enrolled and Never Treated|1|||
37713276|NCT02071082|69191748|FG000|Overall Study|Adverse Event|0|||
37713277|NCT02071082|69191749|FG001|Overall Study|Adverse Event|1|||
37713278|NCT02071082|69191748|FG000|Overall Study|Withdrew Consent|0|||
37713279|NCT02071082|69191749|FG001|Overall Study|Withdrew Consent|4|||
37713280|NCT02071082|69191748|FG000|Overall Study|Lost to Follow-up|1|||
37713281|NCT02071082|69191749|FG001|Overall Study|Lost to Follow-up|1|||
37713282|NCT02123108|69191757|FG000|Overall Study|Death|2|||
37713283|NCT02123108|69191758|FG001|Overall Study|Death|3|||
37713284|NCT02121392|69191766|FG000|Prior to Intervention|Protocol Violation|40|||
37713285|NCT02121392|69191767|FG001|Prior to Intervention|Protocol Violation|35|||
37713286|NCT02121392|69191766|FG000|Prior to Intervention|Withdrawal by Subject|8|||
37713287|NCT02121392|69191767|FG001|Prior to Intervention|Withdrawal by Subject|6|||
37713288|NCT02121392|69191766|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
37713289|NCT02121392|69191767|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
37713290|NCT02121392|69191766|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
37713291|NCT02121392|69191767|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
37713292|NCT02097056|69191773|FG000|Overall Study|Protocol Violation|2|||
37713293|NCT02097056|69191773|FG000|Overall Study|Withdrawal by Subject|15|||
37838758|NCT00472290|69523329|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
37838759|NCT00472290|69523329|FG000|Overall Study|Protocol Specified Criteria|7|||
37838760|NCT00472290|69523329|FG000|Overall Study|Administrative Decision|37|||
37838761|NCT00472290|69523329|FG000|Overall Study|Death|3|||
37838762|NCT00472290|69523329|FG000|Overall Study|Lost to Follow-up|1|||
37838763|NCT00472290|69523329|FG000|Overall Study|Lack of Efficacy|1|||
37838764|NCT00472290|69523329|FG000|Overall Study|Disease Progression|4|||
37838765|NCT00472290|69523329|FG000|Overall Study|Withdrawal by Subject|5|||
37838766|NCT00472290|69523329|FG000|Overall Study|Adverse Event|6|||
37838767|NCT00472290|69523329|FG000|Overall Study|Requirement for alternative therapy|7|||
37838768|NCT01133704|69523335|FG000|Overall Study|Death|44|||
37838769|NCT01133704|69523336|FG001|Overall Study|Death|26|||
37838770|NCT01133704|69523335|FG000|Overall Study|Patient refused to continue|4|||
37838771|NCT01133704|69523336|FG001|Overall Study|Patient refused to continue|0|||
37838772|NCT01133704|69523335|FG000|Overall Study|Study Closure|1|||
37838773|NCT01133704|69523336|FG001|Overall Study|Study Closure|0|||
37838774|NCT01133665|69523342|FG000|Overall Study|Physician Decision|2|||
37838775|NCT01133626|69523349|FG000|Overall Study|Adverse Event|0|||
37838776|NCT01133626|69523350|FG001|Overall Study|Adverse Event|1|||
37838777|NCT01133626|69523351|FG002|Overall Study|Adverse Event|0|||
37838778|NCT01133626|69523349|FG000|Overall Study|Withdrawal by Subject|1|||
37838779|NCT01133626|69523350|FG001|Overall Study|Withdrawal by Subject|2|||
37838780|NCT01133626|69523351|FG002|Overall Study|Withdrawal by Subject|2|||
37838781|NCT01133626|69523349|FG000|Overall Study|Other|0|||
37838782|NCT01133626|69523350|FG001|Overall Study|Other|2|||
37838783|NCT01133626|69523351|FG002|Overall Study|Other|0|||
37838784|NCT01133392|69523361|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
37838785|NCT01133392|69523362|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
37838786|NCT01133392|69523361|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
37838787|NCT01133392|69523362|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
37838788|NCT00471354|69523368|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
37838789|NCT00471354|69523368|FG000|Overall Study|Adverse Event|13|||
37838790|NCT00471354|69523368|FG000|Overall Study|Protocol Violation|12|||
37838791|NCT00471354|69523368|FG000|Overall Study|Withdrawal by Subject|1|||
37838792|NCT00471354|69523368|FG000|Overall Study|Physician Decision|4|||
37838793|NCT00471354|69523368|FG000|Overall Study|Sponsor Decision|1|||
37838794|NCT00471354|69523368|FG000|Overall Study|Lost to Follow-up|3|||
37838795|NCT00471354|69523368|FG000|Overall Study|Lack of Efficacy|5|||
37838796|NCT00471354|69523368|FG000|Overall Study|Patient/Caregiver Decision|12|||
37838797|NCT00471315|69523372|FG000|Overall Study|Adverse Event|7|||
37838798|NCT00471315|69523372|FG000|Overall Study|Withdrawal by Subject|1|||
37838799|NCT00471237|69523383|FG000|Overall Study|Adverse Event|6|||
37838800|NCT00471237|69523384|FG001|Overall Study|Adverse Event|5|||
37838801|NCT00471237|69523385|FG002|Overall Study|Adverse Event|4|||
37838802|NCT00471237|69523386|FG003|Overall Study|Adverse Event|8|||
37838803|NCT00471237|69523387|FG004|Overall Study|Adverse Event|7|||
37838804|NCT00471237|69523388|FG005|Overall Study|Adverse Event|5|||
37838805|NCT00471237|69523389|FG006|Overall Study|Adverse Event|0|||
37838806|NCT00471237|69523383|FG000|Overall Study|Lost to Follow-up|1|||
37838807|NCT00471237|69523384|FG001|Overall Study|Lost to Follow-up|1|||
37838808|NCT00471237|69523385|FG002|Overall Study|Lost to Follow-up|0|||
37838809|NCT00471237|69523386|FG003|Overall Study|Lost to Follow-up|2|||
37838810|NCT00471237|69523387|FG004|Overall Study|Lost to Follow-up|3|||
37838811|NCT00471237|69523388|FG005|Overall Study|Lost to Follow-up|0|||
37838812|NCT00471237|69523389|FG006|Overall Study|Lost to Follow-up|0|||
37838813|NCT00471237|69523383|FG000|Overall Study|Protocol Violation|3|||
37838814|NCT00471237|69523384|FG001|Overall Study|Protocol Violation|6|||
37838815|NCT00471237|69523385|FG002|Overall Study|Protocol Violation|3|||
37838816|NCT00471237|69523386|FG003|Overall Study|Protocol Violation|2|||
37838817|NCT00471237|69523387|FG004|Overall Study|Protocol Violation|2|||
37838818|NCT00471237|69523388|FG005|Overall Study|Protocol Violation|4|||
37838819|NCT00471237|69523389|FG006|Overall Study|Protocol Violation|1|||
37838820|NCT00471237|69523383|FG000|Overall Study|Withdrawal by Subject|8|||
37838821|NCT00471237|69523384|FG001|Overall Study|Withdrawal by Subject|6|||
37838822|NCT00471237|69523385|FG002|Overall Study|Withdrawal by Subject|5|||
37838823|NCT00471237|69523386|FG003|Overall Study|Withdrawal by Subject|8|||
37838824|NCT00471237|69523387|FG004|Overall Study|Withdrawal by Subject|7|||
37838825|NCT00471237|69523388|FG005|Overall Study|Withdrawal by Subject|4|||
37838826|NCT00471237|69523389|FG006|Overall Study|Withdrawal by Subject|2|||
37838827|NCT00471237|69523383|FG000|Overall Study|Sponsor terminated study|20|||
37915428|NCT00882908|69602209|FG003|Overall Study|Protocol Violation|0|||
37713294|NCT02097056|69191773|FG000|Overall Study|Lost to Follow-up|2|||
37713295|NCT02097056|69191773|FG000|Overall Study|Adverse Event|37|||
37713296|NCT02097056|69191773|FG000|Overall Study|Other|2|||
37713297|NCT02121002|69191780|FG000|Overall Study|Physician Decision|2|||
37713298|NCT02121002|69191781|FG001|Overall Study|Physician Decision|0|||
37713299|NCT02121002|69191782|FG002|Overall Study|Physician Decision|0|||
37713300|NCT02121002|69191780|FG000|Overall Study|Withdrawal by Subject|3|||
37713301|NCT02121002|69191781|FG001|Overall Study|Withdrawal by Subject|1|||
37713302|NCT02121002|69191782|FG002|Overall Study|Withdrawal by Subject|4|||
37713303|NCT02121002|69191780|FG000|Overall Study|Protocol Violation|1|||
37713304|NCT02121002|69191781|FG001|Overall Study|Protocol Violation|2|||
37713305|NCT02121002|69191782|FG002|Overall Study|Protocol Violation|4|||
37713306|NCT02121002|69191780|FG000|Overall Study|Concomitant therapy|0|||
37713307|NCT02121002|69191781|FG001|Overall Study|Concomitant therapy|1|||
37713308|NCT02121002|69191782|FG002|Overall Study|Concomitant therapy|1|||
37713309|NCT02121002|69191780|FG000|Overall Study|Others|1|||
37713310|NCT02121002|69191781|FG001|Overall Study|Others|0|||
37713311|NCT02121002|69191782|FG002|Overall Study|Others|1|||
37713312|NCT02096900|69191792|FG000|Overall Study|Did not receive medication|3|||
37713313|NCT02096900|69191793|FG001|Overall Study|Did not receive medication|1|||
37713314|NCT02096900|69191792|FG000|Overall Study|Surgery cancelled- medication received|1|||
37713315|NCT02096900|69191793|FG001|Overall Study|Surgery cancelled- medication received|1|||
37713316|NCT02120924|69191802|FG000|Overall Study|Lack of Efficacy|1|||
37713317|NCT02120924|69191803|FG001|Overall Study|Lack of Efficacy|2|||
37713318|NCT02120924|69191804|FG002|Overall Study|Lack of Efficacy|3|||
37713319|NCT02120924|69191802|FG000|Overall Study|Adverse Event|0|||
37713320|NCT02120924|69191803|FG001|Overall Study|Adverse Event|1|||
37713321|NCT02120924|69191804|FG002|Overall Study|Adverse Event|3|||
37713322|NCT02120924|69191802|FG000|Overall Study|Withdrawal by Subject|16|||
37713323|NCT02120924|69191803|FG001|Overall Study|Withdrawal by Subject|20|||
37713324|NCT02120924|69191804|FG002|Overall Study|Withdrawal by Subject|8|||
37713325|NCT02120924|69191802|FG000|Overall Study|Lost to Follow-up|14|||
37713326|NCT02120924|69191803|FG001|Overall Study|Lost to Follow-up|14|||
37713327|NCT02120924|69191804|FG002|Overall Study|Lost to Follow-up|11|||
37713328|NCT02120924|69191802|FG000|Overall Study|Pregnancy|2|||
37713329|NCT02120924|69191803|FG001|Overall Study|Pregnancy|0|||
37713330|NCT02120924|69191804|FG002|Overall Study|Pregnancy|0|||
37713331|NCT02120924|69191802|FG000|Overall Study|Protocol Violation|3|||
37713332|NCT02120924|69191803|FG001|Overall Study|Protocol Violation|7|||
37713333|NCT02120924|69191804|FG002|Overall Study|Protocol Violation|2|||
37713334|NCT02120924|69191802|FG000|Overall Study|Physician Decision|0|||
37713335|NCT02120924|69191803|FG001|Overall Study|Physician Decision|1|||
37713336|NCT02120924|69191804|FG002|Overall Study|Physician Decision|1|||
37713337|NCT02120924|69191802|FG000|Overall Study|Death|1|||
37713338|NCT02120924|69191803|FG001|Overall Study|Death|0|||
37713339|NCT02120924|69191804|FG002|Overall Study|Death|0|||
37713340|NCT02120924|69191802|FG000|Overall Study|Compliance with IP|5|||
37713341|NCT02120924|69191803|FG001|Overall Study|Compliance with IP|1|||
37713342|NCT02120924|69191804|FG002|Overall Study|Compliance with IP|1|||
37713343|NCT02096744|69191813|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
37713344|NCT02096744|69191814|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
37713345|NCT02096744|69191813|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
37713346|NCT02096744|69191814|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
37713347|NCT02096744|69191813|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
37713348|NCT02096744|69191814|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
37713349|NCT02120456|69191831|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
37713350|NCT02120456|69191832|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
37713351|NCT02120456|69191833|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
37713352|NCT02120456|69191834|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
37713353|NCT02120456|69191835|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
37713354|NCT02120456|69191836|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
37713355|NCT02120456|69191837|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
37713356|NCT02120456|69191838|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
37713357|NCT02120456|69191839|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
37713358|NCT02120456|69191831|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
37713359|NCT02120456|69191832|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
37713360|NCT02120456|69191833|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
37713361|NCT02120456|69191834|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
37713362|NCT02120456|69191835|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
37713363|NCT02120456|69191836|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
37713364|NCT02120456|69191837|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
37713365|NCT02120456|69191838|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
37838828|NCT00471237|69523384|FG001|Overall Study|Sponsor terminated study|23|||
37713366|NCT02120456|69191839|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
37713367|NCT02120456|69191831|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
37713368|NCT02120456|69191832|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
37713369|NCT02120456|69191833|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
37713370|NCT02120456|69191834|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
37713371|NCT02120456|69191835|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
37713372|NCT02120456|69191836|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
37713373|NCT02120456|69191837|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
37713374|NCT02120456|69191838|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
37713375|NCT02120456|69191839|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
37713376|NCT02120300|69191863|FG000|Overall Study|Enrolled but Never Treated|2|||
37713377|NCT02120300|69191864|FG001|Overall Study|Enrolled but Never Treated|0|||
37713378|NCT02120300|69191865|FG002|Overall Study|Enrolled but Never Treated|0|||
37713379|NCT02120300|69191866|FG003|Overall Study|Enrolled but Never Treated|0|||
37713380|NCT02120300|69191863|FG000|Overall Study|Lack of Efficacy|0|||
37713381|NCT02120300|69191864|FG001|Overall Study|Lack of Efficacy|0|||
37713382|NCT02120300|69191865|FG002|Overall Study|Lack of Efficacy|0|||
37713383|NCT02120300|69191866|FG003|Overall Study|Lack of Efficacy|1|||
37713384|NCT02120300|69191863|FG000|Overall Study|Lost to Follow-up|1|||
37713385|NCT02120300|69191864|FG001|Overall Study|Lost to Follow-up|0|||
37713386|NCT02120300|69191865|FG002|Overall Study|Lost to Follow-up|0|||
37713387|NCT02120300|69191866|FG003|Overall Study|Lost to Follow-up|0|||
37713388|NCT02070380|69191882|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
37713389|NCT02070380|69191883|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
37713390|NCT02070380|69191884|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
37713391|NCT02070380|69191885|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
37713392|NCT02070380|69191882|FG000|Second Injection|Image sets missing or technically inadeq|0|||
37713393|NCT02070380|69191883|FG001|Second Injection|Image sets missing or technically inadeq|1|||
37713394|NCT02070380|69191884|FG002|Second Injection|Image sets missing or technically inadeq|0|||
37713395|NCT02070380|69191885|FG003|Second Injection|Image sets missing or technically inadeq|0|||
37713396|NCT02070380|69191882|FG000|Second Injection|Protocol Violation|0|||
37713397|NCT02070380|69191883|FG001|Second Injection|Protocol Violation|1|||
37713398|NCT02070380|69191884|FG002|Second Injection|Protocol Violation|1|||
37713399|NCT02070380|69191885|FG003|Second Injection|Protocol Violation|5|||
37713400|NCT02069366|69191903|FG000|Overall Study|Lost to Follow-up|0|||
37713401|NCT02069366|69191904|FG001|Overall Study|Lost to Follow-up|0|||
37713402|NCT02069366|69191905|FG002|Overall Study|Lost to Follow-up|1|||
37713403|NCT02069366|69191906|FG003|Overall Study|Lost to Follow-up|0|||
37713404|NCT02069366|69191907|FG004|Overall Study|Lost to Follow-up|0|||
37713405|NCT02069366|69191908|FG005|Overall Study|Lost to Follow-up|2|||
37713406|NCT02069366|69191903|FG000|Overall Study|Protocol Violation|0|||
37713407|NCT02069366|69191904|FG001|Overall Study|Protocol Violation|0|||
37713408|NCT02069366|69191905|FG002|Overall Study|Protocol Violation|1|||
37713409|NCT02069366|69191906|FG003|Overall Study|Protocol Violation|0|||
37713410|NCT02069366|69191907|FG004|Overall Study|Protocol Violation|0|||
37713411|NCT02069366|69191908|FG005|Overall Study|Protocol Violation|0|||
37713412|NCT02069366|69191903|FG000|Overall Study|Withdrawal by Subject|1|||
37713413|NCT02069366|69191904|FG001|Overall Study|Withdrawal by Subject|0|||
37713414|NCT02069366|69191905|FG002|Overall Study|Withdrawal by Subject|1|||
37713415|NCT02069366|69191906|FG003|Overall Study|Withdrawal by Subject|2|||
37713416|NCT02069366|69191907|FG004|Overall Study|Withdrawal by Subject|0|||
37713417|NCT02069366|69191908|FG005|Overall Study|Withdrawal by Subject|0|||
37713418|NCT02068508|69191923|FG000|Overall Study|Case report forms uncollected|27|||
37713419|NCT02068508|69191923|FG000|Overall Study|Patient did not visit the study site|1|||
37713420|NCT02068508|69191923|FG000|Overall Study|Protocol Violation|4|||
37713421|NCT02068352|69191930|FG000|Overall Study|Lost to Follow-up|0|||
37838829|NCT00471237|69523385|FG002|Overall Study|Sponsor terminated study|19|||
37838830|NCT00471237|69523386|FG003|Overall Study|Sponsor terminated study|22|||
37838831|NCT00471237|69523387|FG004|Overall Study|Sponsor terminated study|18|||
37713422|NCT02068352|69191931|FG001|Overall Study|Lost to Follow-up|2|||
37713423|NCT02068352|69191932|FG002|Overall Study|Lost to Follow-up|0|||
37713424|NCT02068352|69191930|FG000|Overall Study|Adverse Event|4|||
37713425|NCT02068352|69191931|FG001|Overall Study|Adverse Event|2|||
37713426|NCT02068352|69191932|FG002|Overall Study|Adverse Event|7|||
37713427|NCT02068352|69191930|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
37713428|NCT02068352|69191931|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
37713429|NCT02068352|69191932|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
37713430|NCT02068352|69191930|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
37713431|NCT02068352|69191931|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
37713432|NCT02068352|69191932|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
37713433|NCT02068352|69191930|FG000|Overall Study|Protocol Deviation|0|||
37713434|NCT02068352|69191931|FG001|Overall Study|Protocol Deviation|0|||
37713435|NCT02068352|69191932|FG002|Overall Study|Protocol Deviation|1|||
37713436|NCT02207231|69191943|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
37713437|NCT02207231|69191944|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
37713438|NCT02207231|69191945|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
37713439|NCT02207231|69191946|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
37713440|NCT02207231|69191943|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
37713441|NCT02207231|69191944|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
37713442|NCT02207231|69191945|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
37713443|NCT02207231|69191946|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
37713444|NCT02207231|69191943|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
37713445|NCT02207231|69191944|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
37713446|NCT02207231|69191945|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
37713447|NCT02207231|69191946|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
37713448|NCT02207231|69191943|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
37713449|NCT02207231|69191944|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
37713450|NCT02207231|69191945|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
37713451|NCT02207231|69191946|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
37713452|NCT02207231|69191943|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
37713453|NCT02207231|69191944|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
37713454|NCT02207231|69191945|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
37713455|NCT02207231|69191946|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
37713456|NCT02207231|69191943|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
37713457|NCT02207231|69191944|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
37713458|NCT02207231|69191945|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
37713459|NCT02207231|69191946|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
37713460|NCT02207231|69191943|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
37713461|NCT02207231|69191944|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
37713462|NCT02207231|69191945|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
37713463|NCT02207231|69191946|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
37713464|NCT02207231|69191943|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
37713465|NCT02207231|69191944|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
37713466|NCT02207231|69191945|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
37713467|NCT02207231|69191946|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
37713468|NCT02207231|69191943|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
37713469|NCT02207231|69191944|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
37713470|NCT02207231|69191945|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
37713471|NCT02207231|69191946|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
37713472|NCT02207231|69191943|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
37713473|NCT02207231|69191944|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
37713474|NCT02207231|69191945|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
37713475|NCT02207231|69191946|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
37713476|NCT02207231|69191943|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
37713477|NCT02207231|69191944|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
37713478|NCT02207231|69191945|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
37713479|NCT02207231|69191946|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
37713480|NCT02207231|69191943|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
37713481|NCT02207231|69191944|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
37713482|NCT02207231|69191945|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
37713483|NCT02207231|69191946|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
37713484|NCT02207231|69191943|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
37713485|NCT02207231|69191944|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
37713486|NCT02207231|69191945|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
37713487|NCT02207231|69191946|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
37713488|NCT02207231|69191943|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
37713489|NCT02207231|69191944|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
37713490|NCT02207231|69191945|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
37713491|NCT02207231|69191946|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
37713492|NCT02207231|69191943|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
37713493|NCT02207231|69191944|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
37713494|NCT02207231|69191945|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
37713495|NCT02207231|69191946|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
37713496|NCT02207231|69191943|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
37713497|NCT02207231|69191944|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
37713498|NCT02207231|69191945|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
37713499|NCT02207231|69191946|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
37713500|NCT02207231|69191943|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
37713501|NCT02207231|69191944|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
37713502|NCT02207231|69191945|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
37713503|NCT02207231|69191946|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
37713504|NCT02207231|69191943|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
37713505|NCT02207231|69191944|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
37713506|NCT02207231|69191945|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
37713507|NCT02207231|69191946|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
37713508|NCT02207231|69191943|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
37713509|NCT02207231|69191944|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
37713510|NCT02207231|69191945|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
37713511|NCT02207231|69191946|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
37713512|NCT02207231|69191943|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
37713513|NCT02207231|69191944|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
37713514|NCT02207231|69191945|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
37713515|NCT02207231|69191946|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
37713516|NCT02207231|69191943|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
37713517|NCT02207231|69191944|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
37713518|NCT02207231|69191945|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
37713519|NCT02207231|69191946|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
37713520|NCT02239601|69191966|FG000|Overall Study|Withdrawal by Subject|3|||
37713521|NCT02239601|69191967|FG001|Overall Study|Withdrawal by Subject|4|||
37713522|NCT02239601|69191966|FG000|Overall Study|Protocol Violation|4|||
37713523|NCT02239601|69191967|FG001|Overall Study|Protocol Violation|2|||
37713524|NCT02236559|69191980|FG000|Overall Study|Met Exclusion|3|||
37713525|NCT02236559|69191981|FG001|Overall Study|Met Exclusion|6|||
37713526|NCT02236559|69191980|FG000|Overall Study|Did not Meet Inclusion|3|||
37713527|NCT02236559|69191981|FG001|Overall Study|Did not Meet Inclusion|3|||
37713528|NCT02236559|69191980|FG000|Overall Study|Subject Did Not Consent|4|||
37713529|NCT02236559|69191981|FG001|Overall Study|Subject Did Not Consent|2|||
37713530|NCT02236559|69191980|FG000|Overall Study|Physician Decision|1|||
37713531|NCT02236559|69191981|FG001|Overall Study|Physician Decision|1|||
37713532|NCT02236559|69191980|FG000|Overall Study|Withdrawal by Subject|1|||
37713533|NCT02236559|69191981|FG001|Overall Study|Withdrawal by Subject|0|||
37713534|NCT02206685|69191989|FG000|Overall Study|Surgery cancelled/changed|2|||
37713535|NCT02206685|69191990|FG001|Overall Study|Surgery cancelled/changed|3|||
37713536|NCT02206685|69191989|FG000|Overall Study|Withdrawal by Subject|1|||
37713537|NCT02206685|69191990|FG001|Overall Study|Withdrawal by Subject|2|||
37713538|NCT02206685|69191989|FG000|Overall Study|Protocol Violation|2|||
37713539|NCT02206685|69191990|FG001|Overall Study|Protocol Violation|2|||
37713540|NCT02206607|69191996|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
37713541|NCT02206607|69191997|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
37713542|NCT02206607|69191998|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
37713543|NCT02206607|69191999|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
37713544|NCT02206607|69192000|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
37713545|NCT02206607|69191996|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
37713546|NCT02206607|69191997|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
37713547|NCT02206607|69191998|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
37713548|NCT02206607|69191999|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
37713549|NCT02206607|69192000|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
37713550|NCT02119676|69192020|FG000|Overall Study|Adverse Event|9|||
37713551|NCT02119676|69192021|FG001|Overall Study|Adverse Event|17|||
37713552|NCT02119676|69192022|FG002|Overall Study|Adverse Event|10|||
37713553|NCT02119676|69192023|FG003|Overall Study|Adverse Event|10|||
37713554|NCT02119676|69192020|FG000|Overall Study|Disease progression|53|||
37713555|NCT02119676|69192021|FG001|Overall Study|Disease progression|55|||
37713556|NCT02119676|69192022|FG002|Overall Study|Disease progression|68|||
37713557|NCT02119676|69192023|FG003|Overall Study|Disease progression|73|||
37713558|NCT02119676|69192020|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
37915429|NCT00882908|69602210|FG004|Overall Study|Protocol Violation|0|||
37713559|NCT02119676|69192021|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
37713560|NCT02119676|69192022|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
37713561|NCT02119676|69192023|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
37713562|NCT02119676|69192020|FG000|Overall Study|Physician Decision|4|||
37713563|NCT02119676|69192021|FG001|Overall Study|Physician Decision|2|||
37713564|NCT02119676|69192022|FG002|Overall Study|Physician Decision|3|||
37713565|NCT02119676|69192023|FG003|Overall Study|Physician Decision|2|||
37713566|NCT02119676|69192020|FG000|Overall Study|Death|9|||
37713567|NCT02119676|69192021|FG001|Overall Study|Death|3|||
37713568|NCT02119676|69192022|FG002|Overall Study|Death|2|||
37713569|NCT02119676|69192023|FG003|Overall Study|Death|1|||
37713570|NCT02119676|69192020|FG000|Overall Study|Noncompliance|0|||
37713571|NCT02119676|69192021|FG001|Overall Study|Noncompliance|1|||
37713572|NCT02119676|69192022|FG002|Overall Study|Noncompliance|0|||
37713573|NCT02119676|69192023|FG003|Overall Study|Noncompliance|0|||
37713574|NCT02119676|69192020|FG000|Overall Study|Lost to Follow-up|0|||
37713575|NCT02119676|69192021|FG001|Overall Study|Lost to Follow-up|0|||
37713576|NCT02119676|69192022|FG002|Overall Study|Lost to Follow-up|1|||
37713577|NCT02119676|69192023|FG003|Overall Study|Lost to Follow-up|0|||
37713578|NCT02119676|69192020|FG000|Overall Study|Protocol deviation|0|||
37713579|NCT02119676|69192021|FG001|Overall Study|Protocol deviation|0|||
37713580|NCT02119676|69192022|FG002|Overall Study|Protocol deviation|1|||
37713581|NCT02119676|69192023|FG003|Overall Study|Protocol deviation|0|||
37713582|NCT02119676|69192020|FG000|Overall Study|Other, unspecified|2|||
37713583|NCT02119676|69192021|FG001|Overall Study|Other, unspecified|1|||
37713584|NCT02119676|69192022|FG002|Overall Study|Other, unspecified|3|||
37713585|NCT02119676|69192023|FG003|Overall Study|Other, unspecified|4|||
37713586|NCT02119676|69192020|FG000|Overall Study|Did not receive study med|2|||
37713587|NCT02119676|69192021|FG001|Overall Study|Did not receive study med|2|||
37713588|NCT02119676|69192022|FG002|Overall Study|Did not receive study med|4|||
37713589|NCT02119676|69192023|FG003|Overall Study|Did not receive study med|5|||
37713590|NCT02206061|69192036|FG000|Overall Study|Withdrawal by Subject|4|||
37713591|NCT02206061|69192037|FG001|Overall Study|Withdrawal by Subject|7|||
37713592|NCT02206061|69192038|FG002|Overall Study|Withdrawal by Subject|1|||
37713593|NCT02206061|69192036|FG000|Overall Study|Lost to Follow-up|14|||
37713594|NCT02206061|69192037|FG001|Overall Study|Lost to Follow-up|7|||
37713595|NCT02206061|69192038|FG002|Overall Study|Lost to Follow-up|20|||
37713596|NCT02095106|69192048|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
37713597|NCT02095106|69192049|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
37713598|NCT01631747|69192061|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
37713599|NCT01631747|69192062|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
37713600|NCT01631747|69192061|FG000|Live Birth|Pregnancy Termination|1|||
37713601|NCT01631747|69192062|FG001|Live Birth|Pregnancy Termination|0|||
37713602|NCT01631747|69192061|FG000|Live Birth|MIscarriage|2|||
37713603|NCT01631747|69192062|FG001|Live Birth|MIscarriage|0|||
37713604|NCT01631747|69192061|FG000|Live Birth|Stillbirth|1|||
37713605|NCT01631747|69192062|FG001|Live Birth|Stillbirth|1|||
37713606|NCT01631747|69192061|FG000|One Year Infant Outcomes|Patient Refused|13|||
37713607|NCT01631747|69192062|FG001|One Year Infant Outcomes|Patient Refused|9|||
37713608|NCT02068118|69192071|FG000|18-month Comparative Study Period|Death|90|||
37713609|NCT02068118|69192072|FG001|18-month Comparative Study Period|Death|97|||
37713610|NCT02068118|69192071|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
37713611|NCT02068118|69192072|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
37713612|NCT02068118|69192071|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
37713613|NCT02068118|69192072|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
37713614|NCT02068118|69192071|FG000|18-month Comparative Study Period|Heart transplant|9|||
37713615|NCT02068118|69192072|FG001|18-month Comparative Study Period|Heart transplant|15|||
37713616|NCT02068118|69192071|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
37713617|NCT02068118|69192072|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
37713618|NCT02068118|69192071|FG000|18-month Comparative Study Period|Hemiplegia|0|||
37713619|NCT02068118|69192072|FG001|18-month Comparative Study Period|Hemiplegia|1|||
37713620|NCT02068118|69192071|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
37713621|NCT02068118|69192072|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
37713622|NCT02068118|69192071|FG000|18-month Comparative Study Period|Move|0|||
37713623|NCT02068118|69192072|FG001|18-month Comparative Study Period|Move|1|||
37713624|NCT02068118|69192071|FG000|18-month Comparative Study Period|Hearing loss|0|||
37713625|NCT02068118|69192072|FG001|18-month Comparative Study Period|Hearing loss|1|||
37713626|NCT02068118|69192071|FG000|Extension Period|Death|0|||
37713627|NCT02068118|69192072|FG001|Extension Period|Death|2|||
37713628|NCT02068118|69192071|FG000|Extension Period|Withdrawal by Subject|1|||
37713629|NCT02068118|69192072|FG001|Extension Period|Withdrawal by Subject|0|||
37713630|NCT02068118|69192071|FG000|Extension Period|Heart transplant|1|||
37713631|NCT02068118|69192072|FG001|Extension Period|Heart transplant|0|||
37713632|NCT02068118|69192071|FG000|Extension Period|Wrong device use|0|||
37713633|NCT02068118|69192072|FG001|Extension Period|Wrong device use|1|||
37713634|NCT01623830|69192082|FG000|Overall Study|Withdrawal by Subject|6|||
37713635|NCT01623830|69192083|FG001|Overall Study|Withdrawal by Subject|7|||
37713636|NCT01623830|69192082|FG000|Overall Study|Exclusion from Study|1|||
37713637|NCT01623830|69192083|FG001|Overall Study|Exclusion from Study|2|||
37713638|NCT01634165|69192089|FG000|Period 2|Adverse Event|0|||
37713639|NCT01634165|69192090|FG001|Period 2|Adverse Event|1|||
37713640|NCT01634165|69192091|FG002|Period 2|Adverse Event|0|||
37713641|NCT01634165|69192092|FG003|Period 2|Adverse Event|0|||
37713642|NCT03575897|69192104|FG000|Overall Study|Lost to Follow-up|12|||
37713643|NCT03575897|69192105|FG001|Overall Study|Lost to Follow-up|13|||
37713644|NCT02235311|69192113|FG000|Overall Study|Lost to Follow-up|0|||
37713645|NCT02235311|69192114|FG001|Overall Study|Lost to Follow-up|1|||
37713646|NCT02235311|69192113|FG000|Overall Study|Protocol Violation|0|||
37713647|NCT02235311|69192114|FG001|Overall Study|Protocol Violation|1|||
37713648|NCT02204579|69192120|FG000|Overall Study|Screen failures|2|||
37713649|NCT02235077|69192131|FG000|Overall Study|Death|5|||
37713650|NCT02235077|69192132|FG001|Overall Study|Death|7|||
37713651|NCT02235077|69192131|FG000|Overall Study|Lost to Follow-up|5|||
37713652|NCT02235077|69192132|FG001|Overall Study|Lost to Follow-up|6|||
37713653|NCT02235077|69192131|FG000|Overall Study|Withdrawal by Subject|8|||
37713654|NCT02235077|69192132|FG001|Overall Study|Withdrawal by Subject|5|||
37713655|NCT02235077|69192131|FG000|Overall Study|Physician Decision|0|||
37713656|NCT02235077|69192132|FG001|Overall Study|Physician Decision|1|||
37713657|NCT02234141|69192142|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
37713658|NCT02234141|69192143|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
37713659|NCT02234141|69192144|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
37713660|NCT02234141|69192145|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
37713661|NCT02234141|69192146|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
37713662|NCT02234141|69192147|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
37713663|NCT02234141|69192148|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
37713664|NCT02234141|69192142|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
37713665|NCT02234141|69192143|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
37713666|NCT02234141|69192144|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
37713667|NCT02234141|69192145|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
37713668|NCT02234141|69192146|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
37713669|NCT02234141|69192147|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
37713670|NCT02234141|69192148|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
37713671|NCT02234141|69192142|FG000|Treatment Period (24 Weeks)|Death|1|||
37713672|NCT02234141|69192143|FG001|Treatment Period (24 Weeks)|Death|2|||
37713673|NCT02234141|69192144|FG002|Treatment Period (24 Weeks)|Death|0|||
37713674|NCT02234141|69192145|FG003|Treatment Period (24 Weeks)|Death|1|||
37713675|NCT02234141|69192146|FG004|Treatment Period (24 Weeks)|Death|0|||
37713676|NCT02234141|69192147|FG005|Treatment Period (24 Weeks)|Death|0|||
37713677|NCT02234141|69192148|FG006|Treatment Period (24 Weeks)|Death|0|||
37713678|NCT02234141|69192142|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
37713679|NCT02234141|69192143|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
37713680|NCT02234141|69192144|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
37713681|NCT02234141|69192145|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
37713682|NCT02234141|69192146|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
37713683|NCT02234141|69192147|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
37713684|NCT02234141|69192148|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
37713685|NCT02234141|69192142|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
37713686|NCT02234141|69192143|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
37713687|NCT02234141|69192144|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
37713688|NCT02234141|69192145|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
37713689|NCT02234141|69192146|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
37713690|NCT02234141|69192147|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
37713691|NCT02234141|69192148|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
37713692|NCT02234141|69192142|FG000|Long-Term Treatment Period|Death|0|||
37713693|NCT02234141|69192143|FG001|Long-Term Treatment Period|Death|0|||
37713694|NCT02234141|69192144|FG002|Long-Term Treatment Period|Death|0|||
37713695|NCT02234141|69192145|FG003|Long-Term Treatment Period|Death|0|||
37713696|NCT02234141|69192146|FG004|Long-Term Treatment Period|Death|0|||
37713697|NCT02234141|69192147|FG005|Long-Term Treatment Period|Death|1|||
37713698|NCT02234141|69192148|FG006|Long-Term Treatment Period|Death|0|||
37713699|NCT02234141|69192142|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
37713700|NCT02234141|69192143|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
37838832|NCT00471237|69523388|FG005|Overall Study|Sponsor terminated study|24|||
38024582|NCT04209530|69708314|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
37713701|NCT02234141|69192144|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
37713702|NCT02234141|69192145|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
37713703|NCT02234141|69192146|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
37713704|NCT02234141|69192147|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
37838833|NCT00471237|69523389|FG006|Overall Study|Sponsor terminated study|0|||
37713705|NCT02234141|69192148|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
37713706|NCT02234141|69192142|FG000|Long-Term Treatment Period|Adverse Event|4|||
37713707|NCT02234141|69192143|FG001|Long-Term Treatment Period|Adverse Event|0|||
37713708|NCT02234141|69192144|FG002|Long-Term Treatment Period|Adverse Event|5|||
37713709|NCT02234141|69192145|FG003|Long-Term Treatment Period|Adverse Event|0|||
37713710|NCT02234141|69192146|FG004|Long-Term Treatment Period|Adverse Event|1|||
37713711|NCT02234141|69192147|FG005|Long-Term Treatment Period|Adverse Event|1|||
37713712|NCT02234141|69192148|FG006|Long-Term Treatment Period|Adverse Event|1|||
37713713|NCT02234141|69192142|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
37713714|NCT02234141|69192143|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
37713715|NCT02234141|69192144|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
37713716|NCT02234141|69192145|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
37713717|NCT02234141|69192146|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
37713718|NCT02234141|69192147|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
37713719|NCT02234141|69192148|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
37713720|NCT02234141|69192142|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
37713721|NCT02234141|69192143|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
37713722|NCT02234141|69192144|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
37713723|NCT02234141|69192145|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
37713724|NCT02234141|69192146|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
37713725|NCT02234141|69192147|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
37713726|NCT02234141|69192148|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
37713727|NCT02234063|69192161|FG000|Overall Study|Lost to Follow-up|235|||
37838834|NCT00471237|69523383|FG000|Overall Study|Non-compliance|0|||
37838835|NCT00471237|69523384|FG001|Overall Study|Non-compliance|1|||
37838836|NCT00471237|69523385|FG002|Overall Study|Non-compliance|0|||
37838837|NCT00471237|69523386|FG003|Overall Study|Non-compliance|1|||
37838838|NCT00471237|69523387|FG004|Overall Study|Non-compliance|0|||
37838839|NCT00471237|69523388|FG005|Overall Study|Non-compliance|0|||
37838840|NCT00471237|69523389|FG006|Overall Study|Non-compliance|0|||
37838841|NCT00471237|69523383|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
37838842|NCT00471237|69523384|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
37838843|NCT00471237|69523385|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
37838844|NCT00471237|69523386|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
37838845|NCT00471237|69523387|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
37838846|NCT00471237|69523388|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
37838847|NCT00471237|69523389|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
37838848|NCT00471237|69523383|FG000|Overall Study|Early stopping due to non-efficacy|1|||
37838849|NCT00471237|69523384|FG001|Overall Study|Early stopping due to non-efficacy|0|||
37838850|NCT00471237|69523385|FG002|Overall Study|Early stopping due to non-efficacy|0|||
37838851|NCT00471237|69523386|FG003|Overall Study|Early stopping due to non-efficacy|0|||
37838852|NCT00471237|69523387|FG004|Overall Study|Early stopping due to non-efficacy|1|||
37838853|NCT00471237|69523388|FG005|Overall Study|Early stopping due to non-efficacy|0|||
37838854|NCT00471237|69523389|FG006|Overall Study|Early stopping due to non-efficacy|0|||
37838855|NCT00471237|69523383|FG000|Overall Study|Participant planned to travel to abraod|1|||
37838856|NCT00471237|69523384|FG001|Overall Study|Participant planned to travel to abraod|0|||
37838857|NCT00471237|69523385|FG002|Overall Study|Participant planned to travel to abraod|0|||
37838858|NCT00471237|69523386|FG003|Overall Study|Participant planned to travel to abraod|0|||
37838859|NCT00471237|69523387|FG004|Overall Study|Participant planned to travel to abraod|0|||
37838860|NCT00471237|69523388|FG005|Overall Study|Participant planned to travel to abraod|1|||
37838861|NCT00471237|69523389|FG006|Overall Study|Participant planned to travel to abraod|0|||
37838862|NCT00471237|69523383|FG000|Overall Study|High parathyroid hormone|0|||
37838863|NCT00471237|69523384|FG001|Overall Study|High parathyroid hormone|0|||
37838864|NCT00471237|69523385|FG002|Overall Study|High parathyroid hormone|1|||
37838865|NCT00471237|69523386|FG003|Overall Study|High parathyroid hormone|0|||
37838866|NCT00471237|69523387|FG004|Overall Study|High parathyroid hormone|0|||
37838867|NCT00471237|69523388|FG005|Overall Study|High parathyroid hormone|0|||
37838868|NCT00471237|69523389|FG006|Overall Study|High parathyroid hormone|0|||
37838869|NCT00471237|69523383|FG000|Overall Study|Participant lost medication|0|||
37838870|NCT00471237|69523384|FG001|Overall Study|Participant lost medication|0|||
37838871|NCT00471237|69523385|FG002|Overall Study|Participant lost medication|0|||
37838872|NCT00471237|69523386|FG003|Overall Study|Participant lost medication|0|||
37838873|NCT00471237|69523387|FG004|Overall Study|Participant lost medication|1|||
37838874|NCT00471237|69523388|FG005|Overall Study|Participant lost medication|0|||
37838875|NCT00471237|69523389|FG006|Overall Study|Participant lost medication|0|||
37838876|NCT00471237|69523383|FG000|Overall Study|Administration of prohibited medicine|0|||
37838877|NCT00471237|69523384|FG001|Overall Study|Administration of prohibited medicine|0|||
37838878|NCT00471237|69523385|FG002|Overall Study|Administration of prohibited medicine|0|||
37838879|NCT00471237|69523386|FG003|Overall Study|Administration of prohibited medicine|0|||
37713728|NCT02234063|69192162|FG001|Overall Study|Lost to Follow-up|42|||
37838880|NCT00471237|69523387|FG004|Overall Study|Administration of prohibited medicine|1|||
37713729|NCT02234063|69192161|FG000|Overall Study|Withdrawal by Subject|20|||
37713730|NCT02234063|69192162|FG001|Overall Study|Withdrawal by Subject|1|||
37713731|NCT02232893|69192175|FG000|Overall Study|Withdrawal by Subject|4|||
37713732|NCT02232893|69192176|FG001|Overall Study|Withdrawal by Subject|1|||
37713733|NCT02232893|69192175|FG000|Overall Study|Adverse Event|0|||
37713734|NCT02232893|69192176|FG001|Overall Study|Adverse Event|1|||
37713735|NCT02232893|69192175|FG000|Overall Study|Sponsor request early termination|0|||
37713736|NCT02232893|69192176|FG001|Overall Study|Sponsor request early termination|1|||
37713737|NCT02232893|69192175|FG000|Overall Study|Developed exclusion criteria|0|||
37713738|NCT02232893|69192176|FG001|Overall Study|Developed exclusion criteria|1|||
37713739|NCT02232893|69192175|FG000|Overall Study|Other|0|||
37713740|NCT02232893|69192176|FG001|Overall Study|Other|3|||
37713741|NCT02203721|69192184|FG000|Overall Study|Lost to Follow-up|1|||
37713742|NCT02203721|69192185|FG001|Overall Study|Lost to Follow-up|0|||
37713743|NCT02203721|69192184|FG000|Overall Study|Death|0|||
37713744|NCT02203721|69192185|FG001|Overall Study|Death|2|||
37713745|NCT02203721|69192184|FG000|Overall Study|Illness|0|||
37713746|NCT02203721|69192185|FG001|Overall Study|Illness|1|||
37713747|NCT01618695|69192195|FG000|Core Phase|Adverse Event|4|||
37713748|NCT01618695|69192196|FG001|Core Phase|Adverse Event|5|||
37713749|NCT01618695|69192197|FG002|Core Phase|Adverse Event|15|||
37713750|NCT01618695|69192198|FG003|Core Phase|Adverse Event|20|||
37713751|NCT01618695|69192195|FG000|Core Phase|Lost to Follow-up|0|||
37713752|NCT01618695|69192196|FG001|Core Phase|Lost to Follow-up|0|||
37713753|NCT01618695|69192197|FG002|Core Phase|Lost to Follow-up|1|||
37713754|NCT01618695|69192198|FG003|Core Phase|Lost to Follow-up|0|||
37713755|NCT01618695|69192195|FG000|Core Phase|Withdrawal by Subject|16|||
37713756|NCT01618695|69192196|FG001|Core Phase|Withdrawal by Subject|11|||
37713757|NCT01618695|69192197|FG002|Core Phase|Withdrawal by Subject|9|||
37713758|NCT01618695|69192198|FG003|Core Phase|Withdrawal by Subject|13|||
37713759|NCT01618695|69192195|FG000|Core Phase|Pregnancy|2|||
37713760|NCT01618695|69192196|FG001|Core Phase|Pregnancy|0|||
37713761|NCT01618695|69192197|FG002|Core Phase|Pregnancy|0|||
37713762|NCT01618695|69192198|FG003|Core Phase|Pregnancy|0|||
37713763|NCT01618695|69192195|FG000|Core Phase|Lack of Efficacy|1|||
37713764|NCT01618695|69192196|FG001|Core Phase|Lack of Efficacy|2|||
37713765|NCT01618695|69192197|FG002|Core Phase|Lack of Efficacy|1|||
37713766|NCT01618695|69192198|FG003|Core Phase|Lack of Efficacy|1|||
37713767|NCT01618695|69192195|FG000|Core Phase|Other than specified|1|||
37713768|NCT01618695|69192196|FG001|Core Phase|Other than specified|2|||
37713769|NCT01618695|69192197|FG002|Core Phase|Other than specified|2|||
37713770|NCT01618695|69192198|FG003|Core Phase|Other than specified|2|||
37713771|NCT01618695|69192195|FG000|Core Phase|Not treated|1|||
37713772|NCT01618695|69192196|FG001|Core Phase|Not treated|0|||
37713773|NCT01618695|69192197|FG002|Core Phase|Not treated|2|||
37713774|NCT01618695|69192198|FG003|Core Phase|Not treated|0|||
37713775|NCT01618695|69192195|FG000|Extension Phase|Lack of Efficacy|17|||
37713776|NCT01618695|69192196|FG001|Extension Phase|Lack of Efficacy|33|||
37713777|NCT01618695|69192197|FG002|Extension Phase|Lack of Efficacy|26|||
37713778|NCT01618695|69192198|FG003|Extension Phase|Lack of Efficacy|24|||
37713779|NCT01618695|69192195|FG000|Extension Phase|Pregnancy|2|||
37713780|NCT01618695|69192196|FG001|Extension Phase|Pregnancy|0|||
37713781|NCT01618695|69192197|FG002|Extension Phase|Pregnancy|1|||
37713782|NCT01618695|69192198|FG003|Extension Phase|Pregnancy|1|||
37713783|NCT01618695|69192195|FG000|Extension Phase|Withdrawal by Subject|43|||
37713784|NCT01618695|69192196|FG001|Extension Phase|Withdrawal by Subject|48|||
37713785|NCT01618695|69192197|FG002|Extension Phase|Withdrawal by Subject|42|||
37713786|NCT01618695|69192198|FG003|Extension Phase|Withdrawal by Subject|33|||
37713787|NCT01618695|69192195|FG000|Extension Phase|Adverse Event|18|||
37713788|NCT01618695|69192196|FG001|Extension Phase|Adverse Event|16|||
37713789|NCT01618695|69192197|FG002|Extension Phase|Adverse Event|9|||
37713790|NCT01618695|69192198|FG003|Extension Phase|Adverse Event|20|||
37713791|NCT01618695|69192195|FG000|Extension Phase|Lost to Follow-up|2|||
37713792|NCT01618695|69192196|FG001|Extension Phase|Lost to Follow-up|1|||
37713793|NCT01618695|69192197|FG002|Extension Phase|Lost to Follow-up|1|||
38043502|NCT03698019|69731622|FG000|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|6|||
37713794|NCT01618695|69192198|FG003|Extension Phase|Lost to Follow-up|1|||
37713795|NCT01618695|69192195|FG000|Extension Phase|Other than specified|13|||
37713796|NCT01618695|69192196|FG001|Extension Phase|Other than specified|18|||
37713797|NCT01618695|69192197|FG002|Extension Phase|Other than specified|13|||
37713798|NCT01618695|69192198|FG003|Extension Phase|Other than specified|18|||
37713799|NCT01896531|69192211|FG000|Overall Study|Death|57|||
37713800|NCT01896531|69192212|FG001|Overall Study|Death|59|||
37713801|NCT01896531|69192211|FG000|Overall Study|Lost to Follow-up|3|||
37713802|NCT01896531|69192212|FG001|Overall Study|Lost to Follow-up|0|||
37713803|NCT01896531|69192211|FG000|Overall Study|Non-compliance|0|||
37713804|NCT01896531|69192212|FG001|Overall Study|Non-compliance|1|||
37713805|NCT01896531|69192211|FG000|Overall Study|Study Ended by Sponsor|7|||
37713806|NCT01896531|69192212|FG001|Overall Study|Study Ended by Sponsor|20|||
37838881|NCT00471237|69523388|FG005|Overall Study|Administration of prohibited medicine|0|||
37838882|NCT00471237|69523389|FG006|Overall Study|Administration of prohibited medicine|0|||
37713807|NCT01896531|69192211|FG000|Overall Study|Withdrawal by Subject|3|||
37713808|NCT01896531|69192212|FG001|Overall Study|Withdrawal by Subject|2|||
37713809|NCT01896531|69192211|FG000|Overall Study|Death Prior to Treatment|1|||
37713810|NCT01896531|69192212|FG001|Overall Study|Death Prior to Treatment|0|||
37713811|NCT01618305|69192220|FG000|Overall Study|Death|0|||
37713812|NCT01618305|69192221|FG001|Overall Study|Death|1|||
37713813|NCT01618305|69192220|FG000|Overall Study|Lost to Follow-up|11|||
37713814|NCT01618305|69192221|FG001|Overall Study|Lost to Follow-up|7|||
37713815|NCT01618305|69192220|FG000|Overall Study|Protocol Violation|1|||
37713816|NCT01618305|69192221|FG001|Overall Study|Protocol Violation|0|||
37713817|NCT01618305|69192220|FG000|Overall Study|Withdrawal by Subject|3|||
37713818|NCT01618305|69192221|FG001|Overall Study|Withdrawal by Subject|2|||
37713819|NCT01886313|69192233|FG000|Overall Study|Adverse Event|1|||
37713820|NCT01886313|69192234|FG001|Overall Study|Adverse Event|1|||
37713821|NCT01896297|69192240|FG000|Overall Study|Died in post treatment phase|1|||
37713822|NCT01884675|69192246|FG000|Overall Study|Study closed/terminated|3|||
37713823|NCT01884675|69192247|FG001|Overall Study|Study closed/terminated|2|||
37713824|NCT01884597|69192258|FG000|Overall Study|Adverse Event|0|||
37713825|NCT01884597|69192259|FG001|Overall Study|Adverse Event|0|||
37713826|NCT01884597|69192260|FG002|Overall Study|Adverse Event|1|||
37713827|NCT01884597|69192258|FG000|Overall Study|Lack of Efficacy|1|||
37713828|NCT01884597|69192259|FG001|Overall Study|Lack of Efficacy|0|||
37713829|NCT01884597|69192260|FG002|Overall Study|Lack of Efficacy|0|||
37713830|NCT01884597|69192258|FG000|Overall Study|Death|0|||
37713831|NCT01884597|69192259|FG001|Overall Study|Death|1|||
37713832|NCT01884597|69192260|FG002|Overall Study|Death|0|||
37713833|NCT01895361|69192277|FG000|Overall Study|Adverse Event|1|||
37713834|NCT01895361|69192278|FG001|Overall Study|Adverse Event|1|||
37713835|NCT01895361|69192279|FG002|Overall Study|Adverse Event|3|||
37713836|NCT01895361|69192277|FG000|Overall Study|Death|2|||
37713837|NCT01895361|69192278|FG001|Overall Study|Death|1|||
37713838|NCT01895361|69192279|FG002|Overall Study|Death|2|||
37713839|NCT01895361|69192277|FG000|Overall Study|Lost to Follow-up|4|||
37713840|NCT01895361|69192278|FG001|Overall Study|Lost to Follow-up|4|||
37713841|NCT01895361|69192279|FG002|Overall Study|Lost to Follow-up|6|||
37713842|NCT01895361|69192277|FG000|Overall Study|Non-compliance with study|1|||
37713843|NCT01895361|69192278|FG001|Overall Study|Non-compliance with study|3|||
37713844|NCT01895361|69192279|FG002|Overall Study|Non-compliance with study|1|||
37713845|NCT01895361|69192277|FG000|Overall Study|Physician Decision|2|||
37713846|NCT01895361|69192278|FG001|Overall Study|Physician Decision|2|||
37713847|NCT01895361|69192279|FG002|Overall Study|Physician Decision|2|||
37713848|NCT01895361|69192277|FG000|Overall Study|Withdrawal by Subject|7|||
37713849|NCT01895361|69192278|FG001|Overall Study|Withdrawal by Subject|6|||
37713850|NCT01895361|69192279|FG002|Overall Study|Withdrawal by Subject|6|||
37713851|NCT01895361|69192277|FG000|Overall Study|Lack of Efficacy|0|||
37713852|NCT01895361|69192278|FG001|Overall Study|Lack of Efficacy|1|||
37713853|NCT01895361|69192279|FG002|Overall Study|Lack of Efficacy|0|||
37713854|NCT01895361|69192277|FG000|Overall Study|Reasons different from categories above|7|||
37713855|NCT01895361|69192278|FG001|Overall Study|Reasons different from categories above|3|||
37713856|NCT01895361|69192279|FG002|Overall Study|Reasons different from categories above|4|||
37713857|NCT01883895|69192287|FG000|Overall Study|Lost to Follow-up|2|||
37713858|NCT01864005|69192293|FG000|Overall Study|Protocol Violation|0|||
37713859|NCT01864005|69192294|FG001|Overall Study|Protocol Violation|1|||
37713860|NCT01864005|69192293|FG000|Overall Study|Withdrawal by Subject|0|||
37713861|NCT01864005|69192294|FG001|Overall Study|Withdrawal by Subject|1|||
37713862|NCT01864005|69192293|FG000|Overall Study|Incorrect enrolment|1|||
37713863|NCT01864005|69192294|FG001|Overall Study|Incorrect enrolment|0|||
37713864|NCT01864005|69192293|FG000|Overall Study|Disease need|1|||
37713865|NCT01864005|69192294|FG001|Overall Study|Disease need|1|||
37713866|NCT01864005|69192293|FG000|Overall Study|Need GP IIb/IIIa|1|||
37713867|NCT01864005|69192294|FG001|Overall Study|Need GP IIb/IIIa|3|||
37713868|NCT01863849|69192302|FG000|Overall Study|Lost to Follow-up|1|||
38043503|NCT03698019|69731623|FG001|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|16|||
37713869|NCT01863849|69192303|FG001|Overall Study|Lost to Follow-up|0|||
37713870|NCT01863771|69192310|FG000|Induction Phase|Adverse Event|9|||
37713871|NCT01863771|69192311|FG001|Induction Phase|Adverse Event|0|||
37713872|NCT01863771|69192312|FG002|Induction Phase|Adverse Event|0|||
37713873|NCT01863771|69192313|FG003|Induction Phase|Adverse Event|0|||
37713874|NCT01863771|69192310|FG000|Induction Phase|Lack of Efficacy|10|||
37713875|NCT01863771|69192311|FG001|Induction Phase|Lack of Efficacy|0|||
37713876|NCT01863771|69192312|FG002|Induction Phase|Lack of Efficacy|0|||
37713877|NCT01863771|69192313|FG003|Induction Phase|Lack of Efficacy|0|||
37713878|NCT01863771|69192310|FG000|Induction Phase|Withdrawal by Subject|2|||
37713879|NCT01863771|69192311|FG001|Induction Phase|Withdrawal by Subject|0|||
37713880|NCT01863771|69192312|FG002|Induction Phase|Withdrawal by Subject|0|||
37838883|NCT00471237|69523383|FG000|Overall Study|Participant shifted residence|0|||
37713881|NCT01863771|69192313|FG003|Induction Phase|Withdrawal by Subject|0|||
37713882|NCT01863771|69192310|FG000|Maintenance Phase|Adverse Event|0|||
37713883|NCT01863771|69192311|FG001|Maintenance Phase|Adverse Event|0|||
37713884|NCT01863771|69192312|FG002|Maintenance Phase|Adverse Event|1|||
37713885|NCT01863771|69192313|FG003|Maintenance Phase|Adverse Event|1|||
37713886|NCT01863771|69192310|FG000|Maintenance Phase|Lack of Efficacy|0|||
37713887|NCT01863771|69192311|FG001|Maintenance Phase|Lack of Efficacy|3|||
37713888|NCT01863771|69192312|FG002|Maintenance Phase|Lack of Efficacy|7|||
37713889|NCT01863771|69192313|FG003|Maintenance Phase|Lack of Efficacy|38|||
37713890|NCT01863771|69192310|FG000|Maintenance Phase|Physician Decision|0|||
37713891|NCT01863771|69192311|FG001|Maintenance Phase|Physician Decision|0|||
37713892|NCT01863771|69192312|FG002|Maintenance Phase|Physician Decision|2|||
37713893|NCT01863771|69192313|FG003|Maintenance Phase|Physician Decision|1|||
37713894|NCT01863771|69192310|FG000|Maintenance Phase|Pregnancy|0|||
37713895|NCT01863771|69192311|FG001|Maintenance Phase|Pregnancy|1|||
37713896|NCT01863771|69192312|FG002|Maintenance Phase|Pregnancy|0|||
37713897|NCT01863771|69192313|FG003|Maintenance Phase|Pregnancy|0|||
37713898|NCT01863771|69192310|FG000|Maintenance Phase|Withdrawal by Subject|0|||
37713899|NCT01863771|69192311|FG001|Maintenance Phase|Withdrawal by Subject|1|||
37713900|NCT01863771|69192312|FG002|Maintenance Phase|Withdrawal by Subject|2|||
37713901|NCT01863771|69192313|FG003|Maintenance Phase|Withdrawal by Subject|3|||
37713902|NCT01894581|69192323|FG000|Overall Study|Withdrawal by Subject|2|||
37713903|NCT01894581|69192324|FG001|Overall Study|Withdrawal by Subject|3|||
37713904|NCT01894581|69192323|FG000|Overall Study|Screen Failure|3|||
37713905|NCT01894581|69192324|FG001|Overall Study|Screen Failure|4|||
37713906|NCT01893411|69192333|FG000|Overall Study|Protocol Violation|1|||
37713907|NCT01893411|69192334|FG001|Overall Study|Protocol Violation|0|||
37713908|NCT01893411|69192335|FG002|Overall Study|Protocol Violation|0|||
37713909|NCT01893411|69192333|FG000|Overall Study|Physician Decision|1|||
37713910|NCT01893411|69192334|FG001|Overall Study|Physician Decision|1|||
37713911|NCT01893411|69192335|FG002|Overall Study|Physician Decision|2|||
37713912|NCT01893411|69192333|FG000|Overall Study|Lack of Efficacy|2|||
37713913|NCT01893411|69192334|FG001|Overall Study|Lack of Efficacy|1|||
37713914|NCT01893411|69192335|FG002|Overall Study|Lack of Efficacy|0|||
37713915|NCT01893411|69192333|FG000|Overall Study|Other|3|||
37713916|NCT01893411|69192334|FG001|Overall Study|Other|1|||
37713917|NCT01893411|69192335|FG002|Overall Study|Other|3|||
37713918|NCT01893411|69192333|FG000|Overall Study|Adverse Event|1|||
37713919|NCT01893411|69192334|FG001|Overall Study|Adverse Event|0|||
37713920|NCT01893411|69192335|FG002|Overall Study|Adverse Event|0|||
37713921|NCT01893411|69192333|FG000|Overall Study|Withdrawal by Subject|7|||
37713922|NCT01893411|69192334|FG001|Overall Study|Withdrawal by Subject|4|||
37713923|NCT01893411|69192335|FG002|Overall Study|Withdrawal by Subject|3|||
37713924|NCT01893411|69192333|FG000|Overall Study|Lost to Follow-up|2|||
37713925|NCT01893411|69192334|FG001|Overall Study|Lost to Follow-up|0|||
37713926|NCT01893411|69192335|FG002|Overall Study|Lost to Follow-up|1|||
37713927|NCT02232425|69192345|FG000|Overall Study|Lost to Follow-up|6|||
37713928|NCT02232425|69192346|FG001|Overall Study|Lost to Follow-up|2|||
37713929|NCT02232425|69192345|FG000|Overall Study|Adverse Event|2|||
37713930|NCT02232425|69192346|FG001|Overall Study|Adverse Event|0|||
37713931|NCT02232425|69192345|FG000|Overall Study|Withdrawal by Subject|5|||
37713932|NCT02232425|69192346|FG001|Overall Study|Withdrawal by Subject|6|||
37713933|NCT02232425|69192345|FG000|Overall Study|Lack of Efficacy|1|||
37713934|NCT02232425|69192346|FG001|Overall Study|Lack of Efficacy|0|||
37713935|NCT01631435|69192352|FG000|Overall Study|Adverse Event|2|||
37713936|NCT01631435|69192352|FG000|Overall Study|Withdrawal by Subject|2|||
37713937|NCT01631435|69192352|FG000|Overall Study|incomplete study procedure|5|||
37713938|NCT02230085|69192357|FG000|Overall Study|Physician Decision|1|||
37713939|NCT02230085|69192357|FG000|Overall Study|Withdrawal by Subject|3|||
37713940|NCT02202785|69192364|FG000|Overall Study|Study Terminated by Sponsor|1|||
37713941|NCT02202785|69192365|FG001|Overall Study|Study Terminated by Sponsor|6|||
37713942|NCT02202785|69192366|FG002|Overall Study|Study Terminated by Sponsor|4|||
37713943|NCT02202785|69192364|FG000|Overall Study|Withdrawal by Subject|0|||
37713944|NCT02202785|69192365|FG001|Overall Study|Withdrawal by Subject|1|||
37713945|NCT02202785|69192366|FG002|Overall Study|Withdrawal by Subject|0|||
37713946|NCT02202785|69192364|FG000|Overall Study|Lost to Follow-up|0|||
37713947|NCT02202785|69192365|FG001|Overall Study|Lost to Follow-up|1|||
37713948|NCT02202785|69192366|FG002|Overall Study|Lost to Follow-up|0|||
37713949|NCT02202785|69192364|FG000|Overall Study|Reason not Specified|10|||
37713950|NCT02202785|69192365|FG001|Overall Study|Reason not Specified|7|||
37713951|NCT02202785|69192366|FG002|Overall Study|Reason not Specified|13|||
37713952|NCT01882647|69192376|FG000|Overall Study|Lost to Follow-up|2|||
37713953|NCT01882647|69192377|FG001|Overall Study|Lost to Follow-up|2|||
37713954|NCT01882647|69192376|FG000|Overall Study|Withdrawal by Subject|0|||
37713955|NCT01882647|69192377|FG001|Overall Study|Withdrawal by Subject|4|||
37713956|NCT01882257|69192386|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
37713957|NCT01882257|69192387|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
37713958|NCT01882257|69192388|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
37713959|NCT01882257|69192386|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
37713960|NCT01882257|69192387|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
37713961|NCT01882257|69192388|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
37713962|NCT01862991|69192398|FG000|Overall Study|Lost to Follow-up|2|||
37713963|NCT01862991|69192399|FG001|Overall Study|Lost to Follow-up|1|||
37713964|NCT01862991|69192400|FG002|Overall Study|Lost to Follow-up|1|||
37713965|NCT01862991|69192398|FG000|Overall Study|Protocol Violation|1|||
37713966|NCT01862991|69192399|FG001|Overall Study|Protocol Violation|0|||
37713967|NCT01862991|69192400|FG002|Overall Study|Protocol Violation|0|||
37713968|NCT02202551|69192412|FG000|Overall Study|Adverse Event|8|||
37713969|NCT02202551|69192413|FG001|Overall Study|Adverse Event|19|||
37713970|NCT02202551|69192414|FG002|Overall Study|Adverse Event|5|||
37713971|NCT02202551|69192415|FG003|Overall Study|Adverse Event|9|||
37713972|NCT02202551|69192412|FG000|Overall Study|Death|3|||
37713973|NCT02202551|69192413|FG001|Overall Study|Death|2|||
37713974|NCT02202551|69192414|FG002|Overall Study|Death|1|||
37713975|NCT02202551|69192415|FG003|Overall Study|Death|1|||
37713976|NCT02202551|69192412|FG000|Overall Study|Lost to Follow-up|0|||
37713977|NCT02202551|69192413|FG001|Overall Study|Lost to Follow-up|1|||
37713978|NCT02202551|69192414|FG002|Overall Study|Lost to Follow-up|0|||
37713979|NCT02202551|69192415|FG003|Overall Study|Lost to Follow-up|1|||
37713980|NCT02202551|69192412|FG000|Overall Study|Needed to take excluded medication|0|||
37713981|NCT02202551|69192413|FG001|Overall Study|Needed to take excluded medication|2|||
37713982|NCT02202551|69192414|FG002|Overall Study|Needed to take excluded medication|0|||
37713983|NCT02202551|69192415|FG003|Overall Study|Needed to take excluded medication|1|||
37713984|NCT02202551|69192412|FG000|Overall Study|Subject moved away|0|||
37713985|NCT02202551|69192413|FG001|Overall Study|Subject moved away|1|||
37713986|NCT02202551|69192414|FG002|Overall Study|Subject moved away|0|||
37713987|NCT02202551|69192415|FG003|Overall Study|Subject moved away|0|||
37713988|NCT02202551|69192412|FG000|Overall Study|DBS surgery|3|||
37713989|NCT02202551|69192413|FG001|Overall Study|DBS surgery|0|||
37713990|NCT02202551|69192414|FG002|Overall Study|DBS surgery|0|||
37713991|NCT02202551|69192415|FG003|Overall Study|DBS surgery|0|||
37713992|NCT02202551|69192412|FG000|Overall Study|Dyskinesia upon taper|1|||
37713993|NCT02202551|69192413|FG001|Overall Study|Dyskinesia upon taper|0|||
37713994|NCT02202551|69192414|FG002|Overall Study|Dyskinesia upon taper|0|||
37713995|NCT02202551|69192415|FG003|Overall Study|Dyskinesia upon taper|0|||
37713996|NCT02202551|69192412|FG000|Overall Study|Lack of Efficacy|0|||
37713997|NCT02202551|69192413|FG001|Overall Study|Lack of Efficacy|1|||
37713998|NCT02202551|69192414|FG002|Overall Study|Lack of Efficacy|0|||
37713999|NCT02202551|69192415|FG003|Overall Study|Lack of Efficacy|0|||
37714000|NCT02202551|69192412|FG000|Overall Study|Physician Decision|1|||
37714001|NCT02202551|69192413|FG001|Overall Study|Physician Decision|0|||
38024583|NCT04209530|69708315|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
38024584|NCT04209530|69708314|FG000|Overall Study|Withdrawal by Subject|0|||
38024585|NCT04209530|69708315|FG001|Overall Study|Withdrawal by Subject|1|||
38024586|NCT04349098|69708323|FG000|Overall Study|Death|16|||
38024587|NCT04349098|69708324|FG001|Overall Study|Death|8|||
38024588|NCT04349098|69708323|FG000|Overall Study|Lost to Follow-up|11|||
38024589|NCT04349098|69708324|FG001|Overall Study|Lost to Follow-up|8|||
38024590|NCT04349098|69708323|FG000|Overall Study|Withdrawal by Subject|8|||
38024591|NCT04349098|69708324|FG001|Overall Study|Withdrawal by Subject|5|||
38024592|NCT04349098|69708323|FG000|Overall Study|Other|3|||
38024593|NCT04349098|69708324|FG001|Overall Study|Other|5|||
38024594|NCT04208750|69708332|FG000|Overall Study|Lost to Follow-up|16|||
38024595|NCT04208750|69708333|FG001|Overall Study|Lost to Follow-up|15|||
38024596|NCT04381988|69708341|FG000|Overall Study|The study was terminated|4|||
38024597|NCT04381988|69708342|FG001|Overall Study|The study was terminated|0|||
38024598|NCT04333498|69708350|FG000|Overall Study|Lost to Follow-up|1|||
37714002|NCT02202551|69192414|FG002|Overall Study|Physician Decision|0|||
37714003|NCT02202551|69192415|FG003|Overall Study|Physician Decision|0|||
37714004|NCT02202551|69192412|FG000|Overall Study|Site closure|3|||
37714005|NCT02202551|69192413|FG001|Overall Study|Site closure|0|||
37838884|NCT00471237|69523384|FG001|Overall Study|Participant shifted residence|0|||
37714006|NCT02202551|69192414|FG002|Overall Study|Site closure|0|||
38024599|NCT04333498|69708351|FG001|Overall Study|Lost to Follow-up|0|||
38024600|NCT04333498|69708350|FG000|Overall Study|Lost to Follow-up|0|||
38024601|NCT04333498|69708351|FG001|Overall Study|Lost to Follow-up|1|||
37714007|NCT02202551|69192415|FG003|Overall Study|Site closure|1|||
37714008|NCT02202551|69192412|FG000|Overall Study|Unable to complete visits per protocol|1|||
37714009|NCT02202551|69192413|FG001|Overall Study|Unable to complete visits per protocol|0|||
37714010|NCT02202551|69192414|FG002|Overall Study|Unable to complete visits per protocol|0|||
37714011|NCT02202551|69192415|FG003|Overall Study|Unable to complete visits per protocol|0|||
37714012|NCT02202551|69192412|FG000|Overall Study|Worsening Dyskinesia|0|||
37714013|NCT02202551|69192413|FG001|Overall Study|Worsening Dyskinesia|0|||
38024602|NCT03355664|69708359|FG000|Overall Study|Adverse Event|1|||
38024603|NCT03355664|69708360|FG001|Overall Study|Adverse Event|2|||
38024604|NCT03355664|69708359|FG000|Overall Study|Lost to Follow-up|11|||
38024605|NCT03355664|69708360|FG001|Overall Study|Lost to Follow-up|7|||
38024606|NCT03355664|69708359|FG000|Overall Study|Protocol Violation|1|||
38024607|NCT03355664|69708360|FG001|Overall Study|Protocol Violation|2|||
38024608|NCT03355664|69708359|FG000|Overall Study|Withdrawal by Subject|2|||
38024609|NCT03355664|69708360|FG001|Overall Study|Withdrawal by Subject|1|||
38024610|NCT04170686|69708368|FG000|Screening|Physician Decision|12|||
38024611|NCT04170686|69708369|FG001|Screening|Physician Decision|13|||
38024612|NCT04170686|69708368|FG000|Randomization and Treatment|Lost to Follow-up|26|||
37714014|NCT02202551|69192414|FG002|Overall Study|Worsening Dyskinesia|0|||
37714015|NCT02202551|69192415|FG003|Overall Study|Worsening Dyskinesia|1|||
37714016|NCT02202551|69192412|FG000|Overall Study|Protocol Violation|0|||
37714017|NCT02202551|69192413|FG001|Overall Study|Protocol Violation|1|||
37714018|NCT02202551|69192414|FG002|Overall Study|Protocol Violation|0|||
37714019|NCT02202551|69192415|FG003|Overall Study|Protocol Violation|0|||
37714020|NCT02202551|69192412|FG000|Overall Study|Sponsor's decision|2|||
37714021|NCT02202551|69192413|FG001|Overall Study|Sponsor's decision|0|||
37714022|NCT02202551|69192414|FG002|Overall Study|Sponsor's decision|0|||
37714023|NCT02202551|69192415|FG003|Overall Study|Sponsor's decision|0|||
37714024|NCT02202551|69192412|FG000|Overall Study|Subject unwilling to proceed|1|||
37714025|NCT02202551|69192413|FG001|Overall Study|Subject unwilling to proceed|5|||
37714026|NCT02202551|69192414|FG002|Overall Study|Subject unwilling to proceed|3|||
37714027|NCT02202551|69192415|FG003|Overall Study|Subject unwilling to proceed|5|||
37714028|NCT02202551|69192412|FG000|Overall Study|Subject consent withdrawn|0|||
37714029|NCT02202551|69192413|FG001|Overall Study|Subject consent withdrawn|3|||
37714030|NCT02202551|69192414|FG002|Overall Study|Subject consent withdrawn|1|||
37714031|NCT02202551|69192415|FG003|Overall Study|Subject consent withdrawn|2|||
37714032|NCT02202551|69192412|FG000|Overall Study|eGFR<50mL/min/m2|2|||
37714033|NCT02202551|69192413|FG001|Overall Study|eGFR<50mL/min/m2|2|||
37714034|NCT02202551|69192414|FG002|Overall Study|eGFR<50mL/min/m2|0|||
37714035|NCT02202551|69192415|FG003|Overall Study|eGFR<50mL/min/m2|1|||
37714036|NCT02202317|69192429|FG000|Overall Study|Lost to Follow-up|1|||
37714037|NCT02118337|69192442|FG000|Overall Study|Other|1|||
37714038|NCT02118337|69192443|FG001|Overall Study|Other|0|||
37714039|NCT02118337|69192444|FG002|Overall Study|Other|0|||
37714040|NCT02118337|69192445|FG003|Overall Study|Other|0|||
37714041|NCT02118337|69192446|FG004|Overall Study|Other|2|||
37714042|NCT02118337|69192447|FG005|Overall Study|Other|3|||
37714043|NCT02118337|69192448|FG006|Overall Study|Other|1|||
37714044|NCT02118337|69192449|FG007|Overall Study|Other|28|||
37714045|NCT02118337|69192450|FG008|Overall Study|Other|15|||
37714046|NCT02118337|69192442|FG000|Overall Study|Lost to Follow-up|0|||
37714047|NCT02118337|69192443|FG001|Overall Study|Lost to Follow-up|0|||
37714048|NCT02118337|69192444|FG002|Overall Study|Lost to Follow-up|0|||
37714049|NCT02118337|69192445|FG003|Overall Study|Lost to Follow-up|0|||
37714050|NCT02118337|69192446|FG004|Overall Study|Lost to Follow-up|0|||
37714051|NCT02118337|69192447|FG005|Overall Study|Lost to Follow-up|0|||
37714052|NCT02118337|69192448|FG006|Overall Study|Lost to Follow-up|0|||
37714053|NCT02118337|69192449|FG007|Overall Study|Lost to Follow-up|1|||
37714054|NCT02118337|69192450|FG008|Overall Study|Lost to Follow-up|0|||
37714055|NCT02118337|69192442|FG000|Overall Study|Withdrawal by Subject|1|||
37714056|NCT02118337|69192443|FG001|Overall Study|Withdrawal by Subject|3|||
37714057|NCT02118337|69192444|FG002|Overall Study|Withdrawal by Subject|2|||
37714058|NCT02118337|69192445|FG003|Overall Study|Withdrawal by Subject|1|||
37714059|NCT02118337|69192446|FG004|Overall Study|Withdrawal by Subject|2|||
37714060|NCT02118337|69192447|FG005|Overall Study|Withdrawal by Subject|2|||
37714061|NCT02118337|69192448|FG006|Overall Study|Withdrawal by Subject|1|||
37714062|NCT02118337|69192449|FG007|Overall Study|Withdrawal by Subject|4|||
37714063|NCT02118337|69192450|FG008|Overall Study|Withdrawal by Subject|2|||
37714064|NCT02118337|69192442|FG000|Overall Study|Death|2|||
37714065|NCT02118337|69192443|FG001|Overall Study|Death|2|||
37714066|NCT02118337|69192444|FG002|Overall Study|Death|1|||
37714067|NCT02118337|69192445|FG003|Overall Study|Death|2|||
37714068|NCT02118337|69192446|FG004|Overall Study|Death|5|||
37714069|NCT02118337|69192447|FG005|Overall Study|Death|1|||
37714070|NCT02118337|69192448|FG006|Overall Study|Death|2|||
37714071|NCT02118337|69192449|FG007|Overall Study|Death|9|||
37714072|NCT02118337|69192450|FG008|Overall Study|Death|4|||
37714073|NCT02117713|69192474|FG000|Week 48|Adverse Event|4|||
37714074|NCT02117713|69192474|FG000|Week 48|Withdrawal by caregiver|2|||
37714075|NCT02117713|69192474|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
37714076|NCT02117713|69192474|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
38024613|NCT04170686|69708369|FG001|Randomization and Treatment|Lost to Follow-up|15|||
37714077|NCT02117713|69192474|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
37838885|NCT00471237|69523385|FG002|Overall Study|Participant shifted residence|0|||
37714078|NCT02117713|69192474|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
37714079|NCT02105467|69192488|FG000|Period 1|Lost to Follow-up|1|||
38024614|NCT03695094|69708377|FG000|Overall Study|Adverse Event|1|||
37714080|NCT02105467|69192489|FG001|Period 1|Lost to Follow-up|0|||
37714081|NCT02105467|69192488|FG000|Period 1|Death|1|||
37714082|NCT02105467|69192489|FG001|Period 1|Death|0|||
37714083|NCT02105467|69192488|FG000|Period 2|Lost to Follow-up|1|||
37714084|NCT02105467|69192489|FG001|Period 2|Lost to Follow-up|0|||
37714085|NCT02105467|69192488|FG000|Period 2|Death|1|||
37714086|NCT02105467|69192489|FG001|Period 2|Death|0|||
37714087|NCT02105467|69192488|FG000|Period 2|Withdrawal by Subject|0|||
37714088|NCT02105467|69192489|FG001|Period 2|Withdrawal by Subject|2|||
37714089|NCT02105467|69192488|FG000|Period 3|Lost to Follow-up|0|||
37714090|NCT02105467|69192489|FG001|Period 3|Lost to Follow-up|1|||
37714091|NCT02202161|69192504|FG000|Overall Study|Adverse Event|1|||
37915430|NCT00882908|69602206|FG000|Overall Study|Withdrawal by Subject|0|||
37915431|NCT00882908|69602207|FG001|Overall Study|Withdrawal by Subject|0|||
37915432|NCT00882908|69602208|FG002|Overall Study|Withdrawal by Subject|3|||
37915433|NCT00882908|69602209|FG003|Overall Study|Withdrawal by Subject|5|||
37915434|NCT00882908|69602210|FG004|Overall Study|Withdrawal by Subject|2|||
37915435|NCT00882908|69602206|FG000|Overall Study|Subject reached a virologic endpoint|0|||
37714092|NCT02202161|69192505|FG001|Overall Study|Adverse Event|1|||
37714093|NCT02202161|69192506|FG002|Overall Study|Adverse Event|0|||
37714094|NCT02202161|69192507|FG003|Overall Study|Adverse Event|0|||
37714095|NCT02202161|69192508|FG004|Overall Study|Adverse Event|0|||
37714096|NCT02202161|69192509|FG005|Overall Study|Adverse Event|1|||
37714097|NCT02202161|69192510|FG006|Overall Study|Adverse Event|0|||
37714098|NCT02202161|69192511|FG007|Overall Study|Adverse Event|0|||
37714099|NCT02202161|69192504|FG000|Overall Study|Did not meet continuation criteria|0|||
37714100|NCT02202161|69192505|FG001|Overall Study|Did not meet continuation criteria|0|||
37714101|NCT02202161|69192506|FG002|Overall Study|Did not meet continuation criteria|0|||
37714102|NCT02202161|69192507|FG003|Overall Study|Did not meet continuation criteria|0|||
37714103|NCT02202161|69192508|FG004|Overall Study|Did not meet continuation criteria|0|||
37714104|NCT02202161|69192509|FG005|Overall Study|Did not meet continuation criteria|0|||
37714105|NCT02202161|69192510|FG006|Overall Study|Did not meet continuation criteria|0|||
37714106|NCT02202161|69192511|FG007|Overall Study|Did not meet continuation criteria|3|||
37714107|NCT02202161|69192504|FG000|Overall Study|Physician Decision|0|||
37714108|NCT02202161|69192505|FG001|Overall Study|Physician Decision|0|||
37714109|NCT02202161|69192506|FG002|Overall Study|Physician Decision|0|||
37714110|NCT02202161|69192507|FG003|Overall Study|Physician Decision|0|||
37714111|NCT02202161|69192508|FG004|Overall Study|Physician Decision|0|||
37714112|NCT02202161|69192509|FG005|Overall Study|Physician Decision|0|||
37714113|NCT02202161|69192510|FG006|Overall Study|Physician Decision|0|||
37714114|NCT02202161|69192511|FG007|Overall Study|Physician Decision|3|||
37714115|NCT02202161|69192504|FG000|Overall Study|Withdrawal by Subject|0|||
37714116|NCT02202161|69192505|FG001|Overall Study|Withdrawal by Subject|0|||
37714117|NCT02202161|69192506|FG002|Overall Study|Withdrawal by Subject|0|||
37714118|NCT02202161|69192507|FG003|Overall Study|Withdrawal by Subject|0|||
37714119|NCT02202161|69192508|FG004|Overall Study|Withdrawal by Subject|1|||
37714120|NCT02202161|69192509|FG005|Overall Study|Withdrawal by Subject|0|||
37714121|NCT02202161|69192510|FG006|Overall Study|Withdrawal by Subject|0|||
37714122|NCT02202161|69192511|FG007|Overall Study|Withdrawal by Subject|0|||
37714123|NCT01461928|69192530|FG000|Induction (up to 8 Months)|Adverse Event|76|||
37714124|NCT01461928|69192531|FG001|Induction (up to 8 Months)|Adverse Event|0|||
37714125|NCT01461928|69192532|FG002|Induction (up to 8 Months)|Adverse Event|0|||
37714126|NCT01461928|69192530|FG000|Induction (up to 8 Months)|Death|3|||
37714127|NCT01461928|69192531|FG001|Induction (up to 8 Months)|Death|0|||
37714128|NCT01461928|69192532|FG002|Induction (up to 8 Months)|Death|0|||
37714129|NCT01461928|69192530|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
37838886|NCT00471237|69523386|FG003|Overall Study|Participant shifted residence|0|||
37838887|NCT00471237|69523387|FG004|Overall Study|Participant shifted residence|1|||
37838888|NCT00471237|69523388|FG005|Overall Study|Participant shifted residence|0|||
37838889|NCT00471237|69523389|FG006|Overall Study|Participant shifted residence|0|||
37838890|NCT00471237|69523383|FG000|Overall Study|Participant's decision|0|||
37838891|NCT00471237|69523384|FG001|Overall Study|Participant's decision|0|||
37838892|NCT00471237|69523385|FG002|Overall Study|Participant's decision|0|||
37838893|NCT00471237|69523386|FG003|Overall Study|Participant's decision|0|||
37838894|NCT00471237|69523387|FG004|Overall Study|Participant's decision|0|||
37915436|NCT00882908|69602207|FG001|Overall Study|Subject reached a virologic endpoint|0|||
37714130|NCT01461928|69192531|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
37714131|NCT01461928|69192532|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
37915437|NCT00882908|69602208|FG002|Overall Study|Subject reached a virologic endpoint|0|||
38024615|NCT03695094|69708378|FG001|Overall Study|Adverse Event|1|||
38024616|NCT03695094|69708377|FG000|Overall Study|Withdrawal by Subject|1|||
37714132|NCT01461928|69192530|FG000|Induction (up to 8 Months)|Physician Decision|9|||
37714133|NCT01461928|69192531|FG001|Induction (up to 8 Months)|Physician Decision|0|||
37714134|NCT01461928|69192532|FG002|Induction (up to 8 Months)|Physician Decision|0|||
37838895|NCT00471237|69523388|FG005|Overall Study|Participant's decision|1|||
37838896|NCT00471237|69523389|FG006|Overall Study|Participant's decision|0|||
37714135|NCT01461928|69192530|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
37714136|NCT01461928|69192531|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
37714137|NCT01461928|69192532|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
37714138|NCT01461928|69192530|FG000|Induction (up to 8 Months)|Disease progression|45|||
37714139|NCT01461928|69192531|FG001|Induction (up to 8 Months)|Disease progression|0|||
37714140|NCT01461928|69192532|FG002|Induction (up to 8 Months)|Disease progression|0|||
37714141|NCT01461928|69192530|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
37714142|NCT01461928|69192531|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
37714143|NCT01461928|69192532|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
37714144|NCT01461928|69192530|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
37714145|NCT01461928|69192531|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
37714146|NCT01461928|69192532|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
37714147|NCT01461928|69192530|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
37714148|NCT01461928|69192531|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
37714149|NCT01461928|69192532|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
37714150|NCT01461928|69192530|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
37714151|NCT01461928|69192531|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
37714152|NCT01461928|69192532|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
37714153|NCT01461928|69192530|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
37714154|NCT01461928|69192531|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
37714155|NCT01461928|69192532|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
37714156|NCT01461928|69192530|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
37714157|NCT01461928|69192531|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
37714158|NCT01461928|69192532|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
37714159|NCT01461928|69192530|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
37714160|NCT01461928|69192531|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
37714161|NCT01461928|69192532|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
37714162|NCT01461928|69192530|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
37714163|NCT01461928|69192531|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
37714164|NCT01461928|69192532|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
37714165|NCT01461928|69192530|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
37714166|NCT01461928|69192531|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
37714167|NCT01461928|69192532|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
37714168|NCT01461928|69192530|FG000|Induction (up to 8 Months)|Promotor request|1|||
37714169|NCT01461928|69192531|FG001|Induction (up to 8 Months)|Promotor request|0|||
37714170|NCT01461928|69192532|FG002|Induction (up to 8 Months)|Promotor request|0|||
37714171|NCT01461928|69192530|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
37714172|NCT01461928|69192531|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
37714173|NCT01461928|69192532|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
37714174|NCT01461928|69192530|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
37714175|NCT01461928|69192531|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
37714176|NCT01461928|69192532|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
37714177|NCT01461928|69192530|FG000|Maintenance I (24 Months)|Death|3|||
37838897|NCT00471081|69523411|FG000|Active Phase|Protocol Violation|1|||
37838898|NCT00471081|69523412|FG001|Active Phase|Protocol Violation|1|||
37838899|NCT00471081|69523411|FG000|Active Phase|Withdrawal by Subject|0|||
37838900|NCT00471081|69523412|FG001|Active Phase|Withdrawal by Subject|3|||
37838901|NCT00471081|69523411|FG000|Active Phase|Lost to Follow-up|0|||
37838902|NCT00471081|69523412|FG001|Active Phase|Lost to Follow-up|1|||
37838903|NCT00471081|69523411|FG000|Active Phase|Lost health plan/insurance|1|||
37838904|NCT00471081|69523412|FG001|Active Phase|Lost health plan/insurance|8|||
37838905|NCT00471081|69523411|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
37838906|NCT00471081|69523412|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
37838907|NCT00471081|69523411|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
37838908|NCT00471081|69523412|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
37838909|NCT00471081|69523411|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
37838910|NCT00471081|69523412|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
37838911|NCT00470847|69523419|FG000|Overall Study|Pt still receiving treatment|1|||
37838912|NCT00470535|69523425|FG000|Overall Study|Disease Progression|13|||
37838913|NCT00470535|69523425|FG000|Overall Study|Withdrawal by Subject|1|||
38024617|NCT03695094|69708378|FG001|Overall Study|Withdrawal by Subject|0|||
37714178|NCT01461928|69192531|FG001|Maintenance I (24 Months)|Death|0|||
37714179|NCT01461928|69192532|FG002|Maintenance I (24 Months)|Death|0|||
37838914|NCT00470535|69523425|FG000|Overall Study|Adverse Event|1|||
37838915|NCT00470535|69523425|FG000|Overall Study|Death|1|||
37838916|NCT00470535|69523425|FG000|Overall Study|Other|2|||
37838917|NCT00470418|69523431|FG000|Overall Study|Withdrawal by Subject|1|||
37714180|NCT01461928|69192530|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
37714181|NCT01461928|69192531|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
37714182|NCT01461928|69192532|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
37714183|NCT01461928|69192530|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
37714184|NCT01461928|69192531|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
37714185|NCT01461928|69192532|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
37714186|NCT01461928|69192530|FG000|Maintenance I (24 Months)|Diseases progression|91|||
37714187|NCT01461928|69192531|FG001|Maintenance I (24 Months)|Diseases progression|0|||
37714188|NCT01461928|69192532|FG002|Maintenance I (24 Months)|Diseases progression|0|||
37714189|NCT01461928|69192530|FG000|Maintenance I (24 Months)|Adverse Event|70|||
37714190|NCT01461928|69192531|FG001|Maintenance I (24 Months)|Adverse Event|0|||
37714191|NCT01461928|69192532|FG002|Maintenance I (24 Months)|Adverse Event|0|||
37714192|NCT01461928|69192530|FG000|Maintenance I (24 Months)|Physician Decision|9|||
37714193|NCT01461928|69192531|FG001|Maintenance I (24 Months)|Physician Decision|0|||
37714194|NCT01461928|69192532|FG002|Maintenance I (24 Months)|Physician Decision|0|||
37714195|NCT01461928|69192530|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
37714196|NCT01461928|69192531|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
37714197|NCT01461928|69192532|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
37714198|NCT01461928|69192530|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
37714199|NCT01461928|69192531|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
37714200|NCT01461928|69192532|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
37714201|NCT01461928|69192530|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
37714202|NCT01461928|69192531|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
37714203|NCT01461928|69192532|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
37714204|NCT01461928|69192530|FG000|Maintenance I (24 Months)|Not compliant|1|||
37714205|NCT01461928|69192531|FG001|Maintenance I (24 Months)|Not compliant|0|||
37714206|NCT01461928|69192532|FG002|Maintenance I (24 Months)|Not compliant|0|||
37714207|NCT01461928|69192530|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
37714208|NCT01461928|69192531|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
37714209|NCT01461928|69192532|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
37714210|NCT01461928|69192530|FG000|Maintenance II (15 Months)|Adverse Event|0|||
37714211|NCT01461928|69192531|FG001|Maintenance II (15 Months)|Adverse Event|2|||
37714212|NCT01461928|69192532|FG002|Maintenance II (15 Months)|Adverse Event|0|||
37714213|NCT01461928|69192530|FG000|Maintenance II (15 Months)|Death|0|||
37714214|NCT01461928|69192531|FG001|Maintenance II (15 Months)|Death|10|||
37714215|NCT01461928|69192532|FG002|Maintenance II (15 Months)|Death|8|||
37714216|NCT01461928|69192530|FG000|Maintenance II (15 Months)|Physician Decision|0|||
37714217|NCT01461928|69192531|FG001|Maintenance II (15 Months)|Physician Decision|0|||
37714218|NCT01461928|69192532|FG002|Maintenance II (15 Months)|Physician Decision|4|||
37714219|NCT01461928|69192530|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
37714220|NCT01461928|69192531|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
37714221|NCT01461928|69192532|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
37714222|NCT01461928|69192530|FG000|Maintenance II (15 Months)|Moved to another town|0|||
37714223|NCT01461928|69192531|FG001|Maintenance II (15 Months)|Moved to another town|1|||
37838918|NCT00470418|69523432|FG001|Overall Study|Withdrawal by Subject|0|||
38024618|NCT04497948|69708386|FG000|Overall Study|Death|2|||
37714224|NCT01461928|69192532|FG002|Maintenance II (15 Months)|Moved to another town|0|||
37714225|NCT01461928|69192530|FG000|Maintenance II (15 Months)|Disease progression|0|||
37714226|NCT01461928|69192531|FG001|Maintenance II (15 Months)|Disease progression|0|||
37714227|NCT01461928|69192532|FG002|Maintenance II (15 Months)|Disease progression|3|||
37714228|NCT01461928|69192530|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
37714229|NCT01461928|69192531|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
37714230|NCT01461928|69192532|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
37714231|NCT01461928|69192530|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
37714232|NCT01461928|69192531|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
37714233|NCT01461928|69192532|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
37714234|NCT01461928|69192530|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
37714235|NCT01461928|69192531|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
37714236|NCT01461928|69192532|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
37714237|NCT01461928|69192530|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
37714238|NCT01461928|69192531|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
37714239|NCT01461928|69192532|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
37714240|NCT01461928|69192530|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
37714241|NCT01461928|69192531|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
37714242|NCT01461928|69192532|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
37714243|NCT03097991|69192545|FG000|Overall Study|Didn't meet study criteria|8|||
37714244|NCT03097991|69192546|FG001|Overall Study|Didn't meet study criteria|0|||
37714245|NCT03097991|69192545|FG000|Overall Study|Withdrawal by Subject|12|||
37714246|NCT03097991|69192546|FG001|Overall Study|Withdrawal by Subject|6|||
37714247|NCT03097991|69192545|FG000|Overall Study|Death of Baby|3|||
37714248|NCT03097991|69192546|FG001|Overall Study|Death of Baby|1|||
37714249|NCT03097991|69192545|FG000|Overall Study|Lost to Follow-up|24|||
37714250|NCT03097991|69192546|FG001|Overall Study|Lost to Follow-up|38|||
37714251|NCT03097991|69192545|FG000|Overall Study|Adverse Event|3|||
37714252|NCT03097991|69192546|FG001|Overall Study|Adverse Event|5|||
37714253|NCT02623205|69192558|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
37714254|NCT02623205|69192559|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
37714255|NCT01500694|69192568|FG000|Overall Study|Adverse Event|4|||
37714256|NCT01500694|69192569|FG001|Overall Study|Adverse Event|3|||
37714257|NCT01500694|69192568|FG000|Overall Study|Protocol Violation|0|||
37714258|NCT01500694|69192569|FG001|Overall Study|Protocol Violation|1|||
37714259|NCT01500694|69192568|FG000|Overall Study|Withdrawal by Subject|23|||
37714260|NCT01500694|69192569|FG001|Overall Study|Withdrawal by Subject|14|||
37714261|NCT01500694|69192568|FG000|Overall Study|Lost to Follow-up|2|||
37714262|NCT01500694|69192569|FG001|Overall Study|Lost to Follow-up|3|||
37714263|NCT01500694|69192568|FG000|Overall Study|Lack of Efficacy|14|||
37714264|NCT01500694|69192569|FG001|Overall Study|Lack of Efficacy|5|||
37714265|NCT01500694|69192568|FG000|Overall Study|Other|9|||
37714266|NCT01500694|69192569|FG001|Overall Study|Other|3|||
37714267|NCT01500382|69192579|FG000|Washout Period|Study site went out of business|0|||
37714268|NCT01500382|69192580|FG001|Washout Period|Study site went out of business|0|||
37714269|NCT01500382|69192581|FG002|Washout Period|Study site went out of business|1|||
37714270|NCT01500382|69192582|FG003|Washout Period|Study site went out of business|0|||
37714271|NCT02137837|69192595|FG000|Overall Study|Adverse Event|0|||
37714272|NCT02137837|69192596|FG001|Overall Study|Adverse Event|2|||
37714273|NCT02137837|69192597|FG002|Overall Study|Adverse Event|1|||
37714274|NCT02137837|69192595|FG000|Overall Study|Refusal unrelated to adverse event|2|||
37714275|NCT02137837|69192596|FG001|Overall Study|Refusal unrelated to adverse event|2|||
37714276|NCT02137837|69192597|FG002|Overall Study|Refusal unrelated to adverse event|1|||
37714277|NCT02137837|69192595|FG000|Overall Study|Progression/relapse|9|||
37714278|NCT02137837|69192596|FG001|Overall Study|Progression/relapse|7|||
37714279|NCT02137837|69192597|FG002|Overall Study|Progression/relapse|7|||
37714280|NCT02137837|69192595|FG000|Overall Study|Not protocol specified|2|||
37714281|NCT02137837|69192596|FG001|Overall Study|Not protocol specified|1|||
37714282|NCT02137837|69192597|FG002|Overall Study|Not protocol specified|3|||
37714283|NCT01483690|69192612|FG000|Overall Study|Adverse Event|1|||
37714284|NCT01483690|69192613|FG001|Overall Study|Adverse Event|2|||
37714285|NCT01483690|69192612|FG000|Overall Study|clinical deterioration|1|||
37714286|NCT01483690|69192613|FG001|Overall Study|clinical deterioration|0|||
37714287|NCT01483690|69192612|FG000|Overall Study|Physician Decision|0|||
37714288|NCT01483690|69192613|FG001|Overall Study|Physician Decision|2|||
37714289|NCT01483690|69192612|FG000|Overall Study|exclusionary procedure|0|||
37714290|NCT01483690|69192613|FG001|Overall Study|exclusionary procedure|1|||
37714291|NCT02104765|69192626|FG000|Overall Study|Lost to Follow-up|0|||
37714292|NCT02104765|69192627|FG001|Overall Study|Lost to Follow-up|0|||
37838919|NCT01133275|69523438|FG000|Overall Study|Withdrawal by Subject|1|||
37714293|NCT02104765|69192628|FG002|Overall Study|Lost to Follow-up|1|||
37714294|NCT02104765|69192629|FG003|Overall Study|Lost to Follow-up|0|||
37714295|NCT02104765|69192630|FG004|Overall Study|Lost to Follow-up|0|||
37714296|NCT02104765|69192631|FG005|Overall Study|Lost to Follow-up|0|||
37714297|NCT02104765|69192632|FG006|Overall Study|Lost to Follow-up|0|||
37714298|NCT02104765|69192626|FG000|Overall Study|Withdrawal by Subject|0|||
37714299|NCT02104765|69192627|FG001|Overall Study|Withdrawal by Subject|0|||
37714300|NCT02104765|69192628|FG002|Overall Study|Withdrawal by Subject|0|||
37714301|NCT02104765|69192629|FG003|Overall Study|Withdrawal by Subject|1|||
37714302|NCT02104765|69192630|FG004|Overall Study|Withdrawal by Subject|1|||
37714303|NCT02104765|69192631|FG005|Overall Study|Withdrawal by Subject|0|||
37714304|NCT02104765|69192632|FG006|Overall Study|Withdrawal by Subject|1|||
37714305|NCT01483144|69192657|FG000|Overall Study|Adverse Event|9|||
37714306|NCT01483144|69192658|FG001|Overall Study|Adverse Event|4|||
37714307|NCT01483144|69192659|FG002|Overall Study|Adverse Event|6|||
37714308|NCT01483144|69192657|FG000|Overall Study|Withdrawal by Subject|0|||
37714309|NCT01483144|69192658|FG001|Overall Study|Withdrawal by Subject|2|||
37714310|NCT01483144|69192659|FG002|Overall Study|Withdrawal by Subject|5|||
37714311|NCT01483144|69192657|FG000|Overall Study|Physician Decision|1|||
37714312|NCT01483144|69192658|FG001|Overall Study|Physician Decision|0|||
37714313|NCT01483144|69192659|FG002|Overall Study|Physician Decision|0|||
37714314|NCT01483144|69192657|FG000|Overall Study|Lost to Follow-up|2|||
38024619|NCT04495374|69708396|FG000|Overall Study|Protocol Violation|2|||
38024620|NCT04495374|69708397|FG001|Overall Study|Protocol Violation|1|||
38024621|NCT04794270|69708403|FG000|Period 1|Non Compliance|1|||
38024622|NCT04794270|69708404|FG001|Period 1|Non Compliance|0|||
38024623|NCT04794270|69708403|FG000|Period 1|Adverse Event|1|||
38024624|NCT04794270|69708404|FG001|Period 1|Adverse Event|0|||
38024625|NCT04794270|69708403|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
38024626|NCT04794270|69708404|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
38024627|NCT04567186|69708410|FG000|Period 1|COVID-19 related|1|||
38024628|NCT04567186|69708411|FG001|Period 1|COVID-19 related|0|||
38024629|NCT04567186|69708410|FG000|Period 1|Protocol Violation|0|||
38024630|NCT04567186|69708411|FG001|Period 1|Protocol Violation|1|||
38024631|NCT04567186|69708410|FG000|Period 1|Adverse Event|0|||
38024632|NCT04567186|69708411|FG001|Period 1|Adverse Event|2|||
38024633|NCT04567186|69708410|FG000|Period 2|COVID-19 Related|0|||
38024634|NCT04567186|69708411|FG001|Period 2|COVID-19 Related|1|||
38024635|NCT04567186|69708410|FG000|Period 2|Protocol Violation|0|||
38024636|NCT04567186|69708411|FG001|Period 2|Protocol Violation|1|||
38024637|NCT04567186|69708410|FG000|Period 2|Lost to Follow-up|0|||
38024638|NCT04567186|69708411|FG001|Period 2|Lost to Follow-up|1|||
38024639|NCT04567186|69708410|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
38024640|NCT04567186|69708411|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
38024641|NCT04168190|69708422|FG000|Overall Study|Lost to Follow-up|0|||
38024642|NCT04168190|69708423|FG001|Overall Study|Lost to Follow-up|1|||
38024643|NCT04168190|69708424|FG002|Overall Study|Lost to Follow-up|0|||
38024644|NCT04168190|69708425|FG003|Overall Study|Lost to Follow-up|7|||
38024645|NCT04168190|69708426|FG004|Overall Study|Lost to Follow-up|5|||
38024646|NCT04168190|69708422|FG000|Overall Study|Withdrawal by Subject|1|||
38024647|NCT04168190|69708423|FG001|Overall Study|Withdrawal by Subject|0|||
38024648|NCT04168190|69708424|FG002|Overall Study|Withdrawal by Subject|0|||
38024649|NCT04168190|69708425|FG003|Overall Study|Withdrawal by Subject|2|||
38024650|NCT04168190|69708426|FG004|Overall Study|Withdrawal by Subject|4|||
38024651|NCT04168190|69708422|FG000|Overall Study|Death|0|||
38024652|NCT04168190|69708423|FG001|Overall Study|Death|0|||
38024653|NCT04168190|69708424|FG002|Overall Study|Death|0|||
38024654|NCT04168190|69708425|FG003|Overall Study|Death|1|||
38024655|NCT04168190|69708426|FG004|Overall Study|Death|0|||
38024656|NCT03529942|69708438|FG000|Overall Study|Withdrawal by Subject|13|||
38024657|NCT03529942|69708438|FG000|Overall Study|Physician Decision|1|||
37714315|NCT01483144|69192658|FG001|Overall Study|Lost to Follow-up|4|||
37838920|NCT01133275|69523438|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
37838921|NCT00470184|69523442|FG000|Overall Study|Not Treated(became ineligible)|4|||
37838922|NCT00470184|69523442|FG000|Overall Study|Not treated (other)|1|||
37838923|NCT00470184|69523442|FG000|Overall Study|disease Progression|4|||
37838924|NCT00470184|69523442|FG000|Overall Study|Adverse Event|3|||
37838925|NCT00470184|69523442|FG000|Overall Study|Withdrawal by Subject|4|||
38024658|NCT03529942|69708438|FG000|Overall Study|Lost to Follow-up|7|||
38024659|NCT03529942|69708438|FG000|Overall Study|Needle inserted but no drug administered|1|||
38024660|NCT03529942|69708438|FG000|Overall Study|Personal reasons|1|||
37714316|NCT01483144|69192659|FG002|Overall Study|Lost to Follow-up|1|||
37714317|NCT01483144|69192657|FG000|Overall Study|Protocol Violation|3|||
37838926|NCT00470184|69523442|FG000|Overall Study|other|5|||
38024661|NCT04732338|69708447|FG000|Overall Study|Lost to Follow-up|3|||
38024662|NCT04732338|69708448|FG001|Overall Study|Lost to Follow-up|3|||
38024663|NCT04194008|69708454|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
38024664|NCT04194008|69708454|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
38024665|NCT04194008|69708454|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
37714318|NCT01483144|69192658|FG001|Overall Study|Protocol Violation|3|||
37714319|NCT01483144|69192659|FG002|Overall Study|Protocol Violation|3|||
37714320|NCT01881789|69192673|FG000|Overall Study|Withdrawal by Subject|0|||
37714321|NCT01881789|69192674|FG001|Overall Study|Withdrawal by Subject|2|||
37714322|NCT01881789|69192675|FG002|Overall Study|Withdrawal by Subject|1|||
37714323|NCT01881789|69192676|FG003|Overall Study|Withdrawal by Subject|0|||
37714324|NCT01881789|69192677|FG004|Overall Study|Withdrawal by Subject|1|||
37714325|NCT01881789|69192678|FG005|Overall Study|Withdrawal by Subject|1|||
37714326|NCT01881789|69192673|FG000|Overall Study|Study Terminated by Sponsor|0|||
37714327|NCT01881789|69192674|FG001|Overall Study|Study Terminated by Sponsor|0|||
37714328|NCT01881789|69192675|FG002|Overall Study|Study Terminated by Sponsor|0|||
37714329|NCT01881789|69192676|FG003|Overall Study|Study Terminated by Sponsor|0|||
37714330|NCT01881789|69192677|FG004|Overall Study|Study Terminated by Sponsor|0|||
37714331|NCT01881789|69192678|FG005|Overall Study|Study Terminated by Sponsor|1|||
37714332|NCT01881789|69192673|FG000|Overall Study|Other|3|||
37714333|NCT01881789|69192674|FG001|Overall Study|Other|5|||
37714334|NCT01881789|69192675|FG002|Overall Study|Other|2|||
37714335|NCT01881789|69192676|FG003|Overall Study|Other|3|||
37714336|NCT01881789|69192677|FG004|Overall Study|Other|1|||
37714337|NCT01881789|69192678|FG005|Overall Study|Other|1|||
37714338|NCT02075203|69192696|FG000|Overall Study|Withdrawal by Subject|1|||
37714339|NCT02075203|69192697|FG001|Overall Study|Withdrawal by Subject|0|||
37714340|NCT02075203|69192698|FG002|Overall Study|Withdrawal by Subject|1|||
37714341|NCT02075203|69192696|FG000|Overall Study|Adverse Event|1|||
37714342|NCT02075203|69192697|FG001|Overall Study|Adverse Event|0|||
37838927|NCT00470184|69523442|FG000|Overall Study|recurrence|1|||
37838928|NCT00470067|69523447|FG000|Overall Study|Death|1|||
37838929|NCT00470067|69523447|FG000|Overall Study|Disease Progression|6|||
37838930|NCT00475020|69523451|FG000|Overall Study|Physician Decision|3|||
37838931|NCT00475020|69523451|FG000|Overall Study|Insurance Denial|1|||
37838932|NCT00475020|69523451|FG000|Overall Study|Donor not able to donate the last minute|1|||
37838933|NCT02484456|69523457|FG000|Washout Period|Withdrawal by Subject|0|||
37838934|NCT02484456|69523458|FG001|Washout Period|Withdrawal by Subject|1|||
37838935|NCT02484456|69523457|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
38024666|NCT04194008|69708454|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
37714343|NCT02075203|69192698|FG002|Overall Study|Adverse Event|0|||
37714344|NCT02075203|69192696|FG000|Overall Study|participant refused to use contraception|1|||
37714345|NCT02075203|69192697|FG001|Overall Study|participant refused to use contraception|0|||
37714346|NCT02075203|69192698|FG002|Overall Study|participant refused to use contraception|0|||
37714347|NCT01892163|69192708|FG000|Overall Study|Death|1|||
37714348|NCT01892163|69192709|FG001|Overall Study|Death|1|||
37714349|NCT01892163|69192708|FG000|Overall Study|Lost to Follow-up|1|||
37714350|NCT01892163|69192709|FG001|Overall Study|Lost to Follow-up|0|||
37714351|NCT01881009|69192717|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
37714352|NCT01881009|69192718|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
37714353|NCT01500226|69192727|FG000|Overall Study|Adverse Event|31|||
37714354|NCT01500226|69192728|FG001|Overall Study|Adverse Event|38|||
37714355|NCT01500226|69192727|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
37714356|NCT01500226|69192728|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
37714357|NCT01500226|69192727|FG000|Overall Study|Withdrawal by Subject|93|||
37714358|NCT01500226|69192728|FG001|Overall Study|Withdrawal by Subject|96|||
37714359|NCT01500226|69192727|FG000|Overall Study|Death|12|||
37714360|NCT01500226|69192728|FG001|Overall Study|Death|4|||
37714361|NCT01500226|69192727|FG000|Overall Study|Disease Progression|16|||
37714362|NCT01500226|69192728|FG001|Overall Study|Disease Progression|14|||
37714363|NCT01500226|69192727|FG000|Overall Study|Protocol Violation|53|||
37714364|NCT01500226|69192728|FG001|Overall Study|Protocol Violation|39|||
37714365|NCT01500226|69192727|FG000|Overall Study|Physician Decision|17|||
37714366|NCT01500226|69192728|FG001|Overall Study|Physician Decision|15|||
37714367|NCT01500226|69192727|FG000|Overall Study|Lack of Efficacy|14|||
37714368|NCT01500226|69192728|FG001|Overall Study|Lack of Efficacy|30|||
37714369|NCT01500226|69192727|FG000|Overall Study|Lost to Follow-up|9|||
37714370|NCT01500226|69192728|FG001|Overall Study|Lost to Follow-up|5|||
38024667|NCT04194008|69708454|FG000|Treatment Phase With Nerivio|Missing data|4|||
37714371|NCT01500226|69192727|FG000|Overall Study|Other Reasons|19|||
37838936|NCT02484456|69523458|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
37714372|NCT01500226|69192728|FG001|Overall Study|Other Reasons|16|||
37714373|NCT02075047|69192736|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
37714374|NCT02075047|69192737|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
37714375|NCT02075047|69192736|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
37714376|NCT02075047|69192737|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
37714377|NCT02075047|69192736|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
37714378|NCT02075047|69192737|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
37714379|NCT02075047|69192736|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
37714380|NCT02075047|69192737|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
37714381|NCT02075047|69192736|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
37714382|NCT02075047|69192737|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
37714383|NCT02075047|69192736|FG000|Treatment Phase (4 Weeks)|Other|1|||
37714384|NCT02075047|69192737|FG001|Treatment Phase (4 Weeks)|Other|1|||
37714385|NCT02075047|69192736|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
37714386|NCT02075047|69192737|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
37714387|NCT02075047|69192736|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
37714388|NCT02075047|69192737|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
37714389|NCT02075047|69192736|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
37714390|NCT02075047|69192737|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
37714391|NCT02075047|69192736|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
37714392|NCT02075047|69192737|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
37714393|NCT02075047|69192736|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
37714394|NCT02075047|69192737|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
37714395|NCT02075047|69192736|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
37714396|NCT02075047|69192737|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
37714397|NCT02075047|69192736|FG000|Follow up Phase (5 Weeks)|Other|1|||
37714398|NCT02075047|69192737|FG001|Follow up Phase (5 Weeks)|Other|2|||
37714399|NCT02075047|69192736|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
37714400|NCT02075047|69192737|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
37714401|NCT01859949|69192745|FG000|Overall Study|Family Matters|0|||
37714402|NCT01859949|69192746|FG001|Overall Study|Family Matters|1|||
37714403|NCT01859949|69192745|FG000|Overall Study|Physician Decision|2|||
37714404|NCT01859949|69192746|FG001|Overall Study|Physician Decision|4|||
37714405|NCT01859949|69192745|FG000|Overall Study|Withdrawal by Subject|11|||
37714406|NCT01859949|69192746|FG001|Overall Study|Withdrawal by Subject|10|||
37714407|NCT01859949|69192745|FG000|Overall Study|Protocol Violation|1|||
37714408|NCT01859949|69192746|FG001|Overall Study|Protocol Violation|1|||
37714409|NCT01859949|69192745|FG000|Overall Study|Adverse Event|0|||
37714410|NCT01859949|69192746|FG001|Overall Study|Adverse Event|1|||
37714411|NCT01859793|69192754|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
37714412|NCT01859793|69192755|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
37714413|NCT01859793|69192754|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
37714414|NCT01859793|69192755|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
37714415|NCT01859793|69192754|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
37714416|NCT01859793|69192755|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
37714417|NCT01859793|69192754|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
37714418|NCT01859793|69192755|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
37714419|NCT01859715|69192764|FG000|Overall Study|No 2nd VAS|16|||
37714420|NCT01859715|69192765|FG001|Overall Study|No 2nd VAS|8|||
37714421|NCT01859715|69192766|FG002|Overall Study|No 2nd VAS|23|||
37714422|NCT01890915|69192778|FG000|Overall Study|Adverse Event|1|||
37714423|NCT01890915|69192779|FG001|Overall Study|Adverse Event|0|||
37714424|NCT01890915|69192778|FG000|Overall Study|Protocol Violation|2|||
37714425|NCT01890915|69192779|FG001|Overall Study|Protocol Violation|0|||
37714426|NCT01890915|69192778|FG000|Overall Study|Equipment Malfunction|0|||
37714427|NCT01890915|69192779|FG001|Overall Study|Equipment Malfunction|1|||
37714428|NCT01615263|69192787|FG000|Overall Study|Post-randomization exclusion|0|||
37714429|NCT01615263|69192788|FG001|Overall Study|Post-randomization exclusion|2|||
37714430|NCT01859403|69192805|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
37714431|NCT01859403|69192806|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
37714432|NCT01859403|69192805|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
37714433|NCT01859403|69192806|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
37714434|NCT01859403|69192805|FG000|Primary Endpoint Measure|Physician Decision|0|||
37714435|NCT01859403|69192806|FG001|Primary Endpoint Measure|Physician Decision|1|||
37714436|NCT01859403|69192805|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
37714437|NCT01859403|69192806|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
37714438|NCT01858701|69192812|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
37714439|NCT01858701|69192813|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
37714440|NCT01858701|69192812|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
37714441|NCT01858701|69192813|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
37714442|NCT01858701|69192812|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
37714443|NCT01858701|69192813|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
37714444|NCT01858701|69192812|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
37714445|NCT01858701|69192813|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
37714446|NCT01461538|69192822|FG000|Overall Study|Death|15|||
37838937|NCT02484456|69523457|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
37714447|NCT01461538|69192823|FG001|Overall Study|Death|6|||
37714448|NCT01461538|69192824|FG002|Overall Study|Death|2|||
37714449|NCT01461538|69192822|FG000|Overall Study|Study Stopped by Sponsor|2|||
37714450|NCT01461538|69192823|FG001|Overall Study|Study Stopped by Sponsor|1|||
37714451|NCT01461538|69192824|FG002|Overall Study|Study Stopped by Sponsor|0|||
37714452|NCT01461538|69192822|FG000|Overall Study|Withdrawal by Subject|1|||
37714453|NCT01461538|69192823|FG001|Overall Study|Withdrawal by Subject|1|||
37714454|NCT01461538|69192824|FG002|Overall Study|Withdrawal by Subject|0|||
37714455|NCT02117479|69192836|FG000|Overall Study|Death|13|||
37714456|NCT02117479|69192837|FG001|Overall Study|Death|8|||
37714457|NCT02117479|69192836|FG000|Overall Study|Adverse Event|8|||
37714458|NCT02117479|69192837|FG001|Overall Study|Adverse Event|16|||
37714459|NCT02117479|69192836|FG000|Overall Study|Subject decision|8|||
37714460|NCT02117479|69192837|FG001|Overall Study|Subject decision|9|||
37714461|NCT02117479|69192836|FG000|Overall Study|Disease progression|104|||
37714462|NCT02117479|69192837|FG001|Overall Study|Disease progression|108|||
37714463|NCT02117479|69192836|FG000|Overall Study|Noncompliance with study treatment|1|||
37714464|NCT02117479|69192837|FG001|Overall Study|Noncompliance with study treatment|0|||
37714465|NCT02117479|69192836|FG000|Overall Study|Study terminated by the sponsor|4|||
37714466|NCT02117479|69192837|FG001|Overall Study|Study terminated by the sponsor|6|||
37714467|NCT02117479|69192836|FG000|Overall Study|Physician Decision|7|||
37714468|NCT02117479|69192837|FG001|Overall Study|Physician Decision|2|||
37714469|NCT02117479|69192836|FG000|Overall Study|Other unspecified|11|||
37714470|NCT02117479|69192837|FG001|Overall Study|Other unspecified|7|||
37714471|NCT02229851|69192846|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
37714472|NCT02229851|69192847|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
37714473|NCT02229851|69192848|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
37714474|NCT02229851|69192849|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
37714475|NCT02229851|69192850|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
37714476|NCT02229851|69192851|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
37714477|NCT02229851|69192852|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
37714478|NCT02229851|69192846|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
37714479|NCT02229851|69192847|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
37714480|NCT02229851|69192848|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
37714481|NCT02229851|69192849|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
37714482|NCT02229851|69192850|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
37714483|NCT02229851|69192851|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
37714484|NCT02229851|69192852|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
37714485|NCT02229851|69192846|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
37714486|NCT02229851|69192847|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
37714487|NCT02229851|69192848|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
37714488|NCT02229851|69192849|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
37714489|NCT02229851|69192850|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
37714490|NCT02229851|69192851|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
37714491|NCT02229851|69192852|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
37714492|NCT02229851|69192846|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
37714493|NCT02229851|69192847|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
37714494|NCT02229851|69192848|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
37714495|NCT02229851|69192849|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
37714496|NCT02229851|69192850|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
37714497|NCT02229851|69192851|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
37714498|NCT02229851|69192852|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
37714499|NCT02229851|69192846|FG000|Main Phase (Double-blind Phase)|Death|1|||
37714500|NCT02229851|69192847|FG001|Main Phase (Double-blind Phase)|Death|1|||
37714501|NCT02229851|69192848|FG002|Main Phase (Double-blind Phase)|Death|0|||
37714502|NCT02229851|69192849|FG003|Main Phase (Double-blind Phase)|Death|0|||
37714503|NCT02229851|69192850|FG004|Main Phase (Double-blind Phase)|Death|0|||
37714504|NCT02229851|69192851|FG005|Main Phase (Double-blind Phase)|Death|0|||
37714505|NCT02229851|69192852|FG006|Main Phase (Double-blind Phase)|Death|0|||
37714506|NCT02229851|69192846|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
37714507|NCT02229851|69192847|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
37714508|NCT02229851|69192848|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
37714509|NCT02229851|69192849|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
37714510|NCT02229851|69192850|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
37714511|NCT02229851|69192851|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
37714512|NCT02229851|69192852|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
37714513|NCT02229851|69192846|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
37714514|NCT02229851|69192847|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
37714515|NCT02229851|69192848|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
37714516|NCT02229851|69192849|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
37714517|NCT02229851|69192850|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
37714518|NCT02229851|69192851|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
37714519|NCT02229851|69192852|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
37714520|NCT02229851|69192846|FG000|Extension Phase (Open-label Phase)|Death|0|||
37714521|NCT02229851|69192847|FG001|Extension Phase (Open-label Phase)|Death|0|||
37714522|NCT02229851|69192848|FG002|Extension Phase (Open-label Phase)|Death|0|||
37714523|NCT02229851|69192849|FG003|Extension Phase (Open-label Phase)|Death|1|||
37714524|NCT02229851|69192850|FG004|Extension Phase (Open-label Phase)|Death|0|||
37714525|NCT02229851|69192851|FG005|Extension Phase (Open-label Phase)|Death|1|||
37714526|NCT02229851|69192852|FG006|Extension Phase (Open-label Phase)|Death|1|||
37714527|NCT01482910|69192869|FG000|Overall Study|Adverse Event|6|||
37714528|NCT01482910|69192870|FG001|Overall Study|Adverse Event|5|||
37714529|NCT01482910|69192869|FG000|Overall Study|Lost to Follow-up|0|||
37714530|NCT01482910|69192870|FG001|Overall Study|Lost to Follow-up|1|||
37714531|NCT01482910|69192869|FG000|Overall Study|Protocol Violation|1|||
37714532|NCT01482910|69192870|FG001|Overall Study|Protocol Violation|1|||
37714533|NCT01482910|69192869|FG000|Overall Study|Withdrawal by Subject|7|||
37714534|NCT01482910|69192870|FG001|Overall Study|Withdrawal by Subject|2|||
37714535|NCT01482910|69192869|FG000|Overall Study|Death|1|||
37714536|NCT01482910|69192870|FG001|Overall Study|Death|0|||
37714537|NCT01626391|69192880|FG000|Overall Study|Physician Decision|1|||
37714538|NCT01626391|69192881|FG001|Overall Study|Physician Decision|0|||
37714539|NCT01626391|69192880|FG000|Overall Study|Withdrawal by Subject|1|||
37714540|NCT01626391|69192881|FG001|Overall Study|Withdrawal by Subject|0|||
37714541|NCT02103439|69192889|FG000|Overall Study|Adverse Event|0|||
37714542|NCT02103439|69192890|FG001|Overall Study|Adverse Event|2|||
37714543|NCT02103439|69192889|FG000|Overall Study|Withdrawal by Subject|3|||
37714544|NCT02103439|69192890|FG001|Overall Study|Withdrawal by Subject|1|||
37714545|NCT02229539|69192903|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
37714546|NCT02229539|69192904|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
37714547|NCT02229539|69192905|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
37714548|NCT02229539|69192903|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
38024668|NCT04194008|69708454|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
38024669|NCT04189952|69708467|FG000|Follow-up Period|Death|1|||
37714549|NCT02229539|69192904|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
37714550|NCT02229539|69192905|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
37714551|NCT02229539|69192903|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
37714552|NCT02229539|69192904|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
37714553|NCT02229539|69192905|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
37714554|NCT02229539|69192903|FG000|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|3|||
37714555|NCT02229539|69192904|FG001|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|4|||
37714556|NCT02229539|69192905|FG002|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|1|||
37714557|NCT02229539|69192903|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
37714558|NCT02229539|69192904|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
37714559|NCT02229539|69192905|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
37714560|NCT02229539|69192903|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
37714561|NCT02229539|69192904|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
37714562|NCT02229539|69192905|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
37714563|NCT02229539|69192903|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
37714564|NCT02229539|69192904|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
37714565|NCT02229539|69192905|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
37714566|NCT02229539|69192903|FG000|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0|||
37714567|NCT02229539|69192904|FG001|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0|||
37714568|NCT02229539|69192905|FG002|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|3|||
37714569|NCT02229539|69192903|FG000|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|2|||
37714570|NCT02229539|69192904|FG001|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|1|||
37714571|NCT02229539|69192905|FG002|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|0|||
37714572|NCT01835223|69192915|FG000|Overall Study|Adverse Event|1|||
37714573|NCT01835223|69192916|FG001|Overall Study|Adverse Event|0|||
37714574|NCT01835223|69192915|FG000|Overall Study|Withdrawal by Subject|2|||
37714575|NCT01835223|69192916|FG001|Overall Study|Withdrawal by Subject|0|||
38024670|NCT04189952|69708467|FG000|Follow-up Period|Withdrawal by Subject|1|||
38024671|NCT04716426|69708473|FG000|Overall Study|Vaccination|1|||
38024672|NCT04716426|69708474|FG001|Overall Study|Vaccination|1|||
38024673|NCT04716426|69708473|FG000|Overall Study|Contamination|1|||
38024674|NCT04716426|69708474|FG001|Overall Study|Contamination|0|||
37714576|NCT01835223|69192915|FG000|Overall Study|Disease progression|2|||
37714577|NCT01835223|69192916|FG001|Overall Study|Disease progression|1|||
37714578|NCT01835223|69192915|FG000|Overall Study|Became Inelligible|4|||
37714579|NCT01835223|69192916|FG001|Overall Study|Became Inelligible|0|||
37714580|NCT01482598|69192926|FG000|Overall Study|Death|7|||
38024675|NCT03694548|69708482|FG000|Part A Survey|Protocol Violation|3|||
37714581|NCT01482598|69192927|FG001|Overall Study|Death|10|||
37714582|NCT01482598|69192926|FG000|Overall Study|Physician Decision|0|||
37714583|NCT01482598|69192927|FG001|Overall Study|Physician Decision|3|||
37714584|NCT01482598|69192926|FG000|Overall Study|Withdrawal by Subject|4|||
37714585|NCT01482598|69192927|FG001|Overall Study|Withdrawal by Subject|5|||
37714586|NCT01482598|69192926|FG000|Overall Study|Lost to Follow-up|5|||
37714587|NCT01482598|69192927|FG001|Overall Study|Lost to Follow-up|4|||
37714588|NCT01460446|69192935|FG000|Overall Study|Non-compliance|2|||
37714589|NCT01460446|69192936|FG001|Overall Study|Non-compliance|9|||
37714590|NCT01460446|69192935|FG000|Overall Study|Consent Withdrawn|0|||
37714591|NCT01460446|69192936|FG001|Overall Study|Consent Withdrawn|4|||
37714592|NCT01460446|69192935|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
37714593|NCT01460446|69192936|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
37714594|NCT01460446|69192935|FG000|Overall Study|Surgery/Illness|1|||
37714595|NCT01460446|69192936|FG001|Overall Study|Surgery/Illness|1|||
37714596|NCT01460446|69192935|FG000|Overall Study|Pregnancy|1|||
37714597|NCT01460446|69192936|FG001|Overall Study|Pregnancy|0|||
37714598|NCT01460446|69192935|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
37714599|NCT01460446|69192936|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
37714600|NCT02229383|69192945|FG000|Overall Study|Adverse Event|7|||
37714601|NCT02229383|69192946|FG001|Overall Study|Adverse Event|4|||
37714602|NCT02229383|69192945|FG000|Overall Study|Death|0|||
37714603|NCT02229383|69192946|FG001|Overall Study|Death|1|||
37714604|NCT02229383|69192945|FG000|Overall Study|Lost to Follow-up|5|||
37714605|NCT02229383|69192946|FG001|Overall Study|Lost to Follow-up|3|||
37714606|NCT02229383|69192945|FG000|Overall Study|Withdrawal by Subject|4|||
37714607|NCT02229383|69192946|FG001|Overall Study|Withdrawal by Subject|6|||
37714608|NCT02229383|69192945|FG000|Overall Study|Did not receive treatment|1|||
37714609|NCT02229383|69192946|FG001|Overall Study|Did not receive treatment|0|||
37714610|NCT02229383|69192945|FG000|Overall Study|Other|3|||
37714611|NCT02229383|69192946|FG001|Overall Study|Other|8|||
37714612|NCT01499368|69192955|FG000|Overall Study|Did not meet I/E criteria|8|||
37714613|NCT01499368|69192956|FG001|Overall Study|Did not meet I/E criteria|4|||
37714614|NCT01499368|69192957|FG002|Overall Study|Did not meet I/E criteria|4|||
37714615|NCT01499368|69192955|FG000|Overall Study|Prohibited Concomitant medication|1|||
37714616|NCT01499368|69192956|FG001|Overall Study|Prohibited Concomitant medication|1|||
37714617|NCT01499368|69192957|FG002|Overall Study|Prohibited Concomitant medication|0|||
37714618|NCT01499368|69192955|FG000|Overall Study|Withdrawal by Subject|11|||
37714619|NCT01499368|69192956|FG001|Overall Study|Withdrawal by Subject|10|||
37714620|NCT01499368|69192957|FG002|Overall Study|Withdrawal by Subject|8|||
37714621|NCT01499368|69192955|FG000|Overall Study|Lost to Follow-up|3|||
37714622|NCT01499368|69192956|FG001|Overall Study|Lost to Follow-up|2|||
37714623|NCT01499368|69192957|FG002|Overall Study|Lost to Follow-up|5|||
37714624|NCT01499368|69192955|FG000|Overall Study|Adverse Event|4|||
37714625|NCT01499368|69192956|FG001|Overall Study|Adverse Event|0|||
37714626|NCT01499368|69192957|FG002|Overall Study|Adverse Event|2|||
37714627|NCT01499368|69192955|FG000|Overall Study|Physician Decision|0|||
37714628|NCT01499368|69192956|FG001|Overall Study|Physician Decision|1|||
37714629|NCT01499368|69192957|FG002|Overall Study|Physician Decision|0|||
37714630|NCT01499368|69192955|FG000|Overall Study|Deviation from visit window|0|||
37714631|NCT01499368|69192956|FG001|Overall Study|Deviation from visit window|0|||
37714632|NCT01499368|69192957|FG002|Overall Study|Deviation from visit window|1|||
37714633|NCT01499368|69192955|FG000|Overall Study|Error of Prescriptions|0|||
37714634|NCT01499368|69192956|FG001|Overall Study|Error of Prescriptions|0|||
37714635|NCT01499368|69192957|FG002|Overall Study|Error of Prescriptions|1|||
37714636|NCT01835145|69192967|FG000|Overall Study|Ineligible prior to treatment|1|||
37714637|NCT01835145|69192968|FG001|Overall Study|Ineligible prior to treatment|0|||
37714638|NCT02229227|69192978|FG000|Overall Study|Adverse Event|14|||
37714639|NCT02229227|69192979|FG001|Overall Study|Adverse Event|9|||
37714640|NCT02229227|69192978|FG000|Overall Study|Lack of Efficacy|3|||
37714641|NCT02229227|69192979|FG001|Overall Study|Lack of Efficacy|3|||
37915438|NCT00882908|69602209|FG003|Overall Study|Subject reached a virologic endpoint|0|||
37915439|NCT00882908|69602210|FG004|Overall Study|Subject reached a virologic endpoint|1|||
37915440|NCT00882908|69602206|FG000|Overall Study|Study terminated in error|0|||
37915441|NCT00882908|69602207|FG001|Overall Study|Study terminated in error|0|||
37714642|NCT02229227|69192978|FG000|Overall Study|Protocol Violation|6|||
37714643|NCT02229227|69192979|FG001|Overall Study|Protocol Violation|8|||
37714644|NCT02229227|69192978|FG000|Overall Study|Protocol defined stopping criteria|1|||
37714645|NCT02229227|69192979|FG001|Overall Study|Protocol defined stopping criteria|3|||
37714646|NCT02229227|69192978|FG000|Overall Study|Lost to Follow-up|3|||
37714647|NCT02229227|69192979|FG001|Overall Study|Lost to Follow-up|3|||
37915442|NCT00882908|69602208|FG002|Overall Study|Study terminated in error|0|||
37714648|NCT02229227|69192978|FG000|Overall Study|Study terminated by sponsor|11|||
37714649|NCT02229227|69192979|FG001|Overall Study|Study terminated by sponsor|11|||
37714650|NCT02229227|69192978|FG000|Overall Study|Withdrawal by Subject|8|||
37714651|NCT02229227|69192979|FG001|Overall Study|Withdrawal by Subject|12|||
37714652|NCT02229227|69192978|FG000|Overall Study|Other|0|||
37714653|NCT02229227|69192979|FG001|Overall Study|Other|1|||
37714654|NCT02229227|69192978|FG000|Overall Study|Physician Decision|5|||
37714655|NCT02229227|69192979|FG001|Overall Study|Physician Decision|12|||
37714656|NCT01499290|69192987|FG000|Overall Study|Withdrawal by Subject|22|||
37714657|NCT01499290|69192988|FG001|Overall Study|Withdrawal by Subject|15|||
37714658|NCT01499290|69192987|FG000|Overall Study|Not specified in study report|11|||
37714659|NCT01499290|69192988|FG001|Overall Study|Not specified in study report|5|||
37714660|NCT01499290|69192987|FG000|Overall Study|Condition improved/subject recovered|1|||
37714661|NCT01499290|69192988|FG001|Overall Study|Condition improved/subject recovered|0|||
37714662|NCT01499290|69192987|FG000|Overall Study|Lack of Efficacy|7|||
37714663|NCT01499290|69192988|FG001|Overall Study|Lack of Efficacy|8|||
37714664|NCT01499290|69192987|FG000|Overall Study|Adverse Event|14|||
37714665|NCT01499290|69192988|FG001|Overall Study|Adverse Event|7|||
37714666|NCT01833897|69193013|FG000|Overall Study|Lack of Efficacy|1|||
37714667|NCT01481896|69193017|FG000|Overall Study|Lost to Follow-up|12|||
37714668|NCT02226653|69193033|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
37714669|NCT02226653|69193034|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
37714670|NCT02226653|69193033|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
37714671|NCT02226653|69193034|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
37714672|NCT02201771|69193050|FG000|Overall Study|Death|3|||
37714673|NCT02201771|69193051|FG001|Overall Study|Death|2|||
37714674|NCT02201771|69193052|FG002|Overall Study|Death|0|||
37714675|NCT02201771|69193050|FG000|Overall Study|Protocol Violation|10|||
37714676|NCT02201771|69193051|FG001|Overall Study|Protocol Violation|8|||
37714677|NCT02201771|69193052|FG002|Overall Study|Protocol Violation|10|||
37714678|NCT01460368|69193062|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
37714679|NCT01460368|69193063|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
37714680|NCT01460368|69193064|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
37714681|NCT01460368|69193065|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
37714682|NCT01460368|69193066|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
37714683|NCT01460368|69193067|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
37714684|NCT01460368|69193068|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
37714685|NCT01460368|69193062|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
37714686|NCT01460368|69193063|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
37714687|NCT01460368|69193064|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
37714688|NCT01460368|69193065|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
37714689|NCT01460368|69193066|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
37714690|NCT01460368|69193067|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
37714691|NCT01460368|69193068|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
37714692|NCT01460368|69193062|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
37714693|NCT01460368|69193063|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
37714694|NCT01460368|69193064|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
37714695|NCT01460368|69193065|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
37714696|NCT01460368|69193066|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
37714697|NCT01460368|69193067|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
37714698|NCT01460368|69193068|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
37714699|NCT01460368|69193062|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
37714700|NCT01460368|69193063|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
37714701|NCT01460368|69193064|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
37714702|NCT01460368|69193065|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
37714703|NCT01460368|69193066|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
37714704|NCT01460368|69193067|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
37714705|NCT01460368|69193068|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
37714706|NCT01460368|69193062|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
37714707|NCT01460368|69193063|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
37714708|NCT01460368|69193064|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
37714709|NCT01460368|69193065|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
37714710|NCT01460368|69193066|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
37714711|NCT01460368|69193067|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
37714712|NCT01460368|69193068|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
37714713|NCT01460290|69193077|FG000|Overall Study|Adverse Event|3|||
37714714|NCT01460290|69193077|FG000|Overall Study|Elevated liver function|1|||
37714715|NCT02200211|69193086|FG000|Overall Study|Lost to Follow-up|7|||
37714716|NCT02200211|69193087|FG001|Overall Study|Lost to Follow-up|7|||
37714717|NCT02200211|69193088|FG002|Overall Study|Lost to Follow-up|1|||
37714718|NCT02200211|69193089|FG003|Overall Study|Lost to Follow-up|2|||
37714719|NCT02200211|69193086|FG000|Overall Study|Withdrawal by Subject|1|||
37714720|NCT02200211|69193087|FG001|Overall Study|Withdrawal by Subject|0|||
37714721|NCT02200211|69193088|FG002|Overall Study|Withdrawal by Subject|0|||
37714722|NCT02200211|69193089|FG003|Overall Study|Withdrawal by Subject|0|||
37714723|NCT01459666|69193109|FG000|Overall Study|PI left institution|5|||
37714724|NCT01459666|69193110|FG001|Overall Study|PI left institution|4|||
37714725|NCT01858389|69193118|FG000|Overall Study|Death|1|||
37714726|NCT01858389|69193119|FG001|Overall Study|Death|3|||
37714727|NCT01858389|69193118|FG000|Overall Study|Study terminated by sponsor|0|||
37714728|NCT01858389|69193119|FG001|Overall Study|Study terminated by sponsor|2|||
37714729|NCT01858389|69193118|FG000|Overall Study|Withdrawal by Subject|0|||
37714730|NCT01858389|69193119|FG001|Overall Study|Withdrawal by Subject|1|||
37714731|NCT01858389|69193118|FG000|Overall Study|Progressive disease|10|||
37714732|NCT01858389|69193119|FG001|Overall Study|Progressive disease|11|||
37714733|NCT01858389|69193118|FG000|Overall Study|Other|2|||
37714734|NCT01858389|69193119|FG001|Overall Study|Other|4|||
37714735|NCT01858389|69193118|FG000|Overall Study|Adverse Event|3|||
37714736|NCT01858389|69193119|FG001|Overall Study|Adverse Event|1|||
37714737|NCT01858389|69193118|FG000|Overall Study|Did not receive treatment|0|||
37714738|NCT01858389|69193119|FG001|Overall Study|Did not receive treatment|3|||
37714739|NCT02199509|69193127|FG000|Overall Study|Suicidal Ideation|0|||
37714740|NCT02199509|69193128|FG001|Overall Study|Suicidal Ideation|1|||
37714741|NCT02199509|69193127|FG000|Overall Study|Misunderstood titration schedule|1|||
37714742|NCT02199509|69193128|FG001|Overall Study|Misunderstood titration schedule|0|||
37714743|NCT01458574|69193141|FG000|Overall Study|Adverse Event|5|||
37714744|NCT01458574|69193142|FG001|Overall Study|Adverse Event|9|||
37714745|NCT01458574|69193143|FG002|Overall Study|Adverse Event|7|||
37714746|NCT01458574|69193141|FG000|Overall Study|Lack of Efficacy|70|||
37714747|NCT01458574|69193142|FG001|Overall Study|Lack of Efficacy|53|||
37714748|NCT01458574|69193143|FG002|Overall Study|Lack of Efficacy|132|||
37714749|NCT01458574|69193141|FG000|Overall Study|Lost to Follow-up|3|||
37714750|NCT01458574|69193142|FG001|Overall Study|Lost to Follow-up|2|||
37714751|NCT01458574|69193143|FG002|Overall Study|Lost to Follow-up|1|||
37714752|NCT01458574|69193141|FG000|Overall Study|Pregnancy|1|||
37714753|NCT01458574|69193142|FG001|Overall Study|Pregnancy|1|||
37714754|NCT01458574|69193143|FG002|Overall Study|Pregnancy|0|||
37714755|NCT01458574|69193141|FG000|Overall Study|Protocol Violation|0|||
37714756|NCT01458574|69193142|FG001|Overall Study|Protocol Violation|1|||
37714757|NCT01458574|69193143|FG002|Overall Study|Protocol Violation|0|||
37714758|NCT01458574|69193141|FG000|Overall Study|Withdrawal by Subject|6|||
37714759|NCT01458574|69193142|FG001|Overall Study|Withdrawal by Subject|3|||
37714760|NCT01458574|69193143|FG002|Overall Study|Withdrawal by Subject|5|||
37714761|NCT01458574|69193141|FG000|Overall Study|Other|2|||
37714762|NCT01458574|69193142|FG001|Overall Study|Other|1|||
37714763|NCT01458574|69193143|FG002|Overall Study|Other|0|||
37714764|NCT01458574|69193141|FG000|Overall Study|Randomized but not treated|0|||
37714765|NCT01458574|69193142|FG001|Overall Study|Randomized but not treated|1|||
37714766|NCT01458574|69193143|FG002|Overall Study|Randomized but not treated|0|||
37714767|NCT02224703|69193154|FG000|Overall Study|Adverse Event|0|||
37714768|NCT02224703|69193155|FG001|Overall Study|Adverse Event|5|||
37714769|NCT02224703|69193156|FG002|Overall Study|Adverse Event|0|||
37714770|NCT02224703|69193154|FG000|Overall Study|Withdrawn by investigator|1|||
37714771|NCT02224703|69193155|FG001|Overall Study|Withdrawn by investigator|0|||
37714772|NCT02224703|69193156|FG002|Overall Study|Withdrawn by investigator|0|||
37714773|NCT02224703|69193154|FG000|Overall Study|Advised by medical monitor|1|||
37714774|NCT02224703|69193155|FG001|Overall Study|Advised by medical monitor|0|||
37714775|NCT02224703|69193156|FG002|Overall Study|Advised by medical monitor|0|||
37714776|NCT02224703|69193154|FG000|Overall Study|Withdrawn by parent/guardian|0|||
37714777|NCT02224703|69193155|FG001|Overall Study|Withdrawn by parent/guardian|1|||
37714778|NCT02224703|69193156|FG002|Overall Study|Withdrawn by parent/guardian|0|||
37714779|NCT02224703|69193154|FG000|Overall Study|Lack of Efficacy|1|||
37714780|NCT02224703|69193155|FG001|Overall Study|Lack of Efficacy|0|||
37714781|NCT02224703|69193156|FG002|Overall Study|Lack of Efficacy|0|||
37714782|NCT02198963|69193165|FG000|Overall Study|Adverse Event|1|||
37714783|NCT02198963|69193165|FG000|Overall Study|Withdrawal by Subject|6|||
37714784|NCT01458106|69193189|FG000|Overall Study|Withdrawal by Subject|2|||
37714785|NCT01458106|69193190|FG001|Overall Study|Withdrawal by Subject|0|||
37714786|NCT01458106|69193189|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
37714787|NCT01458106|69193190|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
37838938|NCT02484456|69523458|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
37838939|NCT02484456|69523457|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
37714788|NCT01458106|69193189|FG000|Overall Study|Withdrawn Per Protocol|0|||
37838940|NCT02484456|69523458|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
37714789|NCT01458106|69193190|FG001|Overall Study|Withdrawn Per Protocol|1|||
37714790|NCT01457950|69193201|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
37714791|NCT01457950|69193202|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
37714792|NCT01457950|69193203|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
37714793|NCT01457950|69193204|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
37714794|NCT01457950|69193201|FG000|Double-Blind Phase|Protocol Violation|2|||
37714795|NCT01457950|69193202|FG001|Double-Blind Phase|Protocol Violation|1|||
37714796|NCT01457950|69193203|FG002|Double-Blind Phase|Protocol Violation|0|||
37714797|NCT01457950|69193204|FG003|Double-Blind Phase|Protocol Violation|0|||
37714798|NCT01457950|69193201|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
37714799|NCT01457950|69193202|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
37714800|NCT01457950|69193203|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
37714801|NCT01457950|69193204|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
37714802|NCT01457950|69193201|FG000|Open-Label Phase|Adverse Event|0|||
37714803|NCT01457950|69193202|FG001|Open-Label Phase|Adverse Event|0|||
37714804|NCT01457950|69193203|FG002|Open-Label Phase|Adverse Event|0|||
37714805|NCT01457950|69193204|FG003|Open-Label Phase|Adverse Event|1|||
37714806|NCT01457950|69193201|FG000|Open-Label Phase|Protocol Violation|0|||
37714807|NCT01457950|69193202|FG001|Open-Label Phase|Protocol Violation|0|||
37714808|NCT01457950|69193203|FG002|Open-Label Phase|Protocol Violation|0|||
37714809|NCT01457950|69193204|FG003|Open-Label Phase|Protocol Violation|1|||
37714810|NCT01457950|69193201|FG000|Open-Label Phase|Withdrawal by Subject|0|||
37714811|NCT01457950|69193202|FG001|Open-Label Phase|Withdrawal by Subject|0|||
37714812|NCT01457950|69193203|FG002|Open-Label Phase|Withdrawal by Subject|2|||
37714813|NCT01457950|69193204|FG003|Open-Label Phase|Withdrawal by Subject|0|||
37714814|NCT01499134|69193217|FG000|Overall Study|Withdrawal by Subject|0|||
37714815|NCT01499134|69193218|FG001|Overall Study|Withdrawal by Subject|1|||
37714816|NCT02198651|69193224|FG000|Lead-in Period|Withdrew consent|13|||
37714817|NCT02198651|69193225|FG001|Lead-in Period|Withdrew consent|0|||
37714818|NCT02198651|69193226|FG002|Lead-in Period|Withdrew consent|0|||
37714819|NCT02198651|69193227|FG003|Lead-in Period|Withdrew consent|0|||
37714820|NCT02198651|69193228|FG004|Lead-in Period|Withdrew consent|0|||
37714821|NCT02198651|69193224|FG000|Lead-in Period|Adverse Event|2|||
37714822|NCT02198651|69193225|FG001|Lead-in Period|Adverse Event|0|||
37714823|NCT02198651|69193226|FG002|Lead-in Period|Adverse Event|0|||
37714824|NCT02198651|69193227|FG003|Lead-in Period|Adverse Event|0|||
37714825|NCT02198651|69193228|FG004|Lead-in Period|Adverse Event|0|||
37714826|NCT02198651|69193224|FG000|Lead-in Period|Other, not specified|22|||
37714827|NCT02198651|69193225|FG001|Lead-in Period|Other, not specified|0|||
37714828|NCT02198651|69193226|FG002|Lead-in Period|Other, not specified|0|||
37714829|NCT02198651|69193227|FG003|Lead-in Period|Other, not specified|0|||
37714830|NCT02198651|69193228|FG004|Lead-in Period|Other, not specified|0|||
37714831|NCT02198651|69193224|FG000|Double-blind Period|Withdrew consent|0|||
37714832|NCT02198651|69193225|FG001|Double-blind Period|Withdrew consent|4|||
37714833|NCT02198651|69193226|FG002|Double-blind Period|Withdrew consent|0|||
37714834|NCT02198651|69193227|FG003|Double-blind Period|Withdrew consent|0|||
37714835|NCT02198651|69193228|FG004|Double-blind Period|Withdrew consent|0|||
37714836|NCT02198651|69193224|FG000|Double-blind Period|Adverse Event|0|||
37714837|NCT02198651|69193225|FG001|Double-blind Period|Adverse Event|1|||
37714838|NCT02198651|69193226|FG002|Double-blind Period|Adverse Event|0|||
37714839|NCT02198651|69193227|FG003|Double-blind Period|Adverse Event|0|||
37714840|NCT02198651|69193228|FG004|Double-blind Period|Adverse Event|0|||
37714841|NCT02198651|69193224|FG000|Double-blind Period|Other, not specified|0|||
37714842|NCT02198651|69193225|FG001|Double-blind Period|Other, not specified|4|||
37714843|NCT02198651|69193226|FG002|Double-blind Period|Other, not specified|1|||
37714844|NCT02198651|69193227|FG003|Double-blind Period|Other, not specified|0|||
37714845|NCT02198651|69193228|FG004|Double-blind Period|Other, not specified|0|||
37714846|NCT02198651|69193224|FG000|Open-label Rescue Period|Withdrew consent|0|||
37714847|NCT02198651|69193225|FG001|Open-label Rescue Period|Withdrew consent|0|||
37714848|NCT02198651|69193226|FG002|Open-label Rescue Period|Withdrew consent|0|||
37714849|NCT02198651|69193227|FG003|Open-label Rescue Period|Withdrew consent|2|||
37714850|NCT02198651|69193228|FG004|Open-label Rescue Period|Withdrew consent|0|||
37714851|NCT02198651|69193224|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
37714852|NCT02198651|69193225|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
37714853|NCT02198651|69193226|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
37714854|NCT02198651|69193227|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
37714855|NCT02198651|69193228|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
37714856|NCT01498822|69193243|FG000|Overall Study|Protocol Violation|8|||
37714857|NCT01498822|69193244|FG001|Overall Study|Protocol Violation|4|||
37714858|NCT01498822|69193243|FG000|Overall Study|Other Reason|5|||
37714859|NCT01498822|69193244|FG001|Overall Study|Other Reason|2|||
37714860|NCT01498822|69193243|FG000|Overall Study|Lack of Efficacy|7|||
37714861|NCT01498822|69193244|FG001|Overall Study|Lack of Efficacy|2|||
37714862|NCT01498822|69193243|FG000|Overall Study|AE, non-serious non-fatal|8|||
37714863|NCT01498822|69193244|FG001|Overall Study|AE, non-serious non-fatal|17|||
37714864|NCT01498822|69193243|FG000|Overall Study|SAE, non-fatal|2|||
37714865|NCT01498822|69193244|FG001|Overall Study|SAE, non-fatal|2|||
37714866|NCT01498822|69193243|FG000|Overall Study|Adverse Event, serious fatal|1|||
37714867|NCT01498822|69193244|FG001|Overall Study|Adverse Event, serious fatal|1|||
37714868|NCT01498822|69193243|FG000|Overall Study|Withdrawal by Subject|15|||
37714869|NCT01498822|69193244|FG001|Overall Study|Withdrawal by Subject|25|||
37714870|NCT01498822|69193243|FG000|Overall Study|Lost to Follow-up|8|||
37714871|NCT01498822|69193244|FG001|Overall Study|Lost to Follow-up|3|||
37714872|NCT01498120|69193252|FG000|Overall Study|Lost to Follow-up|1|||
37714873|NCT01498120|69193252|FG000|Overall Study|Withdrawal by Subject|5|||
37714874|NCT01498120|69193252|FG000|Overall Study|AE, non-serious non-fatal|3|||
37714875|NCT01498120|69193252|FG000|Overall Study|Other|4|||
37714876|NCT01497262|69193256|FG000|Overall Study|Abnormal Lab Values|4|||
37714877|NCT01497262|69193256|FG000|Overall Study|Abnormal Test Procedure Result|1|||
37714878|NCT01497262|69193256|FG000|Overall Study|Physician Decision|1|||
37714879|NCT01497262|69193256|FG000|Overall Study|Withdrawal by Subject|2|||
37714880|NCT01497262|69193256|FG000|Overall Study|Adverse Event|2|||
37714881|NCT01497262|69193256|FG000|Overall Study|Protocol Violation|1|||
37714882|NCT02224625|69193260|FG000|Irritation|Adverse Event|6|||
37714883|NCT02224625|69193260|FG000|Sensitization|Adverse Event|55|||
37714884|NCT02197247|69193272|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
37714885|NCT02197247|69193272|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
37714886|NCT02197247|69193272|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
37714887|NCT02197247|69193272|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
37714888|NCT02197247|69193272|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
37714889|NCT02197247|69193272|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
37714890|NCT02197247|69193272|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
37714891|NCT02197247|69193272|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
37714892|NCT02224157|69193284|FG000|Overall Study|Severe non-compliance to protocol|2|||
37714893|NCT02224157|69193285|FG001|Overall Study|Severe non-compliance to protocol|2|||
37714894|NCT02224157|69193284|FG000|Overall Study|Other|13|||
37714895|NCT02224157|69193285|FG001|Overall Study|Other|10|||
37714896|NCT02224157|69193284|FG000|Overall Study|Subject decision|58|||
37714897|NCT02224157|69193285|FG001|Overall Study|Subject decision|50|||
37714898|NCT02224157|69193284|FG000|Overall Study|Prematurely closed site|4|||
37714899|NCT02224157|69193285|FG001|Overall Study|Prematurely closed site|2|||
37714900|NCT02224157|69193284|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
37714901|NCT02224157|69193285|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
37714902|NCT02224157|69193284|FG000|Overall Study|Lost to Follow-up|27|||
37714903|NCT02224157|69193285|FG001|Overall Study|Lost to Follow-up|35|||
37714904|NCT02224157|69193284|FG000|Overall Study|Death|1|||
37714905|NCT02224157|69193285|FG001|Overall Study|Death|1|||
37714906|NCT02224157|69193284|FG000|Overall Study|Adverse Event|1|||
37714907|NCT02224157|69193285|FG001|Overall Study|Adverse Event|3|||
37714908|NCT02196701|69193293|FG000|Overall Study|Adverse Event|1|||
37714909|NCT02196701|69193293|FG000|Overall Study|Lost to Follow-up|1|||
37714910|NCT02196701|69193293|FG000|Overall Study|Non-adherence to Protocol|1|||
37714911|NCT01481116|69193303|FG000|Overall Study|Adverse Event|26|||
37714912|NCT01481116|69193304|FG001|Overall Study|Adverse Event|26|||
37714913|NCT01481116|69193305|FG002|Overall Study|Adverse Event|42|||
37714914|NCT01481116|69193303|FG000|Overall Study|Major Protocol Deviation|3|||
37714915|NCT01481116|69193304|FG001|Overall Study|Major Protocol Deviation|7|||
37714916|NCT01481116|69193305|FG002|Overall Study|Major Protocol Deviation|1|||
37714917|NCT01481116|69193303|FG000|Overall Study|Lost to Follow-up|8|||
37714918|NCT01481116|69193304|FG001|Overall Study|Lost to Follow-up|12|||
37714919|NCT01481116|69193305|FG002|Overall Study|Lost to Follow-up|11|||
37714920|NCT01481116|69193303|FG000|Overall Study|Withdrawal by Subject|37|||
37714921|NCT01481116|69193304|FG001|Overall Study|Withdrawal by Subject|33|||
37714922|NCT01481116|69193305|FG002|Overall Study|Withdrawal by Subject|37|||
37714923|NCT01481116|69193303|FG000|Overall Study|Study Termination|730|||
37714924|NCT01481116|69193304|FG001|Overall Study|Study Termination|729|||
37714925|NCT01481116|69193305|FG002|Overall Study|Study Termination|713|||
37714926|NCT01481116|69193303|FG000|Overall Study|Pregnancy|0|||
37714927|NCT01481116|69193304|FG001|Overall Study|Pregnancy|0|||
37714928|NCT01481116|69193305|FG002|Overall Study|Pregnancy|1|||
37714929|NCT01481116|69193303|FG000|Overall Study|Lack of Efficacy|3|||
37714930|NCT01481116|69193304|FG001|Overall Study|Lack of Efficacy|3|||
37714931|NCT01481116|69193305|FG002|Overall Study|Lack of Efficacy|1|||
37714932|NCT01481116|69193303|FG000|Overall Study|Contraindications|1|||
37714933|NCT01481116|69193304|FG001|Overall Study|Contraindications|1|||
37714934|NCT01481116|69193305|FG002|Overall Study|Contraindications|0|||
38024676|NCT03694548|69708483|FG001|Part A Survey|Protocol Violation|3|||
37714935|NCT01481116|69193303|FG000|Overall Study|Other|1|||
37714936|NCT01481116|69193304|FG001|Overall Study|Other|1|||
37714937|NCT01481116|69193305|FG002|Overall Study|Other|0|||
37714938|NCT01481116|69193303|FG000|Overall Study|Participant Started Taking Glipizide|1|||
37714939|NCT01481116|69193304|FG001|Overall Study|Participant Started Taking Glipizide|0|||
37714940|NCT01481116|69193305|FG002|Overall Study|Participant Started Taking Glipizide|0|||
37714941|NCT01481116|69193303|FG000|Overall Study|Participant Moved Out of Area|2|||
38024677|NCT03694548|69708484|FG002|Part A Survey|Protocol Violation|0|||
38024678|NCT03694548|69708482|FG000|Part B Yoga Program|Protocol Violation|0|||
37714942|NCT01481116|69193304|FG001|Overall Study|Participant Moved Out of Area|0|||
37714943|NCT01481116|69193305|FG002|Overall Study|Participant Moved Out of Area|1|||
37714944|NCT01481116|69193303|FG000|Overall Study|Participant Moved Out of Country|1|||
37714945|NCT01481116|69193304|FG001|Overall Study|Participant Moved Out of Country|0|||
37714946|NCT01481116|69193305|FG002|Overall Study|Participant Moved Out of Country|1|||
37714947|NCT01481116|69193303|FG000|Overall Study|Investigator Decision|3|||
37714948|NCT01481116|69193304|FG001|Overall Study|Investigator Decision|2|||
37714949|NCT01481116|69193305|FG002|Overall Study|Investigator Decision|1|||
37714950|NCT01481116|69193303|FG000|Overall Study|Sponsor Decision|0|||
37714951|NCT01481116|69193304|FG001|Overall Study|Sponsor Decision|1|||
37714952|NCT01481116|69193305|FG002|Overall Study|Sponsor Decision|3|||
37714953|NCT01481116|69193303|FG000|Overall Study|Non-Compliant With Study Drug|0|||
37714954|NCT01481116|69193304|FG001|Overall Study|Non-Compliant With Study Drug|1|||
37714955|NCT01481116|69193305|FG002|Overall Study|Non-Compliant With Study Drug|1|||
37714956|NCT01481116|69193303|FG000|Overall Study|Investigator's Discretion|2|||
37714957|NCT01481116|69193304|FG001|Overall Study|Investigator's Discretion|0|||
37714958|NCT01481116|69193305|FG002|Overall Study|Investigator's Discretion|0|||
37714959|NCT01481116|69193303|FG000|Overall Study|Death|2|||
37714960|NCT01481116|69193304|FG001|Overall Study|Death|1|||
37714961|NCT01481116|69193305|FG002|Overall Study|Death|0|||
37714962|NCT01481116|69193303|FG000|Overall Study|Hypoglycemic Event|4|||
37714963|NCT01481116|69193304|FG001|Overall Study|Hypoglycemic Event|0|||
37714964|NCT01481116|69193305|FG002|Overall Study|Hypoglycemic Event|0|||
37714965|NCT02222207|69193313|FG000|Overall Study|Death|1|||
37714966|NCT02222207|69193313|FG000|Overall Study|Other reasons|2|||
37838941|NCT01132807|69523465|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
37838942|NCT01132807|69523466|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
37838943|NCT01132807|69523467|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
37838944|NCT01132807|69523465|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
37838945|NCT01132807|69523466|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
37838946|NCT01132807|69523467|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
37838947|NCT01132651|69523477|FG000|Overall Study|Lost to Follow-up|1|||
37838948|NCT01132651|69523478|FG001|Overall Study|Lost to Follow-up|1|||
37838949|NCT01089543|69523488|FG000|Overall Study|Withdrawal by Subject|2|||
37838950|NCT01089543|69523489|FG001|Overall Study|Withdrawal by Subject|3|||
37838951|NCT01089543|69523490|FG002|Overall Study|Withdrawal by Subject|3|||
37838952|NCT01089543|69523491|FG003|Overall Study|Withdrawal by Subject|1|||
37838953|NCT01089543|69523488|FG000|Overall Study|Physician Decision|1|||
37838954|NCT01089543|69523489|FG001|Overall Study|Physician Decision|0|||
37838955|NCT01089543|69523490|FG002|Overall Study|Physician Decision|0|||
37838956|NCT01089543|69523491|FG003|Overall Study|Physician Decision|1|||
37838957|NCT01089543|69523488|FG000|Overall Study|Adverse Event|0|||
37838958|NCT01089543|69523489|FG001|Overall Study|Adverse Event|1|||
37838959|NCT01089543|69523490|FG002|Overall Study|Adverse Event|0|||
37838960|NCT01089543|69523491|FG003|Overall Study|Adverse Event|0|||
37838961|NCT01089504|69523503|FG000|Overall Study|Lost to Follow-up|1|||
37838962|NCT01089504|69523504|FG001|Overall Study|Lost to Follow-up|1|||
37838963|NCT01089504|69523503|FG000|Overall Study|Withdrawal by Subject|2|||
37838964|NCT01089504|69523504|FG001|Overall Study|Withdrawal by Subject|0|||
37838965|NCT01088997|69523512|FG000|Overall Study|Physician Decision|1|||
37838966|NCT01088997|69523513|FG001|Overall Study|Physician Decision|1|||
37838967|NCT01088997|69523512|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
37838968|NCT01088997|69523513|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
37838969|NCT01088997|69523512|FG000|Overall Study|Excluded prior to receiving drug|1|||
37838970|NCT01088997|69523513|FG001|Overall Study|Excluded prior to receiving drug|1|||
37838971|NCT01088529|69523524|FG000|Overall Study|Did not receive study treatment|0|||
37838972|NCT01088529|69523525|FG001|Overall Study|Did not receive study treatment|1|||
37838973|NCT01087944|69523531|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
37838974|NCT01087944|69523532|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
37838975|NCT01087944|69523531|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
37838976|NCT01087944|69523532|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
37838977|NCT01132612|69523541|FG000|Overall Study|Death|0|||
37838978|NCT01132612|69523542|FG001|Overall Study|Death|0|||
37838979|NCT01132612|69523543|FG002|Overall Study|Death|1|||
37838980|NCT01132612|69523541|FG000|Overall Study|Protocol deviation|0|||
37838981|NCT01132612|69523542|FG001|Overall Study|Protocol deviation|0|||
37915443|NCT00882908|69602209|FG003|Overall Study|Study terminated in error|1|||
37915444|NCT00882908|69602210|FG004|Overall Study|Study terminated in error|0|||
37915445|NCT00851799|69602226|FG000|Overall Study|Death|1|||
37714967|NCT02222207|69193313|FG000|Overall Study|Adverse Event|1|||
37714968|NCT01457014|69193317|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
37714969|NCT01457014|69193318|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
37714970|NCT01457014|69193319|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
37714971|NCT01457014|69193320|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
37838982|NCT01132612|69523543|FG002|Overall Study|Protocol deviation|3|||
37838983|NCT01132612|69523541|FG000|Overall Study|Lost to Follow-up|2|||
37838984|NCT01132612|69523542|FG001|Overall Study|Lost to Follow-up|2|||
37838985|NCT01132612|69523543|FG002|Overall Study|Lost to Follow-up|7|||
37915446|NCT00851799|69602227|FG001|Overall Study|Death|0|||
37838986|NCT01132612|69523541|FG000|Overall Study|Adverse Event|5|||
37838987|NCT01132612|69523542|FG001|Overall Study|Adverse Event|2|||
37838988|NCT01132612|69523543|FG002|Overall Study|Adverse Event|15|||
37838989|NCT01132612|69523541|FG000|Overall Study|Withdrawal by Subject|5|||
37838990|NCT01132612|69523542|FG001|Overall Study|Withdrawal by Subject|8|||
37838991|NCT01132612|69523543|FG002|Overall Study|Withdrawal by Subject|19|||
37838992|NCT01132612|69523541|FG000|Overall Study|Administrative problems|5|||
37838993|NCT01132612|69523542|FG001|Overall Study|Administrative problems|1|||
37838994|NCT01132612|69523543|FG002|Overall Study|Administrative problems|52|||
38024679|NCT03694548|69708483|FG001|Part B Yoga Program|Protocol Violation|0|||
37838995|NCT01132612|69523541|FG000|Overall Study|Lack of Efficacy|23|||
38024680|NCT03694548|69708484|FG002|Part B Yoga Program|Protocol Violation|3|||
37714972|NCT01457014|69193317|FG000|First Night|Withdrawal by Subject|3|||
37714973|NCT01457014|69193318|FG001|First Night|Withdrawal by Subject|0|||
37714974|NCT01457014|69193319|FG002|First Night|Withdrawal by Subject|0|||
37714975|NCT01457014|69193320|FG003|First Night|Withdrawal by Subject|0|||
37714976|NCT02254421|69193330|FG000|Overall Study|Randomized but Not Treated|1|||
37714977|NCT02254421|69193331|FG001|Overall Study|Randomized but Not Treated|0|||
37714978|NCT02254421|69193330|FG000|Overall Study|Death|0|||
37714979|NCT02254421|69193331|FG001|Overall Study|Death|2|||
37714980|NCT02254421|69193330|FG000|Overall Study|Withdrew Consent|1|||
37714981|NCT02254421|69193331|FG001|Overall Study|Withdrew Consent|1|||
37714982|NCT02252939|69193337|FG000|Overall Study|Lost to Follow-up|3|||
37714983|NCT02196077|69193346|FG000|Overall Study|Adverse Event|4|||
37714984|NCT02196077|69193346|FG000|Overall Study|Lack of Efficacy|1|||
37714985|NCT02196077|69193346|FG000|Overall Study|Withdrawal by Subject|14|||
38024681|NCT03694548|69708482|FG000|Part B Yoga Program|Did not attend intervention|0|||
38024682|NCT03694548|69708483|FG001|Part B Yoga Program|Did not attend intervention|0|||
38024683|NCT03694548|69708484|FG002|Part B Yoga Program|Did not attend intervention|8|||
38024684|NCT04166630|69708496|FG000|Overall Study|Withdrawal by Subject|0|||
38024685|NCT04166630|69708497|FG001|Overall Study|Withdrawal by Subject|1|||
38024686|NCT04164758|69708506|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
38024687|NCT04164758|69708507|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
38024688|NCT04164758|69708508|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
38024689|NCT04164758|69708506|FG000|Overall Study|Adverse Event|0|||
37714986|NCT02196077|69193346|FG000|Overall Study|Physician Decision|1|||
37714987|NCT02196077|69193346|FG000|Overall Study|Lost to Follow-up|3|||
37714988|NCT02196077|69193346|FG000|Overall Study|Protocol Violation|24|||
37714989|NCT02195687|69193360|FG000|Overall Study|Personal Reasons|1|||
37714990|NCT02195687|69193361|FG001|Overall Study|Personal Reasons|1|||
37714991|NCT02195687|69193360|FG000|Overall Study|Lost to Follow-up|4|||
37714992|NCT02195687|69193361|FG001|Overall Study|Lost to Follow-up|1|||
37714993|NCT02195531|69193370|FG000|Overall Study|Withdrawal by Subject|1|||
37714994|NCT02195531|69193371|FG001|Overall Study|Withdrawal by Subject|1|||
37714995|NCT02195531|69193372|FG002|Overall Study|Withdrawal by Subject|1|||
37714996|NCT02252081|69193382|FG000|Overall Study|Withdrawal by Subject|2|||
37714997|NCT02252081|69193383|FG001|Overall Study|Withdrawal by Subject|1|||
37714998|NCT02252081|69193382|FG000|Overall Study|Adverse Event|4|||
37714999|NCT02252081|69193383|FG001|Overall Study|Adverse Event|1|||
38024690|NCT04164758|69708507|FG001|Overall Study|Adverse Event|1|||
38024691|NCT04164758|69708508|FG002|Overall Study|Adverse Event|0|||
37715000|NCT02252081|69193382|FG000|Overall Study|non compliance & others|0|||
37715001|NCT02252081|69193383|FG001|Overall Study|non compliance & others|2|||
37715002|NCT01623752|69193397|FG000|Phase 1 (78 Weeks)|No Data|249|||
37715003|NCT01623752|69193398|FG001|Phase 1 (78 Weeks)|No Data|66|||
37715004|NCT01623752|69193399|FG002|Phase 1 (78 Weeks)|No Data|2|||
37715005|NCT01623752|69193397|FG000|Phase 1 (78 Weeks)|Other|33|||
37715006|NCT01623752|69193398|FG001|Phase 1 (78 Weeks)|Other|20|||
37715007|NCT01623752|69193399|FG002|Phase 1 (78 Weeks)|Other|0|||
37715008|NCT01623752|69193397|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
38024692|NCT04178720|69708518|FG000|Overall Study|Withdrawal by Subject|2|||
38024693|NCT04178720|69708519|FG001|Overall Study|Withdrawal by Subject|0|||
38024694|NCT04178720|69708518|FG000|Overall Study|Relocation|0|||
37715009|NCT01623752|69193398|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
37715010|NCT01623752|69193399|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
37838996|NCT01132612|69523542|FG001|Overall Study|Lack of Efficacy|22|||
37838997|NCT01132612|69523543|FG002|Overall Study|Lack of Efficacy|73|||
37838998|NCT01132495|69523555|FG000|Overall Study|Various reasons|40|||
37838999|NCT01132495|69523556|FG001|Overall Study|Various reasons|38|||
38024695|NCT04178720|69708519|FG001|Overall Study|Relocation|1|||
38024696|NCT04177862|69708530|FG000|Overall Study|Protocol Violation|2|||
37715011|NCT01623752|69193397|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
37715012|NCT01623752|69193398|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
37715013|NCT01623752|69193399|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
37839000|NCT01132495|69523557|FG002|Overall Study|Various reasons|20|||
37839001|NCT01132495|69523558|FG003|Overall Study|Various reasons|12|||
37715014|NCT01623752|69193397|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
37715015|NCT01623752|69193398|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
37839002|NCT01087905|69523577|FG000|Overall Study|Lost to Follow-up|24|||
37715016|NCT01623752|69193399|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
37715017|NCT01623752|69193397|FG000|Phase 2 (78 Weeks)|Other|5|||
37715018|NCT01623752|69193398|FG001|Phase 2 (78 Weeks)|Other|1|||
37715019|NCT01623752|69193399|FG002|Phase 2 (78 Weeks)|Other|0|||
37715020|NCT01623752|69193397|FG000|Phase 2 (78 Weeks)|No Data|43|||
37715021|NCT01623752|69193398|FG001|Phase 2 (78 Weeks)|No Data|11|||
37715022|NCT01623752|69193399|FG002|Phase 2 (78 Weeks)|No Data|0|||
37715023|NCT01623752|69193397|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
37715024|NCT01623752|69193398|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
37715025|NCT01623752|69193399|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
37715026|NCT01623596|69193410|FG000|Overall Study|Abnormal laboratory values|2|||
37715027|NCT01623596|69193411|FG001|Overall Study|Abnormal laboratory values|0|||
37715028|NCT01623596|69193410|FG000|Overall Study|Administrative problems|9|||
37715029|NCT01623596|69193411|FG001|Overall Study|Administrative problems|13|||
37715030|NCT01623596|69193410|FG000|Overall Study|Adverse Event|20|||
37715031|NCT01623596|69193411|FG001|Overall Study|Adverse Event|29|||
37715032|NCT01623596|69193410|FG000|Overall Study|Death|0|||
37715033|NCT01623596|69193411|FG001|Overall Study|Death|2|||
37715034|NCT01623596|69193410|FG000|Overall Study|Lost to Follow-up|12|||
37715035|NCT01623596|69193411|FG001|Overall Study|Lost to Follow-up|16|||
37715036|NCT01623596|69193410|FG000|Overall Study|Withdrawal by Subject|13|||
37715037|NCT01623596|69193411|FG001|Overall Study|Withdrawal by Subject|31|||
37715038|NCT01623596|69193410|FG000|Overall Study|Patient no longer requires study drug|1|||
37715039|NCT01623596|69193411|FG001|Overall Study|Patient no longer requires study drug|0|||
37715040|NCT01623596|69193410|FG000|Overall Study|Protocol Violation|0|||
37715041|NCT01623596|69193411|FG001|Overall Study|Protocol Violation|6|||
37715042|NCT01623596|69193410|FG000|Overall Study|Lack of Efficacy|5|||
37715043|NCT01623596|69193411|FG001|Overall Study|Lack of Efficacy|3|||
37715044|NCT02219477|69193422|FG000|Overall Study|Adverse Event|0|||
37715045|NCT02219477|69193423|FG001|Overall Study|Adverse Event|1|||
37715046|NCT02219477|69193424|FG002|Overall Study|Adverse Event|1|||
37715047|NCT02219477|69193422|FG000|Overall Study|Withdrawal by Subject|0|||
37715048|NCT02219477|69193423|FG001|Overall Study|Withdrawal by Subject|1|||
37715049|NCT02219477|69193424|FG002|Overall Study|Withdrawal by Subject|0|||
37715050|NCT02119286|69193436|FG000|Overall Study|Adverse Event|9|||
37715051|NCT02119286|69193437|FG001|Overall Study|Adverse Event|7|||
37715052|NCT02119286|69193438|FG002|Overall Study|Adverse Event|2|||
37715053|NCT02119286|69193436|FG000|Overall Study|Lack of Efficacy|11|||
37715054|NCT02119286|69193437|FG001|Overall Study|Lack of Efficacy|3|||
37715055|NCT02119286|69193438|FG002|Overall Study|Lack of Efficacy|4|||
37715056|NCT02119286|69193436|FG000|Overall Study|Lost to Follow-up|2|||
37715057|NCT02119286|69193437|FG001|Overall Study|Lost to Follow-up|0|||
37715058|NCT02119286|69193438|FG002|Overall Study|Lost to Follow-up|1|||
37715059|NCT02119286|69193436|FG000|Overall Study|Withdrawal by Subject|4|||
37715060|NCT02119286|69193437|FG001|Overall Study|Withdrawal by Subject|1|||
37715061|NCT02119286|69193438|FG002|Overall Study|Withdrawal by Subject|0|||
37715062|NCT02250443|69193446|FG000|Overall Study|Administrative problems|7|||
37715063|NCT02250443|69193446|FG000|Overall Study|Adverse Event|3|||
37715064|NCT02093390|69193452|FG000|Overall Study|Withdrawal by Subject|0|||
37715065|NCT02093390|69193453|FG001|Overall Study|Withdrawal by Subject|1|||
37715066|NCT02194985|69193460|FG000|Overall Study|Adverse Event|1|||
37715067|NCT02194985|69193460|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
37715068|NCT02194985|69193460|FG000|Overall Study|Physician Decision|4|||
37715069|NCT02194985|69193460|FG000|Overall Study|Lost to Follow-up|1|||
37715070|NCT02194985|69193460|FG000|Overall Study|Withdrawal by Subject|2|||
37715071|NCT02219087|69193466|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
37715072|NCT02219087|69193467|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
37715073|NCT02248961|69193475|FG000|Overall Study|Adverse Event|1|||
37715074|NCT02248961|69193476|FG001|Overall Study|Adverse Event|0|||
37715075|NCT02248961|69193475|FG000|Overall Study|Withdrawal by Subject|1|||
37715076|NCT02248961|69193476|FG001|Overall Study|Withdrawal by Subject|2|||
37715077|NCT02248961|69193475|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
37715078|NCT02248961|69193476|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
37715079|NCT02219009|69193484|FG000|Overall Study|Withdrawal by Subject|5|||
37715080|NCT02219009|69193485|FG001|Overall Study|Withdrawal by Subject|1|||
37715081|NCT02219009|69193484|FG000|Overall Study|Adverse Event|2|||
37839003|NCT01087905|69523578|FG001|Overall Study|Lost to Follow-up|28|||
37839004|NCT01087905|69523579|FG002|Overall Study|Lost to Follow-up|18|||
37715082|NCT02219009|69193485|FG001|Overall Study|Adverse Event|4|||
37715083|NCT02219009|69193484|FG000|Overall Study|Lost to Follow-up|2|||
37839005|NCT01087905|69523580|FG003|Overall Study|Lost to Follow-up|31|||
37715084|NCT02219009|69193485|FG001|Overall Study|Lost to Follow-up|2|||
37715085|NCT02219009|69193484|FG000|Overall Study|Protocol deviation|1|||
37715086|NCT02219009|69193485|FG001|Overall Study|Protocol deviation|0|||
37715087|NCT02219009|69193484|FG000|Overall Study|Physician Decision|0|||
37839006|NCT01087905|69523581|FG004|Overall Study|Lost to Follow-up|27|||
37715088|NCT02219009|69193485|FG001|Overall Study|Physician Decision|1|||
37715089|NCT02248649|69193493|FG000|Overall Study|Death|7|||
37715090|NCT02248649|69193494|FG001|Overall Study|Death|11|||
37715091|NCT02248649|69193493|FG000|Overall Study|Lost to Follow-up|14|||
37715092|NCT02248649|69193494|FG001|Overall Study|Lost to Follow-up|10|||
37715093|NCT02218541|69193502|FG000|Overall Study|Lost to Follow-up|2|||
37715094|NCT02218541|69193503|FG001|Overall Study|Lost to Follow-up|1|||
37715095|NCT02218541|69193502|FG000|Overall Study|Implant Failure|4|||
37715096|NCT02218541|69193503|FG001|Overall Study|Implant Failure|1|||
37715097|NCT02217527|69193512|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
37715098|NCT02217527|69193513|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
37715099|NCT02217527|69193512|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
37715100|NCT02217527|69193513|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
37715101|NCT01456936|69193523|FG000|Overall Study|Other reason|41|||
37715102|NCT01456936|69193524|FG001|Overall Study|Other reason|30|||
37715103|NCT01456936|69193525|FG002|Overall Study|Other reason|36|||
37715104|NCT01456936|69193526|FG003|Overall Study|Other reason|33|||
37715105|NCT01456936|69193523|FG000|Overall Study|No longer meets eligibility criteria|4|||
37715106|NCT01456936|69193524|FG001|Overall Study|No longer meets eligibility criteria|8|||
37715107|NCT01456936|69193525|FG002|Overall Study|No longer meets eligibility criteria|6|||
37715108|NCT01456936|69193526|FG003|Overall Study|No longer meets eligibility criteria|5|||
37839007|NCT01087905|69523582|FG005|Overall Study|Lost to Follow-up|25|||
37839008|NCT01087905|69523583|FG006|Overall Study|Lost to Follow-up|20|||
37839009|NCT01087905|69523584|FG007|Overall Study|Lost to Follow-up|24|||
37839010|NCT01087905|69523577|FG000|Overall Study|Withdrawal by Subject|5|||
37839011|NCT01087905|69523578|FG001|Overall Study|Withdrawal by Subject|4|||
37839012|NCT01087905|69523579|FG002|Overall Study|Withdrawal by Subject|4|||
37839013|NCT01087905|69523580|FG003|Overall Study|Withdrawal by Subject|5|||
37839014|NCT01087905|69523581|FG004|Overall Study|Withdrawal by Subject|4|||
37839015|NCT01087905|69523582|FG005|Overall Study|Withdrawal by Subject|3|||
37839016|NCT01087905|69523583|FG006|Overall Study|Withdrawal by Subject|3|||
37839017|NCT01087905|69523584|FG007|Overall Study|Withdrawal by Subject|5|||
37839018|NCT01087788|69523603|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
37839019|NCT01087788|69523604|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
37839020|NCT01087788|69523605|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
37839021|NCT01087788|69523603|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
37839022|NCT01087788|69523604|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
37839023|NCT01087788|69523605|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
37839024|NCT01087788|69523603|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
37839025|NCT01087788|69523604|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
37839026|NCT01087788|69523605|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
37839027|NCT01087788|69523603|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
37839028|NCT01087788|69523604|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
37839029|NCT01087788|69523605|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
37839030|NCT01087788|69523603|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
37839031|NCT01087788|69523604|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
37839032|NCT01087788|69523605|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
37839033|NCT01087788|69523603|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
37839034|NCT01087788|69523604|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
37839035|NCT01087788|69523605|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
37839036|NCT01087788|69523603|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
37915447|NCT00851799|69602228|FG002|Overall Study|Death|1|||
37715109|NCT01456936|69193523|FG000|Overall Study|Protocol Violation|4|||
37715110|NCT01456936|69193524|FG001|Overall Study|Protocol Violation|2|||
37715111|NCT01456936|69193525|FG002|Overall Study|Protocol Violation|5|||
37839037|NCT01087788|69523604|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
37839038|NCT01087788|69523605|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
37839039|NCT01087788|69523603|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
37839040|NCT01087788|69523604|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
37839041|NCT01087788|69523605|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
37839042|NCT01087788|69523603|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
37839043|NCT01087788|69523604|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
37839044|NCT01087788|69523605|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
37839045|NCT01087788|69523603|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
37839046|NCT01087788|69523604|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
37839047|NCT01087788|69523605|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
37839048|NCT01087788|69523603|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
37715112|NCT01456936|69193526|FG003|Overall Study|Protocol Violation|5|||
37715113|NCT01456936|69193523|FG000|Overall Study|Pregnancy|1|||
37715114|NCT01456936|69193524|FG001|Overall Study|Pregnancy|0|||
37715115|NCT01456936|69193525|FG002|Overall Study|Pregnancy|0|||
37915448|NCT00851799|69602226|FG000|Overall Study|Lost to Follow-up|5|||
37915449|NCT00851799|69602227|FG001|Overall Study|Lost to Follow-up|3|||
37715116|NCT01456936|69193526|FG003|Overall Study|Pregnancy|1|||
37715117|NCT01456936|69193523|FG000|Overall Study|Insufficient clinical response|4|||
37715118|NCT01456936|69193524|FG001|Overall Study|Insufficient clinical response|4|||
37715119|NCT01456936|69193525|FG002|Overall Study|Insufficient clinical response|14|||
37715120|NCT01456936|69193526|FG003|Overall Study|Insufficient clinical response|13|||
37715121|NCT01456936|69193523|FG000|Overall Study|No longer willing to participate|195|||
37715122|NCT01456936|69193524|FG001|Overall Study|No longer willing to participate|218|||
37715123|NCT01456936|69193525|FG002|Overall Study|No longer willing to participate|224|||
37715124|NCT01456936|69193526|FG003|Overall Study|No longer willing to participate|248|||
37715125|NCT01456936|69193523|FG000|Overall Study|Lost to Follow-up|135|||
37715126|NCT01456936|69193524|FG001|Overall Study|Lost to Follow-up|126|||
37715127|NCT01456936|69193525|FG002|Overall Study|Lost to Follow-up|144|||
37715128|NCT01456936|69193526|FG003|Overall Study|Lost to Follow-up|127|||
37715129|NCT01456936|69193523|FG000|Overall Study|Medication error|0|||
37715130|NCT01456936|69193524|FG001|Overall Study|Medication error|1|||
37715131|NCT01456936|69193525|FG002|Overall Study|Medication error|0|||
37715132|NCT01456936|69193526|FG003|Overall Study|Medication error|1|||
37715133|NCT01456936|69193523|FG000|Overall Study|Adverse event (study drug)|25|||
37715134|NCT01456936|69193524|FG001|Overall Study|Adverse event (study drug)|21|||
37715135|NCT01456936|69193525|FG002|Overall Study|Adverse event (study drug)|26|||
37715136|NCT01456936|69193526|FG003|Overall Study|Adverse event (study drug)|17|||
37715137|NCT01456936|69193523|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
37715138|NCT01456936|69193524|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
37715139|NCT01456936|69193525|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
37715140|NCT01456936|69193526|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
37715141|NCT01456936|69193523|FG000|Overall Study|Death|0|||
37715142|NCT01456936|69193524|FG001|Overall Study|Death|3|||
37715143|NCT01456936|69193525|FG002|Overall Study|Death|1|||
37715144|NCT01456936|69193526|FG003|Overall Study|Death|3|||
37715145|NCT01456936|69193523|FG000|Overall Study|Randomized but not treated|21|||
37715146|NCT01456936|69193524|FG001|Overall Study|Randomized but not treated|28|||
37715147|NCT01456936|69193525|FG002|Overall Study|Randomized but not treated|16|||
37715148|NCT01456936|69193526|FG003|Overall Study|Randomized but not treated|21|||
37715149|NCT01456780|69193539|FG000|Overall Study|Lost to Follow-up|3|||
37715150|NCT01456780|69193540|FG001|Overall Study|Lost to Follow-up|3|||
37715151|NCT01456780|69193541|FG002|Overall Study|Lost to Follow-up|0|||
37715152|NCT01480258|69193551|FG000|Infant Series|Protocol Violation|2|||
37715153|NCT01480258|69193552|FG001|Infant Series|Protocol Violation|0|||
37715154|NCT01480258|69193551|FG000|Infant Series|Physician Decision|0|||
37715155|NCT01480258|69193552|FG001|Infant Series|Physician Decision|1|||
37715156|NCT01480258|69193551|FG000|Infant Series|Not Vaccinated|3|||
37715157|NCT01480258|69193552|FG001|Infant Series|Not Vaccinated|0|||
37715158|NCT01480258|69193551|FG000|Infant Series|Adverse Event|1|||
37715159|NCT01480258|69193552|FG001|Infant Series|Adverse Event|1|||
37715160|NCT01480258|69193551|FG000|Infant Series|Withdrawal by Subject|1|||
37715161|NCT01480258|69193552|FG001|Infant Series|Withdrawal by Subject|6|||
37715162|NCT01480258|69193551|FG000|Interim Period|Lost to Follow-up|0|||
37715163|NCT01480258|69193552|FG001|Interim Period|Lost to Follow-up|2|||
37715164|NCT01480258|69193551|FG000|Interim Period|Physician Decision|1|||
37715165|NCT01480258|69193552|FG001|Interim Period|Physician Decision|0|||
37715166|NCT01480258|69193551|FG000|Interim Period|Protocol Violation|0|||
37715167|NCT01480258|69193552|FG001|Interim Period|Protocol Violation|1|||
37715168|NCT01480258|69193551|FG000|Interim Period|Withdrawal by Subject|9|||
37715169|NCT01480258|69193552|FG001|Interim Period|Withdrawal by Subject|6|||
37715170|NCT01479868|69193558|FG000|Overall Study|Adverse Event|1|||
37915450|NCT00851799|69602228|FG002|Overall Study|Lost to Follow-up|10|||
37915451|NCT00851799|69602226|FG000|Overall Study|Not able to get to clinic|8|||
37915452|NCT00851799|69602227|FG001|Overall Study|Not able to get to clinic|5|||
37915453|NCT00851799|69602228|FG002|Overall Study|Not able to get to clinic|9|||
37915454|NCT00851799|69602226|FG000|Overall Study|Not willing to adhere to requirements|1|||
37915455|NCT00851799|69602227|FG001|Overall Study|Not willing to adhere to requirements|2|||
37915456|NCT00851799|69602228|FG002|Overall Study|Not willing to adhere to requirements|2|||
37715171|NCT01479868|69193558|FG000|Overall Study|Lost to Follow-up|4|||
37715172|NCT01479868|69193558|FG000|Overall Study|Protocol Violation|1|||
37715173|NCT01479868|69193558|FG000|Overall Study|Withdrawal by Subject|1|||
37715174|NCT01479868|69193558|FG000|Overall Study|Sponsor's Decision|1|||
37715175|NCT01479868|69193558|FG000|Overall Study|Initiation of new HCV Therapy|1|||
37715176|NCT01478620|69193562|FG000|Overall Study|Lost to Follow-up|6|||
37715177|NCT01455220|69193566|FG000|Overall Study|screen fail|30|||
37715178|NCT01454830|69193575|FG000|Overall Study|Withdrawal by Subject|4|||
37715179|NCT01454830|69193576|FG001|Overall Study|Withdrawal by Subject|4|||
37715180|NCT01454830|69193575|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
37915457|NCT00851799|69602226|FG000|Overall Study|Withdrew consent prior study completion|1|||
38024697|NCT04177862|69708531|FG001|Overall Study|Protocol Violation|7|||
37715181|NCT01454830|69193576|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
37715182|NCT01454830|69193575|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
37715183|NCT01454830|69193576|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
37715184|NCT01454830|69193575|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
37715185|NCT01454830|69193576|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
37715186|NCT01454830|69193575|FG000|Overall Study|Withdrawal - no polysomnography|3|||
37715187|NCT01454830|69193576|FG001|Overall Study|Withdrawal - no polysomnography|2|||
37715188|NCT01454596|69193594|FG000|Overall Study|Death|0|||
37715189|NCT01454596|69193595|FG001|Overall Study|Death|0|||
37715190|NCT01454596|69193596|FG002|Overall Study|Death|0|||
37715191|NCT01454596|69193597|FG003|Overall Study|Death|0|||
37715192|NCT01454596|69193598|FG004|Overall Study|Death|0|||
37715193|NCT01454596|69193599|FG005|Overall Study|Death|0|||
37715194|NCT01454596|69193600|FG006|Overall Study|Death|0|||
37715195|NCT01454596|69193601|FG007|Overall Study|Death|0|||
37715196|NCT01454596|69193602|FG008|Overall Study|Death|0|||
37715197|NCT01454596|69193603|FG009|Overall Study|Death|1|||
37715198|NCT01454596|69193604|FG010|Overall Study|Death|1|||
37715199|NCT01454596|69193605|FG011|Overall Study|Death|0|||
37715200|NCT02247479|69193634|FG000|Overall Study|Adverse Event|8|||
37715201|NCT02247479|69193635|FG001|Overall Study|Adverse Event|9|||
37715202|NCT02247479|69193636|FG002|Overall Study|Adverse Event|8|||
37715203|NCT02247479|69193634|FG000|Overall Study|Death|5|||
37715204|NCT02247479|69193635|FG001|Overall Study|Death|4|||
37715205|NCT02247479|69193636|FG002|Overall Study|Death|6|||
37715206|NCT02247479|69193634|FG000|Overall Study|Lost to Follow-up|3|||
37715207|NCT02247479|69193635|FG001|Overall Study|Lost to Follow-up|3|||
37715208|NCT02247479|69193636|FG002|Overall Study|Lost to Follow-up|1|||
37715209|NCT02247479|69193634|FG000|Overall Study|Non-compliance|0|||
37715210|NCT02247479|69193635|FG001|Overall Study|Non-compliance|0|||
37715211|NCT02247479|69193636|FG002|Overall Study|Non-compliance|1|||
37715212|NCT02247479|69193634|FG000|Overall Study|Withdrawal by Subject|25|||
37715213|NCT02247479|69193635|FG001|Overall Study|Withdrawal by Subject|29|||
37715214|NCT02247479|69193636|FG002|Overall Study|Withdrawal by Subject|24|||
37715215|NCT02247479|69193634|FG000|Overall Study|Study Terminated by Sponsor|98|||
37715216|NCT02247479|69193635|FG001|Overall Study|Study Terminated by Sponsor|88|||
37715217|NCT02247479|69193636|FG002|Overall Study|Study Terminated by Sponsor|94|||
37715218|NCT02247479|69193634|FG000|Overall Study|Physician Decision|1|||
37715219|NCT02247479|69193635|FG001|Overall Study|Physician Decision|0|||
37715220|NCT02247479|69193636|FG002|Overall Study|Physician Decision|2|||
37715221|NCT02247479|69193634|FG000|Overall Study|Unspecified Reason|2|||
37715222|NCT02247479|69193635|FG001|Overall Study|Unspecified Reason|5|||
38024698|NCT04173572|69708540|FG000|Overall Study|Withdrawal by Subject|1|||
38024699|NCT04173572|69708541|FG001|Overall Study|Withdrawal by Subject|5|||
38024700|NCT04173572|69708540|FG000|Overall Study|Lost to Follow-up|3|||
38024701|NCT04173572|69708541|FG001|Overall Study|Lost to Follow-up|1|||
38024702|NCT04157738|69708549|FG000|Overall Study|Moved out of state|0|||
38024703|NCT04157738|69708550|FG001|Overall Study|Moved out of state|2|||
38024704|NCT04157738|69708549|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
38024705|NCT04157738|69708550|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
38024706|NCT04156646|69708558|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
38024707|NCT04156646|69708559|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
38024708|NCT04676412|69708570|FG000|Overall Study|Death|17|||
38024709|NCT04676412|69708571|FG001|Overall Study|Death|23|||
38024710|NCT04676412|69708570|FG000|Overall Study|Withdrawal by Subject|0|||
38024711|NCT04676412|69708571|FG001|Overall Study|Withdrawal by Subject|2|||
38024712|NCT04676412|69708570|FG000|Overall Study|Participants ongoing|32|||
38024713|NCT04676412|69708571|FG001|Overall Study|Participants ongoing|33|||
38024714|NCT04150250|69708579|FG000|Overall Study|Lost to Follow-up|0|||
37715223|NCT02247479|69193636|FG002|Overall Study|Unspecified Reason|2|||
37715224|NCT01454284|69193646|FG000|Overall Study|Adverse Event|20|||
37715225|NCT01454284|69193647|FG001|Overall Study|Adverse Event|7|||
37715226|NCT01454284|69193646|FG000|Overall Study|Death|0|||
37715227|NCT01454284|69193647|FG001|Overall Study|Death|3|||
37715228|NCT01454284|69193646|FG000|Overall Study|Lost to Follow-up|13|||
38024715|NCT04150250|69708580|FG001|Overall Study|Lost to Follow-up|2|||
37715229|NCT01454284|69193647|FG001|Overall Study|Lost to Follow-up|8|||
37715230|NCT01454284|69193646|FG000|Overall Study|Protocol Violation|9|||
37715231|NCT01454284|69193647|FG001|Overall Study|Protocol Violation|6|||
37715232|NCT01454284|69193646|FG000|Overall Study|Withdrawal by Subject|58|||
37715233|NCT01454284|69193647|FG001|Overall Study|Withdrawal by Subject|36|||
37715234|NCT01454284|69193646|FG000|Overall Study|Physician Decision|16|||
37715235|NCT01454284|69193647|FG001|Overall Study|Physician Decision|11|||
37715236|NCT01454284|69193646|FG000|Overall Study|Sponsor Decision|0|||
37715237|NCT01454284|69193647|FG001|Overall Study|Sponsor Decision|2|||
37715238|NCT02247401|69193656|FG000|Overall Study|Adverse Event|1|||
37715239|NCT02247401|69193657|FG001|Overall Study|Adverse Event|0|||
37715240|NCT02247401|69193658|FG002|Overall Study|Adverse Event|0|||
38024716|NCT04537806|69708588|FG000|Overall Study|Randomized but not treated|1|||
37715241|NCT02247401|69193656|FG000|Overall Study|Withdrawal by Subject|4|||
38024717|NCT04537806|69708589|FG001|Overall Study|Randomized but not treated|0|||
37715242|NCT02247401|69193657|FG001|Overall Study|Withdrawal by Subject|1|||
37715243|NCT02247401|69193658|FG002|Overall Study|Withdrawal by Subject|1|||
37715244|NCT02247401|69193656|FG000|Overall Study|Lost to Follow-up|1|||
37715245|NCT02247401|69193657|FG001|Overall Study|Lost to Follow-up|1|||
37715246|NCT02247401|69193658|FG002|Overall Study|Lost to Follow-up|1|||
37715247|NCT02247011|69193669|FG000|Overall Study|Poor quality of radiological results|125|||
37715248|NCT02246777|69193676|FG000|Overall Study|Adverse Event|2|||
37715249|NCT02246777|69193676|FG000|Overall Study|Change of residence|1|||
37715250|NCT01495702|69193687|FG000|Randomized Phase|Randomized But Not Treated|1|||
37715251|NCT01495702|69193688|FG001|Randomized Phase|Randomized But Not Treated|4|||
37715252|NCT01495702|69193687|FG000|Randomized Phase|Adverse Event|2|||
37715253|NCT01495702|69193688|FG001|Randomized Phase|Adverse Event|2|||
37715254|NCT01495702|69193687|FG000|Randomized Phase|Death|1|||
37715255|NCT01495702|69193688|FG001|Randomized Phase|Death|0|||
37715256|NCT01495702|69193687|FG000|Randomized Phase|Lack of Efficacy|2|||
37715257|NCT01495702|69193688|FG001|Randomized Phase|Lack of Efficacy|0|||
37715258|NCT01495702|69193687|FG000|Randomized Phase|Investigators Discretion|2|||
37715259|NCT01495702|69193688|FG001|Randomized Phase|Investigators Discretion|0|||
37715260|NCT01495702|69193687|FG000|Randomized Phase|Withdrew Consent|10|||
37715261|NCT01495702|69193688|FG001|Randomized Phase|Withdrew Consent|18|||
37715262|NCT01495702|69193687|FG000|Randomized Phase|Lost to Follow-up|4|||
37715263|NCT01495702|69193688|FG001|Randomized Phase|Lost to Follow-up|3|||
37715264|NCT01495702|69193687|FG000|Randomized Phase|Participant Noncompliance|1|||
37715265|NCT01495702|69193688|FG001|Randomized Phase|Participant Noncompliance|0|||
37715266|NCT01495702|69193687|FG000|Randomized Phase|Protocol Violation|3|||
37715267|NCT01495702|69193688|FG001|Randomized Phase|Protocol Violation|1|||
37715268|NCT01630889|69193695|FG000|Overall Study|Death|2|||
37715269|NCT01630889|69193695|FG000|Overall Study|Withdrawal by Subject|1|||
37715270|NCT01630889|69193695|FG000|Overall Study|Other than Specified|2|||
37715271|NCT01630889|69193695|FG000|Overall Study|Lost to Follow-up|4|||
37715272|NCT01630889|69193695|FG000|Overall Study|Other|1|||
37715273|NCT01495000|69193701|FG000|Overall Study|Lost to Follow-up|2|||
37715274|NCT01495000|69193702|FG001|Overall Study|Lost to Follow-up|2|||
37715275|NCT01495000|69193701|FG000|Overall Study|Protocol Violation|1|||
37715276|NCT01495000|69193702|FG001|Overall Study|Protocol Violation|0|||
37715277|NCT01495000|69193701|FG000|Overall Study|Withdrawal by Subject|10|||
37715278|NCT01495000|69193702|FG001|Overall Study|Withdrawal by Subject|10|||
37715279|NCT01494922|69193708|FG000|Overall Study|Adverse Event|1|||
37715280|NCT02192099|69193712|FG000|Overall Study|Adverse Event|1|||
37715281|NCT02192099|69193712|FG000|Overall Study|Lost to Follow-up|2|||
37715282|NCT02192099|69193712|FG000|Overall Study|Physician Decision|1|||
37715283|NCT02192099|69193712|FG000|Overall Study|Pregnancy|1|||
37715284|NCT02192099|69193712|FG000|Overall Study|Protocol Violation|8|||
37715285|NCT02192099|69193712|FG000|Overall Study|Study Terminated by Sponsor|32|||
37715286|NCT02192099|69193712|FG000|Overall Study|Withdrawal by Subject|11|||
37715287|NCT02192099|69193712|FG000|Overall Study|Miscellaneous Reasons|5|||
37715288|NCT01494610|69193716|FG000|Period 1|Withdrawal by Subject|1|||
37715289|NCT01494610|69193717|FG001|Period 1|Withdrawal by Subject|1|||
37715290|NCT01494610|69193716|FG000|Period 3|Adverse Event|1|||
37715291|NCT01494610|69193717|FG001|Period 3|Adverse Event|0|||
37715292|NCT01494610|69193716|FG000|Period 3|Withdrawal by Subject|1|||
37715293|NCT01494610|69193717|FG001|Period 3|Withdrawal by Subject|0|||
37715294|NCT01494610|69193716|FG000|Period 4|Protocol Violation|1|||
37715295|NCT01494610|69193717|FG001|Period 4|Protocol Violation|0|||
37715296|NCT02116777|69193736|FG000|Overall Study|Adverse Event|0|||
37715297|NCT02116777|69193737|FG001|Overall Study|Adverse Event|0|||
37715298|NCT02116777|69193738|FG002|Overall Study|Adverse Event|0|||
37715299|NCT02116777|69193739|FG003|Overall Study|Adverse Event|0|||
37715300|NCT02116777|69193740|FG004|Overall Study|Adverse Event|2|||
37715301|NCT02116777|69193741|FG005|Overall Study|Adverse Event|2|||
37715302|NCT02116777|69193742|FG006|Overall Study|Adverse Event|0|||
37715303|NCT02116777|69193736|FG000|Overall Study|Death|0|||
37715304|NCT02116777|69193737|FG001|Overall Study|Death|0|||
37715305|NCT02116777|69193738|FG002|Overall Study|Death|0|||
37715306|NCT02116777|69193739|FG003|Overall Study|Death|1|||
37715307|NCT02116777|69193740|FG004|Overall Study|Death|0|||
37915458|NCT00851799|69602227|FG001|Overall Study|Withdrew consent prior study completion|2|||
37715308|NCT02116777|69193741|FG005|Overall Study|Death|0|||
37915459|NCT00851799|69602228|FG002|Overall Study|Withdrew consent prior study completion|1|||
37715309|NCT02116777|69193742|FG006|Overall Study|Death|0|||
37715310|NCT02116777|69193736|FG000|Overall Study|Lack of Efficacy|3|||
37715311|NCT02116777|69193737|FG001|Overall Study|Lack of Efficacy|3|||
37915460|NCT00851799|69602226|FG000|Overall Study|Severe Debilitation|0|||
37715312|NCT02116777|69193738|FG002|Overall Study|Lack of Efficacy|3|||
37715313|NCT02116777|69193739|FG003|Overall Study|Lack of Efficacy|8|||
37715314|NCT02116777|69193740|FG004|Overall Study|Lack of Efficacy|4|||
37715315|NCT02116777|69193741|FG005|Overall Study|Lack of Efficacy|1|||
37715316|NCT02116777|69193742|FG006|Overall Study|Lack of Efficacy|9|||
37715317|NCT02116777|69193736|FG000|Overall Study|Physician Decision|0|||
37715318|NCT02116777|69193737|FG001|Overall Study|Physician Decision|0|||
37715319|NCT02116777|69193738|FG002|Overall Study|Physician Decision|0|||
37715320|NCT02116777|69193739|FG003|Overall Study|Physician Decision|2|||
37715321|NCT02116777|69193740|FG004|Overall Study|Physician Decision|0|||
37715322|NCT02116777|69193741|FG005|Overall Study|Physician Decision|0|||
37715323|NCT02116777|69193742|FG006|Overall Study|Physician Decision|0|||
37715324|NCT02116777|69193736|FG000|Overall Study|Protocol Violation|0|||
37715325|NCT02116777|69193737|FG001|Overall Study|Protocol Violation|0|||
37715326|NCT02116777|69193738|FG002|Overall Study|Protocol Violation|0|||
37715327|NCT02116777|69193739|FG003|Overall Study|Protocol Violation|1|||
37715328|NCT02116777|69193740|FG004|Overall Study|Protocol Violation|0|||
37715329|NCT02116777|69193741|FG005|Overall Study|Protocol Violation|0|||
37715330|NCT02116777|69193742|FG006|Overall Study|Protocol Violation|0|||
37715331|NCT02116777|69193736|FG000|Overall Study|Withdrawal by Subject|0|||
38024718|NCT04537806|69708588|FG000|Overall Study|Adverse Event|1|||
38024719|NCT04537806|69708589|FG001|Overall Study|Adverse Event|1|||
38024720|NCT04015232|69708597|FG000|Overall Study|Withdrawal by Subject|7|||
37715332|NCT02116777|69193737|FG001|Overall Study|Withdrawal by Subject|0|||
37715333|NCT02116777|69193738|FG002|Overall Study|Withdrawal by Subject|0|||
37715334|NCT02116777|69193739|FG003|Overall Study|Withdrawal by Subject|1|||
37839049|NCT01087788|69523604|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
37839050|NCT01087788|69523605|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
37839051|NCT01087788|69523603|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
37839052|NCT01087788|69523604|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
37715335|NCT02116777|69193740|FG004|Overall Study|Withdrawal by Subject|0|||
37715336|NCT02116777|69193741|FG005|Overall Study|Withdrawal by Subject|0|||
37715337|NCT02116777|69193742|FG006|Overall Study|Withdrawal by Subject|0|||
37715338|NCT01494532|69193767|FG000|Overall Study|Adverse Event|4|||
37715339|NCT01494532|69193768|FG001|Overall Study|Adverse Event|1|||
37715340|NCT01494532|69193769|FG002|Overall Study|Adverse Event|8|||
37715341|NCT01494532|69193770|FG003|Overall Study|Adverse Event|6|||
37715342|NCT01494532|69193771|FG004|Overall Study|Adverse Event|5|||
37715343|NCT01494532|69193772|FG005|Overall Study|Adverse Event|0|||
37715344|NCT01494532|69193767|FG000|Overall Study|Lack of Efficacy|0|||
37715345|NCT01494532|69193768|FG001|Overall Study|Lack of Efficacy|0|||
37715346|NCT01494532|69193769|FG002|Overall Study|Lack of Efficacy|0|||
37715347|NCT01494532|69193770|FG003|Overall Study|Lack of Efficacy|0|||
37715348|NCT01494532|69193771|FG004|Overall Study|Lack of Efficacy|2|||
37715349|NCT01494532|69193772|FG005|Overall Study|Lack of Efficacy|0|||
37715350|NCT01494532|69193767|FG000|Overall Study|Protocol deviation|2|||
37715351|NCT01494532|69193768|FG001|Overall Study|Protocol deviation|1|||
37715352|NCT01494532|69193769|FG002|Overall Study|Protocol deviation|3|||
37715353|NCT01494532|69193770|FG003|Overall Study|Protocol deviation|2|||
37715354|NCT01494532|69193771|FG004|Overall Study|Protocol deviation|3|||
37715355|NCT01494532|69193772|FG005|Overall Study|Protocol deviation|0|||
37715356|NCT01494532|69193767|FG000|Overall Study|Protocol-defined stopping criteria|0|||
37715357|NCT01494532|69193768|FG001|Overall Study|Protocol-defined stopping criteria|0|||
37715358|NCT01494532|69193769|FG002|Overall Study|Protocol-defined stopping criteria|1|||
37715359|NCT01494532|69193770|FG003|Overall Study|Protocol-defined stopping criteria|0|||
37715360|NCT01494532|69193771|FG004|Overall Study|Protocol-defined stopping criteria|0|||
37715361|NCT01494532|69193772|FG005|Overall Study|Protocol-defined stopping criteria|0|||
37715362|NCT01494532|69193767|FG000|Overall Study|Lost to Follow-up|1|||
37715363|NCT01494532|69193768|FG001|Overall Study|Lost to Follow-up|0|||
37715364|NCT01494532|69193769|FG002|Overall Study|Lost to Follow-up|0|||
37715365|NCT01494532|69193770|FG003|Overall Study|Lost to Follow-up|2|||
37715366|NCT01494532|69193771|FG004|Overall Study|Lost to Follow-up|0|||
37715367|NCT01494532|69193772|FG005|Overall Study|Lost to Follow-up|0|||
37715368|NCT01494532|69193767|FG000|Overall Study|Physician Decision|0|||
37839053|NCT01087788|69523605|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
37839054|NCT01087788|69523603|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
37839055|NCT01087788|69523604|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
37839056|NCT01087788|69523605|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
37839057|NCT01087788|69523603|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
37839058|NCT01087788|69523604|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
37839059|NCT01087788|69523605|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
37839060|NCT01087788|69523603|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
38024721|NCT04015232|69708598|FG001|Overall Study|Withdrawal by Subject|4|||
38024722|NCT04015232|69708597|FG000|Overall Study|Protocol Violation|1|||
37715369|NCT01494532|69193768|FG001|Overall Study|Physician Decision|1|||
37715370|NCT01494532|69193769|FG002|Overall Study|Physician Decision|1|||
37715371|NCT01494532|69193770|FG003|Overall Study|Physician Decision|2|||
37715372|NCT01494532|69193771|FG004|Overall Study|Physician Decision|0|||
37715373|NCT01494532|69193772|FG005|Overall Study|Physician Decision|0|||
37715374|NCT01494532|69193767|FG000|Overall Study|Withdrawal by Subject|3|||
37715375|NCT01494532|69193768|FG001|Overall Study|Withdrawal by Subject|1|||
37715376|NCT01494532|69193769|FG002|Overall Study|Withdrawal by Subject|4|||
37715377|NCT01494532|69193770|FG003|Overall Study|Withdrawal by Subject|3|||
37715378|NCT01494532|69193771|FG004|Overall Study|Withdrawal by Subject|2|||
37715379|NCT01494532|69193772|FG005|Overall Study|Withdrawal by Subject|0|||
37715380|NCT02191397|69193789|FG000|Overall Study|Adverse Event|28|||
37715381|NCT02191397|69193790|FG001|Overall Study|Adverse Event|17|||
37715382|NCT02191397|69193789|FG000|Overall Study|Lack of Efficacy|10|||
37715383|NCT02191397|69193790|FG001|Overall Study|Lack of Efficacy|5|||
37715384|NCT02191397|69193789|FG000|Overall Study|Protocol Violation|0|||
37715385|NCT02191397|69193790|FG001|Overall Study|Protocol Violation|3|||
37715386|NCT02191397|69193789|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
37715387|NCT02191397|69193790|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
37715388|NCT02191397|69193789|FG000|Overall Study|Lost to Follow-up|10|||
37715389|NCT02191397|69193790|FG001|Overall Study|Lost to Follow-up|11|||
37715390|NCT02191397|69193789|FG000|Overall Study|Physician Decision|8|||
37715391|NCT02191397|69193790|FG001|Overall Study|Physician Decision|3|||
37715392|NCT02191397|69193789|FG000|Overall Study|Withdrawal by Subject|22|||
37715393|NCT02191397|69193790|FG001|Overall Study|Withdrawal by Subject|27|||
37715394|NCT01630811|69193796|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
37715395|NCT01630811|69193797|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
37715396|NCT01494298|69193807|FG000|Overall Study|Protocol Violation|2|||
37715397|NCT01494298|69193808|FG001|Overall Study|Protocol Violation|8|||
37715398|NCT02169791|69193816|FG000|Overall Study|Death|6|||
37715399|NCT02169791|69193816|FG000|Overall Study|patient withdrew consent|1|||
37715400|NCT02216591|69193822|FG000|Overall Study|Lost to Follow-up|0|||
37715401|NCT02216591|69193823|FG001|Overall Study|Lost to Follow-up|1|||
37715402|NCT02216357|69193831|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
37715403|NCT02216357|69193832|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
37715404|NCT01492426|69193840|FG000|Treatment|Death|0|||
37715405|NCT01492426|69193841|FG001|Treatment|Death|1|||
37715406|NCT01492426|69193840|FG000|Treatment|Other|1|||
37715407|NCT01492426|69193841|FG001|Treatment|Other|0|||
37715408|NCT01492426|69193840|FG000|Treatment|Adverse Event|25|||
37715409|NCT01492426|69193841|FG001|Treatment|Adverse Event|25|||
37715410|NCT01492426|69193840|FG000|Treatment|Lack of Efficacy|38|||
37715411|NCT01492426|69193841|FG001|Treatment|Lack of Efficacy|5|||
37715412|NCT01492426|69193840|FG000|Treatment|Participant withdrew consent|1|||
37715413|NCT01492426|69193841|FG001|Treatment|Participant withdrew consent|2|||
37715414|NCT01492426|69193840|FG000|Treatment|Poor compliance/noncompliance|1|||
37715415|NCT01492426|69193841|FG001|Treatment|Poor compliance/noncompliance|0|||
37715416|NCT01492426|69193840|FG000|Treatment|Subject requested discontinue study drug|7|||
37715417|NCT01492426|69193841|FG001|Treatment|Subject requested discontinue study drug|3|||
37715418|NCT01492426|69193840|FG000|Treatment|Lost to Follow-up|9|||
37715419|NCT01492426|69193841|FG001|Treatment|Lost to Follow-up|4|||
37715420|NCT01492426|69193840|FG000|Treatment|Participant does not meet study criteria|1|||
37715421|NCT01492426|69193841|FG001|Treatment|Participant does not meet study criteria|0|||
37715422|NCT01492426|69193840|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
37715423|NCT01492426|69193841|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
37715424|NCT01492426|69193840|FG000|Follow-Up|Death|1|||
37715425|NCT01492426|69193841|FG001|Follow-Up|Death|0|||
37715426|NCT01492426|69193840|FG000|Follow-Up|Other|4|||
37715427|NCT01492426|69193841|FG001|Follow-Up|Other|2|||
37715428|NCT01492426|69193840|FG000|Follow-Up|Participant Withdrew Consent|6|||
37839061|NCT01087788|69523604|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
37839062|NCT01087788|69523605|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
37839063|NCT01087788|69523603|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
37839064|NCT01087788|69523604|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
37839065|NCT01087788|69523605|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
37839066|NCT01087788|69523603|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
37839067|NCT01087788|69523604|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
37839068|NCT01087788|69523605|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
37839069|NCT01087788|69523603|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
37839070|NCT01087788|69523604|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
37715429|NCT01492426|69193841|FG001|Follow-Up|Participant Withdrew Consent|1|||
37839071|NCT01087788|69523605|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
37839072|NCT01087788|69523603|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
37915461|NCT00851799|69602227|FG001|Overall Study|Severe Debilitation|1|||
37715430|NCT01492426|69193840|FG000|Follow-Up|Lost to Follow-up|12|||
37715431|NCT01492426|69193841|FG001|Follow-Up|Lost to Follow-up|6|||
37715432|NCT01453348|69193854|FG000|Overall Study|Death|0|||
37715433|NCT01453348|69193855|FG001|Overall Study|Death|0|||
37715434|NCT01453348|69193856|FG002|Overall Study|Death|1|||
37715435|NCT01453348|69193854|FG000|Overall Study|Withdrawal by Subject|0|||
37715436|NCT01453348|69193855|FG001|Overall Study|Withdrawal by Subject|1|||
37715437|NCT01453348|69193856|FG002|Overall Study|Withdrawal by Subject|0|||
37715438|NCT01453348|69193854|FG000|Overall Study|Protocol Violation|1|||
37839073|NCT01087788|69523604|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
37839074|NCT01087788|69523605|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
37839075|NCT01087788|69523603|FG000|24-weeks Dose-blind Period|Patient moved|0|||
37839076|NCT01087788|69523604|FG001|24-weeks Dose-blind Period|Patient moved|0|||
37839077|NCT01087788|69523605|FG002|24-weeks Dose-blind Period|Patient moved|1|||
37715439|NCT01453348|69193855|FG001|Overall Study|Protocol Violation|0|||
37715440|NCT01453348|69193856|FG002|Overall Study|Protocol Violation|0|||
37715441|NCT01453036|69193870|FG000|Overall Study|Lost to Follow-up|26|||
37715442|NCT01453036|69193871|FG001|Overall Study|Lost to Follow-up|115|||
37715443|NCT01453036|69193872|FG002|Overall Study|Lost to Follow-up|31|||
37715444|NCT01475734|69193882|FG000|Overall Study|Withdrawal by Subject|1|||
37715445|NCT01475734|69193883|FG001|Overall Study|Withdrawal by Subject|0|||
37715446|NCT01475734|69193882|FG000|Overall Study|Protocol Violation|1|||
37715447|NCT01475734|69193883|FG001|Overall Study|Protocol Violation|0|||
37715448|NCT01475734|69193882|FG000|Overall Study|Physician Decision|0|||
37715449|NCT01475734|69193883|FG001|Overall Study|Physician Decision|1|||
37715450|NCT01452412|69193891|FG000|Overall Study|Withdrawal by Subject|15|||
37715451|NCT01452412|69193892|FG001|Overall Study|Withdrawal by Subject|11|||
37715452|NCT01452412|69193891|FG000|Overall Study|Adverse Event|4|||
37715453|NCT01452412|69193892|FG001|Overall Study|Adverse Event|3|||
37715454|NCT01452412|69193891|FG000|Overall Study|Lost to Follow-up|5|||
37715455|NCT01452412|69193892|FG001|Overall Study|Lost to Follow-up|3|||
37715456|NCT01452412|69193891|FG000|Overall Study|Death|1|||
37715457|NCT01452412|69193892|FG001|Overall Study|Death|0|||
37715458|NCT01452412|69193891|FG000|Overall Study|Initiated dialysis|1|||
37715459|NCT01452412|69193892|FG001|Overall Study|Initiated dialysis|0|||
37715460|NCT01452412|69193891|FG000|Overall Study|Other|2|||
37715461|NCT01452412|69193892|FG001|Overall Study|Other|0|||
37715462|NCT01474876|69193901|FG000|Overall Study|Adverse Event|11|||
37715463|NCT01474876|69193902|FG001|Overall Study|Adverse Event|5|||
37715464|NCT01474876|69193903|FG002|Overall Study|Adverse Event|0|||
37715465|NCT01474876|69193901|FG000|Overall Study|Serious Adverse Event|2|||
37715466|NCT01474876|69193902|FG001|Overall Study|Serious Adverse Event|3|||
37715467|NCT01474876|69193903|FG002|Overall Study|Serious Adverse Event|0|||
37715468|NCT01474876|69193901|FG000|Overall Study|Lost to Follow-up|5|||
37715469|NCT01474876|69193902|FG001|Overall Study|Lost to Follow-up|4|||
37715470|NCT01474876|69193903|FG002|Overall Study|Lost to Follow-up|0|||
37715471|NCT01474876|69193901|FG000|Overall Study|Investigator's decision|28|||
37715472|NCT01474876|69193902|FG001|Overall Study|Investigator's decision|6|||
37715473|NCT01474876|69193903|FG002|Overall Study|Investigator's decision|0|||
37715474|NCT01474876|69193901|FG000|Overall Study|Patient's request|19|||
37715475|NCT01474876|69193902|FG001|Overall Study|Patient's request|5|||
37715476|NCT01474876|69193903|FG002|Overall Study|Patient's request|0|||
37715477|NCT01474876|69193901|FG000|Overall Study|Investigator's decision and pt request|1|||
37715478|NCT01474876|69193902|FG001|Overall Study|Investigator's decision and pt request|0|||
37715479|NCT01474876|69193903|FG002|Overall Study|Investigator's decision and pt request|0|||
37715480|NCT01491802|69193909|FG000|Overall Study|Adverse Event|1|||
37715481|NCT01491802|69193910|FG001|Overall Study|Adverse Event|1|||
37715482|NCT01491802|69193909|FG000|Overall Study|Withdrawal by Subject|0|||
37715483|NCT01491802|69193910|FG001|Overall Study|Withdrawal by Subject|1|||
37715484|NCT02168777|69193920|FG000|Overall Study|Withdrawal by Subject|1|||
37715485|NCT02168777|69193921|FG001|Overall Study|Withdrawal by Subject|0|||
37715486|NCT02168777|69193922|FG002|Overall Study|Withdrawal by Subject|2|||
37715487|NCT02168777|69193920|FG000|Overall Study|Adverse Event|1|||
37839078|NCT01087788|69523603|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
37839079|NCT01087788|69523604|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
37839080|NCT01087788|69523605|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
37839081|NCT01087788|69523603|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
37839082|NCT01087788|69523604|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
37839083|NCT01087788|69523605|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
37839084|NCT01087788|69523603|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
37839085|NCT01087788|69523604|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
37715488|NCT02168777|69193921|FG001|Overall Study|Adverse Event|0|||
37715489|NCT02168777|69193922|FG002|Overall Study|Adverse Event|1|||
37715490|NCT02168777|69193920|FG000|Overall Study|Disease recurrence|0|||
37839086|NCT01087788|69523605|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
37915462|NCT00851799|69602228|FG002|Overall Study|Severe Debilitation|0|||
37915463|NCT00851799|69602226|FG000|Overall Study|Completed protocol due to pregnancy|0|||
37915464|NCT00851799|69602227|FG001|Overall Study|Completed protocol due to pregnancy|0|||
37715491|NCT02168777|69193921|FG001|Overall Study|Disease recurrence|0|||
37715492|NCT02168777|69193922|FG002|Overall Study|Disease recurrence|1|||
37715493|NCT02168777|69193920|FG000|Overall Study|Radiological disease progression|0|||
37715494|NCT02168777|69193921|FG001|Overall Study|Radiological disease progression|5|||
37715495|NCT02168777|69193922|FG002|Overall Study|Radiological disease progression|5|||
37715496|NCT02168777|69193920|FG000|Overall Study|Clinical disease progression|0|||
37715497|NCT02168777|69193921|FG001|Overall Study|Clinical disease progression|1|||
37715498|NCT02168777|69193922|FG002|Overall Study|Clinical disease progression|2|||
37715499|NCT02168777|69193920|FG000|Overall Study|Other reason|0|||
37715500|NCT02168777|69193921|FG001|Overall Study|Other reason|1|||
37715501|NCT02168777|69193922|FG002|Overall Study|Other reason|0|||
37715502|NCT01491178|69193933|FG000|Overall Study|Adverse Event|1016|||
37715503|NCT01491178|69193933|FG000|Overall Study|Improvement of NVAF|210|||
37715504|NCT01491178|69193933|FG000|Overall Study|To conduct invasive treatment|59|||
37715505|NCT01491178|69193933|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
37715506|NCT01491178|69193933|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
37715507|NCT01491178|69193933|FG000|Overall Study|To take a contraindication|20|||
37715508|NCT01491178|69193933|FG000|Overall Study|Other than specified above|657|||
37715509|NCT02189837|69193941|FG000|Overall Study|Withdrawal by Subject|2|||
37715510|NCT02189837|69193942|FG001|Overall Study|Withdrawal by Subject|1|||
37715511|NCT02189837|69193943|FG002|Overall Study|Withdrawal by Subject|3|||
37715512|NCT02189837|69193944|FG003|Overall Study|Withdrawal by Subject|1|||
37715513|NCT02189837|69193941|FG000|Overall Study|Sponsor Decision|0|||
37715514|NCT02189837|69193942|FG001|Overall Study|Sponsor Decision|0|||
37715515|NCT02189837|69193943|FG002|Overall Study|Sponsor Decision|0|||
37715516|NCT02189837|69193944|FG003|Overall Study|Sponsor Decision|1|||
37715517|NCT02216123|69193956|FG000|Overall Study|Lost to Follow-up|4|||
37715518|NCT02216123|69193957|FG001|Overall Study|Lost to Follow-up|2|||
37715519|NCT02216123|69193956|FG000|Overall Study|Withdrawal by Subject|2|||
37715520|NCT02216123|69193957|FG001|Overall Study|Withdrawal by Subject|0|||
37715521|NCT02189759|69193971|FG000|Overall Study|Lost to Follow-up|0|||
37715522|NCT02189759|69193972|FG001|Overall Study|Lost to Follow-up|0|||
37715523|NCT02189759|69193973|FG002|Overall Study|Lost to Follow-up|2|||
37715524|NCT02189759|69193974|FG003|Overall Study|Lost to Follow-up|5|||
37715525|NCT01490866|69193986|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
37715526|NCT01490866|69193986|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
37715527|NCT01490866|69193986|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
37715528|NCT01490866|69193986|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
37715529|NCT01490866|69193986|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
37715530|NCT01490866|69193986|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
37715531|NCT01490866|69193986|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
37715532|NCT01490866|69193986|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
37715533|NCT01490866|69193986|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
37715534|NCT01490866|69193986|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
37715535|NCT01490866|69193986|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
37715536|NCT02215967|69193997|FG000|Overall Study|Patient became ineligible for treatment|0|||
37715537|NCT02215967|69193998|FG001|Overall Study|Patient became ineligible for treatment|0|||
37715538|NCT02215967|69193999|FG002|Overall Study|Patient became ineligible for treatment|0|||
37715539|NCT02215967|69194000|FG003|Overall Study|Patient became ineligible for treatment|3|||
37715540|NCT02215967|69193997|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
37715541|NCT02215967|69193998|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
37715542|NCT02215967|69193999|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
37715543|NCT02215967|69194000|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
37715544|NCT02168387|69194012|FG000|Overall Study|Planned exubation|6|||
37715545|NCT02168387|69194013|FG001|Overall Study|Planned exubation|3|||
37715546|NCT02168387|69194012|FG000|Overall Study|Death|1|||
37715547|NCT02168387|69194013|FG001|Overall Study|Death|0|||
37715548|NCT02188589|69194019|FG000|Overall Study|Withdrawal by Subject|5|||
37715549|NCT02167451|69194024|FG000|Overall Study|Withdrawal by Subject|1|||
37715550|NCT02167139|69194030|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
37715551|NCT02167139|69194031|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
37715552|NCT02167139|69194032|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
37715553|NCT02167139|69194033|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
37715554|NCT02167139|69194030|FG000|Randomised, Double-blind|Adverse Event|2|||
37715555|NCT02167139|69194031|FG001|Randomised, Double-blind|Adverse Event|9|||
37715556|NCT02167139|69194032|FG002|Randomised, Double-blind|Adverse Event|0|||
37715557|NCT02167139|69194033|FG003|Randomised, Double-blind|Adverse Event|0|||
37715558|NCT02167139|69194030|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
37715559|NCT02167139|69194031|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
37715560|NCT02167139|69194032|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
37715561|NCT02167139|69194033|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
37715562|NCT02167139|69194030|FG000|Randomised, Double-blind|Other|3|||
37715563|NCT02167139|69194031|FG001|Randomised, Double-blind|Other|0|||
37715564|NCT02167139|69194032|FG002|Randomised, Double-blind|Other|0|||
37715565|NCT02167139|69194033|FG003|Randomised, Double-blind|Other|0|||
37715566|NCT02167139|69194030|FG000|Transition-extension|Adverse Event|2|||
37715567|NCT02167139|69194031|FG001|Transition-extension|Adverse Event|0|||
37715568|NCT02167139|69194032|FG002|Transition-extension|Adverse Event|2|||
37715569|NCT02167139|69194033|FG003|Transition-extension|Adverse Event|3|||
37715570|NCT02167139|69194030|FG000|Transition-extension|Withdrawal by Subject|2|||
37715571|NCT02167139|69194031|FG001|Transition-extension|Withdrawal by Subject|0|||
37715572|NCT02167139|69194032|FG002|Transition-extension|Withdrawal by Subject|4|||
37715573|NCT02167139|69194033|FG003|Transition-extension|Withdrawal by Subject|1|||
37715574|NCT02167139|69194030|FG000|Transition-extension|Lack of Efficacy|0|||
37715575|NCT02167139|69194031|FG001|Transition-extension|Lack of Efficacy|0|||
37715576|NCT02167139|69194032|FG002|Transition-extension|Lack of Efficacy|1|||
37715577|NCT02167139|69194033|FG003|Transition-extension|Lack of Efficacy|1|||
37715578|NCT02167139|69194030|FG000|Transition-extension|Other|1|||
37715579|NCT02167139|69194031|FG001|Transition-extension|Other|0|||
37715580|NCT02167139|69194032|FG002|Transition-extension|Other|1|||
37715581|NCT02167139|69194033|FG003|Transition-extension|Other|0|||
37715582|NCT02167139|69194030|FG000|Transition-extension|Lost to Follow-up|1|||
37715583|NCT02167139|69194031|FG001|Transition-extension|Lost to Follow-up|0|||
37715584|NCT02167139|69194032|FG002|Transition-extension|Lost to Follow-up|0|||
37715585|NCT02167139|69194033|FG003|Transition-extension|Lost to Follow-up|0|||
37715586|NCT02116621|69194049|FG000|Baseline|Withdrawal by Subject|0|||
37715587|NCT02116621|69194050|FG001|Baseline|Withdrawal by Subject|4|||
37715588|NCT02116621|69194049|FG000|Three Month Follow-up|Death|1|||
37715589|NCT02116621|69194050|FG001|Three Month Follow-up|Death|1|||
37715590|NCT02116621|69194049|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
37715591|NCT02116621|69194050|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
37715592|NCT02116621|69194049|FG000|Three Month Follow-up|Lost to Follow-up|0|||
37715593|NCT02116621|69194050|FG001|Three Month Follow-up|Lost to Follow-up|1|||
37715594|NCT02116621|69194049|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
37839087|NCT01087788|69523603|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
37839088|NCT01087788|69523604|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
37839089|NCT01087788|69523605|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
37839090|NCT01087788|69523603|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
37839091|NCT01087788|69523604|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
37839092|NCT01087788|69523605|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
37839093|NCT01087788|69523603|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
37839094|NCT01087788|69523604|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
37839095|NCT01087788|69523605|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
38024723|NCT04015232|69708598|FG001|Overall Study|Protocol Violation|0|||
38024724|NCT04015232|69708597|FG000|Overall Study|Medical Grounds|3|||
38024725|NCT04015232|69708598|FG001|Overall Study|Medical Grounds|3|||
38024726|NCT04533204|69708610|FG000|Overall Study|Unable to understand training instructions|1|||
38024727|NCT04533204|69708611|FG001|Overall Study|Unable to understand training instructions|1|||
38024728|NCT04465422|69708619|FG000|Overall Study|Lost to Follow-up|0|||
38024729|NCT04465422|69708620|FG001|Overall Study|Lost to Follow-up|2|||
38024730|NCT04014062|69708630|FG000|Period I: Dosing|Medical Grounds|4|||
38024731|NCT04014062|69708631|FG001|Period I: Dosing|Medical Grounds|5|||
38024732|NCT04014062|69708630|FG000|Period I: Dosing|Withdrawal by Subject|3|||
38024733|NCT04014062|69708631|FG001|Period I: Dosing|Withdrawal by Subject|1|||
38024734|NCT04531098|69708645|FG000|Stage I|Adverse Event|0|||
38024735|NCT04531098|69708646|FG001|Stage I|Adverse Event|0|||
38024736|NCT04531098|69708647|FG002|Stage I|Adverse Event|3|||
38024737|NCT04531098|69708645|FG000|Stage I|Protocol Violation|0|||
38024738|NCT04531098|69708646|FG001|Stage I|Protocol Violation|0|||
38024739|NCT04531098|69708647|FG002|Stage I|Protocol Violation|5|||
38024740|NCT04531098|69708645|FG000|Stage I|Withdrawal by Subject|0|||
38024741|NCT04531098|69708646|FG001|Stage I|Withdrawal by Subject|5|||
38024742|NCT04531098|69708647|FG002|Stage I|Withdrawal by Subject|10|||
38024743|NCT04531098|69708645|FG000|Stage II|Adverse Event|1|||
38024744|NCT04531098|69708646|FG001|Stage II|Adverse Event|2|||
38024745|NCT04531098|69708647|FG002|Stage II|Adverse Event|0|||
38024746|NCT04531098|69708645|FG000|Stage II|Protocol Violation|1|||
37839096|NCT01087788|69523603|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
38024747|NCT04531098|69708646|FG001|Stage II|Protocol Violation|2|||
38024748|NCT04531098|69708647|FG002|Stage II|Protocol Violation|0|||
38024749|NCT04531098|69708645|FG000|Stage II|Withdrawal by Subject|3|||
38024750|NCT04531098|69708646|FG001|Stage II|Withdrawal by Subject|1|||
38024751|NCT04531098|69708647|FG002|Stage II|Withdrawal by Subject|0|||
38024752|NCT04531098|69708645|FG000|Stage II|Moved from study area|8|||
37715595|NCT02116621|69194050|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
37715596|NCT02116621|69194049|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
37715597|NCT02116621|69194050|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
37715598|NCT02116621|69194049|FG000|Six Month Follow-up|Lost to Follow-up|2|||
37715599|NCT02116621|69194050|FG001|Six Month Follow-up|Lost to Follow-up|1|||
37715600|NCT02116621|69194049|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
37715601|NCT02116621|69194050|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
37715602|NCT02116621|69194049|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
37715603|NCT02116621|69194050|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
37715604|NCT02116621|69194049|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
37715605|NCT02116621|69194050|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
37715606|NCT02116621|69194049|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
37715607|NCT02116621|69194050|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
37715608|NCT02116621|69194049|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
37715609|NCT02116621|69194050|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
37715610|NCT02116309|69194058|FG000|Overall Study|Lost to Follow-up|0|||
37715611|NCT02116309|69194059|FG001|Overall Study|Lost to Follow-up|1|||
37715612|NCT02115607|69194065|FG000|Overall Study|Withdrawal by Subject|1|||
37715613|NCT01490632|69194074|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
37715614|NCT01490632|69194075|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
37715615|NCT01490632|69194076|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
37715616|NCT01490632|69194077|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
37715617|NCT01490632|69194078|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
37715618|NCT01490632|69194079|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
37715619|NCT01490632|69194080|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
37715620|NCT01490632|69194081|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
37715621|NCT01490632|69194082|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
37715622|NCT01490632|69194083|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
37715623|NCT01490632|69194084|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
37715624|NCT01490632|69194085|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
37839097|NCT01087788|69523604|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
37839098|NCT01087788|69523605|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
37839099|NCT01087788|69523603|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
37839100|NCT01087788|69523604|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
37839101|NCT01087788|69523605|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
37839102|NCT01087788|69523603|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
37839103|NCT01087788|69523604|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
38024753|NCT04531098|69708646|FG001|Stage II|Moved from study area|5|||
38024754|NCT04531098|69708647|FG002|Stage II|Moved from study area|0|||
38024755|NCT04144166|69708655|FG000|Overall Study|Discharged before study start|1|||
37715625|NCT01490632|69194086|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
37715626|NCT01490632|69194087|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
37839104|NCT01087788|69523605|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
37839105|NCT01087788|69523603|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
38024756|NCT04144166|69708655|FG000|Overall Study|Pregnancy|1|||
38024757|NCT04144166|69708655|FG000|Overall Study|Nail polish could not be removed from finger|1|||
38024758|NCT04142450|69708664|FG000|Overall Study|Screen Failure|1|||
38024759|NCT04142450|69708664|FG000|Overall Study|Lost to Follow-up|1|||
38024760|NCT04529850|69708668|FG000|Overall Study|Death|2|||
38024761|NCT04529850|69708668|FG000|Overall Study|Physician Decision|1|||
38024762|NCT04529850|69708668|FG000|Overall Study|Withdrawal by Subject|2|||
38024763|NCT04225676|69708672|FG000|Overall Study|Physician Decision|1|||
38024764|NCT04225676|69708672|FG000|Overall Study|Lack of Efficacy|1|||
38024765|NCT04225676|69708672|FG000|Overall Study|Study terminated by sponsor|3|||
38024766|NCT04142216|69708680|FG000|Overall Study|Hospitalization|0|||
38024767|NCT04142216|69708681|FG001|Overall Study|Hospitalization|2|||
38024768|NCT04142216|69708680|FG000|Overall Study|Death|3|||
37715627|NCT01490632|69194088|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
37715628|NCT01490632|69194089|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
37715629|NCT01490632|69194090|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
37839106|NCT01087788|69523604|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
37839107|NCT01087788|69523605|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
37839108|NCT01087788|69523603|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
37839109|NCT01087788|69523604|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
37839110|NCT01087788|69523605|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
37839111|NCT01087788|69523603|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
37839112|NCT01087788|69523604|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
37839113|NCT01087788|69523605|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
37839114|NCT01087788|69523603|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
38024769|NCT04142216|69708681|FG001|Overall Study|Death|1|||
38024770|NCT04142216|69708680|FG000|Overall Study|Referral to another hemodialysis unit|3|||
38024771|NCT04142216|69708681|FG001|Overall Study|Referral to another hemodialysis unit|2|||
38024772|NCT04142216|69708680|FG000|Overall Study|Use of clove|0|||
38024773|NCT04142216|69708681|FG001|Overall Study|Use of clove|1|||
37715630|NCT01490632|69194091|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
37915465|NCT00851799|69602228|FG002|Overall Study|Completed protocol due to pregnancy|1|||
38024774|NCT04140890|69708689|FG000|Overall Study|Withdrawal by Subject|0|||
38024775|NCT04140890|69708690|FG001|Overall Study|Withdrawal by Subject|1|||
38024776|NCT03700320|69708701|FG000|Overall Study|Adverse Event|5|||
38024777|NCT03700320|69708702|FG001|Overall Study|Adverse Event|31|||
38024778|NCT03700320|69708701|FG000|Overall Study|Lack of Efficacy|2|||
38024779|NCT03700320|69708702|FG001|Overall Study|Lack of Efficacy|5|||
37915466|NCT00521053|69602236|FG000|Observation Phase|Disease Progression|55|||
37915467|NCT00521053|69602236|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
37915468|NCT00521053|69602236|FG000|Observation Phase|Death|2|||
37915469|NCT00521053|69602236|FG000|Observation Phase|Adverse Event|1|||
37915470|NCT00521053|69602236|FG000|Observation Phase|Other non-study melanoma treatment|1|||
37915471|NCT00521053|69602236|FG000|Observation Phase|Physician Decision|1|||
37915472|NCT00853047|69602248|FG000|Core Phase|Participant Request|0|||
37915473|NCT00853047|69602249|FG001|Core Phase|Participant Request|0|||
37715631|NCT01490632|69194092|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
37715632|NCT01490632|69194093|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
37715633|NCT01490632|69194074|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
37715634|NCT01490632|69194075|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
37715635|NCT01490632|69194076|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
37715636|NCT01490632|69194077|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
37715637|NCT01490632|69194078|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
37715638|NCT01490632|69194079|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
37715639|NCT01490632|69194080|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
37715640|NCT01490632|69194081|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
37715641|NCT01490632|69194082|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
37715642|NCT01490632|69194083|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
37715643|NCT01490632|69194084|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
37715644|NCT01490632|69194085|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
37715645|NCT01490632|69194086|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
37715646|NCT01490632|69194087|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
37715647|NCT01490632|69194088|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
37715648|NCT01490632|69194089|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
37715649|NCT01490632|69194090|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
37715650|NCT01490632|69194091|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
37715651|NCT01490632|69194092|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
37715652|NCT01490632|69194093|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
37715653|NCT01490632|69194074|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
37715654|NCT01490632|69194075|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
37715655|NCT01490632|69194076|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
37715656|NCT01490632|69194077|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
37715657|NCT01490632|69194078|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
37715658|NCT01490632|69194079|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
37715659|NCT01490632|69194080|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
37715660|NCT01490632|69194081|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
37715661|NCT01490632|69194082|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
37715662|NCT01490632|69194083|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
37715663|NCT01490632|69194084|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
37715664|NCT01490632|69194085|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
37715665|NCT01490632|69194086|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
37715666|NCT01490632|69194087|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
37715667|NCT01490632|69194088|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
37715668|NCT01490632|69194089|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
37715669|NCT01490632|69194090|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
37715670|NCT01490632|69194091|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
37715671|NCT01490632|69194092|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
37915474|NCT00853047|69602250|FG002|Core Phase|Participant Request|0|||
37915475|NCT00853047|69602251|FG003|Core Phase|Participant Request|1|||
37915476|NCT00853047|69602252|FG004|Core Phase|Participant Request|0|||
38024780|NCT03700320|69708701|FG000|Overall Study|Withdrawal by Subject|29|||
37715672|NCT01490632|69194093|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
37715673|NCT01490632|69194074|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
37915477|NCT00853047|69602253|FG005|Core Phase|Participant Request|0|||
37915478|NCT00853047|69602248|FG000|Open-Label Extension Phase|Participant Request|0|||
37915479|NCT00853047|69602249|FG001|Open-Label Extension Phase|Participant Request|0|||
37915480|NCT00853047|69602250|FG002|Open-Label Extension Phase|Participant Request|0|||
37715674|NCT01490632|69194075|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
37715675|NCT01490632|69194076|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
37715676|NCT01490632|69194077|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
37715677|NCT01490632|69194078|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
37715678|NCT01490632|69194079|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
37715679|NCT01490632|69194080|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
37715680|NCT01490632|69194081|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
37715681|NCT01490632|69194082|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
37715682|NCT01490632|69194083|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
37715683|NCT01490632|69194084|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
37715684|NCT01490632|69194085|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
37715685|NCT01490632|69194086|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
37715686|NCT01490632|69194087|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
37715687|NCT01490632|69194088|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
37715688|NCT01490632|69194089|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
37715689|NCT01490632|69194090|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
37715690|NCT01490632|69194091|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
37715691|NCT01490632|69194092|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
37715692|NCT01490632|69194093|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
37715693|NCT01490632|69194074|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
37715694|NCT01490632|69194075|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
37715695|NCT01490632|69194076|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
37715696|NCT01490632|69194077|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
37715697|NCT01490632|69194078|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
37715698|NCT01490632|69194079|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
37715699|NCT01490632|69194080|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
37715700|NCT01490632|69194081|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
37715701|NCT01490632|69194082|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
37715702|NCT01490632|69194083|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
37715703|NCT01490632|69194084|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
37715704|NCT01490632|69194085|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
37715705|NCT01490632|69194086|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
37715706|NCT01490632|69194087|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
37715707|NCT01490632|69194088|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
37715708|NCT01490632|69194089|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
37715709|NCT01490632|69194090|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
37715710|NCT01490632|69194091|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
37715711|NCT01490632|69194092|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
37715712|NCT01490632|69194093|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
37715713|NCT01490632|69194074|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
37715714|NCT01490632|69194075|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
37715715|NCT01490632|69194076|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
37715716|NCT01490632|69194077|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
37715717|NCT01490632|69194078|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
37715718|NCT01490632|69194079|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
37715719|NCT01490632|69194080|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
37715720|NCT01490632|69194081|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
37715721|NCT01490632|69194082|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
37715722|NCT01490632|69194083|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
37715723|NCT01490632|69194084|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
37715724|NCT01490632|69194085|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
37715725|NCT01490632|69194086|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
37715726|NCT01490632|69194087|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
37715727|NCT01490632|69194088|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
37715728|NCT01490632|69194089|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
37715729|NCT01490632|69194090|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
37715730|NCT01490632|69194091|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
37715731|NCT01490632|69194092|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
37715732|NCT01490632|69194093|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
37715733|NCT01490632|69194074|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
37715734|NCT01490632|69194075|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
37715735|NCT01490632|69194076|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
37715736|NCT01490632|69194077|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
37715737|NCT01490632|69194078|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
37715738|NCT01490632|69194079|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
37715739|NCT01490632|69194080|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
37715740|NCT01490632|69194081|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
37715741|NCT01490632|69194082|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
37715742|NCT01490632|69194083|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
37715743|NCT01490632|69194084|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
37715744|NCT01490632|69194085|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
37715745|NCT01490632|69194086|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
37715746|NCT01490632|69194087|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
37715747|NCT01490632|69194088|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
37715748|NCT01490632|69194089|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
37715749|NCT01490632|69194090|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
37715750|NCT01490632|69194091|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
37715751|NCT01490632|69194092|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
37715752|NCT01490632|69194093|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
37715753|NCT01490632|69194074|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
37715754|NCT01490632|69194075|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
37715755|NCT01490632|69194076|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
37715756|NCT01490632|69194077|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
37715757|NCT01490632|69194078|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
37715758|NCT01490632|69194079|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
37715759|NCT01490632|69194080|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
37715760|NCT01490632|69194081|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
37715761|NCT01490632|69194082|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
37715762|NCT01490632|69194083|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
37715763|NCT01490632|69194084|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
37715764|NCT01490632|69194085|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
37715765|NCT01490632|69194086|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
37715766|NCT01490632|69194087|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
37715767|NCT01490632|69194088|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
37715768|NCT01490632|69194089|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
37715769|NCT01490632|69194090|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
37715770|NCT01490632|69194091|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
37715771|NCT01490632|69194092|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
37715772|NCT01490632|69194093|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
37715773|NCT01490632|69194074|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
37715774|NCT01490632|69194075|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
37715775|NCT01490632|69194076|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
37715776|NCT01490632|69194077|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
37715777|NCT01490632|69194078|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
37715778|NCT01490632|69194079|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
37715779|NCT01490632|69194080|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
37715780|NCT01490632|69194081|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
37715781|NCT01490632|69194082|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
37715782|NCT01490632|69194083|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
37715783|NCT01490632|69194084|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
37715784|NCT01490632|69194085|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
37715785|NCT01490632|69194086|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
37715786|NCT01490632|69194087|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
37715787|NCT01490632|69194088|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
37715788|NCT01490632|69194089|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
37715789|NCT01490632|69194090|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
37715790|NCT01490632|69194091|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
37715791|NCT01490632|69194092|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
37715792|NCT01490632|69194093|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
37715793|NCT01490632|69194074|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
37715794|NCT01490632|69194075|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
37715795|NCT01490632|69194076|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
37715796|NCT01490632|69194077|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
37715797|NCT01490632|69194078|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
37715798|NCT01490632|69194079|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
37715799|NCT01490632|69194080|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
37715800|NCT01490632|69194081|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
37715801|NCT01490632|69194082|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
37715802|NCT01490632|69194083|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
37715803|NCT01490632|69194084|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
37715804|NCT01490632|69194085|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
37715805|NCT01490632|69194086|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
37715806|NCT01490632|69194087|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
37715807|NCT01490632|69194088|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
37715808|NCT01490632|69194089|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
37715809|NCT01490632|69194090|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
37715810|NCT01490632|69194091|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
37715811|NCT01490632|69194092|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
37715812|NCT01490632|69194093|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
37715813|NCT01490632|69194074|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
37715814|NCT01490632|69194075|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
37715815|NCT01490632|69194076|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
37715816|NCT01490632|69194077|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
37715817|NCT01490632|69194078|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
37715818|NCT01490632|69194079|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
37715819|NCT01490632|69194080|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
37715820|NCT01490632|69194081|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
37715821|NCT01490632|69194082|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
37715822|NCT01490632|69194083|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
37715823|NCT01490632|69194084|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
37715824|NCT01490632|69194085|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
37715825|NCT01490632|69194086|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
37715826|NCT01490632|69194087|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
37715827|NCT01490632|69194088|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
37715828|NCT01490632|69194089|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
37715829|NCT01490632|69194090|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
37715830|NCT01490632|69194091|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
37715831|NCT01490632|69194092|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
37715832|NCT01490632|69194093|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
37715833|NCT01490632|69194074|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
37715834|NCT01490632|69194075|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
37715835|NCT01490632|69194076|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
37715836|NCT01490632|69194077|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
37715837|NCT01490632|69194078|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
37715838|NCT01490632|69194079|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
37715839|NCT01490632|69194080|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
37715840|NCT01490632|69194081|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
37715841|NCT01490632|69194082|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
37715842|NCT01490632|69194083|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
37715843|NCT01490632|69194084|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
37715844|NCT01490632|69194085|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
37715845|NCT01490632|69194086|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
37715846|NCT01490632|69194087|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
37715847|NCT01490632|69194088|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
37715848|NCT01490632|69194089|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
37915481|NCT00853047|69602251|FG003|Open-Label Extension Phase|Participant Request|0|||
38024781|NCT03700320|69708702|FG001|Overall Study|Withdrawal by Subject|75|||
38024782|NCT03700320|69708701|FG000|Overall Study|Lost to Follow-up|16|||
38024783|NCT03700320|69708702|FG001|Overall Study|Lost to Follow-up|23|||
38024784|NCT03700320|69708701|FG000|Overall Study|Pregnancy|2|||
37715849|NCT01490632|69194090|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
37715850|NCT01490632|69194091|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
37715851|NCT01490632|69194092|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
37715852|NCT01490632|69194093|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
37715853|NCT01490632|69194074|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
37715854|NCT01490632|69194075|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
37715855|NCT01490632|69194076|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
37715856|NCT01490632|69194077|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
37715857|NCT01490632|69194078|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
37715858|NCT01490632|69194079|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
37715859|NCT01490632|69194080|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
37715860|NCT01490632|69194081|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
37715861|NCT01490632|69194082|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
37715862|NCT01490632|69194083|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
37715863|NCT01490632|69194084|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
37715864|NCT01490632|69194085|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
37715865|NCT01490632|69194086|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
37715866|NCT01490632|69194087|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
37715867|NCT01490632|69194088|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
37715868|NCT01490632|69194089|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
37715869|NCT01490632|69194090|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
37715870|NCT01490632|69194091|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
37715871|NCT01490632|69194092|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
37715872|NCT01490632|69194093|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
37715873|NCT01490632|69194074|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
37839115|NCT01087788|69523604|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
37839116|NCT01087788|69523605|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
37839117|NCT01086969|69523617|FG000|Overall Study|Withdrawal by Subject|1|||
37839118|NCT01086969|69523618|FG001|Overall Study|Withdrawal by Subject|2|||
37839119|NCT01086969|69523619|FG002|Overall Study|Withdrawal by Subject|0|||
37839120|NCT01086423|69523630|FG000|Overall Study|Protocol Violation|0|||
37839121|NCT01086423|69523631|FG001|Overall Study|Protocol Violation|0|||
37839122|NCT01086423|69523632|FG002|Overall Study|Protocol Violation|1|||
37839123|NCT01086423|69523630|FG000|Overall Study|Migrated/moved from study area|2|||
37839124|NCT01086423|69523631|FG001|Overall Study|Migrated/moved from study area|0|||
37839125|NCT01086423|69523632|FG002|Overall Study|Migrated/moved from study area|4|||
37839126|NCT01086423|69523630|FG000|Overall Study|Adverse event, fatal|1|||
37839127|NCT01086423|69523631|FG001|Overall Study|Adverse event, fatal|1|||
37839128|NCT01086423|69523632|FG002|Overall Study|Adverse event, fatal|0|||
37839129|NCT01086423|69523630|FG000|Overall Study|Adverse event, non-fatal|2|||
37839130|NCT01086423|69523631|FG001|Overall Study|Adverse event, non-fatal|1|||
37839131|NCT01086423|69523632|FG002|Overall Study|Adverse event, non-fatal|0|||
37839132|NCT01086423|69523630|FG000|Overall Study|Withdrawal by Subject|5|||
37839133|NCT01086423|69523631|FG001|Overall Study|Withdrawal by Subject|1|||
37839134|NCT01086423|69523632|FG002|Overall Study|Withdrawal by Subject|3|||
37839135|NCT01086423|69523630|FG000|Overall Study|Lost to Follow-up|0|||
37839136|NCT01086423|69523631|FG001|Overall Study|Lost to Follow-up|0|||
37715874|NCT01490632|69194075|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
37715875|NCT01490632|69194076|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
37715876|NCT01490632|69194077|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
37715877|NCT01490632|69194078|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
37715878|NCT01490632|69194079|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
37715879|NCT01490632|69194080|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
37715880|NCT01490632|69194081|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
37715881|NCT01490632|69194082|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
37715882|NCT01490632|69194083|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
37715883|NCT01490632|69194084|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
37715884|NCT01490632|69194085|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
37715885|NCT01490632|69194086|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
37715886|NCT01490632|69194087|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
37715887|NCT01490632|69194088|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
37715888|NCT01490632|69194089|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
37715889|NCT01490632|69194090|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
37715890|NCT01490632|69194091|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
37715891|NCT01490632|69194092|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
37715892|NCT01490632|69194093|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
37715893|NCT01490632|69194074|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
37715894|NCT01490632|69194075|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
37715895|NCT01490632|69194076|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
37715896|NCT01490632|69194077|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
37715897|NCT01490632|69194078|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
37715898|NCT01490632|69194079|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
37715899|NCT01490632|69194080|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
37715900|NCT01490632|69194081|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
37715901|NCT01490632|69194082|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
37715902|NCT01490632|69194083|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
37715903|NCT01490632|69194084|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
37715904|NCT01490632|69194085|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
37715905|NCT01490632|69194086|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
37715906|NCT01490632|69194087|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
37715907|NCT01490632|69194088|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
37839137|NCT01086423|69523632|FG002|Overall Study|Lost to Follow-up|1|||
37715908|NCT01490632|69194089|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
37715909|NCT01490632|69194090|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
37715910|NCT01490632|69194091|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
37715911|NCT01490632|69194092|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
37715912|NCT01490632|69194093|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
37715913|NCT01490632|69194074|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
37839138|NCT01086150|69523643|FG000|Overall Study|Withdrawal by Subject|0|||
37839139|NCT01086150|69523644|FG001|Overall Study|Withdrawal by Subject|4|||
37839140|NCT01086150|69523645|FG002|Overall Study|Withdrawal by Subject|1|||
37839141|NCT01086150|69523643|FG000|Overall Study|Lost to Follow-up|0|||
37715914|NCT01490632|69194075|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
37715915|NCT01490632|69194076|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
37715916|NCT01490632|69194077|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
37715917|NCT01490632|69194078|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
37715918|NCT01490632|69194079|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
37715919|NCT01490632|69194080|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
37715920|NCT01490632|69194081|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
37715921|NCT01490632|69194082|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
37715922|NCT01490632|69194083|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
37715923|NCT01490632|69194084|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
37715924|NCT01490632|69194085|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
37715925|NCT01490632|69194086|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
37715926|NCT01490632|69194087|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
37715927|NCT01490632|69194088|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
37715928|NCT01490632|69194089|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
37715929|NCT01490632|69194090|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
37715930|NCT01490632|69194091|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
37715931|NCT01490632|69194092|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
37715932|NCT01490632|69194093|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
37715933|NCT01490632|69194074|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
37715934|NCT01490632|69194075|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
37715935|NCT01490632|69194076|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
37715936|NCT01490632|69194077|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
37715937|NCT01490632|69194078|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
37715938|NCT01490632|69194079|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
37715939|NCT01490632|69194080|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
37715940|NCT01490632|69194081|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
37715941|NCT01490632|69194082|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
37715942|NCT01490632|69194083|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
37715943|NCT01490632|69194084|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
37715944|NCT01490632|69194085|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
37715945|NCT01490632|69194086|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
37715946|NCT01490632|69194087|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
37715947|NCT01490632|69194088|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
37715948|NCT01490632|69194089|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
37715949|NCT01490632|69194090|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
37715950|NCT01490632|69194091|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
37715951|NCT01490632|69194092|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
37715952|NCT01490632|69194093|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
37715953|NCT01490632|69194074|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
37715954|NCT01490632|69194075|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
37715955|NCT01490632|69194076|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
37715956|NCT01490632|69194077|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
37715957|NCT01490632|69194078|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
37715958|NCT01490632|69194079|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
37715959|NCT01490632|69194080|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
37715960|NCT01490632|69194081|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
37715961|NCT01490632|69194082|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
37715962|NCT01490632|69194083|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
37715963|NCT01490632|69194084|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
37715964|NCT01490632|69194085|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
37839142|NCT01086150|69523644|FG001|Overall Study|Lost to Follow-up|1|||
37839143|NCT01086150|69523645|FG002|Overall Study|Lost to Follow-up|0|||
37839144|NCT01086150|69523643|FG000|Overall Study|Screen Failure|0|||
37839145|NCT01086150|69523644|FG001|Overall Study|Screen Failure|1|||
37839146|NCT01086150|69523645|FG002|Overall Study|Screen Failure|0|||
37839147|NCT01086033|69523653|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
37715965|NCT01490632|69194086|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
37715966|NCT01490632|69194087|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
37715967|NCT01490632|69194088|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
37715968|NCT01490632|69194089|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
37715969|NCT01490632|69194090|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
37715970|NCT01490632|69194091|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
37715971|NCT01490632|69194092|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
37715972|NCT01490632|69194093|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
37715973|NCT01490632|69194074|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
37715974|NCT01490632|69194075|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
37715975|NCT01490632|69194076|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
37715976|NCT01490632|69194077|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
37715977|NCT01490632|69194078|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
37715978|NCT01490632|69194079|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
37715979|NCT01490632|69194080|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
37715980|NCT01490632|69194081|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
37715981|NCT01490632|69194082|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
37715982|NCT01490632|69194083|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
37715983|NCT01490632|69194084|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
37715984|NCT01490632|69194085|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
37715985|NCT01490632|69194086|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
37715986|NCT01490632|69194087|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
37715987|NCT01490632|69194088|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
37715988|NCT01490632|69194089|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
37715989|NCT01490632|69194090|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
37715990|NCT01490632|69194091|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
37715991|NCT01490632|69194092|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
37715992|NCT01490632|69194093|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
37715993|NCT01490632|69194074|FG000|Part D: Re-Treatment Period|Death|0|||
37715994|NCT01490632|69194075|FG001|Part D: Re-Treatment Period|Death|0|||
37715995|NCT01490632|69194076|FG002|Part D: Re-Treatment Period|Death|0|||
37715996|NCT01490632|69194077|FG003|Part D: Re-Treatment Period|Death|0|||
37715997|NCT01490632|69194078|FG004|Part D: Re-Treatment Period|Death|0|||
37715998|NCT01490632|69194079|FG005|Part D: Re-Treatment Period|Death|0|||
37715999|NCT01490632|69194080|FG006|Part D: Re-Treatment Period|Death|0|||
37839148|NCT01086033|69523653|FG000|Overall Study|Lost to Follow-up|86|||
37839149|NCT01086033|69523653|FG000|Overall Study|Adverse Event|42|||
37839150|NCT01086033|69523653|FG000|Overall Study|Withdrawal by Subject|41|||
37839151|NCT01086033|69523653|FG000|Overall Study|Other|14|||
37839152|NCT01086033|69523653|FG000|Overall Study|Other|13|||
37839153|NCT01086033|69523653|FG000|Overall Study|AE and Withdrew Consent|5|||
37839154|NCT01086033|69523653|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
37839155|NCT01086033|69523653|FG000|Overall Study|Withdrew consent and Other Reason|4|||
37839156|NCT01086033|69523653|FG000|Overall Study|AE and Lack of Efficacy|4|||
38024785|NCT03700320|69708702|FG001|Overall Study|Pregnancy|4|||
38024786|NCT03700320|69708701|FG000|Overall Study|Protocol Deviation|7|||
38024787|NCT03700320|69708702|FG001|Overall Study|Protocol Deviation|31|||
38024788|NCT03700320|69708701|FG000|Overall Study|Non-compliance with Study Drug|1|||
38024789|NCT03700320|69708702|FG001|Overall Study|Non-compliance with Study Drug|3|||
38024790|NCT03700320|69708701|FG000|Overall Study|Reason not Specified|0|||
38024791|NCT03700320|69708702|FG001|Overall Study|Reason not Specified|1|||
38024792|NCT04139018|69708710|FG000|Overall Study|Screen fail|1|||
38024793|NCT04139018|69708711|FG001|Overall Study|Screen fail|0|||
38043504|NCT03653390|69731634|FG000|Overall Study|Lost to Follow-up|12|||
37716000|NCT01490632|69194081|FG007|Part D: Re-Treatment Period|Death|0|||
37716001|NCT01490632|69194082|FG008|Part D: Re-Treatment Period|Death|0|||
37716002|NCT01490632|69194083|FG009|Part D: Re-Treatment Period|Death|0|||
37716003|NCT01490632|69194084|FG010|Part D: Re-Treatment Period|Death|0|||
37716004|NCT01490632|69194085|FG011|Part D: Re-Treatment Period|Death|0|||
37839157|NCT01086033|69523653|FG000|Overall Study|Death|1|||
37839158|NCT01086033|69523653|FG000|Overall Study|AE and Lost to Follow-up|1|||
37716005|NCT01490632|69194086|FG012|Part D: Re-Treatment Period|Death|0|||
37716006|NCT01490632|69194087|FG013|Part D: Re-Treatment Period|Death|0|||
37716007|NCT01490632|69194088|FG014|Part D: Re-Treatment Period|Death|0|||
37716008|NCT01490632|69194089|FG015|Part D: Re-Treatment Period|Death|0|||
37716009|NCT01490632|69194090|FG016|Part D: Re-Treatment Period|Death|0|||
37716010|NCT01490632|69194091|FG017|Part D: Re-Treatment Period|Death|0|||
37716011|NCT01490632|69194092|FG018|Part D: Re-Treatment Period|Death|1|||
37716012|NCT01490632|69194093|FG019|Part D: Re-Treatment Period|Death|0|||
37716013|NCT01490632|69194074|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
37716014|NCT01490632|69194075|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
37716015|NCT01490632|69194076|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
37716016|NCT01490632|69194077|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
37716017|NCT01490632|69194078|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
37716018|NCT01490632|69194079|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
37716019|NCT01490632|69194080|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
37716020|NCT01490632|69194081|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
37716021|NCT01490632|69194082|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
37716022|NCT01490632|69194083|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
37716023|NCT01490632|69194084|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
37716024|NCT01490632|69194085|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
37716025|NCT01490632|69194086|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
37716026|NCT01490632|69194087|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
37716027|NCT01490632|69194088|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
37716028|NCT01490632|69194089|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
37716029|NCT01490632|69194090|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
37716030|NCT01490632|69194091|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
37716031|NCT01490632|69194092|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
37716032|NCT01490632|69194093|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
37716033|NCT01490632|69194074|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
37716034|NCT01490632|69194075|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
37716035|NCT01490632|69194076|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
37716036|NCT01490632|69194077|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
37716037|NCT01490632|69194078|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
37716038|NCT01490632|69194079|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
37716039|NCT01490632|69194080|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
37716040|NCT01490632|69194081|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
37716041|NCT01490632|69194082|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
37716042|NCT01490632|69194083|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
37716043|NCT01490632|69194084|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
37716044|NCT01490632|69194085|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
37716045|NCT01490632|69194086|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
37716046|NCT01490632|69194087|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
37716047|NCT01490632|69194088|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
37716048|NCT01490632|69194089|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
37716049|NCT01490632|69194090|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
37716050|NCT01490632|69194091|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
37716051|NCT01490632|69194092|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
37716052|NCT01490632|69194093|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
37716053|NCT01490632|69194074|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
37716054|NCT01490632|69194075|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
37716055|NCT01490632|69194076|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
37716056|NCT01490632|69194077|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
37716057|NCT01490632|69194078|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
37716058|NCT01490632|69194079|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
37716059|NCT01490632|69194080|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
37716060|NCT01490632|69194081|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
37716061|NCT01490632|69194082|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
37716062|NCT01490632|69194083|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
37716063|NCT01490632|69194084|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
37716064|NCT01490632|69194085|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
37716065|NCT01490632|69194086|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
37716066|NCT01490632|69194087|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
37716067|NCT01490632|69194088|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
37716068|NCT01490632|69194089|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
37716069|NCT01490632|69194090|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
37716070|NCT01490632|69194091|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
37716071|NCT01490632|69194092|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
37716072|NCT01490632|69194093|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
37716073|NCT01490632|69194074|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
37716074|NCT01490632|69194075|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
37915482|NCT00853047|69602252|FG004|Open-Label Extension Phase|Participant Request|0|||
37716075|NCT01490632|69194076|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
37716076|NCT01490632|69194077|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
37716077|NCT01490632|69194078|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
37716078|NCT01490632|69194079|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
37716079|NCT01490632|69194080|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
37716080|NCT01490632|69194081|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
37839159|NCT01086033|69523653|FG000|Overall Study|AE and Other Reason|1|||
37839160|NCT01086033|69523653|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
37839161|NCT01085682|69523662|FG000|Overall Study|Withdrawal by Subject|25|||
37839162|NCT01085682|69523663|FG001|Overall Study|Withdrawal by Subject|25|||
37839163|NCT01085214|69523669|FG000|Overall Study|Alternate treatment required|1|||
37839164|NCT01085136|69523673|FG000|Part A|Other Adverse event|223|||
37839165|NCT01085136|69523674|FG001|Part A|Other Adverse event|0|||
37839166|NCT01085136|69523675|FG002|Part A|Other Adverse event|0|||
37839167|NCT01085136|69523673|FG000|Part A|Protocol Violation|3|||
37839168|NCT01085136|69523674|FG001|Part A|Protocol Violation|0|||
37839169|NCT01085136|69523675|FG002|Part A|Protocol Violation|0|||
37839170|NCT01085136|69523673|FG000|Part A|Lost to Follow-up|3|||
37839171|NCT01085136|69523674|FG001|Part A|Lost to Follow-up|0|||
37839172|NCT01085136|69523675|FG002|Part A|Lost to Follow-up|0|||
37839173|NCT01085136|69523673|FG000|Part A|Refusal to continue trial medication|64|||
37839174|NCT01085136|69523674|FG001|Part A|Refusal to continue trial medication|0|||
37716081|NCT01490632|69194082|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
37716082|NCT01490632|69194083|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
37716083|NCT01490632|69194084|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
37716084|NCT01490632|69194085|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
37716085|NCT01490632|69194086|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
37716086|NCT01490632|69194087|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
37716087|NCT01490632|69194088|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
37716088|NCT01490632|69194089|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
37716089|NCT01490632|69194090|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
37716090|NCT01490632|69194091|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
37716091|NCT01490632|69194092|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
37716092|NCT01490632|69194093|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
37716093|NCT01490632|69194074|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
37716094|NCT01490632|69194075|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
37839175|NCT01085136|69523675|FG002|Part A|Refusal to continue trial medication|0|||
37839176|NCT01085136|69523673|FG000|Part A|Other reason not defined above|30|||
37839177|NCT01085136|69523674|FG001|Part A|Other reason not defined above|0|||
38024794|NCT04139018|69708710|FG000|Overall Study|Withdrawal by Subject|2|||
37716095|NCT01490632|69194076|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
37716096|NCT01490632|69194077|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
37716097|NCT01490632|69194078|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
37716098|NCT01490632|69194079|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
37716099|NCT01490632|69194080|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
37716100|NCT01490632|69194081|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
37716101|NCT01490632|69194082|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
37716102|NCT01490632|69194083|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
37716103|NCT01490632|69194084|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
37716104|NCT01490632|69194085|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
37716105|NCT01490632|69194086|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
37716106|NCT01490632|69194087|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
37716107|NCT01490632|69194088|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
37716108|NCT01490632|69194089|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
37716109|NCT01490632|69194090|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
37716110|NCT01490632|69194091|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
37716111|NCT01490632|69194092|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
37716112|NCT01490632|69194093|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
37716113|NCT02073643|69194136|FG000|Overall Study|Lost to Follow-up|24|||
37716114|NCT01451554|69194142|FG000|Overall Study|Withdrawal by Subject|14|||
37716115|NCT01451554|69194143|FG001|Overall Study|Withdrawal by Subject|9|||
37839178|NCT01085136|69523675|FG002|Part A|Other reason not defined above|0|||
38024795|NCT04139018|69708711|FG001|Overall Study|Withdrawal by Subject|0|||
38024796|NCT04139018|69708710|FG000|Overall Study|Lost to Follow-up|0|||
38024797|NCT04139018|69708711|FG001|Overall Study|Lost to Follow-up|1|||
38024798|NCT04527978|69708719|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
37716116|NCT01474486|69194149|FG000|Overall Study|Death|2|||
37716117|NCT01474486|69194149|FG000|Overall Study|Withdrawal by Subject|4|||
37716118|NCT01474486|69194149|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
37839179|NCT01085136|69523673|FG000|Part B|Other AE|0|||
37839180|NCT01085136|69523674|FG001|Part B|Other AE|29|||
37839181|NCT01085136|69523675|FG002|Part B|Other AE|8|||
37839182|NCT01085136|69523673|FG000|Part B|Refusal to continue trial medication|0|||
37716119|NCT01451398|69194159|FG000|Overall Study|Adverse Event|7|||
37716120|NCT01451398|69194160|FG001|Overall Study|Adverse Event|9|||
37716121|NCT01451398|69194159|FG000|Overall Study|Protocol Violation|1|||
37716122|NCT01451398|69194160|FG001|Overall Study|Protocol Violation|2|||
37716123|NCT01451398|69194159|FG000|Overall Study|Physician Decision|1|||
37716124|NCT01451398|69194160|FG001|Overall Study|Physician Decision|1|||
37716125|NCT01451398|69194159|FG000|Overall Study|Withdrawal by Subject|10|||
37716126|NCT01451398|69194160|FG001|Overall Study|Withdrawal by Subject|14|||
37716127|NCT01451398|69194159|FG000|Overall Study|Lost to Follow-up|6|||
37716128|NCT01451398|69194160|FG001|Overall Study|Lost to Follow-up|4|||
37716129|NCT01451398|69194159|FG000|Overall Study|Non-compliance with study drug|1|||
37716130|NCT01451398|69194160|FG001|Overall Study|Non-compliance with study drug|3|||
37716131|NCT01451398|69194159|FG000|Overall Study|Non-compliance with protocol|1|||
37716132|NCT01451398|69194160|FG001|Overall Study|Non-compliance with protocol|1|||
37716133|NCT01451398|69194159|FG000|Overall Study|Moved out of country|0|||
37716134|NCT01451398|69194160|FG001|Overall Study|Moved out of country|1|||
37716135|NCT01451398|69194159|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
37716136|NCT01451398|69194160|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
37716137|NCT01451398|69194159|FG000|Overall Study|Lack of Efficacy|0|||
37716138|NCT01451398|69194160|FG001|Overall Study|Lack of Efficacy|1|||
37716139|NCT02073565|69194168|FG000|Cohort A|Withdrawal by Subject|1|||
37716140|NCT02073565|69194169|FG001|Cohort A|Withdrawal by Subject|0|||
37716141|NCT02073565|69194168|FG000|Cohort B|Withdrawal by Subject|1|||
37716142|NCT02073565|69194169|FG001|Cohort B|Withdrawal by Subject|2|||
37716143|NCT02073565|69194168|FG000|Cohort C|Withdrawal by Subject|0|||
37716144|NCT02073565|69194169|FG001|Cohort C|Withdrawal by Subject|2|||
37716145|NCT02073565|69194168|FG000|Cohort C|Lost to Follow-up|0|||
37716146|NCT02073565|69194169|FG001|Cohort C|Lost to Follow-up|2|||
37716147|NCT02072941|69194177|FG000|Overall Study|Withdrawal by Subject|29|||
37716148|NCT02072941|69194178|FG001|Overall Study|Withdrawal by Subject|21|||
37716149|NCT02072941|69194177|FG000|Overall Study|Lost to Follow-up|4|||
37716150|NCT02072941|69194178|FG001|Overall Study|Lost to Follow-up|4|||
37716151|NCT02072941|69194177|FG000|Overall Study|Death|3|||
37716152|NCT02072941|69194178|FG001|Overall Study|Death|2|||
37716153|NCT02072941|69194177|FG000|Overall Study|Removed by Study Staff|2|||
37716154|NCT02072941|69194178|FG001|Overall Study|Removed by Study Staff|2|||
37716155|NCT02100631|69194187|FG000|Overall Study|Withdrawal by Subject|1|||
37716156|NCT02100631|69194188|FG001|Overall Study|Withdrawal by Subject|0|||
37716157|NCT02100631|69194189|FG002|Overall Study|Withdrawal by Subject|0|||
37716158|NCT02100631|69194187|FG000|Overall Study|Lost to Follow-up|3|||
37716159|NCT02100631|69194188|FG001|Overall Study|Lost to Follow-up|4|||
37716160|NCT02100631|69194189|FG002|Overall Study|Lost to Follow-up|0|||
37716161|NCT02100631|69194187|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
37716162|NCT02100631|69194188|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
37716163|NCT02100631|69194189|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
37716164|NCT01451164|69194201|FG000|Overall Study|Adverse Event|19|||
37716165|NCT01451164|69194202|FG001|Overall Study|Adverse Event|12|||
37716166|NCT01451164|69194203|FG002|Overall Study|Adverse Event|18|||
37716167|NCT01451164|69194204|FG003|Overall Study|Adverse Event|21|||
37716168|NCT01451164|69194201|FG000|Overall Study|Withdrawal Criteria|1|||
37716169|NCT01451164|69194202|FG001|Overall Study|Withdrawal Criteria|1|||
37716170|NCT01451164|69194203|FG002|Overall Study|Withdrawal Criteria|1|||
37716171|NCT01451164|69194204|FG003|Overall Study|Withdrawal Criteria|1|||
37716172|NCT01451164|69194201|FG000|Overall Study|Physician Decision|2|||
37716173|NCT01451164|69194202|FG001|Overall Study|Physician Decision|0|||
37716174|NCT01451164|69194203|FG002|Overall Study|Physician Decision|1|||
37716175|NCT01451164|69194204|FG003|Overall Study|Physician Decision|0|||
37716176|NCT01451164|69194201|FG000|Overall Study|Withdrawal by Subject|14|||
37716177|NCT01451164|69194202|FG001|Overall Study|Withdrawal by Subject|11|||
37716178|NCT01451164|69194203|FG002|Overall Study|Withdrawal by Subject|16|||
37716179|NCT01451164|69194204|FG003|Overall Study|Withdrawal by Subject|17|||
37716180|NCT01451164|69194201|FG000|Overall Study|Protocol Violation|0|||
37716181|NCT01451164|69194202|FG001|Overall Study|Protocol Violation|1|||
37716182|NCT01451164|69194203|FG002|Overall Study|Protocol Violation|0|||
37716183|NCT01451164|69194204|FG003|Overall Study|Protocol Violation|0|||
37716184|NCT01451164|69194201|FG000|Overall Study|Lack of Efficacy|7|||
37716185|NCT01451164|69194202|FG001|Overall Study|Lack of Efficacy|9|||
37716186|NCT01451164|69194203|FG002|Overall Study|Lack of Efficacy|9|||
37716187|NCT01451164|69194204|FG003|Overall Study|Lack of Efficacy|7|||
37716188|NCT02071849|69194214|FG000|6-month Primary Endpoint|Did not receive device|4|||
37716189|NCT02071849|69194214|FG000|6-month Primary Endpoint|Adverse Event|1|||
37716190|NCT02071849|69194214|FG000|2-year Extended Follow-up|Adverse Event|1|||
37716191|NCT02071771|69194218|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
37716192|NCT02071771|69194219|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
37716193|NCT02071771|69194218|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
37716194|NCT02071771|69194219|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
37716195|NCT02071225|69194225|FG000|Overall Study|Withdrawal of Consent|2|||
37716196|NCT02071225|69194225|FG000|Overall Study|Protocol Deviation|1|||
37716197|NCT02071225|69194225|FG000|Overall Study|Lost to Follow-up|2|||
37716198|NCT02071225|69194225|FG000|Overall Study|Death|25|||
37716199|NCT01450696|69194231|FG000|Overall Study|Never Treated|1|||
37716200|NCT01450696|69194232|FG001|Overall Study|Never Treated|1|||
37716201|NCT01450696|69194231|FG000|Overall Study|Death|77|||
37716202|NCT01450696|69194232|FG001|Overall Study|Death|84|||
37716203|NCT01450696|69194231|FG000|Overall Study|Lost to Follow-up|3|||
37716204|NCT01450696|69194232|FG001|Overall Study|Lost to Follow-up|3|||
37716205|NCT01450696|69194231|FG000|Overall Study|Non-Compliance|1|||
37716206|NCT01450696|69194232|FG001|Overall Study|Non-Compliance|0|||
37716207|NCT01450696|69194231|FG000|Overall Study|Withdrawal by Subject|13|||
37716208|NCT01450696|69194232|FG001|Overall Study|Withdrawal by Subject|2|||
37716209|NCT01450696|69194231|FG000|Overall Study|Study Terminated by Sponsor|53|||
37716210|NCT01450696|69194232|FG001|Overall Study|Study Terminated by Sponsor|58|||
37716211|NCT02070991|69194240|FG000|Overall Study|Death|2|||
37716212|NCT02070991|69194241|FG001|Overall Study|Death|0|||
37716213|NCT02070991|69194240|FG000|Overall Study|Withdrawal by Subject|1|||
37716214|NCT02070991|69194241|FG001|Overall Study|Withdrawal by Subject|0|||
37716215|NCT02114515|69194249|FG000|Overall Study|Lost to Follow-up|52|||
37716216|NCT02114515|69194250|FG001|Overall Study|Lost to Follow-up|55|||
37716217|NCT02114515|69194249|FG000|Overall Study|Death|12|||
37716218|NCT02114515|69194250|FG001|Overall Study|Death|12|||
37716219|NCT02114515|69194249|FG000|Overall Study|Withdrawal by Subject|4|||
37716220|NCT02114515|69194250|FG001|Overall Study|Withdrawal by Subject|22|||
37716221|NCT02114515|69194249|FG000|Overall Study|Other|65|||
37716222|NCT02114515|69194250|FG001|Overall Study|Other|61|||
37716223|NCT01490086|69194261|FG000|Overall Study|Consent withdrawn|4|||
37716224|NCT01490086|69194262|FG001|Overall Study|Consent withdrawn|4|||
37716225|NCT01490086|69194263|FG002|Overall Study|Consent withdrawn|3|||
37716226|NCT01490086|69194264|FG003|Overall Study|Consent withdrawn|0|||
37716227|NCT01490086|69194265|FG004|Overall Study|Consent withdrawn|1|||
37716228|NCT01490086|69194261|FG000|Overall Study|Non-compliance|0|||
37716229|NCT01490086|69194262|FG001|Overall Study|Non-compliance|1|||
37716230|NCT01490086|69194263|FG002|Overall Study|Non-compliance|0|||
37716231|NCT01490086|69194264|FG003|Overall Study|Non-compliance|0|||
37716232|NCT01490086|69194265|FG004|Overall Study|Non-compliance|0|||
37716233|NCT01490086|69194261|FG000|Overall Study|Abnormal laboratory findings|1|||
37716234|NCT01490086|69194262|FG001|Overall Study|Abnormal laboratory findings|0|||
37716235|NCT01490086|69194263|FG002|Overall Study|Abnormal laboratory findings|0|||
37716236|NCT01490086|69194264|FG003|Overall Study|Abnormal laboratory findings|0|||
37716237|NCT01490086|69194265|FG004|Overall Study|Abnormal laboratory findings|0|||
37716238|NCT01490086|69194261|FG000|Overall Study|Lost to Follow-up|0|||
37716239|NCT01490086|69194262|FG001|Overall Study|Lost to Follow-up|0|||
37716240|NCT01490086|69194263|FG002|Overall Study|Lost to Follow-up|0|||
37716241|NCT01490086|69194264|FG003|Overall Study|Lost to Follow-up|0|||
37716242|NCT01490086|69194265|FG004|Overall Study|Lost to Follow-up|1|||
37716243|NCT01490086|69194261|FG000|Overall Study|Physician Decision|3|||
37716244|NCT01490086|69194262|FG001|Overall Study|Physician Decision|4|||
37716245|NCT01490086|69194263|FG002|Overall Study|Physician Decision|2|||
37716246|NCT01490086|69194264|FG003|Overall Study|Physician Decision|3|||
37716247|NCT01490086|69194265|FG004|Overall Study|Physician Decision|1|||
37716248|NCT01490086|69194261|FG000|Overall Study|Adverse Event|0|||
37716249|NCT01490086|69194262|FG001|Overall Study|Adverse Event|0|||
37716250|NCT01490086|69194263|FG002|Overall Study|Adverse Event|1|||
37716251|NCT01490086|69194264|FG003|Overall Study|Adverse Event|2|||
37716252|NCT01490086|69194265|FG004|Overall Study|Adverse Event|0|||
37716253|NCT01490086|69194261|FG000|Overall Study|Lack of Efficacy|0|||
37716254|NCT01490086|69194262|FG001|Overall Study|Lack of Efficacy|3|||
37716255|NCT01490086|69194263|FG002|Overall Study|Lack of Efficacy|1|||
37716256|NCT01490086|69194264|FG003|Overall Study|Lack of Efficacy|0|||
37716257|NCT01490086|69194265|FG004|Overall Study|Lack of Efficacy|8|||
37716258|NCT01490086|69194261|FG000|Overall Study|Worsening of symptoms|0|||
37716259|NCT01490086|69194262|FG001|Overall Study|Worsening of symptoms|1|||
37716260|NCT01490086|69194263|FG002|Overall Study|Worsening of symptoms|0|||
37716261|NCT01490086|69194264|FG003|Overall Study|Worsening of symptoms|1|||
37716262|NCT01490086|69194265|FG004|Overall Study|Worsening of symptoms|0|||
37716263|NCT01490086|69194261|FG000|Overall Study|Subject uncontrollable and abusive|0|||
37716264|NCT01490086|69194262|FG001|Overall Study|Subject uncontrollable and abusive|1|||
37716265|NCT01490086|69194263|FG002|Overall Study|Subject uncontrollable and abusive|0|||
37716266|NCT01490086|69194264|FG003|Overall Study|Subject uncontrollable and abusive|0|||
37716267|NCT01490086|69194265|FG004|Overall Study|Subject uncontrollable and abusive|0|||
37716268|NCT01490086|69194261|FG000|Overall Study|Subject left hospital|0|||
37716269|NCT01490086|69194262|FG001|Overall Study|Subject left hospital|1|||
37716270|NCT01490086|69194263|FG002|Overall Study|Subject left hospital|0|||
37716271|NCT01490086|69194264|FG003|Overall Study|Subject left hospital|1|||
37716272|NCT01490086|69194265|FG004|Overall Study|Subject left hospital|0|||
37716273|NCT02114203|69194280|FG000|Overall Study|Adverse Event|0|||
37716274|NCT02114203|69194281|FG001|Overall Study|Adverse Event|1|||
37716275|NCT02114203|69194282|FG002|Overall Study|Adverse Event|0|||
37716276|NCT02114203|69194280|FG000|Overall Study|Withdrawal by Subject|0|||
37716277|NCT02114203|69194281|FG001|Overall Study|Withdrawal by Subject|1|||
37716278|NCT02114203|69194282|FG002|Overall Study|Withdrawal by Subject|0|||
37716279|NCT02113579|69194292|FG000|Overall Study|Adverse Event|1|||
37716280|NCT02113579|69194293|FG001|Overall Study|Adverse Event|0|||
37716281|NCT02113579|69194292|FG000|Overall Study|Withdrawal by Subject|3|||
37716282|NCT02113579|69194293|FG001|Overall Study|Withdrawal by Subject|2|||
37716283|NCT02113579|69194292|FG000|Overall Study|Lost to Follow-up|6|||
37716284|NCT02113579|69194293|FG001|Overall Study|Lost to Follow-up|2|||
37716285|NCT01474018|69194301|FG000|Overall Study|Lost to Follow-up|0|||
37716286|NCT01474018|69194302|FG001|Overall Study|Lost to Follow-up|1|||
37716287|NCT01474018|69194301|FG000|Overall Study|Withdrawal by Subject|0|||
37716288|NCT01474018|69194302|FG001|Overall Study|Withdrawal by Subject|2|||
37716289|NCT02100475|69194310|FG000|Overall Study|Unclassified|1|||
37716290|NCT02100475|69194311|FG001|Overall Study|Unclassified|2|||
37716291|NCT02100475|69194310|FG000|Overall Study|Withdrawal criteria|1|||
37716292|NCT02100475|69194311|FG001|Overall Study|Withdrawal criteria|0|||
37716293|NCT02113189|69194320|FG000|Overall Study|Lost to follow up|2|||
37716294|NCT02113189|69194321|FG001|Overall Study|Lost to follow up|1|||
37716295|NCT02113189|69194322|FG002|Overall Study|Lost to follow up|3|||
37716296|NCT01440946|69194335|FG000|Overall Study|Lost to Follow-up|1|||
37716297|NCT01440946|69194336|FG001|Overall Study|Lost to Follow-up|1|||
37716298|NCT01440946|69194335|FG000|Overall Study|Physician Decision|1|||
37716299|NCT01440946|69194336|FG001|Overall Study|Physician Decision|0|||
37716300|NCT01450540|69194345|FG000|Overall Study|Withdrawal by Subject|19|||
37716301|NCT01450540|69194346|FG001|Overall Study|Withdrawal by Subject|13|||
37716302|NCT01450540|69194345|FG000|Overall Study|protocol deviation|3|||
37716303|NCT01450540|69194346|FG001|Overall Study|protocol deviation|23|||
37716304|NCT02070757|69194356|FG000|Overall Study|Adverse Event|107|||
37716305|NCT02070757|69194357|FG001|Overall Study|Adverse Event|99|||
37716306|NCT02070757|69194356|FG000|Overall Study|Lost to Follow-up|7|||
37716307|NCT02070757|69194357|FG001|Overall Study|Lost to Follow-up|4|||
37716308|NCT02070757|69194356|FG000|Overall Study|Protocol Violation|0|||
37716309|NCT02070757|69194357|FG001|Overall Study|Protocol Violation|4|||
37716310|NCT02070757|69194356|FG000|Overall Study|Withdrawal by Subject|1|||
37716311|NCT02070757|69194357|FG001|Overall Study|Withdrawal by Subject|3|||
37716312|NCT02070757|69194356|FG000|Overall Study|Investigator Decision|0|||
37716313|NCT02070757|69194357|FG001|Overall Study|Investigator Decision|2|||
37716314|NCT02070757|69194356|FG000|Overall Study|Discharged from Study Hospital|2|||
37716315|NCT02070757|69194357|FG001|Overall Study|Discharged from Study Hospital|2|||
37716316|NCT02100319|69194363|FG000|Overall Study|Case Report Forms Uncollected|11|||
37716317|NCT02100319|69194363|FG000|Overall Study|Protocol Deviation|5|||
37716318|NCT01625845|69194369|FG000|Overall Study|Adverse Event|1|||
37716319|NCT01625845|69194370|FG001|Overall Study|Adverse Event|2|||
37716320|NCT01625845|69194369|FG000|Overall Study|Lost to Follow-up|2|||
37716321|NCT01625845|69194370|FG001|Overall Study|Lost to Follow-up|1|||
37716322|NCT01625845|69194369|FG000|Overall Study|Withdrawal by Subject|2|||
37716323|NCT01625845|69194370|FG001|Overall Study|Withdrawal by Subject|0|||
37716324|NCT01473940|69194380|FG000|Induction Therapy|Death|0|||
37716325|NCT01473940|69194381|FG001|Induction Therapy|Death|0|||
37716326|NCT01473940|69194382|FG002|Induction Therapy|Death|1|||
37716327|NCT01473940|69194383|FG003|Induction Therapy|Death|1|||
37716328|NCT01473940|69194380|FG000|Induction Therapy|Progressive Disease|0|||
37716329|NCT01473940|69194381|FG001|Induction Therapy|Progressive Disease|1|||
37716330|NCT01473940|69194382|FG002|Induction Therapy|Progressive Disease|1|||
37716331|NCT01473940|69194383|FG003|Induction Therapy|Progressive Disease|0|||
37716332|NCT01473940|69194380|FG000|Maintenance Therapy|Progressive Disease|1|||
37839183|NCT01085136|69523674|FG001|Part B|Refusal to continue trial medication|12|||
37716333|NCT01473940|69194381|FG001|Maintenance Therapy|Progressive Disease|2|||
37716334|NCT01473940|69194382|FG002|Maintenance Therapy|Progressive Disease|1|||
37716335|NCT01473940|69194383|FG003|Maintenance Therapy|Progressive Disease|4|||
37716336|NCT01832727|69194405|FG000|Overall Study|Adverse Event|4|||
37716337|NCT01832727|69194406|FG001|Overall Study|Adverse Event|6|||
37716338|NCT01832727|69194407|FG002|Overall Study|Adverse Event|1|||
37716339|NCT01832727|69194408|FG003|Overall Study|Adverse Event|0|||
37716340|NCT01832727|69194409|FG004|Overall Study|Adverse Event|1|||
37716341|NCT01832727|69194410|FG005|Overall Study|Adverse Event|1|||
37716342|NCT01832727|69194411|FG006|Overall Study|Adverse Event|2|||
37716343|NCT01832727|69194412|FG007|Overall Study|Adverse Event|1|||
37716344|NCT01832727|69194413|FG008|Overall Study|Adverse Event|9|||
37716345|NCT01832727|69194405|FG000|Overall Study|Disease progression|3|||
37716346|NCT01832727|69194406|FG001|Overall Study|Disease progression|0|||
37716347|NCT01832727|69194407|FG002|Overall Study|Disease progression|2|||
37716348|NCT01832727|69194408|FG003|Overall Study|Disease progression|1|||
37716349|NCT01832727|69194409|FG004|Overall Study|Disease progression|3|||
37839184|NCT01085136|69523675|FG002|Part B|Refusal to continue trial medication|7|||
37716350|NCT01832727|69194410|FG005|Overall Study|Disease progression|3|||
37716351|NCT01832727|69194411|FG006|Overall Study|Disease progression|6|||
37716352|NCT01832727|69194412|FG007|Overall Study|Disease progression|2|||
37716353|NCT01832727|69194413|FG008|Overall Study|Disease progression|7|||
37716354|NCT01832727|69194405|FG000|Overall Study|Lost to Follow-up|0|||
37716355|NCT01832727|69194406|FG001|Overall Study|Lost to Follow-up|0|||
37716356|NCT01832727|69194407|FG002|Overall Study|Lost to Follow-up|0|||
37716357|NCT01832727|69194408|FG003|Overall Study|Lost to Follow-up|1|||
37716358|NCT01832727|69194409|FG004|Overall Study|Lost to Follow-up|0|||
37716359|NCT01832727|69194410|FG005|Overall Study|Lost to Follow-up|0|||
37716360|NCT01832727|69194411|FG006|Overall Study|Lost to Follow-up|0|||
37716361|NCT01832727|69194412|FG007|Overall Study|Lost to Follow-up|0|||
37716362|NCT01832727|69194413|FG008|Overall Study|Lost to Follow-up|0|||
37716363|NCT01832727|69194405|FG000|Overall Study|Physician Decision|1|||
37716364|NCT01832727|69194406|FG001|Overall Study|Physician Decision|0|||
37716365|NCT01832727|69194407|FG002|Overall Study|Physician Decision|0|||
37716366|NCT01832727|69194408|FG003|Overall Study|Physician Decision|1|||
37716367|NCT01832727|69194409|FG004|Overall Study|Physician Decision|0|||
37716368|NCT01832727|69194410|FG005|Overall Study|Physician Decision|1|||
37716369|NCT01832727|69194411|FG006|Overall Study|Physician Decision|0|||
37716370|NCT01832727|69194412|FG007|Overall Study|Physician Decision|0|||
37716371|NCT01832727|69194413|FG008|Overall Study|Physician Decision|0|||
37716372|NCT01832727|69194405|FG000|Overall Study|Withdrawal by Subject|1|||
37716373|NCT01832727|69194406|FG001|Overall Study|Withdrawal by Subject|1|||
37716374|NCT01832727|69194407|FG002|Overall Study|Withdrawal by Subject|0|||
37716375|NCT01832727|69194408|FG003|Overall Study|Withdrawal by Subject|1|||
37716376|NCT01832727|69194409|FG004|Overall Study|Withdrawal by Subject|0|||
37716377|NCT01832727|69194410|FG005|Overall Study|Withdrawal by Subject|1|||
37716378|NCT01832727|69194411|FG006|Overall Study|Withdrawal by Subject|0|||
37716379|NCT01832727|69194412|FG007|Overall Study|Withdrawal by Subject|2|||
37716380|NCT01832727|69194413|FG008|Overall Study|Withdrawal by Subject|1|||
37716381|NCT01832727|69194405|FG000|Overall Study|Study terminated by sponsor|0|||
37716382|NCT01832727|69194406|FG001|Overall Study|Study terminated by sponsor|0|||
37716383|NCT01832727|69194407|FG002|Overall Study|Study terminated by sponsor|0|||
37839185|NCT01085136|69523673|FG000|Part B|Not treated|0|||
37839186|NCT01085136|69523674|FG001|Part B|Not treated|4|||
37839187|NCT01085136|69523675|FG002|Part B|Not treated|8|||
37839188|NCT01085136|69523673|FG000|Part B|Other reason not defined above|0|||
37839189|NCT01085136|69523674|FG001|Part B|Other reason not defined above|6|||
37839190|NCT01085136|69523675|FG002|Part B|Other reason not defined above|3|||
37839191|NCT01084707|69523685|FG000|Overall Study|Withdrawal by Subject|6|||
37839192|NCT01084668|69523697|FG000|Overall Study|Lack of Efficacy|5|||
37839193|NCT01084668|69523697|FG000|Overall Study|Withdrawal by Subject|2|||
37839194|NCT01084668|69523697|FG000|Overall Study|Pregnancy|1|||
37839195|NCT01084668|69523697|FG000|Overall Study|Non-compliance|1|||
37839196|NCT01084551|69523706|FG000|Overall Study|Adverse Event|2|||
37716384|NCT01832727|69194408|FG003|Overall Study|Study terminated by sponsor|0|||
37716385|NCT01832727|69194409|FG004|Overall Study|Study terminated by sponsor|0|||
37716386|NCT01832727|69194410|FG005|Overall Study|Study terminated by sponsor|0|||
37716387|NCT01832727|69194411|FG006|Overall Study|Study terminated by sponsor|0|||
37716388|NCT01832727|69194412|FG007|Overall Study|Study terminated by sponsor|1|||
37716389|NCT01832727|69194413|FG008|Overall Study|Study terminated by sponsor|1|||
37716390|NCT01473394|69194444|FG000|Overall Study|Adverse Event|13|||
37716391|NCT01473394|69194445|FG001|Overall Study|Adverse Event|16|||
37716392|NCT01473394|69194444|FG000|Overall Study|Insufficient Therapeutic Response|4|||
37716393|NCT01473394|69194445|FG001|Overall Study|Insufficient Therapeutic Response|1|||
37716394|NCT01473394|69194444|FG000|Overall Study|Protocol Violation|7|||
37716395|NCT01473394|69194445|FG001|Overall Study|Protocol Violation|5|||
37716396|NCT01473394|69194444|FG000|Overall Study|Withdrew Consent|12|||
37839197|NCT01084551|69523707|FG001|Overall Study|Adverse Event|9|||
37915483|NCT00853047|69602253|FG005|Open-Label Extension Phase|Participant Request|7|||
37839198|NCT01084551|69523708|FG002|Overall Study|Adverse Event|4|||
37915484|NCT00853047|69602248|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
37915485|NCT00853047|69602249|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
37915486|NCT00853047|69602250|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
37915487|NCT00853047|69602251|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
37716397|NCT01473394|69194445|FG001|Overall Study|Withdrew Consent|10|||
37716398|NCT01473394|69194444|FG000|Overall Study|Lost to Follow-up|9|||
37716399|NCT01473394|69194445|FG001|Overall Study|Lost to Follow-up|11|||
37716400|NCT01449682|69194453|FG000|Overall Study|Death|0|||
37839199|NCT01084551|69523706|FG000|Overall Study|Lack of Efficacy|2|||
37839200|NCT01084551|69523707|FG001|Overall Study|Lack of Efficacy|0|||
37839201|NCT01084551|69523708|FG002|Overall Study|Lack of Efficacy|1|||
37716401|NCT01449682|69194454|FG001|Overall Study|Death|1|||
37716402|NCT01449682|69194453|FG000|Overall Study|Adverse Event|1|||
37716403|NCT01449682|69194454|FG001|Overall Study|Adverse Event|0|||
37716404|NCT01449526|69194462|FG000|Overall Study|Lost to Follow-up|1|||
37716405|NCT01449526|69194463|FG001|Overall Study|Lost to Follow-up|2|||
37716406|NCT01449526|69194462|FG000|Overall Study|Withdrawal by Subject|1|||
37716407|NCT01449526|69194463|FG001|Overall Study|Withdrawal by Subject|1|||
37716408|NCT01449526|69194462|FG000|Overall Study|Symptoms/complaints|0|||
37716409|NCT01449526|69194463|FG001|Overall Study|Symptoms/complaints|1|||
37716410|NCT01449526|69194462|FG000|Overall Study|Lack of Motivation|0|||
37716411|NCT01449526|69194463|FG001|Overall Study|Lack of Motivation|1|||
37716412|NCT01449526|69194462|FG000|Overall Study|Cannot maintain visits|0|||
37716413|NCT01449526|69194463|FG001|Overall Study|Cannot maintain visits|1|||
37716414|NCT01440322|69194471|FG000|Overall Study|Discomfort|2|||
37716415|NCT01440322|69194472|FG001|Overall Study|Discomfort|0|||
37716416|NCT01440322|69194471|FG000|Overall Study|Biomicroscopy|1|||
37716417|NCT01440322|69194472|FG001|Overall Study|Biomicroscopy|0|||
37716418|NCT01440322|69194471|FG000|Overall Study|Symptoms and Problems|1|||
37716419|NCT01440322|69194472|FG001|Overall Study|Symptoms and Problems|0|||
37716420|NCT01440322|69194471|FG000|Overall Study|Unacceptable Subjective Vision|1|||
37716421|NCT01440322|69194472|FG001|Overall Study|Unacceptable Subjective Vision|0|||
37716422|NCT01440322|69194471|FG000|Overall Study|Other Product Related|1|||
37716423|NCT01440322|69194472|FG001|Overall Study|Other Product Related|0|||
37716424|NCT01440322|69194471|FG000|Overall Study|Unrelated Medical Problem|0|||
37716425|NCT01440322|69194472|FG001|Overall Study|Unrelated Medical Problem|1|||
37716426|NCT01440322|69194471|FG000|Overall Study|Other Non-Product Related|1|||
37716427|NCT01440322|69194472|FG001|Overall Study|Other Non-Product Related|0|||
37716428|NCT01832493|69194478|FG000|Overall Study|Physician Decision|2|||
37716429|NCT01832493|69194478|FG000|Overall Study|Protocol Violation|4|||
37839202|NCT01084551|69523706|FG000|Overall Study|Withdrawal by Subject|2|||
37839203|NCT01084551|69523707|FG001|Overall Study|Withdrawal by Subject|1|||
37716430|NCT01832493|69194478|FG000|Overall Study|Unable to place LV lead|2|||
37716431|NCT01831791|69194482|FG000|Overall Study|Withdrawal by Subject|10|||
37716432|NCT01857531|69194486|FG000|Overall Study|Withdrawal by Subject|4|||
37716433|NCT02166047|69194502|FG000|Overall Study|Withdrawal by Participant|0|||
37716434|NCT02166047|69194503|FG001|Overall Study|Withdrawal by Participant|1|||
37716435|NCT02166047|69194504|FG002|Overall Study|Withdrawal by Participant|2|||
37716436|NCT02166047|69194505|FG003|Overall Study|Withdrawal by Participant|0|||
37716437|NCT02166047|69194506|FG004|Overall Study|Withdrawal by Participant|0|||
37716438|NCT02166047|69194507|FG005|Overall Study|Withdrawal by Participant|0|||
37716439|NCT02166047|69194508|FG006|Overall Study|Withdrawal by Participant|1|||
37716440|NCT02166047|69194509|FG007|Overall Study|Withdrawal by Participant|0|||
37716441|NCT02166047|69194510|FG008|Overall Study|Withdrawal by Participant|0|||
37716442|NCT02166047|69194511|FG009|Overall Study|Withdrawal by Participant|0|||
37716443|NCT02166047|69194512|FG010|Overall Study|Withdrawal by Participant|0|||
37716444|NCT02166047|69194513|FG011|Overall Study|Withdrawal by Participant|0|||
37716445|NCT02166047|69194502|FG000|Overall Study|Adverse Event|0|||
37716446|NCT02166047|69194503|FG001|Overall Study|Adverse Event|0|||
37716447|NCT02166047|69194504|FG002|Overall Study|Adverse Event|0|||
37716448|NCT02166047|69194505|FG003|Overall Study|Adverse Event|0|||
37716449|NCT02166047|69194506|FG004|Overall Study|Adverse Event|1|||
37716450|NCT02166047|69194507|FG005|Overall Study|Adverse Event|0|||
37716451|NCT02166047|69194508|FG006|Overall Study|Adverse Event|1|||
37716452|NCT02166047|69194509|FG007|Overall Study|Adverse Event|0|||
37716453|NCT02166047|69194510|FG008|Overall Study|Adverse Event|0|||
37716454|NCT02166047|69194511|FG009|Overall Study|Adverse Event|0|||
37716455|NCT02166047|69194512|FG010|Overall Study|Adverse Event|2|||
37716456|NCT02166047|69194513|FG011|Overall Study|Adverse Event|0|||
37716457|NCT01493284|69194539|FG000|Overall Study|Death|29|||
37716458|NCT01493284|69194539|FG000|Overall Study|Withdrawal by Subject|32|||
37716459|NCT02165735|69194545|FG000|Overall Study|Lost to Follow-up|12|||
37716460|NCT02165735|69194546|FG001|Overall Study|Lost to Follow-up|10|||
37716461|NCT02165735|69194545|FG000|Overall Study|Withdrawal by Subject|3|||
37716462|NCT02165735|69194546|FG001|Overall Study|Withdrawal by Subject|0|||
37839204|NCT01084551|69523708|FG002|Overall Study|Withdrawal by Subject|0|||
37716463|NCT02165735|69194545|FG000|Overall Study|Participant indicated lack of time|1|||
37716464|NCT02165735|69194546|FG001|Overall Study|Participant indicated lack of time|3|||
37839205|NCT01084551|69523706|FG000|Overall Study|Protocol Violation|2|||
38024799|NCT04527978|69708720|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
37716465|NCT02165735|69194545|FG000|Overall Study|Protocol Violation|0|||
37716466|NCT02165735|69194546|FG001|Overall Study|Protocol Violation|1|||
37716467|NCT02069899|69194555|FG000|Overall Study|Adverse Event|6|||
37716468|NCT02069899|69194556|FG001|Overall Study|Adverse Event|0|||
37716469|NCT02069899|69194557|FG002|Overall Study|Adverse Event|1|||
37716470|NCT02069899|69194555|FG000|Overall Study|Withdrawal by Participant|2|||
37716471|NCT02069899|69194556|FG001|Overall Study|Withdrawal by Participant|0|||
37716472|NCT02069899|69194557|FG002|Overall Study|Withdrawal by Participant|0|||
37716473|NCT02069899|69194555|FG000|Overall Study|Lost to Follow-up|1|||
37716474|NCT02069899|69194556|FG001|Overall Study|Lost to Follow-up|0|||
37716475|NCT02069899|69194557|FG002|Overall Study|Lost to Follow-up|1|||
37716476|NCT02069899|69194555|FG000|Overall Study|Other|4|||
37716477|NCT02069899|69194556|FG001|Overall Study|Other|0|||
37716478|NCT02069899|69194557|FG002|Overall Study|Other|0|||
37716479|NCT02069899|69194555|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
37716480|NCT02069899|69194556|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
37716481|NCT02069899|69194557|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
37716482|NCT02069899|69194555|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
37716483|NCT02069899|69194556|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
37716484|NCT02069899|69194557|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
37716485|NCT01831089|69194572|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
37716486|NCT01831089|69194573|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
37716487|NCT01831089|69194574|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
37716488|NCT01831089|69194575|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
37716489|NCT01831089|69194576|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
37716490|NCT01831089|69194577|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
37716491|NCT01831089|69194572|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
37716492|NCT01831089|69194573|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
37716493|NCT01831089|69194574|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
37716494|NCT01831089|69194575|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
37716495|NCT01831089|69194576|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
37716496|NCT01831089|69194577|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
37716497|NCT01831089|69194572|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
37716498|NCT01831089|69194573|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
37716499|NCT01831089|69194574|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
37716500|NCT01831089|69194575|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
37716501|NCT01831089|69194576|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
37716502|NCT01831089|69194577|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
37716503|NCT01831089|69194572|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
37716504|NCT01831089|69194573|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
37716505|NCT01831089|69194574|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
37716506|NCT01831089|69194575|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
37716507|NCT01831089|69194576|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
37716508|NCT01831089|69194577|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
37716509|NCT01831089|69194572|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
37716510|NCT01831089|69194573|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
37716511|NCT01831089|69194574|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
37716512|NCT01831089|69194575|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
37716513|NCT01831089|69194576|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
37716514|NCT01831089|69194577|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
37716515|NCT01831089|69194572|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
37716516|NCT01831089|69194573|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
37716517|NCT01831089|69194574|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
37716518|NCT01831089|69194575|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
37716519|NCT01831089|69194576|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
37716520|NCT01831089|69194577|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
37716521|NCT01831089|69194572|FG000|Cohort III: Dose Level 3|Global end of study|0|||
37716522|NCT01831089|69194573|FG001|Cohort III: Dose Level 3|Global end of study|0|||
37716523|NCT01831089|69194574|FG002|Cohort III: Dose Level 3|Global end of study|1|||
37716524|NCT01831089|69194575|FG003|Cohort III: Dose Level 3|Global end of study|0|||
37716525|NCT01831089|69194576|FG004|Cohort III: Dose Level 3|Global end of study|0|||
37716526|NCT01831089|69194577|FG005|Cohort III: Dose Level 3|Global end of study|0|||
37716527|NCT01831089|69194572|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
37716528|NCT01831089|69194573|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
37716529|NCT01831089|69194574|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
37716530|NCT01831089|69194575|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
37716531|NCT01831089|69194576|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
37716532|NCT01831089|69194577|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
37716533|NCT01831089|69194572|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
37716534|NCT01831089|69194573|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
37716535|NCT01831089|69194574|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
37716536|NCT01831089|69194575|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
37716537|NCT01831089|69194576|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
37716538|NCT01831089|69194577|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
37716539|NCT01831089|69194572|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
37716540|NCT01831089|69194573|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
38043505|NCT03653390|69731635|FG001|Overall Study|Lost to Follow-up|8|||
37839206|NCT01084551|69523707|FG001|Overall Study|Protocol Violation|4|||
37716541|NCT01831089|69194574|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
37716542|NCT01831089|69194575|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
37716543|NCT01831089|69194576|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
37716544|NCT01831089|69194577|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
37716545|NCT01831089|69194572|FG000|Cohort V: Dose Level 5|Death|0|||
37716546|NCT01831089|69194573|FG001|Cohort V: Dose Level 5|Death|0|||
37716547|NCT01831089|69194574|FG002|Cohort V: Dose Level 5|Death|0|||
37716548|NCT01831089|69194575|FG003|Cohort V: Dose Level 5|Death|0|||
37716549|NCT01831089|69194576|FG004|Cohort V: Dose Level 5|Death|1|||
37716550|NCT01831089|69194577|FG005|Cohort V: Dose Level 5|Death|0|||
37716551|NCT01831089|69194572|FG000|Cohort V: Dose Level 5|Global end of study|0|||
37716552|NCT01831089|69194573|FG001|Cohort V: Dose Level 5|Global end of study|0|||
37716553|NCT01831089|69194574|FG002|Cohort V: Dose Level 5|Global end of study|0|||
37716554|NCT01831089|69194575|FG003|Cohort V: Dose Level 5|Global end of study|0|||
37716555|NCT01831089|69194576|FG004|Cohort V: Dose Level 5|Global end of study|2|||
37716556|NCT01831089|69194577|FG005|Cohort V: Dose Level 5|Global end of study|0|||
37716557|NCT01831089|69194572|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
37716558|NCT01831089|69194573|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
37716559|NCT01831089|69194574|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
37716560|NCT01831089|69194575|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
37716561|NCT01831089|69194576|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
37716562|NCT01831089|69194577|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
37716563|NCT01831089|69194572|FG000|Cohort B: Arm B|Progressive disease|0|||
37716564|NCT01831089|69194573|FG001|Cohort B: Arm B|Progressive disease|0|||
37716565|NCT01831089|69194574|FG002|Cohort B: Arm B|Progressive disease|0|||
37716566|NCT01831089|69194575|FG003|Cohort B: Arm B|Progressive disease|0|||
37716567|NCT01831089|69194576|FG004|Cohort B: Arm B|Progressive disease|0|||
37716568|NCT01831089|69194577|FG005|Cohort B: Arm B|Progressive disease|8|||
37716569|NCT01831089|69194572|FG000|Cohort B: Arm B|Physician Decision|0|||
37716570|NCT01831089|69194573|FG001|Cohort B: Arm B|Physician Decision|0|||
37716571|NCT01831089|69194574|FG002|Cohort B: Arm B|Physician Decision|0|||
37716572|NCT01831089|69194575|FG003|Cohort B: Arm B|Physician Decision|0|||
37716573|NCT01831089|69194576|FG004|Cohort B: Arm B|Physician Decision|0|||
37716574|NCT01831089|69194577|FG005|Cohort B: Arm B|Physician Decision|2|||
37716575|NCT01831089|69194572|FG000|Cohort B: Arm B|Never treated|0|||
37716576|NCT01831089|69194573|FG001|Cohort B: Arm B|Never treated|0|||
37716577|NCT01831089|69194574|FG002|Cohort B: Arm B|Never treated|0|||
37716578|NCT01831089|69194575|FG003|Cohort B: Arm B|Never treated|0|||
37716579|NCT01831089|69194576|FG004|Cohort B: Arm B|Never treated|0|||
37716580|NCT01831089|69194577|FG005|Cohort B: Arm B|Never treated|2|||
37716581|NCT01831089|69194572|FG000|Cohort B: Arm B|Adverse Event|0|||
37716582|NCT01831089|69194573|FG001|Cohort B: Arm B|Adverse Event|0|||
37716583|NCT01831089|69194574|FG002|Cohort B: Arm B|Adverse Event|0|||
37716584|NCT01831089|69194575|FG003|Cohort B: Arm B|Adverse Event|0|||
37716585|NCT01831089|69194576|FG004|Cohort B: Arm B|Adverse Event|0|||
37716586|NCT01831089|69194577|FG005|Cohort B: Arm B|Adverse Event|1|||
37716587|NCT01831089|69194572|FG000|Cohort B: Arm B|Global end of study|0|||
37839207|NCT01084551|69523708|FG002|Overall Study|Protocol Violation|0|||
37839208|NCT01084551|69523706|FG000|Overall Study|Lost to Follow-up|0|||
37839209|NCT01084551|69523707|FG001|Overall Study|Lost to Follow-up|0|||
37839210|NCT01084551|69523708|FG002|Overall Study|Lost to Follow-up|3|||
37839211|NCT01084551|69523706|FG000|Overall Study|Physician Decision|1|||
37839212|NCT01084551|69523707|FG001|Overall Study|Physician Decision|0|||
37839213|NCT01084551|69523708|FG002|Overall Study|Physician Decision|0|||
37839214|NCT01084005|69523718|FG000|Overall Study|Adverse Event|1|||
37839215|NCT01084005|69523719|FG001|Overall Study|Adverse Event|8|||
37839216|NCT01084005|69523718|FG000|Overall Study|Protocol Violation|3|||
37716588|NCT01831089|69194573|FG001|Cohort B: Arm B|Global end of study|0|||
37716589|NCT01831089|69194574|FG002|Cohort B: Arm B|Global end of study|0|||
37716590|NCT01831089|69194575|FG003|Cohort B: Arm B|Global end of study|0|||
37716591|NCT01831089|69194576|FG004|Cohort B: Arm B|Global end of study|0|||
37839217|NCT01084005|69523719|FG001|Overall Study|Protocol Violation|7|||
37716592|NCT01831089|69194577|FG005|Cohort B: Arm B|Global end of study|1|||
37716593|NCT02112877|69194594|FG000|Overall Study|Withdrawal by Subject|1|||
37716594|NCT02112877|69194595|FG001|Overall Study|Withdrawal by Subject|7|||
37716595|NCT02112877|69194594|FG000|Overall Study|Visit Missed|1|||
37716596|NCT02112877|69194595|FG001|Overall Study|Visit Missed|6|||
37716597|NCT02098369|69194606|FG000|Overall Study|Withdrawal by Subject|1|||
37716598|NCT02098369|69194607|FG001|Overall Study|Withdrawal by Subject|5|||
37716599|NCT02098369|69194608|FG002|Overall Study|Withdrawal by Subject|0|||
37716600|NCT02098369|69194606|FG000|Overall Study|Lost to Follow-up|5|||
37716601|NCT02098369|69194607|FG001|Overall Study|Lost to Follow-up|1|||
37716602|NCT02098369|69194608|FG002|Overall Study|Lost to Follow-up|3|||
37716603|NCT02098369|69194606|FG000|Overall Study|Death|1|||
37716604|NCT02098369|69194607|FG001|Overall Study|Death|1|||
37716605|NCT02098369|69194608|FG002|Overall Study|Death|1|||
37716606|NCT02098369|69194606|FG000|Overall Study|Other|0|||
37716607|NCT02098369|69194607|FG001|Overall Study|Other|2|||
37716608|NCT02098369|69194608|FG002|Overall Study|Other|1|||
37716609|NCT02111785|69194620|FG000|Overall Study|Death|0|||
37716610|NCT02111785|69194621|FG001|Overall Study|Death|1|||
37716611|NCT02111785|69194622|FG002|Overall Study|Death|0|||
37716612|NCT02111785|69194623|FG003|Overall Study|Death|0|||
37716613|NCT02068885|69194640|FG000|Overall Study|Withdrew|3|||
37716614|NCT02068885|69194641|FG001|Overall Study|Withdrew|5|||
37716615|NCT02068885|69194642|FG002|Overall Study|Withdrew|8|||
37716616|NCT02068495|69194651|FG000|Overall Study|Case Report Forms Uncollected|60|||
37716617|NCT02068495|69194651|FG000|Overall Study|Protocol Deviation|49|||
37716618|NCT02097823|69194657|FG000|Overall Study|Withdrawal by Subject|1|||
37716619|NCT02097823|69194658|FG001|Overall Study|Withdrawal by Subject|1|||
37716620|NCT01830855|69194669|FG000|Overall Study|Other|7|||
37716621|NCT01830855|69194670|FG001|Overall Study|Other|1|||
37716622|NCT01830855|69194671|FG002|Overall Study|Other|4|||
37716623|NCT01830855|69194672|FG003|Overall Study|Other|4|||
37716624|NCT01830855|69194669|FG000|Overall Study|Medication error without associated AE|1|||
37716625|NCT01830855|69194670|FG001|Overall Study|Medication error without associated AE|0|||
37716626|NCT01830855|69194671|FG002|Overall Study|Medication error without associated AE|0|||
37716627|NCT01830855|69194672|FG003|Overall Study|Medication error without associated AE|1|||
37716628|NCT01830855|69194669|FG000|Overall Study|Pregnancy|3|||
37716629|NCT01830855|69194670|FG001|Overall Study|Pregnancy|1|||
37716630|NCT01830855|69194671|FG002|Overall Study|Pregnancy|2|||
37716631|NCT01830855|69194672|FG003|Overall Study|Pregnancy|1|||
37716632|NCT01830855|69194669|FG000|Overall Study|No longer meets eligibility criteria|11|||
37716633|NCT01830855|69194670|FG001|Overall Study|No longer meets eligibility criteria|2|||
37716634|NCT01830855|69194671|FG002|Overall Study|No longer meets eligibility criteria|3|||
37716635|NCT01830855|69194672|FG003|Overall Study|No longer meets eligibility criteria|5|||
37716636|NCT01830855|69194669|FG000|Overall Study|Adverse Event|11|||
37716637|NCT01830855|69194670|FG001|Overall Study|Adverse Event|5|||
37716638|NCT01830855|69194671|FG002|Overall Study|Adverse Event|6|||
37716639|NCT01830855|69194672|FG003|Overall Study|Adverse Event|3|||
37716640|NCT01830855|69194669|FG000|Overall Study|Protocol deviation|10|||
37716641|NCT01830855|69194670|FG001|Overall Study|Protocol deviation|5|||
37716642|NCT01830855|69194671|FG002|Overall Study|Protocol deviation|6|||
37716643|NCT01830855|69194672|FG003|Overall Study|Protocol deviation|6|||
37716644|NCT01830855|69194669|FG000|Overall Study|Withdrawal by Subject|33|||
37716645|NCT01830855|69194670|FG001|Overall Study|Withdrawal by Subject|14|||
37716646|NCT01830855|69194671|FG002|Overall Study|Withdrawal by Subject|10|||
37716647|NCT01830855|69194672|FG003|Overall Study|Withdrawal by Subject|12|||
37716648|NCT01830855|69194669|FG000|Overall Study|No longer willing to participate|32|||
37716649|NCT01830855|69194670|FG001|Overall Study|No longer willing to participate|13|||
37716650|NCT01830855|69194671|FG002|Overall Study|No longer willing to participate|12|||
37716651|NCT01830855|69194672|FG003|Overall Study|No longer willing to participate|17|||
37716652|NCT01830855|69194669|FG000|Overall Study|Lost to Follow-up|47|||
37716653|NCT01830855|69194670|FG001|Overall Study|Lost to Follow-up|20|||
37716654|NCT01830855|69194671|FG002|Overall Study|Lost to Follow-up|23|||
37716655|NCT01830855|69194672|FG003|Overall Study|Lost to Follow-up|33|||
37716656|NCT01857063|69194689|FG000|Period 1 (7 Days)|Adverse Event|0|||
37716657|NCT01857063|69194690|FG001|Period 1 (7 Days)|Adverse Event|1|||
37716658|NCT01857063|69194689|FG000|Period 1 (7 Days)|Physician Decision|1|||
37716659|NCT01857063|69194690|FG001|Period 1 (7 Days)|Physician Decision|0|||
37716660|NCT01857063|69194689|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
37716661|NCT01857063|69194690|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
37716662|NCT01857063|69194689|FG000|Period 2 (7 Days)|Adverse Event|2|||
37716663|NCT01857063|69194690|FG001|Period 2 (7 Days)|Adverse Event|1|||
37716664|NCT01857063|69194689|FG000|Period 2 (7 Days)|Physician Decision|1|||
37716665|NCT01857063|69194690|FG001|Period 2 (7 Days)|Physician Decision|1|||
37716666|NCT01857063|69194689|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
37716667|NCT01857063|69194690|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
37716668|NCT01856907|69194699|FG000|Overall Study|Pregnancy|0|||
38024800|NCT04136444|69708731|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
37716669|NCT01856907|69194700|FG001|Overall Study|Pregnancy|1|||
38024801|NCT04136444|69708732|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
37716670|NCT01856907|69194701|FG002|Overall Study|Pregnancy|0|||
37716671|NCT01856907|69194699|FG000|Overall Study|Pregnancy|0|||
37716672|NCT01856907|69194700|FG001|Overall Study|Pregnancy|1|||
37716673|NCT01856907|69194701|FG002|Overall Study|Pregnancy|0|||
37716674|NCT01856907|69194699|FG000|Overall Study|Withdrawal by Subject|0|||
37716675|NCT01856907|69194700|FG001|Overall Study|Withdrawal by Subject|1|||
37716676|NCT01856907|69194701|FG002|Overall Study|Withdrawal by Subject|0|||
37716677|NCT02212457|69194718|FG000|Overall Study|Adverse Event|1|||
37716678|NCT02212457|69194719|FG001|Overall Study|Adverse Event|2|||
37716679|NCT02212457|69194720|FG002|Overall Study|Adverse Event|2|||
37716680|NCT02212457|69194721|FG003|Overall Study|Adverse Event|2|||
37716681|NCT02212457|69194722|FG004|Overall Study|Adverse Event|0|||
37716682|NCT02212457|69194723|FG005|Overall Study|Adverse Event|1|||
37716683|NCT02212457|69194718|FG000|Overall Study|Withdrawal by Subject|8|||
37716684|NCT02212457|69194719|FG001|Overall Study|Withdrawal by Subject|10|||
37716685|NCT02212457|69194720|FG002|Overall Study|Withdrawal by Subject|8|||
37716686|NCT02212457|69194721|FG003|Overall Study|Withdrawal by Subject|6|||
37716687|NCT02212457|69194722|FG004|Overall Study|Withdrawal by Subject|5|||
37716688|NCT02212457|69194723|FG005|Overall Study|Withdrawal by Subject|4|||
37716689|NCT02212457|69194718|FG000|Overall Study|Lost to Follow-up|6|||
37716690|NCT02212457|69194719|FG001|Overall Study|Lost to Follow-up|7|||
37716691|NCT02212457|69194720|FG002|Overall Study|Lost to Follow-up|4|||
37716692|NCT02212457|69194721|FG003|Overall Study|Lost to Follow-up|1|||
37716693|NCT02212457|69194722|FG004|Overall Study|Lost to Follow-up|8|||
37716694|NCT02212457|69194723|FG005|Overall Study|Lost to Follow-up|4|||
37716695|NCT02212457|69194718|FG000|Overall Study|Protocol Violation|2|||
37716696|NCT02212457|69194719|FG001|Overall Study|Protocol Violation|1|||
37716697|NCT02212457|69194720|FG002|Overall Study|Protocol Violation|0|||
37716698|NCT02212457|69194721|FG003|Overall Study|Protocol Violation|1|||
37716699|NCT02212457|69194722|FG004|Overall Study|Protocol Violation|2|||
37716700|NCT02212457|69194723|FG005|Overall Study|Protocol Violation|3|||
37716701|NCT02212457|69194718|FG000|Overall Study|Other|2|||
37716702|NCT02212457|69194719|FG001|Overall Study|Other|1|||
37716703|NCT02212457|69194720|FG002|Overall Study|Other|2|||
37716704|NCT02212457|69194721|FG003|Overall Study|Other|1|||
37716705|NCT02212457|69194722|FG004|Overall Study|Other|0|||
37716706|NCT02212457|69194723|FG005|Overall Study|Other|1|||
37716707|NCT02097745|69194744|FG000|Overall Study|Adverse Event|25|||
37716708|NCT02097745|69194744|FG000|Overall Study|Death|16|||
37716709|NCT02097745|69194744|FG000|Overall Study|Failure to Return|14|||
37716710|NCT02097745|69194744|FG000|Overall Study|Administrative/Other|27|||
37839218|NCT01084005|69523718|FG000|Overall Study|Withdrawal by Subject|1|||
37839219|NCT01084005|69523719|FG001|Overall Study|Withdrawal by Subject|1|||
37839220|NCT01083810|69523728|FG000|Overall Study|Lost to Follow-up|23|||
37839221|NCT01083810|69523729|FG001|Overall Study|Lost to Follow-up|11|||
37839222|NCT01083810|69523730|FG002|Overall Study|Lost to Follow-up|4|||
37839223|NCT01083810|69523728|FG000|Overall Study|Adverse Event|15|||
37839224|NCT01083810|69523729|FG001|Overall Study|Adverse Event|11|||
37839225|NCT01083810|69523730|FG002|Overall Study|Adverse Event|4|||
37839226|NCT01083810|69523728|FG000|Overall Study|Withdrawal by Subject|7|||
37839227|NCT01083810|69523729|FG001|Overall Study|Withdrawal by Subject|2|||
37839228|NCT01083810|69523730|FG002|Overall Study|Withdrawal by Subject|4|||
37839229|NCT01083810|69523728|FG000|Overall Study|Reason not reported|6|||
37839230|NCT01083810|69523729|FG001|Overall Study|Reason not reported|1|||
37839231|NCT01083810|69523730|FG002|Overall Study|Reason not reported|1|||
37839232|NCT01083810|69523728|FG000|Overall Study|Non-compliance|4|||
37839233|NCT01083810|69523729|FG001|Overall Study|Non-compliance|7|||
37839234|NCT01083810|69523730|FG002|Overall Study|Non-compliance|2|||
37839235|NCT01083810|69523728|FG000|Overall Study|Simplification|4|||
37839236|NCT01083810|69523729|FG001|Overall Study|Simplification|1|||
37839237|NCT01083810|69523730|FG002|Overall Study|Simplification|0|||
37839238|NCT01083810|69523728|FG000|Overall Study|Death|2|||
37839239|NCT01083810|69523729|FG001|Overall Study|Death|2|||
37839240|NCT01083810|69523730|FG002|Overall Study|Death|3|||
37839241|NCT01083810|69523728|FG000|Overall Study|Co-morbidities|1|||
37839242|NCT01083810|69523729|FG001|Overall Study|Co-morbidities|0|||
37839243|NCT01083810|69523730|FG002|Overall Study|Co-morbidities|0|||
37839244|NCT01083810|69523728|FG000|Overall Study|Participation in study|1|||
37839245|NCT01083810|69523729|FG001|Overall Study|Participation in study|0|||
37716711|NCT02097745|69194744|FG000|Overall Study|Reason Not Specified|96|||
37716712|NCT02111083|69194753|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
37839246|NCT01083810|69523730|FG002|Overall Study|Participation in study|0|||
37839247|NCT01083810|69523728|FG000|Overall Study|Therapy break|1|||
37839248|NCT01083810|69523729|FG001|Overall Study|Therapy break|2|||
37839249|NCT01083810|69523730|FG002|Overall Study|Therapy break|2|||
37716713|NCT02111083|69194754|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
37839250|NCT01083810|69523728|FG000|Overall Study|Virologic failure|1|||
37839251|NCT01083810|69523729|FG001|Overall Study|Virologic failure|8|||
37716714|NCT01629563|69194762|FG000|Overall Study|Adverse Event|16|||
37716715|NCT01629563|69194763|FG001|Overall Study|Adverse Event|16|||
37716716|NCT01629563|69194762|FG000|Overall Study|Death|2|||
37716717|NCT01629563|69194763|FG001|Overall Study|Death|0|||
37716718|NCT01629563|69194762|FG000|Overall Study|Lack of Efficacy|2|||
37716719|NCT01629563|69194763|FG001|Overall Study|Lack of Efficacy|3|||
37839252|NCT01083810|69523730|FG002|Overall Study|Virologic failure|0|||
37839253|NCT01083771|69523736|FG000|Overall Study|non-compliant|2|||
37839254|NCT01083771|69523736|FG000|Overall Study|Withdrawal by Subject|3|||
37716720|NCT01629563|69194762|FG000|Overall Study|Lost to Follow-up|1|||
37716721|NCT01629563|69194763|FG001|Overall Study|Lost to Follow-up|0|||
37716722|NCT01629563|69194762|FG000|Overall Study|Pregnancy|1|||
37839255|NCT01083693|69523743|FG000|Overall Study|Adverse Event|1|||
37716723|NCT01629563|69194763|FG001|Overall Study|Pregnancy|2|||
37716724|NCT01629563|69194762|FG000|Overall Study|Protocol Violation|0|||
37716725|NCT01629563|69194763|FG001|Overall Study|Protocol Violation|1|||
37716726|NCT01629563|69194762|FG000|Overall Study|Withdrawal by Subject|27|||
37716727|NCT01629563|69194763|FG001|Overall Study|Withdrawal by Subject|20|||
37716728|NCT01629563|69194762|FG000|Overall Study|surgery|0|||
37716729|NCT01629563|69194763|FG001|Overall Study|surgery|3|||
37716730|NCT01629563|69194762|FG000|Overall Study|Lack of return of menses|12|||
37716731|NCT01629563|69194763|FG001|Overall Study|Lack of return of menses|7|||
37716732|NCT01629563|69194762|FG000|Overall Study|Protocol Violation|0|||
37716733|NCT01629563|69194763|FG001|Overall Study|Protocol Violation|1|||
37716734|NCT02097277|69194774|FG000|Overall Study|Subject no longer meets study criteria|0|||
37716735|NCT02097277|69194775|FG001|Overall Study|Subject no longer meets study criteria|1|||
37716736|NCT02097277|69194776|FG002|Overall Study|Subject no longer meets study criteria|0|||
37716737|NCT02097277|69194777|FG003|Overall Study|Subject no longer meets study criteria|1|||
37716738|NCT02097277|69194778|FG004|Overall Study|Subject no longer meets study criteria|0|||
37716739|NCT02097277|69194774|FG000|Overall Study|Subject request to discontinue treatment|0|||
37716740|NCT02097277|69194775|FG001|Overall Study|Subject request to discontinue treatment|0|||
37716741|NCT02097277|69194776|FG002|Overall Study|Subject request to discontinue treatment|0|||
37716742|NCT02097277|69194777|FG003|Overall Study|Subject request to discontinue treatment|0|||
37716743|NCT02097277|69194778|FG004|Overall Study|Subject request to discontinue treatment|1|||
37716744|NCT02097277|69194774|FG000|Overall Study|Lost to Follow-up|0|||
37716745|NCT02097277|69194775|FG001|Overall Study|Lost to Follow-up|1|||
37716746|NCT02097277|69194776|FG002|Overall Study|Lost to Follow-up|1|||
37716747|NCT02097277|69194777|FG003|Overall Study|Lost to Follow-up|0|||
37716748|NCT02097277|69194778|FG004|Overall Study|Lost to Follow-up|0|||
37716749|NCT02097277|69194774|FG000|Overall Study|Withdrawal by Subject|2|||
37716750|NCT02097277|69194775|FG001|Overall Study|Withdrawal by Subject|1|||
37716751|NCT02097277|69194776|FG002|Overall Study|Withdrawal by Subject|0|||
37716752|NCT02097277|69194777|FG003|Overall Study|Withdrawal by Subject|1|||
37716753|NCT02097277|69194778|FG004|Overall Study|Withdrawal by Subject|0|||
37716754|NCT02097277|69194774|FG000|Overall Study|Adverse Event|0|||
37716755|NCT02097277|69194775|FG001|Overall Study|Adverse Event|0|||
37716756|NCT02097277|69194776|FG002|Overall Study|Adverse Event|1|||
37716757|NCT02097277|69194777|FG003|Overall Study|Adverse Event|2|||
37716758|NCT02097277|69194778|FG004|Overall Study|Adverse Event|0|||
37716759|NCT02212379|69194794|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
37716760|NCT02212379|69194794|FG000|From Baseline to Week 48|Adverse Event|7|||
37716761|NCT02212379|69194794|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
37716762|NCT02212379|69194794|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
37716763|NCT02212379|69194794|FG000|From Week 48 to Week 96|Adverse Event|1|||
37716764|NCT02212379|69194794|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
37716765|NCT02110693|69194801|FG000|Overall Study|Withdrawal by Subject|6|||
37716766|NCT02110693|69194802|FG001|Overall Study|Withdrawal by Subject|7|||
37716767|NCT02110693|69194801|FG000|Overall Study|skipped assessment|15|||
37716768|NCT02110693|69194802|FG001|Overall Study|skipped assessment|18|||
37716769|NCT02110693|69194801|FG000|Overall Study|technical difficulties|6|||
37716770|NCT02110693|69194802|FG001|Overall Study|technical difficulties|4|||
37716771|NCT02110693|69194801|FG000|Overall Study|Other|1|||
37716772|NCT02110693|69194802|FG001|Overall Study|Other|0|||
37716773|NCT02212301|69194822|FG000|Period 1|Lost to Follow-up|0|||
37716774|NCT02212301|69194823|FG001|Period 1|Lost to Follow-up|1|||
37716775|NCT02211209|69194832|FG000|Overall Study|Investigator judgment|0|||
37716776|NCT02211209|69194833|FG001|Overall Study|Investigator judgment|1|||
37716777|NCT02211209|69194832|FG000|Overall Study|Voluntary withdrawal|1|||
37716778|NCT02211209|69194833|FG001|Overall Study|Voluntary withdrawal|4|||
37716779|NCT02211209|69194832|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
37716780|NCT02211209|69194833|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
37716781|NCT02211209|69194832|FG000|Overall Study|Reason Not Specified|1|||
37716782|NCT02211209|69194833|FG001|Overall Study|Reason Not Specified|0|||
37716783|NCT02187809|69194839|FG000|Overall Study|The study was terminated|3|||
37716784|NCT02110225|69194846|FG000|Overall Study|Lost to Follow-up|0|||
37716785|NCT02110225|69194847|FG001|Overall Study|Lost to Follow-up|1|||
37716786|NCT02110225|69194848|FG002|Overall Study|Lost to Follow-up|0|||
37716787|NCT02187029|69194861|FG000|Overall Study|Adverse Event|0|||
37716788|NCT02187029|69194862|FG001|Overall Study|Adverse Event|1|||
37716789|NCT02187029|69194863|FG002|Overall Study|Adverse Event|1|||
37716790|NCT02187029|69194864|FG003|Overall Study|Adverse Event|0|||
37716791|NCT02187029|69194861|FG000|Overall Study|Study Terminated by Sponsor|0|||
37716792|NCT02187029|69194862|FG001|Overall Study|Study Terminated by Sponsor|0|||
37716793|NCT02187029|69194863|FG002|Overall Study|Study Terminated by Sponsor|10|||
38024802|NCT04425252|69708746|FG000|Overall Study|Withdrawal by Subject|2|||
37716794|NCT02187029|69194864|FG003|Overall Study|Study Terminated by Sponsor|3|||
37716795|NCT02187029|69194861|FG000|Overall Study|Withdrawal by Subject|1|||
37716796|NCT02187029|69194862|FG001|Overall Study|Withdrawal by Subject|0|||
38024803|NCT04425252|69708747|FG001|Overall Study|Withdrawal by Subject|1|||
38024804|NCT04425252|69708746|FG000|Overall Study|Lost to Follow-up|1|||
38024805|NCT04425252|69708747|FG001|Overall Study|Lost to Follow-up|0|||
38024806|NCT04425252|69708746|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
38024807|NCT04425252|69708747|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
38024808|NCT03696576|69708758|FG000|Overall Study|Soreness of throat after therapy|1|||
38024809|NCT03696576|69708759|FG001|Overall Study|Soreness of throat after therapy|1|||
38024810|NCT03696576|69708758|FG000|Overall Study|Lost to Follow-up|2|||
38024811|NCT03696576|69708759|FG001|Overall Study|Lost to Follow-up|4|||
38024812|NCT04003610|69708768|FG000|Overall Study|Lost to Follow-up|0|||
38024813|NCT04003610|69708769|FG001|Overall Study|Lost to Follow-up|1|||
38024814|NCT04003610|69708770|FG002|Overall Study|Lost to Follow-up|0|||
37716797|NCT02187029|69194863|FG002|Overall Study|Withdrawal by Subject|0|||
38024815|NCT04003610|69708768|FG000|Overall Study|Death|0|||
38024816|NCT04003610|69708769|FG001|Overall Study|Death|0|||
38024817|NCT04003610|69708770|FG002|Overall Study|Death|3|||
38024818|NCT04003610|69708768|FG000|Overall Study|Study Terminated by Sponsor|0|||
38043506|NCT03653390|69731636|FG002|Overall Study|Lost to Follow-up|7|||
38043507|NCT03653390|69731634|FG000|Overall Study|Withdrawal by Subject|6|||
38043508|NCT03653390|69731635|FG001|Overall Study|Withdrawal by Subject|1|||
38043509|NCT03653390|69731636|FG002|Overall Study|Withdrawal by Subject|1|||
38043510|NCT03653390|69731634|FG000|Overall Study|Death|1|||
38043511|NCT03653390|69731635|FG001|Overall Study|Death|0|||
38043512|NCT03653390|69731636|FG002|Overall Study|Death|0|||
38043513|NCT03653390|69731634|FG000|Overall Study|Paper Survey Lost|1|||
38043514|NCT03653390|69731635|FG001|Overall Study|Paper Survey Lost|0|||
38043515|NCT03653390|69731636|FG002|Overall Study|Paper Survey Lost|0|||
38043516|NCT03509467|69731652|FG000|Overall Study|Withdrawal by Subject|5|||
38043517|NCT03509467|69731653|FG001|Overall Study|Withdrawal by Subject|1|||
38043518|NCT03509467|69731654|FG002|Overall Study|Withdrawal by Subject|6|||
38043519|NCT03509467|69731655|FG003|Overall Study|Withdrawal by Subject|7|||
38043520|NCT03509467|69731656|FG004|Overall Study|Withdrawal by Subject|10|||
38043521|NCT03509467|69731657|FG005|Overall Study|Withdrawal by Subject|10|||
38043522|NCT03509467|69731658|FG006|Overall Study|Withdrawal by Subject|10|||
38043523|NCT03509467|69731659|FG007|Overall Study|Withdrawal by Subject|10|||
38043524|NCT03509467|69731652|FG000|Overall Study|Death|0|||
38043525|NCT03509467|69731653|FG001|Overall Study|Death|0|||
38043526|NCT03509467|69731654|FG002|Overall Study|Death|2|||
37716798|NCT02187029|69194864|FG003|Overall Study|Withdrawal by Subject|0|||
37716799|NCT02162771|69194876|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
37716800|NCT02162771|69194877|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
37716801|NCT02162771|69194876|FG000|Core Study Period (Part 2)|Adverse Event|4|||
37716802|NCT02162771|69194877|FG001|Core Study Period (Part 2)|Adverse Event|1|||
37716803|NCT02162771|69194876|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
37716804|NCT02162771|69194877|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
37716805|NCT02162771|69194876|FG000|Core Study Period (Part 2)|Physician Decision|0|||
37716806|NCT02162771|69194877|FG001|Core Study Period (Part 2)|Physician Decision|2|||
37716807|NCT02162771|69194876|FG000|Core Study Period (Part 2)|Death|1|||
37716808|NCT02162771|69194877|FG001|Core Study Period (Part 2)|Death|0|||
37716809|NCT02162771|69194876|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
37716810|NCT02162771|69194877|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
37716811|NCT02162771|69194876|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
37716812|NCT02162771|69194877|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
37716813|NCT02162771|69194876|FG000|Maintenance Study Period (Part 2)|Death|2|||
37716814|NCT02162771|69194877|FG001|Maintenance Study Period (Part 2)|Death|1|||
37716815|NCT02162771|69194876|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
37716816|NCT02162771|69194877|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
37716817|NCT02162771|69194876|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
37716818|NCT02162771|69194877|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
37716819|NCT02162771|69194876|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
37716820|NCT02162771|69194877|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
37716821|NCT02161757|69194886|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
37716822|NCT02161757|69194887|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
37716823|NCT02161757|69194888|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
37716824|NCT02161757|69194886|FG000|Treatment Through Study Completion|Adverse Event|1|||
37716825|NCT02161757|69194887|FG001|Treatment Through Study Completion|Adverse Event|1|||
37716826|NCT02161757|69194888|FG002|Treatment Through Study Completion|Adverse Event|0|||
37716827|NCT02161757|69194886|FG000|Treatment Through Study Completion|Protocol Violation|0|||
37716828|NCT02161757|69194887|FG001|Treatment Through Study Completion|Protocol Violation|1|||
37716829|NCT02161757|69194888|FG002|Treatment Through Study Completion|Protocol Violation|2|||
37716830|NCT02161757|69194886|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
37716831|NCT02161757|69194887|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
38024819|NCT04003610|69708769|FG001|Overall Study|Study Terminated by Sponsor|0|||
38024820|NCT04003610|69708770|FG002|Overall Study|Study Terminated by Sponsor|3|||
38024821|NCT03999554|69708784|FG000|Overall Study|Lost to Follow-up|4|||
37716832|NCT02161757|69194888|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
37716833|NCT02161757|69194886|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
37716834|NCT02161757|69194887|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
37716835|NCT02161757|69194888|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
37716836|NCT02161757|69194886|FG000|Treatment Through Study Completion|Other|20|||
37716837|NCT02161757|69194887|FG001|Treatment Through Study Completion|Other|19|||
37716838|NCT02161757|69194888|FG002|Treatment Through Study Completion|Other|12|||
37716839|NCT02161757|69194886|FG000|Treatment Through Study Completion|Death|2|||
37716840|NCT02161757|69194887|FG001|Treatment Through Study Completion|Death|1|||
37716841|NCT02161757|69194888|FG002|Treatment Through Study Completion|Death|1|||
37716842|NCT02160977|69194898|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
37716843|NCT02160977|69194899|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
37716844|NCT02160977|69194898|FG000|Three Months After Surgery|Lost to Follow-up|0|||
37716845|NCT02160977|69194899|FG001|Three Months After Surgery|Lost to Follow-up|2|||
37716846|NCT02160977|69194898|FG000|Six Months After Surgery|Lost to Follow-up|2|||
37716847|NCT02160977|69194899|FG001|Six Months After Surgery|Lost to Follow-up|1|||
37915488|NCT00853047|69602252|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
37915489|NCT00853047|69602253|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
37915490|NCT00853047|69602248|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
37915491|NCT00853047|69602249|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
37716848|NCT02160899|69194911|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
37716849|NCT02160899|69194912|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
37716850|NCT02160899|69194913|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
37716851|NCT02160899|69194914|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
37716852|NCT02160899|69194915|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
37716853|NCT02160899|69194916|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
37716854|NCT02160041|69194930|FG000|Overall Study|Adverse Event|11|||
37716855|NCT02160041|69194930|FG000|Overall Study|Death|2|||
37716856|NCT02160041|69194930|FG000|Overall Study|disease progression|57|||
37716857|NCT02160041|69194930|FG000|Overall Study|Protocol Violation|1|||
37716858|NCT02160041|69194930|FG000|Overall Study|non-compliance with study|1|||
37716859|NCT02160041|69194930|FG000|Overall Study|Physician Decision|3|||
37716860|NCT02160041|69194930|FG000|Overall Study|Withdrawal by Subject|8|||
37716861|NCT02160041|69194930|FG000|Overall Study|study terminated by by sponsor|1|||
37716862|NCT02186873|69194936|FG000|Overall Study|Adverse Event|1|||
37716863|NCT02186873|69194937|FG001|Overall Study|Adverse Event|3|||
37716864|NCT02186873|69194936|FG000|Overall Study|Lack of Efficacy|0|||
37716865|NCT02186873|69194937|FG001|Overall Study|Lack of Efficacy|1|||
37716866|NCT02186873|69194936|FG000|Overall Study|Lost to Follow-up|1|||
37716867|NCT02186873|69194937|FG001|Overall Study|Lost to Follow-up|2|||
37716868|NCT02186873|69194936|FG000|Overall Study|Withdrawal by Subject|7|||
37716869|NCT02186873|69194937|FG001|Overall Study|Withdrawal by Subject|2|||
37716870|NCT02096263|69194947|FG000|Overall Study|Adverse Event|1|||
37915492|NCT00853047|69602250|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
37915493|NCT00853047|69602251|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
37915494|NCT00853047|69602252|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
37716871|NCT02096263|69194948|FG001|Overall Study|Adverse Event|0|||
37716872|NCT02096263|69194949|FG002|Overall Study|Adverse Event|1|||
37716873|NCT02096263|69194947|FG000|Overall Study|Lost to Follow-up|14|||
37716874|NCT02096263|69194948|FG001|Overall Study|Lost to Follow-up|18|||
37716875|NCT02096263|69194949|FG002|Overall Study|Lost to Follow-up|15|||
37716876|NCT02096263|69194947|FG000|Overall Study|Other|7|||
37716877|NCT02096263|69194948|FG001|Overall Study|Other|9|||
37716878|NCT02096263|69194949|FG002|Overall Study|Other|6|||
37716879|NCT02096263|69194947|FG000|Overall Study|Sponsor study termination|0|||
37716880|NCT02096263|69194948|FG001|Overall Study|Sponsor study termination|0|||
37716881|NCT02096263|69194949|FG002|Overall Study|Sponsor study termination|1|||
37716882|NCT02096263|69194947|FG000|Overall Study|Protocol Violation|7|||
37716883|NCT02096263|69194948|FG001|Overall Study|Protocol Violation|2|||
37716884|NCT02096263|69194949|FG002|Overall Study|Protocol Violation|8|||
37716885|NCT02096263|69194947|FG000|Overall Study|Withdrawal by Subject|5|||
37716886|NCT02096263|69194948|FG001|Overall Study|Withdrawal by Subject|7|||
37716887|NCT02096263|69194949|FG002|Overall Study|Withdrawal by Subject|8|||
37915495|NCT00853047|69602253|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
37716888|NCT01830543|69194960|FG000|Overall Study|Subject Decision|19|||
37716889|NCT01830543|69194961|FG001|Overall Study|Subject Decision|21|||
37716890|NCT01830543|69194962|FG002|Overall Study|Subject Decision|57|||
37716891|NCT01830543|69194960|FG000|Overall Study|Adverse Event|91|||
37716892|NCT01830543|69194961|FG001|Overall Study|Adverse Event|77|||
37716893|NCT01830543|69194962|FG002|Overall Study|Adverse Event|76|||
37716894|NCT01830543|69194960|FG000|Overall Study|Death|20|||
37716895|NCT01830543|69194961|FG001|Overall Study|Death|22|||
37716896|NCT01830543|69194962|FG002|Overall Study|Death|22|||
38024822|NCT03999554|69708785|FG001|Overall Study|Lost to Follow-up|5|||
38024823|NCT03999554|69708786|FG002|Overall Study|Lost to Follow-up|4|||
38024824|NCT03999554|69708787|FG003|Overall Study|Lost to Follow-up|5|||
38024825|NCT03999554|69708788|FG004|Overall Study|Lost to Follow-up|8|||
38024826|NCT03999554|69708784|FG000|Overall Study|Protocol Violation|0|||
37839256|NCT01083693|69523744|FG001|Overall Study|Adverse Event|1|||
37839257|NCT01083693|69523745|FG002|Overall Study|Adverse Event|0|||
37716897|NCT01830543|69194960|FG000|Overall Study|Protocol Violation|3|||
37839258|NCT01083693|69523743|FG000|Overall Study|Lost to Follow-up|2|||
37839259|NCT01083693|69523744|FG001|Overall Study|Lost to Follow-up|0|||
37839260|NCT01083693|69523745|FG002|Overall Study|Lost to Follow-up|2|||
37839261|NCT01083693|69523743|FG000|Overall Study|Lack of effectiveness|13|||
37839262|NCT01083693|69523744|FG001|Overall Study|Lack of effectiveness|2|||
37716898|NCT01830543|69194961|FG001|Overall Study|Protocol Violation|7|||
37716899|NCT01830543|69194962|FG002|Overall Study|Protocol Violation|7|||
37716900|NCT01830543|69194960|FG000|Overall Study|Physician Decision|11|||
37716901|NCT01830543|69194961|FG001|Overall Study|Physician Decision|5|||
37716902|NCT01830543|69194962|FG002|Overall Study|Physician Decision|12|||
37716903|NCT01830543|69194960|FG000|Overall Study|Withdrawal by consent|3|||
37716904|NCT01830543|69194961|FG001|Overall Study|Withdrawal by consent|3|||
37716905|NCT01830543|69194962|FG002|Overall Study|Withdrawal by consent|3|||
37716906|NCT01830543|69194960|FG000|Overall Study|Other|12|||
37716907|NCT01830543|69194961|FG001|Overall Study|Other|17|||
37716908|NCT01830543|69194962|FG002|Overall Study|Other|37|||
37716909|NCT02109445|69194970|FG000|Overall Study|Symptomatic deterioration|2|||
37716910|NCT02109445|69194970|FG000|Overall Study|Adverse Event|1|||
37716911|NCT02109133|69194976|FG000|Overall Study|Lost to Follow-up|1|||
37716912|NCT02109133|69194977|FG001|Overall Study|Lost to Follow-up|0|||
37839263|NCT01083693|69523745|FG002|Overall Study|Lack of effectiveness|2|||
37839264|NCT01083693|69523743|FG000|Overall Study|Patient Moved|0|||
37716913|NCT01623271|69194985|FG000|Overall Study|Withdrawal by Subject|2|||
37716914|NCT01856673|69194992|FG000|Overall Study|Withdrawal by Subject|44|||
37716915|NCT01856673|69194993|FG001|Overall Study|Withdrawal by Subject|50|||
37716916|NCT01856673|69194994|FG002|Overall Study|Withdrawal by Subject|33|||
37716917|NCT01856673|69194992|FG000|Overall Study|Lost to Follow-up|31|||
37716918|NCT01856673|69194993|FG001|Overall Study|Lost to Follow-up|34|||
37716919|NCT01856673|69194994|FG002|Overall Study|Lost to Follow-up|0|||
37716920|NCT01856673|69194992|FG000|Overall Study|Unknown reasons|9|||
37716921|NCT01856673|69194993|FG001|Overall Study|Unknown reasons|0|||
37716922|NCT01856673|69194994|FG002|Overall Study|Unknown reasons|0|||
37716923|NCT01856673|69194992|FG000|Overall Study|Psychologist decision|1|||
37716924|NCT01856673|69194993|FG001|Overall Study|Psychologist decision|0|||
37716925|NCT01856673|69194994|FG002|Overall Study|Psychologist decision|0|||
37716926|NCT01856673|69194992|FG000|Overall Study|Paperwork errors|8|||
37716927|NCT01856673|69194993|FG001|Overall Study|Paperwork errors|0|||
37716928|NCT01856673|69194994|FG002|Overall Study|Paperwork errors|0|||
37716929|NCT01856673|69194992|FG000|Overall Study|Death|1|||
37716930|NCT01856673|69194993|FG001|Overall Study|Death|1|||
37716931|NCT01856673|69194994|FG002|Overall Study|Death|0|||
37716932|NCT01856673|69194992|FG000|Overall Study|Protocol Violation|1|||
37716933|NCT01856673|69194993|FG001|Overall Study|Protocol Violation|0|||
37716934|NCT01856673|69194994|FG002|Overall Study|Protocol Violation|1|||
37716935|NCT02095951|69195004|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
37716936|NCT02095951|69195005|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
37716937|NCT02095873|69195017|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
37716938|NCT02095873|69195018|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
37716939|NCT02095873|69195017|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
37839265|NCT01083693|69523744|FG001|Overall Study|Patient Moved|1|||
37839266|NCT01083693|69523745|FG002|Overall Study|Patient Moved|0|||
38024827|NCT03999554|69708785|FG001|Overall Study|Protocol Violation|0|||
38024828|NCT03999554|69708786|FG002|Overall Study|Protocol Violation|5|||
37716940|NCT02095873|69195018|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
37716941|NCT02095873|69195017|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
37716942|NCT02095873|69195018|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
37716943|NCT02094937|69195026|FG000|8 Weeks in Period 1|Adverse Event|9|||
37716944|NCT02094937|69195027|FG001|8 Weeks in Period 1|Adverse Event|0|||
37716945|NCT02094937|69195028|FG002|8 Weeks in Period 1|Adverse Event|0|||
37716946|NCT02094937|69195029|FG003|8 Weeks in Period 1|Adverse Event|0|||
37716947|NCT02094937|69195026|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
37716948|NCT02094937|69195027|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
37716949|NCT02094937|69195028|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
37716950|NCT02094937|69195029|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
37716951|NCT02094937|69195026|FG000|8 Weeks in Period 1|Protocol Violation|2|||
37839267|NCT01083693|69523743|FG000|Overall Study|Complete remission|0|||
38024829|NCT03999554|69708787|FG003|Overall Study|Protocol Violation|0|||
37716952|NCT02094937|69195027|FG001|8 Weeks in Period 1|Protocol Violation|0|||
37716953|NCT02094937|69195028|FG002|8 Weeks in Period 1|Protocol Violation|0|||
37716954|NCT02094937|69195029|FG003|8 Weeks in Period 1|Protocol Violation|0|||
37716955|NCT02094937|69195026|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
37716956|NCT02094937|69195027|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
37716957|NCT02094937|69195028|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
38024830|NCT03999554|69708788|FG004|Overall Study|Protocol Violation|0|||
38024831|NCT03999554|69708784|FG000|Overall Study|Pregnancy|0|||
37716958|NCT02094937|69195029|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
37716959|NCT02094937|69195026|FG000|8 Weeks in Period 1|Physician Decision|1|||
37716960|NCT02094937|69195027|FG001|8 Weeks in Period 1|Physician Decision|0|||
37716961|NCT02094937|69195028|FG002|8 Weeks in Period 1|Physician Decision|0|||
37716962|NCT02094937|69195029|FG003|8 Weeks in Period 1|Physician Decision|0|||
37716963|NCT02094937|69195026|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
37716964|NCT02094937|69195027|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
37716965|NCT02094937|69195028|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
37716966|NCT02094937|69195029|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
37716967|NCT02094937|69195026|FG000|12 Weeks in Period 2|Adverse Event|0|||
37716968|NCT02094937|69195027|FG001|12 Weeks in Period 2|Adverse Event|2|||
37716969|NCT02094937|69195028|FG002|12 Weeks in Period 2|Adverse Event|4|||
37716970|NCT02094937|69195029|FG003|12 Weeks in Period 2|Adverse Event|1|||
37716971|NCT02094937|69195026|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
37716972|NCT02094937|69195027|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
37716973|NCT02094937|69195028|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
37716974|NCT02094937|69195029|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
37716975|NCT02094937|69195026|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
37716976|NCT02094937|69195027|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
38024832|NCT03999554|69708785|FG001|Overall Study|Pregnancy|0|||
38024833|NCT03999554|69708786|FG002|Overall Study|Pregnancy|1|||
38024834|NCT03999554|69708787|FG003|Overall Study|Pregnancy|0|||
38024835|NCT03999554|69708788|FG004|Overall Study|Pregnancy|0|||
38024836|NCT03999554|69708784|FG000|Overall Study|Withdrawal by Subject|2|||
38024837|NCT03999554|69708785|FG001|Overall Study|Withdrawal by Subject|2|||
38024838|NCT03999554|69708786|FG002|Overall Study|Withdrawal by Subject|2|||
38024839|NCT03999554|69708787|FG003|Overall Study|Withdrawal by Subject|1|||
38024840|NCT03999554|69708788|FG004|Overall Study|Withdrawal by Subject|1|||
38024841|NCT03999554|69708784|FG000|Overall Study|failure to comply with protocol requirements|0|||
38024842|NCT03999554|69708785|FG001|Overall Study|failure to comply with protocol requirements|0|||
38024843|NCT03999554|69708786|FG002|Overall Study|failure to comply with protocol requirements|0|||
38024844|NCT03999554|69708787|FG003|Overall Study|failure to comply with protocol requirements|1|||
38024845|NCT03999554|69708788|FG004|Overall Study|failure to comply with protocol requirements|0|||
38024846|NCT04129346|69708803|FG000|Overall Study|Death|1|||
38024847|NCT04129346|69708804|FG001|Overall Study|Death|0|||
38024848|NCT04526574|69708812|FG000|Overall Study|Protocol Violation|3|||
38024849|NCT04526574|69708813|FG001|Overall Study|Protocol Violation|1|||
38024850|NCT04526574|69708812|FG000|Overall Study|Withdrawal by Subject|12|||
38024851|NCT04526574|69708813|FG001|Overall Study|Withdrawal by Subject|9|||
38024852|NCT04526574|69708812|FG000|Overall Study|Other|1|||
38024853|NCT04526574|69708813|FG001|Overall Study|Other|2|||
38024854|NCT04526574|69708812|FG000|Overall Study|Adverse Event|1|||
38024855|NCT04526574|69708813|FG001|Overall Study|Adverse Event|1|||
38024856|NCT04526574|69708812|FG000|Overall Study|Death|2|||
38024857|NCT04526574|69708813|FG001|Overall Study|Death|3|||
38024858|NCT04526574|69708812|FG000|Overall Study|Lost to Follow-up|9|||
38024859|NCT04526574|69708813|FG001|Overall Study|Lost to Follow-up|9|||
38024860|NCT04526574|69708812|FG000|Overall Study|No longer meets eligibility criteria|8|||
38024861|NCT04526574|69708813|FG001|Overall Study|No longer meets eligibility criteria|8|||
38024862|NCT03993392|69708823|FG000|Overall Study|Withdrawal by Subject|3|||
38024863|NCT03993392|69708823|FG000|Overall Study|Lost to Follow-up|2|||
38024864|NCT03993392|69708823|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
38024865|NCT04422990|69708830|FG000|Overall Study|Withdrawal by Subject|0|||
38024866|NCT04422990|69708831|FG001|Overall Study|Withdrawal by Subject|1|||
37716977|NCT02094937|69195028|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
37716978|NCT02094937|69195029|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
37716979|NCT02094937|69195026|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
37716980|NCT02094937|69195027|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
37716981|NCT02094937|69195028|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
37716982|NCT02094937|69195029|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
37716983|NCT02094937|69195026|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
38024867|NCT04422990|69708830|FG000|Overall Study|Travel|3|||
38024868|NCT04422990|69708831|FG001|Overall Study|Travel|0|||
38024869|NCT04377308|69708842|FG000|Overall Study|Withdrawal by Subject|0|||
38024870|NCT04377308|69708843|FG001|Overall Study|Withdrawal by Subject|1|||
38024871|NCT04447404|69708851|FG000|Overall Study|Death|2|||
38024872|NCT04447404|69708852|FG001|Overall Study|Death|0|||
37716984|NCT02094937|69195027|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
37716985|NCT02094937|69195028|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
37716986|NCT02094937|69195029|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
37716987|NCT02093923|69195043|FG000|Overall Study|Lost to Follow-up|0|||
37716988|NCT02093923|69195044|FG001|Overall Study|Lost to Follow-up|0|||
37716989|NCT02093923|69195045|FG002|Overall Study|Lost to Follow-up|0|||
37716990|NCT02093923|69195046|FG003|Overall Study|Lost to Follow-up|1|||
37716991|NCT02093923|69195047|FG004|Overall Study|Lost to Follow-up|0|||
37716992|NCT02093923|69195043|FG000|Overall Study|Screen failure after randomization|0|||
37716993|NCT02093923|69195044|FG001|Overall Study|Screen failure after randomization|0|||
37716994|NCT02093923|69195045|FG002|Overall Study|Screen failure after randomization|0|||
37716995|NCT02093923|69195046|FG003|Overall Study|Screen failure after randomization|1|||
37716996|NCT02093923|69195047|FG004|Overall Study|Screen failure after randomization|0|||
37716997|NCT02186561|69195063|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
37716998|NCT02186561|69195063|FG000|Enrollment|Enrollment Cap Reached|5|||
37716999|NCT02186561|69195063|FG000|Enrollment|Insurance Denial|2|||
37717000|NCT02186561|69195063|FG000|Enrollment|Withdrawal by Subject|2|||
37717001|NCT02186561|69195063|FG000|Enrollment|Investigator Withdrew Consent|1|||
37717002|NCT02186561|69195063|FG000|30-Day Post Index Procedure Visit|Death|1|||
37839268|NCT01083693|69523744|FG001|Overall Study|Complete remission|1|||
37839269|NCT01083693|69523745|FG002|Overall Study|Complete remission|0|||
37839270|NCT01083693|69523743|FG000|Overall Study|Other medical condition/surgery|1|||
37839271|NCT01083693|69523744|FG001|Overall Study|Other medical condition/surgery|1|||
37839272|NCT01083693|69523745|FG002|Overall Study|Other medical condition/surgery|0|||
37839273|NCT01083693|69523743|FG000|Overall Study|Withdrawal by Subject|3|||
37839274|NCT01083693|69523744|FG001|Overall Study|Withdrawal by Subject|0|||
37839275|NCT01083693|69523745|FG002|Overall Study|Withdrawal by Subject|2|||
37839276|NCT01083693|69523743|FG000|Overall Study|Reason unknown|0|||
37839277|NCT01083693|69523744|FG001|Overall Study|Reason unknown|0|||
37839278|NCT01083693|69523745|FG002|Overall Study|Reason unknown|1|||
37839279|NCT01083576|69523759|FG000|Overall Study|Treatment Failure|6|||
37839280|NCT01083576|69523760|FG001|Overall Study|Treatment Failure|1|||
37839281|NCT01083186|69523767|FG000|Overall Study|Lost to Follow-up|48|||
37839282|NCT01083186|69523767|FG000|Overall Study|Consent Withdrawal|7|||
37717003|NCT02186561|69195063|FG000|1- Year Post Index Procedure Visit|Death|1|||
37717004|NCT02186561|69195063|FG000|1- Year Post Index Procedure Visit|Missed|1|||
37717005|NCT02066467|69195069|FG000|Overall Study|Did not undergo implant procedure|24|||
37717006|NCT02066467|69195069|FG000|Overall Study|Attempted to implant withoput success|43|||
37717007|NCT02066467|69195069|FG000|Overall Study|Consent ineligible|1|||
37717008|NCT02066467|69195069|FG000|Overall Study|Death|54|||
37717009|NCT02066467|69195069|FG000|Overall Study|Lost to Follow-up|51|||
37717010|NCT02066467|69195069|FG000|Overall Study|Adverse Event|20|||
37717011|NCT02066467|69195069|FG000|Overall Study|Withdrawal by Subject|16|||
37717012|NCT02066467|69195069|FG000|Overall Study|Physician Decision|2|||
37717013|NCT02066467|69195069|FG000|Overall Study|Not defined|4|||
37717014|NCT02186171|69195075|FG000|Overall Study|Withdrawal by Subject|1|||
37717015|NCT02186171|69195076|FG001|Overall Study|Withdrawal by Subject|9|||
37717016|NCT02186171|69195075|FG000|Overall Study|Lost to Follow-up|2|||
37717017|NCT02186171|69195076|FG001|Overall Study|Lost to Follow-up|2|||
37717018|NCT02186171|69195075|FG000|Overall Study|Death|1|||
37717019|NCT02186171|69195076|FG001|Overall Study|Death|2|||
37839283|NCT01083186|69523767|FG000|Overall Study|Death|3|||
37839284|NCT01083186|69523767|FG000|Overall Study|Adverse Event|3|||
37839285|NCT01083186|69523767|FG000|Overall Study|Lack of Efficacy|2|||
37839286|NCT01083186|69523767|FG000|Overall Study|Hemodialysis Initiation|28|||
37839287|NCT01083186|69523767|FG000|Overall Study|Administrative Reasons|2|||
37839288|NCT01083186|69523767|FG000|Overall Study|Non-compliance to Study Treatment|1|||
37839289|NCT01082640|69523794|FG000|Overall Study|Adverse Event|9|||
37717020|NCT02186171|69195075|FG000|Overall Study|Protocol-specified Criteria|0|||
37717021|NCT02186171|69195076|FG001|Overall Study|Protocol-specified Criteria|2|||
37717022|NCT02186015|69195084|FG000|Overall Study|Physician Decision|1|||
37717023|NCT02186015|69195085|FG001|Overall Study|Physician Decision|0|||
37717024|NCT02066389|69195098|FG000|Overall Study|Adverse Event|1|||
37717025|NCT02066389|69195099|FG001|Overall Study|Adverse Event|1|||
37717026|NCT02066389|69195100|FG002|Overall Study|Adverse Event|1|||
37717027|NCT02066389|69195101|FG003|Overall Study|Adverse Event|1|||
37717028|NCT02066389|69195102|FG004|Overall Study|Adverse Event|5|||
37717029|NCT02066389|69195103|FG005|Overall Study|Adverse Event|1|||
37717030|NCT02066389|69195098|FG000|Overall Study|Withdrawal by Subject|4|||
37717031|NCT02066389|69195099|FG001|Overall Study|Withdrawal by Subject|0|||
37717032|NCT02066389|69195100|FG002|Overall Study|Withdrawal by Subject|5|||
37717033|NCT02066389|69195101|FG003|Overall Study|Withdrawal by Subject|1|||
37717034|NCT02066389|69195102|FG004|Overall Study|Withdrawal by Subject|1|||
37839290|NCT01082640|69523795|FG001|Overall Study|Adverse Event|5|||
37839291|NCT01082640|69523796|FG002|Overall Study|Adverse Event|3|||
37839292|NCT01082640|69523794|FG000|Overall Study|Withdrawal by Subject|3|||
37839293|NCT01082640|69523795|FG001|Overall Study|Withdrawal by Subject|3|||
37717035|NCT02066389|69195103|FG005|Overall Study|Withdrawal by Subject|2|||
37717036|NCT02066389|69195098|FG000|Overall Study|Lost to Follow-up|0|||
37717037|NCT02066389|69195099|FG001|Overall Study|Lost to Follow-up|0|||
37717038|NCT02066389|69195100|FG002|Overall Study|Lost to Follow-up|0|||
37717039|NCT02066389|69195101|FG003|Overall Study|Lost to Follow-up|1|||
37717040|NCT02066389|69195102|FG004|Overall Study|Lost to Follow-up|1|||
37717041|NCT02066389|69195103|FG005|Overall Study|Lost to Follow-up|1|||
37717042|NCT02066389|69195098|FG000|Overall Study|Randomized in Error|0|||
37717043|NCT02066389|69195099|FG001|Overall Study|Randomized in Error|0|||
37717044|NCT02066389|69195100|FG002|Overall Study|Randomized in Error|0|||
37717045|NCT02066389|69195101|FG003|Overall Study|Randomized in Error|0|||
37717046|NCT02066389|69195102|FG004|Overall Study|Randomized in Error|0|||
37717047|NCT02066389|69195103|FG005|Overall Study|Randomized in Error|1|||
37717048|NCT02106403|69195117|FG000|Follow-Up Visit 3|Other Reason|0|||
37717049|NCT02106403|69195118|FG001|Follow-Up Visit 3|Other Reason|0|||
37717050|NCT02106403|69195119|FG002|Follow-Up Visit 3|Other Reason|0|||
37717051|NCT02106403|69195120|FG003|Follow-Up Visit 3|Other Reason|0|||
37717052|NCT02106403|69195121|FG004|Follow-Up Visit 3|Other Reason|0|||
37717053|NCT02106403|69195122|FG005|Follow-Up Visit 3|Other Reason|1|||
37717054|NCT02133131|69195139|FG000|Overall Study|Adverse Event|0|||
37717055|NCT02133131|69195140|FG001|Overall Study|Adverse Event|0|||
37717056|NCT02133131|69195141|FG002|Overall Study|Adverse Event|0|||
37717057|NCT02133131|69195142|FG003|Overall Study|Adverse Event|1|||
37717058|NCT02133131|69195143|FG004|Overall Study|Adverse Event|0|||
37717059|NCT02133131|69195144|FG005|Overall Study|Adverse Event|0|||
37717060|NCT02133131|69195145|FG006|Overall Study|Adverse Event|0|||
37717061|NCT02133131|69195139|FG000|Overall Study|Lost to Follow-up|1|||
37717062|NCT02133131|69195140|FG001|Overall Study|Lost to Follow-up|0|||
37717063|NCT02133131|69195141|FG002|Overall Study|Lost to Follow-up|0|||
37717064|NCT02133131|69195142|FG003|Overall Study|Lost to Follow-up|1|||
37717065|NCT02133131|69195143|FG004|Overall Study|Lost to Follow-up|0|||
37717066|NCT02133131|69195144|FG005|Overall Study|Lost to Follow-up|0|||
37839294|NCT01082640|69523796|FG002|Overall Study|Withdrawal by Subject|2|||
37839295|NCT01082640|69523794|FG000|Overall Study|Major protocol deviation|3|||
37839296|NCT01082640|69523795|FG001|Overall Study|Major protocol deviation|3|||
37839297|NCT01082640|69523796|FG002|Overall Study|Major protocol deviation|0|||
37717067|NCT02133131|69195145|FG006|Overall Study|Lost to Follow-up|0|||
37717068|NCT02133131|69195139|FG000|Overall Study|Status not recorded|4|||
37717069|NCT02133131|69195140|FG001|Overall Study|Status not recorded|5|||
37717070|NCT02133131|69195141|FG002|Overall Study|Status not recorded|1|||
37717071|NCT02133131|69195142|FG003|Overall Study|Status not recorded|4|||
37717072|NCT02133131|69195143|FG004|Overall Study|Status not recorded|0|||
37839298|NCT01082640|69523794|FG000|Overall Study|Lost to Follow-up|0|||
37839299|NCT01082640|69523795|FG001|Overall Study|Lost to Follow-up|3|||
37839300|NCT01082640|69523796|FG002|Overall Study|Lost to Follow-up|0|||
37839301|NCT01082640|69523794|FG000|Overall Study|Other|2|||
37717073|NCT02133131|69195144|FG005|Overall Study|Status not recorded|0|||
37717074|NCT02133131|69195145|FG006|Overall Study|Status not recorded|0|||
37717075|NCT02133131|69195139|FG000|Overall Study|Ongoing in study|0|||
37717076|NCT02133131|69195140|FG001|Overall Study|Ongoing in study|0|||
37839302|NCT01082640|69523795|FG001|Overall Study|Other|1|||
37839303|NCT01082640|69523796|FG002|Overall Study|Other|3|||
37839304|NCT01082367|69523809|FG000|Double-blind Period|Administrative problems|0|||
37839305|NCT01082367|69523810|FG001|Double-blind Period|Administrative problems|1|||
37839306|NCT01082367|69523809|FG000|Double-blind Period|Lack of Efficacy|5|||
37839307|NCT01082367|69523810|FG001|Double-blind Period|Lack of Efficacy|11|||
37839308|NCT01082367|69523809|FG000|Double-blind Period|Adverse Event|0|||
37839309|NCT01082367|69523810|FG001|Double-blind Period|Adverse Event|1|||
37839310|NCT01082367|69523809|FG000|Follow-up (F-U) Period|Administrative problems|1|||
37839311|NCT01082367|69523810|FG001|Follow-up (F-U) Period|Administrative problems|0|||
37839312|NCT01082367|69523809|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
37717077|NCT02133131|69195141|FG002|Overall Study|Ongoing in study|0|||
37717078|NCT02133131|69195142|FG003|Overall Study|Ongoing in study|0|||
37717079|NCT02133131|69195143|FG004|Overall Study|Ongoing in study|15|||
37717080|NCT02133131|69195144|FG005|Overall Study|Ongoing in study|14|||
37717081|NCT02133131|69195145|FG006|Overall Study|Ongoing in study|11|||
37717082|NCT02133131|69195139|FG000|Overall Study|Protocol Violation|0|||
37717083|NCT02133131|69195140|FG001|Overall Study|Protocol Violation|0|||
37717084|NCT02133131|69195141|FG002|Overall Study|Protocol Violation|0|||
37717085|NCT02133131|69195142|FG003|Overall Study|Protocol Violation|0|||
37717086|NCT02133131|69195143|FG004|Overall Study|Protocol Violation|0|||
37717087|NCT02133131|69195144|FG005|Overall Study|Protocol Violation|0|||
37717088|NCT02133131|69195145|FG006|Overall Study|Protocol Violation|1|||
37717089|NCT02106325|69195163|FG000|Phase 1|Lost to Follow-up|2|||
37717090|NCT02106325|69195164|FG001|Phase 1|Lost to Follow-up|2|||
37717091|NCT02106325|69195163|FG000|Phase 2|Lost to Follow-up|2|||
37717092|NCT02106325|69195164|FG001|Phase 2|Lost to Follow-up|3|||
37717093|NCT02106325|69195163|FG000|Phase 3|Lost to Follow-up|2|||
37717094|NCT02106325|69195164|FG001|Phase 3|Lost to Follow-up|1|||
37717095|NCT01625689|69195172|FG000|Overall Study|Migration|2|||
37717096|NCT01625689|69195173|FG001|Overall Study|Migration|1|||
37717097|NCT02184611|69195181|FG000|Overall Study|Lack of Efficacy|11|||
37717098|NCT02184611|69195182|FG001|Overall Study|Lack of Efficacy|15|||
37717099|NCT02184611|69195181|FG000|Overall Study|Withdrawal by Subject|5|||
37717100|NCT02184611|69195182|FG001|Overall Study|Withdrawal by Subject|6|||
37717101|NCT02184611|69195181|FG000|Overall Study|Adverse Event|4|||
37717102|NCT02184611|69195182|FG001|Overall Study|Adverse Event|5|||
37717103|NCT02184611|69195181|FG000|Overall Study|Protocol Violation|1|||
37717104|NCT02184611|69195182|FG001|Overall Study|Protocol Violation|1|||
37717105|NCT02184611|69195181|FG000|Overall Study|Protocol defined stopping criteria|0|||
37717106|NCT02184611|69195182|FG001|Overall Study|Protocol defined stopping criteria|1|||
37717107|NCT02066311|69195188|FG000|Overall Study|Adverse Event|4|||
37717108|NCT02066311|69195188|FG000|Overall Study|Withdrawal by Subject|1|||
37717109|NCT02184455|69195192|FG000|Overall Study|Lost to Follow-up|1|||
37717110|NCT02184143|69195198|FG000|Overall Study|Withdrawal by Subject|4|||
37717111|NCT02184143|69195199|FG001|Overall Study|Withdrawal by Subject|4|||
37717112|NCT02184143|69195198|FG000|Overall Study|Lost to Follow-up|5|||
37717113|NCT02184143|69195199|FG001|Overall Study|Lost to Follow-up|3|||
37717114|NCT02184143|69195198|FG000|Overall Study|Death|1|||
37839313|NCT01082367|69523810|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
37839314|NCT01082367|69523809|FG000|Follow-up (F-U) Period|Adverse Event|0|||
37839315|NCT01082367|69523810|FG001|Follow-up (F-U) Period|Adverse Event|1|||
37839316|NCT01082211|69523820|FG000|Overall Study|Protocol Violation|4|||
37717115|NCT02184143|69195199|FG001|Overall Study|Death|0|||
37717116|NCT01625611|69195209|FG000|Overall Study|No adlib drinks Lab 1|3|||
37717117|NCT01625611|69195210|FG001|Overall Study|No adlib drinks Lab 1|0|||
37717118|NCT01625611|69195209|FG000|Overall Study|Technical issues with PET|1|||
37717119|NCT01625611|69195210|FG001|Overall Study|Technical issues with PET|0|||
37717120|NCT01625611|69195209|FG000|Overall Study|Unable to complete study procedures|1|||
37717121|NCT01625611|69195210|FG001|Overall Study|Unable to complete study procedures|0|||
37717122|NCT01625611|69195209|FG000|Overall Study|Withdrawal by Subject|3|||
37717123|NCT01625611|69195210|FG001|Overall Study|Withdrawal by Subject|0|||
37717124|NCT02159807|69195220|FG000|Overall Study|Adverse Event|0|||
37717125|NCT02159807|69195221|FG001|Overall Study|Adverse Event|0|||
37717126|NCT02159807|69195222|FG002|Overall Study|Adverse Event|1|||
37717127|NCT02159807|69195220|FG000|Overall Study|No CSF|1|||
37717128|NCT02159807|69195221|FG001|Overall Study|No CSF|1|||
37717129|NCT02159807|69195222|FG002|Overall Study|No CSF|1|||
37717130|NCT02159807|69195220|FG000|Overall Study|elevated blood pressure|0|||
37717131|NCT02159807|69195221|FG001|Overall Study|elevated blood pressure|0|||
37717132|NCT02159807|69195222|FG002|Overall Study|elevated blood pressure|1|||
37717133|NCT02066233|69195232|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
37717134|NCT02066233|69195233|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
37717135|NCT02159729|69195241|FG000|Overall Study|Adverse Event|0|||
37717136|NCT02159729|69195242|FG001|Overall Study|Adverse Event|1|||
37717137|NCT02159729|69195241|FG000|Overall Study|Subject's Request|13|||
37717138|NCT02159729|69195242|FG001|Overall Study|Subject's Request|10|||
37717139|NCT02159729|69195241|FG000|Overall Study|Lost to Follow-up|24|||
37717140|NCT02159729|69195242|FG001|Overall Study|Lost to Follow-up|9|||
37717141|NCT02159729|69195241|FG000|Overall Study|Non compliance|2|||
37717142|NCT02159729|69195242|FG001|Overall Study|Non compliance|0|||
37717143|NCT02159729|69195241|FG000|Overall Study|Other Unspecified|3|||
37717144|NCT02159729|69195242|FG001|Overall Study|Other Unspecified|1|||
37717145|NCT02159183|69195250|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
37717146|NCT02159183|69195251|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
37717147|NCT02159183|69195250|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
37717148|NCT02159183|69195251|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
37717149|NCT02159183|69195250|FG000|Analysis After the 36 Months Follow-up|Death|0|||
37717150|NCT02159183|69195251|FG001|Analysis After the 36 Months Follow-up|Death|1|||
37717151|NCT02159183|69195250|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
37717152|NCT02159183|69195251|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
37717153|NCT02159183|69195250|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
37717154|NCT02159183|69195251|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
37717155|NCT02183675|69195263|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
37717156|NCT02183675|69195264|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
37717157|NCT02183675|69195265|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
37717158|NCT02183675|69195266|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
37717159|NCT02183675|69195267|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
37717160|NCT02183675|69195268|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
37717161|NCT02183519|69195280|FG000|Overall Study|computer error|3|||
37717162|NCT02183519|69195281|FG001|Overall Study|computer error|0|||
37717163|NCT02183519|69195280|FG000|Overall Study|Did not respond to cough inducter|0|||
37717164|NCT02183519|69195281|FG001|Overall Study|Did not respond to cough inducter|3|||
37717165|NCT02132195|69195290|FG000|Initial Assignment|Relapsed|14|||
37717166|NCT02132195|69195291|FG001|Initial Assignment|Relapsed|0|||
37717167|NCT02132195|69195292|FG002|Initial Assignment|Relapsed|0|||
37717168|NCT02132195|69195290|FG000|Rescue Therapy|Relapsed|0|||
37717169|NCT02132195|69195291|FG001|Rescue Therapy|Relapsed|0|||
37717170|NCT02132195|69195292|FG002|Rescue Therapy|Relapsed|7|||
37717171|NCT02132195|69195290|FG000|Rescue Therapy|Physician Decision|0|||
37717172|NCT02132195|69195291|FG001|Rescue Therapy|Physician Decision|0|||
37717173|NCT02132195|69195292|FG002|Rescue Therapy|Physician Decision|1|||
37717174|NCT02132195|69195290|FG000|Rescue Therapy|Withdrawal by Subject|0|||
37717175|NCT02132195|69195291|FG001|Rescue Therapy|Withdrawal by Subject|0|||
37717176|NCT02132195|69195292|FG002|Rescue Therapy|Withdrawal by Subject|1|||
37717177|NCT02132195|69195290|FG000|Rescue Therapy|Adverse Event|0|||
37717178|NCT02132195|69195291|FG001|Rescue Therapy|Adverse Event|0|||
37717179|NCT02132195|69195292|FG002|Rescue Therapy|Adverse Event|2|||
37717180|NCT02182973|69195302|FG000|Overall Study|Withdrawal by Subject|3|||
37717181|NCT02182973|69195303|FG001|Overall Study|Withdrawal by Subject|0|||
37717182|NCT02182895|69195312|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
37717183|NCT02182895|69195313|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
37717184|NCT01625377|69195321|FG000|Overall Study|Death|1|||
37717185|NCT01625377|69195322|FG001|Overall Study|Death|1|||
37717186|NCT01625377|69195321|FG000|Overall Study|Administrative Problem|1|||
37717187|NCT01625377|69195322|FG001|Overall Study|Administrative Problem|1|||
37717188|NCT01625377|69195321|FG000|Overall Study|Protocol Violation|0|||
37717189|NCT01625377|69195322|FG001|Overall Study|Protocol Violation|3|||
37717190|NCT01625377|69195321|FG000|Overall Study|Adverse Event|3|||
37717191|NCT01625377|69195322|FG001|Overall Study|Adverse Event|16|||
37717192|NCT01625377|69195321|FG000|Overall Study|Graft loss|1|||
37717193|NCT01625377|69195322|FG001|Overall Study|Graft loss|0|||
37717194|NCT01625377|69195321|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
37717195|NCT01625377|69195322|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
37717196|NCT01625377|69195321|FG000|Overall Study|Abnormal laboratory values|1|||
37717197|NCT01625377|69195322|FG001|Overall Study|Abnormal laboratory values|0|||
37717198|NCT02158949|69195330|FG000|Overall Study|Withdrawal by Subject|1|||
37717199|NCT02158949|69195331|FG001|Overall Study|Withdrawal by Subject|0|||
37717200|NCT02158949|69195330|FG000|Overall Study|Lost to Follow-up|5|||
37717201|NCT02158949|69195331|FG001|Overall Study|Lost to Follow-up|11|||
37717202|NCT02132117|69195339|FG000|Overall Study|Adverse Event|6|||
37717203|NCT02132117|69195340|FG001|Overall Study|Adverse Event|1|||
37717204|NCT02132117|69195339|FG000|Overall Study|Lost to Follow-up|2|||
37717205|NCT02132117|69195340|FG001|Overall Study|Lost to Follow-up|2|||
37717206|NCT02132117|69195339|FG000|Overall Study|Personal Reasons|1|||
37717207|NCT02132117|69195340|FG001|Overall Study|Personal Reasons|2|||
37717208|NCT02132117|69195339|FG000|Overall Study|Other Miscellaneous Reasons|2|||
37717209|NCT02132117|69195340|FG001|Overall Study|Other Miscellaneous Reasons|0|||
37717210|NCT02093689|69195349|FG000|Overall Study|Physician Decision|4|||
37717211|NCT02093689|69195350|FG001|Overall Study|Physician Decision|0|||
37717212|NCT02093689|69195351|FG002|Overall Study|Physician Decision|0|||
37717213|NCT02047045|69195359|FG000|Baseline|Withdrawal by Subject|3|||
37717214|NCT02047045|69195360|FG001|Baseline|Withdrawal by Subject|2|||
37717215|NCT02047045|69195359|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
37717216|NCT02047045|69195360|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
37717217|NCT02047045|69195359|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
37717218|NCT02047045|69195360|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
37717219|NCT02047045|69195359|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
37717220|NCT02047045|69195360|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
37717221|NCT02047045|69195359|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
37717222|NCT02047045|69195360|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
37717223|NCT02047045|69195359|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
37717224|NCT02047045|69195360|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
37717225|NCT02047045|69195359|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
37717226|NCT02047045|69195360|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
37717227|NCT02047045|69195359|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
37717228|NCT02047045|69195360|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
37717229|NCT02047045|69195359|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
37717230|NCT02047045|69195360|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
37717231|NCT02131259|69195366|FG000|Overall Study|Progressive disease|751|||
37717232|NCT02131259|69195366|FG000|Overall Study|Adverse Event|341|||
37717233|NCT02131259|69195366|FG000|Overall Study|Lost to Follow-up|7|||
37717234|NCT02131259|69195366|FG000|Overall Study|Relocation|32|||
37717235|NCT02131259|69195366|FG000|Overall Study|Other|63|||
37717236|NCT02131259|69195366|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
37717237|NCT02131259|69195366|FG000|Overall Study|Progressive disease/relocation|1|||
37717238|NCT02131259|69195366|FG000|Overall Study|Progressive disease/other|2|||
37717239|NCT02131259|69195366|FG000|Overall Study|AE/lost to follow-up|1|||
37717240|NCT02131259|69195366|FG000|Overall Study|AE/other|1|||
37717241|NCT02131259|69195366|FG000|Overall Study|Progressive disease/AE/other|1|||
37717242|NCT02131259|69195366|FG000|Overall Study|Missing|3|||
37717243|NCT01856595|69195379|FG000|Overall Study|Withdrawal by Subject|0|||
37717244|NCT01856595|69195380|FG001|Overall Study|Withdrawal by Subject|1|||
37717245|NCT01856595|69195381|FG002|Overall Study|Withdrawal by Subject|0|||
37717246|NCT01856595|69195382|FG003|Overall Study|Withdrawal by Subject|0|||
37717247|NCT01856595|69195383|FG004|Overall Study|Withdrawal by Subject|0|||
37717248|NCT01856595|69195384|FG005|Overall Study|Withdrawal by Subject|0|||
37717249|NCT01856595|69195385|FG006|Overall Study|Withdrawal by Subject|1|||
37717250|NCT01856595|69195386|FG007|Overall Study|Withdrawal by Subject|0|||
37717251|NCT01856595|69195387|FG008|Overall Study|Withdrawal by Subject|0|||
37717252|NCT02158247|69195424|FG000|Overall Study|Invisible vocal cords|5|||
37717253|NCT01829295|69195446|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
37717254|NCT01829295|69195447|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
37717255|NCT01829295|69195448|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
37717256|NCT01829295|69195449|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
37717257|NCT01829295|69195446|FG000|6-12 Months|Adverse Event|0|||
37717258|NCT01829295|69195447|FG001|6-12 Months|Adverse Event|0|||
37717259|NCT01829295|69195448|FG002|6-12 Months|Adverse Event|3|||
37717260|NCT01829295|69195449|FG003|6-12 Months|Adverse Event|2|||
37717261|NCT01829295|69195446|FG000|6-12 Months|Lost to Follow-up|2|||
37717262|NCT01829295|69195447|FG001|6-12 Months|Lost to Follow-up|0|||
37717263|NCT01829295|69195448|FG002|6-12 Months|Lost to Follow-up|0|||
37717264|NCT01829295|69195449|FG003|6-12 Months|Lost to Follow-up|0|||
37717265|NCT01829295|69195446|FG000|6-12 Months|Withdrawal by Subject|2|||
37839317|NCT01082211|69523820|FG000|Overall Study|No protocol treatment received|3|||
37839318|NCT01081665|69523827|FG000|Overall Study|Death|41|||
37839319|NCT01081665|69523827|FG000|Overall Study|Lost to Follow-up|18|||
37717266|NCT01829295|69195447|FG001|6-12 Months|Withdrawal by Subject|2|||
37717267|NCT01829295|69195448|FG002|6-12 Months|Withdrawal by Subject|0|||
37717268|NCT01829295|69195449|FG003|6-12 Months|Withdrawal by Subject|0|||
37717269|NCT02157935|69195461|FG000|Overall Study|Withdrawal by Subject|25|||
37717270|NCT02157935|69195462|FG001|Overall Study|Withdrawal by Subject|39|||
37717271|NCT02157935|69195461|FG000|Overall Study|Screen failure|1|||
37717272|NCT02157935|69195462|FG001|Overall Study|Screen failure|2|||
37717273|NCT02157935|69195461|FG000|Overall Study|Protocol Violation|1|||
37717274|NCT02157935|69195462|FG001|Overall Study|Protocol Violation|0|||
37717275|NCT02157935|69195461|FG000|Overall Study|Progressive disease|0|||
37717276|NCT02157935|69195462|FG001|Overall Study|Progressive disease|2|||
37717277|NCT02157935|69195461|FG000|Overall Study|Other|5|||
37717278|NCT02157935|69195462|FG001|Overall Study|Other|12|||
37717279|NCT02157935|69195461|FG000|Overall Study|Lack of Efficacy|0|||
37717280|NCT02157935|69195462|FG001|Overall Study|Lack of Efficacy|1|||
37717281|NCT02157935|69195461|FG000|Overall Study|Death|4|||
37717282|NCT02157935|69195462|FG001|Overall Study|Death|4|||
37717283|NCT02157935|69195461|FG000|Overall Study|Adverse Event|3|||
37717284|NCT02157935|69195462|FG001|Overall Study|Adverse Event|5|||
37717285|NCT02157779|69195470|FG000|Overall Study|Logistical|9|||
37717286|NCT02157779|69195471|FG001|Overall Study|Logistical|3|||
37717287|NCT02157779|69195470|FG000|Overall Study|Stopped attending, reason unknown|11|||
37717288|NCT02157779|69195471|FG001|Overall Study|Stopped attending, reason unknown|7|||
37717289|NCT02157779|69195470|FG000|Overall Study|No response to outreach after Baseline|1|||
37717290|NCT02157779|69195471|FG001|Overall Study|No response to outreach after Baseline|1|||
37717291|NCT02157779|69195470|FG000|Overall Study|Moved|1|||
37717292|NCT02157779|69195471|FG001|Overall Study|Moved|0|||
37717293|NCT02157779|69195470|FG000|Overall Study|Medical|1|||
37717294|NCT02157779|69195471|FG001|Overall Study|Medical|0|||
37717295|NCT02157779|69195470|FG000|Overall Study|Legal issue|1|||
37717296|NCT02157779|69195471|FG001|Overall Study|Legal issue|0|||
37717297|NCT02093221|69195485|FG000|Overall Study|Adverse Event|1|||
37717298|NCT02093221|69195486|FG001|Overall Study|Adverse Event|0|||
37717299|NCT02093221|69195487|FG002|Overall Study|Adverse Event|0|||
37717300|NCT02093221|69195488|FG003|Overall Study|Adverse Event|0|||
37717301|NCT02093221|69195489|FG004|Overall Study|Adverse Event|0|||
37717302|NCT02093221|69195485|FG000|Overall Study|Withdrawal by Subject|1|||
37717303|NCT02093221|69195486|FG001|Overall Study|Withdrawal by Subject|1|||
37717304|NCT02093221|69195487|FG002|Overall Study|Withdrawal by Subject|4|||
37717305|NCT02093221|69195488|FG003|Overall Study|Withdrawal by Subject|1|||
37717306|NCT02093221|69195489|FG004|Overall Study|Withdrawal by Subject|1|||
37717307|NCT02093221|69195485|FG000|Overall Study|Lost to Follow-up|2|||
37717308|NCT02093221|69195486|FG001|Overall Study|Lost to Follow-up|0|||
37717309|NCT02093221|69195487|FG002|Overall Study|Lost to Follow-up|1|||
37717310|NCT02093221|69195488|FG003|Overall Study|Lost to Follow-up|1|||
37717311|NCT02093221|69195489|FG004|Overall Study|Lost to Follow-up|0|||
37717312|NCT02093221|69195485|FG000|Overall Study|Death|0|||
37717313|NCT02093221|69195486|FG001|Overall Study|Death|1|||
37717314|NCT02093221|69195487|FG002|Overall Study|Death|0|||
37717315|NCT02093221|69195488|FG003|Overall Study|Death|0|||
37717316|NCT02093221|69195489|FG004|Overall Study|Death|0|||
37717317|NCT02093221|69195485|FG000|Overall Study|Protocol Violation|0|||
37717318|NCT02093221|69195486|FG001|Overall Study|Protocol Violation|1|||
37717319|NCT02093221|69195487|FG002|Overall Study|Protocol Violation|0|||
37717320|NCT02093221|69195488|FG003|Overall Study|Protocol Violation|0|||
37717321|NCT02093221|69195489|FG004|Overall Study|Protocol Violation|0|||
37717322|NCT02093221|69195485|FG000|Overall Study|Study termination|6|||
37717323|NCT02093221|69195486|FG001|Overall Study|Study termination|5|||
37717324|NCT02093221|69195487|FG002|Overall Study|Study termination|4|||
37717325|NCT02093221|69195488|FG003|Overall Study|Study termination|6|||
37717326|NCT02093221|69195489|FG004|Overall Study|Study termination|7|||
37717327|NCT02092909|69195505|FG000|Overall Study|Adverse Event|0|||
37717328|NCT02092909|69195506|FG001|Overall Study|Adverse Event|0|||
37717329|NCT02092909|69195507|FG002|Overall Study|Adverse Event|4|||
37717330|NCT02092909|69195508|FG003|Overall Study|Adverse Event|2|||
37717331|NCT02092909|69195505|FG000|Overall Study|Lack of Efficacy|0|||
37717332|NCT02092909|69195506|FG001|Overall Study|Lack of Efficacy|2|||
37717333|NCT02092909|69195507|FG002|Overall Study|Lack of Efficacy|1|||
37717334|NCT02092909|69195508|FG003|Overall Study|Lack of Efficacy|0|||
37717335|NCT02092909|69195505|FG000|Overall Study|Withdrawal by Subject|0|||
37717336|NCT02092909|69195506|FG001|Overall Study|Withdrawal by Subject|0|||
37717337|NCT02092909|69195507|FG002|Overall Study|Withdrawal by Subject|2|||
37717338|NCT02092909|69195508|FG003|Overall Study|Withdrawal by Subject|1|||
38024873|NCT03988166|69708858|FG000|Overall Study|Lost to Follow-up|2|||
37717339|NCT02092909|69195505|FG000|Overall Study|Study terminated by Sponsor|0|||
38024874|NCT03988166|69708858|FG000|Overall Study|Death|1|||
37717340|NCT02092909|69195506|FG001|Overall Study|Study terminated by Sponsor|0|||
37717341|NCT02092909|69195507|FG002|Overall Study|Study terminated by Sponsor|0|||
37717342|NCT02092909|69195508|FG003|Overall Study|Study terminated by Sponsor|2|||
37717343|NCT02092909|69195505|FG000|Overall Study|Miscellaneous|1|||
37717344|NCT02092909|69195506|FG001|Overall Study|Miscellaneous|1|||
37717345|NCT02092909|69195507|FG002|Overall Study|Miscellaneous|2|||
37717346|NCT02092909|69195508|FG003|Overall Study|Miscellaneous|1|||
37717347|NCT01623115|69195520|FG000|Overall Study|Randomized but not treated|0|||
37717348|NCT01623115|69195521|FG001|Overall Study|Randomized but not treated|1|||
37717349|NCT01623115|69195520|FG000|Overall Study|Physician Decision|1|||
37717350|NCT01623115|69195521|FG001|Overall Study|Physician Decision|0|||
37717351|NCT01623115|69195520|FG000|Overall Study|Participants moved|1|||
37717352|NCT01623115|69195521|FG001|Overall Study|Participants moved|5|||
38043527|NCT03509467|69731655|FG003|Overall Study|Death|2|||
37717353|NCT01623115|69195520|FG000|Overall Study|Adverse Event|10|||
37717354|NCT01623115|69195521|FG001|Overall Study|Adverse Event|13|||
37717355|NCT01623115|69195520|FG000|Overall Study|Poor compliance to protocol|4|||
37717356|NCT01623115|69195521|FG001|Overall Study|Poor compliance to protocol|10|||
37717357|NCT01623115|69195520|FG000|Overall Study|Consent withdrawn by participant|2|||
37717358|NCT01623115|69195521|FG001|Overall Study|Consent withdrawn by participant|6|||
37717359|NCT01623115|69195520|FG000|Overall Study|Related to study drug administration|0|||
37717360|NCT01623115|69195521|FG001|Overall Study|Related to study drug administration|2|||
37717361|NCT01623115|69195520|FG000|Overall Study|Last visit outside protocol visit window|14|||
37717362|NCT01623115|69195521|FG001|Overall Study|Last visit outside protocol visit window|26|||
37717363|NCT01623115|69195520|FG000|Overall Study|Site closure|1|||
37717364|NCT01623115|69195521|FG001|Overall Study|Site closure|7|||
37717365|NCT01623115|69195520|FG000|Overall Study|Death|0|||
37717366|NCT01623115|69195521|FG001|Overall Study|Death|4|||
37717367|NCT01623115|69195520|FG000|Overall Study|Other than specified above|0|||
37717368|NCT01623115|69195521|FG001|Overall Study|Other than specified above|3|||
37717369|NCT02092285|69195527|FG000|Induction Phase|Adverse Event|7|||
37717370|NCT02092285|69195527|FG000|Induction Phase|Physician Decision|4|||
37717371|NCT02092285|69195527|FG000|Induction Phase|Pregnancy|1|||
37717372|NCT02092285|69195527|FG000|Induction Phase|Relapse/Recurrence|7|||
37717373|NCT02092285|69195527|FG000|Induction Phase|Withdrawal by Subject|2|||
37717374|NCT02092285|69195527|FG000|Induction Phase|Lack of Efficacy|14|||
37717375|NCT02092285|69195527|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
37717376|NCT02092285|69195527|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
37717377|NCT02092285|69195527|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
37717378|NCT02092285|69195527|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
37717379|NCT02092285|69195527|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
37717380|NCT02092285|69195527|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
37717381|NCT02092285|69195527|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
37717382|NCT02092285|69195527|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
37717383|NCT02092285|69195527|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
37717384|NCT02091739|69195534|FG000|MP: 16 Weeks|Adverse Event|1|||
37717385|NCT02091739|69195535|FG001|MP: 16 Weeks|Adverse Event|1|||
37717386|NCT02091739|69195536|FG002|MP: 16 Weeks|Adverse Event|1|||
37717387|NCT02091739|69195537|FG003|MP: 16 Weeks|Adverse Event|0|||
37717388|NCT02091739|69195538|FG004|MP: 16 Weeks|Adverse Event|0|||
37717389|NCT02091739|69195534|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
37717390|NCT02091739|69195535|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
37717391|NCT02091739|69195536|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
37717392|NCT02091739|69195537|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
37717393|NCT02091739|69195538|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
37717394|NCT02091739|69195534|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
37717395|NCT02091739|69195535|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
37717396|NCT02091739|69195536|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
37717397|NCT02091739|69195537|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
37717398|NCT02091739|69195538|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
37717399|NCT02091739|69195534|FG000|EP: 48 Weeks|Other|0|||
37717400|NCT02091739|69195535|FG001|EP: 48 Weeks|Other|0|||
37717401|NCT02091739|69195536|FG002|EP: 48 Weeks|Other|0|||
37717402|NCT02091739|69195537|FG003|EP: 48 Weeks|Other|1|||
37717403|NCT02091739|69195538|FG004|EP: 48 Weeks|Other|0|||
37717404|NCT02091739|69195534|FG000|EP: 48 Weeks|Death|0|||
37717405|NCT02091739|69195535|FG001|EP: 48 Weeks|Death|0|||
37717406|NCT02091739|69195536|FG002|EP: 48 Weeks|Death|0|||
37717407|NCT02091739|69195537|FG003|EP: 48 Weeks|Death|3|||
37717408|NCT02091739|69195538|FG004|EP: 48 Weeks|Death|2|||
37717409|NCT02091739|69195534|FG000|EP: 48 Weeks|Adverse Event|0|||
37717410|NCT02091739|69195535|FG001|EP: 48 Weeks|Adverse Event|0|||
37717411|NCT02091739|69195536|FG002|EP: 48 Weeks|Adverse Event|0|||
37717412|NCT02091739|69195537|FG003|EP: 48 Weeks|Adverse Event|2|||
37717413|NCT02091739|69195538|FG004|EP: 48 Weeks|Adverse Event|6|||
37717414|NCT02091739|69195534|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
37717415|NCT02091739|69195535|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
37717416|NCT02091739|69195536|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
37717417|NCT02091739|69195537|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
37717418|NCT02091739|69195538|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
37717419|NCT02045875|69195550|FG000|Overall Study|Lost to Follow-up|3|||
37717420|NCT02045875|69195551|FG001|Overall Study|Lost to Follow-up|0|||
37717421|NCT02045875|69195550|FG000|Overall Study|Withdrawal by Subject|4|||
37717422|NCT02045875|69195551|FG001|Overall Study|Withdrawal by Subject|3|||
37717423|NCT01597635|69195560|FG000|Part A|Adverse Event|3|||
37717424|NCT01597635|69195561|FG001|Part A|Adverse Event|0|||
37717425|NCT01597635|69195562|FG002|Part A|Adverse Event|0|||
37717426|NCT01597635|69195560|FG000|Part B|Adverse Event|0|||
37717427|NCT01597635|69195561|FG001|Part B|Adverse Event|0|||
37717428|NCT01597635|69195562|FG002|Part B|Adverse Event|1|||
37717429|NCT01597635|69195560|FG000|Part B|Protocol Violation|0|||
37717430|NCT01597635|69195561|FG001|Part B|Protocol Violation|1|||
37717431|NCT01597635|69195562|FG002|Part B|Protocol Violation|0|||
37717432|NCT01597635|69195560|FG000|Part B|Protocol-defined stopping criteria|0|||
37717433|NCT01597635|69195561|FG001|Part B|Protocol-defined stopping criteria|4|||
37717434|NCT01597635|69195562|FG002|Part B|Protocol-defined stopping criteria|3|||
37717435|NCT01597635|69195560|FG000|Part B|Withdrawal by Subject|0|||
37717436|NCT01597635|69195561|FG001|Part B|Withdrawal by Subject|1|||
37717437|NCT01597635|69195562|FG002|Part B|Withdrawal by Subject|0|||
37717438|NCT01828281|69195573|FG000|Overall Study|Withdrawal by Subject|1|||
37717439|NCT01828281|69195574|FG001|Overall Study|Withdrawal by Subject|0|||
37717440|NCT01827267|69195583|FG000|Overall Study|Did not receive study drug|1|||
37915496|NCT00853047|69602248|FG000|Open-Label Extension Phase|Investigator Decision|0|||
37717441|NCT01827267|69195584|FG001|Overall Study|Did not receive study drug|1|||
37717442|NCT01827267|69195583|FG000|Overall Study|Physician Decision|1|||
37717443|NCT01827267|69195584|FG001|Overall Study|Physician Decision|0|||
37717444|NCT01827267|69195583|FG000|Overall Study|Disease Progression|1|||
37717445|NCT01827267|69195584|FG001|Overall Study|Disease Progression|1|||
37717446|NCT01827267|69195583|FG000|Overall Study|Sponsor Discontinued Study|2|||
37717447|NCT01827267|69195584|FG001|Overall Study|Sponsor Discontinued Study|8|||
37717448|NCT01827267|69195583|FG000|Overall Study|Still on study|0|||
37717449|NCT01827267|69195584|FG001|Overall Study|Still on study|2|||
37717450|NCT01855425|69195591|FG000|Overall Study|Physician Decision|20|||
37717451|NCT01854879|69195595|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
37717452|NCT01854879|69195595|FG000|Overall Study|screen fail|3|||
37717453|NCT01854879|69195595|FG000|Overall Study|incomplete data set|1|||
37717454|NCT01827111|69195599|FG000|Overall Study|Disease Progression|1|||
37717455|NCT02045095|69195603|FG000|Overall Study|Other|0|||
37717456|NCT02045095|69195604|FG001|Overall Study|Other|0|||
37717457|NCT02045095|69195605|FG002|Overall Study|Other|1|||
37717458|NCT02045095|69195606|FG003|Overall Study|Other|0|||
37717459|NCT02045095|69195607|FG004|Overall Study|Other|0|||
37717460|NCT02045095|69195608|FG005|Overall Study|Other|2|||
37717461|NCT02045095|69195609|FG006|Overall Study|Other|0|||
37717462|NCT02045095|69195603|FG000|Overall Study|Progressive Disease|3|||
37717463|NCT02045095|69195604|FG001|Overall Study|Progressive Disease|3|||
37717464|NCT02045095|69195605|FG002|Overall Study|Progressive Disease|2|||
37717465|NCT02045095|69195606|FG003|Overall Study|Progressive Disease|4|||
37717466|NCT02045095|69195607|FG004|Overall Study|Progressive Disease|2|||
37717467|NCT02045095|69195608|FG005|Overall Study|Progressive Disease|4|||
37717468|NCT02045095|69195609|FG006|Overall Study|Progressive Disease|1|||
37717469|NCT02045095|69195603|FG000|Overall Study|Withdrawal by Subject|0|||
37717470|NCT02045095|69195604|FG001|Overall Study|Withdrawal by Subject|0|||
37717471|NCT02045095|69195605|FG002|Overall Study|Withdrawal by Subject|0|||
37717472|NCT02045095|69195606|FG003|Overall Study|Withdrawal by Subject|0|||
37717473|NCT02045095|69195607|FG004|Overall Study|Withdrawal by Subject|3|||
37717474|NCT02045095|69195608|FG005|Overall Study|Withdrawal by Subject|0|||
37717475|NCT02045095|69195609|FG006|Overall Study|Withdrawal by Subject|0|||
37717476|NCT02045095|69195603|FG000|Overall Study|Adverse Event|0|||
37717477|NCT02045095|69195604|FG001|Overall Study|Adverse Event|1|||
37717478|NCT02045095|69195605|FG002|Overall Study|Adverse Event|1|||
37839320|NCT01081665|69523827|FG000|Overall Study|Withdrawal by Subject|17|||
37839321|NCT01081665|69523827|FG000|Overall Study|Change of dialysis unit|10|||
37839322|NCT01081665|69523827|FG000|Overall Study|Regulation of iPTH|5|||
37839323|NCT01081665|69523827|FG000|Overall Study|Change in renal replacement therapy|2|||
37839324|NCT01081665|69523827|FG000|Overall Study|Adverse Event|1|||
37839325|NCT01081665|69523827|FG000|Overall Study|Lack of Efficacy|1|||
37839326|NCT01081626|69523833|FG000|Overall Study|Dosing error|1|||
37839327|NCT01081626|69523834|FG001|Overall Study|Dosing error|1|||
37839328|NCT01081626|69523833|FG000|Overall Study|Missing Estradiol|25|||
37839329|NCT01081626|69523834|FG001|Overall Study|Missing Estradiol|28|||
37839330|NCT01081626|69523833|FG000|Overall Study|Low antral follicle count|1|||
37839331|NCT01081626|69523834|FG001|Overall Study|Low antral follicle count|0|||
37717479|NCT02045095|69195606|FG003|Overall Study|Adverse Event|0|||
37717480|NCT02045095|69195607|FG004|Overall Study|Adverse Event|0|||
37717481|NCT02045095|69195608|FG005|Overall Study|Adverse Event|2|||
37717482|NCT02045095|69195609|FG006|Overall Study|Adverse Event|0|||
37717483|NCT02181803|69195634|FG000|Overall Study|Withdrawal by Subject|0|||
37717484|NCT02181803|69195635|FG001|Overall Study|Withdrawal by Subject|2|||
37717485|NCT02181803|69195636|FG002|Overall Study|Withdrawal by Subject|0|||
37717486|NCT02181803|69195637|FG003|Overall Study|Withdrawal by Subject|0|||
37717487|NCT02181803|69195638|FG004|Overall Study|Withdrawal by Subject|0|||
37717488|NCT02181803|69195639|FG005|Overall Study|Withdrawal by Subject|0|||
37717489|NCT02181803|69195640|FG006|Overall Study|Withdrawal by Subject|0|||
37717490|NCT02181803|69195641|FG007|Overall Study|Withdrawal by Subject|0|||
37717491|NCT02181803|69195642|FG008|Overall Study|Withdrawal by Subject|0|||
37717492|NCT02181803|69195634|FG000|Overall Study|Physician Decision|0|||
37717493|NCT02181803|69195635|FG001|Overall Study|Physician Decision|0|||
37717494|NCT02181803|69195636|FG002|Overall Study|Physician Decision|0|||
37717495|NCT02181803|69195637|FG003|Overall Study|Physician Decision|1|||
37839332|NCT01081626|69523833|FG000|Overall Study|Overstimulation|0|||
37839333|NCT01081626|69523834|FG001|Overall Study|Overstimulation|1|||
37717496|NCT02181803|69195638|FG004|Overall Study|Physician Decision|0|||
37717497|NCT02181803|69195639|FG005|Overall Study|Physician Decision|0|||
37717498|NCT02181803|69195640|FG006|Overall Study|Physician Decision|0|||
37717499|NCT02181803|69195641|FG007|Overall Study|Physician Decision|1|||
37717500|NCT02181803|69195642|FG008|Overall Study|Physician Decision|0|||
37717501|NCT02181803|69195634|FG000|Overall Study|Adverse Event|0|||
37717502|NCT02181803|69195635|FG001|Overall Study|Adverse Event|2|||
37717503|NCT02181803|69195636|FG002|Overall Study|Adverse Event|0|||
37717504|NCT02181803|69195637|FG003|Overall Study|Adverse Event|1|||
37717505|NCT02181803|69195638|FG004|Overall Study|Adverse Event|0|||
37717506|NCT02181803|69195639|FG005|Overall Study|Adverse Event|0|||
37717507|NCT02181803|69195640|FG006|Overall Study|Adverse Event|1|||
37717508|NCT02181803|69195641|FG007|Overall Study|Adverse Event|0|||
37717509|NCT02181803|69195642|FG008|Overall Study|Adverse Event|0|||
37717510|NCT01826487|69195689|FG000|Overall Study|Adverse Event|1|||
37717511|NCT01826487|69195690|FG001|Overall Study|Adverse Event|1|||
37717512|NCT01826487|69195689|FG000|Overall Study|Lost to Follow-up|1|||
37717513|NCT01826487|69195690|FG001|Overall Study|Lost to Follow-up|0|||
37717514|NCT01826487|69195689|FG000|Overall Study|Withdrawal by Subject|1|||
37717515|NCT01826487|69195690|FG001|Overall Study|Withdrawal by Subject|3|||
37717516|NCT01826487|69195689|FG000|Overall Study|Protocol Violation|1|||
37717517|NCT01826487|69195690|FG001|Overall Study|Protocol Violation|1|||
37717518|NCT02064439|69195700|FG000|Overall Study|Adverse Event|51|||
37839334|NCT01081626|69523833|FG000|Overall Study|Lost to Follow-up|0|||
37839335|NCT01081626|69523834|FG001|Overall Study|Lost to Follow-up|1|||
37839336|NCT01081626|69523833|FG000|Overall Study|Other|33|||
37839337|NCT01081626|69523834|FG001|Overall Study|Other|30|||
37839338|NCT01080768|69523842|FG000|Overall Study|Protocol Deviation|2|||
37839339|NCT01080768|69523843|FG001|Overall Study|Protocol Deviation|1|||
37839340|NCT01080300|69523851|FG000|Overall Study|Adverse Event|49|||
37839341|NCT01080300|69523852|FG001|Overall Study|Adverse Event|35|||
37839342|NCT01080300|69523851|FG000|Overall Study|Lack of Efficacy|12|||
37839343|NCT01080300|69523852|FG001|Overall Study|Lack of Efficacy|15|||
37839344|NCT01080300|69523851|FG000|Overall Study|Protocol Violation|7|||
37839345|NCT01080300|69523852|FG001|Overall Study|Protocol Violation|13|||
37839346|NCT01080300|69523851|FG000|Overall Study|Lost to Follow-up|10|||
37839347|NCT01080300|69523852|FG001|Overall Study|Lost to Follow-up|6|||
37839348|NCT01080300|69523851|FG000|Overall Study|Death|0|||
37839349|NCT01080300|69523852|FG001|Overall Study|Death|1|||
37839350|NCT01080300|69523851|FG000|Overall Study|Withdrawal by Subject|12|||
37839351|NCT01080300|69523852|FG001|Overall Study|Withdrawal by Subject|28|||
37839352|NCT01080300|69523851|FG000|Overall Study|Reasons not specified|4|||
37839353|NCT01080300|69523852|FG001|Overall Study|Reasons not specified|6|||
37839354|NCT01085097|69523863|FG000|Overall Study|Adverse Event|0|||
37839355|NCT01085097|69523864|FG001|Overall Study|Adverse Event|0|||
37839356|NCT01085097|69523865|FG002|Overall Study|Adverse Event|2|||
37839357|NCT01085097|69523863|FG000|Overall Study|Treatment failure|2|||
37839358|NCT01085097|69523864|FG001|Overall Study|Treatment failure|0|||
37839359|NCT01085097|69523865|FG002|Overall Study|Treatment failure|0|||
37839360|NCT03450629|69523879|FG000|Overall Study|Adverse Event|15|||
37839361|NCT03450629|69523880|FG001|Overall Study|Adverse Event|14|||
37839362|NCT03450629|69523879|FG000|Overall Study|Physician Decision|2|||
37839363|NCT03450629|69523880|FG001|Overall Study|Physician Decision|2|||
37839364|NCT03450629|69523879|FG000|Overall Study|Lack of Efficacy|2|||
37839365|NCT03450629|69523880|FG001|Overall Study|Lack of Efficacy|0|||
37839366|NCT03450629|69523879|FG000|Overall Study|Lost to Follow-up|4|||
37839367|NCT03450629|69523880|FG001|Overall Study|Lost to Follow-up|2|||
37839368|NCT03450629|69523879|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
37839369|NCT03450629|69523880|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
37839370|NCT03450629|69523879|FG000|Overall Study|Non-Compliance With Study Drug|2|||
37839371|NCT03450629|69523880|FG001|Overall Study|Non-Compliance With Study Drug|1|||
37839372|NCT03450629|69523879|FG000|Overall Study|Protocol Violation|11|||
37839373|NCT03450629|69523880|FG001|Overall Study|Protocol Violation|8|||
37839374|NCT03450629|69523879|FG000|Overall Study|Withdrawal by Subject|12|||
37839375|NCT03450629|69523880|FG001|Overall Study|Withdrawal by Subject|6|||
37839376|NCT00198029|69523886|FG000|Overall Study|Withdrawal by Subject|4|||
37839377|NCT00197054|69523893|FG000|Overall Study|Withdrawal by Subject|9|||
37717519|NCT02064439|69195701|FG001|Overall Study|Adverse Event|47|||
37717520|NCT02064439|69195702|FG002|Overall Study|Adverse Event|46|||
37717521|NCT02064439|69195700|FG000|Overall Study|Death|0|||
37717522|NCT02064439|69195701|FG001|Overall Study|Death|2|||
37717523|NCT02064439|69195702|FG002|Overall Study|Death|3|||
37717524|NCT02064439|69195700|FG000|Overall Study|Withdrawal by Subject|29|||
37839378|NCT00197054|69523894|FG001|Overall Study|Withdrawal by Subject|3|||
37839379|NCT00197054|69523895|FG002|Overall Study|Withdrawal by Subject|3|||
37839380|NCT00197054|69523893|FG000|Overall Study|Moved from area|7|||
37717525|NCT02064439|69195701|FG001|Overall Study|Withdrawal by Subject|18|||
37717526|NCT02064439|69195702|FG002|Overall Study|Withdrawal by Subject|26|||
37717527|NCT02064439|69195700|FG000|Overall Study|Protocol Violation|3|||
37717528|NCT02064439|69195701|FG001|Overall Study|Protocol Violation|5|||
37717529|NCT02064439|69195702|FG002|Overall Study|Protocol Violation|3|||
37717530|NCT02064439|69195700|FG000|Overall Study|Lost to Follow-up|1|||
37717531|NCT02064439|69195701|FG001|Overall Study|Lost to Follow-up|3|||
37717532|NCT02064439|69195702|FG002|Overall Study|Lost to Follow-up|4|||
37717533|NCT02064439|69195700|FG000|Overall Study|Non-compliance with study medication|21|||
37717534|NCT02064439|69195701|FG001|Overall Study|Non-compliance with study medication|19|||
37717535|NCT02064439|69195702|FG002|Overall Study|Non-compliance with study medication|23|||
37717536|NCT02064439|69195700|FG000|Overall Study|Physician Decision|0|||
37717537|NCT02064439|69195701|FG001|Overall Study|Physician Decision|1|||
37717538|NCT02064439|69195702|FG002|Overall Study|Physician Decision|1|||
37717539|NCT02064439|69195700|FG000|Overall Study|Logistical difficulties|6|||
37717540|NCT02064439|69195701|FG001|Overall Study|Logistical difficulties|5|||
37717541|NCT02064439|69195702|FG002|Overall Study|Logistical difficulties|2|||
37717542|NCT02064439|69195700|FG000|Overall Study|Efficacy outcome reached|18|||
37717543|NCT02064439|69195701|FG001|Overall Study|Efficacy outcome reached|16|||
37717544|NCT02064439|69195702|FG002|Overall Study|Efficacy outcome reached|57|||
37717545|NCT02064439|69195700|FG000|Overall Study|Safety outcome reached|12|||
37717546|NCT02064439|69195701|FG001|Overall Study|Safety outcome reached|20|||
37717547|NCT02064439|69195702|FG002|Overall Study|Safety outcome reached|10|||
37717548|NCT02064439|69195700|FG000|Overall Study|Other|2|||
37717549|NCT02064439|69195701|FG001|Overall Study|Other|2|||
37717550|NCT02064439|69195702|FG002|Overall Study|Other|7|||
37717551|NCT02130557|69195712|FG000|Overall Study|Withdrawal by Subject|12|||
37717552|NCT02130557|69195713|FG001|Overall Study|Withdrawal by Subject|12|||
37717553|NCT02130557|69195712|FG000|Overall Study|Investigator Request|0|||
37717554|NCT02130557|69195713|FG001|Overall Study|Investigator Request|2|||
37717555|NCT02130557|69195712|FG000|Overall Study|Deceased|14|||
37717556|NCT02130557|69195713|FG001|Overall Study|Deceased|14|||
37717557|NCT02130557|69195712|FG000|Overall Study|Lost to Follow-up|6|||
37717558|NCT02130557|69195713|FG001|Overall Study|Lost to Follow-up|7|||
37717559|NCT02130557|69195712|FG000|Overall Study|Other|2|||
37717560|NCT02130557|69195713|FG001|Overall Study|Other|1|||
37717561|NCT02130557|69195712|FG000|Overall Study|Missing|2|||
37717562|NCT02130557|69195713|FG001|Overall Study|Missing|1|||
37717563|NCT01854645|69195724|FG000|Overall Study|Protocol-Specified Criteria|13|||
37717564|NCT01854645|69195725|FG001|Overall Study|Protocol-Specified Criteria|10|||
37717565|NCT01854645|69195726|FG002|Overall Study|Protocol-Specified Criteria|8|||
37717566|NCT01854645|69195727|FG003|Overall Study|Protocol-Specified Criteria|5|||
37717567|NCT01854645|69195728|FG004|Overall Study|Protocol-Specified Criteria|7|||
37717568|NCT01854645|69195724|FG000|Overall Study|Administrative Reasons / Missing|0|||
37717569|NCT01854645|69195725|FG001|Overall Study|Administrative Reasons / Missing|0|||
37717570|NCT01854645|69195726|FG002|Overall Study|Administrative Reasons / Missing|0|||
37717571|NCT01854645|69195727|FG003|Overall Study|Administrative Reasons / Missing|1|||
37717572|NCT01854645|69195728|FG004|Overall Study|Administrative Reasons / Missing|1|||
37717573|NCT01854645|69195724|FG000|Overall Study|Protocol Violation|3|||
37717574|NCT01854645|69195725|FG001|Overall Study|Protocol Violation|0|||
37717575|NCT01854645|69195726|FG002|Overall Study|Protocol Violation|5|||
37717576|NCT01854645|69195727|FG003|Overall Study|Protocol Violation|4|||
37717577|NCT01854645|69195728|FG004|Overall Study|Protocol Violation|1|||
37717578|NCT01854645|69195724|FG000|Overall Study|Lost to Follow-up|10|||
37717579|NCT01854645|69195725|FG001|Overall Study|Lost to Follow-up|7|||
37717580|NCT01854645|69195726|FG002|Overall Study|Lost to Follow-up|8|||
37717581|NCT01854645|69195727|FG003|Overall Study|Lost to Follow-up|5|||
37839381|NCT00197054|69523894|FG001|Overall Study|Moved from area|14|||
37839382|NCT00197054|69523895|FG002|Overall Study|Moved from area|9|||
37717582|NCT01854645|69195728|FG004|Overall Study|Lost to Follow-up|0|||
37839383|NCT00197054|69523893|FG000|Overall Study|Lost to Follow-up|1|||
37717583|NCT01854645|69195724|FG000|Overall Study|Physician Decision|1|||
37717584|NCT01854645|69195725|FG001|Overall Study|Physician Decision|5|||
37717585|NCT01854645|69195726|FG002|Overall Study|Physician Decision|3|||
37717586|NCT01854645|69195727|FG003|Overall Study|Physician Decision|3|||
37717587|NCT01854645|69195728|FG004|Overall Study|Physician Decision|7|||
37717588|NCT01854645|69195724|FG000|Overall Study|Withdrawal by Subject|31|||
37717589|NCT01854645|69195725|FG001|Overall Study|Withdrawal by Subject|41|||
37717590|NCT01854645|69195726|FG002|Overall Study|Withdrawal by Subject|30|||
37717591|NCT01854645|69195727|FG003|Overall Study|Withdrawal by Subject|21|||
37717592|NCT01854645|69195728|FG004|Overall Study|Withdrawal by Subject|24|||
37717593|NCT01854645|69195724|FG000|Overall Study|Lack of Efficacy|7|||
37717594|NCT01854645|69195725|FG001|Overall Study|Lack of Efficacy|12|||
37717595|NCT01854645|69195726|FG002|Overall Study|Lack of Efficacy|9|||
37717596|NCT01854645|69195727|FG003|Overall Study|Lack of Efficacy|3|||
37717597|NCT01854645|69195728|FG004|Overall Study|Lack of Efficacy|9|||
37717598|NCT01854645|69195724|FG000|Overall Study|Adverse Event|33|||
37717599|NCT01854645|69195725|FG001|Overall Study|Adverse Event|31|||
37717600|NCT01854645|69195726|FG002|Overall Study|Adverse Event|19|||
37717601|NCT01854645|69195727|FG003|Overall Study|Adverse Event|20|||
37839384|NCT00197054|69523894|FG001|Overall Study|Lost to Follow-up|4|||
37839385|NCT00197054|69523895|FG002|Overall Study|Lost to Follow-up|0|||
37839386|NCT00197015|69523916|FG000|Overall Study|Adverse Event|3|||
37839387|NCT00197015|69523917|FG001|Overall Study|Adverse Event|0|||
37839388|NCT00197015|69523918|FG002|Overall Study|Adverse Event|1|||
37839389|NCT00197015|69523916|FG000|Overall Study|Protocol Violation|0|||
37839390|NCT00197015|69523917|FG001|Overall Study|Protocol Violation|3|||
37839391|NCT00197015|69523918|FG002|Overall Study|Protocol Violation|3|||
37839392|NCT00197015|69523916|FG000|Overall Study|Withdrawal by Subject|17|||
37717602|NCT01854645|69195728|FG004|Overall Study|Adverse Event|11|||
37717603|NCT01825941|69195742|FG000|Overall Study|Lost to Follow-up|4|||
37717604|NCT01825941|69195743|FG001|Overall Study|Lost to Follow-up|1|||
37717605|NCT02064205|69195749|FG000|Overall Study|Withdrawal by Subject|1|||
37717606|NCT02090959|69195765|FG000|Overall Study|Withdrawal by Subject|10|||
37717607|NCT02090959|69195765|FG000|Overall Study|Adverse Event|1|||
37717608|NCT02090959|69195765|FG000|Overall Study|Investigator decision|2|||
37717609|NCT02090959|69195765|FG000|Overall Study|Study termination|6|||
37717610|NCT02090959|69195765|FG000|Overall Study|Enrolled but not treated|1|||
37717611|NCT02090959|69195765|FG000|Overall Study|Transfer for compassionate use medicine|4|||
37717612|NCT02090959|69195765|FG000|Overall Study|Move to medical need program|3|||
37717613|NCT02090959|69195765|FG000|Overall Study|Entered in to other study|34|||
37717614|NCT02090959|69195765|FG000|Overall Study|Switched to commercial supply|88|||
37717615|NCT02090959|69195765|FG000|Overall Study|Other than specified|2|||
37717616|NCT02044159|69195771|FG000|Overall Study|Consent declined (deferred consent)|2|||
37717617|NCT02044159|69195772|FG001|Overall Study|Consent declined (deferred consent)|4|||
37717618|NCT02044159|69195771|FG000|Overall Study|No longer eligible, drug not given|1|||
37717619|NCT02044159|69195772|FG001|Overall Study|No longer eligible, drug not given|0|||
37839393|NCT00197015|69523917|FG001|Overall Study|Withdrawal by Subject|37|||
37839394|NCT00197015|69523918|FG002|Overall Study|Withdrawal by Subject|34|||
37717620|NCT02044159|69195771|FG000|Overall Study|Nurse declined to give study drug|1|||
37717621|NCT02044159|69195772|FG001|Overall Study|Nurse declined to give study drug|0|||
37717622|NCT02090725|69195781|FG000|Overall Study|Withdrawal by Subject|1|||
37717623|NCT02090725|69195781|FG000|Overall Study|participants moved from area|3|||
37717624|NCT02180165|69195789|FG000|Overall Study|Not Treated|0|||
37717625|NCT02180165|69195790|FG001|Overall Study|Not Treated|0|||
37717626|NCT02180165|69195791|FG002|Overall Study|Not Treated|1|||
37717627|NCT02180165|69195792|FG003|Overall Study|Not Treated|0|||
37717628|NCT02180165|69195789|FG000|Overall Study|Adverse Event|7|||
37717629|NCT02180165|69195790|FG001|Overall Study|Adverse Event|0|||
37717630|NCT02180165|69195791|FG002|Overall Study|Adverse Event|18|||
37717631|NCT02180165|69195792|FG003|Overall Study|Adverse Event|3|||
37717632|NCT02180165|69195789|FG000|Overall Study|Lack of Efficacy|0|||
37717633|NCT02180165|69195790|FG001|Overall Study|Lack of Efficacy|1|||
37717634|NCT02180165|69195791|FG002|Overall Study|Lack of Efficacy|3|||
37717635|NCT02180165|69195792|FG003|Overall Study|Lack of Efficacy|2|||
37717636|NCT02180165|69195789|FG000|Overall Study|Physician Decision|1|||
37717637|NCT02180165|69195790|FG001|Overall Study|Physician Decision|0|||
37717638|NCT02180165|69195791|FG002|Overall Study|Physician Decision|5|||
37717639|NCT02180165|69195792|FG003|Overall Study|Physician Decision|0|||
37717640|NCT02180165|69195789|FG000|Overall Study|Withdrawal by Subject|3|||
37717641|NCT02180165|69195790|FG001|Overall Study|Withdrawal by Subject|0|||
37717642|NCT02180165|69195791|FG002|Overall Study|Withdrawal by Subject|2|||
37717643|NCT02180165|69195792|FG003|Overall Study|Withdrawal by Subject|1|||
37839395|NCT00197015|69523916|FG000|Overall Study|Lost to Follow-up|28|||
37839396|NCT00197015|69523917|FG001|Overall Study|Lost to Follow-up|46|||
37839397|NCT00197015|69523918|FG002|Overall Study|Lost to Follow-up|37|||
37839398|NCT00197015|69523916|FG000|Overall Study|Other|2|||
37839399|NCT00197015|69523917|FG001|Overall Study|Other|3|||
37839400|NCT00197015|69523918|FG002|Overall Study|Other|2|||
37717644|NCT02155985|69195807|FG000|Overall Study|Withdrawal by Subject|0|||
37717645|NCT02155985|69195808|FG001|Overall Study|Withdrawal by Subject|0|||
37717646|NCT02155985|69195809|FG002|Overall Study|Withdrawal by Subject|1|||
37717647|NCT02155985|69195807|FG000|Overall Study|Lost to Follow-up|1|||
37717648|NCT02155985|69195808|FG001|Overall Study|Lost to Follow-up|0|||
37717649|NCT02155985|69195809|FG002|Overall Study|Lost to Follow-up|0|||
37717650|NCT02155829|69195819|FG000|Overall Study|Adverse Event|1|||
37839401|NCT00196976|69523940|FG000|Primary Study|Migrated from study area|0|||
37839402|NCT00196976|69523941|FG001|Primary Study|Migrated from study area|0|||
37717651|NCT02155829|69195820|FG001|Overall Study|Adverse Event|0|||
37717652|NCT02155829|69195819|FG000|Overall Study|Withdrawal by Subject|3|||
37717653|NCT02155829|69195820|FG001|Overall Study|Withdrawal by Subject|3|||
37717654|NCT02155829|69195819|FG000|Overall Study|Protocol Violation|2|||
37839403|NCT00196976|69523942|FG002|Primary Study|Migrated from study area|0|||
37839404|NCT00196976|69523943|FG003|Primary Study|Migrated from study area|0|||
37717655|NCT02155829|69195820|FG001|Overall Study|Protocol Violation|0|||
37717656|NCT02129777|69195832|FG000|Double-Blind Period|Adverse Event|0|||
37717657|NCT02129777|69195833|FG001|Double-Blind Period|Adverse Event|0|||
37717658|NCT02129777|69195834|FG002|Double-Blind Period|Adverse Event|0|||
37717659|NCT02129777|69195835|FG003|Double-Blind Period|Adverse Event|0|||
37717660|NCT02129777|69195836|FG004|Double-Blind Period|Adverse Event|1|||
37717661|NCT02129777|69195837|FG005|Double-Blind Period|Adverse Event|0|||
37717662|NCT02129777|69195838|FG006|Double-Blind Period|Adverse Event|0|||
37717663|NCT02129777|69195832|FG000|Double-Blind Period|Lost to Follow-up|1|||
37717664|NCT02129777|69195833|FG001|Double-Blind Period|Lost to Follow-up|1|||
37717665|NCT02129777|69195834|FG002|Double-Blind Period|Lost to Follow-up|1|||
37717666|NCT02129777|69195835|FG003|Double-Blind Period|Lost to Follow-up|2|||
37717667|NCT02129777|69195836|FG004|Double-Blind Period|Lost to Follow-up|0|||
37717668|NCT02129777|69195837|FG005|Double-Blind Period|Lost to Follow-up|0|||
37717669|NCT02129777|69195838|FG006|Double-Blind Period|Lost to Follow-up|0|||
37717670|NCT02129777|69195832|FG000|Double-Blind Period|Withdrawal by Subject|2|||
37717671|NCT02129777|69195833|FG001|Double-Blind Period|Withdrawal by Subject|4|||
37717672|NCT02129777|69195834|FG002|Double-Blind Period|Withdrawal by Subject|3|||
37717673|NCT02129777|69195835|FG003|Double-Blind Period|Withdrawal by Subject|2|||
37717674|NCT02129777|69195836|FG004|Double-Blind Period|Withdrawal by Subject|3|||
37717675|NCT02129777|69195837|FG005|Double-Blind Period|Withdrawal by Subject|0|||
37717676|NCT02129777|69195838|FG006|Double-Blind Period|Withdrawal by Subject|0|||
37717677|NCT02129777|69195832|FG000|Double-Blind Period|Pregnancy|0|||
37717678|NCT02129777|69195833|FG001|Double-Blind Period|Pregnancy|0|||
37717679|NCT02129777|69195834|FG002|Double-Blind Period|Pregnancy|0|||
37717680|NCT02129777|69195835|FG003|Double-Blind Period|Pregnancy|0|||
37717681|NCT02129777|69195836|FG004|Double-Blind Period|Pregnancy|1|||
37717682|NCT02129777|69195837|FG005|Double-Blind Period|Pregnancy|0|||
37717683|NCT02129777|69195838|FG006|Double-Blind Period|Pregnancy|0|||
37717684|NCT02129777|69195832|FG000|Double-Blind Period|Lack of Efficacy|3|||
37717685|NCT02129777|69195833|FG001|Double-Blind Period|Lack of Efficacy|1|||
37717686|NCT02129777|69195834|FG002|Double-Blind Period|Lack of Efficacy|0|||
37717687|NCT02129777|69195835|FG003|Double-Blind Period|Lack of Efficacy|3|||
37717688|NCT02129777|69195836|FG004|Double-Blind Period|Lack of Efficacy|2|||
37717689|NCT02129777|69195837|FG005|Double-Blind Period|Lack of Efficacy|0|||
37717690|NCT02129777|69195838|FG006|Double-Blind Period|Lack of Efficacy|0|||
37717691|NCT02129777|69195832|FG000|Double-Blind Period|Other|1|||
37717692|NCT02129777|69195833|FG001|Double-Blind Period|Other|2|||
37717693|NCT02129777|69195834|FG002|Double-Blind Period|Other|0|||
37717694|NCT02129777|69195835|FG003|Double-Blind Period|Other|0|||
37717695|NCT02129777|69195836|FG004|Double-Blind Period|Other|0|||
37717696|NCT02129777|69195837|FG005|Double-Blind Period|Other|0|||
37717697|NCT02129777|69195838|FG006|Double-Blind Period|Other|0|||
37717698|NCT02129777|69195832|FG000|Open-Label Period|Lack of Efficacy|0|||
37717699|NCT02129777|69195833|FG001|Open-Label Period|Lack of Efficacy|0|||
37717700|NCT02129777|69195834|FG002|Open-Label Period|Lack of Efficacy|0|||
37717701|NCT02129777|69195835|FG003|Open-Label Period|Lack of Efficacy|0|||
37717702|NCT02129777|69195836|FG004|Open-Label Period|Lack of Efficacy|0|||
37717703|NCT02129777|69195837|FG005|Open-Label Period|Lack of Efficacy|0|||
37717704|NCT02129777|69195838|FG006|Open-Label Period|Lack of Efficacy|5|||
37717705|NCT02129777|69195832|FG000|Open-Label Period|Lost to Follow-up|0|||
37717706|NCT02129777|69195833|FG001|Open-Label Period|Lost to Follow-up|0|||
37717707|NCT02129777|69195834|FG002|Open-Label Period|Lost to Follow-up|0|||
37717708|NCT02129777|69195835|FG003|Open-Label Period|Lost to Follow-up|0|||
37717709|NCT02129777|69195836|FG004|Open-Label Period|Lost to Follow-up|0|||
37717710|NCT02129777|69195837|FG005|Open-Label Period|Lost to Follow-up|1|||
37717711|NCT02129777|69195838|FG006|Open-Label Period|Lost to Follow-up|1|||
37717712|NCT02129777|69195832|FG000|Open-Label Period|Withdrawal by Subject|0|||
37717713|NCT02129777|69195833|FG001|Open-Label Period|Withdrawal by Subject|0|||
37717714|NCT02129777|69195834|FG002|Open-Label Period|Withdrawal by Subject|0|||
37717715|NCT02129777|69195835|FG003|Open-Label Period|Withdrawal by Subject|0|||
37717716|NCT02129777|69195836|FG004|Open-Label Period|Withdrawal by Subject|0|||
37717717|NCT02129777|69195837|FG005|Open-Label Period|Withdrawal by Subject|1|||
37717718|NCT02129777|69195838|FG006|Open-Label Period|Withdrawal by Subject|3|||
37839405|NCT00196976|69523944|FG004|Primary Study|Migrated from study area|0|||
37839406|NCT00196976|69523945|FG005|Primary Study|Migrated from study area|0|||
37717719|NCT02129777|69195832|FG000|Open-Label Period|Study Termination|0|||
37717720|NCT02129777|69195833|FG001|Open-Label Period|Study Termination|0|||
37717721|NCT02129777|69195834|FG002|Open-Label Period|Study Termination|0|||
37717722|NCT02129777|69195835|FG003|Open-Label Period|Study Termination|0|||
37717723|NCT02129777|69195836|FG004|Open-Label Period|Study Termination|0|||
37717724|NCT02129777|69195837|FG005|Open-Label Period|Study Termination|10|||
37717725|NCT02129777|69195838|FG006|Open-Label Period|Study Termination|39|||
37717726|NCT02178995|69195859|FG000|Double Blind|Adverse Event|0|||
37717727|NCT02178995|69195860|FG001|Double Blind|Adverse Event|0|||
37717728|NCT02178995|69195861|FG002|Double Blind|Adverse Event|0|||
37717729|NCT02178995|69195862|FG003|Double Blind|Adverse Event|0|||
37717730|NCT02178995|69195863|FG004|Double Blind|Adverse Event|0|||
37717731|NCT02178995|69195864|FG005|Double Blind|Adverse Event|1|||
37717732|NCT02178995|69195865|FG006|Double Blind|Adverse Event|0|||
37717733|NCT02178995|69195866|FG007|Double Blind|Adverse Event|1|||
37717734|NCT02178995|69195867|FG008|Double Blind|Adverse Event|1|||
37717735|NCT02178995|69195859|FG000|Double Blind|Lost to Follow-up|0|||
37717736|NCT02178995|69195860|FG001|Double Blind|Lost to Follow-up|1|||
37717737|NCT02178995|69195861|FG002|Double Blind|Lost to Follow-up|0|||
37717738|NCT02178995|69195862|FG003|Double Blind|Lost to Follow-up|0|||
37717739|NCT02178995|69195863|FG004|Double Blind|Lost to Follow-up|0|||
37717740|NCT02178995|69195864|FG005|Double Blind|Lost to Follow-up|0|||
37717741|NCT02178995|69195865|FG006|Double Blind|Lost to Follow-up|0|||
37717742|NCT02178995|69195866|FG007|Double Blind|Lost to Follow-up|1|||
37717743|NCT02178995|69195867|FG008|Double Blind|Lost to Follow-up|0|||
37717744|NCT02178995|69195859|FG000|Open Label|Adverse Event|2|||
37717745|NCT02178995|69195860|FG001|Open Label|Adverse Event|0|||
37717746|NCT02178995|69195861|FG002|Open Label|Adverse Event|0|||
37717747|NCT02178995|69195862|FG003|Open Label|Adverse Event|0|||
37717748|NCT02178995|69195863|FG004|Open Label|Adverse Event|0|||
37717749|NCT02178995|69195864|FG005|Open Label|Adverse Event|0|||
37717750|NCT02178995|69195865|FG006|Open Label|Adverse Event|0|||
37717751|NCT02178995|69195866|FG007|Open Label|Adverse Event|0|||
37717752|NCT02178995|69195867|FG008|Open Label|Adverse Event|0|||
37717753|NCT02128997|69195893|FG000|Overall Study|Lost to Follow-up|6|||
37717754|NCT02128997|69195894|FG001|Overall Study|Lost to Follow-up|11|||
37717755|NCT02155283|69195900|FG000|Overall Study|Lost to Follow-up|3|||
37717756|NCT02155283|69195900|FG000|Overall Study|Withdrawal by Subject|1|||
37717757|NCT02155283|69195900|FG000|Overall Study|Protocol Violation|3|||
37717758|NCT02154581|69195906|FG000|Overall Study|Lost to Follow-up|7|||
37717759|NCT02154581|69195907|FG001|Overall Study|Lost to Follow-up|8|||
37717760|NCT02154425|69195915|FG000|Screening Period|Adverse Event|1|||
37717761|NCT02154347|69195925|FG000|Double-blind Period|Adverse Event|1|||
37717762|NCT02154347|69195926|FG001|Double-blind Period|Adverse Event|2|||
37717763|NCT02154347|69195925|FG000|Double-blind Period|Lack of Efficacy|1|||
37717764|NCT02154347|69195926|FG001|Double-blind Period|Lack of Efficacy|0|||
37717765|NCT02154347|69195925|FG000|Double-blind Period|Physician Decision|0|||
37717766|NCT02154347|69195926|FG001|Double-blind Period|Physician Decision|1|||
37717767|NCT02154347|69195925|FG000|Double-blind Period|Withdrawal by Subject|1|||
37717768|NCT02154347|69195926|FG001|Double-blind Period|Withdrawal by Subject|1|||
37717769|NCT02154347|69195925|FG000|Open-label Period|Adverse Event|3|||
37717770|NCT02154347|69195926|FG001|Open-label Period|Adverse Event|4|||
37717771|NCT02154347|69195925|FG000|Open-label Period|Lack of Efficacy|4|||
37717772|NCT02154347|69195926|FG001|Open-label Period|Lack of Efficacy|19|||
37717773|NCT02154347|69195925|FG000|Open-label Period|Protocol Violation|0|||
37717774|NCT02154347|69195926|FG001|Open-label Period|Protocol Violation|1|||
37717775|NCT02154347|69195925|FG000|Open-label Period|Withdrawal by Subject|0|||
37717776|NCT02154347|69195926|FG001|Open-label Period|Withdrawal by Subject|1|||
37717777|NCT01627067|69195933|FG000|Overall Study|Screen Failure|1|||
37717778|NCT02178059|69195939|FG000|Washout|Physician Decision|1|||
37717779|NCT02178059|69195940|FG001|Washout|Physician Decision|0|||
37717780|NCT01626989|69195946|FG000|Screening Period|Screen Failure|15|||
37717781|NCT01626989|69195947|FG001|Screening Period|Screen Failure|0|||
37717782|NCT01626989|69195948|FG002|Screening Period|Screen Failure|0|||
37717783|NCT01626989|69195946|FG000|Screening Period|Withdrawal by Subject|2|||
37717784|NCT01626989|69195947|FG001|Screening Period|Withdrawal by Subject|0|||
37717785|NCT01626989|69195948|FG002|Screening Period|Withdrawal by Subject|0|||
37839407|NCT00196976|69523946|FG006|Primary Study|Migrated from study area|0|||
37839408|NCT00196976|69523947|FG007|Primary Study|Migrated from study area|1|||
37717786|NCT02128217|69195959|FG000|Overall Study|Lost to Follow-up|0|||
37717787|NCT02128217|69195960|FG001|Overall Study|Lost to Follow-up|1|||
37717788|NCT01629953|69195973|FG000|Overall Study|Death|3|||
37839409|NCT00196976|69523948|FG008|Primary Study|Migrated from study area|0|||
37839410|NCT00196976|69523949|FG009|Primary Study|Migrated from study area|0|||
37717789|NCT01629953|69195974|FG001|Overall Study|Death|1|||
37717790|NCT01629953|69195973|FG000|Overall Study|Lost to Follow-up|10|||
37717791|NCT01629953|69195974|FG001|Overall Study|Lost to Follow-up|14|||
37717792|NCT02127281|69195982|FG000|Overall Study|Lost to Follow-up|1|||
37717793|NCT02127281|69195983|FG001|Overall Study|Lost to Follow-up|0|||
37717794|NCT01628549|69195993|FG000|Overall Study|Adverse Event|1|||
37717795|NCT01628549|69195994|FG001|Overall Study|Adverse Event|1|||
37717796|NCT01628549|69195995|FG002|Overall Study|Adverse Event|0|||
37717797|NCT01628549|69195996|FG003|Overall Study|Adverse Event|4|||
37717798|NCT01628549|69195993|FG000|Overall Study|Lost to Follow-up|3|||
37717799|NCT01628549|69195994|FG001|Overall Study|Lost to Follow-up|4|||
37839411|NCT00196976|69523950|FG010|Primary Study|Migrated from study area|0|||
37717800|NCT01628549|69195995|FG002|Overall Study|Lost to Follow-up|3|||
37839412|NCT00196976|69523951|FG011|Primary Study|Migrated from study area|0|||
37717801|NCT01628549|69195996|FG003|Overall Study|Lost to Follow-up|3|||
37717802|NCT01628549|69195993|FG000|Overall Study|Withdrawal by Subject|3|||
37717803|NCT01628549|69195994|FG001|Overall Study|Withdrawal by Subject|4|||
37717804|NCT01628549|69195995|FG002|Overall Study|Withdrawal by Subject|4|||
37717805|NCT01628549|69195996|FG003|Overall Study|Withdrawal by Subject|1|||
37717806|NCT01628549|69195993|FG000|Overall Study|Protocol Violation|2|||
37717807|NCT01628549|69195994|FG001|Overall Study|Protocol Violation|1|||
37717808|NCT01628549|69195995|FG002|Overall Study|Protocol Violation|1|||
37717809|NCT01628549|69195996|FG003|Overall Study|Protocol Violation|0|||
37717810|NCT01628549|69195993|FG000|Overall Study|withdrawn for noncompliance|0|||
37717811|NCT01628549|69195994|FG001|Overall Study|withdrawn for noncompliance|2|||
37717812|NCT01628549|69195995|FG002|Overall Study|withdrawn for noncompliance|1|||
37717813|NCT01628549|69195996|FG003|Overall Study|withdrawn for noncompliance|0|||
37717814|NCT01628549|69195993|FG000|Overall Study|abnormal laboratory test results|0|||
37717815|NCT01628549|69195994|FG001|Overall Study|abnormal laboratory test results|0|||
37717816|NCT01628549|69195995|FG002|Overall Study|abnormal laboratory test results|1|||
37717817|NCT01628549|69195996|FG003|Overall Study|abnormal laboratory test results|0|||
37717818|NCT01628549|69195993|FG000|Overall Study|positive pregnancy test|0|||
37717819|NCT01628549|69195994|FG001|Overall Study|positive pregnancy test|0|||
37717820|NCT01628549|69195995|FG002|Overall Study|positive pregnancy test|0|||
37717821|NCT01628549|69195996|FG003|Overall Study|positive pregnancy test|1|||
37717822|NCT02127125|69196015|FG000|Overall Study|Lost to Follow-up|0|||
37717823|NCT02127125|69196016|FG001|Overall Study|Lost to Follow-up|0|||
37717824|NCT02127125|69196017|FG002|Overall Study|Lost to Follow-up|0|||
37717825|NCT02127125|69196018|FG003|Overall Study|Lost to Follow-up|0|||
37717826|NCT02127125|69196019|FG004|Overall Study|Lost to Follow-up|2|||
37717827|NCT02127125|69196020|FG005|Overall Study|Lost to Follow-up|1|||
37717828|NCT02127125|69196021|FG006|Overall Study|Lost to Follow-up|0|||
37717829|NCT02127125|69196022|FG007|Overall Study|Lost to Follow-up|0|||
37717830|NCT02127125|69196023|FG008|Overall Study|Lost to Follow-up|0|||
37717831|NCT02127125|69196015|FG000|Overall Study|Withdrawal by Subject|0|||
37717832|NCT02127125|69196016|FG001|Overall Study|Withdrawal by Subject|0|||
37717833|NCT02127125|69196017|FG002|Overall Study|Withdrawal by Subject|0|||
37717834|NCT02127125|69196018|FG003|Overall Study|Withdrawal by Subject|1|||
37717835|NCT02127125|69196019|FG004|Overall Study|Withdrawal by Subject|0|||
37717836|NCT02127125|69196020|FG005|Overall Study|Withdrawal by Subject|0|||
37717837|NCT02127125|69196021|FG006|Overall Study|Withdrawal by Subject|0|||
37717838|NCT02127125|69196022|FG007|Overall Study|Withdrawal by Subject|0|||
37717839|NCT02127125|69196023|FG008|Overall Study|Withdrawal by Subject|0|||
37717840|NCT02127125|69196015|FG000|Overall Study|Physician Decision|0|||
37717841|NCT02127125|69196016|FG001|Overall Study|Physician Decision|0|||
37717842|NCT02127125|69196017|FG002|Overall Study|Physician Decision|1|||
37717843|NCT02127125|69196018|FG003|Overall Study|Physician Decision|0|||
37717844|NCT02127125|69196019|FG004|Overall Study|Physician Decision|1|||
37717845|NCT02127125|69196020|FG005|Overall Study|Physician Decision|2|||
37717846|NCT02127125|69196021|FG006|Overall Study|Physician Decision|0|||
37717847|NCT02127125|69196022|FG007|Overall Study|Physician Decision|0|||
37717848|NCT02127125|69196023|FG008|Overall Study|Physician Decision|0|||
37717849|NCT02090413|69196046|FG000|Overall Study|Adverse Event|11|||
37717850|NCT02090413|69196047|FG001|Overall Study|Adverse Event|15|||
37717851|NCT02090413|69196048|FG002|Overall Study|Adverse Event|20|||
37717852|NCT02090413|69196046|FG000|Overall Study|Flushing event|2|||
37717853|NCT02090413|69196047|FG001|Overall Study|Flushing event|0|||
37717854|NCT02090413|69196048|FG002|Overall Study|Flushing event|1|||
37717855|NCT02090413|69196046|FG000|Overall Study|Withdrawal by Subject|2|||
37717856|NCT02090413|69196047|FG001|Overall Study|Withdrawal by Subject|2|||
37717857|NCT02090413|69196048|FG002|Overall Study|Withdrawal by Subject|2|||
37717858|NCT02090413|69196046|FG000|Overall Study|Investigator Decision|1|||
37717859|NCT02090413|69196047|FG001|Overall Study|Investigator Decision|1|||
37717860|NCT02090413|69196048|FG002|Overall Study|Investigator Decision|0|||
37717861|NCT02090413|69196046|FG000|Overall Study|Other|2|||
37717862|NCT02090413|69196047|FG001|Overall Study|Other|1|||
37717863|NCT02090413|69196048|FG002|Overall Study|Other|0|||
37717864|NCT02090413|69196046|FG000|Overall Study|Lost to Follow-up|1|||
37717865|NCT02090413|69196047|FG001|Overall Study|Lost to Follow-up|1|||
37717866|NCT02090413|69196048|FG002|Overall Study|Lost to Follow-up|0|||
37717867|NCT02063737|69196059|FG000|Overall Study|Lost to Follow-up|11|||
37717868|NCT02063737|69196060|FG001|Overall Study|Lost to Follow-up|4|||
37717869|NCT02125877|69196068|FG000|Overall Study|Physician Decision|1|||
37717870|NCT02125877|69196069|FG001|Overall Study|Physician Decision|0|||
37717871|NCT02125877|69196068|FG000|Overall Study|Death|0|||
37717872|NCT02125877|69196069|FG001|Overall Study|Death|1|||
37717873|NCT02125877|69196068|FG000|Overall Study|Administrative problems|0|||
37717874|NCT02125877|69196069|FG001|Overall Study|Administrative problems|1|||
37717875|NCT02125877|69196068|FG000|Overall Study|Participant/guardian decision|0|||
37717876|NCT02125877|69196069|FG001|Overall Study|Participant/guardian decision|2|||
37717877|NCT02125877|69196068|FG000|Overall Study|Withdrawal by Subject|2|||
37717878|NCT02125877|69196069|FG001|Overall Study|Withdrawal by Subject|1|||
37717879|NCT02125877|69196068|FG000|Overall Study|Protocol deviation|4|||
37717880|NCT02125877|69196069|FG001|Overall Study|Protocol deviation|1|||
37717881|NCT02125877|69196068|FG000|Overall Study|Adverse Event|6|||
37717882|NCT02125877|69196069|FG001|Overall Study|Adverse Event|4|||
37717883|NCT01598987|69196075|FG000|Baseline to Month 12|Administrative problems|2|||
37717884|NCT01598987|69196075|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
37717885|NCT01598987|69196075|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
37717886|NCT01598987|69196075|FG000|Baseline to 24 Month|Administrative problems|2|||
37717887|NCT01598987|69196075|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
37717888|NCT02063659|69196089|FG000|Double-Blind Treatment Period|Adverse Event|1|||
37717889|NCT02063659|69196090|FG001|Double-Blind Treatment Period|Adverse Event|2|||
37717890|NCT02063659|69196091|FG002|Double-Blind Treatment Period|Adverse Event|0|||
37717891|NCT02063659|69196092|FG003|Double-Blind Treatment Period|Adverse Event|0|||
37717892|NCT02063659|69196089|FG000|Double-Blind Treatment Period|Physician Decision|1|||
37717893|NCT02063659|69196090|FG001|Double-Blind Treatment Period|Physician Decision|0|||
37717894|NCT02063659|69196091|FG002|Double-Blind Treatment Period|Physician Decision|0|||
37717895|NCT02063659|69196092|FG003|Double-Blind Treatment Period|Physician Decision|0|||
37717896|NCT02063659|69196089|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
38024875|NCT03988088|69708867|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
38024876|NCT03988088|69708868|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
38024877|NCT03988088|69708869|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
38024878|NCT03988088|69708870|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
38024879|NCT03988088|69708867|FG000|Open-Label Addendum|Lost to Follow-up|0|||
38024880|NCT03988088|69708868|FG001|Open-Label Addendum|Lost to Follow-up|0|||
38024881|NCT03988088|69708869|FG002|Open-Label Addendum|Lost to Follow-up|1|||
38024882|NCT03988088|69708870|FG003|Open-Label Addendum|Lost to Follow-up|0|||
38024883|NCT03987932|69708881|FG000|Overall Study|Lost to Follow-up|2|||
38024884|NCT03987932|69708882|FG001|Overall Study|Lost to Follow-up|1|||
38024885|NCT03987932|69708883|FG002|Overall Study|Lost to Follow-up|1|||
38024886|NCT03987932|69708881|FG000|Overall Study|Non-study related elective surgery|0|||
38024887|NCT03987932|69708882|FG001|Overall Study|Non-study related elective surgery|0|||
38024888|NCT03987932|69708883|FG002|Overall Study|Non-study related elective surgery|1|||
38024889|NCT03987620|69708893|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
38024890|NCT03987620|69708894|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
38024891|NCT03987620|69708893|FG000|Overall Study|Adverse Event|3|||
38024892|NCT03987620|69708894|FG001|Overall Study|Adverse Event|0|||
38024893|NCT03987620|69708893|FG000|Overall Study|Lost to Follow-up|1|||
38024894|NCT03987620|69708894|FG001|Overall Study|Lost to Follow-up|2|||
38024895|NCT03987620|69708893|FG000|Overall Study|Physician Decision|0|||
38024896|NCT03987620|69708894|FG001|Overall Study|Physician Decision|1|||
38024897|NCT03987620|69708893|FG000|Overall Study|Pregnancy|1|||
38024898|NCT03987620|69708894|FG001|Overall Study|Pregnancy|0|||
38024899|NCT03987620|69708893|FG000|Overall Study|Withdrawal by Subject|7|||
38024900|NCT03987620|69708894|FG001|Overall Study|Withdrawal by Subject|1|||
38024901|NCT03987620|69708893|FG000|Overall Study|Other|2|||
38024902|NCT03987620|69708894|FG001|Overall Study|Other|5|||
38024903|NCT04376060|69708900|FG000|Overall Study|Physician Decision|1|||
38024904|NCT04413552|69708914|FG000|Overall Study|Adverse Event|0|||
38024905|NCT04413552|69708915|FG001|Overall Study|Adverse Event|0|||
38024906|NCT04413552|69708916|FG002|Overall Study|Adverse Event|0|||
38024907|NCT04413552|69708917|FG003|Overall Study|Adverse Event|0|||
38024908|NCT04413552|69708918|FG004|Overall Study|Adverse Event|0|||
37717897|NCT02063659|69196090|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
37717898|NCT02063659|69196091|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
37717899|NCT02063659|69196092|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
37717900|NCT02063659|69196089|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
37717901|NCT02063659|69196090|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
37717902|NCT02063659|69196091|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
37717903|NCT02063659|69196092|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
37717904|NCT02063659|69196089|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
37717905|NCT02063659|69196090|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
37717906|NCT02063659|69196091|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
38024909|NCT04413552|69708919|FG005|Overall Study|Adverse Event|0|||
38024910|NCT04413552|69708920|FG006|Overall Study|Adverse Event|1|||
38024911|NCT04413552|69708921|FG007|Overall Study|Adverse Event|0|||
38024912|NCT04413552|69708922|FG008|Overall Study|Adverse Event|0|||
38024913|NCT04413552|69708923|FG009|Overall Study|Adverse Event|0|||
38024914|NCT03987074|69708954|FG000|Overall Study|Withdrew Consent|1|||
38024915|NCT03987074|69708955|FG001|Overall Study|Withdrew Consent|1|||
38024916|NCT03987074|69708956|FG002|Overall Study|Withdrew Consent|0|||
37717907|NCT02063659|69196092|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
37717908|NCT02063659|69196089|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
38024917|NCT03987074|69708957|FG003|Overall Study|Withdrew Consent|2|||
38024918|NCT03987074|69708958|FG004|Overall Study|Withdrew Consent|1|||
38024919|NCT03987074|69708954|FG000|Overall Study|Adverse Event|2|||
38024920|NCT03987074|69708955|FG001|Overall Study|Adverse Event|1|||
37717909|NCT02063659|69196090|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
37717910|NCT02063659|69196091|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
37717911|NCT02063659|69196092|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
37717912|NCT02063659|69196089|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
37717913|NCT02063659|69196090|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
37717914|NCT02063659|69196091|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
37717915|NCT02063659|69196092|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
37717916|NCT02063659|69196089|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
37717917|NCT02063659|69196090|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
37717918|NCT02063659|69196091|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
37717919|NCT02063659|69196092|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
37717920|NCT02062879|69196108|FG000|Overall Study|Withdrawal by Subject|4|||
37839413|NCT00196976|69523952|FG012|Primary Study|Migrated from study area|0|||
37839414|NCT00196976|69523953|FG013|Primary Study|Migrated from study area|0|||
37839415|NCT00196976|69523940|FG000|Primary Study|Protocol Violation|0|||
37839416|NCT00196976|69523941|FG001|Primary Study|Protocol Violation|1|||
37839417|NCT00196976|69523942|FG002|Primary Study|Protocol Violation|1|||
37839418|NCT00196976|69523943|FG003|Primary Study|Protocol Violation|0|||
37839419|NCT00196976|69523944|FG004|Primary Study|Protocol Violation|0|||
37839420|NCT00196976|69523945|FG005|Primary Study|Protocol Violation|0|||
37839421|NCT00196976|69523946|FG006|Primary Study|Protocol Violation|0|||
37839422|NCT00196976|69523947|FG007|Primary Study|Protocol Violation|0|||
37839423|NCT00196976|69523948|FG008|Primary Study|Protocol Violation|0|||
37839424|NCT00196976|69523949|FG009|Primary Study|Protocol Violation|0|||
37839425|NCT00196976|69523950|FG010|Primary Study|Protocol Violation|0|||
37839426|NCT00196976|69523951|FG011|Primary Study|Protocol Violation|0|||
37839427|NCT00196976|69523952|FG012|Primary Study|Protocol Violation|0|||
37839428|NCT00196976|69523953|FG013|Primary Study|Protocol Violation|0|||
37839429|NCT00196976|69523940|FG000|Primary Study|Withdrawal by Subject|1|||
37839430|NCT00196976|69523941|FG001|Primary Study|Withdrawal by Subject|0|||
37915497|NCT00853047|69602249|FG001|Open-Label Extension Phase|Investigator Decision|0|||
37717921|NCT02062879|69196109|FG001|Overall Study|Withdrawal by Subject|1|||
37717922|NCT02062645|69196115|FG000|Overall Study|Adverse Event|2|||
37717923|NCT02062645|69196115|FG000|Overall Study|Protocol Violation|8|||
37717924|NCT02062645|69196115|FG000|Overall Study|Lost to Follow-up|5|||
37717925|NCT02088697|69196121|FG000|Period I|Physician Decision|1|||
37717926|NCT02088697|69196122|FG001|Period I|Physician Decision|4|||
37717927|NCT02088697|69196121|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
37717928|NCT02088697|69196122|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
37717929|NCT01825785|69196135|FG000|Overall Study|Adverse Event|0|||
37717930|NCT01825785|69196136|FG001|Overall Study|Adverse Event|0|||
37717931|NCT01825785|69196137|FG002|Overall Study|Adverse Event|0|||
37717932|NCT01825785|69196138|FG003|Overall Study|Adverse Event|0|||
37717933|NCT01825785|69196139|FG004|Overall Study|Adverse Event|1|||
37717934|NCT01825785|69196140|FG005|Overall Study|Adverse Event|0|||
37717935|NCT01825785|69196141|FG006|Overall Study|Adverse Event|0|||
37717936|NCT01825785|69196135|FG000|Overall Study|Withdrawal by Subject|0|||
37717937|NCT01825785|69196136|FG001|Overall Study|Withdrawal by Subject|0|||
37717938|NCT01825785|69196137|FG002|Overall Study|Withdrawal by Subject|0|||
37717939|NCT01825785|69196138|FG003|Overall Study|Withdrawal by Subject|0|||
37717940|NCT01825785|69196139|FG004|Overall Study|Withdrawal by Subject|1|||
37717941|NCT01825785|69196140|FG005|Overall Study|Withdrawal by Subject|1|||
37717942|NCT01825785|69196141|FG006|Overall Study|Withdrawal by Subject|0|||
37717943|NCT02043301|69196166|FG000|Overall Study|Discontinued|0|||
37717944|NCT02043301|69196167|FG001|Overall Study|Discontinued|1|||
37717945|NCT02043301|69196168|FG002|Overall Study|Discontinued|0|||
37717946|NCT01598753|69196180|FG000|Overall Study|Adverse Event|1|||
37717947|NCT01598753|69196181|FG001|Overall Study|Adverse Event|9|||
37717948|NCT01598753|69196182|FG002|Overall Study|Adverse Event|1|||
37717949|NCT01598753|69196183|FG003|Overall Study|Adverse Event|7|||
37839431|NCT00196976|69523942|FG002|Primary Study|Withdrawal by Subject|1|||
37839432|NCT00196976|69523943|FG003|Primary Study|Withdrawal by Subject|1|||
37839433|NCT00196976|69523944|FG004|Primary Study|Withdrawal by Subject|2|||
37915498|NCT00853047|69602250|FG002|Open-Label Extension Phase|Investigator Decision|0|||
37717950|NCT01598753|69196180|FG000|Overall Study|Lost to Follow-up|4|||
37717951|NCT01598753|69196181|FG001|Overall Study|Lost to Follow-up|3|||
37717952|NCT01598753|69196182|FG002|Overall Study|Lost to Follow-up|7|||
37717953|NCT01598753|69196183|FG003|Overall Study|Lost to Follow-up|5|||
37717954|NCT01598753|69196180|FG000|Overall Study|Physician Decision|0|||
37717955|NCT01598753|69196181|FG001|Overall Study|Physician Decision|1|||
37717956|NCT01598753|69196182|FG002|Overall Study|Physician Decision|0|||
37717957|NCT01598753|69196183|FG003|Overall Study|Physician Decision|2|||
37839434|NCT00196976|69523945|FG005|Primary Study|Withdrawal by Subject|1|||
37839435|NCT00196976|69523946|FG006|Primary Study|Withdrawal by Subject|0|||
37717958|NCT01598753|69196180|FG000|Overall Study|Withdrawal by Subject|7|||
37717959|NCT01598753|69196181|FG001|Overall Study|Withdrawal by Subject|2|||
37717960|NCT01598753|69196182|FG002|Overall Study|Withdrawal by Subject|0|||
37717961|NCT01598753|69196183|FG003|Overall Study|Withdrawal by Subject|1|||
37717962|NCT02177123|69196193|FG000|Overall Study|Lost to Follow-up|6|||
37717963|NCT02177123|69196193|FG000|Overall Study|Withdrawal by Subject|4|||
37717964|NCT02177123|69196193|FG000|Overall Study|Adverse Event|4|||
37717965|NCT02177123|69196193|FG000|Overall Study|Physician Decision|3|||
37717966|NCT02177123|69196193|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
37717967|NCT02177123|69196193|FG000|Overall Study|Excluded for medical reasons|2|||
37717968|NCT02177123|69196193|FG000|Overall Study|Death|1|||
37717969|NCT02177123|69196193|FG000|Overall Study|Other|1|||
37717970|NCT02177123|69196193|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
37717971|NCT01824693|69196203|FG000|Overall Study|Death|0|||
37717972|NCT01824693|69196204|FG001|Overall Study|Death|1|||
37717973|NCT01824693|69196205|FG002|Overall Study|Death|0|||
37717974|NCT01824693|69196203|FG000|Overall Study|Physician Decision|1|||
37717975|NCT01824693|69196204|FG001|Overall Study|Physician Decision|1|||
37717976|NCT01824693|69196205|FG002|Overall Study|Physician Decision|1|||
37717977|NCT01824693|69196203|FG000|Overall Study|Withdrawal by Subject|0|||
37717978|NCT01824693|69196204|FG001|Overall Study|Withdrawal by Subject|0|||
37717979|NCT01824693|69196205|FG002|Overall Study|Withdrawal by Subject|1|||
37717980|NCT01824693|69196203|FG000|Overall Study|Progressive Disease|0|||
37717981|NCT01824693|69196204|FG001|Overall Study|Progressive Disease|5|||
37717982|NCT01824693|69196205|FG002|Overall Study|Progressive Disease|0|||
37717983|NCT01824693|69196203|FG000|Overall Study|Ineligible|0|||
37839436|NCT00196976|69523947|FG007|Primary Study|Withdrawal by Subject|0|||
37839437|NCT00196976|69523948|FG008|Primary Study|Withdrawal by Subject|0|||
37717984|NCT01824693|69196204|FG001|Overall Study|Ineligible|0|||
37717985|NCT01824693|69196205|FG002|Overall Study|Ineligible|3|||
37717986|NCT01824693|69196203|FG000|Overall Study|No Transplant Planned|0|||
37717987|NCT01824693|69196204|FG001|Overall Study|No Transplant Planned|0|||
37717988|NCT01824693|69196205|FG002|Overall Study|No Transplant Planned|10|||
37717989|NCT02176655|69196212|FG000|Overall Study|Subjects did not treat|6|||
37717990|NCT02125331|69196219|FG000|Overall Study|Protocol Violation|1|||
37717991|NCT02125331|69196220|FG001|Overall Study|Protocol Violation|0|||
37717992|NCT02125331|69196219|FG000|Overall Study|technical problem|2|||
37717993|NCT02125331|69196220|FG001|Overall Study|technical problem|0|||
37717994|NCT02125331|69196219|FG000|Overall Study|screen failure|2|||
37717995|NCT02125331|69196220|FG001|Overall Study|screen failure|0|||
37717996|NCT01622569|69196230|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
37717997|NCT01622569|69196231|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
37717998|NCT01622569|69196232|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
37717999|NCT01622569|69196233|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
37718000|NCT01622569|69196230|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
37718001|NCT01622569|69196231|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
37718002|NCT01622569|69196232|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
37718003|NCT01622569|69196233|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
37718004|NCT01622569|69196230|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
37718005|NCT01622569|69196231|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
37718006|NCT01622569|69196232|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
37718007|NCT01622569|69196233|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
37718008|NCT01622569|69196230|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
37718009|NCT01622569|69196231|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
37718010|NCT01622569|69196232|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
37718011|NCT01622569|69196233|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
37718012|NCT01622569|69196230|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
37718013|NCT01622569|69196231|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
37718014|NCT01622569|69196232|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
37718015|NCT01622569|69196233|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
37718016|NCT01622569|69196230|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
37718017|NCT01622569|69196231|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
37718018|NCT01622569|69196232|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
37718019|NCT01622569|69196233|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
37718020|NCT01622569|69196230|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
37839438|NCT00196976|69523949|FG009|Primary Study|Withdrawal by Subject|1|||
37839439|NCT00196976|69523950|FG010|Primary Study|Withdrawal by Subject|0|||
38024921|NCT03987074|69708956|FG002|Overall Study|Adverse Event|0|||
37718021|NCT01622569|69196231|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
37718022|NCT01622569|69196232|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
37839440|NCT00196976|69523951|FG011|Primary Study|Withdrawal by Subject|0|||
37718023|NCT01622569|69196233|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
37718024|NCT01622569|69196230|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
37718025|NCT01622569|69196231|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
37718026|NCT01622569|69196232|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
37718027|NCT01622569|69196233|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
37718028|NCT01824303|69196255|FG000|Randomized Study|Withdrawal by Subject|1|||
37718029|NCT01824303|69196256|FG001|Randomized Study|Withdrawal by Subject|1|||
37718030|NCT01824303|69196255|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
37718031|NCT01824303|69196256|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
37718032|NCT01853397|69196268|FG000|Overall Study|Withdrawal by Subject|0|||
37718033|NCT01853397|69196269|FG001|Overall Study|Withdrawal by Subject|0|||
37718034|NCT01853397|69196270|FG002|Overall Study|Withdrawal by Subject|0|||
37718035|NCT01853397|69196271|FG003|Overall Study|Withdrawal by Subject|1|||
37718036|NCT01853397|69196268|FG000|Overall Study|Subject Noncompliance|0|||
37718037|NCT01853397|69196269|FG001|Overall Study|Subject Noncompliance|0|||
37718038|NCT01853397|69196270|FG002|Overall Study|Subject Noncompliance|0|||
37718039|NCT01853397|69196271|FG003|Overall Study|Subject Noncompliance|1|||
37718040|NCT02088073|69196286|FG000|Acute Phase|Withdrawal by Subject|5|||
37718041|NCT02088073|69196287|FG001|Acute Phase|Withdrawal by Subject|0|||
37718042|NCT02088073|69196288|FG002|Acute Phase|Withdrawal by Subject|0|||
37718043|NCT02088073|69196289|FG003|Acute Phase|Withdrawal by Subject|0|||
37718044|NCT02088073|69196290|FG004|Acute Phase|Withdrawal by Subject|0|||
37718045|NCT02088073|69196286|FG000|Acute Phase|Hyperkalemia|2|||
37718046|NCT02088073|69196287|FG001|Acute Phase|Hyperkalemia|0|||
37718047|NCT02088073|69196288|FG002|Acute Phase|Hyperkalemia|0|||
37718048|NCT02088073|69196289|FG003|Acute Phase|Hyperkalemia|0|||
37718049|NCT02088073|69196290|FG004|Acute Phase|Hyperkalemia|0|||
37718050|NCT02088073|69196286|FG000|Maintanance Phase|Withdrawal by Subject|0|||
37718051|NCT02088073|69196287|FG001|Maintanance Phase|Withdrawal by Subject|2|||
37718052|NCT02088073|69196288|FG002|Maintanance Phase|Withdrawal by Subject|0|||
37718053|NCT02088073|69196289|FG003|Maintanance Phase|Withdrawal by Subject|0|||
37718054|NCT02088073|69196290|FG004|Maintanance Phase|Withdrawal by Subject|0|||
37718055|NCT02088073|69196286|FG000|Maintanance Phase|Adverse Event|0|||
37718056|NCT02088073|69196287|FG001|Maintanance Phase|Adverse Event|0|||
37718057|NCT02088073|69196288|FG002|Maintanance Phase|Adverse Event|3|||
37718058|NCT02088073|69196289|FG003|Maintanance Phase|Adverse Event|0|||
37718059|NCT02088073|69196290|FG004|Maintanance Phase|Adverse Event|1|||
37718060|NCT02088073|69196286|FG000|Maintanance Phase|Physician Decision|0|||
37718061|NCT02088073|69196287|FG001|Maintanance Phase|Physician Decision|0|||
37718062|NCT02088073|69196288|FG002|Maintanance Phase|Physician Decision|0|||
37718063|NCT02088073|69196289|FG003|Maintanance Phase|Physician Decision|0|||
37718064|NCT02088073|69196290|FG004|Maintanance Phase|Physician Decision|1|||
37718065|NCT02088073|69196286|FG000|Maintanance Phase|Sponsor's decision|0|||
37718066|NCT02088073|69196287|FG001|Maintanance Phase|Sponsor's decision|2|||
37718067|NCT02088073|69196288|FG002|Maintanance Phase|Sponsor's decision|0|||
37718068|NCT02088073|69196289|FG003|Maintanance Phase|Sponsor's decision|2|||
37718069|NCT02088073|69196290|FG004|Maintanance Phase|Sponsor's decision|1|||
37718070|NCT02088073|69196286|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
37718071|NCT02088073|69196287|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
37718072|NCT02088073|69196288|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
37718073|NCT02088073|69196289|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
37718074|NCT02088073|69196290|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
37718075|NCT02088073|69196286|FG000|Maintanance Phase|Miscellaneous|0|||
37718076|NCT02088073|69196287|FG001|Maintanance Phase|Miscellaneous|2|||
37718077|NCT02088073|69196288|FG002|Maintanance Phase|Miscellaneous|1|||
37718078|NCT02088073|69196289|FG003|Maintanance Phase|Miscellaneous|2|||
37718079|NCT02088073|69196290|FG004|Maintanance Phase|Miscellaneous|1|||
37718080|NCT02088073|69196286|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
37718081|NCT02088073|69196287|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
37718082|NCT02088073|69196288|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
37718083|NCT02088073|69196289|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
37718084|NCT02088073|69196290|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
37718085|NCT02088073|69196286|FG000|Maintanance Phase|Subject compliance|0|||
37718086|NCT02088073|69196287|FG001|Maintanance Phase|Subject compliance|1|||
37718087|NCT02088073|69196288|FG002|Maintanance Phase|Subject compliance|0|||
37718088|NCT02088073|69196289|FG003|Maintanance Phase|Subject compliance|0|||
37718089|NCT02088073|69196290|FG004|Maintanance Phase|Subject compliance|0|||
37718090|NCT01823991|69196305|FG000|Overall Study|Withdrawal by Subject|8|||
37718091|NCT01823991|69196306|FG001|Overall Study|Withdrawal by Subject|5|||
37718092|NCT02087059|69196316|FG000|Overall Study|Disease Progression|1|||
37718093|NCT02087059|69196316|FG000|Overall Study|Adverse Event|5|||
37718094|NCT02087059|69196316|FG000|Overall Study|Lost to Follow-up|1|||
37718095|NCT02152163|69196322|FG000|Overall Study|Physician Decision|12|||
37718096|NCT02152163|69196323|FG001|Overall Study|Physician Decision|13|||
37718097|NCT02152007|69196329|FG000|Overall Study|Withdrawal by Subject|1|||
37718098|NCT02151851|69196336|FG000|Overall Study|Lack of Efficacy|67|||
37718099|NCT02151851|69196337|FG001|Overall Study|Lack of Efficacy|94|||
37718100|NCT02151851|69196336|FG000|Overall Study|Protocol Violation|0|||
37718101|NCT02151851|69196337|FG001|Overall Study|Protocol Violation|1|||
37718102|NCT02151851|69196336|FG000|Overall Study|Withdrawal by Subject|2|||
37718103|NCT02151851|69196337|FG001|Overall Study|Withdrawal by Subject|5|||
37718104|NCT02151851|69196336|FG000|Overall Study|Medical impairment|1|||
37718105|NCT02151851|69196337|FG001|Overall Study|Medical impairment|0|||
37718106|NCT02151851|69196336|FG000|Overall Study|Low compliance to study visits|0|||
37718107|NCT02151851|69196337|FG001|Overall Study|Low compliance to study visits|1|||
37718108|NCT02151851|69196336|FG000|Overall Study|Subject entered into study in error|0|||
37718109|NCT02151851|69196337|FG001|Overall Study|Subject entered into study in error|1|||
37718110|NCT02151851|69196336|FG000|Overall Study|Adverse Event|6|||
37718111|NCT02151851|69196337|FG001|Overall Study|Adverse Event|28|||
37718112|NCT02176421|69196343|FG000|Overall Study|Lost to Follow-up|4|||
37718113|NCT02176421|69196343|FG000|Overall Study|Adverse Event|1|||
37718114|NCT02042443|69196349|FG000|Overall Study|Adverse Event|2|||
37718115|NCT02042443|69196350|FG001|Overall Study|Adverse Event|1|||
37718116|NCT02042443|69196349|FG000|Overall Study|Withdrawal by Subject|0|||
37718117|NCT02042443|69196350|FG001|Overall Study|Withdrawal by Subject|1|||
37718118|NCT02042443|69196349|FG000|Overall Study|Progression|21|||
37718119|NCT02042443|69196350|FG001|Overall Study|Progression|17|||
37718120|NCT02042443|69196349|FG000|Overall Study|not protocol specified|1|||
37718121|NCT02042443|69196350|FG001|Overall Study|not protocol specified|1|||
37718122|NCT02042443|69196349|FG000|Overall Study|Not eligible/not analyzable|3|||
37718123|NCT02042443|69196350|FG001|Overall Study|Not eligible/not analyzable|6|||
37718124|NCT02118896|69196367|FG000|Overall Study|Death|4|||
37718125|NCT02118896|69196368|FG001|Overall Study|Death|0|||
37718126|NCT02118896|69196369|FG002|Overall Study|Death|4|||
37718127|NCT02118896|69196370|FG003|Overall Study|Death|6|||
37718128|NCT02118896|69196371|FG004|Overall Study|Death|3|||
37718129|NCT02118896|69196372|FG005|Overall Study|Death|1|||
37718130|NCT02118896|69196373|FG006|Overall Study|Death|0|||
37718131|NCT02118896|69196374|FG007|Overall Study|Death|0|||
37718132|NCT02118896|69196375|FG008|Overall Study|Death|0|||
37718133|NCT02118896|69196376|FG009|Overall Study|Death|0|||
37718134|NCT02118896|69196367|FG000|Overall Study|Adverse Event|5|||
37718135|NCT02118896|69196368|FG001|Overall Study|Adverse Event|4|||
37718136|NCT02118896|69196369|FG002|Overall Study|Adverse Event|4|||
37718137|NCT02118896|69196370|FG003|Overall Study|Adverse Event|5|||
37718138|NCT02118896|69196371|FG004|Overall Study|Adverse Event|5|||
37718139|NCT02118896|69196372|FG005|Overall Study|Adverse Event|9|||
37718140|NCT02118896|69196373|FG006|Overall Study|Adverse Event|1|||
37718141|NCT02118896|69196374|FG007|Overall Study|Adverse Event|1|||
37718142|NCT02118896|69196375|FG008|Overall Study|Adverse Event|4|||
37718143|NCT02118896|69196376|FG009|Overall Study|Adverse Event|0|||
37718144|NCT02118896|69196367|FG000|Overall Study|Consent withdrawn|2|||
37718145|NCT02118896|69196368|FG001|Overall Study|Consent withdrawn|0|||
37718146|NCT02118896|69196369|FG002|Overall Study|Consent withdrawn|3|||
37718147|NCT02118896|69196370|FG003|Overall Study|Consent withdrawn|4|||
37718148|NCT02118896|69196371|FG004|Overall Study|Consent withdrawn|1|||
37718149|NCT02118896|69196372|FG005|Overall Study|Consent withdrawn|4|||
37718150|NCT02118896|69196373|FG006|Overall Study|Consent withdrawn|0|||
37718151|NCT02118896|69196374|FG007|Overall Study|Consent withdrawn|0|||
37718152|NCT02118896|69196375|FG008|Overall Study|Consent withdrawn|0|||
37718153|NCT02118896|69196376|FG009|Overall Study|Consent withdrawn|0|||
37718154|NCT02118896|69196367|FG000|Overall Study|Non-compliance|2|||
37718155|NCT02118896|69196368|FG001|Overall Study|Non-compliance|1|||
37718156|NCT02118896|69196369|FG002|Overall Study|Non-compliance|1|||
37718157|NCT02118896|69196370|FG003|Overall Study|Non-compliance|5|||
37718158|NCT02118896|69196371|FG004|Overall Study|Non-compliance|0|||
37718159|NCT02118896|69196372|FG005|Overall Study|Non-compliance|1|||
37718160|NCT02118896|69196373|FG006|Overall Study|Non-compliance|0|||
37718161|NCT02118896|69196374|FG007|Overall Study|Non-compliance|1|||
37718162|NCT02118896|69196375|FG008|Overall Study|Non-compliance|0|||
37718163|NCT02118896|69196376|FG009|Overall Study|Non-compliance|0|||
37718164|NCT02118896|69196367|FG000|Overall Study|Pregnancy|1|||
37718165|NCT02118896|69196368|FG001|Overall Study|Pregnancy|1|||
37718166|NCT02118896|69196369|FG002|Overall Study|Pregnancy|0|||
37718167|NCT02118896|69196370|FG003|Overall Study|Pregnancy|0|||
37718168|NCT02118896|69196371|FG004|Overall Study|Pregnancy|1|||
37718169|NCT02118896|69196372|FG005|Overall Study|Pregnancy|3|||
37718170|NCT02118896|69196373|FG006|Overall Study|Pregnancy|1|||
37718171|NCT02118896|69196374|FG007|Overall Study|Pregnancy|0|||
37718172|NCT02118896|69196375|FG008|Overall Study|Pregnancy|0|||
37718173|NCT02118896|69196376|FG009|Overall Study|Pregnancy|0|||
37718174|NCT02118896|69196367|FG000|Overall Study|Lost to Follow-up|1|||
37718175|NCT02118896|69196368|FG001|Overall Study|Lost to Follow-up|2|||
37718176|NCT02118896|69196369|FG002|Overall Study|Lost to Follow-up|1|||
37718177|NCT02118896|69196370|FG003|Overall Study|Lost to Follow-up|0|||
37718178|NCT02118896|69196371|FG004|Overall Study|Lost to Follow-up|2|||
37718179|NCT02118896|69196372|FG005|Overall Study|Lost to Follow-up|1|||
37718180|NCT02118896|69196373|FG006|Overall Study|Lost to Follow-up|0|||
37718181|NCT02118896|69196374|FG007|Overall Study|Lost to Follow-up|0|||
37839441|NCT00196976|69523952|FG012|Primary Study|Withdrawal by Subject|0|||
37839442|NCT00196976|69523953|FG013|Primary Study|Withdrawal by Subject|0|||
37839443|NCT00196976|69523940|FG000|Primary Study|Lost to Follow-up|0|||
37839444|NCT00196976|69523941|FG001|Primary Study|Lost to Follow-up|0|||
37839445|NCT00196976|69523942|FG002|Primary Study|Lost to Follow-up|0|||
37839446|NCT00196976|69523943|FG003|Primary Study|Lost to Follow-up|0|||
37839447|NCT00196976|69523944|FG004|Primary Study|Lost to Follow-up|1|||
37839448|NCT00196976|69523945|FG005|Primary Study|Lost to Follow-up|1|||
37839449|NCT00196976|69523946|FG006|Primary Study|Lost to Follow-up|0|||
37839450|NCT00196976|69523947|FG007|Primary Study|Lost to Follow-up|2|||
37839451|NCT00196976|69523948|FG008|Primary Study|Lost to Follow-up|0|||
37839452|NCT00196976|69523949|FG009|Primary Study|Lost to Follow-up|0|||
37718182|NCT02118896|69196375|FG008|Overall Study|Lost to Follow-up|0|||
37718183|NCT02118896|69196376|FG009|Overall Study|Lost to Follow-up|0|||
37718184|NCT02118896|69196367|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
37718185|NCT02118896|69196368|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
37718186|NCT02118896|69196369|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
37718187|NCT02118896|69196370|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
37718188|NCT02118896|69196371|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
37718189|NCT02118896|69196372|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
37718190|NCT02118896|69196373|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
37718191|NCT02118896|69196374|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
37839453|NCT00196976|69523950|FG010|Primary Study|Lost to Follow-up|0|||
37839454|NCT00196976|69523951|FG011|Primary Study|Lost to Follow-up|0|||
37839455|NCT00196976|69523952|FG012|Primary Study|Lost to Follow-up|0|||
37839456|NCT00196976|69523953|FG013|Primary Study|Lost to Follow-up|0|||
37839457|NCT00196976|69523940|FG000|Primary Study|Other|0|||
37839458|NCT00196976|69523941|FG001|Primary Study|Other|0|||
37839459|NCT00196976|69523942|FG002|Primary Study|Other|2|||
37839460|NCT00196976|69523943|FG003|Primary Study|Other|0|||
37718192|NCT02118896|69196375|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
37718193|NCT02118896|69196376|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
37839461|NCT00196976|69523944|FG004|Primary Study|Other|0|||
37839462|NCT00196976|69523945|FG005|Primary Study|Other|0|||
37839463|NCT00196976|69523946|FG006|Primary Study|Other|0|||
37839464|NCT00196976|69523947|FG007|Primary Study|Other|0|||
37839465|NCT00196976|69523948|FG008|Primary Study|Other|0|||
37839466|NCT00196976|69523949|FG009|Primary Study|Other|0|||
37839467|NCT00196976|69523950|FG010|Primary Study|Other|0|||
37839468|NCT00196976|69523951|FG011|Primary Study|Other|0|||
37839469|NCT00196976|69523952|FG012|Primary Study|Other|0|||
37839470|NCT00196976|69523953|FG013|Primary Study|Other|0|||
37839471|NCT00196976|69523940|FG000|Booster Study|Withdrawal by Subject|0|||
37839472|NCT00196976|69523941|FG001|Booster Study|Withdrawal by Subject|0|||
37839473|NCT00196976|69523942|FG002|Booster Study|Withdrawal by Subject|0|||
37839474|NCT00196976|69523943|FG003|Booster Study|Withdrawal by Subject|0|||
37839475|NCT00196976|69523944|FG004|Booster Study|Withdrawal by Subject|0|||
37839476|NCT00196976|69523945|FG005|Booster Study|Withdrawal by Subject|0|||
37839477|NCT00196976|69523946|FG006|Booster Study|Withdrawal by Subject|0|||
37839478|NCT00196976|69523947|FG007|Booster Study|Withdrawal by Subject|0|||
37839479|NCT00196976|69523948|FG008|Booster Study|Withdrawal by Subject|0|||
37839480|NCT00196976|69523949|FG009|Booster Study|Withdrawal by Subject|0|||
37839481|NCT00196976|69523950|FG010|Booster Study|Withdrawal by Subject|1|||
37718194|NCT02118896|69196367|FG000|Overall Study|Prohibited medication|0|||
37718195|NCT02118896|69196368|FG001|Overall Study|Prohibited medication|0|||
37718196|NCT02118896|69196369|FG002|Overall Study|Prohibited medication|0|||
37718197|NCT02118896|69196370|FG003|Overall Study|Prohibited medication|0|||
37718198|NCT02118896|69196371|FG004|Overall Study|Prohibited medication|1|||
37718199|NCT02118896|69196372|FG005|Overall Study|Prohibited medication|3|||
37718200|NCT02118896|69196373|FG006|Overall Study|Prohibited medication|0|||
37718201|NCT02118896|69196374|FG007|Overall Study|Prohibited medication|0|||
37718202|NCT02118896|69196375|FG008|Overall Study|Prohibited medication|0|||
37718203|NCT02118896|69196376|FG009|Overall Study|Prohibited medication|0|||
37839482|NCT00196976|69523951|FG011|Booster Study|Withdrawal by Subject|0|||
37839483|NCT00196976|69523952|FG012|Booster Study|Withdrawal by Subject|0|||
37839484|NCT00196976|69523953|FG013|Booster Study|Withdrawal by Subject|0|||
37839485|NCT00196976|69523940|FG000|Booster Study|Lost to Follow-up|0|||
37839486|NCT00196976|69523941|FG001|Booster Study|Lost to Follow-up|0|||
37839487|NCT00196976|69523942|FG002|Booster Study|Lost to Follow-up|0|||
37839488|NCT00196976|69523943|FG003|Booster Study|Lost to Follow-up|0|||
37839489|NCT00196976|69523944|FG004|Booster Study|Lost to Follow-up|0|||
37839490|NCT00196976|69523945|FG005|Booster Study|Lost to Follow-up|0|||
37839491|NCT00196976|69523946|FG006|Booster Study|Lost to Follow-up|0|||
37839492|NCT00196976|69523947|FG007|Booster Study|Lost to Follow-up|0|||
37839493|NCT00196976|69523948|FG008|Booster Study|Lost to Follow-up|0|||
37839494|NCT00196976|69523949|FG009|Booster Study|Lost to Follow-up|0|||
37718204|NCT02118896|69196367|FG000|Overall Study|Miscellaneous|1|||
37839495|NCT00196976|69523950|FG010|Booster Study|Lost to Follow-up|1|||
37839496|NCT00196976|69523951|FG011|Booster Study|Lost to Follow-up|2|||
37839497|NCT00196976|69523952|FG012|Booster Study|Lost to Follow-up|0|||
37839498|NCT00196976|69523953|FG013|Booster Study|Lost to Follow-up|0|||
37839499|NCT00196313|69523995|FG000|Overall Study|Protocol Violation|2|||
37839500|NCT00196313|69523996|FG001|Overall Study|Protocol Violation|3|||
37839501|NCT00196313|69523995|FG000|Overall Study|Withdrawal by Subject|3|||
37839502|NCT00196313|69523996|FG001|Overall Study|Withdrawal by Subject|1|||
37839503|NCT00196313|69523995|FG000|Overall Study|Adverse Event|3|||
37839504|NCT00196313|69523996|FG001|Overall Study|Adverse Event|1|||
37839505|NCT00196313|69523995|FG000|Overall Study|Subject Pregnant|1|||
37839506|NCT00196313|69523996|FG001|Overall Study|Subject Pregnant|1|||
37839507|NCT00196313|69523995|FG000|Overall Study|Lost to Follow-up|2|||
37839508|NCT00196313|69523996|FG001|Overall Study|Lost to Follow-up|2|||
37839509|NCT00196196|69524003|FG000|Overall Study|Withdrawal by Subject|2|||
37839510|NCT00196196|69524003|FG000|Overall Study|Did not have required condition (hydroce|5|||
37839511|NCT00195650|69524007|FG000|Overall Study|Adverse Event|194|||
37839512|NCT00195650|69524007|FG000|Overall Study|Lack of Efficacy|99|||
37839513|NCT00195650|69524007|FG000|Overall Study|Withdrawal by Subject|67|||
37839514|NCT00195650|69524007|FG000|Overall Study|Lost to Follow-up|44|||
37839515|NCT00195650|69524007|FG000|Overall Study|Death|23|||
37839516|NCT00195650|69524007|FG000|Overall Study|Protocol Violation|15|||
37839517|NCT00195650|69524007|FG000|Overall Study|Administrative reasons|83|||
37839518|NCT00195494|69524013|FG000|Year 1|Adverse Event|0|||
37839519|NCT00195494|69524014|FG001|Year 1|Adverse Event|0|||
37839520|NCT00195494|69524015|FG002|Year 1|Adverse Event|0|||
37839521|NCT00195494|69524016|FG003|Year 1|Adverse Event|0|||
37839522|NCT00195494|69524017|FG004|Year 1|Adverse Event|34|||
37839523|NCT00195494|69524018|FG005|Year 1|Adverse Event|27|||
37839524|NCT00195494|69524013|FG000|Year 1|System Toxicity|0|||
37839525|NCT00195494|69524014|FG001|Year 1|System Toxicity|0|||
37839526|NCT00195494|69524015|FG002|Year 1|System Toxicity|0|||
37839527|NCT00195494|69524016|FG003|Year 1|System Toxicity|0|||
37839528|NCT00195494|69524017|FG004|Year 1|System Toxicity|0|||
37839529|NCT00195494|69524018|FG005|Year 1|System Toxicity|1|||
37718205|NCT02118896|69196368|FG001|Overall Study|Miscellaneous|2|||
37718206|NCT02118896|69196369|FG002|Overall Study|Miscellaneous|0|||
37718207|NCT02118896|69196370|FG003|Overall Study|Miscellaneous|2|||
37718208|NCT02118896|69196371|FG004|Overall Study|Miscellaneous|0|||
37718209|NCT02118896|69196372|FG005|Overall Study|Miscellaneous|4|||
37718210|NCT02118896|69196373|FG006|Overall Study|Miscellaneous|0|||
37718211|NCT02118896|69196374|FG007|Overall Study|Miscellaneous|0|||
37839530|NCT00195494|69524013|FG000|Year 1|Lack of Efficacy|0|||
37839531|NCT00195494|69524014|FG001|Year 1|Lack of Efficacy|0|||
38024922|NCT03987074|69708957|FG003|Overall Study|Adverse Event|0|||
38024923|NCT03987074|69708958|FG004|Overall Study|Adverse Event|1|||
38024924|NCT03987074|69708954|FG000|Overall Study|Lost to Follow-up|0|||
38024925|NCT03987074|69708955|FG001|Overall Study|Lost to Follow-up|0|||
37718212|NCT02118896|69196375|FG008|Overall Study|Miscellaneous|0|||
37718213|NCT02118896|69196376|FG009|Overall Study|Miscellaneous|0|||
37718214|NCT02124707|69196399|FG000|Overall Study|Adverse Event|5|||
37718215|NCT02124707|69196399|FG000|Overall Study|Physician Decision|1|||
37718216|NCT02124707|69196399|FG000|Overall Study|Death|1|||
37718217|NCT02067728|69196406|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
37718218|NCT02067728|69196407|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
37718219|NCT02067728|69196406|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
37718220|NCT02067728|69196407|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
37718221|NCT02067728|69196406|FG000|6 Month Measurements|Unable to attend|114|||
37718222|NCT02067728|69196407|FG001|6 Month Measurements|Unable to attend|97|||
37718223|NCT02118428|69196415|FG000|Overall Study|Physician Decision|0|||
37839532|NCT00195494|69524015|FG002|Year 1|Lack of Efficacy|0|||
37839533|NCT00195494|69524016|FG003|Year 1|Lack of Efficacy|0|||
37839534|NCT00195494|69524017|FG004|Year 1|Lack of Efficacy|24|||
37839535|NCT00195494|69524018|FG005|Year 1|Lack of Efficacy|9|||
37839536|NCT00195494|69524013|FG000|Year 1|Compliance|0|||
37839537|NCT00195494|69524014|FG001|Year 1|Compliance|0|||
37839538|NCT00195494|69524015|FG002|Year 1|Compliance|0|||
37839539|NCT00195494|69524016|FG003|Year 1|Compliance|0|||
37839540|NCT00195494|69524017|FG004|Year 1|Compliance|5|||
37839541|NCT00195494|69524018|FG005|Year 1|Compliance|1|||
37839542|NCT00195494|69524013|FG000|Year 1|Lost to Follow-up|0|||
37839543|NCT00195494|69524014|FG001|Year 1|Lost to Follow-up|0|||
37915499|NCT00853047|69602251|FG003|Open-Label Extension Phase|Investigator Decision|0|||
37839544|NCT00195494|69524015|FG002|Year 1|Lost to Follow-up|0|||
37839545|NCT00195494|69524016|FG003|Year 1|Lost to Follow-up|0|||
37839546|NCT00195494|69524017|FG004|Year 1|Lost to Follow-up|1|||
37839547|NCT00195494|69524018|FG005|Year 1|Lost to Follow-up|0|||
37839548|NCT00195494|69524013|FG000|Year 1|Missed >4 consecutive doses|0|||
37839549|NCT00195494|69524014|FG001|Year 1|Missed >4 consecutive doses|0|||
37839550|NCT00195494|69524015|FG002|Year 1|Missed >4 consecutive doses|0|||
37839551|NCT00195494|69524016|FG003|Year 1|Missed >4 consecutive doses|0|||
37839552|NCT00195494|69524017|FG004|Year 1|Missed >4 consecutive doses|3|||
37839553|NCT00195494|69524018|FG005|Year 1|Missed >4 consecutive doses|2|||
37839554|NCT00195494|69524013|FG000|Year 1|Protocol deviation|0|||
37839555|NCT00195494|69524014|FG001|Year 1|Protocol deviation|0|||
37839556|NCT00195494|69524015|FG002|Year 1|Protocol deviation|0|||
37718224|NCT02118428|69196416|FG001|Overall Study|Physician Decision|1|||
37718225|NCT02118428|69196417|FG002|Overall Study|Physician Decision|0|||
37718226|NCT02118428|69196415|FG000|Overall Study|Withdrawal by Subject|2|||
37718227|NCT02118428|69196416|FG001|Overall Study|Withdrawal by Subject|2|||
37718228|NCT02118428|69196417|FG002|Overall Study|Withdrawal by Subject|0|||
37718229|NCT02118428|69196415|FG000|Overall Study|Death|7|||
37718230|NCT02118428|69196416|FG001|Overall Study|Death|5|||
37718231|NCT02118428|69196417|FG002|Overall Study|Death|0|||
37718232|NCT02118428|69196415|FG000|Overall Study|Lost to Follow-up|3|||
37718233|NCT02118428|69196416|FG001|Overall Study|Lost to Follow-up|1|||
37718234|NCT02118428|69196417|FG002|Overall Study|Lost to Follow-up|0|||
37718235|NCT02118428|69196415|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
37718236|NCT02118428|69196416|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
37718237|NCT02118428|69196417|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
37718238|NCT02067104|69196425|FG000|Overall Study|Study termination due to low accrual|4|||
37718239|NCT02067104|69196426|FG001|Overall Study|Study termination due to low accrual|5|||
37718240|NCT02092220|69196432|FG000|Period 1|Unrelated Illness|0|||
37718241|NCT02092220|69196433|FG001|Period 1|Unrelated Illness|2|||
37718242|NCT02092220|69196432|FG000|Period 2|Severe Hypoglycaemia|1|||
37718243|NCT02092220|69196433|FG001|Period 2|Severe Hypoglycaemia|0|||
37718244|NCT02092220|69196432|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
37718245|NCT02092220|69196433|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
37718246|NCT02066402|69196443|FG000|Overall Study|Adverse Event|1|||
37718247|NCT02066402|69196444|FG001|Overall Study|Adverse Event|2|||
37718248|NCT02066402|69196443|FG000|Overall Study|Lost to Follow-up|11|||
37718249|NCT02066402|69196444|FG001|Overall Study|Lost to Follow-up|8|||
37718250|NCT02066402|69196443|FG000|Overall Study|Withdrawal by Subject|14|||
37718251|NCT02066402|69196444|FG001|Overall Study|Withdrawal by Subject|11|||
37718252|NCT02066402|69196443|FG000|Overall Study|Progressive disease-clinical progression|0|||
37718253|NCT02066402|69196444|FG001|Overall Study|Progressive disease-clinical progression|1|||
37718254|NCT02066402|69196443|FG000|Overall Study|Protocol driven decision point|0|||
37718255|NCT02066402|69196444|FG001|Overall Study|Protocol driven decision point|1|||
37718256|NCT02060383|69196455|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
37718257|NCT02060383|69196456|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
37718258|NCT02060383|69196457|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
37718259|NCT02060383|69196458|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
37718260|NCT02060383|69196459|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
37718261|NCT02060383|69196455|FG000|Core Phase|Adverse Event|2|||
37718262|NCT02060383|69196456|FG001|Core Phase|Adverse Event|0|||
37718263|NCT02060383|69196457|FG002|Core Phase|Adverse Event|0|||
37718264|NCT02060383|69196458|FG003|Core Phase|Adverse Event|2|||
37718265|NCT02060383|69196459|FG004|Core Phase|Adverse Event|6|||
37718266|NCT02060383|69196455|FG000|Core Phase|Administrative problems|0|||
37718267|NCT02060383|69196456|FG001|Core Phase|Administrative problems|1|||
37718268|NCT02060383|69196457|FG002|Core Phase|Administrative problems|0|||
37718269|NCT02060383|69196458|FG003|Core Phase|Administrative problems|0|||
37718270|NCT02060383|69196459|FG004|Core Phase|Administrative problems|0|||
37718271|NCT02060383|69196455|FG000|Core Phase|Protocol Violation|0|||
37718272|NCT02060383|69196456|FG001|Core Phase|Protocol Violation|0|||
37718273|NCT02060383|69196457|FG002|Core Phase|Protocol Violation|0|||
37718274|NCT02060383|69196458|FG003|Core Phase|Protocol Violation|1|||
37718275|NCT02060383|69196459|FG004|Core Phase|Protocol Violation|0|||
37718276|NCT02060383|69196455|FG000|Core Phase|Withdrawal by Subject|0|||
37718277|NCT02060383|69196456|FG001|Core Phase|Withdrawal by Subject|0|||
37718278|NCT02060383|69196457|FG002|Core Phase|Withdrawal by Subject|0|||
37718279|NCT02060383|69196458|FG003|Core Phase|Withdrawal by Subject|4|||
37718280|NCT02060383|69196459|FG004|Core Phase|Withdrawal by Subject|2|||
37718281|NCT02060383|69196455|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
37718282|NCT02060383|69196456|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
37718283|NCT02060383|69196457|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
37718284|NCT02060383|69196458|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
37718285|NCT02060383|69196459|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
37718286|NCT02060383|69196455|FG000|Extension Phase|Adverse Event|1|||
37718287|NCT02060383|69196456|FG001|Extension Phase|Adverse Event|1|||
37718288|NCT02060383|69196457|FG002|Extension Phase|Adverse Event|2|||
37718289|NCT02060383|69196458|FG003|Extension Phase|Adverse Event|0|||
37718290|NCT02060383|69196459|FG004|Extension Phase|Adverse Event|1|||
37718291|NCT02060383|69196455|FG000|Extension Phase|Withdrawal by Subject|0|||
37718292|NCT02060383|69196456|FG001|Extension Phase|Withdrawal by Subject|1|||
37718293|NCT02060383|69196457|FG002|Extension Phase|Withdrawal by Subject|0|||
37718294|NCT02060383|69196458|FG003|Extension Phase|Withdrawal by Subject|0|||
37718295|NCT02060383|69196459|FG004|Extension Phase|Withdrawal by Subject|2|||
37839557|NCT00195494|69524016|FG003|Year 1|Protocol deviation|0|||
37839558|NCT00195494|69524017|FG004|Year 1|Protocol deviation|2|||
37839559|NCT00195494|69524018|FG005|Year 1|Protocol deviation|3|||
37839560|NCT00195494|69524013|FG000|Year 1|Physician Decision|0|||
37839561|NCT00195494|69524014|FG001|Year 1|Physician Decision|0|||
37839562|NCT00195494|69524015|FG002|Year 1|Physician Decision|0|||
37839563|NCT00195494|69524016|FG003|Year 1|Physician Decision|0|||
37839564|NCT00195494|69524017|FG004|Year 1|Physician Decision|1|||
37839565|NCT00195494|69524018|FG005|Year 1|Physician Decision|0|||
37839566|NCT00195494|69524013|FG000|Year 1|Withdrawal by Subject|0|||
37839567|NCT00195494|69524014|FG001|Year 1|Withdrawal by Subject|0|||
37839568|NCT00195494|69524015|FG002|Year 1|Withdrawal by Subject|0|||
37839569|NCT00195494|69524016|FG003|Year 1|Withdrawal by Subject|0|||
37839570|NCT00195494|69524017|FG004|Year 1|Withdrawal by Subject|8|||
37839571|NCT00195494|69524018|FG005|Year 1|Withdrawal by Subject|9|||
37839572|NCT00195494|69524013|FG000|Year 1|Protocol Violation|0|||
37839573|NCT00195494|69524014|FG001|Year 1|Protocol Violation|0|||
37839574|NCT00195494|69524015|FG002|Year 1|Protocol Violation|0|||
37839575|NCT00195494|69524016|FG003|Year 1|Protocol Violation|0|||
37839576|NCT00195494|69524017|FG004|Year 1|Protocol Violation|1|||
37839577|NCT00195494|69524018|FG005|Year 1|Protocol Violation|1|||
37839578|NCT00195494|69524013|FG000|Year 2|Adverse Event|3|||
37839579|NCT00195494|69524014|FG001|Year 2|Adverse Event|7|||
37839580|NCT00195494|69524015|FG002|Year 2|Adverse Event|5|||
37718296|NCT02060383|69196455|FG000|Extension Phase|Administrative problems|1|||
37718297|NCT02060383|69196456|FG001|Extension Phase|Administrative problems|0|||
37718298|NCT02060383|69196457|FG002|Extension Phase|Administrative problems|0|||
37718299|NCT02060383|69196458|FG003|Extension Phase|Administrative problems|0|||
37718300|NCT02060383|69196459|FG004|Extension Phase|Administrative problems|0|||
37718301|NCT02060383|69196455|FG000|Extension Phase|Death|0|||
37839581|NCT00195494|69524016|FG003|Year 2|Adverse Event|9|||
37839582|NCT00195494|69524017|FG004|Year 2|Adverse Event|0|||
37718302|NCT02060383|69196456|FG001|Extension Phase|Death|0|||
37718303|NCT02060383|69196457|FG002|Extension Phase|Death|1|||
37718304|NCT02060383|69196458|FG003|Extension Phase|Death|0|||
37718305|NCT02060383|69196459|FG004|Extension Phase|Death|1|||
37718306|NCT02060383|69196455|FG000|Extension Phase|Protocol Violation|0|||
37839583|NCT00195494|69524018|FG005|Year 2|Adverse Event|0|||
37718307|NCT02060383|69196456|FG001|Extension Phase|Protocol Violation|0|||
37839584|NCT00195494|69524013|FG000|Year 2|Lack of Efficacy|0|||
37839585|NCT00195494|69524014|FG001|Year 2|Lack of Efficacy|1|||
37839586|NCT00195494|69524015|FG002|Year 2|Lack of Efficacy|7|||
37839587|NCT00195494|69524016|FG003|Year 2|Lack of Efficacy|7|||
37839588|NCT00195494|69524017|FG004|Year 2|Lack of Efficacy|0|||
37839589|NCT00195494|69524018|FG005|Year 2|Lack of Efficacy|0|||
37839590|NCT00195494|69524013|FG000|Year 2|Compliance|1|||
37839591|NCT00195494|69524014|FG001|Year 2|Compliance|0|||
37839592|NCT00195494|69524015|FG002|Year 2|Compliance|0|||
37915500|NCT00853047|69602252|FG004|Open-Label Extension Phase|Investigator Decision|0|||
37915501|NCT00853047|69602253|FG005|Open-Label Extension Phase|Investigator Decision|1|||
37718308|NCT02060383|69196457|FG002|Extension Phase|Protocol Violation|0|||
37718309|NCT02060383|69196458|FG003|Extension Phase|Protocol Violation|0|||
37718310|NCT02060383|69196459|FG004|Extension Phase|Protocol Violation|1|||
37718311|NCT02086591|69196471|FG000|Overall Study|Adverse Event|1|||
37718312|NCT02086591|69196471|FG000|Overall Study|Withdrawal by Subject|1|||
37718313|NCT02086591|69196471|FG000|Overall Study|protocol terminated|3|||
37718314|NCT02065622|69196477|FG000|Induction Study|Adverse Event|13|||
37718315|NCT02065622|69196478|FG001|Induction Study|Adverse Event|19|||
37718316|NCT02065622|69196479|FG002|Induction Study|Adverse Event|0|||
37718317|NCT02065622|69196480|FG003|Induction Study|Adverse Event|0|||
37718318|NCT02065622|69196481|FG004|Induction Study|Adverse Event|0|||
37718319|NCT02065622|69196477|FG000|Induction Study|Withdrawal by Subject|3|||
37718320|NCT02065622|69196478|FG001|Induction Study|Withdrawal by Subject|5|||
37718321|NCT02065622|69196479|FG002|Induction Study|Withdrawal by Subject|0|||
37718322|NCT02065622|69196480|FG003|Induction Study|Withdrawal by Subject|0|||
37718323|NCT02065622|69196481|FG004|Induction Study|Withdrawal by Subject|0|||
37718324|NCT02065622|69196477|FG000|Induction Study|Lost to Follow-up|1|||
37718325|NCT02065622|69196478|FG001|Induction Study|Lost to Follow-up|0|||
37718326|NCT02065622|69196479|FG002|Induction Study|Lost to Follow-up|0|||
37839593|NCT00195494|69524016|FG003|Year 2|Compliance|2|||
37839594|NCT00195494|69524017|FG004|Year 2|Compliance|0|||
37839595|NCT00195494|69524018|FG005|Year 2|Compliance|0|||
37839596|NCT00195494|69524013|FG000|Year 2|Lost to Follow-up|0|||
37839597|NCT00195494|69524014|FG001|Year 2|Lost to Follow-up|0|||
37839598|NCT00195494|69524015|FG002|Year 2|Lost to Follow-up|1|||
37839599|NCT00195494|69524016|FG003|Year 2|Lost to Follow-up|1|||
37839600|NCT00195494|69524017|FG004|Year 2|Lost to Follow-up|0|||
37718327|NCT02065622|69196480|FG003|Induction Study|Lost to Follow-up|0|||
37839601|NCT00195494|69524018|FG005|Year 2|Lost to Follow-up|0|||
37839602|NCT00195494|69524013|FG000|Year 2|Missed >4 consecutive doses|1|||
37839603|NCT00195494|69524014|FG001|Year 2|Missed >4 consecutive doses|1|||
37839604|NCT00195494|69524015|FG002|Year 2|Missed >4 consecutive doses|1|||
37839605|NCT00195494|69524016|FG003|Year 2|Missed >4 consecutive doses|0|||
37839606|NCT00195494|69524017|FG004|Year 2|Missed >4 consecutive doses|0|||
37839607|NCT00195494|69524018|FG005|Year 2|Missed >4 consecutive doses|0|||
37839608|NCT00195494|69524013|FG000|Year 2|Protocol deviation|0|||
37718328|NCT02065622|69196481|FG004|Induction Study|Lost to Follow-up|0|||
37718329|NCT02065622|69196477|FG000|Induction Study|Lack of Efficacy|22|||
37718330|NCT02065622|69196478|FG001|Induction Study|Lack of Efficacy|27|||
37718331|NCT02065622|69196479|FG002|Induction Study|Lack of Efficacy|0|||
37718332|NCT02065622|69196480|FG003|Induction Study|Lack of Efficacy|0|||
37718333|NCT02065622|69196481|FG004|Induction Study|Lack of Efficacy|0|||
37718334|NCT02065622|69196477|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
37718335|NCT02065622|69196478|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
37718336|NCT02065622|69196479|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
37718337|NCT02065622|69196480|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
37718338|NCT02065622|69196481|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
37718339|NCT02065622|69196477|FG000|Induction Study|Subject Noncompliance|1|||
37718340|NCT02065622|69196478|FG001|Induction Study|Subject Noncompliance|1|||
37718341|NCT02065622|69196479|FG002|Induction Study|Subject Noncompliance|0|||
37718342|NCT02065622|69196480|FG003|Induction Study|Subject Noncompliance|0|||
37718343|NCT02065622|69196481|FG004|Induction Study|Subject Noncompliance|0|||
37718344|NCT02065622|69196477|FG000|Induction Study|Other, Not Specified|3|||
37718345|NCT02065622|69196478|FG001|Induction Study|Other, Not Specified|2|||
37718346|NCT02065622|69196479|FG002|Induction Study|Other, Not Specified|0|||
37718347|NCT02065622|69196480|FG003|Induction Study|Other, Not Specified|0|||
37718348|NCT02065622|69196481|FG004|Induction Study|Other, Not Specified|0|||
37718349|NCT02065622|69196477|FG000|Maintenance Study|Adverse Event|0|||
37718350|NCT02065622|69196478|FG001|Maintenance Study|Adverse Event|0|||
38024926|NCT03987074|69708956|FG002|Overall Study|Lost to Follow-up|1|||
38024927|NCT03987074|69708957|FG003|Overall Study|Lost to Follow-up|1|||
38024928|NCT03987074|69708958|FG004|Overall Study|Lost to Follow-up|0|||
37718351|NCT02065622|69196479|FG002|Maintenance Study|Adverse Event|25|||
37718352|NCT02065622|69196480|FG003|Maintenance Study|Adverse Event|22|||
37718353|NCT02065622|69196481|FG004|Maintenance Study|Adverse Event|11|||
37718354|NCT02065622|69196477|FG000|Maintenance Study|Withdrawal by Subject|0|||
37718355|NCT02065622|69196478|FG001|Maintenance Study|Withdrawal by Subject|0|||
37718356|NCT02065622|69196479|FG002|Maintenance Study|Withdrawal by Subject|11|||
37718357|NCT02065622|69196480|FG003|Maintenance Study|Withdrawal by Subject|5|||
37718358|NCT02065622|69196481|FG004|Maintenance Study|Withdrawal by Subject|7|||
37718359|NCT02065622|69196477|FG000|Maintenance Study|Lost to Follow-up|0|||
37718360|NCT02065622|69196478|FG001|Maintenance Study|Lost to Follow-up|0|||
37718361|NCT02065622|69196479|FG002|Maintenance Study|Lost to Follow-up|4|||
37718362|NCT02065622|69196480|FG003|Maintenance Study|Lost to Follow-up|1|||
37718363|NCT02065622|69196481|FG004|Maintenance Study|Lost to Follow-up|1|||
37718364|NCT02065622|69196477|FG000|Maintenance Study|Lack of Efficacy|0|||
37718365|NCT02065622|69196478|FG001|Maintenance Study|Lack of Efficacy|0|||
37718366|NCT02065622|69196479|FG002|Maintenance Study|Lack of Efficacy|70|||
37718367|NCT02065622|69196480|FG003|Maintenance Study|Lack of Efficacy|55|||
37718368|NCT02065622|69196481|FG004|Maintenance Study|Lack of Efficacy|19|||
37718369|NCT02065622|69196477|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
37718370|NCT02065622|69196478|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
37718371|NCT02065622|69196479|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
37718372|NCT02065622|69196480|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
37718373|NCT02065622|69196481|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
37718374|NCT02065622|69196477|FG000|Maintenance Study|Subject Non-Compliance|0|||
37718375|NCT02065622|69196478|FG001|Maintenance Study|Subject Non-Compliance|0|||
37718376|NCT02065622|69196479|FG002|Maintenance Study|Subject Non-Compliance|1|||
37718377|NCT02065622|69196480|FG003|Maintenance Study|Subject Non-Compliance|3|||
37718378|NCT02065622|69196481|FG004|Maintenance Study|Subject Non-Compliance|2|||
37718379|NCT02065622|69196477|FG000|Maintenance Study|Other, Not Specified|0|||
37718380|NCT02065622|69196478|FG001|Maintenance Study|Other, Not Specified|0|||
37718381|NCT02065622|69196479|FG002|Maintenance Study|Other, Not Specified|6|||
37718382|NCT02065622|69196480|FG003|Maintenance Study|Other, Not Specified|14|||
37718383|NCT02065622|69196481|FG004|Maintenance Study|Other, Not Specified|2|||
37718384|NCT02065622|69196477|FG000|Maintenance Study|Unknown Reason|0|||
38024929|NCT03987074|69708954|FG000|Overall Study|Investigator's Discretion|0|||
37718385|NCT02065622|69196478|FG001|Maintenance Study|Unknown Reason|0|||
37718386|NCT02065622|69196479|FG002|Maintenance Study|Unknown Reason|0|||
37718387|NCT02065622|69196480|FG003|Maintenance Study|Unknown Reason|1|||
37718388|NCT02065622|69196481|FG004|Maintenance Study|Unknown Reason|0|||
37718389|NCT02117648|69196496|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
37718390|NCT02117648|69196496|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
37718391|NCT02117648|69196496|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
37718392|NCT02117648|69196496|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
37718393|NCT02117648|69196496|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
37718394|NCT02117648|69196496|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
37839609|NCT00195494|69524014|FG001|Year 2|Protocol deviation|1|||
37839610|NCT00195494|69524015|FG002|Year 2|Protocol deviation|0|||
37839611|NCT00195494|69524016|FG003|Year 2|Protocol deviation|0|||
37839612|NCT00195494|69524017|FG004|Year 2|Protocol deviation|0|||
37718395|NCT02117648|69196496|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
37718396|NCT02117648|69196496|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
37718397|NCT02117648|69196496|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
37718398|NCT02117648|69196496|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
37718399|NCT02117648|69196496|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
37718400|NCT02124161|69196506|FG000|Overall Study|Other unspecified|0|||
37718401|NCT02124161|69196507|FG001|Overall Study|Other unspecified|1|||
37718402|NCT02124161|69196506|FG000|Overall Study|Death|1|||
37718403|NCT02124161|69196507|FG001|Overall Study|Death|0|||
37718404|NCT02124161|69196506|FG000|Overall Study|Protocol Violation|2|||
37718405|NCT02124161|69196507|FG001|Overall Study|Protocol Violation|1|||
37718406|NCT02124161|69196506|FG000|Overall Study|Withdrawal by Subject|1|||
37718407|NCT02124161|69196507|FG001|Overall Study|Withdrawal by Subject|2|||
37718408|NCT02124161|69196506|FG000|Overall Study|Adverse Event|2|||
37718409|NCT02124161|69196507|FG001|Overall Study|Adverse Event|0|||
37718410|NCT02124161|69196506|FG000|Overall Study|Does not meet entrance criteria|2|||
37718411|NCT02124161|69196507|FG001|Overall Study|Does not meet entrance criteria|3|||
37718412|NCT02124161|69196506|FG000|Overall Study|No longer meets eligibility criteria|5|||
37718413|NCT02124161|69196507|FG001|Overall Study|No longer meets eligibility criteria|4|||
37718414|NCT02124161|69196506|FG000|Overall Study|Lost to Follow-up|3|||
37718415|NCT02124161|69196507|FG001|Overall Study|Lost to Follow-up|4|||
37718416|NCT02175641|69196522|FG000|Overall Study|Death|3|||
37718417|NCT02175641|69196523|FG001|Overall Study|Death|4|||
37718418|NCT02175641|69196522|FG000|Overall Study|Lost to Follow-up|4|||
37718419|NCT02175641|69196523|FG001|Overall Study|Lost to Follow-up|4|||
37718420|NCT02175641|69196522|FG000|Overall Study|Withdrawal by Subject|7|||
37718421|NCT02175641|69196523|FG001|Overall Study|Withdrawal by Subject|4|||
37718422|NCT02175641|69196522|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
37718423|NCT02175641|69196523|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
37718424|NCT02175641|69196522|FG000|Overall Study|Developed Contraindicated Condition|8|||
37718425|NCT02175641|69196523|FG001|Overall Study|Developed Contraindicated Condition|0|||
37718426|NCT02117570|69196532|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
37718427|NCT02117570|69196533|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
37718428|NCT02117570|69196534|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
37718429|NCT02117570|69196532|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
37718430|NCT02117570|69196533|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
37718431|NCT02117570|69196534|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
37718432|NCT02117570|69196532|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
37718433|NCT02117570|69196533|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
37718434|NCT02117570|69196534|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
37718435|NCT02117570|69196532|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
37718436|NCT02117570|69196533|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
37718437|NCT02117570|69196534|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
37718438|NCT02117570|69196532|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
37718439|NCT02117570|69196533|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
37718440|NCT02117570|69196534|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
37718441|NCT02117570|69196532|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
37718442|NCT02117570|69196533|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
37718443|NCT02117570|69196534|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
37718444|NCT02117570|69196532|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
37718445|NCT02117570|69196533|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
37718446|NCT02117570|69196534|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
37718447|NCT02123459|69196545|FG000|Washout Period (1 Day)|Adverse Event|1|||
37718448|NCT02123459|69196546|FG001|Washout Period (1 Day)|Adverse Event|0|||
37718449|NCT01853475|69196555|FG000|Overall Study|Withdrawal by Subject|0|||
37718450|NCT01853475|69196556|FG001|Overall Study|Withdrawal by Subject|1|||
37718451|NCT01853475|69196557|FG002|Overall Study|Withdrawal by Subject|0|||
37718452|NCT02151773|69196565|FG000|Overall Study|Protocol Deviation|64|||
37718453|NCT02151461|69196573|FG000|Overall Study|Adverse Event|5|||
37718454|NCT02151461|69196574|FG001|Overall Study|Adverse Event|1|||
37718455|NCT02151461|69196575|FG002|Overall Study|Adverse Event|0|||
37718456|NCT02151461|69196576|FG003|Overall Study|Adverse Event|2|||
37718457|NCT02151461|69196573|FG000|Overall Study|Lost to Follow-up|0|||
37718458|NCT02151461|69196574|FG001|Overall Study|Lost to Follow-up|0|||
37718459|NCT02151461|69196575|FG002|Overall Study|Lost to Follow-up|1|||
37839613|NCT00195494|69524018|FG005|Year 2|Protocol deviation|0|||
37718460|NCT02151461|69196576|FG003|Overall Study|Lost to Follow-up|1|||
37718461|NCT02151461|69196573|FG000|Overall Study|Withdrawal by Subject|1|||
37718462|NCT02151461|69196574|FG001|Overall Study|Withdrawal by Subject|0|||
37718463|NCT02151461|69196575|FG002|Overall Study|Withdrawal by Subject|1|||
37718464|NCT02151461|69196576|FG003|Overall Study|Withdrawal by Subject|1|||
37718465|NCT02151461|69196573|FG000|Overall Study|Treatment discontinuation|0|||
37718466|NCT02151461|69196574|FG001|Overall Study|Treatment discontinuation|0|||
37718467|NCT02151461|69196575|FG002|Overall Study|Treatment discontinuation|1|||
37718468|NCT02151461|69196576|FG003|Overall Study|Treatment discontinuation|0|||
37718469|NCT02117414|69196588|FG000|Overall Study|Death|5|||
37718470|NCT02117414|69196589|FG001|Overall Study|Death|2|||
37718471|NCT02117414|69196588|FG000|Overall Study|Withdrawal by Subject|10|||
37718472|NCT02117414|69196589|FG001|Overall Study|Withdrawal by Subject|4|||
37718473|NCT02091986|69196600|FG000|Overall Study|7 rand in error 1 patient decision|2|||
37718474|NCT02091986|69196601|FG001|Overall Study|7 rand in error 1 patient decision|3|||
37718475|NCT02091986|69196602|FG002|Overall Study|7 rand in error 1 patient decision|3|||
37718476|NCT02091986|69196600|FG000|Overall Study|Lost to Follow-up|1|||
37718477|NCT02091986|69196601|FG001|Overall Study|Lost to Follow-up|0|||
37718478|NCT02091986|69196602|FG002|Overall Study|Lost to Follow-up|0|||
37718479|NCT02091986|69196600|FG000|Overall Study|Withdrawal by Subject|4|||
37718480|NCT02091986|69196601|FG001|Overall Study|Withdrawal by Subject|8|||
37718481|NCT02091986|69196602|FG002|Overall Study|Withdrawal by Subject|3|||
37718482|NCT02091986|69196600|FG000|Overall Study|Adverse Event|0|||
37718483|NCT02091986|69196601|FG001|Overall Study|Adverse Event|0|||
37718484|NCT02091986|69196602|FG002|Overall Study|Adverse Event|2|||
37718485|NCT02091752|69196610|FG000|Overall Study|Study terminated by Sponsor|2|||
37718486|NCT02091752|69196610|FG000|Overall Study|Adverse Event|1|||
37718487|NCT02117024|69196616|FG000|Overall Study|Progressive Disease|26|||
37718488|NCT02117024|69196617|FG001|Overall Study|Progressive Disease|9|||
37718489|NCT02117024|69196616|FG000|Overall Study|Significant Clinical Progression|7|||
37718490|NCT02117024|69196617|FG001|Overall Study|Significant Clinical Progression|4|||
37718491|NCT02117024|69196616|FG000|Overall Study|Death|5|||
37718492|NCT02117024|69196617|FG001|Overall Study|Death|0|||
37718493|NCT02117024|69196616|FG000|Overall Study|Withdrawal by Subject|3|||
37718494|NCT02117024|69196617|FG001|Overall Study|Withdrawal by Subject|1|||
37718495|NCT02117024|69196616|FG000|Overall Study|Protocol Violation|1|||
37718496|NCT02117024|69196617|FG001|Overall Study|Protocol Violation|0|||
37718497|NCT02117024|69196616|FG000|Overall Study|Adverse Event|1|||
37718498|NCT02117024|69196617|FG001|Overall Study|Adverse Event|2|||
37718499|NCT02117024|69196616|FG000|Overall Study|Randomized in Error|1|||
37718500|NCT02117024|69196617|FG001|Overall Study|Randomized in Error|0|||
37718501|NCT02117024|69196616|FG000|Overall Study|Patient returned to primary oncologist|0|||
37718502|NCT02117024|69196617|FG001|Overall Study|Patient returned to primary oncologist|1|||
37718503|NCT02117024|69196616|FG000|Overall Study|Patient took treatment break|0|||
37718504|NCT02117024|69196617|FG001|Overall Study|Patient took treatment break|1|||
37718505|NCT02117024|69196616|FG000|Overall Study|Physician Decision|0|||
37718506|NCT02117024|69196617|FG001|Overall Study|Physician Decision|2|||
37718507|NCT02091440|69196623|FG000|Overall Study|Death|2|||
37718508|NCT02064920|69196629|FG000|Overall Study|Adverse Event|0|||
37718509|NCT02064920|69196630|FG001|Overall Study|Adverse Event|4|||
37718510|NCT02064920|69196629|FG000|Overall Study|Physician Decision|0|||
37718511|NCT02064920|69196630|FG001|Overall Study|Physician Decision|1|||
37718512|NCT02064920|69196629|FG000|Overall Study|Technical Problems|0|||
37718513|NCT02064920|69196630|FG001|Overall Study|Technical Problems|1|||
37718514|NCT02064920|69196629|FG000|Overall Study|Withdrawal by Subject|1|||
37718515|NCT02064920|69196630|FG001|Overall Study|Withdrawal by Subject|3|||
37718516|NCT02151149|69196638|FG000|Treatment Period|Death|2|||
37718517|NCT02151149|69196639|FG001|Treatment Period|Death|3|||
37718518|NCT02151149|69196638|FG000|Treatment Period|Adverse Event|17|||
37718519|NCT02151149|69196639|FG001|Treatment Period|Adverse Event|14|||
37718520|NCT02151149|69196638|FG000|Treatment Period|Progressive Disease|25|||
37718521|NCT02151149|69196639|FG001|Treatment Period|Progressive Disease|24|||
37718522|NCT02151149|69196638|FG000|Treatment Period|Symptomatic Deterioration|2|||
37718523|NCT02151149|69196639|FG001|Treatment Period|Symptomatic Deterioration|10|||
37718524|NCT02151149|69196638|FG000|Treatment Period|Withdrawal by Subject|13|||
37718525|NCT02151149|69196639|FG001|Treatment Period|Withdrawal by Subject|11|||
37718526|NCT02151149|69196638|FG000|Treatment Period|Miscellaneous|8|||
37718527|NCT02151149|69196639|FG001|Treatment Period|Miscellaneous|7|||
37718528|NCT02151149|69196638|FG000|Treatment Period|Participants randomized but not treated|3|||
37718529|NCT02151149|69196639|FG001|Treatment Period|Participants randomized but not treated|2|||
37718530|NCT02151149|69196638|FG000|Follow-Up Period|Lost to Follow-up|2|||
37718531|NCT02151149|69196639|FG001|Follow-Up Period|Lost to Follow-up|3|||
37718532|NCT02151149|69196638|FG000|Follow-Up Period|Death|37|||
37718533|NCT02151149|69196639|FG001|Follow-Up Period|Death|34|||
37718534|NCT02150213|69196645|FG000|Overall Study|Lost to Follow-up|1|||
37718535|NCT02150213|69196645|FG000|Overall Study|Withdrawal by Subject|1|||
37718536|NCT02091362|69196651|FG000|Period 1|Protocol Violation|1|||
37718537|NCT02091362|69196652|FG001|Period 1|Protocol Violation|0|||
37718538|NCT02091362|69196651|FG000|Period 1|Withdrawal by Subject|2|||
37718539|NCT02091362|69196652|FG001|Period 1|Withdrawal by Subject|3|||
37718540|NCT02091362|69196651|FG000|Period 1|Lost to Follow-up|0|||
37839614|NCT00195494|69524013|FG000|Year 2|Physician Decision|1|||
37839615|NCT00195494|69524014|FG001|Year 2|Physician Decision|1|||
37839616|NCT00195494|69524015|FG002|Year 2|Physician Decision|0|||
37839617|NCT00195494|69524016|FG003|Year 2|Physician Decision|0|||
37839618|NCT00195494|69524017|FG004|Year 2|Physician Decision|0|||
37718541|NCT02091362|69196652|FG001|Period 1|Lost to Follow-up|1|||
37718542|NCT02091362|69196651|FG000|Period 1|Adverse Event|2|||
37718543|NCT02091362|69196652|FG001|Period 1|Adverse Event|0|||
37718544|NCT02091362|69196651|FG000|Wash-out|Lost to Follow-up|1|||
37718545|NCT02091362|69196652|FG001|Wash-out|Lost to Follow-up|1|||
37718546|NCT02091362|69196651|FG000|Wash-out|Withdrawal by Subject|0|||
37718547|NCT02091362|69196652|FG001|Wash-out|Withdrawal by Subject|2|||
37718548|NCT02091362|69196651|FG000|Period 2|Adverse Event|1|||
37718549|NCT02091362|69196652|FG001|Period 2|Adverse Event|0|||
37718550|NCT02091362|69196651|FG000|Period 2|Lost to Follow-up|0|||
37718551|NCT02091362|69196652|FG001|Period 2|Lost to Follow-up|1|||
37718552|NCT02091362|69196651|FG000|Period 2|Withdrawal by Subject|1|||
37718553|NCT02091362|69196652|FG001|Period 2|Withdrawal by Subject|1|||
37718554|NCT02150057|69196664|FG000|Overall Study|Lost to Follow-up|6|||
37718555|NCT02150057|69196665|FG001|Overall Study|Lost to Follow-up|4|||
37718556|NCT02064296|69196674|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
37718557|NCT02064296|69196675|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
37718558|NCT02064296|69196676|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
37718559|NCT02064296|69196674|FG000|Intervention|Withdrawal by Subject|0|||
37718560|NCT02064296|69196675|FG001|Intervention|Withdrawal by Subject|1|||
37718561|NCT02064296|69196676|FG002|Intervention|Withdrawal by Subject|2|||
37718562|NCT02063984|69196688|FG000|Overall Study|Lost to Follow-up|6|||
37718563|NCT02063984|69196689|FG001|Overall Study|Lost to Follow-up|5|||
37718564|NCT02091284|69196701|FG000|Overall Study|Withdrawal by Subject|2|||
37718565|NCT02091284|69196702|FG001|Overall Study|Withdrawal by Subject|1|||
37718566|NCT02091284|69196701|FG000|Overall Study|unreliable data|1|||
37718567|NCT02091284|69196702|FG001|Overall Study|unreliable data|0|||
37718568|NCT02115386|69196710|FG000|Overall Study|Protocol Violation|1|||
37718569|NCT02115386|69196710|FG000|Overall Study|Administrative - trial was terminated|6|||
37718570|NCT02091206|69196718|FG000|Treatment Period|Adverse Event|0|||
37718571|NCT02091206|69196719|FG001|Treatment Period|Adverse Event|1|||
37718572|NCT02091206|69196720|FG002|Treatment Period|Adverse Event|0|||
37718573|NCT02091206|69196721|FG003|Treatment Period|Adverse Event|0|||
37718574|NCT02091206|69196718|FG000|Treatment Period|Met withdrawal criteria|0|||
37718575|NCT02091206|69196719|FG001|Treatment Period|Met withdrawal criteria|0|||
37718576|NCT02091206|69196720|FG002|Treatment Period|Met withdrawal criteria|1|||
37718577|NCT02091206|69196721|FG003|Treatment Period|Met withdrawal criteria|0|||
37718578|NCT02091206|69196718|FG000|Taper Period|Participant refused study drug|1|||
37718579|NCT02091206|69196719|FG001|Taper Period|Participant refused study drug|0|||
37718580|NCT02091206|69196720|FG002|Taper Period|Participant refused study drug|0|||
37718581|NCT02091206|69196721|FG003|Taper Period|Participant refused study drug|1|||
37718582|NCT02091206|69196718|FG000|Taper Period|Lost to Follow-up|0|||
37718583|NCT02091206|69196719|FG001|Taper Period|Lost to Follow-up|0|||
37718584|NCT02091206|69196720|FG002|Taper Period|Lost to Follow-up|0|||
37718585|NCT02091206|69196721|FG003|Taper Period|Lost to Follow-up|1|||
37718586|NCT02090426|69196733|FG000|Overall Study|Lost to Follow-up|12|||
37718587|NCT02090426|69196734|FG001|Overall Study|Lost to Follow-up|6|||
37718588|NCT02063828|69196743|FG000|Overall Study|Withdrawal by Subject|4|||
37718589|NCT02063828|69196744|FG001|Overall Study|Withdrawal by Subject|6|||
37718590|NCT02063828|69196745|FG002|Overall Study|Withdrawal by Subject|3|||
37718591|NCT02063828|69196743|FG000|Overall Study|Death|0|||
37718592|NCT02063828|69196744|FG001|Overall Study|Death|0|||
37839619|NCT00195494|69524018|FG005|Year 2|Physician Decision|0|||
37718593|NCT02063828|69196745|FG002|Overall Study|Death|1|||
37718594|NCT02063672|69196755|FG000|Overall Study|Ongoing Follow-up|27|||
37718595|NCT02063672|69196756|FG001|Overall Study|Ongoing Follow-up|14|||
37718596|NCT02063672|69196755|FG000|Overall Study|Death|5|||
37718597|NCT02063672|69196756|FG001|Overall Study|Death|3|||
37718598|NCT02063672|69196755|FG000|Overall Study|Lost to Follow-up|1|||
37718599|NCT02063672|69196756|FG001|Overall Study|Lost to Follow-up|3|||
37718600|NCT02063672|69196755|FG000|Overall Study|Withdrawal by Subject|2|||
37718601|NCT02063672|69196756|FG001|Overall Study|Withdrawal by Subject|2|||
37718602|NCT02062658|69196762|FG000|Overall Study|Withdrawal by Subject|1|||
37839620|NCT00195494|69524013|FG000|Year 2|Withdrawal by Subject|1|||
37839621|NCT00195494|69524014|FG001|Year 2|Withdrawal by Subject|5|||
37718603|NCT02062658|69196762|FG000|Overall Study|Lack of Efficacy|1|||
37718604|NCT02115308|69196768|FG000|Overall Study|Safety Screening|2|||
37839622|NCT00195494|69524015|FG002|Year 2|Withdrawal by Subject|4|||
37718605|NCT02115308|69196769|FG001|Overall Study|Safety Screening|2|||
37718606|NCT02114684|69196781|FG000|Overall Study|Death|6|||
37718607|NCT02114684|69196782|FG001|Overall Study|Death|4|||
37718608|NCT02114684|69196781|FG000|Overall Study|Lost to Follow-up|1|||
37718609|NCT02114684|69196782|FG001|Overall Study|Lost to Follow-up|2|||
37718610|NCT02114684|69196781|FG000|Overall Study|Withdrawal by Subject|1|||
37718611|NCT02114684|69196782|FG001|Overall Study|Withdrawal by Subject|2|||
37718612|NCT02114684|69196781|FG000|Overall Study|Relocation|3|||
37718613|NCT02114684|69196782|FG001|Overall Study|Relocation|1|||
37718614|NCT02114684|69196781|FG000|Overall Study|Rifampicin resistant on culture|0|||
37718615|NCT02114684|69196782|FG001|Overall Study|Rifampicin resistant on culture|1|||
37718616|NCT02114684|69196781|FG000|Overall Study|Patient Incarcerated|1|||
37718617|NCT02114684|69196782|FG001|Overall Study|Patient Incarcerated|0|||
37718618|NCT02090114|69196796|FG000|Overall Study|Withdrawal by Subject|3|||
37718619|NCT02090114|69196797|FG001|Overall Study|Withdrawal by Subject|6|||
37718620|NCT02090114|69196798|FG002|Overall Study|Withdrawal by Subject|2|||
37718621|NCT02090114|69196799|FG003|Overall Study|Withdrawal by Subject|1|||
37718622|NCT02090114|69196796|FG000|Overall Study|Physician Decision|5|||
37718623|NCT02090114|69196797|FG001|Overall Study|Physician Decision|0|||
37718624|NCT02090114|69196798|FG002|Overall Study|Physician Decision|1|||
37718625|NCT02090114|69196799|FG003|Overall Study|Physician Decision|1|||
37718626|NCT02090114|69196796|FG000|Overall Study|Adverse Event|1|||
37718627|NCT02090114|69196797|FG001|Overall Study|Adverse Event|2|||
37718628|NCT02090114|69196798|FG002|Overall Study|Adverse Event|2|||
37718629|NCT02090114|69196799|FG003|Overall Study|Adverse Event|0|||
37718630|NCT02090114|69196796|FG000|Overall Study|Progressive Disease|20|||
37718631|NCT02090114|69196797|FG001|Overall Study|Progressive Disease|21|||
37718632|NCT02090114|69196798|FG002|Overall Study|Progressive Disease|23|||
37718633|NCT02090114|69196799|FG003|Overall Study|Progressive Disease|6|||
37718634|NCT02090114|69196796|FG000|Overall Study|Death|1|||
37718635|NCT02090114|69196797|FG001|Overall Study|Death|0|||
37718636|NCT02090114|69196798|FG002|Overall Study|Death|1|||
37718637|NCT02090114|69196799|FG003|Overall Study|Death|0|||
37718638|NCT01623050|69196809|FG000|Overall Study|Lost to Follow-up|9|||
37718639|NCT02089334|69196817|FG000|Overall Study|Withdrawal by Subject|0|||
37718640|NCT02089334|69196818|FG001|Overall Study|Withdrawal by Subject|0|||
37718641|NCT02089334|69196819|FG002|Overall Study|Withdrawal by Subject|0|||
37718642|NCT02089334|69196820|FG003|Overall Study|Withdrawal by Subject|2|||
37718643|NCT02089334|69196817|FG000|Overall Study|Adverse Event|0|||
37718644|NCT02089334|69196818|FG001|Overall Study|Adverse Event|0|||
37718645|NCT02089334|69196819|FG002|Overall Study|Adverse Event|0|||
37718646|NCT02089334|69196820|FG003|Overall Study|Adverse Event|2|||
37718647|NCT02089334|69196817|FG000|Overall Study|Progressive disease|0|||
37718648|NCT02089334|69196818|FG001|Overall Study|Progressive disease|0|||
37718649|NCT02089334|69196819|FG002|Overall Study|Progressive disease|0|||
37718650|NCT02089334|69196820|FG003|Overall Study|Progressive disease|2|||
37718651|NCT02089334|69196817|FG000|Overall Study|Physician Decision|0|||
37718652|NCT02089334|69196818|FG001|Overall Study|Physician Decision|0|||
37718653|NCT02089334|69196819|FG002|Overall Study|Physician Decision|1|||
37718654|NCT02089334|69196820|FG003|Overall Study|Physician Decision|1|||
37718655|NCT02114606|69196833|FG000|Overall Study|Unable to swallow Cytosponge|6|||
37718656|NCT02113436|69196839|FG000|Period 1: 8 Weeks|Adverse Event|1|||
37718657|NCT02113436|69196840|FG001|Period 1: 8 Weeks|Adverse Event|0|||
37718658|NCT02113436|69196841|FG002|Period 1: 8 Weeks|Adverse Event|0|||
37718659|NCT02113436|69196842|FG003|Period 1: 8 Weeks|Adverse Event|0|||
37718660|NCT02113436|69196839|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
37718661|NCT02113436|69196840|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
37718662|NCT02113436|69196841|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
37718663|NCT02113436|69196842|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
37718664|NCT02113436|69196839|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
37718665|NCT02113436|69196840|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
37718666|NCT02113436|69196841|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
37718667|NCT02113436|69196842|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
37718668|NCT02113436|69196839|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
37718669|NCT02113436|69196840|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
37718670|NCT02113436|69196841|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
37718671|NCT02113436|69196842|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
37718672|NCT02113436|69196839|FG000|Period 2: 16 Weeks|Adverse Event|0|||
37718673|NCT02113436|69196840|FG001|Period 2: 16 Weeks|Adverse Event|0|||
37718674|NCT02113436|69196841|FG002|Period 2: 16 Weeks|Adverse Event|4|||
37718675|NCT02113436|69196842|FG003|Period 2: 16 Weeks|Adverse Event|5|||
37718676|NCT02113436|69196839|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
37718677|NCT02113436|69196840|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
37718678|NCT02113436|69196841|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
37718679|NCT02113436|69196842|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
37718680|NCT02113436|69196839|FG000|Period 2: 16 Weeks|Physician Decision|0|||
37718681|NCT02113436|69196840|FG001|Period 2: 16 Weeks|Physician Decision|0|||
37718682|NCT02113436|69196841|FG002|Period 2: 16 Weeks|Physician Decision|2|||
37718683|NCT02113436|69196842|FG003|Period 2: 16 Weeks|Physician Decision|0|||
37718684|NCT02113436|69196839|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
37718685|NCT02113436|69196840|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
37718686|NCT02113436|69196841|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
37718687|NCT02113436|69196842|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
37718688|NCT02113124|69196853|FG000|Overall Study|Unable to retrieve blood sample|1|||
37718689|NCT02113124|69196854|FG001|Overall Study|Unable to retrieve blood sample|1|||
37718690|NCT02087774|69196862|FG000|Overall Study|Were absent day of data collection|8|||
37718691|NCT02087774|69196863|FG001|Overall Study|Were absent day of data collection|20|||
37718692|NCT02111564|69196871|FG000|Overall Study|Death|109|||
37718693|NCT02111564|69196872|FG001|Overall Study|Death|120|||
37718694|NCT02111564|69196871|FG000|Overall Study|Lost to Follow-up|2|||
37718695|NCT02111564|69196872|FG001|Overall Study|Lost to Follow-up|3|||
37718696|NCT02111564|69196871|FG000|Overall Study|Withdrawal by Subject|20|||
37718697|NCT02111564|69196872|FG001|Overall Study|Withdrawal by Subject|20|||
37718698|NCT02087150|69196881|FG000|Overall Study|Death|0|||
37718699|NCT02087150|69196882|FG001|Overall Study|Death|1|||
37718700|NCT02087150|69196883|FG002|Overall Study|Death|0|||
37718701|NCT02087150|69196881|FG000|Overall Study|Lost to Follow-up|6|||
37718702|NCT02087150|69196882|FG001|Overall Study|Lost to Follow-up|13|||
37718703|NCT02087150|69196883|FG002|Overall Study|Lost to Follow-up|7|||
37718704|NCT02087150|69196881|FG000|Overall Study|Withdrawal by Subject|2|||
37718705|NCT02087150|69196882|FG001|Overall Study|Withdrawal by Subject|5|||
37718706|NCT02087150|69196883|FG002|Overall Study|Withdrawal by Subject|3|||
37718707|NCT02087150|69196881|FG000|Overall Study|Physician Decision|0|||
37839623|NCT00195494|69524016|FG003|Year 2|Withdrawal by Subject|3|||
37839624|NCT00195494|69524017|FG004|Year 2|Withdrawal by Subject|0|||
37718708|NCT02087150|69196882|FG001|Overall Study|Physician Decision|1|||
37718709|NCT02087150|69196883|FG002|Overall Study|Physician Decision|0|||
37718710|NCT02087150|69196881|FG000|Overall Study|Procedure not done|1|||
37718711|NCT02087150|69196882|FG001|Overall Study|Procedure not done|13|||
37718712|NCT02087150|69196883|FG002|Overall Study|Procedure not done|0|||
37718713|NCT02087150|69196881|FG000|Overall Study|F/U not completed w/in study window|0|||
37718714|NCT02087150|69196882|FG001|Overall Study|F/U not completed w/in study window|0|||
37718715|NCT02087150|69196883|FG002|Overall Study|F/U not completed w/in study window|1|||
37718716|NCT02087150|69196881|FG000|Overall Study|Other|1|||
37718717|NCT02087150|69196882|FG001|Overall Study|Other|0|||
37718718|NCT02087150|69196883|FG002|Overall Study|Other|0|||
37718719|NCT02087150|69196881|FG000|Overall Study|Pt moved out of town|0|||
37718720|NCT02087150|69196882|FG001|Overall Study|Pt moved out of town|1|||
37718721|NCT02087150|69196883|FG002|Overall Study|Pt moved out of town|0|||
37718722|NCT02111174|69196894|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
37718723|NCT02111174|69196895|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
37718724|NCT02111174|69196894|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
37718725|NCT02111174|69196895|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
37718726|NCT02111174|69196894|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
37718727|NCT02111174|69196895|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
37718728|NCT02111174|69196894|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
37718729|NCT02111174|69196895|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
37718730|NCT02111096|69196904|FG000|Overall Study|Adverse Event|4|||
37718731|NCT02111096|69196905|FG001|Overall Study|Adverse Event|1|||
37718732|NCT02111096|69196906|FG002|Overall Study|Adverse Event|2|||
37718733|NCT02111096|69196904|FG000|Overall Study|Non-Compliance with Study Drug|1|||
37718734|NCT02111096|69196905|FG001|Overall Study|Non-Compliance with Study Drug|1|||
37718735|NCT02111096|69196906|FG002|Overall Study|Non-Compliance with Study Drug|0|||
37718736|NCT02111096|69196904|FG000|Overall Study|Lost to Follow Up|1|||
37718737|NCT02111096|69196905|FG001|Overall Study|Lost to Follow Up|1|||
37718738|NCT02111096|69196906|FG002|Overall Study|Lost to Follow Up|1|||
37839625|NCT00195494|69524018|FG005|Year 2|Withdrawal by Subject|0|||
37839626|NCT00195494|69524013|FG000|Year 2|System toxicity|0|||
37839627|NCT00195494|69524014|FG001|Year 2|System toxicity|0|||
37839628|NCT00195494|69524015|FG002|Year 2|System toxicity|0|||
37718739|NCT02111096|69196904|FG000|Overall Study|Physician Decision|0|||
37718740|NCT02111096|69196905|FG001|Overall Study|Physician Decision|1|||
37718741|NCT02111096|69196906|FG002|Overall Study|Physician Decision|0|||
37839629|NCT00195494|69524016|FG003|Year 2|System toxicity|1|||
37718742|NCT02111096|69196904|FG000|Overall Study|Protocol Violation|1|||
37718743|NCT02111096|69196905|FG001|Overall Study|Protocol Violation|0|||
37718744|NCT02111096|69196906|FG002|Overall Study|Protocol Violation|1|||
37718745|NCT02111096|69196904|FG000|Overall Study|Terminated by Sponsor|53|||
37839630|NCT00195494|69524017|FG004|Year 2|System toxicity|0|||
37839631|NCT00195494|69524018|FG005|Year 2|System toxicity|0|||
37718746|NCT02111096|69196905|FG001|Overall Study|Terminated by Sponsor|35|||
37718747|NCT02111096|69196906|FG002|Overall Study|Terminated by Sponsor|54|||
37718748|NCT02111096|69196904|FG000|Overall Study|Withdrawal by Subject|4|||
37718749|NCT02111096|69196905|FG001|Overall Study|Withdrawal by Subject|2|||
37718750|NCT02111096|69196906|FG002|Overall Study|Withdrawal by Subject|8|||
37718751|NCT02110706|69196919|FG000|Overall Study|Adverse Event|2|||
37718752|NCT02110706|69196920|FG001|Overall Study|Adverse Event|3|||
37718753|NCT02110706|69196919|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
37718754|NCT02110706|69196920|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
37718755|NCT02110238|69196930|FG000|12 Week Pivotal Phase|Adverse Event|3|||
37718756|NCT02110238|69196931|FG001|12 Week Pivotal Phase|Adverse Event|0|||
37718757|NCT02110238|69196930|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
37718758|NCT02110238|69196931|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
37718759|NCT02110238|69196930|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
37718760|NCT02110238|69196931|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
37718761|NCT02110238|69196930|FG000|12 Week Pivotal Phase|Physician Decision|0|||
37839632|NCT00194987|69524036|FG000|Overall Study|Withdrawal by Subject|0|||
37839633|NCT00194987|69524037|FG001|Overall Study|Withdrawal by Subject|3|||
37839634|NCT00194792|69524045|FG000|Overall Study|Withdrawal by Subject|1|||
37839635|NCT00194675|69524060|FG000|Overall Study|Lost to Follow-up|1|||
37718762|NCT02110238|69196931|FG001|12 Week Pivotal Phase|Physician Decision|2|||
37718763|NCT02110238|69196930|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
37718764|NCT02110238|69196931|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
37718765|NCT02110238|69196930|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
37718766|NCT02110238|69196931|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
37718767|NCT02110238|69196930|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
37718768|NCT02110238|69196931|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
37718769|NCT02110238|69196930|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
37718770|NCT02110238|69196931|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
37839636|NCT00194675|69524061|FG001|Overall Study|Lost to Follow-up|1|||
37839637|NCT00194675|69524060|FG000|Overall Study|lack of interest|1|||
37839638|NCT00194675|69524061|FG001|Overall Study|lack of interest|1|||
37839639|NCT00194675|69524060|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
37839640|NCT00194675|69524061|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
37839641|NCT00194675|69524060|FG000|Overall Study|Protocol Violation|1|||
37839642|NCT00194675|69524061|FG001|Overall Study|Protocol Violation|0|||
37839643|NCT00194675|69524060|FG000|Overall Study|Death|1|||
37839644|NCT00194675|69524061|FG001|Overall Study|Death|0|||
37839645|NCT00194012|69524071|FG000|Randomized Phase|Lack of Efficacy|8|||
37839646|NCT00194012|69524072|FG001|Randomized Phase|Lack of Efficacy|18|||
37839647|NCT00194012|69524071|FG000|Randomized Phase|Study nonadherence|2|||
37839648|NCT00194012|69524072|FG001|Randomized Phase|Study nonadherence|1|||
37839649|NCT00194012|69524071|FG000|Randomized Phase|Withdrawal by Subject|3|||
37839650|NCT00194012|69524072|FG001|Randomized Phase|Withdrawal by Subject|3|||
37839651|NCT00194012|69524071|FG000|Randomized Phase|Adverse Event|2|||
37839652|NCT00194012|69524072|FG001|Randomized Phase|Adverse Event|1|||
37839653|NCT00194012|69524071|FG000|Randomized Phase|Participant reported having a rash|1|||
37839654|NCT00194012|69524072|FG001|Randomized Phase|Participant reported having a rash|0|||
37839655|NCT00194012|69524071|FG000|Randomized Phase|Emesis and enuresis|0|||
37839656|NCT00194012|69524072|FG001|Randomized Phase|Emesis and enuresis|1|||
37839657|NCT00194012|69524071|FG000|Randomized Phase|Oral/nasal twitching|0|||
37839658|NCT00194012|69524072|FG001|Randomized Phase|Oral/nasal twitching|1|||
37839659|NCT00194012|69524071|FG000|Open Label Extension (OLE)|Weight Gain|1|||
37839660|NCT00194012|69524072|FG001|Open Label Extension (OLE)|Weight Gain|0|||
37839661|NCT00194012|69524071|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
37839662|NCT00194012|69524072|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
37839663|NCT00194012|69524071|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
37839664|NCT00194012|69524072|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
37839665|NCT00194012|69524071|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
37839666|NCT00194012|69524072|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
37839667|NCT00192647|69524086|FG000|Overall Study|Death|1|||
37839668|NCT00192647|69524087|FG001|Overall Study|Death|1|||
37839669|NCT00192647|69524086|FG000|Overall Study|Adverse Event|35|||
37839670|NCT00192647|69524087|FG001|Overall Study|Adverse Event|29|||
37839671|NCT00192647|69524086|FG000|Overall Study|Laboratory Test Abnormality|4|||
38043528|NCT03509467|69731656|FG004|Overall Study|Death|1|||
37718771|NCT02110238|69196930|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
37718772|NCT02110238|69196931|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
37718773|NCT02110238|69196930|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
37839672|NCT00192647|69524087|FG001|Overall Study|Laboratory Test Abnormality|2|||
37839673|NCT00192647|69524086|FG000|Overall Study|Insufficient Therapeutic Response|53|||
37839674|NCT00192647|69524087|FG001|Overall Study|Insufficient Therapeutic Response|83|||
37839675|NCT00192647|69524086|FG000|Overall Study|Entry Criteria Violation|6|||
37839676|NCT00192647|69524087|FG001|Overall Study|Entry Criteria Violation|6|||
37839677|NCT00192647|69524086|FG000|Overall Study|Protocol Violation|3|||
37839678|NCT00192647|69524087|FG001|Overall Study|Protocol Violation|1|||
37718774|NCT02110238|69196931|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
37839679|NCT00192647|69524086|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
37839680|NCT00192647|69524087|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
37718775|NCT02110238|69196930|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
37718776|NCT02110238|69196931|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
37718777|NCT02108912|69196939|FG000|Overall Study|Lost to Follow-up|1|||
37718778|NCT02108912|69196940|FG001|Overall Study|Lost to Follow-up|1|||
37718779|NCT02108912|69196939|FG000|Overall Study|lack of transportation|1|||
37718780|NCT02108912|69196940|FG001|Overall Study|lack of transportation|0|||
37718781|NCT02108912|69196939|FG000|Overall Study|high blood pressure|1|||
37718782|NCT02108912|69196940|FG001|Overall Study|high blood pressure|0|||
37718783|NCT02108600|69196948|FG000|Overall Study|Withdrawal by Subject|2|||
37718784|NCT02108600|69196949|FG001|Overall Study|Withdrawal by Subject|0|||
37718785|NCT02108600|69196948|FG000|Overall Study|Lost to Follow-up|1|||
37718786|NCT02108600|69196949|FG001|Overall Study|Lost to Follow-up|1|||
37718787|NCT02107898|69196957|FG000|Overall Study|Adverse Event|4|||
37718788|NCT02107898|69196958|FG001|Overall Study|Adverse Event|7|||
37718789|NCT02107898|69196957|FG000|Overall Study|Poor compliance to protocol|0|||
37718790|NCT02107898|69196958|FG001|Overall Study|Poor compliance to protocol|1|||
37718791|NCT02107898|69196957|FG000|Overall Study|Participant moved|0|||
37718792|NCT02107898|69196958|FG001|Overall Study|Participant moved|2|||
37718793|NCT02107898|69196957|FG000|Overall Study|Consent withdrawn by participant|2|||
37718794|NCT02107898|69196958|FG001|Overall Study|Consent withdrawn by participant|1|||
37718795|NCT02107898|69196957|FG000|Overall Study|Randomized but not treated|0|||
37718796|NCT02107898|69196958|FG001|Overall Study|Randomized but not treated|1|||
37718797|NCT02059148|69196964|FG000|Treatment 1|Protocol Violation|0|||
37718798|NCT02059148|69196965|FG001|Treatment 1|Protocol Violation|0|||
37718799|NCT02059148|69196966|FG002|Treatment 1|Protocol Violation|0|||
37718800|NCT02059148|69196967|FG003|Treatment 1|Protocol Violation|0|||
37718801|NCT02059148|69196968|FG004|Treatment 1|Protocol Violation|0|||
37718802|NCT02059148|69196969|FG005|Treatment 1|Protocol Violation|1|||
37718803|NCT02058992|69196980|FG000|Overall Study|Lost to Follow-up|4|||
37718804|NCT02058992|69196980|FG000|Overall Study|Protocol Violation|92|||
37718805|NCT02058992|69196980|FG000|Overall Study|CRF Uncollected|20|||
37718806|NCT02058836|69196986|FG000|Overall Study|Withdrawal by Subject|1|||
37718807|NCT02058836|69196987|FG001|Overall Study|Withdrawal by Subject|1|||
37718808|NCT02107274|69196995|FG000|Treatment vs. Placebo|Adverse Event|3|||
37718809|NCT02107274|69196996|FG001|Treatment vs. Placebo|Adverse Event|0|||
37718810|NCT02107274|69196995|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
37718811|NCT02107274|69196996|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
37718812|NCT02107274|69196995|FG000|Control Phase|Lost to Follow-up|1|||
37718813|NCT02107274|69196996|FG001|Control Phase|Lost to Follow-up|1|||
37718814|NCT02107274|69196995|FG000|Control Phase|Death|2|||
37718815|NCT02107274|69196996|FG001|Control Phase|Death|0|||
37718816|NCT02107274|69196995|FG000|Control Phase|Adverse Event|0|||
37718817|NCT02107274|69196996|FG001|Control Phase|Adverse Event|1|||
37718818|NCT02174627|69197004|FG000|Overall Study|Missing|0|||
37718819|NCT02174627|69197005|FG001|Overall Study|Missing|1|||
37718820|NCT02174627|69197004|FG000|Overall Study|Incorrect enrolment before randomization|0|||
37718821|NCT02174627|69197005|FG001|Overall Study|Incorrect enrolment before randomization|1|||
37718822|NCT02174627|69197004|FG000|Overall Study|Participant decision|84|||
37718823|NCT02174627|69197005|FG001|Overall Study|Participant decision|128|||
37718824|NCT02173769|69197011|FG000|Overall Study|Protocol Violation|4|||
37718825|NCT02121509|69197018|FG000|Washout Period (35 Days)|Adverse Event|1|||
37718826|NCT02121509|69197019|FG001|Washout Period (35 Days)|Adverse Event|1|||
37718827|NCT02121509|69197020|FG002|Washout Period (35 Days)|Adverse Event|0|||
37718828|NCT02121509|69197021|FG003|Washout Period (35 Days)|Adverse Event|0|||
37718829|NCT02121509|69197018|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
37718830|NCT02121509|69197019|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
37839681|NCT00192647|69524086|FG000|Overall Study|Failure to Return|11|||
37839682|NCT00192647|69524087|FG001|Overall Study|Failure to Return|13|||
37839683|NCT00192647|69524086|FG000|Overall Study|Other/Administrative|5|||
37718831|NCT02121509|69197020|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
37839684|NCT00192647|69524087|FG001|Overall Study|Other/Administrative|3|||
37839685|NCT00192296|69524097|FG000|Overall Study|Withdrawal by Subject|0|||
37839686|NCT00192296|69524098|FG001|Overall Study|Withdrawal by Subject|1|||
37839687|NCT00192296|69524099|FG002|Overall Study|Withdrawal by Subject|0|||
37839688|NCT00192296|69524100|FG003|Overall Study|Withdrawal by Subject|0|||
37839689|NCT00192023|69524112|FG000|Period III - Double-Blind|Adverse Event|3|||
37839690|NCT00192023|69524113|FG001|Period III - Double-Blind|Adverse Event|0|||
37839691|NCT00192023|69524112|FG000|Period III - Double-Blind|Physician Decision|2|||
37718832|NCT02121509|69197021|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
37718833|NCT02121509|69197018|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
37839692|NCT00192023|69524113|FG001|Period III - Double-Blind|Physician Decision|0|||
38024930|NCT03987074|69708955|FG001|Overall Study|Investigator's Discretion|0|||
38024931|NCT03987074|69708956|FG002|Overall Study|Investigator's Discretion|0|||
38024932|NCT03987074|69708957|FG003|Overall Study|Investigator's Discretion|1|||
38024933|NCT03987074|69708958|FG004|Overall Study|Investigator's Discretion|0|||
38024934|NCT04439214|69708970|FG000|Overall Study|Adverse Event|13|||
38024935|NCT04439214|69708970|FG000|Overall Study|Disease progression|16|||
38024936|NCT04439214|69708970|FG000|Overall Study|Death|1|||
38024937|NCT04439214|69708970|FG000|Overall Study|Withdrawal by Subject|2|||
38024938|NCT04439214|69708970|FG000|Overall Study|Declining health|1|||
38024939|NCT04439214|69708970|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
38024940|NCT04439214|69708970|FG000|Overall Study|Ineligible|5|||
38024941|NCT03696342|69708976|FG000|Overall Study|Lost to Follow-up|1|||
38024942|NCT03696342|69708977|FG001|Overall Study|Lost to Follow-up|0|||
37718834|NCT02121509|69197019|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
37718835|NCT02121509|69197020|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
37718836|NCT02121509|69197021|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
37718837|NCT02149199|69197034|FG000|Overall Study|Study specific withdrawal criteria|4|||
37718838|NCT02149199|69197035|FG001|Overall Study|Study specific withdrawal criteria|21|||
37718839|NCT02149199|69197036|FG002|Overall Study|Study specific withdrawal criteria|6|||
37718840|NCT02149199|69197034|FG000|Overall Study|Other|20|||
37718841|NCT02149199|69197035|FG001|Overall Study|Other|25|||
37718842|NCT02149199|69197036|FG002|Overall Study|Other|20|||
37718843|NCT02149199|69197034|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
37718844|NCT02149199|69197035|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
37718845|NCT02149199|69197036|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
37718846|NCT02149199|69197034|FG000|Overall Study|Withdrawal by Subject|75|||
37718847|NCT02149199|69197035|FG001|Overall Study|Withdrawal by Subject|93|||
37718848|NCT02149199|69197036|FG002|Overall Study|Withdrawal by Subject|77|||
37718849|NCT02149199|69197034|FG000|Overall Study|Protocol Violation|16|||
37718850|NCT02149199|69197035|FG001|Overall Study|Protocol Violation|13|||
37718851|NCT02149199|69197036|FG002|Overall Study|Protocol Violation|15|||
37718852|NCT02149199|69197034|FG000|Overall Study|Lost to Follow-up|3|||
37718853|NCT02149199|69197035|FG001|Overall Study|Lost to Follow-up|12|||
37718854|NCT02149199|69197036|FG002|Overall Study|Lost to Follow-up|11|||
37718855|NCT02149199|69197034|FG000|Overall Study|Death|0|||
37718856|NCT02149199|69197035|FG001|Overall Study|Death|0|||
37718857|NCT02149199|69197036|FG002|Overall Study|Death|1|||
37718858|NCT02149199|69197034|FG000|Overall Study|Adverse Event|6|||
37718859|NCT02149199|69197035|FG001|Overall Study|Adverse Event|15|||
37718860|NCT02149199|69197036|FG002|Overall Study|Adverse Event|9|||
38024943|NCT04411680|69708985|FG000|Treatment Period|Adverse Event|3|||
38024944|NCT04411680|69708986|FG001|Treatment Period|Adverse Event|0|||
38024945|NCT04411680|69708985|FG000|Treatment Period|Discharged from hospital|18|||
38024946|NCT04411680|69708986|FG001|Treatment Period|Discharged from hospital|7|||
38024947|NCT04411680|69708985|FG000|Treatment Period|Missed 1 or more doses|8|||
38024948|NCT04411680|69708986|FG001|Treatment Period|Missed 1 or more doses|0|||
37718861|NCT02120417|69197046|FG000|Overall Study|Death|5|||
37718862|NCT02120417|69197047|FG001|Overall Study|Death|1|||
37718863|NCT02120417|69197046|FG000|Overall Study|Adverse Event|3|||
37718864|NCT02120417|69197047|FG001|Overall Study|Adverse Event|9|||
37718865|NCT02120417|69197046|FG000|Overall Study|Participant decision|4|||
37718866|NCT02120417|69197047|FG001|Overall Study|Participant decision|4|||
37718867|NCT02120417|69197046|FG000|Overall Study|Disease progression|41|||
37718868|NCT02120417|69197047|FG001|Overall Study|Disease progression|45|||
37718869|NCT02120417|69197046|FG000|Overall Study|Noncompliance with study treatment|0|||
37718870|NCT02120417|69197047|FG001|Overall Study|Noncompliance with study treatment|2|||
37718871|NCT02120417|69197046|FG000|Overall Study|Physician Decision|2|||
37718872|NCT02120417|69197047|FG001|Overall Study|Physician Decision|3|||
37718873|NCT02120417|69197046|FG000|Overall Study|Other unspecified|5|||
37718874|NCT02120417|69197047|FG001|Overall Study|Other unspecified|4|||
37839693|NCT00192023|69524112|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
38024949|NCT04411680|69708985|FG000|Treatment Period|Transferred to another hospital|0|||
37718875|NCT02148263|69197055|FG000|Overall Study|Withdrawal by Subject|3|||
37718876|NCT02148263|69197056|FG001|Overall Study|Withdrawal by Subject|2|||
37718877|NCT02147561|69197062|FG000|Overall Study|Lost to Follow-up|3|||
38043529|NCT03509467|69731657|FG005|Overall Study|Death|0|||
37718878|NCT02147561|69197062|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
37718879|NCT02058368|69197068|FG000|Overall Study|Adverse Event|15|||
37718880|NCT02058368|69197069|FG001|Overall Study|Adverse Event|20|||
37718881|NCT02058368|69197068|FG000|Overall Study|Lack of Efficacy|0|||
37718882|NCT02058368|69197069|FG001|Overall Study|Lack of Efficacy|1|||
37718883|NCT02058368|69197068|FG000|Overall Study|Protocol Violation|0|||
37718884|NCT02058368|69197069|FG001|Overall Study|Protocol Violation|4|||
37718885|NCT02058368|69197068|FG000|Overall Study|Lost to Follow-up|2|||
37718886|NCT02058368|69197069|FG001|Overall Study|Lost to Follow-up|0|||
37718887|NCT02058368|69197068|FG000|Overall Study|Physician Decision|2|||
37718888|NCT02058368|69197069|FG001|Overall Study|Physician Decision|3|||
37718889|NCT02058368|69197068|FG000|Overall Study|Withdrawal by Subject|22|||
37718890|NCT02058368|69197069|FG001|Overall Study|Withdrawal by Subject|26|||
37718891|NCT02107196|69197077|FG000|12-week Treatment Period|Adverse Event|6|||
37718892|NCT02107196|69197078|FG001|12-week Treatment Period|Adverse Event|3|||
37718893|NCT02107196|69197077|FG000|12-week Treatment Period|Lack of Efficacy|2|||
37718894|NCT02107196|69197078|FG001|12-week Treatment Period|Lack of Efficacy|1|||
37718895|NCT02107196|69197077|FG000|12-week Treatment Period|Lost to Follow-up|3|||
37718896|NCT02107196|69197078|FG001|12-week Treatment Period|Lost to Follow-up|6|||
37718897|NCT02107196|69197077|FG000|12-week Treatment Period|Physician Decision|0|||
37718898|NCT02107196|69197078|FG001|12-week Treatment Period|Physician Decision|1|||
37718899|NCT02107196|69197077|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
37718900|NCT02107196|69197078|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
37718901|NCT02107196|69197077|FG000|12-week Treatment Period|Protocol Violation|7|||
37718902|NCT02107196|69197078|FG001|12-week Treatment Period|Protocol Violation|8|||
37718903|NCT02107196|69197077|FG000|12-week Treatment Period|Reason Missing|11|||
37718904|NCT02107196|69197078|FG001|12-week Treatment Period|Reason Missing|8|||
37718905|NCT02107196|69197077|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
37718906|NCT02107196|69197078|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
37718907|NCT02107196|69197077|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
37718908|NCT02107196|69197078|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
37718909|NCT02107196|69197077|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
37718910|NCT02107196|69197078|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
37718911|NCT02107196|69197077|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
37718912|NCT02107196|69197078|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
37718913|NCT02058290|69197086|FG000|Overall Study|Protocol Violation|2|||
37718914|NCT02058290|69197087|FG001|Overall Study|Protocol Violation|1|||
37718915|NCT02058290|69197086|FG000|Overall Study|Physician Decision|1|||
37718916|NCT02058290|69197087|FG001|Overall Study|Physician Decision|0|||
37718917|NCT02058290|69197086|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
37718918|NCT02058290|69197087|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
37718919|NCT02058290|69197086|FG000|Overall Study|Withdrawal by Subject|0|||
37718920|NCT02058290|69197087|FG001|Overall Study|Withdrawal by Subject|1|||
37718921|NCT02082158|69197099|FG000|Overall Study|Withdrawal by Subject|0|||
37718922|NCT02082158|69197100|FG001|Overall Study|Withdrawal by Subject|0|||
37718923|NCT02082158|69197101|FG002|Overall Study|Withdrawal by Subject|0|||
37718924|NCT02082158|69197102|FG003|Overall Study|Withdrawal by Subject|0|||
37718925|NCT02082158|69197103|FG004|Overall Study|Withdrawal by Subject|1|||
37718926|NCT02082158|69197104|FG005|Overall Study|Withdrawal by Subject|0|||
37718927|NCT02082158|69197099|FG000|Overall Study|Failed Fit-testing|8|||
37718928|NCT02082158|69197100|FG001|Overall Study|Failed Fit-testing|8|||
37718929|NCT02082158|69197101|FG002|Overall Study|Failed Fit-testing|14|||
37718930|NCT02082158|69197102|FG003|Overall Study|Failed Fit-testing|4|||
37718931|NCT02082158|69197103|FG004|Overall Study|Failed Fit-testing|3|||
37718932|NCT02082158|69197104|FG005|Overall Study|Failed Fit-testing|7|||
37718933|NCT02106884|69197126|FG000|Overall Study|Change of diagnosis/exclusion|0|||
37718934|NCT02106884|69197127|FG001|Overall Study|Change of diagnosis/exclusion|1|||
37718935|NCT02081846|69197138|FG000|Overall Study|Withdrawal by Subject|1|||
37718936|NCT02081846|69197139|FG001|Overall Study|Withdrawal by Subject|0|||
37718937|NCT02081846|69197138|FG000|Overall Study|invalid consent|1|||
37718938|NCT02081846|69197139|FG001|Overall Study|invalid consent|0|||
37718939|NCT02081690|69197145|FG000|Overall Study|Death|3|||
37718940|NCT02081690|69197145|FG000|Overall Study|Physician Decision|3|||
37718941|NCT02081690|69197145|FG000|Overall Study|Withdrawal by Subject|1|||
37718942|NCT02057666|69197151|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
37718943|NCT02057666|69197152|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
38024950|NCT04411680|69708986|FG001|Treatment Period|Transferred to another hospital|1|||
37718944|NCT02057666|69197151|FG000|Double Blind Treatment Period|Poor tolerability|7|||
37718945|NCT02057666|69197152|FG001|Double Blind Treatment Period|Poor tolerability|2|||
37718946|NCT02057666|69197151|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
37718947|NCT02057666|69197152|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
37718948|NCT02057666|69197151|FG000|Double Blind Treatment Period|Physician Decision|1|||
38043530|NCT03509467|69731658|FG006|Overall Study|Death|1|||
37718949|NCT02057666|69197152|FG001|Double Blind Treatment Period|Physician Decision|0|||
37718950|NCT02057666|69197151|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
37718951|NCT02057666|69197152|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
37718952|NCT02057666|69197151|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
37718953|NCT02057666|69197152|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
37718954|NCT02057666|69197151|FG000|Double Blind Treatment Period|Sponsor's request|70|||
37718955|NCT02057666|69197152|FG001|Double Blind Treatment Period|Sponsor's request|34|||
37718956|NCT02057666|69197151|FG000|Open-Label Treatment Period|Poor tolerability|0|||
37718957|NCT02057666|69197152|FG001|Open-Label Treatment Period|Poor tolerability|1|||
37718958|NCT02057666|69197151|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
37718959|NCT02057666|69197152|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
37718960|NCT02057666|69197151|FG000|Open-Label Treatment Period|Sponsor's request|0|||
37718961|NCT02057666|69197152|FG001|Open-Label Treatment Period|Sponsor's request|4|||
37718962|NCT01625000|69197163|FG000|Overall Study|Physician Decision|15|||
37718963|NCT01625000|69197164|FG001|Overall Study|Physician Decision|7|||
37718964|NCT01625000|69197165|FG002|Overall Study|Physician Decision|7|||
37718965|NCT01625000|69197166|FG003|Overall Study|Physician Decision|2|||
37718966|NCT01625000|69197167|FG004|Overall Study|Physician Decision|15|||
37718967|NCT01625000|69197163|FG000|Overall Study|Protocol Violation|3|||
37718968|NCT01625000|69197164|FG001|Overall Study|Protocol Violation|10|||
37718969|NCT01625000|69197165|FG002|Overall Study|Protocol Violation|4|||
37718970|NCT01625000|69197166|FG003|Overall Study|Protocol Violation|1|||
37718971|NCT01625000|69197167|FG004|Overall Study|Protocol Violation|2|||
37718972|NCT01625000|69197163|FG000|Overall Study|Withdrawal by Subject|19|||
37718973|NCT01625000|69197164|FG001|Overall Study|Withdrawal by Subject|16|||
37718974|NCT01625000|69197165|FG002|Overall Study|Withdrawal by Subject|11|||
37718975|NCT01625000|69197166|FG003|Overall Study|Withdrawal by Subject|9|||
37718976|NCT01625000|69197167|FG004|Overall Study|Withdrawal by Subject|17|||
37718977|NCT01625000|69197163|FG000|Overall Study|Adverse Event (including Death)|15|||
37718978|NCT01625000|69197164|FG001|Overall Study|Adverse Event (including Death)|19|||
37718979|NCT01625000|69197165|FG002|Overall Study|Adverse Event (including Death)|11|||
37718980|NCT01625000|69197166|FG003|Overall Study|Adverse Event (including Death)|7|||
37718981|NCT01625000|69197167|FG004|Overall Study|Adverse Event (including Death)|21|||
37718982|NCT02081534|69197186|FG000|Overall Study|Adverse Event|5|||
37718983|NCT02081534|69197187|FG001|Overall Study|Adverse Event|4|||
37718984|NCT02081534|69197188|FG002|Overall Study|Adverse Event|3|||
37718985|NCT02081534|69197189|FG003|Overall Study|Adverse Event|10|||
37718986|NCT02081534|69197190|FG004|Overall Study|Adverse Event|2|||
37718987|NCT02081534|69197191|FG005|Overall Study|Adverse Event|8|||
37718988|NCT02081534|69197192|FG006|Overall Study|Adverse Event|2|||
37718989|NCT02081534|69197186|FG000|Overall Study|Withdrawal by Subject|0|||
37718990|NCT02081534|69197187|FG001|Overall Study|Withdrawal by Subject|1|||
37718991|NCT02081534|69197188|FG002|Overall Study|Withdrawal by Subject|1|||
37718992|NCT02081534|69197189|FG003|Overall Study|Withdrawal by Subject|1|||
37718993|NCT02081534|69197190|FG004|Overall Study|Withdrawal by Subject|1|||
37718994|NCT02081534|69197191|FG005|Overall Study|Withdrawal by Subject|0|||
37718995|NCT02081534|69197192|FG006|Overall Study|Withdrawal by Subject|1|||
37718996|NCT02081534|69197186|FG000|Overall Study|Protocol Violation|0|||
37718997|NCT02081534|69197187|FG001|Overall Study|Protocol Violation|3|||
37915502|NCT00853047|69602248|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
37915503|NCT00853047|69602249|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
37915504|NCT00853047|69602250|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
37915505|NCT00853047|69602251|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
37915506|NCT00853047|69602252|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
37915507|NCT00853047|69602253|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
37915508|NCT00520975|69602270|FG000|Overall Study|Disease progression|31|||
37915509|NCT00520975|69602271|FG001|Overall Study|Disease progression|23|||
37915510|NCT00520975|69602270|FG000|Overall Study|Adverse Event|7|||
37915511|NCT00520975|69602271|FG001|Overall Study|Adverse Event|10|||
37915512|NCT00520975|69602270|FG000|Overall Study|Death|0|||
37839694|NCT00192023|69524113|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
37839695|NCT00192023|69524112|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
37839696|NCT00192023|69524113|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
37839697|NCT00192023|69524112|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
37839698|NCT00192023|69524113|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
37839699|NCT00192023|69524112|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
37839700|NCT00192023|69524113|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
37839701|NCT00192023|69524112|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
37839702|NCT00192023|69524113|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
37839703|NCT00192023|69524112|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
37915513|NCT00520975|69602271|FG001|Overall Study|Death|2|||
37915514|NCT00520975|69602270|FG000|Overall Study|Withdrawal by Subject|3|||
37915515|NCT00520975|69602271|FG001|Overall Study|Withdrawal by Subject|5|||
37915516|NCT00520975|69602270|FG000|Overall Study|Other therapy|2|||
37915517|NCT00520975|69602271|FG001|Overall Study|Other therapy|4|||
37915518|NCT00520975|69602270|FG000|Overall Study|Other reasons|4|||
37915519|NCT00520975|69602271|FG001|Overall Study|Other reasons|2|||
37915520|NCT00520975|69602270|FG000|Overall Study|Not start protocol therapy|1|||
37915521|NCT00520975|69602271|FG001|Overall Study|Not start protocol therapy|2|||
37718998|NCT02081534|69197188|FG002|Overall Study|Protocol Violation|0|||
37718999|NCT02081534|69197189|FG003|Overall Study|Protocol Violation|0|||
37719000|NCT02081534|69197190|FG004|Overall Study|Protocol Violation|0|||
37719001|NCT02081534|69197191|FG005|Overall Study|Protocol Violation|0|||
37719002|NCT02081534|69197192|FG006|Overall Study|Protocol Violation|1|||
37719003|NCT02081534|69197186|FG000|Overall Study|Lost to Follow-up|0|||
37719004|NCT02081534|69197187|FG001|Overall Study|Lost to Follow-up|0|||
37719005|NCT02081534|69197188|FG002|Overall Study|Lost to Follow-up|0|||
37719006|NCT02081534|69197189|FG003|Overall Study|Lost to Follow-up|2|||
37719007|NCT02081534|69197190|FG004|Overall Study|Lost to Follow-up|1|||
37719008|NCT02081534|69197191|FG005|Overall Study|Lost to Follow-up|1|||
37719009|NCT02081534|69197192|FG006|Overall Study|Lost to Follow-up|0|||
37719010|NCT02057198|69197211|FG000|Overall Study|Death|0|||
37719011|NCT02057198|69197212|FG001|Overall Study|Death|0|||
37719012|NCT02057198|69197213|FG002|Overall Study|Death|1|||
37719013|NCT02057198|69197211|FG000|Overall Study|Discharged early; lost to followup|0|||
37719014|NCT02057198|69197212|FG001|Overall Study|Discharged early; lost to followup|1|||
37719015|NCT02057198|69197213|FG002|Overall Study|Discharged early; lost to followup|0|||
37719016|NCT02056652|69197223|FG000|Overall Study|Withdrawal by Subject|1|||
37719017|NCT02056652|69197224|FG001|Overall Study|Withdrawal by Subject|0|||
37719018|NCT02056652|69197223|FG000|Overall Study|Lost to Follow-up|0|||
37719019|NCT02056652|69197224|FG001|Overall Study|Lost to Follow-up|3|||
37719020|NCT02056340|69197232|FG000|Overall Study|Lost to Follow-up|5|||
37719021|NCT02056340|69197233|FG001|Overall Study|Lost to Follow-up|5|||
37719022|NCT02056340|69197232|FG000|Overall Study|Withdrawal by Subject|2|||
37719023|NCT02056340|69197233|FG001|Overall Study|Withdrawal by Subject|6|||
37719024|NCT02046122|69197239|FG000|Overall Study|Physician Decision|8|||
37719025|NCT02046122|69197239|FG000|Overall Study|Withdrawal by Subject|1|||
37719026|NCT02080832|69197246|FG000|Overall Study|Excluded from analysis by MRI|9|||
37719027|NCT02080832|69197247|FG001|Overall Study|Excluded from analysis by MRI|10|||
37719028|NCT02080832|69197248|FG002|Overall Study|Excluded from analysis by MRI|14|||
37719029|NCT02080832|69197246|FG000|Overall Study|Lost to Follow-up|0|||
37719030|NCT02080832|69197247|FG001|Overall Study|Lost to Follow-up|2|||
37719031|NCT02080832|69197248|FG002|Overall Study|Lost to Follow-up|2|||
37719032|NCT02080364|69197262|FG000|Baseline Period|Protocol Violation|2|||
37719033|NCT02080364|69197263|FG001|Baseline Period|Protocol Violation|1|||
37719034|NCT02080364|69197264|FG002|Baseline Period|Protocol Violation|0|||
37915522|NCT00851721|69602279|FG000|Overall Study|planned surgery|1|||
37719035|NCT02080364|69197265|FG003|Baseline Period|Protocol Violation|0|||
37719036|NCT02080364|69197262|FG000|Baseline Period|Other|0|||
37719037|NCT02080364|69197263|FG001|Baseline Period|Other|1|||
38024951|NCT04411680|69708985|FG000|Follow up Period|Withdrawal by Subject|2|||
37915523|NCT00851721|69602280|FG001|Overall Study|planned surgery|0|||
37915524|NCT00851721|69602279|FG000|Overall Study|Death|1|||
37839704|NCT00192023|69524113|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
37839705|NCT00192023|69524112|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
37839706|NCT00192023|69524113|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
37839707|NCT00192023|69524112|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
37839708|NCT00192023|69524113|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
37839709|NCT00191984|69524119|FG000|Overall Study|Disease Progression|21|||
37839710|NCT00191984|69524119|FG000|Overall Study|Adverse Event|4|||
37839711|NCT00191984|69524119|FG000|Overall Study|Death|2|||
37839712|NCT00191984|69524119|FG000|Overall Study|Entry Criteria Exclusion|1|||
37839713|NCT00191984|69524119|FG000|Overall Study|Withdrawal by Subject|7|||
37839714|NCT00191984|69524119|FG000|Overall Study|Physician Decision|4|||
37839715|NCT00191906|69524127|FG000|Study Period II|Adverse Event|0|||
37839716|NCT00191906|69524128|FG001|Study Period II|Adverse Event|1|||
37839717|NCT00191906|69524129|FG002|Study Period II|Adverse Event|0|||
37839718|NCT00191906|69524130|FG003|Study Period II|Adverse Event|0|||
37839719|NCT00191906|69524127|FG000|Study Period II|Withdrawal by Subject|0|||
37839720|NCT00191906|69524128|FG001|Study Period II|Withdrawal by Subject|3|||
37839721|NCT00191906|69524129|FG002|Study Period II|Withdrawal by Subject|0|||
37839722|NCT00191906|69524130|FG003|Study Period II|Withdrawal by Subject|0|||
37839723|NCT00191906|69524127|FG000|Study Period II|Parent/Caregiver Decision|0|||
37839724|NCT00191906|69524128|FG001|Study Period II|Parent/Caregiver Decision|1|||
37839725|NCT00191906|69524129|FG002|Study Period II|Parent/Caregiver Decision|0|||
37839726|NCT00191906|69524130|FG003|Study Period II|Parent/Caregiver Decision|0|||
37839727|NCT00191906|69524127|FG000|Study Period II|Entry Criteria Exclusion|0|||
37839728|NCT00191906|69524128|FG001|Study Period II|Entry Criteria Exclusion|0|||
37839729|NCT00191906|69524129|FG002|Study Period II|Entry Criteria Exclusion|1|||
37839730|NCT00191906|69524130|FG003|Study Period II|Entry Criteria Exclusion|0|||
37839731|NCT00191906|69524127|FG000|Study Period III|Adverse Event|1|||
37839732|NCT00191906|69524128|FG001|Study Period III|Adverse Event|0|||
37839733|NCT00191906|69524129|FG002|Study Period III|Adverse Event|0|||
37839734|NCT00191906|69524130|FG003|Study Period III|Adverse Event|0|||
37839735|NCT00191906|69524127|FG000|Study Period III|Lost to Follow-up|0|||
37839736|NCT00191906|69524128|FG001|Study Period III|Lost to Follow-up|1|||
37839737|NCT00191906|69524129|FG002|Study Period III|Lost to Follow-up|0|||
37839738|NCT00191906|69524130|FG003|Study Period III|Lost to Follow-up|0|||
37839739|NCT00191906|69524127|FG000|Study Period III|Parent/Caregiver Decision|1|||
37839740|NCT00191906|69524128|FG001|Study Period III|Parent/Caregiver Decision|0|||
37839741|NCT00191906|69524129|FG002|Study Period III|Parent/Caregiver Decision|0|||
37839742|NCT00191906|69524130|FG003|Study Period III|Parent/Caregiver Decision|0|||
37839743|NCT00191906|69524127|FG000|Study Period III|Lack of Efficacy|3|||
37839744|NCT00191906|69524128|FG001|Study Period III|Lack of Efficacy|3|||
37839745|NCT00191906|69524129|FG002|Study Period III|Lack of Efficacy|0|||
37839746|NCT00191906|69524130|FG003|Study Period III|Lack of Efficacy|0|||
37839747|NCT00191789|69524146|FG000|Overall Study|Adverse Event|5|||
37839748|NCT00191789|69524146|FG000|Overall Study|Patient: Satisfactory Response|5|||
37839749|NCT00191789|69524146|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
37839750|NCT00191789|69524146|FG000|Overall Study|Withdrawal by Subject|4|||
37839751|NCT00191789|69524146|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
37839752|NCT00191789|69524146|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
37839753|NCT00191789|69524146|FG000|Overall Study|Death - Not Study-Drug Related|1|||
37839754|NCT00191282|69524152|FG000|Overall Study|Adverse Event|5|||
37839755|NCT00191282|69524153|FG001|Overall Study|Adverse Event|6|||
37839756|NCT00191282|69524152|FG000|Overall Study|Death|51|||
37839757|NCT00191282|69524153|FG001|Overall Study|Death|51|||
37839758|NCT00191282|69524152|FG000|Overall Study|Lack of Efficacy|11|||
37839759|NCT00191282|69524153|FG001|Overall Study|Lack of Efficacy|6|||
37839760|NCT00191282|69524152|FG000|Overall Study|Noncompliance|14|||
37839761|NCT00191282|69524153|FG001|Overall Study|Noncompliance|17|||
37839762|NCT00191282|69524152|FG000|Overall Study|Patient moved|11|||
37839763|NCT00191282|69524153|FG001|Overall Study|Patient moved|14|||
37839764|NCT00191282|69524152|FG000|Overall Study|Withdrawal by Subject|59|||
37839765|NCT00191282|69524153|FG001|Overall Study|Withdrawal by Subject|44|||
37839766|NCT00191282|69524152|FG000|Overall Study|Physician Decision|18|||
37839767|NCT00191282|69524153|FG001|Overall Study|Physician Decision|15|||
37839768|NCT00191282|69524152|FG000|Overall Study|Protocol entry criteria not met|14|||
37839769|NCT00191282|69524153|FG001|Overall Study|Protocol entry criteria not met|9|||
37839770|NCT00191282|69524152|FG000|Overall Study|Protocol Violation|9|||
37839771|NCT00191282|69524153|FG001|Overall Study|Protocol Violation|12|||
38043531|NCT03509467|69731659|FG007|Overall Study|Death|0|||
37839772|NCT00191282|69524152|FG000|Overall Study|Severity of outcome|2|||
37839773|NCT00191282|69524153|FG001|Overall Study|Severity of outcome|5|||
37839774|NCT00191282|69524152|FG000|Overall Study|Sponsor's decision|2|||
37839775|NCT00191282|69524153|FG001|Overall Study|Sponsor's decision|2|||
37839776|NCT00191282|69524152|FG000|Overall Study|Lost to Follow-up|24|||
37839777|NCT00191282|69524153|FG001|Overall Study|Lost to Follow-up|31|||
37839778|NCT00191165|69524161|FG000|Overall Study|Adverse Event|2|||
37839779|NCT00191165|69524162|FG001|Overall Study|Adverse Event|0|||
37839780|NCT00191165|69524161|FG000|Overall Study|Protocol Violation|0|||
37839781|NCT00191165|69524162|FG001|Overall Study|Protocol Violation|1|||
37839782|NCT00191165|69524161|FG000|Overall Study|Participant Moved Away|0|||
37839783|NCT00191165|69524162|FG001|Overall Study|Participant Moved Away|1|||
37839784|NCT00190775|69524170|FG000|Overall Study|Adverse Event|57|||
37839785|NCT00190775|69524171|FG001|Overall Study|Adverse Event|22|||
37839786|NCT00190775|69524170|FG000|Overall Study|Satisfactory Response|1|||
37719038|NCT02080364|69197264|FG002|Baseline Period|Other|1|||
37719039|NCT02080364|69197265|FG003|Baseline Period|Other|0|||
37719040|NCT02080364|69197262|FG000|Treatment Period|Adverse Event|10|||
37719041|NCT02080364|69197263|FG001|Treatment Period|Adverse Event|15|||
37719042|NCT02080364|69197264|FG002|Treatment Period|Adverse Event|11|||
37719043|NCT02080364|69197265|FG003|Treatment Period|Adverse Event|14|||
37719044|NCT02080364|69197262|FG000|Treatment Period|Lost to Follow-up|2|||
37719045|NCT02080364|69197263|FG001|Treatment Period|Lost to Follow-up|3|||
37719046|NCT02080364|69197264|FG002|Treatment Period|Lost to Follow-up|5|||
37719047|NCT02080364|69197265|FG003|Treatment Period|Lost to Follow-up|0|||
37719048|NCT02080364|69197262|FG000|Treatment Period|Protocol Violation|5|||
37719049|NCT02080364|69197263|FG001|Treatment Period|Protocol Violation|3|||
37719050|NCT02080364|69197264|FG002|Treatment Period|Protocol Violation|5|||
37719051|NCT02080364|69197265|FG003|Treatment Period|Protocol Violation|1|||
37719052|NCT02080364|69197262|FG000|Treatment Period|Withdrawal by Subject|16|||
37719053|NCT02080364|69197263|FG001|Treatment Period|Withdrawal by Subject|16|||
37719054|NCT02080364|69197264|FG002|Treatment Period|Withdrawal by Subject|15|||
37719055|NCT02080364|69197265|FG003|Treatment Period|Withdrawal by Subject|10|||
37719056|NCT02080364|69197262|FG000|Treatment Period|Study Terminated by Sponsor|0|||
37719057|NCT02080364|69197263|FG001|Treatment Period|Study Terminated by Sponsor|0|||
37719058|NCT02080364|69197264|FG002|Treatment Period|Study Terminated by Sponsor|180|||
37719059|NCT02080364|69197265|FG003|Treatment Period|Study Terminated by Sponsor|183|||
37719060|NCT02080364|69197262|FG000|Treatment Period|Other|14|||
37719061|NCT02080364|69197263|FG001|Treatment Period|Other|12|||
37719062|NCT02080364|69197264|FG002|Treatment Period|Other|21|||
37719063|NCT02080364|69197265|FG003|Treatment Period|Other|16|||
37719064|NCT02079038|69197277|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
37719065|NCT02079038|69197278|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
37719066|NCT02079038|69197277|FG000|Modified Intent to Treat Population|Death|1|||
37719067|NCT02079038|69197278|FG001|Modified Intent to Treat Population|Death|0|||
37719068|NCT02079038|69197277|FG000|Completed 6 Months|Lost to Follow-up|2|||
37719069|NCT02079038|69197278|FG001|Completed 6 Months|Lost to Follow-up|1|||
37719070|NCT02045732|69197286|FG000|Overall Study|At the discretion of the investigator|1|||
37719071|NCT02045732|69197287|FG001|Overall Study|At the discretion of the investigator|1|||
37719072|NCT02044874|69197296|FG000|Overall Study|Adverse Event|5|||
37719073|NCT02044874|69197297|FG001|Overall Study|Adverse Event|6|||
37719074|NCT02044874|69197298|FG002|Overall Study|Adverse Event|6|||
37719075|NCT02044874|69197296|FG000|Overall Study|Withdrawal by Subject|8|||
37719076|NCT02044874|69197297|FG001|Overall Study|Withdrawal by Subject|16|||
37719077|NCT02044874|69197298|FG002|Overall Study|Withdrawal by Subject|23|||
37719078|NCT02044874|69197296|FG000|Overall Study|Physician Decision|0|||
37719079|NCT02044874|69197297|FG001|Overall Study|Physician Decision|2|||
37719080|NCT02044874|69197298|FG002|Overall Study|Physician Decision|1|||
37719081|NCT02044874|69197296|FG000|Overall Study|Lost to Follow-up|10|||
37719082|NCT02044874|69197297|FG001|Overall Study|Lost to Follow-up|27|||
37719083|NCT02044874|69197298|FG002|Overall Study|Lost to Follow-up|21|||
37719084|NCT02044874|69197296|FG000|Overall Study|Sponsor Decision|0|||
37719085|NCT02044874|69197297|FG001|Overall Study|Sponsor Decision|1|||
37719086|NCT02044874|69197298|FG002|Overall Study|Sponsor Decision|1|||
37719087|NCT02044874|69197296|FG000|Overall Study|Other|7|||
37719088|NCT02044874|69197297|FG001|Overall Study|Other|3|||
37719089|NCT02044874|69197298|FG002|Overall Study|Other|8|||
37719090|NCT02078960|69197311|FG000|Treatment Period|Other|0|||
37719091|NCT02078960|69197312|FG001|Treatment Period|Other|0|||
37839787|NCT00190775|69524171|FG001|Overall Study|Satisfactory Response|0|||
37719092|NCT02078960|69197313|FG002|Treatment Period|Other|1|||
37719093|NCT02078960|69197311|FG000|Treatment Period|Lack of Efficacy|0|||
37719094|NCT02078960|69197312|FG001|Treatment Period|Lack of Efficacy|1|||
37719095|NCT02078960|69197313|FG002|Treatment Period|Lack of Efficacy|0|||
37719096|NCT02078960|69197311|FG000|Treatment Period|Disease progression - accelerated phase|0|||
37839788|NCT00190775|69524170|FG000|Overall Study|Lack of Efficacy|28|||
37839789|NCT00190775|69524171|FG001|Overall Study|Lack of Efficacy|32|||
37719097|NCT02078960|69197312|FG001|Treatment Period|Disease progression - accelerated phase|1|||
37719098|NCT02078960|69197313|FG002|Treatment Period|Disease progression - accelerated phase|0|||
37719099|NCT02078960|69197311|FG000|Treatment Period|Disease progression - blast phase|1|||
37719100|NCT02078960|69197312|FG001|Treatment Period|Disease progression - blast phase|0|||
37719101|NCT02078960|69197313|FG002|Treatment Period|Disease progression - blast phase|0|||
37719102|NCT02078960|69197311|FG000|Treatment Period|Withdrawal by Subject|0|||
37839790|NCT00190775|69524170|FG000|Overall Study|Lost to Follow-up|31|||
37719103|NCT02078960|69197312|FG001|Treatment Period|Withdrawal by Subject|1|||
37719104|NCT02078960|69197313|FG002|Treatment Period|Withdrawal by Subject|1|||
37719105|NCT02078960|69197311|FG000|Treatment Period|Adverse Event|1|||
37719106|NCT02078960|69197312|FG001|Treatment Period|Adverse Event|0|||
37839791|NCT00190775|69524171|FG001|Overall Study|Lost to Follow-up|23|||
37839792|NCT00190775|69524170|FG000|Overall Study|Participant Moved|0|||
37719107|NCT02078960|69197313|FG002|Treatment Period|Adverse Event|0|||
37719108|NCT02078960|69197311|FG000|Treatment Period|Death|0|||
37719109|NCT02078960|69197312|FG001|Treatment Period|Death|0|||
37719110|NCT02078960|69197313|FG002|Treatment Period|Death|1|||
37719111|NCT02078960|69197311|FG000|Follow-up Period|Death|2|||
37719112|NCT02078960|69197312|FG001|Follow-up Period|Death|0|||
37719113|NCT02078960|69197313|FG002|Follow-up Period|Death|0|||
37719114|NCT02078960|69197311|FG000|Follow-up Period|Lost to Follow-up|0|||
37719115|NCT02078960|69197312|FG001|Follow-up Period|Lost to Follow-up|1|||
37719116|NCT02078960|69197313|FG002|Follow-up Period|Lost to Follow-up|0|||
37719117|NCT02078102|69197325|FG000|Overall Study|Adverse Event|1|||
37719118|NCT02078102|69197326|FG001|Overall Study|Adverse Event|0|||
37839793|NCT00190775|69524171|FG001|Overall Study|Participant Moved|1|||
37839794|NCT00190775|69524170|FG000|Overall Study|Withdrawal by Subject|24|||
37839795|NCT00190775|69524171|FG001|Overall Study|Withdrawal by Subject|13|||
37839796|NCT00190775|69524170|FG000|Overall Study|Sponsor Decision|1|||
37839797|NCT00190775|69524171|FG001|Overall Study|Sponsor Decision|0|||
37839798|NCT00190775|69524170|FG000|Overall Study|Physician Decision|3|||
37719119|NCT02078102|69197325|FG000|Overall Study|Withdrawal by Subject|1|||
37719120|NCT02078102|69197326|FG001|Overall Study|Withdrawal by Subject|0|||
37719121|NCT02078102|69197325|FG000|Overall Study|Physician Decision|0|||
37719122|NCT02078102|69197326|FG001|Overall Study|Physician Decision|1|||
37719123|NCT02054702|69197335|FG000|Overall Study|Lost to Follow-up|3|||
37719124|NCT02054702|69197336|FG001|Overall Study|Lost to Follow-up|5|||
37719125|NCT02054702|69197335|FG000|Overall Study|Adverse Event|3|||
37719126|NCT02054702|69197336|FG001|Overall Study|Adverse Event|1|||
37719127|NCT02054702|69197335|FG000|Overall Study|Met Withdrawal Criteria|4|||
37719128|NCT02054702|69197336|FG001|Overall Study|Met Withdrawal Criteria|1|||
37719129|NCT02054702|69197335|FG000|Overall Study|Physician Decision|0|||
37719130|NCT02054702|69197336|FG001|Overall Study|Physician Decision|1|||
37719131|NCT02054702|69197335|FG000|Overall Study|Withdrawal by Subject|14|||
37719132|NCT02054702|69197336|FG001|Overall Study|Withdrawal by Subject|4|||
37719133|NCT02044094|69197342|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
37719134|NCT02044094|69197342|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
37719135|NCT02044094|69197342|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
37719136|NCT02044094|69197342|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
37719137|NCT02044094|69197342|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
37719138|NCT02044094|69197342|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
37719139|NCT02044094|69197342|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
37719140|NCT02044094|69197342|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
37719141|NCT02043938|69197357|FG000|Overall Study|Withdrawal by Subject|7|||
37719142|NCT02043938|69197357|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
37719143|NCT02043938|69197357|FG000|Overall Study|No show by subject|1|||
37719144|NCT02043938|69197357|FG000|Overall Study|Investigator decision|1|||
37719145|NCT02053610|69197366|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
37719146|NCT02053610|69197367|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
37719147|NCT02053610|69197366|FG000|Overall Study|Withdrew Consent|2|||
37719148|NCT02053610|69197367|FG001|Overall Study|Withdrew Consent|9|||
37719149|NCT02053610|69197366|FG000|Overall Study|Death|5|||
37839799|NCT00190775|69524171|FG001|Overall Study|Physician Decision|0|||
37839800|NCT00190775|69524170|FG000|Overall Study|Noncompliance|3|||
37839801|NCT00190775|69524171|FG001|Overall Study|Noncompliance|5|||
37839802|NCT00190775|69524170|FG000|Overall Study|Protocol Violation|0|||
37839803|NCT00190775|69524171|FG001|Overall Study|Protocol Violation|1|||
37915525|NCT00851721|69602280|FG001|Overall Study|Death|0|||
37915526|NCT00851721|69602279|FG000|Overall Study|Adverse Event|0|||
37915527|NCT00851721|69602280|FG001|Overall Study|Adverse Event|1|||
37915528|NCT00520741|69602294|FG000|Overall Study|Adverse Event|16|||
37915529|NCT00520741|69602295|FG001|Overall Study|Adverse Event|56|||
37839804|NCT00190775|69524170|FG000|Overall Study|Exclusion Criteria Met|1|||
37839805|NCT00190775|69524171|FG001|Overall Study|Exclusion Criteria Met|3|||
37839806|NCT00199901|69524186|FG000|Overall Study|Protocol Violation|2|||
37839807|NCT00199901|69524187|FG001|Overall Study|Protocol Violation|0|||
37839808|NCT00199901|69524186|FG000|Overall Study|Withdrawal by Subject|1|||
37839809|NCT00199901|69524187|FG001|Overall Study|Withdrawal by Subject|0|||
37839810|NCT00199901|69524186|FG000|Overall Study|Progressive Disease|24|||
37719150|NCT02053610|69197367|FG001|Overall Study|Death|5|||
37719151|NCT02053610|69197366|FG000|Overall Study|Administrative/Other|1|||
37719152|NCT02053610|69197367|FG001|Overall Study|Administrative/Other|1|||
37719153|NCT02053610|69197366|FG000|Overall Study|Disease Progression|2|||
37719154|NCT02053610|69197367|FG001|Overall Study|Disease Progression|3|||
37719155|NCT02053610|69197366|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
37719156|NCT02053610|69197367|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
37719157|NCT02053610|69197366|FG000|Overall Study|Did not Receive Treatment|4|||
37719158|NCT02053610|69197367|FG001|Overall Study|Did not Receive Treatment|2|||
37719159|NCT02053610|69197366|FG000|Overall Study|Insufficient Therapeutic Response|1|||
37719160|NCT02053610|69197367|FG001|Overall Study|Insufficient Therapeutic Response|1|||
37719161|NCT02053610|69197366|FG000|Overall Study|Violation of Selection Criteria|1|||
37719162|NCT02053610|69197367|FG001|Overall Study|Violation of Selection Criteria|0|||
37719163|NCT02075606|69197373|FG000|Overall Study|Adverse Event|5|||
37719164|NCT02075606|69197373|FG000|Overall Study|Withdrawal by Subject|1|||
37719165|NCT02075606|69197373|FG000|Overall Study|Death|1|||
37719166|NCT02075606|69197373|FG000|Overall Study|Investigator's decision|1|||
37719167|NCT02075606|69197373|FG000|Overall Study|Symptom management|1|||
37719168|NCT02075606|69197373|FG000|Overall Study|Increasing Symptoms|1|||
37719169|NCT02043782|69197382|FG000|Period 1|Adverse Event|0|||
37719170|NCT02043782|69197383|FG001|Period 1|Adverse Event|0|||
37719171|NCT02043782|69197384|FG002|Period 1|Adverse Event|1|||
37719172|NCT02043782|69197385|FG003|Period 1|Adverse Event|0|||
37719173|NCT02043782|69197386|FG004|Period 1|Adverse Event|0|||
37719174|NCT02043782|69197387|FG005|Period 1|Adverse Event|0|||
37719175|NCT02052596|69197397|FG000|Active Phase|Adverse Event|3|||
37719176|NCT02052596|69197398|FG001|Active Phase|Adverse Event|2|||
37719177|NCT02052596|69197397|FG000|Active Phase|Lost to Follow-up|8|||
37719178|NCT02052596|69197398|FG001|Active Phase|Lost to Follow-up|11|||
37719179|NCT02052596|69197397|FG000|Active Phase|Protocol Violation|1|||
37719180|NCT02052596|69197398|FG001|Active Phase|Protocol Violation|2|||
37719181|NCT02052596|69197397|FG000|Active Phase|Withdrawal by Subject|3|||
37719182|NCT02052596|69197398|FG001|Active Phase|Withdrawal by Subject|4|||
37719183|NCT02052596|69197397|FG000|Active Phase|Enrolled in error|1|||
37719184|NCT02052596|69197398|FG001|Active Phase|Enrolled in error|0|||
37719185|NCT02052596|69197397|FG000|Active Phase|Lost due to Crohn's disease|0|||
37719186|NCT02052596|69197398|FG001|Active Phase|Lost due to Crohn's disease|1|||
37719187|NCT02052596|69197397|FG000|Safety Phase|Adverse Event|6|||
37719188|NCT02052596|69197398|FG001|Safety Phase|Adverse Event|3|||
37719189|NCT02052596|69197397|FG000|Safety Phase|Lost to Follow-up|11|||
37719190|NCT02052596|69197398|FG001|Safety Phase|Lost to Follow-up|18|||
37719191|NCT02052596|69197397|FG000|Safety Phase|Protocol Violation|1|||
37719192|NCT02052596|69197398|FG001|Safety Phase|Protocol Violation|2|||
37719193|NCT02052596|69197397|FG000|Safety Phase|Withdrawal by Subject|8|||
37719194|NCT02052596|69197398|FG001|Safety Phase|Withdrawal by Subject|11|||
37719195|NCT02052596|69197397|FG000|Safety Phase|Enrolled in error|1|||
37719196|NCT02052596|69197398|FG001|Safety Phase|Enrolled in error|0|||
37719197|NCT02052596|69197397|FG000|Safety Phase|Lost due to Crohn's disease|0|||
37719198|NCT02052596|69197398|FG001|Safety Phase|Lost due to Crohn's disease|1|||
37719199|NCT02052440|69197406|FG000|Overall Study|Withdrawal by Subject|0|||
37719200|NCT02052440|69197407|FG001|Overall Study|Withdrawal by Subject|1|||
37719201|NCT02049944|69197413|FG000|Overall Study|Protocol Violation|2|||
37719202|NCT02043548|69197419|FG000|Overall Study|Lack of Efficacy|1|||
37719203|NCT02043548|69197420|FG001|Overall Study|Lack of Efficacy|0|||
37719204|NCT02043548|69197419|FG000|Overall Study|Adverse Event|0|||
37719205|NCT02043548|69197420|FG001|Overall Study|Adverse Event|1|||
37719206|NCT01622348|69197429|FG000|Overall Study|Withdrawal by Subject|1|||
37719207|NCT01622348|69197430|FG001|Overall Study|Withdrawal by Subject|0|||
37719208|NCT01622348|69197431|FG002|Overall Study|Withdrawal by Subject|1|||
37839811|NCT00199901|69524187|FG001|Overall Study|Progressive Disease|24|||
37839812|NCT00198107|69524197|FG000|Double-Blind Period|Adverse Event|1|||
37839813|NCT00198107|69524198|FG001|Double-Blind Period|Adverse Event|1|||
37839814|NCT00198107|69524199|FG002|Double-Blind Period|Adverse Event|0|||
38024952|NCT04411680|69708986|FG001|Follow up Period|Withdrawal by Subject|0|||
38024953|NCT04411680|69708985|FG000|Follow up Period|Lost to Follow-up|5|||
37719209|NCT01621880|69197441|FG000|Overall Study|Adverse Event|5|||
37719210|NCT01621880|69197442|FG001|Overall Study|Adverse Event|1|||
37719211|NCT01621880|69197441|FG000|Overall Study|Withdrawal by Subject|5|||
37719212|NCT01621880|69197442|FG001|Overall Study|Withdrawal by Subject|4|||
37719213|NCT01621802|69197455|FG000|Overall Study|Protocol Violation|0|||
37719214|NCT01621802|69197456|FG001|Overall Study|Protocol Violation|0|||
37719215|NCT01621802|69197457|FG002|Overall Study|Protocol Violation|0|||
37719216|NCT01621802|69197458|FG003|Overall Study|Protocol Violation|0|||
37719217|NCT01621802|69197459|FG004|Overall Study|Protocol Violation|0|||
37719218|NCT01621802|69197460|FG005|Overall Study|Protocol Violation|1|||
37719219|NCT01621802|69197455|FG000|Overall Study|Withdrawal by Subject|8|||
37719220|NCT01621802|69197456|FG001|Overall Study|Withdrawal by Subject|4|||
37719221|NCT01621802|69197457|FG002|Overall Study|Withdrawal by Subject|4|||
37719222|NCT01621802|69197458|FG003|Overall Study|Withdrawal by Subject|2|||
37719223|NCT01621802|69197459|FG004|Overall Study|Withdrawal by Subject|2|||
37719224|NCT01621802|69197460|FG005|Overall Study|Withdrawal by Subject|0|||
37719225|NCT01621802|69197455|FG000|Overall Study|Migrated/moved from study area|0|||
37719226|NCT01621802|69197456|FG001|Overall Study|Migrated/moved from study area|0|||
37719227|NCT01621802|69197457|FG002|Overall Study|Migrated/moved from study area|2|||
37839815|NCT00198107|69524197|FG000|Double-Blind Period|Lack of Efficacy|2|||
37839816|NCT00198107|69524198|FG001|Double-Blind Period|Lack of Efficacy|0|||
37839817|NCT00198107|69524199|FG002|Double-Blind Period|Lack of Efficacy|0|||
37839818|NCT00198107|69524197|FG000|Double-Blind Period|Lost to Follow-up|2|||
37839819|NCT00198107|69524198|FG001|Double-Blind Period|Lost to Follow-up|1|||
37839820|NCT00198107|69524199|FG002|Double-Blind Period|Lost to Follow-up|0|||
37839821|NCT00198107|69524197|FG000|Double-Blind Period|Physician Decision|1|||
37839822|NCT00198107|69524198|FG001|Double-Blind Period|Physician Decision|0|||
37839823|NCT00198107|69524199|FG002|Double-Blind Period|Physician Decision|0|||
37839824|NCT00198107|69524197|FG000|Double-Blind Period|Withdrawal by Subject|0|||
37839825|NCT00198107|69524198|FG001|Double-Blind Period|Withdrawal by Subject|1|||
37839826|NCT00198107|69524199|FG002|Double-Blind Period|Withdrawal by Subject|0|||
37839827|NCT00198107|69524197|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
37915530|NCT00520741|69602294|FG000|Overall Study|Lack of Efficacy|11|||
37915531|NCT00520741|69602295|FG001|Overall Study|Lack of Efficacy|30|||
37719228|NCT01621802|69197458|FG003|Overall Study|Migrated/moved from study area|0|||
37719229|NCT01621802|69197459|FG004|Overall Study|Migrated/moved from study area|1|||
37719230|NCT01621802|69197460|FG005|Overall Study|Migrated/moved from study area|0|||
37719231|NCT01621802|69197455|FG000|Overall Study|Others|3|||
37719232|NCT01621802|69197456|FG001|Overall Study|Others|3|||
37719233|NCT01621802|69197457|FG002|Overall Study|Others|3|||
37719234|NCT01621802|69197458|FG003|Overall Study|Others|2|||
37719235|NCT01621802|69197459|FG004|Overall Study|Others|1|||
37719236|NCT01621802|69197460|FG005|Overall Study|Others|0|||
37719237|NCT01621802|69197455|FG000|Overall Study|Lost to Follow-up|36|||
37719238|NCT01621802|69197456|FG001|Overall Study|Lost to Follow-up|16|||
37719239|NCT01621802|69197457|FG002|Overall Study|Lost to Follow-up|24|||
37719240|NCT01621802|69197458|FG003|Overall Study|Lost to Follow-up|7|||
37719241|NCT01621802|69197459|FG004|Overall Study|Lost to Follow-up|31|||
37719242|NCT01621802|69197460|FG005|Overall Study|Lost to Follow-up|11|||
37719243|NCT02059291|69197486|FG000|Epoch 2|Lack of Efficacy|0|||
37719244|NCT02059291|69197487|FG001|Epoch 2|Lack of Efficacy|0|||
37719245|NCT02059291|69197488|FG002|Epoch 2|Lack of Efficacy|0|||
37719246|NCT02059291|69197489|FG003|Epoch 2|Lack of Efficacy|1|||
37719247|NCT02059291|69197490|FG004|Epoch 2|Lack of Efficacy|0|||
37719248|NCT02059291|69197491|FG005|Epoch 2|Lack of Efficacy|1|||
37719249|NCT02059291|69197492|FG006|Epoch 2|Lack of Efficacy|0|||
37719250|NCT02059291|69197493|FG007|Epoch 2|Lack of Efficacy|0|||
37719251|NCT02059291|69197494|FG008|Epoch 2|Lack of Efficacy|0|||
37719252|NCT02059291|69197495|FG009|Epoch 2|Lack of Efficacy|0|||
37719253|NCT02059291|69197496|FG010|Epoch 2|Lack of Efficacy|0|||
37719254|NCT02059291|69197497|FG011|Epoch 2|Lack of Efficacy|0|||
37719255|NCT02059291|69197498|FG012|Epoch 2|Lack of Efficacy|0|||
37719256|NCT02059291|69197499|FG013|Epoch 2|Lack of Efficacy|0|||
37719257|NCT02059291|69197500|FG014|Epoch 2|Lack of Efficacy|0|||
37719258|NCT02059291|69197501|FG015|Epoch 2|Lack of Efficacy|0|||
37719259|NCT02059291|69197502|FG016|Epoch 2|Lack of Efficacy|0|||
37719260|NCT02059291|69197503|FG017|Epoch 2|Lack of Efficacy|0|||
37719261|NCT02059291|69197504|FG018|Epoch 2|Lack of Efficacy|0|||
37719262|NCT02059291|69197505|FG019|Epoch 2|Lack of Efficacy|0|||
37719263|NCT02059291|69197506|FG020|Epoch 2|Lack of Efficacy|0|||
37719264|NCT02059291|69197507|FG021|Epoch 2|Lack of Efficacy|0|||
37839828|NCT00198107|69524198|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
37839829|NCT00198107|69524199|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
37915532|NCT00520741|69602294|FG000|Overall Study|Withdrawal by Subject|0|||
37719265|NCT02059291|69197508|FG022|Epoch 2|Lack of Efficacy|0|||
37719266|NCT02059291|69197509|FG023|Epoch 2|Lack of Efficacy|0|||
37719267|NCT02059291|69197510|FG024|Epoch 2|Lack of Efficacy|0|||
37719268|NCT02059291|69197486|FG000|Epoch 2|Adverse Event|0|||
37719269|NCT02059291|69197487|FG001|Epoch 2|Adverse Event|0|||
37719270|NCT02059291|69197488|FG002|Epoch 2|Adverse Event|1|||
37719271|NCT02059291|69197489|FG003|Epoch 2|Adverse Event|1|||
37719272|NCT02059291|69197490|FG004|Epoch 2|Adverse Event|0|||
37719273|NCT02059291|69197491|FG005|Epoch 2|Adverse Event|0|||
37719274|NCT02059291|69197492|FG006|Epoch 2|Adverse Event|0|||
37719275|NCT02059291|69197493|FG007|Epoch 2|Adverse Event|1|||
37719276|NCT02059291|69197494|FG008|Epoch 2|Adverse Event|1|||
37719277|NCT02059291|69197495|FG009|Epoch 2|Adverse Event|0|||
37719278|NCT02059291|69197496|FG010|Epoch 2|Adverse Event|0|||
37719279|NCT02059291|69197497|FG011|Epoch 2|Adverse Event|0|||
37719280|NCT02059291|69197498|FG012|Epoch 2|Adverse Event|0|||
37719281|NCT02059291|69197499|FG013|Epoch 2|Adverse Event|0|||
37719282|NCT02059291|69197500|FG014|Epoch 2|Adverse Event|0|||
37719283|NCT02059291|69197501|FG015|Epoch 2|Adverse Event|0|||
37719284|NCT02059291|69197502|FG016|Epoch 2|Adverse Event|0|||
37719285|NCT02059291|69197503|FG017|Epoch 2|Adverse Event|0|||
37719286|NCT02059291|69197504|FG018|Epoch 2|Adverse Event|0|||
37719287|NCT02059291|69197505|FG019|Epoch 2|Adverse Event|0|||
37719288|NCT02059291|69197506|FG020|Epoch 2|Adverse Event|0|||
37719289|NCT02059291|69197507|FG021|Epoch 2|Adverse Event|0|||
37719290|NCT02059291|69197508|FG022|Epoch 2|Adverse Event|0|||
37719291|NCT02059291|69197509|FG023|Epoch 2|Adverse Event|0|||
37719292|NCT02059291|69197510|FG024|Epoch 2|Adverse Event|0|||
37719293|NCT02059291|69197486|FG000|Epoch 2|Withdrawal by Subject|0|||
37719294|NCT02059291|69197487|FG001|Epoch 2|Withdrawal by Subject|1|||
37719295|NCT02059291|69197488|FG002|Epoch 2|Withdrawal by Subject|0|||
37719296|NCT02059291|69197489|FG003|Epoch 2|Withdrawal by Subject|0|||
37719297|NCT02059291|69197490|FG004|Epoch 2|Withdrawal by Subject|0|||
37719298|NCT02059291|69197491|FG005|Epoch 2|Withdrawal by Subject|1|||
37719299|NCT02059291|69197492|FG006|Epoch 2|Withdrawal by Subject|0|||
37719300|NCT02059291|69197493|FG007|Epoch 2|Withdrawal by Subject|0|||
37719301|NCT02059291|69197494|FG008|Epoch 2|Withdrawal by Subject|1|||
37719302|NCT02059291|69197495|FG009|Epoch 2|Withdrawal by Subject|0|||
37719303|NCT02059291|69197496|FG010|Epoch 2|Withdrawal by Subject|0|||
37719304|NCT02059291|69197497|FG011|Epoch 2|Withdrawal by Subject|0|||
37719305|NCT02059291|69197498|FG012|Epoch 2|Withdrawal by Subject|0|||
37719306|NCT02059291|69197499|FG013|Epoch 2|Withdrawal by Subject|0|||
37719307|NCT02059291|69197500|FG014|Epoch 2|Withdrawal by Subject|0|||
37719308|NCT02059291|69197501|FG015|Epoch 2|Withdrawal by Subject|0|||
37719309|NCT02059291|69197502|FG016|Epoch 2|Withdrawal by Subject|0|||
37719310|NCT02059291|69197503|FG017|Epoch 2|Withdrawal by Subject|0|||
37719311|NCT02059291|69197504|FG018|Epoch 2|Withdrawal by Subject|0|||
37719312|NCT02059291|69197505|FG019|Epoch 2|Withdrawal by Subject|0|||
37719313|NCT02059291|69197506|FG020|Epoch 2|Withdrawal by Subject|0|||
37719314|NCT02059291|69197507|FG021|Epoch 2|Withdrawal by Subject|0|||
37719315|NCT02059291|69197508|FG022|Epoch 2|Withdrawal by Subject|0|||
37719316|NCT02059291|69197509|FG023|Epoch 2|Withdrawal by Subject|0|||
37719317|NCT02059291|69197510|FG024|Epoch 2|Withdrawal by Subject|0|||
37719318|NCT02059291|69197486|FG000|Epoch 3|Physician Decision|0|||
37719319|NCT02059291|69197487|FG001|Epoch 3|Physician Decision|0|||
37719320|NCT02059291|69197488|FG002|Epoch 3|Physician Decision|0|||
37839830|NCT00179660|69524207|FG000|Overall Study|Adverse Event|7|||
37839831|NCT00179660|69524207|FG000|Overall Study|Lack of therapeutic effect|28|||
37839832|NCT00179660|69524207|FG000|Overall Study|Withdrawal by Subject|2|||
37839833|NCT00179660|69524207|FG000|Overall Study|Lost to Follow-up|1|||
37839834|NCT00179660|69524207|FG000|Overall Study|Death|3|||
37839835|NCT00179660|69524207|FG000|Overall Study|Other - Unspecified|9|||
37839836|NCT00178256|69524211|FG000|Overall Study|Adverse Event|2|||
37839837|NCT00178256|69524212|FG001|Overall Study|Adverse Event|0|||
37839838|NCT00178256|69524213|FG002|Overall Study|Adverse Event|0|||
37839839|NCT00178256|69524214|FG003|Overall Study|Adverse Event|0|||
37839840|NCT00178256|69524211|FG000|Overall Study|Death|0|||
37839841|NCT00178256|69524212|FG001|Overall Study|Death|1|||
37839842|NCT00178256|69524213|FG002|Overall Study|Death|0|||
37839843|NCT00178256|69524214|FG003|Overall Study|Death|1|||
37839844|NCT00178256|69524211|FG000|Overall Study|Cancer progression|2|||
37839845|NCT00178256|69524212|FG001|Overall Study|Cancer progression|0|||
37839846|NCT00178256|69524213|FG002|Overall Study|Cancer progression|0|||
37839847|NCT00178256|69524214|FG003|Overall Study|Cancer progression|1|||
37839848|NCT00177164|69524223|FG000|Overall Study|Protocol Violation|0|||
37839849|NCT00177164|69524224|FG001|Overall Study|Protocol Violation|7|||
37839850|NCT00177164|69524223|FG000|Overall Study|Lost to Follow-up|4|||
37839851|NCT00177164|69524224|FG001|Overall Study|Lost to Follow-up|5|||
37839852|NCT00177164|69524223|FG000|Overall Study|increase in alcohol and drug use|1|||
37839853|NCT00177164|69524224|FG001|Overall Study|increase in alcohol and drug use|2|||
37839854|NCT00177164|69524223|FG000|Overall Study|Adverse Event|1|||
37839855|NCT00177164|69524224|FG001|Overall Study|Adverse Event|0|||
37839856|NCT00177164|69524223|FG000|Overall Study|discharge from hospital|1|||
37719321|NCT02059291|69197489|FG003|Epoch 3|Physician Decision|0|||
37719322|NCT02059291|69197490|FG004|Epoch 3|Physician Decision|0|||
37719323|NCT02059291|69197491|FG005|Epoch 3|Physician Decision|0|||
37719324|NCT02059291|69197492|FG006|Epoch 3|Physician Decision|0|||
37719325|NCT02059291|69197493|FG007|Epoch 3|Physician Decision|0|||
37719326|NCT02059291|69197494|FG008|Epoch 3|Physician Decision|0|||
37719327|NCT02059291|69197495|FG009|Epoch 3|Physician Decision|0|||
37719328|NCT02059291|69197496|FG010|Epoch 3|Physician Decision|0|||
37839857|NCT00177164|69524224|FG001|Overall Study|discharge from hospital|0|||
38043532|NCT03509467|69731652|FG000|Overall Study|Proxy Withdrawal|0|||
37719329|NCT02059291|69197497|FG011|Epoch 3|Physician Decision|0|||
37719330|NCT02059291|69197498|FG012|Epoch 3|Physician Decision|0|||
37719331|NCT02059291|69197499|FG013|Epoch 3|Physician Decision|1|||
37719332|NCT02059291|69197500|FG014|Epoch 3|Physician Decision|0|||
37719333|NCT02059291|69197501|FG015|Epoch 3|Physician Decision|1|||
37719334|NCT02059291|69197502|FG016|Epoch 3|Physician Decision|0|||
37839858|NCT00177164|69524223|FG000|Overall Study|Lack of Efficacy|2|||
37839859|NCT00177164|69524224|FG001|Overall Study|Lack of Efficacy|1|||
37839860|NCT00177164|69524223|FG000|Overall Study|Pregnancy|0|||
37839861|NCT00177164|69524224|FG001|Overall Study|Pregnancy|1|||
37839862|NCT02489942|69524247|FG000|Overall Study|Request by patient|602|||
37839863|NCT02489942|69524247|FG000|Overall Study|Improvement/remission|157|||
37839864|NCT02489942|69524247|FG000|Overall Study|No change/Progressive disease|263|||
37839865|NCT02489942|69524247|FG000|Overall Study|Adverse Event|522|||
37839866|NCT02489942|69524247|FG000|Overall Study|Other personal reasons|1218|||
37839867|NCT02489942|69524247|FG000|Overall Study|Lost to Follow-up|456|||
37839868|NCT02489942|69524247|FG000|Overall Study|Not continuously investigated|7|||
37839869|NCT02489942|69524247|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
37839870|NCT02489942|69524247|FG000|Overall Study|Multiple registration|1|||
37839871|NCT02489942|69524247|FG000|Overall Study|No patient visit after entry|100|||
37839872|NCT02489942|69524247|FG000|Overall Study|No treatment with Jardiance|2|||
37839873|NCT02489942|69524247|FG000|Overall Study|Patient received Jardiance before registration|1|||
37839874|NCT02489942|69524247|FG000|Overall Study|No CRF collected|86|||
37839875|NCT00176462|69524253|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
37839876|NCT00176462|69524254|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
37839877|NCT00176462|69524253|FG000|Induction (4 Weeks)|Death|1|||
37839878|NCT00176462|69524254|FG001|Induction (4 Weeks)|Death|2|||
37839879|NCT00176462|69524253|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
37839880|NCT00176462|69524254|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
37839881|NCT00176462|69524253|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
37839882|NCT00176462|69524254|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
37839883|NCT00176462|69524253|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
37839884|NCT00176462|69524254|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
37839885|NCT00176462|69524253|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
37839886|NCT00176462|69524254|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
37839887|NCT00176462|69524253|FG000|Consolidation (12 Weeks)|Not documented|0|||
37839888|NCT00176462|69524254|FG001|Consolidation (12 Weeks)|Not documented|1|||
37839889|NCT00176462|69524253|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
37839890|NCT00176462|69524254|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
37839891|NCT00176462|69524253|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
37839892|NCT00176462|69524254|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
37839893|NCT00175019|69524264|FG000|Overall Study|Adverse Event|54|||
37839894|NCT00175019|69524265|FG001|Overall Study|Adverse Event|22|||
37839895|NCT00175019|69524266|FG002|Overall Study|Adverse Event|2|||
37839896|NCT00175019|69524264|FG000|Overall Study|Protocol Violation|6|||
37839897|NCT00175019|69524265|FG001|Overall Study|Protocol Violation|3|||
37839898|NCT00175019|69524266|FG002|Overall Study|Protocol Violation|3|||
37839899|NCT00175019|69524264|FG000|Overall Study|Lost to Follow-up|42|||
37839900|NCT00175019|69524265|FG001|Overall Study|Lost to Follow-up|39|||
37839901|NCT00175019|69524266|FG002|Overall Study|Lost to Follow-up|9|||
37839902|NCT00175019|69524264|FG000|Overall Study|Did not continue under Amendment 4|1|||
37839903|NCT00175019|69524265|FG001|Overall Study|Did not continue under Amendment 4|1|||
37839904|NCT00175019|69524266|FG002|Overall Study|Did not continue under Amendment 4|2|||
37839905|NCT00175019|69524264|FG000|Overall Study|Personal Reason(s)|39|||
37839906|NCT00175019|69524265|FG001|Overall Study|Personal Reason(s)|31|||
37839907|NCT00175019|69524266|FG002|Overall Study|Personal Reason(s)|8|||
37839908|NCT00175019|69524264|FG000|Overall Study|Therapeutic Failure|10|||
37839909|NCT00175019|69524265|FG001|Overall Study|Therapeutic Failure|38|||
37839910|NCT00175019|69524266|FG002|Overall Study|Therapeutic Failure|22|||
37839911|NCT00175019|69524264|FG000|Overall Study|Gout Flare|2|||
37839912|NCT00175019|69524265|FG001|Overall Study|Gout Flare|3|||
37839913|NCT00175019|69524266|FG002|Overall Study|Gout Flare|0|||
37839914|NCT00175019|69524264|FG000|Overall Study|Reason Not Specified|40|||
37839915|NCT00175019|69524265|FG001|Overall Study|Reason Not Specified|34|||
37839916|NCT00175019|69524266|FG002|Overall Study|Reason Not Specified|11|||
37839917|NCT00174941|69524277|FG000|Overall Study|Adverse Event|1|||
37839918|NCT00174941|69524278|FG001|Overall Study|Adverse Event|10|||
37839919|NCT00174941|69524279|FG002|Overall Study|Adverse Event|2|||
37839920|NCT00174941|69524280|FG003|Overall Study|Adverse Event|13|||
37839921|NCT00174941|69524277|FG000|Overall Study|Protocol Violation|0|||
37839922|NCT00174941|69524278|FG001|Overall Study|Protocol Violation|1|||
37839923|NCT00174941|69524279|FG002|Overall Study|Protocol Violation|0|||
37839924|NCT00174941|69524280|FG003|Overall Study|Protocol Violation|1|||
37839925|NCT00174941|69524277|FG000|Overall Study|Lost to Follow-up|0|||
37839926|NCT00174941|69524278|FG001|Overall Study|Lost to Follow-up|3|||
37839927|NCT00174941|69524279|FG002|Overall Study|Lost to Follow-up|2|||
37839928|NCT00174941|69524280|FG003|Overall Study|Lost to Follow-up|5|||
37839929|NCT00174941|69524277|FG000|Overall Study|Personal Reason(s)|0|||
37839930|NCT00174941|69524278|FG001|Overall Study|Personal Reason(s)|14|||
38024954|NCT04411680|69708986|FG001|Follow up Period|Lost to Follow-up|6|||
37839931|NCT00174941|69524279|FG002|Overall Study|Personal Reason(s)|8|||
37839932|NCT00174941|69524280|FG003|Overall Study|Personal Reason(s)|22|||
37839933|NCT00174941|69524277|FG000|Overall Study|Gout Flare|0|||
37839934|NCT00174941|69524278|FG001|Overall Study|Gout Flare|4|||
37839935|NCT00174941|69524279|FG002|Overall Study|Gout Flare|4|||
37839936|NCT00174941|69524280|FG003|Overall Study|Gout Flare|8|||
38024955|NCT04411680|69708985|FG000|Follow up Period|Death|11|||
37839937|NCT00174941|69524277|FG000|Overall Study|Reason Not Specified|1|||
37839938|NCT00174941|69524278|FG001|Overall Study|Reason Not Specified|6|||
37839939|NCT00174941|69524279|FG002|Overall Study|Reason Not Specified|2|||
37839940|NCT00174941|69524280|FG003|Overall Study|Reason Not Specified|9|||
37839941|NCT00171704|69524292|FG000|Overall Study|Adverse Event|24|||
37839942|NCT00171704|69524293|FG001|Overall Study|Adverse Event|33|||
37839943|NCT00171704|69524292|FG000|Overall Study|Disease Progression|14|||
37839944|NCT00171704|69524293|FG001|Overall Study|Disease Progression|9|||
37839945|NCT00171704|69524292|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
37839946|NCT00171704|69524293|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
37839947|NCT00171704|69524292|FG000|Overall Study|Administrative Problems|2|||
37839948|NCT00171704|69524293|FG001|Overall Study|Administrative Problems|1|||
37839949|NCT00171704|69524292|FG000|Overall Study|Death|2|||
37839950|NCT00171704|69524293|FG001|Overall Study|Death|2|||
37839951|NCT00171704|69524292|FG000|Overall Study|Withdrawal by Subject|1|||
37839952|NCT00171704|69524293|FG001|Overall Study|Withdrawal by Subject|3|||
37839953|NCT00171704|69524292|FG000|Overall Study|Protocol Violation|0|||
37839954|NCT00171704|69524293|FG001|Overall Study|Protocol Violation|1|||
37839955|NCT00171314|69524301|FG000|Overall Study|Adverse Event|44|||
37839956|NCT00171314|69524302|FG001|Overall Study|Adverse Event|41|||
37839957|NCT00171314|69524301|FG000|Overall Study|Lack of Efficacy|19|||
37839958|NCT00171314|69524302|FG001|Overall Study|Lack of Efficacy|14|||
37839959|NCT00171314|69524301|FG000|Overall Study|Withdrawal by Subject|9|||
37839960|NCT00171314|69524302|FG001|Overall Study|Withdrawal by Subject|6|||
37839961|NCT00171314|69524301|FG000|Overall Study|Abnormal Test Procedure Results|9|||
37839962|NCT00171314|69524302|FG001|Overall Study|Abnormal Test Procedure Results|3|||
37839963|NCT00171314|69524301|FG000|Overall Study|Protocol Violation|3|||
37839964|NCT00171314|69524302|FG001|Overall Study|Protocol Violation|7|||
37839965|NCT00171314|69524301|FG000|Overall Study|Administrative Problems|4|||
37839966|NCT00171314|69524302|FG001|Overall Study|Administrative Problems|3|||
37839967|NCT00171314|69524301|FG000|Overall Study|Lost to Follow-up|1|||
37839968|NCT00171314|69524302|FG001|Overall Study|Lost to Follow-up|3|||
37719335|NCT02059291|69197503|FG017|Epoch 3|Physician Decision|0|||
37719336|NCT02059291|69197504|FG018|Epoch 3|Physician Decision|0|||
37719337|NCT02059291|69197505|FG019|Epoch 3|Physician Decision|0|||
37719338|NCT02059291|69197506|FG020|Epoch 3|Physician Decision|0|||
37719339|NCT02059291|69197507|FG021|Epoch 3|Physician Decision|0|||
37719340|NCT02059291|69197508|FG022|Epoch 3|Physician Decision|0|||
37719341|NCT02059291|69197509|FG023|Epoch 3|Physician Decision|0|||
37719342|NCT02059291|69197510|FG024|Epoch 3|Physician Decision|0|||
37719343|NCT02059291|69197486|FG000|Epoch 3|Adverse Event|0|||
37719344|NCT02059291|69197487|FG001|Epoch 3|Adverse Event|0|||
37719345|NCT02059291|69197488|FG002|Epoch 3|Adverse Event|0|||
37719346|NCT02059291|69197489|FG003|Epoch 3|Adverse Event|0|||
37719347|NCT02059291|69197490|FG004|Epoch 3|Adverse Event|0|||
37719348|NCT02059291|69197491|FG005|Epoch 3|Adverse Event|0|||
37719349|NCT02059291|69197492|FG006|Epoch 3|Adverse Event|0|||
37719350|NCT02059291|69197493|FG007|Epoch 3|Adverse Event|0|||
37719351|NCT02059291|69197494|FG008|Epoch 3|Adverse Event|0|||
37719352|NCT02059291|69197495|FG009|Epoch 3|Adverse Event|0|||
37719353|NCT02059291|69197496|FG010|Epoch 3|Adverse Event|0|||
37719354|NCT02059291|69197497|FG011|Epoch 3|Adverse Event|0|||
37719355|NCT02059291|69197498|FG012|Epoch 3|Adverse Event|0|||
37719356|NCT02059291|69197499|FG013|Epoch 3|Adverse Event|0|||
37719357|NCT02059291|69197500|FG014|Epoch 3|Adverse Event|0|||
37719358|NCT02059291|69197501|FG015|Epoch 3|Adverse Event|1|||
37719359|NCT02059291|69197502|FG016|Epoch 3|Adverse Event|0|||
37839969|NCT00171314|69524301|FG000|Overall Study|Death|2|||
38024956|NCT04411680|69708986|FG001|Follow up Period|Death|8|||
37839970|NCT00171314|69524302|FG001|Overall Study|Death|1|||
37839971|NCT00171158|69524308|FG000|Core Study|Death|27|||
37719360|NCT02059291|69197503|FG017|Epoch 3|Adverse Event|0|||
37719361|NCT02059291|69197504|FG018|Epoch 3|Adverse Event|0|||
37719362|NCT02059291|69197505|FG019|Epoch 3|Adverse Event|0|||
37719363|NCT02059291|69197506|FG020|Epoch 3|Adverse Event|0|||
37719364|NCT02059291|69197507|FG021|Epoch 3|Adverse Event|0|||
37719365|NCT02059291|69197508|FG022|Epoch 3|Adverse Event|0|||
37719366|NCT02059291|69197509|FG023|Epoch 3|Adverse Event|0|||
37719367|NCT02059291|69197510|FG024|Epoch 3|Adverse Event|0|||
37719368|NCT02059291|69197486|FG000|Epoch 3|Lack of Efficacy|0|||
37719369|NCT02059291|69197487|FG001|Epoch 3|Lack of Efficacy|0|||
37719370|NCT02059291|69197488|FG002|Epoch 3|Lack of Efficacy|0|||
37719371|NCT02059291|69197489|FG003|Epoch 3|Lack of Efficacy|0|||
37719372|NCT02059291|69197490|FG004|Epoch 3|Lack of Efficacy|0|||
37719373|NCT02059291|69197491|FG005|Epoch 3|Lack of Efficacy|0|||
37719374|NCT02059291|69197492|FG006|Epoch 3|Lack of Efficacy|0|||
37719375|NCT02059291|69197493|FG007|Epoch 3|Lack of Efficacy|0|||
37719376|NCT02059291|69197494|FG008|Epoch 3|Lack of Efficacy|0|||
37719377|NCT02059291|69197495|FG009|Epoch 3|Lack of Efficacy|0|||
37719378|NCT02059291|69197496|FG010|Epoch 3|Lack of Efficacy|0|||
37719379|NCT02059291|69197497|FG011|Epoch 3|Lack of Efficacy|0|||
37719380|NCT02059291|69197498|FG012|Epoch 3|Lack of Efficacy|0|||
37719381|NCT02059291|69197499|FG013|Epoch 3|Lack of Efficacy|0|||
37719382|NCT02059291|69197500|FG014|Epoch 3|Lack of Efficacy|0|||
37719383|NCT02059291|69197501|FG015|Epoch 3|Lack of Efficacy|3|||
37719384|NCT02059291|69197502|FG016|Epoch 3|Lack of Efficacy|0|||
37719385|NCT02059291|69197503|FG017|Epoch 3|Lack of Efficacy|0|||
37719386|NCT02059291|69197504|FG018|Epoch 3|Lack of Efficacy|0|||
37719387|NCT02059291|69197505|FG019|Epoch 3|Lack of Efficacy|0|||
37719388|NCT02059291|69197506|FG020|Epoch 3|Lack of Efficacy|0|||
37719389|NCT02059291|69197507|FG021|Epoch 3|Lack of Efficacy|0|||
37719390|NCT02059291|69197508|FG022|Epoch 3|Lack of Efficacy|0|||
37719391|NCT02059291|69197509|FG023|Epoch 3|Lack of Efficacy|0|||
37719392|NCT02059291|69197510|FG024|Epoch 3|Lack of Efficacy|0|||
37719393|NCT02059291|69197486|FG000|Epoch 3|Withdrawal by Subject|0|||
37719394|NCT02059291|69197487|FG001|Epoch 3|Withdrawal by Subject|0|||
37719395|NCT02059291|69197488|FG002|Epoch 3|Withdrawal by Subject|0|||
37719396|NCT02059291|69197489|FG003|Epoch 3|Withdrawal by Subject|0|||
37719397|NCT02059291|69197490|FG004|Epoch 3|Withdrawal by Subject|0|||
37719398|NCT02059291|69197491|FG005|Epoch 3|Withdrawal by Subject|0|||
37719399|NCT02059291|69197492|FG006|Epoch 3|Withdrawal by Subject|0|||
37719400|NCT02059291|69197493|FG007|Epoch 3|Withdrawal by Subject|0|||
37719401|NCT02059291|69197494|FG008|Epoch 3|Withdrawal by Subject|0|||
37719402|NCT02059291|69197495|FG009|Epoch 3|Withdrawal by Subject|0|||
37719403|NCT02059291|69197496|FG010|Epoch 3|Withdrawal by Subject|0|||
37719404|NCT02059291|69197497|FG011|Epoch 3|Withdrawal by Subject|0|||
37719405|NCT02059291|69197498|FG012|Epoch 3|Withdrawal by Subject|0|||
37719406|NCT02059291|69197499|FG013|Epoch 3|Withdrawal by Subject|0|||
37719407|NCT02059291|69197500|FG014|Epoch 3|Withdrawal by Subject|0|||
37719408|NCT02059291|69197501|FG015|Epoch 3|Withdrawal by Subject|1|||
37719409|NCT02059291|69197502|FG016|Epoch 3|Withdrawal by Subject|0|||
37719410|NCT02059291|69197503|FG017|Epoch 3|Withdrawal by Subject|0|||
37719411|NCT02059291|69197504|FG018|Epoch 3|Withdrawal by Subject|0|||
37719412|NCT02059291|69197505|FG019|Epoch 3|Withdrawal by Subject|0|||
37719413|NCT02059291|69197506|FG020|Epoch 3|Withdrawal by Subject|0|||
38024957|NCT04410198|69708992|FG000|Overall Study|Death|10|||
38024958|NCT04410198|69708992|FG000|Overall Study|Withdrawal by Subject|7|||
38024959|NCT04410198|69708992|FG000|Overall Study|Transferred/Relocation|4|||
38024960|NCT04410198|69708992|FG000|Overall Study|Kidney Transplant|9|||
38024961|NCT04410198|69708992|FG000|Overall Study|Adverse Event|4|||
38024962|NCT04410198|69708992|FG000|Overall Study|Physician Decision|2|||
38024963|NCT04410198|69708992|FG000|Overall Study|Other than specified|1|||
38024964|NCT04161144|69708998|FG000|Overall Study|Withdrawal by Subject|0|||
38024965|NCT04161144|69708999|FG001|Overall Study|Withdrawal by Subject|1|||
37719414|NCT02059291|69197507|FG021|Epoch 3|Withdrawal by Subject|0|||
38024966|NCT04161144|69708998|FG000|Overall Study|Protocol Violation|1|||
38024967|NCT04161144|69708999|FG001|Overall Study|Protocol Violation|0|||
37719415|NCT02059291|69197508|FG022|Epoch 3|Withdrawal by Subject|0|||
37719416|NCT02059291|69197509|FG023|Epoch 3|Withdrawal by Subject|0|||
37719417|NCT02059291|69197510|FG024|Epoch 3|Withdrawal by Subject|0|||
37719418|NCT02059291|69197486|FG000|Epoch 4|Adverse Event|0|||
37719419|NCT02059291|69197487|FG001|Epoch 4|Adverse Event|0|||
37719420|NCT02059291|69197488|FG002|Epoch 4|Adverse Event|0|||
38024968|NCT03984812|69709016|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
38024969|NCT03984812|69709017|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
38024970|NCT03984812|69709018|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
37719421|NCT02059291|69197489|FG003|Epoch 4|Adverse Event|0|||
37719422|NCT02059291|69197490|FG004|Epoch 4|Adverse Event|0|||
37719423|NCT02059291|69197491|FG005|Epoch 4|Adverse Event|0|||
37719424|NCT02059291|69197492|FG006|Epoch 4|Adverse Event|0|||
37719425|NCT02059291|69197493|FG007|Epoch 4|Adverse Event|0|||
37719426|NCT02059291|69197494|FG008|Epoch 4|Adverse Event|0|||
37719427|NCT02059291|69197495|FG009|Epoch 4|Adverse Event|0|||
37719428|NCT02059291|69197496|FG010|Epoch 4|Adverse Event|0|||
37719429|NCT02059291|69197497|FG011|Epoch 4|Adverse Event|0|||
38024971|NCT03984812|69709019|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
38024972|NCT03984812|69709020|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
38024973|NCT03984812|69709021|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
38024974|NCT03984812|69709022|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
38024975|NCT03984812|69709023|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
38024976|NCT03984812|69709024|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
38024977|NCT03984812|69709025|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
38024978|NCT03984812|69709026|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
38024979|NCT04160988|69709053|FG000|Overall Study|poor image quality|28|||
37719430|NCT02059291|69197498|FG012|Epoch 4|Adverse Event|0|||
37719431|NCT02059291|69197499|FG013|Epoch 4|Adverse Event|0|||
37719432|NCT02059291|69197500|FG014|Epoch 4|Adverse Event|0|||
37719433|NCT02059291|69197501|FG015|Epoch 4|Adverse Event|0|||
37719434|NCT02059291|69197502|FG016|Epoch 4|Adverse Event|1|||
37719435|NCT02059291|69197503|FG017|Epoch 4|Adverse Event|0|||
37719436|NCT02059291|69197504|FG018|Epoch 4|Adverse Event|0|||
37719437|NCT02059291|69197505|FG019|Epoch 4|Adverse Event|0|||
37719438|NCT02059291|69197506|FG020|Epoch 4|Adverse Event|0|||
37719439|NCT02059291|69197507|FG021|Epoch 4|Adverse Event|0|||
37719440|NCT02059291|69197508|FG022|Epoch 4|Adverse Event|1|||
37719441|NCT02059291|69197509|FG023|Epoch 4|Adverse Event|0|||
37719442|NCT02059291|69197510|FG024|Epoch 4|Adverse Event|0|||
37719443|NCT02059291|69197486|FG000|Epoch 4|Pregnancy|0|||
37719444|NCT02059291|69197487|FG001|Epoch 4|Pregnancy|0|||
37719445|NCT02059291|69197488|FG002|Epoch 4|Pregnancy|0|||
37719446|NCT02059291|69197489|FG003|Epoch 4|Pregnancy|0|||
37719447|NCT02059291|69197490|FG004|Epoch 4|Pregnancy|0|||
37719448|NCT02059291|69197491|FG005|Epoch 4|Pregnancy|0|||
37719449|NCT02059291|69197492|FG006|Epoch 4|Pregnancy|0|||
37719450|NCT02059291|69197493|FG007|Epoch 4|Pregnancy|0|||
37719451|NCT02059291|69197494|FG008|Epoch 4|Pregnancy|0|||
37719452|NCT02059291|69197495|FG009|Epoch 4|Pregnancy|0|||
37719453|NCT02059291|69197496|FG010|Epoch 4|Pregnancy|0|||
37719454|NCT02059291|69197497|FG011|Epoch 4|Pregnancy|0|||
37719455|NCT02059291|69197498|FG012|Epoch 4|Pregnancy|0|||
37719456|NCT02059291|69197499|FG013|Epoch 4|Pregnancy|0|||
37719457|NCT02059291|69197500|FG014|Epoch 4|Pregnancy|0|||
37719458|NCT02059291|69197501|FG015|Epoch 4|Pregnancy|0|||
37719459|NCT02059291|69197502|FG016|Epoch 4|Pregnancy|1|||
37719460|NCT02059291|69197503|FG017|Epoch 4|Pregnancy|0|||
37719461|NCT02059291|69197504|FG018|Epoch 4|Pregnancy|0|||
37719462|NCT02059291|69197505|FG019|Epoch 4|Pregnancy|0|||
37719463|NCT02059291|69197506|FG020|Epoch 4|Pregnancy|0|||
37719464|NCT02059291|69197507|FG021|Epoch 4|Pregnancy|0|||
37719465|NCT02059291|69197508|FG022|Epoch 4|Pregnancy|0|||
37719466|NCT02059291|69197509|FG023|Epoch 4|Pregnancy|0|||
37719467|NCT02059291|69197510|FG024|Epoch 4|Pregnancy|0|||
37839972|NCT00171158|69524308|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
37839973|NCT00171158|69524308|FG000|Core Study|Protocol Violation|4|||
37839974|NCT00171158|69524308|FG000|Core Study|Administrative problems|1|||
37839975|NCT00171158|69524308|FG000|Core Study|Adverse event, non-fatal|21|||
37719468|NCT02059291|69197486|FG000|Epoch 4|Withdrawal by Subject|0|||
37839976|NCT00171158|69524308|FG000|Core Study|Consent withdrawn by subject|6|||
37839977|NCT00171158|69524308|FG000|Core Study|No longer required drug (BMT)|14|||
37839978|NCT00171158|69524308|FG000|Core Study|Abnormal Laboratory Values|2|||
37839979|NCT00171158|69524308|FG000|Core Study|Lost to Follow-up|1|||
37839980|NCT00171158|69524308|FG000|E2 Extension|Other|7|||
37839981|NCT00170846|69524315|FG000|Overall Study|Subject withdrew Informed Consent|5|||
37839982|NCT00170846|69524316|FG001|Overall Study|Subject withdrew Informed Consent|12|||
37839983|NCT00170846|69524317|FG002|Overall Study|Subject withdrew Informed Consent|8|||
37839984|NCT00170846|69524315|FG000|Overall Study|Lost to Follow-up|6|||
37719469|NCT02059291|69197487|FG001|Epoch 4|Withdrawal by Subject|0|||
37719470|NCT02059291|69197488|FG002|Epoch 4|Withdrawal by Subject|0|||
37719471|NCT02059291|69197489|FG003|Epoch 4|Withdrawal by Subject|0|||
37719472|NCT02059291|69197490|FG004|Epoch 4|Withdrawal by Subject|0|||
37719473|NCT02059291|69197491|FG005|Epoch 4|Withdrawal by Subject|0|||
37719474|NCT02059291|69197492|FG006|Epoch 4|Withdrawal by Subject|0|||
37719475|NCT02059291|69197493|FG007|Epoch 4|Withdrawal by Subject|0|||
38024980|NCT04153188|69709074|FG000|Overall Study|Lost to Follow-up|1|||
38024981|NCT04153188|69709075|FG001|Overall Study|Lost to Follow-up|1|||
37719476|NCT02059291|69197494|FG008|Epoch 4|Withdrawal by Subject|0|||
37719477|NCT02059291|69197495|FG009|Epoch 4|Withdrawal by Subject|0|||
37719478|NCT02059291|69197496|FG010|Epoch 4|Withdrawal by Subject|0|||
37719479|NCT02059291|69197497|FG011|Epoch 4|Withdrawal by Subject|0|||
37719480|NCT02059291|69197498|FG012|Epoch 4|Withdrawal by Subject|0|||
37719481|NCT02059291|69197499|FG013|Epoch 4|Withdrawal by Subject|0|||
37719482|NCT02059291|69197500|FG014|Epoch 4|Withdrawal by Subject|0|||
37719483|NCT02059291|69197501|FG015|Epoch 4|Withdrawal by Subject|0|||
37719484|NCT02059291|69197502|FG016|Epoch 4|Withdrawal by Subject|0|||
37719485|NCT02059291|69197503|FG017|Epoch 4|Withdrawal by Subject|0|||
37719486|NCT02059291|69197504|FG018|Epoch 4|Withdrawal by Subject|0|||
37839985|NCT00170846|69524316|FG001|Overall Study|Lost to Follow-up|3|||
37839986|NCT00170846|69524317|FG002|Overall Study|Lost to Follow-up|2|||
37719487|NCT02059291|69197505|FG019|Epoch 4|Withdrawal by Subject|0|||
37719488|NCT02059291|69197506|FG020|Epoch 4|Withdrawal by Subject|1|||
37719489|NCT02059291|69197507|FG021|Epoch 4|Withdrawal by Subject|0|||
37719490|NCT02059291|69197508|FG022|Epoch 4|Withdrawal by Subject|0|||
37719491|NCT02059291|69197509|FG023|Epoch 4|Withdrawal by Subject|0|||
37719492|NCT02059291|69197510|FG024|Epoch 4|Withdrawal by Subject|0|||
37719493|NCT02059291|69197486|FG000|Epoch 4|Lack of Efficacy|0|||
37719494|NCT02059291|69197487|FG001|Epoch 4|Lack of Efficacy|0|||
37719495|NCT02059291|69197488|FG002|Epoch 4|Lack of Efficacy|0|||
37719496|NCT02059291|69197489|FG003|Epoch 4|Lack of Efficacy|0|||
37719497|NCT02059291|69197490|FG004|Epoch 4|Lack of Efficacy|0|||
37719498|NCT02059291|69197491|FG005|Epoch 4|Lack of Efficacy|0|||
37839987|NCT00170846|69524315|FG000|Overall Study|Death|0|||
37839988|NCT00170846|69524316|FG001|Overall Study|Death|3|||
37719499|NCT02059291|69197492|FG006|Epoch 4|Lack of Efficacy|0|||
37719500|NCT02059291|69197493|FG007|Epoch 4|Lack of Efficacy|0|||
37719501|NCT02059291|69197494|FG008|Epoch 4|Lack of Efficacy|0|||
37719502|NCT02059291|69197495|FG009|Epoch 4|Lack of Efficacy|0|||
37719503|NCT02059291|69197496|FG010|Epoch 4|Lack of Efficacy|0|||
37719504|NCT02059291|69197497|FG011|Epoch 4|Lack of Efficacy|0|||
37719505|NCT02059291|69197498|FG012|Epoch 4|Lack of Efficacy|0|||
37719506|NCT02059291|69197499|FG013|Epoch 4|Lack of Efficacy|0|||
37719507|NCT02059291|69197500|FG014|Epoch 4|Lack of Efficacy|0|||
37719508|NCT02059291|69197501|FG015|Epoch 4|Lack of Efficacy|0|||
37719509|NCT02059291|69197502|FG016|Epoch 4|Lack of Efficacy|0|||
37719510|NCT02059291|69197503|FG017|Epoch 4|Lack of Efficacy|0|||
37719511|NCT02059291|69197504|FG018|Epoch 4|Lack of Efficacy|0|||
37719512|NCT02059291|69197505|FG019|Epoch 4|Lack of Efficacy|0|||
37719513|NCT02059291|69197506|FG020|Epoch 4|Lack of Efficacy|0|||
37719514|NCT02059291|69197507|FG021|Epoch 4|Lack of Efficacy|0|||
37719515|NCT02059291|69197508|FG022|Epoch 4|Lack of Efficacy|0|||
37719516|NCT02059291|69197509|FG023|Epoch 4|Lack of Efficacy|1|||
37719517|NCT02059291|69197510|FG024|Epoch 4|Lack of Efficacy|0|||
37719518|NCT02042924|69197538|FG000|Overall Study|Early Death|1|||
37719519|NCT02041520|69197544|FG000|Overall Study|Adverse Event|2|||
37719520|NCT02041520|69197545|FG001|Overall Study|Adverse Event|1|||
37719521|NCT02041520|69197544|FG000|Overall Study|Withdrawal by Subject|3|||
37719522|NCT02041520|69197545|FG001|Overall Study|Withdrawal by Subject|4|||
37719523|NCT02041520|69197544|FG000|Overall Study|Protocol Violation|1|||
37719524|NCT02041520|69197545|FG001|Overall Study|Protocol Violation|0|||
37719525|NCT02041520|69197544|FG000|Overall Study|Lost to Follow-up|0|||
37719526|NCT02041520|69197545|FG001|Overall Study|Lost to Follow-up|1|||
37719527|NCT02041520|69197544|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
37719528|NCT02041520|69197545|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
37719529|NCT02041429|69197557|FG000|Overall Study|Progressive Disease|2|||
37719530|NCT02041429|69197558|FG001|Overall Study|Progressive Disease|2|||
37719531|NCT02041429|69197559|FG002|Overall Study|Progressive Disease|3|||
37719532|NCT02041429|69197560|FG003|Overall Study|Progressive Disease|2|||
37719533|NCT02041429|69197557|FG000|Overall Study|Toxicity|0|||
37719534|NCT02041429|69197558|FG001|Overall Study|Toxicity|1|||
37719535|NCT02041429|69197559|FG002|Overall Study|Toxicity|4|||
37719536|NCT02041429|69197560|FG003|Overall Study|Toxicity|2|||
37719537|NCT02041429|69197557|FG000|Overall Study|Withdrawal by Subject|0|||
37719538|NCT02041429|69197558|FG001|Overall Study|Withdrawal by Subject|1|||
37719539|NCT02041429|69197559|FG002|Overall Study|Withdrawal by Subject|0|||
37719540|NCT02041429|69197560|FG003|Overall Study|Withdrawal by Subject|0|||
37719541|NCT02041429|69197557|FG000|Overall Study|On Maintenance Therapy|1|||
37719542|NCT02041429|69197558|FG001|Overall Study|On Maintenance Therapy|0|||
37719543|NCT02041429|69197559|FG002|Overall Study|On Maintenance Therapy|0|||
37719544|NCT02041429|69197560|FG003|Overall Study|On Maintenance Therapy|2|||
37839989|NCT00170846|69524317|FG002|Overall Study|Death|3|||
37839990|NCT00170846|69524315|FG000|Overall Study|Reason Missing|0|||
37839991|NCT00170846|69524316|FG001|Overall Study|Reason Missing|1|||
37839992|NCT00170846|69524317|FG002|Overall Study|Reason Missing|0|||
37719545|NCT02083783|69197577|FG000|Overall Study|Withdrawal by Subject|1|||
37719546|NCT02083783|69197578|FG001|Overall Study|Withdrawal by Subject|0|||
37719547|NCT02083081|69197588|FG000|Overall Study|Lost to Follow-up|31|||
37719548|NCT02083081|69197589|FG001|Overall Study|Lost to Follow-up|9|||
37719549|NCT02040805|69197597|FG000|Overall Study|Lost to Follow-up|14|||
37719550|NCT02040805|69197598|FG001|Overall Study|Lost to Follow-up|9|||
37719551|NCT02040805|69197597|FG000|Overall Study|Withdrawal by Subject|28|||
37719552|NCT02040805|69197598|FG001|Overall Study|Withdrawal by Subject|41|||
37719553|NCT02040259|69197604|FG000|Overall Study|Death|280|||
37719554|NCT02040259|69197604|FG000|Overall Study|Lost to Follow-up|76|||
37719555|NCT02040259|69197604|FG000|Overall Study|Assessment not completed|3|||
37719556|NCT02040259|69197604|FG000|Overall Study|Withdrawal by Subject|4|||
37719557|NCT02059135|69197612|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
37719558|NCT02059135|69197613|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
37719559|NCT02059135|69197612|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
37839993|NCT00479882|69524329|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
37719560|NCT02059135|69197613|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
37719561|NCT02059135|69197612|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
37719562|NCT02059135|69197613|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
37719563|NCT02059135|69197612|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
37719564|NCT02059135|69197613|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
37719565|NCT02059135|69197612|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
37719566|NCT02059135|69197613|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
37719567|NCT02059135|69197612|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
37719568|NCT02059135|69197613|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
37719569|NCT02059135|69197612|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
37719570|NCT02059135|69197613|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
37719571|NCT02059135|69197612|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
37719572|NCT02059135|69197613|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
37719573|NCT02081677|69197625|FG000|Overall Study|Adverse Event|0|||
37719574|NCT02081677|69197626|FG001|Overall Study|Adverse Event|0|||
37719575|NCT02081677|69197627|FG002|Overall Study|Adverse Event|1|||
37719576|NCT02081677|69197628|FG003|Overall Study|Adverse Event|0|||
37719577|NCT02081677|69197625|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
37719578|NCT02081677|69197626|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
37719579|NCT02081677|69197627|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
37719580|NCT02081677|69197628|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
37719581|NCT02081677|69197625|FG000|Overall Study|Not comfortable with lens care system|1|||
37719582|NCT02081677|69197626|FG001|Overall Study|Not comfortable with lens care system|0|||
37719583|NCT02081677|69197627|FG002|Overall Study|Not comfortable with lens care system|0|||
37719584|NCT02081677|69197628|FG003|Overall Study|Not comfortable with lens care system|0|||
37719585|NCT02081677|69197625|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
37719586|NCT02081677|69197626|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
37839994|NCT00479882|69524330|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
37839995|NCT00479882|69524331|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
37839996|NCT00479882|69524332|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
37839997|NCT00479882|69524329|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
37839998|NCT00479882|69524330|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
37839999|NCT00479882|69524331|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
37719587|NCT02081677|69197627|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
37719588|NCT02081677|69197628|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
37719589|NCT02038933|69197640|FG000|Overall Study|Disease progression|104|||
37719590|NCT02038933|69197640|FG000|Overall Study|Study drug toxicity|6|||
37719591|NCT02038933|69197640|FG000|Overall Study|Adverse event unrelated to study drug|6|||
37719592|NCT02038933|69197640|FG000|Overall Study|Participant request to discontinue treatment|2|||
37719593|NCT02038933|69197640|FG000|Overall Study|Lost to Follow-up|1|||
37719594|NCT02038933|69197640|FG000|Overall Study|Other reasons|2|||
37719595|NCT02081599|69197647|FG000|Period 1：Double-blind Period|Adverse Event|3|||
37719596|NCT02081599|69197648|FG001|Period 1：Double-blind Period|Adverse Event|0|||
37719597|NCT02081599|69197647|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
37719598|NCT02081599|69197648|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
37719599|NCT02081599|69197647|FG000|Period 1：Double-blind Period|Physician Decision|1|||
37719600|NCT02081599|69197648|FG001|Period 1：Double-blind Period|Physician Decision|0|||
37719601|NCT02081599|69197647|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
37719602|NCT02081599|69197648|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
37719603|NCT02081599|69197647|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
37719604|NCT02081599|69197648|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
37719605|NCT02081599|69197647|FG000|Period 1：Double-blind Period|stopping criteria|1|||
37719606|NCT02081599|69197648|FG001|Period 1：Double-blind Period|stopping criteria|0|||
37719607|NCT02081599|69197647|FG000|Period 2：Open-label Period|Adverse Event|1|||
37719608|NCT02081599|69197648|FG001|Period 2：Open-label Period|Adverse Event|0|||
37719609|NCT02081599|69197647|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
37719610|NCT02081599|69197648|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
37719611|NCT02081599|69197647|FG000|Period 2：Open-label Period|Physician Decision|1|||
37719612|NCT02081599|69197648|FG001|Period 2：Open-label Period|Physician Decision|0|||
37719613|NCT02081599|69197647|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
37719614|NCT02081599|69197648|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
37719615|NCT02038543|69197660|FG000|Overall Study|Screen Failure|0|||
37719616|NCT02038543|69197661|FG001|Overall Study|Screen Failure|0|||
37840000|NCT00479882|69524332|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
37840001|NCT00479882|69524329|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
37840002|NCT00479882|69524330|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
37719617|NCT02038543|69197662|FG002|Overall Study|Screen Failure|0|||
37840003|NCT00479882|69524331|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
37719618|NCT02038543|69197663|FG003|Overall Study|Screen Failure|1|||
37719619|NCT02038543|69197660|FG000|Overall Study|Withdrawal by Subject|0|||
37719620|NCT02038543|69197661|FG001|Overall Study|Withdrawal by Subject|0|||
37719621|NCT02038543|69197662|FG002|Overall Study|Withdrawal by Subject|0|||
37719622|NCT02038543|69197663|FG003|Overall Study|Withdrawal by Subject|1|||
37719623|NCT02038153|69197673|FG000|Overall Study|Withdrawal by Subject|1|||
37719624|NCT02038075|69197679|FG000|Overall Study|Withdrawal by Subject|3|||
37719625|NCT02038075|69197680|FG001|Overall Study|Withdrawal by Subject|0|||
37719626|NCT02058589|69197688|FG000|Overall Study|Serious Adverse Event|1|||
37719627|NCT02058589|69197689|FG001|Overall Study|Serious Adverse Event|1|||
37719628|NCT02058589|69197688|FG000|Overall Study|Non-Serious Adverse Event|1|||
37719629|NCT02058589|69197689|FG001|Overall Study|Non-Serious Adverse Event|0|||
37719630|NCT02058589|69197688|FG000|Overall Study|Withdrawal by Subject|0|||
37719631|NCT02058589|69197689|FG001|Overall Study|Withdrawal by Subject|1|||
37719632|NCT02079805|69197699|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
37719633|NCT02079805|69197700|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
37719634|NCT02079805|69197699|FG000|Overall Study|Voluntary Withdrawal|0|||
37719635|NCT02079805|69197700|FG001|Overall Study|Voluntary Withdrawal|1|||
37719636|NCT02037295|69197710|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
37719637|NCT02037295|69197711|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
37719638|NCT02037295|69197712|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
37719639|NCT02037295|69197713|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
37719640|NCT02079649|69197729|FG000|Overall Study|Lost to Follow-up|0|||
37719641|NCT02079649|69197730|FG001|Overall Study|Lost to Follow-up|0|||
37719642|NCT02079649|69197731|FG002|Overall Study|Lost to Follow-up|0|||
37719643|NCT02079649|69197732|FG003|Overall Study|Lost to Follow-up|1|||
37719644|NCT02079649|69197729|FG000|Overall Study|Withdrawal by Subject|0|||
37719645|NCT02079649|69197730|FG001|Overall Study|Withdrawal by Subject|0|||
37719646|NCT02079649|69197731|FG002|Overall Study|Withdrawal by Subject|0|||
37719647|NCT02079649|69197732|FG003|Overall Study|Withdrawal by Subject|1|||
37719648|NCT02079649|69197729|FG000|Overall Study|Randomization error (prior to treatment)|1|||
37719649|NCT02079649|69197730|FG001|Overall Study|Randomization error (prior to treatment)|0|||
37719650|NCT02079649|69197731|FG002|Overall Study|Randomization error (prior to treatment)|1|||
37719651|NCT02079649|69197732|FG003|Overall Study|Randomization error (prior to treatment)|0|||
37719652|NCT02036515|69197746|FG000|Overall Study|Adverse Event|1|||
37719653|NCT02036515|69197747|FG001|Overall Study|Adverse Event|1|||
37719654|NCT02036515|69197748|FG002|Overall Study|Adverse Event|2|||
37719655|NCT02036515|69197746|FG000|Overall Study|Lost to Follow-up|0|||
37719656|NCT02036515|69197747|FG001|Overall Study|Lost to Follow-up|2|||
37719657|NCT02036515|69197748|FG002|Overall Study|Lost to Follow-up|0|||
37719658|NCT02036515|69197746|FG000|Overall Study|Non-compliance with study drug|0|||
37719659|NCT02036515|69197747|FG001|Overall Study|Non-compliance with study drug|0|||
37719660|NCT02036515|69197748|FG002|Overall Study|Non-compliance with study drug|2|||
37719661|NCT02036515|69197746|FG000|Overall Study|Screen failure|0|||
37719662|NCT02036515|69197747|FG001|Overall Study|Screen failure|2|||
37719663|NCT02036515|69197748|FG002|Overall Study|Screen failure|0|||
37719664|NCT02036515|69197746|FG000|Overall Study|Withdrawal by Subject|4|||
37719665|NCT02036515|69197747|FG001|Overall Study|Withdrawal by Subject|7|||
37719666|NCT02036515|69197748|FG002|Overall Study|Withdrawal by Subject|9|||
37719667|NCT02036515|69197746|FG000|Overall Study|Hyperglycemia|0|||
37719668|NCT02036515|69197747|FG001|Overall Study|Hyperglycemia|0|||
37719669|NCT02036515|69197748|FG002|Overall Study|Hyperglycemia|1|||
37719670|NCT02078713|69197760|FG000|Overall Study|Lost to Follow-up|49|||
37719671|NCT02078713|69197761|FG001|Overall Study|Lost to Follow-up|55|||
37719672|NCT02078713|69197762|FG002|Overall Study|Lost to Follow-up|0|||
37719673|NCT02078713|69197763|FG003|Overall Study|Lost to Follow-up|0|||
37719674|NCT02078713|69197760|FG000|Overall Study|Pregnant at baseline|3|||
37719675|NCT02078713|69197761|FG001|Overall Study|Pregnant at baseline|5|||
37719676|NCT02078713|69197762|FG002|Overall Study|Pregnant at baseline|0|||
37719677|NCT02078713|69197763|FG003|Overall Study|Pregnant at baseline|0|||
37719678|NCT02078713|69197760|FG000|Overall Study|Enrolled twice|0|||
37719679|NCT02078713|69197761|FG001|Overall Study|Enrolled twice|1|||
37719680|NCT02078713|69197762|FG002|Overall Study|Enrolled twice|0|||
37719681|NCT02078713|69197763|FG003|Overall Study|Enrolled twice|0|||
37719682|NCT02035267|69197779|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
37719683|NCT02035267|69197780|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
37719684|NCT02035267|69197781|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
37719685|NCT02035267|69197782|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
37719686|NCT02035267|69197779|FG000|Overall Study|Adverse Event|0|||
37719687|NCT02035267|69197780|FG001|Overall Study|Adverse Event|0|||
37719688|NCT02035267|69197781|FG002|Overall Study|Adverse Event|1|||
37719689|NCT02035267|69197782|FG003|Overall Study|Adverse Event|0|||
38024982|NCT04153188|69709074|FG000|Overall Study|Withdrawal by Subject|2|||
37719690|NCT02035267|69197779|FG000|Overall Study|Lost to Follow-up|0|||
37719691|NCT02035267|69197780|FG001|Overall Study|Lost to Follow-up|0|||
37719692|NCT02035267|69197781|FG002|Overall Study|Lost to Follow-up|0|||
37719693|NCT02035267|69197782|FG003|Overall Study|Lost to Follow-up|1|||
37719694|NCT02035267|69197779|FG000|Overall Study|Other unspecified|0|||
37719695|NCT02035267|69197780|FG001|Overall Study|Other unspecified|1|||
37719696|NCT02035267|69197781|FG002|Overall Study|Other unspecified|0|||
37719697|NCT02035267|69197782|FG003|Overall Study|Other unspecified|0|||
37719698|NCT04373460|69197816|FG000|Overall Study|Did not receive tranfusion|18|||
37719699|NCT04373460|69197817|FG001|Overall Study|Did not receive tranfusion|26|||
37719700|NCT04280081|69197827|FG000|Overall Study|Adverse Event|4|||
37719701|NCT04280081|69197827|FG000|Overall Study|Death|2|||
37719702|NCT04280081|69197827|FG000|Overall Study|Progressive Disease|6|||
37719703|NCT04159805|69197843|FG000|Overall Study|Withdrawal by Subject|0|||
37719704|NCT04159805|69197844|FG001|Overall Study|Withdrawal by Subject|2|||
37719705|NCT04159805|69197845|FG002|Overall Study|Withdrawal by Subject|2|||
37719706|NCT03901456|69197856|FG000|Overall Study|Withdrawal by Subject|0|||
37719707|NCT03901456|69197857|FG001|Overall Study|Withdrawal by Subject|0|||
37719708|NCT03901456|69197858|FG002|Overall Study|Withdrawal by Subject|1|||
37719709|NCT03901456|69197856|FG000|Overall Study|Lost to Follow-up|0|||
37719710|NCT03901456|69197857|FG001|Overall Study|Lost to Follow-up|1|||
37719711|NCT03901456|69197858|FG002|Overall Study|Lost to Follow-up|0|||
37719712|NCT03226249|69197909|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
37719713|NCT03226249|69197909|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
37719714|NCT03226249|69197909|FG000|Survival Follow-up|Patients still in follow-up.|30|||
37719715|NCT02849548|69197915|FG000|Overall Study|Lost to Follow-up|1|||
37719716|NCT02849548|69197916|FG001|Overall Study|Lost to Follow-up|2|||
37719717|NCT02849548|69197915|FG000|Overall Study|Protocol Violation|1|||
37840004|NCT00479882|69524332|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
37840005|NCT00479882|69524329|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
37840006|NCT00479882|69524330|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
37840007|NCT00479882|69524331|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
37840008|NCT00479882|69524332|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
37840009|NCT00479882|69524329|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
37840010|NCT00479882|69524330|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
37840011|NCT00479882|69524331|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
37840012|NCT00479882|69524332|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
37915533|NCT00520741|69602295|FG001|Overall Study|Withdrawal by Subject|11|||
37915534|NCT00520741|69602294|FG000|Overall Study|Protocol Violation|2|||
37915535|NCT00520741|69602295|FG001|Overall Study|Protocol Violation|15|||
37719718|NCT02849548|69197916|FG001|Overall Study|Protocol Violation|0|||
37719719|NCT02411448|69197934|FG000|Overall Study|Withdrawal by Subject|1|||
37719720|NCT02411448|69197935|FG001|Overall Study|Withdrawal by Subject|14|||
37719721|NCT02411448|69197936|FG002|Overall Study|Withdrawal by Subject|9|||
37719722|NCT02411448|69197934|FG000|Overall Study|Other|0|||
37719723|NCT02411448|69197935|FG001|Overall Study|Other|2|||
37719724|NCT02411448|69197936|FG002|Overall Study|Other|0|||
37719725|NCT02411448|69197934|FG000|Overall Study|Did not receive study treatment|0|||
37719726|NCT02411448|69197935|FG001|Overall Study|Did not receive study treatment|3|||
37719727|NCT02411448|69197936|FG002|Overall Study|Did not receive study treatment|0|||
37719728|NCT02411448|69197934|FG000|Overall Study|Alive on study treatment|3|||
37719729|NCT02411448|69197935|FG001|Overall Study|Alive on study treatment|64|||
37719730|NCT02411448|69197936|FG002|Overall Study|Alive on study treatment|43|||
37719731|NCT02321514|69197948|FG000|Overall Study|Death|15|||
37719732|NCT02321514|69197948|FG000|Overall Study|Missed Visit|7|||
37719733|NCT02321514|69197948|FG000|Overall Study|Study Exit|3|||
37719734|NCT02266134|69197956|FG000|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|6|||
37719735|NCT02266134|69197957|FG001|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|3|||
37719736|NCT02266134|69197958|FG002|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
37719737|NCT02266134|69197959|FG003|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
37719738|NCT02266134|69197956|FG000|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|8|||
37719739|NCT02266134|69197957|FG001|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|2|||
37719740|NCT02266134|69197958|FG002|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
37840013|NCT00479882|69524329|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
37915536|NCT00520741|69602294|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
37915537|NCT00520741|69602295|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
37915538|NCT00520741|69602294|FG000|Overall Study|Lost to Follow-up|4|||
37719741|NCT02266134|69197959|FG003|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
37719742|NCT02266134|69197956|FG000|Clinics #7-10: Beginning May 2016|Lost to Follow-up|10|||
37719743|NCT02266134|69197957|FG001|Clinics #7-10: Beginning May 2016|Lost to Follow-up|5|||
37719744|NCT02266134|69197958|FG002|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
37719745|NCT02266134|69197959|FG003|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
37719746|NCT02266134|69197956|FG000|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|3|||
37719747|NCT02266134|69197957|FG001|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
37719748|NCT02266134|69197958|FG002|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
37719749|NCT02266134|69197959|FG003|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
37719750|NCT02266134|69197956|FG000|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|6|||
37719751|NCT02266134|69197957|FG001|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|2|||
37719752|NCT02266134|69197958|FG002|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
37719753|NCT02266134|69197959|FG003|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
37719754|NCT02266134|69197956|FG000|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|3|||
37719755|NCT02266134|69197957|FG001|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
37719756|NCT02266134|69197958|FG002|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
37719757|NCT02266134|69197959|FG003|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
37719758|NCT01847274|69197987|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
37719759|NCT01847274|69197988|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
37719760|NCT01847274|69197989|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
37719761|NCT01847274|69197990|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
37719762|NCT01847274|69197991|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
37719763|NCT01847274|69197992|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
37719764|NCT01847274|69197993|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
37719765|NCT01847274|69197994|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
37719766|NCT01847274|69197995|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
37719767|NCT01847274|69197996|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
37719768|NCT01847274|69197997|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
37719769|NCT01847274|69197987|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
37719770|NCT01847274|69197988|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
37719771|NCT01847274|69197989|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
37719772|NCT01847274|69197990|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
37719773|NCT01847274|69197991|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
37719774|NCT01847274|69197992|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
37719775|NCT01847274|69197993|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
37719776|NCT01847274|69197994|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
37719777|NCT01847274|69197995|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
37719778|NCT01847274|69197996|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
37719779|NCT01847274|69197997|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
37719780|NCT01847274|69197987|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
37719781|NCT01847274|69197988|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
37719782|NCT01847274|69197989|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
37719783|NCT01847274|69197990|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
37719784|NCT01847274|69197991|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
37719785|NCT01847274|69197992|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
37719786|NCT01847274|69197993|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
37719787|NCT01847274|69197994|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
37719788|NCT01847274|69197995|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
37719789|NCT01847274|69197996|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
37719790|NCT01847274|69197997|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
37719791|NCT01847274|69197987|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
37719792|NCT01847274|69197988|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
37719793|NCT01847274|69197989|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
37719794|NCT01847274|69197990|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
37719795|NCT01847274|69197991|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
37719796|NCT01847274|69197992|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
37719797|NCT01847274|69197993|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
37719798|NCT01847274|69197994|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
37719799|NCT01847274|69197995|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
37719800|NCT01847274|69197996|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
37719801|NCT01847274|69197997|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
37719802|NCT01847274|69197987|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
37719803|NCT01847274|69197988|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
37719804|NCT01847274|69197989|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
37719805|NCT01847274|69197990|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
37719806|NCT01847274|69197991|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
37719807|NCT01847274|69197992|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
37719808|NCT01847274|69197993|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
37719809|NCT01847274|69197994|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
37915539|NCT00520741|69602295|FG001|Overall Study|Lost to Follow-up|4|||
37719810|NCT01847274|69197995|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
37719811|NCT01847274|69197996|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
37719812|NCT01847274|69197997|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
37719813|NCT01847274|69197987|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
37719814|NCT01847274|69197988|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
37719815|NCT01847274|69197989|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
37840014|NCT00479882|69524330|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
38024983|NCT04153188|69709075|FG001|Overall Study|Withdrawal by Subject|0|||
38024984|NCT04153188|69709074|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
38024985|NCT04153188|69709075|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
38024986|NCT04113746|69709083|FG000|Overall Study|Lost to Follow-up|4|||
38024987|NCT04113746|69709084|FG001|Overall Study|Lost to Follow-up|4|||
38024988|NCT03611010|69709094|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
38024989|NCT03611010|69709095|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
38024990|NCT03611010|69709096|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
38024991|NCT03611010|69709097|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
38024992|NCT04357782|69709112|FG000|Overall Study|Discharged from hospital|1|||
38024993|NCT04357782|69709113|FG001|Overall Study|Discharged from hospital|0|||
38024994|NCT04357782|69709112|FG000|Overall Study|Death|0|||
38024995|NCT04357782|69709113|FG001|Overall Study|Death|2|||
38024996|NCT03980522|69709124|FG000|Treatment Period|Adverse Event|1|||
38024997|NCT03980522|69709125|FG001|Treatment Period|Adverse Event|0|||
38024998|NCT03980522|69709126|FG002|Treatment Period|Adverse Event|0|||
38024999|NCT03980522|69709127|FG003|Treatment Period|Adverse Event|0|||
38025000|NCT03980522|69709128|FG004|Treatment Period|Adverse Event|0|||
38025001|NCT04402866|69709146|FG000|Overall Study|Discontinued Prior to Treatment|0|||
38025002|NCT04402866|69709147|FG001|Overall Study|Discontinued Prior to Treatment|0|||
38025003|NCT04402866|69709148|FG002|Overall Study|Discontinued Prior to Treatment|0|||
38025004|NCT04402866|69709149|FG003|Overall Study|Discontinued Prior to Treatment|0|||
38025005|NCT04402866|69709150|FG004|Overall Study|Discontinued Prior to Treatment|2|||
38025006|NCT04402866|69709151|FG005|Overall Study|Discontinued Prior to Treatment|3|||
38025007|NCT04402866|69709146|FG000|Overall Study|Adverse Event|2|||
38025008|NCT04402866|69709147|FG001|Overall Study|Adverse Event|1|||
38025009|NCT04402866|69709148|FG002|Overall Study|Adverse Event|0|||
38025010|NCT04402866|69709149|FG003|Overall Study|Adverse Event|0|||
38025011|NCT04402866|69709150|FG004|Overall Study|Adverse Event|13|||
38025012|NCT04402866|69709151|FG005|Overall Study|Adverse Event|8|||
38025013|NCT04402866|69709146|FG000|Overall Study|Miscellaneous|0|||
38025014|NCT04402866|69709147|FG001|Overall Study|Miscellaneous|0|||
38025015|NCT04402866|69709148|FG002|Overall Study|Miscellaneous|1|||
38025016|NCT04402866|69709149|FG003|Overall Study|Miscellaneous|0|||
38025017|NCT04402866|69709150|FG004|Overall Study|Miscellaneous|0|||
38025018|NCT04402866|69709151|FG005|Overall Study|Miscellaneous|0|||
38025019|NCT04402866|69709146|FG000|Overall Study|Lost to Follow-up|0|||
38025020|NCT04402866|69709147|FG001|Overall Study|Lost to Follow-up|0|||
38025021|NCT04402866|69709148|FG002|Overall Study|Lost to Follow-up|0|||
38025022|NCT04402866|69709149|FG003|Overall Study|Lost to Follow-up|0|||
38025023|NCT04402866|69709150|FG004|Overall Study|Lost to Follow-up|0|||
38025024|NCT04402866|69709151|FG005|Overall Study|Lost to Follow-up|1|||
37719816|NCT01847274|69197990|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
38025025|NCT04402866|69709146|FG000|Overall Study|Withdrawal by Subject|0|||
38025026|NCT04402866|69709147|FG001|Overall Study|Withdrawal by Subject|0|||
38025027|NCT04402866|69709148|FG002|Overall Study|Withdrawal by Subject|0|||
38025028|NCT04402866|69709149|FG003|Overall Study|Withdrawal by Subject|0|||
38025029|NCT04402866|69709150|FG004|Overall Study|Withdrawal by Subject|0|||
38025030|NCT04402866|69709151|FG005|Overall Study|Withdrawal by Subject|2|||
38025031|NCT04400682|69709163|FG000|Period 1|Withdrawal by Subject|1|||
38025032|NCT04400682|69709164|FG001|Period 1|Withdrawal by Subject|4|||
38025033|NCT03066778|69709172|FG000|Overall Study|Death|195|||
38025034|NCT03066778|69709173|FG001|Overall Study|Death|205|||
38025035|NCT03066778|69709172|FG000|Overall Study|Withdrawal by Subject|5|||
37719817|NCT01847274|69197991|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
37719818|NCT01847274|69197992|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
37719819|NCT01847274|69197993|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
38025036|NCT03066778|69709173|FG001|Overall Study|Withdrawal by Subject|7|||
38025037|NCT04348656|69709182|FG000|Overall Study|Withdrawal by Subject|2|||
38025038|NCT04348656|69709183|FG001|Overall Study|Withdrawal by Subject|0|||
38025039|NCT04348656|69709182|FG000|Overall Study|Lost to Follow-up|11|||
38025040|NCT04348656|69709183|FG001|Overall Study|Lost to Follow-up|6|||
38025041|NCT04348500|69709198|FG000|Overall Study|Death|2|||
38025042|NCT04348500|69709199|FG001|Overall Study|Death|2|||
38025043|NCT04348500|69709198|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
38025044|NCT04348500|69709199|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
38025045|NCT04347954|69709208|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
37719820|NCT01847274|69197994|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
37840015|NCT00479882|69524331|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
37840016|NCT00479882|69524332|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
37840017|NCT00479882|69524329|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
37840018|NCT00479882|69524330|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
37840019|NCT00479882|69524331|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
37840020|NCT00479882|69524332|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
37840021|NCT00479882|69524329|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
37840022|NCT00479882|69524330|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
37840023|NCT00479882|69524331|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
37840024|NCT00479882|69524332|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
37840025|NCT00479882|69524329|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
37840026|NCT00479882|69524330|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
38025046|NCT04347954|69709209|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
38025047|NCT04347954|69709210|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
37719821|NCT01847274|69197995|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
37719822|NCT01847274|69197996|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
37719823|NCT01847274|69197997|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
37719824|NCT01847274|69197987|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
37719825|NCT01847274|69197988|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
37719826|NCT01847274|69197989|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
37719827|NCT01847274|69197990|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
37719828|NCT01847274|69197991|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
37719829|NCT01847274|69197992|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
37719830|NCT01847274|69197993|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
37719831|NCT01847274|69197994|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
37719832|NCT01847274|69197995|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
37719833|NCT01847274|69197996|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
37719834|NCT01847274|69197997|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
37719835|NCT01847274|69197987|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
37719836|NCT01847274|69197988|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
37719837|NCT01847274|69197989|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
37719838|NCT01847274|69197990|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
37719839|NCT01847274|69197991|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
37719840|NCT01847274|69197992|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
37719841|NCT01847274|69197993|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
37719842|NCT01847274|69197994|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
37719843|NCT01847274|69197995|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
37719844|NCT01847274|69197996|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
37719845|NCT01847274|69197997|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
37719846|NCT01847274|69197987|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
37719847|NCT01847274|69197988|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
37719848|NCT01847274|69197989|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
37719849|NCT01847274|69197990|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
37719850|NCT01847274|69197991|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
37719851|NCT01847274|69197992|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
37719852|NCT01847274|69197993|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
37719853|NCT01847274|69197994|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
37719854|NCT01847274|69197995|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
37719855|NCT01847274|69197996|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
37719856|NCT01847274|69197997|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
37719857|NCT01847274|69197987|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
37719858|NCT01847274|69197988|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
37719859|NCT01847274|69197989|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
37719860|NCT01847274|69197990|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
37719861|NCT01847274|69197991|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
37719862|NCT01847274|69197992|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
37719863|NCT01847274|69197993|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
37719864|NCT01847274|69197994|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
37719865|NCT01847274|69197995|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
38025048|NCT04347954|69709208|FG000|Overall Study|Lost to Follow-up|0|||
37719866|NCT01847274|69197996|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
37719867|NCT01847274|69197997|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
37719868|NCT01847274|69197987|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
37719869|NCT01847274|69197988|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
37719870|NCT01847274|69197989|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
37719871|NCT01847274|69197990|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
37719872|NCT01847274|69197991|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
37719873|NCT01847274|69197992|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
37719874|NCT01847274|69197993|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
37719875|NCT01847274|69197994|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
37719876|NCT01847274|69197995|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
37719877|NCT01847274|69197996|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
37719878|NCT01847274|69197997|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
37719879|NCT01847274|69197987|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
37719880|NCT01847274|69197988|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
37719881|NCT01847274|69197989|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
37719882|NCT01847274|69197990|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
37719883|NCT01847274|69197991|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
37719884|NCT01847274|69197992|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
37719885|NCT01847274|69197993|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
37719886|NCT01847274|69197994|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
37719887|NCT01847274|69197995|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
37719888|NCT01847274|69197996|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
37719889|NCT01847274|69197997|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
37719890|NCT01847274|69197987|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
37719891|NCT01847274|69197988|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
37719892|NCT01847274|69197989|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
37719893|NCT01847274|69197990|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
37719894|NCT01847274|69197991|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
37719895|NCT01847274|69197992|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
37719896|NCT01847274|69197993|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
37719897|NCT01847274|69197994|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
37719898|NCT01847274|69197995|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
37719899|NCT01847274|69197996|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
37719900|NCT01847274|69197997|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
37719901|NCT01847274|69197987|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
37719902|NCT01847274|69197988|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
37719903|NCT01847274|69197989|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
37719904|NCT01847274|69197990|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
37719905|NCT01847274|69197991|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
37719906|NCT01847274|69197992|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
37719907|NCT01847274|69197993|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
37719908|NCT01847274|69197994|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
37719909|NCT01847274|69197995|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
37719910|NCT01847274|69197996|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
37719911|NCT01847274|69197997|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
37719912|NCT01847274|69197987|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
37719913|NCT01847274|69197988|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
37719914|NCT01847274|69197989|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
37719915|NCT01847274|69197990|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
37719916|NCT01847274|69197991|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
37719917|NCT01847274|69197992|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
37719918|NCT01847274|69197993|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
37719919|NCT01847274|69197994|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
37719920|NCT01847274|69197995|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
37719921|NCT01847274|69197996|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
37719922|NCT01847274|69197997|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
37719923|NCT01847274|69197987|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
37719924|NCT01847274|69197988|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
37719925|NCT01847274|69197989|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
37719926|NCT01847274|69197990|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
37719927|NCT01847274|69197991|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
37719928|NCT01847274|69197992|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
37719929|NCT01847274|69197993|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
37719930|NCT01847274|69197994|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
37719931|NCT01847274|69197995|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
37719932|NCT01847274|69197996|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
37719933|NCT01847274|69197997|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
37719934|NCT01560819|69198036|FG000|Overall Study|Physician Decision|1|||
37719935|NCT01560819|69198037|FG001|Overall Study|Physician Decision|0|||
37719936|NCT01425528|69198043|FG000|Overall Study|Withdrawal by Subject|1|||
37719937|NCT01425528|69198044|FG001|Overall Study|Withdrawal by Subject|1|||
37719938|NCT00442104|69198050|FG000|Overall Study|Adverse Event|5|||
37719939|NCT00442104|69198050|FG000|Overall Study|Death|2|||
37719940|NCT00442104|69198050|FG000|Overall Study|Lost to Follow-up|3|||
37719941|NCT00442104|69198050|FG000|Overall Study|Withdrawal by Subject|5|||
37719942|NCT00442104|69198050|FG000|Overall Study|Insufficient Clinical Response|10|||
37719943|NCT00442104|69198050|FG000|Overall Study|Other|21|||
37719944|NCT00442104|69198050|FG000|Overall Study|Discretion of the Investigator/Sponsor|1|||
37719945|NCT00441896|69198064|FG000|Overall Study|Withdrawal by Subject|0|||
37719946|NCT00441896|69198065|FG001|Overall Study|Withdrawal by Subject|0|||
37719947|NCT00441896|69198066|FG002|Overall Study|Withdrawal by Subject|0|||
37719948|NCT00441896|69198067|FG003|Overall Study|Withdrawal by Subject|1|||
37719949|NCT00441896|69198068|FG004|Overall Study|Withdrawal by Subject|0|||
37719950|NCT00441896|69198069|FG005|Overall Study|Withdrawal by Subject|0|||
37840027|NCT00479882|69524331|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
37840028|NCT00479882|69524332|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
37840029|NCT00479882|69524329|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
38025049|NCT04347954|69709209|FG001|Overall Study|Lost to Follow-up|1|||
38025050|NCT04347954|69709210|FG002|Overall Study|Lost to Follow-up|0|||
38025051|NCT03065530|69709222|FG000|Overall Study|Lack of Efficacy|1|||
38025052|NCT03065530|69709223|FG001|Overall Study|Lack of Efficacy|1|||
38025053|NCT03065530|69709224|FG002|Overall Study|Lack of Efficacy|0|||
38025054|NCT03065530|69709225|FG003|Overall Study|Lack of Efficacy|1|||
38025055|NCT03065530|69709222|FG000|Overall Study|Protocol Violation|1|||
38025056|NCT03065530|69709223|FG001|Overall Study|Protocol Violation|0|||
38025057|NCT03065530|69709224|FG002|Overall Study|Protocol Violation|1|||
38025058|NCT03065530|69709225|FG003|Overall Study|Protocol Violation|1|||
37840030|NCT00479882|69524330|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
37840031|NCT00479882|69524331|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
37840032|NCT00479882|69524332|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
37840033|NCT00479882|69524329|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
37840034|NCT00479882|69524330|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
37840035|NCT00479882|69524331|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
37840036|NCT00479882|69524332|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
37840037|NCT00479882|69524329|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
37840038|NCT00479882|69524330|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
37840039|NCT00479882|69524331|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
37840040|NCT00479882|69524332|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
37840041|NCT00479882|69524329|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
37840042|NCT00479882|69524330|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
37840043|NCT00479882|69524331|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
37840044|NCT00479882|69524332|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
37840045|NCT00479882|69524329|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
37840046|NCT00479882|69524330|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
37840047|NCT00479882|69524331|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
37840048|NCT00479882|69524332|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
37840049|NCT00479765|69524358|FG000|Overall Study|study terminated|4|||
37840050|NCT00479687|69524364|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
37840051|NCT00479687|69524365|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
37840052|NCT00479687|69524366|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
38025059|NCT03979820|69709247|FG000|Overall Study|Protocol Violation|1|||
38025060|NCT03979820|69709248|FG001|Overall Study|Protocol Violation|0|||
38025061|NCT03979820|69709249|FG002|Overall Study|Protocol Violation|0|||
38025062|NCT03979820|69709250|FG003|Overall Study|Protocol Violation|0|||
38025063|NCT03979820|69709247|FG000|Overall Study|Withdrawal by Subject|0|||
38025064|NCT03979820|69709248|FG001|Overall Study|Withdrawal by Subject|0|||
38025065|NCT03979820|69709249|FG002|Overall Study|Withdrawal by Subject|1|||
38025066|NCT03979820|69709250|FG003|Overall Study|Withdrawal by Subject|0|||
38025067|NCT03979820|69709247|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
38025068|NCT03979820|69709248|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
38025069|NCT03979820|69709249|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
38043533|NCT03509467|69731653|FG001|Overall Study|Proxy Withdrawal|0|||
38025070|NCT03979820|69709250|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
37719951|NCT00441896|69198070|FG006|Overall Study|Withdrawal by Subject|0|||
37719952|NCT00441896|69198071|FG007|Overall Study|Withdrawal by Subject|0|||
37719953|NCT00441896|69198072|FG008|Overall Study|Withdrawal by Subject|0|||
37719954|NCT00441896|69198073|FG009|Overall Study|Withdrawal by Subject|0|||
37719955|NCT00441896|69198064|FG000|Overall Study|Other|0|||
37719956|NCT00441896|69198065|FG001|Overall Study|Other|0|||
37719957|NCT00441896|69198066|FG002|Overall Study|Other|0|||
37719958|NCT00441896|69198067|FG003|Overall Study|Other|0|||
37719959|NCT00441896|69198068|FG004|Overall Study|Other|1|||
37719960|NCT00441896|69198069|FG005|Overall Study|Other|0|||
37719961|NCT00441896|69198070|FG006|Overall Study|Other|0|||
37719962|NCT00441896|69198071|FG007|Overall Study|Other|0|||
37840053|NCT00479687|69524364|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
37840054|NCT00479687|69524365|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
37840055|NCT00479687|69524366|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
37840056|NCT00479687|69524364|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
37840057|NCT00479687|69524365|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
37719963|NCT00441896|69198072|FG008|Overall Study|Other|0|||
37719964|NCT00441896|69198073|FG009|Overall Study|Other|0|||
37719965|NCT02034877|69198101|FG000|Overall Study|Lost to Follow-up|0|||
37719966|NCT02034877|69198102|FG001|Overall Study|Lost to Follow-up|3|||
37719967|NCT02034877|69198101|FG000|Overall Study|No Longer Willing to Participate|0|||
37719968|NCT02034877|69198102|FG001|Overall Study|No Longer Willing to Participate|3|||
37719969|NCT02034799|69198110|FG000|Overall Study|Withdrawal by Subject|0|||
37719970|NCT02034799|69198111|FG001|Overall Study|Withdrawal by Subject|2|||
37719971|NCT02034799|69198110|FG000|Overall Study|Lost to Follow-up|0|||
37719972|NCT02034799|69198111|FG001|Overall Study|Lost to Follow-up|1|||
37719973|NCT02034799|69198110|FG000|Overall Study|Death|2|||
37719974|NCT02034799|69198111|FG001|Overall Study|Death|1|||
37719975|NCT02057575|69198121|FG000|Overall Study|Adverse Event|0|||
37719976|NCT02057575|69198122|FG001|Overall Study|Adverse Event|2|||
37719977|NCT02057575|69198123|FG002|Overall Study|Adverse Event|0|||
37719978|NCT02057575|69198124|FG003|Overall Study|Adverse Event|1|||
37719979|NCT02057575|69198121|FG000|Overall Study|Withdrawal by Subject|1|||
37719980|NCT02057575|69198122|FG001|Overall Study|Withdrawal by Subject|0|||
37840058|NCT00479687|69524366|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
37840059|NCT00479687|69524364|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
37840060|NCT00479687|69524365|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
37719981|NCT02057575|69198123|FG002|Overall Study|Withdrawal by Subject|0|||
37840061|NCT00479687|69524366|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
37719982|NCT02057575|69198124|FG003|Overall Study|Withdrawal by Subject|0|||
37719983|NCT02057575|69198121|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
37719984|NCT02057575|69198122|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
37719985|NCT02057575|69198123|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
37719986|NCT02057575|69198124|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
37719987|NCT02057575|69198121|FG000|Overall Study|Protocol Violation|0|||
37719988|NCT02057575|69198122|FG001|Overall Study|Protocol Violation|1|||
37719989|NCT02057575|69198123|FG002|Overall Study|Protocol Violation|0|||
37719990|NCT02057575|69198124|FG003|Overall Study|Protocol Violation|0|||
37719991|NCT02077465|69198136|FG000|Overall Study|Withdrew Consent|0|||
37719992|NCT02077465|69198137|FG001|Overall Study|Withdrew Consent|1|||
37840062|NCT00479687|69524364|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
37840063|NCT00479687|69524365|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
37840064|NCT00479687|69524366|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
37840065|NCT00479687|69524364|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
37840066|NCT00479687|69524365|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
37840067|NCT00479687|69524366|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
37840068|NCT00479687|69524364|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
37840069|NCT00479687|69524365|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
37840070|NCT00479687|69524366|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
37840071|NCT00479687|69524364|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
37840072|NCT00479687|69524365|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
37840073|NCT00479687|69524366|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
37840074|NCT00479687|69524364|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
37840075|NCT00479687|69524365|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
37840076|NCT00479687|69524366|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
37840077|NCT00479336|69524377|FG000|Overall Study|Adverse Event|1|||
37840078|NCT00479336|69524378|FG001|Overall Study|Adverse Event|1|||
37840079|NCT00479336|69524379|FG002|Overall Study|Adverse Event|1|||
37840080|NCT00479336|69524380|FG003|Overall Study|Adverse Event|3|||
37840081|NCT00479336|69524377|FG000|Overall Study|Lack of Efficacy|1|||
37840082|NCT00479336|69524378|FG001|Overall Study|Lack of Efficacy|0|||
37840083|NCT00479336|69524379|FG002|Overall Study|Lack of Efficacy|0|||
37840084|NCT00479336|69524380|FG003|Overall Study|Lack of Efficacy|0|||
37840085|NCT00479336|69524377|FG000|Overall Study|Protocol Violation|0|||
37719993|NCT02077465|69198136|FG000|Overall Study|Lost to Follow-up|1|||
37719994|NCT02077465|69198137|FG001|Overall Study|Lost to Follow-up|0|||
37719995|NCT02034565|69198143|FG000|Overall Study|Adverse Event|1|||
37719996|NCT02034565|69198144|FG001|Overall Study|Adverse Event|0|||
37719997|NCT02075515|69198155|FG000|Overall Study|Serious Adverse Event|1|||
37719998|NCT02075515|69198156|FG001|Overall Study|Serious Adverse Event|1|||
37719999|NCT02075515|69198157|FG002|Overall Study|Serious Adverse Event|1|||
37720000|NCT02075515|69198155|FG000|Overall Study|Non-Serious Adverse Event|0|||
37720001|NCT02075515|69198156|FG001|Overall Study|Non-Serious Adverse Event|1|||
37720002|NCT02075515|69198157|FG002|Overall Study|Non-Serious Adverse Event|0|||
37720003|NCT02075515|69198155|FG000|Overall Study|Withdrawal by Subject|2|||
37720004|NCT02075515|69198156|FG001|Overall Study|Withdrawal by Subject|0|||
37720005|NCT02075515|69198157|FG002|Overall Study|Withdrawal by Subject|1|||
37720006|NCT02075515|69198155|FG000|Overall Study|Lost to Follow-up|1|||
37915540|NCT00520741|69602294|FG000|Overall Study|Other reasons for premature termination|0|||
37915541|NCT00520741|69602295|FG001|Overall Study|Other reasons for premature termination|6|||
37915542|NCT00882518|69602305|FG000|Overall Study|Adverse Event|9|||
37720007|NCT02075515|69198156|FG001|Overall Study|Lost to Follow-up|3|||
37720008|NCT02075515|69198157|FG002|Overall Study|Lost to Follow-up|6|||
37720009|NCT02034409|69198168|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
37720010|NCT02034409|69198169|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
37720011|NCT02034409|69198168|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
37720012|NCT02034409|69198169|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
37720013|NCT02034409|69198168|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
38025071|NCT03647488|69709267|FG000|Overall Study|Progressive disease|10|||
38025072|NCT03647488|69709268|FG001|Overall Study|Progressive disease|0|||
37720014|NCT02034409|69198169|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
37720015|NCT02034409|69198168|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
37840086|NCT00479336|69524378|FG001|Overall Study|Protocol Violation|1|||
37915543|NCT00882518|69602306|FG001|Overall Study|Adverse Event|18|||
37720016|NCT02034409|69198169|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
37840087|NCT00479336|69524379|FG002|Overall Study|Protocol Violation|0|||
37840088|NCT00479336|69524380|FG003|Overall Study|Protocol Violation|0|||
37720017|NCT02034409|69198168|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
37840089|NCT00479336|69524377|FG000|Overall Study|Withdrawal by Subject|1|||
37840090|NCT00479336|69524378|FG001|Overall Study|Withdrawal by Subject|2|||
37840091|NCT00479336|69524379|FG002|Overall Study|Withdrawal by Subject|0|||
37840092|NCT00479336|69524380|FG003|Overall Study|Withdrawal by Subject|0|||
37840093|NCT00479336|69524377|FG000|Overall Study|Physician Decision|0|||
37840094|NCT00479336|69524378|FG001|Overall Study|Physician Decision|1|||
37840095|NCT00479336|69524379|FG002|Overall Study|Physician Decision|0|||
37720018|NCT02034409|69198169|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
37720019|NCT02034409|69198168|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
37720020|NCT02034409|69198169|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
37720021|NCT02021318|69198177|FG000|Overall Study|Adverse Event|2|||
37720022|NCT02021318|69198178|FG001|Overall Study|Adverse Event|1|||
37720023|NCT02021318|69198177|FG000|Overall Study|Death|33|||
37720024|NCT02021318|69198178|FG001|Overall Study|Death|34|||
37720025|NCT02021318|69198177|FG000|Overall Study|Lost to Follow-up|3|||
37720026|NCT02021318|69198178|FG001|Overall Study|Lost to Follow-up|3|||
37720027|NCT02021318|69198177|FG000|Overall Study|Progressive Disease|0|||
37720028|NCT02021318|69198178|FG001|Overall Study|Progressive Disease|1|||
37720029|NCT02021318|69198177|FG000|Overall Study|Withdrawal by Subject|30|||
37720030|NCT02021318|69198178|FG001|Overall Study|Withdrawal by Subject|18|||
37720031|NCT02021318|69198177|FG000|Overall Study|Physician Decision|3|||
37720032|NCT02021318|69198178|FG001|Overall Study|Physician Decision|3|||
37720033|NCT02021318|69198177|FG000|Overall Study|Miscellaneous|2|||
37720034|NCT02021318|69198178|FG001|Overall Study|Miscellaneous|3|||
37720035|NCT02041286|69198185|FG000|Overall Study|Adverse Event|1|||
37720036|NCT02020616|69198198|FG000|Overall Study|Adverse Event|0|||
37720037|NCT02020616|69198199|FG001|Overall Study|Adverse Event|0|||
37720038|NCT02020616|69198200|FG002|Overall Study|Adverse Event|0|||
37720039|NCT02020616|69198201|FG003|Overall Study|Adverse Event|0|||
37720040|NCT02020616|69198202|FG004|Overall Study|Adverse Event|0|||
37720041|NCT02020616|69198203|FG005|Overall Study|Adverse Event|1|||
37720042|NCT02020616|69198204|FG006|Overall Study|Adverse Event|1|||
37720043|NCT02020616|69198198|FG000|Overall Study|Physician Decision|0|||
37720044|NCT02020616|69198199|FG001|Overall Study|Physician Decision|0|||
37720045|NCT02020616|69198200|FG002|Overall Study|Physician Decision|0|||
37720046|NCT02020616|69198201|FG003|Overall Study|Physician Decision|0|||
37720047|NCT02020616|69198202|FG004|Overall Study|Physician Decision|0|||
37720048|NCT02020616|69198203|FG005|Overall Study|Physician Decision|1|||
37720049|NCT02020616|69198204|FG006|Overall Study|Physician Decision|2|||
37720050|NCT02020616|69198198|FG000|Overall Study|Withdrawal by Subject|0|||
37720051|NCT02020616|69198199|FG001|Overall Study|Withdrawal by Subject|0|||
37720052|NCT02020616|69198200|FG002|Overall Study|Withdrawal by Subject|1|||
37720053|NCT02020616|69198201|FG003|Overall Study|Withdrawal by Subject|0|||
37720054|NCT02020616|69198202|FG004|Overall Study|Withdrawal by Subject|0|||
37720055|NCT02020616|69198203|FG005|Overall Study|Withdrawal by Subject|1|||
37720056|NCT02020616|69198204|FG006|Overall Study|Withdrawal by Subject|1|||
37720057|NCT02020616|69198198|FG000|Overall Study|Lost to Follow-up|0|||
37720058|NCT02020616|69198199|FG001|Overall Study|Lost to Follow-up|1|||
37720059|NCT02020616|69198200|FG002|Overall Study|Lost to Follow-up|0|||
37720060|NCT02020616|69198201|FG003|Overall Study|Lost to Follow-up|1|||
37840096|NCT00479336|69524380|FG003|Overall Study|Physician Decision|2|||
37840097|NCT00479336|69524377|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
37840098|NCT00479336|69524378|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
37840099|NCT00479336|69524379|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
37840100|NCT00479336|69524380|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
37840101|NCT00478244|69524390|FG000|Overall Study|Did not receive transplant|1|||
37840102|NCT00478205|69524396|FG000|Overall Study|Adverse Event|182|||
37840103|NCT00478205|69524397|FG001|Overall Study|Adverse Event|39|||
37840104|NCT00478205|69524396|FG000|Overall Study|Medication Non-compliance|9|||
37840105|NCT00478205|69524397|FG001|Overall Study|Medication Non-compliance|4|||
37840106|NCT00478205|69524396|FG000|Overall Study|Protocol Violation|15|||
37840107|NCT00478205|69524397|FG001|Overall Study|Protocol Violation|5|||
37840108|NCT00478205|69524396|FG000|Overall Study|Request of Investigator or Sponsor|4|||
37840109|NCT00478205|69524397|FG001|Overall Study|Request of Investigator or Sponsor|5|||
37840110|NCT00478205|69524396|FG000|Overall Study|Withdrawal by Subject|61|||
37840111|NCT00478205|69524397|FG001|Overall Study|Withdrawal by Subject|22|||
37720061|NCT02020616|69198202|FG004|Overall Study|Lost to Follow-up|1|||
37720062|NCT02020616|69198203|FG005|Overall Study|Lost to Follow-up|1|||
37720063|NCT02020616|69198204|FG006|Overall Study|Lost to Follow-up|0|||
37720064|NCT02020616|69198198|FG000|Overall Study|Early Termination Criteria Met|0|||
37720065|NCT02020616|69198199|FG001|Overall Study|Early Termination Criteria Met|0|||
38025073|NCT03647488|69709269|FG002|Overall Study|Progressive disease|0|||
37840112|NCT00478205|69524396|FG000|Overall Study|Lack of Efficacy|1|||
38025074|NCT03647488|69709267|FG000|Overall Study|Adverse Event|5|||
37720066|NCT02020616|69198200|FG002|Overall Study|Early Termination Criteria Met|1|||
37720067|NCT02020616|69198201|FG003|Overall Study|Early Termination Criteria Met|0|||
37720068|NCT02020616|69198202|FG004|Overall Study|Early Termination Criteria Met|0|||
37720069|NCT02020616|69198203|FG005|Overall Study|Early Termination Criteria Met|1|||
37720070|NCT02020616|69198204|FG006|Overall Study|Early Termination Criteria Met|0|||
37720071|NCT02020616|69198198|FG000|Overall Study|Randomized in Error|0|||
37720072|NCT02020616|69198199|FG001|Overall Study|Randomized in Error|0|||
37720073|NCT02020616|69198200|FG002|Overall Study|Randomized in Error|0|||
37720074|NCT02020616|69198201|FG003|Overall Study|Randomized in Error|1|||
37720075|NCT02020616|69198202|FG004|Overall Study|Randomized in Error|0|||
37720076|NCT02020616|69198203|FG005|Overall Study|Randomized in Error|0|||
37720077|NCT02020616|69198204|FG006|Overall Study|Randomized in Error|0|||
37720078|NCT02020616|69198198|FG000|Overall Study|Lack of Efficacy|0|||
37720079|NCT02020616|69198199|FG001|Overall Study|Lack of Efficacy|0|||
37720080|NCT02020616|69198200|FG002|Overall Study|Lack of Efficacy|0|||
37720081|NCT02020616|69198201|FG003|Overall Study|Lack of Efficacy|0|||
37720082|NCT02020616|69198202|FG004|Overall Study|Lack of Efficacy|1|||
37720083|NCT02020616|69198203|FG005|Overall Study|Lack of Efficacy|0|||
37720084|NCT02020616|69198204|FG006|Overall Study|Lack of Efficacy|0|||
37720085|NCT02048072|69198234|FG000|Overall Study|Adverse Event|3|||
37720086|NCT02048072|69198234|FG000|Overall Study|Lost to Follow-up|1|||
37720087|NCT02047604|69198244|FG000|Overall Study|Withdrawal by Subject|0|||
37720088|NCT02047604|69198245|FG001|Overall Study|Withdrawal by Subject|0|||
37720089|NCT02047604|69198246|FG002|Overall Study|Withdrawal by Subject|0|||
37720090|NCT02047604|69198247|FG003|Overall Study|Withdrawal by Subject|0|||
37720091|NCT02047604|69198248|FG004|Overall Study|Withdrawal by Subject|1|||
37720092|NCT02047604|69198249|FG005|Overall Study|Withdrawal by Subject|1|||
37720093|NCT01622660|69198263|FG000|Overall Study|Adverse Event|1|||
37720094|NCT02019602|69198269|FG000|Screening Period|Ineligibility|4|||
37720095|NCT02019602|69198270|FG001|Screening Period|Ineligibility|0|||
37720096|NCT02019602|69198269|FG000|Screening Period|Adverse Event|1|||
37720097|NCT02019602|69198270|FG001|Screening Period|Adverse Event|0|||
37720098|NCT01994876|69198277|FG000|Test Period 1|Withdrawal by Subject|0|||
37720099|NCT01994876|69198278|FG001|Test Period 1|Withdrawal by Subject|1|||
37720100|NCT01994876|69198277|FG000|Test Period 1|Adverse Event|0|||
37720101|NCT01994876|69198278|FG001|Test Period 1|Adverse Event|1|||
37720102|NCT01994876|69198277|FG000|Test Period 2|Adverse Event|1|||
37720103|NCT01994876|69198278|FG001|Test Period 2|Adverse Event|0|||
37720104|NCT01994876|69198277|FG000|Test Period 2|Protocol Violation|0|||
37720105|NCT01994876|69198278|FG001|Test Period 2|Protocol Violation|1|||
37720106|NCT02040428|69198288|FG000|Overall Study|Death|4|||
37720107|NCT02040428|69198289|FG001|Overall Study|Death|3|||
37720108|NCT02040428|69198288|FG000|Overall Study|Withdrawal by Subject|1|||
37720109|NCT02040428|69198289|FG001|Overall Study|Withdrawal by Subject|1|||
37720110|NCT02018822|69198297|FG000|Overall Study|filling replaced by crown|0|||
37720111|NCT02018822|69198298|FG001|Overall Study|filling replaced by crown|1|||
37720112|NCT02018822|69198299|FG002|Overall Study|filling replaced by crown|0|||
37720113|NCT02018822|69198297|FG000|Overall Study|Physician Decision|0|||
37720114|NCT02018822|69198298|FG001|Overall Study|Physician Decision|1|||
37720115|NCT02018822|69198299|FG002|Overall Study|Physician Decision|1|||
37720116|NCT02018822|69198297|FG000|Overall Study|Lost to Follow-up|6|||
37720117|NCT02018822|69198298|FG001|Overall Study|Lost to Follow-up|6|||
37720118|NCT02018822|69198299|FG002|Overall Study|Lost to Follow-up|5|||
37720119|NCT02055157|69198314|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
37720120|NCT02055157|69198315|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
37720121|NCT02055157|69198316|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
37720122|NCT02055157|69198317|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
37720123|NCT02055157|69198314|FG000|Initial 6 Months|Adverse Event|0|||
37720124|NCT02055157|69198315|FG001|Initial 6 Months|Adverse Event|0|||
37720125|NCT02055157|69198316|FG002|Initial 6 Months|Adverse Event|0|||
37720126|NCT02055157|69198317|FG003|Initial 6 Months|Adverse Event|1|||
37720127|NCT02055157|69198314|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
37720128|NCT02055157|69198315|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
37720129|NCT02055157|69198316|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
37720130|NCT02055157|69198317|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
37720131|NCT02055157|69198314|FG000|18-month Extension|Investigator decision|0|||
37720132|NCT02055157|69198315|FG001|18-month Extension|Investigator decision|1|||
37720133|NCT02055157|69198316|FG002|18-month Extension|Investigator decision|0|||
37720134|NCT02055157|69198317|FG003|18-month Extension|Investigator decision|0|||
37720135|NCT02055157|69198314|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
37720136|NCT02055157|69198315|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
37720137|NCT02055157|69198316|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
37720138|NCT02055157|69198317|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
37720139|NCT02022007|69198341|FG000|Overall Study|Withdrawal by Subject|1|||
37720140|NCT02022007|69198342|FG001|Overall Study|Withdrawal by Subject|1|||
37720141|NCT02022007|69198343|FG002|Overall Study|Withdrawal by Subject|1|||
37720142|NCT02022007|69198341|FG000|Overall Study|Noncompliant|0|||
37720143|NCT02022007|69198342|FG001|Overall Study|Noncompliant|0|||
37720144|NCT02022007|69198343|FG002|Overall Study|Noncompliant|1|||
37720145|NCT02031679|69198353|FG000|Overall Study|Protocol Violation|0|||
37720146|NCT02031679|69198354|FG001|Overall Study|Protocol Violation|1|||
37720147|NCT02031679|69198353|FG000|Overall Study|Lack of Efficacy|0|||
37720148|NCT02031679|69198354|FG001|Overall Study|Lack of Efficacy|1|||
37720149|NCT02053753|69198362|FG000|Overall Study|Withdrawal by Subject|2|||
37720150|NCT02053753|69198363|FG001|Overall Study|Withdrawal by Subject|4|||
37720151|NCT02053753|69198362|FG000|Overall Study|Decision by Sponsor|1|||
37720152|NCT02053753|69198363|FG001|Overall Study|Decision by Sponsor|1|||
37720153|NCT02053753|69198362|FG000|Overall Study|Lost to Follow-up|4|||
37720154|NCT02053753|69198363|FG001|Overall Study|Lost to Follow-up|3|||
37720155|NCT02019979|69198369|FG000|Overall Study|study terminated|14|||
37720156|NCT02019667|69198373|FG000|First Intervention (6 Months)|Adverse Event|0|||
37720157|NCT02019667|69198374|FG001|First Intervention (6 Months)|Adverse Event|1|||
37720158|NCT02019667|69198373|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
37720159|NCT02019667|69198374|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
37720160|NCT02019667|69198373|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
37720161|NCT02019667|69198374|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
37720162|NCT02030821|69198386|FG000|Overall Study|Physician Decision|2|||
37720163|NCT02030821|69198387|FG001|Overall Study|Physician Decision|2|||
37720164|NCT02030821|69198388|FG002|Overall Study|Physician Decision|5|||
37720165|NCT02030821|69198389|FG003|Overall Study|Physician Decision|2|||
37720166|NCT02052739|69198401|FG000|Overall Study|Withdrew due to Adverse Event|3|||
37720167|NCT02052739|69198402|FG001|Overall Study|Withdrew due to Adverse Event|0|||
37720168|NCT02052739|69198401|FG000|Overall Study|Participant Died|2|||
37720169|NCT02052739|69198402|FG001|Overall Study|Participant Died|1|||
37720170|NCT02019277|69198410|FG000|Overall Study|Withdrawal by Subject|3|||
37720171|NCT02019277|69198410|FG000|Overall Study|Death|7|||
37720172|NCT02019277|69198410|FG000|Overall Study|Did no Cooperate|1|||
37720173|NCT02019277|69198410|FG000|Overall Study|Adverse Event|1|||
37720174|NCT02030119|69198418|FG000|Overall Study|Withdrawal by Subject|3|||
37720175|NCT02030119|69198419|FG001|Overall Study|Withdrawal by Subject|1|||
37720176|NCT02030119|69198420|FG002|Overall Study|Withdrawal by Subject|5|||
37720177|NCT02030119|69198421|FG003|Overall Study|Withdrawal by Subject|3|||
37720178|NCT02030119|69198418|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
37720179|NCT02030119|69198419|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
37720180|NCT02030119|69198420|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
37720181|NCT02030119|69198421|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
37720182|NCT01823835|69198446|FG000|Overall Study|Adverse Event|0|||
37720183|NCT01823835|69198447|FG001|Overall Study|Adverse Event|0|||
37720184|NCT01823835|69198448|FG002|Overall Study|Adverse Event|0|||
37720185|NCT01823835|69198449|FG003|Overall Study|Adverse Event|0|||
37720186|NCT01823835|69198450|FG004|Overall Study|Adverse Event|1|||
37720187|NCT01823835|69198451|FG005|Overall Study|Adverse Event|0|||
37720188|NCT01823835|69198452|FG006|Overall Study|Adverse Event|1|||
37720189|NCT01823835|69198453|FG007|Overall Study|Adverse Event|0|||
37720190|NCT01823835|69198454|FG008|Overall Study|Adverse Event|0|||
37720191|NCT01823835|69198455|FG009|Overall Study|Adverse Event|0|||
37720192|NCT01823835|69198456|FG010|Overall Study|Adverse Event|1|||
37720193|NCT01823835|69198457|FG011|Overall Study|Adverse Event|2|||
37720194|NCT01823835|69198458|FG012|Overall Study|Adverse Event|0|||
37720195|NCT01823835|69198459|FG013|Overall Study|Adverse Event|0|||
37720196|NCT01823835|69198460|FG014|Overall Study|Adverse Event|0|||
37720197|NCT01823835|69198446|FG000|Overall Study|Physician Decision|0|||
37720198|NCT01823835|69198447|FG001|Overall Study|Physician Decision|0|||
37720199|NCT01823835|69198448|FG002|Overall Study|Physician Decision|0|||
37720200|NCT01823835|69198449|FG003|Overall Study|Physician Decision|0|||
37720201|NCT01823835|69198450|FG004|Overall Study|Physician Decision|0|||
37720202|NCT01823835|69198451|FG005|Overall Study|Physician Decision|0|||
37720203|NCT01823835|69198452|FG006|Overall Study|Physician Decision|0|||
37915544|NCT00882518|69602305|FG000|Overall Study|Withdrawal by Subject|9|||
37915545|NCT00882518|69602306|FG001|Overall Study|Withdrawal by Subject|13|||
37915546|NCT00882518|69602305|FG000|Overall Study|Lack of Efficacy|12|||
37720204|NCT01823835|69198453|FG007|Overall Study|Physician Decision|0|||
37720205|NCT01823835|69198454|FG008|Overall Study|Physician Decision|0|||
37915547|NCT00882518|69602306|FG001|Overall Study|Lack of Efficacy|9|||
37915548|NCT00882518|69602305|FG000|Overall Study|Severe non-compliance to protocol|3|||
37720206|NCT01823835|69198455|FG009|Overall Study|Physician Decision|0|||
37720207|NCT01823835|69198456|FG010|Overall Study|Physician Decision|0|||
37720208|NCT01823835|69198457|FG011|Overall Study|Physician Decision|2|||
37720209|NCT01823835|69198458|FG012|Overall Study|Physician Decision|0|||
37720210|NCT01823835|69198459|FG013|Overall Study|Physician Decision|0|||
37720211|NCT01823835|69198460|FG014|Overall Study|Physician Decision|0|||
37720212|NCT01823835|69198446|FG000|Overall Study|Progressive Disease|3|||
37720213|NCT01823835|69198447|FG001|Overall Study|Progressive Disease|4|||
37915549|NCT00882518|69602306|FG001|Overall Study|Severe non-compliance to protocol|1|||
37720214|NCT01823835|69198448|FG002|Overall Study|Progressive Disease|3|||
37720215|NCT01823835|69198449|FG003|Overall Study|Progressive Disease|6|||
37720216|NCT01823835|69198450|FG004|Overall Study|Progressive Disease|4|||
37720217|NCT01823835|69198451|FG005|Overall Study|Progressive Disease|6|||
37720218|NCT01823835|69198452|FG006|Overall Study|Progressive Disease|5|||
37720219|NCT01823835|69198453|FG007|Overall Study|Progressive Disease|3|||
37720220|NCT01823835|69198454|FG008|Overall Study|Progressive Disease|3|||
37720221|NCT01823835|69198455|FG009|Overall Study|Progressive Disease|18|||
37720222|NCT01823835|69198456|FG010|Overall Study|Progressive Disease|8|||
37720223|NCT01823835|69198457|FG011|Overall Study|Progressive Disease|46|||
37720224|NCT01823835|69198458|FG012|Overall Study|Progressive Disease|18|||
37720225|NCT01823835|69198459|FG013|Overall Study|Progressive Disease|4|||
37720226|NCT01823835|69198460|FG014|Overall Study|Progressive Disease|6|||
37720227|NCT01823835|69198446|FG000|Overall Study|Study Termination|0|||
37720228|NCT01823835|69198447|FG001|Overall Study|Study Termination|0|||
37720229|NCT01823835|69198448|FG002|Overall Study|Study Termination|0|||
37720230|NCT01823835|69198449|FG003|Overall Study|Study Termination|0|||
37720231|NCT01823835|69198450|FG004|Overall Study|Study Termination|1|||
37720232|NCT01823835|69198451|FG005|Overall Study|Study Termination|0|||
37720233|NCT01823835|69198452|FG006|Overall Study|Study Termination|0|||
37720234|NCT01823835|69198453|FG007|Overall Study|Study Termination|0|||
37720235|NCT01823835|69198454|FG008|Overall Study|Study Termination|0|||
37720236|NCT01823835|69198455|FG009|Overall Study|Study Termination|0|||
37720237|NCT01823835|69198456|FG010|Overall Study|Study Termination|0|||
37720238|NCT01823835|69198457|FG011|Overall Study|Study Termination|1|||
37720239|NCT01823835|69198458|FG012|Overall Study|Study Termination|0|||
37720240|NCT01823835|69198459|FG013|Overall Study|Study Termination|0|||
37720241|NCT01823835|69198460|FG014|Overall Study|Study Termination|0|||
37720242|NCT01823835|69198446|FG000|Overall Study|Withdrawal by Subject|0|||
37720243|NCT01823835|69198447|FG001|Overall Study|Withdrawal by Subject|0|||
37720244|NCT01823835|69198448|FG002|Overall Study|Withdrawal by Subject|1|||
37720245|NCT01823835|69198449|FG003|Overall Study|Withdrawal by Subject|0|||
37720246|NCT01823835|69198450|FG004|Overall Study|Withdrawal by Subject|0|||
37720247|NCT01823835|69198451|FG005|Overall Study|Withdrawal by Subject|0|||
37720248|NCT01823835|69198452|FG006|Overall Study|Withdrawal by Subject|0|||
37720249|NCT01823835|69198453|FG007|Overall Study|Withdrawal by Subject|0|||
37720250|NCT01823835|69198454|FG008|Overall Study|Withdrawal by Subject|0|||
37720251|NCT01823835|69198455|FG009|Overall Study|Withdrawal by Subject|1|||
37720252|NCT01823835|69198456|FG010|Overall Study|Withdrawal by Subject|1|||
37720253|NCT01823835|69198457|FG011|Overall Study|Withdrawal by Subject|2|||
37720254|NCT01823835|69198458|FG012|Overall Study|Withdrawal by Subject|1|||
37720255|NCT01823835|69198459|FG013|Overall Study|Withdrawal by Subject|0|||
37720256|NCT01823835|69198460|FG014|Overall Study|Withdrawal by Subject|0|||
37720257|NCT01823679|69198500|FG000|Overall Study|Death|1|||
37720258|NCT01823289|69198505|FG000|Overall Study|Lost to Follow-up|5|||
37720259|NCT01823289|69198505|FG000|Overall Study|Adverse Event|5|||
37720260|NCT01823289|69198505|FG000|Overall Study|Lack of Efficacy|1|||
37720261|NCT01823289|69198505|FG000|Overall Study|Physician Decision|9|||
37720262|NCT01823289|69198505|FG000|Overall Study|Administered contraindicated medicine|1|||
37720263|NCT01823289|69198505|FG000|Overall Study|Transaminase increased more than 3 times|1|||
37720264|NCT01823289|69198505|FG000|Overall Study|Drug affected efficacy and safety|1|||
37720265|NCT01823289|69198505|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
37720266|NCT01822899|69198511|FG000|Overall Study|Adverse Event|6|||
37720267|NCT01822899|69198512|FG001|Overall Study|Adverse Event|5|||
37720268|NCT01822899|69198511|FG000|Overall Study|Lack of Efficacy|6|||
37720269|NCT01822899|69198512|FG001|Overall Study|Lack of Efficacy|3|||
37720270|NCT01822899|69198511|FG000|Overall Study|Protocol Violation|6|||
37720271|NCT01822899|69198512|FG001|Overall Study|Protocol Violation|3|||
37720272|NCT01822899|69198511|FG000|Overall Study|Lost to Follow-up|1|||
37840113|NCT00478205|69524397|FG001|Overall Study|Lack of Efficacy|0|||
37840114|NCT00478205|69524396|FG000|Overall Study|Other|24|||
37840115|NCT00478205|69524397|FG001|Overall Study|Other|12|||
37840116|NCT00477971|69524405|FG000|Overall Study|Disease progression|6|||
37840117|NCT00477971|69524406|FG001|Overall Study|Disease progression|0|||
37720273|NCT01822899|69198512|FG001|Overall Study|Lost to Follow-up|0|||
37720274|NCT01822899|69198511|FG000|Overall Study|Withdrawal by Subject|5|||
37720275|NCT01822899|69198512|FG001|Overall Study|Withdrawal by Subject|7|||
37720276|NCT01822821|69198520|FG000|Overall Study|Eligible surgery cancelled|1|||
37840118|NCT00477971|69524405|FG000|Overall Study|Withdrawal by Subject|3|||
37840119|NCT00477971|69524406|FG001|Overall Study|Withdrawal by Subject|1|||
37720277|NCT01822821|69198521|FG001|Overall Study|Eligible surgery cancelled|1|||
37720278|NCT01822821|69198520|FG000|Overall Study|Other reasons|1|||
37720279|NCT01822821|69198521|FG001|Overall Study|Other reasons|0|||
37720280|NCT01822665|69198527|FG000|Overall Study|Adverse Event|3|||
37720281|NCT01822665|69198527|FG000|Overall Study|Other Reason|5|||
37720282|NCT02173301|69198549|FG000|Overall Study|Adverse Event|7|||
37720283|NCT02173301|69198550|FG001|Overall Study|Adverse Event|8|||
37720284|NCT02173301|69198551|FG002|Overall Study|Adverse Event|13|||
37720285|NCT02173301|69198552|FG003|Overall Study|Adverse Event|5|||
37720286|NCT02173301|69198549|FG000|Overall Study|Withdrawal by Subject|8|||
37720287|NCT02173301|69198550|FG001|Overall Study|Withdrawal by Subject|10|||
37840120|NCT00477971|69524405|FG000|Overall Study|Adverse Event|3|||
37840121|NCT00477971|69524406|FG001|Overall Study|Adverse Event|0|||
37720288|NCT02173301|69198551|FG002|Overall Study|Withdrawal by Subject|4|||
37720289|NCT02173301|69198552|FG003|Overall Study|Withdrawal by Subject|8|||
37720290|NCT02173301|69198549|FG000|Overall Study|Lost to Follow-up|4|||
37720291|NCT02173301|69198550|FG001|Overall Study|Lost to Follow-up|4|||
37720292|NCT02173301|69198551|FG002|Overall Study|Lost to Follow-up|2|||
37720293|NCT02173301|69198552|FG003|Overall Study|Lost to Follow-up|2|||
37720294|NCT02173301|69198549|FG000|Overall Study|Protocol Violation|0|||
37720295|NCT02173301|69198550|FG001|Overall Study|Protocol Violation|1|||
37720296|NCT02173301|69198551|FG002|Overall Study|Protocol Violation|0|||
37720297|NCT02173301|69198552|FG003|Overall Study|Protocol Violation|0|||
37720298|NCT02173301|69198549|FG000|Overall Study|Physician Decision|0|||
37720299|NCT02173301|69198550|FG001|Overall Study|Physician Decision|0|||
37720300|NCT02173301|69198551|FG002|Overall Study|Physician Decision|1|||
37720301|NCT02173301|69198552|FG003|Overall Study|Physician Decision|0|||
37720302|NCT02173301|69198549|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
37720303|NCT02173301|69198550|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
37720304|NCT02173301|69198551|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
37720305|NCT02173301|69198552|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
37720306|NCT01822587|69198565|FG000|Overall Study|Lost to Follow-up|7|||
37720307|NCT01822587|69198566|FG001|Overall Study|Lost to Follow-up|9|||
37720308|NCT01822587|69198567|FG002|Overall Study|Lost to Follow-up|12|||
37720309|NCT01822587|69198565|FG000|Overall Study|Physician Decision|9|||
37720310|NCT01822587|69198566|FG001|Overall Study|Physician Decision|6|||
37720311|NCT01822587|69198567|FG002|Overall Study|Physician Decision|6|||
37720312|NCT01822353|69198578|FG000|Overall Study|Adverse Event|1|||
37720313|NCT01822353|69198579|FG001|Overall Study|Adverse Event|3|||
37720314|NCT01822353|69198580|FG002|Overall Study|Adverse Event|1|||
37720315|NCT01822353|69198578|FG000|Overall Study|Pregnancy|0|||
37720316|NCT01822353|69198579|FG001|Overall Study|Pregnancy|1|||
37720317|NCT01822353|69198580|FG002|Overall Study|Pregnancy|0|||
37720318|NCT01822353|69198578|FG000|Overall Study|Withdrawal by Subject|3|||
37720319|NCT01822353|69198579|FG001|Overall Study|Withdrawal by Subject|1|||
37720320|NCT01822353|69198580|FG002|Overall Study|Withdrawal by Subject|0|||
37720321|NCT01821963|69198591|FG000|Overall Study|Adverse Event|1|||
37720322|NCT01821807|69198597|FG000|Overall Study|Lost to Follow-up|3|||
37720323|NCT01821807|69198598|FG001|Overall Study|Lost to Follow-up|1|||
37720324|NCT01821729|69198604|FG000|Overall Study|Withdrawal by Subject|1|||
37720325|NCT01820637|69198608|FG000|Overall Study|Death|2|||
37720326|NCT01820637|69198608|FG000|Overall Study|Withdrawal by Subject|1|||
37720327|NCT02172911|69198614|FG000|Overall Study|Serious Adverse Event|0|||
37720328|NCT02172911|69198615|FG001|Overall Study|Serious Adverse Event|1|||
37720329|NCT02172911|69198614|FG000|Overall Study|Progression of Disease|0|||
37720330|NCT02172911|69198615|FG001|Overall Study|Progression of Disease|1|||
37720331|NCT02172911|69198614|FG000|Overall Study|Loss of insurance coverage|1|||
37720332|NCT02172911|69198615|FG001|Overall Study|Loss of insurance coverage|0|||
37720333|NCT02120027|69198623|FG000|Overall Study|Adverse Event|4|||
37720334|NCT02120027|69198624|FG001|Overall Study|Adverse Event|5|||
37720335|NCT02120027|69198623|FG000|Overall Study|Lack of Efficacy|3|||
37720336|NCT02120027|69198624|FG001|Overall Study|Lack of Efficacy|5|||
37720337|NCT02120027|69198623|FG000|Overall Study|Lost to Follow-up|5|||
37720338|NCT02120027|69198624|FG001|Overall Study|Lost to Follow-up|13|||
37720339|NCT02120027|69198623|FG000|Overall Study|Other|4|||
37720340|NCT02120027|69198624|FG001|Overall Study|Other|0|||
37720341|NCT02120027|69198623|FG000|Overall Study|Physician Decision|4|||
37720342|NCT02120027|69198624|FG001|Overall Study|Physician Decision|3|||
37720343|NCT02120027|69198623|FG000|Overall Study|Protocol Violation|18|||
37720344|NCT02120027|69198624|FG001|Overall Study|Protocol Violation|21|||
37720345|NCT02120027|69198623|FG000|Overall Study|Study terminated by Sponsor|45|||
37720346|NCT02120027|69198624|FG001|Overall Study|Study terminated by Sponsor|47|||
37720347|NCT02120027|69198623|FG000|Overall Study|Withdrawal by Subject|33|||
37720348|NCT02120027|69198624|FG001|Overall Study|Withdrawal by Subject|25|||
37840122|NCT00477971|69524405|FG000|Overall Study|Death|2|||
38025075|NCT03647488|69709268|FG001|Overall Study|Adverse Event|0|||
37720349|NCT01850823|69198633|FG000|Overall Study|Early Visit Window|0|||
37720350|NCT01850823|69198634|FG001|Overall Study|Early Visit Window|1|||
37720351|NCT01850823|69198635|FG002|Overall Study|Early Visit Window|4|||
37720352|NCT01850823|69198633|FG000|Overall Study|Enrolled in Error|0|||
37720353|NCT01850823|69198634|FG001|Overall Study|Enrolled in Error|1|||
37840123|NCT00477971|69524406|FG001|Overall Study|Death|4|||
37720354|NCT01850823|69198635|FG002|Overall Study|Enrolled in Error|2|||
37720355|NCT01850823|69198633|FG000|Overall Study|Lack of Efficacy|1|||
37720356|NCT01850823|69198634|FG001|Overall Study|Lack of Efficacy|0|||
37720357|NCT01850823|69198635|FG002|Overall Study|Lack of Efficacy|0|||
37720358|NCT01850823|69198633|FG000|Overall Study|Lost to Follow-up|0|||
37720359|NCT01850823|69198634|FG001|Overall Study|Lost to Follow-up|0|||
37720360|NCT01850823|69198635|FG002|Overall Study|Lost to Follow-up|1|||
37720361|NCT01850823|69198633|FG000|Overall Study|Restricted Medication|0|||
37720362|NCT01850823|69198634|FG001|Overall Study|Restricted Medication|0|||
37720363|NCT01850823|69198635|FG002|Overall Study|Restricted Medication|2|||
37720364|NCT01850823|69198633|FG000|Overall Study|Significant worstening of SAR|0|||
37720365|NCT01850823|69198634|FG001|Overall Study|Significant worstening of SAR|1|||
37720366|NCT01850823|69198635|FG002|Overall Study|Significant worstening of SAR|0|||
37720367|NCT01850823|69198633|FG000|Overall Study|Withdrawal by Subject|2|||
37720368|NCT01850823|69198634|FG001|Overall Study|Withdrawal by Subject|0|||
37840124|NCT00477971|69524405|FG000|Overall Study|Alternative treatment|3|||
37840125|NCT00477971|69524406|FG001|Overall Study|Alternative treatment|1|||
37840126|NCT00477464|69524412|FG000|Overall Study|Lost to Follow-up|1|||
37840127|NCT00477464|69524412|FG000|Overall Study|Death|36|||
37840128|NCT00477464|69524412|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
37840129|NCT00477386|69524420|FG000|Overall Study|Adverse Event|4|||
37840130|NCT00477386|69524421|FG001|Overall Study|Adverse Event|8|||
37840131|NCT00477386|69524420|FG000|Overall Study|Disease progression, relapse|3|||
37840132|NCT00477386|69524421|FG001|Overall Study|Disease progression, relapse|4|||
37840133|NCT00477386|69524420|FG000|Overall Study|Disease progression, refractory|1|||
37840134|NCT00477386|69524421|FG001|Overall Study|Disease progression, refractory|3|||
37840135|NCT00477386|69524420|FG000|Overall Study|Other|1|||
37720369|NCT01850823|69198635|FG002|Overall Study|Withdrawal by Subject|1|||
37720370|NCT01820559|69198648|FG000|Overall Study|Adverse Event|4|||
37720371|NCT01820559|69198649|FG001|Overall Study|Adverse Event|6|||
37720372|NCT01820559|69198650|FG002|Overall Study|Adverse Event|13|||
37720373|NCT01820559|69198648|FG000|Overall Study|Withdrawal by Subject|1|||
37915550|NCT00882518|69602305|FG000|Overall Study|Incorrect enrolment|4|||
37915551|NCT00882518|69602306|FG001|Overall Study|Incorrect enrolment|2|||
37915552|NCT00882518|69602305|FG000|Overall Study|Central lab closure for National day|1|||
38025076|NCT03647488|69709269|FG002|Overall Study|Adverse Event|0|||
37720374|NCT01820559|69198649|FG001|Overall Study|Withdrawal by Subject|2|||
37720375|NCT01820559|69198650|FG002|Overall Study|Withdrawal by Subject|5|||
37720376|NCT01820559|69198648|FG000|Overall Study|Protocol Violation|2|||
37720377|NCT01820559|69198649|FG001|Overall Study|Protocol Violation|1|||
37720378|NCT01820559|69198650|FG002|Overall Study|Protocol Violation|3|||
37720379|NCT01820559|69198648|FG000|Overall Study|Subject's non-compliance|1|||
37720380|NCT01820559|69198649|FG001|Overall Study|Subject's non-compliance|0|||
37720381|NCT01820559|69198650|FG002|Overall Study|Subject's non-compliance|2|||
37720382|NCT01820559|69198648|FG000|Overall Study|Lost to Follow-up|3|||
37720383|NCT01820559|69198649|FG001|Overall Study|Lost to Follow-up|2|||
37720384|NCT01820559|69198650|FG002|Overall Study|Lost to Follow-up|2|||
37720385|NCT01820559|69198648|FG000|Overall Study|At sponsor request|0|||
37720386|NCT01820559|69198649|FG001|Overall Study|At sponsor request|0|||
37720387|NCT01820559|69198650|FG002|Overall Study|At sponsor request|1|||
37720388|NCT01820559|69198648|FG000|Overall Study|Lack of Efficacy|3|||
37840136|NCT00477386|69524421|FG001|Overall Study|Other|2|||
37840137|NCT00477386|69524420|FG000|Overall Study|Physician Decision|1|||
37840138|NCT00477386|69524421|FG001|Overall Study|Physician Decision|0|||
37840139|NCT00477386|69524420|FG000|Overall Study|Withdrawal by Subject|1|||
37840140|NCT00477386|69524421|FG001|Overall Study|Withdrawal by Subject|0|||
37840141|NCT00477269|69524429|FG000|Core Study|Adverse Event|6|||
37840142|NCT00477269|69524430|FG001|Core Study|Adverse Event|4|||
37840143|NCT00477269|69524431|FG002|Core Study|Adverse Event|0|||
37840144|NCT00477269|69524429|FG000|Core Study|Death|3|||
37840145|NCT00477269|69524430|FG001|Core Study|Death|3|||
37840146|NCT00477269|69524431|FG002|Core Study|Death|0|||
37840147|NCT00477269|69524429|FG000|Core Study|Withdrawn Consent|0|||
37840148|NCT00477269|69524430|FG001|Core Study|Withdrawn Consent|1|||
37840149|NCT00477269|69524431|FG002|Core Study|Withdrawn Consent|0|||
37840150|NCT00477269|69524429|FG000|Open Label Extension|Adverse Event|0|||
38025077|NCT03647488|69709267|FG000|Overall Study|Clinical progression|2|||
38025078|NCT03647488|69709268|FG001|Overall Study|Clinical progression|0|||
37720389|NCT01820559|69198649|FG001|Overall Study|Lack of Efficacy|2|||
37840151|NCT00477269|69524430|FG001|Open Label Extension|Adverse Event|0|||
37840152|NCT00477269|69524431|FG002|Open Label Extension|Adverse Event|4|||
37915553|NCT00882518|69602306|FG001|Overall Study|Central lab closure for National day|0|||
37915554|NCT00882518|69602305|FG000|Overall Study|Allocating random number by mistake|0|||
37720390|NCT01820559|69198650|FG002|Overall Study|Lack of Efficacy|3|||
37720391|NCT01818765|69198658|FG000|Overall Study|Death|2|||
37840153|NCT00477269|69524429|FG000|Open Label Extension|Abnormal laboratory values|0|||
37840154|NCT00477269|69524430|FG001|Open Label Extension|Abnormal laboratory values|0|||
37840155|NCT00477269|69524431|FG002|Open Label Extension|Abnormal laboratory values|1|||
37840156|NCT00477269|69524429|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
37720392|NCT01850589|69198665|FG000|Overall Study|Withdrawal by Subject|8|||
37720393|NCT01850589|69198666|FG001|Overall Study|Withdrawal by Subject|0|||
37720394|NCT01818531|69198674|FG000|Overall Study|Withdrawn for case delay after block|1|||
37720395|NCT01818531|69198675|FG001|Overall Study|Withdrawn for case delay after block|0|||
37720396|NCT01818531|69198674|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
37720397|NCT01818531|69198675|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
37720398|NCT01818531|69198674|FG000|Overall Study|Withdrawn for failure to place block|0|||
37720399|NCT01818531|69198675|FG001|Overall Study|Withdrawn for failure to place block|1|||
37720400|NCT02171429|69198684|FG000|Overall Study|Other|0|||
37720401|NCT02171429|69198685|FG001|Overall Study|Other|1|||
37720402|NCT02171429|69198686|FG002|Overall Study|Other|1|||
37720403|NCT02171429|69198684|FG000|Overall Study|Non-Compliance|0|||
37720404|NCT02171429|69198685|FG001|Overall Study|Non-Compliance|0|||
37720405|NCT02171429|69198686|FG002|Overall Study|Non-Compliance|1|||
37720406|NCT02171429|69198684|FG000|Overall Study|Physician Decision|0|||
37720407|NCT02171429|69198685|FG001|Overall Study|Physician Decision|0|||
37720408|NCT02171429|69198686|FG002|Overall Study|Physician Decision|1|||
37720409|NCT02171429|69198684|FG000|Overall Study|Withdrawal by Subject|1|||
37720410|NCT02171429|69198685|FG001|Overall Study|Withdrawal by Subject|1|||
37720411|NCT02171429|69198686|FG002|Overall Study|Withdrawal by Subject|1|||
37720412|NCT02171429|69198684|FG000|Overall Study|Lost to Follow-up|0|||
37720413|NCT02171429|69198685|FG001|Overall Study|Lost to Follow-up|1|||
37720414|NCT02171429|69198686|FG002|Overall Study|Lost to Follow-up|0|||
37720415|NCT02171429|69198684|FG000|Overall Study|Death|0|||
37720416|NCT02171429|69198685|FG001|Overall Study|Death|0|||
37720417|NCT02171429|69198686|FG002|Overall Study|Death|1|||
37720418|NCT01818297|69198699|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
37720419|NCT01818297|69198700|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
37720420|NCT01818297|69198699|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
37720421|NCT01818297|69198700|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
37720422|NCT01818297|69198699|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
37720423|NCT01818297|69198700|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
37720424|NCT01818141|69198708|FG000|Overall Study|Withdrawal by Subject|2|||
37720425|NCT01818141|69198709|FG001|Overall Study|Withdrawal by Subject|0|||
37720426|NCT01818141|69198708|FG000|Overall Study|No baseline C.diff colonies|1|||
37840157|NCT00477269|69524430|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
37840158|NCT00477269|69524431|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
37840159|NCT00477269|69524429|FG000|Open Label Extension|Adminiatrative problems|0|||
37840160|NCT00477269|69524430|FG001|Open Label Extension|Adminiatrative problems|0|||
37840161|NCT00477269|69524431|FG002|Open Label Extension|Adminiatrative problems|2|||
37840162|NCT00477269|69524429|FG000|Open Label Extension|Death|0|||
37840163|NCT00477269|69524430|FG001|Open Label Extension|Death|0|||
37840164|NCT00477269|69524431|FG002|Open Label Extension|Death|4|||
37840165|NCT00477152|69524439|FG000|Overall Study|Parent withdrew consent|2|||
37840166|NCT00477152|69524439|FG000|Overall Study|Adverse Event|1|||
37840167|NCT00476996|69524446|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
37840168|NCT00476996|69524447|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
37840169|NCT00476996|69524448|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
37840170|NCT00476996|69524449|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
37840171|NCT00476996|69524446|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
37840172|NCT00476996|69524447|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
37840173|NCT00476996|69524448|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
37840174|NCT00476996|69524449|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
37840175|NCT00476996|69524446|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
37840176|NCT00476996|69524447|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
37840177|NCT00476996|69524448|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
37840178|NCT00476996|69524449|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
37840179|NCT00476996|69524446|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
37840180|NCT00476996|69524447|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
37840181|NCT00476996|69524448|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
37840182|NCT00476996|69524449|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
37840183|NCT00476996|69524446|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
37840184|NCT00476996|69524447|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
37840185|NCT00476996|69524448|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
37840186|NCT00476996|69524449|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
37840187|NCT00476996|69524446|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
37840188|NCT00476996|69524447|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
38025079|NCT03647488|69709269|FG002|Overall Study|Clinical progression|0|||
38025080|NCT03647488|69709267|FG000|Overall Study|Participant refused to take investigational product|1|||
37720427|NCT01818141|69198709|FG001|Overall Study|No baseline C.diff colonies|1|||
37720428|NCT01818141|69198708|FG000|Overall Study|Lost to Follow-up|0|||
37720429|NCT01818141|69198709|FG001|Overall Study|Lost to Follow-up|2|||
37720430|NCT01849497|69198717|FG000|Overall Study|Withdrawal by Subject|1|||
37720431|NCT01849497|69198718|FG001|Overall Study|Withdrawal by Subject|2|||
37840189|NCT00476996|69524448|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
37840190|NCT00476996|69524449|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
37840191|NCT00476996|69524446|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
37840192|NCT00476996|69524447|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
37840193|NCT00476996|69524448|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
37840194|NCT00476996|69524449|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
37840195|NCT00476996|69524446|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
37840196|NCT00476996|69524447|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
37840197|NCT00476996|69524448|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
37840198|NCT00476996|69524449|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
37840199|NCT00476996|69524446|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
37840200|NCT00476996|69524447|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
37840201|NCT00476996|69524448|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
37840202|NCT00476996|69524449|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
37840203|NCT00476996|69524446|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
37840204|NCT00476996|69524447|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
37840205|NCT00476996|69524448|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
37915555|NCT00882518|69602306|FG001|Overall Study|Allocating random number by mistake|1|||
37720432|NCT01849497|69198717|FG000|Overall Study|Sponsor Decision|0|||
37720433|NCT01849497|69198718|FG001|Overall Study|Sponsor Decision|1|||
37720434|NCT01849497|69198717|FG000|Overall Study|Lost to Follow-up|0|||
37720435|NCT01849497|69198718|FG001|Overall Study|Lost to Follow-up|1|||
37720436|NCT02147093|69198726|FG000|Period 1|Lost to Follow-up|0|||
37720437|NCT02147093|69198727|FG001|Period 1|Lost to Follow-up|1|||
37720438|NCT02147093|69198726|FG000|Period 2|Protocol Violation|2|||
37720439|NCT02147093|69198727|FG001|Period 2|Protocol Violation|0|||
37720440|NCT02119325|69198733|FG000|Washout Period 1|Adverse Event|0|||
37720441|NCT02119325|69198734|FG001|Washout Period 1|Adverse Event|1|||
37720442|NCT01816893|69198744|FG000|Washout Period|Withdrawal by Subject|2|||
37720443|NCT01816893|69198745|FG001|Washout Period|Withdrawal by Subject|0|||
37720444|NCT01848483|69198753|FG000|Overall Study|Death|2|||
37720445|NCT01848483|69198754|FG001|Overall Study|Death|1|||
37720446|NCT01848483|69198753|FG000|Overall Study|Lost to Follow-up|6|||
37720447|NCT01848483|69198754|FG001|Overall Study|Lost to Follow-up|8|||
37720448|NCT01848483|69198753|FG000|Overall Study|Withdrawal by Subject|1|||
37720449|NCT01848483|69198754|FG001|Overall Study|Withdrawal by Subject|0|||
37720450|NCT01848483|69198753|FG000|Overall Study|Incarceration|2|||
37720451|NCT01848483|69198754|FG001|Overall Study|Incarceration|2|||
37720452|NCT01610271|69198763|FG000|Overall Study|Surgery not complete|0|||
37720453|NCT01610271|69198764|FG001|Overall Study|Surgery not complete|1|||
37720454|NCT01610271|69198763|FG000|Overall Study|Prosthesis not implanted|2|||
37720455|NCT01610271|69198764|FG001|Overall Study|Prosthesis not implanted|3|||
37720456|NCT02170727|69198774|FG000|Overall Study|Lost to Follow-up|1|||
37720457|NCT02170727|69198775|FG001|Overall Study|Lost to Follow-up|0|||
37720458|NCT02170727|69198774|FG000|Overall Study|Withdrawal by Subject|2|||
37720459|NCT02170727|69198775|FG001|Overall Study|Withdrawal by Subject|0|||
37720460|NCT01847313|69198786|FG000|Overall Study|Death|0|||
37720461|NCT01847313|69198787|FG001|Overall Study|Death|1|||
37720462|NCT01847313|69198786|FG000|Overall Study|Withdrawal by Subject|0|||
37720463|NCT01847313|69198787|FG001|Overall Study|Withdrawal by Subject|1|||
37720464|NCT02144285|69198803|FG000|Overall Study|Withdrawal by Subject|0|||
37720465|NCT02144285|69198804|FG001|Overall Study|Withdrawal by Subject|0|||
37720466|NCT02144285|69198805|FG002|Overall Study|Withdrawal by Subject|0|||
37720467|NCT02144285|69198806|FG003|Overall Study|Withdrawal by Subject|0|||
37720468|NCT02144285|69198807|FG004|Overall Study|Withdrawal by Subject|1|||
37720469|NCT02144285|69198808|FG005|Overall Study|Withdrawal by Subject|0|||
37720470|NCT02144285|69198809|FG006|Overall Study|Withdrawal by Subject|0|||
37720471|NCT02144285|69198810|FG007|Overall Study|Withdrawal by Subject|0|||
37720472|NCT02144285|69198811|FG008|Overall Study|Withdrawal by Subject|0|||
37720473|NCT02144285|69198812|FG009|Overall Study|Withdrawal by Subject|0|||
37720474|NCT02117687|69198850|FG000|Overall Study|Lost to Follow-up|0|||
37720475|NCT02117687|69198851|FG001|Overall Study|Lost to Follow-up|1|||
37915556|NCT00882362|69602323|FG000|Overall Study|Adverse Event|13|||
37720476|NCT02117687|69198850|FG000|Overall Study|Adverse Event|0|||
37720477|NCT02117687|69198851|FG001|Overall Study|Adverse Event|2|||
37915557|NCT00882362|69602324|FG001|Overall Study|Adverse Event|10|||
37915558|NCT00882362|69602323|FG000|Overall Study|Withdrawal by Subject|13|||
37720478|NCT02117687|69198850|FG000|Overall Study|Other Reasons|1|||
37720479|NCT02117687|69198851|FG001|Overall Study|Other Reasons|1|||
37720480|NCT02143583|69198860|FG000|Overall Study|Withdrawal by Subject|1|||
37720481|NCT02143583|69198861|FG001|Overall Study|Withdrawal by Subject|0|||
37840206|NCT00476996|69524449|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
37840207|NCT00476996|69524446|FG000|OLE Phase (From Week 48)|Death|0|||
37915559|NCT00882362|69602324|FG001|Overall Study|Withdrawal by Subject|10|||
37720482|NCT02143583|69198862|FG002|Overall Study|Withdrawal by Subject|1|||
37720483|NCT02143583|69198860|FG000|Overall Study|husband illness|0|||
37720484|NCT02143583|69198861|FG001|Overall Study|husband illness|0|||
37720485|NCT02143583|69198862|FG002|Overall Study|husband illness|1|||
37720486|NCT02105987|69198872|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
37720487|NCT02105987|69198873|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
37720488|NCT02105987|69198874|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
37720489|NCT02105987|69198875|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
37720490|NCT02105987|69198876|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
37720491|NCT02105987|69198877|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
37720492|NCT02105987|69198872|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
37720493|NCT02105987|69198873|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
37720494|NCT02105987|69198874|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
37720495|NCT02105987|69198875|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
37720496|NCT02105987|69198876|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
37720497|NCT02105987|69198877|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
37720498|NCT02105987|69198872|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
37720499|NCT02105987|69198873|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
37720500|NCT02105987|69198874|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
37720501|NCT02105987|69198875|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
37720502|NCT02105987|69198876|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
37720503|NCT02105987|69198877|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
37720504|NCT02105987|69198872|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
37720505|NCT02105987|69198873|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
37720506|NCT02105987|69198874|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
37720507|NCT02105987|69198875|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
37720508|NCT02105987|69198876|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
37720509|NCT02105987|69198877|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
37720510|NCT02105987|69198872|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
37720511|NCT02105987|69198873|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
37720512|NCT02105987|69198874|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
37720513|NCT02105987|69198875|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
37720514|NCT02105987|69198876|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
37720515|NCT02105987|69198877|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
37720516|NCT02105987|69198872|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
37720517|NCT02105987|69198873|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
37840208|NCT00476996|69524447|FG001|OLE Phase (From Week 48)|Death|0|||
37840209|NCT00476996|69524448|FG002|OLE Phase (From Week 48)|Death|0|||
37840210|NCT00476996|69524449|FG003|OLE Phase (From Week 48)|Death|7|||
37840211|NCT00476996|69524446|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
37840212|NCT00476996|69524447|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
37840213|NCT00476996|69524448|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
37840214|NCT00476996|69524449|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
37840215|NCT00476996|69524446|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
37840216|NCT00476996|69524447|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
37840217|NCT00476996|69524448|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
37840218|NCT00476996|69524449|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
37720518|NCT02105987|69198874|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
37720519|NCT02105987|69198875|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
37720520|NCT02105987|69198876|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
37720521|NCT02105987|69198877|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
37720522|NCT02105987|69198872|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
37720523|NCT02105987|69198873|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
37720524|NCT02105987|69198874|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
37720525|NCT02105987|69198875|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
37720526|NCT02105987|69198876|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
37720527|NCT02105987|69198877|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
37720528|NCT02105987|69198872|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
37720529|NCT02105987|69198873|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
37720530|NCT02105987|69198874|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
37720531|NCT02105987|69198875|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
37720532|NCT02105987|69198876|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
37720533|NCT02105987|69198877|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
37720534|NCT02105987|69198872|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
37840219|NCT00476996|69524446|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
37840220|NCT00476996|69524447|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
37720535|NCT02105987|69198873|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
37720536|NCT02105987|69198874|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
37840221|NCT00476996|69524448|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
37840222|NCT00476996|69524449|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
37840223|NCT00476996|69524446|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
37915560|NCT00882362|69602323|FG000|Overall Study|Lack of Efficacy|3|||
37720537|NCT02105987|69198875|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
37720538|NCT02105987|69198876|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
37720539|NCT02105987|69198877|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
37720540|NCT02105987|69198872|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
37720541|NCT02105987|69198873|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
37720542|NCT02105987|69198874|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
37720543|NCT02105987|69198875|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
37720544|NCT02105987|69198876|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
37720545|NCT02105987|69198877|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
37720546|NCT02105987|69198872|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
37720547|NCT02105987|69198873|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
37720548|NCT02105987|69198874|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
37720549|NCT02105987|69198875|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
37720550|NCT02105987|69198876|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
37720551|NCT02105987|69198877|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
37720552|NCT02105987|69198872|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
37720553|NCT02105987|69198873|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
37720554|NCT02105987|69198874|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
37720555|NCT02105987|69198875|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
37720556|NCT02105987|69198876|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
37840224|NCT00476996|69524447|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
37840225|NCT00476996|69524448|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
37840226|NCT00476996|69524449|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
37840227|NCT00476957|69524460|FG000|Overall Study|Lost to Follow-up|176|||
37840228|NCT00476957|69524461|FG001|Overall Study|Lost to Follow-up|193|||
37840229|NCT00475865|69524470|FG000|Overall Study|Adverse Event|0|||
37840230|NCT00475865|69524471|FG001|Overall Study|Adverse Event|3|||
37840231|NCT00475865|69524472|FG002|Overall Study|Adverse Event|4|||
37720557|NCT02105987|69198877|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
37720558|NCT02105987|69198872|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
37720559|NCT02105987|69198873|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
37720560|NCT02105987|69198874|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
37720561|NCT02105987|69198875|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
37720562|NCT02105987|69198876|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
37720563|NCT02105987|69198877|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
37720564|NCT02105987|69198872|FG000|Continuation Phase|Protocol Violation|0|||
37720565|NCT02105987|69198873|FG001|Continuation Phase|Protocol Violation|0|||
37720566|NCT02105987|69198874|FG002|Continuation Phase|Protocol Violation|0|||
37840232|NCT00475865|69524470|FG000|Overall Study|Lack of Efficacy|1|||
37840233|NCT00475865|69524471|FG001|Overall Study|Lack of Efficacy|0|||
37840234|NCT00475865|69524472|FG002|Overall Study|Lack of Efficacy|0|||
37840235|NCT00475865|69524470|FG000|Overall Study|Progressive disease|0|||
37720567|NCT02105987|69198875|FG003|Continuation Phase|Protocol Violation|0|||
37720568|NCT02105987|69198876|FG004|Continuation Phase|Protocol Violation|1|||
37720569|NCT02105987|69198877|FG005|Continuation Phase|Protocol Violation|0|||
37720570|NCT02141633|69198885|FG000|Overall Study|Physician Decision|1|||
37720571|NCT02141633|69198886|FG001|Overall Study|Physician Decision|0|||
37720572|NCT01846611|69198894|FG000|Overall Study|Lost to Follow-up|4|||
37720573|NCT01846611|69198895|FG001|Overall Study|Lost to Follow-up|6|||
37720574|NCT01846611|69198894|FG000|Overall Study|Withdrawal by Subject|15|||
37720575|NCT01846611|69198895|FG001|Overall Study|Withdrawal by Subject|19|||
37720576|NCT01846611|69198894|FG000|Overall Study|Other|19|||
37720577|NCT01846611|69198895|FG001|Overall Study|Other|18|||
37720578|NCT02141399|69198901|FG000|Overall Study|Adverse Event|158|||
37720579|NCT02141399|69198901|FG000|Overall Study|Lack of Efficacy|62|||
37720580|NCT02141399|69198901|FG000|Overall Study|Lost to Follow-up|151|||
37720581|NCT02141399|69198901|FG000|Overall Study|Non-compliance with study drug|18|||
37720582|NCT02141399|69198901|FG000|Overall Study|Other|45|||
37840236|NCT00475865|69524471|FG001|Overall Study|Progressive disease|1|||
37840237|NCT00475865|69524472|FG002|Overall Study|Progressive disease|2|||
37720583|NCT02141399|69198901|FG000|Overall Study|Physician Decision|17|||
37840238|NCT00475865|69524470|FG000|Overall Study|Participant did not wish to continue|1|||
37720584|NCT02141399|69198901|FG000|Overall Study|Pregnancy|3|||
37720585|NCT02141399|69198901|FG000|Overall Study|Protocol Violation|38|||
37720586|NCT02141399|69198901|FG000|Overall Study|Withdrawal by Subject|238|||
37720587|NCT02141399|69198901|FG000|Overall Study|Failure to meet eligibility criteria|14|||
37720588|NCT01846299|69198907|FG000|Overall Study|Physician Decision|4|||
37720589|NCT01846299|69198908|FG001|Overall Study|Physician Decision|2|||
37840239|NCT00475865|69524471|FG001|Overall Study|Participant did not wish to continue|0|||
37840240|NCT00475865|69524472|FG002|Overall Study|Participant did not wish to continue|0|||
37840241|NCT00475865|69524470|FG000|Overall Study|Other than above|0|||
37840242|NCT00475865|69524471|FG001|Overall Study|Other than above|1|||
37840243|NCT00475865|69524472|FG002|Overall Study|Other than above|0|||
37840244|NCT00475709|69524482|FG000|Overall Study|Did not meet eligibility criteria|8|||
37840245|NCT00475709|69524482|FG000|Overall Study|Death|41|||
37720590|NCT01846299|69198907|FG000|Overall Study|Protocol deviation|1|||
37720591|NCT01846299|69198908|FG001|Overall Study|Protocol deviation|0|||
37720592|NCT01846299|69198907|FG000|Overall Study|Death|1|||
37720593|NCT01846299|69198908|FG001|Overall Study|Death|2|||
37720594|NCT01846299|69198907|FG000|Overall Study|Lost to Follow-up|3|||
37720595|NCT01846299|69198908|FG001|Overall Study|Lost to Follow-up|0|||
37720596|NCT01846299|69198907|FG000|Overall Study|Withdrawal by Subject|1|||
37720597|NCT01846299|69198908|FG001|Overall Study|Withdrawal by Subject|6|||
37720598|NCT01846299|69198907|FG000|Overall Study|Adverse Event|2|||
37720599|NCT01846299|69198908|FG001|Overall Study|Adverse Event|0|||
37720600|NCT01628393|69198919|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
37720601|NCT01628393|69198920|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
37720602|NCT01628393|69198921|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
37720603|NCT01628393|69198922|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
37720604|NCT01628393|69198923|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
37720605|NCT01628393|69198919|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
37720606|NCT01628393|69198920|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
37720607|NCT01628393|69198921|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
37720608|NCT01628393|69198922|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
37720609|NCT01628393|69198923|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
37720610|NCT01628393|69198919|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
37720611|NCT01628393|69198920|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
37720612|NCT01628393|69198921|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
37720613|NCT01628393|69198922|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
37720614|NCT01628393|69198923|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
37720615|NCT01628393|69198919|FG000|Blinded Active Extension Period|Adverse Event|0|||
37720616|NCT01628393|69198920|FG001|Blinded Active Extension Period|Adverse Event|1|||
37720617|NCT01628393|69198921|FG002|Blinded Active Extension Period|Adverse Event|0|||
37720618|NCT01628393|69198922|FG003|Blinded Active Extension Period|Adverse Event|2|||
37720619|NCT01628393|69198923|FG004|Blinded Active Extension Period|Adverse Event|2|||
37720620|NCT01628393|69198919|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
37720621|NCT01628393|69198920|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
37720622|NCT01628393|69198921|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
37720623|NCT01628393|69198922|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
37720624|NCT01628393|69198923|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
37720625|NCT01628393|69198919|FG000|Blinded Active Extension Period|Physician Decision|0|||
37720626|NCT01628393|69198920|FG001|Blinded Active Extension Period|Physician Decision|3|||
37720627|NCT01628393|69198921|FG002|Blinded Active Extension Period|Physician Decision|0|||
37720628|NCT01628393|69198922|FG003|Blinded Active Extension Period|Physician Decision|1|||
37720629|NCT01628393|69198923|FG004|Blinded Active Extension Period|Physician Decision|0|||
37720630|NCT01628393|69198919|FG000|Blinded Active Extension Period|Protocol Violation|0|||
37840246|NCT00475709|69524482|FG000|Overall Study|Device Explant|6|||
37840247|NCT00475709|69524482|FG000|Overall Study|Lost to Follow-up|21|||
37840248|NCT00475670|69524488|FG000|Overall Study|Death|0|||
37840249|NCT00475670|69524489|FG001|Overall Study|Death|1|||
37840250|NCT00475670|69524488|FG000|Overall Study|Lack of Efficacy|3|||
37840251|NCT00475670|69524489|FG001|Overall Study|Lack of Efficacy|34|||
37840252|NCT00475670|69524488|FG000|Overall Study|Refused treatment|0|||
37840253|NCT00475670|69524489|FG001|Overall Study|Refused treatment|2|||
37840254|NCT00475670|69524488|FG000|Overall Study|Failure to Return|0|||
37840255|NCT00475670|69524489|FG001|Overall Study|Failure to Return|1|||
37840256|NCT00475670|69524488|FG000|Overall Study|Other|0|||
37840257|NCT00475670|69524489|FG001|Overall Study|Other|3|||
37840258|NCT00474968|69524497|FG000|Overall Study|Withdrawal by Subject|8|||
37840259|NCT00474968|69524498|FG001|Overall Study|Withdrawal by Subject|7|||
38025081|NCT03647488|69709268|FG001|Overall Study|Participant refused to take investigational product|0|||
38025082|NCT03647488|69709269|FG002|Overall Study|Participant refused to take investigational product|0|||
38025083|NCT03693950|69709277|FG000|Overall Study|Withdrawal by Subject|1|||
38025084|NCT03693950|69709278|FG001|Overall Study|Withdrawal by Subject|0|||
38025085|NCT04110314|69709290|FG000|Overall Study|Did not meet inclusion criteria|35255|||
38025086|NCT04110314|69709291|FG001|Overall Study|Did not meet inclusion criteria|35104|||
37720631|NCT01628393|69198920|FG001|Blinded Active Extension Period|Protocol Violation|0|||
37720632|NCT01628393|69198921|FG002|Blinded Active Extension Period|Protocol Violation|2|||
37840260|NCT00474968|69524497|FG000|Overall Study|Protocol Violation|9|||
37840261|NCT00474968|69524498|FG001|Overall Study|Protocol Violation|8|||
38043534|NCT03509467|69731654|FG002|Overall Study|Proxy Withdrawal|0|||
37840262|NCT00474968|69524497|FG000|Overall Study|Sample not collected|1|||
37840263|NCT00474968|69524498|FG001|Overall Study|Sample not collected|1|||
37840264|NCT00474929|69524509|FG000|Overall Study|Withdrawal by Subject|0|||
37840265|NCT00474929|69524510|FG001|Overall Study|Withdrawal by Subject|1|||
37840266|NCT00474929|69524511|FG002|Overall Study|Withdrawal by Subject|0|||
37840267|NCT00474929|69524512|FG003|Overall Study|Withdrawal by Subject|0|||
37840268|NCT00474929|69524513|FG004|Overall Study|Withdrawal by Subject|0|||
37840269|NCT00474929|69524509|FG000|Overall Study|Unrelated medical condition|0|||
37840270|NCT00474929|69524510|FG001|Overall Study|Unrelated medical condition|0|||
37840271|NCT00474929|69524511|FG002|Overall Study|Unrelated medical condition|1|||
37840272|NCT00474929|69524512|FG003|Overall Study|Unrelated medical condition|0|||
37840273|NCT00474929|69524513|FG004|Overall Study|Unrelated medical condition|0|||
37840274|NCT00474929|69524509|FG000|Overall Study|Physician Decision|0|||
37840275|NCT00474929|69524510|FG001|Overall Study|Physician Decision|0|||
38025087|NCT04110314|69709292|FG002|Overall Study|Did not meet inclusion criteria|35636|||
38025088|NCT04110314|69709293|FG003|Overall Study|Did not meet inclusion criteria|35135|||
38025089|NCT04110314|69709294|FG004|Overall Study|Did not meet inclusion criteria|35247|||
38025090|NCT04110314|69709295|FG005|Overall Study|Did not meet inclusion criteria|35727|||
38025091|NCT04098458|69709307|FG000|Overall Study|Death|1|||
38025092|NCT04098458|69709307|FG000|Overall Study|did not meet study inclusion criteria|3|||
37720633|NCT01628393|69198922|FG003|Blinded Active Extension Period|Protocol Violation|1|||
37720634|NCT01628393|69198923|FG004|Blinded Active Extension Period|Protocol Violation|0|||
37720635|NCT01628393|69198919|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
37720636|NCT01628393|69198920|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
37720637|NCT01628393|69198921|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
37720638|NCT01628393|69198922|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
37720639|NCT01628393|69198923|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
37720640|NCT01846221|69198939|FG000|Overall Study|Catheter Failure|2|||
37720641|NCT01846221|69198940|FG001|Overall Study|Catheter Failure|0|||
37720642|NCT01846221|69198939|FG000|Overall Study|Age Exclusion|1|||
37720643|NCT01846221|69198940|FG001|Overall Study|Age Exclusion|0|||
37720644|NCT01815099|69198946|FG000|Overall Study|Lack of Efficacy|1|||
37720645|NCT01815099|69198946|FG000|Overall Study|unable to attend study visits|1|||
37720646|NCT01845831|69198953|FG000|Inpatient Phase|Withdrawal by Subject|1|||
37720647|NCT01845831|69198954|FG001|Inpatient Phase|Withdrawal by Subject|1|||
37720648|NCT01845831|69198955|FG002|Inpatient Phase|Withdrawal by Subject|0|||
37720649|NCT01845831|69198956|FG003|Inpatient Phase|Withdrawal by Subject|0|||
37720650|NCT01845831|69198957|FG004|Inpatient Phase|Withdrawal by Subject|0|||
37720651|NCT01627691|69198968|FG000|Overall Study|Death|11|||
38025093|NCT03447262|69709312|FG000|Overall Study|Adverse Event|7|||
38025094|NCT03447262|69709312|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
38025095|NCT03447262|69709312|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
38025096|NCT03447262|69709312|FG000|Overall Study|Death|2|||
38025097|NCT03447262|69709312|FG000|Overall Study|Study Termination by Sponsor|455|||
38025098|NCT03447262|69709312|FG000|Overall Study|Other|4|||
38025099|NCT04094870|69709321|FG000|Overall Study|Lost to Follow-up|1|||
38025100|NCT04094870|69709322|FG001|Overall Study|Lost to Follow-up|1|||
38025101|NCT04399356|69709337|FG000|Overall Study|Lost to Follow-up|1|||
38025102|NCT04399356|69709338|FG001|Overall Study|Lost to Follow-up|1|||
38025103|NCT04399356|69709337|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
38025104|NCT04399356|69709338|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
38025105|NCT04399356|69709337|FG000|Overall Study|Withdrawal by Subject|1|||
38025106|NCT04399356|69709338|FG001|Overall Study|Withdrawal by Subject|0|||
38025107|NCT03692676|69709348|FG000|Overall Study|exclude patients with prior use|4424|||
38025108|NCT03692676|69709349|FG001|Overall Study|exclude patients with prior use|24726|||
38025109|NCT03692676|69709350|FG002|Overall Study|exclude patients with prior use|0|||
38025110|NCT03692676|69709351|FG003|Overall Study|exclude patients with prior use|0|||
37720652|NCT01627691|69198968|FG000|Overall Study|Lost to Follow-up|3|||
37720653|NCT01627691|69198968|FG000|Overall Study|Withdrawal by Subject|1|||
37840276|NCT00474929|69524511|FG002|Overall Study|Physician Decision|1|||
37840277|NCT00474929|69524512|FG003|Overall Study|Physician Decision|2|||
37840278|NCT00474929|69524513|FG004|Overall Study|Physician Decision|0|||
37840279|NCT00474812|69524526|FG000|Overall Study|Withdrawal by Subject|5|||
38025111|NCT03692676|69709348|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
38025112|NCT03692676|69709349|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
38025113|NCT03692676|69709350|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
37720654|NCT01627691|69198968|FG000|Overall Study|Missed the visit|3|||
37720655|NCT01844895|69198972|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
37720656|NCT01844895|69198972|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
37720657|NCT01844895|69198972|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
37840280|NCT00474812|69524526|FG000|Overall Study|No Initiation of treatment|2|||
37840281|NCT00474383|69524530|FG000|Main Study|Adverse Event|11|||
37720658|NCT01844895|69198972|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
37720659|NCT01844895|69198972|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
37720660|NCT01844895|69198972|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
37720661|NCT01844895|69198972|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
37720662|NCT02116361|69198989|FG000|Overall Study|Pregnancy|0|||
37720663|NCT02116361|69198990|FG001|Overall Study|Pregnancy|0|||
37720664|NCT02116361|69198991|FG002|Overall Study|Pregnancy|0|||
37720665|NCT02116361|69198992|FG003|Overall Study|Pregnancy|1|||
37720666|NCT02116361|69198989|FG000|Overall Study|Protocol Violation|1|||
37720667|NCT02116361|69198990|FG001|Overall Study|Protocol Violation|0|||
37720668|NCT02116361|69198991|FG002|Overall Study|Protocol Violation|0|||
37720669|NCT02116361|69198992|FG003|Overall Study|Protocol Violation|2|||
37720670|NCT02116361|69198989|FG000|Overall Study|Physician Decision|2|||
37720671|NCT02116361|69198990|FG001|Overall Study|Physician Decision|3|||
37720672|NCT02116361|69198991|FG002|Overall Study|Physician Decision|0|||
37720673|NCT02116361|69198992|FG003|Overall Study|Physician Decision|0|||
37720674|NCT02116361|69198989|FG000|Overall Study|Adverse Event|1|||
37720675|NCT02116361|69198990|FG001|Overall Study|Adverse Event|0|||
37720676|NCT02116361|69198991|FG002|Overall Study|Adverse Event|0|||
37720677|NCT02116361|69198992|FG003|Overall Study|Adverse Event|3|||
37720678|NCT02116361|69198989|FG000|Overall Study|Other Reasons|3|||
37720679|NCT02116361|69198990|FG001|Overall Study|Other Reasons|3|||
37720680|NCT02116361|69198991|FG002|Overall Study|Other Reasons|3|||
37720681|NCT02116361|69198992|FG003|Overall Study|Other Reasons|3|||
37720682|NCT02116361|69198989|FG000|Overall Study|Lack of Efficacy|5|||
37720683|NCT02116361|69198990|FG001|Overall Study|Lack of Efficacy|7|||
37720684|NCT02116361|69198991|FG002|Overall Study|Lack of Efficacy|4|||
37840282|NCT00474383|69524531|FG001|Main Study|Adverse Event|0|||
37840283|NCT00474383|69524530|FG000|Main Study|Symptomatic Deterioration|1|||
37840284|NCT00474383|69524531|FG001|Main Study|Symptomatic Deterioration|0|||
37840285|NCT00474383|69524530|FG000|Main Study|Progressive Disease|23|||
37840286|NCT00474383|69524531|FG001|Main Study|Progressive Disease|0|||
37840287|NCT00474383|69524530|FG000|Main Study|Other|1|||
37840288|NCT00474383|69524531|FG001|Main Study|Other|0|||
37840289|NCT00474383|69524530|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
37840290|NCT00474383|69524531|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
37840291|NCT00474383|69524530|FG000|Extension|Progressive Disease|0|||
37840292|NCT00474383|69524531|FG001|Extension|Progressive Disease|5|||
37840293|NCT00474266|69524539|FG000|Overall Study|Withdrawal by Subject|7|||
37840294|NCT00474266|69524540|FG001|Overall Study|Withdrawal by Subject|20|||
37840295|NCT00474266|69524541|FG002|Overall Study|Withdrawal by Subject|4|||
37840296|NCT00474266|69524542|FG003|Overall Study|Withdrawal by Subject|7|||
37840297|NCT00473564|69524555|FG000|Overall Study|robot surgery aborted in OR|23|||
37840298|NCT00472199|69524561|FG000|Overall Study|Adverse Event|19|||
37840299|NCT00472199|69524562|FG001|Overall Study|Adverse Event|23|||
37840300|NCT00472199|69524561|FG000|Overall Study|Lack of Efficacy|4|||
37840301|NCT00472199|69524562|FG001|Overall Study|Lack of Efficacy|25|||
37840302|NCT00472199|69524561|FG000|Overall Study|Lost to Follow-up|2|||
37840303|NCT00472199|69524562|FG001|Overall Study|Lost to Follow-up|4|||
37840304|NCT00472199|69524561|FG000|Overall Study|Protocol Violation|3|||
37840305|NCT00472199|69524562|FG001|Overall Study|Protocol Violation|2|||
37840306|NCT00472199|69524561|FG000|Overall Study|Withdrawal by Subject|6|||
37840307|NCT00472199|69524562|FG001|Overall Study|Withdrawal by Subject|5|||
37840308|NCT00472199|69524561|FG000|Overall Study|personal reason|0|||
37840309|NCT00472199|69524562|FG001|Overall Study|personal reason|1|||
37840310|NCT00472199|69524561|FG000|Overall Study|patient was asymptomatic|1|||
37840311|NCT00472199|69524562|FG001|Overall Study|patient was asymptomatic|0|||
37840312|NCT00472082|69524568|FG000|Overall Study|Study prematurely terminated|5|||
37840313|NCT00471887|69524572|FG000|Overall Study|Adverse Event|9|||
38025114|NCT03692676|69709351|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
37720685|NCT02116361|69198992|FG003|Overall Study|Lack of Efficacy|3|||
37840314|NCT00471536|69524576|FG000|Overall Study|Withdrawal by Subject|1|||
37720686|NCT02116361|69198989|FG000|Overall Study|Lost to Follow-up|4|||
37840315|NCT00470834|69524582|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
37840316|NCT00470834|69524583|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
37840317|NCT00470834|69524582|FG000|Treatment Period (18 Months)|Adverse Event|7|||
37840318|NCT00470834|69524583|FG001|Treatment Period (18 Months)|Adverse Event|6|||
37840319|NCT00470834|69524582|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
37840320|NCT00470834|69524583|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
37915561|NCT00882362|69602324|FG001|Overall Study|Lack of Efficacy|0|||
37720687|NCT02116361|69198990|FG001|Overall Study|Lost to Follow-up|5|||
37720688|NCT02116361|69198991|FG002|Overall Study|Lost to Follow-up|7|||
37720689|NCT02116361|69198992|FG003|Overall Study|Lost to Follow-up|5|||
37720690|NCT02116361|69198989|FG000|Overall Study|Personal Reasons|6|||
37720691|NCT02116361|69198990|FG001|Overall Study|Personal Reasons|6|||
37720692|NCT02116361|69198991|FG002|Overall Study|Personal Reasons|4|||
37720693|NCT02116361|69198992|FG003|Overall Study|Personal Reasons|9|||
37720694|NCT02116361|69198989|FG000|Overall Study|Investigator Decision - Relapse|9|||
37720695|NCT02116361|69198990|FG001|Overall Study|Investigator Decision - Relapse|7|||
37720696|NCT02116361|69198991|FG002|Overall Study|Investigator Decision - Relapse|8|||
37720697|NCT02116361|69198992|FG003|Overall Study|Investigator Decision - Relapse|5|||
37720698|NCT02140775|69199004|FG000|Overall Study|Withdrawal by Subject|30|||
37720699|NCT02140775|69199005|FG001|Overall Study|Withdrawal by Subject|7|||
37720700|NCT01844817|69199015|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
37720701|NCT01844817|69199016|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
37720702|NCT01844817|69199015|FG000|Treatment|Progressive Disease|27|||
37720703|NCT01844817|69199016|FG001|Treatment|Progressive Disease|36|||
37720704|NCT01844817|69199015|FG000|Treatment|Adverse Event|17|||
37720705|NCT01844817|69199016|FG001|Treatment|Adverse Event|9|||
37720706|NCT01844817|69199015|FG000|Treatment|Withdrawal by Subject|10|||
37720707|NCT01844817|69199016|FG001|Treatment|Withdrawal by Subject|6|||
37720708|NCT01844817|69199015|FG000|Treatment|Death|10|||
37720709|NCT01844817|69199016|FG001|Treatment|Death|8|||
37720710|NCT01844817|69199015|FG000|Treatment|Lost to Follow-up|0|||
37720711|NCT01844817|69199016|FG001|Treatment|Lost to Follow-up|1|||
37720712|NCT01844817|69199015|FG000|Treatment|Other|0|||
37720713|NCT01844817|69199016|FG001|Treatment|Other|3|||
37720714|NCT01814553|69199025|FG000|Overall Study|PD per clinical progression|6|||
37720715|NCT01814553|69199026|FG001|Overall Study|PD per clinical progression|8|||
37720716|NCT01814553|69199025|FG000|Overall Study|Other Adverse Event|4|||
37720717|NCT01814553|69199026|FG001|Overall Study|Other Adverse Event|5|||
37720718|NCT01814553|69199025|FG000|Overall Study|Withdrawal by Subject|1|||
37720719|NCT01814553|69199026|FG001|Overall Study|Withdrawal by Subject|1|||
37720720|NCT01814553|69199025|FG000|Overall Study|Other than stated|7|||
37720721|NCT01814553|69199026|FG001|Overall Study|Other than stated|8|||
37720722|NCT02116205|69199036|FG000|Overall Study|Withdrawal by Subject|2|||
37720723|NCT02116205|69199037|FG001|Overall Study|Withdrawal by Subject|4|||
37720724|NCT02116205|69199038|FG002|Overall Study|Withdrawal by Subject|1|||
37720725|NCT02116205|69199039|FG003|Overall Study|Withdrawal by Subject|3|||
37720726|NCT02116205|69199036|FG000|Overall Study|Lost to Follow-up|0|||
37720727|NCT02116205|69199037|FG001|Overall Study|Lost to Follow-up|2|||
37720728|NCT02116205|69199038|FG002|Overall Study|Lost to Follow-up|1|||
37720729|NCT02116205|69199039|FG003|Overall Study|Lost to Follow-up|2|||
37720730|NCT02116205|69199036|FG000|Overall Study|Physician Decision|0|||
37720731|NCT02116205|69199037|FG001|Overall Study|Physician Decision|1|||
37720732|NCT02116205|69199038|FG002|Overall Study|Physician Decision|1|||
37720733|NCT02116205|69199039|FG003|Overall Study|Physician Decision|1|||
37720734|NCT02116205|69199036|FG000|Overall Study|Exclusion criteria|0|||
37720735|NCT02116205|69199037|FG001|Overall Study|Exclusion criteria|0|||
37720736|NCT02116205|69199038|FG002|Overall Study|Exclusion criteria|1|||
37720737|NCT02116205|69199039|FG003|Overall Study|Exclusion criteria|0|||
37720738|NCT01844583|69199051|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
37720739|NCT01844583|69199052|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
37720740|NCT02115815|69199070|FG000|Overall Study|Withdrawal by Subject|2|||
37720741|NCT02115815|69199071|FG001|Overall Study|Withdrawal by Subject|0|||
37720742|NCT02115815|69199072|FG002|Overall Study|Withdrawal by Subject|0|||
37720743|NCT02115815|69199073|FG003|Overall Study|Withdrawal by Subject|0|||
37720744|NCT02115815|69199074|FG004|Overall Study|Withdrawal by Subject|0|||
37720745|NCT02115815|69199075|FG005|Overall Study|Withdrawal by Subject|0|||
37720746|NCT02115815|69199076|FG006|Overall Study|Withdrawal by Subject|0|||
37720747|NCT02115815|69199070|FG000|Overall Study|Not enough drug to dose participant|0|||
37720748|NCT02115815|69199071|FG001|Overall Study|Not enough drug to dose participant|0|||
37720749|NCT02115815|69199072|FG002|Overall Study|Not enough drug to dose participant|0|||
37720750|NCT02115815|69199073|FG003|Overall Study|Not enough drug to dose participant|0|||
37720751|NCT02115815|69199074|FG004|Overall Study|Not enough drug to dose participant|0|||
37720752|NCT02115815|69199075|FG005|Overall Study|Not enough drug to dose participant|1|||
38043535|NCT03509467|69731655|FG003|Overall Study|Proxy Withdrawal|0|||
37720753|NCT02115815|69199076|FG006|Overall Study|Not enough drug to dose participant|0|||
37720754|NCT02115815|69199070|FG000|Overall Study|Missed appointment, randomized in error|0|||
37720755|NCT02115815|69199071|FG001|Overall Study|Missed appointment, randomized in error|0|||
37720756|NCT02115815|69199072|FG002|Overall Study|Missed appointment, randomized in error|0|||
37720757|NCT02115815|69199073|FG003|Overall Study|Missed appointment, randomized in error|0|||
37720758|NCT02115815|69199074|FG004|Overall Study|Missed appointment, randomized in error|0|||
37720759|NCT02115815|69199075|FG005|Overall Study|Missed appointment, randomized in error|1|||
37720760|NCT02115815|69199076|FG006|Overall Study|Missed appointment, randomized in error|0|||
37720761|NCT02115269|69199092|FG000|Overall Study|Lost to Follow-up|43|||
37720762|NCT02115269|69199092|FG000|Overall Study|Did not complete patient diary|3|||
37720763|NCT02115269|69199092|FG000|Overall Study|Moved to another city|7|||
37720764|NCT02115269|69199092|FG000|Overall Study|Withdrawal by Subject|2|||
37720765|NCT02115269|69199092|FG000|Overall Study|Didn't take study drug|2|||
37720766|NCT02115113|69199107|FG000|Participants in Run-in Period|Death|0|||
37720767|NCT02115113|69199108|FG001|Participants in Run-in Period|Death|0|||
37720768|NCT02115113|69199109|FG002|Participants in Run-in Period|Death|1|||
37720769|NCT02115113|69199107|FG000|Participants in Run-in Period|Administrative problems|0|||
37720770|NCT02115113|69199108|FG001|Participants in Run-in Period|Administrative problems|0|||
37720771|NCT02115113|69199109|FG002|Participants in Run-in Period|Administrative problems|1|||
37720772|NCT02115113|69199107|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
37720773|NCT02115113|69199108|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
37720774|NCT02115113|69199109|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
37720775|NCT02115113|69199107|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
37720776|NCT02115113|69199108|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
37720777|NCT02115113|69199109|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
37720778|NCT02115113|69199107|FG000|Participants Randomized|Lost to Follow-up|1|||
37720779|NCT02115113|69199108|FG001|Participants Randomized|Lost to Follow-up|0|||
37720780|NCT02115113|69199109|FG002|Participants Randomized|Lost to Follow-up|0|||
37720781|NCT02115113|69199107|FG000|Participants Randomized|Death|1|||
37720782|NCT02115113|69199108|FG001|Participants Randomized|Death|0|||
37720783|NCT02115113|69199109|FG002|Participants Randomized|Death|0|||
37720784|NCT02114879|69199120|FG000|Overall Study|Withdrawal by Subject|9|||
37720785|NCT02114879|69199121|FG001|Overall Study|Withdrawal by Subject|5|||
37720786|NCT02114879|69199120|FG000|Overall Study|Death|6|||
37720787|NCT02114879|69199121|FG001|Overall Study|Death|11|||
37720788|NCT02114879|69199120|FG000|Overall Study|Lost to Follow-up|4|||
37720789|NCT02114879|69199121|FG001|Overall Study|Lost to Follow-up|6|||
37720790|NCT02114879|69199120|FG000|Overall Study|Physician Decision|0|||
37720791|NCT02114879|69199121|FG001|Overall Study|Physician Decision|2|||
37720792|NCT02114177|69199129|FG000|Overall Study|Lost to Follow-up|1|||
37720793|NCT02114177|69199130|FG001|Overall Study|Lost to Follow-up|2|||
37720794|NCT02114177|69199129|FG000|Overall Study|Withdrawal by Subject|6|||
37720795|NCT02114177|69199130|FG001|Overall Study|Withdrawal by Subject|1|||
37720796|NCT02114177|69199129|FG000|Overall Study|Other|2|||
37720797|NCT02114177|69199130|FG001|Overall Study|Other|1|||
37720798|NCT02138825|69199138|FG000|Main Study Treatment|Adverse Event|11|||
37720799|NCT02138825|69199139|FG001|Main Study Treatment|Adverse Event|3|||
37720800|NCT02138825|69199138|FG000|Main Study Treatment|Death|1|||
37720801|NCT02138825|69199139|FG001|Main Study Treatment|Death|2|||
37720802|NCT02138825|69199138|FG000|Main Study Treatment|Protocol Violation|2|||
37720803|NCT02138825|69199139|FG001|Main Study Treatment|Protocol Violation|2|||
37720804|NCT02138825|69199138|FG000|Main Study Treatment|Sponsor decision|12|||
37720805|NCT02138825|69199139|FG001|Main Study Treatment|Sponsor decision|18|||
37720806|NCT02138825|69199138|FG000|Main Study Treatment|Study terminated by sponsor|10|||
37720807|NCT02138825|69199139|FG001|Main Study Treatment|Study terminated by sponsor|9|||
37720808|NCT02138825|69199138|FG000|Main Study Treatment|Withdrawal by Subject|3|||
37720809|NCT02138825|69199139|FG001|Main Study Treatment|Withdrawal by Subject|1|||
37720810|NCT02138825|69199138|FG000|Main Study Treatment|Medical decision|1|||
37720811|NCT02138825|69199139|FG001|Main Study Treatment|Medical decision|0|||
37720812|NCT02138825|69199138|FG000|Long-term Extension|Study termination by sponsor|32|||
37720813|NCT02138825|69199139|FG001|Long-term Extension|Study termination by sponsor|38|||
37720814|NCT02138825|69199138|FG000|Safety Follow-up|Adverse Event|4|||
37720815|NCT02138825|69199139|FG001|Safety Follow-up|Adverse Event|3|||
37720816|NCT02138825|69199138|FG000|Safety Follow-up|Death|11|||
37720817|NCT02138825|69199139|FG001|Safety Follow-up|Death|5|||
37720818|NCT02138825|69199138|FG000|Safety Follow-up|Withdrawal by Subject|5|||
37720819|NCT02138825|69199139|FG001|Safety Follow-up|Withdrawal by Subject|3|||
37720820|NCT02138825|69199138|FG000|Safety Follow-up|clinic worsening|1|||
37720821|NCT02138825|69199139|FG001|Safety Follow-up|clinic worsening|0|||
37720822|NCT02138825|69199138|FG000|Safety Follow-up|withdrawal by PI|1|||
37720823|NCT02138825|69199139|FG001|Safety Follow-up|withdrawal by PI|0|||
37720824|NCT02138825|69199138|FG000|Safety Follow-up|logistical difficulties|0|||
37720825|NCT02138825|69199139|FG001|Safety Follow-up|logistical difficulties|1|||
37720826|NCT02138825|69199138|FG000|Safety Follow-up|progressive disease|0|||
37720827|NCT02138825|69199139|FG001|Safety Follow-up|progressive disease|2|||
37720828|NCT02138825|69199138|FG000|Safety Follow-up|too unwell to attend the visit|0|||
37720829|NCT02138825|69199139|FG001|Safety Follow-up|too unwell to attend the visit|1|||
37720830|NCT02138825|69199138|FG000|Safety Follow-up|treatment unblinded|0|||
37720831|NCT02138825|69199139|FG001|Safety Follow-up|treatment unblinded|1|||
37720832|NCT02138825|69199138|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
37720833|NCT02138825|69199139|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
37720834|NCT02138747|69199154|FG000|Treatment Period 1|Adverse Event|10|||
37720835|NCT02138747|69199155|FG001|Treatment Period 1|Adverse Event|14|||
37720836|NCT02138747|69199156|FG002|Treatment Period 1|Adverse Event|2|||
37720837|NCT02138747|69199157|FG003|Treatment Period 1|Adverse Event|1|||
37720838|NCT02138747|69199154|FG000|Treatment Period 1|Lost to Follow-up|0|||
37720839|NCT02138747|69199155|FG001|Treatment Period 1|Lost to Follow-up|1|||
37720840|NCT02138747|69199156|FG002|Treatment Period 1|Lost to Follow-up|1|||
37720841|NCT02138747|69199157|FG003|Treatment Period 1|Lost to Follow-up|0|||
37720842|NCT02138747|69199154|FG000|Treatment Period 1|Protocol Violation|0|||
37720843|NCT02138747|69199155|FG001|Treatment Period 1|Protocol Violation|2|||
37720844|NCT02138747|69199156|FG002|Treatment Period 1|Protocol Violation|0|||
37720845|NCT02138747|69199157|FG003|Treatment Period 1|Protocol Violation|0|||
37720846|NCT02138747|69199154|FG000|Treatment Period 1|Withdrawal by Subject|8|||
37720847|NCT02138747|69199155|FG001|Treatment Period 1|Withdrawal by Subject|4|||
37720848|NCT02138747|69199156|FG002|Treatment Period 1|Withdrawal by Subject|1|||
37720849|NCT02138747|69199157|FG003|Treatment Period 1|Withdrawal by Subject|3|||
37720850|NCT02138747|69199154|FG000|Treatment Period 1|Other - Miscellaneous|2|||
37720851|NCT02138747|69199155|FG001|Treatment Period 1|Other - Miscellaneous|4|||
37720852|NCT02138747|69199156|FG002|Treatment Period 1|Other - Miscellaneous|0|||
37720853|NCT02138747|69199157|FG003|Treatment Period 1|Other - Miscellaneous|0|||
37720854|NCT02138747|69199154|FG000|Treatment Period 2|Adverse Event|6|||
37720855|NCT02138747|69199155|FG001|Treatment Period 2|Adverse Event|3|||
37720856|NCT02138747|69199156|FG002|Treatment Period 2|Adverse Event|1|||
37720857|NCT02138747|69199157|FG003|Treatment Period 2|Adverse Event|1|||
37720858|NCT02138747|69199154|FG000|Treatment Period 2|Lost to Follow-up|2|||
37720859|NCT02138747|69199155|FG001|Treatment Period 2|Lost to Follow-up|0|||
37720860|NCT02138747|69199156|FG002|Treatment Period 2|Lost to Follow-up|0|||
37720861|NCT02138747|69199157|FG003|Treatment Period 2|Lost to Follow-up|0|||
37720862|NCT02138747|69199154|FG000|Treatment Period 2|Protocol Violation|1|||
37720863|NCT02138747|69199155|FG001|Treatment Period 2|Protocol Violation|0|||
37720864|NCT02138747|69199156|FG002|Treatment Period 2|Protocol Violation|0|||
37720865|NCT02138747|69199157|FG003|Treatment Period 2|Protocol Violation|0|||
37720866|NCT02138747|69199154|FG000|Treatment Period 2|Withdrawal by Subject|5|||
37720867|NCT02138747|69199155|FG001|Treatment Period 2|Withdrawal by Subject|4|||
37720868|NCT02138747|69199156|FG002|Treatment Period 2|Withdrawal by Subject|1|||
37720869|NCT02138747|69199157|FG003|Treatment Period 2|Withdrawal by Subject|2|||
37720870|NCT02138747|69199154|FG000|Treatment Period 2|Other - Miscellaneous|3|||
37720871|NCT02138747|69199155|FG001|Treatment Period 2|Other - Miscellaneous|0|||
37720872|NCT02138747|69199156|FG002|Treatment Period 2|Other - Miscellaneous|0|||
37720873|NCT02138747|69199157|FG003|Treatment Period 2|Other - Miscellaneous|0|||
37720874|NCT02105285|69199170|FG000|Overall Study|Adverse Event|1|||
37720875|NCT02105285|69199171|FG001|Overall Study|Adverse Event|1|||
37720876|NCT02105285|69199172|FG002|Overall Study|Adverse Event|0|||
37720877|NCT02105285|69199170|FG000|Overall Study|Protocol Violation|0|||
37720878|NCT02105285|69199171|FG001|Overall Study|Protocol Violation|1|||
37720879|NCT02105285|69199172|FG002|Overall Study|Protocol Violation|0|||
37720880|NCT02105285|69199170|FG000|Overall Study|Withdrawal by Subject|1|||
37720881|NCT02105285|69199171|FG001|Overall Study|Withdrawal by Subject|0|||
37720882|NCT02105285|69199172|FG002|Overall Study|Withdrawal by Subject|0|||
37720883|NCT02104895|69199181|FG000|Overall Study|Withdrawal by Subject|0|||
37720884|NCT02104895|69199182|FG001|Overall Study|Withdrawal by Subject|14|||
37720885|NCT01621490|69199197|FG000|Overall Study|Participant completed treatment|4|||
37720886|NCT01621490|69199198|FG001|Overall Study|Participant completed treatment|4|||
37720887|NCT01621490|69199199|FG002|Overall Study|Participant completed treatment|1|||
37720888|NCT01621490|69199200|FG003|Overall Study|Participant completed treatment|0|||
37720889|NCT01621490|69199201|FG004|Overall Study|Participant completed treatment|0|||
37720890|NCT01621490|69199202|FG005|Overall Study|Participant completed treatment|0|||
37720891|NCT01621490|69199203|FG006|Overall Study|Participant completed treatment|0|||
37720892|NCT01621490|69199204|FG007|Overall Study|Participant completed treatment|1|||
37720893|NCT01621490|69199205|FG008|Overall Study|Participant completed treatment|0|||
37720894|NCT01621490|69199197|FG000|Overall Study|Patient could not travel|1|||
37720895|NCT01621490|69199198|FG001|Overall Study|Patient could not travel|0|||
37720896|NCT01621490|69199199|FG002|Overall Study|Patient could not travel|0|||
37720897|NCT01621490|69199200|FG003|Overall Study|Patient could not travel|0|||
37720898|NCT01621490|69199201|FG004|Overall Study|Patient could not travel|0|||
37720899|NCT01621490|69199202|FG005|Overall Study|Patient could not travel|0|||
37720900|NCT01621490|69199203|FG006|Overall Study|Patient could not travel|0|||
37720901|NCT01621490|69199204|FG007|Overall Study|Patient could not travel|0|||
37720902|NCT01621490|69199205|FG008|Overall Study|Patient could not travel|0|||
37720903|NCT01621490|69199197|FG000|Overall Study|Subject no longer meets study criteria|0|||
37720904|NCT01621490|69199198|FG001|Overall Study|Subject no longer meets study criteria|0|||
37720905|NCT01621490|69199199|FG002|Overall Study|Subject no longer meets study criteria|0|||
37720906|NCT01621490|69199200|FG003|Overall Study|Subject no longer meets study criteria|0|||
37720907|NCT01621490|69199201|FG004|Overall Study|Subject no longer meets study criteria|1|||
37720908|NCT01621490|69199202|FG005|Overall Study|Subject no longer meets study criteria|0|||
37720909|NCT01621490|69199203|FG006|Overall Study|Subject no longer meets study criteria|0|||
37720910|NCT01621490|69199204|FG007|Overall Study|Subject no longer meets study criteria|0|||
37720911|NCT01621490|69199205|FG008|Overall Study|Subject no longer meets study criteria|0|||
38043536|NCT03509467|69731656|FG004|Overall Study|Proxy Withdrawal|0|||
37720912|NCT01621490|69199197|FG000|Overall Study|Maximum clinical benefit|3|||
37720913|NCT01621490|69199198|FG001|Overall Study|Maximum clinical benefit|2|||
37720914|NCT01621490|69199199|FG002|Overall Study|Maximum clinical benefit|0|||
37720915|NCT01621490|69199200|FG003|Overall Study|Maximum clinical benefit|0|||
37720916|NCT01621490|69199201|FG004|Overall Study|Maximum clinical benefit|0|||
37720917|NCT01621490|69199202|FG005|Overall Study|Maximum clinical benefit|0|||
37720918|NCT01621490|69199203|FG006|Overall Study|Maximum clinical benefit|1|||
37720919|NCT01621490|69199204|FG007|Overall Study|Maximum clinical benefit|2|||
37720920|NCT01621490|69199205|FG008|Overall Study|Maximum clinical benefit|0|||
37720921|NCT01621490|69199197|FG000|Overall Study|Withdrawal by Subject|1|||
37720922|NCT01621490|69199198|FG001|Overall Study|Withdrawal by Subject|0|||
37720923|NCT01621490|69199199|FG002|Overall Study|Withdrawal by Subject|0|||
37720924|NCT01621490|69199200|FG003|Overall Study|Withdrawal by Subject|0|||
37720925|NCT01621490|69199201|FG004|Overall Study|Withdrawal by Subject|0|||
37720926|NCT01621490|69199202|FG005|Overall Study|Withdrawal by Subject|3|||
37720927|NCT01621490|69199203|FG006|Overall Study|Withdrawal by Subject|0|||
37720928|NCT01621490|69199204|FG007|Overall Study|Withdrawal by Subject|0|||
37720929|NCT01621490|69199205|FG008|Overall Study|Withdrawal by Subject|0|||
37720930|NCT01621490|69199197|FG000|Overall Study|Subject request to discontinue study|1|||
37720931|NCT01621490|69199198|FG001|Overall Study|Subject request to discontinue study|3|||
37720932|NCT01621490|69199199|FG002|Overall Study|Subject request to discontinue study|1|||
37720933|NCT01621490|69199200|FG003|Overall Study|Subject request to discontinue study|1|||
37720934|NCT01621490|69199201|FG004|Overall Study|Subject request to discontinue study|0|||
37720935|NCT01621490|69199202|FG005|Overall Study|Subject request to discontinue study|2|||
37720936|NCT01621490|69199203|FG006|Overall Study|Subject request to discontinue study|1|||
37720937|NCT01621490|69199204|FG007|Overall Study|Subject request to discontinue study|0|||
37720938|NCT01621490|69199205|FG008|Overall Study|Subject request to discontinue study|1|||
37720939|NCT01621490|69199197|FG000|Overall Study|Adverse event unrelated to study drug|2|||
37720940|NCT01621490|69199198|FG001|Overall Study|Adverse event unrelated to study drug|1|||
37720941|NCT01621490|69199199|FG002|Overall Study|Adverse event unrelated to study drug|0|||
37720942|NCT01621490|69199200|FG003|Overall Study|Adverse event unrelated to study drug|0|||
37720943|NCT01621490|69199201|FG004|Overall Study|Adverse event unrelated to study drug|0|||
37720944|NCT01621490|69199202|FG005|Overall Study|Adverse event unrelated to study drug|0|||
37720945|NCT01621490|69199203|FG006|Overall Study|Adverse event unrelated to study drug|0|||
37720946|NCT01621490|69199204|FG007|Overall Study|Adverse event unrelated to study drug|2|||
37720947|NCT01621490|69199205|FG008|Overall Study|Adverse event unrelated to study drug|1|||
37720948|NCT01621490|69199197|FG000|Overall Study|Disease progression|27|||
37720949|NCT01621490|69199198|FG001|Overall Study|Disease progression|28|||
37720950|NCT01621490|69199199|FG002|Overall Study|Disease progression|1|||
37720951|NCT01621490|69199200|FG003|Overall Study|Disease progression|5|||
37720952|NCT01621490|69199201|FG004|Overall Study|Disease progression|3|||
37720953|NCT01621490|69199202|FG005|Overall Study|Disease progression|8|||
37720954|NCT01621490|69199203|FG006|Overall Study|Disease progression|7|||
37720955|NCT01621490|69199204|FG007|Overall Study|Disease progression|0|||
37720956|NCT01621490|69199205|FG008|Overall Study|Disease progression|4|||
37720957|NCT01621490|69199197|FG000|Overall Study|Study drug toxicity|1|||
37720958|NCT01621490|69199198|FG001|Overall Study|Study drug toxicity|4|||
37720959|NCT01621490|69199199|FG002|Overall Study|Study drug toxicity|5|||
37720960|NCT01621490|69199200|FG003|Overall Study|Study drug toxicity|3|||
37720961|NCT01621490|69199201|FG004|Overall Study|Study drug toxicity|1|||
37720962|NCT01621490|69199202|FG005|Overall Study|Study drug toxicity|10|||
37720963|NCT01621490|69199203|FG006|Overall Study|Study drug toxicity|1|||
37720964|NCT01621490|69199204|FG007|Overall Study|Study drug toxicity|4|||
37720965|NCT01621490|69199205|FG008|Overall Study|Study drug toxicity|1|||
37720966|NCT01621490|69199197|FG000|Overall Study|Death|0|||
37720967|NCT01621490|69199198|FG001|Overall Study|Death|0|||
37720968|NCT01621490|69199199|FG002|Overall Study|Death|0|||
37720969|NCT01621490|69199200|FG003|Overall Study|Death|0|||
37720970|NCT01621490|69199201|FG004|Overall Study|Death|0|||
37720971|NCT01621490|69199202|FG005|Overall Study|Death|0|||
37720972|NCT01621490|69199203|FG006|Overall Study|Death|0|||
37720973|NCT01621490|69199204|FG007|Overall Study|Death|1|||
37720974|NCT01621490|69199205|FG008|Overall Study|Death|0|||
37720975|NCT01621490|69199197|FG000|Overall Study|Grade 4 Lipase elevation|1|||
37720976|NCT01621490|69199198|FG001|Overall Study|Grade 4 Lipase elevation|0|||
37720977|NCT01621490|69199199|FG002|Overall Study|Grade 4 Lipase elevation|0|||
37720978|NCT01621490|69199200|FG003|Overall Study|Grade 4 Lipase elevation|0|||
37720979|NCT01621490|69199201|FG004|Overall Study|Grade 4 Lipase elevation|0|||
37720980|NCT01621490|69199202|FG005|Overall Study|Grade 4 Lipase elevation|0|||
37720981|NCT01621490|69199203|FG006|Overall Study|Grade 4 Lipase elevation|0|||
37720982|NCT01621490|69199204|FG007|Overall Study|Grade 4 Lipase elevation|0|||
37720983|NCT01621490|69199205|FG008|Overall Study|Grade 4 Lipase elevation|0|||
37720984|NCT01621490|69199197|FG000|Overall Study|BMS informed of patient status|0|||
37720985|NCT01621490|69199198|FG001|Overall Study|BMS informed of patient status|0|||
37720986|NCT01621490|69199199|FG002|Overall Study|BMS informed of patient status|1|||
37720987|NCT01621490|69199200|FG003|Overall Study|BMS informed of patient status|0|||
37720988|NCT01621490|69199201|FG004|Overall Study|BMS informed of patient status|0|||
37720989|NCT01621490|69199202|FG005|Overall Study|BMS informed of patient status|0|||
37720990|NCT01621490|69199203|FG006|Overall Study|BMS informed of patient status|0|||
37720991|NCT01621490|69199204|FG007|Overall Study|BMS informed of patient status|0|||
37720992|NCT01621490|69199205|FG008|Overall Study|BMS informed of patient status|0|||
37720993|NCT01621490|69199197|FG000|Overall Study|Investigator decision|0|||
37720994|NCT01621490|69199198|FG001|Overall Study|Investigator decision|0|||
37720995|NCT01621490|69199199|FG002|Overall Study|Investigator decision|1|||
37720996|NCT01621490|69199200|FG003|Overall Study|Investigator decision|0|||
37720997|NCT01621490|69199201|FG004|Overall Study|Investigator decision|1|||
37720998|NCT01621490|69199202|FG005|Overall Study|Investigator decision|0|||
37720999|NCT01621490|69199203|FG006|Overall Study|Investigator decision|1|||
37721000|NCT01621490|69199204|FG007|Overall Study|Investigator decision|0|||
37721001|NCT01621490|69199205|FG008|Overall Study|Investigator decision|0|||
37721002|NCT01621490|69199197|FG000|Overall Study|Documented disease progression|0|||
37721003|NCT01621490|69199198|FG001|Overall Study|Documented disease progression|0|||
37721004|NCT01621490|69199199|FG002|Overall Study|Documented disease progression|1|||
37721005|NCT01621490|69199200|FG003|Overall Study|Documented disease progression|0|||
37721006|NCT01621490|69199201|FG004|Overall Study|Documented disease progression|0|||
37721007|NCT01621490|69199202|FG005|Overall Study|Documented disease progression|0|||
37721008|NCT01621490|69199203|FG006|Overall Study|Documented disease progression|0|||
37721009|NCT01621490|69199204|FG007|Overall Study|Documented disease progression|0|||
37721010|NCT01621490|69199205|FG008|Overall Study|Documented disease progression|0|||
37721011|NCT01621490|69199197|FG000|Overall Study|Patient reached treatment 2 yr limit|0|||
37721012|NCT01621490|69199198|FG001|Overall Study|Patient reached treatment 2 yr limit|1|||
37721013|NCT01621490|69199199|FG002|Overall Study|Patient reached treatment 2 yr limit|0|||
37721014|NCT01621490|69199200|FG003|Overall Study|Patient reached treatment 2 yr limit|0|||
37721015|NCT01621490|69199201|FG004|Overall Study|Patient reached treatment 2 yr limit|0|||
37721016|NCT01621490|69199202|FG005|Overall Study|Patient reached treatment 2 yr limit|0|||
37721017|NCT01621490|69199203|FG006|Overall Study|Patient reached treatment 2 yr limit|0|||
37721018|NCT01621490|69199204|FG007|Overall Study|Patient reached treatment 2 yr limit|0|||
37721019|NCT01621490|69199205|FG008|Overall Study|Patient reached treatment 2 yr limit|0|||
37721020|NCT01621490|69199197|FG000|Overall Study|Clinical deterioration|0|||
37721021|NCT01621490|69199198|FG001|Overall Study|Clinical deterioration|1|||
37721022|NCT01621490|69199199|FG002|Overall Study|Clinical deterioration|0|||
37721023|NCT01621490|69199200|FG003|Overall Study|Clinical deterioration|0|||
37721024|NCT01621490|69199201|FG004|Overall Study|Clinical deterioration|0|||
37721025|NCT01621490|69199202|FG005|Overall Study|Clinical deterioration|0|||
37721026|NCT01621490|69199203|FG006|Overall Study|Clinical deterioration|0|||
37721027|NCT01621490|69199204|FG007|Overall Study|Clinical deterioration|0|||
37721028|NCT01621490|69199205|FG008|Overall Study|Clinical deterioration|0|||
37721029|NCT01621490|69199197|FG000|Overall Study|Complete response|0|||
37721030|NCT01621490|69199198|FG001|Overall Study|Complete response|0|||
37721031|NCT01621490|69199199|FG002|Overall Study|Complete response|0|||
37721032|NCT01621490|69199200|FG003|Overall Study|Complete response|0|||
37721033|NCT01621490|69199201|FG004|Overall Study|Complete response|0|||
37721034|NCT01621490|69199202|FG005|Overall Study|Complete response|0|||
37721035|NCT01621490|69199203|FG006|Overall Study|Complete response|0|||
37721036|NCT01621490|69199204|FG007|Overall Study|Complete response|0|||
37721037|NCT01621490|69199205|FG008|Overall Study|Complete response|1|||
37721038|NCT01621490|69199197|FG000|Overall Study|Patient delayed due to toxicity|0|||
37721039|NCT01621490|69199198|FG001|Overall Study|Patient delayed due to toxicity|0|||
37721040|NCT01621490|69199199|FG002|Overall Study|Patient delayed due to toxicity|0|||
37721041|NCT01621490|69199200|FG003|Overall Study|Patient delayed due to toxicity|0|||
37721042|NCT01621490|69199201|FG004|Overall Study|Patient delayed due to toxicity|0|||
37721043|NCT01621490|69199202|FG005|Overall Study|Patient delayed due to toxicity|1|||
37721044|NCT01621490|69199203|FG006|Overall Study|Patient delayed due to toxicity|0|||
37721045|NCT01621490|69199204|FG007|Overall Study|Patient delayed due to toxicity|0|||
37721046|NCT01621490|69199205|FG008|Overall Study|Patient delayed due to toxicity|0|||
37721047|NCT02018887|69199326|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
37721048|NCT02018887|69199327|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
38025115|NCT03692676|69709348|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
37721049|NCT02018887|69199328|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
37721050|NCT02018887|69199329|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
37721051|NCT02018887|69199330|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
37721052|NCT02018887|69199331|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
37721053|NCT02018887|69199332|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
37721054|NCT02018887|69199333|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
37721055|NCT02018887|69199334|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
37721056|NCT02018887|69199335|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
37721057|NCT02018887|69199336|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
37721058|NCT02018887|69199326|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
37721059|NCT02018887|69199327|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
37721060|NCT02018887|69199328|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
37721061|NCT02018887|69199329|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
37721062|NCT02018887|69199330|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
37721063|NCT02018887|69199331|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
37721064|NCT02018887|69199332|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
37721065|NCT02018887|69199333|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
37721066|NCT02018887|69199334|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
37721067|NCT02018887|69199335|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
37721068|NCT02018887|69199336|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
37721069|NCT02018887|69199326|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
37721070|NCT02018887|69199327|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
37721071|NCT02018887|69199328|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
37721072|NCT02018887|69199329|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
37721073|NCT02018887|69199330|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
37721074|NCT02018887|69199331|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
37721075|NCT02018887|69199332|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
37721076|NCT02018887|69199333|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
37721077|NCT02018887|69199334|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
37721078|NCT02018887|69199335|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
37721079|NCT02018887|69199336|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
37721080|NCT02018887|69199326|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
37721081|NCT02018887|69199327|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
37721082|NCT02018887|69199328|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
37721083|NCT02018887|69199329|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
37721084|NCT02018887|69199330|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
37721085|NCT02018887|69199331|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
37721086|NCT02018887|69199332|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
37721087|NCT02018887|69199333|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
37721088|NCT02018887|69199334|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
37721089|NCT02018887|69199335|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
37721090|NCT02018887|69199336|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
37721091|NCT02030041|69199405|FG000|Overall Study|Withdrawal by Subject|2|||
37721092|NCT02030041|69199406|FG001|Overall Study|Withdrawal by Subject|2|||
37721093|NCT02030041|69199407|FG002|Overall Study|Withdrawal by Subject|1|||
37721094|NCT01994720|69199417|FG000|Overall Study|Withdrawal by Subject|46|||
37721095|NCT01994720|69199418|FG001|Overall Study|Withdrawal by Subject|56|||
37721096|NCT01814397|69199424|FG000|Overall Study|Adverse Event|7|||
37721097|NCT01814397|69199424|FG000|Overall Study|Withdrawal by Subject|7|||
37721098|NCT01814007|69199428|FG000|Overall Study|Withdrawal by Subject|1|||
37721099|NCT01844115|69199435|FG000|Overall Study|Adverse Event|4|||
37721100|NCT01844115|69199436|FG001|Overall Study|Adverse Event|22|||
37721101|NCT01844115|69199435|FG000|Overall Study|Lack of Efficacy|1|||
37721102|NCT01844115|69199436|FG001|Overall Study|Lack of Efficacy|4|||
37721103|NCT01844115|69199435|FG000|Overall Study|Protocol Violation|12|||
37721104|NCT01844115|69199436|FG001|Overall Study|Protocol Violation|10|||
37721105|NCT01844115|69199435|FG000|Overall Study|Withdrawal by Subject|11|||
37721106|NCT01844115|69199436|FG001|Overall Study|Withdrawal by Subject|11|||
37721107|NCT01844115|69199435|FG000|Overall Study|Lost to Follow-up|11|||
37721108|NCT01844115|69199436|FG001|Overall Study|Lost to Follow-up|10|||
37721109|NCT01844115|69199435|FG000|Overall Study|Pregnancy|0|||
37721110|NCT01844115|69199436|FG001|Overall Study|Pregnancy|1|||
37721111|NCT02018042|69199442|FG000|Overall Study|Withdrawal by Subject|1|||
37721112|NCT01813305|69199448|FG000|Overall Study|Withdrawal by Subject|12|||
37721113|NCT01813305|69199449|FG001|Overall Study|Withdrawal by Subject|5|||
37721114|NCT01813305|69199448|FG000|Overall Study|Safety Concern|4|||
37721115|NCT01813305|69199449|FG001|Overall Study|Safety Concern|0|||
37721116|NCT01813305|69199448|FG000|Overall Study|Ulcer became worse|4|||
37721117|NCT01813305|69199449|FG001|Overall Study|Ulcer became worse|0|||
37721118|NCT01813305|69199448|FG000|Overall Study|Physician Decision|4|||
37721119|NCT01813305|69199449|FG001|Overall Study|Physician Decision|0|||
37721120|NCT01813305|69199448|FG000|Overall Study|Lost to Follow-up|3|||
37721121|NCT01813305|69199449|FG001|Overall Study|Lost to Follow-up|1|||
37721122|NCT01813305|69199448|FG000|Overall Study|Protocol Violation|1|||
37721123|NCT01813305|69199449|FG001|Overall Study|Protocol Violation|0|||
37721124|NCT01813305|69199448|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
38025116|NCT03692676|69709349|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
38025117|NCT03692676|69709350|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
37721125|NCT01813305|69199449|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
37721126|NCT01993940|69199459|FG000|Overall Study|Adverse Event|16|||
38025118|NCT03692676|69709351|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
38025119|NCT03692676|69709348|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
37721127|NCT01993940|69199460|FG001|Overall Study|Adverse Event|11|||
37721128|NCT01993940|69199459|FG000|Overall Study|Withdrawal by Subject|15|||
37721129|NCT01993940|69199460|FG001|Overall Study|Withdrawal by Subject|19|||
37721130|NCT01993940|69199459|FG000|Overall Study|Lost to Follow-up|2|||
37721131|NCT01993940|69199460|FG001|Overall Study|Lost to Follow-up|5|||
37721132|NCT01993940|69199459|FG000|Overall Study|Protocol Violation|5|||
37721133|NCT01993940|69199460|FG001|Overall Study|Protocol Violation|8|||
37721134|NCT01993940|69199459|FG000|Overall Study|Death|1|||
37721135|NCT01993940|69199460|FG001|Overall Study|Death|0|||
37721136|NCT01993940|69199459|FG000|Overall Study|Other - Miscellaneous|1|||
37721137|NCT01993940|69199460|FG001|Overall Study|Other - Miscellaneous|1|||
37721138|NCT01843803|69199468|FG000|Overall Study|not a Veteran, did not see provider|1|||
37721139|NCT01843803|69199469|FG001|Overall Study|not a Veteran, did not see provider|3|||
37721140|NCT02017171|69199477|FG000|Overall Study|Death|10|||
37721141|NCT02017171|69199478|FG001|Overall Study|Death|4|||
37721142|NCT02017171|69199477|FG000|Overall Study|Withdrawal by Subject|23|||
37721143|NCT02017171|69199478|FG001|Overall Study|Withdrawal by Subject|17|||
37721144|NCT02017171|69199477|FG000|Overall Study|Lost to Follow-up|21|||
37721145|NCT02017171|69199478|FG001|Overall Study|Lost to Follow-up|20|||
37721146|NCT02017171|69199477|FG000|Overall Study|ESKD|6|||
37721147|NCT02017171|69199478|FG001|Overall Study|ESKD|2|||
37721148|NCT02017171|69199477|FG000|Overall Study|Miscellaneous|2|||
37721149|NCT02017171|69199478|FG001|Overall Study|Miscellaneous|3|||
37721150|NCT02029417|69199485|FG000|Overall Study|Death|1|||
37721151|NCT02029417|69199485|FG000|Overall Study|Adverse Event|1|||
37721152|NCT02016716|69199492|FG000|Overall Study|Withdrawal by Subject|5|||
37721153|NCT02016716|69199493|FG001|Overall Study|Withdrawal by Subject|5|||
37721154|NCT02016716|69199494|FG002|Overall Study|Withdrawal by Subject|5|||
37721155|NCT02016716|69199492|FG000|Overall Study|Protocol-specified Criteria|0|||
37721156|NCT02016716|69199493|FG001|Overall Study|Protocol-specified Criteria|1|||
37721157|NCT02016716|69199494|FG002|Overall Study|Protocol-specified Criteria|0|||
38025120|NCT03692676|69709349|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
38025121|NCT03692676|69709350|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
38025122|NCT03692676|69709351|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
38025123|NCT03692676|69709348|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
37721158|NCT02016716|69199492|FG000|Overall Study|Lost to Follow-up|1|||
37721159|NCT02016716|69199493|FG001|Overall Study|Lost to Follow-up|2|||
37721160|NCT02016716|69199494|FG002|Overall Study|Lost to Follow-up|1|||
37721161|NCT02050321|69199503|FG000|Overall Study|Withdrawal by Subject|1|||
37721162|NCT02050321|69199503|FG000|Overall Study|Adverse Event|1|||
37721163|NCT02039414|69199509|FG000|Overall Study|Delivered|1|||
37721164|NCT02039414|69199510|FG001|Overall Study|Delivered|1|||
37721165|NCT02039414|69199509|FG000|Overall Study|Lost to Follow-up|2|||
37721166|NCT02039414|69199510|FG001|Overall Study|Lost to Follow-up|0|||
37721167|NCT02039414|69199509|FG000|Overall Study|Protocol Violation|3|||
37721168|NCT02039414|69199510|FG001|Overall Study|Protocol Violation|1|||
37721169|NCT02017015|69199516|FG000|Overall Study|Adverse Event|9|||
37721170|NCT02017015|69199516|FG000|Overall Study|Withdrawal by Subject|21|||
37721171|NCT02017015|69199516|FG000|Overall Study|Death|4|||
37721172|NCT02017015|69199516|FG000|Overall Study|Progressive Disease|31|||
37721173|NCT02017015|69199516|FG000|Overall Study|Non-compliance with study drug|2|||
37721174|NCT02017015|69199516|FG000|Overall Study|Physician Decision|2|||
37721175|NCT02016625|69199523|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
37721176|NCT02016625|69199524|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
37721177|NCT02016625|69199523|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
37840321|NCT00470834|69524582|FG000|Treatment Period (18 Months)|Physician Decision|4|||
37840322|NCT00470834|69524583|FG001|Treatment Period (18 Months)|Physician Decision|4|||
37840323|NCT00470834|69524582|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
37840324|NCT00470834|69524583|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
37840325|NCT00470834|69524582|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
37840326|NCT00470834|69524583|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
37840327|NCT00470834|69524582|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
37840328|NCT00470834|69524583|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
37840329|NCT00470834|69524582|FG000|Treatment Period (18 Months)|Non-compliance|1|||
37840330|NCT00470834|69524583|FG001|Treatment Period (18 Months)|Non-compliance|0|||
37840331|NCT00470834|69524582|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
37840332|NCT00470834|69524583|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
37840333|NCT00470834|69524582|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
37721178|NCT02016625|69199524|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
37840334|NCT00470834|69524583|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
37840335|NCT00470834|69524582|FG000|Extension Period (24 Months)|Adverse Event|3|||
37721179|NCT02016625|69199523|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
37721180|NCT02016625|69199524|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
37721181|NCT02016482|69199542|FG000|Period A|Adverse Event|3|||
37840336|NCT00470834|69524583|FG001|Extension Period (24 Months)|Adverse Event|4|||
37840337|NCT00470834|69524582|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
37721182|NCT02016482|69199543|FG001|Period A|Adverse Event|5|||
37721183|NCT02016482|69199542|FG000|Period A|Withdrawal by Subject|3|||
37721184|NCT02016482|69199543|FG001|Period A|Withdrawal by Subject|4|||
37721185|NCT02016482|69199542|FG000|Period A|Lost to Follow-up|3|||
37721186|NCT02016482|69199543|FG001|Period A|Lost to Follow-up|3|||
37840338|NCT00470834|69524583|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
37840339|NCT00470834|69524582|FG000|Extension Period (24 Months)|Physician Decision|4|||
37840340|NCT00470834|69524583|FG001|Extension Period (24 Months)|Physician Decision|3|||
37840341|NCT00470834|69524582|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
37840342|NCT00470834|69524583|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
37840343|NCT00470834|69524582|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
37840344|NCT00470834|69524583|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
37721187|NCT02016482|69199542|FG000|Period A|Lack of Efficacy|2|||
37721188|NCT02016482|69199543|FG001|Period A|Lack of Efficacy|1|||
37721189|NCT02016482|69199542|FG000|Period A|Other|3|||
37721190|NCT02016482|69199543|FG001|Period A|Other|0|||
37721191|NCT02016482|69199542|FG000|Period A|Protocol Violation|0|||
37721192|NCT02016482|69199543|FG001|Period A|Protocol Violation|1|||
37721193|NCT02016482|69199542|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
37721194|NCT02016482|69199543|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
37721195|NCT02016482|69199542|FG000|Period B|Withdrawal by Subject|1|||
37721196|NCT02016482|69199543|FG001|Period B|Withdrawal by Subject|1|||
37721197|NCT02016482|69199542|FG000|Period B|Lost to Follow-up|2|||
37721198|NCT02016482|69199543|FG001|Period B|Lost to Follow-up|0|||
37721199|NCT02016482|69199542|FG000|Period B|Lack of Efficacy|6|||
37721200|NCT02016482|69199543|FG001|Period B|Lack of Efficacy|4|||
37721201|NCT02016482|69199542|FG000|Period B|Other|4|||
37721202|NCT02016482|69199543|FG001|Period B|Other|0|||
37721203|NCT02016482|69199542|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
37721204|NCT02016482|69199543|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
37721205|NCT02028871|69199553|FG000|Overall Study|Positive urine drug screen|1|||
37721206|NCT02028871|69199554|FG001|Overall Study|Positive urine drug screen|1|||
37721207|NCT02028871|69199553|FG000|Overall Study|Withdrawal by Subject|1|||
37721208|NCT02028871|69199554|FG001|Overall Study|Withdrawal by Subject|2|||
37721209|NCT02028871|69199553|FG000|Overall Study|IV placement difficulty|1|||
37721210|NCT02028871|69199554|FG001|Overall Study|IV placement difficulty|0|||
37721211|NCT02028871|69199553|FG000|Overall Study|Current Illness|1|||
37721212|NCT02028871|69199554|FG001|Overall Study|Current Illness|0|||
37721213|NCT02028715|69199565|FG000|Overall Study|Adverse Event|2|||
37721214|NCT02028715|69199566|FG001|Overall Study|Adverse Event|2|||
37721215|NCT02028715|69199565|FG000|Overall Study|Physician Decision|1|||
37721216|NCT02028715|69199566|FG001|Overall Study|Physician Decision|0|||
37721217|NCT02028715|69199565|FG000|Overall Study|Did not complete satisfaction surveys|2|||
37721218|NCT02028715|69199566|FG001|Overall Study|Did not complete satisfaction surveys|2|||
37721219|NCT02016170|69199575|FG000|Overall Study|Adverse Event|1|||
37721220|NCT02016170|69199576|FG001|Overall Study|Adverse Event|1|||
37721221|NCT02016170|69199577|FG002|Overall Study|Adverse Event|0|||
37721222|NCT02016170|69199575|FG000|Overall Study|Protocol Violation|1|||
37721223|NCT02016170|69199576|FG001|Overall Study|Protocol Violation|0|||
37721224|NCT02016170|69199577|FG002|Overall Study|Protocol Violation|0|||
37721225|NCT02028169|69199584|FG000|Overall Study|Lost to Follow-up|21|||
37721226|NCT02028169|69199584|FG000|Overall Study|Lack of Efficacy|2|||
37721227|NCT02028169|69199584|FG000|Overall Study|Withdrawal by Subject|2|||
37721228|NCT02028169|69199584|FG000|Overall Study|Adverse Event|1|||
37721229|NCT02028169|69199584|FG000|Overall Study|Cessation of Drug|1|||
37721230|NCT02028169|69199584|FG000|Overall Study|Concomitant Medication Usage|1|||
37721231|NCT02015546|69199591|FG000|Overall Study|Withdrawal by Subject|1|||
37721232|NCT02015546|69199592|FG001|Overall Study|Withdrawal by Subject|1|||
37721233|NCT02015546|69199593|FG002|Overall Study|Withdrawal by Subject|1|||
37721234|NCT02015546|69199591|FG000|Overall Study|Screem Failure|2|||
37721235|NCT02015546|69199592|FG001|Overall Study|Screem Failure|1|||
37721236|NCT02015546|69199593|FG002|Overall Study|Screem Failure|3|||
37721237|NCT02027701|69199601|FG000|Overall Study|Adverse Event|3|||
37721238|NCT02027701|69199601|FG000|Overall Study|Lack of Efficacy|8|||
37721239|NCT02027701|69199601|FG000|Overall Study|Physician Decision|2|||
37721240|NCT02027701|69199601|FG000|Overall Study|Withdrawal by Subject|3|||
37840345|NCT00470834|69524582|FG000|Extension Period (24 Months)|Non-compliance|0|||
37840346|NCT00470834|69524583|FG001|Extension Period (24 Months)|Non-compliance|1|||
37840347|NCT00470834|69524582|FG000|Extension Period (24 Months)|Disease Progression|0|||
37721241|NCT02038790|69199607|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
37721242|NCT02038790|69199608|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
37721243|NCT02027623|69199617|FG000|Overall Study|Lost to Follow-up|3|||
37721244|NCT02027623|69199618|FG001|Overall Study|Lost to Follow-up|3|||
37721245|NCT02027623|69199617|FG000|Overall Study|Withdrawal by Subject|6|||
37721246|NCT02027623|69199618|FG001|Overall Study|Withdrawal by Subject|9|||
37721247|NCT02015221|69199627|FG000|Overall Study|Withdrawal by Subject|8|||
37721248|NCT02015221|69199628|FG001|Overall Study|Withdrawal by Subject|6|||
37721249|NCT02015221|69199627|FG000|Overall Study|Lost to Follow-up|1|||
37721250|NCT02015221|69199628|FG001|Overall Study|Lost to Follow-up|0|||
37721251|NCT02027311|69199636|FG000|Overall Study|Protocol Violation|3|||
37721252|NCT02027311|69199637|FG001|Overall Study|Protocol Violation|2|||
37721253|NCT02047903|69199645|FG000|Overall Study|Adverse Event|14|||
37721254|NCT02047903|69199645|FG000|Overall Study|Serious adverse event|10|||
37721255|NCT02047903|69199645|FG000|Overall Study|Withdrawal by Subject|16|||
37721256|NCT02047903|69199645|FG000|Overall Study|Lost to Follow-up|4|||
37721257|NCT02047903|69199645|FG000|Overall Study|Reason not listed|6|||
37721258|NCT02047903|69199645|FG000|Overall Study|Not Treated|9|||
37721259|NCT02015065|69199652|FG000|Overall Study|Death on study|1|||
37721260|NCT02015065|69199653|FG001|Overall Study|Death on study|2|||
37721261|NCT02015065|69199654|FG002|Overall Study|Death on study|1|||
37721262|NCT02026141|69199664|FG000|Overall Study|Protocol Violation|0|||
37721263|NCT02026141|69199665|FG001|Overall Study|Protocol Violation|1|||
37721264|NCT02026063|69199673|FG000|Overall Study|Physician Decision|0|||
37721265|NCT02026063|69199674|FG001|Overall Study|Physician Decision|10|||
37721266|NCT02026063|69199673|FG000|Overall Study|Noncompliance with Study Drug|1|||
37721267|NCT02026063|69199674|FG001|Overall Study|Noncompliance with Study Drug|1|||
37721268|NCT02026063|69199673|FG000|Overall Study|Withdrawal of Consent|1|||
37721269|NCT02026063|69199674|FG001|Overall Study|Withdrawal of Consent|6|||
37721270|NCT02026063|69199673|FG000|Overall Study|Adverse Event|5|||
37721271|NCT02026063|69199674|FG001|Overall Study|Adverse Event|20|||
37721272|NCT02026063|69199673|FG000|Overall Study|Lack of Efficacy|0|||
37721273|NCT02026063|69199674|FG001|Overall Study|Lack of Efficacy|4|||
37721274|NCT02026063|69199673|FG000|Overall Study|Lost to Follow-up|0|||
37721275|NCT02026063|69199674|FG001|Overall Study|Lost to Follow-up|1|||
37721276|NCT02026063|69199673|FG000|Overall Study|Reason not Specified|2|||
37721277|NCT02026063|69199674|FG001|Overall Study|Reason not Specified|7|||
37721278|NCT02025907|69199683|FG000|Overall Study|Lack of Efficacy|1|||
37721279|NCT02025907|69199684|FG001|Overall Study|Lack of Efficacy|0|||
37721280|NCT02025907|69199683|FG000|Overall Study|Withdrawal by Subject|15|||
37721281|NCT02025907|69199684|FG001|Overall Study|Withdrawal by Subject|8|||
37721282|NCT02025907|69199683|FG000|Overall Study|Protocol Violation|2|||
37721283|NCT02025907|69199684|FG001|Overall Study|Protocol Violation|0|||
37721284|NCT02025907|69199683|FG000|Overall Study|Physician Decision|2|||
37721285|NCT02025907|69199684|FG001|Overall Study|Physician Decision|0|||
37721286|NCT02025907|69199683|FG000|Overall Study|Lost to Follow-up|2|||
37721287|NCT02025907|69199684|FG001|Overall Study|Lost to Follow-up|2|||
37721288|NCT02025907|69199683|FG000|Overall Study|Adverse Event|3|||
37721289|NCT02025907|69199684|FG001|Overall Study|Adverse Event|1|||
37721290|NCT02025907|69199683|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
37721291|NCT02025907|69199684|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
37721292|NCT01813071|69199699|FG000|Overall Study|Protocol Violation|0|||
37721293|NCT01813071|69199700|FG001|Overall Study|Protocol Violation|0|||
37721294|NCT01813071|69199701|FG002|Overall Study|Protocol Violation|0|||
37721295|NCT01813071|69199702|FG003|Overall Study|Protocol Violation|0|||
37721296|NCT01813071|69199703|FG004|Overall Study|Protocol Violation|1|||
37721297|NCT01813071|69199704|FG005|Overall Study|Protocol Violation|4|||
37721298|NCT01813071|69199705|FG006|Overall Study|Protocol Violation|2|||
37721299|NCT01813071|69199706|FG007|Overall Study|Protocol Violation|4|||
37721300|NCT01813071|69199707|FG008|Overall Study|Protocol Violation|2|||
37721301|NCT01813071|69199699|FG000|Overall Study|Withdrawal by Subject|0|||
37721302|NCT01813071|69199700|FG001|Overall Study|Withdrawal by Subject|0|||
37721303|NCT01813071|69199701|FG002|Overall Study|Withdrawal by Subject|0|||
37721304|NCT01813071|69199702|FG003|Overall Study|Withdrawal by Subject|0|||
37721305|NCT01813071|69199703|FG004|Overall Study|Withdrawal by Subject|0|||
37721306|NCT01813071|69199704|FG005|Overall Study|Withdrawal by Subject|1|||
37721307|NCT01813071|69199705|FG006|Overall Study|Withdrawal by Subject|0|||
37721308|NCT01813071|69199706|FG007|Overall Study|Withdrawal by Subject|0|||
37840348|NCT00470834|69524583|FG001|Extension Period (24 Months)|Disease Progression|1|||
37840349|NCT00470366|69524589|FG000|Overall Study|Adverse Event|3|||
37840350|NCT00470366|69524589|FG000|Overall Study|Poor compliance|1|||
37840351|NCT00470093|69524593|FG000|Overall Study|Adverse Event|2|||
37840352|NCT00470054|69524597|FG000|Overall Study|Ineligible|1|||
37840353|NCT00474188|69524601|FG000|Overall Study|Withdrawal by Subject|1|||
37721309|NCT01813071|69199707|FG008|Overall Study|Withdrawal by Subject|0|||
37721310|NCT01813071|69199699|FG000|Overall Study|Adverse Event|0|||
37721311|NCT01813071|69199700|FG001|Overall Study|Adverse Event|0|||
37721312|NCT01813071|69199701|FG002|Overall Study|Adverse Event|0|||
37721313|NCT01813071|69199702|FG003|Overall Study|Adverse Event|0|||
37721314|NCT01813071|69199703|FG004|Overall Study|Adverse Event|0|||
37721315|NCT01813071|69199704|FG005|Overall Study|Adverse Event|1|||
37721316|NCT01813071|69199705|FG006|Overall Study|Adverse Event|0|||
37721317|NCT01813071|69199706|FG007|Overall Study|Adverse Event|0|||
37721318|NCT01813071|69199707|FG008|Overall Study|Adverse Event|0|||
37721319|NCT01813071|69199699|FG000|Overall Study|Physician Decision|0|||
37721320|NCT01813071|69199700|FG001|Overall Study|Physician Decision|0|||
37721321|NCT01813071|69199701|FG002|Overall Study|Physician Decision|0|||
37721322|NCT01813071|69199702|FG003|Overall Study|Physician Decision|0|||
37721323|NCT01813071|69199703|FG004|Overall Study|Physician Decision|0|||
37721324|NCT01813071|69199704|FG005|Overall Study|Physician Decision|0|||
37721325|NCT01813071|69199705|FG006|Overall Study|Physician Decision|1|||
37721326|NCT01813071|69199706|FG007|Overall Study|Physician Decision|0|||
37840354|NCT00474188|69524601|FG000|Overall Study|Study discontinued by sponsor|5|||
37840355|NCT00475982|69524606|FG000|Overall Study|surgery rescheduled|7|||
37840356|NCT00475982|69524607|FG001|Overall Study|surgery rescheduled|3|||
37840357|NCT01089647|69524615|FG000|Overall Study|Lost to Follow-up|2|||
37840358|NCT01089647|69524616|FG001|Overall Study|Lost to Follow-up|2|||
37840359|NCT01089647|69524615|FG000|Overall Study|Withdrawal by Subject|2|||
37840360|NCT01089647|69524616|FG001|Overall Study|Withdrawal by Subject|1|||
37840361|NCT01089647|69524615|FG000|Overall Study|Adverse Event|0|||
37840362|NCT01089647|69524616|FG001|Overall Study|Adverse Event|1|||
37721327|NCT01813071|69199707|FG008|Overall Study|Physician Decision|0|||
37721328|NCT01813071|69199699|FG000|Overall Study|Met inc/exc criteria|0|||
37721329|NCT01813071|69199700|FG001|Overall Study|Met inc/exc criteria|0|||
37721330|NCT01813071|69199701|FG002|Overall Study|Met inc/exc criteria|0|||
37721331|NCT01813071|69199702|FG003|Overall Study|Met inc/exc criteria|0|||
37721332|NCT01813071|69199703|FG004|Overall Study|Met inc/exc criteria|0|||
37840363|NCT01089608|69524624|FG000|Overall Study|Adverse Event|0|||
37721333|NCT01813071|69199704|FG005|Overall Study|Met inc/exc criteria|1|||
37721334|NCT01813071|69199705|FG006|Overall Study|Met inc/exc criteria|0|||
37721335|NCT01813071|69199706|FG007|Overall Study|Met inc/exc criteria|1|||
37721336|NCT01813071|69199707|FG008|Overall Study|Met inc/exc criteria|1|||
37721337|NCT02025751|69199743|FG000|Overall Study|Lost to Follow-up|1|||
37721338|NCT02025751|69199744|FG001|Overall Study|Lost to Follow-up|0|||
37721339|NCT02025751|69199743|FG000|Overall Study|Adverse Event|0|||
37721340|NCT02025751|69199744|FG001|Overall Study|Adverse Event|1|||
37721341|NCT02025751|69199743|FG000|Overall Study|Physician Decision|0|||
37721342|NCT02025751|69199744|FG001|Overall Study|Physician Decision|1|||
37721343|NCT02025751|69199743|FG000|Overall Study|Withdrawal by Subject|0|||
37721344|NCT02025751|69199744|FG001|Overall Study|Withdrawal by Subject|1|||
37721345|NCT02025205|69199752|FG000|Overall Study|Withdrawal by Subject|1|||
37721346|NCT02025205|69199753|FG001|Overall Study|Withdrawal by Subject|1|||
37721347|NCT02025205|69199752|FG000|Overall Study|Protocol Violation|2|||
37721348|NCT02025205|69199753|FG001|Overall Study|Protocol Violation|1|||
37721349|NCT02025205|69199752|FG000|Overall Study|Death|0|||
37721350|NCT02025205|69199753|FG001|Overall Study|Death|1|||
37840364|NCT01089608|69524625|FG001|Overall Study|Adverse Event|4|||
37840365|NCT01089608|69524624|FG000|Overall Study|Lost to Follow-up|0|||
37840366|NCT01089608|69524625|FG001|Overall Study|Lost to Follow-up|2|||
37840367|NCT01089413|69524634|FG000|Overall Study|Lost to Follow-up|1|||
37840368|NCT01089413|69524634|FG000|Overall Study|Progressive Disease|93|||
37840369|NCT01089413|69524634|FG000|Overall Study|Participant Withdrew Consent|1|||
37840370|NCT01089413|69524634|FG000|Overall Study|Unacceptable Toxicity|12|||
37840371|NCT01089413|69524634|FG000|Overall Study|Death|10|||
37840372|NCT01089413|69524634|FG000|Overall Study|Metastasectomy|13|||
37840373|NCT01089413|69524634|FG000|Overall Study|Other|71|||
37840374|NCT01089023|69524644|FG000|Overall Study|Lost to Follow-up|3|||
37840375|NCT01089023|69524644|FG000|Overall Study|Adverse Event|1|||
37840376|NCT01089023|69524644|FG000|Overall Study|Withdrawal by Subject|1|||
37840377|NCT01089023|69524644|FG000|Overall Study|Protocol Violation|1|||
37840378|NCT01089023|69524644|FG000|Overall Study|Lack of Efficacy|1|||
37840379|NCT01088984|69524650|FG000|Phase 1|Death|2|||
37840380|NCT01088984|69524651|FG001|Phase 1|Death|1|||
37840381|NCT01088984|69524650|FG000|Phase 1|Disease Progression|2|||
37840382|NCT01088984|69524651|FG001|Phase 1|Disease Progression|4|||
37840383|NCT01088984|69524650|FG000|Phase 1|Other|1|||
37840384|NCT01088984|69524651|FG001|Phase 1|Other|1|||
37840385|NCT01088984|69524650|FG000|Phase 2|Death|0|||
37840386|NCT01088984|69524651|FG001|Phase 2|Death|5|||
37840387|NCT01088984|69524650|FG000|Phase 2|Withdrawal by Subject|0|||
37721351|NCT01812837|69199762|FG000|Overall Study|Lost to Follow-up|1|||
37721352|NCT01812837|69199763|FG001|Overall Study|Lost to Follow-up|1|||
38025124|NCT03692676|69709349|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
37840388|NCT01088984|69524651|FG001|Phase 2|Withdrawal by Subject|1|||
37840389|NCT01088984|69524650|FG000|Phase 2|DIsease Progression|0|||
37840390|NCT01088984|69524651|FG001|Phase 2|DIsease Progression|25|||
37840391|NCT01088984|69524650|FG000|Phase 2|Other|0|||
38025125|NCT03692676|69709350|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
37840392|NCT01088984|69524651|FG001|Phase 2|Other|1|||
37840393|NCT01088438|69524662|FG000|Overall Study|Withdrawal by Subject|11|||
38043537|NCT03509467|69731657|FG005|Overall Study|Proxy Withdrawal|0|||
37840394|NCT01088438|69524663|FG001|Overall Study|Withdrawal by Subject|6|||
37840395|NCT01088438|69524662|FG000|Overall Study|Lost to Follow-up|18|||
37721353|NCT01812837|69199764|FG002|Overall Study|Lost to Follow-up|0|||
37721354|NCT01812837|69199762|FG000|Overall Study|Protocol Violation|1|||
37721355|NCT01812837|69199763|FG001|Overall Study|Protocol Violation|0|||
37721356|NCT01812837|69199764|FG002|Overall Study|Protocol Violation|0|||
37721357|NCT02024971|69199772|FG000|Overall Study|Data Not Available|30|||
37721358|NCT02024971|69199772|FG000|Overall Study|Lost to Follow-up|6|||
37840396|NCT01088438|69524663|FG001|Overall Study|Lost to Follow-up|30|||
37840397|NCT01088243|69524671|FG000|Overall Study|Adverse Event|1|||
37840398|NCT01088243|69524672|FG001|Overall Study|Adverse Event|0|||
37721359|NCT01843023|69199778|FG000|Overall Study|Death|1|||
37721360|NCT01843023|69199779|FG001|Overall Study|Death|0|||
37721361|NCT01843023|69199778|FG000|Overall Study|Lost to Follow-up|24|||
37721362|NCT01843023|69199779|FG001|Overall Study|Lost to Follow-up|29|||
37721363|NCT01843023|69199778|FG000|Overall Study|Withdrawal by Subject|8|||
37721364|NCT01843023|69199779|FG001|Overall Study|Withdrawal by Subject|6|||
37721365|NCT01812759|69199788|FG000|Overall Study|Physician Decision|0|||
37721366|NCT01812759|69199789|FG001|Overall Study|Physician Decision|0|||
37721367|NCT01812759|69199790|FG002|Overall Study|Physician Decision|1|||
37721368|NCT01812057|69199800|FG000|Overall Study|Protocol Violation|1|||
37721369|NCT01812057|69199801|FG001|Overall Study|Protocol Violation|0|||
37721370|NCT01812057|69199800|FG000|Overall Study|Physician Decision|1|||
37721371|NCT01812057|69199801|FG001|Overall Study|Physician Decision|0|||
37721372|NCT01842633|69199814|FG000|Overall Study|Screen Failure|1|||
37721373|NCT01842633|69199815|FG001|Overall Study|Screen Failure|0|||
37721374|NCT01842633|69199816|FG002|Overall Study|Screen Failure|0|||
37721375|NCT01842633|69199814|FG000|Overall Study|Adverse Event|1|||
37721376|NCT01842633|69199815|FG001|Overall Study|Adverse Event|1|||
37721377|NCT01842633|69199816|FG002|Overall Study|Adverse Event|0|||
37721378|NCT01842633|69199814|FG000|Overall Study|Withdrawal by Subject|0|||
37721379|NCT01842633|69199815|FG001|Overall Study|Withdrawal by Subject|1|||
37721380|NCT01842633|69199816|FG002|Overall Study|Withdrawal by Subject|0|||
37721381|NCT01842633|69199814|FG000|Overall Study|Technical issues|1|||
37721382|NCT01842633|69199815|FG001|Overall Study|Technical issues|0|||
37721383|NCT01842633|69199816|FG002|Overall Study|Technical issues|0|||
37721384|NCT01810263|69199828|FG000|Overall Study|Lost to Follow-up|8|||
37721385|NCT01810263|69199829|FG001|Overall Study|Lost to Follow-up|7|||
37721386|NCT01841697|69199837|FG000|Overall Study|Death|0|||
37721387|NCT01841697|69199838|FG001|Overall Study|Death|1|||
37721388|NCT01841697|69199837|FG000|Overall Study|Lost to Follow-up|4|||
37721389|NCT01841697|69199838|FG001|Overall Study|Lost to Follow-up|1|||
37721390|NCT01841697|69199837|FG000|Overall Study|Withdrawal by Subject|16|||
37721391|NCT01841697|69199838|FG001|Overall Study|Withdrawal by Subject|16|||
37721392|NCT01841073|69199846|FG000|Overall Study|Adverse Event|1|||
37721393|NCT01841073|69199847|FG001|Overall Study|Adverse Event|1|||
37721394|NCT01841073|69199846|FG000|Overall Study|Physician Decision|1|||
37721395|NCT01841073|69199847|FG001|Overall Study|Physician Decision|0|||
37721396|NCT01841073|69199846|FG000|Overall Study|Lost to Follow-up|0|||
37721397|NCT01841073|69199847|FG001|Overall Study|Lost to Follow-up|2|||
37721398|NCT01809327|69199860|FG000|Overall Study|Lost to Follow-up|5|||
37721399|NCT01809327|69199861|FG001|Overall Study|Lost to Follow-up|2|||
37721400|NCT01809327|69199862|FG002|Overall Study|Lost to Follow-up|4|||
37721401|NCT01809327|69199863|FG003|Overall Study|Lost to Follow-up|2|||
37721402|NCT01809327|69199864|FG004|Overall Study|Lost to Follow-up|3|||
37721403|NCT01809327|69199860|FG000|Overall Study|Withdrawal by Subject|6|||
37721404|NCT01809327|69199861|FG001|Overall Study|Withdrawal by Subject|4|||
37721405|NCT01809327|69199862|FG002|Overall Study|Withdrawal by Subject|4|||
37721406|NCT01809327|69199863|FG003|Overall Study|Withdrawal by Subject|2|||
37721407|NCT01809327|69199864|FG004|Overall Study|Withdrawal by Subject|5|||
37721408|NCT01809327|69199860|FG000|Overall Study|Adverse Event|4|||
37721409|NCT01809327|69199861|FG001|Overall Study|Adverse Event|3|||
37840399|NCT01088048|69524688|FG000|Overall Study|Adverse Event|7|||
37840400|NCT01088048|69524689|FG001|Overall Study|Adverse Event|9|||
37840401|NCT01088048|69524690|FG002|Overall Study|Adverse Event|7|||
37840402|NCT01088048|69524691|FG003|Overall Study|Adverse Event|5|||
37840403|NCT01088048|69524692|FG004|Overall Study|Adverse Event|6|||
37840404|NCT01088048|69524693|FG005|Overall Study|Adverse Event|3|||
37840405|NCT01088048|69524694|FG006|Overall Study|Adverse Event|3|||
37721410|NCT01809327|69199862|FG002|Overall Study|Adverse Event|7|||
37721411|NCT01809327|69199863|FG003|Overall Study|Adverse Event|4|||
37721412|NCT01809327|69199864|FG004|Overall Study|Adverse Event|8|||
37721413|NCT01809327|69199860|FG000|Overall Study|Death|1|||
37721414|NCT01809327|69199861|FG001|Overall Study|Death|0|||
37721415|NCT01809327|69199862|FG002|Overall Study|Death|0|||
37721416|NCT01809327|69199863|FG003|Overall Study|Death|0|||
37721417|NCT01809327|69199864|FG004|Overall Study|Death|0|||
37721418|NCT01809327|69199860|FG000|Overall Study|Protocol Violation|0|||
37721419|NCT01809327|69199861|FG001|Overall Study|Protocol Violation|1|||
37721420|NCT01809327|69199862|FG002|Overall Study|Protocol Violation|0|||
37721421|NCT01809327|69199863|FG003|Overall Study|Protocol Violation|0|||
37721422|NCT01809327|69199864|FG004|Overall Study|Protocol Violation|0|||
37721423|NCT01809327|69199860|FG000|Overall Study|Physician Decision|1|||
37721424|NCT01809327|69199861|FG001|Overall Study|Physician Decision|1|||
37721425|NCT01809327|69199862|FG002|Overall Study|Physician Decision|0|||
37721426|NCT01809327|69199863|FG003|Overall Study|Physician Decision|0|||
37721427|NCT01809327|69199864|FG004|Overall Study|Physician Decision|0|||
37721428|NCT01809327|69199860|FG000|Overall Study|Pregnancy|1|||
37721429|NCT01809327|69199861|FG001|Overall Study|Pregnancy|0|||
37721430|NCT01809327|69199862|FG002|Overall Study|Pregnancy|0|||
37721431|NCT01809327|69199863|FG003|Overall Study|Pregnancy|0|||
37721432|NCT01809327|69199864|FG004|Overall Study|Pregnancy|0|||
37721433|NCT01809327|69199860|FG000|Overall Study|Other|14|||
37721434|NCT01809327|69199861|FG001|Overall Study|Other|15|||
37721435|NCT01809327|69199862|FG002|Overall Study|Other|7|||
37721436|NCT01809327|69199863|FG003|Overall Study|Other|4|||
37721437|NCT01809327|69199864|FG004|Overall Study|Other|9|||
37721438|NCT01808313|69199885|FG000|Overall Study|Adverse Event|5|||
37721439|NCT01808313|69199885|FG000|Overall Study|Protocol Violation|2|||
37721440|NCT01808313|69199885|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
37721441|NCT01808313|69199885|FG000|Overall Study|Lost to Follow-up|1|||
37721442|NCT01808313|69199885|FG000|Overall Study|Physician Decision|1|||
37721443|NCT01840605|69199891|FG000|Overall Study|Adverse Event|0|||
37721444|NCT01840605|69199892|FG001|Overall Study|Adverse Event|1|||
37721445|NCT01840605|69199891|FG000|Overall Study|Physician Decision|2|||
37721446|NCT01840605|69199892|FG001|Overall Study|Physician Decision|1|||
37721447|NCT02023879|69199901|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
37721448|NCT02023879|69199902|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
37721449|NCT02023879|69199903|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
37721450|NCT02023879|69199901|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
37721451|NCT02023879|69199902|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
37721452|NCT02023879|69199903|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
37721453|NCT02023879|69199901|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
37721454|NCT02023879|69199902|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
37721455|NCT02023879|69199903|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
37721456|NCT02023879|69199901|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
37721457|NCT02023879|69199902|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
37721458|NCT02023879|69199903|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
37721459|NCT02023879|69199901|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
37721460|NCT02023879|69199902|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
37721461|NCT02023879|69199903|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
37721462|NCT02023879|69199901|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
37721463|NCT02023879|69199902|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
37721464|NCT02023879|69199903|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
37721465|NCT02023879|69199901|FG000|Extension Open Label Treatment|Adverse Event|1|||
37721466|NCT02023879|69199902|FG001|Extension Open Label Treatment|Adverse Event|7|||
37721467|NCT02023879|69199903|FG002|Extension Open Label Treatment|Adverse Event|3|||
37721468|NCT02023879|69199901|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
37721469|NCT02023879|69199902|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
37721470|NCT02023879|69199903|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
37721471|NCT02023879|69199901|FG000|Extension Open Label Treatment|Participant moved|1|||
37721472|NCT02023879|69199902|FG001|Extension Open Label Treatment|Participant moved|2|||
37721473|NCT02023879|69199903|FG002|Extension Open Label Treatment|Participant moved|0|||
37721474|NCT02023879|69199901|FG000|Extension Open Label Treatment|Other than specified above|2|||
37721475|NCT02023879|69199902|FG001|Extension Open Label Treatment|Other than specified above|7|||
37721476|NCT02023879|69199903|FG002|Extension Open Label Treatment|Other than specified above|2|||
37721477|NCT02014441|69199918|FG000|Overall Study|Withdrawal by Subject|12|||
37721478|NCT02013817|69199924|FG000|Overall Study|Adverse Event|12|||
37721479|NCT02013817|69199924|FG000|Overall Study|Withdrawal by Subject|4|||
37721480|NCT02013817|69199924|FG000|Overall Study|Death|2|||
37721481|NCT02013817|69199924|FG000|Overall Study|Other|9|||
37721482|NCT01994863|69199928|FG000|Period 1|Adverse Event|4|||
37721483|NCT01994863|69199929|FG001|Period 1|Adverse Event|0|||
37721484|NCT01994863|69199928|FG000|Period 1|Withdrawal by Subject|1|||
37721485|NCT01994863|69199929|FG001|Period 1|Withdrawal by Subject|0|||
37721486|NCT01994863|69199928|FG000|Period 1|Trial stopped by sponsor|1|||
37721487|NCT01994863|69199929|FG001|Period 1|Trial stopped by sponsor|3|||
37721488|NCT01994863|69199928|FG000|Period 1|Lack of Efficacy|1|||
37721489|NCT01994863|69199929|FG001|Period 1|Lack of Efficacy|0|||
37721490|NCT01994863|69199928|FG000|Period 2|Adverse Event|0|||
37721491|NCT01994863|69199929|FG001|Period 2|Adverse Event|1|||
37721492|NCT01994863|69199928|FG000|Period 2|Lack of Efficacy|0|||
37721493|NCT01994863|69199929|FG001|Period 2|Lack of Efficacy|2|||
37721494|NCT01994863|69199928|FG000|Period 2|Withdrawal by Subject|1|||
37721495|NCT01994863|69199929|FG001|Period 2|Withdrawal by Subject|1|||
37721496|NCT02023099|69199938|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
37721497|NCT02023099|69199939|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
37721498|NCT02023099|69199940|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
37721499|NCT02023099|69199938|FG000|Overall Study|Withdrawn Consent|3|||
37721500|NCT02023099|69199939|FG001|Overall Study|Withdrawn Consent|0|||
37721501|NCT02023099|69199940|FG002|Overall Study|Withdrawn Consent|1|||
37721502|NCT02023099|69199938|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
37721503|NCT02023099|69199939|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
37721504|NCT02023099|69199940|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
37721505|NCT02013037|69199948|FG000|Overall Study|Death|6|||
37721506|NCT02013037|69199948|FG000|Overall Study|Withdrawal by Subject|1|||
37721507|NCT02013037|69199948|FG000|Overall Study|Awaiting Transplantation|7|||
37721508|NCT02013037|69199948|FG000|Overall Study|Transplanted without DSA|2|||
37721509|NCT01967719|69199955|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
37721510|NCT01967719|69199956|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
37721511|NCT01967719|69199957|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
37721512|NCT01967719|69199958|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
37721513|NCT01967719|69199955|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
37721514|NCT01967719|69199956|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
37721515|NCT01967719|69199957|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
37721516|NCT01967719|69199958|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
37721517|NCT01967173|69199976|FG000|Overall Study|Lost to Follow-up|5|||
37721518|NCT01967173|69199977|FG001|Overall Study|Lost to Follow-up|3|||
37721519|NCT01967173|69199978|FG002|Overall Study|Lost to Follow-up|2|||
37721520|NCT01967173|69199979|FG003|Overall Study|Lost to Follow-up|4|||
37721521|NCT01967173|69199980|FG004|Overall Study|Lost to Follow-up|8|||
37721522|NCT01967173|69199981|FG005|Overall Study|Lost to Follow-up|12|||
37721523|NCT01967173|69199982|FG006|Overall Study|Lost to Follow-up|6|||
37721524|NCT01967173|69199983|FG007|Overall Study|Lost to Follow-up|8|||
37721525|NCT01967173|69199976|FG000|Overall Study|Physician Decision|2|||
37721526|NCT01967173|69199977|FG001|Overall Study|Physician Decision|0|||
37721527|NCT01967173|69199978|FG002|Overall Study|Physician Decision|2|||
37721528|NCT01967173|69199979|FG003|Overall Study|Physician Decision|1|||
37721529|NCT01967173|69199980|FG004|Overall Study|Physician Decision|1|||
37721530|NCT01967173|69199981|FG005|Overall Study|Physician Decision|1|||
37721531|NCT01967173|69199982|FG006|Overall Study|Physician Decision|1|||
37721532|NCT01967173|69199983|FG007|Overall Study|Physician Decision|0|||
37721533|NCT01967173|69199976|FG000|Overall Study|Lack of Efficacy|2|||
37721534|NCT01967173|69199977|FG001|Overall Study|Lack of Efficacy|0|||
37721535|NCT01967173|69199978|FG002|Overall Study|Lack of Efficacy|2|||
37721536|NCT01967173|69199979|FG003|Overall Study|Lack of Efficacy|2|||
37721537|NCT01967173|69199980|FG004|Overall Study|Lack of Efficacy|0|||
37721538|NCT01967173|69199981|FG005|Overall Study|Lack of Efficacy|1|||
37721539|NCT01967173|69199982|FG006|Overall Study|Lack of Efficacy|0|||
37721540|NCT01967173|69199983|FG007|Overall Study|Lack of Efficacy|2|||
37721541|NCT01967173|69199976|FG000|Overall Study|Pregnancy|0|||
37721542|NCT01967173|69199977|FG001|Overall Study|Pregnancy|0|||
37721543|NCT01967173|69199978|FG002|Overall Study|Pregnancy|0|||
37721544|NCT01967173|69199979|FG003|Overall Study|Pregnancy|0|||
37721545|NCT01967173|69199980|FG004|Overall Study|Pregnancy|0|||
37721546|NCT01967173|69199981|FG005|Overall Study|Pregnancy|0|||
37721547|NCT01967173|69199982|FG006|Overall Study|Pregnancy|1|||
37721548|NCT01967173|69199983|FG007|Overall Study|Pregnancy|1|||
37721549|NCT01967173|69199976|FG000|Overall Study|Adverse Event|0|||
37721550|NCT01967173|69199977|FG001|Overall Study|Adverse Event|0|||
37721551|NCT01967173|69199978|FG002|Overall Study|Adverse Event|0|||
37721552|NCT01967173|69199979|FG003|Overall Study|Adverse Event|0|||
37721553|NCT01967173|69199980|FG004|Overall Study|Adverse Event|0|||
37721554|NCT01967173|69199981|FG005|Overall Study|Adverse Event|0|||
37721555|NCT01967173|69199982|FG006|Overall Study|Adverse Event|0|||
37721556|NCT01967173|69199983|FG007|Overall Study|Adverse Event|1|||
37721557|NCT01967173|69199976|FG000|Overall Study|Withdrawal by Subject|15|||
37721558|NCT01967173|69199977|FG001|Overall Study|Withdrawal by Subject|14|||
37721559|NCT01967173|69199978|FG002|Overall Study|Withdrawal by Subject|10|||
37721560|NCT01967173|69199979|FG003|Overall Study|Withdrawal by Subject|7|||
37721561|NCT01967173|69199980|FG004|Overall Study|Withdrawal by Subject|8|||
37721562|NCT01967173|69199981|FG005|Overall Study|Withdrawal by Subject|9|||
37721563|NCT01967173|69199982|FG006|Overall Study|Withdrawal by Subject|10|||
37721564|NCT01967173|69199983|FG007|Overall Study|Withdrawal by Subject|12|||
37721565|NCT01994629|69199997|FG000|Overall Study|Withdrawal by Subject|1|||
37721566|NCT01994629|69199998|FG001|Overall Study|Withdrawal by Subject|0|||
37721567|NCT01994629|69199997|FG000|Overall Study|Lost to Follow-up|0|||
37721568|NCT01994629|69199998|FG001|Overall Study|Lost to Follow-up|3|||
37721569|NCT01994395|69200006|FG000|Overall Study|Withdrawal by Subject|1|||
37721570|NCT01994395|69200007|FG001|Overall Study|Withdrawal by Subject|2|||
37721571|NCT01992536|69200023|FG000|Overall Study|Administrative Reason|0|||
37721572|NCT01992536|69200024|FG001|Overall Study|Administrative Reason|0|||
37721573|NCT01992536|69200025|FG002|Overall Study|Administrative Reason|0|||
37721574|NCT01992536|69200026|FG003|Overall Study|Administrative Reason|0|||
37721575|NCT01992536|69200027|FG004|Overall Study|Administrative Reason|0|||
37721576|NCT01992536|69200028|FG005|Overall Study|Administrative Reason|0|||
37721577|NCT01992536|69200029|FG006|Overall Study|Administrative Reason|7|||
37721578|NCT01992536|69200030|FG007|Overall Study|Administrative Reason|0|||
37721579|NCT01992536|69200031|FG008|Overall Study|Administrative Reason|0|||
37721580|NCT01992536|69200032|FG009|Overall Study|Administrative Reason|0|||
37721581|NCT01992536|69200023|FG000|Overall Study|Lost to Follow-up|4|||
37721582|NCT01992536|69200024|FG001|Overall Study|Lost to Follow-up|2|||
37721583|NCT01992536|69200025|FG002|Overall Study|Lost to Follow-up|1|||
37721584|NCT01992536|69200026|FG003|Overall Study|Lost to Follow-up|0|||
37721585|NCT01992536|69200027|FG004|Overall Study|Lost to Follow-up|0|||
37721586|NCT01992536|69200028|FG005|Overall Study|Lost to Follow-up|1|||
37721587|NCT01992536|69200029|FG006|Overall Study|Lost to Follow-up|0|||
37721588|NCT01992536|69200030|FG007|Overall Study|Lost to Follow-up|0|||
37721589|NCT01992536|69200031|FG008|Overall Study|Lost to Follow-up|1|||
37721590|NCT01992536|69200032|FG009|Overall Study|Lost to Follow-up|1|||
37721591|NCT01992536|69200023|FG000|Overall Study|Withdrawal by Subject|0|||
37721592|NCT01992536|69200024|FG001|Overall Study|Withdrawal by Subject|1|||
37721593|NCT01992536|69200025|FG002|Overall Study|Withdrawal by Subject|0|||
37721594|NCT01992536|69200026|FG003|Overall Study|Withdrawal by Subject|2|||
37721595|NCT01992536|69200027|FG004|Overall Study|Withdrawal by Subject|0|||
37721596|NCT01992536|69200028|FG005|Overall Study|Withdrawal by Subject|0|||
37721597|NCT01992536|69200029|FG006|Overall Study|Withdrawal by Subject|0|||
37721598|NCT01992536|69200030|FG007|Overall Study|Withdrawal by Subject|0|||
37721599|NCT01992536|69200031|FG008|Overall Study|Withdrawal by Subject|0|||
37721600|NCT01992536|69200032|FG009|Overall Study|Withdrawal by Subject|0|||
37721601|NCT01993927|69200074|FG000|Overall Study|Case Report Forms Uncollected|18|||
37721602|NCT01993927|69200074|FG000|Overall Study|Protocol Violation|11|||
37721603|NCT02015390|69200080|FG000|Overall Study|Lost to Follow-up|1|||
37721604|NCT02015390|69200081|FG001|Overall Study|Lost to Follow-up|0|||
37721605|NCT02015390|69200080|FG000|Overall Study|Adverse Event|0|||
37721606|NCT02015390|69200081|FG001|Overall Study|Adverse Event|3|||
37721607|NCT02015390|69200080|FG000|Overall Study|Physician Decision|0|||
37721608|NCT02015390|69200081|FG001|Overall Study|Physician Decision|1|||
37721609|NCT02012959|69200088|FG000|Treatment Phase A|Adverse Event|2|||
37721610|NCT02012959|69200089|FG001|Treatment Phase A|Adverse Event|0|||
37721611|NCT02012959|69200090|FG002|Treatment Phase A|Adverse Event|0|||
37721612|NCT02012959|69200091|FG003|Treatment Phase A|Adverse Event|0|||
37721613|NCT02012959|69200092|FG004|Treatment Phase A|Adverse Event|0|||
37721614|NCT01990742|69200104|FG000|Overall Study|Withdrawal by facility|407|||
37721615|NCT01990742|69200105|FG001|Overall Study|Withdrawal by facility|1083|||
37721616|NCT01990742|69200104|FG000|Overall Study|Facility closed|0|||
37721617|NCT01990742|69200105|FG001|Overall Study|Facility closed|270|||
37721618|NCT02012491|69200113|FG000|Overall Study|Lost to Follow-up|1|||
37721619|NCT02012491|69200114|FG001|Overall Study|Lost to Follow-up|0|||
37721620|NCT02012491|69200113|FG000|Overall Study|Protocol Violation|0|||
37721621|NCT02012491|69200114|FG001|Overall Study|Protocol Violation|1|||
37721622|NCT02012491|69200113|FG000|Overall Study|Withdrawal by Subject|1|||
37721623|NCT02012491|69200114|FG001|Overall Study|Withdrawal by Subject|0|||
37721624|NCT01990664|69200122|FG000|Overall Study|Lost to Follow-up|2|||
37721625|NCT01990664|69200123|FG001|Overall Study|Lost to Follow-up|6|||
37721626|NCT01990664|69200122|FG000|Overall Study|Withdrawal by Subject|2|||
37721627|NCT01990664|69200123|FG001|Overall Study|Withdrawal by Subject|3|||
37721628|NCT01990664|69200122|FG000|Overall Study|Protocol Violation|1|||
37721629|NCT01990664|69200123|FG001|Overall Study|Protocol Violation|0|||
37721630|NCT01990664|69200122|FG000|Overall Study|Lens Discomfort|1|||
37721631|NCT01990664|69200123|FG001|Overall Study|Lens Discomfort|1|||
37721632|NCT01990664|69200122|FG000|Overall Study|Lens Handling Difficulties|1|||
38043538|NCT03509467|69731658|FG006|Overall Study|Proxy Withdrawal|0|||
37721633|NCT01990664|69200123|FG001|Overall Study|Lens Handling Difficulties|0|||
37721634|NCT01990664|69200122|FG000|Overall Study|Unsatisfactory Visual Response|0|||
37721635|NCT01990664|69200123|FG001|Overall Study|Unsatisfactory Visual Response|1|||
37721636|NCT02038010|69200129|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
37721637|NCT02038010|69200130|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
37721638|NCT02038010|69200131|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
37721639|NCT02038010|69200132|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
37721640|NCT02038010|69200129|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
37721641|NCT02038010|69200130|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
37721642|NCT02038010|69200131|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
37721643|NCT02038010|69200132|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
37721644|NCT02038010|69200129|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
37721645|NCT02038010|69200130|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
37721646|NCT02038010|69200131|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
37721647|NCT02038010|69200132|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
37721648|NCT02038010|69200129|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
37721649|NCT02038010|69200130|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
37721650|NCT02038010|69200131|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
37721651|NCT02038010|69200132|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
37721652|NCT02038010|69200129|FG000|Follow Up|Death|4|||
37721653|NCT02038010|69200130|FG001|Follow Up|Death|3|||
37721654|NCT02038010|69200131|FG002|Follow Up|Death|0|||
37721655|NCT02038010|69200132|FG003|Follow Up|Death|0|||
37721656|NCT02038010|69200129|FG000|Follow Up|Other|3|||
37721657|NCT02038010|69200130|FG001|Follow Up|Other|0|||
37721658|NCT02038010|69200131|FG002|Follow Up|Other|0|||
37721659|NCT02038010|69200132|FG003|Follow Up|Other|0|||
37721660|NCT01989572|69200146|FG000|Overall Study|Lack of Efficacy|35|||
37721661|NCT01989572|69200147|FG001|Overall Study|Lack of Efficacy|48|||
37721662|NCT01989572|69200148|FG002|Overall Study|Lack of Efficacy|48|||
37721663|NCT01989572|69200149|FG003|Overall Study|Lack of Efficacy|43|||
37721664|NCT01989572|69200150|FG004|Overall Study|Lack of Efficacy|71|||
37721665|NCT01989572|69200151|FG005|Overall Study|Lack of Efficacy|79|||
37721666|NCT01989572|69200146|FG000|Overall Study|Adverse Event|2|||
37721667|NCT01989572|69200147|FG001|Overall Study|Adverse Event|1|||
37721668|NCT01989572|69200148|FG002|Overall Study|Adverse Event|3|||
37721669|NCT01989572|69200149|FG003|Overall Study|Adverse Event|0|||
37721670|NCT01989572|69200150|FG004|Overall Study|Adverse Event|3|||
37721671|NCT01989572|69200151|FG005|Overall Study|Adverse Event|0|||
37721672|NCT01989572|69200146|FG000|Overall Study|Death|0|||
37721673|NCT01989572|69200147|FG001|Overall Study|Death|0|||
37721674|NCT01989572|69200148|FG002|Overall Study|Death|0|||
37721675|NCT01989572|69200149|FG003|Overall Study|Death|0|||
37721676|NCT01989572|69200150|FG004|Overall Study|Death|1|||
37721677|NCT01989572|69200151|FG005|Overall Study|Death|0|||
37721678|NCT01989572|69200146|FG000|Overall Study|Withdrawal by Subject|4|||
37721679|NCT01989572|69200147|FG001|Overall Study|Withdrawal by Subject|1|||
37721680|NCT01989572|69200148|FG002|Overall Study|Withdrawal by Subject|5|||
37721681|NCT01989572|69200149|FG003|Overall Study|Withdrawal by Subject|1|||
37721682|NCT01989572|69200150|FG004|Overall Study|Withdrawal by Subject|12|||
37721683|NCT01989572|69200151|FG005|Overall Study|Withdrawal by Subject|4|||
37721684|NCT01989572|69200146|FG000|Overall Study|complicating disease|1|||
37721685|NCT01989572|69200147|FG001|Overall Study|complicating disease|1|||
37721686|NCT01989572|69200148|FG002|Overall Study|complicating disease|2|||
37721687|NCT01989572|69200149|FG003|Overall Study|complicating disease|0|||
37721688|NCT01989572|69200150|FG004|Overall Study|complicating disease|1|||
37721689|NCT01989572|69200151|FG005|Overall Study|complicating disease|0|||
37721690|NCT01989572|69200146|FG000|Overall Study|error|2|||
37721691|NCT01989572|69200147|FG001|Overall Study|error|1|||
37721692|NCT01989572|69200148|FG002|Overall Study|error|1|||
37721693|NCT01989572|69200149|FG003|Overall Study|error|1|||
37721694|NCT01989572|69200150|FG004|Overall Study|error|1|||
37721695|NCT01989572|69200151|FG005|Overall Study|error|1|||
37721696|NCT01989572|69200146|FG000|Overall Study|maximum dose reached|0|||
37721697|NCT01989572|69200147|FG001|Overall Study|maximum dose reached|1|||
37721698|NCT01989572|69200148|FG002|Overall Study|maximum dose reached|0|||
37721699|NCT01989572|69200149|FG003|Overall Study|maximum dose reached|0|||
37721700|NCT01989572|69200150|FG004|Overall Study|maximum dose reached|1|||
37721701|NCT01989572|69200151|FG005|Overall Study|maximum dose reached|0|||
37721702|NCT01989572|69200146|FG000|Overall Study|unknown/not specify|3|||
37721703|NCT01989572|69200147|FG001|Overall Study|unknown/not specify|4|||
37721704|NCT01989572|69200148|FG002|Overall Study|unknown/not specify|1|||
37721705|NCT01989572|69200149|FG003|Overall Study|unknown/not specify|3|||
37840406|NCT01088048|69524695|FG007|Overall Study|Adverse Event|0|||
37840407|NCT01088048|69524696|FG008|Overall Study|Adverse Event|2|||
37840408|NCT01088048|69524697|FG009|Overall Study|Adverse Event|2|||
37840409|NCT01088048|69524688|FG000|Overall Study|Withdrew Consent|1|||
37840410|NCT01088048|69524689|FG001|Overall Study|Withdrew Consent|1|||
37840411|NCT01088048|69524690|FG002|Overall Study|Withdrew Consent|1|||
37721706|NCT01989572|69200150|FG004|Overall Study|unknown/not specify|3|||
37721707|NCT01989572|69200151|FG005|Overall Study|unknown/not specify|5|||
37721708|NCT01989572|69200146|FG000|Overall Study|not start protocol therapy|5|||
37721709|NCT01989572|69200147|FG001|Overall Study|not start protocol therapy|1|||
37721710|NCT01989572|69200148|FG002|Overall Study|not start protocol therapy|2|||
37721711|NCT01989572|69200149|FG003|Overall Study|not start protocol therapy|3|||
37721712|NCT01989572|69200150|FG004|Overall Study|not start protocol therapy|4|||
37721713|NCT01989572|69200151|FG005|Overall Study|not start protocol therapy|18|||
37721714|NCT01989572|69200146|FG000|Overall Study|alternative therapy|3|||
37721715|NCT01989572|69200147|FG001|Overall Study|alternative therapy|0|||
37721716|NCT01989572|69200148|FG002|Overall Study|alternative therapy|0|||
37721717|NCT01989572|69200149|FG003|Overall Study|alternative therapy|0|||
37721718|NCT01989572|69200150|FG004|Overall Study|alternative therapy|1|||
37721719|NCT01989572|69200151|FG005|Overall Study|alternative therapy|3|||
37721720|NCT02036294|69200171|FG000|Overall Study|Death|7|||
37721721|NCT02036294|69200172|FG001|Overall Study|Death|8|||
37721722|NCT02036294|69200171|FG000|Overall Study|Withdrawal by Subject|2|||
37721723|NCT02036294|69200172|FG001|Overall Study|Withdrawal by Subject|3|||
37721724|NCT02035748|69200178|FG000|Overall Study|Adverse Event|5|||
37721725|NCT02035748|69200178|FG000|Overall Study|Death|3|||
37721726|NCT02035748|69200178|FG000|Overall Study|Lost to Follow-up|2|||
37721727|NCT02035748|69200178|FG000|Overall Study|Physician Decision|3|||
37721728|NCT02035748|69200178|FG000|Overall Study|Withdrawal by Subject|6|||
37721729|NCT02035748|69200178|FG000|Overall Study|Progressive Disease|1|||
37721730|NCT02014376|69200186|FG000|Overall Study|Adverse Event|1|||
37721731|NCT02014376|69200187|FG001|Overall Study|Adverse Event|1|||
37721732|NCT02014376|69200188|FG002|Overall Study|Adverse Event|0|||
37721733|NCT02014376|69200186|FG000|Overall Study|Lost to Follow-up|2|||
37721734|NCT02014376|69200187|FG001|Overall Study|Lost to Follow-up|0|||
37721735|NCT02014376|69200188|FG002|Overall Study|Lost to Follow-up|0|||
37721736|NCT02035202|69200199|FG000|Overall Study|Lost to Follow-up|8|||
37721737|NCT02035202|69200200|FG001|Overall Study|Lost to Follow-up|16|||
37721738|NCT02035202|69200201|FG002|Overall Study|Lost to Follow-up|2|||
37721739|NCT01988402|69200211|FG000|Overall Study|Adverse Event|1|||
37721740|NCT01988402|69200212|FG001|Overall Study|Adverse Event|2|||
37721741|NCT01988402|69200211|FG000|Overall Study|Withdrawal by Subject|1|||
37721742|NCT01988402|69200212|FG001|Overall Study|Withdrawal by Subject|0|||
37721743|NCT01988090|69200220|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
37721744|NCT01988090|69200221|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
37721745|NCT01988090|69200220|FG000|Start Treament After Randomization|Protocol Violation|0|||
37721746|NCT01988090|69200221|FG001|Start Treament After Randomization|Protocol Violation|1|||
37721747|NCT01988090|69200220|FG000|Complete Study After Start|Withdrawal by Subject|2|||
37721748|NCT01988090|69200221|FG001|Complete Study After Start|Withdrawal by Subject|0|||
37721749|NCT01988090|69200220|FG000|Complete Study After Start|Protocol Violation|1|||
37721750|NCT01988090|69200221|FG001|Complete Study After Start|Protocol Violation|1|||
37721751|NCT01988012|69200227|FG000|Overall Study|Adverse Event|5|||
37721752|NCT01988012|69200227|FG000|Overall Study|Insufficient Therapeutic Response|3|||
37721753|NCT01988012|69200227|FG000|Overall Study|Patient Withdrawal of Consent|4|||
37721754|NCT01988012|69200227|FG000|Overall Study|Lost to Follow-up|1|||
37721755|NCT01988012|69200227|FG000|Overall Study|Physician Decision|1|||
37721756|NCT01988012|69200227|FG000|Overall Study|Protocol Violation|1|||
37721757|NCT02011945|69200234|FG000|Overall Study|Participant requested to Discontinue|0|||
37721758|NCT02011945|69200235|FG001|Overall Study|Participant requested to Discontinue|1|||
37721759|NCT02011945|69200236|FG002|Overall Study|Participant requested to Discontinue|1|||
37721760|NCT02011945|69200234|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
37721761|NCT02011945|69200235|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
37721762|NCT02011945|69200236|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
37721763|NCT02011945|69200234|FG000|Overall Study|Study Drug Toxicity|0|||
37721764|NCT02011945|69200235|FG001|Overall Study|Study Drug Toxicity|0|||
37721765|NCT02011945|69200236|FG002|Overall Study|Study Drug Toxicity|1|||
37721766|NCT02011945|69200234|FG000|Overall Study|Treatment Failure|0|||
37721767|NCT02011945|69200235|FG001|Overall Study|Treatment Failure|7|||
37721768|NCT02011945|69200236|FG002|Overall Study|Treatment Failure|6|||
37840412|NCT01088048|69524691|FG003|Overall Study|Withdrew Consent|1|||
37840413|NCT01088048|69524692|FG004|Overall Study|Withdrew Consent|2|||
37840414|NCT01088048|69524693|FG005|Overall Study|Withdrew Consent|1|||
37840415|NCT01088048|69524694|FG006|Overall Study|Withdrew Consent|0|||
37840416|NCT01088048|69524695|FG007|Overall Study|Withdrew Consent|2|||
37840417|NCT01088048|69524696|FG008|Overall Study|Withdrew Consent|2|||
37840418|NCT01088048|69524697|FG009|Overall Study|Withdrew Consent|1|||
37840419|NCT01088048|69524688|FG000|Overall Study|Concomitant Medication Prohibited|1|||
37840420|NCT01088048|69524689|FG001|Overall Study|Concomitant Medication Prohibited|0|||
37840421|NCT01088048|69524690|FG002|Overall Study|Concomitant Medication Prohibited|0|||
37840422|NCT01088048|69524691|FG003|Overall Study|Concomitant Medication Prohibited|0|||
37721769|NCT02011945|69200234|FG000|Overall Study|No Longer Meets Study Criteria|1|||
37721770|NCT02011945|69200235|FG001|Overall Study|No Longer Meets Study Criteria|0|||
37721771|NCT02011945|69200236|FG002|Overall Study|No Longer Meets Study Criteria|0|||
37721772|NCT02011945|69200234|FG000|Overall Study|Proceeded to stem cell transplant|0|||
37721773|NCT02011945|69200235|FG001|Overall Study|Proceeded to stem cell transplant|0|||
37721774|NCT02011945|69200236|FG002|Overall Study|Proceeded to stem cell transplant|1|||
37721775|NCT02011945|69200234|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
37721776|NCT02011945|69200235|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
37721777|NCT02011945|69200236|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
37721778|NCT02013830|69200244|FG000|Overall Study|Adverse Event|3|||
37721779|NCT02013830|69200244|FG000|Overall Study|Death|1|||
37721780|NCT02013830|69200244|FG000|Overall Study|Insufficient therapeutic response|25|||
37840423|NCT01088048|69524692|FG004|Overall Study|Concomitant Medication Prohibited|0|||
37721781|NCT02013830|69200244|FG000|Overall Study|Refused treatment|1|||
37721782|NCT02010775|69200253|FG000|Overall Study|Adverse Event|0|||
37840424|NCT01088048|69524693|FG005|Overall Study|Concomitant Medication Prohibited|0|||
37840425|NCT01088048|69524694|FG006|Overall Study|Concomitant Medication Prohibited|0|||
37840426|NCT01088048|69524695|FG007|Overall Study|Concomitant Medication Prohibited|0|||
37840427|NCT01088048|69524696|FG008|Overall Study|Concomitant Medication Prohibited|0|||
37840428|NCT01088048|69524697|FG009|Overall Study|Concomitant Medication Prohibited|0|||
37840429|NCT01088048|69524688|FG000|Overall Study|Investigator Request|2|||
37840430|NCT01088048|69524689|FG001|Overall Study|Investigator Request|2|||
37840431|NCT01088048|69524690|FG002|Overall Study|Investigator Request|0|||
37721783|NCT02010775|69200254|FG001|Overall Study|Adverse Event|0|||
37721784|NCT02010775|69200255|FG002|Overall Study|Adverse Event|0|||
37721785|NCT02010775|69200256|FG003|Overall Study|Adverse Event|0|||
37721786|NCT02010775|69200257|FG004|Overall Study|Adverse Event|1|||
37721787|NCT02010775|69200253|FG000|Overall Study|Pregnancy|0|||
37721788|NCT02010775|69200254|FG001|Overall Study|Pregnancy|0|||
37721789|NCT02010775|69200255|FG002|Overall Study|Pregnancy|2|||
37721790|NCT02010775|69200256|FG003|Overall Study|Pregnancy|0|||
37721791|NCT02010775|69200257|FG004|Overall Study|Pregnancy|0|||
37721792|NCT02010775|69200253|FG000|Overall Study|Lost to Follow-up|2|||
37721793|NCT02010775|69200254|FG001|Overall Study|Lost to Follow-up|0|||
37721794|NCT02010775|69200255|FG002|Overall Study|Lost to Follow-up|0|||
37721795|NCT02010775|69200256|FG003|Overall Study|Lost to Follow-up|1|||
37721796|NCT02010775|69200257|FG004|Overall Study|Lost to Follow-up|1|||
37721797|NCT02010775|69200253|FG000|Overall Study|Personal Reasons|3|||
37721798|NCT02010775|69200254|FG001|Overall Study|Personal Reasons|3|||
37721799|NCT02010775|69200255|FG002|Overall Study|Personal Reasons|1|||
37721800|NCT02010775|69200256|FG003|Overall Study|Personal Reasons|2|||
37721801|NCT02010775|69200257|FG004|Overall Study|Personal Reasons|4|||
37721802|NCT01993615|69200271|FG000|Overall Study|Death|1|||
37721803|NCT01993615|69200272|FG001|Overall Study|Death|0|||
37721804|NCT01619059|69200280|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
37721805|NCT01619059|69200281|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
37721806|NCT01619059|69200280|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
37721807|NCT01619059|69200281|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
37721808|NCT01619059|69200280|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
37721809|NCT01619059|69200281|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
37721810|NCT01619059|69200280|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
37721811|NCT01619059|69200281|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
37721812|NCT01619059|69200280|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
37721813|NCT01619059|69200281|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
37721814|NCT01619059|69200280|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
37721815|NCT01619059|69200281|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
37721816|NCT01619059|69200280|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
37721817|NCT01619059|69200281|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
37840432|NCT01088048|69524691|FG003|Overall Study|Investigator Request|0|||
37840433|NCT01088048|69524692|FG004|Overall Study|Investigator Request|3|||
37840434|NCT01088048|69524693|FG005|Overall Study|Investigator Request|1|||
37840435|NCT01088048|69524694|FG006|Overall Study|Investigator Request|1|||
37840436|NCT01088048|69524695|FG007|Overall Study|Investigator Request|0|||
37721818|NCT01619059|69200280|FG000|Long-Term (LT) Treatment Period|Death|1|||
37721819|NCT01619059|69200281|FG001|Long-Term (LT) Treatment Period|Death|0|||
37721820|NCT01619059|69200280|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
37721821|NCT01619059|69200281|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
37721822|NCT01619059|69200280|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
37721823|NCT01619059|69200281|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
37721824|NCT02013206|69200289|FG000|Overall Study|Progressive disease (PD)|14|||
37721825|NCT02013206|69200290|FG001|Overall Study|Progressive disease (PD)|17|||
37721826|NCT02013206|69200289|FG000|Overall Study|Symptomatic deterioration|3|||
37840437|NCT01088048|69524696|FG008|Overall Study|Investigator Request|0|||
37840438|NCT01088048|69524697|FG009|Overall Study|Investigator Request|0|||
37840439|NCT01088048|69524688|FG000|Overall Study|Patient Non-compliance|0|||
37840440|NCT01088048|69524689|FG001|Overall Study|Patient Non-compliance|1|||
37721827|NCT02013206|69200290|FG001|Overall Study|Symptomatic deterioration|1|||
37721828|NCT02013206|69200289|FG000|Overall Study|Adverse Event|1|||
37721829|NCT02013206|69200290|FG001|Overall Study|Adverse Event|0|||
37721830|NCT02013206|69200289|FG000|Overall Study|Patient refusal|2|||
37721831|NCT02013206|69200290|FG001|Overall Study|Patient refusal|0|||
37721832|NCT02013206|69200289|FG000|Overall Study|Patient non-compliance|1|||
37721833|NCT02013206|69200290|FG001|Overall Study|Patient non-compliance|0|||
37721834|NCT02013206|69200289|FG000|Overall Study|Death|1|||
37721835|NCT02013206|69200290|FG001|Overall Study|Death|2|||
37721836|NCT02013206|69200289|FG000|Overall Study|Other reasons off treatment|5|||
37840441|NCT01088048|69524690|FG002|Overall Study|Patient Non-compliance|0|||
37721837|NCT02013206|69200290|FG001|Overall Study|Other reasons off treatment|2|||
37721838|NCT01807923|69200299|FG000|Overall Study|Adverse Event|2|||
37721839|NCT01807923|69200300|FG001|Overall Study|Adverse Event|1|||
37721840|NCT01807923|69200301|FG002|Overall Study|Adverse Event|2|||
37721841|NCT01807923|69200299|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
37721842|NCT01807923|69200300|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
37721843|NCT01807923|69200301|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
37721844|NCT01807923|69200299|FG000|Overall Study|Physician Decision|0|||
37721845|NCT01807923|69200300|FG001|Overall Study|Physician Decision|0|||
37721846|NCT01807923|69200301|FG002|Overall Study|Physician Decision|1|||
37721847|NCT01807923|69200299|FG000|Overall Study|Not Eligible (Genotype)|0|||
37721848|NCT01807923|69200300|FG001|Overall Study|Not Eligible (Genotype)|0|||
37721849|NCT01807923|69200301|FG002|Overall Study|Not Eligible (Genotype)|1|||
37721850|NCT01807923|69200299|FG000|Overall Study|Randomized But Not Treated|3|||
37721851|NCT01807923|69200300|FG001|Overall Study|Randomized But Not Treated|2|||
37721852|NCT01807923|69200301|FG002|Overall Study|Randomized But Not Treated|5|||
37721853|NCT01966003|69200313|FG000|Overall Study|Death|43|||
37721854|NCT01966003|69200314|FG001|Overall Study|Death|36|||
37721855|NCT01966003|69200313|FG000|Overall Study|Protocol Violation|6|||
37721856|NCT01966003|69200314|FG001|Overall Study|Protocol Violation|4|||
37721857|NCT01966003|69200313|FG000|Overall Study|Lost to Follow-up|4|||
37721858|NCT01966003|69200314|FG001|Overall Study|Lost to Follow-up|3|||
37721859|NCT01966003|69200313|FG000|Overall Study|Physician Decision|12|||
37721860|NCT01966003|69200314|FG001|Overall Study|Physician Decision|13|||
37721861|NCT01966003|69200313|FG000|Overall Study|Withdrawal by Subject|29|||
37721862|NCT01966003|69200314|FG001|Overall Study|Withdrawal by Subject|19|||
37721863|NCT01966003|69200313|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
37721864|NCT01966003|69200314|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
37721865|NCT01966003|69200313|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
37721866|NCT01966003|69200314|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
37721867|NCT01966003|69200313|FG000|Overall Study|Other|1|||
37721868|NCT01966003|69200314|FG001|Overall Study|Other|1|||
37721869|NCT01839279|69200323|FG000|Overall Study|Adverse Event|4|||
37721870|NCT01839279|69200324|FG001|Overall Study|Adverse Event|1|||
37721871|NCT01839279|69200325|FG002|Overall Study|Adverse Event|1|||
37721872|NCT01839279|69200323|FG000|Overall Study|Withdrawal by Subject|4|||
37721873|NCT01839279|69200324|FG001|Overall Study|Withdrawal by Subject|1|||
37721874|NCT01839279|69200325|FG002|Overall Study|Withdrawal by Subject|1|||
37721875|NCT01839279|69200323|FG000|Overall Study|Classified as 'Other'|5|||
37721876|NCT01839279|69200324|FG001|Overall Study|Classified as 'Other'|0|||
37721877|NCT01839279|69200325|FG002|Overall Study|Classified as 'Other'|0|||
37721878|NCT01807299|69200344|FG000|Overall Study|Protocol Violation|3|||
37721879|NCT01807299|69200345|FG001|Overall Study|Protocol Violation|1|||
37721880|NCT01807299|69200346|FG002|Overall Study|Protocol Violation|0|||
37721881|NCT01807299|69200347|FG003|Overall Study|Protocol Violation|2|||
37721882|NCT01965535|69200359|FG000|Overall Study|Lack of Efficacy|2|||
37721883|NCT01965535|69200360|FG001|Overall Study|Lack of Efficacy|1|||
37721884|NCT01964755|69200366|FG000|Overall Study|Death|2|||
37721885|NCT01964521|69200370|FG000|Overall Study|Lost to Follow-up|4|||
37721886|NCT01992757|69200375|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
37721887|NCT01991743|69200384|FG000|Overall Study|external cephalic version not performed|0|||
37721888|NCT01991743|69200385|FG001|Overall Study|external cephalic version not performed|0|||
37721889|NCT01991743|69200386|FG002|Overall Study|external cephalic version not performed|1|||
37721890|NCT01991743|69200387|FG003|Overall Study|external cephalic version not performed|0|||
37721891|NCT01991197|69200399|FG000|Overall Study|Lost to Follow-up|1|||
37721892|NCT01991197|69200400|FG001|Overall Study|Lost to Follow-up|1|||
37721893|NCT01991197|69200399|FG000|Overall Study|Physician Decision|0|||
37721894|NCT01991197|69200400|FG001|Overall Study|Physician Decision|2|||
37721895|NCT01991197|69200399|FG000|Overall Study|Withdrawal by Subject|2|||
37721896|NCT01991197|69200400|FG001|Overall Study|Withdrawal by Subject|0|||
37721897|NCT01990573|69200414|FG000|Overall Study|Physician Decision|0|||
37721898|NCT01990573|69200415|FG001|Overall Study|Physician Decision|0|||
37721899|NCT01990573|69200416|FG002|Overall Study|Physician Decision|1|||
37721900|NCT01990495|69200426|FG000|Overall Study|Physician Decision|5|||
37721901|NCT01990495|69200427|FG001|Overall Study|Physician Decision|4|||
37721902|NCT01990339|69200435|FG000|Overall Study|Data Not Available|49|||
37721903|NCT01990339|69200435|FG000|Overall Study|Voluntary Withdrawal|1402|||
37721904|NCT01990339|69200435|FG000|Overall Study|Lost to Follow-up|861|||
37721905|NCT02007577|69200441|FG000|Overall Study|Adverse Event|1|||
37721906|NCT02007577|69200442|FG001|Overall Study|Adverse Event|0|||
37721907|NCT02007577|69200441|FG000|Overall Study|Withdrawal by Subject|0|||
37721908|NCT02007577|69200442|FG001|Overall Study|Withdrawal by Subject|1|||
37721909|NCT01990261|69200448|FG000|Overall Study|Death Before Treatment Start|2|||
37721910|NCT01990261|69200448|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
37721911|NCT01990261|69200448|FG000|Overall Study|Death From other Causes|1|||
37721912|NCT01990261|69200448|FG000|Overall Study|Disease Progression (PD)|8|||
37721913|NCT01990261|69200448|FG000|Overall Study|PD Before Treatment Start|1|||
37721914|NCT01990261|69200448|FG000|Overall Study|Dossier not Approved|1|||
37721915|NCT01990261|69200448|FG000|Overall Study|Lost to Follow-up|2|||
37721916|NCT01963117|69200452|FG000|Overall Study|Death|1|||
37721917|NCT02007109|69200456|FG000|Overall Study|Diary not returned or excluded|102|||
37721918|NCT02007109|69200456|FG000|Overall Study|Excluded - Age<7yo|9|||
37721919|NCT02006719|69200465|FG000|Overall Study|Withdrawal by Subject|10|||
37721920|NCT02006719|69200466|FG001|Overall Study|Withdrawal by Subject|2|||
37721921|NCT02006719|69200465|FG000|Overall Study|Lost to Follow-up|5|||
37721922|NCT02006719|69200466|FG001|Overall Study|Lost to Follow-up|1|||
37721923|NCT02006719|69200465|FG000|Overall Study|Protocol Violation|2|||
37721924|NCT02006719|69200466|FG001|Overall Study|Protocol Violation|0|||
37721925|NCT02006719|69200465|FG000|Overall Study|Adverse Event|1|||
37721926|NCT02006719|69200466|FG001|Overall Study|Adverse Event|1|||
37721927|NCT02006719|69200465|FG000|Overall Study|Other/Unknown|0|||
37721928|NCT02006719|69200466|FG001|Overall Study|Other/Unknown|1|||
37721929|NCT01962493|69200474|FG000|Overall Study|Adverse Event|1|||
37721930|NCT01962493|69200475|FG001|Overall Study|Adverse Event|2|||
37721931|NCT01962493|69200474|FG000|Overall Study|Protocol Violation|0|||
37721932|NCT01962493|69200475|FG001|Overall Study|Protocol Violation|1|||
37721933|NCT01962493|69200474|FG000|Overall Study|Withdrawal by Subject|4|||
37721934|NCT01962493|69200475|FG001|Overall Study|Withdrawal by Subject|2|||
37721935|NCT01989169|69200483|FG000|Period 2|Adverse Event|0|||
37721936|NCT01989169|69200484|FG001|Period 2|Adverse Event|1|||
37721937|NCT01988779|69200492|FG000|Overall Study|Withdrawal by Subject|2|||
37721938|NCT01988779|69200493|FG001|Overall Study|Withdrawal by Subject|2|||
37721939|NCT01988779|69200492|FG000|Overall Study|Protocol Violation|1|||
37721940|NCT01988779|69200493|FG001|Overall Study|Protocol Violation|0|||
37721941|NCT01988233|69200501|FG000|Overall Study|Lost to Follow-up|64|||
37721942|NCT01988233|69200502|FG001|Overall Study|Lost to Follow-up|51|||
37721943|NCT01987765|69200508|FG000|Overall Study|Protocol Violation|65|||
37721944|NCT01987765|69200508|FG000|Overall Study|Lost to Follow-up|37|||
37721945|NCT01987609|69200512|FG000|Overall Study|Adverse Event|1|||
37721946|NCT02013674|69200528|FG000|Overall Study|Death|0|||
37721947|NCT02013674|69200529|FG001|Overall Study|Death|1|||
37721948|NCT02013674|69200528|FG000|Overall Study|Lost to Follow-up|1|||
37721949|NCT02013674|69200529|FG001|Overall Study|Lost to Follow-up|0|||
37721950|NCT01987232|69200540|FG000|Overall Study|Ongoing in Study|0|||
37721951|NCT01987232|69200541|FG001|Overall Study|Ongoing in Study|0|||
37721952|NCT01987232|69200542|FG002|Overall Study|Ongoing in Study|0|||
37721953|NCT01987232|69200543|FG003|Overall Study|Ongoing in Study|1|||
37721954|NCT01987232|69200544|FG004|Overall Study|Ongoing in Study|0|||
37721955|NCT01986920|69200558|FG000|A- 101 25%|Withdrawal by Subject|1|||
37840442|NCT01088048|69524691|FG003|Overall Study|Patient Non-compliance|0|||
37840443|NCT01088048|69524692|FG004|Overall Study|Patient Non-compliance|0|||
37840444|NCT01088048|69524693|FG005|Overall Study|Patient Non-compliance|0|||
38043539|NCT03509467|69731659|FG007|Overall Study|Proxy Withdrawal|1|||
37840445|NCT01088048|69524694|FG006|Overall Study|Patient Non-compliance|0|||
37840446|NCT01088048|69524695|FG007|Overall Study|Patient Non-compliance|0|||
37840447|NCT01088048|69524696|FG008|Overall Study|Patient Non-compliance|0|||
37840448|NCT01088048|69524697|FG009|Overall Study|Patient Non-compliance|0|||
37840449|NCT01088048|69524688|FG000|Overall Study|Disease Progression|7|||
37721956|NCT01986920|69200559|FG001|A- 101 25%|Withdrawal by Subject|0|||
37721957|NCT01986920|69200560|FG002|A- 101 25%|Withdrawal by Subject|0|||
37721958|NCT01986920|69200561|FG003|A- 101 25%|Withdrawal by Subject|0|||
37721959|NCT01986920|69200558|FG000|A-101 32.5%|Withdrawal by Subject|0|||
37721960|NCT01986920|69200559|FG001|A-101 32.5%|Withdrawal by Subject|1|||
37721961|NCT01986920|69200560|FG002|A-101 32.5%|Withdrawal by Subject|0|||
37721962|NCT01986920|69200561|FG003|A-101 32.5%|Withdrawal by Subject|0|||
37721963|NCT01986920|69200558|FG000|A-101 40%|Withdrawal by Subject|0|||
37721964|NCT01986920|69200559|FG001|A-101 40%|Withdrawal by Subject|0|||
37840450|NCT01088048|69524689|FG001|Overall Study|Disease Progression|4|||
37721965|NCT01986920|69200560|FG002|A-101 40%|Withdrawal by Subject|1|||
37721966|NCT01986920|69200561|FG003|A-101 40%|Withdrawal by Subject|0|||
37721967|NCT01986920|69200558|FG000|Placebo|Withdrawal by Subject|0|||
37721968|NCT01986920|69200559|FG001|Placebo|Withdrawal by Subject|0|||
37721969|NCT01986920|69200560|FG002|Placebo|Withdrawal by Subject|0|||
37721970|NCT01986920|69200561|FG003|Placebo|Withdrawal by Subject|1|||
37721971|NCT02010632|69200571|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
37721972|NCT02010632|69200572|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
37721973|NCT01986140|69200580|FG000|Overall Study|Withdrawal by Subject|31|||
37721974|NCT01986140|69200581|FG001|Overall Study|Withdrawal by Subject|25|||
37721975|NCT01986140|69200580|FG000|Overall Study|alternative treatment|1|||
37721976|NCT01986140|69200581|FG001|Overall Study|alternative treatment|1|||
37721977|NCT01986140|69200580|FG000|Overall Study|found not eligible|3|||
37721978|NCT01986140|69200581|FG001|Overall Study|found not eligible|0|||
37721979|NCT01986140|69200580|FG000|Overall Study|Adverse Event|0|||
37721980|NCT01986140|69200581|FG001|Overall Study|Adverse Event|1|||
37721981|NCT01986140|69200580|FG000|Overall Study|progression disease|0|||
37721982|NCT01986140|69200581|FG001|Overall Study|progression disease|1|||
37721983|NCT01986062|69200589|FG000|Overall Study|Lost to Follow-up|1|||
37721984|NCT01986062|69200590|FG001|Overall Study|Lost to Follow-up|0|||
37721985|NCT01986062|69200589|FG000|Overall Study|Withdrawal by Subject|0|||
37721986|NCT01986062|69200590|FG001|Overall Study|Withdrawal by Subject|1|||
37721987|NCT01985360|69200598|FG000|Overall Study|Withdrawal by Subject|4|||
37721988|NCT01985360|69200599|FG001|Overall Study|Withdrawal by Subject|0|||
37721989|NCT01985360|69200598|FG000|Overall Study|Lost to Follow-up|5|||
37721990|NCT01985360|69200599|FG001|Overall Study|Lost to Follow-up|3|||
37721991|NCT02032706|69200605|FG000|Overall Study|Did not qualify|5|||
37721992|NCT02032706|69200605|FG000|Overall Study|Protocol Violation|1|||
37721993|NCT02032238|69200611|FG000|Overall Study|Lost to Follow-up|2|||
37721994|NCT02032238|69200612|FG001|Overall Study|Lost to Follow-up|0|||
37721995|NCT02009930|69200618|FG000|Overall Study|withdrawn|5|||
37721996|NCT01985126|69200631|FG000|Overall Study|Death|15|||
37721997|NCT01985126|69200632|FG001|Overall Study|Death|69|||
37721998|NCT01985126|69200631|FG000|Overall Study|Lost to Follow-up|0|||
37721999|NCT01985126|69200632|FG001|Overall Study|Lost to Follow-up|8|||
37722000|NCT01985126|69200631|FG000|Overall Study|Study Terminated By Sponsor|1|||
37722001|NCT01985126|69200632|FG001|Overall Study|Study Terminated By Sponsor|22|||
37722002|NCT01985126|69200631|FG000|Overall Study|Withdrawal by Subject|2|||
37722003|NCT01985126|69200632|FG001|Overall Study|Withdrawal by Subject|7|||
37722004|NCT01984892|69200638|FG000|Overall Study|Progressive disease|7|||
37722005|NCT01807221|69200648|FG000|Overall Study|Progressive disease|1|||
37722006|NCT01807221|69200649|FG001|Overall Study|Progressive disease|0|||
37722007|NCT01807221|69200650|FG002|Overall Study|Progressive disease|1|||
37722008|NCT01807221|69200651|FG003|Overall Study|Progressive disease|0|||
37722009|NCT01807221|69200652|FG004|Overall Study|Progressive disease|0|||
37722010|NCT01807221|69200653|FG005|Overall Study|Progressive disease|0|||
37722011|NCT01807221|69200648|FG000|Overall Study|Death|7|||
37722012|NCT01807221|69200649|FG001|Overall Study|Death|9|||
37722013|NCT01807221|69200650|FG002|Overall Study|Death|4|||
37722014|NCT01807221|69200651|FG003|Overall Study|Death|2|||
37722015|NCT01807221|69200652|FG004|Overall Study|Death|1|||
37722016|NCT01807221|69200653|FG005|Overall Study|Death|6|||
37722017|NCT01807221|69200648|FG000|Overall Study|Physician Decision|2|||
37722018|NCT01807221|69200649|FG001|Overall Study|Physician Decision|1|||
37722019|NCT01807221|69200650|FG002|Overall Study|Physician Decision|0|||
37722020|NCT01807221|69200651|FG003|Overall Study|Physician Decision|0|||
37722021|NCT01807221|69200652|FG004|Overall Study|Physician Decision|0|||
37722022|NCT01807221|69200653|FG005|Overall Study|Physician Decision|0|||
37722023|NCT01807221|69200648|FG000|Overall Study|Adverse Event|33|||
37722024|NCT01807221|69200649|FG001|Overall Study|Adverse Event|22|||
37722025|NCT01807221|69200650|FG002|Overall Study|Adverse Event|26|||
37722026|NCT01807221|69200651|FG003|Overall Study|Adverse Event|25|||
37722027|NCT01807221|69200652|FG004|Overall Study|Adverse Event|18|||
37722028|NCT01807221|69200653|FG005|Overall Study|Adverse Event|21|||
37722029|NCT01807221|69200648|FG000|Overall Study|Protocol Violation|0|||
37722030|NCT01807221|69200649|FG001|Overall Study|Protocol Violation|2|||
37722031|NCT01807221|69200650|FG002|Overall Study|Protocol Violation|1|||
37722032|NCT01807221|69200651|FG003|Overall Study|Protocol Violation|2|||
37722033|NCT01807221|69200652|FG004|Overall Study|Protocol Violation|0|||
37722034|NCT01807221|69200653|FG005|Overall Study|Protocol Violation|1|||
37722035|NCT01807221|69200648|FG000|Overall Study|Non-compliance|1|||
37722036|NCT01807221|69200649|FG001|Overall Study|Non-compliance|2|||
37722037|NCT01807221|69200650|FG002|Overall Study|Non-compliance|0|||
37722038|NCT01807221|69200651|FG003|Overall Study|Non-compliance|1|||
37722039|NCT01807221|69200652|FG004|Overall Study|Non-compliance|0|||
37722040|NCT01807221|69200653|FG005|Overall Study|Non-compliance|0|||
37722041|NCT01807221|69200648|FG000|Overall Study|Logistical difficulties|0|||
37722042|NCT01807221|69200649|FG001|Overall Study|Logistical difficulties|1|||
37722043|NCT01807221|69200650|FG002|Overall Study|Logistical difficulties|0|||
37722044|NCT01807221|69200651|FG003|Overall Study|Logistical difficulties|0|||
37722045|NCT01807221|69200652|FG004|Overall Study|Logistical difficulties|1|||
37722046|NCT01807221|69200653|FG005|Overall Study|Logistical difficulties|0|||
37722047|NCT01807221|69200648|FG000|Overall Study|Withdrawal by Subject|33|||
37722048|NCT01807221|69200649|FG001|Overall Study|Withdrawal by Subject|15|||
37722049|NCT01807221|69200650|FG002|Overall Study|Withdrawal by Subject|8|||
37722050|NCT01807221|69200651|FG003|Overall Study|Withdrawal by Subject|14|||
37722051|NCT01807221|69200652|FG004|Overall Study|Withdrawal by Subject|16|||
37722052|NCT01807221|69200653|FG005|Overall Study|Withdrawal by Subject|13|||
37722053|NCT01807221|69200648|FG000|Overall Study|Sponsor decision|2|||
37722054|NCT01807221|69200649|FG001|Overall Study|Sponsor decision|0|||
37722055|NCT01807221|69200650|FG002|Overall Study|Sponsor decision|1|||
37722056|NCT01807221|69200651|FG003|Overall Study|Sponsor decision|1|||
37722057|NCT01807221|69200652|FG004|Overall Study|Sponsor decision|0|||
37722058|NCT01807221|69200653|FG005|Overall Study|Sponsor decision|0|||
37722059|NCT01807221|69200648|FG000|Overall Study|Lost to Follow-up|1|||
37722060|NCT01807221|69200649|FG001|Overall Study|Lost to Follow-up|0|||
37722061|NCT01807221|69200650|FG002|Overall Study|Lost to Follow-up|2|||
37722062|NCT01807221|69200651|FG003|Overall Study|Lost to Follow-up|1|||
37722063|NCT01807221|69200652|FG004|Overall Study|Lost to Follow-up|0|||
37722064|NCT01807221|69200653|FG005|Overall Study|Lost to Follow-up|0|||
37722065|NCT01838499|69200669|FG000|Overall Study|Protocol Violation|0|||
37722066|NCT01838499|69200670|FG001|Overall Study|Protocol Violation|1|||
37722067|NCT01838499|69200669|FG000|Overall Study|Lost to Follow-up|2|||
37722068|NCT01838499|69200670|FG001|Overall Study|Lost to Follow-up|4|||
37722069|NCT01838499|69200669|FG000|Overall Study|Lack of Efficacy|1|||
37722070|NCT01838499|69200670|FG001|Overall Study|Lack of Efficacy|2|||
37722071|NCT01838499|69200669|FG000|Overall Study|Adverse Event|2|||
37722072|NCT01838499|69200670|FG001|Overall Study|Adverse Event|1|||
37722073|NCT01838499|69200669|FG000|Overall Study|Withdrawal by Subject|19|||
37840451|NCT01088048|69524690|FG002|Overall Study|Disease Progression|3|||
37840452|NCT01088048|69524691|FG003|Overall Study|Disease Progression|5|||
37840453|NCT01088048|69524692|FG004|Overall Study|Disease Progression|3|||
38025126|NCT03692676|69709351|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
38025127|NCT03692676|69709348|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
38025128|NCT03692676|69709349|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
38025129|NCT03692676|69709350|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
38025130|NCT03692676|69709351|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
38025131|NCT03692676|69709348|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
38025132|NCT03692676|69709349|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
38025133|NCT03692676|69709350|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
38025134|NCT03692676|69709351|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
38025135|NCT03692676|69709348|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
38025136|NCT03692676|69709349|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
38025137|NCT03692676|69709350|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
38025138|NCT03692676|69709351|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
38025139|NCT03692676|69709348|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
38025140|NCT03692676|69709349|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
38025141|NCT03692676|69709350|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
38025142|NCT03692676|69709351|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
38025143|NCT03692676|69709348|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
38025144|NCT03692676|69709349|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
38025145|NCT03692676|69709350|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
38025146|NCT03692676|69709351|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
38025147|NCT03692676|69709348|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
38025148|NCT03692676|69709349|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
38025149|NCT03692676|69709350|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
38025150|NCT03692676|69709351|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
38025151|NCT03692676|69709348|FG000|Overall Study|Other|0|||
38025152|NCT03692676|69709349|FG001|Overall Study|Other|805|||
38025153|NCT03692676|69709350|FG002|Overall Study|Other|758|||
37722074|NCT01838499|69200670|FG001|Overall Study|Withdrawal by Subject|9|||
37722075|NCT01807065|69200678|FG000|Overall Study|Receive no sip-T due to IV access|1|||
37722076|NCT01807065|69200679|FG001|Overall Study|Receive no sip-T due to IV access|1|||
37722077|NCT02031458|69200692|FG000|May 8, 2015 to January 11, 2019|Death|89|||
37722078|NCT02031458|69200693|FG001|May 8, 2015 to January 11, 2019|Death|193|||
37722079|NCT02031458|69200694|FG002|May 8, 2015 to January 11, 2019|Death|198|||
37722080|NCT02031458|69200692|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
37722081|NCT02031458|69200693|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
37722082|NCT02031458|69200694|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
37722083|NCT02031458|69200692|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
37722084|NCT02031458|69200693|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
37722085|NCT02031458|69200694|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
37722086|NCT02031458|69200692|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
37722087|NCT02031458|69200693|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
37722088|NCT02031458|69200694|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
37722089|NCT02031458|69200692|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
37722090|NCT02031458|69200693|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
37722091|NCT02031458|69200694|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
37722092|NCT02031458|69200692|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
37722093|NCT02031458|69200693|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
37722094|NCT02031458|69200694|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
37722095|NCT02031458|69200692|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
37722096|NCT02031458|69200693|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
37722097|NCT02031458|69200694|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
37722098|NCT02031458|69200692|FG000|Baseline to May 8, 2015|Death|36|||
37722099|NCT02031458|69200693|FG001|Baseline to May 8, 2015|Death|87|||
37722100|NCT02031458|69200694|FG002|Baseline to May 8, 2015|Death|100|||
37722101|NCT02031458|69200692|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
37722102|NCT02031458|69200693|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
37722103|NCT02031458|69200694|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
37722104|NCT02031458|69200692|FG000|Baseline to May 8, 2015|Physician Decision|0|||
37722105|NCT02031458|69200693|FG001|Baseline to May 8, 2015|Physician Decision|1|||
37722106|NCT02031458|69200694|FG002|Baseline to May 8, 2015|Physician Decision|0|||
37722107|NCT02031458|69200692|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
37722108|NCT02031458|69200693|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
37722109|NCT02031458|69200694|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
37722110|NCT02031458|69200692|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
37722111|NCT02031458|69200693|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
37722112|NCT02031458|69200694|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
37722113|NCT02031458|69200692|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
37722114|NCT02031458|69200693|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
37722115|NCT02031458|69200694|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
37722116|NCT02031458|69200692|FG000|Baseline to May 8, 2015|On Treatment|43|||
37722117|NCT02031458|69200693|FG001|Baseline to May 8, 2015|On Treatment|81|||
37722118|NCT02031458|69200694|FG002|Baseline to May 8, 2015|On Treatment|73|||
37722119|NCT02031458|69200692|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
37722120|NCT02031458|69200693|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
37722121|NCT02031458|69200694|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
37722122|NCT02009696|69200704|FG000|Overall Study|Withdrawal by Subject|2|||
37722123|NCT01806597|69200711|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
37722124|NCT01806597|69200712|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
37722125|NCT01806597|69200713|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
37722126|NCT01806597|69200714|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
37722127|NCT01806597|69200715|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
37722128|NCT01806597|69200716|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
37722129|NCT01806597|69200711|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
37722130|NCT01806597|69200712|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
37722131|NCT01806597|69200713|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
37722132|NCT01806597|69200714|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
37722133|NCT01806597|69200715|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
37722134|NCT01806597|69200716|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
37722135|NCT01806597|69200711|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
37722136|NCT01806597|69200712|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
37722137|NCT01806597|69200713|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
37722138|NCT01806597|69200714|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
37722139|NCT01806597|69200715|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
37722140|NCT01806597|69200716|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
37722141|NCT01806597|69200711|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
37722142|NCT01806597|69200712|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
37722143|NCT01806597|69200713|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
37722144|NCT01806597|69200714|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
37722145|NCT01806597|69200715|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
37840454|NCT01088048|69524693|FG005|Overall Study|Disease Progression|3|||
37840455|NCT01088048|69524694|FG006|Overall Study|Disease Progression|2|||
37840456|NCT01088048|69524695|FG007|Overall Study|Disease Progression|1|||
37722146|NCT01806597|69200716|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
37722147|NCT01806597|69200711|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
37840457|NCT01088048|69524696|FG008|Overall Study|Disease Progression|0|||
37840458|NCT01088048|69524697|FG009|Overall Study|Disease Progression|0|||
37722148|NCT01806597|69200712|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
37722149|NCT01806597|69200713|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
37722150|NCT01806597|69200714|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
37722151|NCT01806597|69200715|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
37722152|NCT01806597|69200716|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
37722153|NCT01806597|69200711|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
37722154|NCT01806597|69200712|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
37722155|NCT01806597|69200713|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
37722156|NCT01806597|69200714|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
37722157|NCT01806597|69200715|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
37722158|NCT01806597|69200716|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
37722159|NCT01806597|69200711|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
37722160|NCT01806597|69200712|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
37722161|NCT01806597|69200713|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
37722162|NCT01806597|69200714|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
37722163|NCT01806597|69200715|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
37722164|NCT01806597|69200716|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
37722165|NCT01806597|69200711|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
37722166|NCT01806597|69200712|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
37722167|NCT01806597|69200713|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
37722168|NCT01806597|69200714|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
37722169|NCT01806597|69200715|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
37722170|NCT01806597|69200716|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
37722171|NCT01806597|69200711|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
37722172|NCT01806597|69200712|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
37722173|NCT01806597|69200713|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
37722174|NCT01806597|69200714|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
37722175|NCT01806597|69200715|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
37722176|NCT01806597|69200716|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
37722177|NCT01806597|69200711|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
37722178|NCT01806597|69200712|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
37722179|NCT01806597|69200713|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
37722180|NCT01806597|69200714|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
37722181|NCT01806597|69200715|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
37722182|NCT01806597|69200716|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
37722183|NCT01806597|69200711|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
37722184|NCT01806597|69200712|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
37722185|NCT01806597|69200713|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
37722186|NCT01806597|69200714|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
37840459|NCT01088048|69524688|FG000|Overall Study|Death|1|||
37840460|NCT01088048|69524689|FG001|Overall Study|Death|5|||
37840461|NCT01088048|69524690|FG002|Overall Study|Death|3|||
37840462|NCT01088048|69524691|FG003|Overall Study|Death|3|||
37840463|NCT01088048|69524692|FG004|Overall Study|Death|1|||
37840464|NCT01088048|69524693|FG005|Overall Study|Death|3|||
37840465|NCT01088048|69524694|FG006|Overall Study|Death|0|||
37840466|NCT01088048|69524695|FG007|Overall Study|Death|0|||
37840467|NCT01088048|69524696|FG008|Overall Study|Death|3|||
37840468|NCT01088048|69524697|FG009|Overall Study|Death|1|||
37840469|NCT01088048|69524688|FG000|Overall Study|Other|3|||
37840470|NCT01088048|69524689|FG001|Overall Study|Other|5|||
37840471|NCT01088048|69524690|FG002|Overall Study|Other|0|||
37840472|NCT01088048|69524691|FG003|Overall Study|Other|0|||
37840473|NCT01088048|69524692|FG004|Overall Study|Other|2|||
37840474|NCT01088048|69524693|FG005|Overall Study|Other|0|||
37840475|NCT01088048|69524694|FG006|Overall Study|Other|0|||
37840476|NCT01088048|69524695|FG007|Overall Study|Other|2|||
37840477|NCT01088048|69524696|FG008|Overall Study|Other|0|||
37840478|NCT01088048|69524697|FG009|Overall Study|Other|0|||
37840479|NCT01087970|69524730|FG000|Overall Study|Protocol Violation|2|||
37840480|NCT01087814|69524737|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
37840481|NCT01087814|69524738|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
37840482|NCT01087814|69524737|FG000|Second Intervention (5 Days)|Physician Decision|1|||
37840483|NCT01087814|69524738|FG001|Second Intervention (5 Days)|Physician Decision|0|||
37840484|NCT01087775|69524744|FG000|Overall Study|failed inclusion criteria|2|||
37840485|NCT01087502|69524751|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
37840486|NCT01087502|69524752|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
37840487|NCT01087502|69524751|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
37840488|NCT01087502|69524752|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
37840489|NCT01087502|69524751|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
37722187|NCT01806597|69200715|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
37722188|NCT01806597|69200716|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
37722189|NCT01806597|69200711|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
37722190|NCT01806597|69200712|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
37722191|NCT01806597|69200713|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
37722192|NCT01806597|69200714|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
37722193|NCT01806597|69200715|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
37722194|NCT01806597|69200716|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
37722195|NCT01806597|69200711|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
37840490|NCT01087502|69524752|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
37840491|NCT01087502|69524751|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
37840492|NCT01087502|69524752|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
37840493|NCT01087502|69524751|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
37840494|NCT01087502|69524752|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
37840495|NCT01087502|69524751|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
37840496|NCT01087502|69524752|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
37840497|NCT01087502|69524751|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
37840498|NCT01087502|69524752|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
37840499|NCT01087502|69524751|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
37840500|NCT01087502|69524752|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
37840501|NCT01087502|69524751|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
37840502|NCT01087502|69524752|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
37840503|NCT01087502|69524751|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
37840504|NCT01087502|69524752|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
37840505|NCT01087502|69524751|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
37840506|NCT01087502|69524752|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
37840507|NCT01087502|69524751|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
37840508|NCT01087502|69524752|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
37840509|NCT01086410|69524764|FG000|Overall Study|Adverse Event|1|||
37840510|NCT01086410|69524765|FG001|Overall Study|Adverse Event|0|||
37840511|NCT01086410|69524766|FG002|Overall Study|Adverse Event|0|||
37840512|NCT01086410|69524767|FG003|Overall Study|Adverse Event|2|||
37840513|NCT01086410|69524764|FG000|Overall Study|Lack of Efficacy|1|||
37840514|NCT01086410|69524765|FG001|Overall Study|Lack of Efficacy|1|||
37840515|NCT01086410|69524766|FG002|Overall Study|Lack of Efficacy|0|||
37840516|NCT01086410|69524767|FG003|Overall Study|Lack of Efficacy|0|||
37840517|NCT01086410|69524764|FG000|Overall Study|Protocol Violation|1|||
37840518|NCT01086410|69524765|FG001|Overall Study|Protocol Violation|1|||
37840519|NCT01086410|69524766|FG002|Overall Study|Protocol Violation|0|||
37840520|NCT01086410|69524767|FG003|Overall Study|Protocol Violation|0|||
37840521|NCT01086410|69524764|FG000|Overall Study|Lost to Follow-up|0|||
37840522|NCT01086410|69524765|FG001|Overall Study|Lost to Follow-up|0|||
37840523|NCT01086410|69524766|FG002|Overall Study|Lost to Follow-up|1|||
37840524|NCT01086410|69524767|FG003|Overall Study|Lost to Follow-up|0|||
37840525|NCT04553679|69524779|FG000|Overall Study|Withdrawal by Subject|2|||
37840526|NCT04553679|69524780|FG001|Overall Study|Withdrawal by Subject|0|||
37840527|NCT04553679|69524779|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
37840528|NCT04553679|69524780|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
37840529|NCT01086215|69524794|FG000|Overall Study|Death|14|||
37840530|NCT01086215|69524795|FG001|Overall Study|Death|8|||
37840531|NCT01086215|69524796|FG002|Overall Study|Death|8|||
37915562|NCT00882362|69602323|FG000|Overall Study|Protocol Violation|7|||
37915563|NCT00882362|69602324|FG001|Overall Study|Protocol Violation|2|||
37915564|NCT00882362|69602323|FG000|Overall Study|Pregnancy|1|||
37840532|NCT01086215|69524797|FG003|Overall Study|Death|1|||
37840533|NCT01086215|69524794|FG000|Overall Study|Lost to Follow-up|22|||
37840534|NCT01086215|69524795|FG001|Overall Study|Lost to Follow-up|39|||
37915565|NCT00882362|69602324|FG001|Overall Study|Pregnancy|0|||
37915566|NCT00882362|69602323|FG000|Overall Study|Physician Decision|5|||
38025154|NCT03692676|69709351|FG003|Overall Study|Other|277|||
38025155|NCT03692676|69709348|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
38025156|NCT03692676|69709349|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
38025157|NCT03692676|69709350|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
38025158|NCT03692676|69709351|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
38025159|NCT03691428|69709363|FG000|Overall Study|Withdrawal by Subject|6|||
38025160|NCT03691428|69709364|FG001|Overall Study|Withdrawal by Subject|8|||
38025161|NCT04122534|69709370|FG000|Overall Study|Lost to Follow-up|4|||
37840535|NCT01086215|69524796|FG002|Overall Study|Lost to Follow-up|18|||
37840536|NCT01086215|69524797|FG003|Overall Study|Lost to Follow-up|2|||
37840537|NCT01085591|69524810|FG000|Overall Study|Adverse Event|0|||
37840538|NCT01085591|69524811|FG001|Overall Study|Adverse Event|1|||
37840539|NCT01085591|69524812|FG002|Overall Study|Adverse Event|3|||
37840540|NCT01085591|69524810|FG000|Overall Study|Physician Decision|1|||
37840541|NCT01085591|69524811|FG001|Overall Study|Physician Decision|0|||
37722196|NCT01806597|69200712|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
37722197|NCT01806597|69200713|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
37722198|NCT01806597|69200714|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
37722199|NCT01806597|69200715|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
37722200|NCT01806597|69200716|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
37722201|NCT01806597|69200711|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
37722202|NCT01806597|69200712|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
37722203|NCT01806597|69200713|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
37722204|NCT01806597|69200714|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
37722205|NCT01806597|69200715|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
37722206|NCT01806597|69200716|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
37722207|NCT01806597|69200711|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
37722208|NCT01806597|69200712|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
37722209|NCT01806597|69200713|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
37722210|NCT01806597|69200714|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
37722211|NCT01806597|69200715|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
37722212|NCT01806597|69200716|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
37840542|NCT01085591|69524812|FG002|Overall Study|Physician Decision|1|||
37840543|NCT01085591|69524810|FG000|Overall Study|Withdrawal by Subject|0|||
37722213|NCT01806597|69200711|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
37722214|NCT01806597|69200712|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
37722215|NCT01806597|69200713|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
37722216|NCT01806597|69200714|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
37722217|NCT01806597|69200715|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
37722218|NCT01806597|69200716|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
37722219|NCT01806597|69200711|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
37722220|NCT01806597|69200712|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
37722221|NCT01806597|69200713|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
37722222|NCT01806597|69200714|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
37722223|NCT01806597|69200715|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
37722224|NCT01806597|69200716|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
37840544|NCT01085591|69524811|FG001|Overall Study|Withdrawal by Subject|2|||
37840545|NCT01085591|69524812|FG002|Overall Study|Withdrawal by Subject|1|||
37840546|NCT01085591|69524810|FG000|Overall Study|Lost to Follow-up|0|||
37840547|NCT01085591|69524811|FG001|Overall Study|Lost to Follow-up|1|||
37840548|NCT01085591|69524812|FG002|Overall Study|Lost to Follow-up|1|||
37840549|NCT01085591|69524810|FG000|Overall Study|Protocol Violation|1|||
37840550|NCT01085591|69524811|FG001|Overall Study|Protocol Violation|1|||
37840551|NCT01085591|69524812|FG002|Overall Study|Protocol Violation|1|||
37840552|NCT01085591|69524810|FG000|Overall Study|Other|0|||
37840553|NCT01085591|69524811|FG001|Overall Study|Other|1|||
37840554|NCT01085591|69524812|FG002|Overall Study|Other|0|||
37722225|NCT01806597|69200711|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
37722226|NCT01806597|69200712|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
37722227|NCT01806597|69200713|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
37722228|NCT01806597|69200714|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
37722229|NCT01806597|69200715|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
37840555|NCT01085591|69524810|FG000|Overall Study|Not Properly Consented|1|||
37840556|NCT01085591|69524811|FG001|Overall Study|Not Properly Consented|0|||
37840557|NCT01085591|69524812|FG002|Overall Study|Not Properly Consented|0|||
37840558|NCT01085357|69524823|FG000|Overall Study|Adverse Event|1|||
37840559|NCT01085357|69524824|FG001|Overall Study|Adverse Event|1|||
37840560|NCT01085357|69524823|FG000|Overall Study|Subject Decision|4|||
37840561|NCT01085357|69524824|FG001|Overall Study|Subject Decision|3|||
37840562|NCT01085357|69524823|FG000|Overall Study|Investigator Decision|1|||
37840563|NCT01085357|69524824|FG001|Overall Study|Investigator Decision|1|||
37840564|NCT01085357|69524823|FG000|Overall Study|Death|11|||
37840565|NCT01085357|69524824|FG001|Overall Study|Death|1|||
37840566|NCT01085357|69524823|FG000|Overall Study|Lost to Follow-up|2|||
37840567|NCT01085357|69524824|FG001|Overall Study|Lost to Follow-up|0|||
37840568|NCT01085201|69524835|FG000|Overall Study|Scheduling conflict|1|||
37840569|NCT01085201|69524836|FG001|Overall Study|Scheduling conflict|0|||
37840570|NCT01085201|69524837|FG002|Overall Study|Scheduling conflict|1|||
37840571|NCT01085201|69524838|FG003|Overall Study|Scheduling conflict|0|||
37840572|NCT01085201|69524839|FG004|Overall Study|Scheduling conflict|0|||
37840573|NCT01085201|69524835|FG000|Overall Study|Unknown- no study drug|2|||
37840574|NCT01085201|69524836|FG001|Overall Study|Unknown- no study drug|0|||
37840575|NCT01085201|69524837|FG002|Overall Study|Unknown- no study drug|0|||
37840576|NCT01085201|69524838|FG003|Overall Study|Unknown- no study drug|0|||
37840577|NCT01085201|69524839|FG004|Overall Study|Unknown- no study drug|0|||
37840578|NCT01085201|69524835|FG000|Overall Study|Fond ineligible after consent|0|||
37840579|NCT01085201|69524836|FG001|Overall Study|Fond ineligible after consent|1|||
37840580|NCT01085201|69524837|FG002|Overall Study|Fond ineligible after consent|1|||
37840581|NCT01085201|69524838|FG003|Overall Study|Fond ineligible after consent|0|||
37840582|NCT01085201|69524839|FG004|Overall Study|Fond ineligible after consent|0|||
37840583|NCT01085084|69524859|FG000|Overall Study|Withdrawal by Subject|1|||
37840584|NCT01085084|69524860|FG001|Overall Study|Withdrawal by Subject|0|||
37840585|NCT01085084|69524861|FG002|Overall Study|Withdrawal by Subject|0|||
37840586|NCT01085084|69524859|FG000|Overall Study|Lost to Follow-up|2|||
37840587|NCT01085084|69524860|FG001|Overall Study|Lost to Follow-up|1|||
37840588|NCT01085084|69524861|FG002|Overall Study|Lost to Follow-up|1|||
37840589|NCT01085084|69524859|FG000|Overall Study|Adverse Event|4|||
37840590|NCT01085084|69524860|FG001|Overall Study|Adverse Event|3|||
37840591|NCT01085084|69524861|FG002|Overall Study|Adverse Event|6|||
37840592|NCT01085084|69524859|FG000|Overall Study|Treatment Failure|0|||
37840593|NCT01085084|69524860|FG001|Overall Study|Treatment Failure|1|||
37840594|NCT01085084|69524861|FG002|Overall Study|Treatment Failure|2|||
37840595|NCT01085045|69524869|FG000|Part A|Withdrawal by Subject|4|||
37840596|NCT01085045|69524869|FG000|Part A|Adverse Event|6|||
37840597|NCT01085045|69524869|FG000|Part A|Protocol Violation|1|||
37840598|NCT01085045|69524869|FG000|Part A|Protocol Specified Criteria|7|||
37840599|NCT01085045|69524869|FG000|Part B|Withdrawal by Subject|2|||
37840600|NCT01085045|69524869|FG000|Part B|Protocol Specified Criteria|6|||
37722230|NCT01806597|69200716|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
37722231|NCT01806597|69200711|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
37722232|NCT01806597|69200712|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
37722233|NCT01806597|69200713|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
37722234|NCT01806597|69200714|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
37722235|NCT01806597|69200715|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
37722236|NCT01806597|69200716|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
37722237|NCT02031302|69200732|FG000|Overall Study|Death|115|||
37722238|NCT02031302|69200733|FG001|Overall Study|Death|0|||
37722239|NCT02031302|69200732|FG000|Overall Study|Not treated with study valve system|18|||
37722240|NCT02031302|69200733|FG001|Overall Study|Not treated with study valve system|0|||
37722241|NCT02031302|69200732|FG000|Overall Study|Missed Follow Up|27|||
37722242|NCT02031302|69200733|FG001|Overall Study|Missed Follow Up|0|||
37722243|NCT02031302|69200732|FG000|Overall Study|Lost to Follow-up|4|||
37722244|NCT02031302|69200733|FG001|Overall Study|Lost to Follow-up|0|||
37722245|NCT01610037|69200743|FG000|All Patients|Adverse Event|27|||
37722246|NCT01610037|69200744|FG001|All Patients|Adverse Event|22|||
37722247|NCT01610037|69200745|FG002|All Patients|Adverse Event|26|||
37722248|NCT01610037|69200743|FG000|All Patients|Withdrawal by Subject|12|||
37722249|NCT01610037|69200744|FG001|All Patients|Withdrawal by Subject|10|||
37722250|NCT01610037|69200745|FG002|All Patients|Withdrawal by Subject|20|||
37722251|NCT01610037|69200743|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
37722252|NCT01610037|69200744|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
37722253|NCT01610037|69200745|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
37722254|NCT01610037|69200743|FG000|All Patients|Death|4|||
37722255|NCT01610037|69200744|FG001|All Patients|Death|2|||
37722256|NCT01610037|69200745|FG002|All Patients|Death|1|||
37722257|NCT01610037|69200743|FG000|All Patients|Protocol deviation|4|||
37722258|NCT01610037|69200744|FG001|All Patients|Protocol deviation|3|||
37722259|NCT01610037|69200745|FG002|All Patients|Protocol deviation|3|||
37722260|NCT01610037|69200743|FG000|All Patients|Abnormal laboratory value|1|||
37722261|NCT01610037|69200744|FG001|All Patients|Abnormal laboratory value|1|||
37722262|NCT01610037|69200745|FG002|All Patients|Abnormal laboratory value|0|||
37722263|NCT01610037|69200743|FG000|All Patients|Administrative problems|1|||
37722264|NCT01610037|69200744|FG001|All Patients|Administrative problems|4|||
37722265|NCT01610037|69200745|FG002|All Patients|Administrative problems|4|||
38043540|NCT03366844|69731681|FG000|Overall Study|Physician Decision|1|||
37722266|NCT01610037|69200743|FG000|All Patients|Lost to Follow-up|1|||
37722267|NCT01610037|69200744|FG001|All Patients|Lost to Follow-up|0|||
37722268|NCT01610037|69200745|FG002|All Patients|Lost to Follow-up|0|||
37722269|NCT01610037|69200743|FG000|All Patients|Abnormal test procedure result(s)|0|||
37722270|NCT01610037|69200744|FG001|All Patients|Abnormal test procedure result(s)|1|||
37840601|NCT01085045|69524869|FG000|Part B|Lost to Follow-up|1|||
37840602|NCT01085045|69524869|FG000|Part B|Adverse Event|6|||
37840603|NCT01084772|69524891|FG000|Baseline|Withdrawal by Subject|7|||
37840604|NCT01084772|69524892|FG001|Baseline|Withdrawal by Subject|6|||
37840605|NCT01084772|69524891|FG000|3 Months|Death|1|||
37840606|NCT01084772|69524892|FG001|3 Months|Death|0|||
37840607|NCT01084772|69524891|FG000|3 Months|Study Termination|2|||
37840608|NCT01084772|69524892|FG001|3 Months|Study Termination|2|||
37915567|NCT00882362|69602324|FG001|Overall Study|Physician Decision|1|||
37722271|NCT01610037|69200745|FG002|All Patients|Abnormal test procedure result(s)|3|||
37722272|NCT01610037|69200743|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
37722273|NCT01610037|69200744|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
37722274|NCT01610037|69200745|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
37722275|NCT01610037|69200743|FG000|Treatment and Follow up Period|Death|10|||
37722276|NCT01610037|69200744|FG001|Treatment and Follow up Period|Death|5|||
37722277|NCT01610037|69200745|FG002|Treatment and Follow up Period|Death|4|||
37722278|NCT01610037|69200743|FG000|Treatment and Follow up Period|Administrative problems|1|||
37722279|NCT01610037|69200744|FG001|Treatment and Follow up Period|Administrative problems|3|||
37722280|NCT01610037|69200745|FG002|Treatment and Follow up Period|Administrative problems|2|||
37722281|NCT01610037|69200743|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
37722282|NCT01610037|69200744|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
37722283|NCT01610037|69200745|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
37722284|NCT01806051|69200753|FG000|Overall Study|Withdrawal by Subject|6|||
37722285|NCT01837797|69200762|FG000|Period 1|Adverse Event|9|||
37722286|NCT01837797|69200763|FG001|Period 1|Adverse Event|0|||
37722287|NCT01837797|69200764|FG002|Period 1|Adverse Event|0|||
37722288|NCT01837797|69200765|FG003|Period 1|Adverse Event|0|||
37722289|NCT01837797|69200766|FG004|Period 1|Adverse Event|0|||
37722290|NCT01837797|69200762|FG000|Period 1|Withdrawal by Subject|6|||
37722291|NCT01837797|69200763|FG001|Period 1|Withdrawal by Subject|0|||
37722292|NCT01837797|69200764|FG002|Period 1|Withdrawal by Subject|0|||
37722293|NCT01837797|69200765|FG003|Period 1|Withdrawal by Subject|0|||
37722294|NCT01837797|69200766|FG004|Period 1|Withdrawal by Subject|0|||
38025162|NCT04091360|69709380|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
38025163|NCT04091360|69709381|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
37722295|NCT01837797|69200762|FG000|Period 1|Administrative reasons|76|||
37722296|NCT01837797|69200763|FG001|Period 1|Administrative reasons|0|||
37722297|NCT01837797|69200764|FG002|Period 1|Administrative reasons|0|||
37722298|NCT01837797|69200765|FG003|Period 1|Administrative reasons|0|||
37722299|NCT01837797|69200766|FG004|Period 1|Administrative reasons|0|||
37722300|NCT01837797|69200762|FG000|Period 1|Withdrawal of consent before treatment|1|||
37722301|NCT01837797|69200763|FG001|Period 1|Withdrawal of consent before treatment|0|||
37722302|NCT01837797|69200764|FG002|Period 1|Withdrawal of consent before treatment|0|||
37722303|NCT01837797|69200765|FG003|Period 1|Withdrawal of consent before treatment|0|||
37722304|NCT01837797|69200766|FG004|Period 1|Withdrawal of consent before treatment|0|||
37722305|NCT01837797|69200762|FG000|Period 1|Other|10|||
37722306|NCT01837797|69200763|FG001|Period 1|Other|0|||
37722307|NCT01837797|69200764|FG002|Period 1|Other|0|||
37722308|NCT01837797|69200765|FG003|Period 1|Other|0|||
37722309|NCT01837797|69200766|FG004|Period 1|Other|0|||
37722310|NCT01837797|69200762|FG000|Period 2|Administrative or other reasons|0|||
37722311|NCT01837797|69200763|FG001|Period 2|Administrative or other reasons|5|||
37722312|NCT01837797|69200764|FG002|Period 2|Administrative or other reasons|2|||
37722313|NCT01837797|69200765|FG003|Period 2|Administrative or other reasons|4|||
37722314|NCT01837797|69200766|FG004|Period 2|Administrative or other reasons|0|||
37722315|NCT01837797|69200762|FG000|Period 2|Adverse Event|0|||
37722316|NCT01837797|69200763|FG001|Period 2|Adverse Event|0|||
37722317|NCT01837797|69200764|FG002|Period 2|Adverse Event|0|||
37722318|NCT01837797|69200765|FG003|Period 2|Adverse Event|1|||
37722319|NCT01837797|69200766|FG004|Period 2|Adverse Event|0|||
37722320|NCT01837797|69200762|FG000|Period 3|Adverse Event|0|||
37722321|NCT01837797|69200763|FG001|Period 3|Adverse Event|0|||
37722322|NCT01837797|69200764|FG002|Period 3|Adverse Event|0|||
37722323|NCT01837797|69200765|FG003|Period 3|Adverse Event|0|||
37722324|NCT01837797|69200766|FG004|Period 3|Adverse Event|1|||
37722325|NCT01837797|69200762|FG000|Period 3|Administrative reasons|0|||
37840609|NCT01084772|69524891|FG000|1 Year|Withdrawal by Subject|0|||
37840610|NCT01084772|69524892|FG001|1 Year|Withdrawal by Subject|1|||
37840611|NCT01084772|69524891|FG000|1 Year|Lost to Follow-up|3|||
37840612|NCT01084772|69524892|FG001|1 Year|Lost to Follow-up|0|||
37722326|NCT01837797|69200763|FG001|Period 3|Administrative reasons|0|||
37722327|NCT01837797|69200764|FG002|Period 3|Administrative reasons|0|||
37722328|NCT01837797|69200765|FG003|Period 3|Administrative reasons|0|||
37722329|NCT01837797|69200766|FG004|Period 3|Administrative reasons|20|||
37722330|NCT01837797|69200762|FG000|Period 3|Other|0|||
37722331|NCT01837797|69200763|FG001|Period 3|Other|0|||
37722332|NCT01837797|69200764|FG002|Period 3|Other|0|||
37722333|NCT01837797|69200765|FG003|Period 3|Other|0|||
37722334|NCT01837797|69200766|FG004|Period 3|Other|2|||
37722335|NCT01984424|69200776|FG000|Overall Study|Withdrawal by Subject|3|||
37840613|NCT01084772|69524891|FG000|1 Year|Study Termination|0|||
37722336|NCT01984424|69200777|FG001|Overall Study|Withdrawal by Subject|5|||
37722337|NCT01984424|69200776|FG000|Overall Study|Sponsor Decision|0|||
37722338|NCT01984424|69200777|FG001|Overall Study|Sponsor Decision|1|||
37722339|NCT01984424|69200776|FG000|Overall Study|Lost to Follow-up|0|||
37722340|NCT01984424|69200777|FG001|Overall Study|Lost to Follow-up|1|||
37840614|NCT01084772|69524892|FG001|1 Year|Study Termination|7|||
37840615|NCT01084772|69524891|FG000|2 Years|Withdrawal by Subject|1|||
37840616|NCT01084772|69524892|FG001|2 Years|Withdrawal by Subject|0|||
37840617|NCT01084772|69524891|FG000|2 Years|Lost to Follow-up|5|||
37840618|NCT01084772|69524892|FG001|2 Years|Lost to Follow-up|2|||
37840619|NCT01084772|69524891|FG000|2 Years|Study Termination|3|||
37840620|NCT01084772|69524892|FG001|2 Years|Study Termination|2|||
37840621|NCT00179673|69524898|FG000|Overall Study|Adverse Event|7|||
37840622|NCT00179673|69524898|FG000|Overall Study|Lack of Efficacy|15|||
37840623|NCT00179673|69524898|FG000|Overall Study|Withdrawal by Subject|3|||
37840624|NCT00179673|69524898|FG000|Overall Study|Death|4|||
37840625|NCT00179673|69524898|FG000|Overall Study|Other Observations and options|14|||
37840626|NCT01084655|69524905|FG000|Overall Study|Radiographic disease progression|3|||
37722341|NCT01837719|69200783|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
37722342|NCT01837719|69200783|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
37722343|NCT01984268|69200798|FG000|Overall Study|Study Terminated|15|||
37722344|NCT02031146|69200804|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
37840627|NCT01084655|69524906|FG001|Overall Study|Radiographic disease progression|2|||
37722345|NCT02031146|69200805|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
37840628|NCT01084655|69524907|FG002|Overall Study|Radiographic disease progression|8|||
37840629|NCT01084655|69524905|FG000|Overall Study|Withdrawal by Subject|1|||
37840630|NCT01084655|69524906|FG001|Overall Study|Withdrawal by Subject|0|||
37840631|NCT01084655|69524907|FG002|Overall Study|Withdrawal by Subject|4|||
37722346|NCT02031146|69200806|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
37722347|NCT02031146|69200807|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
37722348|NCT02031146|69200808|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
37722349|NCT02031146|69200809|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
37722350|NCT02031146|69200810|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
37722351|NCT02009384|69200820|FG000|Overall Study|Death|2|||
37722352|NCT01805037|69200824|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
37722353|NCT01805037|69200825|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
37722354|NCT01805037|69200824|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
37722355|NCT01805037|69200825|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
37722356|NCT01805037|69200824|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
37722357|NCT01805037|69200825|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
37722358|NCT01805037|69200824|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
37722359|NCT01805037|69200825|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
37722360|NCT01805037|69200824|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
37722361|NCT01805037|69200825|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
37722362|NCT01805037|69200824|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
37722363|NCT01805037|69200825|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
37722364|NCT01805037|69200824|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
37722365|NCT01805037|69200825|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
37722366|NCT01805037|69200824|FG000|Follow Up (up to 3 Years)|Death|0|||
37722367|NCT01805037|69200825|FG001|Follow Up (up to 3 Years)|Death|2|||
37722368|NCT01805037|69200824|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
37722369|NCT01805037|69200825|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
37722370|NCT01805037|69200824|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
37722371|NCT01805037|69200825|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
37722372|NCT01803711|69200831|FG000|Overall Study|Adverse Event|1|||
37722373|NCT01803711|69200832|FG001|Overall Study|Adverse Event|1|||
37722374|NCT01836549|69200846|FG000|Overall Study|Did not receive study drug|0|||
37722375|NCT01836549|69200847|FG001|Overall Study|Did not receive study drug|0|||
37722376|NCT01836549|69200848|FG002|Overall Study|Did not receive study drug|1|||
37722377|NCT01836549|69200849|FG003|Overall Study|Did not receive study drug|0|||
37722378|NCT01836549|69200850|FG004|Overall Study|Did not receive study drug|0|||
37722379|NCT01836549|69200851|FG005|Overall Study|Did not receive study drug|0|||
37722380|NCT01836549|69200852|FG006|Overall Study|Did not receive study drug|0|||
37722381|NCT01836549|69200846|FG000|Overall Study|Patient declared ineligible|0|||
37722382|NCT01836549|69200847|FG001|Overall Study|Patient declared ineligible|0|||
37722383|NCT01836549|69200848|FG002|Overall Study|Patient declared ineligible|0|||
37722384|NCT01836549|69200849|FG003|Overall Study|Patient declared ineligible|1|||
37722385|NCT01836549|69200850|FG004|Overall Study|Patient declared ineligible|0|||
37722386|NCT01836549|69200851|FG005|Overall Study|Patient declared ineligible|0|||
37722387|NCT01836549|69200852|FG006|Overall Study|Patient declared ineligible|0|||
37722388|NCT01836549|69200846|FG000|Overall Study|Patient inevaluable to start therapy|0|||
37722389|NCT01836549|69200847|FG001|Overall Study|Patient inevaluable to start therapy|0|||
37722390|NCT01836549|69200848|FG002|Overall Study|Patient inevaluable to start therapy|0|||
37722391|NCT01836549|69200849|FG003|Overall Study|Patient inevaluable to start therapy|0|||
37722392|NCT01836549|69200850|FG004|Overall Study|Patient inevaluable to start therapy|0|||
37722393|NCT01836549|69200851|FG005|Overall Study|Patient inevaluable to start therapy|0|||
37722394|NCT01836549|69200852|FG006|Overall Study|Patient inevaluable to start therapy|1|||
37722395|NCT01836471|69200873|FG000|Overall Study|Pregnancy|1|||
37722396|NCT01836471|69200874|FG001|Overall Study|Pregnancy|0|||
37722397|NCT01836471|69200875|FG002|Overall Study|Pregnancy|0|||
37722398|NCT01836471|69200876|FG003|Overall Study|Pregnancy|0|||
37722399|NCT01836471|69200877|FG004|Overall Study|Pregnancy|0|||
37722400|NCT01836471|69200873|FG000|Overall Study|Withdrawal by Subject|3|||
37722401|NCT01836471|69200874|FG001|Overall Study|Withdrawal by Subject|4|||
37722402|NCT01836471|69200875|FG002|Overall Study|Withdrawal by Subject|1|||
37722403|NCT01836471|69200876|FG003|Overall Study|Withdrawal by Subject|0|||
37722404|NCT01836471|69200877|FG004|Overall Study|Withdrawal by Subject|2|||
37722405|NCT01836471|69200873|FG000|Overall Study|Physician Decision|0|||
37722406|NCT01836471|69200874|FG001|Overall Study|Physician Decision|1|||
37915568|NCT00882362|69602323|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
37915569|NCT00882362|69602324|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
37722407|NCT01836471|69200875|FG002|Overall Study|Physician Decision|0|||
37722408|NCT01836471|69200876|FG003|Overall Study|Physician Decision|0|||
37722409|NCT01836471|69200877|FG004|Overall Study|Physician Decision|0|||
37722410|NCT01836471|69200873|FG000|Overall Study|Lost to Follow-up|0|||
37722411|NCT01836471|69200874|FG001|Overall Study|Lost to Follow-up|0|||
37722412|NCT01836471|69200875|FG002|Overall Study|Lost to Follow-up|0|||
37722413|NCT01836471|69200876|FG003|Overall Study|Lost to Follow-up|1|||
37722414|NCT01836471|69200877|FG004|Overall Study|Lost to Follow-up|1|||
37722415|NCT01836471|69200873|FG000|Overall Study|Adverse Event|6|||
37722416|NCT01836471|69200874|FG001|Overall Study|Adverse Event|3|||
37722417|NCT01836471|69200875|FG002|Overall Study|Adverse Event|1|||
37722418|NCT01836471|69200876|FG003|Overall Study|Adverse Event|1|||
37722419|NCT01836471|69200877|FG004|Overall Study|Adverse Event|2|||
37722420|NCT01836471|69200873|FG000|Overall Study|Non compliance with tx|1|||
37722421|NCT01836471|69200874|FG001|Overall Study|Non compliance with tx|1|||
37722422|NCT01836471|69200875|FG002|Overall Study|Non compliance with tx|0|||
37722423|NCT01836471|69200876|FG003|Overall Study|Non compliance with tx|0|||
37840632|NCT01084655|69524905|FG000|Overall Study|Adverse Event|2|||
37840633|NCT01084655|69524906|FG001|Overall Study|Adverse Event|1|||
37840634|NCT01084655|69524907|FG002|Overall Study|Adverse Event|2|||
37840635|NCT01084655|69524905|FG000|Overall Study|Other|0|||
37840636|NCT01084655|69524906|FG001|Overall Study|Other|3|||
37840637|NCT01084655|69524907|FG002|Overall Study|Other|2|||
37840638|NCT01084655|69524905|FG000|Overall Study|Symptomatic deterioration|0|||
37840639|NCT01084655|69524906|FG001|Overall Study|Symptomatic deterioration|0|||
37840640|NCT01084655|69524907|FG002|Overall Study|Symptomatic deterioration|2|||
37840641|NCT01084655|69524905|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
37722424|NCT01836471|69200877|FG004|Overall Study|Non compliance with tx|0|||
37722425|NCT02030600|69200892|FG000|Treatment Period 1|Adverse Event|5|||
37722426|NCT02030600|69200893|FG001|Treatment Period 1|Adverse Event|7|||
37722427|NCT02030600|69200892|FG000|Treatment Period 1|Lack of Efficacy|0|||
37722428|NCT02030600|69200893|FG001|Treatment Period 1|Lack of Efficacy|1|||
37722429|NCT02030600|69200892|FG000|Treatment Period 1|Lost to Follow-up|11|||
37722430|NCT02030600|69200893|FG001|Treatment Period 1|Lost to Follow-up|3|||
37722431|NCT02030600|69200892|FG000|Treatment Period 1|Protocol Violation|22|||
37722432|NCT02030600|69200893|FG001|Treatment Period 1|Protocol Violation|17|||
37722433|NCT02030600|69200892|FG000|Treatment Period 1|Withdrawal by Subject|13|||
37722434|NCT02030600|69200893|FG001|Treatment Period 1|Withdrawal by Subject|17|||
37722435|NCT02030600|69200892|FG000|Treatment Period 1|Casebook Unsigned|1|||
37722436|NCT02030600|69200893|FG001|Treatment Period 1|Casebook Unsigned|0|||
37722437|NCT02030600|69200892|FG000|Treatment Period 1|Unclassified|1|||
37722438|NCT02030600|69200893|FG001|Treatment Period 1|Unclassified|0|||
37722439|NCT02030600|69200892|FG000|Treatment Period 2|Adverse Event|4|||
37722440|NCT02030600|69200893|FG001|Treatment Period 2|Adverse Event|4|||
37722441|NCT02030600|69200892|FG000|Treatment Period 2|Lack of Efficacy|2|||
37722442|NCT02030600|69200893|FG001|Treatment Period 2|Lack of Efficacy|1|||
37840642|NCT01084655|69524906|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
37840643|NCT01084655|69524907|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
37840644|NCT01084538|69524919|FG000|Overall Study|Drug not available|30|||
37840645|NCT01084538|69524919|FG000|Overall Study|Adverse Event|9|||
37915570|NCT00882362|69602323|FG000|Overall Study|change of residence or other commitments|5|||
37915571|NCT00882362|69602324|FG001|Overall Study|change of residence or other commitments|0|||
37915572|NCT00851643|69602336|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
37722443|NCT02030600|69200892|FG000|Treatment Period 2|Lost to Follow-up|4|||
37722444|NCT02030600|69200893|FG001|Treatment Period 2|Lost to Follow-up|2|||
37722445|NCT02030600|69200892|FG000|Treatment Period 2|Protocol Violation|1|||
37722446|NCT02030600|69200893|FG001|Treatment Period 2|Protocol Violation|2|||
37722447|NCT02030600|69200892|FG000|Treatment Period 2|Withdrawal by Subject|13|||
37722448|NCT02030600|69200893|FG001|Treatment Period 2|Withdrawal by Subject|9|||
37722449|NCT02030600|69200892|FG000|Treatment Period 2|Unclassified|1|||
37722450|NCT02030600|69200893|FG001|Treatment Period 2|Unclassified|0|||
37722451|NCT01802775|69200903|FG000|Overall Study|Death|0|||
37722452|NCT01802775|69200904|FG001|Overall Study|Death|3|||
37722453|NCT01802775|69200903|FG000|Overall Study|Reason not provided|0|||
37722454|NCT01802775|69200904|FG001|Overall Study|Reason not provided|1|||
37722455|NCT01802775|69200903|FG000|Overall Study|Physician Decision|1|||
37722456|NCT01802775|69200904|FG001|Overall Study|Physician Decision|0|||
37722457|NCT01802775|69200903|FG000|Overall Study|Adverse Event|1|||
37722458|NCT01802775|69200904|FG001|Overall Study|Adverse Event|1|||
37915573|NCT00851643|69602337|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
37915574|NCT00851643|69602338|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
37915575|NCT00851643|69602339|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
37915576|NCT00851643|69602340|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
37722459|NCT01802775|69200903|FG000|Overall Study|Withdrawal by Subject|3|||
37722460|NCT01802775|69200904|FG001|Overall Study|Withdrawal by Subject|5|||
37722461|NCT01802775|69200903|FG000|Overall Study|Lost to Follow-up|1|||
37915577|NCT00851643|69602341|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
37915578|NCT00851643|69602336|FG000|Base Study (Up to 12 Months)|Other|0|||
37722462|NCT01802775|69200904|FG001|Overall Study|Lost to Follow-up|2|||
37722463|NCT01802385|69200912|FG000|Overall Study|Death|106|||
37915579|NCT00851643|69602337|FG001|Base Study (Up to 12 Months)|Other|0|||
37915580|NCT00851643|69602338|FG002|Base Study (Up to 12 Months)|Other|0|||
37722464|NCT01802385|69200913|FG001|Overall Study|Death|120|||
37722465|NCT01773993|69200919|FG000|Overall Study|No Visit After Treatment|35|||
37722466|NCT01802073|69200925|FG000|Overall Study|Lost to Follow-up|0|||
37722467|NCT01802073|69200926|FG001|Overall Study|Lost to Follow-up|1|||
37722468|NCT01802073|69200925|FG000|Overall Study|Non-compliant|4|||
37722469|NCT01802073|69200926|FG001|Overall Study|Non-compliant|2|||
37722470|NCT01802073|69200925|FG000|Overall Study|Withdrawal by Subject|1|||
37722471|NCT01802073|69200926|FG001|Overall Study|Withdrawal by Subject|1|||
37722472|NCT01802073|69200925|FG000|Overall Study|Physician Decision|0|||
37722473|NCT01802073|69200926|FG001|Overall Study|Physician Decision|7|||
37722474|NCT01607073|69200932|FG000|Overall Study|Adverse Event|1|||
37722475|NCT01773291|69200942|FG000|Overall Study|Protocol Violation|1|||
37722476|NCT01773291|69200943|FG001|Overall Study|Protocol Violation|0|||
37722477|NCT01773291|69200944|FG002|Overall Study|Protocol Violation|0|||
37722478|NCT01773291|69200942|FG000|Overall Study|Withdrawal by Subject|0|||
37722479|NCT01773291|69200943|FG001|Overall Study|Withdrawal by Subject|0|||
37722480|NCT01773291|69200944|FG002|Overall Study|Withdrawal by Subject|1|||
37722481|NCT01801917|69200957|FG000|Period 1 - Randomized|Adverse Event|1|||
37722482|NCT01801917|69200958|FG001|Period 1 - Randomized|Adverse Event|0|||
37722483|NCT01801917|69200959|FG002|Period 1 - Randomized|Adverse Event|1|||
37722484|NCT01801917|69200960|FG003|Period 1 - Randomized|Adverse Event|0|||
37722485|NCT02008916|69200974|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
37722486|NCT02008916|69200975|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
37722487|NCT02008916|69200976|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
37722488|NCT02008916|69200974|FG000|Week 16 - 156|Adverse Event|4|||
37722489|NCT02008916|69200975|FG001|Week 16 - 156|Adverse Event|2|||
37722490|NCT02008916|69200976|FG002|Week 16 - 156|Adverse Event|3|||
37722491|NCT02008916|69200974|FG000|Week 16 - 156|Withdrawal by Subject|7|||
37722492|NCT02008916|69200975|FG001|Week 16 - 156|Withdrawal by Subject|3|||
37722493|NCT02008916|69200976|FG002|Week 16 - 156|Withdrawal by Subject|5|||
37722494|NCT02008916|69200974|FG000|Week 16 - 156|No longer requires treatment|0|||
37722495|NCT02008916|69200975|FG001|Week 16 - 156|No longer requires treatment|1|||
37722496|NCT02008916|69200976|FG002|Week 16 - 156|No longer requires treatment|0|||
37722497|NCT02008916|69200974|FG000|Week 16 - 156|Lost to Follow-up|5|||
37722498|NCT02008916|69200975|FG001|Week 16 - 156|Lost to Follow-up|0|||
37722499|NCT02008916|69200976|FG002|Week 16 - 156|Lost to Follow-up|0|||
37722500|NCT02008916|69200974|FG000|Week 16 - 156|Lack of Efficacy|3|||
37722501|NCT02008916|69200975|FG001|Week 16 - 156|Lack of Efficacy|5|||
37722502|NCT02008916|69200976|FG002|Week 16 - 156|Lack of Efficacy|2|||
37722503|NCT02008916|69200974|FG000|Week 16 - 156|Pregnancy|0|||
37722504|NCT02008916|69200975|FG001|Week 16 - 156|Pregnancy|1|||
37722505|NCT02008916|69200976|FG002|Week 16 - 156|Pregnancy|0|||
37722506|NCT02008916|69200974|FG000|Week 16 - 156|Physician Decision|0|||
37722507|NCT02008916|69200975|FG001|Week 16 - 156|Physician Decision|1|||
37722508|NCT02008916|69200976|FG002|Week 16 - 156|Physician Decision|0|||
37722509|NCT01772823|69200987|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
37722510|NCT01772823|69200988|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
37722511|NCT01772823|69200987|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
37722512|NCT01772823|69200988|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
37722513|NCT01772823|69200987|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
37722514|NCT01772823|69200988|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
37722515|NCT01772823|69200987|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
37722516|NCT01772823|69200988|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
37722517|NCT01772823|69200987|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
37722518|NCT01772823|69200988|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
37722519|NCT01772823|69200987|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
37722520|NCT01772823|69200988|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
37722521|NCT01772823|69200987|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
37722522|NCT01772823|69200988|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
37722523|NCT01772823|69200987|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
37722524|NCT01772823|69200988|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
37722525|NCT01772823|69200987|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
37722526|NCT01772823|69200988|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
37722527|NCT01772823|69200987|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
37722528|NCT01772823|69200988|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
37722529|NCT01772823|69200987|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
37840646|NCT01084538|69524919|FG000|Overall Study|Kidney transplant|6|||
37840647|NCT01084538|69524919|FG000|Overall Study|Serious Adverse Event|3|||
37840648|NCT01084538|69524919|FG000|Overall Study|Lack of effectiveness|2|||
37840649|NCT01084538|69524919|FG000|Overall Study|Patient noncompliance|2|||
37840650|NCT01084538|69524919|FG000|Overall Study|Hyperphosphatemia|2|||
37840651|NCT01084538|69524919|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
37840652|NCT01084538|69524919|FG000|Overall Study|Change of residence|2|||
37840653|NCT01084538|69524919|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
37722530|NCT01772823|69200988|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
37722531|NCT01772823|69200987|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
37722532|NCT01772823|69200988|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
37722533|NCT01772823|69200987|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
37722534|NCT01772823|69200988|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
37722535|NCT01772823|69200987|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
37722536|NCT01772823|69200988|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
37722537|NCT01772823|69200987|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
37722538|NCT01772823|69200988|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
37722539|NCT01772823|69200987|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
37722540|NCT01772823|69200988|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
37722541|NCT02029976|69201001|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
37722542|NCT02029976|69201002|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
37722543|NCT02029976|69201001|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
38025164|NCT04091360|69709382|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
38025165|NCT04091360|69709383|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
38025166|NCT04091360|69709384|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
38025167|NCT04091360|69709385|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
37722544|NCT02029976|69201002|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
37722545|NCT02029976|69201001|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
37722546|NCT02029976|69201002|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
37722547|NCT02029976|69201001|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
37722548|NCT02029976|69201002|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
37722549|NCT01983254|69201010|FG000|Overall Study|Death|6|||
37722550|NCT01983254|69201011|FG001|Overall Study|Death|6|||
37722551|NCT01983254|69201010|FG000|Overall Study|Lost to Follow-up|17|||
37722552|NCT01983254|69201011|FG001|Overall Study|Lost to Follow-up|16|||
37722553|NCT01983254|69201010|FG000|Overall Study|too ill|11|||
37722554|NCT01983254|69201011|FG001|Overall Study|too ill|8|||
37722555|NCT01771809|69201019|FG000|Overall Study|Adverse Event|4|||
37722556|NCT01771809|69201020|FG001|Overall Study|Adverse Event|12|||
37722557|NCT01771809|69201019|FG000|Overall Study|Protocol Violation|0|||
37722558|NCT01771809|69201020|FG001|Overall Study|Protocol Violation|1|||
37722559|NCT01771809|69201019|FG000|Overall Study|Withdrawal by Subject|34|||
37722560|NCT01771809|69201020|FG001|Overall Study|Withdrawal by Subject|42|||
37722561|NCT01771809|69201019|FG000|Overall Study|Lost to Follow-up|1|||
37722562|NCT01771809|69201020|FG001|Overall Study|Lost to Follow-up|3|||
37722563|NCT01771809|69201019|FG000|Overall Study|Other (Insufficient clinical response)|22|||
37722564|NCT01771809|69201020|FG001|Overall Study|Other (Insufficient clinical response)|20|||
37722565|NCT01771809|69201019|FG000|Overall Study|Death|1|||
37722566|NCT01771809|69201020|FG001|Overall Study|Death|0|||
37722567|NCT01771809|69201019|FG000|Overall Study|Other (other)|9|||
37722568|NCT01771809|69201020|FG001|Overall Study|Other (other)|5|||
37722569|NCT01771731|69201028|FG000|Overall Study|Physician Decision|1|||
37722570|NCT01771731|69201029|FG001|Overall Study|Physician Decision|0|||
37722571|NCT01771731|69201028|FG000|Overall Study|Protocol Violation|0|||
37722572|NCT01771731|69201029|FG001|Overall Study|Protocol Violation|1|||
37722573|NCT01771731|69201028|FG000|Overall Study|Adverse event: Pain Crisis|1|||
37722574|NCT01771731|69201029|FG001|Overall Study|Adverse event: Pain Crisis|1|||
37722575|NCT01982942|69201037|FG000|Overall Study|Adverse Event|10|||
37722576|NCT01982942|69201038|FG001|Overall Study|Adverse Event|5|||
37722577|NCT01982942|69201037|FG000|Overall Study|Lost to Follow-up|4|||
37722578|NCT01982942|69201038|FG001|Overall Study|Lost to Follow-up|3|||
37722579|NCT01982942|69201037|FG000|Overall Study|Multiple sclerosis progression|3|||
37722580|NCT01982942|69201038|FG001|Overall Study|Multiple sclerosis progression|2|||
37722581|NCT01982942|69201037|FG000|Overall Study|Wanted to try therapy not permitted|1|||
37722582|NCT01982942|69201038|FG001|Overall Study|Wanted to try therapy not permitted|0|||
37722583|NCT01982942|69201037|FG000|Overall Study|Subject declined future visits|0|||
37722584|NCT01982942|69201038|FG001|Overall Study|Subject declined future visits|1|||
37722585|NCT01982942|69201037|FG000|Overall Study|Left geographical area|2|||
37722586|NCT01982942|69201038|FG001|Overall Study|Left geographical area|0|||
37722587|NCT01982942|69201037|FG000|Overall Study|Too many pills|1|||
37722588|NCT01982942|69201038|FG001|Overall Study|Too many pills|0|||
37722589|NCT01982942|69201037|FG000|Overall Study|MS Relapse|0|||
37722590|NCT01982942|69201038|FG001|Overall Study|MS Relapse|1|||
37722591|NCT01982942|69201037|FG000|Overall Study|Chose to join a stem cell trial|0|||
37722592|NCT01982942|69201038|FG001|Overall Study|Chose to join a stem cell trial|1|||
37722593|NCT01982942|69201037|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
37722594|NCT01982942|69201038|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
37722595|NCT01769469|69201044|FG000|Overall Study|Consent Withdrawn|5|||
37722596|NCT01769469|69201044|FG000|Overall Study|Moved Out Of Area|3|||
37722597|NCT01769469|69201044|FG000|Overall Study|Lost to Follow-up|17|||
37722598|NCT01769469|69201044|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
37722599|NCT01769469|69201044|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
37722600|NCT02008526|69201053|FG000|Overall Study|Death|0|||
37722601|NCT02008526|69201054|FG001|Overall Study|Death|2|||
37722602|NCT02008526|69201055|FG002|Overall Study|Death|1|||
37722603|NCT02008526|69201053|FG000|Overall Study|Withdrawal by Subject|3|||
37722604|NCT02008526|69201054|FG001|Overall Study|Withdrawal by Subject|3|||
37722605|NCT02008526|69201055|FG002|Overall Study|Withdrawal by Subject|2|||
37722606|NCT02008526|69201053|FG000|Overall Study|Lost to Follow-up|5|||
37722607|NCT02008526|69201054|FG001|Overall Study|Lost to Follow-up|9|||
37722608|NCT02008526|69201055|FG002|Overall Study|Lost to Follow-up|6|||
37722609|NCT01769391|69201065|FG000|Overall Study|Death|10|||
37722610|NCT01769391|69201066|FG001|Overall Study|Death|1|||
37722611|NCT01769391|69201065|FG000|Overall Study|Adverse Event|0|||
37722612|NCT01769391|69201066|FG001|Overall Study|Adverse Event|3|||
37722613|NCT01769391|69201065|FG000|Overall Study|Progressive Disease|1|||
37722614|NCT01769391|69201066|FG001|Overall Study|Progressive Disease|2|||
37722615|NCT01769391|69201065|FG000|Overall Study|Withdrawal by Subject|4|||
37722616|NCT01769391|69201066|FG001|Overall Study|Withdrawal by Subject|3|||
37722617|NCT01769391|69201065|FG000|Overall Study|Investigator Decision|2|||
37722618|NCT01769391|69201066|FG001|Overall Study|Investigator Decision|0|||
37722619|NCT01800903|69201078|FG000|Second Test Period|unable to catheterise|1|||
37722620|NCT01800903|69201079|FG001|Second Test Period|unable to catheterise|0|||
37722621|NCT01800903|69201080|FG002|Second Test Period|unable to catheterise|0|||
37722622|NCT01800903|69201081|FG003|Second Test Period|unable to catheterise|0|||
37722623|NCT01800903|69201082|FG004|Second Test Period|unable to catheterise|0|||
37722624|NCT01800903|69201083|FG005|Second Test Period|unable to catheterise|0|||
37722625|NCT01767987|69201091|FG000|Overall Study|Physician Decision|4|||
37722626|NCT01767987|69201092|FG001|Overall Study|Physician Decision|1|||
37722627|NCT01800201|69201100|FG000|Overall Study|Withdrawal by Subject|2|||
37722628|NCT01800201|69201101|FG001|Overall Study|Withdrawal by Subject|0|||
37722629|NCT01800201|69201100|FG000|Overall Study|patient privacy concerns|1|||
37722630|NCT01800201|69201101|FG001|Overall Study|patient privacy concerns|1|||
37722631|NCT01800201|69201100|FG000|Overall Study|did not want to use device|0|||
37722632|NCT01800201|69201101|FG001|Overall Study|did not want to use device|1|||
37722633|NCT01800201|69201100|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
37722634|NCT01800201|69201101|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
37722635|NCT01767909|69201110|FG000|Overall Study|Withdrawal by Subject|4|||
37722636|NCT01767909|69201111|FG001|Overall Study|Withdrawal by Subject|7|||
37722637|NCT01767909|69201110|FG000|Overall Study|Adverse Event|3|||
37722638|NCT01767909|69201111|FG001|Overall Study|Adverse Event|1|||
37722639|NCT01767909|69201110|FG000|Overall Study|Withdrawal by Study Partner|3|||
37722640|NCT01767909|69201111|FG001|Overall Study|Withdrawal by Study Partner|1|||
37722641|NCT01767909|69201110|FG000|Overall Study|Non-Compliance|2|||
37722642|NCT01767909|69201111|FG001|Overall Study|Non-Compliance|0|||
37722643|NCT01767909|69201110|FG000|Overall Study|Perceived Lack of Efficacy|1|||
37722644|NCT01767909|69201111|FG001|Overall Study|Perceived Lack of Efficacy|0|||
37722645|NCT01767909|69201110|FG000|Overall Study|Investigator Recommendation|0|||
37722646|NCT01767909|69201111|FG001|Overall Study|Investigator Recommendation|1|||
37722647|NCT01767909|69201110|FG000|Overall Study|Lost to Follow-up|0|||
37722648|NCT01767909|69201111|FG001|Overall Study|Lost to Follow-up|1|||
37722649|NCT01767909|69201110|FG000|Overall Study|LP uncessessful|0|||
37840654|NCT01084538|69524919|FG000|Overall Study|Reason unknown|8|||
37840655|NCT01083680|69524923|FG000|Overall Study|Lost to Follow-up|2758|||
37840656|NCT01083680|69524923|FG000|Overall Study|Withdrawal by Subject|1086|||
37722650|NCT01767909|69201111|FG001|Overall Study|LP uncessessful|1|||
37722651|NCT02029274|69201123|FG000|Overall Study|Adverse Event|1|||
37722652|NCT02029274|69201124|FG001|Overall Study|Adverse Event|0|||
37722653|NCT02029274|69201125|FG002|Overall Study|Adverse Event|2|||
37722654|NCT02029274|69201126|FG003|Overall Study|Adverse Event|2|||
37722655|NCT02008370|69201140|FG000|Overall Study|Lost to Follow-up|7|||
37722656|NCT01981616|69201146|FG000|Overall Study|Adverse Event|0|||
37722657|NCT01981616|69201147|FG001|Overall Study|Adverse Event|1|||
37722658|NCT01981616|69201146|FG000|Overall Study|Protocol Violation|1|||
37722659|NCT01981616|69201147|FG001|Overall Study|Protocol Violation|0|||
37722660|NCT02104817|69201155|FG000|Overall Study|Death|363|||
37722661|NCT02104817|69201156|FG001|Overall Study|Death|330|||
37722662|NCT02104817|69201155|FG000|Overall Study|Lost to Follow-up|3|||
37840657|NCT00179517|69524929|FG000|Overall Study|Withdrawal by Subject|2|||
37840658|NCT00179517|69524930|FG001|Overall Study|Withdrawal by Subject|1|||
37722663|NCT02104817|69201156|FG001|Overall Study|Lost to Follow-up|2|||
37722664|NCT02104817|69201155|FG000|Overall Study|Protocol Violation|0|||
37722665|NCT02104817|69201156|FG001|Overall Study|Protocol Violation|1|||
37722666|NCT02104817|69201155|FG000|Overall Study|Study terminated by sponsor|5854|||
37840659|NCT01083641|69524936|FG000|Overall Study|Withdrawal by Subject|2|||
37722667|NCT02104817|69201156|FG001|Overall Study|Study terminated by sponsor|5901|||
37722668|NCT02104817|69201155|FG000|Overall Study|Withdrawal by Subject|111|||
37722669|NCT02104817|69201156|FG001|Overall Study|Withdrawal by Subject|78|||
37722670|NCT02104817|69201155|FG000|Overall Study|Other reasons|128|||
37722671|NCT02104817|69201156|FG001|Overall Study|Other reasons|135|||
37722672|NCT01962103|69201171|FG000|Phase 1|Adverse Event|4|||
37722673|NCT01962103|69201172|FG001|Phase 1|Adverse Event|0|||
37722674|NCT01962103|69201173|FG002|Phase 1|Adverse Event|2|||
37722675|NCT01962103|69201174|FG003|Phase 1|Adverse Event|1|||
37722676|NCT01962103|69201175|FG004|Phase 1|Adverse Event|2|||
37840660|NCT00179010|69524942|FG000|Overall Study|Muscle probe defective|1|||
37840661|NCT00179010|69524943|FG001|Overall Study|Muscle probe defective|1|||
37840662|NCT00179010|69524942|FG000|Overall Study|Failure to place arterial line|0|||
37840663|NCT00179010|69524943|FG001|Overall Study|Failure to place arterial line|1|||
37840664|NCT01083602|69524950|FG000|Overall Study|Adverse Event|11|||
37840665|NCT01083602|69524950|FG000|Overall Study|New Cancer Therapy|2|||
37840666|NCT01083602|69524950|FG000|Overall Study|Death|1|||
37840667|NCT01083602|69524950|FG000|Overall Study|Withdrawal by Subject|5|||
37840668|NCT01083602|69524950|FG000|Overall Study|Lack of Efficacy|36|||
37840669|NCT00178464|69524954|FG000|Overall Study|Withdrawal by Subject|1|||
37840670|NCT00178464|69524954|FG000|Overall Study|Physician Decision|1|||
37722677|NCT01962103|69201176|FG005|Phase 1|Adverse Event|2|||
37840671|NCT01083485|69524960|FG000|Overall Study|Adverse Event|0|||
37840672|NCT01083485|69524961|FG001|Overall Study|Adverse Event|1|||
37722678|NCT01962103|69201177|FG006|Phase 1|Adverse Event|0|||
37840673|NCT01083485|69524960|FG000|Overall Study|Protocol Violation|1|||
37840674|NCT01083485|69524961|FG001|Overall Study|Protocol Violation|0|||
37840675|NCT01083485|69524960|FG000|Overall Study|Withdrawal by Subject|5|||
37840676|NCT01083485|69524961|FG001|Overall Study|Withdrawal by Subject|2|||
37840677|NCT01083485|69524960|FG000|Overall Study|Other|1|||
37840678|NCT01083485|69524961|FG001|Overall Study|Other|0|||
37840679|NCT01083173|69524969|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
37840680|NCT01083173|69524970|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
37840681|NCT01083173|69524969|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
37840682|NCT01083173|69524970|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
37840683|NCT01083173|69524969|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
37840684|NCT01083173|69524970|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
37840685|NCT01083173|69524969|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
37722679|NCT01962103|69201178|FG007|Phase 1|Adverse Event|0|||
37722680|NCT01962103|69201179|FG008|Phase 1|Adverse Event|0|||
37722681|NCT01962103|69201171|FG000|Phase 1|Progressive Disease|8|||
37722682|NCT01962103|69201172|FG001|Phase 1|Progressive Disease|6|||
37722683|NCT01962103|69201173|FG002|Phase 1|Progressive Disease|8|||
37722684|NCT01962103|69201174|FG003|Phase 1|Progressive Disease|4|||
37722685|NCT01962103|69201175|FG004|Phase 1|Progressive Disease|5|||
37722686|NCT01962103|69201176|FG005|Phase 1|Progressive Disease|4|||
37722687|NCT01962103|69201177|FG006|Phase 1|Progressive Disease|0|||
37722688|NCT01962103|69201178|FG007|Phase 1|Progressive Disease|0|||
37722689|NCT01962103|69201179|FG008|Phase 1|Progressive Disease|0|||
37722690|NCT01962103|69201171|FG000|Phase 1|Withdrawal by Subject|0|||
37722691|NCT01962103|69201172|FG001|Phase 1|Withdrawal by Subject|0|||
37722692|NCT01962103|69201173|FG002|Phase 1|Withdrawal by Subject|0|||
37722693|NCT01962103|69201174|FG003|Phase 1|Withdrawal by Subject|2|||
37722694|NCT01962103|69201175|FG004|Phase 1|Withdrawal by Subject|0|||
37722695|NCT01962103|69201176|FG005|Phase 1|Withdrawal by Subject|0|||
37722696|NCT01962103|69201177|FG006|Phase 1|Withdrawal by Subject|0|||
37722697|NCT01962103|69201178|FG007|Phase 1|Withdrawal by Subject|0|||
37722698|NCT01962103|69201179|FG008|Phase 1|Withdrawal by Subject|0|||
37722699|NCT01962103|69201171|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
37722700|NCT01962103|69201172|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
37722701|NCT01962103|69201173|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
37722702|NCT01962103|69201174|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
37722703|NCT01962103|69201175|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
37722704|NCT01962103|69201176|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
37722705|NCT01962103|69201177|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
37722706|NCT01962103|69201178|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
37722707|NCT01962103|69201179|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
37722708|NCT01962103|69201171|FG000|Phase 1|Physician Decision|0|||
37840686|NCT01083173|69524970|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
37840687|NCT01083173|69524969|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
37840688|NCT01083173|69524970|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
37840689|NCT01083173|69524969|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
37840690|NCT01083173|69524970|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
37840691|NCT01083173|69524969|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
37840692|NCT01083173|69524970|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
37840693|NCT01083173|69524969|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
37840694|NCT01083173|69524970|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
37840695|NCT01083173|69524969|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
37840696|NCT01083173|69524970|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
37840697|NCT01083173|69524969|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
37840698|NCT01083173|69524970|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
37840699|NCT01083173|69524969|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
37840700|NCT01083173|69524970|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
37840701|NCT00177294|69524981|FG000|Overall Study|Withdrawal by Subject|7|||
37722709|NCT01962103|69201172|FG001|Phase 1|Physician Decision|0|||
37722710|NCT01962103|69201173|FG002|Phase 1|Physician Decision|0|||
37722711|NCT01962103|69201174|FG003|Phase 1|Physician Decision|1|||
37722712|NCT01962103|69201175|FG004|Phase 1|Physician Decision|0|||
37722713|NCT01962103|69201176|FG005|Phase 1|Physician Decision|0|||
37840702|NCT00177294|69524982|FG001|Overall Study|Withdrawal by Subject|5|||
37840703|NCT01082081|69524991|FG000|Overall Study|Lost to Follow-up|0|||
37840704|NCT01082081|69524992|FG001|Overall Study|Lost to Follow-up|0|||
37840705|NCT01082081|69524993|FG002|Overall Study|Lost to Follow-up|1|||
37840706|NCT01082081|69524991|FG000|Overall Study|Withdrawal by Subject|0|||
37722714|NCT01962103|69201177|FG006|Phase 1|Physician Decision|0|||
37722715|NCT01962103|69201178|FG007|Phase 1|Physician Decision|0|||
37722716|NCT01962103|69201179|FG008|Phase 1|Physician Decision|0|||
37722717|NCT01962103|69201171|FG000|Phase 1|Symptomatic Deterioration|3|||
37840707|NCT01082081|69524992|FG001|Overall Study|Withdrawal by Subject|0|||
37840708|NCT01082081|69524993|FG002|Overall Study|Withdrawal by Subject|1|||
37840709|NCT01082081|69524991|FG000|Overall Study|Other Reason|0|||
37840710|NCT01082081|69524992|FG001|Overall Study|Other Reason|1|||
37840711|NCT01082081|69524993|FG002|Overall Study|Other Reason|0|||
38025168|NCT04091360|69709386|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
38025169|NCT04091360|69709387|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
38025170|NCT04091360|69709388|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
37722718|NCT01962103|69201172|FG001|Phase 1|Symptomatic Deterioration|2|||
37722719|NCT01962103|69201173|FG002|Phase 1|Symptomatic Deterioration|2|||
37722720|NCT01962103|69201174|FG003|Phase 1|Symptomatic Deterioration|2|||
37722721|NCT01962103|69201175|FG004|Phase 1|Symptomatic Deterioration|1|||
37722722|NCT01962103|69201176|FG005|Phase 1|Symptomatic Deterioration|1|||
37722723|NCT01962103|69201177|FG006|Phase 1|Symptomatic Deterioration|0|||
37722724|NCT01962103|69201178|FG007|Phase 1|Symptomatic Deterioration|0|||
37722725|NCT01962103|69201179|FG008|Phase 1|Symptomatic Deterioration|0|||
37722726|NCT01962103|69201171|FG000|Phase 1|Miscellaneous|1|||
37722727|NCT01962103|69201172|FG001|Phase 1|Miscellaneous|0|||
37722728|NCT01962103|69201173|FG002|Phase 1|Miscellaneous|0|||
37722729|NCT01962103|69201174|FG003|Phase 1|Miscellaneous|0|||
37722730|NCT01962103|69201175|FG004|Phase 1|Miscellaneous|0|||
37722731|NCT01962103|69201176|FG005|Phase 1|Miscellaneous|0|||
37722732|NCT01962103|69201177|FG006|Phase 1|Miscellaneous|0|||
37722733|NCT01962103|69201178|FG007|Phase 1|Miscellaneous|0|||
37840712|NCT00177216|69525004|FG000|Overall Study|Withdrawal by Subject|6|||
38025171|NCT04091360|69709389|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
38025172|NCT04091360|69709380|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
38025173|NCT04091360|69709381|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
38025174|NCT04091360|69709382|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
38025175|NCT04091360|69709383|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
38025176|NCT04091360|69709384|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
38025177|NCT04091360|69709385|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
38025178|NCT04091360|69709386|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
38025179|NCT04091360|69709387|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
38025180|NCT04091360|69709388|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
38025181|NCT04091360|69709389|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
38025182|NCT04091360|69709380|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
38025183|NCT04091360|69709381|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
38025184|NCT04091360|69709382|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
38025185|NCT04091360|69709383|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
38025186|NCT04091360|69709384|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
38025187|NCT04091360|69709385|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
38025188|NCT04091360|69709386|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
38025189|NCT04091360|69709387|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
38025190|NCT04091360|69709388|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
38025191|NCT04091360|69709389|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
38025192|NCT04118166|69709411|FG000|Overall Study|Adverse Event|1|||
38025193|NCT04346628|69709418|FG000|Overall Study|Lost to Follow-up|4|||
38025194|NCT04346628|69709419|FG001|Overall Study|Lost to Follow-up|4|||
38025195|NCT04346628|69709418|FG000|Overall Study|Withdrew (had personal reasons)|2|||
37722734|NCT01962103|69201179|FG008|Phase 1|Miscellaneous|0|||
37722735|NCT01962103|69201171|FG000|Phase 2|Adverse Event|0|||
37840713|NCT00177216|69525005|FG001|Overall Study|Withdrawal by Subject|3|||
37840714|NCT00177216|69525006|FG002|Overall Study|Withdrawal by Subject|1|||
37840715|NCT01081886|69525020|FG000|Overall Study|Study termination|11|||
37840716|NCT01081886|69525021|FG001|Overall Study|Study termination|13|||
38025196|NCT04346628|69709419|FG001|Overall Study|Withdrew (had personal reasons)|5|||
38025197|NCT04346628|69709418|FG000|Overall Study|Withdrew (medication intolerant)|0|||
37722736|NCT01962103|69201172|FG001|Phase 2|Adverse Event|0|||
37722737|NCT01962103|69201173|FG002|Phase 2|Adverse Event|0|||
37722738|NCT01962103|69201174|FG003|Phase 2|Adverse Event|0|||
37722739|NCT01962103|69201175|FG004|Phase 2|Adverse Event|0|||
37722740|NCT01962103|69201176|FG005|Phase 2|Adverse Event|0|||
37840717|NCT01081769|69525029|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
37722741|NCT01962103|69201177|FG006|Phase 2|Adverse Event|1|||
37722742|NCT01962103|69201178|FG007|Phase 2|Adverse Event|0|||
37722743|NCT01962103|69201179|FG008|Phase 2|Adverse Event|3|||
37722744|NCT01962103|69201171|FG000|Phase 2|Progressive Disease|0|||
37722745|NCT01962103|69201172|FG001|Phase 2|Progressive Disease|0|||
37722746|NCT01962103|69201173|FG002|Phase 2|Progressive Disease|0|||
37722747|NCT01962103|69201174|FG003|Phase 2|Progressive Disease|0|||
37722748|NCT01962103|69201175|FG004|Phase 2|Progressive Disease|0|||
37722749|NCT01962103|69201176|FG005|Phase 2|Progressive Disease|0|||
37722750|NCT01962103|69201177|FG006|Phase 2|Progressive Disease|11|||
37722751|NCT01962103|69201178|FG007|Phase 2|Progressive Disease|12|||
37722752|NCT01962103|69201179|FG008|Phase 2|Progressive Disease|11|||
37722753|NCT01962103|69201171|FG000|Phase 2|Symptomatic Deterioration|0|||
37722754|NCT01962103|69201172|FG001|Phase 2|Symptomatic Deterioration|0|||
37722755|NCT01962103|69201173|FG002|Phase 2|Symptomatic Deterioration|0|||
37722756|NCT01962103|69201174|FG003|Phase 2|Symptomatic Deterioration|0|||
37722757|NCT01962103|69201175|FG004|Phase 2|Symptomatic Deterioration|0|||
37722758|NCT01962103|69201176|FG005|Phase 2|Symptomatic Deterioration|0|||
37722759|NCT01962103|69201177|FG006|Phase 2|Symptomatic Deterioration|2|||
37722760|NCT01962103|69201178|FG007|Phase 2|Symptomatic Deterioration|2|||
37722761|NCT01962103|69201179|FG008|Phase 2|Symptomatic Deterioration|0|||
37722762|NCT01961323|69201199|FG000|Overall Study|Withdrawal by Subject|7|||
37722763|NCT01961323|69201199|FG000|Overall Study|Lost to Follow-up|8|||
37722764|NCT01961323|69201199|FG000|Overall Study|screen failure|34|||
37722765|NCT01960855|69201208|FG000|Overall Study|Subject noncompliant|1|||
37722766|NCT01960855|69201209|FG001|Overall Study|Subject noncompliant|0|||
37722767|NCT01960855|69201210|FG002|Overall Study|Subject noncompliant|0|||
37722768|NCT01960855|69201211|FG003|Overall Study|Subject noncompliant|0|||
37722769|NCT01960855|69201212|FG004|Overall Study|Subject noncompliant|0|||
37722770|NCT01960855|69201208|FG000|Overall Study|Adverse Event|2|||
37722771|NCT01960855|69201209|FG001|Overall Study|Adverse Event|0|||
37722772|NCT01960855|69201210|FG002|Overall Study|Adverse Event|6|||
37722773|NCT01960855|69201211|FG003|Overall Study|Adverse Event|2|||
37722774|NCT01960855|69201212|FG004|Overall Study|Adverse Event|2|||
37722775|NCT01960855|69201208|FG000|Overall Study|Lack of Efficacy|1|||
37722776|NCT01960855|69201209|FG001|Overall Study|Lack of Efficacy|1|||
37722777|NCT01960855|69201210|FG002|Overall Study|Lack of Efficacy|0|||
37722778|NCT01960855|69201211|FG003|Overall Study|Lack of Efficacy|0|||
37722779|NCT01960855|69201212|FG004|Overall Study|Lack of Efficacy|0|||
37722780|NCT01960855|69201208|FG000|Overall Study|Other|2|||
37722781|NCT01960855|69201209|FG001|Overall Study|Other|1|||
37722782|NCT01960855|69201210|FG002|Overall Study|Other|1|||
37722783|NCT01960855|69201211|FG003|Overall Study|Other|1|||
37722784|NCT01960855|69201212|FG004|Overall Study|Other|0|||
37722785|NCT01960855|69201208|FG000|Overall Study|Consent withdrawn by subject|3|||
37722786|NCT01960855|69201209|FG001|Overall Study|Consent withdrawn by subject|1|||
37722787|NCT01960855|69201210|FG002|Overall Study|Consent withdrawn by subject|2|||
37722788|NCT01960855|69201211|FG003|Overall Study|Consent withdrawn by subject|1|||
37722789|NCT01960855|69201212|FG004|Overall Study|Consent withdrawn by subject|1|||
37722790|NCT01960855|69201208|FG000|Overall Study|Lost to Follow-up|2|||
37722791|NCT01960855|69201209|FG001|Overall Study|Lost to Follow-up|1|||
37722792|NCT01960855|69201210|FG002|Overall Study|Lost to Follow-up|0|||
37722793|NCT01960855|69201211|FG003|Overall Study|Lost to Follow-up|0|||
37722794|NCT01960855|69201212|FG004|Overall Study|Lost to Follow-up|2|||
37722795|NCT02007434|69201232|FG000|Overall Study|Lost to Follow-up|0|||
37722796|NCT02007434|69201233|FG001|Overall Study|Lost to Follow-up|1|||
37722797|NCT02007434|69201234|FG002|Overall Study|Lost to Follow-up|0|||
37722798|NCT02007434|69201235|FG003|Overall Study|Lost to Follow-up|0|||
37722799|NCT02007434|69201236|FG004|Overall Study|Lost to Follow-up|0|||
37722800|NCT02007434|69201237|FG005|Overall Study|Lost to Follow-up|0|||
37722801|NCT02007434|69201238|FG006|Overall Study|Lost to Follow-up|0|||
37722802|NCT02007434|69201239|FG007|Overall Study|Lost to Follow-up|0|||
37722803|NCT02007434|69201232|FG000|Overall Study|Non-compliance|1|||
37722804|NCT02007434|69201233|FG001|Overall Study|Non-compliance|0|||
37722805|NCT02007434|69201234|FG002|Overall Study|Non-compliance|1|||
37722806|NCT02007434|69201235|FG003|Overall Study|Non-compliance|0|||
37722807|NCT02007434|69201236|FG004|Overall Study|Non-compliance|0|||
37722808|NCT02007434|69201237|FG005|Overall Study|Non-compliance|0|||
37722809|NCT02007434|69201238|FG006|Overall Study|Non-compliance|0|||
37722810|NCT02007434|69201239|FG007|Overall Study|Non-compliance|0|||
37722811|NCT01987453|69201261|FG000|Overall Study|Death|0|||
37722812|NCT01987453|69201262|FG001|Overall Study|Death|0|||
37722813|NCT01987453|69201263|FG002|Overall Study|Death|1|||
37722814|NCT01987453|69201261|FG000|Overall Study|Lack of Efficacy|1|||
37722815|NCT01987453|69201262|FG001|Overall Study|Lack of Efficacy|12|||
37722816|NCT01987453|69201263|FG002|Overall Study|Lack of Efficacy|0|||
37722817|NCT02006641|69201278|FG000|Overall Study|Withdrawal before treatment|2|||
37722818|NCT02006641|69201279|FG001|Overall Study|Withdrawal before treatment|5|||
37722819|NCT02006641|69201280|FG002|Overall Study|Withdrawal before treatment|3|||
37722820|NCT02006641|69201278|FG000|Overall Study|Adverse Event|15|||
37722821|NCT02006641|69201279|FG001|Overall Study|Adverse Event|11|||
37722822|NCT02006641|69201280|FG002|Overall Study|Adverse Event|15|||
37722823|NCT02006641|69201278|FG000|Overall Study|Protocol Violation|0|||
37722824|NCT02006641|69201279|FG001|Overall Study|Protocol Violation|2|||
37722825|NCT02006641|69201280|FG002|Overall Study|Protocol Violation|2|||
37722826|NCT02006641|69201278|FG000|Overall Study|Lost to Follow-up|0|||
37722827|NCT02006641|69201279|FG001|Overall Study|Lost to Follow-up|1|||
37722828|NCT02006641|69201280|FG002|Overall Study|Lost to Follow-up|0|||
37722829|NCT02006641|69201278|FG000|Overall Study|Withdrawal by Subject|7|||
37722830|NCT02006641|69201279|FG001|Overall Study|Withdrawal by Subject|12|||
37722831|NCT02006641|69201280|FG002|Overall Study|Withdrawal by Subject|11|||
37722832|NCT02006641|69201278|FG000|Overall Study|Other reason: patient didn't show up|1|||
37722833|NCT02006641|69201279|FG001|Overall Study|Other reason: patient didn't show up|0|||
37722834|NCT02006641|69201280|FG002|Overall Study|Other reason: patient didn't show up|0|||
37722835|NCT02006641|69201278|FG000|Overall Study|Other reason:patient didn't want to come|0|||
37722836|NCT02006641|69201279|FG001|Overall Study|Other reason:patient didn't want to come|0|||
37722837|NCT02006641|69201280|FG002|Overall Study|Other reason:patient didn't want to come|1|||
37722838|NCT02006641|69201278|FG000|Overall Study|Other reason: patient has moved|1|||
37722839|NCT02006641|69201279|FG001|Overall Study|Other reason: patient has moved|0|||
37722840|NCT02006641|69201280|FG002|Overall Study|Other reason: patient has moved|1|||
37722841|NCT02006641|69201278|FG000|Overall Study|Other reason: caregiver in hospital|0|||
37722842|NCT02006641|69201279|FG001|Overall Study|Other reason: caregiver in hospital|1|||
37722843|NCT02006641|69201280|FG002|Overall Study|Other reason: caregiver in hospital|0|||
37722844|NCT02006641|69201278|FG000|Overall Study|Other reason: patient's wife has died|0|||
37722845|NCT02006641|69201279|FG001|Overall Study|Other reason: patient's wife has died|0|||
37722846|NCT02006641|69201280|FG002|Overall Study|Other reason: patient's wife has died|1|||
37722847|NCT02006641|69201278|FG000|Overall Study|Other reason: hospitalisation|0|||
37722848|NCT02006641|69201279|FG001|Overall Study|Other reason: hospitalisation|1|||
37722849|NCT02006641|69201280|FG002|Overall Study|Other reason: hospitalisation|0|||
37722850|NCT02006641|69201278|FG000|Overall Study|Other reason: caregiver impossibility|0|||
37722851|NCT02006641|69201279|FG001|Overall Study|Other reason: caregiver impossibility|0|||
37722852|NCT02006641|69201280|FG002|Overall Study|Other reason: caregiver impossibility|1|||
37722853|NCT02006641|69201278|FG000|Overall Study|Other reason: protocol non-compliance|0|||
37722854|NCT02006641|69201279|FG001|Overall Study|Other reason: protocol non-compliance|0|||
37722855|NCT02006641|69201280|FG002|Overall Study|Other reason: protocol non-compliance|1|||
37722856|NCT01959919|69201288|FG000|Overall Study|Did not meet the eligibility criteria|2|||
37722857|NCT01986985|69201296|FG000|Overall Study|Withdrawal by Subject|4|||
37722858|NCT01986985|69201296|FG000|Overall Study|Scan not completed due to malfunction|3|||
37722859|NCT01986907|69201300|FG000|Overall Study|Adverse Event|11|||
37722860|NCT01986907|69201300|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
37722861|NCT01986907|69201300|FG000|Overall Study|Protocol Violation|4|||
37722862|NCT01986907|69201300|FG000|Overall Study|Withdrawal by Subject|76|||
37722863|NCT01986907|69201300|FG000|Overall Study|Lost to Follow-up|38|||
37722864|NCT01986907|69201300|FG000|Overall Study|Death|9|||
37722865|NCT01959841|69201310|FG000|Overall Study|Adverse Event|1|||
37722866|NCT01959841|69201311|FG001|Overall Study|Adverse Event|3|||
37722867|NCT01959841|69201312|FG002|Overall Study|Adverse Event|2|||
37722868|NCT01959841|69201310|FG000|Overall Study|Lack of Efficacy|5|||
37722869|NCT01959841|69201311|FG001|Overall Study|Lack of Efficacy|0|||
37722870|NCT01959841|69201312|FG002|Overall Study|Lack of Efficacy|0|||
37722871|NCT01959841|69201310|FG000|Overall Study|Lost to Follow-up|1|||
37722872|NCT01959841|69201311|FG001|Overall Study|Lost to Follow-up|1|||
37722873|NCT01959841|69201312|FG002|Overall Study|Lost to Follow-up|0|||
37722874|NCT01959841|69201310|FG000|Overall Study|Physician Decision|0|||
37722875|NCT01959841|69201311|FG001|Overall Study|Physician Decision|2|||
37722876|NCT01959841|69201312|FG002|Overall Study|Physician Decision|3|||
37722877|NCT01959841|69201310|FG000|Overall Study|Protocol Violation|16|||
37722878|NCT01959841|69201311|FG001|Overall Study|Protocol Violation|23|||
37722879|NCT01959841|69201312|FG002|Overall Study|Protocol Violation|16|||
37722880|NCT01959841|69201310|FG000|Overall Study|Withdrawal by Subject|7|||
37722881|NCT01959841|69201311|FG001|Overall Study|Withdrawal by Subject|7|||
37722882|NCT01959841|69201312|FG002|Overall Study|Withdrawal by Subject|5|||
37722883|NCT01959841|69201310|FG000|Overall Study|Clinical laboratory value|2|||
37722884|NCT01959841|69201311|FG001|Overall Study|Clinical laboratory value|6|||
37722885|NCT01959841|69201312|FG002|Overall Study|Clinical laboratory value|6|||
37722886|NCT01959841|69201310|FG000|Overall Study|Platelet count below on day1 or 4|11|||
37722887|NCT01959841|69201311|FG001|Overall Study|Platelet count below on day1 or 4|15|||
37722888|NCT01959841|69201312|FG002|Overall Study|Platelet count below on day1 or 4|11|||
37722889|NCT02005627|69201322|FG000|Overall Study|Lost to Follow-up|1|||
37722890|NCT02005627|69201323|FG001|Overall Study|Lost to Follow-up|2|||
37722891|NCT02005627|69201322|FG000|Overall Study|Withdrawal by Subject|1|||
37722892|NCT02005627|69201323|FG001|Overall Study|Withdrawal by Subject|2|||
37722893|NCT02104583|69201335|FG000|Overall Study|New ICD or CRT-D implanted|2|||
37722894|NCT02104583|69201336|FG001|Overall Study|New ICD or CRT-D implanted|0|||
37722895|NCT02104583|69201337|FG002|Overall Study|New ICD or CRT-D implanted|1|||
37722896|NCT02104583|69201338|FG003|Overall Study|New ICD or CRT-D implanted|0|||
37722897|NCT02104583|69201339|FG004|Overall Study|New ICD or CRT-D implanted|0|||
37722898|NCT02104583|69201335|FG000|Overall Study|Death|2|||
37722899|NCT02104583|69201336|FG001|Overall Study|Death|1|||
37722900|NCT02104583|69201337|FG002|Overall Study|Death|3|||
37722901|NCT02104583|69201338|FG003|Overall Study|Death|3|||
37722902|NCT02104583|69201339|FG004|Overall Study|Death|5|||
37722903|NCT02104583|69201335|FG000|Overall Study|Subject required cardiac ablation|6|||
37722904|NCT02104583|69201336|FG001|Overall Study|Subject required cardiac ablation|4|||
37722905|NCT02104583|69201337|FG002|Overall Study|Subject required cardiac ablation|4|||
37722906|NCT02104583|69201338|FG003|Overall Study|Subject required cardiac ablation|5|||
37722907|NCT02104583|69201339|FG004|Overall Study|Subject required cardiac ablation|4|||
37722908|NCT02104583|69201335|FG000|Overall Study|Subject required prohibited medication|0|||
37722909|NCT02104583|69201336|FG001|Overall Study|Subject required prohibited medication|1|||
37722910|NCT02104583|69201337|FG002|Overall Study|Subject required prohibited medication|1|||
37722911|NCT02104583|69201338|FG003|Overall Study|Subject required prohibited medication|0|||
37722912|NCT02104583|69201339|FG004|Overall Study|Subject required prohibited medication|1|||
37722913|NCT02104583|69201335|FG000|Overall Study|Withdrew Consent|3|||
37722914|NCT02104583|69201336|FG001|Overall Study|Withdrew Consent|2|||
37722915|NCT02104583|69201337|FG002|Overall Study|Withdrew Consent|0|||
37722916|NCT02104583|69201338|FG003|Overall Study|Withdrew Consent|2|||
37722917|NCT02104583|69201339|FG004|Overall Study|Withdrew Consent|1|||
37722918|NCT02104583|69201335|FG000|Overall Study|Investigator's Discretion|1|||
37722919|NCT02104583|69201336|FG001|Overall Study|Investigator's Discretion|0|||
37722920|NCT02104583|69201337|FG002|Overall Study|Investigator's Discretion|0|||
37722921|NCT02104583|69201338|FG003|Overall Study|Investigator's Discretion|0|||
37722922|NCT02104583|69201339|FG004|Overall Study|Investigator's Discretion|0|||
37722923|NCT02104583|69201335|FG000|Overall Study|Protocol Violation|0|||
37722924|NCT02104583|69201336|FG001|Overall Study|Protocol Violation|0|||
37722925|NCT02104583|69201337|FG002|Overall Study|Protocol Violation|1|||
37722926|NCT02104583|69201338|FG003|Overall Study|Protocol Violation|0|||
37722927|NCT02104583|69201339|FG004|Overall Study|Protocol Violation|0|||
37722928|NCT02104583|69201335|FG000|Overall Study|Adverse Event|3|||
37722929|NCT02104583|69201336|FG001|Overall Study|Adverse Event|3|||
37722930|NCT02104583|69201337|FG002|Overall Study|Adverse Event|6|||
37722931|NCT02104583|69201338|FG003|Overall Study|Adverse Event|6|||
37722932|NCT02104583|69201339|FG004|Overall Study|Adverse Event|1|||
37722933|NCT02104583|69201335|FG000|Overall Study|Lost to Follow-up|1|||
37722934|NCT02104583|69201336|FG001|Overall Study|Lost to Follow-up|0|||
37722935|NCT02104583|69201337|FG002|Overall Study|Lost to Follow-up|0|||
37722936|NCT02104583|69201338|FG003|Overall Study|Lost to Follow-up|0|||
37722937|NCT02104583|69201339|FG004|Overall Study|Lost to Follow-up|0|||
37722938|NCT02104583|69201335|FG000|Overall Study|Randomized but Never Treated|0|||
37722939|NCT02104583|69201336|FG001|Overall Study|Randomized but Never Treated|0|||
37722940|NCT02104583|69201337|FG002|Overall Study|Randomized but Never Treated|0|||
37722941|NCT02104583|69201338|FG003|Overall Study|Randomized but Never Treated|1|||
37722942|NCT02104583|69201339|FG004|Overall Study|Randomized but Never Treated|0|||
37722943|NCT02074553|69201362|FG000|Intervention Period 1|Family Emergency|0|||
37722944|NCT02074553|69201363|FG001|Intervention Period 1|Family Emergency|0|||
37722945|NCT02074553|69201364|FG002|Intervention Period 1|Family Emergency|0|||
38025198|NCT04346628|69709419|FG001|Overall Study|Withdrew (medication intolerant)|3|||
38025199|NCT04346628|69709418|FG000|Overall Study|Withdrew (declined intervention)|0|||
38025200|NCT04346628|69709419|FG001|Overall Study|Withdrew (declined intervention)|1|||
37722946|NCT02074553|69201365|FG003|Intervention Period 1|Family Emergency|1|||
37722947|NCT02074553|69201366|FG004|Intervention Period 1|Family Emergency|0|||
37722948|NCT02074553|69201367|FG005|Intervention Period 1|Family Emergency|0|||
37722949|NCT02074553|69201368|FG006|Intervention Period 1|Family Emergency|0|||
37722950|NCT02074553|69201369|FG007|Intervention Period 1|Family Emergency|0|||
37722951|NCT02074553|69201362|FG000|Washout Period 1|Adverse Event|1|||
37722952|NCT02074553|69201363|FG001|Washout Period 1|Adverse Event|0|||
37722953|NCT02074553|69201364|FG002|Washout Period 1|Adverse Event|0|||
37722954|NCT02074553|69201365|FG003|Washout Period 1|Adverse Event|0|||
37722955|NCT02074553|69201366|FG004|Washout Period 1|Adverse Event|0|||
37722956|NCT02074553|69201367|FG005|Washout Period 1|Adverse Event|0|||
37722957|NCT02074553|69201368|FG006|Washout Period 1|Adverse Event|0|||
37722958|NCT02074553|69201369|FG007|Washout Period 1|Adverse Event|0|||
37722959|NCT02074553|69201362|FG000|Washout Period 1|Physician Decision|0|||
37722960|NCT02074553|69201363|FG001|Washout Period 1|Physician Decision|0|||
37722961|NCT02074553|69201364|FG002|Washout Period 1|Physician Decision|0|||
37722962|NCT02074553|69201365|FG003|Washout Period 1|Physician Decision|1|||
37722963|NCT02074553|69201366|FG004|Washout Period 1|Physician Decision|0|||
37722964|NCT02074553|69201367|FG005|Washout Period 1|Physician Decision|0|||
37722965|NCT02074553|69201368|FG006|Washout Period 1|Physician Decision|0|||
37722966|NCT02074553|69201369|FG007|Washout Period 1|Physician Decision|0|||
37722967|NCT02074553|69201362|FG000|Washout Period 1|Other|0|||
37722968|NCT02074553|69201363|FG001|Washout Period 1|Other|0|||
37722969|NCT02074553|69201364|FG002|Washout Period 1|Other|0|||
37722970|NCT02074553|69201365|FG003|Washout Period 1|Other|0|||
37722971|NCT02074553|69201366|FG004|Washout Period 1|Other|0|||
37722972|NCT02074553|69201367|FG005|Washout Period 1|Other|1|||
37722973|NCT02074553|69201368|FG006|Washout Period 1|Other|0|||
37722974|NCT02074553|69201369|FG007|Washout Period 1|Other|0|||
37722975|NCT02074553|69201362|FG000|Washout Period 2|Adverse Event|0|||
37722976|NCT02074553|69201363|FG001|Washout Period 2|Adverse Event|0|||
37722977|NCT02074553|69201364|FG002|Washout Period 2|Adverse Event|0|||
37722978|NCT02074553|69201365|FG003|Washout Period 2|Adverse Event|0|||
37722979|NCT02074553|69201366|FG004|Washout Period 2|Adverse Event|0|||
37722980|NCT02074553|69201367|FG005|Washout Period 2|Adverse Event|0|||
37722981|NCT02074553|69201368|FG006|Washout Period 2|Adverse Event|1|||
37722982|NCT02074553|69201369|FG007|Washout Period 2|Adverse Event|0|||
37722983|NCT02074553|69201362|FG000|Washout Period 2|Physician Decision|0|||
37722984|NCT02074553|69201363|FG001|Washout Period 2|Physician Decision|0|||
37722985|NCT02074553|69201364|FG002|Washout Period 2|Physician Decision|0|||
37722986|NCT02074553|69201365|FG003|Washout Period 2|Physician Decision|0|||
37722987|NCT02074553|69201366|FG004|Washout Period 2|Physician Decision|0|||
37722988|NCT02074553|69201367|FG005|Washout Period 2|Physician Decision|1|||
37722989|NCT02074553|69201368|FG006|Washout Period 2|Physician Decision|0|||
37722990|NCT02074553|69201369|FG007|Washout Period 2|Physician Decision|0|||
37722991|NCT02074553|69201362|FG000|Washout Period 2|Lost to Follow-up|0|||
37722992|NCT02074553|69201363|FG001|Washout Period 2|Lost to Follow-up|0|||
37722993|NCT02074553|69201364|FG002|Washout Period 2|Lost to Follow-up|1|||
37722994|NCT02074553|69201365|FG003|Washout Period 2|Lost to Follow-up|0|||
37722995|NCT02074553|69201366|FG004|Washout Period 2|Lost to Follow-up|0|||
37722996|NCT02074553|69201367|FG005|Washout Period 2|Lost to Follow-up|0|||
37722997|NCT02074553|69201368|FG006|Washout Period 2|Lost to Follow-up|0|||
37722998|NCT02074553|69201369|FG007|Washout Period 2|Lost to Follow-up|0|||
37722999|NCT02074553|69201362|FG000|Washout Period 3|Physician Decision|0|||
37723000|NCT02074553|69201363|FG001|Washout Period 3|Physician Decision|0|||
37723001|NCT02074553|69201364|FG002|Washout Period 3|Physician Decision|0|||
37723002|NCT02074553|69201365|FG003|Washout Period 3|Physician Decision|0|||
37723003|NCT02074553|69201366|FG004|Washout Period 3|Physician Decision|0|||
37723004|NCT02074553|69201367|FG005|Washout Period 3|Physician Decision|0|||
37723005|NCT02074553|69201368|FG006|Washout Period 3|Physician Decision|0|||
37723006|NCT02074553|69201369|FG007|Washout Period 3|Physician Decision|1|||
37723007|NCT02073929|69201389|FG000|Overall Study|Lost to Follow-up|2|||
37723008|NCT02073929|69201390|FG001|Overall Study|Lost to Follow-up|1|||
37723009|NCT02073929|69201389|FG000|Overall Study|Adverse Event|2|||
37723010|NCT02073929|69201390|FG001|Overall Study|Adverse Event|1|||
37723011|NCT02073929|69201389|FG000|Overall Study|Withdrawal by Subject|0|||
37723012|NCT02073929|69201390|FG001|Overall Study|Withdrawal by Subject|1|||
37723013|NCT02113007|69201396|FG000|Overall Study|Progressive disease|2|||
37723014|NCT02104505|69201402|FG000|First Intervention (14 Days)|Adverse Event|2|||
37723015|NCT02104505|69201403|FG001|First Intervention (14 Days)|Adverse Event|0|||
37723016|NCT02104505|69201402|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
37723017|NCT02104505|69201403|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
37723018|NCT02104505|69201402|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
37723019|NCT02104505|69201403|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
37840718|NCT01081769|69525030|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
37840719|NCT01081769|69525029|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
37840720|NCT01081769|69525030|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
37840721|NCT01081769|69525029|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
37840722|NCT01081769|69525030|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
37840723|NCT01081769|69525029|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
37840724|NCT01081769|69525030|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
37840725|NCT01081769|69525029|FG000|CORE Intent-To-Treat|Adverse Event|14|||
37840726|NCT01081769|69525030|FG001|CORE Intent-To-Treat|Adverse Event|11|||
37915581|NCT00851643|69602339|FG003|Base Study (Up to 12 Months)|Other|0|||
37723020|NCT02104505|69201402|FG000|First Intervention (14 Days)|exclusionary condition|0|||
37723021|NCT02104505|69201403|FG001|First Intervention (14 Days)|exclusionary condition|1|||
37723022|NCT02104505|69201402|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
37840727|NCT01081769|69525029|FG000|CORE Intent-To-Treat|Death|1|||
37723023|NCT02104505|69201403|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
37723024|NCT02104505|69201402|FG000|Second Intervention (14 Days)|Adverse Event|2|||
37723025|NCT02104505|69201403|FG001|Second Intervention (14 Days)|Adverse Event|0|||
37723026|NCT02111993|69201412|FG000|Overall Study|Physician Decision|5|||
37723027|NCT02111993|69201413|FG001|Overall Study|Physician Decision|4|||
37723028|NCT01959607|69201423|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
37723029|NCT01959607|69201424|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
37723030|NCT01959607|69201425|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
37723031|NCT01959607|69201426|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
37723032|NCT02111603|69201435|FG000|Overall Study|Withdrawal by Subject|1|||
37723033|NCT02102399|69201441|FG000|Overall Study|Withdrawal by Subject|6|||
37723034|NCT02102399|69201442|FG001|Overall Study|Withdrawal by Subject|4|||
37723035|NCT02111369|69201453|FG000|Overall Study|Lost to Follow-up|2|||
37723036|NCT02111369|69201453|FG000|Overall Study|Withdrawal by Subject|1|||
37723037|NCT02111213|69201459|FG000|Overall Study|Withdrawal by Subject|3|||
37723038|NCT02111213|69201460|FG001|Overall Study|Withdrawal by Subject|2|||
37723039|NCT02111213|69201459|FG000|Overall Study|Lost to Follow-up|3|||
37723040|NCT02111213|69201460|FG001|Overall Study|Lost to Follow-up|4|||
37723041|NCT02110901|69201468|FG000|Overall Study|Death|6|||
37723042|NCT02110901|69201469|FG001|Overall Study|Death|3|||
37723043|NCT02110901|69201468|FG000|Overall Study|Lost to Follow-up|12|||
37723044|NCT02110901|69201469|FG001|Overall Study|Lost to Follow-up|8|||
37723045|NCT02110901|69201468|FG000|Overall Study|Withdrawal by Subject|7|||
37723046|NCT02110901|69201469|FG001|Overall Study|Withdrawal by Subject|3|||
37723047|NCT02110901|69201468|FG000|Overall Study|received a kidney transplant|5|||
37723048|NCT02110901|69201469|FG001|Overall Study|received a kidney transplant|0|||
37723049|NCT02070965|69201479|FG000|Overall Study|Lost to Follow-up|0|||
37723050|NCT02070965|69201480|FG001|Overall Study|Lost to Follow-up|1|||
37723051|NCT02070965|69201481|FG002|Overall Study|Lost to Follow-up|0|||
37723052|NCT02070965|69201479|FG000|Overall Study|Withdrawal by Subject|1|||
37723053|NCT02070965|69201480|FG001|Overall Study|Withdrawal by Subject|1|||
37723054|NCT02070965|69201481|FG002|Overall Study|Withdrawal by Subject|1|||
37723055|NCT02070965|69201479|FG000|Overall Study|Subject moved|1|||
37723056|NCT02070965|69201480|FG001|Overall Study|Subject moved|0|||
37723057|NCT02070965|69201481|FG002|Overall Study|Subject moved|0|||
37723058|NCT02109107|69201489|FG000|Overall Study|Lost to Follow-up|2|||
37723059|NCT02100839|69201495|FG000|Multiple Ascending Dose|Adverse Event|2|||
37723060|NCT02100839|69201496|FG001|Multiple Ascending Dose|Adverse Event|0|||
37723061|NCT02100839|69201495|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
37723062|NCT02100839|69201496|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
37723063|NCT02069093|69201502|FG000|Overall Study|Disease progression|14|||
37723064|NCT02069093|69201502|FG000|Overall Study|New cancer therapy|1|||
37723065|NCT02069093|69201502|FG000|Overall Study|Death|1|||
37723066|NCT02069093|69201502|FG000|Overall Study|Administrative problems|1|||
37723067|NCT02069093|69201502|FG000|Overall Study|Withdrawal by Subject|2|||
37723068|NCT02069093|69201502|FG000|Overall Study|Abnormal laboratory values|1|||
37723069|NCT02069093|69201502|FG000|Overall Study|Adverse Event|10|||
37723070|NCT02109029|69201509|FG000|Part B|Adverse Event|0|||
37723071|NCT02109029|69201510|FG001|Part B|Adverse Event|0|||
37723072|NCT02109029|69201511|FG002|Part B|Adverse Event|0|||
37723073|NCT02109029|69201512|FG003|Part B|Adverse Event|0|||
37723074|NCT02109029|69201513|FG004|Part B|Adverse Event|1|||
37723075|NCT02109029|69201514|FG005|Part B|Adverse Event|1|||
37723076|NCT02069015|69201527|FG000|Overall Study|Lost to Follow-up|39|||
37723077|NCT02069015|69201528|FG001|Overall Study|Lost to Follow-up|32|||
37723078|NCT02069015|69201527|FG000|Overall Study|Withdrawal by Subject|1|||
37723079|NCT02069015|69201528|FG001|Overall Study|Withdrawal by Subject|1|||
37840728|NCT01081769|69525030|FG001|CORE Intent-To-Treat|Death|1|||
37840729|NCT01081769|69525029|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
37723080|NCT01598129|69201535|FG000|Overall Study|Disease progression|6|||
37723081|NCT01598129|69201535|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
37723082|NCT01598129|69201535|FG000|Overall Study|Withdrawal by Subject|1|||
37723083|NCT02068547|69201542|FG000|Overall Study|Lost to Follow-up|3|||
37723084|NCT02068547|69201543|FG001|Overall Study|Lost to Follow-up|3|||
37723085|NCT02068547|69201542|FG000|Overall Study|Physician Decision|1|||
37723086|NCT02068547|69201543|FG001|Overall Study|Physician Decision|0|||
37723087|NCT02108951|69201549|FG000|Overall Study|Lost to Follow-up|1|||
37840730|NCT01081769|69525030|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
37723088|NCT02108951|69201549|FG000|Overall Study|Patient's/guardian's decision|1|||
37723089|NCT02108951|69201549|FG000|Overall Study|Study Terminated by Sponsor|14|||
37723090|NCT02107859|69201553|FG000|Overall Study|Withdrawal by Subject|14|||
37723091|NCT02107859|69201553|FG000|Overall Study|Adverse Event|3|||
37723092|NCT02107859|69201553|FG000|Overall Study|Study closure|41|||
37723093|NCT02107859|69201553|FG000|Overall Study|Other than specified|3|||
37723094|NCT02007278|69201559|FG000|Overall Study|Failure to comply with an eligibility|0|||
37723095|NCT02007278|69201560|FG001|Overall Study|Failure to comply with an eligibility|1|||
38025201|NCT03681470|69709425|FG000|Overall Study|Lack of Efficacy|3|||
37723096|NCT02007278|69201559|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
37840731|NCT01081769|69525029|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
38025202|NCT03681470|69709425|FG000|Overall Study|Lost to Follow-up|1|||
38025203|NCT03681470|69709425|FG000|Overall Study|Protocol Violation|3|||
37723097|NCT02007278|69201560|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
37723098|NCT02007278|69201559|FG000|Overall Study|Incorrect medication administration|1|||
37723099|NCT02007278|69201560|FG001|Overall Study|Incorrect medication administration|0|||
37723100|NCT02007278|69201559|FG000|Overall Study|Mis-randomization|1|||
37723101|NCT02007278|69201560|FG001|Overall Study|Mis-randomization|1|||
37723102|NCT02107313|69201566|FG000|Overall Study|One participant did not do the FED cohor|0|||
37723103|NCT02107313|69201567|FG001|Overall Study|One participant did not do the FED cohor|1|||
37723104|NCT02028338|69201575|FG000|Overall Study|Withdrawal by Subject|3|||
37723105|NCT02028338|69201576|FG001|Overall Study|Withdrawal by Subject|1|||
37723106|NCT02028338|69201575|FG000|Overall Study|Unable to contact participant|1|||
37723107|NCT02028338|69201576|FG001|Overall Study|Unable to contact participant|0|||
37723108|NCT01625897|69201584|FG000|Overall Study|Adverse Event|27|||
37723109|NCT01625897|69201585|FG001|Overall Study|Adverse Event|10|||
37723110|NCT01625897|69201584|FG000|Overall Study|Physician Decision|0|||
37723111|NCT01625897|69201585|FG001|Overall Study|Physician Decision|1|||
37723112|NCT01625897|69201584|FG000|Overall Study|Withdrawal by Subject|25|||
37723113|NCT01625897|69201585|FG001|Overall Study|Withdrawal by Subject|3|||
37723114|NCT02106923|69201594|FG000|Overall Study|Protocol Violation|0|||
37723115|NCT02106923|69201595|FG001|Overall Study|Protocol Violation|0|||
37723116|NCT02106923|69201596|FG002|Overall Study|Protocol Violation|0|||
37723117|NCT02106923|69201597|FG003|Overall Study|Protocol Violation|0|||
37723118|NCT02106923|69201598|FG004|Overall Study|Protocol Violation|0|||
37723119|NCT02106923|69201599|FG005|Overall Study|Protocol Violation|1|||
37723120|NCT02006732|69201617|FG000|Overall Study|Adverse Event|10|||
37723121|NCT02006732|69201618|FG001|Overall Study|Adverse Event|7|||
37723122|NCT02006732|69201619|FG002|Overall Study|Adverse Event|4|||
37723123|NCT02006732|69201620|FG003|Overall Study|Adverse Event|2|||
37723124|NCT02006732|69201617|FG000|Overall Study|Lack of Efficacy|6|||
37723125|NCT02006732|69201618|FG001|Overall Study|Lack of Efficacy|3|||
37723126|NCT02006732|69201619|FG002|Overall Study|Lack of Efficacy|1|||
37723127|NCT02006732|69201620|FG003|Overall Study|Lack of Efficacy|1|||
37723128|NCT02006732|69201617|FG000|Overall Study|Protocol Violation|1|||
37723129|NCT02006732|69201618|FG001|Overall Study|Protocol Violation|1|||
37723130|NCT02006732|69201619|FG002|Overall Study|Protocol Violation|0|||
37723131|NCT02006732|69201620|FG003|Overall Study|Protocol Violation|0|||
37723132|NCT02006732|69201617|FG000|Overall Study|Lost to Follow-up|0|||
37723133|NCT02006732|69201618|FG001|Overall Study|Lost to Follow-up|1|||
37840732|NCT01081769|69525030|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
37840733|NCT01081769|69525029|FG000|CORE Intent-To-Treat|Pregnancy|1|||
37840734|NCT01081769|69525030|FG001|CORE Intent-To-Treat|Pregnancy|0|||
38025204|NCT03681470|69709425|FG000|Overall Study|Withdrawal by Subject|1|||
38025205|NCT04343976|69709431|FG000|Overall Study|Withdrawal by Subject|0|||
38025206|NCT04343976|69709432|FG001|Overall Study|Withdrawal by Subject|1|||
38025207|NCT03322540|69709440|FG000|Overall Study|Death|21|||
38025208|NCT03322540|69709441|FG001|Overall Study|Death|28|||
38025209|NCT03322540|69709440|FG000|Overall Study|Lost to Follow-up|0|||
37840735|NCT01081769|69525029|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
37840736|NCT01081769|69525030|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
38025210|NCT03322540|69709441|FG001|Overall Study|Lost to Follow-up|1|||
38025211|NCT03322540|69709440|FG000|Overall Study|Physician Decision|7|||
38025212|NCT03322540|69709441|FG001|Overall Study|Physician Decision|6|||
38025213|NCT03322540|69709440|FG000|Overall Study|Withdrawal by Subject|3|||
38025214|NCT03322540|69709441|FG001|Overall Study|Withdrawal by Subject|1|||
38025215|NCT03322540|69709440|FG000|Overall Study|Study terminated by sponsor|0|||
37723134|NCT02006732|69201619|FG002|Overall Study|Lost to Follow-up|0|||
37723135|NCT02006732|69201620|FG003|Overall Study|Lost to Follow-up|0|||
37723136|NCT02006732|69201617|FG000|Overall Study|Withdrawal by Subject|3|||
37723137|NCT02006732|69201618|FG001|Overall Study|Withdrawal by Subject|0|||
37723138|NCT02006732|69201619|FG002|Overall Study|Withdrawal by Subject|4|||
37723139|NCT02006732|69201620|FG003|Overall Study|Withdrawal by Subject|1|||
37723140|NCT02098733|69201630|FG000|Overall Study|Data Not Available|5|||
37840737|NCT01081769|69525029|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
37840738|NCT01081769|69525030|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
38025216|NCT03322540|69709441|FG001|Overall Study|Study terminated by sponsor|1|||
37723141|NCT02098733|69201630|FG000|Overall Study|Lost to Follow-up|5|||
37723142|NCT02028182|69201634|FG000|Overall Study|Protocol Violation|2|||
37723143|NCT02098109|69201641|FG000|Overall Study|Protocol Violation|3|||
37723144|NCT02098109|69201642|FG001|Overall Study|Protocol Violation|0|||
37723145|NCT02097719|69201650|FG000|Overall Study|Subject Withdrew Consent|1|||
37723146|NCT02097719|69201651|FG001|Overall Study|Subject Withdrew Consent|0|||
37723147|NCT02097719|69201650|FG000|Overall Study|Lost to Follow-up|0|||
37723148|NCT02097719|69201651|FG001|Overall Study|Lost to Follow-up|1|||
37723149|NCT02097719|69201650|FG000|Overall Study|Adverse Event|2|||
37723150|NCT02097719|69201651|FG001|Overall Study|Adverse Event|0|||
37723151|NCT01449370|69201682|FG000|Overall Study|Disease Progression|5|||
37723152|NCT01449370|69201683|FG001|Overall Study|Disease Progression|4|||
37723153|NCT01449370|69201684|FG002|Overall Study|Disease Progression|8|||
37723154|NCT01449370|69201685|FG003|Overall Study|Disease Progression|3|||
37723155|NCT01449370|69201686|FG004|Overall Study|Disease Progression|3|||
37723156|NCT01449370|69201687|FG005|Overall Study|Disease Progression|3|||
37723157|NCT01449370|69201688|FG006|Overall Study|Disease Progression|3|||
37723158|NCT01449370|69201689|FG007|Overall Study|Disease Progression|2|||
37723159|NCT01449370|69201690|FG008|Overall Study|Disease Progression|9|||
37723160|NCT01449370|69201691|FG009|Overall Study|Disease Progression|1|||
37723161|NCT01449370|69201692|FG010|Overall Study|Disease Progression|3|||
37723162|NCT01449370|69201693|FG011|Overall Study|Disease Progression|3|||
37723163|NCT01449370|69201694|FG012|Overall Study|Disease Progression|2|||
37723164|NCT01449370|69201695|FG013|Overall Study|Disease Progression|8|||
37723165|NCT01449370|69201696|FG014|Overall Study|Disease Progression|3|||
37723166|NCT01449370|69201697|FG015|Overall Study|Disease Progression|1|||
37723167|NCT01449370|69201698|FG016|Overall Study|Disease Progression|4|||
38025217|NCT04339296|69709451|FG000|Overall Study|Refuse to participate after allocation|1|||
38025218|NCT04339296|69709452|FG001|Overall Study|Refuse to participate after allocation|1|||
38025219|NCT04339296|69709451|FG000|Overall Study|Withdrew after completion of baseline|2|||
38025220|NCT04339296|69709452|FG001|Overall Study|Withdrew after completion of baseline|1|||
38025221|NCT04339296|69709451|FG000|Overall Study|Lost to Follow-up|0|||
38025222|NCT04339296|69709452|FG001|Overall Study|Lost to Follow-up|4|||
38025223|NCT04339296|69709451|FG000|Overall Study|Discontinued intervention|5|||
38025224|NCT04339296|69709452|FG001|Overall Study|Discontinued intervention|3|||
38025225|NCT02025556|69709461|FG000|Overall Study|Adverse Event|0|||
38025226|NCT02025556|69709462|FG001|Overall Study|Adverse Event|4|||
38025227|NCT02025556|69709463|FG002|Overall Study|Adverse Event|2|||
38025228|NCT02025556|69709461|FG000|Overall Study|Lack of Efficacy|2|||
37723168|NCT01449370|69201699|FG017|Overall Study|Disease Progression|3|||
37723169|NCT01449370|69201700|FG018|Overall Study|Disease Progression|1|||
37723170|NCT01449370|69201701|FG019|Overall Study|Disease Progression|2|||
37723171|NCT01449370|69201702|FG020|Overall Study|Disease Progression|5|||
37723172|NCT01449370|69201703|FG021|Overall Study|Disease Progression|2|||
37723173|NCT01449370|69201704|FG022|Overall Study|Disease Progression|3|||
37723174|NCT01449370|69201705|FG023|Overall Study|Disease Progression|7|||
37723175|NCT01449370|69201706|FG024|Overall Study|Disease Progression|3|||
37723176|NCT01449370|69201682|FG000|Overall Study|Adverse Event|1|||
37723177|NCT01449370|69201683|FG001|Overall Study|Adverse Event|2|||
37723178|NCT01449370|69201684|FG002|Overall Study|Adverse Event|0|||
37723179|NCT01449370|69201685|FG003|Overall Study|Adverse Event|1|||
37723180|NCT01449370|69201686|FG004|Overall Study|Adverse Event|0|||
37723181|NCT01449370|69201687|FG005|Overall Study|Adverse Event|0|||
37723182|NCT01449370|69201688|FG006|Overall Study|Adverse Event|0|||
37723183|NCT01449370|69201689|FG007|Overall Study|Adverse Event|0|||
37723184|NCT01449370|69201690|FG008|Overall Study|Adverse Event|1|||
37723185|NCT01449370|69201691|FG009|Overall Study|Adverse Event|1|||
37723186|NCT01449370|69201692|FG010|Overall Study|Adverse Event|0|||
37723187|NCT01449370|69201693|FG011|Overall Study|Adverse Event|0|||
37723188|NCT01449370|69201694|FG012|Overall Study|Adverse Event|0|||
37723189|NCT01449370|69201695|FG013|Overall Study|Adverse Event|2|||
37723190|NCT01449370|69201696|FG014|Overall Study|Adverse Event|0|||
37723191|NCT01449370|69201697|FG015|Overall Study|Adverse Event|1|||
37723192|NCT01449370|69201698|FG016|Overall Study|Adverse Event|0|||
37723193|NCT01449370|69201699|FG017|Overall Study|Adverse Event|0|||
38025229|NCT02025556|69709462|FG001|Overall Study|Lack of Efficacy|1|||
38025230|NCT02025556|69709463|FG002|Overall Study|Lack of Efficacy|0|||
38025231|NCT02025556|69709461|FG000|Overall Study|Protocol Violation|2|||
37723194|NCT01449370|69201700|FG018|Overall Study|Adverse Event|1|||
37723195|NCT01449370|69201701|FG019|Overall Study|Adverse Event|1|||
37723196|NCT01449370|69201702|FG020|Overall Study|Adverse Event|0|||
37723197|NCT01449370|69201703|FG021|Overall Study|Adverse Event|1|||
37723198|NCT01449370|69201704|FG022|Overall Study|Adverse Event|0|||
37723199|NCT01449370|69201705|FG023|Overall Study|Adverse Event|1|||
37723200|NCT01449370|69201706|FG024|Overall Study|Adverse Event|3|||
37723201|NCT01449370|69201682|FG000|Overall Study|Participant Decision|0|||
37723202|NCT01449370|69201683|FG001|Overall Study|Participant Decision|0|||
37723203|NCT01449370|69201684|FG002|Overall Study|Participant Decision|0|||
37723204|NCT01449370|69201685|FG003|Overall Study|Participant Decision|0|||
37723205|NCT01449370|69201686|FG004|Overall Study|Participant Decision|0|||
37723206|NCT01449370|69201687|FG005|Overall Study|Participant Decision|0|||
37723207|NCT01449370|69201688|FG006|Overall Study|Participant Decision|0|||
37723208|NCT01449370|69201689|FG007|Overall Study|Participant Decision|1|||
37723209|NCT01449370|69201690|FG008|Overall Study|Participant Decision|1|||
37723210|NCT01449370|69201691|FG009|Overall Study|Participant Decision|0|||
37723211|NCT01449370|69201692|FG010|Overall Study|Participant Decision|0|||
37723212|NCT01449370|69201693|FG011|Overall Study|Participant Decision|0|||
37723213|NCT01449370|69201694|FG012|Overall Study|Participant Decision|1|||
37723214|NCT01449370|69201695|FG013|Overall Study|Participant Decision|1|||
37723215|NCT01449370|69201696|FG014|Overall Study|Participant Decision|0|||
37723216|NCT01449370|69201697|FG015|Overall Study|Participant Decision|1|||
38025232|NCT02025556|69709462|FG001|Overall Study|Protocol Violation|1|||
38025233|NCT02025556|69709463|FG002|Overall Study|Protocol Violation|0|||
38025234|NCT02025556|69709461|FG000|Overall Study|Withdrawal by Subject|0|||
38025235|NCT02025556|69709462|FG001|Overall Study|Withdrawal by Subject|3|||
38025236|NCT02025556|69709463|FG002|Overall Study|Withdrawal by Subject|6|||
38025237|NCT02025556|69709461|FG000|Overall Study|Lost to Follow-up|2|||
38025238|NCT02025556|69709462|FG001|Overall Study|Lost to Follow-up|4|||
38025239|NCT02025556|69709463|FG002|Overall Study|Lost to Follow-up|0|||
38025240|NCT02025556|69709461|FG000|Overall Study|Reason not reported|0|||
38025241|NCT02025556|69709462|FG001|Overall Study|Reason not reported|0|||
38025242|NCT02025556|69709463|FG002|Overall Study|Reason not reported|1|||
38025243|NCT04334460|69709473|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
38025244|NCT04334460|69709474|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
38025245|NCT04334460|69709473|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
38025246|NCT04334460|69709474|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
38025247|NCT04334148|69709483|FG000|Overall Study|positive nasal swab at baseline|0|||
38025248|NCT04334148|69709484|FG001|Overall Study|positive nasal swab at baseline|1|||
38025249|NCT04399122|69709492|FG000|Overall Study|Lost to Follow-up|2|||
37723217|NCT01449370|69201698|FG016|Overall Study|Participant Decision|3|||
37723218|NCT01449370|69201699|FG017|Overall Study|Participant Decision|0|||
37723219|NCT01449370|69201700|FG018|Overall Study|Participant Decision|1|||
38025250|NCT04399122|69709493|FG001|Overall Study|Lost to Follow-up|0|||
38025251|NCT04399122|69709492|FG000|Overall Study|Withdrawal by Subject|1|||
38025252|NCT04399122|69709493|FG001|Overall Study|Withdrawal by Subject|0|||
37723220|NCT01449370|69201701|FG019|Overall Study|Participant Decision|0|||
37915582|NCT00851643|69602340|FG004|Base Study (Up to 12 Months)|Other|0|||
37915583|NCT00851643|69602341|FG005|Base Study (Up to 12 Months)|Other|1|||
37915584|NCT00851643|69602336|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
37723221|NCT01449370|69201702|FG020|Overall Study|Participant Decision|0|||
37723222|NCT01449370|69201703|FG021|Overall Study|Participant Decision|1|||
37723223|NCT01449370|69201704|FG022|Overall Study|Participant Decision|0|||
37723224|NCT01449370|69201705|FG023|Overall Study|Participant Decision|0|||
37723225|NCT01449370|69201706|FG024|Overall Study|Participant Decision|1|||
37723226|NCT01449370|69201682|FG000|Overall Study|Lost to Follow-up|0|||
37723227|NCT01449370|69201683|FG001|Overall Study|Lost to Follow-up|0|||
37723228|NCT01449370|69201684|FG002|Overall Study|Lost to Follow-up|0|||
37723229|NCT01449370|69201685|FG003|Overall Study|Lost to Follow-up|0|||
37723230|NCT01449370|69201686|FG004|Overall Study|Lost to Follow-up|0|||
37723231|NCT01449370|69201687|FG005|Overall Study|Lost to Follow-up|0|||
37723232|NCT01449370|69201688|FG006|Overall Study|Lost to Follow-up|0|||
37723233|NCT01449370|69201689|FG007|Overall Study|Lost to Follow-up|0|||
37723234|NCT01449370|69201690|FG008|Overall Study|Lost to Follow-up|0|||
37723235|NCT01449370|69201691|FG009|Overall Study|Lost to Follow-up|0|||
37723236|NCT01449370|69201692|FG010|Overall Study|Lost to Follow-up|0|||
37723237|NCT01449370|69201693|FG011|Overall Study|Lost to Follow-up|0|||
37723238|NCT01449370|69201694|FG012|Overall Study|Lost to Follow-up|0|||
37723239|NCT01449370|69201695|FG013|Overall Study|Lost to Follow-up|0|||
37723240|NCT01449370|69201696|FG014|Overall Study|Lost to Follow-up|0|||
37723241|NCT01449370|69201697|FG015|Overall Study|Lost to Follow-up|0|||
37723242|NCT01449370|69201698|FG016|Overall Study|Lost to Follow-up|0|||
37723243|NCT01449370|69201699|FG017|Overall Study|Lost to Follow-up|0|||
37723244|NCT01449370|69201700|FG018|Overall Study|Lost to Follow-up|0|||
37723245|NCT01449370|69201701|FG019|Overall Study|Lost to Follow-up|0|||
37723246|NCT01449370|69201702|FG020|Overall Study|Lost to Follow-up|1|||
37723247|NCT01449370|69201703|FG021|Overall Study|Lost to Follow-up|0|||
37840739|NCT01081769|69525029|FG000|CORE Intent-To-Treat|Other|0|||
37840740|NCT01081769|69525030|FG001|CORE Intent-To-Treat|Other|1|||
37840741|NCT01081769|69525029|FG000|CORE Intent-To-Treat|Ineligibility|3|||
37840742|NCT01081769|69525030|FG001|CORE Intent-To-Treat|Ineligibility|4|||
37840743|NCT01081769|69525029|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
37840744|NCT01081769|69525030|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
37840745|NCT01081769|69525029|FG000|CORE Intent-To-Treat|Patient Moved|2|||
37840746|NCT01081769|69525030|FG001|CORE Intent-To-Treat|Patient Moved|2|||
37840747|NCT01081301|69525036|FG000|Overall Study|Bereaved|3|||
37840748|NCT01081301|69525036|FG000|Overall Study|Too busy|5|||
37840749|NCT01081301|69525036|FG000|Overall Study|Patient too ill|2|||
37840750|NCT01081301|69525036|FG000|Overall Study|Lost to Follow-up|4|||
37840751|NCT00174954|69525057|FG000|Overall Study|Adverse Event|2|||
37840752|NCT00174954|69525057|FG000|Overall Study|No tophi found in MRI|1|||
37840753|NCT00174954|69525057|FG000|Overall Study|Physician Decision|1|||
37840754|NCT01081145|69525061|FG000|Open-Label Phase|Lack of Efficacy|56|||
37723248|NCT01449370|69201704|FG022|Overall Study|Lost to Follow-up|0|||
37723249|NCT01449370|69201705|FG023|Overall Study|Lost to Follow-up|0|||
37723250|NCT01449370|69201706|FG024|Overall Study|Lost to Follow-up|0|||
37723251|NCT01449370|69201682|FG000|Overall Study|Other|0|||
37723252|NCT01449370|69201683|FG001|Overall Study|Other|0|||
37723253|NCT01449370|69201684|FG002|Overall Study|Other|0|||
37723254|NCT01449370|69201685|FG003|Overall Study|Other|0|||
37723255|NCT01449370|69201686|FG004|Overall Study|Other|0|||
37723256|NCT01449370|69201687|FG005|Overall Study|Other|0|||
37723257|NCT01449370|69201688|FG006|Overall Study|Other|0|||
37723258|NCT01449370|69201689|FG007|Overall Study|Other|0|||
37723259|NCT01449370|69201690|FG008|Overall Study|Other|1|||
37723260|NCT01449370|69201691|FG009|Overall Study|Other|1|||
37723261|NCT01449370|69201692|FG010|Overall Study|Other|0|||
37723262|NCT01449370|69201693|FG011|Overall Study|Other|0|||
37723263|NCT01449370|69201694|FG012|Overall Study|Other|0|||
37723264|NCT01449370|69201695|FG013|Overall Study|Other|0|||
37723265|NCT01449370|69201696|FG014|Overall Study|Other|0|||
37723266|NCT01449370|69201697|FG015|Overall Study|Other|0|||
37840755|NCT01081145|69525062|FG001|Open-Label Phase|Lack of Efficacy|0|||
37723267|NCT01449370|69201698|FG016|Overall Study|Other|0|||
37723268|NCT01449370|69201699|FG017|Overall Study|Other|0|||
37723269|NCT01449370|69201700|FG018|Overall Study|Other|0|||
37723270|NCT01449370|69201701|FG019|Overall Study|Other|0|||
37723271|NCT01449370|69201702|FG020|Overall Study|Other|0|||
37723272|NCT01449370|69201703|FG021|Overall Study|Other|0|||
37723273|NCT01449370|69201704|FG022|Overall Study|Other|1|||
37723274|NCT01449370|69201705|FG023|Overall Study|Other|1|||
37723275|NCT01449370|69201706|FG024|Overall Study|Other|0|||
37723276|NCT01449370|69201682|FG000|Overall Study|Medication Prohibited by Protocol|0|||
37840756|NCT01081145|69525061|FG000|Open-Label Phase|Response criteria not met|46|||
37840757|NCT01081145|69525062|FG001|Open-Label Phase|Response criteria not met|0|||
37840758|NCT01081145|69525061|FG000|Open-Label Phase|Adverse Event|42|||
37723277|NCT01449370|69201683|FG001|Overall Study|Medication Prohibited by Protocol|0|||
37723278|NCT01449370|69201684|FG002|Overall Study|Medication Prohibited by Protocol|0|||
37723279|NCT01449370|69201685|FG003|Overall Study|Medication Prohibited by Protocol|0|||
37840759|NCT01081145|69525062|FG001|Open-Label Phase|Adverse Event|0|||
37723280|NCT01449370|69201686|FG004|Overall Study|Medication Prohibited by Protocol|0|||
37723281|NCT01449370|69201687|FG005|Overall Study|Medication Prohibited by Protocol|0|||
37723282|NCT01449370|69201688|FG006|Overall Study|Medication Prohibited by Protocol|0|||
37723283|NCT01449370|69201689|FG007|Overall Study|Medication Prohibited by Protocol|0|||
37723284|NCT01449370|69201690|FG008|Overall Study|Medication Prohibited by Protocol|0|||
37723285|NCT01449370|69201691|FG009|Overall Study|Medication Prohibited by Protocol|0|||
37723286|NCT01449370|69201692|FG010|Overall Study|Medication Prohibited by Protocol|0|||
37723287|NCT01449370|69201693|FG011|Overall Study|Medication Prohibited by Protocol|0|||
37723288|NCT01449370|69201694|FG012|Overall Study|Medication Prohibited by Protocol|0|||
37723289|NCT01449370|69201695|FG013|Overall Study|Medication Prohibited by Protocol|0|||
37723290|NCT01449370|69201696|FG014|Overall Study|Medication Prohibited by Protocol|0|||
37723291|NCT01449370|69201697|FG015|Overall Study|Medication Prohibited by Protocol|0|||
37723292|NCT01449370|69201698|FG016|Overall Study|Medication Prohibited by Protocol|0|||
37723293|NCT01449370|69201699|FG017|Overall Study|Medication Prohibited by Protocol|0|||
37723294|NCT01449370|69201700|FG018|Overall Study|Medication Prohibited by Protocol|0|||
37723295|NCT01449370|69201701|FG019|Overall Study|Medication Prohibited by Protocol|0|||
37723296|NCT01449370|69201702|FG020|Overall Study|Medication Prohibited by Protocol|0|||
37723297|NCT01449370|69201703|FG021|Overall Study|Medication Prohibited by Protocol|0|||
37723298|NCT01449370|69201704|FG022|Overall Study|Medication Prohibited by Protocol|0|||
37723299|NCT01449370|69201705|FG023|Overall Study|Medication Prohibited by Protocol|1|||
37723300|NCT01449370|69201706|FG024|Overall Study|Medication Prohibited by Protocol|0|||
37723301|NCT01449370|69201682|FG000|Overall Study|Death|0|||
37723302|NCT01449370|69201683|FG001|Overall Study|Death|0|||
37723303|NCT01449370|69201684|FG002|Overall Study|Death|0|||
37723304|NCT01449370|69201685|FG003|Overall Study|Death|0|||
37723305|NCT01449370|69201686|FG004|Overall Study|Death|0|||
37723306|NCT01449370|69201687|FG005|Overall Study|Death|0|||
37723307|NCT01449370|69201688|FG006|Overall Study|Death|0|||
37723308|NCT01449370|69201689|FG007|Overall Study|Death|0|||
37723309|NCT01449370|69201690|FG008|Overall Study|Death|0|||
37723310|NCT01449370|69201691|FG009|Overall Study|Death|0|||
37723311|NCT01449370|69201692|FG010|Overall Study|Death|0|||
37723312|NCT01449370|69201693|FG011|Overall Study|Death|0|||
37723313|NCT01449370|69201694|FG012|Overall Study|Death|0|||
37723314|NCT01449370|69201695|FG013|Overall Study|Death|0|||
37723315|NCT01449370|69201696|FG014|Overall Study|Death|0|||
37723316|NCT01449370|69201697|FG015|Overall Study|Death|0|||
37723317|NCT01449370|69201698|FG016|Overall Study|Death|0|||
37723318|NCT01449370|69201699|FG017|Overall Study|Death|0|||
37723319|NCT01449370|69201700|FG018|Overall Study|Death|0|||
37723320|NCT01449370|69201701|FG019|Overall Study|Death|0|||
37723321|NCT01449370|69201702|FG020|Overall Study|Death|0|||
37723322|NCT01449370|69201703|FG021|Overall Study|Death|0|||
37723323|NCT01449370|69201704|FG022|Overall Study|Death|0|||
37723324|NCT01449370|69201705|FG023|Overall Study|Death|0|||
37723325|NCT01449370|69201706|FG024|Overall Study|Death|1|||
37723326|NCT02067533|69201781|FG000|Overall Study|Lost to Follow-up|4|||
37723327|NCT02067533|69201782|FG001|Overall Study|Lost to Follow-up|2|||
37723328|NCT02066129|69201790|FG000|Overall Study|Lost to Follow-up|13|||
37723329|NCT02066129|69201791|FG001|Overall Study|Lost to Follow-up|12|||
37723330|NCT02066129|69201790|FG000|Overall Study|Withdrawal by Subject|7|||
37723331|NCT02066129|69201791|FG001|Overall Study|Withdrawal by Subject|10|||
37723332|NCT02066129|69201790|FG000|Overall Study|Lack of Efficacy|8|||
37723333|NCT02066129|69201791|FG001|Overall Study|Lack of Efficacy|10|||
37723334|NCT02066129|69201790|FG000|Overall Study|Physician Decision|1|||
37723335|NCT02066129|69201791|FG001|Overall Study|Physician Decision|1|||
37723336|NCT02066051|69201797|FG000|Overall Study|Subject developed active GVHD|1|||
37723337|NCT01980992|69201803|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
37723338|NCT01980992|69201804|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
37723339|NCT01980992|69201803|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
37723340|NCT01980992|69201804|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
37723341|NCT01980992|69201803|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
37723342|NCT01980992|69201804|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
37723343|NCT01980992|69201803|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
37723344|NCT01980992|69201804|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
37723345|NCT01980992|69201803|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
37723346|NCT01980992|69201804|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
37723347|NCT01980992|69201803|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
37723348|NCT01980992|69201804|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
37723349|NCT02065895|69201817|FG000|Overall Study|Protocol Violation|1|||
37723350|NCT02065895|69201818|FG001|Overall Study|Protocol Violation|0|||
37723351|NCT02065895|69201819|FG002|Overall Study|Protocol Violation|0|||
37723352|NCT02065895|69201820|FG003|Overall Study|Protocol Violation|1|||
37723353|NCT02065895|69201821|FG004|Overall Study|Protocol Violation|0|||
37723354|NCT02065895|69201822|FG005|Overall Study|Protocol Violation|0|||
37723355|NCT02065895|69201817|FG000|Overall Study|Scheduling conflicts|0|||
37723356|NCT02065895|69201818|FG001|Overall Study|Scheduling conflicts|1|||
37723357|NCT02065895|69201819|FG002|Overall Study|Scheduling conflicts|0|||
37723358|NCT02065895|69201820|FG003|Overall Study|Scheduling conflicts|0|||
37723359|NCT02065895|69201821|FG004|Overall Study|Scheduling conflicts|0|||
37723360|NCT02065895|69201822|FG005|Overall Study|Scheduling conflicts|0|||
37723361|NCT02106455|69201839|FG000|Overall Study|Case Report Form Uncollected|6|||
37723362|NCT02106455|69201839|FG000|Overall Study|Protocol Deviation|2|||
37723363|NCT02006654|69201845|FG000|Overall Study|Withdrawal before treatment|4|||
37723364|NCT02006654|69201846|FG001|Overall Study|Withdrawal before treatment|2|||
37723365|NCT02006654|69201845|FG000|Overall Study|Adverse Event|16|||
37723366|NCT02006654|69201846|FG001|Overall Study|Adverse Event|17|||
37723367|NCT02006654|69201845|FG000|Overall Study|Death|1|||
37723368|NCT02006654|69201846|FG001|Overall Study|Death|0|||
37723369|NCT02006654|69201845|FG000|Overall Study|Withdrawal by Subject|14|||
37723370|NCT02006654|69201846|FG001|Overall Study|Withdrawal by Subject|12|||
37723371|NCT02006654|69201845|FG000|Overall Study|Protocol Violation|5|||
37723372|NCT02006654|69201846|FG001|Overall Study|Protocol Violation|8|||
37723373|NCT02006654|69201845|FG000|Overall Study|Lost to Follow-up|1|||
37723374|NCT02006654|69201846|FG001|Overall Study|Lost to Follow-up|0|||
37723375|NCT02006654|69201845|FG000|Overall Study|patient's will|2|||
37723376|NCT02006654|69201846|FG001|Overall Study|patient's will|1|||
37723377|NCT02006654|69201845|FG000|Overall Study|insufficient compliance|1|||
37723378|NCT02006654|69201846|FG001|Overall Study|insufficient compliance|0|||
37723379|NCT02006654|69201845|FG000|Overall Study|worsening cognitive condition|0|||
37723380|NCT02006654|69201846|FG001|Overall Study|worsening cognitive condition|1|||
37723381|NCT02006654|69201845|FG000|Overall Study|faecal incontinence|0|||
37723382|NCT02006654|69201846|FG001|Overall Study|faecal incontinence|1|||
37723383|NCT02006654|69201845|FG000|Overall Study|mood disorder|0|||
37723384|NCT02006654|69201846|FG001|Overall Study|mood disorder|1|||
37723385|NCT02006654|69201845|FG000|Overall Study|disallowed medication|1|||
37723386|NCT02006654|69201846|FG001|Overall Study|disallowed medication|0|||
37723387|NCT02006654|69201845|FG000|Overall Study|moving out of state|0|||
37723388|NCT02006654|69201846|FG001|Overall Study|moving out of state|1|||
37723389|NCT01980056|69201856|FG000|Overall Study|Death|1|||
37723390|NCT01980056|69201857|FG001|Overall Study|Death|1|||
37723391|NCT01980056|69201858|FG002|Overall Study|Death|0|||
37840760|NCT01081145|69525061|FG000|Open-Label Phase|Withdrawal by Subject|41|||
37840761|NCT01081145|69525062|FG001|Open-Label Phase|Withdrawal by Subject|0|||
37840762|NCT01081145|69525061|FG000|Open-Label Phase|Other|12|||
37840763|NCT01081145|69525062|FG001|Open-Label Phase|Other|0|||
37840764|NCT01081145|69525061|FG000|Open-Label Phase|Lost to Follow-up|11|||
37723392|NCT02027558|69201872|FG000|Overall Study|Death|0|||
37723393|NCT02027558|69201873|FG001|Overall Study|Death|1|||
37723394|NCT02027558|69201872|FG000|Overall Study|Withdrawal by Subject|2|||
37723395|NCT02027558|69201873|FG001|Overall Study|Withdrawal by Subject|0|||
37723396|NCT02027558|69201872|FG000|Overall Study|Lost to Follow-up|4|||
37723397|NCT02027558|69201873|FG001|Overall Study|Lost to Follow-up|1|||
37723398|NCT02027558|69201872|FG000|Overall Study|Refused assessment|3|||
37723399|NCT02027558|69201873|FG001|Overall Study|Refused assessment|0|||
37723400|NCT02006576|69201884|FG000|Overall Study|Withdrawal by Subject|4|||
37723401|NCT02006576|69201885|FG001|Overall Study|Withdrawal by Subject|6|||
37723402|NCT02006576|69201886|FG002|Overall Study|Withdrawal by Subject|2|||
37840765|NCT01081145|69525062|FG001|Open-Label Phase|Lost to Follow-up|0|||
37840766|NCT01081145|69525061|FG000|Open-Label Phase|Protocol Violation|4|||
37840767|NCT01081145|69525062|FG001|Open-Label Phase|Protocol Violation|0|||
37723403|NCT02006576|69201884|FG000|Overall Study|Death|0|||
37723404|NCT02006576|69201885|FG001|Overall Study|Death|0|||
37723405|NCT02006576|69201886|FG002|Overall Study|Death|1|||
37723406|NCT02006576|69201884|FG000|Overall Study|Lost to Follow-up|1|||
37723407|NCT02006576|69201885|FG001|Overall Study|Lost to Follow-up|0|||
37723408|NCT02006576|69201886|FG002|Overall Study|Lost to Follow-up|1|||
37723409|NCT02006576|69201884|FG000|Overall Study|Screen Failure, too sick, other|13|||
37840768|NCT01081145|69525061|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
37840769|NCT01081145|69525062|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
37915585|NCT00851643|69602337|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
37723410|NCT02006576|69201885|FG001|Overall Study|Screen Failure, too sick, other|1|||
37723411|NCT02006576|69201886|FG002|Overall Study|Screen Failure, too sick, other|13|||
37723412|NCT02027402|69201896|FG000|Overall Study|Withdrawal by Subject|4|||
37723413|NCT02027402|69201897|FG001|Overall Study|Withdrawal by Subject|1|||
37723414|NCT01448824|69201913|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
37723415|NCT01448824|69201914|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
37723416|NCT01448824|69201915|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
37723417|NCT01448824|69201916|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
37723418|NCT01448824|69201917|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
37723419|NCT01448824|69201918|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
37723420|NCT01448824|69201919|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
37723421|NCT01448824|69201920|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
37723422|NCT01448824|69201913|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
37723423|NCT01448824|69201914|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
37723424|NCT01448824|69201915|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
37723425|NCT01448824|69201916|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
37723426|NCT01448824|69201917|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
37723427|NCT01448824|69201918|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
37723428|NCT01448824|69201919|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
37723429|NCT01448824|69201920|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
37723430|NCT01448824|69201913|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
37723431|NCT01448824|69201914|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
37723432|NCT01448824|69201915|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
37723433|NCT01448824|69201916|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
37723434|NCT01448824|69201917|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
37723435|NCT01448824|69201918|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
37723436|NCT01448824|69201919|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
37723437|NCT01448824|69201920|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
37723438|NCT01448824|69201913|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
37723439|NCT01448824|69201914|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
37723440|NCT01448824|69201915|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
37723441|NCT01448824|69201916|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
37723442|NCT01448824|69201917|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
37723443|NCT01448824|69201918|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
37723444|NCT01448824|69201919|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
37723445|NCT01448824|69201920|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
37723446|NCT01448824|69201913|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
37723447|NCT01448824|69201914|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
37723448|NCT01448824|69201915|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
37723449|NCT01448824|69201916|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
37723450|NCT01448824|69201917|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
37723451|NCT01448824|69201918|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
37723452|NCT01448824|69201919|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
37723453|NCT01448824|69201920|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
37723454|NCT01448824|69201913|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
37840770|NCT01081145|69525061|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
38025253|NCT04398732|69709514|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
37723455|NCT01448824|69201914|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
37723456|NCT01448824|69201915|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
37723457|NCT01448824|69201916|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
37723458|NCT01448824|69201917|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
37723459|NCT01448824|69201918|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
37723460|NCT01448824|69201919|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
37723461|NCT01448824|69201920|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
37723462|NCT01448824|69201913|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
37723463|NCT01448824|69201914|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
37723464|NCT01448824|69201915|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
37723465|NCT01448824|69201916|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
37723466|NCT01448824|69201917|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
37723467|NCT01448824|69201918|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
37723468|NCT01448824|69201919|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
37723469|NCT01448824|69201920|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
37723470|NCT01448824|69201913|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
37723471|NCT01448824|69201914|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
37723472|NCT01448824|69201915|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
37723473|NCT01448824|69201916|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
37723474|NCT01448824|69201917|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
37723475|NCT01448824|69201918|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
37723476|NCT01448824|69201919|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
37723477|NCT01448824|69201920|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
37723478|NCT02005562|69201950|FG000|Overall Study|Death|2|||
37840771|NCT01081145|69525062|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
37840772|NCT01081145|69525061|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
37840773|NCT01081145|69525062|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
38025254|NCT04398030|69709520|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
38025255|NCT04398030|69709521|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
37723479|NCT02005562|69201951|FG001|Overall Study|Death|2|||
37723480|NCT02005562|69201950|FG000|Overall Study|Graft loss|7|||
37723481|NCT02005562|69201951|FG001|Overall Study|Graft loss|6|||
37723482|NCT02005562|69201950|FG000|Overall Study|Withdrawal by Subject|2|||
37723483|NCT02005562|69201951|FG001|Overall Study|Withdrawal by Subject|2|||
37723484|NCT02005562|69201950|FG000|Overall Study|No transplant|1|||
37723485|NCT02005562|69201951|FG001|Overall Study|No transplant|4|||
37723486|NCT02005562|69201950|FG000|Overall Study|Physician Decision|0|||
37723487|NCT02005562|69201951|FG001|Overall Study|Physician Decision|1|||
37723488|NCT01448044|69201959|FG000|Treatment Period|Adverse Event|4|||
37723489|NCT01448044|69201960|FG001|Treatment Period|Adverse Event|3|||
37723490|NCT01448044|69201959|FG000|Treatment Period|Lack of Efficacy|5|||
37723491|NCT01448044|69201960|FG001|Treatment Period|Lack of Efficacy|12|||
37723492|NCT01448044|69201959|FG000|Treatment Period|Subject requested discontinue study drug|1|||
37723493|NCT01448044|69201960|FG001|Treatment Period|Subject requested discontinue study drug|0|||
37723494|NCT01448044|69201959|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
38025256|NCT04398030|69709520|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
38025257|NCT04398030|69709521|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
38025258|NCT03064438|69709529|FG000|Overall Study|Lost to Follow-up|1|||
38025259|NCT03064438|69709530|FG001|Overall Study|Lost to Follow-up|0|||
37723495|NCT01448044|69201960|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
37723496|NCT01448044|69201959|FG000|Treatment Period|Participant does not meet study criteria|1|||
37723497|NCT01448044|69201960|FG001|Treatment Period|Participant does not meet study criteria|0|||
37723498|NCT01448044|69201959|FG000|Treatment Period|Lost to Follow-up|2|||
37723499|NCT01448044|69201960|FG001|Treatment Period|Lost to Follow-up|1|||
37723500|NCT01448044|69201959|FG000|Treatment Period|Other reason|2|||
37723501|NCT01448044|69201960|FG001|Treatment Period|Other reason|0|||
37723502|NCT01448044|69201959|FG000|Follow Up Period|Withdrawal by Subject|1|||
37723503|NCT01448044|69201960|FG001|Follow Up Period|Withdrawal by Subject|1|||
37723504|NCT01448044|69201959|FG000|Follow Up Period|Lost to Follow-up|6|||
37723505|NCT01448044|69201960|FG001|Follow Up Period|Lost to Follow-up|2|||
37723506|NCT01448044|69201959|FG000|Follow Up Period|Other|5|||
37723507|NCT01448044|69201960|FG001|Follow Up Period|Other|11|||
37723508|NCT02025530|69201968|FG000|Overall Study|No longer met elligibility criteria|5|||
37723509|NCT02025530|69201969|FG001|Overall Study|No longer met elligibility criteria|1|||
37723510|NCT01472380|69201975|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
37723511|NCT01472380|69201975|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
37723512|NCT01978262|69201982|FG000|Overall Study|Withdrawal by Subject|9|||
37723513|NCT01978262|69201982|FG000|Overall Study|Lost to Follow-up|2|||
37723514|NCT01447576|69201987|FG000|Overall Study|Lost to Follow-up|52|||
37723515|NCT01447576|69201987|FG000|Overall Study|Adverse Event|127|||
37723516|NCT01447576|69201987|FG000|Overall Study|Participant met withdrawal criteria|40|||
37723517|NCT01447576|69201987|FG000|Overall Study|Withdrawal by Subject|100|||
37723518|NCT01447576|69201987|FG000|Overall Study|Protocol deviation|83|||
37723519|NCT01447576|69201987|FG000|Overall Study|Lack of Efficacy|68|||
37840774|NCT01081145|69525061|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
37840775|NCT01081145|69525062|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
37840776|NCT01081145|69525061|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
37840777|NCT01081145|69525062|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
37723520|NCT01447576|69201987|FG000|Overall Study|Physician Decision|6|||
37723521|NCT01447420|69201994|FG000|Overall Study|Adverse Event|2|||
37723522|NCT01447420|69201995|FG001|Overall Study|Adverse Event|4|||
37840778|NCT01081145|69525061|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
37723523|NCT01447420|69201996|FG002|Overall Study|Adverse Event|2|||
37723524|NCT01447420|69201994|FG000|Overall Study|Protocol Violation|3|||
37840779|NCT01081145|69525062|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
37723525|NCT01447420|69201995|FG001|Overall Study|Protocol Violation|3|||
37840780|NCT01081145|69525061|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
37723526|NCT01447420|69201996|FG002|Overall Study|Protocol Violation|0|||
37723527|NCT01447420|69201994|FG000|Overall Study|Withdrawal by Subject|4|||
37723528|NCT01447420|69201995|FG001|Overall Study|Withdrawal by Subject|1|||
37723529|NCT01447420|69201996|FG002|Overall Study|Withdrawal by Subject|0|||
37723530|NCT01447420|69201994|FG000|Overall Study|Lack of Efficacy|1|||
37723531|NCT01447420|69201995|FG001|Overall Study|Lack of Efficacy|19|||
37723532|NCT01447420|69201996|FG002|Overall Study|Lack of Efficacy|8|||
37723533|NCT01446874|69202006|FG000|Overall Study|Not eligible|1|||
37723534|NCT01446874|69202007|FG001|Overall Study|Not eligible|0|||
37723535|NCT01446874|69202008|FG002|Overall Study|Not eligible|0|||
37723536|NCT01446874|69202006|FG000|Overall Study|No surgery/No qualifying surgery|1|||
37723537|NCT01446874|69202007|FG001|Overall Study|No surgery/No qualifying surgery|0|||
37723538|NCT01446874|69202008|FG002|Overall Study|No surgery/No qualifying surgery|12|||
37723539|NCT01446874|69202006|FG000|Overall Study|Non-compliance|0|||
37723540|NCT01446874|69202007|FG001|Overall Study|Non-compliance|4|||
37723541|NCT01446874|69202008|FG002|Overall Study|Non-compliance|0|||
37723542|NCT01446874|69202006|FG000|Overall Study|Antibiotics for pre-op infection|0|||
37723543|NCT01446874|69202007|FG001|Overall Study|Antibiotics for pre-op infection|0|||
37723544|NCT01446874|69202008|FG002|Overall Study|Antibiotics for pre-op infection|2|||
37723545|NCT01446874|69202006|FG000|Overall Study|Withdrawal by Subject|0|||
37723546|NCT01446874|69202007|FG001|Overall Study|Withdrawal by Subject|0|||
37723547|NCT01446874|69202008|FG002|Overall Study|Withdrawal by Subject|4|||
37723548|NCT01446796|69202016|FG000|Overall Study|Withdrawal by Subject|1|||
37723549|NCT01446796|69202017|FG001|Overall Study|Withdrawal by Subject|0|||
37723550|NCT01439074|69202027|FG000|Overall Study|Lost to Follow-up|3|||
37723551|NCT01439074|69202028|FG001|Overall Study|Lost to Follow-up|4|||
37723552|NCT01439074|69202027|FG000|Overall Study|Subject shedding|1|||
37723553|NCT01439074|69202028|FG001|Overall Study|Subject shedding|0|||
37723554|NCT01439074|69202027|FG000|Overall Study|Withdrawal by Subject|1|||
37723555|NCT01439074|69202028|FG001|Overall Study|Withdrawal by Subject|5|||
37723556|NCT01439074|69202027|FG000|Overall Study|Other|4|||
37723557|NCT01439074|69202028|FG001|Overall Study|Other|4|||
37723558|NCT01438996|69202037|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
37723559|NCT01438996|69202038|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
37723560|NCT01438996|69202039|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
37723561|NCT01438840|69202049|FG000|Core Study|Adverse Event|0|||
37723562|NCT01438840|69202050|FG001|Core Study|Adverse Event|3|||
37723563|NCT01438840|69202051|FG002|Core Study|Adverse Event|0|||
37723564|NCT01438840|69202049|FG000|Core Study|Lack of Efficacy|15|||
37723565|NCT01438840|69202050|FG001|Core Study|Lack of Efficacy|7|||
37723566|NCT01438840|69202051|FG002|Core Study|Lack of Efficacy|0|||
37915586|NCT00851643|69602338|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
37915587|NCT00851643|69602339|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
37915588|NCT00851643|69602340|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
37915589|NCT00851643|69602341|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
37915590|NCT00851643|69602336|FG000|Extension Study (Up to 36 Months)|Moved|0|||
37915591|NCT00851643|69602337|FG001|Extension Study (Up to 36 Months)|Moved|2|||
37915592|NCT00851643|69602338|FG002|Extension Study (Up to 36 Months)|Moved|1|||
37915593|NCT00851643|69602339|FG003|Extension Study (Up to 36 Months)|Moved|1|||
37915594|NCT00851643|69602340|FG004|Extension Study (Up to 36 Months)|Moved|0|||
37723567|NCT01438840|69202049|FG000|Core Study|Withdrawal of consent|1|||
37723568|NCT01438840|69202050|FG001|Core Study|Withdrawal of consent|0|||
37723569|NCT01438840|69202051|FG002|Core Study|Withdrawal of consent|0|||
37723570|NCT01438840|69202049|FG000|Extension Phase|Adverse Event|0|||
37723571|NCT01438840|69202050|FG001|Extension Phase|Adverse Event|0|||
37723572|NCT01438840|69202051|FG002|Extension Phase|Adverse Event|3|||
37723573|NCT01438840|69202049|FG000|Extension Phase|Lost to Follow-up|0|||
37723574|NCT01438840|69202050|FG001|Extension Phase|Lost to Follow-up|0|||
37723575|NCT01438840|69202051|FG002|Extension Phase|Lost to Follow-up|1|||
37723576|NCT01438840|69202049|FG000|Extension Phase|Withdrawal by Subject|0|||
37723577|NCT01438840|69202050|FG001|Extension Phase|Withdrawal by Subject|0|||
37915595|NCT00851643|69602341|FG005|Extension Study (Up to 36 Months)|Moved|1|||
37723578|NCT01438840|69202051|FG002|Extension Phase|Withdrawal by Subject|3|||
37723579|NCT01438840|69202049|FG000|Extension Phase|Lack of Efficacy|0|||
37723580|NCT01438840|69202050|FG001|Extension Phase|Lack of Efficacy|0|||
37723581|NCT01438840|69202051|FG002|Extension Phase|Lack of Efficacy|2|||
37723582|NCT01438840|69202049|FG000|Extension Phase|Other|0|||
37723583|NCT01438840|69202050|FG001|Extension Phase|Other|0|||
37723584|NCT01438840|69202051|FG002|Extension Phase|Other|1|||
37723585|NCT01471054|69202060|FG000|Overall Study|Study terminated prematurely|4|||
37723586|NCT01471054|69202061|FG001|Overall Study|Study terminated prematurely|0|||
37723587|NCT01978184|69202079|FG000|Overall Study|Progressive disease|5|||
37723588|NCT01978184|69202080|FG001|Overall Study|Progressive disease|5|||
37723589|NCT01978184|69202079|FG000|Overall Study|Other than PDA|2|||
37723590|NCT01978184|69202080|FG001|Overall Study|Other than PDA|2|||
37723591|NCT01978184|69202079|FG000|Overall Study|Physician Decision|0|||
37723592|NCT01978184|69202080|FG001|Overall Study|Physician Decision|3|||
37723593|NCT01978184|69202079|FG000|Overall Study|Noncompliance|1|||
37723594|NCT01978184|69202080|FG001|Overall Study|Noncompliance|2|||
37723595|NCT01978184|69202079|FG000|Overall Study|Death|1|||
37723596|NCT01978184|69202080|FG001|Overall Study|Death|0|||
37723597|NCT01978184|69202079|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
37723598|NCT01978184|69202080|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
37723599|NCT01445548|69202086|FG000|Overall Study|Adverse Event|1|||
37723600|NCT01977794|69202092|FG000|Overall Study|Adverse Event|2|||
37723601|NCT01977794|69202093|FG001|Overall Study|Adverse Event|2|||
37723602|NCT01977794|69202092|FG000|Overall Study|Lost to Follow-up|2|||
37723603|NCT01977794|69202093|FG001|Overall Study|Lost to Follow-up|1|||
37723604|NCT01977794|69202092|FG000|Overall Study|Protocol Violation|1|||
37723605|NCT01977794|69202093|FG001|Overall Study|Protocol Violation|0|||
37723606|NCT01977794|69202092|FG000|Overall Study|Death|1|||
37723607|NCT01977794|69202093|FG001|Overall Study|Death|1|||
37723608|NCT01977794|69202092|FG000|Overall Study|Withdrew consent|2|||
37723609|NCT01977794|69202093|FG001|Overall Study|Withdrew consent|1|||
37723610|NCT01977794|69202092|FG000|Overall Study|Other|0|||
37723611|NCT01977794|69202093|FG001|Overall Study|Other|1|||
37723612|NCT02005484|69202099|FG000|Overall Study|Death|1|||
37723613|NCT02005484|69202099|FG000|Overall Study|Disease progression|1|||
37723614|NCT02005484|69202099|FG000|Overall Study|Changed to a Different Study|1|||
37840781|NCT01081145|69525062|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
37840782|NCT00174915|69525075|FG000|Overall Study|Lost to Follow-up|19|||
37840783|NCT00174915|69525076|FG001|Overall Study|Lost to Follow-up|17|||
37840784|NCT00174915|69525077|FG002|Overall Study|Lost to Follow-up|9|||
37840785|NCT00174915|69525078|FG003|Overall Study|Lost to Follow-up|17|||
37840786|NCT00174915|69525079|FG004|Overall Study|Lost to Follow-up|10|||
37840787|NCT00174915|69525075|FG000|Overall Study|Adverse Event|18|||
37840788|NCT00174915|69525076|FG001|Overall Study|Adverse Event|16|||
37840789|NCT00174915|69525077|FG002|Overall Study|Adverse Event|11|||
37840790|NCT00174915|69525078|FG003|Overall Study|Adverse Event|18|||
37840791|NCT00174915|69525079|FG004|Overall Study|Adverse Event|5|||
37840792|NCT00174915|69525075|FG000|Overall Study|Personal Reason(s)|16|||
37840793|NCT00174915|69525076|FG001|Overall Study|Personal Reason(s)|16|||
37840794|NCT00174915|69525077|FG002|Overall Study|Personal Reason(s)|9|||
37840795|NCT00174915|69525078|FG003|Overall Study|Personal Reason(s)|9|||
37840796|NCT00174915|69525079|FG004|Overall Study|Personal Reason(s)|9|||
37840797|NCT00174915|69525075|FG000|Overall Study|Other|15|||
37840798|NCT00174915|69525076|FG001|Overall Study|Other|8|||
37840799|NCT00174915|69525077|FG002|Overall Study|Other|6|||
37840800|NCT00174915|69525078|FG003|Overall Study|Other|5|||
37840801|NCT00174915|69525079|FG004|Overall Study|Other|3|||
37840802|NCT00174915|69525075|FG000|Overall Study|Gout Flare|13|||
37840803|NCT00174915|69525076|FG001|Overall Study|Gout Flare|6|||
37840804|NCT00174915|69525077|FG002|Overall Study|Gout Flare|8|||
37840805|NCT00174915|69525078|FG003|Overall Study|Gout Flare|1|||
37840806|NCT00174915|69525079|FG004|Overall Study|Gout Flare|0|||
37840807|NCT00174915|69525075|FG000|Overall Study|Protocol Violation|6|||
37840808|NCT00174915|69525076|FG001|Overall Study|Protocol Violation|3|||
37840809|NCT00174915|69525077|FG002|Overall Study|Protocol Violation|3|||
37840810|NCT00174915|69525078|FG003|Overall Study|Protocol Violation|6|||
37840811|NCT00174915|69525079|FG004|Overall Study|Protocol Violation|3|||
37840812|NCT00174915|69525075|FG000|Overall Study|Therapeutic Failure|6|||
37840813|NCT00174915|69525076|FG001|Overall Study|Therapeutic Failure|3|||
37840814|NCT00174915|69525077|FG002|Overall Study|Therapeutic Failure|2|||
37840815|NCT00174915|69525078|FG003|Overall Study|Therapeutic Failure|1|||
37840816|NCT00174915|69525079|FG004|Overall Study|Therapeutic Failure|3|||
37840817|NCT01080716|69525095|FG000|Part 1|Physician Decision|1|||
37840818|NCT01080716|69525096|FG001|Part 1|Physician Decision|0|||
37840819|NCT01080716|69525097|FG002|Part 1|Physician Decision|0|||
38025260|NCT03064438|69709529|FG000|Overall Study|Withdrawal by Subject|0|||
38025261|NCT03064438|69709530|FG001|Overall Study|Withdrawal by Subject|1|||
38025262|NCT04327986|69709536|FG000|Overall Study|Physician Decision|2|||
37723615|NCT02005484|69202099|FG000|Overall Study|Sponsor decision|1|||
37723616|NCT02005250|69202105|FG000|Overall Study|Lost to Follow-up|15|||
37723617|NCT02005250|69202106|FG001|Overall Study|Lost to Follow-up|5|||
37723618|NCT02024750|69202114|FG000|Overall Study|Withdrawal by Subject|2|||
37840820|NCT01080716|69525098|FG003|Part 1|Physician Decision|0|||
37840821|NCT00172185|69525116|FG000|Overall Study|Adverse Event|0|||
37840822|NCT00172185|69525117|FG001|Overall Study|Adverse Event|1|||
37723619|NCT02024750|69202115|FG001|Overall Study|Withdrawal by Subject|1|||
37840823|NCT00172185|69525118|FG002|Overall Study|Adverse Event|3|||
37840824|NCT00172185|69525119|FG003|Overall Study|Adverse Event|4|||
37840825|NCT00172185|69525116|FG000|Overall Study|Physician Decision|0|||
37840826|NCT00172185|69525117|FG001|Overall Study|Physician Decision|0|||
37840827|NCT00172185|69525118|FG002|Overall Study|Physician Decision|1|||
37840828|NCT00172185|69525119|FG003|Overall Study|Physician Decision|0|||
37840829|NCT00172185|69525116|FG000|Overall Study|SPONSOR Decision|0|||
37840830|NCT00172185|69525117|FG001|Overall Study|SPONSOR Decision|1|||
37840831|NCT00172185|69525118|FG002|Overall Study|SPONSOR Decision|0|||
37840832|NCT00172185|69525119|FG003|Overall Study|SPONSOR Decision|0|||
37840833|NCT00172185|69525116|FG000|Overall Study|Withdrawal by Subject|0|||
37723620|NCT01597973|69202123|FG000|Overall Study|Found ineligible before study medication started|4|||
37723621|NCT01597973|69202124|FG001|Overall Study|Found ineligible before study medication started|2|||
37723622|NCT01597973|69202123|FG000|Overall Study|Eligible pathogen not confirmed|14|||
37723623|NCT01597973|69202124|FG001|Overall Study|Eligible pathogen not confirmed|15|||
37723624|NCT01597973|69202123|FG000|Overall Study|LAR not authorized to consent|0|||
37723625|NCT01597973|69202124|FG001|Overall Study|LAR not authorized to consent|1|||
37723626|NCT01597973|69202123|FG000|Overall Study|Ineligible due to early seizures|1|||
37723627|NCT01597973|69202124|FG001|Overall Study|Ineligible due to early seizures|0|||
37723628|NCT01597973|69202123|FG000|Overall Study|Ineligible due to non-target infection|1|||
37723629|NCT01597973|69202124|FG001|Overall Study|Ineligible due to non-target infection|1|||
37723630|NCT02023268|69202134|FG000|Overall Study|Lack of Efficacy|0|||
37723631|NCT02023268|69202135|FG001|Overall Study|Lack of Efficacy|1|||
37723632|NCT02023268|69202134|FG000|Overall Study|Adverse Event|0|||
37723633|NCT02023268|69202135|FG001|Overall Study|Adverse Event|2|||
37723634|NCT02023268|69202134|FG000|Overall Study|Withdrawal by Subject|0|||
37723635|NCT02023268|69202135|FG001|Overall Study|Withdrawal by Subject|1|||
37723636|NCT02047253|69202141|FG000|Overall Study|Lost to Follow-up|8|||
37723637|NCT02096705|69202147|FG000|Treatment|Adverse Event|6|||
37723638|NCT02096705|69202148|FG001|Treatment|Adverse Event|3|||
37723639|NCT02096705|69202147|FG000|Treatment|Subject request to discontinue treatment|1|||
37723640|NCT02096705|69202148|FG001|Treatment|Subject request to discontinue treatment|1|||
37723641|NCT02096705|69202147|FG000|Treatment|Withdrawal by Subject|1|||
37723642|NCT02096705|69202148|FG001|Treatment|Withdrawal by Subject|0|||
37723643|NCT02096705|69202147|FG000|Treatment|Other|1|||
37723644|NCT02096705|69202148|FG001|Treatment|Other|1|||
37723645|NCT02096705|69202147|FG000|Follow-up|Withdrawal by Subject|1|||
37723646|NCT02096705|69202148|FG001|Follow-up|Withdrawal by Subject|0|||
37723647|NCT02096705|69202147|FG000|Follow-up|Adverse Event|2|||
37723648|NCT02096705|69202148|FG001|Follow-up|Adverse Event|2|||
37723649|NCT02096705|69202147|FG000|Follow-up|Subjects not reporting status|1|||
37723650|NCT02096705|69202148|FG001|Follow-up|Subjects not reporting status|2|||
37723651|NCT02096471|69202154|FG000|Overall Study|Adverse Event|1|||
37723652|NCT02096471|69202154|FG000|Overall Study|Lack of Efficacy|7|||
37723653|NCT02096471|69202154|FG000|Overall Study|Withdrawal by Subject|3|||
37723654|NCT02096471|69202154|FG000|Overall Study|Non-Compliant|2|||
37723655|NCT02096003|69202160|FG000|Overall Study|Protocol Violation|0|||
37723656|NCT02096003|69202161|FG001|Overall Study|Protocol Violation|2|||
37723657|NCT02096003|69202160|FG000|Overall Study|additional surgery|2|||
37723658|NCT02096003|69202161|FG001|Overall Study|additional surgery|1|||
37723659|NCT02062385|69202171|FG000|Overall Study|Adverse Event|19|||
37723660|NCT02062385|69202172|FG001|Overall Study|Adverse Event|13|||
37723661|NCT02062385|69202173|FG002|Overall Study|Adverse Event|1|||
37723662|NCT02062385|69202174|FG003|Overall Study|Adverse Event|0|||
37840834|NCT00172185|69525117|FG001|Overall Study|Withdrawal by Subject|0|||
37840835|NCT00172185|69525118|FG002|Overall Study|Withdrawal by Subject|1|||
37840836|NCT00172185|69525119|FG003|Overall Study|Withdrawal by Subject|0|||
37840837|NCT01080326|69525133|FG000|Overall Study|Patient deterioration prior to procedure|3|||
37840838|NCT01080326|69525133|FG000|Overall Study|Surgeon decision|1|||
37840839|NCT00171951|69525137|FG000|Overall Study|Adverse Event|1|||
37840840|NCT00171951|69525137|FG000|Overall Study|Abnormal Laboratory Values|2|||
37840841|NCT00171951|69525137|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
37840842|NCT00171951|69525137|FG000|Overall Study|Participants Withdrew Consent|3|||
37840843|NCT00171951|69525137|FG000|Overall Study|New Cancer Therapy|5|||
37723663|NCT02062385|69202171|FG000|Overall Study|Protocol Violation|1|||
37723664|NCT02062385|69202172|FG001|Overall Study|Protocol Violation|0|||
37723665|NCT02062385|69202173|FG002|Overall Study|Protocol Violation|0|||
37840844|NCT00171951|69525137|FG000|Overall Study|Reason not Specified|2|||
37840845|NCT01080131|69525146|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
37915596|NCT00529243|69602354|FG000|Overall Study|Adverse Event|1|||
37915597|NCT00529243|69602354|FG000|Overall Study|Death|1|||
37915598|NCT00529243|69602354|FG000|Overall Study|Relocated|1|||
37915599|NCT03728309|69602360|FG000|Overall Study|Randomized but not Treated|0|||
37915600|NCT03728309|69602361|FG001|Overall Study|Randomized but not Treated|1|||
37723666|NCT02062385|69202174|FG003|Overall Study|Protocol Violation|0|||
37723667|NCT02062385|69202171|FG000|Overall Study|Incomplete EPI by database lock|2|||
37723668|NCT02062385|69202172|FG001|Overall Study|Incomplete EPI by database lock|0|||
37723669|NCT02062385|69202173|FG002|Overall Study|Incomplete EPI by database lock|0|||
37723670|NCT02062385|69202174|FG003|Overall Study|Incomplete EPI by database lock|0|||
37723671|NCT02062385|69202171|FG000|Overall Study|Moved|10|||
37723672|NCT02062385|69202172|FG001|Overall Study|Moved|11|||
37723673|NCT02062385|69202173|FG002|Overall Study|Moved|1|||
37840846|NCT01080131|69525147|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
37915601|NCT03728309|69602360|FG000|Overall Study|Adverse Event|0|||
37723674|NCT02062385|69202174|FG003|Overall Study|Moved|0|||
37723675|NCT02062385|69202171|FG000|Overall Study|Withdrawn by parent/guardian|46|||
37723676|NCT02062385|69202172|FG001|Overall Study|Withdrawn by parent/guardian|41|||
37723677|NCT02062385|69202173|FG002|Overall Study|Withdrawn by parent/guardian|9|||
37723678|NCT02062385|69202174|FG003|Overall Study|Withdrawn by parent/guardian|8|||
37723679|NCT02062385|69202171|FG000|Overall Study|Death|0|||
37723680|NCT02062385|69202172|FG001|Overall Study|Death|0|||
37723681|NCT02062385|69202173|FG002|Overall Study|Death|0|||
37723682|NCT02062385|69202174|FG003|Overall Study|Death|1|||
37723683|NCT02062385|69202171|FG000|Overall Study|Lost to Follow-up|0|||
37723684|NCT02062385|69202172|FG001|Overall Study|Lost to Follow-up|0|||
37723685|NCT02062385|69202173|FG002|Overall Study|Lost to Follow-up|1|||
37723686|NCT02062385|69202174|FG003|Overall Study|Lost to Follow-up|0|||
37723687|NCT02062151|69202182|FG000|Overall Study|screen failure|1|||
37723688|NCT02060903|69202188|FG000|Overall Study|Lost to Follow-up|4|||
37723689|NCT02060903|69202189|FG001|Overall Study|Lost to Follow-up|0|||
37723690|NCT02060903|69202188|FG000|Overall Study|Withdrawal by Subject|0|||
37723691|NCT02060903|69202189|FG001|Overall Study|Withdrawal by Subject|7|||
37723692|NCT02095691|69202195|FG000|Overall Study|Physician Decision|1|||
37723693|NCT02095535|69202211|FG000|Recruitment|Protocol Violation|2|||
37723694|NCT02095223|69202217|FG000|Overall Study|Withdrawal by Subject|1|||
37723695|NCT02095223|69202218|FG001|Overall Study|Withdrawal by Subject|0|||
37723696|NCT02095145|69202226|FG000|Overall Study|Withdrawal by Subject|1|||
37723697|NCT02095145|69202227|FG001|Overall Study|Withdrawal by Subject|0|||
37723698|NCT02059187|69202237|FG000|Overall Study|Adverse Event|0|||
37723699|NCT02059187|69202238|FG001|Overall Study|Adverse Event|3|||
37723700|NCT02059187|69202237|FG000|Overall Study|Death|1|||
37723701|NCT02059187|69202238|FG001|Overall Study|Death|1|||
37723702|NCT02059187|69202237|FG000|Overall Study|Lost to Follow-up|9|||
37723703|NCT02059187|69202238|FG001|Overall Study|Lost to Follow-up|8|||
37723704|NCT02059187|69202237|FG000|Overall Study|Non-compliance with study drug|1|||
37723705|NCT02059187|69202238|FG001|Overall Study|Non-compliance with study drug|0|||
37723706|NCT02059187|69202237|FG000|Overall Study|Physician Decision|1|||
37723707|NCT02059187|69202238|FG001|Overall Study|Physician Decision|2|||
37723708|NCT02059187|69202237|FG000|Overall Study|Protocol Violation|1|||
37723709|NCT02059187|69202238|FG001|Overall Study|Protocol Violation|0|||
37723710|NCT02059187|69202237|FG000|Overall Study|Withdrawal by Subject|12|||
37723711|NCT02059187|69202238|FG001|Overall Study|Withdrawal by Subject|8|||
37723712|NCT02043899|69202244|FG000|Overall Study|Adverse Event|3|||
37723713|NCT02043899|69202244|FG000|Overall Study|Physician Decision|1|||
37723714|NCT02043899|69202244|FG000|Overall Study|Withdrawal by Subject|2|||
37723715|NCT02043899|69202244|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
37723716|NCT02043899|69202244|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
37723717|NCT02043899|69202244|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
37723718|NCT02043899|69202244|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
37723719|NCT02043899|69202244|FG000|Overall Study|Treatment delayed|1|||
37840847|NCT01080131|69525146|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
37840848|NCT01080131|69525147|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
37840849|NCT01080131|69525146|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
37840850|NCT01080131|69525147|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
37840851|NCT01080131|69525146|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
37840852|NCT01080131|69525147|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
37840853|NCT01080131|69525146|FG000|Core Study (0- 12 Weeks)|Death|1|||
37840854|NCT01080131|69525147|FG001|Core Study (0- 12 Weeks)|Death|0|||
37840855|NCT01080131|69525146|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
37840856|NCT01080131|69525147|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
37840857|NCT01080131|69525146|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
37840858|NCT01080131|69525147|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
37840859|NCT01080131|69525146|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
37723720|NCT02043509|69202250|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
37723721|NCT02043509|69202251|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
37840860|NCT01080131|69525147|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
37840861|NCT01080131|69525146|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
37840862|NCT01080131|69525147|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
37840863|NCT01080131|69525146|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
37723722|NCT02043509|69202250|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
37723723|NCT02043509|69202251|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
37723724|NCT02043509|69202250|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
37723725|NCT02043509|69202251|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
37723726|NCT02043509|69202250|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
37723727|NCT02043509|69202251|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
37723728|NCT02058563|69202259|FG000|Overall Study|Lost to Follow-up|26|||
37723729|NCT02058563|69202260|FG001|Overall Study|Lost to Follow-up|22|||
37840864|NCT01080131|69525147|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
37915602|NCT03728309|69602361|FG001|Overall Study|Adverse Event|1|||
37723730|NCT02058563|69202259|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
37723731|NCT02058563|69202260|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
37723732|NCT02058563|69202259|FG000|Overall Study|Consent Withdrawal|1|||
37723733|NCT02058563|69202260|FG001|Overall Study|Consent Withdrawal|1|||
37723734|NCT02058563|69202259|FG000|Overall Study|Other (patient incarcerated)|0|||
37723735|NCT02058563|69202260|FG001|Overall Study|Other (patient incarcerated)|1|||
37723736|NCT01622231|69202266|FG000|Overall Study|Physician Decision|1|||
37723737|NCT01622231|69202266|FG000|Overall Study|Withdrawal by Subject|1|||
37723738|NCT02042183|69202272|FG000|Overall Study|Physician Decision|7|||
37723739|NCT02042183|69202273|FG001|Overall Study|Physician Decision|2|||
37723740|NCT02042183|69202272|FG000|Overall Study|Lack of Efficacy|4|||
37723741|NCT02042183|69202273|FG001|Overall Study|Lack of Efficacy|3|||
37723742|NCT02042183|69202272|FG000|Overall Study|Non-compliance with Study Drug|2|||
37723743|NCT02042183|69202273|FG001|Overall Study|Non-compliance with Study Drug|3|||
37723744|NCT02042183|69202272|FG000|Overall Study|Adverse Event|17|||
37723745|NCT02042183|69202273|FG001|Overall Study|Adverse Event|6|||
37723746|NCT02042183|69202272|FG000|Overall Study|Other|3|||
37723747|NCT02042183|69202273|FG001|Overall Study|Other|3|||
37723748|NCT02042183|69202272|FG000|Overall Study|Withdrawal by Subject|21|||
37723749|NCT02042183|69202273|FG001|Overall Study|Withdrawal by Subject|16|||
37723750|NCT02042183|69202272|FG000|Overall Study|Site Terminated by Sponsor|2|||
37723751|NCT02042183|69202273|FG001|Overall Study|Site Terminated by Sponsor|1|||
37723752|NCT02042183|69202272|FG000|Overall Study|Lost to Follow-up|9|||
37723753|NCT02042183|69202273|FG001|Overall Study|Lost to Follow-up|2|||
37723754|NCT01977482|69202287|FG000|Overall Study|Adverse Event|0|||
37723755|NCT01977482|69202288|FG001|Overall Study|Adverse Event|1|||
37723756|NCT01977482|69202289|FG002|Overall Study|Adverse Event|1|||
37723757|NCT01977482|69202290|FG003|Overall Study|Adverse Event|0|||
37723758|NCT01977482|69202291|FG004|Overall Study|Adverse Event|2|||
37723759|NCT01977482|69202292|FG005|Overall Study|Adverse Event|0|||
37723760|NCT01977482|69202287|FG000|Overall Study|Lost to Follow-up|1|||
37840865|NCT01080131|69525146|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
37840866|NCT01080131|69525147|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
37915603|NCT03728309|69602360|FG000|Overall Study|Withdrawal by Subject|2|||
37915604|NCT03728309|69602361|FG001|Overall Study|Withdrawal by Subject|8|||
37915605|NCT03728309|69602360|FG000|Overall Study|Lost to Follow-up|9|||
37915606|NCT03728309|69602361|FG001|Overall Study|Lost to Follow-up|10|||
37723761|NCT01977482|69202288|FG001|Overall Study|Lost to Follow-up|0|||
37723762|NCT01977482|69202289|FG002|Overall Study|Lost to Follow-up|0|||
37723763|NCT01977482|69202290|FG003|Overall Study|Lost to Follow-up|0|||
37723764|NCT01977482|69202291|FG004|Overall Study|Lost to Follow-up|0|||
37723765|NCT01977482|69202292|FG005|Overall Study|Lost to Follow-up|0|||
37723766|NCT01977482|69202287|FG000|Overall Study|Physician Decision|0|||
37723767|NCT01977482|69202288|FG001|Overall Study|Physician Decision|1|||
37723768|NCT01977482|69202289|FG002|Overall Study|Physician Decision|0|||
37723769|NCT01977482|69202290|FG003|Overall Study|Physician Decision|0|||
37723770|NCT01977482|69202291|FG004|Overall Study|Physician Decision|0|||
37723771|NCT01977482|69202292|FG005|Overall Study|Physician Decision|0|||
37723772|NCT01977482|69202287|FG000|Overall Study|Protocol Violation|0|||
37723773|NCT01977482|69202288|FG001|Overall Study|Protocol Violation|0|||
37723774|NCT01977482|69202289|FG002|Overall Study|Protocol Violation|1|||
37723775|NCT01977482|69202290|FG003|Overall Study|Protocol Violation|0|||
37723776|NCT01977482|69202291|FG004|Overall Study|Protocol Violation|0|||
37723777|NCT01977482|69202292|FG005|Overall Study|Protocol Violation|0|||
37723778|NCT01977482|69202287|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
37723779|NCT01977482|69202288|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
37840867|NCT01080131|69525146|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
37840868|NCT01080131|69525147|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
37840869|NCT01080131|69525146|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
37840870|NCT01080131|69525147|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
37840871|NCT00171873|69525173|FG000|Overall Study|Withdrawal by Subject|4|||
37840872|NCT00171873|69525174|FG001|Overall Study|Withdrawal by Subject|2|||
37915607|NCT03728309|69602360|FG000|Overall Study|Protocol Deviation|0|||
37915608|NCT03728309|69602361|FG001|Overall Study|Protocol Deviation|1|||
37915609|NCT03728309|69602360|FG000|Overall Study|Due to COVID|1|||
37915610|NCT03728309|69602361|FG001|Overall Study|Due to COVID|3|||
37915611|NCT03683719|69602378|FG000|Overall Study|Lack of Efficacy|1|||
37723780|NCT01977482|69202289|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
37723781|NCT01977482|69202290|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
37723782|NCT01977482|69202291|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
37723783|NCT01977482|69202292|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
37723784|NCT01977482|69202287|FG000|Overall Study|Withdrawal by Subject|2|||
37723785|NCT01977482|69202288|FG001|Overall Study|Withdrawal by Subject|4|||
37723786|NCT01977482|69202289|FG002|Overall Study|Withdrawal by Subject|1|||
37723787|NCT01977482|69202290|FG003|Overall Study|Withdrawal by Subject|3|||
37840873|NCT00171873|69525173|FG000|Overall Study|Adverse Event|5|||
37840874|NCT00171873|69525174|FG001|Overall Study|Adverse Event|0|||
37723788|NCT01977482|69202291|FG004|Overall Study|Withdrawal by Subject|1|||
37723789|NCT01977482|69202292|FG005|Overall Study|Withdrawal by Subject|5|||
37840875|NCT00171873|69525173|FG000|Overall Study|Switched to Octreotide|0|||
37840876|NCT00171873|69525174|FG001|Overall Study|Switched to Octreotide|1|||
37840877|NCT00171834|69525187|FG000|Overall Study|Adverse Event|2|||
37840878|NCT00171834|69525188|FG001|Overall Study|Adverse Event|1|||
37840879|NCT00171834|69525189|FG002|Overall Study|Adverse Event|3|||
37840880|NCT00171834|69525190|FG003|Overall Study|Adverse Event|2|||
37840881|NCT00171834|69525191|FG004|Overall Study|Adverse Event|2|||
37840882|NCT00171834|69525192|FG005|Overall Study|Adverse Event|15|||
37840883|NCT00171834|69525193|FG006|Overall Study|Adverse Event|1|||
37840884|NCT00171834|69525187|FG000|Overall Study|Withdrawal by Subject|0|||
37840885|NCT00171834|69525188|FG001|Overall Study|Withdrawal by Subject|2|||
37840886|NCT00171834|69525189|FG002|Overall Study|Withdrawal by Subject|0|||
37840887|NCT00171834|69525190|FG003|Overall Study|Withdrawal by Subject|1|||
37840888|NCT00171834|69525191|FG004|Overall Study|Withdrawal by Subject|1|||
37840889|NCT00171834|69525192|FG005|Overall Study|Withdrawal by Subject|1|||
37840890|NCT00171834|69525193|FG006|Overall Study|Withdrawal by Subject|0|||
37840891|NCT00171834|69525187|FG000|Overall Study|Death from study indication|0|||
37840892|NCT00171834|69525188|FG001|Overall Study|Death from study indication|1|||
37840893|NCT00171834|69525189|FG002|Overall Study|Death from study indication|0|||
37840894|NCT00171834|69525190|FG003|Overall Study|Death from study indication|0|||
37840895|NCT00171834|69525191|FG004|Overall Study|Death from study indication|1|||
37840896|NCT00171834|69525192|FG005|Overall Study|Death from study indication|0|||
37840897|NCT00171834|69525193|FG006|Overall Study|Death from study indication|0|||
37840898|NCT00171834|69525187|FG000|Overall Study|Disease Progression|4|||
37840899|NCT00171834|69525188|FG001|Overall Study|Disease Progression|8|||
37840900|NCT00171834|69525189|FG002|Overall Study|Disease Progression|8|||
37840901|NCT00171834|69525190|FG003|Overall Study|Disease Progression|9|||
37840902|NCT00171834|69525191|FG004|Overall Study|Disease Progression|2|||
37840903|NCT00171834|69525192|FG005|Overall Study|Disease Progression|18|||
37840904|NCT00171834|69525193|FG006|Overall Study|Disease Progression|3|||
37840905|NCT00171834|69525187|FG000|Overall Study|Treatment Duration Completed|0|||
37840906|NCT00171834|69525188|FG001|Overall Study|Treatment Duration Completed|0|||
37840907|NCT00171834|69525189|FG002|Overall Study|Treatment Duration Completed|1|||
37840908|NCT00171834|69525190|FG003|Overall Study|Treatment Duration Completed|0|||
37840909|NCT00171834|69525191|FG004|Overall Study|Treatment Duration Completed|2|||
37840910|NCT00171834|69525192|FG005|Overall Study|Treatment Duration Completed|1|||
37840911|NCT00171834|69525193|FG006|Overall Study|Treatment Duration Completed|0|||
37840912|NCT00171249|69525223|FG000|Overall Study|Withdrawal by Subject|2|||
37840913|NCT00171249|69525224|FG001|Overall Study|Withdrawal by Subject|0|||
37840914|NCT00171249|69525225|FG002|Overall Study|Withdrawal by Subject|0|||
37840915|NCT00171249|69525226|FG003|Overall Study|Withdrawal by Subject|6|||
37840916|NCT00171249|69525227|FG004|Overall Study|Withdrawal by Subject|0|||
37840917|NCT00171249|69525228|FG005|Overall Study|Withdrawal by Subject|0|||
37840918|NCT00171249|69525229|FG006|Overall Study|Withdrawal by Subject|0|||
37840919|NCT00171249|69525223|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
37840920|NCT00171249|69525224|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
37840921|NCT00171249|69525225|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
37840922|NCT00171249|69525226|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
37840923|NCT00171249|69525227|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
37840924|NCT00171249|69525228|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
37840925|NCT00171249|69525229|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
37840926|NCT00171249|69525223|FG000|Overall Study|Death|7|||
37840927|NCT00171249|69525224|FG001|Overall Study|Death|1|||
37840928|NCT00171249|69525225|FG002|Overall Study|Death|0|||
37840929|NCT00171249|69525226|FG003|Overall Study|Death|4|||
37840930|NCT00171249|69525227|FG004|Overall Study|Death|0|||
37915612|NCT03683719|69602379|FG001|Overall Study|Lack of Efficacy|3|||
37915613|NCT03683719|69602380|FG002|Overall Study|Lack of Efficacy|4|||
38025263|NCT04327986|69709537|FG001|Overall Study|Physician Decision|0|||
37840931|NCT00171249|69525228|FG005|Overall Study|Death|3|||
37840932|NCT00171249|69525229|FG006|Overall Study|Death|1|||
37840933|NCT00171249|69525223|FG000|Overall Study|Other|10|||
37840934|NCT00171249|69525224|FG001|Overall Study|Other|0|||
37840935|NCT00171249|69525225|FG002|Overall Study|Other|0|||
37840936|NCT00171249|69525226|FG003|Overall Study|Other|43|||
37840937|NCT00171249|69525227|FG004|Overall Study|Other|0|||
37840938|NCT00171249|69525228|FG005|Overall Study|Other|2|||
37723790|NCT02058095|69202313|FG000|Overall Study|Adverse Event|1|||
37723791|NCT02058095|69202314|FG001|Overall Study|Adverse Event|0|||
37723792|NCT02023112|69202322|FG000|Overall Study|Withdrawal by Subject|2|||
37723793|NCT02023112|69202323|FG001|Overall Study|Withdrawal by Subject|1|||
37723794|NCT01977092|69202333|FG000|Overall Study|Death|3|||
37723795|NCT01977092|69202334|FG001|Overall Study|Death|4|||
37723796|NCT01977092|69202333|FG000|Overall Study|Lost to Follow-up|23|||
37723797|NCT01977092|69202334|FG001|Overall Study|Lost to Follow-up|14|||
37723798|NCT01977092|69202333|FG000|Overall Study|Withdrawal by Subject|2|||
37723799|NCT01977092|69202334|FG001|Overall Study|Withdrawal by Subject|1|||
37723800|NCT01977092|69202333|FG000|Overall Study|In prison|3|||
37723801|NCT01977092|69202334|FG001|Overall Study|In prison|11|||
37723802|NCT01976624|69202340|FG000|Overall Study|Participants contraindicated|2|||
37723803|NCT01976624|69202340|FG000|Overall Study|Participants age less than 19 years|12|||
37723804|NCT02041091|69202346|FG000|Treatment|Adverse Event|3|||
37723805|NCT02041091|69202347|FG001|Treatment|Adverse Event|3|||
37723806|NCT02041091|69202346|FG000|Treatment|Withdrawal by Subject|2|||
37723807|NCT02041091|69202347|FG001|Treatment|Withdrawal by Subject|4|||
37723808|NCT02041091|69202346|FG000|Treatment|Physician Decision|1|||
37723809|NCT02041091|69202347|FG001|Treatment|Physician Decision|0|||
37723810|NCT02041091|69202346|FG000|Treatment|Sponsor Decision|15|||
37723811|NCT02041091|69202347|FG001|Treatment|Sponsor Decision|16|||
37723812|NCT02041091|69202346|FG000|Treatment|Lost to Follow-up|1|||
37723813|NCT02041091|69202347|FG001|Treatment|Lost to Follow-up|0|||
37723814|NCT02041091|69202346|FG000|Optional Safety Extension Period|Adverse Event|4|||
37723815|NCT02041091|69202347|FG001|Optional Safety Extension Period|Adverse Event|2|||
37723816|NCT02041091|69202346|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
37723817|NCT02041091|69202347|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
37723818|NCT02041091|69202346|FG000|Optional Safety Extension Period|Protocol Violation|2|||
37723819|NCT02041091|69202347|FG001|Optional Safety Extension Period|Protocol Violation|0|||
37723820|NCT02041091|69202346|FG000|Optional Safety Extension Period|Physician Decision|2|||
37723821|NCT02041091|69202347|FG001|Optional Safety Extension Period|Physician Decision|1|||
37723822|NCT02041091|69202346|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
37723823|NCT02041091|69202347|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
37723824|NCT02041091|69202346|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
37723825|NCT02041091|69202347|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
37723826|NCT02057549|69202361|FG000|Overall Study|Lost to Follow-up|1|||
37723827|NCT02057549|69202362|FG001|Overall Study|Lost to Follow-up|0|||
37723828|NCT02057549|69202361|FG000|Overall Study|Physician Decision|1|||
37723829|NCT02057549|69202362|FG001|Overall Study|Physician Decision|0|||
37723830|NCT02057549|69202361|FG000|Overall Study|Withdrawal by Subject|1|||
37723831|NCT02057549|69202362|FG001|Overall Study|Withdrawal by Subject|0|||
37723832|NCT02057393|69202368|FG000|Overall Study|Withdrawal by Subject|1|||
37723833|NCT02057393|69202368|FG000|Overall Study|Patient did not meet criteria|1|||
37723834|NCT02040779|69202375|FG000|Overall Study|Adverse Event|1|||
37723835|NCT02040779|69202376|FG001|Overall Study|Adverse Event|0|||
37723836|NCT02040779|69202377|FG002|Overall Study|Adverse Event|0|||
37723837|NCT02040779|69202375|FG000|Overall Study|Withdrawal by Subject|4|||
37723838|NCT02040779|69202376|FG001|Overall Study|Withdrawal by Subject|1|||
37723839|NCT02040779|69202377|FG002|Overall Study|Withdrawal by Subject|3|||
37723840|NCT02040779|69202375|FG000|Overall Study|Non-compliance|0|||
37723841|NCT02040779|69202376|FG001|Overall Study|Non-compliance|1|||
37723842|NCT02040779|69202377|FG002|Overall Study|Non-compliance|0|||
37723843|NCT02040779|69202375|FG000|Overall Study|Protocol Violation|2|||
37723844|NCT02040779|69202376|FG001|Overall Study|Protocol Violation|1|||
37723845|NCT02040779|69202377|FG002|Overall Study|Protocol Violation|0|||
37723846|NCT02040779|69202375|FG000|Overall Study|Lost to Follow-up|1|||
37723847|NCT02040779|69202376|FG001|Overall Study|Lost to Follow-up|2|||
37723848|NCT02040779|69202377|FG002|Overall Study|Lost to Follow-up|1|||
37723849|NCT02040779|69202375|FG000|Overall Study|Lack of Efficacy|4|||
37723850|NCT02040779|69202376|FG001|Overall Study|Lack of Efficacy|2|||
37723851|NCT02040779|69202377|FG002|Overall Study|Lack of Efficacy|0|||
37840939|NCT00171249|69525229|FG006|Overall Study|Other|0|||
37723852|NCT02056301|69202387|FG000|Overall Study|Protocol Violation|1|||
37723853|NCT02056301|69202388|FG001|Overall Study|Protocol Violation|2|||
37723854|NCT02056301|69202387|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
37723855|NCT02056301|69202388|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
37723856|NCT02056301|69202387|FG000|Overall Study|Withdrawal by Subject|0|||
37723857|NCT02056301|69202388|FG001|Overall Study|Withdrawal by Subject|1|||
37723858|NCT02056301|69202387|FG000|Overall Study|Issues with epidural|0|||
37723859|NCT02056301|69202388|FG001|Overall Study|Issues with epidural|3|||
37723860|NCT01967732|69202396|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
37723861|NCT01967732|69202397|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
37723862|NCT01967732|69202398|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
37723863|NCT01967732|69202399|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
37723864|NCT01967732|69202396|FG000|First Intervention (Day 1)|Poor venous access|0|||
37723865|NCT01967732|69202397|FG001|First Intervention (Day 1)|Poor venous access|1|||
37723866|NCT01967732|69202398|FG002|First Intervention (Day 1)|Poor venous access|0|||
37723867|NCT01967732|69202399|FG003|First Intervention (Day 1)|Poor venous access|0|||
37723868|NCT01967576|69202407|FG000|Overall Study|Withdrawal by Subject|3|||
37723869|NCT01967576|69202407|FG000|Overall Study|Progressed/Removed from treatment|1|||
37723870|NCT01967576|69202407|FG000|Overall Study|Study closing at site|1|||
37723871|NCT01967576|69202407|FG000|Overall Study|Adverse Event|1|||
37723872|NCT01967576|69202407|FG000|Overall Study|Refused further treatment|1|||
37723873|NCT02039687|69202415|FG000|Overall Study|Adverse Event|0|||
37723874|NCT02039687|69202416|FG001|Overall Study|Adverse Event|0|||
37723875|NCT02039687|69202417|FG002|Overall Study|Adverse Event|1|||
37723876|NCT02039687|69202418|FG003|Overall Study|Adverse Event|0|||
37723877|NCT02039687|69202415|FG000|Overall Study|Withdrawal by Subject|0|||
37723878|NCT02039687|69202416|FG001|Overall Study|Withdrawal by Subject|1|||
37723879|NCT02039687|69202417|FG002|Overall Study|Withdrawal by Subject|0|||
37723880|NCT02039687|69202418|FG003|Overall Study|Withdrawal by Subject|0|||
37723881|NCT02039687|69202415|FG000|Overall Study|treatment assignment could not be confir|0|||
37723882|NCT02039687|69202416|FG001|Overall Study|treatment assignment could not be confir|0|||
37723883|NCT02039687|69202417|FG002|Overall Study|treatment assignment could not be confir|2|||
37840940|NCT00171249|69525223|FG000|Overall Study|No Longer Requires Study Drug|4|||
37840941|NCT00171249|69525224|FG001|Overall Study|No Longer Requires Study Drug|0|||
37840942|NCT00171249|69525225|FG002|Overall Study|No Longer Requires Study Drug|0|||
37840943|NCT00171249|69525226|FG003|Overall Study|No Longer Requires Study Drug|3|||
37840944|NCT00171249|69525227|FG004|Overall Study|No Longer Requires Study Drug|0|||
37840945|NCT00171249|69525228|FG005|Overall Study|No Longer Requires Study Drug|5|||
37840946|NCT00171249|69525229|FG006|Overall Study|No Longer Requires Study Drug|0|||
37840947|NCT00171249|69525223|FG000|Overall Study|Administrative Problems|1|||
37840948|NCT00171249|69525224|FG001|Overall Study|Administrative Problems|0|||
37840949|NCT00171249|69525225|FG002|Overall Study|Administrative Problems|0|||
37840950|NCT00171249|69525226|FG003|Overall Study|Administrative Problems|2|||
37840951|NCT00171249|69525227|FG004|Overall Study|Administrative Problems|0|||
37840952|NCT00171249|69525228|FG005|Overall Study|Administrative Problems|0|||
37840953|NCT00171249|69525229|FG006|Overall Study|Administrative Problems|0|||
37840954|NCT00171249|69525223|FG000|Overall Study|Adverse Event|3|||
37840955|NCT00171249|69525224|FG001|Overall Study|Adverse Event|1|||
37840956|NCT00171249|69525225|FG002|Overall Study|Adverse Event|0|||
37840957|NCT00171249|69525226|FG003|Overall Study|Adverse Event|15|||
37840958|NCT00171249|69525227|FG004|Overall Study|Adverse Event|0|||
37840959|NCT00171249|69525228|FG005|Overall Study|Adverse Event|2|||
37840960|NCT00171249|69525229|FG006|Overall Study|Adverse Event|0|||
37840961|NCT00171249|69525223|FG000|Overall Study|Lost to Follow-up|5|||
37723884|NCT02039687|69202418|FG003|Overall Study|treatment assignment could not be confir|0|||
37723885|NCT02003534|69202428|FG000|Overall Study|Lost to Follow-up|47|||
37723886|NCT02055365|69202432|FG000|Overall Study|Prematurely Withdrawn|1|||
37723887|NCT02039375|69202443|FG000|Overall Study|Lost to Follow-up|2|||
37723888|NCT02054897|69202450|FG000|Overall Study|Withdrawal by Subject|2|||
37840962|NCT00171249|69525224|FG001|Overall Study|Lost to Follow-up|0|||
37840963|NCT00171249|69525225|FG002|Overall Study|Lost to Follow-up|0|||
37840964|NCT00171249|69525226|FG003|Overall Study|Lost to Follow-up|9|||
37840965|NCT00171249|69525227|FG004|Overall Study|Lost to Follow-up|0|||
37840966|NCT00171249|69525228|FG005|Overall Study|Lost to Follow-up|0|||
37840967|NCT00171249|69525229|FG006|Overall Study|Lost to Follow-up|0|||
37723889|NCT02054897|69202451|FG001|Overall Study|Withdrawal by Subject|0|||
37723890|NCT02054897|69202452|FG002|Overall Study|Withdrawal by Subject|2|||
37723891|NCT02054897|69202450|FG000|Overall Study|Missing follow-up information|3|||
37840968|NCT01085630|69525240|FG000|Overall Study|Insufficient data|1|||
37840969|NCT01085630|69525241|FG001|Overall Study|Insufficient data|0|||
37840970|NCT01085630|69525240|FG000|Overall Study|Ineligible|3|||
37723892|NCT02054897|69202451|FG001|Overall Study|Missing follow-up information|5|||
37723893|NCT02054897|69202452|FG002|Overall Study|Missing follow-up information|3|||
37723894|NCT02054897|69202450|FG000|Overall Study|Lost to Follow-up|4|||
37723895|NCT02054897|69202451|FG001|Overall Study|Lost to Follow-up|2|||
37723896|NCT02054897|69202452|FG002|Overall Study|Lost to Follow-up|7|||
37723897|NCT02054897|69202450|FG000|Overall Study|Randomized but not exposed|1|||
37723898|NCT02054897|69202451|FG001|Overall Study|Randomized but not exposed|0|||
37723899|NCT02054897|69202452|FG002|Overall Study|Randomized but not exposed|0|||
37723900|NCT01976312|69202462|FG000|Overall Study|Pregnancy|0|||
37723901|NCT01976312|69202463|FG001|Overall Study|Pregnancy|1|||
37723902|NCT01976312|69202462|FG000|Overall Study|Lost to Follow-up|2|||
37723903|NCT01976312|69202463|FG001|Overall Study|Lost to Follow-up|0|||
37723904|NCT01976312|69202462|FG000|Overall Study|Withdrawal by Subject|7|||
37723905|NCT01976312|69202463|FG001|Overall Study|Withdrawal by Subject|2|||
37723906|NCT01976312|69202462|FG000|Overall Study|Adverse Event|6|||
37723907|NCT01976312|69202463|FG001|Overall Study|Adverse Event|6|||
37723908|NCT01976312|69202462|FG000|Overall Study|Protocol Violation|2|||
37723909|NCT01976312|69202463|FG001|Overall Study|Protocol Violation|0|||
37723910|NCT02039219|69202472|FG000|Treatment|Withdrawal by Subject|1|||
37723911|NCT02039219|69202473|FG001|Treatment|Withdrawal by Subject|0|||
37723912|NCT02039219|69202472|FG000|Treatment|Adverse Event|0|||
37723913|NCT02039219|69202473|FG001|Treatment|Adverse Event|1|||
37723914|NCT02039219|69202472|FG000|Treatment|Physician Decision|1|||
37840971|NCT01085630|69525241|FG001|Overall Study|Ineligible|0|||
37840972|NCT00171210|69525249|FG000|Overall Study|Adverse Event|16|||
37840973|NCT00171210|69525250|FG001|Overall Study|Adverse Event|27|||
37840974|NCT00171210|69525249|FG000|Overall Study|Abnormal laboratory value(s)|6|||
37840975|NCT00171210|69525250|FG001|Overall Study|Abnormal laboratory value(s)|3|||
37840976|NCT00171210|69525249|FG000|Overall Study|Abnormal test procedure result(s)|0|||
37840977|NCT00171210|69525250|FG001|Overall Study|Abnormal test procedure result(s)|1|||
37840978|NCT00171210|69525249|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
37840979|NCT00171210|69525250|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
37840980|NCT00171210|69525249|FG000|Overall Study|Protocol Violation|0|||
37840981|NCT00171210|69525250|FG001|Overall Study|Protocol Violation|2|||
37840982|NCT00171210|69525249|FG000|Overall Study|Withdrawal by Subject|32|||
37840983|NCT00171210|69525250|FG001|Overall Study|Withdrawal by Subject|30|||
37840984|NCT00171210|69525249|FG000|Overall Study|Lost to Follow-up|1|||
37915614|NCT03683719|69602381|FG003|Overall Study|Lack of Efficacy|0|||
38025264|NCT04327986|69709538|FG002|Overall Study|Physician Decision|0|||
37723915|NCT02039219|69202473|FG001|Treatment|Physician Decision|0|||
37723916|NCT02039219|69202472|FG000|Treatment|Lost to Follow-up|0|||
37723917|NCT02039219|69202473|FG001|Treatment|Lost to Follow-up|1|||
37723918|NCT02039219|69202472|FG000|Treatment|Protocol Violation|1|||
37723919|NCT02039219|69202473|FG001|Treatment|Protocol Violation|0|||
37723920|NCT02039219|69202472|FG000|Treatment|Death|1|||
37723921|NCT02039219|69202473|FG001|Treatment|Death|0|||
37723922|NCT02039219|69202472|FG000|Follow up|Adverse Event|0|||
37723923|NCT02039219|69202473|FG001|Follow up|Adverse Event|1|||
37723924|NCT02053493|69202481|FG000|Overall Study|Withdrawal by Subject|1|||
37723925|NCT02053493|69202482|FG001|Overall Study|Withdrawal by Subject|1|||
37723926|NCT02003144|69202490|FG000|Open Label Maintenance Phase|Other than specified|2|||
37723927|NCT02003144|69202491|FG001|Open Label Maintenance Phase|Other than specified|4|||
37723928|NCT02003144|69202490|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
37723929|NCT02003144|69202491|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
37723930|NCT02003144|69202490|FG000|Open Label Maintenance Phase|Pregnancy|0|||
37723931|NCT02003144|69202491|FG001|Open Label Maintenance Phase|Pregnancy|2|||
37723932|NCT02003144|69202490|FG000|Open Label Maintenance Phase|Physician Decision|1|||
37723933|NCT02003144|69202491|FG001|Open Label Maintenance Phase|Physician Decision|1|||
37723934|NCT02003144|69202490|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
37723935|NCT02003144|69202491|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
37723936|NCT02003144|69202490|FG000|Open Label Maintenance Phase|Adverse Event|2|||
37723937|NCT02003144|69202491|FG001|Open Label Maintenance Phase|Adverse Event|1|||
37723938|NCT02001194|69202502|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
37840985|NCT00171210|69525250|FG001|Overall Study|Lost to Follow-up|0|||
37915615|NCT03683719|69602382|FG004|Overall Study|Lack of Efficacy|4|||
37915616|NCT03683719|69602378|FG000|Overall Study|Adverse Event|6|||
37915617|NCT03683719|69602379|FG001|Overall Study|Adverse Event|6|||
38025265|NCT04327986|69709536|FG000|Overall Study|Death|1|||
37723939|NCT02001194|69202503|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
37723940|NCT02001194|69202504|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
37723941|NCT02001194|69202505|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
37723942|NCT02001194|69202502|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
37723943|NCT02001194|69202503|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
37723944|NCT02001194|69202504|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
37840986|NCT00171210|69525249|FG000|Overall Study|Administrative problems|1|||
37840987|NCT00171210|69525250|FG001|Overall Study|Administrative problems|1|||
37840988|NCT00171210|69525249|FG000|Overall Study|Death|2|||
37723945|NCT02001194|69202505|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
37723946|NCT02038907|69202529|FG000|Overall Study|Protocol Violation|0|||
37723947|NCT02038907|69202530|FG001|Overall Study|Protocol Violation|0|||
37915618|NCT03683719|69602380|FG002|Overall Study|Adverse Event|0|||
37915619|NCT03683719|69602381|FG003|Overall Study|Adverse Event|1|||
37915620|NCT03683719|69602382|FG004|Overall Study|Adverse Event|3|||
37915621|NCT03683719|69602378|FG000|Overall Study|Withdrawal by Subject|4|||
37915622|NCT03683719|69602379|FG001|Overall Study|Withdrawal by Subject|4|||
37915623|NCT03683719|69602380|FG002|Overall Study|Withdrawal by Subject|3|||
37915624|NCT03683719|69602381|FG003|Overall Study|Withdrawal by Subject|5|||
37915625|NCT03683719|69602382|FG004|Overall Study|Withdrawal by Subject|5|||
37723948|NCT02038907|69202531|FG002|Overall Study|Protocol Violation|0|||
37723949|NCT02038907|69202532|FG003|Overall Study|Protocol Violation|0|||
37723950|NCT02038907|69202533|FG004|Overall Study|Protocol Violation|0|||
37723951|NCT02038907|69202534|FG005|Overall Study|Protocol Violation|0|||
37723952|NCT02038907|69202535|FG006|Overall Study|Protocol Violation|0|||
37723953|NCT02038907|69202536|FG007|Overall Study|Protocol Violation|0|||
37723954|NCT02038907|69202537|FG008|Overall Study|Protocol Violation|0|||
37723955|NCT02038907|69202538|FG009|Overall Study|Protocol Violation|0|||
37723956|NCT02038907|69202539|FG010|Overall Study|Protocol Violation|1|||
37723957|NCT02038907|69202540|FG011|Overall Study|Protocol Violation|0|||
37723958|NCT02038907|69202541|FG012|Overall Study|Protocol Violation|0|||
37723959|NCT02038907|69202542|FG013|Overall Study|Protocol Violation|0|||
37840989|NCT00171210|69525250|FG001|Overall Study|Death|3|||
37840990|NCT00171210|69525249|FG000|Overall Study|Stopped at end of core|0|||
37840991|NCT00171210|69525250|FG001|Overall Study|Stopped at end of core|32|||
37840992|NCT00171210|69525249|FG000|Overall Study|Stopped at end of extension 1|0|||
37840993|NCT00171210|69525250|FG001|Overall Study|Stopped at end of extension 1|1|||
37840994|NCT00171054|69525258|FG000|Overall Study|Protocol Violation|1|||
37840995|NCT00171054|69525259|FG001|Overall Study|Protocol Violation|2|||
37840996|NCT00171054|69525258|FG000|Overall Study|Patient withdrew consent|1|||
37840997|NCT00171054|69525259|FG001|Overall Study|Patient withdrew consent|0|||
37840998|NCT00171054|69525258|FG000|Overall Study|Lost to Follow-up|0|||
37840999|NCT00171054|69525259|FG001|Overall Study|Lost to Follow-up|1|||
37915626|NCT03683719|69602378|FG000|Overall Study|Lost to Follow-up|1|||
37915627|NCT03683719|69602379|FG001|Overall Study|Lost to Follow-up|0|||
37915628|NCT03683719|69602380|FG002|Overall Study|Lost to Follow-up|0|||
37915629|NCT03683719|69602381|FG003|Overall Study|Lost to Follow-up|1|||
37915630|NCT03683719|69602382|FG004|Overall Study|Lost to Follow-up|1|||
37915631|NCT03683719|69602378|FG000|Overall Study|Other personal reasons|0|||
37915632|NCT03683719|69602379|FG001|Overall Study|Other personal reasons|0|||
37915633|NCT03683719|69602380|FG002|Overall Study|Other personal reasons|1|||
37915634|NCT03683719|69602381|FG003|Overall Study|Other personal reasons|0|||
37915635|NCT03683719|69602382|FG004|Overall Study|Other personal reasons|1|||
37915636|NCT00851253|69602396|FG000|Overall Study|Disease Progression|1|||
37723960|NCT02038907|69202529|FG000|Overall Study|Withdrawal by Subject|0|||
37723961|NCT02038907|69202530|FG001|Overall Study|Withdrawal by Subject|0|||
37723962|NCT02038907|69202531|FG002|Overall Study|Withdrawal by Subject|0|||
37723963|NCT02038907|69202532|FG003|Overall Study|Withdrawal by Subject|0|||
37723964|NCT02038907|69202533|FG004|Overall Study|Withdrawal by Subject|0|||
37723965|NCT02038907|69202534|FG005|Overall Study|Withdrawal by Subject|0|||
37723966|NCT02038907|69202535|FG006|Overall Study|Withdrawal by Subject|0|||
37723967|NCT02038907|69202536|FG007|Overall Study|Withdrawal by Subject|0|||
37723968|NCT02038907|69202537|FG008|Overall Study|Withdrawal by Subject|0|||
37723969|NCT02038907|69202538|FG009|Overall Study|Withdrawal by Subject|0|||
37723970|NCT02038907|69202539|FG010|Overall Study|Withdrawal by Subject|1|||
37723971|NCT02038907|69202540|FG011|Overall Study|Withdrawal by Subject|0|||
37723972|NCT02038907|69202541|FG012|Overall Study|Withdrawal by Subject|0|||
37723973|NCT02038907|69202542|FG013|Overall Study|Withdrawal by Subject|0|||
37723974|NCT02038829|69202574|FG000|Washout Period 1|Death|0|||
37723975|NCT02038829|69202575|FG001|Washout Period 1|Death|0|||
37723976|NCT02038829|69202576|FG002|Washout Period 1|Death|0|||
37723977|NCT02038829|69202577|FG003|Washout Period 1|Death|0|||
37723978|NCT02038829|69202578|FG004|Washout Period 1|Death|1|||
37723979|NCT02038829|69202579|FG005|Washout Period 1|Death|0|||
37723980|NCT02038829|69202580|FG006|Washout Period 1|Death|0|||
37723981|NCT02038829|69202581|FG007|Washout Period 1|Death|0|||
37723982|NCT02038829|69202582|FG008|Washout Period 1|Death|0|||
37723983|NCT02038829|69202583|FG009|Washout Period 1|Death|0|||
37723984|NCT02038829|69202584|FG010|Washout Period 1|Death|0|||
37723985|NCT02038829|69202585|FG011|Washout Period 1|Death|0|||
37723986|NCT02038829|69202574|FG000|Treatment Period 2|Adverse Event|0|||
37841000|NCT00171054|69525258|FG000|Overall Study|Adverse Event|8|||
37841001|NCT00171054|69525259|FG001|Overall Study|Adverse Event|8|||
37915637|NCT00851253|69602397|FG001|Overall Study|Disease Progression|0|||
37915638|NCT00520351|69602405|FG000|First Intervention|Withdrawal by Subject|1|||
37915639|NCT00520351|69602406|FG001|First Intervention|Withdrawal by Subject|1|||
37915640|NCT00850395|69602416|FG000|Overall Study|Death|1|||
37723987|NCT02038829|69202575|FG001|Treatment Period 2|Adverse Event|0|||
37723988|NCT02038829|69202576|FG002|Treatment Period 2|Adverse Event|0|||
37723989|NCT02038829|69202577|FG003|Treatment Period 2|Adverse Event|0|||
37723990|NCT02038829|69202578|FG004|Treatment Period 2|Adverse Event|0|||
37723991|NCT02038829|69202579|FG005|Treatment Period 2|Adverse Event|0|||
37723992|NCT02038829|69202580|FG006|Treatment Period 2|Adverse Event|0|||
37723993|NCT02038829|69202581|FG007|Treatment Period 2|Adverse Event|0|||
37723994|NCT02038829|69202582|FG008|Treatment Period 2|Adverse Event|0|||
37723995|NCT02038829|69202583|FG009|Treatment Period 2|Adverse Event|0|||
37723996|NCT02038829|69202584|FG010|Treatment Period 2|Adverse Event|1|||
37723997|NCT02038829|69202585|FG011|Treatment Period 2|Adverse Event|0|||
37723998|NCT02038829|69202574|FG000|Treatment Period 2|Withdrawal by Subject|1|||
37723999|NCT02038829|69202575|FG001|Treatment Period 2|Withdrawal by Subject|0|||
37724000|NCT02038829|69202576|FG002|Treatment Period 2|Withdrawal by Subject|0|||
37724001|NCT02038829|69202577|FG003|Treatment Period 2|Withdrawal by Subject|0|||
37724002|NCT02038829|69202578|FG004|Treatment Period 2|Withdrawal by Subject|0|||
37724003|NCT02038829|69202579|FG005|Treatment Period 2|Withdrawal by Subject|0|||
37724004|NCT02038829|69202580|FG006|Treatment Period 2|Withdrawal by Subject|0|||
37724005|NCT02038829|69202581|FG007|Treatment Period 2|Withdrawal by Subject|0|||
37724006|NCT02038829|69202582|FG008|Treatment Period 2|Withdrawal by Subject|0|||
37724007|NCT02038829|69202583|FG009|Treatment Period 2|Withdrawal by Subject|0|||
37724008|NCT02038829|69202584|FG010|Treatment Period 2|Withdrawal by Subject|0|||
37724009|NCT02038829|69202585|FG011|Treatment Period 2|Withdrawal by Subject|0|||
37724010|NCT02038829|69202574|FG000|Washout Period 2|Adverse Event|0|||
37724011|NCT02038829|69202575|FG001|Washout Period 2|Adverse Event|0|||
37724012|NCT02038829|69202576|FG002|Washout Period 2|Adverse Event|0|||
37724013|NCT02038829|69202577|FG003|Washout Period 2|Adverse Event|0|||
37724014|NCT02038829|69202578|FG004|Washout Period 2|Adverse Event|0|||
37724015|NCT02038829|69202579|FG005|Washout Period 2|Adverse Event|0|||
37724016|NCT02038829|69202580|FG006|Washout Period 2|Adverse Event|0|||
37724017|NCT02038829|69202581|FG007|Washout Period 2|Adverse Event|0|||
37724018|NCT02038829|69202582|FG008|Washout Period 2|Adverse Event|1|||
37724019|NCT02038829|69202583|FG009|Washout Period 2|Adverse Event|0|||
37724020|NCT02038829|69202584|FG010|Washout Period 2|Adverse Event|0|||
37724021|NCT02038829|69202585|FG011|Washout Period 2|Adverse Event|0|||
37724022|NCT02038829|69202574|FG000|Washout Period 2|Withdrawal by Subject|0|||
37724023|NCT02038829|69202575|FG001|Washout Period 2|Withdrawal by Subject|0|||
37841002|NCT00171054|69525258|FG000|Overall Study|Condition no longer required study drug|0|||
37841003|NCT00171054|69525259|FG001|Overall Study|Condition no longer required study drug|1|||
37841004|NCT01084694|69525267|FG000|Overall Study|Withdrawal by Subject|2|||
37841005|NCT01084694|69525268|FG001|Overall Study|Withdrawal by Subject|1|||
37841006|NCT01084694|69525267|FG000|Overall Study|Death|2|||
37841007|NCT01084694|69525268|FG001|Overall Study|Death|12|||
37841008|NCT01084694|69525267|FG000|Overall Study|eligibility not maintained|2|||
37841009|NCT01084694|69525268|FG001|Overall Study|eligibility not maintained|7|||
37841010|NCT00479856|69525282|FG000|Overall Study|Adverse Event|1|||
37724024|NCT02038829|69202576|FG002|Washout Period 2|Withdrawal by Subject|0|||
37724025|NCT02038829|69202577|FG003|Washout Period 2|Withdrawal by Subject|0|||
37724026|NCT02038829|69202578|FG004|Washout Period 2|Withdrawal by Subject|0|||
38025266|NCT04327986|69709537|FG001|Overall Study|Death|0|||
38025267|NCT04327986|69709538|FG002|Overall Study|Death|0|||
37724027|NCT02038829|69202579|FG005|Washout Period 2|Withdrawal by Subject|1|||
37841011|NCT00479856|69525282|FG000|Overall Study|Withdrawal by Subject|1|||
37724028|NCT02038829|69202580|FG006|Washout Period 2|Withdrawal by Subject|0|||
37724029|NCT02038829|69202581|FG007|Washout Period 2|Withdrawal by Subject|0|||
37724030|NCT02038829|69202582|FG008|Washout Period 2|Withdrawal by Subject|0|||
37841012|NCT00479856|69525282|FG000|Overall Study|Physician Decision|1|||
37841013|NCT00479466|69525292|FG000|Overall Study|Adverse Event|5|||
37841014|NCT00479466|69525293|FG001|Overall Study|Adverse Event|1|||
37841015|NCT00479466|69525294|FG002|Overall Study|Adverse Event|0|||
37841016|NCT00479466|69525295|FG003|Overall Study|Adverse Event|1|||
37724031|NCT02038829|69202583|FG009|Washout Period 2|Withdrawal by Subject|0|||
37724032|NCT02038829|69202584|FG010|Washout Period 2|Withdrawal by Subject|0|||
37724033|NCT02038829|69202585|FG011|Washout Period 2|Withdrawal by Subject|0|||
37724034|NCT02038829|69202574|FG000|Treatment Period 4|Adverse Event|0|||
37915641|NCT00850395|69602416|FG000|Overall Study|Adverse Event|1|||
37915642|NCT00850395|69602416|FG000|Overall Study|Insufficient clinical response|3|||
37915643|NCT00850395|69602416|FG000|Overall Study|Other|5|||
37915644|NCT00520039|69602422|FG000|Overall Study|Exclusion criteria met at first visit|7|||
37915645|NCT00520039|69602423|FG001|Overall Study|Exclusion criteria met at first visit|5|||
37915646|NCT00577720|69602435|FG000|Overall Study|Adverse Event|2|||
37915647|NCT00577720|69602436|FG001|Overall Study|Adverse Event|1|||
37915648|NCT00577720|69602437|FG002|Overall Study|Adverse Event|0|||
37724035|NCT02038829|69202575|FG001|Treatment Period 4|Adverse Event|1|||
37724036|NCT02038829|69202576|FG002|Treatment Period 4|Adverse Event|0|||
37724037|NCT02038829|69202577|FG003|Treatment Period 4|Adverse Event|0|||
37724038|NCT02038829|69202578|FG004|Treatment Period 4|Adverse Event|0|||
37724039|NCT02038829|69202579|FG005|Treatment Period 4|Adverse Event|0|||
37724040|NCT02038829|69202580|FG006|Treatment Period 4|Adverse Event|0|||
37724041|NCT02038829|69202581|FG007|Treatment Period 4|Adverse Event|0|||
37724042|NCT02038829|69202582|FG008|Treatment Period 4|Adverse Event|0|||
37724043|NCT02038829|69202583|FG009|Treatment Period 4|Adverse Event|0|||
37724044|NCT02038829|69202584|FG010|Treatment Period 4|Adverse Event|0|||
37724045|NCT02038829|69202585|FG011|Treatment Period 4|Adverse Event|0|||
37724046|NCT02038829|69202574|FG000|Washout Period 4|Adverse Event|0|||
37724047|NCT02038829|69202575|FG001|Washout Period 4|Adverse Event|0|||
37724048|NCT02038829|69202576|FG002|Washout Period 4|Adverse Event|0|||
37724049|NCT02038829|69202577|FG003|Washout Period 4|Adverse Event|0|||
37724050|NCT02038829|69202578|FG004|Washout Period 4|Adverse Event|0|||
37724051|NCT02038829|69202579|FG005|Washout Period 4|Adverse Event|0|||
37724052|NCT02038829|69202580|FG006|Washout Period 4|Adverse Event|1|||
37724053|NCT02038829|69202581|FG007|Washout Period 4|Adverse Event|0|||
37724054|NCT02038829|69202582|FG008|Washout Period 4|Adverse Event|0|||
37724055|NCT02038829|69202583|FG009|Washout Period 4|Adverse Event|0|||
37724056|NCT02038829|69202584|FG010|Washout Period 4|Adverse Event|0|||
37724057|NCT02038829|69202585|FG011|Washout Period 4|Adverse Event|0|||
37724058|NCT02038829|69202574|FG000|Treatment Period 6|Adverse Event|0|||
37724059|NCT02038829|69202575|FG001|Treatment Period 6|Adverse Event|0|||
37724060|NCT02038829|69202576|FG002|Treatment Period 6|Adverse Event|1|||
37724061|NCT02038829|69202577|FG003|Treatment Period 6|Adverse Event|0|||
37724062|NCT02038829|69202578|FG004|Treatment Period 6|Adverse Event|0|||
37724063|NCT02038829|69202579|FG005|Treatment Period 6|Adverse Event|0|||
37724064|NCT02038829|69202580|FG006|Treatment Period 6|Adverse Event|0|||
37841017|NCT00479466|69525296|FG004|Overall Study|Adverse Event|2|||
37841018|NCT00479466|69525297|FG005|Overall Study|Adverse Event|0|||
37724065|NCT02038829|69202581|FG007|Treatment Period 6|Adverse Event|0|||
37724066|NCT02038829|69202582|FG008|Treatment Period 6|Adverse Event|0|||
37841019|NCT00479466|69525292|FG000|Overall Study|Hyperglycemia|0|||
37724067|NCT02038829|69202583|FG009|Treatment Period 6|Adverse Event|0|||
37724068|NCT02038829|69202584|FG010|Treatment Period 6|Adverse Event|0|||
37724069|NCT02038829|69202585|FG011|Treatment Period 6|Adverse Event|0|||
37841020|NCT00479466|69525293|FG001|Overall Study|Hyperglycemia|0|||
37841021|NCT00479466|69525294|FG002|Overall Study|Hyperglycemia|0|||
37841022|NCT00479466|69525295|FG003|Overall Study|Hyperglycemia|0|||
37841023|NCT00479466|69525296|FG004|Overall Study|Hyperglycemia|0|||
37915649|NCT00577720|69602438|FG003|Overall Study|Adverse Event|4|||
37915650|NCT00577720|69602435|FG000|Overall Study|Lost to Follow-up|0|||
37915651|NCT00577720|69602436|FG001|Overall Study|Lost to Follow-up|0|||
37915652|NCT00577720|69602437|FG002|Overall Study|Lost to Follow-up|1|||
37915653|NCT00577720|69602438|FG003|Overall Study|Lost to Follow-up|0|||
38025268|NCT04322682|69709544|FG000|Overall Study|Withdrawal by Subject|33|||
37724070|NCT02038049|69202602|FG000|Overall Study|Lost to Follow-up|1|||
37724071|NCT02038049|69202603|FG001|Overall Study|Lost to Follow-up|0|||
37724072|NCT02052011|69202615|FG000|Overall Study|Lost to Follow-up|3|||
37915654|NCT00577720|69602435|FG000|Overall Study|Protocol Violation|0|||
38025269|NCT04322682|69709545|FG001|Overall Study|Withdrawal by Subject|47|||
37724073|NCT02052011|69202616|FG001|Overall Study|Lost to Follow-up|0|||
37841024|NCT00479466|69525297|FG005|Overall Study|Hyperglycemia|1|||
37915655|NCT00577720|69602436|FG001|Overall Study|Protocol Violation|0|||
37724074|NCT02052011|69202615|FG000|Overall Study|Withdrawal by Subject|1|||
37724075|NCT02052011|69202616|FG001|Overall Study|Withdrawal by Subject|2|||
37724076|NCT02036645|69202634|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
37915656|NCT00577720|69602437|FG002|Overall Study|Protocol Violation|0|||
37915657|NCT00577720|69602438|FG003|Overall Study|Protocol Violation|1|||
37724077|NCT02036645|69202635|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
37724078|NCT02036645|69202636|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
37724079|NCT02036645|69202637|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
37724080|NCT02036645|69202638|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
37724081|NCT02036645|69202639|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
37724082|NCT02036645|69202640|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
37724083|NCT02036645|69202641|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
37724084|NCT02036645|69202642|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
37724085|NCT02036645|69202643|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
37724086|NCT02036645|69202644|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
37724087|NCT02036645|69202645|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
37724088|NCT02036645|69202634|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
37724089|NCT02036645|69202635|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
37724090|NCT02036645|69202636|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
37724091|NCT02036645|69202637|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
37724092|NCT02036645|69202638|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
37724093|NCT02036645|69202639|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
37724094|NCT02036645|69202640|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
37724095|NCT02036645|69202641|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
37724096|NCT02036645|69202642|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
37724097|NCT02036645|69202643|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
37724098|NCT02036645|69202644|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
37724099|NCT02036645|69202645|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
37724100|NCT02051933|69202685|FG000|Overall Study|Physician Decision|0|||
37724101|NCT02051933|69202686|FG001|Overall Study|Physician Decision|1|||
37724102|NCT02050373|69202699|FG000|Overall Study|Adverse Event|4|||
37724103|NCT02050373|69202700|FG001|Overall Study|Adverse Event|7|||
37724104|NCT02050373|69202699|FG000|Overall Study|Death|3|||
37724105|NCT02050373|69202700|FG001|Overall Study|Death|3|||
37724106|NCT02049437|69202709|FG000|Period 1|Adverse Event|1|||
37724107|NCT02049437|69202710|FG001|Period 1|Adverse Event|1|||
37724108|NCT02049437|69202709|FG000|Period 1|Adverse Event|1|||
37724109|NCT02049437|69202710|FG001|Period 1|Adverse Event|0|||
37724110|NCT02035553|69202718|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
37724111|NCT02035553|69202719|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
37724112|NCT02035553|69202718|FG000|Overall Study|Adverse Event|10|||
37724113|NCT02035553|69202719|FG001|Overall Study|Adverse Event|6|||
37724114|NCT02035553|69202718|FG000|Overall Study|Physician Decision|3|||
37724115|NCT02035553|69202719|FG001|Overall Study|Physician Decision|2|||
37724116|NCT02035553|69202718|FG000|Overall Study|Lack of Efficacy|1|||
37724117|NCT02035553|69202719|FG001|Overall Study|Lack of Efficacy|1|||
37724118|NCT02035553|69202718|FG000|Overall Study|Withdrawal by Subject|4|||
37724119|NCT02035553|69202719|FG001|Overall Study|Withdrawal by Subject|7|||
37724120|NCT02035553|69202718|FG000|Overall Study|Non-compliance with Study Drug|0|||
37724121|NCT02035553|69202719|FG001|Overall Study|Non-compliance with Study Drug|1|||
37724122|NCT02035553|69202718|FG000|Overall Study|Lost to Follow-up|0|||
37724123|NCT02035553|69202719|FG001|Overall Study|Lost to Follow-up|1|||
37724124|NCT02035553|69202718|FG000|Overall Study|Other Reason|0|||
37724125|NCT02035553|69202719|FG001|Overall Study|Other Reason|4|||
37724126|NCT01445080|69202734|FG000|Overall Study|Adverse Event|5|||
37724127|NCT01445080|69202735|FG001|Overall Study|Adverse Event|3|||
37724128|NCT01445080|69202736|FG002|Overall Study|Adverse Event|11|||
37724129|NCT01445080|69202737|FG003|Overall Study|Adverse Event|6|||
37724130|NCT01445080|69202738|FG004|Overall Study|Adverse Event|2|||
37724131|NCT01445080|69202739|FG005|Overall Study|Adverse Event|3|||
37724132|NCT01445080|69202740|FG006|Overall Study|Adverse Event|0|||
37724133|NCT01445080|69202741|FG007|Overall Study|Adverse Event|3|||
37724134|NCT01445080|69202742|FG008|Overall Study|Adverse Event|10|||
37724135|NCT01445080|69202734|FG000|Overall Study|Physician Decision|0|||
37724136|NCT01445080|69202735|FG001|Overall Study|Physician Decision|0|||
37724137|NCT01445080|69202736|FG002|Overall Study|Physician Decision|1|||
37724138|NCT01445080|69202737|FG003|Overall Study|Physician Decision|0|||
37724139|NCT01445080|69202738|FG004|Overall Study|Physician Decision|0|||
37724140|NCT01445080|69202739|FG005|Overall Study|Physician Decision|3|||
37724141|NCT01445080|69202740|FG006|Overall Study|Physician Decision|2|||
37724142|NCT01445080|69202741|FG007|Overall Study|Physician Decision|2|||
37724143|NCT01445080|69202742|FG008|Overall Study|Physician Decision|0|||
37724144|NCT01445080|69202734|FG000|Overall Study|Withdrawal by Subject|1|||
37724145|NCT01445080|69202735|FG001|Overall Study|Withdrawal by Subject|0|||
37724146|NCT01445080|69202736|FG002|Overall Study|Withdrawal by Subject|0|||
37724147|NCT01445080|69202737|FG003|Overall Study|Withdrawal by Subject|1|||
37724148|NCT01445080|69202738|FG004|Overall Study|Withdrawal by Subject|0|||
37724149|NCT01445080|69202739|FG005|Overall Study|Withdrawal by Subject|0|||
37724150|NCT01445080|69202740|FG006|Overall Study|Withdrawal by Subject|0|||
37724151|NCT01445080|69202741|FG007|Overall Study|Withdrawal by Subject|0|||
37724152|NCT01445080|69202742|FG008|Overall Study|Withdrawal by Subject|2|||
37724153|NCT01445080|69202734|FG000|Overall Study|Ineligible/Inevaluable|1|||
37724154|NCT01445080|69202735|FG001|Overall Study|Ineligible/Inevaluable|2|||
37724155|NCT01445080|69202736|FG002|Overall Study|Ineligible/Inevaluable|0|||
37724156|NCT01445080|69202737|FG003|Overall Study|Ineligible/Inevaluable|1|||
37724157|NCT01445080|69202738|FG004|Overall Study|Ineligible/Inevaluable|2|||
37724158|NCT01445080|69202739|FG005|Overall Study|Ineligible/Inevaluable|3|||
37724159|NCT01445080|69202740|FG006|Overall Study|Ineligible/Inevaluable|0|||
37724160|NCT01445080|69202741|FG007|Overall Study|Ineligible/Inevaluable|0|||
37724161|NCT01445080|69202742|FG008|Overall Study|Ineligible/Inevaluable|6|||
37724162|NCT02035475|69202777|FG000|Overall Study|Withdrawal by Subject|4|||
37724163|NCT02035475|69202777|FG000|Overall Study|Physician Decision|1|||
37724164|NCT02035475|69202777|FG000|Overall Study|Equipment Error|1|||
37724165|NCT01444456|69202783|FG000|Overall Study|Withdrawal by Subject|21|||
37724166|NCT01444456|69202783|FG000|Overall Study|Physician Decision|9|||
37724167|NCT01444456|69202783|FG000|Overall Study|Lost to Follow-up|37|||
37724168|NCT01444456|69202783|FG000|Overall Study|Death|73|||
37724169|NCT01444456|69202783|FG000|Overall Study|Ineligibility determined|23|||
37724170|NCT01444456|69202783|FG000|Overall Study|Other|18|||
37724171|NCT01444456|69202783|FG000|Overall Study|Not treated|104|||
37724172|NCT01438294|69202789|FG000|Overall Study|Lost to Follow-up|3|||
37724173|NCT01438294|69202790|FG001|Overall Study|Lost to Follow-up|7|||
37724174|NCT02033759|69202798|FG000|Overall Study|Withdrawal by Subject|2|||
37724175|NCT02033759|69202799|FG001|Overall Study|Withdrawal by Subject|1|||
37724176|NCT02033759|69202798|FG000|Overall Study|Protocol Violation|1|||
37724177|NCT02033759|69202799|FG001|Overall Study|Protocol Violation|1|||
37724178|NCT01959529|69202807|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
37724179|NCT01959529|69202808|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
37724180|NCT01959529|69202807|FG000|Overall Study|Lost to Follow-up|4|||
37724181|NCT01959529|69202808|FG001|Overall Study|Lost to Follow-up|1|||
37724182|NCT01959529|69202807|FG000|Overall Study|Other|70|||
37724183|NCT01959529|69202808|FG001|Overall Study|Other|68|||
37724184|NCT01959529|69202807|FG000|Overall Study|Hypoglycaemia|1|||
37724185|NCT01959529|69202808|FG001|Overall Study|Hypoglycaemia|1|||
37724186|NCT01959529|69202807|FG000|Overall Study|Lack of glycaemic control|1|||
37724187|NCT01959529|69202808|FG001|Overall Study|Lack of glycaemic control|1|||
37724188|NCT02033369|69202816|FG000|Overall Study|Physician Decision|1|||
37724189|NCT02033369|69202817|FG001|Overall Study|Physician Decision|2|||
37724190|NCT02033369|69202816|FG000|Overall Study|Not a good demographic match|0|||
37724191|NCT02033369|69202817|FG001|Overall Study|Not a good demographic match|2|||
37724192|NCT02033369|69202816|FG000|Overall Study|Withdrawal by Subject|1|||
37724193|NCT02033369|69202817|FG001|Overall Study|Withdrawal by Subject|1|||
37724194|NCT02033369|69202816|FG000|Overall Study|Lost to Follow-up|1|||
37724195|NCT02033369|69202817|FG001|Overall Study|Lost to Follow-up|0|||
37724196|NCT02033369|69202816|FG000|Overall Study|Protocol Violation|2|||
37724197|NCT02033369|69202817|FG001|Overall Study|Protocol Violation|0|||
37724198|NCT02032901|69202823|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
37724199|NCT02032901|69202824|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
37724200|NCT02032901|69202823|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
37724201|NCT02032901|69202824|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
37724202|NCT02020967|69202834|FG000|Overall Study|Withdrawal by Subject|51|||
37724203|NCT01986829|69202840|FG000|Overall Study|Death|1|||
37724204|NCT01986751|69202849|FG000|Overall Study|improperly consented|10|||
37724205|NCT01986751|69202850|FG001|Overall Study|improperly consented|2|||
37724206|NCT02004847|69202862|FG000|Overall Study|Protocol Violation|1|||
37724207|NCT02004847|69202863|FG001|Overall Study|Protocol Violation|1|||
37724208|NCT01438060|69202880|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
37724209|NCT01438060|69202881|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
37724210|NCT01438060|69202880|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
37724211|NCT01438060|69202881|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
37841025|NCT00479466|69525292|FG000|Overall Study|Lack of Efficacy|2|||
37841026|NCT00479466|69525293|FG001|Overall Study|Lack of Efficacy|0|||
37841027|NCT00479466|69525294|FG002|Overall Study|Lack of Efficacy|1|||
37841028|NCT00479466|69525295|FG003|Overall Study|Lack of Efficacy|0|||
37841029|NCT00479466|69525296|FG004|Overall Study|Lack of Efficacy|0|||
37841030|NCT00479466|69525297|FG005|Overall Study|Lack of Efficacy|0|||
37841031|NCT00479466|69525292|FG000|Overall Study|Lost to Follow-up|0|||
37841032|NCT00479466|69525293|FG001|Overall Study|Lost to Follow-up|1|||
37841033|NCT00479466|69525294|FG002|Overall Study|Lost to Follow-up|1|||
37724212|NCT01438060|69202880|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
37724213|NCT01438060|69202881|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
37724214|NCT01438060|69202880|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
37724215|NCT01438060|69202881|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
37724216|NCT01438060|69202880|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
37841034|NCT00479466|69525295|FG003|Overall Study|Lost to Follow-up|0|||
37841035|NCT00479466|69525296|FG004|Overall Study|Lost to Follow-up|2|||
37724217|NCT01438060|69202881|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
37841036|NCT00479466|69525297|FG005|Overall Study|Lost to Follow-up|2|||
37841037|NCT00479466|69525292|FG000|Overall Study|Physician Decision|2|||
37841038|NCT00479466|69525293|FG001|Overall Study|Physician Decision|1|||
37841039|NCT00479466|69525294|FG002|Overall Study|Physician Decision|1|||
37841040|NCT00479466|69525295|FG003|Overall Study|Physician Decision|0|||
37841041|NCT00479466|69525296|FG004|Overall Study|Physician Decision|0|||
37841042|NCT00479466|69525297|FG005|Overall Study|Physician Decision|0|||
37841043|NCT00479466|69525292|FG000|Overall Study|Pregnancy|0|||
37841044|NCT00479466|69525293|FG001|Overall Study|Pregnancy|0|||
37841045|NCT00479466|69525294|FG002|Overall Study|Pregnancy|0|||
37841046|NCT00479466|69525295|FG003|Overall Study|Pregnancy|0|||
37841047|NCT00479466|69525296|FG004|Overall Study|Pregnancy|1|||
37841048|NCT00479466|69525297|FG005|Overall Study|Pregnancy|0|||
37841049|NCT00479466|69525292|FG000|Overall Study|Protocol Violation|1|||
37841050|NCT00479466|69525293|FG001|Overall Study|Protocol Violation|0|||
38025270|NCT04322682|69709544|FG000|Overall Study|Death|5|||
37841051|NCT00479466|69525294|FG002|Overall Study|Protocol Violation|0|||
37841052|NCT00479466|69525295|FG003|Overall Study|Protocol Violation|0|||
37841053|NCT00479466|69525296|FG004|Overall Study|Protocol Violation|0|||
37841054|NCT00479466|69525297|FG005|Overall Study|Protocol Violation|0|||
37841055|NCT00479466|69525292|FG000|Overall Study|Withdrawal by Subject|3|||
37841056|NCT00479466|69525293|FG001|Overall Study|Withdrawal by Subject|5|||
37841057|NCT00479466|69525294|FG002|Overall Study|Withdrawal by Subject|0|||
37841058|NCT00479466|69525295|FG003|Overall Study|Withdrawal by Subject|2|||
37724218|NCT01438060|69202880|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
37724219|NCT01438060|69202881|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
37724220|NCT01438060|69202880|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
37724221|NCT01438060|69202881|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
37724222|NCT01438060|69202880|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
37724223|NCT01438060|69202881|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
37724224|NCT01438060|69202880|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
37724225|NCT01438060|69202881|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
37724226|NCT01438060|69202880|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
37724227|NCT01438060|69202881|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
37724228|NCT01438060|69202880|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
37724229|NCT01438060|69202881|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
37724230|NCT01438060|69202880|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
37724231|NCT01438060|69202881|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
37724232|NCT01438060|69202880|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
37724233|NCT01438060|69202881|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
37724234|NCT01438060|69202880|FG000|On Study Beyond Week 140|Adverse Event|0|||
37724235|NCT01438060|69202881|FG001|On Study Beyond Week 140|Adverse Event|2|||
37724236|NCT01438060|69202880|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
37724237|NCT01438060|69202881|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
37724238|NCT01438060|69202880|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
37724239|NCT01438060|69202881|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
37724240|NCT01438060|69202880|FG000|On Study Beyond Week 140|Death|0|||
37724241|NCT01438060|69202881|FG001|On Study Beyond Week 140|Death|1|||
37724242|NCT01438060|69202880|FG000|On Study Beyond Week 140|Other Reason|0|||
37724243|NCT01438060|69202881|FG001|On Study Beyond Week 140|Other Reason|3|||
37724244|NCT01469182|69202894|FG000|Overall Study|Adverse Event|21|||
37724245|NCT01469182|69202895|FG001|Overall Study|Adverse Event|3|||
37724246|NCT01469182|69202894|FG000|Overall Study|Lost to Follow-up|3|||
37724247|NCT01469182|69202895|FG001|Overall Study|Lost to Follow-up|0|||
37724248|NCT01469182|69202894|FG000|Overall Study|Withdrawal by Subject|4|||
37724249|NCT01469182|69202895|FG001|Overall Study|Withdrawal by Subject|1|||
37724250|NCT01469182|69202894|FG000|Overall Study|Protocol Violation|4|||
37724251|NCT01469182|69202895|FG001|Overall Study|Protocol Violation|2|||
37724252|NCT01469182|69202894|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
37724253|NCT01469182|69202895|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
37724254|NCT01444378|69202901|FG000|Overall Study|Lost to Follow-up|1|||
37724255|NCT01444378|69202901|FG000|Overall Study|Withdrawal by Subject|1|||
37724256|NCT01444378|69202901|FG000|Overall Study|Death|3|||
37724257|NCT01444378|69202901|FG000|Overall Study|Administrative Closure Of The Study|2|||
38025271|NCT04322682|69709545|FG001|Overall Study|Death|9|||
38025272|NCT04322682|69709544|FG000|Overall Study|Lost to Follow-up|4|||
38025273|NCT04322682|69709545|FG001|Overall Study|Lost to Follow-up|8|||
37724258|NCT01444378|69202901|FG000|Overall Study|Missed Visits|10|||
37724259|NCT02020889|69202910|FG000|Overall Study|Adverse Event|0|||
37724260|NCT02020889|69202911|FG001|Overall Study|Adverse Event|1|||
37841059|NCT00479466|69525296|FG004|Overall Study|Withdrawal by Subject|3|||
37841060|NCT00479466|69525297|FG005|Overall Study|Withdrawal by Subject|1|||
38025274|NCT04322682|69709544|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
37841061|NCT00479388|69525313|FG000|Overall Study|Adverse Event|90|||
38025275|NCT04322682|69709545|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
37841062|NCT00479388|69525314|FG001|Overall Study|Adverse Event|45|||
37724261|NCT02020889|69202910|FG000|Overall Study|Lack of Efficacy|1|||
37724262|NCT02020889|69202911|FG001|Overall Study|Lack of Efficacy|0|||
37724263|NCT02020889|69202910|FG000|Overall Study|Lost to Follow-up|1|||
37724264|NCT02020889|69202911|FG001|Overall Study|Lost to Follow-up|0|||
37724265|NCT02020889|69202910|FG000|Overall Study|Physician Decision|2|||
37724266|NCT02020889|69202911|FG001|Overall Study|Physician Decision|0|||
37724267|NCT02020889|69202910|FG000|Overall Study|Withdrawal by Subject|3|||
37724268|NCT02020889|69202911|FG001|Overall Study|Withdrawal by Subject|2|||
37724269|NCT01444300|69202919|FG000|Overall Study|Adverse Event|4|||
37724270|NCT01444300|69202920|FG001|Overall Study|Adverse Event|0|||
37724271|NCT01443364|69202927|FG000|Overall Study|Lack of Efficacy|14|||
37724272|NCT01443364|69202927|FG000|Overall Study|Lost to Follow-up|3|||
37724273|NCT01443364|69202927|FG000|Overall Study|Withdrawal by Subject|5|||
37724274|NCT01443364|69202927|FG000|Overall Study|Other Reason|4|||
37724275|NCT01443364|69202927|FG000|Overall Study|SAE, non-fatal|6|||
37724276|NCT01443364|69202927|FG000|Overall Study|AE, non-serious non-fatal|8|||
37724277|NCT01443364|69202927|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
37724278|NCT02020577|69202933|FG000|Overall Study|Progressive disease|3|||
37724279|NCT02020577|69202934|FG001|Overall Study|Progressive disease|38|||
37724280|NCT02020577|69202933|FG000|Overall Study|Other AE or clinical progression|0|||
37724281|NCT02020577|69202934|FG001|Overall Study|Other AE or clinical progression|15|||
37724282|NCT02020577|69202933|FG000|Overall Study|Withdrawal by Subject|0|||
37724283|NCT02020577|69202934|FG001|Overall Study|Withdrawal by Subject|1|||
37724284|NCT02020577|69202933|FG000|Overall Study|Other than stated above|0|||
37724285|NCT02020577|69202934|FG001|Overall Study|Other than stated above|1|||
37724286|NCT02020031|69202944|FG000|Overall Study|Physician Decision|1|||
37724287|NCT02020031|69202945|FG001|Overall Study|Physician Decision|1|||
37724288|NCT04179305|69202955|FG000|Overall Study|Death|1|||
37724289|NCT04179305|69202956|FG001|Overall Study|Death|1|||
37724290|NCT04179305|69202957|FG002|Overall Study|Death|0|||
37724291|NCT04179305|69202958|FG003|Overall Study|Death|0|||
37724292|NCT04179305|69202955|FG000|Overall Study|Lost to Follow-up|1|||
37724293|NCT04179305|69202956|FG001|Overall Study|Lost to Follow-up|1|||
37724294|NCT04179305|69202957|FG002|Overall Study|Lost to Follow-up|0|||
37724295|NCT04179305|69202958|FG003|Overall Study|Lost to Follow-up|0|||
37724296|NCT04179305|69202955|FG000|Overall Study|Withdrawal by Subject|0|||
37724297|NCT04179305|69202956|FG001|Overall Study|Withdrawal by Subject|1|||
37724298|NCT04179305|69202957|FG002|Overall Study|Withdrawal by Subject|0|||
37724299|NCT04179305|69202958|FG003|Overall Study|Withdrawal by Subject|0|||
37724300|NCT04179305|69202955|FG000|Overall Study|Did not have scan|1|||
37724301|NCT04179305|69202956|FG001|Overall Study|Did not have scan|0|||
37724302|NCT04179305|69202957|FG002|Overall Study|Did not have scan|0|||
37724303|NCT04179305|69202958|FG003|Overall Study|Did not have scan|0|||
37724304|NCT04179305|69202955|FG000|Overall Study|In hospice care|3|||
37724305|NCT04179305|69202956|FG001|Overall Study|In hospice care|0|||
37724306|NCT04179305|69202957|FG002|Overall Study|In hospice care|0|||
37724307|NCT04179305|69202958|FG003|Overall Study|In hospice care|0|||
37724308|NCT02019719|69202974|FG000|Overall Study|Adverse Event|1|||
37724309|NCT02019719|69202975|FG001|Overall Study|Adverse Event|0|||
37724310|NCT02019719|69202976|FG002|Overall Study|Adverse Event|0|||
37724311|NCT02019719|69202977|FG003|Overall Study|Adverse Event|1|||
37724312|NCT02019719|69202978|FG004|Overall Study|Adverse Event|1|||
37724313|NCT02019719|69202974|FG000|Overall Study|Protocol Violation|1|||
37724314|NCT02019719|69202975|FG001|Overall Study|Protocol Violation|1|||
37724315|NCT02019719|69202976|FG002|Overall Study|Protocol Violation|0|||
37724316|NCT02019719|69202977|FG003|Overall Study|Protocol Violation|0|||
37724317|NCT02019719|69202978|FG004|Overall Study|Protocol Violation|0|||
37724318|NCT02019719|69202974|FG000|Overall Study|Protocol defined stopping criteria|2|||
37724319|NCT02019719|69202975|FG001|Overall Study|Protocol defined stopping criteria|0|||
37724320|NCT02019719|69202976|FG002|Overall Study|Protocol defined stopping criteria|0|||
37724321|NCT02019719|69202977|FG003|Overall Study|Protocol defined stopping criteria|1|||
37724322|NCT02019719|69202978|FG004|Overall Study|Protocol defined stopping criteria|1|||
37724323|NCT02019719|69202974|FG000|Overall Study|Physician Decision|2|||
37724324|NCT02019719|69202975|FG001|Overall Study|Physician Decision|0|||
37724325|NCT02019719|69202976|FG002|Overall Study|Physician Decision|0|||
37724326|NCT02019719|69202977|FG003|Overall Study|Physician Decision|0|||
37724327|NCT02019719|69202978|FG004|Overall Study|Physician Decision|0|||
37724328|NCT02030405|69202997|FG000|Overall Study|Withdrawal by Subject|1|||
37724329|NCT02030405|69202997|FG000|Overall Study|Lost to Follow-up|1|||
37724330|NCT01975376|69203004|FG000|Overall Study|Adverse Event|5|||
37724331|NCT01975376|69203005|FG001|Overall Study|Adverse Event|5|||
37724332|NCT01975376|69203004|FG000|Overall Study|Death|65|||
37724333|NCT01975376|69203005|FG001|Overall Study|Death|72|||
37724334|NCT01975376|69203004|FG000|Overall Study|Lost to Follow-up|70|||
37724335|NCT01975376|69203005|FG001|Overall Study|Lost to Follow-up|66|||
37724336|NCT01975376|69203004|FG000|Overall Study|Withdrew consent|68|||
37724337|NCT01975376|69203005|FG001|Overall Study|Withdrew consent|62|||
37724338|NCT01975376|69203004|FG000|Overall Study|Other|2|||
37724339|NCT01975376|69203005|FG001|Overall Study|Other|4|||
37724340|NCT01975376|69203004|FG000|Overall Study|Randomized, Not Treated|16|||
37724341|NCT01975376|69203005|FG001|Overall Study|Randomized, Not Treated|8|||
37724342|NCT01443130|69203017|FG000|Overall Study|Lost to Follow-up|44|||
37724343|NCT01443130|69203018|FG001|Overall Study|Lost to Follow-up|42|||
37724344|NCT01443130|69203019|FG002|Overall Study|Lost to Follow-up|50|||
37724345|NCT01443130|69203020|FG003|Overall Study|Lost to Follow-up|23|||
37724346|NCT01443130|69203021|FG004|Overall Study|Lost to Follow-up|25|||
37724347|NCT01443130|69203022|FG005|Overall Study|Lost to Follow-up|21|||
37724348|NCT01443130|69203017|FG000|Overall Study|Death|0|||
37724349|NCT01443130|69203018|FG001|Overall Study|Death|1|||
37724350|NCT01443130|69203019|FG002|Overall Study|Death|0|||
37724351|NCT01443130|69203020|FG003|Overall Study|Death|7|||
37724352|NCT01443130|69203021|FG004|Overall Study|Death|10|||
37724353|NCT01443130|69203022|FG005|Overall Study|Death|8|||
37724354|NCT01443130|69203017|FG000|Overall Study|Adverse Event|2|||
37724355|NCT01443130|69203018|FG001|Overall Study|Adverse Event|1|||
37724356|NCT01443130|69203019|FG002|Overall Study|Adverse Event|1|||
37724357|NCT01443130|69203020|FG003|Overall Study|Adverse Event|0|||
37724358|NCT01443130|69203021|FG004|Overall Study|Adverse Event|0|||
37724359|NCT01443130|69203022|FG005|Overall Study|Adverse Event|0|||
37724360|NCT01443130|69203017|FG000|Overall Study|Protocol Violation|2|||
37724361|NCT01443130|69203018|FG001|Overall Study|Protocol Violation|1|||
37724362|NCT01443130|69203019|FG002|Overall Study|Protocol Violation|3|||
37724363|NCT01443130|69203020|FG003|Overall Study|Protocol Violation|2|||
37724364|NCT01443130|69203021|FG004|Overall Study|Protocol Violation|2|||
37724365|NCT01443130|69203022|FG005|Overall Study|Protocol Violation|3|||
37724366|NCT01443130|69203017|FG000|Overall Study|Withdrawal by Subject|15|||
37724367|NCT01443130|69203018|FG001|Overall Study|Withdrawal by Subject|14|||
37724368|NCT01443130|69203019|FG002|Overall Study|Withdrawal by Subject|12|||
37724369|NCT01443130|69203020|FG003|Overall Study|Withdrawal by Subject|7|||
37724370|NCT01443130|69203021|FG004|Overall Study|Withdrawal by Subject|7|||
37724371|NCT01443130|69203022|FG005|Overall Study|Withdrawal by Subject|2|||
37724372|NCT01443130|69203017|FG000|Overall Study|Death of Subject's Infant|5|||
37841063|NCT00479388|69525313|FG000|Overall Study|Lost to Follow-up|0|||
37841064|NCT00479388|69525314|FG001|Overall Study|Lost to Follow-up|2|||
37841065|NCT00479388|69525313|FG000|Overall Study|Protocol Violation|10|||
37841066|NCT00479388|69525314|FG001|Overall Study|Protocol Violation|9|||
37724373|NCT01443130|69203018|FG001|Overall Study|Death of Subject's Infant|10|||
37724374|NCT01443130|69203019|FG002|Overall Study|Death of Subject's Infant|11|||
37724375|NCT01443130|69203020|FG003|Overall Study|Death of Subject's Infant|0|||
37724376|NCT01443130|69203021|FG004|Overall Study|Death of Subject's Infant|0|||
37724377|NCT01443130|69203022|FG005|Overall Study|Death of Subject's Infant|0|||
37724378|NCT01436500|69203038|FG000|Overall Study|Death|1|||
37724379|NCT01436500|69203039|FG001|Overall Study|Death|0|||
37724380|NCT01436500|69203040|FG002|Overall Study|Death|0|||
37724381|NCT01436500|69203041|FG003|Overall Study|Death|0|||
37724382|NCT01436500|69203042|FG004|Overall Study|Death|0|||
37724383|NCT01436500|69203038|FG000|Overall Study|Adverse Event|0|||
37724384|NCT01436500|69203039|FG001|Overall Study|Adverse Event|2|||
37724385|NCT01436500|69203040|FG002|Overall Study|Adverse Event|2|||
37724386|NCT01436500|69203041|FG003|Overall Study|Adverse Event|0|||
37724387|NCT01436500|69203042|FG004|Overall Study|Adverse Event|1|||
37724388|NCT01436500|69203038|FG000|Overall Study|Withdrawal by Subject|0|||
37724389|NCT01436500|69203039|FG001|Overall Study|Withdrawal by Subject|0|||
37724390|NCT01436500|69203040|FG002|Overall Study|Withdrawal by Subject|2|||
37724391|NCT01436500|69203041|FG003|Overall Study|Withdrawal by Subject|0|||
37724392|NCT01436500|69203042|FG004|Overall Study|Withdrawal by Subject|2|||
37724393|NCT01436500|69203038|FG000|Overall Study|Physician Decision|0|||
37724394|NCT01436500|69203039|FG001|Overall Study|Physician Decision|0|||
37724395|NCT01436500|69203040|FG002|Overall Study|Physician Decision|1|||
37724396|NCT01436500|69203041|FG003|Overall Study|Physician Decision|0|||
37724397|NCT01436500|69203042|FG004|Overall Study|Physician Decision|0|||
37841067|NCT00479388|69525313|FG000|Overall Study|Withdrawal by Subject|32|||
37724398|NCT01436500|69203038|FG000|Overall Study|liver transplant|1|||
37724399|NCT01436500|69203039|FG001|Overall Study|liver transplant|0|||
37724400|NCT01436500|69203040|FG002|Overall Study|liver transplant|0|||
37724401|NCT01436500|69203041|FG003|Overall Study|liver transplant|0|||
37724402|NCT01436500|69203042|FG004|Overall Study|liver transplant|0|||
37724403|NCT01436500|69203038|FG000|Overall Study|initiation of dialysis|0|||
37724404|NCT01436500|69203039|FG001|Overall Study|initiation of dialysis|0|||
37724405|NCT01436500|69203040|FG002|Overall Study|initiation of dialysis|0|||
37724406|NCT01436500|69203041|FG003|Overall Study|initiation of dialysis|0|||
37724407|NCT01436500|69203042|FG004|Overall Study|initiation of dialysis|1|||
37724408|NCT01436500|69203038|FG000|Overall Study|discontinued study drug|1|||
37724409|NCT01436500|69203039|FG001|Overall Study|discontinued study drug|0|||
37724410|NCT01436500|69203040|FG002|Overall Study|discontinued study drug|0|||
37724411|NCT01436500|69203041|FG003|Overall Study|discontinued study drug|0|||
37724412|NCT01436500|69203042|FG004|Overall Study|discontinued study drug|0|||
37724413|NCT01436500|69203038|FG000|Overall Study|Other|0|||
37724414|NCT01436500|69203039|FG001|Overall Study|Other|1|||
37724415|NCT01436500|69203040|FG002|Overall Study|Other|0|||
37724416|NCT01436500|69203041|FG003|Overall Study|Other|1|||
37841068|NCT00479388|69525314|FG001|Overall Study|Withdrawal by Subject|17|||
37724417|NCT01436500|69203042|FG004|Overall Study|Other|0|||
37724418|NCT01958827|69203055|FG000|Overall Study|Adverse Event|3|||
37724419|NCT01958827|69203055|FG000|Overall Study|Lack of Efficacy|6|||
37724420|NCT01958827|69203055|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
37724421|NCT01620086|69203061|FG000|Overall Study|Withdrawal by Subject|3|||
37724422|NCT01620086|69203062|FG001|Overall Study|Withdrawal by Subject|3|||
37841069|NCT00479232|69525322|FG000|Overall Study|Adverse Event|0|||
37724423|NCT01620086|69203063|FG002|Overall Study|Withdrawal by Subject|0|||
37724424|NCT01620086|69203061|FG000|Overall Study|failed study criteria|1|||
37724425|NCT01620086|69203062|FG001|Overall Study|failed study criteria|4|||
37724426|NCT01620086|69203063|FG002|Overall Study|failed study criteria|0|||
37724427|NCT01620086|69203061|FG000|Overall Study|Physician Decision|1|||
37724428|NCT01620086|69203062|FG001|Overall Study|Physician Decision|0|||
37724429|NCT01620086|69203063|FG002|Overall Study|Physician Decision|0|||
37724430|NCT01436110|69203075|FG000|Overall Study|Lack of Efficacy|23|||
37724431|NCT01436110|69203076|FG001|Overall Study|Lack of Efficacy|14|||
37724432|NCT01436110|69203077|FG002|Overall Study|Lack of Efficacy|9|||
37724433|NCT01436110|69203075|FG000|Overall Study|Withdrawal by Subject|6|||
37724434|NCT01436110|69203076|FG001|Overall Study|Withdrawal by Subject|8|||
37724435|NCT01436110|69203077|FG002|Overall Study|Withdrawal by Subject|4|||
37724436|NCT01436110|69203075|FG000|Overall Study|Adverse Event|2|||
37841070|NCT00479232|69525323|FG001|Overall Study|Adverse Event|0|||
37841071|NCT00479232|69525324|FG002|Overall Study|Adverse Event|5|||
37841072|NCT00479232|69525325|FG003|Overall Study|Adverse Event|0|||
37841073|NCT00479232|69525326|FG004|Overall Study|Adverse Event|0|||
37841074|NCT00479232|69525327|FG005|Overall Study|Adverse Event|10|||
37841075|NCT00479232|69525322|FG000|Overall Study|Deviation from Protocol|0|||
37841076|NCT00479232|69525323|FG001|Overall Study|Deviation from Protocol|0|||
37841077|NCT00479232|69525324|FG002|Overall Study|Deviation from Protocol|1|||
37841078|NCT00479232|69525325|FG003|Overall Study|Deviation from Protocol|0|||
37841079|NCT00479232|69525326|FG004|Overall Study|Deviation from Protocol|0|||
37841080|NCT00479232|69525327|FG005|Overall Study|Deviation from Protocol|0|||
37841081|NCT00479232|69525322|FG000|Overall Study|Lack of Efficacy|0|||
37841082|NCT00479232|69525323|FG001|Overall Study|Lack of Efficacy|0|||
37841083|NCT00479232|69525324|FG002|Overall Study|Lack of Efficacy|2|||
37841084|NCT00479232|69525325|FG003|Overall Study|Lack of Efficacy|0|||
37841085|NCT00479232|69525326|FG004|Overall Study|Lack of Efficacy|0|||
37841086|NCT00479232|69525327|FG005|Overall Study|Lack of Efficacy|4|||
37841087|NCT00479232|69525322|FG000|Overall Study|Physician Decision|0|||
37915658|NCT00577720|69602435|FG000|Overall Study|Withdrawal by Subject|2|||
37915659|NCT00577720|69602436|FG001|Overall Study|Withdrawal by Subject|0|||
37915660|NCT00577720|69602437|FG002|Overall Study|Withdrawal by Subject|0|||
37915661|NCT00577720|69602438|FG003|Overall Study|Withdrawal by Subject|2|||
37915662|NCT00519649|69602448|FG000|Overall Study|Withdrawal by Subject|1|||
37915663|NCT00512707|69602466|FG000|Overall Study|Lost to Follow-up|5|||
37915664|NCT00512707|69602467|FG001|Overall Study|Lost to Follow-up|11|||
37915665|NCT00512707|69602466|FG000|Overall Study|Developed skin irritation|2|||
37841088|NCT00479232|69525323|FG001|Overall Study|Physician Decision|0|||
37841089|NCT00479232|69525324|FG002|Overall Study|Physician Decision|2|||
37724437|NCT01436110|69203076|FG001|Overall Study|Adverse Event|1|||
37841090|NCT00479232|69525325|FG003|Overall Study|Physician Decision|0|||
37915666|NCT00512707|69602467|FG001|Overall Study|Developed skin irritation|1|||
37915667|NCT00512707|69602466|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
37841091|NCT00479232|69525326|FG004|Overall Study|Physician Decision|0|||
37724438|NCT01436110|69203077|FG002|Overall Study|Adverse Event|2|||
37724439|NCT01436110|69203075|FG000|Overall Study|Physician Decision|3|||
37724440|NCT01436110|69203076|FG001|Overall Study|Physician Decision|1|||
37724441|NCT01436110|69203077|FG002|Overall Study|Physician Decision|1|||
37724442|NCT01436110|69203075|FG000|Overall Study|Lost to Follow-up|1|||
37724443|NCT01436110|69203076|FG001|Overall Study|Lost to Follow-up|1|||
37724444|NCT01436110|69203077|FG002|Overall Study|Lost to Follow-up|3|||
37724445|NCT01436110|69203075|FG000|Overall Study|Protocol Violation|3|||
37724446|NCT01436110|69203076|FG001|Overall Study|Protocol Violation|1|||
37724447|NCT01436110|69203077|FG002|Overall Study|Protocol Violation|1|||
37724448|NCT01436110|69203075|FG000|Overall Study|Did Not Receive Trial Medication|1|||
37724449|NCT01436110|69203076|FG001|Overall Study|Did Not Receive Trial Medication|0|||
37724450|NCT01436110|69203077|FG002|Overall Study|Did Not Receive Trial Medication|3|||
37724451|NCT01619852|69203087|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
37724452|NCT01619852|69203088|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
37724453|NCT01619852|69203087|FG000|3 Month Follow up|Lost to Follow-up|31|||
37724454|NCT01619852|69203088|FG001|3 Month Follow up|Lost to Follow-up|34|||
37724455|NCT02000882|69203095|FG000|Overall Study|Adverse Event|3|||
37724456|NCT02000882|69203095|FG000|Overall Study|Physician Decision|2|||
37724457|NCT02000882|69203095|FG000|Overall Study|Withdrawal by Subject|1|||
37724458|NCT01965938|69203101|FG000|Overall Study|Withdrawal by Subject|1|||
37724459|NCT01965938|69203102|FG001|Overall Study|Withdrawal by Subject|0|||
37724460|NCT01965860|69203113|FG000|Overall Study|Pregnancy|1|||
37724461|NCT01965860|69203114|FG001|Overall Study|Pregnancy|0|||
37724462|NCT01965860|69203115|FG002|Overall Study|Pregnancy|1|||
37724463|NCT01965860|69203113|FG000|Overall Study|Logistics|1|||
37724464|NCT01965860|69203114|FG001|Overall Study|Logistics|0|||
37724465|NCT01965860|69203115|FG002|Overall Study|Logistics|0|||
37724466|NCT01965704|69203136|FG000|Overall Study|Withdrawal by Subject|2|||
37724467|NCT01965704|69203137|FG001|Overall Study|Withdrawal by Subject|2|||
37724468|NCT01965704|69203138|FG002|Overall Study|Withdrawal by Subject|1|||
37724469|NCT01965704|69203139|FG003|Overall Study|Withdrawal by Subject|1|||
37841092|NCT00479232|69525327|FG005|Overall Study|Physician Decision|1|||
37841093|NCT00479232|69525322|FG000|Overall Study|Progressive Disease|3|||
37724470|NCT01965704|69203136|FG000|Overall Study|Delivered at home|1|||
37724471|NCT01965704|69203137|FG001|Overall Study|Delivered at home|1|||
37724472|NCT01965704|69203138|FG002|Overall Study|Delivered at home|0|||
37724473|NCT01965704|69203139|FG003|Overall Study|Delivered at home|0|||
37724474|NCT01965704|69203136|FG000|Overall Study|Experienced complications|0|||
37724475|NCT01965704|69203137|FG001|Overall Study|Experienced complications|0|||
37724476|NCT01965704|69203138|FG002|Overall Study|Experienced complications|2|||
37724477|NCT01965704|69203139|FG003|Overall Study|Experienced complications|2|||
37841094|NCT00479232|69525323|FG001|Overall Study|Progressive Disease|1|||
37841095|NCT00479232|69525324|FG002|Overall Study|Progressive Disease|12|||
37724478|NCT01965704|69203136|FG000|Overall Study|Adverse Event|0|||
37724479|NCT01965704|69203137|FG001|Overall Study|Adverse Event|0|||
37724480|NCT01965704|69203138|FG002|Overall Study|Adverse Event|1|||
37724481|NCT01965704|69203139|FG003|Overall Study|Adverse Event|1|||
37724482|NCT01965704|69203136|FG000|Overall Study|Did not meet inclusion criteria|0|||
37724483|NCT01965704|69203137|FG001|Overall Study|Did not meet inclusion criteria|0|||
37724484|NCT01965704|69203138|FG002|Overall Study|Did not meet inclusion criteria|1|||
37724485|NCT01965704|69203139|FG003|Overall Study|Did not meet inclusion criteria|1|||
37724486|NCT02003365|69203150|FG000|Overall Study|Lost to Follow-up|0|||
37724487|NCT02003365|69203151|FG001|Overall Study|Lost to Follow-up|0|||
37724488|NCT02003365|69203152|FG002|Overall Study|Lost to Follow-up|1|||
37724489|NCT01975220|69203163|FG000|Test Period 1|Not treated|0|||
37724490|NCT01975220|69203164|FG001|Test Period 1|Not treated|1|||
37724491|NCT01975220|69203165|FG002|Test Period 1|Not treated|0|||
37724492|NCT01975220|69203166|FG003|Test Period 1|Not treated|0|||
37724493|NCT01975220|69203167|FG004|Test Period 1|Not treated|0|||
37724494|NCT01975220|69203168|FG005|Test Period 1|Not treated|0|||
37724495|NCT01958437|69203185|FG000|Overall Study|Incidental MRI findings|0|||
37724496|NCT01958437|69203186|FG001|Overall Study|Incidental MRI findings|0|||
37724497|NCT01958437|69203187|FG002|Overall Study|Incidental MRI findings|1|||
37724498|NCT01958437|69203188|FG003|Overall Study|Incidental MRI findings|1|||
37724499|NCT01974752|69203207|FG000|Overall Study|Death|33|||
37724500|NCT01974752|69203208|FG001|Overall Study|Death|11|||
37724501|NCT01974752|69203207|FG000|Overall Study|Lost to Follow-up|2|||
37724502|NCT01974752|69203208|FG001|Overall Study|Lost to Follow-up|0|||
37724503|NCT01974752|69203207|FG000|Overall Study|Withdrawal by Subject|2|||
37724504|NCT01974752|69203208|FG001|Overall Study|Withdrawal by Subject|3|||
37724505|NCT01974752|69203207|FG000|Overall Study|Other Eligibility Criteria|0|||
37724506|NCT01974752|69203208|FG001|Overall Study|Other Eligibility Criteria|1|||
37724507|NCT01999946|69203217|FG000|Overall Study|Participant not released from jail|2|||
37724508|NCT01999946|69203218|FG001|Overall Study|Participant not released from jail|2|||
37724509|NCT01999946|69203219|FG002|Overall Study|Participant not released from jail|0|||
37724510|NCT01999946|69203217|FG000|Overall Study|Not included in primary outcome analysis|0|||
37724511|NCT01999946|69203218|FG001|Overall Study|Not included in primary outcome analysis|0|||
37724512|NCT01999946|69203219|FG002|Overall Study|Not included in primary outcome analysis|79|||
37724513|NCT01958281|69203229|FG000|Overall Study|Lack of Efficacy|5|||
37724514|NCT01958281|69203230|FG001|Overall Study|Lack of Efficacy|2|||
37724515|NCT01958281|69203231|FG002|Overall Study|Lack of Efficacy|0|||
37724516|NCT01958281|69203229|FG000|Overall Study|Adverse Event|0|||
37724517|NCT01958281|69203230|FG001|Overall Study|Adverse Event|2|||
37724518|NCT01958281|69203231|FG002|Overall Study|Adverse Event|0|||
37724519|NCT01958281|69203229|FG000|Overall Study|Withdrew Consent|1|||
37724520|NCT01958281|69203230|FG001|Overall Study|Withdrew Consent|0|||
37724521|NCT01958281|69203231|FG002|Overall Study|Withdrew Consent|0|||
37724522|NCT01958125|69203242|FG000|Overall Study|Missing diary data|2|||
37724523|NCT01958125|69203243|FG001|Overall Study|Missing diary data|6|||
37724524|NCT01958125|69203242|FG000|Overall Study|No headache attacks|0|||
37724525|NCT01958125|69203243|FG001|Overall Study|No headache attacks|2|||
37724526|NCT02002975|69203249|FG000|Overall Study|Case Report Forms Uncollected|135|||
37724527|NCT02002975|69203249|FG000|Overall Study|Protocol Deviation|437|||
37724528|NCT02001181|69203255|FG000|Overall Study|Adverse Event|0|||
37724529|NCT02001181|69203256|FG001|Overall Study|Adverse Event|2|||
37724530|NCT02001181|69203255|FG000|Overall Study|Lost to Follow-up|1|||
37724531|NCT02001181|69203256|FG001|Overall Study|Lost to Follow-up|0|||
37724532|NCT02001181|69203255|FG000|Overall Study|Withdrawal by Subject|0|||
37724533|NCT02001181|69203256|FG001|Overall Study|Withdrawal by Subject|1|||
37724534|NCT01999465|69203264|FG000|Overall Study|Lost to Follow-up|0|||
37724535|NCT01999465|69203265|FG001|Overall Study|Lost to Follow-up|2|||
37724536|NCT01999465|69203264|FG000|Overall Study|Protocol Violation|0|||
37841096|NCT00479232|69525325|FG003|Overall Study|Progressive Disease|3|||
37841097|NCT00479232|69525326|FG004|Overall Study|Progressive Disease|3|||
37841098|NCT00479232|69525327|FG005|Overall Study|Progressive Disease|12|||
37841099|NCT00479232|69525322|FG000|Overall Study|Withdrew Consent|0|||
37841100|NCT00479232|69525323|FG001|Overall Study|Withdrew Consent|2|||
37841101|NCT00479232|69525324|FG002|Overall Study|Withdrew Consent|6|||
37841102|NCT00479232|69525325|FG003|Overall Study|Withdrew Consent|0|||
37724537|NCT01999465|69203265|FG001|Overall Study|Protocol Violation|1|||
37724538|NCT01982773|69203273|FG000|Overall Study|Withdrawal by Subject|1|||
37724539|NCT01982773|69203274|FG001|Overall Study|Withdrawal by Subject|3|||
37724540|NCT01982773|69203273|FG000|Overall Study|Lost to Follow-up|7|||
37724541|NCT01982773|69203274|FG001|Overall Study|Lost to Follow-up|1|||
37724542|NCT01974206|69203282|FG000|Overall Study|Did Not Take Study Drug|0|||
37724543|NCT01974206|69203283|FG001|Overall Study|Did Not Take Study Drug|1|||
37724544|NCT01974206|69203282|FG000|Overall Study|Physician Decision|1|||
37724545|NCT01974206|69203283|FG001|Overall Study|Physician Decision|0|||
37724546|NCT01974206|69203282|FG000|Overall Study|Withdrawal by Subject|3|||
37841103|NCT00479232|69525326|FG004|Overall Study|Withdrew Consent|1|||
37841104|NCT00479232|69525327|FG005|Overall Study|Withdrew Consent|3|||
37724547|NCT01974206|69203283|FG001|Overall Study|Withdrawal by Subject|0|||
37724548|NCT01974206|69203282|FG000|Overall Study|Lost to Follow-up|1|||
37724549|NCT01974206|69203283|FG001|Overall Study|Lost to Follow-up|0|||
37724550|NCT01974206|69203282|FG000|Overall Study|Death|1|||
37724551|NCT01974206|69203283|FG001|Overall Study|Death|0|||
37724552|NCT01999868|69203292|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
37724553|NCT01999868|69203293|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
37724554|NCT01999868|69203294|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
37724555|NCT01999868|69203292|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
37724556|NCT01999868|69203293|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
37724557|NCT01999868|69203294|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
37724558|NCT01999868|69203292|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
37724559|NCT01999868|69203293|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
37724560|NCT01999868|69203294|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
37724561|NCT01999868|69203292|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
37724562|NCT01999868|69203293|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
37724563|NCT01999868|69203294|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
37724564|NCT01999868|69203292|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
37724565|NCT01999868|69203293|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
37724566|NCT01999868|69203294|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
37724567|NCT01999868|69203292|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
37724568|NCT01999868|69203293|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
37724569|NCT01999868|69203294|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
37724570|NCT01999868|69203292|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
37724571|NCT01999868|69203293|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
37724572|NCT01999868|69203294|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
37724573|NCT01999868|69203292|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
37724574|NCT01999868|69203293|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
37724575|NCT01999868|69203294|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
37724576|NCT01999868|69203292|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
37724577|NCT01999868|69203293|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
37724578|NCT01999868|69203294|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
37724579|NCT01999868|69203292|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
37724580|NCT01999868|69203293|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
37724581|NCT01999868|69203294|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
37724582|NCT01999868|69203292|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
37724583|NCT01999868|69203293|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
37724584|NCT01999868|69203294|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
37724585|NCT01999868|69203292|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
37724586|NCT01999868|69203293|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
37724587|NCT01999868|69203294|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
37724588|NCT01999868|69203292|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
37724589|NCT01999868|69203293|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
37724590|NCT01999868|69203294|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
37724591|NCT01999868|69203292|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
37724592|NCT01999868|69203293|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
37724593|NCT01999868|69203294|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
37724594|NCT01999868|69203292|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
37724595|NCT01999868|69203293|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
37724596|NCT01999868|69203294|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
37724597|NCT01957579|69203306|FG000|Overall Study|Withdrawal of concent|0|||
37724598|NCT01957579|69203307|FG001|Overall Study|Withdrawal of concent|1|||
37724599|NCT01957579|69203308|FG002|Overall Study|Withdrawal of concent|0|||
37724600|NCT01957579|69203309|FG003|Overall Study|Withdrawal of concent|0|||
37724601|NCT01957579|69203306|FG000|Overall Study|Death|0|||
37724602|NCT01957579|69203307|FG001|Overall Study|Death|0|||
37724603|NCT01957579|69203308|FG002|Overall Study|Death|2|||
37724604|NCT01957579|69203309|FG003|Overall Study|Death|0|||
37724605|NCT01999322|69203338|FG000|Overall Study|Adverse Event|1|||
37724606|NCT01999322|69203339|FG001|Overall Study|Adverse Event|0|||
37724607|NCT01996982|69203345|FG000|Overall Study|PI/team left institution|7|||
37724608|NCT01965158|69203351|FG000|Overall Study|Adverse Event|14|||
37724609|NCT01965158|69203352|FG001|Overall Study|Adverse Event|5|||
37724610|NCT01965158|69203351|FG000|Overall Study|Withdrawal by Subject|16|||
37724611|NCT01965158|69203352|FG001|Overall Study|Withdrawal by Subject|24|||
37724612|NCT01965158|69203351|FG000|Overall Study|Lost to Follow-up|7|||
37724613|NCT01965158|69203352|FG001|Overall Study|Lost to Follow-up|5|||
37724614|NCT01965158|69203351|FG000|Overall Study|Protocol Violation|1|||
37724615|NCT01965158|69203352|FG001|Overall Study|Protocol Violation|1|||
37724616|NCT01965158|69203351|FG000|Overall Study|Other - Miscellaneous|3|||
37724617|NCT01965158|69203352|FG001|Overall Study|Other - Miscellaneous|0|||
37724618|NCT01964924|69203358|FG000|Trametinib Monotherapy|Progression|19|||
37724619|NCT01964924|69203359|FG001|Trametinib Monotherapy|Progression|0|||
37724620|NCT01964378|69203370|FG000|Overall Study|Disc. due to death before first dosing|0|||
37724621|NCT01964378|69203371|FG001|Overall Study|Disc. due to death before first dosing|1|||
37724622|NCT01964378|69203370|FG000|Overall Study|Disc. due to AE before first dosing|1|||
37724623|NCT01964378|69203371|FG001|Overall Study|Disc. due to AE before first dosing|0|||
37724624|NCT01964378|69203370|FG000|Overall Study|Death|3|||
37724625|NCT01964378|69203371|FG001|Overall Study|Death|2|||
37724626|NCT01964378|69203370|FG000|Overall Study|Adverse Event|12|||
37724627|NCT01964378|69203371|FG001|Overall Study|Adverse Event|5|||
37724628|NCT01964378|69203370|FG000|Overall Study|Lack of Efficacy|0|||
37724629|NCT01964378|69203371|FG001|Overall Study|Lack of Efficacy|1|||
37724630|NCT01964378|69203370|FG000|Overall Study|Protocol Violation|0|||
37724631|NCT01964378|69203371|FG001|Overall Study|Protocol Violation|1|||
37724632|NCT01964378|69203370|FG000|Overall Study|Lost to Follow-up|0|||
37724633|NCT01964378|69203371|FG001|Overall Study|Lost to Follow-up|1|||
37724634|NCT01964378|69203370|FG000|Overall Study|Withdrawal by Subject|7|||
37724635|NCT01964378|69203371|FG001|Overall Study|Withdrawal by Subject|5|||
37724636|NCT01964378|69203370|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
37724637|NCT01964378|69203371|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
37724638|NCT01964378|69203370|FG000|Overall Study|Other|1|||
37724639|NCT01964378|69203371|FG001|Overall Study|Other|2|||
37724640|NCT01442038|69203379|FG000|Overall Study|Death|35|||
37724641|NCT01442038|69203380|FG001|Overall Study|Death|29|||
37724642|NCT01442038|69203379|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
37724643|NCT01442038|69203380|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
37724644|NCT01442038|69203379|FG000|Overall Study|Participant Withdrew Consent|137|||
37724645|NCT01442038|69203380|FG001|Overall Study|Participant Withdrew Consent|102|||
37915668|NCT00512707|69602467|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
37915669|NCT00512707|69602466|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
37915670|NCT00512707|69602467|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
37915671|NCT03471767|69602475|FG000|Overall Study|Withdrawal by Subject|3|||
37915672|NCT03471767|69602476|FG001|Overall Study|Withdrawal by Subject|1|||
37915673|NCT03471767|69602475|FG000|Overall Study|Adverse Event|1|||
37915674|NCT03471767|69602476|FG001|Overall Study|Adverse Event|0|||
37915675|NCT03471767|69602475|FG000|Overall Study|Lost to Follow-up|1|||
37915676|NCT03471767|69602476|FG001|Overall Study|Lost to Follow-up|0|||
37915677|NCT03471767|69602475|FG000|Overall Study|PI Withdrawal|1|||
37915678|NCT03471767|69602476|FG001|Overall Study|PI Withdrawal|3|||
38025276|NCT04322526|69709553|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
38025277|NCT04322526|69709554|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
38025278|NCT04322526|69709553|FG000|Washout (1 Week)|Lost to Follow-up|1|||
37724646|NCT01442038|69203379|FG000|Overall Study|Lost to Follow-up|37|||
37724647|NCT01442038|69203380|FG001|Overall Study|Lost to Follow-up|51|||
37724648|NCT01442038|69203379|FG000|Overall Study|Adverse Event|26|||
37724649|NCT01442038|69203380|FG001|Overall Study|Adverse Event|15|||
37724650|NCT01442038|69203379|FG000|Overall Study|Protocol Deviation|9|||
37724651|NCT01442038|69203380|FG001|Overall Study|Protocol Deviation|20|||
37724652|NCT01442038|69203379|FG000|Overall Study|Investigator's Discretion|13|||
37724653|NCT01442038|69203380|FG001|Overall Study|Investigator's Discretion|16|||
37724654|NCT01442038|69203379|FG000|Overall Study|Study Terminated By Sponsor|2|||
37724655|NCT01442038|69203380|FG001|Overall Study|Study Terminated By Sponsor|3|||
37724656|NCT01998919|69203388|FG000|Overall Study|Death|2|||
37724657|NCT01998919|69203389|FG001|Overall Study|Death|2|||
37724658|NCT01998919|69203388|FG000|Overall Study|Adverse Event|0|||
37724659|NCT01998919|69203389|FG001|Overall Study|Adverse Event|5|||
37724660|NCT01998919|69203388|FG000|Overall Study|Disease progression|31|||
37724661|NCT01998919|69203389|FG001|Overall Study|Disease progression|22|||
37724662|NCT01998919|69203388|FG000|Overall Study|Withdrawal by Subject|2|||
37724663|NCT01998919|69203389|FG001|Overall Study|Withdrawal by Subject|4|||
37724664|NCT01998919|69203388|FG000|Overall Study|Lost to Follow-up|2|||
37724665|NCT01998919|69203389|FG001|Overall Study|Lost to Follow-up|0|||
37724666|NCT01998919|69203388|FG000|Overall Study|Other|5|||
37724667|NCT01998919|69203389|FG001|Overall Study|Other|2|||
37724668|NCT01957111|69203397|FG000|Overall Study|Withdrawal by Subject|1|||
37724669|NCT01957111|69203398|FG001|Overall Study|Withdrawal by Subject|1|||
37724670|NCT01964300|69203406|FG000|Overall Study|Ineligible after enrollment|0|||
37724671|NCT01964300|69203407|FG001|Overall Study|Ineligible after enrollment|1|||
37724672|NCT01964300|69203406|FG000|Overall Study|Adverse Event|1|||
37724673|NCT01964300|69203407|FG001|Overall Study|Adverse Event|1|||
37724674|NCT01964300|69203406|FG000|Overall Study|Lack of Efficacy|3|||
37915679|NCT00849693|69602486|FG000|Acute Treatment Phase|Adverse Event|12|||
37915680|NCT00849693|69602487|FG001|Acute Treatment Phase|Adverse Event|7|||
37724675|NCT01964300|69203407|FG001|Overall Study|Lack of Efficacy|5|||
37724676|NCT01964300|69203406|FG000|Overall Study|Withdrawal by Subject|0|||
37724677|NCT01964300|69203407|FG001|Overall Study|Withdrawal by Subject|1|||
37724678|NCT01964300|69203406|FG000|Overall Study|To receive alternative therapy|1|||
37724679|NCT01964300|69203407|FG001|Overall Study|To receive alternative therapy|2|||
37724680|NCT01964300|69203406|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
37724681|NCT01964300|69203407|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
37724682|NCT01964300|69203406|FG000|Overall Study|Weight criteria not met|0|||
37724683|NCT01964300|69203407|FG001|Overall Study|Weight criteria not met|1|||
37724684|NCT01964222|69203415|FG000|Overall Study|Lost to Follow-up|7|||
37724685|NCT01964222|69203416|FG001|Overall Study|Lost to Follow-up|5|||
37724686|NCT01964222|69203415|FG000|Overall Study|Withdrawal by Subject|6|||
37724687|NCT01964222|69203416|FG001|Overall Study|Withdrawal by Subject|6|||
37724688|NCT01964222|69203415|FG000|Overall Study|Screening Failure|2|||
37724689|NCT01964222|69203416|FG001|Overall Study|Screening Failure|0|||
37724690|NCT01467700|69203426|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
37724691|NCT01467700|69203427|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
37724692|NCT01467700|69203428|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
37724693|NCT01467700|69203429|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
37724694|NCT01467700|69203426|FG000|Overall Study|Major Protocol Deviation|3|||
37724695|NCT01467700|69203427|FG001|Overall Study|Major Protocol Deviation|3|||
37724696|NCT01467700|69203428|FG002|Overall Study|Major Protocol Deviation|2|||
37724697|NCT01467700|69203429|FG003|Overall Study|Major Protocol Deviation|3|||
37724698|NCT01467700|69203426|FG000|Overall Study|Lost to Follow-up|6|||
37724699|NCT01467700|69203427|FG001|Overall Study|Lost to Follow-up|5|||
37724700|NCT01467700|69203428|FG002|Overall Study|Lost to Follow-up|2|||
37724701|NCT01467700|69203429|FG003|Overall Study|Lost to Follow-up|3|||
37724702|NCT01467700|69203426|FG000|Overall Study|Voluntary Withdrawal|5|||
37724703|NCT01467700|69203427|FG001|Overall Study|Voluntary Withdrawal|7|||
37724704|NCT01467700|69203428|FG002|Overall Study|Voluntary Withdrawal|6|||
37724705|NCT01467700|69203429|FG003|Overall Study|Voluntary Withdrawal|2|||
37724706|NCT01467700|69203426|FG000|Overall Study|Study Termination|6|||
37724707|NCT01467700|69203427|FG001|Overall Study|Study Termination|5|||
37724708|NCT01467700|69203428|FG002|Overall Study|Study Termination|10|||
37724709|NCT01467700|69203429|FG003|Overall Study|Study Termination|7|||
37724710|NCT01467700|69203426|FG000|Overall Study|Pregnancy|0|||
37724711|NCT01467700|69203427|FG001|Overall Study|Pregnancy|1|||
37724712|NCT01467700|69203428|FG002|Overall Study|Pregnancy|1|||
37724713|NCT01467700|69203429|FG003|Overall Study|Pregnancy|0|||
37724714|NCT01467700|69203426|FG000|Overall Study|Lack of Efficacy|2|||
37724715|NCT01467700|69203427|FG001|Overall Study|Lack of Efficacy|0|||
37724716|NCT01467700|69203428|FG002|Overall Study|Lack of Efficacy|2|||
37724717|NCT01467700|69203429|FG003|Overall Study|Lack of Efficacy|1|||
37724718|NCT01467700|69203426|FG000|Overall Study|Reason not Specified|1|||
37724719|NCT01467700|69203427|FG001|Overall Study|Reason not Specified|3|||
37724720|NCT01467700|69203428|FG002|Overall Study|Reason not Specified|2|||
37724721|NCT01467700|69203429|FG003|Overall Study|Reason not Specified|8|||
37724722|NCT01972724|69203442|FG000|Double-Blind|Rescue Criteria Met|1|||
37724723|NCT01972724|69203443|FG001|Double-Blind|Rescue Criteria Met|0|||
37724724|NCT01972724|69203444|FG002|Double-Blind|Rescue Criteria Met|0|||
37724725|NCT01972724|69203442|FG000|Double-Blind|Adverse Event|1|||
37724726|NCT01972724|69203443|FG001|Double-Blind|Adverse Event|0|||
37724727|NCT01972724|69203444|FG002|Double-Blind|Adverse Event|0|||
37724728|NCT01972724|69203442|FG000|Double-Blind|Withdrawal of Consent|2|||
37724729|NCT01972724|69203443|FG001|Double-Blind|Withdrawal of Consent|1|||
37724730|NCT01972724|69203444|FG002|Double-Blind|Withdrawal of Consent|0|||
37724731|NCT01972724|69203442|FG000|Double-Blind|Significant Protocol Deviation|5|||
37724732|NCT01972724|69203443|FG001|Double-Blind|Significant Protocol Deviation|8|||
37724733|NCT01972724|69203444|FG002|Double-Blind|Significant Protocol Deviation|0|||
37724734|NCT01972724|69203442|FG000|Open-Label|Withdrew Consent|0|||
37724735|NCT01972724|69203443|FG001|Open-Label|Withdrew Consent|0|||
37724736|NCT01972724|69203444|FG002|Open-Label|Withdrew Consent|3|||
37724737|NCT01972724|69203442|FG000|Open-Label|Significant Protocol Deviation|0|||
37724738|NCT01972724|69203443|FG001|Open-Label|Significant Protocol Deviation|0|||
37724739|NCT01972724|69203444|FG002|Open-Label|Significant Protocol Deviation|2|||
37724740|NCT01441960|69203452|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
37724741|NCT01441960|69203453|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
37724742|NCT01441960|69203452|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
37724743|NCT01441960|69203453|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
37724744|NCT01441960|69203452|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
37841105|NCT00478881|69525347|FG000|Overall Study|Adverse Event|31|||
37724745|NCT01441960|69203453|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
37724746|NCT01955707|69203465|FG000|Overall Study|Adverse Event|1|||
37724747|NCT01955707|69203466|FG001|Overall Study|Adverse Event|2|||
37724748|NCT01955707|69203465|FG000|Overall Study|Lost to Follow-up|2|||
37724749|NCT01955707|69203466|FG001|Overall Study|Lost to Follow-up|1|||
37724750|NCT01955707|69203465|FG000|Overall Study|Withdrawal by Subject|0|||
37724751|NCT01955707|69203466|FG001|Overall Study|Withdrawal by Subject|3|||
37724752|NCT01955707|69203465|FG000|Overall Study|Death|13|||
37724753|NCT01955707|69203466|FG001|Overall Study|Death|14|||
37724754|NCT01955707|69203465|FG000|Overall Study|Other|4|||
37724755|NCT01955707|69203466|FG001|Overall Study|Other|2|||
37724756|NCT01435798|69203472|FG000|Overall Study|Withdrawal by Subject|1|||
37724757|NCT01972568|69203485|FG000|Overall Study|Other events|3|||
37724758|NCT01972568|69203486|FG001|Overall Study|Other events|0|||
37724759|NCT01972568|69203487|FG002|Overall Study|Other events|0|||
37724760|NCT01972568|69203485|FG000|Overall Study|Lack of Efficacy|0|||
37724761|NCT01972568|69203486|FG001|Overall Study|Lack of Efficacy|1|||
37724762|NCT01972568|69203487|FG002|Overall Study|Lack of Efficacy|2|||
37724763|NCT01972568|69203485|FG000|Overall Study|Protocol Violation|1|||
37724764|NCT01972568|69203486|FG001|Overall Study|Protocol Violation|2|||
37724765|NCT01972568|69203487|FG002|Overall Study|Protocol Violation|2|||
37724766|NCT01972568|69203485|FG000|Overall Study|Withdrawal by Subject|6|||
37724767|NCT01972568|69203486|FG001|Overall Study|Withdrawal by Subject|3|||
37724768|NCT01972568|69203487|FG002|Overall Study|Withdrawal by Subject|7|||
37724769|NCT01972568|69203485|FG000|Overall Study|Lost to Follow-up|1|||
37724770|NCT01972568|69203486|FG001|Overall Study|Lost to Follow-up|0|||
37724771|NCT01972568|69203487|FG002|Overall Study|Lost to Follow-up|0|||
37724772|NCT01972568|69203485|FG000|Overall Study|Adverse Event|5|||
37724773|NCT01972568|69203486|FG001|Overall Study|Adverse Event|6|||
37724774|NCT01972568|69203487|FG002|Overall Study|Adverse Event|5|||
37724775|NCT01955161|69203498|FG000|Overall Study|Withdrawal before treatment|2|||
37724776|NCT01955161|69203499|FG001|Overall Study|Withdrawal before treatment|0|||
37724777|NCT01955161|69203500|FG002|Overall Study|Withdrawal before treatment|1|||
37724778|NCT01955161|69203498|FG000|Overall Study|Adverse Event|10|||
37724779|NCT01955161|69203499|FG001|Overall Study|Adverse Event|14|||
37724780|NCT01955161|69203500|FG002|Overall Study|Adverse Event|15|||
37724781|NCT01955161|69203498|FG000|Overall Study|Death|1|||
37724782|NCT01955161|69203499|FG001|Overall Study|Death|1|||
37724783|NCT01955161|69203500|FG002|Overall Study|Death|3|||
37724784|NCT01955161|69203498|FG000|Overall Study|Withdrawal by Subject|9|||
37724785|NCT01955161|69203499|FG001|Overall Study|Withdrawal by Subject|8|||
37724786|NCT01955161|69203500|FG002|Overall Study|Withdrawal by Subject|12|||
37724787|NCT01955161|69203498|FG000|Overall Study|Protocol Violation|2|||
37724788|NCT01955161|69203499|FG001|Overall Study|Protocol Violation|0|||
37724789|NCT01955161|69203500|FG002|Overall Study|Protocol Violation|0|||
37724790|NCT01955161|69203498|FG000|Overall Study|Other reason: physician decision|0|||
37724791|NCT01955161|69203499|FG001|Overall Study|Other reason: physician decision|1|||
37724792|NCT01955161|69203500|FG002|Overall Study|Other reason: physician decision|1|||
37724793|NCT01955161|69203498|FG000|Overall Study|Other reason: disallowed medication|1|||
37724794|NCT01955161|69203499|FG001|Overall Study|Other reason: disallowed medication|0|||
37724795|NCT01955161|69203500|FG002|Overall Study|Other reason: disallowed medication|1|||
37724796|NCT01955161|69203498|FG000|Overall Study|Other reason: caregiver unavailable|1|||
37724797|NCT01955161|69203499|FG001|Overall Study|Other reason: caregiver unavailable|0|||
37724798|NCT01955161|69203500|FG002|Overall Study|Other reason: caregiver unavailable|0|||
37724799|NCT01955161|69203498|FG000|Overall Study|Other reason: moved to nursing home|0|||
37724800|NCT01955161|69203499|FG001|Overall Study|Other reason: moved to nursing home|1|||
37841106|NCT00478881|69525348|FG001|Overall Study|Adverse Event|12|||
37841107|NCT00478881|69525347|FG000|Overall Study|Lack of Efficacy|0|||
37841108|NCT00478881|69525348|FG001|Overall Study|Lack of Efficacy|3|||
37841109|NCT00478881|69525347|FG000|Overall Study|Lost to Follow-up|0|||
37841110|NCT00478881|69525348|FG001|Overall Study|Lost to Follow-up|1|||
37841111|NCT00478881|69525347|FG000|Overall Study|Protocol Violation|2|||
37841112|NCT00478881|69525348|FG001|Overall Study|Protocol Violation|2|||
37841113|NCT00478881|69525347|FG000|Overall Study|Withdrawal by Subject|6|||
37841114|NCT00478881|69525348|FG001|Overall Study|Withdrawal by Subject|2|||
37841115|NCT00478881|69525347|FG000|Overall Study|Non-Compliance with Study Medication|0|||
37841116|NCT00478881|69525348|FG001|Overall Study|Non-Compliance with Study Medication|2|||
37724801|NCT01955161|69203500|FG002|Overall Study|Other reason: moved to nursing home|0|||
37724802|NCT01955161|69203498|FG000|Overall Study|Other reason: insufficient compliance|0|||
37724803|NCT01955161|69203499|FG001|Overall Study|Other reason: insufficient compliance|0|||
37724804|NCT01955161|69203500|FG002|Overall Study|Other reason: insufficient compliance|1|||
37724805|NCT01955161|69203498|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
37724806|NCT01955161|69203499|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
37724807|NCT01955161|69203500|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
37724808|NCT01955161|69203498|FG000|Overall Study|Other reason: patient's will|0|||
37841117|NCT00478647|69525354|FG000|Overall Study|Adverse Event|1|||
37841118|NCT00478647|69525354|FG000|Overall Study|Withdrawal by Subject|1|||
37915681|NCT00849693|69602488|FG002|Acute Treatment Phase|Adverse Event|6|||
37841119|NCT00478608|69525358|FG000|Overall Study|Adverse Event|1|||
37724809|NCT01955161|69203499|FG001|Overall Study|Other reason: patient's will|0|||
37724810|NCT01955161|69203500|FG002|Overall Study|Other reason: patient's will|1|||
37724811|NCT01441414|69203508|FG000|Overall Study|Participant died|9|||
37724812|NCT01441414|69203508|FG000|Overall Study|Other reasons|3|||
37724813|NCT01441414|69203508|FG000|Overall Study|Study terminated by sponsor|2|||
37724814|NCT01441414|69203508|FG000|Overall Study|Subject refused further follow-up|1|||
37724815|NCT01971554|69203528|FG000|Overall Study|Lost to Follow-up|1|||
37724816|NCT01971554|69203529|FG001|Overall Study|Lost to Follow-up|0|||
37724817|NCT01971554|69203530|FG002|Overall Study|Lost to Follow-up|0|||
37724818|NCT01971554|69203531|FG003|Overall Study|Lost to Follow-up|0|||
37724819|NCT01955083|69203543|FG000|Overall Study|Lost to Follow-up|1|||
37724820|NCT01955083|69203544|FG001|Overall Study|Lost to Follow-up|1|||
37724821|NCT01955005|69203576|FG000|Overall Study|Withdrawal by Subject|3|||
37724822|NCT01955005|69203577|FG001|Overall Study|Withdrawal by Subject|5|||
37724823|NCT01954927|69203585|FG000|Overall Study|Withdrawal by Subject|3|||
37724824|NCT01954927|69203586|FG001|Overall Study|Withdrawal by Subject|1|||
37724825|NCT01954771|69203595|FG000|Overall Study|Missing HbA1c of end-point|1|||
37724826|NCT01954771|69203596|FG001|Overall Study|Missing HbA1c of end-point|1|||
37724827|NCT01954771|69203597|FG002|Overall Study|Missing HbA1c of end-point|0|||
37724828|NCT01954771|69203595|FG000|Overall Study|Missing CGMS of end-point|1|||
37724829|NCT01954771|69203596|FG001|Overall Study|Missing CGMS of end-point|1|||
37724830|NCT01954771|69203597|FG002|Overall Study|Missing CGMS of end-point|0|||
37724831|NCT01954771|69203595|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
37724832|NCT01954771|69203596|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
37724833|NCT01954771|69203597|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
37724834|NCT01997281|69203610|FG000|Overall Study|Withdrawal by Subject|1|||
37724835|NCT01997281|69203611|FG001|Overall Study|Withdrawal by Subject|0|||
37724836|NCT01996033|69203617|FG000|Overall Study|Death|1|||
37841120|NCT00478608|69525358|FG000|Overall Study|Serious Adverse Event|14|||
37841121|NCT00478608|69525358|FG000|Overall Study|Withdrawal by Subject|2|||
37841122|NCT00478608|69525358|FG000|Overall Study|Protocol Violation|3|||
37841123|NCT00478257|69525364|FG000|Overall Study|Withdrawal by Subject|8|||
37724837|NCT01996033|69203617|FG000|Overall Study|Physician Decision|1|||
37724838|NCT01996033|69203617|FG000|Overall Study|Withdrawal by Subject|4|||
37724839|NCT01996033|69203617|FG000|Overall Study|Lost to Follow-up|3|||
37724840|NCT01953913|69203621|FG000|Overall Study|Disease Progression|349|||
37724841|NCT01953913|69203621|FG000|Overall Study|Worsening of underlying cancer|22|||
37724842|NCT01953913|69203621|FG000|Overall Study|Adverse Event|20|||
37724843|NCT01953913|69203621|FG000|Overall Study|Protocol Violation|6|||
37724844|NCT01953913|69203621|FG000|Overall Study|Lost to Follow-up|4|||
37724845|NCT01953913|69203621|FG000|Overall Study|Withdrawal by Subject|32|||
37724846|NCT01953913|69203621|FG000|Overall Study|Other than listed|108|||
37724847|NCT01953913|69203621|FG000|Overall Study|Not Treated|1|||
37724848|NCT01971476|69203628|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
37724849|NCT01971476|69203629|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
37724850|NCT01971476|69203630|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
37724851|NCT01971476|69203628|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
37724852|NCT01971476|69203629|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
37724853|NCT01971476|69203630|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
37724854|NCT01971476|69203628|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
37724855|NCT01971476|69203629|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
37724856|NCT01971476|69203630|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
37724857|NCT01996904|69203649|FG000|Overall Study|Lost to Follow-up|38|||
37724858|NCT01996904|69203650|FG001|Overall Study|Lost to Follow-up|27|||
37724859|NCT01970540|69203659|FG000|Overall Study|Non-treatment-related AE|0|||
37724860|NCT01970540|69203660|FG001|Overall Study|Non-treatment-related AE|0|||
37724861|NCT01970540|69203661|FG002|Overall Study|Non-treatment-related AE|1|||
37841124|NCT00478257|69525365|FG001|Overall Study|Withdrawal by Subject|3|||
37841125|NCT00478140|69525371|FG000|Overall Study|Clinical Disease Progression|1|||
37841126|NCT00478023|69525380|FG000|Overall Study|Adverse Event|11|||
37841127|NCT00478023|69525381|FG001|Overall Study|Adverse Event|7|||
37841128|NCT00478023|69525382|FG002|Overall Study|Adverse Event|8|||
37841129|NCT00478023|69525383|FG003|Overall Study|Adverse Event|14|||
37841130|NCT00478023|69525384|FG004|Overall Study|Adverse Event|6|||
37841131|NCT00478023|69525380|FG000|Overall Study|Death|1|||
37841132|NCT00478023|69525381|FG001|Overall Study|Death|0|||
38025279|NCT04322526|69709554|FG001|Washout (1 Week)|Lost to Follow-up|2|||
38025280|NCT04115358|69709563|FG000|Overall Study|exfoliation|0|||
37724862|NCT01970540|69203659|FG000|Overall Study|Progressive disease|55|||
37724863|NCT01970540|69203660|FG001|Overall Study|Progressive disease|23|||
37724864|NCT01970540|69203661|FG002|Overall Study|Progressive disease|10|||
37724865|NCT01970540|69203659|FG000|Overall Study|Treatment delay over protocol|0|||
37724866|NCT01970540|69203660|FG001|Overall Study|Treatment delay over protocol|0|||
37724867|NCT01970540|69203661|FG002|Overall Study|Treatment delay over protocol|1|||
37841133|NCT00478023|69525382|FG002|Overall Study|Death|0|||
37841134|NCT00478023|69525383|FG003|Overall Study|Death|0|||
37841135|NCT00478023|69525384|FG004|Overall Study|Death|0|||
37841136|NCT00478023|69525380|FG000|Overall Study|Lack of Efficacy|11|||
37841137|NCT00478023|69525381|FG001|Overall Study|Lack of Efficacy|10|||
37841138|NCT00478023|69525382|FG002|Overall Study|Lack of Efficacy|4|||
37841139|NCT00478023|69525383|FG003|Overall Study|Lack of Efficacy|5|||
37841140|NCT00478023|69525384|FG004|Overall Study|Lack of Efficacy|41|||
37841141|NCT00478023|69525380|FG000|Overall Study|Lost to Follow-up|3|||
37841142|NCT00478023|69525381|FG001|Overall Study|Lost to Follow-up|1|||
38025281|NCT04115358|69709564|FG001|Overall Study|exfoliation|0|||
38025282|NCT04115358|69709565|FG002|Overall Study|exfoliation|1|||
38025283|NCT04109118|69709574|FG000|Overall Study|Lost to Follow-up|3|||
38025284|NCT04105998|69709581|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
37724868|NCT01970540|69203659|FG000|Overall Study|Physician Decision|7|||
37724869|NCT01970540|69203660|FG001|Overall Study|Physician Decision|2|||
37724870|NCT01970540|69203661|FG002|Overall Study|Physician Decision|0|||
37724871|NCT01970540|69203659|FG000|Overall Study|Clinical progression|0|||
37724872|NCT01970540|69203660|FG001|Overall Study|Clinical progression|1|||
37724873|NCT01970540|69203661|FG002|Overall Study|Clinical progression|1|||
37724874|NCT01970540|69203659|FG000|Overall Study|End of study|2|||
37724875|NCT01970540|69203660|FG001|Overall Study|End of study|0|||
37724876|NCT01970540|69203661|FG002|Overall Study|End of study|2|||
37724877|NCT01970540|69203659|FG000|Overall Study|Adverse Event|0|||
37724878|NCT01970540|69203660|FG001|Overall Study|Adverse Event|2|||
37724879|NCT01970540|69203661|FG002|Overall Study|Adverse Event|1|||
37724880|NCT01970540|69203659|FG000|Overall Study|Treatment-related AE|4|||
37724881|NCT01970540|69203660|FG001|Overall Study|Treatment-related AE|0|||
37724882|NCT01970540|69203661|FG002|Overall Study|Treatment-related AE|2|||
37724883|NCT01970540|69203659|FG000|Overall Study|Withdrawal by Subject|4|||
38025285|NCT04105998|69709582|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
37724884|NCT01970540|69203660|FG001|Overall Study|Withdrawal by Subject|0|||
37724885|NCT01970540|69203661|FG002|Overall Study|Withdrawal by Subject|1|||
38025286|NCT04397718|69709590|FG000|Overall Study|Death|7|||
38025287|NCT04397718|69709591|FG001|Overall Study|Death|11|||
38025288|NCT04397718|69709590|FG000|Overall Study|Lost to Follow-up|0|||
38025289|NCT04397718|69709591|FG001|Overall Study|Lost to Follow-up|4|||
38025290|NCT04105218|69709599|FG000|Overall Study|Withdrawal by Subject|3|||
38025291|NCT04105218|69709600|FG001|Overall Study|Withdrawal by Subject|2|||
38025292|NCT04105218|69709599|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
38025293|NCT04105218|69709600|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
38025294|NCT04105218|69709599|FG000|Overall Study|Failed screening tests|2|||
38025295|NCT04105218|69709600|FG001|Overall Study|Failed screening tests|1|||
38025296|NCT04317690|69709611|FG000|Overall Study|did not have complete information for primary outcome|0|||
38025297|NCT04317690|69709612|FG001|Overall Study|did not have complete information for primary outcome|4|||
38025298|NCT04317690|69709613|FG002|Overall Study|did not have complete information for primary outcome|0|||
38025299|NCT04317690|69709614|FG003|Overall Study|did not have complete information for primary outcome|2|||
38025300|NCT04317690|69709615|FG004|Overall Study|did not have complete information for primary outcome|0|||
38025301|NCT03721276|69709642|FG000|Overall Study|Lost to Follow-up|5|||
38025302|NCT03721276|69709643|FG001|Overall Study|Lost to Follow-up|3|||
38025303|NCT03721276|69709642|FG000|Overall Study|Adverse Event|0|||
38025304|NCT03721276|69709643|FG001|Overall Study|Adverse Event|1|||
38025305|NCT03269344|69709658|FG000|Overall Study|Protocol Violation|4|||
37724886|NCT01970540|69203659|FG000|Overall Study|Clinical deterioration|1|||
37724887|NCT01970540|69203660|FG001|Overall Study|Clinical deterioration|0|||
38025306|NCT03269344|69709659|FG001|Overall Study|Protocol Violation|3|||
38025307|NCT04389840|69709671|FG000|Overall Study|Adverse Event|0|||
38025308|NCT04389840|69709672|FG001|Overall Study|Adverse Event|0|||
37724888|NCT01970540|69203661|FG002|Overall Study|Clinical deterioration|0|||
37724889|NCT01963676|69203682|FG000|Overall Study|Withdrawal by Subject|1|||
37724890|NCT01963676|69203683|FG001|Overall Study|Withdrawal by Subject|0|||
37841143|NCT00478023|69525382|FG002|Overall Study|Lost to Follow-up|1|||
37841144|NCT00478023|69525383|FG003|Overall Study|Lost to Follow-up|1|||
37724891|NCT01996826|69203691|FG000|Overall Study|Lost to Follow-up|6|||
37724892|NCT01996826|69203692|FG001|Overall Study|Lost to Follow-up|2|||
37724893|NCT01996826|69203691|FG000|Overall Study|Physician Decision|1|||
37724894|NCT01996826|69203692|FG001|Overall Study|Physician Decision|1|||
37724895|NCT01996748|69203700|FG000|Overall Study|Personal reason|1|||
37724896|NCT01996748|69203701|FG001|Overall Study|Personal reason|0|||
37724897|NCT01996748|69203700|FG000|Overall Study|Physician Decision|2|||
37724898|NCT01996748|69203701|FG001|Overall Study|Physician Decision|0|||
37724899|NCT01996748|69203700|FG000|Overall Study|Adverse Event|1|||
37724900|NCT01996748|69203701|FG001|Overall Study|Adverse Event|4|||
37724901|NCT01996748|69203700|FG000|Overall Study|Withdrawal by Subject|0|||
37724902|NCT01996748|69203701|FG001|Overall Study|Withdrawal by Subject|1|||
37724903|NCT01996748|69203700|FG000|Overall Study|Lost to Follow-up|4|||
37724904|NCT01996748|69203701|FG001|Overall Study|Lost to Follow-up|1|||
37724905|NCT01621178|69203712|FG000|Overall Study|Adverse Event|5|||
37724906|NCT01621178|69203713|FG001|Overall Study|Adverse Event|2|||
37724907|NCT01621178|69203714|FG002|Overall Study|Adverse Event|8|||
37724908|NCT01621178|69203712|FG000|Overall Study|Death|6|||
37724909|NCT01621178|69203713|FG001|Overall Study|Death|7|||
37724910|NCT01621178|69203714|FG002|Overall Study|Death|2|||
37724911|NCT01621178|69203712|FG000|Overall Study|Lost to Follow-up|1|||
37724912|NCT01621178|69203713|FG001|Overall Study|Lost to Follow-up|2|||
37724913|NCT01621178|69203714|FG002|Overall Study|Lost to Follow-up|1|||
37841145|NCT00478023|69525384|FG004|Overall Study|Lost to Follow-up|0|||
37841146|NCT00478023|69525380|FG000|Overall Study|Withdrawal by Subject|2|||
37841147|NCT00478023|69525381|FG001|Overall Study|Withdrawal by Subject|3|||
37841148|NCT00478023|69525382|FG002|Overall Study|Withdrawal by Subject|2|||
37841149|NCT00478023|69525383|FG003|Overall Study|Withdrawal by Subject|4|||
37841150|NCT00478023|69525384|FG004|Overall Study|Withdrawal by Subject|5|||
37841151|NCT00478023|69525380|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
37841152|NCT00478023|69525381|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
37841153|NCT00478023|69525382|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
37841154|NCT00478023|69525383|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
37841155|NCT00478023|69525384|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
37841156|NCT00477750|69525396|FG000|Overall Study|Currently Receiving Treatment|11|||
37841157|NCT00477672|69525405|FG000|Overall Study|Adverse Event|3|||
37841158|NCT00477672|69525406|FG001|Overall Study|Adverse Event|5|||
37841159|NCT00477672|69525407|FG002|Overall Study|Adverse Event|6|||
37841160|NCT00477672|69525405|FG000|Overall Study|Death|0|||
37841161|NCT00477672|69525406|FG001|Overall Study|Death|1|||
37841162|NCT00477672|69525407|FG002|Overall Study|Death|0|||
37841163|NCT00477672|69525405|FG000|Overall Study|Disease progression|0|||
37841164|NCT00477672|69525406|FG001|Overall Study|Disease progression|1|||
37841165|NCT00477672|69525407|FG002|Overall Study|Disease progression|0|||
37841166|NCT00477672|69525405|FG000|Overall Study|Physician Decision|1|||
37841167|NCT00477672|69525406|FG001|Overall Study|Physician Decision|0|||
37841168|NCT00477672|69525407|FG002|Overall Study|Physician Decision|0|||
37841169|NCT00477672|69525405|FG000|Overall Study|Protocol noncompliance|0|||
37841170|NCT00477672|69525406|FG001|Overall Study|Protocol noncompliance|2|||
38025309|NCT04389840|69709673|FG002|Overall Study|Adverse Event|0|||
38025310|NCT04389840|69709674|FG003|Overall Study|Adverse Event|1|||
38025311|NCT04389840|69709675|FG004|Overall Study|Adverse Event|0|||
38025312|NCT04389840|69709676|FG005|Overall Study|Adverse Event|0|||
38025313|NCT04389840|69709671|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
37724914|NCT01621178|69203712|FG000|Overall Study|Withdrawal by Subject|14|||
37841171|NCT00477672|69525407|FG002|Overall Study|Protocol noncompliance|0|||
37841172|NCT00477672|69525405|FG000|Overall Study|Consent withdrawn|2|||
38025314|NCT04389840|69709672|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
38025315|NCT04389840|69709673|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
37724915|NCT01621178|69203713|FG001|Overall Study|Withdrawal by Subject|17|||
37724916|NCT01621178|69203714|FG002|Overall Study|Withdrawal by Subject|18|||
37724917|NCT01621178|69203712|FG000|Overall Study|Physician Decision|5|||
37724918|NCT01621178|69203713|FG001|Overall Study|Physician Decision|2|||
37841173|NCT00477672|69525406|FG001|Overall Study|Consent withdrawn|5|||
37841174|NCT00477672|69525407|FG002|Overall Study|Consent withdrawn|10|||
37841175|NCT00477672|69525405|FG000|Overall Study|Discretion of Sponsor|1|||
37841176|NCT00477672|69525406|FG001|Overall Study|Discretion of Sponsor|2|||
37841177|NCT00477672|69525407|FG002|Overall Study|Discretion of Sponsor|0|||
37724919|NCT01621178|69203714|FG002|Overall Study|Physician Decision|7|||
37841178|NCT00477633|69525415|FG000|Overall Study|Did not receive treatment|23|||
37841179|NCT00477633|69525415|FG000|Overall Study|Adverse Event|143|||
37841180|NCT00477633|69525415|FG000|Overall Study|Pregnancy|23|||
37841181|NCT00477633|69525415|FG000|Overall Study|Lost to Follow-up|271|||
37841182|NCT00477633|69525415|FG000|Overall Study|Withdrawal by Subject|149|||
37841183|NCT00477633|69525415|FG000|Overall Study|Protocol Violation|25|||
37841184|NCT00477633|69525415|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
37841185|NCT01131676|69525431|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
37841186|NCT01131676|69525432|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
37841187|NCT01131676|69525433|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
37841188|NCT01131676|69525431|FG000|Discontinuation From Treatment|Not treated|4|||
37841189|NCT01131676|69525432|FG001|Discontinuation From Treatment|Not treated|2|||
37841190|NCT01131676|69525433|FG002|Discontinuation From Treatment|Not treated|2|||
37841191|NCT01131676|69525431|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
38025316|NCT04389840|69709674|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
38025317|NCT04389840|69709675|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
38025318|NCT04389840|69709676|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
38025319|NCT04389840|69709671|FG000|Overall Study|Death|0|||
37724920|NCT01962974|69203726|FG000|Overall Study|Study termination|7|||
37724921|NCT01996592|69203730|FG000|Overall Study|no response to text/no diary entry|32|||
37724922|NCT01996592|69203730|FG000|Overall Study|change in surgical date|4|||
37724923|NCT01996592|69203730|FG000|Overall Study|Withdrawal by Subject|5|||
37724924|NCT01996592|69203730|FG000|Overall Study|change in mode of delivery|4|||
37724925|NCT01962896|69203739|FG000|Overall Study|Lack of Efficacy|4|||
37724926|NCT01970462|69203746|FG000|Overall Study|Lost to Follow-up|0|||
37724927|NCT01970462|69203747|FG001|Overall Study|Lost to Follow-up|2|||
37724928|NCT01958671|69203756|FG000|Overall Study|Adverse Event|1|||
37724929|NCT01958671|69203757|FG001|Overall Study|Adverse Event|1|||
37724930|NCT01958671|69203758|FG002|Overall Study|Adverse Event|5|||
37724931|NCT01958671|69203756|FG000|Overall Study|Death|1|||
37724932|NCT01958671|69203757|FG001|Overall Study|Death|0|||
37724933|NCT01958671|69203758|FG002|Overall Study|Death|0|||
37724934|NCT01958671|69203756|FG000|Overall Study|Excluded medication|0|||
37724935|NCT01958671|69203757|FG001|Overall Study|Excluded medication|0|||
37724936|NCT01958671|69203758|FG002|Overall Study|Excluded medication|1|||
37724937|NCT01958671|69203756|FG000|Overall Study|Hyperglycemia|0|||
37841192|NCT01131676|69525432|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
37841193|NCT01131676|69525433|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
37841194|NCT01131676|69525431|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
37841195|NCT01131676|69525432|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
37841196|NCT01131676|69525433|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
37841197|NCT01131676|69525431|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
37841198|NCT01131676|69525432|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
38025320|NCT04389840|69709672|FG001|Overall Study|Death|1|||
38025321|NCT04389840|69709673|FG002|Overall Study|Death|0|||
38025322|NCT04389840|69709674|FG003|Overall Study|Death|0|||
38025323|NCT04389840|69709675|FG004|Overall Study|Death|0|||
38025324|NCT04389840|69709676|FG005|Overall Study|Death|0|||
38025325|NCT04307940|69709699|FG000|Overall Study|Adverse Event|1|||
38025326|NCT04307940|69709700|FG001|Overall Study|Adverse Event|0|||
38025327|NCT04307940|69709701|FG002|Overall Study|Adverse Event|0|||
38025328|NCT04307940|69709699|FG000|Overall Study|Withdrawal by Subject|2|||
38025329|NCT04307940|69709700|FG001|Overall Study|Withdrawal by Subject|3|||
38025330|NCT04307940|69709701|FG002|Overall Study|Withdrawal by Subject|1|||
38025331|NCT04307940|69709699|FG000|Overall Study|Lost to Follow-up|2|||
38025332|NCT04307940|69709700|FG001|Overall Study|Lost to Follow-up|0|||
38025333|NCT04307940|69709701|FG002|Overall Study|Lost to Follow-up|1|||
38025334|NCT02054104|69709711|FG000|Overall Study|Did not want to continue due to college classes|1|||
38025335|NCT02054104|69709712|FG001|Overall Study|Did not want to continue due to college classes|0|||
38025336|NCT02054104|69709711|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
38025337|NCT02054104|69709712|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
38025338|NCT02054104|69709711|FG000|Overall Study|No evidence of immunologic response|2|||
38025339|NCT02054104|69709712|FG001|Overall Study|No evidence of immunologic response|2|||
38025340|NCT02054104|69709711|FG000|Overall Study|Disease Progression On Study|4|||
38025341|NCT02054104|69709712|FG001|Overall Study|Disease Progression On Study|5|||
37724938|NCT01958671|69203757|FG001|Overall Study|Hyperglycemia|0|||
37724939|NCT01958671|69203758|FG002|Overall Study|Hyperglycemia|2|||
37724940|NCT01958671|69203756|FG000|Overall Study|Lost to Follow-up|7|||
37724941|NCT01958671|69203757|FG001|Overall Study|Lost to Follow-up|11|||
37724942|NCT01958671|69203758|FG002|Overall Study|Lost to Follow-up|7|||
37724943|NCT01958671|69203756|FG000|Overall Study|Non-compliance with study drug|1|||
37724944|NCT01958671|69203757|FG001|Overall Study|Non-compliance with study drug|1|||
37724945|NCT01958671|69203758|FG002|Overall Study|Non-compliance with study drug|1|||
37724946|NCT01958671|69203756|FG000|Overall Study|Pregnancy|0|||
37724947|NCT01958671|69203757|FG001|Overall Study|Pregnancy|0|||
37724948|NCT01958671|69203758|FG002|Overall Study|Pregnancy|1|||
37724949|NCT01958671|69203756|FG000|Overall Study|Protocol Violation|0|||
37724950|NCT01958671|69203757|FG001|Overall Study|Protocol Violation|1|||
37841199|NCT01131676|69525433|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
37841200|NCT01131676|69525431|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
37841201|NCT01131676|69525432|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
37841202|NCT01131676|69525433|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
37841203|NCT01131676|69525431|FG000|Discontinuation From Treatment|Other than those specified|162|||
37841204|NCT01131676|69525432|FG001|Discontinuation From Treatment|Other than those specified|142|||
37724951|NCT01958671|69203758|FG002|Overall Study|Protocol Violation|0|||
37724952|NCT01958671|69203756|FG000|Overall Study|Study site terminated by sponsor|1|||
37724953|NCT01958671|69203757|FG001|Overall Study|Study site terminated by sponsor|0|||
37724954|NCT01958671|69203758|FG002|Overall Study|Study site terminated by sponsor|1|||
37724955|NCT01958671|69203756|FG000|Overall Study|Participant moved|0|||
37724956|NCT01958671|69203757|FG001|Overall Study|Participant moved|0|||
37841205|NCT01131676|69525433|FG002|Discontinuation From Treatment|Other than those specified|125|||
37841206|NCT01131676|69525431|FG000|Discontinuation From Treatment|Adverse Event|303|||
37841207|NCT01131676|69525432|FG001|Discontinuation From Treatment|Adverse Event|267|||
37841208|NCT01131676|69525433|FG002|Discontinuation From Treatment|Adverse Event|273|||
37841209|NCT01131676|69525431|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
37841210|NCT01131676|69525432|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
37841211|NCT01131676|69525433|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
37841212|NCT01131676|69525431|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
37841213|NCT01131676|69525432|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
37841214|NCT01131676|69525433|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
37841215|NCT01131676|69525431|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
37841216|NCT01131676|69525432|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
37841217|NCT01131676|69525433|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
37841218|NCT01131676|69525431|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
37841219|NCT01131676|69525432|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
37841220|NCT01131676|69525433|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
37915682|NCT00849693|69602489|FG003|Acute Treatment Phase|Adverse Event|4|||
37915683|NCT00849693|69602486|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
37915684|NCT00849693|69602487|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
37724957|NCT01958671|69203758|FG002|Overall Study|Participant moved|1|||
37724958|NCT01958671|69203756|FG000|Overall Study|Withdrawal by Subject|8|||
37724959|NCT01958671|69203757|FG001|Overall Study|Withdrawal by Subject|10|||
37724960|NCT01958671|69203758|FG002|Overall Study|Withdrawal by Subject|13|||
37724961|NCT01995266|69203770|FG000|Overall Study|Death|1|||
37724962|NCT01995266|69203770|FG000|Overall Study|Lack of Efficacy|6|||
37724963|NCT01995266|69203770|FG000|Overall Study|Adverse Event|2|||
37724964|NCT01969058|69203776|FG000|Overall Study|Withdrawal by Subject|2|||
37724965|NCT01969058|69203777|FG001|Overall Study|Withdrawal by Subject|0|||
37724966|NCT01969058|69203776|FG000|Overall Study|Adverse Event|1|||
37724967|NCT01969058|69203777|FG001|Overall Study|Adverse Event|0|||
37724968|NCT01968980|69203785|FG000|Overall Study|Death|0|||
37724969|NCT01968980|69203786|FG001|Overall Study|Death|1|||
37724970|NCT01968980|69203785|FG000|Overall Study|Adverse Event|1|||
37724971|NCT01968980|69203786|FG001|Overall Study|Adverse Event|3|||
37724972|NCT01968980|69203785|FG000|Overall Study|Does not meet entry criteria|1|||
37724973|NCT01968980|69203786|FG001|Overall Study|Does not meet entry criteria|3|||
37841221|NCT01131676|69525431|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
37841222|NCT01131676|69525432|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
37841223|NCT01131676|69525433|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
37724974|NCT01968980|69203785|FG000|Overall Study|Withdrawal by Subject|13|||
37724975|NCT01968980|69203786|FG001|Overall Study|Withdrawal by Subject|5|||
37724976|NCT01968980|69203785|FG000|Overall Study|Other unspecified|1|||
37724977|NCT01968980|69203786|FG001|Overall Study|Other unspecified|2|||
37724978|NCT01961882|69203795|FG000|Overall Study|Adverse Event|3|||
37724979|NCT01961882|69203796|FG001|Overall Study|Adverse Event|2|||
37724980|NCT01961882|69203795|FG000|Overall Study|Physician Decision|1|||
37724981|NCT01961882|69203796|FG001|Overall Study|Physician Decision|0|||
37724982|NCT01961882|69203795|FG000|Overall Study|Withdrawal by Subject|4|||
37724983|NCT01961882|69203796|FG001|Overall Study|Withdrawal by Subject|1|||
37724984|NCT01961882|69203795|FG000|Overall Study|Relapse of AML|39|||
37724985|NCT01961882|69203796|FG001|Overall Study|Relapse of AML|37|||
37724986|NCT01961882|69203795|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
37724987|NCT01961882|69203796|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
37724988|NCT01961882|69203795|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
37724989|NCT01961882|69203796|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
37724990|NCT01968434|69203804|FG000|Overall Study|Lost to Follow-up|3|||
37724991|NCT01968434|69203805|FG001|Overall Study|Lost to Follow-up|6|||
37724992|NCT01946438|69203815|FG000|Overall Study|Adverse Event|0|||
37724993|NCT01946438|69203816|FG001|Overall Study|Adverse Event|0|||
37724994|NCT01946438|69203817|FG002|Overall Study|Adverse Event|0|||
37724995|NCT01946438|69203818|FG003|Overall Study|Adverse Event|1|||
37724996|NCT01946438|69203815|FG000|Overall Study|Serious Adverse event|1|||
37724997|NCT01946438|69203816|FG001|Overall Study|Serious Adverse event|0|||
37724998|NCT01946438|69203817|FG002|Overall Study|Serious Adverse event|0|||
37724999|NCT01946438|69203818|FG003|Overall Study|Serious Adverse event|0|||
37725000|NCT01946438|69203815|FG000|Overall Study|Protocol Violation|0|||
37725001|NCT01946438|69203816|FG001|Overall Study|Protocol Violation|0|||
37725002|NCT01946438|69203817|FG002|Overall Study|Protocol Violation|1|||
37725003|NCT01946438|69203818|FG003|Overall Study|Protocol Violation|0|||
37725004|NCT01946438|69203815|FG000|Overall Study|Withdrawal by Subject|1|||
37725005|NCT01946438|69203816|FG001|Overall Study|Withdrawal by Subject|0|||
37725006|NCT01946438|69203817|FG002|Overall Study|Withdrawal by Subject|0|||
37725007|NCT01946438|69203818|FG003|Overall Study|Withdrawal by Subject|0|||
37725008|NCT01946282|69203837|FG000|Year 1|Did not return FIT kit|4186|||
37725009|NCT01946282|69203838|FG001|Year 1|Did not return FIT kit|608|||
37841224|NCT01131676|69525431|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
37841225|NCT01131676|69525432|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
37841226|NCT01131676|69525433|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
37841227|NCT01131520|69525455|FG000|Overall Study|Computer problem|1|||
37841228|NCT01131520|69525456|FG001|Overall Study|Computer problem|0|||
37841229|NCT01131520|69525455|FG000|Overall Study|Counselor not available|0|||
37841230|NCT01131520|69525456|FG001|Overall Study|Counselor not available|3|||
37841231|NCT01131520|69525455|FG000|Overall Study|Subject changed history after enrollment|0|||
37841232|NCT01131520|69525456|FG001|Overall Study|Subject changed history after enrollment|1|||
37841233|NCT01131325|69525462|FG000|Overall Study|Adverse Event|1|||
37841234|NCT01131325|69525462|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
37841235|NCT01131130|69525466|FG000|Period 1 - Baseline|Pregnancy|1|||
37841236|NCT01131130|69525466|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
37841237|NCT01130974|69525476|FG000|Overall Study|Protocol Violation|10|||
37841238|NCT01130974|69525477|FG001|Overall Study|Protocol Violation|10|||
37841239|NCT01130974|69525476|FG000|Overall Study|Withdrawal by Subject|0|||
37841240|NCT01130974|69525477|FG001|Overall Study|Withdrawal by Subject|1|||
37841241|NCT01130974|69525476|FG000|Overall Study|Ineligibility criteria|5|||
37841242|NCT01130974|69525477|FG001|Overall Study|Ineligibility criteria|2|||
37841243|NCT01130272|69525489|FG000|Overall Study|Adverse Event|2|||
37915685|NCT00849693|69602488|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
38025342|NCT02054104|69709711|FG000|Overall Study|Diagnosis of lymphoma|0|||
37725010|NCT01946282|69203839|FG002|Year 1|Did not return FIT kit|654|||
37725011|NCT01946282|69203837|FG000|Year 2|Did not return FIT kit|803|||
37725012|NCT01946282|69203838|FG001|Year 2|Did not return FIT kit|131|||
37725013|NCT01946282|69203839|FG002|Year 2|Did not return FIT kit|115|||
37725014|NCT01946282|69203837|FG000|Year 3|Did not return FIT kit|288|||
37725015|NCT01946282|69203838|FG001|Year 3|Did not return FIT kit|43|||
37725016|NCT01946282|69203839|FG002|Year 3|Did not return FIT kit|30|||
37841244|NCT01130272|69525490|FG001|Overall Study|Adverse Event|5|||
37841245|NCT01130272|69525491|FG002|Overall Study|Adverse Event|6|||
37841246|NCT01130272|69525492|FG003|Overall Study|Adverse Event|22|||
37841247|NCT01130272|69525493|FG004|Overall Study|Adverse Event|7|||
37841248|NCT01130272|69525489|FG000|Overall Study|IVRS-confirmed constipation|0|||
37841249|NCT01130272|69525490|FG001|Overall Study|IVRS-confirmed constipation|1|||
37841250|NCT01130272|69525491|FG002|Overall Study|IVRS-confirmed constipation|1|||
37725017|NCT01945580|69203851|FG000|Overall Study|Withdrawal by Subject|13|||
37725018|NCT01945580|69203852|FG001|Overall Study|Withdrawal by Subject|35|||
37725019|NCT01945580|69203851|FG000|Overall Study|Physician Decision|3|||
37725020|NCT01945580|69203852|FG001|Overall Study|Physician Decision|2|||
37725021|NCT01945580|69203851|FG000|Overall Study|Lost to Follow-up|26|||
37725022|NCT01945580|69203852|FG001|Overall Study|Lost to Follow-up|39|||
37725023|NCT01945580|69203851|FG000|Overall Study|Death|7|||
37725024|NCT01945580|69203852|FG001|Overall Study|Death|2|||
37725025|NCT01945580|69203851|FG000|Overall Study|Patient moved out of state|0|||
37725026|NCT01945580|69203852|FG001|Overall Study|Patient moved out of state|1|||
37725027|NCT01945580|69203851|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
37725028|NCT01945580|69203852|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
37725029|NCT01945580|69203851|FG000|Overall Study|Family illness - unable to return|0|||
37725030|NCT01945580|69203852|FG001|Overall Study|Family illness - unable to return|1|||
37725031|NCT01945580|69203851|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
37725032|NCT01945580|69203852|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
37725033|NCT01945580|69203851|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
37725034|NCT01945580|69203852|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
37725035|NCT01945580|69203851|FG000|Overall Study|Noncompliance with 36 month visit|1|||
37725036|NCT01945580|69203852|FG001|Overall Study|Noncompliance with 36 month visit|0|||
37841251|NCT01130272|69525492|FG003|Overall Study|IVRS-confirmed constipation|2|||
37841252|NCT01130272|69525493|FG004|Overall Study|IVRS-confirmed constipation|0|||
37841253|NCT01130272|69525489|FG000|Overall Study|Rescue medications due to diarrhea|3|||
37841254|NCT01130272|69525490|FG001|Overall Study|Rescue medications due to diarrhea|5|||
37841255|NCT01130272|69525491|FG002|Overall Study|Rescue medications due to diarrhea|8|||
37841256|NCT01130272|69525492|FG003|Overall Study|Rescue medications due to diarrhea|8|||
37841257|NCT01130272|69525493|FG004|Overall Study|Rescue medications due to diarrhea|6|||
37841258|NCT01130272|69525489|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
37841259|NCT01130272|69525490|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
37841260|NCT01130272|69525491|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
37841261|NCT01130272|69525492|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
37841262|NCT01130272|69525493|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
37841263|NCT01130272|69525489|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
37841264|NCT01130272|69525490|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
37841265|NCT01130272|69525491|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
37841266|NCT01130272|69525492|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
37841267|NCT01130272|69525493|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
37841268|NCT01130272|69525489|FG000|Overall Study|Protocol Violation|0|||
37841269|NCT01130272|69525490|FG001|Overall Study|Protocol Violation|0|||
37841270|NCT01130272|69525491|FG002|Overall Study|Protocol Violation|3|||
37841271|NCT01130272|69525492|FG003|Overall Study|Protocol Violation|5|||
37725037|NCT01945580|69203851|FG000|Overall Study|The patient moved.|1|||
37725038|NCT01945580|69203852|FG001|Overall Study|The patient moved.|0|||
37725039|NCT01945580|69203851|FG000|Overall Study|No data available|0|||
37725040|NCT01945580|69203852|FG001|Overall Study|No data available|2|||
37725041|NCT01945034|69203865|FG000|Overall Study|Medication Error|0|||
37725042|NCT01945034|69203866|FG001|Overall Study|Medication Error|1|||
37841272|NCT01130272|69525493|FG004|Overall Study|Protocol Violation|5|||
37841273|NCT01130272|69525489|FG000|Overall Study|Lost to Follow-up|4|||
37841274|NCT01130272|69525490|FG001|Overall Study|Lost to Follow-up|3|||
37841275|NCT01130272|69525491|FG002|Overall Study|Lost to Follow-up|4|||
37841276|NCT01130272|69525492|FG003|Overall Study|Lost to Follow-up|7|||
37841277|NCT01130272|69525493|FG004|Overall Study|Lost to Follow-up|6|||
37841278|NCT01130272|69525489|FG000|Overall Study|Withdrawal by Subject|4|||
37841279|NCT01130272|69525490|FG001|Overall Study|Withdrawal by Subject|11|||
37841280|NCT01130272|69525491|FG002|Overall Study|Withdrawal by Subject|10|||
37841281|NCT01130272|69525492|FG003|Overall Study|Withdrawal by Subject|9|||
37841282|NCT01130272|69525493|FG004|Overall Study|Withdrawal by Subject|8|||
37725043|NCT01945034|69203867|FG002|Overall Study|Medication Error|0|||
37725044|NCT01945034|69203865|FG000|Overall Study|Withdrawal by Subject|0|||
37725045|NCT01945034|69203866|FG001|Overall Study|Withdrawal by Subject|3|||
37725046|NCT01945034|69203867|FG002|Overall Study|Withdrawal by Subject|1|||
37725047|NCT01945034|69203865|FG000|Overall Study|Other|0|||
37725048|NCT01945034|69203866|FG001|Overall Study|Other|1|||
37725049|NCT01945034|69203867|FG002|Overall Study|Other|3|||
37725050|NCT01945034|69203865|FG000|Overall Study|Lost to Follow-up|0|||
37725051|NCT01945034|69203866|FG001|Overall Study|Lost to Follow-up|0|||
37725052|NCT01945034|69203867|FG002|Overall Study|Lost to Follow-up|2|||
37725053|NCT01945034|69203865|FG000|Overall Study|Protocol Violation|1|||
37725054|NCT01945034|69203866|FG001|Overall Study|Protocol Violation|0|||
37725055|NCT01945034|69203867|FG002|Overall Study|Protocol Violation|1|||
37725056|NCT01960790|69203875|FG000|Overall Study|Survey forms could not be recovered|3|||
37725057|NCT01960790|69203875|FG000|Overall Study|Treat with Humira outside survey period|3|||
37725058|NCT01960790|69203875|FG000|Overall Study|Transferred to another hospital|4|||
37725059|NCT01960790|69203875|FG000|Overall Study|Unevaluable for safety|1|||
37725060|NCT01618214|69203881|FG000|Overall Study|Adverse Event|3|||
37725061|NCT01618214|69203882|FG001|Overall Study|Adverse Event|1|||
37725062|NCT01618214|69203881|FG000|Overall Study|Lack of Efficacy|1|||
37725063|NCT01618214|69203882|FG001|Overall Study|Lack of Efficacy|1|||
37725064|NCT01618214|69203881|FG000|Overall Study|Protocol Violation|1|||
37725065|NCT01618214|69203882|FG001|Overall Study|Protocol Violation|4|||
37725066|NCT01618214|69203881|FG000|Overall Study|Withdrawal Criteria|1|||
37725067|NCT01618214|69203882|FG001|Overall Study|Withdrawal Criteria|2|||
37725068|NCT01618214|69203881|FG000|Overall Study|Unclassified|4|||
37725069|NCT01618214|69203882|FG001|Overall Study|Unclassified|5|||
37725070|NCT01917968|69203890|FG000|Overall Study|Death|3|||
37725071|NCT01917968|69203891|FG001|Overall Study|Death|2|||
37725072|NCT01917968|69203890|FG000|Overall Study|Lost to Follow-up|21|||
38025343|NCT02054104|69709712|FG001|Overall Study|Diagnosis of lymphoma|1|||
38025344|NCT02054104|69709711|FG000|Overall Study|Inconclusive response|0|||
38025345|NCT02054104|69709712|FG001|Overall Study|Inconclusive response|1|||
38025346|NCT04090242|69709720|FG000|Overall Study|Withdrawal by Subject|1|||
38025347|NCT04090242|69709721|FG001|Overall Study|Withdrawal by Subject|0|||
38025348|NCT04090164|69709730|FG000|Overall Study|incomplete data on file|245|||
38025349|NCT04090164|69709731|FG001|Overall Study|incomplete data on file|0|||
37725073|NCT01917968|69203891|FG001|Overall Study|Lost to Follow-up|39|||
37725074|NCT01917968|69203890|FG000|Overall Study|Physician Decision|1|||
37725075|NCT01917968|69203891|FG001|Overall Study|Physician Decision|2|||
37725076|NCT01917968|69203890|FG000|Overall Study|Withdrawal by Subject|20|||
37725077|NCT01917968|69203891|FG001|Overall Study|Withdrawal by Subject|35|||
37725078|NCT01917968|69203890|FG000|Overall Study|Subject Relocation|5|||
37725079|NCT01917968|69203891|FG001|Overall Study|Subject Relocation|1|||
37725080|NCT01917968|69203890|FG000|Overall Study|36M Missed Visit|3|||
37725081|NCT01917968|69203891|FG001|Overall Study|36M Missed Visit|2|||
37725082|NCT01917968|69203890|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
37725083|NCT01917968|69203891|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
37725084|NCT01917968|69203890|FG000|Overall Study|Change in Family Circumstances|0|||
37725085|NCT01917968|69203891|FG001|Overall Study|Change in Family Circumstances|1|||
37725086|NCT01917968|69203890|FG000|Overall Study|No Data Available|0|||
37915686|NCT00849693|69602489|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
37915687|NCT00849693|69602486|FG000|Acute Treatment Phase|Protocol Violation|1|||
38025350|NCT04292730|69709751|FG000|Overall Study|Lost to Follow-up|8|||
38025351|NCT04292730|69709752|FG001|Overall Study|Lost to Follow-up|12|||
37725087|NCT01917968|69203891|FG001|Overall Study|No Data Available|2|||
37725088|NCT01917656|69203906|FG000|Overall Study|Adverse Event|11|||
37725089|NCT01917656|69203907|FG001|Overall Study|Adverse Event|0|||
37725090|NCT01917656|69203906|FG000|Overall Study|Withdrawal criteria|8|||
37725091|NCT01917656|69203907|FG001|Overall Study|Withdrawal criteria|14|||
37725092|NCT01917656|69203906|FG000|Overall Study|Unclassified|0|||
37725093|NCT01917656|69203907|FG001|Overall Study|Unclassified|3|||
37725094|NCT01917656|69203906|FG000|Overall Study|Withdrawal by Subject|4|||
37725095|NCT01917656|69203907|FG001|Overall Study|Withdrawal by Subject|3|||
37725096|NCT01917656|69203906|FG000|Overall Study|Lost to Follow-up|3|||
37725097|NCT01917656|69203907|FG001|Overall Study|Lost to Follow-up|4|||
37725098|NCT01944722|69203915|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
37725099|NCT01944722|69203915|FG000|Overall Study|Specimen Shipping Issues|34|||
37725100|NCT01944722|69203915|FG000|Overall Study|Improper Storage/Transport|5|||
37725101|NCT01944722|69203915|FG000|Overall Study|Insufficient Volume for Test|1|||
37725102|NCT01944722|69203915|FG000|Overall Study|Missing Specimens|3|||
37725103|NCT01944722|69203915|FG000|Overall Study|Specimens Mislabeled|2|||
37725104|NCT01944722|69203915|FG000|Overall Study|Withdrawal by Subject|8|||
37725105|NCT01944722|69203915|FG000|Overall Study|NILM Subjects <30 years old|8106|||
37725106|NCT01944722|69203915|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
37725107|NCT01944722|69203915|FG000|Overall Study|>ASCUS Cytology|1122|||
37725108|NCT01917344|69203924|FG000|Overall Study|Withdrawal by Subject|1|||
37725109|NCT02017535|69203932|FG000|Overall Study|Withdrawal by Subject|1|||
37725110|NCT02017535|69203933|FG001|Overall Study|Withdrawal by Subject|0|||
37725111|NCT02017535|69203934|FG002|Overall Study|Withdrawal by Subject|0|||
37725112|NCT02017535|69203935|FG003|Overall Study|Withdrawal by Subject|0|||
37725113|NCT01944098|69203947|FG000|Overall Study|Physician Decision|1|||
37725114|NCT01944098|69203948|FG001|Overall Study|Physician Decision|0|||
37725115|NCT02017223|69203954|FG000|Overall Study|Algorithm problems|2|||
37725116|NCT01944020|69203960|FG000|Overall Study|Withdrawal by Subject|5|||
37725117|NCT01944020|69203961|FG001|Overall Study|Withdrawal by Subject|0|||
37725118|NCT01943552|69203969|FG000|Overall Study|Adverse Event|3|||
37725119|NCT01943552|69203970|FG001|Overall Study|Adverse Event|2|||
37725120|NCT01943552|69203969|FG000|Overall Study|Withdrawal by Subject|6|||
37725121|NCT01943552|69203970|FG001|Overall Study|Withdrawal by Subject|6|||
37725122|NCT01943552|69203969|FG000|Overall Study|Other Reasons|16|||
37725123|NCT01943552|69203970|FG001|Overall Study|Other Reasons|17|||
37725124|NCT01915940|69203978|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
37725125|NCT01915940|69203979|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
37725126|NCT01915940|69203980|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
37725127|NCT01915940|69203978|FG000|Treatment Period|Decision of Participant|0|||
37725128|NCT01915940|69203979|FG001|Treatment Period|Decision of Participant|1|||
37725129|NCT01915940|69203980|FG002|Treatment Period|Decision of Participant|3|||
37725130|NCT01915940|69203978|FG000|Treatment Period|Adverse Event|0|||
37725131|NCT01915940|69203979|FG001|Treatment Period|Adverse Event|9|||
37841283|NCT01130272|69525489|FG000|Overall Study|Physician Decision|1|||
37841284|NCT01130272|69525490|FG001|Overall Study|Physician Decision|1|||
37841285|NCT01130272|69525491|FG002|Overall Study|Physician Decision|0|||
37841286|NCT01130272|69525492|FG003|Overall Study|Physician Decision|1|||
37841287|NCT01130272|69525493|FG004|Overall Study|Physician Decision|2|||
37725132|NCT01915940|69203980|FG002|Treatment Period|Adverse Event|1|||
37725133|NCT01915940|69203978|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
37725134|NCT01915940|69203979|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
37725135|NCT01915940|69203980|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
37725136|NCT01914926|69203988|FG000|Overall Study|Adverse Event|1|||
37725137|NCT01914926|69203989|FG001|Overall Study|Adverse Event|0|||
37725138|NCT01914926|69203988|FG000|Overall Study|uncooperative, agitated and removed|0|||
37725139|NCT01914926|69203989|FG001|Overall Study|uncooperative, agitated and removed|1|||
37725140|NCT02016755|69203995|FG000|Overall Study|Major amputation of index limb|2|||
37725141|NCT02016755|69203995|FG000|Overall Study|Adverse Event|2|||
37725142|NCT02016755|69203995|FG000|Overall Study|Physician Decision|1|||
37725143|NCT02016755|69203995|FG000|Overall Study|Death|2|||
37725144|NCT01942148|69203999|FG000|Overall Study|Adverse Event|4|||
37725145|NCT01942148|69203999|FG000|Overall Study|Lack of Efficacy|2|||
37725146|NCT01942148|69203999|FG000|Overall Study|Physician Decision|11|||
37725147|NCT01942148|69203999|FG000|Overall Study|Protocol Violation|1|||
37841288|NCT01130272|69525489|FG000|Overall Study|Sponsor decision|6|||
37841289|NCT01130272|69525490|FG001|Overall Study|Sponsor decision|15|||
37841290|NCT01130272|69525491|FG002|Overall Study|Sponsor decision|16|||
37725148|NCT01942148|69203999|FG000|Overall Study|Withdrawal by Subject|8|||
37725149|NCT01942148|69203999|FG000|Overall Study|Use of the prohibition medicine|1|||
37725150|NCT02030015|69204003|FG000|Overall Study|Withdrawal by Subject|3|||
37725151|NCT02030015|69204003|FG000|Overall Study|Death|13|||
37725152|NCT02029235|69204009|FG000|Overall Study|Non-compliance with study meds or diary|4|||
37841291|NCT01130272|69525492|FG003|Overall Study|Sponsor decision|13|||
37841292|NCT01130272|69525493|FG004|Overall Study|Sponsor decision|16|||
37841293|NCT01130272|69525489|FG000|Overall Study|Study arm discontinued|38|||
37725153|NCT02029235|69204010|FG001|Overall Study|Non-compliance with study meds or diary|1|||
37725154|NCT01617434|69204018|FG000|Overall Study|Adverse Event|12|||
37725155|NCT01617434|69204019|FG001|Overall Study|Adverse Event|3|||
37725156|NCT01617434|69204018|FG000|Overall Study|Protocol Violation|8|||
37725157|NCT01617434|69204019|FG001|Overall Study|Protocol Violation|7|||
37725158|NCT01617434|69204018|FG000|Overall Study|Withdrawal Criteria|12|||
37725159|NCT01617434|69204019|FG001|Overall Study|Withdrawal Criteria|37|||
37725160|NCT01617434|69204018|FG000|Overall Study|Unclassified|3|||
37725161|NCT01617434|69204019|FG001|Overall Study|Unclassified|4|||
37725162|NCT01940900|69204027|FG000|Overall Study|Physician Decision|4|||
37725163|NCT01940900|69204028|FG001|Overall Study|Physician Decision|0|||
37725164|NCT01940900|69204027|FG000|Overall Study|Adverse Event|10|||
37725165|NCT01940900|69204028|FG001|Overall Study|Adverse Event|15|||
37725166|NCT01940900|69204027|FG000|Overall Study|Withdrawal by Subject|11|||
37725167|NCT01940900|69204028|FG001|Overall Study|Withdrawal by Subject|15|||
37725168|NCT01940900|69204027|FG000|Overall Study|Lost to Follow-up|1|||
37725169|NCT01940900|69204028|FG001|Overall Study|Lost to Follow-up|0|||
37725170|NCT01940900|69204027|FG000|Overall Study|Sponsor Decision|1|||
37725171|NCT01940900|69204028|FG001|Overall Study|Sponsor Decision|0|||
37725172|NCT01940900|69204027|FG000|Overall Study|subject non-compliance|1|||
37725173|NCT01940900|69204028|FG001|Overall Study|subject non-compliance|1|||
37725174|NCT01940900|69204027|FG000|Overall Study|other|1|||
37725175|NCT01940900|69204028|FG001|Overall Study|other|0|||
37725176|NCT01940354|69204036|FG000|Overall Study|Withdrawal by Subject|4|||
37725177|NCT01940354|69204037|FG001|Overall Study|Withdrawal by Subject|2|||
37725178|NCT01940120|69204043|FG000|Overall Study|Death|40|||
37725179|NCT01940120|69204043|FG000|Overall Study|Withdrawal by Subject|8|||
37725180|NCT01911260|69204052|FG000|Supplementation Period|transference or evasion of school|7|||
37725181|NCT01911260|69204053|FG001|Supplementation Period|transference or evasion of school|9|||
37725182|NCT01911260|69204054|FG002|Supplementation Period|transference or evasion of school|7|||
37725183|NCT01911260|69204055|FG003|Supplementation Period|transference or evasion of school|6|||
37725184|NCT01911260|69204052|FG000|Supplementation Period|Adverse Event|2|||
37725185|NCT01911260|69204053|FG001|Supplementation Period|Adverse Event|0|||
37725186|NCT01911260|69204054|FG002|Supplementation Period|Adverse Event|1|||
37725187|NCT01911260|69204055|FG003|Supplementation Period|Adverse Event|0|||
37725188|NCT01911260|69204052|FG000|Supplementation Period|refused to receive supplement|1|||
37725189|NCT01911260|69204053|FG001|Supplementation Period|refused to receive supplement|0|||
37725190|NCT01911260|69204054|FG002|Supplementation Period|refused to receive supplement|1|||
37725191|NCT01911260|69204055|FG003|Supplementation Period|refused to receive supplement|0|||
37725192|NCT01911260|69204052|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
37725193|NCT01911260|69204053|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
37725194|NCT01911260|69204054|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
37725195|NCT01911260|69204055|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
37725196|NCT01911260|69204052|FG000|Follow-up Period|transference or evasion of school|13|||
37841294|NCT01130272|69525490|FG001|Overall Study|Study arm discontinued|0|||
37841295|NCT01130272|69525491|FG002|Overall Study|Study arm discontinued|0|||
37841296|NCT01130272|69525492|FG003|Overall Study|Study arm discontinued|0|||
37841297|NCT01130272|69525493|FG004|Overall Study|Study arm discontinued|0|||
37725197|NCT01911260|69204053|FG001|Follow-up Period|transference or evasion of school|20|||
37725198|NCT01911260|69204054|FG002|Follow-up Period|transference or evasion of school|15|||
37725199|NCT01911260|69204055|FG003|Follow-up Period|transference or evasion of school|12|||
37725200|NCT02015819|69204069|FG000|Overall Study|Rickham catheter was misaligned|0|||
37725201|NCT02015819|69204070|FG001|Overall Study|Rickham catheter was misaligned|0|||
37725202|NCT02015819|69204071|FG002|Overall Study|Rickham catheter was misaligned|0|||
37725203|NCT02015819|69204072|FG003|Overall Study|Rickham catheter was misaligned|1|||
37725204|NCT01939496|69204089|FG000|Overall Study|Adverse Event|2|||
37915688|NCT00849693|69602487|FG001|Acute Treatment Phase|Protocol Violation|5|||
37915689|NCT00849693|69602488|FG002|Acute Treatment Phase|Protocol Violation|2|||
37915690|NCT00849693|69602489|FG003|Acute Treatment Phase|Protocol Violation|6|||
37915691|NCT00849693|69602486|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
37725205|NCT01939496|69204090|FG001|Overall Study|Adverse Event|0|||
37725206|NCT01939496|69204091|FG002|Overall Study|Adverse Event|0|||
37725207|NCT01939496|69204089|FG000|Overall Study|Lost to Follow-up|1|||
37725208|NCT01939496|69204090|FG001|Overall Study|Lost to Follow-up|1|||
37725209|NCT01939496|69204091|FG002|Overall Study|Lost to Follow-up|0|||
37725210|NCT01939496|69204089|FG000|Overall Study|Physician Decision|1|||
37725211|NCT01939496|69204090|FG001|Overall Study|Physician Decision|0|||
37915692|NCT00849693|69602487|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
37725212|NCT01939496|69204091|FG002|Overall Study|Physician Decision|0|||
37725213|NCT01939496|69204089|FG000|Overall Study|Protocol Violation|3|||
37725214|NCT01939496|69204090|FG001|Overall Study|Protocol Violation|0|||
37725215|NCT01939496|69204091|FG002|Overall Study|Protocol Violation|0|||
37725216|NCT01939496|69204089|FG000|Overall Study|Withdrawal by Subject|0|||
37725217|NCT01939496|69204090|FG001|Overall Study|Withdrawal by Subject|1|||
37915693|NCT00849693|69602488|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
37725218|NCT01939496|69204091|FG002|Overall Study|Withdrawal by Subject|1|||
37725219|NCT01939496|69204089|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
37725220|NCT01939496|69204090|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
37841298|NCT01129960|69525509|FG000|Overall Study|Withdrawal by Subject|3|||
37841299|NCT01129960|69525510|FG001|Overall Study|Withdrawal by Subject|0|||
37841300|NCT01129960|69525511|FG002|Overall Study|Withdrawal by Subject|3|||
37841301|NCT01129960|69525512|FG003|Overall Study|Withdrawal by Subject|2|||
37841302|NCT01129960|69525509|FG000|Overall Study|Lack of Efficacy|1|||
37841303|NCT01129960|69525510|FG001|Overall Study|Lack of Efficacy|1|||
37841304|NCT01129960|69525511|FG002|Overall Study|Lack of Efficacy|1|||
37841305|NCT01129960|69525512|FG003|Overall Study|Lack of Efficacy|1|||
37841306|NCT01129960|69525509|FG000|Overall Study|Adverse Event|23|||
37841307|NCT01129960|69525510|FG001|Overall Study|Adverse Event|16|||
37841308|NCT01129960|69525511|FG002|Overall Study|Adverse Event|16|||
37841309|NCT01129960|69525512|FG003|Overall Study|Adverse Event|7|||
37915694|NCT00849693|69602489|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
37915695|NCT00849693|69602486|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
37915696|NCT00849693|69602487|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
37915697|NCT00849693|69602488|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
37915698|NCT00849693|69602489|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
37915699|NCT00849693|69602486|FG000|Acute Treatment Phase|Physician Decision|2|||
38025352|NCT04292730|69709753|FG002|Overall Study|Lost to Follow-up|12|||
37725221|NCT01939496|69204091|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
37725222|NCT01939496|69204089|FG000|Overall Study|Other|2|||
37725223|NCT01939496|69204090|FG001|Overall Study|Other|0|||
37725224|NCT01939496|69204091|FG002|Overall Study|Other|1|||
37725225|NCT01939028|69204099|FG000|Overall Study|Withdrawal by Subject|5|||
37725226|NCT01939028|69204099|FG000|Overall Study|Physician Decision|7|||
37841310|NCT01129960|69525509|FG000|Overall Study|Protocol Violation|1|||
37841311|NCT01129960|69525510|FG001|Overall Study|Protocol Violation|2|||
37841312|NCT01129960|69525511|FG002|Overall Study|Protocol Violation|3|||
37841313|NCT01129960|69525512|FG003|Overall Study|Protocol Violation|0|||
37841314|NCT01129960|69525509|FG000|Overall Study|Lost to Follow-up|0|||
37841315|NCT01129960|69525510|FG001|Overall Study|Lost to Follow-up|2|||
37841316|NCT01129960|69525511|FG002|Overall Study|Lost to Follow-up|3|||
37841317|NCT01129960|69525512|FG003|Overall Study|Lost to Follow-up|3|||
37841318|NCT01129960|69525509|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
37841319|NCT01129960|69525510|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
37841320|NCT01129960|69525511|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
37841321|NCT01129960|69525512|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
37841322|NCT01129960|69525509|FG000|Overall Study|Physician Decision|1|||
37841323|NCT01129960|69525510|FG001|Overall Study|Physician Decision|0|||
37841324|NCT01129960|69525511|FG002|Overall Study|Physician Decision|0|||
37841325|NCT01129960|69525512|FG003|Overall Study|Physician Decision|0|||
37841326|NCT01129960|69525509|FG000|Overall Study|Pregnancy|1|||
37841327|NCT01129960|69525510|FG001|Overall Study|Pregnancy|0|||
37841328|NCT01129960|69525511|FG002|Overall Study|Pregnancy|0|||
37841329|NCT01129960|69525512|FG003|Overall Study|Pregnancy|0|||
37725227|NCT01938716|69204103|FG000|Overall Study|Physician Decision|2|||
37725228|NCT01938716|69204103|FG000|Overall Study|Withdrawal by Subject|2|||
37725229|NCT01937390|69204107|FG000|Overall Study|Death|2|||
37725230|NCT01937390|69204107|FG000|Overall Study|Lost to Follow-up|7|||
37725231|NCT01937390|69204107|FG000|Overall Study|Withdrawal by Subject|5|||
37725232|NCT01937390|69204107|FG000|Overall Study|Fail to return|21|||
37725233|NCT02028767|69204111|FG000|Treatment Period 2|Non compliant with protocol|1|||
37725234|NCT02028767|69204112|FG001|Treatment Period 2|Non compliant with protocol|0|||
37725235|NCT02028767|69204111|FG000|Treatment Period 2|Reason other than those specified above|1|||
37725236|NCT02028767|69204112|FG001|Treatment Period 2|Reason other than those specified above|0|||
37841330|NCT01129921|69525524|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
37841331|NCT01129921|69525525|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
37841332|NCT01129921|69525524|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
37841333|NCT01129921|69525525|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
37841334|NCT01129921|69525524|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
37841335|NCT01129921|69525525|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
37841336|NCT01129921|69525524|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
37841337|NCT01129921|69525525|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
37841338|NCT01129882|69525544|FG000|Overall Study|Adverse Event|39|||
37841339|NCT01129882|69525544|FG000|Overall Study|Death|6|||
37841340|NCT01129882|69525544|FG000|Overall Study|Lack of Efficacy|5|||
37725237|NCT01959932|69204121|FG000|Overall Study|Withdrawal by Subject|1|||
37725238|NCT01959932|69204122|FG001|Overall Study|Withdrawal by Subject|0|||
37841341|NCT01129882|69525544|FG000|Overall Study|Lost to Follow-up|13|||
37915700|NCT00849693|69602487|FG001|Acute Treatment Phase|Physician Decision|1|||
38025353|NCT04292730|69709754|FG003|Overall Study|Lost to Follow-up|48|||
37725239|NCT01959932|69204123|FG002|Overall Study|Withdrawal by Subject|0|||
37725240|NCT02028065|69204135|FG000|Randomization Through Start Treatment|Not treated|1|||
37725241|NCT02028065|69204136|FG001|Randomization Through Start Treatment|Not treated|3|||
37725242|NCT02028065|69204137|FG002|Randomization Through Start Treatment|Not treated|3|||
37725243|NCT02028065|69204135|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
37725244|NCT02028065|69204136|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
37725245|NCT02028065|69204137|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
37725246|NCT02028065|69204135|FG000|Treatment Through Study Completion|Physician Decision|1|||
37725247|NCT02028065|69204136|FG001|Treatment Through Study Completion|Physician Decision|0|||
37725248|NCT02028065|69204137|FG002|Treatment Through Study Completion|Physician Decision|0|||
37725249|NCT02028065|69204135|FG000|Treatment Through Study Completion|Protocol Violation|1|||
37725250|NCT02028065|69204136|FG001|Treatment Through Study Completion|Protocol Violation|4|||
37725251|NCT02028065|69204137|FG002|Treatment Through Study Completion|Protocol Violation|0|||
37725252|NCT02028065|69204135|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
37725253|NCT02028065|69204136|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
37725254|NCT02028065|69204137|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
37725255|NCT02028065|69204135|FG000|Treatment Through Study Completion|Adverse Event|3|||
37725256|NCT02028065|69204136|FG001|Treatment Through Study Completion|Adverse Event|3|||
37725257|NCT02028065|69204137|FG002|Treatment Through Study Completion|Adverse Event|5|||
37725258|NCT02015195|69204152|FG000|Overall Study|Adverse Event|0|||
37725259|NCT02015195|69204153|FG001|Overall Study|Adverse Event|0|||
37725260|NCT02015195|69204154|FG002|Overall Study|Adverse Event|0|||
37725261|NCT02015195|69204155|FG003|Overall Study|Adverse Event|1|||
37725262|NCT02015195|69204156|FG004|Overall Study|Adverse Event|0|||
37725263|NCT02015195|69204157|FG005|Overall Study|Adverse Event|0|||
37725264|NCT02015195|69204158|FG006|Overall Study|Adverse Event|0|||
37725265|NCT02015039|69204175|FG000|Overall Study|Not eligible|0|||
37725266|NCT02015039|69204176|FG001|Overall Study|Not eligible|1|||
37725267|NCT02025725|69204184|FG000|Overall Study|Adverse Event|5|||
37725268|NCT02025725|69204185|FG001|Overall Study|Adverse Event|0|||
37725269|NCT02025725|69204184|FG000|Overall Study|Lost to Follow-up|2|||
37725270|NCT02025725|69204185|FG001|Overall Study|Lost to Follow-up|0|||
37725271|NCT02025725|69204184|FG000|Overall Study|Protocol Violation|1|||
37725272|NCT02025725|69204185|FG001|Overall Study|Protocol Violation|1|||
37725273|NCT02025725|69204184|FG000|Overall Study|Withdrawal by Subject|3|||
37725274|NCT02025725|69204185|FG001|Overall Study|Withdrawal by Subject|2|||
37725275|NCT02025725|69204184|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
37725276|NCT02025725|69204185|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
37725277|NCT02025179|69204196|FG000|Overall Study|Lost to Follow-up|0|||
37725278|NCT02025179|69204197|FG001|Overall Study|Lost to Follow-up|0|||
37725279|NCT02025179|69204198|FG002|Overall Study|Lost to Follow-up|1|||
37725280|NCT02013791|69204215|FG000|Period 1|Lost to Follow-up|0|||
37725281|NCT02013791|69204216|FG001|Period 1|Lost to Follow-up|0|||
37725282|NCT02013791|69204217|FG002|Period 1|Lost to Follow-up|0|||
37725283|NCT02013791|69204218|FG003|Period 1|Lost to Follow-up|1|||
37725284|NCT02013791|69204219|FG004|Period 1|Lost to Follow-up|0|||
37725285|NCT02013791|69204220|FG005|Period 1|Lost to Follow-up|0|||
37725286|NCT02013791|69204221|FG006|Period 1|Lost to Follow-up|1|||
37725287|NCT02013791|69204222|FG007|Period 1|Lost to Follow-up|1|||
37725288|NCT02013791|69204223|FG008|Period 1|Lost to Follow-up|0|||
37725289|NCT02013791|69204215|FG000|Period 1|Other Miscellaneous Reasons|0|||
37725290|NCT02013791|69204216|FG001|Period 1|Other Miscellaneous Reasons|2|||
37725291|NCT02013791|69204217|FG002|Period 1|Other Miscellaneous Reasons|0|||
37725292|NCT02013791|69204218|FG003|Period 1|Other Miscellaneous Reasons|0|||
37915701|NCT00849693|69602488|FG002|Acute Treatment Phase|Physician Decision|2|||
37915702|NCT00849693|69602489|FG003|Acute Treatment Phase|Physician Decision|1|||
37915703|NCT00849693|69602486|FG000|Acute Treatment Phase|Sponsor decision|0|||
37915704|NCT00849693|69602487|FG001|Acute Treatment Phase|Sponsor decision|0|||
37915705|NCT00849693|69602488|FG002|Acute Treatment Phase|Sponsor decision|1|||
37915706|NCT00849693|69602489|FG003|Acute Treatment Phase|Sponsor decision|0|||
37915707|NCT00849693|69602486|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
37915708|NCT00849693|69602487|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
37915709|NCT00849693|69602488|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
37915710|NCT00849693|69602489|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
37725293|NCT02013791|69204219|FG004|Period 1|Other Miscellaneous Reasons|0|||
37725294|NCT02013791|69204220|FG005|Period 1|Other Miscellaneous Reasons|0|||
37725295|NCT02013791|69204221|FG006|Period 1|Other Miscellaneous Reasons|0|||
37915711|NCT00849693|69602486|FG000|Extension Phase|Adverse Event|4|||
37725296|NCT02013791|69204222|FG007|Period 1|Other Miscellaneous Reasons|0|||
37725297|NCT02013791|69204223|FG008|Period 1|Other Miscellaneous Reasons|0|||
37725298|NCT02024867|69204246|FG000|Overall Study|Protocol Violation|3|||
37725299|NCT02024867|69204247|FG001|Overall Study|Protocol Violation|3|||
37725300|NCT02024867|69204246|FG000|Overall Study|Lost to Follow-up|6|||
37915712|NCT00849693|69602487|FG001|Extension Phase|Adverse Event|6|||
37915713|NCT00849693|69602488|FG002|Extension Phase|Adverse Event|3|||
37725301|NCT02024867|69204247|FG001|Overall Study|Lost to Follow-up|4|||
37725302|NCT01953601|69204256|FG000|Part 1 (Base Study)|Adverse Event|24|||
37725303|NCT01953601|69204257|FG001|Part 1 (Base Study)|Adverse Event|37|||
37725304|NCT01953601|69204258|FG002|Part 1 (Base Study)|Adverse Event|15|||
37725305|NCT01953601|69204256|FG000|Part 1 (Base Study)|Death|2|||
37725306|NCT01953601|69204257|FG001|Part 1 (Base Study)|Death|0|||
37725307|NCT01953601|69204258|FG002|Part 1 (Base Study)|Death|3|||
37725308|NCT01953601|69204256|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
37725309|NCT01953601|69204257|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
37725310|NCT01953601|69204258|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
37725311|NCT01953601|69204256|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
37725312|NCT01953601|69204257|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
37725313|NCT01953601|69204258|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
37725314|NCT01953601|69204256|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
37725315|NCT01953601|69204257|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
37725316|NCT01953601|69204258|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
37725317|NCT01953601|69204256|FG000|Part 1 (Base Study)|Physician Decision|3|||
37725318|NCT01953601|69204257|FG001|Part 1 (Base Study)|Physician Decision|7|||
37725319|NCT01953601|69204258|FG002|Part 1 (Base Study)|Physician Decision|4|||
37725320|NCT01953601|69204256|FG000|Part 1 (Base Study)|Screen failure|1|||
37725321|NCT01953601|69204257|FG001|Part 1 (Base Study)|Screen failure|0|||
37725322|NCT01953601|69204258|FG002|Part 1 (Base Study)|Screen failure|1|||
37725323|NCT01953601|69204256|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
37725324|NCT01953601|69204257|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
37725325|NCT01953601|69204258|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
37725326|NCT01953601|69204256|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
37725327|NCT01953601|69204257|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
37725328|NCT01953601|69204258|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
37725329|NCT01953601|69204256|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
37725330|NCT01953601|69204257|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
37725331|NCT01953601|69204258|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
37725332|NCT01953601|69204256|FG000|Part 1 (Base Study)|Subject moved|2|||
37725333|NCT01953601|69204257|FG001|Part 1 (Base Study)|Subject moved|2|||
37725334|NCT01953601|69204258|FG002|Part 1 (Base Study)|Subject moved|1|||
37725335|NCT01953601|69204256|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
37725336|NCT01953601|69204257|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
37725337|NCT01953601|69204258|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
37725338|NCT01953601|69204256|FG000|Part 2 (Extension Study)|Adverse Event|1|||
37725339|NCT01953601|69204257|FG001|Part 2 (Extension Study)|Adverse Event|1|||
37725340|NCT01953601|69204258|FG002|Part 2 (Extension Study)|Adverse Event|10|||
37725341|NCT01953601|69204256|FG000|Part 2 (Extension Study)|Death|0|||
37841342|NCT01129882|69525544|FG000|Overall Study|Physician Decision|27|||
37841343|NCT01129882|69525544|FG000|Overall Study|Protocol Deviation|3|||
37841344|NCT01129882|69525544|FG000|Overall Study|Withdrawal Criteria Met|19|||
37841345|NCT01129882|69525544|FG000|Overall Study|Trial Termination by Sponsor|6|||
37841346|NCT01129882|69525544|FG000|Overall Study|Withdrawal by Subject|160|||
37841347|NCT01129102|69525551|FG000|Overall Study|No study drug treatment|2|||
37841348|NCT01129102|69525552|FG001|Overall Study|No study drug treatment|3|||
37841349|NCT01129102|69525553|FG002|Overall Study|No study drug treatment|1|||
37841350|NCT01129102|69525551|FG000|Overall Study|Withdrawal by Subject|2|||
37841351|NCT01129102|69525552|FG001|Overall Study|Withdrawal by Subject|0|||
37841352|NCT01129102|69525553|FG002|Overall Study|Withdrawal by Subject|3|||
37841353|NCT01129102|69525551|FG000|Overall Study|Protocol Violation|0|||
37841354|NCT01129102|69525552|FG001|Overall Study|Protocol Violation|1|||
37841355|NCT01129102|69525553|FG002|Overall Study|Protocol Violation|1|||
37841356|NCT01129102|69525551|FG000|Overall Study|Pregnancy|0|||
37841357|NCT01129102|69525552|FG001|Overall Study|Pregnancy|0|||
37841358|NCT01129102|69525553|FG002|Overall Study|Pregnancy|1|||
37841359|NCT01129102|69525551|FG000|Overall Study|Adverse Event|2|||
37841360|NCT01129102|69525552|FG001|Overall Study|Adverse Event|2|||
37841361|NCT01129102|69525553|FG002|Overall Study|Adverse Event|1|||
37841362|NCT01129102|69525551|FG000|Overall Study|Lost to Follow-up|2|||
37841363|NCT01129102|69525552|FG001|Overall Study|Lost to Follow-up|0|||
37841364|NCT01129102|69525553|FG002|Overall Study|Lost to Follow-up|0|||
37725342|NCT01953601|69204257|FG001|Part 2 (Extension Study)|Death|3|||
37725343|NCT01953601|69204258|FG002|Part 2 (Extension Study)|Death|0|||
37725344|NCT01953601|69204256|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
37725345|NCT01953601|69204257|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
37725346|NCT01953601|69204258|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
37725347|NCT01953601|69204256|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
37725348|NCT01953601|69204257|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
37841365|NCT01129024|69525560|FG000|Overall Study|Physician Decision|5|||
37841366|NCT01129024|69525560|FG000|Overall Study|Study Terminated by Sponsor|8|||
37841367|NCT01129024|69525560|FG000|Overall Study|Withdrawal by Subject|2|||
37841368|NCT01129024|69525560|FG000|Overall Study|Lack of Efficacy|3|||
37841369|NCT01129024|69525560|FG000|Overall Study|Needed a Platelet Transfusion|1|||
37841370|NCT01128946|69525564|FG000|Period I|Protocol Violation|0|||
37841371|NCT01128946|69525565|FG001|Period I|Protocol Violation|1|||
37841372|NCT01128946|69525566|FG002|Period I|Protocol Violation|0|||
37841373|NCT01128946|69525567|FG003|Period I|Protocol Violation|0|||
37841374|NCT01128946|69525564|FG000|Period I|Withdrawal by Subject|0|||
37841375|NCT01128946|69525565|FG001|Period I|Withdrawal by Subject|0|||
37841376|NCT01128946|69525566|FG002|Period I|Withdrawal by Subject|1|||
37841377|NCT01128946|69525567|FG003|Period I|Withdrawal by Subject|1|||
37841378|NCT01128946|69525564|FG000|Period II|Protocol Violation|0|||
37841379|NCT01128946|69525565|FG001|Period II|Protocol Violation|1|||
37841380|NCT01128946|69525566|FG002|Period II|Protocol Violation|0|||
37841381|NCT01128946|69525567|FG003|Period II|Protocol Violation|0|||
37841382|NCT01128946|69525564|FG000|Period II|Withdrawal by Subject|0|||
37841383|NCT01128946|69525565|FG001|Period II|Withdrawal by Subject|0|||
37841384|NCT01128946|69525566|FG002|Period II|Withdrawal by Subject|0|||
37841385|NCT01128946|69525567|FG003|Period II|Withdrawal by Subject|1|||
37841386|NCT01128946|69525564|FG000|Period III|Protocol Violation|1|||
37841387|NCT01128946|69525565|FG001|Period III|Protocol Violation|0|||
37841388|NCT01128946|69525566|FG002|Period III|Protocol Violation|0|||
37841389|NCT01128946|69525567|FG003|Period III|Protocol Violation|0|||
37841390|NCT01128595|69525578|FG000|Treatment Period 3|Withdrawal by Subject|0|||
37841391|NCT01128595|69525579|FG001|Treatment Period 3|Withdrawal by Subject|1|||
37841392|NCT01128595|69525580|FG002|Treatment Period 3|Withdrawal by Subject|0|||
37841393|NCT01128595|69525581|FG003|Treatment Period 3|Withdrawal by Subject|0|||
37841394|NCT01129336|69525594|FG000|Overall Study|Protocol Violation|1|||
37841395|NCT01129336|69525595|FG001|Overall Study|Protocol Violation|0|||
37841396|NCT01129336|69525594|FG000|Overall Study|Disease Progression|1|||
37841397|NCT01129336|69525595|FG001|Overall Study|Disease Progression|4|||
37841398|NCT01129336|69525594|FG000|Overall Study|Lost to Follow-up|1|||
37841399|NCT01129336|69525595|FG001|Overall Study|Lost to Follow-up|0|||
37841400|NCT01129336|69525594|FG000|Overall Study|Withdrawal by Subject|7|||
37841401|NCT01129336|69525595|FG001|Overall Study|Withdrawal by Subject|4|||
37841402|NCT01129336|69525594|FG000|Overall Study|Adverse Event|0|||
37841403|NCT01129336|69525595|FG001|Overall Study|Adverse Event|1|||
37915714|NCT00849693|69602489|FG003|Extension Phase|Adverse Event|7|||
37725349|NCT01953601|69204258|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
37725350|NCT01953601|69204256|FG000|Part 2 (Extension Study)|Physician Decision|2|||
37725351|NCT01953601|69204257|FG001|Part 2 (Extension Study)|Physician Decision|0|||
37725352|NCT01953601|69204258|FG002|Part 2 (Extension Study)|Physician Decision|2|||
37725353|NCT01953601|69204256|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
37725354|NCT01953601|69204257|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
37725355|NCT01953601|69204258|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
37725356|NCT01953601|69204256|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
37725357|NCT01953601|69204257|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
37725358|NCT01953601|69204258|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
37725359|NCT01953601|69204256|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
37725360|NCT01953601|69204257|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
37725361|NCT01953601|69204258|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
37725362|NCT01953601|69204256|FG000|Part 2 (Extension Study)|Subject moved|0|||
37725363|NCT01953601|69204257|FG001|Part 2 (Extension Study)|Subject moved|0|||
37725364|NCT01953601|69204258|FG002|Part 2 (Extension Study)|Subject moved|1|||
37725365|NCT01953601|69204256|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
37725366|NCT01953601|69204257|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
37725367|NCT01953601|69204258|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
37725368|NCT01952665|69204271|FG000|Overall Study|Physician Decision|3|||
37725369|NCT01952665|69204272|FG001|Overall Study|Physician Decision|2|||
37725370|NCT01952665|69204271|FG000|Overall Study|Lost to Follow-up|1|||
37725371|NCT01952665|69204272|FG001|Overall Study|Lost to Follow-up|2|||
37725372|NCT01952665|69204271|FG000|Overall Study|Adverse Event|2|||
37725373|NCT01952665|69204272|FG001|Overall Study|Adverse Event|1|||
37725374|NCT01952665|69204271|FG000|Overall Study|Protocol Violation|0|||
37725375|NCT01952665|69204272|FG001|Overall Study|Protocol Violation|1|||
37725376|NCT01952041|69204283|FG000|Overall Study|Lost to Follow-up|9|||
37725377|NCT01952041|69204284|FG001|Overall Study|Lost to Follow-up|16|||
37725378|NCT01952041|69204283|FG000|Overall Study|Withdrawal by Subject|7|||
37841404|NCT01129336|69525594|FG000|Overall Study|Missing Study Completion Status|2|||
37841405|NCT01129336|69525595|FG001|Overall Study|Missing Study Completion Status|3|||
37841406|NCT01129336|69525594|FG000|Overall Study|Death|0|||
37841407|NCT01129336|69525595|FG001|Overall Study|Death|4|||
37841408|NCT01128400|69525604|FG000|Overall Study|Lost to Follow-up|1|||
37841409|NCT01128400|69525605|FG001|Overall Study|Lost to Follow-up|0|||
37841410|NCT01128400|69525606|FG002|Overall Study|Lost to Follow-up|1|||
37841411|NCT01128400|69525604|FG000|Overall Study|Screening failure|1|||
37841412|NCT01128400|69525605|FG001|Overall Study|Screening failure|0|||
37725379|NCT01952041|69204284|FG001|Overall Study|Withdrawal by Subject|5|||
37725380|NCT01952041|69204283|FG000|Overall Study|Death|1|||
37725381|NCT01952041|69204284|FG001|Overall Study|Death|0|||
37725382|NCT01951573|69204290|FG000|Washout Period|Adverse Event|0|||
37725383|NCT01951573|69204291|FG001|Washout Period|Adverse Event|1|||
37725384|NCT02023697|69204300|FG000|Treatment Period|Radiological progression|13|||
37725385|NCT02023697|69204301|FG001|Treatment Period|Radiological progression|17|||
37725386|NCT02023697|69204302|FG002|Treatment Period|Radiological progression|26|||
37725387|NCT02023697|69204300|FG000|Treatment Period|Never Treated|5|||
37725388|NCT02023697|69204301|FG001|Treatment Period|Never Treated|6|||
37725389|NCT02023697|69204302|FG002|Treatment Period|Never Treated|10|||
37725390|NCT02023697|69204300|FG000|Treatment Period|Adverse Event|13|||
37725391|NCT02023697|69204301|FG001|Treatment Period|Adverse Event|25|||
37725392|NCT02023697|69204302|FG002|Treatment Period|Adverse Event|23|||
37725393|NCT02023697|69204300|FG000|Treatment Period|Logistical difficulties|1|||
37725394|NCT02023697|69204301|FG001|Treatment Period|Logistical difficulties|1|||
37725395|NCT02023697|69204302|FG002|Treatment Period|Logistical difficulties|1|||
37725396|NCT02023697|69204300|FG000|Treatment Period|Clinical progression|10|||
37725397|NCT02023697|69204301|FG001|Treatment Period|Clinical progression|8|||
37725398|NCT02023697|69204302|FG002|Treatment Period|Clinical progression|28|||
37725399|NCT02023697|69204300|FG000|Treatment Period|Withdrawal by Subject|4|||
37725400|NCT02023697|69204301|FG001|Treatment Period|Withdrawal by Subject|5|||
37725401|NCT02023697|69204302|FG002|Treatment Period|Withdrawal by Subject|13|||
37725402|NCT02023697|69204300|FG000|Treatment Period|Safety outcome reached|0|||
37725403|NCT02023697|69204301|FG001|Treatment Period|Safety outcome reached|1|||
37725404|NCT02023697|69204302|FG002|Treatment Period|Safety outcome reached|0|||
37725405|NCT02023697|69204300|FG000|Treatment Period|Physician Decision|0|||
37725406|NCT02023697|69204301|FG001|Treatment Period|Physician Decision|0|||
37725407|NCT02023697|69204302|FG002|Treatment Period|Physician Decision|1|||
37725408|NCT02023697|69204300|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
37725409|NCT02023697|69204301|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
37725410|NCT02023697|69204302|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
37725411|NCT02023697|69204300|FG000|Active Follow-up Period|Lost to Follow-up|1|||
37725412|NCT02023697|69204301|FG001|Active Follow-up Period|Lost to Follow-up|1|||
37725413|NCT02023697|69204302|FG002|Active Follow-up Period|Lost to Follow-up|1|||
37725414|NCT02023697|69204300|FG000|Active Follow-up Period|Deterioration of general condition|1|||
37725415|NCT02023697|69204301|FG001|Active Follow-up Period|Deterioration of general condition|1|||
37725416|NCT02023697|69204302|FG002|Active Follow-up Period|Deterioration of general condition|1|||
37725417|NCT02023697|69204300|FG000|Active Follow-up Period|Other unspecified|2|||
37725418|NCT02023697|69204301|FG001|Active Follow-up Period|Other unspecified|0|||
37725419|NCT02023697|69204302|FG002|Active Follow-up Period|Other unspecified|1|||
37725420|NCT02023697|69204300|FG000|Active Follow-up Period|Clinical progression|0|||
37725421|NCT02023697|69204301|FG001|Active Follow-up Period|Clinical progression|2|||
37725422|NCT02023697|69204302|FG002|Active Follow-up Period|Clinical progression|1|||
37725423|NCT02023697|69204300|FG000|Active Follow-up Period|Radiological progression|0|||
37725424|NCT02023697|69204301|FG001|Active Follow-up Period|Radiological progression|0|||
37725425|NCT02023697|69204302|FG002|Active Follow-up Period|Radiological progression|1|||
37725426|NCT02023697|69204300|FG000|Active Follow-up Period|Death|83|||
37725427|NCT02023697|69204301|FG001|Active Follow-up Period|Death|82|||
37725428|NCT02023697|69204302|FG002|Active Follow-up Period|Death|87|||
37725429|NCT02023697|69204300|FG000|Long-term Follow-up Period|Death|9|||
37725430|NCT02023697|69204301|FG001|Long-term Follow-up Period|Death|6|||
37841413|NCT01128400|69525606|FG002|Overall Study|Screening failure|0|||
37841414|NCT01128400|69525604|FG000|Overall Study|were not invited to participate on taste|0|||
37841415|NCT01128400|69525605|FG001|Overall Study|were not invited to participate on taste|0|||
37841416|NCT01128400|69525606|FG002|Overall Study|were not invited to participate on taste|15|||
37841417|NCT01128400|69525604|FG000|Overall Study|Excluded due to sinus problems|0|||
37841418|NCT01128400|69525605|FG001|Overall Study|Excluded due to sinus problems|1|||
37841419|NCT01128400|69525606|FG002|Overall Study|Excluded due to sinus problems|0|||
37725431|NCT02023697|69204302|FG002|Long-term Follow-up Period|Death|4|||
37725432|NCT02023697|69204300|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
37725433|NCT02023697|69204301|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
37725434|NCT02023697|69204302|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
37841420|NCT01128361|69525616|FG000|Overall Study|Lost to Follow-up|0|||
37841421|NCT01128361|69525617|FG001|Overall Study|Lost to Follow-up|1|||
37841422|NCT01128361|69525616|FG000|Overall Study|Withdrawal by Subject|5|||
37841423|NCT01128361|69525617|FG001|Overall Study|Withdrawal by Subject|2|||
37915715|NCT00849693|69602486|FG000|Extension Phase|Lost to Follow-up|7|||
37915716|NCT00849693|69602487|FG001|Extension Phase|Lost to Follow-up|5|||
37915717|NCT00849693|69602488|FG002|Extension Phase|Lost to Follow-up|6|||
37725435|NCT02023697|69204300|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
37725436|NCT02023697|69204301|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
37725437|NCT02023697|69204302|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
37725438|NCT02023697|69204300|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
37725439|NCT02023697|69204301|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
37725440|NCT02023697|69204302|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
37725441|NCT02023697|69204300|FG000|Long-term Follow-up Period|Technical problems|0|||
37725442|NCT02023697|69204301|FG001|Long-term Follow-up Period|Technical problems|0|||
37725443|NCT02023697|69204302|FG002|Long-term Follow-up Period|Technical problems|1|||
37725444|NCT02023697|69204300|FG000|Long-term Follow-up Period|Other unspecified|6|||
37725445|NCT02023697|69204301|FG001|Long-term Follow-up Period|Other unspecified|3|||
37725446|NCT02023697|69204302|FG002|Long-term Follow-up Period|Other unspecified|5|||
37725447|NCT01951417|69204317|FG000|Overall Study|Withdrawal by Subject|1|||
37725448|NCT01951417|69204317|FG000|Overall Study|Protocol Violation|2|||
37725449|NCT01951417|69204317|FG000|Overall Study|Lost to Follow-up|6|||
37725450|NCT01951261|69204327|FG000|Overall Study|Death|1|||
37725451|NCT01951261|69204328|FG001|Overall Study|Death|0|||
37725452|NCT01951261|69204327|FG000|Overall Study|Lost to Follow-up|4|||
37725453|NCT01951261|69204328|FG001|Overall Study|Lost to Follow-up|3|||
37725454|NCT01951261|69204327|FG000|Overall Study|Protocol Violation|4|||
37725455|NCT01951261|69204328|FG001|Overall Study|Protocol Violation|3|||
37725456|NCT02023151|69204334|FG000|Overall Study|Lost to Follow-up|4|||
37725457|NCT01979185|69204340|FG000|Period 2|Other|0|||
37725458|NCT01979185|69204341|FG001|Period 2|Other|1|||
37725459|NCT01946425|69204349|FG000|Overall Study|Protocol Violation|1|||
37725460|NCT01946425|69204350|FG001|Overall Study|Protocol Violation|0|||
37725461|NCT01946425|69204349|FG000|Overall Study|Withdrawal by Subject|1|||
37725462|NCT01946425|69204350|FG001|Overall Study|Withdrawal by Subject|0|||
37725463|NCT01946191|69204359|FG000|Allocation|Did not complete orientation|1|||
37725464|NCT01946191|69204360|FG001|Allocation|Did not complete orientation|1|||
37725465|NCT01946191|69204359|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
37725466|NCT01946191|69204360|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
37725467|NCT01946191|69204359|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
37725468|NCT01946191|69204360|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
37725469|NCT01946191|69204359|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
37725470|NCT01946191|69204360|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
37725471|NCT01937312|69204369|FG000|Overall Study|Adverse Event|10|||
37725472|NCT01937312|69204370|FG001|Overall Study|Adverse Event|1|||
37725473|NCT01937312|69204369|FG000|Overall Study|Lack of Efficacy|0|||
37725474|NCT01937312|69204370|FG001|Overall Study|Lack of Efficacy|1|||
37725475|NCT01937312|69204369|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
37725476|NCT01937312|69204370|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
37725477|NCT01935128|69204377|FG000|Overall Study|Death|1|||
37725478|NCT01935128|69204377|FG000|Overall Study|Adverse Event|6|||
37725479|NCT01934972|69204383|FG000|Overall Study|Withdrawal by Subject|9|||
37725480|NCT01934972|69204384|FG001|Overall Study|Withdrawal by Subject|6|||
37725481|NCT01959230|69204392|FG000|Overall Study|Failure to follow study procedures|0|||
37725482|NCT01959230|69204393|FG001|Overall Study|Failure to follow study procedures|1|||
37841424|NCT01128244|69525623|FG000|Overall Study|Adverse Event|1|||
37841425|NCT01128244|69525623|FG000|Overall Study|Scheduling conflict|2|||
37841426|NCT01127893|69525631|FG000|Overall Study|Study Termination by the Sponsor|1|||
37841427|NCT01126879|69525637|FG000|Overall Study|Progressive Disease|3|||
37841428|NCT01126879|69525638|FG001|Overall Study|Progressive Disease|1|||
37841429|NCT01126879|69525637|FG000|Overall Study|Withdrawal by Subject|1|||
37841430|NCT01126879|69525638|FG001|Overall Study|Withdrawal by Subject|0|||
37841431|NCT01126879|69525637|FG000|Overall Study|Adverse Event|0|||
37841432|NCT01126879|69525638|FG001|Overall Study|Adverse Event|1|||
37841433|NCT01126879|69525637|FG000|Overall Study|Physician Decision|1|||
37841434|NCT01126879|69525638|FG001|Overall Study|Physician Decision|0|||
37841435|NCT01126060|69525646|FG000|Overall Study|Protocol Violation|0|||
37841436|NCT01126060|69525647|FG001|Overall Study|Protocol Violation|2|||
37841437|NCT01125748|69525655|FG000|Overall Study|Adverse Event|0|||
37841438|NCT01125748|69525656|FG001|Overall Study|Adverse Event|2|||
37841439|NCT01125748|69525655|FG000|Overall Study|Lost to Follow-up|0|||
37841440|NCT01125748|69525656|FG001|Overall Study|Lost to Follow-up|1|||
37915718|NCT00849693|69602489|FG003|Extension Phase|Lost to Follow-up|6|||
37725483|NCT01959230|69204392|FG000|Overall Study|Administrative reasons|2|||
37915719|NCT00849693|69602486|FG000|Extension Phase|Protocol Violation|0|||
37725484|NCT01959230|69204393|FG001|Overall Study|Administrative reasons|0|||
37725485|NCT01959230|69204392|FG000|Overall Study|Withdrawal by Subject|2|||
37725486|NCT01959230|69204393|FG001|Overall Study|Withdrawal by Subject|0|||
37725487|NCT01909778|69204399|FG000|Overall Study|failed screening|1|||
37725488|NCT01977937|69204407|FG000|Overall Study|Withdrawal by Subject|2|||
37725489|NCT01977937|69204408|FG001|Overall Study|Withdrawal by Subject|1|||
37725490|NCT01977937|69204407|FG000|Overall Study|Adverse Event|1|||
37725491|NCT01977937|69204408|FG001|Overall Study|Adverse Event|0|||
37841441|NCT01125748|69525655|FG000|Overall Study|Physician Decision|8|||
37725492|NCT01977937|69204407|FG000|Overall Study|Physician Decision|0|||
37915720|NCT00849693|69602487|FG001|Extension Phase|Protocol Violation|3|||
37841442|NCT01125748|69525656|FG001|Overall Study|Physician Decision|7|||
37915721|NCT00849693|69602488|FG002|Extension Phase|Protocol Violation|2|||
37725493|NCT01977937|69204408|FG001|Overall Study|Physician Decision|1|||
37725494|NCT02015663|69204416|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
37725495|NCT02015663|69204417|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
37725496|NCT02015663|69204416|FG000|Overall Study|Withdrawal by Subject|1|||
37725497|NCT02015663|69204417|FG001|Overall Study|Withdrawal by Subject|0|||
37725498|NCT02015663|69204416|FG000|Overall Study|Protocol Violation|0|||
37725499|NCT02015663|69204417|FG001|Overall Study|Protocol Violation|1|||
37725500|NCT02015663|69204416|FG000|Overall Study|Adverse Event|3|||
37725501|NCT02015663|69204417|FG001|Overall Study|Adverse Event|0|||
37725502|NCT02015663|69204416|FG000|Overall Study|Administrative problems|10|||
37725503|NCT02015663|69204417|FG001|Overall Study|Administrative problems|11|||
37725504|NCT01978093|69204426|FG000|Overall Study|Death|1|||
37725505|NCT01978093|69204427|FG001|Overall Study|Death|0|||
37725506|NCT01978093|69204426|FG000|Overall Study|Adverse Event|0|||
37725507|NCT01978093|69204427|FG001|Overall Study|Adverse Event|5|||
37725508|NCT01978093|69204426|FG000|Overall Study|Protocol Violation|8|||
37725509|NCT01978093|69204427|FG001|Overall Study|Protocol Violation|2|||
37725510|NCT01978093|69204426|FG000|Overall Study|Withdrawal by Subject|29|||
37725511|NCT01978093|69204427|FG001|Overall Study|Withdrawal by Subject|25|||
37725512|NCT01978093|69204426|FG000|Overall Study|Lost to Follow-up|11|||
37725513|NCT01978093|69204427|FG001|Overall Study|Lost to Follow-up|15|||
37841443|NCT01125748|69525655|FG000|Overall Study|Patient Decision to Withdraw|2|||
37841444|NCT01125748|69525656|FG001|Overall Study|Patient Decision to Withdraw|4|||
37725514|NCT01978093|69204426|FG000|Overall Study|Migrated/moved from study area|11|||
37841445|NCT01125514|69525662|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
37841446|NCT01125514|69525662|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
37841447|NCT01125514|69525662|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
37841448|NCT01125514|69525662|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
37841449|NCT01125514|69525662|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
37841450|NCT01125514|69525662|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
37841451|NCT01125358|69525680|FG000|Overall Study|Adverse Event|3|||
37841452|NCT01125358|69525681|FG001|Overall Study|Adverse Event|0|||
37841453|NCT01125358|69525682|FG002|Overall Study|Adverse Event|0|||
37841454|NCT01125358|69525683|FG003|Overall Study|Adverse Event|2|||
37841455|NCT01125358|69525680|FG000|Overall Study|Perceived Lack of Efficacy|6|||
37841456|NCT01125358|69525681|FG001|Overall Study|Perceived Lack of Efficacy|3|||
37841457|NCT01125358|69525682|FG002|Overall Study|Perceived Lack of Efficacy|7|||
37841458|NCT01125358|69525683|FG003|Overall Study|Perceived Lack of Efficacy|4|||
37841459|NCT01125358|69525680|FG000|Overall Study|Protocol Violation|1|||
37841460|NCT01125358|69525681|FG001|Overall Study|Protocol Violation|0|||
37841461|NCT01125358|69525682|FG002|Overall Study|Protocol Violation|0|||
37841462|NCT01125358|69525683|FG003|Overall Study|Protocol Violation|0|||
37841463|NCT01125358|69525680|FG000|Overall Study|Sponsor Decision|0|||
37841464|NCT01125358|69525681|FG001|Overall Study|Sponsor Decision|0|||
37841465|NCT01125358|69525682|FG002|Overall Study|Sponsor Decision|1|||
37841466|NCT01125358|69525683|FG003|Overall Study|Sponsor Decision|1|||
37841467|NCT01125358|69525680|FG000|Overall Study|Withdrawal by Subject|2|||
37725515|NCT01978093|69204427|FG001|Overall Study|Migrated/moved from study area|13|||
37725516|NCT01978093|69204426|FG000|Overall Study|Loss of kaiser coverage|4|||
37725517|NCT01978093|69204427|FG001|Overall Study|Loss of kaiser coverage|10|||
37725518|NCT01978093|69204426|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
37725519|NCT01978093|69204427|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
37725520|NCT01978093|69204426|FG000|Overall Study|Mother lost custody of child|0|||
37725521|NCT01978093|69204427|FG001|Overall Study|Mother lost custody of child|1|||
37725522|NCT01978093|69204426|FG000|Overall Study|Child was in care of grandmother|0|||
37725523|NCT01978093|69204427|FG001|Overall Study|Child was in care of grandmother|1|||
37725524|NCT01978093|69204426|FG000|Overall Study|N/A for vaccine administration|0|||
37725525|NCT01978093|69204427|FG001|Overall Study|N/A for vaccine administration|1|||
37841468|NCT01125358|69525681|FG001|Overall Study|Withdrawal by Subject|1|||
37725526|NCT01951105|69204439|FG000|Overall Study|Adverse Event|0|||
37725527|NCT01951105|69204440|FG001|Overall Study|Adverse Event|5|||
37725528|NCT01951105|69204441|FG002|Overall Study|Adverse Event|0|||
37725529|NCT01951105|69204439|FG000|Overall Study|Lost to Follow-up|0|||
37725530|NCT01951105|69204440|FG001|Overall Study|Lost to Follow-up|1|||
37725531|NCT01951105|69204441|FG002|Overall Study|Lost to Follow-up|0|||
37725532|NCT01951105|69204439|FG000|Overall Study|Protocol Violation|1|||
37725533|NCT01951105|69204440|FG001|Overall Study|Protocol Violation|1|||
37841469|NCT01125358|69525682|FG002|Overall Study|Withdrawal by Subject|1|||
37841470|NCT01125358|69525683|FG003|Overall Study|Withdrawal by Subject|1|||
37841471|NCT01125046|69525693|FG000|First 6 Months of Treatment|Death|1|||
37841472|NCT01125046|69525693|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
37841473|NCT01125046|69525693|FG000|First 6 Months of Treatment|Non-compliance|1|||
37725534|NCT01951105|69204441|FG002|Overall Study|Protocol Violation|1|||
37725535|NCT01951105|69204439|FG000|Overall Study|Withdrawal by Subject|0|||
37725536|NCT01951105|69204440|FG001|Overall Study|Withdrawal by Subject|3|||
37841474|NCT01125046|69525693|FG000|First 6 Months of Treatment|Surgery|1|||
37725537|NCT01951105|69204441|FG002|Overall Study|Withdrawal by Subject|1|||
37725538|NCT01958918|69204457|FG000|Overall Study|Death|1|||
37725539|NCT01958918|69204458|FG001|Overall Study|Death|3|||
37725540|NCT01958918|69204457|FG000|Overall Study|Lost to Follow-up|4|||
37725541|NCT01958918|69204458|FG001|Overall Study|Lost to Follow-up|7|||
37725542|NCT01958918|69204457|FG000|Overall Study|Withdrawal by Subject|13|||
37725543|NCT01958918|69204458|FG001|Overall Study|Withdrawal by Subject|8|||
37725544|NCT01958918|69204457|FG000|Overall Study|Lack of Efficacy|13|||
37841475|NCT01125046|69525693|FG000|First 6 Months of Treatment|Progressive Disease|7|||
37841476|NCT01125046|69525693|FG000|First 6 Months of Treatment|Adverse Event|2|||
37841477|NCT01125046|69525693|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
37841478|NCT01125046|69525693|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
37841479|NCT01125046|69525693|FG000|Follow-up/Data Cut Off Point|Death|29|||
37725545|NCT01958918|69204458|FG001|Overall Study|Lack of Efficacy|10|||
37725546|NCT01958918|69204457|FG000|Overall Study|Adverse Event|12|||
37725547|NCT01958918|69204458|FG001|Overall Study|Adverse Event|12|||
37725548|NCT01958918|69204457|FG000|Overall Study|administrative problems|0|||
37841480|NCT01125046|69525693|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
37841481|NCT01124734|69525697|FG000|Overall Study|Disease progression|13|||
37725549|NCT01958918|69204458|FG001|Overall Study|administrative problems|2|||
37841482|NCT01124734|69525697|FG000|Overall Study|Adverse Event|1|||
37725550|NCT01945489|69204466|FG000|Cycle 1|Adverse Event|2|||
37725551|NCT01945489|69204467|FG001|Cycle 1|Adverse Event|0|||
37725552|NCT01945489|69204466|FG000|Cycle 1|Lost to Follow-up|4|||
37725553|NCT01945489|69204467|FG001|Cycle 1|Lost to Follow-up|0|||
37725554|NCT01945489|69204466|FG000|Cycle 1|Personal Reasons|4|||
37725555|NCT01945489|69204467|FG001|Cycle 1|Personal Reasons|2|||
37725556|NCT01945489|69204466|FG000|Cycle 1|Protocol Violation|0|||
37725557|NCT01945489|69204467|FG001|Cycle 1|Protocol Violation|1|||
37725558|NCT01945489|69204466|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
37725559|NCT01945489|69204467|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
37725560|NCT01945489|69204466|FG000|Cycle 2|Adverse Event|1|||
37725561|NCT01945489|69204467|FG001|Cycle 2|Adverse Event|0|||
37725562|NCT01945489|69204466|FG000|Cycle 2|Lost to Follow-up|0|||
37725563|NCT01945489|69204467|FG001|Cycle 2|Lost to Follow-up|1|||
37725564|NCT01934894|69204476|FG000|Overall Study|Adverse Event|1|||
37725565|NCT01934894|69204477|FG001|Overall Study|Adverse Event|2|||
37725566|NCT01934894|69204476|FG000|Overall Study|Death|2|||
37725567|NCT01934894|69204477|FG001|Overall Study|Death|0|||
37725568|NCT01934894|69204476|FG000|Overall Study|Withdrawal by Subject|0|||
37725569|NCT01934894|69204477|FG001|Overall Study|Withdrawal by Subject|1|||
37725570|NCT01934894|69204476|FG000|Overall Study|Progressive Disease|3|||
37725571|NCT01934894|69204477|FG001|Overall Study|Progressive Disease|2|||
37725572|NCT01950169|69204489|FG000|Overall Study|Withdrawal by Subject|2|||
37725573|NCT01950169|69204490|FG001|Overall Study|Withdrawal by Subject|8|||
37725574|NCT01950169|69204491|FG002|Overall Study|Withdrawal by Subject|1|||
37725575|NCT01950169|69204489|FG000|Overall Study|Death|1|||
37725576|NCT01950169|69204490|FG001|Overall Study|Death|0|||
37725577|NCT01950169|69204491|FG002|Overall Study|Death|0|||
37725578|NCT01934504|69204504|FG000|Overall Study|Protocol Deviation|0|||
37725579|NCT01934504|69204505|FG001|Overall Study|Protocol Deviation|0|||
37725580|NCT01934504|69204506|FG002|Overall Study|Protocol Deviation|0|||
37725581|NCT01934504|69204507|FG003|Overall Study|Protocol Deviation|2|||
37725582|NCT01934504|69204504|FG000|Overall Study|Study Terminated by Sponsor|1|||
37725583|NCT01934504|69204505|FG001|Overall Study|Study Terminated by Sponsor|0|||
37725584|NCT01934504|69204506|FG002|Overall Study|Study Terminated by Sponsor|5|||
37725585|NCT01934504|69204507|FG003|Overall Study|Study Terminated by Sponsor|5|||
37725586|NCT01950013|69204520|FG000|Overall Study|Withdrawal by Subject|0|||
37725587|NCT01950013|69204521|FG001|Overall Study|Withdrawal by Subject|2|||
37725588|NCT01950013|69204522|FG002|Overall Study|Withdrawal by Subject|0|||
37725589|NCT01949155|69204532|FG000|Overall Study|Lost to Follow-up|1|||
37725590|NCT01949155|69204533|FG001|Overall Study|Lost to Follow-up|0|||
37725591|NCT01949155|69204532|FG000|Overall Study|Protocol Violation|1|||
37725592|NCT01949155|69204533|FG001|Overall Study|Protocol Violation|0|||
37725593|NCT01909466|69204540|FG000|Overall Study|Lost to Follow-up|5|||
37725594|NCT01909466|69204541|FG001|Overall Study|Lost to Follow-up|7|||
37725595|NCT01909466|69204540|FG000|Overall Study|Adverse Event|3|||
37725596|NCT01909466|69204541|FG001|Overall Study|Adverse Event|4|||
37725597|NCT01909466|69204540|FG000|Overall Study|Met Withdrawal Criteria|0|||
38025354|NCT04292730|69709751|FG000|Overall Study|Death|2|||
38025355|NCT04292730|69709752|FG001|Overall Study|Death|2|||
38025356|NCT04292730|69709753|FG002|Overall Study|Death|4|||
38025357|NCT04292730|69709754|FG003|Overall Study|Death|12|||
38025358|NCT04292730|69709751|FG000|Overall Study|Withdrew Consent|2|||
38025359|NCT04292730|69709752|FG001|Overall Study|Withdrew Consent|2|||
38025360|NCT04292730|69709753|FG002|Overall Study|Withdrew Consent|5|||
38025361|NCT04292730|69709754|FG003|Overall Study|Withdrew Consent|6|||
38025362|NCT04292730|69709751|FG000|Overall Study|Non-Compliance with Study Drug|0|||
38025363|NCT04292730|69709752|FG001|Overall Study|Non-Compliance with Study Drug|1|||
38025364|NCT04292730|69709753|FG002|Overall Study|Non-Compliance with Study Drug|0|||
38025365|NCT04292730|69709754|FG003|Overall Study|Non-Compliance with Study Drug|0|||
38025366|NCT04292730|69709751|FG000|Overall Study|Protocol Violation|0|||
38025367|NCT04292730|69709752|FG001|Overall Study|Protocol Violation|0|||
38025368|NCT04292730|69709753|FG002|Overall Study|Protocol Violation|1|||
38025369|NCT04292730|69709754|FG003|Overall Study|Protocol Violation|0|||
38025370|NCT04292730|69709751|FG000|Overall Study|Randomized but not Treated|8|||
38025371|NCT04292730|69709752|FG001|Overall Study|Randomized but not Treated|4|||
37725598|NCT01909466|69204541|FG001|Overall Study|Met Withdrawal Criteria|3|||
38025372|NCT04292730|69709753|FG002|Overall Study|Randomized but not Treated|0|||
37725599|NCT01909466|69204540|FG000|Overall Study|Physician Decision|2|||
37725600|NCT01909466|69204541|FG001|Overall Study|Physician Decision|0|||
37725601|NCT01909466|69204540|FG000|Overall Study|Withdrawal by Subject|11|||
37841483|NCT01124734|69525697|FG000|Overall Study|Withdrawal by Subject|1|||
37725602|NCT01909466|69204541|FG001|Overall Study|Withdrawal by Subject|9|||
37725603|NCT01909466|69204540|FG000|Overall Study|Lack of Efficacy|1|||
37725604|NCT01909466|69204541|FG001|Overall Study|Lack of Efficacy|0|||
38025373|NCT04292730|69709754|FG003|Overall Study|Randomized but not Treated|14|||
38025374|NCT02861014|69709763|FG000|Primary Analysis|Adverse Event|7|||
37841484|NCT01124734|69525697|FG000|Overall Study|Elected for alternative treatment|2|||
37841485|NCT01124617|69525708|FG000|Overall Study|Adverse Event|5|||
37841486|NCT01124617|69525709|FG001|Overall Study|Adverse Event|2|||
37841487|NCT01124617|69525708|FG000|Overall Study|Lack of Efficacy|2|||
37841488|NCT01124617|69525709|FG001|Overall Study|Lack of Efficacy|1|||
37841489|NCT01124617|69525708|FG000|Overall Study|Protocol Violation|1|||
37841490|NCT01124617|69525709|FG001|Overall Study|Protocol Violation|1|||
37841491|NCT01124617|69525708|FG000|Overall Study|Withdrawal by Subject|9|||
37841492|NCT01124617|69525709|FG001|Overall Study|Withdrawal by Subject|1|||
37841493|NCT01124617|69525708|FG000|Overall Study|Other|2|||
37841494|NCT01124617|69525709|FG001|Overall Study|Other|1|||
37841495|NCT01124422|69525717|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
37841496|NCT01124422|69525718|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
37841497|NCT01124422|69525719|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
37841498|NCT01124422|69525717|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
37841499|NCT01124422|69525718|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
37841500|NCT01124422|69525719|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
37841501|NCT01124422|69525717|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
37841502|NCT01124422|69525718|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
37841503|NCT01124422|69525719|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
37841504|NCT01124422|69525717|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
37841505|NCT01124422|69525718|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
37841506|NCT01124422|69525719|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
37841507|NCT01124422|69525717|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
37841508|NCT01124422|69525718|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
37841509|NCT01124422|69525719|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
37841510|NCT01124422|69525717|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
37841511|NCT01124422|69525718|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
37841512|NCT01124422|69525719|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
37841513|NCT01124422|69525717|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
37841514|NCT01124422|69525718|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
37841515|NCT01124422|69525719|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
37841516|NCT01124422|69525717|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
37841517|NCT01124422|69525718|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
37841518|NCT01124422|69525719|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
37841519|NCT01124422|69525717|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
37841520|NCT01124422|69525718|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
37841521|NCT01124422|69525719|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
37841522|NCT01124422|69525717|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
37841523|NCT01124422|69525718|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
37841524|NCT01124422|69525719|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
37841525|NCT01124149|69525726|FG000|Acute Phase|Withdrawal by Subject|22|||
37841526|NCT01124149|69525726|FG000|Acute Phase|Adverse Event|21|||
37841527|NCT01124149|69525726|FG000|Acute Phase|Lack of Efficacy|17|||
37841528|NCT01124149|69525726|FG000|Acute Phase|Protocol Violation|14|||
37841529|NCT01124149|69525726|FG000|Acute Phase|Lost to Follow-up|2|||
37841530|NCT01124149|69525726|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
37841531|NCT01124149|69525726|FG000|Acute Phase|Sponsor request|1|||
37841532|NCT01124149|69525726|FG000|Acute Phase|UC symptoms not ameliorated|1|||
37841533|NCT01124149|69525726|FG000|Acute Phase|Non-compliance|1|||
37841534|NCT01124149|69525726|FG000|Acute Phase|Low hemoglobin|1|||
37841535|NCT01124149|69525726|FG000|Acute Phase|Travelling to another country|1|||
37841536|NCT01124149|69525726|FG000|Acute Phase|Sponsor decision|1|||
37841537|NCT01124149|69525726|FG000|Maintenance Phase|Lack of Efficacy|40|||
37841538|NCT01124149|69525726|FG000|Maintenance Phase|Adverse Event|24|||
37841539|NCT01124149|69525726|FG000|Maintenance Phase|Lost to Follow-up|15|||
37841540|NCT01124149|69525726|FG000|Maintenance Phase|Withdrawal by Subject|10|||
37841541|NCT01124149|69525726|FG000|Maintenance Phase|Protocol Violation|5|||
37841542|NCT01124149|69525726|FG000|Maintenance Phase|Coordinator error|1|||
37841543|NCT01124149|69525726|FG000|Maintenance Phase|Non-compliance|1|||
37841544|NCT01123642|69525733|FG000|Overall Study|Lost to Follow-up|23|||
37841545|NCT01123642|69525733|FG000|Overall Study|Withdrawal by Subject|9|||
37841546|NCT01123642|69525733|FG000|Overall Study|ineligible at baseline assessment|36|||
37841547|NCT01122862|69525738|FG000|Period 1|Protocol Violation|0|||
37841548|NCT01122862|69525739|FG001|Period 1|Protocol Violation|1|||
37841549|NCT01122862|69525740|FG002|Period 1|Protocol Violation|0|||
37841550|NCT01122862|69525738|FG000|Period 2|Adverse Event|0|||
37841551|NCT01122862|69525739|FG001|Period 2|Adverse Event|0|||
37841552|NCT01122862|69525740|FG002|Period 2|Adverse Event|1|||
37841553|NCT01122394|69525751|FG000|Overall Study|Withdrawal by Subject|1|||
37841554|NCT01122394|69525752|FG001|Overall Study|Withdrawal by Subject|1|||
37841555|NCT01122394|69525751|FG000|Overall Study|Lost to Follow-up|2|||
37841556|NCT01122394|69525752|FG001|Overall Study|Lost to Follow-up|2|||
37841557|NCT01122394|69525751|FG000|Overall Study|Adverse Event|0|||
37841558|NCT01122394|69525752|FG001|Overall Study|Adverse Event|1|||
37841559|NCT01121926|69525760|FG000|First Intervention Period|Adverse Event|1|||
37841560|NCT01121926|69525761|FG001|First Intervention Period|Adverse Event|0|||
37841561|NCT01121926|69525760|FG000|Washout Period|Adverse Event|0|||
37841562|NCT01121926|69525761|FG001|Washout Period|Adverse Event|1|||
37725605|NCT01977625|69204545|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
37725606|NCT01977625|69204546|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
37725607|NCT01977625|69204545|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
37725608|NCT01977625|69204546|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
37725609|NCT01944631|69204556|FG000|Overall Study|Adverse Event|1|||
37725610|NCT01944631|69204557|FG001|Overall Study|Adverse Event|0|||
37725611|NCT01944631|69204556|FG000|Overall Study|Lost to Follow-up|3|||
37725612|NCT01944631|69204557|FG001|Overall Study|Lost to Follow-up|1|||
37725613|NCT01944631|69204556|FG000|Overall Study|Withdrawal by Subject|0|||
37725614|NCT01944631|69204557|FG001|Overall Study|Withdrawal by Subject|1|||
37725615|NCT01948063|69204565|FG000|Overall Study|Boston MCI halted research protocol|0|||
37725616|NCT01948063|69204566|FG001|Overall Study|Boston MCI halted research protocol|1|||
37725617|NCT01948063|69204565|FG000|Overall Study|Discovered an enrollment in other study|0|||
37725618|NCT01948063|69204566|FG001|Overall Study|Discovered an enrollment in other study|1|||
37725619|NCT01948063|69204565|FG000|Overall Study|Blood samples were accidentally thawed|1|||
37841563|NCT01121926|69525760|FG000|Washout Period|Positive pregnancy test|0|||
37841564|NCT01121926|69525761|FG001|Washout Period|Positive pregnancy test|1|||
37915722|NCT00849693|69602489|FG003|Extension Phase|Protocol Violation|3|||
37915723|NCT00849693|69602486|FG000|Extension Phase|Withdrawal by Subject|6|||
37915724|NCT00849693|69602487|FG001|Extension Phase|Withdrawal by Subject|9|||
37915725|NCT00849693|69602488|FG002|Extension Phase|Withdrawal by Subject|10|||
37915726|NCT00849693|69602489|FG003|Extension Phase|Withdrawal by Subject|15|||
37915727|NCT00849693|69602486|FG000|Extension Phase|Parent or caregiver decision|9|||
37915728|NCT00849693|69602487|FG001|Extension Phase|Parent or caregiver decision|4|||
37915729|NCT00849693|69602488|FG002|Extension Phase|Parent or caregiver decision|10|||
37915730|NCT00849693|69602489|FG003|Extension Phase|Parent or caregiver decision|5|||
37915731|NCT00849693|69602486|FG000|Extension Phase|Physician Decision|1|||
37915732|NCT00849693|69602487|FG001|Extension Phase|Physician Decision|1|||
37915733|NCT00849693|69602488|FG002|Extension Phase|Physician Decision|2|||
37915734|NCT00849693|69602489|FG003|Extension Phase|Physician Decision|0|||
37915735|NCT00849693|69602486|FG000|Extension Phase|Sponsor decision|1|||
37915736|NCT00849693|69602487|FG001|Extension Phase|Sponsor decision|0|||
37725620|NCT01948063|69204566|FG001|Overall Study|Blood samples were accidentally thawed|0|||
37725621|NCT01995071|69204584|FG000|Overall Study|Adverse Event|0|||
37725622|NCT01995071|69204585|FG001|Overall Study|Adverse Event|0|||
37725623|NCT01995071|69204586|FG002|Overall Study|Adverse Event|0|||
37725624|NCT01995071|69204587|FG003|Overall Study|Adverse Event|0|||
37725625|NCT01995071|69204588|FG004|Overall Study|Adverse Event|0|||
37725626|NCT01995071|69204589|FG005|Overall Study|Adverse Event|0|||
37725627|NCT01995071|69204590|FG006|Overall Study|Adverse Event|1|||
37725628|NCT01995071|69204591|FG007|Overall Study|Adverse Event|0|||
37725629|NCT01995071|69204592|FG008|Overall Study|Adverse Event|0|||
37725630|NCT01995071|69204593|FG009|Overall Study|Adverse Event|0|||
37725631|NCT01995071|69204594|FG010|Overall Study|Adverse Event|0|||
37725632|NCT01995071|69204595|FG011|Overall Study|Adverse Event|0|||
37725633|NCT01995071|69204584|FG000|Overall Study|Moved|0|||
37725634|NCT01995071|69204585|FG001|Overall Study|Moved|0|||
37725635|NCT01995071|69204586|FG002|Overall Study|Moved|1|||
37725636|NCT01995071|69204587|FG003|Overall Study|Moved|0|||
37841565|NCT01121575|69525782|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
37841566|NCT01121575|69525783|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
37841567|NCT01121575|69525784|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
37841568|NCT01121575|69525785|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
37841569|NCT01121575|69525786|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
37841570|NCT01121575|69525787|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
37725637|NCT01995071|69204588|FG004|Overall Study|Moved|1|||
37725638|NCT01995071|69204589|FG005|Overall Study|Moved|0|||
37725639|NCT01995071|69204590|FG006|Overall Study|Moved|0|||
37725640|NCT01995071|69204591|FG007|Overall Study|Moved|0|||
37725641|NCT01995071|69204592|FG008|Overall Study|Moved|0|||
37725642|NCT01995071|69204593|FG009|Overall Study|Moved|0|||
37725643|NCT01995071|69204594|FG010|Overall Study|Moved|1|||
37725644|NCT01995071|69204595|FG011|Overall Study|Moved|0|||
37725645|NCT01995071|69204584|FG000|Overall Study|Lost to Follow-up|1|||
37725646|NCT01995071|69204585|FG001|Overall Study|Lost to Follow-up|0|||
37725647|NCT01995071|69204586|FG002|Overall Study|Lost to Follow-up|0|||
37725648|NCT01995071|69204587|FG003|Overall Study|Lost to Follow-up|0|||
37725649|NCT01995071|69204588|FG004|Overall Study|Lost to Follow-up|0|||
37725650|NCT01995071|69204589|FG005|Overall Study|Lost to Follow-up|0|||
37725651|NCT01995071|69204590|FG006|Overall Study|Lost to Follow-up|0|||
37725652|NCT01995071|69204591|FG007|Overall Study|Lost to Follow-up|1|||
37725653|NCT01995071|69204592|FG008|Overall Study|Lost to Follow-up|1|||
37725654|NCT01995071|69204593|FG009|Overall Study|Lost to Follow-up|0|||
37725655|NCT01995071|69204594|FG010|Overall Study|Lost to Follow-up|0|||
37725656|NCT01995071|69204595|FG011|Overall Study|Lost to Follow-up|0|||
37725657|NCT01995071|69204584|FG000|Overall Study|Incarcerated|0|||
37725658|NCT01995071|69204585|FG001|Overall Study|Incarcerated|0|||
37725659|NCT01995071|69204586|FG002|Overall Study|Incarcerated|0|||
37725660|NCT01995071|69204587|FG003|Overall Study|Incarcerated|0|||
37725661|NCT01995071|69204588|FG004|Overall Study|Incarcerated|0|||
37725662|NCT01995071|69204589|FG005|Overall Study|Incarcerated|0|||
37725663|NCT01995071|69204590|FG006|Overall Study|Incarcerated|0|||
37725664|NCT01995071|69204591|FG007|Overall Study|Incarcerated|1|||
37725665|NCT01995071|69204592|FG008|Overall Study|Incarcerated|0|||
37725666|NCT01995071|69204593|FG009|Overall Study|Incarcerated|0|||
37841571|NCT01121575|69525782|FG000|Overall Study|Unspecified Reasons|8|||
37725667|NCT01995071|69204594|FG010|Overall Study|Incarcerated|0|||
37725668|NCT01995071|69204595|FG011|Overall Study|Incarcerated|0|||
37725669|NCT01994837|69204627|FG000|Overall Study|Progressive disease per protocol|23|||
37725670|NCT01994837|69204627|FG000|Overall Study|Adv event related to progressive disease|3|||
37725671|NCT01994837|69204627|FG000|Overall Study|Fatal progressive disease|2|||
37725672|NCT01994837|69204627|FG000|Overall Study|Adverse event not related to progression|1|||
37725673|NCT01994837|69204627|FG000|Overall Study|Chose palliative care|1|||
37725674|NCT01994837|69204627|FG000|Overall Study|Proceeded to transplant|1|||
37725675|NCT01994837|69204627|FG000|Overall Study|Removed from study due to no response|1|||
37725676|NCT02010593|69204633|FG000|Overall Study|Lost to Follow-up|1|||
37841572|NCT01121575|69525783|FG001|Overall Study|Unspecified Reasons|6|||
37841573|NCT01121575|69525784|FG002|Overall Study|Unspecified Reasons|7|||
37841574|NCT01121575|69525785|FG003|Overall Study|Unspecified Reasons|5|||
37725677|NCT02010593|69204634|FG001|Overall Study|Lost to Follow-up|0|||
37725678|NCT02010593|69204633|FG000|Overall Study|Physician Decision|1|||
37725679|NCT02010593|69204634|FG001|Overall Study|Physician Decision|0|||
37725680|NCT02010593|69204633|FG000|Overall Study|Unable to adhere to visit schedule|0|||
37725681|NCT02010593|69204634|FG001|Overall Study|Unable to adhere to visit schedule|2|||
37841575|NCT01121575|69525786|FG004|Overall Study|Unspecified Reasons|13|||
37725682|NCT01994291|69204643|FG000|Overall Study|Adverse Event|4|||
37841576|NCT01121575|69525787|FG005|Overall Study|Unspecified Reasons|10|||
37725683|NCT01994291|69204644|FG001|Overall Study|Adverse Event|1|||
37725684|NCT01994291|69204645|FG002|Overall Study|Adverse Event|3|||
37725685|NCT01994291|69204643|FG000|Overall Study|Lost to Follow-up|1|||
37725686|NCT01994291|69204644|FG001|Overall Study|Lost to Follow-up|1|||
37841577|NCT01121575|69525782|FG000|Overall Study|Death|6|||
37841578|NCT01121575|69525783|FG001|Overall Study|Death|0|||
37841579|NCT01121575|69525784|FG002|Overall Study|Death|0|||
37841580|NCT01121575|69525785|FG003|Overall Study|Death|1|||
37841581|NCT01121575|69525786|FG004|Overall Study|Death|7|||
37841582|NCT01121575|69525787|FG005|Overall Study|Death|1|||
37725687|NCT01994291|69204645|FG002|Overall Study|Lost to Follow-up|0|||
37725688|NCT01994291|69204643|FG000|Overall Study|Does not meet entrance criteria|1|||
37725689|NCT01994291|69204644|FG001|Overall Study|Does not meet entrance criteria|0|||
37725690|NCT01994291|69204645|FG002|Overall Study|Does not meet entrance criteria|0|||
37725691|NCT01994291|69204643|FG000|Overall Study|Medication error without associated AE|1|||
37725692|NCT01994291|69204644|FG001|Overall Study|Medication error without associated AE|0|||
37725693|NCT01994291|69204645|FG002|Overall Study|Medication error without associated AE|1|||
37725694|NCT01994291|69204643|FG000|Overall Study|Protocol Violation|1|||
37725695|NCT01994291|69204644|FG001|Overall Study|Protocol Violation|0|||
37725696|NCT01994291|69204645|FG002|Overall Study|Protocol Violation|0|||
37725697|NCT01994291|69204643|FG000|Overall Study|Withdrawal by Subject|6|||
37725698|NCT01994291|69204644|FG001|Overall Study|Withdrawal by Subject|3|||
37725699|NCT01994291|69204645|FG002|Overall Study|Withdrawal by Subject|5|||
37725700|NCT01994291|69204643|FG000|Overall Study|Other|1|||
37725701|NCT01994291|69204644|FG001|Overall Study|Other|2|||
37725702|NCT01994291|69204645|FG002|Overall Study|Other|0|||
37725703|NCT02094677|69204656|FG000|Overall Study|Screening|3|||
37725704|NCT02094677|69204657|FG001|Overall Study|Screening|1|||
37725705|NCT01993823|69204672|FG000|Overall Study|Requested by the patient|6|||
37725706|NCT01993823|69204673|FG001|Overall Study|Requested by the patient|11|||
37725707|NCT01993823|69204672|FG000|Overall Study|Protocol Violation|0|||
37725708|NCT01993823|69204673|FG001|Overall Study|Protocol Violation|1|||
37725709|NCT01993823|69204672|FG000|Overall Study|Lost to Follow-up|1|||
37725710|NCT01993823|69204673|FG001|Overall Study|Lost to Follow-up|4|||
37725711|NCT01993667|69204681|FG000|Overall Study|Insufficient data to analyze|16|||
37725712|NCT01993667|69204682|FG001|Overall Study|Insufficient data to analyze|16|||
37725713|NCT01993667|69204681|FG000|Overall Study|Insufficient altitude reached|3|||
37725714|NCT01993667|69204682|FG001|Overall Study|Insufficient altitude reached|1|||
37725715|NCT01993667|69204681|FG000|Overall Study|Lost to Follow-up|2|||
37725716|NCT01993667|69204682|FG001|Overall Study|Lost to Follow-up|2|||
37725717|NCT01992107|69204691|FG000|Overall Study|Administrative reasons|2|||
37725718|NCT01992107|69204692|FG001|Overall Study|Administrative reasons|0|||
37725719|NCT01992107|69204693|FG002|Overall Study|Administrative reasons|0|||
37725720|NCT01992107|69204691|FG000|Overall Study|Adverse Event|0|||
37725721|NCT01992107|69204692|FG001|Overall Study|Adverse Event|1|||
37725722|NCT01992107|69204693|FG002|Overall Study|Adverse Event|0|||
37725723|NCT01992107|69204691|FG000|Overall Study|Lost to Follow-up|46|||
37725724|NCT01992107|69204692|FG001|Overall Study|Lost to Follow-up|22|||
37725725|NCT01992107|69204693|FG002|Overall Study|Lost to Follow-up|26|||
37725726|NCT01992107|69204691|FG000|Overall Study|noncompliance and were unavailable|7|||
37725727|NCT01992107|69204692|FG001|Overall Study|noncompliance and were unavailable|3|||
37725728|NCT01992107|69204693|FG002|Overall Study|noncompliance and were unavailable|2|||
37725729|NCT01992107|69204691|FG000|Overall Study|Withdrawal by Subject|13|||
37725730|NCT01992107|69204692|FG001|Overall Study|Withdrawal by Subject|7|||
37725731|NCT01992107|69204693|FG002|Overall Study|Withdrawal by Subject|8|||
37725732|NCT01934192|69204722|FG000|Overall Study|Protocol Violation|0|||
37725733|NCT01934192|69204723|FG001|Overall Study|Protocol Violation|0|||
37725734|NCT01934192|69204724|FG002|Overall Study|Protocol Violation|0|||
37841583|NCT01121536|69525810|FG000|Overall Study|Adverse Event|63|||
37841584|NCT01121536|69525810|FG000|Overall Study|Lack of Efficacy|35|||
37841585|NCT01121536|69525810|FG000|Overall Study|Withdrawal by Subject|65|||
37841586|NCT01121536|69525810|FG000|Overall Study|Protocol Violation|20|||
37841587|NCT01121536|69525810|FG000|Overall Study|Noncompliance with study medication|12|||
37841588|NCT01121536|69525810|FG000|Overall Study|Noncompliance with study procedures|9|||
37841589|NCT01121536|69525810|FG000|Overall Study|Lost to Follow-up|39|||
37841590|NCT01121536|69525810|FG000|Overall Study|Other|118|||
37841591|NCT01121263|69525816|FG000|Overall Study|Death|3|||
37725735|NCT01934192|69204725|FG003|Overall Study|Protocol Violation|1|||
37725736|NCT01934192|69204722|FG000|Overall Study|Other: reached stopping criteria|6|||
37725737|NCT01934192|69204723|FG001|Overall Study|Other: reached stopping criteria|5|||
37725738|NCT01934192|69204724|FG002|Overall Study|Other: reached stopping criteria|1|||
37841592|NCT01121263|69525817|FG001|Overall Study|Death|2|||
37725739|NCT01934192|69204725|FG003|Overall Study|Other: reached stopping criteria|0|||
37725740|NCT01934192|69204722|FG000|Overall Study|Physician Decision|3|||
37725741|NCT01934192|69204723|FG001|Overall Study|Physician Decision|2|||
37725742|NCT01934192|69204724|FG002|Overall Study|Physician Decision|0|||
37725743|NCT01934192|69204725|FG003|Overall Study|Physician Decision|0|||
37725744|NCT01933880|69204748|FG000|Overall Study|Withdrawal by Subject|5|||
37841593|NCT01121263|69525816|FG000|Overall Study|Lost to Follow-up|22|||
37841594|NCT01121263|69525817|FG001|Overall Study|Lost to Follow-up|12|||
37841595|NCT01121263|69525816|FG000|Overall Study|Withdrawal by Subject|0|||
37841596|NCT01121263|69525817|FG001|Overall Study|Withdrawal by Subject|1|||
37841597|NCT01121185|69525827|FG000|Overall Study|Not infused|0|||
37841598|NCT01121185|69525828|FG001|Overall Study|Not infused|1|||
37841599|NCT01121185|69525827|FG000|Overall Study|Not transplanted|1|||
37841600|NCT01121185|69525828|FG001|Overall Study|Not transplanted|0|||
37841601|NCT01121146|69525836|FG000|Overall Study|Death|17|||
37841602|NCT01121146|69525837|FG001|Overall Study|Death|15|||
37841603|NCT01121146|69525836|FG000|Overall Study|Adverse Event|2|||
37841604|NCT01121146|69525837|FG001|Overall Study|Adverse Event|11|||
37841605|NCT01121146|69525836|FG000|Overall Study|Lost to Follow-up|7|||
37841606|NCT01121146|69525837|FG001|Overall Study|Lost to Follow-up|16|||
37725745|NCT01933880|69204749|FG001|Overall Study|Withdrawal by Subject|0|||
37725746|NCT01933880|69204748|FG000|Overall Study|Lack of Efficacy|1|||
37841607|NCT01120756|69525846|FG000|Overall Study|Withdrawal by Subject|1|||
37841608|NCT01120756|69525847|FG001|Overall Study|Withdrawal by Subject|1|||
37841609|NCT01120717|69525855|FG000|Overall Study|Withdrawal by Subject|11|||
37725747|NCT01933880|69204749|FG001|Overall Study|Lack of Efficacy|0|||
37725748|NCT01933880|69204748|FG000|Overall Study|Concomitant medication Interference|0|||
37725749|NCT01933880|69204749|FG001|Overall Study|Concomitant medication Interference|1|||
37725750|NCT01933880|69204748|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
37725751|NCT01933880|69204749|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
37841610|NCT01120717|69525856|FG001|Overall Study|Withdrawal by Subject|6|||
37841611|NCT01120717|69525855|FG000|Overall Study|Adverse Event|10|||
37841612|NCT01120717|69525856|FG001|Overall Study|Adverse Event|6|||
37841613|NCT01120717|69525855|FG000|Overall Study|Protocol Deviation|2|||
37841614|NCT01120717|69525856|FG001|Overall Study|Protocol Deviation|5|||
37841615|NCT01120717|69525855|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
37841616|NCT01120717|69525856|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
37841617|NCT01120717|69525855|FG000|Overall Study|Lost to Follow-up|2|||
37841618|NCT01120717|69525856|FG001|Overall Study|Lost to Follow-up|3|||
37841619|NCT01120717|69525855|FG000|Overall Study|Death|3|||
37841620|NCT01120717|69525856|FG001|Overall Study|Death|1|||
37841621|NCT01120717|69525855|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
37841622|NCT01120717|69525856|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
37841623|NCT01120600|69525864|FG000|Overall Study|Adverse Event|7|||
37841624|NCT01120600|69525865|FG001|Overall Study|Adverse Event|7|||
37841625|NCT01120600|69525864|FG000|Overall Study|Excessive Bone Loss|0|||
37841626|NCT01120600|69525865|FG001|Overall Study|Excessive Bone Loss|4|||
37841627|NCT01120600|69525864|FG000|Overall Study|Lost to Follow-up|1|||
37841628|NCT01120600|69525865|FG001|Overall Study|Lost to Follow-up|3|||
37841629|NCT01120600|69525864|FG000|Overall Study|Physician Decision|1|||
37841630|NCT01120600|69525865|FG001|Overall Study|Physician Decision|3|||
37841631|NCT01120600|69525864|FG000|Overall Study|Protocol Violation|0|||
37841632|NCT01120600|69525865|FG001|Overall Study|Protocol Violation|4|||
37841633|NCT01120600|69525864|FG000|Overall Study|Withdrawal by Subject|10|||
37841634|NCT01120600|69525865|FG001|Overall Study|Withdrawal by Subject|11|||
37841635|NCT01120210|69525873|FG000|MAIN INFUSION|Adverse Event|1|||
37841636|NCT01120210|69525874|FG001|MAIN INFUSION|Adverse Event|0|||
37841637|NCT01120210|69525873|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
37841638|NCT01120210|69525874|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
37841639|NCT01120093|69525880|FG000|Treatment Period 1|Adverse Event|0|||
37841640|NCT01120093|69525881|FG001|Treatment Period 1|Adverse Event|0|||
37841641|NCT01120093|69525882|FG002|Treatment Period 1|Adverse Event|1|||
37841642|NCT01120093|69525883|FG003|Treatment Period 1|Adverse Event|0|||
37841643|NCT01120093|69525884|FG004|Treatment Period 1|Adverse Event|1|||
37841644|NCT01120093|69525880|FG000|Treatment Period 1|Withdrawal by Subject|0|||
37841645|NCT01120093|69525881|FG001|Treatment Period 1|Withdrawal by Subject|1|||
37915737|NCT00849693|69602488|FG002|Extension Phase|Sponsor decision|0|||
37915738|NCT00849693|69602489|FG003|Extension Phase|Sponsor decision|1|||
37915739|NCT00849693|69602486|FG000|Extension Phase|Lack of Efficacy|2|||
37915740|NCT00849693|69602487|FG001|Extension Phase|Lack of Efficacy|2|||
37915741|NCT00849693|69602488|FG002|Extension Phase|Lack of Efficacy|2|||
37915742|NCT00849693|69602489|FG003|Extension Phase|Lack of Efficacy|1|||
37915743|NCT00527605|69602513|FG000|Overall Study|Adverse Event|3|||
37915744|NCT00527605|69602514|FG001|Overall Study|Adverse Event|0|||
37915745|NCT00527605|69602513|FG000|Overall Study|Withdrawal by Subject|3|||
37915746|NCT00527605|69602514|FG001|Overall Study|Withdrawal by Subject|7|||
37915747|NCT00527605|69602513|FG000|Overall Study|Lost to Follow-up|6|||
37725752|NCT01933880|69204748|FG000|Overall Study|Other|4|||
37841646|NCT01120093|69525882|FG002|Treatment Period 1|Withdrawal by Subject|0|||
37841647|NCT01120093|69525883|FG003|Treatment Period 1|Withdrawal by Subject|0|||
37841648|NCT01120093|69525884|FG004|Treatment Period 1|Withdrawal by Subject|0|||
37915748|NCT00527605|69602514|FG001|Overall Study|Lost to Follow-up|2|||
37915749|NCT00527605|69602513|FG000|Overall Study|Protocol Violation|1|||
37915750|NCT00527605|69602514|FG001|Overall Study|Protocol Violation|2|||
37841649|NCT01120093|69525880|FG000|Treatment Period 2|Adverse Event|0|||
37841650|NCT01120093|69525881|FG001|Treatment Period 2|Adverse Event|0|||
37725753|NCT01933880|69204749|FG001|Overall Study|Other|0|||
37725754|NCT01933880|69204748|FG000|Overall Study|Protocol Violation|1|||
37725755|NCT01933880|69204749|FG001|Overall Study|Protocol Violation|0|||
37725756|NCT02008877|69204760|FG000|Overall Study|Inevaluable|0|||
37725757|NCT02008877|69204761|FG001|Overall Study|Inevaluable|1|||
37725758|NCT02008877|69204762|FG002|Overall Study|Inevaluable|0|||
37725759|NCT01933334|69204773|FG000|Overall Study|Adverse Event|5|||
37725760|NCT01933334|69204774|FG001|Overall Study|Adverse Event|1|||
37725761|NCT01933334|69204773|FG000|Overall Study|Withdrawal by Subject|0|||
37725762|NCT01933334|69204774|FG001|Overall Study|Withdrawal by Subject|1|||
37725763|NCT01908140|69204782|FG000|Overall Study|Other or Progressive Disease|5|||
37725764|NCT01908140|69204783|FG001|Overall Study|Other or Progressive Disease|12|||
37725765|NCT01908140|69204782|FG000|Overall Study|Lack of Efficacy|7|||
37725766|NCT01908140|69204783|FG001|Overall Study|Lack of Efficacy|5|||
37725767|NCT01908140|69204782|FG000|Overall Study|Withdrawal by Subject|23|||
37725768|NCT01908140|69204783|FG001|Overall Study|Withdrawal by Subject|24|||
37725769|NCT01908140|69204782|FG000|Overall Study|Lost to Follow-up|1|||
37841651|NCT01120093|69525882|FG002|Treatment Period 2|Adverse Event|0|||
37841652|NCT01120093|69525883|FG003|Treatment Period 2|Adverse Event|1|||
37841653|NCT01120093|69525884|FG004|Treatment Period 2|Adverse Event|0|||
37841654|NCT01120093|69525880|FG000|Treatment Period 2|Withdrawal by Subject|0|||
37841655|NCT01120093|69525881|FG001|Treatment Period 2|Withdrawal by Subject|0|||
37841656|NCT01120093|69525882|FG002|Treatment Period 2|Withdrawal by Subject|0|||
37725770|NCT01908140|69204783|FG001|Overall Study|Lost to Follow-up|6|||
37725771|NCT01908140|69204782|FG000|Overall Study|Protocol Violation|8|||
37725772|NCT01908140|69204783|FG001|Overall Study|Protocol Violation|9|||
37725773|NCT01908140|69204782|FG000|Overall Study|Adverse Event|22|||
37725774|NCT01908140|69204783|FG001|Overall Study|Adverse Event|23|||
37725775|NCT02008565|69204793|FG000|Overall Study|Protocol Violation|1|||
37725776|NCT02008565|69204794|FG001|Overall Study|Protocol Violation|1|||
37725777|NCT02008565|69204795|FG002|Overall Study|Protocol Violation|2|||
37725778|NCT02008565|69204796|FG003|Overall Study|Protocol Violation|0|||
37725779|NCT01907906|69204810|FG000|Overall Study|Withdrawal by Subject|1|||
37725780|NCT01907906|69204811|FG001|Overall Study|Withdrawal by Subject|0|||
37725781|NCT01907906|69204810|FG000|Overall Study|Physician Decision|3|||
37725782|NCT01907906|69204811|FG001|Overall Study|Physician Decision|1|||
37725783|NCT01907828|69204821|FG000|Overall Study|Exclusion criteria not met|0|||
37725784|NCT01907828|69204822|FG001|Overall Study|Exclusion criteria not met|1|||
37725785|NCT01907828|69204821|FG000|Overall Study|Withdrawal by Subject|3|||
37725786|NCT01907828|69204822|FG001|Overall Study|Withdrawal by Subject|4|||
37725787|NCT01907828|69204821|FG000|Overall Study|Lost to Follow-up|3|||
37725788|NCT01907828|69204822|FG001|Overall Study|Lost to Follow-up|0|||
37725789|NCT01907828|69204821|FG000|Overall Study|Participant refused 24-month follow-up|1|||
37725790|NCT01907828|69204822|FG001|Overall Study|Participant refused 24-month follow-up|0|||
37725791|NCT01907828|69204821|FG000|Overall Study|Participant met exclusion criteria|0|||
37725792|NCT01907828|69204822|FG001|Overall Study|Participant met exclusion criteria|1|||
37725793|NCT01907516|69204830|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
37725794|NCT01907516|69204831|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
37725795|NCT01907516|69204830|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
37725796|NCT01907516|69204831|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
37725797|NCT01907516|69204830|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
37725798|NCT01907516|69204831|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
37725799|NCT01907516|69204830|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
37725800|NCT01907516|69204831|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
37725801|NCT01931462|69204838|FG000|Overall Study|Withdrawal by Subject|1|||
37725802|NCT01931150|69204844|FG000|Overall Study|Withdrawal by Subject|1|||
37725803|NCT01931150|69204845|FG001|Overall Study|Withdrawal by Subject|2|||
37725804|NCT01930214|69204854|FG000|Overall Study|Death|4|||
37725805|NCT01930214|69204855|FG001|Overall Study|Death|4|||
37725806|NCT01930214|69204856|FG002|Overall Study|Death|11|||
37725807|NCT01930214|69204854|FG000|Overall Study|Lost to Follow-up|12|||
37725808|NCT01930214|69204855|FG001|Overall Study|Lost to Follow-up|13|||
38025375|NCT02861014|69709763|FG000|Primary Analysis|Death|1|||
37725809|NCT01930214|69204856|FG002|Overall Study|Lost to Follow-up|12|||
37841657|NCT01120093|69525883|FG003|Treatment Period 2|Withdrawal by Subject|0|||
37841658|NCT01120093|69525884|FG004|Treatment Period 2|Withdrawal by Subject|1|||
37725810|NCT01930214|69204854|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
37725811|NCT01930214|69204855|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
37725812|NCT01930214|69204856|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
37725813|NCT01930214|69204854|FG000|Overall Study|Physician Decision|2|||
37725814|NCT01930214|69204855|FG001|Overall Study|Physician Decision|0|||
37725815|NCT01930214|69204856|FG002|Overall Study|Physician Decision|0|||
37725816|NCT01958294|69204864|FG000|Overall Study|Clinical Circumstances|2|||
37725817|NCT01906346|69204868|FG000|Overall Study|AEs|1|||
37725818|NCT01958060|69204880|FG000|Overall Study|Not treated|2|||
37725819|NCT01958060|69204881|FG001|Overall Study|Not treated|0|||
37725820|NCT01958060|69204882|FG002|Overall Study|Not treated|0|||
37725821|NCT01958060|69204883|FG003|Overall Study|Not treated|0|||
37725822|NCT01958060|69204884|FG004|Overall Study|Not treated|1|||
37725823|NCT01958060|69204885|FG005|Overall Study|Not treated|0|||
37725824|NCT01929980|69204904|FG000|Overall Study|Physician Decision|1|||
37725825|NCT01363076|69204910|FG000|Overall Study|Withdrawal by Subject|0|||
37725826|NCT01363076|69204911|FG001|Overall Study|Withdrawal by Subject|1|||
37725827|NCT01929044|69204919|FG000|Overall Study|Adverse Event|1|||
37725828|NCT01929044|69204920|FG001|Overall Study|Adverse Event|0|||
37725829|NCT01929044|69204919|FG000|Overall Study|Protocol Violation|9|||
37725830|NCT01929044|69204920|FG001|Overall Study|Protocol Violation|14|||
37725831|NCT01929044|69204919|FG000|Overall Study|Not Treated|1|||
37725832|NCT01929044|69204920|FG001|Overall Study|Not Treated|3|||
37725833|NCT01903460|69204930|FG000|Overall Study|Adverse Event|0|||
37725834|NCT01903460|69204931|FG001|Overall Study|Adverse Event|0|||
37725835|NCT01903460|69204932|FG002|Overall Study|Adverse Event|0|||
37725836|NCT01903460|69204933|FG003|Overall Study|Adverse Event|1|||
37725837|NCT01957202|69204942|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
37725838|NCT01957202|69204943|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
37725839|NCT01957202|69204944|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
37725840|NCT01957202|69204945|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
37725841|NCT01957202|69204946|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
37725842|NCT01957202|69204947|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
37725843|NCT01957202|69204948|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
37725844|NCT01957202|69204949|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
37725845|NCT01957202|69204950|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
37725846|NCT01957202|69204951|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
37725847|NCT01957202|69204952|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
37725848|NCT01957202|69204953|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
37725849|NCT01957202|69204954|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
37841659|NCT01120093|69525880|FG000|Treatment Period 3|Lack of Efficacy|0|||
37841660|NCT01120093|69525881|FG001|Treatment Period 3|Lack of Efficacy|0|||
37841661|NCT01120093|69525882|FG002|Treatment Period 3|Lack of Efficacy|0|||
37841662|NCT01120093|69525883|FG003|Treatment Period 3|Lack of Efficacy|1|||
37725850|NCT01957202|69204955|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
37725851|NCT01957202|69204956|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
37841663|NCT01120093|69525884|FG004|Treatment Period 3|Lack of Efficacy|0|||
37841664|NCT01120093|69525880|FG000|Treatment Period 3|Adverse Event|0|||
37841665|NCT01120093|69525881|FG001|Treatment Period 3|Adverse Event|0|||
37841666|NCT01120093|69525882|FG002|Treatment Period 3|Adverse Event|0|||
37841667|NCT01120093|69525883|FG003|Treatment Period 3|Adverse Event|0|||
37725852|NCT01957202|69204957|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
37725853|NCT01957202|69204958|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
37725854|NCT01957202|69204959|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
37725855|NCT01957202|69204942|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
37725856|NCT01957202|69204943|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
37725857|NCT01957202|69204944|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
37725858|NCT01957202|69204945|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
37725859|NCT01957202|69204946|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
37841668|NCT01120093|69525884|FG004|Treatment Period 3|Adverse Event|1|||
37841669|NCT01120093|69525880|FG000|Treatment Period 3|Withdrawal by Subject|0|||
37841670|NCT01120093|69525881|FG001|Treatment Period 3|Withdrawal by Subject|0|||
37841671|NCT01120093|69525882|FG002|Treatment Period 3|Withdrawal by Subject|1|||
37841672|NCT01120093|69525883|FG003|Treatment Period 3|Withdrawal by Subject|0|||
37841673|NCT01120093|69525884|FG004|Treatment Period 3|Withdrawal by Subject|0|||
37841674|NCT01120093|69525880|FG000|Treatment Period 4|Adverse Event|1|||
37841675|NCT01120093|69525881|FG001|Treatment Period 4|Adverse Event|0|||
37841676|NCT01120093|69525882|FG002|Treatment Period 4|Adverse Event|0|||
37841677|NCT01120093|69525883|FG003|Treatment Period 4|Adverse Event|0|||
37841678|NCT01120093|69525884|FG004|Treatment Period 4|Adverse Event|0|||
37841679|NCT01120093|69525880|FG000|Treatment Period 5|Adverse Event|0|||
37841680|NCT01120093|69525881|FG001|Treatment Period 5|Adverse Event|1|||
38025376|NCT02861014|69709763|FG000|Primary Analysis|Lack of Efficacy|3|||
37725860|NCT01957202|69204947|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
37725861|NCT01957202|69204948|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
37725862|NCT01957202|69204949|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
37725863|NCT01957202|69204950|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
37725864|NCT01957202|69204951|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
37725865|NCT01957202|69204952|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
37725866|NCT01957202|69204953|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
37725867|NCT01957202|69204954|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
37725868|NCT01957202|69204955|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
37841681|NCT01120093|69525882|FG002|Treatment Period 5|Adverse Event|0|||
37725869|NCT01957202|69204956|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
37725870|NCT01957202|69204957|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
37725871|NCT01957202|69204958|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
37725872|NCT01957202|69204959|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
37725873|NCT01616654|69204974|FG000|Overall Study|Lack of Efficacy|1|||
37725874|NCT01616654|69204975|FG001|Overall Study|Lack of Efficacy|0|||
37725875|NCT01616654|69204976|FG002|Overall Study|Lack of Efficacy|0|||
37725876|NCT01616654|69204977|FG003|Overall Study|Lack of Efficacy|0|||
37725877|NCT01616654|69204978|FG004|Overall Study|Lack of Efficacy|1|||
37725878|NCT01616654|69204974|FG000|Overall Study|Adverse Event|0|||
37725879|NCT01616654|69204975|FG001|Overall Study|Adverse Event|1|||
37725880|NCT01616654|69204976|FG002|Overall Study|Adverse Event|2|||
37725881|NCT01616654|69204977|FG003|Overall Study|Adverse Event|1|||
37725882|NCT01616654|69204978|FG004|Overall Study|Adverse Event|0|||
37725883|NCT01616654|69204974|FG000|Overall Study|Withdrawal by Subject|2|||
37725884|NCT01616654|69204975|FG001|Overall Study|Withdrawal by Subject|2|||
37725885|NCT01616654|69204976|FG002|Overall Study|Withdrawal by Subject|3|||
37725886|NCT01616654|69204977|FG003|Overall Study|Withdrawal by Subject|1|||
37725887|NCT01616654|69204978|FG004|Overall Study|Withdrawal by Subject|5|||
37725888|NCT01616654|69204974|FG000|Overall Study|Protocol Violation|0|||
37725889|NCT01616654|69204975|FG001|Overall Study|Protocol Violation|5|||
37725890|NCT01616654|69204976|FG002|Overall Study|Protocol Violation|2|||
37725891|NCT01616654|69204977|FG003|Overall Study|Protocol Violation|4|||
37725892|NCT01616654|69204978|FG004|Overall Study|Protocol Violation|4|||
37725893|NCT01616654|69204974|FG000|Overall Study|Lost to Follow-up|1|||
37725894|NCT01616654|69204975|FG001|Overall Study|Lost to Follow-up|0|||
37725895|NCT01616654|69204976|FG002|Overall Study|Lost to Follow-up|3|||
37725896|NCT01616654|69204977|FG003|Overall Study|Lost to Follow-up|2|||
37725897|NCT01616654|69204978|FG004|Overall Study|Lost to Follow-up|1|||
37725898|NCT01616654|69204974|FG000|Overall Study|Pregnancy|1|||
37841682|NCT01120093|69525883|FG003|Treatment Period 5|Adverse Event|1|||
37841683|NCT01120093|69525884|FG004|Treatment Period 5|Adverse Event|0|||
37841684|NCT01119937|69525898|FG000|Overall Study|Adverse Event|11|||
37841685|NCT01119937|69525899|FG001|Overall Study|Adverse Event|5|||
37841686|NCT01119937|69525898|FG000|Overall Study|Protocol deviation|3|||
37841687|NCT01119937|69525899|FG001|Overall Study|Protocol deviation|1|||
37841688|NCT01119937|69525898|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
37841689|NCT01119937|69525899|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
37841690|NCT01119937|69525898|FG000|Overall Study|Withdrawal by Subject|2|||
37841691|NCT01119937|69525899|FG001|Overall Study|Withdrawal by Subject|1|||
37841692|NCT01119898|69525907|FG000|Overall Study|Adverse Event|4|||
37841693|NCT01119898|69525908|FG001|Overall Study|Adverse Event|5|||
37841694|NCT01119898|69525907|FG000|Overall Study|Withdrawal by Subject|1|||
37841695|NCT01119898|69525908|FG001|Overall Study|Withdrawal by Subject|4|||
37841696|NCT01119898|69525907|FG000|Overall Study|Lack of Efficacy|0|||
37841697|NCT01119898|69525908|FG001|Overall Study|Lack of Efficacy|2|||
37841698|NCT01119898|69525907|FG000|Overall Study|Protocol Violation|1|||
37841699|NCT01119898|69525908|FG001|Overall Study|Protocol Violation|1|||
37841700|NCT01119898|69525907|FG000|Overall Study|Medical procedure|1|||
37841701|NCT01119898|69525908|FG001|Overall Study|Medical procedure|0|||
37841702|NCT01119898|69525907|FG000|Overall Study|Randomized in error did not participate|1|||
37841703|NCT01119898|69525908|FG001|Overall Study|Randomized in error did not participate|0|||
37841704|NCT01119859|69525916|FG000|Overall Study|Adverse Event|9|||
37841705|NCT01119859|69525917|FG001|Overall Study|Adverse Event|10|||
37841706|NCT01119859|69525916|FG000|Overall Study|Death|2|||
37841707|NCT01119859|69525917|FG001|Overall Study|Death|0|||
37725899|NCT01616654|69204975|FG001|Overall Study|Pregnancy|0|||
37725900|NCT01616654|69204976|FG002|Overall Study|Pregnancy|0|||
37725901|NCT01616654|69204977|FG003|Overall Study|Pregnancy|0|||
37725902|NCT01616654|69204978|FG004|Overall Study|Pregnancy|1|||
37725903|NCT01902290|69204993|FG000|Overall Study|Withdrawal by Subject|19|||
37725904|NCT01902290|69204994|FG001|Overall Study|Withdrawal by Subject|27|||
37725905|NCT01902290|69204993|FG000|Overall Study|Lost to Follow-up|2|||
37725906|NCT01902290|69204994|FG001|Overall Study|Lost to Follow-up|2|||
37841708|NCT01119859|69525916|FG000|Overall Study|Insufficient therapeutic response|7|||
37841709|NCT01119859|69525917|FG001|Overall Study|Insufficient therapeutic response|14|||
37725907|NCT01902290|69204993|FG000|Overall Study|Death|1|||
37725908|NCT01902290|69204994|FG001|Overall Study|Death|0|||
37725909|NCT01902290|69204993|FG000|Overall Study|Sponsor Decision|26|||
37841710|NCT01119859|69525916|FG000|Overall Study|Refused treatment|3|||
37841711|NCT01119859|69525917|FG001|Overall Study|Refused treatment|6|||
37841712|NCT01119859|69525916|FG000|Overall Study|Failure to return|3|||
37841713|NCT01119859|69525917|FG001|Overall Study|Failure to return|0|||
37725910|NCT01902290|69204994|FG001|Overall Study|Sponsor Decision|24|||
37725911|NCT01927562|69205001|FG000|Overall Study|Lost to Follow-up|30|||
37725912|NCT01927562|69205001|FG000|Overall Study|Withdrawal by Subject|3|||
37725913|NCT01927562|69205001|FG000|Overall Study|Physician Decision|5|||
37725914|NCT01467466|69205009|FG000|Overall Study|Withdrawal by Subject|15|||
37725915|NCT01467466|69205010|FG001|Overall Study|Withdrawal by Subject|18|||
37725916|NCT01467466|69205011|FG002|Overall Study|Withdrawal by Subject|13|||
37725917|NCT01467466|69205012|FG003|Overall Study|Withdrawal by Subject|11|||
37725918|NCT01467466|69205009|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
37725919|NCT01467466|69205010|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
37725920|NCT01467466|69205011|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
37725921|NCT01467466|69205012|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
37725922|NCT01467466|69205009|FG000|Overall Study|Procedure Cancelled|46|||
37725923|NCT01467466|69205010|FG001|Overall Study|Procedure Cancelled|45|||
37725924|NCT01467466|69205011|FG002|Overall Study|Procedure Cancelled|25|||
37725925|NCT01467466|69205012|FG003|Overall Study|Procedure Cancelled|29|||
37725926|NCT01467466|69205009|FG000|Overall Study|No Endpoint Blood Draw|38|||
37725927|NCT01467466|69205010|FG001|Overall Study|No Endpoint Blood Draw|32|||
37725928|NCT01467466|69205011|FG002|Overall Study|No Endpoint Blood Draw|51|||
37725929|NCT01467466|69205012|FG003|Overall Study|No Endpoint Blood Draw|43|||
37725930|NCT01441180|69205025|FG000|Overall Study|Lost to Follow-up|1|||
37725931|NCT01441180|69205026|FG001|Overall Study|Lost to Follow-up|1|||
37725932|NCT01441180|69205027|FG002|Overall Study|Lost to Follow-up|1|||
37725933|NCT01441180|69205025|FG000|Overall Study|Discontinued|0|||
37725934|NCT01441180|69205026|FG001|Overall Study|Discontinued|0|||
37725935|NCT01441180|69205027|FG002|Overall Study|Discontinued|2|||
37725936|NCT01441102|69205038|FG000|Overall Study|Adverse Event|1|||
37725937|NCT01441102|69205038|FG000|Overall Study|Withdrawal by Subject|2|||
37725938|NCT01467076|69205045|FG000|Overall Study|Lost to Follow-up|1|||
37725939|NCT01467076|69205046|FG001|Overall Study|Lost to Follow-up|0|||
37725940|NCT01467076|69205047|FG002|Overall Study|Lost to Follow-up|0|||
37725941|NCT01466062|69205055|FG000|Overall Study|Adverse Event|1|||
37725942|NCT01466062|69205055|FG000|Overall Study|Withdrawal by Subject|1|||
37725943|NCT01435018|69205062|FG000|Overall Study|Death|37|||
37725944|NCT01435018|69205063|FG001|Overall Study|Death|18|||
37725945|NCT01435018|69205064|FG002|Overall Study|Death|25|||
37841714|NCT01119703|69525925|FG000|Overall Study|Adverse Event|0|||
37841715|NCT01119703|69525926|FG001|Overall Study|Adverse Event|1|||
37841716|NCT01119625|69525933|FG000|Overall Study|Lost to Follow-up|1|||
37841717|NCT01119625|69525934|FG001|Overall Study|Lost to Follow-up|2|||
37841718|NCT01119625|69525933|FG000|Overall Study|Withdrawal by Subject|2|||
37841719|NCT01119625|69525934|FG001|Overall Study|Withdrawal by Subject|1|||
37841720|NCT01119625|69525933|FG000|Overall Study|Other|0|||
37725946|NCT01435018|69205062|FG000|Overall Study|Site is closing|4|||
37841721|NCT01119625|69525934|FG001|Overall Study|Other|1|||
37841722|NCT01119118|69525940|FG000|Overall Study|Adverse Event|1|||
37725947|NCT01435018|69205063|FG001|Overall Study|Site is closing|9|||
37841723|NCT01119001|69525944|FG000|Overall Study|Withdrawal by Subject|2|||
37841724|NCT01118962|69525950|FG000|Overall Study|Adverse Event|2|||
37725948|NCT01435018|69205064|FG002|Overall Study|Site is closing|7|||
37725949|NCT01435018|69205062|FG000|Overall Study|Withdrew consent|0|||
37725950|NCT01435018|69205063|FG001|Overall Study|Withdrew consent|3|||
37841725|NCT01118962|69525950|FG000|Overall Study|Lack of Efficacy|1|||
37841726|NCT01118962|69525950|FG000|Overall Study|Protocol Violation|1|||
37841727|NCT01118962|69525950|FG000|Overall Study|Withdrawal by Subject|4|||
37841728|NCT01118962|69525950|FG000|Overall Study|Pregnancy|1|||
37841729|NCT01118962|69525950|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
37841730|NCT01118728|69525954|FG000|Overall Study|Adverse Event|17|||
37841731|NCT01118728|69525954|FG000|Overall Study|Lack of Efficacy|27|||
37841732|NCT01118728|69525954|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
37841733|NCT01118728|69525954|FG000|Overall Study|Withdrawal by Subject|3|||
37841734|NCT01118728|69525954|FG000|Overall Study|Lost to Follow-up|4|||
37841735|NCT01118455|69525960|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
37841736|NCT01118455|69525961|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
37841737|NCT01118377|69525975|FG000|Overall Study|Did Not Receive Study Medication|1|||
37841738|NCT01118377|69525975|FG000|Overall Study|Death|38|||
37841739|NCT01118377|69525975|FG000|Overall Study|Failure to Return|3|||
37725951|NCT01435018|69205064|FG002|Overall Study|Withdrew consent|1|||
37725952|NCT01435018|69205062|FG000|Overall Study|Not willing to adhere to requirements|0|||
37725953|NCT01435018|69205063|FG001|Overall Study|Not willing to adhere to requirements|2|||
37725954|NCT01435018|69205064|FG002|Overall Study|Not willing to adhere to requirements|3|||
37725955|NCT01435018|69205062|FG000|Overall Study|Not able to get to clinic|2|||
37725956|NCT01435018|69205063|FG001|Overall Study|Not able to get to clinic|0|||
37725957|NCT01435018|69205064|FG002|Overall Study|Not able to get to clinic|2|||
37725958|NCT01435018|69205062|FG000|Overall Study|Severe debilitation, unable to continue|0|||
37725959|NCT01435018|69205063|FG001|Overall Study|Severe debilitation, unable to continue|0|||
37725960|NCT01435018|69205064|FG002|Overall Study|Severe debilitation, unable to continue|1|||
37725961|NCT01435018|69205062|FG000|Overall Study|Unable to contact participant/parent|1|||
37725962|NCT01435018|69205063|FG001|Overall Study|Unable to contact participant/parent|1|||
37725963|NCT01435018|69205064|FG002|Overall Study|Unable to contact participant/parent|1|||
37725964|NCT01435018|69205062|FG000|Overall Study|Enrollment Violation|0|||
37725965|NCT01435018|69205063|FG001|Overall Study|Enrollment Violation|1|||
37725966|NCT01435018|69205064|FG002|Overall Study|Enrollment Violation|0|||
37725967|NCT01435018|69205062|FG000|Overall Study|Never started chemotherapy|3|||
37725968|NCT01435018|69205063|FG001|Overall Study|Never started chemotherapy|0|||
37725969|NCT01435018|69205064|FG002|Overall Study|Never started chemotherapy|1|||
37725970|NCT01419184|69205076|FG000|Overall Study|Site data not available|3|||
37725971|NCT01419184|69205077|FG001|Overall Study|Site data not available|2|||
37725972|NCT01419184|69205076|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
37725973|NCT01419184|69205077|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
37725974|NCT01419184|69205076|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
37725975|NCT01419184|69205077|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
37725976|NCT01419184|69205076|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
37725977|NCT01419184|69205077|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
37725978|NCT01419184|69205076|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
37725979|NCT01419184|69205077|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
37725980|NCT01419184|69205076|FG000|Overall Study|Participant randomized, not treated|1|||
37725981|NCT01419184|69205077|FG001|Overall Study|Participant randomized, not treated|0|||
37725982|NCT01417234|69205083|FG000|Overall Study|Subject non-compliant|3|||
37725983|NCT01417156|69205087|FG000|Overall Study|Adverse Event|12|||
37725984|NCT01417156|69205087|FG000|Overall Study|Protocol Violation|2|||
37725985|NCT01417078|69205091|FG000|Overall Study|Withdrawal by Subject|1|||
37725986|NCT01954394|69205099|FG000|Overall Study|Enrolled but not treated|1|||
37725987|NCT01954394|69205100|FG001|Overall Study|Enrolled but not treated|0|||
37725988|NCT01954394|69205099|FG000|Overall Study|Adverse Event|10|||
37725989|NCT01954394|69205100|FG001|Overall Study|Adverse Event|23|||
37725990|NCT01954394|69205099|FG000|Overall Study|Poor compliance to protocol|7|||
37725991|NCT01954394|69205100|FG001|Overall Study|Poor compliance to protocol|7|||
37725992|NCT01954394|69205099|FG000|Overall Study|Participant Moved|0|||
37725993|NCT01954394|69205100|FG001|Overall Study|Participant Moved|4|||
37725994|NCT01954394|69205099|FG000|Overall Study|Related to Study Drug administration|2|||
37725995|NCT01954394|69205100|FG001|Overall Study|Related to Study Drug administration|2|||
37725996|NCT01954394|69205099|FG000|Overall Study|Other than specified above|10|||
37725997|NCT01954394|69205100|FG001|Overall Study|Other than specified above|21|||
37725998|NCT01464424|69205108|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
37725999|NCT01464424|69205109|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
37726000|NCT01902134|69205121|FG000|Overall Study|Adverse Event|3|||
37841740|NCT01118299|69525981|FG000|Overall Study|Death|7|||
37841741|NCT01118299|69525982|FG001|Overall Study|Death|5|||
37841742|NCT01118299|69525981|FG000|Overall Study|Withdrawal by Subject|8|||
37841743|NCT01118299|69525982|FG001|Overall Study|Withdrawal by Subject|8|||
37841744|NCT01118299|69525981|FG000|Overall Study|Lost to Follow-up|2|||
37841745|NCT01118299|69525982|FG001|Overall Study|Lost to Follow-up|1|||
37726001|NCT01902134|69205122|FG001|Overall Study|Adverse Event|1|||
37726002|NCT01902134|69205123|FG002|Overall Study|Adverse Event|2|||
37726003|NCT01902134|69205124|FG003|Overall Study|Adverse Event|1|||
37726004|NCT01902134|69205125|FG004|Overall Study|Adverse Event|1|||
37726005|NCT01902134|69205126|FG005|Overall Study|Adverse Event|3|||
37726006|NCT01902134|69205121|FG000|Overall Study|Lack of Efficacy|0|||
37726007|NCT01902134|69205122|FG001|Overall Study|Lack of Efficacy|0|||
37726008|NCT01902134|69205123|FG002|Overall Study|Lack of Efficacy|2|||
37726009|NCT01902134|69205124|FG003|Overall Study|Lack of Efficacy|0|||
37726010|NCT01902134|69205125|FG004|Overall Study|Lack of Efficacy|0|||
37726011|NCT01902134|69205126|FG005|Overall Study|Lack of Efficacy|1|||
37726012|NCT01902134|69205121|FG000|Overall Study|Physician Decision|0|||
37726013|NCT01902134|69205122|FG001|Overall Study|Physician Decision|1|||
37726014|NCT01902134|69205123|FG002|Overall Study|Physician Decision|0|||
37726015|NCT01902134|69205124|FG003|Overall Study|Physician Decision|0|||
37726016|NCT01902134|69205125|FG004|Overall Study|Physician Decision|0|||
37726017|NCT01902134|69205126|FG005|Overall Study|Physician Decision|0|||
37726018|NCT01902134|69205121|FG000|Overall Study|Protocol Violation|0|||
37726019|NCT01902134|69205122|FG001|Overall Study|Protocol Violation|0|||
37726020|NCT01902134|69205123|FG002|Overall Study|Protocol Violation|0|||
37726021|NCT01902134|69205124|FG003|Overall Study|Protocol Violation|0|||
37726022|NCT01902134|69205125|FG004|Overall Study|Protocol Violation|0|||
37726023|NCT01902134|69205126|FG005|Overall Study|Protocol Violation|1|||
37726024|NCT01902134|69205121|FG000|Overall Study|Withdrawal by Subject|4|||
37726025|NCT01902134|69205122|FG001|Overall Study|Withdrawal by Subject|8|||
37726026|NCT01902134|69205123|FG002|Overall Study|Withdrawal by Subject|9|||
37726027|NCT01902134|69205124|FG003|Overall Study|Withdrawal by Subject|1|||
37726028|NCT01902134|69205125|FG004|Overall Study|Withdrawal by Subject|5|||
37726029|NCT01902134|69205126|FG005|Overall Study|Withdrawal by Subject|4|||
37726030|NCT01902134|69205121|FG000|Overall Study|no compliance|1|||
37726031|NCT01902134|69205122|FG001|Overall Study|no compliance|0|||
37726032|NCT01902134|69205123|FG002|Overall Study|no compliance|0|||
37726033|NCT01902134|69205124|FG003|Overall Study|no compliance|0|||
37726034|NCT01902134|69205125|FG004|Overall Study|no compliance|0|||
37726035|NCT01902134|69205126|FG005|Overall Study|no compliance|0|||
37726036|NCT01902134|69205121|FG000|Overall Study|Other|0|||
37726037|NCT01902134|69205122|FG001|Overall Study|Other|1|||
37726038|NCT01902134|69205123|FG002|Overall Study|Other|2|||
37726039|NCT01902134|69205124|FG003|Overall Study|Other|0|||
37726040|NCT01902134|69205125|FG004|Overall Study|Other|1|||
37726041|NCT01902134|69205126|FG005|Overall Study|Other|0|||
37726042|NCT01954082|69205144|FG000|Overall Study|Study Suspension|42|||
37726043|NCT01954082|69205145|FG001|Overall Study|Study Suspension|36|||
37726044|NCT01954082|69205144|FG000|Overall Study|Adverse Event|10|||
37726045|NCT01954082|69205145|FG001|Overall Study|Adverse Event|4|||
37726046|NCT01954082|69205144|FG000|Overall Study|Intolerance|0|||
37726047|NCT01954082|69205145|FG001|Overall Study|Intolerance|1|||
37726048|NCT01954082|69205144|FG000|Overall Study|Non-compliance|6|||
37726049|NCT01954082|69205145|FG001|Overall Study|Non-compliance|4|||
37726050|NCT01954082|69205144|FG000|Overall Study|Physician Decision|2|||
37726051|NCT01954082|69205145|FG001|Overall Study|Physician Decision|0|||
37726052|NCT01954082|69205144|FG000|Overall Study|Parent Decision|1|||
37726053|NCT01954082|69205145|FG001|Overall Study|Parent Decision|0|||
37726054|NCT01954082|69205144|FG000|Overall Study|Withdrawal by Subject|0|||
37726055|NCT01954082|69205145|FG001|Overall Study|Withdrawal by Subject|1|||
37726056|NCT01954082|69205144|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
37726057|NCT01954082|69205145|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
37726058|NCT01954082|69205144|FG000|Overall Study|Redirection of Care|0|||
37726059|NCT01954082|69205145|FG001|Overall Study|Redirection of Care|2|||
37726060|NCT01954082|69205144|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
37726061|NCT01954082|69205145|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
37726062|NCT01954082|69205144|FG000|Overall Study|Comfort Care|0|||
37726063|NCT01954082|69205145|FG001|Overall Study|Comfort Care|1|||
37726064|NCT01954082|69205144|FG000|Overall Study|Infant Moved|0|||
37726065|NCT01954082|69205145|FG001|Overall Study|Infant Moved|1|||
37726066|NCT01954082|69205144|FG000|Overall Study|Randomized not Treated|4|||
37726067|NCT01954082|69205145|FG001|Overall Study|Randomized not Treated|2|||
37726068|NCT01417000|69205153|FG000|Overall Study|Death|59|||
37726069|NCT01417000|69205154|FG001|Overall Study|Death|28|||
37726070|NCT01417000|69205153|FG000|Overall Study|Lost to Follow-up|1|||
37726071|NCT01417000|69205154|FG001|Overall Study|Lost to Follow-up|0|||
37726072|NCT01417000|69205153|FG000|Overall Study|Study Terminated by Sponsor|1|||
37726073|NCT01417000|69205154|FG001|Overall Study|Study Terminated by Sponsor|1|||
37726074|NCT01416610|69205160|FG000|Overall Study|Adverse Event|4|||
37726075|NCT01416610|69205160|FG000|Overall Study|Adverse Event -Patient decision|3|||
37726076|NCT01416610|69205160|FG000|Overall Study|Lack of Efficacy|4|||
37726077|NCT01416610|69205160|FG000|Overall Study|No reason given|5|||
37726078|NCT01416610|69205160|FG000|Overall Study|Withdrawal by Subject|13|||
37726079|NCT01416610|69205160|FG000|Overall Study|Lost to Follow-up|7|||
37726080|NCT01416610|69205160|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
37726081|NCT01416142|69205168|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
37726082|NCT01416142|69205169|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
37726083|NCT01416142|69205170|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
37726084|NCT01415986|69205178|FG000|Overall Study|Lost to Follow-up|1|||
37726085|NCT01415908|69205185|FG000|Overall Study|Withdrawal by Subject|1|||
37726086|NCT01415908|69205186|FG001|Overall Study|Withdrawal by Subject|0|||
37726087|NCT01415518|69205194|FG000|Overall Study|Withdrawal by Subject|2|||
37726088|NCT01415518|69205195|FG001|Overall Study|Withdrawal by Subject|12|||
37726089|NCT01415518|69205194|FG000|Overall Study|Protocol Violation|6|||
37726090|NCT01415518|69205195|FG001|Overall Study|Protocol Violation|8|||
37726091|NCT01415518|69205194|FG000|Overall Study|Lost to Follow-up|3|||
37726092|NCT01415518|69205195|FG001|Overall Study|Lost to Follow-up|5|||
37726093|NCT01415518|69205194|FG000|Overall Study|Adverse Event|3|||
37726094|NCT01415518|69205195|FG001|Overall Study|Adverse Event|4|||
37726095|NCT01415518|69205194|FG000|Overall Study|Death|1|||
37726096|NCT01415518|69205195|FG001|Overall Study|Death|1|||
37726097|NCT01415518|69205194|FG000|Overall Study|Condition under Investigation Worsened|1|||
37726098|NCT01415518|69205195|FG001|Overall Study|Condition under Investigation Worsened|1|||
37726099|NCT01393600|69205201|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
37726100|NCT01393600|69205202|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
37726101|NCT01393600|69205203|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
37726102|NCT01393600|69205204|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
37726103|NCT01393600|69205201|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
37726104|NCT01393600|69205202|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
37726105|NCT01393600|69205203|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
37726106|NCT01393600|69205204|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
37841746|NCT01118299|69525981|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
37841747|NCT01118299|69525982|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
37841748|NCT01118143|69525989|FG000|Overall Study|Withdrawal by Subject|2|||
37841749|NCT01118143|69525990|FG001|Overall Study|Withdrawal by Subject|5|||
37841750|NCT01117987|69526000|FG000|Overall Study|Protocol deviation|0|||
37841751|NCT01117987|69526001|FG001|Overall Study|Protocol deviation|1|||
37841752|NCT01117987|69526000|FG000|Overall Study|Subject no longer requires study drug|1|||
37841753|NCT01117987|69526001|FG001|Overall Study|Subject no longer requires study drug|0|||
37841754|NCT01117987|69526000|FG000|Overall Study|Lost to Follow-up|1|||
37841755|NCT01117987|69526001|FG001|Overall Study|Lost to Follow-up|1|||
37841756|NCT01117987|69526000|FG000|Overall Study|Abnormal test procedure result|2|||
37841757|NCT01117987|69526001|FG001|Overall Study|Abnormal test procedure result|0|||
37841758|NCT01117987|69526000|FG000|Overall Study|Lack of Efficacy|3|||
37726107|NCT01393600|69205201|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
37726108|NCT01393600|69205202|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
37726109|NCT01393600|69205203|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
37726110|NCT01393600|69205204|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
37726111|NCT01393600|69205201|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
37726112|NCT01393600|69205202|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
37726113|NCT01393600|69205203|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
37726114|NCT01393600|69205204|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
37726115|NCT01393600|69205201|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
37726116|NCT01393600|69205202|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
37841759|NCT01117987|69526001|FG001|Overall Study|Lack of Efficacy|4|||
37841760|NCT01117987|69526000|FG000|Overall Study|Death|5|||
37726117|NCT01393600|69205203|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
37841761|NCT01117987|69526001|FG001|Overall Study|Death|10|||
37841762|NCT01117987|69526000|FG000|Overall Study|Withdrawal by Subject|5|||
37841763|NCT01117987|69526001|FG001|Overall Study|Withdrawal by Subject|10|||
37841764|NCT01117987|69526000|FG000|Overall Study|Adverse Event|19|||
37841765|NCT01117987|69526001|FG001|Overall Study|Adverse Event|26|||
37841766|NCT01117987|69526000|FG000|Overall Study|Administrative problems|25|||
37841767|NCT01117987|69526001|FG001|Overall Study|Administrative problems|22|||
37726118|NCT01393600|69205204|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
37726119|NCT01393600|69205201|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
37841768|NCT01117870|69526009|FG000|Overall Study|Inability to place needle|1|||
37841769|NCT01117870|69526010|FG001|Overall Study|Inability to place needle|0|||
37841770|NCT01117792|69526020|FG000|Overall Study|Death|1|||
37841771|NCT01117792|69526020|FG000|Overall Study|Adverse Event|3|||
37726120|NCT01393600|69205202|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
37726121|NCT01393600|69205203|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
37726122|NCT01393600|69205204|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
37841772|NCT02219490|69526024|FG000|Overall Study|Adverse Event|24|||
37726123|NCT01393600|69205201|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
37726124|NCT01393600|69205202|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
37726125|NCT01393600|69205203|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
37726126|NCT01393600|69205204|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
37726127|NCT01432756|69205220|FG000|Overall Study|Lost to Follow-up|1|||
37726128|NCT01432756|69205221|FG001|Overall Study|Lost to Follow-up|0|||
37726129|NCT01432756|69205222|FG002|Overall Study|Lost to Follow-up|2|||
37726130|NCT01432756|69205223|FG003|Overall Study|Lost to Follow-up|1|||
37726131|NCT01432600|69205234|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
37726132|NCT01432600|69205235|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
37726133|NCT01432600|69205236|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
37726134|NCT01432444|69205246|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
37726135|NCT01432444|69205247|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
37726136|NCT01432444|69205248|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
37726137|NCT01432444|69205246|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
37726138|NCT01432444|69205247|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
37726139|NCT01432444|69205248|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
37726140|NCT01432444|69205246|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
37726141|NCT01432444|69205247|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
37726142|NCT01432444|69205248|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
37726143|NCT01432444|69205246|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
37726144|NCT01432444|69205247|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
37726145|NCT01432444|69205248|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
37726146|NCT01432444|69205246|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
37726147|NCT01432444|69205247|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
37841773|NCT02219490|69526024|FG000|Overall Study|Withdrew consent|96|||
37841774|NCT02219490|69526024|FG000|Overall Study|Lost to Follow-up|126|||
37841775|NCT02219490|69526024|FG000|Overall Study|COVID-19 infection|2|||
37841776|NCT02219490|69526024|FG000|Overall Study|COVID-19 logistical restrictions|33|||
37841777|NCT02219490|69526024|FG000|Overall Study|Other, not specified|57|||
37841778|NCT01117480|69526032|FG000|Overall Study|Protocol Violation|8|||
37841779|NCT01117480|69526032|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
37841780|NCT01117051|69526038|FG000|Overall Study|Withdrawal by Subject|5|||
37841781|NCT01117051|69526039|FG001|Overall Study|Withdrawal by Subject|3|||
37841782|NCT01117051|69526038|FG000|Overall Study|Adverse Event|4|||
37841783|NCT01117051|69526039|FG001|Overall Study|Adverse Event|3|||
37841784|NCT01117051|69526038|FG000|Overall Study|Lost to Follow-up|0|||
37841785|NCT01117051|69526039|FG001|Overall Study|Lost to Follow-up|1|||
37841786|NCT01117051|69526038|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
37726148|NCT01432444|69205248|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
37841787|NCT01117051|69526039|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
37841788|NCT01117051|69526038|FG000|Overall Study|Sponsor's decision|3|||
37841789|NCT01117051|69526039|FG001|Overall Study|Sponsor's decision|1|||
37841790|NCT01117051|69526038|FG000|Overall Study|Surgical procedure|0|||
37841791|NCT01117051|69526039|FG001|Overall Study|Surgical procedure|1|||
37841792|NCT01117051|69526038|FG000|Overall Study|Randomized by mistake|0|||
37841793|NCT01117051|69526039|FG001|Overall Study|Randomized by mistake|1|||
37841794|NCT01117051|69526038|FG000|Overall Study|Convenience issue|1|||
37841795|NCT01117051|69526039|FG001|Overall Study|Convenience issue|0|||
37841796|NCT02211417|69526048|FG000|Overall Study|Withdrawal by Subject|11|||
37841797|NCT02211417|69526049|FG001|Overall Study|Withdrawal by Subject|8|||
37841798|NCT02211417|69526048|FG000|Overall Study|Protocol Violation|1|||
37841799|NCT02211417|69526049|FG001|Overall Study|Protocol Violation|0|||
37841800|NCT02211417|69526048|FG000|Overall Study|Pregnancy|0|||
37841801|NCT02211417|69526049|FG001|Overall Study|Pregnancy|1|||
37841802|NCT02211417|69526048|FG000|Overall Study|Lost to Follow-up|2|||
37841803|NCT02211417|69526049|FG001|Overall Study|Lost to Follow-up|3|||
37841804|NCT02211417|69526048|FG000|Overall Study|Adverse Event|1|||
37841805|NCT02211417|69526049|FG001|Overall Study|Adverse Event|4|||
37841806|NCT01117012|69526062|FG000|Overall Study|Adverse Event|0|||
37841807|NCT01117012|69526063|FG001|Overall Study|Adverse Event|1|||
37841808|NCT01117012|69526062|FG000|Overall Study|Death|1|||
37841809|NCT01117012|69526063|FG001|Overall Study|Death|1|||
37841810|NCT01117012|69526062|FG000|Overall Study|Withdrawal by Subject|3|||
37841811|NCT01117012|69526063|FG001|Overall Study|Withdrawal by Subject|0|||
37841812|NCT01117012|69526062|FG000|Overall Study|Undefined|4|||
37841813|NCT01117012|69526063|FG001|Overall Study|Undefined|3|||
37841814|NCT01116739|69526071|FG000|Overall Study|Child had 2 years of HS|110|||
37841815|NCT01116739|69526072|FG001|Overall Study|Child had 2 years of HS|128|||
37726149|NCT01432444|69205246|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
37841816|NCT01116739|69526071|FG000|Overall Study|Withdrawal by Subject|6|||
37841817|NCT01116739|69526072|FG001|Overall Study|Withdrawal by Subject|0|||
37841818|NCT01116739|69526071|FG000|Overall Study|child too young|2|||
37841819|NCT01116739|69526072|FG001|Overall Study|child too young|6|||
37841820|NCT01116739|69526071|FG000|Overall Study|child not enrolled in head start|10|||
37841821|NCT01116739|69526072|FG001|Overall Study|child not enrolled in head start|2|||
37841822|NCT01116739|69526071|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
37841823|NCT01116739|69526072|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
37841824|NCT01116544|69526080|FG000|Overall Study|Protocol Violation|1|||
37841825|NCT01116544|69526081|FG001|Overall Study|Protocol Violation|0|||
37841826|NCT01116544|69526080|FG000|Overall Study|Withdrawal by Subject|1|||
37841827|NCT01116544|69526081|FG001|Overall Study|Withdrawal by Subject|1|||
37841828|NCT01116427|69526089|FG000|Core Phase|Adverse Event|0|||
37841829|NCT01116427|69526090|FG001|Core Phase|Adverse Event|1|||
37841830|NCT01116427|69526089|FG000|Core Phase|Lost to Follow-up|1|||
37841831|NCT01116427|69526090|FG001|Core Phase|Lost to Follow-up|0|||
37841832|NCT01116427|69526089|FG000|Core Phase|Withdrawal by Subject|3|||
37841833|NCT01116427|69526090|FG001|Core Phase|Withdrawal by Subject|0|||
37841834|NCT01116427|69526089|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
37841835|NCT01116427|69526090|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
37841836|NCT01116427|69526089|FG000|Extension Phase|Adverse Event|1|||
37841837|NCT01116427|69526090|FG001|Extension Phase|Adverse Event|1|||
37841838|NCT01116427|69526089|FG000|Extension Phase|Lost to Follow-up|2|||
37841839|NCT01116427|69526090|FG001|Extension Phase|Lost to Follow-up|0|||
37841840|NCT01116427|69526089|FG000|Extension Phase|Withdrawal by Subject|5|||
37841841|NCT01116427|69526090|FG001|Extension Phase|Withdrawal by Subject|1|||
37841842|NCT01116427|69526089|FG000|Extension Phase|Not using appropriate birth control|1|||
37915751|NCT00849381|69602520|FG000|Overall Study|Adverse Event|1|||
37915752|NCT00849381|69602520|FG000|Overall Study|Lost to Follow-up|129|||
37915753|NCT00849381|69602520|FG000|Overall Study|Protocol Violation|5|||
37915754|NCT00849381|69602520|FG000|Overall Study|Withdrawal by Subject|6|||
37915755|NCT00849381|69602520|FG000|Overall Study|Other|4|||
37915756|NCT00711412|69602524|FG000|Induction Treatment|Death|2|||
37726150|NCT01432444|69205247|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
37726151|NCT01432444|69205248|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
37726152|NCT01432444|69205246|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
37726153|NCT01432444|69205247|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
37726154|NCT01432444|69205248|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
37726155|NCT01432444|69205246|FG000|Treatment Phase|Lost to Follow-up|0|||
37726156|NCT01432444|69205247|FG001|Treatment Phase|Lost to Follow-up|33|||
37726157|NCT01432444|69205248|FG002|Treatment Phase|Lost to Follow-up|0|||
37726158|NCT01432444|69205246|FG000|Treatment Phase|Adverse Event|0|||
37726159|NCT01432444|69205247|FG001|Treatment Phase|Adverse Event|37|||
37726160|NCT01432444|69205248|FG002|Treatment Phase|Adverse Event|0|||
37726161|NCT01432444|69205246|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
37726162|NCT01432444|69205247|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
37726163|NCT01432444|69205248|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
37726164|NCT01432444|69205246|FG000|Treatment Phase|Physician Decision|0|||
37726165|NCT01432444|69205247|FG001|Treatment Phase|Physician Decision|5|||
37726166|NCT01432444|69205248|FG002|Treatment Phase|Physician Decision|0|||
37726167|NCT01432444|69205246|FG000|Treatment Phase|Withdrawal by Subject|0|||
37726168|NCT01432444|69205247|FG001|Treatment Phase|Withdrawal by Subject|41|||
37726169|NCT01432444|69205248|FG002|Treatment Phase|Withdrawal by Subject|0|||
37726170|NCT01432444|69205246|FG000|Treatment Phase|Protocol Deviation|0|||
37726171|NCT01432444|69205247|FG001|Treatment Phase|Protocol Deviation|3|||
37726172|NCT01432444|69205248|FG002|Treatment Phase|Protocol Deviation|0|||
37726173|NCT01432444|69205246|FG000|Treatment Phase|Lack of Efficacy|0|||
37726174|NCT01432444|69205247|FG001|Treatment Phase|Lack of Efficacy|10|||
37726175|NCT01432444|69205248|FG002|Treatment Phase|Lack of Efficacy|0|||
37726176|NCT01432444|69205246|FG000|Extension Phase|Lost to Follow-up|0|||
37726177|NCT01432444|69205247|FG001|Extension Phase|Lost to Follow-up|0|||
37726178|NCT01432444|69205248|FG002|Extension Phase|Lost to Follow-up|17|||
37841843|NCT01116427|69526090|FG001|Extension Phase|Not using appropriate birth control|0|||
37841844|NCT01116232|69526100|FG000|Overall Study|Progressive diease|4|||
37841845|NCT01115998|69526109|FG000|Overall Study|Lost to Follow-up|6|||
37915757|NCT00711412|69602524|FG000|Induction Treatment|Adverse Event|1|||
37915758|NCT00711412|69602524|FG000|Induction Treatment|Other|1|||
37841846|NCT01115998|69526110|FG001|Overall Study|Lost to Follow-up|6|||
37841847|NCT01205230|69526118|FG000|Overall Study|Adverse Event|4|||
37915759|NCT00711412|69602524|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
37726179|NCT01432444|69205246|FG000|Extension Phase|Adverse Event|0|||
37726180|NCT01432444|69205247|FG001|Extension Phase|Adverse Event|0|||
37915760|NCT00711412|69602524|FG000|Evaluated for Combination Treatment|Death|1|||
37726181|NCT01432444|69205248|FG002|Extension Phase|Adverse Event|10|||
37726182|NCT01432444|69205246|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
37726183|NCT01432444|69205247|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
37726184|NCT01432444|69205248|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
37726185|NCT01432444|69205246|FG000|Extension Phase|Met Withdrawal Criteria|0|||
37726186|NCT01432444|69205247|FG001|Extension Phase|Met Withdrawal Criteria|0|||
37726187|NCT01432444|69205248|FG002|Extension Phase|Met Withdrawal Criteria|144|||
37726188|NCT01432444|69205246|FG000|Extension Phase|Physician Decision|0|||
37726189|NCT01432444|69205247|FG001|Extension Phase|Physician Decision|0|||
37726190|NCT01432444|69205248|FG002|Extension Phase|Physician Decision|1|||
37726191|NCT01432444|69205246|FG000|Extension Phase|Withdrawal by Subject|0|||
37726192|NCT01432444|69205247|FG001|Extension Phase|Withdrawal by Subject|0|||
37726193|NCT01432444|69205248|FG002|Extension Phase|Withdrawal by Subject|13|||
37841848|NCT01205230|69526119|FG001|Overall Study|Adverse Event|0|||
37841849|NCT01205230|69526118|FG000|Overall Study|Physician Decision|1|||
37841850|NCT01205230|69526119|FG001|Overall Study|Physician Decision|0|||
37841851|NCT01205152|69526130|FG000|Overall Study|Death|1|||
37841852|NCT01205035|69526138|FG000|Overall Study|Withdrawal by Subject|1|||
37841853|NCT01205035|69526139|FG001|Overall Study|Withdrawal by Subject|0|||
37841854|NCT01205035|69526138|FG000|Overall Study|Physician Decision|1|||
37841855|NCT01205035|69526139|FG001|Overall Study|Physician Decision|0|||
37841856|NCT01204918|69526148|FG000|Overall Study|Withdrawal by Subject|4|||
37841857|NCT01204918|69526149|FG001|Overall Study|Withdrawal by Subject|10|||
37841858|NCT01204918|69526150|FG002|Overall Study|Withdrawal by Subject|5|||
37841859|NCT01204294|69526165|FG000|Overall Study|Adverse Event|2|||
37841860|NCT01204294|69526166|FG001|Overall Study|Adverse Event|6|||
37841861|NCT01204294|69526167|FG002|Overall Study|Adverse Event|0|||
37841862|NCT01204294|69526168|FG003|Overall Study|Adverse Event|7|||
37841863|NCT01204294|69526169|FG004|Overall Study|Adverse Event|1|||
37841864|NCT01204294|69526170|FG005|Overall Study|Adverse Event|4|||
37841865|NCT01204294|69526171|FG006|Overall Study|Adverse Event|0|||
37841866|NCT01204294|69526165|FG000|Overall Study|Protocol Violation|1|||
37841867|NCT01204294|69526166|FG001|Overall Study|Protocol Violation|0|||
37841868|NCT01204294|69526167|FG002|Overall Study|Protocol Violation|2|||
37841869|NCT01204294|69526168|FG003|Overall Study|Protocol Violation|1|||
37841870|NCT01204294|69526169|FG004|Overall Study|Protocol Violation|0|||
37841871|NCT01204294|69526170|FG005|Overall Study|Protocol Violation|0|||
37841872|NCT01204294|69526171|FG006|Overall Study|Protocol Violation|0|||
37841873|NCT01204294|69526165|FG000|Overall Study|Withdrawal by Subject|0|||
37841874|NCT01204294|69526166|FG001|Overall Study|Withdrawal by Subject|2|||
37841875|NCT01204294|69526167|FG002|Overall Study|Withdrawal by Subject|2|||
37841876|NCT01204294|69526168|FG003|Overall Study|Withdrawal by Subject|1|||
37841877|NCT01204294|69526169|FG004|Overall Study|Withdrawal by Subject|1|||
37841878|NCT01204294|69526170|FG005|Overall Study|Withdrawal by Subject|1|||
37841879|NCT01204294|69526171|FG006|Overall Study|Withdrawal by Subject|2|||
37841880|NCT01204294|69526165|FG000|Overall Study|Lack of Efficacy|0|||
37841881|NCT01204294|69526166|FG001|Overall Study|Lack of Efficacy|0|||
37841882|NCT01204294|69526167|FG002|Overall Study|Lack of Efficacy|0|||
37841883|NCT01204294|69526168|FG003|Overall Study|Lack of Efficacy|2|||
37841884|NCT01204294|69526169|FG004|Overall Study|Lack of Efficacy|0|||
37841885|NCT01204294|69526170|FG005|Overall Study|Lack of Efficacy|0|||
37841886|NCT01204294|69526171|FG006|Overall Study|Lack of Efficacy|0|||
37841887|NCT01204294|69526165|FG000|Overall Study|Other (house moving)|0|||
37841888|NCT01204294|69526166|FG001|Overall Study|Other (house moving)|0|||
37841889|NCT01204294|69526167|FG002|Overall Study|Other (house moving)|1|||
37841890|NCT01204294|69526168|FG003|Overall Study|Other (house moving)|0|||
37841891|NCT01204294|69526169|FG004|Overall Study|Other (house moving)|0|||
37726194|NCT01432366|69205253|FG000|Overall Study|Non-Responder|7|||
37726195|NCT01432366|69205253|FG000|Overall Study|Adverse Event|8|||
37726196|NCT01432366|69205253|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
37726197|NCT01432366|69205253|FG000|Overall Study|Pregnancy|1|||
37726198|NCT01432366|69205253|FG000|Overall Study|Lost to Follow-up|13|||
37726199|NCT01432366|69205253|FG000|Overall Study|Lack of Efficacy|1|||
37726200|NCT01432366|69205253|FG000|Overall Study|Site Closed|20|||
37726201|NCT01432366|69205253|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
37841892|NCT01204294|69526170|FG005|Overall Study|Other (house moving)|0|||
37841893|NCT01204294|69526171|FG006|Overall Study|Other (house moving)|0|||
37841894|NCT01182181|69526189|FG000|First Intervention|Adverse Event|1|||
37841895|NCT01182181|69526190|FG001|First Intervention|Adverse Event|0|||
37841896|NCT01182181|69526189|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
37841897|NCT01182181|69526190|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
37841898|NCT01181986|69526198|FG000|Phase 1|Lost to Follow-up|0|||
37841899|NCT01181986|69526199|FG001|Phase 1|Lost to Follow-up|1|||
37841900|NCT01181986|69526200|FG002|Phase 1|Lost to Follow-up|1|||
37726202|NCT01432366|69205253|FG000|Overall Study|Other|14|||
37841901|NCT01181986|69526198|FG000|Phase 1|Adverse Event|0|||
37841902|NCT01181986|69526199|FG001|Phase 1|Adverse Event|0|||
37841903|NCT01181986|69526200|FG002|Phase 1|Adverse Event|1|||
37726203|NCT01415440|69205260|FG000|Overall Study|Lost to Follow-up|0|||
37726204|NCT01415440|69205261|FG001|Overall Study|Lost to Follow-up|1|||
37726205|NCT01415440|69205262|FG002|Overall Study|Lost to Follow-up|2|||
37726206|NCT01415440|69205260|FG000|Overall Study|Physician Decision|3|||
37726207|NCT01415440|69205261|FG001|Overall Study|Physician Decision|0|||
37726208|NCT01415440|69205262|FG002|Overall Study|Physician Decision|0|||
37726209|NCT01415440|69205260|FG000|Overall Study|Withdrawal by Subject|1|||
37726210|NCT01415440|69205261|FG001|Overall Study|Withdrawal by Subject|0|||
37726211|NCT01415440|69205262|FG002|Overall Study|Withdrawal by Subject|0|||
37726212|NCT01932788|69205280|FG000|Overall Study|Protocol Violation|18|||
37726213|NCT01932788|69205281|FG001|Overall Study|Protocol Violation|0|||
37726214|NCT01932788|69205280|FG000|Overall Study|Lost to Follow-up|18|||
37726215|NCT01932788|69205281|FG001|Overall Study|Lost to Follow-up|46|||
37726216|NCT01932788|69205280|FG000|Overall Study|Lack of Efficacy|2|||
37726217|NCT01932788|69205281|FG001|Overall Study|Lack of Efficacy|0|||
37726218|NCT01932788|69205280|FG000|Overall Study|Withdrawal by Subject|0|||
37726219|NCT01932788|69205281|FG001|Overall Study|Withdrawal by Subject|5|||
37726220|NCT01414738|69205287|FG000|Overall Study|Death|26|||
37726221|NCT01414738|69205287|FG000|Overall Study|Refused testing|5|||
37726222|NCT01414738|69205287|FG000|Overall Study|Lost to Follow-up|2|||
37726223|NCT01414738|69205287|FG000|Overall Study|Refused, disease progression|8|||
37726224|NCT01414738|69205287|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
37726225|NCT01414114|69205291|FG000|Overall Study|Adverse Event|2|||
37726226|NCT01414114|69205291|FG000|Overall Study|Withdrawal by Subject|1|||
37726227|NCT01414114|69205291|FG000|Overall Study|Other|2|||
37726228|NCT01393444|69205297|FG000|Overall Study|Withdrawal by Subject|1|||
37726229|NCT01393444|69205297|FG000|Overall Study|Determined ineligible during screening.|2|||
37726230|NCT01431976|69205301|FG000|Overall Study|Adverse Event|6|||
37726231|NCT01431976|69205301|FG000|Overall Study|Lack of Efficacy|2|||
37726232|NCT01431976|69205301|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
37726233|NCT01431976|69205301|FG000|Overall Study|Physician Decision|1|||
37726234|NCT01431976|69205301|FG000|Overall Study|Withdrawal by Subject|1|||
37726235|NCT01392742|69205305|FG000|Overall Study|Premature study termination|42|||
37841904|NCT01181986|69526198|FG000|Phase 1|Protocol Violation|1|||
37841905|NCT01181986|69526199|FG001|Phase 1|Protocol Violation|0|||
37841906|NCT01181986|69526200|FG002|Phase 1|Protocol Violation|0|||
37841907|NCT01181986|69526198|FG000|Phase 2|Adverse Event|0|||
37841908|NCT01181986|69526199|FG001|Phase 2|Adverse Event|3|||
37841909|NCT01181986|69526200|FG002|Phase 2|Adverse Event|0|||
37841910|NCT01181986|69526198|FG000|Phase 2|Medical condition|0|||
37841911|NCT01181986|69526199|FG001|Phase 2|Medical condition|1|||
37841912|NCT01181986|69526200|FG002|Phase 2|Medical condition|0|||
37841913|NCT01181167|69526216|FG000|Overall Study|Adverse Event|11|||
37841914|NCT01181167|69526217|FG001|Overall Study|Adverse Event|21|||
37841915|NCT01181167|69526216|FG000|Overall Study|Lost to Follow-up|1|||
37841916|NCT01181167|69526217|FG001|Overall Study|Lost to Follow-up|0|||
37841917|NCT01181167|69526216|FG000|Overall Study|Physician Decision|2|||
37841918|NCT01181167|69526217|FG001|Overall Study|Physician Decision|3|||
37841919|NCT01181167|69526216|FG000|Overall Study|Protocol Violation|3|||
37841920|NCT01181167|69526217|FG001|Overall Study|Protocol Violation|0|||
37841921|NCT01181167|69526216|FG000|Overall Study|Withdrawal by Subject|6|||
37841922|NCT01181167|69526217|FG001|Overall Study|Withdrawal by Subject|8|||
37726236|NCT01392742|69205305|FG000|Overall Study|Failure to return|35|||
37726237|NCT01392742|69205305|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
37726238|NCT01392742|69205305|FG000|Overall Study|Lost to Follow-up|34|||
37726239|NCT01392742|69205305|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
37726240|NCT01392742|69205305|FG000|Overall Study|ITR and Protocol deviation|1|||
37726241|NCT01392742|69205305|FG000|Overall Study|Adverse event/intercurrent illness|17|||
37726242|NCT01392742|69205305|FG000|Overall Study|Protocol Violation|14|||
37726243|NCT01392742|69205305|FG000|Overall Study|Other|3|||
37726244|NCT01392742|69205305|FG000|Overall Study|Missing information|13|||
37726245|NCT01413958|69205311|FG000|Overall Study|Lost to Follow-up|0|||
37726246|NCT01413958|69205312|FG001|Overall Study|Lost to Follow-up|1|||
37726247|NCT01413178|69205321|FG000|Overall Study|Toxicity|1|||
37726248|NCT01413178|69205322|FG001|Overall Study|Toxicity|0|||
37726249|NCT01413178|69205321|FG000|Overall Study|Ineligible|0|||
37726250|NCT01413178|69205322|FG001|Overall Study|Ineligible|2|||
37841923|NCT01181128|69526226|FG000|Overall Study|Withdrawal by Subject|2|||
37841924|NCT01181128|69526227|FG001|Overall Study|Withdrawal by Subject|2|||
37841925|NCT01181128|69526228|FG002|Overall Study|Withdrawal by Subject|0|||
37726251|NCT01799889|69205340|FG000|Overall Study|Adverse Event|4|||
37726252|NCT01799889|69205341|FG001|Overall Study|Adverse Event|4|||
37726253|NCT01799889|69205342|FG002|Overall Study|Adverse Event|5|||
37726254|NCT01799889|69205343|FG003|Overall Study|Adverse Event|1|||
37726255|NCT01799889|69205344|FG004|Overall Study|Adverse Event|11|||
37841926|NCT01181128|69526226|FG000|Overall Study|Death|1|||
37841927|NCT01181128|69526227|FG001|Overall Study|Death|0|||
37726256|NCT01799889|69205345|FG005|Overall Study|Adverse Event|1|||
37726257|NCT01799889|69205346|FG006|Overall Study|Adverse Event|5|||
37726258|NCT01799889|69205347|FG007|Overall Study|Adverse Event|2|||
37726259|NCT01799889|69205348|FG008|Overall Study|Adverse Event|3|||
37726260|NCT01799889|69205349|FG009|Overall Study|Adverse Event|1|||
37726261|NCT01799889|69205350|FG010|Overall Study|Adverse Event|1|||
37726262|NCT01799889|69205351|FG011|Overall Study|Adverse Event|0|||
37726263|NCT01799889|69205340|FG000|Overall Study|Death|1|||
37726264|NCT01799889|69205341|FG001|Overall Study|Death|0|||
37726265|NCT01799889|69205342|FG002|Overall Study|Death|5|||
37726266|NCT01799889|69205343|FG003|Overall Study|Death|3|||
37726267|NCT01799889|69205344|FG004|Overall Study|Death|1|||
37726268|NCT01799889|69205345|FG005|Overall Study|Death|0|||
37726269|NCT01799889|69205346|FG006|Overall Study|Death|0|||
37726270|NCT01799889|69205347|FG007|Overall Study|Death|0|||
37726271|NCT01799889|69205348|FG008|Overall Study|Death|1|||
37726272|NCT01799889|69205349|FG009|Overall Study|Death|0|||
37726273|NCT01799889|69205350|FG010|Overall Study|Death|1|||
37726274|NCT01799889|69205351|FG011|Overall Study|Death|0|||
37726275|NCT01799889|69205340|FG000|Overall Study|Lack of Efficacy|1|||
37726276|NCT01799889|69205341|FG001|Overall Study|Lack of Efficacy|1|||
37726277|NCT01799889|69205342|FG002|Overall Study|Lack of Efficacy|0|||
37726278|NCT01799889|69205343|FG003|Overall Study|Lack of Efficacy|1|||
37726279|NCT01799889|69205344|FG004|Overall Study|Lack of Efficacy|2|||
37726280|NCT01799889|69205345|FG005|Overall Study|Lack of Efficacy|2|||
37726281|NCT01799889|69205346|FG006|Overall Study|Lack of Efficacy|0|||
37726282|NCT01799889|69205347|FG007|Overall Study|Lack of Efficacy|0|||
37726283|NCT01799889|69205348|FG008|Overall Study|Lack of Efficacy|2|||
37726284|NCT01799889|69205349|FG009|Overall Study|Lack of Efficacy|0|||
37726285|NCT01799889|69205350|FG010|Overall Study|Lack of Efficacy|1|||
37726286|NCT01799889|69205351|FG011|Overall Study|Lack of Efficacy|0|||
37726287|NCT01799889|69205340|FG000|Overall Study|Lost to Follow-up|0|||
37726288|NCT01799889|69205341|FG001|Overall Study|Lost to Follow-up|1|||
37726289|NCT01799889|69205342|FG002|Overall Study|Lost to Follow-up|0|||
37726290|NCT01799889|69205343|FG003|Overall Study|Lost to Follow-up|0|||
37726291|NCT01799889|69205344|FG004|Overall Study|Lost to Follow-up|0|||
37726292|NCT01799889|69205345|FG005|Overall Study|Lost to Follow-up|0|||
37726293|NCT01799889|69205346|FG006|Overall Study|Lost to Follow-up|0|||
37726294|NCT01799889|69205347|FG007|Overall Study|Lost to Follow-up|0|||
37726295|NCT01799889|69205348|FG008|Overall Study|Lost to Follow-up|0|||
37726296|NCT01799889|69205349|FG009|Overall Study|Lost to Follow-up|0|||
37726297|NCT01799889|69205350|FG010|Overall Study|Lost to Follow-up|0|||
37726298|NCT01799889|69205351|FG011|Overall Study|Lost to Follow-up|0|||
37726299|NCT01799889|69205340|FG000|Overall Study|Physician Decision|3|||
37726300|NCT01799889|69205341|FG001|Overall Study|Physician Decision|2|||
37726301|NCT01799889|69205342|FG002|Overall Study|Physician Decision|4|||
37726302|NCT01799889|69205343|FG003|Overall Study|Physician Decision|4|||
37726303|NCT01799889|69205344|FG004|Overall Study|Physician Decision|5|||
37726304|NCT01799889|69205345|FG005|Overall Study|Physician Decision|5|||
37726305|NCT01799889|69205346|FG006|Overall Study|Physician Decision|5|||
37726306|NCT01799889|69205347|FG007|Overall Study|Physician Decision|2|||
37726307|NCT01799889|69205348|FG008|Overall Study|Physician Decision|6|||
37726308|NCT01799889|69205349|FG009|Overall Study|Physician Decision|0|||
37726309|NCT01799889|69205350|FG010|Overall Study|Physician Decision|0|||
37726310|NCT01799889|69205351|FG011|Overall Study|Physician Decision|1|||
37726311|NCT01799889|69205340|FG000|Overall Study|Progressive Disease|30|||
37726312|NCT01799889|69205341|FG001|Overall Study|Progressive Disease|26|||
37726313|NCT01799889|69205342|FG002|Overall Study|Progressive Disease|25|||
37726314|NCT01799889|69205343|FG003|Overall Study|Progressive Disease|30|||
37726315|NCT01799889|69205344|FG004|Overall Study|Progressive Disease|23|||
37726316|NCT01799889|69205345|FG005|Overall Study|Progressive Disease|9|||
37726317|NCT01799889|69205346|FG006|Overall Study|Progressive Disease|8|||
37726318|NCT01799889|69205347|FG007|Overall Study|Progressive Disease|13|||
37726319|NCT01799889|69205348|FG008|Overall Study|Progressive Disease|18|||
37726320|NCT01799889|69205349|FG009|Overall Study|Progressive Disease|5|||
37726321|NCT01799889|69205350|FG010|Overall Study|Progressive Disease|3|||
37726322|NCT01799889|69205351|FG011|Overall Study|Progressive Disease|1|||
37726323|NCT01799889|69205340|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
37726324|NCT01799889|69205341|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
37726325|NCT01799889|69205342|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
37726326|NCT01799889|69205343|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
37726327|NCT01799889|69205344|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
37726328|NCT01799889|69205345|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
37726329|NCT01799889|69205346|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
37726330|NCT01799889|69205347|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
37726331|NCT01799889|69205348|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
37726332|NCT01799889|69205349|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
37841928|NCT01181128|69526228|FG002|Overall Study|Death|0|||
37726333|NCT01799889|69205350|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
37726334|NCT01799889|69205351|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
37726335|NCT01799889|69205340|FG000|Overall Study|Study Terminated By Sponsor|1|||
37726336|NCT01799889|69205341|FG001|Overall Study|Study Terminated By Sponsor|0|||
37726337|NCT01799889|69205342|FG002|Overall Study|Study Terminated By Sponsor|0|||
37726338|NCT01799889|69205343|FG003|Overall Study|Study Terminated By Sponsor|0|||
37726339|NCT01799889|69205344|FG004|Overall Study|Study Terminated By Sponsor|2|||
37726340|NCT01799889|69205345|FG005|Overall Study|Study Terminated By Sponsor|1|||
37726341|NCT01799889|69205346|FG006|Overall Study|Study Terminated By Sponsor|0|||
37726342|NCT01799889|69205347|FG007|Overall Study|Study Terminated By Sponsor|2|||
37726343|NCT01799889|69205348|FG008|Overall Study|Study Terminated By Sponsor|1|||
37726344|NCT01799889|69205349|FG009|Overall Study|Study Terminated By Sponsor|1|||
37726345|NCT01799889|69205350|FG010|Overall Study|Study Terminated By Sponsor|0|||
37726346|NCT01799889|69205351|FG011|Overall Study|Study Terminated By Sponsor|0|||
37726347|NCT01799889|69205340|FG000|Overall Study|Withdrawal by Subject|1|||
37726348|NCT01799889|69205341|FG001|Overall Study|Withdrawal by Subject|6|||
37726349|NCT01799889|69205342|FG002|Overall Study|Withdrawal by Subject|4|||
37726350|NCT01799889|69205343|FG003|Overall Study|Withdrawal by Subject|0|||
37726351|NCT01799889|69205344|FG004|Overall Study|Withdrawal by Subject|5|||
37726352|NCT01799889|69205345|FG005|Overall Study|Withdrawal by Subject|1|||
37726353|NCT01799889|69205346|FG006|Overall Study|Withdrawal by Subject|3|||
37726354|NCT01799889|69205347|FG007|Overall Study|Withdrawal by Subject|1|||
37726355|NCT01799889|69205348|FG008|Overall Study|Withdrawal by Subject|2|||
37726356|NCT01799889|69205349|FG009|Overall Study|Withdrawal by Subject|1|||
37726357|NCT01799889|69205350|FG010|Overall Study|Withdrawal by Subject|1|||
37726358|NCT01799889|69205351|FG011|Overall Study|Withdrawal by Subject|1|||
37726359|NCT01799889|69205340|FG000|Overall Study|Non-Compliance With Study Drug|0|||
37726360|NCT01799889|69205341|FG001|Overall Study|Non-Compliance With Study Drug|0|||
37726361|NCT01799889|69205342|FG002|Overall Study|Non-Compliance With Study Drug|0|||
37726362|NCT01799889|69205343|FG003|Overall Study|Non-Compliance With Study Drug|0|||
37841929|NCT01181128|69526226|FG000|Overall Study|Physician Decision|2|||
37841930|NCT01181128|69526227|FG001|Overall Study|Physician Decision|0|||
37841931|NCT01181128|69526228|FG002|Overall Study|Physician Decision|0|||
37841932|NCT01181128|69526226|FG000|Overall Study|Adverse Event|0|||
37841933|NCT01181128|69526227|FG001|Overall Study|Adverse Event|2|||
37841934|NCT01181128|69526228|FG002|Overall Study|Adverse Event|0|||
37726363|NCT01799889|69205344|FG004|Overall Study|Non-Compliance With Study Drug|0|||
37726364|NCT01799889|69205345|FG005|Overall Study|Non-Compliance With Study Drug|1|||
37726365|NCT01799889|69205346|FG006|Overall Study|Non-Compliance With Study Drug|0|||
37726366|NCT01799889|69205347|FG007|Overall Study|Non-Compliance With Study Drug|0|||
37726367|NCT01799889|69205348|FG008|Overall Study|Non-Compliance With Study Drug|0|||
37726368|NCT01799889|69205349|FG009|Overall Study|Non-Compliance With Study Drug|0|||
37726369|NCT01799889|69205350|FG010|Overall Study|Non-Compliance With Study Drug|0|||
37726370|NCT01799889|69205351|FG011|Overall Study|Non-Compliance With Study Drug|0|||
37726371|NCT01412944|69205390|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
37726372|NCT01412944|69205391|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
37726373|NCT01412944|69205392|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
37726374|NCT01412944|69205393|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
37726375|NCT01412944|69205394|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
37726376|NCT01412944|69205395|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
37726377|NCT01412944|69205390|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
37726378|NCT01412944|69205391|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
37726379|NCT01412944|69205392|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
37726380|NCT01412944|69205393|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
37726381|NCT01412944|69205394|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
37726382|NCT01412944|69205395|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
37726383|NCT01412944|69205390|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
37726384|NCT01412944|69205391|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
37726385|NCT01412944|69205392|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
37841935|NCT01181128|69526226|FG000|Overall Study|Other|1|||
37841936|NCT01181128|69526227|FG001|Overall Study|Other|1|||
37841937|NCT01181128|69526228|FG002|Overall Study|Other|1|||
37841938|NCT01203787|69526250|FG000|Overall Study|Death|12|||
37841939|NCT01203787|69526251|FG001|Overall Study|Death|10|||
37841940|NCT01203787|69526250|FG000|Overall Study|Withdrawal by Subject|6|||
37841941|NCT01203787|69526251|FG001|Overall Study|Withdrawal by Subject|2|||
37726386|NCT01412944|69205393|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
37726387|NCT01412944|69205394|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
37726388|NCT01412944|69205395|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
37726389|NCT01412944|69205390|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
37726390|NCT01412944|69205391|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
37726391|NCT01412944|69205392|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
37726392|NCT01412944|69205393|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
37726393|NCT01412944|69205394|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
37726394|NCT01412944|69205395|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
37726395|NCT01412944|69205390|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
37726396|NCT01412944|69205391|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
37726397|NCT01412944|69205392|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
37726398|NCT01412944|69205393|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
37726399|NCT01412944|69205394|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
37726400|NCT01412944|69205395|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
37726401|NCT01412944|69205390|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
37726402|NCT01412944|69205391|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
37726403|NCT01412944|69205392|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
37726404|NCT01412944|69205393|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
37726405|NCT01412944|69205394|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
37726406|NCT01412944|69205395|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
37726407|NCT01412944|69205390|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
37726408|NCT01412944|69205391|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
37726409|NCT01412944|69205392|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
37726410|NCT01412944|69205393|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
37726411|NCT01412944|69205394|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
37726412|NCT01412944|69205395|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
37726413|NCT01412944|69205390|FG000|Entire: IV + Maintenance|Adverse Event|0|||
37726414|NCT01412944|69205391|FG001|Entire: IV + Maintenance|Adverse Event|0|||
37726415|NCT01412944|69205392|FG002|Entire: IV + Maintenance|Adverse Event|0|||
37726416|NCT01412944|69205393|FG003|Entire: IV + Maintenance|Adverse Event|0|||
37726417|NCT01412944|69205394|FG004|Entire: IV + Maintenance|Adverse Event|1|||
37726418|NCT01412944|69205395|FG005|Entire: IV + Maintenance|Adverse Event|0|||
37726419|NCT01412944|69205390|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
37726420|NCT01412944|69205391|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
37726421|NCT01412944|69205392|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
37726422|NCT01412944|69205393|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
37726423|NCT01412944|69205394|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
37726424|NCT01412944|69205395|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
37726425|NCT01412944|69205390|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
37726426|NCT01412944|69205391|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
37726427|NCT01412944|69205392|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
37726428|NCT01412944|69205393|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
37726429|NCT01412944|69205394|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
37726430|NCT01412944|69205395|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
37726431|NCT01412944|69205390|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
37726432|NCT01412944|69205391|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
37726433|NCT01412944|69205392|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
37726434|NCT01412944|69205393|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
37726435|NCT01412944|69205394|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
37726436|NCT01412944|69205395|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
37726437|NCT01412944|69205390|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
37726438|NCT01412944|69205391|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
37726439|NCT01412944|69205392|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
37726440|NCT01412944|69205393|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
37726441|NCT01412944|69205394|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
37726442|NCT01412944|69205395|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
37726443|NCT01412944|69205390|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
37726444|NCT01412944|69205391|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
37726445|NCT01412944|69205392|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
37726446|NCT01412944|69205393|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
37726447|NCT01412944|69205394|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
37726448|NCT01412944|69205395|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
37726449|NCT01412944|69205390|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
37726450|NCT01412944|69205391|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
37726451|NCT01412944|69205392|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
37726452|NCT01412944|69205393|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
37726453|NCT01412944|69205394|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
37726454|NCT01412944|69205395|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
37726455|NCT01412944|69205390|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
37726456|NCT01412944|69205391|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
37726457|NCT01412944|69205392|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
37726458|NCT01412944|69205393|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
37726459|NCT01412944|69205394|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
37726460|NCT01412944|69205395|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
37726461|NCT01412944|69205390|FG000|Entire: IV + Maintenance|Adverse Event|0|||
37726462|NCT01412944|69205391|FG001|Entire: IV + Maintenance|Adverse Event|1|||
37726463|NCT01412944|69205392|FG002|Entire: IV + Maintenance|Adverse Event|0|||
37726464|NCT01412944|69205393|FG003|Entire: IV + Maintenance|Adverse Event|0|||
37726465|NCT01412944|69205394|FG004|Entire: IV + Maintenance|Adverse Event|0|||
37726466|NCT01412944|69205395|FG005|Entire: IV + Maintenance|Adverse Event|0|||
37726467|NCT01798485|69205413|FG000|Overall Study|Adverse Event|32|||
37726468|NCT01798485|69205414|FG001|Overall Study|Adverse Event|40|||
37726469|NCT01798485|69205413|FG000|Overall Study|Withdrawal by Subject|27|||
37726470|NCT01798485|69205414|FG001|Overall Study|Withdrawal by Subject|31|||
37726471|NCT01798485|69205413|FG000|Overall Study|Lost to Follow-up|0|||
37726472|NCT01798485|69205414|FG001|Overall Study|Lost to Follow-up|3|||
37726473|NCT01798485|69205413|FG000|Overall Study|Physician Decision|14|||
37726474|NCT01798485|69205414|FG001|Overall Study|Physician Decision|10|||
37726475|NCT01798485|69205413|FG000|Overall Study|Objective Disease Progression|152|||
37841942|NCT01203787|69526250|FG000|Overall Study|Lost to Follow-up|2|||
37841943|NCT01203787|69526251|FG001|Overall Study|Lost to Follow-up|0|||
37841944|NCT01203787|69526250|FG000|Overall Study|Adverse Event|11|||
37841945|NCT01203787|69526251|FG001|Overall Study|Adverse Event|15|||
37841946|NCT01181011|69526259|FG000|Overall Study|Adverse Event|2|||
37841947|NCT01181011|69526259|FG000|Overall Study|Lost to Follow-up|1|||
37841948|NCT01180777|69526268|FG000|Overall Study|Protocol Violation|6|||
37841949|NCT01180777|69526268|FG000|Overall Study|Poor lens fit|4|||
37841950|NCT01180777|69526268|FG000|Overall Study|Lost to Follow-up|1|||
37841951|NCT01180777|69526268|FG000|Overall Study|Adverse Event|1|||
38025377|NCT02861014|69709763|FG000|Primary Analysis|Physician Decision|2|||
38025378|NCT02861014|69709763|FG000|Primary Analysis|Pregnancy|4|||
38025379|NCT02861014|69709763|FG000|Primary Analysis|Protocol Violation|2|||
38025380|NCT02861014|69709763|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
38025381|NCT02861014|69709763|FG000|Primary Analysis|Withdrawal by Subject|14|||
38025382|NCT02861014|69709763|FG000|Primary Analysis|Commercial ocrelizumab|3|||
38025383|NCT02861014|69709763|FG000|Safety Follow-up|Adverse Event|1|||
38025384|NCT02861014|69709763|FG000|Safety Follow-up|Pregnancy|1|||
38025385|NCT02861014|69709763|FG000|Safety Follow-up|Withdrawal by Subject|9|||
38025386|NCT02861014|69709763|FG000|Safety Follow-up|Study terminated by sponsor|1|||
38025387|NCT02861014|69709763|FG000|Safety Follow-up|Physician Decision|1|||
38025388|NCT02861014|69709763|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
38025389|NCT02861014|69709763|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
38025390|NCT04382586|69709771|FG000|Overall Study|Death|3|||
38025391|NCT04382586|69709772|FG001|Overall Study|Death|4|||
38025392|NCT04382586|69709771|FG000|Overall Study|Lost to Follow-up|11|||
38025393|NCT04382586|69709772|FG001|Overall Study|Lost to Follow-up|8|||
38025394|NCT04382586|69709771|FG000|Overall Study|Withdrawal by Subject|3|||
38025395|NCT04382586|69709772|FG001|Overall Study|Withdrawal by Subject|1|||
38025396|NCT04382586|69709771|FG000|Overall Study|Physician Decision|0|||
38025397|NCT04382586|69709772|FG001|Overall Study|Physician Decision|3|||
38025398|NCT04480710|69709782|FG000|Overall Study|Adverse Event|0|||
38025399|NCT04480710|69709783|FG001|Overall Study|Adverse Event|2|||
38025400|NCT04480710|69709784|FG002|Overall Study|Adverse Event|0|||
38025401|NCT04480710|69709785|FG003|Overall Study|Adverse Event|0|||
38025402|NCT04480710|69709782|FG000|Overall Study|Withdrawal by Subject|0|||
38025403|NCT04480710|69709783|FG001|Overall Study|Withdrawal by Subject|1|||
38025404|NCT04480710|69709784|FG002|Overall Study|Withdrawal by Subject|0|||
38025405|NCT04480710|69709785|FG003|Overall Study|Withdrawal by Subject|0|||
38025406|NCT04480710|69709782|FG000|Overall Study|Physician Decision|0|||
38025407|NCT04480710|69709783|FG001|Overall Study|Physician Decision|0|||
38025408|NCT04480710|69709784|FG002|Overall Study|Physician Decision|1|||
37726476|NCT01798485|69205414|FG001|Overall Study|Objective Disease Progression|106|||
37726477|NCT01798485|69205413|FG000|Overall Study|Death|25|||
37841952|NCT01648023|69526276|FG000|Overall Study|Screen Fail Post Randomization|1|||
37841953|NCT01648023|69526277|FG001|Overall Study|Screen Fail Post Randomization|2|||
37841954|NCT02756208|69526291|FG000|Overall Study|Withdrawal by Subject|1|||
37841955|NCT02756208|69526292|FG001|Overall Study|Withdrawal by Subject|0|||
38025409|NCT04480710|69709785|FG003|Overall Study|Physician Decision|0|||
38025410|NCT04268316|69709804|FG000|Overall Study|Withdrawal by Subject|2|||
37841956|NCT02756208|69526293|FG002|Overall Study|Withdrawal by Subject|1|||
37841957|NCT02756208|69526294|FG003|Overall Study|Withdrawal by Subject|3|||
38025411|NCT04268316|69709805|FG001|Overall Study|Withdrawal by Subject|1|||
38025412|NCT04268316|69709806|FG002|Overall Study|Withdrawal by Subject|0|||
38025413|NCT01971970|69709816|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
38025414|NCT01971970|69709817|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
37726478|NCT01798485|69205414|FG001|Overall Study|Death|22|||
37726479|NCT01798485|69205413|FG000|Overall Study|Sponsor Decision|61|||
37726480|NCT01798485|69205414|FG001|Overall Study|Sponsor Decision|54|||
37726481|NCT01798485|69205413|FG000|Overall Study|Clinical Progression|35|||
37726482|NCT01798485|69205414|FG001|Overall Study|Clinical Progression|24|||
37726483|NCT01767597|69205422|FG000|Overall Study|Incomplete intervention|3|||
37726484|NCT01767597|69205423|FG001|Overall Study|Incomplete intervention|1|||
37726485|NCT01767597|69205422|FG000|Overall Study|Withdrawal by Subject|1|||
37726486|NCT01767597|69205423|FG001|Overall Study|Withdrawal by Subject|0|||
37726487|NCT01767519|69205432|FG000|Overall Study|Other Reasons|4|||
37726488|NCT01767519|69205433|FG001|Overall Study|Other Reasons|4|||
37726489|NCT01767519|69205434|FG002|Overall Study|Other Reasons|2|||
37726490|NCT01767519|69205432|FG000|Overall Study|Protocol Violation|0|||
37726491|NCT01767519|69205433|FG001|Overall Study|Protocol Violation|3|||
37726492|NCT01767519|69205434|FG002|Overall Study|Protocol Violation|0|||
37726493|NCT01767519|69205432|FG000|Overall Study|Personal Reasons|1|||
37726494|NCT01767519|69205433|FG001|Overall Study|Personal Reasons|0|||
37726495|NCT01767519|69205434|FG002|Overall Study|Personal Reasons|0|||
37726496|NCT01767519|69205432|FG000|Overall Study|Lost to Follow-up|3|||
37726497|NCT01767519|69205433|FG001|Overall Study|Lost to Follow-up|1|||
37726498|NCT01767519|69205434|FG002|Overall Study|Lost to Follow-up|2|||
37726499|NCT01767519|69205432|FG000|Overall Study|Lack of Efficacy|1|||
37726500|NCT01767519|69205433|FG001|Overall Study|Lack of Efficacy|0|||
37726501|NCT01767519|69205434|FG002|Overall Study|Lack of Efficacy|0|||
37726502|NCT01767519|69205432|FG000|Overall Study|Adverse Event|5|||
37726503|NCT01767519|69205433|FG001|Overall Study|Adverse Event|5|||
37726504|NCT01767519|69205434|FG002|Overall Study|Adverse Event|1|||
37726505|NCT01797783|69205444|FG000|Overall Study|Adverse Event|1|||
37726506|NCT01797783|69205445|FG001|Overall Study|Adverse Event|1|||
37726507|NCT01797783|69205444|FG000|Overall Study|Withdrawal by Subject|1|||
37726508|NCT01797783|69205445|FG001|Overall Study|Withdrawal by Subject|0|||
37726509|NCT01766817|69205462|FG000|Overall Study|Drug-related adverse event|1|||
37726510|NCT01766817|69205463|FG001|Overall Study|Drug-related adverse event|2|||
37726511|NCT01766817|69205464|FG002|Overall Study|Drug-related adverse event|1|||
37726512|NCT01766817|69205462|FG000|Overall Study|Drug-unrelated adverse event|3|||
37726513|NCT01766817|69205463|FG001|Overall Study|Drug-unrelated adverse event|3|||
37726514|NCT01766817|69205464|FG002|Overall Study|Drug-unrelated adverse event|3|||
37726515|NCT01766817|69205462|FG000|Overall Study|Death|1|||
37841958|NCT02756208|69526291|FG000|Overall Study|Lost to Follow-up|3|||
37841959|NCT02756208|69526292|FG001|Overall Study|Lost to Follow-up|1|||
37726516|NCT01766817|69205463|FG001|Overall Study|Death|1|||
37726517|NCT01766817|69205464|FG002|Overall Study|Death|0|||
37726518|NCT01766817|69205462|FG000|Overall Study|Unable to take study drug|0|||
37726519|NCT01766817|69205463|FG001|Overall Study|Unable to take study drug|1|||
37726520|NCT01766817|69205464|FG002|Overall Study|Unable to take study drug|0|||
37726521|NCT01766817|69205462|FG000|Overall Study|Withdrawal by Subject|2|||
37726522|NCT01766817|69205463|FG001|Overall Study|Withdrawal by Subject|0|||
37726523|NCT01766817|69205464|FG002|Overall Study|Withdrawal by Subject|3|||
37726524|NCT01766817|69205462|FG000|Overall Study|Subject non-compliance|0|||
37726525|NCT01766817|69205463|FG001|Overall Study|Subject non-compliance|1|||
37726526|NCT01766817|69205464|FG002|Overall Study|Subject non-compliance|2|||
37726527|NCT01766817|69205462|FG000|Overall Study|Physician Decision|3|||
37726528|NCT01766817|69205463|FG001|Overall Study|Physician Decision|3|||
37726529|NCT01766817|69205464|FG002|Overall Study|Physician Decision|4|||
37726530|NCT01766817|69205462|FG000|Overall Study|Other|1|||
37726531|NCT01766817|69205463|FG001|Overall Study|Other|0|||
37726532|NCT01766817|69205464|FG002|Overall Study|Other|0|||
37726533|NCT01797705|69205472|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
37726534|NCT01797705|69205472|FG000|Overall Study|Withdrawal by Subject|1|||
37726535|NCT01797081|69205480|FG000|Overall Study|Adverse Event|1|||
37726536|NCT01797081|69205481|FG001|Overall Study|Adverse Event|0|||
37841960|NCT02756208|69526293|FG002|Overall Study|Lost to Follow-up|1|||
37726537|NCT01797081|69205482|FG002|Overall Study|Adverse Event|1|||
37726538|NCT01797081|69205483|FG003|Overall Study|Adverse Event|0|||
37726539|NCT01797081|69205480|FG000|Overall Study|Pregnancy|1|||
37726540|NCT01797081|69205481|FG001|Overall Study|Pregnancy|0|||
37726541|NCT01797081|69205482|FG002|Overall Study|Pregnancy|0|||
37726542|NCT01797081|69205483|FG003|Overall Study|Pregnancy|0|||
37726543|NCT01797081|69205480|FG000|Overall Study|Personal Reasons|12|||
37726544|NCT01797081|69205481|FG001|Overall Study|Personal Reasons|4|||
37726545|NCT01797081|69205482|FG002|Overall Study|Personal Reasons|4|||
37726546|NCT01797081|69205483|FG003|Overall Study|Personal Reasons|8|||
37726547|NCT01797081|69205480|FG000|Overall Study|Protocol Violation|0|||
37726548|NCT01797081|69205481|FG001|Overall Study|Protocol Violation|0|||
37726549|NCT01797081|69205482|FG002|Overall Study|Protocol Violation|0|||
37726550|NCT01797081|69205483|FG003|Overall Study|Protocol Violation|1|||
37726551|NCT01794117|69205495|FG000|Overall Study|Adverse Event|1|||
37726552|NCT01794117|69205496|FG001|Overall Study|Adverse Event|0|||
37726553|NCT01794117|69205497|FG002|Overall Study|Adverse Event|0|||
37726554|NCT01794117|69205498|FG003|Overall Study|Adverse Event|0|||
37726555|NCT01794117|69205495|FG000|Overall Study|Participant noncompliance|0|||
37841961|NCT02756208|69526294|FG003|Overall Study|Lost to Follow-up|1|||
37841962|NCT02756208|69526291|FG000|Overall Study|Physician Decision|1|||
37841963|NCT02756208|69526292|FG001|Overall Study|Physician Decision|0|||
37841964|NCT02756208|69526293|FG002|Overall Study|Physician Decision|0|||
37841965|NCT02756208|69526294|FG003|Overall Study|Physician Decision|0|||
37841966|NCT02756208|69526291|FG000|Overall Study|Protocol Violation|0|||
37841967|NCT02756208|69526292|FG001|Overall Study|Protocol Violation|1|||
37841968|NCT02756208|69526293|FG002|Overall Study|Protocol Violation|0|||
37726556|NCT01794117|69205496|FG001|Overall Study|Participant noncompliance|1|||
37726557|NCT01794117|69205497|FG002|Overall Study|Participant noncompliance|0|||
37726558|NCT01794117|69205498|FG003|Overall Study|Participant noncompliance|0|||
37726559|NCT01794117|69205495|FG000|Overall Study|Refused further treatment|0|||
37726560|NCT01794117|69205496|FG001|Overall Study|Refused further treatment|2|||
37726561|NCT01794117|69205497|FG002|Overall Study|Refused further treatment|0|||
37726562|NCT01794117|69205498|FG003|Overall Study|Refused further treatment|0|||
37726563|NCT01766037|69205511|FG000|Overall Study|Adverse Event|1|||
37726564|NCT01766037|69205512|FG001|Overall Study|Adverse Event|0|||
37726565|NCT01766037|69205511|FG000|Overall Study|Lack of Efficacy|1|||
37726566|NCT01766037|69205512|FG001|Overall Study|Lack of Efficacy|0|||
37726567|NCT01766037|69205511|FG000|Overall Study|Lost to Follow-up|0|||
37726568|NCT01766037|69205512|FG001|Overall Study|Lost to Follow-up|10|||
37726569|NCT01766037|69205511|FG000|Overall Study|Physician Decision|0|||
37726570|NCT01766037|69205512|FG001|Overall Study|Physician Decision|1|||
37726571|NCT01766037|69205511|FG000|Overall Study|Withdrawal by Subject|18|||
37726572|NCT01766037|69205512|FG001|Overall Study|Withdrawal by Subject|16|||
37726573|NCT01766037|69205511|FG000|Overall Study|Moved from area|5|||
37726574|NCT01766037|69205512|FG001|Overall Study|Moved from area|0|||
37726575|NCT01766037|69205511|FG000|Overall Study|medical - unrelated|1|||
37726576|NCT01766037|69205512|FG001|Overall Study|medical - unrelated|2|||
37726577|NCT01766037|69205511|FG000|Overall Study|nausea / discomfort|3|||
37726578|NCT01766037|69205512|FG001|Overall Study|nausea / discomfort|0|||
37726579|NCT01765569|69205518|FG000|Period B|Withdrawal by Subject|1|||
37726580|NCT01765569|69205518|FG000|Period C|Death|1|||
37841969|NCT02756208|69526294|FG003|Overall Study|Protocol Violation|0|||
37841970|NCT02756013|69526304|FG000|Overall Study|Adverse Event|1|||
37841971|NCT02756013|69526304|FG000|Overall Study|Hypersensitivity|1|||
37841972|NCT01202773|69526311|FG000|Overall Study|Adverse Event|4|||
37841973|NCT01202773|69526312|FG001|Overall Study|Adverse Event|5|||
37841974|NCT01202773|69526313|FG002|Overall Study|Adverse Event|5|||
37841975|NCT01202773|69526311|FG000|Overall Study|Lack of Efficacy|5|||
37841976|NCT01202773|69526312|FG001|Overall Study|Lack of Efficacy|4|||
37841977|NCT01202773|69526313|FG002|Overall Study|Lack of Efficacy|9|||
37841978|NCT01202773|69526311|FG000|Overall Study|Entry Criteria Not Met|2|||
37841979|NCT01202773|69526312|FG001|Overall Study|Entry Criteria Not Met|0|||
37841980|NCT01202773|69526313|FG002|Overall Study|Entry Criteria Not Met|1|||
37841981|NCT01202773|69526311|FG000|Overall Study|Lost to Follow-up|1|||
37841982|NCT01202773|69526312|FG001|Overall Study|Lost to Follow-up|2|||
37841983|NCT01202773|69526313|FG002|Overall Study|Lost to Follow-up|2|||
37841984|NCT01202773|69526311|FG000|Overall Study|Withdrawal by Subject|13|||
37841985|NCT01202773|69526312|FG001|Overall Study|Withdrawal by Subject|6|||
37841986|NCT01202773|69526313|FG002|Overall Study|Withdrawal by Subject|5|||
37841987|NCT01202773|69526311|FG000|Overall Study|Physician Decision|2|||
37841988|NCT01202773|69526312|FG001|Overall Study|Physician Decision|0|||
37841989|NCT01202773|69526313|FG002|Overall Study|Physician Decision|0|||
37841990|NCT01202773|69526311|FG000|Overall Study|Protocol Violation|11|||
37841991|NCT01202773|69526312|FG001|Overall Study|Protocol Violation|6|||
37841992|NCT01202773|69526313|FG002|Overall Study|Protocol Violation|10|||
37841993|NCT01202773|69526311|FG000|Overall Study|Sponsor Decision|19|||
37841994|NCT01202773|69526312|FG001|Overall Study|Sponsor Decision|20|||
37841995|NCT01202773|69526313|FG002|Overall Study|Sponsor Decision|23|||
37841996|NCT01180660|69526333|FG000|Overall Study|Changed to open surgery|1|||
37841997|NCT01180660|69526334|FG001|Overall Study|Changed to open surgery|0|||
37841998|NCT01202227|69526340|FG000|Overall Study|Adverse Event|16|||
37841999|NCT01202227|69526340|FG000|Overall Study|Withdrawal by Subject|2|||
37842000|NCT01202227|69526340|FG000|Overall Study|Lack of Efficacy|1|||
37842001|NCT01202188|69526349|FG000|Overall Study|Protocol deviation|14|||
37842002|NCT01202188|69526350|FG001|Overall Study|Protocol deviation|8|||
37842003|NCT01202188|69526351|FG002|Overall Study|Protocol deviation|12|||
37842004|NCT01202188|69526352|FG003|Overall Study|Protocol deviation|10|||
37842005|NCT01202188|69526353|FG004|Overall Study|Protocol deviation|11|||
37842006|NCT01202188|69526349|FG000|Overall Study|Subject withdrew consent|12|||
37842007|NCT01202188|69526350|FG001|Overall Study|Subject withdrew consent|13|||
37842008|NCT01202188|69526351|FG002|Overall Study|Subject withdrew consent|22|||
37842009|NCT01202188|69526352|FG003|Overall Study|Subject withdrew consent|11|||
37842010|NCT01202188|69526353|FG004|Overall Study|Subject withdrew consent|13|||
37842011|NCT01202188|69526349|FG000|Overall Study|Adverse Event|5|||
37842012|NCT01202188|69526350|FG001|Overall Study|Adverse Event|23|||
37842013|NCT01202188|69526351|FG002|Overall Study|Adverse Event|13|||
37842014|NCT01202188|69526352|FG003|Overall Study|Adverse Event|10|||
37842015|NCT01202188|69526353|FG004|Overall Study|Adverse Event|10|||
37726581|NCT01609257|69205527|FG000|Overall Study|Lost to Follow-up|2|||
37726582|NCT01609257|69205528|FG001|Overall Study|Lost to Follow-up|1|||
37726583|NCT01609257|69205527|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
37726584|NCT01609257|69205528|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
37726585|NCT01609257|69205527|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
37726586|NCT01609257|69205528|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
37726587|NCT01609023|69205537|FG000|Overall Study|Lack of Efficacy|3|||
37726588|NCT01609023|69205537|FG000|Overall Study|Withdrawal by Subject|4|||
37726589|NCT01609023|69205537|FG000|Overall Study|Lost to Follow-up|8|||
37726590|NCT01609023|69205537|FG000|Overall Study|Toxicity|3|||
37726591|NCT01609023|69205537|FG000|Overall Study|Disease progression|10|||
37726592|NCT01609023|69205537|FG000|Overall Study|Physician Decision|2|||
37726593|NCT01609023|69205537|FG000|Overall Study|Death|2|||
37726594|NCT01609023|69205537|FG000|Overall Study|Personal reasons|1|||
37726595|NCT01765179|69205541|FG000|Overall Study|Adverse Event|3|||
37726596|NCT01765179|69205541|FG000|Overall Study|Lost to Follow-up|5|||
37726597|NCT01765179|69205541|FG000|Overall Study|Non-compliance with study drug|2|||
37726598|NCT01765179|69205541|FG000|Overall Study|Protocol Violation|1|||
37726599|NCT01765179|69205541|FG000|Overall Study|Withdrawal by Subject|8|||
37726600|NCT01765179|69205541|FG000|Overall Study|Hematocrit >54%|3|||
37726601|NCT01765179|69205541|FG000|Overall Study|prohibited med|1|||
37726602|NCT01765179|69205541|FG000|Overall Study|Out of country unable to finish study|1|||
37726603|NCT01765179|69205541|FG000|Overall Study|lack of venous access|1|||
37726604|NCT01765179|69205541|FG000|Overall Study|work conflict|1|||
37726605|NCT01765179|69205541|FG000|Overall Study|Ca elevated 10.6|1|||
37726606|NCT01764945|69205553|FG000|Overall Study|Adverse Event|0|||
37726607|NCT01764945|69205554|FG001|Overall Study|Adverse Event|1|||
37726608|NCT01764945|69205555|FG002|Overall Study|Adverse Event|0|||
37726609|NCT01764945|69205556|FG003|Overall Study|Adverse Event|0|||
37726610|NCT01764945|69205557|FG004|Overall Study|Adverse Event|0|||
37726611|NCT01764945|69205558|FG005|Overall Study|Adverse Event|0|||
37726612|NCT01764945|69205559|FG006|Overall Study|Adverse Event|1|||
37726613|NCT01764945|69205560|FG007|Overall Study|Adverse Event|0|||
37726614|NCT01793883|69205581|FG000|Overall Study|Withdrawal by Subject|3|||
37726615|NCT01793883|69205582|FG001|Overall Study|Withdrawal by Subject|7|||
37726616|NCT01793883|69205583|FG002|Overall Study|Withdrawal by Subject|3|||
37726617|NCT01793883|69205581|FG000|Overall Study|Subject noncompliance|0|||
37726618|NCT01793883|69205582|FG001|Overall Study|Subject noncompliance|1|||
37726619|NCT01793883|69205583|FG002|Overall Study|Subject noncompliance|1|||
37726620|NCT01793883|69205581|FG000|Overall Study|Lost to Follow-up|5|||
37726621|NCT01793883|69205582|FG001|Overall Study|Lost to Follow-up|1|||
37726622|NCT01793883|69205583|FG002|Overall Study|Lost to Follow-up|3|||
37726623|NCT01793883|69205581|FG000|Overall Study|Randomized in error|1|||
37726624|NCT01793883|69205582|FG001|Overall Study|Randomized in error|0|||
37726625|NCT01793883|69205583|FG002|Overall Study|Randomized in error|0|||
37726626|NCT01793883|69205581|FG000|Overall Study|Unable to complete spriometry|1|||
37726627|NCT01793883|69205582|FG001|Overall Study|Unable to complete spriometry|0|||
37726628|NCT01793883|69205583|FG002|Overall Study|Unable to complete spriometry|0|||
37726629|NCT01793883|69205581|FG000|Overall Study|Unable to complete measurements|1|||
37726630|NCT01793883|69205582|FG001|Overall Study|Unable to complete measurements|0|||
37726631|NCT01793883|69205583|FG002|Overall Study|Unable to complete measurements|0|||
37726632|NCT01793883|69205581|FG000|Overall Study|Met exclusion criteria|1|||
37726633|NCT01793883|69205582|FG001|Overall Study|Met exclusion criteria|0|||
37726634|NCT01793883|69205583|FG002|Overall Study|Met exclusion criteria|0|||
37726635|NCT01793883|69205581|FG000|Overall Study|Dosing error|0|||
37726636|NCT01793883|69205582|FG001|Overall Study|Dosing error|1|||
37726637|NCT01793883|69205583|FG002|Overall Study|Dosing error|0|||
37726638|NCT01793883|69205581|FG000|Overall Study|Respiratory distress during spirometry|0|||
37726639|NCT01793883|69205582|FG001|Overall Study|Respiratory distress during spirometry|0|||
37726640|NCT01793883|69205583|FG002|Overall Study|Respiratory distress during spirometry|1|||
37726641|NCT01792635|69205594|FG000|Part B|Adverse Event|0|||
37726642|NCT01792635|69205595|FG001|Part B|Adverse Event|0|||
37726643|NCT01792635|69205596|FG002|Part B|Adverse Event|1|||
37726644|NCT01792635|69205594|FG000|Part B|Study terminated|0|||
37726645|NCT01792635|69205595|FG001|Part B|Study terminated|4|||
37726646|NCT01792635|69205596|FG002|Part B|Study terminated|3|||
37726647|NCT01953692|69205614|FG000|Overall Study|Adverse Event|5|||
37726648|NCT01953692|69205615|FG001|Overall Study|Adverse Event|2|||
37726649|NCT01953692|69205616|FG002|Overall Study|Adverse Event|4|||
37726650|NCT01953692|69205617|FG003|Overall Study|Adverse Event|2|||
37726651|NCT01953692|69205618|FG004|Overall Study|Adverse Event|1|||
37726652|NCT01953692|69205619|FG005|Overall Study|Adverse Event|2|||
37726653|NCT01953692|69205620|FG006|Overall Study|Adverse Event|0|||
37726654|NCT01953692|69205621|FG007|Overall Study|Adverse Event|0|||
37726655|NCT01953692|69205622|FG008|Overall Study|Adverse Event|0|||
37726656|NCT01953692|69205614|FG000|Overall Study|Clinical Progression|0|||
37726657|NCT01953692|69205615|FG001|Overall Study|Clinical Progression|15|||
37726658|NCT01953692|69205616|FG002|Overall Study|Clinical Progression|7|||
37726659|NCT01953692|69205617|FG003|Overall Study|Clinical Progression|5|||
37726660|NCT01953692|69205618|FG004|Overall Study|Clinical Progression|0|||
37726661|NCT01953692|69205619|FG005|Overall Study|Clinical Progression|7|||
37726662|NCT01953692|69205620|FG006|Overall Study|Clinical Progression|20|||
37726663|NCT01953692|69205621|FG007|Overall Study|Clinical Progression|3|||
37726664|NCT01953692|69205622|FG008|Overall Study|Clinical Progression|3|||
37726665|NCT01953692|69205614|FG000|Overall Study|Death|5|||
37726666|NCT01953692|69205615|FG001|Overall Study|Death|0|||
37726667|NCT01953692|69205616|FG002|Overall Study|Death|2|||
37726668|NCT01953692|69205617|FG003|Overall Study|Death|2|||
37726669|NCT01953692|69205618|FG004|Overall Study|Death|1|||
37842016|NCT01202188|69526349|FG000|Overall Study|Administrative problems|3|||
37842017|NCT01202188|69526350|FG001|Overall Study|Administrative problems|2|||
37842018|NCT01202188|69526351|FG002|Overall Study|Administrative problems|1|||
37842019|NCT01202188|69526352|FG003|Overall Study|Administrative problems|1|||
37842020|NCT01202188|69526353|FG004|Overall Study|Administrative problems|2|||
37842021|NCT01202188|69526349|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
37842022|NCT01202188|69526350|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
37842023|NCT01202188|69526351|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
37842024|NCT01202188|69526352|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
37842025|NCT01202188|69526353|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
37842026|NCT01202188|69526349|FG000|Overall Study|Lost to Follow-up|1|||
37842027|NCT01202188|69526350|FG001|Overall Study|Lost to Follow-up|1|||
37842028|NCT01202188|69526351|FG002|Overall Study|Lost to Follow-up|0|||
37842029|NCT01202188|69526352|FG003|Overall Study|Lost to Follow-up|4|||
37842030|NCT01202188|69526353|FG004|Overall Study|Lost to Follow-up|1|||
37842031|NCT01202188|69526349|FG000|Overall Study|Death|1|||
37842032|NCT01202188|69526350|FG001|Overall Study|Death|1|||
37842033|NCT01202188|69526351|FG002|Overall Study|Death|1|||
37842034|NCT01202188|69526352|FG003|Overall Study|Death|1|||
37842035|NCT01202188|69526353|FG004|Overall Study|Death|0|||
37842036|NCT01202188|69526349|FG000|Overall Study|Abnormal test procedure result (s)|0|||
37726670|NCT01953692|69205619|FG005|Overall Study|Death|3|||
37726671|NCT01953692|69205620|FG006|Overall Study|Death|6|||
37726672|NCT01953692|69205621|FG007|Overall Study|Death|2|||
37726673|NCT01953692|69205622|FG008|Overall Study|Death|1|||
37726674|NCT01953692|69205614|FG000|Overall Study|Excluded Medication|1|||
37726675|NCT01953692|69205615|FG001|Overall Study|Excluded Medication|0|||
37726676|NCT01953692|69205616|FG002|Overall Study|Excluded Medication|0|||
37726677|NCT01953692|69205617|FG003|Overall Study|Excluded Medication|0|||
37726678|NCT01953692|69205618|FG004|Overall Study|Excluded Medication|0|||
37726679|NCT01953692|69205619|FG005|Overall Study|Excluded Medication|0|||
37726680|NCT01953692|69205620|FG006|Overall Study|Excluded Medication|0|||
37726681|NCT01953692|69205621|FG007|Overall Study|Excluded Medication|0|||
37726682|NCT01953692|69205622|FG008|Overall Study|Excluded Medication|0|||
37726683|NCT01953692|69205614|FG000|Overall Study|Lost to Follow-up|1|||
37726684|NCT01953692|69205615|FG001|Overall Study|Lost to Follow-up|0|||
37726685|NCT01953692|69205616|FG002|Overall Study|Lost to Follow-up|3|||
37726686|NCT01953692|69205617|FG003|Overall Study|Lost to Follow-up|1|||
37726687|NCT01953692|69205618|FG004|Overall Study|Lost to Follow-up|0|||
37726688|NCT01953692|69205619|FG005|Overall Study|Lost to Follow-up|1|||
37726689|NCT01953692|69205620|FG006|Overall Study|Lost to Follow-up|0|||
37726690|NCT01953692|69205621|FG007|Overall Study|Lost to Follow-up|0|||
37726691|NCT01953692|69205622|FG008|Overall Study|Lost to Follow-up|0|||
37726692|NCT01953692|69205614|FG000|Overall Study|Physician Decision|11|||
37726693|NCT01953692|69205615|FG001|Overall Study|Physician Decision|4|||
37726694|NCT01953692|69205616|FG002|Overall Study|Physician Decision|2|||
37726695|NCT01953692|69205617|FG003|Overall Study|Physician Decision|2|||
37726696|NCT01953692|69205618|FG004|Overall Study|Physician Decision|1|||
37726697|NCT01953692|69205619|FG005|Overall Study|Physician Decision|2|||
37726698|NCT01953692|69205620|FG006|Overall Study|Physician Decision|4|||
37726699|NCT01953692|69205621|FG007|Overall Study|Physician Decision|1|||
37726700|NCT01953692|69205622|FG008|Overall Study|Physician Decision|0|||
37842037|NCT01202188|69526350|FG001|Overall Study|Abnormal test procedure result (s)|0|||
37842038|NCT01202188|69526351|FG002|Overall Study|Abnormal test procedure result (s)|2|||
37842039|NCT01202188|69526352|FG003|Overall Study|Abnormal test procedure result (s)|0|||
37842040|NCT01202188|69526353|FG004|Overall Study|Abnormal test procedure result (s)|0|||
37726701|NCT01953692|69205614|FG000|Overall Study|Protocol Violation|0|||
37726702|NCT01953692|69205615|FG001|Overall Study|Protocol Violation|2|||
37726703|NCT01953692|69205616|FG002|Overall Study|Protocol Violation|1|||
37726704|NCT01953692|69205617|FG003|Overall Study|Protocol Violation|0|||
37842041|NCT01201915|69526374|FG000|Overall Study|Adverse Event|2|||
37726705|NCT01953692|69205618|FG004|Overall Study|Protocol Violation|0|||
37726706|NCT01953692|69205619|FG005|Overall Study|Protocol Violation|0|||
37726707|NCT01953692|69205620|FG006|Overall Study|Protocol Violation|0|||
37726708|NCT01953692|69205621|FG007|Overall Study|Protocol Violation|1|||
37726709|NCT01953692|69205622|FG008|Overall Study|Protocol Violation|0|||
37726710|NCT01953692|69205614|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
37726711|NCT01953692|69205615|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
37726712|NCT01953692|69205616|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
37726713|NCT01953692|69205617|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
37726714|NCT01953692|69205618|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
37726715|NCT01953692|69205619|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
37726716|NCT01953692|69205620|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
37726717|NCT01953692|69205621|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
37726718|NCT01953692|69205622|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
37726719|NCT01953692|69205614|FG000|Overall Study|Withdrawal by Subject|4|||
37726720|NCT01953692|69205615|FG001|Overall Study|Withdrawal by Subject|2|||
37726721|NCT01953692|69205616|FG002|Overall Study|Withdrawal by Subject|1|||
37726722|NCT01953692|69205617|FG003|Overall Study|Withdrawal by Subject|2|||
37726723|NCT01953692|69205618|FG004|Overall Study|Withdrawal by Subject|0|||
37726724|NCT01953692|69205619|FG005|Overall Study|Withdrawal by Subject|3|||
37726725|NCT01953692|69205620|FG006|Overall Study|Withdrawal by Subject|2|||
37726726|NCT01953692|69205621|FG007|Overall Study|Withdrawal by Subject|1|||
37726727|NCT01953692|69205622|FG008|Overall Study|Withdrawal by Subject|1|||
37726728|NCT01791153|69205656|FG000|Part 1: Blinded Period|Adverse Event|7|||
37726729|NCT01791153|69205657|FG001|Part 1: Blinded Period|Adverse Event|3|||
37726730|NCT01791153|69205658|FG002|Part 1: Blinded Period|Adverse Event|2|||
37726731|NCT01791153|69205659|FG003|Part 1: Blinded Period|Adverse Event|0|||
37726732|NCT01791153|69205660|FG004|Part 1: Blinded Period|Adverse Event|0|||
37726733|NCT01791153|69205661|FG005|Part 1: Blinded Period|Adverse Event|0|||
37726734|NCT01791153|69205662|FG006|Part 1: Blinded Period|Adverse Event|0|||
37726735|NCT01791153|69205663|FG007|Part 1: Blinded Period|Adverse Event|0|||
37726736|NCT01791153|69205656|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
37726737|NCT01791153|69205657|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
37726738|NCT01791153|69205658|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
37726739|NCT01791153|69205659|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
37726740|NCT01791153|69205660|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
37726741|NCT01791153|69205661|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
37726742|NCT01791153|69205662|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
37726743|NCT01791153|69205663|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
37726744|NCT01791153|69205656|FG000|Part 1: Blinded Period|Non-Compliance|1|||
37726745|NCT01791153|69205657|FG001|Part 1: Blinded Period|Non-Compliance|0|||
37726746|NCT01791153|69205658|FG002|Part 1: Blinded Period|Non-Compliance|0|||
37726747|NCT01791153|69205659|FG003|Part 1: Blinded Period|Non-Compliance|0|||
37726748|NCT01791153|69205660|FG004|Part 1: Blinded Period|Non-Compliance|0|||
37726749|NCT01791153|69205661|FG005|Part 1: Blinded Period|Non-Compliance|0|||
37726750|NCT01791153|69205662|FG006|Part 1: Blinded Period|Non-Compliance|0|||
37726751|NCT01791153|69205663|FG007|Part 1: Blinded Period|Non-Compliance|0|||
37726752|NCT01791153|69205656|FG000|Part 1: Blinded Period|Physician Decision|0|||
37726753|NCT01791153|69205657|FG001|Part 1: Blinded Period|Physician Decision|0|||
37726754|NCT01791153|69205658|FG002|Part 1: Blinded Period|Physician Decision|0|||
37726755|NCT01791153|69205659|FG003|Part 1: Blinded Period|Physician Decision|1|||
37726756|NCT01791153|69205660|FG004|Part 1: Blinded Period|Physician Decision|0|||
37842042|NCT01201915|69526375|FG001|Overall Study|Adverse Event|1|||
37842043|NCT01201915|69526376|FG002|Overall Study|Adverse Event|1|||
37842044|NCT01201915|69526374|FG000|Overall Study|Lost to Follow-up|0|||
37842045|NCT01201915|69526375|FG001|Overall Study|Lost to Follow-up|4|||
37842046|NCT01201915|69526376|FG002|Overall Study|Lost to Follow-up|0|||
37842047|NCT01201915|69526374|FG000|Overall Study|Physician Decision|3|||
37842048|NCT01201915|69526375|FG001|Overall Study|Physician Decision|0|||
37842049|NCT01201915|69526376|FG002|Overall Study|Physician Decision|0|||
37842050|NCT01201915|69526374|FG000|Overall Study|Subject Decision|3|||
37842051|NCT01201915|69526375|FG001|Overall Study|Subject Decision|3|||
37842052|NCT01201915|69526376|FG002|Overall Study|Subject Decision|5|||
37842053|NCT01201915|69526374|FG000|Overall Study|Target Lesion Progression|0|||
37726757|NCT01791153|69205661|FG005|Part 1: Blinded Period|Physician Decision|0|||
37726758|NCT01791153|69205662|FG006|Part 1: Blinded Period|Physician Decision|0|||
37726759|NCT01791153|69205663|FG007|Part 1: Blinded Period|Physician Decision|0|||
37726760|NCT01791153|69205656|FG000|Part 1: Blinded Period|Protocol Violation|0|||
37726761|NCT01791153|69205657|FG001|Part 1: Blinded Period|Protocol Violation|0|||
37726762|NCT01791153|69205658|FG002|Part 1: Blinded Period|Protocol Violation|0|||
37726763|NCT01791153|69205659|FG003|Part 1: Blinded Period|Protocol Violation|1|||
37726764|NCT01791153|69205660|FG004|Part 1: Blinded Period|Protocol Violation|0|||
37726765|NCT01791153|69205661|FG005|Part 1: Blinded Period|Protocol Violation|0|||
37726766|NCT01791153|69205662|FG006|Part 1: Blinded Period|Protocol Violation|0|||
37726767|NCT01791153|69205663|FG007|Part 1: Blinded Period|Protocol Violation|0|||
37842054|NCT01201915|69526375|FG001|Overall Study|Target Lesion Progression|3|||
37842055|NCT01201915|69526376|FG002|Overall Study|Target Lesion Progression|0|||
37726768|NCT01791153|69205656|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
37726769|NCT01791153|69205657|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
37726770|NCT01791153|69205658|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
37726771|NCT01791153|69205659|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
37726772|NCT01791153|69205660|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
37726773|NCT01791153|69205661|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
37726774|NCT01791153|69205662|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
37726775|NCT01791153|69205663|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
37726776|NCT01791153|69205656|FG000|Part 2: Open-label Period|Adverse Event|0|||
37726777|NCT01791153|69205657|FG001|Part 2: Open-label Period|Adverse Event|0|||
37726778|NCT01791153|69205658|FG002|Part 2: Open-label Period|Adverse Event|0|||
37726779|NCT01791153|69205659|FG003|Part 2: Open-label Period|Adverse Event|0|||
37726780|NCT01791153|69205660|FG004|Part 2: Open-label Period|Adverse Event|0|||
37726781|NCT01791153|69205661|FG005|Part 2: Open-label Period|Adverse Event|1|||
37726782|NCT01791153|69205662|FG006|Part 2: Open-label Period|Adverse Event|1|||
37726783|NCT01791153|69205663|FG007|Part 2: Open-label Period|Adverse Event|2|||
37726784|NCT01791153|69205656|FG000|Part 2: Open-label Period|Death|0|||
37726785|NCT01791153|69205657|FG001|Part 2: Open-label Period|Death|0|||
37726786|NCT01791153|69205658|FG002|Part 2: Open-label Period|Death|0|||
37726787|NCT01791153|69205659|FG003|Part 2: Open-label Period|Death|0|||
37726788|NCT01791153|69205660|FG004|Part 2: Open-label Period|Death|0|||
37842056|NCT01179919|69526384|FG000|Overall Study|Protocol Violation|1|||
37842057|NCT01179919|69526384|FG000|Overall Study|Adverse Event|1|||
37842058|NCT01201798|69526390|FG000|Overall Study|Adverse Event|2|||
37842059|NCT01201798|69526391|FG001|Overall Study|Adverse Event|0|||
37842060|NCT01201798|69526390|FG000|Overall Study|Lost to Follow-up|3|||
37842061|NCT01201798|69526391|FG001|Overall Study|Lost to Follow-up|5|||
37842062|NCT01201798|69526390|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
37842063|NCT01201798|69526391|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
37842064|NCT01201798|69526390|FG000|Overall Study|Noncompliance|1|||
37842065|NCT01201798|69526391|FG001|Overall Study|Noncompliance|0|||
37842066|NCT01201798|69526390|FG000|Overall Study|Protocol Violation|1|||
37842067|NCT01201798|69526391|FG001|Overall Study|Protocol Violation|1|||
37842068|NCT01201798|69526390|FG000|Overall Study|Treatment Failure|1|||
37842069|NCT01201798|69526391|FG001|Overall Study|Treatment Failure|8|||
37842070|NCT01201759|69526399|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
37842071|NCT01201759|69526400|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
37842072|NCT01201759|69526399|FG000|Visit 3 - Washout|Adverse Event|0|||
37842073|NCT01201759|69526400|FG001|Visit 3 - Washout|Adverse Event|3|||
37842074|NCT01201759|69526399|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
37842075|NCT01201759|69526400|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
37842076|NCT01201759|69526399|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
37842077|NCT01201759|69526400|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
37842078|NCT01200589|69526410|FG000|Overall Study|Withdrawal by Subject|13|||
37842079|NCT01200589|69526411|FG001|Overall Study|Withdrawal by Subject|11|||
37842080|NCT01200589|69526410|FG000|Overall Study|Physician Decision|2|||
37842081|NCT01200589|69526411|FG001|Overall Study|Physician Decision|2|||
37842082|NCT01200589|69526410|FG000|Overall Study|Lost to Follow-up|5|||
37842083|NCT01200589|69526411|FG001|Overall Study|Lost to Follow-up|4|||
37842084|NCT01200589|69526410|FG000|Overall Study|Study terminated|170|||
37842085|NCT01200589|69526411|FG001|Overall Study|Study terminated|172|||
37842086|NCT01200511|69526417|FG000|Overall Study|Lost to Follow-up|3|||
37842087|NCT01200511|69526417|FG000|Overall Study|Withdrawal by Subject|1|||
37842088|NCT01200511|69526417|FG000|Overall Study|Adverse Event|1|||
37842089|NCT01179334|69526425|FG000|Treatment Period|Adverse Event|1|||
37842090|NCT01179334|69526426|FG001|Treatment Period|Adverse Event|0|||
37842091|NCT01179334|69526425|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
37842092|NCT01179334|69526426|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
37842093|NCT01179334|69526425|FG000|Long-term Extension (LTE) Period|Death|3|||
37842094|NCT01179334|69526426|FG001|Long-term Extension (LTE) Period|Death|0|||
37842095|NCT01179334|69526425|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
37842096|NCT01179334|69526426|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
37842097|NCT01178671|69526434|FG000|Overall Study|Adverse Event|4|||
37842098|NCT01178671|69526435|FG001|Overall Study|Adverse Event|6|||
37842099|NCT01178671|69526434|FG000|Overall Study|Protocol Violation|1|||
37842100|NCT01178671|69526435|FG001|Overall Study|Protocol Violation|1|||
37842101|NCT01178671|69526434|FG000|Overall Study|Lack of Efficacy|0|||
37842102|NCT01178671|69526435|FG001|Overall Study|Lack of Efficacy|1|||
37842103|NCT01178671|69526434|FG000|Overall Study|Lost to Follow-up|3|||
37842104|NCT01178671|69526435|FG001|Overall Study|Lost to Follow-up|1|||
37842105|NCT01178671|69526434|FG000|Overall Study|Physician Decision|4|||
37842106|NCT01178671|69526435|FG001|Overall Study|Physician Decision|6|||
37842107|NCT01178125|69526441|FG000|Overall Study|Lost to Follow-up|397|||
37842108|NCT01178125|69526441|FG000|Overall Study|Adverse Event|244|||
37842109|NCT01178125|69526441|FG000|Overall Study|Withdrawal by Subject|209|||
37726789|NCT01791153|69205661|FG005|Part 2: Open-label Period|Death|1|||
37726790|NCT01791153|69205662|FG006|Part 2: Open-label Period|Death|1|||
37726791|NCT01791153|69205663|FG007|Part 2: Open-label Period|Death|1|||
37726792|NCT01791153|69205656|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
37726793|NCT01791153|69205657|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
37726794|NCT01791153|69205658|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
37726795|NCT01791153|69205659|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
37726796|NCT01791153|69205660|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
37842110|NCT01178125|69526441|FG000|Overall Study|Noncompliance|184|||
37842111|NCT01178125|69526441|FG000|Overall Study|Pregnancy|55|||
37842112|NCT01178125|69526441|FG000|Overall Study|Other Reason|39|||
37842113|NCT01178125|69526441|FG000|Overall Study|Sponsor Decision|28|||
37842114|NCT01178125|69526441|FG000|Overall Study|Protocol Violation|17|||
37842115|NCT01178125|69526441|FG000|Overall Study|Investigator Decision|5|||
37842116|NCT01178086|69526463|FG000|Overall Study|Participant refusal|7|||
37842117|NCT01178086|69526463|FG000|Overall Study|Physician Decision|44|||
37842118|NCT01178086|69526463|FG000|Overall Study|Switch to other CLL therapy|113|||
37842119|NCT01178086|69526463|FG000|Overall Study|Death|59|||
37842120|NCT01178086|69526463|FG000|Overall Study|Other unspecified|89|||
37842121|NCT01178086|69526463|FG000|Overall Study|Excluded from EAS|20|||
37842122|NCT01177969|69526471|FG000|Overall Study|Protocol Violation|2|||
37842123|NCT01177969|69526472|FG001|Overall Study|Protocol Violation|1|||
37842124|NCT01177969|69526471|FG000|Overall Study|Withdrawal by Subject|1|||
37842125|NCT01177969|69526472|FG001|Overall Study|Withdrawal by Subject|2|||
37726797|NCT01791153|69205661|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
37726798|NCT01791153|69205662|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
37726799|NCT01791153|69205663|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
37726800|NCT01791153|69205656|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
37726801|NCT01791153|69205657|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
37726802|NCT01791153|69205658|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
37726803|NCT01791153|69205659|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
37726804|NCT01791153|69205660|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
37726805|NCT01791153|69205661|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
37726806|NCT01791153|69205662|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
37726807|NCT01791153|69205663|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
37726808|NCT01791153|69205656|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
37726809|NCT01791153|69205657|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
37726810|NCT01791153|69205658|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
37726811|NCT01791153|69205659|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
37726812|NCT01791153|69205660|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
37726813|NCT01791153|69205661|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
37726814|NCT01791153|69205662|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
37726815|NCT01791153|69205663|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
37726816|NCT01791153|69205656|FG000|Part 2: Open-label Period|Physician Decision|0|||
37726817|NCT01791153|69205657|FG001|Part 2: Open-label Period|Physician Decision|0|||
37726818|NCT01791153|69205658|FG002|Part 2: Open-label Period|Physician Decision|0|||
37726819|NCT01791153|69205659|FG003|Part 2: Open-label Period|Physician Decision|0|||
37726820|NCT01791153|69205660|FG004|Part 2: Open-label Period|Physician Decision|1|||
37842126|NCT01177813|69526483|FG000|Overall Study|Adverse Event|8|||
37842127|NCT01177813|69526484|FG001|Overall Study|Adverse Event|2|||
37842128|NCT01177813|69526485|FG002|Overall Study|Adverse Event|4|||
37842129|NCT01177813|69526486|FG003|Overall Study|Adverse Event|6|||
37842130|NCT01177813|69526487|FG004|Overall Study|Adverse Event|3|||
37842131|NCT01177813|69526483|FG000|Overall Study|Lack of Efficacy|1|||
37842132|NCT01177813|69526484|FG001|Overall Study|Lack of Efficacy|0|||
37842133|NCT01177813|69526485|FG002|Overall Study|Lack of Efficacy|0|||
37842134|NCT01177813|69526486|FG003|Overall Study|Lack of Efficacy|0|||
37842135|NCT01177813|69526487|FG004|Overall Study|Lack of Efficacy|0|||
37726821|NCT01791153|69205661|FG005|Part 2: Open-label Period|Physician Decision|1|||
37726822|NCT01791153|69205662|FG006|Part 2: Open-label Period|Physician Decision|0|||
37726823|NCT01791153|69205663|FG007|Part 2: Open-label Period|Physician Decision|0|||
37726824|NCT01926782|69205684|FG000|Overall Study|Participant moved|2|||
37726825|NCT01926782|69205685|FG001|Overall Study|Participant moved|0|||
37726826|NCT01926782|69205686|FG002|Overall Study|Participant moved|1|||
37726827|NCT01926782|69205687|FG003|Overall Study|Participant moved|1|||
37842136|NCT01177813|69526483|FG000|Overall Study|Protocol Violation|3|||
37842137|NCT01177813|69526484|FG001|Overall Study|Protocol Violation|2|||
37842138|NCT01177813|69526485|FG002|Overall Study|Protocol Violation|2|||
37842139|NCT01177813|69526486|FG003|Overall Study|Protocol Violation|0|||
37842140|NCT01177813|69526487|FG004|Overall Study|Protocol Violation|1|||
37842141|NCT01177813|69526483|FG000|Overall Study|Lost to Follow-up|12|||
37726828|NCT01926782|69205688|FG004|Overall Study|Participant moved|0|||
37726829|NCT01926782|69205689|FG005|Overall Study|Participant moved|3|||
37726830|NCT01926782|69205684|FG000|Overall Study|Physician Decision|0|||
37726831|NCT01926782|69205685|FG001|Overall Study|Physician Decision|2|||
37842142|NCT01177813|69526484|FG001|Overall Study|Lost to Follow-up|5|||
37726832|NCT01926782|69205686|FG002|Overall Study|Physician Decision|1|||
37726833|NCT01926782|69205687|FG003|Overall Study|Physician Decision|1|||
37726834|NCT01926782|69205688|FG004|Overall Study|Physician Decision|0|||
37726835|NCT01926782|69205689|FG005|Overall Study|Physician Decision|0|||
37726836|NCT01926782|69205684|FG000|Overall Study|Other than specified|2|||
37726837|NCT01926782|69205685|FG001|Overall Study|Other than specified|3|||
37726838|NCT01926782|69205686|FG002|Overall Study|Other than specified|5|||
37726839|NCT01926782|69205687|FG003|Overall Study|Other than specified|12|||
37726840|NCT01926782|69205688|FG004|Overall Study|Other than specified|4|||
37726841|NCT01926782|69205689|FG005|Overall Study|Other than specified|11|||
37726842|NCT01926782|69205684|FG000|Overall Study|Adverse Event|13|||
37726843|NCT01926782|69205685|FG001|Overall Study|Adverse Event|4|||
37726844|NCT01926782|69205686|FG002|Overall Study|Adverse Event|17|||
37726845|NCT01926782|69205687|FG003|Overall Study|Adverse Event|4|||
37726846|NCT01926782|69205688|FG004|Overall Study|Adverse Event|3|||
37726847|NCT01926782|69205689|FG005|Overall Study|Adverse Event|14|||
37726848|NCT01926782|69205684|FG000|Overall Study|Poor compliance to protocol|5|||
37726849|NCT01926782|69205685|FG001|Overall Study|Poor compliance to protocol|3|||
37726850|NCT01926782|69205686|FG002|Overall Study|Poor compliance to protocol|8|||
37726851|NCT01926782|69205687|FG003|Overall Study|Poor compliance to protocol|0|||
37726852|NCT01926782|69205688|FG004|Overall Study|Poor compliance to protocol|1|||
37726853|NCT01926782|69205689|FG005|Overall Study|Poor compliance to protocol|6|||
37726854|NCT01926782|69205684|FG000|Overall Study|Randomized and not treated|0|||
37726855|NCT01926782|69205685|FG001|Overall Study|Randomized and not treated|0|||
37726856|NCT01926782|69205686|FG002|Overall Study|Randomized and not treated|0|||
37726857|NCT01926782|69205687|FG003|Overall Study|Randomized and not treated|1|||
37726858|NCT01926782|69205688|FG004|Overall Study|Randomized and not treated|0|||
37726859|NCT01926782|69205689|FG005|Overall Study|Randomized and not treated|0|||
37726860|NCT01926782|69205684|FG000|Overall Study|Withdrawal by Subject|6|||
37726861|NCT01926782|69205685|FG001|Overall Study|Withdrawal by Subject|1|||
37726862|NCT01926782|69205686|FG002|Overall Study|Withdrawal by Subject|8|||
37726863|NCT01926782|69205687|FG003|Overall Study|Withdrawal by Subject|1|||
37726864|NCT01926782|69205688|FG004|Overall Study|Withdrawal by Subject|0|||
37726865|NCT01926782|69205689|FG005|Overall Study|Withdrawal by Subject|5|||
37726866|NCT01926782|69205684|FG000|Overall Study|Related to study drug administration|0|||
37726867|NCT01926782|69205685|FG001|Overall Study|Related to study drug administration|0|||
37726868|NCT01926782|69205686|FG002|Overall Study|Related to study drug administration|0|||
37726869|NCT01926782|69205687|FG003|Overall Study|Related to study drug administration|0|||
37726870|NCT01926782|69205688|FG004|Overall Study|Related to study drug administration|0|||
37726871|NCT01926782|69205689|FG005|Overall Study|Related to study drug administration|2|||
37726872|NCT01926626|69205704|FG000|Overall Study|Withdrawal by Subject|15|||
37726873|NCT01926626|69205704|FG000|Overall Study|Lost to Follow-up|7|||
37726874|NCT01953224|69205710|FG000|Overall Study|Lost to Follow-up|1|||
37726875|NCT01953224|69205711|FG001|Overall Study|Lost to Follow-up|1|||
37726876|NCT01953224|69205710|FG000|Overall Study|Withdrawal by Subject|1|||
37726877|NCT01953224|69205711|FG001|Overall Study|Withdrawal by Subject|2|||
37726878|NCT01900730|69205719|FG000|Overall Study|Withdrawal by Subject|1|||
37726879|NCT01900730|69205720|FG001|Overall Study|Withdrawal by Subject|0|||
37726880|NCT01900730|69205719|FG000|Overall Study|Screen Failure|1|||
37726881|NCT01900730|69205720|FG001|Overall Study|Screen Failure|0|||
37726882|NCT01952834|69205726|FG000|Overall Study|Adverse Event|1|||
38025415|NCT01971970|69709816|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
38025416|NCT01971970|69709817|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
37726885|NCT01952054|69205738|FG000|Overall Study|Physician Decision|1|||
37726886|NCT01925768|69205744|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
37726887|NCT01925768|69205745|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
37726888|NCT01925768|69205744|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
37726889|NCT01925768|69205745|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
37726890|NCT01925768|69205744|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
37726891|NCT01925768|69205745|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
37726892|NCT01925768|69205744|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
37726893|NCT01925768|69205745|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
37726894|NCT01925768|69205744|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
37726895|NCT01925768|69205745|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
37726896|NCT01925768|69205744|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
37726897|NCT01925768|69205745|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
37842143|NCT01177813|69526485|FG002|Overall Study|Lost to Follow-up|6|||
37842144|NCT01177813|69526486|FG003|Overall Study|Lost to Follow-up|3|||
37842145|NCT01177813|69526487|FG004|Overall Study|Lost to Follow-up|0|||
37726898|NCT01925768|69205744|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
37726899|NCT01925768|69205745|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
37726900|NCT01925768|69205744|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
37726901|NCT01925768|69205745|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
37726902|NCT01925768|69205744|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
37726903|NCT01925768|69205745|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
37726904|NCT01925768|69205744|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
37726905|NCT01925768|69205745|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
37726906|NCT01925768|69205744|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
37726907|NCT01925768|69205745|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
37726908|NCT01431274|69205760|FG000|Overall Study|Adverse Event|51|||
37726909|NCT01431274|69205761|FG001|Overall Study|Adverse Event|37|||
37726910|NCT01431274|69205762|FG002|Overall Study|Adverse Event|43|||
37726911|NCT01431274|69205763|FG003|Overall Study|Adverse Event|30|||
37726912|NCT01431274|69205764|FG004|Overall Study|Adverse Event|37|||
37726913|NCT01431274|69205760|FG000|Overall Study|Consent withdrawn not due to AE|29|||
37726914|NCT01431274|69205761|FG001|Overall Study|Consent withdrawn not due to AE|20|||
37726915|NCT01431274|69205762|FG002|Overall Study|Consent withdrawn not due to AE|17|||
37726916|NCT01431274|69205763|FG003|Overall Study|Consent withdrawn not due to AE|20|||
37726917|NCT01431274|69205764|FG004|Overall Study|Consent withdrawn not due to AE|11|||
37726918|NCT01431274|69205760|FG000|Overall Study|Non compliant with protocol|5|||
37726919|NCT01431274|69205761|FG001|Overall Study|Non compliant with protocol|8|||
37726920|NCT01431274|69205762|FG002|Overall Study|Non compliant with protocol|4|||
37726921|NCT01431274|69205763|FG003|Overall Study|Non compliant with protocol|4|||
37726922|NCT01431274|69205764|FG004|Overall Study|Non compliant with protocol|4|||
37726923|NCT01431274|69205760|FG000|Overall Study|Lost to Follow-up|6|||
37726924|NCT01431274|69205761|FG001|Overall Study|Lost to Follow-up|7|||
37726925|NCT01431274|69205762|FG002|Overall Study|Lost to Follow-up|1|||
37726926|NCT01431274|69205763|FG003|Overall Study|Lost to Follow-up|4|||
37726927|NCT01431274|69205764|FG004|Overall Study|Lost to Follow-up|0|||
37726928|NCT01431274|69205760|FG000|Overall Study|Other reason not stated above|6|||
37726929|NCT01431274|69205761|FG001|Overall Study|Other reason not stated above|5|||
37726930|NCT01431274|69205762|FG002|Overall Study|Other reason not stated above|7|||
37726931|NCT01431274|69205763|FG003|Overall Study|Other reason not stated above|2|||
37726932|NCT01431274|69205764|FG004|Overall Study|Other reason not stated above|4|||
37726933|NCT01991795|69205778|FG000|Overall Study|Lost to Follow-up|6|||
37726934|NCT01991795|69205779|FG001|Overall Study|Lost to Follow-up|4|||
37726935|NCT01991795|69205778|FG000|Overall Study|Withdrawal by Subject|117|||
37842146|NCT01177813|69526483|FG000|Overall Study|Withdrawal by Subject|12|||
37842147|NCT01177813|69526484|FG001|Overall Study|Withdrawal by Subject|7|||
37842148|NCT01177813|69526485|FG002|Overall Study|Withdrawal by Subject|6|||
37842149|NCT01177813|69526486|FG003|Overall Study|Withdrawal by Subject|5|||
37842150|NCT01177813|69526487|FG004|Overall Study|Withdrawal by Subject|3|||
37842151|NCT01177813|69526483|FG000|Overall Study|Other reason not defined above|5|||
37842152|NCT01177813|69526484|FG001|Overall Study|Other reason not defined above|2|||
37842153|NCT01177813|69526485|FG002|Overall Study|Other reason not defined above|2|||
37842154|NCT01177813|69526486|FG003|Overall Study|Other reason not defined above|3|||
37842155|NCT01177813|69526487|FG004|Overall Study|Other reason not defined above|2|||
37842156|NCT01200394|69526501|FG000|Overall Study|Adverse Event|0|||
37842157|NCT01200394|69526502|FG001|Overall Study|Adverse Event|14|||
37842158|NCT01200394|69526501|FG000|Overall Study|Death|1|||
37842159|NCT01200394|69526502|FG001|Overall Study|Death|0|||
37842160|NCT01200394|69526501|FG000|Overall Study|Lost to Follow-up|0|||
37842161|NCT01200394|69526502|FG001|Overall Study|Lost to Follow-up|1|||
37842162|NCT01200394|69526501|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
37842163|NCT01200394|69526502|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
37842164|NCT01200394|69526501|FG000|Overall Study|Protocol Violation|0|||
37842165|NCT01200394|69526502|FG001|Overall Study|Protocol Violation|3|||
37842166|NCT01200394|69526501|FG000|Overall Study|Withdrawal by Subject|0|||
37842167|NCT01200394|69526502|FG001|Overall Study|Withdrawal by Subject|5|||
37842168|NCT01200394|69526501|FG000|Overall Study|Other|0|||
37842169|NCT01200394|69526502|FG001|Overall Study|Other|1|||
37842170|NCT01200355|69526511|FG000|Overall Study|Death|7|||
37726936|NCT01991795|69205779|FG001|Overall Study|Withdrawal by Subject|94|||
37726937|NCT01991795|69205778|FG000|Overall Study|Site prematurely closed by sponsor|26|||
37726938|NCT01991795|69205779|FG001|Overall Study|Site prematurely closed by sponsor|25|||
37842171|NCT01200355|69526512|FG001|Overall Study|Death|2|||
37842172|NCT01200238|69526520|FG000|Overall Study|Adverse Event|2|||
37842173|NCT01200238|69526521|FG001|Overall Study|Adverse Event|1|||
37842174|NCT01200238|69526520|FG000|Overall Study|Progressive Disease|5|||
37726939|NCT01411852|69205820|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
37842175|NCT01200238|69526521|FG001|Overall Study|Progressive Disease|8|||
37842176|NCT01200238|69526520|FG000|Overall Study|Withdrawal by Subject|0|||
37842177|NCT01200238|69526521|FG001|Overall Study|Withdrawal by Subject|1|||
37842178|NCT01199731|69526530|FG000|Overall Study|Adverse Event|0|||
37842179|NCT01199731|69526531|FG001|Overall Study|Adverse Event|1|||
37842180|NCT01199731|69526532|FG002|Overall Study|Adverse Event|0|||
37842181|NCT01199731|69526530|FG000|Overall Study|Study closed/terminated|7|||
37842182|NCT01199731|69526531|FG001|Overall Study|Study closed/terminated|9|||
37842183|NCT01199731|69526532|FG002|Overall Study|Study closed/terminated|7|||
37842184|NCT01199731|69526530|FG000|Overall Study|Lost to Follow-up|0|||
37842185|NCT01199731|69526531|FG001|Overall Study|Lost to Follow-up|0|||
37842186|NCT01199731|69526532|FG002|Overall Study|Lost to Follow-up|2|||
37842187|NCT01199731|69526530|FG000|Overall Study|Physician Decision|0|||
37842188|NCT01199731|69526531|FG001|Overall Study|Physician Decision|1|||
37726940|NCT01411852|69205821|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
37726941|NCT01411852|69205820|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
37726942|NCT01411852|69205821|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
37726943|NCT01411852|69205820|FG000|Prehospital Intervention Phase|Found to be under age|0|||
37726944|NCT01411852|69205821|FG001|Prehospital Intervention Phase|Found to be under age|1|||
37726945|NCT01411852|69205820|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
37726946|NCT01411852|69205821|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
37726947|NCT01411852|69205820|FG000|Hospital Intervention Phase|Severe head injury|5|||
37726948|NCT01411852|69205821|FG001|Hospital Intervention Phase|Severe head injury|4|||
37726949|NCT01411852|69205820|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
37726950|NCT01411852|69205821|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
37726951|NCT01411852|69205820|FG000|Hospital Intervention Phase|Miscommunication error|1|||
37726952|NCT01411852|69205821|FG001|Hospital Intervention Phase|Miscommunication error|2|||
37726953|NCT01411852|69205820|FG000|Hospital Intervention Phase|CPR administered|3|||
37726954|NCT01411852|69205821|FG001|Hospital Intervention Phase|CPR administered|1|||
37726955|NCT01411852|69205820|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
37726956|NCT01411852|69205821|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
37726957|NCT01411852|69205820|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
37726958|NCT01411852|69205821|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
37726959|NCT01411852|69205820|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
37726960|NCT01411852|69205821|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
37726961|NCT01411852|69205820|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
37726962|NCT01411852|69205821|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
37726963|NCT01411852|69205820|FG000|Hospital Intervention Phase|Other ineligible|2|||
37726964|NCT01411852|69205821|FG001|Hospital Intervention Phase|Other ineligible|2|||
37726965|NCT01411852|69205820|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
37726966|NCT01411852|69205821|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
37842189|NCT01199731|69526532|FG002|Overall Study|Physician Decision|1|||
37842190|NCT01199731|69526530|FG000|Overall Study|Withdrawal by Subject|2|||
37842191|NCT01199731|69526531|FG001|Overall Study|Withdrawal by Subject|0|||
37842192|NCT01199731|69526532|FG002|Overall Study|Withdrawal by Subject|0|||
37842193|NCT01199263|69526542|FG000|Overall Study|Ineligible|0|||
37842194|NCT01199263|69526543|FG001|Overall Study|Ineligible|2|||
37842195|NCT01199263|69526542|FG000|Overall Study|Never Treated|6|||
37842196|NCT01199263|69526543|FG001|Overall Study|Never Treated|0|||
37842197|NCT01199068|69526554|FG000|Overall Study|Unacceptable toxicity|0|||
37842198|NCT01199068|69526555|FG001|Overall Study|Unacceptable toxicity|0|||
37842199|NCT01199068|69526556|FG002|Overall Study|Unacceptable toxicity|2|||
37842200|NCT01199068|69526554|FG000|Overall Study|Progressive disease|3|||
37842201|NCT01199068|69526555|FG001|Overall Study|Progressive disease|3|||
37842202|NCT01199068|69526556|FG002|Overall Study|Progressive disease|6|||
37842203|NCT01199068|69526554|FG000|Overall Study|Withdrawal by Subject|0|||
37842204|NCT01199068|69526555|FG001|Overall Study|Withdrawal by Subject|0|||
37842205|NCT01199068|69526556|FG002|Overall Study|Withdrawal by Subject|1|||
37842206|NCT01198873|69526573|FG000|Overall Study|Adverse Event|4|||
37842207|NCT01198873|69526574|FG001|Overall Study|Adverse Event|7|||
37842208|NCT01198873|69526573|FG000|Overall Study|Study closure|29|||
37842209|NCT01198873|69526574|FG001|Overall Study|Study closure|23|||
37842210|NCT01198873|69526573|FG000|Overall Study|Other than above|4|||
37842211|NCT01198873|69526574|FG001|Overall Study|Other than above|2|||
37842212|NCT01198795|69526580|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
37842213|NCT01198795|69526580|FG000|Overall Study|Withdrawal by Subject|17|||
37842214|NCT01198795|69526580|FG000|Overall Study|Lost to Follow-up|15|||
37842215|NCT01198795|69526580|FG000|Overall Study|Adverse Event|9|||
37842216|NCT01198795|69526580|FG000|Overall Study|Lack of Efficacy|5|||
37842217|NCT01198795|69526580|FG000|Overall Study|Protocol Violation|2|||
37842218|NCT01198795|69526580|FG000|Overall Study|Other Reason|4|||
37842219|NCT01198756|69526588|FG000|Overall Study|Adverse Event|0|||
37842220|NCT01198756|69526589|FG001|Overall Study|Adverse Event|0|||
37726967|NCT01411852|69205820|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
37842221|NCT01198756|69526590|FG002|Overall Study|Adverse Event|0|||
37842222|NCT01198756|69526591|FG003|Overall Study|Adverse Event|1|||
37726968|NCT01411852|69205821|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
37726969|NCT01411852|69205820|FG000|Hospital Intervention Phase|Vascular access failed|1|||
37726970|NCT01411852|69205821|FG001|Hospital Intervention Phase|Vascular access failed|0|||
37726971|NCT01411774|69205831|FG000|Overall Study|Withdrawal by Subject|0|||
37726972|NCT01411774|69205832|FG001|Overall Study|Withdrawal by Subject|3|||
37726973|NCT01411228|69205841|FG000|Overall Study|Lost to Follow-up|0|||
37726974|NCT01411228|69205842|FG001|Overall Study|Lost to Follow-up|0|||
37726975|NCT01411228|69205843|FG002|Overall Study|Lost to Follow-up|1|||
37726976|NCT01411228|69205841|FG000|Overall Study|Withdrawal by Subject|1|||
37726977|NCT01411228|69205842|FG001|Overall Study|Withdrawal by Subject|0|||
37726978|NCT01411228|69205843|FG002|Overall Study|Withdrawal by Subject|0|||
37726979|NCT01410604|69205853|FG000|Overall Study|Adverse Event|2|||
37726980|NCT01410604|69205854|FG001|Overall Study|Adverse Event|1|||
37726981|NCT01410604|69205853|FG000|Overall Study|Lost to Follow-up|1|||
37726982|NCT01410604|69205854|FG001|Overall Study|Lost to Follow-up|0|||
37726983|NCT01410604|69205853|FG000|Overall Study|Physician Decision|0|||
37726984|NCT01410604|69205854|FG001|Overall Study|Physician Decision|1|||
37726985|NCT01991483|69205864|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
37726986|NCT01991483|69205865|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
37726987|NCT01991483|69205866|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
37726988|NCT01991483|69205867|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
37726989|NCT01991483|69205864|FG000|Dose Level 600 mg|Physician Decision|0|||
37726990|NCT01991483|69205865|FG001|Dose Level 600 mg|Physician Decision|0|||
37726991|NCT01991483|69205866|FG002|Dose Level 600 mg|Physician Decision|1|||
37726992|NCT01991483|69205867|FG003|Dose Level 600 mg|Physician Decision|0|||
37726993|NCT01991483|69205864|FG000|Dose Level 1000 mg|Protocol Violation|0|||
37726994|NCT01991483|69205865|FG001|Dose Level 1000 mg|Protocol Violation|0|||
37726995|NCT01991483|69205866|FG002|Dose Level 1000 mg|Protocol Violation|0|||
37726996|NCT01991483|69205867|FG003|Dose Level 1000 mg|Protocol Violation|1|||
37726997|NCT01410448|69205882|FG000|Overall Study|No conversion to everolimus|0|||
37726998|NCT01410448|69205883|FG001|Overall Study|No conversion to everolimus|24|||
37842223|NCT01198756|69526588|FG000|Overall Study|Protocol Violation|0|||
37842224|NCT01198756|69526589|FG001|Overall Study|Protocol Violation|0|||
37842225|NCT01198756|69526590|FG002|Overall Study|Protocol Violation|0|||
37842226|NCT01198756|69526591|FG003|Overall Study|Protocol Violation|2|||
37842227|NCT01198756|69526588|FG000|Overall Study|Withdrawal by Subject|9|||
37726999|NCT01410448|69205882|FG000|Overall Study|Graft loss|4|||
37727000|NCT01410448|69205883|FG001|Overall Study|Graft loss|1|||
37727001|NCT01410448|69205882|FG000|Overall Study|Administrative issues|2|||
37727002|NCT01410448|69205883|FG001|Overall Study|Administrative issues|1|||
37727003|NCT01410448|69205882|FG000|Overall Study|Lost to Follow-up|1|||
37727004|NCT01410448|69205883|FG001|Overall Study|Lost to Follow-up|0|||
37727005|NCT01410448|69205882|FG000|Overall Study|Withdrawal by Subject|3|||
37842228|NCT01198756|69526589|FG001|Overall Study|Withdrawal by Subject|4|||
37727006|NCT01410448|69205883|FG001|Overall Study|Withdrawal by Subject|2|||
37842229|NCT01198756|69526590|FG002|Overall Study|Withdrawal by Subject|7|||
37842230|NCT01198756|69526591|FG003|Overall Study|Withdrawal by Subject|5|||
37842231|NCT01198756|69526588|FG000|Overall Study|Lost to Follow-up|29|||
37842232|NCT01198756|69526589|FG001|Overall Study|Lost to Follow-up|36|||
37842233|NCT01198756|69526590|FG002|Overall Study|Lost to Follow-up|23|||
37842234|NCT01198756|69526591|FG003|Overall Study|Lost to Follow-up|18|||
37842235|NCT01198600|69526608|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
37842236|NCT01198600|69526609|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
37842237|NCT01198600|69526610|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
37842238|NCT01198600|69526611|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
37842239|NCT01198600|69526608|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
37842240|NCT01198600|69526609|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
37842241|NCT01198600|69526610|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
37842242|NCT01198600|69526611|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
37842243|NCT01198600|69526608|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
37842244|NCT01198600|69526609|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
37842245|NCT01198600|69526610|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
37727007|NCT01410448|69205882|FG000|Overall Study|Protocol Violation|0|||
37727008|NCT01410448|69205883|FG001|Overall Study|Protocol Violation|4|||
37727009|NCT01410448|69205882|FG000|Overall Study|Death|2|||
37727010|NCT01410448|69205883|FG001|Overall Study|Death|3|||
37727011|NCT01943851|69205907|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
37727012|NCT01943851|69205908|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
37727013|NCT01943851|69205909|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
37727014|NCT01943851|69205910|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
37727015|NCT01943851|69205911|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
37727016|NCT01943851|69205912|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
37727017|NCT01943851|69205913|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
37727018|NCT01943851|69205914|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
37727019|NCT01943851|69205915|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
37727020|NCT01943851|69205916|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
37727021|NCT01943851|69205917|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
37727022|NCT01943851|69205918|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
37727023|NCT01943851|69205919|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
37727024|NCT01943851|69205920|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
37727025|NCT01943851|69205921|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
37727026|NCT01943851|69205922|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
37727027|NCT01943851|69205923|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
37727028|NCT01943851|69205924|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
37727029|NCT01943851|69205907|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
37727030|NCT01943851|69205908|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
37727031|NCT01943851|69205909|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
37727032|NCT01943851|69205910|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
37727033|NCT01943851|69205911|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
37727034|NCT01943851|69205912|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
37727035|NCT01943851|69205913|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
37727036|NCT01943851|69205914|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
37727037|NCT01943851|69205915|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
37727038|NCT01943851|69205916|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
37727039|NCT01943851|69205917|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
37727040|NCT01943851|69205918|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
37727041|NCT01943851|69205919|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
37727042|NCT01943851|69205920|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
37727043|NCT01943851|69205921|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
37727044|NCT01943851|69205922|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
37727045|NCT01943851|69205923|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
37727046|NCT01943851|69205924|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
37727047|NCT01943851|69205907|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
37842246|NCT01198600|69526611|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
37727048|NCT01943851|69205908|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
37727049|NCT01943851|69205909|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
37727050|NCT01943851|69205910|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
37727051|NCT01943851|69205911|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
37727052|NCT01943851|69205912|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
37727053|NCT01943851|69205913|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
37727054|NCT01943851|69205914|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
37842247|NCT01198600|69526608|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
37842248|NCT01198600|69526609|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
37727055|NCT01943851|69205915|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
37727056|NCT01943851|69205916|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
37727057|NCT01943851|69205917|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
37727058|NCT01943851|69205918|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
37727059|NCT01943851|69205919|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
37727060|NCT01943851|69205920|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
37727061|NCT01943851|69205921|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
37727062|NCT01943851|69205922|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
37727063|NCT01943851|69205923|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
37727064|NCT01943851|69205924|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
37727065|NCT01943851|69205907|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
37727066|NCT01943851|69205908|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
37727067|NCT01943851|69205909|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
37727068|NCT01943851|69205910|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
37727069|NCT01943851|69205911|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
37727070|NCT01943851|69205912|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
37727071|NCT01943851|69205913|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
37727072|NCT01943851|69205914|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
37727073|NCT01943851|69205915|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
37727074|NCT01943851|69205916|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
37727075|NCT01943851|69205917|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
37727076|NCT01943851|69205918|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
37727077|NCT01943851|69205919|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
37727078|NCT01943851|69205920|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
37727079|NCT01943851|69205921|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
37727080|NCT01943851|69205922|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
37727081|NCT01943851|69205923|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
37727082|NCT01943851|69205924|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
37727083|NCT01943851|69205907|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
37727084|NCT01943851|69205908|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
37727085|NCT01943851|69205909|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
37727086|NCT01943851|69205910|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
37727087|NCT01943851|69205911|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
37727088|NCT01943851|69205912|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
37727089|NCT01943851|69205913|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
37727090|NCT01943851|69205914|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
37727091|NCT01943851|69205915|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
37727092|NCT01943851|69205916|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
37727093|NCT01943851|69205917|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
37727094|NCT01943851|69205918|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
37727095|NCT01943851|69205919|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
37727096|NCT01943851|69205920|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
37727097|NCT01943851|69205921|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
37727098|NCT01943851|69205922|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
37727099|NCT01943851|69205923|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
37727100|NCT01943851|69205924|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
37727101|NCT01430104|69205965|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
37727102|NCT01990859|69205972|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
37727103|NCT01990859|69205972|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
37727104|NCT02093897|69205977|FG000|Overall Study|Physician Decision|1|||
37727105|NCT02093897|69205977|FG000|Overall Study|Planned age group closure - no's reached|17|||
37727106|NCT02093897|69205977|FG000|Overall Study|Adverse event, non-fatal|1|||
37727107|NCT01990313|69205988|FG000|Overall Study|Lost to Follow-up|1|||
37727108|NCT01947517|69205994|FG000|Overall Study|Withdrawal by Subject|1|||
37727109|NCT01947517|69205995|FG001|Overall Study|Withdrawal by Subject|1|||
37727110|NCT02006927|69206001|FG000|Overall Study|Adverse Event|2|||
37727111|NCT02006927|69206001|FG000|Overall Study|Withdrawal by Subject|1|||
37727112|NCT01947283|69206012|FG000|Overall Study|Death|1|||
37727113|NCT01947283|69206013|FG001|Overall Study|Death|1|||
37727114|NCT01947283|69206014|FG002|Overall Study|Death|1|||
37727115|NCT01947283|69206015|FG003|Overall Study|Death|0|||
37727116|NCT01947283|69206016|FG004|Overall Study|Death|0|||
37727117|NCT01947283|69206017|FG005|Overall Study|Death|0|||
37727118|NCT01947283|69206018|FG006|Overall Study|Death|0|||
37727119|NCT01947283|69206012|FG000|Overall Study|Lost to Follow-up|4|||
37727120|NCT01947283|69206013|FG001|Overall Study|Lost to Follow-up|6|||
37727121|NCT01947283|69206014|FG002|Overall Study|Lost to Follow-up|5|||
37727122|NCT01947283|69206015|FG003|Overall Study|Lost to Follow-up|5|||
37727123|NCT01947283|69206016|FG004|Overall Study|Lost to Follow-up|0|||
37727124|NCT01947283|69206017|FG005|Overall Study|Lost to Follow-up|2|||
37727125|NCT01947283|69206018|FG006|Overall Study|Lost to Follow-up|5|||
37727126|NCT01947283|69206012|FG000|Overall Study|Withdrawal by Subject|10|||
37727127|NCT01947283|69206013|FG001|Overall Study|Withdrawal by Subject|8|||
37727128|NCT01947283|69206014|FG002|Overall Study|Withdrawal by Subject|4|||
37727129|NCT01947283|69206015|FG003|Overall Study|Withdrawal by Subject|1|||
37727130|NCT01947283|69206016|FG004|Overall Study|Withdrawal by Subject|0|||
37727131|NCT01947283|69206017|FG005|Overall Study|Withdrawal by Subject|0|||
37727132|NCT01947283|69206018|FG006|Overall Study|Withdrawal by Subject|2|||
37727133|NCT01947283|69206012|FG000|Overall Study|No Clinical Recording|12|||
37727134|NCT01947283|69206013|FG001|Overall Study|No Clinical Recording|6|||
37727135|NCT01947283|69206014|FG002|Overall Study|No Clinical Recording|8|||
37727136|NCT01947283|69206015|FG003|Overall Study|No Clinical Recording|10|||
37727137|NCT01947283|69206016|FG004|Overall Study|No Clinical Recording|0|||
37727138|NCT01947283|69206017|FG005|Overall Study|No Clinical Recording|0|||
37727139|NCT01947283|69206018|FG006|Overall Study|No Clinical Recording|0|||
37727140|NCT01947283|69206012|FG000|Overall Study|Non-coding Clinical Recording language|0|||
37727141|NCT01947283|69206013|FG001|Overall Study|Non-coding Clinical Recording language|0|||
37727142|NCT01947283|69206014|FG002|Overall Study|Non-coding Clinical Recording language|0|||
37842249|NCT01198600|69526610|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
37842250|NCT01198600|69526611|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
37727143|NCT01947283|69206015|FG003|Overall Study|Non-coding Clinical Recording language|1|||
37727144|NCT01947283|69206016|FG004|Overall Study|Non-coding Clinical Recording language|0|||
37727145|NCT01947283|69206017|FG005|Overall Study|Non-coding Clinical Recording language|0|||
37727146|NCT01947283|69206018|FG006|Overall Study|Non-coding Clinical Recording language|0|||
37842251|NCT01198600|69526608|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
37842252|NCT01198600|69526609|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
37842253|NCT01198600|69526610|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
37842254|NCT01198600|69526611|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
38025417|NCT01971970|69709816|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
38025418|NCT01971970|69709817|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
37842255|NCT01198600|69526608|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
37842256|NCT01198600|69526609|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
37842257|NCT01198600|69526610|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
37842258|NCT01198600|69526611|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
37842259|NCT01198600|69526608|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
37842260|NCT01198600|69526609|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
37842261|NCT01198600|69526610|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
37842262|NCT01198600|69526611|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
37842263|NCT01198132|69526621|FG000|Overall Study|Withdrawal by Subject|4|||
37842264|NCT01198132|69526622|FG001|Overall Study|Withdrawal by Subject|5|||
37842265|NCT01198132|69526621|FG000|Overall Study|Physician Decision|5|||
37842266|NCT01198132|69526622|FG001|Overall Study|Physician Decision|4|||
37842267|NCT01198132|69526621|FG000|Overall Study|Other Unspecified|3|||
37842268|NCT01198132|69526622|FG001|Overall Study|Other Unspecified|6|||
37842269|NCT01198132|69526621|FG000|Overall Study|Lack of Efficacy|2|||
37842270|NCT01198132|69526622|FG001|Overall Study|Lack of Efficacy|3|||
38025419|NCT01971970|69709816|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
38025420|NCT01971970|69709817|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
38025421|NCT01971970|69709816|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
38025422|NCT01971970|69709817|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
38025423|NCT01971970|69709816|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
38025424|NCT01971970|69709817|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
38025425|NCT01971970|69709816|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
37727147|NCT01947283|69206012|FG000|Overall Study|Missing Follow-up Assessment|2|||
37727148|NCT01947283|69206013|FG001|Overall Study|Missing Follow-up Assessment|2|||
37727149|NCT01947283|69206014|FG002|Overall Study|Missing Follow-up Assessment|3|||
37727150|NCT01947283|69206015|FG003|Overall Study|Missing Follow-up Assessment|0|||
37842271|NCT01198132|69526621|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
37842272|NCT01198132|69526622|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
37842273|NCT01198132|69526621|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
37842274|NCT01198132|69526622|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
37727151|NCT01947283|69206016|FG004|Overall Study|Missing Follow-up Assessment|0|||
37727152|NCT01947283|69206017|FG005|Overall Study|Missing Follow-up Assessment|2|||
37727153|NCT01947283|69206018|FG006|Overall Study|Missing Follow-up Assessment|0|||
37727154|NCT01947283|69206012|FG000|Overall Study|No patients were enrolled in study|0|||
37727155|NCT01947283|69206013|FG001|Overall Study|No patients were enrolled in study|0|||
37727156|NCT01947283|69206014|FG002|Overall Study|No patients were enrolled in study|0|||
37727157|NCT01947283|69206015|FG003|Overall Study|No patients were enrolled in study|0|||
37842275|NCT01198132|69526621|FG000|Overall Study|Adverse Event|0|||
37842276|NCT01198132|69526622|FG001|Overall Study|Adverse Event|1|||
37842277|NCT01198132|69526621|FG000|Overall Study|Protocol Violation|1|||
37842278|NCT01198132|69526622|FG001|Overall Study|Protocol Violation|0|||
37842279|NCT01197508|69526634|FG000|Overall Study|Withdrawal by Subject|8|||
37842280|NCT01197508|69526635|FG001|Overall Study|Withdrawal by Subject|7|||
37842281|NCT01197508|69526636|FG002|Overall Study|Withdrawal by Subject|15|||
37842282|NCT01197508|69526637|FG003|Overall Study|Withdrawal by Subject|4|||
37842283|NCT01197508|69526634|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
37842284|NCT01197508|69526635|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
37842285|NCT01197508|69526636|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
37842286|NCT01197508|69526637|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
37842287|NCT01197508|69526634|FG000|Overall Study|Adverse Event|10|||
37842288|NCT01197508|69526635|FG001|Overall Study|Adverse Event|13|||
37842289|NCT01197508|69526636|FG002|Overall Study|Adverse Event|23|||
37842290|NCT01197508|69526637|FG003|Overall Study|Adverse Event|3|||
37842291|NCT01197508|69526634|FG000|Overall Study|Severe non-compliance to protocol|0|||
37842292|NCT01197508|69526635|FG001|Overall Study|Severe non-compliance to protocol|3|||
37842293|NCT01197508|69526636|FG002|Overall Study|Severe non-compliance to protocol|1|||
37842294|NCT01197508|69526637|FG003|Overall Study|Severe non-compliance to protocol|3|||
37842295|NCT01197508|69526634|FG000|Overall Study|Condition under investigation worsened|1|||
37842296|NCT01197508|69526635|FG001|Overall Study|Condition under investigation worsened|1|||
37842297|NCT01197508|69526636|FG002|Overall Study|Condition under investigation worsened|1|||
37842298|NCT01197508|69526637|FG003|Overall Study|Condition under investigation worsened|1|||
37727158|NCT01947283|69206016|FG004|Overall Study|No patients were enrolled in study|0|||
37842299|NCT01197508|69526634|FG000|Overall Study|Lack of Efficacy|1|||
37842300|NCT01197508|69526635|FG001|Overall Study|Lack of Efficacy|2|||
37842301|NCT01197508|69526636|FG002|Overall Study|Lack of Efficacy|2|||
37842302|NCT01197508|69526637|FG003|Overall Study|Lack of Efficacy|1|||
37842303|NCT01197508|69526634|FG000|Overall Study|Study-specific withdrawal criteria|0|||
37842304|NCT01197508|69526635|FG001|Overall Study|Study-specific withdrawal criteria|0|||
37842305|NCT01197508|69526636|FG002|Overall Study|Study-specific withdrawal criteria|1|||
37842306|NCT01197508|69526637|FG003|Overall Study|Study-specific withdrawal criteria|2|||
37842307|NCT01197508|69526634|FG000|Overall Study|Lost to Follow-up|1|||
37915761|NCT00711412|69602524|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
37915762|NCT00711412|69602524|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
37915763|NCT00711412|69602524|FG000|Combination Treatment|Progressive Disease|1|||
37915764|NCT00711412|69602524|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
37915765|NCT00711412|69602524|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
37915766|NCT00711412|69602524|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
37915767|NCT00711412|69602524|FG000|Evaluation for Response and Surgery|Death|1|||
37915768|NCT00711412|69602524|FG000|Survival Follow up Until Death|Other|12|||
37915769|NCT00577408|69602540|FG000|Overall Study|Stopped attending study visits|9|||
37915770|NCT00577408|69602541|FG001|Overall Study|Stopped attending study visits|11|||
37915771|NCT00577408|69602540|FG000|Overall Study|Continued opioid use|3|||
37915772|NCT00577408|69602541|FG001|Overall Study|Continued opioid use|2|||
37915773|NCT00577408|69602540|FG000|Overall Study|Non-compliance with study meds|0|||
37915774|NCT00577408|69602541|FG001|Overall Study|Non-compliance with study meds|3|||
37915775|NCT00577408|69602540|FG000|Overall Study|Refused Oral Naltrexone|0|||
37915776|NCT00577408|69602541|FG001|Overall Study|Refused Oral Naltrexone|1|||
37915777|NCT00577408|69602540|FG000|Overall Study|Moved out of state|0|||
37915778|NCT00577408|69602541|FG001|Overall Study|Moved out of state|1|||
37915779|NCT00577408|69602540|FG000|Overall Study|Scheduling Issues|0|||
37842308|NCT01197508|69526635|FG001|Overall Study|Lost to Follow-up|1|||
37842309|NCT01197508|69526636|FG002|Overall Study|Lost to Follow-up|2|||
37842310|NCT01197508|69526637|FG003|Overall Study|Lost to Follow-up|0|||
37842311|NCT01197508|69526634|FG000|Overall Study|Other|2|||
37842312|NCT01197508|69526635|FG001|Overall Study|Other|3|||
37842313|NCT01197508|69526636|FG002|Overall Study|Other|2|||
37842314|NCT01197508|69526637|FG003|Overall Study|Other|2|||
37842315|NCT01196416|69526654|FG000|Overall Study|Withdrawal by Subject|2|||
37915780|NCT00577408|69602541|FG001|Overall Study|Scheduling Issues|3|||
37915781|NCT00577408|69602540|FG000|Overall Study|Death|0|||
37915782|NCT00577408|69602541|FG001|Overall Study|Death|1|||
37915783|NCT00577408|69602540|FG000|Overall Study|Psychiatric hospitalization|0|||
37842316|NCT01196104|69526660|FG000|Overall Study|Lost to Follow-up|1|||
37842317|NCT01196104|69526661|FG001|Overall Study|Lost to Follow-up|0|||
37915784|NCT00577408|69602541|FG001|Overall Study|Psychiatric hospitalization|1|||
37915785|NCT00713596|69602550|FG000|Overall Study|Study was terminated|2|||
37915786|NCT00713596|69602551|FG001|Overall Study|Study was terminated|3|||
37727159|NCT01947283|69206017|FG005|Overall Study|No patients were enrolled in study|3|||
37727160|NCT01947283|69206018|FG006|Overall Study|No patients were enrolled in study|1|||
37727161|NCT02006693|69206037|FG000|Overall Study|No Reason Specified|6|||
37727162|NCT02006693|69206038|FG001|Overall Study|No Reason Specified|8|||
37727163|NCT02006693|69206037|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
37727164|NCT02006693|69206038|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
37727165|NCT02006693|69206037|FG000|Overall Study|XEN Implant Explantation|0|||
37727166|NCT02006693|69206038|FG001|Overall Study|XEN Implant Explantation|1|||
37727167|NCT02006693|69206037|FG000|Overall Study|Death|2|||
37727168|NCT02006693|69206038|FG001|Overall Study|Death|2|||
37727169|NCT02006693|69206037|FG000|Overall Study|Lost to Follow-up|4|||
37727170|NCT02006693|69206038|FG001|Overall Study|Lost to Follow-up|1|||
37727171|NCT02006693|69206037|FG000|Overall Study|Patient Decision|4|||
37727172|NCT02006693|69206038|FG001|Overall Study|Patient Decision|0|||
37727173|NCT01947127|69206046|FG000|Overall Study|Protocol Violation|18|||
37727174|NCT01947127|69206047|FG001|Overall Study|Protocol Violation|38|||
37727175|NCT01947127|69206046|FG000|Overall Study|Withdrawal by Subject|1|||
37727176|NCT01947127|69206047|FG001|Overall Study|Withdrawal by Subject|1|||
37727177|NCT01947127|69206046|FG000|Overall Study|Data loss|4|||
37727178|NCT01947127|69206047|FG001|Overall Study|Data loss|4|||
37727179|NCT01976845|69206056|FG000|Overall Study|Physician Decision|8|||
37915787|NCT00713596|69602552|FG002|Overall Study|Study was terminated|2|||
37915788|NCT00880568|69602569|FG000|Overall Study|Disease progression|3|||
37915789|NCT00880568|69602570|FG001|Overall Study|Disease progression|3|||
37915790|NCT00880568|69602571|FG002|Overall Study|Disease progression|3|||
37727180|NCT01976845|69206057|FG001|Overall Study|Physician Decision|8|||
37727181|NCT01976845|69206058|FG002|Overall Study|Physician Decision|3|||
37727182|NCT01989689|69206068|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
37727183|NCT01989689|69206069|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
37727184|NCT01989689|69206068|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
37727185|NCT01989689|69206069|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
37727186|NCT01943539|69206077|FG000|Overall Study|Non-compliance with at-home intervention|4|||
37727187|NCT01943539|69206078|FG001|Overall Study|Non-compliance with at-home intervention|0|||
37727188|NCT01942993|69206085|FG000|Overall Study|Lost to Follow-up|1|||
37727189|NCT01942993|69206085|FG000|Overall Study|Physician Decision|1|||
37727190|NCT01989455|69206094|FG000|Overall Study|Adverse Event|0|||
37727191|NCT01989455|69206095|FG001|Overall Study|Adverse Event|1|||
37727192|NCT01989455|69206096|FG002|Overall Study|Adverse Event|0|||
37727193|NCT01989455|69206097|FG003|Overall Study|Adverse Event|0|||
37727194|NCT01989455|69206098|FG004|Overall Study|Adverse Event|0|||
37727195|NCT01989455|69206094|FG000|Overall Study|Withdrawal by Subject|0|||
37842318|NCT01196104|69526660|FG000|Overall Study|Physician Decision|0|||
37842319|NCT01196104|69526661|FG001|Overall Study|Physician Decision|1|||
37842320|NCT01196104|69526660|FG000|Overall Study|Withdrawal by Subject|3|||
37842321|NCT01196104|69526661|FG001|Overall Study|Withdrawal by Subject|3|||
37842322|NCT01196104|69526660|FG000|Overall Study|Various|0|||
37842323|NCT01196104|69526661|FG001|Overall Study|Various|1|||
37842324|NCT01196026|69526679|FG000|Overall Study|Withdrawal by Subject|1|||
37842325|NCT01196026|69526680|FG001|Overall Study|Withdrawal by Subject|4|||
37842326|NCT01196026|69526681|FG002|Overall Study|Withdrawal by Subject|0|||
37727196|NCT01989455|69206095|FG001|Overall Study|Withdrawal by Subject|1|||
37727197|NCT01989455|69206096|FG002|Overall Study|Withdrawal by Subject|0|||
37842327|NCT01196026|69526682|FG003|Overall Study|Withdrawal by Subject|0|||
37842328|NCT01196026|69526683|FG004|Overall Study|Withdrawal by Subject|0|||
37842329|NCT01196026|69526684|FG005|Overall Study|Withdrawal by Subject|0|||
37915791|NCT00880568|69602572|FG003|Overall Study|Disease progression|1|||
37727198|NCT01989455|69206097|FG003|Overall Study|Withdrawal by Subject|0|||
37727199|NCT01989455|69206098|FG004|Overall Study|Withdrawal by Subject|0|||
37727200|NCT01989455|69206094|FG000|Overall Study|Technical problems with infusion|0|||
37727201|NCT01989455|69206095|FG001|Overall Study|Technical problems with infusion|0|||
37727202|NCT01989455|69206096|FG002|Overall Study|Technical problems with infusion|1|||
37727203|NCT01989455|69206097|FG003|Overall Study|Technical problems with infusion|0|||
37727204|NCT01989455|69206098|FG004|Overall Study|Technical problems with infusion|1|||
37727205|NCT01942837|69206114|FG000|Overall Study|Death|1|||
37727206|NCT01942837|69206114|FG000|Overall Study|Symptomatic or radiographic progression|49|||
37727207|NCT01942837|69206114|FG000|Overall Study|Adverse Event|6|||
37727208|NCT01942837|69206114|FG000|Overall Study|Physician Decision|3|||
37842330|NCT01196026|69526679|FG000|Overall Study|Lost to Follow-up|0|||
37842331|NCT01196026|69526680|FG001|Overall Study|Lost to Follow-up|3|||
37842332|NCT01196026|69526681|FG002|Overall Study|Lost to Follow-up|0|||
37915792|NCT00880568|69602573|FG004|Overall Study|Disease progression|3|||
37842333|NCT01196026|69526682|FG003|Overall Study|Lost to Follow-up|0|||
37842334|NCT01196026|69526683|FG004|Overall Study|Lost to Follow-up|1|||
37842335|NCT01196026|69526684|FG005|Overall Study|Lost to Follow-up|0|||
37842336|NCT01196026|69526679|FG000|Overall Study|Other|0|||
37842337|NCT01196026|69526680|FG001|Overall Study|Other|1|||
37842338|NCT01196026|69526681|FG002|Overall Study|Other|0|||
37842339|NCT01196026|69526682|FG003|Overall Study|Other|0|||
37842340|NCT01196026|69526683|FG004|Overall Study|Other|0|||
37842341|NCT01196026|69526684|FG005|Overall Study|Other|0|||
37842342|NCT01195948|69526703|FG000|Overall Study|Lost to Follow-up|0|||
37842343|NCT01195948|69526704|FG001|Overall Study|Lost to Follow-up|1|||
37842344|NCT01195948|69526705|FG002|Overall Study|Lost to Follow-up|2|||
37842345|NCT01195831|69526718|FG000|Overall Study|Lost to Follow-up|2|||
37842346|NCT01195831|69526719|FG001|Overall Study|Lost to Follow-up|4|||
37842347|NCT01195831|69526718|FG000|Overall Study|Withdrawal by Subject|2|||
37842348|NCT01195831|69526719|FG001|Overall Study|Withdrawal by Subject|2|||
37842349|NCT01195831|69526718|FG000|Overall Study|Adverse Event|4|||
37842350|NCT01195831|69526719|FG001|Overall Study|Adverse Event|2|||
37842351|NCT01195831|69526718|FG000|Overall Study|Protocol Violation|0|||
37842352|NCT01195831|69526719|FG001|Overall Study|Protocol Violation|2|||
37842353|NCT01195675|69526725|FG000|Overall Study|Adverse Event|1|||
37842354|NCT01195675|69526725|FG000|Overall Study|Withdrawal by Subject|2|||
37842355|NCT01195636|69526742|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
37842356|NCT01195636|69526743|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
37842357|NCT01195636|69526742|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
37842358|NCT01195636|69526743|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
37727209|NCT01942837|69206114|FG000|Overall Study|Withdrawal by Subject|2|||
37727210|NCT01942837|69206114|FG000|Overall Study|Intercurrent Illness|1|||
37727211|NCT01942837|69206114|FG000|Overall Study|On treatment|3|||
37727212|NCT01942837|69206114|FG000|Overall Study|Never initiate the treatment|2|||
37727213|NCT01987895|69206121|FG000|Overall Study|Withdrawal by Subject|12|||
37727214|NCT01987895|69206122|FG001|Overall Study|Withdrawal by Subject|7|||
37727215|NCT01987895|69206121|FG000|Overall Study|Physician Decision|8|||
37727216|NCT01987895|69206122|FG001|Overall Study|Physician Decision|10|||
37727217|NCT01987895|69206121|FG000|Overall Study|Death|7|||
37727218|NCT01987895|69206122|FG001|Overall Study|Death|7|||
37727219|NCT01987895|69206121|FG000|Overall Study|Lost to Follow-up|3|||
37727220|NCT01987895|69206122|FG001|Overall Study|Lost to Follow-up|5|||
37727221|NCT01987895|69206121|FG000|Overall Study|randomized before giving IC|0|||
37727222|NCT01987895|69206122|FG001|Overall Study|randomized before giving IC|1|||
37727223|NCT02005445|69206130|FG000|Overall Study|Dual study enrollment|0|||
37727224|NCT02005445|69206131|FG001|Overall Study|Dual study enrollment|1|||
37727225|NCT01618669|69206139|FG000|Overall Study|Lost to Follow-up|1|||
37842359|NCT01195636|69526742|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
37842360|NCT01195636|69526743|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
37842361|NCT01195636|69526742|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
37842362|NCT01195636|69526743|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
37842363|NCT01195636|69526742|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
37842364|NCT01195636|69526743|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
37842365|NCT01195636|69526742|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
37842366|NCT01195636|69526743|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
37842367|NCT01195636|69526742|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
37842368|NCT01195636|69526743|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
37842369|NCT01195636|69526742|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
37842370|NCT01195636|69526743|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
37842371|NCT01195363|69526751|FG000|Overall Study|Lost to Follow-up|7|||
37842372|NCT01195363|69526752|FG001|Overall Study|Lost to Follow-up|4|||
37842373|NCT01195363|69526751|FG000|Overall Study|Adverse Event|3|||
37842374|NCT01195363|69526752|FG001|Overall Study|Adverse Event|1|||
37842375|NCT01195363|69526751|FG000|Overall Study|Lack of Efficacy|0|||
37842376|NCT01195363|69526752|FG001|Overall Study|Lack of Efficacy|4|||
37842377|NCT01195363|69526751|FG000|Overall Study|incarceration|1|||
37915793|NCT00880568|69602574|FG005|Overall Study|Disease progression|3|||
37727226|NCT01618669|69206140|FG001|Overall Study|Lost to Follow-up|1|||
37727227|NCT01618669|69206139|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
37727228|NCT01618669|69206140|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
37842378|NCT01195363|69526752|FG001|Overall Study|incarceration|0|||
37842379|NCT01195090|69526760|FG000|Overall Study|Adverse Event|1|||
37842380|NCT01195090|69526761|FG001|Overall Study|Adverse Event|2|||
37842381|NCT01195090|69526760|FG000|Overall Study|Lost to Follow-up|2|||
37842382|NCT01195090|69526761|FG001|Overall Study|Lost to Follow-up|2|||
37842383|NCT01195090|69526760|FG000|Overall Study|Protocol Violation|3|||
37842384|NCT01195090|69526761|FG001|Overall Study|Protocol Violation|4|||
37842385|NCT01194973|69526767|FG000|Screening Period|Screen Failure|3|||
37727229|NCT01618669|69206139|FG000|Overall Study|Adverse Event|16|||
37727230|NCT01618669|69206140|FG001|Overall Study|Adverse Event|7|||
37727231|NCT01618669|69206139|FG000|Overall Study|Protocol Violation|5|||
37727232|NCT01618669|69206140|FG001|Overall Study|Protocol Violation|3|||
37727233|NCT01618669|69206139|FG000|Overall Study|Withdrawal by Subject|9|||
37727234|NCT01618669|69206140|FG001|Overall Study|Withdrawal by Subject|9|||
37727235|NCT01618669|69206139|FG000|Overall Study|Miscellaneous Reason|0|||
37727236|NCT01618669|69206140|FG001|Overall Study|Miscellaneous Reason|1|||
37727237|NCT01390948|69206161|FG000|Overall Study|End of Study|1|||
37727238|NCT01390948|69206162|FG001|Overall Study|End of Study|0|||
37727239|NCT01390948|69206163|FG002|Overall Study|End of Study|0|||
37727240|NCT01390948|69206161|FG000|Overall Study|Withdrew consent|2|||
37727241|NCT01390948|69206162|FG001|Overall Study|Withdrew consent|2|||
37727242|NCT01390948|69206163|FG002|Overall Study|Withdrew consent|0|||
37727243|NCT01390948|69206161|FG000|Overall Study|Progressive Disease|2|||
37727244|NCT01390948|69206162|FG001|Overall Study|Progressive Disease|5|||
37727245|NCT01390948|69206163|FG002|Overall Study|Progressive Disease|0|||
37727246|NCT01390948|69206161|FG000|Overall Study|Death during follow-up|10|||
37727247|NCT01390948|69206162|FG001|Overall Study|Death during follow-up|11|||
37727248|NCT01390948|69206163|FG002|Overall Study|Death during follow-up|1|||
37727249|NCT02005211|69206177|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
37727250|NCT02005211|69206178|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
37727251|NCT02005211|69206179|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
37842386|NCT01194973|69526767|FG000|26 Week Treatment Period|Adverse Event|1|||
37842387|NCT01194973|69526767|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
37842388|NCT01194973|69526767|FG000|26 Week Treatment Period|Pregnancy|1|||
37842389|NCT02218697|69526773|FG000|Overall Study|Adverse Event|0|||
37842390|NCT02218697|69526774|FG001|Overall Study|Adverse Event|2|||
37842391|NCT02218697|69526773|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
37842392|NCT02218697|69526774|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
37842393|NCT02218697|69526773|FG000|Overall Study|Withdrawal by Subject|2|||
37842394|NCT02218697|69526774|FG001|Overall Study|Withdrawal by Subject|3|||
37842395|NCT01177540|69526782|FG000|Overall Study|Adverse Event|1|||
37842396|NCT01177540|69526783|FG001|Overall Study|Adverse Event|0|||
37842397|NCT01177384|69526791|FG000|Overall Study|Adverse Event|6|||
37842398|NCT01177384|69526792|FG001|Overall Study|Adverse Event|4|||
37842399|NCT01177384|69526791|FG000|Overall Study|Lack of Efficacy|0|||
37842400|NCT01177384|69526792|FG001|Overall Study|Lack of Efficacy|1|||
37842401|NCT01177384|69526791|FG000|Overall Study|Lost to Follow-up|3|||
37842402|NCT01177384|69526792|FG001|Overall Study|Lost to Follow-up|4|||
37842403|NCT01177384|69526791|FG000|Overall Study|Physician Decision|0|||
37842404|NCT01177384|69526792|FG001|Overall Study|Physician Decision|3|||
37842405|NCT01177384|69526791|FG000|Overall Study|Protocol Violation|0|||
37842406|NCT01177384|69526792|FG001|Overall Study|Protocol Violation|2|||
37842407|NCT01177384|69526791|FG000|Overall Study|Withdrawal by Subject|5|||
37842408|NCT01177384|69526792|FG001|Overall Study|Withdrawal by Subject|12|||
37842409|NCT01194154|69526800|FG000|Overall Study|Adverse Event|12|||
37842410|NCT01194154|69526801|FG001|Overall Study|Adverse Event|7|||
37842411|NCT01194154|69526800|FG000|Overall Study|Lost to Follow-up|2|||
37842412|NCT01194154|69526801|FG001|Overall Study|Lost to Follow-up|3|||
37842413|NCT01194154|69526800|FG000|Overall Study|Protocol Violation|0|||
37842414|NCT01194154|69526801|FG001|Overall Study|Protocol Violation|1|||
37842415|NCT01194154|69526800|FG000|Overall Study|Withdrawal by Subject|5|||
37842416|NCT01194154|69526801|FG001|Overall Study|Withdrawal by Subject|6|||
37842417|NCT01194154|69526800|FG000|Overall Study|Blood pressure increase|5|||
37842418|NCT01194154|69526801|FG001|Overall Study|Blood pressure increase|3|||
37842419|NCT01194154|69526800|FG000|Overall Study|Hemoglobin decrease|0|||
37842420|NCT01194154|69526801|FG001|Overall Study|Hemoglobin decrease|1|||
37842421|NCT01194154|69526800|FG000|Overall Study|Hemoglobin increase|12|||
37842422|NCT01194154|69526801|FG001|Overall Study|Hemoglobin increase|3|||
37842423|NCT01194154|69526800|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
37842424|NCT01194154|69526801|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
37842425|NCT01194154|69526800|FG000|Overall Study|Treatment with prohibited medication|4|||
37842426|NCT01194154|69526801|FG001|Overall Study|Treatment with prohibited medication|5|||
37842427|NCT01194154|69526800|FG000|Overall Study|Other|4|||
37842428|NCT01194154|69526801|FG001|Overall Study|Other|0|||
37842429|NCT01194154|69526800|FG000|Overall Study|Did not receive study medication|2|||
37727252|NCT02005211|69206180|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
37727253|NCT02005211|69206181|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
37842430|NCT01194154|69526801|FG001|Overall Study|Did not receive study medication|4|||
37842431|NCT05034731|69526829|FG000|Overall Study|Screen fail|1|||
37842432|NCT05034731|69526830|FG001|Overall Study|Screen fail|1|||
37842433|NCT04984993|69526840|FG000|Overall Study|Withdrawal by Subject|8|||
37842434|NCT04984993|69526841|FG001|Overall Study|Withdrawal by Subject|2|||
37842435|NCT04984993|69526840|FG000|Overall Study|Lost to Follow-up|2|||
37842436|NCT04984993|69526841|FG001|Overall Study|Lost to Follow-up|2|||
37842437|NCT04984993|69526840|FG000|Overall Study|Both patients moved to another country|4|||
37727254|NCT02005211|69206182|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
37727255|NCT02005211|69206183|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
37727256|NCT01429792|69206206|FG000|Overall Study|Other Reasons|67|||
37727257|NCT01429792|69206206|FG000|Overall Study|Unknown Disposition|94|||
37727258|NCT01429792|69206206|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
37727259|NCT01429792|69206206|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
37727260|NCT01429792|69206206|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
37727261|NCT01429792|69206206|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
37727262|NCT01429792|69206206|FG000|Overall Study|Withdrawal by Subject|70|||
37727263|NCT01429792|69206206|FG000|Overall Study|Lost to Follow-up|88|||
37727264|NCT01409434|69206210|FG000|Overall Study|Protocol Violation|4|||
37727265|NCT01940887|69206216|FG000|Year 1|Protocol Violation|0|||
37727266|NCT01940887|69206217|FG001|Year 1|Protocol Violation|1|||
37727267|NCT01940887|69206216|FG000|Year 1|Physician Decision|7|||
37727268|NCT01940887|69206217|FG001|Year 1|Physician Decision|3|||
37727269|NCT01940887|69206216|FG000|Year 1|Death|5|||
37727270|NCT01940887|69206217|FG001|Year 1|Death|3|||
37727271|NCT01940887|69206216|FG000|Year 1|Adverse Event|7|||
37727272|NCT01940887|69206217|FG001|Year 1|Adverse Event|6|||
37727273|NCT01940887|69206216|FG000|Year 1|Withdrawal by Subject|18|||
37727274|NCT01940887|69206217|FG001|Year 1|Withdrawal by Subject|9|||
37727275|NCT01940887|69206216|FG000|Year 1|Lost to Follow-up|2|||
37727276|NCT01940887|69206217|FG001|Year 1|Lost to Follow-up|1|||
37727277|NCT01940887|69206216|FG000|Year 2|Physician Decision|8|||
37727278|NCT01940887|69206217|FG001|Year 2|Physician Decision|1|||
37727279|NCT01940887|69206216|FG000|Year 2|Death|0|||
37727280|NCT01940887|69206217|FG001|Year 2|Death|2|||
37727281|NCT01940887|69206216|FG000|Year 2|Sponsor Decision, early termination|192|||
37727282|NCT01940887|69206217|FG001|Year 2|Sponsor Decision, early termination|203|||
37727283|NCT01940887|69206216|FG000|Year 2|Adverse Event|8|||
37727284|NCT01940887|69206217|FG001|Year 2|Adverse Event|2|||
37727285|NCT01940887|69206216|FG000|Year 2|Withdrawal by Subject|8|||
37727286|NCT01940887|69206217|FG001|Year 2|Withdrawal by Subject|8|||
37727287|NCT01940887|69206216|FG000|Year 2|Lost to Follow-up|1|||
37727288|NCT01940887|69206217|FG001|Year 2|Lost to Follow-up|6|||
37727289|NCT01925612|69206228|FG000|Overall Study|Progressive Disease|1|||
37727290|NCT01925612|69206229|FG001|Overall Study|Progressive Disease|1|||
37727291|NCT01925612|69206230|FG002|Overall Study|Progressive Disease|1|||
37727292|NCT01925612|69206231|FG003|Overall Study|Progressive Disease|0|||
37727293|NCT01925612|69206232|FG004|Overall Study|Progressive Disease|0|||
37727294|NCT01925612|69206228|FG000|Overall Study|Adverse Event|3|||
37727295|NCT01925612|69206229|FG001|Overall Study|Adverse Event|3|||
37727296|NCT01925612|69206230|FG002|Overall Study|Adverse Event|0|||
37727297|NCT01925612|69206231|FG003|Overall Study|Adverse Event|1|||
37727298|NCT01925612|69206232|FG004|Overall Study|Adverse Event|2|||
37727299|NCT02093663|69206244|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
37727300|NCT02093663|69206245|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
37727301|NCT02093663|69206246|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
37727302|NCT02093663|69206247|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
37727303|NCT02093663|69206248|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
37727304|NCT02093663|69206244|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
37727305|NCT02093663|69206245|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
37727306|NCT02093663|69206246|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
37727307|NCT02093663|69206247|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
37727308|NCT02093663|69206248|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
37727309|NCT02093663|69206244|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
37727310|NCT02093663|69206245|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
37727311|NCT02093663|69206246|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
37727312|NCT02093663|69206247|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
37727313|NCT02093663|69206248|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
37727314|NCT02093663|69206244|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
37727315|NCT02093663|69206245|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
37727316|NCT02093663|69206246|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
37727317|NCT02093663|69206247|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
37727318|NCT02093663|69206248|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
37727319|NCT02093663|69206244|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
37727320|NCT02093663|69206245|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
37727321|NCT02093663|69206246|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
37727322|NCT02093663|69206247|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
37727323|NCT02093663|69206248|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
37727324|NCT02093663|69206244|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
37727325|NCT02093663|69206245|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
37842438|NCT04984993|69526841|FG001|Overall Study|Both patients moved to another country|0|||
37842439|NCT04880161|69526848|FG000|Overall Study|Withdrawal by Subject|1|||
37727326|NCT02093663|69206246|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
37727327|NCT02093663|69206247|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
37727328|NCT02093663|69206248|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
37727329|NCT02093663|69206244|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
37727330|NCT02093663|69206245|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
37727331|NCT02093663|69206246|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
37727332|NCT02093663|69206247|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
37727333|NCT02093663|69206248|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
37727334|NCT02093663|69206244|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
37727335|NCT02093663|69206245|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
37727336|NCT02093663|69206246|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
37727337|NCT02093663|69206247|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
37727338|NCT02093663|69206248|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
37727339|NCT02093663|69206244|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
37727340|NCT02093663|69206245|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
37727341|NCT02093663|69206246|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
37727342|NCT02093663|69206247|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
37727343|NCT02093663|69206248|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
37727344|NCT01408888|69206265|FG000|First Intervention|Adverse Event|0|||
37727345|NCT01408888|69206266|FG001|First Intervention|Adverse Event|1|||
37727346|NCT01408888|69206265|FG000|First Intervention|Withdrawal by Subject|0|||
37727347|NCT01408888|69206266|FG001|First Intervention|Withdrawal by Subject|2|||
37727348|NCT01408888|69206265|FG000|Second Intervention|Withdrawal by Subject|1|||
37727349|NCT01408888|69206266|FG001|Second Intervention|Withdrawal by Subject|0|||
37727350|NCT01408888|69206265|FG000|Second Intervention|Adverse Event|1|||
37842440|NCT04880161|69526849|FG001|Overall Study|Withdrawal by Subject|0|||
37727351|NCT01408888|69206266|FG001|Second Intervention|Adverse Event|0|||
37727352|NCT01918033|69206285|FG000|Overall Study|Adverse Event|1|||
37727353|NCT01918033|69206286|FG001|Overall Study|Adverse Event|0|||
37842441|NCT04880161|69526848|FG000|Overall Study|Lack of Compliance|1|||
37842442|NCT04880161|69526849|FG001|Overall Study|Lack of Compliance|1|||
37842443|NCT04880161|69526848|FG000|Overall Study|Incorrectly Randomized followed for Safety|0|||
37842444|NCT04880161|69526849|FG001|Overall Study|Incorrectly Randomized followed for Safety|1|||
37842445|NCT04880161|69526848|FG000|Overall Study|Screen Failure|0|||
37842446|NCT04880161|69526849|FG001|Overall Study|Screen Failure|1|||
37842447|NCT04809220|69526857|FG000|Overall Study|Adverse Event|4|||
37842448|NCT04809220|69526858|FG001|Overall Study|Adverse Event|0|||
37842449|NCT04809220|69526857|FG000|Overall Study|Death|1|||
37842450|NCT04809220|69526858|FG001|Overall Study|Death|0|||
37842451|NCT04809220|69526857|FG000|Overall Study|Lost to Follow-up|3|||
37842452|NCT04809220|69526858|FG001|Overall Study|Lost to Follow-up|0|||
37842453|NCT04809220|69526857|FG000|Overall Study|Physician Decision|0|||
37842454|NCT04809220|69526858|FG001|Overall Study|Physician Decision|1|||
37842455|NCT04809220|69526857|FG000|Overall Study|Withdrawal by Subject|9|||
37842456|NCT04809220|69526858|FG001|Overall Study|Withdrawal by Subject|5|||
37842457|NCT04809220|69526857|FG000|Overall Study|Due to long-term overseas business trips|1|||
37842458|NCT04809220|69526858|FG001|Overall Study|Due to long-term overseas business trips|0|||
37842459|NCT04740827|69526867|FG000|Double-blind Treatment (Up to Week 12)|Adverse Event|2|||
37842460|NCT04740827|69526868|FG001|Double-blind Treatment (Up to Week 12)|Adverse Event|4|||
37842461|NCT04740827|69526867|FG000|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|0|||
37842462|NCT04740827|69526868|FG001|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|1|||
37842463|NCT04740827|69526867|FG000|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
37842464|NCT04740827|69526868|FG001|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
37842465|NCT04740827|69526867|FG000|Double-blind Treatment (Up to Week 12)|Pregnancy|0|||
37842466|NCT04740827|69526868|FG001|Double-blind Treatment (Up to Week 12)|Pregnancy|1|||
37842467|NCT04740827|69526867|FG000|Double-blind Treatment (Up to Week 12)|Protocol Deviation|3|||
37915794|NCT00880568|69602575|FG006|Overall Study|Disease progression|5|||
37915795|NCT00880568|69602576|FG007|Overall Study|Disease progression|0|||
37915796|NCT00880568|69602577|FG008|Overall Study|Disease progression|3|||
37915797|NCT00880568|69602569|FG000|Overall Study|Adverse Event|0|||
37915798|NCT00880568|69602570|FG001|Overall Study|Adverse Event|0|||
37915799|NCT00880568|69602571|FG002|Overall Study|Adverse Event|0|||
37915800|NCT00880568|69602572|FG003|Overall Study|Adverse Event|0|||
37915801|NCT00880568|69602573|FG004|Overall Study|Adverse Event|0|||
37915802|NCT00880568|69602574|FG005|Overall Study|Adverse Event|0|||
37915803|NCT00880568|69602575|FG006|Overall Study|Adverse Event|1|||
37915804|NCT00880568|69602576|FG007|Overall Study|Adverse Event|1|||
37915805|NCT00880568|69602577|FG008|Overall Study|Adverse Event|0|||
37915806|NCT00880568|69602569|FG000|Overall Study|Withdrawal by Subject|0|||
37915807|NCT00880568|69602570|FG001|Overall Study|Withdrawal by Subject|0|||
38025426|NCT01971970|69709817|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
37727354|NCT01918033|69206287|FG002|Overall Study|Adverse Event|2|||
37727355|NCT01918033|69206285|FG000|Overall Study|Lost to Follow-up|0|||
37727356|NCT01918033|69206286|FG001|Overall Study|Lost to Follow-up|1|||
38025427|NCT04079790|69709832|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
38025428|NCT04079790|69709833|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
38025429|NCT04079790|69709834|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
38025430|NCT04079790|69709835|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
37727357|NCT01918033|69206287|FG002|Overall Study|Lost to Follow-up|0|||
37727358|NCT01918033|69206285|FG000|Overall Study|Protocol Violation|2|||
37727359|NCT01918033|69206286|FG001|Overall Study|Protocol Violation|0|||
37727360|NCT01918033|69206287|FG002|Overall Study|Protocol Violation|1|||
37727361|NCT01918033|69206285|FG000|Overall Study|Withdrawal by Subject|2|||
37727362|NCT01918033|69206286|FG001|Overall Study|Withdrawal by Subject|1|||
37727363|NCT01918033|69206287|FG002|Overall Study|Withdrawal by Subject|0|||
37727364|NCT01408732|69206295|FG000|Overall Study|Withdrawal by Subject|2|||
37727365|NCT01408732|69206296|FG001|Overall Study|Withdrawal by Subject|2|||
37727366|NCT01390402|69206302|FG000|Overall Study|Death|1|||
37727367|NCT01390402|69206302|FG000|Overall Study|Disease Progression|4|||
37727368|NCT01976299|69206308|FG000|Overall Study|Withdrawal by Subject|3|||
37727369|NCT01976299|69206309|FG001|Overall Study|Withdrawal by Subject|1|||
37727370|NCT01976299|69206308|FG000|Overall Study|Death|4|||
37727371|NCT01976299|69206309|FG001|Overall Study|Death|2|||
37727372|NCT01976299|69206308|FG000|Overall Study|Lost to Follow-up|7|||
37727373|NCT01976299|69206309|FG001|Overall Study|Lost to Follow-up|1|||
37727374|NCT01976299|69206308|FG000|Overall Study|See clarification above in comments|9|||
37727375|NCT01976299|69206309|FG001|Overall Study|See clarification above in comments|2|||
37727376|NCT01428076|69206317|FG000|Overall Study|Adverse Event|0|||
37727377|NCT01428076|69206318|FG001|Overall Study|Adverse Event|1|||
37727378|NCT01900652|69206328|FG000|Overall Study|Progressive Disease|1|||
37727379|NCT01900652|69206329|FG001|Overall Study|Progressive Disease|0|||
37727380|NCT01900652|69206328|FG000|Overall Study|Consent withdrawn by subject|1|||
37727381|NCT01900652|69206329|FG001|Overall Study|Consent withdrawn by subject|1|||
37727382|NCT01900652|69206328|FG000|Overall Study|Death|3|||
37727383|NCT01900652|69206329|FG001|Overall Study|Death|0|||
37727384|NCT01900652|69206328|FG000|Overall Study|Adverse Event|2|||
37727385|NCT01900652|69206329|FG001|Overall Study|Adverse Event|1|||
37727386|NCT01900652|69206328|FG000|Overall Study|Physician Decision|1|||
37727387|NCT01900652|69206329|FG001|Overall Study|Physician Decision|1|||
37727388|NCT02093351|69206343|FG000|Part A|Adverse Event|0|||
37727389|NCT02093351|69206344|FG001|Part A|Adverse Event|1|||
37727390|NCT02093351|69206345|FG002|Part A|Adverse Event|1|||
37727391|NCT02093351|69206346|FG003|Part A|Adverse Event|0|||
37727392|NCT02093351|69206343|FG000|Part A|Condition under investigation worsened|2|||
37727393|NCT02093351|69206344|FG001|Part A|Condition under investigation worsened|0|||
37727394|NCT02093351|69206345|FG002|Part A|Condition under investigation worsened|2|||
37727395|NCT02093351|69206346|FG003|Part A|Condition under investigation worsened|0|||
37727396|NCT02093351|69206343|FG000|Part A|Death|0|||
38025431|NCT04079790|69709832|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
37727397|NCT02093351|69206344|FG001|Part A|Death|1|||
37727398|NCT02093351|69206345|FG002|Part A|Death|0|||
37842468|NCT04740827|69526868|FG001|Double-blind Treatment (Up to Week 12)|Protocol Deviation|5|||
38025432|NCT04079790|69709833|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
38025433|NCT04079790|69709834|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
38025434|NCT04079790|69709835|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
38025435|NCT04079790|69709832|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
38025436|NCT04079790|69709833|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
37727399|NCT02093351|69206346|FG003|Part A|Death|0|||
37727400|NCT02093351|69206343|FG000|Part B|Patient decision|0|||
37727401|NCT02093351|69206344|FG001|Part B|Patient decision|0|||
37727402|NCT02093351|69206345|FG002|Part B|Patient decision|0|||
37727403|NCT02093351|69206346|FG003|Part B|Patient decision|3|||
37727404|NCT02093351|69206343|FG000|Part B|Disease progression|0|||
37727405|NCT02093351|69206344|FG001|Part B|Disease progression|0|||
37727406|NCT02093351|69206345|FG002|Part B|Disease progression|0|||
37727407|NCT02093351|69206346|FG003|Part B|Disease progression|4|||
37727408|NCT02093351|69206343|FG000|Part B|Complete response|0|||
37842469|NCT04740827|69526867|FG000|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|1|||
37727409|NCT02093351|69206344|FG001|Part B|Complete response|0|||
37727410|NCT02093351|69206345|FG002|Part B|Complete response|0|||
37727411|NCT02093351|69206346|FG003|Part B|Complete response|1|||
37727412|NCT02093351|69206343|FG000|Part B|Adverse event + disease progression|0|||
37727413|NCT02093351|69206344|FG001|Part B|Adverse event + disease progression|0|||
37727414|NCT02093351|69206345|FG002|Part B|Adverse event + disease progression|0|||
37727415|NCT02093351|69206346|FG003|Part B|Adverse event + disease progression|1|||
37727416|NCT02093351|69206343|FG000|Part B|Lack of therapeutic response|0|||
37727417|NCT02093351|69206344|FG001|Part B|Lack of therapeutic response|0|||
37727418|NCT02093351|69206345|FG002|Part B|Lack of therapeutic response|0|||
37727419|NCT02093351|69206346|FG003|Part B|Lack of therapeutic response|12|||
37727420|NCT02093351|69206343|FG000|Part B|Condition under investigation worsened|0|||
37727421|NCT02093351|69206344|FG001|Part B|Condition under investigation worsened|0|||
37727422|NCT02093351|69206345|FG002|Part B|Condition under investigation worsened|0|||
37727423|NCT02093351|69206346|FG003|Part B|Condition under investigation worsened|39|||
37727424|NCT02093351|69206343|FG000|Part B|Adverse Event|0|||
37727425|NCT02093351|69206344|FG001|Part B|Adverse Event|0|||
37727426|NCT02093351|69206345|FG002|Part B|Adverse Event|0|||
37727427|NCT02093351|69206346|FG003|Part B|Adverse Event|2|||
37727428|NCT02093351|69206343|FG000|Part B|Death|0|||
37842470|NCT04740827|69526868|FG001|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|0|||
37842471|NCT04725240|69526874|FG000|Overall Study|Adverse Event|2|||
37842472|NCT04620746|69526889|FG000|Overall Study|Adverse Event|2|||
37842473|NCT04620746|69526890|FG001|Overall Study|Adverse Event|0|||
37842474|NCT04620746|69526889|FG000|Overall Study|Uniterpretable skin test|1|||
37842475|NCT04620746|69526890|FG001|Overall Study|Uniterpretable skin test|0|||
37842476|NCT04620746|69526889|FG000|Overall Study|Withdrawal by Subject|0|||
37842477|NCT04620746|69526890|FG001|Overall Study|Withdrawal by Subject|1|||
37842478|NCT04524858|69526921|FG000|Overall Study|Adverse Event|1|||
37842479|NCT04464265|69526925|FG000|Overall Study|Physician Decision|2|||
37842480|NCT04326231|69526938|FG000|Overall Study|COVID Withdrawn (limited recruitment within study timeline)|10|||
37842481|NCT04275336|69526945|FG000|Overall Study|First venipuncture failed|4|||
37842482|NCT04275336|69526946|FG001|Overall Study|First venipuncture failed|6|||
37842483|NCT04275336|69526947|FG002|Overall Study|First venipuncture failed|5|||
37842484|NCT04275336|69526945|FG000|Overall Study|Unscheduled venipuncture|9|||
37842485|NCT04275336|69526946|FG001|Overall Study|Unscheduled venipuncture|13|||
37842486|NCT04275336|69526947|FG002|Overall Study|Unscheduled venipuncture|7|||
37842487|NCT04275336|69526945|FG000|Overall Study|Failed specimen of saliva|4|||
37842488|NCT04275336|69526946|FG001|Overall Study|Failed specimen of saliva|3|||
37842489|NCT04275336|69526947|FG002|Overall Study|Failed specimen of saliva|4|||
37842490|NCT04251910|69526973|FG000|Overall Study|Covid 19 lockdown|0|||
37842491|NCT04251910|69526974|FG001|Overall Study|Covid 19 lockdown|5|||
37842492|NCT04251910|69526975|FG002|Overall Study|Covid 19 lockdown|0|||
37842493|NCT04251910|69526976|FG003|Overall Study|Covid 19 lockdown|4|||
37842494|NCT04251910|69526977|FG004|Overall Study|Covid 19 lockdown|0|||
37842495|NCT04251910|69526978|FG005|Overall Study|Covid 19 lockdown|0|||
37842496|NCT04251910|69526973|FG000|Overall Study|Assisted living facility was closed|0|||
37842497|NCT04251910|69526974|FG001|Overall Study|Assisted living facility was closed|0|||
37842498|NCT04251910|69526975|FG002|Overall Study|Assisted living facility was closed|0|||
37727429|NCT02093351|69206344|FG001|Part B|Death|0|||
37727430|NCT02093351|69206345|FG002|Part B|Death|0|||
37727431|NCT02093351|69206346|FG003|Part B|Death|1|||
37727432|NCT02092961|69206385|FG000|Overall Study|Not reported|1|||
37727433|NCT02092961|69206386|FG001|Overall Study|Not reported|0|||
37727434|NCT02092961|69206387|FG002|Overall Study|Not reported|1|||
37727435|NCT02092961|69206385|FG000|Overall Study|Study stopped|13|||
37727436|NCT02092961|69206386|FG001|Overall Study|Study stopped|9|||
37727437|NCT02092961|69206387|FG002|Overall Study|Study stopped|12|||
37727438|NCT02092961|69206385|FG000|Overall Study|Lack of therapeutic response|2|||
37727439|NCT02092961|69206386|FG001|Overall Study|Lack of therapeutic response|1|||
37727440|NCT02092961|69206387|FG002|Overall Study|Lack of therapeutic response|3|||
37727441|NCT02092961|69206385|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
37727442|NCT02092961|69206386|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
37727443|NCT02092961|69206387|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
37727444|NCT02092961|69206385|FG000|Overall Study|Adverse Event|2|||
37727445|NCT02092961|69206386|FG001|Overall Study|Adverse Event|4|||
37842499|NCT04251910|69526976|FG003|Overall Study|Assisted living facility was closed|0|||
37727446|NCT02092961|69206387|FG002|Overall Study|Adverse Event|0|||
37727447|NCT01898078|69206398|FG000|Overall Study|Progressive Disease|1|||
37842500|NCT04251910|69526977|FG004|Overall Study|Assisted living facility was closed|1|||
37842501|NCT04251910|69526978|FG005|Overall Study|Assisted living facility was closed|0|||
37727448|NCT01898078|69206399|FG001|Overall Study|Progressive Disease|5|||
37842502|NCT04248491|69526997|FG000|Overall Study|Lost to Follow-up|1|||
37842503|NCT04248491|69526998|FG001|Overall Study|Lost to Follow-up|0|||
37842504|NCT04101318|69527012|FG000|First Intervention (42 +/- 3 Days)|Lost to Follow-up|0|||
37842505|NCT04101318|69527013|FG001|First Intervention (42 +/- 3 Days)|Lost to Follow-up|1|||
37842506|NCT04101318|69527012|FG000|First Intervention (42 +/- 3 Days)|Adverse Event|0|||
37727449|NCT01898078|69206398|FG000|Overall Study|Adverse Event|2|||
37727450|NCT01898078|69206399|FG001|Overall Study|Adverse Event|1|||
37727451|NCT01898078|69206398|FG000|Overall Study|Withdrawal by Subject|1|||
37727452|NCT01898078|69206399|FG001|Overall Study|Withdrawal by Subject|1|||
37727453|NCT01898078|69206398|FG000|Overall Study|Symptomatic Deterioration|2|||
37727454|NCT01898078|69206399|FG001|Overall Study|Symptomatic Deterioration|0|||
37727455|NCT01898078|69206398|FG000|Overall Study|Reason not Specified|0|||
37727456|NCT01898078|69206399|FG001|Overall Study|Reason not Specified|1|||
37727457|NCT01987817|69206409|FG000|Overall Study|Adverse Event|4|||
37727458|NCT01987817|69206410|FG001|Overall Study|Adverse Event|0|||
37727459|NCT01987817|69206409|FG000|Overall Study|Withdrawal by Subject|1|||
37727460|NCT01987817|69206410|FG001|Overall Study|Withdrawal by Subject|1|||
37727461|NCT01987817|69206409|FG000|Overall Study|Physician Decision|1|||
37727462|NCT01987817|69206410|FG001|Overall Study|Physician Decision|0|||
37727463|NCT01940497|69206419|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
37727464|NCT01940497|69206420|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
37727465|NCT01940497|69206419|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
37727466|NCT01940497|69206420|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
37727467|NCT01940497|69206419|FG000|Overall Study|Violation of Entry Criteria|1|||
37727468|NCT01940497|69206420|FG001|Overall Study|Violation of Entry Criteria|1|||
37727469|NCT01940497|69206419|FG000|Overall Study|Refused Treatment|1|||
37727470|NCT01940497|69206420|FG001|Overall Study|Refused Treatment|3|||
37727471|NCT01940497|69206419|FG000|Overall Study|Withdrew Consent|6|||
38025437|NCT04079790|69709834|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
38025438|NCT04079790|69709835|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
38025439|NCT04259346|69709863|FG000|Overall Study|Lost to Follow-up|1|||
38025440|NCT04259346|69709864|FG001|Overall Study|Lost to Follow-up|3|||
38025441|NCT04259346|69709863|FG000|Overall Study|Protocol Violation|1|||
37727472|NCT01940497|69206420|FG001|Overall Study|Withdrew Consent|2|||
37727473|NCT01940497|69206419|FG000|Overall Study|Administrative/Other|1|||
37727474|NCT01940497|69206420|FG001|Overall Study|Administrative/Other|1|||
37727475|NCT01924754|69206440|FG000|Overall Study|Lost to Follow-up|1|||
37727476|NCT01924754|69206441|FG001|Overall Study|Lost to Follow-up|2|||
37727477|NCT01924754|69206442|FG002|Overall Study|Lost to Follow-up|1|||
37727478|NCT01924754|69206440|FG000|Overall Study|Pregnancy|0|||
37727479|NCT01924754|69206441|FG001|Overall Study|Pregnancy|1|||
37727480|NCT01924754|69206442|FG002|Overall Study|Pregnancy|2|||
37727481|NCT01924364|69206453|FG000|Overall Study|Physician Decision|3|||
37727482|NCT01987505|69206470|FG000|Overall Study|Other|9|||
37727483|NCT01987505|69206470|FG000|Overall Study|Withdrawal by Subject|2|||
37727484|NCT01987505|69206470|FG000|Overall Study|Other Reason|2|||
37842507|NCT04101318|69527013|FG001|First Intervention (42 +/- 3 Days)|Adverse Event|1|||
37842508|NCT04101318|69527012|FG000|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
37915808|NCT00880568|69602571|FG002|Overall Study|Withdrawal by Subject|0|||
37727485|NCT01987505|69206470|FG000|Overall Study|Lost to Follow-up|15|||
37727486|NCT01987505|69206470|FG000|Overall Study|Investigator Decision|2|||
37727487|NCT01987505|69206470|FG000|Overall Study|Death|4|||
37727488|NCT01923896|69206478|FG000|Overall Study|Adverse Event|1|||
37727489|NCT01923896|69206479|FG001|Overall Study|Adverse Event|0|||
37727490|NCT02004353|69206485|FG000|Overall Study|Voluntary participation|1334|||
37727491|NCT01938625|69206491|FG000|Overall Study|Withdrawal by Subject|0|||
38025442|NCT04259346|69709864|FG001|Overall Study|Protocol Violation|0|||
38025443|NCT04259346|69709863|FG000|Overall Study|Withdrawal by Subject|1|||
37727492|NCT01938625|69206492|FG001|Overall Study|Withdrawal by Subject|1|||
37727493|NCT01938625|69206491|FG000|Overall Study|Adverse Event|0|||
37727494|NCT01938625|69206492|FG001|Overall Study|Adverse Event|1|||
37727495|NCT01975675|69206502|FG000|Overall Study|Death|0|||
37727496|NCT01975675|69206503|FG001|Overall Study|Death|1|||
37727497|NCT01975675|69206504|FG002|Overall Study|Death|0|||
37727498|NCT01975675|69206505|FG003|Overall Study|Death|0|||
37727499|NCT01975285|69206517|FG000|Overall Study|Failed Block and follow up|2|||
37727500|NCT01975285|69206518|FG001|Overall Study|Failed Block and follow up|2|||
37727501|NCT01974895|69206526|FG000|Overall Study|Protocol Violation|1|||
37727502|NCT01974895|69206527|FG001|Overall Study|Protocol Violation|0|||
37727503|NCT01974895|69206526|FG000|Overall Study|Lost to Follow-up|4|||
37727504|NCT01974895|69206527|FG001|Overall Study|Lost to Follow-up|6|||
37727505|NCT01974895|69206526|FG000|Overall Study|Withdrawal by Subject|0|||
37727506|NCT01974895|69206527|FG001|Overall Study|Withdrawal by Subject|1|||
37727507|NCT01974895|69206526|FG000|Overall Study|Other (Missed Visit)|1|||
37727508|NCT01974895|69206527|FG001|Overall Study|Other (Missed Visit)|0|||
37727509|NCT01974895|69206526|FG000|Overall Study|Other (Reason unknown)|9|||
37727510|NCT01974895|69206527|FG001|Overall Study|Other (Reason unknown)|8|||
37727511|NCT01974817|69206533|FG000|Overall Study|Death|4|||
37727512|NCT01974817|69206533|FG000|Overall Study|Lost to Follow-up|2|||
37727513|NCT01974817|69206533|FG000|Overall Study|Protocol Violation|2|||
37727514|NCT01915849|69206541|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
37727515|NCT01915849|69206542|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
37727516|NCT01915849|69206543|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
37727517|NCT01915849|69206544|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
37727518|NCT01915849|69206541|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
37727519|NCT01915849|69206542|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
37727520|NCT01915849|69206543|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
37727521|NCT01915849|69206544|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
37727522|NCT01915771|69206554|FG000|Day 1|Withdrawal by Subject|1|||
37727523|NCT01915771|69206554|FG000|Day 15|Withdrawal by Subject|1|||
37727524|NCT01938391|69206562|FG000|6 Month Follow up|Withdrawal by Subject|1|||
37727525|NCT01938391|69206562|FG000|12 Month Follow up|Physician Decision|1|||
37727526|NCT01938391|69206562|FG000|12 Month Follow up|Withdrawal by Subject|1|||
37727527|NCT01915303|69206566|FG000|Core Phase|Adverse Event|7|||
37727528|NCT01915303|69206566|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
37727529|NCT01915303|69206566|FG000|Core Phase|Death|2|||
37727530|NCT01915303|69206566|FG000|Core Phase|Protocol Violation|2|||
37727531|NCT01915303|69206566|FG000|Core Phase|Abnormal lab value|1|||
37727532|NCT01915303|69206566|FG000|Core Phase|Withdrawal by Subject|1|||
37727533|NCT01915303|69206566|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
37727534|NCT01915303|69206566|FG000|Extension Phase|Withdrawal by Subject|4|||
37727535|NCT01915303|69206566|FG000|Extension Phase|Adverse Event|3|||
37727536|NCT01915303|69206566|FG000|Extension Phase|Death|1|||
37727537|NCT01915303|69206566|FG000|Extension Phase|Protocol Violation|1|||
37727538|NCT01987427|69206573|FG000|Overall Study|Adverse Event|4|||
37727539|NCT01987427|69206574|FG001|Overall Study|Adverse Event|2|||
37727540|NCT01987427|69206575|FG002|Overall Study|Adverse Event|8|||
37727541|NCT01987427|69206573|FG000|Overall Study|Lost to Follow-up|6|||
37727542|NCT01987427|69206574|FG001|Overall Study|Lost to Follow-up|6|||
37727543|NCT01987427|69206575|FG002|Overall Study|Lost to Follow-up|9|||
37727544|NCT01987427|69206573|FG000|Overall Study|Withdrawal by Subject|2|||
37727545|NCT01987427|69206574|FG001|Overall Study|Withdrawal by Subject|1|||
37727546|NCT01987427|69206575|FG002|Overall Study|Withdrawal by Subject|3|||
37727547|NCT01987427|69206573|FG000|Overall Study|Lack of Efficacy|1|||
37727548|NCT01987427|69206574|FG001|Overall Study|Lack of Efficacy|0|||
37727549|NCT01987427|69206575|FG002|Overall Study|Lack of Efficacy|0|||
37727550|NCT01987427|69206573|FG000|Overall Study|Other|1|||
37727551|NCT01987427|69206574|FG001|Overall Study|Other|1|||
37727552|NCT01987427|69206575|FG002|Overall Study|Other|0|||
37727553|NCT01937299|69206585|FG000|Overall Study|Adverse Event|13|||
37727554|NCT01937299|69206586|FG001|Overall Study|Adverse Event|0|||
37727555|NCT01937299|69206585|FG000|Overall Study|Lack of Efficacy|0|||
37727556|NCT01937299|69206586|FG001|Overall Study|Lack of Efficacy|4|||
37727557|NCT01937299|69206585|FG000|Overall Study|Withdrawal by Subject|1|||
37727558|NCT01937299|69206586|FG001|Overall Study|Withdrawal by Subject|0|||
37727559|NCT02003963|69206595|FG000|Overall Study|Lost to Follow-up|2|||
37727560|NCT02003963|69206596|FG001|Overall Study|Lost to Follow-up|1|||
37727561|NCT01606761|69206607|FG000|Prior to Week 24|Lost to Follow-up|0|||
37727562|NCT01606761|69206608|FG001|Prior to Week 24|Lost to Follow-up|3|||
37727563|NCT01606761|69206609|FG002|Prior to Week 24|Lost to Follow-up|2|||
37727564|NCT01606761|69206610|FG003|Prior to Week 24|Lost to Follow-up|0|||
37727565|NCT01606761|69206611|FG004|Prior to Week 24|Lost to Follow-up|0|||
37727566|NCT01606761|69206607|FG000|Prior to Week 24|Withdrawal by Subject|12|||
37727567|NCT01606761|69206608|FG001|Prior to Week 24|Withdrawal by Subject|10|||
37727568|NCT01606761|69206609|FG002|Prior to Week 24|Withdrawal by Subject|9|||
37727569|NCT01606761|69206610|FG003|Prior to Week 24|Withdrawal by Subject|0|||
37727570|NCT01606761|69206611|FG004|Prior to Week 24|Withdrawal by Subject|0|||
37727571|NCT01606761|69206607|FG000|Prior to Week 24|Adverse Event|11|||
37727572|NCT01606761|69206608|FG001|Prior to Week 24|Adverse Event|18|||
37727573|NCT01606761|69206609|FG002|Prior to Week 24|Adverse Event|22|||
37727574|NCT01606761|69206610|FG003|Prior to Week 24|Adverse Event|0|||
37727575|NCT01606761|69206611|FG004|Prior to Week 24|Adverse Event|0|||
37727576|NCT01606761|69206607|FG000|Prior to Week 24|Lack of Efficacy|15|||
37727577|NCT01606761|69206608|FG001|Prior to Week 24|Lack of Efficacy|14|||
37727578|NCT01606761|69206609|FG002|Prior to Week 24|Lack of Efficacy|8|||
37727579|NCT01606761|69206610|FG003|Prior to Week 24|Lack of Efficacy|0|||
37727580|NCT01606761|69206611|FG004|Prior to Week 24|Lack of Efficacy|0|||
37727581|NCT01606761|69206607|FG000|Prior to Week 24|Physician Decision|0|||
37727582|NCT01606761|69206608|FG001|Prior to Week 24|Physician Decision|3|||
37727583|NCT01606761|69206609|FG002|Prior to Week 24|Physician Decision|1|||
37727584|NCT01606761|69206610|FG003|Prior to Week 24|Physician Decision|0|||
37727585|NCT01606761|69206611|FG004|Prior to Week 24|Physician Decision|0|||
37727586|NCT01606761|69206607|FG000|Prior to Week 24|Other|4|||
37727587|NCT01606761|69206608|FG001|Prior to Week 24|Other|7|||
37727588|NCT01606761|69206609|FG002|Prior to Week 24|Other|5|||
37727589|NCT01606761|69206610|FG003|Prior to Week 24|Other|0|||
37727590|NCT01606761|69206611|FG004|Prior to Week 24|Other|0|||
37727591|NCT01606761|69206607|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
37727592|NCT01606761|69206608|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
37727593|NCT01606761|69206609|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
37727594|NCT01606761|69206610|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
37727595|NCT01606761|69206611|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
37727596|NCT01606761|69206607|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
37727597|NCT01606761|69206608|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
37727598|NCT01606761|69206609|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
37727599|NCT01606761|69206610|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
37727600|NCT01606761|69206611|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
37727601|NCT01606761|69206607|FG000|Week 24 to Week 52|Adverse Event|0|||
37727602|NCT01606761|69206608|FG001|Week 24 to Week 52|Adverse Event|11|||
37727603|NCT01606761|69206609|FG002|Week 24 to Week 52|Adverse Event|14|||
37727604|NCT01606761|69206610|FG003|Week 24 to Week 52|Adverse Event|3|||
37727605|NCT01606761|69206611|FG004|Week 24 to Week 52|Adverse Event|15|||
37727606|NCT01606761|69206607|FG000|Week 24 to Week 52|Death|0|||
37727607|NCT01606761|69206608|FG001|Week 24 to Week 52|Death|0|||
37727608|NCT01606761|69206609|FG002|Week 24 to Week 52|Death|2|||
37727609|NCT01606761|69206610|FG003|Week 24 to Week 52|Death|1|||
37727610|NCT01606761|69206611|FG004|Week 24 to Week 52|Death|0|||
37727611|NCT01606761|69206607|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
37727612|NCT01606761|69206608|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
37727613|NCT01606761|69206609|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
37727614|NCT01606761|69206610|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
37727615|NCT01606761|69206611|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
37727616|NCT01606761|69206607|FG000|Week 24 to Week 52|Physician Decision|0|||
37727617|NCT01606761|69206608|FG001|Week 24 to Week 52|Physician Decision|1|||
37727618|NCT01606761|69206609|FG002|Week 24 to Week 52|Physician Decision|1|||
37727619|NCT01606761|69206610|FG003|Week 24 to Week 52|Physician Decision|0|||
37727620|NCT01606761|69206611|FG004|Week 24 to Week 52|Physician Decision|0|||
37727621|NCT01606761|69206607|FG000|Week 24 to Week 52|Other|0|||
37727622|NCT01606761|69206608|FG001|Week 24 to Week 52|Other|1|||
37727623|NCT01606761|69206609|FG002|Week 24 to Week 52|Other|5|||
37727624|NCT01606761|69206610|FG003|Week 24 to Week 52|Other|2|||
37727625|NCT01606761|69206611|FG004|Week 24 to Week 52|Other|2|||
37727626|NCT01606761|69206607|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
37727627|NCT01606761|69206608|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
37727628|NCT01606761|69206609|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
37727629|NCT01606761|69206610|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
37727630|NCT01606761|69206611|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
37727631|NCT01606761|69206607|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
37727632|NCT01606761|69206608|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
37727633|NCT01606761|69206609|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
37727634|NCT01606761|69206610|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
37727635|NCT01606761|69206611|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
37727636|NCT01606761|69206607|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
37727637|NCT01606761|69206608|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
37727638|NCT01606761|69206609|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
37727639|NCT01606761|69206610|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
37842509|NCT04101318|69527013|FG001|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
37842510|NCT04091672|69527021|FG000|Overall Study|Death|6|||
37842511|NCT04091672|69527022|FG001|Overall Study|Death|6|||
37842512|NCT04091672|69527021|FG000|Overall Study|Lost to Follow-up|7|||
37842513|NCT04091672|69527022|FG001|Overall Study|Lost to Follow-up|7|||
37842514|NCT04091672|69527021|FG000|Overall Study|Withdrawal by Subject|3|||
37842515|NCT04091672|69527022|FG001|Overall Study|Withdrawal by Subject|3|||
37842516|NCT04091672|69527021|FG000|Overall Study|Non-Compliance With Study Schedule|2|||
37842517|NCT04091672|69527022|FG001|Overall Study|Non-Compliance With Study Schedule|2|||
37842518|NCT04003389|69527038|FG000|Overall Study|Adverse Event|27|||
37842519|NCT04003389|69527039|FG001|Overall Study|Adverse Event|34|||
37842520|NCT04003389|69527040|FG002|Overall Study|Adverse Event|28|||
37842521|NCT04003389|69527038|FG000|Overall Study|Lost to Follow-up|39|||
37842522|NCT04003389|69527039|FG001|Overall Study|Lost to Follow-up|30|||
37842523|NCT04003389|69527040|FG002|Overall Study|Lost to Follow-up|33|||
37842524|NCT04003389|69527038|FG000|Overall Study|Protocol Violation|1|||
37842525|NCT04003389|69527039|FG001|Overall Study|Protocol Violation|6|||
37842526|NCT04003389|69527040|FG002|Overall Study|Protocol Violation|5|||
37842527|NCT04003389|69527038|FG000|Overall Study|Withdrawal by Subject|119|||
37842528|NCT04003389|69527039|FG001|Overall Study|Withdrawal by Subject|79|||
37842529|NCT04003389|69527040|FG002|Overall Study|Withdrawal by Subject|85|||
37842530|NCT04003389|69527038|FG000|Overall Study|Miscellaneous|14|||
37842531|NCT04003389|69527039|FG001|Overall Study|Miscellaneous|11|||
37842532|NCT04003389|69527040|FG002|Overall Study|Miscellaneous|14|||
37842533|NCT04003389|69527038|FG000|Overall Study|Participant did not receive study drug|1|||
37842534|NCT04003389|69527039|FG001|Overall Study|Participant did not receive study drug|0|||
37842535|NCT04003389|69527040|FG002|Overall Study|Participant did not receive study drug|0|||
37842536|NCT03960437|69527048|FG000|Overall Study|Removed by PI|4|||
37842537|NCT03960437|69527048|FG000|Overall Study|Lost to Follow-up|2|||
37842538|NCT03960437|69527048|FG000|Overall Study|Withdrawal by Subject|1|||
37842539|NCT03960437|69527048|FG000|Overall Study|Death|2|||
37842540|NCT03959488|69527057|FG000|Season 1|Other|6|||
37842541|NCT03959488|69527058|FG001|Season 1|Other|7|||
37842542|NCT03959488|69527059|FG002|Season 1|Other|0|||
37842543|NCT03959488|69527060|FG003|Season 1|Other|0|||
37842544|NCT03959488|69527061|FG004|Season 1|Other|0|||
37842545|NCT03959488|69527057|FG000|Season 1|Withdrawal by parent/guardian|43|||
37842546|NCT03959488|69527058|FG001|Season 1|Withdrawal by parent/guardian|28|||
37842547|NCT03959488|69527059|FG002|Season 1|Withdrawal by parent/guardian|0|||
37842548|NCT03959488|69527060|FG003|Season 1|Withdrawal by parent/guardian|0|||
37842549|NCT03959488|69527061|FG004|Season 1|Withdrawal by parent/guardian|0|||
37842550|NCT03959488|69527057|FG000|Season 1|Due to COVID-19 pandemic|2|||
37842551|NCT03959488|69527058|FG001|Season 1|Due to COVID-19 pandemic|3|||
37842552|NCT03959488|69527059|FG002|Season 1|Due to COVID-19 pandemic|0|||
37842553|NCT03959488|69527060|FG003|Season 1|Due to COVID-19 pandemic|0|||
37842554|NCT03959488|69527061|FG004|Season 1|Due to COVID-19 pandemic|0|||
37842555|NCT03959488|69527057|FG000|Season 1|Lost to Follow-up|17|||
37842556|NCT03959488|69527058|FG001|Season 1|Lost to Follow-up|7|||
37842557|NCT03959488|69527059|FG002|Season 1|Lost to Follow-up|0|||
37842558|NCT03959488|69527060|FG003|Season 1|Lost to Follow-up|0|||
37842559|NCT03959488|69527061|FG004|Season 1|Lost to Follow-up|0|||
37842560|NCT03959488|69527057|FG000|Season 1|Death|5|||
37842561|NCT03959488|69527058|FG001|Season 1|Death|1|||
37842562|NCT03959488|69527059|FG002|Season 1|Death|0|||
37842563|NCT03959488|69527060|FG003|Season 1|Death|0|||
37842564|NCT03959488|69527061|FG004|Season 1|Death|0|||
37842565|NCT03959488|69527057|FG000|Season 2|Other|0|||
37842566|NCT03959488|69527058|FG001|Season 2|Other|0|||
37842567|NCT03959488|69527059|FG002|Season 2|Other|2|||
37842568|NCT03959488|69527060|FG003|Season 2|Other|0|||
37842569|NCT03959488|69527061|FG004|Season 2|Other|0|||
37842570|NCT03959488|69527057|FG000|Season 2|Withdrawal by parent/guardian|0|||
38025444|NCT04259346|69709864|FG001|Overall Study|Withdrawal by Subject|0|||
38025445|NCT04259346|69709863|FG000|Overall Study|Adverse Event|1|||
38025446|NCT04259346|69709864|FG001|Overall Study|Adverse Event|1|||
38025447|NCT04230876|69709872|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
38025448|NCT04230876|69709873|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
38025449|NCT04228302|69709885|FG000|Overall Study|Adverse Event|0|||
38025450|NCT04228302|69709886|FG001|Overall Study|Adverse Event|0|||
38025451|NCT04228302|69709887|FG002|Overall Study|Adverse Event|0|||
38025452|NCT04228302|69709888|FG003|Overall Study|Adverse Event|0|||
38025453|NCT04228302|69709889|FG004|Overall Study|Adverse Event|1|||
38025454|NCT04228302|69709890|FG005|Overall Study|Adverse Event|0|||
38025455|NCT01348100|69709911|FG000|Overall Study|Subject Withdrew Consent|0|||
37842571|NCT03959488|69527058|FG001|Season 2|Withdrawal by parent/guardian|0|||
37842572|NCT03959488|69527059|FG002|Season 2|Withdrawal by parent/guardian|3|||
37842573|NCT03959488|69527060|FG003|Season 2|Withdrawal by parent/guardian|1|||
37842574|NCT03959488|69527061|FG004|Season 2|Withdrawal by parent/guardian|1|||
37842575|NCT03959488|69527057|FG000|Season 2|Lost to Follow-up|0|||
37842576|NCT03959488|69527058|FG001|Season 2|Lost to Follow-up|0|||
37727640|NCT01606761|69206611|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
37727641|NCT01606761|69206607|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
37727642|NCT01606761|69206608|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
37727643|NCT01606761|69206609|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
37727644|NCT01606761|69206610|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
37727645|NCT01606761|69206611|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
37842577|NCT03959488|69527059|FG002|Season 2|Lost to Follow-up|1|||
37842578|NCT03959488|69527060|FG003|Season 2|Lost to Follow-up|0|||
37842579|NCT03959488|69527061|FG004|Season 2|Lost to Follow-up|1|||
37842580|NCT03847194|69527082|FG000|Overall Study|Lost to Follow-up|2|||
37842581|NCT03847194|69527083|FG001|Overall Study|Lost to Follow-up|5|||
37842582|NCT03847194|69527082|FG000|Overall Study|Withdrawal by Subject|1|||
37842583|NCT03847194|69527083|FG001|Overall Study|Withdrawal by Subject|2|||
37842584|NCT03847194|69527082|FG000|Overall Study|Death|0|||
37842585|NCT03847194|69527083|FG001|Overall Study|Death|1|||
37842586|NCT03828747|69527091|FG000|Double-Blind Treatment Period|Adverse Event|6|||
37842587|NCT03828747|69527092|FG001|Double-Blind Treatment Period|Adverse Event|6|||
37842588|NCT03828747|69527091|FG000|Double-Blind Treatment Period|Death|1|||
37842589|NCT03828747|69527092|FG001|Double-Blind Treatment Period|Death|2|||
37842590|NCT03828747|69527091|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
37842591|NCT03828747|69527092|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
37842592|NCT03828747|69527091|FG000|Double-Blind Treatment Period|Withdrawal by Subject|19|||
37842593|NCT03828747|69527092|FG001|Double-Blind Treatment Period|Withdrawal by Subject|21|||
37842594|NCT03828747|69527091|FG000|Double-Blind Treatment Period|Physician Decision|0|||
37842595|NCT03828747|69527092|FG001|Double-Blind Treatment Period|Physician Decision|3|||
37842596|NCT03828747|69527091|FG000|Double-Blind Treatment Period|Various reasons|5|||
37842597|NCT03828747|69527092|FG001|Double-Blind Treatment Period|Various reasons|3|||
37842598|NCT03828747|69527091|FG000|Open-Label Extension|Continuing on Study|77|||
37842599|NCT03828747|69527092|FG001|Open-Label Extension|Continuing on Study|72|||
37842600|NCT03828747|69527091|FG000|Open-Label Extension|Adverse Event|3|||
37842601|NCT03828747|69527092|FG001|Open-Label Extension|Adverse Event|4|||
37842602|NCT03828747|69527091|FG000|Open-Label Extension|Death|0|||
37842603|NCT03828747|69527092|FG001|Open-Label Extension|Death|2|||
37842604|NCT03828747|69527091|FG000|Open-Label Extension|Lost to Follow-up|4|||
37842605|NCT03828747|69527092|FG001|Open-Label Extension|Lost to Follow-up|0|||
37842606|NCT03828747|69527091|FG000|Open-Label Extension|Withdrawal by Subject|19|||
37842607|NCT03828747|69527092|FG001|Open-Label Extension|Withdrawal by Subject|16|||
37842608|NCT03828747|69527091|FG000|Open-Label Extension|Various reasons|1|||
37842609|NCT03828747|69527092|FG001|Open-Label Extension|Various reasons|1|||
37842610|NCT03816176|69527130|FG000|Overall Study|Miscellaneous|5|||
38025456|NCT01348100|69709912|FG001|Overall Study|Subject Withdrew Consent|0|||
38025457|NCT01348100|69709913|FG002|Overall Study|Subject Withdrew Consent|2|||
38025458|NCT01348100|69709914|FG003|Overall Study|Subject Withdrew Consent|0|||
38025459|NCT01348100|69709915|FG004|Overall Study|Subject Withdrew Consent|1|||
38025460|NCT01348100|69709916|FG005|Overall Study|Subject Withdrew Consent|0|||
37727646|NCT01790295|69206626|FG000|Overall Study|Adverse Event|1|||
37842611|NCT03816176|69527130|FG000|Overall Study|Lack of Efficacy|4|||
37842612|NCT03816176|69527130|FG000|Overall Study|Adverse Event|3|||
37842613|NCT03712098|69527142|FG000|Overall Study|Lost to Follow-up|3|||
37842614|NCT03712098|69527143|FG001|Overall Study|Lost to Follow-up|7|||
37842615|NCT03712098|69527142|FG000|Overall Study|Withdrawal by Subject|9|||
38025461|NCT01348100|69709917|FG006|Overall Study|Subject Withdrew Consent|1|||
37842616|NCT03712098|69527143|FG001|Overall Study|Withdrawal by Subject|4|||
37842617|NCT03712098|69527142|FG000|Overall Study|Protocol Violation|2|||
37842618|NCT03712098|69527143|FG001|Overall Study|Protocol Violation|1|||
37842619|NCT03704688|69527155|FG000|Overall Study|Adverse Event|0|||
37727647|NCT01790295|69206626|FG000|Overall Study|Death|4|||
37727648|NCT01790295|69206626|FG000|Overall Study|Lack of Efficacy|2|||
37727649|NCT01790295|69206626|FG000|Overall Study|Study closure|4|||
37727650|NCT01597557|69206633|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
37727651|NCT01597557|69206634|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
37727652|NCT01760733|69206640|FG000|Waiting List|Death|18|||
37727653|NCT01760733|69206640|FG000|Waiting List|Removed from waiting list|41|||
37727654|NCT01760733|69206640|FG000|Waiting List|Not received a transplant yet|13|||
37727655|NCT01760733|69206640|FG000|Transplanted|Not reached 10 years post transplant|184|||
37727656|NCT01760733|69206640|FG000|Transplanted|Death|26|||
37727657|NCT01760733|69206640|FG000|Transplanted|Graft loss|7|||
37727658|NCT01914757|69206648|FG000|Overall Study|Severe non-compliance to protocol|3|||
37727659|NCT01914757|69206649|FG001|Overall Study|Severe non-compliance to protocol|1|||
37727660|NCT01914757|69206650|FG002|Overall Study|Severe non-compliance to protocol|2|||
37727661|NCT01914757|69206648|FG000|Overall Study|Lost to Follow-up|5|||
37727662|NCT01914757|69206649|FG001|Overall Study|Lost to Follow-up|8|||
37727663|NCT01914757|69206650|FG002|Overall Study|Lost to Follow-up|6|||
37727664|NCT01914757|69206648|FG000|Overall Study|Withdrawal by Subject|15|||
37727665|NCT01914757|69206649|FG001|Overall Study|Withdrawal by Subject|27|||
37727666|NCT01914757|69206650|FG002|Overall Study|Withdrawal by Subject|19|||
37727667|NCT01914757|69206648|FG000|Overall Study|Death|2|||
37727668|NCT01914757|69206649|FG001|Overall Study|Death|2|||
37727669|NCT01914757|69206650|FG002|Overall Study|Death|1|||
37727670|NCT01914757|69206648|FG000|Overall Study|Adverse Event|4|||
37727671|NCT01914757|69206649|FG001|Overall Study|Adverse Event|3|||
37727672|NCT01914757|69206650|FG002|Overall Study|Adverse Event|4|||
37727673|NCT01914757|69206648|FG000|Overall Study|Study specific withdrawal criteria|0|||
37727674|NCT01914757|69206649|FG001|Overall Study|Study specific withdrawal criteria|1|||
37727675|NCT01914757|69206650|FG002|Overall Study|Study specific withdrawal criteria|0|||
37727676|NCT01914757|69206648|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
37727677|NCT01914757|69206649|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
37727678|NCT01914757|69206650|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
37727679|NCT01914757|69206648|FG000|Overall Study|Other reasons|5|||
37727680|NCT01914757|69206649|FG001|Overall Study|Other reasons|9|||
37727681|NCT01914757|69206650|FG002|Overall Study|Other reasons|4|||
37727682|NCT02003573|69206661|FG000|Overall Study|Progressive disease|2|||
37727683|NCT02003573|69206662|FG001|Overall Study|Progressive disease|0|||
37727684|NCT02003573|69206663|FG002|Overall Study|Progressive disease|1|||
37727685|NCT02003573|69206661|FG000|Overall Study|Other Adverse event|0|||
37727686|NCT02003573|69206662|FG001|Overall Study|Other Adverse event|1|||
37727687|NCT02003573|69206663|FG002|Overall Study|Other Adverse event|1|||
37727688|NCT02003573|69206661|FG000|Overall Study|Refuse to take trial medication|0|||
37727689|NCT02003573|69206662|FG001|Overall Study|Refuse to take trial medication|1|||
37727690|NCT02003573|69206663|FG002|Overall Study|Refuse to take trial medication|1|||
37727691|NCT02003573|69206661|FG000|Overall Study|Other than specified|1|||
37727692|NCT02003573|69206662|FG001|Overall Study|Other than specified|2|||
37727693|NCT02003573|69206663|FG002|Overall Study|Other than specified|3|||
37727694|NCT01914679|69206673|FG000|Overall Study|Lack of Efficacy|1|||
37727695|NCT01914679|69206673|FG000|Overall Study|Sponsor terminated study|4|||
37727696|NCT01789281|69206679|FG000|Overall Study|Disease progression|15|||
37727697|NCT01789281|69206680|FG001|Overall Study|Disease progression|4|||
37727698|NCT01789281|69206679|FG000|Overall Study|Adverse Event|5|||
37727699|NCT01789281|69206680|FG001|Overall Study|Adverse Event|5|||
37727700|NCT01789281|69206679|FG000|Overall Study|Withdrawal by Subject|1|||
37727701|NCT01789281|69206680|FG001|Overall Study|Withdrawal by Subject|0|||
37727702|NCT01789281|69206679|FG000|Overall Study|Lost to Follow-up|1|||
37727703|NCT01789281|69206680|FG001|Overall Study|Lost to Follow-up|0|||
37727704|NCT01789281|69206679|FG000|Overall Study|Administrative problems|0|||
37727705|NCT01789281|69206680|FG001|Overall Study|Administrative problems|1|||
37727706|NCT01923740|69206689|FG000|Overall Study|Lost to Follow-up|4|||
37727707|NCT01923740|69206690|FG001|Overall Study|Lost to Follow-up|9|||
37727708|NCT01923740|69206689|FG000|Overall Study|Withdrawal by Subject|2|||
37727709|NCT01923740|69206690|FG001|Overall Study|Withdrawal by Subject|0|||
37727710|NCT01789203|69206698|FG000|Overall Study|Adverse Event|2|||
37727711|NCT01789203|69206699|FG001|Overall Study|Adverse Event|2|||
37727712|NCT01789203|69206698|FG000|Overall Study|Withdrawal by Subject|1|||
37727713|NCT01789203|69206699|FG001|Overall Study|Withdrawal by Subject|0|||
37727714|NCT01789203|69206698|FG000|Overall Study|Death|1|||
37727715|NCT01789203|69206699|FG001|Overall Study|Death|0|||
37727716|NCT01789203|69206698|FG000|Overall Study|Protocol Violation|2|||
37727717|NCT01789203|69206699|FG001|Overall Study|Protocol Violation|1|||
37727718|NCT01789203|69206698|FG000|Overall Study|Other|1|||
37727719|NCT01789203|69206699|FG001|Overall Study|Other|1|||
37727720|NCT01789203|69206698|FG000|Overall Study|patient non-adherent|2|||
37727721|NCT01789203|69206699|FG001|Overall Study|patient non-adherent|0|||
37727722|NCT01789047|69206709|FG000|Overall Study|Adverse Event|3|||
37727723|NCT01789047|69206710|FG001|Overall Study|Adverse Event|2|||
37727724|NCT01789047|69206709|FG000|Overall Study|Withdrawal by Subject|1|||
37727725|NCT01789047|69206710|FG001|Overall Study|Withdrawal by Subject|2|||
37727726|NCT01788423|69206719|FG000|Overall Study|See Comments in Completed (above)|0|||
37727727|NCT01788423|69206720|FG001|Overall Study|See Comments in Completed (above)|4|||
37727728|NCT01788423|69206721|FG002|Overall Study|See Comments in Completed (above)|5|||
37727729|NCT01617187|69206733|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
37727730|NCT01617187|69206734|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
37727731|NCT01617187|69206735|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
37727732|NCT01617187|69206736|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
37727733|NCT01617187|69206733|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
37727734|NCT01617187|69206734|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
37727735|NCT01617187|69206735|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
37727736|NCT01617187|69206736|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
37727737|NCT01617187|69206733|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
37727738|NCT01617187|69206734|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
37727739|NCT01617187|69206735|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
37727740|NCT01617187|69206736|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
37727741|NCT01617187|69206733|FG000|Treatment Through Study Completion|Adverse Event|1|||
37727742|NCT01617187|69206734|FG001|Treatment Through Study Completion|Adverse Event|1|||
37727743|NCT01617187|69206735|FG002|Treatment Through Study Completion|Adverse Event|0|||
37727744|NCT01617187|69206736|FG003|Treatment Through Study Completion|Adverse Event|1|||
37727745|NCT01617187|69206733|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
37727746|NCT01617187|69206734|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
37727747|NCT01617187|69206735|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
37727748|NCT01617187|69206736|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
37727749|NCT01617187|69206733|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
37727750|NCT01617187|69206734|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
37727751|NCT01617187|69206735|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
37727752|NCT01617187|69206736|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
37727753|NCT01617187|69206733|FG000|Treatment Through Study Completion|Protocol Violation|1|||
37727754|NCT01617187|69206734|FG001|Treatment Through Study Completion|Protocol Violation|0|||
37727755|NCT01617187|69206735|FG002|Treatment Through Study Completion|Protocol Violation|0|||
37727756|NCT01617187|69206736|FG003|Treatment Through Study Completion|Protocol Violation|1|||
37727757|NCT01759407|69206748|FG000|Overall Study|Protocol Violation|0|||
37727758|NCT01759407|69206749|FG001|Overall Study|Protocol Violation|2|||
37727759|NCT01787331|69206755|FG000|Overall Study|Physician Decision|1|||
37727760|NCT01787331|69206755|FG000|Overall Study|Withdrawal by Subject|1|||
37727761|NCT01757847|69206761|FG000|Overall Study|Withdrawal by Subject|3|||
37727762|NCT01757847|69206762|FG001|Overall Study|Withdrawal by Subject|4|||
37727763|NCT01787097|69206768|FG000|Overall Study|Withdrawal by Subject|1|||
37727764|NCT01787097|69206769|FG001|Overall Study|Withdrawal by Subject|0|||
37842620|NCT03704688|69527156|FG001|Overall Study|Adverse Event|0|||
37842621|NCT03704688|69527157|FG002|Overall Study|Adverse Event|0|||
37842622|NCT03704688|69527158|FG003|Overall Study|Adverse Event|4|||
37842623|NCT03704688|69527159|FG004|Overall Study|Adverse Event|1|||
37842624|NCT03704688|69527160|FG005|Overall Study|Adverse Event|0|||
37842625|NCT03704688|69527155|FG000|Overall Study|Disease Progression|0|||
37842626|NCT03704688|69527156|FG001|Overall Study|Disease Progression|0|||
37842627|NCT03704688|69527157|FG002|Overall Study|Disease Progression|0|||
37842628|NCT03704688|69527158|FG003|Overall Study|Disease Progression|3|||
37842629|NCT03704688|69527159|FG004|Overall Study|Disease Progression|1|||
37842630|NCT03704688|69527160|FG005|Overall Study|Disease Progression|0|||
37842631|NCT03704688|69527155|FG000|Overall Study|Death|0|||
37842632|NCT03704688|69527156|FG001|Overall Study|Death|0|||
37727765|NCT01787097|69206770|FG002|Overall Study|Withdrawal by Subject|0|||
37842633|NCT03704688|69527157|FG002|Overall Study|Death|0|||
37842634|NCT03704688|69527158|FG003|Overall Study|Death|0|||
37727766|NCT01787097|69206771|FG003|Overall Study|Withdrawal by Subject|0|||
37842635|NCT03704688|69527159|FG004|Overall Study|Death|3|||
37842636|NCT03704688|69527160|FG005|Overall Study|Death|0|||
37727767|NCT01757691|69206791|FG000|Overall Study|Administrative problems|2|||
37727768|NCT01757691|69206792|FG001|Overall Study|Administrative problems|0|||
37727769|NCT01786707|69206800|FG000|Overall Study|Lost to Follow-up|1|||
37727770|NCT01786707|69206801|FG001|Overall Study|Lost to Follow-up|1|||
37727771|NCT01786629|69206809|FG000|Overall Study|Lack of Efficacy|0|||
37842637|NCT03683394|69527177|FG000|Overall Study|Withdrawal by Subject|4|||
37842638|NCT03683394|69527178|FG001|Overall Study|Withdrawal by Subject|8|||
37842639|NCT03683394|69527177|FG000|Overall Study|Lost to Follow-up|7|||
37842640|NCT03683394|69527178|FG001|Overall Study|Lost to Follow-up|0|||
37727772|NCT01786629|69206810|FG001|Overall Study|Lack of Efficacy|4|||
37727773|NCT01786629|69206809|FG000|Overall Study|Adverse Event|0|||
37727774|NCT01786629|69206810|FG001|Overall Study|Adverse Event|1|||
37727775|NCT01786551|69206816|FG000|Overall Study|Participant withdrew consent|2|||
37727776|NCT01973569|69206823|FG000|Overall Study|Adverse Event|9|||
37727777|NCT01973569|69206824|FG001|Overall Study|Adverse Event|2|||
37727778|NCT01973569|69206825|FG002|Overall Study|Adverse Event|4|||
37727779|NCT01973569|69206823|FG000|Overall Study|Protocol Violation|2|||
37727780|NCT01973569|69206824|FG001|Overall Study|Protocol Violation|1|||
37727781|NCT01973569|69206825|FG002|Overall Study|Protocol Violation|3|||
37727782|NCT01973569|69206823|FG000|Overall Study|Withdrawal by Subject|7|||
37727783|NCT01973569|69206824|FG001|Overall Study|Withdrawal by Subject|5|||
37727784|NCT01973569|69206825|FG002|Overall Study|Withdrawal by Subject|2|||
37727785|NCT01973569|69206823|FG000|Overall Study|Invasive dental treatment|3|||
37727786|NCT01973569|69206824|FG001|Overall Study|Invasive dental treatment|5|||
37727787|NCT01973569|69206825|FG002|Overall Study|Invasive dental treatment|6|||
37727788|NCT01973569|69206823|FG000|Overall Study|Prohibited concomitant d|1|||
37727789|NCT01973569|69206824|FG001|Overall Study|Prohibited concomitant d|5|||
37727790|NCT01973569|69206825|FG002|Overall Study|Prohibited concomitant d|0|||
37727791|NCT01973569|69206823|FG000|Overall Study|Disease progression|0|||
37727792|NCT01973569|69206824|FG001|Overall Study|Disease progression|3|||
37727793|NCT01973569|69206825|FG002|Overall Study|Disease progression|0|||
37727794|NCT01973569|69206823|FG000|Overall Study|Other|1|||
37727795|NCT01973569|69206824|FG001|Overall Study|Other|1|||
37727796|NCT01973569|69206825|FG002|Overall Study|Other|0|||
37727797|NCT01973569|69206823|FG000|Overall Study|Did not receive study drug|6|||
37727798|NCT01973569|69206824|FG001|Overall Study|Did not receive study drug|3|||
37727799|NCT01973569|69206825|FG002|Overall Study|Did not receive study drug|3|||
37727800|NCT01973491|69206833|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
37727801|NCT01973491|69206833|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
37727802|NCT01973491|69206833|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
37727803|NCT01951586|69206839|FG000|Overall Study|Death|61|||
37727804|NCT01951586|69206840|FG001|Overall Study|Death|120|||
37727805|NCT01951586|69206839|FG000|Overall Study|Withdrawal by Subject|8|||
37727806|NCT01951586|69206840|FG001|Overall Study|Withdrawal by Subject|17|||
37727807|NCT01951586|69206839|FG000|Overall Study|Lost to Follow-up|0|||
37727808|NCT01951586|69206840|FG001|Overall Study|Lost to Follow-up|1|||
37727809|NCT01951586|69206839|FG000|Overall Study|Sponsor Decision|9|||
37727810|NCT01951586|69206840|FG001|Overall Study|Sponsor Decision|10|||
37727811|NCT01785849|69206849|FG000|Overall Study|Death|7|||
37727812|NCT01785849|69206850|FG001|Overall Study|Death|9|||
37727813|NCT01785849|69206849|FG000|Overall Study|Protocol Specified Criteria|29|||
37727814|NCT01785849|69206850|FG001|Overall Study|Protocol Specified Criteria|1|||
37727815|NCT01785849|69206849|FG000|Overall Study|Withdrawal by Subject|15|||
37727816|NCT01785849|69206850|FG001|Overall Study|Withdrawal by Subject|12|||
37727817|NCT01785849|69206849|FG000|Overall Study|Sponsor Decision|0|||
37727818|NCT01785849|69206850|FG001|Overall Study|Sponsor Decision|1|||
37727819|NCT01785849|69206849|FG000|Overall Study|Lost to Follow-up|10|||
37727820|NCT01785849|69206850|FG001|Overall Study|Lost to Follow-up|11|||
37727821|NCT01756833|69206858|FG000|Overall Study|Withdrawal by Subject|4|||
37727822|NCT01756833|69206859|FG001|Overall Study|Withdrawal by Subject|3|||
37727823|NCT01617967|69206871|FG000|Overall Study|Protocol Violation|0|||
37727824|NCT01617967|69206872|FG001|Overall Study|Protocol Violation|0|||
37727825|NCT01617967|69206873|FG002|Overall Study|Protocol Violation|0|||
37727826|NCT01617967|69206874|FG003|Overall Study|Protocol Violation|1|||
37727827|NCT01617967|69206875|FG004|Overall Study|Protocol Violation|0|||
37727828|NCT01617967|69206876|FG005|Overall Study|Protocol Violation|0|||
37727829|NCT01617967|69206871|FG000|Overall Study|Withdrawal by Subject|0|||
37727830|NCT01617967|69206872|FG001|Overall Study|Withdrawal by Subject|0|||
37727831|NCT01617967|69206873|FG002|Overall Study|Withdrawal by Subject|0|||
37727832|NCT01617967|69206874|FG003|Overall Study|Withdrawal by Subject|0|||
37727833|NCT01617967|69206875|FG004|Overall Study|Withdrawal by Subject|0|||
37727834|NCT01617967|69206876|FG005|Overall Study|Withdrawal by Subject|1|||
37727835|NCT01617967|69206871|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
37727836|NCT01617967|69206872|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
37727837|NCT01617967|69206873|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
37727838|NCT01617967|69206874|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
37727839|NCT01617967|69206875|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
37727840|NCT01617967|69206876|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
37727841|NCT01785615|69206894|FG000|Dietary Phase|Lost to Follow-up|0|||
37727842|NCT01785615|69206895|FG001|Dietary Phase|Lost to Follow-up|0|||
37727843|NCT01785615|69206896|FG002|Dietary Phase|Lost to Follow-up|0|||
37727844|NCT01785615|69206897|FG003|Dietary Phase|Lost to Follow-up|24|||
37727845|NCT01913041|69206909|FG000|Overall Study|Protocol Violation|35|||
37727846|NCT01913041|69206909|FG000|Overall Study|Withdrawal by Subject|3|||
37727847|NCT01913041|69206909|FG000|Overall Study|Physician Decision|1|||
37727848|NCT01756053|69206913|FG000|Period 1 (10 Days)|Protocol Violation|1|||
37727849|NCT01756053|69206914|FG001|Period 1 (10 Days)|Protocol Violation|1|||
37727850|NCT01756053|69206913|FG000|Period 2 (10 Days)|Protocol Violation|0|||
37727851|NCT01756053|69206914|FG001|Period 2 (10 Days)|Protocol Violation|2|||
37727852|NCT01785069|69206924|FG000|Overall Study|Implanted with nonstudy device|1|||
37727853|NCT01785069|69206925|FG001|Overall Study|Implanted with nonstudy device|2|||
37727854|NCT01785069|69206926|FG002|Overall Study|Implanted with nonstudy device|1|||
37727855|NCT01785069|69206927|FG003|Overall Study|Implanted with nonstudy device|0|||
37727856|NCT01785069|69206924|FG000|Overall Study|Death|0|||
37727857|NCT01785069|69206925|FG001|Overall Study|Death|0|||
37727858|NCT01785069|69206926|FG002|Overall Study|Death|2|||
37727859|NCT01785069|69206927|FG003|Overall Study|Death|0|||
37727860|NCT01785069|69206924|FG000|Overall Study|Subject choice|2|||
37727861|NCT01785069|69206925|FG001|Overall Study|Subject choice|2|||
37727862|NCT01785069|69206926|FG002|Overall Study|Subject choice|0|||
37727863|NCT01785069|69206927|FG003|Overall Study|Subject choice|1|||
37727864|NCT01785069|69206924|FG000|Overall Study|Lost to Follow-up|1|||
37727865|NCT01785069|69206925|FG001|Overall Study|Lost to Follow-up|2|||
37727866|NCT01785069|69206926|FG002|Overall Study|Lost to Follow-up|4|||
37727867|NCT01785069|69206927|FG003|Overall Study|Lost to Follow-up|1|||
37727868|NCT01785069|69206924|FG000|Overall Study|Reason not Specified|1|||
37727869|NCT01785069|69206925|FG001|Overall Study|Reason not Specified|2|||
37727870|NCT01785069|69206926|FG002|Overall Study|Reason not Specified|1|||
37727871|NCT01785069|69206927|FG003|Overall Study|Reason not Specified|4|||
37727872|NCT01785069|69206924|FG000|Overall Study|Not evaluable|7|||
37727873|NCT01785069|69206925|FG001|Overall Study|Not evaluable|4|||
37727874|NCT01785069|69206926|FG002|Overall Study|Not evaluable|5|||
37727875|NCT01785069|69206927|FG003|Overall Study|Not evaluable|8|||
37727876|NCT01784523|69206939|FG000|Overall Study|Study closed early|7|||
37727877|NCT01784523|69206940|FG001|Overall Study|Study closed early|4|||
37727878|NCT01784211|69206948|FG000|Part A (Days 1-15)|Adverse Event|1|||
37727879|NCT01784211|69206949|FG001|Part A (Days 1-15)|Adverse Event|1|||
37727880|NCT01784211|69206950|FG002|Part A (Days 1-15)|Adverse Event|0|||
37727881|NCT01784211|69206951|FG003|Part A (Days 1-15)|Adverse Event|0|||
37727882|NCT01784211|69206952|FG004|Part A (Days 1-15)|Adverse Event|0|||
37727883|NCT01784211|69206953|FG005|Part A (Days 1-15)|Adverse Event|0|||
37727884|NCT01784211|69206948|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
37727885|NCT01784211|69206949|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
37727886|NCT01784211|69206950|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
37727887|NCT01784211|69206951|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
37727888|NCT01784211|69206952|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
37727889|NCT01784211|69206953|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
37727890|NCT01783821|69206967|FG000|Overall Study|Screen Failure|1|||
37727891|NCT01783821|69206968|FG001|Overall Study|Screen Failure|1|||
37727892|NCT01783743|69206976|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
37727893|NCT01783743|69206977|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
37727894|NCT01783743|69206976|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
37727895|NCT01783743|69206977|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
37727896|NCT01783743|69206976|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
37727897|NCT01783743|69206977|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
37727898|NCT01608321|69206985|FG000|Overall Study|Withdrawal by Subject|1|||
37727899|NCT01608321|69206986|FG001|Overall Study|Withdrawal by Subject|0|||
37727900|NCT01608087|69206995|FG000|Overall Study|Lost to Follow-up|0|||
37727901|NCT01608087|69206996|FG001|Overall Study|Lost to Follow-up|1|||
37727902|NCT01608087|69206997|FG002|Overall Study|Lost to Follow-up|0|||
37727903|NCT01608087|69206995|FG000|Overall Study|Other Reason|0|||
37727904|NCT01608087|69206996|FG001|Overall Study|Other Reason|1|||
37727905|NCT01608087|69206997|FG002|Overall Study|Other Reason|0|||
37727906|NCT01912963|69207008|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
37727907|NCT01912963|69207009|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
37727908|NCT01912963|69207010|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
37727909|NCT01912963|69207008|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
37727910|NCT01912963|69207009|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
37727911|NCT01912963|69207010|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
37842641|NCT03683394|69527177|FG000|Overall Study|Death|3|||
37727912|NCT01912963|69207008|FG000|Overall Study|Adverse Event|0|||
37727913|NCT01912963|69207009|FG001|Overall Study|Adverse Event|1|||
37727914|NCT01912963|69207010|FG002|Overall Study|Adverse Event|1|||
37727915|NCT01912963|69207008|FG000|Overall Study|Withdrawal by Subject|0|||
37727916|NCT01912963|69207009|FG001|Overall Study|Withdrawal by Subject|1|||
37727917|NCT01912963|69207010|FG002|Overall Study|Withdrawal by Subject|0|||
37727918|NCT01912963|69207008|FG000|Overall Study|Sought treatment locally|0|||
37727919|NCT01912963|69207009|FG001|Overall Study|Sought treatment locally|1|||
37727920|NCT01912963|69207010|FG002|Overall Study|Sought treatment locally|0|||
37727921|NCT01754727|69207018|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
37727922|NCT01912807|69207024|FG000|Overall Study|Did not meet elegibility criteria|6|||
37727923|NCT01912807|69207025|FG001|Overall Study|Did not meet elegibility criteria|4|||
37727924|NCT01912807|69207024|FG000|Overall Study|Lost to Follow-up|36|||
37727925|NCT01912807|69207025|FG001|Overall Study|Lost to Follow-up|37|||
37727926|NCT01782885|69207033|FG000|Overall Study|Lost to Follow-up|4|||
37727927|NCT01782885|69207034|FG001|Overall Study|Lost to Follow-up|6|||
37727928|NCT01912729|69207042|FG000|Overall Study|Withdrawal by Subject|0|||
37727929|NCT01912729|69207043|FG001|Overall Study|Withdrawal by Subject|1|||
37727930|NCT01754493|69207049|FG000|Overall Study|Adverse Event|1|||
37727931|NCT01754493|69207049|FG000|Overall Study|Lost to Follow-up|3|||
37727932|NCT01754493|69207049|FG000|Overall Study|Withdrawal by Subject|1|||
37727933|NCT01754493|69207049|FG000|Overall Study|Moved out of town|1|||
37727934|NCT01754493|69207049|FG000|Overall Study|Scheduling conflict|1|||
37842642|NCT03683394|69527178|FG001|Overall Study|Death|1|||
37842643|NCT03656510|69527190|FG000|Overall Study|Lost to Follow-up|1|||
37842644|NCT03656510|69527191|FG001|Overall Study|Lost to Follow-up|0|||
37842645|NCT03656510|69527192|FG002|Overall Study|Lost to Follow-up|0|||
37842646|NCT03656510|69527193|FG003|Overall Study|Lost to Follow-up|0|||
37842647|NCT03656510|69527194|FG004|Overall Study|Lost to Follow-up|0|||
37842648|NCT03656510|69527195|FG005|Overall Study|Lost to Follow-up|0|||
37842649|NCT03656510|69527190|FG000|Overall Study|Withdrawal by Subject|1|||
37842650|NCT03656510|69527191|FG001|Overall Study|Withdrawal by Subject|1|||
37842651|NCT03656510|69527192|FG002|Overall Study|Withdrawal by Subject|0|||
37842652|NCT03656510|69527193|FG003|Overall Study|Withdrawal by Subject|1|||
37842653|NCT03656510|69527194|FG004|Overall Study|Withdrawal by Subject|0|||
37842654|NCT03656510|69527195|FG005|Overall Study|Withdrawal by Subject|0|||
37842655|NCT03539081|69527224|FG000|Overall Study|Withdrawal by Subject|2|||
37842656|NCT03539081|69527225|FG001|Overall Study|Withdrawal by Subject|3|||
37842657|NCT03539081|69527226|FG002|Overall Study|Withdrawal by Subject|0|||
37842658|NCT03539081|69527224|FG000|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|1|||
37842659|NCT03539081|69527225|FG001|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
37842660|NCT03539081|69527226|FG002|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
37842661|NCT03538626|69527245|FG000|Overall Study|Withdrawal by Subject|0|||
37842662|NCT03538626|69527246|FG001|Overall Study|Withdrawal by Subject|1|||
37842663|NCT03538626|69527247|FG002|Overall Study|Withdrawal by Subject|0|||
37842664|NCT03538626|69527248|FG003|Overall Study|Withdrawal by Subject|0|||
37842665|NCT03538626|69527249|FG004|Overall Study|Withdrawal by Subject|0|||
37842666|NCT03538626|69527250|FG005|Overall Study|Withdrawal by Subject|0|||
37842667|NCT03538626|69527251|FG006|Overall Study|Withdrawal by Subject|0|||
37842668|NCT03538626|69527252|FG007|Overall Study|Withdrawal by Subject|0|||
37842669|NCT03538626|69527245|FG000|Overall Study|Lost to Follow-up|0|||
37842670|NCT03538626|69527246|FG001|Overall Study|Lost to Follow-up|0|||
37842671|NCT03538626|69527247|FG002|Overall Study|Lost to Follow-up|0|||
37842672|NCT03538626|69527248|FG003|Overall Study|Lost to Follow-up|0|||
37842673|NCT03538626|69527249|FG004|Overall Study|Lost to Follow-up|0|||
37842674|NCT03538626|69527250|FG005|Overall Study|Lost to Follow-up|0|||
37727935|NCT01972789|69207055|FG000|Overall Study|Adverse Event|11|||
37727936|NCT01972789|69207056|FG001|Overall Study|Adverse Event|4|||
37727937|NCT01972789|69207055|FG000|Overall Study|Subject withdrew consent|14|||
37727938|NCT01972789|69207056|FG001|Overall Study|Subject withdrew consent|12|||
37727939|NCT01972789|69207055|FG000|Overall Study|Lost to Follow-up|4|||
37727940|NCT01972789|69207056|FG001|Overall Study|Lost to Follow-up|7|||
37727941|NCT01972789|69207055|FG000|Overall Study|Death|7|||
37727942|NCT01972789|69207056|FG001|Overall Study|Death|5|||
37727943|NCT01972789|69207055|FG000|Overall Study|Protocol deviation|1|||
37727944|NCT01972789|69207056|FG001|Overall Study|Protocol deviation|0|||
37727945|NCT01972789|69207055|FG000|Overall Study|Physician Decision|3|||
37727946|NCT01972789|69207056|FG001|Overall Study|Physician Decision|2|||
37727947|NCT01934335|69207064|FG000|Overall Study|Withdrawal by Subject|1|||
37727948|NCT01934335|69207065|FG001|Overall Study|Withdrawal by Subject|1|||
37727949|NCT01912339|69207073|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
38025462|NCT01348100|69709911|FG000|Overall Study|Protocol Deviation|0|||
37727950|NCT01912339|69207074|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
37727951|NCT01912339|69207075|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
37842675|NCT03538626|69527251|FG006|Overall Study|Lost to Follow-up|1|||
37842676|NCT03538626|69527252|FG007|Overall Study|Lost to Follow-up|0|||
37915809|NCT00880568|69602572|FG003|Overall Study|Withdrawal by Subject|0|||
37727952|NCT01912339|69207073|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
37727953|NCT01912339|69207074|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
37727954|NCT01912339|69207075|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
37727955|NCT01912339|69207073|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
37727956|NCT01912339|69207074|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
37842677|NCT03518203|69527270|FG000|Overall Study|The participant died on study prior to receiving 4 doses and was not evaluable.|1|||
37842678|NCT03518203|69527270|FG000|Overall Study|Relapsed with primary malignancy within 6 months of TMA diagnosis making participant unevaluable.|1|||
37842679|NCT03500172|69527284|FG000|Period 1: Baseline Randomization|Death|0|||
37842680|NCT03500172|69527285|FG001|Period 1: Baseline Randomization|Death|0|||
37842681|NCT03500172|69527286|FG002|Period 1: Baseline Randomization|Death|0|||
37842682|NCT03500172|69527287|FG003|Period 1: Baseline Randomization|Death|0|||
37842683|NCT03500172|69527288|FG004|Period 1: Baseline Randomization|Death|0|||
37842684|NCT03500172|69527289|FG005|Period 1: Baseline Randomization|Death|0|||
37842685|NCT03500172|69527290|FG006|Period 1: Baseline Randomization|Death|0|||
37842686|NCT03500172|69527291|FG007|Period 1: Baseline Randomization|Death|0|||
37842687|NCT03500172|69527292|FG008|Period 1: Baseline Randomization|Death|0|||
37842688|NCT03500172|69527293|FG009|Period 1: Baseline Randomization|Death|2|||
37842689|NCT03500172|69527294|FG010|Period 1: Baseline Randomization|Death|0|||
37842690|NCT03500172|69527284|FG000|Period 1: Baseline Randomization|Protocol Violation|0|||
37842691|NCT03500172|69527285|FG001|Period 1: Baseline Randomization|Protocol Violation|0|||
37842692|NCT03500172|69527286|FG002|Period 1: Baseline Randomization|Protocol Violation|0|||
37842693|NCT03500172|69527287|FG003|Period 1: Baseline Randomization|Protocol Violation|0|||
37842694|NCT03500172|69527288|FG004|Period 1: Baseline Randomization|Protocol Violation|0|||
37842695|NCT03500172|69527289|FG005|Period 1: Baseline Randomization|Protocol Violation|0|||
37842696|NCT03500172|69527290|FG006|Period 1: Baseline Randomization|Protocol Violation|0|||
37842697|NCT03500172|69527291|FG007|Period 1: Baseline Randomization|Protocol Violation|0|||
37842698|NCT03500172|69527292|FG008|Period 1: Baseline Randomization|Protocol Violation|0|||
37842699|NCT03500172|69527293|FG009|Period 1: Baseline Randomization|Protocol Violation|1|||
37842700|NCT03500172|69527294|FG010|Period 1: Baseline Randomization|Protocol Violation|0|||
37842701|NCT03500172|69527284|FG000|Period 2: Re-Randomization|Lost to Follow-up|8|||
37842702|NCT03500172|69527285|FG001|Period 2: Re-Randomization|Lost to Follow-up|6|||
37842703|NCT03500172|69527286|FG002|Period 2: Re-Randomization|Lost to Follow-up|87|||
37842704|NCT03500172|69527287|FG003|Period 2: Re-Randomization|Lost to Follow-up|68|||
37842705|NCT03500172|69527288|FG004|Period 2: Re-Randomization|Lost to Follow-up|4|||
37842706|NCT03500172|69527289|FG005|Period 2: Re-Randomization|Lost to Follow-up|6|||
37842707|NCT03500172|69527290|FG006|Period 2: Re-Randomization|Lost to Follow-up|63|||
37842708|NCT03500172|69527291|FG007|Period 2: Re-Randomization|Lost to Follow-up|74|||
37842709|NCT03500172|69527292|FG008|Period 2: Re-Randomization|Lost to Follow-up|0|||
37842710|NCT03500172|69527293|FG009|Period 2: Re-Randomization|Lost to Follow-up|0|||
37842711|NCT03500172|69527294|FG010|Period 2: Re-Randomization|Lost to Follow-up|0|||
37842712|NCT03500172|69527284|FG000|Period 2: Re-Randomization|Death|0|||
37842713|NCT03500172|69527285|FG001|Period 2: Re-Randomization|Death|0|||
37842714|NCT03500172|69527286|FG002|Period 2: Re-Randomization|Death|0|||
37842715|NCT03500172|69527287|FG003|Period 2: Re-Randomization|Death|4|||
37842716|NCT03500172|69527288|FG004|Period 2: Re-Randomization|Death|2|||
37842717|NCT03500172|69527289|FG005|Period 2: Re-Randomization|Death|0|||
37842718|NCT03500172|69527290|FG006|Period 2: Re-Randomization|Death|5|||
37842719|NCT03500172|69527291|FG007|Period 2: Re-Randomization|Death|2|||
37842720|NCT03500172|69527292|FG008|Period 2: Re-Randomization|Death|0|||
37842721|NCT03500172|69527293|FG009|Period 2: Re-Randomization|Death|0|||
37842722|NCT03500172|69527294|FG010|Period 2: Re-Randomization|Death|0|||
37842723|NCT03470922|69527312|FG000|Overall Study|Death|107|||
37842724|NCT03470922|69527313|FG001|Overall Study|Death|118|||
37842725|NCT03470922|69527312|FG000|Overall Study|Lost to Follow-up|5|||
37842726|NCT03470922|69527313|FG001|Overall Study|Lost to Follow-up|5|||
37842727|NCT03470922|69527312|FG000|Overall Study|Participant Withdrew Consent|4|||
37842728|NCT03470922|69527313|FG001|Overall Study|Participant Withdrew Consent|9|||
37842729|NCT03470922|69527312|FG000|Overall Study|Other reasons|1|||
37842730|NCT03470922|69527313|FG001|Overall Study|Other reasons|0|||
37842731|NCT03470922|69527312|FG000|Overall Study|Not reported|1|||
37842732|NCT03470922|69527313|FG001|Overall Study|Not reported|0|||
37727957|NCT01912339|69207075|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
37842733|NCT03440814|69527321|FG000|Overall Study|Adverse Event|2|||
37842734|NCT03440814|69527322|FG001|Overall Study|Adverse Event|1|||
37842735|NCT03440814|69527321|FG000|Overall Study|Lost to Follow-up|2|||
37842736|NCT03440814|69527322|FG001|Overall Study|Lost to Follow-up|0|||
37842737|NCT03440814|69527321|FG000|Overall Study|Consent withdrawn by parent/legal guardian|1|||
37842738|NCT03440814|69527322|FG001|Overall Study|Consent withdrawn by parent/legal guardian|0|||
37842739|NCT03427814|69527330|FG000|Overall Study|Withdrawal by Subject|4|||
37842740|NCT03427814|69527331|FG001|Overall Study|Withdrawal by Subject|4|||
37842741|NCT03427814|69527330|FG000|Overall Study|Lost to Follow-up|0|||
37842742|NCT03427814|69527331|FG001|Overall Study|Lost to Follow-up|2|||
37842743|NCT03427814|69527330|FG000|Overall Study|Death|42|||
37727958|NCT01912339|69207073|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
37727959|NCT01912339|69207074|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
37727960|NCT01912339|69207075|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
37727961|NCT01912339|69207073|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
37727962|NCT01912339|69207074|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
37727963|NCT01912339|69207075|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
37727964|NCT01912339|69207073|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
37727965|NCT01912339|69207074|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
37727966|NCT01912339|69207075|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
37727967|NCT01912339|69207073|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
37727968|NCT01912339|69207074|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
37727969|NCT01912339|69207075|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
37727970|NCT01912339|69207073|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
37727971|NCT01912339|69207074|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
37727972|NCT01912339|69207075|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
37727973|NCT01912339|69207073|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
37727974|NCT01912339|69207074|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
37727975|NCT01912339|69207075|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
37727976|NCT01912339|69207073|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
37727977|NCT01912339|69207074|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
37727978|NCT01912339|69207075|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
37727979|NCT01912339|69207073|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
37727980|NCT01912339|69207074|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
37727981|NCT01912339|69207075|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
37727982|NCT01912339|69207073|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
37727983|NCT01912339|69207074|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
37727984|NCT01912339|69207075|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
37727985|NCT01912339|69207073|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
37727986|NCT01912339|69207074|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
37727987|NCT01912339|69207075|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
37727988|NCT01911793|69207083|FG000|Overall Study|Physician Decision|1|||
37727989|NCT01911793|69207084|FG001|Overall Study|Physician Decision|5|||
37727990|NCT01933789|69207099|FG000|Overall Study|Death|0|||
37727991|NCT01933789|69207100|FG001|Overall Study|Death|0|||
37727992|NCT01933789|69207101|FG002|Overall Study|Death|0|||
37727993|NCT01933789|69207102|FG003|Overall Study|Death|0|||
37727994|NCT01933789|69207103|FG004|Overall Study|Death|21|||
37842744|NCT03427814|69527331|FG001|Overall Study|Death|31|||
37842745|NCT03427814|69527330|FG000|Overall Study|Sponsor's Decision|1|||
37842746|NCT03427814|69527331|FG001|Overall Study|Sponsor's Decision|0|||
37842747|NCT03427814|69527330|FG000|Overall Study|Investigator's Decision|1|||
37842748|NCT03427814|69527331|FG001|Overall Study|Investigator's Decision|2|||
37842749|NCT03427814|69527330|FG000|Overall Study|Disease progression|1|||
37842750|NCT03427814|69527331|FG001|Overall Study|Disease progression|0|||
37842751|NCT03427814|69527330|FG000|Overall Study|Treatment Completed|0|||
37842752|NCT03427814|69527331|FG001|Overall Study|Treatment Completed|1|||
37842753|NCT03427814|69527330|FG000|Overall Study|Sponsor's Decision to End study|21|||
37842754|NCT03427814|69527331|FG001|Overall Study|Sponsor's Decision to End study|25|||
37842755|NCT03427814|69527330|FG000|Overall Study|Transfer to Long Term Extension Study|1|||
37842756|NCT03427814|69527331|FG001|Overall Study|Transfer to Long Term Extension Study|0|||
37842757|NCT03418493|69527348|FG000|Overall Study|Adverse Event|1|||
37727995|NCT01933789|69207104|FG005|Overall Study|Death|32|||
37842758|NCT03418493|69527349|FG001|Overall Study|Adverse Event|0|||
37842759|NCT03418493|69527350|FG002|Overall Study|Adverse Event|0|||
37842760|NCT03418493|69527351|FG003|Overall Study|Adverse Event|0|||
37842761|NCT03418493|69527352|FG004|Overall Study|Adverse Event|0|||
37842762|NCT03418493|69527353|FG005|Overall Study|Adverse Event|0|||
37842763|NCT03418493|69527354|FG006|Overall Study|Adverse Event|0|||
37842764|NCT03418493|69527355|FG007|Overall Study|Adverse Event|0|||
37915810|NCT00880568|69602573|FG004|Overall Study|Withdrawal by Subject|0|||
37915811|NCT00880568|69602574|FG005|Overall Study|Withdrawal by Subject|0|||
37915812|NCT00880568|69602575|FG006|Overall Study|Withdrawal by Subject|0|||
38025463|NCT01348100|69709912|FG001|Overall Study|Protocol Deviation|0|||
37915813|NCT00880568|69602576|FG007|Overall Study|Withdrawal by Subject|1|||
37842765|NCT03418493|69527356|FG008|Overall Study|Adverse Event|0|||
37842766|NCT03418493|69527357|FG009|Overall Study|Adverse Event|0|||
37842767|NCT03418493|69527358|FG010|Overall Study|Adverse Event|0|||
38025464|NCT01348100|69709913|FG002|Overall Study|Protocol Deviation|0|||
37727996|NCT01933789|69207105|FG006|Overall Study|Death|0|||
37727997|NCT01933789|69207106|FG007|Overall Study|Death|0|||
37727998|NCT01933789|69207107|FG008|Overall Study|Death|0|||
37842768|NCT03418493|69527348|FG000|Overall Study|Protocol Violation|0|||
37842769|NCT03418493|69527349|FG001|Overall Study|Protocol Violation|0|||
37842770|NCT03418493|69527350|FG002|Overall Study|Protocol Violation|0|||
37842771|NCT03418493|69527351|FG003|Overall Study|Protocol Violation|0|||
37842772|NCT03418493|69527352|FG004|Overall Study|Protocol Violation|0|||
37842773|NCT03418493|69527353|FG005|Overall Study|Protocol Violation|0|||
37842774|NCT03418493|69527354|FG006|Overall Study|Protocol Violation|0|||
37842775|NCT03418493|69527355|FG007|Overall Study|Protocol Violation|0|||
37842776|NCT03418493|69527356|FG008|Overall Study|Protocol Violation|0|||
37842777|NCT03418493|69527357|FG009|Overall Study|Protocol Violation|1|||
37842778|NCT03418493|69527358|FG010|Overall Study|Protocol Violation|0|||
37842779|NCT03383692|69527393|FG000|Overall Study|Progressive disease as per RECIST|3|||
37842780|NCT03383692|69527394|FG001|Overall Study|Progressive disease as per RECIST|3|||
37842781|NCT03383692|69527393|FG000|Overall Study|Clinical progression|0|||
37842782|NCT03383692|69527394|FG001|Overall Study|Clinical progression|1|||
37842783|NCT03383692|69527393|FG000|Overall Study|Adverse Event|3|||
37842784|NCT03383692|69527394|FG001|Overall Study|Adverse Event|0|||
37842785|NCT03368664|69527402|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
37842786|NCT03368664|69527402|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
37842787|NCT03368664|69527402|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
37842788|NCT03368664|69527402|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
37842789|NCT03343054|69527413|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
37842790|NCT03343054|69527414|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
37842791|NCT03343054|69527415|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
37842792|NCT03343054|69527413|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
37842793|NCT03343054|69527414|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
37842794|NCT03343054|69527415|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
37842795|NCT03343054|69527413|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
37842796|NCT03343054|69527414|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
37842797|NCT03343054|69527415|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
37842798|NCT03343054|69527413|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
37842799|NCT03343054|69527414|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
37842800|NCT03343054|69527415|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
37842801|NCT03330847|69527427|FG000|Overall Study|Patients ongoing study|62|||
37842802|NCT03330847|69527428|FG001|Overall Study|Patients ongoing study|65|||
37842803|NCT03330847|69527429|FG002|Overall Study|Patients ongoing study|15|||
37842804|NCT03309878|69527468|FG000|Overall Study|Adverse Event|1|||
37842805|NCT03309878|69527469|FG001|Overall Study|Adverse Event|0|||
37842806|NCT03309878|69527470|FG002|Overall Study|Adverse Event|0|||
37842807|NCT03309878|69527471|FG003|Overall Study|Adverse Event|0|||
37842808|NCT03309878|69527468|FG000|Overall Study|Did not maintain eligibility|2|||
37842809|NCT03309878|69527469|FG001|Overall Study|Did not maintain eligibility|1|||
37842810|NCT03309878|69527470|FG002|Overall Study|Did not maintain eligibility|0|||
37842811|NCT03309878|69527471|FG003|Overall Study|Did not maintain eligibility|0|||
37842812|NCT03309878|69527468|FG000|Overall Study|Withdrawal by Subject|0|||
37842813|NCT03309878|69527469|FG001|Overall Study|Withdrawal by Subject|1|||
37842814|NCT03309878|69527470|FG002|Overall Study|Withdrawal by Subject|0|||
37842815|NCT03309878|69527471|FG003|Overall Study|Withdrawal by Subject|0|||
37842816|NCT03200704|69527489|FG000|Overall Study|Withdrawal by Subject|1|||
37915814|NCT00880568|69602577|FG008|Overall Study|Withdrawal by Subject|0|||
37915815|NCT00881894|69602604|FG000|Overall Study|Consent withdrawn|0|||
37915816|NCT00881894|69602605|FG001|Overall Study|Consent withdrawn|1|||
37915817|NCT00881894|69602604|FG000|Overall Study|Other reasons for premature termination|1|||
37915818|NCT00881894|69602605|FG001|Overall Study|Other reasons for premature termination|2|||
37915819|NCT00711100|69602611|FG000|Overall Study|Lack of Efficacy|5|||
37915820|NCT00711100|69602611|FG000|Overall Study|Withdrawal by Subject|8|||
37915821|NCT00827931|69602629|FG000|Overall Study|Death|3|||
37842817|NCT03176472|69527495|FG000|Double Blind Treatment Period|Withdrawal by Subject|5|||
37915822|NCT00827931|69602630|FG001|Overall Study|Death|5|||
37915823|NCT00827931|69602629|FG000|Overall Study|Adverse Event|1|||
37915824|NCT00827931|69602630|FG001|Overall Study|Adverse Event|0|||
37915825|NCT00827931|69602629|FG000|Overall Study|Lost to Follow-up|1|||
37915826|NCT00827931|69602630|FG001|Overall Study|Lost to Follow-up|0|||
37915827|NCT00827931|69602629|FG000|Overall Study|Withdrawal by Subject|0|||
37915828|NCT00827931|69602630|FG001|Overall Study|Withdrawal by Subject|1|||
37915829|NCT00827931|69602629|FG000|Overall Study|Other|1|||
37915830|NCT00827931|69602630|FG001|Overall Study|Other|0|||
37915831|NCT00526669|69602636|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
37915832|NCT00526669|69602637|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
37915833|NCT00526669|69602636|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
38025465|NCT01348100|69709914|FG003|Overall Study|Protocol Deviation|1|||
38025466|NCT01348100|69709915|FG004|Overall Study|Protocol Deviation|0|||
38025467|NCT01348100|69709916|FG005|Overall Study|Protocol Deviation|0|||
38025468|NCT01348100|69709917|FG006|Overall Study|Protocol Deviation|0|||
38025469|NCT01348100|69709911|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
38025470|NCT01348100|69709912|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
38025471|NCT01348100|69709913|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
38025472|NCT01348100|69709914|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
38025473|NCT01348100|69709915|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
38025474|NCT01348100|69709916|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
37727999|NCT01933789|69207099|FG000|Overall Study|Lost to Follow-up|0|||
37728000|NCT01933789|69207100|FG001|Overall Study|Lost to Follow-up|0|||
37728001|NCT01933789|69207101|FG002|Overall Study|Lost to Follow-up|0|||
37728002|NCT01933789|69207102|FG003|Overall Study|Lost to Follow-up|1|||
37728003|NCT01933789|69207103|FG004|Overall Study|Lost to Follow-up|8|||
37728004|NCT01933789|69207104|FG005|Overall Study|Lost to Follow-up|9|||
37728005|NCT01933789|69207105|FG006|Overall Study|Lost to Follow-up|1|||
37728006|NCT01933789|69207106|FG007|Overall Study|Lost to Follow-up|4|||
37728007|NCT01933789|69207107|FG008|Overall Study|Lost to Follow-up|0|||
37728008|NCT01933789|69207099|FG000|Overall Study|Withdrawal by Subject|2|||
37728009|NCT01933789|69207100|FG001|Overall Study|Withdrawal by Subject|1|||
37728010|NCT01933789|69207101|FG002|Overall Study|Withdrawal by Subject|0|||
37728011|NCT01933789|69207102|FG003|Overall Study|Withdrawal by Subject|0|||
37728012|NCT01933789|69207103|FG004|Overall Study|Withdrawal by Subject|17|||
37728013|NCT01933789|69207104|FG005|Overall Study|Withdrawal by Subject|16|||
37728014|NCT01933789|69207105|FG006|Overall Study|Withdrawal by Subject|1|||
37728015|NCT01933789|69207106|FG007|Overall Study|Withdrawal by Subject|4|||
37728016|NCT01933789|69207107|FG008|Overall Study|Withdrawal by Subject|0|||
37728017|NCT01933789|69207099|FG000|Overall Study|Became Ineligible|4|||
37728018|NCT01933789|69207100|FG001|Overall Study|Became Ineligible|0|||
37728019|NCT01933789|69207101|FG002|Overall Study|Became Ineligible|0|||
37728020|NCT01933789|69207102|FG003|Overall Study|Became Ineligible|0|||
37728021|NCT01933789|69207103|FG004|Overall Study|Became Ineligible|13|||
37728022|NCT01933789|69207104|FG005|Overall Study|Became Ineligible|10|||
37728023|NCT01933789|69207105|FG006|Overall Study|Became Ineligible|13|||
37728024|NCT01933789|69207106|FG007|Overall Study|Became Ineligible|6|||
37728025|NCT01933789|69207107|FG008|Overall Study|Became Ineligible|0|||
37728026|NCT01910389|69207129|FG000|Overall Study|Withdrawal by Subject|2|||
37728027|NCT01910389|69207130|FG001|Overall Study|Withdrawal by Subject|0|||
37728028|NCT01910389|69207129|FG000|Overall Study|Study Closed|13|||
37728029|NCT01910389|69207130|FG001|Overall Study|Study Closed|8|||
37728030|NCT01970995|69207139|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
37728031|NCT01970995|69207140|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
37728032|NCT01970995|69207141|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
37728033|NCT01970995|69207139|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
37728034|NCT01970995|69207140|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
37728035|NCT01970995|69207141|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
37728036|NCT01970527|69207151|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
37728037|NCT01970527|69207152|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
37728038|NCT01970527|69207151|FG000|Treatment|Disease progression|0|||
37728039|NCT01970527|69207152|FG001|Treatment|Disease progression|1|||
37728040|NCT01970527|69207151|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
37728041|NCT01970527|69207152|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
37728042|NCT01970527|69207151|FG000|Treatment|Death|0|||
37728043|NCT01970527|69207152|FG001|Treatment|Death|1|||
37728044|NCT01970527|69207151|FG000|Follow-up Clinic Visit|Disease progression|1|||
37728045|NCT01970527|69207152|FG001|Follow-up Clinic Visit|Disease progression|1|||
37728046|NCT01970527|69207151|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
37728047|NCT01970527|69207152|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
37728048|NCT01970527|69207151|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
37728049|NCT01970527|69207152|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
37728050|NCT01931995|69207163|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
37728051|NCT01931995|69207164|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
37728052|NCT01931995|69207163|FG000|First Intervention (1 Day)|Physician Decision|1|||
37728053|NCT01931995|69207164|FG001|First Intervention (1 Day)|Physician Decision|1|||
37842818|NCT03176472|69527496|FG001|Double Blind Treatment Period|Withdrawal by Subject|10|||
37842819|NCT03176472|69527495|FG000|Double Blind Treatment Period|Adverse Event|0|||
37842820|NCT03176472|69527496|FG001|Double Blind Treatment Period|Adverse Event|5|||
37842821|NCT03176472|69527495|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
37842822|NCT03176472|69527496|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
37842823|NCT03176472|69527495|FG000|Double Blind Treatment Period|Physician Decision|0|||
37842824|NCT03176472|69527496|FG001|Double Blind Treatment Period|Physician Decision|1|||
37842825|NCT03176472|69527495|FG000|Double Blind Treatment Period|Protocol Violation|1|||
37842826|NCT03176472|69527496|FG001|Double Blind Treatment Period|Protocol Violation|0|||
37842827|NCT03176472|69527495|FG000|Double Blind Treatment Period|Not Provided|1|||
37842828|NCT03176472|69527496|FG001|Double Blind Treatment Period|Not Provided|0|||
37728054|NCT01931995|69207163|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
37728055|NCT01931995|69207164|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
37728056|NCT01408576|69207173|FG000|Overall Study|Lack of Efficacy|17|||
37728057|NCT01408576|69207174|FG001|Overall Study|Lack of Efficacy|30|||
37728058|NCT01408576|69207175|FG002|Overall Study|Lack of Efficacy|48|||
37728059|NCT01408576|69207173|FG000|Overall Study|Protocol Violation|1|||
37728060|NCT01408576|69207174|FG001|Overall Study|Protocol Violation|2|||
37728061|NCT01408576|69207175|FG002|Overall Study|Protocol Violation|2|||
37728062|NCT01408576|69207173|FG000|Overall Study|Lost to Follow-up|10|||
37728063|NCT01408576|69207174|FG001|Overall Study|Lost to Follow-up|9|||
37728064|NCT01408576|69207175|FG002|Overall Study|Lost to Follow-up|17|||
37728065|NCT01408576|69207173|FG000|Overall Study|Withdrawal by Subject|34|||
37728066|NCT01408576|69207174|FG001|Overall Study|Withdrawal by Subject|60|||
37728067|NCT01408576|69207175|FG002|Overall Study|Withdrawal by Subject|66|||
37728068|NCT01408576|69207173|FG000|Overall Study|Sponsor terminated study|89|||
37915834|NCT00526669|69602637|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
37728069|NCT01408576|69207174|FG001|Overall Study|Sponsor terminated study|333|||
37728070|NCT01408576|69207175|FG002|Overall Study|Sponsor terminated study|330|||
37728071|NCT01408576|69207173|FG000|Overall Study|AE, serious fatal|4|||
37728072|NCT01408576|69207174|FG001|Overall Study|AE, serious fatal|4|||
37728073|NCT01408576|69207175|FG002|Overall Study|AE, serious fatal|1|||
37728074|NCT01408576|69207173|FG000|Overall Study|SAE, non-fatal|11|||
37728075|NCT01408576|69207174|FG001|Overall Study|SAE, non-fatal|23|||
37728076|NCT01408576|69207175|FG002|Overall Study|SAE, non-fatal|14|||
37728077|NCT01408576|69207173|FG000|Overall Study|AE, non-serious non-fatal|12|||
37728078|NCT01408576|69207174|FG001|Overall Study|AE, non-serious non-fatal|19|||
37728079|NCT01408576|69207175|FG002|Overall Study|AE, non-serious non-fatal|11|||
37728080|NCT01408576|69207173|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
37728081|NCT01408576|69207174|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
37728082|NCT01408576|69207175|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
37728083|NCT01408576|69207173|FG000|Overall Study|AE, unknown type|0|||
37728084|NCT01408576|69207174|FG001|Overall Study|AE, unknown type|1|||
37728085|NCT01408576|69207175|FG002|Overall Study|AE, unknown type|0|||
37728086|NCT01408576|69207173|FG000|Overall Study|Other|10|||
37728087|NCT01408576|69207174|FG001|Overall Study|Other|16|||
37728088|NCT01408576|69207175|FG002|Overall Study|Other|18|||
37728089|NCT01427920|69207197|FG000|Overall Study|Adverse Event|1|||
37728090|NCT01427920|69207198|FG001|Overall Study|Adverse Event|2|||
37728091|NCT01427920|69207197|FG000|Overall Study|Lack of Efficacy|1|||
37728092|NCT01427920|69207198|FG001|Overall Study|Lack of Efficacy|0|||
37728093|NCT01427920|69207197|FG000|Overall Study|Protocol Violation|1|||
37728094|NCT01427920|69207198|FG001|Overall Study|Protocol Violation|3|||
37728095|NCT01427920|69207197|FG000|Overall Study|Withdrawal Criteria|4|||
37728096|NCT01427920|69207198|FG001|Overall Study|Withdrawal Criteria|4|||
37728097|NCT01427920|69207197|FG000|Overall Study|Unclassified|2|||
37728098|NCT01427920|69207198|FG001|Overall Study|Unclassified|8|||
37728099|NCT01427608|69207206|FG000|Overall Study|Death|1|||
37728100|NCT01427608|69207207|FG001|Overall Study|Death|0|||
37728101|NCT01427608|69207206|FG000|Overall Study|Withdrawal by Subject|7|||
37728102|NCT01427608|69207207|FG001|Overall Study|Withdrawal by Subject|3|||
37728103|NCT01427608|69207206|FG000|Overall Study|Relapsed-all cause|13|||
37728104|NCT01427608|69207207|FG001|Overall Study|Relapsed-all cause|34|||
37728105|NCT01427608|69207206|FG000|Overall Study|Events not attributed to study meds|0|||
37728106|NCT01427608|69207207|FG001|Overall Study|Events not attributed to study meds|1|||
37728107|NCT01408030|69207219|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
37728108|NCT01408030|69207220|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
37728109|NCT01408030|69207221|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
37728110|NCT01408030|69207222|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
37728111|NCT01408030|69207219|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
37728112|NCT01408030|69207220|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
37842829|NCT03176472|69527495|FG000|Open Label Extension|Withdrawal by Subject|3|||
37842830|NCT03176472|69527496|FG001|Open Label Extension|Withdrawal by Subject|4|||
37842831|NCT03176472|69527495|FG000|Open Label Extension|Adverse Event|2|||
37842832|NCT03176472|69527496|FG001|Open Label Extension|Adverse Event|4|||
37842833|NCT03176472|69527495|FG000|Open Label Extension|Lost to Follow-up|1|||
37842834|NCT03176472|69527496|FG001|Open Label Extension|Lost to Follow-up|2|||
37842835|NCT03176472|69527495|FG000|Open Label Extension|Protocol Violation|0|||
37728113|NCT01408030|69207221|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
37728114|NCT01408030|69207222|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
37728115|NCT01408030|69207219|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
37728116|NCT01408030|69207220|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
37842836|NCT03176472|69527496|FG001|Open Label Extension|Protocol Violation|1|||
37728117|NCT01408030|69207221|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
37728118|NCT01408030|69207222|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
37728119|NCT01408030|69207219|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
37728120|NCT01408030|69207220|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
37728121|NCT01408030|69207221|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
37728122|NCT01408030|69207222|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
37728123|NCT01408030|69207219|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
37728124|NCT01408030|69207220|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
37728125|NCT01408030|69207221|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
37728126|NCT01408030|69207222|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
37728127|NCT01408030|69207219|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
37728128|NCT01408030|69207220|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
37728129|NCT01408030|69207221|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
37728130|NCT01408030|69207222|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
37728131|NCT01408030|69207219|FG000|Observation Phase (Off Drug)|Other|1|||
37728132|NCT01408030|69207220|FG001|Observation Phase (Off Drug)|Other|1|||
37728133|NCT01408030|69207221|FG002|Observation Phase (Off Drug)|Other|1|||
37728134|NCT01408030|69207222|FG003|Observation Phase (Off Drug)|Other|1|||
37728135|NCT01897532|69207234|FG000|Discontinuation From Treatment|Not Treated|7|||
37728136|NCT01897532|69207235|FG001|Discontinuation From Treatment|Not Treated|5|||
37728137|NCT01897532|69207234|FG000|Discontinuation From Treatment|Other reason than specified|196|||
37728138|NCT01897532|69207235|FG001|Discontinuation From Treatment|Other reason than specified|176|||
37728139|NCT01897532|69207234|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
37728140|NCT01897532|69207235|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
37728141|NCT01897532|69207234|FG000|Discontinuation From Treatment|Non compliance|24|||
37728142|NCT01897532|69207235|FG001|Discontinuation From Treatment|Non compliance|15|||
37728143|NCT01897532|69207234|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
37728144|NCT01897532|69207235|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
37728145|NCT01897532|69207234|FG000|Discontinuation From Trial|Not Treated|7|||
37728146|NCT01897532|69207235|FG001|Discontinuation From Trial|Not Treated|5|||
37728147|NCT01897532|69207234|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
37728148|NCT01897532|69207235|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
37728149|NCT01923428|69207245|FG000|Overall Study|Adverse Event|8|||
37728150|NCT01923428|69207246|FG001|Overall Study|Adverse Event|6|||
37728151|NCT01923428|69207247|FG002|Overall Study|Adverse Event|3|||
37728152|NCT01923428|69207248|FG003|Overall Study|Adverse Event|3|||
37728153|NCT01923428|69207245|FG000|Overall Study|Withdrawal by Subject|5|||
37728154|NCT01923428|69207246|FG001|Overall Study|Withdrawal by Subject|3|||
37728155|NCT01923428|69207247|FG002|Overall Study|Withdrawal by Subject|0|||
37728156|NCT01923428|69207248|FG003|Overall Study|Withdrawal by Subject|4|||
37728157|NCT01923428|69207245|FG000|Overall Study|Lost to Follow-up|2|||
37728158|NCT01923428|69207246|FG001|Overall Study|Lost to Follow-up|1|||
37728159|NCT01923428|69207247|FG002|Overall Study|Lost to Follow-up|5|||
37728160|NCT01923428|69207248|FG003|Overall Study|Lost to Follow-up|0|||
37728161|NCT01923428|69207245|FG000|Overall Study|Protocol Violation|3|||
37728162|NCT01923428|69207246|FG001|Overall Study|Protocol Violation|0|||
37728163|NCT01923428|69207247|FG002|Overall Study|Protocol Violation|2|||
37728164|NCT01923428|69207248|FG003|Overall Study|Protocol Violation|1|||
37728165|NCT01923428|69207245|FG000|Overall Study|Non Compliance to treatment|1|||
37728166|NCT01923428|69207246|FG001|Overall Study|Non Compliance to treatment|2|||
37728167|NCT01923428|69207247|FG002|Overall Study|Non Compliance to treatment|0|||
37728168|NCT01923428|69207248|FG003|Overall Study|Non Compliance to treatment|1|||
37728169|NCT01923428|69207245|FG000|Overall Study|Lack of Efficacy|0|||
37728170|NCT01923428|69207246|FG001|Overall Study|Lack of Efficacy|0|||
37728171|NCT01923428|69207247|FG002|Overall Study|Lack of Efficacy|1|||
37728172|NCT01923428|69207248|FG003|Overall Study|Lack of Efficacy|1|||
37728173|NCT01896986|69207260|FG000|Overall Study|samples lost|14|||
37728174|NCT01896986|69207261|FG001|Overall Study|samples lost|23|||
37728175|NCT01896128|69207269|FG000|Overall Study|Withdrawal by Subject|3|||
37728176|NCT01896128|69207270|FG001|Overall Study|Withdrawal by Subject|3|||
37728177|NCT01949870|69207276|FG000|Overall Study|Lack of Efficacy|2|||
37728178|NCT01949870|69207276|FG000|Overall Study|Adverse Event|1|||
37728179|NCT01949870|69207276|FG000|Overall Study|Study termination|1|||
37728180|NCT01949870|69207276|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
37728181|NCT01949480|69207282|FG000|Overall Study|Physician Decision|5|||
37728182|NCT01949480|69207283|FG001|Overall Study|Physician Decision|8|||
37728183|NCT01949090|69207294|FG000|Overall Study|Serious Adverse Event|0|||
37728184|NCT01949090|69207295|FG001|Overall Study|Serious Adverse Event|1|||
37728185|NCT01949090|69207296|FG002|Overall Study|Serious Adverse Event|2|||
37728186|NCT01949090|69207297|FG003|Overall Study|Serious Adverse Event|0|||
37728187|NCT01949090|69207298|FG004|Overall Study|Serious Adverse Event|1|||
37728188|NCT01949090|69207294|FG000|Overall Study|Withdrawal by Subject|2|||
37728189|NCT01949090|69207295|FG001|Overall Study|Withdrawal by Subject|0|||
37728190|NCT01949090|69207296|FG002|Overall Study|Withdrawal by Subject|0|||
37915835|NCT00526669|69602636|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
37728191|NCT01949090|69207297|FG003|Overall Study|Withdrawal by Subject|0|||
37728192|NCT01949090|69207298|FG004|Overall Study|Withdrawal by Subject|1|||
37728193|NCT01949090|69207294|FG000|Overall Study|Protocol non-compliance|0|||
37728194|NCT01949090|69207295|FG001|Overall Study|Protocol non-compliance|0|||
37728195|NCT01949090|69207296|FG002|Overall Study|Protocol non-compliance|0|||
37728196|NCT01949090|69207297|FG003|Overall Study|Protocol non-compliance|0|||
37728197|NCT01949090|69207298|FG004|Overall Study|Protocol non-compliance|1|||
37728198|NCT01949090|69207294|FG000|Overall Study|Lost to Follow-up|2|||
37728199|NCT01949090|69207295|FG001|Overall Study|Lost to Follow-up|1|||
37728200|NCT01949090|69207296|FG002|Overall Study|Lost to Follow-up|0|||
37728201|NCT01949090|69207297|FG003|Overall Study|Lost to Follow-up|1|||
37728202|NCT01949090|69207298|FG004|Overall Study|Lost to Follow-up|1|||
37728203|NCT01948076|69207313|FG000|Overall Study|Withdrawal by Subject|0|||
37728204|NCT01948076|69207314|FG001|Overall Study|Withdrawal by Subject|1|||
37728205|NCT01922258|69207324|FG000|Overall Study|Lost to Follow-up|1|||
37728206|NCT01922258|69207325|FG001|Overall Study|Lost to Follow-up|1|||
37728207|NCT01922258|69207324|FG000|Overall Study|Adverse Event|9|||
37728208|NCT01922258|69207325|FG001|Overall Study|Adverse Event|2|||
37728209|NCT01922258|69207324|FG000|Overall Study|Met Withdrawal Criteria|0|||
37728210|NCT01922258|69207325|FG001|Overall Study|Met Withdrawal Criteria|4|||
37728211|NCT01922258|69207324|FG000|Overall Study|Withdrawn by the Investigator|1|||
37728212|NCT01922258|69207325|FG001|Overall Study|Withdrawn by the Investigator|4|||
37728213|NCT01922258|69207324|FG000|Overall Study|Withdrawal by participant|5|||
37728214|NCT01922258|69207325|FG001|Overall Study|Withdrawal by participant|5|||
37728215|NCT01406938|69207333|FG000|Induction Period|Subject/guardian decision|6|||
37728216|NCT01406938|69207334|FG001|Induction Period|Subject/guardian decision|8|||
37728217|NCT01406938|69207335|FG002|Induction Period|Subject/guardian decision|0|||
37728218|NCT01406938|69207336|FG003|Induction Period|Subject/guardian decision|0|||
37728219|NCT01406938|69207337|FG004|Induction Period|Subject/guardian decision|0|||
37728220|NCT01406938|69207338|FG005|Induction Period|Subject/guardian decision|0|||
37728221|NCT01406938|69207333|FG000|Induction Period|Protocol deviation|1|||
37728222|NCT01406938|69207334|FG001|Induction Period|Protocol deviation|0|||
37728223|NCT01406938|69207335|FG002|Induction Period|Protocol deviation|0|||
37728224|NCT01406938|69207336|FG003|Induction Period|Protocol deviation|0|||
37728225|NCT01406938|69207337|FG004|Induction Period|Protocol deviation|0|||
37728226|NCT01406938|69207338|FG005|Induction Period|Protocol deviation|0|||
37728227|NCT01406938|69207333|FG000|Induction Period|Adverse Event|8|||
37728228|NCT01406938|69207334|FG001|Induction Period|Adverse Event|9|||
37728229|NCT01406938|69207335|FG002|Induction Period|Adverse Event|0|||
37728230|NCT01406938|69207336|FG003|Induction Period|Adverse Event|0|||
37728231|NCT01406938|69207337|FG004|Induction Period|Adverse Event|0|||
37728232|NCT01406938|69207338|FG005|Induction Period|Adverse Event|0|||
37728233|NCT01406938|69207333|FG000|Induction Period|Lack of Efficacy|1|||
37728234|NCT01406938|69207334|FG001|Induction Period|Lack of Efficacy|0|||
37728235|NCT01406938|69207335|FG002|Induction Period|Lack of Efficacy|0|||
38025475|NCT01348100|69709917|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
38025476|NCT01348100|69709911|FG000|Overall Study|Lost to Follow-up|0|||
38025477|NCT01348100|69709912|FG001|Overall Study|Lost to Follow-up|0|||
38025478|NCT01348100|69709913|FG002|Overall Study|Lost to Follow-up|0|||
38025479|NCT01348100|69709914|FG003|Overall Study|Lost to Follow-up|0|||
38025480|NCT01348100|69709915|FG004|Overall Study|Lost to Follow-up|0|||
38025481|NCT01348100|69709916|FG005|Overall Study|Lost to Follow-up|0|||
38025482|NCT01348100|69709917|FG006|Overall Study|Lost to Follow-up|1|||
37728236|NCT01406938|69207336|FG003|Induction Period|Lack of Efficacy|0|||
37728237|NCT01406938|69207337|FG004|Induction Period|Lack of Efficacy|0|||
37728238|NCT01406938|69207338|FG005|Induction Period|Lack of Efficacy|0|||
37728239|NCT01406938|69207333|FG000|Induction Period|Lost to Follow-up|2|||
37728240|NCT01406938|69207334|FG001|Induction Period|Lost to Follow-up|3|||
38025483|NCT01348100|69709911|FG000|Overall Study|Administrative Problems|0|||
37728241|NCT01406938|69207335|FG002|Induction Period|Lost to Follow-up|0|||
37728242|NCT01406938|69207336|FG003|Induction Period|Lost to Follow-up|0|||
37728243|NCT01406938|69207337|FG004|Induction Period|Lost to Follow-up|0|||
37728244|NCT01406938|69207338|FG005|Induction Period|Lost to Follow-up|0|||
37728245|NCT01406938|69207333|FG000|Maintenance Period|Adverse Event|0|||
37728246|NCT01406938|69207334|FG001|Maintenance Period|Adverse Event|0|||
37728247|NCT01406938|69207335|FG002|Maintenance Period|Adverse Event|2|||
37728248|NCT01406938|69207336|FG003|Maintenance Period|Adverse Event|8|||
37728249|NCT01406938|69207337|FG004|Maintenance Period|Adverse Event|4|||
37728250|NCT01406938|69207338|FG005|Maintenance Period|Adverse Event|2|||
37728251|NCT01406938|69207333|FG000|Maintenance Period|Death|0|||
37728252|NCT01406938|69207334|FG001|Maintenance Period|Death|0|||
37728253|NCT01406938|69207335|FG002|Maintenance Period|Death|0|||
37728254|NCT01406938|69207336|FG003|Maintenance Period|Death|0|||
37728255|NCT01406938|69207337|FG004|Maintenance Period|Death|1|||
37728256|NCT01406938|69207338|FG005|Maintenance Period|Death|0|||
37728257|NCT01406938|69207333|FG000|Maintenance Period|Subject/guardian decision|0|||
37728258|NCT01406938|69207334|FG001|Maintenance Period|Subject/guardian decision|0|||
37728259|NCT01406938|69207335|FG002|Maintenance Period|Subject/guardian decision|11|||
37728260|NCT01406938|69207336|FG003|Maintenance Period|Subject/guardian decision|7|||
37728261|NCT01406938|69207337|FG004|Maintenance Period|Subject/guardian decision|10|||
37728262|NCT01406938|69207338|FG005|Maintenance Period|Subject/guardian decision|7|||
37728263|NCT01406938|69207333|FG000|Maintenance Period|Protocol Violation|0|||
37728264|NCT01406938|69207334|FG001|Maintenance Period|Protocol Violation|0|||
37728265|NCT01406938|69207335|FG002|Maintenance Period|Protocol Violation|2|||
37728266|NCT01406938|69207336|FG003|Maintenance Period|Protocol Violation|2|||
37728267|NCT01406938|69207337|FG004|Maintenance Period|Protocol Violation|2|||
37728268|NCT01406938|69207338|FG005|Maintenance Period|Protocol Violation|2|||
37728269|NCT01406938|69207333|FG000|Maintenance Period|Pregnancy|0|||
37728270|NCT01406938|69207334|FG001|Maintenance Period|Pregnancy|0|||
37728271|NCT01406938|69207335|FG002|Maintenance Period|Pregnancy|0|||
37728272|NCT01406938|69207336|FG003|Maintenance Period|Pregnancy|0|||
37728273|NCT01406938|69207337|FG004|Maintenance Period|Pregnancy|1|||
37728274|NCT01406938|69207338|FG005|Maintenance Period|Pregnancy|0|||
37728275|NCT01406938|69207333|FG000|Maintenance Period|Lost to Follow-up|0|||
37728276|NCT01406938|69207334|FG001|Maintenance Period|Lost to Follow-up|0|||
37728277|NCT01406938|69207335|FG002|Maintenance Period|Lost to Follow-up|0|||
37728278|NCT01406938|69207336|FG003|Maintenance Period|Lost to Follow-up|0|||
37728279|NCT01406938|69207337|FG004|Maintenance Period|Lost to Follow-up|4|||
37728280|NCT01406938|69207338|FG005|Maintenance Period|Lost to Follow-up|0|||
37728281|NCT01406938|69207333|FG000|Maintenance Period|Lack of Efficacy|0|||
37728282|NCT01406938|69207334|FG001|Maintenance Period|Lack of Efficacy|0|||
37728283|NCT01406938|69207335|FG002|Maintenance Period|Lack of Efficacy|2|||
37728284|NCT01406938|69207336|FG003|Maintenance Period|Lack of Efficacy|1|||
37728285|NCT01406938|69207337|FG004|Maintenance Period|Lack of Efficacy|3|||
37728286|NCT01406938|69207338|FG005|Maintenance Period|Lack of Efficacy|5|||
37728287|NCT01406938|69207333|FG000|Follow up|Lack of Efficacy|3|||
37728288|NCT01406938|69207334|FG001|Follow up|Lack of Efficacy|2|||
37728289|NCT01406938|69207335|FG002|Follow up|Lack of Efficacy|1|||
37728290|NCT01406938|69207336|FG003|Follow up|Lack of Efficacy|0|||
37728291|NCT01406938|69207337|FG004|Follow up|Lack of Efficacy|0|||
37728292|NCT01406938|69207338|FG005|Follow up|Lack of Efficacy|0|||
37728293|NCT01406938|69207333|FG000|Follow up|Patient/guardian decision|4|||
37728294|NCT01406938|69207334|FG001|Follow up|Patient/guardian decision|2|||
37728295|NCT01406938|69207335|FG002|Follow up|Patient/guardian decision|4|||
37728296|NCT01406938|69207336|FG003|Follow up|Patient/guardian decision|2|||
37728297|NCT01406938|69207337|FG004|Follow up|Patient/guardian decision|4|||
37728298|NCT01406938|69207338|FG005|Follow up|Patient/guardian decision|1|||
37728299|NCT01406938|69207333|FG000|Follow up|Protocol Violation|0|||
37728300|NCT01406938|69207334|FG001|Follow up|Protocol Violation|0|||
37728301|NCT01406938|69207335|FG002|Follow up|Protocol Violation|1|||
37842837|NCT03176472|69527495|FG000|Open Label Extension|Not Provided|2|||
37842838|NCT03176472|69527496|FG001|Open Label Extension|Not Provided|1|||
37842839|NCT04876599|69527553|FG000|Overall Study|Missed|2|||
37842840|NCT04876599|69527554|FG001|Overall Study|Missed|0|||
37842841|NCT04876599|69527553|FG000|Overall Study|Declined|2|||
37842842|NCT04876599|69527554|FG001|Overall Study|Declined|3|||
37915836|NCT00526669|69602637|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
37842843|NCT04730947|69527563|FG000|Overall Study|Withdrawal by Subject|0|||
37842844|NCT04730947|69527564|FG001|Overall Study|Withdrawal by Subject|1|||
37842845|NCT04660799|69527572|FG000|Overall Study|Progressive Disease|1|||
37915837|NCT00526669|69602636|FG000|Combined Treatment Phase|Death|0|||
37915838|NCT00526669|69602637|FG001|Combined Treatment Phase|Death|2|||
37728302|NCT01406938|69207336|FG003|Follow up|Protocol Violation|0|||
37728303|NCT01406938|69207337|FG004|Follow up|Protocol Violation|0|||
37728304|NCT01406938|69207338|FG005|Follow up|Protocol Violation|0|||
37728305|NCT01406938|69207333|FG000|Follow up|Physician Decision|0|||
37728306|NCT01406938|69207334|FG001|Follow up|Physician Decision|0|||
37728307|NCT01406938|69207335|FG002|Follow up|Physician Decision|2|||
37842846|NCT04660799|69527573|FG001|Overall Study|Progressive Disease|1|||
37842847|NCT04660799|69527572|FG000|Overall Study|Death|2|||
37915839|NCT00710866|69602649|FG000|Overall Study|Protocol Violation|5|||
37728308|NCT01406938|69207336|FG003|Follow up|Physician Decision|0|||
37728309|NCT01406938|69207337|FG004|Follow up|Physician Decision|3|||
37728310|NCT01406938|69207338|FG005|Follow up|Physician Decision|1|||
37728311|NCT01406938|69207333|FG000|Follow up|Lost to Follow-up|1|||
37728312|NCT01406938|69207334|FG001|Follow up|Lost to Follow-up|1|||
37728313|NCT01406938|69207335|FG002|Follow up|Lost to Follow-up|0|||
37728314|NCT01406938|69207336|FG003|Follow up|Lost to Follow-up|1|||
37728315|NCT01406938|69207337|FG004|Follow up|Lost to Follow-up|2|||
37728316|NCT01406938|69207338|FG005|Follow up|Lost to Follow-up|1|||
37728317|NCT01405924|69207358|FG000|Overall Study|Protocol Violation|8|||
37728318|NCT01405924|69207358|FG000|Overall Study|Missing/Incomplete Data|2|||
37728319|NCT01426438|69207366|FG000|Overall Study|Lost to Follow-up|1|||
37728320|NCT01426438|69207367|FG001|Overall Study|Lost to Follow-up|3|||
37728321|NCT01426438|69207366|FG000|Overall Study|Off study Treatment|9|||
37728322|NCT01426438|69207367|FG001|Overall Study|Off study Treatment|3|||
37728323|NCT01426438|69207366|FG000|Overall Study|Poor scan quality|3|||
37728324|NCT01426438|69207367|FG001|Overall Study|Poor scan quality|2|||
37728325|NCT01426438|69207366|FG000|Overall Study|Missed Scan|2|||
37728326|NCT01426438|69207367|FG001|Overall Study|Missed Scan|2|||
37728327|NCT01425814|69207373|FG000|Period 1|Stability criteria not fulfilled|0|||
37728328|NCT01425814|69207374|FG001|Period 1|Stability criteria not fulfilled|1|||
37728329|NCT01425814|69207375|FG002|Period 1|Stability criteria not fulfilled|0|||
37728330|NCT01425814|69207376|FG003|Period 1|Stability criteria not fulfilled|0|||
37728331|NCT01425814|69207377|FG004|Period 1|Stability criteria not fulfilled|0|||
37728332|NCT01425814|69207378|FG005|Period 1|Stability criteria not fulfilled|0|||
37728333|NCT01425814|69207373|FG000|Period 2|Stability criteria not fulfilled|0|||
37728334|NCT01425814|69207374|FG001|Period 2|Stability criteria not fulfilled|1|||
37728335|NCT01425814|69207375|FG002|Period 2|Stability criteria not fulfilled|0|||
37728336|NCT01425814|69207376|FG003|Period 2|Stability criteria not fulfilled|0|||
37728337|NCT01425814|69207377|FG004|Period 2|Stability criteria not fulfilled|0|||
37728338|NCT01425814|69207378|FG005|Period 2|Stability criteria not fulfilled|0|||
37728339|NCT01425814|69207373|FG000|Period 3|Adverse Event|0|||
37728340|NCT01425814|69207374|FG001|Period 3|Adverse Event|0|||
37728341|NCT01425814|69207375|FG002|Period 3|Adverse Event|0|||
37728342|NCT01425814|69207376|FG003|Period 3|Adverse Event|0|||
37728343|NCT01425814|69207377|FG004|Period 3|Adverse Event|0|||
37728344|NCT01425814|69207378|FG005|Period 3|Adverse Event|1|||
37728345|NCT01425814|69207373|FG000|Period 4|Adverse Event|1|||
37728346|NCT01425814|69207374|FG001|Period 4|Adverse Event|0|||
37728347|NCT01425814|69207375|FG002|Period 4|Adverse Event|1|||
37842848|NCT04660799|69527573|FG001|Overall Study|Death|1|||
37842849|NCT04660799|69527572|FG000|Overall Study|Adverse Event|2|||
37842850|NCT04660799|69527573|FG001|Overall Study|Adverse Event|1|||
37842851|NCT04660799|69527572|FG000|Overall Study|Withdrawal by Subject|2|||
37842852|NCT04660799|69527573|FG001|Overall Study|Withdrawal by Subject|5|||
37842853|NCT04553471|69527588|FG000|Overall Study|Did not start treatment on protocol|3|||
37842854|NCT04553471|69527588|FG000|Overall Study|Death|1|||
37842855|NCT04484831|69527594|FG000|Overall Study|Withdrawal by Subject|1|||
37842856|NCT04484831|69527595|FG001|Overall Study|Withdrawal by Subject|0|||
37842857|NCT04063787|69527633|FG000|Overall Study|Inadequate Doppler data|4|||
37842858|NCT04063787|69527633|FG000|Overall Study|Lost to Follow-up|2|||
37842859|NCT04063787|69527633|FG000|Overall Study|Death|3|||
37842860|NCT03995316|69527647|FG000|Overall Study|Lost to Follow-up|10|||
37728348|NCT01425814|69207376|FG003|Period 4|Adverse Event|0|||
37728349|NCT01425814|69207377|FG004|Period 4|Adverse Event|0|||
37728350|NCT01425814|69207378|FG005|Period 4|Adverse Event|0|||
37728351|NCT01425814|69207373|FG000|Period 5|Stability criteria not fulfilled|0|||
37728352|NCT01425814|69207374|FG001|Period 5|Stability criteria not fulfilled|0|||
37728353|NCT01425814|69207375|FG002|Period 5|Stability criteria not fulfilled|1|||
37728354|NCT01425814|69207376|FG003|Period 5|Stability criteria not fulfilled|0|||
37728355|NCT01425814|69207377|FG004|Period 5|Stability criteria not fulfilled|0|||
37728356|NCT01425814|69207378|FG005|Period 5|Stability criteria not fulfilled|1|||
37728357|NCT01782495|69207403|FG000|Overall Study|Adverse Event|0|||
37728358|NCT01782495|69207404|FG001|Overall Study|Adverse Event|0|||
37728359|NCT01782495|69207405|FG002|Overall Study|Adverse Event|0|||
37728360|NCT01782495|69207406|FG003|Overall Study|Adverse Event|0|||
37842861|NCT03995316|69527648|FG001|Overall Study|Lost to Follow-up|3|||
37728361|NCT01782495|69207407|FG004|Overall Study|Adverse Event|0|||
37728362|NCT01782495|69207408|FG005|Overall Study|Adverse Event|0|||
37728363|NCT01782495|69207409|FG006|Overall Study|Adverse Event|0|||
37728364|NCT01782495|69207410|FG007|Overall Study|Adverse Event|2|||
37728365|NCT01782495|69207411|FG008|Overall Study|Adverse Event|0|||
37728366|NCT01782495|69207412|FG009|Overall Study|Adverse Event|0|||
37728367|NCT01782495|69207413|FG010|Overall Study|Adverse Event|0|||
37842862|NCT03927690|69527657|FG000|Overall Study|Withdrawal by Subject|3|||
37728368|NCT01782495|69207403|FG000|Overall Study|Withdrew Consent|0|||
37728369|NCT01782495|69207404|FG001|Overall Study|Withdrew Consent|1|||
37728370|NCT01782495|69207405|FG002|Overall Study|Withdrew Consent|0|||
37915840|NCT00710866|69602650|FG001|Overall Study|Protocol Violation|4|||
37842863|NCT03927690|69527658|FG001|Overall Study|Withdrawal by Subject|1|||
37842864|NCT03927690|69527659|FG002|Overall Study|Withdrawal by Subject|1|||
37842865|NCT03927690|69527657|FG000|Overall Study|Adverse Event|1|||
37842866|NCT03927690|69527658|FG001|Overall Study|Adverse Event|0|||
37842867|NCT03927690|69527659|FG002|Overall Study|Adverse Event|0|||
37842868|NCT03927690|69527657|FG000|Overall Study|Death|1|||
37842869|NCT03927690|69527658|FG001|Overall Study|Death|0|||
37842870|NCT03927690|69527659|FG002|Overall Study|Death|0|||
37842871|NCT03927690|69527657|FG000|Overall Study|Lost to Follow-up|2|||
37842872|NCT03927690|69527658|FG001|Overall Study|Lost to Follow-up|2|||
37842873|NCT03927690|69527659|FG002|Overall Study|Lost to Follow-up|1|||
37842874|NCT03793842|69527677|FG000|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|0|||
37842875|NCT03793842|69527678|FG001|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|1|||
37842876|NCT03793842|69527677|FG000|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|2|||
37842877|NCT03793842|69527678|FG001|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|1|||
37842878|NCT03675737|69527686|FG000|Overall Study|Death|593|||
37842879|NCT03675737|69527687|FG001|Overall Study|Death|660|||
37842880|NCT03675737|69527686|FG000|Overall Study|Lost to Follow-up|1|||
37842881|NCT03675737|69527687|FG001|Overall Study|Lost to Follow-up|5|||
37842882|NCT03675737|69527686|FG000|Overall Study|Physician Decision|1|||
37842883|NCT03675737|69527687|FG001|Overall Study|Physician Decision|0|||
37842884|NCT03675737|69527686|FG000|Overall Study|Withdrawal by Subject|14|||
37842885|NCT03675737|69527687|FG001|Overall Study|Withdrawal by Subject|12|||
37842886|NCT03675737|69527686|FG000|Overall Study|Ongoing in Study|181|||
37842887|NCT03675737|69527687|FG001|Overall Study|Ongoing in Study|112|||
37842888|NCT03555695|69527698|FG000|Overall Study|Withdrawal by Subject|1|||
37842889|NCT03555695|69527698|FG000|Overall Study|Lost to Follow-up|1|||
37842890|NCT03555695|69527698|FG000|Overall Study|appendicitis (unrelated)|1|||
37842891|NCT03555695|69527698|FG000|Overall Study|pre-existing sciatica|1|||
37842892|NCT03538691|69527702|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|24|||
37842893|NCT03538691|69527703|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
37842894|NCT03538691|69527704|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
37842895|NCT03538691|69527705|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
37842896|NCT03538691|69527702|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|82|||
37842897|NCT03538691|69527703|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
37842898|NCT03538691|69527704|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
37842899|NCT03538691|69527705|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
37842900|NCT03538691|69527702|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|54|||
37842901|NCT03538691|69527703|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
37842902|NCT03538691|69527704|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
37842903|NCT03538691|69527705|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
37842904|NCT03538691|69527702|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Death|1|||
37842905|NCT03538691|69527703|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
37842906|NCT03538691|69527704|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
37842907|NCT03538691|69527705|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
37842908|NCT03538691|69527702|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|9|||
37842909|NCT03538691|69527703|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
37842910|NCT03538691|69527704|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
37842911|NCT03538691|69527705|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
37842912|NCT03538691|69527702|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|185|||
37842913|NCT03538691|69527703|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
37842914|NCT03538691|69527704|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
37842915|NCT03538691|69527705|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
37842916|NCT03538691|69527702|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|12|||
37842917|NCT03538691|69527703|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
37842918|NCT03538691|69527704|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
37842919|NCT03538691|69527705|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
37842920|NCT03538691|69527702|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|1|||
37842921|NCT03538691|69527703|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
37842922|NCT03538691|69527704|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
37842923|NCT03538691|69527705|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
37842924|NCT03538691|69527702|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|15|||
37842925|NCT03538691|69527703|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
37842926|NCT03538691|69527704|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
37728371|NCT01782495|69207406|FG003|Overall Study|Withdrew Consent|0|||
37842927|NCT03538691|69527705|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
37842928|NCT03538691|69527702|FG000|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
37842929|NCT03538691|69527703|FG001|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|5|||
37842930|NCT03538691|69527704|FG002|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
37842931|NCT03538691|69527705|FG003|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
37842932|NCT03538691|69527702|FG000|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
37842933|NCT03538691|69527703|FG001|Phase B: Stabilization (12 Weeks)|Adverse Event|52|||
37842934|NCT03538691|69527704|FG002|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
37842935|NCT03538691|69527705|FG003|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
37842936|NCT03538691|69527702|FG000|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
37842937|NCT03538691|69527703|FG001|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|47|||
37842938|NCT03538691|69527704|FG002|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
37842939|NCT03538691|69527705|FG003|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
37842940|NCT03538691|69527702|FG000|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
37842941|NCT03538691|69527703|FG001|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|9|||
37842942|NCT03538691|69527704|FG002|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
37842943|NCT03538691|69527705|FG003|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
37842944|NCT03538691|69527702|FG000|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
37842945|NCT03538691|69527703|FG001|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|136|||
37842946|NCT03538691|69527704|FG002|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
37842947|NCT03538691|69527705|FG003|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
37842948|NCT03538691|69527702|FG000|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
37842949|NCT03538691|69527703|FG001|Phase B: Stabilization (12 Weeks)|Pregnancy|1|||
37842950|NCT03538691|69527704|FG002|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
37842951|NCT03538691|69527705|FG003|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
37842952|NCT03538691|69527702|FG000|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
37842953|NCT03538691|69527703|FG001|Phase B: Stabilization (12 Weeks)|Protocol Deviation|9|||
37842954|NCT03538691|69527704|FG002|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
37842955|NCT03538691|69527705|FG003|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
37842956|NCT03538691|69527702|FG000|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
37842957|NCT03538691|69527703|FG001|Phase B: Stabilization (12 Weeks)|Physician Decision|6|||
37842958|NCT03538691|69527704|FG002|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
37842959|NCT03538691|69527705|FG003|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
37842960|NCT03538691|69527702|FG000|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
37842961|NCT03538691|69527703|FG001|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|1|||
37842962|NCT03538691|69527704|FG002|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
37842963|NCT03538691|69527705|FG003|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
37842964|NCT03538691|69527702|FG000|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
37842965|NCT03538691|69527703|FG001|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|11|||
37842966|NCT03538691|69527704|FG002|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
37842967|NCT03538691|69527705|FG003|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
37842968|NCT03538691|69527702|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
37842969|NCT03538691|69527703|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
37842970|NCT03538691|69527704|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|16|||
37842971|NCT03538691|69527705|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|4|||
37842972|NCT03538691|69527702|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
37842973|NCT03538691|69527703|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
37842974|NCT03538691|69527704|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
37842975|NCT03538691|69527705|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
37842976|NCT03538691|69527702|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
37842977|NCT03538691|69527703|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
37842978|NCT03538691|69527704|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|6|||
37842979|NCT03538691|69527705|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|19|||
37842980|NCT03538691|69527702|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
37842981|NCT03538691|69527703|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
37842982|NCT03538691|69527704|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|1|||
37842983|NCT03538691|69527705|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|2|||
37842984|NCT03538691|69527702|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
37842985|NCT03538691|69527703|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
37842986|NCT03538691|69527704|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|32|||
37842987|NCT03538691|69527705|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|28|||
37842988|NCT03538691|69527702|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
37842989|NCT03538691|69527703|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
37842990|NCT03538691|69527704|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|1|||
37842991|NCT03538691|69527705|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
37842992|NCT03538691|69527702|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
37842993|NCT03538691|69527703|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
37842994|NCT03538691|69527704|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|54|||
37842995|NCT03538691|69527705|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|52|||
37842996|NCT03538691|69527702|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
37842997|NCT03538691|69527703|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
37842998|NCT03538691|69527704|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
37842999|NCT03538691|69527705|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|1|||
37843000|NCT03538691|69527702|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
37843001|NCT03538691|69527703|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
37843002|NCT03538691|69527704|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|4|||
37843003|NCT03538691|69527705|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|6|||
37843004|NCT03511664|69527715|FG000|Overall Study|Treatment ongoing|49|||
37843005|NCT03511664|69527716|FG001|Overall Study|Treatment ongoing|5|||
37843006|NCT03511664|69527715|FG000|Overall Study|Entered long-term follow-up|140|||
37843007|NCT03511664|69527716|FG001|Overall Study|Entered long-term follow-up|50|||
37843008|NCT03511664|69527715|FG000|Overall Study|Withdrawal by Subject|29|||
37843009|NCT03511664|69527716|FG001|Overall Study|Withdrawal by Subject|53|||
37843010|NCT03511664|69527715|FG000|Overall Study|Lost to Follow-up|4|||
37843011|NCT03511664|69527716|FG001|Overall Study|Lost to Follow-up|4|||
37843012|NCT03511664|69527715|FG000|Overall Study|Physician Decision|0|||
37915841|NCT00710866|69602649|FG000|Overall Study|Withdrawal by Subject|2|||
37728372|NCT01782495|69207407|FG004|Overall Study|Withdrew Consent|0|||
37728373|NCT01782495|69207408|FG005|Overall Study|Withdrew Consent|0|||
37728374|NCT01782495|69207409|FG006|Overall Study|Withdrew Consent|0|||
37728375|NCT01782495|69207410|FG007|Overall Study|Withdrew Consent|1|||
37728376|NCT01782495|69207411|FG008|Overall Study|Withdrew Consent|0|||
37728377|NCT01782495|69207412|FG009|Overall Study|Withdrew Consent|0|||
37728378|NCT01782495|69207413|FG010|Overall Study|Withdrew Consent|0|||
37728379|NCT01922102|69207440|FG000|Overall Study|Withdrawal by Subject|7|||
37728380|NCT01922102|69207441|FG001|Overall Study|Withdrawal by Subject|3|||
37728381|NCT01922102|69207442|FG002|Overall Study|Withdrawal by Subject|7|||
37728382|NCT01922102|69207440|FG000|Overall Study|Physician Decision|0|||
37728383|NCT01922102|69207441|FG001|Overall Study|Physician Decision|2|||
37728384|NCT01922102|69207442|FG002|Overall Study|Physician Decision|1|||
37728385|NCT01922102|69207440|FG000|Overall Study|Adverse Event|1|||
37728386|NCT01922102|69207441|FG001|Overall Study|Adverse Event|2|||
37728387|NCT01922102|69207442|FG002|Overall Study|Adverse Event|0|||
37728388|NCT01922102|69207440|FG000|Overall Study|Lost to Follow-up|1|||
37728389|NCT01922102|69207441|FG001|Overall Study|Lost to Follow-up|0|||
37728390|NCT01922102|69207442|FG002|Overall Study|Lost to Follow-up|0|||
37728391|NCT01922102|69207440|FG000|Overall Study|Administrative problems|0|||
37728392|NCT01922102|69207441|FG001|Overall Study|Administrative problems|2|||
37728393|NCT01922102|69207442|FG002|Overall Study|Administrative problems|0|||
37728394|NCT01405768|69207456|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
37728395|NCT01405768|69207457|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
37728396|NCT01913353|69207465|FG000|Overall Study|Adverse Event|2|||
37728397|NCT01913353|69207466|FG001|Overall Study|Adverse Event|0|||
37728398|NCT01913353|69207465|FG000|Overall Study|Physician Decision|0|||
37728399|NCT01913353|69207466|FG001|Overall Study|Physician Decision|2|||
37728400|NCT01913353|69207465|FG000|Overall Study|Withdrawal by Subject|20|||
37728401|NCT01913353|69207466|FG001|Overall Study|Withdrawal by Subject|6|||
37728402|NCT01913353|69207465|FG000|Overall Study|multiple reasons|10|||
37728403|NCT01913353|69207466|FG001|Overall Study|multiple reasons|7|||
37843013|NCT03511664|69527716|FG001|Overall Study|Physician Decision|1|||
37915842|NCT00710866|69602650|FG001|Overall Study|Withdrawal by Subject|1|||
37915843|NCT00710866|69602649|FG000|Overall Study|Lost to Follow-up|1|||
37728404|NCT01754259|69207481|FG000|Overall Study|Withdrawal by Subject|2|||
37728405|NCT01754259|69207482|FG001|Overall Study|Withdrawal by Subject|4|||
37728406|NCT01754259|69207481|FG000|Overall Study|Adverse Event|3|||
37728407|NCT01754259|69207482|FG001|Overall Study|Adverse Event|1|||
37728408|NCT01754259|69207481|FG000|Overall Study|Lost to Follow-up|0|||
37728409|NCT01754259|69207482|FG001|Overall Study|Lost to Follow-up|1|||
37728410|NCT01405456|69207490|FG000|Overall Study|Lost to Follow-up|2|||
37728411|NCT01405456|69207491|FG001|Overall Study|Lost to Follow-up|1|||
37728412|NCT01405456|69207490|FG000|Overall Study|Physician Decision|1|||
37728413|NCT01405456|69207491|FG001|Overall Study|Physician Decision|0|||
37728414|NCT01404988|69207500|FG000|Overall Study|Death|2|||
37728415|NCT01404988|69207501|FG001|Overall Study|Death|0|||
37728416|NCT01404988|69207502|FG002|Overall Study|Death|2|||
37728417|NCT01404988|69207500|FG000|Overall Study|Adverse Event|1|||
37728418|NCT01404988|69207501|FG001|Overall Study|Adverse Event|0|||
37728419|NCT01404988|69207502|FG002|Overall Study|Adverse Event|0|||
37728420|NCT01404988|69207500|FG000|Overall Study|Withdrawal by Subject|2|||
37728421|NCT01404988|69207501|FG001|Overall Study|Withdrawal by Subject|2|||
37728422|NCT01404988|69207502|FG002|Overall Study|Withdrawal by Subject|0|||
37728423|NCT01404988|69207500|FG000|Overall Study|Lost to Follow-up|1|||
37728424|NCT01404988|69207501|FG001|Overall Study|Lost to Follow-up|2|||
37728425|NCT01404988|69207502|FG002|Overall Study|Lost to Follow-up|1|||
37728426|NCT01389232|69207513|FG000|Overall Study|Had scaffold removed|15|||
37728427|NCT01389232|69207513|FG000|Overall Study|Personal reasons|2|||
37728428|NCT01389232|69207513|FG000|Overall Study|Adverse Event|1|||
37728429|NCT01389232|69207513|FG000|Overall Study|Death|1|||
37728430|NCT01404208|69207529|FG000|Overall Study|Discontinued|3|||
37728431|NCT01404208|69207530|FG001|Overall Study|Discontinued|0|||
37728432|NCT01617668|69207538|FG000|Overall Study|Adverse Event|7|||
38025484|NCT01348100|69709912|FG001|Overall Study|Administrative Problems|0|||
38025485|NCT01348100|69709913|FG002|Overall Study|Administrative Problems|0|||
38025486|NCT01348100|69709914|FG003|Overall Study|Administrative Problems|0|||
38025487|NCT01348100|69709915|FG004|Overall Study|Administrative Problems|0|||
38025488|NCT01348100|69709916|FG005|Overall Study|Administrative Problems|1|||
38025489|NCT01348100|69709917|FG006|Overall Study|Administrative Problems|1|||
38025490|NCT03676634|69709938|FG000|Overall Study|Red blood cell loss|1|||
38025491|NCT03676634|69709938|FG000|Overall Study|Out-of-limit pulse|2|||
38025492|NCT03675776|69709945|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
38025493|NCT03675776|69709946|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
38025494|NCT03675776|69709947|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
38025495|NCT03675776|69709945|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
38025496|NCT03675776|69709946|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
38025497|NCT03675776|69709947|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
38025498|NCT03673670|69709961|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
38025499|NCT03673670|69709962|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
38025500|NCT03673670|69709963|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
38025501|NCT03673670|69709964|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
38025502|NCT03673670|69709965|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
38025503|NCT03673670|69709966|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
38025504|NCT03673670|69709961|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
38025505|NCT03673670|69709962|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
38025506|NCT03673670|69709963|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
38025507|NCT03673670|69709964|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
38025508|NCT03673670|69709965|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
38025509|NCT03673670|69709966|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
38025510|NCT03673670|69709961|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
38025511|NCT03673670|69709962|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
38025512|NCT03673670|69709963|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
38025513|NCT03673670|69709964|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
38025514|NCT03673670|69709965|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
38025515|NCT03673670|69709966|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
38025516|NCT03673670|69709961|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
38025517|NCT03673670|69709962|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
38025518|NCT03673670|69709963|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
38025519|NCT03673670|69709964|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
38025520|NCT03673670|69709965|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
38025521|NCT03673670|69709966|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
38025522|NCT03673670|69709961|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
38025523|NCT03673670|69709962|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
38025524|NCT03673670|69709963|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
38025525|NCT03673670|69709964|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
38025526|NCT03673670|69709965|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
38025527|NCT03673670|69709966|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
37728433|NCT01617668|69207539|FG001|Overall Study|Adverse Event|0|||
37728434|NCT01617668|69207540|FG002|Overall Study|Adverse Event|12|||
37728435|NCT01617668|69207541|FG003|Overall Study|Adverse Event|5|||
37728436|NCT01617668|69207538|FG000|Overall Study|Physician Decision|1|||
37728437|NCT01617668|69207539|FG001|Overall Study|Physician Decision|2|||
37728438|NCT01617668|69207540|FG002|Overall Study|Physician Decision|3|||
37728439|NCT01617668|69207541|FG003|Overall Study|Physician Decision|0|||
37728440|NCT01617668|69207538|FG000|Overall Study|Progressive Disease|4|||
37728441|NCT01617668|69207539|FG001|Overall Study|Progressive Disease|4|||
37728442|NCT01617668|69207540|FG002|Overall Study|Progressive Disease|6|||
37728443|NCT01617668|69207541|FG003|Overall Study|Progressive Disease|9|||
37728444|NCT01617668|69207538|FG000|Overall Study|Subject/guardian decision|1|||
37728445|NCT01617668|69207539|FG001|Overall Study|Subject/guardian decision|3|||
37728446|NCT01617668|69207540|FG002|Overall Study|Subject/guardian decision|2|||
37728447|NCT01617668|69207541|FG003|Overall Study|Subject/guardian decision|1|||
37728448|NCT01425268|69207557|FG000|Overall Study|Withdrawal by Subject|2|||
37728449|NCT01425268|69207558|FG001|Overall Study|Withdrawal by Subject|0|||
37728450|NCT01425268|69207557|FG000|Overall Study|Sponsor Decision|5|||
37728451|NCT01425268|69207558|FG001|Overall Study|Sponsor Decision|0|||
37728452|NCT01425268|69207557|FG000|Overall Study|Physician Decision|1|||
37728453|NCT01425268|69207558|FG001|Overall Study|Physician Decision|0|||
37728454|NCT01425190|69207567|FG000|Overall Study|Full dose not consumed.|1|||
37728455|NCT01425190|69207568|FG001|Overall Study|Full dose not consumed.|0|||
37728456|NCT01425190|69207569|FG002|Overall Study|Full dose not consumed.|0|||
37728457|NCT01388530|69207577|FG000|Overall Study|Lost to Follow-up|5|||
37728458|NCT01895270|69207583|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
37728459|NCT01895270|69207584|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
37728460|NCT01895270|69207583|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
37728461|NCT01895270|69207584|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
37728462|NCT01895270|69207583|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
37728463|NCT01895270|69207584|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
37728464|NCT01895270|69207583|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
37728465|NCT01895270|69207584|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
37728466|NCT01895270|69207583|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
37728467|NCT01895270|69207584|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
37728468|NCT01895270|69207583|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
37728469|NCT01895270|69207584|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
37728470|NCT01895270|69207583|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
37728471|NCT01895270|69207584|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
37728472|NCT01424722|69207590|FG000|Overall Study|Sponsor terminated investigation|2258|||
37728473|NCT01424644|69207596|FG000|Overall Study|Adverse Event|2|||
37728474|NCT01424644|69207597|FG001|Overall Study|Adverse Event|0|||
37728475|NCT01424644|69207596|FG000|Overall Study|Withdrawal by Subject|9|||
37728476|NCT01424644|69207597|FG001|Overall Study|Withdrawal by Subject|12|||
37728477|NCT01424644|69207596|FG000|Overall Study|Lost to Follow-up|16|||
37728478|NCT01424644|69207597|FG001|Overall Study|Lost to Follow-up|12|||
37728479|NCT01424644|69207596|FG000|Overall Study|Protocol Violation|4|||
37728480|NCT01424644|69207597|FG001|Overall Study|Protocol Violation|3|||
37843014|NCT03120949|69527733|FG000|Overall Study|randomized in error|1|||
37843015|NCT03120949|69527734|FG001|Overall Study|randomized in error|0|||
37843016|NCT03120949|69527733|FG000|Overall Study|Death|13|||
37843017|NCT03120949|69527734|FG001|Overall Study|Death|13|||
37843018|NCT03120949|69527733|FG000|Overall Study|Lost to Follow-up|23|||
37843019|NCT03120949|69527734|FG001|Overall Study|Lost to Follow-up|13|||
37843020|NCT03120949|69527733|FG000|Overall Study|Withdrawal by Subject|139|||
37843021|NCT03120949|69527734|FG001|Overall Study|Withdrawal by Subject|124|||
37843022|NCT03120949|69527733|FG000|Overall Study|Covid-19|43|||
37843023|NCT03120949|69527734|FG001|Overall Study|Covid-19|34|||
37843024|NCT03120949|69527733|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
37843025|NCT03120949|69527734|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
37843026|NCT03120949|69527733|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
37915844|NCT00710866|69602650|FG001|Overall Study|Lost to Follow-up|0|||
37915845|NCT00710866|69602649|FG000|Overall Study|Failed to meet eligibility|1|||
37915846|NCT00710866|69602650|FG001|Overall Study|Failed to meet eligibility|1|||
37728481|NCT01424644|69207596|FG000|Overall Study|Administrative Reason|1|||
37728482|NCT01424644|69207597|FG001|Overall Study|Administrative Reason|0|||
37728483|NCT01424644|69207596|FG000|Overall Study|Unable to Classify|1|||
37728484|NCT01424644|69207597|FG001|Overall Study|Unable to Classify|0|||
37728485|NCT01920854|69207610|FG000|Overall Study|Withdrawal by Subject|1|||
37728486|NCT01920854|69207611|FG001|Overall Study|Withdrawal by Subject|0|||
37728487|NCT01920854|69207612|FG002|Overall Study|Withdrawal by Subject|0|||
37728488|NCT01920854|69207613|FG003|Overall Study|Withdrawal by Subject|0|||
37728489|NCT01920854|69207614|FG004|Overall Study|Withdrawal by Subject|1|||
37915847|NCT00827775|69602667|FG000|Overall Study|Withdrawal by Subject|0|||
37843027|NCT03120949|69527734|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
37843028|NCT03120949|69527733|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
37728490|NCT01920854|69207615|FG005|Overall Study|Withdrawal by Subject|0|||
37728491|NCT01920854|69207616|FG006|Overall Study|Withdrawal by Subject|1|||
37728492|NCT01403194|69207651|FG000|Overall Study|Screen Failure|2|||
37728493|NCT01403194|69207651|FG000|Overall Study|Lost to Follow-up|8|||
37728494|NCT01403116|69207657|FG000|Overall Study|Adverse Event|7|||
37728495|NCT01403116|69207658|FG001|Overall Study|Adverse Event|4|||
37728496|NCT01403116|69207657|FG000|Overall Study|Lost to Follow-up|7|||
37728497|NCT01403116|69207658|FG001|Overall Study|Lost to Follow-up|5|||
37728498|NCT01403116|69207657|FG000|Overall Study|Withdrawal by Subject|12|||
37728499|NCT01403116|69207658|FG001|Overall Study|Withdrawal by Subject|15|||
37728500|NCT01403116|69207657|FG000|Overall Study|Non-compliance of study drug|3|||
37728501|NCT01403116|69207658|FG001|Overall Study|Non-compliance of study drug|0|||
38025528|NCT03673670|69709961|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
38025529|NCT03673670|69709962|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
38025530|NCT03673670|69709963|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
38025531|NCT03673670|69709964|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
38025532|NCT03673670|69709965|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
38025533|NCT03673670|69709966|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
38025534|NCT03673670|69709961|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
38025535|NCT03673670|69709962|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
38025536|NCT03673670|69709963|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
38025537|NCT03673670|69709964|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
38025538|NCT03673670|69709965|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
38025539|NCT03673670|69709966|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
38025540|NCT04369742|69709985|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
38025541|NCT04369742|69709986|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
38025542|NCT04369742|69709985|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
38025543|NCT04369742|69709986|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
37843029|NCT03120949|69527734|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
37843030|NCT03120949|69527733|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
37843031|NCT03120949|69527734|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
37843032|NCT03120949|69527733|FG000|Overall Study|Site was closed|2|||
37843033|NCT03120949|69527734|FG001|Overall Study|Site was closed|3|||
37843034|NCT03120949|69527733|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
37843035|NCT03120949|69527734|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
37843036|NCT03120949|69527733|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
37843037|NCT03120949|69527734|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
37843038|NCT03120949|69527733|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
38025544|NCT04369430|69709994|FG000|Overall Study|Adverse Event|2|||
38025545|NCT04369430|69709995|FG001|Overall Study|Adverse Event|3|||
38025546|NCT04369430|69709994|FG000|Overall Study|Death|1|||
37728502|NCT01403116|69207657|FG000|Overall Study|Protocol Violation|0|||
37728503|NCT01403116|69207658|FG001|Overall Study|Protocol Violation|1|||
37728504|NCT01403116|69207657|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
37728505|NCT01403116|69207658|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
37728506|NCT01403116|69207657|FG000|Overall Study|Hct >54%|2|||
37728507|NCT01403116|69207658|FG001|Overall Study|Hct >54%|0|||
37728508|NCT01403116|69207657|FG000|Overall Study|unable to keep appointments|0|||
37728509|NCT01403116|69207658|FG001|Overall Study|unable to keep appointments|2|||
37728510|NCT01402570|69207664|FG000|Overall Study|Adverse Event|1|||
37728511|NCT01753401|69207671|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
37728512|NCT01753401|69207672|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
37728513|NCT01753401|69207673|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
37728514|NCT01753401|69207674|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
37728515|NCT01753401|69207671|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
37728516|NCT01753401|69207672|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
37728517|NCT01753401|69207673|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
37728518|NCT01753401|69207674|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
37728519|NCT01753401|69207671|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
38025547|NCT04369430|69709995|FG001|Overall Study|Death|0|||
38025548|NCT04369430|69709994|FG000|Overall Study|Withdrawal by Subject|4|||
37728520|NCT01753401|69207672|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
37728521|NCT01753401|69207673|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
37728522|NCT01753401|69207674|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
38025549|NCT04369430|69709995|FG001|Overall Study|Withdrawal by Subject|3|||
37728523|NCT01753401|69207671|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
37728524|NCT01753401|69207672|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
37728525|NCT01753401|69207673|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
37728526|NCT01753401|69207674|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
37728527|NCT01753401|69207671|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
37728528|NCT01753401|69207672|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
37728529|NCT01753401|69207673|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
37728530|NCT01753401|69207674|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
37728531|NCT01753401|69207671|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
37728532|NCT01753401|69207672|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
37728533|NCT01753401|69207673|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
37728534|NCT01753401|69207674|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
37728535|NCT01753401|69207671|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
37728536|NCT01753401|69207672|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
37728537|NCT01753401|69207673|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
37728538|NCT01753401|69207674|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
37728539|NCT01618916|69207690|FG000|Overall Study|Adverse Event|1|||
37728540|NCT01618916|69207691|FG001|Overall Study|Adverse Event|0|||
37728541|NCT01618916|69207692|FG002|Overall Study|Adverse Event|0|||
37728542|NCT01618916|69207693|FG003|Overall Study|Adverse Event|0|||
37843039|NCT03120949|69527734|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
37843040|NCT03120949|69527733|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
37843041|NCT03120949|69527734|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
37843042|NCT03120949|69527733|FG000|Overall Study|Other: Adverse Event|0|||
37843043|NCT03120949|69527734|FG001|Overall Study|Other: Adverse Event|1|||
37843044|NCT03120949|69527733|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
37843045|NCT03120949|69527734|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
37843046|NCT03120949|69527733|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
37843047|NCT03120949|69527734|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
37843048|NCT03120949|69527733|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
37843049|NCT03120949|69527734|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
37843050|NCT03120949|69527733|FG000|Overall Study|Personal Reasons|0|||
37843051|NCT03120949|69527734|FG001|Overall Study|Personal Reasons|1|||
37843052|NCT03120949|69527733|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
37843053|NCT03120949|69527734|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
37843054|NCT03120949|69527733|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
37843055|NCT03120949|69527734|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
37843056|NCT03120949|69527733|FG000|Overall Study|Compliance With Medication|0|||
37843057|NCT03120949|69527734|FG001|Overall Study|Compliance With Medication|1|||
37843058|NCT03120949|69527733|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
37843059|NCT03120949|69527734|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
37843060|NCT03120949|69527733|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
37843061|NCT03120949|69527734|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
37843062|NCT03120949|69527733|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
37843063|NCT03120949|69527734|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
37843064|NCT02921256|69527757|FG000|Arm 1a v. Arm II|Adverse Event|6|||
37843065|NCT02921256|69527758|FG001|Arm 1a v. Arm II|Adverse Event|15|||
37843066|NCT02921256|69527759|FG002|Arm 1a v. Arm II|Adverse Event|0|||
37843067|NCT02921256|69527757|FG000|Arm 1a v. Arm II|Death|0|||
37843068|NCT02921256|69527758|FG001|Arm 1a v. Arm II|Death|2|||
37843069|NCT02921256|69527759|FG002|Arm 1a v. Arm II|Death|0|||
37843070|NCT02921256|69527757|FG000|Arm 1a v. Arm II|Lack of Efficacy|2|||
37843071|NCT02921256|69527758|FG001|Arm 1a v. Arm II|Lack of Efficacy|0|||
37843072|NCT02921256|69527759|FG002|Arm 1a v. Arm II|Lack of Efficacy|0|||
37843073|NCT02921256|69527757|FG000|Arm 1a v. Arm II|Lost to Follow-up|2|||
37843074|NCT02921256|69527758|FG001|Arm 1a v. Arm II|Lost to Follow-up|9|||
37843075|NCT02921256|69527759|FG002|Arm 1a v. Arm II|Lost to Follow-up|0|||
37843076|NCT02921256|69527757|FG000|Arm 1a v. Arm II|Physician Decision|1|||
37843077|NCT02921256|69527758|FG001|Arm 1a v. Arm II|Physician Decision|1|||
37843078|NCT02921256|69527759|FG002|Arm 1a v. Arm II|Physician Decision|0|||
37843079|NCT02921256|69527757|FG000|Arm 1a v. Arm II|Withdrawal by Subject|5|||
37728543|NCT01618916|69207694|FG004|Overall Study|Adverse Event|0|||
37728544|NCT01618916|69207695|FG005|Overall Study|Adverse Event|0|||
37728545|NCT01618916|69207690|FG000|Overall Study|Withdrawal by Subject|0|||
37728546|NCT01618916|69207691|FG001|Overall Study|Withdrawal by Subject|1|||
37728547|NCT01618916|69207692|FG002|Overall Study|Withdrawal by Subject|1|||
37728548|NCT01618916|69207693|FG003|Overall Study|Withdrawal by Subject|0|||
37728549|NCT01618916|69207694|FG004|Overall Study|Withdrawal by Subject|1|||
37728550|NCT01618916|69207695|FG005|Overall Study|Withdrawal by Subject|0|||
37728551|NCT01618916|69207690|FG000|Overall Study|Lost to Follow-up|1|||
37728552|NCT01618916|69207691|FG001|Overall Study|Lost to Follow-up|0|||
37728553|NCT01618916|69207692|FG002|Overall Study|Lost to Follow-up|0|||
37728554|NCT01618916|69207693|FG003|Overall Study|Lost to Follow-up|2|||
37728555|NCT01618916|69207694|FG004|Overall Study|Lost to Follow-up|0|||
37728556|NCT01618916|69207695|FG005|Overall Study|Lost to Follow-up|0|||
37728557|NCT01753323|69207711|FG000|Overall Study|Lack of Efficacy|0|||
37728558|NCT01753323|69207712|FG001|Overall Study|Lack of Efficacy|0|||
37728559|NCT01753323|69207713|FG002|Overall Study|Lack of Efficacy|8|||
37728560|NCT01753323|69207711|FG000|Overall Study|Protocol deviation|1|||
37728561|NCT01753323|69207712|FG001|Overall Study|Protocol deviation|0|||
37728562|NCT01753323|69207713|FG002|Overall Study|Protocol deviation|0|||
37843080|NCT02921256|69527758|FG001|Arm 1a v. Arm II|Withdrawal by Subject|6|||
37843081|NCT02921256|69527759|FG002|Arm 1a v. Arm II|Withdrawal by Subject|0|||
37843082|NCT02921256|69527757|FG000|Arm Ib v Arm III|Adverse Event|9|||
37843083|NCT02921256|69527758|FG001|Arm Ib v Arm III|Adverse Event|0|||
37843084|NCT02921256|69527759|FG002|Arm Ib v Arm III|Adverse Event|4|||
37843085|NCT02921256|69527757|FG000|Arm Ib v Arm III|Death|1|||
37843086|NCT02921256|69527758|FG001|Arm Ib v Arm III|Death|0|||
37843087|NCT02921256|69527759|FG002|Arm Ib v Arm III|Death|1|||
37843088|NCT02921256|69527757|FG000|Arm Ib v Arm III|Lack of Efficacy|2|||
37843089|NCT02921256|69527758|FG001|Arm Ib v Arm III|Lack of Efficacy|0|||
37843090|NCT02921256|69527759|FG002|Arm Ib v Arm III|Lack of Efficacy|2|||
37843091|NCT02921256|69527757|FG000|Arm Ib v Arm III|Lost to Follow-up|1|||
37843092|NCT02921256|69527758|FG001|Arm Ib v Arm III|Lost to Follow-up|0|||
37843093|NCT02921256|69527759|FG002|Arm Ib v Arm III|Lost to Follow-up|3|||
37843094|NCT02921256|69527757|FG000|Arm Ib v Arm III|Physician Decision|4|||
37843095|NCT02921256|69527758|FG001|Arm Ib v Arm III|Physician Decision|0|||
37843096|NCT02921256|69527759|FG002|Arm Ib v Arm III|Physician Decision|1|||
37843097|NCT02921256|69527757|FG000|Arm Ib v Arm III|Withdrawal by Subject|7|||
37843098|NCT02921256|69527758|FG001|Arm Ib v Arm III|Withdrawal by Subject|0|||
37843099|NCT02921256|69527759|FG002|Arm Ib v Arm III|Withdrawal by Subject|4|||
37843100|NCT02757885|69527773|FG000|Overall Study|Screen Failures|4|||
37843101|NCT02635867|69527791|FG000|Overall Study|Lost to Follow-up|4|||
37843102|NCT02635867|69527792|FG001|Overall Study|Lost to Follow-up|3|||
37843103|NCT02635867|69527793|FG002|Overall Study|Lost to Follow-up|3|||
37843104|NCT02635867|69527794|FG003|Overall Study|Lost to Follow-up|4|||
37843105|NCT02635867|69527795|FG004|Overall Study|Lost to Follow-up|1|||
37843106|NCT02426658|69527812|FG000|Overall Study|Withdrawal by Subject|1|||
37843107|NCT02426658|69527812|FG000|Overall Study|Patient expired before treatment|2|||
37843108|NCT02158091|69527819|FG000|Overall Study|DLT|2|||
37843109|NCT02158091|69527820|FG001|Overall Study|DLT|1|||
37843110|NCT02158091|69527821|FG002|Overall Study|DLT|0|||
37843111|NCT02136134|69527831|FG000|Overall Study|Death|35|||
37843112|NCT02136134|69527832|FG001|Overall Study|Death|29|||
37843113|NCT02136134|69527831|FG000|Overall Study|Withdrawal by Subject|14|||
37843114|NCT02136134|69527832|FG001|Overall Study|Withdrawal by Subject|4|||
37843115|NCT02136134|69527831|FG000|Overall Study|Other|3|||
37843116|NCT02136134|69527832|FG001|Overall Study|Other|3|||
37843117|NCT02136134|69527831|FG000|Overall Study|Ongoing|185|||
37843118|NCT02136134|69527832|FG001|Overall Study|Ongoing|207|||
37843119|NCT02136134|69527831|FG000|Overall Study|Subjects randomized but not treated|10|||
37843120|NCT02136134|69527832|FG001|Overall Study|Subjects randomized but not treated|8|||
37843121|NCT01774487|69527840|FG000|Overall Study|Did not tolerate taste|4|||
37843122|NCT01774487|69527841|FG001|Overall Study|Did not tolerate taste|4|||
37843123|NCT02903420|69527879|FG000|Overall Study|Death|3|||
37843124|NCT02831933|69527883|FG000|Overall Study|Physician Decision|11|||
37843125|NCT02813668|69527887|FG000|Overall Study|Death|4|||
37843126|NCT02813668|69527887|FG000|Overall Study|Lost to Follow-up|509|||
37843127|NCT02813668|69527887|FG000|Overall Study|Withdrawal by Subject|148|||
37843128|NCT02813668|69527887|FG000|Overall Study|No longer at worksite|85|||
37843129|NCT02813668|69527887|FG000|Overall Study|Medical reasons not related to the study|4|||
37843130|NCT02763566|69527899|FG000|Overall Study|Lost to Follow-up|1|||
37843131|NCT02763566|69527900|FG001|Overall Study|Lost to Follow-up|4|||
37843132|NCT02763566|69527901|FG002|Overall Study|Lost to Follow-up|0|||
37843133|NCT02763566|69527902|FG003|Overall Study|Lost to Follow-up|1|||
37843134|NCT02763566|69527899|FG000|Overall Study|On study treatment at study conclusion|114|||
38025550|NCT04369430|69709994|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
38025551|NCT04369430|69709995|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
37728563|NCT01753323|69207711|FG000|Overall Study|Adverse Event|0|||
37843135|NCT02763566|69527900|FG001|Overall Study|On study treatment at study conclusion|34|||
37843136|NCT02763566|69527901|FG002|Overall Study|On study treatment at study conclusion|54|||
37843137|NCT02763566|69527902|FG003|Overall Study|On study treatment at study conclusion|13|||
37843138|NCT02763566|69527899|FG000|Overall Study|Withdrawal by Subject|3|||
37843139|NCT02763566|69527900|FG001|Overall Study|Withdrawal by Subject|1|||
37728564|NCT01753323|69207712|FG001|Overall Study|Adverse Event|0|||
37728565|NCT01753323|69207713|FG002|Overall Study|Adverse Event|1|||
37728566|NCT01894568|69207724|FG000|Overall Study|Adverse Event|2|||
37843140|NCT02763566|69527901|FG002|Overall Study|Withdrawal by Subject|0|||
37728567|NCT01894568|69207725|FG001|Overall Study|Adverse Event|3|||
37728568|NCT01894568|69207724|FG000|Overall Study|Protocol required discontinuation|2|||
37728569|NCT01894568|69207725|FG001|Overall Study|Protocol required discontinuation|1|||
37728570|NCT01894568|69207724|FG000|Overall Study|Withdrawal by Subject|5|||
37728571|NCT01894568|69207725|FG001|Overall Study|Withdrawal by Subject|5|||
37728572|NCT01894568|69207724|FG000|Overall Study|Physician Decision|1|||
37728573|NCT01894568|69207725|FG001|Overall Study|Physician Decision|0|||
37728574|NCT01894568|69207724|FG000|Overall Study|Lost to Follow-up|0|||
37728575|NCT01894568|69207725|FG001|Overall Study|Lost to Follow-up|1|||
37728576|NCT01618838|69207732|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
37728577|NCT01920152|69207739|FG000|Overall Study|Withdrawal by Subject|1|||
37728578|NCT01920152|69207740|FG001|Overall Study|Withdrawal by Subject|2|||
37728579|NCT01752933|69207748|FG000|Treatment|Disease Progression|3|||
37728580|NCT01752933|69207749|FG001|Treatment|Disease Progression|29|||
37728581|NCT01752933|69207748|FG000|Treatment|Withdrawal by Subject|0|||
37728582|NCT01752933|69207749|FG001|Treatment|Withdrawal by Subject|5|||
37728583|NCT01752933|69207748|FG000|Treatment|Adverse Event|1|||
37728584|NCT01752933|69207749|FG001|Treatment|Adverse Event|4|||
37728585|NCT01752933|69207748|FG000|Treatment|Physician Decision|0|||
37728586|NCT01752933|69207749|FG001|Treatment|Physician Decision|3|||
37728587|NCT01752933|69207748|FG000|Treatment|Death|0|||
37728588|NCT01752933|69207749|FG001|Treatment|Death|2|||
37728589|NCT01752933|69207748|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
37728590|NCT01752933|69207749|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
37728591|NCT01752933|69207748|FG000|Treatment|Patient noncompliant|0|||
37728592|NCT01752933|69207749|FG001|Treatment|Patient noncompliant|1|||
37728593|NCT01752933|69207748|FG000|Treatment|Patient unable to travel to appointments|0|||
37728594|NCT01752933|69207749|FG001|Treatment|Patient unable to travel to appointments|1|||
37728595|NCT01752933|69207748|FG000|Overall Study and Follow-up|Death|4|||
37728596|NCT01752933|69207749|FG001|Overall Study and Follow-up|Death|34|||
37728597|NCT01752933|69207748|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
37728598|NCT01752933|69207749|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
37728599|NCT01752933|69207748|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
37728600|NCT01752933|69207749|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
37728601|NCT01752933|69207748|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
37728602|NCT01752933|69207749|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
37728603|NCT01752855|69207758|FG000|Overall Study|Adverse Event|1|||
37728604|NCT01752855|69207759|FG001|Overall Study|Adverse Event|0|||
37728605|NCT01752855|69207758|FG000|Overall Study|Withdrew Consent|0|||
37728606|NCT01752855|69207759|FG001|Overall Study|Withdrew Consent|2|||
37728607|NCT01752855|69207758|FG000|Overall Study|Lack of Efficacy|0|||
37728608|NCT01752855|69207759|FG001|Overall Study|Lack of Efficacy|2|||
37728609|NCT01402492|69207768|FG000|Overall Study|Withdrawal by Subject|17|||
37728610|NCT01402492|69207769|FG001|Overall Study|Withdrawal by Subject|11|||
37728611|NCT01402492|69207770|FG002|Overall Study|Withdrawal by Subject|11|||
37728612|NCT01402492|69207768|FG000|Overall Study|Adverse Event|2|||
37728613|NCT01402492|69207769|FG001|Overall Study|Adverse Event|3|||
37728614|NCT01402492|69207770|FG002|Overall Study|Adverse Event|4|||
37728615|NCT01402492|69207768|FG000|Overall Study|Physician Decision|0|||
37728616|NCT01402492|69207769|FG001|Overall Study|Physician Decision|3|||
37728617|NCT01402492|69207770|FG002|Overall Study|Physician Decision|0|||
37728618|NCT01402492|69207768|FG000|Overall Study|Incarcerated (N=3)|2|||
37728619|NCT01402492|69207769|FG001|Overall Study|Incarcerated (N=3)|0|||
37728620|NCT01402492|69207770|FG002|Overall Study|Incarcerated (N=3)|1|||
37728621|NCT01402102|69207780|FG000|Overall Study|Protocol Violation|1|||
37728622|NCT01402102|69207781|FG001|Overall Study|Protocol Violation|0|||
37728623|NCT01402102|69207780|FG000|Overall Study|Insufficiency of compliance|1|||
37728624|NCT01402102|69207781|FG001|Overall Study|Insufficiency of compliance|1|||
37728625|NCT01402102|69207780|FG000|Overall Study|Withdrawal by Subject|0|||
37728626|NCT01402102|69207781|FG001|Overall Study|Withdrawal by Subject|2|||
37728627|NCT01423084|69207791|FG000|Overall Study|Adverse Event|0|||
37728628|NCT01423084|69207792|FG001|Overall Study|Adverse Event|1|||
37728629|NCT01423084|69207791|FG000|Overall Study|Withdrawal by Subject|2|||
37728630|NCT01423084|69207792|FG001|Overall Study|Withdrawal by Subject|3|||
37728631|NCT01894256|69207802|FG000|Part A|Adverse Event|0|||
37728632|NCT01894256|69207803|FG001|Part A|Adverse Event|1|||
37728633|NCT01894256|69207804|FG002|Part A|Adverse Event|0|||
37728634|NCT01894256|69207802|FG000|Part B|Death|0|||
37728635|NCT01894256|69207803|FG001|Part B|Death|1|||
37728636|NCT01894256|69207804|FG002|Part B|Death|1|||
37728637|NCT01894256|69207802|FG000|Part B|Withdrawal by Subject|0|||
38025552|NCT04369430|69709994|FG000|Overall Study|Lost to Follow-up|0|||
37728638|NCT01894256|69207803|FG001|Part B|Withdrawal by Subject|1|||
37728639|NCT01894256|69207804|FG002|Part B|Withdrawal by Subject|0|||
37728640|NCT01894256|69207802|FG000|Part B|Lack of Efficacy|15|||
37728641|NCT01894256|69207803|FG001|Part B|Lack of Efficacy|12|||
37728642|NCT01894256|69207804|FG002|Part B|Lack of Efficacy|13|||
37728643|NCT01780935|69207817|FG000|Overall Study|Admin problems due to early termination|321|||
37728644|NCT01780935|69207818|FG001|Overall Study|Admin problems due to early termination|309|||
37728645|NCT01780935|69207817|FG000|Overall Study|Adverse Event|2|||
37728646|NCT01780935|69207818|FG001|Overall Study|Adverse Event|4|||
37728647|NCT01780935|69207817|FG000|Overall Study|Death|1|||
37728648|NCT01780935|69207818|FG001|Overall Study|Death|6|||
37728649|NCT01780935|69207817|FG000|Overall Study|Lost to Follow-up|2|||
37728650|NCT01780935|69207818|FG001|Overall Study|Lost to Follow-up|6|||
37728651|NCT01780935|69207817|FG000|Overall Study|Physician Decision|1|||
37728652|NCT01780935|69207818|FG001|Overall Study|Physician Decision|1|||
37728653|NCT01780935|69207817|FG000|Overall Study|Protocol deviation|0|||
37728654|NCT01780935|69207818|FG001|Overall Study|Protocol deviation|1|||
37728655|NCT01780935|69207817|FG000|Overall Study|Patient withdrew consent|8|||
37728656|NCT01780935|69207818|FG001|Overall Study|Patient withdrew consent|9|||
37728657|NCT01894100|69207826|FG000|Overall Study|Lost to Follow-up|0|||
37728658|NCT01894100|69207827|FG001|Overall Study|Lost to Follow-up|1|||
37728659|NCT01894100|69207826|FG000|Overall Study|Withdrawal by Subject|3|||
37728660|NCT01894100|69207827|FG001|Overall Study|Withdrawal by Subject|0|||
37728661|NCT01401478|69207873|FG000|Overall Study|Study drug not available|6|||
37728662|NCT01401478|69207873|FG000|Overall Study|Adverse Event|5|||
37728663|NCT01401478|69207873|FG000|Overall Study|Hyperphosphatemia|5|||
37728664|NCT01401478|69207873|FG000|Overall Study|Lost to Follow-up|5|||
37728665|NCT01401478|69207873|FG000|Overall Study|Kidney transplantation|3|||
37728666|NCT01401478|69207873|FG000|Overall Study|Withdrawal by Subject|3|||
37728667|NCT01401478|69207873|FG000|Overall Study|Blood samples not available|1|||
37728668|NCT01401478|69207873|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
37728669|NCT01401478|69207873|FG000|Overall Study|Low intact parathyroid hormone|1|||
37728670|NCT01401478|69207873|FG000|Overall Study|Serious adverse event|1|||
37728671|NCT01422850|69207877|FG000|Overall Study|Physician Decision|3|||
37728672|NCT01422538|69207886|FG000|Overall Study|Lost to Follow-up|0|||
37728673|NCT01422538|69207887|FG001|Overall Study|Lost to Follow-up|1|||
37728674|NCT01422538|69207888|FG002|Overall Study|Lost to Follow-up|1|||
37728675|NCT01422538|69207886|FG000|Overall Study|Missed visit|0|||
37728676|NCT01422538|69207887|FG001|Overall Study|Missed visit|1|||
37728677|NCT01422538|69207888|FG002|Overall Study|Missed visit|1|||
37728678|NCT01422382|69207897|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
37728679|NCT01401322|69207901|FG000|Overall Study|Withdrawal by Subject|1|||
37728680|NCT01401322|69207901|FG000|Overall Study|Physician Decision|1|||
37728681|NCT01387594|69207907|FG000|Overall Study|Withdrawal by Subject|0|||
37728682|NCT01387594|69207908|FG001|Overall Study|Withdrawal by Subject|2|||
37728683|NCT01387594|69207907|FG000|Overall Study|Lost to Follow-up|0|||
37728684|NCT01387594|69207908|FG001|Overall Study|Lost to Follow-up|1|||
37728685|NCT01401010|69207919|FG000|Overall Study|Could not interpret assay results|1|||
37728686|NCT01401010|69207920|FG001|Overall Study|Could not interpret assay results|0|||
37728687|NCT01400932|69207933|FG000|Overall Study|Adverse Event|10|||
37728688|NCT01400932|69207934|FG001|Overall Study|Adverse Event|5|||
37728689|NCT01400932|69207933|FG000|Overall Study|Lack of Efficacy|0|||
37728690|NCT01400932|69207934|FG001|Overall Study|Lack of Efficacy|3|||
37728691|NCT01400932|69207933|FG000|Overall Study|Withdrawal by Subject|2|||
37843141|NCT02763566|69527902|FG003|Overall Study|Withdrawal by Subject|0|||
37843142|NCT02760433|69527921|FG000|Overall Study|Lost to Follow-up|1|||
37843143|NCT02760433|69527922|FG001|Overall Study|Lost to Follow-up|0|||
37843144|NCT02760433|69527923|FG002|Overall Study|Lost to Follow-up|1|||
37843145|NCT02760433|69527924|FG003|Overall Study|Lost to Follow-up|0|||
37843146|NCT02760433|69527925|FG004|Overall Study|Lost to Follow-up|0|||
37843147|NCT02760433|69527921|FG000|Overall Study|Withdrawal by Subject|23|||
37843148|NCT02760433|69527922|FG001|Overall Study|Withdrawal by Subject|9|||
37843149|NCT02760433|69527923|FG002|Overall Study|Withdrawal by Subject|0|||
37843150|NCT02760433|69527924|FG003|Overall Study|Withdrawal by Subject|2|||
37843151|NCT02760433|69527925|FG004|Overall Study|Withdrawal by Subject|9|||
37915848|NCT00827775|69602668|FG001|Overall Study|Withdrawal by Subject|5|||
37915849|NCT00827541|69602676|FG000|Overall Study|Exitus|1|||
37915850|NCT00827541|69602677|FG001|Overall Study|Exitus|8|||
37728692|NCT01400932|69207934|FG001|Overall Study|Withdrawal by Subject|6|||
37728693|NCT01400932|69207933|FG000|Overall Study|Lost to Follow-up|1|||
37728694|NCT01400932|69207934|FG001|Overall Study|Lost to Follow-up|0|||
37728695|NCT01400932|69207933|FG000|Overall Study|Protocol Deviation|0|||
37728696|NCT01400932|69207934|FG001|Overall Study|Protocol Deviation|1|||
37728697|NCT01400932|69207933|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
37728698|NCT01400932|69207934|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
37728699|NCT01400698|69207944|FG000|Overall Study|Lost to Follow-up|2|||
37728700|NCT01400698|69207945|FG001|Overall Study|Lost to Follow-up|5|||
37728701|NCT01400698|69207946|FG002|Overall Study|Lost to Follow-up|2|||
37728702|NCT01400698|69207947|FG003|Overall Study|Lost to Follow-up|1|||
37728703|NCT01400698|69207948|FG004|Overall Study|Lost to Follow-up|4|||
37728704|NCT01400698|69207949|FG005|Overall Study|Lost to Follow-up|3|||
37728705|NCT01400698|69207944|FG000|Overall Study|Withdrawal by Subject|8|||
37843152|NCT02760433|69527921|FG000|Overall Study|Lack of Response At Week 14|0|||
37915851|NCT00827541|69602676|FG000|Overall Study|Other|1|||
37843153|NCT02760433|69527922|FG001|Overall Study|Lack of Response At Week 14|0|||
37843154|NCT02760433|69527923|FG002|Overall Study|Lack of Response At Week 14|0|||
37843155|NCT02760433|69527924|FG003|Overall Study|Lack of Response At Week 14|0|||
37843156|NCT02760433|69527925|FG004|Overall Study|Lack of Response At Week 14|1|||
37843157|NCT02760433|69527921|FG000|Overall Study|Subject refused to continue the study|1|||
37843158|NCT02760433|69527922|FG001|Overall Study|Subject refused to continue the study|0|||
37843159|NCT02760433|69527923|FG002|Overall Study|Subject refused to continue the study|0|||
37843160|NCT02760433|69527924|FG003|Overall Study|Subject refused to continue the study|0|||
37843161|NCT02760433|69527925|FG004|Overall Study|Subject refused to continue the study|0|||
37843162|NCT02760433|69527921|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
37843163|NCT02760433|69527922|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
37843164|NCT02760433|69527923|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
37843165|NCT02760433|69527924|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
37843166|NCT02760433|69527925|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
37843167|NCT02760433|69527921|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
37843168|NCT02760433|69527922|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
37843169|NCT02760433|69527923|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
37843170|NCT02760433|69527924|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
37843171|NCT02760433|69527925|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
37843172|NCT02760407|69527945|FG000|Overall Study|Death|2|||
37843173|NCT02760407|69527946|FG001|Overall Study|Death|3|||
37843174|NCT02760407|69527947|FG002|Overall Study|Death|1|||
37843175|NCT02760407|69527948|FG003|Overall Study|Death|1|||
37843176|NCT02760407|69527945|FG000|Overall Study|Lost to Follow-up|1|||
37843177|NCT02760407|69527946|FG001|Overall Study|Lost to Follow-up|7|||
37843178|NCT02760407|69527947|FG002|Overall Study|Lost to Follow-up|4|||
37843179|NCT02760407|69527948|FG003|Overall Study|Lost to Follow-up|6|||
37843180|NCT02760407|69527945|FG000|Overall Study|Withdrawal by Subject|25|||
37843181|NCT02760407|69527946|FG001|Overall Study|Withdrawal by Subject|31|||
37843182|NCT02760407|69527947|FG002|Overall Study|Withdrawal by Subject|37|||
37843183|NCT02760407|69527948|FG003|Overall Study|Withdrawal by Subject|25|||
37843184|NCT02760407|69527945|FG000|Overall Study|Violation of Eligibility criteria|0|||
37843185|NCT02760407|69527946|FG001|Overall Study|Violation of Eligibility criteria|0|||
37728706|NCT01400698|69207945|FG001|Overall Study|Withdrawal by Subject|2|||
37728707|NCT01400698|69207946|FG002|Overall Study|Withdrawal by Subject|0|||
37728708|NCT01400698|69207947|FG003|Overall Study|Withdrawal by Subject|4|||
37728709|NCT01400698|69207948|FG004|Overall Study|Withdrawal by Subject|1|||
37728710|NCT01400698|69207949|FG005|Overall Study|Withdrawal by Subject|3|||
37728711|NCT01400698|69207944|FG000|Overall Study|Protocol Violation|0|||
37728712|NCT01400698|69207945|FG001|Overall Study|Protocol Violation|1|||
37728713|NCT01400698|69207946|FG002|Overall Study|Protocol Violation|0|||
37728714|NCT01400698|69207947|FG003|Overall Study|Protocol Violation|0|||
37728715|NCT01400698|69207948|FG004|Overall Study|Protocol Violation|1|||
37728716|NCT01400698|69207949|FG005|Overall Study|Protocol Violation|0|||
37728717|NCT01400698|69207944|FG000|Overall Study|Non-compliance|0|||
37728718|NCT01400698|69207945|FG001|Overall Study|Non-compliance|1|||
37728719|NCT01400698|69207946|FG002|Overall Study|Non-compliance|0|||
37728720|NCT01400698|69207947|FG003|Overall Study|Non-compliance|1|||
37728721|NCT01400698|69207948|FG004|Overall Study|Non-compliance|0|||
37728722|NCT01400698|69207949|FG005|Overall Study|Non-compliance|0|||
37728723|NCT01400698|69207944|FG000|Overall Study|Adverse Event|1|||
37728724|NCT01400698|69207945|FG001|Overall Study|Adverse Event|0|||
37843186|NCT02760407|69527947|FG002|Overall Study|Violation of Eligibility criteria|1|||
37843187|NCT02760407|69527948|FG003|Overall Study|Violation of Eligibility criteria|1|||
37843188|NCT02760407|69527945|FG000|Overall Study|Personal reasons|0|||
37843189|NCT02760407|69527946|FG001|Overall Study|Personal reasons|0|||
37843190|NCT02760407|69527947|FG002|Overall Study|Personal reasons|0|||
37843191|NCT02760407|69527948|FG003|Overall Study|Personal reasons|1|||
37843192|NCT02760407|69527945|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
37843193|NCT02760407|69527946|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
37843194|NCT02760407|69527947|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
37843195|NCT02760407|69527948|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
37843196|NCT02760407|69527945|FG000|Overall Study|Use of prohibited Medication|0|||
37843197|NCT02760407|69527946|FG001|Overall Study|Use of prohibited Medication|0|||
37843198|NCT02760407|69527947|FG002|Overall Study|Use of prohibited Medication|1|||
37915852|NCT00827541|69602677|FG001|Overall Study|Other|3|||
37728725|NCT01400698|69207946|FG002|Overall Study|Adverse Event|0|||
37728726|NCT01400698|69207947|FG003|Overall Study|Adverse Event|0|||
37728727|NCT01400698|69207948|FG004|Overall Study|Adverse Event|0|||
37843199|NCT02760407|69527948|FG003|Overall Study|Use of prohibited Medication|0|||
37843200|NCT02760407|69527945|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
37843201|NCT02760407|69527946|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
37843202|NCT02760407|69527947|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
37843203|NCT02760407|69527948|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
37843204|NCT02760407|69527945|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
37843205|NCT02760407|69527946|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
37843206|NCT02760407|69527947|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
37843207|NCT02760407|69527948|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
37843208|NCT02760407|69527945|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
37843209|NCT02760407|69527946|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
37843210|NCT02760407|69527947|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
37843211|NCT02760407|69527948|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
37843212|NCT02760407|69527945|FG000|Overall Study|Inadequately Enrolled|0|||
37843213|NCT02760407|69527946|FG001|Overall Study|Inadequately Enrolled|0|||
37843214|NCT02760407|69527947|FG002|Overall Study|Inadequately Enrolled|0|||
37843215|NCT02760407|69527948|FG003|Overall Study|Inadequately Enrolled|1|||
37843216|NCT02760407|69527945|FG000|Overall Study|Withdrawal By PI's Decision|0|||
37843217|NCT02760407|69527946|FG001|Overall Study|Withdrawal By PI's Decision|1|||
37843218|NCT02760407|69527947|FG002|Overall Study|Withdrawal By PI's Decision|0|||
37843219|NCT02760407|69527948|FG003|Overall Study|Withdrawal By PI's Decision|0|||
37843220|NCT02760407|69527945|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
37843221|NCT02760407|69527946|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
37843222|NCT02760407|69527947|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
37843223|NCT02760407|69527948|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
37843224|NCT02760407|69527945|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
37843225|NCT02760407|69527946|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
37843226|NCT02760407|69527947|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
37843227|NCT02760407|69527948|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
37843228|NCT02760407|69527945|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
37843229|NCT02760407|69527946|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
37843230|NCT02760407|69527947|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
37843231|NCT02760407|69527948|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
37843232|NCT02760407|69527945|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
37843233|NCT02760407|69527946|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
37843234|NCT02760407|69527947|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
37843235|NCT02760407|69527948|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
37843236|NCT02760407|69527945|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
37843237|NCT02760407|69527946|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
37843238|NCT02760407|69527947|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
37843239|NCT02760407|69527948|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
37843240|NCT02760407|69527945|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
37915853|NCT00827541|69602676|FG000|Overall Study|Pathogen not susceptible|1|||
37915854|NCT00827541|69602677|FG001|Overall Study|Pathogen not susceptible|0|||
37915855|NCT00827541|69602676|FG000|Overall Study|Lack of effectiveness|1|||
37915856|NCT00827541|69602677|FG001|Overall Study|Lack of effectiveness|0|||
37915857|NCT00518323|69602687|FG000|Overall Study|Lack of Efficacy|14|||
37915858|NCT00518323|69602688|FG001|Overall Study|Lack of Efficacy|2|||
37915859|NCT00518323|69602689|FG002|Overall Study|Lack of Efficacy|4|||
37728728|NCT01400698|69207949|FG005|Overall Study|Adverse Event|0|||
37728729|NCT01400698|69207944|FG000|Overall Study|Other|4|||
37728730|NCT01400698|69207945|FG001|Overall Study|Other|2|||
37728731|NCT01400698|69207946|FG002|Overall Study|Other|0|||
37728732|NCT01400698|69207947|FG003|Overall Study|Other|2|||
37728733|NCT01400698|69207948|FG004|Overall Study|Other|1|||
37728734|NCT01400698|69207949|FG005|Overall Study|Other|0|||
37728735|NCT01890746|69207961|FG000|Overall Study|Death|39|||
37728736|NCT01890746|69207962|FG001|Overall Study|Death|30|||
37728737|NCT01890746|69207961|FG000|Overall Study|Adverse Event|1|||
37728738|NCT01890746|69207962|FG001|Overall Study|Adverse Event|0|||
37728739|NCT01890746|69207961|FG000|Overall Study|Lost to Follow-up|4|||
37728740|NCT01890746|69207962|FG001|Overall Study|Lost to Follow-up|1|||
37728741|NCT01890746|69207961|FG000|Overall Study|Physician Decision|3|||
37728742|NCT01890746|69207962|FG001|Overall Study|Physician Decision|2|||
37728743|NCT01890746|69207961|FG000|Overall Study|Withdrawal by Subject|5|||
37728744|NCT01890746|69207962|FG001|Overall Study|Withdrawal by Subject|8|||
37728745|NCT01422304|69207970|FG000|Overall Study|Adverse Event|0|||
37728746|NCT01422304|69207971|FG001|Overall Study|Adverse Event|1|||
37728747|NCT01422304|69207970|FG000|Overall Study|Lost to Follow-up|14|||
37728748|NCT01422304|69207971|FG001|Overall Study|Lost to Follow-up|20|||
37728749|NCT01422304|69207970|FG000|Overall Study|Never Entered Follow-up|2|||
37728750|NCT01422304|69207971|FG001|Overall Study|Never Entered Follow-up|1|||
37728751|NCT01422304|69207970|FG000|Overall Study|Protocol Violation|1|||
37728752|NCT01422304|69207971|FG001|Overall Study|Protocol Violation|0|||
37728753|NCT01422304|69207970|FG000|Overall Study|Withdrawal by Subject|4|||
37728754|NCT01422304|69207971|FG001|Overall Study|Withdrawal by Subject|2|||
37728755|NCT01422304|69207970|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
37728756|NCT01422304|69207971|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
37728757|NCT01422304|69207970|FG000|Overall Study|Not Treated|3|||
37728758|NCT01422304|69207971|FG001|Overall Study|Not Treated|11|||
37728759|NCT01387516|69207981|FG000|Overall Study|Lost to Follow-up|4|||
37728760|NCT01387516|69207982|FG001|Overall Study|Lost to Follow-up|4|||
37728761|NCT01387516|69207983|FG002|Overall Study|Lost to Follow-up|2|||
37728762|NCT01387516|69207984|FG003|Overall Study|Lost to Follow-up|3|||
37728763|NCT01387516|69207981|FG000|Overall Study|Withdrawal by Subject|1|||
37728764|NCT01387516|69207982|FG001|Overall Study|Withdrawal by Subject|1|||
37728765|NCT01387516|69207983|FG002|Overall Study|Withdrawal by Subject|2|||
37843241|NCT02760407|69527946|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
37843242|NCT02760407|69527947|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
37843243|NCT02760407|69527948|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
37843244|NCT02760407|69527945|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
37843245|NCT02760407|69527946|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
37728766|NCT01387516|69207984|FG003|Overall Study|Withdrawal by Subject|0|||
37728767|NCT01387516|69207981|FG000|Overall Study|Death|0|||
37728768|NCT01387516|69207982|FG001|Overall Study|Death|0|||
37728769|NCT01387516|69207983|FG002|Overall Study|Death|0|||
37728770|NCT01387516|69207984|FG003|Overall Study|Death|1|||
37728771|NCT01421134|69208005|FG000|Overall Study|Adverse Event|3|||
37728772|NCT01421134|69208006|FG001|Overall Study|Adverse Event|5|||
37728773|NCT01421134|69208005|FG000|Overall Study|Lack of Efficacy|2|||
37728774|NCT01421134|69208006|FG001|Overall Study|Lack of Efficacy|4|||
37728775|NCT01421134|69208005|FG000|Overall Study|Protocol Violation|0|||
37728776|NCT01421134|69208006|FG001|Overall Study|Protocol Violation|3|||
37728777|NCT01421134|69208005|FG000|Overall Study|Withdrawal by Subject|1|||
37728778|NCT01421134|69208006|FG001|Overall Study|Withdrawal by Subject|1|||
37728779|NCT01421134|69208005|FG000|Overall Study|Administrative|0|||
37728780|NCT01421134|69208006|FG001|Overall Study|Administrative|1|||
37728781|NCT01421134|69208005|FG000|Overall Study|Lost to Follow-up|1|||
37728782|NCT01421134|69208006|FG001|Overall Study|Lost to Follow-up|1|||
37728783|NCT01894022|69208014|FG000|Overall Study|Death|1|||
37728784|NCT01894022|69208015|FG001|Overall Study|Death|0|||
37728785|NCT01894022|69208014|FG000|Overall Study|Adverse Event, non-fatal|1|||
37728786|NCT01894022|69208015|FG001|Overall Study|Adverse Event, non-fatal|0|||
37728787|NCT01894022|69208014|FG000|Overall Study|Study Closed/terminated|7|||
37728788|NCT01894022|69208015|FG001|Overall Study|Study Closed/terminated|10|||
37728789|NCT01615328|69208024|FG000|Overall Study|Lost to Follow-up|3|||
37728790|NCT01615328|69208025|FG001|Overall Study|Lost to Follow-up|5|||
37728791|NCT01890512|69208035|FG000|Overall Study|Physician Decision|1|||
37728792|NCT01890512|69208035|FG000|Overall Study|Withdrawal by Subject|1|||
37728793|NCT01890512|69208035|FG000|Overall Study|Protocol Violation|1|||
37728794|NCT01387282|69208041|FG000|Overall Study|Death|47|||
37728795|NCT01387282|69208042|FG001|Overall Study|Death|16|||
37728796|NCT01387282|69208041|FG000|Overall Study|Other|5|||
37728797|NCT01387282|69208042|FG001|Overall Study|Other|1|||
37728798|NCT01387282|69208041|FG000|Overall Study|Unrelated AE|6|||
37843246|NCT02760407|69527947|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
37728799|NCT01387282|69208042|FG001|Overall Study|Unrelated AE|4|||
37728800|NCT01387282|69208041|FG000|Overall Study|Withdrawal by patient|33|||
37728801|NCT01387282|69208042|FG001|Overall Study|Withdrawal by patient|23|||
37728802|NCT01387282|69208041|FG000|Overall Study|Study drug-related AE|2|||
37843247|NCT02760407|69527948|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
37728803|NCT01387282|69208042|FG001|Overall Study|Study drug-related AE|2|||
37728804|NCT01387282|69208041|FG000|Overall Study|Lost to Follow-up|4|||
37728805|NCT01387282|69208042|FG001|Overall Study|Lost to Follow-up|1|||
37728806|NCT01386970|69208050|FG000|Overall Study|Withdrawal by Subject|0|||
37728807|NCT01386970|69208051|FG001|Overall Study|Withdrawal by Subject|1|||
37728808|NCT01386970|69208050|FG000|Overall Study|Adverse Event|4|||
37728809|NCT01386970|69208051|FG001|Overall Study|Adverse Event|1|||
37915860|NCT00518323|69602690|FG003|Overall Study|Lack of Efficacy|20|||
37728810|NCT01890434|69208059|FG000|Overall Study|Adverse Event|8|||
37728811|NCT01890434|69208059|FG000|Overall Study|PCI at external hospital|1|||
37728812|NCT01890434|69208059|FG000|Overall Study|Assessment discrepancy|1|||
37728813|NCT01890434|69208059|FG000|Overall Study|CRC didn't contact participant for FU|1|||
37728814|NCT01890434|69208059|FG000|Overall Study|Could not get whole set of images|1|||
37728815|NCT01890434|69208059|FG000|Overall Study|Decline to return for GSPECT|1|||
37728816|NCT01890434|69208059|FG000|Overall Study|GSPECT at rest was not done|1|||
37728817|NCT01890434|69208059|FG000|Overall Study|Participant didn't complete MRI|1|||
37728818|NCT01890434|69208059|FG000|Overall Study|Uncontactable by phone|1|||
37728819|NCT01890434|69208059|FG000|Overall Study|Moved out of position|1|||
37728820|NCT01890434|69208059|FG000|Overall Study|Unable to contact|1|||
37728821|NCT01890434|69208059|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
37728822|NCT01385566|69208069|FG000|Overall Study|Lost to Follow-up|1|||
37728823|NCT01385566|69208070|FG001|Overall Study|Lost to Follow-up|0|||
37728824|NCT01385566|69208071|FG002|Overall Study|Lost to Follow-up|0|||
37728825|NCT01385566|69208072|FG003|Overall Study|Lost to Follow-up|0|||
37728826|NCT01385566|69208073|FG004|Overall Study|Lost to Follow-up|0|||
37728827|NCT01385566|69208074|FG005|Overall Study|Lost to Follow-up|0|||
37728828|NCT01385566|69208069|FG000|Overall Study|Withdrawal by Subject|0|||
37728829|NCT01385566|69208070|FG001|Overall Study|Withdrawal by Subject|0|||
37728830|NCT01385566|69208071|FG002|Overall Study|Withdrawal by Subject|0|||
37728831|NCT01385566|69208072|FG003|Overall Study|Withdrawal by Subject|1|||
37728832|NCT01385566|69208073|FG004|Overall Study|Withdrawal by Subject|0|||
37728833|NCT01385566|69208074|FG005|Overall Study|Withdrawal by Subject|0|||
37728834|NCT01780545|69208092|FG000|Overall Study|Withdrawal by Subject|3|||
37728835|NCT01780545|69208093|FG001|Overall Study|Withdrawal by Subject|1|||
37728836|NCT01780545|69208092|FG000|Overall Study|Lost to Follow-up|1|||
37728837|NCT01780545|69208093|FG001|Overall Study|Lost to Follow-up|1|||
37728838|NCT01780389|69208102|FG000|Overall Study|Adverse Event|1|||
37728839|NCT01778985|69208109|FG000|Overall Study|Lost to Follow-up|1|||
37728840|NCT01778985|69208110|FG001|Overall Study|Lost to Follow-up|0|||
37728841|NCT01778985|69208109|FG000|Overall Study|Physician Decision|2|||
37728842|NCT01778985|69208110|FG001|Overall Study|Physician Decision|2|||
37728843|NCT01778985|69208109|FG000|Overall Study|Protocol Violation|4|||
37728844|NCT01778985|69208110|FG001|Overall Study|Protocol Violation|1|||
37728845|NCT01778751|69208118|FG000|Overall Study|Lost to Follow-up|1|||
37728846|NCT01778751|69208119|FG001|Overall Study|Lost to Follow-up|0|||
37728847|NCT01778751|69208118|FG000|Overall Study|Withdrawal by Subject|0|||
37728848|NCT01778751|69208119|FG001|Overall Study|Withdrawal by Subject|2|||
37728849|NCT01778751|69208118|FG000|Overall Study|Transfered care|1|||
37728850|NCT01778751|69208119|FG001|Overall Study|Transfered care|0|||
37728851|NCT01865084|69208128|FG000|Double Blind Period (DB)|Adverse Event|2|||
37843248|NCT02760407|69527945|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
37843249|NCT02760407|69527946|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
37843250|NCT02760407|69527947|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
37843251|NCT02760407|69527948|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
37843252|NCT02760407|69527945|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
37843253|NCT02760407|69527946|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
37843254|NCT02760407|69527947|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
37843255|NCT02760407|69527948|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
37843256|NCT02760368|69527964|FG000|Overall Study|Withdrawal by Subject|8|||
37843257|NCT02760368|69527965|FG001|Overall Study|Withdrawal by Subject|12|||
37843258|NCT02760368|69527966|FG002|Overall Study|Withdrawal by Subject|9|||
37843259|NCT02760368|69527964|FG000|Overall Study|Screen Failure|0|||
37843260|NCT02760368|69527965|FG001|Overall Study|Screen Failure|0|||
37843261|NCT02760368|69527966|FG002|Overall Study|Screen Failure|1|||
37843262|NCT02760368|69527964|FG000|Overall Study|Death|0|||
37843263|NCT02760368|69527965|FG001|Overall Study|Death|1|||
37843264|NCT02760368|69527966|FG002|Overall Study|Death|0|||
37843265|NCT02760368|69527964|FG000|Overall Study|Withdrawal by Sponsor|0|||
37843266|NCT02760368|69527965|FG001|Overall Study|Withdrawal by Sponsor|0|||
37843267|NCT02760368|69527966|FG002|Overall Study|Withdrawal by Sponsor|1|||
37843268|NCT02747004|69527980|FG000|Overall Study|Withdrawal by Subject|8|||
37843269|NCT02747004|69527981|FG001|Overall Study|Withdrawal by Subject|5|||
37843270|NCT02747004|69527982|FG002|Overall Study|Withdrawal by Subject|4|||
37843271|NCT02747004|69527980|FG000|Overall Study|Lost to Follow-up|1|||
37843272|NCT02747004|69527981|FG001|Overall Study|Lost to Follow-up|2|||
37728852|NCT01865084|69208129|FG001|Double Blind Period (DB)|Adverse Event|2|||
37728853|NCT01865084|69208130|FG002|Double Blind Period (DB)|Adverse Event|1|||
37728854|NCT01865084|69208128|FG000|Double Blind Period (DB)|Protocol Violation|0|||
37728855|NCT01865084|69208129|FG001|Double Blind Period (DB)|Protocol Violation|0|||
37728856|NCT01865084|69208130|FG002|Double Blind Period (DB)|Protocol Violation|1|||
37728857|NCT01865084|69208128|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
37728858|NCT01865084|69208129|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
37843273|NCT02747004|69527982|FG002|Overall Study|Lost to Follow-up|2|||
37843274|NCT02747004|69527980|FG000|Overall Study|on study treatment/follow-up|48|||
37728859|NCT01865084|69208130|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
37843275|NCT02747004|69527981|FG001|Overall Study|on study treatment/follow-up|42|||
37843276|NCT02747004|69527982|FG002|Overall Study|on study treatment/follow-up|41|||
37728860|NCT01865084|69208128|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
37728861|NCT01865084|69208129|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
37728862|NCT01865084|69208130|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
37728863|NCT01865084|69208128|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
37728864|NCT01865084|69208129|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
37728865|NCT01865084|69208130|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
37728866|NCT01865084|69208128|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
37728867|NCT01865084|69208129|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
37728868|NCT01865084|69208130|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
37728869|NCT01865084|69208128|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
37728870|NCT01865084|69208129|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
37728871|NCT01865084|69208130|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
37728872|NCT01865084|69208128|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
37728873|NCT01865084|69208129|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
37728874|NCT01865084|69208130|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
37728875|NCT01865084|69208128|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
37728876|NCT01865084|69208129|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
38025553|NCT04369430|69709995|FG001|Overall Study|Lost to Follow-up|1|||
38025554|NCT04363736|69710003|FG000|Overall Study|Withdrawal by Subject|1|||
37728877|NCT01865084|69208130|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
37728878|NCT01778127|69208145|FG000|Overall Study|Lost to Follow-up|5|||
37728879|NCT01778127|69208146|FG001|Overall Study|Lost to Follow-up|1|||
37728880|NCT01778127|69208147|FG002|Overall Study|Lost to Follow-up|2|||
37728881|NCT01778127|69208145|FG000|Overall Study|Withdrawal by Subject|3|||
37728882|NCT01778127|69208146|FG001|Overall Study|Withdrawal by Subject|1|||
37728883|NCT01778127|69208147|FG002|Overall Study|Withdrawal by Subject|4|||
37728884|NCT01892540|69208158|FG000|Overall Study|Did not complete PET/MRI|0|||
37728885|NCT01892540|69208159|FG001|Overall Study|Did not complete PET/MRI|0|||
37728886|NCT01892540|69208160|FG002|Overall Study|Did not complete PET/MRI|2|||
37728887|NCT01892540|69208158|FG000|Overall Study|Did not fit in scanner|0|||
37728888|NCT01892540|69208159|FG001|Overall Study|Did not fit in scanner|0|||
37728889|NCT01892540|69208160|FG002|Overall Study|Did not fit in scanner|1|||
37728890|NCT01385098|69208168|FG000|Overall Study|Adverse Event|10|||
37728891|NCT01385098|69208168|FG000|Overall Study|Lost to Follow-up|4|||
37728892|NCT01398514|69208176|FG000|Overall Study|Adverse Event|1|||
37728893|NCT01398514|69208177|FG001|Overall Study|Adverse Event|0|||
37728894|NCT01398514|69208176|FG000|Overall Study|Non-compliance with study procedures|2|||
37728895|NCT01398514|69208177|FG001|Overall Study|Non-compliance with study procedures|0|||
37728896|NCT01398514|69208176|FG000|Overall Study|Physiologic non-responsiveness|1|||
37728897|NCT01398514|69208177|FG001|Overall Study|Physiologic non-responsiveness|3|||
37728898|NCT01398514|69208176|FG000|Overall Study|Failure to show a conditioned response|4|||
37728899|NCT01398514|69208177|FG001|Overall Study|Failure to show a conditioned response|3|||
37728900|NCT01398358|69208188|FG000|Overall Study|Lost to Follow-up|11|||
37728901|NCT01398358|69208189|FG001|Overall Study|Lost to Follow-up|21|||
37728902|NCT01398358|69208190|FG002|Overall Study|Lost to Follow-up|18|||
37728903|NCT01398358|69208188|FG000|Overall Study|Withdrawal by Subject|3|||
37728904|NCT01398358|69208189|FG001|Overall Study|Withdrawal by Subject|2|||
37728905|NCT01398358|69208190|FG002|Overall Study|Withdrawal by Subject|2|||
37728906|NCT01398358|69208188|FG000|Overall Study|no longer eligible|1|||
37728907|NCT01398358|69208189|FG001|Overall Study|no longer eligible|0|||
37728908|NCT01398358|69208190|FG002|Overall Study|no longer eligible|1|||
37728909|NCT01778049|69208200|FG000|Open Label Treatment Period|Adverse Event|5|||
37728910|NCT01778049|69208201|FG001|Open Label Treatment Period|Adverse Event|15|||
37728911|NCT01778049|69208202|FG002|Open Label Treatment Period|Adverse Event|0|||
37728912|NCT01778049|69208203|FG003|Open Label Treatment Period|Adverse Event|0|||
37843277|NCT02741570|69527992|FG000|Pre-Treatment Period|Other reasons|0|||
37843278|NCT02741570|69527993|FG001|Pre-Treatment Period|Other reasons|3|||
37843279|NCT02741570|69527992|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
37843280|NCT02741570|69527993|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
37843281|NCT02741570|69527992|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
37843282|NCT02741570|69527993|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
37843283|NCT02741570|69527992|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
37843284|NCT02741570|69527993|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
37843285|NCT02741570|69527992|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
37843286|NCT02741570|69527993|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
37843287|NCT02741570|69527992|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
37728913|NCT01778049|69208204|FG004|Open Label Treatment Period|Adverse Event|0|||
37843288|NCT02741570|69527993|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
37843289|NCT02741570|69527992|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
37843290|NCT02741570|69527993|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
37843291|NCT02741570|69527992|FG000|Pre-Treatment Period|Death|0|||
37843292|NCT02741570|69527993|FG001|Pre-Treatment Period|Death|1|||
37843293|NCT02741570|69527992|FG000|Pre-Treatment Period|Disease progression|0|||
37843294|NCT02741570|69527993|FG001|Pre-Treatment Period|Disease progression|1|||
37843295|NCT02741570|69527992|FG000|Treatment Period|Other reasons|47|||
37843296|NCT02741570|69527993|FG001|Treatment Period|Other reasons|12|||
37843297|NCT02741570|69527992|FG000|Treatment Period|Poor/non-compliance|0|||
37728914|NCT01778049|69208205|FG005|Open Label Treatment Period|Adverse Event|0|||
37728915|NCT01778049|69208200|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
37728916|NCT01778049|69208201|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
37728917|NCT01778049|69208202|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
37728918|NCT01778049|69208203|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
37728919|NCT01778049|69208204|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
37728920|NCT01778049|69208205|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
37728921|NCT01778049|69208200|FG000|Open Label Treatment Period|Protocol Violation|5|||
37728922|NCT01778049|69208201|FG001|Open Label Treatment Period|Protocol Violation|5|||
37728923|NCT01778049|69208202|FG002|Open Label Treatment Period|Protocol Violation|0|||
37728924|NCT01778049|69208203|FG003|Open Label Treatment Period|Protocol Violation|0|||
37728925|NCT01778049|69208204|FG004|Open Label Treatment Period|Protocol Violation|0|||
37728926|NCT01778049|69208205|FG005|Open Label Treatment Period|Protocol Violation|0|||
37728927|NCT01778049|69208200|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
37728928|NCT01778049|69208201|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
37728929|NCT01778049|69208202|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
37728930|NCT01778049|69208203|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
37728931|NCT01778049|69208204|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
37728932|NCT01778049|69208205|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
37728933|NCT01778049|69208200|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
37728934|NCT01778049|69208201|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
37728935|NCT01778049|69208202|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
37728936|NCT01778049|69208203|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
37728937|NCT01778049|69208204|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
37728938|NCT01778049|69208205|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
37728939|NCT01778049|69208200|FG000|Open Label Treatment Period|Not treated|2|||
37728940|NCT01778049|69208201|FG001|Open Label Treatment Period|Not treated|1|||
37728941|NCT01778049|69208202|FG002|Open Label Treatment Period|Not treated|0|||
37728942|NCT01778049|69208203|FG003|Open Label Treatment Period|Not treated|0|||
37728943|NCT01778049|69208204|FG004|Open Label Treatment Period|Not treated|0|||
37728944|NCT01778049|69208205|FG005|Open Label Treatment Period|Not treated|0|||
37728945|NCT01778049|69208200|FG000|Open Label Treatment Period|Other reason not defined above|77|||
37728946|NCT01778049|69208201|FG001|Open Label Treatment Period|Other reason not defined above|94|||
37728947|NCT01778049|69208202|FG002|Open Label Treatment Period|Other reason not defined above|0|||
37728948|NCT01778049|69208203|FG003|Open Label Treatment Period|Other reason not defined above|0|||
37728949|NCT01778049|69208204|FG004|Open Label Treatment Period|Other reason not defined above|0|||
37728950|NCT01778049|69208205|FG005|Open Label Treatment Period|Other reason not defined above|0|||
37728951|NCT01778049|69208200|FG000|Double Blind Treatment Period|Adverse Event|0|||
37728952|NCT01778049|69208201|FG001|Double Blind Treatment Period|Adverse Event|0|||
37728953|NCT01778049|69208202|FG002|Double Blind Treatment Period|Adverse Event|4|||
37728954|NCT01778049|69208203|FG003|Double Blind Treatment Period|Adverse Event|5|||
37728955|NCT01778049|69208204|FG004|Double Blind Treatment Period|Adverse Event|3|||
37728956|NCT01778049|69208205|FG005|Double Blind Treatment Period|Adverse Event|2|||
37728957|NCT01778049|69208200|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
37728958|NCT01778049|69208201|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
37728959|NCT01778049|69208202|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
37843298|NCT02741570|69527993|FG001|Treatment Period|Poor/non-compliance|2|||
37843299|NCT02741570|69527992|FG000|Treatment Period|Maximum clinical benefit|4|||
37843300|NCT02741570|69527993|FG001|Treatment Period|Maximum clinical benefit|6|||
37843301|NCT02741570|69527992|FG000|Treatment Period|Lost to Follow-up|1|||
37843302|NCT02741570|69527993|FG001|Treatment Period|Lost to Follow-up|3|||
37843303|NCT02741570|69527992|FG000|Treatment Period|Participant withdrew consent|9|||
37915861|NCT00518323|69602687|FG000|Overall Study|Withdrawal by Subject|1|||
37915862|NCT00518323|69602688|FG001|Overall Study|Withdrawal by Subject|2|||
37728960|NCT01778049|69208203|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
37843304|NCT02741570|69527993|FG001|Treatment Period|Participant withdrew consent|13|||
37843305|NCT02741570|69527992|FG000|Treatment Period|Participant request to discontinue treatment|8|||
37843306|NCT02741570|69527993|FG001|Treatment Period|Participant request to discontinue treatment|23|||
37843307|NCT02741570|69527992|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
37843308|NCT02741570|69527993|FG001|Treatment Period|Adverse event unrelated to study drug|26|||
37843309|NCT02741570|69527992|FG000|Treatment Period|Death|9|||
37843310|NCT02741570|69527993|FG001|Treatment Period|Death|7|||
37843311|NCT02741570|69527992|FG000|Treatment Period|Study drug toxicity|55|||
37843312|NCT02741570|69527993|FG001|Treatment Period|Study drug toxicity|47|||
37843313|NCT02741570|69527992|FG000|Treatment Period|Disease progression|294|||
37843314|NCT02741570|69527993|FG001|Treatment Period|Disease progression|301|||
37843315|NCT02741570|69527992|FG000|Treatment Period|Administrative reason by sponsor|0|||
37843316|NCT02741570|69527993|FG001|Treatment Period|Administrative reason by sponsor|1|||
37843317|NCT02675231|69528020|FG000|Overall Study|Withdrawal by Subject|1|||
37843318|NCT02675231|69528021|FG001|Overall Study|Withdrawal by Subject|3|||
37843319|NCT02675231|69528022|FG002|Overall Study|Withdrawal by Subject|1|||
37843320|NCT02675231|69528020|FG000|Overall Study|Lost to Follow-up|2|||
37843321|NCT02675231|69528021|FG001|Overall Study|Lost to Follow-up|2|||
37843322|NCT02675231|69528022|FG002|Overall Study|Lost to Follow-up|2|||
37843323|NCT02675231|69528020|FG000|Overall Study|On study treatment/follow up|23|||
37728961|NCT01778049|69208204|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
37728962|NCT01778049|69208205|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
37728963|NCT01778049|69208200|FG000|Double Blind Treatment Period|Protocol Violation|0|||
37728964|NCT01778049|69208201|FG001|Double Blind Treatment Period|Protocol Violation|0|||
37843324|NCT02675231|69528021|FG001|Overall Study|On study treatment/follow up|31|||
37843325|NCT02675231|69528022|FG002|Overall Study|On study treatment/follow up|23|||
37843326|NCT02603887|69528035|FG000|Stage 1|Adverse Event|4|||
37843327|NCT02603887|69528035|FG000|Stage 1|Disease progression|1|||
37843328|NCT02603887|69528035|FG000|Stage 2|FDA guidance|1|||
37843329|NCT02564900|69528054|FG000|Dose Escalation|Progressive disease per RECIST|2|||
37843330|NCT02564900|69528055|FG001|Dose Escalation|Progressive disease per RECIST|3|||
37843331|NCT02564900|69528056|FG002|Dose Escalation|Progressive disease per RECIST|3|||
37843332|NCT02564900|69528057|FG003|Dose Escalation|Progressive disease per RECIST|3|||
37843333|NCT02564900|69528058|FG004|Dose Escalation|Progressive disease per RECIST|3|||
37843334|NCT02564900|69528059|FG005|Dose Escalation|Progressive disease per RECIST|1|||
37843335|NCT02564900|69528060|FG006|Dose Escalation|Progressive disease per RECIST|0|||
37843336|NCT02564900|69528061|FG007|Dose Escalation|Progressive disease per RECIST|0|||
37843337|NCT02564900|69528062|FG008|Dose Escalation|Progressive disease per RECIST|0|||
37843338|NCT02564900|69528063|FG009|Dose Escalation|Progressive disease per RECIST|0|||
37843339|NCT02564900|69528064|FG010|Dose Escalation|Progressive disease per RECIST|0|||
37843340|NCT02564900|69528065|FG011|Dose Escalation|Progressive disease per RECIST|0|||
37843341|NCT02564900|69528066|FG012|Dose Escalation|Progressive disease per RECIST|0|||
37843342|NCT02564900|69528067|FG013|Dose Escalation|Progressive disease per RECIST|0|||
37843343|NCT02564900|69528068|FG014|Dose Escalation|Progressive disease per RECIST|0|||
37843344|NCT02564900|69528054|FG000|Dose Escalation|Ongoing|1|||
37843345|NCT02564900|69528055|FG001|Dose Escalation|Ongoing|0|||
37843346|NCT02564900|69528056|FG002|Dose Escalation|Ongoing|0|||
37843347|NCT02564900|69528057|FG003|Dose Escalation|Ongoing|2|||
37843348|NCT02564900|69528058|FG004|Dose Escalation|Ongoing|2|||
37843349|NCT02564900|69528059|FG005|Dose Escalation|Ongoing|2|||
37843350|NCT02564900|69528060|FG006|Dose Escalation|Ongoing|0|||
37843351|NCT02564900|69528061|FG007|Dose Escalation|Ongoing|0|||
37843352|NCT02564900|69528062|FG008|Dose Escalation|Ongoing|0|||
37843353|NCT02564900|69528063|FG009|Dose Escalation|Ongoing|0|||
37843354|NCT02564900|69528064|FG010|Dose Escalation|Ongoing|0|||
37843355|NCT02564900|69528065|FG011|Dose Escalation|Ongoing|0|||
37843356|NCT02564900|69528066|FG012|Dose Escalation|Ongoing|0|||
37915863|NCT00518323|69602689|FG002|Overall Study|Withdrawal by Subject|4|||
37915864|NCT00518323|69602690|FG003|Overall Study|Withdrawal by Subject|2|||
37915865|NCT00518323|69602687|FG000|Overall Study|Lost to Follow-up|0|||
37728965|NCT01778049|69208202|FG002|Double Blind Treatment Period|Protocol Violation|2|||
37843357|NCT02564900|69528067|FG013|Dose Escalation|Ongoing|0|||
37843358|NCT02564900|69528068|FG014|Dose Escalation|Ongoing|0|||
37843359|NCT02564900|69528054|FG000|Dose Escalation|Adverse Event|0|||
37843360|NCT02564900|69528055|FG001|Dose Escalation|Adverse Event|0|||
37843361|NCT02564900|69528056|FG002|Dose Escalation|Adverse Event|0|||
37843362|NCT02564900|69528057|FG003|Dose Escalation|Adverse Event|1|||
37843363|NCT02564900|69528058|FG004|Dose Escalation|Adverse Event|1|||
37843364|NCT02564900|69528059|FG005|Dose Escalation|Adverse Event|3|||
37843365|NCT02564900|69528060|FG006|Dose Escalation|Adverse Event|0|||
37843366|NCT02564900|69528061|FG007|Dose Escalation|Adverse Event|0|||
37843367|NCT02564900|69528062|FG008|Dose Escalation|Adverse Event|0|||
37843368|NCT02564900|69528063|FG009|Dose Escalation|Adverse Event|0|||
37843369|NCT02564900|69528064|FG010|Dose Escalation|Adverse Event|0|||
37843370|NCT02564900|69528065|FG011|Dose Escalation|Adverse Event|0|||
37843371|NCT02564900|69528066|FG012|Dose Escalation|Adverse Event|0|||
37843372|NCT02564900|69528067|FG013|Dose Escalation|Adverse Event|0|||
37843373|NCT02564900|69528068|FG014|Dose Escalation|Adverse Event|0|||
37843374|NCT02564900|69528054|FG000|Dose Expansion|Progressive disease per RECIST|0|||
37843375|NCT02564900|69528055|FG001|Dose Expansion|Progressive disease per RECIST|0|||
37728966|NCT01778049|69208203|FG003|Double Blind Treatment Period|Protocol Violation|0|||
37728967|NCT01778049|69208204|FG004|Double Blind Treatment Period|Protocol Violation|0|||
37728968|NCT01778049|69208205|FG005|Double Blind Treatment Period|Protocol Violation|0|||
37728969|NCT01778049|69208200|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
37728970|NCT01778049|69208201|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
37728971|NCT01778049|69208202|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
37728972|NCT01778049|69208203|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
37728973|NCT01778049|69208204|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
37728974|NCT01778049|69208205|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
37728975|NCT01778049|69208200|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
37728976|NCT01778049|69208201|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
37728977|NCT01778049|69208202|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
37728978|NCT01778049|69208203|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
37728979|NCT01778049|69208204|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
37728980|NCT01778049|69208205|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
37728981|NCT01778049|69208200|FG000|Double Blind Treatment Period|Not treated|0|||
37728982|NCT01778049|69208201|FG001|Double Blind Treatment Period|Not treated|0|||
37728983|NCT01778049|69208202|FG002|Double Blind Treatment Period|Not treated|0|||
37728984|NCT01778049|69208203|FG003|Double Blind Treatment Period|Not treated|2|||
37843376|NCT02564900|69528056|FG002|Dose Expansion|Progressive disease per RECIST|0|||
37843377|NCT02564900|69528057|FG003|Dose Expansion|Progressive disease per RECIST|0|||
37843378|NCT02564900|69528058|FG004|Dose Expansion|Progressive disease per RECIST|0|||
37728985|NCT01778049|69208204|FG004|Double Blind Treatment Period|Not treated|2|||
37728986|NCT01778049|69208205|FG005|Double Blind Treatment Period|Not treated|0|||
37728987|NCT01778049|69208200|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
37728988|NCT01778049|69208201|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
37728989|NCT01778049|69208202|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
37728990|NCT01778049|69208203|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
37843379|NCT02564900|69528059|FG005|Dose Expansion|Progressive disease per RECIST|0|||
37843380|NCT02564900|69528060|FG006|Dose Expansion|Progressive disease per RECIST|19|||
37843381|NCT02564900|69528061|FG007|Dose Expansion|Progressive disease per RECIST|17|||
37843382|NCT02564900|69528062|FG008|Dose Expansion|Progressive disease per RECIST|8|||
37843383|NCT02564900|69528063|FG009|Dose Expansion|Progressive disease per RECIST|16|||
37843384|NCT02564900|69528064|FG010|Dose Expansion|Progressive disease per RECIST|13|||
37843385|NCT02564900|69528065|FG011|Dose Expansion|Progressive disease per RECIST|19|||
37843386|NCT02564900|69528066|FG012|Dose Expansion|Progressive disease per RECIST|10|||
37843387|NCT02564900|69528067|FG013|Dose Expansion|Progressive disease per RECIST|13|||
37843388|NCT02564900|69528068|FG014|Dose Expansion|Progressive disease per RECIST|11|||
37843389|NCT02564900|69528054|FG000|Dose Expansion|Clinical progression|0|||
37843390|NCT02564900|69528055|FG001|Dose Expansion|Clinical progression|0|||
37728991|NCT01778049|69208204|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
37728992|NCT01778049|69208205|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
37728993|NCT01777581|69208219|FG000|Overall Study|Lost to Follow-up|1|||
37728994|NCT01777581|69208220|FG001|Overall Study|Lost to Follow-up|1|||
37728995|NCT01777581|69208219|FG000|Overall Study|Adverse Event|2|||
37728996|NCT01777581|69208220|FG001|Overall Study|Adverse Event|0|||
37728997|NCT01777581|69208219|FG000|Overall Study|Lack of Efficacy|0|||
37728998|NCT01777581|69208220|FG001|Overall Study|Lack of Efficacy|1|||
37728999|NCT01864148|69208231|FG000|Overall Study|Other|2|||
37729000|NCT01864148|69208232|FG001|Overall Study|Other|1|||
37729001|NCT01864148|69208233|FG002|Overall Study|Other|1|||
37729002|NCT01864148|69208234|FG003|Overall Study|Other|3|||
37729003|NCT01864148|69208235|FG004|Overall Study|Other|1|||
37729004|NCT01864148|69208231|FG000|Overall Study|Death|0|||
37729005|NCT01864148|69208232|FG001|Overall Study|Death|0|||
37729006|NCT01864148|69208233|FG002|Overall Study|Death|0|||
37729007|NCT01864148|69208234|FG003|Overall Study|Death|1|||
37729008|NCT01864148|69208235|FG004|Overall Study|Death|0|||
37729009|NCT01864148|69208231|FG000|Overall Study|Investigator Decision|5|||
37729010|NCT01864148|69208232|FG001|Overall Study|Investigator Decision|0|||
37915866|NCT00518323|69602688|FG001|Overall Study|Lost to Follow-up|2|||
37729011|NCT01864148|69208233|FG002|Overall Study|Investigator Decision|0|||
37729012|NCT01864148|69208234|FG003|Overall Study|Investigator Decision|4|||
37729013|NCT01864148|69208235|FG004|Overall Study|Investigator Decision|6|||
37843391|NCT02564900|69528056|FG002|Dose Expansion|Clinical progression|0|||
37915867|NCT00518323|69602689|FG002|Overall Study|Lost to Follow-up|1|||
37729014|NCT01864148|69208231|FG000|Overall Study|Withdrawal by Subject|9|||
37729015|NCT01864148|69208232|FG001|Overall Study|Withdrawal by Subject|2|||
37729016|NCT01864148|69208233|FG002|Overall Study|Withdrawal by Subject|6|||
37729017|NCT01864148|69208234|FG003|Overall Study|Withdrawal by Subject|8|||
37729018|NCT01864148|69208235|FG004|Overall Study|Withdrawal by Subject|8|||
37729019|NCT01864148|69208231|FG000|Overall Study|Lost to Follow-up|0|||
37729020|NCT01864148|69208232|FG001|Overall Study|Lost to Follow-up|0|||
37729021|NCT01864148|69208233|FG002|Overall Study|Lost to Follow-up|0|||
37729022|NCT01864148|69208234|FG003|Overall Study|Lost to Follow-up|2|||
37729023|NCT01864148|69208235|FG004|Overall Study|Lost to Follow-up|1|||
37729024|NCT01864148|69208231|FG000|Overall Study|Adverse Event|4|||
37729025|NCT01864148|69208232|FG001|Overall Study|Adverse Event|2|||
37729026|NCT01864148|69208233|FG002|Overall Study|Adverse Event|4|||
37729027|NCT01864148|69208234|FG003|Overall Study|Adverse Event|7|||
37729028|NCT01864148|69208235|FG004|Overall Study|Adverse Event|7|||
37729029|NCT01864148|69208231|FG000|Overall Study|Not Dosed|0|||
37729030|NCT01864148|69208232|FG001|Overall Study|Not Dosed|0|||
37729031|NCT01864148|69208233|FG002|Overall Study|Not Dosed|0|||
37729032|NCT01864148|69208234|FG003|Overall Study|Not Dosed|1|||
37729033|NCT01864148|69208235|FG004|Overall Study|Not Dosed|0|||
37729034|NCT01751139|69208252|FG000|Overall Study|Other|135|||
37729035|NCT01751139|69208252|FG000|Overall Study|Sponsor study termination|1609|||
37729036|NCT01751139|69208252|FG000|Overall Study|Lost to Follow-up|240|||
37729037|NCT01751139|69208252|FG000|Overall Study|Withdrawal by Subject|251|||
37729038|NCT01751139|69208252|FG000|Overall Study|Adverse Event|1|||
37729039|NCT01751139|69208252|FG000|Overall Study|Death|31|||
37729040|NCT01890122|69208260|FG000|Overall Study|Adverse Event|1|||
37729041|NCT01890122|69208261|FG001|Overall Study|Adverse Event|1|||
37729042|NCT01890122|69208262|FG002|Overall Study|Adverse Event|1|||
37729043|NCT01890122|69208263|FG003|Overall Study|Adverse Event|2|||
37729044|NCT01890122|69208260|FG000|Overall Study|Major Protocol Deviation|3|||
37729045|NCT01890122|69208261|FG001|Overall Study|Major Protocol Deviation|1|||
37729046|NCT01890122|69208262|FG002|Overall Study|Major Protocol Deviation|0|||
37729047|NCT01890122|69208263|FG003|Overall Study|Major Protocol Deviation|1|||
37729048|NCT01890122|69208260|FG000|Overall Study|Lost to Follow-up|0|||
37729049|NCT01890122|69208261|FG001|Overall Study|Lost to Follow-up|1|||
37729050|NCT01890122|69208262|FG002|Overall Study|Lost to Follow-up|2|||
37729051|NCT01890122|69208263|FG003|Overall Study|Lost to Follow-up|2|||
37729052|NCT01890122|69208260|FG000|Overall Study|Voluntary Withdrawal|8|||
37729053|NCT01890122|69208261|FG001|Overall Study|Voluntary Withdrawal|8|||
37729054|NCT01890122|69208262|FG002|Overall Study|Voluntary Withdrawal|2|||
37729055|NCT01890122|69208263|FG003|Overall Study|Voluntary Withdrawal|11|||
37729056|NCT01890122|69208260|FG000|Overall Study|Lack of Efficacy|14|||
37729057|NCT01890122|69208261|FG001|Overall Study|Lack of Efficacy|24|||
37729058|NCT01890122|69208262|FG002|Overall Study|Lack of Efficacy|7|||
37729059|NCT01890122|69208263|FG003|Overall Study|Lack of Efficacy|41|||
37729060|NCT01890122|69208260|FG000|Overall Study|Reason not Specified|0|||
37729061|NCT01890122|69208261|FG001|Overall Study|Reason not Specified|1|||
37729062|NCT01890122|69208262|FG002|Overall Study|Reason not Specified|1|||
37729063|NCT01890122|69208263|FG003|Overall Study|Reason not Specified|2|||
37729064|NCT01890122|69208260|FG000|Overall Study|Randomized but not Treated|1|||
37729065|NCT01890122|69208261|FG001|Overall Study|Randomized but not Treated|1|||
37729066|NCT01890122|69208262|FG002|Overall Study|Randomized but not Treated|0|||
37729067|NCT01890122|69208263|FG003|Overall Study|Randomized but not Treated|0|||
37729068|NCT01397890|69208275|FG000|Overall Study|Withdrawal by Subject|7|||
37729069|NCT01397890|69208276|FG001|Overall Study|Withdrawal by Subject|11|||
37843392|NCT02564900|69528057|FG003|Dose Expansion|Clinical progression|0|||
37843393|NCT02564900|69528058|FG004|Dose Expansion|Clinical progression|0|||
37843394|NCT02564900|69528059|FG005|Dose Expansion|Clinical progression|0|||
37843395|NCT02564900|69528060|FG006|Dose Expansion|Clinical progression|5|||
37843396|NCT02564900|69528061|FG007|Dose Expansion|Clinical progression|12|||
37843397|NCT02564900|69528062|FG008|Dose Expansion|Clinical progression|0|||
37729070|NCT01397890|69208275|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
37729071|NCT01397890|69208276|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
37729072|NCT01397890|69208275|FG000|Overall Study|Death|2|||
37729073|NCT01397890|69208276|FG001|Overall Study|Death|3|||
37729074|NCT01397890|69208275|FG000|Overall Study|Lost to Follow-up|1|||
37729075|NCT01397890|69208276|FG001|Overall Study|Lost to Follow-up|4|||
37729076|NCT01397890|69208275|FG000|Overall Study|Condition under Investigation Worsened|1|||
37729077|NCT01397890|69208276|FG001|Overall Study|Condition under Investigation Worsened|3|||
37729078|NCT01397890|69208275|FG000|Overall Study|Adverse Event|1|||
37729079|NCT01397890|69208276|FG001|Overall Study|Adverse Event|2|||
37729080|NCT01397890|69208275|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
37729081|NCT01397890|69208276|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
37729082|NCT01397890|69208275|FG000|Overall Study|Others|2|||
37729083|NCT01397890|69208276|FG001|Overall Study|Others|1|||
37843398|NCT02564900|69528063|FG009|Dose Expansion|Clinical progression|3|||
37843399|NCT02564900|69528064|FG010|Dose Expansion|Clinical progression|2|||
37729084|NCT01777269|69208284|FG000|Overall Study|Adverse Event|24|||
37729085|NCT01777269|69208285|FG001|Overall Study|Adverse Event|33|||
37729086|NCT01777269|69208284|FG000|Overall Study|Lack of Efficacy|8|||
37843400|NCT02564900|69528065|FG011|Dose Expansion|Clinical progression|0|||
37843401|NCT02564900|69528066|FG012|Dose Expansion|Clinical progression|1|||
37843402|NCT02564900|69528067|FG013|Dose Expansion|Clinical progression|3|||
37843403|NCT02564900|69528068|FG014|Dose Expansion|Clinical progression|1|||
37843404|NCT02564900|69528054|FG000|Dose Expansion|Adverse Event|0|||
37843405|NCT02564900|69528055|FG001|Dose Expansion|Adverse Event|0|||
37843406|NCT02564900|69528056|FG002|Dose Expansion|Adverse Event|0|||
37843407|NCT02564900|69528057|FG003|Dose Expansion|Adverse Event|0|||
37843408|NCT02564900|69528058|FG004|Dose Expansion|Adverse Event|0|||
37843409|NCT02564900|69528059|FG005|Dose Expansion|Adverse Event|0|||
37843410|NCT02564900|69528060|FG006|Dose Expansion|Adverse Event|9|||
37843411|NCT02564900|69528061|FG007|Dose Expansion|Adverse Event|22|||
37843412|NCT02564900|69528062|FG008|Dose Expansion|Adverse Event|0|||
37843413|NCT02564900|69528063|FG009|Dose Expansion|Adverse Event|11|||
37843414|NCT02564900|69528064|FG010|Dose Expansion|Adverse Event|0|||
37843415|NCT02564900|69528065|FG011|Dose Expansion|Adverse Event|5|||
37843416|NCT02564900|69528066|FG012|Dose Expansion|Adverse Event|2|||
37843417|NCT02564900|69528067|FG013|Dose Expansion|Adverse Event|2|||
37843418|NCT02564900|69528068|FG014|Dose Expansion|Adverse Event|1|||
37843419|NCT02564900|69528054|FG000|Dose Expansion|Ongoing|0|||
37729087|NCT01777269|69208285|FG001|Overall Study|Lack of Efficacy|10|||
37729088|NCT01777269|69208284|FG000|Overall Study|Protocol Violation|4|||
37729089|NCT01777269|69208285|FG001|Overall Study|Protocol Violation|4|||
37729090|NCT01777269|69208284|FG000|Overall Study|Participants reached stopping criteria|1|||
37729091|NCT01777269|69208285|FG001|Overall Study|Participants reached stopping criteria|1|||
37729092|NCT01777269|69208284|FG000|Overall Study|Lost to Follow-up|4|||
37729093|NCT01777269|69208285|FG001|Overall Study|Lost to Follow-up|0|||
37729094|NCT01777269|69208284|FG000|Overall Study|Physician Decision|5|||
37729095|NCT01777269|69208285|FG001|Overall Study|Physician Decision|2|||
37729096|NCT01777269|69208284|FG000|Overall Study|Withdrawal by Subject|9|||
37729097|NCT01777269|69208285|FG001|Overall Study|Withdrawal by Subject|9|||
37729098|NCT04016272|69208293|FG000|Overall Study|Withdrawal by Subject|1|||
37729099|NCT04016272|69208294|FG001|Overall Study|Withdrawal by Subject|2|||
37729100|NCT01751061|69208302|FG000|Overall Study|Death|1|||
37729101|NCT01751061|69208303|FG001|Overall Study|Death|0|||
37729102|NCT01751061|69208302|FG000|Overall Study|patient death|5|||
37729103|NCT01751061|69208303|FG001|Overall Study|patient death|0|||
37729104|NCT01751061|69208302|FG000|Overall Study|Lost to Follow-up|40|||
37729105|NCT01751061|69208303|FG001|Overall Study|Lost to Follow-up|25|||
37729106|NCT01751061|69208302|FG000|Overall Study|patient regained decisional capacity|4|||
37729107|NCT01751061|69208303|FG001|Overall Study|patient regained decisional capacity|8|||
37729108|NCT01751061|69208302|FG000|Overall Study|Withdrawal by Subject|4|||
37729109|NCT01751061|69208303|FG001|Overall Study|Withdrawal by Subject|1|||
37729110|NCT01751061|69208302|FG000|Overall Study|Physician Decision|2|||
37729111|NCT01751061|69208303|FG001|Overall Study|Physician Decision|0|||
37729112|NCT01777191|69208311|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
37729113|NCT01777191|69208312|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
37729114|NCT01777191|69208311|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
37843420|NCT02564900|69528055|FG001|Dose Expansion|Ongoing|0|||
37843421|NCT02564900|69528056|FG002|Dose Expansion|Ongoing|0|||
37843422|NCT02564900|69528057|FG003|Dose Expansion|Ongoing|0|||
37843423|NCT02564900|69528058|FG004|Dose Expansion|Ongoing|0|||
37843424|NCT02564900|69528059|FG005|Dose Expansion|Ongoing|0|||
37843425|NCT02564900|69528060|FG006|Dose Expansion|Ongoing|9|||
37843426|NCT02564900|69528061|FG007|Dose Expansion|Ongoing|10|||
37843427|NCT02564900|69528062|FG008|Dose Expansion|Ongoing|11|||
37729115|NCT01777191|69208312|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
37729116|NCT01777191|69208311|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
37843428|NCT02564900|69528063|FG009|Dose Expansion|Ongoing|3|||
37843429|NCT02564900|69528064|FG010|Dose Expansion|Ongoing|0|||
37843430|NCT02564900|69528065|FG011|Dose Expansion|Ongoing|0|||
37843431|NCT02564900|69528066|FG012|Dose Expansion|Ongoing|4|||
37843432|NCT02564900|69528067|FG013|Dose Expansion|Ongoing|0|||
37843433|NCT02564900|69528068|FG014|Dose Expansion|Ongoing|6|||
37843434|NCT02564900|69528054|FG000|Dose Expansion|Death|0|||
37843435|NCT02564900|69528055|FG001|Dose Expansion|Death|0|||
37843436|NCT02564900|69528056|FG002|Dose Expansion|Death|0|||
37843437|NCT02564900|69528057|FG003|Dose Expansion|Death|0|||
37843438|NCT02564900|69528058|FG004|Dose Expansion|Death|0|||
37843439|NCT02564900|69528059|FG005|Dose Expansion|Death|0|||
37843440|NCT02564900|69528060|FG006|Dose Expansion|Death|1|||
37843441|NCT02564900|69528061|FG007|Dose Expansion|Death|0|||
37843442|NCT02564900|69528062|FG008|Dose Expansion|Death|0|||
37843443|NCT02564900|69528063|FG009|Dose Expansion|Death|0|||
37843444|NCT02564900|69528064|FG010|Dose Expansion|Death|1|||
37843445|NCT02564900|69528065|FG011|Dose Expansion|Death|0|||
37843446|NCT02564900|69528066|FG012|Dose Expansion|Death|1|||
37843447|NCT02564900|69528067|FG013|Dose Expansion|Death|1|||
37843448|NCT02564900|69528068|FG014|Dose Expansion|Death|0|||
37843449|NCT02564900|69528054|FG000|Dose Expansion|Withdrawal by Subject|0|||
37729117|NCT01777191|69208312|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
37729118|NCT01777191|69208311|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
37729119|NCT01777191|69208312|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
37729120|NCT01777191|69208311|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
38025555|NCT04363736|69710004|FG001|Overall Study|Withdrawal by Subject|0|||
38025556|NCT04363736|69710003|FG000|Overall Study|Lost to Follow-up|10|||
37729121|NCT01777191|69208312|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
37729122|NCT01777191|69208311|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
37729123|NCT01777191|69208312|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
37729124|NCT01777191|69208311|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
37729125|NCT01777191|69208312|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
37729126|NCT01777191|69208311|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
37729127|NCT01777191|69208312|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
37729128|NCT01777191|69208311|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
37729129|NCT01777191|69208312|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
37729130|NCT01777191|69208311|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
37729131|NCT01777191|69208312|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
37729132|NCT01777191|69208311|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
37729133|NCT01777191|69208312|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
37729134|NCT01896050|69208323|FG000|Overall Study|Adverse Event|37|||
37729135|NCT01896050|69208324|FG001|Overall Study|Adverse Event|2|||
37729136|NCT01896050|69208323|FG000|Overall Study|Death|1|||
37729137|NCT01896050|69208324|FG001|Overall Study|Death|0|||
37729138|NCT01775787|69208332|FG000|First 7-10 Days|Adverse Event|0|||
37729139|NCT01775787|69208333|FG001|First 7-10 Days|Adverse Event|1|||
37729140|NCT01775787|69208332|FG000|First 7-10 Days|family emergency|0|||
37729141|NCT01775787|69208333|FG001|First 7-10 Days|family emergency|1|||
37729142|NCT01775787|69208332|FG000|First 7-10 Days|time commitment|0|||
37729143|NCT01775787|69208333|FG001|First 7-10 Days|time commitment|2|||
37729144|NCT01775787|69208332|FG000|First 7-10 Days|concerns with using IV|1|||
37729145|NCT01775787|69208333|FG001|First 7-10 Days|concerns with using IV|2|||
37729146|NCT01775787|69208332|FG000|Second 7-10 Days|time commitment|0|||
37729147|NCT01775787|69208333|FG001|Second 7-10 Days|time commitment|1|||
37729148|NCT01775787|69208332|FG000|Second 7-10 Days|concerns with using IV|0|||
37729149|NCT01775787|69208333|FG001|Second 7-10 Days|concerns with using IV|1|||
37729150|NCT01775553|69208341|FG000|Overall Study|Adverse Event|1|||
37729151|NCT01775553|69208341|FG000|Overall Study|Disease Progression|12|||
37729152|NCT01775475|69208347|FG000|Overall Study|Death|3|||
37729153|NCT01775475|69208348|FG001|Overall Study|Death|3|||
37729154|NCT01774929|69208354|FG000|Overall Study|Adverse Event|3|||
37729155|NCT01888874|69208365|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
37729156|NCT01888874|69208366|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
37729157|NCT01888874|69208367|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
37729158|NCT01888874|69208368|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
37729159|NCT01888874|69208369|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
37729160|NCT01888874|69208370|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
37729161|NCT01888874|69208371|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
37729162|NCT01888874|69208365|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
37729163|NCT01888874|69208366|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
37729164|NCT01888874|69208367|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
37729165|NCT01888874|69208368|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
37729166|NCT01888874|69208369|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
37729167|NCT01888874|69208370|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
37729168|NCT01888874|69208371|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
37729169|NCT01888874|69208365|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
37729170|NCT01888874|69208366|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
37729171|NCT01888874|69208367|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
37729172|NCT01888874|69208368|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
37729173|NCT01888874|69208369|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
37729174|NCT01888874|69208370|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
37729175|NCT01888874|69208371|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
37843450|NCT02564900|69528055|FG001|Dose Expansion|Withdrawal by Subject|0|||
37843451|NCT02564900|69528056|FG002|Dose Expansion|Withdrawal by Subject|0|||
37843452|NCT02564900|69528057|FG003|Dose Expansion|Withdrawal by Subject|0|||
37843453|NCT02564900|69528058|FG004|Dose Expansion|Withdrawal by Subject|0|||
37843454|NCT02564900|69528059|FG005|Dose Expansion|Withdrawal by Subject|0|||
37729176|NCT01888874|69208365|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
37729177|NCT01888874|69208366|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
37843455|NCT02564900|69528060|FG006|Dose Expansion|Withdrawal by Subject|4|||
37915868|NCT00518323|69602690|FG003|Overall Study|Lost to Follow-up|3|||
37915869|NCT00518323|69602687|FG000|Overall Study|Adverse Event|1|||
37915870|NCT00518323|69602688|FG001|Overall Study|Adverse Event|1|||
37915871|NCT00518323|69602689|FG002|Overall Study|Adverse Event|1|||
37915872|NCT00518323|69602690|FG003|Overall Study|Adverse Event|0|||
37915873|NCT00518323|69602687|FG000|Overall Study|Prohibited medication and others|3|||
37915874|NCT00518323|69602688|FG001|Overall Study|Prohibited medication and others|1|||
37915875|NCT00518323|69602689|FG002|Overall Study|Prohibited medication and others|1|||
37915876|NCT00518323|69602690|FG003|Overall Study|Prohibited medication and others|0|||
37915877|NCT00826449|69602702|FG000|Overall Study|Disease Progression|4|||
37915878|NCT00826449|69602702|FG000|Overall Study|Withdrawal by Subject|1|||
37915879|NCT00825825|69602707|FG000|First Medication Period (14 Days)|Adverse Event|1|||
37729178|NCT01888874|69208367|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
37729179|NCT01888874|69208368|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
37729180|NCT01888874|69208369|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
37729181|NCT01888874|69208370|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
37729182|NCT01888874|69208371|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
37729183|NCT01888874|69208365|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
37729184|NCT01888874|69208366|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
37729185|NCT01888874|69208367|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
37729186|NCT01888874|69208368|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
37729187|NCT01888874|69208369|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
37729188|NCT01888874|69208370|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
37729189|NCT01888874|69208371|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
37729190|NCT01888874|69208365|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
37729191|NCT01888874|69208366|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
37729192|NCT01888874|69208367|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
37729193|NCT01888874|69208368|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
37729194|NCT01888874|69208369|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
37729195|NCT01888874|69208370|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
37729196|NCT01888874|69208371|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
37729197|NCT01888874|69208365|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
37729198|NCT01888874|69208366|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
37729199|NCT01888874|69208367|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
37729200|NCT01888874|69208368|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
37729201|NCT01888874|69208369|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
37729202|NCT01888874|69208370|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
37843456|NCT02564900|69528061|FG007|Dose Expansion|Withdrawal by Subject|0|||
37843457|NCT02564900|69528062|FG008|Dose Expansion|Withdrawal by Subject|0|||
37843458|NCT02564900|69528063|FG009|Dose Expansion|Withdrawal by Subject|0|||
37843459|NCT02564900|69528064|FG010|Dose Expansion|Withdrawal by Subject|1|||
37843460|NCT02564900|69528065|FG011|Dose Expansion|Withdrawal by Subject|0|||
37843461|NCT02564900|69528066|FG012|Dose Expansion|Withdrawal by Subject|0|||
37843462|NCT02564900|69528067|FG013|Dose Expansion|Withdrawal by Subject|1|||
37843463|NCT02564900|69528068|FG014|Dose Expansion|Withdrawal by Subject|1|||
37843464|NCT02564900|69528054|FG000|Dose Expansion|Other|0|||
37843465|NCT02564900|69528055|FG001|Dose Expansion|Other|0|||
37843466|NCT02564900|69528056|FG002|Dose Expansion|Other|0|||
37843467|NCT02564900|69528057|FG003|Dose Expansion|Other|0|||
37843468|NCT02564900|69528058|FG004|Dose Expansion|Other|0|||
38025557|NCT04363736|69710004|FG001|Overall Study|Lost to Follow-up|7|||
38025558|NCT04363736|69710003|FG000|Overall Study|Death|8|||
37843469|NCT02564900|69528059|FG005|Dose Expansion|Other|0|||
37843470|NCT02564900|69528060|FG006|Dose Expansion|Other|1|||
37843471|NCT02564900|69528061|FG007|Dose Expansion|Other|0|||
37915880|NCT00825825|69602708|FG001|First Medication Period (14 Days)|Adverse Event|0|||
37915881|NCT00825825|69602709|FG002|First Medication Period (14 Days)|Adverse Event|0|||
37729203|NCT01888874|69208371|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
37729204|NCT01888874|69208365|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
37729205|NCT01888874|69208366|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
37729206|NCT01888874|69208367|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
37729207|NCT01888874|69208368|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
37729208|NCT01888874|69208369|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
37729209|NCT01888874|69208370|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
37729210|NCT01888874|69208371|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
37729211|NCT01888874|69208365|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
37729212|NCT01888874|69208366|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
37729213|NCT01888874|69208367|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
37729214|NCT01888874|69208368|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
37843472|NCT02564900|69528062|FG008|Dose Expansion|Other|1|||
37843473|NCT02564900|69528063|FG009|Dose Expansion|Other|0|||
37843474|NCT02564900|69528064|FG010|Dose Expansion|Other|0|||
37843475|NCT02564900|69528065|FG011|Dose Expansion|Other|0|||
37843476|NCT02564900|69528066|FG012|Dose Expansion|Other|0|||
37843477|NCT02564900|69528067|FG013|Dose Expansion|Other|0|||
37843478|NCT02564900|69528068|FG014|Dose Expansion|Other|1|||
37843479|NCT02564900|69528054|FG000|Dose Expansion|Did not receive treatment|0|||
37843480|NCT02564900|69528055|FG001|Dose Expansion|Did not receive treatment|0|||
37843481|NCT02564900|69528056|FG002|Dose Expansion|Did not receive treatment|0|||
37843482|NCT02564900|69528057|FG003|Dose Expansion|Did not receive treatment|0|||
38025559|NCT04363736|69710004|FG001|Overall Study|Death|6|||
38025560|NCT04362176|69710012|FG000|Overall Study|Lost to Follow-up|5|||
38025561|NCT04362176|69710013|FG001|Overall Study|Lost to Follow-up|8|||
38025562|NCT04362176|69710012|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
38025563|NCT04362176|69710013|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
38025564|NCT04079816|69710019|FG000|Overall Study|Request of Subject|2|||
38025565|NCT04079816|69710019|FG000|Overall Study|Unable to draw samples|1|||
38025566|NCT04079114|69710023|FG000|Overall Study|Study prematuely terminated.|166|||
38025567|NCT03055936|69710031|FG000|Overall Study|Adverse Event|0|||
38025568|NCT03055936|69710032|FG001|Overall Study|Adverse Event|1|||
38025569|NCT03055936|69710033|FG002|Overall Study|Adverse Event|1|||
38025570|NCT03055936|69710034|FG003|Overall Study|Adverse Event|1|||
38025571|NCT03055936|69710031|FG000|Overall Study|Personal reason|2|||
38025572|NCT03055936|69710032|FG001|Overall Study|Personal reason|0|||
38025573|NCT03055936|69710033|FG002|Overall Study|Personal reason|1|||
38025574|NCT03055936|69710034|FG003|Overall Study|Personal reason|0|||
38025575|NCT03891524|69710076|FG000|Overall Study|Death|0|||
38025576|NCT03891524|69710077|FG001|Overall Study|Death|0|||
38025577|NCT03891524|69710078|FG002|Overall Study|Death|0|||
38025578|NCT03891524|69710079|FG003|Overall Study|Death|0|||
38025579|NCT03891524|69710080|FG004|Overall Study|Death|0|||
38025580|NCT03891524|69710081|FG005|Overall Study|Death|0|||
38025581|NCT03891524|69710082|FG006|Overall Study|Death|0|||
38025582|NCT03891524|69710083|FG007|Overall Study|Death|1|||
38025583|NCT03891524|69710076|FG000|Overall Study|Withdrawal by Subject|0|||
38025584|NCT03891524|69710077|FG001|Overall Study|Withdrawal by Subject|1|||
38025585|NCT03891524|69710078|FG002|Overall Study|Withdrawal by Subject|2|||
38025586|NCT03891524|69710079|FG003|Overall Study|Withdrawal by Subject|1|||
38025587|NCT03891524|69710080|FG004|Overall Study|Withdrawal by Subject|2|||
38025588|NCT03891524|69710081|FG005|Overall Study|Withdrawal by Subject|2|||
38025589|NCT03891524|69710082|FG006|Overall Study|Withdrawal by Subject|2|||
38025590|NCT03891524|69710083|FG007|Overall Study|Withdrawal by Subject|1|||
38025591|NCT03055624|69710118|FG000|Overall Study|Study closed|9|||
38025592|NCT01346176|69710125|FG000|Recruited|Protocol Violation|1|||
38025593|NCT01346176|69710126|FG001|Recruited|Protocol Violation|0|||
38025594|NCT01346176|69710127|FG002|Recruited|Protocol Violation|0|||
38025595|NCT01346176|69710125|FG000|Completed Advance Directive|Death|3|||
38025596|NCT01346176|69710126|FG001|Completed Advance Directive|Death|2|||
38025597|NCT01346176|69710127|FG002|Completed Advance Directive|Death|2|||
38025598|NCT01346176|69710125|FG000|Completed Advance Directive|Became Ineligible|3|||
38025599|NCT01346176|69710126|FG001|Completed Advance Directive|Became Ineligible|0|||
38025600|NCT01346176|69710127|FG002|Completed Advance Directive|Became Ineligible|1|||
38025601|NCT01346176|69710125|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
38025602|NCT01346176|69710126|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
38025603|NCT01346176|69710127|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
38025604|NCT01346176|69710125|FG000|Completed Satisfaction Survey|Death|3|||
38025605|NCT01346176|69710126|FG001|Completed Satisfaction Survey|Death|0|||
37843483|NCT02564900|69528058|FG004|Dose Expansion|Did not receive treatment|0|||
37843484|NCT02564900|69528059|FG005|Dose Expansion|Did not receive treatment|0|||
38025606|NCT01346176|69710127|FG002|Completed Satisfaction Survey|Death|2|||
38025607|NCT01346176|69710125|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
38025608|NCT01346176|69710126|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
37729215|NCT01888874|69208369|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
37729216|NCT01888874|69208370|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
37729217|NCT01888874|69208371|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
37729218|NCT01888874|69208365|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
37729219|NCT01888874|69208366|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
37729220|NCT01888874|69208367|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
37729221|NCT01888874|69208368|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
37729222|NCT01888874|69208369|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
37729223|NCT01888874|69208370|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
37729224|NCT01888874|69208371|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
37729225|NCT01888874|69208365|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
37729226|NCT01888874|69208366|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
37729227|NCT01888874|69208367|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
37729228|NCT01888874|69208368|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
37729229|NCT01888874|69208369|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
37729230|NCT01888874|69208370|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
37729231|NCT01888874|69208371|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
37729232|NCT01888874|69208365|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
37729233|NCT01888874|69208366|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
37729234|NCT01888874|69208367|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
37729235|NCT01888874|69208368|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
37729236|NCT01888874|69208369|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
37729237|NCT01888874|69208370|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
37729238|NCT01888874|69208371|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
37729239|NCT01888874|69208365|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
37729240|NCT01888874|69208366|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
37729241|NCT01888874|69208367|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
37729242|NCT01888874|69208368|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
37729243|NCT01888874|69208369|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
37729244|NCT01888874|69208370|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
37729245|NCT01888874|69208371|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
37729246|NCT01749735|69208390|FG000|Overall Study|Withdrawal by Subject|1|||
37729247|NCT01749735|69208391|FG001|Overall Study|Withdrawal by Subject|0|||
37729248|NCT01749033|69208400|FG000|Overall Study|Did not receive allocated intervention|3|||
37729249|NCT01749033|69208401|FG001|Overall Study|Did not receive allocated intervention|3|||
37729250|NCT01749033|69208402|FG002|Overall Study|Did not receive allocated intervention|0|||
37729251|NCT01749033|69208400|FG000|Overall Study|Lost to Follow-up|0|||
37729252|NCT01749033|69208401|FG001|Overall Study|Lost to Follow-up|2|||
37729253|NCT01749033|69208402|FG002|Overall Study|Lost to Follow-up|1|||
37729254|NCT01774305|69208413|FG000|Overall Study|Physician Decision|1|||
37729255|NCT01774305|69208414|FG001|Overall Study|Physician Decision|0|||
37729256|NCT01737021|69208422|FG000|Overall Study|Lost to Follow-up|5|||
37729257|NCT01737021|69208423|FG001|Overall Study|Lost to Follow-up|3|||
37729258|NCT01397422|69208433|FG000|Overall Study|Adverse Event|0|||
37729259|NCT01397422|69208434|FG001|Overall Study|Adverse Event|3|||
37729260|NCT01397422|69208435|FG002|Overall Study|Adverse Event|3|||
37729261|NCT01397422|69208436|FG003|Overall Study|Adverse Event|8|||
37729262|NCT01397422|69208433|FG000|Overall Study|Withdrawal by Subject|1|||
37729263|NCT01397422|69208434|FG001|Overall Study|Withdrawal by Subject|0|||
37729264|NCT01397422|69208435|FG002|Overall Study|Withdrawal by Subject|0|||
37729265|NCT01397422|69208436|FG003|Overall Study|Withdrawal by Subject|0|||
37729266|NCT01397422|69208433|FG000|Overall Study|Increased bradykinesia related to PD|1|||
37729267|NCT01397422|69208434|FG001|Overall Study|Increased bradykinesia related to PD|0|||
37729268|NCT01397422|69208435|FG002|Overall Study|Increased bradykinesia related to PD|0|||
37729269|NCT01397422|69208436|FG003|Overall Study|Increased bradykinesia related to PD|0|||
37729270|NCT01736553|69208450|FG000|Overall Study|Death|12|||
37729271|NCT01736553|69208451|FG001|Overall Study|Death|0|||
37729272|NCT01736553|69208450|FG000|Overall Study|Withdrawal by Subject|5|||
37729273|NCT01736553|69208451|FG001|Overall Study|Withdrawal by Subject|2|||
37729274|NCT01736553|69208450|FG000|Overall Study|Lost to Follow-up|2|||
37729275|NCT01736553|69208451|FG001|Overall Study|Lost to Follow-up|2|||
37729276|NCT01888640|69208478|FG000|Overall Study|Lost to Follow-up|1|||
37729277|NCT01888640|69208479|FG001|Overall Study|Lost to Follow-up|2|||
37729278|NCT01888640|69208480|FG002|Overall Study|Lost to Follow-up|0|||
37729279|NCT01888640|69208478|FG000|Overall Study|Withdrawal by Subject|15|||
38025609|NCT01346176|69710127|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
37729280|NCT01888640|69208479|FG001|Overall Study|Withdrawal by Subject|11|||
37843485|NCT02564900|69528060|FG006|Dose Expansion|Did not receive treatment|1|||
37843486|NCT02564900|69528061|FG007|Dose Expansion|Did not receive treatment|1|||
37843487|NCT02564900|69528062|FG008|Dose Expansion|Did not receive treatment|0|||
37843488|NCT02564900|69528063|FG009|Dose Expansion|Did not receive treatment|0|||
37729281|NCT01888640|69208480|FG002|Overall Study|Withdrawal by Subject|4|||
37729282|NCT01888640|69208478|FG000|Overall Study|Minimum dose not met|10|||
37729283|NCT01888640|69208479|FG001|Overall Study|Minimum dose not met|16|||
37729284|NCT01888640|69208480|FG002|Overall Study|Minimum dose not met|0|||
37729285|NCT01888640|69208478|FG000|Overall Study|Given wrong unit (placebo)|1|||
37729286|NCT01888640|69208479|FG001|Overall Study|Given wrong unit (placebo)|0|||
37729287|NCT01888640|69208480|FG002|Overall Study|Given wrong unit (placebo)|0|||
37729288|NCT01888640|69208478|FG000|Overall Study|Excluded for prior TENS|0|||
37729289|NCT01888640|69208479|FG001|Overall Study|Excluded for prior TENS|1|||
37729290|NCT01888640|69208480|FG002|Overall Study|Excluded for prior TENS|0|||
37729291|NCT01888640|69208478|FG000|Overall Study|Researcher Termination of Participant|0|||
37729292|NCT01888640|69208479|FG001|Overall Study|Researcher Termination of Participant|1|||
37729293|NCT01888640|69208480|FG002|Overall Study|Researcher Termination of Participant|1|||
37729294|NCT01736475|69208493|FG000|Overall Study|Adverse Event|4|||
37729295|NCT01736475|69208494|FG001|Overall Study|Adverse Event|0|||
37729296|NCT01736475|69208493|FG000|Overall Study|Withdrawal by Subject|2|||
37729297|NCT01736475|69208494|FG001|Overall Study|Withdrawal by Subject|0|||
37729298|NCT01736475|69208493|FG000|Overall Study|Protocol Violation|4|||
37729299|NCT01736475|69208494|FG001|Overall Study|Protocol Violation|0|||
37729300|NCT01736475|69208493|FG000|Overall Study|Other - Screen failure|1|||
37729301|NCT01736475|69208494|FG001|Overall Study|Other - Screen failure|0|||
37729302|NCT01736475|69208493|FG000|Overall Study|Other - Surgical procedure|1|||
37729303|NCT01736475|69208494|FG001|Overall Study|Other - Surgical procedure|0|||
37729304|NCT01863758|69208511|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
37729305|NCT01863758|69208511|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
37729306|NCT01863680|69208515|FG000|Overall Study|Adverse Event|17|||
37729307|NCT01863680|69208515|FG000|Overall Study|Risk of OHSS|17|||
37729308|NCT01863680|69208515|FG000|Overall Study|Spontaneous pregnancy|2|||
37729309|NCT01863680|69208515|FG000|Overall Study|Withdrawal by Subject|1|||
37729310|NCT01863680|69208515|FG000|Overall Study|Did not undergo IVF/ET|14|||
37729311|NCT01863680|69208515|FG000|Overall Study|Other|6|||
37729312|NCT01747629|69208521|FG000|Overall Study|Adverse Event|1|||
37729313|NCT01747629|69208522|FG001|Overall Study|Adverse Event|2|||
37729314|NCT01747629|69208521|FG000|Overall Study|Withdrawal by Subject|2|||
37729315|NCT01747629|69208522|FG001|Overall Study|Withdrawal by Subject|2|||
37729316|NCT01747629|69208521|FG000|Overall Study|Noncompliance|1|||
37729317|NCT01747629|69208522|FG001|Overall Study|Noncompliance|1|||
37729318|NCT01747629|69208521|FG000|Overall Study|Inclusion criteria not met|1|||
37729319|NCT01747629|69208522|FG001|Overall Study|Inclusion criteria not met|0|||
37729320|NCT01747629|69208521|FG000|Overall Study|Not treated|1|||
37729321|NCT01747629|69208522|FG001|Overall Study|Not treated|0|||
37729322|NCT01747629|69208521|FG000|Overall Study|Other|2|||
37729323|NCT01747629|69208522|FG001|Overall Study|Other|1|||
37729324|NCT01863368|69208530|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
37729325|NCT01863368|69208531|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
37729326|NCT01863368|69208530|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
37729327|NCT01863368|69208531|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
37729328|NCT01863368|69208530|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
37729329|NCT01863368|69208531|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
37729330|NCT01863368|69208530|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
37729331|NCT01863368|69208531|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
37729332|NCT01863368|69208530|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
37729333|NCT01863368|69208531|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
37729334|NCT01863368|69208530|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
37729335|NCT01863368|69208531|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
37729336|NCT01886690|69208540|FG000|Overall Study|Protocol Violation|0|||
37729337|NCT01886690|69208541|FG001|Overall Study|Protocol Violation|1|||
37729338|NCT01886690|69208540|FG000|Overall Study|Personal Reasons|0|||
37729339|NCT01886690|69208541|FG001|Overall Study|Personal Reasons|1|||
37729340|NCT01886378|69208547|FG000|Overall Study|Adverse Event|1|||
37915882|NCT00825825|69602710|FG003|First Medication Period (14 Days)|Adverse Event|0|||
37729341|NCT01886378|69208547|FG000|Overall Study|Withdrawal by Subject|4|||
37729342|NCT01886300|69208551|FG000|Overall Study|Trial terminated by sponsor|16|||
37729343|NCT01885208|69208557|FG000|Overall Study|Unclassified|32|||
37729344|NCT01885208|69208558|FG001|Overall Study|Unclassified|38|||
37729345|NCT01859702|69208564|FG000|Overall Study|Protocol deviation|3|||
37729346|NCT01859702|69208564|FG000|Overall Study|Adverse Event|2|||
37729347|NCT01835132|69208568|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
37729348|NCT01747551|69208574|FG000|Overall Study|Progressive Disease|24|||
37729349|NCT01747551|69208575|FG001|Overall Study|Progressive Disease|17|||
37729350|NCT01747551|69208574|FG000|Overall Study|Death|3|||
37729351|NCT01747551|69208575|FG001|Overall Study|Death|1|||
37729352|NCT01747551|69208574|FG000|Overall Study|Adverse Event|7|||
37729353|NCT01747551|69208575|FG001|Overall Study|Adverse Event|1|||
37729354|NCT01747551|69208574|FG000|Overall Study|Prolonged Treatment Delay|2|||
37729355|NCT01747551|69208575|FG001|Overall Study|Prolonged Treatment Delay|0|||
37729356|NCT01747551|69208574|FG000|Overall Study|Withdrawal by Subject|3|||
37729357|NCT01747551|69208575|FG001|Overall Study|Withdrawal by Subject|1|||
37729358|NCT01747551|69208574|FG000|Overall Study|Physician Decision|2|||
37729359|NCT01747551|69208575|FG001|Overall Study|Physician Decision|1|||
37729360|NCT01747551|69208574|FG000|Overall Study|Other|2|||
37729361|NCT01747551|69208575|FG001|Overall Study|Other|0|||
37729362|NCT01736397|69208583|FG000|Overall Study|Lack of Efficacy|1|||
37729363|NCT01736397|69208584|FG001|Overall Study|Lack of Efficacy|11|||
37729364|NCT01736397|69208583|FG000|Overall Study|Withdrawal by Subject|6|||
37729365|NCT01736397|69208584|FG001|Overall Study|Withdrawal by Subject|5|||
37729366|NCT01736397|69208583|FG000|Overall Study|Lost to Follow-up|0|||
37729367|NCT01736397|69208584|FG001|Overall Study|Lost to Follow-up|1|||
37729368|NCT01736397|69208583|FG000|Overall Study|Adverse Event|6|||
37729369|NCT01736397|69208584|FG001|Overall Study|Adverse Event|3|||
37843489|NCT02564900|69528064|FG010|Dose Expansion|Did not receive treatment|0|||
37843490|NCT02564900|69528065|FG011|Dose Expansion|Did not receive treatment|0|||
37843491|NCT02564900|69528066|FG012|Dose Expansion|Did not receive treatment|0|||
37843492|NCT02564900|69528067|FG013|Dose Expansion|Did not receive treatment|0|||
37843493|NCT02564900|69528068|FG014|Dose Expansion|Did not receive treatment|1|||
37729370|NCT01736397|69208583|FG000|Overall Study|Not stated|1|||
37729371|NCT01736397|69208584|FG001|Overall Study|Not stated|4|||
37729372|NCT01859390|69208592|FG000|Overall Study|Insufficient Sputum Collected|1|||
37729373|NCT01859390|69208593|FG001|Overall Study|Insufficient Sputum Collected|3|||
37729374|NCT01859390|69208592|FG000|Overall Study|Sample Missing Collection Date|0|||
37729375|NCT01859390|69208593|FG001|Overall Study|Sample Missing Collection Date|1|||
37729376|NCT01859390|69208592|FG000|Overall Study|Tube Cracked|0|||
37729377|NCT01859390|69208593|FG001|Overall Study|Tube Cracked|2|||
37729378|NCT01859390|69208592|FG000|Overall Study|Shipment Error|0|||
37729379|NCT01859390|69208593|FG001|Overall Study|Shipment Error|1|||
37729380|NCT01858766|69208618|FG000|Overall Study|Randomized but Never Treated|0|||
37729381|NCT01858766|69208619|FG001|Overall Study|Randomized but Never Treated|0|||
37729382|NCT01858766|69208620|FG002|Overall Study|Randomized but Never Treated|0|||
37729383|NCT01858766|69208621|FG003|Overall Study|Randomized but Never Treated|0|||
37729384|NCT01858766|69208622|FG004|Overall Study|Randomized but Never Treated|0|||
37729385|NCT01858766|69208623|FG005|Overall Study|Randomized but Never Treated|1|||
37729386|NCT01858766|69208624|FG006|Overall Study|Randomized but Never Treated|0|||
37729387|NCT01858766|69208625|FG007|Overall Study|Randomized but Never Treated|0|||
37729388|NCT01858766|69208626|FG008|Overall Study|Randomized but Never Treated|0|||
37729389|NCT01858766|69208627|FG009|Overall Study|Randomized but Never Treated|0|||
37729390|NCT01858766|69208628|FG010|Overall Study|Randomized but Never Treated|0|||
37843494|NCT02554279|69528111|FG000|Overall Study|Adverse Event|2|||
37843495|NCT02554279|69528112|FG001|Overall Study|Adverse Event|5|||
37843496|NCT02554279|69528111|FG000|Overall Study|Lost to Follow-up|3|||
37843497|NCT02554279|69528112|FG001|Overall Study|Lost to Follow-up|2|||
37915883|NCT00825825|69602711|FG004|First Medication Period (14 Days)|Adverse Event|0|||
37915884|NCT00825825|69602712|FG005|First Medication Period (14 Days)|Adverse Event|1|||
37915885|NCT00825825|69602707|FG000|First Medication Period (14 Days)|Physician Decision|2|||
37915886|NCT00825825|69602708|FG001|First Medication Period (14 Days)|Physician Decision|0|||
37915887|NCT00825825|69602709|FG002|First Medication Period (14 Days)|Physician Decision|1|||
37915888|NCT00825825|69602710|FG003|First Medication Period (14 Days)|Physician Decision|0|||
37915889|NCT00825825|69602711|FG004|First Medication Period (14 Days)|Physician Decision|0|||
37915890|NCT00825825|69602712|FG005|First Medication Period (14 Days)|Physician Decision|1|||
37915891|NCT00825825|69602707|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
37915892|NCT00825825|69602708|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
37915893|NCT00825825|69602709|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
37915894|NCT00825825|69602710|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
37729391|NCT01858766|69208629|FG011|Overall Study|Randomized but Never Treated|0|||
37729392|NCT01858766|69208630|FG012|Overall Study|Randomized but Never Treated|0|||
37729393|NCT01858766|69208631|FG013|Overall Study|Randomized but Never Treated|0|||
37729394|NCT01858766|69208632|FG014|Overall Study|Randomized but Never Treated|0|||
37843498|NCT02554279|69528111|FG000|Overall Study|Withdrawal by Subject|6|||
37915895|NCT00825825|69602711|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
37729395|NCT01858766|69208633|FG015|Overall Study|Randomized but Never Treated|0|||
37729396|NCT01858766|69208634|FG016|Overall Study|Randomized but Never Treated|0|||
37729397|NCT01858766|69208635|FG017|Overall Study|Randomized but Never Treated|1|||
37729398|NCT01858766|69208636|FG018|Overall Study|Randomized but Never Treated|0|||
37729399|NCT01858766|69208618|FG000|Overall Study|Death|0|||
37729400|NCT01858766|69208619|FG001|Overall Study|Death|0|||
37729401|NCT01858766|69208620|FG002|Overall Study|Death|1|||
37843499|NCT02554279|69528112|FG001|Overall Study|Withdrawal by Subject|4|||
37843500|NCT02554279|69528111|FG000|Overall Study|Protocol Violation|2|||
37843501|NCT02554279|69528112|FG001|Overall Study|Protocol Violation|1|||
37843502|NCT02554279|69528111|FG000|Overall Study|Other reason|19|||
37843503|NCT02554279|69528112|FG001|Overall Study|Other reason|6|||
37843504|NCT02542293|69528127|FG000|Overall Study|Death|367|||
37729402|NCT01858766|69208621|FG003|Overall Study|Death|0|||
37729403|NCT01858766|69208622|FG004|Overall Study|Death|0|||
37729404|NCT01858766|69208623|FG005|Overall Study|Death|0|||
37729405|NCT01858766|69208624|FG006|Overall Study|Death|0|||
37729406|NCT01858766|69208625|FG007|Overall Study|Death|0|||
37729407|NCT01858766|69208626|FG008|Overall Study|Death|0|||
37729408|NCT01858766|69208627|FG009|Overall Study|Death|0|||
37729409|NCT01858766|69208628|FG010|Overall Study|Death|0|||
37729410|NCT01858766|69208629|FG011|Overall Study|Death|0|||
37729411|NCT01858766|69208630|FG012|Overall Study|Death|0|||
37729412|NCT01858766|69208631|FG013|Overall Study|Death|0|||
37729413|NCT01858766|69208632|FG014|Overall Study|Death|0|||
37729414|NCT01858766|69208633|FG015|Overall Study|Death|0|||
37729415|NCT01858766|69208634|FG016|Overall Study|Death|0|||
37729416|NCT01858766|69208635|FG017|Overall Study|Death|0|||
37729417|NCT01858766|69208636|FG018|Overall Study|Death|0|||
37729418|NCT01858766|69208618|FG000|Overall Study|Lack of Efficacy|1|||
37729419|NCT01858766|69208619|FG001|Overall Study|Lack of Efficacy|0|||
37729420|NCT01858766|69208620|FG002|Overall Study|Lack of Efficacy|0|||
37729421|NCT01858766|69208621|FG003|Overall Study|Lack of Efficacy|0|||
37729422|NCT01858766|69208622|FG004|Overall Study|Lack of Efficacy|1|||
37729423|NCT01858766|69208623|FG005|Overall Study|Lack of Efficacy|2|||
37729424|NCT01858766|69208624|FG006|Overall Study|Lack of Efficacy|0|||
37729425|NCT01858766|69208625|FG007|Overall Study|Lack of Efficacy|0|||
37729426|NCT01858766|69208626|FG008|Overall Study|Lack of Efficacy|0|||
37729427|NCT01858766|69208627|FG009|Overall Study|Lack of Efficacy|0|||
37729428|NCT01858766|69208628|FG010|Overall Study|Lack of Efficacy|0|||
37729429|NCT01858766|69208629|FG011|Overall Study|Lack of Efficacy|3|||
37729430|NCT01858766|69208630|FG012|Overall Study|Lack of Efficacy|5|||
37729431|NCT01858766|69208631|FG013|Overall Study|Lack of Efficacy|3|||
37729432|NCT01858766|69208632|FG014|Overall Study|Lack of Efficacy|5|||
37729433|NCT01858766|69208633|FG015|Overall Study|Lack of Efficacy|5|||
37729434|NCT01858766|69208634|FG016|Overall Study|Lack of Efficacy|2|||
37729435|NCT01858766|69208635|FG017|Overall Study|Lack of Efficacy|3|||
37729436|NCT01858766|69208636|FG018|Overall Study|Lack of Efficacy|3|||
37729437|NCT01858766|69208618|FG000|Overall Study|Lost to Follow-up|0|||
37729438|NCT01858766|69208619|FG001|Overall Study|Lost to Follow-up|0|||
37729439|NCT01858766|69208620|FG002|Overall Study|Lost to Follow-up|0|||
37729440|NCT01858766|69208621|FG003|Overall Study|Lost to Follow-up|0|||
37729441|NCT01858766|69208622|FG004|Overall Study|Lost to Follow-up|0|||
37843505|NCT02542293|69528128|FG001|Overall Study|Death|377|||
37843506|NCT02542293|69528127|FG000|Overall Study|Withdrawal by Subject|8|||
37843507|NCT02542293|69528128|FG001|Overall Study|Withdrawal by Subject|19|||
37843508|NCT02439450|69528156|FG000|Overall Study|Adverse Event|4|||
37843509|NCT02439450|69528157|FG001|Overall Study|Adverse Event|1|||
37843510|NCT02439450|69528158|FG002|Overall Study|Adverse Event|0|||
37843511|NCT02439450|69528159|FG003|Overall Study|Adverse Event|0|||
37915896|NCT00825825|69602712|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
37915897|NCT00825825|69602707|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
37915898|NCT00825825|69602708|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
37915899|NCT00825825|69602709|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
37915900|NCT00825825|69602710|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
37915901|NCT00825825|69602711|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
37915902|NCT00825825|69602712|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
37915903|NCT00825825|69602707|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
37729442|NCT01858766|69208623|FG005|Overall Study|Lost to Follow-up|1|||
37843512|NCT02439450|69528156|FG000|Overall Study|Withdrawal by Subject|1|||
37843513|NCT02439450|69528157|FG001|Overall Study|Withdrawal by Subject|2|||
37915904|NCT00825825|69602708|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
37729443|NCT01858766|69208624|FG006|Overall Study|Lost to Follow-up|0|||
37729444|NCT01858766|69208625|FG007|Overall Study|Lost to Follow-up|2|||
37729445|NCT01858766|69208626|FG008|Overall Study|Lost to Follow-up|0|||
37729446|NCT01858766|69208627|FG009|Overall Study|Lost to Follow-up|0|||
37729447|NCT01858766|69208628|FG010|Overall Study|Lost to Follow-up|0|||
37729448|NCT01858766|69208629|FG011|Overall Study|Lost to Follow-up|1|||
37729449|NCT01858766|69208630|FG012|Overall Study|Lost to Follow-up|0|||
37729450|NCT01858766|69208631|FG013|Overall Study|Lost to Follow-up|0|||
37729451|NCT01858766|69208632|FG014|Overall Study|Lost to Follow-up|3|||
37729452|NCT01858766|69208633|FG015|Overall Study|Lost to Follow-up|1|||
37729453|NCT01858766|69208634|FG016|Overall Study|Lost to Follow-up|1|||
37729454|NCT01858766|69208635|FG017|Overall Study|Lost to Follow-up|0|||
37729455|NCT01858766|69208636|FG018|Overall Study|Lost to Follow-up|1|||
37729456|NCT01858766|69208618|FG000|Overall Study|Withdrew Consent|0|||
37729457|NCT01858766|69208619|FG001|Overall Study|Withdrew Consent|0|||
37843514|NCT02439450|69528158|FG002|Overall Study|Withdrawal by Subject|0|||
37843515|NCT02439450|69528159|FG003|Overall Study|Withdrawal by Subject|0|||
37843516|NCT02439450|69528156|FG000|Overall Study|Death|3|||
37843517|NCT02439450|69528157|FG001|Overall Study|Death|0|||
37843518|NCT02439450|69528158|FG002|Overall Study|Death|0|||
37843519|NCT02439450|69528159|FG003|Overall Study|Death|1|||
37843520|NCT02439450|69528156|FG000|Overall Study|Progressive Disease|18|||
37843521|NCT02439450|69528157|FG001|Overall Study|Progressive Disease|41|||
37843522|NCT02439450|69528158|FG002|Overall Study|Progressive Disease|2|||
37843523|NCT02439450|69528159|FG003|Overall Study|Progressive Disease|3|||
38025610|NCT04075604|69710138|FG000|Overall Study|Adverse Event|0|||
38025611|NCT04075604|69710139|FG001|Overall Study|Adverse Event|0|||
38025612|NCT04075604|69710140|FG002|Overall Study|Adverse Event|3|||
37843527|NCT02312258|69528184|FG000|Overall Study|Lost to Follow-up|8|||
37843528|NCT02312258|69528185|FG001|Overall Study|Lost to Follow-up|8|||
37843529|NCT02312258|69528184|FG000|Overall Study|Withdrawal by Patient|49|||
37843530|NCT02312258|69528185|FG001|Overall Study|Withdrawal by Patient|76|||
37843531|NCT02312258|69528184|FG000|Overall Study|Reason not Specified|107|||
37843532|NCT02312258|69528185|FG001|Overall Study|Reason not Specified|159|||
37843533|NCT02312258|69528184|FG000|Overall Study|Missing|2|||
37843534|NCT02312258|69528185|FG001|Overall Study|Missing|1|||
37843535|NCT02312258|69528184|FG000|Overall Study|Death|115|||
37843536|NCT02312258|69528185|FG001|Overall Study|Death|181|||
37915905|NCT00825825|69602709|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
37915906|NCT00825825|69602710|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
37915907|NCT00825825|69602711|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
37915908|NCT00825825|69602712|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
37915909|NCT00825825|69602707|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
37915910|NCT00825825|69602708|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
38025613|NCT04075604|69710138|FG000|Overall Study|Participant request to discontinue study treatment|0|||
38025614|NCT04075604|69710139|FG001|Overall Study|Participant request to discontinue study treatment|0|||
38025615|NCT04075604|69710140|FG002|Overall Study|Participant request to discontinue study treatment|1|||
37729458|NCT01858766|69208620|FG002|Overall Study|Withdrew Consent|0|||
37729459|NCT01858766|69208621|FG003|Overall Study|Withdrew Consent|0|||
37729460|NCT01858766|69208622|FG004|Overall Study|Withdrew Consent|0|||
37729461|NCT01858766|69208623|FG005|Overall Study|Withdrew Consent|0|||
37729462|NCT01858766|69208624|FG006|Overall Study|Withdrew Consent|0|||
37729463|NCT01858766|69208625|FG007|Overall Study|Withdrew Consent|0|||
37729464|NCT01858766|69208626|FG008|Overall Study|Withdrew Consent|0|||
37729465|NCT01858766|69208627|FG009|Overall Study|Withdrew Consent|0|||
37729466|NCT01858766|69208628|FG010|Overall Study|Withdrew Consent|0|||
37729467|NCT01858766|69208629|FG011|Overall Study|Withdrew Consent|1|||
37729468|NCT01858766|69208630|FG012|Overall Study|Withdrew Consent|0|||
37729469|NCT01858766|69208631|FG013|Overall Study|Withdrew Consent|0|||
37729470|NCT01858766|69208632|FG014|Overall Study|Withdrew Consent|0|||
37729471|NCT01858766|69208633|FG015|Overall Study|Withdrew Consent|0|||
37729472|NCT01858766|69208634|FG016|Overall Study|Withdrew Consent|0|||
37729473|NCT01858766|69208635|FG017|Overall Study|Withdrew Consent|0|||
37729474|NCT01858766|69208636|FG018|Overall Study|Withdrew Consent|0|||
37729475|NCT01734993|69208669|FG000|Overall Study|Adverse Event|1|||
37729476|NCT01734993|69208669|FG000|Overall Study|Lack of Efficacy|1|||
37729477|NCT01745367|69208676|FG000|Overall Study|Death|1|||
37729478|NCT01745367|69208677|FG001|Overall Study|Death|0|||
37729479|NCT01745367|69208676|FG000|Overall Study|Withdrawal by Subject|1|||
37729480|NCT01745367|69208677|FG001|Overall Study|Withdrawal by Subject|2|||
37729481|NCT01745367|69208676|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
37915911|NCT00825825|69602709|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
37729482|NCT01745367|69208677|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
37729483|NCT01745367|69208676|FG000|Overall Study|Other Reasons Unspecified|0|||
37729484|NCT01745367|69208677|FG001|Overall Study|Other Reasons Unspecified|2|||
37729485|NCT01733121|69208685|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
37729486|NCT01733121|69208686|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
37729487|NCT01733121|69208685|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
37729488|NCT01733121|69208686|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
37729489|NCT01733121|69208685|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
37915912|NCT00825825|69602710|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
37915913|NCT00825825|69602711|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
37729490|NCT01733121|69208686|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
37915914|NCT00825825|69602712|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
37915915|NCT00825825|69602707|FG000|Third Medication Period (14 Days)|poor data quality|0|||
37915916|NCT00825825|69602708|FG001|Third Medication Period (14 Days)|poor data quality|1|||
37915917|NCT00825825|69602709|FG002|Third Medication Period (14 Days)|poor data quality|0|||
37915918|NCT00825825|69602710|FG003|Third Medication Period (14 Days)|poor data quality|0|||
37915919|NCT00825825|69602711|FG004|Third Medication Period (14 Days)|poor data quality|0|||
37915920|NCT00825825|69602712|FG005|Third Medication Period (14 Days)|poor data quality|0|||
37915921|NCT00710710|69602721|FG000|Overall Study|Consent withdrawn|2|||
37915922|NCT00710710|69602722|FG001|Overall Study|Consent withdrawn|2|||
37915923|NCT00710710|69602721|FG000|Overall Study|Protocol Violation|0|||
37915924|NCT00710710|69602722|FG001|Overall Study|Protocol Violation|1|||
37915925|NCT00710710|69602721|FG000|Overall Study|Adverse Event|3|||
37915926|NCT00710710|69602722|FG001|Overall Study|Adverse Event|3|||
37915927|NCT00710710|69602721|FG000|Overall Study|Progressive disease|40|||
37915928|NCT00710710|69602722|FG001|Overall Study|Progressive disease|38|||
37915929|NCT00880334|69602730|FG000|Randomized Phase|Physician Decision|1|||
37915930|NCT00880334|69602731|FG001|Randomized Phase|Physician Decision|0|||
37915931|NCT00880334|69602730|FG000|Randomized Phase|Withdrawal by Subject|2|||
37915932|NCT00880334|69602731|FG001|Randomized Phase|Withdrawal by Subject|1|||
37915933|NCT00880334|69602730|FG000|Randomized Phase|Inadequate Labs|1|||
37915934|NCT00880334|69602731|FG001|Randomized Phase|Inadequate Labs|1|||
37915935|NCT00880334|69602730|FG000|Randomized Phase|Brain Metastasis|0|||
37915936|NCT00880334|69602731|FG001|Randomized Phase|Brain Metastasis|1|||
37915937|NCT00880334|69602730|FG000|Randomized Phase|Crossover Participants|0|||
37915938|NCT00880334|69602731|FG001|Randomized Phase|Crossover Participants|37|||
37915939|NCT00865566|69602743|FG000|Overall Study|Death|1|||
37915940|NCT00865566|69602744|FG001|Overall Study|Death|11|||
37915941|NCT00865566|69602743|FG000|Overall Study|Lost to Follow-up|314|||
37915942|NCT00865566|69602744|FG001|Overall Study|Lost to Follow-up|315|||
37915943|NCT00865566|69602743|FG000|Overall Study|Withdrawal by Subject|45|||
37915944|NCT00865566|69602744|FG001|Overall Study|Withdrawal by Subject|65|||
37915945|NCT00865566|69602743|FG000|Overall Study|Physician Decision|0|||
37915946|NCT00865566|69602744|FG001|Overall Study|Physician Decision|1|||
37915947|NCT00865566|69602743|FG000|Overall Study|Participant relocated|78|||
37915948|NCT00865566|69602744|FG001|Overall Study|Participant relocated|107|||
37915949|NCT00865566|69602743|FG000|Overall Study|Participant unable to adhere|27|||
37915950|NCT00865566|69602744|FG001|Overall Study|Participant unable to adhere|42|||
37915951|NCT00865566|69602743|FG000|Overall Study|Other; N=245 due to early study closure|154|||
37915952|NCT00865566|69602744|FG001|Overall Study|Other; N=245 due to early study closure|139|||
37915953|NCT00865566|69602743|FG000|Overall Study|HIV infection|5|||
37915954|NCT00865566|69602744|FG001|Overall Study|HIV infection|7|||
37915955|NCT03866473|69602752|FG000|Phase 1|Death|1|||
37915956|NCT03866473|69602753|FG001|Phase 1|Death|0|||
37915957|NCT03866473|69602752|FG000|Phase 2|Death|0|||
37915958|NCT03866473|69602753|FG001|Phase 2|Death|2|||
37915959|NCT03866473|69602752|FG000|Phase 2|Dropped|1|||
37915960|NCT03866473|69602753|FG001|Phase 2|Dropped|1|||
37915961|NCT03866473|69602752|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
37915962|NCT03866473|69602753|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
37915963|NCT00525499|69602767|FG000|Overall Study|Lost to Follow-up|2|||
37915964|NCT00525499|69602768|FG001|Overall Study|Lost to Follow-up|4|||
37915965|NCT00525499|69602769|FG002|Overall Study|Lost to Follow-up|1|||
37729491|NCT01733121|69208685|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
37729492|NCT01733121|69208686|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
37729493|NCT01744977|69208696|FG000|Overall Study|Withdrawal by Subject|1|||
37729494|NCT01744977|69208697|FG001|Overall Study|Withdrawal by Subject|2|||
37729495|NCT01744977|69208696|FG000|Overall Study|Death|2|||
37729496|NCT01744977|69208697|FG001|Overall Study|Death|3|||
37729497|NCT01744977|69208696|FG000|Overall Study|Lost to Follow-up|2|||
37729498|NCT01744977|69208697|FG001|Overall Study|Lost to Follow-up|0|||
37729499|NCT01744977|69208696|FG000|Overall Study|No longer meets inclusion|6|||
37729500|NCT01744977|69208697|FG001|Overall Study|No longer meets inclusion|0|||
37729501|NCT01383928|69208706|FG000|Overall Study|Initiation of ASCT|2|||
37729502|NCT01383928|69208707|FG001|Overall Study|Initiation of ASCT|1|||
37729503|NCT01383928|69208708|FG002|Overall Study|Initiation of ASCT|18|||
37729504|NCT01383928|69208706|FG000|Overall Study|Adverse Event|1|||
37729505|NCT01383928|69208707|FG001|Overall Study|Adverse Event|2|||
37729506|NCT01383928|69208708|FG002|Overall Study|Adverse Event|8|||
37729507|NCT01383928|69208706|FG000|Overall Study|Other|1|||
37729508|NCT01383928|69208707|FG001|Overall Study|Other|3|||
37729509|NCT01383928|69208708|FG002|Overall Study|Other|4|||
37729510|NCT01383928|69208706|FG000|Overall Study|Progressive Disease|1|||
37729511|NCT01383928|69208707|FG001|Overall Study|Progressive Disease|1|||
37729512|NCT01383928|69208708|FG002|Overall Study|Progressive Disease|5|||
37729513|NCT01383928|69208706|FG000|Overall Study|Withdrawal by Subject|0|||
37729514|NCT01383928|69208707|FG001|Overall Study|Withdrawal by Subject|0|||
37729515|NCT01383928|69208708|FG002|Overall Study|Withdrawal by Subject|4|||
37729516|NCT01383928|69208706|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
37729517|NCT01383928|69208707|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
37729518|NCT01383928|69208708|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
37729519|NCT01382602|69208720|FG000|Overall Study|Protocol Violation|0|||
37729520|NCT01382602|69208721|FG001|Overall Study|Protocol Violation|3|||
37729521|NCT01382602|69208720|FG000|Overall Study|Withdrawal by Subject|0|||
37729522|NCT01382602|69208721|FG001|Overall Study|Withdrawal by Subject|1|||
37729523|NCT04801420|69208730|FG000|Overall Study|Other|1|||
37729524|NCT04801420|69208731|FG001|Overall Study|Other|2|||
37729525|NCT04801420|69208732|FG002|Overall Study|Other|1|||
37729526|NCT04801420|69208730|FG000|Overall Study|Lost to Follow-up|7|||
37729527|NCT04801420|69208731|FG001|Overall Study|Lost to Follow-up|9|||
37729528|NCT04801420|69208732|FG002|Overall Study|Lost to Follow-up|10|||
37729529|NCT04801420|69208730|FG000|Overall Study|Moved from study area|0|||
37729530|NCT04801420|69208731|FG001|Overall Study|Moved from study area|1|||
37729531|NCT04801420|69208732|FG002|Overall Study|Moved from study area|1|||
37729532|NCT04801420|69208730|FG000|Overall Study|Withdrawal by Subject|5|||
37729533|NCT04801420|69208731|FG001|Overall Study|Withdrawal by Subject|1|||
37729534|NCT04801420|69208732|FG002|Overall Study|Withdrawal by Subject|4|||
37729535|NCT04801420|69208730|FG000|Overall Study|Individual stopping criteria reached|0|||
37729536|NCT04801420|69208731|FG001|Overall Study|Individual stopping criteria reached|1|||
37729537|NCT04801420|69208732|FG002|Overall Study|Individual stopping criteria reached|0|||
37729538|NCT04801420|69208730|FG000|Overall Study|Ongoing in the study|195|||
37729539|NCT04801420|69208731|FG001|Overall Study|Ongoing in the study|195|||
37729540|NCT04801420|69208732|FG002|Overall Study|Ongoing in the study|192|||
37729541|NCT04294472|69208747|FG000|Overall Study|Adverse Event|0|||
37729542|NCT04294472|69208748|FG001|Overall Study|Adverse Event|1|||
37729543|NCT04294472|69208749|FG002|Overall Study|Adverse Event|1|||
37729544|NCT04294472|69208747|FG000|Overall Study|Randomized but not treated|0|||
37729545|NCT04294472|69208748|FG001|Overall Study|Randomized but not treated|1|||
37915966|NCT00525499|69602770|FG003|Overall Study|Lost to Follow-up|4|||
37729546|NCT04294472|69208749|FG002|Overall Study|Randomized but not treated|1|||
37729547|NCT04233918|69208759|FG000|Part C (Extension Period)|Ongoing in study|0|||
37729548|NCT04233918|69208760|FG001|Part C (Extension Period)|Ongoing in study|0|||
37729549|NCT04233918|69208761|FG002|Part C (Extension Period)|Ongoing in study|15|||
37729550|NCT04060251|69208773|FG000|Overall Study|Study terminated due to low enrollment.|7|||
37729551|NCT04060251|69208774|FG001|Overall Study|Study terminated due to low enrollment.|5|||
37729552|NCT04060251|69208775|FG002|Overall Study|Study terminated due to low enrollment.|7|||
37729553|NCT04060251|69208773|FG000|Overall Study|Adverse Event|1|||
37729554|NCT04060251|69208774|FG001|Overall Study|Adverse Event|1|||
37729555|NCT04060251|69208775|FG002|Overall Study|Adverse Event|0|||
37729556|NCT04048876|69208787|FG000|Placebo Controlled Phase|Withdrawal by Subject|1|||
37729557|NCT04048876|69208788|FG001|Placebo Controlled Phase|Withdrawal by Subject|2|||
37729558|NCT04048876|69208789|FG002|Placebo Controlled Phase|Withdrawal by Subject|0|||
37729559|NCT04048876|69208790|FG003|Placebo Controlled Phase|Withdrawal by Subject|1|||
37729560|NCT04048876|69208787|FG000|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
37729561|NCT04048876|69208788|FG001|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
37729562|NCT04048876|69208789|FG002|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
37729563|NCT04048876|69208790|FG003|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
37729564|NCT04048876|69208787|FG000|Placebo Controlled Phase|Adverse Event|0|||
37729565|NCT04048876|69208788|FG001|Placebo Controlled Phase|Adverse Event|1|||
37729566|NCT04048876|69208789|FG002|Placebo Controlled Phase|Adverse Event|0|||
37729567|NCT04048876|69208790|FG003|Placebo Controlled Phase|Adverse Event|0|||
37729568|NCT04048876|69208787|FG000|Active Treatment Phase|Study Terminated by Sponsor|2|||
37729569|NCT04048876|69208788|FG001|Active Treatment Phase|Study Terminated by Sponsor|0|||
37729570|NCT04048876|69208789|FG002|Active Treatment Phase|Study Terminated by Sponsor|3|||
37729571|NCT04048876|69208790|FG003|Active Treatment Phase|Study Terminated by Sponsor|2|||
37729572|NCT03921424|69208817|FG000|Overall Study|Lost to Follow-up|0|||
37729573|NCT03921424|69208818|FG001|Overall Study|Lost to Follow-up|1|||
37729574|NCT03921424|69208817|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
37729575|NCT03921424|69208818|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
37729576|NCT03852628|69208841|FG000|Overall Study|Lost to Follow-up|7|||
37729577|NCT03852628|69208842|FG001|Overall Study|Lost to Follow-up|6|||
37729578|NCT03852628|69208841|FG000|Overall Study|Lack of Efficacy|6|||
37729579|NCT03852628|69208842|FG001|Overall Study|Lack of Efficacy|6|||
37729580|NCT03602976|69208848|FG000|Overall Study|Withdrawal by Subject|1|||
37729581|NCT03278106|69208864|FG000|Overall Study|No protocol treatment|1|||
37729582|NCT03214198|69208868|FG000|Overall Study|Case Report Forms Uncollected|18|||
37729583|NCT03214198|69208868|FG000|Overall Study|Protocol Deviation|18|||
37729584|NCT03052608|69208874|FG000|Treatment Phase|Adverse Event|10|||
37729585|NCT03052608|69208875|FG001|Treatment Phase|Adverse Event|12|||
37729586|NCT03052608|69208874|FG000|Treatment Phase|Death|6|||
37729587|NCT03052608|69208875|FG001|Treatment Phase|Death|4|||
37729588|NCT03052608|69208874|FG000|Treatment Phase|Withdrawal by Subject|4|||
37729589|NCT03052608|69208875|FG001|Treatment Phase|Withdrawal by Subject|12|||
37729590|NCT03052608|69208874|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
37729591|NCT03052608|69208875|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
37729592|NCT03052608|69208874|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
37729593|NCT03052608|69208875|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
37729594|NCT03052608|69208874|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
37729595|NCT03052608|69208875|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
37729596|NCT03052608|69208874|FG000|Treatment Phase|Ongoing|103|||
37729597|NCT03052608|69208875|FG001|Treatment Phase|Ongoing|31|||
37729598|NCT03052608|69208874|FG000|Long-Term Follow-up Phase|Death|23|||
37729599|NCT03052608|69208875|FG001|Long-Term Follow-up Phase|Death|28|||
37729600|NCT03052608|69208874|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
37729601|NCT03052608|69208875|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
37729602|NCT03052608|69208874|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
37729603|NCT03052608|69208875|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
37729604|NCT03052608|69208874|FG000|Long-Term Follow-up Phase|Ongoing|122|||
37729605|NCT03052608|69208875|FG001|Long-Term Follow-up Phase|Ongoing|99|||
37729606|NCT02914639|69208883|FG000|Overall Study|Withdrawal by Subject|0|||
37729607|NCT02914639|69208884|FG001|Overall Study|Withdrawal by Subject|2|||
37729608|NCT02865018|69208891|FG000|Overall Study|Withdrawal by Subject|1|||
37729609|NCT02704208|69208906|FG000|Overall Study|Lost to Follow-up|42|||
37729610|NCT02704208|69208907|FG001|Overall Study|Lost to Follow-up|37|||
37729611|NCT02553460|69208913|FG000|Overall Study|Death|3|||
37729612|NCT02553460|69208913|FG000|Overall Study|Withdrawal by Subject|1|||
37729613|NCT02553460|69208913|FG000|Overall Study|Development of unacceptable toxicity during treatment|1|||
37729614|NCT02553460|69208913|FG000|Overall Study|Relapse or Transplant|14|||
37729615|NCT02553460|69208913|FG000|Overall Study|No response to treatment|2|||
37729616|NCT02553460|69208913|FG000|Overall Study|Still on therapy|7|||
37729617|NCT02553460|69208913|FG000|Overall Study|CAR T cells|1|||
37729618|NCT02315898|69208930|FG000|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|2|||
37729619|NCT02315898|69208931|FG001|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
37729620|NCT02315898|69208932|FG002|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
37729621|NCT02315898|69208933|FG003|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|1|||
37729622|NCT02157883|69208940|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
37729623|NCT02157883|69208940|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
37729624|NCT02157883|69208940|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
37729625|NCT02157883|69208940|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
37729626|NCT02157883|69208940|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
37729627|NCT02071290|69208949|FG000|Overall Study|Death|1|||
37729628|NCT02071290|69208950|FG001|Overall Study|Death|0|||
37729629|NCT02071290|69208949|FG000|Overall Study|Withdrawal by Subject|0|||
37729630|NCT02071290|69208950|FG001|Overall Study|Withdrawal by Subject|1|||
37729631|NCT02071290|69208949|FG000|Overall Study|Protocol Violation|3|||
37729632|NCT02071290|69208950|FG001|Overall Study|Protocol Violation|5|||
37729633|NCT02071290|69208949|FG000|Overall Study|Physician Decision|0|||
37729634|NCT02071290|69208950|FG001|Overall Study|Physician Decision|1|||
37729635|NCT02066181|69208958|FG000|Overall Study|Withdrawal by Subject|1|||
37729636|NCT02066181|69208959|FG001|Overall Study|Withdrawal by Subject|1|||
37729637|NCT01970865|69208985|FG000|Overall Study|Death|3|||
37729638|NCT01970865|69208986|FG001|Overall Study|Death|1|||
37729639|NCT01970865|69208987|FG002|Overall Study|Death|3|||
37729640|NCT01970865|69208988|FG003|Overall Study|Death|4|||
37729641|NCT01970865|69208989|FG004|Overall Study|Death|6|||
37729642|NCT01970865|69208990|FG005|Overall Study|Death|3|||
37729643|NCT01970865|69208991|FG006|Overall Study|Death|1|||
37729644|NCT01970865|69208992|FG007|Overall Study|Death|3|||
37729645|NCT01970865|69208993|FG008|Overall Study|Death|2|||
37729646|NCT01970865|69208994|FG009|Overall Study|Death|1|||
37729647|NCT01970865|69208995|FG010|Overall Study|Death|1|||
37729648|NCT01970865|69208996|FG011|Overall Study|Death|4|||
37729649|NCT01970865|69208997|FG012|Overall Study|Death|14|||
37729650|NCT01970865|69208998|FG013|Overall Study|Death|19|||
37729651|NCT01970865|69208999|FG014|Overall Study|Death|15|||
37729652|NCT01970865|69209000|FG015|Overall Study|Death|10|||
37729653|NCT01970865|69209001|FG016|Overall Study|Death|1|||
37729654|NCT01970865|69208985|FG000|Overall Study|Lost to Follow-up|0|||
37729655|NCT01970865|69208986|FG001|Overall Study|Lost to Follow-up|0|||
37729656|NCT01970865|69208987|FG002|Overall Study|Lost to Follow-up|0|||
37729657|NCT01970865|69208988|FG003|Overall Study|Lost to Follow-up|1|||
37729658|NCT01970865|69208989|FG004|Overall Study|Lost to Follow-up|1|||
37729659|NCT01970865|69208990|FG005|Overall Study|Lost to Follow-up|0|||
37729660|NCT01970865|69208991|FG006|Overall Study|Lost to Follow-up|0|||
37729661|NCT01970865|69208992|FG007|Overall Study|Lost to Follow-up|0|||
37729662|NCT01970865|69208993|FG008|Overall Study|Lost to Follow-up|0|||
37729663|NCT01970865|69208994|FG009|Overall Study|Lost to Follow-up|0|||
37729664|NCT01970865|69208995|FG010|Overall Study|Lost to Follow-up|0|||
37729665|NCT01970865|69208996|FG011|Overall Study|Lost to Follow-up|0|||
37729666|NCT01970865|69208997|FG012|Overall Study|Lost to Follow-up|1|||
37729667|NCT01970865|69208998|FG013|Overall Study|Lost to Follow-up|0|||
37915967|NCT00525499|69602767|FG000|Overall Study|Adverse Event|0|||
37915968|NCT00525499|69602768|FG001|Overall Study|Adverse Event|1|||
37729668|NCT01970865|69208999|FG014|Overall Study|Lost to Follow-up|0|||
37729669|NCT01970865|69209000|FG015|Overall Study|Lost to Follow-up|0|||
37843579|NCT02242942|69528230|FG000|Overall Study|Death|17|||
37843580|NCT02242942|69528231|FG001|Overall Study|Death|20|||
37843581|NCT02242942|69528232|FG002|Overall Study|Death|2|||
37843582|NCT02242942|69528230|FG000|Overall Study|Physician Decision|1|||
37843583|NCT02242942|69528231|FG001|Overall Study|Physician Decision|0|||
37843584|NCT02242942|69528232|FG002|Overall Study|Physician Decision|0|||
37843585|NCT02242942|69528230|FG000|Overall Study|Withdrawal by Subject|8|||
37843586|NCT02242942|69528231|FG001|Overall Study|Withdrawal by Subject|10|||
37843587|NCT02242942|69528232|FG002|Overall Study|Withdrawal by Subject|0|||
37843588|NCT02242942|69528230|FG000|Overall Study|On-going in Study|190|||
37729670|NCT01970865|69209001|FG016|Overall Study|Lost to Follow-up|0|||
37729671|NCT01970865|69208985|FG000|Overall Study|Withdrawal by Subject|0|||
37729672|NCT01970865|69208986|FG001|Overall Study|Withdrawal by Subject|0|||
37729673|NCT01970865|69208987|FG002|Overall Study|Withdrawal by Subject|0|||
37843589|NCT02242942|69528231|FG001|Overall Study|On-going in Study|186|||
37729674|NCT01970865|69208988|FG003|Overall Study|Withdrawal by Subject|1|||
37729675|NCT01970865|69208989|FG004|Overall Study|Withdrawal by Subject|2|||
37843590|NCT02242942|69528232|FG002|Overall Study|On-going in Study|11|||
37843591|NCT02049515|69528262|FG000|Overall Study|Adverse Event|46|||
37843592|NCT02049515|69528263|FG001|Overall Study|Adverse Event|2|||
37843593|NCT02049515|69528262|FG000|Overall Study|Protocol-specified Disease Progression|23|||
37729676|NCT01970865|69208990|FG005|Overall Study|Withdrawal by Subject|0|||
37729677|NCT01970865|69208991|FG006|Overall Study|Withdrawal by Subject|0|||
37729678|NCT01970865|69208992|FG007|Overall Study|Withdrawal by Subject|0|||
37729679|NCT01970865|69208993|FG008|Overall Study|Withdrawal by Subject|0|||
37729680|NCT01970865|69208994|FG009|Overall Study|Withdrawal by Subject|0|||
37729681|NCT01970865|69208995|FG010|Overall Study|Withdrawal by Subject|0|||
37729682|NCT01970865|69208996|FG011|Overall Study|Withdrawal by Subject|1|||
37729683|NCT01970865|69208997|FG012|Overall Study|Withdrawal by Subject|2|||
37729684|NCT01970865|69208998|FG013|Overall Study|Withdrawal by Subject|5|||
37843594|NCT02049515|69528263|FG001|Overall Study|Protocol-specified Disease Progression|2|||
37729685|NCT01970865|69208999|FG014|Overall Study|Withdrawal by Subject|2|||
37729686|NCT01970865|69209000|FG015|Overall Study|Withdrawal by Subject|7|||
37729687|NCT01970865|69209001|FG016|Overall Study|Withdrawal by Subject|0|||
37843595|NCT02049515|69528262|FG000|Overall Study|Death|6|||
37843596|NCT02049515|69528263|FG001|Overall Study|Death|0|||
37843597|NCT02049515|69528262|FG000|Overall Study|Physician Decision|5|||
37843598|NCT02049515|69528263|FG001|Overall Study|Physician Decision|1|||
37843599|NCT02049515|69528262|FG000|Overall Study|Withdrawal by Subject|3|||
37729688|NCT01970865|69208985|FG000|Overall Study|Other|0|||
37729689|NCT01970865|69208986|FG001|Overall Study|Other|0|||
37729690|NCT01970865|69208987|FG002|Overall Study|Other|0|||
37729691|NCT01970865|69208988|FG003|Overall Study|Other|1|||
37729692|NCT01970865|69208989|FG004|Overall Study|Other|0|||
37729693|NCT01970865|69208990|FG005|Overall Study|Other|0|||
37729694|NCT01970865|69208991|FG006|Overall Study|Other|0|||
37729695|NCT01970865|69208992|FG007|Overall Study|Other|0|||
37729696|NCT01970865|69208993|FG008|Overall Study|Other|0|||
37729697|NCT01970865|69208994|FG009|Overall Study|Other|0|||
37729698|NCT01970865|69208995|FG010|Overall Study|Other|0|||
37729699|NCT01970865|69208996|FG011|Overall Study|Other|0|||
37729700|NCT01970865|69208997|FG012|Overall Study|Other|0|||
37729701|NCT01970865|69208998|FG013|Overall Study|Other|1|||
37729702|NCT01970865|69208999|FG014|Overall Study|Other|0|||
37729703|NCT01970865|69209000|FG015|Overall Study|Other|1|||
37729704|NCT01970865|69209001|FG016|Overall Study|Other|0|||
37729705|NCT01970865|69208985|FG000|Overall Study|Study ongoing|0|||
37729706|NCT01970865|69208986|FG001|Overall Study|Study ongoing|2|||
37729707|NCT01970865|69208987|FG002|Overall Study|Study ongoing|0|||
37729708|NCT01970865|69208988|FG003|Overall Study|Study ongoing|6|||
37729709|NCT01970865|69208989|FG004|Overall Study|Study ongoing|8|||
37729710|NCT01970865|69208990|FG005|Overall Study|Study ongoing|0|||
37729711|NCT01970865|69208991|FG006|Overall Study|Study ongoing|2|||
37729712|NCT01970865|69208992|FG007|Overall Study|Study ongoing|0|||
37729713|NCT01970865|69208993|FG008|Overall Study|Study ongoing|1|||
37729714|NCT01970865|69208994|FG009|Overall Study|Study ongoing|3|||
37729715|NCT01970865|69208995|FG010|Overall Study|Study ongoing|29|||
37729716|NCT01970865|69208996|FG011|Overall Study|Study ongoing|22|||
37729717|NCT01970865|69208997|FG012|Overall Study|Study ongoing|43|||
37729718|NCT01970865|69208998|FG013|Overall Study|Study ongoing|41|||
37729719|NCT01970865|69208999|FG014|Overall Study|Study ongoing|29|||
37729720|NCT01970865|69209000|FG015|Overall Study|Study ongoing|29|||
37729721|NCT01970865|69209001|FG016|Overall Study|Study ongoing|2|||
37729722|NCT01711541|69209076|FG000|Overall Study|Cancel prior to treatment|0|||
37729723|NCT01711541|69209077|FG001|Overall Study|Cancel prior to treatment|0|||
37729724|NCT01711541|69209078|FG002|Overall Study|Cancel prior to treatment|0|||
37729725|NCT01711541|69209079|FG003|Overall Study|Cancel prior to treatment|1|||
37729726|NCT01711541|69209080|FG004|Overall Study|Cancel prior to treatment|0|||
37729727|NCT01711541|69209076|FG000|Overall Study|Ineligible|0|||
37729728|NCT01711541|69209077|FG001|Overall Study|Ineligible|1|||
37729729|NCT01711541|69209078|FG002|Overall Study|Ineligible|0|||
37729730|NCT01711541|69209079|FG003|Overall Study|Ineligible|0|||
37729731|NCT01711541|69209080|FG004|Overall Study|Ineligible|0|||
37729732|NCT01382446|69209116|FG000|Overall Study|Withdrawal by Subject|0|||
37729733|NCT01382446|69209117|FG001|Overall Study|Withdrawal by Subject|1|||
37729734|NCT01382446|69209116|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
37729735|NCT01382446|69209117|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
37729736|NCT01382212|69209123|FG000|Overall Study|Kidney transplant|1|||
37729737|NCT01382212|69209123|FG000|Overall Study|Withdrew consent|1|||
37729738|NCT01381900|69209130|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
37729739|NCT01381900|69209131|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
37729740|NCT01381900|69209132|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
37729741|NCT01381900|69209130|FG000|Overall Study|Adverse Event|4|||
37729742|NCT01381900|69209131|FG001|Overall Study|Adverse Event|6|||
37729743|NCT01381900|69209132|FG002|Overall Study|Adverse Event|7|||
37729744|NCT01381900|69209130|FG000|Overall Study|Noncompliance with study drug|0|||
37729745|NCT01381900|69209131|FG001|Overall Study|Noncompliance with study drug|0|||
37729746|NCT01381900|69209132|FG002|Overall Study|Noncompliance with study drug|1|||
37729747|NCT01381900|69209130|FG000|Overall Study|Physician Decision|0|||
37729748|NCT01381900|69209131|FG001|Overall Study|Physician Decision|1|||
37729749|NCT01381900|69209132|FG002|Overall Study|Physician Decision|1|||
37729750|NCT01381900|69209130|FG000|Overall Study|Protocol Violation|0|||
37729751|NCT01381900|69209131|FG001|Overall Study|Protocol Violation|1|||
37729752|NCT01381900|69209132|FG002|Overall Study|Protocol Violation|1|||
37729753|NCT01381900|69209130|FG000|Overall Study|Withdrawal by Subject|0|||
37729754|NCT01381900|69209131|FG001|Overall Study|Withdrawal by Subject|0|||
37729755|NCT01381900|69209132|FG002|Overall Study|Withdrawal by Subject|1|||
37729756|NCT01381900|69209130|FG000|Overall Study|Early withdraw|3|||
37729757|NCT01381900|69209131|FG001|Overall Study|Early withdraw|1|||
37729758|NCT01381900|69209132|FG002|Overall Study|Early withdraw|1|||
37843600|NCT02049515|69528263|FG001|Overall Study|Withdrawal by Subject|0|||
37729759|NCT01744665|69209140|FG000|Monitoring Phase|Adverse Event|4|||
37729760|NCT01744665|69209140|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
37729761|NCT01744665|69209140|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
37729762|NCT01744665|69209140|FG000|Monitoring Phase|Withdrawal by Subject|5|||
37729763|NCT01744665|69209140|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
37729764|NCT01744665|69209140|FG000|Consolidation Phase|Adverse Event|2|||
37729765|NCT01744665|69209140|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
37729766|NCT01744665|69209140|FG000|Consolidation Phase|Withdrawal by Subject|4|||
37729767|NCT01744665|69209140|FG000|Consolidation Phase|Administrative problems|9|||
37729768|NCT01744665|69209140|FG000|Re-initiation Phase|Administrative problems|10|||
37729769|NCT01744665|69209140|FG000|Re-initiation Phase|Adverse Event|1|||
37729770|NCT01744665|69209140|FG000|Re-initiation Phase|No longer required treatment|1|||
37729771|NCT01744665|69209140|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
37729772|NCT01744197|69209149|FG000|Overall Study|Received 1 patch|2|||
37729773|NCT01744197|69209150|FG001|Overall Study|Received 1 patch|1|||
37729774|NCT01744197|69209149|FG000|Overall Study|No patch received|2|||
37729775|NCT01744197|69209150|FG001|Overall Study|No patch received|2|||
37729776|NCT01732107|69209156|FG000|Overall Study|Adverse Event|2|||
37729777|NCT01732107|69209156|FG000|Overall Study|Disease Progression|8|||
37729778|NCT01732107|69209156|FG000|Overall Study|Physician Decision|1|||
37729779|NCT01732107|69209156|FG000|Overall Study|Withdrawal by Subject|2|||
37729780|NCT01743027|69209164|FG000|Overall Study|Adverse Event|2|||
37729781|NCT01743027|69209165|FG001|Overall Study|Adverse Event|0|||
37729782|NCT01743027|69209166|FG002|Overall Study|Adverse Event|0|||
37729783|NCT01743027|69209167|FG003|Overall Study|Adverse Event|0|||
37729784|NCT01743027|69209164|FG000|Overall Study|Lost to Follow-up|0|||
37729785|NCT01743027|69209165|FG001|Overall Study|Lost to Follow-up|0|||
37729786|NCT01743027|69209166|FG002|Overall Study|Lost to Follow-up|2|||
37729787|NCT01743027|69209167|FG003|Overall Study|Lost to Follow-up|0|||
37729788|NCT01743027|69209164|FG000|Overall Study|Progressive Disease|1|||
37729789|NCT01743027|69209165|FG001|Overall Study|Progressive Disease|4|||
37729790|NCT01743027|69209166|FG002|Overall Study|Progressive Disease|3|||
37729791|NCT01743027|69209167|FG003|Overall Study|Progressive Disease|0|||
37729792|NCT01743027|69209164|FG000|Overall Study|Protocol Violation|1|||
37729793|NCT01743027|69209165|FG001|Overall Study|Protocol Violation|1|||
37729794|NCT01743027|69209166|FG002|Overall Study|Protocol Violation|1|||
37729795|NCT01743027|69209167|FG003|Overall Study|Protocol Violation|0|||
37729796|NCT01743027|69209164|FG000|Overall Study|Withdrawal by Subject|1|||
37729797|NCT01743027|69209165|FG001|Overall Study|Withdrawal by Subject|0|||
37729798|NCT01743027|69209166|FG002|Overall Study|Withdrawal by Subject|3|||
37729799|NCT01743027|69209167|FG003|Overall Study|Withdrawal by Subject|1|||
37729800|NCT01380730|69209185|FG000|Overall Study|Death|0|||
37729801|NCT01380730|69209186|FG001|Overall Study|Death|0|||
37729802|NCT01380730|69209187|FG002|Overall Study|Death|0|||
37729803|NCT01380730|69209188|FG003|Overall Study|Death|0|||
37729804|NCT01380730|69209189|FG004|Overall Study|Death|1|||
37729805|NCT01380730|69209190|FG005|Overall Study|Death|0|||
37729806|NCT01380730|69209191|FG006|Overall Study|Death|0|||
37729807|NCT01380730|69209192|FG007|Overall Study|Death|0|||
37729808|NCT01395784|69209210|FG000|Overall Study|Lost to Follow-up|7|||
37729809|NCT01395784|69209210|FG000|Overall Study|Withdrawal by Subject|3|||
37729810|NCT01395784|69209210|FG000|Overall Study|Physician Decision|5|||
37729811|NCT01380184|69209214|FG000|Part 1 (19 Days)|Adverse Event|1|||
37729812|NCT01380184|69209214|FG000|Part 2|Adverse Event|5|||
37729813|NCT01380184|69209214|FG000|Part 2|Disease Progression|8|||
37729814|NCT01380184|69209214|FG000|Part 2|Lost to Follow-up|1|||
37729815|NCT01395394|69209221|FG000|Baseline Study Visit|Protocol Violation|1|||
37729816|NCT01395394|69209222|FG001|Baseline Study Visit|Protocol Violation|0|||
37729817|NCT01395394|69209223|FG002|Baseline Study Visit|Protocol Violation|0|||
37729818|NCT01395316|69209231|FG000|Overall Study|Lost to Follow-up|2|||
37729819|NCT01395316|69209231|FG000|Overall Study|poor MRI quality|1|||
37729820|NCT01742091|69209241|FG000|Overall Study|Adverse Event|0|||
37729821|NCT01742091|69209242|FG001|Overall Study|Adverse Event|0|||
37729822|NCT01742091|69209243|FG002|Overall Study|Adverse Event|0|||
37729823|NCT01742091|69209244|FG003|Overall Study|Adverse Event|0|||
37729824|NCT01742091|69209245|FG004|Overall Study|Adverse Event|1|||
37729825|NCT01742091|69209246|FG005|Overall Study|Adverse Event|0|||
37729826|NCT01742091|69209241|FG000|Overall Study|Physician Decision|0|||
37729827|NCT01742091|69209242|FG001|Overall Study|Physician Decision|0|||
37729828|NCT01742091|69209243|FG002|Overall Study|Physician Decision|0|||
37843601|NCT02049515|69528262|FG000|Overall Study|Termination of the Study by Sponsor|2|||
37843602|NCT02049515|69528263|FG001|Overall Study|Termination of the Study by Sponsor|0|||
37729829|NCT01742091|69209244|FG003|Overall Study|Physician Decision|0|||
37729830|NCT01742091|69209245|FG004|Overall Study|Physician Decision|0|||
37729831|NCT01742091|69209246|FG005|Overall Study|Physician Decision|1|||
37729832|NCT01742091|69209241|FG000|Overall Study|Withdrawal by Subject|0|||
37729833|NCT01742091|69209242|FG001|Overall Study|Withdrawal by Subject|0|||
37843603|NCT02049515|69528262|FG000|Overall Study|Protocol Violation|1|||
37843604|NCT02049515|69528263|FG001|Overall Study|Protocol Violation|1|||
37729834|NCT01742091|69209243|FG002|Overall Study|Withdrawal by Subject|0|||
37729835|NCT01742091|69209244|FG003|Overall Study|Withdrawal by Subject|1|||
37729836|NCT01742091|69209245|FG004|Overall Study|Withdrawal by Subject|0|||
37729837|NCT01742091|69209246|FG005|Overall Study|Withdrawal by Subject|0|||
37729838|NCT01742091|69209241|FG000|Overall Study|Lost to Follow-up|0|||
37729839|NCT01742091|69209242|FG001|Overall Study|Lost to Follow-up|0|||
37729840|NCT01742091|69209243|FG002|Overall Study|Lost to Follow-up|0|||
37729841|NCT01742091|69209244|FG003|Overall Study|Lost to Follow-up|0|||
37729842|NCT01742091|69209245|FG004|Overall Study|Lost to Follow-up|0|||
37729843|NCT01742091|69209246|FG005|Overall Study|Lost to Follow-up|1|||
37729844|NCT01731951|69209266|FG000|Overall Study|Documented Disease Progression|1|||
37729845|NCT01731951|69209267|FG001|Overall Study|Documented Disease Progression|0|||
37729846|NCT01731951|69209268|FG002|Overall Study|Documented Disease Progression|0|||
37729847|NCT01731951|69209269|FG003|Overall Study|Documented Disease Progression|0|||
37729848|NCT01731951|69209270|FG004|Overall Study|Documented Disease Progression|0|||
37729849|NCT01731951|69209271|FG005|Overall Study|Documented Disease Progression|0|||
37729850|NCT01731951|69209266|FG000|Overall Study|Lost to Follow-up|2|||
37729851|NCT01731951|69209267|FG001|Overall Study|Lost to Follow-up|0|||
37729852|NCT01731951|69209268|FG002|Overall Study|Lost to Follow-up|0|||
37729853|NCT01731951|69209269|FG003|Overall Study|Lost to Follow-up|1|||
37729854|NCT01731951|69209270|FG004|Overall Study|Lost to Follow-up|3|||
37729855|NCT01731951|69209271|FG005|Overall Study|Lost to Follow-up|1|||
37729856|NCT01731951|69209266|FG000|Overall Study|Withdrawal of Consent|1|||
37729857|NCT01731951|69209267|FG001|Overall Study|Withdrawal of Consent|0|||
37729858|NCT01731951|69209268|FG002|Overall Study|Withdrawal of Consent|0|||
37729859|NCT01731951|69209269|FG003|Overall Study|Withdrawal of Consent|0|||
37729860|NCT01731951|69209270|FG004|Overall Study|Withdrawal of Consent|0|||
37729861|NCT01731951|69209271|FG005|Overall Study|Withdrawal of Consent|2|||
37729862|NCT01731951|69209266|FG000|Overall Study|Death|13|||
37729863|NCT01731951|69209267|FG001|Overall Study|Death|15|||
37729864|NCT01731951|69209268|FG002|Overall Study|Death|9|||
37729865|NCT01731951|69209269|FG003|Overall Study|Death|8|||
37729866|NCT01731951|69209270|FG004|Overall Study|Death|9|||
37729867|NCT01731951|69209271|FG005|Overall Study|Death|6|||
37729868|NCT01731171|69209291|FG000|Overall Study|Withdrawal by Subject|4|||
37729869|NCT01731171|69209292|FG001|Overall Study|Withdrawal by Subject|1|||
37729870|NCT01731171|69209291|FG000|Overall Study|Lost to Follow-up|3|||
37729871|NCT01731171|69209292|FG001|Overall Study|Lost to Follow-up|2|||
37729872|NCT01731171|69209291|FG000|Overall Study|Moved out of Area|0|||
37729873|NCT01731171|69209292|FG001|Overall Study|Moved out of Area|2|||
37729874|NCT01731171|69209291|FG000|Overall Study|Terminated for Lack of Adherence|0|||
37729875|NCT01731171|69209292|FG001|Overall Study|Terminated for Lack of Adherence|1|||
37729876|NCT01731171|69209291|FG000|Overall Study|Terminated for Safety Reasons|0|||
37729877|NCT01731171|69209292|FG001|Overall Study|Terminated for Safety Reasons|1|||
37729878|NCT01741701|69209300|FG000|Overall Study|Adverse Event|5|||
37729879|NCT01741701|69209301|FG001|Overall Study|Adverse Event|1|||
37729880|NCT01741701|69209300|FG000|Overall Study|Withdrawal by Subject|0|||
37729881|NCT01741701|69209301|FG001|Overall Study|Withdrawal by Subject|1|||
37729882|NCT01741545|69209309|FG000|Treatment Period|Lack of Efficacy|0|||
37729883|NCT01741545|69209310|FG001|Treatment Period|Lack of Efficacy|1|||
37729884|NCT01741545|69209309|FG000|Treatment Period|Adverse event, non-fatal|1|||
37729885|NCT01741545|69209310|FG001|Treatment Period|Adverse event, non-fatal|3|||
37729886|NCT01741545|69209309|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
37729887|NCT01741545|69209310|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
37729888|NCT01741545|69209309|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
37729889|NCT01741545|69209310|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
37729890|NCT01884350|69209318|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
37729891|NCT01884350|69209319|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
37729892|NCT01884350|69209320|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
37729893|NCT01884350|69209318|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
37729894|NCT01884350|69209319|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
37729895|NCT01884350|69209320|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
37729896|NCT01884350|69209318|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
37729897|NCT01884350|69209319|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
37729898|NCT01884350|69209320|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
37729899|NCT01884350|69209318|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
37729900|NCT01884350|69209319|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
37729901|NCT01884350|69209320|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
37729902|NCT01884350|69209318|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
37729903|NCT01884350|69209319|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
37729904|NCT01884350|69209320|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
37729905|NCT01884350|69209318|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
37915969|NCT00525499|69602769|FG002|Overall Study|Adverse Event|0|||
37915970|NCT00525499|69602770|FG003|Overall Study|Adverse Event|1|||
37729906|NCT01884350|69209319|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
37729907|NCT01884350|69209320|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
37729908|NCT01884350|69209318|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
37729909|NCT01884350|69209319|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
37729910|NCT01884350|69209320|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
37729911|NCT01884350|69209318|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
37729912|NCT01884350|69209319|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
37729913|NCT01884350|69209320|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
37729914|NCT01884350|69209318|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
37729915|NCT01884350|69209319|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
37729916|NCT01884350|69209320|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
37729917|NCT01884350|69209318|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
37729918|NCT01884350|69209319|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
37729919|NCT01884350|69209320|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
37729920|NCT01884350|69209318|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
37729921|NCT01884350|69209319|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
37729922|NCT01884350|69209320|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
38025616|NCT04075604|69710138|FG000|Overall Study|Participant withdrew consent|0|||
38025617|NCT04075604|69710139|FG001|Overall Study|Participant withdrew consent|0|||
37729923|NCT01884350|69209318|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
37729924|NCT01884350|69209319|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
37729925|NCT01884350|69209320|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
37729926|NCT01884350|69209318|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
37729927|NCT01884350|69209319|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
37729928|NCT01884350|69209320|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
37729929|NCT01884350|69209318|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
37729930|NCT01884350|69209319|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
37729931|NCT01884350|69209320|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
37729932|NCT01884350|69209318|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
37729933|NCT01884350|69209319|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
37729934|NCT01884350|69209320|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
37729935|NCT01884350|69209318|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
37729936|NCT01884350|69209319|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
37729937|NCT01884350|69209320|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
37729938|NCT01884350|69209318|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
37729939|NCT01884350|69209319|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
37729940|NCT01884350|69209320|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
37729941|NCT01884350|69209318|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
37729942|NCT01884350|69209319|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
37729943|NCT01884350|69209320|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
37729944|NCT01884350|69209318|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
37729945|NCT01884350|69209319|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
37729946|NCT01884350|69209320|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
37729947|NCT01884350|69209318|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
37729948|NCT01884350|69209319|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
37729949|NCT01884350|69209320|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
37729950|NCT01884350|69209318|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
37729951|NCT01884350|69209319|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
37729952|NCT01884350|69209320|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
37729953|NCT01884350|69209318|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
37729954|NCT01884350|69209319|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
37729955|NCT01884350|69209320|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
37729956|NCT01614795|69209334|FG000|Overall Study|Adverse Event|0|||
37729957|NCT01614795|69209335|FG001|Overall Study|Adverse Event|0|||
37729958|NCT01614795|69209336|FG002|Overall Study|Adverse Event|1|||
37729959|NCT01614795|69209337|FG003|Overall Study|Adverse Event|1|||
37729960|NCT01614795|69209334|FG000|Overall Study|Lack of Efficacy|10|||
37729961|NCT01614795|69209335|FG001|Overall Study|Lack of Efficacy|10|||
37729962|NCT01614795|69209336|FG002|Overall Study|Lack of Efficacy|9|||
37843605|NCT02049515|69528262|FG000|Overall Study|Clinical Deterioration|1|||
37843606|NCT02049515|69528263|FG001|Overall Study|Clinical Deterioration|0|||
37843607|NCT02049515|69528262|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
38025618|NCT04075604|69710140|FG002|Overall Study|Participant withdrew consent|1|||
38025619|NCT04075604|69710138|FG000|Overall Study|Other reasons|1|||
37729963|NCT01614795|69209337|FG003|Overall Study|Lack of Efficacy|8|||
37729964|NCT01614795|69209334|FG000|Overall Study|Physician Decision|1|||
37729965|NCT01614795|69209335|FG001|Overall Study|Physician Decision|0|||
37729966|NCT01614795|69209336|FG002|Overall Study|Physician Decision|1|||
37843608|NCT02049515|69528263|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
37843609|NCT02049515|69528262|FG000|Overall Study|Treatment Interruption >42 Days|1|||
37729967|NCT01614795|69209337|FG003|Overall Study|Physician Decision|1|||
37729968|NCT01614795|69209334|FG000|Overall Study|Withdrawal by Subject|0|||
37729969|NCT01614795|69209335|FG001|Overall Study|Withdrawal by Subject|1|||
37729970|NCT01614795|69209336|FG002|Overall Study|Withdrawal by Subject|0|||
37729971|NCT01614795|69209337|FG003|Overall Study|Withdrawal by Subject|2|||
37729972|NCT01614795|69209334|FG000|Overall Study|Ineligible|0|||
37729973|NCT01614795|69209335|FG001|Overall Study|Ineligible|1|||
37729974|NCT01614795|69209336|FG002|Overall Study|Ineligible|0|||
37729975|NCT01614795|69209337|FG003|Overall Study|Ineligible|0|||
37729976|NCT01834586|69209348|FG000|Overall Study|Adverse Event|1|||
37729977|NCT01614249|69209354|FG000|Overall Study|Lost to Follow-up|11|||
37729978|NCT01614249|69209355|FG001|Overall Study|Lost to Follow-up|23|||
37843610|NCT02049515|69528263|FG001|Overall Study|Treatment Interruption >42 Days|0|||
37843611|NCT02049515|69528262|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
37843612|NCT02049515|69528263|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
37843613|NCT02039401|69528271|FG000|Overall Study|Adverse Event|0|||
37843614|NCT02039401|69528272|FG001|Overall Study|Adverse Event|1|||
37843615|NCT02004691|69528281|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
37843616|NCT02004691|69528282|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
37843617|NCT02004691|69528281|FG000|ETP: Ongoing From Week 52|Related to Coronavirus Disease (COVID-19)|1|||
37843618|NCT02004691|69528282|FG001|ETP: Ongoing From Week 52|Related to Coronavirus Disease (COVID-19)|0|||
37843619|NCT02004691|69528281|FG000|ETP: Ongoing From Week 52|Withdrawal by Subject|0|||
37843620|NCT02004691|69528282|FG001|ETP: Ongoing From Week 52|Withdrawal by Subject|1|||
37843621|NCT02004691|69528281|FG000|ETP: Ongoing From Week 52|Other|0|||
37843622|NCT02004691|69528282|FG001|ETP: Ongoing From Week 52|Other|1|||
37843623|NCT02004691|69528281|FG000|ETP: Ongoing From Week 52|Ongoing|16|||
37843624|NCT02004691|69528282|FG001|ETP: Ongoing From Week 52|Ongoing|16|||
37843625|NCT02004522|69528290|FG000|Overall Study|Adverse Event|55|||
37843626|NCT02004522|69528291|FG001|Overall Study|Adverse Event|6|||
37843627|NCT02004522|69528290|FG000|Overall Study|Withdrawal by Subject|13|||
37843628|NCT02004522|69528291|FG001|Overall Study|Withdrawal by Subject|7|||
37843629|NCT02004522|69528290|FG000|Overall Study|Death|12|||
37843630|NCT02004522|69528291|FG001|Overall Study|Death|3|||
37843631|NCT02004522|69528290|FG000|Overall Study|Physician Decision|3|||
37729979|NCT01597778|69209363|FG000|Overall Study|Death|7|||
37729980|NCT01597778|69209364|FG001|Overall Study|Death|10|||
37729981|NCT01597778|69209363|FG000|Overall Study|Withdrawal by Subject|3|||
37729982|NCT01597778|69209364|FG001|Overall Study|Withdrawal by Subject|4|||
37729983|NCT01597778|69209363|FG000|Overall Study|Adverse Event|1|||
37729984|NCT01597778|69209364|FG001|Overall Study|Adverse Event|1|||
37729985|NCT01597778|69209363|FG000|Overall Study|Protocol Violation|1|||
37729986|NCT01597778|69209364|FG001|Overall Study|Protocol Violation|11|||
37915971|NCT00525499|69602767|FG000|Overall Study|Withdrawal by Subject|5|||
37729987|NCT01597778|69209363|FG000|Overall Study|Transplanted off protocol|2|||
37729988|NCT01597778|69209364|FG001|Overall Study|Transplanted off protocol|3|||
37915972|NCT00525499|69602768|FG001|Overall Study|Withdrawal by Subject|1|||
37915973|NCT00525499|69602769|FG002|Overall Study|Withdrawal by Subject|5|||
37915974|NCT00525499|69602770|FG003|Overall Study|Withdrawal by Subject|2|||
37915975|NCT00525499|69602767|FG000|Overall Study|Protocol Violation|0|||
37915976|NCT00525499|69602768|FG001|Overall Study|Protocol Violation|1|||
37915977|NCT00525499|69602769|FG002|Overall Study|Protocol Violation|1|||
37915978|NCT00525499|69602770|FG003|Overall Study|Protocol Violation|0|||
37915979|NCT00824655|69602782|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
38025620|NCT04075604|69710139|FG001|Overall Study|Other reasons|0|||
38025621|NCT04075604|69710140|FG002|Overall Study|Other reasons|0|||
37729989|NCT01614093|69209370|FG000|Overall Study|Withdrawal by Subject|1|||
37729990|NCT01834274|69209377|FG000|Overall Study|Study Termination|41|||
37729991|NCT01834274|69209378|FG001|Overall Study|Study Termination|38|||
37729992|NCT01834274|69209377|FG000|Overall Study|Withdrawal by Subject|1|||
37729993|NCT01834274|69209378|FG001|Overall Study|Withdrawal by Subject|1|||
37729994|NCT01834274|69209377|FG000|Overall Study|Lost to Follow-up|3|||
37729995|NCT01834274|69209378|FG001|Overall Study|Lost to Follow-up|1|||
37729996|NCT01834274|69209377|FG000|Overall Study|Other|2|||
37729997|NCT01834274|69209378|FG001|Overall Study|Other|1|||
37729998|NCT01739595|69209387|FG000|Overall Study|Adverse Event|3|||
37729999|NCT01739595|69209388|FG001|Overall Study|Adverse Event|0|||
37730000|NCT01739595|69209389|FG002|Overall Study|Adverse Event|0|||
37730001|NCT01739595|69209387|FG000|Overall Study|Lost to Follow-up|2|||
37730002|NCT01739595|69209388|FG001|Overall Study|Lost to Follow-up|0|||
37730003|NCT01739595|69209389|FG002|Overall Study|Lost to Follow-up|0|||
37730004|NCT01739595|69209387|FG000|Overall Study|Withdrawal by Subject|2|||
37730005|NCT01739595|69209388|FG001|Overall Study|Withdrawal by Subject|1|||
37730006|NCT01739595|69209389|FG002|Overall Study|Withdrawal by Subject|2|||
37730007|NCT01739595|69209387|FG000|Overall Study|Eligibility issue|3|||
37730008|NCT01739595|69209388|FG001|Overall Study|Eligibility issue|0|||
37730009|NCT01739595|69209389|FG002|Overall Study|Eligibility issue|0|||
37730010|NCT01739595|69209387|FG000|Overall Study|Protocol Violation|1|||
37730011|NCT01739595|69209388|FG001|Overall Study|Protocol Violation|0|||
37730012|NCT01739595|69209389|FG002|Overall Study|Protocol Violation|0|||
37730013|NCT01739595|69209387|FG000|Overall Study|Lab assessment|1|||
37730014|NCT01739595|69209388|FG001|Overall Study|Lab assessment|0|||
37730015|NCT01739595|69209389|FG002|Overall Study|Lab assessment|0|||
37730016|NCT01739595|69209387|FG000|Overall Study|Drug discrepancy|1|||
37730017|NCT01739595|69209388|FG001|Overall Study|Drug discrepancy|0|||
37730018|NCT01739595|69209389|FG002|Overall Study|Drug discrepancy|0|||
37730019|NCT01833494|69209396|FG000|Overall Study|Adverse Event|24|||
37730020|NCT01833494|69209396|FG000|Overall Study|Physician Decision|6|||
37730021|NCT01833494|69209396|FG000|Overall Study|Withdrawal by Subject|6|||
37730022|NCT01833494|69209396|FG000|Overall Study|Decrease in serum phosphorus|4|||
37730023|NCT01833494|69209396|FG000|Overall Study|Decrease in serum calcium|4|||
37730024|NCT01833494|69209396|FG000|Overall Study|Increase in serum ferritin|1|||
37730025|NCT01738971|69209403|FG000|Overall Study|Lost to Follow-up|19|||
37730026|NCT01738971|69209404|FG001|Overall Study|Lost to Follow-up|30|||
37730027|NCT01738971|69209405|FG002|Overall Study|Lost to Follow-up|17|||
37730028|NCT01738581|69209415|FG000|Overall Study|Lost to Follow-up|1|||
37730029|NCT01738581|69209416|FG001|Overall Study|Lost to Follow-up|0|||
37730030|NCT01738503|69209428|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
37730031|NCT01738503|69209429|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
37730032|NCT01738503|69209430|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
37730033|NCT01738503|69209431|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
37730034|NCT01738503|69209432|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
37730035|NCT01738503|69209433|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
37730036|NCT01738503|69209434|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
37730037|NCT01738503|69209428|FG000|Treatment Period|Adverse Event|0|||
37730038|NCT01738503|69209429|FG001|Treatment Period|Adverse Event|1|||
37730039|NCT01738503|69209430|FG002|Treatment Period|Adverse Event|0|||
37730040|NCT01738503|69209431|FG003|Treatment Period|Adverse Event|1|||
37730041|NCT01738503|69209432|FG004|Treatment Period|Adverse Event|2|||
37730042|NCT01738503|69209433|FG005|Treatment Period|Adverse Event|2|||
37730043|NCT01738503|69209434|FG006|Treatment Period|Adverse Event|2|||
37730044|NCT01738503|69209428|FG000|Treatment Period|Lost to Follow-up|0|||
37730045|NCT01738503|69209429|FG001|Treatment Period|Lost to Follow-up|0|||
37730046|NCT01738503|69209430|FG002|Treatment Period|Lost to Follow-up|3|||
37730047|NCT01738503|69209431|FG003|Treatment Period|Lost to Follow-up|4|||
37730048|NCT01738503|69209432|FG004|Treatment Period|Lost to Follow-up|1|||
37730049|NCT01738503|69209433|FG005|Treatment Period|Lost to Follow-up|1|||
37730050|NCT01738503|69209434|FG006|Treatment Period|Lost to Follow-up|5|||
37730051|NCT01738503|69209428|FG000|Treatment Period|Withdrawal by Subject|0|||
37730052|NCT01738503|69209429|FG001|Treatment Period|Withdrawal by Subject|1|||
37730053|NCT01738503|69209430|FG002|Treatment Period|Withdrawal by Subject|0|||
37730054|NCT01738503|69209431|FG003|Treatment Period|Withdrawal by Subject|1|||
37730055|NCT01738503|69209432|FG004|Treatment Period|Withdrawal by Subject|1|||
37730056|NCT01738503|69209433|FG005|Treatment Period|Withdrawal by Subject|1|||
37730057|NCT01738503|69209434|FG006|Treatment Period|Withdrawal by Subject|1|||
37730058|NCT01738503|69209428|FG000|Treatment Period|Protocol Violation|0|||
37730059|NCT01738503|69209429|FG001|Treatment Period|Protocol Violation|3|||
37730060|NCT01738503|69209430|FG002|Treatment Period|Protocol Violation|1|||
37730061|NCT01738503|69209431|FG003|Treatment Period|Protocol Violation|0|||
37730062|NCT01738503|69209432|FG004|Treatment Period|Protocol Violation|4|||
37730063|NCT01738503|69209433|FG005|Treatment Period|Protocol Violation|2|||
37730064|NCT01738503|69209434|FG006|Treatment Period|Protocol Violation|0|||
37730065|NCT01738503|69209428|FG000|Treatment Period|Other|0|||
37730066|NCT01738503|69209429|FG001|Treatment Period|Other|0|||
37730067|NCT01738503|69209430|FG002|Treatment Period|Other|1|||
37730068|NCT01738503|69209431|FG003|Treatment Period|Other|0|||
37730069|NCT01738503|69209432|FG004|Treatment Period|Other|0|||
37730070|NCT01738503|69209433|FG005|Treatment Period|Other|0|||
37730071|NCT01738503|69209434|FG006|Treatment Period|Other|0|||
37730072|NCT01738503|69209428|FG000|PET Imaging Sub-study|Adverse Event|0|||
37730073|NCT01738503|69209429|FG001|PET Imaging Sub-study|Adverse Event|0|||
37730074|NCT01738503|69209430|FG002|PET Imaging Sub-study|Adverse Event|0|||
37730075|NCT01738503|69209431|FG003|PET Imaging Sub-study|Adverse Event|0|||
37730076|NCT01738503|69209432|FG004|PET Imaging Sub-study|Adverse Event|0|||
37730077|NCT01738503|69209433|FG005|PET Imaging Sub-study|Adverse Event|1|||
37730078|NCT01738503|69209434|FG006|PET Imaging Sub-study|Adverse Event|0|||
37730079|NCT01738503|69209428|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
37730080|NCT01738503|69209429|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
37730081|NCT01738503|69209430|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
37730082|NCT01738503|69209431|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
37730083|NCT01738503|69209432|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
37730084|NCT01738503|69209433|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
37730085|NCT01738503|69209434|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
37730086|NCT01738191|69209458|FG000|Overall Study|Withdrawal by Subject|4|||
37730087|NCT01738191|69209459|FG001|Overall Study|Withdrawal by Subject|1|||
37730088|NCT01737879|69209465|FG000|Overall Study|Death|1|||
37730089|NCT01737879|69209465|FG000|Overall Study|Sponsor decision|40|||
37730090|NCT01879683|69209469|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
37730091|NCT01605825|69209475|FG000|Overall Study|Adverse Event|4|||
37730092|NCT01605825|69209476|FG001|Overall Study|Adverse Event|2|||
37730093|NCT01605825|69209475|FG000|Overall Study|Withdrawal by Subject|0|||
37730094|NCT01605825|69209476|FG001|Overall Study|Withdrawal by Subject|1|||
37730095|NCT01605825|69209475|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
37730096|NCT01605825|69209476|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
37730097|NCT01605825|69209475|FG000|Overall Study|Non-Compliance with Protocol|3|||
37730098|NCT01605825|69209476|FG001|Overall Study|Non-Compliance with Protocol|0|||
37730099|NCT01727505|69209482|FG000|First 24 Hours|Adverse Event|0|||
37730100|NCT01727505|69209483|FG001|First 24 Hours|Adverse Event|1|||
37730101|NCT01727505|69209482|FG000|Second 24 Hours|Missing data|0|||
37730102|NCT01727505|69209483|FG001|Second 24 Hours|Missing data|1|||
37730103|NCT01726803|69209491|FG000|Overall Study|Lost to Follow-up|6|||
37730104|NCT01726803|69209492|FG001|Overall Study|Lost to Follow-up|1|||
37730105|NCT01726803|69209491|FG000|Overall Study|Withdrawal by Subject|1|||
37730106|NCT01726803|69209492|FG001|Overall Study|Withdrawal by Subject|0|||
37730107|NCT01726335|69209498|FG000|Overall Study|Lost to Follow-up|2|||
37730108|NCT01726335|69209498|FG000|Overall Study|Withdrawal by Subject|15|||
37730109|NCT01726335|69209498|FG000|Overall Study|Adverse Event|4|||
37730110|NCT01726335|69209498|FG000|Overall Study|Lost to Follow-up|2|||
37730111|NCT01726335|69209498|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
37730112|NCT01877421|69209534|FG000|Phase 2|Lost to Follow-up|0|||
37730113|NCT01877421|69209535|FG001|Phase 2|Lost to Follow-up|0|||
37730114|NCT01877421|69209536|FG002|Phase 2|Lost to Follow-up|0|||
37730115|NCT01877421|69209537|FG003|Phase 2|Lost to Follow-up|0|||
37730116|NCT01877421|69209538|FG004|Phase 2|Lost to Follow-up|0|||
37730117|NCT01877421|69209539|FG005|Phase 2|Lost to Follow-up|0|||
37730118|NCT01877421|69209540|FG006|Phase 2|Lost to Follow-up|1|||
37730119|NCT01877421|69209541|FG007|Phase 2|Lost to Follow-up|0|||
37730120|NCT01877421|69209542|FG008|Phase 2|Lost to Follow-up|0|||
37730121|NCT01877421|69209543|FG009|Phase 2|Lost to Follow-up|0|||
37730122|NCT01877421|69209544|FG010|Phase 2|Lost to Follow-up|0|||
37730123|NCT01877421|69209545|FG011|Phase 2|Lost to Follow-up|0|||
37730124|NCT01877421|69209546|FG012|Phase 2|Lost to Follow-up|0|||
37730125|NCT01877421|69209547|FG013|Phase 2|Lost to Follow-up|0|||
37730126|NCT01877421|69209548|FG014|Phase 2|Lost to Follow-up|0|||
37730127|NCT01877421|69209549|FG015|Phase 2|Lost to Follow-up|0|||
37730128|NCT01877421|69209550|FG016|Phase 2|Lost to Follow-up|0|||
37730129|NCT01877421|69209551|FG017|Phase 2|Lost to Follow-up|0|||
37730130|NCT01877421|69209534|FG000|Phase 2|Withdrawal by Subject|0|||
37730131|NCT01877421|69209535|FG001|Phase 2|Withdrawal by Subject|0|||
37730132|NCT01877421|69209536|FG002|Phase 2|Withdrawal by Subject|0|||
37730133|NCT01877421|69209537|FG003|Phase 2|Withdrawal by Subject|0|||
37730134|NCT01877421|69209538|FG004|Phase 2|Withdrawal by Subject|0|||
37730135|NCT01877421|69209539|FG005|Phase 2|Withdrawal by Subject|0|||
37730136|NCT01877421|69209540|FG006|Phase 2|Withdrawal by Subject|0|||
37730137|NCT01877421|69209541|FG007|Phase 2|Withdrawal by Subject|0|||
37730138|NCT01877421|69209542|FG008|Phase 2|Withdrawal by Subject|1|||
37730139|NCT01877421|69209543|FG009|Phase 2|Withdrawal by Subject|0|||
37730140|NCT01877421|69209544|FG010|Phase 2|Withdrawal by Subject|1|||
37730141|NCT01877421|69209545|FG011|Phase 2|Withdrawal by Subject|0|||
37730142|NCT01877421|69209546|FG012|Phase 2|Withdrawal by Subject|1|||
37730143|NCT01877421|69209547|FG013|Phase 2|Withdrawal by Subject|0|||
37730144|NCT01877421|69209548|FG014|Phase 2|Withdrawal by Subject|0|||
37730145|NCT01877421|69209549|FG015|Phase 2|Withdrawal by Subject|1|||
37730146|NCT01877421|69209550|FG016|Phase 2|Withdrawal by Subject|0|||
37730147|NCT01877421|69209551|FG017|Phase 2|Withdrawal by Subject|0|||
37730148|NCT01877421|69209534|FG000|Phase 2|Protocol Violation|0|||
37730149|NCT01877421|69209535|FG001|Phase 2|Protocol Violation|0|||
37730150|NCT01877421|69209536|FG002|Phase 2|Protocol Violation|0|||
37730151|NCT01877421|69209537|FG003|Phase 2|Protocol Violation|0|||
37730152|NCT01877421|69209538|FG004|Phase 2|Protocol Violation|0|||
37730153|NCT01877421|69209539|FG005|Phase 2|Protocol Violation|0|||
37730154|NCT01877421|69209540|FG006|Phase 2|Protocol Violation|0|||
37730155|NCT01877421|69209541|FG007|Phase 2|Protocol Violation|0|||
37730156|NCT01877421|69209542|FG008|Phase 2|Protocol Violation|0|||
37730157|NCT01877421|69209543|FG009|Phase 2|Protocol Violation|0|||
37730158|NCT01877421|69209544|FG010|Phase 2|Protocol Violation|1|||
37730159|NCT01877421|69209545|FG011|Phase 2|Protocol Violation|0|||
37730160|NCT01877421|69209546|FG012|Phase 2|Protocol Violation|0|||
37730161|NCT01877421|69209547|FG013|Phase 2|Protocol Violation|0|||
37730162|NCT01877421|69209548|FG014|Phase 2|Protocol Violation|0|||
37730163|NCT01877421|69209549|FG015|Phase 2|Protocol Violation|0|||
37730164|NCT01877421|69209550|FG016|Phase 2|Protocol Violation|0|||
37730165|NCT01877421|69209551|FG017|Phase 2|Protocol Violation|0|||
37730166|NCT01726023|69209633|FG000|Overall Study|Death|1|||
37730167|NCT01726023|69209634|FG001|Overall Study|Death|1|||
37730168|NCT01726023|69209633|FG000|Overall Study|Lost to Follow-up|5|||
37730169|NCT01726023|69209634|FG001|Overall Study|Lost to Follow-up|10|||
37730170|NCT01726023|69209633|FG000|Overall Study|Other Eligibility criteria|7|||
37730171|NCT01726023|69209634|FG001|Overall Study|Other Eligibility criteria|7|||
37730172|NCT01726023|69209633|FG000|Overall Study|Withdrawal by Subject|16|||
37730173|NCT01726023|69209634|FG001|Overall Study|Withdrawal by Subject|8|||
37730174|NCT01877265|69209647|FG000|Treatment Period 1|Sponsor Decision|0|||
37730175|NCT01877265|69209648|FG001|Treatment Period 1|Sponsor Decision|0|||
37730176|NCT01877265|69209649|FG002|Treatment Period 1|Sponsor Decision|1|||
37730177|NCT01877265|69209650|FG003|Treatment Period 1|Sponsor Decision|0|||
37730178|NCT01877265|69209651|FG004|Treatment Period 1|Sponsor Decision|0|||
37730179|NCT01877265|69209652|FG005|Treatment Period 1|Sponsor Decision|0|||
37730180|NCT01877265|69209647|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
37730181|NCT01877265|69209648|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
37730182|NCT01877265|69209649|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
37730183|NCT01877265|69209650|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
37730184|NCT01877265|69209651|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
37730185|NCT01877265|69209652|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
37730186|NCT01877265|69209647|FG000|Treatment Period 3|Lost to Follow-up|1|||
37730187|NCT01877265|69209648|FG001|Treatment Period 3|Lost to Follow-up|0|||
37730188|NCT01877265|69209649|FG002|Treatment Period 3|Lost to Follow-up|0|||
37730189|NCT01877265|69209650|FG003|Treatment Period 3|Lost to Follow-up|0|||
37730190|NCT01877265|69209651|FG004|Treatment Period 3|Lost to Follow-up|0|||
37730191|NCT01877265|69209652|FG005|Treatment Period 3|Lost to Follow-up|0|||
37730192|NCT01877187|69209663|FG000|Overall Study|Death|2|||
37730193|NCT01877187|69209663|FG000|Overall Study|Withdrawal by Subject|4|||
37730194|NCT01877187|69209663|FG000|Overall Study|Lost to Follow-up|3|||
37730195|NCT01877187|69209663|FG000|Overall Study|Declining clinical status|11|||
37730196|NCT01877187|69209663|FG000|Overall Study|Liver transplant|2|||
37730197|NCT01858532|69209674|FG000|Overall Study|Adverse Event|58|||
37730198|NCT01858532|69209675|FG001|Overall Study|Adverse Event|50|||
37730199|NCT01858532|69209676|FG002|Overall Study|Adverse Event|23|||
37730200|NCT01858532|69209677|FG003|Overall Study|Adverse Event|28|||
37730201|NCT01858532|69209674|FG000|Overall Study|Withdrew consent|71|||
37730202|NCT01858532|69209675|FG001|Overall Study|Withdrew consent|93|||
37730203|NCT01858532|69209676|FG002|Overall Study|Withdrew consent|46|||
37730204|NCT01858532|69209677|FG003|Overall Study|Withdrew consent|27|||
37730205|NCT01858532|69209674|FG000|Overall Study|Lost to Follow-up|17|||
37730206|NCT01858532|69209675|FG001|Overall Study|Lost to Follow-up|26|||
37730207|NCT01858532|69209676|FG002|Overall Study|Lost to Follow-up|11|||
37730208|NCT01858532|69209677|FG003|Overall Study|Lost to Follow-up|14|||
37730209|NCT01858532|69209674|FG000|Overall Study|Deterioration of medical status|3|||
37730210|NCT01858532|69209675|FG001|Overall Study|Deterioration of medical status|4|||
37730211|NCT01858532|69209676|FG002|Overall Study|Deterioration of medical status|3|||
37730212|NCT01858532|69209677|FG003|Overall Study|Deterioration of medical status|7|||
37730213|NCT01858532|69209674|FG000|Overall Study|Investigator request|3|||
37730214|NCT01858532|69209675|FG001|Overall Study|Investigator request|4|||
37730215|NCT01858532|69209676|FG002|Overall Study|Investigator request|2|||
37730216|NCT01858532|69209677|FG003|Overall Study|Investigator request|6|||
37730217|NCT01858532|69209674|FG000|Overall Study|Other, not specified|29|||
37730218|NCT01858532|69209675|FG001|Overall Study|Other, not specified|15|||
37730219|NCT01858532|69209676|FG002|Overall Study|Other, not specified|13|||
37730220|NCT01858532|69209677|FG003|Overall Study|Other, not specified|11|||
37730221|NCT01883492|69209689|FG000|Overall Study|Lost to Follow-up|3|||
37730222|NCT01883492|69209690|FG001|Overall Study|Lost to Follow-up|4|||
37730223|NCT01883492|69209689|FG000|Overall Study|Surgery on contra-lateral hip|0|||
37730224|NCT01883492|69209690|FG001|Overall Study|Surgery on contra-lateral hip|1|||
37730225|NCT01883492|69209689|FG000|Overall Study|Poor X-ray quality|7|||
37730226|NCT01883492|69209690|FG001|Overall Study|Poor X-ray quality|4|||
37730227|NCT01883492|69209689|FG000|Overall Study|Withdrawal by Subject|1|||
37730228|NCT01883492|69209690|FG001|Overall Study|Withdrawal by Subject|0|||
37730229|NCT01883492|69209689|FG000|Overall Study|inappropriate implant used|1|||
37730230|NCT01883492|69209690|FG001|Overall Study|inappropriate implant used|1|||
37730231|NCT01883492|69209689|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
37730232|NCT01883492|69209690|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
37730233|NCT01832480|69209698|FG000|Overall Study|Lost to Follow-up|33|||
37730234|NCT01832480|69209699|FG001|Overall Study|Lost to Follow-up|30|||
37730235|NCT01832480|69209698|FG000|Overall Study|Withdrawal by Subject|0|||
37730236|NCT01832480|69209699|FG001|Overall Study|Withdrawal by Subject|2|||
37730237|NCT01832480|69209698|FG000|Overall Study|post randomization ineligible|8|||
37730238|NCT01832480|69209699|FG001|Overall Study|post randomization ineligible|10|||
37730239|NCT01858376|69209705|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
37730240|NCT01831856|69209711|FG000|Overall Study|Adverse Event|5|||
37730241|NCT01831856|69209712|FG001|Overall Study|Adverse Event|8|||
37730242|NCT01831856|69209711|FG000|Overall Study|Lack of Efficacy|13|||
37730243|NCT01831856|69209712|FG001|Overall Study|Lack of Efficacy|11|||
37730244|NCT01831856|69209711|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
37730245|NCT01831856|69209712|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
37730246|NCT01831544|69209718|FG000|Overall Study|Death|1|||
37730247|NCT01831544|69209718|FG000|Overall Study|Still on original MVAD device|2|||
38025622|NCT04075604|69710138|FG000|Overall Study|Disease progression|0|||
38025623|NCT04075604|69710139|FG001|Overall Study|Disease progression|1|||
38025624|NCT04075604|69710140|FG002|Overall Study|Disease progression|0|||
38025625|NCT04075604|69710138|FG000|Overall Study|Study drug toxicity|0|||
38025626|NCT04075604|69710139|FG001|Overall Study|Study drug toxicity|5|||
38025627|NCT04075604|69710140|FG002|Overall Study|Study drug toxicity|1|||
38025628|NCT03796208|69710150|FG000|Overall Study|Withdrawal by Subject|3|||
38025629|NCT03796208|69710151|FG001|Overall Study|Withdrawal by Subject|0|||
38025630|NCT03796208|69710150|FG000|Overall Study|Loss of pregnancy|1|||
38025631|NCT03796208|69710151|FG001|Overall Study|Loss of pregnancy|1|||
38025632|NCT03796208|69710150|FG000|Overall Study|Changed prenatal clinics|0|||
38025633|NCT03796208|69710151|FG001|Overall Study|Changed prenatal clinics|5|||
37730248|NCT01857206|69209724|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
37730249|NCT01857206|69209725|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
37730250|NCT01857206|69209724|FG000|Overall Study|Lost to Follow-up|9|||
37730251|NCT01857206|69209725|FG001|Overall Study|Lost to Follow-up|6|||
37730252|NCT01857206|69209724|FG000|Overall Study|Unclassified|3|||
37730253|NCT01857206|69209725|FG001|Overall Study|Unclassified|3|||
37730254|NCT01857206|69209724|FG000|Overall Study|Withdrawal by Subject|1|||
37730255|NCT01857206|69209725|FG001|Overall Study|Withdrawal by Subject|0|||
37730256|NCT01882088|69209735|FG000|Overall Study|Intolerance of esophageal manometry|1|||
37730257|NCT01882088|69209735|FG000|Overall Study|no possibility to place the catheter|1|||
37730258|NCT01882088|69209735|FG000|Overall Study|Protocol Violation|1|||
37730259|NCT01882088|69209735|FG000|Overall Study|inadequate pH-impedance tracings|2|||
37730260|NCT01881776|69209742|FG000|Overall Study|Lost to Follow-up|1|||
37730261|NCT01881776|69209743|FG001|Overall Study|Lost to Follow-up|2|||
37730262|NCT01881776|69209744|FG002|Overall Study|Lost to Follow-up|1|||
37730263|NCT01881776|69209742|FG000|Overall Study|Protocol Violation|0|||
37730264|NCT01881776|69209743|FG001|Overall Study|Protocol Violation|2|||
37730265|NCT01881776|69209744|FG002|Overall Study|Protocol Violation|1|||
37730266|NCT01708161|69209758|FG000|Overall Study|Adverse Event|1|||
37730267|NCT01708161|69209759|FG001|Overall Study|Adverse Event|3|||
37730268|NCT01708161|69209760|FG002|Overall Study|Adverse Event|4|||
37730269|NCT01708161|69209761|FG003|Overall Study|Adverse Event|2|||
37730270|NCT01708161|69209762|FG004|Overall Study|Adverse Event|3|||
37730271|NCT01708161|69209763|FG005|Overall Study|Adverse Event|0|||
37730272|NCT01708161|69209758|FG000|Overall Study|Death|0|||
37730273|NCT01708161|69209759|FG001|Overall Study|Death|0|||
37730274|NCT01708161|69209760|FG002|Overall Study|Death|0|||
37730275|NCT01708161|69209761|FG003|Overall Study|Death|1|||
37730276|NCT01708161|69209762|FG004|Overall Study|Death|0|||
37730277|NCT01708161|69209763|FG005|Overall Study|Death|1|||
37730278|NCT01708161|69209758|FG000|Overall Study|Withdrawal by Subject|0|||
37730279|NCT01708161|69209759|FG001|Overall Study|Withdrawal by Subject|1|||
37730280|NCT01708161|69209760|FG002|Overall Study|Withdrawal by Subject|1|||
37730281|NCT01708161|69209761|FG003|Overall Study|Withdrawal by Subject|0|||
37730282|NCT01708161|69209762|FG004|Overall Study|Withdrawal by Subject|0|||
37915980|NCT00824655|69602783|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
37915981|NCT00824655|69602782|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
37915982|NCT00824655|69602783|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
37915983|NCT00525265|69602793|FG000|Overall Study|Protocol Violation|1|||
37915984|NCT00525265|69602794|FG001|Overall Study|Protocol Violation|0|||
37915985|NCT00880256|69602800|FG000|Overall Study|Lost to Follow-up|28|||
37915986|NCT03865381|69602809|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
37730283|NCT01708161|69209763|FG005|Overall Study|Withdrawal by Subject|0|||
37730284|NCT01708161|69209758|FG000|Overall Study|Administrative problems|0|||
37730285|NCT01708161|69209759|FG001|Overall Study|Administrative problems|1|||
37730286|NCT01708161|69209760|FG002|Overall Study|Administrative problems|0|||
37730287|NCT01708161|69209761|FG003|Overall Study|Administrative problems|0|||
37730288|NCT01708161|69209762|FG004|Overall Study|Administrative problems|0|||
37915987|NCT03865381|69602809|FG000|Overall Study|Withdrawal by Subject|2|||
37915988|NCT00865098|69602813|FG000|Overall Study|Progressive disease|1|||
38025634|NCT03796208|69710150|FG000|Overall Study|Lost to Follow-up|20|||
37730289|NCT01708161|69209763|FG005|Overall Study|Administrative problems|0|||
37730290|NCT01708161|69209758|FG000|Overall Study|Disease progression|3|||
37730291|NCT01708161|69209759|FG001|Overall Study|Disease progression|5|||
37730292|NCT01708161|69209760|FG002|Overall Study|Disease progression|5|||
37730293|NCT01708161|69209761|FG003|Overall Study|Disease progression|13|||
37730294|NCT01708161|69209762|FG004|Overall Study|Disease progression|3|||
37730295|NCT01708161|69209763|FG005|Overall Study|Disease progression|0|||
37730296|NCT01707693|69209779|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
37730297|NCT01707693|69209780|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
37730298|NCT01707693|69209779|FG000|Overall Study Allocation|Protocol Violation|4|||
37730299|NCT01707693|69209780|FG001|Overall Study Allocation|Protocol Violation|3|||
37730300|NCT01707693|69209779|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
37730301|NCT01707693|69209780|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
37730302|NCT01707693|69209779|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
37730303|NCT01707693|69209780|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
37730304|NCT01722669|69209793|FG000|Overall Study|Withdrawal by Subject|0|||
37730305|NCT01722669|69209794|FG001|Overall Study|Withdrawal by Subject|0|||
37730306|NCT01722669|69209795|FG002|Overall Study|Withdrawal by Subject|0|||
37730307|NCT01722669|69209796|FG003|Overall Study|Withdrawal by Subject|0|||
37730308|NCT01722669|69209797|FG004|Overall Study|Withdrawal by Subject|0|||
37730309|NCT01722669|69209798|FG005|Overall Study|Withdrawal by Subject|2|||
37730310|NCT01707147|69209818|FG000|Overall Study|Administered Trajenta prior to contract|5|||
37730311|NCT01707147|69209818|FG000|Overall Study|Patients who have not taken Trajenta|1|||
37730312|NCT01707147|69209818|FG000|Overall Study|Follow-up failure|17|||
37730313|NCT01707147|69209818|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
37730314|NCT01876251|69209825|FG000|Overall Study|Clinical progression|1|||
37730315|NCT01876251|69209826|FG001|Overall Study|Clinical progression|0|||
37730316|NCT01876251|69209827|FG002|Overall Study|Clinical progression|0|||
37730317|NCT01876251|69209825|FG000|Overall Study|Death|2|||
37730318|NCT01876251|69209826|FG001|Overall Study|Death|0|||
37730319|NCT01876251|69209827|FG002|Overall Study|Death|1|||
37730320|NCT01876251|69209825|FG000|Overall Study|Participant started new treatment|1|||
37730321|NCT01876251|69209826|FG001|Overall Study|Participant started new treatment|0|||
37730322|NCT01876251|69209827|FG002|Overall Study|Participant started new treatment|1|||
37730323|NCT01876251|69209825|FG000|Overall Study|Participant refused further follow-up|0|||
37730324|NCT01876251|69209826|FG001|Overall Study|Participant refused further follow-up|0|||
37730325|NCT01876251|69209827|FG002|Overall Study|Participant refused further follow-up|1|||
37730326|NCT01876251|69209825|FG000|Overall Study|Study terminated|1|||
37730327|NCT01876251|69209826|FG001|Overall Study|Study terminated|0|||
37730328|NCT01876251|69209827|FG002|Overall Study|Study terminated|0|||
37730329|NCT01876251|69209825|FG000|Overall Study|Objective progression or relapse|10|||
37730330|NCT01876251|69209826|FG001|Overall Study|Objective progression or relapse|3|||
37730331|NCT01876251|69209827|FG002|Overall Study|Objective progression or relapse|8|||
37730332|NCT01875471|69209838|FG000|Overall Study|Adverse Event|0|||
37730333|NCT01875471|69209839|FG001|Overall Study|Adverse Event|1|||
37730334|NCT01875471|69209838|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
37730335|NCT01875471|69209839|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
37730336|NCT01875237|69209847|FG000|Overall Study|GVDH before DLI|1|||
37730337|NCT01875237|69209848|FG001|Overall Study|GVDH before DLI|0|||
37730338|NCT01875237|69209847|FG000|Overall Study|DLI cells could not be produced|1|||
37730339|NCT01875237|69209848|FG001|Overall Study|DLI cells could not be produced|0|||
37730340|NCT01874535|69209858|FG000|Overall Study|Lost to Follow-up|10|||
37730341|NCT01874535|69209859|FG001|Overall Study|Lost to Follow-up|9|||
37730342|NCT01874535|69209858|FG000|Overall Study|incomplete symptom resolution|45|||
37730343|NCT01874535|69209859|FG001|Overall Study|incomplete symptom resolution|35|||
37730344|NCT01722045|69209865|FG000|Overall Study|Adverse Event|8|||
37730345|NCT01722045|69209865|FG000|Overall Study|Death|3|||
37730346|NCT01722045|69209865|FG000|Overall Study|Withdrawal by Subject|8|||
37730347|NCT01722045|69209865|FG000|Overall Study|Lost to Follow-up|4|||
37730348|NCT01722045|69209865|FG000|Overall Study|Protocol Deviation|1|||
37730349|NCT01722045|69209865|FG000|Overall Study|Physician Decision|3|||
37730350|NCT01722045|69209865|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
38025635|NCT03796208|69710151|FG001|Overall Study|Lost to Follow-up|16|||
38025636|NCT01318876|69710157|FG000|Day 8 Survey|email address invalid|96|||
38025637|NCT01318876|69710157|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
38025638|NCT01318876|69710157|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
37730351|NCT01721109|69209869|FG000|Overall Study|Lack of Efficacy|1|||
37730352|NCT01721109|69209869|FG000|Overall Study|Non- Compliance with Study Drug|3|||
37730353|NCT01721109|69209869|FG000|Overall Study|Withdrew Consent|1|||
37730354|NCT01721109|69209869|FG000|Overall Study|Lost to Follow-up|2|||
37730355|NCT01874145|69209875|FG000|Core Period|Non-compliance|1|||
37730356|NCT01874145|69209876|FG001|Core Period|Non-compliance|0|||
37730357|NCT01874145|69209875|FG000|Core Period|Protocol Violation|1|||
38025639|NCT03668600|69710161|FG000|Overall Study|Study Terminated by the Sponsor|157|||
38025640|NCT03668600|69710161|FG000|Overall Study|Protocol Violation|1|||
38025641|NCT03668600|69710161|FG000|Overall Study|Pregnancy|1|||
38025642|NCT03668600|69710161|FG000|Overall Study|Lost to Follow-up|7|||
38025643|NCT03668600|69710161|FG000|Overall Study|Withdrawal by Subject|56|||
38025644|NCT03668600|69710161|FG000|Overall Study|Lack of Efficacy|7|||
38025645|NCT03668600|69710161|FG000|Overall Study|Adverse Event|1|||
38025646|NCT04073186|69710165|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
38025647|NCT04073186|69710165|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
37730358|NCT01874145|69209876|FG001|Core Period|Protocol Violation|1|||
37730359|NCT01874145|69209875|FG000|Core Period|Physician Decision|1|||
37730360|NCT01874145|69209876|FG001|Core Period|Physician Decision|1|||
37730361|NCT01874145|69209875|FG000|Core Period|Adverse Event|0|||
38025648|NCT04073186|69710165|FG000|First Wearing Cycle|Protocol Violation|1|||
38025649|NCT04073186|69710165|FG000|First Wearing Cycle|Lens Discomfort|2|||
38025650|NCT04073186|69710165|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
38025651|NCT04073186|69710165|FG000|Second Wearing Cycle|Adverse Event|1|||
37730362|NCT01874145|69209876|FG001|Core Period|Adverse Event|1|||
37730363|NCT01874145|69209875|FG000|Core Period|Withdrawal by Subject|0|||
37730364|NCT01874145|69209876|FG001|Core Period|Withdrawal by Subject|4|||
37843632|NCT02004522|69528291|FG001|Overall Study|Physician Decision|4|||
37843633|NCT02004522|69528290|FG000|Overall Study|Protocol Violation|1|||
37843634|NCT02004522|69528291|FG001|Overall Study|Protocol Violation|0|||
37843635|NCT02004522|69528290|FG000|Overall Study|Other is reason listed by PI|4|||
38025652|NCT03054064|69710170|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
38025653|NCT03054064|69710170|FG000|Overall Study|Investigator Decision|2|||
38025654|NCT03054064|69710170|FG000|Overall Study|Bladder Issue|1|||
38025655|NCT03054064|69710170|FG000|Overall Study|High Blood Pressure|1|||
38025656|NCT03054064|69710170|FG000|Overall Study|Change in Status|1|||
38025657|NCT03053518|69710174|FG000|Overall Study|Withdrawal by Subject|3|||
38025658|NCT03053518|69710174|FG000|Overall Study|Lost to Follow-up|2|||
38025659|NCT03053518|69710174|FG000|Overall Study|Ineligible|5|||
38025660|NCT04015336|69710178|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
38025661|NCT04071158|69710201|FG000|Overall Study|Lost to Follow-up|1|||
38025662|NCT04071158|69710202|FG001|Overall Study|Lost to Follow-up|2|||
38025663|NCT04071158|69710203|FG002|Overall Study|Lost to Follow-up|3|||
38025664|NCT04071158|69710204|FG003|Overall Study|Lost to Follow-up|3|||
38025665|NCT04071158|69710205|FG004|Overall Study|Lost to Follow-up|5|||
38025666|NCT04071158|69710201|FG000|Overall Study|Randomized but not treated|2|||
38025667|NCT04071158|69710202|FG001|Overall Study|Randomized but not treated|2|||
37843636|NCT02004522|69528291|FG001|Overall Study|Other is reason listed by PI|1|||
37843637|NCT02004522|69528290|FG000|Overall Study|Never Dosed|2|||
37730365|NCT01874145|69209875|FG000|Extension Period|Adverse Event|3|||
37843638|NCT02004522|69528291|FG001|Overall Study|Never Dosed|4|||
37843639|NCT02004522|69528290|FG000|Overall Study|Disease Progression|35|||
37843640|NCT02004522|69528291|FG001|Overall Study|Disease Progression|31|||
37843641|NCT02004522|69528290|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
37843642|NCT02004522|69528291|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
37843643|NCT01959139|69528301|FG000|Phase II|Disease progression|0|||
37843644|NCT01959139|69528302|FG001|Phase II|Disease progression|0|||
37843645|NCT01959139|69528303|FG002|Phase II|Disease progression|26|||
37843646|NCT01959139|69528304|FG003|Phase II|Disease progression|34|||
37843647|NCT01959139|69528301|FG000|Phase II|Adverse Event|0|||
37843648|NCT01959139|69528302|FG001|Phase II|Adverse Event|0|||
37843649|NCT01959139|69528303|FG002|Phase II|Adverse Event|10|||
37843650|NCT01959139|69528304|FG003|Phase II|Adverse Event|11|||
37843651|NCT01959139|69528301|FG000|Phase II|Patient Refusal|0|||
37843652|NCT01959139|69528302|FG001|Phase II|Patient Refusal|0|||
37843653|NCT01959139|69528303|FG002|Phase II|Patient Refusal|5|||
37843654|NCT01959139|69528304|FG003|Phase II|Patient Refusal|4|||
37843655|NCT01959139|69528301|FG000|Phase II|Death|0|||
37843656|NCT01959139|69528302|FG001|Phase II|Death|0|||
37843657|NCT01959139|69528303|FG002|Phase II|Death|3|||
37843658|NCT01959139|69528304|FG003|Phase II|Death|1|||
37843659|NCT01959139|69528301|FG000|Phase II|Other/Unknown|0|||
37843660|NCT01959139|69528302|FG001|Phase II|Other/Unknown|0|||
37843661|NCT01959139|69528303|FG002|Phase II|Other/Unknown|8|||
37843662|NCT01959139|69528304|FG003|Phase II|Other/Unknown|5|||
37843663|NCT01959139|69528301|FG000|Phase II|On treatment|0|||
37843664|NCT01959139|69528302|FG001|Phase II|On treatment|0|||
37843665|NCT01959139|69528303|FG002|Phase II|On treatment|4|||
37843666|NCT01959139|69528304|FG003|Phase II|On treatment|0|||
37843667|NCT01932697|69528321|FG000|Overall Study|Received a different amount of tx|1|||
37843668|NCT01932697|69528322|FG001|Overall Study|Received a different amount of tx|0|||
37843669|NCT01932697|69528321|FG000|Overall Study|Ineligible|1|||
37843670|NCT01932697|69528322|FG001|Overall Study|Ineligible|0|||
37730366|NCT01874145|69209876|FG001|Extension Period|Adverse Event|2|||
37730367|NCT01874145|69209875|FG000|Extension Period|Withdrawal by Subject|2|||
37730368|NCT01874145|69209876|FG001|Extension Period|Withdrawal by Subject|1|||
37730369|NCT01874145|69209875|FG000|Extension Period|Lost to Follow-up|1|||
37730370|NCT01874145|69209876|FG001|Extension Period|Lost to Follow-up|1|||
37730371|NCT01720797|69209888|FG000|Overall Study|Withdrawal by Subject|3|||
37730372|NCT01720797|69209889|FG001|Overall Study|Withdrawal by Subject|0|||
37730373|NCT01831466|69209907|FG000|Overall Study|Protocol Violation|1|||
37730374|NCT01831466|69209908|FG001|Overall Study|Protocol Violation|1|||
37730375|NCT01831466|69209909|FG002|Overall Study|Protocol Violation|2|||
37730376|NCT01831466|69209910|FG003|Overall Study|Protocol Violation|0|||
37730377|NCT01831466|69209911|FG004|Overall Study|Protocol Violation|0|||
37730378|NCT01831466|69209912|FG005|Overall Study|Protocol Violation|1|||
37730379|NCT01831466|69209913|FG006|Overall Study|Protocol Violation|0|||
37730380|NCT01831466|69209914|FG007|Overall Study|Protocol Violation|0|||
37730381|NCT01831466|69209915|FG008|Overall Study|Protocol Violation|0|||
37730382|NCT01831466|69209916|FG009|Overall Study|Protocol Violation|0|||
37730383|NCT01831466|69209917|FG010|Overall Study|Protocol Violation|0|||
37730384|NCT01831466|69209918|FG011|Overall Study|Protocol Violation|0|||
37730385|NCT01831466|69209907|FG000|Overall Study|Other|2|||
37730386|NCT01831466|69209908|FG001|Overall Study|Other|3|||
37730387|NCT01831466|69209909|FG002|Overall Study|Other|2|||
37730388|NCT01831466|69209910|FG003|Overall Study|Other|2|||
37730389|NCT01831466|69209911|FG004|Overall Study|Other|2|||
37730390|NCT01831466|69209912|FG005|Overall Study|Other|1|||
37730391|NCT01831466|69209913|FG006|Overall Study|Other|0|||
37730392|NCT01831466|69209914|FG007|Overall Study|Other|0|||
37730393|NCT01831466|69209915|FG008|Overall Study|Other|0|||
37730394|NCT01831466|69209916|FG009|Overall Study|Other|0|||
37730395|NCT01831466|69209917|FG010|Overall Study|Other|0|||
37730396|NCT01831466|69209918|FG011|Overall Study|Other|0|||
37730397|NCT01831466|69209907|FG000|Overall Study|Non-compliance with study treatment|2|||
37730398|NCT01831466|69209908|FG001|Overall Study|Non-compliance with study treatment|1|||
37730399|NCT01831466|69209909|FG002|Overall Study|Non-compliance with study treatment|1|||
37730400|NCT01831466|69209910|FG003|Overall Study|Non-compliance with study treatment|0|||
37730401|NCT01831466|69209911|FG004|Overall Study|Non-compliance with study treatment|0|||
37730402|NCT01831466|69209912|FG005|Overall Study|Non-compliance with study treatment|1|||
37730403|NCT01831466|69209913|FG006|Overall Study|Non-compliance with study treatment|0|||
37730404|NCT01831466|69209914|FG007|Overall Study|Non-compliance with study treatment|0|||
37730405|NCT01831466|69209915|FG008|Overall Study|Non-compliance with study treatment|0|||
37730406|NCT01831466|69209916|FG009|Overall Study|Non-compliance with study treatment|0|||
37730407|NCT01831466|69209917|FG010|Overall Study|Non-compliance with study treatment|0|||
37730408|NCT01831466|69209918|FG011|Overall Study|Non-compliance with study treatment|0|||
37730409|NCT01831466|69209907|FG000|Overall Study|Death|0|||
37730410|NCT01831466|69209908|FG001|Overall Study|Death|1|||
37730411|NCT01831466|69209909|FG002|Overall Study|Death|0|||
37730412|NCT01831466|69209910|FG003|Overall Study|Death|0|||
37730413|NCT01831466|69209911|FG004|Overall Study|Death|0|||
37730414|NCT01831466|69209912|FG005|Overall Study|Death|0|||
37730415|NCT01831466|69209913|FG006|Overall Study|Death|0|||
37730416|NCT01831466|69209914|FG007|Overall Study|Death|0|||
37730417|NCT01831466|69209915|FG008|Overall Study|Death|0|||
37730418|NCT01831466|69209916|FG009|Overall Study|Death|0|||
37730419|NCT01831466|69209917|FG010|Overall Study|Death|0|||
37730420|NCT01831466|69209918|FG011|Overall Study|Death|0|||
37730421|NCT01831466|69209907|FG000|Overall Study|Withdrawal by Subject|6|||
37730422|NCT01831466|69209908|FG001|Overall Study|Withdrawal by Subject|3|||
37730423|NCT01831466|69209909|FG002|Overall Study|Withdrawal by Subject|3|||
37730424|NCT01831466|69209910|FG003|Overall Study|Withdrawal by Subject|3|||
37730425|NCT01831466|69209911|FG004|Overall Study|Withdrawal by Subject|3|||
37730426|NCT01831466|69209912|FG005|Overall Study|Withdrawal by Subject|5|||
37730427|NCT01831466|69209913|FG006|Overall Study|Withdrawal by Subject|0|||
37730428|NCT01831466|69209914|FG007|Overall Study|Withdrawal by Subject|0|||
37730429|NCT01831466|69209915|FG008|Overall Study|Withdrawal by Subject|0|||
37730430|NCT01831466|69209916|FG009|Overall Study|Withdrawal by Subject|1|||
37730431|NCT01831466|69209917|FG010|Overall Study|Withdrawal by Subject|0|||
37730432|NCT01831466|69209918|FG011|Overall Study|Withdrawal by Subject|1|||
37730433|NCT01831466|69209907|FG000|Overall Study|Lost to Follow-up|0|||
37730434|NCT01831466|69209908|FG001|Overall Study|Lost to Follow-up|1|||
37843671|NCT01739309|69528368|FG000|Overall Study|Adverse Event|1|||
37730435|NCT01831466|69209909|FG002|Overall Study|Lost to Follow-up|4|||
37730436|NCT01831466|69209910|FG003|Overall Study|Lost to Follow-up|2|||
37730437|NCT01831466|69209911|FG004|Overall Study|Lost to Follow-up|0|||
37730438|NCT01831466|69209912|FG005|Overall Study|Lost to Follow-up|3|||
37730439|NCT01831466|69209913|FG006|Overall Study|Lost to Follow-up|0|||
37730440|NCT01831466|69209914|FG007|Overall Study|Lost to Follow-up|0|||
37730441|NCT01831466|69209915|FG008|Overall Study|Lost to Follow-up|0|||
37730442|NCT01831466|69209916|FG009|Overall Study|Lost to Follow-up|1|||
37730443|NCT01831466|69209917|FG010|Overall Study|Lost to Follow-up|0|||
37730444|NCT01831466|69209918|FG011|Overall Study|Lost to Follow-up|1|||
37730445|NCT01831466|69209907|FG000|Overall Study|Lack of Efficacy|5|||
37730446|NCT01831466|69209908|FG001|Overall Study|Lack of Efficacy|8|||
37730447|NCT01831466|69209909|FG002|Overall Study|Lack of Efficacy|7|||
37730448|NCT01831466|69209910|FG003|Overall Study|Lack of Efficacy|6|||
37730449|NCT01831466|69209911|FG004|Overall Study|Lack of Efficacy|9|||
37730450|NCT01831466|69209912|FG005|Overall Study|Lack of Efficacy|8|||
37730451|NCT01831466|69209913|FG006|Overall Study|Lack of Efficacy|1|||
37730452|NCT01831466|69209914|FG007|Overall Study|Lack of Efficacy|1|||
37730453|NCT01831466|69209915|FG008|Overall Study|Lack of Efficacy|2|||
37730454|NCT01831466|69209916|FG009|Overall Study|Lack of Efficacy|2|||
37730455|NCT01831466|69209917|FG010|Overall Study|Lack of Efficacy|2|||
37730456|NCT01831466|69209918|FG011|Overall Study|Lack of Efficacy|0|||
37730457|NCT01831466|69209907|FG000|Overall Study|Adverse Event|0|||
37730458|NCT01831466|69209908|FG001|Overall Study|Adverse Event|0|||
37730459|NCT01831466|69209909|FG002|Overall Study|Adverse Event|4|||
37730460|NCT01831466|69209910|FG003|Overall Study|Adverse Event|6|||
37730461|NCT01831466|69209911|FG004|Overall Study|Adverse Event|3|||
37730462|NCT01831466|69209912|FG005|Overall Study|Adverse Event|7|||
37730463|NCT01831466|69209913|FG006|Overall Study|Adverse Event|0|||
37730464|NCT01831466|69209914|FG007|Overall Study|Adverse Event|1|||
37730465|NCT01831466|69209915|FG008|Overall Study|Adverse Event|1|||
37730466|NCT01831466|69209916|FG009|Overall Study|Adverse Event|1|||
37730467|NCT01831466|69209917|FG010|Overall Study|Adverse Event|0|||
37730468|NCT01831466|69209918|FG011|Overall Study|Adverse Event|2|||
37730469|NCT01881620|69209938|FG000|Overall Study|Protocol Violation|4|||
37730470|NCT01830920|69209947|FG000|Overall Study|Adverse Event|1|||
37730471|NCT01830920|69209948|FG001|Overall Study|Adverse Event|0|||
37730472|NCT01830920|69209949|FG002|Overall Study|Adverse Event|1|||
37730473|NCT01830920|69209950|FG003|Overall Study|Adverse Event|0|||
37730474|NCT01830920|69209951|FG004|Overall Study|Adverse Event|0|||
37730475|NCT01830920|69209947|FG000|Overall Study|Withdrawal by Subject|2|||
37730476|NCT01830920|69209948|FG001|Overall Study|Withdrawal by Subject|2|||
37730477|NCT01830920|69209949|FG002|Overall Study|Withdrawal by Subject|1|||
37730478|NCT01830920|69209950|FG003|Overall Study|Withdrawal by Subject|7|||
37730479|NCT01830920|69209951|FG004|Overall Study|Withdrawal by Subject|1|||
37730480|NCT01830920|69209947|FG000|Overall Study|Death|3|||
37730481|NCT01830920|69209948|FG001|Overall Study|Death|3|||
37730482|NCT01830920|69209949|FG002|Overall Study|Death|5|||
37730483|NCT01830920|69209950|FG003|Overall Study|Death|4|||
37730484|NCT01830920|69209951|FG004|Overall Study|Death|4|||
37730485|NCT01830920|69209947|FG000|Overall Study|Other|15|||
37730486|NCT01830920|69209948|FG001|Overall Study|Other|1|||
37730487|NCT01830920|69209949|FG002|Overall Study|Other|1|||
37730488|NCT01830920|69209950|FG003|Overall Study|Other|5|||
37730489|NCT01830920|69209951|FG004|Overall Study|Other|3|||
37730490|NCT01881230|69209966|FG000|Overall Study|Death|2|||
37730491|NCT01881230|69209967|FG001|Overall Study|Death|0|||
37730492|NCT01881230|69209968|FG002|Overall Study|Death|1|||
37730493|NCT01881230|69209966|FG000|Overall Study|Adverse Event|9|||
37730494|NCT01881230|69209967|FG001|Overall Study|Adverse Event|13|||
37730495|NCT01881230|69209968|FG002|Overall Study|Adverse Event|12|||
37730496|NCT01881230|69209966|FG000|Overall Study|Progressive Disease|31|||
37730497|NCT01881230|69209967|FG001|Overall Study|Progressive Disease|35|||
37730498|NCT01881230|69209968|FG002|Overall Study|Progressive Disease|36|||
37843672|NCT01739309|69528368|FG000|Overall Study|Withdrawal by Subject|1|||
37843673|NCT01659658|69528379|FG000|Overall Study|Withdrawal by Patient|18|||
37843674|NCT01659658|69528380|FG001|Overall Study|Withdrawal by Patient|4|||
37843675|NCT01659658|69528381|FG002|Overall Study|Withdrawal by Patient|2|||
37843676|NCT01659658|69528382|FG003|Overall Study|Withdrawal by Patient|0|||
37730499|NCT01881230|69209966|FG000|Overall Study|Symptomatic Deterioration|3|||
37730500|NCT01881230|69209967|FG001|Overall Study|Symptomatic Deterioration|3|||
37730501|NCT01881230|69209968|FG002|Overall Study|Symptomatic Deterioration|1|||
37730502|NCT01881230|69209966|FG000|Overall Study|Withdrawal by Subject|6|||
37730503|NCT01881230|69209967|FG001|Overall Study|Withdrawal by Subject|4|||
37730504|NCT01881230|69209968|FG002|Overall Study|Withdrawal by Subject|6|||
37730505|NCT01881230|69209966|FG000|Overall Study|Physician Decision|4|||
37730506|NCT01881230|69209967|FG001|Overall Study|Physician Decision|3|||
37730507|NCT01881230|69209968|FG002|Overall Study|Physician Decision|6|||
37843677|NCT01659658|69528383|FG004|Overall Study|Withdrawal by Patient|11|||
37843678|NCT01659658|69528379|FG000|Overall Study|Study Terminated by Sponsor|9|||
38025668|NCT04071158|69710203|FG002|Overall Study|Randomized but not treated|0|||
38025669|NCT04071158|69710204|FG003|Overall Study|Randomized but not treated|0|||
37730508|NCT01881230|69209966|FG000|Overall Study|Non-Compliance with Study Drug|1|||
37730509|NCT01881230|69209967|FG001|Overall Study|Non-Compliance with Study Drug|2|||
37730510|NCT01881230|69209968|FG002|Overall Study|Non-Compliance with Study Drug|0|||
38025670|NCT04071158|69710205|FG004|Overall Study|Randomized but not treated|0|||
37730511|NCT01881230|69209966|FG000|Overall Study|Given Commercially Available Drug|0|||
37730512|NCT01881230|69209967|FG001|Overall Study|Given Commercially Available Drug|0|||
37730513|NCT01881230|69209968|FG002|Overall Study|Given Commercially Available Drug|2|||
37730514|NCT01881230|69209966|FG000|Overall Study|Protocol Violation|1|||
37730515|NCT01881230|69209967|FG001|Overall Study|Protocol Violation|1|||
37730516|NCT01881230|69209968|FG002|Overall Study|Protocol Violation|0|||
37730517|NCT01881230|69209966|FG000|Overall Study|Miscellaneous|3|||
37730518|NCT01881230|69209967|FG001|Overall Study|Miscellaneous|3|||
37730519|NCT01881230|69209968|FG002|Overall Study|Miscellaneous|0|||
37730520|NCT01881230|69209966|FG000|Overall Study|Untreated: Other|0|||
37730521|NCT01881230|69209967|FG001|Overall Study|Untreated: Other|0|||
37730522|NCT01881230|69209968|FG002|Overall Study|Untreated: Other|1|||
37730523|NCT01881230|69209966|FG000|Overall Study|Untreated: Death|0|||
37730524|NCT01881230|69209967|FG001|Overall Study|Untreated: Death|0|||
37730525|NCT01881230|69209968|FG002|Overall Study|Untreated: Death|1|||
37730526|NCT01881230|69209966|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
37730527|NCT01881230|69209967|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
37730528|NCT01881230|69209968|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
37730529|NCT01856582|69209976|FG000|Overall Study|Died prior to Boost infusion|1|||
37730530|NCT01829360|69209984|FG000|Overall Study|Protocol Violation|0|||
37730531|NCT01829360|69209985|FG001|Overall Study|Protocol Violation|0|||
37730532|NCT01829360|69209986|FG002|Overall Study|Protocol Violation|1|||
37730533|NCT01829360|69209987|FG003|Overall Study|Protocol Violation|0|||
37730534|NCT01856114|69210003|FG000|Overall Study|Withdrawal by Subject|1|||
37730535|NCT01856114|69210004|FG001|Overall Study|Withdrawal by Subject|0|||
37730536|NCT01856114|69210003|FG000|Overall Study|Adverse Event|1|||
37730537|NCT01856114|69210004|FG001|Overall Study|Adverse Event|0|||
37730538|NCT01855958|69210012|FG000|Overall Study|Withdrawal by Subject|1|||
37730539|NCT01855958|69210013|FG001|Overall Study|Withdrawal by Subject|0|||
37730540|NCT01855412|69210024|FG000|Overall Study|Death|77|||
37730541|NCT01855412|69210025|FG001|Overall Study|Death|123|||
37730542|NCT01855412|69210026|FG002|Overall Study|Death|30|||
37730543|NCT01855412|69210024|FG000|Overall Study|Lost to Follow-up|28|||
37730544|NCT01855412|69210025|FG001|Overall Study|Lost to Follow-up|46|||
37843679|NCT01659658|69528380|FG001|Overall Study|Study Terminated by Sponsor|7|||
37843680|NCT01659658|69528381|FG002|Overall Study|Study Terminated by Sponsor|0|||
37843681|NCT01659658|69528382|FG003|Overall Study|Study Terminated by Sponsor|1|||
37843682|NCT01659658|69528383|FG004|Overall Study|Study Terminated by Sponsor|4|||
37843683|NCT01659658|69528379|FG000|Overall Study|Reason not Specified|61|||
37843684|NCT01659658|69528380|FG001|Overall Study|Reason not Specified|15|||
37843685|NCT01659658|69528381|FG002|Overall Study|Reason not Specified|8|||
37843686|NCT01659658|69528382|FG003|Overall Study|Reason not Specified|1|||
37843687|NCT01659658|69528383|FG004|Overall Study|Reason not Specified|34|||
37843688|NCT01659658|69528379|FG000|Overall Study|Lost to Follow-up|2|||
37843689|NCT01659658|69528380|FG001|Overall Study|Lost to Follow-up|0|||
37843690|NCT01659658|69528381|FG002|Overall Study|Lost to Follow-up|0|||
37843691|NCT01659658|69528382|FG003|Overall Study|Lost to Follow-up|0|||
37843692|NCT01659658|69528383|FG004|Overall Study|Lost to Follow-up|0|||
37843693|NCT01357161|69528403|FG000|Part 1 (Open Label Run-in)|Death|5|||
37843694|NCT01357161|69528404|FG001|Part 1 (Open Label Run-in)|Death|0|||
37730545|NCT01855412|69210026|FG002|Overall Study|Lost to Follow-up|15|||
37843695|NCT01357161|69528405|FG002|Part 1 (Open Label Run-in)|Death|0|||
37730546|NCT01855412|69210024|FG000|Overall Study|Withdrawal by Subject|77|||
37730547|NCT01855412|69210025|FG001|Overall Study|Withdrawal by Subject|123|||
37730548|NCT01855412|69210026|FG002|Overall Study|Withdrawal by Subject|24|||
37730549|NCT01855412|69210024|FG000|Overall Study|Physician Decision|25|||
37730550|NCT01855412|69210025|FG001|Overall Study|Physician Decision|31|||
37730551|NCT01855412|69210026|FG002|Overall Study|Physician Decision|3|||
37730552|NCT01855412|69210024|FG000|Overall Study|Site Closure|4|||
37730553|NCT01855412|69210025|FG001|Overall Study|Site Closure|18|||
37730554|NCT01855412|69210026|FG002|Overall Study|Site Closure|1|||
37730555|NCT01855412|69210024|FG000|Overall Study|Reason not Specified|1|||
37730556|NCT01855412|69210025|FG001|Overall Study|Reason not Specified|2|||
37730557|NCT01855412|69210026|FG002|Overall Study|Reason not Specified|3|||
37730558|NCT01614470|69210042|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
37730559|NCT01614470|69210043|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
37730560|NCT01614470|69210044|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
37730561|NCT01614470|69210042|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
37730562|NCT01614470|69210043|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
37730563|NCT01614470|69210044|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
37730564|NCT01880528|69210055|FG000|Overall Study|Other|1|||
37730565|NCT01880528|69210056|FG001|Overall Study|Other|1|||
37730566|NCT01854944|69210065|FG000|Overall Study|Withdrawal by Subject|0|||
37730567|NCT01854944|69210066|FG001|Overall Study|Withdrawal by Subject|0|||
37730568|NCT01854944|69210067|FG002|Overall Study|Withdrawal by Subject|1|||
37730569|NCT01829048|69210094|FG000|Overall Study|Withdrawal by Subject|0|||
37730570|NCT01829048|69210095|FG001|Overall Study|Withdrawal by Subject|0|||
37730571|NCT01829048|69210096|FG002|Overall Study|Withdrawal by Subject|0|||
37730572|NCT01829048|69210097|FG003|Overall Study|Withdrawal by Subject|2|||
37730573|NCT01829048|69210098|FG004|Overall Study|Withdrawal by Subject|0|||
37730574|NCT01854710|69210111|FG000|Overall Study|Withdrawal by Subject|2|||
37730575|NCT01854710|69210112|FG001|Overall Study|Withdrawal by Subject|1|||
37730576|NCT01854710|69210113|FG002|Overall Study|Withdrawal by Subject|0|||
37730577|NCT01854710|69210114|FG003|Overall Study|Withdrawal by Subject|0|||
37730578|NCT01854710|69210115|FG004|Overall Study|Withdrawal by Subject|0|||
37730579|NCT01854710|69210116|FG005|Overall Study|Withdrawal by Subject|0|||
37730580|NCT01854710|69210111|FG000|Overall Study|CRI procedural error|2|||
37730581|NCT01854710|69210112|FG001|Overall Study|CRI procedural error|2|||
37730582|NCT01854710|69210113|FG002|Overall Study|CRI procedural error|2|||
37730583|NCT01854710|69210114|FG003|Overall Study|CRI procedural error|2|||
37730584|NCT01854710|69210115|FG004|Overall Study|CRI procedural error|2|||
37730585|NCT01854710|69210116|FG005|Overall Study|CRI procedural error|2|||
37730586|NCT01828034|69210130|FG000|Overall Study|Withdrawal by Subject|0|||
37730587|NCT01828034|69210131|FG001|Overall Study|Withdrawal by Subject|0|||
37730588|NCT01828034|69210132|FG002|Overall Study|Withdrawal by Subject|0|||
37730589|NCT01828034|69210133|FG003|Overall Study|Withdrawal by Subject|1|||
37730590|NCT01853696|69210142|FG000|Overall Study|Withdrawal by Subject|1|||
37730591|NCT01853696|69210143|FG001|Overall Study|Withdrawal by Subject|1|||
37730592|NCT01853696|69210142|FG000|Overall Study|Lost to Follow-up|5|||
37730593|NCT01853696|69210143|FG001|Overall Study|Lost to Follow-up|4|||
37730594|NCT01871805|69210155|FG000|Phase I|Death|7|||
37730595|NCT01871805|69210156|FG001|Phase I|Death|4|||
37730596|NCT01871805|69210157|FG002|Phase I|Death|6|||
37730597|NCT01871805|69210158|FG003|Phase I|Death|2|||
37730598|NCT01871805|69210159|FG004|Phase I|Death|9|||
37730599|NCT01871805|69210160|FG005|Phase I|Death|0|||
37730600|NCT01871805|69210155|FG000|Phase I|Alive in Survival Follow-up|0|||
37730601|NCT01871805|69210156|FG001|Phase I|Alive in Survival Follow-up|2|||
37730602|NCT01871805|69210157|FG002|Phase I|Alive in Survival Follow-up|4|||
37730603|NCT01871805|69210158|FG003|Phase I|Alive in Survival Follow-up|5|||
37730604|NCT01871805|69210159|FG004|Phase I|Alive in Survival Follow-up|4|||
37730605|NCT01871805|69210160|FG005|Phase I|Alive in Survival Follow-up|0|||
37730606|NCT01871805|69210155|FG000|Phase I|Lost to Follow-up|0|||
37730607|NCT01871805|69210156|FG001|Phase I|Lost to Follow-up|1|||
37730608|NCT01871805|69210157|FG002|Phase I|Lost to Follow-up|3|||
37730609|NCT01871805|69210158|FG003|Phase I|Lost to Follow-up|0|||
37730610|NCT01871805|69210159|FG004|Phase I|Lost to Follow-up|0|||
37730611|NCT01871805|69210160|FG005|Phase I|Lost to Follow-up|0|||
37730612|NCT01871805|69210155|FG000|Phase II|Death|0|||
37730613|NCT01871805|69210156|FG001|Phase II|Death|0|||
37730614|NCT01871805|69210157|FG002|Phase II|Death|0|||
37730615|NCT01871805|69210158|FG003|Phase II|Death|0|||
37730616|NCT01871805|69210159|FG004|Phase II|Death|0|||
37730617|NCT01871805|69210160|FG005|Phase II|Death|45|||
37730618|NCT01871805|69210155|FG000|Phase II|Alive in Survival Follow-up|0|||
37730619|NCT01871805|69210156|FG001|Phase II|Alive in Survival Follow-up|0|||
37730620|NCT01871805|69210157|FG002|Phase II|Alive in Survival Follow-up|0|||
37730621|NCT01871805|69210158|FG003|Phase II|Alive in Survival Follow-up|0|||
37730622|NCT01871805|69210159|FG004|Phase II|Alive in Survival Follow-up|0|||
37730623|NCT01871805|69210160|FG005|Phase II|Alive in Survival Follow-up|29|||
37843696|NCT01357161|69528403|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
37843697|NCT01357161|69528404|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
37730624|NCT01871805|69210155|FG000|Phase II|Lost to Follow-up|0|||
37730625|NCT01871805|69210156|FG001|Phase II|Lost to Follow-up|0|||
37730626|NCT01871805|69210157|FG002|Phase II|Lost to Follow-up|0|||
37730627|NCT01871805|69210158|FG003|Phase II|Lost to Follow-up|0|||
37730628|NCT01871805|69210159|FG004|Phase II|Lost to Follow-up|0|||
37730629|NCT01871805|69210160|FG005|Phase II|Lost to Follow-up|13|||
37730630|NCT01719861|69210191|FG000|Cycle 1|Death|4|||
37730631|NCT01719861|69210191|FG000|Cycle 2|Death|1|||
37730632|NCT01853618|69210201|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
37730633|NCT01853618|69210202|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
37730634|NCT01853618|69210203|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
37730635|NCT01853618|69210204|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
37730636|NCT01853618|69210205|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
37730637|NCT01853618|69210201|FG000|Overall Study|Progressive disease|1|||
37730638|NCT01853618|69210202|FG001|Overall Study|Progressive disease|1|||
37730639|NCT01853618|69210203|FG002|Overall Study|Progressive disease|1|||
37730640|NCT01853618|69210204|FG003|Overall Study|Progressive disease|1|||
37730641|NCT01853618|69210205|FG004|Overall Study|Progressive disease|2|||
37730642|NCT01853618|69210201|FG000|Overall Study|Physician Decision|0|||
37730643|NCT01853618|69210202|FG001|Overall Study|Physician Decision|1|||
37730644|NCT01853618|69210203|FG002|Overall Study|Physician Decision|1|||
37730645|NCT01853618|69210204|FG003|Overall Study|Physician Decision|0|||
37730646|NCT01853618|69210205|FG004|Overall Study|Physician Decision|0|||
37730647|NCT01853618|69210201|FG000|Overall Study|Refused further treatment|0|||
37730648|NCT01853618|69210202|FG001|Overall Study|Refused further treatment|0|||
37730649|NCT01853618|69210203|FG002|Overall Study|Refused further treatment|0|||
37730650|NCT01853618|69210204|FG003|Overall Study|Refused further treatment|0|||
37730651|NCT01853618|69210205|FG004|Overall Study|Refused further treatment|1|||
37730652|NCT01853462|69210220|FG000|Overall Study|Withdrawal by Subject|1|||
37730653|NCT01853462|69210221|FG001|Overall Study|Withdrawal by Subject|1|||
37730654|NCT01719783|69210231|FG000|Dose 2|Physician Decision|1|||
37730655|NCT01719783|69210232|FG001|Dose 2|Physician Decision|0|||
37730656|NCT01853384|69210260|FG000|Randomized|Adverse Event|5|||
37730657|NCT01853384|69210261|FG001|Randomized|Adverse Event|3|||
37730658|NCT01853384|69210260|FG000|Randomized|Death|1|||
37730659|NCT01853384|69210261|FG001|Randomized|Death|2|||
37730660|NCT01853384|69210260|FG000|Randomized|Lost to Follow-up|1|||
37730661|NCT01853384|69210261|FG001|Randomized|Lost to Follow-up|1|||
37730662|NCT01853384|69210260|FG000|Randomized|Withdrawal by Subject|5|||
37730663|NCT01853384|69210261|FG001|Randomized|Withdrawal by Subject|3|||
37730664|NCT01853384|69210260|FG000|Randomized|Sponsor Decision|47|||
37730665|NCT01853384|69210261|FG001|Randomized|Sponsor Decision|34|||
37730666|NCT01853384|69210260|FG000|Randomized|Other|3|||
37730667|NCT01853384|69210261|FG001|Randomized|Other|3|||
37730668|NCT01853384|69210260|FG000|Completed Follow up Visit 1|Early Termination|13|||
37730669|NCT01853384|69210261|FG001|Completed Follow up Visit 1|Early Termination|9|||
37730670|NCT01853384|69210260|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
37730671|NCT01853384|69210261|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
37730672|NCT01853384|69210260|FG000|Completed Follow up Visit 2|Adverse Event|1|||
37730673|NCT01853384|69210261|FG001|Completed Follow up Visit 2|Adverse Event|0|||
37730674|NCT01853384|69210260|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
37730675|NCT01853384|69210261|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
37730676|NCT01853384|69210260|FG000|Completed Follow up Visit 2|Death|1|||
37730677|NCT01853384|69210261|FG001|Completed Follow up Visit 2|Death|0|||
37730678|NCT01853384|69210260|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
37730679|NCT01853384|69210261|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
37730680|NCT01878890|69210271|FG000|Overall Study|Protocol Violation|0|||
37730681|NCT01878890|69210272|FG001|Overall Study|Protocol Violation|1|||
37730682|NCT01878890|69210273|FG002|Overall Study|Protocol Violation|0|||
37730683|NCT01878890|69210274|FG003|Overall Study|Protocol Violation|0|||
37843698|NCT01357161|69528405|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
37730684|NCT01827332|69210287|FG000|Overall Study|Lost to Follow-up|2|||
37730685|NCT01827332|69210288|FG001|Overall Study|Lost to Follow-up|1|||
37730686|NCT01719003|69210302|FG000|Overall Study|Non compliant with protocol|1|||
37730687|NCT01719003|69210303|FG001|Overall Study|Non compliant with protocol|1|||
37730688|NCT01719003|69210304|FG002|Overall Study|Non compliant with protocol|0|||
37730689|NCT01719003|69210305|FG003|Overall Study|Non compliant with protocol|1|||
37730690|NCT01719003|69210306|FG004|Overall Study|Non compliant with protocol|2|||
37730691|NCT01719003|69210307|FG005|Overall Study|Non compliant with protocol|1|||
37730692|NCT01719003|69210308|FG006|Overall Study|Non compliant with protocol|2|||
37730693|NCT01719003|69210309|FG007|Overall Study|Non compliant with protocol|3|||
37730694|NCT01719003|69210310|FG008|Overall Study|Non compliant with protocol|0|||
37843699|NCT01357161|69528403|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
37843700|NCT01357161|69528404|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
37843701|NCT01357161|69528405|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
37843702|NCT01357161|69528403|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
37843703|NCT01357161|69528404|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
37843704|NCT01357161|69528405|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
37843705|NCT01357161|69528403|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
37843706|NCT01357161|69528404|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
37843707|NCT01357161|69528405|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
37843708|NCT01357161|69528403|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
37915989|NCT00880100|69602817|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
37730695|NCT01719003|69210302|FG000|Overall Study|Adverse Event|6|||
37730696|NCT01719003|69210303|FG001|Overall Study|Adverse Event|5|||
37730697|NCT01719003|69210304|FG002|Overall Study|Adverse Event|4|||
37730698|NCT01719003|69210305|FG003|Overall Study|Adverse Event|3|||
37730699|NCT01719003|69210306|FG004|Overall Study|Adverse Event|4|||
37730700|NCT01719003|69210307|FG005|Overall Study|Adverse Event|3|||
37730701|NCT01719003|69210308|FG006|Overall Study|Adverse Event|6|||
37730702|NCT01719003|69210309|FG007|Overall Study|Adverse Event|5|||
37730703|NCT01719003|69210310|FG008|Overall Study|Adverse Event|0|||
37730704|NCT01719003|69210302|FG000|Overall Study|Lost to Follow-up|0|||
37730705|NCT01719003|69210303|FG001|Overall Study|Lost to Follow-up|6|||
37730706|NCT01719003|69210304|FG002|Overall Study|Lost to Follow-up|7|||
37730707|NCT01719003|69210305|FG003|Overall Study|Lost to Follow-up|2|||
37730708|NCT01719003|69210306|FG004|Overall Study|Lost to Follow-up|3|||
37730709|NCT01719003|69210307|FG005|Overall Study|Lost to Follow-up|4|||
37730710|NCT01719003|69210308|FG006|Overall Study|Lost to Follow-up|3|||
37730711|NCT01719003|69210309|FG007|Overall Study|Lost to Follow-up|2|||
37730712|NCT01719003|69210310|FG008|Overall Study|Lost to Follow-up|2|||
37730713|NCT01719003|69210302|FG000|Overall Study|Refusal to continue, not due to AE|2|||
37730714|NCT01719003|69210303|FG001|Overall Study|Refusal to continue, not due to AE|5|||
37730715|NCT01719003|69210304|FG002|Overall Study|Refusal to continue, not due to AE|4|||
37730716|NCT01719003|69210305|FG003|Overall Study|Refusal to continue, not due to AE|4|||
37730717|NCT01719003|69210306|FG004|Overall Study|Refusal to continue, not due to AE|4|||
37730718|NCT01719003|69210307|FG005|Overall Study|Refusal to continue, not due to AE|3|||
37730719|NCT01719003|69210308|FG006|Overall Study|Refusal to continue, not due to AE|8|||
37730720|NCT01719003|69210309|FG007|Overall Study|Refusal to continue, not due to AE|7|||
37730721|NCT01719003|69210310|FG008|Overall Study|Refusal to continue, not due to AE|1|||
37730722|NCT01719003|69210302|FG000|Overall Study|Reason other than those specified|0|||
37730723|NCT01719003|69210303|FG001|Overall Study|Reason other than those specified|0|||
37730724|NCT01719003|69210304|FG002|Overall Study|Reason other than those specified|2|||
37730725|NCT01719003|69210305|FG003|Overall Study|Reason other than those specified|3|||
37730726|NCT01719003|69210306|FG004|Overall Study|Reason other than those specified|4|||
37730727|NCT01719003|69210307|FG005|Overall Study|Reason other than those specified|1|||
37730728|NCT01719003|69210308|FG006|Overall Study|Reason other than those specified|0|||
37730729|NCT01719003|69210309|FG007|Overall Study|Reason other than those specified|3|||
37730730|NCT01719003|69210310|FG008|Overall Study|Reason other than those specified|1|||
37730731|NCT01719003|69210302|FG000|Overall Study|Lack of Efficacy|0|||
37730732|NCT01719003|69210303|FG001|Overall Study|Lack of Efficacy|0|||
37730733|NCT01719003|69210304|FG002|Overall Study|Lack of Efficacy|0|||
37730734|NCT01719003|69210305|FG003|Overall Study|Lack of Efficacy|0|||
37843709|NCT01357161|69528404|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
37843710|NCT01357161|69528405|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
37843711|NCT01357161|69528403|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
37915990|NCT00880100|69602817|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
37915991|NCT00880100|69602817|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
37915992|NCT00518011|69602823|FG000|Overall Study|Death|1|||
37915993|NCT00518011|69602824|FG001|Overall Study|Death|1|||
37915994|NCT00518011|69602823|FG000|Overall Study|Adverse Event|2|||
37915995|NCT00518011|69602824|FG001|Overall Study|Adverse Event|3|||
37730735|NCT01719003|69210306|FG004|Overall Study|Lack of Efficacy|0|||
37730736|NCT01719003|69210307|FG005|Overall Study|Lack of Efficacy|0|||
37730737|NCT01719003|69210308|FG006|Overall Study|Lack of Efficacy|1|||
37730738|NCT01719003|69210309|FG007|Overall Study|Lack of Efficacy|0|||
37730739|NCT01719003|69210310|FG008|Overall Study|Lack of Efficacy|0|||
37730740|NCT01853228|69210329|FG000|Phase 1|Lack of Efficacy|8|||
37730741|NCT01853228|69210330|FG001|Phase 1|Lack of Efficacy|0|||
37730742|NCT01853228|69210329|FG000|Phase 1|Other|1|||
37730743|NCT01853228|69210330|FG001|Phase 1|Other|0|||
37730744|NCT01853228|69210329|FG000|Phase 2|Physician Decision|0|||
37730745|NCT01853228|69210330|FG001|Phase 2|Physician Decision|1|||
37730746|NCT01853228|69210329|FG000|Phase 2|Proceed To Transplant|0|||
37730747|NCT01853228|69210330|FG001|Phase 2|Proceed To Transplant|3|||
37730748|NCT01853228|69210329|FG000|Phase 2|Lack of Efficacy|0|||
37730749|NCT01853228|69210330|FG001|Phase 2|Lack of Efficacy|4|||
37730750|NCT01705587|69210337|FG000|Overall Study|Withdrawal by Subject|0|||
37730751|NCT01705587|69210338|FG001|Overall Study|Withdrawal by Subject|1|||
37730752|NCT01718535|69210354|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
37730753|NCT01718535|69210355|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
37730754|NCT01718535|69210356|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
37730755|NCT01718535|69210357|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
37730756|NCT01718535|69210358|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
37730757|NCT01718535|69210359|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
37730758|NCT01718535|69210360|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
37730759|NCT01718535|69210361|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
37730760|NCT01718535|69210362|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
37730761|NCT01718535|69210363|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
37730762|NCT01717989|69210385|FG000|Overall Study|Ineligibility determined|6|||
37730763|NCT01717989|69210385|FG000|Overall Study|Protocol deviation|6|||
37730764|NCT01717989|69210385|FG000|Overall Study|Withdrawal by Subject|11|||
37730765|NCT01717989|69210385|FG000|Overall Study|Physician Decision|2|||
37730766|NCT01717989|69210385|FG000|Overall Study|Lost to Follow-up|11|||
37730767|NCT01717989|69210385|FG000|Overall Study|Death|439|||
37730768|NCT01717989|69210385|FG000|Overall Study|Protocol-specified criteria|551|||
37730769|NCT01717989|69210385|FG000|Overall Study|Other|40|||
37730770|NCT01705509|69210404|FG000|Inclusion CPET|Screen Failure|5|||
37730771|NCT01705509|69210404|FG000|Inclusion CPET|Withdrawal by Subject|2|||
37730772|NCT01705509|69210404|FG000|CPET w/ Ranexa|Screen Failure|2|||
37730773|NCT01853072|69210410|FG000|Overall Study|Adverse event prior to treatment|0|||
37730774|NCT01853072|69210411|FG001|Overall Study|Adverse event prior to treatment|1|||
37730775|NCT01853072|69210410|FG000|Overall Study|Adverse Event|0|||
37730776|NCT01853072|69210411|FG001|Overall Study|Adverse Event|3|||
37730777|NCT01853072|69210410|FG000|Overall Study|Death|1|||
37730778|NCT01853072|69210411|FG001|Overall Study|Death|4|||
37730779|NCT01853072|69210410|FG000|Overall Study|Lost to Follow-up|0|||
37730780|NCT01853072|69210411|FG001|Overall Study|Lost to Follow-up|3|||
37730781|NCT01853072|69210410|FG000|Overall Study|Non-compliance with study drug|0|||
37730782|NCT01853072|69210411|FG001|Overall Study|Non-compliance with study drug|1|||
37730783|NCT01853072|69210410|FG000|Overall Study|Physician Decision|1|||
37730784|NCT01853072|69210411|FG001|Overall Study|Physician Decision|1|||
37730785|NCT01853072|69210410|FG000|Overall Study|Withdrawal by Subject|1|||
37730786|NCT01853072|69210411|FG001|Overall Study|Withdrawal by Subject|2|||
37730787|NCT01853072|69210410|FG000|Overall Study|Reason not specified|9|||
37730788|NCT01853072|69210411|FG001|Overall Study|Reason not specified|6|||
37730789|NCT01877720|69210419|FG000|Overall Study|Adverse Event|1|||
37730790|NCT01877720|69210420|FG001|Overall Study|Adverse Event|0|||
37730791|NCT01870869|69210430|FG000|Overall Study|Implanted with nonstudy device|1|||
37730792|NCT01870869|69210431|FG001|Overall Study|Implanted with nonstudy device|3|||
37730793|NCT01870869|69210432|FG002|Overall Study|Implanted with nonstudy device|14|||
37730794|NCT01870869|69210433|FG003|Overall Study|Implanted with nonstudy device|4|||
37730795|NCT01870869|69210430|FG000|Overall Study|Death|0|||
37730796|NCT01870869|69210431|FG001|Overall Study|Death|0|||
37730797|NCT01870869|69210432|FG002|Overall Study|Death|7|||
37730798|NCT01870869|69210433|FG003|Overall Study|Death|1|||
37730799|NCT01870869|69210430|FG000|Overall Study|Subject choice|6|||
37730800|NCT01870869|69210431|FG001|Overall Study|Subject choice|2|||
37730801|NCT01870869|69210432|FG002|Overall Study|Subject choice|22|||
37730802|NCT01870869|69210433|FG003|Overall Study|Subject choice|8|||
37730803|NCT01870869|69210430|FG000|Overall Study|Lost to Follow-up|10|||
37843712|NCT01357161|69528404|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
37843713|NCT01357161|69528405|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
37843714|NCT01357161|69528403|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
37730804|NCT01870869|69210431|FG001|Overall Study|Lost to Follow-up|2|||
37730805|NCT01870869|69210432|FG002|Overall Study|Lost to Follow-up|25|||
37730806|NCT01870869|69210433|FG003|Overall Study|Lost to Follow-up|3|||
37730807|NCT01870869|69210430|FG000|Overall Study|Reason not Specified|1|||
37730808|NCT01870869|69210431|FG001|Overall Study|Reason not Specified|2|||
37730809|NCT01870869|69210432|FG002|Overall Study|Reason not Specified|20|||
37730810|NCT01870869|69210433|FG003|Overall Study|Reason not Specified|4|||
37730811|NCT01870869|69210430|FG000|Overall Study|Not evaluable|10|||
37730812|NCT01870869|69210431|FG001|Overall Study|Not evaluable|5|||
37730813|NCT01870869|69210432|FG002|Overall Study|Not evaluable|42|||
37730814|NCT01870869|69210433|FG003|Overall Study|Not evaluable|10|||
37730815|NCT01877408|69210445|FG000|Overall Study|Lost to Follow-up|0|||
37730816|NCT01877408|69210446|FG001|Overall Study|Lost to Follow-up|2|||
37730817|NCT01717287|69210455|FG000|Overall Study|Lost to Follow-up|0|||
37730818|NCT01717287|69210456|FG001|Overall Study|Lost to Follow-up|2|||
37730819|NCT01717287|69210455|FG000|Overall Study|Protocol Violation|0|||
37730820|NCT01717287|69210456|FG001|Overall Study|Protocol Violation|1|||
37730821|NCT01827254|69210462|FG000|Overall Study|Death|10|||
37730822|NCT01827254|69210462|FG000|Overall Study|Case report form not completed|4|||
37730823|NCT01827254|69210462|FG000|Overall Study|Invalidated centre|3|||
37730824|NCT01827254|69210462|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
37730825|NCT01827254|69210462|FG000|Overall Study|Did not complete re-challenge|1|||
37730826|NCT01827254|69210462|FG000|Overall Study|Disease progression|36|||
37730827|NCT01827254|69210462|FG000|Overall Study|Intolerance to treatment|4|||
37730828|NCT01824602|69210474|FG000|Overall Study|Withdrawal by Subject|0|||
37730829|NCT01824602|69210475|FG001|Overall Study|Withdrawal by Subject|0|||
37730830|NCT01824602|69210476|FG002|Overall Study|Withdrawal by Subject|1|||
37730831|NCT01824602|69210477|FG003|Overall Study|Withdrawal by Subject|2|||
37730832|NCT01824602|69210474|FG000|Overall Study|Patient non-compliance|0|||
37730833|NCT01824602|69210475|FG001|Overall Study|Patient non-compliance|0|||
37730834|NCT01824602|69210476|FG002|Overall Study|Patient non-compliance|1|||
37730835|NCT01824602|69210477|FG003|Overall Study|Patient non-compliance|0|||
37730836|NCT01824602|69210474|FG000|Overall Study|Adverse Event|1|||
37730837|NCT01824602|69210475|FG001|Overall Study|Adverse Event|0|||
37730838|NCT01824602|69210476|FG002|Overall Study|Adverse Event|2|||
37730839|NCT01824602|69210477|FG003|Overall Study|Adverse Event|2|||
37730840|NCT01824602|69210474|FG000|Overall Study|Treatment failure|0|||
37730841|NCT01824602|69210475|FG001|Overall Study|Treatment failure|0|||
37730842|NCT01824602|69210476|FG002|Overall Study|Treatment failure|0|||
37730843|NCT01824602|69210477|FG003|Overall Study|Treatment failure|1|||
37730844|NCT01704651|69210489|FG000|Overall Study|Pre-op withdrawal by subject|1|||
37730845|NCT01704651|69210490|FG001|Overall Study|Pre-op withdrawal by subject|1|||
37730846|NCT01704651|69210489|FG000|Overall Study|Pre-op change in treatment plan|1|||
37730847|NCT01704651|69210490|FG001|Overall Study|Pre-op change in treatment plan|4|||
37730848|NCT01704651|69210489|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
37730849|NCT01704651|69210490|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
37730850|NCT01704651|69210489|FG000|Overall Study|Post-op did not have laparotomy|2|||
37730851|NCT01704651|69210490|FG001|Overall Study|Post-op did not have laparotomy|1|||
37730852|NCT01876706|69210496|FG000|Overall Study|BPH Intervention|9|||
37730853|NCT01876706|69210496|FG000|Overall Study|Lost to Follow-up|7|||
37730854|NCT01876706|69210496|FG000|Overall Study|Withdrawals|6|||
37730855|NCT01876706|69210496|FG000|Overall Study|Death|3|||
37730856|NCT01876082|69210502|FG000|Overall Study|Withdrawal by Subject|0|||
37730857|NCT01876082|69210503|FG001|Overall Study|Withdrawal by Subject|2|||
37730858|NCT01876082|69210502|FG000|Overall Study|Protocol Violation|1|||
37730859|NCT01876082|69210503|FG001|Overall Study|Protocol Violation|0|||
37730860|NCT01876082|69210502|FG000|Overall Study|Adverse Event|1|||
37730861|NCT01876082|69210503|FG001|Overall Study|Adverse Event|1|||
37730862|NCT01876082|69210502|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
37730863|NCT01876082|69210503|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
37730864|NCT01704495|69210513|FG000|Subjects Randomized|Other Reason|3|||
37730865|NCT01704495|69210514|FG001|Subjects Randomized|Other Reason|2|||
37730866|NCT01704495|69210515|FG002|Subjects Randomized|Other Reason|3|||
37730867|NCT01704495|69210516|FG003|Subjects Randomized|Other Reason|2|||
37730868|NCT01704495|69210513|FG000|Subjects Randomized|Discontinuation criteria met|4|||
37730869|NCT01704495|69210514|FG001|Subjects Randomized|Discontinuation criteria met|2|||
37730870|NCT01704495|69210515|FG002|Subjects Randomized|Discontinuation criteria met|2|||
37730871|NCT01704495|69210516|FG003|Subjects Randomized|Discontinuation criteria met|0|||
37730872|NCT01704495|69210513|FG000|Subjects Randomized|Adverse Event|8|||
37730873|NCT01704495|69210514|FG001|Subjects Randomized|Adverse Event|2|||
37730874|NCT01704495|69210515|FG002|Subjects Randomized|Adverse Event|0|||
37730875|NCT01704495|69210516|FG003|Subjects Randomized|Adverse Event|7|||
37730876|NCT01704495|69210513|FG000|Subjects Randomized|Withdrawal by Subject|5|||
37730877|NCT01704495|69210514|FG001|Subjects Randomized|Withdrawal by Subject|5|||
37730878|NCT01704495|69210515|FG002|Subjects Randomized|Withdrawal by Subject|5|||
37730879|NCT01704495|69210516|FG003|Subjects Randomized|Withdrawal by Subject|5|||
37730880|NCT01704495|69210513|FG000|Subjects Randomized|Protocol Violation|1|||
37730881|NCT01704495|69210514|FG001|Subjects Randomized|Protocol Violation|1|||
37730882|NCT01704495|69210515|FG002|Subjects Randomized|Protocol Violation|2|||
37730883|NCT01704495|69210516|FG003|Subjects Randomized|Protocol Violation|0|||
37730884|NCT01704495|69210513|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
37730885|NCT01704495|69210514|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
37915996|NCT00518011|69602823|FG000|Overall Study|Disease Progression|2|||
37730886|NCT01704495|69210515|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
37730887|NCT01704495|69210516|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
37730888|NCT01704495|69210513|FG000|Optional Safety Extension|Adverse Event|0|||
37730889|NCT01704495|69210514|FG001|Optional Safety Extension|Adverse Event|4|||
37730890|NCT01704495|69210515|FG002|Optional Safety Extension|Adverse Event|0|||
37730891|NCT01704495|69210516|FG003|Optional Safety Extension|Adverse Event|1|||
37730892|NCT01704495|69210513|FG000|Optional Safety Extension|Other reason|27|||
37730893|NCT01704495|69210514|FG001|Optional Safety Extension|Other reason|29|||
37730894|NCT01704495|69210515|FG002|Optional Safety Extension|Other reason|30|||
37730895|NCT01704495|69210516|FG003|Optional Safety Extension|Other reason|28|||
37730896|NCT01704495|69210513|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
37730897|NCT01704495|69210514|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
37730898|NCT01704495|69210515|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
37730899|NCT01704495|69210516|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
37730900|NCT01716663|69210526|FG000|Overall Study|Withdrawn prior to procedure|4|||
37730901|NCT01716663|69210526|FG000|Overall Study|Treated with non-study catheter|2|||
37730902|NCT01716585|69210532|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
37730903|NCT01716585|69210533|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
37730904|NCT01716585|69210532|FG000|Double-blind Treatment|Adverse Event|2|||
37730905|NCT01716585|69210533|FG001|Double-blind Treatment|Adverse Event|1|||
37730906|NCT01716585|69210532|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
37730907|NCT01716585|69210533|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
37730908|NCT01716585|69210532|FG000|Double-blind Treatment|Lost to Follow-up|2|||
37730909|NCT01716585|69210533|FG001|Double-blind Treatment|Lost to Follow-up|0|||
37730910|NCT01716585|69210532|FG000|Double-blind Treatment|Subject Noncompliant|1|||
37730911|NCT01716585|69210533|FG001|Double-blind Treatment|Subject Noncompliant|0|||
37730912|NCT01716585|69210532|FG000|Double-blind Treatment|Other|1|||
37730913|NCT01716585|69210533|FG001|Double-blind Treatment|Other|0|||
37730914|NCT01716585|69210532|FG000|Open-label Treatment|Adverse Event|0|||
37730915|NCT01716585|69210533|FG001|Open-label Treatment|Adverse Event|2|||
37730916|NCT01716585|69210532|FG000|Open-label Treatment|Virologic Failure|0|||
37730917|NCT01716585|69210533|FG001|Open-label Treatment|Virologic Failure|2|||
37730918|NCT01716585|69210532|FG000|Open-label Treatment|Withdrawal by Subject|0|||
37730919|NCT01716585|69210533|FG001|Open-label Treatment|Withdrawal by Subject|3|||
37730920|NCT01852292|69210542|FG000|Overall Study|Untreated - did not receive study drug|3|||
37730921|NCT01852292|69210543|FG001|Overall Study|Untreated - did not receive study drug|1|||
37730922|NCT01852292|69210542|FG000|Overall Study|Death|9|||
37730923|NCT01852292|69210543|FG001|Overall Study|Death|8|||
37730924|NCT01852292|69210542|FG000|Overall Study|Patient/guardian decision|8|||
37730925|NCT01852292|69210543|FG001|Overall Study|Patient/guardian decision|4|||
37730926|NCT01852292|69210542|FG000|Overall Study|Adverse Event|8|||
37730927|NCT01852292|69210543|FG001|Overall Study|Adverse Event|11|||
37730928|NCT01852292|69210542|FG000|Overall Study|Physician Decision|6|||
37730929|NCT01852292|69210543|FG001|Overall Study|Physician Decision|2|||
37730930|NCT01852292|69210542|FG000|Overall Study|Protocol Violation|2|||
37730931|NCT01852292|69210543|FG001|Overall Study|Protocol Violation|0|||
37730932|NCT01852292|69210542|FG000|Overall Study|Non-compliance with study treatment|1|||
37730933|NCT01852292|69210543|FG001|Overall Study|Non-compliance with study treatment|0|||
37730934|NCT01852292|69210542|FG000|Overall Study|Study terminated by Sponsor|0|||
37730935|NCT01852292|69210543|FG001|Overall Study|Study terminated by Sponsor|1|||
37730936|NCT01852292|69210542|FG000|Overall Study|Progressive disease|42|||
37730937|NCT01852292|69210543|FG001|Overall Study|Progressive disease|52|||
37730938|NCT01715805|69210549|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
37730939|NCT01715805|69210550|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
37730940|NCT01715805|69210551|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
37730941|NCT01715805|69210552|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
37730942|NCT01715805|69210549|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
37730943|NCT01715805|69210550|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
37730944|NCT01715805|69210551|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
37730945|NCT01715805|69210552|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
37730946|NCT01715805|69210549|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
37730947|NCT01715805|69210550|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
37730948|NCT01715805|69210551|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
37730949|NCT01715805|69210552|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
37730950|NCT01715805|69210549|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
37730951|NCT01715805|69210550|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
37730952|NCT01715805|69210551|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
37730953|NCT01715805|69210552|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
37730954|NCT01715805|69210549|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
37730955|NCT01715805|69210550|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
37730956|NCT01715805|69210551|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
37843715|NCT01357161|69528404|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
37730957|NCT01715805|69210552|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
37730958|NCT01715805|69210549|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
37730959|NCT01715805|69210550|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
37730960|NCT01715805|69210551|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
37730961|NCT01715805|69210552|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
37843716|NCT01357161|69528405|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
37843717|NCT01357161|69528403|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
37843718|NCT01357161|69528404|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
37843719|NCT01357161|69528405|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
37843720|NCT01357161|69528403|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
37730962|NCT01715805|69210549|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
37730963|NCT01715805|69210550|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
37730964|NCT01715805|69210551|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
37843721|NCT01357161|69528404|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
37843722|NCT01357161|69528405|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
37843723|NCT01357161|69528403|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
37843724|NCT01357161|69528404|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
37843725|NCT01357161|69528405|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
37843726|NCT01321073|69528413|FG000|Overall Study|Did not attempt implant|4|||
37843727|NCT01321073|69528413|FG000|Overall Study|Death|3|||
37843728|NCT01276704|69528419|FG000|Overall Study|Lost to Follow-up|2|||
37843729|NCT01276704|69528420|FG001|Overall Study|Lost to Follow-up|3|||
37843730|NCT01276704|69528419|FG000|Overall Study|Non-compliant|2|||
37915997|NCT00518011|69602824|FG001|Overall Study|Disease Progression|2|||
37915998|NCT00518011|69602823|FG000|Overall Study|Other Reasons|3|||
37915999|NCT00518011|69602824|FG001|Overall Study|Other Reasons|2|||
37730965|NCT01715805|69210552|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
37730966|NCT01715805|69210549|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
37730967|NCT01715805|69210550|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
37730968|NCT01715805|69210551|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
37730969|NCT01715805|69210552|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
37730970|NCT01715805|69210549|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
37730971|NCT01715805|69210550|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
37730972|NCT01715805|69210551|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
37730973|NCT01715805|69210552|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
37730974|NCT01715805|69210549|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
37730975|NCT01715805|69210550|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
37730976|NCT01715805|69210551|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
37730977|NCT01715805|69210552|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
37730978|NCT01715805|69210549|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
37730979|NCT01715805|69210550|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
37730980|NCT01715805|69210551|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
37730981|NCT01715805|69210552|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
37730982|NCT01715805|69210549|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
37730983|NCT01715805|69210550|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
37730984|NCT01715805|69210551|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
37730985|NCT01715805|69210552|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
37730986|NCT01715805|69210549|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
37843731|NCT01276704|69528420|FG001|Overall Study|Non-compliant|2|||
37730987|NCT01715805|69210550|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
37916000|NCT00518011|69602823|FG000|Overall Study|Withdrawal by Subject|1|||
37916001|NCT00518011|69602824|FG001|Overall Study|Withdrawal by Subject|0|||
37916002|NCT00865020|69602833|FG000|Overall Study|Withdrawal by Subject|22|||
37916003|NCT00865020|69602834|FG001|Overall Study|Withdrawal by Subject|16|||
37916004|NCT00865020|69602833|FG000|Overall Study|Adverse Event|9|||
37916005|NCT00865020|69602834|FG001|Overall Study|Adverse Event|14|||
37916006|NCT00865020|69602833|FG000|Overall Study|Abnormal test procedure result(s)|6|||
37916007|NCT00865020|69602834|FG001|Overall Study|Abnormal test procedure result(s)|8|||
37916008|NCT00865020|69602833|FG000|Overall Study|Lost to Follow-up|6|||
37916009|NCT00865020|69602834|FG001|Overall Study|Lost to Follow-up|4|||
37916010|NCT00865020|69602833|FG000|Overall Study|Protocol deviation|4|||
37916011|NCT00865020|69602834|FG001|Overall Study|Protocol deviation|1|||
37916012|NCT00865020|69602833|FG000|Overall Study|Administrative problems|0|||
37916013|NCT00865020|69602834|FG001|Overall Study|Administrative problems|2|||
37916014|NCT00865020|69602833|FG000|Overall Study|Abnormal laboratory value(s)|0|||
37916015|NCT00865020|69602834|FG001|Overall Study|Abnormal laboratory value(s)|1|||
37916016|NCT00865020|69602833|FG000|Overall Study|Death|0|||
37916017|NCT00865020|69602834|FG001|Overall Study|Death|1|||
37916018|NCT00865020|69602833|FG000|Overall Study|Randomized but discontinued|2|||
37916019|NCT00865020|69602834|FG001|Overall Study|Randomized but discontinued|4|||
37916020|NCT00517933|69602842|FG000|Period 1|Death|2|||
37916021|NCT00517933|69602843|FG001|Period 1|Death|1|||
37916022|NCT00517933|69602842|FG000|Period 1|Adverse Event|4|||
37916023|NCT00517933|69602843|FG001|Period 1|Adverse Event|4|||
37916024|NCT00517933|69602842|FG000|Period 1|Lost to Follow-up|2|||
37916025|NCT00517933|69602843|FG001|Period 1|Lost to Follow-up|0|||
37916026|NCT00517933|69602842|FG000|Period 1|Underwent lung transplant|0|||
37916027|NCT00517933|69602843|FG001|Period 1|Underwent lung transplant|1|||
37916028|NCT00517933|69602842|FG000|Period 2|Death|2|||
37916029|NCT00517933|69602843|FG001|Period 2|Death|4|||
37916030|NCT00517933|69602842|FG000|Period 2|Adverse Event|2|||
37916031|NCT00517933|69602843|FG001|Period 2|Adverse Event|4|||
37916032|NCT00517933|69602842|FG000|Period 2|Physician Decision|1|||
37916033|NCT00517933|69602843|FG001|Period 2|Physician Decision|0|||
37916034|NCT00517933|69602842|FG000|Period 2|Withdrawal by Subject|1|||
37730988|NCT01715805|69210551|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
37730989|NCT01715805|69210552|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
37730990|NCT01715805|69210549|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
37730991|NCT01715805|69210550|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
37730992|NCT01715805|69210551|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
37730993|NCT01715805|69210552|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
37730994|NCT01852214|69210560|FG000|Period 1|Adverse Event|1|||
37730995|NCT01852214|69210561|FG001|Period 1|Adverse Event|2|||
37730996|NCT01852214|69210560|FG000|Period 1|Withdrawal by Subject|0|||
37730997|NCT01852214|69210561|FG001|Period 1|Withdrawal by Subject|1|||
37730998|NCT01852214|69210560|FG000|Washout Period|Withdrawal by Subject|0|||
37730999|NCT01852214|69210561|FG001|Washout Period|Withdrawal by Subject|1|||
37731000|NCT01393990|69210586|FG000|Overall Study|Adverse Event|0|||
37731001|NCT01393990|69210587|FG001|Overall Study|Adverse Event|0|||
37731002|NCT01393990|69210588|FG002|Overall Study|Adverse Event|0|||
37731003|NCT01393990|69210589|FG003|Overall Study|Adverse Event|0|||
37731004|NCT01393990|69210590|FG004|Overall Study|Adverse Event|0|||
37731005|NCT01393990|69210591|FG005|Overall Study|Adverse Event|0|||
37731006|NCT01393990|69210592|FG006|Overall Study|Adverse Event|0|||
37731007|NCT01393990|69210593|FG007|Overall Study|Adverse Event|0|||
37731008|NCT01393990|69210594|FG008|Overall Study|Adverse Event|0|||
37731009|NCT01393990|69210595|FG009|Overall Study|Adverse Event|0|||
37731010|NCT01393990|69210596|FG010|Overall Study|Adverse Event|0|||
37916035|NCT00517933|69602843|FG001|Period 2|Withdrawal by Subject|3|||
37916036|NCT00517933|69602842|FG000|Period 2|Underwent lung transplant|0|||
37916037|NCT00517933|69602843|FG001|Period 2|Underwent lung transplant|2|||
38025671|NCT01317940|69710229|FG000|Overall Study|Death|1|||
37731011|NCT01393990|69210597|FG011|Overall Study|Adverse Event|0|||
37731012|NCT01393990|69210598|FG012|Overall Study|Adverse Event|0|||
37843732|NCT01276704|69528419|FG000|Overall Study|Withdrawal by Subject|7|||
37843733|NCT01276704|69528420|FG001|Overall Study|Withdrawal by Subject|1|||
37843734|NCT01276704|69528419|FG000|Overall Study|Physician Decision|3|||
37843735|NCT01276704|69528420|FG001|Overall Study|Physician Decision|5|||
37843736|NCT01190930|69528428|FG000|Induction|Adverse Event|17|||
37843737|NCT01190930|69528429|FG001|Induction|Adverse Event|0|||
37843738|NCT01190930|69528430|FG002|Induction|Adverse Event|0|||
37843739|NCT01190930|69528431|FG003|Induction|Adverse Event|0|||
37843740|NCT01190930|69528432|FG004|Induction|Adverse Event|0|||
37843741|NCT01190930|69528433|FG005|Induction|Adverse Event|0|||
37843742|NCT01190930|69528434|FG006|Induction|Adverse Event|0|||
37843743|NCT01190930|69528435|FG007|Induction|Adverse Event|0|||
37843744|NCT01190930|69528436|FG008|Induction|Adverse Event|0|||
37843745|NCT01190930|69528437|FG009|Induction|Adverse Event|0|||
37843746|NCT01190930|69528428|FG000|Induction|Death|34|||
37843747|NCT01190930|69528429|FG001|Induction|Death|0|||
37731013|NCT01393990|69210599|FG013|Overall Study|Adverse Event|0|||
37731014|NCT01393990|69210600|FG014|Overall Study|Adverse Event|1|||
37731015|NCT01393990|69210601|FG015|Overall Study|Adverse Event|1|||
37731016|NCT01393990|69210602|FG016|Overall Study|Adverse Event|0|||
37731017|NCT01393990|69210603|FG017|Overall Study|Adverse Event|0|||
37731018|NCT01393990|69210586|FG000|Overall Study|Progressive Disease|1|||
37731019|NCT01393990|69210587|FG001|Overall Study|Progressive Disease|0|||
37731020|NCT01393990|69210588|FG002|Overall Study|Progressive Disease|0|||
37731021|NCT01393990|69210589|FG003|Overall Study|Progressive Disease|1|||
37731022|NCT01393990|69210590|FG004|Overall Study|Progressive Disease|1|||
37731023|NCT01393990|69210591|FG005|Overall Study|Progressive Disease|1|||
37731024|NCT01393990|69210592|FG006|Overall Study|Progressive Disease|1|||
37731025|NCT01393990|69210593|FG007|Overall Study|Progressive Disease|1|||
37731026|NCT01393990|69210594|FG008|Overall Study|Progressive Disease|3|||
37731027|NCT01393990|69210595|FG009|Overall Study|Progressive Disease|1|||
37731028|NCT01393990|69210596|FG010|Overall Study|Progressive Disease|0|||
37731029|NCT01393990|69210597|FG011|Overall Study|Progressive Disease|0|||
37731030|NCT01393990|69210598|FG012|Overall Study|Progressive Disease|0|||
37731031|NCT01393990|69210599|FG013|Overall Study|Progressive Disease|1|||
37731032|NCT01393990|69210600|FG014|Overall Study|Progressive Disease|6|||
37731033|NCT01393990|69210601|FG015|Overall Study|Progressive Disease|1|||
37731034|NCT01393990|69210602|FG016|Overall Study|Progressive Disease|0|||
37731035|NCT01393990|69210603|FG017|Overall Study|Progressive Disease|0|||
37843748|NCT01190930|69528430|FG002|Induction|Death|0|||
37843749|NCT01190930|69528431|FG003|Induction|Death|0|||
37843750|NCT01190930|69528432|FG004|Induction|Death|0|||
37843751|NCT01190930|69528433|FG005|Induction|Death|0|||
37843752|NCT01190930|69528434|FG006|Induction|Death|0|||
37843753|NCT01190930|69528435|FG007|Induction|Death|0|||
37843754|NCT01190930|69528436|FG008|Induction|Death|0|||
37843755|NCT01190930|69528437|FG009|Induction|Death|0|||
37843756|NCT01190930|69528428|FG000|Induction|Lost to Follow-up|1|||
37843757|NCT01190930|69528429|FG001|Induction|Lost to Follow-up|0|||
37843758|NCT01190930|69528430|FG002|Induction|Lost to Follow-up|0|||
37843759|NCT01190930|69528431|FG003|Induction|Lost to Follow-up|0|||
37843760|NCT01190930|69528432|FG004|Induction|Lost to Follow-up|0|||
37843761|NCT01190930|69528433|FG005|Induction|Lost to Follow-up|0|||
37843762|NCT01190930|69528434|FG006|Induction|Lost to Follow-up|0|||
37843763|NCT01190930|69528435|FG007|Induction|Lost to Follow-up|0|||
37843764|NCT01190930|69528436|FG008|Induction|Lost to Follow-up|0|||
37843765|NCT01190930|69528437|FG009|Induction|Lost to Follow-up|0|||
37843766|NCT01190930|69528428|FG000|Induction|Physician Decision|125|||
37843767|NCT01190930|69528429|FG001|Induction|Physician Decision|3|||
37843768|NCT01190930|69528430|FG002|Induction|Physician Decision|0|||
37843769|NCT01190930|69528431|FG003|Induction|Physician Decision|0|||
37843770|NCT01190930|69528432|FG004|Induction|Physician Decision|0|||
37843771|NCT01190930|69528433|FG005|Induction|Physician Decision|0|||
37843772|NCT01190930|69528434|FG006|Induction|Physician Decision|0|||
37731036|NCT01393990|69210586|FG000|Overall Study|Death|0|||
37843773|NCT01190930|69528435|FG007|Induction|Physician Decision|0|||
37731037|NCT01393990|69210587|FG001|Overall Study|Death|0|||
37731038|NCT01393990|69210588|FG002|Overall Study|Death|0|||
37731039|NCT01393990|69210589|FG003|Overall Study|Death|0|||
37843774|NCT01190930|69528436|FG008|Induction|Physician Decision|0|||
37843775|NCT01190930|69528437|FG009|Induction|Physician Decision|0|||
37843776|NCT01190930|69528428|FG000|Induction|Withdrawal by Subject|9|||
37731040|NCT01393990|69210590|FG004|Overall Study|Death|1|||
37731041|NCT01393990|69210591|FG005|Overall Study|Death|0|||
37731042|NCT01393990|69210592|FG006|Overall Study|Death|0|||
37731043|NCT01393990|69210593|FG007|Overall Study|Death|0|||
37843777|NCT01190930|69528429|FG001|Induction|Withdrawal by Subject|0|||
37843778|NCT01190930|69528430|FG002|Induction|Withdrawal by Subject|0|||
37843779|NCT01190930|69528431|FG003|Induction|Withdrawal by Subject|0|||
37843780|NCT01190930|69528432|FG004|Induction|Withdrawal by Subject|0|||
37843781|NCT01190930|69528433|FG005|Induction|Withdrawal by Subject|0|||
37843782|NCT01190930|69528434|FG006|Induction|Withdrawal by Subject|0|||
37843783|NCT01190930|69528435|FG007|Induction|Withdrawal by Subject|0|||
37843784|NCT01190930|69528436|FG008|Induction|Withdrawal by Subject|0|||
37843785|NCT01190930|69528437|FG009|Induction|Withdrawal by Subject|0|||
37843786|NCT01190930|69528428|FG000|Induction|Refusal|235|||
37731044|NCT01393990|69210594|FG008|Overall Study|Death|0|||
37731045|NCT01393990|69210595|FG009|Overall Study|Death|0|||
37731046|NCT01393990|69210596|FG010|Overall Study|Death|0|||
37843787|NCT01190930|69528429|FG001|Induction|Refusal|0|||
37843788|NCT01190930|69528430|FG002|Induction|Refusal|0|||
37843789|NCT01190930|69528431|FG003|Induction|Refusal|0|||
37843790|NCT01190930|69528432|FG004|Induction|Refusal|0|||
37843791|NCT01190930|69528433|FG005|Induction|Refusal|0|||
37843792|NCT01190930|69528434|FG006|Induction|Refusal|0|||
37843793|NCT01190930|69528435|FG007|Induction|Refusal|0|||
37843794|NCT01190930|69528436|FG008|Induction|Refusal|0|||
37843795|NCT01190930|69528437|FG009|Induction|Refusal|0|||
37843796|NCT01190930|69528428|FG000|Induction|Inevaluable|23|||
37843797|NCT01190930|69528429|FG001|Induction|Inevaluable|1|||
37843798|NCT01190930|69528430|FG002|Induction|Inevaluable|0|||
37843799|NCT01190930|69528431|FG003|Induction|Inevaluable|0|||
37843800|NCT01190930|69528432|FG004|Induction|Inevaluable|0|||
37843801|NCT01190930|69528433|FG005|Induction|Inevaluable|0|||
37843802|NCT01190930|69528434|FG006|Induction|Inevaluable|0|||
37843803|NCT01190930|69528435|FG007|Induction|Inevaluable|0|||
37843804|NCT01190930|69528436|FG008|Induction|Inevaluable|0|||
37843805|NCT01190930|69528437|FG009|Induction|Inevaluable|0|||
37843806|NCT01190930|69528428|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
37843807|NCT01190930|69528429|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
37843808|NCT01190930|69528430|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
37843809|NCT01190930|69528431|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
37843810|NCT01190930|69528432|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
37843811|NCT01190930|69528433|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
37843812|NCT01190930|69528434|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
37843813|NCT01190930|69528435|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
37843814|NCT01190930|69528436|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
37843815|NCT01190930|69528437|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
37843816|NCT01190930|69528428|FG000|Induction|High Risk Downs|80|||
37843817|NCT01190930|69528429|FG001|Induction|High Risk Downs|0|||
37843818|NCT01190930|69528430|FG002|Induction|High Risk Downs|0|||
37843819|NCT01190930|69528431|FG003|Induction|High Risk Downs|0|||
37731047|NCT01393990|69210597|FG011|Overall Study|Death|0|||
37731048|NCT01393990|69210598|FG012|Overall Study|Death|0|||
37731049|NCT01393990|69210599|FG013|Overall Study|Death|1|||
37731050|NCT01393990|69210600|FG014|Overall Study|Death|1|||
37731051|NCT01393990|69210601|FG015|Overall Study|Death|0|||
37731052|NCT01393990|69210602|FG016|Overall Study|Death|0|||
37731053|NCT01393990|69210603|FG017|Overall Study|Death|0|||
37731054|NCT01393990|69210586|FG000|Overall Study|Withdrawal by Subject|0|||
37731055|NCT01393990|69210587|FG001|Overall Study|Withdrawal by Subject|0|||
37731056|NCT01393990|69210588|FG002|Overall Study|Withdrawal by Subject|0|||
37731057|NCT01393990|69210589|FG003|Overall Study|Withdrawal by Subject|0|||
37731058|NCT01393990|69210590|FG004|Overall Study|Withdrawal by Subject|0|||
37731059|NCT01393990|69210591|FG005|Overall Study|Withdrawal by Subject|0|||
37731060|NCT01393990|69210592|FG006|Overall Study|Withdrawal by Subject|0|||
37731061|NCT01393990|69210593|FG007|Overall Study|Withdrawal by Subject|0|||
37731062|NCT01393990|69210594|FG008|Overall Study|Withdrawal by Subject|0|||
37731063|NCT01393990|69210595|FG009|Overall Study|Withdrawal by Subject|0|||
37731064|NCT01393990|69210596|FG010|Overall Study|Withdrawal by Subject|0|||
37731065|NCT01393990|69210597|FG011|Overall Study|Withdrawal by Subject|0|||
37731066|NCT01393990|69210598|FG012|Overall Study|Withdrawal by Subject|0|||
37731067|NCT01393990|69210599|FG013|Overall Study|Withdrawal by Subject|0|||
37731068|NCT01393990|69210600|FG014|Overall Study|Withdrawal by Subject|1|||
37731069|NCT01393990|69210601|FG015|Overall Study|Withdrawal by Subject|1|||
37731070|NCT01393990|69210602|FG016|Overall Study|Withdrawal by Subject|0|||
37731071|NCT01393990|69210603|FG017|Overall Study|Withdrawal by Subject|0|||
37731072|NCT00210184|69210652|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
37731073|NCT00210106|69210656|FG000|Overall Study|Death|1|||
37731074|NCT00210106|69210656|FG000|Overall Study|Protocol Violation|13|||
37843820|NCT01190930|69528432|FG004|Induction|High Risk Downs|0|||
37843821|NCT01190930|69528433|FG005|Induction|High Risk Downs|0|||
37843822|NCT01190930|69528434|FG006|Induction|High Risk Downs|0|||
37843823|NCT01190930|69528435|FG007|Induction|High Risk Downs|0|||
37843824|NCT01190930|69528436|FG008|Induction|High Risk Downs|0|||
37843825|NCT01190930|69528437|FG009|Induction|High Risk Downs|0|||
37731075|NCT01851590|69210664|FG000|Overall Study|Withdrawal by Subject|0|||
37731076|NCT01851590|69210665|FG001|Overall Study|Withdrawal by Subject|0|||
37843826|NCT01190930|69528428|FG000|Induction|Enrollment onto another COG Protocol|1|||
37843827|NCT01190930|69528429|FG001|Induction|Enrollment onto another COG Protocol|0|||
37731077|NCT01851590|69210666|FG002|Overall Study|Withdrawal by Subject|1|||
37731078|NCT01851590|69210664|FG000|Overall Study|Adverse Event|0|||
37843828|NCT01190930|69528430|FG002|Induction|Enrollment onto another COG Protocol|0|||
37843829|NCT01190930|69528431|FG003|Induction|Enrollment onto another COG Protocol|0|||
37843830|NCT01190930|69528432|FG004|Induction|Enrollment onto another COG Protocol|0|||
37731079|NCT01851590|69210665|FG001|Overall Study|Adverse Event|0|||
37731080|NCT01851590|69210666|FG002|Overall Study|Adverse Event|2|||
37731081|NCT01851590|69210664|FG000|Overall Study|Lack of Efficacy|0|||
37731082|NCT01851590|69210665|FG001|Overall Study|Lack of Efficacy|1|||
37731083|NCT01851590|69210666|FG002|Overall Study|Lack of Efficacy|0|||
37731084|NCT01852058|69210681|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
37731085|NCT01852058|69210682|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
37731086|NCT01852058|69210683|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
37731087|NCT01852058|69210684|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
37731088|NCT01852058|69210685|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
37731089|NCT01852058|69210686|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
37731090|NCT01852058|69210687|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
37731091|NCT01852058|69210688|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
37731092|NCT01852058|69210689|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
37731093|NCT01852058|69210690|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
37731094|NCT01852058|69210691|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
37731095|NCT01852058|69210692|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
37731096|NCT01852058|69210681|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
37731097|NCT01852058|69210682|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
37731098|NCT01852058|69210683|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
37731099|NCT01852058|69210684|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
37731100|NCT01852058|69210685|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
37731101|NCT01852058|69210686|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
37731102|NCT01852058|69210687|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
37731103|NCT01852058|69210688|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
37731104|NCT01852058|69210689|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
37731105|NCT01852058|69210690|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
37731106|NCT01852058|69210691|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
37731107|NCT01852058|69210692|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
37731108|NCT01852058|69210681|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
37731109|NCT01852058|69210682|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
37731110|NCT01852058|69210683|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
37731111|NCT01852058|69210684|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
37731112|NCT01852058|69210685|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
37731113|NCT01852058|69210686|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
37731114|NCT01852058|69210687|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
37731115|NCT01852058|69210688|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
37731116|NCT01852058|69210689|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
37731117|NCT01852058|69210690|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
37731118|NCT01852058|69210691|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
37731119|NCT01852058|69210692|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
37731120|NCT01852058|69210681|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
37731121|NCT01852058|69210682|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
37731122|NCT01852058|69210683|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
37731123|NCT01852058|69210684|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
37731124|NCT01852058|69210685|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
37731125|NCT01852058|69210686|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
37731126|NCT01852058|69210687|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
37731127|NCT01852058|69210688|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
37731128|NCT01852058|69210689|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
37731129|NCT01852058|69210690|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
37731130|NCT01852058|69210691|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
37731131|NCT01852058|69210692|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
37731132|NCT01852058|69210681|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
37731133|NCT01852058|69210682|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
37916038|NCT00701038|69602854|FG000|Overall Study|study amended pilot group of patients|4|||
37731134|NCT01852058|69210683|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
37731135|NCT01852058|69210684|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
37731136|NCT01852058|69210685|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
37731137|NCT01852058|69210686|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
37731138|NCT01852058|69210687|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
37731139|NCT01852058|69210688|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
37731140|NCT01852058|69210689|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
37731141|NCT01852058|69210690|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
37731142|NCT01852058|69210691|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
37731143|NCT01852058|69210692|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
37731144|NCT01852058|69210681|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
37731145|NCT01852058|69210682|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
37731146|NCT01852058|69210683|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
37731147|NCT01852058|69210684|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
37731148|NCT01852058|69210685|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
37731149|NCT01852058|69210686|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
37731150|NCT01852058|69210687|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
37731151|NCT01852058|69210688|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
37731152|NCT01852058|69210689|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
37731153|NCT01852058|69210690|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
37731154|NCT01852058|69210691|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
37731155|NCT01852058|69210692|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
37731156|NCT01852058|69210681|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
37731157|NCT01852058|69210682|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
37731158|NCT01852058|69210683|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
37731159|NCT01852058|69210684|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
37731160|NCT01852058|69210685|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
37731161|NCT01852058|69210686|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
37731162|NCT01852058|69210687|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
37731163|NCT01852058|69210688|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
37731164|NCT01852058|69210689|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
37731165|NCT01852058|69210690|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
37731166|NCT01852058|69210691|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
37731167|NCT01852058|69210692|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
37731168|NCT01852058|69210681|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
37731169|NCT01852058|69210682|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
37731170|NCT01852058|69210683|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
37731171|NCT01852058|69210684|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
37731172|NCT01852058|69210685|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
37731173|NCT01852058|69210686|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
37731174|NCT01852058|69210687|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
37731175|NCT01852058|69210688|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
37731176|NCT01852058|69210689|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
37731177|NCT01852058|69210690|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
37731178|NCT01852058|69210691|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
37731179|NCT01852058|69210692|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
37731180|NCT01852058|69210681|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
37731181|NCT01852058|69210682|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
37731182|NCT01852058|69210683|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
37731183|NCT01852058|69210684|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
37731184|NCT01852058|69210685|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
37731185|NCT01852058|69210686|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
37731186|NCT01852058|69210687|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
37731187|NCT01852058|69210688|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
37731188|NCT01852058|69210689|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
37731189|NCT01852058|69210690|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
37731190|NCT01852058|69210691|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
37731191|NCT01852058|69210692|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
37731192|NCT00218296|69210729|FG000|Overall Study|Lost to Follow-up|9|||
37843831|NCT01190930|69528433|FG005|Induction|Enrollment onto another COG Protocol|0|||
37731193|NCT00218296|69210730|FG001|Overall Study|Lost to Follow-up|7|||
37731194|NCT00218296|69210729|FG000|Overall Study|Withdrawal by Subject|36|||
37731195|NCT00218296|69210730|FG001|Overall Study|Withdrawal by Subject|47|||
37731196|NCT00218296|69210729|FG000|Overall Study|Randomized but did not enter treatment|66|||
37731197|NCT00218296|69210730|FG001|Overall Study|Randomized but did not enter treatment|67|||
37731198|NCT00217672|69210738|FG000|Allocation|Ineligible|2|||
37731199|NCT00217672|69210739|FG001|Allocation|Ineligible|0|||
37731200|NCT00217672|69210738|FG000|Treatment|disease progression|33|||
37731201|NCT00217672|69210739|FG001|Treatment|disease progression|4|||
37731202|NCT00217672|69210738|FG000|Treatment|Adverse Event|18|||
37731203|NCT00217672|69210739|FG001|Treatment|Adverse Event|2|||
37731204|NCT00217672|69210738|FG000|Treatment|reqd treatment not permitted by protocol|6|||
37731205|NCT00217672|69210739|FG001|Treatment|reqd treatment not permitted by protocol|0|||
37731206|NCT00217672|69210738|FG000|Treatment|Physician Decision|6|||
37731207|NCT00217672|69210739|FG001|Treatment|Physician Decision|0|||
37731208|NCT00217672|69210738|FG000|Treatment|insurance issues|1|||
37731209|NCT00217672|69210739|FG001|Treatment|insurance issues|1|||
37731210|NCT00217672|69210738|FG000|Treatment|Death|2|||
37731211|NCT00217672|69210739|FG001|Treatment|Death|0|||
37731212|NCT00217672|69210738|FG000|Treatment|secondary malignancy|1|||
37731213|NCT00217672|69210739|FG001|Treatment|secondary malignancy|0|||
37731214|NCT00217672|69210738|FG000|Follow-up|Withdrawal by Subject|4|||
37731215|NCT00217672|69210739|FG001|Follow-up|Withdrawal by Subject|0|||
37731216|NCT00217672|69210738|FG000|Follow-up|Lost to Follow-up|1|||
37731217|NCT00217672|69210739|FG001|Follow-up|Lost to Follow-up|0|||
37731218|NCT00216736|69210745|FG000|Overall Study|Lost to Follow-up|1|||
37731219|NCT00216736|69210746|FG001|Overall Study|Lost to Follow-up|1|||
37731220|NCT01850030|69210754|FG000|Overall Study|Adverse Event|64|||
37731221|NCT01850030|69210755|FG001|Overall Study|Adverse Event|82|||
37731222|NCT01850030|69210754|FG000|Overall Study|Lack of Efficacy|3|||
37731223|NCT01850030|69210755|FG001|Overall Study|Lack of Efficacy|1|||
37731224|NCT01850030|69210754|FG000|Overall Study|Lost to Follow-up|5|||
37731225|NCT01850030|69210755|FG001|Overall Study|Lost to Follow-up|5|||
37731226|NCT01850030|69210754|FG000|Overall Study|Withdrawal by Subject|3|||
37731227|NCT01850030|69210755|FG001|Overall Study|Withdrawal by Subject|4|||
37731228|NCT01850030|69210754|FG000|Overall Study|Protocol Violation|24|||
37731229|NCT01850030|69210755|FG001|Overall Study|Protocol Violation|28|||
37731230|NCT01850030|69210754|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
37731231|NCT01850030|69210755|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
37731232|NCT00215644|69210763|FG000|Overall Study|Disease Progression|28|||
37731233|NCT00215644|69210764|FG001|Overall Study|Disease Progression|10|||
37731234|NCT00215644|69210763|FG000|Overall Study|Adverse Event|2|||
37731235|NCT00215644|69210764|FG001|Overall Study|Adverse Event|9|||
37731236|NCT00215644|69210763|FG000|Overall Study|Death|1|||
37843832|NCT01190930|69528434|FG006|Induction|Enrollment onto another COG Protocol|0|||
37843833|NCT01190930|69528435|FG007|Induction|Enrollment onto another COG Protocol|0|||
37843834|NCT01190930|69528436|FG008|Induction|Enrollment onto another COG Protocol|0|||
37843835|NCT01190930|69528437|FG009|Induction|Enrollment onto another COG Protocol|0|||
37843836|NCT01190930|69528428|FG000|Induction|Average Risk|1847|||
37843837|NCT01190930|69528429|FG001|Induction|Average Risk|0|||
37843838|NCT01190930|69528430|FG002|Induction|Average Risk|0|||
37843839|NCT01190930|69528431|FG003|Induction|Average Risk|0|||
37843840|NCT01190930|69528432|FG004|Induction|Average Risk|0|||
37843841|NCT01190930|69528433|FG005|Induction|Average Risk|0|||
37843842|NCT01190930|69528434|FG006|Induction|Average Risk|0|||
37843843|NCT01190930|69528435|FG007|Induction|Average Risk|0|||
37843844|NCT01190930|69528436|FG008|Induction|Average Risk|0|||
37731237|NCT00215644|69210764|FG001|Overall Study|Death|2|||
37731238|NCT00215644|69210763|FG000|Overall Study|Withdrawal by Subject|1|||
37843845|NCT01190930|69528437|FG009|Induction|Average Risk|0|||
37843846|NCT01190930|69528428|FG000|Induction|High Risk|1227|||
37731239|NCT00215644|69210764|FG001|Overall Study|Withdrawal by Subject|0|||
37731240|NCT00215644|69210763|FG000|Overall Study|Other|3|||
37731241|NCT00215644|69210764|FG001|Overall Study|Other|15|||
37731242|NCT00215644|69210763|FG000|Overall Study|Randomized but Not Treated|1|||
37731243|NCT00215644|69210764|FG001|Overall Study|Randomized but Not Treated|0|||
37731244|NCT01870401|69210772|FG000|Overall Study|Death|48|||
37731245|NCT01870401|69210773|FG001|Overall Study|Death|24|||
37731246|NCT01870401|69210772|FG000|Overall Study|Withdrawal by Subject|39|||
37731247|NCT01870401|69210773|FG001|Overall Study|Withdrawal by Subject|26|||
37731248|NCT01870401|69210772|FG000|Overall Study|Lost to Follow-up|19|||
37731249|NCT01870401|69210773|FG001|Overall Study|Lost to Follow-up|14|||
37731250|NCT01870401|69210772|FG000|Overall Study|Other|9|||
37731251|NCT01870401|69210773|FG001|Overall Study|Other|7|||
37731252|NCT01870401|69210772|FG000|Overall Study|On-going in the Study|35|||
37731253|NCT01870401|69210773|FG001|Overall Study|On-going in the Study|25|||
37731254|NCT00213148|69210785|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
37731255|NCT00213148|69210786|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
37843847|NCT01190930|69528429|FG001|Induction|High Risk|0|||
37843848|NCT01190930|69528430|FG002|Induction|High Risk|0|||
37843849|NCT01190930|69528431|FG003|Induction|High Risk|0|||
37731256|NCT00213148|69210787|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
37731257|NCT00213148|69210788|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
37731258|NCT00213148|69210789|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
37731259|NCT00213148|69210785|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
37731260|NCT00213148|69210786|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
37731261|NCT00213148|69210787|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
37731262|NCT00213148|69210788|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
37731263|NCT00213148|69210789|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
37731264|NCT00213148|69210785|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
37731265|NCT00213148|69210786|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
37731266|NCT00213148|69210787|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
37731267|NCT00213148|69210788|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
37731268|NCT00213148|69210789|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
37731269|NCT00213148|69210785|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
37731270|NCT00213148|69210786|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
37731271|NCT00213148|69210787|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
37731272|NCT00213148|69210788|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
37731273|NCT00213148|69210789|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
37731274|NCT00213148|69210785|FG000|Cycle 1 (1 Month)|Other|3|||
37731275|NCT00213148|69210786|FG001|Cycle 1 (1 Month)|Other|0|||
37731276|NCT00213148|69210787|FG002|Cycle 1 (1 Month)|Other|2|||
37731277|NCT00213148|69210788|FG003|Cycle 1 (1 Month)|Other|2|||
37731278|NCT00213148|69210789|FG004|Cycle 1 (1 Month)|Other|7|||
37731279|NCT00213148|69210785|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
37731280|NCT00213148|69210786|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
37731281|NCT00213148|69210787|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
37731282|NCT00213148|69210788|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
37731283|NCT00213148|69210789|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
37843850|NCT01190930|69528432|FG004|Induction|High Risk|0|||
37843851|NCT01190930|69528433|FG005|Induction|High Risk|0|||
37843852|NCT01190930|69528434|FG006|Induction|High Risk|0|||
37843853|NCT01190930|69528435|FG007|Induction|High Risk|0|||
37843854|NCT01190930|69528436|FG008|Induction|High Risk|0|||
37843855|NCT01190930|69528437|FG009|Induction|High Risk|0|||
37843856|NCT01190930|69528428|FG000|Induction|Low Risk|443|||
37843857|NCT01190930|69528429|FG001|Induction|Low Risk|0|||
37843858|NCT01190930|69528430|FG002|Induction|Low Risk|0|||
37843859|NCT01190930|69528431|FG003|Induction|Low Risk|0|||
37843860|NCT01190930|69528432|FG004|Induction|Low Risk|0|||
37843861|NCT01190930|69528433|FG005|Induction|Low Risk|0|||
37843862|NCT01190930|69528434|FG006|Induction|Low Risk|0|||
37843863|NCT01190930|69528435|FG007|Induction|Low Risk|0|||
37843864|NCT01190930|69528436|FG008|Induction|Low Risk|0|||
37843865|NCT01190930|69528437|FG009|Induction|Low Risk|0|||
37843866|NCT01190930|69528428|FG000|Induction|Very High Risk|1012|||
37843867|NCT01190930|69528429|FG001|Induction|Very High Risk|0|||
37843868|NCT01190930|69528430|FG002|Induction|Very High Risk|0|||
37843869|NCT01190930|69528431|FG003|Induction|Very High Risk|0|||
37843870|NCT01190930|69528432|FG004|Induction|Very High Risk|0|||
37843871|NCT01190930|69528433|FG005|Induction|Very High Risk|0|||
37843872|NCT01190930|69528434|FG006|Induction|Very High Risk|0|||
37843873|NCT01190930|69528435|FG007|Induction|Very High Risk|0|||
37843874|NCT01190930|69528436|FG008|Induction|Very High Risk|0|||
37843875|NCT01190930|69528437|FG009|Induction|Very High Risk|0|||
37843876|NCT01190930|69528428|FG000|Induction|Philadelphia chromosome-positive|99|||
37843877|NCT01190930|69528429|FG001|Induction|Philadelphia chromosome-positive|0|||
37843878|NCT01190930|69528430|FG002|Induction|Philadelphia chromosome-positive|0|||
37843879|NCT01190930|69528431|FG003|Induction|Philadelphia chromosome-positive|0|||
37843880|NCT01190930|69528432|FG004|Induction|Philadelphia chromosome-positive|0|||
37843881|NCT01190930|69528433|FG005|Induction|Philadelphia chromosome-positive|0|||
38025672|NCT01317940|69710230|FG001|Overall Study|Death|0|||
38025673|NCT01317940|69710231|FG002|Overall Study|Death|1|||
37843882|NCT01190930|69528434|FG006|Induction|Philadelphia chromosome-positive|0|||
37843883|NCT01190930|69528435|FG007|Induction|Philadelphia chromosome-positive|0|||
37843884|NCT01190930|69528436|FG008|Induction|Philadelphia chromosome-positive|0|||
37843885|NCT01190930|69528437|FG009|Induction|Philadelphia chromosome-positive|0|||
37843886|NCT01190930|69528428|FG000|Induction|Incomplete Induction data|63|||
37731284|NCT00213148|69210785|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
37731285|NCT00213148|69210786|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
37843887|NCT01190930|69528429|FG001|Induction|Incomplete Induction data|0|||
37843888|NCT01190930|69528430|FG002|Induction|Incomplete Induction data|0|||
37731286|NCT00213148|69210787|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
37731287|NCT00213148|69210788|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
37731288|NCT00213148|69210789|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
37731289|NCT00213148|69210785|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
37843889|NCT01190930|69528431|FG003|Induction|Incomplete Induction data|0|||
37843890|NCT01190930|69528432|FG004|Induction|Incomplete Induction data|0|||
37843891|NCT01190930|69528433|FG005|Induction|Incomplete Induction data|0|||
38025674|NCT01317940|69710232|FG003|Overall Study|Death|0|||
37843892|NCT01190930|69528434|FG006|Induction|Incomplete Induction data|0|||
37843893|NCT01190930|69528435|FG007|Induction|Incomplete Induction data|0|||
37843894|NCT01190930|69528436|FG008|Induction|Incomplete Induction data|0|||
37843895|NCT01190930|69528437|FG009|Induction|Incomplete Induction data|0|||
37843896|NCT01190930|69528428|FG000|Induction|Progressive disease|0|||
37843897|NCT01190930|69528429|FG001|Induction|Progressive disease|1|||
37843898|NCT01190930|69528430|FG002|Induction|Progressive disease|0|||
37843899|NCT01190930|69528431|FG003|Induction|Progressive disease|0|||
37843900|NCT01190930|69528432|FG004|Induction|Progressive disease|0|||
37843901|NCT01190930|69528433|FG005|Induction|Progressive disease|0|||
37843902|NCT01190930|69528434|FG006|Induction|Progressive disease|0|||
37843903|NCT01190930|69528435|FG007|Induction|Progressive disease|0|||
37843904|NCT01190930|69528436|FG008|Induction|Progressive disease|0|||
37843905|NCT01190930|69528437|FG009|Induction|Progressive disease|0|||
37843906|NCT01190930|69528428|FG000|Induction|No treatment|3|||
37843907|NCT01190930|69528429|FG001|Induction|No treatment|0|||
37843908|NCT01190930|69528430|FG002|Induction|No treatment|0|||
37843909|NCT01190930|69528431|FG003|Induction|No treatment|0|||
37843910|NCT01190930|69528432|FG004|Induction|No treatment|0|||
37843911|NCT01190930|69528433|FG005|Induction|No treatment|0|||
37843912|NCT01190930|69528434|FG006|Induction|No treatment|0|||
37843913|NCT01190930|69528435|FG007|Induction|No treatment|0|||
37843914|NCT01190930|69528436|FG008|Induction|No treatment|0|||
37843915|NCT01190930|69528437|FG009|Induction|No treatment|0|||
37843916|NCT01190930|69528428|FG000|Induction|Ineligible|69|||
37843917|NCT01190930|69528429|FG001|Induction|Ineligible|4|||
37843918|NCT01190930|69528430|FG002|Induction|Ineligible|0|||
37843919|NCT01190930|69528431|FG003|Induction|Ineligible|0|||
37843920|NCT01190930|69528432|FG004|Induction|Ineligible|0|||
37843921|NCT01190930|69528433|FG005|Induction|Ineligible|0|||
37843922|NCT01190930|69528434|FG006|Induction|Ineligible|0|||
37843923|NCT01190930|69528435|FG007|Induction|Ineligible|0|||
37843924|NCT01190930|69528436|FG008|Induction|Ineligible|0|||
37843925|NCT01190930|69528437|FG009|Induction|Ineligible|0|||
37843926|NCT01190930|69528428|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
37843927|NCT01190930|69528429|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
37843928|NCT01190930|69528430|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
37843929|NCT01190930|69528431|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
37843930|NCT01190930|69528432|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
37843931|NCT01190930|69528433|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
37843932|NCT01190930|69528434|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
37843933|NCT01190930|69528435|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
37843934|NCT01190930|69528436|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
37843935|NCT01190930|69528437|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
37916039|NCT00701038|69602855|FG001|Overall Study|study amended pilot group of patients|4|||
37916040|NCT00857766|69602863|FG000|Overall Study|Adverse Event|13|||
37916041|NCT00857766|69602864|FG001|Overall Study|Adverse Event|12|||
38025675|NCT01317940|69710233|FG004|Overall Study|Death|0|||
38025676|NCT01317940|69710234|FG005|Overall Study|Death|0|||
37731290|NCT00213148|69210786|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
37731291|NCT00213148|69210787|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
37731292|NCT00213148|69210788|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
37731293|NCT00213148|69210789|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
37731294|NCT00213148|69210785|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
37843936|NCT01190930|69528428|FG000|Post Induction Pre-Maintenance|Death|0|||
37843937|NCT01190930|69528429|FG001|Post Induction Pre-Maintenance|Death|0|||
37843938|NCT01190930|69528430|FG002|Post Induction Pre-Maintenance|Death|8|||
37843939|NCT01190930|69528431|FG003|Post Induction Pre-Maintenance|Death|4|||
37843940|NCT01190930|69528432|FG004|Post Induction Pre-Maintenance|Death|0|||
38025677|NCT01317940|69710229|FG000|Overall Study|Lost to Follow-up|0|||
37731295|NCT00213148|69210786|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
37843941|NCT01190930|69528433|FG005|Post Induction Pre-Maintenance|Death|0|||
37843942|NCT01190930|69528434|FG006|Post Induction Pre-Maintenance|Death|0|||
37843943|NCT01190930|69528435|FG007|Post Induction Pre-Maintenance|Death|0|||
37843944|NCT01190930|69528436|FG008|Post Induction Pre-Maintenance|Death|0|||
37843945|NCT01190930|69528437|FG009|Post Induction Pre-Maintenance|Death|0|||
37843946|NCT01190930|69528428|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
37843947|NCT01190930|69528429|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
37843948|NCT01190930|69528430|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
37843949|NCT01190930|69528431|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
37843950|NCT01190930|69528432|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
37843951|NCT01190930|69528433|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
37843952|NCT01190930|69528434|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
37731296|NCT00213148|69210787|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
37731297|NCT00213148|69210788|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
37731298|NCT00213148|69210789|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
37731299|NCT00213148|69210785|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
37731300|NCT00213148|69210786|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
37731301|NCT00213148|69210787|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
37731302|NCT00213148|69210788|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
37731303|NCT00213148|69210789|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
37731304|NCT00213148|69210785|FG000|Cycle 2 (1 Month)|Other|2|||
37731305|NCT00213148|69210786|FG001|Cycle 2 (1 Month)|Other|1|||
37731306|NCT00213148|69210787|FG002|Cycle 2 (1 Month)|Other|2|||
37731307|NCT00213148|69210788|FG003|Cycle 2 (1 Month)|Other|8|||
37731308|NCT00213148|69210789|FG004|Cycle 2 (1 Month)|Other|7|||
37731309|NCT00213148|69210785|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
37731310|NCT00213148|69210786|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
37731311|NCT00213148|69210787|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
37731312|NCT00213148|69210788|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
37731313|NCT00213148|69210789|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
37731314|NCT00213148|69210785|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
37731315|NCT00213148|69210786|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
37731316|NCT00213148|69210787|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
37731317|NCT00213148|69210788|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
37731318|NCT00213148|69210789|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
37731319|NCT00213148|69210785|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
37731320|NCT00213148|69210786|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
37731321|NCT00213148|69210787|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
37731322|NCT00213148|69210788|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
37731323|NCT00213148|69210789|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
37731324|NCT00213148|69210785|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
37731325|NCT00213148|69210786|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
37731326|NCT00213148|69210787|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
37731327|NCT00213148|69210788|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
37731328|NCT00213148|69210789|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
37731329|NCT00213148|69210785|FG000|Cycle 3 (1 Month)|Other|0|||
37731330|NCT00213148|69210786|FG001|Cycle 3 (1 Month)|Other|0|||
37731331|NCT00213148|69210787|FG002|Cycle 3 (1 Month)|Other|1|||
37731332|NCT00213148|69210788|FG003|Cycle 3 (1 Month)|Other|1|||
37731333|NCT00213148|69210789|FG004|Cycle 3 (1 Month)|Other|0|||
37731334|NCT01704261|69210811|FG000|Overall Study|Withdrawal by Subject|12|||
37731335|NCT01704261|69210812|FG001|Overall Study|Withdrawal by Subject|15|||
37731336|NCT01704261|69210811|FG000|Overall Study|Lost to Follow-up|1|||
37731337|NCT01704261|69210812|FG001|Overall Study|Lost to Follow-up|0|||
37731338|NCT01715571|69210818|FG000|Overall Study|Lost to Follow-up|8|||
37731339|NCT00212758|69210822|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
37731340|NCT00212758|69210823|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
37731341|NCT00212758|69210822|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
37731342|NCT00212758|69210823|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
37731343|NCT01824290|69210831|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
37731344|NCT01824290|69210832|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
37731345|NCT01824290|69210833|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
37731346|NCT01824290|69210834|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
37731347|NCT01824290|69210831|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
37731348|NCT01824290|69210832|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
37731349|NCT01824290|69210833|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
37731350|NCT01824290|69210834|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
37731351|NCT01824290|69210831|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
37731352|NCT01824290|69210832|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
37731353|NCT01824290|69210833|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
37731354|NCT01824290|69210834|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
37731355|NCT01824290|69210831|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
37731356|NCT01824290|69210832|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
37731357|NCT01824290|69210833|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
37731358|NCT01824290|69210834|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
37731359|NCT01824290|69210831|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
37731360|NCT01824290|69210832|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
37731361|NCT01824290|69210833|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
37731362|NCT01824290|69210834|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
37731363|NCT01824290|69210831|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
37731364|NCT01824290|69210832|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
37731365|NCT01824290|69210833|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
37731366|NCT01824290|69210834|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
37731367|NCT01715415|69210848|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
37731368|NCT01715415|69210849|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
37731369|NCT01715415|69210848|FG000|Double-blind Treatment|Adverse Event|3|||
37731370|NCT01715415|69210849|FG001|Double-blind Treatment|Adverse Event|0|||
37731371|NCT01715415|69210848|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
37731372|NCT01715415|69210849|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
37731373|NCT01715415|69210848|FG000|Double-blind Treatment|Other|1|||
37731374|NCT01715415|69210849|FG001|Double-blind Treatment|Other|0|||
37731375|NCT01715415|69210848|FG000|Open-label Treatment|Adverse Event|0|||
37731376|NCT01715415|69210849|FG001|Open-label Treatment|Adverse Event|1|||
37731377|NCT01715415|69210848|FG000|Open-label Treatment|Subject Noncompliant|0|||
37731378|NCT01715415|69210849|FG001|Open-label Treatment|Subject Noncompliant|1|||
37731379|NCT00211510|69210858|FG000|Overall Study|Physician Decision|3|||
37731380|NCT00211510|69210859|FG001|Overall Study|Physician Decision|1|||
37731381|NCT00211510|69210858|FG000|Overall Study|Withdrawal by Subject|3|||
37731382|NCT00211510|69210859|FG001|Overall Study|Withdrawal by Subject|1|||
37731383|NCT01869777|69210868|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
37731384|NCT01714947|69210872|FG000|Part B|Progressive Disease|3|||
37731385|NCT01869699|69210878|FG000|Overall Study|Withdrawal by Subject|1|||
37731386|NCT01869699|69210879|FG001|Overall Study|Withdrawal by Subject|0|||
37731387|NCT01714635|69210888|FG000|Overall Study|Discontinued|1|||
37731388|NCT01714635|69210889|FG001|Overall Study|Discontinued|0|||
37731389|NCT01714635|69210890|FG002|Overall Study|Discontinued|2|||
37731390|NCT01714635|69210888|FG000|Overall Study|Missed 6-month exam|1|||
37731391|NCT01714635|69210889|FG001|Overall Study|Missed 6-month exam|0|||
37731392|NCT01714635|69210890|FG002|Overall Study|Missed 6-month exam|0|||
37731393|NCT01713933|69210898|FG000|Overall Study|Lost to Follow-up|2|||
37731394|NCT01713933|69210898|FG000|Overall Study|Withdrawal by Subject|3|||
37731395|NCT01713933|69210898|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
37731396|NCT01868997|69210904|FG000|Overall Study|Adverse Event|2|||
37731397|NCT01868997|69210905|FG001|Overall Study|Adverse Event|5|||
37731398|NCT01868997|69210904|FG000|Overall Study|Lack of Efficacy|2|||
37731399|NCT01868997|69210905|FG001|Overall Study|Lack of Efficacy|0|||
37731400|NCT01868997|69210904|FG000|Overall Study|Other|3|||
37731401|NCT01868997|69210905|FG001|Overall Study|Other|1|||
37731402|NCT01875848|69210913|FG000|Overall Study|Withdrawal by Subject|2|||
37731403|NCT01875848|69210914|FG001|Overall Study|Withdrawal by Subject|0|||
37731404|NCT04191382|69210923|FG000|Overall Study|Withdrawal by Subject|1|||
37731405|NCT04191382|69210924|FG001|Overall Study|Withdrawal by Subject|0|||
37731406|NCT04191382|69210925|FG002|Overall Study|Withdrawal by Subject|0|||
37731407|NCT01703091|69210935|FG000|Overall Study|Adverse Event|5|||
37731408|NCT01703091|69210936|FG001|Overall Study|Adverse Event|3|||
37731409|NCT01703091|69210935|FG000|Overall Study|Physician Decision|2|||
37731410|NCT01703091|69210936|FG001|Overall Study|Physician Decision|1|||
37731411|NCT01703091|69210935|FG000|Overall Study|Withdrawal by Subject|1|||
37731412|NCT01703091|69210936|FG001|Overall Study|Withdrawal by Subject|0|||
37731413|NCT01703091|69210935|FG000|Overall Study|Sponsor Decision|1|||
37731414|NCT01703091|69210936|FG001|Overall Study|Sponsor Decision|0|||
37731415|NCT01712685|69210942|FG000|Overall Study|pt declined to participate before trmt|1|||
37731416|NCT01867671|69210948|FG000|Overall Study|Adverse Event|5|||
37731417|NCT01867671|69210949|FG001|Overall Study|Adverse Event|3|||
37731418|NCT01867671|69210948|FG000|Overall Study|Anaphylaxis|0|||
37731419|NCT01867671|69210949|FG001|Overall Study|Anaphylaxis|1|||
37731420|NCT01867671|69210948|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
37731421|NCT01867671|69210949|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
37731422|NCT01867671|69210948|FG000|Overall Study|Lost to Follow-up|0|||
37731423|NCT01867671|69210949|FG001|Overall Study|Lost to Follow-up|1|||
37731424|NCT01867671|69210948|FG000|Overall Study|Non-compliance with Study Drug|1|||
37731425|NCT01867671|69210949|FG001|Overall Study|Non-compliance with Study Drug|2|||
37731426|NCT01867671|69210948|FG000|Overall Study|Withdrawal by Subject|21|||
37916042|NCT00857766|69602863|FG000|Overall Study|Protocol Violation|11|||
37916043|NCT00857766|69602864|FG001|Overall Study|Protocol Violation|11|||
37916044|NCT00857766|69602863|FG000|Overall Study|Lost to Follow-up|1|||
37916045|NCT00857766|69602864|FG001|Overall Study|Lost to Follow-up|0|||
37916046|NCT00857766|69602863|FG000|Overall Study|Investigator Discretion|2|||
37916047|NCT00857766|69602864|FG001|Overall Study|Investigator Discretion|3|||
37731427|NCT01867671|69210949|FG001|Overall Study|Withdrawal by Subject|21|||
37731428|NCT01702311|69210957|FG000|Overall Study|Withdrawal by Subject|3|||
37731429|NCT01702311|69210958|FG001|Overall Study|Withdrawal by Subject|2|||
37731430|NCT01702311|69210957|FG000|Overall Study|Discharge less than 24 hours|10|||
37731431|NCT01702311|69210958|FG001|Overall Study|Discharge less than 24 hours|7|||
37731432|NCT01702311|69210957|FG000|Overall Study|Physician Decision|3|||
37731433|NCT01702311|69210958|FG001|Overall Study|Physician Decision|4|||
37731434|NCT01712061|69210974|FG000|Overall Study|Adverse Event|4|||
37731435|NCT01712061|69210975|FG001|Overall Study|Adverse Event|9|||
37731436|NCT01712061|69210976|FG002|Overall Study|Adverse Event|5|||
37731437|NCT01712061|69210974|FG000|Overall Study|Death|0|||
37731438|NCT01712061|69210975|FG001|Overall Study|Death|0|||
37731439|NCT01712061|69210976|FG002|Overall Study|Death|1|||
37731440|NCT01712061|69210974|FG000|Overall Study|Lost to Follow-up|1|||
37731441|NCT01712061|69210975|FG001|Overall Study|Lost to Follow-up|0|||
37731442|NCT01712061|69210976|FG002|Overall Study|Lost to Follow-up|1|||
37731443|NCT01712061|69210974|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
37731444|NCT01712061|69210975|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
37731445|NCT01712061|69210976|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
37731446|NCT01712061|69210974|FG000|Overall Study|Medication Error Without Associated AE|0|||
37731447|NCT01712061|69210975|FG001|Overall Study|Medication Error Without Associated AE|1|||
37731448|NCT01712061|69210976|FG002|Overall Study|Medication Error Without Associated AE|0|||
37731449|NCT01712061|69210974|FG000|Overall Study|Withdrawal by Subject|1|||
37731450|NCT01712061|69210975|FG001|Overall Study|Withdrawal by Subject|7|||
37731451|NCT01712061|69210976|FG002|Overall Study|Withdrawal by Subject|1|||
37731452|NCT01712061|69210974|FG000|Overall Study|Other|0|||
37731453|NCT01712061|69210975|FG001|Overall Study|Other|3|||
37731454|NCT01712061|69210976|FG002|Overall Study|Other|0|||
37731455|NCT03592186|69210987|FG000|Overall Study|Withdrawal by Subject|1|||
37731456|NCT03592186|69210988|FG001|Overall Study|Withdrawal by Subject|0|||
37731457|NCT03592186|69210987|FG000|Overall Study|Lost to Follow-up|16|||
37731458|NCT03592186|69210988|FG001|Overall Study|Lost to Follow-up|11|||
37731459|NCT03598114|69210996|FG000|Overall Study|Staff turnover/left the program|3|||
37731460|NCT03598114|69210997|FG001|Overall Study|Staff turnover/left the program|39|||
37731461|NCT01711983|69211024|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
37731462|NCT01711983|69211024|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
37731463|NCT01711983|69211024|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
37731464|NCT01711983|69211024|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
37731465|NCT01874288|69211038|FG000|Overall Study|Withdrawal by Subject|1|||
37731466|NCT01874288|69211039|FG001|Overall Study|Withdrawal by Subject|0|||
37731467|NCT01874288|69211040|FG002|Overall Study|Withdrawal by Subject|2|||
37731468|NCT01874288|69211041|FG003|Overall Study|Withdrawal by Subject|1|||
37731469|NCT01874288|69211042|FG004|Overall Study|Withdrawal by Subject|1|||
37731470|NCT01874288|69211038|FG000|Overall Study|Physician Decision|0|||
37731471|NCT01874288|69211039|FG001|Overall Study|Physician Decision|0|||
37731472|NCT01874288|69211040|FG002|Overall Study|Physician Decision|0|||
37731473|NCT01874288|69211041|FG003|Overall Study|Physician Decision|1|||
37731474|NCT01874288|69211042|FG004|Overall Study|Physician Decision|0|||
37731475|NCT01874288|69211038|FG000|Overall Study|Progressive disease|2|||
37731476|NCT01874288|69211039|FG001|Overall Study|Progressive disease|0|||
37731477|NCT01874288|69211040|FG002|Overall Study|Progressive disease|3|||
37731478|NCT01874288|69211041|FG003|Overall Study|Progressive disease|5|||
37731479|NCT01874288|69211042|FG004|Overall Study|Progressive disease|1|||
37731480|NCT01874054|69211071|FG000|Overall Study|Withdrawal by Subject|3|||
37731481|NCT01874054|69211071|FG000|Overall Study|Study Termination by Sponsor|42|||
37731482|NCT01874054|69211071|FG000|Overall Study|Lost to Follow-up|5|||
37731483|NCT01874054|69211071|FG000|Overall Study|Death|5|||
37731484|NCT01873742|69211077|FG000|Overall Study|Lost to Follow-up|68|||
37731485|NCT01873742|69211078|FG001|Overall Study|Lost to Follow-up|76|||
37731486|NCT01873586|69211084|FG000|Overall Study|Lost to Follow-up|3|||
37731487|NCT04027348|69211118|FG000|Overall Study|Adverse Event|2|||
37843953|NCT01190930|69528435|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
38025678|NCT01317940|69710230|FG001|Overall Study|Lost to Follow-up|0|||
38025679|NCT01317940|69710231|FG002|Overall Study|Lost to Follow-up|1|||
38025680|NCT01317940|69710232|FG003|Overall Study|Lost to Follow-up|1|||
38025681|NCT01317940|69710233|FG004|Overall Study|Lost to Follow-up|1|||
37731488|NCT04196686|69211131|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
37731489|NCT04196686|69211132|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
37731490|NCT02708680|69211141|FG000|Overall Study|Withdrawal by Subject|4|||
37731491|NCT02708680|69211142|FG001|Overall Study|Withdrawal by Subject|12|||
37731492|NCT02708680|69211143|FG002|Overall Study|Withdrawal by Subject|12|||
37731493|NCT02708680|69211141|FG000|Overall Study|Death|4|||
37731494|NCT02708680|69211142|FG001|Overall Study|Death|19|||
37731495|NCT02708680|69211143|FG002|Overall Study|Death|21|||
37731496|NCT02708680|69211141|FG000|Overall Study|Lost to Follow-up|0|||
37731497|NCT02708680|69211142|FG001|Overall Study|Lost to Follow-up|3|||
37731498|NCT02708680|69211143|FG002|Overall Study|Lost to Follow-up|3|||
37731499|NCT02708680|69211141|FG000|Overall Study|Study Terminated By Sponsor|0|||
37731500|NCT02708680|69211142|FG001|Overall Study|Study Terminated By Sponsor|5|||
37731501|NCT02708680|69211143|FG002|Overall Study|Study Terminated By Sponsor|4|||
37731502|NCT02708680|69211141|FG000|Overall Study|Other than Specified|0|||
37843954|NCT01190930|69528436|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
37843955|NCT01190930|69528437|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
37731503|NCT02708680|69211142|FG001|Overall Study|Other than Specified|0|||
37731504|NCT02708680|69211143|FG002|Overall Study|Other than Specified|1|||
37731505|NCT02708680|69211141|FG000|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
37731506|NCT02708680|69211142|FG001|Overall Study|Discontinued Treatment but Remained in Follow-up|1|||
37731507|NCT02708680|69211143|FG002|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
37731508|NCT01611974|69211157|FG000|Overall Study|Death|10|||
37731509|NCT01611974|69211158|FG001|Overall Study|Death|12|||
37731510|NCT01611974|69211159|FG002|Overall Study|Death|10|||
37731511|NCT01611974|69211157|FG000|Overall Study|Lost to Follow-up|0|||
37731512|NCT01611974|69211158|FG001|Overall Study|Lost to Follow-up|1|||
37731513|NCT01611974|69211159|FG002|Overall Study|Lost to Follow-up|0|||
37731514|NCT01611974|69211157|FG000|Overall Study|Physician Decision|5|||
37731515|NCT01611974|69211158|FG001|Overall Study|Physician Decision|1|||
37731516|NCT01611974|69211159|FG002|Overall Study|Physician Decision|2|||
37731517|NCT01611974|69211157|FG000|Overall Study|Withdrawal by Subject|0|||
38025682|NCT01317940|69710234|FG005|Overall Study|Lost to Follow-up|0|||
38025683|NCT01317940|69710229|FG000|Overall Study|Change in therapy plan|0|||
38025684|NCT01317940|69710230|FG001|Overall Study|Change in therapy plan|0|||
38025685|NCT01317940|69710231|FG002|Overall Study|Change in therapy plan|3|||
38025686|NCT01317940|69710232|FG003|Overall Study|Change in therapy plan|0|||
38025687|NCT01317940|69710233|FG004|Overall Study|Change in therapy plan|0|||
38025688|NCT01317940|69710234|FG005|Overall Study|Change in therapy plan|0|||
37843956|NCT01190930|69528428|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
37843957|NCT01190930|69528429|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
37843958|NCT01190930|69528430|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
37843959|NCT01190930|69528431|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
37843960|NCT01190930|69528432|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
37843961|NCT01190930|69528433|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
37843962|NCT01190930|69528434|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
37843963|NCT01190930|69528435|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
37843964|NCT01190930|69528436|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
37843965|NCT01190930|69528437|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
37843966|NCT01190930|69528428|FG000|Post Induction Pre-Maintenance|Refusal|0|||
37843967|NCT01190930|69528429|FG001|Post Induction Pre-Maintenance|Refusal|2|||
37843968|NCT01190930|69528430|FG002|Post Induction Pre-Maintenance|Refusal|694|||
37843969|NCT01190930|69528431|FG003|Post Induction Pre-Maintenance|Refusal|4|||
37843970|NCT01190930|69528432|FG004|Post Induction Pre-Maintenance|Refusal|0|||
37843971|NCT01190930|69528433|FG005|Post Induction Pre-Maintenance|Refusal|3|||
38025689|NCT01345786|69710253|FG000|Overall Study|Adverse Event|0|||
38025690|NCT01345786|69710254|FG001|Overall Study|Adverse Event|1|||
38025691|NCT01345786|69710255|FG002|Overall Study|Adverse Event|3|||
38025692|NCT01345786|69710256|FG003|Overall Study|Adverse Event|1|||
38025693|NCT01345786|69710253|FG000|Overall Study|Subject withdrew consent|2|||
38025694|NCT01345786|69710254|FG001|Overall Study|Subject withdrew consent|2|||
38025695|NCT01345786|69710255|FG002|Overall Study|Subject withdrew consent|1|||
38025696|NCT01345786|69710256|FG003|Overall Study|Subject withdrew consent|0|||
38025697|NCT01345786|69710253|FG000|Overall Study|Noncompliance with protocol|1|||
37731518|NCT01611974|69211158|FG001|Overall Study|Withdrawal by Subject|1|||
37731519|NCT01611974|69211159|FG002|Overall Study|Withdrawal by Subject|4|||
37731520|NCT01848938|69211169|FG000|Overall Study|Lost to Follow-up|1|||
37731521|NCT01848938|69211170|FG001|Overall Study|Lost to Follow-up|1|||
37731522|NCT01871870|69211176|FG000|Overall Study|Hardware issues|7|||
37731523|NCT01871870|69211176|FG000|Overall Study|hyperglycemia|2|||
37731524|NCT01871558|69211189|FG000|Overall Study|Other reason|0|||
37731525|NCT01871558|69211190|FG001|Overall Study|Other reason|1|||
37731526|NCT01871558|69211189|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
37731527|NCT01871558|69211190|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
37731528|NCT01871558|69211189|FG000|Overall Study|Withdrawal by Subject|2|||
37731529|NCT01871558|69211190|FG001|Overall Study|Withdrawal by Subject|0|||
37731530|NCT01711359|69211199|FG000|Treatment Period|Withdrawal by Subject|18|||
37731531|NCT01711359|69211200|FG001|Treatment Period|Withdrawal by Subject|7|||
37731532|NCT01711359|69211201|FG002|Treatment Period|Withdrawal by Subject|13|||
37843972|NCT01190930|69528434|FG006|Post Induction Pre-Maintenance|Refusal|0|||
38025698|NCT01345786|69710254|FG001|Overall Study|Noncompliance with protocol|0|||
38025699|NCT01345786|69710255|FG002|Overall Study|Noncompliance with protocol|1|||
37731533|NCT01711359|69211199|FG000|Treatment Period|Lack of Efficacy|13|||
37731534|NCT01711359|69211200|FG001|Treatment Period|Lack of Efficacy|2|||
37731535|NCT01711359|69211201|FG002|Treatment Period|Lack of Efficacy|2|||
37731536|NCT01711359|69211199|FG000|Treatment Period|Adverse Event|8|||
37731537|NCT01711359|69211200|FG001|Treatment Period|Adverse Event|10|||
37731538|NCT01711359|69211201|FG002|Treatment Period|Adverse Event|24|||
37731539|NCT01711359|69211199|FG000|Treatment Period|Physician Decision|4|||
37843973|NCT01190930|69528435|FG007|Post Induction Pre-Maintenance|Refusal|0|||
37843974|NCT01190930|69528436|FG008|Post Induction Pre-Maintenance|Refusal|0|||
37843975|NCT01190930|69528437|FG009|Post Induction Pre-Maintenance|Refusal|0|||
37731540|NCT01711359|69211200|FG001|Treatment Period|Physician Decision|3|||
37731541|NCT01711359|69211201|FG002|Treatment Period|Physician Decision|2|||
37731542|NCT01711359|69211199|FG000|Treatment Period|Death|3|||
37731543|NCT01711359|69211200|FG001|Treatment Period|Death|0|||
37731544|NCT01711359|69211201|FG002|Treatment Period|Death|0|||
37731545|NCT01711359|69211199|FG000|Treatment Period|Entry Criteria Not Met|1|||
37731546|NCT01711359|69211200|FG001|Treatment Period|Entry Criteria Not Met|0|||
37731547|NCT01711359|69211201|FG002|Treatment Period|Entry Criteria Not Met|0|||
37731548|NCT01711359|69211199|FG000|Treatment Period|Sponsor Decision|1|||
37731549|NCT01711359|69211200|FG001|Treatment Period|Sponsor Decision|0|||
37731550|NCT01711359|69211201|FG002|Treatment Period|Sponsor Decision|0|||
37731551|NCT01711359|69211199|FG000|Treatment Period|Lost to Follow-up|1|||
37731552|NCT01711359|69211200|FG001|Treatment Period|Lost to Follow-up|1|||
37731553|NCT01711359|69211201|FG002|Treatment Period|Lost to Follow-up|1|||
37731554|NCT01711359|69211199|FG000|Treatment Period|Randomized, Not Treated|3|||
37731555|NCT01711359|69211200|FG001|Treatment Period|Randomized, Not Treated|1|||
37731556|NCT01711359|69211201|FG002|Treatment Period|Randomized, Not Treated|0|||
37731557|NCT01710657|69211228|FG000|Overall Study|Lost to Follow-up|2|||
37731558|NCT01710657|69211229|FG001|Overall Study|Lost to Follow-up|0|||
37731559|NCT01710657|69211230|FG002|Overall Study|Lost to Follow-up|1|||
37731560|NCT01710657|69211228|FG000|Overall Study|Protocol Violation|2|||
37731561|NCT01710657|69211229|FG001|Overall Study|Protocol Violation|2|||
37731562|NCT01710657|69211230|FG002|Overall Study|Protocol Violation|0|||
37731563|NCT01710657|69211228|FG000|Overall Study|Adverse Event|14|||
37731564|NCT01710657|69211229|FG001|Overall Study|Adverse Event|8|||
37731565|NCT01710657|69211230|FG002|Overall Study|Adverse Event|28|||
37731566|NCT01710657|69211228|FG000|Overall Study|Withdrawal by Subject|0|||
37731567|NCT01710657|69211229|FG001|Overall Study|Withdrawal by Subject|1|||
37731568|NCT01710657|69211230|FG002|Overall Study|Withdrawal by Subject|2|||
37731569|NCT01710657|69211228|FG000|Overall Study|Lack of Efficacy|0|||
37731570|NCT01710657|69211229|FG001|Overall Study|Lack of Efficacy|1|||
37731571|NCT01710657|69211230|FG002|Overall Study|Lack of Efficacy|1|||
37731572|NCT01701063|69211241|FG000|Overall Study|Lost to Follow-up|0|||
37731573|NCT01701063|69211242|FG001|Overall Study|Lost to Follow-up|1|||
37731574|NCT01701063|69211243|FG002|Overall Study|Lost to Follow-up|0|||
37731575|NCT01701063|69211241|FG000|Overall Study|Withdrawal by Subject|0|||
37731576|NCT01701063|69211242|FG001|Overall Study|Withdrawal by Subject|0|||
37731577|NCT01701063|69211243|FG002|Overall Study|Withdrawal by Subject|1|||
37731578|NCT01701063|69211241|FG000|Overall Study|Other|0|||
37731579|NCT01701063|69211242|FG001|Overall Study|Other|0|||
37731580|NCT01701063|69211243|FG002|Overall Study|Other|1|||
37731581|NCT01700985|69211254|FG000|Overall Study|Incarcerated|0|||
37731582|NCT01700985|69211255|FG001|Overall Study|Incarcerated|1|||
37731583|NCT01710501|69211264|FG000|Overall Study|Lost to Follow-up|2|||
37731584|NCT01710501|69211265|FG001|Overall Study|Lost to Follow-up|0|||
37731585|NCT01710501|69211266|FG002|Overall Study|Lost to Follow-up|0|||
37731586|NCT01700829|69211276|FG000|Overall Study|Withdrawal by Subject|1|||
37731587|NCT01700829|69211277|FG001|Overall Study|Withdrawal by Subject|1|||
37731588|NCT01710345|69211286|FG000|Overall Study|Adverse Event|0|||
37731589|NCT01710345|69211287|FG001|Overall Study|Adverse Event|2|||
37731590|NCT01710345|69211288|FG002|Overall Study|Adverse Event|0|||
37731591|NCT01710345|69211286|FG000|Overall Study|Lack of Efficacy|2|||
37731592|NCT01710345|69211287|FG001|Overall Study|Lack of Efficacy|3|||
37731593|NCT01710345|69211288|FG002|Overall Study|Lack of Efficacy|1|||
37731594|NCT01710345|69211286|FG000|Overall Study|Drug Dosing Error|1|||
37731595|NCT01710345|69211287|FG001|Overall Study|Drug Dosing Error|0|||
37731596|NCT01710345|69211288|FG002|Overall Study|Drug Dosing Error|0|||
37731597|NCT01710033|69211304|FG000|Stage 2|Adverse Event|0|||
37731598|NCT01710033|69211305|FG001|Stage 2|Adverse Event|0|||
37731599|NCT01710033|69211306|FG002|Stage 2|Adverse Event|0|||
37731600|NCT01710033|69211307|FG003|Stage 2|Adverse Event|0|||
37731601|NCT01710033|69211308|FG004|Stage 2|Adverse Event|1|||
37731602|NCT01822496|69211325|FG000|Overall Study|Protocol Violation|2|||
37731603|NCT01822496|69211326|FG001|Overall Study|Protocol Violation|2|||
37731604|NCT01822496|69211327|FG002|Overall Study|Protocol Violation|0|||
37731605|NCT01822496|69211328|FG003|Overall Study|Protocol Violation|1|||
37731606|NCT01822496|69211325|FG000|Overall Study|Withdrawal by Subject|0|||
37731607|NCT01822496|69211326|FG001|Overall Study|Withdrawal by Subject|0|||
37731608|NCT01822496|69211327|FG002|Overall Study|Withdrawal by Subject|0|||
37731609|NCT01822496|69211328|FG003|Overall Study|Withdrawal by Subject|3|||
37731610|NCT01867047|69211340|FG000|Overall Study|Lost to Follow-up|3|||
37731611|NCT01867047|69211341|FG001|Overall Study|Lost to Follow-up|3|||
37731612|NCT01867047|69211340|FG000|Overall Study|Withdrawal by Subject|2|||
37731613|NCT01867047|69211341|FG001|Overall Study|Withdrawal by Subject|0|||
37731614|NCT01867047|69211340|FG000|Overall Study|Physician Decision|2|||
37731615|NCT01867047|69211341|FG001|Overall Study|Physician Decision|0|||
37731616|NCT01867047|69211340|FG000|Overall Study|surgery not indicated in protocol|1|||
37731617|NCT01867047|69211341|FG001|Overall Study|surgery not indicated in protocol|2|||
37731618|NCT01821560|69211353|FG000|Overall Study|Lost to Follow-up|5|||
37731619|NCT01821560|69211354|FG001|Overall Study|Lost to Follow-up|5|||
37731620|NCT01821560|69211353|FG000|Overall Study|Withdrawal by Subject|1|||
37731621|NCT01821560|69211354|FG001|Overall Study|Withdrawal by Subject|1|||
37731622|NCT01821560|69211353|FG000|Overall Study|Protocol Violation|0|||
37731623|NCT01821560|69211354|FG001|Overall Study|Protocol Violation|1|||
37731624|NCT01871402|69211362|FG000|Overall Study|Lost to Follow-up|1|||
37731625|NCT01871402|69211363|FG001|Overall Study|Lost to Follow-up|0|||
37731626|NCT01871402|69211362|FG000|Overall Study|Withdrawal by Subject|0|||
37731627|NCT01871402|69211363|FG001|Overall Study|Withdrawal by Subject|2|||
37731628|NCT01871402|69211362|FG000|Overall Study|Non-compliance|0|||
37731629|NCT01871402|69211363|FG001|Overall Study|Non-compliance|1|||
37731630|NCT01846442|69211382|FG000|Overall Study|Adverse Event|2|||
37731631|NCT01846442|69211383|FG001|Overall Study|Adverse Event|4|||
37731632|NCT01846442|69211384|FG002|Overall Study|Adverse Event|2|||
37731633|NCT01846442|69211385|FG003|Overall Study|Adverse Event|1|||
37731634|NCT01846442|69211382|FG000|Overall Study|Lost to Follow-up|0|||
37731635|NCT01846442|69211383|FG001|Overall Study|Lost to Follow-up|0|||
37731636|NCT01846442|69211384|FG002|Overall Study|Lost to Follow-up|1|||
37731637|NCT01846442|69211385|FG003|Overall Study|Lost to Follow-up|0|||
37731638|NCT01846442|69211382|FG000|Overall Study|Withdrawal by Subject|3|||
37731639|NCT01846442|69211383|FG001|Overall Study|Withdrawal by Subject|2|||
37731640|NCT01846442|69211384|FG002|Overall Study|Withdrawal by Subject|0|||
37731641|NCT01846442|69211385|FG003|Overall Study|Withdrawal by Subject|1|||
37731642|NCT01846442|69211382|FG000|Overall Study|Left the city/Lost medication|1|||
37731643|NCT01846442|69211383|FG001|Overall Study|Left the city/Lost medication|0|||
37731644|NCT01846442|69211384|FG002|Overall Study|Left the city/Lost medication|1|||
37731645|NCT01846442|69211385|FG003|Overall Study|Left the city/Lost medication|1|||
37731646|NCT01709721|69211398|FG000|Open Label Phase|Withdrawal by Subject|0|||
37731647|NCT01709721|69211399|FG001|Open Label Phase|Withdrawal by Subject|0|||
37731648|NCT01709721|69211400|FG002|Open Label Phase|Withdrawal by Subject|5|||
37731649|NCT01709721|69211398|FG000|Open Label Phase|Adverse Event|0|||
37731650|NCT01709721|69211399|FG001|Open Label Phase|Adverse Event|0|||
37731651|NCT01709721|69211400|FG002|Open Label Phase|Adverse Event|8|||
37731652|NCT01709721|69211398|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
37731653|NCT01709721|69211399|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
37731654|NCT01709721|69211400|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
37731655|NCT01709721|69211398|FG000|Open Label Phase|Investigator Decision|0|||
37731656|NCT01709721|69211399|FG001|Open Label Phase|Investigator Decision|0|||
37731657|NCT01709721|69211400|FG002|Open Label Phase|Investigator Decision|1|||
37731658|NCT01709721|69211398|FG000|Open Label Phase|Sponsor Decision|0|||
37731659|NCT01709721|69211399|FG001|Open Label Phase|Sponsor Decision|0|||
37731660|NCT01709721|69211400|FG002|Open Label Phase|Sponsor Decision|2|||
37731661|NCT01709721|69211398|FG000|Open Label Phase|Protocol Violation|0|||
37731662|NCT01709721|69211399|FG001|Open Label Phase|Protocol Violation|0|||
37731663|NCT01709721|69211400|FG002|Open Label Phase|Protocol Violation|1|||
37731664|NCT01709721|69211398|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
37731665|NCT01709721|69211399|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
37731666|NCT01709721|69211400|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
37731667|NCT01709721|69211398|FG000|Open Label Phase|Inadequate Pain Control|0|||
37731668|NCT01709721|69211399|FG001|Open Label Phase|Inadequate Pain Control|0|||
37731669|NCT01709721|69211400|FG002|Open Label Phase|Inadequate Pain Control|37|||
37731670|NCT01709721|69211398|FG000|Open Label Phase|Other, Specify in text field in database|0|||
37731671|NCT01709721|69211399|FG001|Open Label Phase|Other, Specify in text field in database|0|||
37731672|NCT01709721|69211400|FG002|Open Label Phase|Other, Specify in text field in database|14|||
37731673|NCT01709721|69211398|FG000|Randomized Phase|Adverse Event|0|||
37731674|NCT01709721|69211399|FG001|Randomized Phase|Adverse Event|1|||
37731675|NCT01709721|69211400|FG002|Randomized Phase|Adverse Event|0|||
37731676|NCT01709721|69211398|FG000|Randomized Phase|Lost to Follow-up|1|||
37731677|NCT01709721|69211399|FG001|Randomized Phase|Lost to Follow-up|0|||
37731678|NCT01709721|69211400|FG002|Randomized Phase|Lost to Follow-up|0|||
37731679|NCT01709721|69211398|FG000|Randomized Phase|Inadequate Pain Control|1|||
37731680|NCT01709721|69211399|FG001|Randomized Phase|Inadequate Pain Control|2|||
37731681|NCT01709721|69211400|FG002|Randomized Phase|Inadequate Pain Control|0|||
37731682|NCT01709721|69211398|FG000|Randomized Phase|Other, Specify text field in database|1|||
37731683|NCT01709721|69211399|FG001|Randomized Phase|Other, Specify text field in database|3|||
37731684|NCT01709721|69211400|FG002|Randomized Phase|Other, Specify text field in database|0|||
37731685|NCT01866657|69211410|FG000|Overall Study|Surgery canceled|2|||
37731686|NCT01866657|69211411|FG001|Overall Study|Surgery canceled|0|||
37731687|NCT01700205|69211419|FG000|Overall Study|Withdrawal by Subject|13|||
37731688|NCT01700205|69211420|FG001|Overall Study|Withdrawal by Subject|13|||
37731689|NCT01700205|69211419|FG000|Overall Study|Protocol Violation|2|||
37731690|NCT01700205|69211420|FG001|Overall Study|Protocol Violation|2|||
37731691|NCT01700049|69211426|FG000|Overall Study|Withdrawal by Subject|1|||
37731692|NCT01699815|69211433|FG000|Overall Study|Protocol Violation|4|||
37731693|NCT01699815|69211434|FG001|Overall Study|Protocol Violation|7|||
37731694|NCT01699815|69211433|FG000|Overall Study|record could not be located|1|||
38025700|NCT01345786|69710256|FG003|Overall Study|Noncompliance with protocol|0|||
38025701|NCT01345786|69710253|FG000|Overall Study|Administrative|3|||
38025702|NCT01345786|69710254|FG001|Overall Study|Administrative|5|||
37731695|NCT01699815|69211434|FG001|Overall Study|record could not be located|0|||
37731696|NCT01699815|69211433|FG000|Overall Study|Adverse Event|0|||
37731697|NCT01699815|69211434|FG001|Overall Study|Adverse Event|1|||
37731698|NCT01866423|69211440|FG000|Overall Study|Lack of Efficacy|3|||
37731699|NCT01866423|69211440|FG000|Overall Study|Sponsor Decision|1|||
37731700|NCT01846208|69211447|FG000|Overall Study|Withdrew prior to treatment|1|||
37731701|NCT01846208|69211448|FG001|Overall Study|Withdrew prior to treatment|1|||
37731702|NCT01846208|69211449|FG002|Overall Study|Withdrew prior to treatment|1|||
37731703|NCT01846208|69211447|FG000|Overall Study|Dosing Symptoms|1|||
37731704|NCT01846208|69211448|FG001|Overall Study|Dosing Symptoms|2|||
37731705|NCT01846208|69211449|FG002|Overall Study|Dosing Symptoms|6|||
37731706|NCT01846208|69211447|FG000|Overall Study|Withdrawal by Subject|5|||
37731707|NCT01846208|69211448|FG001|Overall Study|Withdrawal by Subject|0|||
37731708|NCT01846208|69211449|FG002|Overall Study|Withdrawal by Subject|0|||
37731709|NCT01846208|69211447|FG000|Overall Study|Non-compliance|1|||
37731710|NCT01846208|69211448|FG001|Overall Study|Non-compliance|1|||
37731711|NCT01846208|69211449|FG002|Overall Study|Non-compliance|0|||
37731712|NCT01846208|69211447|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
37731713|NCT01846208|69211448|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
37731714|NCT01846208|69211449|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
37731715|NCT01846208|69211447|FG000|Overall Study|Refused SU OFC|0|||
37731716|NCT01846208|69211448|FG001|Overall Study|Refused SU OFC|0|||
37731717|NCT01846208|69211449|FG002|Overall Study|Refused SU OFC|1|||
37731718|NCT01845974|69211459|FG000|Overall Study|screen failure|1|||
37731719|NCT01845974|69211460|FG001|Overall Study|screen failure|0|||
37731720|NCT01865487|69211472|FG000|Overall Study|Lost to Follow-up|0|||
37731721|NCT01865487|69211473|FG001|Overall Study|Lost to Follow-up|0|||
37731722|NCT01865487|69211474|FG002|Overall Study|Lost to Follow-up|0|||
37731723|NCT01865487|69211475|FG003|Overall Study|Lost to Follow-up|1|||
37731724|NCT01865487|69211476|FG004|Overall Study|Lost to Follow-up|0|||
37731725|NCT01865487|69211477|FG005|Overall Study|Lost to Follow-up|0|||
37731726|NCT01865487|69211478|FG006|Overall Study|Lost to Follow-up|1|||
37731727|NCT01865487|69211479|FG007|Overall Study|Lost to Follow-up|0|||
37731728|NCT01865487|69211480|FG008|Overall Study|Lost to Follow-up|0|||
37731729|NCT01865487|69211481|FG009|Overall Study|Lost to Follow-up|0|||
37731730|NCT01865487|69211472|FG000|Overall Study|Withdrawal by Subject|0|||
37731731|NCT01865487|69211473|FG001|Overall Study|Withdrawal by Subject|0|||
37731732|NCT01865487|69211474|FG002|Overall Study|Withdrawal by Subject|0|||
37731733|NCT01865487|69211475|FG003|Overall Study|Withdrawal by Subject|0|||
37731734|NCT01865487|69211476|FG004|Overall Study|Withdrawal by Subject|1|||
37731735|NCT01865487|69211477|FG005|Overall Study|Withdrawal by Subject|0|||
37731736|NCT01865487|69211478|FG006|Overall Study|Withdrawal by Subject|0|||
37731737|NCT01865487|69211479|FG007|Overall Study|Withdrawal by Subject|0|||
38025703|NCT01345786|69710255|FG002|Overall Study|Administrative|0|||
38025704|NCT01345786|69710256|FG003|Overall Study|Administrative|0|||
38025705|NCT01345786|69710253|FG000|Overall Study|Lost to Follow-up|0|||
38025706|NCT01345786|69710254|FG001|Overall Study|Lost to Follow-up|0|||
38025707|NCT01345786|69710255|FG002|Overall Study|Lost to Follow-up|0|||
38025708|NCT01345786|69710256|FG003|Overall Study|Lost to Follow-up|2|||
38025709|NCT01317550|69710270|FG000|Overall Study|Withdrawal by Subject|1|||
38025710|NCT01317550|69710271|FG001|Overall Study|Withdrawal by Subject|0|||
38025711|NCT01317550|69710272|FG002|Overall Study|Withdrawal by Subject|0|||
38025712|NCT01317550|69710273|FG003|Overall Study|Withdrawal by Subject|0|||
38025713|NCT01317550|69710270|FG000|Overall Study|Lack of compliance study med|1|||
38025714|NCT01317550|69710271|FG001|Overall Study|Lack of compliance study med|0|||
38025715|NCT01317550|69710272|FG002|Overall Study|Lack of compliance study med|0|||
38025716|NCT01317550|69710273|FG003|Overall Study|Lack of compliance study med|0|||
38025717|NCT01317472|69710285|FG000|Overall Study|Withdrawal by Subject|1|||
37731738|NCT01865487|69211480|FG008|Overall Study|Withdrawal by Subject|0|||
37731739|NCT01865487|69211481|FG009|Overall Study|Withdrawal by Subject|0|||
38025718|NCT01317472|69710286|FG001|Overall Study|Withdrawal by Subject|0|||
38025719|NCT01317472|69710285|FG000|Overall Study|Unrelated hospitalization|1|||
38025720|NCT01317472|69710286|FG001|Overall Study|Unrelated hospitalization|0|||
37731740|NCT01699503|69211511|FG000|Overall Study|Death|31|||
37731741|NCT01699503|69211512|FG001|Overall Study|Death|40|||
37731742|NCT01699503|69211511|FG000|Overall Study|Withdrawal by Subject|65|||
37731743|NCT01699503|69211512|FG001|Overall Study|Withdrawal by Subject|57|||
37731744|NCT01699503|69211511|FG000|Overall Study|Lost to Follow-up|121|||
37731745|NCT01699503|69211512|FG001|Overall Study|Lost to Follow-up|117|||
37731746|NCT01699503|69211511|FG000|Overall Study|Excluded due to quality|783|||
37843976|NCT01190930|69528428|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
38025721|NCT01345630|69710294|FG000|Overall Study|Adverse Event|22|||
37843977|NCT01190930|69528429|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
37843978|NCT01190930|69528430|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
37731747|NCT01699503|69211512|FG001|Overall Study|Excluded due to quality|791|||
37731748|NCT01709409|69211520|FG000|Overall Study|Protocol Violation|1|||
37731749|NCT01709409|69211521|FG001|Overall Study|Protocol Violation|0|||
37731750|NCT01698879|69211530|FG000|Overall Study|Withdrawal by Subject|1|||
37731751|NCT01698879|69211531|FG001|Overall Study|Withdrawal by Subject|0|||
37731752|NCT01698879|69211532|FG002|Overall Study|Withdrawal by Subject|0|||
37731753|NCT01698801|69211571|FG000|Treatment Phase|Adverse Event|4|||
37731754|NCT01698801|69211571|FG000|Treatment Phase|Protocol Violation|1|||
37731755|NCT01698801|69211571|FG000|Treatment Phase|Other|4|||
37731756|NCT01698801|69211571|FG000|Treatment Phase|Withdrawal by Subject|1|||
37731757|NCT01698801|69211571|FG000|Treatment Phase|Disease progression|1|||
37731758|NCT01698801|69211571|FG000|Follow Up Phase|Withdrawal by Subject|1|||
37731759|NCT01698801|69211571|FG000|Follow Up Phase|Death|4|||
37731760|NCT01682811|69211583|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
37731761|NCT01682811|69211584|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
37731762|NCT01682811|69211585|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
37731763|NCT01682811|69211586|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
37731764|NCT01682811|69211587|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
37731765|NCT01682811|69211588|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
37731766|NCT01682811|69211589|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
37731767|NCT01682811|69211583|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
37731768|NCT01682811|69211584|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
37731769|NCT01682811|69211585|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
37731770|NCT01682811|69211586|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
37731771|NCT01682811|69211587|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
37731772|NCT01682811|69211588|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
37731773|NCT01682811|69211589|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
37731774|NCT01682811|69211583|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
37731775|NCT01682811|69211584|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
37731776|NCT01682811|69211585|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
37731777|NCT01682811|69211586|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
37731778|NCT01682811|69211587|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
37731779|NCT01682811|69211588|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
37731780|NCT01682811|69211589|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
37731781|NCT01682811|69211583|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
37731782|NCT01682811|69211584|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
37731783|NCT01682811|69211585|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
37731784|NCT01682811|69211586|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
37731785|NCT01682811|69211587|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
37731786|NCT01682811|69211588|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
37731787|NCT01682811|69211589|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
37731788|NCT01682031|69211610|FG000|Overall Study|Withdrawal by Subject|0|||
37731789|NCT01682031|69211611|FG001|Overall Study|Withdrawal by Subject|1|||
37731790|NCT01682031|69211610|FG000|Overall Study|Adverse Event|0|||
37731791|NCT01682031|69211611|FG001|Overall Study|Adverse Event|2|||
37731792|NCT01682031|69211610|FG000|Overall Study|MRI results indicate increased nodul|0|||
37731793|NCT01682031|69211611|FG001|Overall Study|MRI results indicate increased nodul|1|||
37731794|NCT01682031|69211610|FG000|Overall Study|Patient could not swallow tablets|1|||
37731795|NCT01682031|69211611|FG001|Overall Study|Patient could not swallow tablets|0|||
37731796|NCT01682031|69211610|FG000|Overall Study|Patient stopped selenium on his own|0|||
37731797|NCT01682031|69211611|FG001|Overall Study|Patient stopped selenium on his own|1|||
37731798|NCT01567527|69211632|FG000|Conversion Phase.|Protocol deviation|3|||
37843979|NCT01190930|69528431|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
37843980|NCT01190930|69528432|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
37843981|NCT01190930|69528433|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
37843982|NCT01190930|69528434|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
37843983|NCT01190930|69528435|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
37843984|NCT01190930|69528436|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
37843985|NCT01190930|69528437|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
37843986|NCT01190930|69528428|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
37843987|NCT01190930|69528429|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
38025722|NCT01345630|69710295|FG001|Overall Study|Adverse Event|23|||
37731799|NCT01567527|69211633|FG001|Conversion Phase.|Protocol deviation|0|||
37843988|NCT01190930|69528430|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
37731800|NCT01567527|69211634|FG002|Conversion Phase.|Protocol deviation|0|||
37731801|NCT01567527|69211635|FG003|Conversion Phase.|Protocol deviation|0|||
37731802|NCT01567527|69211636|FG004|Conversion Phase.|Protocol deviation|0|||
37731803|NCT01567527|69211632|FG000|Conversion Phase.|Met withdrawal criteria|10|||
37731804|NCT01567527|69211633|FG001|Conversion Phase.|Met withdrawal criteria|0|||
37731805|NCT01567527|69211634|FG002|Conversion Phase.|Met withdrawal criteria|0|||
37731806|NCT01567527|69211635|FG003|Conversion Phase.|Met withdrawal criteria|0|||
37731807|NCT01567527|69211636|FG004|Conversion Phase.|Met withdrawal criteria|0|||
37731808|NCT01567527|69211632|FG000|Conversion Phase.|Withdrawal by Subject|32|||
37731809|NCT01567527|69211633|FG001|Conversion Phase.|Withdrawal by Subject|0|||
37731810|NCT01567527|69211634|FG002|Conversion Phase.|Withdrawal by Subject|0|||
37731811|NCT01567527|69211635|FG003|Conversion Phase.|Withdrawal by Subject|0|||
37731812|NCT01567527|69211636|FG004|Conversion Phase.|Withdrawal by Subject|0|||
37731813|NCT01567527|69211632|FG000|Conversion Phase.|Lost to Follow-up|16|||
37731814|NCT01567527|69211633|FG001|Conversion Phase.|Lost to Follow-up|0|||
37731815|NCT01567527|69211634|FG002|Conversion Phase.|Lost to Follow-up|0|||
37731816|NCT01567527|69211635|FG003|Conversion Phase.|Lost to Follow-up|0|||
37731817|NCT01567527|69211636|FG004|Conversion Phase.|Lost to Follow-up|0|||
37731818|NCT01567527|69211632|FG000|Conversion Phase.|Lack of Efficacy|2|||
37731819|NCT01567527|69211633|FG001|Conversion Phase.|Lack of Efficacy|0|||
37731820|NCT01567527|69211634|FG002|Conversion Phase.|Lack of Efficacy|0|||
37731821|NCT01567527|69211635|FG003|Conversion Phase.|Lack of Efficacy|0|||
37731822|NCT01567527|69211636|FG004|Conversion Phase.|Lack of Efficacy|0|||
37731823|NCT01567527|69211632|FG000|Conversion Phase.|Adverse Event|33|||
37731824|NCT01567527|69211633|FG001|Conversion Phase.|Adverse Event|0|||
37731825|NCT01567527|69211634|FG002|Conversion Phase.|Adverse Event|0|||
37731826|NCT01567527|69211635|FG003|Conversion Phase.|Adverse Event|0|||
37731827|NCT01567527|69211636|FG004|Conversion Phase.|Adverse Event|0|||
37731828|NCT01567527|69211632|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
37731829|NCT01567527|69211633|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
37731830|NCT01567527|69211634|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
37731831|NCT01567527|69211635|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
37731832|NCT01567527|69211636|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
37731833|NCT01567527|69211632|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
37731834|NCT01567527|69211633|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
37731835|NCT01567527|69211634|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
37731836|NCT01567527|69211635|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
37731837|NCT01567527|69211636|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
37731838|NCT01567527|69211632|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
37731839|NCT01567527|69211633|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
37731840|NCT01567527|69211634|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
37731841|NCT01567527|69211635|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
37731842|NCT01567527|69211636|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
37731843|NCT01567527|69211632|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
37731844|NCT01567527|69211633|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
37731845|NCT01567527|69211634|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
37731846|NCT01567527|69211635|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
37731847|NCT01567527|69211636|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
37843989|NCT01190930|69528431|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
37843990|NCT01190930|69528432|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
37843991|NCT01190930|69528433|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
37843992|NCT01190930|69528434|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
37843993|NCT01190930|69528435|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
37843994|NCT01190930|69528436|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
37843995|NCT01190930|69528437|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
37843996|NCT01190930|69528428|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
37843997|NCT01190930|69528429|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
37916048|NCT00857766|69602863|FG000|Overall Study|Participant Withdrew Consent|4|||
37916049|NCT00857766|69602864|FG001|Overall Study|Participant Withdrew Consent|4|||
37916050|NCT00517699|69602870|FG000|Overall Study|Withdrawal by Subject|1|||
37916051|NCT00517699|69602870|FG000|Overall Study|Lack of Efficacy|1|||
37916052|NCT00517699|69602870|FG000|Overall Study|Administrative error|1|||
37916053|NCT00517699|69602870|FG000|Overall Study|Study terminated by Sponsor|2|||
37916054|NCT00857454|69602874|FG000|Overall Study|Withdrawal by Subject|2|||
37916055|NCT00857454|69602874|FG000|Overall Study|Lost to Follow-up|1|||
37731848|NCT01567527|69211632|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
37731849|NCT01567527|69211633|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
37731850|NCT01567527|69211634|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
37731851|NCT01567527|69211635|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
37731852|NCT01567527|69211636|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
37731853|NCT01567527|69211632|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
37731854|NCT01567527|69211633|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
37731855|NCT01567527|69211634|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
37731856|NCT01567527|69211635|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
37731857|NCT01567527|69211636|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
37731858|NCT01567527|69211632|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
37731859|NCT01567527|69211633|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
37731860|NCT01567527|69211634|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
37731861|NCT01567527|69211635|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
37731862|NCT01567527|69211636|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
37731863|NCT01567527|69211632|FG000|IM Depot Stabilization.|Protocol deviation|0|||
37731864|NCT01567527|69211633|FG001|IM Depot Stabilization.|Protocol deviation|0|||
37731865|NCT01567527|69211634|FG002|IM Depot Stabilization.|Protocol deviation|5|||
37731866|NCT01567527|69211635|FG003|IM Depot Stabilization.|Protocol deviation|0|||
37731867|NCT01567527|69211636|FG004|IM Depot Stabilization.|Protocol deviation|0|||
37731868|NCT01567527|69211632|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
38025723|NCT01345630|69710294|FG000|Overall Study|Lost to Follow-up|17|||
38025724|NCT01345630|69710295|FG001|Overall Study|Lost to Follow-up|16|||
37731869|NCT01567527|69211633|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
37731870|NCT01567527|69211634|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
37731871|NCT01567527|69211635|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
37731872|NCT01567527|69211636|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
37731873|NCT01567527|69211632|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
37731874|NCT01567527|69211633|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
37731875|NCT01567527|69211634|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
37731876|NCT01567527|69211635|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
37731877|NCT01567527|69211636|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
37731878|NCT01567527|69211632|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
37731879|NCT01567527|69211633|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
37731880|NCT01567527|69211634|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
37731881|NCT01567527|69211635|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
37731882|NCT01567527|69211636|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
37731883|NCT01567527|69211632|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
37731884|NCT01567527|69211633|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
37731885|NCT01567527|69211634|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
37731886|NCT01567527|69211635|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
37731887|NCT01567527|69211636|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
37731888|NCT01567527|69211632|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
37731889|NCT01567527|69211633|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
37731890|NCT01567527|69211634|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
37731891|NCT01567527|69211635|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
37731892|NCT01567527|69211636|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
37731893|NCT01567527|69211632|FG000|IM Depot Stabilization.|Adverse Event|0|||
37731894|NCT01567527|69211633|FG001|IM Depot Stabilization.|Adverse Event|0|||
37731895|NCT01567527|69211634|FG002|IM Depot Stabilization.|Adverse Event|37|||
37731896|NCT01567527|69211635|FG003|IM Depot Stabilization.|Adverse Event|0|||
37731897|NCT01567527|69211636|FG004|IM Depot Stabilization.|Adverse Event|0|||
37731898|NCT01567527|69211632|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
37843998|NCT01190930|69528430|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
37843999|NCT01190930|69528431|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
37844000|NCT01190930|69528432|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
37844001|NCT01190930|69528433|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
37844002|NCT01190930|69528434|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
37844003|NCT01190930|69528435|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
37844004|NCT01190930|69528436|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
37844005|NCT01190930|69528437|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
37844006|NCT01190930|69528428|FG000|Post Induction Pre-Maintenance|Relapse|0|||
37844007|NCT01190930|69528429|FG001|Post Induction Pre-Maintenance|Relapse|0|||
37916056|NCT00857454|69602874|FG000|Overall Study|Adverse Event|2|||
38025725|NCT01345630|69710294|FG000|Overall Study|Protocol Violation|4|||
38025726|NCT01345630|69710295|FG001|Overall Study|Protocol Violation|1|||
38025727|NCT01345630|69710294|FG000|Overall Study|Medication error without associated AE|0|||
38025728|NCT01345630|69710295|FG001|Overall Study|Medication error without associated AE|1|||
38025729|NCT01345630|69710294|FG000|Overall Study|Study terminated by sponsor|254|||
38025730|NCT01345630|69710295|FG001|Overall Study|Study terminated by sponsor|285|||
38025731|NCT01345630|69710294|FG000|Overall Study|Other reasons|6|||
38025732|NCT01345630|69710295|FG001|Overall Study|Other reasons|8|||
38025733|NCT01345630|69710294|FG000|Overall Study|Withdrawn due to pregnancy|1|||
38025734|NCT01345630|69710295|FG001|Overall Study|Withdrawn due to pregnancy|2|||
38025735|NCT01345630|69710294|FG000|Overall Study|No longer willing to participate|9|||
38025736|NCT01345630|69710295|FG001|Overall Study|No longer willing to participate|12|||
38025737|NCT01345630|69710294|FG000|Overall Study|Insufficient clinical response|48|||
38025738|NCT01345630|69710295|FG001|Overall Study|Insufficient clinical response|11|||
38025739|NCT03693612|69710312|FG000|Overall Study|Lost to Follow-up|0|||
38025740|NCT03693612|69710313|FG001|Overall Study|Lost to Follow-up|0|||
38025741|NCT03693612|69710314|FG002|Overall Study|Lost to Follow-up|0|||
38025742|NCT03693612|69710315|FG003|Overall Study|Lost to Follow-up|0|||
38025743|NCT03693612|69710316|FG004|Overall Study|Lost to Follow-up|1|||
38025744|NCT03693612|69710317|FG005|Overall Study|Lost to Follow-up|0|||
38025745|NCT03693612|69710318|FG006|Overall Study|Lost to Follow-up|0|||
38025746|NCT03693612|69710312|FG000|Overall Study|Withdrawal by Subject|0|||
38025747|NCT03693612|69710313|FG001|Overall Study|Withdrawal by Subject|0|||
38025748|NCT03693612|69710314|FG002|Overall Study|Withdrawal by Subject|1|||
38025749|NCT03693612|69710315|FG003|Overall Study|Withdrawal by Subject|0|||
38025750|NCT03693612|69710316|FG004|Overall Study|Withdrawal by Subject|2|||
38025751|NCT03693612|69710317|FG005|Overall Study|Withdrawal by Subject|0|||
37731899|NCT01567527|69211633|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
37731900|NCT01567527|69211634|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
37731901|NCT01567527|69211635|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
37731902|NCT01567527|69211636|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
37731903|NCT01567527|69211632|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
37731904|NCT01567527|69211633|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
37731905|NCT01567527|69211634|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
37731906|NCT01567527|69211635|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
37731907|NCT01567527|69211636|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
37731908|NCT01567527|69211632|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
37731909|NCT01567527|69211633|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
37731910|NCT01567527|69211634|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
37731911|NCT01567527|69211635|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
37731912|NCT01567527|69211636|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
37731913|NCT01567527|69211632|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
37731914|NCT01567527|69211633|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
37731915|NCT01567527|69211634|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
37731916|NCT01567527|69211635|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
37731917|NCT01567527|69211636|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
37731918|NCT01567527|69211632|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
37731919|NCT01567527|69211633|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
37731920|NCT01567527|69211634|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
37731921|NCT01567527|69211635|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
37731922|NCT01567527|69211636|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
37731923|NCT01567527|69211632|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
37731924|NCT01567527|69211633|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
37731925|NCT01567527|69211634|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
37731926|NCT01567527|69211635|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
37731927|NCT01567527|69211636|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
37731928|NCT01567527|69211632|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
37844008|NCT01190930|69528430|FG002|Post Induction Pre-Maintenance|Relapse|1|||
37844009|NCT01190930|69528431|FG003|Post Induction Pre-Maintenance|Relapse|0|||
37844010|NCT01190930|69528432|FG004|Post Induction Pre-Maintenance|Relapse|0|||
37844011|NCT01190930|69528433|FG005|Post Induction Pre-Maintenance|Relapse|0|||
37844012|NCT01190930|69528434|FG006|Post Induction Pre-Maintenance|Relapse|0|||
37844013|NCT01190930|69528435|FG007|Post Induction Pre-Maintenance|Relapse|0|||
37844014|NCT01190930|69528436|FG008|Post Induction Pre-Maintenance|Relapse|0|||
37844015|NCT01190930|69528437|FG009|Post Induction Pre-Maintenance|Relapse|0|||
37844016|NCT01190930|69528428|FG000|Maintenance|Adverse Event|0|||
37844017|NCT01190930|69528429|FG001|Maintenance|Adverse Event|0|||
37844018|NCT01190930|69528430|FG002|Maintenance|Adverse Event|0|||
37844019|NCT01190930|69528431|FG003|Maintenance|Adverse Event|0|||
37844020|NCT01190930|69528432|FG004|Maintenance|Adverse Event|0|||
38025752|NCT03693612|69710318|FG006|Overall Study|Withdrawal by Subject|0|||
38025753|NCT03693612|69710312|FG000|Overall Study|Study Terminated by Sponsor|0|||
38025754|NCT03693612|69710313|FG001|Overall Study|Study Terminated by Sponsor|1|||
38025755|NCT03693612|69710314|FG002|Overall Study|Study Terminated by Sponsor|0|||
37731929|NCT01567527|69211633|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
37731930|NCT01567527|69211634|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
37731931|NCT01567527|69211635|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
37731932|NCT01567527|69211636|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
37731933|NCT01567527|69211632|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
37731934|NCT01567527|69211633|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
37731935|NCT01567527|69211634|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
37731936|NCT01567527|69211635|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
37731937|NCT01567527|69211636|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
37731938|NCT01567527|69211632|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
37731939|NCT01567527|69211633|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
37731940|NCT01567527|69211634|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
37731941|NCT01567527|69211635|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
37731942|NCT01567527|69211636|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
37731943|NCT01818752|69211647|FG000|Overall Study|Adverse Event|64|||
37731944|NCT01818752|69211648|FG001|Overall Study|Adverse Event|74|||
37731945|NCT01818752|69211647|FG000|Overall Study|Death|14|||
37731946|NCT01818752|69211648|FG001|Overall Study|Death|18|||
37731947|NCT01818752|69211647|FG000|Overall Study|Non-compliance|16|||
37731948|NCT01818752|69211648|FG001|Overall Study|Non-compliance|20|||
37731949|NCT01818752|69211647|FG000|Overall Study|Withdrawal by Subject|15|||
37731950|NCT01818752|69211648|FG001|Overall Study|Withdrawal by Subject|14|||
37731951|NCT01818752|69211647|FG000|Overall Study|Physician Decision|9|||
37731952|NCT01818752|69211648|FG001|Overall Study|Physician Decision|8|||
37731953|NCT01818752|69211647|FG000|Overall Study|Disease Progression|54|||
37731954|NCT01818752|69211648|FG001|Overall Study|Disease Progression|48|||
37731955|NCT01818752|69211647|FG000|Overall Study|Other|7|||
37731956|NCT01818752|69211648|FG001|Overall Study|Other|8|||
37731957|NCT01818752|69211647|FG000|Overall Study|Continuing Treatment|1|||
37731958|NCT01818752|69211648|FG001|Overall Study|Continuing Treatment|4|||
37731959|NCT01818752|69211647|FG000|Overall Study|Randomized but not Dosed|7|||
37731960|NCT01818752|69211648|FG001|Overall Study|Randomized but not Dosed|4|||
37731961|NCT01845818|69211656|FG000|Overall Study|Withdrawal by Subject|0|||
37731962|NCT01845818|69211657|FG001|Overall Study|Withdrawal by Subject|1|||
37731963|NCT01845818|69211656|FG000|Overall Study|Lost to Follow-up|7|||
37731964|NCT01845818|69211657|FG001|Overall Study|Lost to Follow-up|5|||
37731965|NCT01845818|69211656|FG000|Overall Study|Administrative Reasons|3|||
37731966|NCT01845818|69211657|FG001|Overall Study|Administrative Reasons|1|||
37731967|NCT01845818|69211656|FG000|Overall Study|Serious Adverse Event|1|||
37731968|NCT01845818|69211657|FG001|Overall Study|Serious Adverse Event|1|||
37731969|NCT01845818|69211656|FG000|Overall Study|Other|25|||
37731970|NCT01845818|69211657|FG001|Overall Study|Other|8|||
37731971|NCT01845818|69211656|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
37731972|NCT01845818|69211657|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
37731973|NCT01845818|69211656|FG000|Overall Study|No Follow-Up Data Available|4|||
37731974|NCT01845818|69211657|FG001|Overall Study|No Follow-Up Data Available|1|||
37731975|NCT01362608|69211667|FG000|Overall Study|Protocol Violation|0|||
37731976|NCT01362608|69211668|FG001|Overall Study|Protocol Violation|1|||
37731977|NCT01362608|69211667|FG000|Overall Study|Lost to Follow-up|3|||
37731978|NCT01362608|69211668|FG001|Overall Study|Lost to Follow-up|1|||
37731979|NCT01362608|69211667|FG000|Overall Study|Withdrawal by Subject|1|||
37731980|NCT01362608|69211668|FG001|Overall Study|Withdrawal by Subject|2|||
37731981|NCT01362608|69211667|FG000|Overall Study|Lack of Efficacy|0|||
37731982|NCT01362608|69211668|FG001|Overall Study|Lack of Efficacy|2|||
37731983|NCT01362608|69211667|FG000|Overall Study|Adverse Event|0|||
37731984|NCT01362608|69211668|FG001|Overall Study|Adverse Event|2|||
37731985|NCT01871090|69211676|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
37731986|NCT01871090|69211677|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
37731987|NCT01871090|69211676|FG000|Overall Study|Interrogation not completed correctly|1|||
37731988|NCT01871090|69211677|FG001|Overall Study|Interrogation not completed correctly|0|||
37731989|NCT01871090|69211676|FG000|Overall Study|Subject Non-Compliance|0|||
37731990|NCT01871090|69211677|FG001|Overall Study|Subject Non-Compliance|1|||
37731991|NCT01818596|69211685|FG000|Overall Study|Enrolled but Not Treated|4|||
37731992|NCT01818596|69211686|FG001|Overall Study|Enrolled but Not Treated|0|||
37731993|NCT01818596|69211685|FG000|Overall Study|Adverse Event|7|||
37731994|NCT01818596|69211686|FG001|Overall Study|Adverse Event|0|||
37731995|NCT01818596|69211685|FG000|Overall Study|Death|3|||
37731996|NCT01818596|69211686|FG001|Overall Study|Death|0|||
37731997|NCT01818596|69211685|FG000|Overall Study|Investigator's Discretion|4|||
37731998|NCT01818596|69211686|FG001|Overall Study|Investigator's Discretion|0|||
37731999|NCT01818596|69211685|FG000|Overall Study|Protocol Violation|1|||
37732000|NCT01818596|69211686|FG001|Overall Study|Protocol Violation|0|||
37732001|NCT01818596|69211685|FG000|Overall Study|Withdrew Consent|5|||
37732002|NCT01818596|69211686|FG001|Overall Study|Withdrew Consent|0|||
37732003|NCT01818596|69211685|FG000|Overall Study|Lost to Follow-up|7|||
37732004|NCT01818596|69211686|FG001|Overall Study|Lost to Follow-up|0|||
37732005|NCT04577794|69211699|FG000|Overall Study|Adverse Event|1|||
37732006|NCT04577794|69211700|FG001|Overall Study|Adverse Event|1|||
37732007|NCT01594281|69211717|FG000|Interventional Core Phase|Protocol Deviation|1|||
37732008|NCT01594281|69211718|FG001|Interventional Core Phase|Protocol Deviation|0|||
37732009|NCT01594281|69211719|FG002|Interventional Core Phase|Protocol Deviation|0|||
37844021|NCT01190930|69528433|FG005|Maintenance|Adverse Event|1|||
37844022|NCT01190930|69528434|FG006|Maintenance|Adverse Event|1|||
37844023|NCT01190930|69528435|FG007|Maintenance|Adverse Event|3|||
37844024|NCT01190930|69528436|FG008|Maintenance|Adverse Event|3|||
37844025|NCT01190930|69528437|FG009|Maintenance|Adverse Event|0|||
37844026|NCT01190930|69528428|FG000|Maintenance|Death|0|||
37844027|NCT01190930|69528429|FG001|Maintenance|Death|0|||
37844028|NCT01190930|69528430|FG002|Maintenance|Death|0|||
37732010|NCT01594281|69211717|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
37732011|NCT01594281|69211718|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
37732012|NCT01594281|69211719|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
37732013|NCT01594281|69211717|FG000|Interventional Core Phase|Death|1|||
37732014|NCT01594281|69211718|FG001|Interventional Core Phase|Death|1|||
37732015|NCT01594281|69211719|FG002|Interventional Core Phase|Death|2|||
37732016|NCT01594281|69211717|FG000|Interventional Core Phase|Lost to Follow-up|1|||
37732017|NCT01594281|69211718|FG001|Interventional Core Phase|Lost to Follow-up|4|||
37732018|NCT01594281|69211719|FG002|Interventional Core Phase|Lost to Follow-up|1|||
37732019|NCT01594281|69211717|FG000|Interventional Core Phase|Adverse Event|4|||
37732020|NCT01594281|69211718|FG001|Interventional Core Phase|Adverse Event|4|||
37732021|NCT01594281|69211719|FG002|Interventional Core Phase|Adverse Event|4|||
37732022|NCT01594281|69211717|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
37732023|NCT01594281|69211718|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
37732024|NCT01594281|69211719|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
37732025|NCT01594281|69211717|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
37732026|NCT01594281|69211718|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
37732027|NCT01594281|69211719|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
37732028|NCT01594281|69211717|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
37732029|NCT01594281|69211718|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
37732030|NCT01594281|69211719|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
37732031|NCT01566981|69211732|FG000|Overall Study|Lost to Follow-up|5|||
37732032|NCT01566981|69211733|FG001|Overall Study|Lost to Follow-up|8|||
37732033|NCT01870778|69211743|FG000|Overall Study|Withdrawal by Subject|8|||
37732034|NCT01870778|69211744|FG001|Overall Study|Withdrawal by Subject|7|||
37732035|NCT01870778|69211743|FG000|Overall Study|Lost to Follow-up|0|||
37732036|NCT01870778|69211744|FG001|Overall Study|Lost to Follow-up|2|||
37732037|NCT01818284|69211757|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
37732038|NCT01818284|69211758|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
37732039|NCT01818284|69211757|FG000|Overall Study|Death|0|||
37732040|NCT01818284|69211758|FG001|Overall Study|Death|2|||
37732041|NCT01610492|69211794|FG000|Overall Study|Adverse Event|1|||
37732042|NCT01610492|69211794|FG000|Overall Study|Lack of Efficacy|3|||
37732043|NCT01610492|69211794|FG000|Overall Study|Other: Reached stopping criteria|1|||
37732044|NCT01610492|69211794|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
37732045|NCT01817582|69211801|FG000|Overall Study|Withdrawal by Subject|0|||
37732046|NCT01817582|69211802|FG001|Overall Study|Withdrawal by Subject|1|||
37844029|NCT01190930|69528431|FG003|Maintenance|Death|1|||
37732047|NCT01817582|69211803|FG002|Overall Study|Withdrawal by Subject|0|||
37732048|NCT01817582|69211801|FG000|Overall Study|Participant revealed masked treatment|1|||
37732049|NCT01817582|69211802|FG001|Overall Study|Participant revealed masked treatment|0|||
38025756|NCT03693612|69710315|FG003|Overall Study|Study Terminated by Sponsor|0|||
37844030|NCT01190930|69528432|FG004|Maintenance|Death|0|||
37844031|NCT01190930|69528433|FG005|Maintenance|Death|0|||
37732050|NCT01817582|69211803|FG002|Overall Study|Participant revealed masked treatment|0|||
37732051|NCT01817582|69211801|FG000|Overall Study|Randomized but exclusion criteria met|1|||
37732052|NCT01817582|69211802|FG001|Overall Study|Randomized but exclusion criteria met|0|||
37732053|NCT01817582|69211803|FG002|Overall Study|Randomized but exclusion criteria met|0|||
37732054|NCT01594125|69211816|FG000|Overall Study|Withdrawal by Subject|1|||
37732055|NCT01594125|69211817|FG001|Overall Study|Withdrawal by Subject|0|||
37844032|NCT01190930|69528434|FG006|Maintenance|Death|2|||
37844033|NCT01190930|69528435|FG007|Maintenance|Death|2|||
37732056|NCT01594125|69211818|FG002|Overall Study|Withdrawal by Subject|0|||
37732057|NCT01594125|69211819|FG003|Overall Study|Withdrawal by Subject|1|||
37732058|NCT01594125|69211820|FG004|Overall Study|Withdrawal by Subject|0|||
37732059|NCT01594125|69211816|FG000|Overall Study|Progressive Disease|3|||
37732060|NCT01594125|69211817|FG001|Overall Study|Progressive Disease|12|||
37732061|NCT01594125|69211818|FG002|Overall Study|Progressive Disease|3|||
37732062|NCT01594125|69211819|FG003|Overall Study|Progressive Disease|3|||
37732063|NCT01594125|69211820|FG004|Overall Study|Progressive Disease|7|||
37732064|NCT01870076|69211836|FG000|Overall Study|Withdrawal by Subject|1|||
37732065|NCT01870076|69211837|FG001|Overall Study|Withdrawal by Subject|0|||
37732066|NCT01870076|69211838|FG002|Overall Study|Withdrawal by Subject|1|||
37732067|NCT01870076|69211839|FG003|Overall Study|Withdrawal by Subject|0|||
37732068|NCT01592721|69211849|FG000|Long-term Follow-up|Death|1|||
37732069|NCT01613378|69211853|FG000|Overall Study|Lack of Efficacy|13|||
37732070|NCT01613378|69211853|FG000|Overall Study|Adverse Event|11|||
37732071|NCT01613378|69211853|FG000|Overall Study|Withdrawal by Subject|8|||
37732072|NCT01613378|69211853|FG000|Overall Study|Death|2|||
37732073|NCT01613378|69211853|FG000|Overall Study|Lost to Follow-up|1|||
37732074|NCT01613378|69211853|FG000|Overall Study|Other Reason|4|||
37732075|NCT01592409|69211859|FG000|Overall Study|Withdrawal by Subject|0|||
37732076|NCT01592409|69211860|FG001|Overall Study|Withdrawal by Subject|1|||
37732077|NCT01697319|69211879|FG000|Primary Phase|Withdrawal by Subject|1|||
37732078|NCT01697319|69211879|FG000|Extension Phase|Terminated by Sponsor|15|||
37732079|NCT01566435|69211894|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
37732080|NCT01696929|69211902|FG000|Overall Study|Physician Decision|1|||
37732081|NCT01696773|69211912|FG000|Days 15-27, Washout|Adverse Event|1|||
37732082|NCT01696773|69211913|FG001|Days 15-27, Washout|Adverse Event|0|||
37732083|NCT01696695|69211928|FG000|Overall Study|Disease progression|373|||
37732084|NCT01696695|69211928|FG000|Overall Study|Death|29|||
37732085|NCT01696695|69211928|FG000|Overall Study|Adverse Event|74|||
37732086|NCT01696695|69211928|FG000|Overall Study|Withdrawal by Subject|92|||
37732087|NCT01696695|69211928|FG000|Overall Study|Lost to Follow-up|48|||
37732088|NCT01696695|69211928|FG000|Overall Study|Other|74|||
37732089|NCT01696695|69211928|FG000|Overall Study|Major Protocol Violation|192|||
37732090|NCT01565889|69211960|FG000|Part A|Withdrawal by Subject|1|||
37732091|NCT01565889|69211961|FG001|Part A|Withdrawal by Subject|0|||
37732092|NCT01565889|69211962|FG002|Part A|Withdrawal by Subject|0|||
37732093|NCT01565889|69211963|FG003|Part A|Withdrawal by Subject|0|||
37732094|NCT01565889|69211964|FG004|Part A|Withdrawal by Subject|0|||
37732095|NCT01565889|69211965|FG005|Part A|Withdrawal by Subject|0|||
37732096|NCT01565889|69211960|FG000|Part B|Withdrawal by Subject|0|||
37732097|NCT01565889|69211961|FG001|Part B|Withdrawal by Subject|0|||
37732098|NCT01565889|69211962|FG002|Part B|Withdrawal by Subject|0|||
37732099|NCT01565889|69211963|FG003|Part B|Withdrawal by Subject|0|||
37732100|NCT01565889|69211964|FG004|Part B|Withdrawal by Subject|0|||
37732101|NCT01565889|69211965|FG005|Part B|Withdrawal by Subject|1|||
37732102|NCT01565889|69211960|FG000|Part B|Lack of Efficacy|0|||
37732103|NCT01565889|69211961|FG001|Part B|Lack of Efficacy|0|||
38025757|NCT03693612|69710316|FG004|Overall Study|Study Terminated by Sponsor|3|||
37732104|NCT01565889|69211962|FG002|Part B|Lack of Efficacy|0|||
37732105|NCT01565889|69211963|FG003|Part B|Lack of Efficacy|0|||
37732106|NCT01565889|69211964|FG004|Part B|Lack of Efficacy|0|||
37732107|NCT01565889|69211965|FG005|Part B|Lack of Efficacy|2|||
37732108|NCT01565889|69211960|FG000|Part B|Lost to Follow-up|0|||
37732109|NCT01565889|69211961|FG001|Part B|Lost to Follow-up|0|||
37732110|NCT01565889|69211962|FG002|Part B|Lost to Follow-up|0|||
37732111|NCT01565889|69211963|FG003|Part B|Lost to Follow-up|0|||
37732112|NCT01565889|69211964|FG004|Part B|Lost to Follow-up|0|||
37732113|NCT01565889|69211965|FG005|Part B|Lost to Follow-up|1|||
37732114|NCT01696071|69211980|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
37732115|NCT01696071|69211981|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
37732116|NCT01591863|69211992|FG000|Overall Study|Adverse Event|3|||
37732117|NCT01591863|69211992|FG000|Overall Study|Withdrawal by Subject|1|||
37732118|NCT01591863|69211992|FG000|Overall Study|recurrence|9|||
37732119|NCT01591863|69211992|FG000|Overall Study|Lack of Efficacy|1|||
37732120|NCT01591785|69211998|FG000|Overall Study|worsening condition|1|||
37732121|NCT01591785|69211999|FG001|Overall Study|worsening condition|2|||
37732122|NCT01591785|69211998|FG000|Overall Study|Protocol Violation|2|||
37732123|NCT01591785|69211999|FG001|Overall Study|Protocol Violation|0|||
37732124|NCT01591785|69211998|FG000|Overall Study|Lost to Follow-up|1|||
37732125|NCT01591785|69211999|FG001|Overall Study|Lost to Follow-up|0|||
37732126|NCT01695993|69212008|FG000|Overall Study|Lost to Follow-up|2|||
37732127|NCT01695993|69212009|FG001|Overall Study|Lost to Follow-up|1|||
37732128|NCT01695993|69212010|FG002|Overall Study|Lost to Follow-up|3|||
37732129|NCT01695993|69212008|FG000|Overall Study|Withdrawal by Subject|2|||
37732130|NCT01695993|69212009|FG001|Overall Study|Withdrawal by Subject|2|||
37732131|NCT01695993|69212010|FG002|Overall Study|Withdrawal by Subject|2|||
37732132|NCT01695993|69212008|FG000|Overall Study|To ill to continue|1|||
37732133|NCT01695993|69212009|FG001|Overall Study|To ill to continue|2|||
37732134|NCT01695993|69212010|FG002|Overall Study|To ill to continue|0|||
37732135|NCT01695993|69212008|FG000|Overall Study|Changed Medical Facility|0|||
37732136|NCT01695993|69212009|FG001|Overall Study|Changed Medical Facility|0|||
37732137|NCT01695993|69212010|FG002|Overall Study|Changed Medical Facility|1|||
37732138|NCT01565343|69212021|FG000|Overall Study|Administrative decision/technical issues|1|||
37732139|NCT01565343|69212022|FG001|Overall Study|Administrative decision/technical issues|0|||
37732140|NCT01565343|69212023|FG002|Overall Study|Administrative decision/technical issues|0|||
37732141|NCT01695135|69212048|FG000|Double-blind Treatment Phase|Progressive disease|50|||
37732142|NCT01695135|69212049|FG001|Double-blind Treatment Phase|Progressive disease|110|||
37732143|NCT01695135|69212050|FG002|Double-blind Treatment Phase|Progressive disease|0|||
37732144|NCT01695135|69212051|FG003|Double-blind Treatment Phase|Progressive disease|0|||
37732145|NCT01695135|69212048|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
37732146|NCT01695135|69212049|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
37732147|NCT01695135|69212050|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
37844034|NCT01190930|69528436|FG008|Maintenance|Death|2|||
38025758|NCT03693612|69710317|FG005|Overall Study|Study Terminated by Sponsor|0|||
38025759|NCT03693612|69710318|FG006|Overall Study|Study Terminated by Sponsor|0|||
38025760|NCT03692910|69710334|FG000|Overall Study|Lost to Follow-up|4|||
38025761|NCT03692910|69710335|FG001|Overall Study|Lost to Follow-up|0|||
38025762|NCT03692910|69710336|FG002|Overall Study|Lost to Follow-up|0|||
38025763|NCT03692910|69710334|FG000|Overall Study|Withdrawal by Subject|2|||
38025764|NCT03692910|69710335|FG001|Overall Study|Withdrawal by Subject|0|||
38025765|NCT03692910|69710336|FG002|Overall Study|Withdrawal by Subject|0|||
37732148|NCT01695135|69212051|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
37732149|NCT01695135|69212048|FG000|Double-blind Treatment Phase|Adverse Event|7|||
37732150|NCT01695135|69212049|FG001|Double-blind Treatment Phase|Adverse Event|7|||
37844035|NCT01190930|69528437|FG009|Maintenance|Death|2|||
37844036|NCT01190930|69528428|FG000|Maintenance|Lost to Follow-up|0|||
37732151|NCT01695135|69212050|FG002|Double-blind Treatment Phase|Adverse Event|0|||
37844037|NCT01190930|69528429|FG001|Maintenance|Lost to Follow-up|0|||
38025766|NCT04223232|69710342|FG000|Overall Study|Withdrawal by Subject|1|||
37732152|NCT01695135|69212051|FG003|Double-blind Treatment Phase|Adverse Event|0|||
37732153|NCT01695135|69212048|FG000|Double-blind Treatment Phase|Other|1|||
37732154|NCT01695135|69212049|FG001|Double-blind Treatment Phase|Other|3|||
37732155|NCT01695135|69212050|FG002|Double-blind Treatment Phase|Other|0|||
37732156|NCT01695135|69212051|FG003|Double-blind Treatment Phase|Other|0|||
37732157|NCT01695135|69212048|FG000|Double-blind Treatment Phase|Physician Decision|6|||
37732158|NCT01695135|69212049|FG001|Double-blind Treatment Phase|Physician Decision|3|||
37732159|NCT01695135|69212050|FG002|Double-blind Treatment Phase|Physician Decision|0|||
37732160|NCT01695135|69212051|FG003|Double-blind Treatment Phase|Physician Decision|0|||
37732161|NCT01695135|69212048|FG000|Double-blind Treatment Phase|Death|1|||
37732162|NCT01695135|69212049|FG001|Double-blind Treatment Phase|Death|1|||
37732163|NCT01695135|69212050|FG002|Double-blind Treatment Phase|Death|0|||
37732164|NCT01695135|69212051|FG003|Double-blind Treatment Phase|Death|0|||
37732165|NCT01695135|69212048|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
37732166|NCT01695135|69212049|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
37732167|NCT01695135|69212050|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
37732168|NCT01695135|69212051|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
37732169|NCT01695135|69212048|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
37732170|NCT01695135|69212049|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
37732171|NCT01695135|69212050|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
37732172|NCT01695135|69212051|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
37732173|NCT01695135|69212048|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
37732174|NCT01695135|69212049|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
37732175|NCT01695135|69212050|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
37732176|NCT01695135|69212051|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
37732177|NCT01695135|69212048|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
37732178|NCT01695135|69212049|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
37732179|NCT01695135|69212050|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
37732180|NCT01695135|69212051|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
37732181|NCT01695135|69212048|FG000|Open Label Extension Treatment Phase|Other|0|||
37732182|NCT01695135|69212049|FG001|Open Label Extension Treatment Phase|Other|0|||
37732183|NCT01695135|69212050|FG002|Open Label Extension Treatment Phase|Other|4|||
37732184|NCT01695135|69212051|FG003|Open Label Extension Treatment Phase|Other|7|||
37732185|NCT01695135|69212048|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
37732186|NCT01695135|69212049|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
37732187|NCT01695135|69212050|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
37732188|NCT01695135|69212051|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
37732189|NCT01695135|69212048|FG000|Open Label Extension Treatment Phase|Death|0|||
37732190|NCT01695135|69212049|FG001|Open Label Extension Treatment Phase|Death|0|||
37732191|NCT01695135|69212050|FG002|Open Label Extension Treatment Phase|Death|2|||
37732192|NCT01695135|69212051|FG003|Open Label Extension Treatment Phase|Death|7|||
37732193|NCT01695135|69212048|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
37732194|NCT01695135|69212049|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
37732195|NCT01695135|69212050|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
37844038|NCT01190930|69528430|FG002|Maintenance|Lost to Follow-up|0|||
37844039|NCT01190930|69528431|FG003|Maintenance|Lost to Follow-up|0|||
37844040|NCT01190930|69528432|FG004|Maintenance|Lost to Follow-up|0|||
37844041|NCT01190930|69528433|FG005|Maintenance|Lost to Follow-up|0|||
37844042|NCT01190930|69528434|FG006|Maintenance|Lost to Follow-up|1|||
37844043|NCT01190930|69528435|FG007|Maintenance|Lost to Follow-up|1|||
37844044|NCT01190930|69528436|FG008|Maintenance|Lost to Follow-up|1|||
37844045|NCT01190930|69528437|FG009|Maintenance|Lost to Follow-up|0|||
37844046|NCT01190930|69528428|FG000|Maintenance|Physician Decision|0|||
37844047|NCT01190930|69528429|FG001|Maintenance|Physician Decision|1|||
37844048|NCT01190930|69528430|FG002|Maintenance|Physician Decision|0|||
37844049|NCT01190930|69528431|FG003|Maintenance|Physician Decision|5|||
37844050|NCT01190930|69528432|FG004|Maintenance|Physician Decision|9|||
37844051|NCT01190930|69528433|FG005|Maintenance|Physician Decision|4|||
37844052|NCT01190930|69528434|FG006|Maintenance|Physician Decision|8|||
37844053|NCT01190930|69528435|FG007|Maintenance|Physician Decision|8|||
37844054|NCT01190930|69528436|FG008|Maintenance|Physician Decision|10|||
37844055|NCT01190930|69528437|FG009|Maintenance|Physician Decision|17|||
37732196|NCT01695135|69212051|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
37732197|NCT01610414|69212061|FG000|Study Start - Month 13|Serious Adverse Event|65|||
37732198|NCT01610414|69212062|FG001|Study Start - Month 13|Serious Adverse Event|67|||
37844056|NCT01190930|69528428|FG000|Maintenance|Withdrawal by Subject|0|||
37844057|NCT01190930|69528429|FG001|Maintenance|Withdrawal by Subject|0|||
37844058|NCT01190930|69528430|FG002|Maintenance|Withdrawal by Subject|0|||
37844059|NCT01190930|69528431|FG003|Maintenance|Withdrawal by Subject|0|||
37844060|NCT01190930|69528432|FG004|Maintenance|Withdrawal by Subject|0|||
37732199|NCT01610414|69212061|FG000|Study Start - Month 13|Adverse Event|14|||
37732200|NCT01610414|69212062|FG001|Study Start - Month 13|Adverse Event|14|||
37732201|NCT01610414|69212061|FG000|Study Start - Month 13|Protocol Violation|3|||
37732202|NCT01610414|69212062|FG001|Study Start - Month 13|Protocol Violation|1|||
37732203|NCT01610414|69212061|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
37732204|NCT01610414|69212062|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
37732205|NCT01610414|69212061|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
37732206|NCT01610414|69212062|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
37732207|NCT01610414|69212061|FG000|Study Start - Month 13|Lost to Follow-up|4|||
37732208|NCT01610414|69212062|FG001|Study Start - Month 13|Lost to Follow-up|6|||
37732209|NCT01610414|69212061|FG000|Study Start - Month 13|Suspected HZ episode|1|||
37732210|NCT01610414|69212062|FG001|Study Start - Month 13|Suspected HZ episode|3|||
37732211|NCT01610414|69212061|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
37732212|NCT01610414|69212062|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
37732213|NCT01610414|69212061|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
37732214|NCT01610414|69212062|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
37916057|NCT00857454|69602874|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
37732215|NCT01610414|69212061|FG000|Month 13 - Month 25|Adverse Event|8|||
37732216|NCT01610414|69212062|FG001|Month 13 - Month 25|Adverse Event|4|||
37732217|NCT01610414|69212061|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
37732218|NCT01610414|69212062|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
37732219|NCT01610414|69212061|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
37732220|NCT01610414|69212062|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
37732221|NCT01610414|69212061|FG000|Month 13 - Month 25|Protocol Violation|0|||
37732222|NCT01610414|69212062|FG001|Month 13 - Month 25|Protocol Violation|2|||
37732223|NCT01610414|69212061|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
37732224|NCT01610414|69212062|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
37732225|NCT01610414|69212061|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
37732226|NCT01610414|69212062|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
37732227|NCT01610414|69212061|FG000|After Month 25|Study end not reached|48|||
37732228|NCT01610414|69212062|FG001|After Month 25|Study end not reached|53|||
37732229|NCT01564407|69212090|FG000|Overall Study|Lost to Follow-up|0|||
37732230|NCT01564407|69212091|FG001|Overall Study|Lost to Follow-up|1|||
37732231|NCT01564407|69212092|FG002|Overall Study|Lost to Follow-up|0|||
37732232|NCT01564407|69212093|FG003|Overall Study|Lost to Follow-up|0|||
37732233|NCT01564407|69212094|FG004|Overall Study|Lost to Follow-up|0|||
37732234|NCT01564407|69212090|FG000|Overall Study|Withdrawal by Subject|0|||
37732235|NCT01564407|69212091|FG001|Overall Study|Withdrawal by Subject|1|||
37732236|NCT01564407|69212092|FG002|Overall Study|Withdrawal by Subject|0|||
37732237|NCT01564407|69212093|FG003|Overall Study|Withdrawal by Subject|0|||
37732238|NCT01564407|69212094|FG004|Overall Study|Withdrawal by Subject|0|||
37732239|NCT01564407|69212090|FG000|Overall Study|funding lost, study ended|0|||
37732240|NCT01564407|69212091|FG001|Overall Study|funding lost, study ended|0|||
37732241|NCT01564407|69212092|FG002|Overall Study|funding lost, study ended|0|||
37732242|NCT01564407|69212093|FG003|Overall Study|funding lost, study ended|1|||
37732243|NCT01564407|69212094|FG004|Overall Study|funding lost, study ended|0|||
37732244|NCT01590771|69212117|FG000|Overall Study|Other Protocol Specified Criteria|5|||
37732245|NCT01590771|69212118|FG001|Overall Study|Other Protocol Specified Criteria|14|||
37732246|NCT01590771|69212117|FG000|Overall Study|Withdrawal by Subject|8|||
37732247|NCT01590771|69212118|FG001|Overall Study|Withdrawal by Subject|15|||
37732248|NCT01590771|69212117|FG000|Overall Study|Protocol Violation|1|||
37732249|NCT01590771|69212118|FG001|Overall Study|Protocol Violation|2|||
37732250|NCT01590771|69212117|FG000|Overall Study|Lost to Follow-up|1|||
37732251|NCT01590771|69212118|FG001|Overall Study|Lost to Follow-up|1|||
37732252|NCT01590771|69212117|FG000|Overall Study|Lack of Efficacy|1|||
37732253|NCT01590771|69212118|FG001|Overall Study|Lack of Efficacy|0|||
37732254|NCT01590771|69212117|FG000|Overall Study|Adverse Event|3|||
37844061|NCT01190930|69528433|FG005|Maintenance|Withdrawal by Subject|0|||
37844062|NCT01190930|69528434|FG006|Maintenance|Withdrawal by Subject|2|||
37844063|NCT01190930|69528435|FG007|Maintenance|Withdrawal by Subject|1|||
37844064|NCT01190930|69528436|FG008|Maintenance|Withdrawal by Subject|4|||
37844065|NCT01190930|69528437|FG009|Maintenance|Withdrawal by Subject|1|||
37844066|NCT01190930|69528428|FG000|Maintenance|Refusal|0|||
37844067|NCT01190930|69528429|FG001|Maintenance|Refusal|1|||
37844068|NCT01190930|69528430|FG002|Maintenance|Refusal|0|||
37844069|NCT01190930|69528431|FG003|Maintenance|Refusal|2|||
37844070|NCT01190930|69528432|FG004|Maintenance|Refusal|0|||
37732255|NCT01590771|69212118|FG001|Overall Study|Adverse Event|7|||
37732256|NCT01563237|69212124|FG000|Overall Study|Lost to Follow-up|6|||
37732257|NCT01563237|69212125|FG001|Overall Study|Lost to Follow-up|0|||
37732258|NCT01563237|69212124|FG000|Overall Study|Withdrawal by Subject|1|||
37732259|NCT01563237|69212125|FG001|Overall Study|Withdrawal by Subject|0|||
37732260|NCT01563237|69212124|FG000|Overall Study|Adverse Event|1|||
37732261|NCT01563237|69212125|FG001|Overall Study|Adverse Event|0|||
37732262|NCT01563237|69212124|FG000|Overall Study|Medical Reasons|1|||
37844071|NCT01190930|69528433|FG005|Maintenance|Refusal|4|||
37732263|NCT01563237|69212125|FG001|Overall Study|Medical Reasons|0|||
37732264|NCT01563237|69212124|FG000|Overall Study|Death|1|||
37732265|NCT01563237|69212125|FG001|Overall Study|Death|0|||
37732266|NCT01694433|69212141|FG000|Overall Study|Adverse Event|7|||
37732267|NCT01694433|69212142|FG001|Overall Study|Adverse Event|0|||
37732268|NCT01694433|69212141|FG000|Overall Study|Physician Decision|1|||
37732269|NCT01694433|69212142|FG001|Overall Study|Physician Decision|0|||
37732270|NCT01694433|69212141|FG000|Overall Study|Withdrawal by Subject|3|||
37732271|NCT01694433|69212142|FG001|Overall Study|Withdrawal by Subject|4|||
37732272|NCT01694121|69212150|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
37732273|NCT01694121|69212151|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
37732274|NCT01562613|69212157|FG000|Overall Study|Lost to Follow-up|2|||
37732275|NCT01562613|69212157|FG000|Overall Study|Withdrawal by Subject|2|||
38025767|NCT04206384|69710346|FG000|Overall Study|Withdrawal by Subject|8|||
38025768|NCT04206384|69710346|FG000|Overall Study|Adverse Event|2|||
37732276|NCT01693185|69212163|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
37732277|NCT01693185|69212164|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
37732278|NCT01693029|69212204|FG000|Overall Study|Withdrawal by Subject|15|||
37732279|NCT01693029|69212205|FG001|Overall Study|Withdrawal by Subject|22|||
37732280|NCT01693029|69212204|FG000|Overall Study|Kidney transplantation|7|||
37732281|NCT01693029|69212205|FG001|Overall Study|Kidney transplantation|7|||
37732282|NCT01693029|69212204|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
37732283|NCT01693029|69212205|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
37732284|NCT01693029|69212204|FG000|Overall Study|Protocol Violation|6|||
37732285|NCT01693029|69212205|FG001|Overall Study|Protocol Violation|7|||
37732286|NCT01693029|69212204|FG000|Overall Study|Change in dialysis modality|2|||
37732287|NCT01693029|69212205|FG001|Overall Study|Change in dialysis modality|1|||
37732288|NCT01693029|69212204|FG000|Overall Study|Physician Decision|0|||
37732289|NCT01693029|69212205|FG001|Overall Study|Physician Decision|2|||
37732290|NCT01693029|69212204|FG000|Overall Study|Lost to Follow-up|0|||
37732291|NCT01693029|69212205|FG001|Overall Study|Lost to Follow-up|1|||
37732292|NCT01693029|69212204|FG000|Overall Study|Adverse Event|1|||
37732293|NCT01693029|69212205|FG001|Overall Study|Adverse Event|6|||
37732294|NCT01693029|69212204|FG000|Overall Study|Death|5|||
37732295|NCT01693029|69212205|FG001|Overall Study|Death|8|||
37732296|NCT01693029|69212204|FG000|Overall Study|Non-compliance|2|||
37732297|NCT01693029|69212205|FG001|Overall Study|Non-compliance|1|||
37732298|NCT01589445|69212211|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
37732299|NCT01589445|69212211|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
37732300|NCT01589445|69212211|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
37732301|NCT01589445|69212211|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
37732302|NCT01589445|69212211|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
37732303|NCT01589445|69212211|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
37732304|NCT01589445|69212211|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
37732305|NCT01589445|69212211|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
37732306|NCT01589445|69212211|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
37732307|NCT01589445|69212211|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
37732308|NCT01588509|69212221|FG000|Overall Study|Lost to Follow-up|1|||
37732309|NCT01588509|69212222|FG001|Overall Study|Lost to Follow-up|0|||
37732310|NCT01588353|69212231|FG000|Step2|Withdrawal by Subject|0|||
37732311|NCT01588353|69212232|FG001|Step2|Withdrawal by Subject|1|||
37732312|NCT01588353|69212233|FG002|Step2|Withdrawal by Subject|0|||
37732313|NCT01588353|69212231|FG000|Step3|Adverse Event|0|||
37732314|NCT01588353|69212232|FG001|Step3|Adverse Event|0|||
37732315|NCT01588353|69212233|FG002|Step3|Adverse Event|2|||
37732316|NCT01588197|69212242|FG000|Overall Study|Lack of Efficacy|0|||
37732317|NCT01588197|69212243|FG001|Overall Study|Lack of Efficacy|1|||
37732318|NCT01588197|69212242|FG000|Overall Study|No MRI|1|||
37732319|NCT01588197|69212243|FG001|Overall Study|No MRI|0|||
37732320|NCT01561989|69212251|FG000|Overall Study|accural target not met.|5|||
37916058|NCT00857454|69602874|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
38025769|NCT04051944|69710352|FG000|Overall Study|Study ending|1|||
37732321|NCT01561989|69212252|FG001|Overall Study|accural target not met.|6|||
37732322|NCT01587885|69212267|FG000|Treatment Period 1|Failure to Return|0|||
37732323|NCT01587885|69212268|FG001|Treatment Period 1|Failure to Return|1|||
37732324|NCT01587885|69212267|FG000|Treatment Period 1|Protocol Violation|0|||
37732325|NCT01587885|69212268|FG001|Treatment Period 1|Protocol Violation|2|||
37732326|NCT01587651|69212278|FG000|Overall Study|Adverse Event|0|||
37732327|NCT01587651|69212279|FG001|Overall Study|Adverse Event|1|||
37732328|NCT01587651|69212280|FG002|Overall Study|Adverse Event|0|||
37732329|NCT01587651|69212278|FG000|Overall Study|Protocol Violation|0|||
37732330|NCT01587651|69212279|FG001|Overall Study|Protocol Violation|1|||
37732331|NCT01587651|69212280|FG002|Overall Study|Protocol Violation|1|||
37732332|NCT01587651|69212278|FG000|Overall Study|Withdrawal by Subject|0|||
37732333|NCT01587651|69212279|FG001|Overall Study|Withdrawal by Subject|1|||
37732334|NCT01587651|69212280|FG002|Overall Study|Withdrawal by Subject|0|||
37732335|NCT01691859|69212302|FG000|Overall Study|Adverse Event|19|||
37732336|NCT01691859|69212302|FG000|Overall Study|Lack of Efficacy|11|||
37732337|NCT01691859|69212302|FG000|Overall Study|Protocol Violation|4|||
37732338|NCT01691859|69212302|FG000|Overall Study|Product commercially available|221|||
37732339|NCT01691859|69212302|FG000|Overall Study|Study closed/terminated|50|||
37732340|NCT01691859|69212302|FG000|Overall Study|Lost to Follow-up|5|||
37732341|NCT01691859|69212302|FG000|Overall Study|Physician Decision|6|||
37732342|NCT01691859|69212302|FG000|Overall Study|Withdrawal by Subject|31|||
37732343|NCT01691781|69212346|FG000|Overall Study|Withdrawal by Subject|4|||
37732344|NCT01691781|69212347|FG001|Overall Study|Withdrawal by Subject|3|||
37732345|NCT01691781|69212346|FG000|Overall Study|Physician Decision|1|||
37732346|NCT01691781|69212347|FG001|Overall Study|Physician Decision|1|||
37844072|NCT01190930|69528434|FG006|Maintenance|Refusal|5|||
37844073|NCT01190930|69528435|FG007|Maintenance|Refusal|17|||
37844074|NCT01190930|69528436|FG008|Maintenance|Refusal|13|||
37844075|NCT01190930|69528437|FG009|Maintenance|Refusal|6|||
37844076|NCT01190930|69528428|FG000|Maintenance|second malignant neoplasm|0|||
37844077|NCT01190930|69528429|FG001|Maintenance|second malignant neoplasm|0|||
37844078|NCT01190930|69528430|FG002|Maintenance|second malignant neoplasm|0|||
37844079|NCT01190930|69528431|FG003|Maintenance|second malignant neoplasm|1|||
37844080|NCT01190930|69528432|FG004|Maintenance|second malignant neoplasm|0|||
37844081|NCT01190930|69528433|FG005|Maintenance|second malignant neoplasm|1|||
37844082|NCT01190930|69528434|FG006|Maintenance|second malignant neoplasm|0|||
37844083|NCT01190930|69528435|FG007|Maintenance|second malignant neoplasm|0|||
37844084|NCT01190930|69528436|FG008|Maintenance|second malignant neoplasm|1|||
37844085|NCT01190930|69528437|FG009|Maintenance|second malignant neoplasm|0|||
37844086|NCT01190930|69528428|FG000|Maintenance|Inevaluable|0|||
37844087|NCT01190930|69528429|FG001|Maintenance|Inevaluable|0|||
37844088|NCT01190930|69528430|FG002|Maintenance|Inevaluable|0|||
37844089|NCT01190930|69528431|FG003|Maintenance|Inevaluable|0|||
37844090|NCT01190930|69528432|FG004|Maintenance|Inevaluable|0|||
37844091|NCT01190930|69528433|FG005|Maintenance|Inevaluable|1|||
37844092|NCT01190930|69528434|FG006|Maintenance|Inevaluable|1|||
37844093|NCT01190930|69528435|FG007|Maintenance|Inevaluable|1|||
37844094|NCT01190930|69528436|FG008|Maintenance|Inevaluable|0|||
37844095|NCT01190930|69528437|FG009|Maintenance|Inevaluable|0|||
37844096|NCT01190930|69528428|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
37844097|NCT01190930|69528429|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
37844098|NCT01190930|69528430|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
37844099|NCT01190930|69528431|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
37844100|NCT01190930|69528432|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
37844101|NCT01190930|69528433|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
37844102|NCT01190930|69528434|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
37844103|NCT01190930|69528435|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
37844104|NCT01190930|69528436|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
37844105|NCT01190930|69528437|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
37844106|NCT01190930|69528428|FG000|Maintenance|Relapse|0|||
37844107|NCT01190930|69528429|FG001|Maintenance|Relapse|0|||
37844108|NCT01190930|69528430|FG002|Maintenance|Relapse|0|||
37844109|NCT01190930|69528431|FG003|Maintenance|Relapse|2|||
37916059|NCT00857454|69602874|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
37916060|NCT00525031|69602880|FG000|Overall Study|Disease Progression|1|||
37916061|NCT00525031|69602881|FG001|Overall Study|Disease Progression|1|||
37916062|NCT00524485|69602888|FG000|Overall Study|Withdrawal by Subject|5|||
37916063|NCT00857220|69602892|FG000|Overall Study|Adverse Event|35|||
37916064|NCT00857220|69602892|FG000|Overall Study|Death|1|||
37916065|NCT00857220|69602892|FG000|Overall Study|Lack of Efficacy|11|||
37916066|NCT00857220|69602892|FG000|Overall Study|Lost to Follow-up|30|||
37916067|NCT00857220|69602892|FG000|Overall Study|Physician Decision|4|||
37916068|NCT00857220|69602892|FG000|Overall Study|Protocol Violation|16|||
37916069|NCT00857220|69602892|FG000|Overall Study|Withdrawal by Subject|67|||
37916070|NCT00857220|69602892|FG000|Overall Study|Clinical Hold|6|||
37844110|NCT01190930|69528432|FG004|Maintenance|Relapse|0|||
37916071|NCT00857220|69602892|FG000|Overall Study|Site Closed|5|||
37916072|NCT00857220|69602892|FG000|Overall Study|Miscellaneous|8|||
37844111|NCT01190930|69528433|FG005|Maintenance|Relapse|1|||
37844112|NCT01190930|69528434|FG006|Maintenance|Relapse|6|||
37844113|NCT01190930|69528435|FG007|Maintenance|Relapse|13|||
37844114|NCT01190930|69528436|FG008|Maintenance|Relapse|11|||
37844115|NCT01190930|69528437|FG009|Maintenance|Relapse|11|||
37916073|NCT00524173|69602898|FG000|Overall Study|Lost to Follow-up|0|||
37844116|NCT01190930|69528428|FG000|Maintenance|Still on therapy|0|||
37916074|NCT00524173|69602899|FG001|Overall Study|Lost to Follow-up|1|||
37732347|NCT01691781|69212346|FG000|Overall Study|Protocol Violation|2|||
37732348|NCT01691781|69212347|FG001|Overall Study|Protocol Violation|2|||
37844117|NCT01190930|69528429|FG001|Maintenance|Still on therapy|8|||
37844118|NCT01190930|69528430|FG002|Maintenance|Still on therapy|0|||
37916075|NCT00524173|69602898|FG000|Overall Study|Death|1|||
37916076|NCT00524173|69602899|FG001|Overall Study|Death|0|||
37844119|NCT01190930|69528431|FG003|Maintenance|Still on therapy|29|||
37844120|NCT01190930|69528432|FG004|Maintenance|Still on therapy|0|||
37844121|NCT01190930|69528433|FG005|Maintenance|Still on therapy|0|||
37844122|NCT01190930|69528434|FG006|Maintenance|Still on therapy|0|||
37916077|NCT00524173|69602898|FG000|Overall Study|Had not reached endpoint at study close|4|||
37844123|NCT01190930|69528435|FG007|Maintenance|Still on therapy|0|||
37844124|NCT01190930|69528436|FG008|Maintenance|Still on therapy|0|||
37844125|NCT01190930|69528437|FG009|Maintenance|Still on therapy|0|||
37844126|NCT01163682|69528486|FG000|Overall Study|Lost to Follow-up|6|||
37844127|NCT01163682|69528487|FG001|Overall Study|Lost to Follow-up|9|||
37844128|NCT01047007|69528497|FG000|Overall Study|Adverse Event|0|||
37844129|NCT01047007|69528498|FG001|Overall Study|Adverse Event|2|||
37844130|NCT01047007|69528499|FG002|Overall Study|Adverse Event|1|||
37844131|NCT01047007|69528500|FG003|Overall Study|Adverse Event|0|||
37844132|NCT01047007|69528497|FG000|Overall Study|Progressive Disease|2|||
37844133|NCT01047007|69528498|FG001|Overall Study|Progressive Disease|4|||
37844134|NCT01047007|69528499|FG002|Overall Study|Progressive Disease|1|||
37844135|NCT01047007|69528500|FG003|Overall Study|Progressive Disease|0|||
37844136|NCT00680901|69528525|FG000|Overall Study|Lost to Follow-up|8|||
37844137|NCT00680901|69528526|FG001|Overall Study|Lost to Follow-up|8|||
37844138|NCT00680901|69528525|FG000|Overall Study|Withdrawal by Subject|4|||
37844139|NCT00680901|69528526|FG001|Overall Study|Withdrawal by Subject|13|||
37844140|NCT00680901|69528525|FG000|Overall Study|Physician Decision|0|||
37844141|NCT00680901|69528526|FG001|Overall Study|Physician Decision|1|||
37844142|NCT00680901|69528525|FG000|Overall Study|Ongoing: On Study Treatment|16|||
37844143|NCT00680901|69528526|FG001|Overall Study|Ongoing: On Study Treatment|13|||
37844144|NCT00680901|69528525|FG000|Overall Study|Ongoing: In Follow Up|45|||
37844145|NCT00680901|69528526|FG001|Overall Study|Ongoing: In Follow Up|41|||
37844146|NCT00546351|69528649|FG000|Overall Study|Adverse Event|76|||
37844147|NCT00546351|69528649|FG000|Overall Study|Lack of Efficacy|15|||
37844148|NCT00546351|69528649|FG000|Overall Study|Withdrawal by Subject|109|||
37844149|NCT00546351|69528649|FG000|Overall Study|Lost to Follow-up|9|||
37844150|NCT00546351|69528649|FG000|Overall Study|Protocol Deviation|1|||
37844151|NCT00546351|69528649|FG000|Overall Study|Unsatisfactory compliance|9|||
37844152|NCT00546351|69528649|FG000|Overall Study|Other reasons for premature termination|17|||
37844153|NCT00003838|69528665|FG000|Overall Study|Death|0|||
37844154|NCT00003838|69528666|FG001|Overall Study|Death|12|||
37844155|NCT00003838|69528667|FG002|Overall Study|Death|7|||
37844156|NCT00003838|69528665|FG000|Overall Study|Lost to Follow-up|0|||
37844157|NCT00003838|69528666|FG001|Overall Study|Lost to Follow-up|1|||
37844158|NCT00003838|69528667|FG002|Overall Study|Lost to Follow-up|1|||
37844159|NCT00003838|69528665|FG000|Overall Study|Disease Progression|0|||
37844160|NCT00003838|69528666|FG001|Overall Study|Disease Progression|12|||
37844161|NCT00003838|69528667|FG002|Overall Study|Disease Progression|0|||
37844162|NCT04276883|69528699|FG000|Overall Study|Withdrawal by Subject|2|||
37844163|NCT04276883|69528700|FG001|Overall Study|Withdrawal by Subject|3|||
37844164|NCT04276883|69528701|FG002|Overall Study|Withdrawal by Subject|6|||
37844165|NCT04276883|69528699|FG000|Overall Study|Lost to Follow-up|1|||
37844166|NCT04276883|69528700|FG001|Overall Study|Lost to Follow-up|3|||
37844167|NCT04276883|69528701|FG002|Overall Study|Lost to Follow-up|0|||
37844168|NCT04276883|69528699|FG000|Overall Study|Adverse Event|0|||
37844169|NCT04276883|69528700|FG001|Overall Study|Adverse Event|1|||
37916078|NCT00524173|69602899|FG001|Overall Study|Had not reached endpoint at study close|1|||
37916079|NCT00879710|69602907|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
37916080|NCT00879710|69602908|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
37732349|NCT01691781|69212346|FG000|Overall Study|Adverse Event|0|||
37844170|NCT04276883|69528701|FG002|Overall Study|Adverse Event|0|||
37844171|NCT04276883|69528699|FG000|Overall Study|Randomized in error - di dnot receive treatment|1|||
37844172|NCT04276883|69528700|FG001|Overall Study|Randomized in error - di dnot receive treatment|1|||
37844173|NCT04276883|69528701|FG002|Overall Study|Randomized in error - di dnot receive treatment|0|||
37844174|NCT04099888|69528711|FG000|Overall Study|Study terminated by sponsor|9|||
37844175|NCT04099888|69528712|FG001|Overall Study|Study terminated by sponsor|11|||
37844176|NCT04099888|69528711|FG000|Overall Study|Lost to Follow-up|1|||
37844177|NCT04099888|69528712|FG001|Overall Study|Lost to Follow-up|1|||
37844178|NCT04099888|69528711|FG000|Overall Study|Withdrawal by Subject|5|||
37844179|NCT04099888|69528712|FG001|Overall Study|Withdrawal by Subject|6|||
37844180|NCT04099888|69528711|FG000|Overall Study|Death|5|||
37844181|NCT04099888|69528712|FG001|Overall Study|Death|2|||
37916081|NCT00879710|69602909|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
37844182|NCT04099888|69528711|FG000|Overall Study|Other|1|||
37844183|NCT04099888|69528712|FG001|Overall Study|Other|0|||
37844184|NCT04081389|69528722|FG000|Overall Study|Withdrawal by Subject|0|||
37844185|NCT04081389|69528723|FG001|Overall Study|Withdrawal by Subject|0|||
37732350|NCT01691781|69212347|FG001|Overall Study|Adverse Event|1|||
37732351|NCT01561755|69212355|FG000|Overall Study|Lost to Follow-up|0|||
37732352|NCT01561755|69212356|FG001|Overall Study|Lost to Follow-up|1|||
37732353|NCT01585155|69212376|FG000|Overall Study|Adverse Event|1|||
37732354|NCT01585155|69212376|FG000|Overall Study|Lack of Efficacy|2|||
37732355|NCT01585155|69212376|FG000|Overall Study|Worsening ulcerative colitis|2|||
37732356|NCT01560507|69212383|FG000|Overall Study|Lost to Follow-up|3|||
37732357|NCT01560507|69212384|FG001|Overall Study|Lost to Follow-up|1|||
37732358|NCT01560507|69212385|FG002|Overall Study|Lost to Follow-up|2|||
37732359|NCT01560507|69212383|FG000|Overall Study|Withdrawal by Subject|1|||
37732360|NCT01560507|69212384|FG001|Overall Study|Withdrawal by Subject|1|||
37732361|NCT01560507|69212385|FG002|Overall Study|Withdrawal by Subject|0|||
37732362|NCT01584843|69212400|FG000|First Treatment Period|Adverse Event|0|||
37732363|NCT01584843|69212401|FG001|First Treatment Period|Adverse Event|0|||
37732364|NCT01584843|69212402|FG002|First Treatment Period|Adverse Event|1|||
37732365|NCT01584843|69212403|FG003|First Treatment Period|Adverse Event|0|||
37732366|NCT01584843|69212404|FG004|First Treatment Period|Adverse Event|0|||
37732367|NCT01584843|69212405|FG005|First Treatment Period|Adverse Event|0|||
37732368|NCT01584843|69212400|FG000|First Treatment Period|Protocol Violation|0|||
37732369|NCT01584843|69212401|FG001|First Treatment Period|Protocol Violation|0|||
37732370|NCT01584843|69212402|FG002|First Treatment Period|Protocol Violation|0|||
37732371|NCT01584843|69212403|FG003|First Treatment Period|Protocol Violation|0|||
37732372|NCT01584843|69212404|FG004|First Treatment Period|Protocol Violation|0|||
37732373|NCT01584843|69212405|FG005|First Treatment Period|Protocol Violation|1|||
37732374|NCT01584843|69212400|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
37732375|NCT01584843|69212401|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
37732376|NCT01584843|69212402|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
37732377|NCT01584843|69212403|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
37732378|NCT01584843|69212404|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
37732379|NCT01584843|69212405|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
37732380|NCT01584843|69212400|FG000|Second Treatment Period|Withdrawal by Subject|0|||
37732381|NCT01584843|69212401|FG001|Second Treatment Period|Withdrawal by Subject|0|||
37732382|NCT01584843|69212402|FG002|Second Treatment Period|Withdrawal by Subject|0|||
37732383|NCT01584843|69212403|FG003|Second Treatment Period|Withdrawal by Subject|0|||
37732384|NCT01584843|69212404|FG004|Second Treatment Period|Withdrawal by Subject|0|||
37732385|NCT01584843|69212405|FG005|Second Treatment Period|Withdrawal by Subject|1|||
37732386|NCT01560429|69212423|FG000|Overall Study|Protocol Violation|3|||
37732387|NCT01560429|69212424|FG001|Overall Study|Protocol Violation|6|||
37732388|NCT01582971|69212434|FG000|Overall Study|Death|2|||
37732389|NCT01582971|69212435|FG001|Overall Study|Death|1|||
37732390|NCT01582971|69212434|FG000|Overall Study|Lost to Follow-up|18|||
37732391|NCT01582971|69212435|FG001|Overall Study|Lost to Follow-up|21|||
37844186|NCT04081389|69528724|FG002|Overall Study|Withdrawal by Subject|1|||
37844187|NCT04081389|69528725|FG003|Overall Study|Withdrawal by Subject|0|||
37844188|NCT04032080|69528735|FG000|Overall Study|Death|6|||
37844189|NCT03781323|69528749|FG000|Overall Study|Withdrawal by Subject|1|||
37844190|NCT03729362|69528755|FG000|Overall Study|Withdrawal by Subject|2|||
37844191|NCT03729362|69528756|FG001|Overall Study|Withdrawal by Subject|0|||
37844192|NCT03729362|69528755|FG000|Overall Study|Physician Decision|1|||
37844193|NCT03729362|69528756|FG001|Overall Study|Physician Decision|0|||
37732392|NCT01582971|69212434|FG000|Overall Study|Withdrawal by Subject|4|||
37732393|NCT01582971|69212435|FG001|Overall Study|Withdrawal by Subject|2|||
37732394|NCT01582971|69212434|FG000|Overall Study|Other|15|||
37732395|NCT01582971|69212435|FG001|Overall Study|Other|13|||
37732396|NCT01690299|69212450|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
37732397|NCT01690299|69212451|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
37732398|NCT01690299|69212452|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
37844194|NCT03729362|69528755|FG000|Overall Study|COVID-19 Pandemic|1|||
37844195|NCT03729362|69528756|FG001|Overall Study|COVID-19 Pandemic|0|||
38025770|NCT04051944|69710353|FG001|Overall Study|Study ending|1|||
37732399|NCT01690299|69212453|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
37732400|NCT01690299|69212454|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
37732401|NCT01690299|69212455|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
37732402|NCT01690299|69212450|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
37732403|NCT01690299|69212451|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
37732404|NCT01690299|69212452|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
37732405|NCT01690299|69212453|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
37844196|NCT03729362|69528755|FG000|Overall Study|Discontinued due to COVID-19 related pneumonia|1|||
37732406|NCT01690299|69212454|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
37732407|NCT01690299|69212455|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
37732408|NCT01690299|69212450|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
37732409|NCT01690299|69212451|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
37732410|NCT01690299|69212452|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
37732411|NCT01690299|69212453|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
37732412|NCT01690299|69212454|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
37732413|NCT01690299|69212455|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
37732414|NCT01690299|69212450|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
37732415|NCT01690299|69212451|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
37732416|NCT01690299|69212452|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
37732417|NCT01690299|69212453|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
37732418|NCT01690299|69212454|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
37732419|NCT01690299|69212455|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
37732420|NCT01690299|69212450|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
37732421|NCT01690299|69212451|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
37732422|NCT01690299|69212452|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
37732423|NCT01690299|69212453|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
37732424|NCT01690299|69212454|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
37732425|NCT01690299|69212455|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
37732426|NCT01690299|69212450|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
37732427|NCT01690299|69212451|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
37732428|NCT01690299|69212452|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
37732429|NCT01690299|69212453|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
37732430|NCT01690299|69212454|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
37732431|NCT01690299|69212455|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
37732432|NCT01690299|69212450|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
37732433|NCT01690299|69212451|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
37732434|NCT01690299|69212452|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
37732435|NCT01690299|69212453|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
37732436|NCT01690299|69212454|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
37844197|NCT03729362|69528756|FG001|Overall Study|Discontinued due to COVID-19 related pneumonia|0|||
37844198|NCT03729362|69528755|FG000|Overall Study|Adverse Event|0|||
37844199|NCT03729362|69528756|FG001|Overall Study|Adverse Event|1|||
37732437|NCT01690299|69212455|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
37732438|NCT01690299|69212450|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
37732439|NCT01690299|69212451|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
37732440|NCT01690299|69212452|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
37732441|NCT01690299|69212453|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
37732442|NCT01690299|69212454|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
37732443|NCT01690299|69212455|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
37732444|NCT01690299|69212450|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
37732445|NCT01690299|69212451|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
37732446|NCT01690299|69212452|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
37732447|NCT01690299|69212453|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
37732448|NCT01690299|69212454|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
37732449|NCT01690299|69212455|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
37732450|NCT01690299|69212450|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
37732451|NCT01690299|69212451|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
37732452|NCT01690299|69212452|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
37732453|NCT01690299|69212453|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
37732454|NCT01690299|69212454|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
37844200|NCT03729362|69528755|FG000|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|0|||
37844201|NCT03729362|69528756|FG001|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|2|||
37844202|NCT03340766|69528783|FG000|Overall Study|Death|6|||
37844203|NCT03340766|69528784|FG001|Overall Study|Death|6|||
37844204|NCT03340766|69528785|FG002|Overall Study|Death|2|||
37844205|NCT03340766|69528783|FG000|Overall Study|Withdrawal by Subject|2|||
37844206|NCT03340766|69528784|FG001|Overall Study|Withdrawal by Subject|1|||
37844207|NCT03340766|69528785|FG002|Overall Study|Withdrawal by Subject|2|||
37844208|NCT03340766|69528783|FG000|Overall Study|Continuing Study|3|||
37844209|NCT03340766|69528784|FG001|Overall Study|Continuing Study|3|||
37844210|NCT03340766|69528785|FG002|Overall Study|Continuing Study|5|||
37732455|NCT01690299|69212455|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
37732456|NCT01690143|69212484|FG000|Overall Study|Withdrawal by Subject|1|||
37732457|NCT01559259|69212503|FG000|Overall Study|Withdrawal by Subject|0|||
37732458|NCT01559259|69212504|FG001|Overall Study|Withdrawal by Subject|0|||
37732459|NCT01559259|69212505|FG002|Overall Study|Withdrawal by Subject|0|||
37732460|NCT01559259|69212506|FG003|Overall Study|Withdrawal by Subject|1|||
37732461|NCT01559259|69212507|FG004|Overall Study|Withdrawal by Subject|0|||
37732462|NCT01559259|69212503|FG000|Overall Study|Adverse Event|0|||
37732463|NCT01559259|69212504|FG001|Overall Study|Adverse Event|1|||
37732464|NCT01559259|69212505|FG002|Overall Study|Adverse Event|1|||
37844211|NCT02711852|69528821|FG000|Overall Study|Death|5|||
37844212|NCT02711852|69528821|FG000|Overall Study|Lost to Follow-up|1|||
37844213|NCT02711852|69528821|FG000|Overall Study|Completed follow-up|3|||
37844214|NCT02711852|69528821|FG000|Overall Study|Withdrawal by Subject|1|||
37844215|NCT01977417|69528859|FG000|Overall Study|Adverse Event|1|||
37844216|NCT01977417|69528860|FG001|Overall Study|Adverse Event|0|||
37844217|NCT01977417|69528859|FG000|Overall Study|Withdrawal by Subject|2|||
37844218|NCT01977417|69528860|FG001|Overall Study|Withdrawal by Subject|4|||
37844219|NCT01977417|69528859|FG000|Overall Study|Female enrollment goal met|0|||
37844220|NCT01977417|69528860|FG001|Overall Study|Female enrollment goal met|2|||
37844221|NCT01951885|69528868|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
37844222|NCT01951885|69528869|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
37844223|NCT01951885|69528868|FG000|Overall Study|Adverse Event|1|||
37844224|NCT01951885|69528869|FG001|Overall Study|Adverse Event|0|||
37844225|NCT01951885|69528868|FG000|Overall Study|Withdrawal by Subject|0|||
37844226|NCT01951885|69528869|FG001|Overall Study|Withdrawal by Subject|1|||
37844227|NCT01951885|69528868|FG000|Overall Study|ineligible due to a change in donor|0|||
37844228|NCT01951885|69528869|FG001|Overall Study|ineligible due to a change in donor|1|||
37844229|NCT01951885|69528868|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
37844230|NCT01951885|69528869|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
37844231|NCT00626990|69528879|FG000|Overall Study|Lack of Efficacy|6|||
37844232|NCT00626990|69528880|FG001|Overall Study|Lack of Efficacy|7|||
37844233|NCT00626990|69528881|FG002|Overall Study|Lack of Efficacy|49|||
37844234|NCT00626990|69528882|FG003|Overall Study|Lack of Efficacy|40|||
37844235|NCT00626990|69528879|FG000|Overall Study|Adverse Event|1|||
37732465|NCT01559259|69212506|FG003|Overall Study|Adverse Event|0|||
37732466|NCT01559259|69212507|FG004|Overall Study|Adverse Event|0|||
37732467|NCT01670500|69212531|FG000|Overall Study|Withdrawal by Subject|1|||
37732468|NCT01670500|69212532|FG001|Overall Study|Withdrawal by Subject|0|||
37732469|NCT02400736|69212540|FG000|Overall Study|Lost to Follow-up|6|||
37732470|NCT02400736|69212541|FG001|Overall Study|Lost to Follow-up|6|||
37732471|NCT02400736|69212540|FG000|Overall Study|Withdrawal by Subject|2|||
37732472|NCT02400736|69212541|FG001|Overall Study|Withdrawal by Subject|1|||
37732473|NCT02400736|69212540|FG000|Overall Study|Moved from the area|3|||
37732474|NCT02400736|69212541|FG001|Overall Study|Moved from the area|1|||
37732475|NCT01689519|69212553|FG000|Intent to Treat|Death|157|||
37732476|NCT01689519|69212554|FG001|Intent to Treat|Death|167|||
37732477|NCT01689519|69212553|FG000|Intent to Treat|Lost to Follow-up|4|||
37732478|NCT01689519|69212554|FG001|Intent to Treat|Lost to Follow-up|8|||
37732479|NCT01689519|69212553|FG000|Intent to Treat|Other|2|||
37732480|NCT01689519|69212554|FG001|Intent to Treat|Other|4|||
37732481|NCT01689519|69212553|FG000|Intent to Treat|Physician Decision|4|||
37732482|NCT01689519|69212554|FG001|Intent to Treat|Physician Decision|1|||
37732483|NCT01689519|69212553|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
37732484|NCT01689519|69212554|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
37732485|NCT01689519|69212553|FG000|Intent to Treat|Withdrawal by Subject|21|||
37732486|NCT01689519|69212554|FG001|Intent to Treat|Withdrawal by Subject|20|||
37732487|NCT01689519|69212553|FG000|Safety Population|Death|158|||
37732488|NCT01689519|69212554|FG001|Safety Population|Death|165|||
37844236|NCT00626990|69528880|FG001|Overall Study|Adverse Event|7|||
37844237|NCT00626990|69528881|FG002|Overall Study|Adverse Event|14|||
37844238|NCT00626990|69528882|FG003|Overall Study|Adverse Event|28|||
37844239|NCT00626990|69528879|FG000|Overall Study|Death|0|||
37844240|NCT00626990|69528880|FG001|Overall Study|Death|1|||
37844241|NCT00626990|69528881|FG002|Overall Study|Death|0|||
37844242|NCT00626990|69528882|FG003|Overall Study|Death|0|||
37732489|NCT01689519|69212553|FG000|Safety Population|Lost to Follow-up|4|||
37732490|NCT01689519|69212554|FG001|Safety Population|Lost to Follow-up|8|||
37732491|NCT01689519|69212553|FG000|Safety Population|Other|2|||
37732492|NCT01689519|69212554|FG001|Safety Population|Other|4|||
37732493|NCT01689519|69212553|FG000|Safety Population|Physician Decision|4|||
37732494|NCT01689519|69212554|FG001|Safety Population|Physician Decision|1|||
37732495|NCT01689519|69212553|FG000|Safety Population|Study Terminated By Sponsor|60|||
37732496|NCT01689519|69212554|FG001|Safety Population|Study Terminated By Sponsor|47|||
37844243|NCT00626990|69528879|FG000|Overall Study|Withdrawal by Subject|3|||
37732497|NCT01689519|69212553|FG000|Safety Population|Withdrawal by Subject|20|||
37844244|NCT00626990|69528880|FG001|Overall Study|Withdrawal by Subject|1|||
37732498|NCT01689519|69212554|FG001|Safety Population|Withdrawal by Subject|20|||
37732499|NCT01689363|69212560|FG000|Overall Study|Protocol Violation|0|||
37732500|NCT01689363|69212561|FG001|Overall Study|Protocol Violation|1|||
37732501|NCT01689363|69212562|FG002|Overall Study|Protocol Violation|0|||
37732502|NCT01689363|69212563|FG003|Overall Study|Protocol Violation|0|||
37732503|NCT01689363|69212564|FG004|Overall Study|Protocol Violation|0|||
37732504|NCT01689363|69212565|FG005|Overall Study|Protocol Violation|0|||
37732505|NCT01689363|69212566|FG006|Overall Study|Protocol Violation|0|||
37732506|NCT01689363|69212567|FG007|Overall Study|Protocol Violation|0|||
37732507|NCT01558635|69212583|FG000|Overall Study|Death|1|||
37732508|NCT01558635|69212583|FG000|Overall Study|Withdrawal by Subject|2|||
37732509|NCT01558635|69212583|FG000|Overall Study|Physician Decision|1|||
37732510|NCT01558635|69212583|FG000|Overall Study|Subject received other treatment|1|||
37732511|NCT01558635|69212583|FG000|Overall Study|Reveal XT was explanted|1|||
37732512|NCT00089986|69212597|FG000|Overall Study|Adverse Event|6|||
37732513|NCT00089986|69212598|FG001|Overall Study|Adverse Event|9|||
37732514|NCT00089986|69212599|FG002|Overall Study|Adverse Event|6|||
37732515|NCT00089986|69212597|FG000|Overall Study|Lost to Follow-up|3|||
37732516|NCT00089986|69212598|FG001|Overall Study|Lost to Follow-up|1|||
37732517|NCT00089986|69212599|FG002|Overall Study|Lost to Follow-up|1|||
37732518|NCT00089986|69212597|FG000|Overall Study|Protocol Violation|0|||
37732519|NCT00089986|69212598|FG001|Overall Study|Protocol Violation|1|||
37732520|NCT00089986|69212599|FG002|Overall Study|Protocol Violation|0|||
37732521|NCT00089986|69212597|FG000|Overall Study|Patient transferred to another hospital|2|||
37732522|NCT00089986|69212598|FG001|Overall Study|Patient transferred to another hospital|1|||
37732523|NCT00089986|69212599|FG002|Overall Study|Patient transferred to another hospital|0|||
37732524|NCT00089986|69212597|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
37732525|NCT00089986|69212598|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
37732526|NCT00089986|69212599|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
37732527|NCT00089986|69212597|FG000|Overall Study|Hemohlobin stopping rule|0|||
37732528|NCT00089986|69212598|FG001|Overall Study|Hemohlobin stopping rule|1|||
37844245|NCT00626990|69528881|FG002|Overall Study|Withdrawal by Subject|5|||
37844246|NCT00626990|69528882|FG003|Overall Study|Withdrawal by Subject|11|||
37844247|NCT00626990|69528879|FG000|Overall Study|Protocol Violation|0|||
37844248|NCT00626990|69528880|FG001|Overall Study|Protocol Violation|1|||
37844249|NCT00626990|69528881|FG002|Overall Study|Protocol Violation|1|||
37844250|NCT00626990|69528882|FG003|Overall Study|Protocol Violation|0|||
37844251|NCT00626990|69528879|FG000|Overall Study|Various different reasons/missing|4|||
37844252|NCT00626990|69528880|FG001|Overall Study|Various different reasons/missing|8|||
37844253|NCT00626990|69528881|FG002|Overall Study|Various different reasons/missing|8|||
37844254|NCT00626990|69528882|FG003|Overall Study|Various different reasons/missing|16|||
37844255|NCT00107198|69528896|FG000|Overall Study|Lack of Efficacy|28|||
37844256|NCT00107198|69528896|FG000|Overall Study|Lost to Follow-up|12|||
38025771|NCT04051944|69710352|FG000|Overall Study|Early study termination by participant|1|||
38025772|NCT04051944|69710353|FG001|Overall Study|Early study termination by participant|0|||
38025773|NCT04051944|69710352|FG000|Overall Study|Withdrawal by Subject|2|||
37844257|NCT00107198|69528896|FG000|Overall Study|Protocol Violation|1|||
37844258|NCT00107198|69528896|FG000|Overall Study|Withdrawal by Subject|6|||
37844259|NCT00107198|69528896|FG000|Overall Study|Ineligible|5|||
37844260|NCT01193920|69528919|FG000|Overall Study|Withdrawal by Subject|1|||
37844261|NCT01193920|69528920|FG001|Overall Study|Withdrawal by Subject|0|||
37844262|NCT01193920|69528921|FG002|Overall Study|Withdrawal by Subject|5|||
37844263|NCT01193920|69528922|FG003|Overall Study|Withdrawal by Subject|1|||
37844264|NCT01193920|69528923|FG004|Overall Study|Withdrawal by Subject|3|||
37844265|NCT01193920|69528924|FG005|Overall Study|Withdrawal by Subject|1|||
37844266|NCT01193920|69528925|FG006|Overall Study|Withdrawal by Subject|3|||
37844267|NCT01193920|69528926|FG007|Overall Study|Withdrawal by Subject|0|||
38025774|NCT04051944|69710353|FG001|Overall Study|Withdrawal by Subject|2|||
38025775|NCT04051944|69710352|FG000|Overall Study|Lack of Efficacy|3|||
37844268|NCT01193920|69528927|FG008|Overall Study|Withdrawal by Subject|1|||
37844269|NCT01193920|69528928|FG009|Overall Study|Withdrawal by Subject|0|||
37844270|NCT01193920|69528919|FG000|Overall Study|Lost to Follow-up|1|||
37732529|NCT00089986|69212599|FG002|Overall Study|Hemohlobin stopping rule|0|||
37732530|NCT00089986|69212597|FG000|Overall Study|Investigator decision to withdrew|0|||
37844271|NCT01193920|69528920|FG001|Overall Study|Lost to Follow-up|0|||
37844272|NCT01193920|69528921|FG002|Overall Study|Lost to Follow-up|1|||
37844273|NCT01193920|69528922|FG003|Overall Study|Lost to Follow-up|1|||
37844274|NCT01193920|69528923|FG004|Overall Study|Lost to Follow-up|3|||
37844275|NCT01193920|69528924|FG005|Overall Study|Lost to Follow-up|3|||
37916082|NCT00879710|69602910|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
38025776|NCT04051944|69710353|FG001|Overall Study|Lack of Efficacy|0|||
37732531|NCT00089986|69212598|FG001|Overall Study|Investigator decision to withdrew|1|||
37732532|NCT00089986|69212599|FG002|Overall Study|Investigator decision to withdrew|0|||
37732533|NCT00089986|69212597|FG000|Overall Study|Enrollment in another study|0|||
37732534|NCT00089986|69212598|FG001|Overall Study|Enrollment in another study|1|||
37732535|NCT00089986|69212599|FG002|Overall Study|Enrollment in another study|0|||
37732536|NCT00089986|69212597|FG000|Overall Study|Family decision|0|||
37732537|NCT00089986|69212598|FG001|Overall Study|Family decision|1|||
37732538|NCT00089986|69212599|FG002|Overall Study|Family decision|0|||
37732539|NCT00089986|69212597|FG000|Overall Study|Do not resuscitate (DNR)|0|||
37732540|NCT00089986|69212598|FG001|Overall Study|Do not resuscitate (DNR)|0|||
37732541|NCT00089986|69212599|FG002|Overall Study|Do not resuscitate (DNR)|1|||
37732542|NCT00089986|69212597|FG000|Overall Study|Withdrawal by Subject|3|||
37732543|NCT00089986|69212598|FG001|Overall Study|Withdrawal by Subject|6|||
37732544|NCT00089986|69212599|FG002|Overall Study|Withdrawal by Subject|2|||
37732545|NCT01689207|69212622|FG000|Overall Study|Adverse Event|0|||
37732546|NCT01689207|69212623|FG001|Overall Study|Adverse Event|1|||
37732547|NCT01689207|69212624|FG002|Overall Study|Adverse Event|0|||
37732548|NCT01689207|69212625|FG003|Overall Study|Adverse Event|0|||
37732549|NCT01689207|69212626|FG004|Overall Study|Adverse Event|2|||
37732550|NCT01689207|69212627|FG005|Overall Study|Adverse Event|1|||
37732551|NCT01689207|69212628|FG006|Overall Study|Adverse Event|0|||
37732552|NCT01689207|69212629|FG007|Overall Study|Adverse Event|0|||
37732553|NCT01689207|69212630|FG008|Overall Study|Adverse Event|1|||
37732554|NCT01689207|69212631|FG009|Overall Study|Adverse Event|0|||
37732555|NCT01689207|69212632|FG010|Overall Study|Adverse Event|0|||
37732556|NCT00089284|69212667|FG000|Overall Study|Adverse event before starting treatment|0|||
37732557|NCT00089284|69212668|FG001|Overall Study|Adverse event before starting treatment|0|||
37732558|NCT00089284|69212669|FG002|Overall Study|Adverse event before starting treatment|0|||
37732559|NCT00089284|69212670|FG003|Overall Study|Adverse event before starting treatment|0|||
37732560|NCT00089284|69212671|FG004|Overall Study|Adverse event before starting treatment|0|||
37732561|NCT00089284|69212672|FG005|Overall Study|Adverse event before starting treatment|0|||
37732562|NCT00089284|69212673|FG006|Overall Study|Adverse event before starting treatment|1|||
37732563|NCT01688973|69212697|FG000|Overall Study|Ineligible|2|||
37732564|NCT01688973|69212698|FG001|Overall Study|Ineligible|3|||
37732565|NCT00087646|69212709|FG000|Overall Study|Adverse Event|37|||
37732566|NCT00087646|69212710|FG001|Overall Study|Adverse Event|6|||
37732567|NCT00087646|69212711|FG002|Overall Study|Adverse Event|18|||
37732568|NCT00087646|69212712|FG003|Overall Study|Adverse Event|20|||
37732569|NCT00087646|69212709|FG000|Overall Study|Death|0|||
37732570|NCT00087646|69212710|FG001|Overall Study|Death|1|||
37732571|NCT00087646|69212711|FG002|Overall Study|Death|0|||
37732572|NCT00087646|69212712|FG003|Overall Study|Death|0|||
37732573|NCT00087646|69212709|FG000|Overall Study|Withdrawal by Subject|6|||
37732574|NCT00087646|69212710|FG001|Overall Study|Withdrawal by Subject|1|||
37732575|NCT00087646|69212711|FG002|Overall Study|Withdrawal by Subject|2|||
37732576|NCT00087646|69212712|FG003|Overall Study|Withdrawal by Subject|2|||
37732577|NCT00087646|69212709|FG000|Overall Study|Insufficient therapeutic response|64|||
37732578|NCT00087646|69212710|FG001|Overall Study|Insufficient therapeutic response|24|||
37732579|NCT00087646|69212711|FG002|Overall Study|Insufficient therapeutic response|38|||
37732580|NCT00087646|69212712|FG003|Overall Study|Insufficient therapeutic response|51|||
37732581|NCT00087646|69212709|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
37732582|NCT00087646|69212710|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
37732583|NCT00087646|69212711|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
37732584|NCT00087646|69212712|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
37732585|NCT00087646|69212709|FG000|Overall Study|Failure to Return|5|||
37732586|NCT00087646|69212710|FG001|Overall Study|Failure to Return|2|||
37732587|NCT00087646|69212711|FG002|Overall Study|Failure to Return|2|||
37732588|NCT00087646|69212712|FG003|Overall Study|Failure to Return|3|||
37732589|NCT00087646|69212709|FG000|Overall Study|Administrative/Other|6|||
37732590|NCT00087646|69212710|FG001|Overall Study|Administrative/Other|1|||
37732591|NCT00087646|69212711|FG002|Overall Study|Administrative/Other|1|||
37732592|NCT00087646|69212712|FG003|Overall Study|Administrative/Other|2|||
37732593|NCT00087646|69212709|FG000|Overall Study|Other Protocol Violation|3|||
37732594|NCT00087646|69212710|FG001|Overall Study|Other Protocol Violation|1|||
37732595|NCT00087646|69212711|FG002|Overall Study|Other Protocol Violation|0|||
37732596|NCT00087646|69212712|FG003|Overall Study|Other Protocol Violation|0|||
37732597|NCT00087646|69212709|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
37732598|NCT00087646|69212710|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
37732599|NCT00087646|69212711|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
37732600|NCT00087646|69212712|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
37732601|NCT00087568|69212729|FG000|Overall Study|Adverse Event|4|||
37732602|NCT00087568|69212730|FG001|Overall Study|Adverse Event|0|||
37732603|NCT00087568|69212729|FG000|Overall Study|Withdrawal by Subject|1|||
37732604|NCT00087568|69212730|FG001|Overall Study|Withdrawal by Subject|1|||
37732605|NCT00087568|69212729|FG000|Overall Study|Lost to Follow-up|1|||
37732606|NCT00087568|69212730|FG001|Overall Study|Lost to Follow-up|0|||
37732607|NCT00087568|69212729|FG000|Overall Study|Lack of Efficacy|24|||
37732608|NCT00087568|69212730|FG001|Overall Study|Lack of Efficacy|1|||
37732609|NCT00085540|69212738|FG000|Overall Study|Withdrawal by Subject|0|||
37732610|NCT00085540|69212739|FG001|Overall Study|Withdrawal by Subject|1|||
37732611|NCT00085540|69212738|FG000|Overall Study|Protocol Violation|0|||
37732612|NCT00085540|69212739|FG001|Overall Study|Protocol Violation|1|||
37732613|NCT01688739|69212755|FG000|Overall Study|Administrative Decision|1|||
37732614|NCT01688739|69212756|FG001|Overall Study|Administrative Decision|0|||
37732615|NCT01688739|69212757|FG002|Overall Study|Administrative Decision|0|||
37732616|NCT01688739|69212758|FG003|Overall Study|Administrative Decision|0|||
37732617|NCT01688739|69212759|FG004|Overall Study|Administrative Decision|0|||
37732618|NCT01688739|69212760|FG005|Overall Study|Administrative Decision|0|||
37732619|NCT01688739|69212761|FG006|Overall Study|Administrative Decision|0|||
37732620|NCT01688739|69212762|FG007|Overall Study|Administrative Decision|0|||
37732621|NCT01688739|69212763|FG008|Overall Study|Administrative Decision|0|||
37732622|NCT01688739|69212764|FG009|Overall Study|Administrative Decision|0|||
37732623|NCT00084838|69212794|FG000|Overall Study|Death|1|||
37732624|NCT00084838|69212794|FG000|Overall Study|Adverse Event|2|||
37732625|NCT00084838|69212794|FG000|Overall Study|Withdrawal by Subject|1|||
37732626|NCT00084838|69212794|FG000|Overall Study|Progressive Disease|4|||
37732627|NCT00084838|69212794|FG000|Overall Study|Pt Non-Compliance|1|||
37732628|NCT00084838|69212794|FG000|Overall Study|Ineligible|4|||
37732629|NCT01558089|69212800|FG000|Overall Study|Adverse Event|1|||
37732630|NCT01558089|69212800|FG000|Overall Study|Lack of Efficacy|1|||
37732631|NCT01558089|69212800|FG000|Overall Study|Lost to Follow-up|5|||
37732632|NCT01558089|69212800|FG000|Overall Study|Withdrawal by Subject|6|||
37732633|NCT01581021|69212806|FG000|Overall Study|Lost to Follow-up|4|||
37732634|NCT01581021|69212807|FG001|Overall Study|Lost to Follow-up|6|||
37732635|NCT01581021|69212806|FG000|Overall Study|More than 2 hooks in thoracic|3|||
37732636|NCT01581021|69212807|FG001|Overall Study|More than 2 hooks in thoracic|0|||
37732637|NCT01581021|69212806|FG000|Overall Study|Neuromuscular|2|||
37732638|NCT01581021|69212807|FG001|Overall Study|Neuromuscular|1|||
37732639|NCT01581021|69212806|FG000|Overall Study|Not Randomized|1|||
37732640|NCT01581021|69212807|FG001|Overall Study|Not Randomized|2|||
37732641|NCT01581021|69212806|FG000|Overall Study|Lenke 6 Classification|0|||
37732642|NCT01581021|69212807|FG001|Overall Study|Lenke 6 Classification|1|||
37732643|NCT01581021|69212806|FG000|Overall Study|Lack of Efficacy|0|||
37732644|NCT01581021|69212807|FG001|Overall Study|Lack of Efficacy|1|||
37732645|NCT00084682|69212813|FG000|Overall Study|Withdrawal by Subject|1|||
37732646|NCT01556997|69212821|FG000|Overall Study|Adverse Event|10|||
37732647|NCT01556997|69212822|FG001|Overall Study|Adverse Event|12|||
37732648|NCT01556997|69212823|FG002|Overall Study|Adverse Event|12|||
37732649|NCT01556997|69212821|FG000|Overall Study|Lost to Follow-up|6|||
37732650|NCT01556997|69212822|FG001|Overall Study|Lost to Follow-up|6|||
37732651|NCT01556997|69212823|FG002|Overall Study|Lost to Follow-up|4|||
37732652|NCT01556997|69212821|FG000|Overall Study|Physician Decision|1|||
37732653|NCT01556997|69212822|FG001|Overall Study|Physician Decision|1|||
37732654|NCT01556997|69212823|FG002|Overall Study|Physician Decision|1|||
37732655|NCT01556997|69212821|FG000|Overall Study|Withdrawal by Subject|7|||
37732656|NCT01556997|69212822|FG001|Overall Study|Withdrawal by Subject|6|||
37732657|NCT01556997|69212823|FG002|Overall Study|Withdrawal by Subject|8|||
37732658|NCT01556997|69212821|FG000|Overall Study|Other|2|||
37732659|NCT01556997|69212822|FG001|Overall Study|Other|3|||
37732660|NCT01556997|69212823|FG002|Overall Study|Other|7|||
37732661|NCT00082888|69212834|FG000|Overall Study|Ineligible|1|||
37732662|NCT00082888|69212835|FG001|Overall Study|Ineligible|0|||
37732663|NCT00082888|69212836|FG002|Overall Study|Ineligible|0|||
37732664|NCT00082810|69212845|FG000|Overall Study|Adverse Event|3|||
37732665|NCT00082810|69212845|FG000|Overall Study|Progressive disease|24|||
37732666|NCT00082810|69212845|FG000|Overall Study|Withdrawal by Subject|4|||
37732667|NCT01577745|69212856|FG000|Overall Study|Withdrawal by Subject|0|||
37732668|NCT01577745|69212857|FG001|Overall Study|Withdrawal by Subject|1|||
37732669|NCT01577745|69212858|FG002|Overall Study|Withdrawal by Subject|0|||
37732670|NCT01577745|69212859|FG003|Overall Study|Withdrawal by Subject|3|||
37732671|NCT01577745|69212860|FG004|Overall Study|Withdrawal by Subject|2|||
37732672|NCT01577745|69212861|FG005|Overall Study|Withdrawal by Subject|0|||
37732673|NCT01577745|69212856|FG000|Overall Study|Death|3|||
37732674|NCT01577745|69212857|FG001|Overall Study|Death|2|||
37732675|NCT01577745|69212858|FG002|Overall Study|Death|2|||
37732676|NCT01577745|69212859|FG003|Overall Study|Death|1|||
37732677|NCT01577745|69212860|FG004|Overall Study|Death|1|||
37732678|NCT01577745|69212861|FG005|Overall Study|Death|3|||
37732679|NCT01577745|69212856|FG000|Overall Study|Physician Decision|0|||
37732680|NCT01577745|69212857|FG001|Overall Study|Physician Decision|0|||
37732681|NCT01577745|69212858|FG002|Overall Study|Physician Decision|0|||
37732682|NCT01577745|69212859|FG003|Overall Study|Physician Decision|1|||
37732683|NCT01577745|69212860|FG004|Overall Study|Physician Decision|1|||
37732684|NCT01577745|69212861|FG005|Overall Study|Physician Decision|0|||
37732685|NCT01577745|69212856|FG000|Overall Study|Lost to Follow-up|0|||
37732686|NCT01577745|69212857|FG001|Overall Study|Lost to Follow-up|0|||
37732687|NCT01577745|69212858|FG002|Overall Study|Lost to Follow-up|0|||
37732688|NCT01577745|69212859|FG003|Overall Study|Lost to Follow-up|0|||
37732689|NCT01577745|69212860|FG004|Overall Study|Lost to Follow-up|0|||
37732690|NCT01577745|69212861|FG005|Overall Study|Lost to Follow-up|1|||
37732691|NCT01577745|69212856|FG000|Overall Study|Alternative Therapy|0|||
37732692|NCT01577745|69212857|FG001|Overall Study|Alternative Therapy|0|||
37732693|NCT01577745|69212858|FG002|Overall Study|Alternative Therapy|0|||
37732694|NCT01577745|69212859|FG003|Overall Study|Alternative Therapy|1|||
37732695|NCT01577745|69212860|FG004|Overall Study|Alternative Therapy|1|||
37732696|NCT01577745|69212861|FG005|Overall Study|Alternative Therapy|0|||
37732697|NCT01688037|69212883|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
37732698|NCT01688037|69212884|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
37732699|NCT01688037|69212885|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
37844276|NCT01193920|69528925|FG006|Overall Study|Lost to Follow-up|1|||
37844277|NCT01193920|69528926|FG007|Overall Study|Lost to Follow-up|0|||
37844278|NCT01193920|69528927|FG008|Overall Study|Lost to Follow-up|2|||
37844279|NCT01193920|69528928|FG009|Overall Study|Lost to Follow-up|3|||
37844280|NCT01193920|69528919|FG000|Overall Study|Protocol Violation|1|||
37844281|NCT01193920|69528920|FG001|Overall Study|Protocol Violation|0|||
37844282|NCT01193920|69528921|FG002|Overall Study|Protocol Violation|0|||
37844283|NCT01193920|69528922|FG003|Overall Study|Protocol Violation|0|||
37844284|NCT01193920|69528923|FG004|Overall Study|Protocol Violation|0|||
37844285|NCT01193920|69528924|FG005|Overall Study|Protocol Violation|0|||
37844286|NCT01193920|69528925|FG006|Overall Study|Protocol Violation|0|||
37844287|NCT01193920|69528926|FG007|Overall Study|Protocol Violation|0|||
37844288|NCT01193920|69528927|FG008|Overall Study|Protocol Violation|0|||
37844289|NCT01193920|69528928|FG009|Overall Study|Protocol Violation|0|||
37844290|NCT01193920|69528919|FG000|Overall Study|Death|0|||
37844291|NCT01193920|69528920|FG001|Overall Study|Death|0|||
37844292|NCT01193920|69528921|FG002|Overall Study|Death|0|||
37844293|NCT01193920|69528922|FG003|Overall Study|Death|1|||
37844294|NCT01193920|69528923|FG004|Overall Study|Death|0|||
37844295|NCT01193920|69528924|FG005|Overall Study|Death|0|||
37844296|NCT01193920|69528925|FG006|Overall Study|Death|2|||
37844297|NCT01193920|69528926|FG007|Overall Study|Death|3|||
37844298|NCT01193920|69528927|FG008|Overall Study|Death|2|||
37844299|NCT01193920|69528928|FG009|Overall Study|Death|4|||
37844300|NCT01193920|69528919|FG000|Overall Study|Unable to classify|0|||
37844301|NCT01193920|69528920|FG001|Overall Study|Unable to classify|0|||
37844302|NCT01193920|69528921|FG002|Overall Study|Unable to classify|0|||
37844303|NCT01193920|69528922|FG003|Overall Study|Unable to classify|1|||
37844304|NCT01193920|69528923|FG004|Overall Study|Unable to classify|0|||
37844305|NCT01193920|69528924|FG005|Overall Study|Unable to classify|0|||
37844306|NCT01193920|69528925|FG006|Overall Study|Unable to classify|0|||
37844307|NCT01193920|69528926|FG007|Overall Study|Unable to classify|1|||
37844308|NCT01193920|69528927|FG008|Overall Study|Unable to classify|0|||
37844309|NCT01193920|69528928|FG009|Overall Study|Unable to classify|0|||
37732700|NCT01688037|69212883|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
37732701|NCT01688037|69212884|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
37732702|NCT01688037|69212885|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
37732703|NCT01688037|69212883|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
37732704|NCT01688037|69212884|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
37732705|NCT01688037|69212885|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
37732706|NCT01688037|69212883|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
37732707|NCT01688037|69212884|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
37732708|NCT01688037|69212885|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
37844310|NCT01193686|69528953|FG000|Overall Study|Withdrawal by Subject|4|||
37844311|NCT01193686|69528954|FG001|Overall Study|Withdrawal by Subject|1|||
37844312|NCT01193686|69528953|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
37844313|NCT01193686|69528954|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
37844314|NCT01193608|69528967|FG000|Overall Study|Other|0|||
37844315|NCT01193608|69528968|FG001|Overall Study|Other|1|||
37844316|NCT01193608|69528969|FG002|Overall Study|Other|0|||
37844317|NCT01193608|69528970|FG003|Overall Study|Other|0|||
37844318|NCT01193608|69528971|FG004|Overall Study|Other|0|||
37844319|NCT01193608|69528972|FG005|Overall Study|Other|0|||
37844320|NCT01193608|69528967|FG000|Overall Study|Withdrawal by Subject|0|||
37732709|NCT01688037|69212883|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
37844321|NCT01193608|69528968|FG001|Overall Study|Withdrawal by Subject|1|||
37844322|NCT01193608|69528969|FG002|Overall Study|Withdrawal by Subject|2|||
37844323|NCT01193608|69528970|FG003|Overall Study|Withdrawal by Subject|3|||
37844324|NCT01193608|69528971|FG004|Overall Study|Withdrawal by Subject|3|||
37844325|NCT01193608|69528972|FG005|Overall Study|Withdrawal by Subject|0|||
37844326|NCT01193608|69528967|FG000|Overall Study|Lost to Follow-up|0|||
38025777|NCT04051944|69710352|FG000|Overall Study|Adverse event, non- fatal|1|||
38025778|NCT04051944|69710353|FG001|Overall Study|Adverse event, non- fatal|1|||
38025779|NCT04050618|69710361|FG000|First Intervention|Withdrawal by Subject|2|||
38025780|NCT04050618|69710362|FG001|First Intervention|Withdrawal by Subject|0|||
38025781|NCT04050618|69710361|FG000|Second Intervention|Withdrawal by Subject|1|||
38025782|NCT04050618|69710362|FG001|Second Intervention|Withdrawal by Subject|0|||
38025783|NCT04067492|69710379|FG000|Overall Study|Lost to Follow-up|0|||
38025784|NCT04067492|69710380|FG001|Overall Study|Lost to Follow-up|0|||
38025785|NCT04067492|69710381|FG002|Overall Study|Lost to Follow-up|0|||
38025786|NCT04067492|69710382|FG003|Overall Study|Lost to Follow-up|0|||
38025787|NCT04067492|69710383|FG004|Overall Study|Lost to Follow-up|0|||
38025788|NCT04067492|69710384|FG005|Overall Study|Lost to Follow-up|1|||
38025789|NCT04067492|69710379|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
38025790|NCT04067492|69710380|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
38025791|NCT04067492|69710381|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
38025792|NCT04067492|69710382|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
38025793|NCT04067492|69710383|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
38025794|NCT04067492|69710384|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
38025795|NCT04067492|69710379|FG000|Overall Study|COVID-19 epidemiological situation|0|||
38025796|NCT04067492|69710380|FG001|Overall Study|COVID-19 epidemiological situation|0|||
38025797|NCT04067492|69710381|FG002|Overall Study|COVID-19 epidemiological situation|0|||
38025798|NCT04067492|69710382|FG003|Overall Study|COVID-19 epidemiological situation|1|||
38025799|NCT04067492|69710383|FG004|Overall Study|COVID-19 epidemiological situation|0|||
38025800|NCT04067492|69710384|FG005|Overall Study|COVID-19 epidemiological situation|0|||
38025801|NCT04375878|69710402|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
38025802|NCT04375878|69710403|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
38025803|NCT04375878|69710404|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
38025804|NCT04375878|69710405|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
38025805|NCT04375878|69710406|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
38025806|NCT04375878|69710407|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
38025807|NCT04375878|69710402|FG000|Crossover First and Second Interventions|Adverse Event|0|||
38025808|NCT04375878|69710403|FG001|Crossover First and Second Interventions|Adverse Event|0|||
38025809|NCT04375878|69710404|FG002|Crossover First and Second Interventions|Adverse Event|1|||
38025810|NCT04375878|69710405|FG003|Crossover First and Second Interventions|Adverse Event|0|||
38025811|NCT04375878|69710406|FG004|Crossover First and Second Interventions|Adverse Event|0|||
38025812|NCT04375878|69710407|FG005|Crossover First and Second Interventions|Adverse Event|0|||
38025813|NCT04375878|69710402|FG000|Extension Phase|Withdrawal by Subject|0|||
38025814|NCT04375878|69710403|FG001|Extension Phase|Withdrawal by Subject|0|||
38025815|NCT04375878|69710404|FG002|Extension Phase|Withdrawal by Subject|0|||
38025816|NCT04375878|69710405|FG003|Extension Phase|Withdrawal by Subject|0|||
38025817|NCT04375878|69710406|FG004|Extension Phase|Withdrawal by Subject|1|||
38025818|NCT04375878|69710407|FG005|Extension Phase|Withdrawal by Subject|0|||
38025819|NCT04189224|69710427|FG000|Period 2|Adverse Event|0|||
38025820|NCT04189224|69710428|FG001|Period 2|Adverse Event|1|||
38025821|NCT04186806|69710436|FG000|Period 1: 7 Days|Adverse Event|1|||
38025822|NCT04186806|69710437|FG001|Period 1: 7 Days|Adverse Event|0|||
38025823|NCT04041414|69710446|FG000|Overall Study|Lost to Follow-up|1|||
38025824|NCT04041414|69710447|FG001|Overall Study|Lost to Follow-up|2|||
38025825|NCT04370028|69710456|FG000|Overall Study|Withdrawal by Subject|695|||
38025826|NCT04370028|69710456|FG000|Overall Study|Protocol Violation|9|||
38025827|NCT04370028|69710456|FG000|Overall Study|Adverse Event|3|||
38025828|NCT04037748|69710469|FG000|Treatment Period 1|Withdrawal by Subject|3|||
38025829|NCT04037748|69710470|FG001|Treatment Period 1|Withdrawal by Subject|0|||
38025830|NCT04037748|69710469|FG000|Treatment Period 1|Adverse Event|1|||
38025831|NCT04037748|69710470|FG001|Treatment Period 1|Adverse Event|1|||
38025832|NCT04037748|69710469|FG000|Treatment Period 1|Protocol Violation|4|||
38025833|NCT04037748|69710470|FG001|Treatment Period 1|Protocol Violation|5|||
38025834|NCT04037748|69710469|FG000|Treatment Period 2|Adverse Event|0|||
38025835|NCT04037748|69710470|FG001|Treatment Period 2|Adverse Event|1|||
38025836|NCT04037748|69710469|FG000|Treatment Period 2|Protocol Violation|2|||
38025837|NCT04037748|69710470|FG001|Treatment Period 2|Protocol Violation|0|||
38025838|NCT04036110|69710479|FG000|Overall Study|Lost to Follow-up|3|||
37844327|NCT01193608|69528968|FG001|Overall Study|Lost to Follow-up|0|||
37844328|NCT01193608|69528969|FG002|Overall Study|Lost to Follow-up|0|||
37844329|NCT01193608|69528970|FG003|Overall Study|Lost to Follow-up|0|||
38025839|NCT04036110|69710480|FG001|Overall Study|Lost to Follow-up|2|||
38025840|NCT04036110|69710481|FG002|Overall Study|Lost to Follow-up|1|||
37844330|NCT01193608|69528971|FG004|Overall Study|Lost to Follow-up|1|||
37844331|NCT01193608|69528972|FG005|Overall Study|Lost to Follow-up|2|||
37844332|NCT01193608|69528967|FG000|Overall Study|Adverse Event|0|||
37916083|NCT00879710|69602907|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
37916084|NCT00879710|69602908|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
37916085|NCT00879710|69602909|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
37916086|NCT00879710|69602910|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
37916087|NCT00597506|69602918|FG000|Overall Study|Subject is being followed for survival|1|||
37916088|NCT00708682|69602931|FG000|Infant Series|Adverse Event|1|||
37916089|NCT00708682|69602931|FG000|Infant Series|Lost to Follow-up|4|||
37916090|NCT00708682|69602931|FG000|Infant Series|Protocol Violation|1|||
37916091|NCT00708682|69602931|FG000|Infant Series|Parent/legal guardian request|6|||
37732710|NCT01688037|69212884|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
37732711|NCT01688037|69212885|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
37732712|NCT01688037|69212883|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
37732713|NCT01688037|69212884|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
37844333|NCT01193608|69528968|FG001|Overall Study|Adverse Event|0|||
37844334|NCT01193608|69528969|FG002|Overall Study|Adverse Event|0|||
37844335|NCT01193608|69528970|FG003|Overall Study|Adverse Event|0|||
37844336|NCT01193608|69528971|FG004|Overall Study|Adverse Event|1|||
37844337|NCT01193608|69528972|FG005|Overall Study|Adverse Event|0|||
37844338|NCT01177228|69528995|FG000|Overall Study|Positive tuberculosis test|0|||
37844339|NCT01177228|69528996|FG001|Overall Study|Positive tuberculosis test|1|||
37844340|NCT01177228|69528997|FG002|Overall Study|Positive tuberculosis test|0|||
37732714|NCT01688037|69212885|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
37732715|NCT01688037|69212883|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
37732716|NCT01688037|69212884|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
37732717|NCT01688037|69212885|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
37732718|NCT01688037|69212883|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
37732719|NCT01688037|69212884|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
37732720|NCT01688037|69212885|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
37732721|NCT01688037|69212883|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
37732722|NCT01688037|69212884|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
37732723|NCT01688037|69212885|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
37732724|NCT01688037|69212883|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
37732725|NCT01688037|69212884|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
37844341|NCT01177228|69528998|FG003|Overall Study|Positive tuberculosis test|0|||
37844342|NCT01177228|69528995|FG000|Overall Study|Worsening disease activity|1|||
37844343|NCT01177228|69528996|FG001|Overall Study|Worsening disease activity|0|||
37844344|NCT01177228|69528997|FG002|Overall Study|Worsening disease activity|0|||
37844345|NCT01177228|69528998|FG003|Overall Study|Worsening disease activity|0|||
37844346|NCT01177228|69528995|FG000|Overall Study|Withdrawal by Subject|0|||
37732726|NCT01688037|69212885|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
37732727|NCT01610336|69212908|FG000|Overall Study|Progressive Disease|4|||
37732728|NCT01610336|69212909|FG001|Overall Study|Progressive Disease|6|||
37732729|NCT01610336|69212910|FG002|Overall Study|Progressive Disease|6|||
37732730|NCT01610336|69212911|FG003|Overall Study|Progressive Disease|5|||
37732731|NCT01610336|69212912|FG004|Overall Study|Progressive Disease|3|||
37732732|NCT01610336|69212913|FG005|Overall Study|Progressive Disease|10|||
37732733|NCT01610336|69212914|FG006|Overall Study|Progressive Disease|1|||
37732734|NCT01610336|69212915|FG007|Overall Study|Progressive Disease|6|||
37732735|NCT01610336|69212916|FG008|Overall Study|Progressive Disease|6|||
37732736|NCT01610336|69212917|FG009|Overall Study|Progressive Disease|40|||
37732737|NCT01610336|69212918|FG010|Overall Study|Progressive Disease|36|||
37732738|NCT01610336|69212908|FG000|Overall Study|Adverse Event|0|||
37732739|NCT01610336|69212909|FG001|Overall Study|Adverse Event|0|||
37732740|NCT01610336|69212910|FG002|Overall Study|Adverse Event|0|||
37732741|NCT01610336|69212911|FG003|Overall Study|Adverse Event|1|||
37732742|NCT01610336|69212912|FG004|Overall Study|Adverse Event|1|||
37844347|NCT01177228|69528996|FG001|Overall Study|Withdrawal by Subject|1|||
37844348|NCT01177228|69528997|FG002|Overall Study|Withdrawal by Subject|0|||
37844349|NCT01177228|69528998|FG003|Overall Study|Withdrawal by Subject|0|||
37844350|NCT01193530|69529015|FG000|Overall Study|Withdrawal by Subject|2|||
37732743|NCT01610336|69212913|FG005|Overall Study|Adverse Event|1|||
37732744|NCT01610336|69212914|FG006|Overall Study|Adverse Event|0|||
37844351|NCT01193530|69529016|FG001|Overall Study|Withdrawal by Subject|2|||
37844352|NCT01193530|69529015|FG000|Overall Study|Began Contraindicated Therapy|1|||
37844353|NCT01193530|69529016|FG001|Overall Study|Began Contraindicated Therapy|0|||
37732745|NCT01610336|69212915|FG007|Overall Study|Adverse Event|0|||
37732746|NCT01610336|69212916|FG008|Overall Study|Adverse Event|2|||
37732747|NCT01610336|69212917|FG009|Overall Study|Adverse Event|8|||
37844354|NCT01193530|69529015|FG000|Overall Study|Lost Light Box|0|||
37844355|NCT01193530|69529016|FG001|Overall Study|Lost Light Box|1|||
37916092|NCT00708682|69602931|FG000|Infant Series|Failed to return|2|||
37916093|NCT00708682|69602931|FG000|Infant Series|Other|19|||
37916094|NCT00708682|69602931|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
37732748|NCT01610336|69212918|FG010|Overall Study|Adverse Event|6|||
37732749|NCT01610336|69212908|FG000|Overall Study|Subject/Guardian decision|1|||
37732750|NCT01610336|69212909|FG001|Overall Study|Subject/Guardian decision|1|||
37732751|NCT01610336|69212910|FG002|Overall Study|Subject/Guardian decision|0|||
37732752|NCT01610336|69212911|FG003|Overall Study|Subject/Guardian decision|1|||
37732753|NCT01610336|69212912|FG004|Overall Study|Subject/Guardian decision|0|||
37732754|NCT01610336|69212913|FG005|Overall Study|Subject/Guardian decision|0|||
37732755|NCT01610336|69212914|FG006|Overall Study|Subject/Guardian decision|0|||
37732756|NCT01610336|69212915|FG007|Overall Study|Subject/Guardian decision|1|||
37732757|NCT01610336|69212916|FG008|Overall Study|Subject/Guardian decision|0|||
37732758|NCT01610336|69212917|FG009|Overall Study|Subject/Guardian decision|2|||
37732759|NCT01610336|69212918|FG010|Overall Study|Subject/Guardian decision|2|||
37732760|NCT01610336|69212908|FG000|Overall Study|Death|0|||
37732761|NCT01610336|69212909|FG001|Overall Study|Death|0|||
37732762|NCT01610336|69212910|FG002|Overall Study|Death|0|||
37732763|NCT01610336|69212911|FG003|Overall Study|Death|0|||
37732764|NCT01610336|69212912|FG004|Overall Study|Death|0|||
37732765|NCT01610336|69212913|FG005|Overall Study|Death|1|||
37732766|NCT01610336|69212914|FG006|Overall Study|Death|3|||
37732767|NCT01610336|69212915|FG007|Overall Study|Death|0|||
37732768|NCT01610336|69212916|FG008|Overall Study|Death|0|||
37732769|NCT01610336|69212917|FG009|Overall Study|Death|1|||
37732770|NCT01610336|69212918|FG010|Overall Study|Death|2|||
37732771|NCT01610336|69212908|FG000|Overall Study|Non-Compliance with study treatment|0|||
37732772|NCT01610336|69212909|FG001|Overall Study|Non-Compliance with study treatment|0|||
37732773|NCT01610336|69212910|FG002|Overall Study|Non-Compliance with study treatment|0|||
37732774|NCT01610336|69212911|FG003|Overall Study|Non-Compliance with study treatment|0|||
37732775|NCT01610336|69212912|FG004|Overall Study|Non-Compliance with study treatment|0|||
37732776|NCT01610336|69212913|FG005|Overall Study|Non-Compliance with study treatment|0|||
37732777|NCT01610336|69212914|FG006|Overall Study|Non-Compliance with study treatment|0|||
37844356|NCT01193530|69529015|FG000|Overall Study|Returned home - out of state|0|||
37844357|NCT01193530|69529016|FG001|Overall Study|Returned home - out of state|1|||
37732778|NCT01610336|69212915|FG007|Overall Study|Non-Compliance with study treatment|0|||
37732779|NCT01610336|69212916|FG008|Overall Study|Non-Compliance with study treatment|0|||
37844358|NCT01193530|69529015|FG000|Overall Study|Non-Compliance|0|||
37732780|NCT01610336|69212917|FG009|Overall Study|Non-Compliance with study treatment|1|||
37732781|NCT01610336|69212918|FG010|Overall Study|Non-Compliance with study treatment|0|||
37732782|NCT01610336|69212908|FG000|Overall Study|Physician Decision|0|||
37732783|NCT01610336|69212909|FG001|Overall Study|Physician Decision|0|||
37732784|NCT01610336|69212910|FG002|Overall Study|Physician Decision|0|||
37732785|NCT01610336|69212911|FG003|Overall Study|Physician Decision|0|||
37732786|NCT01610336|69212912|FG004|Overall Study|Physician Decision|0|||
37732787|NCT01610336|69212913|FG005|Overall Study|Physician Decision|0|||
37732788|NCT01610336|69212914|FG006|Overall Study|Physician Decision|1|||
37732789|NCT01610336|69212915|FG007|Overall Study|Physician Decision|0|||
37732790|NCT01610336|69212916|FG008|Overall Study|Physician Decision|0|||
37732791|NCT01610336|69212917|FG009|Overall Study|Physician Decision|0|||
37732792|NCT01610336|69212918|FG010|Overall Study|Physician Decision|0|||
37732793|NCT01610336|69212908|FG000|Overall Study|Protocol Deviation|0|||
37732794|NCT01610336|69212909|FG001|Overall Study|Protocol Deviation|0|||
37732795|NCT01610336|69212910|FG002|Overall Study|Protocol Deviation|0|||
37732796|NCT01610336|69212911|FG003|Overall Study|Protocol Deviation|0|||
37732797|NCT01610336|69212912|FG004|Overall Study|Protocol Deviation|0|||
37732798|NCT01610336|69212913|FG005|Overall Study|Protocol Deviation|0|||
37732799|NCT01610336|69212914|FG006|Overall Study|Protocol Deviation|0|||
37732800|NCT01610336|69212915|FG007|Overall Study|Protocol Deviation|0|||
37732801|NCT01610336|69212916|FG008|Overall Study|Protocol Deviation|0|||
37732802|NCT01610336|69212917|FG009|Overall Study|Protocol Deviation|1|||
37732803|NCT01610336|69212918|FG010|Overall Study|Protocol Deviation|0|||
37732804|NCT01610336|69212908|FG000|Overall Study|Transfer to another trial|0|||
37732805|NCT01610336|69212909|FG001|Overall Study|Transfer to another trial|0|||
37732806|NCT01610336|69212910|FG002|Overall Study|Transfer to another trial|0|||
37732807|NCT01610336|69212911|FG003|Overall Study|Transfer to another trial|0|||
37732808|NCT01610336|69212912|FG004|Overall Study|Transfer to another trial|0|||
37732809|NCT01610336|69212913|FG005|Overall Study|Transfer to another trial|0|||
37732810|NCT01610336|69212914|FG006|Overall Study|Transfer to another trial|0|||
37732811|NCT01610336|69212915|FG007|Overall Study|Transfer to another trial|0|||
37732812|NCT01610336|69212916|FG008|Overall Study|Transfer to another trial|0|||
37732813|NCT01610336|69212917|FG009|Overall Study|Transfer to another trial|0|||
37732814|NCT01610336|69212918|FG010|Overall Study|Transfer to another trial|1|||
37732815|NCT01613222|69212946|FG000|Overall Study|Physician Decision|1|||
37732816|NCT01613222|69212946|FG000|Overall Study|Unable to place arterial line|1|||
37732817|NCT01613222|69212946|FG000|Overall Study|Reused disposable sensors|10|||
37732818|NCT01612676|69212993|FG000|Overall Study|Adverse Event|2|||
37732819|NCT01612676|69212994|FG001|Overall Study|Adverse Event|3|||
37732820|NCT01612676|69212995|FG002|Overall Study|Adverse Event|1|||
37732821|NCT01612676|69212996|FG003|Overall Study|Adverse Event|3|||
37732822|NCT01612676|69212993|FG000|Overall Study|Protocol Violation|0|||
37732823|NCT01612676|69212994|FG001|Overall Study|Protocol Violation|1|||
37732824|NCT01612676|69212995|FG002|Overall Study|Protocol Violation|0|||
37844359|NCT01193530|69529016|FG001|Overall Study|Non-Compliance|1|||
37844360|NCT00107172|69529024|FG000|Overall Study|Withdrawal by Subject|1|||
37844361|NCT00107172|69529025|FG001|Overall Study|Withdrawal by Subject|0|||
37844362|NCT00107172|69529024|FG000|Overall Study|Death|0|||
37844363|NCT00107172|69529025|FG001|Overall Study|Death|2|||
37844364|NCT00107172|69529024|FG000|Overall Study|Other Reason|4|||
37844365|NCT00107172|69529025|FG001|Overall Study|Other Reason|3|||
37844366|NCT01680965|69529039|FG000|Overall Study|Death|0|||
37844367|NCT01680965|69529040|FG001|Overall Study|Death|0|||
37844368|NCT01680965|69529041|FG002|Overall Study|Death|0|||
37844369|NCT01680965|69529042|FG003|Overall Study|Death|6|||
37844370|NCT01339923|69529057|FG000|Overall Study|Adverse Event|1|||
37844371|NCT01339923|69529058|FG001|Overall Study|Adverse Event|1|||
37844372|NCT01339923|69529059|FG002|Overall Study|Adverse Event|1|||
37844373|NCT01339923|69529060|FG003|Overall Study|Adverse Event|0|||
37844374|NCT01339923|69529061|FG004|Overall Study|Adverse Event|0|||
37732825|NCT01612676|69212996|FG003|Overall Study|Protocol Violation|0|||
37844375|NCT01339923|69529062|FG005|Overall Study|Adverse Event|0|||
37844376|NCT01339923|69529063|FG006|Overall Study|Adverse Event|1|||
37732826|NCT01869764|69213010|FG000|Overall Study|Withdrawal by Subject|0|||
37732827|NCT01869764|69213011|FG001|Overall Study|Withdrawal by Subject|2|||
37732828|NCT01842620|69213017|FG000|Period 1|Withdrawal by Subject|1|||
37732829|NCT01842620|69213018|FG001|Period 1|Withdrawal by Subject|0|||
37732830|NCT01931839|69213044|FG000|Overall Study|Death|0|||
37844377|NCT01339923|69529057|FG000|Overall Study|Inappropriate Enrollment|1|||
37844378|NCT01339923|69529058|FG001|Overall Study|Inappropriate Enrollment|0|||
37732831|NCT01931839|69213045|FG001|Overall Study|Death|1|||
37732832|NCT01931839|69213046|FG002|Overall Study|Death|2|||
37732833|NCT01931839|69213047|FG003|Overall Study|Death|0|||
37732834|NCT01931839|69213048|FG004|Overall Study|Death|0|||
37732835|NCT01931839|69213049|FG005|Overall Study|Death|0|||
37732836|NCT01931839|69213050|FG006|Overall Study|Death|0|||
37732837|NCT01931839|69213044|FG000|Overall Study|Physician Decision|1|||
37732838|NCT01931839|69213045|FG001|Overall Study|Physician Decision|0|||
37732839|NCT01931839|69213046|FG002|Overall Study|Physician Decision|1|||
37732840|NCT01931839|69213047|FG003|Overall Study|Physician Decision|0|||
37732841|NCT01931839|69213048|FG004|Overall Study|Physician Decision|0|||
37732842|NCT01931839|69213049|FG005|Overall Study|Physician Decision|0|||
37844379|NCT01339923|69529059|FG002|Overall Study|Inappropriate Enrollment|0|||
37844380|NCT01339923|69529060|FG003|Overall Study|Inappropriate Enrollment|0|||
37844381|NCT01339923|69529061|FG004|Overall Study|Inappropriate Enrollment|0|||
37844382|NCT01339923|69529062|FG005|Overall Study|Inappropriate Enrollment|1|||
37844383|NCT01339923|69529063|FG006|Overall Study|Inappropriate Enrollment|0|||
37844384|NCT01339923|69529057|FG000|Overall Study|Lost to Follow-up|4|||
37844385|NCT01339923|69529058|FG001|Overall Study|Lost to Follow-up|4|||
37844386|NCT01339923|69529059|FG002|Overall Study|Lost to Follow-up|0|||
37844387|NCT01339923|69529060|FG003|Overall Study|Lost to Follow-up|3|||
37844388|NCT01339923|69529061|FG004|Overall Study|Lost to Follow-up|1|||
37844389|NCT01339923|69529062|FG005|Overall Study|Lost to Follow-up|1|||
37844390|NCT01339923|69529063|FG006|Overall Study|Lost to Follow-up|5|||
37844391|NCT01339923|69529057|FG000|Overall Study|Protocol Violation|0|||
37844392|NCT01339923|69529058|FG001|Overall Study|Protocol Violation|0|||
37844393|NCT01339923|69529059|FG002|Overall Study|Protocol Violation|0|||
37732843|NCT01931839|69213050|FG006|Overall Study|Physician Decision|1|||
37732844|NCT01931839|69213044|FG000|Overall Study|Withdrawal of consent|0|||
37732845|NCT01931839|69213045|FG001|Overall Study|Withdrawal of consent|0|||
37732846|NCT01931839|69213046|FG002|Overall Study|Withdrawal of consent|0|||
37732847|NCT01931839|69213047|FG003|Overall Study|Withdrawal of consent|0|||
37732848|NCT01931839|69213048|FG004|Overall Study|Withdrawal of consent|1|||
37732849|NCT01931839|69213049|FG005|Overall Study|Withdrawal of consent|0|||
37732850|NCT01931839|69213050|FG006|Overall Study|Withdrawal of consent|0|||
37732851|NCT01931839|69213044|FG000|Overall Study|Adverse Event|9|||
37732852|NCT01931839|69213045|FG001|Overall Study|Adverse Event|4|||
37732853|NCT01931839|69213046|FG002|Overall Study|Adverse Event|1|||
37732854|NCT01931839|69213047|FG003|Overall Study|Adverse Event|3|||
37732855|NCT01931839|69213048|FG004|Overall Study|Adverse Event|0|||
37732856|NCT01931839|69213049|FG005|Overall Study|Adverse Event|0|||
37732857|NCT01931839|69213050|FG006|Overall Study|Adverse Event|1|||
37732858|NCT01931839|69213044|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
37732859|NCT01931839|69213045|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
37732860|NCT01931839|69213046|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
37732861|NCT01931839|69213047|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
37732862|NCT01931839|69213048|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
37732863|NCT01931839|69213049|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
37732864|NCT01931839|69213050|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
37732865|NCT01931839|69213044|FG000|Overall Study|Other non-compliance|15|||
37732866|NCT01931839|69213045|FG001|Overall Study|Other non-compliance|9|||
37732867|NCT01931839|69213046|FG002|Overall Study|Other non-compliance|12|||
37732868|NCT01931839|69213047|FG003|Overall Study|Other non-compliance|3|||
37732869|NCT01931839|69213048|FG004|Overall Study|Other non-compliance|0|||
37732870|NCT01931839|69213049|FG005|Overall Study|Other non-compliance|3|||
37732871|NCT01931839|69213050|FG006|Overall Study|Other non-compliance|0|||
37732872|NCT01931839|69213044|FG000|Overall Study|Lost to Follow-up|1|||
37732873|NCT01931839|69213045|FG001|Overall Study|Lost to Follow-up|2|||
37732874|NCT01931839|69213046|FG002|Overall Study|Lost to Follow-up|4|||
37732875|NCT01931839|69213047|FG003|Overall Study|Lost to Follow-up|5|||
37732876|NCT01931839|69213048|FG004|Overall Study|Lost to Follow-up|0|||
37732877|NCT01931839|69213049|FG005|Overall Study|Lost to Follow-up|0|||
37732878|NCT01931839|69213050|FG006|Overall Study|Lost to Follow-up|0|||
37732879|NCT01931839|69213044|FG000|Overall Study|Other|4|||
37732880|NCT01931839|69213045|FG001|Overall Study|Other|2|||
37732881|NCT01931839|69213046|FG002|Overall Study|Other|6|||
37732882|NCT01931839|69213047|FG003|Overall Study|Other|0|||
37732883|NCT01931839|69213048|FG004|Overall Study|Other|0|||
37732884|NCT01931839|69213049|FG005|Overall Study|Other|0|||
37732885|NCT01931839|69213050|FG006|Overall Study|Other|0|||
37732886|NCT01842308|69213075|FG000|Overall Study|Withdrawal by Subject|0|||
37732887|NCT01842308|69213076|FG001|Overall Study|Withdrawal by Subject|0|||
37732888|NCT01842308|69213077|FG002|Overall Study|Withdrawal by Subject|0|||
37732889|NCT01842308|69213078|FG003|Overall Study|Withdrawal by Subject|0|||
37732890|NCT01842308|69213079|FG004|Overall Study|Withdrawal by Subject|1|||
37844394|NCT01339923|69529060|FG003|Overall Study|Protocol Violation|0|||
37916095|NCT00708682|69602931|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
37916096|NCT00708682|69602931|FG000|Toddler Dose|Lost to Follow-up|3|||
37732891|NCT01931059|69213094|FG000|Day 1|Pregnancy|0|||
37732892|NCT01931059|69213095|FG001|Day 1|Pregnancy|1|||
37732893|NCT01931059|69213094|FG000|Day3|Lost to Follow-up|1|||
37732894|NCT01931059|69213095|FG001|Day3|Lost to Follow-up|0|||
37732895|NCT01841762|69213107|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
37732896|NCT01841762|69213107|FG000|Treatment Period|Adverse Event|16|||
37844395|NCT01339923|69529061|FG004|Overall Study|Protocol Violation|0|||
37844396|NCT01339923|69529062|FG005|Overall Study|Protocol Violation|3|||
37732897|NCT01841762|69213107|FG000|Treatment Period|Death|1|||
37732898|NCT01841762|69213107|FG000|Treatment Period|Withdrawal by Subject|7|||
37732899|NCT01841762|69213107|FG000|Treatment Period|Lost to Follow-up|1|||
37732900|NCT01841762|69213107|FG000|Treatment Period|Physician Decision|2|||
37732901|NCT01841762|69213107|FG000|Treatment Period|Other, including non-compliance|5|||
37732902|NCT01841762|69213107|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
37732903|NCT01841762|69213107|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
37732904|NCT01841762|69213107|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
37732905|NCT01841762|69213107|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
37732906|NCT01841060|69213124|FG000|Overall Study|Protocol Violation|10|||
37732907|NCT01814696|69213130|FG000|Overall Study|Withdrawal by Subject|1|||
37732908|NCT01814696|69213131|FG001|Overall Study|Withdrawal by Subject|0|||
37732909|NCT01814696|69213130|FG000|Overall Study|Randomized to wrong group|1|||
37732910|NCT01814696|69213131|FG001|Overall Study|Randomized to wrong group|0|||
37732911|NCT01970371|69213140|FG000|Overall Study|Death|8|||
37732912|NCT01970371|69213141|FG001|Overall Study|Death|13|||
37732913|NCT01970371|69213142|FG002|Overall Study|Death|12|||
37732914|NCT01970371|69213140|FG000|Overall Study|Lost to Follow-up|0|||
37732915|NCT01970371|69213141|FG001|Overall Study|Lost to Follow-up|0|||
37732916|NCT01970371|69213142|FG002|Overall Study|Lost to Follow-up|1|||
37732917|NCT01868594|69213163|FG000|Overall Study|Do not meet inclusion criteria|4|||
37732918|NCT01868594|69213164|FG001|Overall Study|Do not meet inclusion criteria|3|||
37844397|NCT01339923|69529063|FG006|Overall Study|Protocol Violation|1|||
37844398|NCT01339923|69529057|FG000|Overall Study|Unable to Classify|1|||
37844399|NCT01339923|69529058|FG001|Overall Study|Unable to Classify|0|||
37844400|NCT01339923|69529059|FG002|Overall Study|Unable to Classify|1|||
37844401|NCT01339923|69529060|FG003|Overall Study|Unable to Classify|0|||
37844402|NCT01339923|69529061|FG004|Overall Study|Unable to Classify|0|||
37844403|NCT01339923|69529062|FG005|Overall Study|Unable to Classify|1|||
37844404|NCT01339923|69529063|FG006|Overall Study|Unable to Classify|5|||
37844405|NCT01339923|69529057|FG000|Overall Study|Withdrawal by Subject|7|||
37844406|NCT01339923|69529058|FG001|Overall Study|Withdrawal by Subject|11|||
37844407|NCT01339923|69529059|FG002|Overall Study|Withdrawal by Subject|6|||
37844408|NCT01339923|69529060|FG003|Overall Study|Withdrawal by Subject|1|||
37916097|NCT00708682|69602931|FG000|Toddler Dose|Failed to Return|4|||
37916098|NCT00712348|69602937|FG000|Overall Study|Withdrawal by Subject|1|||
37916099|NCT00881504|69602941|FG000|Overall Study|Withdrawal by Subject|1|||
37916100|NCT01936831|69602954|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
37916101|NCT01936831|69602955|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
37916102|NCT01936831|69602956|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
37916103|NCT01936831|69602957|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
37916104|NCT01936831|69602958|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
37916105|NCT01936831|69602959|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
37844409|NCT01339923|69529061|FG004|Overall Study|Withdrawal by Subject|4|||
37844410|NCT01339923|69529062|FG005|Overall Study|Withdrawal by Subject|3|||
37844411|NCT01339923|69529063|FG006|Overall Study|Withdrawal by Subject|2|||
37844412|NCT01380093|69529096|FG000|Naloxone Challenge Phase|Screen failures|21|||
37844413|NCT01380093|69529097|FG001|Naloxone Challenge Phase|Screen failures|0|||
37844414|NCT01380093|69529098|FG002|Naloxone Challenge Phase|Screen failures|0|||
37844415|NCT01380093|69529099|FG003|Naloxone Challenge Phase|Screen failures|0|||
37844416|NCT01380093|69529100|FG004|Naloxone Challenge Phase|Screen failures|0|||
37844417|NCT01380093|69529101|FG005|Naloxone Challenge Phase|Screen failures|0|||
37844418|NCT01380093|69529102|FG006|Naloxone Challenge Phase|Screen failures|0|||
37844419|NCT01380093|69529103|FG007|Naloxone Challenge Phase|Screen failures|0|||
37844420|NCT01380093|69529104|FG008|Naloxone Challenge Phase|Screen failures|0|||
37844421|NCT01380093|69529096|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
37844422|NCT01380093|69529097|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
37844423|NCT01380093|69529098|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
37844424|NCT01380093|69529099|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
37844425|NCT01380093|69529100|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
37844426|NCT01380093|69529101|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
37844427|NCT01380093|69529102|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
37844428|NCT01380093|69529103|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
37844429|NCT01380093|69529104|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
37732919|NCT01616953|69213174|FG000|Overall Study|Lost to Follow-up|1|||
37732920|NCT01616953|69213175|FG001|Overall Study|Lost to Follow-up|0|||
37732921|NCT01616953|69213174|FG000|Overall Study|lack of bone and soft tissue|1|||
37732922|NCT01616953|69213175|FG001|Overall Study|lack of bone and soft tissue|0|||
37732923|NCT01867658|69213181|FG000|Overall Study|Withdrawal by Subject|6|||
37732924|NCT01867658|69213181|FG000|Overall Study|Death|2|||
37732925|NCT01867658|69213181|FG000|Overall Study|Subject could not be contacted|1|||
37732926|NCT01867580|69213187|FG000|Overall Study|Withdrawal by Subject|2|||
37732927|NCT01867580|69213188|FG001|Overall Study|Withdrawal by Subject|3|||
37732928|NCT01867580|69213187|FG000|Overall Study|Physician Decision|17|||
37732929|NCT01867580|69213188|FG001|Overall Study|Physician Decision|12|||
37732930|NCT01867580|69213187|FG000|Overall Study|Lost to Follow-up|3|||
37732931|NCT01867580|69213188|FG001|Overall Study|Lost to Follow-up|5|||
37732932|NCT01867580|69213187|FG000|Overall Study|Sponsor terminated study|1|||
37732933|NCT01867580|69213188|FG001|Overall Study|Sponsor terminated study|0|||
37732934|NCT01867580|69213187|FG000|Overall Study|Missed follow-up assessment|2|||
37732935|NCT01867580|69213188|FG001|Overall Study|Missed follow-up assessment|1|||
37732936|NCT01867580|69213187|FG000|Overall Study|Interruption to therapy|3|||
37732937|NCT01867580|69213188|FG001|Overall Study|Interruption to therapy|0|||
37732938|NCT01867580|69213187|FG000|Overall Study|Osteomyelitis|0|||
37732939|NCT01867580|69213188|FG001|Overall Study|Osteomyelitis|1|||
37732940|NCT01867580|69213187|FG000|Overall Study|Continuation of therapy|0|||
37732941|NCT01867580|69213188|FG001|Overall Study|Continuation of therapy|1|||
37732942|NCT01867580|69213187|FG000|Overall Study|Wound recurrence|0|||
37732943|NCT01867580|69213188|FG001|Overall Study|Wound recurrence|1|||
37732944|NCT01839656|69213202|FG000|Overall Study|Withdrawal by Subject|1|||
37732945|NCT01839656|69213203|FG001|Overall Study|Withdrawal by Subject|1|||
37732946|NCT01839656|69213202|FG000|Overall Study|Adverse event, serious fatal|1|||
37732947|NCT01839656|69213203|FG001|Overall Study|Adverse event, serious fatal|4|||
37732948|NCT01839656|69213202|FG000|Overall Study|Early study closure|0|||
37732949|NCT01839656|69213203|FG001|Overall Study|Early study closure|11|||
37732950|NCT01839656|69213202|FG000|Overall Study|Adverse Event|1|||
37732951|NCT01839656|69213203|FG001|Overall Study|Adverse Event|0|||
37732952|NCT01839188|69213209|FG000|Overall Study|Withdrawal by Subject|1|||
37732953|NCT01838876|69213218|FG000|Overall Study|Adverse Event|49|||
37844430|NCT01380093|69529096|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
37844431|NCT01380093|69529097|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
37844432|NCT01380093|69529098|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
37844433|NCT01380093|69529099|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
37844434|NCT01380093|69529100|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
37844435|NCT01380093|69529101|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
37844436|NCT01380093|69529102|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
37844437|NCT01380093|69529103|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
37844438|NCT01380093|69529104|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
37844439|NCT01380093|69529096|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
37916106|NCT01936831|69602960|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
37916107|NCT01936831|69602961|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
37732954|NCT01838876|69213218|FG000|Overall Study|Insufficient Therapeutic Response|10|||
37732955|NCT01838876|69213218|FG000|Overall Study|Protocol Violation|34|||
37732956|NCT01838876|69213218|FG000|Overall Study|Withdrawal of Consent|33|||
37732957|NCT01838876|69213218|FG000|Overall Study|Lost to Follow-up|21|||
37732958|NCT01838876|69213218|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
37732959|NCT01838876|69213218|FG000|Overall Study|Reason not Specified|7|||
37732960|NCT01838876|69213218|FG000|Overall Study|Did not meet eligibility criteria|78|||
37732961|NCT01838642|69213233|FG000|Overall Study|Died on study|1|||
37732962|NCT01611194|69213240|FG000|Overall Study|Lost to Follow-up|0|||
37732963|NCT01611194|69213241|FG001|Overall Study|Lost to Follow-up|1|||
37732964|NCT01611194|69213240|FG000|Overall Study|Withdrawal by Subject|0|||
37732965|NCT01611194|69213241|FG001|Overall Study|Withdrawal by Subject|1|||
37732966|NCT01611194|69213240|FG000|Overall Study|drug use|0|||
37732967|NCT01611194|69213241|FG001|Overall Study|drug use|1|||
37732968|NCT01813058|69213249|FG000|Overall Study|Withdrawal by Subject|5|||
37732969|NCT01813058|69213250|FG001|Overall Study|Withdrawal by Subject|4|||
37732970|NCT01867424|69213258|FG000|Overall Study|Patient noncompliance|2|||
37732971|NCT01867424|69213259|FG001|Overall Study|Patient noncompliance|1|||
37732972|NCT01811732|69213267|FG000|Overall Study|Lost to Follow-up|24|||
37732973|NCT01811732|69213268|FG001|Overall Study|Lost to Follow-up|30|||
37732974|NCT01811732|69213267|FG000|Overall Study|Withdrawal by Subject|16|||
37844440|NCT01380093|69529097|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
37844441|NCT01380093|69529098|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
38025841|NCT04036110|69710479|FG000|Overall Study|Study Suspended|4|||
37732975|NCT01811732|69213268|FG001|Overall Study|Withdrawal by Subject|10|||
37732976|NCT01811732|69213267|FG000|Overall Study|Adverse Event|3|||
37732977|NCT01811732|69213268|FG001|Overall Study|Adverse Event|9|||
37732978|NCT01811732|69213267|FG000|Overall Study|Lack of Efficacy|3|||
37732979|NCT01811732|69213268|FG001|Overall Study|Lack of Efficacy|1|||
37732980|NCT01811732|69213267|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
37732981|NCT01811732|69213268|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
37732982|NCT01811732|69213267|FG000|Overall Study|Physician Decision|2|||
37732983|NCT01811732|69213268|FG001|Overall Study|Physician Decision|0|||
37844442|NCT01380093|69529099|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
37844443|NCT01380093|69529100|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
37844444|NCT01380093|69529101|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
38025842|NCT04036110|69710480|FG001|Overall Study|Study Suspended|5|||
38025843|NCT04036110|69710481|FG002|Overall Study|Study Suspended|1|||
37732984|NCT01811732|69213267|FG000|Overall Study|Death|1|||
37732985|NCT01811732|69213268|FG001|Overall Study|Death|1|||
37732986|NCT01811732|69213267|FG000|Overall Study|Insufficient venous access|0|||
37732987|NCT01811732|69213268|FG001|Overall Study|Insufficient venous access|1|||
37732988|NCT01811732|69213267|FG000|Overall Study|Protocol Violation|0|||
37732989|NCT01811732|69213268|FG001|Overall Study|Protocol Violation|1|||
37732990|NCT01811732|69213267|FG000|Overall Study|Subject incarcerated|1|||
37732991|NCT01811732|69213268|FG001|Overall Study|Subject incarcerated|2|||
37732992|NCT01811732|69213267|FG000|Overall Study|Admitted to another facility|1|||
37732993|NCT01811732|69213268|FG001|Overall Study|Admitted to another facility|0|||
37732994|NCT01811732|69213267|FG000|Overall Study|Correct study drug not available on site|1|||
37732995|NCT01811732|69213268|FG001|Overall Study|Correct study drug not available on site|0|||
37732996|NCT01836458|69213279|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
37732997|NCT01836458|69213280|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
37732998|NCT01836458|69213281|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
37732999|NCT01836458|69213282|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
37733000|NCT01811186|69213294|FG000|Overall Study|Adverse Event|54|||
37733001|NCT01811186|69213295|FG001|Overall Study|Adverse Event|38|||
37733002|NCT01811186|69213294|FG000|Overall Study|Protocol Violation|5|||
37733003|NCT01811186|69213295|FG001|Overall Study|Protocol Violation|6|||
37733004|NCT01811186|69213294|FG000|Overall Study|Withdrawal by Subject|5|||
37733005|NCT01811186|69213295|FG001|Overall Study|Withdrawal by Subject|10|||
37733006|NCT01811186|69213294|FG000|Overall Study|Lack of Efficacy|3|||
37733007|NCT01811186|69213295|FG001|Overall Study|Lack of Efficacy|6|||
37733008|NCT01811186|69213294|FG000|Overall Study|Lost to Follow-up|4|||
37733009|NCT01811186|69213295|FG001|Overall Study|Lost to Follow-up|2|||
37733010|NCT01866098|69213308|FG000|Overall Study|Lost to Follow-up|11|||
37733011|NCT01866098|69213309|FG001|Overall Study|Lost to Follow-up|18|||
37733012|NCT01866098|69213310|FG002|Overall Study|Lost to Follow-up|13|||
37733013|NCT01866098|69213308|FG000|Overall Study|Physician Decision|0|||
37733014|NCT01866098|69213309|FG001|Overall Study|Physician Decision|1|||
37733015|NCT01866098|69213310|FG002|Overall Study|Physician Decision|2|||
37733016|NCT01866098|69213308|FG000|Overall Study|Adverse Event|1|||
37733017|NCT01866098|69213309|FG001|Overall Study|Adverse Event|5|||
37733018|NCT01866098|69213310|FG002|Overall Study|Adverse Event|4|||
37733019|NCT01866098|69213308|FG000|Overall Study|Protocol Violation|1|||
37733020|NCT01866098|69213309|FG001|Overall Study|Protocol Violation|0|||
37733021|NCT01866098|69213310|FG002|Overall Study|Protocol Violation|0|||
37733022|NCT01866098|69213308|FG000|Overall Study|Withdrawal by Subject|1|||
37733023|NCT01866098|69213309|FG001|Overall Study|Withdrawal by Subject|2|||
37733024|NCT01866098|69213310|FG002|Overall Study|Withdrawal by Subject|0|||
37733025|NCT01866098|69213308|FG000|Overall Study|Unrelated Hospitalization|2|||
37733026|NCT01866098|69213309|FG001|Overall Study|Unrelated Hospitalization|0|||
37733027|NCT01866098|69213310|FG002|Overall Study|Unrelated Hospitalization|1|||
37733028|NCT01866098|69213308|FG000|Overall Study|Non-compliance|1|||
37733029|NCT01866098|69213309|FG001|Overall Study|Non-compliance|0|||
37733030|NCT01866098|69213310|FG002|Overall Study|Non-compliance|1|||
37733031|NCT01866098|69213308|FG000|Overall Study|Pregnancy|2|||
37733032|NCT01866098|69213309|FG001|Overall Study|Pregnancy|0|||
37733033|NCT01866098|69213310|FG002|Overall Study|Pregnancy|0|||
37733034|NCT01866098|69213308|FG000|Overall Study|Death|0|||
37733035|NCT01866098|69213309|FG001|Overall Study|Death|1|||
37733036|NCT01866098|69213310|FG002|Overall Study|Death|0|||
37733037|NCT01865552|69213324|FG000|Period 1|Adverse Event|1|||
37733038|NCT01865552|69213325|FG001|Period 1|Adverse Event|0|||
37733039|NCT01865552|69213326|FG002|Period 1|Adverse Event|0|||
37844445|NCT01380093|69529102|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
38025844|NCT03053050|69710492|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
37733040|NCT01865552|69213327|FG003|Period 1|Adverse Event|1|||
37733041|NCT01865552|69213328|FG004|Period 1|Adverse Event|1|||
37733042|NCT01865552|69213329|FG005|Period 1|Adverse Event|1|||
37733043|NCT01865552|69213324|FG000|Period 1|Pathological lab|0|||
37733044|NCT01865552|69213325|FG001|Period 1|Pathological lab|0|||
37733045|NCT01865552|69213326|FG002|Period 1|Pathological lab|0|||
37733046|NCT01865552|69213327|FG003|Period 1|Pathological lab|0|||
37733047|NCT01865552|69213328|FG004|Period 1|Pathological lab|1|||
37733048|NCT01865552|69213329|FG005|Period 1|Pathological lab|0|||
37733049|NCT01865552|69213324|FG000|Period 1|Other|0|||
37733050|NCT01865552|69213325|FG001|Period 1|Other|0|||
37733051|NCT01865552|69213326|FG002|Period 1|Other|0|||
37844446|NCT01380093|69529103|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
37844447|NCT01380093|69529104|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
37844448|NCT01380093|69529096|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
37844449|NCT01380093|69529097|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
37844450|NCT01380093|69529098|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
37844451|NCT01380093|69529099|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
37844452|NCT01380093|69529100|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
37844453|NCT01380093|69529101|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
37844454|NCT01380093|69529102|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
37844455|NCT01380093|69529103|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
37844456|NCT01380093|69529104|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
37844457|NCT01380093|69529096|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
37844458|NCT01380093|69529097|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
37844459|NCT01380093|69529098|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
37916108|NCT01936831|69602962|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
37733052|NCT01865552|69213327|FG003|Period 1|Other|0|||
37733053|NCT01865552|69213328|FG004|Period 1|Other|1|||
37733054|NCT01865552|69213329|FG005|Period 1|Other|0|||
37733055|NCT01809314|69213343|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
37733056|NCT01809314|69213343|FG000|Overall Study|Adverse Event|6|||
37733057|NCT01809314|69213343|FG000|Overall Study|Insufficient Therapeutic Response|14|||
37733058|NCT01809314|69213343|FG000|Overall Study|Lost to Follow-up|724|||
37733059|NCT01803464|69213351|FG000|Overall Study|Incomplete data|0|||
37733060|NCT01803464|69213352|FG001|Overall Study|Incomplete data|0|||
37733061|NCT01803464|69213353|FG002|Overall Study|Incomplete data|4|||
37733062|NCT01803464|69213354|FG003|Overall Study|Incomplete data|0|||
37733063|NCT01803464|69213351|FG000|Overall Study|Withdrawal by Subject|1|||
37733064|NCT01803464|69213352|FG001|Overall Study|Withdrawal by Subject|0|||
37733065|NCT01803464|69213353|FG002|Overall Study|Withdrawal by Subject|0|||
37733066|NCT01803464|69213354|FG003|Overall Study|Withdrawal by Subject|0|||
37733067|NCT01808690|69213370|FG000|Overall Study|Withdrawal by Subject|1|||
37733068|NCT01808690|69213371|FG001|Overall Study|Withdrawal by Subject|2|||
37733069|NCT01363297|69213382|FG000|Overall Study|Other|0|||
37733070|NCT01363297|69213383|FG001|Overall Study|Other|0|||
37733071|NCT01363297|69213384|FG002|Overall Study|Other|0|||
37733072|NCT01363297|69213385|FG003|Overall Study|Other|0|||
37733073|NCT01363297|69213386|FG004|Overall Study|Other|1|||
37733074|NCT01363297|69213382|FG000|Overall Study|Death|3|||
37733075|NCT01363297|69213383|FG001|Overall Study|Death|6|||
37733076|NCT01363297|69213384|FG002|Overall Study|Death|6|||
37733077|NCT01363297|69213385|FG003|Overall Study|Death|10|||
37733078|NCT01363297|69213386|FG004|Overall Study|Death|30|||
37733079|NCT01908907|69213405|FG000|Overall Study|Physician Decision|1|||
37733080|NCT01908907|69213406|FG001|Overall Study|Physician Decision|0|||
37733081|NCT01908907|69213405|FG000|Overall Study|Protocol Violation|1|||
37733082|NCT01908907|69213406|FG001|Overall Study|Protocol Violation|0|||
37733083|NCT01808612|69213419|FG000|Treatment Period|Adverse Event|8|||
37733084|NCT01808612|69213420|FG001|Treatment Period|Adverse Event|4|||
37733085|NCT01808612|69213421|FG002|Treatment Period|Adverse Event|3|||
37733086|NCT01808612|69213419|FG000|Treatment Period|Lost to Follow-up|2|||
37733087|NCT01808612|69213420|FG001|Treatment Period|Lost to Follow-up|2|||
37733088|NCT01808612|69213421|FG002|Treatment Period|Lost to Follow-up|1|||
37733089|NCT01808612|69213419|FG000|Treatment Period|Protocol Violation|1|||
37733090|NCT01808612|69213420|FG001|Treatment Period|Protocol Violation|0|||
37733091|NCT01808612|69213421|FG002|Treatment Period|Protocol Violation|0|||
37733092|NCT01808612|69213419|FG000|Treatment Period|Withdrawal by Subject|1|||
37733093|NCT01808612|69213420|FG001|Treatment Period|Withdrawal by Subject|0|||
37733094|NCT01808612|69213421|FG002|Treatment Period|Withdrawal by Subject|4|||
37733095|NCT01808612|69213419|FG000|Treatment Period|Physician Decision|1|||
37733096|NCT01808612|69213420|FG001|Treatment Period|Physician Decision|0|||
37733097|NCT01808612|69213421|FG002|Treatment Period|Physician Decision|4|||
37733098|NCT01808612|69213419|FG000|Treatment Period|Sponsor Decision|1|||
37916109|NCT03863353|69602979|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
37733099|NCT01808612|69213420|FG001|Treatment Period|Sponsor Decision|0|||
37733100|NCT01808612|69213421|FG002|Treatment Period|Sponsor Decision|0|||
37733101|NCT01808612|69213419|FG000|Treatment Period|Lack of Efficacy|1|||
37733102|NCT01808612|69213420|FG001|Treatment Period|Lack of Efficacy|1|||
37733103|NCT01808612|69213421|FG002|Treatment Period|Lack of Efficacy|2|||
37733104|NCT01808612|69213419|FG000|Discontinuation Period|Adverse Event|1|||
37733105|NCT01808612|69213420|FG001|Discontinuation Period|Adverse Event|0|||
37733106|NCT01808612|69213421|FG002|Discontinuation Period|Adverse Event|0|||
37733107|NCT01808612|69213419|FG000|Discontinuation Period|Physician Decision|1|||
37733108|NCT01808612|69213420|FG001|Discontinuation Period|Physician Decision|0|||
37733109|NCT01808612|69213421|FG002|Discontinuation Period|Physician Decision|0|||
37733110|NCT01808612|69213419|FG000|Discontinuation Period|Lost to Follow-up|0|||
37733111|NCT01808612|69213420|FG001|Discontinuation Period|Lost to Follow-up|1|||
37733112|NCT01808612|69213421|FG002|Discontinuation Period|Lost to Follow-up|0|||
37844460|NCT01380093|69529099|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
37844461|NCT01380093|69529100|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
37844462|NCT01380093|69529101|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
37844463|NCT01380093|69529102|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
37844464|NCT01380093|69529103|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
37844465|NCT01380093|69529104|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
37844466|NCT01380093|69529096|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
37844467|NCT01380093|69529097|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
37844468|NCT01380093|69529098|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
37844469|NCT01380093|69529099|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
37844470|NCT01380093|69529100|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
37844471|NCT01380093|69529101|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
37844472|NCT01380093|69529102|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
37844473|NCT01380093|69529103|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
37844474|NCT01380093|69529104|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
37844475|NCT01380093|69529096|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
37844476|NCT01380093|69529097|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
37844477|NCT01380093|69529098|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
37844478|NCT01380093|69529099|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
37844479|NCT01380093|69529100|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
37844480|NCT01380093|69529101|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
37844481|NCT01380093|69529102|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
37844482|NCT01380093|69529103|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
37844483|NCT01380093|69529104|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
37844484|NCT01380093|69529096|FG000|Treatment Phase: Second Intervention|Other|0|||
37844485|NCT01380093|69529097|FG001|Treatment Phase: Second Intervention|Other|0|||
37844486|NCT01380093|69529098|FG002|Treatment Phase: Second Intervention|Other|0|||
37844487|NCT01380093|69529099|FG003|Treatment Phase: Second Intervention|Other|1|||
37844488|NCT01380093|69529100|FG004|Treatment Phase: Second Intervention|Other|0|||
37844489|NCT01380093|69529101|FG005|Treatment Phase: Second Intervention|Other|0|||
37844490|NCT01380093|69529102|FG006|Treatment Phase: Second Intervention|Other|0|||
37844491|NCT01380093|69529103|FG007|Treatment Phase: Second Intervention|Other|0|||
37844492|NCT01380093|69529104|FG008|Treatment Phase: Second Intervention|Other|0|||
37844493|NCT01380093|69529096|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
37844494|NCT01380093|69529097|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
37844495|NCT01380093|69529098|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
37844496|NCT01380093|69529099|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
37844497|NCT01380093|69529100|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
37844498|NCT01380093|69529101|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
37844499|NCT01380093|69529102|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
37844500|NCT01380093|69529103|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
37844501|NCT01380093|69529104|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
37844502|NCT01380093|69529096|FG000|Treatment Phase: Third Intervention|Other|0|||
37844503|NCT01380093|69529097|FG001|Treatment Phase: Third Intervention|Other|0|||
37844504|NCT01380093|69529098|FG002|Treatment Phase: Third Intervention|Other|0|||
37844505|NCT01380093|69529099|FG003|Treatment Phase: Third Intervention|Other|0|||
37844506|NCT01380093|69529100|FG004|Treatment Phase: Third Intervention|Other|0|||
37916110|NCT03863353|69602980|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
37916111|NCT00523705|69602988|FG000|Overall Study|No time for study.|0|||
37916112|NCT00523705|69602989|FG001|Overall Study|No time for study.|1|||
37916113|NCT00523549|69603002|FG000|Overall Study|Adverse Event|6|||
37916114|NCT00523549|69603003|FG001|Overall Study|Adverse Event|3|||
37916115|NCT00523549|69603002|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
37916116|NCT00523549|69603003|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
38025845|NCT03053050|69710493|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
38025846|NCT03053050|69710494|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
37733113|NCT01908829|69213435|FG000|Overall Study|Adverse Event|13|||
37844507|NCT01380093|69529101|FG005|Treatment Phase: Third Intervention|Other|0|||
38025847|NCT03053050|69710495|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
37733114|NCT01908829|69213436|FG001|Overall Study|Adverse Event|11|||
37844508|NCT01380093|69529102|FG006|Treatment Phase: Third Intervention|Other|0|||
37916117|NCT00523549|69603002|FG000|Overall Study|Protocol Deviation|3|||
37733115|NCT01908829|69213437|FG002|Overall Study|Adverse Event|13|||
37733116|NCT01908829|69213435|FG000|Overall Study|Lost to Follow-up|4|||
37733117|NCT01908829|69213436|FG001|Overall Study|Lost to Follow-up|2|||
37916118|NCT00523549|69603003|FG001|Overall Study|Protocol Deviation|1|||
37916119|NCT00523549|69603002|FG000|Overall Study|Patient withdrew consent|7|||
37916120|NCT00523549|69603003|FG001|Overall Study|Patient withdrew consent|6|||
37916121|NCT00523549|69603002|FG000|Overall Study|Lost to Follow-up|3|||
37916122|NCT00523549|69603003|FG001|Overall Study|Lost to Follow-up|5|||
37916123|NCT03504085|69603011|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
38025848|NCT03053050|69710492|FG000|Randomized Phase|Withdrew Consent|16|||
38025849|NCT03053050|69710493|FG001|Randomized Phase|Withdrew Consent|8|||
37733118|NCT01908829|69213437|FG002|Overall Study|Lost to Follow-up|1|||
37733119|NCT01908829|69213435|FG000|Overall Study|Randomized no double-blind drug received|1|||
37733120|NCT01908829|69213436|FG001|Overall Study|Randomized no double-blind drug received|0|||
37733121|NCT01908829|69213437|FG002|Overall Study|Randomized no double-blind drug received|1|||
37733122|NCT01908829|69213435|FG000|Overall Study|Discontinued (no EoT page)|2|||
37733123|NCT01908829|69213436|FG001|Overall Study|Discontinued (no EoT page)|0|||
37733124|NCT01908829|69213437|FG002|Overall Study|Discontinued (no EoT page)|0|||
37733125|NCT01908829|69213435|FG000|Overall Study|Miscellaneous|0|||
37733126|NCT01908829|69213436|FG001|Overall Study|Miscellaneous|2|||
37733127|NCT01908829|69213437|FG002|Overall Study|Miscellaneous|0|||
37733128|NCT01908829|69213435|FG000|Overall Study|Protocol Violation|2|||
37733129|NCT01908829|69213436|FG001|Overall Study|Protocol Violation|2|||
37733130|NCT01908829|69213437|FG002|Overall Study|Protocol Violation|0|||
37733131|NCT01908829|69213435|FG000|Overall Study|Lack of Efficacy|1|||
37733132|NCT01908829|69213436|FG001|Overall Study|Lack of Efficacy|3|||
37733133|NCT01908829|69213437|FG002|Overall Study|Lack of Efficacy|2|||
37733134|NCT01908829|69213435|FG000|Overall Study|Withdrawal by Subject|26|||
37733135|NCT01908829|69213436|FG001|Overall Study|Withdrawal by Subject|29|||
37733136|NCT01908829|69213437|FG002|Overall Study|Withdrawal by Subject|22|||
37733137|NCT01773122|69213449|FG000|Overall Study|Due to amended age eligibility criteria|3|||
37733138|NCT01773122|69213450|FG001|Overall Study|Due to amended age eligibility criteria|1|||
37733139|NCT01773122|69213451|FG002|Overall Study|Due to amended age eligibility criteria|0|||
37733140|NCT01773122|69213452|FG003|Overall Study|Due to amended age eligibility criteria|1|||
37733141|NCT01808534|69213462|FG000|Overall Study|Disease progression|3|||
37733142|NCT01808534|69213462|FG000|Overall Study|Physician Decision|1|||
37733143|NCT01808222|69213466|FG000|Overall Study|mpMR scan was not performed|1|||
37733144|NCT01772576|69213470|FG000|Overall Study|Death|15|||
37733145|NCT01772576|69213470|FG000|Overall Study|Protocol Violation|1|||
37733146|NCT01772576|69213470|FG000|Overall Study|Lost to Follow-up|3|||
38025850|NCT03053050|69710494|FG002|Randomized Phase|Withdrew Consent|9|||
37733147|NCT01772576|69213470|FG000|Overall Study|Study device not used|3|||
37733148|NCT01772576|69213470|FG000|Overall Study|Adverse Event|6|||
37733149|NCT01772576|69213470|FG000|Overall Study|Withdrawal by Subject|6|||
37916124|NCT03504085|69603012|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
37733150|NCT01802216|69213497|FG000|4 Month Visit|Participant did not show to visit|3|||
37733151|NCT01802216|69213498|FG001|4 Month Visit|Participant did not show to visit|4|||
37733152|NCT01802216|69213497|FG000|8 Month Visit|Participant did not show to visit|3|||
37733153|NCT01802216|69213498|FG001|8 Month Visit|Participant did not show to visit|5|||
37733154|NCT01802216|69213497|FG000|12 Month Visit|Participant did not show to visit|3|||
37733155|NCT01802216|69213498|FG001|12 Month Visit|Participant did not show to visit|4|||
37733156|NCT01808144|69213506|FG000|Overall Study|Death|1|||
37733157|NCT01808144|69213507|FG001|Overall Study|Death|0|||
37733158|NCT01808144|69213506|FG000|Overall Study|Withdrawal by Subject|16|||
37733159|NCT01808144|69213507|FG001|Overall Study|Withdrawal by Subject|23|||
37733160|NCT01808144|69213506|FG000|Overall Study|Lost to Follow-up|6|||
37733161|NCT01808144|69213507|FG001|Overall Study|Lost to Follow-up|3|||
37733162|NCT01808144|69213506|FG000|Overall Study|Protocol Violation|6|||
37733163|NCT01808144|69213507|FG001|Overall Study|Protocol Violation|6|||
37733164|NCT01808144|69213506|FG000|Overall Study|Gout flare|0|||
37733165|NCT01808144|69213507|FG001|Overall Study|Gout flare|1|||
37733166|NCT01808144|69213506|FG000|Overall Study|Adverse Event|11|||
37733167|NCT01808144|69213507|FG001|Overall Study|Adverse Event|15|||
37733168|NCT01801982|69213513|FG000|Overall Study|Lost to Follow-up|1|||
37733169|NCT01808066|69213526|FG000|Overall Study|Withdrawal by Subject|15|||
37733170|NCT01604343|69213534|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
37733171|NCT01604343|69213535|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
37733172|NCT01604343|69213536|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
37733173|NCT01604343|69213537|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
37733174|NCT01604343|69213538|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
37844509|NCT01380093|69529103|FG007|Treatment Phase: Third Intervention|Other|0|||
37844510|NCT01380093|69529104|FG008|Treatment Phase: Third Intervention|Other|1|||
37844511|NCT01379937|69529122|FG000|Overall Study|Protocol Violation|0|||
37844512|NCT01379937|69529123|FG001|Overall Study|Protocol Violation|0|||
37844513|NCT01379937|69529124|FG002|Overall Study|Protocol Violation|0|||
37844514|NCT01379937|69529125|FG003|Overall Study|Protocol Violation|1|||
37844515|NCT01379937|69529122|FG000|Overall Study|Consent withdrawal|0|||
37844516|NCT01379937|69529123|FG001|Overall Study|Consent withdrawal|1|||
37844517|NCT01379937|69529124|FG002|Overall Study|Consent withdrawal|0|||
37844518|NCT01379937|69529125|FG003|Overall Study|Consent withdrawal|0|||
37733175|NCT01604343|69213534|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
37844519|NCT01379937|69529122|FG000|Overall Study|Lost to Follow-up|1|||
37844520|NCT01379937|69529123|FG001|Overall Study|Lost to Follow-up|2|||
37916125|NCT03504085|69603011|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
37916126|NCT03504085|69603012|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
37916127|NCT00700102|69603020|FG000|Overall Study|Died|394|||
37916128|NCT00700102|69603021|FG001|Overall Study|Died|385|||
37916129|NCT00700102|69603020|FG000|Overall Study|Lost to Follow-up|8|||
37916130|NCT00700102|69603021|FG001|Overall Study|Lost to Follow-up|10|||
37916131|NCT00595478|69603029|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
37916132|NCT00595478|69603030|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
37916133|NCT00595478|69603029|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
37916134|NCT00595478|69603030|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
37916135|NCT00516295|69603039|FG000|Overall Study|Lack of Efficacy|2|||
37916136|NCT00516295|69603040|FG001|Overall Study|Lack of Efficacy|0|||
37916137|NCT00516295|69603041|FG002|Overall Study|Lack of Efficacy|0|||
37916138|NCT00516295|69603039|FG000|Overall Study|Ineligible|1|||
37916139|NCT00516295|69603040|FG001|Overall Study|Ineligible|0|||
37916140|NCT00516295|69603041|FG002|Overall Study|Ineligible|0|||
37916141|NCT03861559|69603051|FG000|Overall Study|Adverse Event|0|||
37916142|NCT03861559|69603052|FG001|Overall Study|Adverse Event|2|||
37916143|NCT03861559|69603051|FG000|Overall Study|Treatment failure|0|||
37916144|NCT03861559|69603052|FG001|Overall Study|Treatment failure|2|||
37916145|NCT03861559|69603051|FG000|Overall Study|Noncompliance|1|||
37916146|NCT03861559|69603052|FG001|Overall Study|Noncompliance|1|||
37916147|NCT03861559|69603051|FG000|Overall Study|Did not meet eligibility requirements|1|||
37916148|NCT03861559|69603052|FG001|Overall Study|Did not meet eligibility requirements|0|||
37916149|NCT00516139|69603058|FG000|Overall Study|Adverse Event|27|||
37916150|NCT00516139|69603058|FG000|Overall Study|Lost to Follow-up|1|||
37916151|NCT00516139|69603058|FG000|Overall Study|Protocol Violation|1|||
37916152|NCT00516139|69603058|FG000|Overall Study|Withdrawal by Subject|8|||
37916153|NCT00516139|69603058|FG000|Overall Study|Lack of Efficacy|1|||
37733176|NCT01604343|69213535|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
37733177|NCT01604343|69213536|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
37733178|NCT01604343|69213537|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
37844521|NCT01379937|69529124|FG002|Overall Study|Lost to Follow-up|2|||
37844522|NCT01379937|69529125|FG003|Overall Study|Lost to Follow-up|0|||
37916154|NCT00515827|69603068|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
37916155|NCT00515827|69603069|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
37733179|NCT01604343|69213538|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
37844523|NCT01379781|69529151|FG000|Overall Study|Lost to Follow-up|11|||
37844524|NCT01379781|69529152|FG001|Overall Study|Lost to Follow-up|8|||
37844525|NCT01379703|69529158|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
37733180|NCT01604343|69213534|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
37733181|NCT01604343|69213535|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
37733182|NCT01604343|69213536|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
37733183|NCT01604343|69213537|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
37733184|NCT01604343|69213538|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
37733185|NCT01604343|69213534|FG000|Prior to W52 Administration(Through W52)|Death|5|||
37733186|NCT01604343|69213535|FG001|Prior to W52 Administration(Through W52)|Death|0|||
37733187|NCT01604343|69213536|FG002|Prior to W52 Administration(Through W52)|Death|2|||
37733188|NCT01604343|69213537|FG003|Prior to W52 Administration(Through W52)|Death|0|||
37733189|NCT01604343|69213538|FG004|Prior to W52 Administration(Through W52)|Death|4|||
37733190|NCT01604343|69213534|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
37733191|NCT01604343|69213535|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
37733192|NCT01604343|69213536|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
37733193|NCT01604343|69213537|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
37733194|NCT01604343|69213538|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
37733195|NCT01604343|69213534|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
37733196|NCT01604343|69213535|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
37733197|NCT01604343|69213536|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
37733198|NCT01604343|69213537|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
37733199|NCT01604343|69213538|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
37733200|NCT01604343|69213534|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
37733201|NCT01604343|69213535|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
37733202|NCT01604343|69213536|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
37733203|NCT01604343|69213537|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
37733204|NCT01604343|69213538|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
37733205|NCT01604343|69213534|FG000|Prior to W52 Administration(Through W52)|Other|15|||
37733206|NCT01604343|69213535|FG001|Prior to W52 Administration(Through W52)|Other|0|||
37733207|NCT01604343|69213536|FG002|Prior to W52 Administration(Through W52)|Other|10|||
37844526|NCT01379703|69529159|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
37844527|NCT01379703|69529160|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
37733208|NCT01604343|69213537|FG003|Prior to W52 Administration(Through W52)|Other|0|||
37733209|NCT01604343|69213538|FG004|Prior to W52 Administration(Through W52)|Other|6|||
37733210|NCT01604343|69213534|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
37844528|NCT01379703|69529158|FG000|Study Start Through 9 Months|Adverse Event|0|||
37844529|NCT01379703|69529159|FG001|Study Start Through 9 Months|Adverse Event|14|||
37844530|NCT01379703|69529160|FG002|Study Start Through 9 Months|Adverse Event|10|||
37844531|NCT01379703|69529158|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
37844532|NCT01379703|69529159|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
37844533|NCT01379703|69529160|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
37844534|NCT01379703|69529158|FG000|Study Start Through 9 Months|Treatment Failure|0|||
37844535|NCT01379703|69529159|FG001|Study Start Through 9 Months|Treatment Failure|2|||
37844536|NCT01379703|69529160|FG002|Study Start Through 9 Months|Treatment Failure|2|||
37844537|NCT01379703|69529158|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
37844538|NCT01379703|69529159|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
37844539|NCT01379703|69529160|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
37844540|NCT01379703|69529158|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
37844541|NCT01379703|69529159|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
37844542|NCT01379703|69529160|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
37844543|NCT01379703|69529158|FG000|Study Start Through 9 Months|Medication not available|0|||
37844544|NCT01379703|69529159|FG001|Study Start Through 9 Months|Medication not available|2|||
37844545|NCT01379703|69529160|FG002|Study Start Through 9 Months|Medication not available|1|||
37844546|NCT01379703|69529158|FG000|Study Start Through 9 Months|Poor general condition|0|||
37916156|NCT00515827|69603068|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
37733211|NCT01604343|69213535|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
37733212|NCT01604343|69213536|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
37733213|NCT01604343|69213537|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
37733214|NCT01604343|69213538|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
37733215|NCT01604343|69213534|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
37733216|NCT01604343|69213535|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
37733217|NCT01604343|69213536|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
37733218|NCT01604343|69213537|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
37733219|NCT01604343|69213538|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
37733220|NCT01604343|69213534|FG000|Week 52 to Week 104|Adverse Event|0|||
37733221|NCT01604343|69213535|FG001|Week 52 to Week 104|Adverse Event|12|||
37733222|NCT01604343|69213536|FG002|Week 52 to Week 104|Adverse Event|26|||
37733223|NCT01604343|69213537|FG003|Week 52 to Week 104|Adverse Event|21|||
37733224|NCT01604343|69213538|FG004|Week 52 to Week 104|Adverse Event|27|||
37733225|NCT01604343|69213534|FG000|Week 52 to Week 104|Death|0|||
37733226|NCT01604343|69213535|FG001|Week 52 to Week 104|Death|4|||
37733227|NCT01604343|69213536|FG002|Week 52 to Week 104|Death|2|||
37733228|NCT01604343|69213537|FG003|Week 52 to Week 104|Death|5|||
37733229|NCT01604343|69213538|FG004|Week 52 to Week 104|Death|0|||
37733230|NCT01604343|69213534|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
37733231|NCT01604343|69213535|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
37733232|NCT01604343|69213536|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
37733233|NCT01604343|69213537|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
37733234|NCT01604343|69213538|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
37733235|NCT01604343|69213534|FG000|Week 52 to Week 104|Physician Decision|0|||
37733236|NCT01604343|69213535|FG001|Week 52 to Week 104|Physician Decision|1|||
37733237|NCT01604343|69213536|FG002|Week 52 to Week 104|Physician Decision|0|||
37733238|NCT01604343|69213537|FG003|Week 52 to Week 104|Physician Decision|0|||
37733239|NCT01604343|69213538|FG004|Week 52 to Week 104|Physician Decision|2|||
37733240|NCT01604343|69213534|FG000|Week 52 to Week 104|Pregnancy|0|||
37733241|NCT01604343|69213535|FG001|Week 52 to Week 104|Pregnancy|0|||
37733242|NCT01604343|69213536|FG002|Week 52 to Week 104|Pregnancy|1|||
37733243|NCT01604343|69213537|FG003|Week 52 to Week 104|Pregnancy|2|||
37733244|NCT01604343|69213538|FG004|Week 52 to Week 104|Pregnancy|1|||
37733245|NCT01604343|69213534|FG000|Week 52 to Week 104|Other|0|||
37733246|NCT01604343|69213535|FG001|Week 52 to Week 104|Other|11|||
37733247|NCT01604343|69213536|FG002|Week 52 to Week 104|Other|11|||
37733248|NCT01604343|69213537|FG003|Week 52 to Week 104|Other|6|||
37733249|NCT01604343|69213538|FG004|Week 52 to Week 104|Other|3|||
37733250|NCT01604343|69213534|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
37733251|NCT01604343|69213535|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
37733252|NCT01604343|69213536|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
37733253|NCT01604343|69213537|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
37733254|NCT01604343|69213538|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
37733255|NCT01604343|69213534|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
37733256|NCT01604343|69213535|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
37733257|NCT01604343|69213536|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
37733258|NCT01604343|69213537|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
37733259|NCT01604343|69213538|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
37733260|NCT01604343|69213534|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
37733261|NCT01604343|69213535|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
37844547|NCT01379703|69529159|FG001|Study Start Through 9 Months|Poor general condition|1|||
37844548|NCT01379703|69529160|FG002|Study Start Through 9 Months|Poor general condition|0|||
37844549|NCT01379703|69529158|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
37844550|NCT01379703|69529159|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
37844551|NCT01379703|69529160|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
37844552|NCT01379703|69529158|FG000|Study Start Through 9 Months|Reason unknown|2|||
37844553|NCT01379703|69529159|FG001|Study Start Through 9 Months|Reason unknown|31|||
37844554|NCT01379703|69529160|FG002|Study Start Through 9 Months|Reason unknown|24|||
37844555|NCT01379703|69529158|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
38025851|NCT03053050|69710495|FG003|Randomized Phase|Withdrew Consent|0|||
38025852|NCT03053050|69710492|FG000|Randomized Phase|Investigator's Discretion|6|||
38025853|NCT03053050|69710493|FG001|Randomized Phase|Investigator's Discretion|6|||
38025854|NCT03053050|69710494|FG002|Randomized Phase|Investigator's Discretion|3|||
38025855|NCT03053050|69710495|FG003|Randomized Phase|Investigator's Discretion|0|||
37733262|NCT01604343|69213536|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
37733263|NCT01604343|69213537|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
37733264|NCT01604343|69213538|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
37733265|NCT01801436|69213548|FG000|Overall Study|Withdrawal by Subject|3|||
37844556|NCT01379703|69529159|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
37844557|NCT01379703|69529160|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
37733266|NCT01801436|69213548|FG000|Overall Study|Adverse Event|2|||
37733267|NCT01801436|69213548|FG000|Overall Study|Progressive disease|4|||
37733268|NCT01771250|69213552|FG000|Period 1|Met exclusion criteria|1|||
37733269|NCT01771250|69213553|FG001|Period 1|Met exclusion criteria|0|||
37733270|NCT01770860|69213559|FG000|Overall Study|Withdrawal by Subject|4|||
37733271|NCT01770860|69213559|FG000|Overall Study|Lost to Follow-up|1|||
37733272|NCT01770860|69213559|FG000|Overall Study|Administrative decision made by the PI|1|||
37733273|NCT01603875|69213570|FG000|Overall Study|Preexisting rabies antibody|3|||
37733274|NCT01603875|69213571|FG001|Overall Study|Preexisting rabies antibody|4|||
37733275|NCT01603875|69213572|FG002|Overall Study|Preexisting rabies antibody|3|||
37733276|NCT01603875|69213570|FG000|Overall Study|Lost to Follow-up|4|||
37733277|NCT01603875|69213571|FG001|Overall Study|Lost to Follow-up|3|||
37733278|NCT01603875|69213572|FG002|Overall Study|Lost to Follow-up|6|||
37733279|NCT01603875|69213570|FG000|Overall Study|Protocol Violation|0|||
37733280|NCT01603875|69213571|FG001|Overall Study|Protocol Violation|1|||
37844558|NCT01379703|69529158|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
37844559|NCT01379703|69529159|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
37733281|NCT01603875|69213572|FG002|Overall Study|Protocol Violation|0|||
37733282|NCT01770392|69213580|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
37733283|NCT01603641|69213590|FG000|Overall Study|Did not Receive Treatment|3|||
37733284|NCT01603641|69213590|FG000|Overall Study|Adverse Event|1|||
37733285|NCT01603641|69213590|FG000|Overall Study|Lack of Efficacy|1|||
37733286|NCT01603641|69213590|FG000|Overall Study|Lost to Follow-up|6|||
37733287|NCT01603641|69213590|FG000|Overall Study|Personal Reasons|18|||
37733288|NCT01603641|69213590|FG000|Overall Study|Other Miscellaneous Reasons|6|||
37844560|NCT01379703|69529160|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
37844561|NCT01379703|69529158|FG000|9 Months Through 18 Months|Adverse Event|0|||
37844562|NCT01379703|69529159|FG001|9 Months Through 18 Months|Adverse Event|6|||
37844563|NCT01379703|69529160|FG002|9 Months Through 18 Months|Adverse Event|0|||
37844564|NCT01379703|69529158|FG000|9 Months Through 18 Months|Treatment failure|0|||
37844565|NCT01379703|69529159|FG001|9 Months Through 18 Months|Treatment failure|5|||
37844566|NCT01379703|69529160|FG002|9 Months Through 18 Months|Treatment failure|0|||
37844567|NCT01379703|69529158|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
37844568|NCT01379703|69529159|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
37844569|NCT01379703|69529160|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
37844570|NCT01379703|69529158|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
37844571|NCT01379703|69529159|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
37844572|NCT01379703|69529160|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
37844573|NCT01379703|69529158|FG000|9 Months Through 18 Months|Fatigue|0|||
37844574|NCT01379703|69529159|FG001|9 Months Through 18 Months|Fatigue|1|||
37844575|NCT01379703|69529160|FG002|9 Months Through 18 Months|Fatigue|0|||
37844576|NCT01379703|69529158|FG000|9 Months Through 18 Months|Reason Unknown|0|||
37844577|NCT01379703|69529159|FG001|9 Months Through 18 Months|Reason Unknown|23|||
37844578|NCT01379703|69529160|FG002|9 Months Through 18 Months|Reason Unknown|0|||
37844579|NCT01335477|69529171|FG000|Overall Study|Adverse Event|30|||
37844580|NCT01335477|69529172|FG001|Overall Study|Adverse Event|42|||
37844581|NCT01335477|69529171|FG000|Overall Study|Non compliant with protocol|0|||
37844582|NCT01335477|69529172|FG001|Overall Study|Non compliant with protocol|2|||
38025856|NCT03053050|69710492|FG000|Randomized Phase|Lost to Follow-up|5|||
37733289|NCT01556763|69213597|FG000|Overall Study|Withdrawal by Subject|0|||
37733290|NCT01556763|69213598|FG001|Overall Study|Withdrawal by Subject|1|||
37733291|NCT01556763|69213599|FG002|Overall Study|Withdrawal by Subject|0|||
37733292|NCT01576575|69213609|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
37733293|NCT01576575|69213609|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
37733294|NCT01576575|69213609|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
37733295|NCT01555983|69213619|FG000|Overall Study|Withdrawal by Subject|1|||
37733296|NCT01555983|69213620|FG001|Overall Study|Withdrawal by Subject|0|||
37733297|NCT01555983|69213621|FG002|Overall Study|Withdrawal by Subject|0|||
37733298|NCT01555983|69213622|FG003|Overall Study|Withdrawal by Subject|0|||
37733299|NCT01555983|69213623|FG004|Overall Study|Withdrawal by Subject|1|||
37733300|NCT01555983|69213624|FG005|Overall Study|Withdrawal by Subject|1|||
37733301|NCT01576341|69213632|FG000|Overall Study|Withdrawal by Subject|24|||
37733302|NCT01576341|69213632|FG000|Overall Study|Adverse Event|10|||
37733303|NCT01576341|69213632|FG000|Overall Study|Death|21|||
37733304|NCT01576341|69213632|FG000|Overall Study|Physician Decision|2|||
37733305|NCT01576341|69213632|FG000|Overall Study|Lost to Follow-up|2|||
37733306|NCT01576341|69213632|FG000|Overall Study|Kidney transplantation|10|||
37844583|NCT01335477|69529171|FG000|Overall Study|Lost to Follow-up|1|||
37844584|NCT01335477|69529172|FG001|Overall Study|Lost to Follow-up|2|||
37844585|NCT01335477|69529171|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
37844586|NCT01335477|69529172|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
37844587|NCT01335477|69529171|FG000|Overall Study|Not treated|1|||
37844588|NCT01335477|69529172|FG001|Overall Study|Not treated|2|||
38025857|NCT03053050|69710493|FG001|Randomized Phase|Lost to Follow-up|1|||
38025858|NCT03053050|69710494|FG002|Randomized Phase|Lost to Follow-up|1|||
38025859|NCT03053050|69710495|FG003|Randomized Phase|Lost to Follow-up|0|||
38025860|NCT03053050|69710492|FG000|Randomized Phase|Adverse Event|0|||
38025861|NCT03053050|69710493|FG001|Randomized Phase|Adverse Event|1|||
38025862|NCT03053050|69710494|FG002|Randomized Phase|Adverse Event|0|||
37733307|NCT01576341|69213632|FG000|Overall Study|Protocol Violation|12|||
37733308|NCT01576341|69213632|FG000|Overall Study|Other|12|||
37733309|NCT01687413|69213650|FG000|Overall Study|Withdrawal by Subject|0|||
37733310|NCT01687413|69213651|FG001|Overall Study|Withdrawal by Subject|2|||
38025863|NCT03053050|69710495|FG003|Randomized Phase|Adverse Event|0|||
38025864|NCT03053050|69710492|FG000|Randomized Phase|Randomized but Never Treated|2|||
38025865|NCT03053050|69710493|FG001|Randomized Phase|Randomized but Never Treated|2|||
37733311|NCT01687413|69213650|FG000|Overall Study|Not eligible|0|||
37733312|NCT01687413|69213651|FG001|Overall Study|Not eligible|2|||
37733313|NCT01687413|69213650|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
37733314|NCT01687413|69213651|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
37733315|NCT01555671|69213677|FG000|Overall Study|Physician Decision|20|||
37733316|NCT01555671|69213678|FG001|Overall Study|Physician Decision|25|||
37733317|NCT01801358|69213692|FG000|Overall Study|Adverse Event|0|||
37733318|NCT01801358|69213693|FG001|Overall Study|Adverse Event|2|||
37733319|NCT01801358|69213694|FG002|Overall Study|Adverse Event|1|||
37733320|NCT01801358|69213695|FG003|Overall Study|Adverse Event|0|||
37733321|NCT01801358|69213696|FG004|Overall Study|Adverse Event|0|||
37733322|NCT01801358|69213697|FG005|Overall Study|Adverse Event|1|||
37733323|NCT01801358|69213692|FG000|Overall Study|Physician Decision|0|||
37733324|NCT01801358|69213693|FG001|Overall Study|Physician Decision|0|||
37733325|NCT01801358|69213694|FG002|Overall Study|Physician Decision|1|||
37733326|NCT01801358|69213695|FG003|Overall Study|Physician Decision|0|||
37733327|NCT01801358|69213696|FG004|Overall Study|Physician Decision|0|||
37733328|NCT01801358|69213697|FG005|Overall Study|Physician Decision|0|||
37733329|NCT01801358|69213692|FG000|Overall Study|Progressive Disease|6|||
37733330|NCT01801358|69213693|FG001|Overall Study|Progressive Disease|4|||
37733331|NCT01801358|69213694|FG002|Overall Study|Progressive Disease|4|||
37733332|NCT01801358|69213695|FG003|Overall Study|Progressive Disease|5|||
37733333|NCT01801358|69213696|FG004|Overall Study|Progressive Disease|6|||
37733334|NCT01801358|69213697|FG005|Overall Study|Progressive Disease|5|||
37733335|NCT01801358|69213692|FG000|Overall Study|Withdrawal by Subject|0|||
37733336|NCT01801358|69213693|FG001|Overall Study|Withdrawal by Subject|0|||
37733337|NCT01801358|69213694|FG002|Overall Study|Withdrawal by Subject|0|||
37733338|NCT01801358|69213695|FG003|Overall Study|Withdrawal by Subject|1|||
37733339|NCT01801358|69213696|FG004|Overall Study|Withdrawal by Subject|0|||
37733340|NCT01801358|69213697|FG005|Overall Study|Withdrawal by Subject|2|||
37733341|NCT01807598|69213732|FG000|Overall Study|Withdrawal by Subject|4|||
37733342|NCT01807598|69213732|FG000|Overall Study|Adverse Event|1|||
37733343|NCT01807598|69213732|FG000|Overall Study|Other Physician Decision|1|||
37733344|NCT01801280|69213740|FG000|Period 1|Withdrawal by Subject|0|||
37733345|NCT01801280|69213741|FG001|Period 1|Withdrawal by Subject|1|||
37733346|NCT01801280|69213742|FG002|Period 1|Withdrawal by Subject|0|||
37733347|NCT01801280|69213743|FG003|Period 1|Withdrawal by Subject|0|||
37733348|NCT01801280|69213740|FG000|Period 2|Withdrawal by Subject|1|||
37733349|NCT01801280|69213741|FG001|Period 2|Withdrawal by Subject|0|||
37733350|NCT01801280|69213742|FG002|Period 2|Withdrawal by Subject|0|||
37733351|NCT01801280|69213743|FG003|Period 2|Withdrawal by Subject|0|||
37733352|NCT01801280|69213740|FG000|Period 4|Protocol Violation|0|||
37733353|NCT01801280|69213741|FG001|Period 4|Protocol Violation|0|||
37733354|NCT01801280|69213742|FG002|Period 4|Protocol Violation|1|||
37733355|NCT01801280|69213743|FG003|Period 4|Protocol Violation|0|||
37733356|NCT01769456|69213753|FG000|Overall Study|Lost to Follow-up|19|||
37733357|NCT01769456|69213753|FG000|Overall Study|Withdrawal by Subject|3|||
37733358|NCT01769456|69213753|FG000|Overall Study|Did not receive PCC intervention|6|||
37733359|NCT01769456|69213753|FG000|Overall Study|Moved out of the area|3|||
37733360|NCT01769456|69213753|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
37733361|NCT01769456|69213753|FG000|Overall Study|Parental request to youth to withdraw|1|||
37733362|NCT01769378|69213760|FG000|Overall Study|Adverse Event|10|||
37733363|NCT01769378|69213761|FG001|Overall Study|Adverse Event|0|||
37733364|NCT01769378|69213760|FG000|Overall Study|Entry criteria not met|1|||
37733365|NCT01769378|69213761|FG001|Overall Study|Entry criteria not met|0|||
37733366|NCT01769378|69213760|FG000|Overall Study|Protocol Violation|1|||
37733367|NCT01769378|69213761|FG001|Overall Study|Protocol Violation|1|||
37733368|NCT01769378|69213760|FG000|Overall Study|Withdrawal by Subject|10|||
37733369|NCT01769378|69213761|FG001|Overall Study|Withdrawal by Subject|3|||
37733370|NCT01769378|69213760|FG000|Overall Study|Sponsor Decision|1|||
37733371|NCT01769378|69213761|FG001|Overall Study|Sponsor Decision|0|||
37733372|NCT01769378|69213760|FG000|Overall Study|Lost to Follow-up|2|||
37733373|NCT01769378|69213761|FG001|Overall Study|Lost to Follow-up|0|||
37733374|NCT01807520|69213770|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
37733375|NCT01807520|69213771|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
37733376|NCT01807520|69213772|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
37733377|NCT01807520|69213773|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
37733378|NCT01807520|69213774|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
37733379|NCT01807520|69213775|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
37733380|NCT01807520|69213776|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
37733381|NCT01807520|69213770|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
37733382|NCT01807520|69213771|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
37733383|NCT01807520|69213772|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
37733384|NCT01807520|69213773|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
37733385|NCT01807520|69213774|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
37733386|NCT01807520|69213775|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
37733387|NCT01807520|69213776|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
37733388|NCT01807520|69213770|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
37733389|NCT01807520|69213771|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
37733390|NCT01807520|69213772|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
37733391|NCT01807520|69213773|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
37733392|NCT01807520|69213774|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
37733393|NCT01807520|69213775|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
37733394|NCT01807520|69213776|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
37733395|NCT01807520|69213770|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
37733396|NCT01807520|69213771|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
37733397|NCT01807520|69213772|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
37733398|NCT01807520|69213773|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
37733399|NCT01807520|69213774|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
37733400|NCT01807520|69213775|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
37733401|NCT01807520|69213776|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
37733402|NCT01807520|69213770|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
37733403|NCT01807520|69213771|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
37733404|NCT01807520|69213772|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
37733405|NCT01807520|69213773|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
37733406|NCT01807520|69213774|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
37733407|NCT01807520|69213775|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
37733408|NCT01807520|69213776|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
37733409|NCT01807520|69213770|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
37733410|NCT01807520|69213771|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
37733411|NCT01807520|69213772|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
37733412|NCT01807520|69213773|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
37733413|NCT01807520|69213774|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
37733414|NCT01807520|69213775|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
37733415|NCT01807520|69213776|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
37733416|NCT01807520|69213770|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
37733417|NCT01807520|69213771|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
37733418|NCT01807520|69213772|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
37733419|NCT01807520|69213773|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
37844589|NCT01335477|69529171|FG000|Overall Study|Reason other than those stated above|2|||
37844590|NCT01335477|69529172|FG001|Overall Study|Reason other than those stated above|2|||
37844591|NCT01371825|69529178|FG000|Overall Study|Death|4|||
37844592|NCT01371747|69529188|FG000|Overall Study|Adverse Event|4|||
37844593|NCT01371747|69529189|FG001|Overall Study|Adverse Event|2|||
37844594|NCT01371747|69529190|FG002|Overall Study|Adverse Event|7|||
37844595|NCT01371747|69529191|FG003|Overall Study|Adverse Event|2|||
37733420|NCT01807520|69213774|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
37733421|NCT01807520|69213775|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
37733422|NCT01807520|69213776|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
37733423|NCT01807520|69213770|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
37733424|NCT01807520|69213771|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
37844596|NCT01371747|69529192|FG004|Overall Study|Adverse Event|2|||
37916157|NCT00515827|69603069|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
37844597|NCT01371747|69529193|FG005|Overall Study|Adverse Event|2|||
37733425|NCT01807520|69213772|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
37733426|NCT01807520|69213773|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
37733427|NCT01807520|69213774|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
37733428|NCT01807520|69213775|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
37733429|NCT01807520|69213776|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
37733430|NCT01807520|69213770|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
37733431|NCT01807520|69213771|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
37733432|NCT01807520|69213772|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
37733433|NCT01807520|69213773|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
37733434|NCT01807520|69213774|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
37733435|NCT01807520|69213775|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
37733436|NCT01807520|69213776|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
37733437|NCT01807520|69213770|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
37733438|NCT01807520|69213771|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
37733439|NCT01807520|69213772|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
37733440|NCT01807520|69213773|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
37733441|NCT01807520|69213774|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
37733442|NCT01807520|69213775|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
37733443|NCT01807520|69213776|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
37733444|NCT01807520|69213770|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
37733445|NCT01807520|69213771|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
37733446|NCT01807520|69213772|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
37733447|NCT01807520|69213773|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
37733448|NCT01807520|69213774|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
37733449|NCT01807520|69213775|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
37733450|NCT01807520|69213776|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
37733451|NCT01807520|69213770|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
37733452|NCT01807520|69213771|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
37733453|NCT01807520|69213772|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
37733454|NCT01807520|69213773|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
37733455|NCT01807520|69213774|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
37733456|NCT01807520|69213775|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
37733457|NCT01807520|69213776|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
37733458|NCT01807520|69213770|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
37733459|NCT01807520|69213771|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
37733460|NCT01807520|69213772|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
37733461|NCT01807520|69213773|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
37733462|NCT01807520|69213774|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
37733463|NCT01807520|69213775|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
37733464|NCT01807520|69213776|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
37733465|NCT01807520|69213770|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
37733466|NCT01807520|69213771|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
37733467|NCT01807520|69213772|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
37733468|NCT01807520|69213773|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
37733469|NCT01807520|69213774|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
37733470|NCT01807520|69213775|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
37733471|NCT01807520|69213776|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
37733472|NCT01807520|69213770|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
37733473|NCT01807520|69213771|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
37733474|NCT01807520|69213772|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
37733475|NCT01807520|69213773|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
37733476|NCT01807520|69213774|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
37733477|NCT01807520|69213775|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
37733478|NCT01807520|69213776|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
37733479|NCT01807520|69213770|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
37733480|NCT01807520|69213771|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
37733481|NCT01807520|69213772|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
37733482|NCT01807520|69213773|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
37733483|NCT01807520|69213774|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
37733484|NCT01807520|69213775|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
37844598|NCT01371747|69529188|FG000|Overall Study|Death|1|||
37844599|NCT01371747|69529189|FG001|Overall Study|Death|0|||
37844600|NCT01371747|69529190|FG002|Overall Study|Death|4|||
37733485|NCT01807520|69213776|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
37733486|NCT01807520|69213770|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
37844601|NCT01371747|69529191|FG003|Overall Study|Death|1|||
37844602|NCT01371747|69529192|FG004|Overall Study|Death|2|||
37844603|NCT01371747|69529193|FG005|Overall Study|Death|0|||
37733487|NCT01807520|69213771|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
37733488|NCT01807520|69213772|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
37733489|NCT01807520|69213773|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
37733490|NCT01807520|69213774|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
37733491|NCT01807520|69213775|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
37733492|NCT01807520|69213776|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
37733493|NCT01806896|69213789|FG000|Overall Study|Adverse Event|2|||
37733494|NCT01806896|69213790|FG001|Overall Study|Adverse Event|0|||
37733495|NCT01806896|69213789|FG000|Overall Study|Other|1|||
37733496|NCT01806896|69213790|FG001|Overall Study|Other|0|||
37733497|NCT01768676|69213798|FG000|Overall Study|Adverse Event|3|||
37733498|NCT01768676|69213799|FG001|Overall Study|Adverse Event|3|||
37733499|NCT01768676|69213798|FG000|Overall Study|Lost to Follow-up|13|||
37733500|NCT01768676|69213799|FG001|Overall Study|Lost to Follow-up|16|||
37733501|NCT01768676|69213798|FG000|Overall Study|Protocol Violation|1|||
37733502|NCT01768676|69213799|FG001|Overall Study|Protocol Violation|1|||
37733503|NCT01768676|69213798|FG000|Overall Study|Physician Decision|4|||
37733504|NCT01768676|69213799|FG001|Overall Study|Physician Decision|1|||
37733505|NCT01768676|69213798|FG000|Overall Study|Withdrawal by Subject|3|||
37733506|NCT01768676|69213799|FG001|Overall Study|Withdrawal by Subject|10|||
37733507|NCT01555125|69213808|FG000|Induction Period|Lost to Follow-up|0|||
37733508|NCT01555125|69213809|FG001|Induction Period|Lost to Follow-up|2|||
37733509|NCT01555125|69213810|FG002|Induction Period|Lost to Follow-up|0|||
37733510|NCT01555125|69213811|FG003|Induction Period|Lost to Follow-up|0|||
37733511|NCT01555125|69213812|FG004|Induction Period|Lost to Follow-up|0|||
37733512|NCT01555125|69213808|FG000|Induction Period|Adverse Event|0|||
37733513|NCT01555125|69213809|FG001|Induction Period|Adverse Event|1|||
37733514|NCT01555125|69213810|FG002|Induction Period|Adverse Event|0|||
37733515|NCT01555125|69213811|FG003|Induction Period|Adverse Event|0|||
37733516|NCT01555125|69213812|FG004|Induction Period|Adverse Event|1|||
37733517|NCT01555125|69213808|FG000|Induction Period|Subject / guardian decision|0|||
37733518|NCT01555125|69213809|FG001|Induction Period|Subject / guardian decision|0|||
37733519|NCT01555125|69213810|FG002|Induction Period|Subject / guardian decision|0|||
37733520|NCT01555125|69213811|FG003|Induction Period|Subject / guardian decision|0|||
37733521|NCT01555125|69213812|FG004|Induction Period|Subject / guardian decision|2|||
37733522|NCT01555125|69213808|FG000|Induction Period|Death|1|||
37733523|NCT01555125|69213809|FG001|Induction Period|Death|0|||
37733524|NCT01555125|69213810|FG002|Induction Period|Death|0|||
37733525|NCT01555125|69213811|FG003|Induction Period|Death|0|||
37733526|NCT01555125|69213812|FG004|Induction Period|Death|0|||
37733527|NCT01555125|69213808|FG000|Maintenance Period|Adverse Event|1|||
37733528|NCT01555125|69213809|FG001|Maintenance Period|Adverse Event|1|||
37733529|NCT01555125|69213810|FG002|Maintenance Period|Adverse Event|0|||
37733530|NCT01555125|69213811|FG003|Maintenance Period|Adverse Event|0|||
37733531|NCT01555125|69213812|FG004|Maintenance Period|Adverse Event|0|||
37733532|NCT01555125|69213808|FG000|Maintenance Period|Subject / guardian decision|1|||
37733533|NCT01555125|69213809|FG001|Maintenance Period|Subject / guardian decision|2|||
37733534|NCT01555125|69213810|FG002|Maintenance Period|Subject / guardian decision|0|||
37733535|NCT01555125|69213811|FG003|Maintenance Period|Subject / guardian decision|0|||
37733536|NCT01555125|69213812|FG004|Maintenance Period|Subject / guardian decision|0|||
37733537|NCT01555125|69213808|FG000|Maintenance Period|Lost to Follow-up|2|||
37733538|NCT01555125|69213809|FG001|Maintenance Period|Lost to Follow-up|0|||
37844604|NCT01371747|69529188|FG000|Overall Study|Abnormal Renal Function|0|||
37844605|NCT01371747|69529189|FG001|Overall Study|Abnormal Renal Function|2|||
37844606|NCT01371747|69529190|FG002|Overall Study|Abnormal Renal Function|0|||
37844607|NCT01371747|69529191|FG003|Overall Study|Abnormal Renal Function|1|||
37844608|NCT01371747|69529192|FG004|Overall Study|Abnormal Renal Function|0|||
37844609|NCT01371747|69529193|FG005|Overall Study|Abnormal Renal Function|1|||
37733539|NCT01555125|69213810|FG002|Maintenance Period|Lost to Follow-up|0|||
37733540|NCT01555125|69213811|FG003|Maintenance Period|Lost to Follow-up|1|||
37733541|NCT01555125|69213812|FG004|Maintenance Period|Lost to Follow-up|0|||
37733542|NCT01555125|69213808|FG000|Maintenance Period|Lack of Efficacy|6|||
37733543|NCT01555125|69213809|FG001|Maintenance Period|Lack of Efficacy|1|||
37733544|NCT01555125|69213810|FG002|Maintenance Period|Lack of Efficacy|3|||
37733545|NCT01555125|69213811|FG003|Maintenance Period|Lack of Efficacy|0|||
37733546|NCT01555125|69213812|FG004|Maintenance Period|Lack of Efficacy|0|||
37733547|NCT01555125|69213808|FG000|Maintenance Period|Physician Decision|0|||
37733548|NCT01555125|69213809|FG001|Maintenance Period|Physician Decision|0|||
37733549|NCT01555125|69213810|FG002|Maintenance Period|Physician Decision|1|||
37733550|NCT01555125|69213811|FG003|Maintenance Period|Physician Decision|0|||
37733551|NCT01555125|69213812|FG004|Maintenance Period|Physician Decision|0|||
37844610|NCT01371747|69529188|FG000|Overall Study|High Serum Potassium Results|1|||
37733552|NCT01555125|69213808|FG000|Maintenance Period|Death|0|||
37733553|NCT01555125|69213809|FG001|Maintenance Period|Death|0|||
37733554|NCT01555125|69213810|FG002|Maintenance Period|Death|0|||
37733555|NCT01555125|69213811|FG003|Maintenance Period|Death|1|||
37733556|NCT01555125|69213812|FG004|Maintenance Period|Death|0|||
37733557|NCT01555125|69213808|FG000|Extension|Adverse Event|1|||
37733558|NCT01555125|69213809|FG001|Extension|Adverse Event|2|||
37733559|NCT01555125|69213810|FG002|Extension|Adverse Event|1|||
37733560|NCT01555125|69213811|FG003|Extension|Adverse Event|1|||
37733561|NCT01555125|69213812|FG004|Extension|Adverse Event|0|||
37733562|NCT01555125|69213808|FG000|Extension|Protocol deviation|1|||
37733563|NCT01555125|69213809|FG001|Extension|Protocol deviation|0|||
37733564|NCT01555125|69213810|FG002|Extension|Protocol deviation|0|||
37733565|NCT01555125|69213811|FG003|Extension|Protocol deviation|0|||
37733566|NCT01555125|69213812|FG004|Extension|Protocol deviation|0|||
37733567|NCT01555125|69213808|FG000|Extension|Lack of Efficacy|7|||
37733568|NCT01555125|69213809|FG001|Extension|Lack of Efficacy|6|||
37733569|NCT01555125|69213810|FG002|Extension|Lack of Efficacy|3|||
37733570|NCT01555125|69213811|FG003|Extension|Lack of Efficacy|0|||
37733571|NCT01555125|69213812|FG004|Extension|Lack of Efficacy|0|||
37733572|NCT01555125|69213808|FG000|Extension|Lost to Follow-up|2|||
37733573|NCT01555125|69213809|FG001|Extension|Lost to Follow-up|1|||
37733574|NCT01555125|69213810|FG002|Extension|Lost to Follow-up|2|||
37733575|NCT01555125|69213811|FG003|Extension|Lost to Follow-up|0|||
37733576|NCT01555125|69213812|FG004|Extension|Lost to Follow-up|0|||
37733577|NCT01555125|69213808|FG000|Extension|Study terminated by sponsor|32|||
37733578|NCT01555125|69213809|FG001|Extension|Study terminated by sponsor|33|||
37733579|NCT01555125|69213810|FG002|Extension|Study terminated by sponsor|16|||
37733580|NCT01555125|69213811|FG003|Extension|Study terminated by sponsor|20|||
37733581|NCT01555125|69213812|FG004|Extension|Study terminated by sponsor|0|||
37733582|NCT01555125|69213808|FG000|Extension|Subject/guardian decision|1|||
37733583|NCT01555125|69213809|FG001|Extension|Subject/guardian decision|9|||
37733584|NCT01555125|69213810|FG002|Extension|Subject/guardian decision|1|||
37733585|NCT01555125|69213811|FG003|Extension|Subject/guardian decision|0|||
37733586|NCT01555125|69213812|FG004|Extension|Subject/guardian decision|0|||
37733587|NCT01555125|69213808|FG000|Extension|Technical Problems|1|||
37733588|NCT01555125|69213809|FG001|Extension|Technical Problems|0|||
37733589|NCT01555125|69213810|FG002|Extension|Technical Problems|0|||
37733590|NCT01555125|69213811|FG003|Extension|Technical Problems|1|||
37733591|NCT01555125|69213812|FG004|Extension|Technical Problems|0|||
37733592|NCT01555125|69213808|FG000|Follow-Up Period|Lost to Follow-up|1|||
37733593|NCT01555125|69213809|FG001|Follow-Up Period|Lost to Follow-up|0|||
37733594|NCT01555125|69213810|FG002|Follow-Up Period|Lost to Follow-up|0|||
37733595|NCT01555125|69213811|FG003|Follow-Up Period|Lost to Follow-up|0|||
37733596|NCT01555125|69213812|FG004|Follow-Up Period|Lost to Follow-up|0|||
37733597|NCT01555125|69213808|FG000|Follow-Up Period|Subject / guardian decision|3|||
37733598|NCT01555125|69213809|FG001|Follow-Up Period|Subject / guardian decision|1|||
37733599|NCT01555125|69213810|FG002|Follow-Up Period|Subject / guardian decision|1|||
37733600|NCT01555125|69213811|FG003|Follow-Up Period|Subject / guardian decision|1|||
37733601|NCT01555125|69213812|FG004|Follow-Up Period|Subject / guardian decision|0|||
37733602|NCT01768286|69213831|FG000|Overall Study|Randomized But Not Treated|0|||
37733603|NCT01768286|69213832|FG001|Overall Study|Randomized But Not Treated|0|||
37733604|NCT01768286|69213833|FG002|Overall Study|Randomized But Not Treated|1|||
37733605|NCT01768286|69213834|FG003|Overall Study|Randomized But Not Treated|0|||
37733606|NCT01768286|69213831|FG000|Overall Study|Lack of Efficacy|7|||
37733607|NCT01768286|69213832|FG001|Overall Study|Lack of Efficacy|4|||
37733608|NCT01768286|69213833|FG002|Overall Study|Lack of Efficacy|0|||
37733609|NCT01768286|69213834|FG003|Overall Study|Lack of Efficacy|1|||
37733610|NCT01768286|69213831|FG000|Overall Study|Withdrew Consent|0|||
37733611|NCT01768286|69213832|FG001|Overall Study|Withdrew Consent|0|||
37733612|NCT01768286|69213833|FG002|Overall Study|Withdrew Consent|1|||
37733613|NCT01768286|69213834|FG003|Overall Study|Withdrew Consent|0|||
37733614|NCT01800968|69213846|FG000|Overall Study|Death|23|||
37733615|NCT01800968|69213847|FG001|Overall Study|Death|16|||
37733616|NCT01800968|69213846|FG000|Overall Study|Lost to Follow-up|5|||
37733617|NCT01800968|69213847|FG001|Overall Study|Lost to Follow-up|7|||
37733618|NCT01800968|69213846|FG000|Overall Study|Withdrawal by Subject|7|||
37733619|NCT01800968|69213847|FG001|Overall Study|Withdrawal by Subject|9|||
37844611|NCT01371747|69529189|FG001|Overall Study|High Serum Potassium Results|1|||
37733620|NCT01800968|69213846|FG000|Overall Study|Physician Decision|1|||
37733621|NCT01800968|69213847|FG001|Overall Study|Physician Decision|0|||
37733622|NCT01799720|69213856|FG000|Overall Study|Withdrawal by Subject|3|||
37733623|NCT01799720|69213857|FG001|Overall Study|Withdrawal by Subject|0|||
37733624|NCT01799720|69213858|FG002|Overall Study|Withdrawal by Subject|0|||
37844612|NCT01371747|69529190|FG002|Overall Study|High Serum Potassium Results|1|||
37733625|NCT01799720|69213856|FG000|Overall Study|Protocol Violation|0|||
37733626|NCT01799720|69213857|FG001|Overall Study|Protocol Violation|1|||
37733627|NCT01799720|69213858|FG002|Overall Study|Protocol Violation|0|||
37733628|NCT01799720|69213856|FG000|Overall Study|Pregnancy|0|||
37733629|NCT01799720|69213857|FG001|Overall Study|Pregnancy|0|||
37733630|NCT01799720|69213858|FG002|Overall Study|Pregnancy|1|||
37733631|NCT01687257|69213868|FG000|Overall Study|Efficacy Failure|6|||
37733632|NCT01687257|69213869|FG001|Overall Study|Efficacy Failure|0|||
37733633|NCT01687257|69213870|FG002|Overall Study|Efficacy Failure|5|||
37733634|NCT01687257|69213868|FG000|Overall Study|Subject Withdrew Consent|1|||
37733635|NCT01687257|69213869|FG001|Overall Study|Subject Withdrew Consent|1|||
37733636|NCT01687257|69213870|FG002|Overall Study|Subject Withdrew Consent|1|||
37733637|NCT01687257|69213868|FG000|Overall Study|Adverse Event|1|||
37733638|NCT01687257|69213869|FG001|Overall Study|Adverse Event|0|||
37733639|NCT01687257|69213870|FG002|Overall Study|Adverse Event|0|||
37733640|NCT01687257|69213868|FG000|Overall Study|Investigator's Discretion|0|||
37733641|NCT01687257|69213869|FG001|Overall Study|Investigator's Discretion|3|||
37733642|NCT01687257|69213870|FG002|Overall Study|Investigator's Discretion|0|||
37733643|NCT01806740|69213884|FG000|Overall Study|Withdrawal by Subject|4|||
37733644|NCT01806740|69213884|FG000|Overall Study|Physician Decision|1|||
37733645|NCT01806740|69213884|FG000|Overall Study|Patient's refusal of treatment|1|||
37733646|NCT01687101|69213891|FG000|Overall Study|Lost to Follow-up|7|||
37733647|NCT01968967|69213897|FG000|Treatment Period|Other|22|||
37733648|NCT01968967|69213898|FG001|Treatment Period|Other|22|||
37733649|NCT01968967|69213899|FG002|Treatment Period|Other|0|||
37733650|NCT01968967|69213900|FG003|Treatment Period|Other|0|||
37733651|NCT01968967|69213901|FG004|Treatment Period|Other|0|||
37733652|NCT01968967|69213897|FG000|Treatment Period|Withdrawal by Subject|71|||
37733653|NCT01968967|69213898|FG001|Treatment Period|Withdrawal by Subject|61|||
37733654|NCT01968967|69213899|FG002|Treatment Period|Withdrawal by Subject|0|||
37733655|NCT01968967|69213900|FG003|Treatment Period|Withdrawal by Subject|0|||
37733656|NCT01968967|69213901|FG004|Treatment Period|Withdrawal by Subject|0|||
37733657|NCT01968967|69213897|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
37733658|NCT01968967|69213898|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
37733659|NCT01968967|69213899|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
37733660|NCT01968967|69213900|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
37733661|NCT01968967|69213901|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
37733662|NCT01968967|69213897|FG000|Treatment Period|Lost to Follow-up|26|||
37733663|NCT01968967|69213898|FG001|Treatment Period|Lost to Follow-up|31|||
37733664|NCT01968967|69213899|FG002|Treatment Period|Lost to Follow-up|0|||
37733665|NCT01968967|69213900|FG003|Treatment Period|Lost to Follow-up|0|||
37733666|NCT01968967|69213901|FG004|Treatment Period|Lost to Follow-up|0|||
37733667|NCT01968967|69213897|FG000|Treatment Period|Protocol Violation|1|||
37733668|NCT01968967|69213898|FG001|Treatment Period|Protocol Violation|2|||
37733669|NCT01968967|69213899|FG002|Treatment Period|Protocol Violation|0|||
37733670|NCT01968967|69213900|FG003|Treatment Period|Protocol Violation|0|||
37733671|NCT01968967|69213901|FG004|Treatment Period|Protocol Violation|0|||
37733672|NCT01968967|69213897|FG000|Treatment Period|Adverse Event|9|||
37733673|NCT01968967|69213898|FG001|Treatment Period|Adverse Event|8|||
37733674|NCT01968967|69213899|FG002|Treatment Period|Adverse Event|0|||
37733675|NCT01968967|69213900|FG003|Treatment Period|Adverse Event|0|||
37733676|NCT01968967|69213901|FG004|Treatment Period|Adverse Event|0|||
37733677|NCT01968967|69213897|FG000|Treatment Period|Death|9|||
37733678|NCT01968967|69213898|FG001|Treatment Period|Death|2|||
37733679|NCT01968967|69213899|FG002|Treatment Period|Death|0|||
37733680|NCT01968967|69213900|FG003|Treatment Period|Death|0|||
37733681|NCT01968967|69213901|FG004|Treatment Period|Death|0|||
37733682|NCT01968967|69213897|FG000|Treatment Period|Randomized Not Treated|6|||
37733683|NCT01968967|69213898|FG001|Treatment Period|Randomized Not Treated|5|||
37733684|NCT01968967|69213899|FG002|Treatment Period|Randomized Not Treated|0|||
37733685|NCT01968967|69213900|FG003|Treatment Period|Randomized Not Treated|0|||
37733686|NCT01968967|69213901|FG004|Treatment Period|Randomized Not Treated|0|||
38025866|NCT03053050|69710494|FG002|Randomized Phase|Randomized but Never Treated|2|||
38025867|NCT03053050|69710495|FG003|Randomized Phase|Randomized but Never Treated|0|||
38025868|NCT03053050|69710492|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
38025869|NCT03053050|69710493|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
37733687|NCT01968967|69213897|FG000|Extension Period|Withdrew Consent|0|||
37733688|NCT01968967|69213898|FG001|Extension Period|Withdrew Consent|0|||
37733689|NCT01968967|69213899|FG002|Extension Period|Withdrew Consent|2|||
37733690|NCT01968967|69213900|FG003|Extension Period|Withdrew Consent|0|||
37733691|NCT01968967|69213901|FG004|Extension Period|Withdrew Consent|5|||
37733692|NCT01554579|69213917|FG000|Overall Study|Adverse Event|6|||
37733693|NCT01554579|69213918|FG001|Overall Study|Adverse Event|25|||
37844613|NCT01371747|69529191|FG003|Overall Study|High Serum Potassium Results|2|||
37733694|NCT01554579|69213917|FG000|Overall Study|Lack of Efficacy|2|||
37733695|NCT01554579|69213918|FG001|Overall Study|Lack of Efficacy|1|||
37733696|NCT01554579|69213917|FG000|Overall Study|Withdrawal by Subject|2|||
37733697|NCT01554579|69213918|FG001|Overall Study|Withdrawal by Subject|1|||
37733698|NCT01806662|69213925|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
37733699|NCT01806662|69213926|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
37844614|NCT01371747|69529192|FG004|Overall Study|High Serum Potassium Results|0|||
37733700|NCT01806662|69213925|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
37733701|NCT01806662|69213926|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
37733702|NCT01806662|69213925|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
37733703|NCT01806662|69213926|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
37733704|NCT01806662|69213925|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
37733705|NCT01806662|69213926|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
37733706|NCT01930123|69213934|FG000|Overall Study|Adverse Event|1|||
37733707|NCT01930123|69213935|FG001|Overall Study|Adverse Event|0|||
37733708|NCT01930123|69213934|FG000|Overall Study|Physician Decision|21|||
37733709|NCT01930123|69213935|FG001|Overall Study|Physician Decision|8|||
37733710|NCT01930123|69213934|FG000|Overall Study|Withdrawal by Subject|1|||
37733711|NCT01930123|69213935|FG001|Overall Study|Withdrawal by Subject|0|||
37733712|NCT01930045|69213941|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
37733713|NCT01930045|69213942|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
37733714|NCT01930045|69213943|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
37733715|NCT01930045|69213944|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
37733716|NCT01930045|69213945|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
37733717|NCT01930045|69213946|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
37733718|NCT01930045|69213941|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
37733719|NCT01930045|69213942|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
37733720|NCT01930045|69213943|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
37733721|NCT01930045|69213944|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
37844615|NCT01371747|69529193|FG005|Overall Study|High Serum Potassium Results|2|||
37844616|NCT01371747|69529188|FG000|Overall Study|Low Serum Potassium Results|1|||
37844617|NCT01371747|69529189|FG001|Overall Study|Low Serum Potassium Results|1|||
37844618|NCT01371747|69529190|FG002|Overall Study|Low Serum Potassium Results|1|||
37844619|NCT01371747|69529191|FG003|Overall Study|Low Serum Potassium Results|1|||
37844620|NCT01371747|69529192|FG004|Overall Study|Low Serum Potassium Results|0|||
37844621|NCT01371747|69529193|FG005|Overall Study|Low Serum Potassium Results|3|||
37844622|NCT01371747|69529188|FG000|Overall Study|Protocol Violation|0|||
37844623|NCT01371747|69529189|FG001|Overall Study|Protocol Violation|0|||
37844624|NCT01371747|69529190|FG002|Overall Study|Protocol Violation|1|||
37733722|NCT01930045|69213945|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
37733723|NCT01930045|69213946|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
37733724|NCT01929343|69213961|FG000|Overall Study|Physician Decision|0|||
37733725|NCT01929343|69213962|FG001|Overall Study|Physician Decision|2|||
37733726|NCT01929343|69213963|FG002|Overall Study|Physician Decision|0|||
37733727|NCT01929343|69213961|FG000|Overall Study|Withdrawal by Subject|1|||
37733728|NCT01929343|69213962|FG001|Overall Study|Withdrawal by Subject|0|||
37733729|NCT01929343|69213963|FG002|Overall Study|Withdrawal by Subject|0|||
37733730|NCT01968811|69213971|FG000|Overall Study|Protocol Violation|4|||
37733731|NCT01968811|69213971|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
37733732|NCT01806584|69213977|FG000|Overall Study|Adverse Event|2|||
37733733|NCT01806584|69213978|FG001|Overall Study|Adverse Event|1|||
37733734|NCT01806584|69213977|FG000|Overall Study|Death|1|||
37733735|NCT01806584|69213978|FG001|Overall Study|Death|0|||
37733736|NCT01806584|69213977|FG000|Overall Study|Lost to Follow-up|0|||
37733737|NCT01806584|69213978|FG001|Overall Study|Lost to Follow-up|2|||
37733738|NCT01806584|69213977|FG000|Overall Study|Study terminated by sponsor|9|||
37733739|NCT01806584|69213978|FG001|Overall Study|Study terminated by sponsor|14|||
37733740|NCT01806584|69213977|FG000|Overall Study|Withdrawal by Subject|1|||
37733741|NCT01806584|69213978|FG001|Overall Study|Withdrawal by Subject|1|||
37733742|NCT01806584|69213977|FG000|Overall Study|Other unspecified|1|||
37733743|NCT01806584|69213978|FG001|Overall Study|Other unspecified|0|||
37844625|NCT01371747|69529191|FG003|Overall Study|Protocol Violation|0|||
37844626|NCT01371747|69529192|FG004|Overall Study|Protocol Violation|0|||
37844627|NCT01371747|69529193|FG005|Overall Study|Protocol Violation|0|||
37844628|NCT01371747|69529188|FG000|Overall Study|Non-Compliance|3|||
37844629|NCT01371747|69529189|FG001|Overall Study|Non-Compliance|4|||
37916158|NCT00522457|69603077|FG000|Overall Study|Due to disease progression|16|||
37916159|NCT00522457|69603077|FG000|Overall Study|Adverse Event|2|||
37916160|NCT00856986|69603086|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
37916161|NCT00856986|69603087|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
37733744|NCT01798706|69213986|FG000|Overall Study|Adverse Event|15|||
37733745|NCT01798706|69213987|FG001|Overall Study|Adverse Event|10|||
37844630|NCT01371747|69529190|FG002|Overall Study|Non-Compliance|3|||
37733746|NCT01798706|69213986|FG000|Overall Study|Lack of Efficacy|0|||
37733747|NCT01798706|69213987|FG001|Overall Study|Lack of Efficacy|2|||
37733748|NCT01798706|69213986|FG000|Overall Study|Poor compliance to protocol|1|||
37733749|NCT01798706|69213987|FG001|Overall Study|Poor compliance to protocol|0|||
37733750|NCT01798706|69213986|FG000|Overall Study|Other than specified above|5|||
37733751|NCT01798706|69213987|FG001|Overall Study|Other than specified above|9|||
37733752|NCT01767194|69213995|FG000|Overall Study|Adverse Event|1|||
37844631|NCT01371747|69529191|FG003|Overall Study|Non-Compliance|0|||
37844632|NCT01371747|69529192|FG004|Overall Study|Non-Compliance|0|||
37844633|NCT01371747|69529193|FG005|Overall Study|Non-Compliance|1|||
37733753|NCT01767194|69213996|FG001|Overall Study|Adverse Event|1|||
37844634|NCT01371747|69529188|FG000|Overall Study|Physician Decision|0|||
37844635|NCT01371747|69529189|FG001|Overall Study|Physician Decision|0|||
37844636|NCT01371747|69529190|FG002|Overall Study|Physician Decision|0|||
37844637|NCT01371747|69529191|FG003|Overall Study|Physician Decision|0|||
37844638|NCT01371747|69529192|FG004|Overall Study|Physician Decision|1|||
37844639|NCT01371747|69529193|FG005|Overall Study|Physician Decision|0|||
37844640|NCT01371747|69529188|FG000|Overall Study|Withdrawal by Subject|6|||
37844641|NCT01371747|69529189|FG001|Overall Study|Withdrawal by Subject|12|||
37844642|NCT01371747|69529190|FG002|Overall Study|Withdrawal by Subject|5|||
37844643|NCT01371747|69529191|FG003|Overall Study|Withdrawal by Subject|2|||
37844644|NCT01371747|69529192|FG004|Overall Study|Withdrawal by Subject|2|||
37844645|NCT01371747|69529193|FG005|Overall Study|Withdrawal by Subject|4|||
37844646|NCT01371747|69529188|FG000|Overall Study|Other Reasons|2|||
37844647|NCT01371747|69529189|FG001|Overall Study|Other Reasons|1|||
37844648|NCT01371747|69529190|FG002|Overall Study|Other Reasons|2|||
37844649|NCT01371747|69529191|FG003|Overall Study|Other Reasons|0|||
37733754|NCT01767194|69213995|FG000|Overall Study|Death|0|||
37733755|NCT01767194|69213996|FG001|Overall Study|Death|1|||
37844650|NCT01371747|69529192|FG004|Overall Study|Other Reasons|0|||
37844651|NCT01371747|69529193|FG005|Overall Study|Other Reasons|1|||
37844652|NCT01371708|69529228|FG000|Overall Study|Insufficient clinical response|3|||
37844653|NCT01371708|69529229|FG001|Overall Study|Insufficient clinical response|2|||
37844654|NCT01371708|69529230|FG002|Overall Study|Insufficient clinical response|0|||
37844655|NCT01371708|69529228|FG000|Overall Study|Lost to Follow-up|5|||
37733756|NCT01767194|69213995|FG000|Overall Study|Lack of Efficacy|12|||
37733757|NCT01767194|69213996|FG001|Overall Study|Lack of Efficacy|11|||
37733758|NCT01767194|69213995|FG000|Overall Study|Physician Decision|2|||
37733759|NCT01767194|69213996|FG001|Overall Study|Physician Decision|23|||
37733760|NCT01767194|69213995|FG000|Overall Study|Withdrawal by Subject|0|||
37733761|NCT01767194|69213996|FG001|Overall Study|Withdrawal by Subject|1|||
37733762|NCT01767194|69213995|FG000|Overall Study|Ineligible|1|||
37733763|NCT01767194|69213996|FG001|Overall Study|Ineligible|1|||
37733764|NCT01767194|69213995|FG000|Overall Study|Refusal by patient/parent|2|||
37733765|NCT01767194|69213996|FG001|Overall Study|Refusal by patient/parent|4|||
37733766|NCT01767194|69213995|FG000|Overall Study|Criteria not met on time for next cycle|0|||
37733767|NCT01767194|69213996|FG001|Overall Study|Criteria not met on time for next cycle|1|||
37733768|NCT01575873|69214007|FG000|Overall Study|Withdrawal by Subject|15|||
37733769|NCT01575873|69214008|FG001|Overall Study|Withdrawal by Subject|20|||
37733770|NCT01575873|69214009|FG002|Overall Study|Withdrawal by Subject|34|||
37733771|NCT01575873|69214010|FG003|Overall Study|Withdrawal by Subject|34|||
37733772|NCT01575873|69214007|FG000|Overall Study|Adverse Event|7|||
37733773|NCT01575873|69214008|FG001|Overall Study|Adverse Event|7|||
37733774|NCT01575873|69214009|FG002|Overall Study|Adverse Event|9|||
37733775|NCT01575873|69214010|FG003|Overall Study|Adverse Event|12|||
37733776|NCT01575873|69214007|FG000|Overall Study|Lost to Follow-up|1|||
37733777|NCT01575873|69214008|FG001|Overall Study|Lost to Follow-up|3|||
37733778|NCT01575873|69214009|FG002|Overall Study|Lost to Follow-up|13|||
37733779|NCT01575873|69214010|FG003|Overall Study|Lost to Follow-up|5|||
37733780|NCT01575873|69214007|FG000|Overall Study|Death|3|||
37733781|NCT01575873|69214008|FG001|Overall Study|Death|2|||
37733782|NCT01575873|69214009|FG002|Overall Study|Death|8|||
37733783|NCT01575873|69214010|FG003|Overall Study|Death|9|||
37733784|NCT01575873|69214007|FG000|Overall Study|Noncompliance|1|||
37733785|NCT01575873|69214008|FG001|Overall Study|Noncompliance|2|||
37733786|NCT01575873|69214009|FG002|Overall Study|Noncompliance|4|||
37733787|NCT01575873|69214010|FG003|Overall Study|Noncompliance|3|||
37733788|NCT01575873|69214007|FG000|Overall Study|Administrative decision|1|||
37733789|NCT01575873|69214008|FG001|Overall Study|Administrative decision|1|||
37733790|NCT01575873|69214009|FG002|Overall Study|Administrative decision|1|||
37733791|NCT01575873|69214010|FG003|Overall Study|Administrative decision|0|||
37733792|NCT01575873|69214007|FG000|Overall Study|Protocol deviation|0|||
37733793|NCT01575873|69214008|FG001|Overall Study|Protocol deviation|1|||
37733794|NCT01575873|69214009|FG002|Overall Study|Protocol deviation|0|||
37733795|NCT01575873|69214010|FG003|Overall Study|Protocol deviation|1|||
37733796|NCT01575873|69214007|FG000|Overall Study|Requirement for Alternative Therapy|0|||
37733797|NCT01575873|69214008|FG001|Overall Study|Requirement for Alternative Therapy|0|||
37733798|NCT01575873|69214009|FG002|Overall Study|Requirement for Alternative Therapy|1|||
37733799|NCT01575873|69214010|FG003|Overall Study|Requirement for Alternative Therapy|1|||
37733800|NCT01575873|69214007|FG000|Overall Study|Other|0|||
37733801|NCT01575873|69214008|FG001|Overall Study|Other|0|||
37733802|NCT01575873|69214009|FG002|Overall Study|Other|4|||
37733803|NCT01575873|69214010|FG003|Overall Study|Other|2|||
37733804|NCT01575561|69214018|FG000|Overall Study|Adverse Event|9|||
37733805|NCT01575561|69214018|FG000|Overall Study|Lack of Efficacy|8|||
37733806|NCT01575561|69214018|FG000|Overall Study|Lost to Follow-up|6|||
37733807|NCT01575561|69214018|FG000|Overall Study|Protocol Violation|4|||
37733808|NCT01575561|69214018|FG000|Overall Study|Withdrawal by Subject|11|||
37733809|NCT01575561|69214018|FG000|Overall Study|administration|1|||
37733810|NCT01609790|69214025|FG000|Overall Study|Protocol Violation|1|||
37733811|NCT01609790|69214026|FG001|Overall Study|Protocol Violation|7|||
37733812|NCT01609790|69214027|FG002|Overall Study|Protocol Violation|8|||
37733813|NCT01767116|69214037|FG000|Overall Study|Lost to Follow-up|2|||
37733814|NCT01767116|69214038|FG001|Overall Study|Lost to Follow-up|2|||
37733815|NCT01574703|69214048|FG000|Overall Study|Adverse Event|0|||
37733816|NCT01574703|69214049|FG001|Overall Study|Adverse Event|2|||
38025870|NCT03053050|69710494|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
37733817|NCT01574703|69214050|FG002|Overall Study|Adverse Event|1|||
37733818|NCT01574703|69214051|FG003|Overall Study|Adverse Event|1|||
37733819|NCT01574703|69214048|FG000|Overall Study|Protocol Violation|0|||
37733820|NCT01574703|69214049|FG001|Overall Study|Protocol Violation|0|||
37733821|NCT01574703|69214050|FG002|Overall Study|Protocol Violation|0|||
37733822|NCT01574703|69214051|FG003|Overall Study|Protocol Violation|1|||
37733823|NCT01574703|69214048|FG000|Overall Study|Unspecified Reason|27|||
37733824|NCT01574703|69214049|FG001|Overall Study|Unspecified Reason|15|||
37733825|NCT01574703|69214050|FG002|Overall Study|Unspecified Reason|20|||
37733826|NCT01574703|69214051|FG003|Overall Study|Unspecified Reason|16|||
37733827|NCT01574703|69214048|FG000|Overall Study|Withdrawal by Subject|53|||
37733828|NCT01574703|69214049|FG001|Overall Study|Withdrawal by Subject|52|||
37733829|NCT01574703|69214050|FG002|Overall Study|Withdrawal by Subject|36|||
37733830|NCT01574703|69214051|FG003|Overall Study|Withdrawal by Subject|61|||
37733831|NCT01574703|69214048|FG000|Overall Study|Met Withdrawal Criteria|0|||
37733832|NCT01574703|69214049|FG001|Overall Study|Met Withdrawal Criteria|1|||
37733833|NCT01574703|69214050|FG002|Overall Study|Met Withdrawal Criteria|1|||
37733834|NCT01574703|69214051|FG003|Overall Study|Met Withdrawal Criteria|0|||
37733835|NCT01574703|69214048|FG000|Overall Study|Lost to Follow-up|43|||
37733836|NCT01574703|69214049|FG001|Overall Study|Lost to Follow-up|41|||
37733837|NCT01574703|69214050|FG002|Overall Study|Lost to Follow-up|46|||
37733838|NCT01574703|69214051|FG003|Overall Study|Lost to Follow-up|35|||
37733839|NCT01574703|69214048|FG000|Overall Study|Death|2|||
37733840|NCT01574703|69214049|FG001|Overall Study|Death|1|||
37733841|NCT01574703|69214050|FG002|Overall Study|Death|1|||
37733842|NCT01574703|69214051|FG003|Overall Study|Death|0|||
37733843|NCT01686633|69214064|FG000|Overall Study|Lack of Efficacy|33|||
37733844|NCT01686633|69214065|FG001|Overall Study|Lack of Efficacy|13|||
37733845|NCT01686633|69214066|FG002|Overall Study|Lack of Efficacy|11|||
37733846|NCT01686633|69214064|FG000|Overall Study|Withdrawal by Subject|8|||
37733847|NCT01686633|69214065|FG001|Overall Study|Withdrawal by Subject|8|||
37733848|NCT01686633|69214066|FG002|Overall Study|Withdrawal by Subject|5|||
37733849|NCT01686633|69214064|FG000|Overall Study|Physician Decision|3|||
37733850|NCT01686633|69214065|FG001|Overall Study|Physician Decision|4|||
37733851|NCT01686633|69214066|FG002|Overall Study|Physician Decision|4|||
37733852|NCT01686633|69214064|FG000|Overall Study|Adverse Event|4|||
37733853|NCT01686633|69214065|FG001|Overall Study|Adverse Event|3|||
37733854|NCT01686633|69214066|FG002|Overall Study|Adverse Event|3|||
37733855|NCT01686633|69214064|FG000|Overall Study|Protocol Violation|2|||
37733856|NCT01686633|69214065|FG001|Overall Study|Protocol Violation|3|||
37733857|NCT01686633|69214066|FG002|Overall Study|Protocol Violation|0|||
37733858|NCT01686633|69214064|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
37733859|NCT01686633|69214065|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
37733860|NCT01686633|69214066|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
37733861|NCT01686633|69214064|FG000|Overall Study|Lost to Follow-up|0|||
37733862|NCT01686633|69214065|FG001|Overall Study|Lost to Follow-up|1|||
37733863|NCT01686633|69214066|FG002|Overall Study|Lost to Follow-up|1|||
37733864|NCT01685697|69214076|FG000|Overall Study|Protocol Violation|3|||
37733865|NCT01685697|69214077|FG001|Overall Study|Protocol Violation|3|||
37733866|NCT02395120|69214088|FG000|Overall Study|Missed follow-up dental exam|57|||
37733867|NCT02395120|69214089|FG001|Overall Study|Missed follow-up dental exam|62|||
37844656|NCT01371708|69529229|FG001|Overall Study|Lost to Follow-up|9|||
37844657|NCT01371708|69529230|FG002|Overall Study|Lost to Follow-up|7|||
37844658|NCT01371708|69529228|FG000|Overall Study|Protocol Violation|2|||
37844659|NCT01371708|69529229|FG001|Overall Study|Protocol Violation|1|||
37844660|NCT01371708|69529230|FG002|Overall Study|Protocol Violation|2|||
37844661|NCT01371708|69529228|FG000|Overall Study|No longer willing to participate|7|||
37844662|NCT01371708|69529229|FG001|Overall Study|No longer willing to participate|7|||
37844663|NCT01371708|69529230|FG002|Overall Study|No longer willing to participate|13|||
37844664|NCT01371708|69529228|FG000|Overall Study|Medication error/not related to AE|0|||
37844665|NCT01371708|69529229|FG001|Overall Study|Medication error/not related to AE|1|||
37844666|NCT01371708|69529230|FG002|Overall Study|Medication error/not related to AE|0|||
37844667|NCT01371708|69529228|FG000|Overall Study|Other|3|||
37844668|NCT01371708|69529229|FG001|Overall Study|Other|2|||
37844669|NCT01371708|69529230|FG002|Overall Study|Other|4|||
37844670|NCT01371708|69529228|FG000|Overall Study|Adverse Event|5|||
37844671|NCT01371708|69529229|FG001|Overall Study|Adverse Event|8|||
37844672|NCT01371708|69529230|FG002|Overall Study|Adverse Event|12|||
37844673|NCT01371708|69529228|FG000|Overall Study|Started but did not receive treatment|1|||
37844674|NCT01371708|69529229|FG001|Overall Study|Started but did not receive treatment|0|||
37844675|NCT01371708|69529230|FG002|Overall Study|Started but did not receive treatment|1|||
37844676|NCT01335399|69529242|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
37916162|NCT00856986|69603088|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
37733868|NCT02395120|69214090|FG002|Overall Study|Missed follow-up dental exam|6|||
37733869|NCT02395120|69214091|FG003|Overall Study|Missed follow-up dental exam|6|||
37733870|NCT02395120|69214092|FG004|Overall Study|Missed follow-up dental exam|51|||
37733871|NCT01685229|69214106|FG000|Overall Study|Subjects missing Study Exit form|3|||
37733872|NCT01685229|69214107|FG001|Overall Study|Subjects missing Study Exit form|1|||
37844677|NCT01335399|69529243|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
37844678|NCT01335399|69529242|FG000|Pre-treatment Period|Participant request to discontinue|0|||
37844679|NCT01335399|69529243|FG001|Pre-treatment Period|Participant request to discontinue|1|||
37844680|NCT01335399|69529242|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
37733873|NCT01685229|69214106|FG000|Overall Study|Lost to Follow-up|16|||
37733874|NCT01685229|69214107|FG001|Overall Study|Lost to Follow-up|10|||
37733875|NCT01685229|69214106|FG000|Overall Study|Withdrawal by Subject|6|||
37733876|NCT01685229|69214107|FG001|Overall Study|Withdrawal by Subject|5|||
37733877|NCT01685229|69214106|FG000|Overall Study|Death|1|||
37733878|NCT01685229|69214107|FG001|Overall Study|Death|0|||
37844681|NCT01335399|69529243|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
37844682|NCT01335399|69529242|FG000|Pre-treatment Period|Consent withdrawal|3|||
37844683|NCT01335399|69529243|FG001|Pre-treatment Period|Consent withdrawal|0|||
37844684|NCT01335399|69529242|FG000|Treatment Period|Disease progression|117|||
37733879|NCT01551693|69214118|FG000|Overall Study|Disease Progression|1|||
37733880|NCT01551693|69214119|FG001|Overall Study|Disease Progression|0|||
37733881|NCT01551693|69214118|FG000|Overall Study|Adverse Event|0|||
37733882|NCT01551693|69214119|FG001|Overall Study|Adverse Event|1|||
37733883|NCT01551693|69214118|FG000|Overall Study|Withdrawal by Subject|0|||
37733884|NCT01551693|69214119|FG001|Overall Study|Withdrawal by Subject|1|||
37733885|NCT01574157|69214127|FG000|Overall Study|Withdrawal by Subject|4|||
37733886|NCT01574157|69214128|FG001|Overall Study|Withdrawal by Subject|5|||
37733887|NCT01574157|69214127|FG000|Overall Study|Lost to Follow-up|0|||
37733888|NCT01574157|69214128|FG001|Overall Study|Lost to Follow-up|3|||
37733889|NCT01574079|69214140|FG000|Overall Study|Physician Decision|0|||
37733890|NCT01574079|69214141|FG001|Overall Study|Physician Decision|2|||
37733891|NCT01574079|69214140|FG000|Overall Study|Lost to Follow-up|1|||
37733892|NCT01574079|69214141|FG001|Overall Study|Lost to Follow-up|0|||
37733893|NCT01573767|69214151|FG000|Overall Study|Adverse Event|0|||
37733894|NCT01573767|69214152|FG001|Overall Study|Adverse Event|1|||
37733895|NCT01573767|69214153|FG002|Overall Study|Adverse Event|0|||
37733896|NCT01573767|69214154|FG003|Overall Study|Adverse Event|1|||
37733897|NCT01573767|69214151|FG000|Overall Study|Lack of Efficacy|18|||
37733898|NCT01573767|69214152|FG001|Overall Study|Lack of Efficacy|15|||
37733899|NCT01573767|69214153|FG002|Overall Study|Lack of Efficacy|12|||
37733900|NCT01573767|69214154|FG003|Overall Study|Lack of Efficacy|17|||
37733901|NCT01573767|69214151|FG000|Overall Study|Protocol Violation|3|||
37733902|NCT01573767|69214152|FG001|Overall Study|Protocol Violation|1|||
37733903|NCT01573767|69214153|FG002|Overall Study|Protocol Violation|1|||
37733904|NCT01573767|69214154|FG003|Overall Study|Protocol Violation|3|||
37733905|NCT01573767|69214151|FG000|Overall Study|Lost to Follow-up|0|||
37733906|NCT01573767|69214152|FG001|Overall Study|Lost to Follow-up|1|||
37733907|NCT01573767|69214153|FG002|Overall Study|Lost to Follow-up|1|||
37733908|NCT01573767|69214154|FG003|Overall Study|Lost to Follow-up|1|||
37733909|NCT01573767|69214151|FG000|Overall Study|Physician Decision|1|||
37733910|NCT01573767|69214152|FG001|Overall Study|Physician Decision|2|||
37733911|NCT01573767|69214153|FG002|Overall Study|Physician Decision|0|||
37733912|NCT01573767|69214154|FG003|Overall Study|Physician Decision|2|||
37733913|NCT01573767|69214151|FG000|Overall Study|Withdrawal by Subject|0|||
37733914|NCT01573767|69214152|FG001|Overall Study|Withdrawal by Subject|1|||
37733915|NCT01573767|69214153|FG002|Overall Study|Withdrawal by Subject|0|||
37733916|NCT01573767|69214154|FG003|Overall Study|Withdrawal by Subject|0|||
37733917|NCT01551303|69214166|FG000|Overall Study|failed awareness check on vision test|4|||
37733918|NCT01551303|69214167|FG001|Overall Study|failed awareness check on vision test|7|||
37733919|NCT00638404|69214175|FG000|Overall Study|Physician Decision|8|||
37733920|NCT00638404|69214176|FG001|Overall Study|Physician Decision|0|||
37733921|NCT01550757|69214190|FG000|Overall Study|Lost to Follow-up|21|||
37733922|NCT01550757|69214191|FG001|Overall Study|Lost to Follow-up|14|||
37733923|NCT01550757|69214192|FG002|Overall Study|Lost to Follow-up|42|||
37733924|NCT01550757|69214193|FG003|Overall Study|Lost to Follow-up|53|||
37733925|NCT01550757|69214190|FG000|Overall Study|Withdrawal by Subject|2|||
37733926|NCT01550757|69214191|FG001|Overall Study|Withdrawal by Subject|0|||
37733927|NCT01550757|69214192|FG002|Overall Study|Withdrawal by Subject|3|||
37733928|NCT01550757|69214193|FG003|Overall Study|Withdrawal by Subject|1|||
37733929|NCT01685073|69214205|FG000|Overall Study|Lost to Follow-up|6|||
37733930|NCT01685073|69214206|FG001|Overall Study|Lost to Follow-up|8|||
37733931|NCT01685073|69214205|FG000|Overall Study|Withdrawal by Subject|24|||
37844685|NCT01335399|69529243|FG001|Treatment Period|Disease progression|145|||
37844686|NCT01335399|69529242|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
37844687|NCT01335399|69529243|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
37844688|NCT01335399|69529242|FG000|Treatment Period|Study drug toxicity|52|||
38025871|NCT03053050|69710495|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
38025872|NCT03053050|69710492|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
38025873|NCT03053050|69710493|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
38025874|NCT03053050|69710494|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
38025875|NCT03053050|69710495|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
37733932|NCT01685073|69214206|FG001|Overall Study|Withdrawal by Subject|24|||
37733933|NCT01572909|69214214|FG000|Overall Study|Adverse Event|7|||
37733934|NCT01572909|69214215|FG001|Overall Study|Adverse Event|2|||
37733935|NCT01572909|69214214|FG000|Overall Study|Death|3|||
37733936|NCT01572909|69214215|FG001|Overall Study|Death|1|||
37733937|NCT01572909|69214214|FG000|Overall Study|Lost to Follow-up|8|||
37733938|NCT01572909|69214215|FG001|Overall Study|Lost to Follow-up|7|||
37733939|NCT01572909|69214214|FG000|Overall Study|Physician Decision|1|||
37733940|NCT01572909|69214215|FG001|Overall Study|Physician Decision|1|||
37733941|NCT01572909|69214214|FG000|Overall Study|Technical Issues|1|||
37733942|NCT01572909|69214215|FG001|Overall Study|Technical Issues|0|||
37733943|NCT01572909|69214214|FG000|Overall Study|Withdrawal by Subject|12|||
38025876|NCT03053050|69710492|FG000|Open-label Phase|Withdrew Consent|0|||
38025877|NCT03053050|69710493|FG001|Open-label Phase|Withdrew Consent|0|||
37733944|NCT01572909|69214215|FG001|Overall Study|Withdrawal by Subject|11|||
37733945|NCT01572909|69214214|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
37733946|NCT01572909|69214215|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
37733947|NCT01572675|69214225|FG000|Overall Study|End of prescribed treatment|140|||
37733948|NCT01572675|69214226|FG001|Overall Study|End of prescribed treatment|118|||
37733949|NCT01572675|69214225|FG000|Overall Study|Recovery|16|||
37733950|NCT01572675|69214226|FG001|Overall Study|Recovery|23|||
37733951|NCT01572675|69214225|FG000|Overall Study|Lack of Efficacy|31|||
38025878|NCT03053050|69710494|FG002|Open-label Phase|Withdrew Consent|0|||
37733952|NCT01572675|69214226|FG001|Overall Study|Lack of Efficacy|31|||
37733953|NCT01572675|69214225|FG000|Overall Study|Intolerance|6|||
37733954|NCT01572675|69214226|FG001|Overall Study|Intolerance|5|||
37733955|NCT01572675|69214225|FG000|Overall Study|Improved symptoms|8|||
37733956|NCT01572675|69214226|FG001|Overall Study|Improved symptoms|2|||
37733957|NCT01572675|69214225|FG000|Overall Study|Surgical intervention|3|||
37733958|NCT01572675|69214226|FG001|Overall Study|Surgical intervention|6|||
37733959|NCT01572675|69214225|FG000|Overall Study|Withdrawal by Subject|5|||
37733960|NCT01572675|69214226|FG001|Overall Study|Withdrawal by Subject|1|||
37733961|NCT01572675|69214225|FG000|Overall Study|Physician Decision|2|||
37733962|NCT01572675|69214226|FG001|Overall Study|Physician Decision|2|||
37733963|NCT01572675|69214225|FG000|Overall Study|Death unrelated to coxibs|1|||
37733964|NCT01572675|69214226|FG001|Overall Study|Death unrelated to coxibs|1|||
37733965|NCT01572675|69214225|FG000|Overall Study|Other disease detected|1|||
37733966|NCT01572675|69214226|FG001|Overall Study|Other disease detected|1|||
37733967|NCT01572675|69214225|FG000|Overall Study|Unknown reason|1|||
37733968|NCT01572675|69214226|FG001|Overall Study|Unknown reason|1|||
37733969|NCT01572675|69214225|FG000|Overall Study|Rheumatologist new evaluation|0|||
37733970|NCT01572675|69214226|FG001|Overall Study|Rheumatologist new evaluation|1|||
37733971|NCT01572675|69214225|FG000|Overall Study|Missing data|1|||
37733972|NCT01572675|69214226|FG001|Overall Study|Missing data|4|||
37733973|NCT01572675|69214225|FG000|Overall Study|Lost to Follow-up|22|||
37733974|NCT01572675|69214226|FG001|Overall Study|Lost to Follow-up|27|||
37733975|NCT05065983|69214245|FG000|Overall Study|Lost to Follow-up|2|||
37733976|NCT04797650|69214252|FG000|Overall Study|Reason Not Specified|5|||
37733977|NCT04797650|69214253|FG001|Overall Study|Reason Not Specified|12|||
37733978|NCT04797650|69214254|FG002|Overall Study|Reason Not Specified|5|||
37733979|NCT04797650|69214252|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|1|||
37733980|NCT04797650|69214253|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|7|||
37733981|NCT04797650|69214254|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|0|||
37733982|NCT04797650|69214252|FG000|Overall Study|Lack of Efficacy|1|||
37733983|NCT04797650|69214253|FG001|Overall Study|Lack of Efficacy|0|||
37733984|NCT04797650|69214254|FG002|Overall Study|Lack of Efficacy|1|||
37733985|NCT04797650|69214252|FG000|Overall Study|Non-compliance with Study Drug|0|||
37733986|NCT04797650|69214253|FG001|Overall Study|Non-compliance with Study Drug|0|||
37733987|NCT04797650|69214254|FG002|Overall Study|Non-compliance with Study Drug|2|||
37733988|NCT04797650|69214252|FG000|Overall Study|Lost to Follow-up|4|||
37733989|NCT04797650|69214253|FG001|Overall Study|Lost to Follow-up|6|||
37733990|NCT04797650|69214254|FG002|Overall Study|Lost to Follow-up|1|||
37733991|NCT04705597|69214266|FG000|Overall Study|Death|16|||
37733992|NCT04705597|69214267|FG001|Overall Study|Death|9|||
37733993|NCT04705597|69214266|FG000|Overall Study|Lost to Follow-up|1|||
37733994|NCT04705597|69214267|FG001|Overall Study|Lost to Follow-up|0|||
37733995|NCT04705597|69214266|FG000|Overall Study|Withdrawal by Subject|1|||
37733996|NCT04705597|69214267|FG001|Overall Study|Withdrawal by Subject|2|||
37733997|NCT04534114|69214277|FG000|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
37733998|NCT04534114|69214278|FG001|Main Treatment Period|COVID-19 pandemic: Participant decision|1|||
37733999|NCT04534114|69214279|FG002|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
37734000|NCT04534114|69214280|FG003|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
37734001|NCT04534114|69214277|FG000|Main Treatment Period|COVID-19 pandemic: Death|0|||
37734002|NCT04534114|69214278|FG001|Main Treatment Period|COVID-19 pandemic: Death|1|||
37734003|NCT04534114|69214279|FG002|Main Treatment Period|COVID-19 pandemic: Death|0|||
37734004|NCT04534114|69214280|FG003|Main Treatment Period|COVID-19 pandemic: Death|2|||
37734005|NCT04534114|69214277|FG000|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
37734006|NCT04534114|69214278|FG001|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
37734007|NCT04534114|69214279|FG002|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
37734008|NCT04534114|69214280|FG003|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
37734009|NCT04534114|69214277|FG000|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
37734010|NCT04534114|69214278|FG001|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
37844689|NCT01335399|69529243|FG001|Treatment Period|Study drug toxicity|64|||
37734011|NCT04534114|69214279|FG002|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
38025879|NCT03053050|69710495|FG003|Open-label Phase|Withdrew Consent|6|||
37734012|NCT04534114|69214280|FG003|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
37734013|NCT04534114|69214277|FG000|Main Treatment Period|Physician Decision|0|||
37734014|NCT04534114|69214278|FG001|Main Treatment Period|Physician Decision|0|||
37734015|NCT04534114|69214279|FG002|Main Treatment Period|Physician Decision|0|||
37734016|NCT04534114|69214280|FG003|Main Treatment Period|Physician Decision|1|||
37734017|NCT04534114|69214277|FG000|Main Treatment Period|Death|1|||
37734018|NCT04534114|69214278|FG001|Main Treatment Period|Death|0|||
37734019|NCT04534114|69214279|FG002|Main Treatment Period|Death|0|||
37734020|NCT04534114|69214280|FG003|Main Treatment Period|Death|1|||
37734021|NCT04534114|69214277|FG000|Main Treatment Period|Other reason|1|||
37734022|NCT04534114|69214278|FG001|Main Treatment Period|Other reason|1|||
37734023|NCT04534114|69214279|FG002|Main Treatment Period|Other reason|0|||
37844690|NCT01335399|69529242|FG000|Treatment Period|Participant request to discontinue|30|||
37844691|NCT01335399|69529243|FG001|Treatment Period|Participant request to discontinue|22|||
37844692|NCT01335399|69529242|FG000|Treatment Period|Other reasons|30|||
37844693|NCT01335399|69529243|FG001|Treatment Period|Other reasons|30|||
37844694|NCT01335399|69529242|FG000|Treatment Period|Consent withdrawal|10|||
37844695|NCT01335399|69529243|FG001|Treatment Period|Consent withdrawal|7|||
37844696|NCT01335399|69529242|FG000|Treatment Period|Death|7|||
37844697|NCT01335399|69529243|FG001|Treatment Period|Death|6|||
37844698|NCT01335399|69529242|FG000|Treatment Period|Poor/Non-compliance|3|||
37844699|NCT01335399|69529243|FG001|Treatment Period|Poor/Non-compliance|4|||
37844700|NCT01335399|69529242|FG000|Treatment Period|Lost to Follow-up|2|||
37844701|NCT01335399|69529243|FG001|Treatment Period|Lost to Follow-up|2|||
37844702|NCT01335399|69529242|FG000|Treatment Period|Maximum clinical benefit|1|||
37844703|NCT01335399|69529243|FG001|Treatment Period|Maximum clinical benefit|1|||
37844704|NCT01335399|69529242|FG000|Treatment Period|No longer meet study criteria|1|||
37844705|NCT01335399|69529243|FG001|Treatment Period|No longer meet study criteria|1|||
37844706|NCT01335399|69529242|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
37844707|NCT01335399|69529243|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
37844708|NCT01366521|69529253|FG000|Overall Study|Adverse Event|1|||
37844709|NCT01366521|69529254|FG001|Overall Study|Adverse Event|0|||
37844710|NCT01366521|69529255|FG002|Overall Study|Adverse Event|0|||
37916163|NCT00856986|69603089|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
37916164|NCT00856986|69603090|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
37916165|NCT00856986|69603086|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
37916166|NCT00856986|69603087|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
37916167|NCT00856986|69603088|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
37916168|NCT00856986|69603089|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
37916169|NCT00856986|69603090|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
37916170|NCT00856986|69603086|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
37916171|NCT00856986|69603087|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
37916172|NCT00856986|69603088|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
37916173|NCT00856986|69603089|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
37916174|NCT00856986|69603090|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
37916175|NCT00856986|69603086|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
37916176|NCT00856986|69603087|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
37916177|NCT00856986|69603088|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
37916178|NCT00856986|69603089|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
37916179|NCT00856986|69603090|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
37916180|NCT00856986|69603086|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
37916181|NCT00856986|69603087|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
37916182|NCT00856986|69603088|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
37916183|NCT00856986|69603089|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
37916184|NCT00856986|69603090|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
37916185|NCT00856986|69603086|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
37916186|NCT00856986|69603087|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
37916187|NCT00856986|69603088|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
37916188|NCT00856986|69603089|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
37916189|NCT00856986|69603090|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
37916190|NCT00856986|69603086|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
37734024|NCT04534114|69214280|FG003|Main Treatment Period|Other reason|0|||
37734025|NCT04534114|69214277|FG000|Main Treatment Period|Participant decision|1|||
37844711|NCT01366521|69529256|FG003|Overall Study|Adverse Event|0|||
37916191|NCT00856986|69603087|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
37916192|NCT00856986|69603088|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
37844712|NCT01366521|69529253|FG000|Overall Study|Protocol Violation|0|||
37844713|NCT01366521|69529254|FG001|Overall Study|Protocol Violation|0|||
37916193|NCT00856986|69603089|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
37734026|NCT04534114|69214278|FG001|Main Treatment Period|Participant decision|3|||
37734027|NCT04534114|69214279|FG002|Main Treatment Period|Participant decision|3|||
37734028|NCT04534114|69214280|FG003|Main Treatment Period|Participant decision|1|||
37734029|NCT04534114|69214277|FG000|Main Treatment Period|Protocol-specified withdrawal criterion met|2|||
37734030|NCT04534114|69214278|FG001|Main Treatment Period|Protocol-specified withdrawal criterion met|1|||
37734031|NCT04534114|69214279|FG002|Main Treatment Period|Protocol-specified withdrawal criterion met|4|||
37734032|NCT04534114|69214280|FG003|Main Treatment Period|Protocol-specified withdrawal criterion met|6|||
37734033|NCT04534114|69214277|FG000|Main Treatment Period|Adverse Event|4|||
37734034|NCT04534114|69214278|FG001|Main Treatment Period|Adverse Event|2|||
37734035|NCT04534114|69214279|FG002|Main Treatment Period|Adverse Event|1|||
37734036|NCT04534114|69214280|FG003|Main Treatment Period|Adverse Event|2|||
37734037|NCT04534114|69214277|FG000|Extension Treatment Period|COVID-19 pandemic: Death|0|||
37734038|NCT04534114|69214278|FG001|Extension Treatment Period|COVID-19 pandemic: Death|0|||
37734039|NCT04534114|69214279|FG002|Extension Treatment Period|COVID-19 pandemic: Death|0|||
37734040|NCT04534114|69214280|FG003|Extension Treatment Period|COVID-19 pandemic: Death|1|||
37734041|NCT04534114|69214277|FG000|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
37734042|NCT04534114|69214278|FG001|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
37734043|NCT04534114|69214279|FG002|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
37734044|NCT04534114|69214280|FG003|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
37734045|NCT04534114|69214277|FG000|Extension Treatment Period|Other reason|0|||
37734046|NCT04534114|69214278|FG001|Extension Treatment Period|Other reason|1|||
37734047|NCT04534114|69214279|FG002|Extension Treatment Period|Other reason|0|||
37734048|NCT04534114|69214280|FG003|Extension Treatment Period|Other reason|0|||
37734049|NCT04534114|69214277|FG000|Extension Treatment Period|Death|0|||
37734050|NCT04534114|69214278|FG001|Extension Treatment Period|Death|0|||
37734051|NCT04534114|69214279|FG002|Extension Treatment Period|Death|1|||
37734052|NCT04534114|69214280|FG003|Extension Treatment Period|Death|2|||
37734053|NCT04534114|69214277|FG000|Extension Treatment Period|Adverse Event|0|||
37734054|NCT04534114|69214278|FG001|Extension Treatment Period|Adverse Event|1|||
37734055|NCT04534114|69214279|FG002|Extension Treatment Period|Adverse Event|0|||
37734056|NCT04534114|69214280|FG003|Extension Treatment Period|Adverse Event|1|||
37734057|NCT04534114|69214277|FG000|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
37734058|NCT04534114|69214278|FG001|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
37734059|NCT04534114|69214279|FG002|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|0|||
37734060|NCT04534114|69214280|FG003|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|1|||
37734061|NCT04474366|69214301|FG000|Overall Study|Lost to Follow-up|2|||
37734062|NCT04474366|69214302|FG001|Overall Study|Lost to Follow-up|5|||
37734063|NCT04422431|69214308|FG000|Treatment Period (48 Weeks)|Adverse Event|3|||
37734064|NCT04422431|69214308|FG000|Treatment Period (48 Weeks)|Withdrawal by Subject|1|||
37734065|NCT04422431|69214308|FG000|Treatment Period (48 Weeks)|Other than specified|1|||
37734066|NCT04422431|69214308|FG000|Extension Period (48 Weeks)|ongoing in the Extension Period|25|||
37734067|NCT04115488|69214319|FG000|Overall Study|Adverse Event|8|||
37734068|NCT04115488|69214320|FG001|Overall Study|Adverse Event|4|||
37734069|NCT04115488|69214319|FG000|Overall Study|Withdrawal by Subject|3|||
37734070|NCT04115488|69214320|FG001|Overall Study|Withdrawal by Subject|6|||
37734071|NCT04115488|69214319|FG000|Overall Study|Investigator/ Sponsor Decision|2|||
37734072|NCT04115488|69214320|FG001|Overall Study|Investigator/ Sponsor Decision|0|||
37734073|NCT04115488|69214319|FG000|Overall Study|Patient 's location change|1|||
37734074|NCT04115488|69214320|FG001|Overall Study|Patient 's location change|0|||
37734075|NCT04115488|69214319|FG000|Overall Study|Due to COVID-19 restrictions at site|0|||
37734076|NCT04115488|69214320|FG001|Overall Study|Due to COVID-19 restrictions at site|1|||
37734077|NCT04080752|69214344|FG000|Overall Study|Adverse Event|2|||
37734078|NCT04080752|69214345|FG001|Overall Study|Adverse Event|3|||
37734079|NCT04080752|69214344|FG000|Overall Study|Lack of Efficacy|1|||
37734080|NCT04080752|69214345|FG001|Overall Study|Lack of Efficacy|0|||
37734081|NCT04080752|69214344|FG000|Overall Study|Lost to Follow-up|1|||
37734082|NCT04080752|69214345|FG001|Overall Study|Lost to Follow-up|0|||
37734083|NCT04080752|69214344|FG000|Overall Study|Pregnancy|0|||
37734084|NCT04080752|69214345|FG001|Overall Study|Pregnancy|1|||
37734085|NCT04080752|69214344|FG000|Overall Study|Withdrawal by Subject|7|||
37734086|NCT04080752|69214345|FG001|Overall Study|Withdrawal by Subject|0|||
37734087|NCT04080752|69214344|FG000|Overall Study|Non-Compliance with Study Drug|0|||
37734088|NCT04080752|69214345|FG001|Overall Study|Non-Compliance with Study Drug|1|||
37734089|NCT04080752|69214344|FG000|Overall Study|Other|2|||
37734090|NCT04080752|69214345|FG001|Overall Study|Other|1|||
37734091|NCT03968419|69214355|FG000|Treatment Period|Adverse Event|0|||
37734092|NCT03968419|69214356|FG001|Treatment Period|Adverse Event|0|||
37734093|NCT03968419|69214357|FG002|Treatment Period|Adverse Event|1|||
37734094|NCT03968419|69214355|FG000|Safety Follow-up Period|Death|3|||
37734095|NCT03968419|69214356|FG001|Safety Follow-up Period|Death|2|||
37734096|NCT03968419|69214357|FG002|Safety Follow-up Period|Death|1|||
37734097|NCT03968419|69214355|FG000|Safety Follow-up Period|Subject Decision|2|||
37734098|NCT03968419|69214356|FG001|Safety Follow-up Period|Subject Decision|1|||
37734099|NCT03968419|69214357|FG002|Safety Follow-up Period|Subject Decision|0|||
37734100|NCT03784846|69214371|FG000|Pre-COVID Study|Lost to Follow-up|3|||
37734101|NCT03784846|69214372|FG001|Pre-COVID Study|Lost to Follow-up|3|||
37734102|NCT03784846|69214373|FG002|Pre-COVID Study|Lost to Follow-up|2|||
37734103|NCT03784846|69214371|FG000|Pre-COVID Study|Withdrawal by Subject|1|||
37734104|NCT03784846|69214372|FG001|Pre-COVID Study|Withdrawal by Subject|2|||
37734105|NCT03784846|69214373|FG002|Pre-COVID Study|Withdrawal by Subject|1|||
37734106|NCT03784846|69214371|FG000|Pre-COVID Study|Discontinued by Researchers|7|||
37734107|NCT03784846|69214372|FG001|Pre-COVID Study|Discontinued by Researchers|6|||
37734108|NCT03784846|69214373|FG002|Pre-COVID Study|Discontinued by Researchers|2|||
37734109|NCT03784846|69214371|FG000|Post-COVID Study|Lost to Follow-up|3|||
37734110|NCT03784846|69214372|FG001|Post-COVID Study|Lost to Follow-up|5|||
37734111|NCT03784846|69214373|FG002|Post-COVID Study|Lost to Follow-up|1|||
37734112|NCT03784846|69214371|FG000|Post-COVID Study|Withdrawal by Subject|1|||
37734113|NCT03784846|69214372|FG001|Post-COVID Study|Withdrawal by Subject|2|||
37734114|NCT03784846|69214373|FG002|Post-COVID Study|Withdrawal by Subject|0|||
37734115|NCT03756350|69214381|FG000|Overall Study|Lost to Follow-up|1|||
37734116|NCT03648996|69214403|FG000|Overall Study|Withdrawal by Subject|0|||
37734117|NCT03648996|69214404|FG001|Overall Study|Withdrawal by Subject|2|||
37734118|NCT03648996|69214405|FG002|Overall Study|Withdrawal by Subject|2|||
37734119|NCT03648996|69214403|FG000|Overall Study|Physician Decision|2|||
37734120|NCT03648996|69214404|FG001|Overall Study|Physician Decision|0|||
37734121|NCT03648996|69214405|FG002|Overall Study|Physician Decision|0|||
37734122|NCT03483961|69214430|FG000|Overall Study|Lost to Follow-up|7|||
37734123|NCT03483961|69214431|FG001|Overall Study|Lost to Follow-up|6|||
37734124|NCT03483961|69214432|FG002|Overall Study|Lost to Follow-up|6|||
37734125|NCT03483961|69214433|FG003|Overall Study|Lost to Follow-up|6|||
37734126|NCT03483961|69214434|FG004|Overall Study|Lost to Follow-up|6|||
37734127|NCT03483961|69214435|FG005|Overall Study|Lost to Follow-up|4|||
37734128|NCT03483961|69214436|FG006|Overall Study|Lost to Follow-up|4|||
37734129|NCT03483961|69214437|FG007|Overall Study|Lost to Follow-up|11|||
37734130|NCT03483961|69214438|FG008|Overall Study|Lost to Follow-up|1|||
37734131|NCT03483961|69214439|FG009|Overall Study|Lost to Follow-up|0|||
37734132|NCT03483961|69214430|FG000|Overall Study|Withdrawal by Subject|3|||
37734133|NCT03483961|69214431|FG001|Overall Study|Withdrawal by Subject|4|||
37734134|NCT03483961|69214432|FG002|Overall Study|Withdrawal by Subject|5|||
37734135|NCT03483961|69214433|FG003|Overall Study|Withdrawal by Subject|3|||
37734136|NCT03483961|69214434|FG004|Overall Study|Withdrawal by Subject|4|||
37734137|NCT03483961|69214435|FG005|Overall Study|Withdrawal by Subject|2|||
37734138|NCT03483961|69214436|FG006|Overall Study|Withdrawal by Subject|1|||
37734139|NCT03483961|69214437|FG007|Overall Study|Withdrawal by Subject|2|||
37734140|NCT03483961|69214438|FG008|Overall Study|Withdrawal by Subject|1|||
37734141|NCT03483961|69214439|FG009|Overall Study|Withdrawal by Subject|0|||
37734142|NCT03483961|69214430|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
37734143|NCT03483961|69214431|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
37734144|NCT03483961|69214432|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
37734145|NCT03483961|69214433|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
37734146|NCT03483961|69214434|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
37734147|NCT03483961|69214435|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
37734148|NCT03483961|69214436|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
37734149|NCT03483961|69214437|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
37734150|NCT03483961|69214438|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
37734151|NCT03483961|69214439|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
37734152|NCT03483961|69214430|FG000|Overall Study|Adverse Event|0|||
37734153|NCT03483961|69214431|FG001|Overall Study|Adverse Event|0|||
37734154|NCT03483961|69214432|FG002|Overall Study|Adverse Event|1|||
37734155|NCT03483961|69214433|FG003|Overall Study|Adverse Event|0|||
37734156|NCT03483961|69214434|FG004|Overall Study|Adverse Event|0|||
37734157|NCT03483961|69214435|FG005|Overall Study|Adverse Event|0|||
37734158|NCT03483961|69214436|FG006|Overall Study|Adverse Event|0|||
37734159|NCT03483961|69214437|FG007|Overall Study|Adverse Event|0|||
37734160|NCT03483961|69214438|FG008|Overall Study|Adverse Event|0|||
37734161|NCT03483961|69214439|FG009|Overall Study|Adverse Event|0|||
37734162|NCT03459807|69214462|FG000|Overall Study|Withdrawal due to transplant|0|||
37734163|NCT03459807|69214463|FG001|Overall Study|Withdrawal due to transplant|1|||
37844714|NCT01366521|69529255|FG002|Overall Study|Protocol Violation|1|||
37734164|NCT03439293|69214476|FG000|Overall Study|Ongoing on Treatment|15|||
37734165|NCT03439293|69214476|FG000|Overall Study|Ongoing off Treatment|19|||
37734166|NCT03439293|69214476|FG000|Overall Study|Death|18|||
37734167|NCT03439293|69214476|FG000|Overall Study|Withdrawal by Subject|7|||
37734168|NCT03439293|69214476|FG000|Overall Study|Lost to Follow-up|2|||
37734169|NCT03423979|69214481|FG000|Overall Study|Death|1|||
37734170|NCT03239210|69214487|FG000|Overall Study|Lost to Follow-up|2|||
37734171|NCT03239210|69214488|FG001|Overall Study|Lost to Follow-up|2|||
37734172|NCT03239210|69214487|FG000|Overall Study|Withdrawal by subject (personal reasons)|2|||
37734173|NCT03239210|69214488|FG001|Overall Study|Withdrawal by subject (personal reasons)|2|||
37734174|NCT03239210|69214487|FG000|Overall Study|Withdrawal by subject (reported medical side effects)|2|||
37734175|NCT03239210|69214488|FG001|Overall Study|Withdrawal by subject (reported medical side effects)|1|||
37734176|NCT03227224|69214498|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
37734177|NCT03227224|69214499|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
37734178|NCT03227224|69214500|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
37734179|NCT03227224|69214501|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
37734180|NCT03227224|69214498|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
37734181|NCT03227224|69214499|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
37734182|NCT03227224|69214500|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
37734183|NCT03227224|69214501|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
37734184|NCT03227224|69214498|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
37734185|NCT03227224|69214499|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
37734186|NCT03227224|69214500|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
37734187|NCT03227224|69214501|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
37734188|NCT03227224|69214498|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
37734189|NCT03227224|69214499|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
37734190|NCT03227224|69214500|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
37734191|NCT03227224|69214501|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
37734192|NCT03227224|69214498|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
37734193|NCT03227224|69214499|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
37734194|NCT03227224|69214500|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
37734195|NCT03227224|69214501|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
37734196|NCT03227224|69214498|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
37734197|NCT03227224|69214499|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
37734198|NCT03227224|69214500|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
37734199|NCT03227224|69214501|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
37734200|NCT03227224|69214498|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
37844715|NCT01366521|69529256|FG003|Overall Study|Protocol Violation|0|||
37844716|NCT01366521|69529253|FG000|Overall Study|Physician Decision|0|||
37844717|NCT01366521|69529254|FG001|Overall Study|Physician Decision|0|||
37844718|NCT01366521|69529255|FG002|Overall Study|Physician Decision|1|||
37844719|NCT01366521|69529256|FG003|Overall Study|Physician Decision|0|||
37844720|NCT01366521|69529253|FG000|Overall Study|Withdrawal by Subject|0|||
37844721|NCT01366521|69529254|FG001|Overall Study|Withdrawal by Subject|1|||
37844722|NCT01366521|69529255|FG002|Overall Study|Withdrawal by Subject|0|||
37844723|NCT01366521|69529256|FG003|Overall Study|Withdrawal by Subject|0|||
37844724|NCT01335009|69529270|FG000|Overall Study|Too ill to travel to study sites|1|||
37844725|NCT01335009|69529271|FG001|Overall Study|Too ill to travel to study sites|0|||
37844726|NCT01335009|69529270|FG000|Overall Study|Death|28|||
37844727|NCT01335009|69529271|FG001|Overall Study|Death|32|||
37844728|NCT01335009|69529270|FG000|Overall Study|Withdrawal by Subject|1|||
37844729|NCT01335009|69529271|FG001|Overall Study|Withdrawal by Subject|1|||
37844730|NCT01335009|69529270|FG000|Overall Study|Lost to Follow-up|1|||
37844731|NCT01335009|69529271|FG001|Overall Study|Lost to Follow-up|0|||
37844732|NCT01366443|69529286|FG000|Overall Study|Lost to Follow-up|2|||
37844733|NCT01366443|69529286|FG000|Overall Study|Under 18 yo|1|||
37844734|NCT01332630|69529291|FG000|Overall Study|Withdrawal by Subject|3|||
37844735|NCT01366209|69529297|FG000|Overall Study|Adverse Event|6|||
37844736|NCT01366209|69529298|FG001|Overall Study|Adverse Event|7|||
37844737|NCT01366209|69529297|FG000|Overall Study|Withdrawal by Subject|4|||
37844738|NCT01366209|69529298|FG001|Overall Study|Withdrawal by Subject|4|||
37844739|NCT01366209|69529297|FG000|Overall Study|Death|12|||
37844740|NCT01366209|69529298|FG001|Overall Study|Death|19|||
37844741|NCT01366209|69529297|FG000|Overall Study|Lung transplantation|6|||
37844742|NCT01366209|69529298|FG001|Overall Study|Lung transplantation|1|||
37844743|NCT01366209|69529297|FG000|Overall Study|Lost to Follow-up|2|||
37844744|NCT01366209|69529298|FG001|Overall Study|Lost to Follow-up|1|||
37844745|NCT01366209|69529297|FG000|Overall Study|Physician Decision|1|||
37844746|NCT01366209|69529298|FG001|Overall Study|Physician Decision|0|||
37844747|NCT01366209|69529297|FG000|Overall Study|Sponsors decision|0|||
37844748|NCT01366209|69529298|FG001|Overall Study|Sponsors decision|1|||
37844749|NCT01366209|69529297|FG000|Overall Study|Withdrew consent|4|||
37844750|NCT01366209|69529298|FG001|Overall Study|Withdrew consent|3|||
37844751|NCT01365546|69529304|FG000|Overall Study|Withdrawal by Subject|1|||
37844752|NCT01365546|69529304|FG000|Overall Study|Screen failure|9|||
37844753|NCT01365546|69529304|FG000|Overall Study|Study termination|1|||
37844754|NCT01365507|69529314|FG000|Overall Study|Withdrawal Criteria|8|||
37844755|NCT01365507|69529315|FG001|Overall Study|Withdrawal Criteria|5|||
37844756|NCT01365507|69529314|FG000|Overall Study|Unclassified|1|||
37844757|NCT01365507|69529315|FG001|Overall Study|Unclassified|4|||
37844758|NCT01365468|69529339|FG000|Overall Study|Physician Decision|1|||
37734201|NCT03227224|69214499|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
37734202|NCT03227224|69214500|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
37734203|NCT03227224|69214501|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
37734204|NCT03227224|69214498|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
37734205|NCT03227224|69214499|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
37734206|NCT03227224|69214500|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
37734207|NCT03227224|69214501|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
37734208|NCT03227224|69214498|FG000|Follow-up Phase (2 Weeks)|Other|4|||
37734209|NCT03227224|69214499|FG001|Follow-up Phase (2 Weeks)|Other|4|||
37734210|NCT03227224|69214500|FG002|Follow-up Phase (2 Weeks)|Other|6|||
37734211|NCT03227224|69214501|FG003|Follow-up Phase (2 Weeks)|Other|3|||
37734212|NCT03086343|69214520|FG000|Overall Study|Adverse Event|7|||
37734213|NCT03086343|69214521|FG001|Overall Study|Adverse Event|7|||
37734214|NCT03086343|69214520|FG000|Overall Study|Withdrawal by Subject|10|||
37734215|NCT03086343|69214521|FG001|Overall Study|Withdrawal by Subject|6|||
37734216|NCT03086343|69214520|FG000|Overall Study|Lost to Follow-up|3|||
37734217|NCT03086343|69214521|FG001|Overall Study|Lost to Follow-up|1|||
37734218|NCT03086343|69214520|FG000|Overall Study|Lack of Efficacy|4|||
37734219|NCT03086343|69214521|FG001|Overall Study|Lack of Efficacy|6|||
37844759|NCT01365468|69529340|FG001|Overall Study|Physician Decision|0|||
37844760|NCT01365468|69529339|FG000|Overall Study|Disease progression|1|||
37916194|NCT00856986|69603090|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
37844761|NCT01365468|69529340|FG001|Overall Study|Disease progression|0|||
37844762|NCT01365468|69529339|FG000|Overall Study|Lost to Follow-up|2|||
37844763|NCT01365468|69529340|FG001|Overall Study|Lost to Follow-up|0|||
37844764|NCT01357980|69529351|FG000|Overall Study|Lack of Efficacy|0|||
37844765|NCT01357980|69529352|FG001|Overall Study|Lack of Efficacy|1|||
37844766|NCT01357980|69529353|FG002|Overall Study|Lack of Efficacy|0|||
37844767|NCT01357980|69529354|FG003|Overall Study|Lack of Efficacy|0|||
37916195|NCT00856986|69603086|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
37916196|NCT00856986|69603087|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
37844768|NCT01357980|69529351|FG000|Overall Study|Consent withdrawn|0|||
37844769|NCT01357980|69529352|FG001|Overall Study|Consent withdrawn|0|||
37844770|NCT01357980|69529353|FG002|Overall Study|Consent withdrawn|1|||
37844771|NCT01357980|69529354|FG003|Overall Study|Consent withdrawn|0|||
37844772|NCT01332318|69529368|FG000|Overall Study|Adverse Event|0|||
37916197|NCT00856986|69603088|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
37916198|NCT00856986|69603089|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
37916199|NCT00856986|69603090|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
37916200|NCT00856986|69603086|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
37916201|NCT00856986|69603087|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
37916202|NCT00856986|69603088|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
37916203|NCT00856986|69603089|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
37916204|NCT00856986|69603090|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
37916205|NCT00856986|69603086|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
37916206|NCT00856986|69603087|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
37844773|NCT01332318|69529369|FG001|Overall Study|Adverse Event|3|||
37844774|NCT01332318|69529370|FG002|Overall Study|Adverse Event|0|||
37844775|NCT01332318|69529371|FG003|Overall Study|Adverse Event|0|||
37844776|NCT01332318|69529368|FG000|Overall Study|Withdrawal by Subject|1|||
37844777|NCT01332318|69529369|FG001|Overall Study|Withdrawal by Subject|1|||
37916207|NCT00856986|69603088|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
37916208|NCT00856986|69603089|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
37916209|NCT00856986|69603090|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
37916210|NCT00856986|69603086|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
37844778|NCT01332318|69529370|FG002|Overall Study|Withdrawal by Subject|0|||
37844779|NCT01332318|69529371|FG003|Overall Study|Withdrawal by Subject|1|||
37844780|NCT01332318|69529368|FG000|Overall Study|Protocol Violation|1|||
37844781|NCT01332318|69529369|FG001|Overall Study|Protocol Violation|0|||
37844782|NCT01332318|69529370|FG002|Overall Study|Protocol Violation|1|||
37844783|NCT01332318|69529371|FG003|Overall Study|Protocol Violation|1|||
37844784|NCT01331109|69529386|FG000|Overall Study|Adverse Event|6|||
37844785|NCT01331109|69529386|FG000|Overall Study|Lack of Efficacy|2|||
37844786|NCT01331109|69529386|FG000|Overall Study|Protocol Violation|3|||
37844787|NCT01331109|69529386|FG000|Overall Study|Withdrawal by Subject|7|||
37844788|NCT01331109|69529386|FG000|Overall Study|Lost to Follow-up|1|||
37844789|NCT01331109|69529386|FG000|Overall Study|Study Terminated by Sponsor|38|||
37844790|NCT01357551|69529392|FG000|Overall Study|Withdrawal by Subject|6|||
37844791|NCT01357551|69529393|FG001|Overall Study|Withdrawal by Subject|4|||
37916211|NCT00856986|69603087|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
37916212|NCT00856986|69603088|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
37916213|NCT00856986|69603089|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
37916214|NCT00856986|69603090|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
37916215|NCT00856986|69603086|FG000|Main Period, Weeks 0-26|Unclassified|7|||
37916216|NCT00856986|69603087|FG001|Main Period, Weeks 0-26|Unclassified|6|||
37916217|NCT00856986|69603088|FG002|Main Period, Weeks 0-26|Unclassified|7|||
38025880|NCT03053050|69710492|FG000|Open-label Phase|Investigator's Discretion|0|||
37844792|NCT01357551|69529392|FG000|Overall Study|Death|0|||
37844793|NCT01357551|69529393|FG001|Overall Study|Death|1|||
37844794|NCT01357551|69529392|FG000|Overall Study|Lost to Follow-up|16|||
37844795|NCT01357551|69529393|FG001|Overall Study|Lost to Follow-up|6|||
37844796|NCT01357239|69529406|FG000|Stratum: All Patients|Adverse Event|0|||
37844797|NCT01357239|69529407|FG001|Stratum: All Patients|Adverse Event|0|||
37844798|NCT01357239|69529408|FG002|Stratum: All Patients|Adverse Event|1|||
37844799|NCT01357239|69529409|FG003|Stratum: All Patients|Adverse Event|1|||
37844800|NCT01357239|69529406|FG000|Stratum: All Patients|Subject withdrew consent|0|||
37844801|NCT01357239|69529407|FG001|Stratum: All Patients|Subject withdrew consent|0|||
37844802|NCT01357239|69529408|FG002|Stratum: All Patients|Subject withdrew consent|1|||
37844803|NCT01357239|69529409|FG003|Stratum: All Patients|Subject withdrew consent|1|||
37844804|NCT01357239|69529406|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
37844805|NCT01357239|69529407|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
37844806|NCT01357239|69529408|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
37844807|NCT01357239|69529409|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
37844808|NCT01357239|69529406|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
37844809|NCT01357239|69529407|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
37844810|NCT01357239|69529408|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
37844811|NCT01357239|69529409|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
37844812|NCT01357239|69529406|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
37844813|NCT01357239|69529407|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
37844814|NCT01357239|69529408|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
37844815|NCT01357239|69529409|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
37844816|NCT01351350|69529427|FG000|Overall Study|Disease Progression|5|||
37844817|NCT01351350|69529428|FG001|Overall Study|Disease Progression|13|||
37844818|NCT01351350|69529429|FG002|Overall Study|Disease Progression|6|||
37916218|NCT00856986|69603089|FG003|Main Period, Weeks 0-26|Unclassified|0|||
37916219|NCT00856986|69603090|FG004|Main Period, Weeks 0-26|Unclassified|0|||
37844819|NCT01351350|69529430|FG003|Overall Study|Disease Progression|8|||
37844820|NCT01351350|69529431|FG004|Overall Study|Disease Progression|5|||
37844821|NCT01351350|69529427|FG000|Overall Study|Adverse Event|1|||
37844822|NCT01351350|69529428|FG001|Overall Study|Adverse Event|10|||
37844823|NCT01351350|69529429|FG002|Overall Study|Adverse Event|1|||
37844824|NCT01351350|69529430|FG003|Overall Study|Adverse Event|2|||
37844825|NCT01351350|69529431|FG004|Overall Study|Adverse Event|0|||
37844826|NCT01351350|69529427|FG000|Overall Study|Participant Decision|2|||
37844827|NCT01351350|69529428|FG001|Overall Study|Participant Decision|6|||
37844828|NCT01351350|69529429|FG002|Overall Study|Participant Decision|3|||
37844829|NCT01351350|69529430|FG003|Overall Study|Participant Decision|3|||
37844830|NCT01351350|69529431|FG004|Overall Study|Participant Decision|2|||
37844831|NCT01351350|69529427|FG000|Overall Study|Enrolled but not Treated|0|||
37844832|NCT01351350|69529428|FG001|Overall Study|Enrolled but not Treated|0|||
37844833|NCT01351350|69529429|FG002|Overall Study|Enrolled but not Treated|1|||
37844834|NCT01351350|69529430|FG003|Overall Study|Enrolled but not Treated|0|||
37844835|NCT01351350|69529431|FG004|Overall Study|Enrolled but not Treated|0|||
37844836|NCT01350999|69529459|FG000|Overall Study|Adverse Event|4|||
37844837|NCT01350999|69529460|FG001|Overall Study|Adverse Event|9|||
37844838|NCT01350999|69529461|FG002|Overall Study|Adverse Event|10|||
37844839|NCT01350999|69529459|FG000|Overall Study|Voluntary withdrawal|3|||
37844840|NCT01350999|69529460|FG001|Overall Study|Voluntary withdrawal|4|||
37844841|NCT01350999|69529461|FG002|Overall Study|Voluntary withdrawal|6|||
37844842|NCT01350999|69529459|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
37844843|NCT01350999|69529460|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
37844844|NCT01350999|69529461|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
37844845|NCT01330914|69529480|FG000|Overall Study|Withdrawal by Subject|4|||
37844846|NCT01330914|69529480|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
37844847|NCT01350804|69529488|FG000|Core Study|Withdrawal by Subject|11|||
37844848|NCT01350804|69529489|FG001|Core Study|Withdrawal by Subject|17|||
37844849|NCT01350804|69529490|FG002|Core Study|Withdrawal by Subject|16|||
37844850|NCT01350804|69529491|FG003|Core Study|Withdrawal by Subject|7|||
37844851|NCT01350804|69529488|FG000|Core Study|Study terminated by Sponsor|0|||
37844852|NCT01350804|69529489|FG001|Core Study|Study terminated by Sponsor|0|||
37844853|NCT01350804|69529490|FG002|Core Study|Study terminated by Sponsor|0|||
37844854|NCT01350804|69529491|FG003|Core Study|Study terminated by Sponsor|2|||
37844855|NCT01350804|69529488|FG000|Core Study|Protocol deviation|1|||
37844856|NCT01350804|69529489|FG001|Core Study|Protocol deviation|0|||
37844857|NCT01350804|69529490|FG002|Core Study|Protocol deviation|1|||
37844858|NCT01350804|69529491|FG003|Core Study|Protocol deviation|0|||
37844859|NCT01350804|69529488|FG000|Core Study|Physician Decision|1|||
37844860|NCT01350804|69529489|FG001|Core Study|Physician Decision|0|||
37844861|NCT01350804|69529490|FG002|Core Study|Physician Decision|1|||
37844862|NCT01350804|69529491|FG003|Core Study|Physician Decision|3|||
37844863|NCT01350804|69529488|FG000|Core Study|Lost to Follow-up|3|||
37844864|NCT01350804|69529489|FG001|Core Study|Lost to Follow-up|0|||
37844865|NCT01350804|69529490|FG002|Core Study|Lost to Follow-up|2|||
37844866|NCT01350804|69529491|FG003|Core Study|Lost to Follow-up|1|||
37844867|NCT01350804|69529488|FG000|Core Study|Lack of Efficacy|16|||
37844868|NCT01350804|69529489|FG001|Core Study|Lack of Efficacy|19|||
37844869|NCT01350804|69529490|FG002|Core Study|Lack of Efficacy|18|||
37844870|NCT01350804|69529491|FG003|Core Study|Lack of Efficacy|5|||
37844871|NCT01350804|69529488|FG000|Core Study|Death|1|||
37844872|NCT01350804|69529489|FG001|Core Study|Death|1|||
37844873|NCT01350804|69529490|FG002|Core Study|Death|1|||
37844874|NCT01350804|69529491|FG003|Core Study|Death|0|||
37844875|NCT01350804|69529488|FG000|Core Study|Adverse Event|8|||
37844876|NCT01350804|69529489|FG001|Core Study|Adverse Event|10|||
37844877|NCT01350804|69529490|FG002|Core Study|Adverse Event|8|||
37844878|NCT01350804|69529491|FG003|Core Study|Adverse Event|8|||
37844879|NCT01350804|69529488|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
37844880|NCT01350804|69529489|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
37844881|NCT01350804|69529490|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
37844882|NCT01350804|69529491|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
37844883|NCT01350804|69529488|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
37916220|NCT00856986|69603086|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
37844884|NCT01350804|69529489|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
37844885|NCT01350804|69529490|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
37844886|NCT01350804|69529491|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
37844887|NCT01350804|69529488|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
37844888|NCT01350804|69529489|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
37844889|NCT01350804|69529490|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
37844890|NCT01350804|69529491|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
37844891|NCT01350804|69529488|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
37844892|NCT01350804|69529489|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
37844893|NCT01350804|69529490|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
37844894|NCT01350804|69529491|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
37844895|NCT01350804|69529488|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
37844896|NCT01350804|69529489|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
37844897|NCT01350804|69529490|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
37844898|NCT01350804|69529491|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
37844899|NCT01350804|69529488|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
37844900|NCT01350804|69529489|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
37844901|NCT01350804|69529490|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
37844902|NCT01350804|69529491|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
37844903|NCT01350492|69529513|FG000|Intervention|Lost to Follow-up|2|||
37844904|NCT01350492|69529514|FG001|Intervention|Lost to Follow-up|5|||
37844905|NCT01350492|69529513|FG000|Intervention|Withdrawal by Subject|3|||
37844906|NCT01350492|69529514|FG001|Intervention|Withdrawal by Subject|1|||
37844907|NCT01350492|69529513|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
37844908|NCT01350492|69529514|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
37844909|NCT01350492|69529513|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
37844910|NCT01350492|69529514|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
37844911|NCT02270957|69529522|FG000|Overall Study|Lack of Efficacy|2|||
37844912|NCT02270957|69529523|FG001|Overall Study|Lack of Efficacy|4|||
37844913|NCT02270957|69529522|FG000|Overall Study|Adverse Event|2|||
37844914|NCT02270957|69529523|FG001|Overall Study|Adverse Event|0|||
37844915|NCT01350414|69529530|FG000|Overall Study|Lost to Follow-up|13|||
37844916|NCT01350414|69529530|FG000|Overall Study|Withdrawal by Subject|4|||
37844917|NCT01350414|69529530|FG000|Overall Study|Physician Decision|2|||
37844918|NCT01350336|69529540|FG000|Overall Study|Lost to Follow-up|31|||
37844919|NCT01350336|69529540|FG000|Overall Study|Withdrawal by Subject|14|||
37844920|NCT01350336|69529540|FG000|Overall Study|Physician Decision|8|||
37844921|NCT01350336|69529540|FG000|Overall Study|Death|4|||
37844922|NCT01349049|69529598|FG000|Overall Study|Disease progression|3|||
37844923|NCT01349049|69529599|FG001|Overall Study|Disease progression|5|||
37844924|NCT01349049|69529600|FG002|Overall Study|Disease progression|3|||
37844925|NCT01349049|69529601|FG003|Overall Study|Disease progression|2|||
37844926|NCT01349049|69529602|FG004|Overall Study|Disease progression|2|||
37844927|NCT01349049|69529603|FG005|Overall Study|Disease progression|2|||
37844928|NCT01349049|69529604|FG006|Overall Study|Disease progression|3|||
37844929|NCT01349049|69529605|FG007|Overall Study|Disease progression|2|||
37844930|NCT01349049|69529606|FG008|Overall Study|Disease progression|33|||
37844931|NCT01349049|69529598|FG000|Overall Study|Adverse Event|0|||
37844932|NCT01349049|69529599|FG001|Overall Study|Adverse Event|1|||
37844933|NCT01349049|69529600|FG002|Overall Study|Adverse Event|0|||
37844934|NCT01349049|69529601|FG003|Overall Study|Adverse Event|0|||
37844935|NCT01349049|69529602|FG004|Overall Study|Adverse Event|0|||
37844936|NCT01349049|69529603|FG005|Overall Study|Adverse Event|3|||
37844937|NCT01349049|69529604|FG006|Overall Study|Adverse Event|1|||
37844938|NCT01349049|69529605|FG007|Overall Study|Adverse Event|0|||
37844939|NCT01349049|69529606|FG008|Overall Study|Adverse Event|4|||
37844940|NCT01349049|69529598|FG000|Overall Study|Physician Decision|0|||
37916221|NCT00856986|69603087|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
38025881|NCT03053050|69710493|FG001|Open-label Phase|Investigator's Discretion|0|||
37844941|NCT01349049|69529599|FG001|Overall Study|Physician Decision|1|||
37844942|NCT01349049|69529600|FG002|Overall Study|Physician Decision|0|||
37844943|NCT01349049|69529601|FG003|Overall Study|Physician Decision|0|||
37844944|NCT01349049|69529602|FG004|Overall Study|Physician Decision|0|||
37844945|NCT01349049|69529603|FG005|Overall Study|Physician Decision|0|||
37844946|NCT01349049|69529604|FG006|Overall Study|Physician Decision|0|||
37844947|NCT01349049|69529605|FG007|Overall Study|Physician Decision|0|||
37844948|NCT01349049|69529606|FG008|Overall Study|Physician Decision|2|||
37844949|NCT01349049|69529598|FG000|Overall Study|Protocol Violation|0|||
37844950|NCT01349049|69529599|FG001|Overall Study|Protocol Violation|0|||
37844951|NCT01349049|69529600|FG002|Overall Study|Protocol Violation|0|||
37844952|NCT01349049|69529601|FG003|Overall Study|Protocol Violation|0|||
37844953|NCT01349049|69529602|FG004|Overall Study|Protocol Violation|0|||
37844954|NCT01349049|69529603|FG005|Overall Study|Protocol Violation|0|||
37844955|NCT01349049|69529604|FG006|Overall Study|Protocol Violation|0|||
37844956|NCT01349049|69529605|FG007|Overall Study|Protocol Violation|0|||
37844957|NCT01349049|69529606|FG008|Overall Study|Protocol Violation|1|||
38025882|NCT03053050|69710494|FG002|Open-label Phase|Investigator's Discretion|0|||
37844958|NCT01349049|69529598|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
37844959|NCT01349049|69529599|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
37844960|NCT01349049|69529600|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
37844961|NCT01349049|69529601|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
37844962|NCT01349049|69529602|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
37844963|NCT01349049|69529603|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
38025883|NCT03053050|69710495|FG003|Open-label Phase|Investigator's Discretion|4|||
37844964|NCT01349049|69529604|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
37844965|NCT01349049|69529605|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
37844966|NCT01349049|69529606|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
37844967|NCT01349049|69529598|FG000|Overall Study|Other|0|||
37844968|NCT01349049|69529599|FG001|Overall Study|Other|0|||
37844969|NCT01349049|69529600|FG002|Overall Study|Other|0|||
37844970|NCT01349049|69529601|FG003|Overall Study|Other|0|||
37844971|NCT01349049|69529602|FG004|Overall Study|Other|0|||
37844972|NCT01349049|69529603|FG005|Overall Study|Other|1|||
37844973|NCT01349049|69529604|FG006|Overall Study|Other|0|||
37844974|NCT01349049|69529605|FG007|Overall Study|Other|0|||
37916222|NCT00856986|69603088|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
37916223|NCT00856986|69603089|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
37916224|NCT00856986|69603090|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
37916225|NCT00856986|69603086|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
37916226|NCT00856986|69603087|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
37844975|NCT01349049|69529606|FG008|Overall Study|Other|4|||
37844976|NCT01349049|69529598|FG000|Overall Study|Death|0|||
37844977|NCT01349049|69529599|FG001|Overall Study|Death|0|||
37844978|NCT01349049|69529600|FG002|Overall Study|Death|0|||
37844979|NCT01349049|69529601|FG003|Overall Study|Death|0|||
37844980|NCT01349049|69529602|FG004|Overall Study|Death|0|||
37844981|NCT01349049|69529603|FG005|Overall Study|Death|0|||
37844982|NCT01349049|69529604|FG006|Overall Study|Death|0|||
37844983|NCT01349049|69529605|FG007|Overall Study|Death|1|||
37844984|NCT01349049|69529606|FG008|Overall Study|Death|5|||
37844985|NCT01349049|69529598|FG000|Overall Study|Non-compliance|0|||
37844986|NCT01349049|69529599|FG001|Overall Study|Non-compliance|0|||
37844987|NCT01349049|69529600|FG002|Overall Study|Non-compliance|0|||
37844988|NCT01349049|69529601|FG003|Overall Study|Non-compliance|1|||
37844989|NCT01349049|69529602|FG004|Overall Study|Non-compliance|0|||
37844990|NCT01349049|69529603|FG005|Overall Study|Non-compliance|0|||
37844991|NCT01349049|69529604|FG006|Overall Study|Non-compliance|0|||
37844992|NCT01349049|69529605|FG007|Overall Study|Non-compliance|0|||
37844993|NCT01349049|69529606|FG008|Overall Study|Non-compliance|0|||
37916227|NCT00856986|69603088|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
37916228|NCT00856986|69603089|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
37916229|NCT00856986|69603090|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
37916230|NCT00856986|69603086|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
37916231|NCT00856986|69603087|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
37916232|NCT00856986|69603088|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
37916233|NCT00856986|69603089|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
37916234|NCT00856986|69603090|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
37916235|NCT00856986|69603086|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
37916236|NCT00856986|69603087|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
37916237|NCT00856986|69603088|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
37844994|NCT01349049|69529598|FG000|Overall Study|Withdrawal by Subject|0|||
37844995|NCT01349049|69529599|FG001|Overall Study|Withdrawal by Subject|0|||
37844996|NCT01349049|69529600|FG002|Overall Study|Withdrawal by Subject|0|||
37844997|NCT01349049|69529601|FG003|Overall Study|Withdrawal by Subject|0|||
37844998|NCT01349049|69529602|FG004|Overall Study|Withdrawal by Subject|0|||
37844999|NCT01349049|69529603|FG005|Overall Study|Withdrawal by Subject|0|||
37845000|NCT01349049|69529604|FG006|Overall Study|Withdrawal by Subject|0|||
37845001|NCT01349049|69529605|FG007|Overall Study|Withdrawal by Subject|0|||
37845002|NCT01349049|69529606|FG008|Overall Study|Withdrawal by Subject|6|||
37845003|NCT01348854|69529640|FG000|Overall Study|Lost to Follow-up|2|||
37845004|NCT01348854|69529641|FG001|Overall Study|Lost to Follow-up|1|||
37845005|NCT01348854|69529640|FG000|Overall Study|Withdrawal by Subject|1|||
37845006|NCT01348854|69529641|FG001|Overall Study|Withdrawal by Subject|0|||
37845007|NCT01348776|69529647|FG000|Overall Study|Lost to Follow-up|3|||
37845008|NCT01348698|69529660|FG000|Overall Study|Does not meet lesion size criteria|1|||
37845009|NCT01348698|69529660|FG000|Overall Study|Death|3|||
37845010|NCT01348698|69529660|FG000|Overall Study|PI decision to close study|68|||
37916238|NCT00856986|69603089|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
37916239|NCT00856986|69603090|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
37916240|NCT00856986|69603086|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
37845011|NCT01348542|69529666|FG000|Overall Study|Withdrawal by Subject|3|||
37845012|NCT01348542|69529667|FG001|Overall Study|Withdrawal by Subject|0|||
37845013|NCT01346709|69529673|FG000|Overall Study|Protocol Violation|35|||
37845014|NCT01346709|69529673|FG000|Overall Study|Lost to Follow-up|31|||
37845015|NCT01346709|69529673|FG000|Overall Study|Missing data in candidate risk factor|285|||
37845016|NCT01346592|69529680|FG000|Overall Study|Lost to Follow-up|62|||
37845017|NCT01346592|69529681|FG001|Overall Study|Lost to Follow-up|29|||
37916241|NCT00856986|69603087|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
37916242|NCT00856986|69603088|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
37916243|NCT00856986|69603089|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
37916244|NCT00856986|69603090|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
37916245|NCT00856986|69603086|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
37916246|NCT00856986|69603087|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
37916247|NCT00856986|69603088|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
37916248|NCT00856986|69603089|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
37916249|NCT00856986|69603090|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
37916250|NCT00707746|69603104|FG000|Treatment Period|Adverse Event|2|||
37916251|NCT00707746|69603105|FG001|Treatment Period|Adverse Event|4|||
37916252|NCT00707746|69603104|FG000|Treatment Period|Ineligibility|0|||
37916253|NCT00707746|69603105|FG001|Treatment Period|Ineligibility|1|||
37916254|NCT00856908|69603113|FG000|Overall Study|Lost to Follow-up|1|||
37916255|NCT00856908|69603114|FG001|Overall Study|Lost to Follow-up|0|||
37916256|NCT00522379|69603125|FG000|Overall Study|Adverse Event|12|||
37916257|NCT00522379|69603126|FG001|Overall Study|Adverse Event|15|||
37916258|NCT00522379|69603127|FG002|Overall Study|Adverse Event|12|||
37916259|NCT00522379|69603128|FG003|Overall Study|Adverse Event|5|||
37916260|NCT00522379|69603129|FG004|Overall Study|Adverse Event|17|||
37916261|NCT00522379|69603125|FG000|Overall Study|Lack of Efficacy|3|||
37916262|NCT00522379|69603126|FG001|Overall Study|Lack of Efficacy|0|||
37734220|NCT03086343|69214520|FG000|Overall Study|Other, not specified|8|||
37734221|NCT03086343|69214521|FG001|Overall Study|Other, not specified|4|||
37845018|NCT01346592|69529682|FG002|Overall Study|Lost to Follow-up|29|||
37845019|NCT01346592|69529680|FG000|Overall Study|Protocol Violation|2|||
37845020|NCT01346592|69529681|FG001|Overall Study|Protocol Violation|1|||
37845021|NCT01346592|69529682|FG002|Overall Study|Protocol Violation|0|||
37845022|NCT01346592|69529680|FG000|Overall Study|Death|1|||
37845023|NCT01346592|69529681|FG001|Overall Study|Death|3|||
37845024|NCT01346592|69529682|FG002|Overall Study|Death|4|||
37845025|NCT01346592|69529680|FG000|Overall Study|Adverse Event|0|||
37845026|NCT01346592|69529681|FG001|Overall Study|Adverse Event|1|||
37845027|NCT01346592|69529682|FG002|Overall Study|Adverse Event|0|||
37845028|NCT01346592|69529680|FG000|Overall Study|Withdrawal by Subject|77|||
37845029|NCT01346592|69529681|FG001|Overall Study|Withdrawal by Subject|51|||
37845030|NCT01346592|69529682|FG002|Overall Study|Withdrawal by Subject|38|||
37845031|NCT01346592|69529680|FG000|Overall Study|Inappropriate enrollment|3|||
37734222|NCT03086343|69214520|FG000|Overall Study|Missing|0|||
37734223|NCT03086343|69214521|FG001|Overall Study|Missing|1|||
37734224|NCT02788045|69214565|FG000|Main Study (Up to Week 72)|Adverse Event|0|||
37734225|NCT02788045|69214566|FG001|Main Study (Up to Week 72)|Adverse Event|1|||
37734226|NCT02788045|69214567|FG002|Main Study (Up to Week 72)|Adverse Event|1|||
37734227|NCT02788045|69214565|FG000|Main Study (Up to Week 72)|Lost to Follow-up|5|||
37734228|NCT02788045|69214566|FG001|Main Study (Up to Week 72)|Lost to Follow-up|4|||
37734229|NCT02788045|69214567|FG002|Main Study (Up to Week 72)|Lost to Follow-up|3|||
37734230|NCT02788045|69214565|FG000|Main Study (Up to Week 72)|Pregnancy|1|||
37734231|NCT02788045|69214566|FG001|Main Study (Up to Week 72)|Pregnancy|1|||
37734232|NCT02788045|69214567|FG002|Main Study (Up to Week 72)|Pregnancy|0|||
37734233|NCT02788045|69214565|FG000|Main Study (Up to Week 72)|Protocol Violation|1|||
37734234|NCT02788045|69214566|FG001|Main Study (Up to Week 72)|Protocol Violation|0|||
37734235|NCT02788045|69214567|FG002|Main Study (Up to Week 72)|Protocol Violation|0|||
37734236|NCT02788045|69214565|FG000|Main Study (Up to Week 72)|Withdrawal by Subject|6|||
37734237|NCT02788045|69214566|FG001|Main Study (Up to Week 72)|Withdrawal by Subject|4|||
37734238|NCT02788045|69214567|FG002|Main Study (Up to Week 72)|Withdrawal by Subject|1|||
37734239|NCT02788045|69214565|FG000|Main Study (Up to Week 72)|Other|3|||
37734240|NCT02788045|69214566|FG001|Main Study (Up to Week 72)|Other|0|||
37734241|NCT02788045|69214567|FG002|Main Study (Up to Week 72)|Other|0|||
37734242|NCT02788045|69214565|FG000|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|8|||
37734243|NCT02788045|69214566|FG001|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
37734244|NCT02788045|69214567|FG002|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
37734245|NCT02788045|69214565|FG000|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|8|||
37734246|NCT02788045|69214566|FG001|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
37734247|NCT02788045|69214567|FG002|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
37734248|NCT02788045|69214565|FG000|Long Term Extension (From Wk 72 to 264)|Other|1|||
37734249|NCT02788045|69214566|FG001|Long Term Extension (From Wk 72 to 264)|Other|0|||
37734250|NCT02788045|69214567|FG002|Long Term Extension (From Wk 72 to 264)|Other|0|||
37845032|NCT01346592|69529681|FG001|Overall Study|Inappropriate enrollment|1|||
37845033|NCT01346592|69529682|FG002|Overall Study|Inappropriate enrollment|1|||
37845034|NCT01346592|69529680|FG000|Overall Study|Administrative reason|1|||
37845035|NCT01346592|69529681|FG001|Overall Study|Administrative reason|0|||
37916263|NCT00522379|69603127|FG002|Overall Study|Lack of Efficacy|2|||
37916264|NCT00522379|69603128|FG003|Overall Study|Lack of Efficacy|2|||
37916265|NCT00522379|69603129|FG004|Overall Study|Lack of Efficacy|7|||
37734251|NCT02315703|69214601|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
37734252|NCT02315703|69214602|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
37734253|NCT02315703|69214603|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
37734254|NCT02315703|69214604|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
37734255|NCT02315703|69214605|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
37845036|NCT01346592|69529682|FG002|Overall Study|Administrative reason|0|||
37845037|NCT01346592|69529680|FG000|Overall Study|Unable to Classify|7|||
37845038|NCT01346592|69529681|FG001|Overall Study|Unable to Classify|3|||
37845039|NCT01346592|69529682|FG002|Overall Study|Unable to Classify|6|||
37845040|NCT01346514|69529709|FG000|Overall Study|Lost to Follow-up|19|||
37845041|NCT01346514|69529710|FG001|Overall Study|Lost to Follow-up|30|||
37845042|NCT01346514|69529709|FG000|Overall Study|Withdrawal by Subject|7|||
37845043|NCT01346514|69529710|FG001|Overall Study|Withdrawal by Subject|3|||
37845044|NCT01346514|69529709|FG000|Overall Study|Death|3|||
37845045|NCT01346514|69529710|FG001|Overall Study|Death|4|||
37845046|NCT01193335|69529720|FG000|After Infant Series|Lost to Follow-up|1|||
37845047|NCT01193335|69529721|FG001|After Infant Series|Lost to Follow-up|2|||
37845048|NCT01193335|69529720|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
37845049|NCT01193335|69529721|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
37845050|NCT01193335|69529720|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
37845051|NCT01193335|69529721|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
37845052|NCT01193335|69529720|FG000|1-Year Follow-up|Lost to Follow-up|4|||
37845053|NCT01193335|69529721|FG001|1-Year Follow-up|Lost to Follow-up|0|||
37845054|NCT01193335|69529720|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
37845055|NCT01193335|69529721|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
37845056|NCT01193335|69529720|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
37845057|NCT01193335|69529721|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
37845058|NCT01342887|69529743|FG000|Overall Study|Death|2|||
37845059|NCT01342341|69529749|FG000|Overall Study|Lost to Follow-up|4|||
37845060|NCT01342341|69529750|FG001|Overall Study|Lost to Follow-up|4|||
37845061|NCT01340664|69529759|FG000|Overall Study|Adverse Event|0|||
37845062|NCT01340664|69529760|FG001|Overall Study|Adverse Event|1|||
37845063|NCT01340664|69529761|FG002|Overall Study|Adverse Event|7|||
37845064|NCT01340664|69529759|FG000|Overall Study|Lost to Follow-up|2|||
37845065|NCT01340664|69529760|FG001|Overall Study|Lost to Follow-up|0|||
37845066|NCT01340664|69529761|FG002|Overall Study|Lost to Follow-up|2|||
37845067|NCT01340664|69529759|FG000|Overall Study|Withdrawal by Subject|2|||
37845068|NCT01340664|69529760|FG001|Overall Study|Withdrawal by Subject|4|||
37845069|NCT01340664|69529761|FG002|Overall Study|Withdrawal by Subject|0|||
37845070|NCT01340664|69529759|FG000|Overall Study|Glycemic withdrawal criteria|2|||
37845071|NCT01340664|69529760|FG001|Overall Study|Glycemic withdrawal criteria|0|||
37845072|NCT01340664|69529761|FG002|Overall Study|Glycemic withdrawal criteria|0|||
37845073|NCT01340664|69529759|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
37845074|NCT01340664|69529760|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
37845075|NCT01340664|69529761|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
37845076|NCT01340664|69529759|FG000|Overall Study|Other|1|||
37845077|NCT01340664|69529760|FG001|Overall Study|Other|2|||
37845078|NCT01340664|69529761|FG002|Overall Study|Other|2|||
37845079|NCT01340625|69529771|FG000|First Intervention|Adverse Event|1|||
37845080|NCT01340625|69529772|FG001|First Intervention|Adverse Event|0|||
37845081|NCT01340625|69529771|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
37845082|NCT01340625|69529772|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
37845083|NCT01340196|69529778|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
37845084|NCT01327599|69529787|FG000|Overall Study|Adverse Event|1|||
37845085|NCT01327599|69529787|FG000|Overall Study|Could Not Attend Visit|1|||
37845086|NCT01327599|69529787|FG000|Overall Study|Withdrawal of Consent|1|||
37845087|NCT01193257|69529793|FG000|Overall Study|Death|202|||
37845088|NCT01193257|69529794|FG001|Overall Study|Death|391|||
37845089|NCT01193257|69529793|FG000|Overall Study|Study termination by sponsor|0|||
37845090|NCT01193257|69529794|FG001|Overall Study|Study termination by sponsor|3|||
37845091|NCT01193257|69529793|FG000|Overall Study|Withdrawal by Subject|26|||
37845092|NCT01193257|69529794|FG001|Overall Study|Withdrawal by Subject|86|||
37845093|NCT01193257|69529793|FG000|Overall Study|Lost to Follow-up|2|||
37845094|NCT01193257|69529794|FG001|Overall Study|Lost to Follow-up|3|||
37916266|NCT00522379|69603125|FG000|Overall Study|Withdrawal by Subject|2|||
37916267|NCT00522379|69603126|FG001|Overall Study|Withdrawal by Subject|3|||
37734256|NCT02315703|69214606|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
37845095|NCT01193257|69529793|FG000|Overall Study|Unblinded due to futility|135|||
37845096|NCT01193257|69529794|FG001|Overall Study|Unblinded due to futility|251|||
37916268|NCT00522379|69603127|FG002|Overall Study|Withdrawal by Subject|1|||
37916269|NCT00522379|69603128|FG003|Overall Study|Withdrawal by Subject|2|||
37845097|NCT01193218|69529805|FG000|0-12 Weeks|Adverse Event|6|||
37845098|NCT01193218|69529806|FG001|0-12 Weeks|Adverse Event|0|||
37845099|NCT01193218|69529807|FG002|0-12 Weeks|Adverse Event|1|||
37845100|NCT01193218|69529808|FG003|0-12 Weeks|Adverse Event|0|||
37845101|NCT01193218|69529809|FG004|0-12 Weeks|Adverse Event|0|||
37845102|NCT01193218|69529810|FG005|0-12 Weeks|Adverse Event|2|||
37845103|NCT01193218|69529811|FG006|0-12 Weeks|Adverse Event|2|||
37845104|NCT01193218|69529812|FG007|0-12 Weeks|Adverse Event|0|||
37845105|NCT01193218|69529805|FG000|0-12 Weeks|Protocol Violation|0|||
37845106|NCT01193218|69529806|FG001|0-12 Weeks|Protocol Violation|0|||
37845107|NCT01193218|69529807|FG002|0-12 Weeks|Protocol Violation|0|||
37845108|NCT01193218|69529808|FG003|0-12 Weeks|Protocol Violation|0|||
37845109|NCT01193218|69529809|FG004|0-12 Weeks|Protocol Violation|1|||
37845110|NCT01193218|69529810|FG005|0-12 Weeks|Protocol Violation|1|||
37845111|NCT01193218|69529811|FG006|0-12 Weeks|Protocol Violation|0|||
37845112|NCT01193218|69529812|FG007|0-12 Weeks|Protocol Violation|0|||
37845113|NCT01193218|69529805|FG000|0-12 Weeks|Withdrawal by Subject|3|||
37845114|NCT01193218|69529806|FG001|0-12 Weeks|Withdrawal by Subject|0|||
37845115|NCT01193218|69529807|FG002|0-12 Weeks|Withdrawal by Subject|2|||
37845116|NCT01193218|69529808|FG003|0-12 Weeks|Withdrawal by Subject|0|||
37845117|NCT01193218|69529809|FG004|0-12 Weeks|Withdrawal by Subject|0|||
37845118|NCT01193218|69529810|FG005|0-12 Weeks|Withdrawal by Subject|0|||
37845119|NCT01193218|69529811|FG006|0-12 Weeks|Withdrawal by Subject|1|||
37845120|NCT01193218|69529812|FG007|0-12 Weeks|Withdrawal by Subject|0|||
37845121|NCT01193218|69529805|FG000|12-52 Weeks|Adverse Event|1|||
37845122|NCT01193218|69529806|FG001|12-52 Weeks|Adverse Event|0|||
37845123|NCT01193218|69529807|FG002|12-52 Weeks|Adverse Event|1|||
37916270|NCT00522379|69603129|FG004|Overall Study|Withdrawal by Subject|0|||
37916271|NCT00522379|69603125|FG000|Overall Study|Protocol Violation|1|||
37916272|NCT00522379|69603126|FG001|Overall Study|Protocol Violation|1|||
37916273|NCT00522379|69603127|FG002|Overall Study|Protocol Violation|2|||
37916274|NCT00522379|69603128|FG003|Overall Study|Protocol Violation|0|||
37916275|NCT00522379|69603129|FG004|Overall Study|Protocol Violation|0|||
37916276|NCT00522379|69603125|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
37916277|NCT00522379|69603126|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
37916278|NCT00522379|69603127|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
37916279|NCT00522379|69603128|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
37916280|NCT00522379|69603129|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
37916281|NCT00522379|69603125|FG000|Overall Study|Lost to Follow-up|1|||
37916282|NCT00522379|69603126|FG001|Overall Study|Lost to Follow-up|0|||
37916283|NCT00522379|69603127|FG002|Overall Study|Lost to Follow-up|4|||
37916284|NCT00522379|69603128|FG003|Overall Study|Lost to Follow-up|2|||
37916285|NCT00522379|69603129|FG004|Overall Study|Lost to Follow-up|2|||
37916286|NCT00522379|69603125|FG000|Overall Study|Randomization error|0|||
37916287|NCT00522379|69603126|FG001|Overall Study|Randomization error|0|||
37916288|NCT00522379|69603127|FG002|Overall Study|Randomization error|0|||
37916289|NCT00522379|69603128|FG003|Overall Study|Randomization error|0|||
37916290|NCT00522379|69603129|FG004|Overall Study|Randomization error|1|||
37916291|NCT00522379|69603125|FG000|Overall Study|Dispensing error|1|||
37916292|NCT00522379|69603126|FG001|Overall Study|Dispensing error|0|||
37916293|NCT00522379|69603127|FG002|Overall Study|Dispensing error|0|||
37916294|NCT00522379|69603128|FG003|Overall Study|Dispensing error|1|||
37916295|NCT00522379|69603129|FG004|Overall Study|Dispensing error|0|||
37916296|NCT00522379|69603125|FG000|Overall Study|Subject Moved|1|||
37916297|NCT00522379|69603126|FG001|Overall Study|Subject Moved|1|||
37916298|NCT00522379|69603127|FG002|Overall Study|Subject Moved|0|||
37916299|NCT00522379|69603128|FG003|Overall Study|Subject Moved|0|||
37916300|NCT00522379|69603129|FG004|Overall Study|Subject Moved|0|||
37916301|NCT00522379|69603125|FG000|Overall Study|Sponsor Request|0|||
37916302|NCT00522379|69603126|FG001|Overall Study|Sponsor Request|1|||
37916303|NCT00522379|69603127|FG002|Overall Study|Sponsor Request|0|||
37916304|NCT00522379|69603128|FG003|Overall Study|Sponsor Request|0|||
37916305|NCT00522379|69603129|FG004|Overall Study|Sponsor Request|0|||
37916306|NCT00522379|69603125|FG000|Overall Study|Family Problem|0|||
37916307|NCT00522379|69603126|FG001|Overall Study|Family Problem|0|||
37916308|NCT00522379|69603127|FG002|Overall Study|Family Problem|1|||
37845124|NCT01193218|69529808|FG003|12-52 Weeks|Adverse Event|2|||
37845125|NCT01193218|69529809|FG004|12-52 Weeks|Adverse Event|3|||
37845126|NCT01193218|69529810|FG005|12-52 Weeks|Adverse Event|3|||
37845127|NCT01193218|69529811|FG006|12-52 Weeks|Adverse Event|1|||
37916309|NCT00522379|69603128|FG003|Overall Study|Family Problem|0|||
37916310|NCT00522379|69603129|FG004|Overall Study|Family Problem|0|||
37916311|NCT00522379|69603125|FG000|Overall Study|Site Closed|0|||
37916312|NCT00522379|69603126|FG001|Overall Study|Site Closed|0|||
37916313|NCT00522379|69603127|FG002|Overall Study|Site Closed|0|||
37845128|NCT01193218|69529812|FG007|12-52 Weeks|Adverse Event|2|||
37916314|NCT00522379|69603128|FG003|Overall Study|Site Closed|1|||
37845129|NCT01193218|69529805|FG000|12-52 Weeks|Lack of Efficacy|0|||
37845130|NCT01193218|69529806|FG001|12-52 Weeks|Lack of Efficacy|0|||
37845131|NCT01193218|69529807|FG002|12-52 Weeks|Lack of Efficacy|0|||
37845132|NCT01193218|69529808|FG003|12-52 Weeks|Lack of Efficacy|0|||
37845133|NCT01193218|69529809|FG004|12-52 Weeks|Lack of Efficacy|0|||
37845134|NCT01193218|69529810|FG005|12-52 Weeks|Lack of Efficacy|0|||
37916315|NCT00522379|69603129|FG004|Overall Study|Site Closed|0|||
37916316|NCT00522379|69603125|FG000|Overall Study|Subject Withdrawal|0|||
37916317|NCT00522379|69603126|FG001|Overall Study|Subject Withdrawal|0|||
37845135|NCT01193218|69529811|FG006|12-52 Weeks|Lack of Efficacy|1|||
37845136|NCT01193218|69529812|FG007|12-52 Weeks|Lack of Efficacy|0|||
37845137|NCT01193218|69529805|FG000|12-52 Weeks|Withdrawal by Subject|3|||
37845138|NCT01193218|69529806|FG001|12-52 Weeks|Withdrawal by Subject|0|||
37845139|NCT01193218|69529807|FG002|12-52 Weeks|Withdrawal by Subject|3|||
37845140|NCT01193218|69529808|FG003|12-52 Weeks|Withdrawal by Subject|0|||
37845141|NCT01193218|69529809|FG004|12-52 Weeks|Withdrawal by Subject|0|||
37845142|NCT01193218|69529810|FG005|12-52 Weeks|Withdrawal by Subject|2|||
38025884|NCT04369950|69710506|FG000|Overall Study|Protocol Violation|2|||
37916318|NCT00522379|69603127|FG002|Overall Study|Subject Withdrawal|0|||
37916319|NCT00522379|69603128|FG003|Overall Study|Subject Withdrawal|1|||
37916320|NCT00522379|69603129|FG004|Overall Study|Subject Withdrawal|0|||
37916321|NCT00856830|69603145|FG000|Irinotecan & Bendamustine|Death|0|||
37916322|NCT00856830|69603146|FG001|Irinotecan & Bendamustine|Death|0|||
37916323|NCT00856830|69603147|FG002|Irinotecan & Bendamustine|Death|0|||
38025885|NCT04369950|69710507|FG001|Overall Study|Protocol Violation|2|||
38025886|NCT04035564|69710515|FG000|Overall Study|Protocol Violation|1|||
38025887|NCT04035564|69710516|FG001|Overall Study|Protocol Violation|2|||
38025888|NCT04035564|69710515|FG000|Overall Study|No laboratory available|2|||
38025889|NCT04035564|69710516|FG001|Overall Study|No laboratory available|2|||
38025890|NCT04035564|69710515|FG000|Overall Study|Guardian declined consent|1|||
38025891|NCT04035564|69710516|FG001|Overall Study|Guardian declined consent|2|||
38025892|NCT02955602|69710525|FG000|Overall Study|Adverse Event|0|||
38025893|NCT02955602|69710526|FG001|Overall Study|Adverse Event|3|||
38025894|NCT02955602|69710527|FG002|Overall Study|Adverse Event|0|||
37916324|NCT00856830|69603148|FG003|Irinotecan & Bendamustine|Death|2|||
38025895|NCT02955602|69710525|FG000|Overall Study|Withdrawal of informed consent|1|||
38025896|NCT02955602|69710526|FG001|Overall Study|Withdrawal of informed consent|3|||
38025897|NCT02955602|69710527|FG002|Overall Study|Withdrawal of informed consent|2|||
38025898|NCT02955602|69710525|FG000|Overall Study|Lost to Follow-up|0|||
38025899|NCT02955602|69710526|FG001|Overall Study|Lost to Follow-up|0|||
38025900|NCT02955602|69710527|FG002|Overall Study|Lost to Follow-up|1|||
38025901|NCT02955602|69710525|FG000|Overall Study|Other|0|||
38025902|NCT02955602|69710526|FG001|Overall Study|Other|1|||
38025903|NCT02955602|69710527|FG002|Overall Study|Other|3|||
38025904|NCT04179786|69710535|FG000|Overall Study|Withdrawal by Subject|8|||
38025905|NCT04175808|69710539|FG000|Part A|Miscellaneous|2|||
38025906|NCT04175808|69710540|FG001|Part A|Miscellaneous|0|||
38025907|NCT04175808|69710541|FG002|Part A|Miscellaneous|0|||
38025908|NCT04175808|69710542|FG003|Part A|Miscellaneous|0|||
38025909|NCT04175808|69710543|FG004|Part A|Miscellaneous|0|||
38025910|NCT04175808|69710544|FG005|Part A|Miscellaneous|0|||
38025911|NCT04175808|69710545|FG006|Part A|Miscellaneous|0|||
38025912|NCT04057196|69710561|FG000|Overall Study|Withdrawal by Subject|3|||
38025913|NCT04057196|69710561|FG000|Overall Study|Death|3|||
38025914|NCT04027686|69710567|FG000|Overall Study|Lost to Follow-up|2|||
38025915|NCT04027686|69710568|FG001|Overall Study|Lost to Follow-up|0|||
38025916|NCT04027686|69710567|FG000|Overall Study|Withdrawal by Subject|0|||
38025917|NCT04027686|69710568|FG001|Overall Study|Withdrawal by Subject|1|||
38025918|NCT03052426|69710581|FG000|Overall Study|Withdrawal by Subject|0|||
38025919|NCT03052426|69710582|FG001|Overall Study|Withdrawal by Subject|1|||
38025920|NCT03052426|69710583|FG002|Overall Study|Withdrawal by Subject|0|||
37916325|NCT00856830|69603145|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
37916326|NCT00856830|69603146|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
37916327|NCT00856830|69603147|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
37916328|NCT00856830|69603148|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
37916329|NCT00522301|69603153|FG000|Overall Study|Withdrawal by Subject|1|||
37916330|NCT00522301|69603153|FG000|Overall Study|Adverse Event|5|||
38025921|NCT03052426|69710581|FG000|Overall Study|Lost to Follow-up|2|||
38025922|NCT03052426|69710582|FG001|Overall Study|Lost to Follow-up|0|||
38025923|NCT03052426|69710583|FG002|Overall Study|Lost to Follow-up|1|||
38025924|NCT03688880|69710598|FG000|Overall Study|Withdrawal by Subject|0|||
37916331|NCT00863928|69603159|FG000|Overall Study|Protocol Violation|26|||
37916332|NCT00863928|69603160|FG001|Overall Study|Protocol Violation|0|||
38025925|NCT03688880|69710599|FG001|Overall Study|Withdrawal by Subject|2|||
38025926|NCT03688880|69710598|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
38025927|NCT03688880|69710599|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
37845143|NCT01193218|69529811|FG006|12-52 Weeks|Withdrawal by Subject|1|||
37916333|NCT00863928|69603159|FG000|Overall Study|Withdrawal by Subject|3|||
37916334|NCT00863928|69603160|FG001|Overall Study|Withdrawal by Subject|0|||
38025928|NCT03688880|69710598|FG000|Overall Study|Lost to Follow-up|4|||
38025929|NCT03688880|69710599|FG001|Overall Study|Lost to Follow-up|7|||
38025930|NCT03688880|69710598|FG000|Overall Study|Adverse Event|0|||
38025931|NCT03688880|69710599|FG001|Overall Study|Adverse Event|2|||
38025932|NCT03688880|69710598|FG000|Overall Study|Device deficiencies|0|||
38025933|NCT03688880|69710599|FG001|Overall Study|Device deficiencies|2|||
38025934|NCT03688880|69710598|FG000|Overall Study|Other|10|||
37845144|NCT01193218|69529812|FG007|12-52 Weeks|Withdrawal by Subject|2|||
37845145|NCT01193218|69529805|FG000|12-52 Weeks|Other reason than above|1|||
37845146|NCT01193218|69529806|FG001|12-52 Weeks|Other reason than above|0|||
37845147|NCT01193218|69529807|FG002|12-52 Weeks|Other reason than above|0|||
37845148|NCT01193218|69529808|FG003|12-52 Weeks|Other reason than above|1|||
37845149|NCT01193218|69529809|FG004|12-52 Weeks|Other reason than above|1|||
37845150|NCT01193218|69529810|FG005|12-52 Weeks|Other reason than above|0|||
37845151|NCT01193218|69529811|FG006|12-52 Weeks|Other reason than above|0|||
37845152|NCT01193218|69529812|FG007|12-52 Weeks|Other reason than above|0|||
37845153|NCT01193101|69529832|FG000|Overall Study|Adverse Event|0|||
37845154|NCT01193101|69529833|FG001|Overall Study|Adverse Event|1|||
37845155|NCT01193101|69529834|FG002|Overall Study|Adverse Event|1|||
37845156|NCT01193101|69529835|FG003|Overall Study|Adverse Event|3|||
37845157|NCT01193101|69529832|FG000|Overall Study|Lack of Efficacy|3|||
37845158|NCT01193101|69529833|FG001|Overall Study|Lack of Efficacy|1|||
37845159|NCT01193101|69529834|FG002|Overall Study|Lack of Efficacy|0|||
37845160|NCT01193101|69529835|FG003|Overall Study|Lack of Efficacy|8|||
37845161|NCT01193101|69529832|FG000|Overall Study|Withdrawal by Subject|2|||
37845162|NCT01193101|69529833|FG001|Overall Study|Withdrawal by Subject|4|||
37845163|NCT01193101|69529834|FG002|Overall Study|Withdrawal by Subject|1|||
37845164|NCT01193101|69529835|FG003|Overall Study|Withdrawal by Subject|1|||
37845165|NCT01193101|69529832|FG000|Overall Study|Administrative problems|0|||
37845166|NCT01193101|69529833|FG001|Overall Study|Administrative problems|0|||
37845167|NCT01193101|69529834|FG002|Overall Study|Administrative problems|1|||
37845168|NCT01193101|69529835|FG003|Overall Study|Administrative problems|0|||
37845169|NCT01193101|69529832|FG000|Overall Study|Abnormal test procedure results|0|||
37845170|NCT01193101|69529833|FG001|Overall Study|Abnormal test procedure results|1|||
37845171|NCT01193101|69529834|FG002|Overall Study|Abnormal test procedure results|0|||
37845172|NCT01193101|69529835|FG003|Overall Study|Abnormal test procedure results|0|||
37845173|NCT01192516|69529848|FG000|Overall Study|Lost to Follow-up|7|||
37845174|NCT01192516|69529849|FG001|Overall Study|Lost to Follow-up|10|||
37845175|NCT01192516|69529850|FG002|Overall Study|Lost to Follow-up|7|||
37845176|NCT01192516|69529848|FG000|Overall Study|Withdrawal by Subject|4|||
37845177|NCT01192516|69529849|FG001|Overall Study|Withdrawal by Subject|4|||
37845178|NCT01192516|69529850|FG002|Overall Study|Withdrawal by Subject|1|||
37845179|NCT01192516|69529848|FG000|Overall Study|started new treatment|5|||
37845180|NCT01192516|69529849|FG001|Overall Study|started new treatment|1|||
37845181|NCT01192516|69529850|FG002|Overall Study|started new treatment|0|||
37845182|NCT01192516|69529848|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
37845183|NCT01192516|69529849|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
37845184|NCT01192516|69529850|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
37845185|NCT01192399|69529862|FG000|Overall Study|Lack of Efficacy|2|||
37845186|NCT01176916|69529866|FG000|Overall Study|Adverse Event|61|||
37845187|NCT01176916|69529866|FG000|Overall Study|Death|1|||
37845188|NCT01176916|69529866|FG000|Overall Study|Lost to Follow-up|15|||
37845189|NCT01176916|69529866|FG000|Overall Study|Objective progression or relapse|17|||
37845190|NCT01176916|69529866|FG000|Overall Study|Protocol Violation|24|||
37845191|NCT01176916|69529866|FG000|Overall Study|Withdrawal by Subject|37|||
37845192|NCT01176916|69529866|FG000|Overall Study|Other|6|||
37845193|NCT01176916|69529866|FG000|Overall Study|Withdrawal prior to Treatment|6|||
37845194|NCT01192204|69529872|FG000|Overall Study|could not keep recall appointments|1|||
37845195|NCT01192204|69529873|FG001|Overall Study|could not keep recall appointments|0|||
37845196|NCT01192126|69529880|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
37845197|NCT01192126|69529881|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
37845198|NCT01192126|69529880|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
37845199|NCT01192126|69529881|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
37845200|NCT01327482|69529887|FG000|Overall Study|Adverse Event|1|||
37845201|NCT01176565|69529893|FG000|Overall Study|Lost to Follow-up|12|||
37845202|NCT01176565|69529894|FG001|Overall Study|Lost to Follow-up|16|||
37845203|NCT01176565|69529893|FG000|Overall Study|Withdrawal by Subject|7|||
37845204|NCT01176565|69529894|FG001|Overall Study|Withdrawal by Subject|1|||
37845205|NCT01176565|69529893|FG000|Overall Study|Not Analyzed (any other reason)|1|||
37845206|NCT01176565|69529894|FG001|Overall Study|Not Analyzed (any other reason)|2|||
37845207|NCT01176292|69529902|FG000|Overall Study|Lost to Follow-up|2|||
37845208|NCT01176292|69529903|FG001|Overall Study|Lost to Follow-up|4|||
38025935|NCT03688880|69710599|FG001|Overall Study|Other|16|||
37845209|NCT01176292|69529902|FG000|Overall Study|Adverse Event|1|||
37845210|NCT01176292|69529903|FG001|Overall Study|Adverse Event|1|||
37845211|NCT01176292|69529902|FG000|Overall Study|Physician Decision|0|||
37845212|NCT01176292|69529903|FG001|Overall Study|Physician Decision|2|||
37845213|NCT01176292|69529902|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
37845214|NCT01176292|69529903|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
37845215|NCT01113541|69529909|FG000|Overall Study|Withdrawal by Subject|1|||
37845216|NCT01113541|69529909|FG000|Overall Study|Protocol Violation|1|||
37845217|NCT01113541|69529909|FG000|Overall Study|Study Terminated by Sponsor|7|||
37845218|NCT01113541|69529909|FG000|Overall Study|Adverse Event|4|||
37734257|NCT02315703|69214607|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
37734258|NCT02315703|69214608|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
37734259|NCT02315703|69214601|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
37734260|NCT02315703|69214602|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
37734261|NCT02315703|69214603|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
37734262|NCT02315703|69214604|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
37734263|NCT02315703|69214605|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
37734264|NCT02315703|69214606|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
37734265|NCT02315703|69214607|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
37734266|NCT02315703|69214608|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
37734267|NCT02315703|69214601|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
37734268|NCT02315703|69214602|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
37734269|NCT02315703|69214603|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
37845219|NCT01113502|69529922|FG000|Overall Study|Withdrawal by Subject|1|||
37845220|NCT01113502|69529923|FG001|Overall Study|Withdrawal by Subject|0|||
37845221|NCT01113502|69529924|FG002|Overall Study|Withdrawal by Subject|1|||
37845222|NCT01113502|69529925|FG003|Overall Study|Withdrawal by Subject|1|||
37845223|NCT01113502|69529926|FG004|Overall Study|Withdrawal by Subject|0|||
37845224|NCT01113502|69529922|FG000|Overall Study|Adverse Event|0|||
37845225|NCT01113502|69529923|FG001|Overall Study|Adverse Event|0|||
37845226|NCT01113502|69529924|FG002|Overall Study|Adverse Event|3|||
37845227|NCT01113502|69529925|FG003|Overall Study|Adverse Event|2|||
37845228|NCT01113502|69529926|FG004|Overall Study|Adverse Event|0|||
37845229|NCT01113463|69529939|FG000|Overall Study|Physician Decision|5|||
37845230|NCT01112917|69529943|FG000|Overall Study|Death|2|||
37845231|NCT01112917|69529944|FG001|Overall Study|Death|11|||
37845232|NCT01112917|69529943|FG000|Overall Study|Lost to Follow-up|1|||
37845233|NCT01112917|69529944|FG001|Overall Study|Lost to Follow-up|1|||
37845234|NCT01112917|69529943|FG000|Overall Study|Withdrawal by Subject|1|||
37845235|NCT01112917|69529944|FG001|Overall Study|Withdrawal by Subject|3|||
37845236|NCT01112917|69529943|FG000|Overall Study|Unable to Convert Filter|3|||
37845237|NCT01112917|69529944|FG001|Overall Study|Unable to Convert Filter|0|||
37845238|NCT01176058|69529950|FG000|Overall Study|Adverse Event|1|||
37845239|NCT01176058|69529951|FG001|Overall Study|Adverse Event|0|||
37845240|NCT01176058|69529950|FG000|Overall Study|Insufficient clinical response|2|||
37845241|NCT01176058|69529951|FG001|Overall Study|Insufficient clinical response|2|||
37916335|NCT00863928|69603159|FG000|Overall Study|surgery cancellation|4|||
37916336|NCT00863928|69603160|FG001|Overall Study|surgery cancellation|0|||
37916337|NCT00863928|69603159|FG000|Overall Study|medication allergy|3|||
37916338|NCT00863928|69603160|FG001|Overall Study|medication allergy|0|||
37916339|NCT00856518|69603168|FG000|Overall Study|Lost to Follow-up|4|||
37916340|NCT00856518|69603169|FG001|Overall Study|Lost to Follow-up|2|||
37916341|NCT00506389|69603180|FG000|In-treatment Period|Other|3|||
37916342|NCT00506389|69603181|FG001|In-treatment Period|Other|3|||
37916343|NCT00506389|69603182|FG002|In-treatment Period|Other|4|||
37916344|NCT00506389|69603180|FG000|In-treatment Period|Lost to Follow-up|0|||
37916345|NCT00506389|69603181|FG001|In-treatment Period|Lost to Follow-up|0|||
37916346|NCT00506389|69603182|FG002|In-treatment Period|Lost to Follow-up|1|||
37916347|NCT00506389|69603180|FG000|In-treatment Period|Lack of compliance|1|||
37916348|NCT00506389|69603181|FG001|In-treatment Period|Lack of compliance|0|||
37916349|NCT00506389|69603182|FG002|In-treatment Period|Lack of compliance|0|||
37916350|NCT00506389|69603180|FG000|In-treatment Period|Reasons not related to trial|4|||
37916351|NCT00506389|69603181|FG001|In-treatment Period|Reasons not related to trial|1|||
37916352|NCT00506389|69603182|FG002|In-treatment Period|Reasons not related to trial|0|||
38025936|NCT03051178|69710605|FG000|Overall Study|Withdrawal by Subject|5|||
37734270|NCT02315703|69214604|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
37734271|NCT02315703|69214605|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
37734272|NCT02315703|69214606|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
37734273|NCT02315703|69214607|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
37734274|NCT02315703|69214608|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
37734275|NCT02315703|69214601|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
37734276|NCT02315703|69214602|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
37734277|NCT02315703|69214603|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
37734278|NCT02315703|69214604|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
37734279|NCT02315703|69214605|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
37734280|NCT02315703|69214606|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
37845242|NCT01176058|69529950|FG000|Overall Study|Insufficient mycological response|0|||
37845243|NCT01176058|69529951|FG001|Overall Study|Insufficient mycological response|1|||
37845244|NCT01176058|69529950|FG000|Overall Study|Withdrawal by Subject|1|||
37845245|NCT01176058|69529951|FG001|Overall Study|Withdrawal by Subject|0|||
37845246|NCT01175824|69529959|FG000|Overall Study|Adverse Event|2|||
37734281|NCT02315703|69214607|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
37916353|NCT00506389|69603180|FG000|In-treatment Period|Withdrawal by Subject|3|||
37916354|NCT00506389|69603181|FG001|In-treatment Period|Withdrawal by Subject|3|||
37916355|NCT00506389|69603182|FG002|In-treatment Period|Withdrawal by Subject|4|||
37916356|NCT00506389|69603180|FG000|In-treatment Period|Lack of Efficacy|0|||
37916357|NCT00506389|69603181|FG001|In-treatment Period|Lack of Efficacy|2|||
37916358|NCT00506389|69603182|FG002|In-treatment Period|Lack of Efficacy|0|||
37916359|NCT00506389|69603180|FG000|In-treatment Period|Adverse Event|11|||
37916360|NCT00506389|69603181|FG001|In-treatment Period|Adverse Event|5|||
37916361|NCT00506389|69603182|FG002|In-treatment Period|Adverse Event|2|||
37916362|NCT00506389|69603180|FG000|In-treatment Period|Randomized but not treated|4|||
37916363|NCT00506389|69603181|FG001|In-treatment Period|Randomized but not treated|1|||
37916364|NCT00506389|69603182|FG002|In-treatment Period|Randomized but not treated|1|||
37916365|NCT00871338|69603195|FG000|Prior to Booster|Withdrawal by Subject|1|||
37916366|NCT00871338|69603196|FG001|Prior to Booster|Withdrawal by Subject|3|||
37916367|NCT00871338|69603195|FG000|Prior to Booster|Lost to Follow-up|1|||
37916368|NCT00871338|69603196|FG001|Prior to Booster|Lost to Follow-up|0|||
37916369|NCT00824421|69603205|FG000|Overall Study|Adverse Event|6|||
37916370|NCT00824421|69603206|FG001|Overall Study|Adverse Event|6|||
37916371|NCT00824421|69603207|FG002|Overall Study|Adverse Event|6|||
37916372|NCT00824421|69603205|FG000|Overall Study|Death|0|||
37916373|NCT00824421|69603206|FG001|Overall Study|Death|1|||
37916374|NCT00824421|69603207|FG002|Overall Study|Death|0|||
37916375|NCT00824421|69603205|FG000|Overall Study|Lack of Efficacy|5|||
37916376|NCT00824421|69603206|FG001|Overall Study|Lack of Efficacy|7|||
37916377|NCT00824421|69603207|FG002|Overall Study|Lack of Efficacy|4|||
37916378|NCT00824421|69603205|FG000|Overall Study|Lost to Follow-up|2|||
37916379|NCT00824421|69603206|FG001|Overall Study|Lost to Follow-up|3|||
37916380|NCT00824421|69603207|FG002|Overall Study|Lost to Follow-up|0|||
37916381|NCT00824421|69603205|FG000|Overall Study|Pregnancy|1|||
37916382|NCT00824421|69603206|FG001|Overall Study|Pregnancy|0|||
37916383|NCT00824421|69603207|FG002|Overall Study|Pregnancy|1|||
37916384|NCT00824421|69603205|FG000|Overall Study|Withdrawal by Subject|2|||
37734282|NCT02315703|69214608|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
37734283|NCT02315703|69214601|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
37734284|NCT02315703|69214602|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
37734285|NCT02315703|69214603|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
37734286|NCT02315703|69214604|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
37734287|NCT02315703|69214605|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
37734288|NCT02315703|69214606|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
37734289|NCT02315703|69214607|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
37734290|NCT02315703|69214608|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
37734291|NCT02315703|69214601|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
37734292|NCT02315703|69214602|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
37734293|NCT02315703|69214603|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
37734294|NCT02315703|69214604|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
37734295|NCT02315703|69214605|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
37734296|NCT02315703|69214606|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
37734297|NCT02315703|69214607|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
37734298|NCT02315703|69214608|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
37734299|NCT02315703|69214601|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
37734300|NCT02315703|69214602|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
37734301|NCT02315703|69214603|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
37734302|NCT02315703|69214604|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
37734303|NCT02315703|69214605|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
37734304|NCT02315703|69214606|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
37734305|NCT02315703|69214607|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
37734306|NCT02315703|69214608|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
37916385|NCT00824421|69603206|FG001|Overall Study|Withdrawal by Subject|3|||
38025937|NCT03051100|69710611|FG000|Overall Study|Withdrawal by Subject|1|||
37916386|NCT00824421|69603207|FG002|Overall Study|Withdrawal by Subject|3|||
37916387|NCT00824421|69603205|FG000|Overall Study|Randomized but not Treated|1|||
37916388|NCT00824421|69603206|FG001|Overall Study|Randomized but not Treated|1|||
37916389|NCT00824421|69603207|FG002|Overall Study|Randomized but not Treated|0|||
37916390|NCT00824421|69603205|FG000|Overall Study|Other|0|||
37916391|NCT00824421|69603206|FG001|Overall Study|Other|1|||
37916392|NCT00824421|69603207|FG002|Overall Study|Other|0|||
37916393|NCT00514813|69603221|FG000|Overall Study|Study terminated|14|||
38025938|NCT03051100|69710612|FG001|Overall Study|Withdrawal by Subject|0|||
38025939|NCT01343368|69710620|FG000|Overall Study|Death|1|||
37916394|NCT00514813|69603222|FG001|Overall Study|Study terminated|74|||
37916395|NCT00514813|69603223|FG002|Overall Study|Study terminated|40|||
37916396|NCT00514813|69603224|FG003|Overall Study|Study terminated|2|||
37916397|NCT00514813|69603221|FG000|Overall Study|Adverse Event|0|||
37916398|NCT00514813|69603222|FG001|Overall Study|Adverse Event|2|||
37916399|NCT00514813|69603223|FG002|Overall Study|Adverse Event|2|||
37916400|NCT00514813|69603224|FG003|Overall Study|Adverse Event|0|||
37916401|NCT00514813|69603221|FG000|Overall Study|Protocol Violation|1|||
37916402|NCT00514813|69603222|FG001|Overall Study|Protocol Violation|0|||
37916403|NCT00514813|69603223|FG002|Overall Study|Protocol Violation|0|||
37916404|NCT00514813|69603224|FG003|Overall Study|Protocol Violation|0|||
37916405|NCT00514813|69603221|FG000|Overall Study|Withdrawal by Subject|0|||
37916406|NCT00514813|69603222|FG001|Overall Study|Withdrawal by Subject|1|||
37916407|NCT00514813|69603223|FG002|Overall Study|Withdrawal by Subject|0|||
37916408|NCT00514813|69603224|FG003|Overall Study|Withdrawal by Subject|0|||
37916409|NCT00514813|69603221|FG000|Overall Study|Lack of Efficacy|0|||
37916410|NCT00514813|69603222|FG001|Overall Study|Lack of Efficacy|1|||
37916411|NCT00514813|69603223|FG002|Overall Study|Lack of Efficacy|0|||
37916412|NCT00514813|69603224|FG003|Overall Study|Lack of Efficacy|0|||
37916413|NCT00514813|69603221|FG000|Overall Study|Kidney transplant|0|||
37916414|NCT00514813|69603222|FG001|Overall Study|Kidney transplant|6|||
37916415|NCT00514813|69603223|FG002|Overall Study|Kidney transplant|2|||
37916416|NCT00514813|69603224|FG003|Overall Study|Kidney transplant|0|||
37916417|NCT00514813|69603221|FG000|Overall Study|Death|0|||
37916418|NCT00514813|69603222|FG001|Overall Study|Death|2|||
37916419|NCT00514813|69603223|FG002|Overall Study|Death|3|||
37916420|NCT00514813|69603224|FG003|Overall Study|Death|2|||
37916421|NCT00597116|69603236|FG000|Overall Study|Adverse Event|2|||
37916422|NCT00597116|69603237|FG001|Overall Study|Adverse Event|1|||
37916423|NCT00597116|69603236|FG000|Overall Study|Withdrawal by Subject|0|||
37916424|NCT00597116|69603237|FG001|Overall Study|Withdrawal by Subject|2|||
37916425|NCT00597116|69603236|FG000|Overall Study|Physician Decision|0|||
37916426|NCT00597116|69603237|FG001|Overall Study|Physician Decision|1|||
37916427|NCT00597116|69603236|FG000|Overall Study|Death|0|||
37916428|NCT00597116|69603237|FG001|Overall Study|Death|1|||
37916429|NCT00597116|69603236|FG000|Overall Study|Lost to Follow-up|1|||
37916430|NCT00597116|69603237|FG001|Overall Study|Lost to Follow-up|0|||
37916431|NCT00597116|69603236|FG000|Overall Study|Progressive disease|11|||
37916432|NCT00597116|69603237|FG001|Overall Study|Progressive disease|6|||
37916433|NCT00514735|69603245|FG000|Overall Study|Withdrawal by Subject|13|||
37916434|NCT00514735|69603246|FG001|Overall Study|Withdrawal by Subject|5|||
37916435|NCT00514735|69603245|FG000|Overall Study|Death|1|||
37916436|NCT00514735|69603246|FG001|Overall Study|Death|0|||
37734307|NCT02315703|69214601|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
37734308|NCT02315703|69214602|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
37734309|NCT02315703|69214603|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
37734310|NCT02315703|69214604|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
37734311|NCT02315703|69214605|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
37734312|NCT02315703|69214606|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
37734313|NCT02315703|69214607|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
37734314|NCT02315703|69214608|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
37734315|NCT02315703|69214601|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
37734316|NCT02315703|69214602|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
37734317|NCT02315703|69214603|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
37734318|NCT02315703|69214604|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
37734319|NCT02315703|69214605|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
37734320|NCT02315703|69214606|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
37734321|NCT02315703|69214607|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
37734322|NCT02315703|69214608|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
37916437|NCT00514735|69603245|FG000|Overall Study|Lost to Follow-up|0|||
37916438|NCT00514735|69603246|FG001|Overall Study|Lost to Follow-up|1|||
37734323|NCT02049359|69214628|FG000|Overall Study|Lost to Follow-up|26|||
37734324|NCT02049359|69214629|FG001|Overall Study|Lost to Follow-up|19|||
37734325|NCT01698905|69214659|FG000|Overall Study|Adverse Event|4|||
37734326|NCT01698905|69214659|FG000|Overall Study|Physician Decision|2|||
37916439|NCT03252587|69603258|FG000|Overall Study|Adverse Event|3|||
37916440|NCT03252587|69603259|FG001|Overall Study|Adverse Event|8|||
37916441|NCT03252587|69603260|FG002|Overall Study|Adverse Event|6|||
37916442|NCT03252587|69603261|FG003|Overall Study|Adverse Event|12|||
37916443|NCT03252587|69603258|FG000|Overall Study|Lack of Efficacy|7|||
37916444|NCT03252587|69603259|FG001|Overall Study|Lack of Efficacy|2|||
37916445|NCT03252587|69603260|FG002|Overall Study|Lack of Efficacy|2|||
37916446|NCT03252587|69603261|FG003|Overall Study|Lack of Efficacy|4|||
37916447|NCT03252587|69603258|FG000|Overall Study|Lost to Follow-up|2|||
37916448|NCT03252587|69603259|FG001|Overall Study|Lost to Follow-up|0|||
37916449|NCT03252587|69603260|FG002|Overall Study|Lost to Follow-up|0|||
37916450|NCT03252587|69603261|FG003|Overall Study|Lost to Follow-up|2|||
37916451|NCT03252587|69603258|FG000|Overall Study|Pregnancy|2|||
37916452|NCT03252587|69603259|FG001|Overall Study|Pregnancy|1|||
37916453|NCT03252587|69603260|FG002|Overall Study|Pregnancy|0|||
37916454|NCT03252587|69603261|FG003|Overall Study|Pregnancy|1|||
37916455|NCT03252587|69603258|FG000|Overall Study|Withdrawal by Subject|8|||
37916456|NCT03252587|69603259|FG001|Overall Study|Withdrawal by Subject|4|||
37916457|NCT03252587|69603260|FG002|Overall Study|Withdrawal by Subject|4|||
37916458|NCT03252587|69603261|FG003|Overall Study|Withdrawal by Subject|4|||
37916459|NCT03252587|69603258|FG000|Overall Study|Other Reasons|2|||
37916460|NCT03252587|69603259|FG001|Overall Study|Other Reasons|5|||
37916461|NCT03252587|69603260|FG002|Overall Study|Other Reasons|5|||
37916462|NCT03252587|69603261|FG003|Overall Study|Other Reasons|4|||
37916463|NCT00511147|69603274|FG000|Overall Study|Withdrawal by Subject|1|||
37916464|NCT00511147|69603274|FG000|Overall Study|Disease progression|5|||
37916465|NCT00511147|69603274|FG000|Overall Study|Required platelet transfusion|1|||
37916466|NCT00510835|69603281|FG000|Overall Study|Withdrawal by Subject|6|||
37916467|NCT00510835|69603282|FG001|Overall Study|Withdrawal by Subject|2|||
37916468|NCT00510835|69603283|FG002|Overall Study|Withdrawal by Subject|2|||
37916469|NCT00506077|69603293|FG000|Treatment Period 1|Adverse Event|2|||
37916470|NCT00506077|69603294|FG001|Treatment Period 1|Adverse Event|1|||
37916471|NCT00506077|69603293|FG000|Treatment Period 1|Lost to Follow-up|0|||
37916472|NCT00506077|69603294|FG001|Treatment Period 1|Lost to Follow-up|2|||
37916473|NCT00506077|69603293|FG000|Treatment Period 1|Withdrawal by Subject|2|||
37916474|NCT00506077|69603294|FG001|Treatment Period 1|Withdrawal by Subject|0|||
37916475|NCT00506077|69603293|FG000|Treatment Period 2|Adverse Event|0|||
37916476|NCT00506077|69603294|FG001|Treatment Period 2|Adverse Event|1|||
37916477|NCT00506077|69603293|FG000|Treatment Period 2|Withdrawal by Subject|1|||
37916478|NCT00506077|69603294|FG001|Treatment Period 2|Withdrawal by Subject|0|||
37916479|NCT00505921|69603300|FG000|Overall Study|Ineligible|1|||
37916480|NCT00505921|69603300|FG000|Overall Study|Failed to Mobilize|8|||
37916481|NCT00596960|69603306|FG000|Overall Study|Death|1|||
37916482|NCT00596960|69603307|FG001|Overall Study|Death|2|||
37916483|NCT00596960|69603306|FG000|Overall Study|Lost to Follow-up|6|||
37916484|NCT00596960|69603307|FG001|Overall Study|Lost to Follow-up|5|||
37916485|NCT00596960|69603306|FG000|Overall Study|Withdrawal by Subject|1|||
37916486|NCT00596960|69603307|FG001|Overall Study|Withdrawal by Subject|0|||
37916487|NCT00596960|69603306|FG000|Overall Study|Incarcerated|2|||
37916488|NCT00596960|69603307|FG001|Overall Study|Incarcerated|0|||
37916489|NCT00596960|69603306|FG000|Overall Study|Physician Decision|1|||
37916490|NCT00596960|69603307|FG001|Overall Study|Physician Decision|0|||
37916491|NCT00596960|69603306|FG000|Overall Study|Protocol Violation|0|||
37916492|NCT00596960|69603307|FG001|Overall Study|Protocol Violation|1|||
37916493|NCT00596960|69603306|FG000|Overall Study|No alcohol use data|0|||
37916494|NCT00596960|69603307|FG001|Overall Study|No alcohol use data|1|||
37916495|NCT00505765|69603316|FG000|Overall Study|Withdrawal by Subject|1|||
37916496|NCT00505765|69603317|FG001|Overall Study|Withdrawal by Subject|0|||
37916497|NCT00505765|69603318|FG002|Overall Study|Withdrawal by Subject|0|||
37916498|NCT00505765|69603316|FG000|Overall Study|Adverse Event|1|||
37916499|NCT00505765|69603317|FG001|Overall Study|Adverse Event|2|||
37916500|NCT00505765|69603318|FG002|Overall Study|Adverse Event|0|||
37916501|NCT00505765|69603316|FG000|Overall Study|Noncompliance|0|||
37916502|NCT00505765|69603317|FG001|Overall Study|Noncompliance|1|||
37916503|NCT00505765|69603318|FG002|Overall Study|Noncompliance|3|||
37916504|NCT00505687|69603326|FG000|Overall Study|Important protocol violation|2|||
37916505|NCT00505687|69603326|FG000|Overall Study|Lack of Efficacy|15|||
37916506|NCT00505687|69603326|FG000|Overall Study|Adverse Event|48|||
37916507|NCT00505687|69603326|FG000|Overall Study|Subject withdrew consent|15|||
38025940|NCT01343368|69710621|FG001|Overall Study|Death|0|||
37916508|NCT00505687|69603326|FG000|Overall Study|Lost to Follow-up|1|||
37916509|NCT00505687|69603326|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
37916510|NCT00505687|69603326|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
37916511|NCT00505687|69603326|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
37916512|NCT00505687|69603326|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
37916513|NCT00505687|69603326|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
37916514|NCT00505687|69603326|FG000|Overall Study|Other: Disease Progression|1|||
37916515|NCT00505687|69603326|FG000|Overall Study|Other: As Per Sponsor|8|||
37916516|NCT00505375|69603332|FG000|Overall Study|Death|1|||
37916517|NCT00505375|69603333|FG001|Overall Study|Death|0|||
37916518|NCT00505375|69603332|FG000|Overall Study|Withdrawal by Subject|2|||
37916519|NCT00505375|69603333|FG001|Overall Study|Withdrawal by Subject|2|||
37916520|NCT00505375|69603332|FG000|Overall Study|Lost to Follow-up|0|||
37916521|NCT00505375|69603333|FG001|Overall Study|Lost to Follow-up|2|||
37916522|NCT00505375|69603332|FG000|Overall Study|Pregnancy|1|||
38025941|NCT01343368|69710620|FG000|Overall Study|Lost to Follow-up|1|||
37916523|NCT00505375|69603333|FG001|Overall Study|Pregnancy|0|||
37916524|NCT00505375|69603332|FG000|Overall Study|Travel issues|0|||
37916525|NCT00505375|69603333|FG001|Overall Study|Travel issues|1|||
37916526|NCT00594932|69603341|FG000|First 3 Months|Withdrawal by Subject|1|||
37916527|NCT00594932|69603342|FG001|First 3 Months|Withdrawal by Subject|3|||
37916528|NCT00594932|69603341|FG000|Final 3 Months|Withdrawal by Subject|4|||
37916529|NCT00594932|69603342|FG001|Final 3 Months|Withdrawal by Subject|3|||
37916530|NCT00504829|69603351|FG000|Overall Study|Protocol Violation|6|||
37916531|NCT00504829|69603352|FG001|Overall Study|Protocol Violation|4|||
37916532|NCT00504829|69603353|FG002|Overall Study|Protocol Violation|10|||
37916533|NCT00504595|69603365|FG000|Overall Study|Lack of Efficacy|1|||
37916534|NCT00504595|69603366|FG001|Overall Study|Lack of Efficacy|0|||
37916535|NCT00504595|69603367|FG002|Overall Study|Lack of Efficacy|0|||
37916536|NCT00504595|69603368|FG003|Overall Study|Lack of Efficacy|0|||
37916537|NCT00504595|69603365|FG000|Overall Study|Other|0|||
37916538|NCT00504595|69603366|FG001|Overall Study|Other|0|||
37916539|NCT00504595|69603367|FG002|Overall Study|Other|2|||
37916540|NCT00504595|69603368|FG003|Overall Study|Other|0|||
37916541|NCT00513409|69603380|FG000|Overall Study|Adverse Event|0|||
37916542|NCT00513409|69603381|FG001|Overall Study|Adverse Event|1|||
37916543|NCT00513409|69603380|FG000|Overall Study|Withdrawal by Subject|0|||
37916544|NCT00513409|69603381|FG001|Overall Study|Withdrawal by Subject|2|||
37916545|NCT00513409|69603380|FG000|Overall Study|Lost to Follow-up|0|||
37916546|NCT00513409|69603381|FG001|Overall Study|Lost to Follow-up|1|||
37916547|NCT00513409|69603380|FG000|Overall Study|Physician Decision|1|||
37916548|NCT00513409|69603381|FG001|Overall Study|Physician Decision|0|||
37916549|NCT00513409|69603380|FG000|Overall Study|Visit 3 not done|1|||
37916550|NCT00513409|69603381|FG001|Overall Study|Visit 3 not done|2|||
37916551|NCT03150095|69603389|FG000|Overall Study|Death|0|||
37916552|NCT03150095|69603390|FG001|Overall Study|Death|1|||
37916553|NCT03150095|69603389|FG000|Overall Study|Lost to Follow-up|1|||
37916554|NCT03150095|69603390|FG001|Overall Study|Lost to Follow-up|1|||
37916555|NCT03150095|69603389|FG000|Overall Study|Withdrawal by Subject|4|||
37916556|NCT03150095|69603390|FG001|Overall Study|Withdrawal by Subject|0|||
37916557|NCT03150095|69603389|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
37916558|NCT03150095|69603390|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
37916559|NCT00705016|69603399|FG000|Overall Study|Adverse Event|6|||
37916560|NCT00705016|69603400|FG001|Overall Study|Adverse Event|11|||
37916561|NCT00705016|69603401|FG002|Overall Study|Adverse Event|10|||
38025942|NCT01343368|69710621|FG001|Overall Study|Lost to Follow-up|0|||
37845247|NCT01175824|69529960|FG001|Overall Study|Adverse Event|1|||
37845248|NCT01175824|69529959|FG000|Overall Study|Lack of Efficacy|2|||
37845249|NCT01175824|69529960|FG001|Overall Study|Lack of Efficacy|0|||
37845250|NCT01175824|69529959|FG000|Overall Study|Lost to Follow-up|0|||
37845251|NCT01175824|69529960|FG001|Overall Study|Lost to Follow-up|1|||
37845252|NCT01175824|69529959|FG000|Overall Study|Physician Decision|0|||
37845253|NCT01175824|69529960|FG001|Overall Study|Physician Decision|4|||
37845254|NCT01175824|69529959|FG000|Overall Study|Protocol Violation|2|||
37845255|NCT01175824|69529960|FG001|Overall Study|Protocol Violation|5|||
37845256|NCT01175824|69529959|FG000|Overall Study|Withdrawal by Subject|3|||
37845257|NCT01175824|69529960|FG001|Overall Study|Withdrawal by Subject|7|||
37845258|NCT01175824|69529959|FG000|Overall Study|Sponsor Decision|1|||
37845259|NCT01175824|69529960|FG001|Overall Study|Sponsor Decision|0|||
37845260|NCT01175824|69529959|FG000|Overall Study|Entry Criteria Not Met|6|||
37845261|NCT01175824|69529960|FG001|Overall Study|Entry Criteria Not Met|4|||
37845262|NCT01175707|69529968|FG000|Overall Study|Adverse Event|4|||
37845263|NCT01175707|69529969|FG001|Overall Study|Adverse Event|6|||
37845264|NCT01112059|69529978|FG000|Overall Study|Withdrawal by Subject|1|||
37845265|NCT01112059|69529979|FG001|Overall Study|Withdrawal by Subject|0|||
37916562|NCT00705016|69603399|FG000|Overall Study|Death|5|||
37916563|NCT00705016|69603400|FG001|Overall Study|Death|7|||
37916564|NCT00705016|69603401|FG002|Overall Study|Death|5|||
37916565|NCT00705016|69603399|FG000|Overall Study|Protocol Violation|0|||
37916566|NCT00705016|69603400|FG001|Overall Study|Protocol Violation|1|||
37916567|NCT00705016|69603401|FG002|Overall Study|Protocol Violation|1|||
37916568|NCT00705016|69603399|FG000|Overall Study|Withdrawal by Subject|4|||
37916569|NCT00705016|69603400|FG001|Overall Study|Withdrawal by Subject|3|||
37916570|NCT00705016|69603401|FG002|Overall Study|Withdrawal by Subject|2|||
38025943|NCT02955212|69710629|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
37916571|NCT00705016|69603399|FG000|Overall Study|Progressive Disease|33|||
37916572|NCT00705016|69603400|FG001|Overall Study|Progressive Disease|29|||
37916573|NCT00705016|69603401|FG002|Overall Study|Progressive Disease|33|||
37916574|NCT00705016|69603399|FG000|Overall Study|Symptomatic Deterioration|3|||
37916575|NCT00705016|69603400|FG001|Overall Study|Symptomatic Deterioration|1|||
37916576|NCT00705016|69603401|FG002|Overall Study|Symptomatic Deterioration|1|||
37916577|NCT00705016|69603399|FG000|Overall Study|Other|9|||
37916578|NCT00705016|69603400|FG001|Overall Study|Other|6|||
37916579|NCT00705016|69603401|FG002|Overall Study|Other|6|||
37916580|NCT00595868|69603411|FG000|Overall Study|Lost to Follow-up|45|||
37916581|NCT00595868|69603412|FG001|Overall Study|Lost to Follow-up|50|||
37916582|NCT00856284|69603442|FG000|Overall Study|Hyperglycemic rescue|231|||
37916583|NCT00856284|69603443|FG001|Overall Study|Hyperglycemic rescue|201|||
37916584|NCT00856284|69603444|FG002|Overall Study|Hyperglycemic rescue|235|||
37916585|NCT00856284|69603442|FG000|Overall Study|Adverse Event|60|||
37916586|NCT00856284|69603443|FG001|Overall Study|Adverse Event|74|||
37916587|NCT00856284|69603444|FG002|Overall Study|Adverse Event|82|||
37916588|NCT00856284|69603442|FG000|Overall Study|Major protocol deviation|24|||
37734327|NCT01698905|69214659|FG000|Overall Study|Pregnancy|1|||
37734328|NCT01698905|69214659|FG000|Overall Study|Protocol Violation|1|||
37734329|NCT01698905|69214659|FG000|Overall Study|Subject/guardian decision|2|||
37734330|NCT01698905|69214659|FG000|Overall Study|Death|1|||
37734331|NCT01466686|69214670|FG000|Overall Study|Withdrawal by Subject|1|||
37734332|NCT01550289|69214676|FG000|Overall Study|Protocol Violation|1|||
37734333|NCT01550289|69214677|FG001|Overall Study|Protocol Violation|0|||
37734334|NCT01550289|69214676|FG000|Overall Study|Lost to Follow-up|1|||
37734335|NCT01550289|69214677|FG001|Overall Study|Lost to Follow-up|1|||
37734336|NCT01550289|69214676|FG000|Overall Study|Withdrawal by Subject|11|||
37916589|NCT00856284|69603443|FG001|Overall Study|Major protocol deviation|16|||
37916590|NCT00856284|69603444|FG002|Overall Study|Major protocol deviation|15|||
37916591|NCT00856284|69603442|FG000|Overall Study|Lost to Follow-up|20|||
37916592|NCT00856284|69603443|FG001|Overall Study|Lost to Follow-up|22|||
37734337|NCT01550289|69214677|FG001|Overall Study|Withdrawal by Subject|3|||
37734338|NCT01968031|69214688|FG000|Overall Study|Adverse Event|13|||
37734339|NCT01968031|69214689|FG001|Overall Study|Adverse Event|10|||
37734340|NCT01968031|69214690|FG002|Overall Study|Adverse Event|22|||
37734341|NCT01968031|69214688|FG000|Overall Study|Withdrawal by Subject|3|||
37734342|NCT01968031|69214689|FG001|Overall Study|Withdrawal by Subject|7|||
37734343|NCT01968031|69214690|FG002|Overall Study|Withdrawal by Subject|3|||
37734344|NCT01968031|69214688|FG000|Overall Study|Did not meet entry criteria|1|||
37734345|NCT01968031|69214689|FG001|Overall Study|Did not meet entry criteria|1|||
37734346|NCT01968031|69214690|FG002|Overall Study|Did not meet entry criteria|1|||
38025944|NCT02955212|69710630|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
38025945|NCT02955212|69710629|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
38025946|NCT02955212|69710630|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
38025947|NCT02955212|69710629|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
38025948|NCT02955212|69710630|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
38025949|NCT02955212|69710629|FG000|Period 1: Double-blind Treatment Period|Other|3|||
38025950|NCT02955212|69710630|FG001|Period 1: Double-blind Treatment Period|Other|2|||
38025951|NCT02955212|69710629|FG000|Period 2: Open-label Extension|Adverse Event|11|||
38025952|NCT02955212|69710630|FG001|Period 2: Open-label Extension|Adverse Event|7|||
38025953|NCT02955212|69710629|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
38025954|NCT02955212|69710630|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
38025955|NCT02955212|69710629|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
38025956|NCT02955212|69710630|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
38025957|NCT02955212|69710629|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
38025958|NCT02955212|69710630|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
38025959|NCT02955212|69710629|FG000|Period 2: Open-label Extension|Other|2|||
38025960|NCT02955212|69710630|FG001|Period 2: Open-label Extension|Other|4|||
37734347|NCT01968031|69214688|FG000|Overall Study|Noncompliance|0|||
37734348|NCT01968031|69214689|FG001|Overall Study|Noncompliance|0|||
37734349|NCT01968031|69214690|FG002|Overall Study|Noncompliance|2|||
37734350|NCT01968031|69214688|FG000|Overall Study|Failed inclusion criteria|0|||
37734351|NCT01968031|69214689|FG001|Overall Study|Failed inclusion criteria|2|||
37734352|NCT01968031|69214690|FG002|Overall Study|Failed inclusion criteria|0|||
37734353|NCT01968031|69214688|FG000|Overall Study|Death|0|||
37734354|NCT01968031|69214689|FG001|Overall Study|Death|0|||
37734355|NCT01968031|69214690|FG002|Overall Study|Death|1|||
37916593|NCT00856284|69603444|FG002|Overall Study|Lost to Follow-up|28|||
37916594|NCT00856284|69603442|FG000|Overall Study|Voluntary withdrawal|48|||
37916595|NCT00856284|69603443|FG001|Overall Study|Voluntary withdrawal|52|||
37916596|NCT00856284|69603444|FG002|Overall Study|Voluntary withdrawal|62|||
37916597|NCT00856284|69603442|FG000|Overall Study|Pregnancy|1|||
37734356|NCT01968031|69214688|FG000|Overall Study|Prohibited concomitant medication|1|||
37734357|NCT01968031|69214689|FG001|Overall Study|Prohibited concomitant medication|0|||
37734358|NCT01968031|69214690|FG002|Overall Study|Prohibited concomitant medication|0|||
37734359|NCT01684215|69214702|FG000|Phase 1, Part 1|Adverse Event|1|||
37734360|NCT01684215|69214703|FG001|Phase 1, Part 1|Adverse Event|0|||
37734361|NCT01684215|69214704|FG002|Phase 1, Part 1|Adverse Event|0|||
37734362|NCT01684215|69214705|FG003|Phase 1, Part 1|Adverse Event|0|||
37734363|NCT01684215|69214702|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
37734364|NCT01684215|69214703|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
37734365|NCT01684215|69214704|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
37916598|NCT00856284|69603443|FG001|Overall Study|Pregnancy|2|||
37916599|NCT00856284|69603444|FG002|Overall Study|Pregnancy|0|||
37916600|NCT00856284|69603442|FG000|Overall Study|Investigator discretion|9|||
37916601|NCT00856284|69603443|FG001|Overall Study|Investigator discretion|8|||
37916602|NCT00856284|69603444|FG002|Overall Study|Investigator discretion|10|||
37916603|NCT00856284|69603442|FG000|Overall Study|Other|15|||
37916604|NCT00856284|69603443|FG001|Overall Study|Other|17|||
37916605|NCT00856284|69603444|FG002|Overall Study|Other|14|||
37916606|NCT00856284|69603442|FG000|Overall Study|Randomized in error|0|||
37734366|NCT01684215|69214705|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
37734367|NCT01684215|69214702|FG000|Phase 1, Part 2|Adverse Event|0|||
37734368|NCT01684215|69214703|FG001|Phase 1, Part 2|Adverse Event|0|||
37734369|NCT01684215|69214704|FG002|Phase 1, Part 2|Adverse Event|1|||
37734370|NCT01684215|69214705|FG003|Phase 1, Part 2|Adverse Event|0|||
37734371|NCT01684215|69214702|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
37734372|NCT01684215|69214703|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
37734373|NCT01684215|69214704|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
37734374|NCT01684215|69214705|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
37734375|NCT01684215|69214702|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
37734376|NCT01684215|69214703|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
37734377|NCT01684215|69214704|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
37734378|NCT01684215|69214705|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
37734379|NCT01684215|69214702|FG000|Phase 2|Death|0|||
37734380|NCT01684215|69214703|FG001|Phase 2|Death|0|||
37734381|NCT01684215|69214704|FG002|Phase 2|Death|0|||
37734382|NCT01684215|69214705|FG003|Phase 2|Death|8|||
37734383|NCT01684215|69214702|FG000|Phase 2|Study terminated by sponsor|0|||
37734384|NCT01684215|69214703|FG001|Phase 2|Study terminated by sponsor|0|||
37734385|NCT01684215|69214704|FG002|Phase 2|Study terminated by sponsor|0|||
37734386|NCT01684215|69214705|FG003|Phase 2|Study terminated by sponsor|30|||
37734387|NCT01684215|69214702|FG000|Phase 2|Enrolled but not treated|0|||
37734388|NCT01684215|69214703|FG001|Phase 2|Enrolled but not treated|0|||
37734389|NCT01684215|69214704|FG002|Phase 2|Enrolled but not treated|0|||
37734390|NCT01684215|69214705|FG003|Phase 2|Enrolled but not treated|1|||
37734391|NCT01684215|69214702|FG000|Phase 2|Lost to Follow-up|0|||
37734392|NCT01684215|69214703|FG001|Phase 2|Lost to Follow-up|0|||
37734393|NCT01684215|69214704|FG002|Phase 2|Lost to Follow-up|0|||
37734394|NCT01684215|69214705|FG003|Phase 2|Lost to Follow-up|4|||
37734395|NCT01549275|69214720|FG000|Overall Study|Lost to Follow-up|1|||
37734396|NCT01549275|69214721|FG001|Overall Study|Lost to Follow-up|0|||
37734397|NCT01908205|69214733|FG000|Overall Study|Lost to Follow-up|2|||
37734398|NCT01908205|69214734|FG001|Overall Study|Lost to Follow-up|0|||
37734399|NCT01908205|69214733|FG000|Overall Study|Withdrawal by Subject|3|||
37734400|NCT01908205|69214734|FG001|Overall Study|Withdrawal by Subject|1|||
37734401|NCT01549041|69214755|FG000|Overall Study|Lack of Efficacy|2|||
37734402|NCT01549041|69214756|FG001|Overall Study|Lack of Efficacy|4|||
37734403|NCT01549041|69214755|FG000|Overall Study|Adverse Event|0|||
37734404|NCT01549041|69214756|FG001|Overall Study|Adverse Event|4|||
37734405|NCT01907815|69214764|FG000|Overall Study|Withdrawal by Subject|1|||
37845266|NCT01175668|69529990|FG000|Overall Study|Withdrawal by Subject|2|||
37845267|NCT01175668|69529991|FG001|Overall Study|Withdrawal by Subject|0|||
37845268|NCT01111825|69530001|FG000|Overall Study|Withdrawal by Subject|0|||
37845269|NCT01111825|69530002|FG001|Overall Study|Withdrawal by Subject|0|||
37845270|NCT01111825|69530003|FG002|Overall Study|Withdrawal by Subject|1|||
37845271|NCT01111825|69530004|FG003|Overall Study|Withdrawal by Subject|0|||
37845272|NCT01111825|69530001|FG000|Overall Study|Lost to Follow-up|0|||
37845273|NCT01111825|69530002|FG001|Overall Study|Lost to Follow-up|0|||
37845274|NCT01111825|69530003|FG002|Overall Study|Lost to Follow-up|3|||
37845275|NCT01111825|69530004|FG003|Overall Study|Lost to Follow-up|1|||
37916607|NCT00856284|69603443|FG001|Overall Study|Randomized in error|0|||
37916608|NCT00856284|69603444|FG002|Overall Study|Randomized in error|1|||
37916609|NCT00510289|69603452|FG000|Overall Study|Withdrawal by Subject|7|||
37734406|NCT01907815|69214765|FG001|Overall Study|Withdrawal by Subject|0|||
37734407|NCT01548573|69214773|FG000|Overall Study|Death|3|||
37734408|NCT01548573|69214773|FG000|Overall Study|Withdrawal by Subject|2|||
37734409|NCT01907737|69214778|FG000|Overall Study|Withdrawal by Subject|1|||
37734410|NCT01570491|69214790|FG000|Overall Study|Lost to Follow-up|3|||
37734411|NCT01570491|69214791|FG001|Overall Study|Lost to Follow-up|1|||
37734412|NCT01570491|69214790|FG000|Overall Study|treatment: not given or discontinued|2|||
37734413|NCT01570491|69214791|FG001|Overall Study|treatment: not given or discontinued|0|||
37734414|NCT01929109|69214802|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
37734415|NCT01929109|69214803|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
37734416|NCT01929109|69214804|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
37734417|NCT01929109|69214805|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
37734418|NCT01929109|69214806|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
37734419|NCT01518153|69214821|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
37734420|NCT01518153|69214822|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
37734421|NCT01518153|69214823|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
37734422|NCT01518153|69214821|FG000|Stem Cell Transplant|Death|2|||
37734423|NCT01518153|69214822|FG001|Stem Cell Transplant|Death|0|||
37734424|NCT01518153|69214823|FG002|Stem Cell Transplant|Death|0|||
37734425|NCT01518153|69214821|FG000|Stem Cell Transplant|Secondary graft failure|1|||
37734426|NCT01518153|69214822|FG001|Stem Cell Transplant|Secondary graft failure|0|||
37734427|NCT01518153|69214823|FG002|Stem Cell Transplant|Secondary graft failure|0|||
37734428|NCT01518153|69214821|FG000|Stem Cell Transplant|Adverse Event|1|||
37734429|NCT01518153|69214822|FG001|Stem Cell Transplant|Adverse Event|0|||
37734430|NCT01518153|69214823|FG002|Stem Cell Transplant|Adverse Event|0|||
37734431|NCT01518153|69214821|FG000|Donor Lymphocyte Infusion|Death|0|||
37734432|NCT01518153|69214822|FG001|Donor Lymphocyte Infusion|Death|2|||
37734433|NCT01518153|69214823|FG002|Donor Lymphocyte Infusion|Death|1|||
37734434|NCT01906489|69214833|FG000|Overall Study|Adverse Event|10|||
37734435|NCT01906489|69214834|FG001|Overall Study|Adverse Event|3|||
37734436|NCT01906489|69214833|FG000|Overall Study|Worsening of CKD|6|||
37734437|NCT01906489|69214834|FG001|Overall Study|Worsening of CKD|4|||
37734438|NCT01906489|69214833|FG000|Overall Study|Withdrawal by Subject|5|||
37734439|NCT01906489|69214834|FG001|Overall Study|Withdrawal by Subject|0|||
37734440|NCT01906489|69214833|FG000|Overall Study|Worsening of Anemia|1|||
37734441|NCT01906489|69214834|FG001|Overall Study|Worsening of Anemia|0|||
37734442|NCT01906489|69214833|FG000|Overall Study|Protocol Violation|0|||
37734443|NCT01906489|69214834|FG001|Overall Study|Protocol Violation|1|||
37734444|NCT01906489|69214833|FG000|Overall Study|Non- Compliance|1|||
37734445|NCT01906489|69214834|FG001|Overall Study|Non- Compliance|0|||
37734446|NCT01906489|69214833|FG000|Overall Study|Sponsor Decision|1|||
37734447|NCT01906489|69214834|FG001|Overall Study|Sponsor Decision|0|||
37734448|NCT01906489|69214833|FG000|Overall Study|Lost to Follow-up|1|||
37734449|NCT01906489|69214834|FG001|Overall Study|Lost to Follow-up|1|||
37734450|NCT01906489|69214833|FG000|Overall Study|Other|1|||
37734451|NCT01906489|69214834|FG001|Overall Study|Other|0|||
37734452|NCT01517373|69214845|FG000|Run-in Period|Death|1|||
37734453|NCT01517373|69214846|FG001|Run-in Period|Death|0|||
37734454|NCT01517373|69214847|FG002|Run-in Period|Death|0|||
37734455|NCT01517373|69214848|FG003|Run-in Period|Death|0|||
37734456|NCT01517373|69214849|FG004|Run-in Period|Death|0|||
37734457|NCT01517373|69214850|FG005|Run-in Period|Death|0|||
37734458|NCT01517373|69214845|FG000|Run-in Period|Adverse Event|5|||
37734459|NCT01517373|69214846|FG001|Run-in Period|Adverse Event|0|||
37845276|NCT01111825|69530001|FG000|Overall Study|Adverse Event|2|||
37845277|NCT01111825|69530002|FG001|Overall Study|Adverse Event|1|||
37845278|NCT01111825|69530003|FG002|Overall Study|Adverse Event|4|||
37845279|NCT01111825|69530004|FG003|Overall Study|Adverse Event|0|||
37845280|NCT01111825|69530001|FG000|Overall Study|Disease Progression|1|||
37845281|NCT01111825|69530002|FG001|Overall Study|Disease Progression|0|||
37916610|NCT00510289|69603452|FG000|Overall Study|Refused bone marrow biopsy|2|||
37916611|NCT00510289|69603452|FG000|Overall Study|Lost to Follow-up|1|||
37916612|NCT00510289|69603452|FG000|Overall Study|Progressed prior to starting drug|2|||
37916613|NCT00492115|69603459|FG000|Overall Study|Withdrawal by Subject|3|||
37734460|NCT01517373|69214847|FG002|Run-in Period|Adverse Event|0|||
37734461|NCT01517373|69214848|FG003|Run-in Period|Adverse Event|0|||
37734462|NCT01517373|69214849|FG004|Run-in Period|Adverse Event|0|||
37734463|NCT01517373|69214850|FG005|Run-in Period|Adverse Event|0|||
37734464|NCT01517373|69214845|FG000|Run-in Period|Did not meet eligibility criteria|34|||
37845282|NCT01111825|69530003|FG002|Overall Study|Disease Progression|0|||
37845283|NCT01111825|69530004|FG003|Overall Study|Disease Progression|0|||
37916614|NCT00492115|69603460|FG001|Overall Study|Withdrawal by Subject|4|||
37734465|NCT01517373|69214846|FG001|Run-in Period|Did not meet eligibility criteria|0|||
37734466|NCT01517373|69214847|FG002|Run-in Period|Did not meet eligibility criteria|0|||
37734467|NCT01517373|69214848|FG003|Run-in Period|Did not meet eligibility criteria|0|||
37734468|NCT01517373|69214849|FG004|Run-in Period|Did not meet eligibility criteria|0|||
37734469|NCT01517373|69214850|FG005|Run-in Period|Did not meet eligibility criteria|0|||
37916615|NCT00856206|69603468|FG000|Overall Study|Protocol Violation|6|||
37734470|NCT01517373|69214845|FG000|Run-in Period|Lost to Follow-up|1|||
37734471|NCT01517373|69214846|FG001|Run-in Period|Lost to Follow-up|0|||
37734472|NCT01517373|69214847|FG002|Run-in Period|Lost to Follow-up|0|||
37734473|NCT01517373|69214848|FG003|Run-in Period|Lost to Follow-up|0|||
37916616|NCT00856206|69603469|FG001|Overall Study|Protocol Violation|18|||
37845284|NCT01111825|69530001|FG000|Overall Study|Discontinuation by Sponsor|0|||
37845285|NCT01111825|69530002|FG001|Overall Study|Discontinuation by Sponsor|0|||
37845286|NCT01111825|69530003|FG002|Overall Study|Discontinuation by Sponsor|0|||
37845287|NCT01111825|69530004|FG003|Overall Study|Discontinuation by Sponsor|20|||
37845288|NCT01175590|69530016|FG000|Overall Study|Lost to Follow-up|1|||
37845289|NCT01175590|69530017|FG001|Overall Study|Lost to Follow-up|0|||
37845290|NCT01175590|69530016|FG000|Overall Study|Withdrawal by Subject|0|||
37845291|NCT01175590|69530017|FG001|Overall Study|Withdrawal by Subject|2|||
37845292|NCT01175590|69530016|FG000|Overall Study|Adverse Event|4|||
37845293|NCT01175590|69530017|FG001|Overall Study|Adverse Event|0|||
37845294|NCT01175590|69530016|FG000|Overall Study|Physician Decision|1|||
37845295|NCT01175590|69530017|FG001|Overall Study|Physician Decision|4|||
37845296|NCT01175590|69530016|FG000|Overall Study|Lack of Efficacy|1|||
37845297|NCT01175590|69530017|FG001|Overall Study|Lack of Efficacy|1|||
37845298|NCT01175590|69530016|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
37845299|NCT01175590|69530017|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
37845300|NCT01175590|69530016|FG000|Overall Study|Treated not as randomized|3|||
37845301|NCT01175590|69530017|FG001|Overall Study|Treated not as randomized|2|||
37845302|NCT01175590|69530016|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
37845303|NCT01175590|69530017|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
37845304|NCT01175590|69530016|FG000|Overall Study|Protocol Violation|0|||
37845305|NCT01175590|69530017|FG001|Overall Study|Protocol Violation|1|||
37845306|NCT01175473|69530026|FG000|Overall Study|Adverse Event|2|||
37845307|NCT01175473|69530027|FG001|Overall Study|Adverse Event|2|||
37916617|NCT00856206|69603468|FG000|Overall Study|Adverse Event|10|||
37916618|NCT00856206|69603469|FG001|Overall Study|Adverse Event|46|||
37916619|NCT00856206|69603468|FG000|Overall Study|Lack of Efficacy|1|||
37734474|NCT01517373|69214849|FG004|Run-in Period|Lost to Follow-up|0|||
37734475|NCT01517373|69214850|FG005|Run-in Period|Lost to Follow-up|0|||
37916620|NCT00856206|69603469|FG001|Overall Study|Lack of Efficacy|2|||
37916621|NCT00856206|69603468|FG000|Overall Study|Withdrawal by Subject|15|||
37916622|NCT00856206|69603469|FG001|Overall Study|Withdrawal by Subject|36|||
37916623|NCT00856206|69603468|FG000|Overall Study|Lost to Follow-up|13|||
38025961|NCT03050398|69710637|FG000|Overall Study|Study terminated by sponsor|8|||
38025962|NCT03662750|69710641|FG000|Overall Study|Withdrawal by Subject|1|||
38025963|NCT04052204|69710645|FG000|Overall Study|Death|1|||
38025964|NCT04052204|69710646|FG001|Overall Study|Death|0|||
38025965|NCT04052204|69710647|FG002|Overall Study|Death|0|||
38025966|NCT04052204|69710645|FG000|Overall Study|Progressive disease|1|||
38025967|NCT04052204|69710646|FG001|Overall Study|Progressive disease|0|||
38025968|NCT04052204|69710647|FG002|Overall Study|Progressive disease|0|||
38025969|NCT04052204|69710645|FG000|Overall Study|Other|1|||
38025970|NCT04052204|69710646|FG001|Overall Study|Other|0|||
38025971|NCT04052204|69710647|FG002|Overall Study|Other|0|||
38025972|NCT04050722|69710653|FG000|Overall Study|Withdrawal by Subject|1|||
38025973|NCT04050722|69710654|FG001|Overall Study|Withdrawal by Subject|0|||
37734476|NCT01517373|69214845|FG000|Run-in Period|Withdrawal by Subject|12|||
37845308|NCT01111552|69530033|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
37916624|NCT00856206|69603469|FG001|Overall Study|Lost to Follow-up|39|||
37916625|NCT00856206|69603468|FG000|Overall Study|Death|2|||
37916626|NCT00856206|69603469|FG001|Overall Study|Death|2|||
37916627|NCT00856206|69603468|FG000|Overall Study|Decision by the Sponsor|4|||
37916628|NCT00856206|69603469|FG001|Overall Study|Decision by the Sponsor|8|||
37916629|NCT00856206|69603468|FG000|Overall Study|Other than specified above|3|||
37916630|NCT00856206|69603469|FG001|Overall Study|Other than specified above|10|||
37916631|NCT00593112|69603477|FG000|Overall Study|Scan Anxiety|3|||
37916632|NCT00593112|69603478|FG001|Overall Study|Scan Anxiety|0|||
37916633|NCT00593112|69603477|FG000|Overall Study|Abnormal Scan|1|||
37916634|NCT00593112|69603478|FG001|Overall Study|Abnormal Scan|0|||
38025974|NCT04049552|69710660|FG000|Overall Study|Lost to Follow-up|1|||
38025975|NCT03048058|69710668|FG000|Overall Study|Lost to Follow-up|4|||
37845309|NCT01111552|69530034|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
37845310|NCT01111552|69530035|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
37845311|NCT01111552|69530036|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
37845312|NCT01111552|69530037|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
37916635|NCT00593112|69603477|FG000|Overall Study|Unreadable Scan|1|||
37916636|NCT00593112|69603478|FG001|Overall Study|Unreadable Scan|0|||
37916637|NCT00593112|69603477|FG000|Overall Study|Withdrawal by Subject|5|||
38025976|NCT03048058|69710669|FG001|Overall Study|Lost to Follow-up|0|||
38025977|NCT03048058|69710668|FG000|Overall Study|Withdrawal by Subject|0|||
38025978|NCT03048058|69710669|FG001|Overall Study|Withdrawal by Subject|4|||
38025979|NCT03047980|69710675|FG000|Overall Study|Adverse Event|1|||
38025980|NCT04048382|69710681|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
38025981|NCT04048382|69710682|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
37845313|NCT01111552|69530033|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
37845314|NCT01111552|69530034|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
38025982|NCT04048382|69710681|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
38025983|NCT04048382|69710682|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
37845315|NCT01111552|69530035|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
37845316|NCT01111552|69530036|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
37845317|NCT01111552|69530037|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
37845318|NCT01111552|69530033|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
37845319|NCT01111552|69530034|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
37845320|NCT01111552|69530035|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
37845321|NCT01111552|69530036|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
37845322|NCT01111552|69530037|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
37845323|NCT01111552|69530033|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
37845324|NCT01111552|69530034|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
37845325|NCT01111552|69530035|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
37845326|NCT01111552|69530036|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
37845327|NCT01111552|69530037|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
37845328|NCT01111552|69530033|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
37845329|NCT01111552|69530034|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
37845330|NCT01111552|69530035|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
37845331|NCT01111552|69530036|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
37845332|NCT01111552|69530037|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
37845333|NCT01111552|69530033|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
37845334|NCT01111552|69530034|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
37845335|NCT01111552|69530035|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
37845336|NCT01111552|69530036|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
37845337|NCT01111552|69530037|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
37845338|NCT01111552|69530033|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
37845339|NCT01111552|69530034|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
37845340|NCT01111552|69530035|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
37845341|NCT01111552|69530036|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
37845342|NCT01111552|69530037|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
37845343|NCT01111552|69530033|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
37845344|NCT01111552|69530034|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
37845345|NCT01111552|69530035|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
37845346|NCT01111552|69530036|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
37845347|NCT01111552|69530037|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
37845348|NCT01111552|69530033|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
37845349|NCT01111552|69530034|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
37845350|NCT01111552|69530035|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
37845351|NCT01111552|69530036|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
37845352|NCT01111552|69530037|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
37845353|NCT01111552|69530033|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
37845354|NCT01111552|69530034|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
37845355|NCT01111552|69530035|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
37845356|NCT01111552|69530036|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
37845357|NCT01111552|69530037|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
37845358|NCT01111552|69530033|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
37845359|NCT01111552|69530034|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
37845360|NCT01111552|69530035|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
37845361|NCT01111552|69530036|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
37845362|NCT01111552|69530037|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
37845363|NCT01111552|69530033|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
37845364|NCT01111552|69530034|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
37845365|NCT01111552|69530035|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
37845366|NCT01111552|69530036|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
37916638|NCT00593112|69603478|FG001|Overall Study|Withdrawal by Subject|0|||
37916639|NCT00491179|69603486|FG000|Overall Study|Adverse Event|5|||
37916640|NCT00491179|69603487|FG001|Overall Study|Adverse Event|1|||
37916641|NCT00491179|69603486|FG000|Overall Study|Withdrawal by Subject|2|||
37916642|NCT00491179|69603487|FG001|Overall Study|Withdrawal by Subject|1|||
37916643|NCT00503581|69603496|FG000|Overall Study|Study closed|3|||
37845367|NCT01111552|69530037|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
37845368|NCT01111552|69530033|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
37845369|NCT01111552|69530034|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
37845370|NCT01111552|69530035|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
37845371|NCT01111552|69530036|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
37845372|NCT01111552|69530037|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
37845373|NCT01111552|69530033|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
37845374|NCT01111552|69530034|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
37845375|NCT01111552|69530035|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
37845376|NCT01111552|69530036|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
37845377|NCT01111552|69530037|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
37845378|NCT01175083|69530053|FG000|Primary Epoch|Withdrawal by Subject|0|||
37845379|NCT01175083|69530054|FG001|Primary Epoch|Withdrawal by Subject|0|||
37845380|NCT01175083|69530055|FG002|Primary Epoch|Withdrawal by Subject|0|||
37845381|NCT01175083|69530056|FG003|Primary Epoch|Withdrawal by Subject|0|||
37845382|NCT01175083|69530057|FG004|Primary Epoch|Withdrawal by Subject|0|||
37845383|NCT01175083|69530058|FG005|Primary Epoch|Withdrawal by Subject|2|||
37845384|NCT01175083|69530053|FG000|Primary Epoch|Lost to Follow-up|0|||
37845385|NCT01175083|69530054|FG001|Primary Epoch|Lost to Follow-up|0|||
37845386|NCT01175083|69530055|FG002|Primary Epoch|Lost to Follow-up|0|||
37845387|NCT01175083|69530056|FG003|Primary Epoch|Lost to Follow-up|0|||
37845388|NCT01175083|69530057|FG004|Primary Epoch|Lost to Follow-up|0|||
37845389|NCT01175083|69530058|FG005|Primary Epoch|Lost to Follow-up|1|||
37845390|NCT01175083|69530053|FG000|Booster Epoch|Death|0|||
37845391|NCT01175083|69530054|FG001|Booster Epoch|Death|0|||
37845392|NCT01175083|69530055|FG002|Booster Epoch|Death|1|||
37845393|NCT01175083|69530056|FG003|Booster Epoch|Death|0|||
37845394|NCT01175083|69530057|FG004|Booster Epoch|Death|0|||
37845395|NCT01175083|69530058|FG005|Booster Epoch|Death|0|||
37845396|NCT01175083|69530053|FG000|Booster Epoch|Withdrawal by Subject|0|||
37845397|NCT01175083|69530054|FG001|Booster Epoch|Withdrawal by Subject|0|||
37845398|NCT01175083|69530055|FG002|Booster Epoch|Withdrawal by Subject|0|||
37845399|NCT01175083|69530056|FG003|Booster Epoch|Withdrawal by Subject|1|||
37845400|NCT01175083|69530057|FG004|Booster Epoch|Withdrawal by Subject|0|||
37845401|NCT01175083|69530058|FG005|Booster Epoch|Withdrawal by Subject|0|||
37845402|NCT01174459|69530076|FG000|Overall Study|case report form (CRF) not collected|5|||
37845403|NCT01174342|69530080|FG000|Overall Study|Conversion to cesarean section|4|||
37845404|NCT01111474|69530084|FG000|Overall Study|Lost to Follow-up|12|||
37845405|NCT01174264|69530093|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
37845406|NCT01174264|69530094|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
37845407|NCT01174264|69530095|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
37845408|NCT01174264|69530093|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
37845409|NCT01174264|69530094|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
37845410|NCT01174264|69530095|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
37845411|NCT01174264|69530093|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
37845412|NCT01174264|69530094|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
37845413|NCT01174264|69530095|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
37845414|NCT01174186|69530105|FG000|Overall Study|Lost to Follow-up|0|||
37845415|NCT01174186|69530106|FG001|Overall Study|Lost to Follow-up|1|||
37845416|NCT01174186|69530105|FG000|Overall Study|Withdrawal by Subject|0|||
37845417|NCT01174186|69530106|FG001|Overall Study|Withdrawal by Subject|2|||
37845418|NCT01173718|69530112|FG000|Overall Study|Death|17|||
37845419|NCT01173718|69530112|FG000|Overall Study|Abandonment of study graft|27|||
37845420|NCT01111240|69530116|FG000|Overall Study|Adverse Event|190|||
37845421|NCT01111240|69530116|FG000|Overall Study|Lack of Efficacy|545|||
37845422|NCT01111240|69530116|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
37845423|NCT01111240|69530116|FG000|Overall Study|Other|312|||
37845424|NCT01111123|69530122|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
37845425|NCT01111123|69530123|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
37845426|NCT01111123|69530122|FG000|Maintenance Phase|Lost to Follow-up|0|||
37845427|NCT01111123|69530123|FG001|Maintenance Phase|Lost to Follow-up|2|||
37845428|NCT01173679|69530131|FG000|Overall Study|Death|1|||
37845429|NCT01110382|69530138|FG000|Overall Study|Withdrawal by Subject|0|||
37845430|NCT01110382|69530139|FG001|Overall Study|Withdrawal by Subject|1|||
37845431|NCT01110382|69530138|FG000|Overall Study|Protocol Violation|0|||
37845432|NCT01110382|69530139|FG001|Overall Study|Protocol Violation|1|||
37845433|NCT01173601|69530149|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
37845434|NCT01173601|69530150|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
37845435|NCT01173601|69530151|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
37845436|NCT01173601|69530152|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
37845437|NCT01173601|69530153|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
37845438|NCT01173601|69530149|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
37845439|NCT01173601|69530150|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
37845440|NCT01173601|69530151|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
37845441|NCT01173601|69530152|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
37845442|NCT01173601|69530153|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
37845443|NCT01173601|69530149|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
37734477|NCT01517373|69214846|FG001|Run-in Period|Withdrawal by Subject|0|||
37734478|NCT01517373|69214847|FG002|Run-in Period|Withdrawal by Subject|0|||
37734479|NCT01517373|69214848|FG003|Run-in Period|Withdrawal by Subject|0|||
37845444|NCT01173601|69530150|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
37845445|NCT01173601|69530151|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
37845446|NCT01173601|69530152|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
37845447|NCT01173601|69530153|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
37845448|NCT01173601|69530149|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
37845449|NCT01173601|69530150|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
37845450|NCT01173601|69530151|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
37845451|NCT01173601|69530152|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
37845452|NCT01173601|69530153|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
37845453|NCT01173601|69530149|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
37845454|NCT01173601|69530150|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
37845455|NCT01173601|69530151|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
37845456|NCT01173601|69530152|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
37845457|NCT01173601|69530153|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
37845458|NCT01173601|69530149|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
37845459|NCT01173601|69530150|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
37845460|NCT01173601|69530151|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
37845461|NCT01173601|69530152|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
37845462|NCT01173601|69530153|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
37845463|NCT01173601|69530149|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
37845464|NCT01173601|69530150|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
37845465|NCT01173601|69530151|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
37845466|NCT01173601|69530152|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
37845467|NCT01173601|69530153|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
37845468|NCT01173601|69530149|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
37845469|NCT01173601|69530150|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
37845470|NCT01173601|69530151|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
37845471|NCT01173601|69530152|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
37845472|NCT01173601|69530153|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
37845473|NCT01173601|69530149|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
37845474|NCT01173601|69530150|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
37845475|NCT01173601|69530151|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
37845476|NCT01173601|69530152|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
37845477|NCT01173601|69530153|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
37845478|NCT01173601|69530149|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
37845479|NCT01173601|69530150|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
37845480|NCT01173601|69530151|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
37845481|NCT01173601|69530152|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
37845482|NCT01173601|69530153|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
37916644|NCT00503581|69603497|FG001|Overall Study|Study closed|4|||
37734480|NCT01517373|69214849|FG004|Run-in Period|Withdrawal by Subject|0|||
37734481|NCT01517373|69214850|FG005|Run-in Period|Withdrawal by Subject|0|||
37734482|NCT01517373|69214845|FG000|Run-in Period|Sponsor Decision|3|||
37734483|NCT01517373|69214846|FG001|Run-in Period|Sponsor Decision|0|||
37734484|NCT01517373|69214847|FG002|Run-in Period|Sponsor Decision|0|||
37734485|NCT01517373|69214848|FG003|Run-in Period|Sponsor Decision|0|||
37734486|NCT01517373|69214849|FG004|Run-in Period|Sponsor Decision|0|||
37734487|NCT01517373|69214850|FG005|Run-in Period|Sponsor Decision|0|||
37734488|NCT01517373|69214845|FG000|Run-in Period|Other|1|||
37734489|NCT01517373|69214846|FG001|Run-in Period|Other|0|||
37734490|NCT01517373|69214847|FG002|Run-in Period|Other|0|||
37734491|NCT01517373|69214848|FG003|Run-in Period|Other|0|||
37734492|NCT01517373|69214849|FG004|Run-in Period|Other|0|||
37734493|NCT01517373|69214850|FG005|Run-in Period|Other|0|||
37734494|NCT01517373|69214845|FG000|Treatment Period|Adverse Event|0|||
37734495|NCT01517373|69214846|FG001|Treatment Period|Adverse Event|0|||
37734496|NCT01517373|69214847|FG002|Treatment Period|Adverse Event|0|||
37734497|NCT01517373|69214848|FG003|Treatment Period|Adverse Event|0|||
37734498|NCT01517373|69214849|FG004|Treatment Period|Adverse Event|0|||
37734499|NCT01517373|69214850|FG005|Treatment Period|Adverse Event|2|||
37734500|NCT01517373|69214845|FG000|Treatment Period|Lost to Follow-up|0|||
37845483|NCT01173601|69530149|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
37845484|NCT01173601|69530150|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
37845485|NCT01173601|69530151|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
37845486|NCT01173601|69530152|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
37845487|NCT01173601|69530153|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
37845488|NCT01173601|69530149|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
37845489|NCT01173601|69530150|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
37845490|NCT01173601|69530151|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
37845491|NCT01173601|69530152|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
37845492|NCT01173601|69530153|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
37845493|NCT01173601|69530149|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
37845494|NCT01173601|69530150|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
37845495|NCT01173601|69530151|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
37845496|NCT01173601|69530152|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
37845497|NCT01173601|69530153|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
37845498|NCT01173601|69530149|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
37845499|NCT01173601|69530150|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
37845500|NCT01173601|69530151|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
37845501|NCT01173601|69530152|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
37845502|NCT01173601|69530153|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
37845503|NCT01173523|69530173|FG000|Overall Study|Clinical Progression|1|||
37845504|NCT01173523|69530174|FG001|Overall Study|Clinical Progression|1|||
37845505|NCT01173523|69530173|FG000|Overall Study|Progressive Disease|10|||
37845506|NCT01173523|69530174|FG001|Overall Study|Progressive Disease|8|||
37845507|NCT01173523|69530173|FG000|Overall Study|Other|2|||
37845508|NCT01173523|69530174|FG001|Overall Study|Other|3|||
37845509|NCT01173055|69530182|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
37845510|NCT01173055|69530183|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
37845511|NCT01173055|69530182|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
37845512|NCT01173055|69530183|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
37845513|NCT01172938|69530192|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
37845514|NCT01172938|69530193|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
37845515|NCT01172938|69530194|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
37845516|NCT01172938|69530195|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
37845517|NCT01172938|69530196|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
37845518|NCT01172938|69530197|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
37845519|NCT01172938|69530198|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
37845520|NCT01172938|69530199|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
37845521|NCT01172938|69530200|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
37845522|NCT01172938|69530192|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
37845523|NCT01172938|69530193|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
37845524|NCT01172938|69530194|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
37845525|NCT01172938|69530195|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
37845526|NCT01172938|69530196|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
37845527|NCT01172938|69530197|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
37845528|NCT01172938|69530198|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
37845529|NCT01172938|69530199|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
37845530|NCT01172938|69530200|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
37845531|NCT01172938|69530192|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
37845532|NCT01172938|69530193|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
37845533|NCT01172938|69530194|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
37845534|NCT01172938|69530195|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
37845535|NCT01172938|69530196|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
37845536|NCT01172938|69530197|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
37845537|NCT01172938|69530198|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
37845538|NCT01172938|69530199|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
37845539|NCT01172938|69530200|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
37845540|NCT01172938|69530192|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
37845541|NCT01172938|69530193|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
37845542|NCT01172938|69530194|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
37845543|NCT01172938|69530195|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
37845544|NCT01172938|69530196|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
37916645|NCT00503581|69603498|FG002|Overall Study|Study closed|2|||
37916646|NCT00703534|69603508|FG000|Overall Study|Adverse Event|14|||
37677373|NCT01659255|69152290|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
37845545|NCT01172938|69530197|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
37845546|NCT01172938|69530198|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
37845547|NCT01172938|69530199|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
37845548|NCT01172938|69530200|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
37845549|NCT01172938|69530192|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
37845550|NCT01172938|69530193|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
37845551|NCT01172938|69530194|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
37845552|NCT01172938|69530195|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
37845553|NCT01172938|69530196|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
37845554|NCT01172938|69530197|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
37845555|NCT01172938|69530198|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
37845556|NCT01172938|69530199|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
37845557|NCT01172938|69530200|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
37845558|NCT01172938|69530192|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
37845559|NCT01172938|69530193|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
37845560|NCT01172938|69530194|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
37845561|NCT01172938|69530195|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
37845562|NCT01172938|69530196|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
37845563|NCT01172938|69530197|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
37845564|NCT01172938|69530198|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
37845565|NCT01172938|69530199|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
37845566|NCT01172938|69530200|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
37845567|NCT01172938|69530192|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
37845568|NCT01172938|69530193|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
37845569|NCT01172938|69530194|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
37845570|NCT01172938|69530195|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
37845571|NCT01172938|69530196|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
37845572|NCT01172938|69530197|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
37845573|NCT01172938|69530198|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
37845574|NCT01172938|69530199|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
37845575|NCT01172938|69530200|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
37845576|NCT01172938|69530192|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
37845577|NCT01172938|69530193|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
37845578|NCT01172938|69530194|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
37845579|NCT01172938|69530195|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
37845580|NCT01172938|69530196|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
37845581|NCT01172938|69530197|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
37845582|NCT01172938|69530198|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
37845583|NCT01172938|69530199|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
37845584|NCT01172938|69530200|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
37845585|NCT01172938|69530192|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
37845586|NCT01172938|69530193|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
37845587|NCT01172938|69530194|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
37845588|NCT01172938|69530195|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
37845589|NCT01172938|69530196|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
37845590|NCT01172938|69530197|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
38025984|NCT04048382|69710681|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
38025985|NCT04048382|69710682|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
38025986|NCT04047446|69710690|FG000|Overall Study|Physician Decision|1|||
38025987|NCT04047446|69710691|FG001|Overall Study|Physician Decision|0|||
38025988|NCT03655106|69710699|FG000|Overall Study|Withdrawal by Subject|3|||
38025989|NCT03655106|69710700|FG001|Overall Study|Withdrawal by Subject|2|||
38025990|NCT03655106|69710699|FG000|Overall Study|Lost to Follow-up|2|||
38025991|NCT03655106|69710700|FG001|Overall Study|Lost to Follow-up|1|||
38025992|NCT03655106|69710699|FG000|Overall Study|Duplicate Enrollment|1|||
38025993|NCT03655106|69710700|FG001|Overall Study|Duplicate Enrollment|1|||
38025994|NCT03655106|69710699|FG000|Overall Study|Protocol Violation|3|||
38025995|NCT03655106|69710700|FG001|Overall Study|Protocol Violation|0|||
38025996|NCT03630302|69710706|FG000|Surgery|hardware issue prevented LFP recordings|1|||
38025997|NCT03630302|69710706|FG000|3 Month Visit|Adverse Event|2|||
37845591|NCT01172938|69530198|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
37916647|NCT00703534|69603509|FG001|Overall Study|Adverse Event|3|||
38025998|NCT03630302|69710706|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
38025999|NCT04041440|69710712|FG000|Overall Study|Withdrawal by Subject|0|||
38026000|NCT04041440|69710713|FG001|Overall Study|Withdrawal by Subject|1|||
38026001|NCT04041440|69710712|FG000|Overall Study|Lost to Follow-up|0|||
38026002|NCT04041440|69710713|FG001|Overall Study|Lost to Follow-up|1|||
38026003|NCT03654560|69710722|FG000|Overall Study|Death|3|||
37677374|NCT01659255|69152291|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
37845592|NCT01172938|69530199|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
37845593|NCT01172938|69530200|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
37845594|NCT01172938|69530192|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
37845595|NCT01172938|69530193|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
37845596|NCT01172938|69530194|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
37845597|NCT01172938|69530195|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
37845598|NCT01172938|69530196|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
37845599|NCT01172938|69530197|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
37845600|NCT01172938|69530198|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
37845601|NCT01172938|69530199|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
37845602|NCT01172938|69530200|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
37845603|NCT01172938|69530192|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
37845604|NCT01172938|69530193|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
37845605|NCT01172938|69530194|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
37845606|NCT01172938|69530195|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
37845607|NCT01172938|69530196|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
37845608|NCT01172938|69530197|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
37845609|NCT01172938|69530198|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
37845610|NCT01172938|69530199|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
37845611|NCT01172938|69530200|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
37845612|NCT01172938|69530192|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
37845613|NCT01172938|69530193|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
37845614|NCT01172938|69530194|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
37845615|NCT01172938|69530195|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
37845616|NCT01172938|69530196|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
37845617|NCT01172938|69530197|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
37845618|NCT01172938|69530198|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
37845619|NCT01172938|69530199|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
37734501|NCT01517373|69214846|FG001|Treatment Period|Lost to Follow-up|0|||
37734502|NCT01517373|69214847|FG002|Treatment Period|Lost to Follow-up|1|||
37734503|NCT01517373|69214848|FG003|Treatment Period|Lost to Follow-up|1|||
37734504|NCT01517373|69214849|FG004|Treatment Period|Lost to Follow-up|0|||
37734505|NCT01517373|69214850|FG005|Treatment Period|Lost to Follow-up|0|||
37734506|NCT01517373|69214845|FG000|Treatment Period|Withdrawal by Subject|0|||
37734507|NCT01517373|69214846|FG001|Treatment Period|Withdrawal by Subject|3|||
37734508|NCT01517373|69214847|FG002|Treatment Period|Withdrawal by Subject|2|||
37734509|NCT01517373|69214848|FG003|Treatment Period|Withdrawal by Subject|2|||
37845620|NCT01172938|69530200|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
37845621|NCT01172938|69530192|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
37845622|NCT01172938|69530193|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
37845623|NCT01172938|69530194|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
37845624|NCT01172938|69530195|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
37845625|NCT01172938|69530196|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
37845626|NCT01172938|69530197|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
37845627|NCT01172938|69530198|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
37845628|NCT01172938|69530199|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
37845629|NCT01172938|69530200|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
37845630|NCT01172938|69530192|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
37845631|NCT01172938|69530193|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
37845632|NCT01172938|69530194|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
37845633|NCT01172938|69530195|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
37845634|NCT01172938|69530196|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
37734510|NCT01517373|69214849|FG004|Treatment Period|Withdrawal by Subject|2|||
37734511|NCT01517373|69214850|FG005|Treatment Period|Withdrawal by Subject|3|||
37845635|NCT01172938|69530197|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
37845636|NCT01172938|69530198|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
37845637|NCT01172938|69530199|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
37845638|NCT01172938|69530200|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
37845639|NCT01172938|69530192|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
37845640|NCT01172938|69530193|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
37845641|NCT01172938|69530194|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
37845642|NCT01172938|69530195|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
37845643|NCT01172938|69530196|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
37734512|NCT01517373|69214845|FG000|Treatment Period|Other|0|||
37734513|NCT01517373|69214846|FG001|Treatment Period|Other|0|||
37734514|NCT01517373|69214847|FG002|Treatment Period|Other|0|||
37734515|NCT01517373|69214848|FG003|Treatment Period|Other|0|||
37845644|NCT01172938|69530197|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
37845645|NCT01172938|69530198|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
37845646|NCT01172938|69530199|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
37845647|NCT01172938|69530200|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
37845648|NCT01172938|69530192|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
37845649|NCT01172938|69530193|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
37845650|NCT01172938|69530194|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
37845651|NCT01172938|69530195|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
38026004|NCT03654560|69710723|FG001|Overall Study|Death|1|||
38026005|NCT03654560|69710722|FG000|Overall Study|Lost to Follow-up|1|||
38026006|NCT03654560|69710723|FG001|Overall Study|Lost to Follow-up|0|||
38026007|NCT03629054|69710731|FG000|Period 2 (4 Days)|Not treated|0|||
38026008|NCT03629054|69710732|FG001|Period 2 (4 Days)|Not treated|1|||
37734516|NCT01517373|69214849|FG004|Treatment Period|Other|1|||
37845652|NCT01172938|69530196|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
37845653|NCT01172938|69530197|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
37845654|NCT01172938|69530198|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
37845655|NCT01172938|69530199|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
37845656|NCT01172938|69530200|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
37845657|NCT01172938|69530192|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
37845658|NCT01172938|69530193|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
37845659|NCT01172938|69530194|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
37845660|NCT01172938|69530195|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
37845661|NCT01172938|69530196|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
37845662|NCT01172938|69530197|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
37845663|NCT01172938|69530198|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
37845664|NCT01172938|69530199|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
37845665|NCT01172938|69530200|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
37845666|NCT01172938|69530192|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
37845667|NCT01172938|69530193|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
37845668|NCT01172938|69530194|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
37845669|NCT01172938|69530195|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
38026009|NCT03628898|69710738|FG000|Overall Study|Device deficiency|1|||
37734517|NCT01517373|69214850|FG005|Treatment Period|Other|0|||
37734518|NCT01517373|69214845|FG000|Treatment Period|Protocol Violation|0|||
37734519|NCT01517373|69214846|FG001|Treatment Period|Protocol Violation|0|||
37734520|NCT01517373|69214847|FG002|Treatment Period|Protocol Violation|0|||
37734521|NCT01517373|69214848|FG003|Treatment Period|Protocol Violation|0|||
37734522|NCT01517373|69214849|FG004|Treatment Period|Protocol Violation|1|||
37734523|NCT01517373|69214850|FG005|Treatment Period|Protocol Violation|0|||
37734524|NCT01517373|69214845|FG000|Treatment Period|Lack of Efficacy|0|||
37734525|NCT01517373|69214846|FG001|Treatment Period|Lack of Efficacy|1|||
37734526|NCT01517373|69214847|FG002|Treatment Period|Lack of Efficacy|1|||
37734527|NCT01517373|69214848|FG003|Treatment Period|Lack of Efficacy|3|||
37734528|NCT01517373|69214849|FG004|Treatment Period|Lack of Efficacy|2|||
37734529|NCT01517373|69214850|FG005|Treatment Period|Lack of Efficacy|0|||
37734530|NCT01517373|69214845|FG000|Treatment Period|Medication error without AEs|0|||
37734531|NCT01517373|69214846|FG001|Treatment Period|Medication error without AEs|0|||
37734532|NCT01517373|69214847|FG002|Treatment Period|Medication error without AEs|2|||
37734533|NCT01517373|69214848|FG003|Treatment Period|Medication error without AEs|1|||
37734534|NCT01517373|69214849|FG004|Treatment Period|Medication error without AEs|0|||
37734535|NCT01517373|69214850|FG005|Treatment Period|Medication error without AEs|2|||
37734536|NCT01517295|69214865|FG000|Overall Study|Physician Decision|1|||
37734537|NCT01517295|69214866|FG001|Overall Study|Physician Decision|0|||
37734538|NCT01541865|69214872|FG000|Overall Study|Lost to Follow-up|11|||
37734539|NCT01541865|69214872|FG000|Overall Study|Withdrawal by Subject|9|||
37734540|NCT01541865|69214872|FG000|Overall Study|Adverse Event|1|||
37734541|NCT01541865|69214872|FG000|Overall Study|Protocol Violation|1|||
37734542|NCT01541397|69214878|FG000|Overall Study|Study ended prior to data collection|4|||
37734543|NCT01541397|69214879|FG001|Overall Study|Study ended prior to data collection|2|||
37734544|NCT01548417|69214887|FG000|Overall Study|Withdrawal by Subject|0|||
37734545|NCT01548417|69214888|FG001|Overall Study|Withdrawal by Subject|2|||
37734546|NCT01546857|69214896|FG000|Overall Study|Withdrawal by Subject|2|||
37734547|NCT01546857|69214897|FG001|Overall Study|Withdrawal by Subject|3|||
37734548|NCT01540851|69214906|FG000|Overall Study|Lost to Follow-up|14|||
37734549|NCT01540851|69214907|FG001|Overall Study|Lost to Follow-up|15|||
37734550|NCT01540851|69214906|FG000|Overall Study|Withdrawal by Subject|7|||
37734551|NCT01540851|69214907|FG001|Overall Study|Withdrawal by Subject|3|||
37734552|NCT01516749|69214915|FG000|Active Therapy|Lost to Follow-up|1|||
37734553|NCT01516749|69214915|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
37734554|NCT01516437|69214923|FG000|Overall Study|Reason not specified|0|||
37845670|NCT01172938|69530196|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
37845671|NCT01172938|69530197|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
37845672|NCT01172938|69530198|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
37845673|NCT01172938|69530199|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
37845674|NCT01172938|69530200|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
37845675|NCT01172938|69530192|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
37845676|NCT01172938|69530193|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
37845677|NCT01172938|69530194|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
37845678|NCT01172938|69530195|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
37845679|NCT01172938|69530196|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
37845680|NCT01172938|69530197|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
37845681|NCT01172938|69530198|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
37845682|NCT01172938|69530199|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
37845683|NCT01172938|69530200|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
37845684|NCT01172938|69530192|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
37845685|NCT01172938|69530193|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
37845686|NCT01172938|69530194|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
37845687|NCT01172938|69530195|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
37845688|NCT01172938|69530196|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
37845689|NCT01172938|69530197|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
37845690|NCT01172938|69530198|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
37845691|NCT01172938|69530199|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
37845692|NCT01172938|69530200|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
37845693|NCT01172938|69530192|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
37845694|NCT01172938|69530193|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
37845695|NCT01172938|69530194|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
37845696|NCT01172938|69530195|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
37845697|NCT01172938|69530196|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
37845698|NCT01172938|69530197|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
37845699|NCT01172938|69530198|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
37845700|NCT01172938|69530199|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
37845701|NCT01172938|69530200|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
37845702|NCT01172938|69530192|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
37845703|NCT01172938|69530193|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
37845704|NCT01172938|69530194|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
37845705|NCT01172938|69530195|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
37734555|NCT01516437|69214924|FG001|Overall Study|Reason not specified|0|||
37734556|NCT01516437|69214925|FG002|Overall Study|Reason not specified|1|||
37845706|NCT01172938|69530196|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
37845707|NCT01172938|69530197|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
37845708|NCT01172938|69530198|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
37845709|NCT01172938|69530199|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
37845710|NCT01172938|69530200|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
37845711|NCT01172938|69530192|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
37845712|NCT01172938|69530193|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
37845713|NCT01172938|69530194|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
37845714|NCT01172938|69530195|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
37845715|NCT01172938|69530196|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
37845716|NCT01172938|69530197|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
37845717|NCT01172938|69530198|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
37734557|NCT01516437|69214926|FG003|Overall Study|Reason not specified|1|||
37734558|NCT01515423|69214940|FG000|Open Label Phase|Adverse Event|57|||
37734559|NCT01515423|69214941|FG001|Open Label Phase|Adverse Event|0|||
37734560|NCT01515423|69214942|FG002|Open Label Phase|Adverse Event|0|||
37734561|NCT01515423|69214940|FG000|Open Label Phase|Death|2|||
37734562|NCT01515423|69214941|FG001|Open Label Phase|Death|0|||
37734563|NCT01515423|69214942|FG002|Open Label Phase|Death|0|||
37734564|NCT01515423|69214940|FG000|Open Label Phase|Lack of Efficacy|117|||
37734565|NCT01515423|69214941|FG001|Open Label Phase|Lack of Efficacy|0|||
37734566|NCT01515423|69214942|FG002|Open Label Phase|Lack of Efficacy|0|||
37734567|NCT01515423|69214940|FG000|Open Label Phase|Lost to Follow-up|21|||
37734568|NCT01515423|69214941|FG001|Open Label Phase|Lost to Follow-up|0|||
37734569|NCT01515423|69214942|FG002|Open Label Phase|Lost to Follow-up|0|||
37734570|NCT01515423|69214940|FG000|Open Label Phase|Withdrawal by Subject|118|||
37734571|NCT01515423|69214941|FG001|Open Label Phase|Withdrawal by Subject|0|||
37734572|NCT01515423|69214942|FG002|Open Label Phase|Withdrawal by Subject|0|||
37734573|NCT01515423|69214940|FG000|Open Label Phase|excluded from DB Phase|70|||
37916648|NCT00703534|69603508|FG000|Overall Study|Withdrawal by Subject|8|||
37916649|NCT00703534|69603509|FG001|Overall Study|Withdrawal by Subject|7|||
37734574|NCT01515423|69214941|FG001|Open Label Phase|excluded from DB Phase|0|||
37916650|NCT00703534|69603508|FG000|Overall Study|Incorrect Enrollment|6|||
37734575|NCT01515423|69214942|FG002|Open Label Phase|excluded from DB Phase|0|||
37734576|NCT01515423|69214940|FG000|Open Label Phase|Other|28|||
37734577|NCT01515423|69214941|FG001|Open Label Phase|Other|0|||
37734578|NCT01515423|69214942|FG002|Open Label Phase|Other|0|||
37916651|NCT00703534|69603509|FG001|Overall Study|Incorrect Enrollment|6|||
37845718|NCT01172938|69530199|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
37734579|NCT01515423|69214940|FG000|DOUBLE BLIND|Adverse Event|0|||
37734580|NCT01515423|69214941|FG001|DOUBLE BLIND|Adverse Event|15|||
37734581|NCT01515423|69214942|FG002|DOUBLE BLIND|Adverse Event|13|||
37734582|NCT01515423|69214940|FG000|DOUBLE BLIND|Death|0|||
37734583|NCT01515423|69214941|FG001|DOUBLE BLIND|Death|1|||
37916652|NCT00703534|69603508|FG000|Overall Study|Lost to Follow-up|1|||
37916653|NCT00703534|69603509|FG001|Overall Study|Lost to Follow-up|4|||
37916654|NCT00703534|69603508|FG000|Overall Study|Severe Non Compliance|1|||
38026010|NCT03628508|69710742|FG000|Overall Study|Lost to Follow-up|1|||
38026011|NCT03045328|69710746|FG000|Overall Study|Withdrawal by Subject|2|||
38026012|NCT02154490|69710752|FG000|Overall Study|No tissue submitted|23|||
38026013|NCT02154490|69710752|FG000|Overall Study|No biomarker results|167|||
38026014|NCT02154490|69710752|FG000|Overall Study|Not assigned to a sub-study|270|||
38026015|NCT02154490|69710752|FG000|Overall Study|Did not register to a sub-study|749|||
38026016|NCT03627494|69710768|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
38026017|NCT03627494|69710769|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
38026018|NCT03627494|69710770|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
38026019|NCT03627494|69710771|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
38026020|NCT03627494|69710772|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
38026021|NCT03627494|69710773|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
38026022|NCT03627494|69710774|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
38026023|NCT03627494|69710775|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
38026024|NCT03627494|69710776|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
37916655|NCT00703534|69603509|FG001|Overall Study|Severe Non Compliance|5|||
37916656|NCT00503425|69603515|FG000|Overall Study|Participant files lost|6|||
37916657|NCT00503425|69603515|FG000|Overall Study|Adverse Event|5|||
37916658|NCT00503425|69603515|FG000|Overall Study|Lack of Efficacy|25|||
38026025|NCT03627494|69710777|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
38026026|NCT03627494|69710778|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
38026027|NCT03627494|69710779|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
38026028|NCT03627494|69710768|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
38026029|NCT03627494|69710769|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
38026030|NCT03627494|69710770|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
38026031|NCT03627494|69710771|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
38026032|NCT03627494|69710772|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
38026033|NCT03627494|69710773|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
38026034|NCT03627494|69710774|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
37845719|NCT01172938|69530200|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
37845720|NCT01172938|69530192|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
37845721|NCT01172938|69530193|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
37845722|NCT01172938|69530194|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
37845723|NCT01172938|69530195|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
37845724|NCT01172938|69530196|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
37916659|NCT00503425|69603515|FG000|Overall Study|Withdrawal by Subject|8|||
37916660|NCT00503425|69603515|FG000|Overall Study|Lost to Follow-up|3|||
37916661|NCT00503425|69603515|FG000|Overall Study|Death|3|||
37916662|NCT00503425|69603515|FG000|Overall Study|Missing Data/Unknown|4|||
38026035|NCT03627494|69710775|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
38026036|NCT03627494|69710776|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
38026037|NCT03627494|69710777|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
38026038|NCT03627494|69710778|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
37916663|NCT00863772|69603523|FG000|Overall Study|Adverse Event|1|||
37916664|NCT00863772|69603524|FG001|Overall Study|Adverse Event|4|||
37916665|NCT00863772|69603525|FG002|Overall Study|Adverse Event|0|||
38026039|NCT03627494|69710779|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
37734584|NCT01515423|69214942|FG002|DOUBLE BLIND|Death|2|||
37916666|NCT00863772|69603523|FG000|Overall Study|Lack of Efficacy|4|||
38026040|NCT03627494|69710768|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
37845725|NCT01172938|69530197|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
37845726|NCT01172938|69530198|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
37845727|NCT01172938|69530199|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
37845728|NCT01172938|69530200|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
37845729|NCT01172938|69530192|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
37845730|NCT01172938|69530193|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
37845731|NCT01172938|69530194|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
37916667|NCT00863772|69603524|FG001|Overall Study|Lack of Efficacy|2|||
37916668|NCT00863772|69603525|FG002|Overall Study|Lack of Efficacy|4|||
37916669|NCT00863772|69603523|FG000|Overall Study|Lost to Follow-up|5|||
37916670|NCT00863772|69603524|FG001|Overall Study|Lost to Follow-up|1|||
37916671|NCT00863772|69603525|FG002|Overall Study|Lost to Follow-up|1|||
37916672|NCT00863772|69603523|FG000|Overall Study|Protocol Violation|2|||
37916673|NCT00863772|69603524|FG001|Overall Study|Protocol Violation|0|||
37916674|NCT00863772|69603525|FG002|Overall Study|Protocol Violation|2|||
38026041|NCT03627494|69710769|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
38026042|NCT03627494|69710770|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
38026043|NCT03627494|69710771|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
38026044|NCT03627494|69710772|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
38026045|NCT03627494|69710773|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
38026046|NCT03627494|69710774|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
37916675|NCT00863772|69603523|FG000|Overall Study|Withdrawal by Subject|4|||
37916676|NCT00863772|69603524|FG001|Overall Study|Withdrawal by Subject|7|||
37916677|NCT00863772|69603525|FG002|Overall Study|Withdrawal by Subject|5|||
37916678|NCT00863772|69603523|FG000|Overall Study|Study terminated by sponsor|44|||
37916679|NCT00863772|69603524|FG001|Overall Study|Study terminated by sponsor|45|||
37916680|NCT00863772|69603525|FG002|Overall Study|Study terminated by sponsor|36|||
38026047|NCT03627494|69710775|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
38026048|NCT03627494|69710776|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
38026049|NCT03627494|69710777|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
38026050|NCT03627494|69710778|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
38026051|NCT03627494|69710779|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
38026052|NCT03627416|69710820|FG000|Overall Study|Adverse Event|0|||
38026053|NCT03627416|69710821|FG001|Overall Study|Adverse Event|1|||
38026054|NCT00097539|69710834|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
38026055|NCT00097539|69710835|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
38026056|NCT00097539|69710836|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
38026057|NCT00097539|69710837|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
38026058|NCT00097539|69710838|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
38026059|NCT00097539|69710839|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
38026060|NCT00097539|69710840|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
38026061|NCT00097539|69710834|FG000|Overall Study|Withdrawal by Subject|925|||
38026062|NCT00097539|69710835|FG001|Overall Study|Withdrawal by Subject|323|||
38026063|NCT00097539|69710836|FG002|Overall Study|Withdrawal by Subject|346|||
38026064|NCT00097539|69710837|FG003|Overall Study|Withdrawal by Subject|217|||
38026065|NCT00097539|69710838|FG004|Overall Study|Withdrawal by Subject|68|||
38026066|NCT00097539|69710839|FG005|Overall Study|Withdrawal by Subject|229|||
38026067|NCT00097539|69710840|FG006|Overall Study|Withdrawal by Subject|3|||
38026068|NCT00097539|69710834|FG000|Overall Study|Participant Non-compliant|2140|||
38026069|NCT00097539|69710835|FG001|Overall Study|Participant Non-compliant|567|||
38026070|NCT00097539|69710836|FG002|Overall Study|Participant Non-compliant|1067|||
38026071|NCT00097539|69710837|FG003|Overall Study|Participant Non-compliant|353|||
38026072|NCT00097539|69710838|FG004|Overall Study|Participant Non-compliant|136|||
38026073|NCT00097539|69710839|FG005|Overall Study|Participant Non-compliant|543|||
38026074|NCT00097539|69710840|FG006|Overall Study|Participant Non-compliant|18|||
38026075|NCT00097539|69710834|FG000|Overall Study|Lack of Efficacy|249|||
37845732|NCT01172938|69530195|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
37845733|NCT01172938|69530196|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
37916681|NCT00863772|69603523|FG000|Overall Study|Entered extension study|6|||
37916682|NCT00863772|69603524|FG001|Overall Study|Entered extension study|4|||
37916683|NCT00863772|69603525|FG002|Overall Study|Entered extension study|9|||
37916684|NCT00863772|69603523|FG000|Overall Study|Other|1|||
37916685|NCT00863772|69603524|FG001|Overall Study|Other|2|||
37916686|NCT00863772|69603525|FG002|Overall Study|Other|4|||
37916687|NCT00863772|69603523|FG000|Overall Study|Randomized but not Treated|1|||
38026076|NCT00097539|69710835|FG001|Overall Study|Lack of Efficacy|122|||
38026077|NCT00097539|69710836|FG002|Overall Study|Lack of Efficacy|202|||
38026078|NCT00097539|69710837|FG003|Overall Study|Lack of Efficacy|105|||
38026079|NCT00097539|69710838|FG004|Overall Study|Lack of Efficacy|45|||
38026080|NCT00097539|69710839|FG005|Overall Study|Lack of Efficacy|228|||
38026081|NCT00097539|69710840|FG006|Overall Study|Lack of Efficacy|5|||
38026082|NCT00097539|69710834|FG000|Overall Study|Adverse Event|78|||
38026083|NCT00097539|69710835|FG001|Overall Study|Adverse Event|133|||
38026084|NCT00097539|69710836|FG002|Overall Study|Adverse Event|37|||
37845734|NCT01172938|69530197|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
37845735|NCT01172938|69530198|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
37845736|NCT01172938|69530199|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
37845737|NCT01172938|69530200|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
37845738|NCT01172938|69530192|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
37845739|NCT01172938|69530193|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
37845740|NCT01172938|69530194|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
37845741|NCT01172938|69530195|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
37845742|NCT01172938|69530196|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
37845743|NCT01172938|69530197|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
37845744|NCT01172938|69530198|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
37845745|NCT01172938|69530199|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
37845746|NCT01172938|69530200|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
37845747|NCT01172938|69530192|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
37845748|NCT01172938|69530193|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
37845749|NCT01172938|69530194|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
37845750|NCT01172938|69530195|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
37845751|NCT01172938|69530196|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
37845752|NCT01172938|69530197|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
37845753|NCT01172938|69530198|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
37845754|NCT01172938|69530199|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
37845755|NCT01172938|69530200|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
37845756|NCT01172938|69530192|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
37845757|NCT01172938|69530193|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
37845758|NCT01172938|69530194|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
37845759|NCT01172938|69530195|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
37845760|NCT01172938|69530196|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
37845761|NCT01172938|69530197|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
37845762|NCT01172938|69530198|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
37845763|NCT01172938|69530199|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
37916688|NCT00863772|69603524|FG001|Overall Study|Randomized but not Treated|0|||
37916689|NCT00863772|69603525|FG002|Overall Study|Randomized but not Treated|0|||
37916690|NCT00502801|69603533|FG000|Treatment Period|Withdrawal by Subject|3|||
37916691|NCT00502801|69603533|FG000|Treatment Period|Adverse Event|7|||
37845764|NCT01172938|69530200|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
37845765|NCT01172938|69530192|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
37845766|NCT01172938|69530193|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
37845767|NCT01172938|69530194|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
37845768|NCT01172938|69530195|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
37845769|NCT01172938|69530196|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
37845770|NCT01172938|69530197|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
37845771|NCT01172938|69530198|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
37916692|NCT00502801|69603533|FG000|Treatment Period|Death|14|||
37916693|NCT00502801|69603533|FG000|Treatment Period|OTHER|30|||
37916694|NCT00502801|69603533|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
37916695|NCT00502801|69603533|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
37916696|NCT00502801|69603533|FG000|End of Therapy to Test of Cure|Death|3|||
37916697|NCT00502801|69603533|FG000|End of Therapy to Test of Cure|OTHER|2|||
37916698|NCT00824265|69603539|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
37916699|NCT00824265|69603540|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
37916700|NCT00824265|69603539|FG000|Treatment Phase|Protocol Violation|1|||
37916701|NCT00824265|69603540|FG001|Treatment Phase|Protocol Violation|0|||
37916702|NCT00824265|69603539|FG000|Treatment Phase|Lost to Follow-up|1|||
37916703|NCT00824265|69603540|FG001|Treatment Phase|Lost to Follow-up|1|||
37916704|NCT00824265|69603539|FG000|Treatment Phase|Physician Decision|6|||
37916705|NCT00824265|69603540|FG001|Treatment Phase|Physician Decision|12|||
37916706|NCT00824265|69603539|FG000|Treatment Phase|Withdrawal by Subject|6|||
37916707|NCT00824265|69603540|FG001|Treatment Phase|Withdrawal by Subject|15|||
37916708|NCT00824265|69603539|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
37916709|NCT00824265|69603540|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
37916710|NCT00824265|69603539|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
37916711|NCT00824265|69603540|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
37916712|NCT00855894|69603550|FG000|Overall Study|Death|31|||
37916713|NCT00855894|69603550|FG000|Overall Study|Patient's decision|1|||
37916714|NCT00855894|69603550|FG000|Overall Study|Disease progression|1|||
37916715|NCT00855816|69603556|FG000|Overall Study|Withdrawal by Subject|22|||
37916716|NCT00855816|69603557|FG001|Overall Study|Withdrawal by Subject|15|||
37916717|NCT00855816|69603556|FG000|Overall Study|Lost to Follow-up|3|||
37916718|NCT00855816|69603557|FG001|Overall Study|Lost to Follow-up|5|||
37845772|NCT01172938|69530199|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
37845773|NCT01172938|69530200|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
37845774|NCT01172938|69530192|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
37845775|NCT01172938|69530193|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
37845776|NCT01172938|69530194|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
37845777|NCT01172938|69530195|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
37845778|NCT01172938|69530196|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
37845779|NCT01172938|69530197|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
37845780|NCT01172938|69530198|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
37845781|NCT01172938|69530199|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
37845782|NCT01172938|69530200|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
37845783|NCT01172938|69530192|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
37845784|NCT01172938|69530193|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
37845785|NCT01172938|69530194|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
37845786|NCT01172938|69530195|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
37845787|NCT01172938|69530196|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
37845788|NCT01172938|69530197|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
37845789|NCT01172938|69530198|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
37845790|NCT01172938|69530199|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
37845791|NCT01172938|69530200|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
37845792|NCT01172938|69530192|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
37845793|NCT01172938|69530193|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
37845794|NCT01172938|69530194|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
37845795|NCT01172938|69530195|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
37845796|NCT01172938|69530196|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
37845797|NCT01172938|69530197|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
37845798|NCT01172938|69530198|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
37845799|NCT01172938|69530199|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
37845800|NCT01172938|69530200|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
37845801|NCT01172938|69530192|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
37845802|NCT01172938|69530193|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
37845803|NCT01172938|69530194|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
37845804|NCT01172938|69530195|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
37845805|NCT01172938|69530196|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
37845806|NCT01172938|69530197|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
37845807|NCT01172938|69530198|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
37845808|NCT01172938|69530199|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
37845809|NCT01172938|69530200|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
37845810|NCT01172938|69530192|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
37845811|NCT01172938|69530193|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
37845812|NCT01172938|69530194|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
37845813|NCT01172938|69530195|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
37845814|NCT01172938|69530196|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
37845815|NCT01172938|69530197|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
37845816|NCT01172938|69530198|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
37845817|NCT01172938|69530199|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
37845818|NCT01172938|69530200|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
37845819|NCT01172938|69530192|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
37845820|NCT01172938|69530193|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
37845821|NCT01172938|69530194|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
37845822|NCT01172938|69530195|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
37845823|NCT01172938|69530196|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
37845824|NCT01172938|69530197|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
37845825|NCT01172938|69530198|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
37845826|NCT01172938|69530199|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
37845827|NCT01172938|69530200|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
37845828|NCT01172938|69530192|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
37845829|NCT01172938|69530193|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
37916719|NCT00855816|69603556|FG000|Overall Study|Death|1|||
37916720|NCT00855816|69603557|FG001|Overall Study|Death|0|||
37916721|NCT00855816|69603556|FG000|Overall Study|Became ineligible|0|||
37916722|NCT00855816|69603557|FG001|Overall Study|Became ineligible|1|||
38026085|NCT00097539|69710837|FG003|Overall Study|Adverse Event|27|||
37734585|NCT01515423|69214940|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
37734586|NCT01515423|69214941|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
37845830|NCT01172938|69530194|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
37845831|NCT01172938|69530195|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
37845832|NCT01172938|69530196|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
37845833|NCT01172938|69530197|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
37845834|NCT01172938|69530198|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
37845835|NCT01172938|69530199|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
37845836|NCT01172938|69530200|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
37845837|NCT01172938|69530192|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
38026086|NCT00097539|69710838|FG004|Overall Study|Adverse Event|30|||
38026087|NCT00097539|69710839|FG005|Overall Study|Adverse Event|59|||
38026088|NCT00097539|69710840|FG006|Overall Study|Adverse Event|1|||
38026089|NCT00097539|69710834|FG000|Overall Study|Death|2|||
38026090|NCT00097539|69710835|FG001|Overall Study|Death|7|||
38026091|NCT00097539|69710836|FG002|Overall Study|Death|0|||
38026092|NCT00097539|69710837|FG003|Overall Study|Death|0|||
38026093|NCT00097539|69710838|FG004|Overall Study|Death|1|||
38026094|NCT00097539|69710839|FG005|Overall Study|Death|3|||
38026095|NCT00097539|69710840|FG006|Overall Study|Death|0|||
38026096|NCT00097539|69710834|FG000|Overall Study|Reasons Other Than Above|3602|||
38026097|NCT00097539|69710835|FG001|Overall Study|Reasons Other Than Above|1382|||
38026098|NCT00097539|69710836|FG002|Overall Study|Reasons Other Than Above|1757|||
38026099|NCT00097539|69710837|FG003|Overall Study|Reasons Other Than Above|692|||
38026100|NCT00097539|69710838|FG004|Overall Study|Reasons Other Than Above|361|||
37845838|NCT01172938|69530193|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
37845839|NCT01172938|69530194|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
37845840|NCT01172938|69530195|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
37845841|NCT01172938|69530196|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
37845842|NCT01172938|69530197|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
37845843|NCT01172938|69530198|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
37845844|NCT01172938|69530199|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
37845845|NCT01172938|69530200|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
37845846|NCT01172938|69530192|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
37845847|NCT01172938|69530193|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
37845848|NCT01172938|69530194|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
37845849|NCT01172938|69530195|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
37845850|NCT01172938|69530196|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
37845851|NCT01172938|69530197|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
37845852|NCT01172938|69530198|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
37845853|NCT01172938|69530199|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
37845854|NCT01172938|69530200|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
37845855|NCT01172938|69530192|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
37845856|NCT01172938|69530193|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
37845857|NCT01172938|69530194|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
38026101|NCT00097539|69710839|FG005|Overall Study|Reasons Other Than Above|1244|||
38026102|NCT00097539|69710840|FG006|Overall Study|Reasons Other Than Above|34|||
38026103|NCT00097539|69710834|FG000|Overall Study|Reason not Specified|111|||
38026104|NCT00097539|69710835|FG001|Overall Study|Reason not Specified|49|||
38026105|NCT00097539|69710836|FG002|Overall Study|Reason not Specified|53|||
38026106|NCT00097539|69710837|FG003|Overall Study|Reason not Specified|21|||
38026107|NCT00097539|69710838|FG004|Overall Study|Reason not Specified|11|||
38026108|NCT00097539|69710839|FG005|Overall Study|Reason not Specified|40|||
38026109|NCT00097539|69710840|FG006|Overall Study|Reason not Specified|2|||
38026110|NCT03925324|69710858|FG000|Overall Study|Death|1|||
37845858|NCT01172938|69530195|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
37845859|NCT01172938|69530196|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
37845860|NCT01172938|69530197|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
37845861|NCT01172938|69530198|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
37845862|NCT01172938|69530199|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
37845863|NCT01172938|69530200|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
37845864|NCT01109992|69530220|FG000|Overall Study|Withdrawal by Subject|0|||
37845865|NCT01109992|69530221|FG001|Overall Study|Withdrawal by Subject|1|||
37845866|NCT01109992|69530220|FG000|Overall Study|Movement during rest scan.|0|||
37916723|NCT00855738|69603563|FG000|Overall Study|Lost to Follow-up|2|||
37916724|NCT00855738|69603563|FG000|Overall Study|Adverse Event|1|||
37916725|NCT00855738|69603563|FG000|Overall Study|Subject Defaulted|1|||
37916726|NCT00855738|69603563|FG000|Overall Study|Death|1|||
38026111|NCT03925324|69710859|FG001|Overall Study|Death|1|||
38026112|NCT03042910|69710865|FG000|Overall Study|Adverse Event|1|||
38026113|NCT03042910|69710865|FG000|Overall Study|Disease Progression|2|||
38026114|NCT03042910|69710865|FG000|Overall Study|Withdrawal by Subject|3|||
38026115|NCT03042910|69710865|FG000|Overall Study|Enrolled but not treated|1|||
38026116|NCT03059446|69710869|FG000|Overall Study|Adverse Event|11|||
37845867|NCT01109992|69530221|FG001|Overall Study|Movement during rest scan.|1|||
37845868|NCT01109524|69530230|FG000|Overall Study|Disease Progression|29|||
37845869|NCT01109524|69530230|FG000|Overall Study|Study Drug toxicity|6|||
37845870|NCT01109524|69530230|FG000|Overall Study|Adverse Event|4|||
38026117|NCT03059446|69710869|FG000|Overall Study|Withdrawal of Consent|16|||
38026118|NCT03059446|69710869|FG000|Overall Study|Lost to Follow-up|3|||
38026119|NCT03059446|69710869|FG000|Overall Study|Protocol Violation|1|||
38026120|NCT03059446|69710869|FG000|Overall Study|Study Terminated by Sponsor|131|||
38026121|NCT03059446|69710869|FG000|Overall Study|Reason not Specified|5|||
38026122|NCT00090519|69710875|FG000|Overall Study|Adverse Event|5|||
38026123|NCT00090519|69710876|FG001|Overall Study|Adverse Event|4|||
38026124|NCT00090519|69710875|FG000|Overall Study|Death|9|||
38026125|NCT00090519|69710876|FG001|Overall Study|Death|9|||
38026126|NCT00090519|69710875|FG000|Overall Study|Lost to Follow-up|26|||
37845871|NCT01109524|69530230|FG000|Overall Study|Withdrawal by Subject|2|||
37845872|NCT01109524|69530230|FG000|Overall Study|Maximum clinical benefit|3|||
37845873|NCT01109524|69530230|FG000|Overall Study|Death|2|||
37845874|NCT01109524|69530230|FG000|Overall Study|No longer meets criteria|2|||
37845875|NCT01109524|69530230|FG000|Overall Study|Participant requested to end treatment|4|||
37845876|NCT01109524|69530230|FG000|Overall Study|Other|5|||
37845877|NCT01109173|69530245|FG000|Overall Study|Adverse Event|15|||
37845878|NCT01109173|69530246|FG001|Overall Study|Adverse Event|17|||
37845879|NCT01109173|69530247|FG002|Overall Study|Adverse Event|9|||
37845880|NCT01109173|69530248|FG003|Overall Study|Adverse Event|6|||
37845881|NCT01109173|69530245|FG000|Overall Study|Lost to Follow-up|0|||
37845882|NCT01109173|69530246|FG001|Overall Study|Lost to Follow-up|1|||
37845883|NCT01109173|69530247|FG002|Overall Study|Lost to Follow-up|0|||
37845884|NCT01109173|69530248|FG003|Overall Study|Lost to Follow-up|0|||
37845885|NCT01109173|69530245|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
37845886|NCT01109173|69530246|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
37845887|NCT01109173|69530247|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
37845888|NCT01109173|69530248|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
37845889|NCT01109173|69530245|FG000|Overall Study|Noncompliance|0|||
37845890|NCT01109173|69530246|FG001|Overall Study|Noncompliance|1|||
37845891|NCT01109173|69530247|FG002|Overall Study|Noncompliance|0|||
37845892|NCT01109173|69530248|FG003|Overall Study|Noncompliance|0|||
37845893|NCT01109173|69530245|FG000|Overall Study|Treatment Failure|25|||
37845894|NCT01109173|69530246|FG001|Overall Study|Treatment Failure|32|||
37845895|NCT01109173|69530247|FG002|Overall Study|Treatment Failure|69|||
37845896|NCT01109173|69530248|FG003|Overall Study|Treatment Failure|64|||
37845897|NCT01109173|69530245|FG000|Overall Study|Protocol Violation|4|||
38026127|NCT00090519|69710876|FG001|Overall Study|Lost to Follow-up|29|||
38026128|NCT00090519|69710875|FG000|Overall Study|Withdrawal by Subject|28|||
38026129|NCT00090519|69710876|FG001|Overall Study|Withdrawal by Subject|29|||
38026130|NCT00090519|69710875|FG000|Overall Study|Physician Decision|2|||
38026131|NCT00090519|69710876|FG001|Overall Study|Physician Decision|3|||
37734587|NCT01515423|69214942|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
37734588|NCT01515423|69214940|FG000|DOUBLE BLIND|Pregnancy|0|||
37734589|NCT01515423|69214941|FG001|DOUBLE BLIND|Pregnancy|2|||
37734590|NCT01515423|69214942|FG002|DOUBLE BLIND|Pregnancy|0|||
37734591|NCT01515423|69214940|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
37734592|NCT01515423|69214941|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
37734593|NCT01515423|69214942|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
37845898|NCT01109173|69530246|FG001|Overall Study|Protocol Violation|5|||
37845899|NCT01109173|69530247|FG002|Overall Study|Protocol Violation|1|||
37845900|NCT01109173|69530248|FG003|Overall Study|Protocol Violation|2|||
37845901|NCT01109173|69530245|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
37845902|NCT01109173|69530246|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
37845903|NCT01109173|69530247|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
37845904|NCT01109173|69530248|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
37845905|NCT01109173|69530245|FG000|Overall Study|Not Specifiied|5|||
37845906|NCT01109173|69530246|FG001|Overall Study|Not Specifiied|4|||
37845907|NCT01109173|69530247|FG002|Overall Study|Not Specifiied|9|||
37734594|NCT01515423|69214940|FG000|DOUBLE BLIND|Other|0|||
37845908|NCT01109173|69530248|FG003|Overall Study|Not Specifiied|14|||
37845909|NCT01172821|69530262|FG000|Overall Study|Adverse Event|5|||
37845910|NCT01172821|69530263|FG001|Overall Study|Adverse Event|2|||
37845911|NCT01172821|69530264|FG002|Overall Study|Adverse Event|2|||
37845912|NCT01172821|69530265|FG003|Overall Study|Adverse Event|7|||
37845913|NCT01172821|69530262|FG000|Overall Study|Protocol Violation|0|||
37845914|NCT01172821|69530263|FG001|Overall Study|Protocol Violation|2|||
37845915|NCT01172821|69530264|FG002|Overall Study|Protocol Violation|1|||
37845916|NCT01172821|69530265|FG003|Overall Study|Protocol Violation|2|||
38026132|NCT00090519|69710875|FG000|Overall Study|Sponsor Decision|3|||
38026133|NCT00090519|69710876|FG001|Overall Study|Sponsor Decision|1|||
38026134|NCT00096993|69710906|FG000|Overall Study|Death|1|||
38026135|NCT00096993|69710907|FG001|Overall Study|Death|0|||
38026136|NCT00096993|69710906|FG000|Overall Study|Disease progression|56|||
38026137|NCT00096993|69710907|FG001|Overall Study|Disease progression|53|||
37845917|NCT01172821|69530262|FG000|Overall Study|Lost to Follow-up|4|||
37845918|NCT01172821|69530263|FG001|Overall Study|Lost to Follow-up|1|||
37845919|NCT01172821|69530264|FG002|Overall Study|Lost to Follow-up|2|||
37845920|NCT01172821|69530265|FG003|Overall Study|Lost to Follow-up|2|||
37845921|NCT01172821|69530262|FG000|Overall Study|Withdrawal by Subject|2|||
37845922|NCT01172821|69530263|FG001|Overall Study|Withdrawal by Subject|3|||
37845923|NCT01172821|69530264|FG002|Overall Study|Withdrawal by Subject|3|||
37845924|NCT01172821|69530265|FG003|Overall Study|Withdrawal by Subject|3|||
37845925|NCT01172821|69530262|FG000|Overall Study|Other|3|||
37845926|NCT01172821|69530263|FG001|Overall Study|Other|4|||
37845927|NCT01172821|69530264|FG002|Overall Study|Other|5|||
37845928|NCT01172821|69530265|FG003|Overall Study|Other|3|||
37845929|NCT01172275|69530277|FG000|Overall Study|Lost to Follow-up|1|||
37845930|NCT01172275|69530278|FG001|Overall Study|Lost to Follow-up|0|||
37845931|NCT01172275|69530277|FG000|Overall Study|Protocol Violation|1|||
37845932|NCT01172275|69530278|FG001|Overall Study|Protocol Violation|0|||
37845933|NCT01108510|69530286|FG000|Overall Study|Randomized but Not Treated|5|||
37845934|NCT01108510|69530287|FG001|Overall Study|Randomized but Not Treated|1|||
37845935|NCT01108510|69530286|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
37845936|NCT01108510|69530287|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
37845937|NCT01108510|69530286|FG000|Overall Study|Adverse Event|26|||
37845938|NCT01108510|69530287|FG001|Overall Study|Adverse Event|19|||
37845939|NCT01108510|69530286|FG000|Overall Study|Lost to Follow-up|20|||
37845940|NCT01108510|69530287|FG001|Overall Study|Lost to Follow-up|17|||
37845941|NCT01108510|69530286|FG000|Overall Study|Withdrew Consent|21|||
37845942|NCT01108510|69530287|FG001|Overall Study|Withdrew Consent|15|||
37845943|NCT01108510|69530286|FG000|Overall Study|Investigator's Discretion|12|||
37845944|NCT01108510|69530287|FG001|Overall Study|Investigator's Discretion|10|||
37845945|NCT01108510|69530286|FG000|Overall Study|Participant Noncompliance|5|||
37845946|NCT01108510|69530287|FG001|Overall Study|Participant Noncompliance|7|||
37845947|NCT01108510|69530286|FG000|Overall Study|Lack of Efficacy|3|||
37845948|NCT01108510|69530287|FG001|Overall Study|Lack of Efficacy|0|||
37845949|NCT01108510|69530286|FG000|Overall Study|Pregnancy|0|||
37845950|NCT01108510|69530287|FG001|Overall Study|Pregnancy|3|||
37845951|NCT01108510|69530286|FG000|Overall Study|Death|1|||
37845952|NCT01108510|69530287|FG001|Overall Study|Death|1|||
37845953|NCT01340027|69530305|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
37845954|NCT01340027|69530306|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
37845955|NCT01340027|69530307|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
37845956|NCT01340027|69530308|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
37845957|NCT01340027|69530309|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
37845958|NCT01340027|69530310|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
37845959|NCT01340027|69530311|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
37845960|NCT01340027|69530312|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
37845961|NCT01340027|69530313|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
37845962|NCT01340027|69530314|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
37916727|NCT00490945|69603574|FG000|Overall Study|Adverse Event|0|||
37916728|NCT00490945|69603575|FG001|Overall Study|Adverse Event|1|||
37916729|NCT00490945|69603576|FG002|Overall Study|Adverse Event|0|||
37916730|NCT00490945|69603577|FG003|Overall Study|Adverse Event|0|||
37916731|NCT00490945|69603578|FG004|Overall Study|Adverse Event|0|||
37916732|NCT00879398|69603596|FG000|Overall Study|Visit Stop|399|||
37916733|NCT00879398|69603596|FG000|Overall Study|Lack of Efficacy|64|||
37916734|NCT00879398|69603596|FG000|Overall Study|Adverse Event|41|||
37916735|NCT00879398|69603596|FG000|Overall Study|Other Reasons|171|||
37916736|NCT00696436|69603605|FG000|Overall Study|Adverse Event|7|||
37916737|NCT00696436|69603606|FG001|Overall Study|Adverse Event|9|||
37916738|NCT00696436|69603607|FG002|Overall Study|Adverse Event|8|||
37845963|NCT01340027|69530315|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
37845964|NCT01340027|69530316|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
37845965|NCT01340027|69530305|FG000|Overall Study|Adverse Event|0|||
37845966|NCT01340027|69530306|FG001|Overall Study|Adverse Event|1|||
37845967|NCT01340027|69530307|FG002|Overall Study|Adverse Event|2|||
37916739|NCT00696436|69603608|FG003|Overall Study|Adverse Event|6|||
37734595|NCT01515423|69214941|FG001|DOUBLE BLIND|Other|6|||
37734596|NCT01515423|69214942|FG002|DOUBLE BLIND|Other|12|||
37734597|NCT01515423|69214940|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
37845968|NCT01340027|69530308|FG003|Overall Study|Adverse Event|0|||
37845969|NCT01340027|69530309|FG004|Overall Study|Adverse Event|1|||
37845970|NCT01340027|69530310|FG005|Overall Study|Adverse Event|2|||
37845971|NCT01340027|69530311|FG006|Overall Study|Adverse Event|2|||
37845972|NCT01340027|69530312|FG007|Overall Study|Adverse Event|1|||
37845973|NCT01340027|69530313|FG008|Overall Study|Adverse Event|4|||
37916740|NCT00696436|69603609|FG004|Overall Study|Adverse Event|4|||
37916741|NCT00696436|69603605|FG000|Overall Study|Protocol Violation|3|||
37845974|NCT01340027|69530314|FG009|Overall Study|Adverse Event|1|||
37916742|NCT00696436|69603606|FG001|Overall Study|Protocol Violation|2|||
38026138|NCT00096993|69710906|FG000|Overall Study|Adverse Event|2|||
37845975|NCT01340027|69530315|FG010|Overall Study|Adverse Event|1|||
37845976|NCT01340027|69530316|FG011|Overall Study|Adverse Event|3|||
37845977|NCT01340027|69530305|FG000|Overall Study|Lack of Efficacy|0|||
37845978|NCT01340027|69530306|FG001|Overall Study|Lack of Efficacy|0|||
37845979|NCT01340027|69530307|FG002|Overall Study|Lack of Efficacy|0|||
37845980|NCT01340027|69530308|FG003|Overall Study|Lack of Efficacy|0|||
37845981|NCT01340027|69530309|FG004|Overall Study|Lack of Efficacy|0|||
37845982|NCT01340027|69530310|FG005|Overall Study|Lack of Efficacy|0|||
37845983|NCT01340027|69530311|FG006|Overall Study|Lack of Efficacy|1|||
37845984|NCT01340027|69530312|FG007|Overall Study|Lack of Efficacy|1|||
38026139|NCT00096993|69710907|FG001|Overall Study|Adverse Event|8|||
38026140|NCT00096993|69710906|FG000|Overall Study|Subject's decision|3|||
38026141|NCT00096993|69710907|FG001|Overall Study|Subject's decision|1|||
38026142|NCT00096993|69710906|FG000|Overall Study|Physician Decision|2|||
38026143|NCT00096993|69710907|FG001|Overall Study|Physician Decision|1|||
38026144|NCT00096993|69710906|FG000|Overall Study|Non-compliance|0|||
38026145|NCT00096993|69710907|FG001|Overall Study|Non-compliance|1|||
38026146|NCT00096993|69710906|FG000|Overall Study|Other unspecified|1|||
38026147|NCT00096993|69710907|FG001|Overall Study|Other unspecified|1|||
38026148|NCT03040336|69710915|FG000|Overall Study|Death|1|||
38026149|NCT03040336|69710916|FG001|Overall Study|Death|0|||
38026150|NCT03040336|69710915|FG000|Overall Study|Withdrawal by Subject|2|||
38026151|NCT03040336|69710916|FG001|Overall Study|Withdrawal by Subject|3|||
38026152|NCT00072189|69710923|FG000|Overall Study|Withdrawal by Subject|1|||
38026153|NCT03040024|69710930|FG000|Overall Study|Adverse Event|0|||
38026154|NCT03040024|69710931|FG001|Overall Study|Adverse Event|1|||
38026155|NCT03040024|69710932|FG002|Overall Study|Adverse Event|0|||
38026156|NCT03040024|69710930|FG000|Overall Study|Death|0|||
38026157|NCT03040024|69710931|FG001|Overall Study|Death|1|||
38026158|NCT03040024|69710932|FG002|Overall Study|Death|0|||
38026159|NCT03040024|69710930|FG000|Overall Study|Physician Decision|0|||
38026160|NCT03040024|69710931|FG001|Overall Study|Physician Decision|0|||
38026161|NCT03040024|69710932|FG002|Overall Study|Physician Decision|1|||
38026162|NCT03039790|69710960|FG000|Overall Study|Lost to Follow-up|2|||
38026163|NCT03039790|69710961|FG001|Overall Study|Lost to Follow-up|0|||
38026164|NCT03039790|69710962|FG002|Overall Study|Lost to Follow-up|1|||
38026165|NCT03039790|69710963|FG003|Overall Study|Lost to Follow-up|1|||
37845985|NCT01340027|69530313|FG008|Overall Study|Lack of Efficacy|1|||
37845986|NCT01340027|69530314|FG009|Overall Study|Lack of Efficacy|0|||
37845987|NCT01340027|69530315|FG010|Overall Study|Lack of Efficacy|0|||
37845988|NCT01340027|69530316|FG011|Overall Study|Lack of Efficacy|0|||
37845989|NCT01340027|69530305|FG000|Overall Study|Lost to Follow-up|0|||
37845990|NCT01340027|69530306|FG001|Overall Study|Lost to Follow-up|1|||
37845991|NCT01340027|69530307|FG002|Overall Study|Lost to Follow-up|0|||
37845992|NCT01340027|69530308|FG003|Overall Study|Lost to Follow-up|0|||
37845993|NCT01340027|69530309|FG004|Overall Study|Lost to Follow-up|0|||
37845994|NCT01340027|69530310|FG005|Overall Study|Lost to Follow-up|0|||
37845995|NCT01340027|69530311|FG006|Overall Study|Lost to Follow-up|1|||
37845996|NCT01340027|69530312|FG007|Overall Study|Lost to Follow-up|0|||
37845997|NCT01340027|69530313|FG008|Overall Study|Lost to Follow-up|0|||
37845998|NCT01340027|69530314|FG009|Overall Study|Lost to Follow-up|1|||
37845999|NCT01340027|69530315|FG010|Overall Study|Lost to Follow-up|0|||
37846000|NCT01340027|69530316|FG011|Overall Study|Lost to Follow-up|0|||
37846001|NCT01340027|69530305|FG000|Overall Study|Protocol Violation|1|||
37846002|NCT01340027|69530306|FG001|Overall Study|Protocol Violation|2|||
37846003|NCT01340027|69530307|FG002|Overall Study|Protocol Violation|0|||
37846004|NCT01340027|69530308|FG003|Overall Study|Protocol Violation|0|||
37846005|NCT01340027|69530309|FG004|Overall Study|Protocol Violation|6|||
37846006|NCT01340027|69530310|FG005|Overall Study|Protocol Violation|0|||
37846007|NCT01340027|69530311|FG006|Overall Study|Protocol Violation|0|||
37846008|NCT01340027|69530312|FG007|Overall Study|Protocol Violation|1|||
37846009|NCT01340027|69530313|FG008|Overall Study|Protocol Violation|2|||
37846010|NCT01340027|69530314|FG009|Overall Study|Protocol Violation|2|||
37846011|NCT01340027|69530315|FG010|Overall Study|Protocol Violation|0|||
37846012|NCT01340027|69530316|FG011|Overall Study|Protocol Violation|0|||
37846013|NCT01340027|69530305|FG000|Overall Study|Withdrawal by Subject|4|||
38026166|NCT03039790|69710964|FG004|Overall Study|Lost to Follow-up|0|||
38026167|NCT03039790|69710965|FG005|Overall Study|Lost to Follow-up|1|||
38026168|NCT03039790|69710966|FG006|Overall Study|Lost to Follow-up|1|||
38026169|NCT03039790|69710967|FG007|Overall Study|Lost to Follow-up|1|||
38026170|NCT03039790|69710968|FG008|Overall Study|Lost to Follow-up|0|||
38026171|NCT03039790|69710969|FG009|Overall Study|Lost to Follow-up|1|||
38026172|NCT03039790|69710970|FG010|Overall Study|Lost to Follow-up|1|||
38026173|NCT03039790|69710971|FG011|Overall Study|Lost to Follow-up|0|||
38026174|NCT03039790|69710972|FG012|Overall Study|Lost to Follow-up|1|||
37846014|NCT01340027|69530306|FG001|Overall Study|Withdrawal by Subject|3|||
37846015|NCT01340027|69530307|FG002|Overall Study|Withdrawal by Subject|1|||
37846016|NCT01340027|69530308|FG003|Overall Study|Withdrawal by Subject|3|||
37846017|NCT01340027|69530309|FG004|Overall Study|Withdrawal by Subject|3|||
38026175|NCT03039790|69710973|FG013|Overall Study|Lost to Follow-up|0|||
37846018|NCT01340027|69530310|FG005|Overall Study|Withdrawal by Subject|2|||
37846019|NCT01340027|69530311|FG006|Overall Study|Withdrawal by Subject|3|||
37846020|NCT01340027|69530312|FG007|Overall Study|Withdrawal by Subject|4|||
37846021|NCT01340027|69530313|FG008|Overall Study|Withdrawal by Subject|1|||
37846022|NCT01340027|69530314|FG009|Overall Study|Withdrawal by Subject|2|||
37846023|NCT01340027|69530315|FG010|Overall Study|Withdrawal by Subject|0|||
37846024|NCT01340027|69530316|FG011|Overall Study|Withdrawal by Subject|1|||
37846025|NCT01340027|69530305|FG000|Overall Study|Miscellaneous|0|||
37734598|NCT01515423|69214941|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
37734599|NCT01515423|69214942|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
37734600|NCT00637156|69214951|FG000|Overall Study|Withdrawal by Subject|0|||
37734601|NCT00637156|69214952|FG001|Overall Study|Withdrawal by Subject|7|||
37734602|NCT00637156|69214951|FG000|Overall Study|Death|0|||
37734603|NCT00637156|69214952|FG001|Overall Study|Death|1|||
37846026|NCT01340027|69530306|FG001|Overall Study|Miscellaneous|0|||
37846027|NCT01340027|69530307|FG002|Overall Study|Miscellaneous|0|||
37846028|NCT01340027|69530308|FG003|Overall Study|Miscellaneous|1|||
37846029|NCT01340027|69530309|FG004|Overall Study|Miscellaneous|0|||
37846030|NCT01340027|69530310|FG005|Overall Study|Miscellaneous|0|||
37846031|NCT01340027|69530311|FG006|Overall Study|Miscellaneous|0|||
37846032|NCT01340027|69530312|FG007|Overall Study|Miscellaneous|0|||
37846033|NCT01340027|69530313|FG008|Overall Study|Miscellaneous|0|||
37846034|NCT01340027|69530314|FG009|Overall Study|Miscellaneous|0|||
37846035|NCT01340027|69530315|FG010|Overall Study|Miscellaneous|1|||
37846036|NCT01340027|69530316|FG011|Overall Study|Miscellaneous|0|||
37846037|NCT01327053|69530344|FG000|Overall Study|Adverse Event|23|||
37846038|NCT01327053|69530345|FG001|Overall Study|Adverse Event|57|||
37846039|NCT01327053|69530344|FG000|Overall Study|Patient/guardian decision|11|||
37846040|NCT01327053|69530345|FG001|Overall Study|Patient/guardian decision|35|||
37846041|NCT01327053|69530344|FG000|Overall Study|Physician Decision|10|||
37846042|NCT01327053|69530345|FG001|Overall Study|Physician Decision|14|||
37846043|NCT01327053|69530344|FG000|Overall Study|Death|1|||
37846044|NCT01327053|69530345|FG001|Overall Study|Death|5|||
37846045|NCT01327053|69530344|FG000|Overall Study|Lost to Follow-up|2|||
37846046|NCT01327053|69530345|FG001|Overall Study|Lost to Follow-up|4|||
37846047|NCT01327053|69530344|FG000|Overall Study|Non-compliance with study treatment|0|||
37846048|NCT01327053|69530345|FG001|Overall Study|Non-compliance with study treatment|5|||
38026176|NCT03039790|69710974|FG014|Overall Study|Lost to Follow-up|3|||
38026177|NCT03039790|69710975|FG015|Overall Study|Lost to Follow-up|1|||
38026178|NCT03039790|69710976|FG016|Overall Study|Lost to Follow-up|2|||
38026179|NCT03039790|69710977|FG017|Overall Study|Lost to Follow-up|2|||
38026180|NCT03039790|69710978|FG018|Overall Study|Lost to Follow-up|1|||
38026181|NCT03039790|69710979|FG019|Overall Study|Lost to Follow-up|3|||
38026182|NCT03039790|69710960|FG000|Overall Study|Withdrawal of Consent|1|||
38026183|NCT03039790|69710961|FG001|Overall Study|Withdrawal of Consent|0|||
38026184|NCT03039790|69710962|FG002|Overall Study|Withdrawal of Consent|0|||
37734604|NCT00637156|69214951|FG000|Overall Study|Lost to Follow-up|10|||
37846049|NCT01327053|69530344|FG000|Overall Study|Study terminated by Sponsor|1|||
37846050|NCT01327053|69530345|FG001|Overall Study|Study terminated by Sponsor|3|||
37846051|NCT01327053|69530344|FG000|Overall Study|Progressive disease|31|||
37846052|NCT01327053|69530345|FG001|Overall Study|Progressive disease|26|||
37846053|NCT01327053|69530344|FG000|Overall Study|Protocol Violation|0|||
37846054|NCT01327053|69530345|FG001|Overall Study|Protocol Violation|1|||
37846055|NCT01327053|69530344|FG000|Overall Study|Untreated|0|||
37846056|NCT01327053|69530345|FG001|Overall Study|Untreated|1|||
37846057|NCT01107925|69530359|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
37916743|NCT00696436|69603607|FG002|Overall Study|Protocol Violation|2|||
37916744|NCT00696436|69603608|FG003|Overall Study|Protocol Violation|0|||
37916745|NCT00696436|69603609|FG004|Overall Study|Protocol Violation|1|||
37916746|NCT00696436|69603605|FG000|Overall Study|Lost to Follow-up|1|||
37916747|NCT00696436|69603606|FG001|Overall Study|Lost to Follow-up|6|||
37916748|NCT00696436|69603607|FG002|Overall Study|Lost to Follow-up|2|||
37916749|NCT00696436|69603608|FG003|Overall Study|Lost to Follow-up|4|||
37916750|NCT00696436|69603609|FG004|Overall Study|Lost to Follow-up|3|||
37916751|NCT00696436|69603605|FG000|Overall Study|Withdrawal by Subject|4|||
37916752|NCT00696436|69603606|FG001|Overall Study|Withdrawal by Subject|11|||
37916753|NCT00696436|69603607|FG002|Overall Study|Withdrawal by Subject|5|||
37916754|NCT00696436|69603608|FG003|Overall Study|Withdrawal by Subject|7|||
37916755|NCT00696436|69603609|FG004|Overall Study|Withdrawal by Subject|1|||
37916756|NCT00696436|69603605|FG000|Overall Study|Lack of Efficacy|3|||
37916757|NCT00696436|69603606|FG001|Overall Study|Lack of Efficacy|1|||
37916758|NCT00696436|69603607|FG002|Overall Study|Lack of Efficacy|5|||
37916759|NCT00696436|69603608|FG003|Overall Study|Lack of Efficacy|2|||
38026185|NCT03039790|69710963|FG003|Overall Study|Withdrawal of Consent|1|||
38026186|NCT03039790|69710964|FG004|Overall Study|Withdrawal of Consent|0|||
37734605|NCT00637156|69214952|FG001|Overall Study|Lost to Follow-up|16|||
37846058|NCT01107925|69530360|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
37846059|NCT01107925|69530361|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
37846060|NCT01107925|69530362|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
37846061|NCT01107925|69530363|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
37846062|NCT01107925|69530364|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
37846063|NCT01107925|69530359|FG000|Period 2|Withdrawal by Subject|0|||
37846064|NCT01107925|69530360|FG001|Period 2|Withdrawal by Subject|1|||
37846065|NCT01107925|69530361|FG002|Period 2|Withdrawal by Subject|0|||
37846066|NCT01107925|69530362|FG003|Period 2|Withdrawal by Subject|0|||
37846067|NCT01107925|69530363|FG004|Period 2|Withdrawal by Subject|0|||
37846068|NCT01107925|69530364|FG005|Period 2|Withdrawal by Subject|1|||
37846069|NCT01339832|69530392|FG000|Overall Study|Lost to Follow-up|3|||
37846070|NCT01339832|69530392|FG000|Overall Study|Death|11|||
37846071|NCT01339559|69530396|FG000|Overall Study|Adverse Event|92|||
37846072|NCT01339559|69530396|FG000|Overall Study|Death|5|||
37846073|NCT01339559|69530396|FG000|Overall Study|Lack of Efficacy|164|||
37846074|NCT01339559|69530396|FG000|Overall Study|Lost to Follow-up|22|||
37734606|NCT00637000|69214960|FG000|Overall Study|Withdrawal by Subject|4|||
37846075|NCT01339559|69530396|FG000|Overall Study|Subject choice|89|||
37846076|NCT01339559|69530396|FG000|Overall Study|Protocol Violation|15|||
37846077|NCT01339559|69530396|FG000|Overall Study|Study closure at site|1|||
37846078|NCT01339559|69530396|FG000|Overall Study|Incarcerated|2|||
37846079|NCT01339559|69530396|FG000|Overall Study|Epilepsy surgery|1|||
37846080|NCT01339559|69530396|FG000|Overall Study|Pregnancy planned|2|||
37846081|NCT01339559|69530396|FG000|Overall Study|Left the country|1|||
37846082|NCT01339559|69530396|FG000|Overall Study|Investigator decision|2|||
37846083|NCT01339559|69530396|FG000|Overall Study|Patient didn't wish to continue|1|||
37846084|NCT01339559|69530396|FG000|Overall Study|PI decision|1|||
37846085|NCT00107900|69530407|FG000|Overall Study|Adverse Event|3|||
37846086|NCT00107900|69530408|FG001|Overall Study|Adverse Event|2|||
37846087|NCT00107900|69530409|FG002|Overall Study|Adverse Event|10|||
37846088|NCT00107900|69530410|FG003|Overall Study|Adverse Event|3|||
37846089|NCT00107900|69530411|FG004|Overall Study|Adverse Event|5|||
37846090|NCT00107900|69530412|FG005|Overall Study|Adverse Event|3|||
37846091|NCT00107900|69530407|FG000|Overall Study|Death|0|||
37846092|NCT00107900|69530408|FG001|Overall Study|Death|0|||
37846093|NCT00107900|69530409|FG002|Overall Study|Death|0|||
37846094|NCT00107900|69530410|FG003|Overall Study|Death|0|||
37846095|NCT00107900|69530411|FG004|Overall Study|Death|1|||
37846096|NCT00107900|69530412|FG005|Overall Study|Death|0|||
37846097|NCT00107900|69530407|FG000|Overall Study|Lost to Follow-up|4|||
37846098|NCT00107900|69530408|FG001|Overall Study|Lost to Follow-up|1|||
37846099|NCT00107900|69530409|FG002|Overall Study|Lost to Follow-up|3|||
37846100|NCT00107900|69530410|FG003|Overall Study|Lost to Follow-up|2|||
37846101|NCT00107900|69530411|FG004|Overall Study|Lost to Follow-up|5|||
37846102|NCT00107900|69530412|FG005|Overall Study|Lost to Follow-up|5|||
37846103|NCT00107900|69530407|FG000|Overall Study|Protocol Violation|1|||
37846104|NCT00107900|69530408|FG001|Overall Study|Protocol Violation|0|||
37734607|NCT00637000|69214961|FG001|Overall Study|Withdrawal by Subject|3|||
37734608|NCT01515189|69214969|FG000|Induction|Disease Progression|109|||
37734609|NCT01515189|69214970|FG001|Induction|Disease Progression|155|||
37734610|NCT01515189|69214969|FG000|Induction|Study drug toxicity|86|||
37734611|NCT01515189|69214970|FG001|Induction|Study drug toxicity|36|||
37734612|NCT01515189|69214969|FG000|Induction|Death|24|||
37734613|NCT01515189|69214970|FG001|Induction|Death|17|||
37734614|NCT01515189|69214969|FG000|Induction|Adverse Event|14|||
37734615|NCT01515189|69214970|FG001|Induction|Adverse Event|9|||
37734616|NCT01515189|69214969|FG000|Induction|Withdrawal by Subject|3|||
37734617|NCT01515189|69214970|FG001|Induction|Withdrawal by Subject|9|||
37734618|NCT01515189|69214969|FG000|Induction|No longer meets study criteria|0|||
37734619|NCT01515189|69214970|FG001|Induction|No longer meets study criteria|2|||
37734620|NCT01515189|69214969|FG000|Induction|Lost to Follow-up|1|||
37846105|NCT00107900|69530409|FG002|Overall Study|Protocol Violation|5|||
37846106|NCT00107900|69530410|FG003|Overall Study|Protocol Violation|5|||
37846107|NCT00107900|69530411|FG004|Overall Study|Protocol Violation|7|||
37846108|NCT00107900|69530412|FG005|Overall Study|Protocol Violation|0|||
37734621|NCT01515189|69214970|FG001|Induction|Lost to Follow-up|0|||
37734622|NCT01515189|69214969|FG000|Induction|Other|0|||
37846109|NCT00107900|69530407|FG000|Overall Study|Withdrawal by Subject|1|||
37846110|NCT00107900|69530408|FG001|Overall Study|Withdrawal by Subject|0|||
37846111|NCT00107900|69530409|FG002|Overall Study|Withdrawal by Subject|5|||
37846112|NCT00107900|69530410|FG003|Overall Study|Withdrawal by Subject|0|||
37846113|NCT00107900|69530411|FG004|Overall Study|Withdrawal by Subject|1|||
37846114|NCT00107900|69530412|FG005|Overall Study|Withdrawal by Subject|1|||
37846115|NCT00107900|69530407|FG000|Overall Study|Administrative Reasons|1|||
37846116|NCT00107900|69530408|FG001|Overall Study|Administrative Reasons|0|||
37734623|NCT01515189|69214970|FG001|Induction|Other|4|||
37734624|NCT01515189|69214969|FG000|First Re-Induction Phase|Disease progression|6|||
37846117|NCT00107900|69530409|FG002|Overall Study|Administrative Reasons|2|||
37846118|NCT00107900|69530410|FG003|Overall Study|Administrative Reasons|2|||
37846119|NCT00107900|69530411|FG004|Overall Study|Administrative Reasons|2|||
37846120|NCT00107900|69530412|FG005|Overall Study|Administrative Reasons|0|||
37846121|NCT01339052|69530428|FG000|Overall Study|Disease progression|13|||
37846122|NCT01339052|69530429|FG001|Overall Study|Disease progression|46|||
37846123|NCT01339052|69530428|FG000|Overall Study|Adverse Event|1|||
37846124|NCT01339052|69530429|FG001|Overall Study|Adverse Event|1|||
37846125|NCT01339052|69530428|FG000|Overall Study|Withdrawal by Subject|0|||
37846126|NCT01339052|69530429|FG001|Overall Study|Withdrawal by Subject|3|||
37846127|NCT01339052|69530428|FG000|Overall Study|Physician Decision|1|||
37846128|NCT01339052|69530429|FG001|Overall Study|Physician Decision|0|||
37846129|NCT00107315|69530438|FG000|Overall Study|Disease Progression|9|||
37846130|NCT00107315|69530438|FG000|Overall Study|Adverse Event|4|||
37846131|NCT00107315|69530438|FG000|Overall Study|Withdrawal by Subject|2|||
37846132|NCT01335971|69530445|FG000|Overall Study|Withdrawal by Subject|1|||
37846133|NCT01335971|69530446|FG001|Overall Study|Withdrawal by Subject|0|||
37846134|NCT01335971|69530447|FG002|Overall Study|Withdrawal by Subject|0|||
37846135|NCT01335971|69530445|FG000|Overall Study|Did not complete bronchoscopy|1|||
37846136|NCT01335971|69530446|FG001|Overall Study|Did not complete bronchoscopy|1|||
37846137|NCT01335971|69530447|FG002|Overall Study|Did not complete bronchoscopy|1|||
37846138|NCT00107276|69530455|FG000|Overall Study|Progression|46|||
37846139|NCT00107276|69530455|FG000|Overall Study|Adverse Event|6|||
38026187|NCT03039790|69710965|FG005|Overall Study|Withdrawal of Consent|0|||
38026188|NCT03039790|69710966|FG006|Overall Study|Withdrawal of Consent|0|||
38026189|NCT03039790|69710967|FG007|Overall Study|Withdrawal of Consent|0|||
38026190|NCT03039790|69710968|FG008|Overall Study|Withdrawal of Consent|0|||
38026191|NCT03039790|69710969|FG009|Overall Study|Withdrawal of Consent|1|||
38026192|NCT03039790|69710970|FG010|Overall Study|Withdrawal of Consent|0|||
37734625|NCT01515189|69214970|FG001|First Re-Induction Phase|Disease progression|14|||
37734626|NCT01515189|69214969|FG000|First Re-Induction Phase|Study drug toxicity|5|||
37734627|NCT01515189|69214970|FG001|First Re-Induction Phase|Study drug toxicity|0|||
38026193|NCT03039790|69710971|FG011|Overall Study|Withdrawal of Consent|0|||
38026194|NCT03039790|69710972|FG012|Overall Study|Withdrawal of Consent|2|||
38026195|NCT03039790|69710973|FG013|Overall Study|Withdrawal of Consent|0|||
38026196|NCT03039790|69710974|FG014|Overall Study|Withdrawal of Consent|1|||
38026197|NCT03039790|69710975|FG015|Overall Study|Withdrawal of Consent|5|||
38026198|NCT03039790|69710976|FG016|Overall Study|Withdrawal of Consent|3|||
38026199|NCT03039790|69710977|FG017|Overall Study|Withdrawal of Consent|0|||
38026200|NCT03039790|69710978|FG018|Overall Study|Withdrawal of Consent|2|||
38026201|NCT03039790|69710979|FG019|Overall Study|Withdrawal of Consent|5|||
38026202|NCT03039790|69710960|FG000|Overall Study|Death|0|||
38026203|NCT03039790|69710961|FG001|Overall Study|Death|0|||
38026204|NCT03039790|69710962|FG002|Overall Study|Death|0|||
38026205|NCT03039790|69710963|FG003|Overall Study|Death|0|||
37734628|NCT01515189|69214969|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
37734629|NCT01515189|69214970|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
37734630|NCT01515189|69214969|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
37734631|NCT01515189|69214970|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
37734632|NCT01515189|69214969|FG000|First Re-Induction Phase|Other|1|||
37734633|NCT01515189|69214970|FG001|First Re-Induction Phase|Other|0|||
37734634|NCT01546623|69214978|FG000|Overall Study|Adverse Event|2|||
37734635|NCT01546623|69214979|FG001|Overall Study|Adverse Event|3|||
37734636|NCT01546623|69214978|FG000|Overall Study|Major Protocol Deviation|1|||
37734637|NCT01546623|69214979|FG001|Overall Study|Major Protocol Deviation|1|||
37734638|NCT01546623|69214978|FG000|Overall Study|High Prostate specific antigen|2|||
37734639|NCT01546623|69214979|FG001|Overall Study|High Prostate specific antigen|1|||
37734640|NCT01546623|69214978|FG000|Overall Study|Did Not Receive Study Drug|1|||
37734641|NCT01546623|69214979|FG001|Overall Study|Did Not Receive Study Drug|1|||
37734642|NCT01546155|69214985|FG000|Overall Study|could not tolerate long scan duration|3|||
37734643|NCT00636610|69214991|FG000|Overall Study|Adverse Event|4|||
37846140|NCT00107276|69530455|FG000|Overall Study|M.D. decision|2|||
37846141|NCT00107276|69530455|FG000|Overall Study|Patient refusal|1|||
37846142|NCT00107276|69530455|FG000|Overall Study|Death|1|||
37846143|NCT00107276|69530455|FG000|Overall Study|Ineligible|16|||
38026206|NCT03039790|69710964|FG004|Overall Study|Death|0|||
38026207|NCT03039790|69710965|FG005|Overall Study|Death|0|||
38026208|NCT03039790|69710966|FG006|Overall Study|Death|0|||
37734644|NCT00636610|69214992|FG001|Overall Study|Adverse Event|4|||
37846144|NCT01335698|69530465|FG000|Treatment Stage 1|Lack of Efficacy|3|||
37846145|NCT01335698|69530466|FG001|Treatment Stage 1|Lack of Efficacy|1|||
37846146|NCT01335698|69530467|FG002|Treatment Stage 1|Lack of Efficacy|3|||
38026209|NCT03039790|69710967|FG007|Overall Study|Death|0|||
38026210|NCT03039790|69710968|FG008|Overall Study|Death|0|||
38026211|NCT03039790|69710969|FG009|Overall Study|Death|0|||
37734645|NCT00636610|69214991|FG000|Overall Study|Death|6|||
37734646|NCT00636610|69214992|FG001|Overall Study|Death|3|||
37846147|NCT01335698|69530468|FG003|Treatment Stage 1|Lack of Efficacy|3|||
37846148|NCT01335698|69530469|FG004|Treatment Stage 1|Lack of Efficacy|1|||
37846149|NCT01335698|69530465|FG000|Treatment Stage 1|Adverse Event|1|||
37846150|NCT01335698|69530466|FG001|Treatment Stage 1|Adverse Event|2|||
37846151|NCT01335698|69530467|FG002|Treatment Stage 1|Adverse Event|2|||
37846152|NCT01335698|69530468|FG003|Treatment Stage 1|Adverse Event|1|||
37846153|NCT01335698|69530469|FG004|Treatment Stage 1|Adverse Event|1|||
37846154|NCT01335698|69530465|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
37846155|NCT01335698|69530466|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
38026212|NCT03039790|69710970|FG010|Overall Study|Death|0|||
38026213|NCT03039790|69710971|FG011|Overall Study|Death|0|||
38026214|NCT03039790|69710972|FG012|Overall Study|Death|0|||
38026215|NCT03039790|69710973|FG013|Overall Study|Death|0|||
38026216|NCT03039790|69710974|FG014|Overall Study|Death|0|||
38026217|NCT03039790|69710975|FG015|Overall Study|Death|1|||
38026218|NCT03039790|69710976|FG016|Overall Study|Death|3|||
38026219|NCT03039790|69710977|FG017|Overall Study|Death|0|||
38026220|NCT03039790|69710978|FG018|Overall Study|Death|2|||
38026221|NCT03039790|69710979|FG019|Overall Study|Death|0|||
38026222|NCT03039790|69710960|FG000|Overall Study|Reason, not Specified|1|||
37846156|NCT01335698|69530467|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
37846157|NCT01335698|69530468|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
37846158|NCT01335698|69530469|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
38026223|NCT03039790|69710961|FG001|Overall Study|Reason, not Specified|0|||
38026224|NCT03039790|69710962|FG002|Overall Study|Reason, not Specified|0|||
38026225|NCT03039790|69710963|FG003|Overall Study|Reason, not Specified|0|||
38026226|NCT03039790|69710964|FG004|Overall Study|Reason, not Specified|0|||
38026227|NCT03039790|69710965|FG005|Overall Study|Reason, not Specified|0|||
38026228|NCT03039790|69710966|FG006|Overall Study|Reason, not Specified|0|||
38026229|NCT03039790|69710967|FG007|Overall Study|Reason, not Specified|0|||
38026230|NCT03039790|69710968|FG008|Overall Study|Reason, not Specified|0|||
38026231|NCT03039790|69710969|FG009|Overall Study|Reason, not Specified|0|||
38026232|NCT03039790|69710970|FG010|Overall Study|Reason, not Specified|0|||
38026233|NCT03039790|69710971|FG011|Overall Study|Reason, not Specified|0|||
38026234|NCT03039790|69710972|FG012|Overall Study|Reason, not Specified|0|||
38026235|NCT03039790|69710973|FG013|Overall Study|Reason, not Specified|0|||
38026236|NCT03039790|69710974|FG014|Overall Study|Reason, not Specified|0|||
38026237|NCT03039790|69710975|FG015|Overall Study|Reason, not Specified|0|||
38026238|NCT03039790|69710976|FG016|Overall Study|Reason, not Specified|2|||
38026239|NCT03039790|69710977|FG017|Overall Study|Reason, not Specified|0|||
37734647|NCT00636610|69214991|FG000|Overall Study|Physician decision to withdraw patient|15|||
37734648|NCT00636610|69214992|FG001|Overall Study|Physician decision to withdraw patient|9|||
37846159|NCT01335698|69530465|FG000|Treatment Stage 1|Lost to Follow-up|1|||
37846160|NCT01335698|69530466|FG001|Treatment Stage 1|Lost to Follow-up|1|||
37846161|NCT01335698|69530467|FG002|Treatment Stage 1|Lost to Follow-up|0|||
37846162|NCT01335698|69530468|FG003|Treatment Stage 1|Lost to Follow-up|0|||
37846163|NCT01335698|69530469|FG004|Treatment Stage 1|Lost to Follow-up|0|||
37846164|NCT01335698|69530465|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
37916760|NCT00696436|69603609|FG004|Overall Study|Lack of Efficacy|4|||
37916761|NCT00696436|69603605|FG000|Overall Study|Participant Unavailability|2|||
37916762|NCT00696436|69603606|FG001|Overall Study|Participant Unavailability|0|||
37916763|NCT00696436|69603607|FG002|Overall Study|Participant Unavailability|2|||
37916764|NCT00696436|69603608|FG003|Overall Study|Participant Unavailability|1|||
37846165|NCT01335698|69530466|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
37846166|NCT01335698|69530467|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
37846167|NCT01335698|69530468|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
37846168|NCT01335698|69530469|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
37846169|NCT01335698|69530465|FG000|Treatment Stage 1|No longer meets study criteria|1|||
37846170|NCT01335698|69530466|FG001|Treatment Stage 1|No longer meets study criteria|1|||
37846171|NCT01335698|69530467|FG002|Treatment Stage 1|No longer meets study criteria|0|||
37846172|NCT01335698|69530468|FG003|Treatment Stage 1|No longer meets study criteria|1|||
37916765|NCT00696436|69603609|FG004|Overall Study|Participant Unavailability|0|||
37916766|NCT00696436|69603605|FG000|Overall Study|Administrative Error|2|||
37916767|NCT00696436|69603606|FG001|Overall Study|Administrative Error|0|||
38026240|NCT03039790|69710978|FG018|Overall Study|Reason, not Specified|1|||
38026241|NCT03039790|69710979|FG019|Overall Study|Reason, not Specified|0|||
38026242|NCT03038620|69711052|FG000|Overall Study|Lost to Follow-up|18|||
38026243|NCT03038620|69711053|FG001|Overall Study|Lost to Follow-up|23|||
38026244|NCT03038620|69711052|FG000|Overall Study|Withdrawal by Subject|0|||
38026245|NCT03038620|69711053|FG001|Overall Study|Withdrawal by Subject|15|||
38026246|NCT03038620|69711052|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
38026247|NCT03038620|69711053|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
38026248|NCT01350934|69711074|FG000|Base Study|Adverse Event|6|||
38026249|NCT01350934|69711075|FG001|Base Study|Adverse Event|0|||
38026250|NCT01350934|69711074|FG000|Base Study|Lost to Follow-up|1|||
38026251|NCT01350934|69711075|FG001|Base Study|Lost to Follow-up|0|||
38026252|NCT01350934|69711074|FG000|Base Study|Protocol Violation|1|||
38026253|NCT01350934|69711075|FG001|Base Study|Protocol Violation|1|||
38026254|NCT01350934|69711074|FG000|Base Study|Withdrawal by Subject|1|||
38026255|NCT01350934|69711075|FG001|Base Study|Withdrawal by Subject|2|||
37846173|NCT01335698|69530469|FG004|Treatment Stage 1|No longer meets study criteria|0|||
37846174|NCT01335698|69530465|FG000|Treatment Stage 1|Other|1|||
37846175|NCT01335698|69530466|FG001|Treatment Stage 1|Other|0|||
37846176|NCT01335698|69530467|FG002|Treatment Stage 1|Other|0|||
37846177|NCT01335698|69530468|FG003|Treatment Stage 1|Other|1|||
37846178|NCT01335698|69530469|FG004|Treatment Stage 1|Other|0|||
37846179|NCT01335698|69530465|FG000|Treatment Stage 2|Lack of Efficacy|2|||
37846180|NCT01335698|69530466|FG001|Treatment Stage 2|Lack of Efficacy|1|||
37846181|NCT01335698|69530467|FG002|Treatment Stage 2|Lack of Efficacy|3|||
37846182|NCT01335698|69530468|FG003|Treatment Stage 2|Lack of Efficacy|1|||
37846183|NCT01335698|69530469|FG004|Treatment Stage 2|Lack of Efficacy|0|||
37846184|NCT01335698|69530465|FG000|Treatment Stage 2|Adverse Event|2|||
37846185|NCT01335698|69530466|FG001|Treatment Stage 2|Adverse Event|0|||
37846186|NCT01335698|69530467|FG002|Treatment Stage 2|Adverse Event|0|||
37846187|NCT01335698|69530468|FG003|Treatment Stage 2|Adverse Event|3|||
37846188|NCT01335698|69530469|FG004|Treatment Stage 2|Adverse Event|0|||
37846189|NCT01335698|69530465|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
37846190|NCT01335698|69530466|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
37846191|NCT01335698|69530467|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
37916768|NCT00696436|69603607|FG002|Overall Study|Administrative Error|2|||
37916769|NCT00696436|69603608|FG003|Overall Study|Administrative Error|0|||
37916770|NCT00696436|69603609|FG004|Overall Study|Administrative Error|0|||
37916771|NCT00696436|69603605|FG000|Overall Study|Participant Non-compliance|0|||
37916772|NCT00696436|69603606|FG001|Overall Study|Participant Non-compliance|0|||
37916773|NCT00696436|69603607|FG002|Overall Study|Participant Non-compliance|1|||
37916774|NCT00696436|69603608|FG003|Overall Study|Participant Non-compliance|2|||
37916775|NCT00696436|69603609|FG004|Overall Study|Participant Non-compliance|0|||
37916776|NCT00696436|69603605|FG000|Overall Study|Administrative Decision|1|||
37916777|NCT00696436|69603606|FG001|Overall Study|Administrative Decision|0|||
37916778|NCT00696436|69603607|FG002|Overall Study|Administrative Decision|0|||
37916779|NCT00696436|69603608|FG003|Overall Study|Administrative Decision|0|||
37916780|NCT00696436|69603609|FG004|Overall Study|Administrative Decision|0|||
37916781|NCT00696436|69603605|FG000|Overall Study|Missing|0|||
37916782|NCT00696436|69603606|FG001|Overall Study|Missing|1|||
37916783|NCT00696436|69603607|FG002|Overall Study|Missing|1|||
37916784|NCT00696436|69603608|FG003|Overall Study|Missing|0|||
37916785|NCT00696436|69603609|FG004|Overall Study|Missing|0|||
37916786|NCT00878072|69603621|FG000|Overall Study|Withdrew consent|2|||
37916787|NCT00594854|69603649|FG000|Overall Study|Study terminated|7|||
37916788|NCT00594854|69603650|FG001|Overall Study|Study terminated|10|||
37916789|NCT00855582|69603659|FG000|Overall Study|Adverse Event|2|||
37916790|NCT00855582|69603660|FG001|Overall Study|Adverse Event|6|||
37916791|NCT00855582|69603661|FG002|Overall Study|Adverse Event|3|||
37916792|NCT00855582|69603659|FG000|Overall Study|Death|1|||
37916793|NCT00855582|69603660|FG001|Overall Study|Death|0|||
37916794|NCT00855582|69603661|FG002|Overall Study|Death|0|||
37916795|NCT00855582|69603659|FG000|Overall Study|Lack of Efficacy|1|||
37916796|NCT00855582|69603660|FG001|Overall Study|Lack of Efficacy|3|||
37846192|NCT01335698|69530468|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
37846193|NCT01335698|69530469|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
37846194|NCT01335698|69530465|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
37846195|NCT01335698|69530466|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
37846196|NCT01335698|69530467|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
37846197|NCT01335698|69530468|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
37916797|NCT00855582|69603661|FG002|Overall Study|Lack of Efficacy|8|||
37846198|NCT01335698|69530469|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
37846199|NCT01335698|69530465|FG000|Treatment Stage 2|Lost to Follow-up|1|||
37846200|NCT01335698|69530466|FG001|Treatment Stage 2|Lost to Follow-up|0|||
37846201|NCT01335698|69530467|FG002|Treatment Stage 2|Lost to Follow-up|0|||
37846202|NCT01335698|69530468|FG003|Treatment Stage 2|Lost to Follow-up|0|||
37846203|NCT01335698|69530469|FG004|Treatment Stage 2|Lost to Follow-up|0|||
37916798|NCT00855582|69603659|FG000|Overall Study|Lost to Follow-up|1|||
37916799|NCT00855582|69603660|FG001|Overall Study|Lost to Follow-up|3|||
37846204|NCT01335698|69530465|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
37846205|NCT01335698|69530466|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
37916800|NCT00855582|69603661|FG002|Overall Study|Lost to Follow-up|1|||
37916801|NCT00855582|69603659|FG000|Overall Study|Physician Decision|0|||
37916802|NCT00855582|69603660|FG001|Overall Study|Physician Decision|0|||
37916803|NCT00855582|69603661|FG002|Overall Study|Physician Decision|1|||
38026256|NCT01350934|69711074|FG000|Base Study|Non-Compliance With Study Drug|2|||
38026257|NCT01350934|69711075|FG001|Base Study|Non-Compliance With Study Drug|0|||
37916804|NCT00855582|69603659|FG000|Overall Study|Protocol Violation|6|||
37916805|NCT00855582|69603660|FG001|Overall Study|Protocol Violation|2|||
37846206|NCT01335698|69530467|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
37846207|NCT01335698|69530468|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
37846208|NCT01335698|69530469|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
37846209|NCT01335698|69530465|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
37846210|NCT01335698|69530466|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
37846211|NCT01335698|69530467|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
37846212|NCT01335698|69530468|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
37846213|NCT01335698|69530469|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
37846214|NCT01335698|69530465|FG000|Treatment Stage 2|Switched to another formulation|1|||
37846215|NCT01335698|69530466|FG001|Treatment Stage 2|Switched to another formulation|1|||
37846216|NCT01335698|69530467|FG002|Treatment Stage 2|Switched to another formulation|0|||
37846217|NCT01335698|69530468|FG003|Treatment Stage 2|Switched to another formulation|0|||
37846218|NCT01335698|69530469|FG004|Treatment Stage 2|Switched to another formulation|0|||
37846219|NCT00107120|69530485|FG000|Overall Study|Adverse Event|4|||
37846220|NCT00107120|69530486|FG001|Overall Study|Adverse Event|1|||
37846221|NCT00107120|69530485|FG000|Overall Study|Lack of Efficacy|5|||
37846222|NCT00107120|69530486|FG001|Overall Study|Lack of Efficacy|5|||
37846223|NCT00107120|69530485|FG000|Overall Study|Protocol Violation|3|||
37846224|NCT00107120|69530486|FG001|Overall Study|Protocol Violation|0|||
37846225|NCT00107120|69530485|FG000|Overall Study|Withdrawal by Subject|8|||
37846226|NCT00107120|69530486|FG001|Overall Study|Withdrawal by Subject|9|||
37846227|NCT00107120|69530485|FG000|Overall Study|Lost to Follow-up|8|||
37846228|NCT00107120|69530486|FG001|Overall Study|Lost to Follow-up|6|||
37846229|NCT00107120|69530485|FG000|Overall Study|Pregnancy|0|||
37846230|NCT00107120|69530486|FG001|Overall Study|Pregnancy|1|||
37846231|NCT00107120|69530485|FG000|Overall Study|moving away from site|1|||
37846232|NCT00107120|69530486|FG001|Overall Study|moving away from site|1|||
37846233|NCT00107120|69530485|FG000|Overall Study|death of parent|0|||
37846234|NCT00107120|69530486|FG001|Overall Study|death of parent|1|||
37846235|NCT01335464|69530494|FG000|Overall Study|Adverse Event|15|||
37846236|NCT01335464|69530495|FG001|Overall Study|Adverse Event|25|||
37846237|NCT01335464|69530494|FG000|Overall Study|Non compliant with protocol|2|||
37846238|NCT01335464|69530495|FG001|Overall Study|Non compliant with protocol|0|||
37846239|NCT01335464|69530494|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
37846240|NCT01335464|69530495|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
37846241|NCT01335464|69530494|FG000|Overall Study|Not treated|2|||
37846242|NCT01335464|69530495|FG001|Overall Study|Not treated|0|||
37846243|NCT01335464|69530494|FG000|Overall Study|Reason other than those stated above|1|||
37846244|NCT01335464|69530495|FG001|Overall Study|Reason other than those stated above|1|||
37846245|NCT00107042|69530503|FG000|Overall Study|Lost to Follow-up|9|||
37846246|NCT00107042|69530504|FG001|Overall Study|Lost to Follow-up|7|||
37846247|NCT00107042|69530503|FG000|Overall Study|Withdrawal by Subject|6|||
37846248|NCT00107042|69530504|FG001|Overall Study|Withdrawal by Subject|1|||
37846249|NCT00107042|69530503|FG000|Overall Study|Moved out of area|5|||
37846250|NCT00107042|69530504|FG001|Overall Study|Moved out of area|3|||
37846251|NCT00107042|69530503|FG000|Overall Study|Pregnancy|1|||
37846252|NCT00107042|69530504|FG001|Overall Study|Pregnancy|1|||
37846253|NCT00107042|69530503|FG000|Overall Study|Inadvertent enrollment|0|||
37846254|NCT00107042|69530504|FG001|Overall Study|Inadvertent enrollment|1|||
37846255|NCT00107042|69530503|FG000|Overall Study|vaccinated outside window|1|||
37734649|NCT00636610|69214991|FG000|Overall Study|Subject decision to withdraw|15|||
37734650|NCT00636610|69214992|FG001|Overall Study|Subject decision to withdraw|11|||
37734651|NCT00636610|69214991|FG000|Overall Study|Disease progression - radiographic|41|||
37734652|NCT00636610|69214992|FG001|Overall Study|Disease progression - radiographic|51|||
37734653|NCT00636610|69214991|FG000|Overall Study|Disease progression - clinical|8|||
37734654|NCT00636610|69214992|FG001|Overall Study|Disease progression - clinical|3|||
37734655|NCT00636610|69214991|FG000|Overall Study|Reason for discontinuation not available|3|||
37734656|NCT00636610|69214992|FG001|Overall Study|Reason for discontinuation not available|2|||
37734657|NCT00635050|69215000|FG000|Overall Study|Withdrawal by Subject|1|||
37734658|NCT00634504|69215009|FG000|Overall Study|Protocol Violation|1|||
37734659|NCT00634504|69215010|FG001|Overall Study|Protocol Violation|0|||
37734660|NCT00634114|69215019|FG000|Overall Study|Adverse Event|6|||
37846256|NCT00107042|69530504|FG001|Overall Study|vaccinated outside window|1|||
37846257|NCT00107042|69530503|FG000|Overall Study|Disallowed medications|0|||
37846258|NCT00107042|69530504|FG001|Overall Study|Disallowed medications|2|||
37846259|NCT00106964|69530555|FG000|Overall Study|Lost to Follow-up|8|||
37846260|NCT00106964|69530556|FG001|Overall Study|Lost to Follow-up|6|||
37846261|NCT00106964|69530557|FG002|Overall Study|Lost to Follow-up|2|||
37846262|NCT00106964|69530555|FG000|Overall Study|Pregnancy|2|||
37846263|NCT00106964|69530556|FG001|Overall Study|Pregnancy|3|||
37846264|NCT00106964|69530557|FG002|Overall Study|Pregnancy|2|||
37846265|NCT00106964|69530555|FG000|Overall Study|Death|1|||
37846266|NCT00106964|69530556|FG001|Overall Study|Death|1|||
37734661|NCT00634114|69215020|FG001|Overall Study|Adverse Event|8|||
37734662|NCT00634114|69215021|FG002|Overall Study|Adverse Event|3|||
37734663|NCT00634114|69215019|FG000|Overall Study|Withdrawal by Subject|9|||
37846267|NCT00106964|69530557|FG002|Overall Study|Death|0|||
37846268|NCT00106964|69530555|FG000|Overall Study|Incarceration|0|||
37846269|NCT00106964|69530556|FG001|Overall Study|Incarceration|1|||
37846270|NCT00106964|69530557|FG002|Overall Study|Incarceration|0|||
37846271|NCT00106964|69530555|FG000|Overall Study|Site Funding Terminated|0|||
37846272|NCT00106964|69530556|FG001|Overall Study|Site Funding Terminated|1|||
37846273|NCT00106964|69530557|FG002|Overall Study|Site Funding Terminated|1|||
37846274|NCT00106964|69530555|FG000|Overall Study|Failure to adhere|2|||
37846275|NCT00106964|69530556|FG001|Overall Study|Failure to adhere|0|||
37846276|NCT00106964|69530557|FG002|Overall Study|Failure to adhere|0|||
37846277|NCT00106964|69530555|FG000|Overall Study|Did not meet eligibility criteria|0|||
37846278|NCT00106964|69530556|FG001|Overall Study|Did not meet eligibility criteria|2|||
37846279|NCT00106964|69530557|FG002|Overall Study|Did not meet eligibility criteria|2|||
37846280|NCT00106964|69530555|FG000|Overall Study|Required disallowed medication|0|||
37846281|NCT00106964|69530556|FG001|Overall Study|Required disallowed medication|1|||
37846282|NCT00106964|69530557|FG002|Overall Study|Required disallowed medication|0|||
37846283|NCT00106184|69530576|FG000|Overall Study|Withdrawal by Subject|3|||
37846284|NCT00106184|69530577|FG001|Overall Study|Withdrawal by Subject|2|||
37846285|NCT01334918|69530587|FG000|Overall Study|Did not receive study drug|6|||
37846286|NCT01334918|69530588|FG001|Overall Study|Did not receive study drug|0|||
37846287|NCT01334918|69530587|FG000|Overall Study|Adverse Event|2|||
37846288|NCT01334918|69530588|FG001|Overall Study|Adverse Event|0|||
37846289|NCT01334918|69530587|FG000|Overall Study|Withdrawal by Subject|0|||
37846290|NCT01334918|69530588|FG001|Overall Study|Withdrawal by Subject|1|||
37846291|NCT01332968|69530607|FG000|Induction Period|Adverse Event|23|||
37846292|NCT01332968|69530608|FG001|Induction Period|Adverse Event|26|||
37846293|NCT01332968|69530609|FG002|Induction Period|Adverse Event|0|||
37846294|NCT01332968|69530610|FG003|Induction Period|Adverse Event|0|||
37846295|NCT01332968|69530611|FG004|Induction Period|Adverse Event|0|||
37846296|NCT01332968|69530612|FG005|Induction Period|Adverse Event|0|||
37846297|NCT01332968|69530613|FG006|Induction Period|Adverse Event|0|||
37846298|NCT01332968|69530614|FG007|Induction Period|Adverse Event|0|||
37846299|NCT01332968|69530607|FG000|Induction Period|Death|1|||
37846300|NCT01332968|69530608|FG001|Induction Period|Death|4|||
38026258|NCT01350934|69711074|FG000|Extension Study|Adverse Event|2|||
38026259|NCT01350934|69711075|FG001|Extension Study|Adverse Event|1|||
38026260|NCT01350934|69711074|FG000|Extension Study|Lost to Follow-up|2|||
38026261|NCT01350934|69711075|FG001|Extension Study|Lost to Follow-up|0|||
38026262|NCT01350934|69711074|FG000|Extension Study|Protocol Violation|1|||
38026263|NCT01350934|69711075|FG001|Extension Study|Protocol Violation|1|||
38026264|NCT01350934|69711074|FG000|Extension Study|Lack of Efficacy|0|||
38026265|NCT01350934|69711075|FG001|Extension Study|Lack of Efficacy|1|||
38026266|NCT01350934|69711074|FG000|Extension Study|Withdrawal by Subject|0|||
38026267|NCT01350934|69711075|FG001|Extension Study|Withdrawal by Subject|1|||
37846301|NCT01332968|69530609|FG002|Induction Period|Death|0|||
37846302|NCT01332968|69530610|FG003|Induction Period|Death|0|||
37846303|NCT01332968|69530611|FG004|Induction Period|Death|0|||
37846304|NCT01332968|69530612|FG005|Induction Period|Death|0|||
37846305|NCT01332968|69530613|FG006|Induction Period|Death|0|||
37846306|NCT01332968|69530614|FG007|Induction Period|Death|0|||
37846307|NCT01332968|69530607|FG000|Induction Period|Non-compliance|1|||
37846308|NCT01332968|69530608|FG001|Induction Period|Non-compliance|0|||
37846309|NCT01332968|69530609|FG002|Induction Period|Non-compliance|0|||
37846310|NCT01332968|69530610|FG003|Induction Period|Non-compliance|0|||
37846311|NCT01332968|69530611|FG004|Induction Period|Non-compliance|0|||
37846312|NCT01332968|69530612|FG005|Induction Period|Non-compliance|0|||
37846313|NCT01332968|69530613|FG006|Induction Period|Non-compliance|0|||
37846314|NCT01332968|69530614|FG007|Induction Period|Non-compliance|0|||
37916806|NCT00855582|69603661|FG002|Overall Study|Protocol Violation|6|||
37916807|NCT00855582|69603659|FG000|Overall Study|Entry Criteria Not Met|8|||
37916808|NCT00855582|69603660|FG001|Overall Study|Entry Criteria Not Met|6|||
37916809|NCT00855582|69603661|FG002|Overall Study|Entry Criteria Not Met|3|||
37916810|NCT00855582|69603659|FG000|Overall Study|Withdrawal by Subject|7|||
37916811|NCT00855582|69603660|FG001|Overall Study|Withdrawal by Subject|4|||
37916812|NCT00855582|69603661|FG002|Overall Study|Withdrawal by Subject|8|||
38026268|NCT03622580|69711099|FG000|Overall Study|Death|16|||
37846315|NCT01332968|69530607|FG000|Induction Period|Other|2|||
37846316|NCT01332968|69530608|FG001|Induction Period|Other|2|||
37846317|NCT01332968|69530609|FG002|Induction Period|Other|0|||
37846318|NCT01332968|69530610|FG003|Induction Period|Other|0|||
37846319|NCT01332968|69530611|FG004|Induction Period|Other|0|||
37846320|NCT01332968|69530612|FG005|Induction Period|Other|0|||
37846321|NCT01332968|69530613|FG006|Induction Period|Other|0|||
37846322|NCT01332968|69530614|FG007|Induction Period|Other|0|||
37846323|NCT01332968|69530607|FG000|Induction Period|Physician Decision|6|||
37846324|NCT01332968|69530608|FG001|Induction Period|Physician Decision|1|||
37916813|NCT00854724|69603674|FG000|First Intervention|Withdrawal by Subject|1|||
37916814|NCT00854724|69603675|FG001|First Intervention|Withdrawal by Subject|1|||
37916815|NCT00854724|69603674|FG000|Washout|Protocol Violation|1|||
37846325|NCT01332968|69530609|FG002|Induction Period|Physician Decision|0|||
37846326|NCT01332968|69530610|FG003|Induction Period|Physician Decision|0|||
37846327|NCT01332968|69530611|FG004|Induction Period|Physician Decision|0|||
37846328|NCT01332968|69530612|FG005|Induction Period|Physician Decision|0|||
37846329|NCT01332968|69530613|FG006|Induction Period|Physician Decision|0|||
37846330|NCT01332968|69530614|FG007|Induction Period|Physician Decision|0|||
37846331|NCT01332968|69530607|FG000|Induction Period|Progressive Disease|15|||
37846332|NCT01332968|69530608|FG001|Induction Period|Progressive Disease|7|||
37846333|NCT01332968|69530609|FG002|Induction Period|Progressive Disease|0|||
37846334|NCT01332968|69530610|FG003|Induction Period|Progressive Disease|0|||
37846335|NCT01332968|69530611|FG004|Induction Period|Progressive Disease|0|||
37846336|NCT01332968|69530612|FG005|Induction Period|Progressive Disease|0|||
37846337|NCT01332968|69530613|FG006|Induction Period|Progressive Disease|0|||
37846338|NCT01332968|69530614|FG007|Induction Period|Progressive Disease|0|||
37846339|NCT01332968|69530607|FG000|Induction Period|Protocol Violation|3|||
37846340|NCT01332968|69530608|FG001|Induction Period|Protocol Violation|4|||
37846341|NCT01332968|69530609|FG002|Induction Period|Protocol Violation|0|||
37846342|NCT01332968|69530610|FG003|Induction Period|Protocol Violation|0|||
37734664|NCT00634114|69215020|FG001|Overall Study|Withdrawal by Subject|6|||
37734665|NCT00634114|69215021|FG002|Overall Study|Withdrawal by Subject|11|||
37734666|NCT00634114|69215019|FG000|Overall Study|Lost to Follow-up|0|||
37846343|NCT01332968|69530611|FG004|Induction Period|Protocol Violation|0|||
37846344|NCT01332968|69530612|FG005|Induction Period|Protocol Violation|0|||
37846345|NCT01332968|69530613|FG006|Induction Period|Protocol Violation|0|||
37846346|NCT01332968|69530614|FG007|Induction Period|Protocol Violation|0|||
37846347|NCT01332968|69530607|FG000|Induction Period|Withdrawal by Subject|3|||
37846348|NCT01332968|69530608|FG001|Induction Period|Withdrawal by Subject|5|||
37846349|NCT01332968|69530609|FG002|Induction Period|Withdrawal by Subject|0|||
37846350|NCT01332968|69530610|FG003|Induction Period|Withdrawal by Subject|0|||
37846351|NCT01332968|69530611|FG004|Induction Period|Withdrawal by Subject|0|||
37846352|NCT01332968|69530612|FG005|Induction Period|Withdrawal by Subject|0|||
37846353|NCT01332968|69530613|FG006|Induction Period|Withdrawal by Subject|0|||
37846354|NCT01332968|69530614|FG007|Induction Period|Withdrawal by Subject|0|||
37916816|NCT00854724|69603675|FG001|Washout|Protocol Violation|0|||
37916817|NCT00854724|69603674|FG000|Washout|Withdrawal by Subject|0|||
37916818|NCT00854724|69603675|FG001|Washout|Withdrawal by Subject|1|||
37916819|NCT00854724|69603674|FG000|Second Intervention|Protocol Violation|1|||
37916820|NCT00854724|69603675|FG001|Second Intervention|Protocol Violation|0|||
37916821|NCT00854724|69603674|FG000|Second Intervention|Physician Decision|0|||
38026269|NCT03622580|69711100|FG001|Overall Study|Death|21|||
37916822|NCT00854724|69603675|FG001|Second Intervention|Physician Decision|1|||
37916823|NCT00698932|69603713|FG000|Overall Study|Adverse Event|0|||
37916824|NCT00698932|69603714|FG001|Overall Study|Adverse Event|2|||
37916825|NCT00698932|69603713|FG000|Overall Study|Incorrect enrollment|0|||
37916826|NCT00698932|69603714|FG001|Overall Study|Incorrect enrollment|2|||
37916827|NCT00698932|69603713|FG000|Overall Study|Study specific discontinuation criteria|3|||
37916828|NCT00698932|69603714|FG001|Overall Study|Study specific discontinuation criteria|4|||
37916829|NCT00698932|69603713|FG000|Overall Study|Withdrawal by Subject|11|||
37916830|NCT00698932|69603714|FG001|Overall Study|Withdrawal by Subject|23|||
37916831|NCT00698932|69603713|FG000|Overall Study|Lost to Follow-up|6|||
37916832|NCT00698932|69603714|FG001|Overall Study|Lost to Follow-up|1|||
37916833|NCT00698932|69603713|FG000|Overall Study|Severe non-compliance to protocol|1|||
37916834|NCT00698932|69603714|FG001|Overall Study|Severe non-compliance to protocol|2|||
37916835|NCT00698932|69603713|FG000|Overall Study|Safety reasons|0|||
37916836|NCT00698932|69603714|FG001|Overall Study|Safety reasons|2|||
37916837|NCT00698932|69603713|FG000|Overall Study|Death|1|||
37916838|NCT00698932|69603714|FG001|Overall Study|Death|0|||
38026270|NCT03622580|69711101|FG002|Overall Study|Death|13|||
38026271|NCT03622580|69711099|FG000|Overall Study|Adverse Event|6|||
38026272|NCT03622580|69711100|FG001|Overall Study|Adverse Event|6|||
38026273|NCT03622580|69711101|FG002|Overall Study|Adverse Event|5|||
38026274|NCT03622580|69711099|FG000|Overall Study|Withdrawal by Subject|12|||
38026275|NCT03622580|69711100|FG001|Overall Study|Withdrawal by Subject|7|||
38026276|NCT03622580|69711101|FG002|Overall Study|Withdrawal by Subject|19|||
38026277|NCT03622580|69711099|FG000|Overall Study|Lost to Follow-up|12|||
38026278|NCT03622580|69711100|FG001|Overall Study|Lost to Follow-up|9|||
38026279|NCT03622580|69711101|FG002|Overall Study|Lost to Follow-up|9|||
38026280|NCT03622580|69711099|FG000|Overall Study|Protocol Violation|1|||
37734667|NCT00634114|69215020|FG001|Overall Study|Lost to Follow-up|0|||
37846355|NCT01332968|69530607|FG000|Induction Period|Randomised but not treated|4|||
37846356|NCT01332968|69530608|FG001|Induction Period|Randomised but not treated|7|||
37846357|NCT01332968|69530609|FG002|Induction Period|Randomised but not treated|0|||
37846358|NCT01332968|69530610|FG003|Induction Period|Randomised but not treated|0|||
37846359|NCT01332968|69530611|FG004|Induction Period|Randomised but not treated|0|||
38026281|NCT03622580|69711100|FG001|Overall Study|Protocol Violation|0|||
38026282|NCT03622580|69711101|FG002|Overall Study|Protocol Violation|1|||
38026283|NCT03622580|69711099|FG000|Overall Study|Physician Decision|3|||
38026284|NCT03622580|69711100|FG001|Overall Study|Physician Decision|0|||
38026285|NCT03622580|69711101|FG002|Overall Study|Physician Decision|1|||
38026286|NCT03622580|69711099|FG000|Overall Study|Pregnancy|0|||
38026287|NCT03622580|69711100|FG001|Overall Study|Pregnancy|1|||
38026288|NCT03622580|69711101|FG002|Overall Study|Pregnancy|0|||
38026289|NCT03622580|69711099|FG000|Overall Study|Lack of Efficacy|0|||
38026290|NCT03622580|69711100|FG001|Overall Study|Lack of Efficacy|0|||
38026291|NCT03622580|69711101|FG002|Overall Study|Lack of Efficacy|1|||
38026292|NCT03622580|69711099|FG000|Overall Study|Other|2|||
38026293|NCT03622580|69711100|FG001|Overall Study|Other|0|||
37846360|NCT01332968|69530612|FG005|Induction Period|Randomised but not treated|0|||
37846361|NCT01332968|69530613|FG006|Induction Period|Randomised but not treated|0|||
37846362|NCT01332968|69530614|FG007|Induction Period|Randomised but not treated|0|||
37846363|NCT01332968|69530607|FG000|Maintenance/Observation Period|Adverse Event|0|||
37846364|NCT01332968|69530608|FG001|Maintenance/Observation Period|Adverse Event|0|||
37846365|NCT01332968|69530609|FG002|Maintenance/Observation Period|Adverse Event|53|||
37846366|NCT01332968|69530610|FG003|Maintenance/Observation Period|Adverse Event|66|||
37846367|NCT01332968|69530611|FG004|Maintenance/Observation Period|Adverse Event|0|||
37846368|NCT01332968|69530612|FG005|Maintenance/Observation Period|Adverse Event|0|||
37846369|NCT01332968|69530613|FG006|Maintenance/Observation Period|Adverse Event|0|||
37846370|NCT01332968|69530614|FG007|Maintenance/Observation Period|Adverse Event|0|||
37846371|NCT01332968|69530607|FG000|Maintenance/Observation Period|Death|0|||
37846372|NCT01332968|69530608|FG001|Maintenance/Observation Period|Death|0|||
37846373|NCT01332968|69530609|FG002|Maintenance/Observation Period|Death|5|||
37846374|NCT01332968|69530610|FG003|Maintenance/Observation Period|Death|6|||
37846375|NCT01332968|69530611|FG004|Maintenance/Observation Period|Death|0|||
37846376|NCT01332968|69530612|FG005|Maintenance/Observation Period|Death|0|||
37846377|NCT01332968|69530613|FG006|Maintenance/Observation Period|Death|0|||
37846378|NCT01332968|69530614|FG007|Maintenance/Observation Period|Death|0|||
37846379|NCT01332968|69530607|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
37846380|NCT01332968|69530608|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
37846381|NCT01332968|69530609|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
37846382|NCT01332968|69530610|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
37846383|NCT01332968|69530611|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
37846384|NCT01332968|69530612|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
37846385|NCT01332968|69530613|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
37846386|NCT01332968|69530614|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
37846387|NCT01332968|69530607|FG000|Maintenance/Observation Period|Non-compliance|0|||
37846388|NCT01332968|69530608|FG001|Maintenance/Observation Period|Non-compliance|0|||
37846389|NCT01332968|69530609|FG002|Maintenance/Observation Period|Non-compliance|4|||
37846390|NCT01332968|69530610|FG003|Maintenance/Observation Period|Non-compliance|3|||
37846391|NCT01332968|69530611|FG004|Maintenance/Observation Period|Non-compliance|0|||
37846392|NCT01332968|69530612|FG005|Maintenance/Observation Period|Non-compliance|0|||
37846393|NCT01332968|69530613|FG006|Maintenance/Observation Period|Non-compliance|0|||
37846394|NCT01332968|69530614|FG007|Maintenance/Observation Period|Non-compliance|0|||
37846395|NCT01332968|69530607|FG000|Maintenance/Observation Period|Other|0|||
37846396|NCT01332968|69530608|FG001|Maintenance/Observation Period|Other|0|||
37846397|NCT01332968|69530609|FG002|Maintenance/Observation Period|Other|4|||
38026294|NCT03622580|69711101|FG002|Overall Study|Other|3|||
38026295|NCT00461032|69711112|FG000|Overall Study|Adverse Event|5|||
38026296|NCT00461032|69711113|FG001|Overall Study|Adverse Event|6|||
38026297|NCT00461032|69711112|FG000|Overall Study|Lack of Efficacy|5|||
38026298|NCT00461032|69711113|FG001|Overall Study|Lack of Efficacy|1|||
38026299|NCT00461032|69711112|FG000|Overall Study|Lost to Follow-up|7|||
37916839|NCT00823719|69603722|FG000|Overall Study|Adverse Event|1|||
37916840|NCT00823719|69603723|FG001|Overall Study|Adverse Event|2|||
37916841|NCT00823719|69603722|FG000|Overall Study|Physician Decision|1|||
37916842|NCT00823719|69603723|FG001|Overall Study|Physician Decision|4|||
37916843|NCT00823719|69603722|FG000|Overall Study|Withdrawal by Subject|0|||
37916844|NCT00823719|69603723|FG001|Overall Study|Withdrawal by Subject|1|||
37846398|NCT01332968|69530610|FG003|Maintenance/Observation Period|Other|7|||
37846399|NCT01332968|69530611|FG004|Maintenance/Observation Period|Other|0|||
37846400|NCT01332968|69530612|FG005|Maintenance/Observation Period|Other|0|||
37846401|NCT01332968|69530613|FG006|Maintenance/Observation Period|Other|0|||
37916845|NCT00823719|69603722|FG000|Overall Study|Disease Progression|4|||
37916846|NCT00823719|69603723|FG001|Overall Study|Disease Progression|4|||
37916847|NCT00875420|69603736|FG000|Overall Study|Adverse Event|0|||
37916848|NCT00875420|69603737|FG001|Overall Study|Adverse Event|1|||
37916849|NCT00875420|69603738|FG002|Overall Study|Adverse Event|1|||
37916850|NCT00875420|69603739|FG003|Overall Study|Adverse Event|0|||
37846402|NCT01332968|69530614|FG007|Maintenance/Observation Period|Other|0|||
37846403|NCT01332968|69530607|FG000|Maintenance/Observation Period|Physician Decision|0|||
37916851|NCT00875420|69603740|FG004|Overall Study|Adverse Event|0|||
38026300|NCT00461032|69711113|FG001|Overall Study|Lost to Follow-up|12|||
37846404|NCT01332968|69530608|FG001|Maintenance/Observation Period|Physician Decision|0|||
37846405|NCT01332968|69530609|FG002|Maintenance/Observation Period|Physician Decision|14|||
37846406|NCT01332968|69530610|FG003|Maintenance/Observation Period|Physician Decision|19|||
37846407|NCT01332968|69530611|FG004|Maintenance/Observation Period|Physician Decision|0|||
37846408|NCT01332968|69530612|FG005|Maintenance/Observation Period|Physician Decision|1|||
37846409|NCT01332968|69530613|FG006|Maintenance/Observation Period|Physician Decision|0|||
37846410|NCT01332968|69530614|FG007|Maintenance/Observation Period|Physician Decision|0|||
37846411|NCT01332968|69530607|FG000|Maintenance/Observation Period|Progressive Disease|0|||
37846412|NCT01332968|69530608|FG001|Maintenance/Observation Period|Progressive Disease|0|||
37846413|NCT01332968|69530609|FG002|Maintenance/Observation Period|Progressive Disease|72|||
37846414|NCT01332968|69530610|FG003|Maintenance/Observation Period|Progressive Disease|40|||
37846415|NCT01332968|69530611|FG004|Maintenance/Observation Period|Progressive Disease|0|||
37846416|NCT01332968|69530612|FG005|Maintenance/Observation Period|Progressive Disease|0|||
37846417|NCT01332968|69530613|FG006|Maintenance/Observation Period|Progressive Disease|0|||
37846418|NCT01332968|69530614|FG007|Maintenance/Observation Period|Progressive Disease|0|||
37846419|NCT01332968|69530607|FG000|Maintenance/Observation Period|Protocol Violation|0|||
37846420|NCT01332968|69530608|FG001|Maintenance/Observation Period|Protocol Violation|0|||
37846421|NCT01332968|69530609|FG002|Maintenance/Observation Period|Protocol Violation|1|||
37846422|NCT01332968|69530610|FG003|Maintenance/Observation Period|Protocol Violation|1|||
37846423|NCT01332968|69530611|FG004|Maintenance/Observation Period|Protocol Violation|0|||
37846424|NCT01332968|69530612|FG005|Maintenance/Observation Period|Protocol Violation|0|||
37846425|NCT01332968|69530613|FG006|Maintenance/Observation Period|Protocol Violation|0|||
37846426|NCT01332968|69530614|FG007|Maintenance/Observation Period|Protocol Violation|0|||
37846427|NCT01332968|69530607|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
37846428|NCT01332968|69530608|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
37846429|NCT01332968|69530609|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
37846430|NCT01332968|69530610|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
37846431|NCT01332968|69530611|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
37846432|NCT01332968|69530612|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
37846433|NCT01332968|69530613|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
37846434|NCT01332968|69530614|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
37846435|NCT01332968|69530607|FG000|Follow-Up Period|Adverse Event|0|||
37846436|NCT01332968|69530608|FG001|Follow-Up Period|Adverse Event|0|||
37846437|NCT01332968|69530609|FG002|Follow-Up Period|Adverse Event|0|||
37846438|NCT01332968|69530610|FG003|Follow-Up Period|Adverse Event|0|||
37846439|NCT01332968|69530611|FG004|Follow-Up Period|Adverse Event|0|||
37846440|NCT01332968|69530612|FG005|Follow-Up Period|Adverse Event|0|||
37846441|NCT01332968|69530613|FG006|Follow-Up Period|Adverse Event|0|||
37846442|NCT01332968|69530614|FG007|Follow-Up Period|Adverse Event|4|||
37846443|NCT01332968|69530607|FG000|Follow-Up Period|Death|0|||
37846444|NCT01332968|69530608|FG001|Follow-Up Period|Death|0|||
37846445|NCT01332968|69530609|FG002|Follow-Up Period|Death|0|||
37846446|NCT01332968|69530610|FG003|Follow-Up Period|Death|0|||
37846447|NCT01332968|69530611|FG004|Follow-Up Period|Death|0|||
37846448|NCT01332968|69530612|FG005|Follow-Up Period|Death|0|||
37846449|NCT01332968|69530613|FG006|Follow-Up Period|Death|27|||
37846450|NCT01332968|69530614|FG007|Follow-Up Period|Death|30|||
37846451|NCT01332968|69530607|FG000|Follow-Up Period|Lost to Follow-up|0|||
37846452|NCT01332968|69530608|FG001|Follow-Up Period|Lost to Follow-up|0|||
37846453|NCT01332968|69530609|FG002|Follow-Up Period|Lost to Follow-up|0|||
37846454|NCT01332968|69530610|FG003|Follow-Up Period|Lost to Follow-up|0|||
37846455|NCT01332968|69530611|FG004|Follow-Up Period|Lost to Follow-up|0|||
37846456|NCT01332968|69530612|FG005|Follow-Up Period|Lost to Follow-up|0|||
37846457|NCT01332968|69530613|FG006|Follow-Up Period|Lost to Follow-up|11|||
37846458|NCT01332968|69530614|FG007|Follow-Up Period|Lost to Follow-up|15|||
37846459|NCT01332968|69530607|FG000|Follow-Up Period|Non-compliance|0|||
37846460|NCT01332968|69530608|FG001|Follow-Up Period|Non-compliance|0|||
37846461|NCT01332968|69530609|FG002|Follow-Up Period|Non-compliance|0|||
37846462|NCT01332968|69530610|FG003|Follow-Up Period|Non-compliance|0|||
37846463|NCT01332968|69530611|FG004|Follow-Up Period|Non-compliance|0|||
37846464|NCT01332968|69530612|FG005|Follow-Up Period|Non-compliance|0|||
37916852|NCT00875420|69603736|FG000|Overall Study|Inability to complete study procedures|1|||
37734668|NCT00634114|69215021|FG002|Overall Study|Lost to Follow-up|1|||
37734669|NCT00634114|69215019|FG000|Overall Study|Protocol Violation|3|||
37846465|NCT01332968|69530613|FG006|Follow-Up Period|Non-compliance|4|||
37846466|NCT01332968|69530614|FG007|Follow-Up Period|Non-compliance|9|||
37846467|NCT01332968|69530607|FG000|Follow-Up Period|Other|0|||
37846468|NCT01332968|69530608|FG001|Follow-Up Period|Other|0|||
37846469|NCT01332968|69530609|FG002|Follow-Up Period|Other|0|||
37846470|NCT01332968|69530610|FG003|Follow-Up Period|Other|0|||
37846471|NCT01332968|69530611|FG004|Follow-Up Period|Other|0|||
37846472|NCT01332968|69530612|FG005|Follow-Up Period|Other|0|||
37846473|NCT01332968|69530613|FG006|Follow-Up Period|Other|18|||
37846474|NCT01332968|69530614|FG007|Follow-Up Period|Other|21|||
37846475|NCT01332968|69530607|FG000|Follow-Up Period|Physician Decision|0|||
37846476|NCT01332968|69530608|FG001|Follow-Up Period|Physician Decision|0|||
37846477|NCT01332968|69530609|FG002|Follow-Up Period|Physician Decision|0|||
37846478|NCT01332968|69530610|FG003|Follow-Up Period|Physician Decision|0|||
37846479|NCT01332968|69530611|FG004|Follow-Up Period|Physician Decision|0|||
37846480|NCT01332968|69530612|FG005|Follow-Up Period|Physician Decision|0|||
37846481|NCT01332968|69530613|FG006|Follow-Up Period|Physician Decision|12|||
37846482|NCT01332968|69530614|FG007|Follow-Up Period|Physician Decision|15|||
37846483|NCT01332968|69530607|FG000|Follow-Up Period|Progressive Disease|0|||
37846484|NCT01332968|69530608|FG001|Follow-Up Period|Progressive Disease|0|||
37846485|NCT01332968|69530609|FG002|Follow-Up Period|Progressive Disease|0|||
37846486|NCT01332968|69530610|FG003|Follow-Up Period|Progressive Disease|0|||
37846487|NCT01332968|69530611|FG004|Follow-Up Period|Progressive Disease|0|||
37846488|NCT01332968|69530612|FG005|Follow-Up Period|Progressive Disease|0|||
37846489|NCT01332968|69530613|FG006|Follow-Up Period|Progressive Disease|126|||
37846490|NCT01332968|69530614|FG007|Follow-Up Period|Progressive Disease|106|||
37846491|NCT01332968|69530607|FG000|Follow-Up Period|Protocol Violation|0|||
37846492|NCT01332968|69530608|FG001|Follow-Up Period|Protocol Violation|0|||
37846493|NCT01332968|69530609|FG002|Follow-Up Period|Protocol Violation|0|||
37846494|NCT01332968|69530610|FG003|Follow-Up Period|Protocol Violation|0|||
37846495|NCT01332968|69530611|FG004|Follow-Up Period|Protocol Violation|0|||
37846496|NCT01332968|69530612|FG005|Follow-Up Period|Protocol Violation|0|||
37846497|NCT01332968|69530613|FG006|Follow-Up Period|Protocol Violation|1|||
37846498|NCT01332968|69530614|FG007|Follow-Up Period|Protocol Violation|0|||
37846499|NCT01332968|69530607|FG000|Follow-Up Period|Withdrawal by Subject|0|||
37846500|NCT01332968|69530608|FG001|Follow-Up Period|Withdrawal by Subject|0|||
37846501|NCT01332968|69530609|FG002|Follow-Up Period|Withdrawal by Subject|0|||
37846502|NCT01332968|69530610|FG003|Follow-Up Period|Withdrawal by Subject|0|||
37846503|NCT01332968|69530611|FG004|Follow-Up Period|Withdrawal by Subject|0|||
37846504|NCT01332968|69530612|FG005|Follow-Up Period|Withdrawal by Subject|0|||
37846505|NCT01332968|69530613|FG006|Follow-Up Period|Withdrawal by Subject|29|||
37846506|NCT01332968|69530614|FG007|Follow-Up Period|Withdrawal by Subject|32|||
37846507|NCT01332968|69530607|FG000|Follow-Up Period|No reason provided|0|||
37846508|NCT01332968|69530608|FG001|Follow-Up Period|No reason provided|0|||
37846509|NCT01332968|69530609|FG002|Follow-Up Period|No reason provided|0|||
37846510|NCT01332968|69530610|FG003|Follow-Up Period|No reason provided|0|||
37846511|NCT01332968|69530611|FG004|Follow-Up Period|No reason provided|0|||
37846512|NCT01332968|69530612|FG005|Follow-Up Period|No reason provided|0|||
37846513|NCT01332968|69530613|FG006|Follow-Up Period|No reason provided|2|||
37846514|NCT01332968|69530614|FG007|Follow-Up Period|No reason provided|3|||
37846515|NCT01332851|69530624|FG000|Overall Study|Withdrawal by Subject|4|||
37846516|NCT01332851|69530625|FG001|Overall Study|Withdrawal by Subject|2|||
37846517|NCT01332851|69530624|FG000|Overall Study|Lost to Follow-up|7|||
37846518|NCT01332851|69530625|FG001|Overall Study|Lost to Follow-up|11|||
37846519|NCT01332305|69530640|FG000|Overall Study|Adverse Event|1|||
37846520|NCT01332305|69530641|FG001|Overall Study|Adverse Event|4|||
37846521|NCT01332305|69530642|FG002|Overall Study|Adverse Event|6|||
37846522|NCT01332305|69530643|FG003|Overall Study|Adverse Event|3|||
37846523|NCT01332305|69530644|FG004|Overall Study|Adverse Event|5|||
37846524|NCT01332305|69530640|FG000|Overall Study|Withdrawal by Subject|6|||
37846525|NCT01332305|69530641|FG001|Overall Study|Withdrawal by Subject|5|||
37846526|NCT01332305|69530642|FG002|Overall Study|Withdrawal by Subject|4|||
37846527|NCT01332305|69530643|FG003|Overall Study|Withdrawal by Subject|1|||
37846528|NCT01332305|69530644|FG004|Overall Study|Withdrawal by Subject|0|||
37846529|NCT01332305|69530640|FG000|Overall Study|Lost to Follow-up|0|||
37846530|NCT01332305|69530641|FG001|Overall Study|Lost to Follow-up|2|||
37846531|NCT01332305|69530642|FG002|Overall Study|Lost to Follow-up|3|||
37846532|NCT01332305|69530643|FG003|Overall Study|Lost to Follow-up|2|||
37846533|NCT01332305|69530644|FG004|Overall Study|Lost to Follow-up|3|||
37846534|NCT01332305|69530640|FG000|Overall Study|Protocol Violation|1|||
37846535|NCT01332305|69530641|FG001|Overall Study|Protocol Violation|2|||
37734670|NCT00634114|69215020|FG001|Overall Study|Protocol Violation|3|||
37734671|NCT00634114|69215021|FG002|Overall Study|Protocol Violation|1|||
37846536|NCT01332305|69530642|FG002|Overall Study|Protocol Violation|1|||
37846537|NCT01332305|69530643|FG003|Overall Study|Protocol Violation|0|||
37846538|NCT01332305|69530644|FG004|Overall Study|Protocol Violation|3|||
37846539|NCT01332305|69530640|FG000|Overall Study|Withdrawal by Sponsor|1|||
37846540|NCT01332305|69530641|FG001|Overall Study|Withdrawal by Sponsor|0|||
37846541|NCT01332305|69530642|FG002|Overall Study|Withdrawal by Sponsor|0|||
37846542|NCT01332305|69530643|FG003|Overall Study|Withdrawal by Sponsor|1|||
37846543|NCT01332305|69530644|FG004|Overall Study|Withdrawal by Sponsor|1|||
37846544|NCT01332305|69530640|FG000|Overall Study|Treatment Failure|1|||
37846545|NCT01332305|69530641|FG001|Overall Study|Treatment Failure|1|||
37846546|NCT01332305|69530642|FG002|Overall Study|Treatment Failure|0|||
37846547|NCT01332305|69530643|FG003|Overall Study|Treatment Failure|0|||
37846548|NCT01332305|69530644|FG004|Overall Study|Treatment Failure|0|||
37846549|NCT01332305|69530640|FG000|Overall Study|Physician Decision|0|||
37846550|NCT01332305|69530641|FG001|Overall Study|Physician Decision|0|||
37846551|NCT01332305|69530642|FG002|Overall Study|Physician Decision|0|||
37846552|NCT01332305|69530643|FG003|Overall Study|Physician Decision|1|||
37846553|NCT01332305|69530644|FG004|Overall Study|Physician Decision|0|||
37846554|NCT01332227|69530658|FG000|Overall Study|Adverse Event|4|||
37846555|NCT01332227|69530659|FG001|Overall Study|Adverse Event|1|||
37846556|NCT01332227|69530658|FG000|Overall Study|Withdrawal by Subject|5|||
37846557|NCT01332227|69530659|FG001|Overall Study|Withdrawal by Subject|1|||
37846558|NCT01332227|69530658|FG000|Overall Study|Lost to Follow-up|2|||
37846559|NCT01332227|69530659|FG001|Overall Study|Lost to Follow-up|0|||
37846560|NCT01332227|69530658|FG000|Overall Study|Lack of Efficacy|3|||
37846561|NCT01332227|69530659|FG001|Overall Study|Lack of Efficacy|1|||
37846562|NCT01332227|69530658|FG000|Overall Study|Poor compliance/noncompliance|1|||
37916853|NCT00875420|69603737|FG001|Overall Study|Inability to complete study procedures|0|||
37916854|NCT00875420|69603738|FG002|Overall Study|Inability to complete study procedures|1|||
37916855|NCT00875420|69603739|FG003|Overall Study|Inability to complete study procedures|1|||
37916856|NCT00875420|69603740|FG004|Overall Study|Inability to complete study procedures|1|||
37916857|NCT00875420|69603736|FG000|Overall Study|Lost to Follow-up|1|||
37916858|NCT00875420|69603737|FG001|Overall Study|Lost to Follow-up|0|||
37916859|NCT00875420|69603738|FG002|Overall Study|Lost to Follow-up|0|||
37916860|NCT00875420|69603739|FG003|Overall Study|Lost to Follow-up|0|||
37916861|NCT00875420|69603740|FG004|Overall Study|Lost to Follow-up|0|||
37916862|NCT00875420|69603736|FG000|Overall Study|Personal reason|0|||
37916863|NCT00875420|69603737|FG001|Overall Study|Personal reason|0|||
37916864|NCT00875420|69603738|FG002|Overall Study|Personal reason|0|||
37916865|NCT00875420|69603739|FG003|Overall Study|Personal reason|0|||
37916866|NCT00875420|69603740|FG004|Overall Study|Personal reason|1|||
37916867|NCT00875420|69603736|FG000|Overall Study|Prohibited medication|0|||
37916868|NCT00875420|69603737|FG001|Overall Study|Prohibited medication|0|||
37916869|NCT00875420|69603738|FG002|Overall Study|Prohibited medication|0|||
37916870|NCT00875420|69603739|FG003|Overall Study|Prohibited medication|1|||
37916871|NCT00875420|69603740|FG004|Overall Study|Prohibited medication|0|||
37916872|NCT00875420|69603736|FG000|Overall Study|Sponsor decision|0|||
37916873|NCT00875420|69603737|FG001|Overall Study|Sponsor decision|1|||
37916874|NCT00875420|69603738|FG002|Overall Study|Sponsor decision|0|||
37916875|NCT00875420|69603739|FG003|Overall Study|Sponsor decision|0|||
37916876|NCT00875420|69603740|FG004|Overall Study|Sponsor decision|0|||
37916877|NCT00875420|69603736|FG000|Overall Study|Withdrawal by Subject|0|||
37916878|NCT00875420|69603737|FG001|Overall Study|Withdrawal by Subject|0|||
37916879|NCT00875420|69603738|FG002|Overall Study|Withdrawal by Subject|1|||
37916880|NCT00875420|69603739|FG003|Overall Study|Withdrawal by Subject|0|||
37916881|NCT00875420|69603740|FG004|Overall Study|Withdrawal by Subject|0|||
37916882|NCT00822237|69603754|FG000|Dose 1 Vaccination|Not vaccinated|3|||
37916883|NCT00822237|69603755|FG001|Dose 1 Vaccination|Not vaccinated|0|||
37916884|NCT00822237|69603754|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
37916885|NCT00822237|69603755|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
37916886|NCT00822237|69603754|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
37916887|NCT00822237|69603755|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
37916888|NCT00822237|69603754|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
37916889|NCT00822237|69603755|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
37916890|NCT00822237|69603754|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
37916891|NCT00822237|69603755|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
37916892|NCT00577096|69603762|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
37916893|NCT00577096|69603763|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
37916894|NCT00577096|69603762|FG000|Short Term Participation|Withdrawal by Subject|3|||
37916895|NCT00577096|69603763|FG001|Short Term Participation|Withdrawal by Subject|5|||
37916896|NCT00577096|69603762|FG000|Short Term Participation|Death|1|||
37916897|NCT00577096|69603763|FG001|Short Term Participation|Death|1|||
37916898|NCT00863304|69603773|FG000|Overall Study|Adverse Event|10|||
37916899|NCT00863304|69603774|FG001|Overall Study|Adverse Event|4|||
37916900|NCT00863304|69603775|FG002|Overall Study|Adverse Event|14|||
37916901|NCT00863304|69603776|FG003|Overall Study|Adverse Event|16|||
37916902|NCT00863304|69603773|FG000|Overall Study|Lost to Follow-up|1|||
37916903|NCT00863304|69603774|FG001|Overall Study|Lost to Follow-up|5|||
37916904|NCT00863304|69603775|FG002|Overall Study|Lost to Follow-up|4|||
37916905|NCT00863304|69603776|FG003|Overall Study|Lost to Follow-up|2|||
37916906|NCT00863304|69603773|FG000|Overall Study|Lack of Efficacy|57|||
37916907|NCT00863304|69603774|FG001|Overall Study|Lack of Efficacy|26|||
37916908|NCT00863304|69603775|FG002|Overall Study|Lack of Efficacy|30|||
37846563|NCT01332227|69530659|FG001|Overall Study|Poor compliance/noncompliance|1|||
37846564|NCT01332227|69530658|FG000|Overall Study|Patient moved from area|1|||
37846565|NCT01332227|69530659|FG001|Overall Study|Patient moved from area|0|||
37846566|NCT01332227|69530658|FG000|Overall Study|Patient began prohibited medication|0|||
37846567|NCT01332227|69530659|FG001|Overall Study|Patient began prohibited medication|1|||
37846568|NCT01332149|69530667|FG000|Overall Study|Adverse Event|11|||
37846569|NCT01332149|69530668|FG001|Overall Study|Adverse Event|9|||
37846570|NCT01332149|69530667|FG000|Overall Study|Other unspecified|5|||
37846571|NCT01332149|69530668|FG001|Overall Study|Other unspecified|7|||
37846572|NCT01332149|69530667|FG000|Overall Study|Protocol Violation|1|||
37846573|NCT01332149|69530668|FG001|Overall Study|Protocol Violation|3|||
37846574|NCT01332149|69530667|FG000|Overall Study|Withdrawal by Subject|4|||
37846575|NCT01332149|69530668|FG001|Overall Study|Withdrawal by Subject|5|||
37846576|NCT01332149|69530667|FG000|Overall Study|Lost to Follow-up|1|||
37846577|NCT01332149|69530668|FG001|Overall Study|Lost to Follow-up|1|||
37846578|NCT01332149|69530667|FG000|Overall Study|Insufficient clinical response|4|||
37846579|NCT01332149|69530668|FG001|Overall Study|Insufficient clinical response|7|||
37846580|NCT01332149|69530667|FG000|Overall Study|Did not meet entrance criteria|3|||
37846581|NCT01332149|69530668|FG001|Overall Study|Did not meet entrance criteria|4|||
37916909|NCT00863304|69603776|FG003|Overall Study|Lack of Efficacy|28|||
37916910|NCT00863304|69603773|FG000|Overall Study|Withdrawal by Subject|19|||
37916911|NCT00863304|69603774|FG001|Overall Study|Withdrawal by Subject|14|||
37916912|NCT00863304|69603775|FG002|Overall Study|Withdrawal by Subject|20|||
37916913|NCT00863304|69603776|FG003|Overall Study|Withdrawal by Subject|18|||
37916914|NCT00863304|69603773|FG000|Overall Study|Other|1|||
37916915|NCT00863304|69603774|FG001|Overall Study|Other|0|||
37916916|NCT00863304|69603775|FG002|Overall Study|Other|0|||
37916917|NCT00863304|69603776|FG003|Overall Study|Other|1|||
37916918|NCT00863304|69603773|FG000|Overall Study|Protocol Violation|2|||
37916919|NCT00863304|69603774|FG001|Overall Study|Protocol Violation|6|||
37916920|NCT00863304|69603775|FG002|Overall Study|Protocol Violation|2|||
37916921|NCT00863304|69603776|FG003|Overall Study|Protocol Violation|0|||
37916922|NCT00863304|69603773|FG000|Overall Study|Randomized, but not Treated|3|||
37916923|NCT00863304|69603774|FG001|Overall Study|Randomized, but not Treated|1|||
37916924|NCT00863304|69603775|FG002|Overall Study|Randomized, but not Treated|4|||
37916925|NCT00863304|69603776|FG003|Overall Study|Randomized, but not Treated|1|||
37916926|NCT00863304|69603773|FG000|Overall Study|Entered extension study|101|||
37916927|NCT00863304|69603774|FG001|Overall Study|Entered extension study|129|||
37916928|NCT00863304|69603775|FG002|Overall Study|Entered extension study|113|||
37916929|NCT00863304|69603776|FG003|Overall Study|Entered extension study|125|||
37916930|NCT00695110|69603788|FG000|Treatment Period 1|Adverse Event|1|||
37916931|NCT00695110|69603788|FG000|Treatment Period 1|Withdrawal by Subject|2|||
37916932|NCT00695110|69603788|FG000|Treatment Period 3|Withdrawal by Subject|1|||
37916933|NCT00695110|69603788|FG000|Treatment Period 4|Adverse Event|1|||
37916934|NCT00594386|69603795|FG000|Overall Study|Major protocol violation|2|||
37916935|NCT00594386|69603795|FG000|Overall Study|Lack of Efficacy|12|||
37916936|NCT00594386|69603795|FG000|Overall Study|Adverse Event|68|||
37916937|NCT00594386|69603795|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
37916938|NCT00594386|69603795|FG000|Overall Study|Subject withdrew consent|35|||
37916939|NCT00594386|69603795|FG000|Overall Study|Study ended per sponsor|115|||
37916940|NCT00594386|69603795|FG000|Overall Study|Lost to Follow-up|6|||
37916941|NCT00594386|69603795|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
37916942|NCT00594386|69603795|FG000|Overall Study|Other: Subject moved to Seattle|1|||
37916943|NCT00594386|69603795|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
37916944|NCT00594386|69603795|FG000|Overall Study|Other: Study terminated per investigator|2|||
37916945|NCT00594386|69603795|FG000|Overall Study|Other: Sponsor closure of study|1|||
37916946|NCT00594386|69603795|FG000|Overall Study|Other: Site terminated participation|1|||
37916947|NCT00594386|69603795|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
37916948|NCT00594386|69603795|FG000|Overall Study|Other: Loss of drivers license|1|||
37916949|NCT00862992|69603802|FG000|Overall Study|Adverse Event|2|||
37916950|NCT00862992|69603803|FG001|Overall Study|Adverse Event|1|||
37916951|NCT00862992|69603804|FG002|Overall Study|Adverse Event|1|||
37916952|NCT00862992|69603802|FG000|Overall Study|Physician Decision|1|||
37916953|NCT00862992|69603803|FG001|Overall Study|Physician Decision|0|||
37916954|NCT00862992|69603804|FG002|Overall Study|Physician Decision|0|||
37916955|NCT00862992|69603802|FG000|Overall Study|Withdrawal by Subject|0|||
37916956|NCT00862992|69603803|FG001|Overall Study|Withdrawal by Subject|0|||
37916957|NCT00862992|69603804|FG002|Overall Study|Withdrawal by Subject|2|||
37916958|NCT00694096|69603812|FG000|Overall Study|Withdrawal by Subject|5|||
37916959|NCT00854100|69603819|FG000|Overall Study|Inability to complete the study visits|0|||
37916960|NCT00854100|69603820|FG001|Overall Study|Inability to complete the study visits|0|||
37916961|NCT00854100|69603821|FG002|Overall Study|Inability to complete the study visits|1|||
37916962|NCT00854100|69603819|FG000|Overall Study|Lost to Follow-up|2|||
37846582|NCT01332149|69530667|FG000|Overall Study|Randomized but not treated|1|||
37846583|NCT01332149|69530668|FG001|Overall Study|Randomized but not treated|2|||
37846584|NCT01330628|69530676|FG000|Overall Study|Death|2|||
37846585|NCT01330628|69530677|FG001|Overall Study|Death|3|||
37916963|NCT00854100|69603820|FG001|Overall Study|Lost to Follow-up|0|||
37916964|NCT00854100|69603821|FG002|Overall Study|Lost to Follow-up|3|||
37916965|NCT00854100|69603819|FG000|Overall Study|Withdrawal by Subject|3|||
37846586|NCT01330628|69530676|FG000|Overall Study|Lost to Follow-up|5|||
37846587|NCT01330628|69530677|FG001|Overall Study|Lost to Follow-up|6|||
37846588|NCT01330628|69530676|FG000|Overall Study|Adverse Event|44|||
37846589|NCT01330628|69530677|FG001|Overall Study|Adverse Event|25|||
37846590|NCT01330628|69530676|FG000|Overall Study|Withdrawn|18|||
37846591|NCT01330628|69530677|FG001|Overall Study|Withdrawn|6|||
37846592|NCT01330628|69530676|FG000|Overall Study|Didn't receive study treatment|1|||
37846593|NCT01330628|69530677|FG001|Overall Study|Didn't receive study treatment|0|||
37846594|NCT01330433|69530685|FG000|Overall Study|Death|1|||
37846595|NCT01330433|69530686|FG001|Overall Study|Death|3|||
37846596|NCT01330433|69530685|FG000|Overall Study|Lost to Follow-up|1|||
37846597|NCT01330433|69530686|FG001|Overall Study|Lost to Follow-up|0|||
37846598|NCT01330316|69530694|FG000|Overall Study|Adverse Event|2|||
37846599|NCT01330316|69530695|FG001|Overall Study|Adverse Event|2|||
37846600|NCT01330316|69530694|FG000|Overall Study|Lack of Efficacy|0|||
37846601|NCT01330316|69530695|FG001|Overall Study|Lack of Efficacy|10|||
37846602|NCT01330316|69530694|FG000|Overall Study|Lost to Follow-up|0|||
37846603|NCT01330316|69530695|FG001|Overall Study|Lost to Follow-up|1|||
37846604|NCT01330316|69530694|FG000|Overall Study|Withdrawal by Subject|0|||
37846605|NCT01330316|69530695|FG001|Overall Study|Withdrawal by Subject|1|||
37846606|NCT01330316|69530694|FG000|Overall Study|other than above|0|||
37846607|NCT01330316|69530695|FG001|Overall Study|other than above|1|||
37846608|NCT01326702|69530708|FG000|Overall Study|Other|1|||
37846609|NCT01326702|69530709|FG001|Overall Study|Other|0|||
37846610|NCT01326702|69530710|FG002|Overall Study|Other|0|||
37846611|NCT01326702|69530711|FG003|Overall Study|Other|0|||
37846612|NCT01326702|69530712|FG004|Overall Study|Other|0|||
37846613|NCT01326702|69530713|FG005|Overall Study|Other|1|||
37846614|NCT01326702|69530714|FG006|Overall Study|Other|0|||
37846615|NCT01326702|69530708|FG000|Overall Study|progressive disease|1|||
37846616|NCT01326702|69530709|FG001|Overall Study|progressive disease|1|||
37846617|NCT01326702|69530710|FG002|Overall Study|progressive disease|3|||
37846618|NCT01326702|69530711|FG003|Overall Study|progressive disease|1|||
37846619|NCT01326702|69530712|FG004|Overall Study|progressive disease|3|||
37846620|NCT01326702|69530713|FG005|Overall Study|progressive disease|2|||
37846621|NCT01326702|69530714|FG006|Overall Study|progressive disease|3|||
37846622|NCT01326702|69530708|FG000|Overall Study|Death|0|||
37846623|NCT01326702|69530709|FG001|Overall Study|Death|1|||
37846624|NCT01326702|69530710|FG002|Overall Study|Death|0|||
37846625|NCT01326702|69530711|FG003|Overall Study|Death|0|||
37846626|NCT01326702|69530712|FG004|Overall Study|Death|0|||
37846627|NCT01326702|69530713|FG005|Overall Study|Death|0|||
37846628|NCT01326702|69530714|FG006|Overall Study|Death|0|||
37846629|NCT01326702|69530708|FG000|Overall Study|Adverse Event|0|||
37846630|NCT01326702|69530709|FG001|Overall Study|Adverse Event|0|||
37846631|NCT01326702|69530710|FG002|Overall Study|Adverse Event|1|||
37846632|NCT01326702|69530711|FG003|Overall Study|Adverse Event|1|||
37846633|NCT01326702|69530712|FG004|Overall Study|Adverse Event|0|||
37846634|NCT01326702|69530713|FG005|Overall Study|Adverse Event|3|||
37846635|NCT01326702|69530714|FG006|Overall Study|Adverse Event|1|||
37846636|NCT01326702|69530708|FG000|Overall Study|Withdrawal by Subject|0|||
37846637|NCT01326702|69530709|FG001|Overall Study|Withdrawal by Subject|0|||
37846638|NCT01326702|69530710|FG002|Overall Study|Withdrawal by Subject|1|||
37846639|NCT01326702|69530711|FG003|Overall Study|Withdrawal by Subject|0|||
37846640|NCT01326702|69530712|FG004|Overall Study|Withdrawal by Subject|1|||
37846641|NCT01326702|69530713|FG005|Overall Study|Withdrawal by Subject|1|||
37846642|NCT01326702|69530714|FG006|Overall Study|Withdrawal by Subject|3|||
37916966|NCT00854100|69603820|FG001|Overall Study|Withdrawal by Subject|1|||
38026301|NCT00461032|69711112|FG000|Overall Study|Protocol Violation|4|||
37734672|NCT00634114|69215019|FG000|Overall Study|Pregnancy|1|||
37734673|NCT00634114|69215020|FG001|Overall Study|Pregnancy|0|||
37734674|NCT00634114|69215021|FG002|Overall Study|Pregnancy|0|||
37734675|NCT00634114|69215019|FG000|Overall Study|Incorrect enrolment|0|||
37846643|NCT01326702|69530708|FG000|Overall Study|Not Treated|0|||
37846644|NCT01326702|69530709|FG001|Overall Study|Not Treated|0|||
37846645|NCT01326702|69530710|FG002|Overall Study|Not Treated|0|||
37846646|NCT01326702|69530711|FG003|Overall Study|Not Treated|1|||
37846647|NCT01326702|69530712|FG004|Overall Study|Not Treated|0|||
37846648|NCT01326702|69530713|FG005|Overall Study|Not Treated|1|||
37846649|NCT01326702|69530714|FG006|Overall Study|Not Treated|0|||
37846650|NCT01327703|69530733|FG000|Second Treatment Period|Adverse Event|1|||
37846651|NCT01327703|69530734|FG001|Second Treatment Period|Adverse Event|1|||
37846652|NCT01327703|69530733|FG000|Second Treatment Period|Protocol Violation|0|||
37846653|NCT01327703|69530734|FG001|Second Treatment Period|Protocol Violation|1|||
37846654|NCT01380080|69530745|FG000|Overall Study|Death|36|||
37846655|NCT01380080|69530746|FG001|Overall Study|Death|44|||
37846656|NCT01380080|69530745|FG000|Overall Study|Site is closing|28|||
37846657|NCT01380080|69530746|FG001|Overall Study|Site is closing|31|||
37846658|NCT01380080|69530745|FG000|Overall Study|Not able to get to clinic|7|||
37846659|NCT01380080|69530746|FG001|Overall Study|Not able to get to clinic|1|||
37846660|NCT01380080|69530745|FG000|Overall Study|Not willing to adhere to requirements|6|||
37846661|NCT01380080|69530746|FG001|Overall Study|Not willing to adhere to requirements|2|||
37846662|NCT01380080|69530745|FG000|Overall Study|Withdrawal by Subject|5|||
37846663|NCT01380080|69530746|FG001|Overall Study|Withdrawal by Subject|2|||
37846664|NCT01380080|69530745|FG000|Overall Study|Lost to Follow-up|3|||
37846665|NCT01380080|69530746|FG001|Overall Study|Lost to Follow-up|3|||
37846666|NCT01379768|69530755|FG000|Overall Study|Adverse Event|1|||
37846667|NCT01379768|69530756|FG001|Overall Study|Adverse Event|1|||
37846668|NCT01379768|69530757|FG002|Overall Study|Adverse Event|0|||
37846669|NCT01379768|69530755|FG000|Overall Study|Lost to Follow-up|2|||
37846670|NCT01379768|69530756|FG001|Overall Study|Lost to Follow-up|0|||
37846671|NCT01379768|69530757|FG002|Overall Study|Lost to Follow-up|0|||
37846672|NCT01379573|69530765|FG000|Overall Study|Lost to Follow-up|1|||
37846673|NCT01379573|69530765|FG000|Overall Study|Screen Failure|10|||
37846674|NCT01379534|69530771|FG000|Treatment Phase|Withdrawal by Subject|2|||
37846675|NCT01379534|69530772|FG001|Treatment Phase|Withdrawal by Subject|2|||
37846676|NCT01379534|69530771|FG000|Treatment Phase|Progressive disease|13|||
37846677|NCT01379534|69530772|FG001|Treatment Phase|Progressive disease|22|||
37846678|NCT01379534|69530771|FG000|Treatment Phase|Adverse Event|7|||
37846679|NCT01379534|69530772|FG001|Treatment Phase|Adverse Event|7|||
37846680|NCT01379534|69530771|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
37846681|NCT01379534|69530772|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
37846682|NCT01379534|69530771|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
37846683|NCT01379534|69530772|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
37846684|NCT01379534|69530771|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
37846685|NCT01379534|69530772|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
37846686|NCT01379534|69530771|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
37846687|NCT01379534|69530772|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
37846688|NCT01371851|69530780|FG000|Overall Study|Lost to Follow-up|5|||
37846689|NCT01371851|69530781|FG001|Overall Study|Lost to Follow-up|8|||
37846690|NCT01371851|69530780|FG000|Overall Study|was arrested and put in jail|0|||
37846691|NCT01371851|69530781|FG001|Overall Study|was arrested and put in jail|1|||
37846692|NCT01371851|69530780|FG000|Overall Study|non study related adverse event|1|||
37846693|NCT01371851|69530781|FG001|Overall Study|non study related adverse event|0|||
37846694|NCT01371851|69530780|FG000|Overall Study|Blood Pressure outside study parameters|2|||
37846695|NCT01371851|69530781|FG001|Overall Study|Blood Pressure outside study parameters|0|||
37846696|NCT01371734|69530790|FG000|Overall Study|Other|2|||
37846697|NCT01371734|69530791|FG001|Overall Study|Other|1|||
37846698|NCT01371734|69530792|FG002|Overall Study|Other|2|||
37846699|NCT01371734|69530790|FG000|Overall Study|Withdrawal by Subject|3|||
37846700|NCT01371734|69530791|FG001|Overall Study|Withdrawal by Subject|4|||
37846701|NCT01371734|69530792|FG002|Overall Study|Withdrawal by Subject|9|||
37846702|NCT01371734|69530790|FG000|Overall Study|Lost to Follow-up|5|||
37846703|NCT01371734|69530791|FG001|Overall Study|Lost to Follow-up|3|||
37846704|NCT01371734|69530792|FG002|Overall Study|Lost to Follow-up|1|||
37846705|NCT01371734|69530790|FG000|Overall Study|Protocol Violation|3|||
37846706|NCT01371734|69530791|FG001|Overall Study|Protocol Violation|1|||
37846707|NCT01371734|69530792|FG002|Overall Study|Protocol Violation|2|||
37846708|NCT01371734|69530790|FG000|Overall Study|Adverse Event|8|||
37846709|NCT01371734|69530791|FG001|Overall Study|Adverse Event|8|||
37846710|NCT01371734|69530792|FG002|Overall Study|Adverse Event|3|||
37846711|NCT01371734|69530790|FG000|Overall Study|Lack of Efficacy|2|||
37846712|NCT01371734|69530791|FG001|Overall Study|Lack of Efficacy|2|||
37846713|NCT01371734|69530792|FG002|Overall Study|Lack of Efficacy|0|||
37846714|NCT01365494|69530802|FG000|Overall Study|Adverse Event|1|||
37846715|NCT01365494|69530803|FG001|Overall Study|Adverse Event|0|||
37846716|NCT01365494|69530802|FG000|Overall Study|Withdrawal by Subject|0|||
37846717|NCT01365494|69530803|FG001|Overall Study|Withdrawal by Subject|1|||
37846718|NCT01365494|69530802|FG000|Overall Study|Lost to Follow-up|1|||
37846719|NCT01365494|69530803|FG001|Overall Study|Lost to Follow-up|2|||
37846720|NCT01357889|69530812|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
37846721|NCT01357889|69530813|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
37846722|NCT01357889|69530812|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
37846723|NCT01357889|69530813|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
37846724|NCT01357889|69530812|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
37846725|NCT01357889|69530813|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
37846726|NCT01357889|69530812|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
37846727|NCT01357889|69530813|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
37846728|NCT01357889|69530812|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
37846729|NCT01357889|69530813|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
38026302|NCT00461032|69711113|FG001|Overall Study|Protocol Violation|4|||
37846730|NCT01357889|69530812|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
37846731|NCT01357889|69530813|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
37846732|NCT01357889|69530812|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
37846733|NCT01357889|69530813|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
37846734|NCT01357889|69530812|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
37846735|NCT01357889|69530813|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
37846736|NCT01357889|69530812|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
37846737|NCT01357889|69530813|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
37846738|NCT01357889|69530812|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
37846739|NCT01357889|69530813|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
37846740|NCT01357889|69530812|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
37846741|NCT01357889|69530813|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
37916967|NCT00854100|69603821|FG002|Overall Study|Withdrawal by Subject|2|||
37916968|NCT00854100|69603819|FG000|Overall Study|Protocol Violation|2|||
37916969|NCT00854100|69603820|FG001|Overall Study|Protocol Violation|4|||
37916970|NCT00854100|69603821|FG002|Overall Study|Protocol Violation|3|||
37916971|NCT00854100|69603819|FG000|Overall Study|Adverse Event|2|||
37846742|NCT01357889|69530812|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
37846743|NCT01357889|69530813|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
37846744|NCT01357889|69530812|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
37846745|NCT01357889|69530813|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
37846746|NCT01357850|69530825|FG000|Overall Study|Lost to Follow-up|1|||
37846747|NCT01357850|69530826|FG001|Overall Study|Lost to Follow-up|0|||
37846748|NCT01357850|69530827|FG002|Overall Study|Lost to Follow-up|0|||
37846749|NCT01357850|69530828|FG003|Overall Study|Lost to Follow-up|0|||
37846750|NCT01357655|69530841|FG000|Overall Study|Administrative Reason by Sponsor|45|||
37846751|NCT01357655|69530842|FG001|Overall Study|Administrative Reason by Sponsor|0|||
37846752|NCT01357655|69530841|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
37846753|NCT01357655|69530842|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
37846754|NCT01357655|69530841|FG000|Overall Study|Disease Progression|1|||
37846755|NCT01357655|69530842|FG001|Overall Study|Disease Progression|0|||
37846756|NCT01357655|69530841|FG000|Overall Study|Lost to Follow-up|2|||
37846757|NCT01357655|69530842|FG001|Overall Study|Lost to Follow-up|0|||
37846758|NCT01357655|69530841|FG000|Overall Study|Maximum Clinical Benefit|2|||
37846759|NCT01357655|69530842|FG001|Overall Study|Maximum Clinical Benefit|0|||
37846760|NCT01357655|69530841|FG000|Overall Study|Reason Unspecified|1|||
37846761|NCT01357655|69530842|FG001|Overall Study|Reason Unspecified|0|||
37846762|NCT01357655|69530841|FG000|Overall Study|Study Drug Toxicity|11|||
37846763|NCT01357655|69530842|FG001|Overall Study|Study Drug Toxicity|0|||
37846764|NCT01357655|69530841|FG000|Overall Study|Subject Withdrew Consent|1|||
37846765|NCT01357655|69530842|FG001|Overall Study|Subject Withdrew Consent|0|||
37846766|NCT01357616|69530849|FG000|Overall Study|Adverse Event|1|||
37846767|NCT01357616|69530850|FG001|Overall Study|Adverse Event|1|||
37846768|NCT01357616|69530849|FG000|Overall Study|Lost to Follow-up|4|||
37846769|NCT01357616|69530850|FG001|Overall Study|Lost to Follow-up|3|||
37846770|NCT01357616|69530849|FG000|Overall Study|Protocol Violation|0|||
37846771|NCT01357616|69530850|FG001|Overall Study|Protocol Violation|2|||
37846772|NCT01357616|69530849|FG000|Overall Study|Inadequate Control of IOP|1|||
37846773|NCT01357616|69530850|FG001|Overall Study|Inadequate Control of IOP|2|||
37846774|NCT01357616|69530849|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
37846775|NCT01357616|69530850|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
37846776|NCT01357616|69530849|FG000|Overall Study|Withdrawal by Subject|1|||
37846777|NCT01357616|69530850|FG001|Overall Study|Withdrawal by Subject|0|||
37846778|NCT01357577|69530858|FG000|Overall Study|Lost to Follow-up|20|||
37846779|NCT01357577|69530859|FG001|Overall Study|Lost to Follow-up|16|||
37916972|NCT00854100|69603820|FG001|Overall Study|Adverse Event|1|||
37846780|NCT01357577|69530858|FG000|Overall Study|Withdrawal by Subject|16|||
37846781|NCT01357577|69530859|FG001|Overall Study|Withdrawal by Subject|8|||
37846782|NCT01357577|69530858|FG000|Overall Study|look at data in database?|1|||
37846783|NCT01357577|69530859|FG001|Overall Study|look at data in database?|2|||
37846784|NCT01351025|69530868|FG000|Week 0 - 20|Lost to Follow-up|2|||
37846785|NCT01351025|69530869|FG001|Week 0 - 20|Lost to Follow-up|1|||
37916973|NCT00854100|69603821|FG002|Overall Study|Adverse Event|2|||
37916974|NCT00509899|69603838|FG000|Overall Study|Progressive disease|1|||
37846786|NCT01351025|69530868|FG000|Week 0 - 20|Withdrawal by Subject|1|||
37846787|NCT01351025|69530869|FG001|Week 0 - 20|Withdrawal by Subject|0|||
37846788|NCT01351025|69530868|FG000|Week 24 - 44|Lost to Follow-up|0|||
37846789|NCT01351025|69530869|FG001|Week 24 - 44|Lost to Follow-up|2|||
37846790|NCT01351025|69530868|FG000|Week 24 - 44|Site closed|0|||
37846791|NCT01351025|69530869|FG001|Week 24 - 44|Site closed|1|||
37846792|NCT01351025|69530868|FG000|Week 24 - 44|unable to get to clinic|1|||
37846793|NCT01351025|69530869|FG001|Week 24 - 44|unable to get to clinic|1|||
37846794|NCT01349036|69530883|FG000|Overall Study|Disease progression|13|||
37846795|NCT01349036|69530884|FG001|Overall Study|Disease progression|22|||
37846796|NCT01349036|69530883|FG000|Overall Study|Other|1|||
37846797|NCT01349036|69530884|FG001|Overall Study|Other|0|||
37846798|NCT01349036|69530883|FG000|Overall Study|Withdrawal by Subject|0|||
37846799|NCT01349036|69530884|FG001|Overall Study|Withdrawal by Subject|2|||
37846800|NCT01348763|69530894|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
37846801|NCT01348763|69530894|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
37846802|NCT01346969|69530902|FG000|Overall Study|Withdrawal by Subject|0|||
37846803|NCT01346969|69530903|FG001|Overall Study|Withdrawal by Subject|0|||
37846804|NCT01346969|69530904|FG002|Overall Study|Withdrawal by Subject|1|||
37846805|NCT01346969|69530905|FG003|Overall Study|Withdrawal by Subject|0|||
37846806|NCT01346969|69530902|FG000|Overall Study|Lost to Follow-up|1|||
37846807|NCT01346969|69530903|FG001|Overall Study|Lost to Follow-up|0|||
37846808|NCT01346969|69530904|FG002|Overall Study|Lost to Follow-up|2|||
37846809|NCT01346969|69530905|FG003|Overall Study|Lost to Follow-up|0|||
37846810|NCT01346969|69530902|FG000|Overall Study|Physician Decision|0|||
37846811|NCT01346969|69530903|FG001|Overall Study|Physician Decision|0|||
37846812|NCT01346969|69530904|FG002|Overall Study|Physician Decision|0|||
37846813|NCT01346969|69530905|FG003|Overall Study|Physician Decision|1|||
37846814|NCT01346969|69530902|FG000|Overall Study|Randomized but not treated|1|||
37846815|NCT01346969|69530903|FG001|Overall Study|Randomized but not treated|0|||
37846816|NCT01346969|69530904|FG002|Overall Study|Randomized but not treated|0|||
37846817|NCT01346969|69530905|FG003|Overall Study|Randomized but not treated|0|||
37846818|NCT01346774|69530917|FG000|Overall Study|Did not take a single dose|6|||
37846819|NCT01346774|69530918|FG001|Overall Study|Did not take a single dose|4|||
37846820|NCT01346774|69530917|FG000|Overall Study|Lost to Follow-up|3|||
37846821|NCT01346774|69530918|FG001|Overall Study|Lost to Follow-up|4|||
37846822|NCT01346774|69530917|FG000|Overall Study|Withdrawal by Subject|1|||
37846823|NCT01346774|69530918|FG001|Overall Study|Withdrawal by Subject|4|||
37846824|NCT01346774|69530917|FG000|Overall Study|Protocol Violation|2|||
37846825|NCT01346774|69530918|FG001|Overall Study|Protocol Violation|3|||
37846826|NCT01346774|69530917|FG000|Overall Study|Adverse Event|1|||
37846827|NCT01346774|69530918|FG001|Overall Study|Adverse Event|2|||
37846828|NCT01346696|69530924|FG000|Overall Study|Death|1|||
37846829|NCT01346540|69530930|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
37846830|NCT01346540|69530931|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
37846831|NCT01346540|69530930|FG000|Overall Study|Adverse Event|0|||
37916975|NCT00509899|69603839|FG001|Overall Study|Progressive disease|3|||
37916976|NCT00509899|69603840|FG002|Overall Study|Progressive disease|5|||
37916977|NCT00509899|69603841|FG003|Overall Study|Progressive disease|1|||
37916978|NCT00509899|69603842|FG004|Overall Study|Progressive disease|0|||
37916979|NCT00509899|69603843|FG005|Overall Study|Progressive disease|1|||
37916980|NCT00509899|69603844|FG006|Overall Study|Progressive disease|0|||
37916981|NCT00509899|69603845|FG007|Overall Study|Progressive disease|0|||
37916982|NCT00509899|69603838|FG000|Overall Study|Unacceptable Toxicity|1|||
37916983|NCT00509899|69603839|FG001|Overall Study|Unacceptable Toxicity|0|||
37916984|NCT00509899|69603840|FG002|Overall Study|Unacceptable Toxicity|0|||
37846832|NCT01346540|69530931|FG001|Overall Study|Adverse Event|4|||
37846833|NCT01342913|69530940|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
37916985|NCT00509899|69603841|FG003|Overall Study|Unacceptable Toxicity|2|||
37916986|NCT00509899|69603842|FG004|Overall Study|Unacceptable Toxicity|0|||
37916987|NCT00509899|69603843|FG005|Overall Study|Unacceptable Toxicity|0|||
37846834|NCT01342913|69530941|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
37846835|NCT01342913|69530942|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
37846836|NCT01342913|69530940|FG000|2-week Run-in Period|Physician Decision|6|||
37846837|NCT01342913|69530941|FG001|2-week Run-in Period|Physician Decision|0|||
38026303|NCT00461032|69711112|FG000|Overall Study|Withdrawal by Subject|7|||
38026304|NCT00461032|69711113|FG001|Overall Study|Withdrawal by Subject|15|||
38026305|NCT00461032|69711112|FG000|Overall Study|Patient Moved or Relocated|2|||
38026306|NCT00461032|69711113|FG001|Overall Study|Patient Moved or Relocated|1|||
37846838|NCT01342913|69530942|FG002|2-week Run-in Period|Physician Decision|0|||
37846839|NCT01342913|69530940|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
38026307|NCT00461032|69711112|FG000|Overall Study|Other|7|||
38026308|NCT00461032|69711113|FG001|Overall Study|Other|5|||
38026309|NCT00090142|69711119|FG000|Treatment Period I|Lost to Follow-up|1|||
38026310|NCT00090142|69711120|FG001|Treatment Period I|Lost to Follow-up|2|||
38026311|NCT00090142|69711119|FG000|Treatment Period I|Protocol Violation|2|||
37916988|NCT00509899|69603844|FG006|Overall Study|Unacceptable Toxicity|0|||
37734676|NCT00634114|69215020|FG001|Overall Study|Incorrect enrolment|1|||
37734677|NCT00634114|69215021|FG002|Overall Study|Incorrect enrolment|0|||
37734678|NCT00634114|69215019|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
37734679|NCT00634114|69215020|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
38026312|NCT00090142|69711120|FG001|Treatment Period I|Protocol Violation|0|||
37916989|NCT00509899|69603845|FG007|Overall Study|Unacceptable Toxicity|0|||
37916990|NCT00509899|69603838|FG000|Overall Study|Withdrawal by Subject|6|||
37916991|NCT00509899|69603839|FG001|Overall Study|Withdrawal by Subject|2|||
37916992|NCT00509899|69603840|FG002|Overall Study|Withdrawal by Subject|3|||
37916993|NCT00509899|69603841|FG003|Overall Study|Withdrawal by Subject|0|||
37916994|NCT00509899|69603842|FG004|Overall Study|Withdrawal by Subject|3|||
37916995|NCT00509899|69603843|FG005|Overall Study|Withdrawal by Subject|2|||
37916996|NCT00509899|69603844|FG006|Overall Study|Withdrawal by Subject|0|||
37916997|NCT00509899|69603845|FG007|Overall Study|Withdrawal by Subject|0|||
37916998|NCT00509899|69603838|FG000|Overall Study|Physician Decision|4|||
37916999|NCT00509899|69603839|FG001|Overall Study|Physician Decision|2|||
37917000|NCT00509899|69603840|FG002|Overall Study|Physician Decision|7|||
37917001|NCT00509899|69603841|FG003|Overall Study|Physician Decision|0|||
37917002|NCT00509899|69603842|FG004|Overall Study|Physician Decision|1|||
37917003|NCT00509899|69603843|FG005|Overall Study|Physician Decision|4|||
37917004|NCT00509899|69603844|FG006|Overall Study|Physician Decision|0|||
37917005|NCT00509899|69603845|FG007|Overall Study|Physician Decision|0|||
37917006|NCT00509899|69603838|FG000|Overall Study|Intercurrent Illness|1|||
38026313|NCT00090142|69711119|FG000|Treatment Period I|Withdrawal by Subject|2|||
38026314|NCT00090142|69711120|FG001|Treatment Period I|Withdrawal by Subject|0|||
37734680|NCT00634114|69215021|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
37734681|NCT00634114|69215019|FG000|Overall Study|Difficult to continue|3|||
37734682|NCT00634114|69215020|FG001|Overall Study|Difficult to continue|1|||
37734683|NCT00634114|69215021|FG002|Overall Study|Difficult to continue|1|||
37734684|NCT00634114|69215019|FG000|Overall Study|Other reason|1|||
37734685|NCT00634114|69215020|FG001|Overall Study|Other reason|1|||
37734686|NCT00634114|69215021|FG002|Overall Study|Other reason|1|||
37734687|NCT00634036|69215031|FG000|Overall Study|Lost to Follow-up|1|||
37734688|NCT00634036|69215032|FG001|Overall Study|Lost to Follow-up|1|||
37734689|NCT00634036|69215031|FG000|Overall Study|Withdrawal by Subject|1|||
37734690|NCT00634036|69215032|FG001|Overall Study|Withdrawal by Subject|1|||
37734691|NCT01545375|69215040|FG000|Overall Study|Adverse Event|2|||
37734692|NCT01545375|69215041|FG001|Overall Study|Adverse Event|1|||
37734693|NCT01545375|69215040|FG000|Overall Study|Lost to Follow-up|34|||
37734694|NCT01545375|69215041|FG001|Overall Study|Lost to Follow-up|31|||
37734695|NCT01545375|69215040|FG000|Overall Study|Protocol Violation|3|||
37734696|NCT01545375|69215041|FG001|Overall Study|Protocol Violation|3|||
38026315|NCT00090142|69711119|FG000|Treatment Period I|Other|0|||
38026316|NCT00090142|69711120|FG001|Treatment Period I|Other|1|||
38026317|NCT00090142|69711119|FG000|Treatment Period II|Other|1|||
37846840|NCT01342913|69530941|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
37846841|NCT01342913|69530942|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
37846842|NCT01342913|69530940|FG000|2-week Run-in Period|Adverse Event|2|||
37846843|NCT01342913|69530941|FG001|2-week Run-in Period|Adverse Event|0|||
37846844|NCT01342913|69530942|FG002|2-week Run-in Period|Adverse Event|0|||
37846845|NCT01342913|69530940|FG000|2-week Run-in Period|Protocol Violation|5|||
37917007|NCT00509899|69603839|FG001|Overall Study|Intercurrent Illness|0|||
37917008|NCT00509899|69603840|FG002|Overall Study|Intercurrent Illness|0|||
37846846|NCT01342913|69530941|FG001|2-week Run-in Period|Protocol Violation|0|||
37917009|NCT00509899|69603841|FG003|Overall Study|Intercurrent Illness|1|||
37917010|NCT00509899|69603842|FG004|Overall Study|Intercurrent Illness|0|||
38026318|NCT00090142|69711120|FG001|Treatment Period II|Other|0|||
38026319|NCT03622112|69711137|FG000|Overall Study|Withdrawal by Subject|6|||
38026320|NCT03622112|69711138|FG001|Overall Study|Withdrawal by Subject|2|||
38026321|NCT03622112|69711139|FG002|Overall Study|Withdrawal by Subject|4|||
38026322|NCT03622112|69711140|FG003|Overall Study|Withdrawal by Subject|2|||
37917011|NCT00509899|69603843|FG005|Overall Study|Intercurrent Illness|1|||
37917012|NCT00509899|69603844|FG006|Overall Study|Intercurrent Illness|0|||
37917013|NCT00509899|69603845|FG007|Overall Study|Intercurrent Illness|0|||
37917014|NCT00509899|69603838|FG000|Overall Study|Death|2|||
38026323|NCT03622112|69711141|FG004|Overall Study|Withdrawal by Subject|1|||
38026324|NCT03622112|69711142|FG005|Overall Study|Withdrawal by Subject|2|||
38026325|NCT03622112|69711143|FG006|Overall Study|Withdrawal by Subject|2|||
38026326|NCT03622112|69711137|FG000|Overall Study|Death|0|||
38026327|NCT03622112|69711138|FG001|Overall Study|Death|0|||
37917015|NCT00509899|69603839|FG001|Overall Study|Death|2|||
38026328|NCT03622112|69711139|FG002|Overall Study|Death|0|||
37917016|NCT00509899|69603840|FG002|Overall Study|Death|3|||
37917017|NCT00509899|69603841|FG003|Overall Study|Death|0|||
37917018|NCT00509899|69603842|FG004|Overall Study|Death|1|||
37917019|NCT00509899|69603843|FG005|Overall Study|Death|1|||
37917020|NCT00509899|69603844|FG006|Overall Study|Death|1|||
37917021|NCT00509899|69603845|FG007|Overall Study|Death|1|||
37917022|NCT00509899|69603838|FG000|Overall Study|Lack of Efficacy|1|||
37917023|NCT00509899|69603839|FG001|Overall Study|Lack of Efficacy|0|||
37917024|NCT00509899|69603840|FG002|Overall Study|Lack of Efficacy|2|||
37917025|NCT00509899|69603841|FG003|Overall Study|Lack of Efficacy|0|||
37917026|NCT00509899|69603842|FG004|Overall Study|Lack of Efficacy|0|||
37917027|NCT00509899|69603843|FG005|Overall Study|Lack of Efficacy|1|||
37917028|NCT00509899|69603844|FG006|Overall Study|Lack of Efficacy|0|||
37917029|NCT00509899|69603845|FG007|Overall Study|Lack of Efficacy|0|||
37917030|NCT00862836|69603859|FG000|Overall Study|Withdrawal by Subject|1|||
37846847|NCT01342913|69530942|FG002|2-week Run-in Period|Protocol Violation|0|||
37734697|NCT01545375|69215040|FG000|Overall Study|Withdrawal by Subject|58|||
37734698|NCT01545375|69215041|FG001|Overall Study|Withdrawal by Subject|55|||
37734699|NCT01539837|69215050|FG000|Overall Study|reduce neutrophil level|0|||
37734700|NCT01539837|69215051|FG001|Overall Study|reduce neutrophil level|1|||
37846848|NCT01342913|69530940|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
37846849|NCT01342913|69530941|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
37846850|NCT01342913|69530942|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
37846851|NCT01342913|69530940|FG000|Double-Blind Treatment Period|Adverse Event|0|||
37846852|NCT01342913|69530941|FG001|Double-Blind Treatment Period|Adverse Event|3|||
37846853|NCT01342913|69530942|FG002|Double-Blind Treatment Period|Adverse Event|6|||
37846854|NCT01342913|69530940|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
37846855|NCT01342913|69530941|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
37846856|NCT01342913|69530942|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
37846857|NCT01342913|69530940|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
37846858|NCT01342913|69530941|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
37846859|NCT01342913|69530942|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
37846860|NCT01342913|69530940|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
37846861|NCT01342913|69530941|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
37846862|NCT01342913|69530942|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
37846863|NCT01342913|69530940|FG000|Double-Blind Treatment Period|Physician Decision|0|||
37846864|NCT01342913|69530941|FG001|Double-Blind Treatment Period|Physician Decision|2|||
37846865|NCT01342913|69530942|FG002|Double-Blind Treatment Period|Physician Decision|0|||
37846866|NCT01342913|69530940|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
37846867|NCT01342913|69530941|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
37846868|NCT01342913|69530942|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
37846869|NCT01342796|69530950|FG000|Overall Study|Withdrawal by Subject|2|||
37846870|NCT01342796|69530951|FG001|Overall Study|Withdrawal by Subject|0|||
37846871|NCT01342796|69530950|FG000|Overall Study|Lost to Follow-up|0|||
37846872|NCT01342796|69530951|FG001|Overall Study|Lost to Follow-up|3|||
37846873|NCT01342796|69530950|FG000|Overall Study|Inappropriate enrollment|1|||
37846874|NCT01342796|69530951|FG001|Overall Study|Inappropriate enrollment|0|||
37846875|NCT01342640|69530957|FG000|Overall Study|Adverse Event|3|||
37846876|NCT01342640|69530957|FG000|Overall Study|Protocol Violation|16|||
37846877|NCT01342640|69530957|FG000|Overall Study|Lost to Follow-up|21|||
37846878|NCT01342640|69530957|FG000|Overall Study|Other|1|||
37846879|NCT01342484|69530964|FG000|Overall Study|Other Reasons|1|||
37846880|NCT01342484|69530965|FG001|Overall Study|Other Reasons|0|||
37846881|NCT01342484|69530966|FG002|Overall Study|Other Reasons|0|||
37846882|NCT01342484|69530964|FG000|Overall Study|Protocol Violation|0|||
37846883|NCT01342484|69530965|FG001|Overall Study|Protocol Violation|0|||
37846884|NCT01342484|69530966|FG002|Overall Study|Protocol Violation|1|||
37917031|NCT00820755|69603863|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
37917032|NCT00820755|69603864|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
37846885|NCT01342484|69530964|FG000|Overall Study|Withdrawal by Subject|1|||
37846886|NCT01342484|69530965|FG001|Overall Study|Withdrawal by Subject|0|||
37846887|NCT01342484|69530966|FG002|Overall Study|Withdrawal by Subject|0|||
37734701|NCT01539837|69215052|FG002|Overall Study|reduce neutrophil level|1|||
37734702|NCT01539837|69215050|FG000|Overall Study|bad compliance|0|||
37734703|NCT01539837|69215051|FG001|Overall Study|bad compliance|0|||
37846888|NCT01342445|69530976|FG000|Overall Study|Experienced side effects|0|||
37846889|NCT01342445|69530977|FG001|Overall Study|Experienced side effects|2|||
37846890|NCT01342211|69530992|FG000|Overall Study|Lost to Follow-up|0|||
37846891|NCT01342211|69530993|FG001|Overall Study|Lost to Follow-up|0|||
37846892|NCT01342211|69530994|FG002|Overall Study|Lost to Follow-up|0|||
37846893|NCT01342211|69530995|FG003|Overall Study|Lost to Follow-up|1|||
37846894|NCT01342211|69530996|FG004|Overall Study|Lost to Follow-up|0|||
37917033|NCT00820755|69603865|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
37917034|NCT00820755|69603863|FG000|Period 1: Combination Therapy Phase|Death|28|||
37917035|NCT00820755|69603864|FG001|Period 1: Combination Therapy Phase|Death|0|||
37734704|NCT01539837|69215052|FG002|Overall Study|bad compliance|1|||
37846895|NCT01342211|69530992|FG000|Overall Study|Adverse Event|0|||
37846896|NCT01342211|69530993|FG001|Overall Study|Adverse Event|0|||
37846897|NCT01342211|69530994|FG002|Overall Study|Adverse Event|0|||
37846898|NCT01342211|69530995|FG003|Overall Study|Adverse Event|0|||
37846899|NCT01342211|69530996|FG004|Overall Study|Adverse Event|1|||
37846900|NCT01342211|69530992|FG000|Overall Study|Withdrawal by Subject|0|||
37846901|NCT01342211|69530993|FG001|Overall Study|Withdrawal by Subject|0|||
37846902|NCT01342211|69530994|FG002|Overall Study|Withdrawal by Subject|0|||
37846903|NCT01342211|69530995|FG003|Overall Study|Withdrawal by Subject|1|||
37917036|NCT00820755|69603865|FG002|Period 1: Combination Therapy Phase|Death|0|||
37917037|NCT00820755|69603863|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
37917038|NCT00820755|69603864|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
37917039|NCT00820755|69603865|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
37917040|NCT00820755|69603863|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
37917041|NCT00820755|69603864|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
37917042|NCT00820755|69603865|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
37917043|NCT00820755|69603863|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
37917044|NCT00820755|69603864|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
37917045|NCT00820755|69603865|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
37917046|NCT00820755|69603863|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
37917047|NCT00820755|69603864|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
37917048|NCT00820755|69603865|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
37917049|NCT00820755|69603863|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
37917050|NCT00820755|69603864|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
37917051|NCT00820755|69603865|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
37917052|NCT00820755|69603863|FG000|Period 1: Combination Therapy Phase|Other|11|||
37917053|NCT00820755|69603864|FG001|Period 1: Combination Therapy Phase|Other|0|||
37917054|NCT00820755|69603865|FG002|Period 1: Combination Therapy Phase|Other|0|||
37917055|NCT00820755|69603863|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
37917056|NCT00820755|69603864|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
37917057|NCT00820755|69603865|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
37917058|NCT00820599|69603873|FG000|Overall Study|Death|129|||
37917059|NCT00820599|69603873|FG000|Overall Study|Withdrawal by Subject|2|||
37917060|NCT00819741|69603879|FG000|Overall Study|Adverse Event|5|||
37917061|NCT00819741|69603880|FG001|Overall Study|Adverse Event|2|||
37917062|NCT00819741|69603879|FG000|Overall Study|Lack of Efficacy|0|||
37917063|NCT00819741|69603880|FG001|Overall Study|Lack of Efficacy|2|||
37917064|NCT00819741|69603879|FG000|Overall Study|Lost to Follow-up|3|||
37917065|NCT00819741|69603880|FG001|Overall Study|Lost to Follow-up|1|||
37917066|NCT00819741|69603879|FG000|Overall Study|Protocol Violation|3|||
37917067|NCT00819741|69603880|FG001|Overall Study|Protocol Violation|4|||
37917068|NCT00819741|69603879|FG000|Overall Study|Withdrawal by Subject|2|||
37917069|NCT00819741|69603880|FG001|Overall Study|Withdrawal by Subject|2|||
37917070|NCT00819741|69603879|FG000|Overall Study|Unclassified|6|||
37917071|NCT00819741|69603880|FG001|Overall Study|Unclassified|0|||
37917072|NCT00819741|69603879|FG000|Overall Study|Reasons unknown|3|||
37917073|NCT00819741|69603880|FG001|Overall Study|Reasons unknown|3|||
37917074|NCT00862134|69603888|FG000|Overall Study|Death|1|||
37917075|NCT00862134|69603889|FG001|Overall Study|Death|0|||
37917076|NCT00862134|69603888|FG000|Overall Study|Physician Decision|0|||
37917077|NCT00862134|69603889|FG001|Overall Study|Physician Decision|1|||
37917078|NCT00862134|69603888|FG000|Overall Study|Withdrawal by Subject|1|||
37917079|NCT00862134|69603889|FG001|Overall Study|Withdrawal by Subject|2|||
37917080|NCT00862134|69603888|FG000|Overall Study|Sponsor terminated study|5|||
37917081|NCT00862134|69603889|FG001|Overall Study|Sponsor terminated study|7|||
37917082|NCT00862134|69603888|FG000|Overall Study|Adverse Event|2|||
37917083|NCT00862134|69603889|FG001|Overall Study|Adverse Event|2|||
37917084|NCT00862134|69603888|FG000|Overall Study|Withdrew prior to dosing|2|||
37917085|NCT00862134|69603889|FG001|Overall Study|Withdrew prior to dosing|0|||
37917086|NCT00848484|69603897|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
37917087|NCT00848484|69603898|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
37917088|NCT00848484|69603897|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
37917089|NCT00848484|69603898|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
37917090|NCT00848484|69603897|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
37917091|NCT00848484|69603898|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
37917092|NCT00848484|69603897|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
37917093|NCT00848484|69603898|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
37917094|NCT00848484|69603897|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
38026329|NCT03622112|69711140|FG003|Overall Study|Death|1|||
37846904|NCT01342211|69530996|FG004|Overall Study|Withdrawal by Subject|0|||
37846905|NCT01342211|69530992|FG000|Overall Study|Randomized, but not Treated|0|||
37846906|NCT01342211|69530993|FG001|Overall Study|Randomized, but not Treated|2|||
37846907|NCT01342211|69530994|FG002|Overall Study|Randomized, but not Treated|0|||
37846908|NCT01342211|69530995|FG003|Overall Study|Randomized, but not Treated|0|||
37846909|NCT01342211|69530996|FG004|Overall Study|Randomized, but not Treated|1|||
37846910|NCT01342094|69531014|FG000|Overall Study|Adverse Event|5|||
37846911|NCT01342094|69531015|FG001|Overall Study|Adverse Event|0|||
37846912|NCT01342094|69531014|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
37846913|NCT01342094|69531015|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
37846914|NCT01342094|69531014|FG000|Overall Study|Withdrawal by Subject|0|||
37846915|NCT01342094|69531015|FG001|Overall Study|Withdrawal by Subject|2|||
37846916|NCT01340768|69531023|FG000|Overall Study|Lost to Follow-up|10|||
37846917|NCT01340768|69531024|FG001|Overall Study|Lost to Follow-up|4|||
37846918|NCT01340768|69531023|FG000|Overall Study|Withdrawal by Subject|5|||
37846919|NCT01340768|69531024|FG001|Overall Study|Withdrawal by Subject|1|||
37846920|NCT01340768|69531023|FG000|Overall Study|Other|2|||
37917095|NCT00848484|69603898|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
37917096|NCT00509821|69603906|FG000|Study Period 1 (Induction)|Death|0|||
37917097|NCT00509821|69603907|FG001|Study Period 1 (Induction)|Death|1|||
37917098|NCT00509821|69603906|FG000|Study Period 1 (Induction)|Adverse Event|0|||
37917099|NCT00509821|69603907|FG001|Study Period 1 (Induction)|Adverse Event|2|||
37917100|NCT00509821|69603906|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
37917101|NCT00509821|69603907|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
37917102|NCT00508651|69603920|FG000|Overall Study|Lost to Follow-up|3|||
37846921|NCT01340768|69531024|FG001|Overall Study|Other|0|||
37846922|NCT01340651|69531030|FG000|Overall Study|Adverse Event|3|||
37846923|NCT01340651|69531030|FG000|Overall Study|Consent Withdrawn|2|||
37846924|NCT01340651|69531030|FG000|Overall Study|Commercial Supply per Sponsor|12|||
37846925|NCT01340495|69531036|FG000|Overall Study|Withdrawal by Subject|1|||
37846926|NCT01340300|69531044|FG000|Overall Study|Lost to Follow-up|3|||
37846927|NCT01340300|69531045|FG001|Overall Study|Lost to Follow-up|0|||
37846928|NCT01340300|69531046|FG002|Overall Study|Lost to Follow-up|5|||
37846929|NCT01340300|69531047|FG003|Overall Study|Lost to Follow-up|10|||
37846930|NCT01340300|69531044|FG000|Overall Study|Withdrawal by Subject|5|||
37846931|NCT01340300|69531045|FG001|Overall Study|Withdrawal by Subject|6|||
37917103|NCT00508651|69603921|FG001|Overall Study|Lost to Follow-up|1|||
37917104|NCT00508651|69603920|FG000|Overall Study|Withdrawal by Subject|1|||
37846932|NCT01340300|69531046|FG002|Overall Study|Withdrawal by Subject|6|||
37846933|NCT01340300|69531047|FG003|Overall Study|Withdrawal by Subject|3|||
37846934|NCT01340300|69531044|FG000|Overall Study|Adverse Event|1|||
37846935|NCT01340300|69531045|FG001|Overall Study|Adverse Event|0|||
37846936|NCT01340300|69531046|FG002|Overall Study|Adverse Event|4|||
37846937|NCT01340300|69531047|FG003|Overall Study|Adverse Event|0|||
37846938|NCT01340300|69531044|FG000|Overall Study|Physician Decision|0|||
37846939|NCT01340300|69531045|FG001|Overall Study|Physician Decision|1|||
37846940|NCT01340300|69531046|FG002|Overall Study|Physician Decision|0|||
37846941|NCT01340300|69531047|FG003|Overall Study|Physician Decision|0|||
37846942|NCT01340300|69531044|FG000|Overall Study|Unrelated sickness|0|||
37846943|NCT01340300|69531045|FG001|Overall Study|Unrelated sickness|2|||
37917105|NCT00508651|69603921|FG001|Overall Study|Withdrawal by Subject|1|||
37917106|NCT00490555|69603931|FG000|Overall Study|noncompliant with drug administration|0|||
37917107|NCT00490555|69603932|FG001|Overall Study|noncompliant with drug administration|0|||
37917108|NCT00490555|69603933|FG002|Overall Study|noncompliant with drug administration|2|||
37917109|NCT00490555|69603934|FG003|Overall Study|noncompliant with drug administration|0|||
37917110|NCT00501085|69603944|FG000|Overall Study|Lost to Follow-up|195|||
38026330|NCT03622112|69711141|FG004|Overall Study|Death|0|||
37734705|NCT01539759|69215062|FG000|Overall Study|Lost to Follow-up|6|||
37734706|NCT01539759|69215063|FG001|Overall Study|Lost to Follow-up|8|||
37734707|NCT00633022|69215072|FG000|Overall Study|Adverse Event|1|||
37734708|NCT00633022|69215073|FG001|Overall Study|Adverse Event|0|||
37734709|NCT00633022|69215074|FG002|Overall Study|Adverse Event|5|||
37734710|NCT00633022|69215072|FG000|Overall Study|Physician Decision|0|||
37917111|NCT00501085|69603944|FG000|Overall Study|Withdrawal by Subject|34|||
37917112|NCT00501085|69603944|FG000|Overall Study|Subject Decision|1|||
38026331|NCT03622112|69711142|FG005|Overall Study|Death|0|||
37734711|NCT00633022|69215073|FG001|Overall Study|Physician Decision|1|||
37846944|NCT01340300|69531046|FG002|Overall Study|Unrelated sickness|0|||
37846945|NCT01340300|69531047|FG003|Overall Study|Unrelated sickness|1|||
37846946|NCT01340066|69531059|FG000|Placebo Run in Period|Screen Failures|27|||
37846947|NCT01340066|69531060|FG001|Placebo Run in Period|Screen Failures|0|||
37846948|NCT01340066|69531061|FG002|Placebo Run in Period|Screen Failures|0|||
37846949|NCT01340066|69531059|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
37846950|NCT01340066|69531060|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
37846951|NCT01340066|69531061|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
37846952|NCT01340066|69531059|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
37846953|NCT01340066|69531060|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
37917113|NCT00501085|69603944|FG000|Overall Study|Revision Surgery|7|||
37734712|NCT00633022|69215074|FG002|Overall Study|Physician Decision|0|||
37734713|NCT00630994|69215082|FG000|Overall Study|Adverse Event|1|||
37734714|NCT00630994|69215082|FG000|Overall Study|Disease Progression|1|||
37734715|NCT00630994|69215082|FG000|Overall Study|Lack of Efficacy|1|||
37734716|NCT00630994|69215082|FG000|Overall Study|Other|1|||
37734717|NCT00630838|69215088|FG000|Overall Study|Death|0|||
37734718|NCT00630838|69215089|FG001|Overall Study|Death|1|||
37734719|NCT00630838|69215088|FG000|Overall Study|Lost to Follow-up|0|||
37734720|NCT00630838|69215089|FG001|Overall Study|Lost to Follow-up|1|||
37846954|NCT01340066|69531061|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
37846955|NCT01340066|69531059|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
37846956|NCT01340066|69531060|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
37846957|NCT01340066|69531061|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
37846958|NCT01107535|69531068|FG000|Overall Study|Death|5|||
37917114|NCT00501085|69603944|FG000|Overall Study|Explantation Surgery|26|||
37917115|NCT00501085|69603944|FG000|Overall Study|Adverse Event|4|||
37917116|NCT00501085|69603944|FG000|Overall Study|Non-Compliance|24|||
37917117|NCT00501085|69603944|FG000|Overall Study|Study closed by sponsor|109|||
37917118|NCT00501085|69603944|FG000|Overall Study|Other loss to follow-up|32|||
37917119|NCT00501007|69603948|FG000|Overall Study|Inclusion criteria not met.|29|||
37917120|NCT00501007|69603949|FG001|Overall Study|Inclusion criteria not met.|25|||
37917121|NCT00873860|69603959|FG000|Overall Study|Lost to Follow-up|1|||
37917122|NCT00873860|69603960|FG001|Overall Study|Lost to Follow-up|0|||
37917123|NCT00873860|69603961|FG002|Overall Study|Lost to Follow-up|0|||
37917124|NCT00873860|69603962|FG003|Overall Study|Lost to Follow-up|1|||
37917125|NCT00873860|69603959|FG000|Overall Study|Withdrawal by Subject|1|||
37917126|NCT00873860|69603960|FG001|Overall Study|Withdrawal by Subject|0|||
37917127|NCT00873860|69603961|FG002|Overall Study|Withdrawal by Subject|2|||
37917128|NCT00873860|69603962|FG003|Overall Study|Withdrawal by Subject|0|||
37917129|NCT00873860|69603959|FG000|Overall Study|Death|1|||
37917130|NCT00873860|69603960|FG001|Overall Study|Death|0|||
37917131|NCT00873860|69603961|FG002|Overall Study|Death|0|||
37917132|NCT00873860|69603962|FG003|Overall Study|Death|0|||
37917133|NCT00873860|69603959|FG000|Overall Study|Other|1|||
37917134|NCT00873860|69603960|FG001|Overall Study|Other|0|||
37846959|NCT01326546|69531074|FG000|Overall Study|Lost to Follow-up|8|||
37846960|NCT01326546|69531075|FG001|Overall Study|Lost to Follow-up|7|||
37917135|NCT00873860|69603961|FG002|Overall Study|Other|1|||
37917136|NCT00873860|69603962|FG003|Overall Study|Other|0|||
37917137|NCT03853291|69603985|FG000|Overall Study|Lost to Follow-up|1|||
37917138|NCT03853291|69603986|FG001|Overall Study|Lost to Follow-up|2|||
37917139|NCT03853291|69603987|FG002|Overall Study|Lost to Follow-up|0|||
37917140|NCT03853291|69603988|FG003|Overall Study|Lost to Follow-up|0|||
37917141|NCT03853291|69603989|FG004|Overall Study|Lost to Follow-up|0|||
37917142|NCT03853291|69603990|FG005|Overall Study|Lost to Follow-up|0|||
37917143|NCT03853291|69603985|FG000|Overall Study|Determined to be ineligible|1|||
37917144|NCT03853291|69603986|FG001|Overall Study|Determined to be ineligible|1|||
37917145|NCT03853291|69603987|FG002|Overall Study|Determined to be ineligible|0|||
37917146|NCT03853291|69603988|FG003|Overall Study|Determined to be ineligible|0|||
37917147|NCT03853291|69603989|FG004|Overall Study|Determined to be ineligible|0|||
37917148|NCT03853291|69603990|FG005|Overall Study|Determined to be ineligible|0|||
37846961|NCT01326546|69531074|FG000|Overall Study|Protocol Violation|3|||
37846962|NCT01326546|69531075|FG001|Overall Study|Protocol Violation|4|||
37846963|NCT01326546|69531074|FG000|Overall Study|Pregnancy|0|||
37846964|NCT01326546|69531075|FG001|Overall Study|Pregnancy|1|||
37846965|NCT01326546|69531074|FG000|Overall Study|Adverse Event|1|||
37846966|NCT01326546|69531075|FG001|Overall Study|Adverse Event|0|||
37846967|NCT01326546|69531074|FG000|Overall Study|Withdrawal by Subject|5|||
37846968|NCT01326546|69531075|FG001|Overall Study|Withdrawal by Subject|1|||
37846969|NCT01325532|69531083|FG000|Overall Study|Withdrawal by Subject|2|||
37917149|NCT03853213|69604003|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
37917150|NCT03853213|69604004|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
37917151|NCT03853213|69604003|FG000|Overall Study|Other (e.g., too busy)|0|||
37734721|NCT00630058|69215099|FG000|Overall Study|Adverse Event|1|||
37846970|NCT01325532|69531084|FG001|Overall Study|Withdrawal by Subject|0|||
37846971|NCT01171963|69531092|FG000|Overall Study|Adverse Event|10|||
37917152|NCT03853213|69604004|FG001|Overall Study|Other (e.g., too busy)|2|||
37917153|NCT02666105|69604030|FG000|Overall Study|Death|1|||
37917154|NCT00819585|69604049|FG000|Core Study|Adverse Event|2|||
37734722|NCT00630058|69215100|FG001|Overall Study|Adverse Event|1|||
37846972|NCT01171963|69531093|FG001|Overall Study|Adverse Event|15|||
37846973|NCT01171963|69531092|FG000|Overall Study|Lost to Follow-up|23|||
37917155|NCT00819585|69604050|FG001|Core Study|Adverse Event|1|||
37917156|NCT00819585|69604051|FG002|Core Study|Adverse Event|1|||
37917157|NCT00819585|69604052|FG003|Core Study|Adverse Event|4|||
37846974|NCT01171963|69531093|FG001|Overall Study|Lost to Follow-up|24|||
37846975|NCT01171963|69531092|FG000|Overall Study|Other - diarrhoea|1|||
37846976|NCT01171963|69531093|FG001|Overall Study|Other - diarrhoea|0|||
37846977|NCT01171963|69531092|FG000|Overall Study|Withdrawal by Subject|114|||
37846978|NCT01171963|69531093|FG001|Overall Study|Withdrawal by Subject|129|||
37846979|NCT01171183|69531104|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
37846980|NCT01171183|69531105|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
37846981|NCT01171183|69531104|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
37846982|NCT01171183|69531105|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
37846983|NCT01171183|69531104|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
37846984|NCT01171183|69531105|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
37846985|NCT01171183|69531104|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
37846986|NCT01171183|69531105|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
37846987|NCT01171183|69531104|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
37846988|NCT01171183|69531105|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
37846989|NCT01171183|69531104|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
37846990|NCT01171183|69531105|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
37846991|NCT01170091|69531111|FG000|Overall Study|Missing efficacy evaluation|3|||
37846992|NCT01170091|69531111|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
37846993|NCT01169779|69531117|FG000|Overall Study|Adverse Event|3|||
37846994|NCT01169779|69531118|FG001|Overall Study|Adverse Event|11|||
37846995|NCT01169779|69531117|FG000|Overall Study|Lack of Efficacy|1|||
37846996|NCT01169779|69531118|FG001|Overall Study|Lack of Efficacy|0|||
37846997|NCT01169779|69531117|FG000|Overall Study|Protocol Violation|1|||
37846998|NCT01169779|69531118|FG001|Overall Study|Protocol Violation|1|||
37846999|NCT01169779|69531117|FG000|Overall Study|Withdrawal by Subject|3|||
37847000|NCT01169779|69531118|FG001|Overall Study|Withdrawal by Subject|2|||
37847001|NCT01169779|69531117|FG000|Overall Study|Familial and personal reasons|3|||
37847002|NCT01169779|69531118|FG001|Overall Study|Familial and personal reasons|3|||
37847003|NCT01169701|69531126|FG000|Overall Study|Lost to Follow-up|1|||
37847004|NCT01169701|69531127|FG001|Overall Study|Lost to Follow-up|1|||
37847005|NCT01169701|69531126|FG000|Overall Study|Withdrawal by Subject|1|||
37847006|NCT01169701|69531127|FG001|Overall Study|Withdrawal by Subject|3|||
37847007|NCT01169701|69531126|FG000|Overall Study|Adverse Event|1|||
37847008|NCT01169701|69531127|FG001|Overall Study|Adverse Event|2|||
37847009|NCT01169701|69531126|FG000|Overall Study|Exclusion criteria|2|||
37847010|NCT01169701|69531127|FG001|Overall Study|Exclusion criteria|0|||
37847011|NCT01169701|69531126|FG000|Overall Study|Death|0|||
37847012|NCT01169701|69531127|FG001|Overall Study|Death|1|||
37847013|NCT01169701|69531126|FG000|Overall Study|Administrative problems|0|||
37847014|NCT01169701|69531127|FG001|Overall Study|Administrative problems|1|||
37847015|NCT01169701|69531126|FG000|Overall Study|Serious adverse event|0|||
37847016|NCT01169701|69531127|FG001|Overall Study|Serious adverse event|1|||
37847017|NCT01169701|69531126|FG000|Overall Study|Sponsor decision|0|||
37847018|NCT01169701|69531127|FG001|Overall Study|Sponsor decision|1|||
37847019|NCT01168999|69531137|FG000|Overall Study|Lost to Follow-up|2|||
37847020|NCT01168999|69531138|FG001|Overall Study|Lost to Follow-up|1|||
37847021|NCT01168999|69531139|FG002|Overall Study|Lost to Follow-up|0|||
37847022|NCT01168999|69531140|FG003|Overall Study|Lost to Follow-up|0|||
37847023|NCT01167907|69531152|FG000|Overall Study|Protocol Violation|1|||
37847024|NCT01167907|69531153|FG001|Overall Study|Protocol Violation|0|||
37847025|NCT01167907|69531152|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
37847026|NCT01167907|69531153|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
37847027|NCT01166659|69531159|FG000|Overall Study|Subject Decision|8|||
37847028|NCT01166659|69531159|FG000|Overall Study|Investigator Decision|2|||
37847029|NCT01166659|69531159|FG000|Overall Study|Death|1|||
37847030|NCT01166659|69531159|FG000|Overall Study|Lost to Follow-up|1|||
37917158|NCT00819585|69604053|FG004|Core Study|Adverse Event|1|||
37847031|NCT01166659|69531159|FG000|Overall Study|Study Closed at Site|1|||
37847032|NCT01115491|69531164|FG000|Overall Study|Death|22|||
37847033|NCT01115491|69531164|FG000|Overall Study|Adverse Event|3|||
37847034|NCT01115491|69531164|FG000|Overall Study|Lost to Follow-up|3|||
37847035|NCT01115491|69531164|FG000|Overall Study|Withdrawal by Subject|1|||
37847036|NCT01115491|69531164|FG000|Overall Study|Physician Decision|1|||
37847037|NCT01113931|69531170|FG000|Overall Study|Adverse Event|2|||
37917159|NCT00819585|69604054|FG005|Core Study|Adverse Event|0|||
37847038|NCT01113931|69531171|FG001|Overall Study|Adverse Event|2|||
37847039|NCT01113931|69531170|FG000|Overall Study|Physician Decision|0|||
37847040|NCT01113931|69531171|FG001|Overall Study|Physician Decision|2|||
37847041|NCT01113931|69531170|FG000|Overall Study|Lost to Follow-up|12|||
37847042|NCT01113931|69531171|FG001|Overall Study|Lost to Follow-up|9|||
37847043|NCT01113931|69531170|FG000|Overall Study|Various|2|||
37847044|NCT01113931|69531171|FG001|Overall Study|Various|4|||
37847045|NCT01113931|69531170|FG000|Overall Study|Withdrawal by Subject|3|||
37847046|NCT01113931|69531171|FG001|Overall Study|Withdrawal by Subject|0|||
37847047|NCT01107379|69531177|FG000|Overall Study|Withdrawal by Subject|18|||
37847048|NCT01107379|69531177|FG000|Overall Study|Lost to Follow-up|3|||
37847049|NCT01106911|69531181|FG000|Overall Study|Physician Decision|2|||
37847050|NCT01106911|69531181|FG000|Overall Study|deemed ineligible after screening|3|||
37847051|NCT01106677|69531189|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
37917160|NCT00819585|69604055|FG006|Core Study|Adverse Event|2|||
37917161|NCT00819585|69604056|FG007|Core Study|Adverse Event|0|||
37917162|NCT00819585|69604057|FG008|Core Study|Adverse Event|0|||
37917163|NCT00819585|69604058|FG009|Core Study|Adverse Event|0|||
37917164|NCT00819585|69604059|FG010|Core Study|Adverse Event|0|||
37917165|NCT00819585|69604049|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
37917166|NCT00819585|69604050|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
37917167|NCT00819585|69604051|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
37917168|NCT00819585|69604052|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
37917169|NCT00819585|69604053|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
37917170|NCT00819585|69604054|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
37917171|NCT00819585|69604055|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
37917172|NCT00819585|69604056|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
37917173|NCT00819585|69604057|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
37917174|NCT00819585|69604058|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
37917175|NCT00819585|69604059|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
37917176|NCT00819585|69604049|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
37917177|NCT00819585|69604050|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
37917178|NCT00819585|69604051|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
37917179|NCT00819585|69604052|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
37917180|NCT00819585|69604053|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
37917181|NCT00819585|69604054|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
37917182|NCT00819585|69604055|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
38026332|NCT03622112|69711143|FG006|Overall Study|Death|0|||
38026333|NCT03622112|69711137|FG000|Overall Study|Lost to Follow-up|1|||
38026334|NCT03622112|69711138|FG001|Overall Study|Lost to Follow-up|1|||
38026335|NCT03622112|69711139|FG002|Overall Study|Lost to Follow-up|0|||
38026336|NCT03622112|69711140|FG003|Overall Study|Lost to Follow-up|0|||
38026337|NCT03622112|69711141|FG004|Overall Study|Lost to Follow-up|0|||
38026338|NCT03622112|69711142|FG005|Overall Study|Lost to Follow-up|0|||
38026339|NCT03622112|69711143|FG006|Overall Study|Lost to Follow-up|0|||
38026340|NCT03622112|69711137|FG000|Overall Study|Study-specific withdrawal criteria|10|||
38026341|NCT03622112|69711138|FG001|Overall Study|Study-specific withdrawal criteria|8|||
38026342|NCT03622112|69711139|FG002|Overall Study|Study-specific withdrawal criteria|7|||
38026343|NCT03622112|69711140|FG003|Overall Study|Study-specific withdrawal criteria|6|||
38026344|NCT03622112|69711141|FG004|Overall Study|Study-specific withdrawal criteria|4|||
38026345|NCT03622112|69711142|FG005|Overall Study|Study-specific withdrawal criteria|18|||
38026346|NCT03622112|69711143|FG006|Overall Study|Study-specific withdrawal criteria|4|||
37734723|NCT00630058|69215099|FG000|Overall Study|Withdrawal by Subject|0|||
37734724|NCT00630058|69215100|FG001|Overall Study|Withdrawal by Subject|1|||
37734725|NCT00630058|69215099|FG000|Overall Study|stopping criteria|3|||
37734726|NCT00630058|69215100|FG001|Overall Study|stopping criteria|2|||
37734727|NCT01925794|69215106|FG000|180 Days|Death|2|||
37734728|NCT01925794|69215106|FG000|180 Days|Withdrawal by Subject|2|||
37734729|NCT01925794|69215106|FG000|270 Days|Death|2|||
37734730|NCT01925794|69215106|FG000|270 Days|Protocol Violation|3|||
37734731|NCT00989950|69215118|FG000|Randomized Phase|Protocol Violation|1|||
37734732|NCT00989950|69215119|FG001|Randomized Phase|Protocol Violation|0|||
37734733|NCT00989950|69215120|FG002|Randomized Phase|Protocol Violation|0|||
37734734|NCT00989950|69215121|FG003|Randomized Phase|Protocol Violation|0|||
37917183|NCT00819585|69604056|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
37917184|NCT00819585|69604057|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
37917185|NCT00819585|69604058|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
37917186|NCT00819585|69604059|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
37917187|NCT00819585|69604049|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
37734735|NCT00989950|69215118|FG000|Randomized Phase|Adverse Event|0|||
37734736|NCT00989950|69215119|FG001|Randomized Phase|Adverse Event|1|||
37734737|NCT00989950|69215120|FG002|Randomized Phase|Adverse Event|0|||
37734738|NCT00989950|69215121|FG003|Randomized Phase|Adverse Event|0|||
37734739|NCT01905943|69215131|FG000|Overall Study|Withdrawal of consent|90|||
37734740|NCT01905943|69215131|FG000|Overall Study|Lost to Follow-up|16|||
37734741|NCT01905943|69215131|FG000|Overall Study|Investigator discretion|7|||
37917188|NCT00819585|69604050|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
37847052|NCT01106677|69531190|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
37917189|NCT00819585|69604051|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
37917190|NCT00819585|69604052|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
37847053|NCT01106677|69531191|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
37847054|NCT01106677|69531192|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
37847055|NCT01106677|69531189|FG000|Core Period: Baseline to Week 26|Death|0|||
37847056|NCT01106677|69531190|FG001|Core Period: Baseline to Week 26|Death|0|||
37847057|NCT01106677|69531191|FG002|Core Period: Baseline to Week 26|Death|1|||
37847058|NCT01106677|69531192|FG003|Core Period: Baseline to Week 26|Death|0|||
37847059|NCT01106677|69531189|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
37847060|NCT01106677|69531190|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
37847061|NCT01106677|69531191|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
37847062|NCT01106677|69531192|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
37847063|NCT01106677|69531189|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
37847064|NCT01106677|69531190|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
37847065|NCT01106677|69531191|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
37847066|NCT01106677|69531192|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
37847067|NCT01106677|69531189|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
37847068|NCT01106677|69531190|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
37847069|NCT01106677|69531191|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
37847070|NCT01106677|69531192|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
37847071|NCT01106677|69531189|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
37847072|NCT01106677|69531190|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
37847073|NCT01106677|69531191|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
37847074|NCT01106677|69531192|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
37847075|NCT01106677|69531189|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
37847076|NCT01106677|69531190|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
37847077|NCT01106677|69531191|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
37847078|NCT01106677|69531192|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
37847079|NCT01106677|69531189|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
37847080|NCT01106677|69531190|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
37847081|NCT01106677|69531191|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
37847082|NCT01106677|69531192|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
37847083|NCT01106677|69531189|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
37847084|NCT01106677|69531190|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
37847085|NCT01106677|69531191|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
37847086|NCT01106677|69531192|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
37847087|NCT01106677|69531189|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
37847088|NCT01106677|69531190|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
37847089|NCT01106677|69531191|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
37847090|NCT01106677|69531192|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
37847091|NCT01106677|69531189|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
37847092|NCT01106677|69531190|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
37847093|NCT01106677|69531191|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
37847094|NCT01106677|69531192|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
37847095|NCT01106677|69531189|FG000|Core Period: Baseline to Week 26|Other|8|||
37847096|NCT01106677|69531190|FG001|Core Period: Baseline to Week 26|Other|14|||
37847097|NCT01106677|69531191|FG002|Core Period: Baseline to Week 26|Other|8|||
37847098|NCT01106677|69531192|FG003|Core Period: Baseline to Week 26|Other|23|||
37847099|NCT01106677|69531189|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
37734742|NCT01905943|69215131|FG000|Overall Study|Death|186|||
37734743|NCT01905943|69215131|FG000|Overall Study|Adverse Event|3|||
37734744|NCT01905943|69215131|FG000|Overall Study|Other|12|||
37734745|NCT01905553|69215152|FG000|Period 2|Adverse Event|1|||
37734746|NCT01905553|69215153|FG001|Period 2|Adverse Event|0|||
37734747|NCT01929031|69215163|FG000|Overall Study|Adverse Event|3|||
37734748|NCT01929031|69215164|FG001|Overall Study|Adverse Event|1|||
37734749|NCT01929031|69215165|FG002|Overall Study|Adverse Event|1|||
37734750|NCT01929031|69215166|FG003|Overall Study|Adverse Event|0|||
37734751|NCT01929031|69215167|FG004|Overall Study|Adverse Event|0|||
37734752|NCT01929031|69215168|FG005|Overall Study|Adverse Event|0|||
37734753|NCT01929031|69215163|FG000|Overall Study|Protocol Violation|1|||
37734754|NCT01929031|69215164|FG001|Overall Study|Protocol Violation|0|||
37734755|NCT01929031|69215165|FG002|Overall Study|Protocol Violation|0|||
37734756|NCT01929031|69215166|FG003|Overall Study|Protocol Violation|0|||
37734757|NCT01929031|69215167|FG004|Overall Study|Protocol Violation|0|||
37734758|NCT01929031|69215168|FG005|Overall Study|Protocol Violation|1|||
37734759|NCT01929031|69215163|FG000|Overall Study|Reason other than specified above|0|||
37847100|NCT01106677|69531190|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
37847101|NCT01106677|69531191|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
37847102|NCT01106677|69531192|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
37847103|NCT01106677|69531189|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
37847104|NCT01106677|69531190|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
37847105|NCT01106677|69531191|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
37847106|NCT01106677|69531192|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
37847107|NCT01106677|69531189|FG000|Extension Period: Week 26 to Week 52|Death|0|||
37847108|NCT01106677|69531190|FG001|Extension Period: Week 26 to Week 52|Death|0|||
37847109|NCT01106677|69531191|FG002|Extension Period: Week 26 to Week 52|Death|0|||
37847110|NCT01106677|69531192|FG003|Extension Period: Week 26 to Week 52|Death|1|||
37847111|NCT01106677|69531189|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
37847112|NCT01106677|69531190|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
37847113|NCT01106677|69531191|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
37847114|NCT01106677|69531192|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
37847115|NCT01106677|69531189|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
37847116|NCT01106677|69531190|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
37847117|NCT01106677|69531191|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
37847118|NCT01106677|69531192|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
37847119|NCT01106677|69531189|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
37847120|NCT01106677|69531190|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
37847121|NCT01106677|69531191|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
37847122|NCT01106677|69531192|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
37847123|NCT01106677|69531189|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
37847124|NCT01106677|69531190|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
37847125|NCT01106677|69531191|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
37847126|NCT01106677|69531192|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
37847127|NCT01106677|69531189|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
37847128|NCT01106677|69531190|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
37847129|NCT01106677|69531191|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
37847130|NCT01106677|69531192|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
37847131|NCT01106677|69531189|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
37847132|NCT01106677|69531190|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
37847133|NCT01106677|69531191|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
37847134|NCT01106677|69531192|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
37847135|NCT01106677|69531189|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
37847136|NCT01106677|69531190|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
37847137|NCT01106677|69531191|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
37847138|NCT01106677|69531192|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
37847139|NCT01106677|69531189|FG000|Extension Period: Week 26 to Week 52|Other|6|||
37847140|NCT01106677|69531190|FG001|Extension Period: Week 26 to Week 52|Other|5|||
37847141|NCT01106677|69531191|FG002|Extension Period: Week 26 to Week 52|Other|8|||
37847142|NCT01106677|69531192|FG003|Extension Period: Week 26 to Week 52|Other|5|||
37847143|NCT01106287|69531213|FG000|Overall Study|Adverse Event|1|||
37847144|NCT01106287|69531214|FG001|Overall Study|Adverse Event|0|||
37847145|NCT01106287|69531215|FG002|Overall Study|Adverse Event|0|||
37847146|NCT01106287|69531216|FG003|Overall Study|Adverse Event|0|||
37847147|NCT01104493|69531232|FG000|Overall Study|Lost to Follow-up|0|||
37847148|NCT01104493|69531233|FG001|Overall Study|Lost to Follow-up|2|||
37847149|NCT01104415|69531239|FG000|Core Phase|Consent withdrawn by subjects|1|||
37734760|NCT01929031|69215164|FG001|Overall Study|Reason other than specified above|1|||
37734761|NCT01929031|69215165|FG002|Overall Study|Reason other than specified above|0|||
37734762|NCT01929031|69215166|FG003|Overall Study|Reason other than specified above|0|||
37734763|NCT01929031|69215167|FG004|Overall Study|Reason other than specified above|1|||
37734764|NCT01929031|69215168|FG005|Overall Study|Reason other than specified above|0|||
37734765|NCT00989092|69215180|FG000|Overall Study|Physician Decision|9|||
37734766|NCT00989092|69215181|FG001|Overall Study|Physician Decision|6|||
37734767|NCT00989092|69215180|FG000|Overall Study|Adverse Event|20|||
37734768|NCT00989092|69215181|FG001|Overall Study|Adverse Event|1|||
37847150|NCT01104415|69531240|FG001|Core Phase|Consent withdrawn by subjects|0|||
37734769|NCT00989092|69215180|FG000|Overall Study|Chemotherapy initiated|12|||
37734770|NCT00989092|69215181|FG001|Overall Study|Chemotherapy initiated|4|||
37847151|NCT01104415|69531239|FG000|Extension Period|Progressive disease|0|||
37847152|NCT01104415|69531240|FG001|Extension Period|Progressive disease|4|||
37734771|NCT00989092|69215180|FG000|Overall Study|Withdrawal by Subject|17|||
37734772|NCT00989092|69215181|FG001|Overall Study|Withdrawal by Subject|9|||
37734773|NCT00989092|69215180|FG000|Overall Study|Death|14|||
37734774|NCT00989092|69215181|FG001|Overall Study|Death|2|||
37917191|NCT00819585|69604053|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
37847153|NCT01104415|69531239|FG000|Extension Period|Death|0|||
37847154|NCT01104415|69531240|FG001|Extension Period|Death|1|||
37734775|NCT00989092|69215180|FG000|Overall Study|Ineligibility determined|3|||
37847155|NCT01104415|69531239|FG000|Extension Period|Physician Decision|0|||
37847156|NCT01104415|69531240|FG001|Extension Period|Physician Decision|1|||
37847157|NCT01104415|69531239|FG000|Extension Period|Transition to Study LX1606.302|0|||
37847158|NCT01104415|69531240|FG001|Extension Period|Transition to Study LX1606.302|4|||
37847159|NCT01104415|69531239|FG000|Extension Period|Heart surgery/feeling miserable|0|||
37847160|NCT01104415|69531240|FG001|Extension Period|Heart surgery/feeling miserable|1|||
37847161|NCT01099579|69531250|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
37847162|NCT01099579|69531251|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
37847163|NCT01099579|69531252|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
37847164|NCT01099579|69531250|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
37847165|NCT01099579|69531251|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
37847166|NCT01099579|69531252|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
37847167|NCT01099579|69531250|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
37847168|NCT01099579|69531251|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
37847169|NCT01099579|69531252|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
37847170|NCT01099579|69531250|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
37847171|NCT01099579|69531251|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
37847172|NCT01099579|69531252|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
37847173|NCT01099579|69531250|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
37847174|NCT01099579|69531251|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
37847175|NCT01099579|69531252|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
37847176|NCT01099579|69531250|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
37847177|NCT01099579|69531251|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
37847178|NCT01099579|69531252|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
37847179|NCT01099579|69531250|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
37847180|NCT01099579|69531251|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
37847181|NCT01099579|69531252|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
37847182|NCT01099579|69531250|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
37847183|NCT01099579|69531251|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
37847184|NCT01099579|69531252|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
37847185|NCT01099579|69531250|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
37847186|NCT01099579|69531251|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
37847187|NCT01099579|69531252|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
37847188|NCT01099579|69531250|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
37847189|NCT01099579|69531251|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
37847190|NCT01099579|69531252|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
37847191|NCT01103713|69531262|FG000|Overall Study|Lost to Follow-up|2|||
37847192|NCT01103713|69531262|FG000|Overall Study|Withdrawal by Subject|8|||
37847193|NCT01103713|69531262|FG000|Overall Study|Study terminated by sponsor|2|||
37847194|NCT01103713|69531262|FG000|Overall Study|Other|1|||
37847195|NCT01103479|69531272|FG000|Overall Study|Up to date with CRC screening|1|||
37847196|NCT01103479|69531273|FG001|Overall Study|Up to date with CRC screening|9|||
37847197|NCT01103479|69531274|FG002|Overall Study|Up to date with CRC screening|12|||
37847198|NCT01103479|69531272|FG000|Overall Study|Family history of CRC|1|||
37734776|NCT00989092|69215181|FG001|Overall Study|Ineligibility determined|3|||
37734777|NCT00989092|69215180|FG000|Overall Study|Lost to Follow-up|6|||
37734778|NCT00989092|69215181|FG001|Overall Study|Lost to Follow-up|2|||
37734779|NCT00989092|69215180|FG000|Overall Study|Other|3|||
37734780|NCT00989092|69215181|FG001|Overall Study|Other|1|||
37734781|NCT00989092|69215180|FG000|Overall Study|Protocol deviation|2|||
37734782|NCT00989092|69215181|FG001|Overall Study|Protocol deviation|0|||
37734783|NCT00989092|69215180|FG000|Overall Study|Erythropoietin therapy initiated|2|||
37734784|NCT00989092|69215181|FG001|Overall Study|Erythropoietin therapy initiated|0|||
37734785|NCT00989092|69215180|FG000|Overall Study|Did not receive study drug|2|||
37734786|NCT00989092|69215181|FG001|Overall Study|Did not receive study drug|0|||
37734787|NCT00988858|69215188|FG000|Overall Study|Adverse Event|7|||
37734788|NCT00988858|69215188|FG000|Overall Study|Death|1|||
37734789|NCT00988858|69215188|FG000|Overall Study|Physician Decision|1|||
37734790|NCT00988858|69215188|FG000|Overall Study|Sponsor Decision|1|||
37734791|NCT00986986|69215194|FG000|Overall Study|Lost to Follow-up|0|||
37734792|NCT00986986|69215195|FG001|Overall Study|Lost to Follow-up|1|||
37734793|NCT01904773|69215202|FG000|Screen|Screen failure|3|||
37734794|NCT01904773|69215203|FG001|Screen|Screen failure|0|||
37734795|NCT01904773|69215204|FG002|Screen|Screen failure|0|||
37734796|NCT01904773|69215205|FG003|Screen|Screen failure|0|||
37734797|NCT01904773|69215206|FG004|Screen|Screen failure|0|||
37847199|NCT01103479|69531273|FG001|Overall Study|Family history of CRC|0|||
37847200|NCT01103479|69531274|FG002|Overall Study|Family history of CRC|2|||
37847201|NCT01103479|69531272|FG000|Overall Study|Active cancer|1|||
37734798|NCT01904773|69215207|FG005|Screen|Screen failure|0|||
37734799|NCT01904773|69215208|FG006|Screen|Screen failure|0|||
37734800|NCT01904773|69215209|FG007|Screen|Screen failure|0|||
37734801|NCT01904773|69215210|FG008|Screen|Screen failure|0|||
37734802|NCT01904773|69215202|FG000|Screen|Withdrawal by Subject|1|||
37847202|NCT01103479|69531273|FG001|Overall Study|Active cancer|0|||
37734803|NCT01904773|69215203|FG001|Screen|Withdrawal by Subject|0|||
37734804|NCT01904773|69215204|FG002|Screen|Withdrawal by Subject|0|||
37734805|NCT01904773|69215205|FG003|Screen|Withdrawal by Subject|0|||
37734806|NCT01904773|69215206|FG004|Screen|Withdrawal by Subject|0|||
37734807|NCT01904773|69215207|FG005|Screen|Withdrawal by Subject|0|||
37734808|NCT01904773|69215208|FG006|Screen|Withdrawal by Subject|0|||
37734809|NCT01904773|69215209|FG007|Screen|Withdrawal by Subject|0|||
37734810|NCT01904773|69215210|FG008|Screen|Withdrawal by Subject|0|||
37734811|NCT01904773|69215202|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
37847203|NCT01103479|69531274|FG002|Overall Study|Active cancer|0|||
37847204|NCT01103479|69531272|FG000|Overall Study|Saw non-study physician|2|||
37847205|NCT01103479|69531273|FG001|Overall Study|Saw non-study physician|0|||
37847206|NCT01103479|69531274|FG002|Overall Study|Saw non-study physician|0|||
37847207|NCT01103323|69531285|FG000|Without/Before Drug Switch|Adverse Event|50|||
37847208|NCT01103323|69531286|FG001|Without/Before Drug Switch|Adverse Event|7|||
37847209|NCT01103323|69531285|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
37847210|NCT01103323|69531286|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
37847211|NCT01103323|69531285|FG000|Without/Before Drug Switch|Protocol Violation|2|||
37847212|NCT01103323|69531286|FG001|Without/Before Drug Switch|Protocol Violation|0|||
37847213|NCT01103323|69531285|FG000|Without/Before Drug Switch|Physician Decision|2|||
37847214|NCT01103323|69531286|FG001|Without/Before Drug Switch|Physician Decision|0|||
37847215|NCT01103323|69531285|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
37847216|NCT01103323|69531286|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
37847217|NCT01103323|69531285|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
37847218|NCT01103323|69531286|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
37847219|NCT01103323|69531285|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
37847220|NCT01103323|69531286|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
37847221|NCT01103245|69531297|FG000|Overall Study|Withdrawal by Subject|1|||
37847222|NCT01103245|69531298|FG001|Overall Study|Withdrawal by Subject|0|||
37847223|NCT01103245|69531299|FG002|Overall Study|Withdrawal by Subject|3|||
37847224|NCT01103245|69531300|FG003|Overall Study|Withdrawal by Subject|0|||
37917192|NCT00819585|69604054|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
37917193|NCT00819585|69604055|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
37917194|NCT00819585|69604056|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
37917195|NCT00819585|69604057|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
37917196|NCT00819585|69604058|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
37917197|NCT00819585|69604059|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
37734812|NCT01904773|69215203|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
37847225|NCT01103245|69531297|FG000|Overall Study|Inadequate IV access|1|||
37847226|NCT01103245|69531298|FG001|Overall Study|Inadequate IV access|0|||
37847227|NCT01103245|69531299|FG002|Overall Study|Inadequate IV access|0|||
37917198|NCT00819585|69604049|FG000|Core Study|Subject Withdrew Consent|0|||
37734813|NCT01904773|69215204|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
37917199|NCT00819585|69604050|FG001|Core Study|Subject Withdrew Consent|3|||
37917200|NCT00819585|69604051|FG002|Core Study|Subject Withdrew Consent|2|||
37917201|NCT00819585|69604052|FG003|Core Study|Subject Withdrew Consent|1|||
37917202|NCT00819585|69604053|FG004|Core Study|Subject Withdrew Consent|0|||
37917203|NCT00819585|69604054|FG005|Core Study|Subject Withdrew Consent|0|||
37917204|NCT00819585|69604055|FG006|Core Study|Subject Withdrew Consent|3|||
37847228|NCT01103245|69531300|FG003|Overall Study|Inadequate IV access|0|||
37847229|NCT01103245|69531297|FG000|Overall Study|Adverse Event|0|||
37917205|NCT00819585|69604056|FG007|Core Study|Subject Withdrew Consent|0|||
37917206|NCT00819585|69604057|FG008|Core Study|Subject Withdrew Consent|0|||
37917207|NCT00819585|69604058|FG009|Core Study|Subject Withdrew Consent|0|||
37734814|NCT01904773|69215205|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
37847230|NCT01103245|69531298|FG001|Overall Study|Adverse Event|2|||
37847231|NCT01103245|69531299|FG002|Overall Study|Adverse Event|1|||
37847232|NCT01103245|69531300|FG003|Overall Study|Adverse Event|0|||
37847233|NCT01103245|69531297|FG000|Overall Study|Physician Decision|1|||
37847234|NCT01103245|69531298|FG001|Overall Study|Physician Decision|0|||
37847235|NCT01103245|69531299|FG002|Overall Study|Physician Decision|0|||
37847236|NCT01103245|69531300|FG003|Overall Study|Physician Decision|0|||
37847237|NCT01099267|69531310|FG000|MDS-003 Study|Adverse Event|37|||
37847238|NCT01099267|69531310|FG000|MDS-003 Study|Lack of Efficacy|52|||
37847239|NCT01099267|69531310|FG000|MDS-003 Study|Withdrawal by Subject|8|||
37847240|NCT01099267|69531310|FG000|MDS-003 Study|Lost to Follow-up|1|||
37734815|NCT01904773|69215206|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
37734816|NCT01904773|69215207|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
37734817|NCT01904773|69215208|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
37734818|NCT01904773|69215209|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
37847241|NCT01099267|69531310|FG000|MDS-003 Study|Death|11|||
37917208|NCT00819585|69604059|FG010|Core Study|Subject Withdrew Consent|0|||
37734819|NCT01904773|69215210|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
37734820|NCT01904773|69215202|FG000|First Intervention|Adverse Event|0|||
37847242|NCT01099267|69531310|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
37847243|NCT01099267|69531310|FG000|MDS-003 Study|Disease Progression|7|||
38026347|NCT03622112|69711137|FG000|Overall Study|Protocol Violation|2|||
38026348|NCT03622112|69711138|FG001|Overall Study|Protocol Violation|0|||
38026349|NCT03622112|69711139|FG002|Overall Study|Protocol Violation|1|||
37847244|NCT01099267|69531310|FG000|MDS-003 Study|Investigator Decision|2|||
37917209|NCT00819585|69604049|FG000|Core Study|Lost to Follow-up|2|||
37917210|NCT00819585|69604050|FG001|Core Study|Lost to Follow-up|1|||
37917211|NCT00819585|69604051|FG002|Core Study|Lost to Follow-up|2|||
37847245|NCT01099267|69531310|FG000|MDS-003 Study|Non-Compliance|2|||
37847246|NCT01099267|69531310|FG000|MDS-003 Study|Loss of Response|1|||
37847247|NCT01099267|69531310|FG000|MDS-003 Study|Secondary Malign Disease|1|||
37847248|NCT01098487|69531314|FG000|Overall Study|Adverse Event|22|||
37847249|NCT01098487|69531314|FG000|Overall Study|Lack of Efficacy|11|||
37847250|NCT01098487|69531314|FG000|Overall Study|Withdrawal by Subject|7|||
37847251|NCT01098487|69531314|FG000|Overall Study|Lost to Follow-up|3|||
37847252|NCT01098487|69531314|FG000|Overall Study|Physician Decision|1|||
37847253|NCT01098097|69531318|FG000|Overall Study|Adverse Event|17|||
37847254|NCT01098097|69531318|FG000|Overall Study|Lost to Follow-up|18|||
37847255|NCT01098097|69531318|FG000|Overall Study|Status unknown|16|||
37847256|NCT01098097|69531318|FG000|Overall Study|No reason reported|31|||
37847257|NCT01097863|69531325|FG000|Overall Study|Discomfort|1|||
37847258|NCT01097863|69531326|FG001|Overall Study|Discomfort|0|||
37847259|NCT01097863|69531327|FG002|Overall Study|Discomfort|1|||
37847260|NCT01097863|69531325|FG000|Overall Study|Did not return for final visit|0|||
37847261|NCT01097863|69531326|FG001|Overall Study|Did not return for final visit|0|||
37847262|NCT01097863|69531327|FG002|Overall Study|Did not return for final visit|1|||
37847263|NCT01326962|69531335|FG000|Overall Study|Adverse Event|1|||
37847264|NCT01326962|69531335|FG000|Overall Study|Withdrawal by Subject|1|||
37847265|NCT01326962|69531335|FG000|Overall Study|Lost to Follow-up|3|||
37847266|NCT01326962|69531335|FG000|Overall Study|Other|2|||
37847267|NCT01326728|69531341|FG000|Overall Study|Death|13|||
37847268|NCT01326728|69531342|FG001|Overall Study|Death|0|||
37847269|NCT01326728|69531341|FG000|Overall Study|Early closure of study|34|||
37917212|NCT00819585|69604052|FG003|Core Study|Lost to Follow-up|0|||
37917213|NCT00819585|69604053|FG004|Core Study|Lost to Follow-up|1|||
37917214|NCT00819585|69604054|FG005|Core Study|Lost to Follow-up|1|||
37917215|NCT00819585|69604055|FG006|Core Study|Lost to Follow-up|1|||
37917216|NCT00819585|69604056|FG007|Core Study|Lost to Follow-up|0|||
37917217|NCT00819585|69604057|FG008|Core Study|Lost to Follow-up|0|||
37917218|NCT00819585|69604058|FG009|Core Study|Lost to Follow-up|0|||
37847270|NCT01326728|69531342|FG001|Overall Study|Early closure of study|9|||
37847271|NCT01097707|69531352|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
37847272|NCT01097707|69531353|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
37847273|NCT01097707|69531354|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
37847274|NCT01097707|69531355|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
37847275|NCT01097707|69531356|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
37847276|NCT01097707|69531352|FG000|Overall Study|Adverse Event|4|||
37847277|NCT01097707|69531353|FG001|Overall Study|Adverse Event|2|||
37847278|NCT01097707|69531354|FG002|Overall Study|Adverse Event|3|||
37847279|NCT01097707|69531355|FG003|Overall Study|Adverse Event|1|||
37847280|NCT01097707|69531356|FG004|Overall Study|Adverse Event|3|||
37847281|NCT01097707|69531352|FG000|Overall Study|Entry Criteria Not Met|2|||
37847282|NCT01097707|69531353|FG001|Overall Study|Entry Criteria Not Met|1|||
37847283|NCT01097707|69531354|FG002|Overall Study|Entry Criteria Not Met|1|||
37847284|NCT01097707|69531355|FG003|Overall Study|Entry Criteria Not Met|0|||
37847285|NCT01097707|69531356|FG004|Overall Study|Entry Criteria Not Met|1|||
37847286|NCT01097707|69531352|FG000|Overall Study|Lack of Efficacy|1|||
37847287|NCT01097707|69531353|FG001|Overall Study|Lack of Efficacy|0|||
37847288|NCT01097707|69531354|FG002|Overall Study|Lack of Efficacy|0|||
37917219|NCT00819585|69604059|FG010|Core Study|Lost to Follow-up|0|||
37917220|NCT00819585|69604049|FG000|Core Study|Administrative Problems|0|||
37917221|NCT00819585|69604050|FG001|Core Study|Administrative Problems|0|||
37917222|NCT00819585|69604051|FG002|Core Study|Administrative Problems|0|||
37917223|NCT00819585|69604052|FG003|Core Study|Administrative Problems|0|||
37917224|NCT00819585|69604053|FG004|Core Study|Administrative Problems|0|||
37917225|NCT00819585|69604054|FG005|Core Study|Administrative Problems|0|||
37917226|NCT00819585|69604055|FG006|Core Study|Administrative Problems|2|||
37917227|NCT00819585|69604056|FG007|Core Study|Administrative Problems|0|||
37917228|NCT00819585|69604057|FG008|Core Study|Administrative Problems|0|||
37917229|NCT00819585|69604058|FG009|Core Study|Administrative Problems|0|||
37917230|NCT00819585|69604059|FG010|Core Study|Administrative Problems|0|||
37917231|NCT00819585|69604049|FG000|Core Study|Death|0|||
37917232|NCT00819585|69604050|FG001|Core Study|Death|0|||
37917233|NCT00819585|69604051|FG002|Core Study|Death|0|||
38026350|NCT03622112|69711140|FG003|Overall Study|Protocol Violation|1|||
38026351|NCT03622112|69711141|FG004|Overall Study|Protocol Violation|0|||
38026352|NCT03622112|69711142|FG005|Overall Study|Protocol Violation|0|||
38026353|NCT03622112|69711143|FG006|Overall Study|Protocol Violation|0|||
38026354|NCT03622112|69711137|FG000|Overall Study|Adverse Event|6|||
37917234|NCT00819585|69604052|FG003|Core Study|Death|0|||
37917235|NCT00819585|69604053|FG004|Core Study|Death|0|||
37917236|NCT00819585|69604054|FG005|Core Study|Death|0|||
37917237|NCT00819585|69604055|FG006|Core Study|Death|1|||
37917238|NCT00819585|69604056|FG007|Core Study|Death|0|||
38026355|NCT03622112|69711138|FG001|Overall Study|Adverse Event|8|||
37847289|NCT01097707|69531355|FG003|Overall Study|Lack of Efficacy|1|||
37847290|NCT01097707|69531356|FG004|Overall Study|Lack of Efficacy|0|||
37847291|NCT01097707|69531352|FG000|Overall Study|Lost to Follow-up|1|||
37847292|NCT01097707|69531353|FG001|Overall Study|Lost to Follow-up|1|||
37917239|NCT00819585|69604057|FG008|Core Study|Death|0|||
37917240|NCT00819585|69604058|FG009|Core Study|Death|0|||
37847293|NCT01097707|69531354|FG002|Overall Study|Lost to Follow-up|2|||
37847294|NCT01097707|69531355|FG003|Overall Study|Lost to Follow-up|0|||
37847295|NCT01097707|69531356|FG004|Overall Study|Lost to Follow-up|3|||
37847296|NCT01097707|69531352|FG000|Overall Study|Protocol Violation|2|||
37847297|NCT01097707|69531353|FG001|Overall Study|Protocol Violation|2|||
37847298|NCT01097707|69531354|FG002|Overall Study|Protocol Violation|3|||
37847299|NCT01097707|69531355|FG003|Overall Study|Protocol Violation|2|||
37847300|NCT01097707|69531356|FG004|Overall Study|Protocol Violation|2|||
37847301|NCT01097707|69531352|FG000|Overall Study|Sponsor Decision|31|||
37847302|NCT01097707|69531353|FG001|Overall Study|Sponsor Decision|31|||
37847303|NCT01097707|69531354|FG002|Overall Study|Sponsor Decision|34|||
37847304|NCT01097707|69531355|FG003|Overall Study|Sponsor Decision|35|||
37847305|NCT01097707|69531356|FG004|Overall Study|Sponsor Decision|36|||
37847306|NCT01097707|69531352|FG000|Overall Study|Withdrawal by Subject|3|||
37847307|NCT01097707|69531353|FG001|Overall Study|Withdrawal by Subject|6|||
37847308|NCT01097707|69531354|FG002|Overall Study|Withdrawal by Subject|1|||
37847309|NCT01097707|69531355|FG003|Overall Study|Withdrawal by Subject|4|||
37847310|NCT01097707|69531356|FG004|Overall Study|Withdrawal by Subject|3|||
37847311|NCT01097707|69531352|FG000|Overall Study|Reason unknown|0|||
37847312|NCT01097707|69531353|FG001|Overall Study|Reason unknown|0|||
37847313|NCT01097707|69531354|FG002|Overall Study|Reason unknown|0|||
37847314|NCT01097707|69531355|FG003|Overall Study|Reason unknown|0|||
37847315|NCT01097707|69531356|FG004|Overall Study|Reason unknown|1|||
37847316|NCT01326104|69531370|FG000|Overall Study|progressed prior to vaccine|0|||
37847317|NCT01326104|69531371|FG001|Overall Study|progressed prior to vaccine|2|||
37847318|NCT01326104|69531370|FG000|Overall Study|unable to make vaccine|0|||
37847319|NCT01326104|69531371|FG001|Overall Study|unable to make vaccine|2|||
37847320|NCT01326026|69531379|FG000|Overall Study|Adverse Event|4|||
37847321|NCT01326026|69531380|FG001|Overall Study|Adverse Event|3|||
37847322|NCT01326026|69531379|FG000|Overall Study|Withdrawal Criteria|5|||
37847323|NCT01326026|69531380|FG001|Overall Study|Withdrawal Criteria|7|||
37847324|NCT01326026|69531379|FG000|Overall Study|Other|3|||
37847325|NCT01326026|69531380|FG001|Overall Study|Other|3|||
37847326|NCT01097629|69531389|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
37847327|NCT01097629|69531390|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
37847328|NCT01097629|69531391|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
37847329|NCT01097629|69531392|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
37847330|NCT01097629|69531393|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
37847331|NCT01097629|69531394|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
37847332|NCT01097629|69531395|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
37847333|NCT01097629|69531396|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
37847334|NCT01097629|69531389|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
37847335|NCT01097629|69531390|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
37847336|NCT01097629|69531391|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
37847337|NCT01097629|69531392|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
37847338|NCT01097629|69531393|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
37847339|NCT01097629|69531394|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
37847340|NCT01097629|69531395|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
37847341|NCT01097629|69531396|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
37847342|NCT01097629|69531389|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
37847343|NCT01097629|69531390|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
38026356|NCT03622112|69711139|FG002|Overall Study|Adverse Event|4|||
38026357|NCT03622112|69711140|FG003|Overall Study|Adverse Event|11|||
38026358|NCT03622112|69711141|FG004|Overall Study|Adverse Event|4|||
38026359|NCT03622112|69711142|FG005|Overall Study|Adverse Event|20|||
38026360|NCT03622112|69711143|FG006|Overall Study|Adverse Event|2|||
38026361|NCT03622112|69711137|FG000|Overall Study|Reason not specified|0|||
38026362|NCT03622112|69711138|FG001|Overall Study|Reason not specified|1|||
38026363|NCT03622112|69711139|FG002|Overall Study|Reason not specified|0|||
37847344|NCT01097629|69531391|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
37847345|NCT01097629|69531392|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
37847346|NCT01097629|69531393|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
37847347|NCT01097629|69531394|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
38026364|NCT03622112|69711140|FG003|Overall Study|Reason not specified|1|||
37847348|NCT01097629|69531395|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
37847349|NCT01097629|69531396|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
38026365|NCT03622112|69711141|FG004|Overall Study|Reason not specified|1|||
38026366|NCT03622112|69711142|FG005|Overall Study|Reason not specified|2|||
38026367|NCT03622112|69711143|FG006|Overall Study|Reason not specified|1|||
37847350|NCT01097629|69531389|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
37847351|NCT01097629|69531390|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
37917241|NCT00819585|69604059|FG010|Core Study|Death|0|||
38026368|NCT04032158|69711161|FG000|Overall Study|Study Termination|2|||
37847352|NCT01097629|69531391|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
37847353|NCT01097629|69531392|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
37847354|NCT01097629|69531393|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
37847355|NCT01097629|69531394|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
37847356|NCT01097629|69531395|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
37847357|NCT01097629|69531396|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
37847358|NCT01097629|69531389|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
37847359|NCT01097629|69531390|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
37847360|NCT01097629|69531391|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
37847361|NCT01097629|69531392|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
37847362|NCT01097629|69531393|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
37847363|NCT01097629|69531394|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
37847364|NCT01097629|69531395|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
37847365|NCT01097629|69531396|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
37847366|NCT01097629|69531389|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
37847367|NCT01097629|69531390|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
37847368|NCT01097629|69531391|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
37847369|NCT01097629|69531392|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
37847370|NCT01097629|69531393|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
37847371|NCT01097629|69531394|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
37847372|NCT01097629|69531395|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
37847373|NCT01097629|69531396|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
37847374|NCT01097629|69531389|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
37847375|NCT01097629|69531390|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
37847376|NCT01097629|69531391|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
37847377|NCT01097629|69531392|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
37847378|NCT01097629|69531393|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
37847379|NCT01097629|69531394|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
37847380|NCT01097629|69531395|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
37847381|NCT01097629|69531396|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
37847382|NCT01097629|69531389|FG000|DB RO Phase|Withdrawal by Subject|0|||
37847383|NCT01097629|69531390|FG001|DB RO Phase|Withdrawal by Subject|0|||
37847384|NCT01097629|69531391|FG002|DB RO Phase|Withdrawal by Subject|0|||
37847385|NCT01097629|69531392|FG003|DB RO Phase|Withdrawal by Subject|0|||
37847386|NCT01097629|69531393|FG004|DB RO Phase|Withdrawal by Subject|0|||
37847387|NCT01097629|69531394|FG005|DB RO Phase|Withdrawal by Subject|0|||
37847388|NCT01097629|69531395|FG006|DB RO Phase|Withdrawal by Subject|0|||
37847389|NCT01097629|69531396|FG007|DB RO Phase|Withdrawal by Subject|1|||
37847390|NCT01097629|69531389|FG000|DB RO Phase|Protocol Violation|0|||
37847391|NCT01097629|69531390|FG001|DB RO Phase|Protocol Violation|0|||
37847392|NCT01097629|69531391|FG002|DB RO Phase|Protocol Violation|0|||
37847393|NCT01097629|69531392|FG003|DB RO Phase|Protocol Violation|1|||
37847394|NCT01097629|69531393|FG004|DB RO Phase|Protocol Violation|0|||
37847395|NCT01097629|69531394|FG005|DB RO Phase|Protocol Violation|1|||
37847396|NCT01097629|69531395|FG006|DB RO Phase|Protocol Violation|1|||
37847397|NCT01097629|69531396|FG007|DB RO Phase|Protocol Violation|0|||
37847398|NCT01097629|69531389|FG000|DB RO Phase|Lost to Follow-up|0|||
37847399|NCT01097629|69531390|FG001|DB RO Phase|Lost to Follow-up|0|||
37847400|NCT01097629|69531391|FG002|DB RO Phase|Lost to Follow-up|0|||
37847401|NCT01097629|69531392|FG003|DB RO Phase|Lost to Follow-up|0|||
37847402|NCT01097629|69531393|FG004|DB RO Phase|Lost to Follow-up|0|||
37847403|NCT01097629|69531394|FG005|DB RO Phase|Lost to Follow-up|0|||
37847404|NCT01097629|69531395|FG006|DB RO Phase|Lost to Follow-up|2|||
37847405|NCT01097629|69531396|FG007|DB RO Phase|Lost to Follow-up|0|||
37847406|NCT01324622|69531421|FG000|Overall Study|Lost to Follow-up|7|||
37847407|NCT01324622|69531422|FG001|Overall Study|Lost to Follow-up|7|||
37847408|NCT01324622|69531421|FG000|Overall Study|Death|1|||
37847409|NCT01324622|69531422|FG001|Overall Study|Death|0|||
37847410|NCT01324622|69531421|FG000|Overall Study|Lack of Efficacy|1|||
37847411|NCT01324622|69531422|FG001|Overall Study|Lack of Efficacy|0|||
37847412|NCT01097005|69531429|FG000|Overall Study|Case Report Form not collected|18|||
37847413|NCT01097005|69531429|FG000|Overall Study|Subjects cannot visit the hospital|1|||
37847414|NCT01097005|69531429|FG000|Overall Study|Poor medication compliance|1|||
37847415|NCT01097005|69531429|FG000|Overall Study|No examination data available|244|||
37847416|NCT01097005|69531429|FG000|Overall Study|Deviation from exclusion criteria|37|||
38026369|NCT04032158|69711162|FG001|Overall Study|Study Termination|1|||
37847417|NCT01097005|69531429|FG000|Overall Study|Adverse Event|14|||
37847418|NCT01097005|69531429|FG000|Overall Study|Discontinuance by complication|50|||
37847419|NCT01096849|69531438|FG000|Overall Study|Consent Withdrawn|1|||
37847420|NCT01096849|69531439|FG001|Overall Study|Consent Withdrawn|4|||
37847421|NCT01096849|69531440|FG002|Overall Study|Consent Withdrawn|2|||
37847422|NCT01096849|69531438|FG000|Overall Study|Lack of Efficacy|0|||
37847423|NCT01096849|69531439|FG001|Overall Study|Lack of Efficacy|2|||
37847424|NCT01096849|69531440|FG002|Overall Study|Lack of Efficacy|0|||
37847425|NCT01096849|69531438|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
37847426|NCT01096849|69531439|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
37847427|NCT01096849|69531440|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
37847428|NCT01096849|69531438|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
37847429|NCT01096849|69531439|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
37847430|NCT01096849|69531440|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
37847431|NCT01096849|69531438|FG000|Overall Study|Administrative Reasons|0|||
37847432|NCT01096849|69531439|FG001|Overall Study|Administrative Reasons|1|||
37847433|NCT01096849|69531440|FG002|Overall Study|Administrative Reasons|2|||
37847434|NCT01096849|69531438|FG000|Overall Study|Lost to Follow-up|1|||
37847435|NCT01096849|69531439|FG001|Overall Study|Lost to Follow-up|3|||
37847436|NCT01096849|69531440|FG002|Overall Study|Lost to Follow-up|1|||
37847437|NCT01324388|69531451|FG000|Part 1 of Study|Adverse Event|2|||
37847438|NCT01324388|69531452|FG001|Part 1 of Study|Adverse Event|0|||
37847439|NCT01324388|69531453|FG002|Part 1 of Study|Adverse Event|0|||
37847440|NCT01324388|69531454|FG003|Part 1 of Study|Adverse Event|0|||
37847441|NCT01324388|69531451|FG000|Part 1 of Study|Protocol Violation|1|||
37847442|NCT01324388|69531452|FG001|Part 1 of Study|Protocol Violation|2|||
37847443|NCT01324388|69531453|FG002|Part 1 of Study|Protocol Violation|0|||
37847444|NCT01324388|69531454|FG003|Part 1 of Study|Protocol Violation|0|||
37847445|NCT01324388|69531451|FG000|Part 1 of Study|Physician Decision|1|||
37847446|NCT01324388|69531452|FG001|Part 1 of Study|Physician Decision|0|||
37847447|NCT01324388|69531453|FG002|Part 1 of Study|Physician Decision|0|||
37847448|NCT01324388|69531454|FG003|Part 1 of Study|Physician Decision|0|||
37847449|NCT01324388|69531451|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
37847450|NCT01324388|69531452|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
37847451|NCT01324388|69531453|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
37847452|NCT01324388|69531454|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
37847453|NCT01324388|69531451|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
37847454|NCT01324388|69531452|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
37847455|NCT01324388|69531453|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
37847456|NCT01324388|69531454|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
37847457|NCT01102777|69531468|FG000|Overall Study|Death|2|||
37847458|NCT01102777|69531469|FG001|Overall Study|Death|6|||
37847459|NCT01102777|69531468|FG000|Overall Study|Lost to Follow-up|7|||
37847460|NCT01102777|69531469|FG001|Overall Study|Lost to Follow-up|10|||
37847461|NCT01324310|69531476|FG000|Overall Study|Adverse Event|1|||
37847462|NCT01324310|69531476|FG000|Overall Study|Disease Progression|1|||
37847463|NCT01102231|69531482|FG000|Overall Study|Protocol Violation|3|||
37847464|NCT01102231|69531482|FG000|Overall Study|Lack of Efficacy|2|||
37847465|NCT01102231|69531482|FG000|Overall Study|Death|2|||
37847466|NCT01102231|69531482|FG000|Overall Study|Adverse Event|3|||
37847467|NCT01102231|69531482|FG000|Overall Study|Withdrawal by Subject|1|||
37847468|NCT01102231|69531482|FG000|Overall Study|Did not received the treatment|4|||
37847469|NCT01094743|69531487|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
37847470|NCT01095835|69531495|FG000|Overall Study|Adverse Event|8|||
37917242|NCT00819585|69604049|FG000|Core Study|Protocol Violation|0|||
37917243|NCT00819585|69604050|FG001|Core Study|Protocol Violation|0|||
37847471|NCT01095835|69531496|FG001|Overall Study|Adverse Event|6|||
37847472|NCT01095835|69531497|FG002|Overall Study|Adverse Event|6|||
37847473|NCT01095835|69531495|FG000|Overall Study|Lack of Efficacy|0|||
37847474|NCT01095835|69531496|FG001|Overall Study|Lack of Efficacy|1|||
37847475|NCT01095835|69531497|FG002|Overall Study|Lack of Efficacy|0|||
37847476|NCT01095835|69531495|FG000|Overall Study|Physician Decision|0|||
37847477|NCT01095835|69531496|FG001|Overall Study|Physician Decision|0|||
37847478|NCT01095835|69531497|FG002|Overall Study|Physician Decision|1|||
37847479|NCT01095835|69531495|FG000|Overall Study|Withdrawal by Subject|1|||
37847480|NCT01095835|69531496|FG001|Overall Study|Withdrawal by Subject|3|||
37847481|NCT01095835|69531497|FG002|Overall Study|Withdrawal by Subject|0|||
37847482|NCT01095835|69531495|FG000|Overall Study|Non study compliance|0|||
37847483|NCT01095835|69531496|FG001|Overall Study|Non study compliance|0|||
37847484|NCT01095835|69531497|FG002|Overall Study|Non study compliance|1|||
37847485|NCT01095835|69531495|FG000|Overall Study|Protocol Violation|1|||
37847486|NCT01095835|69531496|FG001|Overall Study|Protocol Violation|2|||
37847487|NCT01095835|69531497|FG002|Overall Study|Protocol Violation|0|||
37917244|NCT00819585|69604051|FG002|Core Study|Protocol Violation|1|||
37917245|NCT00819585|69604052|FG003|Core Study|Protocol Violation|0|||
37847488|NCT01324232|69531510|FG000|Overall Study|Protocol Violation|0|||
37847489|NCT01324232|69531511|FG001|Overall Study|Protocol Violation|0|||
37847490|NCT01324232|69531512|FG002|Overall Study|Protocol Violation|0|||
37917246|NCT00819585|69604053|FG004|Core Study|Protocol Violation|0|||
37917247|NCT00819585|69604054|FG005|Core Study|Protocol Violation|1|||
37917248|NCT00819585|69604055|FG006|Core Study|Protocol Violation|3|||
37917249|NCT00819585|69604056|FG007|Core Study|Protocol Violation|0|||
37917250|NCT00819585|69604057|FG008|Core Study|Protocol Violation|0|||
37917251|NCT00819585|69604058|FG009|Core Study|Protocol Violation|0|||
37917252|NCT00819585|69604059|FG010|Core Study|Protocol Violation|0|||
37917253|NCT00819585|69604049|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
37917254|NCT00819585|69604050|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
37917255|NCT00819585|69604051|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
37847491|NCT01324232|69531513|FG003|Overall Study|Protocol Violation|2|||
37847492|NCT01324232|69531510|FG000|Overall Study|Missing|0|||
37847493|NCT01324232|69531511|FG001|Overall Study|Missing|0|||
37847494|NCT01324232|69531512|FG002|Overall Study|Missing|1|||
37847495|NCT01324232|69531513|FG003|Overall Study|Missing|0|||
37847496|NCT01324232|69531510|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
37847497|NCT01324232|69531511|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
37847498|NCT01324232|69531512|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
37847499|NCT01324232|69531513|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
37847500|NCT01324232|69531510|FG000|Overall Study|Lack of Efficacy|2|||
37847501|NCT01324232|69531511|FG001|Overall Study|Lack of Efficacy|1|||
37847502|NCT01324232|69531512|FG002|Overall Study|Lack of Efficacy|2|||
37847503|NCT01324232|69531513|FG003|Overall Study|Lack of Efficacy|2|||
37847504|NCT01324232|69531510|FG000|Overall Study|Participant Refused Medication|0|||
37847505|NCT01324232|69531511|FG001|Overall Study|Participant Refused Medication|1|||
37847506|NCT01324232|69531512|FG002|Overall Study|Participant Refused Medication|0|||
37847507|NCT01324232|69531513|FG003|Overall Study|Participant Refused Medication|0|||
37847508|NCT01324232|69531510|FG000|Overall Study|Intercurrent illness|0|||
37847509|NCT01324232|69531511|FG001|Overall Study|Intercurrent illness|0|||
37847510|NCT01324232|69531512|FG002|Overall Study|Intercurrent illness|0|||
37847511|NCT01324232|69531513|FG003|Overall Study|Intercurrent illness|1|||
37847512|NCT01324232|69531510|FG000|Overall Study|Adverse Event|2|||
37847513|NCT01324232|69531511|FG001|Overall Study|Adverse Event|5|||
37847514|NCT01324232|69531512|FG002|Overall Study|Adverse Event|6|||
37847515|NCT01324232|69531513|FG003|Overall Study|Adverse Event|6|||
37847516|NCT01324232|69531510|FG000|Overall Study|Withdrawal by Subject|0|||
37847517|NCT01324232|69531511|FG001|Overall Study|Withdrawal by Subject|3|||
37847518|NCT01324232|69531512|FG002|Overall Study|Withdrawal by Subject|4|||
37847519|NCT01324232|69531513|FG003|Overall Study|Withdrawal by Subject|0|||
37847520|NCT01324232|69531510|FG000|Overall Study|Lost to Follow-up|1|||
37917256|NCT00819585|69604052|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
37917257|NCT00819585|69604053|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
37917258|NCT00819585|69604054|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
37917259|NCT00819585|69604055|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
37917260|NCT00819585|69604056|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
37917261|NCT00819585|69604057|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
37917262|NCT00819585|69604058|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
37917263|NCT00819585|69604059|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
37917264|NCT00819585|69604049|FG000|Extension Study|Subject Withdrew Consent|0|||
37917265|NCT00819585|69604050|FG001|Extension Study|Subject Withdrew Consent|0|||
37917266|NCT00819585|69604051|FG002|Extension Study|Subject Withdrew Consent|0|||
37917267|NCT00819585|69604052|FG003|Extension Study|Subject Withdrew Consent|0|||
37917268|NCT00819585|69604053|FG004|Extension Study|Subject Withdrew Consent|0|||
37917269|NCT00819585|69604054|FG005|Extension Study|Subject Withdrew Consent|0|||
37917270|NCT00819585|69604055|FG006|Extension Study|Subject Withdrew Consent|0|||
37917271|NCT00819585|69604056|FG007|Extension Study|Subject Withdrew Consent|0|||
37917272|NCT00819585|69604057|FG008|Extension Study|Subject Withdrew Consent|3|||
37917273|NCT00819585|69604058|FG009|Extension Study|Subject Withdrew Consent|0|||
37917274|NCT00819585|69604059|FG010|Extension Study|Subject Withdrew Consent|1|||
37917275|NCT00819585|69604049|FG000|Extension Study|Lost to Follow-up|0|||
37917276|NCT00819585|69604050|FG001|Extension Study|Lost to Follow-up|0|||
37917277|NCT00819585|69604051|FG002|Extension Study|Lost to Follow-up|0|||
37917278|NCT00819585|69604052|FG003|Extension Study|Lost to Follow-up|0|||
37917279|NCT00819585|69604053|FG004|Extension Study|Lost to Follow-up|0|||
37917280|NCT00819585|69604054|FG005|Extension Study|Lost to Follow-up|0|||
37917281|NCT00819585|69604055|FG006|Extension Study|Lost to Follow-up|0|||
37917282|NCT00819585|69604056|FG007|Extension Study|Lost to Follow-up|0|||
37917283|NCT00819585|69604057|FG008|Extension Study|Lost to Follow-up|2|||
37917284|NCT00819585|69604058|FG009|Extension Study|Lost to Follow-up|1|||
38026370|NCT03620708|69711171|FG000|Overall Study|Lost to Follow-up|1|||
37917285|NCT00819585|69604059|FG010|Extension Study|Lost to Follow-up|1|||
37917286|NCT00819585|69604049|FG000|Extension Study|Death|0|||
37847521|NCT01324232|69531511|FG001|Overall Study|Lost to Follow-up|0|||
37847522|NCT01324232|69531512|FG002|Overall Study|Lost to Follow-up|0|||
37847523|NCT01324232|69531513|FG003|Overall Study|Lost to Follow-up|0|||
37847524|NCT01094119|69531530|FG000|Overall Study|Lack of Efficacy|2|||
37847525|NCT01094119|69531531|FG001|Overall Study|Lack of Efficacy|4|||
37847526|NCT01323920|69531537|FG000|Overall Study|Death|5|||
37847527|NCT01323920|69531537|FG000|Overall Study|Withdrawal by Subject|1|||
37847528|NCT01093885|69531541|FG000|Overall Study|Adverse Event|4|||
37847529|NCT01093885|69531541|FG000|Overall Study|Lost to Follow-up|1|||
37847530|NCT01101997|69531546|FG000|Overall Study|Withdrawal by Subject|2|||
37847531|NCT01324830|69531576|FG000|Overall Study|Progressive Disease|3|||
37847532|NCT01324830|69531577|FG001|Overall Study|Progressive Disease|2|||
37847533|NCT01324830|69531578|FG002|Overall Study|Progressive Disease|3|||
37847534|NCT01324830|69531579|FG003|Overall Study|Progressive Disease|3|||
37847535|NCT01324830|69531580|FG004|Overall Study|Progressive Disease|6|||
37847536|NCT01324830|69531581|FG005|Overall Study|Progressive Disease|6|||
37847537|NCT01324830|69531582|FG006|Overall Study|Progressive Disease|3|||
37847538|NCT01324830|69531583|FG007|Overall Study|Progressive Disease|3|||
37847539|NCT01324830|69531584|FG008|Overall Study|Progressive Disease|3|||
37847540|NCT01324830|69531585|FG009|Overall Study|Progressive Disease|6|||
37847541|NCT01324830|69531586|FG010|Overall Study|Progressive Disease|2|||
37847542|NCT01324830|69531587|FG011|Overall Study|Progressive Disease|1|||
37847543|NCT01324830|69531588|FG012|Overall Study|Progressive Disease|1|||
37847544|NCT01324830|69531589|FG013|Overall Study|Progressive Disease|1|||
37847545|NCT01324830|69531590|FG014|Overall Study|Progressive Disease|1|||
37847546|NCT01324830|69531591|FG015|Overall Study|Progressive Disease|3|||
37847547|NCT01324830|69531592|FG016|Overall Study|Progressive Disease|2|||
37847548|NCT01324830|69531593|FG017|Overall Study|Progressive Disease|3|||
37847549|NCT01324830|69531594|FG018|Overall Study|Progressive Disease|4|||
37847550|NCT01324830|69531576|FG000|Overall Study|Dose limiting toxicity|0|||
37847551|NCT01324830|69531577|FG001|Overall Study|Dose limiting toxicity|0|||
37847552|NCT01324830|69531578|FG002|Overall Study|Dose limiting toxicity|0|||
37847553|NCT01324830|69531579|FG003|Overall Study|Dose limiting toxicity|0|||
37847554|NCT01324830|69531580|FG004|Overall Study|Dose limiting toxicity|1|||
37847555|NCT01324830|69531581|FG005|Overall Study|Dose limiting toxicity|0|||
37847556|NCT01324830|69531582|FG006|Overall Study|Dose limiting toxicity|0|||
37847557|NCT01324830|69531583|FG007|Overall Study|Dose limiting toxicity|0|||
37847558|NCT01324830|69531584|FG008|Overall Study|Dose limiting toxicity|0|||
37847559|NCT01324830|69531585|FG009|Overall Study|Dose limiting toxicity|0|||
37847560|NCT01324830|69531586|FG010|Overall Study|Dose limiting toxicity|0|||
37847561|NCT01324830|69531587|FG011|Overall Study|Dose limiting toxicity|0|||
37847562|NCT01324830|69531588|FG012|Overall Study|Dose limiting toxicity|0|||
37917287|NCT00819585|69604050|FG001|Extension Study|Death|0|||
37917288|NCT00819585|69604051|FG002|Extension Study|Death|0|||
37847563|NCT01324830|69531589|FG013|Overall Study|Dose limiting toxicity|0|||
37847564|NCT01324830|69531590|FG014|Overall Study|Dose limiting toxicity|0|||
37847565|NCT01324830|69531591|FG015|Overall Study|Dose limiting toxicity|0|||
37847566|NCT01324830|69531592|FG016|Overall Study|Dose limiting toxicity|1|||
37847567|NCT01324830|69531593|FG017|Overall Study|Dose limiting toxicity|1|||
37847568|NCT01324830|69531594|FG018|Overall Study|Dose limiting toxicity|1|||
37847569|NCT01324830|69531576|FG000|Overall Study|Reason not mentioned above|0|||
37847570|NCT01324830|69531577|FG001|Overall Study|Reason not mentioned above|0|||
37847571|NCT01324830|69531578|FG002|Overall Study|Reason not mentioned above|0|||
37847572|NCT01324830|69531579|FG003|Overall Study|Reason not mentioned above|0|||
37847573|NCT01324830|69531580|FG004|Overall Study|Reason not mentioned above|0|||
37847574|NCT01324830|69531581|FG005|Overall Study|Reason not mentioned above|0|||
37847575|NCT01324830|69531582|FG006|Overall Study|Reason not mentioned above|0|||
37847576|NCT01324830|69531583|FG007|Overall Study|Reason not mentioned above|0|||
37847577|NCT01324830|69531584|FG008|Overall Study|Reason not mentioned above|0|||
37847578|NCT01324830|69531585|FG009|Overall Study|Reason not mentioned above|0|||
37847579|NCT01324830|69531586|FG010|Overall Study|Reason not mentioned above|0|||
37847580|NCT01324830|69531587|FG011|Overall Study|Reason not mentioned above|0|||
37847581|NCT01324830|69531588|FG012|Overall Study|Reason not mentioned above|0|||
37847582|NCT01324830|69531589|FG013|Overall Study|Reason not mentioned above|0|||
37917289|NCT00819585|69604052|FG003|Extension Study|Death|0|||
37917290|NCT00819585|69604053|FG004|Extension Study|Death|0|||
37917291|NCT00819585|69604054|FG005|Extension Study|Death|0|||
37917292|NCT00819585|69604055|FG006|Extension Study|Death|0|||
37917293|NCT00819585|69604056|FG007|Extension Study|Death|0|||
37917294|NCT00819585|69604057|FG008|Extension Study|Death|2|||
37917295|NCT00819585|69604058|FG009|Extension Study|Death|0|||
37917296|NCT00819585|69604059|FG010|Extension Study|Death|0|||
37917297|NCT00508261|69604091|FG000|Overall Study|Other|0|||
37847583|NCT01324830|69531590|FG014|Overall Study|Reason not mentioned above|0|||
37847584|NCT01324830|69531591|FG015|Overall Study|Reason not mentioned above|0|||
37847585|NCT01324830|69531592|FG016|Overall Study|Reason not mentioned above|0|||
37847586|NCT01324830|69531593|FG017|Overall Study|Reason not mentioned above|1|||
37847587|NCT01324830|69531594|FG018|Overall Study|Reason not mentioned above|0|||
37847588|NCT01324830|69531576|FG000|Overall Study|Adverse Event, serious fatal|0|||
37847589|NCT01324830|69531577|FG001|Overall Study|Adverse Event, serious fatal|1|||
37847590|NCT01324830|69531578|FG002|Overall Study|Adverse Event, serious fatal|0|||
37847591|NCT01324830|69531579|FG003|Overall Study|Adverse Event, serious fatal|0|||
37917298|NCT00508261|69604092|FG001|Overall Study|Other|1|||
37847592|NCT01324830|69531580|FG004|Overall Study|Adverse Event, serious fatal|0|||
37847593|NCT01324830|69531581|FG005|Overall Study|Adverse Event, serious fatal|0|||
37847594|NCT01324830|69531582|FG006|Overall Study|Adverse Event, serious fatal|0|||
37847595|NCT01324830|69531583|FG007|Overall Study|Adverse Event, serious fatal|0|||
37847596|NCT01324830|69531584|FG008|Overall Study|Adverse Event, serious fatal|0|||
37847597|NCT01324830|69531585|FG009|Overall Study|Adverse Event, serious fatal|0|||
37847598|NCT01324830|69531586|FG010|Overall Study|Adverse Event, serious fatal|0|||
37847599|NCT01324830|69531587|FG011|Overall Study|Adverse Event, serious fatal|0|||
37847600|NCT01324830|69531588|FG012|Overall Study|Adverse Event, serious fatal|0|||
37847601|NCT01324830|69531589|FG013|Overall Study|Adverse Event, serious fatal|0|||
37847602|NCT01324830|69531590|FG014|Overall Study|Adverse Event, serious fatal|0|||
37847603|NCT01324830|69531591|FG015|Overall Study|Adverse Event, serious fatal|0|||
37847604|NCT01324830|69531592|FG016|Overall Study|Adverse Event, serious fatal|0|||
37847605|NCT01324830|69531593|FG017|Overall Study|Adverse Event, serious fatal|0|||
37847606|NCT01324830|69531594|FG018|Overall Study|Adverse Event, serious fatal|0|||
37847607|NCT01324830|69531576|FG000|Overall Study|Adverse Event, non-fatal|0|||
37847608|NCT01324830|69531577|FG001|Overall Study|Adverse Event, non-fatal|0|||
37847609|NCT01324830|69531578|FG002|Overall Study|Adverse Event, non-fatal|0|||
37847610|NCT01324830|69531579|FG003|Overall Study|Adverse Event, non-fatal|0|||
37847611|NCT01324830|69531580|FG004|Overall Study|Adverse Event, non-fatal|0|||
37847612|NCT01324830|69531581|FG005|Overall Study|Adverse Event, non-fatal|0|||
37847613|NCT01324830|69531582|FG006|Overall Study|Adverse Event, non-fatal|0|||
37847614|NCT01324830|69531583|FG007|Overall Study|Adverse Event, non-fatal|0|||
37847615|NCT01324830|69531584|FG008|Overall Study|Adverse Event, non-fatal|2|||
37847616|NCT01324830|69531585|FG009|Overall Study|Adverse Event, non-fatal|0|||
37847617|NCT01324830|69531586|FG010|Overall Study|Adverse Event, non-fatal|1|||
37847618|NCT01324830|69531587|FG011|Overall Study|Adverse Event, non-fatal|0|||
37847619|NCT01324830|69531588|FG012|Overall Study|Adverse Event, non-fatal|0|||
37847620|NCT01324830|69531589|FG013|Overall Study|Adverse Event, non-fatal|0|||
37847621|NCT01324830|69531590|FG014|Overall Study|Adverse Event, non-fatal|0|||
37847622|NCT01324830|69531591|FG015|Overall Study|Adverse Event, non-fatal|0|||
37917299|NCT00508261|69604093|FG002|Overall Study|Other|1|||
37917300|NCT00508261|69604094|FG003|Overall Study|Other|0|||
37917301|NCT00508261|69604091|FG000|Overall Study|Serious Adverse Event|0|||
37917302|NCT00508261|69604092|FG001|Overall Study|Serious Adverse Event|1|||
37917303|NCT00508261|69604093|FG002|Overall Study|Serious Adverse Event|0|||
37917304|NCT00508261|69604094|FG003|Overall Study|Serious Adverse Event|0|||
37917305|NCT00508261|69604091|FG000|Overall Study|Withdrawal by Subject|3|||
37917306|NCT00508261|69604092|FG001|Overall Study|Withdrawal by Subject|4|||
37917307|NCT00508261|69604093|FG002|Overall Study|Withdrawal by Subject|4|||
37917308|NCT00508261|69604094|FG003|Overall Study|Withdrawal by Subject|0|||
37917309|NCT00508261|69604091|FG000|Overall Study|Migrated/ moved from study area|0|||
37917310|NCT00508261|69604092|FG001|Overall Study|Migrated/ moved from study area|1|||
37917311|NCT00508261|69604093|FG002|Overall Study|Migrated/ moved from study area|0|||
37917312|NCT00508261|69604094|FG003|Overall Study|Migrated/ moved from study area|0|||
37917313|NCT00508261|69604091|FG000|Overall Study|Lost to Follow-up|0|||
37917314|NCT00508261|69604092|FG001|Overall Study|Lost to Follow-up|1|||
37917315|NCT00508261|69604093|FG002|Overall Study|Lost to Follow-up|1|||
37917316|NCT00508261|69604094|FG003|Overall Study|Lost to Follow-up|1|||
37917317|NCT00819039|69604133|FG000|Overall Study|Physician Decision|1|||
37917318|NCT00819039|69604134|FG001|Overall Study|Physician Decision|0|||
37917319|NCT00819039|69604135|FG002|Overall Study|Physician Decision|1|||
37917320|NCT00819039|69604133|FG000|Overall Study|Protocol Violation|1|||
37917321|NCT00819039|69604134|FG001|Overall Study|Protocol Violation|0|||
37917322|NCT00819039|69604135|FG002|Overall Study|Protocol Violation|0|||
38026371|NCT03620708|69711172|FG001|Overall Study|Lost to Follow-up|1|||
38026372|NCT03620708|69711173|FG002|Overall Study|Lost to Follow-up|2|||
38026373|NCT03620708|69711171|FG000|Overall Study|Withdrawal by Subject|0|||
38026374|NCT03620708|69711172|FG001|Overall Study|Withdrawal by Subject|0|||
38026375|NCT03620708|69711173|FG002|Overall Study|Withdrawal by Subject|1|||
38026376|NCT03654326|69711183|FG000|Overall Study|Withdrawal by Subject|5|||
38026377|NCT03654326|69711184|FG001|Overall Study|Withdrawal by Subject|3|||
38026378|NCT03654326|69711183|FG000|Overall Study|Physician Decision|0|||
38026379|NCT03654326|69711184|FG001|Overall Study|Physician Decision|1|||
38026380|NCT03654326|69711183|FG000|Overall Study|Unable to adhere to study schedule|0|||
38026381|NCT03654326|69711184|FG001|Overall Study|Unable to adhere to study schedule|1|||
38026382|NCT03654326|69711183|FG000|Overall Study|Lost to Follow-up|1|||
37734821|NCT01904773|69215203|FG001|First Intervention|Adverse Event|0|||
38026383|NCT03654326|69711184|FG001|Overall Study|Lost to Follow-up|1|||
37847623|NCT01324830|69531592|FG016|Overall Study|Adverse Event, non-fatal|0|||
37847624|NCT01324830|69531593|FG017|Overall Study|Adverse Event, non-fatal|1|||
37847625|NCT01324830|69531594|FG018|Overall Study|Adverse Event, non-fatal|0|||
37847626|NCT01324830|69531576|FG000|Overall Study|Withdrawal by Subject|0|||
37847627|NCT01324830|69531577|FG001|Overall Study|Withdrawal by Subject|0|||
37847628|NCT01324830|69531578|FG002|Overall Study|Withdrawal by Subject|0|||
37847629|NCT01324830|69531579|FG003|Overall Study|Withdrawal by Subject|0|||
37847630|NCT01324830|69531580|FG004|Overall Study|Withdrawal by Subject|0|||
37734822|NCT01904773|69215204|FG002|First Intervention|Adverse Event|0|||
37734823|NCT01904773|69215205|FG003|First Intervention|Adverse Event|0|||
37734824|NCT01904773|69215206|FG004|First Intervention|Adverse Event|0|||
37734825|NCT01904773|69215207|FG005|First Intervention|Adverse Event|0|||
37734826|NCT01904773|69215208|FG006|First Intervention|Adverse Event|1|||
37847631|NCT01324830|69531581|FG005|Overall Study|Withdrawal by Subject|1|||
37917323|NCT00500539|69604145|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
37917324|NCT00500539|69604145|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
37917325|NCT00500539|69604145|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
37917326|NCT00500539|69604145|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
37917327|NCT00500539|69604145|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
37917328|NCT00500539|69604145|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
37917329|NCT00500539|69604145|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
37917330|NCT00500539|69604145|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
37917331|NCT00500539|69604145|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
37917332|NCT00500539|69604145|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
37917333|NCT00500539|69604145|FG000|Follow-up Period (16 Weeks)|Death|1|||
37917334|NCT00500539|69604145|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
37917335|NCT00500539|69604145|FG000|Follow-up Period (16 Weeks)|Missing|3|||
37917336|NCT00818883|69604154|FG000|Overall Study|Adverse Event|28|||
38026384|NCT04025684|69711194|FG000|Overall Study|Withdrawal by Subject|1|||
38026385|NCT04025684|69711195|FG001|Overall Study|Withdrawal by Subject|1|||
38026386|NCT04025684|69711196|FG002|Overall Study|Withdrawal by Subject|0|||
38026387|NCT04025684|69711197|FG003|Overall Study|Withdrawal by Subject|0|||
38026388|NCT04025684|69711194|FG000|Overall Study|Multiple reasons|1|||
38026389|NCT04025684|69711195|FG001|Overall Study|Multiple reasons|3|||
38026390|NCT04025684|69711196|FG002|Overall Study|Multiple reasons|0|||
38026391|NCT04025684|69711197|FG003|Overall Study|Multiple reasons|1|||
38026392|NCT03617588|69711209|FG000|Overall Study|Withdrawal by Subject|1|||
38026393|NCT03617588|69711210|FG001|Overall Study|Withdrawal by Subject|0|||
37847632|NCT01324830|69531582|FG006|Overall Study|Withdrawal by Subject|0|||
37847633|NCT01324830|69531583|FG007|Overall Study|Withdrawal by Subject|0|||
37847634|NCT01324830|69531584|FG008|Overall Study|Withdrawal by Subject|0|||
37847635|NCT01324830|69531585|FG009|Overall Study|Withdrawal by Subject|0|||
37847636|NCT01324830|69531586|FG010|Overall Study|Withdrawal by Subject|1|||
37847637|NCT01324830|69531587|FG011|Overall Study|Withdrawal by Subject|0|||
38026394|NCT03616106|69711222|FG000|Overall Study|Removed by PI|6|||
38026395|NCT03616106|69711223|FG001|Overall Study|Removed by PI|0|||
38026396|NCT03616106|69711222|FG000|Overall Study|Withdrawal by Subject|1|||
38026397|NCT03616106|69711223|FG001|Overall Study|Withdrawal by Subject|1|||
38026398|NCT03616106|69711222|FG000|Overall Study|Lost to Follow-up|7|||
38026399|NCT03616106|69711223|FG001|Overall Study|Lost to Follow-up|0|||
38026400|NCT04019054|69711230|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
38026401|NCT04019054|69711231|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
38026402|NCT04019054|69711230|FG000|Overall Study|Withdrawal by Subject|3|||
38026403|NCT04019054|69711231|FG001|Overall Study|Withdrawal by Subject|1|||
38026404|NCT00071799|69711239|FG000|Overall Study|Adverse Event|19|||
38026405|NCT00071799|69711240|FG001|Overall Study|Adverse Event|10|||
38026406|NCT00071799|69711239|FG000|Overall Study|Protocol Violation|1|||
38026407|NCT00071799|69711240|FG001|Overall Study|Protocol Violation|7|||
38026408|NCT00071799|69711239|FG000|Overall Study|Lost to Follow-up|1|||
38026409|NCT00071799|69711240|FG001|Overall Study|Lost to Follow-up|1|||
38026410|NCT00071799|69711239|FG000|Overall Study|Withdrawal by Subject|15|||
38026411|NCT00071799|69711240|FG001|Overall Study|Withdrawal by Subject|37|||
38026412|NCT00071799|69711239|FG000|Overall Study|Physician Decision|0|||
38026413|NCT00071799|69711240|FG001|Overall Study|Physician Decision|2|||
38026414|NCT00071799|69711239|FG000|Overall Study|Lack of Efficacy|11|||
37847638|NCT01324830|69531588|FG012|Overall Study|Withdrawal by Subject|0|||
37847639|NCT01324830|69531589|FG013|Overall Study|Withdrawal by Subject|0|||
37847640|NCT01324830|69531590|FG014|Overall Study|Withdrawal by Subject|0|||
37847641|NCT01324830|69531591|FG015|Overall Study|Withdrawal by Subject|0|||
37847642|NCT01324830|69531592|FG016|Overall Study|Withdrawal by Subject|0|||
38026415|NCT00071799|69711240|FG001|Overall Study|Lack of Efficacy|18|||
38026416|NCT00071799|69711239|FG000|Overall Study|Disease Progression|23|||
38026417|NCT00071799|69711240|FG001|Overall Study|Disease Progression|20|||
38026418|NCT00071799|69711239|FG000|Overall Study|Different Central+Local Pathology Review|0|||
37734827|NCT01904773|69215209|FG007|First Intervention|Adverse Event|0|||
37847643|NCT01324830|69531593|FG017|Overall Study|Withdrawal by Subject|0|||
37847644|NCT01324830|69531594|FG018|Overall Study|Withdrawal by Subject|1|||
37917337|NCT00818883|69604155|FG001|Overall Study|Adverse Event|19|||
37917338|NCT00818883|69604154|FG000|Overall Study|Protocol Violation|2|||
37917339|NCT00818883|69604155|FG001|Overall Study|Protocol Violation|2|||
37917340|NCT00818883|69604154|FG000|Overall Study|Lost to Follow-up|3|||
37917341|NCT00818883|69604155|FG001|Overall Study|Lost to Follow-up|2|||
37917342|NCT00818883|69604154|FG000|Overall Study|Withdrawal by Subject|16|||
37917343|NCT00818883|69604155|FG001|Overall Study|Withdrawal by Subject|14|||
37917344|NCT00818883|69604154|FG000|Overall Study|Lack of Efficacy|0|||
37917345|NCT00818883|69604155|FG001|Overall Study|Lack of Efficacy|2|||
37917346|NCT00818883|69604154|FG000|Overall Study|Other|2|||
37917347|NCT00818883|69604155|FG001|Overall Study|Other|7|||
37917348|NCT00508027|69604161|FG000|Dose Level 1|Lost to Follow-up|4|||
37917349|NCT00508027|69604161|FG000|Dose Level 1|Withdrawal by Subject|2|||
37917350|NCT00508027|69604161|FG000|Dose Level 1|Physician Decision|2|||
37917351|NCT00508027|69604161|FG000|Dose Level 2|Lost to Follow-up|2|||
37917352|NCT00508027|69604161|FG000|Dose Level 2|Withdrawal by Subject|2|||
37917353|NCT00500149|69604190|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
37917354|NCT00500149|69604191|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
37917355|NCT00500149|69604190|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
37917356|NCT00500149|69604191|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
37917357|NCT00500149|69604190|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
37917358|NCT00500149|69604191|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
37917359|NCT00500149|69604190|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
37917360|NCT00500149|69604191|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
37917361|NCT00500149|69604190|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
37917362|NCT00500149|69604191|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
37917363|NCT00500149|69604190|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
37917364|NCT00500149|69604191|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
37917365|NCT00500149|69604190|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
37917366|NCT00500149|69604191|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
37917367|NCT00489853|69604197|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
37917368|NCT00489853|69604198|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
37917369|NCT00489853|69604199|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
37917370|NCT00489853|69604197|FG000|Wash-out Period 1|Adverse Event|0|||
37917371|NCT00489853|69604198|FG001|Wash-out Period 1|Adverse Event|1|||
37917372|NCT00489853|69604199|FG002|Wash-out Period 1|Adverse Event|1|||
37917373|NCT00489853|69604197|FG000|Wash-out Period 1|Protocol Violation|0|||
37917374|NCT00489853|69604198|FG001|Wash-out Period 1|Protocol Violation|1|||
37917375|NCT00489853|69604199|FG002|Wash-out Period 1|Protocol Violation|1|||
37917376|NCT00489853|69604197|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
37917377|NCT00489853|69604198|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
37917378|NCT00489853|69604199|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
37917379|NCT00489853|69604197|FG000|Wash-out Period 2|Adverse Event|1|||
37917380|NCT00489853|69604198|FG001|Wash-out Period 2|Adverse Event|1|||
37917381|NCT00489853|69604199|FG002|Wash-out Period 2|Adverse Event|0|||
37917382|NCT00489853|69604197|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
37917383|NCT00489853|69604198|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
37917384|NCT00489853|69604199|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
37917385|NCT00489853|69604197|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
37917386|NCT00489853|69604198|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
37917387|NCT00489853|69604199|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
37917388|NCT03686423|69604207|FG000|Overall Study|Withdrawal by Subject|9|||
37917389|NCT03686423|69604207|FG000|Overall Study|lost to follow up (study interrupted by COVID)|6|||
37917390|NCT00499681|69604213|FG000|Overall Study|toxicity|0|||
37917391|NCT00499681|69604214|FG001|Overall Study|toxicity|1|||
37917392|NCT00499681|69604213|FG000|Overall Study|disease progression|0|||
37917393|NCT00499681|69604214|FG001|Overall Study|disease progression|1|||
37917394|NCT00875810|69604225|FG000|Overall Study|Withdrawal by Subject|1|||
37917395|NCT00875810|69604225|FG000|Overall Study|Physician Decision|3|||
37917396|NCT00875810|69604225|FG000|Overall Study|Lost to Follow-up|39|||
37917397|NCT00875810|69604225|FG000|Overall Study|Patient enroled but not implanted|2|||
37917398|NCT00875810|69604225|FG000|Overall Study|Device explanted|1|||
37917399|NCT00499603|69604231|FG000|Overall Study|Adverse Event|0|||
37917400|NCT00499603|69604232|FG001|Overall Study|Adverse Event|1|||
37917401|NCT00810069|69604251|FG000|Lead-in Period I|Adverse Event|43|||
37917402|NCT00810069|69604252|FG001|Lead-in Period I|Adverse Event|0|||
37917403|NCT00810069|69604253|FG002|Lead-in Period I|Adverse Event|0|||
37917404|NCT00810069|69604251|FG000|Lead-in Period I|Lack of Efficacy|1|||
37917405|NCT00810069|69604252|FG001|Lead-in Period I|Lack of Efficacy|0|||
37917406|NCT00810069|69604253|FG002|Lead-in Period I|Lack of Efficacy|0|||
37917407|NCT00810069|69604251|FG000|Lead-in Period I|Lost to Follow-up|19|||
37917408|NCT00810069|69604252|FG001|Lead-in Period I|Lost to Follow-up|0|||
37917409|NCT00810069|69604253|FG002|Lead-in Period I|Lost to Follow-up|0|||
37917410|NCT00810069|69604251|FG000|Lead-in Period I|Physician Decision|1|||
37917411|NCT00810069|69604252|FG001|Lead-in Period I|Physician Decision|0|||
37917412|NCT00810069|69604253|FG002|Lead-in Period I|Physician Decision|0|||
37917413|NCT00810069|69604251|FG000|Lead-in Period I|Protocol Violation|1|||
37917414|NCT00810069|69604252|FG001|Lead-in Period I|Protocol Violation|0|||
37917415|NCT00810069|69604253|FG002|Lead-in Period I|Protocol Violation|0|||
37917416|NCT00810069|69604251|FG000|Lead-in Period I|Withdrawal by Subject|46|||
37917417|NCT00810069|69604252|FG001|Lead-in Period I|Withdrawal by Subject|0|||
37917418|NCT00810069|69604253|FG002|Lead-in Period I|Withdrawal by Subject|0|||
37917419|NCT00810069|69604251|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
37917420|NCT00810069|69604252|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
37917421|NCT00810069|69604253|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
37917422|NCT00810069|69604251|FG000|Lead-in Period I|Randomization criteria not met|158|||
37917423|NCT00810069|69604252|FG001|Lead-in Period I|Randomization criteria not met|0|||
37917424|NCT00810069|69604253|FG002|Lead-in Period I|Randomization criteria not met|0|||
37917425|NCT00810069|69604251|FG000|Double-Blind Period II|Adverse Event|0|||
37917426|NCT00810069|69604252|FG001|Double-Blind Period II|Adverse Event|9|||
37917427|NCT00810069|69604253|FG002|Double-Blind Period II|Adverse Event|8|||
37917428|NCT00810069|69604251|FG000|Double-Blind Period II|Lack of Efficacy|0|||
37917429|NCT00810069|69604252|FG001|Double-Blind Period II|Lack of Efficacy|7|||
37917430|NCT00810069|69604253|FG002|Double-Blind Period II|Lack of Efficacy|12|||
37917431|NCT00810069|69604251|FG000|Double-Blind Period II|Lost to Follow-up|0|||
37917432|NCT00810069|69604252|FG001|Double-Blind Period II|Lost to Follow-up|9|||
37917433|NCT00810069|69604253|FG002|Double-Blind Period II|Lost to Follow-up|9|||
37917434|NCT00810069|69604251|FG000|Double-Blind Period II|Physician Decision|0|||
37917435|NCT00810069|69604252|FG001|Double-Blind Period II|Physician Decision|0|||
37917436|NCT00810069|69604253|FG002|Double-Blind Period II|Physician Decision|1|||
37917437|NCT00810069|69604251|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
37917438|NCT00810069|69604252|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
37917439|NCT00810069|69604253|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
37917440|NCT00810069|69604251|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
37917441|NCT00810069|69604252|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
37917442|NCT00810069|69604253|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
37917443|NCT00810069|69604251|FG000|Double-Blind Period II|Clinical relapse|0|||
37917444|NCT00810069|69604252|FG001|Double-Blind Period II|Clinical relapse|3|||
37917445|NCT00810069|69604253|FG002|Double-Blind Period II|Clinical relapse|0|||
37917446|NCT00810069|69604251|FG000|Double-Blind Period II|Protocol Violation|0|||
37917447|NCT00810069|69604252|FG001|Double-Blind Period II|Protocol Violation|7|||
37917448|NCT00810069|69604253|FG002|Double-Blind Period II|Protocol Violation|6|||
37917449|NCT00489541|69604264|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
37917450|NCT00489541|69604265|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
37917451|NCT00489541|69604264|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
37917452|NCT00489541|69604265|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
37917453|NCT00489541|69604264|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
37917454|NCT00489541|69604265|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
37917455|NCT00489541|69604264|FG000|12-Month Clinical Follow-up|Death|3|||
37917456|NCT00489541|69604265|FG001|12-Month Clinical Follow-up|Death|2|||
37917457|NCT00489541|69604264|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
37917458|NCT00489541|69604265|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
37917459|NCT00489541|69604264|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
37917460|NCT00489541|69604265|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
37917461|NCT00809835|69604275|FG000|Overall Study|Lost to Follow-up|7|||
37917462|NCT00809835|69604276|FG001|Overall Study|Lost to Follow-up|6|||
37917463|NCT00809835|69604277|FG002|Overall Study|Lost to Follow-up|10|||
37917464|NCT00809835|69604278|FG003|Overall Study|Lost to Follow-up|2|||
37917465|NCT00809835|69604275|FG000|Overall Study|Withdrawal by Subject|1|||
37917466|NCT00809835|69604276|FG001|Overall Study|Withdrawal by Subject|1|||
37917467|NCT00809835|69604277|FG002|Overall Study|Withdrawal by Subject|1|||
37917468|NCT00809835|69604278|FG003|Overall Study|Withdrawal by Subject|0|||
37917469|NCT00853242|69604295|FG000|Overall Study|Adverse Event|0|||
37917470|NCT00853242|69604296|FG001|Overall Study|Adverse Event|1|||
37917471|NCT00853242|69604297|FG002|Overall Study|Adverse Event|1|||
37917472|NCT00853242|69604298|FG003|Overall Study|Adverse Event|0|||
37917473|NCT00853242|69604299|FG004|Overall Study|Adverse Event|3|||
37917474|NCT00853242|69604300|FG005|Overall Study|Adverse Event|1|||
37917475|NCT00853242|69604301|FG006|Overall Study|Adverse Event|1|||
37917476|NCT00853242|69604295|FG000|Overall Study|Noncompliant|0|||
37917477|NCT00853242|69604296|FG001|Overall Study|Noncompliant|0|||
37917478|NCT00853242|69604297|FG002|Overall Study|Noncompliant|0|||
37917479|NCT00853242|69604298|FG003|Overall Study|Noncompliant|0|||
37917480|NCT00853242|69604299|FG004|Overall Study|Noncompliant|1|||
37917481|NCT00853242|69604300|FG005|Overall Study|Noncompliant|0|||
37917482|NCT00853242|69604301|FG006|Overall Study|Noncompliant|0|||
37917483|NCT00853242|69604295|FG000|Overall Study|Withdrawal by Subject|1|||
37917484|NCT00853242|69604296|FG001|Overall Study|Withdrawal by Subject|2|||
37917485|NCT00853242|69604297|FG002|Overall Study|Withdrawal by Subject|0|||
37917486|NCT00853242|69604298|FG003|Overall Study|Withdrawal by Subject|4|||
37917487|NCT00853242|69604299|FG004|Overall Study|Withdrawal by Subject|0|||
37917488|NCT00853242|69604300|FG005|Overall Study|Withdrawal by Subject|0|||
37917489|NCT00853242|69604301|FG006|Overall Study|Withdrawal by Subject|2|||
37917490|NCT00853242|69604295|FG000|Overall Study|Other|2|||
37917491|NCT00853242|69604296|FG001|Overall Study|Other|0|||
37917492|NCT00853242|69604297|FG002|Overall Study|Other|2|||
37917493|NCT00853242|69604298|FG003|Overall Study|Other|0|||
37917494|NCT00853242|69604299|FG004|Overall Study|Other|0|||
37917495|NCT00853242|69604300|FG005|Overall Study|Other|1|||
37917496|NCT00853242|69604301|FG006|Overall Study|Other|2|||
37917497|NCT00848250|69604325|FG000|Overall Study|surgery was completed without cardiopulm|0|||
37917498|NCT00848250|69604326|FG001|Overall Study|surgery was completed without cardiopulm|1|||
37917499|NCT00809757|69604336|FG000|Overall Study|Adverse Event|2|||
37917500|NCT00809757|69604337|FG001|Overall Study|Adverse Event|3|||
37917501|NCT00809757|69604338|FG002|Overall Study|Adverse Event|3|||
37917502|NCT00809757|69604336|FG000|Overall Study|Lost to Follow-up|0|||
37917503|NCT00809757|69604337|FG001|Overall Study|Lost to Follow-up|0|||
37917504|NCT00809757|69604338|FG002|Overall Study|Lost to Follow-up|1|||
37917505|NCT00809757|69604336|FG000|Overall Study|Protocol Violation|1|||
37917506|NCT00809757|69604337|FG001|Overall Study|Protocol Violation|1|||
37917507|NCT00809757|69604338|FG002|Overall Study|Protocol Violation|1|||
37917508|NCT00809757|69604336|FG000|Overall Study|Withdrawal by Subject|2|||
37917509|NCT00809757|69604337|FG001|Overall Study|Withdrawal by Subject|1|||
37917510|NCT00809757|69604338|FG002|Overall Study|Withdrawal by Subject|3|||
37917511|NCT00809757|69604336|FG000|Overall Study|Subject Uncooperative|1|||
37917512|NCT00809757|69604337|FG001|Overall Study|Subject Uncooperative|0|||
37917513|NCT00809757|69604338|FG002|Overall Study|Subject Uncooperative|2|||
37917514|NCT00809757|69604336|FG000|Overall Study|Noncompliance with Medication|0|||
37917515|NCT00809757|69604337|FG001|Overall Study|Noncompliance with Medication|0|||
37917516|NCT00809757|69604338|FG002|Overall Study|Noncompliance with Medication|1|||
37917517|NCT00594464|69604352|FG000|Overall Study|Withdrawal by Subject|1|||
37917518|NCT00594464|69604352|FG000|Overall Study|Delay in operation|2|||
37917519|NCT00809445|69604365|FG000|1 Month Follow-up|Lost contact|1|||
37917520|NCT00809445|69604366|FG001|1 Month Follow-up|Lost contact|2|||
37917521|NCT00809445|69604367|FG002|1 Month Follow-up|Lost contact|1|||
37917522|NCT00809445|69604365|FG000|1 Month Follow-up|Withdrew consent|1|||
37917523|NCT00809445|69604366|FG001|1 Month Follow-up|Withdrew consent|1|||
37917524|NCT00809445|69604367|FG002|1 Month Follow-up|Withdrew consent|1|||
37917525|NCT00809445|69604365|FG000|1 Month Follow-up|Death|0|||
37917526|NCT00809445|69604366|FG001|1 Month Follow-up|Death|1|||
37847645|NCT01324440|69531642|FG000|Overall Study|Subject moved|0|||
37847646|NCT01324440|69531643|FG001|Overall Study|Subject moved|1|||
37847647|NCT01325493|69531651|FG000|Overall Study|Protocol Violation|0|||
37847648|NCT01325493|69531652|FG001|Overall Study|Protocol Violation|1|||
37847649|NCT01325493|69531651|FG000|Overall Study|loss of neuromonitoring signals|0|||
37847650|NCT01325493|69531652|FG001|Overall Study|loss of neuromonitoring signals|2|||
37847651|NCT01325493|69531651|FG000|Overall Study|Allergy|1|||
37847652|NCT01325493|69531652|FG001|Overall Study|Allergy|0|||
37847653|NCT01323972|69531662|FG000|Overall Study|Withdrawal by Subject|1|||
37847654|NCT01323972|69531663|FG001|Overall Study|Withdrawal by Subject|0|||
37847655|NCT01323972|69531664|FG002|Overall Study|Withdrawal by Subject|1|||
37847656|NCT01323972|69531665|FG003|Overall Study|Withdrawal by Subject|0|||
37847657|NCT01323972|69531662|FG000|Overall Study|Migrated/moved from study area|1|||
37847658|NCT01323972|69531663|FG001|Overall Study|Migrated/moved from study area|2|||
37917527|NCT00809445|69604367|FG002|1 Month Follow-up|Death|1|||
37917528|NCT00809445|69604365|FG000|1 Month Follow-up|Incarcerated|0|||
37917529|NCT00809445|69604366|FG001|1 Month Follow-up|Incarcerated|0|||
37917530|NCT00809445|69604367|FG002|1 Month Follow-up|Incarcerated|1|||
37917531|NCT00809445|69604365|FG000|6 Month Follow-up|Lost contact|16|||
37917532|NCT00809445|69604366|FG001|6 Month Follow-up|Lost contact|14|||
37917533|NCT00809445|69604367|FG002|6 Month Follow-up|Lost contact|14|||
37917534|NCT00809445|69604365|FG000|6 Month Follow-up|Death|2|||
37917535|NCT00809445|69604366|FG001|6 Month Follow-up|Death|1|||
37917536|NCT00809445|69604367|FG002|6 Month Follow-up|Death|1|||
37847659|NCT01323972|69531664|FG002|Overall Study|Migrated/moved from study area|0|||
37847660|NCT01323972|69531665|FG003|Overall Study|Migrated/moved from study area|0|||
37847661|NCT01323972|69531662|FG000|Overall Study|Lost to Follow-up|0|||
37847662|NCT01323972|69531663|FG001|Overall Study|Lost to Follow-up|1|||
37917537|NCT00809445|69604365|FG000|6 Month Follow-up|Incarcerated|6|||
37917538|NCT00809445|69604366|FG001|6 Month Follow-up|Incarcerated|8|||
37917539|NCT00809445|69604367|FG002|6 Month Follow-up|Incarcerated|8|||
37917540|NCT00809445|69604365|FG000|6 Month Follow-up|Withdrew consent|0|||
37917541|NCT00809445|69604366|FG001|6 Month Follow-up|Withdrew consent|0|||
37917542|NCT00809445|69604367|FG002|6 Month Follow-up|Withdrew consent|1|||
37917543|NCT00593918|69604390|FG000|Overall Study|Withdrawal by Subject|5|||
37917544|NCT00593918|69604391|FG001|Overall Study|Withdrawal by Subject|24|||
37917545|NCT04135196|69604402|FG000|Overall Study|Lost to Follow-up|8|||
37917546|NCT04135196|69604403|FG001|Overall Study|Lost to Follow-up|7|||
37917547|NCT04135196|69604404|FG002|Overall Study|Lost to Follow-up|8|||
37917548|NCT04135196|69604405|FG003|Overall Study|Lost to Follow-up|9|||
37917549|NCT04135196|69604406|FG004|Overall Study|Lost to Follow-up|1|||
37917550|NCT04135196|69604402|FG000|Overall Study|Pregnancy|0|||
37917551|NCT04135196|69604403|FG001|Overall Study|Pregnancy|0|||
37917552|NCT04135196|69604404|FG002|Overall Study|Pregnancy|1|||
37917553|NCT04135196|69604405|FG003|Overall Study|Pregnancy|0|||
37917554|NCT04135196|69604406|FG004|Overall Study|Pregnancy|0|||
37917555|NCT04135196|69604402|FG000|Overall Study|Withdrawal by Subject|0|||
37917556|NCT04135196|69604403|FG001|Overall Study|Withdrawal by Subject|0|||
37917557|NCT04135196|69604404|FG002|Overall Study|Withdrawal by Subject|0|||
37917558|NCT04135196|69604405|FG003|Overall Study|Withdrawal by Subject|0|||
37917559|NCT04135196|69604406|FG004|Overall Study|Withdrawal by Subject|1|||
37917560|NCT00499369|69604423|FG000|Overall Study|Adverse Event|2|||
37917561|NCT00499369|69604424|FG001|Overall Study|Adverse Event|2|||
37847663|NCT01323972|69531664|FG002|Overall Study|Lost to Follow-up|1|||
37847664|NCT01323972|69531665|FG003|Overall Study|Lost to Follow-up|1|||
37847665|NCT01325337|69531682|FG000|Overall Study|Adverse Event|0|||
37847666|NCT01325337|69531683|FG001|Overall Study|Adverse Event|2|||
37847667|NCT01325337|69531684|FG002|Overall Study|Adverse Event|2|||
37847668|NCT01325337|69531685|FG003|Overall Study|Adverse Event|1|||
37847669|NCT01325337|69531686|FG004|Overall Study|Adverse Event|2|||
37847670|NCT01325337|69531682|FG000|Overall Study|Lost to Follow-up|2|||
37847671|NCT01325337|69531683|FG001|Overall Study|Lost to Follow-up|2|||
37847672|NCT01325337|69531684|FG002|Overall Study|Lost to Follow-up|2|||
37847673|NCT01325337|69531685|FG003|Overall Study|Lost to Follow-up|1|||
37847674|NCT01325337|69531686|FG004|Overall Study|Lost to Follow-up|2|||
37847675|NCT01325337|69531682|FG000|Overall Study|Personal Reasons|2|||
37847676|NCT01325337|69531683|FG001|Overall Study|Personal Reasons|5|||
37847677|NCT01325337|69531684|FG002|Overall Study|Personal Reasons|4|||
37847678|NCT01325337|69531685|FG003|Overall Study|Personal Reasons|8|||
37847679|NCT01325337|69531686|FG004|Overall Study|Personal Reasons|3|||
37847680|NCT01325337|69531682|FG000|Overall Study|Withdrawal by Subject|1|||
37847681|NCT01325337|69531683|FG001|Overall Study|Withdrawal by Subject|0|||
37847682|NCT01325337|69531684|FG002|Overall Study|Withdrawal by Subject|1|||
37847683|NCT01325337|69531685|FG003|Overall Study|Withdrawal by Subject|0|||
37847684|NCT01325337|69531686|FG004|Overall Study|Withdrawal by Subject|1|||
37847685|NCT01324947|69531698|FG000|Overall Study|Adverse Event|7|||
37847686|NCT01324947|69531698|FG000|Overall Study|Death|10|||
37847687|NCT01324947|69531698|FG000|Overall Study|Other|3|||
37847688|NCT01324947|69531698|FG000|Overall Study|Progressive Disease|50|||
37847689|NCT01324947|69531698|FG000|Overall Study|Withdrawal by Subject|3|||
37847690|NCT01324947|69531698|FG000|Overall Study|1 discontinued before starting drug|1|||
37847691|NCT01101841|69531706|FG000|Overall Study|Adverse Event|15|||
37847692|NCT01101841|69531707|FG001|Overall Study|Adverse Event|15|||
37847693|NCT01101841|69531706|FG000|Overall Study|Lost to Follow-up|9|||
37847694|NCT01101841|69531707|FG001|Overall Study|Lost to Follow-up|3|||
37847695|NCT01101841|69531706|FG000|Overall Study|Withdrawal by Subject|21|||
37847696|NCT01101841|69531707|FG001|Overall Study|Withdrawal by Subject|40|||
37917562|NCT00499369|69604425|FG002|Overall Study|Adverse Event|3|||
37917563|NCT00499369|69604426|FG003|Overall Study|Adverse Event|1|||
37917564|NCT00499369|69604427|FG004|Overall Study|Adverse Event|2|||
37917565|NCT00499369|69604423|FG000|Overall Study|Withdrawal by Subject|0|||
37917566|NCT00499369|69604424|FG001|Overall Study|Withdrawal by Subject|1|||
37917567|NCT00499369|69604425|FG002|Overall Study|Withdrawal by Subject|1|||
37917568|NCT00499369|69604426|FG003|Overall Study|Withdrawal by Subject|0|||
37917569|NCT00499369|69604427|FG004|Overall Study|Withdrawal by Subject|0|||
37917570|NCT00499369|69604423|FG000|Overall Study|Progression|10|||
37917571|NCT00499369|69604424|FG001|Overall Study|Progression|12|||
37917572|NCT00499369|69604425|FG002|Overall Study|Progression|9|||
37917573|NCT00499369|69604426|FG003|Overall Study|Progression|6|||
37847697|NCT01101841|69531706|FG000|Overall Study|Protocol Violation|1|||
37847698|NCT01101841|69531707|FG001|Overall Study|Protocol Violation|1|||
37847699|NCT01101841|69531706|FG000|Overall Study|Physician Decision|0|||
37847700|NCT01101841|69531707|FG001|Overall Study|Physician Decision|2|||
37847701|NCT01101841|69531706|FG000|Overall Study|Lack of Efficacy|0|||
37847702|NCT01101841|69531707|FG001|Overall Study|Lack of Efficacy|2|||
37847703|NCT01101841|69531706|FG000|Overall Study|Other|0|||
37847704|NCT01101841|69531707|FG001|Overall Study|Other|1|||
37847705|NCT01101841|69531706|FG000|Overall Study|Suicidality Tracking Scale|3|||
37734828|NCT01904773|69215210|FG008|First Intervention|Adverse Event|0|||
37734829|NCT01904773|69215202|FG000|Placebo Washout First Intervention|Condition worsened|0|||
37734830|NCT01904773|69215203|FG001|Placebo Washout First Intervention|Condition worsened|1|||
37734831|NCT01904773|69215204|FG002|Placebo Washout First Intervention|Condition worsened|0|||
37734832|NCT01904773|69215205|FG003|Placebo Washout First Intervention|Condition worsened|0|||
37734833|NCT01904773|69215206|FG004|Placebo Washout First Intervention|Condition worsened|0|||
37734834|NCT01904773|69215207|FG005|Placebo Washout First Intervention|Condition worsened|0|||
37734835|NCT01904773|69215208|FG006|Placebo Washout First Intervention|Condition worsened|0|||
37734836|NCT01904773|69215209|FG007|Placebo Washout First Intervention|Condition worsened|0|||
37734837|NCT01904773|69215210|FG008|Placebo Washout First Intervention|Condition worsened|0|||
37734838|NCT01904773|69215202|FG000|Fifth Intervention|Adverse Event|0|||
37734839|NCT01904773|69215203|FG001|Fifth Intervention|Adverse Event|0|||
37734840|NCT01904773|69215204|FG002|Fifth Intervention|Adverse Event|0|||
37734841|NCT01904773|69215205|FG003|Fifth Intervention|Adverse Event|0|||
37734842|NCT01904773|69215206|FG004|Fifth Intervention|Adverse Event|0|||
37734843|NCT01904773|69215207|FG005|Fifth Intervention|Adverse Event|0|||
37734844|NCT01904773|69215208|FG006|Fifth Intervention|Adverse Event|0|||
37734845|NCT01904773|69215209|FG007|Fifth Intervention|Adverse Event|1|||
37734846|NCT01904773|69215210|FG008|Fifth Intervention|Adverse Event|0|||
37734847|NCT01904773|69215202|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
37734848|NCT01904773|69215203|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
37734849|NCT01904773|69215204|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
37734850|NCT01904773|69215205|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
37734851|NCT01904773|69215206|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
37734852|NCT01904773|69215207|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
37734853|NCT01904773|69215208|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
37734854|NCT01904773|69215209|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
37734855|NCT01904773|69215210|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
37734856|NCT01928719|69215224|FG000|Overall Study|Lost to Follow-up|26|||
37734857|NCT01928719|69215225|FG001|Overall Study|Lost to Follow-up|11|||
37734858|NCT01928719|69215224|FG000|Overall Study|Withdrawal by Subject|22|||
37734859|NCT01928719|69215225|FG001|Overall Study|Withdrawal by Subject|7|||
37734860|NCT01928719|69215224|FG000|Overall Study|Protocol Violation|3|||
37734861|NCT01928719|69215225|FG001|Overall Study|Protocol Violation|1|||
37734862|NCT01928719|69215224|FG000|Overall Study|Adverse Event|1|||
37734863|NCT01928719|69215225|FG001|Overall Study|Adverse Event|0|||
37734864|NCT00986674|69215236|FG000|Overall Study|Lack of Efficacy|28|||
37734865|NCT00986674|69215237|FG001|Overall Study|Lack of Efficacy|25|||
37734866|NCT00986674|69215238|FG002|Overall Study|Lack of Efficacy|23|||
37734867|NCT00986674|69215236|FG000|Overall Study|Adverse Event|4|||
37734868|NCT00986674|69215237|FG001|Overall Study|Adverse Event|8|||
37734869|NCT00986674|69215238|FG002|Overall Study|Adverse Event|9|||
37734870|NCT00986674|69215236|FG000|Overall Study|Death|5|||
37734871|NCT00986674|69215237|FG001|Overall Study|Death|0|||
37734872|NCT00986674|69215238|FG002|Overall Study|Death|4|||
37734873|NCT00986674|69215236|FG000|Overall Study|Withdrawal by Subject|6|||
37734874|NCT00986674|69215237|FG001|Overall Study|Withdrawal by Subject|2|||
37734875|NCT00986674|69215238|FG002|Overall Study|Withdrawal by Subject|1|||
37734876|NCT00986674|69215236|FG000|Overall Study|alternative therapy|0|||
37734877|NCT00986674|69215237|FG001|Overall Study|alternative therapy|0|||
37734878|NCT00986674|69215238|FG002|Overall Study|alternative therapy|1|||
37734879|NCT00986674|69215236|FG000|Overall Study|not start protocol therapy|4|||
37734880|NCT00986674|69215237|FG001|Overall Study|not start protocol therapy|3|||
37734881|NCT00986674|69215238|FG002|Overall Study|not start protocol therapy|1|||
37734882|NCT00986674|69215236|FG000|Overall Study|unknown/not specify|0|||
37734883|NCT00986674|69215237|FG001|Overall Study|unknown/not specify|7|||
37734884|NCT00986674|69215238|FG002|Overall Study|unknown/not specify|9|||
37734885|NCT00986440|69215248|FG000|Overall Study|Progressive disease|27|||
37734886|NCT00986440|69215249|FG001|Overall Study|Progressive disease|37|||
37734887|NCT00986440|69215248|FG000|Overall Study|Serious adverse event or adverse event|9|||
37734888|NCT00986440|69215249|FG001|Overall Study|Serious adverse event or adverse event|2|||
37734889|NCT00986440|69215248|FG000|Overall Study|Withdrawal by Subject|1|||
37734890|NCT00986440|69215249|FG001|Overall Study|Withdrawal by Subject|2|||
37734891|NCT00986440|69215248|FG000|Overall Study|Screen failure (not dosed)|4|||
37734892|NCT00986440|69215249|FG001|Overall Study|Screen failure (not dosed)|2|||
37734893|NCT01904383|69215255|FG000|Overall Study|CRF not collected|117|||
37734894|NCT01904383|69215255|FG000|Overall Study|Reason not listed|147|||
37734895|NCT01904383|69215255|FG000|Overall Study|Lost to Follow-up|674|||
37734896|NCT01904383|69215255|FG000|Overall Study|Lack of Efficacy|370|||
37734897|NCT01904383|69215255|FG000|Overall Study|Improvement|141|||
37847706|NCT01101841|69531707|FG001|Overall Study|Suicidality Tracking Scale|1|||
37847707|NCT01101841|69531706|FG000|Overall Study|Eligibility Criteria|1|||
37847708|NCT01101841|69531707|FG001|Overall Study|Eligibility Criteria|2|||
37847709|NCT01324401|69531716|FG000|Overall Study|Withdrawn before any treatment|0|||
37847710|NCT01324401|69531717|FG001|Overall Study|Withdrawn before any treatment|3|||
37847711|NCT01324401|69531716|FG000|Overall Study|Adverse Event|1|||
37847712|NCT01324401|69531717|FG001|Overall Study|Adverse Event|3|||
37847713|NCT01323660|69531723|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
37847714|NCT01323660|69531724|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
37847715|NCT01323660|69531725|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
37847716|NCT01323660|69531726|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
37847717|NCT01323660|69531727|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
37847718|NCT01323660|69531728|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
37847719|NCT01323660|69531723|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
37917574|NCT00499369|69604427|FG004|Overall Study|Progression|10|||
37917575|NCT00499369|69604423|FG000|Overall Study|Death|0|||
37917576|NCT00499369|69604424|FG001|Overall Study|Death|1|||
37917577|NCT00499369|69604425|FG002|Overall Study|Death|0|||
37917578|NCT00499369|69604426|FG003|Overall Study|Death|0|||
37917579|NCT00499369|69604427|FG004|Overall Study|Death|0|||
37917580|NCT00499369|69604423|FG000|Overall Study|Not protocol specified|2|||
37917581|NCT00499369|69604424|FG001|Overall Study|Not protocol specified|0|||
37847720|NCT01323660|69531724|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
37847721|NCT01323660|69531725|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
37847722|NCT01323660|69531726|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
37847723|NCT01323660|69531727|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
37847724|NCT01323660|69531728|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
37847725|NCT01323660|69531723|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
37847726|NCT01323660|69531724|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
37847727|NCT01323660|69531725|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
37847728|NCT01323660|69531726|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
37847729|NCT01323660|69531727|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
37847730|NCT01323660|69531728|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
37847731|NCT01323660|69531723|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
37847732|NCT01323660|69531724|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
37847733|NCT01323660|69531725|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
37847734|NCT01323660|69531726|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
37847735|NCT01323660|69531727|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
37847736|NCT01323660|69531728|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
37847737|NCT01323660|69531723|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
37847738|NCT01323660|69531724|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
37847739|NCT01323660|69531725|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
37847740|NCT01323660|69531726|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
37847741|NCT01323660|69531727|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
37847742|NCT01323660|69531728|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
37847743|NCT01323660|69531723|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
37847744|NCT01323660|69531724|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
37847745|NCT01323660|69531725|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
37847746|NCT01323660|69531726|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
37847747|NCT01323660|69531727|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
37847748|NCT01323660|69531728|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
37847749|NCT01323660|69531723|FG000|Washout Period (14 Days)|Adverse Event|0|||
37847750|NCT01323660|69531724|FG001|Washout Period (14 Days)|Adverse Event|0|||
37847751|NCT01323660|69531725|FG002|Washout Period (14 Days)|Adverse Event|0|||
37847752|NCT01323660|69531726|FG003|Washout Period (14 Days)|Adverse Event|0|||
37847753|NCT01323660|69531727|FG004|Washout Period (14 Days)|Adverse Event|1|||
37847754|NCT01323660|69531728|FG005|Washout Period (14 Days)|Adverse Event|0|||
37917582|NCT00499369|69604425|FG002|Overall Study|Not protocol specified|3|||
37917583|NCT00499369|69604426|FG003|Overall Study|Not protocol specified|1|||
37917584|NCT00499369|69604427|FG004|Overall Study|Not protocol specified|0|||
37917585|NCT00499369|69604423|FG000|Overall Study|Ineligible|2|||
37917586|NCT00499369|69604424|FG001|Overall Study|Ineligible|2|||
37917587|NCT00499369|69604425|FG002|Overall Study|Ineligible|1|||
37917588|NCT00499369|69604426|FG003|Overall Study|Ineligible|1|||
37917589|NCT00499369|69604427|FG004|Overall Study|Ineligible|0|||
37917590|NCT00869258|69604439|FG000|Overall Study|Physician Decision|1|||
37917591|NCT00693784|69604443|FG000|Overall Study|Lost to Follow-up|2|||
37917592|NCT00693784|69604443|FG000|Overall Study|Withdrawal by Subject|2|||
37917593|NCT00693706|69604449|FG000|Overall Study|Protocol Violation|0|||
37917594|NCT00693706|69604450|FG001|Overall Study|Protocol Violation|1|||
37917595|NCT00488683|69604459|FG000|Overall Study|Withdrawal by Subject|1|||
37917596|NCT00488683|69604460|FG001|Overall Study|Withdrawal by Subject|2|||
37917597|NCT00488683|69604461|FG002|Overall Study|Withdrawal by Subject|2|||
37917598|NCT00488683|69604459|FG000|Overall Study|Lost to Follow-up|5|||
37917599|NCT00488683|69604460|FG001|Overall Study|Lost to Follow-up|3|||
37917600|NCT00488683|69604461|FG002|Overall Study|Lost to Follow-up|0|||
37917601|NCT00488683|69604459|FG000|Overall Study|Protocol Violation|5|||
37847755|NCT01323660|69531723|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
37847756|NCT01323660|69531724|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
37847757|NCT01323660|69531725|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
37847758|NCT01323660|69531726|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
37847759|NCT01323660|69531727|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
37917602|NCT00488683|69604460|FG001|Overall Study|Protocol Violation|1|||
37917603|NCT00488683|69604461|FG002|Overall Study|Protocol Violation|0|||
37917604|NCT00488683|69604459|FG000|Overall Study|Unable to Classify|1|||
37917605|NCT00488683|69604460|FG001|Overall Study|Unable to Classify|0|||
37917606|NCT00488683|69604461|FG002|Overall Study|Unable to Classify|0|||
37917607|NCT00693472|69604495|FG000|Part 1|Adverse Event|1|||
37917608|NCT00693472|69604496|FG001|Part 1|Adverse Event|1|||
37917609|NCT00693472|69604497|FG002|Part 1|Adverse Event|0|||
37917610|NCT00693472|69604498|FG003|Part 1|Adverse Event|0|||
37917611|NCT00693472|69604495|FG000|Part 1|Lost to Follow-up|0|||
37917612|NCT00693472|69604496|FG001|Part 1|Lost to Follow-up|1|||
37917613|NCT00693472|69604497|FG002|Part 1|Lost to Follow-up|0|||
37917614|NCT00693472|69604498|FG003|Part 1|Lost to Follow-up|0|||
37917615|NCT00693472|69604495|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
37917616|NCT00693472|69604496|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
37917617|NCT00693472|69604497|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
37917618|NCT00693472|69604498|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
37917619|NCT00693472|69604495|FG000|Part 2|Adverse Event|0|||
37917620|NCT00693472|69604496|FG001|Part 2|Adverse Event|0|||
37917621|NCT00693472|69604497|FG002|Part 2|Adverse Event|1|||
37917622|NCT00693472|69604498|FG003|Part 2|Adverse Event|0|||
37917623|NCT00693472|69604495|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
37917624|NCT00693472|69604496|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
37917625|NCT00693472|69604497|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
37917626|NCT00693472|69604498|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
37917627|NCT00498433|69604511|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
37917628|NCT00498433|69604512|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
37917629|NCT00498433|69604513|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
37917630|NCT00498433|69604511|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
37917631|NCT00498433|69604512|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
37917632|NCT00498433|69604513|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
37917633|NCT00498433|69604511|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
37917634|NCT00498433|69604512|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
37917635|NCT00498433|69604513|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
37917636|NCT00498433|69604511|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
37917637|NCT00498433|69604512|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
37917638|NCT00498433|69604513|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
37917639|NCT00498355|69604530|FG000|Overall Study|Lost to Follow-up|1|||
37917640|NCT04327271|69604537|FG000|Overall Study|Death|1|||
37917641|NCT04327271|69604538|FG001|Overall Study|Death|0|||
37917642|NCT04327271|69604537|FG000|Overall Study|Withdrawal by Subject|1|||
37917643|NCT04327271|69604538|FG001|Overall Study|Withdrawal by Subject|0|||
37917644|NCT04327271|69604537|FG000|Overall Study|randomization error (data capture)|4|||
37917645|NCT04327271|69604538|FG001|Overall Study|randomization error (data capture)|3|||
37917646|NCT00688636|69604555|FG000|Overall Study|Adverse Event|2|||
37847760|NCT01323660|69531728|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
37847761|NCT01323660|69531723|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
37847762|NCT01323660|69531724|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
37847763|NCT01323660|69531725|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
37847764|NCT01323660|69531726|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
37847765|NCT01323660|69531727|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
37847766|NCT01323660|69531728|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
37847767|NCT01323660|69531723|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
37847768|NCT01323660|69531724|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
37847769|NCT01323660|69531725|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
37847770|NCT01323660|69531726|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
37847771|NCT01323660|69531727|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
37847772|NCT01323660|69531728|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
37847773|NCT01323660|69531723|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
37847774|NCT01323660|69531724|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
37917647|NCT00688636|69604556|FG001|Overall Study|Adverse Event|1|||
37917648|NCT00870740|69604568|FG000|Overall Study|Adverse Event|2|||
37917649|NCT00870740|69604569|FG001|Overall Study|Adverse Event|1|||
37917650|NCT00870740|69604570|FG002|Overall Study|Adverse Event|3|||
37917651|NCT00870740|69604571|FG003|Overall Study|Adverse Event|2|||
37917652|NCT00870740|69604572|FG004|Overall Study|Adverse Event|1|||
37847775|NCT01323660|69531725|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
37847776|NCT01323660|69531726|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
37847777|NCT01323660|69531727|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
37847778|NCT01323660|69531728|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
37847779|NCT01323660|69531723|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
37847780|NCT01323660|69531724|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
37847781|NCT01323660|69531725|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
37847782|NCT01323660|69531726|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
37847783|NCT01323660|69531727|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
37847784|NCT01323660|69531728|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
37847785|NCT01323660|69531723|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
37847786|NCT01323660|69531724|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
37847787|NCT01323660|69531725|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
37847788|NCT01323660|69531726|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
37847789|NCT01323660|69531727|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
37847790|NCT01323660|69531728|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
37847791|NCT01092637|69531744|FG000|Overall Study|Death|47|||
37847792|NCT01092637|69531745|FG001|Overall Study|Death|49|||
37847793|NCT01324323|69531752|FG000|Overall Study|Withdrawal by Subject|1|||
37847794|NCT01323582|69531766|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
37847795|NCT01323582|69531767|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
37847796|NCT01323582|69531766|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
37847797|NCT01323582|69531767|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
37847798|NCT01323582|69531766|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
37847799|NCT01323582|69531767|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
37847800|NCT01323621|69531777|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
37847801|NCT01323621|69531778|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
37847802|NCT01323621|69531779|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
37847803|NCT01323621|69531777|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
37847804|NCT01323621|69531778|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
37847805|NCT01323621|69531779|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
37847806|NCT01323621|69531777|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
37847807|NCT01323621|69531778|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
37847808|NCT01323621|69531779|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
37847809|NCT01323621|69531777|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
37847810|NCT01323621|69531778|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
37847811|NCT01323621|69531779|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
37847812|NCT01323621|69531777|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
37847813|NCT01323621|69531778|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
37847814|NCT01323621|69531779|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
37847815|NCT01323621|69531777|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
37847816|NCT01323621|69531778|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
37847817|NCT01323621|69531779|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
37847818|NCT01323621|69531777|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
37847819|NCT01323621|69531778|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
37847820|NCT01323621|69531779|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
37847821|NCT01323621|69531777|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
37847822|NCT01323621|69531778|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
37847823|NCT01323621|69531779|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
37847824|NCT01323621|69531777|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
37847825|NCT01323621|69531778|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
37847826|NCT01323621|69531779|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
37847827|NCT01323621|69531777|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
37847828|NCT01323621|69531778|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
37847829|NCT01323621|69531779|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
37847830|NCT01323621|69531777|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
37847831|NCT01323621|69531778|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
37847832|NCT01323621|69531779|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
37847833|NCT01323621|69531777|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
37847834|NCT01323621|69531778|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
37847835|NCT01323621|69531779|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
37847836|NCT01323192|69531787|FG000|Overall Study|Adverse Event|6|||
37847837|NCT01323192|69531788|FG001|Overall Study|Adverse Event|1|||
37917653|NCT00870740|69604573|FG005|Overall Study|Adverse Event|6|||
37917654|NCT00870740|69604568|FG000|Overall Study|Consent Withdrawn|6|||
37847838|NCT01323192|69531787|FG000|Overall Study|Withdrawal by Subject|3|||
37847839|NCT01323192|69531788|FG001|Overall Study|Withdrawal by Subject|1|||
37847840|NCT01323192|69531787|FG000|Overall Study|Noncompliance with study medication|0|||
37847841|NCT01323192|69531788|FG001|Overall Study|Noncompliance with study medication|3|||
37847842|NCT01323192|69531787|FG000|Overall Study|Nonmedical reasons|0|||
37847843|NCT01323192|69531788|FG001|Overall Study|Nonmedical reasons|1|||
37847844|NCT01323387|69531794|FG000|Overall Study|Withdrawal by Subject|41|||
37847845|NCT01323387|69531794|FG000|Overall Study|Radiographic Data Unavailable|1|||
37847846|NCT01323387|69531794|FG000|Overall Study|Revision|14|||
37847847|NCT01323387|69531794|FG000|Overall Study|Protocol Violation|12|||
37847848|NCT01323387|69531794|FG000|Overall Study|Randomized but Never Treated|16|||
37847849|NCT01321749|69531802|FG000|Overall Study|Lost to Follow-up|4|||
37847850|NCT01321749|69531803|FG001|Overall Study|Lost to Follow-up|11|||
37847851|NCT01321749|69531802|FG000|Overall Study|Protocol Violation|4|||
37847852|NCT01321749|69531803|FG001|Overall Study|Protocol Violation|7|||
37917655|NCT00870740|69604569|FG001|Overall Study|Consent Withdrawn|3|||
37917656|NCT00870740|69604570|FG002|Overall Study|Consent Withdrawn|4|||
37917657|NCT00870740|69604571|FG003|Overall Study|Consent Withdrawn|6|||
37917658|NCT00870740|69604572|FG004|Overall Study|Consent Withdrawn|6|||
37917659|NCT00870740|69604573|FG005|Overall Study|Consent Withdrawn|5|||
37917660|NCT00870740|69604568|FG000|Overall Study|Investigator Decision|2|||
37847853|NCT01321749|69531802|FG000|Overall Study|Withdrawal by Subject|5|||
37847854|NCT01321749|69531803|FG001|Overall Study|Withdrawal by Subject|4|||
37847855|NCT01320735|69531809|FG000|Overall Study|Adverse Event|3|||
37847856|NCT01320735|69531809|FG000|Overall Study|Withdrawal by Subject|3|||
37847857|NCT01320735|69531809|FG000|Overall Study|Lost to Follow-up|13|||
37847858|NCT01320735|69531809|FG000|Overall Study|Administrative Reason|6|||
37847859|NCT01320735|69531809|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
37847860|NCT01320735|69531809|FG000|Overall Study|Protocol Violation|1|||
37847861|NCT01320735|69531809|FG000|Overall Study|Other|1|||
37847862|NCT01320735|69531809|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
37847863|NCT01320735|69531809|FG000|Overall Study|Investigator Unable to be Contacted|17|||
37847864|NCT01320033|69531816|FG000|Overall Study|Lack of Efficacy|0|||
37847865|NCT01320033|69531817|FG001|Overall Study|Lack of Efficacy|0|||
37917661|NCT00870740|69604569|FG001|Overall Study|Investigator Decision|0|||
37917662|NCT00870740|69604570|FG002|Overall Study|Investigator Decision|1|||
37917663|NCT00870740|69604571|FG003|Overall Study|Investigator Decision|0|||
37917664|NCT00870740|69604572|FG004|Overall Study|Investigator Decision|0|||
37917665|NCT00870740|69604573|FG005|Overall Study|Investigator Decision|0|||
37917666|NCT00870740|69604568|FG000|Overall Study|Subject Non-compliance|0|||
37917667|NCT00870740|69604569|FG001|Overall Study|Subject Non-compliance|0|||
37917668|NCT00870740|69604570|FG002|Overall Study|Subject Non-compliance|0|||
37917669|NCT00870740|69604571|FG003|Overall Study|Subject Non-compliance|0|||
37917670|NCT00870740|69604572|FG004|Overall Study|Subject Non-compliance|0|||
37847866|NCT01320033|69531818|FG002|Overall Study|Lack of Efficacy|1|||
37847867|NCT01320033|69531816|FG000|Overall Study|Adverse Event|9|||
37847868|NCT01320033|69531817|FG001|Overall Study|Adverse Event|7|||
37847869|NCT01320033|69531818|FG002|Overall Study|Adverse Event|8|||
37847870|NCT01320033|69531816|FG000|Overall Study|Withdrawal by Subject|22|||
37847871|NCT01320033|69531817|FG001|Overall Study|Withdrawal by Subject|23|||
37847872|NCT01320033|69531818|FG002|Overall Study|Withdrawal by Subject|23|||
37847873|NCT01320033|69531816|FG000|Overall Study|Protocol Violation|3|||
37847874|NCT01320033|69531817|FG001|Overall Study|Protocol Violation|5|||
37847875|NCT01320033|69531818|FG002|Overall Study|Protocol Violation|3|||
37847876|NCT01320033|69531816|FG000|Overall Study|Lost to Follow-up|22|||
37847877|NCT01320033|69531817|FG001|Overall Study|Lost to Follow-up|26|||
37847878|NCT01320033|69531818|FG002|Overall Study|Lost to Follow-up|17|||
37847879|NCT01320033|69531816|FG000|Overall Study|Other|2|||
37847880|NCT01320033|69531817|FG001|Overall Study|Other|3|||
37917671|NCT00870740|69604573|FG005|Overall Study|Subject Non-compliance|1|||
37917672|NCT00870740|69604568|FG000|Overall Study|Death|0|||
37847881|NCT01320033|69531818|FG002|Overall Study|Other|1|||
37847882|NCT01101061|69531832|FG000|Overall Study|Adverse Event|0|||
37847883|NCT01101061|69531833|FG001|Overall Study|Adverse Event|0|||
37847884|NCT01101061|69531834|FG002|Overall Study|Adverse Event|1|||
38026419|NCT00071799|69711240|FG001|Overall Study|Different Central+Local Pathology Review|1|||
37847885|NCT01101061|69531835|FG003|Overall Study|Adverse Event|0|||
37847886|NCT01101061|69531836|FG004|Overall Study|Adverse Event|0|||
37847887|NCT01101061|69531837|FG005|Overall Study|Adverse Event|0|||
38026420|NCT00071799|69711239|FG000|Overall Study|Not Documented|0|||
37847888|NCT01317615|69531855|FG000|Overall Study|Disease progression|25|||
37847889|NCT01317615|69531855|FG000|Overall Study|New cancer therapy|5|||
37847890|NCT01317615|69531855|FG000|Overall Study|Death|6|||
37917673|NCT00870740|69604569|FG001|Overall Study|Death|0|||
37847891|NCT01317615|69531855|FG000|Overall Study|Withdrawal by Subject|5|||
37847892|NCT01317615|69531855|FG000|Overall Study|Abnormal laboratory value(s)|1|||
37847893|NCT01317615|69531855|FG000|Overall Study|Adverse Event|7|||
37847894|NCT01078675|69531861|FG000|Overall Study|Withdrawal by Subject|7|||
37847895|NCT01078675|69531862|FG001|Overall Study|Withdrawal by Subject|3|||
37847896|NCT01078675|69531861|FG000|Overall Study|Protocol Violation|56|||
37847897|NCT01078675|69531862|FG001|Overall Study|Protocol Violation|0|||
37847898|NCT01078675|69531861|FG000|Overall Study|Provided in CRF for specific reasons|2|||
37847899|NCT01078675|69531862|FG001|Overall Study|Provided in CRF for specific reasons|3|||
37847900|NCT01078675|69531861|FG000|Overall Study|Adverse Event|3|||
37847901|NCT01078675|69531862|FG001|Overall Study|Adverse Event|0|||
37847902|NCT01100437|69531868|FG000|Titration/Stabilization|Adverse Event|0|||
37847903|NCT01100437|69531869|FG001|Titration/Stabilization|Adverse Event|0|||
37847904|NCT01100437|69531870|FG002|Titration/Stabilization|Adverse Event|4|||
37847905|NCT01100437|69531868|FG000|Titration/Stabilization|Non-compliance|0|||
37847906|NCT01100437|69531869|FG001|Titration/Stabilization|Non-compliance|0|||
37847907|NCT01100437|69531870|FG002|Titration/Stabilization|Non-compliance|1|||
37847908|NCT01100437|69531868|FG000|Titration/Stabilization|Sponsor canceled study|0|||
37847909|NCT01100437|69531869|FG001|Titration/Stabilization|Sponsor canceled study|0|||
37847910|NCT01100437|69531870|FG002|Titration/Stabilization|Sponsor canceled study|1|||
37917674|NCT00870740|69604570|FG002|Overall Study|Death|0|||
37917675|NCT00870740|69604571|FG003|Overall Study|Death|0|||
37917676|NCT00870740|69604572|FG004|Overall Study|Death|1|||
37917677|NCT00870740|69604573|FG005|Overall Study|Death|0|||
37917678|NCT00870740|69604568|FG000|Overall Study|Other|2|||
37917679|NCT00870740|69604569|FG001|Overall Study|Other|5|||
37917680|NCT00870740|69604570|FG002|Overall Study|Other|2|||
37917681|NCT00870740|69604571|FG003|Overall Study|Other|4|||
37917682|NCT00870740|69604572|FG004|Overall Study|Other|3|||
37917683|NCT00870740|69604573|FG005|Overall Study|Other|5|||
37917684|NCT00869024|69604600|FG000|Overall Study|Death|2|||
37917685|NCT00869024|69604601|FG001|Overall Study|Death|3|||
37917686|NCT00869024|69604600|FG000|Overall Study|Lost to Follow-up|0|||
37917687|NCT00869024|69604601|FG001|Overall Study|Lost to Follow-up|1|||
37917688|NCT00869024|69604600|FG000|Overall Study|Protocol Violation|0|||
37917689|NCT00869024|69604601|FG001|Overall Study|Protocol Violation|1|||
37917690|NCT00506779|69604609|FG000|Overall Study|Withdrawal by Subject|1|||
37917691|NCT00506779|69604610|FG001|Overall Study|Withdrawal by Subject|0|||
37917692|NCT00506779|69604611|FG002|Overall Study|Withdrawal by Subject|1|||
37917693|NCT00506779|69604612|FG003|Overall Study|Withdrawal by Subject|0|||
37917694|NCT00506779|69604609|FG000|Overall Study|Adverse Event|0|||
37917695|NCT00506779|69604610|FG001|Overall Study|Adverse Event|1|||
37917696|NCT00506779|69604611|FG002|Overall Study|Adverse Event|1|||
37917697|NCT00506779|69604612|FG003|Overall Study|Adverse Event|1|||
37917698|NCT00488293|69604625|FG000|Overall Study|Lost to Follow-up|28|||
37917699|NCT00488293|69604626|FG001|Overall Study|Lost to Follow-up|25|||
37917700|NCT00488293|69604625|FG000|Overall Study|Withdrawal by Subject|5|||
37917701|NCT00488293|69604626|FG001|Overall Study|Withdrawal by Subject|3|||
37917702|NCT00488293|69604625|FG000|Overall Study|Death|2|||
37917703|NCT00488293|69604626|FG001|Overall Study|Death|1|||
37917704|NCT00488293|69604625|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
37917705|NCT00488293|69604626|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
37917706|NCT00868790|69604632|FG000|Period 1|Adverse Event|1|||
37917707|NCT00868790|69604633|FG001|Period 1|Adverse Event|0|||
37917708|NCT00868790|69604634|FG002|Period 1|Adverse Event|0|||
37917709|NCT00868790|69604635|FG003|Period 1|Adverse Event|0|||
37917710|NCT00868790|69604636|FG004|Period 1|Adverse Event|0|||
37917711|NCT00868790|69604637|FG005|Period 1|Adverse Event|0|||
37917712|NCT00868790|69604638|FG006|Period 1|Adverse Event|0|||
37917713|NCT00868790|69604639|FG007|Period 1|Adverse Event|3|||
37917714|NCT00868790|69604640|FG008|Period 1|Adverse Event|1|||
37917715|NCT00868790|69604641|FG009|Period 1|Adverse Event|0|||
37917716|NCT00868790|69604642|FG010|Period 1|Adverse Event|0|||
37734898|NCT01904383|69215255|FG000|Overall Study|Adverse Event|271|||
37917717|NCT00868790|69604643|FG011|Period 1|Adverse Event|0|||
37917718|NCT00868790|69604644|FG012|Period 1|Adverse Event|0|||
37917719|NCT00868790|69604645|FG013|Period 1|Adverse Event|1|||
37917720|NCT00868790|69604632|FG000|Period 1|Protocol Violation|1|||
37917721|NCT00868790|69604633|FG001|Period 1|Protocol Violation|0|||
37917722|NCT00868790|69604634|FG002|Period 1|Protocol Violation|0|||
37917723|NCT00868790|69604635|FG003|Period 1|Protocol Violation|0|||
37917724|NCT00868790|69604636|FG004|Period 1|Protocol Violation|0|||
37847911|NCT01100437|69531868|FG000|Maintenance|Withdrawal by Subject|0|||
37917725|NCT00868790|69604637|FG005|Period 1|Protocol Violation|0|||
37917726|NCT00868790|69604638|FG006|Period 1|Protocol Violation|0|||
37847912|NCT01100437|69531869|FG001|Maintenance|Withdrawal by Subject|0|||
37847913|NCT01100437|69531870|FG002|Maintenance|Withdrawal by Subject|1|||
37917727|NCT00868790|69604639|FG007|Period 1|Protocol Violation|0|||
37917728|NCT00868790|69604640|FG008|Period 1|Protocol Violation|0|||
37917729|NCT00868790|69604641|FG009|Period 1|Protocol Violation|0|||
37917730|NCT00868790|69604642|FG010|Period 1|Protocol Violation|0|||
37847914|NCT01100437|69531868|FG000|Maintenance|Sponsor termination of study|0|||
37847915|NCT01100437|69531869|FG001|Maintenance|Sponsor termination of study|0|||
37847916|NCT01100437|69531870|FG002|Maintenance|Sponsor termination of study|1|||
37847917|NCT01322490|69531882|FG000|Treatment Period|Adverse Event|12|||
37847918|NCT01322490|69531883|FG001|Treatment Period|Adverse Event|18|||
37847919|NCT01322490|69531884|FG002|Treatment Period|Adverse Event|15|||
37847920|NCT01322490|69531882|FG000|Treatment Period|Death|5|||
37847921|NCT01322490|69531883|FG001|Treatment Period|Death|7|||
37847922|NCT01322490|69531884|FG002|Treatment Period|Death|3|||
37847923|NCT01322490|69531882|FG000|Treatment Period|Lack of Efficacy|89|||
37847924|NCT01322490|69531883|FG001|Treatment Period|Lack of Efficacy|100|||
37847925|NCT01322490|69531884|FG002|Treatment Period|Lack of Efficacy|112|||
37847926|NCT01322490|69531882|FG000|Treatment Period|Physician Decision|0|||
37847927|NCT01322490|69531883|FG001|Treatment Period|Physician Decision|2|||
37847928|NCT01322490|69531884|FG002|Treatment Period|Physician Decision|1|||
37847929|NCT01322490|69531882|FG000|Treatment Period|Protocol Violation|7|||
37847930|NCT01322490|69531883|FG001|Treatment Period|Protocol Violation|5|||
37847931|NCT01322490|69531884|FG002|Treatment Period|Protocol Violation|4|||
37847932|NCT01322490|69531882|FG000|Treatment Period|Withdrawal by Subject|14|||
37847933|NCT01322490|69531883|FG001|Treatment Period|Withdrawal by Subject|16|||
37847934|NCT01322490|69531884|FG002|Treatment Period|Withdrawal by Subject|11|||
37847935|NCT01322490|69531882|FG000|Treatment Period|Non-compliance with study drug|0|||
37847936|NCT01322490|69531883|FG001|Treatment Period|Non-compliance with study drug|0|||
37734899|NCT01904383|69215255|FG000|Overall Study|No patient visit after entry|54|||
37734900|NCT01904149|69215265|FG000|Overall Study|Adverse Event|3|||
37734901|NCT01904149|69215266|FG001|Overall Study|Adverse Event|4|||
37734902|NCT01904149|69215267|FG002|Overall Study|Adverse Event|0|||
37847937|NCT01322490|69531884|FG002|Treatment Period|Non-compliance with study drug|1|||
37847938|NCT01322490|69531882|FG000|Treatment Period|Other per report|2|||
37847939|NCT01322490|69531883|FG001|Treatment Period|Other per report|2|||
37847940|NCT01322490|69531884|FG002|Treatment Period|Other per report|1|||
37847941|NCT01322490|69531882|FG000|Treatment Period|Randomized but Not Treated|3|||
37847942|NCT01322490|69531883|FG001|Treatment Period|Randomized but Not Treated|3|||
37847943|NCT01322490|69531884|FG002|Treatment Period|Randomized but Not Treated|5|||
37847944|NCT01322490|69531882|FG000|Long Term Follow-up Period|Death|235|||
37847945|NCT01322490|69531883|FG001|Long Term Follow-up Period|Death|239|||
37847946|NCT01322490|69531884|FG002|Long Term Follow-up Period|Death|236|||
37847947|NCT01322490|69531882|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
37847948|NCT01322490|69531883|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
37847949|NCT01322490|69531884|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
37847950|NCT01322490|69531882|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
37847951|NCT01322490|69531883|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
37847952|NCT01322490|69531884|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
37847953|NCT01322490|69531882|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
37847954|NCT01322490|69531883|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
37847955|NCT01322490|69531884|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
37847956|NCT01322490|69531882|FG000|Long Term Follow-up Period|Other per report|3|||
37847957|NCT01322490|69531883|FG001|Long Term Follow-up Period|Other per report|2|||
37847958|NCT01322490|69531884|FG002|Long Term Follow-up Period|Other per report|2|||
37847959|NCT01322490|69531882|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
37847960|NCT01322490|69531883|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
37847961|NCT01322490|69531884|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
37847962|NCT01314261|69531896|FG000|Overall Study|Adverse Event|1|||
37847963|NCT01314261|69531897|FG001|Overall Study|Adverse Event|0|||
37847964|NCT01314261|69531898|FG002|Overall Study|Adverse Event|0|||
37847965|NCT01314261|69531899|FG003|Overall Study|Adverse Event|0|||
37847966|NCT01314261|69531896|FG000|Overall Study|Withdrawal by Subject|0|||
37847967|NCT01314261|69531897|FG001|Overall Study|Withdrawal by Subject|3|||
37847968|NCT01314261|69531898|FG002|Overall Study|Withdrawal by Subject|1|||
37847969|NCT01314261|69531899|FG003|Overall Study|Withdrawal by Subject|0|||
37847970|NCT01314261|69531896|FG000|Overall Study|Lost to Follow-up|1|||
37847971|NCT01314261|69531897|FG001|Overall Study|Lost to Follow-up|0|||
37847972|NCT01314261|69531898|FG002|Overall Study|Lost to Follow-up|2|||
37734903|NCT01904149|69215268|FG003|Overall Study|Adverse Event|1|||
37734904|NCT01904149|69215269|FG004|Overall Study|Adverse Event|1|||
37734905|NCT01904149|69215270|FG005|Overall Study|Adverse Event|2|||
37734906|NCT01904149|69215265|FG000|Overall Study|Lack of Efficacy|0|||
37847973|NCT01314261|69531899|FG003|Overall Study|Lost to Follow-up|2|||
37847974|NCT01314261|69531896|FG000|Overall Study|Virologic Failure|0|||
37847975|NCT01314261|69531897|FG001|Overall Study|Virologic Failure|1|||
37847976|NCT01314261|69531898|FG002|Overall Study|Virologic Failure|0|||
37847977|NCT01314261|69531899|FG003|Overall Study|Virologic Failure|1|||
37847978|NCT01321710|69531912|FG000|Overall Study|Lost to Follow-up|4|||
37847979|NCT01321710|69531913|FG001|Overall Study|Lost to Follow-up|5|||
37847980|NCT01321710|69531914|FG002|Overall Study|Lost to Follow-up|0|||
37847981|NCT01321008|69531924|FG000|Overall Study|Early Study Termination|1|||
37847982|NCT01320150|69531930|FG000|Overall Study|Protocol Violation|15|||
37847983|NCT01320150|69531930|FG000|Overall Study|Withdrawal by Subject|5|||
37847984|NCT01320150|69531930|FG000|Overall Study|Death|2|||
37847985|NCT01320150|69531930|FG000|Overall Study|Lost to Follow-up|44|||
37734907|NCT01904149|69215266|FG001|Overall Study|Lack of Efficacy|3|||
37734908|NCT01904149|69215267|FG002|Overall Study|Lack of Efficacy|1|||
37734909|NCT01904149|69215268|FG003|Overall Study|Lack of Efficacy|3|||
37734910|NCT01904149|69215269|FG004|Overall Study|Lack of Efficacy|3|||
37734911|NCT01904149|69215270|FG005|Overall Study|Lack of Efficacy|1|||
37734912|NCT01904149|69215265|FG000|Overall Study|Withdrawal by Subject|1|||
37734913|NCT01904149|69215266|FG001|Overall Study|Withdrawal by Subject|3|||
37734914|NCT01904149|69215267|FG002|Overall Study|Withdrawal by Subject|1|||
37847986|NCT01323530|69531941|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
37847987|NCT01323530|69531942|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
37847988|NCT01323530|69531943|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
37847989|NCT01323530|69531944|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
37847990|NCT01323530|69531945|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
37847991|NCT01323530|69531946|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
38026421|NCT00071799|69711240|FG001|Overall Study|Not Documented|2|||
38026422|NCT03615482|69711254|FG000|Overall Study|Death|1|||
38026423|NCT03615482|69711255|FG001|Overall Study|Death|0|||
38026424|NCT03615482|69711254|FG000|Overall Study|Lost to Follow-up|7|||
38026425|NCT03615482|69711255|FG001|Overall Study|Lost to Follow-up|7|||
38026426|NCT03615482|69711254|FG000|Overall Study|Physician Decision|2|||
38026427|NCT03615482|69711255|FG001|Overall Study|Physician Decision|3|||
38026428|NCT03615482|69711254|FG000|Overall Study|Withdrawal by Subject|7|||
37847992|NCT01323530|69531947|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
37847993|NCT01323530|69531941|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
37847994|NCT01323530|69531942|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
37847995|NCT01323530|69531943|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
37847996|NCT01323530|69531944|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
37847997|NCT01323530|69531945|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
37734915|NCT01904149|69215268|FG003|Overall Study|Withdrawal by Subject|0|||
37734916|NCT01904149|69215269|FG004|Overall Study|Withdrawal by Subject|1|||
37847998|NCT01323530|69531946|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
37847999|NCT01323530|69531947|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
37848000|NCT01323530|69531941|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
37848001|NCT01323530|69531942|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
37848002|NCT01323530|69531943|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
37848003|NCT01323530|69531944|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
37848004|NCT01323530|69531945|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
37848005|NCT01323530|69531946|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
37917731|NCT00868790|69604643|FG011|Period 1|Protocol Violation|0|||
37917732|NCT00868790|69604644|FG012|Period 1|Protocol Violation|0|||
37917733|NCT00868790|69604645|FG013|Period 1|Protocol Violation|0|||
37917734|NCT00868790|69604632|FG000|Period 1|Withdrawal by Subject|0|||
37917735|NCT00868790|69604633|FG001|Period 1|Withdrawal by Subject|1|||
37917736|NCT00868790|69604634|FG002|Period 1|Withdrawal by Subject|0|||
37917737|NCT00868790|69604635|FG003|Period 1|Withdrawal by Subject|0|||
37917738|NCT00868790|69604636|FG004|Period 1|Withdrawal by Subject|0|||
37917739|NCT00868790|69604637|FG005|Period 1|Withdrawal by Subject|0|||
37734917|NCT01904149|69215270|FG005|Overall Study|Withdrawal by Subject|0|||
37848006|NCT01323530|69531947|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
37848007|NCT01323530|69531941|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
37848008|NCT01323530|69531942|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
37917740|NCT00868790|69604638|FG006|Period 1|Withdrawal by Subject|0|||
37917741|NCT00868790|69604639|FG007|Period 1|Withdrawal by Subject|0|||
37734918|NCT01904149|69215265|FG000|Overall Study|Protocol Violation|0|||
37917742|NCT00868790|69604640|FG008|Period 1|Withdrawal by Subject|0|||
38026429|NCT03615482|69711255|FG001|Overall Study|Withdrawal by Subject|7|||
38026430|NCT03688620|69711264|FG000|Overall Study|Other|0|||
38026431|NCT03688620|69711265|FG001|Overall Study|Other|0|||
37848009|NCT01323530|69531943|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
37848010|NCT01323530|69531944|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
37848011|NCT01323530|69531945|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
37848012|NCT01323530|69531946|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
37848013|NCT01323530|69531947|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
37848014|NCT01323530|69531941|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
37848015|NCT01323530|69531942|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
37848016|NCT01323530|69531943|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
37848017|NCT01323530|69531944|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
37848018|NCT01323530|69531945|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
37848019|NCT01323530|69531946|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
37848020|NCT01323530|69531947|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
37848021|NCT01323530|69531941|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
37848022|NCT01323530|69531942|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
37848023|NCT01323530|69531943|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
37848024|NCT01323530|69531944|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
37848025|NCT01323530|69531945|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
37848026|NCT01323530|69531946|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
37848027|NCT01323530|69531947|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
37848028|NCT01323530|69531941|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
37848029|NCT01323530|69531942|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
37917743|NCT00868790|69604641|FG009|Period 1|Withdrawal by Subject|0|||
37917744|NCT00868790|69604642|FG010|Period 1|Withdrawal by Subject|0|||
37917745|NCT00868790|69604643|FG011|Period 1|Withdrawal by Subject|0|||
37917746|NCT00868790|69604644|FG012|Period 1|Withdrawal by Subject|0|||
37917747|NCT00868790|69604645|FG013|Period 1|Withdrawal by Subject|1|||
37917748|NCT00868790|69604632|FG000|Period 1|Abnormal Triglycerides|0|||
37917749|NCT00868790|69604633|FG001|Period 1|Abnormal Triglycerides|0|||
37917750|NCT00868790|69604634|FG002|Period 1|Abnormal Triglycerides|0|||
37917751|NCT00868790|69604635|FG003|Period 1|Abnormal Triglycerides|0|||
37917752|NCT00868790|69604636|FG004|Period 1|Abnormal Triglycerides|1|||
37917753|NCT00868790|69604637|FG005|Period 1|Abnormal Triglycerides|0|||
37917754|NCT00868790|69604638|FG006|Period 1|Abnormal Triglycerides|0|||
37917755|NCT00868790|69604639|FG007|Period 1|Abnormal Triglycerides|0|||
37917756|NCT00868790|69604640|FG008|Period 1|Abnormal Triglycerides|0|||
37917757|NCT00868790|69604641|FG009|Period 1|Abnormal Triglycerides|0|||
37917758|NCT00868790|69604642|FG010|Period 1|Abnormal Triglycerides|0|||
37917759|NCT00868790|69604643|FG011|Period 1|Abnormal Triglycerides|0|||
37917760|NCT00868790|69604644|FG012|Period 1|Abnormal Triglycerides|0|||
37917761|NCT00868790|69604645|FG013|Period 1|Abnormal Triglycerides|0|||
37917762|NCT00868790|69604632|FG000|Period 1|Lost to Follow-up|0|||
37917763|NCT00868790|69604633|FG001|Period 1|Lost to Follow-up|0|||
37917764|NCT00868790|69604634|FG002|Period 1|Lost to Follow-up|0|||
37917765|NCT00868790|69604635|FG003|Period 1|Lost to Follow-up|0|||
37917766|NCT00868790|69604636|FG004|Period 1|Lost to Follow-up|0|||
37917767|NCT00868790|69604637|FG005|Period 1|Lost to Follow-up|1|||
37917768|NCT00868790|69604638|FG006|Period 1|Lost to Follow-up|0|||
37917769|NCT00868790|69604639|FG007|Period 1|Lost to Follow-up|0|||
37917770|NCT00868790|69604640|FG008|Period 1|Lost to Follow-up|0|||
37917771|NCT00868790|69604641|FG009|Period 1|Lost to Follow-up|0|||
37917772|NCT00868790|69604642|FG010|Period 1|Lost to Follow-up|0|||
37917773|NCT00868790|69604643|FG011|Period 1|Lost to Follow-up|0|||
37917774|NCT00868790|69604644|FG012|Period 1|Lost to Follow-up|0|||
37917775|NCT00868790|69604645|FG013|Period 1|Lost to Follow-up|0|||
37917776|NCT00868790|69604632|FG000|Period 2|Adverse Event|0|||
37917777|NCT00868790|69604633|FG001|Period 2|Adverse Event|0|||
37917778|NCT00868790|69604634|FG002|Period 2|Adverse Event|0|||
37917779|NCT00868790|69604635|FG003|Period 2|Adverse Event|0|||
37917780|NCT00868790|69604636|FG004|Period 2|Adverse Event|0|||
37917781|NCT00868790|69604637|FG005|Period 2|Adverse Event|0|||
37917782|NCT00868790|69604638|FG006|Period 2|Adverse Event|0|||
37917783|NCT00868790|69604639|FG007|Period 2|Adverse Event|0|||
37917784|NCT00868790|69604640|FG008|Period 2|Adverse Event|1|||
37917785|NCT00868790|69604641|FG009|Period 2|Adverse Event|0|||
37917786|NCT00868790|69604642|FG010|Period 2|Adverse Event|0|||
37917787|NCT00868790|69604643|FG011|Period 2|Adverse Event|0|||
37917788|NCT00868790|69604644|FG012|Period 2|Adverse Event|0|||
37917789|NCT00868790|69604645|FG013|Period 2|Adverse Event|0|||
37917790|NCT00868790|69604632|FG000|Period 2|Lost to Follow-up|0|||
37917791|NCT00868790|69604633|FG001|Period 2|Lost to Follow-up|1|||
37917792|NCT00868790|69604634|FG002|Period 2|Lost to Follow-up|0|||
37848030|NCT01323530|69531943|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
37848031|NCT01323530|69531944|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
37917793|NCT00868790|69604635|FG003|Period 2|Lost to Follow-up|0|||
37917794|NCT00868790|69604636|FG004|Period 2|Lost to Follow-up|0|||
37917795|NCT00868790|69604637|FG005|Period 2|Lost to Follow-up|1|||
37917796|NCT00868790|69604638|FG006|Period 2|Lost to Follow-up|0|||
37848032|NCT01323530|69531945|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
37848033|NCT01323530|69531946|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
37848034|NCT01323530|69531947|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
37848035|NCT01323530|69531941|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
37848036|NCT01323530|69531942|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
37848037|NCT01323530|69531943|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
37848038|NCT01323530|69531944|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
37848039|NCT01323530|69531945|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
37848040|NCT01323530|69531946|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
37848041|NCT01323530|69531947|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
37848042|NCT01313637|69531968|FG000|Overall Study|Adverse Event|17|||
37848043|NCT01313637|69531969|FG001|Overall Study|Adverse Event|24|||
37848044|NCT01313637|69531970|FG002|Overall Study|Adverse Event|25|||
37848045|NCT01313637|69531971|FG003|Overall Study|Adverse Event|18|||
37848046|NCT01313637|69531968|FG000|Overall Study|Lack of Efficacy|44|||
37848047|NCT01313637|69531969|FG001|Overall Study|Lack of Efficacy|38|||
37848048|NCT01313637|69531970|FG002|Overall Study|Lack of Efficacy|37|||
37848049|NCT01313637|69531971|FG003|Overall Study|Lack of Efficacy|24|||
37848050|NCT01313637|69531968|FG000|Overall Study|Protocol Violation|4|||
37848051|NCT01313637|69531969|FG001|Overall Study|Protocol Violation|3|||
37848052|NCT01313637|69531970|FG002|Overall Study|Protocol Violation|11|||
37848053|NCT01313637|69531971|FG003|Overall Study|Protocol Violation|5|||
37848054|NCT01313637|69531968|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
37848055|NCT01313637|69531969|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
37848056|NCT01313637|69531970|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
37848057|NCT01313637|69531971|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
37848058|NCT01313637|69531968|FG000|Overall Study|Lost to Follow-up|0|||
37848059|NCT01313637|69531969|FG001|Overall Study|Lost to Follow-up|2|||
37848060|NCT01313637|69531970|FG002|Overall Study|Lost to Follow-up|1|||
37848061|NCT01313637|69531971|FG003|Overall Study|Lost to Follow-up|3|||
37848062|NCT01313637|69531968|FG000|Overall Study|Withdrawal by Subject|11|||
37848063|NCT01313637|69531969|FG001|Overall Study|Withdrawal by Subject|13|||
37848064|NCT01313637|69531970|FG002|Overall Study|Withdrawal by Subject|18|||
37848065|NCT01313637|69531971|FG003|Overall Study|Withdrawal by Subject|15|||
37848066|NCT01320722|69531986|FG000|Overall Study|Did not Receive Intervention|3|||
37848067|NCT01320722|69531987|FG001|Overall Study|Did not Receive Intervention|2|||
37848068|NCT01320722|69531988|FG002|Overall Study|Did not Receive Intervention|1|||
37848069|NCT01320722|69531989|FG003|Overall Study|Did not Receive Intervention|1|||
37848070|NCT01320722|69531990|FG004|Overall Study|Did not Receive Intervention|2|||
37848071|NCT01320722|69531986|FG000|Overall Study|Lost to Follow-up|0|||
37848072|NCT01320722|69531987|FG001|Overall Study|Lost to Follow-up|1|||
37848073|NCT01320722|69531988|FG002|Overall Study|Lost to Follow-up|0|||
37848074|NCT01320722|69531989|FG003|Overall Study|Lost to Follow-up|1|||
37848075|NCT01320722|69531990|FG004|Overall Study|Lost to Follow-up|3|||
37848076|NCT01320722|69531986|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
37848077|NCT01320722|69531987|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
37848078|NCT01320722|69531988|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
37848079|NCT01320722|69531989|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
37848080|NCT01320722|69531990|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
37848081|NCT01320722|69531986|FG000|Overall Study|Participant Developed a Rash|0|||
37848082|NCT01320722|69531987|FG001|Overall Study|Participant Developed a Rash|0|||
37848083|NCT01320722|69531988|FG002|Overall Study|Participant Developed a Rash|2|||
37848084|NCT01320722|69531989|FG003|Overall Study|Participant Developed a Rash|1|||
37848085|NCT01320722|69531990|FG004|Overall Study|Participant Developed a Rash|1|||
37848086|NCT01320722|69531986|FG000|Overall Study|Non-compliant with Medication|0|||
37848087|NCT01320722|69531987|FG001|Overall Study|Non-compliant with Medication|0|||
37917797|NCT00868790|69604639|FG007|Period 2|Lost to Follow-up|0|||
37917798|NCT00868790|69604640|FG008|Period 2|Lost to Follow-up|0|||
37917799|NCT00868790|69604641|FG009|Period 2|Lost to Follow-up|0|||
37848088|NCT01320722|69531988|FG002|Overall Study|Non-compliant with Medication|1|||
37848089|NCT01320722|69531989|FG003|Overall Study|Non-compliant with Medication|0|||
37848090|NCT01320722|69531990|FG004|Overall Study|Non-compliant with Medication|0|||
37848091|NCT01320722|69531986|FG000|Overall Study|Adverse Event|0|||
37848092|NCT01320722|69531987|FG001|Overall Study|Adverse Event|0|||
37848093|NCT01320722|69531988|FG002|Overall Study|Adverse Event|3|||
37848094|NCT01320722|69531989|FG003|Overall Study|Adverse Event|6|||
37848095|NCT01320722|69531990|FG004|Overall Study|Adverse Event|0|||
37848096|NCT01320722|69531986|FG000|Overall Study|Not Compliant with Study Procedures|0|||
37848097|NCT01320722|69531987|FG001|Overall Study|Not Compliant with Study Procedures|0|||
37848098|NCT01320722|69531988|FG002|Overall Study|Not Compliant with Study Procedures|0|||
37917800|NCT00868790|69604642|FG010|Period 2|Lost to Follow-up|0|||
37848099|NCT01320722|69531989|FG003|Overall Study|Not Compliant with Study Procedures|4|||
37848100|NCT01320722|69531990|FG004|Overall Study|Not Compliant with Study Procedures|0|||
37848101|NCT01320722|69531986|FG000|Overall Study|Pregnancy|0|||
37848102|NCT01320722|69531987|FG001|Overall Study|Pregnancy|0|||
37848103|NCT01320722|69531988|FG002|Overall Study|Pregnancy|0|||
37848104|NCT01320722|69531989|FG003|Overall Study|Pregnancy|1|||
37848105|NCT01320722|69531990|FG004|Overall Study|Pregnancy|0|||
37848106|NCT01320722|69531986|FG000|Overall Study|Started an Exclusionary Medication|0|||
37848107|NCT01320722|69531987|FG001|Overall Study|Started an Exclusionary Medication|0|||
37848108|NCT01320722|69531988|FG002|Overall Study|Started an Exclusionary Medication|0|||
37848109|NCT01320722|69531989|FG003|Overall Study|Started an Exclusionary Medication|0|||
37848110|NCT01320722|69531990|FG004|Overall Study|Started an Exclusionary Medication|1|||
37848111|NCT01320722|69531986|FG000|Overall Study|Withdrew due to Health Condition|0|||
37848112|NCT01320722|69531987|FG001|Overall Study|Withdrew due to Health Condition|0|||
37848113|NCT01320722|69531988|FG002|Overall Study|Withdrew due to Health Condition|0|||
37848114|NCT01320722|69531989|FG003|Overall Study|Withdrew due to Health Condition|0|||
37848115|NCT01320722|69531990|FG004|Overall Study|Withdrew due to Health Condition|1|||
37848116|NCT01313559|69532007|FG000|Overall Study|Withdrawal by Subject|1|||
37848117|NCT01313559|69532008|FG001|Overall Study|Withdrawal by Subject|2|||
37848118|NCT01313559|69532007|FG000|Overall Study|Disease progression|1|||
37848119|NCT01313559|69532008|FG001|Overall Study|Disease progression|0|||
37848120|NCT01313559|69532007|FG000|Overall Study|Rising PSA|2|||
37848121|NCT01313559|69532008|FG001|Overall Study|Rising PSA|0|||
37848122|NCT01312779|69532014|FG000|Overall Study|Withdrawal by Subject|2|||
37848123|NCT01312779|69532014|FG000|Overall Study|Death|3|||
37848124|NCT01312779|69532014|FG000|Overall Study|Not Implanted with Device|27|||
37848125|NCT01312467|69532027|FG000|Overall Study|Adverse Event|4|||
37848126|NCT01312467|69532027|FG000|Overall Study|Lost to Follow-up|1|||
37848127|NCT01312467|69532027|FG000|Overall Study|Withdrawal by Subject|2|||
37848128|NCT01312467|69532027|FG000|Overall Study|Deported to country of origin|1|||
37848129|NCT01312467|69532027|FG000|Overall Study|Another medical condition|1|||
37848130|NCT01312467|69532027|FG000|Overall Study|Ineligible|4|||
37848131|NCT01310127|69532034|FG000|Overall Study|Protocol Violation|1|||
37848132|NCT01310127|69532035|FG001|Overall Study|Protocol Violation|1|||
37848133|NCT01310127|69532034|FG000|Overall Study|advanced psc cataract outlier|1|||
37848134|NCT01310127|69532035|FG001|Overall Study|advanced psc cataract outlier|0|||
37848135|NCT01309893|69532041|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
37917801|NCT00868790|69604643|FG011|Period 2|Lost to Follow-up|0|||
37917802|NCT00868790|69604644|FG012|Period 2|Lost to Follow-up|0|||
37917803|NCT00868790|69604645|FG013|Period 2|Lost to Follow-up|0|||
37917804|NCT00868790|69604632|FG000|Period 2|Withdrawal by Subject|0|||
37917805|NCT00868790|69604633|FG001|Period 2|Withdrawal by Subject|0|||
37917806|NCT00868790|69604634|FG002|Period 2|Withdrawal by Subject|0|||
37917807|NCT00868790|69604635|FG003|Period 2|Withdrawal by Subject|0|||
37917808|NCT00868790|69604636|FG004|Period 2|Withdrawal by Subject|0|||
37917809|NCT00868790|69604637|FG005|Period 2|Withdrawal by Subject|0|||
37917810|NCT00868790|69604638|FG006|Period 2|Withdrawal by Subject|0|||
37917811|NCT00868790|69604639|FG007|Period 2|Withdrawal by Subject|0|||
37917812|NCT00868790|69604640|FG008|Period 2|Withdrawal by Subject|1|||
37917813|NCT00868790|69604641|FG009|Period 2|Withdrawal by Subject|0|||
37917814|NCT00868790|69604642|FG010|Period 2|Withdrawal by Subject|0|||
37917815|NCT00868790|69604643|FG011|Period 2|Withdrawal by Subject|0|||
37917816|NCT00868790|69604644|FG012|Period 2|Withdrawal by Subject|0|||
37917817|NCT00868790|69604645|FG013|Period 2|Withdrawal by Subject|1|||
37917818|NCT00868790|69604632|FG000|Period 3|Adverse Event|0|||
37917819|NCT00868790|69604633|FG001|Period 3|Adverse Event|0|||
37917820|NCT00868790|69604634|FG002|Period 3|Adverse Event|0|||
37917821|NCT00868790|69604635|FG003|Period 3|Adverse Event|0|||
37917822|NCT00868790|69604636|FG004|Period 3|Adverse Event|0|||
37917823|NCT00868790|69604637|FG005|Period 3|Adverse Event|0|||
37848136|NCT01309893|69532042|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
37848137|NCT01309893|69532041|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
37848138|NCT01309893|69532042|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
37848139|NCT01318902|69532052|FG000|Overall Study|Symptomatic Deterioration|0|||
37848140|NCT01318902|69532053|FG001|Overall Study|Symptomatic Deterioration|1|||
37917824|NCT00868790|69604638|FG006|Period 3|Adverse Event|0|||
37917825|NCT00868790|69604639|FG007|Period 3|Adverse Event|0|||
37917826|NCT00868790|69604640|FG008|Period 3|Adverse Event|0|||
37848141|NCT01318902|69532054|FG002|Overall Study|Symptomatic Deterioration|1|||
37848142|NCT01318902|69532055|FG003|Overall Study|Symptomatic Deterioration|2|||
37848143|NCT01318902|69532052|FG000|Overall Study|Withdrawal by Patient|0|||
37848144|NCT01318902|69532053|FG001|Overall Study|Withdrawal by Patient|1|||
37848145|NCT01318902|69532054|FG002|Overall Study|Withdrawal by Patient|0|||
37848146|NCT01318902|69532055|FG003|Overall Study|Withdrawal by Patient|3|||
37848147|NCT01318902|69532052|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
37917827|NCT00868790|69604641|FG009|Period 3|Adverse Event|1|||
37917828|NCT00868790|69604642|FG010|Period 3|Adverse Event|0|||
37917829|NCT00868790|69604643|FG011|Period 3|Adverse Event|0|||
37848148|NCT01318902|69532053|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
37848149|NCT01318902|69532054|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
37848150|NCT01318902|69532055|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
37848151|NCT01318902|69532052|FG000|Overall Study|Adverse Event|0|||
37848152|NCT01318902|69532053|FG001|Overall Study|Adverse Event|1|||
37848153|NCT01318902|69532054|FG002|Overall Study|Adverse Event|0|||
37848154|NCT01318902|69532055|FG003|Overall Study|Adverse Event|0|||
37848155|NCT01318902|69532052|FG000|Overall Study|Terminated by Sponsor|0|||
37848156|NCT01318902|69532053|FG001|Overall Study|Terminated by Sponsor|0|||
37848157|NCT01318902|69532054|FG002|Overall Study|Terminated by Sponsor|1|||
37848158|NCT01318902|69532055|FG003|Overall Study|Terminated by Sponsor|0|||
37848159|NCT01313858|69532070|FG000|Overall Study|Premature Treatment Termination|251|||
37848160|NCT01313858|69532071|FG001|Overall Study|Premature Treatment Termination|219|||
37848161|NCT01313858|69532072|FG002|Overall Study|Premature Treatment Termination|191|||
37848162|NCT01313858|69532070|FG000|Overall Study|Lost to Follow-up|35|||
37848163|NCT01313858|69532071|FG001|Overall Study|Lost to Follow-up|51|||
37848164|NCT01313858|69532072|FG002|Overall Study|Lost to Follow-up|47|||
37848165|NCT01090765|69532084|FG000|Overall Study|Patient withdrew consent|0|||
37848166|NCT01090765|69532085|FG001|Overall Study|Patient withdrew consent|0|||
37848167|NCT01090765|69532086|FG002|Overall Study|Patient withdrew consent|0|||
37848168|NCT01090765|69532087|FG003|Overall Study|Patient withdrew consent|0|||
37848169|NCT01090765|69532088|FG004|Overall Study|Patient withdrew consent|1|||
37848170|NCT01090765|69532089|FG005|Overall Study|Patient withdrew consent|1|||
37848171|NCT01090765|69532084|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
37848172|NCT01090765|69532085|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
37848173|NCT01090765|69532086|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
37848174|NCT01090765|69532087|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
37848175|NCT01090765|69532088|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
37848176|NCT01090765|69532089|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
37848177|NCT01090765|69532084|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
37848178|NCT01090765|69532085|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
37848179|NCT01090765|69532086|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
37848180|NCT01090765|69532087|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
37848181|NCT01090765|69532088|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
37848182|NCT01090765|69532089|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
37848183|NCT01313780|69532106|FG000|Overall Study|Lack of Efficacy|4|||
37848184|NCT01313780|69532107|FG001|Overall Study|Lack of Efficacy|2|||
37848185|NCT01313780|69532106|FG000|Overall Study|Adverse Event|6|||
37848186|NCT01313780|69532107|FG001|Overall Study|Adverse Event|11|||
37848187|NCT01313780|69532106|FG000|Overall Study|Withdrawal by Subject|2|||
37848188|NCT01313780|69532107|FG001|Overall Study|Withdrawal by Subject|8|||
37848189|NCT01313780|69532106|FG000|Overall Study|Protocol Violation|10|||
37848190|NCT01313780|69532107|FG001|Overall Study|Protocol Violation|4|||
37848191|NCT01313780|69532106|FG000|Overall Study|missing data|3|||
37848192|NCT01313780|69532107|FG001|Overall Study|missing data|3|||
37848193|NCT01090453|69532115|FG000|Overall Study|Withdrawal by Subject|1|||
37848194|NCT01090453|69532116|FG001|Overall Study|Withdrawal by Subject|2|||
37848195|NCT01090453|69532115|FG000|Overall Study|Lost to Follow-up|7|||
37848196|NCT01090453|69532116|FG001|Overall Study|Lost to Follow-up|7|||
37848197|NCT01090453|69532115|FG000|Overall Study|Non serious AEs|1|||
37848198|NCT01090453|69532116|FG001|Overall Study|Non serious AEs|0|||
37848199|NCT01090453|69532115|FG000|Overall Study|Protocol Violation|2|||
37848200|NCT01090453|69532116|FG001|Overall Study|Protocol Violation|0|||
37848201|NCT01090453|69532115|FG000|Overall Study|Other|2|||
37848202|NCT01090453|69532116|FG001|Overall Study|Other|4|||
37848203|NCT01090453|69532115|FG000|Overall Study|Eligibility Criteria|0|||
37848204|NCT01090453|69532116|FG001|Overall Study|Eligibility Criteria|1|||
37848205|NCT01171612|69532122|FG000|Overall Study|Lost to Follow-up|51|||
37848206|NCT01171534|69532131|FG000|Overall Study|Lost to Follow-up|0|||
37848207|NCT01171534|69532132|FG001|Overall Study|Lost to Follow-up|2|||
37848208|NCT01171534|69532131|FG000|Overall Study|screen failure|0|||
37848209|NCT01171534|69532132|FG001|Overall Study|screen failure|1|||
37848210|NCT01170598|69532138|FG000|Overall Study|Withdrawal by Subject|1|||
37848211|NCT01170598|69532138|FG000|Overall Study|Death|3|||
37848212|NCT01170598|69532138|FG000|Overall Study|Lost to Follow-up|1|||
37848213|NCT01170598|69532138|FG000|Overall Study|Refused|1|||
37848214|NCT01170364|69532144|FG000|Overall Study|Protocol Violation|4|||
37848215|NCT01170364|69532145|FG001|Overall Study|Protocol Violation|1|||
37848216|NCT01076179|69532151|FG000|Overall Study|Withdrawal by Subject|1|||
37848217|NCT01170208|69532159|FG000|Overall Study|Withdrawal by Subject|5|||
37848218|NCT01170208|69532160|FG001|Overall Study|Withdrawal by Subject|0|||
37848219|NCT01170208|69532161|FG002|Overall Study|Withdrawal by Subject|1|||
37848220|NCT01170208|69532159|FG000|Overall Study|Protocol Violation|1|||
37848221|NCT01170208|69532160|FG001|Overall Study|Protocol Violation|0|||
37848222|NCT01170208|69532161|FG002|Overall Study|Protocol Violation|1|||
37848223|NCT01313624|69532174|FG000|Double-Blind Phase|Adverse Event|27|||
37848224|NCT01313624|69532175|FG001|Double-Blind Phase|Adverse Event|4|||
37848225|NCT01313624|69532174|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
37848226|NCT01313624|69532175|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
37848227|NCT01313624|69532174|FG000|Double-Blind Phase|Lost to Follow-up|0|||
37848228|NCT01313624|69532175|FG001|Double-Blind Phase|Lost to Follow-up|2|||
37848229|NCT01313624|69532174|FG000|Double-Blind Phase|Physician Decision|1|||
37848230|NCT01313624|69532175|FG001|Double-Blind Phase|Physician Decision|0|||
37848231|NCT01313624|69532174|FG000|Double-Blind Phase|Lack of Efficacy|1|||
37848232|NCT01313624|69532175|FG001|Double-Blind Phase|Lack of Efficacy|0|||
37734919|NCT01904149|69215266|FG001|Overall Study|Protocol Violation|1|||
37734920|NCT01904149|69215267|FG002|Overall Study|Protocol Violation|0|||
37734921|NCT01904149|69215268|FG003|Overall Study|Protocol Violation|0|||
37734922|NCT01904149|69215269|FG004|Overall Study|Protocol Violation|0|||
37734923|NCT01904149|69215270|FG005|Overall Study|Protocol Violation|0|||
37734924|NCT01904149|69215265|FG000|Overall Study|non compliance with study drug|1|||
37734925|NCT01904149|69215266|FG001|Overall Study|non compliance with study drug|0|||
37734926|NCT01904149|69215267|FG002|Overall Study|non compliance with study drug|0|||
37734927|NCT01904149|69215268|FG003|Overall Study|non compliance with study drug|0|||
37734928|NCT01904149|69215269|FG004|Overall Study|non compliance with study drug|0|||
37734929|NCT01904149|69215270|FG005|Overall Study|non compliance with study drug|0|||
37848233|NCT01313624|69532174|FG000|Open-Label Phase|Adverse Event|1|||
37848234|NCT01313624|69532175|FG001|Open-Label Phase|Adverse Event|10|||
37848235|NCT01313624|69532174|FG000|Open-Label Phase|Withdrawal by Subject|2|||
37848236|NCT01313624|69532175|FG001|Open-Label Phase|Withdrawal by Subject|2|||
37848237|NCT01313624|69532174|FG000|Open-Label Phase|Lost to Follow-up|1|||
37848238|NCT01313624|69532175|FG001|Open-Label Phase|Lost to Follow-up|1|||
37848239|NCT01169350|69532183|FG000|Overall Study|Physician Decision|3|||
37848240|NCT01169350|69532183|FG000|Overall Study|Lost to Follow-up|2|||
37848241|NCT01169038|69532187|FG000|Overall Study|Death|1|||
37848242|NCT01169038|69532187|FG000|Overall Study|Adverse Event|5|||
37848243|NCT01169038|69532187|FG000|Overall Study|Required antibiotic administration|1|||
37848244|NCT01167634|69532195|FG000|Overall Study|Lost to Follow-up|1|||
37848245|NCT01167634|69532196|FG001|Overall Study|Lost to Follow-up|3|||
37848246|NCT01167634|69532197|FG002|Overall Study|Lost to Follow-up|3|||
37848247|NCT01167634|69532198|FG003|Overall Study|Lost to Follow-up|4|||
37917830|NCT00868790|69604644|FG012|Period 3|Adverse Event|0|||
37917831|NCT00868790|69604645|FG013|Period 3|Adverse Event|0|||
37917832|NCT00868790|69604632|FG000|Period 3|Protocol Violation|0|||
37917833|NCT00868790|69604633|FG001|Period 3|Protocol Violation|0|||
37917834|NCT00868790|69604634|FG002|Period 3|Protocol Violation|0|||
37917835|NCT00868790|69604635|FG003|Period 3|Protocol Violation|0|||
37917836|NCT00868790|69604636|FG004|Period 3|Protocol Violation|0|||
37917837|NCT00868790|69604637|FG005|Period 3|Protocol Violation|0|||
37917838|NCT00868790|69604638|FG006|Period 3|Protocol Violation|0|||
37917839|NCT00868790|69604639|FG007|Period 3|Protocol Violation|0|||
37917840|NCT00868790|69604640|FG008|Period 3|Protocol Violation|0|||
37917841|NCT00868790|69604641|FG009|Period 3|Protocol Violation|0|||
37917842|NCT00868790|69604642|FG010|Period 3|Protocol Violation|1|||
37917843|NCT00868790|69604643|FG011|Period 3|Protocol Violation|0|||
37917844|NCT00868790|69604644|FG012|Period 3|Protocol Violation|0|||
37917845|NCT00868790|69604645|FG013|Period 3|Protocol Violation|0|||
37917846|NCT00868790|69604632|FG000|Period 3|Study Terminated by Sponsor|0|||
37917847|NCT00868790|69604633|FG001|Period 3|Study Terminated by Sponsor|0|||
37917848|NCT00868790|69604634|FG002|Period 3|Study Terminated by Sponsor|0|||
37917849|NCT00868790|69604635|FG003|Period 3|Study Terminated by Sponsor|1|||
37917850|NCT00868790|69604636|FG004|Period 3|Study Terminated by Sponsor|0|||
37917851|NCT00868790|69604637|FG005|Period 3|Study Terminated by Sponsor|0|||
37917852|NCT00868790|69604638|FG006|Period 3|Study Terminated by Sponsor|0|||
37917853|NCT00868790|69604639|FG007|Period 3|Study Terminated by Sponsor|0|||
37917854|NCT00868790|69604640|FG008|Period 3|Study Terminated by Sponsor|0|||
37917855|NCT00868790|69604641|FG009|Period 3|Study Terminated by Sponsor|0|||
37917856|NCT00868790|69604642|FG010|Period 3|Study Terminated by Sponsor|0|||
37917857|NCT00868790|69604643|FG011|Period 3|Study Terminated by Sponsor|0|||
37848248|NCT01167634|69532195|FG000|Overall Study|Withdrawal by Subject|1|||
37848249|NCT01167634|69532196|FG001|Overall Study|Withdrawal by Subject|1|||
37917858|NCT00868790|69604644|FG012|Period 3|Study Terminated by Sponsor|0|||
37917859|NCT00868790|69604645|FG013|Period 3|Study Terminated by Sponsor|0|||
37917860|NCT00868790|69604632|FG000|Period 4|Adverse Event|0|||
37917861|NCT00868790|69604633|FG001|Period 4|Adverse Event|0|||
37734930|NCT00986362|69215288|FG000|Overall Study|Death|2|||
37848250|NCT01167634|69532197|FG002|Overall Study|Withdrawal by Subject|0|||
37848251|NCT01167634|69532198|FG003|Overall Study|Withdrawal by Subject|0|||
37848252|NCT01166386|69532210|FG000|Overall Study|Withdrawal by Subject|3|||
37848253|NCT01166386|69532211|FG001|Overall Study|Withdrawal by Subject|5|||
37848254|NCT01114828|69532219|FG000|Overall Study|Adverse Event|1|||
37848255|NCT01114828|69532220|FG001|Overall Study|Adverse Event|1|||
37917862|NCT00868790|69604634|FG002|Period 4|Adverse Event|0|||
37917863|NCT00868790|69604635|FG003|Period 4|Adverse Event|0|||
37848256|NCT01114828|69532219|FG000|Overall Study|Lack of Efficacy|0|||
37848257|NCT01114828|69532220|FG001|Overall Study|Lack of Efficacy|2|||
37848258|NCT01114828|69532219|FG000|Overall Study|Protocol Violation|2|||
37848259|NCT01114828|69532220|FG001|Overall Study|Protocol Violation|0|||
37848260|NCT01114828|69532219|FG000|Overall Study|Withdrawal by Subject|0|||
37848261|NCT01114828|69532220|FG001|Overall Study|Withdrawal by Subject|1|||
37848262|NCT01313312|69532226|FG000|Overall Study|Adverse Event|5|||
37848263|NCT01313312|69532226|FG000|Overall Study|Withdrawal by Subject|18|||
37848264|NCT01313312|69532226|FG000|Overall Study|Lack of Efficacy|3|||
37848265|NCT01313312|69532226|FG000|Overall Study|Investigator Decision|1|||
37848266|NCT01313312|69532226|FG000|Overall Study|Observational Phase|1|||
37848267|NCT01313312|69532226|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
37848268|NCT01313312|69532226|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
37848269|NCT01114672|69532232|FG000|Overall Study|Death|0|||
37848270|NCT01114672|69532233|FG001|Overall Study|Death|1|||
37848271|NCT01114672|69532232|FG000|Overall Study|Withdrawal by Subject|2|||
37848272|NCT01114672|69532233|FG001|Overall Study|Withdrawal by Subject|1|||
37848273|NCT01114672|69532232|FG000|Overall Study|Lost to Follow-up|1|||
37848274|NCT01114672|69532233|FG001|Overall Study|Lost to Follow-up|0|||
37848275|NCT01114672|69532232|FG000|Overall Study|transplanted|1|||
37848276|NCT01114672|69532233|FG001|Overall Study|transplanted|0|||
37848277|NCT01114516|69532241|FG000|Overall Study|Lost to Follow-up|2|||
37848278|NCT01114516|69532242|FG001|Overall Study|Lost to Follow-up|1|||
37848279|NCT01114438|69532248|FG000|Overall Study|Adverse Event|10|||
37848280|NCT01114438|69532248|FG000|Overall Study|concomitant medication|1|||
37848281|NCT01114438|69532248|FG000|Overall Study|Physician Decision|1|||
37848282|NCT01114438|69532248|FG000|Overall Study|Withdrawal by Subject|2|||
37848283|NCT01313078|69532257|FG000|Overall Study|Death|1|||
37848284|NCT01313078|69532257|FG000|Overall Study|Discontinued study drug|1|||
37848285|NCT01313078|69532257|FG000|Overall Study|Withdrawal by Subject|1|||
37848286|NCT01114360|69532261|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
37848287|NCT01114360|69532262|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
37848288|NCT01310036|69532282|FG000|Overall Study|Administrative/other|10|||
37848289|NCT01310036|69532282|FG000|Overall Study|Withdrew Consent|11|||
37848290|NCT01310036|69532282|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
37848291|NCT01310036|69532282|FG000|Overall Study|Progression of Disease|164|||
37848292|NCT01310036|69532282|FG000|Overall Study|Death|1|||
37848293|NCT01310036|69532282|FG000|Overall Study|Adverse event or intercurrent illness|12|||
37848294|NCT01309100|69532286|FG000|Overall Study|Protocol Violation|1|||
37848295|NCT01309100|69532286|FG000|Overall Study|Positive Slit lamp finding|1|||
37848296|NCT01308788|69532295|FG000|2-year Treatment|medication change by treating physician|4|||
37848297|NCT01308788|69532296|FG001|2-year Treatment|medication change by treating physician|11|||
37848298|NCT01075321|69532302|FG000|Overall Study|Withdrawal by Subject|0|||
37848299|NCT01075321|69532303|FG001|Overall Study|Withdrawal by Subject|0|||
37848300|NCT01075321|69532304|FG002|Overall Study|Withdrawal by Subject|1|||
37848301|NCT01075321|69532305|FG003|Overall Study|Withdrawal by Subject|1|||
37848302|NCT01075321|69532302|FG000|Overall Study|Protocol Violation|0|||
37848303|NCT01075321|69532303|FG001|Overall Study|Protocol Violation|0|||
37848304|NCT01075321|69532304|FG002|Overall Study|Protocol Violation|1|||
37848305|NCT01075321|69532305|FG003|Overall Study|Protocol Violation|0|||
37848306|NCT01075321|69532302|FG000|Overall Study|Treatment Incomplete due to progression|1|||
37848307|NCT01075321|69532303|FG001|Overall Study|Treatment Incomplete due to progression|0|||
37848308|NCT01075321|69532304|FG002|Overall Study|Treatment Incomplete due to progression|0|||
37848309|NCT01075321|69532305|FG003|Overall Study|Treatment Incomplete due to progression|0|||
37848310|NCT01075321|69532302|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
37848311|NCT01075321|69532303|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
37848312|NCT01075321|69532304|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
37848313|NCT01075321|69532305|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
37848314|NCT01114204|69532319|FG000|Overall Study|Adverse Event|3|||
37848315|NCT01114204|69532320|FG001|Overall Study|Adverse Event|2|||
37848316|NCT01114204|69532319|FG000|Overall Study|Lost to Follow-up|1|||
37848317|NCT01114204|69532320|FG001|Overall Study|Lost to Follow-up|0|||
37848318|NCT01114204|69532319|FG000|Overall Study|Withdrawal by Subject|10|||
37848319|NCT01114204|69532320|FG001|Overall Study|Withdrawal by Subject|6|||
37848320|NCT01114204|69532319|FG000|Overall Study|Death|1|||
37848321|NCT01114204|69532320|FG001|Overall Study|Death|0|||
37848322|NCT01114204|69532319|FG000|Overall Study|Other-Personal reasons|2|||
37848323|NCT01114204|69532320|FG001|Overall Study|Other-Personal reasons|0|||
37848324|NCT01114204|69532319|FG000|Overall Study|Other-Medical monitor request|1|||
37848325|NCT01114204|69532320|FG001|Overall Study|Other-Medical monitor request|0|||
37848326|NCT01114204|69532319|FG000|Overall Study|Other-Participant request|2|||
37848327|NCT01114204|69532320|FG001|Overall Study|Other-Participant request|0|||
37848328|NCT01114204|69532319|FG000|Overall Study|Other-Protocol Violation|1|||
37848329|NCT01114204|69532320|FG001|Overall Study|Other-Protocol Violation|0|||
37848330|NCT01075243|69532329|FG000|Overall Study|Lost to Follow-up|5|||
37848331|NCT01075243|69532330|FG001|Overall Study|Lost to Follow-up|2|||
37848332|NCT01075243|69532331|FG002|Overall Study|Lost to Follow-up|0|||
37848333|NCT01075243|69532329|FG000|Overall Study|Withdrawal by Subject|1|||
37848334|NCT01075243|69532330|FG001|Overall Study|Withdrawal by Subject|1|||
37848335|NCT01075243|69532331|FG002|Overall Study|Withdrawal by Subject|0|||
37848336|NCT01308476|69532343|FG000|Overall Study|Lost to Follow-up|2|||
37848337|NCT01308476|69532344|FG001|Overall Study|Lost to Follow-up|2|||
37848338|NCT01308476|69532343|FG000|Overall Study|Other|1|||
37848339|NCT01308476|69532344|FG001|Overall Study|Other|0|||
37848340|NCT01078441|69532350|FG000|Overall Study|Withdrawal by Subject|1|||
37848341|NCT01308008|69532356|FG000|4 Weeks|Illness, disinterest, time|9|||
37848342|NCT01308008|69532357|FG001|4 Weeks|Illness, disinterest, time|2|||
37848343|NCT01113892|69532365|FG000|Overall Study|Lost to Follow-up|2|||
37848344|NCT01113892|69532366|FG001|Overall Study|Lost to Follow-up|2|||
37848345|NCT01113892|69532365|FG000|Overall Study|Withdrawal by Subject|1|||
37848346|NCT01113892|69532366|FG001|Overall Study|Withdrawal by Subject|1|||
37848347|NCT01113892|69532365|FG000|Overall Study|Death|2|||
37848348|NCT01113892|69532366|FG001|Overall Study|Death|4|||
37848349|NCT01113892|69532365|FG000|Overall Study|Graft no longer evaluable|9|||
37848350|NCT01113892|69532366|FG001|Overall Study|Graft no longer evaluable|9|||
37848351|NCT01090063|69532372|FG000|Screen|Screen Failed|4|||
37848352|NCT01090063|69532372|FG000|Treatment|Withdrawal by Subject|4|||
37848353|NCT01113580|69532388|FG000|Overall Study|Protocol Violation|1|||
37848354|NCT01113580|69532389|FG001|Overall Study|Protocol Violation|0|||
37848355|NCT01306214|69532398|FG000|Overall Study|Death|0|||
37848356|NCT01306214|69532399|FG001|Overall Study|Death|0|||
37848357|NCT01306214|69532400|FG002|Overall Study|Death|1|||
37848358|NCT01306214|69532398|FG000|Overall Study|Lost to Follow-up|3|||
37848359|NCT01306214|69532399|FG001|Overall Study|Lost to Follow-up|5|||
37848360|NCT01306214|69532400|FG002|Overall Study|Lost to Follow-up|4|||
37848361|NCT01306214|69532398|FG000|Overall Study|Withdrawal by Subject|24|||
37848362|NCT01306214|69532399|FG001|Overall Study|Withdrawal by Subject|22|||
37848363|NCT01306214|69532400|FG002|Overall Study|Withdrawal by Subject|16|||
37848364|NCT01306214|69532398|FG000|Overall Study|Not treated|1|||
37848365|NCT01306214|69532399|FG001|Overall Study|Not treated|1|||
37848366|NCT01306214|69532400|FG002|Overall Study|Not treated|1|||
37848367|NCT01077739|69532410|FG000|Overall Study|Premature withdrawal|1|||
37848368|NCT01077739|69532411|FG001|Overall Study|Premature withdrawal|3|||
37848369|NCT01077739|69532410|FG000|Overall Study|Withdrawal by Subject|1|||
37848370|NCT01077739|69532411|FG001|Overall Study|Withdrawal by Subject|0|||
37848371|NCT01077739|69532410|FG000|Overall Study|Death|0|||
37848372|NCT01077739|69532411|FG001|Overall Study|Death|3|||
37848373|NCT01077739|69532410|FG000|Overall Study|Unacceptable toxicity|1|||
37848374|NCT01077739|69532411|FG001|Overall Study|Unacceptable toxicity|2|||
37848375|NCT01077739|69532410|FG000|Overall Study|Other|2|||
37848376|NCT01077739|69532411|FG001|Overall Study|Other|2|||
37848377|NCT01306058|69532417|FG000|Overall Study|Death|1|||
37848378|NCT01306058|69532417|FG000|Overall Study|Enrolled but did not get treatment|1|||
37848379|NCT01305200|69532424|FG000|Overall Study|Physician Decision|4|||
37848380|NCT01305200|69532425|FG001|Overall Study|Physician Decision|6|||
37848381|NCT01305200|69532426|FG002|Overall Study|Physician Decision|1|||
37848382|NCT01305200|69532424|FG000|Overall Study|Withdrawal by Subject|24|||
37848383|NCT01305200|69532425|FG001|Overall Study|Withdrawal by Subject|21|||
37848384|NCT01305200|69532426|FG002|Overall Study|Withdrawal by Subject|1|||
37848385|NCT01305200|69532424|FG000|Overall Study|Ineligible|1|||
37848386|NCT01305200|69532425|FG001|Overall Study|Ineligible|2|||
37848387|NCT01305200|69532426|FG002|Overall Study|Ineligible|1|||
37848388|NCT01305200|69532424|FG000|Overall Study|Death|0|||
37848389|NCT01305200|69532425|FG001|Overall Study|Death|2|||
37848390|NCT01305200|69532426|FG002|Overall Study|Death|0|||
37848391|NCT01077271|69532436|FG000|Overall Study|Parental desire|8|||
37848392|NCT01077271|69532436|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
37848393|NCT01077271|69532436|FG000|Overall Study|Noncompliance|2|||
37848394|NCT01077271|69532436|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
37848395|NCT01077271|69532436|FG000|Overall Study|Changed doctors|2|||
37917864|NCT00868790|69604636|FG004|Period 4|Adverse Event|0|||
37848396|NCT01077271|69532436|FG000|Overall Study|Parents thought too many injections|2|||
37848397|NCT01077271|69532436|FG000|Overall Study|End of RSV season nearly reached|1|||
37848398|NCT01077271|69532436|FG000|Overall Study|Mother unconvinced of the necessity|1|||
37848399|NCT01305044|69532450|FG000|Overall Study|Withdrawal by Subject|3|||
37848400|NCT01305044|69532451|FG001|Overall Study|Withdrawal by Subject|6|||
37848401|NCT01304498|69532459|FG000|Overall Study|Adverse Event|1|||
37848402|NCT01304498|69532460|FG001|Overall Study|Adverse Event|1|||
37848403|NCT01304498|69532459|FG000|Overall Study|Withdrawal by Subject|2|||
37848404|NCT01304498|69532460|FG001|Overall Study|Withdrawal by Subject|3|||
37848405|NCT01304498|69532459|FG000|Overall Study|Protocol Violation|1|||
37848406|NCT01304498|69532460|FG001|Overall Study|Protocol Violation|0|||
37848407|NCT01304498|69532459|FG000|Overall Study|Lost to Follow-up|2|||
37848408|NCT01304498|69532460|FG001|Overall Study|Lost to Follow-up|1|||
37848409|NCT01077193|69532466|FG000|Overall Study|Lost to Follow-up|1|||
37848410|NCT01077193|69532466|FG000|Overall Study|Withdrawal by Subject|2|||
37848411|NCT01077193|69532466|FG000|Overall Study|Lack of Efficacy|1|||
37848412|NCT01077193|69532466|FG000|Overall Study|Study Terminated by Sponsor|40|||
37848413|NCT01074931|69532470|FG000|Overall Study|Economic reasons|1|||
37848414|NCT01074931|69532470|FG000|Overall Study|Death|5|||
37848415|NCT01303172|69532480|FG000|Overall Study|Physician Decision|9|||
37848416|NCT01303172|69532481|FG001|Overall Study|Physician Decision|6|||
37848417|NCT01303172|69532480|FG000|Overall Study|Adverse Event|5|||
37848418|NCT01303172|69532481|FG001|Overall Study|Adverse Event|2|||
37848419|NCT01303172|69532480|FG000|Overall Study|Withdrawal by Subject|4|||
37848420|NCT01303172|69532481|FG001|Overall Study|Withdrawal by Subject|2|||
37848421|NCT01303172|69532480|FG000|Overall Study|Death|20|||
37848422|NCT01303172|69532481|FG001|Overall Study|Death|7|||
37848423|NCT01303172|69532480|FG000|Overall Study|Lack of Efficacy|25|||
37848424|NCT01303172|69532481|FG001|Overall Study|Lack of Efficacy|17|||
37848425|NCT01302938|69532490|FG000|Overall Study|Withdrawal by Subject|1|||
37848426|NCT01302938|69532491|FG001|Overall Study|Withdrawal by Subject|0|||
37848427|NCT01302938|69532490|FG000|Overall Study|Adverse Event|1|||
37848428|NCT01302938|69532491|FG001|Overall Study|Adverse Event|0|||
37848429|NCT01302548|69532500|FG000|Overall Study|Lost to Follow-up|2|||
37848430|NCT01302548|69532501|FG001|Overall Study|Lost to Follow-up|1|||
37848431|NCT01076959|69532507|FG000|Overall Study|Adverse Event|767|||
37848432|NCT01076959|69532507|FG000|Overall Study|Lack of Efficacy|849|||
37848433|NCT01076959|69532507|FG000|Overall Study|Non-compliance|274|||
37848434|NCT01076959|69532507|FG000|Overall Study|Lost to Follow-up|241|||
37848435|NCT01076959|69532507|FG000|Overall Study|Other|119|||
37848436|NCT01302392|69532526|FG000|Overall Study|Lost to Follow-up|1|||
37848437|NCT01302392|69532527|FG001|Overall Study|Lost to Follow-up|0|||
37848438|NCT01302392|69532526|FG000|Overall Study|Withdrawal by Subject|6|||
37848439|NCT01302392|69532527|FG001|Overall Study|Withdrawal by Subject|1|||
37848440|NCT01076647|69532535|FG000|Overall Study|Adverse Event|4|||
37848441|NCT01076647|69532536|FG001|Overall Study|Adverse Event|1|||
37848442|NCT01076647|69532535|FG000|Overall Study|Lack of Efficacy|0|||
37848443|NCT01076647|69532536|FG001|Overall Study|Lack of Efficacy|1|||
37848444|NCT01076647|69532535|FG000|Overall Study|Protocol Violation|7|||
37848445|NCT01076647|69532536|FG001|Overall Study|Protocol Violation|9|||
37848446|NCT01076647|69532535|FG000|Overall Study|Withdrawal criteria|2|||
37848447|NCT01076647|69532536|FG001|Overall Study|Withdrawal criteria|2|||
37848448|NCT01076647|69532535|FG000|Overall Study|Unclassified|12|||
37848449|NCT01076647|69532536|FG001|Overall Study|Unclassified|12|||
37848450|NCT01074307|69532544|FG000|Overall Study|No primary endpoint evaluation|14|||
37848451|NCT01074307|69532545|FG001|Overall Study|No primary endpoint evaluation|6|||
37848452|NCT01074307|69532544|FG000|Overall Study|Exclusion criterion|0|||
37848453|NCT01074307|69532545|FG001|Overall Study|Exclusion criterion|1|||
37848454|NCT01074307|69532544|FG000|Overall Study|Protocol Violation|8|||
37848455|NCT01074307|69532545|FG001|Overall Study|Protocol Violation|5|||
37848456|NCT01076335|69532551|FG000|Overall Study|Withdrawal by Subject|3|||
37848457|NCT01076335|69532551|FG000|Overall Study|Withdrawal without treatment|1|||
37848458|NCT01309737|69532558|FG000|Week 0 to 16|Death|1|||
37917865|NCT00868790|69604637|FG005|Period 4|Adverse Event|0|||
37917866|NCT00868790|69604638|FG006|Period 4|Adverse Event|0|||
37917867|NCT00868790|69604639|FG007|Period 4|Adverse Event|1|||
37848459|NCT01309737|69532559|FG001|Week 0 to 16|Death|0|||
37848460|NCT01309737|69532560|FG002|Week 0 to 16|Death|1|||
37848461|NCT01309737|69532561|FG003|Week 0 to 16|Death|0|||
37848462|NCT01309737|69532562|FG004|Week 0 to 16|Death|0|||
37848463|NCT01309737|69532558|FG000|Week 0 to 16|Adverse Event|11|||
37917868|NCT00868790|69604640|FG008|Period 4|Adverse Event|0|||
37917869|NCT00868790|69604641|FG009|Period 4|Adverse Event|0|||
37917870|NCT00868790|69604642|FG010|Period 4|Adverse Event|1|||
37917871|NCT00868790|69604643|FG011|Period 4|Adverse Event|0|||
37917872|NCT00868790|69604644|FG012|Period 4|Adverse Event|1|||
37917873|NCT00868790|69604645|FG013|Period 4|Adverse Event|0|||
37917874|NCT00868790|69604632|FG000|Period 4|Lost to Follow-up|0|||
37917875|NCT00868790|69604633|FG001|Period 4|Lost to Follow-up|0|||
37917876|NCT00868790|69604634|FG002|Period 4|Lost to Follow-up|0|||
37848464|NCT01309737|69532559|FG001|Week 0 to 16|Adverse Event|10|||
37848465|NCT01309737|69532560|FG002|Week 0 to 16|Adverse Event|5|||
37848466|NCT01309737|69532561|FG003|Week 0 to 16|Adverse Event|0|||
37848467|NCT01309737|69532562|FG004|Week 0 to 16|Adverse Event|0|||
37848468|NCT01309737|69532558|FG000|Week 0 to 16|Lack of Efficacy|15|||
37848469|NCT01309737|69532559|FG001|Week 0 to 16|Lack of Efficacy|2|||
37848470|NCT01309737|69532560|FG002|Week 0 to 16|Lack of Efficacy|24|||
37848471|NCT01309737|69532561|FG003|Week 0 to 16|Lack of Efficacy|0|||
37848472|NCT01309737|69532562|FG004|Week 0 to 16|Lack of Efficacy|0|||
37848473|NCT01309737|69532558|FG000|Week 0 to 16|Lost to Follow-up|7|||
37917877|NCT00868790|69604635|FG003|Period 4|Lost to Follow-up|0|||
37848474|NCT01309737|69532559|FG001|Week 0 to 16|Lost to Follow-up|8|||
37848475|NCT01309737|69532560|FG002|Week 0 to 16|Lost to Follow-up|3|||
37848476|NCT01309737|69532561|FG003|Week 0 to 16|Lost to Follow-up|0|||
37848477|NCT01309737|69532562|FG004|Week 0 to 16|Lost to Follow-up|0|||
37848478|NCT01309737|69532558|FG000|Week 0 to 16|Withdrawal by Subject|7|||
37848479|NCT01309737|69532559|FG001|Week 0 to 16|Withdrawal by Subject|6|||
37848480|NCT01309737|69532560|FG002|Week 0 to 16|Withdrawal by Subject|7|||
37848481|NCT01309737|69532561|FG003|Week 0 to 16|Withdrawal by Subject|0|||
37848482|NCT01309737|69532562|FG004|Week 0 to 16|Withdrawal by Subject|0|||
37848483|NCT01309737|69532558|FG000|Week 0 to 16|Other|10|||
37848484|NCT01309737|69532559|FG001|Week 0 to 16|Other|14|||
37917878|NCT00868790|69604636|FG004|Period 4|Lost to Follow-up|0|||
37917879|NCT00868790|69604637|FG005|Period 4|Lost to Follow-up|0|||
37917880|NCT00868790|69604638|FG006|Period 4|Lost to Follow-up|0|||
37917881|NCT00868790|69604639|FG007|Period 4|Lost to Follow-up|1|||
37917882|NCT00868790|69604640|FG008|Period 4|Lost to Follow-up|0|||
37917883|NCT00868790|69604641|FG009|Period 4|Lost to Follow-up|0|||
37917884|NCT00868790|69604642|FG010|Period 4|Lost to Follow-up|0|||
37917885|NCT00868790|69604643|FG011|Period 4|Lost to Follow-up|0|||
37917886|NCT00868790|69604644|FG012|Period 4|Lost to Follow-up|0|||
37917887|NCT00868790|69604645|FG013|Period 4|Lost to Follow-up|0|||
37917888|NCT00868790|69604632|FG000|Period 4|Study Terminated by Sponsor|2|||
37917889|NCT00868790|69604633|FG001|Period 4|Study Terminated by Sponsor|0|||
37917890|NCT00868790|69604634|FG002|Period 4|Study Terminated by Sponsor|0|||
37917891|NCT00868790|69604635|FG003|Period 4|Study Terminated by Sponsor|0|||
37917892|NCT00868790|69604636|FG004|Period 4|Study Terminated by Sponsor|0|||
37917893|NCT00868790|69604637|FG005|Period 4|Study Terminated by Sponsor|0|||
37917894|NCT00868790|69604638|FG006|Period 4|Study Terminated by Sponsor|0|||
37917895|NCT00868790|69604639|FG007|Period 4|Study Terminated by Sponsor|1|||
37917896|NCT00868790|69604640|FG008|Period 4|Study Terminated by Sponsor|2|||
37917897|NCT00868790|69604641|FG009|Period 4|Study Terminated by Sponsor|0|||
37917898|NCT00868790|69604642|FG010|Period 4|Study Terminated by Sponsor|2|||
37917899|NCT00868790|69604643|FG011|Period 4|Study Terminated by Sponsor|1|||
37917900|NCT00868790|69604644|FG012|Period 4|Study Terminated by Sponsor|0|||
37917901|NCT00868790|69604645|FG013|Period 4|Study Terminated by Sponsor|1|||
37917902|NCT00868790|69604632|FG000|Period 4|Abnormal ALT/AST|0|||
37917903|NCT00868790|69604633|FG001|Period 4|Abnormal ALT/AST|0|||
37917904|NCT00868790|69604634|FG002|Period 4|Abnormal ALT/AST|1|||
37917905|NCT00868790|69604635|FG003|Period 4|Abnormal ALT/AST|0|||
38026432|NCT03688620|69711266|FG002|Overall Study|Other|1|||
38026433|NCT03688620|69711264|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
38026434|NCT03688620|69711265|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
38026435|NCT03688620|69711266|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
38026436|NCT03688620|69711264|FG000|Overall Study|Lost to Follow-up|16|||
38026437|NCT03688620|69711265|FG001|Overall Study|Lost to Follow-up|0|||
38026438|NCT03688620|69711266|FG002|Overall Study|Lost to Follow-up|1|||
38026439|NCT03688620|69711264|FG000|Overall Study|Withdrawal by Subject|0|||
38026440|NCT03688620|69711265|FG001|Overall Study|Withdrawal by Subject|0|||
38026441|NCT03688620|69711266|FG002|Overall Study|Withdrawal by Subject|6|||
38026442|NCT00090363|69711279|FG000|Overall Study|Lost to Follow-up|1|||
38026443|NCT00090363|69711280|FG001|Overall Study|Lost to Follow-up|2|||
38026444|NCT00090363|69711281|FG002|Overall Study|Lost to Follow-up|1|||
38026445|NCT00090363|69711279|FG000|Overall Study|Withdrawal by Subject|7|||
38026446|NCT00090363|69711280|FG001|Overall Study|Withdrawal by Subject|7|||
38026447|NCT00090363|69711281|FG002|Overall Study|Withdrawal by Subject|6|||
38026448|NCT00090363|69711279|FG000|Overall Study|Study-specific discontinuation criteria|75|||
38026449|NCT00090363|69711280|FG001|Overall Study|Study-specific discontinuation criteria|74|||
38026450|NCT00090363|69711281|FG002|Overall Study|Study-specific discontinuation criteria|62|||
38026451|NCT00090363|69711279|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
38026452|NCT00090363|69711280|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
38026453|NCT00090363|69711281|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
38026454|NCT00090363|69711279|FG000|Overall Study|Consent expired|7|||
38026455|NCT00090363|69711280|FG001|Overall Study|Consent expired|10|||
38026456|NCT00090363|69711281|FG002|Overall Study|Consent expired|9|||
37848485|NCT01309737|69532560|FG002|Week 0 to 16|Other|4|||
37848486|NCT01309737|69532561|FG003|Week 0 to 16|Other|0|||
37848487|NCT01309737|69532562|FG004|Week 0 to 16|Other|0|||
37848488|NCT01309737|69532558|FG000|Week 0 to 16|Randomized, but not treated|1|||
38026457|NCT00090363|69711279|FG000|Overall Study|Reasons not specified|2|||
38026458|NCT00090363|69711280|FG001|Overall Study|Reasons not specified|1|||
37848489|NCT01309737|69532559|FG001|Week 0 to 16|Randomized, but not treated|0|||
37848490|NCT01309737|69532560|FG002|Week 0 to 16|Randomized, but not treated|0|||
37917906|NCT00868790|69604636|FG004|Period 4|Abnormal ALT/AST|0|||
37917907|NCT00868790|69604637|FG005|Period 4|Abnormal ALT/AST|0|||
38026459|NCT00090363|69711281|FG002|Overall Study|Reasons not specified|1|||
38026460|NCT00090363|69711279|FG000|Overall Study|Continuing on study off treatment|14|||
38026461|NCT00090363|69711280|FG001|Overall Study|Continuing on study off treatment|13|||
38026462|NCT00090363|69711281|FG002|Overall Study|Continuing on study off treatment|16|||
38026463|NCT03652610|69711291|FG000|Overall Study|Lost to Follow-up|1|||
38026464|NCT03652610|69711292|FG001|Overall Study|Lost to Follow-up|0|||
37848491|NCT01309737|69532561|FG003|Week 0 to 16|Randomized, but not treated|0|||
37848492|NCT01309737|69532562|FG004|Week 0 to 16|Randomized, but not treated|0|||
37848493|NCT01309737|69532558|FG000|Week 16 to 52|Death|0|||
37848494|NCT01309737|69532559|FG001|Week 16 to 52|Death|0|||
37848495|NCT01309737|69532560|FG002|Week 16 to 52|Death|0|||
37848496|NCT01309737|69532561|FG003|Week 16 to 52|Death|0|||
37848497|NCT01309737|69532562|FG004|Week 16 to 52|Death|1|||
37848498|NCT01309737|69532558|FG000|Week 16 to 52|Adverse Event|7|||
37848499|NCT01309737|69532559|FG001|Week 16 to 52|Adverse Event|7|||
37848500|NCT01309737|69532560|FG002|Week 16 to 52|Adverse Event|0|||
37848501|NCT01309737|69532561|FG003|Week 16 to 52|Adverse Event|6|||
37848502|NCT01309737|69532562|FG004|Week 16 to 52|Adverse Event|5|||
37848503|NCT01309737|69532558|FG000|Week 16 to 52|Lack of Efficacy|107|||
37848504|NCT01309737|69532559|FG001|Week 16 to 52|Lack of Efficacy|76|||
37848505|NCT01309737|69532560|FG002|Week 16 to 52|Lack of Efficacy|0|||
37848506|NCT01309737|69532561|FG003|Week 16 to 52|Lack of Efficacy|25|||
37848507|NCT01309737|69532562|FG004|Week 16 to 52|Lack of Efficacy|21|||
37848508|NCT01309737|69532558|FG000|Week 16 to 52|Lost to Follow-up|4|||
37848509|NCT01309737|69532559|FG001|Week 16 to 52|Lost to Follow-up|2|||
37848510|NCT01309737|69532560|FG002|Week 16 to 52|Lost to Follow-up|0|||
37848511|NCT01309737|69532561|FG003|Week 16 to 52|Lost to Follow-up|1|||
37848512|NCT01309737|69532562|FG004|Week 16 to 52|Lost to Follow-up|4|||
37848513|NCT01309737|69532558|FG000|Week 16 to 52|Withdrawal by Subject|5|||
37848514|NCT01309737|69532559|FG001|Week 16 to 52|Withdrawal by Subject|6|||
37848515|NCT01309737|69532560|FG002|Week 16 to 52|Withdrawal by Subject|0|||
37848516|NCT01309737|69532561|FG003|Week 16 to 52|Withdrawal by Subject|0|||
37848517|NCT01309737|69532562|FG004|Week 16 to 52|Withdrawal by Subject|2|||
37848518|NCT01309737|69532558|FG000|Week 16 to 52|Other|10|||
37848519|NCT01309737|69532559|FG001|Week 16 to 52|Other|12|||
37848520|NCT01309737|69532560|FG002|Week 16 to 52|Other|0|||
37848521|NCT01309737|69532561|FG003|Week 16 to 52|Other|2|||
37848522|NCT01309737|69532562|FG004|Week 16 to 52|Other|0|||
37917908|NCT00868790|69604638|FG006|Period 4|Abnormal ALT/AST|0|||
37917909|NCT00868790|69604639|FG007|Period 4|Abnormal ALT/AST|0|||
38026465|NCT03652610|69711291|FG000|Overall Study|Withdrawal by Subject|3|||
38026466|NCT03652610|69711292|FG001|Overall Study|Withdrawal by Subject|5|||
37917910|NCT00868790|69604640|FG008|Period 4|Abnormal ALT/AST|0|||
38026467|NCT03615404|69711298|FG000|Overall Study|Death|1|||
38026468|NCT03615404|69711298|FG000|Overall Study|vaccine did not pass quality assurance|1|||
38026469|NCT03614156|69711305|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
38026470|NCT03614156|69711306|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
38026471|NCT03614156|69711307|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
38026472|NCT03614156|69711308|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
38026473|NCT03614156|69711305|FG000|Open-Label Treatment Period|Adverse Event|7|||
38026474|NCT03614156|69711306|FG001|Open-Label Treatment Period|Adverse Event|0|||
38026475|NCT03614156|69711307|FG002|Open-Label Treatment Period|Adverse Event|0|||
38026476|NCT03614156|69711308|FG003|Open-Label Treatment Period|Adverse Event|0|||
38026477|NCT03614156|69711305|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
38026478|NCT03614156|69711306|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
38026479|NCT03614156|69711307|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
38026480|NCT03614156|69711308|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
38026481|NCT03614156|69711305|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
38026482|NCT03614156|69711306|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
38026483|NCT03614156|69711307|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
38026484|NCT03614156|69711308|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
37917911|NCT00868790|69604641|FG009|Period 4|Abnormal ALT/AST|0|||
37917912|NCT00868790|69604642|FG010|Period 4|Abnormal ALT/AST|0|||
37848523|NCT01074229|69532588|FG000|Overall Study|Lost to Follow-up|1|||
37848524|NCT01074229|69532589|FG001|Overall Study|Lost to Follow-up|0|||
37848525|NCT01074229|69532590|FG002|Overall Study|Lost to Follow-up|0|||
37848526|NCT01074229|69532588|FG000|Overall Study|Change to open surgical procedure|1|||
37848527|NCT01074229|69532589|FG001|Overall Study|Change to open surgical procedure|3|||
37917913|NCT00868790|69604643|FG011|Period 4|Abnormal ALT/AST|0|||
37917914|NCT00868790|69604644|FG012|Period 4|Abnormal ALT/AST|0|||
37917915|NCT00868790|69604645|FG013|Period 4|Abnormal ALT/AST|0|||
37917916|NCT00868790|69604632|FG000|Post-study|Withdrawal by Subject|0|||
37917917|NCT00868790|69604633|FG001|Post-study|Withdrawal by Subject|0|||
37917918|NCT00868790|69604634|FG002|Post-study|Withdrawal by Subject|0|||
38026485|NCT03614156|69711305|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
38026486|NCT03614156|69711306|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
38026487|NCT03614156|69711307|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
38026488|NCT03614156|69711308|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
37848528|NCT01074229|69532590|FG002|Overall Study|Change to open surgical procedure|4|||
37848529|NCT01106014|69532602|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
37848530|NCT01106014|69532603|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
37848531|NCT01106014|69532602|FG000|Overall Study|Adverse Event|78|||
37848532|NCT01106014|69532603|FG001|Overall Study|Adverse Event|42|||
37848533|NCT01106014|69532602|FG000|Overall Study|Withdrawal by Subject|43|||
37848534|NCT01106014|69532603|FG001|Overall Study|Withdrawal by Subject|37|||
37848535|NCT01106014|69532602|FG000|Overall Study|Administrative reason|7|||
38026489|NCT03614156|69711305|FG000|Open-Label Treatment Period|Protocol Violation|2|||
38026490|NCT03614156|69711306|FG001|Open-Label Treatment Period|Protocol Violation|0|||
38026491|NCT03614156|69711307|FG002|Open-Label Treatment Period|Protocol Violation|0|||
38026492|NCT03614156|69711308|FG003|Open-Label Treatment Period|Protocol Violation|0|||
38026493|NCT03614156|69711305|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
38026494|NCT03614156|69711306|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
38026495|NCT03614156|69711307|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
38026496|NCT03614156|69711308|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
38026497|NCT03614156|69711305|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
38026498|NCT03614156|69711306|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
38026499|NCT03614156|69711307|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
38026500|NCT03614156|69711308|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
38026501|NCT03614156|69711305|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
38026502|NCT03614156|69711306|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
38026503|NCT03614156|69711307|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
38026504|NCT03614156|69711308|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
38026505|NCT03614156|69711305|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
38026506|NCT03614156|69711306|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
38026507|NCT03614156|69711307|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
38026508|NCT03614156|69711308|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
38026509|NCT03614156|69711305|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
38026510|NCT03614156|69711306|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
38026511|NCT03614156|69711307|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
38026512|NCT03614156|69711308|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
38026513|NCT03614156|69711305|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
38026514|NCT03614156|69711306|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
38026515|NCT03614156|69711307|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
38026516|NCT03614156|69711308|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
38026517|NCT03614156|69711305|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
38026518|NCT03614156|69711306|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
38026519|NCT03614156|69711307|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
38026520|NCT03614156|69711308|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
38026521|NCT03614156|69711305|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
38026522|NCT03614156|69711306|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
38026523|NCT03614156|69711307|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
38026524|NCT03614156|69711308|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
38026525|NCT03614156|69711305|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
38026526|NCT03614156|69711306|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
38026527|NCT03614156|69711307|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
38026528|NCT03614156|69711308|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
38026529|NCT03614156|69711305|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
38026530|NCT03614156|69711306|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
38026531|NCT03614156|69711307|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
38026532|NCT03614156|69711308|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
38026533|NCT03614156|69711305|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
38026534|NCT03614156|69711306|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
38026535|NCT03614156|69711307|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
38026536|NCT03614156|69711308|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
38026537|NCT03614078|69711320|FG000|Overall Study|Withdrawal by Subject|2|||
38026538|NCT03614078|69711321|FG001|Overall Study|Withdrawal by Subject|2|||
38026539|NCT03614078|69711322|FG002|Overall Study|Withdrawal by Subject|3|||
38026540|NCT03614078|69711320|FG000|Overall Study|Participant Did Not Return for Visit|0|||
38026541|NCT03614078|69711321|FG001|Overall Study|Participant Did Not Return for Visit|1|||
38026542|NCT03614078|69711322|FG002|Overall Study|Participant Did Not Return for Visit|0|||
38026543|NCT03614078|69711320|FG000|Overall Study|High Neutrophils|0|||
38026544|NCT03614078|69711321|FG001|Overall Study|High Neutrophils|0|||
38026545|NCT03614078|69711322|FG002|Overall Study|High Neutrophils|2|||
37848536|NCT01106014|69532603|FG001|Overall Study|Administrative reason|6|||
37848537|NCT01106014|69532602|FG000|Overall Study|Lost to Follow-up|2|||
38026546|NCT03614078|69711320|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
38026547|NCT03614078|69711321|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
38026548|NCT03614078|69711322|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
38026549|NCT03614078|69711320|FG000|Overall Study|Exacerbation of Psoriasis|0|||
38026550|NCT03614078|69711321|FG001|Overall Study|Exacerbation of Psoriasis|1|||
38026551|NCT03614078|69711322|FG002|Overall Study|Exacerbation of Psoriasis|0|||
38026552|NCT03614078|69711320|FG000|Overall Study|Adverse Event|0|||
38026553|NCT03614078|69711321|FG001|Overall Study|Adverse Event|2|||
38026554|NCT03614078|69711322|FG002|Overall Study|Adverse Event|0|||
38026555|NCT03614078|69711320|FG000|Overall Study|Dizziness and Rash|0|||
38026556|NCT03614078|69711321|FG001|Overall Study|Dizziness and Rash|1|||
38026557|NCT03614078|69711322|FG002|Overall Study|Dizziness and Rash|0|||
38026558|NCT03613454|69711332|FG000|Overall Study|Protocol Violation|1|||
38026559|NCT03613454|69711333|FG001|Overall Study|Protocol Violation|0|||
38026560|NCT03613454|69711332|FG000|Overall Study|Protocol Violation|0|||
38026561|NCT03613454|69711333|FG001|Overall Study|Protocol Violation|1|||
38026562|NCT03581786|69711341|FG000|Overall Study|Death|17|||
38026563|NCT03581786|69711342|FG001|Overall Study|Death|12|||
38026564|NCT03581786|69711341|FG000|Overall Study|Withdrawal by Subject|2|||
38026565|NCT03581786|69711342|FG001|Overall Study|Withdrawal by Subject|4|||
38026566|NCT03581786|69711341|FG000|Overall Study|Lost to Follow-up|1|||
37848538|NCT01106014|69532603|FG001|Overall Study|Lost to Follow-up|3|||
37848539|NCT01073605|69532612|FG000|Overall Study|Ongoing at Cutoff Date|1|||
37848540|NCT01073605|69532613|FG001|Overall Study|Ongoing at Cutoff Date|1|||
37848541|NCT01073605|69532614|FG002|Overall Study|Ongoing at Cutoff Date|0|||
37848542|NCT01073605|69532612|FG000|Overall Study|Adverse Event|2|||
37848543|NCT01073605|69532613|FG001|Overall Study|Adverse Event|1|||
37848544|NCT01073605|69532614|FG002|Overall Study|Adverse Event|0|||
37848545|NCT01073605|69532612|FG000|Overall Study|Lost to Follow-up|3|||
37848546|NCT01073605|69532613|FG001|Overall Study|Lost to Follow-up|4|||
37848547|NCT01073605|69532614|FG002|Overall Study|Lost to Follow-up|9|||
37848548|NCT01073605|69532612|FG000|Overall Study|Other|25|||
37848549|NCT01073605|69532613|FG001|Overall Study|Other|21|||
37848550|NCT01073605|69532614|FG002|Overall Study|Other|29|||
37917919|NCT00868790|69604635|FG003|Post-study|Withdrawal by Subject|0|||
37917920|NCT00868790|69604636|FG004|Post-study|Withdrawal by Subject|1|||
37917921|NCT00868790|69604637|FG005|Post-study|Withdrawal by Subject|0|||
37917922|NCT00868790|69604638|FG006|Post-study|Withdrawal by Subject|0|||
37917923|NCT00868790|69604639|FG007|Post-study|Withdrawal by Subject|0|||
37917924|NCT00868790|69604640|FG008|Post-study|Withdrawal by Subject|0|||
37917925|NCT00868790|69604641|FG009|Post-study|Withdrawal by Subject|0|||
37917926|NCT00868790|69604642|FG010|Post-study|Withdrawal by Subject|0|||
37917927|NCT00868790|69604643|FG011|Post-study|Withdrawal by Subject|0|||
37917928|NCT00868790|69604644|FG012|Post-study|Withdrawal by Subject|0|||
37917929|NCT00868790|69604645|FG013|Post-study|Withdrawal by Subject|0|||
37917930|NCT00868790|69604632|FG000|Post-study|Excluded Medication|0|||
37917931|NCT00868790|69604633|FG001|Post-study|Excluded Medication|0|||
37917932|NCT00868790|69604634|FG002|Post-study|Excluded Medication|0|||
38026567|NCT03581786|69711342|FG001|Overall Study|Lost to Follow-up|0|||
38026568|NCT03581786|69711341|FG000|Overall Study|reason other than specified above|0|||
38026569|NCT03581786|69711342|FG001|Overall Study|reason other than specified above|1|||
38026570|NCT03581786|69711341|FG000|Overall Study|Ongoing in the study|123|||
38026571|NCT03581786|69711342|FG001|Overall Study|Ongoing in the study|129|||
38026572|NCT03580382|69711350|FG000|Overall Study|Early Termination of Study|0|||
38026573|NCT03580382|69711351|FG001|Overall Study|Early Termination of Study|3|||
38026574|NCT03579290|69711356|FG000|Overall Study|Lost to Follow-up|9|||
38026575|NCT03611582|69711362|FG000|Overall Study|Adverse Event|26|||
38026576|NCT03611582|69711363|FG001|Overall Study|Adverse Event|6|||
38026577|NCT03611582|69711362|FG000|Overall Study|Protocol Violation|0|||
38026578|NCT03611582|69711363|FG001|Overall Study|Protocol Violation|1|||
38026579|NCT03611582|69711362|FG000|Overall Study|Pregnancy|1|||
37848551|NCT01073605|69532612|FG000|Overall Study|Withdrawal by Subject|31|||
37848552|NCT01073605|69532613|FG001|Overall Study|Withdrawal by Subject|39|||
37917933|NCT00868790|69604635|FG003|Post-study|Excluded Medication|0|||
37917934|NCT00868790|69604636|FG004|Post-study|Excluded Medication|0|||
37917935|NCT00868790|69604637|FG005|Post-study|Excluded Medication|0|||
37917936|NCT00868790|69604638|FG006|Post-study|Excluded Medication|0|||
38026580|NCT03611582|69711363|FG001|Overall Study|Pregnancy|2|||
38026581|NCT03611582|69711362|FG000|Overall Study|Lack of Efficacy|0|||
37917937|NCT00868790|69604639|FG007|Post-study|Excluded Medication|2|||
38026582|NCT03611582|69711363|FG001|Overall Study|Lack of Efficacy|1|||
38026583|NCT03611582|69711362|FG000|Overall Study|At the discretion of the investigator|1|||
37848553|NCT01073605|69532614|FG002|Overall Study|Withdrawal by Subject|22|||
37848554|NCT01073605|69532612|FG000|Overall Study|Randomized But Not Treated|0|||
37917938|NCT00868790|69604640|FG008|Post-study|Excluded Medication|0|||
38026584|NCT03611582|69711363|FG001|Overall Study|At the discretion of the investigator|0|||
37848555|NCT01073605|69532613|FG001|Overall Study|Randomized But Not Treated|1|||
37848556|NCT01073605|69532614|FG002|Overall Study|Randomized But Not Treated|1|||
37848557|NCT01073293|69532624|FG000|Overall Study|Lost to Follow-up|0|||
37848558|NCT01073293|69532625|FG001|Overall Study|Lost to Follow-up|1|||
37848559|NCT01073293|69532624|FG000|Overall Study|Withdrawal by Subject|5|||
37848560|NCT01073293|69532625|FG001|Overall Study|Withdrawal by Subject|10|||
37848561|NCT01105936|69532631|FG000|Period 1|Adverse Event|0|||
37848562|NCT01105936|69532632|FG001|Period 1|Adverse Event|0|||
37848563|NCT01105936|69532633|FG002|Period 1|Adverse Event|0|||
38026585|NCT03611582|69711362|FG000|Overall Study|Safety concern as judged by the investigator|1|||
38026586|NCT03611582|69711363|FG001|Overall Study|Safety concern as judged by the investigator|2|||
38026587|NCT03611582|69711362|FG000|Overall Study|Withdrawal by Subject|4|||
38026588|NCT03611582|69711363|FG001|Overall Study|Withdrawal by Subject|3|||
38026589|NCT03611582|69711362|FG000|Overall Study|Lost to Follow-up|18|||
38026590|NCT03611582|69711363|FG001|Overall Study|Lost to Follow-up|7|||
38026591|NCT03611582|69711362|FG000|Overall Study|other|17|||
38026592|NCT03611582|69711363|FG001|Overall Study|other|16|||
37848564|NCT01105936|69532634|FG003|Period 1|Adverse Event|1|||
37848565|NCT01105936|69532631|FG000|Period 2|Adverse Event|1|||
37848566|NCT01105936|69532632|FG001|Period 2|Adverse Event|0|||
37848567|NCT01105936|69532633|FG002|Period 2|Adverse Event|0|||
37848568|NCT01105936|69532634|FG003|Period 2|Adverse Event|0|||
37848569|NCT01105936|69532631|FG000|Period 3|Protocol Violation|0|||
37848570|NCT01105936|69532632|FG001|Period 3|Protocol Violation|2|||
37848571|NCT01105936|69532633|FG002|Period 3|Protocol Violation|0|||
37848572|NCT01105936|69532634|FG003|Period 3|Protocol Violation|0|||
37848573|NCT01309659|69532645|FG000|Overall Study|Protocol Violation|0|||
37848574|NCT01309659|69532646|FG001|Overall Study|Protocol Violation|1|||
37848575|NCT01104766|69532656|FG000|Overall Study|Did not meet inc/exc criteria|1|||
37848576|NCT01104766|69532657|FG001|Overall Study|Did not meet inc/exc criteria|0|||
37848577|NCT01104766|69532658|FG002|Overall Study|Did not meet inc/exc criteria|0|||
37848578|NCT01104766|69532659|FG003|Overall Study|Did not meet inc/exc criteria|0|||
37848579|NCT01104766|69532656|FG000|Overall Study|Adverse Event|17|||
37848580|NCT01104766|69532657|FG001|Overall Study|Adverse Event|15|||
37848581|NCT01104766|69532658|FG002|Overall Study|Adverse Event|20|||
37848582|NCT01104766|69532659|FG003|Overall Study|Adverse Event|14|||
37848583|NCT01104766|69532656|FG000|Overall Study|Lack of Efficacy|20|||
37848584|NCT01104766|69532657|FG001|Overall Study|Lack of Efficacy|15|||
37848585|NCT01104766|69532658|FG002|Overall Study|Lack of Efficacy|14|||
37848586|NCT01104766|69532659|FG003|Overall Study|Lack of Efficacy|8|||
37848587|NCT01104766|69532656|FG000|Overall Study|Protocol Violation|2|||
37848588|NCT01104766|69532657|FG001|Overall Study|Protocol Violation|0|||
37848589|NCT01104766|69532658|FG002|Overall Study|Protocol Violation|0|||
37848590|NCT01104766|69532659|FG003|Overall Study|Protocol Violation|0|||
37848591|NCT01104766|69532656|FG000|Overall Study|Withdrawal by Subject|17|||
38026593|NCT04015518|69711374|FG000|Overall Study|Adverse Event|6|||
38026594|NCT04015518|69711375|FG001|Overall Study|Adverse Event|1|||
38026595|NCT04015518|69711376|FG002|Overall Study|Adverse Event|1|||
38026596|NCT04015518|69711377|FG003|Overall Study|Adverse Event|3|||
38026597|NCT04015518|69711378|FG004|Overall Study|Adverse Event|3|||
38026598|NCT04015518|69711374|FG000|Overall Study|Lack of Efficacy|1|||
38026599|NCT04015518|69711375|FG001|Overall Study|Lack of Efficacy|0|||
38026600|NCT04015518|69711376|FG002|Overall Study|Lack of Efficacy|1|||
38026601|NCT04015518|69711377|FG003|Overall Study|Lack of Efficacy|0|||
38026602|NCT04015518|69711378|FG004|Overall Study|Lack of Efficacy|4|||
38026603|NCT04015518|69711374|FG000|Overall Study|Lost to Follow-up|0|||
38026604|NCT04015518|69711375|FG001|Overall Study|Lost to Follow-up|0|||
38026605|NCT04015518|69711376|FG002|Overall Study|Lost to Follow-up|0|||
38026606|NCT04015518|69711377|FG003|Overall Study|Lost to Follow-up|0|||
38026607|NCT04015518|69711378|FG004|Overall Study|Lost to Follow-up|1|||
38026608|NCT04015518|69711374|FG000|Overall Study|Withdrawal by Subject|0|||
38026609|NCT04015518|69711375|FG001|Overall Study|Withdrawal by Subject|1|||
38026610|NCT04015518|69711376|FG002|Overall Study|Withdrawal by Subject|0|||
38026611|NCT04015518|69711377|FG003|Overall Study|Withdrawal by Subject|1|||
38026612|NCT04015518|69711378|FG004|Overall Study|Withdrawal by Subject|1|||
38026613|NCT04015518|69711374|FG000|Overall Study|Patient did not come for consecutive visits|0|||
38026614|NCT04015518|69711375|FG001|Overall Study|Patient did not come for consecutive visits|1|||
38026615|NCT04015518|69711376|FG002|Overall Study|Patient did not come for consecutive visits|0|||
38026616|NCT04015518|69711377|FG003|Overall Study|Patient did not come for consecutive visits|0|||
38026617|NCT04015518|69711378|FG004|Overall Study|Patient did not come for consecutive visits|0|||
38026618|NCT04015518|69711374|FG000|Overall Study|not willing to travel due to Covid-19|0|||
38026619|NCT04015518|69711375|FG001|Overall Study|not willing to travel due to Covid-19|0|||
38026620|NCT04015518|69711376|FG002|Overall Study|not willing to travel due to Covid-19|1|||
37848592|NCT01104766|69532657|FG001|Overall Study|Withdrawal by Subject|19|||
37848593|NCT01104766|69532658|FG002|Overall Study|Withdrawal by Subject|25|||
37848594|NCT01104766|69532659|FG003|Overall Study|Withdrawal by Subject|15|||
38026621|NCT04015518|69711377|FG003|Overall Study|not willing to travel due to Covid-19|0|||
38026622|NCT04015518|69711378|FG004|Overall Study|not willing to travel due to Covid-19|0|||
38026623|NCT04015518|69711374|FG000|Overall Study|Patient wants to discontinue treatment|0|||
37848595|NCT01104766|69532656|FG000|Overall Study|Lost to Follow-up|1|||
37848596|NCT01104766|69532657|FG001|Overall Study|Lost to Follow-up|2|||
38026624|NCT04015518|69711375|FG001|Overall Study|Patient wants to discontinue treatment|0|||
38026625|NCT04015518|69711376|FG002|Overall Study|Patient wants to discontinue treatment|0|||
38026626|NCT04015518|69711377|FG003|Overall Study|Patient wants to discontinue treatment|1|||
38026627|NCT04015518|69711378|FG004|Overall Study|Patient wants to discontinue treatment|0|||
38026628|NCT04015518|69711374|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
38026629|NCT04015518|69711375|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
38026630|NCT04015518|69711376|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
38026631|NCT04015518|69711377|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
38026632|NCT04015518|69711378|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
38026633|NCT04015518|69711374|FG000|Overall Study|Pregnancy|0|||
38026634|NCT04015518|69711375|FG001|Overall Study|Pregnancy|0|||
38026635|NCT04015518|69711376|FG002|Overall Study|Pregnancy|0|||
38026636|NCT04015518|69711377|FG003|Overall Study|Pregnancy|0|||
38026637|NCT04015518|69711378|FG004|Overall Study|Pregnancy|1|||
38026638|NCT04015518|69711374|FG000|Overall Study|Personal reasons|1|||
38026639|NCT04015518|69711375|FG001|Overall Study|Personal reasons|0|||
38026640|NCT04015518|69711376|FG002|Overall Study|Personal reasons|0|||
38026641|NCT04015518|69711377|FG003|Overall Study|Personal reasons|0|||
38026642|NCT04015518|69711378|FG004|Overall Study|Personal reasons|1|||
38026643|NCT04015518|69711374|FG000|Overall Study|Withdrew consent|1|||
38026644|NCT04015518|69711375|FG001|Overall Study|Withdrew consent|0|||
38026645|NCT04015518|69711376|FG002|Overall Study|Withdrew consent|0|||
38026646|NCT04015518|69711377|FG003|Overall Study|Withdrew consent|0|||
38026647|NCT04015518|69711378|FG004|Overall Study|Withdrew consent|0|||
38026648|NCT04015518|69711374|FG000|Overall Study|Prostate carcinoma|1|||
38026649|NCT04015518|69711375|FG001|Overall Study|Prostate carcinoma|0|||
38026650|NCT04015518|69711376|FG002|Overall Study|Prostate carcinoma|0|||
38026651|NCT04015518|69711377|FG003|Overall Study|Prostate carcinoma|0|||
38026652|NCT04015518|69711378|FG004|Overall Study|Prostate carcinoma|0|||
38026653|NCT04015518|69711374|FG000|Overall Study|Could not keep appointments due to work|1|||
38026654|NCT04015518|69711375|FG001|Overall Study|Could not keep appointments due to work|0|||
38026655|NCT04015518|69711376|FG002|Overall Study|Could not keep appointments due to work|0|||
38026656|NCT04015518|69711377|FG003|Overall Study|Could not keep appointments due to work|0|||
38026657|NCT04015518|69711378|FG004|Overall Study|Could not keep appointments due to work|0|||
38026658|NCT03577730|69711395|FG000|Overall Study|Physician Decision|3|||
38026659|NCT03577730|69711396|FG001|Overall Study|Physician Decision|1|||
38026660|NCT03577730|69711395|FG000|Overall Study|Did not receive allocated intervention|1|||
38026661|NCT03577730|69711396|FG001|Overall Study|Did not receive allocated intervention|0|||
37848597|NCT01104766|69532658|FG002|Overall Study|Lost to Follow-up|1|||
38026662|NCT03608774|69711404|FG000|Overall Study|Lost to Follow-up|5|||
38026663|NCT03608774|69711405|FG001|Overall Study|Lost to Follow-up|5|||
38026664|NCT03608774|69711404|FG000|Overall Study|Withdrawal by Subject|1|||
38026665|NCT03608774|69711405|FG001|Overall Study|Withdrawal by Subject|0|||
38026666|NCT03608774|69711404|FG000|Overall Study|Protocol Violation|1|||
38026667|NCT03608774|69711405|FG001|Overall Study|Protocol Violation|0|||
38026668|NCT03608774|69711404|FG000|Overall Study|Not eligible at enrollment|0|||
38026669|NCT03608774|69711405|FG001|Overall Study|Not eligible at enrollment|1|||
38026670|NCT03608774|69711404|FG000|Overall Study|Health related event|0|||
38026671|NCT03608774|69711405|FG001|Overall Study|Health related event|1|||
38026672|NCT04021524|69711413|FG000|Overall Study|Change in surgical intervention|0|||
37848598|NCT01104766|69532659|FG003|Overall Study|Lost to Follow-up|1|||
37848599|NCT01104376|69532669|FG000|Overall Study|Withdrawal by Subject|15|||
37848600|NCT01104376|69532669|FG000|Overall Study|Consented but excluded after labs|13|||
37848601|NCT01072357|69532675|FG000|Overall Study|Lost to Follow-up|0|||
37848602|NCT01072357|69532676|FG001|Overall Study|Lost to Follow-up|1|||
37848603|NCT01072201|69532684|FG000|Overall Study|Lost to Follow-up|0|||
37848604|NCT01072201|69532685|FG001|Overall Study|Lost to Follow-up|1|||
37848605|NCT01103362|69532691|FG000|Overall Study|study terminated|596|||
37848606|NCT01103284|69532697|FG000|Overall Study|Death|2|||
37848607|NCT01103284|69532698|FG001|Overall Study|Death|0|||
37848608|NCT01103284|69532697|FG000|Overall Study|Lost to Follow-up|9|||
37848609|NCT01103284|69532698|FG001|Overall Study|Lost to Follow-up|10|||
37848610|NCT01103284|69532697|FG000|Overall Study|Pregnancy|3|||
37848611|NCT01103284|69532698|FG001|Overall Study|Pregnancy|1|||
38026673|NCT04021524|69711414|FG001|Overall Study|Change in surgical intervention|1|||
38026674|NCT03607682|69711420|FG000|Overall Study|Withdrawal by Subject|1|||
38026675|NCT03607682|69711420|FG000|Overall Study|Disease progression|1|||
38026676|NCT03606668|69711424|FG000|Overall Study|Screen Failure|1|||
38026677|NCT03606668|69711424|FG000|Overall Study|Lost to Follow-up|1|||
38026678|NCT03601052|69711428|FG000|Overall Study|Lost to Follow-up|2|||
38026679|NCT03600740|69711437|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
38026680|NCT03600428|69711443|FG000|Overall Study|Not eligible|0|||
38026681|NCT03600428|69711444|FG001|Overall Study|Not eligible|1|||
38026682|NCT03600428|69711443|FG000|Overall Study|Lost to Follow-up|5|||
38026683|NCT03600428|69711444|FG001|Overall Study|Lost to Follow-up|4|||
38026684|NCT03575702|69711452|FG000|Overall Study|Withdrawal by Subject|1|||
38026685|NCT03575702|69711453|FG001|Overall Study|Withdrawal by Subject|1|||
38026686|NCT03575702|69711452|FG000|Overall Study|Lost to Follow-up|1|||
38026687|NCT03575702|69711453|FG001|Overall Study|Lost to Follow-up|2|||
38026688|NCT03575702|69711452|FG000|Overall Study|Protocol Violation|0|||
38026689|NCT03575702|69711453|FG001|Overall Study|Protocol Violation|1|||
38026690|NCT03575702|69711452|FG000|Overall Study|Patient non compliance|4|||
38026691|NCT03575702|69711453|FG001|Overall Study|Patient non compliance|0|||
38026692|NCT03573908|69711461|FG000|Treatment Period|Adverse Event|4|||
38026693|NCT03573908|69711462|FG001|Treatment Period|Adverse Event|9|||
38026694|NCT03573908|69711463|FG002|Treatment Period|Adverse Event|0|||
38026695|NCT03573908|69711464|FG003|Treatment Period|Adverse Event|0|||
38026696|NCT03573908|69711465|FG004|Treatment Period|Adverse Event|0|||
38026697|NCT03573908|69711461|FG000|Treatment Period|Protocol Violation|1|||
37917939|NCT00868790|69604641|FG009|Post-study|Excluded Medication|1|||
37917940|NCT00868790|69604642|FG010|Post-study|Excluded Medication|0|||
37917941|NCT00868790|69604643|FG011|Post-study|Excluded Medication|0|||
37917942|NCT00868790|69604644|FG012|Post-study|Excluded Medication|0|||
37917943|NCT00868790|69604645|FG013|Post-study|Excluded Medication|0|||
37917944|NCT00496483|69604661|FG000|Overall Study|Not dosed|9|||
38026698|NCT03573908|69711462|FG001|Treatment Period|Protocol Violation|0|||
38026699|NCT03573908|69711463|FG002|Treatment Period|Protocol Violation|0|||
37734931|NCT00986362|69215289|FG001|Overall Study|Death|0|||
37917945|NCT00496483|69604661|FG000|Overall Study|Adverse Event|2|||
37917946|NCT00496483|69604661|FG000|Overall Study|Lack of Efficacy|1|||
37917947|NCT03528551|69604671|FG000|Overall Study|Lost to Follow-up|0|||
37917948|NCT03528551|69604672|FG001|Overall Study|Lost to Follow-up|1|||
37917949|NCT03528551|69604673|FG002|Overall Study|Lost to Follow-up|0|||
37917950|NCT03528551|69604671|FG000|Overall Study|Transferred to other arm/group|2|||
37917951|NCT03528551|69604672|FG001|Overall Study|Transferred to other arm/group|3|||
37917952|NCT03528551|69604673|FG002|Overall Study|Transferred to other arm/group|0|||
37917953|NCT03528551|69604671|FG000|Overall Study|Withdrawal by parent/guardian|0|||
37917954|NCT03528551|69604672|FG001|Overall Study|Withdrawal by parent/guardian|5|||
37917955|NCT03528551|69604673|FG002|Overall Study|Withdrawal by parent/guardian|0|||
37917956|NCT03528551|69604671|FG000|Overall Study|Protocol Violation|0|||
37917957|NCT03528551|69604672|FG001|Overall Study|Protocol Violation|3|||
37917958|NCT03528551|69604673|FG002|Overall Study|Protocol Violation|0|||
38026700|NCT03573908|69711464|FG003|Treatment Period|Protocol Violation|0|||
38026701|NCT03573908|69711465|FG004|Treatment Period|Protocol Violation|0|||
38026702|NCT03573908|69711461|FG000|Treatment Period|Withdrawal by Subject|7|||
38026703|NCT03573908|69711462|FG001|Treatment Period|Withdrawal by Subject|5|||
38026704|NCT03573908|69711463|FG002|Treatment Period|Withdrawal by Subject|0|||
38026705|NCT03573908|69711464|FG003|Treatment Period|Withdrawal by Subject|0|||
38026706|NCT03573908|69711465|FG004|Treatment Period|Withdrawal by Subject|0|||
38026707|NCT03573908|69711461|FG000|Treatment Period|Lost to Follow-up|7|||
37734932|NCT00986362|69215288|FG000|Overall Study|Lost to Follow-up|0|||
37917959|NCT03528551|69604671|FG000|Overall Study|Withdrawal by Subject|0|||
37917960|NCT03528551|69604672|FG001|Overall Study|Withdrawal by Subject|7|||
37917961|NCT03528551|69604673|FG002|Overall Study|Withdrawal by Subject|0|||
37917962|NCT00487981|69604682|FG000|Overall Study|Hypothyroidism diagnosis|1|||
37917963|NCT00861744|69604690|FG000|Overall Study|Adverse Event|0|||
37917964|NCT00861744|69604691|FG001|Overall Study|Adverse Event|0|||
37917965|NCT00861744|69604692|FG002|Overall Study|Adverse Event|0|||
37917966|NCT00861744|69604693|FG003|Overall Study|Adverse Event|1|||
37917967|NCT00861744|69604690|FG000|Overall Study|Lost to Follow-up|7|||
37917968|NCT00861744|69604691|FG001|Overall Study|Lost to Follow-up|19|||
37734933|NCT00986362|69215289|FG001|Overall Study|Lost to Follow-up|1|||
37917969|NCT00861744|69604692|FG002|Overall Study|Lost to Follow-up|17|||
37917970|NCT00861744|69604693|FG003|Overall Study|Lost to Follow-up|12|||
37917971|NCT00861744|69604690|FG000|Overall Study|Withdrawal by Subject|10|||
37917972|NCT00861744|69604691|FG001|Overall Study|Withdrawal by Subject|6|||
37917973|NCT00861744|69604692|FG002|Overall Study|Withdrawal by Subject|6|||
38026708|NCT03573908|69711462|FG001|Treatment Period|Lost to Follow-up|6|||
38026709|NCT03573908|69711463|FG002|Treatment Period|Lost to Follow-up|0|||
37734934|NCT01890421|69215295|FG000|Overall Study|Adverse Event|1|||
37917974|NCT00861744|69604693|FG003|Overall Study|Withdrawal by Subject|19|||
38026710|NCT03573908|69711464|FG003|Treatment Period|Lost to Follow-up|0|||
38026711|NCT03573908|69711465|FG004|Treatment Period|Lost to Follow-up|0|||
38026712|NCT03573908|69711461|FG000|Treatment Period|Pregnancy|1|||
38026713|NCT03573908|69711462|FG001|Treatment Period|Pregnancy|0|||
38026714|NCT03573908|69711463|FG002|Treatment Period|Pregnancy|0|||
38026715|NCT03573908|69711464|FG003|Treatment Period|Pregnancy|0|||
38026716|NCT03573908|69711465|FG004|Treatment Period|Pregnancy|0|||
38026717|NCT03573908|69711461|FG000|Treatment Period|Other, Not Specified|4|||
38026718|NCT03573908|69711462|FG001|Treatment Period|Other, Not Specified|6|||
37848612|NCT01103284|69532697|FG000|Overall Study|Protocol Violation|12|||
37848613|NCT01103284|69532698|FG001|Overall Study|Protocol Violation|5|||
37917975|NCT00861744|69604690|FG000|Overall Study|Protocol Violation|0|||
37917976|NCT00861744|69604691|FG001|Overall Study|Protocol Violation|1|||
37917977|NCT00861744|69604692|FG002|Overall Study|Protocol Violation|0|||
37917978|NCT00861744|69604693|FG003|Overall Study|Protocol Violation|0|||
37917979|NCT00861744|69604690|FG000|Overall Study|Migration from study area|0|||
37917980|NCT00861744|69604691|FG001|Overall Study|Migration from study area|3|||
37917981|NCT00861744|69604692|FG002|Overall Study|Migration from study area|1|||
37917982|NCT00861744|69604693|FG003|Overall Study|Migration from study area|0|||
37917983|NCT00861744|69604690|FG000|Overall Study|Blood draws|0|||
37917984|NCT00861744|69604691|FG001|Overall Study|Blood draws|0|||
37917985|NCT00861744|69604692|FG002|Overall Study|Blood draws|0|||
37917986|NCT00861744|69604693|FG003|Overall Study|Blood draws|1|||
37917987|NCT00603239|69604705|FG000|Overall Study|Adverse Event|4|||
37917988|NCT00603239|69604706|FG001|Overall Study|Adverse Event|1|||
37917989|NCT00603239|69604705|FG000|Overall Study|Entry criteria not met|0|||
37917990|NCT00603239|69604706|FG001|Overall Study|Entry criteria not met|1|||
37917991|NCT00603239|69604705|FG000|Overall Study|Loss of glucose control|3|||
37917992|NCT00603239|69604706|FG001|Overall Study|Loss of glucose control|0|||
37917993|NCT00603239|69604705|FG000|Overall Study|Lost to Follow-up|2|||
37917994|NCT00603239|69604706|FG001|Overall Study|Lost to Follow-up|1|||
37917995|NCT00603239|69604705|FG000|Overall Study|Physician Decision|2|||
37917996|NCT00603239|69604706|FG001|Overall Study|Physician Decision|0|||
37917997|NCT00603239|69604705|FG000|Overall Study|Protocol Violation|2|||
37917998|NCT00603239|69604706|FG001|Overall Study|Protocol Violation|0|||
37917999|NCT00603239|69604705|FG000|Overall Study|Subject decision|2|||
37918000|NCT00603239|69604706|FG001|Overall Study|Subject decision|1|||
37918001|NCT00852930|69604715|FG000|Overall Study|Withdrawal by Subject|1|||
37918002|NCT00852930|69604716|FG001|Overall Study|Withdrawal by Subject|1|||
37918003|NCT00852930|69604717|FG002|Overall Study|Withdrawal by Subject|1|||
37918004|NCT00852930|69604715|FG000|Overall Study|Physician Decision|0|||
37918005|NCT00852930|69604716|FG001|Overall Study|Physician Decision|0|||
37918006|NCT00852930|69604717|FG002|Overall Study|Physician Decision|1|||
37918007|NCT00852540|69604728|FG000|Overall Study|Adverse Event|10|||
37918008|NCT00852540|69604729|FG001|Overall Study|Adverse Event|3|||
37918009|NCT00852540|69604728|FG000|Overall Study|Lack of Efficacy|15|||
37918010|NCT00852540|69604729|FG001|Overall Study|Lack of Efficacy|3|||
37918011|NCT00852540|69604728|FG000|Overall Study|Protocol Violation|1|||
37918012|NCT00852540|69604729|FG001|Overall Study|Protocol Violation|2|||
37918013|NCT00852540|69604728|FG000|Overall Study|Lost to Follow-up|2|||
37918014|NCT00852540|69604729|FG001|Overall Study|Lost to Follow-up|3|||
37918015|NCT00852540|69604728|FG000|Overall Study|Investigator Discretion|2|||
37918016|NCT00852540|69604729|FG001|Overall Study|Investigator Discretion|3|||
37918017|NCT00852540|69604728|FG000|Overall Study|Withdrawal by Subject|3|||
37848614|NCT01103284|69532697|FG000|Overall Study|Adverse Event|0|||
37848615|NCT01103284|69532698|FG001|Overall Study|Adverse Event|5|||
37848616|NCT01103284|69532697|FG000|Overall Study|Withdrawal by Subject|14|||
37848617|NCT01103284|69532698|FG001|Overall Study|Withdrawal by Subject|18|||
37848618|NCT01103284|69532697|FG000|Overall Study|Dermal Hypersensitivity|0|||
37848619|NCT01103284|69532698|FG001|Overall Study|Dermal Hypersensitivity|1|||
37848620|NCT01103284|69532697|FG000|Overall Study|Termination by the Sponsor|0|||
37848621|NCT01103284|69532698|FG001|Overall Study|Termination by the Sponsor|1|||
37848622|NCT01103284|69532697|FG000|Overall Study|Not described|2|||
37848623|NCT01103284|69532698|FG001|Overall Study|Not described|1|||
37848624|NCT01103284|69532697|FG000|Overall Study|Missing CRF entries for study completion|0|||
37848625|NCT01103284|69532698|FG001|Overall Study|Missing CRF entries for study completion|2|||
37918018|NCT00852540|69604729|FG001|Overall Study|Withdrawal by Subject|1|||
37918019|NCT00852540|69604728|FG000|Overall Study|Did Not Receive Study Drug|3|||
37918020|NCT00852540|69604729|FG001|Overall Study|Did Not Receive Study Drug|3|||
37918021|NCT00861198|69604736|FG000|Overall Study|SpyGlass Failed|5|||
37918022|NCT00847704|69604740|FG000|Overall Study|Withdrawal by Subject|1|||
37918023|NCT00860574|69604744|FG000|Overall Study|Death|2|||
37918024|NCT00860574|69604744|FG000|Overall Study|Relapse|1|||
37918025|NCT00496015|69604753|FG000|Overall Study|Other|1|||
37918026|NCT00496015|69604754|FG001|Overall Study|Other|0|||
37918027|NCT00496015|69604755|FG002|Overall Study|Other|0|||
37918028|NCT00496015|69604756|FG003|Overall Study|Other|1|||
37918029|NCT00496015|69604757|FG004|Overall Study|Other|0|||
37918030|NCT00487825|69604779|FG000|Overall Study|Adverse Event|2|||
37918031|NCT00487825|69604780|FG001|Overall Study|Adverse Event|2|||
37848626|NCT01070953|69532704|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
37848627|NCT01070953|69532704|FG000|Participants for Safety Evaluation|Off-label use|283|||
37848628|NCT01070953|69532704|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
37848629|NCT01070953|69532704|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
37848630|NCT01070953|69532704|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
37848631|NCT01070953|69532704|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
37848632|NCT01070953|69532704|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
37848633|NCT01070953|69532704|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
38026719|NCT03573908|69711463|FG002|Treatment Period|Other, Not Specified|0|||
38026720|NCT03573908|69711464|FG003|Treatment Period|Other, Not Specified|0|||
38026721|NCT03573908|69711465|FG004|Treatment Period|Other, Not Specified|0|||
38026722|NCT03573908|69711461|FG000|Randomized Withdrawal Period|Adverse Event|0|||
38026723|NCT03573908|69711462|FG001|Randomized Withdrawal Period|Adverse Event|0|||
38026724|NCT03573908|69711463|FG002|Randomized Withdrawal Period|Adverse Event|3|||
37918032|NCT00487825|69604779|FG000|Overall Study|Lack of Efficacy|1|||
37918033|NCT00487825|69604780|FG001|Overall Study|Lack of Efficacy|1|||
37918034|NCT00487825|69604779|FG000|Overall Study|Other|3|||
37918035|NCT00487825|69604780|FG001|Overall Study|Other|2|||
37918036|NCT00487747|69604786|FG000|Overall Study|Adverse Event|1|||
37918037|NCT00487747|69604786|FG000|Overall Study|Lost to Follow-up|9|||
37918038|NCT00487747|69604786|FG000|Overall Study|Lack of Efficacy|1|||
37918039|NCT00487435|69604790|FG000|Overall Study|Adverse Event|146|||
37918040|NCT00487435|69604790|FG000|Overall Study|Death|2|||
37918041|NCT00487435|69604790|FG000|Overall Study|Lack of Efficacy|33|||
37918042|NCT00487435|69604790|FG000|Overall Study|Lost to Follow-up|54|||
38026725|NCT03573908|69711464|FG003|Randomized Withdrawal Period|Adverse Event|0|||
37918043|NCT00487435|69604790|FG000|Overall Study|Pregnancy|2|||
37848634|NCT01070953|69532704|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
37848635|NCT01070953|69532704|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
37848636|NCT01089361|69532716|FG000|Overall Study|Death|1|||
37848637|NCT01089361|69532717|FG001|Overall Study|Death|0|||
37848638|NCT01102972|69532727|FG000|Overall Study|Adverse Event|8|||
37848639|NCT01102972|69532728|FG001|Overall Study|Adverse Event|2|||
37848640|NCT01102972|69532727|FG000|Overall Study|Lack of Efficacy|2|||
37848641|NCT01102972|69532728|FG001|Overall Study|Lack of Efficacy|1|||
37848642|NCT01102972|69532727|FG000|Overall Study|Protocol Violation|1|||
37848643|NCT01102972|69532728|FG001|Overall Study|Protocol Violation|0|||
37848644|NCT01102972|69532727|FG000|Overall Study|Lost to Follow-up|10|||
37848645|NCT01102972|69532728|FG001|Overall Study|Lost to Follow-up|5|||
37848646|NCT01102972|69532727|FG000|Overall Study|Investigator Discretion|2|||
37848647|NCT01102972|69532728|FG001|Overall Study|Investigator Discretion|0|||
37848648|NCT01102972|69532727|FG000|Overall Study|Withdrawal by Subject|6|||
37848649|NCT01102972|69532728|FG001|Overall Study|Withdrawal by Subject|6|||
37848650|NCT01309269|69532734|FG000|Overall Study|Adverse Event|56|||
37848651|NCT01309269|69532734|FG000|Overall Study|Withdrawal by Subject|25|||
37848652|NCT01309269|69532734|FG000|Overall Study|Lack of Acceptance|15|||
37848653|NCT01309269|69532734|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
37848654|NCT01309269|69532734|FG000|Overall Study|Kidney Transplant|25|||
37848655|NCT01309269|69532734|FG000|Overall Study|Administrative Problems|141|||
37848656|NCT01309269|69532734|FG000|Overall Study|Other|256|||
37848657|NCT01309269|69532734|FG000|Overall Study|Other|1|||
37848658|NCT01309269|69532734|FG000|Overall Study|Study Completion Data Not Recorded|95|||
37848659|NCT01309269|69532734|FG000|Overall Study|Enrolled but not Treated|107|||
37848660|NCT01088503|69532741|FG000|Overall Study|Withdrawal by Subject|118|||
37848661|NCT01088503|69532742|FG001|Overall Study|Withdrawal by Subject|327|||
37848662|NCT01088503|69532743|FG002|Overall Study|Withdrawal by Subject|10|||
37848663|NCT01088503|69532741|FG000|Overall Study|Death|64|||
37848664|NCT01088503|69532742|FG001|Overall Study|Death|358|||
37848665|NCT01088503|69532743|FG002|Overall Study|Death|7|||
38026726|NCT03573908|69711465|FG004|Randomized Withdrawal Period|Adverse Event|0|||
38026727|NCT03573908|69711461|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
38026728|NCT03573908|69711462|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
38026729|NCT03573908|69711463|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
38026730|NCT03573908|69711464|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
37848666|NCT01087489|69532749|FG000|Overall Study|enrolled in another VA study|0|||
37848667|NCT01087489|69532750|FG001|Overall Study|enrolled in another VA study|1|||
37848668|NCT01087489|69532749|FG000|Overall Study|Death|0|||
37848669|NCT01087489|69532750|FG001|Overall Study|Death|1|||
37848670|NCT01087489|69532749|FG000|Overall Study|unable to survey by telephone|0|||
37918044|NCT00487435|69604790|FG000|Overall Study|Withdrawal by Subject|132|||
37918045|NCT00487435|69604790|FG000|Overall Study|Resolution Of Pain|1|||
37918046|NCT00487435|69604790|FG000|Overall Study|Study Medication Non-Compliant|32|||
37918047|NCT00487435|69604790|FG000|Overall Study|Other|83|||
37918048|NCT00487279|69604796|FG000|Overall Study|Death|1|||
38026731|NCT03573908|69711465|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
37734935|NCT01890421|69215295|FG000|Overall Study|Other reason|10|||
37848671|NCT01087489|69532750|FG001|Overall Study|unable to survey by telephone|1|||
37918049|NCT00487279|69604797|FG001|Overall Study|Death|0|||
37848672|NCT01082965|69532758|FG000|Overall Study|Protocol Violation|0|||
37848673|NCT01082965|69532759|FG001|Overall Study|Protocol Violation|1|||
37848674|NCT01082965|69532758|FG000|Overall Study|Other|1|||
37848675|NCT01082965|69532759|FG001|Overall Study|Other|1|||
37848676|NCT01102426|69532767|FG000|Overall Study|Randomized but not treated|4|||
37848677|NCT01102426|69532768|FG001|Overall Study|Randomized but not treated|1|||
37848678|NCT01102426|69532767|FG000|Overall Study|Adverse Events (treatment-related)|15|||
37848679|NCT01102426|69532768|FG001|Overall Study|Adverse Events (treatment-related)|8|||
37918050|NCT00487279|69604796|FG000|Overall Study|Withdrawal by Subject|0|||
37848680|NCT01102426|69532767|FG000|Overall Study|Physician Decision|9|||
37848681|NCT01102426|69532768|FG001|Overall Study|Physician Decision|6|||
37848682|NCT01102426|69532767|FG000|Overall Study|Progressive Disease|85|||
37848683|NCT01102426|69532768|FG001|Overall Study|Progressive Disease|44|||
37848684|NCT01102426|69532767|FG000|Overall Study|Adverse Events (unrelated to|9|||
37848685|NCT01102426|69532768|FG001|Overall Study|Adverse Events (unrelated to|1|||
37848686|NCT01102426|69532767|FG000|Overall Study|Patient Refusal|24|||
37848687|NCT01102426|69532768|FG001|Overall Study|Patient Refusal|12|||
37848688|NCT01102426|69532767|FG000|Overall Study|Death (due to adverse events|0|||
37848689|NCT01102426|69532768|FG001|Overall Study|Death (due to adverse events|1|||
37848690|NCT01102426|69532767|FG000|Overall Study|Death (non-related to the study|19|||
37848691|NCT01102426|69532768|FG001|Overall Study|Death (non-related to the study|8|||
37848692|NCT01101334|69532776|FG000|Overall Study|Adverse Event|9|||
37848693|NCT01101334|69532777|FG001|Overall Study|Adverse Event|4|||
37848694|NCT01101334|69532776|FG000|Overall Study|Death|7|||
37848695|NCT01101334|69532777|FG001|Overall Study|Death|1|||
37848696|NCT01101334|69532776|FG000|Overall Study|Withdrawal by Subject|4|||
38026732|NCT03573908|69711461|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
38026733|NCT03573908|69711462|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
38026734|NCT03573908|69711463|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
38026735|NCT03573908|69711464|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
38026736|NCT03573908|69711465|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
38026737|NCT03573908|69711461|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
37848697|NCT01101334|69532777|FG001|Overall Study|Withdrawal by Subject|3|||
37848698|NCT01101334|69532776|FG000|Overall Study|Withdrawal by Sponsor|1|||
37848699|NCT01101334|69532777|FG001|Overall Study|Withdrawal by Sponsor|1|||
37848700|NCT01101334|69532776|FG000|Overall Study|Progressive Disease|22|||
37848701|NCT01101334|69532777|FG001|Overall Study|Progressive Disease|35|||
37848702|NCT01101334|69532776|FG000|Overall Study|Other|2|||
37848703|NCT01101334|69532777|FG001|Overall Study|Other|1|||
37848704|NCT01327547|69532785|FG000|Overall Study|Adverse Event|4|||
37848705|NCT01327547|69532786|FG001|Overall Study|Adverse Event|1|||
37848706|NCT01327547|69532785|FG000|Overall Study|Death|1|||
37848707|NCT01327547|69532786|FG001|Overall Study|Death|2|||
37848708|NCT01327547|69532785|FG000|Overall Study|Lost to Follow-up|6|||
37848709|NCT01327547|69532786|FG001|Overall Study|Lost to Follow-up|6|||
37848710|NCT01327547|69532785|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
37848711|NCT01327547|69532786|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
37848712|NCT01327547|69532785|FG000|Overall Study|Withdrawal by Subject|3|||
37848713|NCT01327547|69532786|FG001|Overall Study|Withdrawal by Subject|7|||
37848714|NCT01327547|69532785|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
37848715|NCT01327547|69532786|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
37848716|NCT01327547|69532785|FG000|Overall Study|Protocol Violation|1|||
37918051|NCT00487279|69604797|FG001|Overall Study|Withdrawal by Subject|2|||
37918052|NCT00495625|69604803|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
37918053|NCT00847626|69604818|FG000|Overall Study|Adverse Event|10|||
37918054|NCT00847626|69604819|FG001|Overall Study|Adverse Event|10|||
37918055|NCT00847626|69604820|FG002|Overall Study|Adverse Event|6|||
37918056|NCT00847626|69604821|FG003|Overall Study|Adverse Event|19|||
37918057|NCT00847626|69604822|FG004|Overall Study|Adverse Event|11|||
37918058|NCT00847626|69604823|FG005|Overall Study|Adverse Event|22|||
37918059|NCT00847626|69604824|FG006|Overall Study|Adverse Event|4|||
38026738|NCT03573908|69711462|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
38026739|NCT03573908|69711463|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
38026740|NCT03573908|69711464|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
38026741|NCT03573908|69711465|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
38026742|NCT03573830|69711476|FG000|Overall Study|Dropped without completing treatment|0|||
38026743|NCT03573830|69711477|FG001|Overall Study|Dropped without completing treatment|7|||
38026744|NCT03573830|69711476|FG000|Overall Study|Lost to Follow-up|4|||
38026745|NCT03573830|69711477|FG001|Overall Study|Lost to Follow-up|0|||
38026746|NCT03595904|69711484|FG000|Overall Study|Protocol Violation|3|||
38026747|NCT03595904|69711485|FG001|Overall Study|Protocol Violation|1|||
38026748|NCT03595904|69711484|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
38026749|NCT03595904|69711485|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
38026750|NCT03595904|69711484|FG000|Overall Study|Insurance complications|1|||
37848717|NCT01327547|69532786|FG001|Overall Study|Protocol Violation|0|||
37848718|NCT01327547|69532785|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
37848719|NCT01327547|69532786|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
37848720|NCT01327547|69532785|FG000|Overall Study|Required prohibited medication|2|||
37848721|NCT01327547|69532786|FG001|Overall Study|Required prohibited medication|0|||
37848722|NCT01327547|69532785|FG000|Overall Study|Non-compliance with study procedures|1|||
37848723|NCT01327547|69532786|FG001|Overall Study|Non-compliance with study procedures|0|||
37918060|NCT00847626|69604825|FG007|Overall Study|Adverse Event|6|||
37918061|NCT00847626|69604826|FG008|Overall Study|Adverse Event|3|||
37918062|NCT00847626|69604827|FG009|Overall Study|Adverse Event|6|||
38026751|NCT03595904|69711485|FG001|Overall Study|Insurance complications|0|||
38026752|NCT03595904|69711484|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
38026753|NCT03595904|69711485|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
38026754|NCT03595280|69711494|FG000|Overall Study|Lost to Follow-up|6|||
38026755|NCT03595280|69711495|FG001|Overall Study|Lost to Follow-up|9|||
38026756|NCT03595280|69711496|FG002|Overall Study|Lost to Follow-up|15|||
37918063|NCT00847626|69604828|FG010|Overall Study|Adverse Event|6|||
37918064|NCT00847626|69604818|FG000|Overall Study|Protocol Violation|2|||
38026757|NCT03593876|69711504|FG000|Overall Study|Withdrawal by Subject|1|||
38026758|NCT03593876|69711504|FG000|Overall Study|Discharged home before intervention completion|2|||
38026759|NCT00071487|69711512|FG000|52-Week Double-Blind Period|Adverse Event|5|||
38026760|NCT00071487|69711513|FG001|52-Week Double-Blind Period|Adverse Event|8|||
38026761|NCT00071487|69711514|FG002|52-Week Double-Blind Period|Adverse Event|4|||
38026762|NCT00071487|69711515|FG003|52-Week Double-Blind Period|Adverse Event|8|||
38026763|NCT00071487|69711512|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
38026764|NCT00071487|69711513|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
38026765|NCT00071487|69711514|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
38026766|NCT00071487|69711515|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
38026767|NCT00071487|69711512|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
38026768|NCT00071487|69711513|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
38026769|NCT00071487|69711514|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
38026770|NCT00071487|69711515|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
38026771|NCT00071487|69711512|FG000|52-Week Double-Blind Period|Physician Decision|1|||
38026772|NCT00071487|69711513|FG001|52-Week Double-Blind Period|Physician Decision|0|||
38026773|NCT00071487|69711514|FG002|52-Week Double-Blind Period|Physician Decision|0|||
38026774|NCT00071487|69711515|FG003|52-Week Double-Blind Period|Physician Decision|0|||
38026775|NCT00071487|69711512|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
38026776|NCT00071487|69711513|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
38026777|NCT00071487|69711514|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
38026778|NCT00071487|69711515|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
38026779|NCT00071487|69711512|FG000|52-Week Double-Blind Period|Pregnancy|0|||
38026780|NCT00071487|69711513|FG001|52-Week Double-Blind Period|Pregnancy|1|||
38026781|NCT00071487|69711514|FG002|52-Week Double-Blind Period|Pregnancy|0|||
38026782|NCT00071487|69711515|FG003|52-Week Double-Blind Period|Pregnancy|0|||
37848724|NCT01327547|69532785|FG000|Overall Study|By investigator in subject's interest|0|||
38026783|NCT00071487|69711512|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
38026784|NCT00071487|69711513|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
38026785|NCT00071487|69711514|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
38026786|NCT00071487|69711515|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
38026787|NCT00071487|69711512|FG000|52-Week Double-Blind Period|Death|0|||
38026788|NCT00071487|69711513|FG001|52-Week Double-Blind Period|Death|1|||
38026789|NCT00071487|69711514|FG002|52-Week Double-Blind Period|Death|0|||
38026790|NCT00071487|69711515|FG003|52-Week Double-Blind Period|Death|0|||
38026791|NCT00071487|69711512|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
38026792|NCT00071487|69711513|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
38026793|NCT00071487|69711514|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
38026794|NCT00071487|69711515|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
38026795|NCT00071487|69711512|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
38026796|NCT00071487|69711513|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
38026797|NCT00071487|69711514|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
38026798|NCT00071487|69711515|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
38026799|NCT00071487|69711512|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
38026800|NCT00071487|69711513|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
38026801|NCT00071487|69711514|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
38026802|NCT00071487|69711515|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
38026803|NCT00071487|69711512|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
38026804|NCT00071487|69711513|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
38026805|NCT00071487|69711514|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
38026806|NCT00071487|69711515|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
38026807|NCT00071487|69711512|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
38026808|NCT00071487|69711513|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
38026809|NCT00071487|69711514|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
37848725|NCT01327547|69532786|FG001|Overall Study|By investigator in subject's interest|1|||
37848726|NCT01308567|69532808|FG000|Overall Study|Lost to Follow-up|2|||
37848727|NCT01308567|69532809|FG001|Overall Study|Lost to Follow-up|4|||
37848728|NCT01308567|69532810|FG002|Overall Study|Lost to Follow-up|4|||
37848729|NCT01307319|69532821|FG000|Overall Study|Adverse Event|2|||
37848730|NCT01307319|69532822|FG001|Overall Study|Adverse Event|2|||
37848731|NCT01307319|69532823|FG002|Overall Study|Adverse Event|1|||
37848732|NCT01307319|69532821|FG000|Overall Study|Lost to Follow-up|1|||
37848733|NCT01307319|69532822|FG001|Overall Study|Lost to Follow-up|0|||
38026810|NCT00071487|69711515|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
38026811|NCT00071487|69711512|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
38026812|NCT00071487|69711513|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
38026813|NCT00071487|69711514|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
38026814|NCT00071487|69711515|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
38026815|NCT00071487|69711512|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
38026816|NCT00071487|69711513|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
38026817|NCT00071487|69711514|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
38026818|NCT00071487|69711515|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
38026819|NCT03591146|69711532|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
38026820|NCT03591146|69711533|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
38026821|NCT03591146|69711534|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
38026822|NCT03591146|69711535|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
38026823|NCT03591146|69711536|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
38026824|NCT03591146|69711532|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
38026825|NCT03591146|69711533|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
38026826|NCT03591146|69711534|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
38026827|NCT03591146|69711535|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
38026828|NCT03591146|69711536|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
38026829|NCT03591146|69711532|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
38026830|NCT03591146|69711533|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
38026831|NCT03591146|69711534|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
37918065|NCT00847626|69604819|FG001|Overall Study|Protocol Violation|1|||
37918066|NCT00847626|69604820|FG002|Overall Study|Protocol Violation|2|||
37918067|NCT00847626|69604821|FG003|Overall Study|Protocol Violation|1|||
37918068|NCT00847626|69604822|FG004|Overall Study|Protocol Violation|1|||
37918069|NCT00847626|69604823|FG005|Overall Study|Protocol Violation|1|||
37918070|NCT00847626|69604824|FG006|Overall Study|Protocol Violation|1|||
37918071|NCT00847626|69604825|FG007|Overall Study|Protocol Violation|1|||
37918072|NCT00847626|69604826|FG008|Overall Study|Protocol Violation|0|||
37918073|NCT00847626|69604827|FG009|Overall Study|Protocol Violation|1|||
37918074|NCT00847626|69604828|FG010|Overall Study|Protocol Violation|1|||
37918075|NCT00847626|69604818|FG000|Overall Study|Lost to Follow-up|0|||
37918076|NCT00847626|69604819|FG001|Overall Study|Lost to Follow-up|1|||
37918077|NCT00847626|69604820|FG002|Overall Study|Lost to Follow-up|1|||
37918078|NCT00847626|69604821|FG003|Overall Study|Lost to Follow-up|1|||
37918079|NCT00847626|69604822|FG004|Overall Study|Lost to Follow-up|0|||
37918080|NCT00847626|69604823|FG005|Overall Study|Lost to Follow-up|3|||
37918081|NCT00847626|69604824|FG006|Overall Study|Lost to Follow-up|1|||
37918082|NCT00847626|69604825|FG007|Overall Study|Lost to Follow-up|3|||
37918083|NCT00847626|69604826|FG008|Overall Study|Lost to Follow-up|1|||
37918084|NCT00847626|69604827|FG009|Overall Study|Lost to Follow-up|0|||
38026832|NCT03591146|69711535|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
38026833|NCT03591146|69711536|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
38026834|NCT03591146|69711532|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
38026835|NCT03591146|69711533|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
38026836|NCT03591146|69711534|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
37848734|NCT01307319|69532823|FG002|Overall Study|Lost to Follow-up|1|||
37848735|NCT01307319|69532821|FG000|Overall Study|Protocol Violation|1|||
37848736|NCT01307319|69532822|FG001|Overall Study|Protocol Violation|1|||
37848737|NCT01307319|69532823|FG002|Overall Study|Protocol Violation|0|||
37918085|NCT00847626|69604828|FG010|Overall Study|Lost to Follow-up|1|||
38026837|NCT03591146|69711535|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
38026838|NCT03591146|69711536|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
38026839|NCT00096447|69711548|FG000|Overall Study|Never treated|1|||
37848738|NCT01307319|69532821|FG000|Overall Study|Withdrawal by Subject|0|||
37848739|NCT01307319|69532822|FG001|Overall Study|Withdrawal by Subject|1|||
37848740|NCT01307319|69532823|FG002|Overall Study|Withdrawal by Subject|2|||
37848741|NCT01307319|69532821|FG000|Overall Study|Other|0|||
37848742|NCT01307319|69532822|FG001|Overall Study|Other|4|||
37848743|NCT01307319|69532823|FG002|Overall Study|Other|3|||
37848744|NCT01080391|69532833|FG000|Overall Study|Randomized but not treated|7|||
38026840|NCT03590366|69711559|FG000|Overall Study|Adverse Event|0|||
38026841|NCT03590366|69711560|FG001|Overall Study|Adverse Event|3|||
37734936|NCT00985738|69215301|FG000|Overall Study|Study closed prematurely|8|||
37848745|NCT01080391|69532834|FG001|Overall Study|Randomized but not treated|4|||
37848746|NCT01070329|69532842|FG000|Overall Study|Adverse Event|13|||
37848747|NCT01070329|69532843|FG001|Overall Study|Adverse Event|10|||
37918086|NCT00847626|69604818|FG000|Overall Study|Withdrawal by Subject|5|||
37918087|NCT00847626|69604819|FG001|Overall Study|Withdrawal by Subject|5|||
37918088|NCT00847626|69604820|FG002|Overall Study|Withdrawal by Subject|3|||
37918089|NCT00847626|69604821|FG003|Overall Study|Withdrawal by Subject|8|||
37918090|NCT00847626|69604822|FG004|Overall Study|Withdrawal by Subject|12|||
37848748|NCT01070329|69532842|FG000|Overall Study|Lost to Follow-up|22|||
37918091|NCT00847626|69604823|FG005|Overall Study|Withdrawal by Subject|9|||
37918092|NCT00847626|69604824|FG006|Overall Study|Withdrawal by Subject|8|||
37918093|NCT00847626|69604825|FG007|Overall Study|Withdrawal by Subject|4|||
37918094|NCT00847626|69604826|FG008|Overall Study|Withdrawal by Subject|4|||
37918095|NCT00847626|69604827|FG009|Overall Study|Withdrawal by Subject|5|||
37918096|NCT00847626|69604828|FG010|Overall Study|Withdrawal by Subject|2|||
37734937|NCT00985738|69215302|FG001|Overall Study|Study closed prematurely|8|||
37734938|NCT01928485|69215310|FG000|Overall Study|Physician Decision|0|||
37734939|NCT01928485|69215311|FG001|Overall Study|Physician Decision|1|||
37734940|NCT00985504|69215319|FG000|Acute Treatment Period|Adverse Event|3|||
37734941|NCT00985504|69215320|FG001|Acute Treatment Period|Adverse Event|4|||
37734942|NCT00985504|69215319|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
37734943|NCT00985504|69215320|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
37734944|NCT00985504|69215319|FG000|Acute Treatment Period|Protocol Violation|2|||
37734945|NCT00985504|69215320|FG001|Acute Treatment Period|Protocol Violation|0|||
37734946|NCT00985504|69215319|FG000|Acute Treatment Period|Sponsor Decision|0|||
38026842|NCT03590366|69711559|FG000|Overall Study|Lost to Follow-up|3|||
38026843|NCT03590366|69711560|FG001|Overall Study|Lost to Follow-up|3|||
37918097|NCT00847626|69604818|FG000|Overall Study|Lack of Efficacy|3|||
37918098|NCT00847626|69604819|FG001|Overall Study|Lack of Efficacy|1|||
37918099|NCT00847626|69604820|FG002|Overall Study|Lack of Efficacy|0|||
37918100|NCT00847626|69604821|FG003|Overall Study|Lack of Efficacy|1|||
37918101|NCT00847626|69604822|FG004|Overall Study|Lack of Efficacy|2|||
38026844|NCT03590366|69711559|FG000|Overall Study|Withdrawal by Subject|0|||
38026845|NCT03590366|69711560|FG001|Overall Study|Withdrawal by Subject|2|||
38026846|NCT03588572|69711568|FG000|Visitation 1|Lack of Efficacy|1|||
38026847|NCT03588572|69711569|FG001|Visitation 1|Lack of Efficacy|1|||
38026848|NCT03588572|69711568|FG000|Visitation 2|Lost to Follow-up|1|||
38026849|NCT03588572|69711569|FG001|Visitation 2|Lost to Follow-up|1|||
38026850|NCT03588572|69711568|FG000|Visitation 2|Lack of Efficacy|0|||
38026851|NCT03588572|69711569|FG001|Visitation 2|Lack of Efficacy|1|||
38026852|NCT03588572|69711568|FG000|Visitation 2|Withdrawal by Subject|1|||
37918102|NCT00847626|69604823|FG005|Overall Study|Lack of Efficacy|0|||
37918103|NCT00847626|69604824|FG006|Overall Study|Lack of Efficacy|6|||
37918104|NCT00847626|69604825|FG007|Overall Study|Lack of Efficacy|2|||
37918105|NCT00847626|69604826|FG008|Overall Study|Lack of Efficacy|5|||
37918106|NCT00847626|69604827|FG009|Overall Study|Lack of Efficacy|1|||
37918107|NCT00847626|69604828|FG010|Overall Study|Lack of Efficacy|7|||
37918108|NCT00847626|69604818|FG000|Overall Study|Other|1|||
37918109|NCT00847626|69604819|FG001|Overall Study|Other|5|||
37918110|NCT00847626|69604820|FG002|Overall Study|Other|4|||
37918111|NCT00847626|69604821|FG003|Overall Study|Other|1|||
37918112|NCT00847626|69604822|FG004|Overall Study|Other|2|||
37918113|NCT00847626|69604823|FG005|Overall Study|Other|2|||
37918114|NCT00847626|69604824|FG006|Overall Study|Other|2|||
37918115|NCT00847626|69604825|FG007|Overall Study|Other|3|||
37918116|NCT00847626|69604826|FG008|Overall Study|Other|1|||
37918117|NCT00847626|69604827|FG009|Overall Study|Other|1|||
37918118|NCT00847626|69604828|FG010|Overall Study|Other|3|||
37918119|NCT00851682|69604857|FG000|Overall Study|screen failure|5|||
37918120|NCT00851682|69604858|FG001|Overall Study|screen failure|0|||
37918121|NCT00860262|69604867|FG000|Overall Study|Adverse Event|9|||
37918122|NCT00860262|69604868|FG001|Overall Study|Adverse Event|6|||
37918123|NCT00860262|69604869|FG002|Overall Study|Adverse Event|7|||
37918124|NCT00860262|69604867|FG000|Overall Study|Protocol Violation|0|||
37918125|NCT00860262|69604868|FG001|Overall Study|Protocol Violation|1|||
38026853|NCT03588572|69711569|FG001|Visitation 2|Withdrawal by Subject|0|||
38026854|NCT03588572|69711568|FG000|Visitation 3|Lost to Follow-up|1|||
38026855|NCT03588572|69711569|FG001|Visitation 3|Lost to Follow-up|1|||
38026856|NCT03588572|69711568|FG000|Visitation 3|Physician Decision|1|||
38026857|NCT03588572|69711569|FG001|Visitation 3|Physician Decision|1|||
38026858|NCT03588572|69711568|FG000|Visitation 3|Withdrawal by Subject|1|||
38026859|NCT03588572|69711569|FG001|Visitation 3|Withdrawal by Subject|0|||
38026860|NCT00090285|69711577|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
38026861|NCT00090285|69711578|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
37734947|NCT00985504|69215320|FG001|Acute Treatment Period|Sponsor Decision|1|||
37848749|NCT01070329|69532843|FG001|Overall Study|Lost to Follow-up|12|||
37848750|NCT01070329|69532842|FG000|Overall Study|Withdrawal by Subject|9|||
37848751|NCT01070329|69532843|FG001|Overall Study|Withdrawal by Subject|11|||
37848752|NCT01070329|69532842|FG000|Overall Study|Protocol Violation|3|||
37848753|NCT01070329|69532843|FG001|Overall Study|Protocol Violation|8|||
37848754|NCT01070329|69532842|FG000|Overall Study|Lack of Efficacy|2|||
37848755|NCT01070329|69532843|FG001|Overall Study|Lack of Efficacy|6|||
37848756|NCT01070329|69532842|FG000|Overall Study|Physician Decision|2|||
37848757|NCT01070329|69532843|FG001|Overall Study|Physician Decision|1|||
37918126|NCT00860262|69604869|FG002|Overall Study|Protocol Violation|0|||
37918127|NCT00860262|69604867|FG000|Overall Study|Lost to Follow-up|2|||
37918128|NCT00860262|69604868|FG001|Overall Study|Lost to Follow-up|0|||
37918129|NCT00860262|69604869|FG002|Overall Study|Lost to Follow-up|1|||
37918130|NCT00860262|69604867|FG000|Overall Study|Withdrawal by Subject|4|||
37918131|NCT00860262|69604868|FG001|Overall Study|Withdrawal by Subject|8|||
37918132|NCT00860262|69604869|FG002|Overall Study|Withdrawal by Subject|6|||
37918133|NCT00860262|69604867|FG000|Overall Study|Lack of Efficacy|0|||
37918134|NCT00860262|69604868|FG001|Overall Study|Lack of Efficacy|4|||
37918135|NCT00860262|69604869|FG002|Overall Study|Lack of Efficacy|3|||
37918136|NCT00860262|69604867|FG000|Overall Study|Other|5|||
37918137|NCT00860262|69604868|FG001|Overall Study|Other|3|||
37918138|NCT00860262|69604869|FG002|Overall Study|Other|1|||
37918139|NCT00860028|69604881|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
37918140|NCT00860028|69604882|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
37918141|NCT00859638|69604892|FG000|Overall Study|Lost to Follow-up|6|||
37918142|NCT00859638|69604893|FG001|Overall Study|Lost to Follow-up|1|||
37918143|NCT00859638|69604892|FG000|Overall Study|Withdrawal by Subject|3|||
37918144|NCT00859638|69604893|FG001|Overall Study|Withdrawal by Subject|2|||
37918145|NCT00859638|69604892|FG000|Overall Study|Ill health|1|||
37918146|NCT00859638|69604893|FG001|Overall Study|Ill health|1|||
37918147|NCT00846846|69604899|FG000|Overall Study|Death|56|||
37918148|NCT00846846|69604899|FG000|Overall Study|Withdrawal by Subject|19|||
37918149|NCT00846768|69604903|FG000|Overall Study|Adverse Event|0|||
37918150|NCT00846768|69604904|FG001|Overall Study|Adverse Event|1|||
37918151|NCT00846768|69604905|FG002|Overall Study|Adverse Event|0|||
38026862|NCT00090285|69711579|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
38026863|NCT00090285|69711580|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
38026864|NCT00090285|69711581|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
38026865|NCT00090285|69711582|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
38026866|NCT00090285|69711577|FG000|Base Study Vaccination Period|Adverse Event|2|||
38026867|NCT00090285|69711578|FG001|Base Study Vaccination Period|Adverse Event|4|||
38026868|NCT00090285|69711579|FG002|Base Study Vaccination Period|Adverse Event|0|||
38026869|NCT00090285|69711580|FG003|Base Study Vaccination Period|Adverse Event|0|||
38026870|NCT00090285|69711581|FG004|Base Study Vaccination Period|Adverse Event|0|||
38026871|NCT00090285|69711582|FG005|Base Study Vaccination Period|Adverse Event|0|||
38026872|NCT00090285|69711577|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
38026873|NCT00090285|69711578|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
38026874|NCT00090285|69711579|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
38026875|NCT00090285|69711580|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
38026876|NCT00090285|69711581|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
37918152|NCT00846768|69604906|FG003|Overall Study|Adverse Event|0|||
37918153|NCT00863798|69604919|FG000|Overall Study|Adverse Event|5|||
37918154|NCT00863798|69604920|FG001|Overall Study|Adverse Event|2|||
37918155|NCT00863798|69604921|FG002|Overall Study|Adverse Event|4|||
37918156|NCT00863798|69604919|FG000|Overall Study|Participant failed to return|2|||
37918157|NCT00863798|69604920|FG001|Overall Study|Participant failed to return|1|||
37918158|NCT00863798|69604921|FG002|Overall Study|Participant failed to return|0|||
37918159|NCT00863798|69604919|FG000|Overall Study|Investigator request|1|||
37918160|NCT00863798|69604920|FG001|Overall Study|Investigator request|2|||
37918161|NCT00863798|69604921|FG002|Overall Study|Investigator request|1|||
37918162|NCT00863798|69604919|FG000|Overall Study|Lack of Efficacy|4|||
37918163|NCT00863798|69604920|FG001|Overall Study|Lack of Efficacy|3|||
37918164|NCT00863798|69604921|FG002|Overall Study|Lack of Efficacy|6|||
37918165|NCT00863798|69604919|FG000|Overall Study|Lost to Follow-up|6|||
37918166|NCT00863798|69604920|FG001|Overall Study|Lost to Follow-up|9|||
37918167|NCT00863798|69604921|FG002|Overall Study|Lost to Follow-up|5|||
37918168|NCT00863798|69604919|FG000|Overall Study|Other|2|||
37918169|NCT00863798|69604920|FG001|Overall Study|Other|3|||
37918170|NCT00863798|69604921|FG002|Overall Study|Other|1|||
37918171|NCT00863798|69604919|FG000|Overall Study|Protocol Violation|0|||
37918172|NCT00863798|69604920|FG001|Overall Study|Protocol Violation|1|||
37918173|NCT00863798|69604921|FG002|Overall Study|Protocol Violation|1|||
37918174|NCT00863798|69604919|FG000|Overall Study|Withdrawal by Subject|8|||
37918175|NCT00863798|69604920|FG001|Overall Study|Withdrawal by Subject|7|||
38026877|NCT00090285|69711582|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
38026878|NCT00090285|69711577|FG000|Base Study Vaccination Period|Protocol Violation|2|||
38026879|NCT00090285|69711578|FG001|Base Study Vaccination Period|Protocol Violation|3|||
38026880|NCT00090285|69711579|FG002|Base Study Vaccination Period|Protocol Violation|0|||
38026881|NCT00090285|69711580|FG003|Base Study Vaccination Period|Protocol Violation|0|||
37734948|NCT00985504|69215319|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
37918176|NCT00863798|69604921|FG002|Overall Study|Withdrawal by Subject|4|||
37918177|NCT00863798|69604919|FG000|Overall Study|Randomized not treated|4|||
37918178|NCT00863798|69604920|FG001|Overall Study|Randomized not treated|2|||
37918179|NCT00863798|69604921|FG002|Overall Study|Randomized not treated|3|||
37918180|NCT00859014|69604929|FG000|Overall Study|Death|4|||
37918181|NCT00859014|69604929|FG000|Overall Study|Lost to Follow-up|1|||
38026882|NCT00090285|69711581|FG004|Base Study Vaccination Period|Protocol Violation|0|||
38026883|NCT00090285|69711582|FG005|Base Study Vaccination Period|Protocol Violation|0|||
38026884|NCT00090285|69711577|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
38026885|NCT00090285|69711578|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
38026886|NCT00090285|69711579|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
37918182|NCT00593606|69604933|FG000|Overall Study|Adverse Event|13|||
37918183|NCT00593606|69604933|FG000|Overall Study|Withdrawal by Subject|1|||
37918184|NCT00593606|69604933|FG000|Overall Study|Protocol Violation|3|||
37918185|NCT00593606|69604933|FG000|Overall Study|Lost to Follow-up|2|||
38026887|NCT00090285|69711580|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
38026888|NCT00090285|69711581|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
38026889|NCT00090285|69711582|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
38026890|NCT00090285|69711577|FG000|Base Study Vaccination Period|Uncooperative|2|||
38026891|NCT00090285|69711578|FG001|Base Study Vaccination Period|Uncooperative|2|||
38026892|NCT00090285|69711579|FG002|Base Study Vaccination Period|Uncooperative|0|||
38026893|NCT00090285|69711580|FG003|Base Study Vaccination Period|Uncooperative|0|||
38026894|NCT00090285|69711581|FG004|Base Study Vaccination Period|Uncooperative|0|||
38026895|NCT00090285|69711582|FG005|Base Study Vaccination Period|Uncooperative|0|||
38026896|NCT00090285|69711577|FG000|Base Study Vaccination Period|Moved|20|||
38026897|NCT00090285|69711578|FG001|Base Study Vaccination Period|Moved|21|||
38026898|NCT00090285|69711579|FG002|Base Study Vaccination Period|Moved|0|||
38026899|NCT00090285|69711580|FG003|Base Study Vaccination Period|Moved|0|||
37918186|NCT00593606|69604933|FG000|Overall Study|Run-In Failure|5|||
37918187|NCT00593606|69604933|FG000|Overall Study|Screen Failure|3|||
37918188|NCT00870584|69604939|FG000|Overall Study|Adverse Event|3|||
37918189|NCT00870584|69604940|FG001|Overall Study|Adverse Event|3|||
37918190|NCT00870584|69604939|FG000|Overall Study|Withdrawal by Subject|6|||
37918191|NCT00870584|69604940|FG001|Overall Study|Withdrawal by Subject|7|||
37918192|NCT00870584|69604939|FG000|Overall Study|Lost to Follow-up|5|||
37918193|NCT00870584|69604940|FG001|Overall Study|Lost to Follow-up|1|||
37918194|NCT00870584|69604939|FG000|Overall Study|Protocol Deviation|2|||
37918195|NCT00870584|69604940|FG001|Overall Study|Protocol Deviation|2|||
37918196|NCT00870194|69604948|FG000|Overall Study|Adverse Event|10|||
37918197|NCT00870194|69604949|FG001|Overall Study|Adverse Event|5|||
37918198|NCT00870194|69604948|FG000|Overall Study|Lack of Efficacy|0|||
37918199|NCT00870194|69604949|FG001|Overall Study|Lack of Efficacy|1|||
37918200|NCT00870194|69604948|FG000|Overall Study|Lost to Follow-up|2|||
37918201|NCT00870194|69604949|FG001|Overall Study|Lost to Follow-up|0|||
37918202|NCT00870194|69604948|FG000|Overall Study|Physician Decision|3|||
37918203|NCT00870194|69604949|FG001|Overall Study|Physician Decision|1|||
37918204|NCT00870194|69604948|FG000|Overall Study|Protocol Violation|3|||
37918205|NCT00870194|69604949|FG001|Overall Study|Protocol Violation|3|||
37918206|NCT00870194|69604948|FG000|Overall Study|Entry Criteria Not Met|1|||
37918207|NCT00870194|69604949|FG001|Overall Study|Entry Criteria Not Met|2|||
38026900|NCT00090285|69711581|FG004|Base Study Vaccination Period|Moved|0|||
38026901|NCT00090285|69711582|FG005|Base Study Vaccination Period|Moved|0|||
38026902|NCT00090285|69711577|FG000|Base Study Vaccination Period|Site Terminated|1|||
38026903|NCT00090285|69711578|FG001|Base Study Vaccination Period|Site Terminated|0|||
38026904|NCT00090285|69711579|FG002|Base Study Vaccination Period|Site Terminated|0|||
38026905|NCT00090285|69711580|FG003|Base Study Vaccination Period|Site Terminated|0|||
38026906|NCT00090285|69711581|FG004|Base Study Vaccination Period|Site Terminated|0|||
38026907|NCT00090285|69711582|FG005|Base Study Vaccination Period|Site Terminated|0|||
38026908|NCT00090285|69711577|FG000|Base Study Vaccination Period|Other|2|||
38026909|NCT00090285|69711578|FG001|Base Study Vaccination Period|Other|2|||
38026910|NCT00090285|69711579|FG002|Base Study Vaccination Period|Other|0|||
38026911|NCT00090285|69711580|FG003|Base Study Vaccination Period|Other|0|||
38026912|NCT00090285|69711581|FG004|Base Study Vaccination Period|Other|0|||
38026913|NCT00090285|69711582|FG005|Base Study Vaccination Period|Other|0|||
38026914|NCT00090285|69711577|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
37918208|NCT00870194|69604948|FG000|Overall Study|Subject Decision|7|||
37918209|NCT00870194|69604949|FG001|Overall Study|Subject Decision|2|||
37918210|NCT00690430|69604957|FG000|Core Phase|Abnormal Laboratory value|0|||
37918211|NCT00690430|69604958|FG001|Core Phase|Abnormal Laboratory value|1|||
37918212|NCT00690430|69604959|FG002|Core Phase|Abnormal Laboratory value|0|||
37918213|NCT00690430|69604957|FG000|Core Phase|Adverse Event|5|||
37918214|NCT00690430|69604958|FG001|Core Phase|Adverse Event|1|||
37918215|NCT00690430|69604959|FG002|Core Phase|Adverse Event|0|||
37918216|NCT00690430|69604957|FG000|Core Phase|Death|0|||
37918217|NCT00690430|69604958|FG001|Core Phase|Death|2|||
37918218|NCT00690430|69604959|FG002|Core Phase|Death|0|||
37918219|NCT00690430|69604957|FG000|Core Phase|Protocol Violation|1|||
37918220|NCT00690430|69604958|FG001|Core Phase|Protocol Violation|0|||
37918221|NCT00690430|69604959|FG002|Core Phase|Protocol Violation|0|||
37918222|NCT00690430|69604957|FG000|Core Phase|Withdrawal by Subject|3|||
37918223|NCT00690430|69604958|FG001|Core Phase|Withdrawal by Subject|3|||
37918224|NCT00690430|69604959|FG002|Core Phase|Withdrawal by Subject|0|||
38026915|NCT00090285|69711578|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
38026916|NCT00090285|69711579|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
38026917|NCT00090285|69711580|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
38026918|NCT00090285|69711581|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
38026919|NCT00090285|69711582|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
38026920|NCT00090285|69711577|FG000|Base Study Vaccination Period|HIV positive|1|||
38026921|NCT00090285|69711578|FG001|Base Study Vaccination Period|HIV positive|1|||
37918225|NCT00690430|69604957|FG000|Core Phase|Subject no longer requires study drug|1|||
37918226|NCT00690430|69604958|FG001|Core Phase|Subject no longer requires study drug|0|||
38026922|NCT00090285|69711579|FG002|Base Study Vaccination Period|HIV positive|0|||
38026923|NCT00090285|69711580|FG003|Base Study Vaccination Period|HIV positive|0|||
38026924|NCT00090285|69711581|FG004|Base Study Vaccination Period|HIV positive|0|||
38026925|NCT00090285|69711582|FG005|Base Study Vaccination Period|HIV positive|0|||
38026926|NCT00090285|69711577|FG000|Base Study Follow-up Period|Adverse Event|3|||
38026927|NCT00090285|69711578|FG001|Base Study Follow-up Period|Adverse Event|10|||
38026928|NCT00090285|69711579|FG002|Base Study Follow-up Period|Adverse Event|0|||
38026929|NCT00090285|69711580|FG003|Base Study Follow-up Period|Adverse Event|0|||
38026930|NCT00090285|69711581|FG004|Base Study Follow-up Period|Adverse Event|0|||
38026931|NCT00090285|69711582|FG005|Base Study Follow-up Period|Adverse Event|0|||
38026932|NCT00090285|69711577|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
38026933|NCT00090285|69711578|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
38026934|NCT00090285|69711579|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
38026935|NCT00090285|69711580|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
38026936|NCT00090285|69711581|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
38026937|NCT00090285|69711582|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
38026938|NCT00090285|69711577|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
38026939|NCT00090285|69711578|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
38026940|NCT00090285|69711579|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
38026941|NCT00090285|69711580|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
38026942|NCT00090285|69711581|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
38026943|NCT00090285|69711582|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
38026944|NCT00090285|69711577|FG000|Base Study Follow-up Period|Moved|41|||
38026945|NCT00090285|69711578|FG001|Base Study Follow-up Period|Moved|36|||
37918227|NCT00690430|69604959|FG002|Core Phase|Subject no longer requires study drug|0|||
37918228|NCT00690430|69604957|FG000|Core Phase|Lack of Efficacy|8|||
37918229|NCT00690430|69604958|FG001|Core Phase|Lack of Efficacy|10|||
38026946|NCT00090285|69711579|FG002|Base Study Follow-up Period|Moved|0|||
38026947|NCT00090285|69711580|FG003|Base Study Follow-up Period|Moved|0|||
38026948|NCT00090285|69711581|FG004|Base Study Follow-up Period|Moved|0|||
38026949|NCT00090285|69711582|FG005|Base Study Follow-up Period|Moved|0|||
38026950|NCT00090285|69711577|FG000|Base Study Follow-up Period|Other|2|||
38026951|NCT00090285|69711578|FG001|Base Study Follow-up Period|Other|0|||
38026952|NCT00090285|69711579|FG002|Base Study Follow-up Period|Other|0|||
38026953|NCT00090285|69711580|FG003|Base Study Follow-up Period|Other|0|||
38026954|NCT00090285|69711581|FG004|Base Study Follow-up Period|Other|0|||
38026955|NCT00090285|69711582|FG005|Base Study Follow-up Period|Other|0|||
38026956|NCT00090285|69711577|FG000|Base Study Follow-up Period|Protocol Violation|1|||
38026957|NCT00090285|69711578|FG001|Base Study Follow-up Period|Protocol Violation|0|||
38026958|NCT00090285|69711579|FG002|Base Study Follow-up Period|Protocol Violation|0|||
38026959|NCT00090285|69711580|FG003|Base Study Follow-up Period|Protocol Violation|0|||
38026960|NCT00090285|69711581|FG004|Base Study Follow-up Period|Protocol Violation|0|||
37734949|NCT00985504|69215320|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
38026961|NCT00090285|69711582|FG005|Base Study Follow-up Period|Protocol Violation|0|||
38026962|NCT00090285|69711577|FG000|Base Study Follow-up Period|Uncooperative|3|||
38026963|NCT00090285|69711578|FG001|Base Study Follow-up Period|Uncooperative|4|||
38026964|NCT00090285|69711579|FG002|Base Study Follow-up Period|Uncooperative|0|||
38026965|NCT00090285|69711580|FG003|Base Study Follow-up Period|Uncooperative|0|||
38026966|NCT00090285|69711581|FG004|Base Study Follow-up Period|Uncooperative|0|||
38026967|NCT00090285|69711582|FG005|Base Study Follow-up Period|Uncooperative|0|||
38026968|NCT00090285|69711577|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
38026969|NCT00090285|69711578|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
38026970|NCT00090285|69711579|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
38026971|NCT00090285|69711580|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
37734950|NCT00985504|69215319|FG000|Optimization Period|Adverse Event|7|||
37734951|NCT00985504|69215320|FG001|Optimization Period|Adverse Event|9|||
38026972|NCT00090285|69711581|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
38026973|NCT00090285|69711582|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
38026974|NCT00090285|69711577|FG000|Extension 1|Adverse Event|0|||
38026975|NCT00090285|69711578|FG001|Extension 1|Adverse Event|0|||
38026976|NCT00090285|69711579|FG002|Extension 1|Adverse Event|2|||
37734952|NCT00985504|69215319|FG000|Optimization Period|Death|0|||
37918230|NCT00690430|69604959|FG002|Core Phase|Lack of Efficacy|0|||
37918231|NCT00690430|69604957|FG000|Core Phase|Administrative Problems|0|||
37918232|NCT00690430|69604958|FG001|Core Phase|Administrative Problems|1|||
37848758|NCT01070329|69532842|FG000|Overall Study|Entry Criteria Not Met|1|||
37848759|NCT01070329|69532843|FG001|Overall Study|Entry Criteria Not Met|0|||
38026977|NCT00090285|69711580|FG003|Extension 1|Adverse Event|0|||
38026978|NCT00090285|69711581|FG004|Extension 1|Adverse Event|0|||
38026979|NCT00090285|69711582|FG005|Extension 1|Adverse Event|0|||
38026980|NCT00090285|69711577|FG000|Extension 1|Lost to Follow-up|0|||
38026981|NCT00090285|69711578|FG001|Extension 1|Lost to Follow-up|0|||
37918233|NCT00690430|69604959|FG002|Core Phase|Administrative Problems|0|||
37918234|NCT00690430|69604957|FG000|Core Phase|Early Termination|0|||
37918235|NCT00690430|69604958|FG001|Core Phase|Early Termination|5|||
37918236|NCT00690430|69604959|FG002|Core Phase|Early Termination|0|||
37918237|NCT00690430|69604957|FG000|Extension Phase|Lack of Efficacy|3|||
37918238|NCT00690430|69604958|FG001|Extension Phase|Lack of Efficacy|1|||
37918239|NCT00690430|69604959|FG002|Extension Phase|Lack of Efficacy|4|||
37918240|NCT00690430|69604957|FG000|Extension Phase|Abnormal Lab Values|1|||
37918241|NCT00690430|69604958|FG001|Extension Phase|Abnormal Lab Values|0|||
37918242|NCT00690430|69604959|FG002|Extension Phase|Abnormal Lab Values|0|||
37918243|NCT00690430|69604957|FG000|Extension Phase|Abnormal test procedure results|1|||
37918244|NCT00690430|69604958|FG001|Extension Phase|Abnormal test procedure results|0|||
37918245|NCT00690430|69604959|FG002|Extension Phase|Abnormal test procedure results|0|||
37918246|NCT00690430|69604957|FG000|Extension Phase|Administrative Problems|0|||
37918247|NCT00690430|69604958|FG001|Extension Phase|Administrative Problems|1|||
37918248|NCT00690430|69604959|FG002|Extension Phase|Administrative Problems|1|||
37918249|NCT00690430|69604957|FG000|Extension Phase|Adverse Event|2|||
37918250|NCT00690430|69604958|FG001|Extension Phase|Adverse Event|1|||
38026982|NCT00090285|69711579|FG002|Extension 1|Lost to Follow-up|35|||
38026983|NCT00090285|69711580|FG003|Extension 1|Lost to Follow-up|0|||
38026984|NCT00090285|69711581|FG004|Extension 1|Lost to Follow-up|0|||
38026985|NCT00090285|69711582|FG005|Extension 1|Lost to Follow-up|0|||
38026986|NCT00090285|69711577|FG000|Extension 1|Withdrawal by Subject|0|||
38026987|NCT00090285|69711578|FG001|Extension 1|Withdrawal by Subject|0|||
38026988|NCT00090285|69711579|FG002|Extension 1|Withdrawal by Subject|13|||
37848760|NCT01070329|69532842|FG000|Overall Study|Sponsor Decision|0|||
37848761|NCT01070329|69532843|FG001|Overall Study|Sponsor Decision|1|||
37848762|NCT01069861|69532849|FG000|Overall Study|Death|1|||
37848763|NCT01069861|69532849|FG000|Overall Study|Adverse Event|1|||
37848764|NCT01069861|69532849|FG000|Overall Study|Did not meet entrance criteria|1|||
37848765|NCT01306929|69532853|FG000|Overall Study|Withdrawal by Subject|23|||
37848766|NCT01306929|69532853|FG000|Overall Study|Adverse Event|21|||
37848767|NCT01306929|69532853|FG000|Overall Study|Physician Decision|13|||
37848768|NCT01306929|69532853|FG000|Overall Study|Death|8|||
37848769|NCT01306929|69532853|FG000|Overall Study|Withdrawal by parent/guardian|5|||
37848770|NCT01306929|69532853|FG000|Overall Study|Protocol Violation|3|||
37848771|NCT01306929|69532853|FG000|Overall Study|Non-compliance with study drug|2|||
37848772|NCT01306929|69532853|FG000|Overall Study|Lost to Follow-up|2|||
37918251|NCT00690430|69604959|FG002|Extension Phase|Adverse Event|2|||
37918252|NCT00690430|69604957|FG000|Extension Phase|Death|1|||
37918253|NCT00690430|69604958|FG001|Extension Phase|Death|1|||
37918254|NCT00690430|69604959|FG002|Extension Phase|Death|1|||
37918255|NCT00690430|69604957|FG000|Extension Phase|Withdrawal by Subject|0|||
37918256|NCT00690430|69604958|FG001|Extension Phase|Withdrawal by Subject|0|||
37918257|NCT00690430|69604959|FG002|Extension Phase|Withdrawal by Subject|2|||
37918258|NCT00690430|69604957|FG000|Extension Phase|Early Termination|10|||
37918259|NCT00690430|69604958|FG001|Extension Phase|Early Termination|1|||
37918260|NCT00690430|69604959|FG002|Extension Phase|Early Termination|3|||
37918261|NCT00863330|69604968|FG000|Overall Study|study terminated early due to administra|6|||
37918262|NCT00688324|69604972|FG000|Overall Study|Withdrawal by Subject|2|||
37918263|NCT00688324|69604972|FG000|Overall Study|Physician Decision|5|||
37918264|NCT00688324|69604972|FG000|Overall Study|Lost to Follow-up|1|||
37918265|NCT00862940|69604979|FG000|Overall Study|Adverse Event|15|||
37918266|NCT00862940|69604980|FG001|Overall Study|Adverse Event|12|||
37918267|NCT00862940|69604979|FG000|Overall Study|Lack of Efficacy|1|||
37918268|NCT00862940|69604980|FG001|Overall Study|Lack of Efficacy|3|||
37918269|NCT00862940|69604979|FG000|Overall Study|Protocol Violation|2|||
37918270|NCT00862940|69604980|FG001|Overall Study|Protocol Violation|5|||
38026989|NCT00090285|69711580|FG003|Extension 1|Withdrawal by Subject|1|||
38026990|NCT00090285|69711581|FG004|Extension 1|Withdrawal by Subject|0|||
37848773|NCT01306929|69532853|FG000|Overall Study|Various|17|||
37848774|NCT01064401|69532859|FG000|Overall Study|Adverse Event|47|||
37848775|NCT01064401|69532860|FG001|Overall Study|Adverse Event|56|||
37918271|NCT00862940|69604979|FG000|Overall Study|Withdrawal by Subject|4|||
37918272|NCT00862940|69604980|FG001|Overall Study|Withdrawal by Subject|6|||
37918273|NCT00862940|69604979|FG000|Overall Study|Non-compliance|4|||
37918274|NCT00862940|69604980|FG001|Overall Study|Non-compliance|0|||
37918275|NCT00862940|69604979|FG000|Overall Study|Lost to Follow-up|0|||
37918276|NCT00862940|69604980|FG001|Overall Study|Lost to Follow-up|1|||
37918277|NCT00862940|69604979|FG000|Overall Study|Administrative or other reason(s)|4|||
37918278|NCT00862940|69604980|FG001|Overall Study|Administrative or other reason(s)|3|||
37918279|NCT00868166|69604988|FG000|Overall Study|Death|58|||
37848776|NCT01064401|69532859|FG000|Overall Study|Lack of Efficacy|46|||
37848777|NCT01064401|69532860|FG001|Overall Study|Lack of Efficacy|23|||
37848778|NCT01064401|69532859|FG000|Overall Study|Lost to Follow-up|12|||
37848779|NCT01064401|69532860|FG001|Overall Study|Lost to Follow-up|9|||
37848780|NCT01064401|69532859|FG000|Overall Study|Consent Withdrawn|98|||
37848781|NCT01064401|69532860|FG001|Overall Study|Consent Withdrawn|80|||
37918280|NCT00868166|69604989|FG001|Overall Study|Death|65|||
37918281|NCT00868166|69604988|FG000|Overall Study|Withdrawal by Subject|33|||
37918282|NCT00868166|69604989|FG001|Overall Study|Withdrawal by Subject|25|||
37918283|NCT00868166|69604988|FG000|Overall Study|Protocol Violation|1|||
37918284|NCT00868166|69604989|FG001|Overall Study|Protocol Violation|0|||
37918285|NCT00868166|69604988|FG000|Overall Study|Lost to Follow-up|1|||
37918286|NCT00868166|69604989|FG001|Overall Study|Lost to Follow-up|3|||
37918287|NCT00868166|69604988|FG000|Overall Study|Adverse Event|9|||
37918288|NCT00868166|69604989|FG001|Overall Study|Adverse Event|10|||
37918289|NCT00868166|69604988|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
37918290|NCT00868166|69604989|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
37918291|NCT00868166|69604988|FG000|Overall Study|Non-compliance with IMP|1|||
37918292|NCT00868166|69604989|FG001|Overall Study|Non-compliance with IMP|1|||
37918293|NCT00858780|69604995|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
37918294|NCT00858780|69604996|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
37918295|NCT00858780|69604997|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
37918296|NCT00858780|69604998|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
37848782|NCT01064401|69532859|FG000|Overall Study|Investigator Decision|4|||
37848783|NCT01064401|69532860|FG001|Overall Study|Investigator Decision|6|||
37918297|NCT00858780|69604999|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
38026991|NCT00090285|69711582|FG005|Extension 1|Withdrawal by Subject|0|||
38026992|NCT00090285|69711577|FG000|Extension 1|Other|0|||
38026993|NCT00090285|69711578|FG001|Extension 1|Other|0|||
38026994|NCT00090285|69711579|FG002|Extension 1|Other|4|||
38026995|NCT00090285|69711580|FG003|Extension 1|Other|0|||
38026996|NCT00090285|69711581|FG004|Extension 1|Other|0|||
38026997|NCT00090285|69711582|FG005|Extension 1|Other|0|||
38026998|NCT00090285|69711577|FG000|Extension 1|Moved|0|||
38026999|NCT00090285|69711578|FG001|Extension 1|Moved|0|||
38027000|NCT00090285|69711579|FG002|Extension 1|Moved|3|||
38027001|NCT00090285|69711580|FG003|Extension 1|Moved|0|||
38027002|NCT00090285|69711581|FG004|Extension 1|Moved|0|||
38027003|NCT00090285|69711582|FG005|Extension 1|Moved|0|||
38027004|NCT00090285|69711577|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
38027005|NCT00090285|69711578|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
38027006|NCT00090285|69711579|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
38027007|NCT00090285|69711580|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
38027008|NCT00090285|69711581|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
38027009|NCT00090285|69711582|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
38027010|NCT00090285|69711577|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
38027011|NCT00090285|69711578|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
37734953|NCT00985504|69215320|FG001|Optimization Period|Death|1|||
37848784|NCT01064401|69532859|FG000|Overall Study|Death|4|||
37848785|NCT01064401|69532860|FG001|Overall Study|Death|0|||
37918298|NCT00858780|69604995|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
37918299|NCT00858780|69604996|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
37918300|NCT00858780|69604997|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
37918301|NCT00858780|69604998|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
37918302|NCT00858780|69604999|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
37918303|NCT00858780|69604995|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
37918304|NCT00858780|69604996|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
37918305|NCT00858780|69604997|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
37918306|NCT00858780|69604998|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
37918307|NCT00858780|69604999|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
37918308|NCT00858780|69604995|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
37918309|NCT00858780|69604996|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
37918310|NCT00858780|69604997|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
37918311|NCT00858780|69604998|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
37918312|NCT00858780|69604999|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
37918313|NCT00858780|69604995|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
37918314|NCT00858780|69604996|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
38027012|NCT00090285|69711579|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
38027013|NCT00090285|69711580|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
38027014|NCT00090285|69711581|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
38027015|NCT00090285|69711582|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
37848786|NCT01064401|69532859|FG000|Overall Study|Pregnancy|4|||
37848787|NCT01064401|69532860|FG001|Overall Study|Pregnancy|7|||
37848788|NCT01064401|69532859|FG000|Overall Study|Noncompliance|7|||
37848789|NCT01064401|69532860|FG001|Overall Study|Noncompliance|8|||
37848790|NCT01064401|69532859|FG000|Overall Study|Site Closure|4|||
37848791|NCT01064401|69532860|FG001|Overall Study|Site Closure|5|||
37848792|NCT01064401|69532859|FG000|Overall Study|Other|2|||
37848793|NCT01064401|69532860|FG001|Overall Study|Other|1|||
37848794|NCT01306617|69532870|FG000|Overall Study|Adverse Event|1|||
37848795|NCT01306617|69532871|FG001|Overall Study|Adverse Event|0|||
37918315|NCT00858780|69604997|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
37918316|NCT00858780|69604998|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
37918317|NCT00858780|69604999|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
37918318|NCT00858780|69604995|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
37918319|NCT00858780|69604996|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
37918320|NCT00858780|69604997|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
37918321|NCT00858780|69604998|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
37918322|NCT00858780|69604999|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
37918323|NCT00850200|69605009|FG000|Overall Study|Physician Decision|2|||
37918324|NCT00850200|69605009|FG000|Overall Study|Did not recieve treatment|2|||
37918325|NCT00850200|69605009|FG000|Overall Study|Withdrawal by Subject|1|||
37918326|NCT00858234|69605016|FG000|Overall Study|Adverse Event|6|||
37918327|NCT00858234|69605016|FG000|Overall Study|Progressive disease|2|||
37918328|NCT00858234|69605016|FG000|Overall Study|Status unknown|1|||
38027016|NCT00090285|69711577|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
38027017|NCT00090285|69711578|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
38027018|NCT00090285|69711579|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
38027019|NCT00090285|69711580|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
38027020|NCT00090285|69711581|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
37918329|NCT00862082|69605022|FG000|Overall Study|Sponsor decision to terminate the study|5|||
37918330|NCT00862082|69605023|FG001|Overall Study|Sponsor decision to terminate the study|0|||
37918331|NCT00862082|69605022|FG000|Overall Study|Withdrawal by Subject|0|||
37918332|NCT00862082|69605023|FG001|Overall Study|Withdrawal by Subject|1|||
37918333|NCT00692770|69605038|FG000|Overall Study|Protocol Violation|2|||
37918334|NCT00692770|69605039|FG001|Overall Study|Protocol Violation|7|||
38027021|NCT00090285|69711582|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
38027022|NCT00090285|69711577|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
38027023|NCT00090285|69711578|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
38027024|NCT00090285|69711579|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
38027025|NCT00090285|69711580|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
38027026|NCT00090285|69711581|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
38027027|NCT00090285|69711582|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
38027028|NCT00070941|69711600|FG000|Overall Study|Adverse Event|10|||
38027029|NCT00070941|69711601|FG001|Overall Study|Adverse Event|8|||
38027030|NCT00070941|69711602|FG002|Overall Study|Adverse Event|4|||
38027031|NCT00070707|69711612|FG000|Overall Study|Adverse Event|1|||
38027032|NCT00070707|69711613|FG001|Overall Study|Adverse Event|2|||
38027033|NCT00070707|69711612|FG000|Overall Study|Lack of Efficacy|4|||
38027034|NCT00070707|69711613|FG001|Overall Study|Lack of Efficacy|1|||
38027035|NCT00070707|69711612|FG000|Overall Study|Protocol Violation|8|||
38027036|NCT00070707|69711613|FG001|Overall Study|Protocol Violation|4|||
38027037|NCT00070707|69711612|FG000|Overall Study|Unrelated to Study Medication|1|||
38027038|NCT00070707|69711613|FG001|Overall Study|Unrelated to Study Medication|0|||
38027039|NCT03036124|69711621|FG000|Overall Study|Lost to Follow-up|0|||
38027040|NCT03036124|69711622|FG001|Overall Study|Lost to Follow-up|2|||
38027041|NCT03036124|69711621|FG000|Overall Study|Withdrawal by Subject|5|||
37848796|NCT01306617|69532872|FG002|Overall Study|Adverse Event|0|||
37918335|NCT00692770|69605038|FG000|Overall Study|Withdrawal by Subject|97|||
37918336|NCT00692770|69605039|FG001|Overall Study|Withdrawal by Subject|36|||
37848797|NCT01306617|69532870|FG000|Overall Study|Virologic Failure|0|||
37848798|NCT01306617|69532871|FG001|Overall Study|Virologic Failure|0|||
37918337|NCT00692770|69605038|FG000|Overall Study|Adverse Event|136|||
37918338|NCT00692770|69605039|FG001|Overall Study|Adverse Event|41|||
37918339|NCT00692770|69605038|FG000|Overall Study|Death|10|||
37918340|NCT00692770|69605039|FG001|Overall Study|Death|5|||
37918341|NCT00692770|69605038|FG000|Overall Study|Lost to Follow-up|7|||
38027042|NCT03036124|69711622|FG001|Overall Study|Withdrawal by Subject|4|||
38027043|NCT00070317|69711628|FG000|Overall Study|Inevaluable (Never Treated)|1|||
38027044|NCT00070317|69711628|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
38027045|NCT00070317|69711628|FG000|Overall Study|Ineligible required test not done|1|||
38027046|NCT00070317|69711628|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
37848799|NCT01306617|69532872|FG002|Overall Study|Virologic Failure|5|||
37918342|NCT00692770|69605039|FG001|Overall Study|Lost to Follow-up|3|||
37918343|NCT00692770|69605038|FG000|Overall Study|Non-compliant with study medication|11|||
37918344|NCT00692770|69605039|FG001|Overall Study|Non-compliant with study medication|5|||
37848800|NCT01306617|69532870|FG000|Overall Study|Non-compliance|0|||
37848801|NCT01306617|69532871|FG001|Overall Study|Non-compliance|1|||
37848802|NCT01306617|69532872|FG002|Overall Study|Non-compliance|0|||
37848803|NCT01306305|69532882|FG000|Overall Study|Lost to Follow-up|1|||
37848804|NCT01306305|69532883|FG001|Overall Study|Lost to Follow-up|0|||
37848805|NCT01306305|69532882|FG000|Overall Study|Withdrew consent|1|||
37848806|NCT01306305|69532883|FG001|Overall Study|Withdrew consent|0|||
37848807|NCT01038427|69532892|FG000|Overall Study|Lost to follow up|1|||
37848808|NCT01038427|69532893|FG001|Overall Study|Lost to follow up|1|||
37848809|NCT01038427|69532894|FG002|Overall Study|Lost to follow up|0|||
37848810|NCT01038427|69532892|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
37848811|NCT01038427|69532893|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
37848812|NCT01038427|69532894|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
37848813|NCT01038427|69532892|FG000|Overall Study|Withdrew consent|0|||
37848814|NCT01038427|69532893|FG001|Overall Study|Withdrew consent|0|||
37848815|NCT01038427|69532894|FG002|Overall Study|Withdrew consent|1|||
37848816|NCT01038427|69532892|FG000|Overall Study|Adverse Event|2|||
37848817|NCT01038427|69532893|FG001|Overall Study|Adverse Event|2|||
37848818|NCT01038427|69532894|FG002|Overall Study|Adverse Event|1|||
37848819|NCT01038427|69532892|FG000|Overall Study|Enrolled in error|0|||
37848820|NCT01038427|69532893|FG001|Overall Study|Enrolled in error|1|||
37848821|NCT01038427|69532894|FG002|Overall Study|Enrolled in error|1|||
37848822|NCT01038427|69532892|FG000|Overall Study|Other|0|||
37848823|NCT01038427|69532893|FG001|Overall Study|Other|2|||
37848824|NCT01038427|69532894|FG002|Overall Study|Other|0|||
37848825|NCT01037413|69532902|FG000|Part A: Skin Testing|Adverse Event|1|||
37848826|NCT01037413|69532903|FG001|Part A: Skin Testing|Adverse Event|0|||
37848827|NCT01037413|69532902|FG000|Part A: Skin Testing|Protocol Violation|1|||
37848828|NCT01037413|69532903|FG001|Part A: Skin Testing|Protocol Violation|0|||
37848829|NCT01037413|69532902|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
37848830|NCT01037413|69532903|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
37848831|NCT01037413|69532902|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
37848832|NCT01037413|69532903|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
37848833|NCT01326845|69532918|FG000|Overall Study|Administrative Problems|5|||
37848834|NCT01326845|69532919|FG001|Overall Study|Administrative Problems|2|||
37848835|NCT01326845|69532918|FG000|Overall Study|Adverse Event|1|||
37848836|NCT01326845|69532919|FG001|Overall Study|Adverse Event|0|||
37848837|NCT01326845|69532918|FG000|Overall Study|Misisng|1|||
37848838|NCT01326845|69532919|FG001|Overall Study|Misisng|3|||
37848839|NCT01062763|69532927|FG000|Overall Study|Adverse Event|3|||
37848840|NCT01062763|69532928|FG001|Overall Study|Adverse Event|4|||
37848841|NCT01048099|69532934|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
37848842|NCT01048099|69532934|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
37848843|NCT01303965|69532942|FG000|Overall Study|Adverse Event|1|||
37848844|NCT01303965|69532943|FG001|Overall Study|Adverse Event|1|||
37848845|NCT01303965|69532942|FG000|Overall Study|Death|0|||
37848846|NCT01303965|69532943|FG001|Overall Study|Death|3|||
37848847|NCT01303965|69532942|FG000|Overall Study|Withdrawal by Subject|1|||
37848848|NCT01303965|69532943|FG001|Overall Study|Withdrawal by Subject|0|||
37848849|NCT01303965|69532942|FG000|Overall Study|Disease Progression|1|||
37848850|NCT01303965|69532943|FG001|Overall Study|Disease Progression|6|||
37848851|NCT01045993|69532953|FG000|Overall Study|Treated-later found eligibility not met|0|||
37848852|NCT01045993|69532954|FG001|Overall Study|Treated-later found eligibility not met|1|||
37848853|NCT01045993|69532955|FG002|Overall Study|Treated-later found eligibility not met|0|||
37848854|NCT01045993|69532956|FG003|Overall Study|Treated-later found eligibility not met|0|||
37848855|NCT01303419|69532966|FG000|Overall Study|Discontinuation of study|60|||
37848856|NCT01303419|69532966|FG000|Overall Study|Did not complete both imaging methods|5|||
37848857|NCT01303419|69532966|FG000|Overall Study|Did not meet all I/E after screening|31|||
37848858|NCT01326533|69532972|FG000|Overall Study|Lost to Follow-up|2|||
37848859|NCT01326533|69532973|FG001|Overall Study|Lost to Follow-up|0|||
37848860|NCT01326533|69532972|FG000|Overall Study|Withdrawal by Subject|1|||
37848861|NCT01326533|69532973|FG001|Overall Study|Withdrawal by Subject|0|||
37848862|NCT01326533|69532972|FG000|Overall Study|Adverse Event|1|||
37848863|NCT01326533|69532973|FG001|Overall Study|Adverse Event|0|||
37848864|NCT01045447|69532981|FG000|Overall Study|Adverse Event|0|||
37918345|NCT00692770|69605038|FG000|Overall Study|Progression by clinical judgment|2|||
37848865|NCT01045447|69532982|FG001|Overall Study|Adverse Event|1|||
37848866|NCT01045447|69532981|FG000|Overall Study|Lack of Efficacy|3|||
37848867|NCT01045447|69532982|FG001|Overall Study|Lack of Efficacy|1|||
37848868|NCT01045447|69532981|FG000|Overall Study|Protocol Violation|6|||
37848869|NCT01045447|69532982|FG001|Overall Study|Protocol Violation|3|||
37848870|NCT01045447|69532981|FG000|Overall Study|Withdrawal Criteria|10|||
37848871|NCT01045447|69532982|FG001|Overall Study|Withdrawal Criteria|10|||
37848872|NCT01045447|69532981|FG000|Overall Study|Unclassified|17|||
37848873|NCT01045447|69532982|FG001|Overall Study|Unclassified|13|||
37848874|NCT01301625|69532988|FG000|Overall Study|Death|5|||
37848875|NCT01301625|69532988|FG000|Overall Study|Not Due|21|||
37848876|NCT01301625|69532988|FG000|Overall Study|Expected|8|||
37848877|NCT01301625|69532988|FG000|Overall Study|Lost to Follow-up|1|||
37848878|NCT01301391|69532992|FG000|Overall Study|Death|13|||
37848879|NCT01301391|69532992|FG000|Overall Study|Lost to Follow-up|3|||
37848880|NCT01301391|69532992|FG000|Overall Study|Physician Decision|2|||
37848881|NCT01301391|69532992|FG000|Overall Study|Sponsor's decision|8|||
37848882|NCT01036321|69532998|FG000|Overall Study|Ineligible after randomization|0|||
37848883|NCT01036321|69532999|FG001|Overall Study|Ineligible after randomization|1|||
37848884|NCT01036321|69532998|FG000|Overall Study|Withdrawal by Subject|3|||
37848885|NCT01036321|69532999|FG001|Overall Study|Withdrawal by Subject|2|||
37848886|NCT01036321|69532998|FG000|Overall Study|Adverse Event|2|||
37848887|NCT01036321|69532999|FG001|Overall Study|Adverse Event|1|||
37848888|NCT01061359|69533005|FG000|Overall Study|Death|32|||
37848889|NCT01061359|69533005|FG000|Overall Study|Lost to Follow-up|1072|||
37918346|NCT00692770|69605039|FG001|Overall Study|Progression by clinical judgment|3|||
37918347|NCT00692770|69605038|FG000|Overall Study|Physician decision not protocol driven|10|||
37918348|NCT00692770|69605039|FG001|Overall Study|Physician decision not protocol driven|14|||
37918349|NCT00692770|69605038|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
37918350|NCT00692770|69605039|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
37918351|NCT00692770|69605038|FG000|Overall Study|Protocol driven decision point|3|||
37918352|NCT00692770|69605039|FG001|Overall Study|Protocol driven decision point|7|||
37918353|NCT00692770|69605038|FG000|Overall Study|Completed all planned assessments|79|||
37918354|NCT00692770|69605039|FG001|Overall Study|Completed all planned assessments|101|||
37918355|NCT00692770|69605038|FG000|Overall Study|Radiological and clinical progression|8|||
37918356|NCT00692770|69605039|FG001|Overall Study|Radiological and clinical progression|8|||
37918357|NCT00692770|69605038|FG000|Overall Study|Clinical endpoint reached|16|||
37918358|NCT00692770|69605039|FG001|Overall Study|Clinical endpoint reached|43|||
37918359|NCT00692770|69605038|FG000|Overall Study|Study terminated by sponsor|2|||
37918360|NCT00692770|69605039|FG001|Overall Study|Study terminated by sponsor|2|||
37918361|NCT00692770|69605038|FG000|Overall Study|Randomized but not treated|3|||
37918362|NCT00692770|69605039|FG001|Overall Study|Randomized but not treated|4|||
37918363|NCT00849108|69605054|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
37918364|NCT00849108|69605055|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
37918365|NCT00849108|69605054|FG000|Cohort 2 Efficacy|Adverse Event|0|||
37918366|NCT00849108|69605055|FG001|Cohort 2 Efficacy|Adverse Event|1|||
37918367|NCT00849108|69605054|FG000|Cohort 2 Efficacy|Other|0|||
37918368|NCT00849108|69605055|FG001|Cohort 2 Efficacy|Other|9|||
37918369|NCT00867308|69605065|FG000|Overall Study|Death|1|||
37918370|NCT00867308|69605066|FG001|Overall Study|Death|0|||
37918371|NCT00867308|69605065|FG000|Overall Study|Adverse Event|1|||
37848890|NCT01061359|69533005|FG000|Overall Study|Relapse|187|||
37848891|NCT01061359|69533005|FG000|Overall Study|Secondary neoplasm|11|||
37848892|NCT01301079|69533011|FG000|Overall Study|Lost to Follow-up|2|||
37848893|NCT01301079|69533012|FG001|Overall Study|Lost to Follow-up|2|||
37848894|NCT01036165|69533022|FG000|Overall Study|Adverse Event|6|||
37848895|NCT01036165|69533022|FG000|Overall Study|Lost to Follow-up|2|||
37848896|NCT01036165|69533022|FG000|Overall Study|Withdrawal by Subject|3|||
37848897|NCT01036165|69533022|FG000|Overall Study|Device Related Issues|3|||
37848898|NCT01036165|69533022|FG000|Overall Study|Problems finding proper area to inject|1|||
37848899|NCT01301001|69533026|FG000|First Intervention|Lost to Follow-up|4|||
37848900|NCT01301001|69533027|FG001|First Intervention|Lost to Follow-up|4|||
37848901|NCT01301001|69533026|FG000|First Intervention|Withdrawal by Subject|1|||
37848902|NCT01301001|69533027|FG001|First Intervention|Withdrawal by Subject|4|||
37848903|NCT01301001|69533026|FG000|First Intervention|Adverse Event|5|||
37848904|NCT01301001|69533027|FG001|First Intervention|Adverse Event|0|||
37848905|NCT01301001|69533026|FG000|First Intervention|Protocol Violation|0|||
37848906|NCT01301001|69533027|FG001|First Intervention|Protocol Violation|1|||
37848907|NCT01301001|69533026|FG000|Second Intervention|Adverse Event|2|||
37848908|NCT01301001|69533027|FG001|Second Intervention|Adverse Event|0|||
37848909|NCT01301001|69533026|FG000|Second Intervention|Withdrawal by Subject|2|||
37848910|NCT01301001|69533027|FG001|Second Intervention|Withdrawal by Subject|0|||
37918372|NCT00867308|69605066|FG001|Overall Study|Adverse Event|4|||
37918373|NCT00867308|69605065|FG000|Overall Study|Lack of Efficacy|6|||
37918374|NCT00867308|69605066|FG001|Overall Study|Lack of Efficacy|12|||
37918375|NCT00867308|69605065|FG000|Overall Study|Withdrawal by Subject|1|||
37918376|NCT00867308|69605066|FG001|Overall Study|Withdrawal by Subject|2|||
37918377|NCT00849186|69605072|FG000|Overall Study|Adverse Event|2|||
37848911|NCT01300923|69533034|FG000|Overall Study|Physician Decision|0|||
37918378|NCT00849186|69605072|FG000|Overall Study|Withdrawal by Subject|1|||
37848912|NCT01300923|69533035|FG001|Overall Study|Physician Decision|2|||
37848913|NCT01300767|69533040|FG000|Overall Study|Discomfort|2|||
37848914|NCT01300767|69533040|FG000|Overall Study|Biomicroscopy|1|||
37848915|NCT01300767|69533040|FG000|Overall Study|Unacceptable fit|1|||
37848916|NCT01300455|69533048|FG000|Washout|Withdrawal by Subject|1|||
37848917|NCT01300455|69533049|FG001|Washout|Withdrawal by Subject|0|||
37848918|NCT01107418|69533059|FG000|Overall Study|Disease Progression|45|||
37918379|NCT00849186|69605072|FG000|Overall Study|not treated|6|||
37848919|NCT01107418|69533059|FG000|Overall Study|Adverse Event|3|||
37848920|NCT01107418|69533059|FG000|Overall Study|Withdrawal by Subject|1|||
37848921|NCT01107418|69533059|FG000|Overall Study|Study Closing|1|||
37848922|NCT01107418|69533059|FG000|Overall Study|Started Other Therapy|1|||
37848923|NCT01107418|69533059|FG000|Overall Study|Entered Extension Study|1|||
37848924|NCT01101178|69533074|FG000|Period 1|Withdrawal by Subject|1|||
37918380|NCT00849186|69605072|FG000|Overall Study|Other|1|||
37918381|NCT00866918|69605079|FG000|Overall Study|Death|1|||
37918382|NCT00866918|69605080|FG001|Overall Study|Death|5|||
37918383|NCT00866918|69605079|FG000|Overall Study|Lack of Efficacy|1|||
37918384|NCT00866918|69605080|FG001|Overall Study|Lack of Efficacy|1|||
37918385|NCT00866918|69605079|FG000|Overall Study|Physician Decision|10|||
37918386|NCT00866918|69605080|FG001|Overall Study|Physician Decision|2|||
37918387|NCT00866918|69605079|FG000|Overall Study|Ineligible|2|||
37918388|NCT00866918|69605080|FG001|Overall Study|Ineligible|4|||
37918389|NCT00866918|69605079|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
37918390|NCT00866918|69605080|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
37918391|NCT00866918|69605079|FG000|Overall Study|Secondary malignancy|1|||
37918392|NCT00866918|69605080|FG001|Overall Study|Secondary malignancy|0|||
37918393|NCT03158285|69605089|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
37918394|NCT03158285|69605090|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
37918395|NCT03158285|69605091|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
37918396|NCT03158285|69605089|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
37918397|NCT03158285|69605090|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
37918398|NCT03158285|69605091|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
37918399|NCT03158285|69605089|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
38027047|NCT00070317|69711628|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
38027048|NCT03649412|69711634|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
38027049|NCT03649412|69711635|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
38027050|NCT03649412|69711634|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
38027051|NCT03649412|69711635|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
38027052|NCT03649412|69711634|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
38027053|NCT03649412|69711635|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
38027054|NCT03649412|69711634|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
38027055|NCT03649412|69711635|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
38027056|NCT03649412|69711634|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
38027057|NCT03649412|69711635|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
38027058|NCT03649412|69711634|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
37848925|NCT01101178|69533075|FG001|Period 1|Withdrawal by Subject|2|||
38027059|NCT03649412|69711635|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
38027060|NCT03587636|69711680|FG000|Overall Study|Lost to Follow-up|2|||
38027061|NCT03587636|69711681|FG001|Overall Study|Lost to Follow-up|5|||
38027062|NCT03586544|69711699|FG000|First Intervention|Adverse Event|0|||
38027063|NCT03586544|69711700|FG001|First Intervention|Adverse Event|1|||
38027064|NCT03586544|69711699|FG000|Second Intervention|Withdrawal by Subject|0|||
38027065|NCT03586544|69711700|FG001|Second Intervention|Withdrawal by Subject|1|||
38027066|NCT03585296|69711706|FG000|Overall Study|Adverse Event|1|||
38027067|NCT03585296|69711706|FG000|Overall Study|Lost to Follow-up|2|||
38027068|NCT03585296|69711706|FG000|Overall Study|Withdrawal by Subject|2|||
38027069|NCT03589768|69711714|FG000|Overall Study|Death|1|||
38027070|NCT03589768|69711715|FG001|Overall Study|Death|0|||
38027071|NCT03589768|69711716|FG002|Overall Study|Death|8|||
38027072|NCT03589768|69711717|FG003|Overall Study|Death|3|||
38027073|NCT03589768|69711714|FG000|Overall Study|Withdrawal by Subject|2|||
38027074|NCT03589768|69711715|FG001|Overall Study|Withdrawal by Subject|0|||
38027075|NCT03589768|69711716|FG002|Overall Study|Withdrawal by Subject|0|||
38027076|NCT03589768|69711717|FG003|Overall Study|Withdrawal by Subject|0|||
38027077|NCT03589768|69711714|FG000|Overall Study|Protocol Violation|1|||
38027078|NCT03589768|69711715|FG001|Overall Study|Protocol Violation|0|||
38027079|NCT03589768|69711716|FG002|Overall Study|Protocol Violation|0|||
38027080|NCT03589768|69711717|FG003|Overall Study|Protocol Violation|0|||
38027081|NCT02892422|69711727|FG000|Overall Study|Enrolled not treated|4|||
38027082|NCT02892422|69711727|FG000|Overall Study|Adverse Event|38|||
38027083|NCT02892422|69711727|FG000|Overall Study|Lack of Efficacy|32|||
37848926|NCT01101178|69533074|FG000|Period 1|Positive drug screen|1|||
37848927|NCT01101178|69533075|FG001|Period 1|Positive drug screen|1|||
38027084|NCT02892422|69711727|FG000|Overall Study|Non-compliance with study drug|11|||
38027085|NCT02892422|69711727|FG000|Overall Study|Protocol Violation|4|||
37848928|NCT01101178|69533074|FG000|Period 1|Adverse Event|2|||
38027086|NCT02892422|69711727|FG000|Overall Study|Withdrawal by Subject|56|||
37848929|NCT01101178|69533075|FG001|Period 1|Adverse Event|1|||
37848930|NCT01101178|69533074|FG000|Period 2|Withdrawal by Subject|0|||
37918400|NCT03158285|69605090|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
37918401|NCT03158285|69605091|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
37848931|NCT01101178|69533075|FG001|Period 2|Withdrawal by Subject|1|||
37918402|NCT03158285|69605089|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
37848932|NCT01101022|69533084|FG000|Overall Study|Adverse Event|6|||
37848933|NCT01101022|69533085|FG001|Overall Study|Adverse Event|2|||
37848934|NCT01101022|69533084|FG000|Overall Study|Protocol Violation|4|||
37848935|NCT01101022|69533085|FG001|Overall Study|Protocol Violation|3|||
37848936|NCT01101022|69533084|FG000|Overall Study|Withdrawal by Subject|3|||
37848937|NCT01101022|69533085|FG001|Overall Study|Withdrawal by Subject|8|||
37848938|NCT01101022|69533084|FG000|Overall Study|Lost to Follow-up|1|||
37848939|NCT01101022|69533085|FG001|Overall Study|Lost to Follow-up|4|||
37848940|NCT01101022|69533084|FG000|Overall Study|Lack of Efficacy|0|||
37848941|NCT01101022|69533085|FG001|Overall Study|Lack of Efficacy|7|||
37848942|NCT01101022|69533084|FG000|Overall Study|Sponsor decision|1|||
37848943|NCT01101022|69533085|FG001|Overall Study|Sponsor decision|1|||
37848944|NCT01101022|69533084|FG000|Overall Study|Non-compliance|1|||
37848945|NCT01101022|69533085|FG001|Overall Study|Non-compliance|0|||
37848946|NCT01101022|69533084|FG000|Overall Study|Work schedule|1|||
37918403|NCT03158285|69605090|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
37918404|NCT03158285|69605091|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
37918405|NCT03158285|69605089|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
37918406|NCT03158285|69605090|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
37918407|NCT03158285|69605091|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
37918408|NCT03158285|69605089|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
37918409|NCT03158285|69605090|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
37848947|NCT01101022|69533085|FG001|Overall Study|Work schedule|1|||
37848948|NCT01101022|69533084|FG000|Overall Study|Vacation|0|||
37848949|NCT01101022|69533085|FG001|Overall Study|Vacation|1|||
37848950|NCT01299909|69533094|FG000|Overall Study|Lost to Follow-up|22|||
37848951|NCT01299909|69533095|FG001|Overall Study|Lost to Follow-up|18|||
37848952|NCT01299909|69533096|FG002|Overall Study|Lost to Follow-up|17|||
37848953|NCT01298661|69533106|FG000|Overall Study|Withdrawal by Subject|2|||
37848954|NCT01298661|69533107|FG001|Overall Study|Withdrawal by Subject|0|||
37848955|NCT01298661|69533108|FG002|Overall Study|Withdrawal by Subject|2|||
37848956|NCT01100944|69533117|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
37848957|NCT01100944|69533118|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
37918410|NCT03158285|69605091|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
37918411|NCT03158285|69605089|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
38027087|NCT02892422|69711727|FG000|Overall Study|Lost to Follow-up|5|||
37848958|NCT01100944|69533119|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
37848959|NCT01100944|69533117|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
37848960|NCT01100944|69533118|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
37848961|NCT01100944|69533119|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
37848962|NCT01100944|69533117|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
37848963|NCT01100944|69533118|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
37848964|NCT01100944|69533119|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
37848965|NCT01100944|69533117|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
37848966|NCT01100944|69533118|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
37848967|NCT01100944|69533119|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
37848968|NCT01100320|69533140|FG000|Period 1|Withdrawal by Subject|2|||
37848969|NCT01100320|69533141|FG001|Period 1|Withdrawal by Subject|4|||
37848970|NCT01100320|69533140|FG000|Period 1|Positive Drug Screen|1|||
37848971|NCT01100320|69533141|FG001|Period 1|Positive Drug Screen|1|||
37848972|NCT01100320|69533140|FG000|Period 1|Adverse Event|2|||
37848973|NCT01100320|69533141|FG001|Period 1|Adverse Event|2|||
37848974|NCT01100320|69533140|FG000|Period 2|Withdrawal by Subject|1|||
37848975|NCT01100320|69533141|FG001|Period 2|Withdrawal by Subject|1|||
37848976|NCT01100086|69533147|FG000|Period 1|Withdrawal by Subject|1|||
37848977|NCT01100086|69533148|FG001|Period 1|Withdrawal by Subject|0|||
37848978|NCT01297959|69533156|FG000|Overall Study|Adverse Event|0|||
37848979|NCT01297959|69533157|FG001|Overall Study|Adverse Event|1|||
37848980|NCT01297959|69533156|FG000|Overall Study|Protocol Violation|2|||
38027088|NCT02892422|69711727|FG000|Overall Study|sponsor information 16159A results|21|||
37848981|NCT01297959|69533157|FG001|Overall Study|Protocol Violation|1|||
37918412|NCT03158285|69605090|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
38027089|NCT02892422|69711727|FG000|Overall Study|withdrawal of consent|13|||
37848982|NCT01297959|69533156|FG000|Overall Study|Withdrawal by Subject|5|||
37848983|NCT01297959|69533157|FG001|Overall Study|Withdrawal by Subject|4|||
37848984|NCT01297959|69533156|FG000|Overall Study|Physician Decision|0|||
37848985|NCT01297959|69533157|FG001|Overall Study|Physician Decision|1|||
37848986|NCT01297959|69533156|FG000|Overall Study|Unrelated medical illness / complication|0|||
37848987|NCT01297959|69533157|FG001|Overall Study|Unrelated medical illness / complication|2|||
37848988|NCT01297959|69533156|FG000|Overall Study|Other|13|||
38027090|NCT02892422|69711727|FG000|Overall Study|exclusion criteria met|3|||
37848989|NCT01297959|69533157|FG001|Overall Study|Other|7|||
37848990|NCT01035229|69533165|FG000|Overall Study|Adverse Event|61|||
37918413|NCT03158285|69605091|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
38027091|NCT02892422|69711727|FG000|Overall Study|moving elsewhere|4|||
37848991|NCT01035229|69533166|FG001|Overall Study|Adverse Event|14|||
37848992|NCT01035229|69533165|FG000|Overall Study|Withdrawal by Subject|20|||
37848993|NCT01035229|69533166|FG001|Overall Study|Withdrawal by Subject|7|||
37848994|NCT01035229|69533165|FG000|Overall Study|Lost to Follow-up|1|||
37848995|NCT01035229|69533166|FG001|Overall Study|Lost to Follow-up|0|||
37848996|NCT01035229|69533165|FG000|Overall Study|Administrative problems|1|||
37848997|NCT01035229|69533166|FG001|Overall Study|Administrative problems|1|||
37848998|NCT01035229|69533165|FG000|Overall Study|Death|13|||
37848999|NCT01035229|69533166|FG001|Overall Study|Death|5|||
37849000|NCT01035229|69533165|FG000|Overall Study|New cancer therapy|2|||
37849001|NCT01035229|69533166|FG001|Overall Study|New cancer therapy|0|||
37849002|NCT01035229|69533165|FG000|Overall Study|Protocol Violation|0|||
37849003|NCT01035229|69533166|FG001|Overall Study|Protocol Violation|2|||
37849004|NCT01035229|69533165|FG000|Overall Study|Sponsor's decision to end study|3|||
37849005|NCT01035229|69533166|FG001|Overall Study|Sponsor's decision to end study|3|||
37849006|NCT01035229|69533165|FG000|Overall Study|Disease Progression|261|||
37849007|NCT01035229|69533166|FG001|Overall Study|Disease Progression|152|||
37849008|NCT01106404|69533176|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
37849009|NCT01106404|69533177|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
37849010|NCT01106404|69533176|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
37849011|NCT01106404|69533177|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
37849012|NCT01106404|69533176|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
37849013|NCT01106404|69533177|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
37849014|NCT01106404|69533176|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
37849015|NCT01106404|69533177|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
37918414|NCT03158285|69605089|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
37918415|NCT03158285|69605090|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
37918416|NCT03158285|69605091|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
37918417|NCT03158285|69605089|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
37918418|NCT03158285|69605090|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
37918419|NCT03158285|69605091|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
37918420|NCT03158285|69605089|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
37918421|NCT03158285|69605090|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
37918422|NCT03158285|69605091|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
37918423|NCT03158285|69605089|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
37918424|NCT03158285|69605090|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
37918425|NCT03158285|69605091|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
37918426|NCT03158285|69605089|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
37849016|NCT01059799|69533191|FG000|Overall Study|Adverse Event|2|||
37849017|NCT01059799|69533192|FG001|Overall Study|Adverse Event|3|||
37849018|NCT01059799|69533191|FG000|Overall Study|Lack of Efficacy|1|||
37849019|NCT01059799|69533192|FG001|Overall Study|Lack of Efficacy|0|||
37849020|NCT01059799|69533191|FG000|Overall Study|Protocol Violation|3|||
37849021|NCT01059799|69533192|FG001|Overall Study|Protocol Violation|2|||
37849022|NCT01059799|69533191|FG000|Overall Study|Withdrawal criteria|13|||
37849023|NCT01059799|69533192|FG001|Overall Study|Withdrawal criteria|2|||
37918427|NCT03158285|69605090|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
37734954|NCT00985504|69215319|FG000|Optimization Period|Lack of Efficacy|5|||
37734955|NCT00985504|69215320|FG001|Optimization Period|Lack of Efficacy|3|||
37849024|NCT01059799|69533191|FG000|Overall Study|Other|12|||
37849025|NCT01059799|69533192|FG001|Overall Study|Other|3|||
37849026|NCT01106248|69533198|FG000|Overall Study|Adverse Event|1|||
37849027|NCT01106248|69533198|FG000|Overall Study|Administrative|2|||
37849028|NCT01059175|69533204|FG000|Overall Study|Death|17|||
37849029|NCT01059175|69533205|FG001|Overall Study|Death|17|||
37849030|NCT01059175|69533204|FG000|Overall Study|Adverse Event|4|||
37849031|NCT01059175|69533205|FG001|Overall Study|Adverse Event|2|||
37849032|NCT01059175|69533204|FG000|Overall Study|Lost to Follow-up|0|||
37849033|NCT01059175|69533205|FG001|Overall Study|Lost to Follow-up|1|||
37849034|NCT01297491|69533213|FG000|Overall Study|Adverse Event|11|||
37849035|NCT01297491|69533214|FG001|Overall Study|Adverse Event|6|||
37849036|NCT01297491|69533213|FG000|Overall Study|Physician Decision|3|||
37849037|NCT01297491|69533214|FG001|Overall Study|Physician Decision|2|||
37849038|NCT01297491|69533213|FG000|Overall Study|Progressive disease|11|||
37849039|NCT01297491|69533214|FG001|Overall Study|Progressive disease|20|||
37849040|NCT01297491|69533213|FG000|Overall Study|Patient/Guardian decision|3|||
37849041|NCT01297491|69533214|FG001|Overall Study|Patient/Guardian decision|4|||
37918428|NCT03158285|69605091|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
37918429|NCT03158285|69605089|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
37918430|NCT03158285|69605090|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
37849042|NCT01297491|69533213|FG000|Overall Study|Death|2|||
37849043|NCT01297491|69533214|FG001|Overall Study|Death|1|||
37734956|NCT00985504|69215319|FG000|Optimization Period|Lost to Follow-up|0|||
37849044|NCT01106092|69533224|FG000|Overall Study|Withdrawal by Subject|0|||
37849045|NCT01106092|69533225|FG001|Overall Study|Withdrawal by Subject|0|||
37849046|NCT01106092|69533226|FG002|Overall Study|Withdrawal by Subject|0|||
37849047|NCT01106092|69533227|FG003|Overall Study|Withdrawal by Subject|1|||
37849048|NCT01097668|69533239|FG000|Overall Study|Withdrawal by Subject|1|||
37849049|NCT01097668|69533240|FG001|Overall Study|Withdrawal by Subject|2|||
37849050|NCT01097668|69533239|FG000|Overall Study|Lost to Follow-up|1|||
37849051|NCT01097668|69533240|FG001|Overall Study|Lost to Follow-up|0|||
37849052|NCT01325207|69533256|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
37849053|NCT01325207|69533257|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
37849054|NCT01325207|69533258|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
37849055|NCT01325207|69533259|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
37849056|NCT01325207|69533260|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
37849057|NCT01325207|69533261|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
37849058|NCT01325207|69533256|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
37849059|NCT01325207|69533257|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
37849060|NCT01325207|69533258|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
37849061|NCT01325207|69533259|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
37849062|NCT01325207|69533260|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
37849063|NCT01325207|69533261|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
37918431|NCT03158285|69605091|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
37918432|NCT03158285|69605089|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
37918433|NCT03158285|69605090|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
37918434|NCT03158285|69605091|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
37918435|NCT03158285|69605089|FG000|Active Treatment Period: Week 52-100|Death|1|||
37918436|NCT03158285|69605090|FG001|Active Treatment Period: Week 52-100|Death|0|||
37918437|NCT03158285|69605091|FG002|Active Treatment Period: Week 52-100|Death|0|||
37918438|NCT03158285|69605089|FG000|Active Treatment Period: Week 52-100|Other|4|||
37918439|NCT03158285|69605090|FG001|Active Treatment Period: Week 52-100|Other|1|||
37918440|NCT03158285|69605091|FG002|Active Treatment Period: Week 52-100|Other|0|||
38027092|NCT02892422|69711727|FG000|Overall Study|non-compliance|10|||
37734957|NCT00985504|69215320|FG001|Optimization Period|Lost to Follow-up|1|||
37734958|NCT00985504|69215319|FG000|Optimization Period|Physician Decision|1|||
37734959|NCT00985504|69215320|FG001|Optimization Period|Physician Decision|0|||
37734960|NCT00985504|69215319|FG000|Optimization Period|Protocol Violation|3|||
37734961|NCT00985504|69215320|FG001|Optimization Period|Protocol Violation|1|||
37849064|NCT01325207|69533256|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
37849065|NCT01325207|69533257|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
37849066|NCT01325207|69533258|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
37849067|NCT01325207|69533259|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
37734962|NCT00985504|69215319|FG000|Optimization Period|Withdrawal by Subject|10|||
37734963|NCT00985504|69215320|FG001|Optimization Period|Withdrawal by Subject|8|||
37734964|NCT00985426|69215328|FG000|Overall Study|Adverse Event|0|||
37734965|NCT00985426|69215329|FG001|Overall Study|Adverse Event|1|||
37734966|NCT00985426|69215328|FG000|Overall Study|Subject Non-Compliance|3|||
37734967|NCT00985426|69215329|FG001|Overall Study|Subject Non-Compliance|3|||
37734968|NCT00985426|69215328|FG000|Overall Study|Withdrawal by Subject|12|||
37849068|NCT01325207|69533260|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
37849069|NCT01325207|69533261|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
37849070|NCT01325207|69533256|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
37918441|NCT00861692|69605104|FG000|Overall Study|Death|6|||
37849071|NCT01325207|69533257|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
37849072|NCT01325207|69533258|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
37849073|NCT01325207|69533259|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
37918442|NCT00602927|69605110|FG000|Period 1: 13 Days|Protocol Violation|2|||
37918443|NCT00602927|69605111|FG001|Period 1: 13 Days|Protocol Violation|4|||
38027093|NCT02892422|69711727|FG000|Overall Study|patient legally incapable|1|||
37918444|NCT00602927|69605110|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
37918445|NCT00602927|69605111|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
37849074|NCT01325207|69533260|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
37849075|NCT01325207|69533261|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
37849076|NCT01325207|69533256|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
37849077|NCT01325207|69533257|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
37849078|NCT01325207|69533258|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
37849079|NCT01325207|69533259|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
37849080|NCT01325207|69533260|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
37849081|NCT01325207|69533261|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
37849082|NCT01325207|69533256|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
37849083|NCT01325207|69533257|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
37849084|NCT01325207|69533258|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
37849085|NCT01325207|69533259|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
37918446|NCT00602927|69605110|FG000|Period 1: 13 Days|Time|1|||
37918447|NCT00602927|69605111|FG001|Period 1: 13 Days|Time|0|||
37918448|NCT00602927|69605110|FG000|Period 1: 13 Days|Claustrophobia|0|||
37918449|NCT00602927|69605111|FG001|Period 1: 13 Days|Claustrophobia|1|||
37918450|NCT00602927|69605110|FG000|Period 2: 14 Days|Protocol Violation|0|||
37918451|NCT00602927|69605111|FG001|Period 2: 14 Days|Protocol Violation|2|||
37918452|NCT00602927|69605110|FG000|Period 3: 13 Days|Protocol Violation|0|||
37918453|NCT00602927|69605111|FG001|Period 3: 13 Days|Protocol Violation|1|||
37918454|NCT00602927|69605110|FG000|Period 3: 13 Days|MRI data quality|2|||
37918455|NCT00602927|69605111|FG001|Period 3: 13 Days|MRI data quality|2|||
37918456|NCT00602537|69605119|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
37849086|NCT01325207|69533260|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
37918457|NCT00602537|69605120|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
37918458|NCT00602537|69605119|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
37918459|NCT00602537|69605120|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
37918460|NCT00602537|69605119|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
37918461|NCT00602537|69605120|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
37918462|NCT00602537|69605119|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
37918463|NCT00602537|69605120|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
37918464|NCT00602537|69605119|FG000|Follow Up Study Comparison|Adverse Event|1|||
37918465|NCT00602537|69605120|FG001|Follow Up Study Comparison|Adverse Event|0|||
37918466|NCT00602537|69605119|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
37918467|NCT00602537|69605120|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
37918468|NCT00602537|69605119|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
37918469|NCT00602537|69605120|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
37918470|NCT00861614|69605128|FG000|Overall Study|Disease Progression|182|||
37918471|NCT00861614|69605129|FG001|Overall Study|Disease Progression|263|||
37918472|NCT00861614|69605128|FG000|Overall Study|Study Drug Toxicity|79|||
37918473|NCT00861614|69605129|FG001|Overall Study|Study Drug Toxicity|6|||
37918474|NCT00861614|69605128|FG000|Overall Study|Death|32|||
37918475|NCT00861614|69605129|FG001|Overall Study|Death|19|||
37918476|NCT00861614|69605128|FG000|Overall Study|Adverse Event|27|||
37918477|NCT00861614|69605129|FG001|Overall Study|Adverse Event|23|||
37918478|NCT00861614|69605128|FG000|Overall Study|Withdrawal by Subject|34|||
37918479|NCT00861614|69605129|FG001|Overall Study|Withdrawal by Subject|35|||
37918480|NCT00861614|69605128|FG000|Overall Study|Other|17|||
37918481|NCT00861614|69605129|FG001|Overall Study|Other|22|||
37918482|NCT00485173|69605137|FG000|Overall Study|Death|4|||
37918483|NCT00485173|69605138|FG001|Overall Study|Death|3|||
37918484|NCT00485173|69605137|FG000|Overall Study|Lost to Follow-up|32|||
37849087|NCT01325207|69533261|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
37849088|NCT01325207|69533256|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
37849089|NCT01325207|69533257|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
37849090|NCT01325207|69533258|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
37849091|NCT01325207|69533259|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
37849092|NCT01325207|69533260|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
37849093|NCT01325207|69533261|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
37849094|NCT01324349|69533278|FG000|Overall Study|Death|1|||
37849095|NCT01324349|69533279|FG001|Overall Study|Death|1|||
37849096|NCT01324349|69533278|FG000|Overall Study|Withdrawal by Subject|0|||
37849097|NCT01324349|69533279|FG001|Overall Study|Withdrawal by Subject|1|||
37849098|NCT01095250|69533289|FG000|Overall Study|administrative reasons|8|||
37849099|NCT01095250|69533290|FG001|Overall Study|administrative reasons|10|||
37849100|NCT01095250|69533291|FG002|Overall Study|administrative reasons|7|||
37849101|NCT01095250|69533292|FG003|Overall Study|administrative reasons|5|||
37918485|NCT00485173|69605138|FG001|Overall Study|Lost to Follow-up|61|||
37849102|NCT01095250|69533289|FG000|Overall Study|Withdrawal by Subject|0|||
37849103|NCT01095250|69533290|FG001|Overall Study|Withdrawal by Subject|0|||
37918486|NCT00495469|69605151|FG000|Overall Study|Adverse Event|0|||
37918487|NCT00495469|69605152|FG001|Overall Study|Adverse Event|1|||
37918488|NCT00495469|69605153|FG002|Overall Study|Adverse Event|3|||
37849104|NCT01095250|69533291|FG002|Overall Study|Withdrawal by Subject|1|||
37849105|NCT01095250|69533292|FG003|Overall Study|Withdrawal by Subject|0|||
37849106|NCT01324271|69533302|FG000|Overall Study|Lost to Follow-up|3|||
37849107|NCT01324271|69533303|FG001|Overall Study|Lost to Follow-up|0|||
37849108|NCT01324271|69533302|FG000|Overall Study|Physician Decision|1|||
37849109|NCT01324271|69533303|FG001|Overall Study|Physician Decision|0|||
37849110|NCT01095094|69533309|FG000|Overall Study|Withdrawal by Subject|1|||
37849111|NCT01095094|69533309|FG000|Overall Study|Death|1|||
37849112|NCT01095094|69533309|FG000|Overall Study|Physician Decision|1|||
37849113|NCT01323647|69533315|FG000|Overall Study|Migrated/moved from study area|2|||
37849114|NCT01323647|69533316|FG001|Overall Study|Migrated/moved from study area|0|||
37849115|NCT01323647|69533315|FG000|Overall Study|Withdrawal by Subject|5|||
37849116|NCT01323647|69533316|FG001|Overall Study|Withdrawal by Subject|0|||
37849117|NCT01323647|69533315|FG000|Overall Study|Lost to Follow-up|2|||
37849118|NCT01323647|69533316|FG001|Overall Study|Lost to Follow-up|0|||
37849119|NCT01094782|69533328|FG000|Overall Study|Withdrawal by Subject|5|||
37849120|NCT01094782|69533329|FG001|Overall Study|Withdrawal by Subject|5|||
37849121|NCT01094782|69533330|FG002|Overall Study|Withdrawal by Subject|1|||
37849122|NCT01094782|69533331|FG003|Overall Study|Withdrawal by Subject|5|||
37849123|NCT01094782|69533332|FG004|Overall Study|Withdrawal by Subject|5|||
37849124|NCT01094782|69533333|FG005|Overall Study|Withdrawal by Subject|0|||
37849125|NCT01094782|69533328|FG000|Overall Study|Lost to Follow-up|1|||
37849126|NCT01094782|69533329|FG001|Overall Study|Lost to Follow-up|0|||
37849127|NCT01094782|69533330|FG002|Overall Study|Lost to Follow-up|0|||
37849128|NCT01094782|69533331|FG003|Overall Study|Lost to Follow-up|2|||
37849129|NCT01094782|69533332|FG004|Overall Study|Lost to Follow-up|1|||
37849130|NCT01094782|69533333|FG005|Overall Study|Lost to Follow-up|4|||
37849131|NCT01094782|69533328|FG000|Overall Study|Positive Drug Screen|2|||
37849132|NCT01094782|69533329|FG001|Overall Study|Positive Drug Screen|2|||
37849133|NCT01094782|69533330|FG002|Overall Study|Positive Drug Screen|1|||
37849134|NCT01094782|69533331|FG003|Overall Study|Positive Drug Screen|1|||
37849135|NCT01094782|69533332|FG004|Overall Study|Positive Drug Screen|3|||
37849136|NCT01094782|69533333|FG005|Overall Study|Positive Drug Screen|2|||
37849137|NCT01094782|69533328|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
37918489|NCT00495469|69605154|FG003|Overall Study|Adverse Event|0|||
37918490|NCT00495469|69605155|FG004|Overall Study|Adverse Event|1|||
37918491|NCT00495469|69605156|FG005|Overall Study|Adverse Event|1|||
37918492|NCT00495469|69605157|FG006|Overall Study|Adverse Event|1|||
37918493|NCT00495469|69605151|FG000|Overall Study|Lost to Follow-up|1|||
37918494|NCT00495469|69605152|FG001|Overall Study|Lost to Follow-up|1|||
37918495|NCT00495469|69605153|FG002|Overall Study|Lost to Follow-up|3|||
37918496|NCT00495469|69605154|FG003|Overall Study|Lost to Follow-up|1|||
38027094|NCT02892422|69711727|FG000|Overall Study|patient decision|7|||
38027095|NCT02892422|69711727|FG000|Overall Study|Investigator decision|1|||
38027096|NCT03571646|69711733|FG000|Overall Study|Adverse Event|1|||
37849138|NCT01094782|69533329|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
37849139|NCT01094782|69533330|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
37849140|NCT01094782|69533331|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
37849141|NCT01094782|69533332|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
37849142|NCT01094782|69533333|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
37849143|NCT01094782|69533328|FG000|Overall Study|Unable to Complete Questionnaires|0|||
37849144|NCT01094782|69533329|FG001|Overall Study|Unable to Complete Questionnaires|1|||
37849145|NCT01094782|69533330|FG002|Overall Study|Unable to Complete Questionnaires|0|||
37849146|NCT01094782|69533331|FG003|Overall Study|Unable to Complete Questionnaires|0|||
37849147|NCT01094782|69533332|FG004|Overall Study|Unable to Complete Questionnaires|0|||
37849148|NCT01094782|69533333|FG005|Overall Study|Unable to Complete Questionnaires|0|||
37849149|NCT01094782|69533328|FG000|Overall Study|Healthy Subject Had Pain|0|||
37849150|NCT01094782|69533329|FG001|Overall Study|Healthy Subject Had Pain|1|||
37849151|NCT01094782|69533330|FG002|Overall Study|Healthy Subject Had Pain|0|||
37849152|NCT01094782|69533331|FG003|Overall Study|Healthy Subject Had Pain|0|||
37849153|NCT01094782|69533332|FG004|Overall Study|Healthy Subject Had Pain|0|||
37918497|NCT00495469|69605155|FG004|Overall Study|Lost to Follow-up|0|||
37918498|NCT00495469|69605156|FG005|Overall Study|Lost to Follow-up|0|||
38027097|NCT03571646|69711734|FG001|Overall Study|Adverse Event|0|||
37849154|NCT01094782|69533333|FG005|Overall Study|Healthy Subject Had Pain|0|||
37849155|NCT01094782|69533328|FG000|Overall Study|Hypertension|0|||
37849156|NCT01094782|69533329|FG001|Overall Study|Hypertension|0|||
37849157|NCT01094782|69533330|FG002|Overall Study|Hypertension|1|||
37849158|NCT01094782|69533331|FG003|Overall Study|Hypertension|0|||
37849159|NCT01094782|69533332|FG004|Overall Study|Hypertension|0|||
37918499|NCT00495469|69605157|FG006|Overall Study|Lost to Follow-up|0|||
37849160|NCT01094782|69533333|FG005|Overall Study|Hypertension|0|||
37849161|NCT01094782|69533328|FG000|Overall Study|Wrong Pain Condition|0|||
37849162|NCT01094782|69533329|FG001|Overall Study|Wrong Pain Condition|0|||
37849163|NCT01094782|69533330|FG002|Overall Study|Wrong Pain Condition|0|||
37918500|NCT00495469|69605151|FG000|Overall Study|Protocol Violation|0|||
37918501|NCT00495469|69605152|FG001|Overall Study|Protocol Violation|0|||
37849164|NCT01094782|69533331|FG003|Overall Study|Wrong Pain Condition|2|||
37849165|NCT01094782|69533332|FG004|Overall Study|Wrong Pain Condition|1|||
37849166|NCT01094782|69533333|FG005|Overall Study|Wrong Pain Condition|1|||
37849167|NCT01094782|69533328|FG000|Overall Study|Recent Interventional Injection|0|||
37849168|NCT01094782|69533329|FG001|Overall Study|Recent Interventional Injection|0|||
37849169|NCT01094782|69533330|FG002|Overall Study|Recent Interventional Injection|0|||
37849170|NCT01094782|69533331|FG003|Overall Study|Recent Interventional Injection|0|||
37849171|NCT01094782|69533332|FG004|Overall Study|Recent Interventional Injection|0|||
37849172|NCT01094782|69533333|FG005|Overall Study|Recent Interventional Injection|1|||
37849173|NCT01094782|69533328|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
37918502|NCT00495469|69605153|FG002|Overall Study|Protocol Violation|0|||
37918503|NCT00495469|69605154|FG003|Overall Study|Protocol Violation|0|||
37918504|NCT00495469|69605155|FG004|Overall Study|Protocol Violation|1|||
37918505|NCT00495469|69605156|FG005|Overall Study|Protocol Violation|2|||
37918506|NCT00495469|69605157|FG006|Overall Study|Protocol Violation|0|||
37918507|NCT00495469|69605151|FG000|Overall Study|Withdrawal by Subject|5|||
37849174|NCT01094782|69533329|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
37849175|NCT01094782|69533330|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
37849176|NCT01094782|69533331|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
37849177|NCT01094782|69533332|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
37849178|NCT01094782|69533333|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
37849179|NCT01094782|69533328|FG000|Overall Study|Noncompliance With Study Schedule|0|||
37849180|NCT01094782|69533329|FG001|Overall Study|Noncompliance With Study Schedule|0|||
37849181|NCT01094782|69533330|FG002|Overall Study|Noncompliance With Study Schedule|0|||
37849182|NCT01094782|69533331|FG003|Overall Study|Noncompliance With Study Schedule|1|||
37849183|NCT01094782|69533332|FG004|Overall Study|Noncompliance With Study Schedule|0|||
37849184|NCT01094782|69533333|FG005|Overall Study|Noncompliance With Study Schedule|0|||
37849185|NCT01097044|69533349|FG000|Overall Study|Withdrawal by Subject|4|||
37849186|NCT01097044|69533350|FG001|Overall Study|Withdrawal by Subject|4|||
37849187|NCT01097044|69533349|FG000|Overall Study|Lost to Follow-up|1|||
37849188|NCT01097044|69533350|FG001|Overall Study|Lost to Follow-up|0|||
37849189|NCT01097044|69533349|FG000|Overall Study|Withdrawal by Sponsor|0|||
37849190|NCT01097044|69533350|FG001|Overall Study|Withdrawal by Sponsor|1|||
37849191|NCT01322009|69533360|FG000|Overall Study|Death|0|||
37918508|NCT00495469|69605152|FG001|Overall Study|Withdrawal by Subject|3|||
37918509|NCT00495469|69605153|FG002|Overall Study|Withdrawal by Subject|1|||
37918510|NCT00495469|69605154|FG003|Overall Study|Withdrawal by Subject|3|||
37918511|NCT00495469|69605155|FG004|Overall Study|Withdrawal by Subject|3|||
37918512|NCT00495469|69605156|FG005|Overall Study|Withdrawal by Subject|2|||
37918513|NCT00495469|69605157|FG006|Overall Study|Withdrawal by Subject|3|||
37849192|NCT01322009|69533361|FG001|Overall Study|Death|1|||
37918514|NCT00495469|69605151|FG000|Overall Study|Lack of Efficacy|0|||
37918515|NCT00495469|69605152|FG001|Overall Study|Lack of Efficacy|0|||
37918516|NCT00495469|69605153|FG002|Overall Study|Lack of Efficacy|0|||
37918517|NCT00495469|69605154|FG003|Overall Study|Lack of Efficacy|0|||
37849193|NCT01322009|69533360|FG000|Overall Study|Adverse Event|0|||
37849194|NCT01322009|69533361|FG001|Overall Study|Adverse Event|1|||
37849195|NCT01322009|69533360|FG000|Overall Study|ng tube discontinued|0|||
37849196|NCT01322009|69533361|FG001|Overall Study|ng tube discontinued|1|||
37849197|NCT01321697|69533367|FG000|Overall Study|Study Terminated|7|||
37849198|NCT01320683|69533371|FG000|Overall Study|Positive antibody response|1|||
37849199|NCT01320293|69533375|FG000|Overall Study|Lack of Efficacy|1|||
37849200|NCT01320293|69533375|FG000|Overall Study|Adverse Event|1|||
37849201|NCT01318811|69533381|FG000|Overall Study|Physician Decision|1|||
37849202|NCT01318811|69533382|FG001|Overall Study|Physician Decision|1|||
37849203|NCT01318811|69533381|FG000|Overall Study|CRRT stopped for head CT|0|||
37849204|NCT01318811|69533382|FG001|Overall Study|CRRT stopped for head CT|1|||
37849205|NCT01318811|69533381|FG000|Overall Study|Death|0|||
37849206|NCT01318811|69533382|FG001|Overall Study|Death|1|||
37849207|NCT01318811|69533381|FG000|Overall Study|CRRT stopped for head MRI|0|||
37849208|NCT01318811|69533382|FG001|Overall Study|CRRT stopped for head MRI|1|||
37849209|NCT01093846|69533391|FG000|Overall Study|Adverse Event|0|||
37849210|NCT01093846|69533392|FG001|Overall Study|Adverse Event|0|||
37918518|NCT00495469|69605155|FG004|Overall Study|Lack of Efficacy|0|||
37849211|NCT01093846|69533393|FG002|Overall Study|Adverse Event|1|||
37849212|NCT01093846|69533391|FG000|Overall Study|Lack of Efficacy|0|||
37849213|NCT01093846|69533392|FG001|Overall Study|Lack of Efficacy|0|||
37849214|NCT01093846|69533393|FG002|Overall Study|Lack of Efficacy|4|||
37849215|NCT01093846|69533391|FG000|Overall Study|Condition no longer required study drug|1|||
37849216|NCT01093846|69533392|FG001|Overall Study|Condition no longer required study drug|1|||
37849217|NCT01093846|69533393|FG002|Overall Study|Condition no longer required study drug|1|||
37849218|NCT01093846|69533391|FG000|Overall Study|Administrative Problems|18|||
37918519|NCT00495469|69605156|FG005|Overall Study|Lack of Efficacy|0|||
37918520|NCT00495469|69605157|FG006|Overall Study|Lack of Efficacy|1|||
37918521|NCT00495469|69605151|FG000|Overall Study|Liver function test abnormality|0|||
37849219|NCT01093846|69533392|FG001|Overall Study|Administrative Problems|17|||
37849220|NCT01093846|69533393|FG002|Overall Study|Administrative Problems|15|||
37849221|NCT01315847|69533401|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
37849222|NCT01315847|69533402|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
37849223|NCT01315847|69533401|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
37849224|NCT01315847|69533402|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
37849225|NCT01093534|69533411|FG000|Overall Study|Adverse Event|2|||
37849226|NCT01093534|69533412|FG001|Overall Study|Adverse Event|5|||
37849227|NCT01093534|69533413|FG002|Overall Study|Adverse Event|2|||
37849228|NCT01093534|69533411|FG000|Overall Study|Lack of Efficacy|2|||
37849229|NCT01093534|69533412|FG001|Overall Study|Lack of Efficacy|1|||
37849230|NCT01093534|69533413|FG002|Overall Study|Lack of Efficacy|1|||
37849231|NCT01093534|69533411|FG000|Overall Study|Withdrawal by Subject|5|||
37849232|NCT01093534|69533412|FG001|Overall Study|Withdrawal by Subject|7|||
37849233|NCT01093534|69533413|FG002|Overall Study|Withdrawal by Subject|2|||
37849234|NCT01093534|69533411|FG000|Overall Study|Other|1|||
37849235|NCT01093534|69533412|FG001|Overall Study|Other|3|||
37849236|NCT01093534|69533413|FG002|Overall Study|Other|4|||
37849237|NCT01314911|69533424|FG000|Overall Study|Lost to Follow-up|3|||
37849238|NCT01314911|69533425|FG001|Overall Study|Lost to Follow-up|2|||
37849239|NCT01314911|69533424|FG000|Overall Study|Withdrawal by Subject|1|||
37849240|NCT01314911|69533425|FG001|Overall Study|Withdrawal by Subject|3|||
37849241|NCT01314911|69533424|FG000|Overall Study|Received Non-randomized Study Drug|0|||
37849242|NCT01314911|69533425|FG001|Overall Study|Received Non-randomized Study Drug|1|||
37849243|NCT01314911|69533424|FG000|Overall Study|Never Started Treatment|1|||
37849244|NCT01314911|69533425|FG001|Overall Study|Never Started Treatment|0|||
37849245|NCT01093222|69533431|FG000|Overall Study|Ineligible|6|||
37849246|NCT01093222|69533431|FG000|Overall Study|Adverse Event|7|||
37849247|NCT01093222|69533431|FG000|Overall Study|Progression/relapse|24|||
37849248|NCT01093222|69533431|FG000|Overall Study|Death|2|||
37918522|NCT00495469|69605152|FG001|Overall Study|Liver function test abnormality|1|||
37918523|NCT00495469|69605153|FG002|Overall Study|Liver function test abnormality|0|||
37918524|NCT00495469|69605154|FG003|Overall Study|Liver function test abnormality|0|||
37918525|NCT00495469|69605155|FG004|Overall Study|Liver function test abnormality|0|||
37918526|NCT00495469|69605156|FG005|Overall Study|Liver function test abnormality|0|||
37918527|NCT00495469|69605157|FG006|Overall Study|Liver function test abnormality|0|||
37918528|NCT00495469|69605151|FG000|Overall Study|ST depression at randomisation in ECG|0|||
37918529|NCT00495469|69605152|FG001|Overall Study|ST depression at randomisation in ECG|1|||
37918530|NCT00495469|69605153|FG002|Overall Study|ST depression at randomisation in ECG|0|||
37918531|NCT00495469|69605154|FG003|Overall Study|ST depression at randomisation in ECG|0|||
37918532|NCT00495469|69605155|FG004|Overall Study|ST depression at randomisation in ECG|0|||
37918533|NCT00495469|69605156|FG005|Overall Study|ST depression at randomisation in ECG|0|||
37918534|NCT00495469|69605157|FG006|Overall Study|ST depression at randomisation in ECG|0|||
37918535|NCT00861380|69605187|FG000|Overall Study|Withdrawal Information not recorded|8427|||
37918536|NCT00861380|69605188|FG001|Overall Study|Withdrawal Information not recorded|9112|||
37918537|NCT00861380|69605189|FG002|Overall Study|Withdrawal Information not recorded|8872|||
37918538|NCT00861380|69605190|FG003|Overall Study|Withdrawal Information not recorded|3689|||
37918539|NCT00861380|69605191|FG004|Overall Study|Withdrawal Information not recorded|1812|||
37918540|NCT00861380|69605192|FG005|Overall Study|Withdrawal Information not recorded|6249|||
37918541|NCT00861380|69605193|FG006|Overall Study|Withdrawal Information not recorded|3020|||
37918542|NCT00495391|69605228|FG000|Overall Study|Lack of Efficacy|34|||
37918543|NCT00495391|69605229|FG001|Overall Study|Lack of Efficacy|18|||
37918544|NCT00495391|69605228|FG000|Overall Study|Withdrawal by Subject|2|||
37918545|NCT00495391|69605229|FG001|Overall Study|Withdrawal by Subject|3|||
37918546|NCT00869960|69605235|FG000|Overall Study|Lost to Follow-up|2|||
37918547|NCT00494299|69605241|FG000|Overall Study|Adverse Event|93|||
37918548|NCT00494299|69605242|FG001|Overall Study|Adverse Event|13|||
38027098|NCT03571646|69711733|FG000|Overall Study|Withdrawal by Subject|1|||
37918549|NCT00494299|69605241|FG000|Overall Study|Lost to Follow-up|1|||
38027099|NCT03571646|69711734|FG001|Overall Study|Withdrawal by Subject|1|||
38027100|NCT03645434|69711740|FG000|Period 1|Adverse Event|0|||
38027101|NCT03645434|69711741|FG001|Period 1|Adverse Event|0|||
37849249|NCT01093222|69533431|FG000|Overall Study|Not protocol specified|1|||
37849250|NCT01313663|69533437|FG000|Overall Study|Study Closed/Terminated|2|||
37849251|NCT01313663|69533438|FG001|Overall Study|Study Closed/Terminated|4|||
37849252|NCT01313663|69533437|FG000|Overall Study|Lost to Follow-up|0|||
37849253|NCT01313663|69533438|FG001|Overall Study|Lost to Follow-up|1|||
37849254|NCT01313663|69533437|FG000|Overall Study|Physician Decision|0|||
37849255|NCT01313663|69533438|FG001|Overall Study|Physician Decision|2|||
37849256|NCT01313663|69533437|FG000|Overall Study|Withdrawal by Subject|2|||
38027102|NCT03645434|69711742|FG002|Period 1|Adverse Event|0|||
37849257|NCT01313663|69533438|FG001|Overall Study|Withdrawal by Subject|1|||
37849258|NCT01092832|69533446|FG000|Overall Study|Other|1|||
37849259|NCT01092832|69533447|FG001|Overall Study|Other|0|||
37849260|NCT01313273|69533455|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
37849261|NCT01313273|69533456|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
37849262|NCT01313273|69533455|FG000|Overall Study|Withdrawal by Subject|1|||
37849263|NCT01313273|69533456|FG001|Overall Study|Withdrawal by Subject|0|||
37849264|NCT01313273|69533455|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
37849265|NCT01313273|69533456|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
37849266|NCT01091974|69533466|FG000|Overall Study|Did not start intervention|3|||
37849267|NCT01091974|69533467|FG001|Overall Study|Did not start intervention|1|||
37849268|NCT01091974|69533468|FG002|Overall Study|Did not start intervention|3|||
37849269|NCT01091974|69533469|FG003|Overall Study|Did not start intervention|1|||
37849270|NCT01091974|69533466|FG000|Overall Study|resumed sleep medication|0|||
37849271|NCT01091974|69533467|FG001|Overall Study|resumed sleep medication|0|||
37918550|NCT00494299|69605242|FG001|Overall Study|Lost to Follow-up|0|||
37918551|NCT00494299|69605241|FG000|Overall Study|Physician Decision|0|||
37849272|NCT01091974|69533468|FG002|Overall Study|resumed sleep medication|1|||
37849273|NCT01091974|69533469|FG003|Overall Study|resumed sleep medication|2|||
37849274|NCT01091974|69533466|FG000|Overall Study|Withdrawal by Subject|1|||
37849275|NCT01091974|69533467|FG001|Overall Study|Withdrawal by Subject|3|||
37849276|NCT01091974|69533468|FG002|Overall Study|Withdrawal by Subject|2|||
37849277|NCT01091974|69533469|FG003|Overall Study|Withdrawal by Subject|2|||
37849278|NCT01091974|69533466|FG000|Overall Study|side-effects|1|||
37918552|NCT00494299|69605242|FG001|Overall Study|Physician Decision|2|||
37918553|NCT00494299|69605241|FG000|Overall Study|Protocol Violation|1|||
37918554|NCT00494299|69605242|FG001|Overall Study|Protocol Violation|2|||
37918555|NCT00494299|69605241|FG000|Overall Study|Withdrawal by Subject|8|||
37918556|NCT00494299|69605242|FG001|Overall Study|Withdrawal by Subject|3|||
37918557|NCT00494299|69605241|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
37918558|NCT00494299|69605242|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
37918559|NCT00494299|69605241|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
37918560|NCT00494299|69605242|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
37918561|NCT00494299|69605241|FG000|Overall Study|Site Closed by Sponsor|6|||
37918562|NCT00494299|69605242|FG001|Overall Study|Site Closed by Sponsor|0|||
37918563|NCT00494299|69605241|FG000|Overall Study|Protocol Driven Decision Point|11|||
37918564|NCT00494299|69605242|FG001|Overall Study|Protocol Driven Decision Point|22|||
37918565|NCT00593684|69605250|FG000|Overall Study|Death|2|||
37918566|NCT00593684|69605251|FG001|Overall Study|Death|1|||
37918567|NCT02963831|69605261|FG000|Overall Study|Progressive Disease|3|||
37849279|NCT01091974|69533467|FG001|Overall Study|side-effects|1|||
37849280|NCT01091974|69533468|FG002|Overall Study|side-effects|0|||
37849281|NCT01091974|69533469|FG003|Overall Study|side-effects|2|||
37849282|NCT01313117|69533479|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
37849283|NCT01313117|69533479|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
37849284|NCT01313039|69533484|FG000|Overall Study|Physician Decision|1|||
38027103|NCT03645434|69711743|FG003|Period 1|Adverse Event|1|||
38027104|NCT03645434|69711744|FG004|Period 1|Adverse Event|0|||
38027105|NCT03645434|69711745|FG005|Period 1|Adverse Event|0|||
38027106|NCT03645434|69711740|FG000|Period 1|COPD exacerbation|0|||
37849285|NCT01313039|69533484|FG000|Overall Study|Adverse Event|1|||
37849286|NCT01091662|69533490|FG000|Overall Study|Adverse Event|1|||
37849287|NCT01091662|69533491|FG001|Overall Study|Adverse Event|9|||
37849288|NCT01091662|69533490|FG000|Overall Study|Physician Decision|1|||
37849289|NCT01091662|69533491|FG001|Overall Study|Physician Decision|1|||
37849290|NCT01091662|69533490|FG000|Overall Study|Withdrawal by Subject|7|||
38027107|NCT03645434|69711741|FG001|Period 1|COPD exacerbation|0|||
38027108|NCT03645434|69711742|FG002|Period 1|COPD exacerbation|0|||
38027109|NCT03645434|69711743|FG003|Period 1|COPD exacerbation|0|||
38027110|NCT03645434|69711744|FG004|Period 1|COPD exacerbation|1|||
37849291|NCT01091662|69533491|FG001|Overall Study|Withdrawal by Subject|6|||
37849292|NCT01091662|69533490|FG000|Overall Study|met exit criteria|7|||
37849293|NCT01091662|69533491|FG001|Overall Study|met exit criteria|13|||
37918568|NCT02963831|69605262|FG001|Overall Study|Progressive Disease|3|||
37918569|NCT02963831|69605263|FG002|Overall Study|Progressive Disease|16|||
37918570|NCT02963831|69605264|FG003|Overall Study|Progressive Disease|27|||
37918571|NCT02963831|69605261|FG000|Overall Study|Withdrawal by Subject|1|||
37918572|NCT02963831|69605262|FG001|Overall Study|Withdrawal by Subject|0|||
37918573|NCT02963831|69605263|FG002|Overall Study|Withdrawal by Subject|2|||
38027111|NCT03645434|69711745|FG005|Period 1|COPD exacerbation|0|||
38027112|NCT00089505|69711757|FG000|Overall Study|Death|4|||
37849294|NCT01091662|69533490|FG000|Overall Study|met exclusion criteria|1|||
37849295|NCT01091662|69533491|FG001|Overall Study|met exclusion criteria|0|||
37849296|NCT01091662|69533490|FG000|Overall Study|Lost to Follow-up|0|||
37849297|NCT01091662|69533491|FG001|Overall Study|Lost to Follow-up|1|||
37918574|NCT02963831|69605264|FG003|Overall Study|Withdrawal by Subject|4|||
37918575|NCT02963831|69605261|FG000|Overall Study|Adverse Event|0|||
37918576|NCT02963831|69605262|FG001|Overall Study|Adverse Event|1|||
37918577|NCT02963831|69605263|FG002|Overall Study|Adverse Event|1|||
37918578|NCT02963831|69605264|FG003|Overall Study|Adverse Event|2|||
37918579|NCT02963831|69605261|FG000|Overall Study|Death|0|||
37918580|NCT02963831|69605262|FG001|Overall Study|Death|0|||
37918581|NCT02963831|69605263|FG002|Overall Study|Death|0|||
37918582|NCT02963831|69605264|FG003|Overall Study|Death|2|||
37918583|NCT00859898|69605279|FG000|Overall Study|Lack of Efficacy|0|||
37918584|NCT00859898|69605280|FG001|Overall Study|Lack of Efficacy|1|||
38027113|NCT00089505|69711758|FG001|Overall Study|Death|1|||
38027114|NCT00089505|69711759|FG002|Overall Study|Death|5|||
38027115|NCT00089505|69711760|FG003|Overall Study|Death|8|||
38027116|NCT00089505|69711757|FG000|Overall Study|Withdrawal by Subject|3|||
38027117|NCT00089505|69711758|FG001|Overall Study|Withdrawal by Subject|0|||
38027118|NCT00089505|69711759|FG002|Overall Study|Withdrawal by Subject|6|||
38027119|NCT00089505|69711760|FG003|Overall Study|Withdrawal by Subject|6|||
38027120|NCT00089505|69711757|FG000|Overall Study|Lost to Follow-up|1|||
38027121|NCT00089505|69711758|FG001|Overall Study|Lost to Follow-up|1|||
38027122|NCT00089505|69711759|FG002|Overall Study|Lost to Follow-up|9|||
37849298|NCT01091662|69533490|FG000|Overall Study|Pregnancy|0|||
38027123|NCT00089505|69711760|FG003|Overall Study|Lost to Follow-up|7|||
38027124|NCT00089505|69711757|FG000|Overall Study|Physician Decision|1|||
38027125|NCT00089505|69711758|FG001|Overall Study|Physician Decision|0|||
38027126|NCT00089505|69711759|FG002|Overall Study|Physician Decision|0|||
38027127|NCT00089505|69711760|FG003|Overall Study|Physician Decision|0|||
38027128|NCT00089505|69711757|FG000|Overall Study|Protocol Violation|0|||
38027129|NCT00089505|69711758|FG001|Overall Study|Protocol Violation|0|||
38027130|NCT00089505|69711759|FG002|Overall Study|Protocol Violation|1|||
38027131|NCT00089505|69711760|FG003|Overall Study|Protocol Violation|0|||
38027132|NCT04009824|69711775|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
38027133|NCT04009824|69711776|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
38027134|NCT04009824|69711777|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
38027135|NCT04009824|69711778|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
38027136|NCT04009824|69711779|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
38027137|NCT03555890|69711795|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
38027138|NCT03555890|69711796|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
38027139|NCT03555890|69711797|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
38027140|NCT03555890|69711798|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
38027141|NCT03688074|69711810|FG000|Overall Study|Adverse Event|0|||
38027142|NCT03688074|69711811|FG001|Overall Study|Adverse Event|1|||
37849299|NCT01091662|69533491|FG001|Overall Study|Pregnancy|1|||
37849300|NCT01091662|69533490|FG000|Overall Study|Protocol Violation|0|||
37849301|NCT01091662|69533491|FG001|Overall Study|Protocol Violation|2|||
37849302|NCT01091662|69533490|FG000|Overall Study|unable to swallow capsule|0|||
37849303|NCT01091662|69533491|FG001|Overall Study|unable to swallow capsule|1|||
37849304|NCT01312961|69533504|FG000|Overall Study|Adverse Event|3|||
37849305|NCT01312961|69533505|FG001|Overall Study|Adverse Event|3|||
37849306|NCT01312961|69533504|FG000|Overall Study|Lack of Efficacy|11|||
37849307|NCT01312961|69533505|FG001|Overall Study|Lack of Efficacy|1|||
37849308|NCT01312961|69533504|FG000|Overall Study|Poor compliance to protocol|1|||
37849309|NCT01312961|69533505|FG001|Overall Study|Poor compliance to protocol|0|||
37849310|NCT01312961|69533504|FG000|Overall Study|Other than specified above|2|||
37849311|NCT01312961|69533505|FG001|Overall Study|Other than specified above|3|||
37849312|NCT01311557|69533514|FG000|Overall Study|Serious adverse event|0|||
37849313|NCT01311557|69533515|FG001|Overall Study|Serious adverse event|1|||
37849314|NCT01311557|69533514|FG000|Overall Study|Protocol Violation|4|||
37849315|NCT01311557|69533515|FG001|Overall Study|Protocol Violation|2|||
37918585|NCT00859898|69605281|FG002|Overall Study|Lack of Efficacy|1|||
37918586|NCT00859898|69605279|FG000|Overall Study|Adverse Event|4|||
37918587|NCT00859898|69605280|FG001|Overall Study|Adverse Event|9|||
37918588|NCT00859898|69605281|FG002|Overall Study|Adverse Event|8|||
38027143|NCT03688074|69711810|FG000|Overall Study|Other|1|||
38027144|NCT03688074|69711811|FG001|Overall Study|Other|0|||
37849316|NCT01311557|69533514|FG000|Overall Study|Lost to Follow-up|0|||
37918589|NCT00859898|69605279|FG000|Overall Study|Withdrawal by Subject|11|||
38027145|NCT03630120|69711821|FG000|Overall Study|Disease progression|0|||
38027146|NCT03630120|69711822|FG001|Overall Study|Disease progression|1|||
37918590|NCT00859898|69605280|FG001|Overall Study|Withdrawal by Subject|8|||
37918591|NCT00859898|69605281|FG002|Overall Study|Withdrawal by Subject|11|||
38027147|NCT03630120|69711823|FG002|Overall Study|Disease progression|1|||
38027148|NCT03630120|69711824|FG003|Overall Study|Disease progression|1|||
37849317|NCT01311557|69533515|FG001|Overall Study|Lost to Follow-up|1|||
37849318|NCT01311557|69533514|FG000|Overall Study|Withdrawal by Subject|1|||
37849319|NCT01311557|69533515|FG001|Overall Study|Withdrawal by Subject|2|||
37918592|NCT00859898|69605279|FG000|Overall Study|Death|0|||
37849320|NCT01310777|69533524|FG000|Overall Study|Adverse Event|23|||
37849321|NCT01310777|69533525|FG001|Overall Study|Adverse Event|1|||
37849322|NCT01310777|69533526|FG002|Overall Study|Adverse Event|15|||
37849323|NCT01310777|69533524|FG000|Overall Study|Lost to Follow-up|0|||
37849324|NCT01310777|69533525|FG001|Overall Study|Lost to Follow-up|4|||
37849325|NCT01310777|69533526|FG002|Overall Study|Lost to Follow-up|1|||
37849326|NCT01310777|69533524|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
37849327|NCT01310777|69533525|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
37849328|NCT01310777|69533526|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
37849329|NCT01310777|69533524|FG000|Overall Study|Inadequate Control of IOP|5|||
37849330|NCT01310777|69533525|FG001|Overall Study|Inadequate Control of IOP|7|||
37849331|NCT01310777|69533526|FG002|Overall Study|Inadequate Control of IOP|10|||
37849332|NCT01310777|69533524|FG000|Overall Study|Other|4|||
37849333|NCT01310777|69533525|FG001|Overall Study|Other|1|||
37849334|NCT01310777|69533526|FG002|Overall Study|Other|2|||
37849335|NCT01310699|69533536|FG000|Overall Study|Patients did not complete tandem.|4|||
37849336|NCT01310699|69533537|FG001|Overall Study|Patients did not complete tandem.|6|||
37849337|NCT01310075|69533547|FG000|Overall Study|Lost to Follow-up|1|||
37849338|NCT01310075|69533548|FG001|Overall Study|Lost to Follow-up|0|||
37849339|NCT01310075|69533547|FG000|Overall Study|Physician Decision|10|||
37849340|NCT01310075|69533548|FG001|Overall Study|Physician Decision|7|||
37849341|NCT01310075|69533547|FG000|Overall Study|Protocol Violation|2|||
37849342|NCT01310075|69533548|FG001|Overall Study|Protocol Violation|2|||
37849343|NCT01310075|69533547|FG000|Overall Study|Withdrawal by Subject|1|||
37849344|NCT01310075|69533548|FG001|Overall Study|Withdrawal by Subject|1|||
37918593|NCT00859898|69605280|FG001|Overall Study|Death|0|||
37918594|NCT00859898|69605281|FG002|Overall Study|Death|1|||
37918595|NCT00859898|69605279|FG000|Overall Study|Lost to Follow-up|10|||
37918596|NCT00859898|69605280|FG001|Overall Study|Lost to Follow-up|11|||
37849345|NCT01309997|69533556|FG000|Overall Study|Adverse Event|1|||
37849346|NCT01309997|69533557|FG001|Overall Study|Adverse Event|0|||
37849347|NCT01309997|69533556|FG000|Overall Study|Death|1|||
37918597|NCT00859898|69605281|FG002|Overall Study|Lost to Follow-up|5|||
37918598|NCT00859898|69605279|FG000|Overall Study|poor/non-compliance|2|||
37918599|NCT00859898|69605280|FG001|Overall Study|poor/non-compliance|0|||
37918600|NCT00859898|69605281|FG002|Overall Study|poor/non-compliance|0|||
37918601|NCT00859898|69605279|FG000|Overall Study|No longer meets criteria|0|||
38027149|NCT03555266|69711836|FG000|Overall Study|Protocol Violation|6|||
37849348|NCT01309997|69533557|FG001|Overall Study|Death|3|||
37849349|NCT01309997|69533556|FG000|Overall Study|Lack of Efficacy|2|||
37849350|NCT01309997|69533557|FG001|Overall Study|Lack of Efficacy|2|||
37849351|NCT01309997|69533556|FG000|Overall Study|Withdrawal by Subject|1|||
37849352|NCT01309997|69533557|FG001|Overall Study|Withdrawal by Subject|1|||
37849353|NCT01309919|69533576|FG000|Overall Study|Did not receive a postpartum IUD|17|||
37849354|NCT01309919|69533577|FG001|Overall Study|Did not receive a postpartum IUD|48|||
37849355|NCT01309841|69533586|FG000|Overall Study|Other|0|||
37849356|NCT01309841|69533587|FG001|Overall Study|Other|1|||
37849357|NCT01309841|69533588|FG002|Overall Study|Other|1|||
37849358|NCT01309841|69533586|FG000|Overall Study|Lost to Follow-up|7|||
37849359|NCT01309841|69533587|FG001|Overall Study|Lost to Follow-up|6|||
38027150|NCT03555266|69711837|FG001|Overall Study|Protocol Violation|4|||
38027151|NCT03629886|69711845|FG000|Overall Study|Migrated / moved from the study area|0|||
38027152|NCT03629886|69711846|FG001|Overall Study|Migrated / moved from the study area|55|||
38027153|NCT03629886|69711845|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
38027154|NCT03629886|69711846|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
38027155|NCT03629886|69711845|FG000|Overall Study|Study vaccine not administrated|0|||
38027156|NCT03629886|69711846|FG001|Overall Study|Study vaccine not administrated|3|||
38027157|NCT03629886|69711845|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
37918602|NCT00859898|69605280|FG001|Overall Study|No longer meets criteria|1|||
37849360|NCT01309841|69533588|FG002|Overall Study|Lost to Follow-up|4|||
37849361|NCT01309841|69533586|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
37918603|NCT00859898|69605281|FG002|Overall Study|No longer meets criteria|0|||
37918604|NCT00859898|69605279|FG000|Overall Study|non-specified|1|||
37918605|NCT00859898|69605280|FG001|Overall Study|non-specified|1|||
37918606|NCT00859898|69605281|FG002|Overall Study|non-specified|1|||
37849362|NCT01309841|69533587|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
37849363|NCT01309841|69533588|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
38027158|NCT03629886|69711846|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
37849364|NCT01309841|69533586|FG000|Overall Study|Lack of Efficacy|0|||
37849365|NCT01309841|69533587|FG001|Overall Study|Lack of Efficacy|0|||
37849366|NCT01309841|69533588|FG002|Overall Study|Lack of Efficacy|2|||
37849367|NCT01309841|69533586|FG000|Overall Study|Adverse Event|9|||
37918607|NCT00859586|69605290|FG000|Overall Study|Donors|4|||
38027159|NCT03629886|69711845|FG000|Overall Study|Refused vaccination step of the study|0|||
37849368|NCT01309841|69533587|FG001|Overall Study|Adverse Event|22|||
37849369|NCT01309841|69533588|FG002|Overall Study|Adverse Event|11|||
37918608|NCT00494221|69605297|FG000|Overall Study|Death|15|||
37849370|NCT01309841|69533586|FG000|Overall Study|Death|1|||
37849371|NCT01309841|69533587|FG001|Overall Study|Death|0|||
38027160|NCT03629886|69711846|FG001|Overall Study|Refused vaccination step of the study|44|||
38027161|NCT03656874|69711855|FG000|Overall Study|Lost to Follow-up|3|||
38027162|NCT03656874|69711856|FG001|Overall Study|Lost to Follow-up|17|||
38027163|NCT03554486|69711864|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
38027164|NCT03554486|69711865|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
38027165|NCT03554486|69711866|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
38027166|NCT03554486|69711864|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
38027167|NCT03554486|69711865|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
38027168|NCT03554486|69711866|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
38027169|NCT03554486|69711864|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
38027170|NCT03554486|69711865|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
38027171|NCT03554486|69711866|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
38027172|NCT03554018|69711875|FG000|Overall Study|Lost to Follow-up|3|||
38027173|NCT03554018|69711876|FG001|Overall Study|Lost to Follow-up|7|||
38027174|NCT03571256|69711885|FG000|Overall Study|Adverse Event|3|||
38027175|NCT03571256|69711886|FG001|Overall Study|Adverse Event|0|||
38027176|NCT03571256|69711887|FG002|Overall Study|Adverse Event|1|||
38027177|NCT03571256|69711885|FG000|Overall Study|Withdrawal by Subject|3|||
38027178|NCT03571256|69711886|FG001|Overall Study|Withdrawal by Subject|1|||
38027179|NCT03571256|69711887|FG002|Overall Study|Withdrawal by Subject|1|||
38027180|NCT03571256|69711885|FG000|Overall Study|Other than specified|0|||
38027181|NCT03571256|69711886|FG001|Overall Study|Other than specified|1|||
38027182|NCT03571256|69711887|FG002|Overall Study|Other than specified|1|||
38027183|NCT03571256|69711885|FG000|Overall Study|Protocol Violation|0|||
38027184|NCT03571256|69711886|FG001|Overall Study|Protocol Violation|1|||
38027185|NCT03571256|69711887|FG002|Overall Study|Protocol Violation|1|||
38027186|NCT03570554|69711901|FG000|Overall Study|Non-compliance with study drug|0|||
38027187|NCT03570554|69711902|FG001|Overall Study|Non-compliance with study drug|0|||
38027188|NCT03570554|69711903|FG002|Overall Study|Non-compliance with study drug|1|||
38027189|NCT03570554|69711904|FG003|Overall Study|Non-compliance with study drug|0|||
38027190|NCT03570554|69711901|FG000|Overall Study|Adverse Event|0|||
38027191|NCT03570554|69711902|FG001|Overall Study|Adverse Event|0|||
38027192|NCT03570554|69711903|FG002|Overall Study|Adverse Event|0|||
38027193|NCT03570554|69711904|FG003|Overall Study|Adverse Event|1|||
38027194|NCT04004208|69711916|FG000|Overall Study|Withdrawal by parent/guardian|1|||
38027195|NCT04004208|69711917|FG001|Overall Study|Withdrawal by parent/guardian|1|||
38027196|NCT04004208|69711916|FG000|Overall Study|Death|3|||
38027197|NCT04004208|69711917|FG001|Overall Study|Death|0|||
38027198|NCT04004208|69711916|FG000|Overall Study|COVID-19 pandemic|1|||
38027199|NCT04004208|69711917|FG001|Overall Study|COVID-19 pandemic|0|||
38027200|NCT04004208|69711916|FG000|Overall Study|Physician Decision|1|||
38027201|NCT04004208|69711917|FG001|Overall Study|Physician Decision|0|||
38027202|NCT04004208|69711916|FG000|Overall Study|Adverse Event|1|||
38027203|NCT04004208|69711917|FG001|Overall Study|Adverse Event|1|||
38027204|NCT03643952|69711923|FG000|Overall Study|Lack of Efficacy|1|||
38027205|NCT03035032|69711935|FG000|Overall Study|Adverse Event|2|||
38027206|NCT03035032|69711935|FG000|Overall Study|Death|9|||
37849372|NCT01309841|69533588|FG002|Overall Study|Death|0|||
37849373|NCT01309841|69533586|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
37849374|NCT01309841|69533587|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
37849375|NCT01309841|69533588|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
38027207|NCT03035032|69711935|FG000|Overall Study|Lost to Follow-up|1|||
37849376|NCT01309841|69533586|FG000|Overall Study|Withdrawal by Subject|17|||
37849377|NCT01309841|69533587|FG001|Overall Study|Withdrawal by Subject|6|||
37849378|NCT01309841|69533588|FG002|Overall Study|Withdrawal by Subject|13|||
37849379|NCT01309841|69533586|FG000|Overall Study|Did Not Receive Treatment|2|||
37849380|NCT01309841|69533587|FG001|Overall Study|Did Not Receive Treatment|0|||
37849381|NCT01309841|69533588|FG002|Overall Study|Did Not Receive Treatment|1|||
37849382|NCT01309841|69533586|FG000|Overall Study|Severe non-compliance with protocol|0|||
37849383|NCT01309841|69533587|FG001|Overall Study|Severe non-compliance with protocol|5|||
37849384|NCT01309841|69533588|FG002|Overall Study|Severe non-compliance with protocol|2|||
37849385|NCT01308749|69533598|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
37849386|NCT01308749|69533599|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
37849387|NCT01308749|69533598|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
37849388|NCT01308749|69533599|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
37849389|NCT01308749|69533598|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
37849390|NCT01308749|69533599|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
38027208|NCT03035032|69711935|FG000|Overall Study|Progressive Disease|22|||
38027209|NCT03035032|69711935|FG000|Overall Study|Protocol Violation|2|||
38027210|NCT03035032|69711935|FG000|Overall Study|Withdrawal by Subject|2|||
38027211|NCT03035032|69711935|FG000|Overall Study|Physician Decision|5|||
38027212|NCT03629184|69711941|FG000|Overall Study|Withdrawal by Subject|2|||
38027213|NCT03629184|69711942|FG001|Overall Study|Withdrawal by Subject|1|||
38027214|NCT03629184|69711941|FG000|Overall Study|Physician Decision|1|||
37849391|NCT01307891|69533621|FG000|Overall Study|Progressive Disease|3|||
37849392|NCT01307891|69533622|FG001|Overall Study|Progressive Disease|1|||
37849393|NCT01307579|69533630|FG000|Overall Study|Death|3|||
37849394|NCT01307579|69533631|FG001|Overall Study|Death|6|||
37849395|NCT01307579|69533630|FG000|Overall Study|Physician Decision|26|||
37849396|NCT01307579|69533631|FG001|Overall Study|Physician Decision|29|||
37849397|NCT01307579|69533630|FG000|Overall Study|Withdrawal by Subject|7|||
37849398|NCT01307579|69533631|FG001|Overall Study|Withdrawal by Subject|3|||
37849399|NCT01307579|69533630|FG000|Overall Study|Institutional diagnosis of IFD|21|||
37849400|NCT01307579|69533631|FG001|Overall Study|Institutional diagnosis of IFD|36|||
37849401|NCT01307579|69533630|FG000|Overall Study|Begin conditioning for HSCT|42|||
37849402|NCT01307579|69533631|FG001|Overall Study|Begin conditioning for HSCT|44|||
37849403|NCT01307579|69533630|FG000|Overall Study|Refractory or relapsed AML|38|||
37849404|NCT01307579|69533631|FG001|Overall Study|Refractory or relapsed AML|23|||
37849405|NCT01307579|69533630|FG000|Overall Study|Ineligible|3|||
37849406|NCT01307579|69533631|FG001|Overall Study|Ineligible|4|||
37849407|NCT01057693|69533637|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
37849408|NCT01057693|69533638|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
37849409|NCT01057693|69533639|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
37849410|NCT01057693|69533637|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
37849411|NCT01057693|69533638|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
37918609|NCT00494221|69605298|FG001|Overall Study|Death|9|||
37918610|NCT00494221|69605299|FG002|Overall Study|Death|14|||
37918611|NCT00494221|69605297|FG000|Overall Study|Withdrawal by Subject|1|||
37918612|NCT00494221|69605298|FG001|Overall Study|Withdrawal by Subject|2|||
37918613|NCT00494221|69605299|FG002|Overall Study|Withdrawal by Subject|0|||
37918614|NCT00857948|69605311|FG000|Overall Study|Withdrawal by Subject|2|||
37918615|NCT00857948|69605312|FG001|Overall Study|Withdrawal by Subject|0|||
37918616|NCT00857948|69605313|FG002|Overall Study|Withdrawal by Subject|0|||
37849412|NCT01057693|69533639|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
37849413|NCT01057693|69533637|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
37849414|NCT01057693|69533638|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
37849415|NCT01057693|69533639|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
37849416|NCT01057693|69533637|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
37849417|NCT01057693|69533638|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
37849418|NCT01057693|69533639|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
37849419|NCT01057693|69533637|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
37849420|NCT01057693|69533638|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
37849421|NCT01057693|69533639|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
37849422|NCT01057693|69533637|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
37849423|NCT01057693|69533638|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
37849424|NCT01057693|69533639|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
37849425|NCT01057693|69533637|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
37849426|NCT01057693|69533638|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
37918617|NCT00857948|69605314|FG003|Overall Study|Withdrawal by Subject|0|||
37918618|NCT00857948|69605311|FG000|Overall Study|Protocol Violation|1|||
37918619|NCT00857948|69605312|FG001|Overall Study|Protocol Violation|0|||
37918620|NCT00857948|69605313|FG002|Overall Study|Protocol Violation|1|||
37918621|NCT00857948|69605314|FG003|Overall Study|Protocol Violation|0|||
38027215|NCT03629184|69711942|FG001|Overall Study|Physician Decision|0|||
37849427|NCT01057693|69533639|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
37849428|NCT01057693|69533637|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
37849429|NCT01057693|69533638|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
37849430|NCT01057693|69533639|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
37849431|NCT01057693|69533637|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
37849432|NCT01057693|69533638|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
37849433|NCT01057693|69533639|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
37849434|NCT01057693|69533637|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
37849435|NCT01057693|69533638|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
37849436|NCT01057693|69533639|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
37849437|NCT01057693|69533637|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
37849438|NCT01057693|69533638|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
37849439|NCT01057693|69533639|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
37849440|NCT01057693|69533637|FG000|Between Single-Blind and Double-Blind|Other|6|||
37849441|NCT01057693|69533638|FG001|Between Single-Blind and Double-Blind|Other|0|||
38027216|NCT03549338|69711960|FG000|Overall Study|Progressive Disease|1|||
38027217|NCT03549338|69711961|FG001|Overall Study|Progressive Disease|0|||
38027218|NCT03549338|69711962|FG002|Overall Study|Progressive Disease|0|||
38027219|NCT03549338|69711960|FG000|Overall Study|Clinical Progression|0|||
38027220|NCT03549338|69711961|FG001|Overall Study|Clinical Progression|1|||
38027221|NCT03549338|69711962|FG002|Overall Study|Clinical Progression|0|||
38027222|NCT03629028|69711970|FG000|Overall Study|Lost to Follow-up|26|||
38027223|NCT03629028|69711971|FG001|Overall Study|Lost to Follow-up|23|||
38027224|NCT03629028|69711970|FG000|Overall Study|Pregnancy|4|||
38027225|NCT03629028|69711971|FG001|Overall Study|Pregnancy|2|||
38027226|NCT03629028|69711970|FG000|Overall Study|intolerance to examination|2|||
38027227|NCT03629028|69711971|FG001|Overall Study|intolerance to examination|0|||
38027228|NCT03549104|69711989|FG000|Overall Study|Physician Decision|2|||
38027229|NCT03549104|69711990|FG001|Overall Study|Physician Decision|0|||
38027230|NCT03549104|69711989|FG000|Overall Study|Withdrawal by Subject|5|||
38027231|NCT03549104|69711990|FG001|Overall Study|Withdrawal by Subject|2|||
38027232|NCT03549104|69711989|FG000|Overall Study|Covid shelter in place|1|||
37918622|NCT00866606|69605324|FG000|Overall Study|Lost to Follow-up|3|||
38027233|NCT03549104|69711990|FG001|Overall Study|Covid shelter in place|2|||
38027234|NCT02892344|69711998|FG000|Overall Study|Protocol deviation|3|||
38027235|NCT02892344|69711999|FG001|Overall Study|Protocol deviation|4|||
38027236|NCT02892344|69711998|FG000|Overall Study|Adverse Event|1|||
38027237|NCT02892344|69711999|FG001|Overall Study|Adverse Event|8|||
38027238|NCT02892344|69711998|FG000|Overall Study|Lost to Follow-up|0|||
38027239|NCT02892344|69711999|FG001|Overall Study|Lost to Follow-up|1|||
38027240|NCT02892344|69711998|FG000|Overall Study|Non-compliance with study treatment|0|||
38027241|NCT02892344|69711999|FG001|Overall Study|Non-compliance with study treatment|1|||
38027242|NCT02892344|69711998|FG000|Overall Study|Physician Decision|0|||
38027243|NCT02892344|69711999|FG001|Overall Study|Physician Decision|2|||
38027244|NCT02892344|69711998|FG000|Overall Study|Subject/guardian decision|0|||
38027245|NCT02892344|69711999|FG001|Overall Study|Subject/guardian decision|4|||
38027246|NCT02892344|69711998|FG000|Overall Study|Technical problems|0|||
38027247|NCT02892344|69711999|FG001|Overall Study|Technical problems|1|||
38027248|NCT03567980|69712005|FG000|Overall Study|Adverse Event|1|||
38027249|NCT02894840|69712013|FG000|Overall Study|Lost to Follow-up|1|||
38027250|NCT02894840|69712014|FG001|Overall Study|Lost to Follow-up|0|||
38027251|NCT02894840|69712015|FG002|Overall Study|Lost to Follow-up|3|||
38027252|NCT02894840|69712016|FG003|Overall Study|Lost to Follow-up|0|||
38027253|NCT03358030|69712035|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
38027254|NCT03358030|69712036|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
38027255|NCT03358030|69712037|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
38027256|NCT03358030|69712038|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
38027257|NCT03358030|69712035|FG000|Overall Study|Ineligibility|0|||
38027258|NCT03358030|69712036|FG001|Overall Study|Ineligibility|0|||
38027259|NCT03358030|69712037|FG002|Overall Study|Ineligibility|0|||
38027260|NCT03358030|69712038|FG003|Overall Study|Ineligibility|2|||
38027261|NCT03358030|69712035|FG000|Overall Study|Voluntary Withdrawal|1|||
38027262|NCT03358030|69712036|FG001|Overall Study|Voluntary Withdrawal|1|||
38027263|NCT03358030|69712037|FG002|Overall Study|Voluntary Withdrawal|3|||
38027264|NCT03358030|69712038|FG003|Overall Study|Voluntary Withdrawal|1|||
38027265|NCT03358030|69712035|FG000|Overall Study|Other|0|||
38027266|NCT03358030|69712036|FG001|Overall Study|Other|0|||
38027267|NCT03358030|69712037|FG002|Overall Study|Other|1|||
38027268|NCT03358030|69712038|FG003|Overall Study|Other|0|||
38027269|NCT03566810|69712052|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
38027270|NCT03566810|69712053|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
38027271|NCT03566810|69712054|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
38027272|NCT03566810|69712055|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
38027273|NCT03628716|69712078|FG000|Overall Study|Adverse Event|1|||
38027274|NCT03628716|69712079|FG001|Overall Study|Adverse Event|1|||
38027275|NCT03628716|69712078|FG000|Overall Study|Death|1|||
38027276|NCT03628716|69712079|FG001|Overall Study|Death|0|||
38027277|NCT03628716|69712078|FG000|Overall Study|Lack of Efficacy|15|||
38027278|NCT03628716|69712079|FG001|Overall Study|Lack of Efficacy|20|||
38027279|NCT03628716|69712078|FG000|Overall Study|Withdrawal by Subject|1|||
38027280|NCT03628716|69712079|FG001|Overall Study|Withdrawal by Subject|2|||
38027281|NCT03628716|69712078|FG000|Overall Study|Study Terminated by Sponsor|1|||
38027282|NCT03628716|69712079|FG001|Overall Study|Study Terminated by Sponsor|0|||
38027283|NCT04002960|69712087|FG000|Overall Study|Withdrawn prior to Completion|2|||
37849442|NCT01057693|69533639|FG002|Between Single-Blind and Double-Blind|Other|0|||
37849443|NCT01057693|69533637|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
37849444|NCT01057693|69533638|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
37849445|NCT01057693|69533639|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
37849446|NCT01057693|69533637|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
37918623|NCT00866606|69605324|FG000|Overall Study|Adverse Event|1|||
37918624|NCT00857792|69605328|FG000|Overall Study|inadequate image quality for analysis|12|||
37918625|NCT00601835|69605334|FG000|Overall Study|Withdrawal by Subject|9|||
37849447|NCT01057693|69533638|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
37849448|NCT01057693|69533639|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
37849449|NCT01057693|69533637|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
37849450|NCT01057693|69533638|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
37849451|NCT01057693|69533639|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
37849452|NCT01057693|69533637|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
37849453|NCT01057693|69533638|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
37849454|NCT01057693|69533639|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
37849455|NCT01057693|69533637|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
37918626|NCT00601835|69605335|FG001|Overall Study|Withdrawal by Subject|6|||
37918627|NCT00601835|69605334|FG000|Overall Study|Physician Decision|1|||
37918628|NCT00601835|69605335|FG001|Overall Study|Physician Decision|0|||
37918629|NCT00601835|69605334|FG000|Overall Study|Lost to Follow-up|37|||
37918630|NCT00601835|69605335|FG001|Overall Study|Lost to Follow-up|5|||
37918631|NCT00601835|69605334|FG000|Overall Study|Adverse Event|1|||
37918632|NCT00601835|69605335|FG001|Overall Study|Adverse Event|1|||
37918633|NCT00601835|69605334|FG000|Overall Study|Relocate|12|||
37918634|NCT00601835|69605335|FG001|Overall Study|Relocate|2|||
37918635|NCT00857246|69605341|FG000|Induction Regimen|Adverse Event|1|||
37918636|NCT00857246|69605341|FG000|Induction Regimen|disease-related complications|1|||
37918637|NCT00857246|69605341|FG000|Induction Regimen|Withdrawal by Subject|1|||
37918638|NCT00857246|69605341|FG000|Surgery (Curative)|disease progression|6|||
37918639|NCT00857246|69605341|FG000|ChemoRT|Withdrawal by Subject|1|||
37849456|NCT01057693|69533638|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
37849457|NCT01057693|69533639|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
37849458|NCT01057693|69533637|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
37849459|NCT01057693|69533638|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
37849460|NCT01057693|69533639|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
37849461|NCT01057693|69533637|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
37849462|NCT01057693|69533638|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
37849463|NCT01057693|69533639|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
37849464|NCT01307501|69533647|FG000|Overall Study|Treatment Failure|1|||
37849465|NCT01307501|69533647|FG000|Overall Study|Death|20|||
37918640|NCT00857246|69605341|FG000|ChemoRT|Adverse Event|2|||
37918641|NCT00856856|69605348|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
38027284|NCT04002648|69712093|FG000|Overall Study|Lost to Follow-up|2|||
38027285|NCT04002648|69712094|FG001|Overall Study|Lost to Follow-up|0|||
38027286|NCT00088413|69712115|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
38027287|NCT00088413|69712116|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
38027288|NCT00088413|69712117|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
38027289|NCT00088413|69712118|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
38027290|NCT00088413|69712115|FG000|Overall Study|Adverse Events/Side Effects|0|||
38027291|NCT00088413|69712116|FG001|Overall Study|Adverse Events/Side Effects|1|||
38027292|NCT00088413|69712117|FG002|Overall Study|Adverse Events/Side Effects|1|||
38027293|NCT00088413|69712118|FG003|Overall Study|Adverse Events/Side Effects|0|||
38027294|NCT00088413|69712115|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
38027295|NCT00088413|69712116|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
38027296|NCT00088413|69712117|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
38027297|NCT00088413|69712118|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
38027298|NCT00088413|69712115|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
38027299|NCT00088413|69712116|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
38027300|NCT00088413|69712117|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
38027301|NCT00088413|69712118|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
38027302|NCT00088413|69712115|FG000|Overall Study|Death|0|||
38027303|NCT00088413|69712116|FG001|Overall Study|Death|1|||
38027304|NCT00088413|69712117|FG002|Overall Study|Death|0|||
38027305|NCT00088413|69712118|FG003|Overall Study|Death|0|||
37849466|NCT01307501|69533647|FG000|Overall Study|Lost to Follow-up|1|||
37849467|NCT01307501|69533647|FG000|Overall Study|Starting Hospice|1|||
37849468|NCT01034137|69533654|FG000|Overall Study|Adverse Event|9|||
37849469|NCT01034137|69533655|FG001|Overall Study|Adverse Event|10|||
37918642|NCT00856856|69605348|FG000|4-year Clinical Follow-up|Missed visit|1|||
37918643|NCT00493285|69605363|FG000|Overall Study|Lost to Follow-up|0|||
37918644|NCT00493285|69605364|FG001|Overall Study|Lost to Follow-up|0|||
37918645|NCT00493285|69605365|FG002|Overall Study|Lost to Follow-up|0|||
37918646|NCT00493285|69605366|FG003|Overall Study|Lost to Follow-up|0|||
37918647|NCT00493285|69605367|FG004|Overall Study|Lost to Follow-up|1|||
37918648|NCT00493285|69605368|FG005|Overall Study|Lost to Follow-up|0|||
37918649|NCT00856778|69605382|FG000|Overall Study|Adverse Event|7|||
37918650|NCT00856778|69605382|FG000|Overall Study|Withdrawal by Subject|10|||
37918651|NCT00856778|69605382|FG000|Overall Study|Study deviation|2|||
37918652|NCT00856778|69605382|FG000|Overall Study|Lost to Follow-up|5|||
37849470|NCT01034137|69533656|FG002|Overall Study|Adverse Event|8|||
37849471|NCT01034137|69533654|FG000|Overall Study|Withdrawal by Subject|4|||
37849472|NCT01034137|69533655|FG001|Overall Study|Withdrawal by Subject|3|||
37849473|NCT01034137|69533656|FG002|Overall Study|Withdrawal by Subject|3|||
37849474|NCT01034137|69533654|FG000|Overall Study|Lack of Efficacy|9|||
37849475|NCT01034137|69533655|FG001|Overall Study|Lack of Efficacy|4|||
37849476|NCT01034137|69533656|FG002|Overall Study|Lack of Efficacy|13|||
37918653|NCT00603473|69605386|FG000|Overall Study|Adverse Event|4|||
37918654|NCT00603473|69605386|FG000|Overall Study|Lack of Efficacy|4|||
37918655|NCT00603473|69605386|FG000|Overall Study|Protocol Violation|1|||
37918656|NCT00486889|69605390|FG000|Overall Study|Death|3|||
37918657|NCT00486889|69605390|FG000|Overall Study|Non-compliant|2|||
37918658|NCT00486889|69605390|FG000|Overall Study|Withdrawal by Subject|6|||
37918659|NCT00486811|69605397|FG000|Overall Study|Adverse Event|28|||
37918660|NCT00486811|69605398|FG001|Overall Study|Adverse Event|60|||
37918661|NCT00486811|69605399|FG002|Overall Study|Adverse Event|135|||
37918662|NCT00486811|69605397|FG000|Overall Study|Lack of Efficacy|34|||
37918663|NCT00486811|69605398|FG001|Overall Study|Lack of Efficacy|14|||
37918664|NCT00486811|69605399|FG002|Overall Study|Lack of Efficacy|7|||
37918665|NCT00486811|69605397|FG000|Overall Study|Lost to Follow-up|4|||
37918666|NCT00486811|69605398|FG001|Overall Study|Lost to Follow-up|6|||
37918667|NCT00486811|69605399|FG002|Overall Study|Lost to Follow-up|4|||
37918668|NCT00486811|69605397|FG000|Overall Study|Withdrawal by Subject|33|||
37918669|NCT00486811|69605398|FG001|Overall Study|Withdrawal by Subject|44|||
37849477|NCT01034137|69533654|FG000|Overall Study|Protocol Violation|2|||
37918670|NCT00486811|69605399|FG002|Overall Study|Withdrawal by Subject|58|||
37918671|NCT00486811|69605397|FG000|Overall Study|Study drug non-compliant|5|||
37918672|NCT00486811|69605398|FG001|Overall Study|Study drug non-compliant|6|||
37918673|NCT00486811|69605399|FG002|Overall Study|Study drug non-compliant|3|||
38027306|NCT00088413|69712115|FG000|Overall Study|Progressive disease|9|||
37918674|NCT00486811|69605397|FG000|Overall Study|All other|18|||
38027307|NCT00088413|69712116|FG001|Overall Study|Progressive disease|11|||
38027308|NCT00088413|69712117|FG002|Overall Study|Progressive disease|8|||
38027309|NCT00088413|69712118|FG003|Overall Study|Progressive disease|14|||
38027310|NCT00088413|69712115|FG000|Overall Study|Other|0|||
38027311|NCT00088413|69712116|FG001|Overall Study|Other|1|||
38027312|NCT00088413|69712117|FG002|Overall Study|Other|0|||
38027313|NCT00088413|69712118|FG003|Overall Study|Other|0|||
38027314|NCT00088413|69712115|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
38027315|NCT00088413|69712116|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
38027316|NCT00088413|69712117|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
38027317|NCT00088413|69712118|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
38027318|NCT03995784|69712130|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
38027319|NCT00086385|69712145|FG000|Overall Study|Death|2|||
38027320|NCT00086385|69712146|FG001|Overall Study|Death|2|||
38027321|NCT00086385|69712147|FG002|Overall Study|Death|1|||
38027322|NCT00086385|69712148|FG003|Overall Study|Death|1|||
38027323|NCT03993288|69712160|FG000|Overall Study|Lost to Follow-up|2|||
38027324|NCT03993288|69712161|FG001|Overall Study|Lost to Follow-up|1|||
38027325|NCT03993288|69712160|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
38027326|NCT03993288|69712161|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
38027327|NCT03993288|69712160|FG000|Overall Study|wrong randomization|0|||
37918675|NCT00486811|69605398|FG001|Overall Study|All other|11|||
37918676|NCT00486811|69605399|FG002|Overall Study|All other|7|||
37918677|NCT00486265|69605407|FG000|Overall Study|Adverse Event|1|||
37918678|NCT00486265|69605407|FG000|Overall Study|Lack of Efficacy|8|||
38027328|NCT03993288|69712161|FG001|Overall Study|wrong randomization|1|||
37918679|NCT02151604|69605411|FG000|Overall Study|Lost to Follow-up|3|||
37918680|NCT02151604|69605411|FG000|Overall Study|Withdrawal by Subject|2|||
37918681|NCT02151604|69605411|FG000|Overall Study|Physician Decision|3|||
38027329|NCT03993288|69712160|FG000|Overall Study|improper enrollment|0|||
38027330|NCT03993288|69712161|FG001|Overall Study|improper enrollment|1|||
38027331|NCT03993288|69712160|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
37849478|NCT01034137|69533655|FG001|Overall Study|Protocol Violation|2|||
37918682|NCT02151604|69605411|FG000|Overall Study|Death|1|||
37849479|NCT01034137|69533656|FG002|Overall Study|Protocol Violation|1|||
37918683|NCT00466921|69605416|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
37918684|NCT00466921|69605416|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
37849480|NCT01034137|69533654|FG000|Overall Study|Refused treatment or did not cooperate|2|||
37849481|NCT01034137|69533655|FG001|Overall Study|Refused treatment or did not cooperate|0|||
37849482|NCT01034137|69533656|FG002|Overall Study|Refused treatment or did not cooperate|1|||
37849483|NCT01034137|69533654|FG000|Overall Study|Administrative or other|2|||
37849484|NCT01034137|69533655|FG001|Overall Study|Administrative or other|3|||
37849485|NCT01034137|69533656|FG002|Overall Study|Administrative or other|4|||
37918685|NCT00466921|69605416|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
38027332|NCT03993288|69712161|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
38027333|NCT03993288|69712160|FG000|Overall Study|developed SAE|2|||
38027334|NCT03993288|69712161|FG001|Overall Study|developed SAE|0|||
38027335|NCT03993288|69712160|FG000|Overall Study|consent withdrawal|1|||
38027336|NCT03993288|69712161|FG001|Overall Study|consent withdrawal|0|||
38027337|NCT03993288|69712160|FG000|Overall Study|did not follow the treatment schedule|1|||
38027338|NCT03993288|69712161|FG001|Overall Study|did not follow the treatment schedule|0|||
38027339|NCT03993288|69712160|FG000|Overall Study|did not follow the treatment regimen|1|||
38027340|NCT03993288|69712161|FG001|Overall Study|did not follow the treatment regimen|0|||
38027341|NCT03993288|69712160|FG000|Overall Study|Adverse Event|1|||
38027342|NCT03993288|69712161|FG001|Overall Study|Adverse Event|0|||
38027343|NCT03993288|69712160|FG000|Overall Study|Withdrawal by Subject|1|||
38027344|NCT03993288|69712161|FG001|Overall Study|Withdrawal by Subject|1|||
38027345|NCT03991494|69712167|FG000|Overall Study|Progressive Disease|4|||
38027346|NCT00086307|69712176|FG000|Overall Study|Lack of Efficacy|1|||
38027347|NCT00086307|69712177|FG001|Overall Study|Lack of Efficacy|1|||
38027348|NCT00086307|69712178|FG002|Overall Study|Lack of Efficacy|2|||
38027349|NCT00086307|69712176|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
38027350|NCT00086307|69712177|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
38027351|NCT00086307|69712178|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
38027352|NCT00086307|69712176|FG000|Overall Study|Nausea and headaches|0|||
38027353|NCT00086307|69712177|FG001|Overall Study|Nausea and headaches|0|||
38027354|NCT00086307|69712178|FG002|Overall Study|Nausea and headaches|1|||
38027355|NCT00086307|69712176|FG000|Overall Study|Constipation and sleepiness|0|||
38027356|NCT00086307|69712177|FG001|Overall Study|Constipation and sleepiness|0|||
38027357|NCT00086307|69712178|FG002|Overall Study|Constipation and sleepiness|1|||
38027358|NCT00086307|69712176|FG000|Overall Study|Suicidal ideation|0|||
38027359|NCT00086307|69712177|FG001|Overall Study|Suicidal ideation|0|||
38027360|NCT00086307|69712178|FG002|Overall Study|Suicidal ideation|1|||
38027361|NCT00086307|69712176|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
38027362|NCT00086307|69712177|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
38027363|NCT00086307|69712178|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
38027364|NCT00086307|69712176|FG000|Overall Study|Withdrawal by Subject|0|||
38027365|NCT00086307|69712177|FG001|Overall Study|Withdrawal by Subject|0|||
38027366|NCT00086307|69712178|FG002|Overall Study|Withdrawal by Subject|2|||
38027367|NCT03624972|69712189|FG000|Overall Study|Lost to Follow-up|2|||
38027368|NCT03624972|69712190|FG001|Overall Study|Lost to Follow-up|0|||
38027369|NCT03624972|69712191|FG002|Overall Study|Lost to Follow-up|0|||
38027370|NCT03624972|69712189|FG000|Overall Study|Withdrawal by Subject|0|||
38027371|NCT03624972|69712190|FG001|Overall Study|Withdrawal by Subject|2|||
38027372|NCT03624972|69712191|FG002|Overall Study|Withdrawal by Subject|0|||
38027373|NCT03988842|69712200|FG000|Overall Study|Death|1|||
38027374|NCT02668822|69712207|FG000|Overall Study|Protocol Violation|2|||
38027375|NCT02668822|69712208|FG001|Overall Study|Protocol Violation|0|||
38027376|NCT02668822|69712207|FG000|Overall Study|Study Terminated by Sponsor|7|||
38027377|NCT02668822|69712208|FG001|Overall Study|Study Terminated by Sponsor|9|||
38027378|NCT02524288|69712214|FG000|Overall Study|Adverse Event|115|||
38027379|NCT02524288|69712214|FG000|Overall Study|Lost to Follow-up|216|||
38027380|NCT02524288|69712214|FG000|Overall Study|Non-Compliance With Protocol|32|||
38027381|NCT02524288|69712214|FG000|Overall Study|Non-Compliance With Study Drug|14|||
38027382|NCT02524288|69712214|FG000|Overall Study|Pregnancy Wish|6|||
38027383|NCT02524288|69712214|FG000|Overall Study|Protocol Violation|6|||
38027384|NCT02524288|69712214|FG000|Overall Study|Screen Failure|2|||
38027385|NCT02524288|69712214|FG000|Overall Study|Site Discontinued Study Participation|1|||
38027386|NCT02524288|69712214|FG000|Overall Study|Study Terminated By Sponsor|1417|||
38027387|NCT02524288|69712214|FG000|Overall Study|Subject Moved|32|||
38027388|NCT02524288|69712214|FG000|Overall Study|Withdrawal by Subject|76|||
38027389|NCT02524288|69712214|FG000|Overall Study|Pregnancy|22|||
38027390|NCT02524288|69712214|FG000|Overall Study|Physician Decision|2|||
38027391|NCT03624504|69712218|FG000|Overall Study|Unsuccessful Implant|1|||
38027392|NCT02954952|69712225|FG000|Overall Study|Withdrawal by Subject|1|||
38027393|NCT02954952|69712226|FG001|Overall Study|Withdrawal by Subject|0|||
38027394|NCT02954952|69712227|FG002|Overall Study|Withdrawal by Subject|0|||
38027395|NCT02954952|69712225|FG000|Overall Study|No data collected|0|||
37918686|NCT00466921|69605416|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
38027396|NCT02954952|69712226|FG001|Overall Study|No data collected|1|||
38027397|NCT02954952|69712227|FG002|Overall Study|No data collected|0|||
37849486|NCT01056289|69533665|FG000|Open-label Phase|Adverse Event|29|||
37918687|NCT00466921|69605416|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
38027398|NCT03547154|69712237|FG000|Overall Study|Disease Progression/Recurrence|6|||
38027399|NCT03547154|69712238|FG001|Overall Study|Disease Progression/Recurrence|14|||
38027400|NCT03547154|69712237|FG000|Overall Study|Adverse Event|26|||
38027401|NCT03547154|69712238|FG001|Overall Study|Adverse Event|31|||
38027402|NCT03547154|69712237|FG000|Overall Study|Protocol Violation|6|||
38027403|NCT03547154|69712238|FG001|Overall Study|Protocol Violation|1|||
38027404|NCT03547154|69712237|FG000|Overall Study|Physician Decision|4|||
37849487|NCT01056289|69533666|FG001|Open-label Phase|Adverse Event|0|||
38027405|NCT03547154|69712238|FG001|Overall Study|Physician Decision|3|||
38027406|NCT03547154|69712237|FG000|Overall Study|Insufficient Therapeutic Response|13|||
38027407|NCT03547154|69712238|FG001|Overall Study|Insufficient Therapeutic Response|10|||
38027408|NCT03547154|69712237|FG000|Overall Study|Withdrawal by Subject|10|||
38027409|NCT03547154|69712238|FG001|Overall Study|Withdrawal by Subject|6|||
38027410|NCT03547154|69712237|FG000|Overall Study|Not Selected|0|||
38027411|NCT03547154|69712238|FG001|Overall Study|Not Selected|1|||
38027412|NCT03547154|69712237|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
38027413|NCT03547154|69712238|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
38027414|NCT02275546|69712244|FG000|Treatment Period 2|Withdrawal by Subject|2|||
38027415|NCT02275546|69712245|FG001|Treatment Period 2|Withdrawal by Subject|1|||
38027416|NCT02275546|69712244|FG000|Treatment Period 2|Protocol Violation|0|||
38027417|NCT02275546|69712245|FG001|Treatment Period 2|Protocol Violation|1|||
38027418|NCT03624192|69712251|FG000|Overall Study|Lost to Follow-up|1|||
38027419|NCT03624192|69712252|FG001|Overall Study|Lost to Follow-up|1|||
38027420|NCT03034954|69712262|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
38027421|NCT03034954|69712263|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
38027422|NCT03546842|69712269|FG000|Overall Study|Protocol Violation|1|||
38027423|NCT03546842|69712269|FG000|Overall Study|Withdrawal by Subject|2|||
38027424|NCT03640052|69712273|FG000|Overall Study|Lost to Follow-up|0|||
38027425|NCT03640052|69712274|FG001|Overall Study|Lost to Follow-up|1|||
38027426|NCT03640052|69712275|FG002|Overall Study|Lost to Follow-up|0|||
38027427|NCT03640052|69712276|FG003|Overall Study|Lost to Follow-up|0|||
38027428|NCT03640052|69712277|FG004|Overall Study|Lost to Follow-up|0|||
38027429|NCT00068601|69712291|FG000|Overall Study|Ineligible|11|||
38027430|NCT00068601|69712292|FG001|Overall Study|Ineligible|13|||
38027431|NCT00068601|69712291|FG000|Overall Study|Not evaluable: withdrew consent|5|||
38027432|NCT00068601|69712292|FG001|Overall Study|Not evaluable: withdrew consent|4|||
38027433|NCT00068601|69712291|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
38027434|NCT00068601|69712292|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
38027435|NCT00068601|69712291|FG000|Overall Study|Death|11|||
38027436|NCT00068601|69712292|FG001|Overall Study|Death|3|||
38027437|NCT00068601|69712291|FG000|Overall Study|Lost to Follow-up|3|||
38027438|NCT00068601|69712292|FG001|Overall Study|Lost to Follow-up|2|||
38027439|NCT00068601|69712291|FG000|Overall Study|Missing primary outcome data|30|||
38027440|NCT00068601|69712292|FG001|Overall Study|Missing primary outcome data|34|||
38027441|NCT03638258|69712301|FG000|Overall Study|Adverse Event|1|||
37849488|NCT01056289|69533667|FG002|Open-label Phase|Adverse Event|0|||
37849489|NCT01056289|69533668|FG003|Open-label Phase|Adverse Event|0|||
37849490|NCT01056289|69533665|FG000|Open-label Phase|Lost to Follow-up|30|||
37849491|NCT01056289|69533666|FG001|Open-label Phase|Lost to Follow-up|0|||
37849492|NCT01056289|69533667|FG002|Open-label Phase|Lost to Follow-up|0|||
37849493|NCT01056289|69533668|FG003|Open-label Phase|Lost to Follow-up|0|||
37849494|NCT01056289|69533665|FG000|Open-label Phase|Other|9|||
37918688|NCT00466921|69605416|FG000|Follow up for a Minimum of 1 Year|Death|6|||
38027442|NCT03638258|69712302|FG001|Overall Study|Adverse Event|0|||
38027443|NCT03638258|69712303|FG002|Overall Study|Adverse Event|2|||
38027444|NCT03638258|69712301|FG000|Overall Study|Lost to Follow-up|2|||
38027445|NCT03638258|69712302|FG001|Overall Study|Lost to Follow-up|4|||
38027446|NCT03638258|69712303|FG002|Overall Study|Lost to Follow-up|5|||
38027447|NCT03638258|69712301|FG000|Overall Study|Pregnancy|0|||
38027448|NCT03638258|69712302|FG001|Overall Study|Pregnancy|0|||
38027449|NCT03638258|69712303|FG002|Overall Study|Pregnancy|1|||
38027450|NCT03638258|69712301|FG000|Overall Study|Protocol Violation|0|||
38027451|NCT03638258|69712302|FG001|Overall Study|Protocol Violation|0|||
38027452|NCT03638258|69712303|FG002|Overall Study|Protocol Violation|1|||
37849495|NCT01056289|69533666|FG001|Open-label Phase|Other|0|||
37849496|NCT01056289|69533667|FG002|Open-label Phase|Other|0|||
37849497|NCT01056289|69533668|FG003|Open-label Phase|Other|0|||
37918689|NCT00601523|69605422|FG000|Overall Study|Adverse Event|42|||
37849498|NCT01056289|69533665|FG000|Open-label Phase|Protocol Violation|6|||
37849499|NCT01056289|69533666|FG001|Open-label Phase|Protocol Violation|0|||
37918690|NCT00601523|69605423|FG001|Overall Study|Adverse Event|14|||
37849500|NCT01056289|69533667|FG002|Open-label Phase|Protocol Violation|0|||
37849501|NCT01056289|69533668|FG003|Open-label Phase|Protocol Violation|0|||
37849502|NCT01056289|69533665|FG000|Open-label Phase|Withdrawal by Subject|26|||
37849503|NCT01056289|69533666|FG001|Open-label Phase|Withdrawal by Subject|0|||
37849504|NCT01056289|69533667|FG002|Open-label Phase|Withdrawal by Subject|0|||
37918691|NCT00601523|69605422|FG000|Overall Study|Lack of Efficacy|3|||
37849505|NCT01056289|69533668|FG003|Open-label Phase|Withdrawal by Subject|0|||
37849506|NCT01056289|69533665|FG000|Open-label Phase|Lack of Efficacy|18|||
37849507|NCT01056289|69533666|FG001|Open-label Phase|Lack of Efficacy|0|||
37849508|NCT01056289|69533667|FG002|Open-label Phase|Lack of Efficacy|0|||
37849509|NCT01056289|69533668|FG003|Open-label Phase|Lack of Efficacy|0|||
37849510|NCT01056289|69533665|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
37849511|NCT01056289|69533666|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
37849512|NCT01056289|69533667|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
37849513|NCT01056289|69533668|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
37849514|NCT01056289|69533665|FG000|Double-blind Phase|Adverse Event|0|||
37849515|NCT01056289|69533666|FG001|Double-blind Phase|Adverse Event|1|||
37849516|NCT01056289|69533667|FG002|Double-blind Phase|Adverse Event|2|||
37849517|NCT01056289|69533668|FG003|Double-blind Phase|Adverse Event|1|||
37849518|NCT01056289|69533665|FG000|Double-blind Phase|Lost to Follow-up|0|||
37918692|NCT00601523|69605423|FG001|Overall Study|Lack of Efficacy|0|||
37918693|NCT00601523|69605422|FG000|Overall Study|Protocol Violation|5|||
37918694|NCT00601523|69605423|FG001|Overall Study|Protocol Violation|1|||
37918695|NCT00601523|69605422|FG000|Overall Study|Lost to Follow-up|0|||
37918696|NCT00601523|69605423|FG001|Overall Study|Lost to Follow-up|1|||
37918697|NCT00601523|69605422|FG000|Overall Study|Withdrawal by Subject|18|||
37918698|NCT00601523|69605423|FG001|Overall Study|Withdrawal by Subject|9|||
38027453|NCT03638258|69712301|FG000|Overall Study|Withdrawal by Subject|4|||
38027454|NCT03638258|69712302|FG001|Overall Study|Withdrawal by Subject|5|||
38027455|NCT03638258|69712303|FG002|Overall Study|Withdrawal by Subject|12|||
37918699|NCT00601523|69605422|FG000|Overall Study|Other|9|||
37918700|NCT00601523|69605423|FG001|Overall Study|Other|1|||
37918701|NCT00466687|69605429|FG000|Overall Study|Adverse Event|1|||
37918702|NCT00466687|69605429|FG000|Overall Study|Other complicating illness|3|||
37918703|NCT00466687|69605429|FG000|Overall Study|Withdrawal by Subject|1|||
37918704|NCT00466687|69605429|FG000|Overall Study|Disease progression|29|||
37918705|NCT00465985|69605451|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
37918706|NCT00465985|69605452|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
37918707|NCT00465985|69605451|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
37918708|NCT00465985|69605452|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
37918709|NCT00465985|69605451|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
37918710|NCT00465985|69605452|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
37918711|NCT00465985|69605451|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
37918712|NCT00465985|69605452|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
37918713|NCT00454051|69605463|FG000|Overall Study|Adverse Event|1|||
37918714|NCT00454051|69605464|FG001|Overall Study|Adverse Event|2|||
37918715|NCT00454051|69605463|FG000|Overall Study|Withdrawal by Subject|1|||
37918716|NCT00454051|69605464|FG001|Overall Study|Withdrawal by Subject|0|||
37918717|NCT00454051|69605463|FG000|Overall Study|Protocol Violation|1|||
37918718|NCT00454051|69605464|FG001|Overall Study|Protocol Violation|1|||
37918719|NCT00484939|69605472|FG000|Overall Study|Death|9|||
37918720|NCT00484939|69605473|FG001|Overall Study|Death|13|||
37918721|NCT00484939|69605472|FG000|Overall Study|Adverse Event|22|||
37918722|NCT00484939|69605473|FG001|Overall Study|Adverse Event|12|||
37918723|NCT00484939|69605472|FG000|Overall Study|Patient Withdrew Consent|19|||
37918724|NCT00484939|69605473|FG001|Overall Study|Patient Withdrew Consent|10|||
37918725|NCT00484939|69605472|FG000|Overall Study|Protocol Violation|3|||
37918726|NCT00484939|69605473|FG001|Overall Study|Protocol Violation|3|||
37918727|NCT00484939|69605472|FG000|Overall Study|Lost to Follow-up|0|||
37918728|NCT00484939|69605473|FG001|Overall Study|Lost to Follow-up|3|||
37918729|NCT00484939|69605472|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
37918730|NCT00484939|69605473|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
37918731|NCT00484939|69605472|FG000|Overall Study|Disease progression|67|||
37918732|NCT00484939|69605473|FG001|Overall Study|Disease progression|88|||
37918733|NCT00484939|69605472|FG000|Overall Study|Screen Failure|2|||
37918734|NCT00484939|69605473|FG001|Overall Study|Screen Failure|2|||
37918735|NCT00484939|69605472|FG000|Overall Study|Reason Not Specified|11|||
37918736|NCT00484939|69605473|FG001|Overall Study|Reason Not Specified|6|||
37918737|NCT00453973|69605481|FG000|Overall Study|Adverse Event|4|||
38027456|NCT03638258|69712301|FG000|Overall Study|Lack of Efficacy|0|||
37918738|NCT00453973|69605482|FG001|Overall Study|Adverse Event|9|||
37918739|NCT00453973|69605481|FG000|Overall Study|Withdrawal by Subject|7|||
37849519|NCT01056289|69533666|FG001|Double-blind Phase|Lost to Follow-up|2|||
37849520|NCT01056289|69533667|FG002|Double-blind Phase|Lost to Follow-up|2|||
37849521|NCT01056289|69533668|FG003|Double-blind Phase|Lost to Follow-up|2|||
37849522|NCT01056289|69533665|FG000|Double-blind Phase|Other|0|||
37849523|NCT01056289|69533666|FG001|Double-blind Phase|Other|0|||
37849524|NCT01056289|69533667|FG002|Double-blind Phase|Other|1|||
37849525|NCT01056289|69533668|FG003|Double-blind Phase|Other|2|||
37849526|NCT01056289|69533665|FG000|Double-blind Phase|Protocol Violation|0|||
37849527|NCT01056289|69533666|FG001|Double-blind Phase|Protocol Violation|0|||
37849528|NCT01056289|69533667|FG002|Double-blind Phase|Protocol Violation|1|||
37849529|NCT01056289|69533668|FG003|Double-blind Phase|Protocol Violation|1|||
37849530|NCT01056289|69533665|FG000|Double-blind Phase|Withdrawal by Subject|0|||
37849531|NCT01056289|69533666|FG001|Double-blind Phase|Withdrawal by Subject|0|||
37849532|NCT01056289|69533667|FG002|Double-blind Phase|Withdrawal by Subject|4|||
37849533|NCT01056289|69533668|FG003|Double-blind Phase|Withdrawal by Subject|2|||
37849534|NCT01056289|69533665|FG000|Double-blind Phase|Discontinuation symptom|0|||
37849535|NCT01056289|69533666|FG001|Double-blind Phase|Discontinuation symptom|1|||
37849536|NCT01056289|69533667|FG002|Double-blind Phase|Discontinuation symptom|2|||
37849537|NCT01056289|69533668|FG003|Double-blind Phase|Discontinuation symptom|2|||
37849538|NCT01056289|69533665|FG000|Double-blind Phase|Physician Decision|0|||
37849539|NCT01056289|69533666|FG001|Double-blind Phase|Physician Decision|0|||
37849540|NCT01056289|69533667|FG002|Double-blind Phase|Physician Decision|1|||
37849541|NCT01056289|69533668|FG003|Double-blind Phase|Physician Decision|0|||
37849542|NCT01039675|69533680|FG000|Overall Study|Adverse Event|0|||
37849543|NCT01039675|69533681|FG001|Overall Study|Adverse Event|2|||
37849544|NCT01039675|69533680|FG000|Overall Study|Lack of Efficacy|0|||
37849545|NCT01039675|69533681|FG001|Overall Study|Lack of Efficacy|2|||
37849546|NCT01039675|69533680|FG000|Overall Study|Withdrawal by Subject|0|||
37849547|NCT01039675|69533681|FG001|Overall Study|Withdrawal by Subject|1|||
37849548|NCT01039675|69533680|FG000|Overall Study|Lost to Follow-up|0|||
37849549|NCT01039675|69533681|FG001|Overall Study|Lost to Follow-up|1|||
37849550|NCT01039675|69533680|FG000|Overall Study|Physician Decision|0|||
37849551|NCT01039675|69533681|FG001|Overall Study|Physician Decision|1|||
37849552|NCT01033825|69533694|FG000|Overall Study|Withdrawal by Subject|2|||
37918740|NCT00453973|69605482|FG001|Overall Study|Withdrawal by Subject|6|||
37918741|NCT00453973|69605481|FG000|Overall Study|PI Decision|0|||
37918742|NCT00453973|69605482|FG001|Overall Study|PI Decision|2|||
37918743|NCT00453973|69605481|FG000|Overall Study|Relocation|1|||
37849553|NCT01033825|69533695|FG001|Overall Study|Withdrawal by Subject|3|||
37849554|NCT01033825|69533696|FG002|Overall Study|Withdrawal by Subject|2|||
37849555|NCT01033825|69533697|FG003|Overall Study|Withdrawal by Subject|1|||
37849556|NCT01033825|69533698|FG004|Overall Study|Withdrawal by Subject|1|||
37849557|NCT01033825|69533699|FG005|Overall Study|Withdrawal by Subject|0|||
37849558|NCT01033825|69533700|FG006|Overall Study|Withdrawal by Subject|0|||
37849559|NCT01033825|69533694|FG000|Overall Study|Adverse Event|0|||
37849560|NCT01033825|69533695|FG001|Overall Study|Adverse Event|0|||
37849561|NCT01033825|69533696|FG002|Overall Study|Adverse Event|0|||
37849562|NCT01033825|69533697|FG003|Overall Study|Adverse Event|1|||
37849563|NCT01033825|69533698|FG004|Overall Study|Adverse Event|0|||
37849564|NCT01033825|69533699|FG005|Overall Study|Adverse Event|0|||
37849565|NCT01033825|69533700|FG006|Overall Study|Adverse Event|0|||
37849566|NCT01033825|69533694|FG000|Overall Study|Protocol Violation|1|||
37849567|NCT01033825|69533695|FG001|Overall Study|Protocol Violation|0|||
37849568|NCT01033825|69533696|FG002|Overall Study|Protocol Violation|0|||
37918744|NCT00453973|69605482|FG001|Overall Study|Relocation|0|||
37918745|NCT00453973|69605481|FG000|Overall Study|Renal transplant|1|||
37918746|NCT00453973|69605482|FG001|Overall Study|Renal transplant|1|||
37918747|NCT00453973|69605481|FG000|Overall Study|Site closed by sponsor|3|||
37918748|NCT00453973|69605482|FG001|Overall Study|Site closed by sponsor|0|||
37918749|NCT00453973|69605481|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
37918750|NCT00453973|69605482|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
37918751|NCT00465361|69605488|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
37918752|NCT00464815|69605494|FG000|Overall Study|Withdrawal by Subject|6|||
37918753|NCT00464815|69605495|FG001|Overall Study|Withdrawal by Subject|3|||
37918754|NCT00464737|69605504|FG000|Overall Study|Adverse Event|12|||
37918755|NCT00464737|69605505|FG001|Overall Study|Adverse Event|17|||
37849569|NCT01033825|69533697|FG003|Overall Study|Protocol Violation|0|||
37849570|NCT01033825|69533698|FG004|Overall Study|Protocol Violation|0|||
37849571|NCT01033825|69533699|FG005|Overall Study|Protocol Violation|0|||
37849572|NCT01033825|69533700|FG006|Overall Study|Protocol Violation|0|||
37849573|NCT01033825|69533694|FG000|Overall Study|Other|0|||
37849574|NCT01033825|69533695|FG001|Overall Study|Other|0|||
37849575|NCT01033825|69533696|FG002|Overall Study|Other|0|||
37849576|NCT01033825|69533697|FG003|Overall Study|Other|0|||
37849577|NCT01033825|69533698|FG004|Overall Study|Other|1|||
37849578|NCT01033825|69533699|FG005|Overall Study|Other|0|||
37849579|NCT01033825|69533700|FG006|Overall Study|Other|0|||
37849580|NCT01033747|69533720|FG000|Overall Study|Adverse Event|9|||
37849581|NCT01033747|69533721|FG001|Overall Study|Adverse Event|4|||
37849582|NCT01033747|69533720|FG000|Overall Study|Abnormal Laboratory Value|1|||
37918756|NCT00464737|69605506|FG002|Overall Study|Adverse Event|33|||
37918757|NCT00464737|69605504|FG000|Overall Study|Lack of Efficacy|7|||
37918758|NCT00464737|69605505|FG001|Overall Study|Lack of Efficacy|7|||
37918759|NCT00464737|69605506|FG002|Overall Study|Lack of Efficacy|4|||
37918760|NCT00464737|69605504|FG000|Overall Study|Withdrawal by Subject|5|||
37918761|NCT00464737|69605505|FG001|Overall Study|Withdrawal by Subject|3|||
37849583|NCT01033747|69533721|FG001|Overall Study|Abnormal Laboratory Value|0|||
37918762|NCT00464737|69605506|FG002|Overall Study|Withdrawal by Subject|5|||
37918763|NCT00464737|69605504|FG000|Overall Study|Protocol Violation|1|||
37918764|NCT00464737|69605505|FG001|Overall Study|Protocol Violation|1|||
37918765|NCT00464737|69605506|FG002|Overall Study|Protocol Violation|5|||
37918766|NCT00464737|69605504|FG000|Overall Study|Non-compliance|0|||
37918767|NCT00464737|69605505|FG001|Overall Study|Non-compliance|1|||
37918768|NCT00464737|69605506|FG002|Overall Study|Non-compliance|1|||
37918769|NCT00464737|69605504|FG000|Overall Study|Lost to Follow-up|5|||
37918770|NCT00464737|69605505|FG001|Overall Study|Lost to Follow-up|2|||
37918771|NCT00464737|69605506|FG002|Overall Study|Lost to Follow-up|5|||
38027457|NCT03638258|69712302|FG001|Overall Study|Lack of Efficacy|0|||
38027458|NCT03638258|69712303|FG002|Overall Study|Lack of Efficacy|2|||
38027459|NCT01670656|69712317|FG000|Overall Study|Non-compliance with study drug|0|||
38027460|NCT01670656|69712318|FG001|Overall Study|Non-compliance with study drug|0|||
38027461|NCT01670656|69712319|FG002|Overall Study|Non-compliance with study drug|3|||
38027462|NCT01670656|69712320|FG003|Overall Study|Non-compliance with study drug|0|||
38027463|NCT01670656|69712321|FG004|Overall Study|Non-compliance with study drug|1|||
37849584|NCT01033747|69533720|FG000|Overall Study|Abnormal test procedure|0|||
37849585|NCT01033747|69533721|FG001|Overall Study|Abnormal test procedure|1|||
38027464|NCT01670656|69712317|FG000|Overall Study|Pregnancy|0|||
38027465|NCT01670656|69712318|FG001|Overall Study|Pregnancy|0|||
38027466|NCT01670656|69712319|FG002|Overall Study|Pregnancy|0|||
38027467|NCT01670656|69712320|FG003|Overall Study|Pregnancy|0|||
38027468|NCT01670656|69712321|FG004|Overall Study|Pregnancy|1|||
38027469|NCT01670656|69712317|FG000|Overall Study|Withdrawal by Subject|1|||
38027470|NCT01670656|69712318|FG001|Overall Study|Withdrawal by Subject|1|||
38027471|NCT01670656|69712319|FG002|Overall Study|Withdrawal by Subject|0|||
38027472|NCT01670656|69712320|FG003|Overall Study|Withdrawal by Subject|0|||
38027473|NCT01670656|69712321|FG004|Overall Study|Withdrawal by Subject|0|||
38027474|NCT01670656|69712317|FG000|Overall Study|Non-compliance with protocol|0|||
38027475|NCT01670656|69712318|FG001|Overall Study|Non-compliance with protocol|3|||
38027476|NCT01670656|69712319|FG002|Overall Study|Non-compliance with protocol|1|||
38027477|NCT01670656|69712320|FG003|Overall Study|Non-compliance with protocol|1|||
38027478|NCT01670656|69712321|FG004|Overall Study|Non-compliance with protocol|2|||
38027479|NCT01670656|69712317|FG000|Overall Study|Adverse Event|2|||
38027480|NCT01670656|69712318|FG001|Overall Study|Adverse Event|2|||
38027481|NCT01670656|69712319|FG002|Overall Study|Adverse Event|2|||
38027482|NCT01670656|69712320|FG003|Overall Study|Adverse Event|3|||
38027483|NCT01670656|69712321|FG004|Overall Study|Adverse Event|3|||
38027484|NCT01670656|69712317|FG000|Overall Study|Subject withdrew consent|0|||
38027485|NCT01670656|69712318|FG001|Overall Study|Subject withdrew consent|1|||
38027486|NCT01670656|69712319|FG002|Overall Study|Subject withdrew consent|2|||
38027487|NCT01670656|69712320|FG003|Overall Study|Subject withdrew consent|1|||
38027488|NCT01670656|69712321|FG004|Overall Study|Subject withdrew consent|1|||
38027489|NCT01670656|69712317|FG000|Overall Study|Lost to Follow-up|0|||
38027490|NCT01670656|69712318|FG001|Overall Study|Lost to Follow-up|0|||
38027491|NCT01670656|69712319|FG002|Overall Study|Lost to Follow-up|0|||
38027492|NCT01670656|69712320|FG003|Overall Study|Lost to Follow-up|0|||
37918772|NCT00464737|69605504|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
37849586|NCT01033747|69533720|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
37849587|NCT01033747|69533721|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
37849588|NCT01033747|69533720|FG000|Overall Study|Protocol Violation|1|||
37849589|NCT01033747|69533721|FG001|Overall Study|Protocol Violation|0|||
37849590|NCT01033747|69533720|FG000|Overall Study|Withdrawal by Subject|9|||
37849591|NCT01033747|69533721|FG001|Overall Study|Withdrawal by Subject|6|||
37918773|NCT00464737|69605505|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
38027493|NCT01670656|69712321|FG004|Overall Study|Lost to Follow-up|3|||
38027494|NCT01670656|69712317|FG000|Overall Study|Subject moved|0|||
38027495|NCT01670656|69712318|FG001|Overall Study|Subject moved|0|||
38027496|NCT01670656|69712319|FG002|Overall Study|Subject moved|0|||
38027497|NCT01670656|69712320|FG003|Overall Study|Subject moved|1|||
37849592|NCT01033747|69533720|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
37849593|NCT01033747|69533721|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
37918774|NCT00464737|69605506|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
38027498|NCT01670656|69712321|FG004|Overall Study|Subject moved|0|||
38027499|NCT00068445|69712335|FG000|Randomization|Cancel|1|||
37849594|NCT01033747|69533720|FG000|Overall Study|Stopped at end of Extension 1|2|||
37849595|NCT01033747|69533721|FG001|Overall Study|Stopped at end of Extension 1|0|||
37849596|NCT01091428|69533731|FG000|Phase 1|Progressive Disease|24|||
37918775|NCT00464737|69605504|FG000|Overall Study|Other: Subject left town; family illness|1|||
37849597|NCT01091428|69533732|FG001|Phase 1|Progressive Disease|8|||
37849598|NCT01091428|69533733|FG002|Phase 1|Progressive Disease|0|||
37849599|NCT01091428|69533734|FG003|Phase 1|Progressive Disease|0|||
37918776|NCT00464737|69605505|FG001|Overall Study|Other: Subject left town; family illness|0|||
37918777|NCT00464737|69605506|FG002|Overall Study|Other: Subject left town; family illness|0|||
37918778|NCT00464737|69605504|FG000|Overall Study|Other: Study demands too great|0|||
37918779|NCT00464737|69605505|FG001|Overall Study|Other: Study demands too great|1|||
37918780|NCT00464737|69605506|FG002|Overall Study|Other: Study demands too great|0|||
37918781|NCT00464737|69605504|FG000|Overall Study|Other: Personal family reasons|0|||
37849600|NCT01091428|69533731|FG000|Phase 1|Symptomatic Deterioration|3|||
37849601|NCT01091428|69533732|FG001|Phase 1|Symptomatic Deterioration|2|||
37849602|NCT01091428|69533733|FG002|Phase 1|Symptomatic Deterioration|0|||
37849603|NCT01091428|69533734|FG003|Phase 1|Symptomatic Deterioration|0|||
37918782|NCT00464737|69605505|FG001|Overall Study|Other: Personal family reasons|0|||
37918783|NCT00464737|69605506|FG002|Overall Study|Other: Personal family reasons|1|||
37918784|NCT00464737|69605504|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
37918785|NCT00464737|69605505|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
37918786|NCT00464737|69605506|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
37918787|NCT00453349|69605516|FG000|Randomized|Adverse Event|12|||
37918788|NCT00453349|69605517|FG001|Randomized|Adverse Event|11|||
37918789|NCT00453349|69605516|FG000|Randomized|Lack of Efficacy|2|||
37918790|NCT00453349|69605517|FG001|Randomized|Lack of Efficacy|1|||
37918791|NCT00453349|69605516|FG000|Randomized|Lost to Follow-up|7|||
37849604|NCT01091428|69533731|FG000|Phase 1|Adverse Event|2|||
37849605|NCT01091428|69533732|FG001|Phase 1|Adverse Event|0|||
37849606|NCT01091428|69533733|FG002|Phase 1|Adverse Event|0|||
37918792|NCT00453349|69605517|FG001|Randomized|Lost to Follow-up|5|||
37918793|NCT00453349|69605516|FG000|Randomized|Protocol Violation|1|||
37918794|NCT00453349|69605517|FG001|Randomized|Protocol Violation|1|||
37918795|NCT00453349|69605516|FG000|Randomized|Withdrawal by Subject|3|||
37918796|NCT00453349|69605517|FG001|Randomized|Withdrawal by Subject|5|||
37918797|NCT00453349|69605516|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
37918798|NCT00453349|69605517|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
37918799|NCT00453349|69605516|FG000|Completed Study|Adverse Event|12|||
37918800|NCT00453349|69605517|FG001|Completed Study|Adverse Event|11|||
37918801|NCT00453349|69605516|FG000|Completed Study|Lack of Efficacy|2|||
37918802|NCT00453349|69605517|FG001|Completed Study|Lack of Efficacy|1|||
37918803|NCT00453349|69605516|FG000|Completed Study|Lost to Follow-up|7|||
37918804|NCT00453349|69605517|FG001|Completed Study|Lost to Follow-up|5|||
37918805|NCT00453349|69605516|FG000|Completed Study|Protocol Violation|1|||
38027500|NCT00068445|69712336|FG001|Randomization|Cancel|3|||
38027501|NCT00068445|69712335|FG000|Randomization|Ineligible|1|||
38027502|NCT00068445|69712336|FG001|Randomization|Ineligible|1|||
38027503|NCT00068445|69712335|FG000|Treatment|Refused Further Treatment|13|||
38027504|NCT00068445|69712336|FG001|Treatment|Refused Further Treatment|10|||
38027505|NCT00068445|69712335|FG000|Treatment|Adverse Event|7|||
38027506|NCT00068445|69712336|FG001|Treatment|Adverse Event|1|||
38027507|NCT00068445|69712335|FG000|Treatment|Other (Specifics not available)|9|||
38027508|NCT00068445|69712336|FG001|Treatment|Other (Specifics not available)|5|||
38027509|NCT03653208|69712351|FG000|Overall Study|Withdrawal by Subject|0|||
38027510|NCT03653208|69712352|FG001|Overall Study|Withdrawal by Subject|0|||
38027511|NCT03653208|69712353|FG002|Overall Study|Withdrawal by Subject|0|||
38027512|NCT03653208|69712354|FG003|Overall Study|Withdrawal by Subject|0|||
38027513|NCT03653208|69712355|FG004|Overall Study|Withdrawal by Subject|1|||
38027514|NCT03653208|69712356|FG005|Overall Study|Withdrawal by Subject|0|||
38027515|NCT03653208|69712357|FG006|Overall Study|Withdrawal by Subject|0|||
38027516|NCT03653208|69712358|FG007|Overall Study|Withdrawal by Subject|1|||
38027517|NCT03653208|69712359|FG008|Overall Study|Withdrawal by Subject|1|||
38027518|NCT03545984|69712381|FG000|Overall Study|CSF cases not present during rotation|11|||
38027519|NCT03545984|69712382|FG001|Overall Study|CSF cases not present during rotation|9|||
38027520|NCT03033784|69712390|FG000|Overall Study|Anxiety related to MRI scanner|0|||
38027521|NCT03033784|69712391|FG001|Overall Study|Anxiety related to MRI scanner|1|||
37918806|NCT00453349|69605517|FG001|Completed Study|Protocol Violation|1|||
37918807|NCT00453349|69605516|FG000|Completed Study|Withdrawal by Subject|3|||
37918808|NCT00453349|69605517|FG001|Completed Study|Withdrawal by Subject|5|||
37918809|NCT00453349|69605516|FG000|Completed Study|Lost to follow up after study treatment|2|||
37918810|NCT00453349|69605517|FG001|Completed Study|Lost to follow up after study treatment|11|||
37918811|NCT00464269|69605527|FG000|Overall Study|Lack of Efficacy|1|||
37918812|NCT00464269|69605528|FG001|Overall Study|Lack of Efficacy|0|||
37918813|NCT00464269|69605529|FG002|Overall Study|Lack of Efficacy|0|||
38027522|NCT03033784|69712392|FG002|Overall Study|Anxiety related to MRI scanner|0|||
38027523|NCT03033784|69712393|FG003|Overall Study|Anxiety related to MRI scanner|0|||
37849607|NCT01091428|69533734|FG003|Phase 1|Adverse Event|0|||
37918814|NCT00464269|69605530|FG003|Overall Study|Lack of Efficacy|0|||
37849608|NCT01091428|69533731|FG000|Phase 1|Withdrawal by Subject|7|||
37849609|NCT01091428|69533732|FG001|Phase 1|Withdrawal by Subject|0|||
37849610|NCT01091428|69533733|FG002|Phase 1|Withdrawal by Subject|0|||
37849611|NCT01091428|69533734|FG003|Phase 1|Withdrawal by Subject|0|||
37849612|NCT01091428|69533731|FG000|Phase 1|Reason not specified|0|||
37849613|NCT01091428|69533732|FG001|Phase 1|Reason not specified|1|||
37849614|NCT01091428|69533733|FG002|Phase 1|Reason not specified|0|||
37849615|NCT01091428|69533734|FG003|Phase 1|Reason not specified|0|||
37849616|NCT01091428|69533731|FG000|Phase 1|Single-Patient IND|2|||
37849617|NCT01091428|69533732|FG001|Phase 1|Single-Patient IND|0|||
38027524|NCT03033784|69712394|FG004|Overall Study|Anxiety related to MRI scanner|0|||
38027525|NCT03033784|69712395|FG005|Overall Study|Anxiety related to MRI scanner|0|||
38027526|NCT03033784|69712396|FG006|Overall Study|Anxiety related to MRI scanner|0|||
38027527|NCT03033784|69712397|FG007|Overall Study|Anxiety related to MRI scanner|0|||
38027528|NCT03033784|69712398|FG008|Overall Study|Anxiety related to MRI scanner|0|||
38027529|NCT03033784|69712399|FG009|Overall Study|Anxiety related to MRI scanner|0|||
38027530|NCT03033784|69712400|FG010|Overall Study|Anxiety related to MRI scanner|0|||
38027531|NCT03033784|69712401|FG011|Overall Study|Anxiety related to MRI scanner|0|||
38027532|NCT03033784|69712402|FG012|Overall Study|Anxiety related to MRI scanner|0|||
38027533|NCT03033784|69712390|FG000|Overall Study|Withdrawal by Subject|0|||
38027534|NCT03033784|69712391|FG001|Overall Study|Withdrawal by Subject|0|||
38027535|NCT03033784|69712392|FG002|Overall Study|Withdrawal by Subject|0|||
38027536|NCT03033784|69712393|FG003|Overall Study|Withdrawal by Subject|0|||
38027537|NCT03033784|69712394|FG004|Overall Study|Withdrawal by Subject|0|||
38027538|NCT03033784|69712395|FG005|Overall Study|Withdrawal by Subject|0|||
38027539|NCT03033784|69712396|FG006|Overall Study|Withdrawal by Subject|0|||
38027540|NCT03033784|69712397|FG007|Overall Study|Withdrawal by Subject|0|||
38027541|NCT03033784|69712398|FG008|Overall Study|Withdrawal by Subject|0|||
38027542|NCT03033784|69712399|FG009|Overall Study|Withdrawal by Subject|0|||
38027543|NCT03033784|69712400|FG010|Overall Study|Withdrawal by Subject|0|||
38027544|NCT03033784|69712401|FG011|Overall Study|Withdrawal by Subject|0|||
38027545|NCT03033784|69712402|FG012|Overall Study|Withdrawal by Subject|2|||
38027546|NCT00038649|69712413|FG000|Overall Study|Adverse Event|9|||
38027547|NCT03544268|69712419|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
38027548|NCT03544268|69712420|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
38027549|NCT03652818|69712431|FG000|Overall Study|Adverse Event|1|||
38027550|NCT03652818|69712432|FG001|Overall Study|Adverse Event|0|||
37849618|NCT01091428|69533733|FG002|Phase 1|Single-Patient IND|0|||
37849619|NCT01091428|69533734|FG003|Phase 1|Single-Patient IND|0|||
37849620|NCT01091428|69533731|FG000|Phase 2|Progressive Disease|0|||
37849621|NCT01091428|69533732|FG001|Phase 2|Progressive Disease|0|||
37849622|NCT01091428|69533733|FG002|Phase 2|Progressive Disease|44|||
37849623|NCT01091428|69533734|FG003|Phase 2|Progressive Disease|46|||
37849624|NCT01091428|69533731|FG000|Phase 2|Symptomatic Deterioration|0|||
37849625|NCT01091428|69533732|FG001|Phase 2|Symptomatic Deterioration|0|||
37849626|NCT01091428|69533733|FG002|Phase 2|Symptomatic Deterioration|1|||
37849627|NCT01091428|69533734|FG003|Phase 2|Symptomatic Deterioration|6|||
37849628|NCT01091428|69533731|FG000|Phase 2|Adverse Event|0|||
38027551|NCT03652818|69712433|FG002|Overall Study|Adverse Event|0|||
38027552|NCT03652818|69712434|FG003|Overall Study|Adverse Event|0|||
38027553|NCT03652818|69712435|FG004|Overall Study|Adverse Event|0|||
38027554|NCT03652818|69712431|FG000|Overall Study|Physician Decision|1|||
37849629|NCT01091428|69533732|FG001|Phase 2|Adverse Event|0|||
37849630|NCT01091428|69533733|FG002|Phase 2|Adverse Event|12|||
37849631|NCT01091428|69533734|FG003|Phase 2|Adverse Event|5|||
37849632|NCT01091428|69533731|FG000|Phase 2|Withdrawal by Subject|0|||
37849633|NCT01091428|69533732|FG001|Phase 2|Withdrawal by Subject|0|||
37849634|NCT01091428|69533733|FG002|Phase 2|Withdrawal by Subject|9|||
37849635|NCT01091428|69533734|FG003|Phase 2|Withdrawal by Subject|8|||
37849636|NCT01091428|69533731|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
37849637|NCT01091428|69533732|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
37849638|NCT01091428|69533733|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
37849639|NCT01091428|69533734|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
37849640|NCT01091428|69533731|FG000|Phase 2|Reason not specified|0|||
37849641|NCT01091428|69533732|FG001|Phase 2|Reason not specified|0|||
37849642|NCT01091428|69533733|FG002|Phase 2|Reason not specified|4|||
37849643|NCT01091428|69533734|FG003|Phase 2|Reason not specified|3|||
37849644|NCT01091428|69533731|FG000|Phase 2|Physician Decision|0|||
37849645|NCT01091428|69533732|FG001|Phase 2|Physician Decision|0|||
37849646|NCT01091428|69533733|FG002|Phase 2|Physician Decision|2|||
37849647|NCT01091428|69533734|FG003|Phase 2|Physician Decision|0|||
37849648|NCT01096342|69533753|FG000|Overall Study|Protocol Violation|1|||
37849649|NCT01039519|69533757|FG000|Treatment|Progressive disease|20|||
37849650|NCT01039519|69533757|FG000|Treatment|Treatment failure|2|||
37849651|NCT01039519|69533757|FG000|Treatment|Adverse Event|3|||
37849652|NCT01039519|69533757|FG000|Treatment|Physician Decision|2|||
37849653|NCT01039519|69533757|FG000|Survival Follow-up|Death|23|||
37849654|NCT01039519|69533757|FG000|Survival Follow-up|Sponsor decision|4|||
37849655|NCT01096186|69533761|FG000|Overall Study|Adverse Event|16|||
37849656|NCT01096186|69533761|FG000|Overall Study|Death|4|||
37849657|NCT01096186|69533761|FG000|Overall Study|Lack of Efficacy|4|||
37849658|NCT01096186|69533761|FG000|Overall Study|Lost to Follow-up|2|||
37849659|NCT01096186|69533761|FG000|Overall Study|Withdrawal by Subject|22|||
37849660|NCT01096186|69533761|FG000|Overall Study|Physician Decision|1|||
37849661|NCT01096186|69533761|FG000|Overall Study|Noncompliance with study drug|1|||
37918815|NCT00464269|69605527|FG000|Overall Study|Lost to Follow-up|0|||
37918816|NCT00464269|69605528|FG001|Overall Study|Lost to Follow-up|4|||
37918817|NCT00464269|69605529|FG002|Overall Study|Lost to Follow-up|0|||
37918818|NCT00464269|69605530|FG003|Overall Study|Lost to Follow-up|1|||
37918819|NCT00464269|69605527|FG000|Overall Study|Withdrawal by Subject|0|||
37918820|NCT00464269|69605528|FG001|Overall Study|Withdrawal by Subject|2|||
37918821|NCT00464269|69605529|FG002|Overall Study|Withdrawal by Subject|1|||
37918822|NCT00464269|69605530|FG003|Overall Study|Withdrawal by Subject|1|||
37918823|NCT00464269|69605527|FG000|Overall Study|Other reason|3|||
37918824|NCT00464269|69605528|FG001|Overall Study|Other reason|3|||
37918825|NCT00464269|69605529|FG002|Overall Study|Other reason|1|||
37918826|NCT00464269|69605530|FG003|Overall Study|Other reason|1|||
37918827|NCT00464269|69605527|FG000|Overall Study|AE, serious fatal|0|||
37918828|NCT00464269|69605528|FG001|Overall Study|AE, serious fatal|0|||
37849662|NCT01032889|69533768|FG000|Overall Study|Adverse Event|2|||
37849663|NCT01032889|69533769|FG001|Overall Study|Adverse Event|2|||
37849664|NCT01032889|69533770|FG002|Overall Study|Adverse Event|0|||
37918829|NCT00464269|69605529|FG002|Overall Study|AE, serious fatal|1|||
37918830|NCT00464269|69605530|FG003|Overall Study|AE, serious fatal|1|||
37918831|NCT00464269|69605527|FG000|Overall Study|SAE, non-fatal|0|||
37918832|NCT00464269|69605528|FG001|Overall Study|SAE, non-fatal|0|||
37918833|NCT00464269|69605529|FG002|Overall Study|SAE, non-fatal|0|||
37918834|NCT00464269|69605530|FG003|Overall Study|SAE, non-fatal|1|||
37918835|NCT00464269|69605527|FG000|Overall Study|AE, non-serious non-fatal|2|||
37918836|NCT00464269|69605528|FG001|Overall Study|AE, non-serious non-fatal|8|||
37918837|NCT00464269|69605529|FG002|Overall Study|AE, non-serious non-fatal|3|||
37918838|NCT00464269|69605530|FG003|Overall Study|AE, non-serious non-fatal|4|||
37918839|NCT00464269|69605527|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
37918840|NCT00464269|69605528|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
37918841|NCT00464269|69605529|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
37918842|NCT00464269|69605530|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
37918843|NCT00484315|69605544|FG000|12-Month Clinical Follow-up|Death|6|||
37918844|NCT00484315|69605545|FG001|12-Month Clinical Follow-up|Death|2|||
37918845|NCT00484315|69605544|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
37918846|NCT00484315|69605545|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
37918847|NCT00484315|69605544|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
37918848|NCT00484315|69605545|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
37918849|NCT00484315|69605544|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
37918850|NCT00484315|69605545|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
37918851|NCT00484315|69605544|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
37918852|NCT00484315|69605545|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
37918853|NCT00484315|69605544|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
37918854|NCT00484315|69605545|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
37918855|NCT00484315|69605544|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
38027555|NCT03652818|69712432|FG001|Overall Study|Physician Decision|0|||
38027556|NCT03652818|69712433|FG002|Overall Study|Physician Decision|0|||
38027557|NCT03652818|69712434|FG003|Overall Study|Physician Decision|0|||
38027558|NCT03652818|69712435|FG004|Overall Study|Physician Decision|0|||
38027559|NCT03652818|69712431|FG000|Overall Study|Lost to Follow-up|0|||
37849665|NCT01032889|69533768|FG000|Overall Study|Withdrawal of Consent|1|||
37849666|NCT01032889|69533769|FG001|Overall Study|Withdrawal of Consent|2|||
37849667|NCT01032889|69533770|FG002|Overall Study|Withdrawal of Consent|1|||
37849668|NCT01032889|69533768|FG000|Overall Study|Patient Request|0|||
37849669|NCT01032889|69533769|FG001|Overall Study|Patient Request|1|||
37918856|NCT00484315|69605545|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
37918857|NCT00463801|69605551|FG000|Overall Study|Protocol Violation|1|||
37918858|NCT00463801|69605551|FG000|Overall Study|Lack of Efficacy|2|||
38027560|NCT03652818|69712432|FG001|Overall Study|Lost to Follow-up|1|||
37918859|NCT00463801|69605551|FG000|Overall Study|Adverse Event|4|||
38027561|NCT03652818|69712433|FG002|Overall Study|Lost to Follow-up|2|||
38027562|NCT03652818|69712434|FG003|Overall Study|Lost to Follow-up|1|||
38027563|NCT03652818|69712435|FG004|Overall Study|Lost to Follow-up|1|||
37849670|NCT01032889|69533770|FG002|Overall Study|Patient Request|0|||
37849671|NCT01032889|69533768|FG000|Overall Study|Lost to Follow-up|1|||
37849672|NCT01032889|69533769|FG001|Overall Study|Lost to Follow-up|1|||
37849673|NCT01032889|69533770|FG002|Overall Study|Lost to Follow-up|0|||
37918860|NCT00463801|69605551|FG000|Overall Study|Lost to Follow-up|5|||
37849674|NCT01032889|69533768|FG000|Overall Study|Lack of Submental Fat|2|||
37849675|NCT01032889|69533769|FG001|Overall Study|Lack of Submental Fat|8|||
37849676|NCT01032889|69533770|FG002|Overall Study|Lack of Submental Fat|1|||
37849677|NCT01032889|69533768|FG000|Overall Study|Miscellaneous Reasons|2|||
37849678|NCT01032889|69533769|FG001|Overall Study|Miscellaneous Reasons|1|||
37849679|NCT01032889|69533770|FG002|Overall Study|Miscellaneous Reasons|1|||
37849680|NCT01049503|69533784|FG000|Overall Study|Lost to Follow-up|11|||
37849681|NCT01049503|69533785|FG001|Overall Study|Lost to Follow-up|12|||
37849682|NCT01049503|69533786|FG002|Overall Study|Lost to Follow-up|24|||
37849683|NCT01049503|69533787|FG003|Overall Study|Lost to Follow-up|26|||
37849684|NCT01049503|69533788|FG004|Overall Study|Lost to Follow-up|27|||
37849685|NCT01049503|69533789|FG005|Overall Study|Lost to Follow-up|8|||
37849686|NCT01029925|69533812|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
37849687|NCT01029925|69533812|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
37849688|NCT01029925|69533812|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
37849689|NCT01029691|69533819|FG000|Continued APAP to Delivery|Death|0|||
37849690|NCT01029691|69533820|FG001|Continued APAP to Delivery|Death|0|||
37849691|NCT01029691|69533821|FG002|Continued APAP to Delivery|Death|1|||
37849692|NCT01029535|69533830|FG000|Overall Study|Lost to Follow-up|24|||
37849693|NCT01029535|69533830|FG000|Overall Study|Protocol Violation|2|||
37849694|NCT01029535|69533830|FG000|Overall Study|Participant Withdrew Consent|2|||
37849695|NCT01029535|69533830|FG000|Overall Study|Adverse Event|1|||
37849696|NCT01029535|69533830|FG000|Overall Study|Use of Another Treatment|1|||
37849697|NCT01029535|69533830|FG000|Overall Study|Death|1|||
37849698|NCT01028053|69533835|FG000|Overall Study|Screen Failure|113|||
37849699|NCT01028053|69533835|FG000|Overall Study|Patient Request|11|||
37849700|NCT01028053|69533835|FG000|Overall Study|Protocol Violation|1|||
37918861|NCT00463801|69605551|FG000|Overall Study|No longer require therapy|1|||
37918862|NCT00463567|69605562|FG000|Overall Study|Adverse Event|29|||
37918863|NCT00463567|69605563|FG001|Overall Study|Adverse Event|26|||
37918864|NCT00463567|69605564|FG002|Overall Study|Adverse Event|17|||
37918865|NCT00463567|69605565|FG003|Overall Study|Adverse Event|46|||
37918866|NCT00463567|69605566|FG004|Overall Study|Adverse Event|10|||
37918867|NCT00463567|69605567|FG005|Overall Study|Adverse Event|10|||
37918868|NCT00463567|69605568|FG006|Overall Study|Adverse Event|4|||
38027564|NCT03619902|69712447|FG000|Overall Study|Termination of Study by Investigator|1|||
37918869|NCT00463567|69605562|FG000|Overall Study|Withdrawal by Subject|29|||
38027565|NCT03619902|69712447|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
38027566|NCT00620464|69712453|FG000|Overall Study|Adverse Event|15|||
38027567|NCT00620464|69712454|FG001|Overall Study|Adverse Event|17|||
38027568|NCT00620464|69712453|FG000|Overall Study|Lost to Follow-up|1|||
38027569|NCT00620464|69712454|FG001|Overall Study|Lost to Follow-up|1|||
38027570|NCT00620464|69712453|FG000|Overall Study|Planning Pregnancy|1|||
38027571|NCT00620464|69712454|FG001|Overall Study|Planning Pregnancy|4|||
38027572|NCT00620464|69712453|FG000|Overall Study|Personal|2|||
38027573|NCT00620464|69712454|FG001|Overall Study|Personal|2|||
38027574|NCT00620464|69712453|FG000|Overall Study|Used prohibited medication|1|||
38027575|NCT00620464|69712454|FG001|Overall Study|Used prohibited medication|0|||
38027576|NCT03652662|69712462|FG000|Overall Study|Withdrawal by Subject|2|||
38027577|NCT03652662|69712463|FG001|Overall Study|Withdrawal by Subject|1|||
38027578|NCT03652662|69712462|FG000|Overall Study|Lost to Follow-up|1|||
38027579|NCT03652662|69712463|FG001|Overall Study|Lost to Follow-up|0|||
38027580|NCT03560258|69712472|FG000|Overall Study|Lost to Follow-up|3|||
38027581|NCT03560258|69712473|FG001|Overall Study|Lost to Follow-up|0|||
38027582|NCT03560258|69712474|FG002|Overall Study|Lost to Follow-up|0|||
38027583|NCT03560258|69712472|FG000|Overall Study|Protocol Violation|0|||
38027584|NCT03560258|69712473|FG001|Overall Study|Protocol Violation|1|||
38027585|NCT03560258|69712474|FG002|Overall Study|Protocol Violation|0|||
38027586|NCT03560258|69712472|FG000|Overall Study|Withdrawal by Subject|0|||
38027587|NCT03560258|69712473|FG001|Overall Study|Withdrawal by Subject|0|||
38027588|NCT03560258|69712474|FG002|Overall Study|Withdrawal by Subject|1|||
38027589|NCT02768662|69712482|FG000|Overall Study|Adverse Event|1|||
38027590|NCT02768662|69712482|FG000|Overall Study|Lost to Follow-up|4|||
38027591|NCT02768662|69712482|FG000|Overall Study|Withdrawal by Subject|3|||
37849701|NCT01028053|69533835|FG000|Overall Study|Physician Decision|2|||
37849702|NCT01028053|69533835|FG000|Overall Study|Technical Problem|1|||
37849703|NCT01028053|69533835|FG000|Overall Study|Terminated by Sponsor|1|||
37849704|NCT01028053|69533835|FG000|Overall Study|Various reasons|4|||
37849705|NCT01023217|69533843|FG000|Overall Study|Withdrawal by Subject|1|||
37849706|NCT01023217|69533844|FG001|Overall Study|Withdrawal by Subject|0|||
37849707|NCT01095796|69533852|FG000|Overall Study|Randomized but Not Treated|5|||
37849708|NCT01095796|69533853|FG001|Overall Study|Randomized but Not Treated|2|||
38027592|NCT02768662|69712482|FG000|Overall Study|Study terminated by Sponsor|78|||
38027593|NCT03539432|69712488|FG000|Overall Study|Lost to Follow-up|0|||
37849709|NCT01095796|69533852|FG000|Overall Study|Adverse Event|9|||
37849710|NCT01095796|69533853|FG001|Overall Study|Adverse Event|19|||
37849711|NCT01095796|69533852|FG000|Overall Study|Death|3|||
37918870|NCT00463567|69605563|FG001|Overall Study|Withdrawal by Subject|22|||
37849712|NCT01095796|69533853|FG001|Overall Study|Death|2|||
37849713|NCT01095796|69533852|FG000|Overall Study|Pregnancy|2|||
37849714|NCT01095796|69533853|FG001|Overall Study|Pregnancy|0|||
37849715|NCT01095796|69533852|FG000|Overall Study|Lack of Efficacy|5|||
37849716|NCT01095796|69533853|FG001|Overall Study|Lack of Efficacy|3|||
37849717|NCT01095796|69533852|FG000|Overall Study|Investigator's Discretion|7|||
37918871|NCT00463567|69605564|FG002|Overall Study|Withdrawal by Subject|20|||
38027594|NCT03539432|69712489|FG001|Overall Study|Lost to Follow-up|1|||
38027595|NCT03615924|69712497|FG000|Overall Study|Withdrawal by Subject|2|||
38027596|NCT03615924|69712498|FG001|Overall Study|Withdrawal by Subject|5|||
38027597|NCT03615924|69712497|FG000|Overall Study|Death|3|||
38027598|NCT03615924|69712498|FG001|Overall Study|Death|1|||
38027599|NCT03615924|69712497|FG000|Overall Study|Lost to Follow-up|1|||
38027600|NCT03615924|69712498|FG001|Overall Study|Lost to Follow-up|0|||
38027601|NCT03615924|69712497|FG000|Overall Study|Randomized in error|1|||
38027602|NCT03615924|69712498|FG001|Overall Study|Randomized in error|0|||
38027603|NCT03615924|69712497|FG000|Overall Study|Study termination by Sponsor|94|||
38027604|NCT03615924|69712498|FG001|Overall Study|Study termination by Sponsor|86|||
38027605|NCT03535844|69712506|FG000|Overall Study|Withdrawal by Subject|0|||
38027606|NCT03535844|69712507|FG001|Overall Study|Withdrawal by Subject|1|||
38027607|NCT03533114|69712524|FG000|Overall|Adverse Event|16|||
38027608|NCT03533114|69712525|FG001|Overall|Adverse Event|11|||
38027609|NCT03533114|69712524|FG000|Overall|Consent Withdrawal by Participant|7|||
38027610|NCT03533114|69712525|FG001|Overall|Consent Withdrawal by Participant|6|||
38027611|NCT03533114|69712524|FG000|Overall|Lack of Efficacy|5|||
38027612|NCT03533114|69712525|FG001|Overall|Lack of Efficacy|3|||
38027613|NCT03533114|69712524|FG000|Overall|Lost to Follow-up|1|||
38027614|NCT03533114|69712525|FG001|Overall|Lost to Follow-up|1|||
38027615|NCT03533114|69712524|FG000|Overall|Physician Decision|0|||
38027616|NCT03533114|69712525|FG001|Overall|Physician Decision|2|||
38027617|NCT03533114|69712524|FG000|Overall|Protocol deviation|1|||
38027618|NCT03533114|69712525|FG001|Overall|Protocol deviation|1|||
38027619|NCT03533114|69712524|FG000|Overall|Failure to meet randomization criteria|1|||
38027620|NCT03533114|69712525|FG001|Overall|Failure to meet randomization criteria|2|||
38027621|NCT03533114|69712524|FG000|Overall|Non-Compliance with study drug|0|||
38027622|NCT03533114|69712525|FG001|Overall|Non-Compliance with study drug|1|||
38027623|NCT03533114|69712524|FG000|Overall|Other|0|||
38027624|NCT03533114|69712525|FG001|Overall|Other|1|||
38027625|NCT03533114|69712524|FG000|Open Label Titration and Optimization|Adverse Event|11|||
38027626|NCT03533114|69712525|FG001|Open Label Titration and Optimization|Adverse Event|8|||
38027627|NCT03533114|69712524|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
38027628|NCT03533114|69712525|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
38027629|NCT03533114|69712524|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
38027630|NCT03533114|69712525|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
38027631|NCT03533114|69712524|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
38027632|NCT03533114|69712525|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
38027633|NCT03533114|69712524|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
38027634|NCT03533114|69712525|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
38027635|NCT03533114|69712524|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
38027636|NCT03533114|69712525|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
38027637|NCT03533114|69712524|FG000|Stable Dose|Adverse Event|0|||
38027638|NCT03533114|69712525|FG001|Stable Dose|Adverse Event|2|||
38027639|NCT03533114|69712524|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
37849718|NCT01095796|69533853|FG001|Overall Study|Investigator's Discretion|2|||
37849719|NCT01095796|69533852|FG000|Overall Study|Withdrew Consent|16|||
37849720|NCT01095796|69533853|FG001|Overall Study|Withdrew Consent|22|||
37849721|NCT01095796|69533852|FG000|Overall Study|Lost to Follow-up|27|||
37849722|NCT01095796|69533853|FG001|Overall Study|Lost to Follow-up|29|||
37849723|NCT01095796|69533852|FG000|Overall Study|Participant Noncompliance|5|||
37918872|NCT00463567|69605565|FG003|Overall Study|Withdrawal by Subject|37|||
38027640|NCT03533114|69712525|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
38027641|NCT03533114|69712524|FG000|Stable Dose|Lack of Efficacy|1|||
37849724|NCT01095796|69533853|FG001|Overall Study|Participant Noncompliance|10|||
37849725|NCT01095796|69533852|FG000|Overall Study|Protocol Violation|1|||
37849726|NCT01095796|69533853|FG001|Overall Study|Protocol Violation|0|||
37849727|NCT01095796|69533852|FG000|Overall Study|Participant Transferred to Another Study|215|||
37849728|NCT01095796|69533853|FG001|Overall Study|Participant Transferred to Another Study|200|||
37849729|NCT01023061|69533859|FG000|Overall Study|Withdrawal prior to treatment|2|||
37849730|NCT01027897|69533863|FG000|Overall Study|Protocol Violation|1|||
37849731|NCT01027897|69533863|FG000|Overall Study|Withdrawal by Subject|1|||
37849732|NCT01027351|69533873|FG000|Overall Study|Withdrawal by Subject|1|||
38027642|NCT03533114|69712525|FG001|Stable Dose|Lack of Efficacy|0|||
38027643|NCT03533114|69712524|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
38027644|NCT03533114|69712525|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
38027645|NCT03533114|69712524|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
37918873|NCT00463567|69605566|FG004|Overall Study|Withdrawal by Subject|6|||
37918874|NCT00463567|69605567|FG005|Overall Study|Withdrawal by Subject|5|||
37918875|NCT00463567|69605568|FG006|Overall Study|Withdrawal by Subject|1|||
37918876|NCT00463567|69605562|FG000|Overall Study|Protocol Deviation|13|||
37918877|NCT00463567|69605563|FG001|Overall Study|Protocol Deviation|9|||
37918878|NCT00463567|69605564|FG002|Overall Study|Protocol Deviation|14|||
37918879|NCT00463567|69605565|FG003|Overall Study|Protocol Deviation|11|||
37918880|NCT00463567|69605566|FG004|Overall Study|Protocol Deviation|1|||
37918881|NCT00463567|69605567|FG005|Overall Study|Protocol Deviation|1|||
37918882|NCT00463567|69605568|FG006|Overall Study|Protocol Deviation|2|||
37918883|NCT00463567|69605562|FG000|Overall Study|Lost to Follow-up|12|||
37918884|NCT00463567|69605563|FG001|Overall Study|Lost to Follow-up|6|||
38027646|NCT03533114|69712525|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
38027647|NCT03533114|69712524|FG000|Open-Label Safety Extension|Adverse Event|3|||
38027648|NCT03533114|69712525|FG001|Open-Label Safety Extension|Adverse Event|0|||
38027649|NCT03533114|69712524|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
38027650|NCT03533114|69712525|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
38027651|NCT03533114|69712524|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
38027652|NCT03533114|69712525|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
38027653|NCT03533114|69712524|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
38027654|NCT03533114|69712525|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
38027655|NCT03533114|69712524|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
38027656|NCT03533114|69712525|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
38027657|NCT03033394|69712533|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
38027658|NCT03033394|69712533|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
38027659|NCT03033394|69712533|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
38027660|NCT03033394|69712533|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
38027661|NCT03033394|69712533|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
38027662|NCT03981822|69712550|FG000|Overall Study|Lost to Follow-up|0|||
38027663|NCT03981822|69712551|FG001|Overall Study|Lost to Follow-up|1|||
38027664|NCT03981822|69712552|FG002|Overall Study|Lost to Follow-up|1|||
38027665|NCT03981822|69712553|FG003|Overall Study|Lost to Follow-up|0|||
38027666|NCT03981822|69712554|FG004|Overall Study|Lost to Follow-up|6|||
38027667|NCT03981822|69712555|FG005|Overall Study|Lost to Follow-up|4|||
38027668|NCT03981822|69712556|FG006|Overall Study|Lost to Follow-up|4|||
38027669|NCT03981822|69712557|FG007|Overall Study|Lost to Follow-up|2|||
38027670|NCT03981822|69712550|FG000|Overall Study|Withdrawal by Subject|0|||
38027671|NCT03981822|69712551|FG001|Overall Study|Withdrawal by Subject|1|||
38027672|NCT03981822|69712552|FG002|Overall Study|Withdrawal by Subject|0|||
38027673|NCT03981822|69712553|FG003|Overall Study|Withdrawal by Subject|0|||
38027674|NCT03981822|69712554|FG004|Overall Study|Withdrawal by Subject|0|||
38027675|NCT03981822|69712555|FG005|Overall Study|Withdrawal by Subject|1|||
38027676|NCT03981822|69712556|FG006|Overall Study|Withdrawal by Subject|0|||
38027677|NCT03981822|69712557|FG007|Overall Study|Withdrawal by Subject|2|||
38027678|NCT03981822|69712550|FG000|Overall Study|COVID-19 Related|0|||
38027679|NCT03981822|69712551|FG001|Overall Study|COVID-19 Related|0|||
38027680|NCT03981822|69712552|FG002|Overall Study|COVID-19 Related|0|||
38027681|NCT03981822|69712553|FG003|Overall Study|COVID-19 Related|0|||
37849733|NCT01027351|69533874|FG001|Overall Study|Withdrawal by Subject|0|||
37849734|NCT01027351|69533875|FG002|Overall Study|Withdrawal by Subject|1|||
37849735|NCT01027351|69533876|FG003|Overall Study|Withdrawal by Subject|0|||
37849736|NCT01027351|69533877|FG004|Overall Study|Withdrawal by Subject|3|||
37849737|NCT01027351|69533878|FG005|Overall Study|Withdrawal by Subject|5|||
37849738|NCT01027351|69533873|FG000|Overall Study|Lost to Follow-up|1|||
37849739|NCT01027351|69533874|FG001|Overall Study|Lost to Follow-up|1|||
37849740|NCT01027351|69533875|FG002|Overall Study|Lost to Follow-up|0|||
37849741|NCT01027351|69533876|FG003|Overall Study|Lost to Follow-up|1|||
37918885|NCT00463567|69605564|FG002|Overall Study|Lost to Follow-up|13|||
37918886|NCT00463567|69605565|FG003|Overall Study|Lost to Follow-up|8|||
38027682|NCT03981822|69712554|FG004|Overall Study|COVID-19 Related|2|||
38027683|NCT03981822|69712555|FG005|Overall Study|COVID-19 Related|1|||
38027684|NCT03981822|69712556|FG006|Overall Study|COVID-19 Related|2|||
38027685|NCT03981822|69712557|FG007|Overall Study|COVID-19 Related|1|||
38027686|NCT03650556|69712569|FG000|Overall Study|Death|2|||
38027687|NCT03650556|69712569|FG000|Overall Study|Withdrawal by Subject|20|||
37849742|NCT01027351|69533877|FG004|Overall Study|Lost to Follow-up|6|||
37849743|NCT01027351|69533878|FG005|Overall Study|Lost to Follow-up|0|||
38027688|NCT03650556|69712569|FG000|Overall Study|Physician Decision|2|||
38027689|NCT03650556|69712569|FG000|Overall Study|Lost to Follow-up|8|||
37918887|NCT00463567|69605566|FG004|Overall Study|Lost to Follow-up|1|||
37918888|NCT00463567|69605567|FG005|Overall Study|Lost to Follow-up|1|||
37918889|NCT00463567|69605568|FG006|Overall Study|Lost to Follow-up|1|||
37918890|NCT00463567|69605562|FG000|Overall Study|Administrative problems|5|||
37918891|NCT00463567|69605563|FG001|Overall Study|Administrative problems|3|||
37918892|NCT00463567|69605564|FG002|Overall Study|Administrative problems|6|||
37918893|NCT00463567|69605565|FG003|Overall Study|Administrative problems|9|||
37918894|NCT00463567|69605566|FG004|Overall Study|Administrative problems|3|||
37918895|NCT00463567|69605567|FG005|Overall Study|Administrative problems|2|||
37918896|NCT00463567|69605568|FG006|Overall Study|Administrative problems|2|||
37918897|NCT00463567|69605562|FG000|Overall Study|Lack of Efficacy|4|||
37918898|NCT00463567|69605563|FG001|Overall Study|Lack of Efficacy|9|||
37918899|NCT00463567|69605564|FG002|Overall Study|Lack of Efficacy|9|||
37918900|NCT00463567|69605565|FG003|Overall Study|Lack of Efficacy|17|||
37918901|NCT00463567|69605566|FG004|Overall Study|Lack of Efficacy|1|||
37918902|NCT00463567|69605567|FG005|Overall Study|Lack of Efficacy|0|||
37918903|NCT00463567|69605568|FG006|Overall Study|Lack of Efficacy|1|||
37918904|NCT00463567|69605562|FG000|Overall Study|Abnormal lab value(s)|1|||
37918905|NCT00463567|69605563|FG001|Overall Study|Abnormal lab value(s)|1|||
37918906|NCT00463567|69605564|FG002|Overall Study|Abnormal lab value(s)|2|||
37918907|NCT00463567|69605565|FG003|Overall Study|Abnormal lab value(s)|1|||
37918908|NCT00463567|69605566|FG004|Overall Study|Abnormal lab value(s)|1|||
37849744|NCT01027351|69533873|FG000|Overall Study|Inappropriate enrollment|0|||
37849745|NCT01027351|69533874|FG001|Overall Study|Inappropriate enrollment|0|||
37849746|NCT01027351|69533875|FG002|Overall Study|Inappropriate enrollment|0|||
37849747|NCT01027351|69533876|FG003|Overall Study|Inappropriate enrollment|0|||
37849748|NCT01027351|69533877|FG004|Overall Study|Inappropriate enrollment|1|||
37849749|NCT01027351|69533878|FG005|Overall Study|Inappropriate enrollment|0|||
37849750|NCT01027351|69533873|FG000|Overall Study|Protocol Violation|1|||
37849751|NCT01027351|69533874|FG001|Overall Study|Protocol Violation|0|||
37849752|NCT01027351|69533875|FG002|Overall Study|Protocol Violation|0|||
37849753|NCT01027351|69533876|FG003|Overall Study|Protocol Violation|1|||
37849754|NCT01027351|69533877|FG004|Overall Study|Protocol Violation|1|||
37849755|NCT01027351|69533878|FG005|Overall Study|Protocol Violation|0|||
37849756|NCT01027273|69533901|FG000|Overall Study|Lost to Follow-up|57|||
37849757|NCT01027273|69533902|FG001|Overall Study|Lost to Follow-up|31|||
37849758|NCT01027273|69533901|FG000|Overall Study|Death|2|||
37849759|NCT01027273|69533902|FG001|Overall Study|Death|2|||
37849760|NCT01022203|69533910|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
37849761|NCT01022203|69533911|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
37849762|NCT01022203|69533910|FG000|Post Treatment Assessment|Physician Decision|2|||
37849763|NCT01022203|69533911|FG001|Post Treatment Assessment|Physician Decision|0|||
37849764|NCT01022203|69533910|FG000|Post Treatment Assessment|Adverse Event|0|||
37849765|NCT01022203|69533911|FG001|Post Treatment Assessment|Adverse Event|2|||
37849766|NCT01022203|69533910|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
37849767|NCT01022203|69533911|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
37849768|NCT01296711|69533928|FG000|Overall Study|Adverse Event|3|||
37849769|NCT01296711|69533929|FG001|Overall Study|Adverse Event|1|||
37849770|NCT01296711|69533930|FG002|Overall Study|Adverse Event|4|||
37849771|NCT01296711|69533931|FG003|Overall Study|Adverse Event|3|||
37849772|NCT01296711|69533932|FG004|Overall Study|Adverse Event|1|||
37849773|NCT01296711|69533933|FG005|Overall Study|Adverse Event|6|||
37849774|NCT01296711|69533934|FG006|Overall Study|Adverse Event|11|||
37849775|NCT01296711|69533935|FG007|Overall Study|Adverse Event|3|||
37849776|NCT01296711|69533928|FG000|Overall Study|Lack of Efficacy|1|||
37849777|NCT01296711|69533929|FG001|Overall Study|Lack of Efficacy|4|||
37849778|NCT01296711|69533930|FG002|Overall Study|Lack of Efficacy|1|||
37849779|NCT01296711|69533931|FG003|Overall Study|Lack of Efficacy|1|||
37849780|NCT01296711|69533932|FG004|Overall Study|Lack of Efficacy|1|||
37849781|NCT01296711|69533933|FG005|Overall Study|Lack of Efficacy|0|||
37849782|NCT01296711|69533934|FG006|Overall Study|Lack of Efficacy|2|||
37849783|NCT01296711|69533935|FG007|Overall Study|Lack of Efficacy|3|||
37849784|NCT01296711|69533928|FG000|Overall Study|Lost to Follow-up|0|||
37849785|NCT01296711|69533929|FG001|Overall Study|Lost to Follow-up|0|||
37849786|NCT01296711|69533930|FG002|Overall Study|Lost to Follow-up|1|||
37849787|NCT01296711|69533931|FG003|Overall Study|Lost to Follow-up|1|||
37918909|NCT00463567|69605567|FG005|Overall Study|Abnormal lab value(s)|0|||
37918910|NCT00463567|69605568|FG006|Overall Study|Abnormal lab value(s)|0|||
37918911|NCT00463567|69605562|FG000|Overall Study|Abnormal test procedure result(s)|1|||
37918912|NCT00463567|69605563|FG001|Overall Study|Abnormal test procedure result(s)|1|||
38027690|NCT03650556|69712569|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
37849788|NCT01296711|69533932|FG004|Overall Study|Lost to Follow-up|2|||
37849789|NCT01296711|69533933|FG005|Overall Study|Lost to Follow-up|0|||
37849790|NCT01296711|69533934|FG006|Overall Study|Lost to Follow-up|4|||
37849791|NCT01296711|69533935|FG007|Overall Study|Lost to Follow-up|2|||
37849792|NCT01296711|69533928|FG000|Overall Study|Protocol Violation|0|||
37918913|NCT00463567|69605564|FG002|Overall Study|Abnormal test procedure result(s)|6|||
37918914|NCT00463567|69605565|FG003|Overall Study|Abnormal test procedure result(s)|2|||
37918915|NCT00463567|69605566|FG004|Overall Study|Abnormal test procedure result(s)|0|||
37918916|NCT00463567|69605567|FG005|Overall Study|Abnormal test procedure result(s)|2|||
37918917|NCT00463567|69605568|FG006|Overall Study|Abnormal test procedure result(s)|0|||
37918918|NCT00463567|69605562|FG000|Overall Study|Death|1|||
37918919|NCT00463567|69605563|FG001|Overall Study|Death|0|||
37918920|NCT00463567|69605564|FG002|Overall Study|Death|2|||
37918921|NCT00463567|69605565|FG003|Overall Study|Death|0|||
37918922|NCT00463567|69605566|FG004|Overall Study|Death|0|||
37918923|NCT00463567|69605567|FG005|Overall Study|Death|0|||
37918924|NCT00463567|69605568|FG006|Overall Study|Death|0|||
37849793|NCT01296711|69533929|FG001|Overall Study|Protocol Violation|0|||
37849794|NCT01296711|69533930|FG002|Overall Study|Protocol Violation|0|||
37849795|NCT01296711|69533931|FG003|Overall Study|Protocol Violation|1|||
37849796|NCT01296711|69533932|FG004|Overall Study|Protocol Violation|1|||
37849797|NCT01296711|69533933|FG005|Overall Study|Protocol Violation|0|||
37849798|NCT01296711|69533934|FG006|Overall Study|Protocol Violation|0|||
37849799|NCT01296711|69533935|FG007|Overall Study|Protocol Violation|0|||
37849800|NCT01296711|69533928|FG000|Overall Study|Withdrawal by Subject|4|||
37849801|NCT01296711|69533929|FG001|Overall Study|Withdrawal by Subject|2|||
37849802|NCT01296711|69533930|FG002|Overall Study|Withdrawal by Subject|2|||
37849803|NCT01296711|69533931|FG003|Overall Study|Withdrawal by Subject|1|||
37849804|NCT01296711|69533932|FG004|Overall Study|Withdrawal by Subject|1|||
37849805|NCT01296711|69533933|FG005|Overall Study|Withdrawal by Subject|1|||
37849806|NCT01296711|69533934|FG006|Overall Study|Withdrawal by Subject|2|||
37849807|NCT01296711|69533935|FG007|Overall Study|Withdrawal by Subject|1|||
37849808|NCT01296711|69533928|FG000|Overall Study|Study termination|8|||
37849809|NCT01296711|69533929|FG001|Overall Study|Study termination|1|||
37918925|NCT00484159|69605593|FG000|Overall Study|Lost to Follow-up|1|||
37918926|NCT00484159|69605594|FG001|Overall Study|Lost to Follow-up|1|||
37918927|NCT00484159|69605595|FG002|Overall Study|Lost to Follow-up|0|||
37918928|NCT00462865|69605603|FG000|Overall Study|Adverse Event|1|||
37918929|NCT03839641|69605609|FG000|Overall Study|Withdrawal by Subject|1|||
37918930|NCT03839641|69605610|FG001|Overall Study|Withdrawal by Subject|1|||
37918931|NCT00462709|69605618|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
37918932|NCT00462709|69605618|FG000|Overall Study|Lost to Follow-up|10|||
37918933|NCT00462709|69605618|FG000|Overall Study|Withdrawal by Subject|8|||
37918934|NCT00462709|69605618|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
37918935|NCT00462709|69605618|FG000|Overall Study|Death|2|||
37918936|NCT00462709|69605618|FG000|Overall Study|Logistical reasons|2|||
37918937|NCT00462709|69605618|FG000|Overall Study|Physician Decision|1|||
37918938|NCT00462709|69605618|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
37918939|NCT00461305|69605624|FG000|Treatment|Adverse Event|26|||
37918940|NCT00461305|69605625|FG001|Treatment|Adverse Event|3|||
37918941|NCT00461305|69605624|FG000|Treatment|Lost to Follow-up|4|||
37918942|NCT00461305|69605625|FG001|Treatment|Lost to Follow-up|2|||
38027691|NCT03650556|69712569|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
38027692|NCT03531632|69712577|FG000|Overall Study|Adverse Event|0|||
38027693|NCT03531632|69712578|FG001|Overall Study|Adverse Event|0|||
38027694|NCT03531632|69712579|FG002|Overall Study|Adverse Event|1|||
38027695|NCT03531632|69712577|FG000|Overall Study|Death|4|||
38027696|NCT03531632|69712578|FG001|Overall Study|Death|0|||
38027697|NCT03531632|69712579|FG002|Overall Study|Death|14|||
38027698|NCT03531632|69712577|FG000|Overall Study|Study Terminated|1|||
38027699|NCT03531632|69712578|FG001|Overall Study|Study Terminated|3|||
38027700|NCT03531632|69712579|FG002|Overall Study|Study Terminated|11|||
38027701|NCT03979638|69712590|FG000|Period 1|Physician Decision|1|||
38027702|NCT03979638|69712591|FG001|Period 1|Physician Decision|1|||
38027703|NCT03979638|69712590|FG000|Period 1|Withdrawal by Subject|4|||
38027704|NCT03979638|69712591|FG001|Period 1|Withdrawal by Subject|3|||
38027705|NCT03979638|69712590|FG000|Period 1|Study terminated by Sponsor|1|||
38027706|NCT03979638|69712591|FG001|Period 1|Study terminated by Sponsor|3|||
38027707|NCT03979638|69712590|FG000|Period 1|Protocol Violation|1|||
37849810|NCT01296711|69533930|FG002|Overall Study|Study termination|5|||
37849811|NCT01296711|69533931|FG003|Overall Study|Study termination|4|||
37849812|NCT01296711|69533932|FG004|Overall Study|Study termination|4|||
38027708|NCT03979638|69712591|FG001|Period 1|Protocol Violation|0|||
38027709|NCT03979638|69712590|FG000|Period 2|Study terminated by Sponsor|1|||
38027710|NCT03979638|69712591|FG001|Period 2|Study terminated by Sponsor|1|||
38027711|NCT03655054|69712606|FG000|Overall Study|Lost to Follow-up|1|||
38027712|NCT03615144|69712612|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
37849813|NCT01296711|69533933|FG005|Overall Study|Study termination|4|||
37849814|NCT01296711|69533934|FG006|Overall Study|Study termination|8|||
37849815|NCT01296711|69533935|FG007|Overall Study|Study termination|10|||
37849816|NCT01296711|69533928|FG000|Overall Study|Continued elevated liver enzymes|0|||
37918943|NCT00461305|69605624|FG000|Treatment|Protocol Violation|13|||
37918944|NCT00461305|69605625|FG001|Treatment|Protocol Violation|2|||
37918945|NCT00461305|69605624|FG000|Treatment|Withdrawal by Subject|48|||
37918946|NCT00461305|69605625|FG001|Treatment|Withdrawal by Subject|2|||
37918947|NCT00461305|69605624|FG000|Treatment|Never dispensed|5|||
37918948|NCT00461305|69605625|FG001|Treatment|Never dispensed|0|||
37918949|NCT00461305|69605624|FG000|Treatment|Study drug not taken|1|||
37849817|NCT01296711|69533929|FG001|Overall Study|Continued elevated liver enzymes|0|||
37849818|NCT01296711|69533930|FG002|Overall Study|Continued elevated liver enzymes|0|||
37849819|NCT01296711|69533931|FG003|Overall Study|Continued elevated liver enzymes|1|||
37849820|NCT01296711|69533932|FG004|Overall Study|Continued elevated liver enzymes|0|||
37849821|NCT01296711|69533933|FG005|Overall Study|Continued elevated liver enzymes|0|||
37849822|NCT01296711|69533934|FG006|Overall Study|Continued elevated liver enzymes|0|||
37849823|NCT01296711|69533935|FG007|Overall Study|Continued elevated liver enzymes|0|||
37849824|NCT01296711|69533928|FG000|Overall Study|Methotrexate discontinued|0|||
37849825|NCT01296711|69533929|FG001|Overall Study|Methotrexate discontinued|0|||
37918950|NCT00461305|69605625|FG001|Treatment|Study drug not taken|0|||
37918951|NCT00461305|69605624|FG000|Treatment|Partially missing diary|2|||
37918952|NCT00461305|69605625|FG001|Treatment|Partially missing diary|0|||
37918953|NCT00461305|69605624|FG000|Treatment|Other (missing drug etc)|2|||
37849826|NCT01296711|69533930|FG002|Overall Study|Methotrexate discontinued|0|||
37849827|NCT01296711|69533931|FG003|Overall Study|Methotrexate discontinued|1|||
37849828|NCT01296711|69533932|FG004|Overall Study|Methotrexate discontinued|0|||
37849829|NCT01296711|69533933|FG005|Overall Study|Methotrexate discontinued|0|||
37849830|NCT01296711|69533934|FG006|Overall Study|Methotrexate discontinued|0|||
37849831|NCT01296711|69533935|FG007|Overall Study|Methotrexate discontinued|0|||
37849832|NCT01296711|69533928|FG000|Overall Study|Investigator discretion|0|||
37849833|NCT01296711|69533929|FG001|Overall Study|Investigator discretion|0|||
37849834|NCT01296711|69533930|FG002|Overall Study|Investigator discretion|0|||
37849835|NCT01296711|69533931|FG003|Overall Study|Investigator discretion|0|||
37918954|NCT00461305|69605625|FG001|Treatment|Other (missing drug etc)|0|||
37918955|NCT00461305|69605624|FG000|Continued Treatment|Adverse Event|26|||
37918956|NCT00461305|69605625|FG001|Continued Treatment|Adverse Event|0|||
37918957|NCT00461305|69605624|FG000|Continued Treatment|Lost to Follow-up|4|||
37918958|NCT00461305|69605625|FG001|Continued Treatment|Lost to Follow-up|0|||
37918959|NCT00461305|69605624|FG000|Continued Treatment|Protocol Violation|13|||
37849836|NCT01296711|69533932|FG004|Overall Study|Investigator discretion|0|||
37849837|NCT01296711|69533933|FG005|Overall Study|Investigator discretion|0|||
37849838|NCT01296711|69533934|FG006|Overall Study|Investigator discretion|1|||
37849839|NCT01296711|69533935|FG007|Overall Study|Investigator discretion|0|||
37849840|NCT01296711|69533928|FG000|Overall Study|Other|0|||
37918960|NCT00461305|69605625|FG001|Continued Treatment|Protocol Violation|0|||
37918961|NCT00461305|69605624|FG000|Continued Treatment|Withdrawal by Subject|48|||
37918962|NCT00461305|69605625|FG001|Continued Treatment|Withdrawal by Subject|0|||
37918963|NCT00461305|69605624|FG000|Continued Treatment|Partially missing diary|2|||
37918964|NCT00461305|69605625|FG001|Continued Treatment|Partially missing diary|0|||
38027713|NCT03615144|69712613|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
38027714|NCT03682302|69712623|FG000|Overall Study|Lost to Follow-up|1|||
38027715|NCT03682302|69712624|FG001|Overall Study|Lost to Follow-up|2|||
38027716|NCT03682302|69712625|FG002|Overall Study|Lost to Follow-up|0|||
38027717|NCT03682302|69712626|FG003|Overall Study|Lost to Follow-up|1|||
38027718|NCT03682302|69712623|FG000|Overall Study|Study drug was not administered|0|||
38027719|NCT03682302|69712624|FG001|Overall Study|Study drug was not administered|0|||
38027720|NCT03682302|69712625|FG002|Overall Study|Study drug was not administered|1|||
38027721|NCT03682302|69712626|FG003|Overall Study|Study drug was not administered|1|||
38027722|NCT03522506|69712640|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
38027723|NCT03522506|69712641|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
38027724|NCT03522506|69712642|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
38027725|NCT03522506|69712643|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
38027726|NCT03522506|69712640|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
38027727|NCT03522506|69712641|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
38027728|NCT03522506|69712642|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
38027729|NCT03522506|69712643|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
38027730|NCT02892734|69712674|FG000|Treatment on Study|Progressive Disease|2|||
38027731|NCT02892734|69712674|FG000|Follow up for 2 Years|Death|2|||
38027732|NCT02892734|69712674|FG000|Follow up for 2 Years|Study closed early|1|||
38027733|NCT00055497|69712682|FG000|Overall Study|Adverse Event|1|||
38027734|NCT00055497|69712683|FG001|Overall Study|Adverse Event|1|||
38027735|NCT00055497|69712684|FG002|Overall Study|Adverse Event|1|||
38027736|NCT00055497|69712685|FG003|Overall Study|Adverse Event|28|||
38027737|NCT00055497|69712682|FG000|Overall Study|Withdrawal by Subject|3|||
38027738|NCT00055497|69712683|FG001|Overall Study|Withdrawal by Subject|1|||
37849841|NCT01296711|69533929|FG001|Overall Study|Other|0|||
37849842|NCT01296711|69533930|FG002|Overall Study|Other|0|||
37849843|NCT01296711|69533931|FG003|Overall Study|Other|0|||
37918965|NCT00461305|69605624|FG000|Continued Treatment|Other (missing drug etc)|2|||
37918966|NCT00461305|69605625|FG001|Continued Treatment|Other (missing drug etc)|0|||
37918967|NCT00856544|69605636|FG000|Overall Study|Randomized but not treated|3|||
37918968|NCT00856544|69605637|FG001|Overall Study|Randomized but not treated|0|||
38027739|NCT00055497|69712684|FG002|Overall Study|Withdrawal by Subject|1|||
38027740|NCT00055497|69712685|FG003|Overall Study|Withdrawal by Subject|15|||
37849844|NCT01296711|69533932|FG004|Overall Study|Other|0|||
37849845|NCT01296711|69533933|FG005|Overall Study|Other|0|||
37849846|NCT01296711|69533934|FG006|Overall Study|Other|1|||
37849847|NCT01296711|69533935|FG007|Overall Study|Other|0|||
37849848|NCT01296711|69533928|FG000|Overall Study|Required restricted steroid injections|0|||
37849849|NCT01296711|69533929|FG001|Overall Study|Required restricted steroid injections|0|||
37849850|NCT01296711|69533930|FG002|Overall Study|Required restricted steroid injections|0|||
37849851|NCT01296711|69533931|FG003|Overall Study|Required restricted steroid injections|0|||
37849852|NCT01296711|69533932|FG004|Overall Study|Required restricted steroid injections|0|||
37918969|NCT00856544|69605638|FG002|Overall Study|Randomized but not treated|0|||
37918970|NCT00856544|69605639|FG003|Overall Study|Randomized but not treated|0|||
37918971|NCT00856544|69605636|FG000|Overall Study|Death|0|||
37849853|NCT01296711|69533933|FG005|Overall Study|Required restricted steroid injections|0|||
37849854|NCT01296711|69533934|FG006|Overall Study|Required restricted steroid injections|1|||
37849855|NCT01296711|69533935|FG007|Overall Study|Required restricted steroid injections|0|||
37849856|NCT01296711|69533928|FG000|Overall Study|Ongoing missed appointments|0|||
37849857|NCT01296711|69533929|FG001|Overall Study|Ongoing missed appointments|0|||
37849858|NCT01296711|69533930|FG002|Overall Study|Ongoing missed appointments|0|||
37849859|NCT01296711|69533931|FG003|Overall Study|Ongoing missed appointments|0|||
37849860|NCT01296711|69533932|FG004|Overall Study|Ongoing missed appointments|0|||
37849861|NCT01296711|69533933|FG005|Overall Study|Ongoing missed appointments|0|||
37849862|NCT01296711|69533934|FG006|Overall Study|Ongoing missed appointments|1|||
37849863|NCT01296711|69533935|FG007|Overall Study|Ongoing missed appointments|0|||
37849864|NCT01296711|69533928|FG000|Overall Study|Failure to comply with visits|0|||
37849865|NCT01296711|69533929|FG001|Overall Study|Failure to comply with visits|0|||
37849866|NCT01296711|69533930|FG002|Overall Study|Failure to comply with visits|0|||
37849867|NCT01296711|69533931|FG003|Overall Study|Failure to comply with visits|0|||
37849868|NCT01296711|69533932|FG004|Overall Study|Failure to comply with visits|0|||
37849869|NCT01296711|69533933|FG005|Overall Study|Failure to comply with visits|0|||
37849870|NCT01296711|69533934|FG006|Overall Study|Failure to comply with visits|0|||
37849871|NCT01296711|69533935|FG007|Overall Study|Failure to comply with visits|1|||
37918972|NCT00856544|69605637|FG001|Overall Study|Death|2|||
37918973|NCT00856544|69605638|FG002|Overall Study|Death|0|||
37918974|NCT00856544|69605639|FG003|Overall Study|Death|0|||
37918975|NCT00856544|69605636|FG000|Overall Study|Adverse Event|20|||
37918976|NCT00856544|69605637|FG001|Overall Study|Adverse Event|29|||
37918977|NCT00856544|69605638|FG002|Overall Study|Adverse Event|2|||
37918978|NCT00856544|69605639|FG003|Overall Study|Adverse Event|3|||
37918979|NCT00856544|69605636|FG000|Overall Study|Lack of Efficacy|16|||
37918980|NCT00856544|69605637|FG001|Overall Study|Lack of Efficacy|12|||
37918981|NCT00856544|69605638|FG002|Overall Study|Lack of Efficacy|3|||
38027741|NCT00055497|69712682|FG000|Overall Study|Lost to Follow-up|0|||
38027742|NCT00055497|69712683|FG001|Overall Study|Lost to Follow-up|1|||
38027743|NCT00055497|69712684|FG002|Overall Study|Lost to Follow-up|0|||
38027744|NCT00055497|69712685|FG003|Overall Study|Lost to Follow-up|5|||
38027745|NCT00055497|69712682|FG000|Overall Study|Protocol Violation|0|||
38027746|NCT00055497|69712683|FG001|Overall Study|Protocol Violation|0|||
38027747|NCT00055497|69712684|FG002|Overall Study|Protocol Violation|0|||
38027748|NCT00055497|69712685|FG003|Overall Study|Protocol Violation|3|||
38027749|NCT00055497|69712682|FG000|Overall Study|Lack of Efficacy|1|||
38027750|NCT00055497|69712683|FG001|Overall Study|Lack of Efficacy|0|||
38027751|NCT00055497|69712684|FG002|Overall Study|Lack of Efficacy|0|||
38027752|NCT00055497|69712685|FG003|Overall Study|Lack of Efficacy|27|||
38027753|NCT00055497|69712682|FG000|Overall Study|Administrative Reasons|0|||
38027754|NCT00055497|69712683|FG001|Overall Study|Administrative Reasons|0|||
38027755|NCT00055497|69712684|FG002|Overall Study|Administrative Reasons|0|||
38027756|NCT00055497|69712685|FG003|Overall Study|Administrative Reasons|1|||
38027757|NCT00055497|69712682|FG000|Overall Study|Other|0|||
38027758|NCT00055497|69712683|FG001|Overall Study|Other|0|||
38027759|NCT00055497|69712684|FG002|Overall Study|Other|0|||
38027760|NCT00055497|69712685|FG003|Overall Study|Other|11|||
38027761|NCT03520400|69712702|FG000|Overall Study|Physician Decision|15|||
38027762|NCT03520400|69712703|FG001|Overall Study|Physician Decision|7|||
38027763|NCT03615066|69712712|FG000|Main Study|Withdrew Consent|0|||
37849872|NCT01296711|69533928|FG000|Overall Study|Patient decision due to transport|0|||
37849873|NCT01296711|69533929|FG001|Overall Study|Patient decision due to transport|0|||
37849874|NCT01296711|69533930|FG002|Overall Study|Patient decision due to transport|0|||
37849875|NCT01296711|69533931|FG003|Overall Study|Patient decision due to transport|0|||
37918982|NCT00856544|69605639|FG003|Overall Study|Lack of Efficacy|3|||
37918983|NCT00856544|69605636|FG000|Overall Study|Other|9|||
37918984|NCT00856544|69605637|FG001|Overall Study|Other|16|||
37918985|NCT00856544|69605638|FG002|Overall Study|Other|1|||
37918986|NCT00856544|69605639|FG003|Overall Study|Other|6|||
38027764|NCT03615066|69712713|FG001|Main Study|Withdrew Consent|1|||
38027765|NCT03615066|69712714|FG002|Main Study|Withdrew Consent|1|||
38027766|NCT03615066|69712712|FG000|Main Study|Lost to Follow-up|0|||
38027767|NCT03615066|69712713|FG001|Main Study|Lost to Follow-up|0|||
37849876|NCT01296711|69533932|FG004|Overall Study|Patient decision due to transport|0|||
37849877|NCT01296711|69533933|FG005|Overall Study|Patient decision due to transport|0|||
37849878|NCT01296711|69533934|FG006|Overall Study|Patient decision due to transport|0|||
37849879|NCT01296711|69533935|FG007|Overall Study|Patient decision due to transport|1|||
38027768|NCT03615066|69712714|FG002|Main Study|Lost to Follow-up|1|||
38027769|NCT03615066|69712712|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
38027770|NCT03615066|69712713|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
37918987|NCT00856544|69605636|FG000|Overall Study|Lost to Follow-up|1|||
37918988|NCT00856544|69605637|FG001|Overall Study|Lost to Follow-up|2|||
37918989|NCT00856544|69605638|FG002|Overall Study|Lost to Follow-up|2|||
37918990|NCT00856544|69605639|FG003|Overall Study|Lost to Follow-up|0|||
37918991|NCT00856544|69605636|FG000|Overall Study|Withdrawal by Subject|8|||
37918992|NCT00856544|69605637|FG001|Overall Study|Withdrawal by Subject|5|||
37918993|NCT00856544|69605638|FG002|Overall Study|Withdrawal by Subject|0|||
37918994|NCT00856544|69605639|FG003|Overall Study|Withdrawal by Subject|1|||
37918995|NCT00856388|69605661|FG000|Overall Study|Other|1|||
38027771|NCT03615066|69712714|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
38027772|NCT03615066|69712712|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
38027773|NCT03615066|69712713|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
38027774|NCT03615066|69712714|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
38027775|NCT03615066|69712712|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
38027776|NCT03615066|69712713|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
38027777|NCT03615066|69712714|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
37734969|NCT00985426|69215329|FG001|Overall Study|Withdrawal by Subject|16|||
37849880|NCT01294917|69533953|FG000|Overall Study|Relocation|5|||
37849881|NCT01294917|69533953|FG000|Overall Study|Inconvenience|1|||
37849882|NCT01294683|69533961|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
37849883|NCT01294683|69533962|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
37849884|NCT01294683|69533961|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
37849885|NCT01294683|69533962|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
37849886|NCT01294683|69533961|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
37849887|NCT01294683|69533962|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
37918996|NCT00848354|69605668|FG000|Phase 1|Adverse Event|5|||
37918997|NCT00848354|69605669|FG001|Phase 1|Adverse Event|4|||
37918998|NCT00848354|69605668|FG000|Phase 1|Discontinuation of study by sponsor|2|||
37918999|NCT00848354|69605669|FG001|Phase 1|Discontinuation of study by sponsor|1|||
37919000|NCT00848354|69605668|FG000|Phase 1|Failed to return|0|||
37919001|NCT00848354|69605669|FG001|Phase 1|Failed to return|1|||
37919002|NCT00848354|69605668|FG000|Phase 1|Lost to Follow-up|1|||
37919003|NCT00848354|69605669|FG001|Phase 1|Lost to Follow-up|1|||
37919004|NCT00848354|69605668|FG000|Phase 1|Unspecified Reason|1|||
37919005|NCT00848354|69605669|FG001|Phase 1|Unspecified Reason|1|||
37919006|NCT00848354|69605668|FG000|Phase 1|Protocol Violation|1|||
37919007|NCT00848354|69605669|FG001|Phase 1|Protocol Violation|1|||
37919008|NCT00848354|69605668|FG000|Phase 1|Withdrawal by Subject|2|||
37919009|NCT00848354|69605669|FG001|Phase 1|Withdrawal by Subject|4|||
37919010|NCT00848354|69605668|FG000|Phase 1|Lack of Efficacy|0|||
37919011|NCT00848354|69605669|FG001|Phase 1|Lack of Efficacy|1|||
37919012|NCT00848354|69605668|FG000|Phase 2 Year 1|Adverse Event|7|||
37919013|NCT00848354|69605669|FG001|Phase 2 Year 1|Adverse Event|2|||
37919014|NCT00848354|69605668|FG000|Phase 2 Year 1|Death|1|||
37919015|NCT00848354|69605669|FG001|Phase 2 Year 1|Death|0|||
37919016|NCT00848354|69605668|FG000|Phase 2 Year 1|Failed to Return|1|||
37919017|NCT00848354|69605669|FG001|Phase 2 Year 1|Failed to Return|1|||
37919018|NCT00848354|69605668|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
37919019|NCT00848354|69605669|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
37919020|NCT00848354|69605668|FG000|Phase 2 Year 1|Unspecified Reason|3|||
37919021|NCT00848354|69605669|FG001|Phase 2 Year 1|Unspecified Reason|0|||
37919022|NCT00848354|69605668|FG000|Phase 2 Year 1|Protocol Violation|4|||
37919023|NCT00848354|69605669|FG001|Phase 2 Year 1|Protocol Violation|1|||
37919024|NCT00848354|69605668|FG000|Phase 2 Year 1|Subject Request|1|||
37919025|NCT00848354|69605669|FG001|Phase 2 Year 1|Subject Request|2|||
37919026|NCT00848354|69605668|FG000|Phase 2 Year 2|Adverse Event|12|||
37919027|NCT00848354|69605669|FG001|Phase 2 Year 2|Adverse Event|2|||
37734970|NCT00985426|69215328|FG000|Overall Study|Lost to Follow-up|8|||
37919028|NCT00848354|69605668|FG000|Phase 2 Year 2|Death|2|||
37919029|NCT00848354|69605669|FG001|Phase 2 Year 2|Death|0|||
37919030|NCT00848354|69605668|FG000|Phase 2 Year 2|Failed to return|3|||
37919031|NCT00848354|69605669|FG001|Phase 2 Year 2|Failed to return|0|||
38027778|NCT03527966|69712728|FG000|Overall Study|Lost to Follow-up|3|||
37919032|NCT00848354|69605668|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
37919033|NCT00848354|69605669|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
37919034|NCT00848354|69605668|FG000|Phase 2 Year 2|Unspecified Reason|1|||
37919035|NCT00848354|69605669|FG001|Phase 2 Year 2|Unspecified Reason|0|||
37919036|NCT00848354|69605668|FG000|Phase 2 Year 2|Protocol Violation|1|||
37919037|NCT00848354|69605669|FG001|Phase 2 Year 2|Protocol Violation|1|||
37919038|NCT00848354|69605668|FG000|Phase 2 Year 2|Subject Request|1|||
37919039|NCT00848354|69605669|FG001|Phase 2 Year 2|Subject Request|1|||
37849888|NCT01294683|69533961|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
37849889|NCT01294683|69533962|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
37849890|NCT01294683|69533961|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
37849891|NCT01294683|69533962|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
37849892|NCT01294683|69533961|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
37849893|NCT01294683|69533962|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
37849894|NCT01294683|69533961|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
37849895|NCT01294683|69533962|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
37849896|NCT01294683|69533961|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
37849897|NCT01294683|69533962|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
37849898|NCT01294683|69533961|FG000|Post Crossover (Period III)|Adverse Event|6|||
37849899|NCT01294683|69533962|FG001|Post Crossover (Period III)|Adverse Event|6|||
37849900|NCT01294683|69533961|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
37849901|NCT01294683|69533962|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
37849902|NCT01294683|69533961|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
37849903|NCT01294683|69533962|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
37849904|NCT01294683|69533961|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
37849905|NCT01294683|69533962|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
37849906|NCT01294449|69533976|FG000|Overall Study|Death|11|||
37849907|NCT01294449|69533977|FG001|Overall Study|Death|12|||
37849908|NCT01294449|69533976|FG000|Overall Study|Withdrawal by Subject|1|||
37849909|NCT01294449|69533977|FG001|Overall Study|Withdrawal by Subject|3|||
37849910|NCT01294371|69533983|FG000|Overall Study|Adverse Event|1|||
37849911|NCT01294371|69533983|FG000|Overall Study|Withdrawal by Subject|12|||
37849912|NCT01294371|69533983|FG000|Overall Study|Lost to Follow-up|6|||
37849913|NCT01294371|69533983|FG000|Overall Study|Administrative Reason|1|||
37849914|NCT01294371|69533983|FG000|Overall Study|Other|14|||
37849915|NCT01293123|69533992|FG000|Overall Study|Lost to Follow-up|0|||
37849916|NCT01293123|69533993|FG001|Overall Study|Lost to Follow-up|1|||
37849917|NCT01292187|69534001|FG000|Overall Study|Adverse Event|10|||
37849918|NCT01292187|69534002|FG001|Overall Study|Adverse Event|5|||
37849919|NCT01292187|69534001|FG000|Overall Study|Withdrawal by Subject|6|||
37849920|NCT01292187|69534002|FG001|Overall Study|Withdrawal by Subject|5|||
37849921|NCT01292187|69534001|FG000|Overall Study|All other reasons|1|||
37849922|NCT01292187|69534002|FG001|Overall Study|All other reasons|3|||
37849923|NCT01026493|69534017|FG000|Overall Study|Protocol Violation|0|||
37849924|NCT01026493|69534018|FG001|Overall Study|Protocol Violation|1|||
37849925|NCT01026493|69534019|FG002|Overall Study|Protocol Violation|0|||
37849926|NCT01026493|69534020|FG003|Overall Study|Protocol Violation|0|||
37849927|NCT01026493|69534021|FG004|Overall Study|Protocol Violation|2|||
37849928|NCT01026493|69534022|FG005|Overall Study|Protocol Violation|3|||
37849929|NCT01026493|69534023|FG006|Overall Study|Protocol Violation|4|||
37849930|NCT01026493|69534024|FG007|Overall Study|Protocol Violation|1|||
37849931|NCT01026103|69534042|FG000|Overall Study|Physician Decision|1|||
37849932|NCT01026103|69534042|FG000|Overall Study|did not receive study device bc of error|1|||
37849933|NCT01291173|69534050|FG000|Overall Study|Adverse Event|0|||
37849934|NCT01291173|69534051|FG001|Overall Study|Adverse Event|3|||
37849935|NCT01291173|69534052|FG002|Overall Study|Adverse Event|1|||
37849936|NCT01291173|69534053|FG003|Overall Study|Adverse Event|3|||
37849937|NCT01291173|69534050|FG000|Overall Study|Protocol Violation|7|||
37919040|NCT00848354|69605668|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
37919041|NCT00848354|69605669|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
37919042|NCT00848198|69605679|FG000|Overall Study|Incomplete Case Report Forms|15|||
37919043|NCT00848120|69605687|FG000|Overall Study|Adverse Event|1|||
37919044|NCT00600821|69605693|FG000|Overall Study|Death|45|||
37919045|NCT00600821|69605694|FG001|Overall Study|Death|46|||
37919046|NCT00600821|69605693|FG000|Overall Study|Lost to Follow-up|2|||
37919047|NCT00600821|69605694|FG001|Overall Study|Lost to Follow-up|2|||
37919048|NCT00600821|69605693|FG000|Overall Study|Withdrawal by Subject|1|||
37919049|NCT00600821|69605694|FG001|Overall Study|Withdrawal by Subject|1|||
37919050|NCT00600821|69605693|FG000|Overall Study|Terminated by sponsor|8|||
37919051|NCT00600821|69605694|FG001|Overall Study|Terminated by sponsor|6|||
37919052|NCT00600821|69605693|FG000|Overall Study|Objective progression or relapse|0|||
37919053|NCT00600821|69605694|FG001|Overall Study|Objective progression or relapse|1|||
37919054|NCT00600821|69605693|FG000|Overall Study|Randomized but not treated|0|||
37919055|NCT00600821|69605694|FG001|Overall Study|Randomized but not treated|1|||
37849938|NCT01291173|69534051|FG001|Overall Study|Protocol Violation|2|||
37849939|NCT01291173|69534052|FG002|Overall Study|Protocol Violation|2|||
37849940|NCT01291173|69534053|FG003|Overall Study|Protocol Violation|5|||
37849941|NCT01291173|69534050|FG000|Overall Study|Withdrawal by Subject|6|||
37849942|NCT01291173|69534051|FG001|Overall Study|Withdrawal by Subject|4|||
37849943|NCT01291173|69534052|FG002|Overall Study|Withdrawal by Subject|4|||
37849944|NCT01291173|69534053|FG003|Overall Study|Withdrawal by Subject|2|||
37849945|NCT01291173|69534050|FG000|Overall Study|Lost to Follow-up|4|||
37919056|NCT00600821|69605693|FG000|Overall Study|Other|2|||
37919057|NCT00600821|69605694|FG001|Overall Study|Other|3|||
37849946|NCT01291173|69534051|FG001|Overall Study|Lost to Follow-up|6|||
37849947|NCT01291173|69534052|FG002|Overall Study|Lost to Follow-up|3|||
37849948|NCT01291173|69534053|FG003|Overall Study|Lost to Follow-up|2|||
37849949|NCT01291173|69534050|FG000|Overall Study|Unable to meet visit schedule|0|||
37849950|NCT01291173|69534051|FG001|Overall Study|Unable to meet visit schedule|0|||
37849951|NCT01291173|69534052|FG002|Overall Study|Unable to meet visit schedule|1|||
37849952|NCT01291173|69534053|FG003|Overall Study|Unable to meet visit schedule|0|||
37849953|NCT01291173|69534050|FG000|Overall Study|Lack of compliance|0|||
37849954|NCT01291173|69534051|FG001|Overall Study|Lack of compliance|0|||
37849955|NCT01291173|69534052|FG002|Overall Study|Lack of compliance|0|||
37849956|NCT01291173|69534053|FG003|Overall Study|Lack of compliance|1|||
37919058|NCT00592904|69605706|FG000|Overall Study|Adverse Event|15|||
37919059|NCT00592904|69605707|FG001|Overall Study|Adverse Event|25|||
37919060|NCT00592904|69605708|FG002|Overall Study|Adverse Event|13|||
37919061|NCT00592904|69605709|FG003|Overall Study|Adverse Event|5|||
37919062|NCT00592904|69605706|FG000|Overall Study|Protocol Violation|1|||
37919063|NCT00592904|69605707|FG001|Overall Study|Protocol Violation|1|||
38027779|NCT03527966|69712729|FG001|Overall Study|Lost to Follow-up|0|||
38027780|NCT03808545|69712737|FG000|Overall Study|Withdrawal by Subject|1|||
38027781|NCT03808545|69712738|FG001|Overall Study|Withdrawal by Subject|1|||
38027782|NCT03807843|69712747|FG000|Overall Study|Lost to Follow-up|1|||
38027783|NCT03807843|69712748|FG001|Overall Study|Lost to Follow-up|0|||
38027784|NCT03519932|69712754|FG000|First Intervention|Adverse Event|1|||
38027785|NCT03519932|69712755|FG001|First Intervention|Adverse Event|3|||
38027786|NCT03806127|69712768|FG000|Overall Study|Withdrawal by Subject|4|||
38027787|NCT03806127|69712769|FG001|Overall Study|Withdrawal by Subject|5|||
38027788|NCT03806127|69712768|FG000|Overall Study|Protocol Violation|3|||
38027789|NCT03806127|69712769|FG001|Overall Study|Protocol Violation|1|||
38027790|NCT03806127|69712768|FG000|Overall Study|Adverse Event|3|||
38027791|NCT03806127|69712769|FG001|Overall Study|Adverse Event|0|||
38027792|NCT03806127|69712768|FG000|Overall Study|Unable to Complete Procedures|0|||
38027793|NCT03806127|69712769|FG001|Overall Study|Unable to Complete Procedures|1|||
38027794|NCT03806127|69712768|FG000|Overall Study|Pregnancy|0|||
38027795|NCT03806127|69712769|FG001|Overall Study|Pregnancy|1|||
38027796|NCT03806127|69712768|FG000|Overall Study|Lost to Follow-up|5|||
38027797|NCT03806127|69712769|FG001|Overall Study|Lost to Follow-up|1|||
38027798|NCT03806127|69712768|FG000|Overall Study|Physician Decision|1|||
38027799|NCT03806127|69712769|FG001|Overall Study|Physician Decision|1|||
38027800|NCT03806127|69712768|FG000|Overall Study|Could Not Come Due to Covid|1|||
38027801|NCT03806127|69712769|FG001|Overall Study|Could Not Come Due to Covid|0|||
38027802|NCT03806127|69712768|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
38027803|NCT03806127|69712769|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
38027804|NCT03806127|69712768|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
38027805|NCT03806127|69712769|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
38027806|NCT03806127|69712768|FG000|Overall Study|Covid 19 Restrictions|2|||
38027807|NCT03806127|69712769|FG001|Overall Study|Covid 19 Restrictions|0|||
38027808|NCT03806127|69712768|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
38027809|NCT03806127|69712769|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
38027810|NCT03806127|69712768|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
38027811|NCT03806127|69712769|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
38027812|NCT02843074|69712775|FG000|Overall Study|Withdrawal by Subject|5|||
38027813|NCT02843074|69712775|FG000|Overall Study|Progressive disease|1|||
38027814|NCT02843074|69712775|FG000|Overall Study|Physician Decision|1|||
38027815|NCT02843074|69712775|FG000|Overall Study|Lost to Follow-up|1|||
38027816|NCT02843074|69712775|FG000|Overall Study|Death|9|||
38027817|NCT03650400|69712781|FG000|Overall Study|Study terminated by sponsor|0|||
38027818|NCT03650400|69712782|FG001|Overall Study|Study terminated by sponsor|5|||
38027819|NCT00038103|69712790|FG000|Overall Study|Adverse Event|5|||
38027820|NCT00038103|69712791|FG001|Overall Study|Adverse Event|6|||
38027821|NCT00038103|69712790|FG000|Overall Study|Lack of Efficacy|48|||
38027822|NCT00038103|69712791|FG001|Overall Study|Lack of Efficacy|41|||
38027823|NCT00038103|69712790|FG000|Overall Study|Withdrawal by Subject|0|||
38027824|NCT00038103|69712791|FG001|Overall Study|Withdrawal by Subject|3|||
37849957|NCT01291173|69534050|FG000|Overall Study|Subject was unblinded|0|||
38027825|NCT00038103|69712790|FG000|Overall Study|Lost to Follow-up|0|||
38027826|NCT00038103|69712791|FG001|Overall Study|Lost to Follow-up|3|||
38027827|NCT00038103|69712790|FG000|Overall Study|Protocol Violation|0|||
38027828|NCT00038103|69712791|FG001|Overall Study|Protocol Violation|2|||
38027829|NCT00038103|69712790|FG000|Overall Study|Sponsor Decision|0|||
38027830|NCT00038103|69712791|FG001|Overall Study|Sponsor Decision|1|||
38027831|NCT00038103|69712790|FG000|Overall Study|Randomized/never treated|2|||
37734971|NCT00985426|69215329|FG001|Overall Study|Lost to Follow-up|10|||
37919064|NCT00592904|69605708|FG002|Overall Study|Protocol Violation|0|||
38027832|NCT00038103|69712791|FG001|Overall Study|Randomized/never treated|0|||
38027833|NCT03680742|69712797|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
37919065|NCT00592904|69605709|FG003|Overall Study|Protocol Violation|1|||
37734972|NCT00985426|69215328|FG000|Overall Study|Death|7|||
37849958|NCT01291173|69534051|FG001|Overall Study|Subject was unblinded|0|||
37849959|NCT01291173|69534052|FG002|Overall Study|Subject was unblinded|1|||
37919066|NCT00592904|69605706|FG000|Overall Study|Withdrawal by Subject|4|||
37919067|NCT00592904|69605707|FG001|Overall Study|Withdrawal by Subject|16|||
37919068|NCT00592904|69605708|FG002|Overall Study|Withdrawal by Subject|1|||
37919069|NCT00592904|69605709|FG003|Overall Study|Withdrawal by Subject|2|||
37919070|NCT00592904|69605706|FG000|Overall Study|Lack of Efficacy|2|||
37919071|NCT00592904|69605707|FG001|Overall Study|Lack of Efficacy|7|||
37919072|NCT00592904|69605708|FG002|Overall Study|Lack of Efficacy|2|||
37919073|NCT00592904|69605709|FG003|Overall Study|Lack of Efficacy|3|||
37849960|NCT01291173|69534053|FG003|Overall Study|Subject was unblinded|0|||
37919074|NCT00592904|69605706|FG000|Overall Study|Physician Decision|0|||
37919075|NCT00592904|69605707|FG001|Overall Study|Physician Decision|3|||
37919076|NCT00592904|69605708|FG002|Overall Study|Physician Decision|1|||
37919077|NCT00592904|69605709|FG003|Overall Study|Physician Decision|0|||
37849961|NCT01291173|69534050|FG000|Overall Study|Excluded therapy|0|||
37849962|NCT01291173|69534051|FG001|Overall Study|Excluded therapy|0|||
37849963|NCT01291173|69534052|FG002|Overall Study|Excluded therapy|1|||
37849964|NCT01291173|69534053|FG003|Overall Study|Excluded therapy|0|||
37849965|NCT01291017|69534063|FG000|Overall Study|Lost to Follow-up|2|||
37849966|NCT01291017|69534063|FG000|Overall Study|Withdrawal by Subject|3|||
37849967|NCT01290315|69534071|FG000|Overall Study|Adverse Event|0|||
37849968|NCT01290315|69534072|FG001|Overall Study|Adverse Event|0|||
37849969|NCT01290315|69534073|FG002|Overall Study|Adverse Event|0|||
37849970|NCT01290315|69534074|FG003|Overall Study|Adverse Event|3|||
37849971|NCT01290315|69534071|FG000|Overall Study|Selection criteria/compliance|2|||
37849972|NCT01290315|69534072|FG001|Overall Study|Selection criteria/compliance|1|||
37849973|NCT01290315|69534073|FG002|Overall Study|Selection criteria/compliance|0|||
37849974|NCT01290315|69534074|FG003|Overall Study|Selection criteria/compliance|2|||
37849975|NCT01290315|69534071|FG000|Overall Study|Lost to Follow-up|0|||
37849976|NCT01290315|69534072|FG001|Overall Study|Lost to Follow-up|1|||
37849977|NCT01290315|69534073|FG002|Overall Study|Lost to Follow-up|0|||
37849978|NCT01290315|69534074|FG003|Overall Study|Lost to Follow-up|0|||
37849979|NCT01290315|69534071|FG000|Overall Study|Withdrawal by Subject|1|||
37849980|NCT01290315|69534072|FG001|Overall Study|Withdrawal by Subject|1|||
37849981|NCT01290315|69534073|FG002|Overall Study|Withdrawal by Subject|0|||
37849982|NCT01290315|69534074|FG003|Overall Study|Withdrawal by Subject|0|||
37849983|NCT01289847|69534083|FG000|Overall Study|Patient could not comply with visits|1|||
37849984|NCT01079182|69534087|FG000|Overall Study|Lost to Follow-up|1634|||
37849985|NCT01079182|69534087|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
37849986|NCT01079182|69534087|FG000|Overall Study|Lack of Efficacy|514|||
37849987|NCT01079182|69534087|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
37849988|NCT01079182|69534087|FG000|Overall Study|Reasons not Evaluated|271|||
37849989|NCT01021813|69534093|FG000|DB Treatment Phase|Adverse Event|60|||
37849990|NCT01021813|69534094|FG001|DB Treatment Phase|Adverse Event|22|||
37849991|NCT01021813|69534095|FG002|DB Treatment Phase|Adverse Event|0|||
37849992|NCT01021813|69534096|FG003|DB Treatment Phase|Adverse Event|0|||
37849993|NCT01021813|69534097|FG004|DB Treatment Phase|Adverse Event|0|||
37849994|NCT01021813|69534093|FG000|DB Treatment Phase|Lack of Efficacy|44|||
37849995|NCT01021813|69534094|FG001|DB Treatment Phase|Lack of Efficacy|28|||
38027834|NCT03678870|69712803|FG000|Overall Study|prescribed non- protocol medications|10|||
37919078|NCT00592904|69605706|FG000|Overall Study|Other|3|||
37919079|NCT00592904|69605707|FG001|Overall Study|Other|3|||
38027835|NCT03678870|69712804|FG001|Overall Study|prescribed non- protocol medications|6|||
38027836|NCT03678870|69712803|FG000|Overall Study|Lost to Follow-up|3|||
38027837|NCT03678870|69712804|FG001|Overall Study|Lost to Follow-up|2|||
38027838|NCT03805971|69712810|FG000|Overall Study|Withdrawal by Subject|1|||
38027839|NCT03805971|69712810|FG000|Overall Study|Protocol Violation|2|||
38027840|NCT03032380|69712817|FG000|Overall Study|Adverse Event|0|||
37734973|NCT00985426|69215329|FG001|Overall Study|Death|3|||
37734974|NCT00985426|69215328|FG000|Overall Study|Protocol Violation|2|||
37849996|NCT01021813|69534095|FG002|DB Treatment Phase|Lack of Efficacy|0|||
37919080|NCT00592904|69605708|FG002|Overall Study|Other|0|||
37919081|NCT00592904|69605709|FG003|Overall Study|Other|0|||
37919082|NCT00855920|69605722|FG000|Overall Study|Protocol Violation|0|||
37734975|NCT00985426|69215329|FG001|Overall Study|Protocol Violation|0|||
37849997|NCT01021813|69534096|FG003|DB Treatment Phase|Lack of Efficacy|0|||
37849998|NCT01021813|69534097|FG004|DB Treatment Phase|Lack of Efficacy|0|||
37849999|NCT01021813|69534093|FG000|DB Treatment Phase|Lost to Follow-up|14|||
37919083|NCT00855920|69605723|FG001|Overall Study|Protocol Violation|0|||
37919084|NCT00855920|69605724|FG002|Overall Study|Protocol Violation|2|||
37850000|NCT01021813|69534094|FG001|DB Treatment Phase|Lost to Follow-up|12|||
37850001|NCT01021813|69534095|FG002|DB Treatment Phase|Lost to Follow-up|0|||
37850002|NCT01021813|69534096|FG003|DB Treatment Phase|Lost to Follow-up|0|||
37919085|NCT00855920|69605722|FG000|Overall Study|Adverse Event|2|||
37919086|NCT00855920|69605723|FG001|Overall Study|Adverse Event|1|||
37919087|NCT00855920|69605724|FG002|Overall Study|Adverse Event|1|||
38027841|NCT03032380|69712818|FG001|Overall Study|Adverse Event|1|||
37850003|NCT01021813|69534097|FG004|DB Treatment Phase|Lost to Follow-up|0|||
37850004|NCT01021813|69534093|FG000|DB Treatment Phase|Physician Decision|17|||
37850005|NCT01021813|69534094|FG001|DB Treatment Phase|Physician Decision|8|||
37850006|NCT01021813|69534095|FG002|DB Treatment Phase|Physician Decision|0|||
37850007|NCT01021813|69534096|FG003|DB Treatment Phase|Physician Decision|0|||
37850008|NCT01021813|69534097|FG004|DB Treatment Phase|Physician Decision|0|||
37850009|NCT01021813|69534093|FG000|DB Treatment Phase|Pregnancy|1|||
37850010|NCT01021813|69534094|FG001|DB Treatment Phase|Pregnancy|0|||
37850011|NCT01021813|69534095|FG002|DB Treatment Phase|Pregnancy|0|||
37850012|NCT01021813|69534096|FG003|DB Treatment Phase|Pregnancy|0|||
37850013|NCT01021813|69534097|FG004|DB Treatment Phase|Pregnancy|0|||
37850014|NCT01021813|69534093|FG000|DB Treatment Phase|Protocol Violation|4|||
37850015|NCT01021813|69534094|FG001|DB Treatment Phase|Protocol Violation|3|||
37850016|NCT01021813|69534095|FG002|DB Treatment Phase|Protocol Violation|0|||
37850017|NCT01021813|69534096|FG003|DB Treatment Phase|Protocol Violation|0|||
37850018|NCT01021813|69534097|FG004|DB Treatment Phase|Protocol Violation|0|||
37850019|NCT01021813|69534093|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
37850020|NCT01021813|69534094|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
37850021|NCT01021813|69534095|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
37850022|NCT01021813|69534096|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
37850023|NCT01021813|69534097|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
37850024|NCT01021813|69534093|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
37850025|NCT01021813|69534094|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
37850026|NCT01021813|69534095|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
37850027|NCT01021813|69534096|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
37850028|NCT01021813|69534097|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
37850029|NCT01021813|69534093|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
37850030|NCT01021813|69534094|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
37850031|NCT01021813|69534095|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
37850032|NCT01021813|69534096|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
37850033|NCT01021813|69534097|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
37850034|NCT01021813|69534093|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
37850035|NCT01021813|69534094|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
37850036|NCT01021813|69534095|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
37850037|NCT01021813|69534096|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
37850038|NCT01021813|69534097|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
37850039|NCT01021813|69534093|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
37850040|NCT01021813|69534094|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
37850041|NCT01021813|69534095|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
37850042|NCT01021813|69534096|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
37850043|NCT01021813|69534097|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
37850044|NCT01021813|69534093|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
37850045|NCT01021813|69534094|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
37850046|NCT01021813|69534095|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
37850047|NCT01021813|69534096|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
37850048|NCT01021813|69534097|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
37850049|NCT01025635|69534116|FG000|Overall Study|Withdrawal by Subject|6|||
37850050|NCT01025635|69534117|FG001|Overall Study|Withdrawal by Subject|7|||
37850051|NCT01025635|69534116|FG000|Overall Study|Protocol Violation|4|||
37850052|NCT01025635|69534117|FG001|Overall Study|Protocol Violation|2|||
37850053|NCT01025635|69534116|FG000|Overall Study|Lack of Efficacy|0|||
37850054|NCT01025635|69534117|FG001|Overall Study|Lack of Efficacy|1|||
37919088|NCT00855920|69605722|FG000|Overall Study|Lack of Efficacy|2|||
37919089|NCT00855920|69605723|FG001|Overall Study|Lack of Efficacy|2|||
37919090|NCT00855920|69605724|FG002|Overall Study|Lack of Efficacy|2|||
37919091|NCT00855920|69605722|FG000|Overall Study|Withdrawal by Subject|2|||
37919092|NCT00855920|69605723|FG001|Overall Study|Withdrawal by Subject|3|||
37919093|NCT00855920|69605724|FG002|Overall Study|Withdrawal by Subject|2|||
37919094|NCT00855920|69605722|FG000|Overall Study|Lost to Follow-up|1|||
37919095|NCT00855920|69605723|FG001|Overall Study|Lost to Follow-up|0|||
37919096|NCT00855920|69605724|FG002|Overall Study|Lost to Follow-up|2|||
37919097|NCT00855920|69605722|FG000|Overall Study|Death|0|||
37850055|NCT01025635|69534116|FG000|Overall Study|Lost to Follow-up|9|||
37850056|NCT01025635|69534117|FG001|Overall Study|Lost to Follow-up|13|||
37850057|NCT01025635|69534116|FG000|Overall Study|Reason not known|4|||
37850058|NCT01025635|69534117|FG001|Overall Study|Reason not known|2|||
37850059|NCT01021423|69534125|FG000|Overall Study|Study terminated|4|||
37850060|NCT01021423|69534126|FG001|Overall Study|Study terminated|5|||
37919098|NCT00855920|69605723|FG001|Overall Study|Death|1|||
37850061|NCT01020877|69534134|FG000|Second Intervention|Withdrawal by Subject|1|||
37850062|NCT01020877|69534135|FG001|Second Intervention|Withdrawal by Subject|0|||
37850063|NCT01020799|69534144|FG000|Overall Study|Adverse Event|4|||
37850064|NCT01020799|69534145|FG001|Overall Study|Adverse Event|3|||
37850065|NCT01020799|69534146|FG002|Overall Study|Adverse Event|2|||
37850066|NCT01020799|69534144|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
37850067|NCT01020799|69534145|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
37850068|NCT01020799|69534146|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
37850069|NCT01020799|69534144|FG000|Overall Study|Protocol Violation|3|||
37850070|NCT01020799|69534145|FG001|Overall Study|Protocol Violation|2|||
37850071|NCT01020799|69534146|FG002|Overall Study|Protocol Violation|0|||
37850072|NCT01020799|69534144|FG000|Overall Study|Withdrawal by Subject|2|||
37850073|NCT01020799|69534145|FG001|Overall Study|Withdrawal by Subject|2|||
37850074|NCT01020799|69534146|FG002|Overall Study|Withdrawal by Subject|3|||
37850075|NCT01020799|69534144|FG000|Overall Study|Lost to Follow-up|6|||
37850076|NCT01020799|69534145|FG001|Overall Study|Lost to Follow-up|4|||
37850077|NCT01020799|69534146|FG002|Overall Study|Lost to Follow-up|2|||
37850078|NCT01288989|69534159|FG000|Overall Study|Death|0|||
37850079|NCT01288989|69534160|FG001|Overall Study|Death|0|||
37850080|NCT01288989|69534161|FG002|Overall Study|Death|0|||
37850081|NCT01288989|69534162|FG003|Overall Study|Death|1|||
37919099|NCT00855920|69605724|FG002|Overall Study|Death|0|||
37919100|NCT00855920|69605722|FG000|Overall Study|Decision by the sponsor|0|||
37919101|NCT00855920|69605723|FG001|Overall Study|Decision by the sponsor|1|||
37919102|NCT00855920|69605724|FG002|Overall Study|Decision by the sponsor|1|||
38027842|NCT03032380|69712817|FG000|Overall Study|Lack of Efficacy|1|||
38027843|NCT03032380|69712818|FG001|Overall Study|Lack of Efficacy|0|||
38027844|NCT03032380|69712817|FG000|Overall Study|Withdrawal by Subject|2|||
38027845|NCT03032380|69712818|FG001|Overall Study|Withdrawal by Subject|3|||
38027846|NCT03032380|69712817|FG000|Overall Study|Recovery|0|||
38027847|NCT03032380|69712818|FG001|Overall Study|Recovery|1|||
38027848|NCT03032380|69712817|FG000|Overall Study|Death|39|||
37919103|NCT00855920|69605722|FG000|Overall Study|Other than specified above|1|||
37919104|NCT00855920|69605723|FG001|Overall Study|Other than specified above|1|||
37919105|NCT00855920|69605724|FG002|Overall Study|Other than specified above|1|||
37919106|NCT00848042|69605735|FG000|Overall Study|Death|1|||
37919107|NCT00848042|69605736|FG001|Overall Study|Death|2|||
37919108|NCT00848042|69605737|FG002|Overall Study|Death|0|||
37919109|NCT00848042|69605735|FG000|Overall Study|Other Therapy|3|||
37919110|NCT00848042|69605736|FG001|Overall Study|Other Therapy|0|||
37919111|NCT00848042|69605737|FG002|Overall Study|Other Therapy|0|||
37919112|NCT00847886|69605747|FG000|Overall Study|Adverse Event|0|||
37919113|NCT00847886|69605748|FG001|Overall Study|Adverse Event|1|||
37919114|NCT00847808|69605754|FG000|Overall Study|Adverse Event|7|||
37919115|NCT00847808|69605754|FG000|Overall Study|Protocol Violation|1|||
37919116|NCT00847808|69605754|FG000|Overall Study|Lost to Follow-up|1|||
37919117|NCT00847808|69605754|FG000|Overall Study|Withdrawal by Subject|4|||
37919118|NCT00847808|69605754|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
38027849|NCT03032380|69712818|FG001|Overall Study|Death|34|||
38027850|NCT03032380|69712817|FG000|Overall Study|Other - Miscellaneous|0|||
38027851|NCT03032380|69712818|FG001|Overall Study|Other - Miscellaneous|1|||
38027852|NCT03519854|69712842|FG000|Overall Study|Technical Error|0|||
38027853|NCT03519854|69712843|FG001|Overall Study|Technical Error|0|||
38027854|NCT03519854|69712844|FG002|Overall Study|Technical Error|1|||
38027855|NCT03519854|69712845|FG003|Overall Study|Technical Error|0|||
38027856|NCT03519854|69712846|FG004|Overall Study|Technical Error|0|||
38027857|NCT03519854|69712847|FG005|Overall Study|Technical Error|0|||
38027858|NCT03519854|69712848|FG006|Overall Study|Technical Error|0|||
38027859|NCT03519854|69712849|FG007|Overall Study|Technical Error|0|||
37850082|NCT01288989|69534163|FG004|Overall Study|Death|0|||
37850083|NCT01288989|69534159|FG000|Overall Study|Dose limiting toxicity|1|||
37850084|NCT01288989|69534160|FG001|Overall Study|Dose limiting toxicity|0|||
37919119|NCT00847808|69605754|FG000|Overall Study|Participant Took Excluded Medication|1|||
37919120|NCT00600353|69605760|FG000|Overall Study|history of malignancy within 5 years|1|||
37919121|NCT00600353|69605761|FG001|Overall Study|history of malignancy within 5 years|0|||
37919122|NCT00600353|69605760|FG000|Overall Study|History of prepartive regimen|0|||
37919123|NCT00600353|69605761|FG001|Overall Study|History of prepartive regimen|1|||
37850085|NCT01288989|69534161|FG002|Overall Study|Dose limiting toxicity|0|||
37850086|NCT01288989|69534162|FG003|Overall Study|Dose limiting toxicity|0|||
37850087|NCT01288989|69534163|FG004|Overall Study|Dose limiting toxicity|0|||
37850088|NCT01288989|69534159|FG000|Overall Study|Adverse Event|0|||
37850089|NCT01288989|69534160|FG001|Overall Study|Adverse Event|0|||
37919124|NCT00691210|69605775|FG000|Overall Study|Progression of Disease|0|||
38027860|NCT03519854|69712850|FG008|Overall Study|Technical Error|0|||
38027861|NCT03519854|69712851|FG009|Overall Study|Technical Error|0|||
38027862|NCT03519854|69712852|FG010|Overall Study|Technical Error|0|||
38027863|NCT03519854|69712853|FG011|Overall Study|Technical Error|0|||
37850090|NCT01288989|69534161|FG002|Overall Study|Adverse Event|0|||
37850091|NCT01288989|69534162|FG003|Overall Study|Adverse Event|0|||
37850092|NCT01288989|69534163|FG004|Overall Study|Adverse Event|2|||
37850093|NCT01288989|69534159|FG000|Overall Study|Physician Decision|0|||
37850094|NCT01288989|69534160|FG001|Overall Study|Physician Decision|0|||
37850095|NCT01288989|69534161|FG002|Overall Study|Physician Decision|0|||
37850096|NCT01288989|69534162|FG003|Overall Study|Physician Decision|0|||
37850097|NCT01288989|69534163|FG004|Overall Study|Physician Decision|1|||
37919125|NCT00691210|69605776|FG001|Overall Study|Progression of Disease|0|||
37919126|NCT00691210|69605777|FG002|Overall Study|Progression of Disease|0|||
37919127|NCT00691210|69605778|FG003|Overall Study|Progression of Disease|2|||
37919128|NCT00691210|69605779|FG004|Overall Study|Progression of Disease|0|||
37919129|NCT00691210|69605780|FG005|Overall Study|Progression of Disease|0|||
37919130|NCT00691210|69605781|FG006|Overall Study|Progression of Disease|0|||
37919131|NCT00691210|69605782|FG007|Overall Study|Progression of Disease|0|||
37919132|NCT00691210|69605775|FG000|Overall Study|Lack of Efficacy|0|||
37919133|NCT00691210|69605776|FG001|Overall Study|Lack of Efficacy|0|||
37919134|NCT00691210|69605777|FG002|Overall Study|Lack of Efficacy|0|||
37919135|NCT00691210|69605778|FG003|Overall Study|Lack of Efficacy|1|||
37919136|NCT00691210|69605779|FG004|Overall Study|Lack of Efficacy|0|||
37919137|NCT00691210|69605780|FG005|Overall Study|Lack of Efficacy|1|||
37919138|NCT00691210|69605781|FG006|Overall Study|Lack of Efficacy|0|||
37919139|NCT00691210|69605782|FG007|Overall Study|Lack of Efficacy|0|||
37919140|NCT00691132|69605802|FG000|Overall Study|Adverse Event|2|||
37919141|NCT00691132|69605803|FG001|Overall Study|Adverse Event|3|||
37919142|NCT00691132|69605802|FG000|Overall Study|Withdrawal by Subject|10|||
37919143|NCT00691132|69605803|FG001|Overall Study|Withdrawal by Subject|10|||
37919144|NCT00855218|69605825|FG000|Overall Study|Adverse Event|43|||
37919145|NCT00855218|69605826|FG001|Overall Study|Adverse Event|27|||
37919146|NCT00855218|69605825|FG000|Overall Study|Withdrawal by Subject|10|||
37919147|NCT00855218|69605826|FG001|Overall Study|Withdrawal by Subject|6|||
37919148|NCT00855218|69605825|FG000|Overall Study|Physician Decision|18|||
37919149|NCT00855218|69605826|FG001|Overall Study|Physician Decision|11|||
37919150|NCT00855218|69605825|FG000|Overall Study|Lost to Follow-up|0|||
37919151|NCT00855218|69605826|FG001|Overall Study|Lost to Follow-up|1|||
37919152|NCT00855218|69605825|FG000|Overall Study|Protocol Violation|5|||
37919153|NCT00855218|69605826|FG001|Overall Study|Protocol Violation|9|||
37919154|NCT00855218|69605825|FG000|Overall Study|non-compliant with study drug|3|||
37919155|NCT00855218|69605826|FG001|Overall Study|non-compliant with study drug|1|||
37919156|NCT00855218|69605825|FG000|Overall Study|patient convenience|2|||
37919157|NCT00855218|69605826|FG001|Overall Study|patient convenience|0|||
37919158|NCT00855218|69605825|FG000|Overall Study|technical problems|2|||
37919159|NCT00855218|69605826|FG001|Overall Study|technical problems|1|||
37919160|NCT00855218|69605825|FG000|Overall Study|Still treated with study medication|0|||
37919161|NCT00855218|69605826|FG001|Overall Study|Still treated with study medication|1|||
37919162|NCT00855218|69605825|FG000|Overall Study|Untreatable disease progression|54|||
37919163|NCT00855218|69605826|FG001|Overall Study|Untreatable disease progression|67|||
37850098|NCT01288989|69534159|FG000|Overall Study|Withdrawal by Subject|0|||
37850099|NCT01288989|69534160|FG001|Overall Study|Withdrawal by Subject|0|||
37850100|NCT01288989|69534161|FG002|Overall Study|Withdrawal by Subject|0|||
37850101|NCT01288989|69534162|FG003|Overall Study|Withdrawal by Subject|0|||
37919164|NCT00855218|69605825|FG000|Overall Study|Second malignancy|0|||
37919165|NCT00855218|69605826|FG001|Overall Study|Second malignancy|1|||
37919166|NCT00855218|69605825|FG000|Overall Study|Progression measurement proven|7|||
37919167|NCT00855218|69605826|FG001|Overall Study|Progression measurement proven|15|||
37850102|NCT01288989|69534163|FG004|Overall Study|Withdrawal by Subject|3|||
37919168|NCT00855218|69605825|FG000|Overall Study|Clinical endpoint reached|10|||
37919169|NCT00855218|69605826|FG001|Overall Study|Clinical endpoint reached|13|||
37919170|NCT01063348|69605834|FG000|Overall Study|Lost to Follow-up|3|||
37919171|NCT01063348|69605835|FG001|Overall Study|Lost to Follow-up|10|||
37919172|NCT00855062|69605843|FG000|Step1|Early Study Closure|5|||
37919173|NCT00855062|69605844|FG001|Step1|Early Study Closure|7|||
37919174|NCT00855062|69605843|FG000|Step1|Adverse Event|1|||
37850103|NCT01020487|69534184|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
37850104|NCT01020487|69534185|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
37850105|NCT01020487|69534186|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
37850106|NCT01020487|69534184|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
37850107|NCT01020487|69534185|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
37850108|NCT01020487|69534186|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
37850109|NCT01020487|69534184|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
38027864|NCT03519854|69712854|FG012|Overall Study|Technical Error|0|||
38027865|NCT03519854|69712855|FG013|Overall Study|Technical Error|0|||
38027866|NCT03519854|69712856|FG014|Overall Study|Technical Error|0|||
38027867|NCT03519854|69712857|FG015|Overall Study|Technical Error|0|||
38027868|NCT03519854|69712858|FG016|Overall Study|Technical Error|0|||
38027869|NCT03519854|69712859|FG017|Overall Study|Technical Error|0|||
38027870|NCT03479216|69712899|FG000|Overall Study|Withdrawal by Subject|3|||
38027871|NCT03479216|69712900|FG001|Overall Study|Withdrawal by Subject|2|||
38027872|NCT03479216|69712899|FG000|Overall Study|Physician Decision|2|||
38027873|NCT03479216|69712900|FG001|Overall Study|Physician Decision|3|||
38027874|NCT03518840|69712906|FG000|Overall Study|Lost to Follow-up|6|||
38027875|NCT03436082|69712915|FG000|Overall Study|Did not undergo procedure|1|||
38027876|NCT03436082|69712916|FG001|Overall Study|Did not undergo procedure|0|||
38027877|NCT03677934|69712924|FG000|Overall Study|Adverse Event|1|||
38027878|NCT03677934|69712925|FG001|Overall Study|Adverse Event|1|||
37919175|NCT00855062|69605844|FG001|Step1|Adverse Event|1|||
37919176|NCT00855062|69605843|FG000|Step1|Protocol Violation|1|||
37919177|NCT00855062|69605844|FG001|Step1|Protocol Violation|0|||
37919178|NCT00855062|69605843|FG000|Step1|Pregnancy|1|||
37919179|NCT00855062|69605844|FG001|Step1|Pregnancy|0|||
37919180|NCT00855062|69605843|FG000|Step1|Withdrawal by Subject|2|||
37919181|NCT00855062|69605844|FG001|Step1|Withdrawal by Subject|3|||
37919182|NCT00855062|69605843|FG000|Step2|Early Study Closure|6|||
37919183|NCT00855062|69605844|FG001|Step2|Early Study Closure|2|||
37919184|NCT00855062|69605843|FG000|Step2|Adverse Event|0|||
37919185|NCT00855062|69605844|FG001|Step2|Adverse Event|3|||
37919186|NCT00855062|69605843|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
38027879|NCT03677934|69712924|FG000|Overall Study|Death|8|||
38027880|NCT03677934|69712925|FG001|Overall Study|Death|4|||
37919187|NCT00855062|69605844|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
37919188|NCT00854906|69605850|FG000|Overall Study|One person had no ocular history|1|||
37919189|NCT00854828|69605861|FG000|Overall Study|Death|1|||
37919190|NCT00854828|69605862|FG001|Overall Study|Death|0|||
37919191|NCT00854828|69605863|FG002|Overall Study|Death|0|||
37919192|NCT00854828|69605864|FG003|Overall Study|Death|0|||
37919193|NCT00854828|69605861|FG000|Overall Study|Withdrawal by Subject|1|||
37919194|NCT00854828|69605862|FG001|Overall Study|Withdrawal by Subject|1|||
37919195|NCT00854828|69605863|FG002|Overall Study|Withdrawal by Subject|0|||
37919196|NCT00854828|69605864|FG003|Overall Study|Withdrawal by Subject|9|||
37919197|NCT00854828|69605861|FG000|Overall Study|Missed 24mo visit|1|||
37919198|NCT00854828|69605862|FG001|Overall Study|Missed 24mo visit|1|||
37919199|NCT00854828|69605863|FG002|Overall Study|Missed 24mo visit|8|||
37919200|NCT00854828|69605864|FG003|Overall Study|Missed 24mo visit|8|||
37919201|NCT00847730|69605874|FG000|Overall Study|Multiple interruptions in therapy|8|||
37919202|NCT00600119|69605884|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
37919203|NCT00600119|69605885|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
37919204|NCT00600119|69605886|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
37919205|NCT00600119|69605887|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
37919206|NCT00600119|69605888|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
37919207|NCT00600119|69605889|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
37850110|NCT01020487|69534185|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
37850111|NCT01020487|69534186|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
37919208|NCT00600119|69605884|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
37919209|NCT00600119|69605885|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
37919210|NCT00600119|69605886|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
38027881|NCT03677934|69712924|FG000|Overall Study|Lost to Follow-up|3|||
38027882|NCT03677934|69712925|FG001|Overall Study|Lost to Follow-up|0|||
38027883|NCT03677934|69712924|FG000|Overall Study|Non-Compliance With Study Drug|1|||
37919211|NCT00600119|69605887|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
37919212|NCT00600119|69605888|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
37850112|NCT01020487|69534184|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
37850113|NCT01020487|69534185|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
37850114|NCT01020487|69534186|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
37850115|NCT01020487|69534184|FG000|Part 2 Open-label Period|Adverse Event|0|||
37919213|NCT00600119|69605889|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
37919214|NCT00600119|69605884|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
37919215|NCT00600119|69605885|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
37919216|NCT00600119|69605886|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
37919217|NCT00600119|69605887|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
37919218|NCT00600119|69605888|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
37919219|NCT00600119|69605889|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
37919220|NCT00600119|69605884|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
37919221|NCT00600119|69605885|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
37919222|NCT00600119|69605886|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
37919223|NCT00600119|69605887|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
37919224|NCT00600119|69605888|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
37850116|NCT01020487|69534185|FG001|Part 2 Open-label Period|Adverse Event|4|||
37850117|NCT01020487|69534186|FG002|Part 2 Open-label Period|Adverse Event|1|||
37850118|NCT01024855|69534196|FG000|Overall Study|Inclusion/exclusion criteria|1|||
37850119|NCT01014013|69534203|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
37850120|NCT01014013|69534204|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
37919225|NCT00600119|69605889|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
37919226|NCT00600119|69605884|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
37919227|NCT00600119|69605885|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
37850121|NCT01014013|69534203|FG000|Overall Study|Clinical adverse experience|4|||
37919228|NCT00600119|69605886|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
37919229|NCT00600119|69605887|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
37919230|NCT00600119|69605888|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
37919231|NCT00600119|69605889|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
37919232|NCT00600119|69605884|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
37919233|NCT00600119|69605885|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
37919234|NCT00600119|69605886|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
37850122|NCT01014013|69534204|FG001|Overall Study|Clinical adverse experience|2|||
37850123|NCT01014013|69534203|FG000|Overall Study|Laboratory adverse experience|1|||
37850124|NCT01014013|69534204|FG001|Overall Study|Laboratory adverse experience|1|||
37850125|NCT01014013|69534203|FG000|Overall Study|Protocol Violation|1|||
37850126|NCT01014013|69534204|FG001|Overall Study|Protocol Violation|3|||
37850127|NCT01014013|69534203|FG000|Overall Study|Withdrawal by Subject|7|||
37850128|NCT01014013|69534204|FG001|Overall Study|Withdrawal by Subject|4|||
37850129|NCT01014013|69534203|FG000|Overall Study|Clinical/microbiologic failure|1|||
37850130|NCT01014013|69534204|FG001|Overall Study|Clinical/microbiologic failure|2|||
37850131|NCT01014013|69534203|FG000|Overall Study|Pathogen culture = no growth|26|||
37850132|NCT01014013|69534204|FG001|Overall Study|Pathogen culture = no growth|34|||
37850133|NCT01014013|69534203|FG000|Overall Study|Negative urine culture|2|||
37850134|NCT01014013|69534204|FG001|Overall Study|Negative urine culture|0|||
37850135|NCT01014013|69534203|FG000|Overall Study|Pathogen resistant|7|||
37850136|NCT01014013|69534204|FG001|Overall Study|Pathogen resistant|4|||
37850137|NCT01014013|69534203|FG000|Overall Study|Physician Decision|0|||
37850138|NCT01014013|69534204|FG001|Overall Study|Physician Decision|1|||
37850139|NCT01014013|69534203|FG000|Overall Study|Another antibiotic therapy required|0|||
37919235|NCT00600119|69605887|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
37919236|NCT00600119|69605888|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
37919237|NCT00600119|69605889|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
37919238|NCT00600119|69605884|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
37919239|NCT00600119|69605885|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
37919240|NCT00600119|69605886|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
37919241|NCT00600119|69605887|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
38027884|NCT03677934|69712925|FG001|Overall Study|Non-Compliance With Study Drug|0|||
38027885|NCT03677934|69712924|FG000|Overall Study|Physician Decision|0|||
38027886|NCT03677934|69712925|FG001|Overall Study|Physician Decision|1|||
38027887|NCT03677934|69712924|FG000|Overall Study|Withdrawal by Subject|1|||
38027888|NCT03677934|69712925|FG001|Overall Study|Withdrawal by Subject|7|||
38027889|NCT03435692|69712937|FG000|Overall Study|Lack of Efficacy|2|||
38027890|NCT03435692|69712938|FG001|Overall Study|Lack of Efficacy|2|||
38027891|NCT03435692|69712939|FG002|Overall Study|Lack of Efficacy|0|||
38027892|NCT03475316|69712953|FG000|6 Month Intervention|Adverse Event|2|||
38027893|NCT03475316|69712954|FG001|6 Month Intervention|Adverse Event|1|||
38027894|NCT03475316|69712953|FG000|6 Month Intervention|Withdrawal by Subject|2|||
38027895|NCT03475316|69712954|FG001|6 Month Intervention|Withdrawal by Subject|0|||
38027896|NCT03475316|69712953|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
38027897|NCT03475316|69712954|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
38027898|NCT03475316|69712953|FG000|9 Months|Study stopped due to COVID pandemic|3|||
38027899|NCT03475316|69712954|FG001|9 Months|Study stopped due to COVID pandemic|4|||
38027900|NCT03673956|69712964|FG000|Overall Study|Lost to Follow-up|1|||
38027901|NCT03673956|69712965|FG001|Overall Study|Lost to Follow-up|0|||
38027902|NCT03673956|69712966|FG002|Overall Study|Lost to Follow-up|0|||
38027903|NCT03673956|69712967|FG003|Overall Study|Lost to Follow-up|0|||
38027904|NCT03673956|69712964|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
38027905|NCT03673956|69712965|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
38027906|NCT03673956|69712966|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
38027907|NCT03673956|69712967|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
38027908|NCT03673098|69712979|FG000|Overall Study|Lost to Follow-up|2|||
38027909|NCT03673098|69712980|FG001|Overall Study|Lost to Follow-up|3|||
38027910|NCT03673098|69712979|FG000|Overall Study|Withdrawal by Subject|6|||
38027911|NCT03673098|69712980|FG001|Overall Study|Withdrawal by Subject|1|||
38027912|NCT03673098|69712979|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
37850140|NCT01014013|69534204|FG001|Overall Study|Another antibiotic therapy required|1|||
37850141|NCT01014013|69534203|FG000|Overall Study|Appendectomy|1|||
38027913|NCT03673098|69712980|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
37850142|NCT01014013|69534204|FG001|Overall Study|Appendectomy|0|||
37850143|NCT01014013|69534203|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
37850144|NCT01014013|69534204|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
37850145|NCT01013701|69534212|FG000|Overall Study|study prematurely terminated|7|||
37850146|NCT01020019|69534219|FG000|Overall Study|Lost to Follow-up|21|||
37850147|NCT01020019|69534220|FG001|Overall Study|Lost to Follow-up|18|||
37850148|NCT01020019|69534219|FG000|Overall Study|Adverse Event|1|||
37850149|NCT01020019|69534220|FG001|Overall Study|Adverse Event|5|||
37850150|NCT01020019|69534219|FG000|Overall Study|not interested in treatment|4|||
37850151|NCT01020019|69534220|FG001|Overall Study|not interested in treatment|4|||
37850152|NCT01020019|69534219|FG000|Overall Study|moving|0|||
37850153|NCT01020019|69534220|FG001|Overall Study|moving|2|||
37850154|NCT01024465|69534226|FG000|Overall Study|Adverse Event|2|||
37850155|NCT01024465|69534226|FG000|Overall Study|Physician Decision|1|||
37850156|NCT01024387|69534230|FG000|Overall Study|Radiographic Progression|29|||
37850157|NCT01024387|69534230|FG000|Overall Study|Symptomatic Progression|10|||
37850158|NCT01024387|69534230|FG000|Overall Study|Physician Decision|5|||
37850159|NCT01024387|69534230|FG000|Overall Study|Withdrawal by Subject|5|||
37850160|NCT01024387|69534230|FG000|Overall Study|Death|2|||
37850161|NCT01024387|69534230|FG000|Overall Study|Prolonged Treatment Delay|1|||
37850162|NCT01024387|69534230|FG000|Overall Study|Adverse Event|3|||
37850163|NCT01024387|69534230|FG000|Overall Study|Other|5|||
37850164|NCT01019317|69534234|FG000|Overall Study|Not Eligible|4|||
37850165|NCT01024309|69534240|FG000|Overall Study|Physician Decision|4|||
37850166|NCT01024309|69534241|FG001|Overall Study|Physician Decision|0|||
37850167|NCT01024309|69534240|FG000|Overall Study|Withdrawal by Subject|4|||
37850168|NCT01024309|69534241|FG001|Overall Study|Withdrawal by Subject|4|||
37850169|NCT01090492|69534255|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
37850170|NCT01090492|69534256|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
37850171|NCT01090492|69534257|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
37850172|NCT01090492|69534258|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
37850173|NCT01090492|69534259|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
37850174|NCT01090492|69534260|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
37850175|NCT01090492|69534261|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
37850176|NCT01090492|69534262|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
37850177|NCT01090492|69534255|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
37850178|NCT01090492|69534256|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
37850179|NCT01090492|69534257|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
37850180|NCT01090492|69534258|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
37850181|NCT01090492|69534259|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
37850182|NCT01090492|69534260|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
37850183|NCT01090492|69534261|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
37850184|NCT01090492|69534262|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
37850185|NCT01090492|69534255|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
37850186|NCT01090492|69534256|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
37850187|NCT01090492|69534257|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
37850188|NCT01090492|69534258|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
37850189|NCT01090492|69534259|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
37850190|NCT01090492|69534260|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
37850191|NCT01090492|69534261|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
37850192|NCT01090492|69534262|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
37850193|NCT01090492|69534255|FG000|First Intervention Period (4 Weeks)|Other|0|||
37850194|NCT01090492|69534256|FG001|First Intervention Period (4 Weeks)|Other|0|||
37850195|NCT01090492|69534257|FG002|First Intervention Period (4 Weeks)|Other|1|||
37850196|NCT01090492|69534258|FG003|First Intervention Period (4 Weeks)|Other|1|||
37850197|NCT01090492|69534259|FG004|First Intervention Period (4 Weeks)|Other|2|||
37850198|NCT01090492|69534260|FG005|First Intervention Period (4 Weeks)|Other|0|||
37850199|NCT01090492|69534261|FG006|First Intervention Period (4 Weeks)|Other|0|||
37850200|NCT01090492|69534262|FG007|First Intervention Period (4 Weeks)|Other|0|||
37850201|NCT01090492|69534255|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
37850202|NCT01090492|69534256|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
37850203|NCT01090492|69534257|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
37850204|NCT01090492|69534258|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
37850205|NCT01090492|69534259|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
37850206|NCT01090492|69534260|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
37850207|NCT01090492|69534261|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
37850208|NCT01090492|69534262|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
37850209|NCT01090492|69534255|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
37850210|NCT01090492|69534256|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
37850211|NCT01090492|69534257|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
37850212|NCT01090492|69534258|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
37850213|NCT01090492|69534259|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
37850214|NCT01090492|69534260|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
37850215|NCT01090492|69534261|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
37850216|NCT01090492|69534262|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
37850217|NCT01090492|69534255|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
37919242|NCT00600119|69605888|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
37850218|NCT01090492|69534256|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
37850219|NCT01090492|69534257|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
37850220|NCT01090492|69534258|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
37850221|NCT01090492|69534259|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
37919243|NCT00600119|69605889|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
37919244|NCT00600119|69605884|FG000|Double-blind Treatment Period|Other|0|||
37919245|NCT00600119|69605885|FG001|Double-blind Treatment Period|Other|0|||
37919246|NCT00600119|69605886|FG002|Double-blind Treatment Period|Other|0|||
37919247|NCT00600119|69605887|FG003|Double-blind Treatment Period|Other|0|||
37919248|NCT00600119|69605888|FG004|Double-blind Treatment Period|Other|2|||
37850222|NCT01090492|69534260|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
37850223|NCT01090492|69534261|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
37850224|NCT01090492|69534262|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
37850225|NCT01090492|69534255|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
37850226|NCT01090492|69534256|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
37850227|NCT01090492|69534257|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
37850228|NCT01090492|69534258|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
37850229|NCT01090492|69534259|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
37850230|NCT01090492|69534260|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
37850231|NCT01090492|69534261|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
37850232|NCT01090492|69534262|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
37850233|NCT01090492|69534255|FG000|Second Intervention Period (4 Weeks)|Other|0|||
37850234|NCT01090492|69534256|FG001|Second Intervention Period (4 Weeks)|Other|1|||
37850235|NCT01090492|69534257|FG002|Second Intervention Period (4 Weeks)|Other|1|||
37919249|NCT00600119|69605889|FG005|Double-blind Treatment Period|Other|1|||
37919250|NCT00600119|69605884|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
37919251|NCT00600119|69605885|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
37919252|NCT00600119|69605886|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
37919253|NCT00600119|69605887|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
37919254|NCT00600119|69605888|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
37919255|NCT00600119|69605889|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
37919256|NCT00600119|69605884|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
37919257|NCT00600119|69605885|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
37919258|NCT00600119|69605886|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
38027914|NCT03435224|69712993|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
38027915|NCT03672396|69712997|FG000|Overall Study|Withdrawal by Subject|4|||
38027916|NCT03672396|69712997|FG000|Overall Study|Physician Decision|1|||
38027917|NCT03672396|69712997|FG000|Overall Study|Adverse Event|1|||
38027918|NCT03434834|69713001|FG000|Overall Study|unable to swallow OCT probe|16|||
38027919|NCT03605862|69713007|FG000|Overall Study|Withdrawal by Subject|12|||
38027920|NCT03605862|69713008|FG001|Overall Study|Withdrawal by Subject|9|||
38027921|NCT03605862|69713007|FG000|Overall Study|Adverse Event|2|||
38027922|NCT03605862|69713008|FG001|Overall Study|Adverse Event|1|||
38027923|NCT03605862|69713007|FG000|Overall Study|Physician Decision|3|||
38027924|NCT03605862|69713008|FG001|Overall Study|Physician Decision|1|||
38027925|NCT03605862|69713007|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
38027926|NCT03605862|69713008|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
38027927|NCT03672006|69713017|FG000|Overall Study|exclusion criteria met|0|||
37850236|NCT01090492|69534258|FG003|Second Intervention Period (4 Weeks)|Other|0|||
37850237|NCT01090492|69534259|FG004|Second Intervention Period (4 Weeks)|Other|0|||
37850238|NCT01090492|69534260|FG005|Second Intervention Period (4 Weeks)|Other|0|||
38027928|NCT03672006|69713018|FG001|Overall Study|exclusion criteria met|1|||
37919259|NCT00600119|69605887|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
38027929|NCT03512288|69713028|FG000|Overall Study|Adverse Event|1|||
37850239|NCT01090492|69534261|FG006|Second Intervention Period (4 Weeks)|Other|0|||
37850240|NCT01090492|69534262|FG007|Second Intervention Period (4 Weeks)|Other|0|||
37919260|NCT00600119|69605888|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
38027930|NCT03512288|69713029|FG001|Overall Study|Adverse Event|0|||
38027931|NCT03512288|69713028|FG000|Overall Study|Lost to Follow-up|12|||
38027932|NCT03512288|69713029|FG001|Overall Study|Lost to Follow-up|15|||
38027933|NCT03512288|69713028|FG000|Overall Study|Physician Decision|0|||
38027934|NCT03512288|69713029|FG001|Overall Study|Physician Decision|2|||
38027935|NCT03512288|69713028|FG000|Overall Study|Protocol Violation|6|||
38027936|NCT03512288|69713029|FG001|Overall Study|Protocol Violation|4|||
38027937|NCT03512288|69713028|FG000|Overall Study|Medication error without associated adverse event|1|||
38027938|NCT03512288|69713029|FG001|Overall Study|Medication error without associated adverse event|0|||
38027939|NCT03512288|69713028|FG000|Overall Study|No longer met eligibility criteria|5|||
38027940|NCT03512288|69713029|FG001|Overall Study|No longer met eligibility criteria|2|||
38027941|NCT03512288|69713028|FG000|Overall Study|Withdrawal by parent/guardian|14|||
38027942|NCT03512288|69713029|FG001|Overall Study|Withdrawal by parent/guardian|18|||
38027943|NCT03512288|69713028|FG000|Overall Study|Other|1|||
38027944|NCT03512288|69713029|FG001|Overall Study|Other|1|||
38027945|NCT03512288|69713028|FG000|Overall Study|Randomized but not treated|1|||
38027946|NCT03512288|69713029|FG001|Overall Study|Randomized but not treated|1|||
38027947|NCT03031678|69713035|FG000|Overall Study|Study closed prior to completion|1|||
38027948|NCT03669588|69713045|FG000|Overall Study|Adverse Event|1|||
38027949|NCT03669588|69713046|FG001|Overall Study|Adverse Event|0|||
38027950|NCT03669588|69713045|FG000|Overall Study|Physician Decision|0|||
37850241|NCT01090492|69534255|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
37850242|NCT01090492|69534256|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
37850243|NCT01090492|69534257|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
37850244|NCT01090492|69534258|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
37850245|NCT01090492|69534259|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
37850246|NCT01090492|69534260|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
37919261|NCT00600119|69605889|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
37919262|NCT00600119|69605884|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
37919263|NCT00600119|69605885|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
37919264|NCT00600119|69605886|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
37919265|NCT00600119|69605887|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
37919266|NCT00600119|69605888|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
37919267|NCT00600119|69605889|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
37919268|NCT00600119|69605884|FG000|Double-blind Treatment Period|Physician Decision|2|||
37919269|NCT00600119|69605885|FG001|Double-blind Treatment Period|Physician Decision|0|||
37919270|NCT00600119|69605886|FG002|Double-blind Treatment Period|Physician Decision|0|||
37919271|NCT00600119|69605887|FG003|Double-blind Treatment Period|Physician Decision|0|||
37850247|NCT01090492|69534261|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
37919272|NCT00600119|69605888|FG004|Double-blind Treatment Period|Physician Decision|0|||
37919273|NCT00600119|69605889|FG005|Double-blind Treatment Period|Physician Decision|0|||
38027951|NCT03669588|69713046|FG001|Overall Study|Physician Decision|1|||
37734976|NCT00985426|69215328|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
37734977|NCT00985426|69215329|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
37850248|NCT01090492|69534262|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
37850249|NCT01090492|69534255|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
37850250|NCT01090492|69534256|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
37850251|NCT01090492|69534257|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
37850252|NCT01090492|69534258|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
37850253|NCT01090492|69534259|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
37850254|NCT01090492|69534260|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
37850255|NCT01090492|69534261|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
37850256|NCT01090492|69534262|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
37850257|NCT01288911|69534283|FG000|Double-blind Period|Death|11|||
37850258|NCT01288911|69534284|FG001|Double-blind Period|Death|7|||
37850259|NCT01288911|69534283|FG000|Double-blind Period|Lost to Follow-up|0|||
37850260|NCT01288911|69534284|FG001|Double-blind Period|Lost to Follow-up|2|||
37919274|NCT00600119|69605884|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
37919275|NCT00600119|69605885|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
37919276|NCT00600119|69605886|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
37919277|NCT00600119|69605887|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
38027952|NCT03669588|69713045|FG000|Overall Study|Protocol Violation|1|||
38027953|NCT03669588|69713046|FG001|Overall Study|Protocol Violation|0|||
38027954|NCT03669588|69713045|FG000|Overall Study|Sponsor Decision|1|||
38027955|NCT03669588|69713046|FG001|Overall Study|Sponsor Decision|1|||
38027956|NCT03669588|69713045|FG000|Overall Study|Withdrawal by Subject|1|||
38027957|NCT03669588|69713046|FG001|Overall Study|Withdrawal by Subject|4|||
38027958|NCT03669588|69713045|FG000|Overall Study|Rescue Therapy Needed|0|||
38027959|NCT03669588|69713046|FG001|Overall Study|Rescue Therapy Needed|1|||
38027960|NCT03598140|69713054|FG000|Overall Study|enrolled but didn't start|1|||
38027961|NCT03598140|69713055|FG001|Overall Study|enrolled but didn't start|0|||
38027962|NCT03644550|69713061|FG000|Overall Study|Withdrawal by Subject|3|||
38027963|NCT03644550|69713061|FG000|Overall Study|Progressive disease|15|||
38027964|NCT00054717|69713068|FG000|Overall Study|Randomized but not treated|2|||
38027965|NCT00054717|69713069|FG001|Overall Study|Randomized but not treated|8|||
37919278|NCT00600119|69605888|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
37919279|NCT00600119|69605889|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
37919280|NCT00600119|69605884|FG000|Double-blind Treatment Period|Adverse Event|1|||
37919281|NCT00600119|69605885|FG001|Double-blind Treatment Period|Adverse Event|1|||
37919282|NCT00600119|69605886|FG002|Double-blind Treatment Period|Adverse Event|0|||
37919283|NCT00600119|69605887|FG003|Double-blind Treatment Period|Adverse Event|1|||
37919284|NCT00600119|69605888|FG004|Double-blind Treatment Period|Adverse Event|2|||
37919285|NCT00600119|69605889|FG005|Double-blind Treatment Period|Adverse Event|10|||
37919286|NCT00600119|69605884|FG000|Follow-up Period|Adverse Event|0|||
37919287|NCT00600119|69605885|FG001|Follow-up Period|Adverse Event|0|||
37919288|NCT00600119|69605886|FG002|Follow-up Period|Adverse Event|0|||
37919289|NCT00600119|69605887|FG003|Follow-up Period|Adverse Event|0|||
37919290|NCT00600119|69605888|FG004|Follow-up Period|Adverse Event|0|||
37919291|NCT00600119|69605889|FG005|Follow-up Period|Adverse Event|1|||
37919292|NCT00600119|69605884|FG000|Follow-up Period|Other|1|||
37919293|NCT00600119|69605885|FG001|Follow-up Period|Other|0|||
37919294|NCT00600119|69605886|FG002|Follow-up Period|Other|0|||
37919295|NCT00600119|69605887|FG003|Follow-up Period|Other|0|||
37919296|NCT00600119|69605888|FG004|Follow-up Period|Other|0|||
37919297|NCT00600119|69605889|FG005|Follow-up Period|Other|0|||
37919298|NCT00866294|69605906|FG000|Overall Study|Adverse Event|12|||
37919299|NCT00866294|69605907|FG001|Overall Study|Adverse Event|13|||
37919300|NCT00866294|69605908|FG002|Overall Study|Adverse Event|9|||
37919301|NCT00866294|69605906|FG000|Overall Study|Lack of Efficacy|7|||
37919302|NCT00866294|69605907|FG001|Overall Study|Lack of Efficacy|1|||
37919303|NCT00866294|69605908|FG002|Overall Study|Lack of Efficacy|0|||
37919304|NCT00866294|69605906|FG000|Overall Study|Protocol Violation|2|||
37919305|NCT00866294|69605907|FG001|Overall Study|Protocol Violation|0|||
37919306|NCT00866294|69605908|FG002|Overall Study|Protocol Violation|0|||
37919307|NCT00866294|69605906|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
38027966|NCT00054717|69713068|FG000|Overall Study|Adverse Event|70|||
37850261|NCT01288911|69534283|FG000|Double-blind Period|Progressive Disease|75|||
37919308|NCT00866294|69605907|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
37919309|NCT00866294|69605908|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
37919310|NCT00866294|69605906|FG000|Overall Study|Lost to Follow-up|1|||
38027967|NCT00054717|69713069|FG001|Overall Study|Adverse Event|22|||
37919311|NCT00866294|69605907|FG001|Overall Study|Lost to Follow-up|3|||
37919312|NCT00866294|69605908|FG002|Overall Study|Lost to Follow-up|0|||
37919313|NCT00866294|69605906|FG000|Overall Study|Physician Decision|6|||
37919314|NCT00866294|69605907|FG001|Overall Study|Physician Decision|2|||
37919315|NCT00866294|69605908|FG002|Overall Study|Physician Decision|1|||
37850262|NCT01288911|69534284|FG001|Double-blind Period|Progressive Disease|103|||
37850263|NCT01288911|69534283|FG000|Double-blind Period|Protocol Violation|1|||
37850264|NCT01288911|69534284|FG001|Double-blind Period|Protocol Violation|0|||
37850265|NCT01288911|69534283|FG000|Double-blind Period|Withdrawal by Subject|25|||
37850266|NCT01288911|69534284|FG001|Double-blind Period|Withdrawal by Subject|26|||
37850267|NCT01288911|69534283|FG000|Double-blind Period|Miscellaneous Reason|29|||
37850268|NCT01288911|69534284|FG001|Double-blind Period|Miscellaneous Reason|42|||
37850269|NCT01288911|69534283|FG000|Double-blind Period|Randomized but never received study drug|1|||
37850270|NCT01288911|69534284|FG001|Double-blind Period|Randomized but never received study drug|2|||
37850271|NCT01288911|69534283|FG000|Open-label Period (All Enzalutamide)|Death|0|||
37850272|NCT01288911|69534284|FG001|Open-label Period (All Enzalutamide)|Death|1|||
37850273|NCT01288911|69534283|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
37850274|NCT01288911|69534284|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
37850275|NCT01288911|69534283|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
37850276|NCT01288911|69534284|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
37850277|NCT01288911|69534283|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
37850278|NCT01288911|69534284|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
37850279|NCT01288911|69534283|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
37850280|NCT01288911|69534284|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
37850281|NCT01288911|69534283|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
37850282|NCT01288911|69534284|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
37850283|NCT01288443|69534299|FG000|Overall Study|Adverse Event|0|||
37850284|NCT01288443|69534300|FG001|Overall Study|Adverse Event|0|||
37919316|NCT00854360|69605928|FG000|Overall Study|Adverse Event|0|||
37919317|NCT00854360|69605929|FG001|Overall Study|Adverse Event|1|||
37919318|NCT00854360|69605930|FG002|Overall Study|Adverse Event|2|||
37919319|NCT00854360|69605931|FG003|Overall Study|Adverse Event|6|||
37919320|NCT00854360|69605928|FG000|Overall Study|Withdrawal by Subject|0|||
37919321|NCT00854360|69605929|FG001|Overall Study|Withdrawal by Subject|0|||
37919322|NCT00854360|69605930|FG002|Overall Study|Withdrawal by Subject|0|||
37919323|NCT00854360|69605931|FG003|Overall Study|Withdrawal by Subject|1|||
37919324|NCT00854360|69605928|FG000|Overall Study|Pregnancy|0|||
37919325|NCT00854360|69605929|FG001|Overall Study|Pregnancy|1|||
37919326|NCT00854360|69605930|FG002|Overall Study|Pregnancy|0|||
37919327|NCT00854360|69605931|FG003|Overall Study|Pregnancy|0|||
37919328|NCT00854360|69605928|FG000|Overall Study|Lack of Efficacy|2|||
37919329|NCT00854360|69605929|FG001|Overall Study|Lack of Efficacy|1|||
37919330|NCT00854360|69605930|FG002|Overall Study|Lack of Efficacy|0|||
37919331|NCT00854360|69605931|FG003|Overall Study|Lack of Efficacy|0|||
37919332|NCT00854360|69605928|FG000|Overall Study|Other|0|||
37919333|NCT00854360|69605929|FG001|Overall Study|Other|0|||
37919334|NCT00854360|69605930|FG002|Overall Study|Other|0|||
37919335|NCT00854360|69605931|FG003|Overall Study|Other|3|||
37919336|NCT00853970|69605943|FG000|Overall Study|Withdrawal by Subject|2|||
37919337|NCT00853970|69605944|FG001|Overall Study|Withdrawal by Subject|1|||
37919338|NCT00853970|69605943|FG000|Overall Study|Cancelled surgery|4|||
37919339|NCT00853970|69605944|FG001|Overall Study|Cancelled surgery|2|||
37919340|NCT00865904|69605972|FG000|Overall Study|Randomized but not Treated|2|||
37919341|NCT00865904|69605973|FG001|Overall Study|Randomized but not Treated|0|||
37919342|NCT00865904|69605974|FG002|Overall Study|Randomized but not Treated|0|||
37919343|NCT00865904|69605975|FG003|Overall Study|Randomized but not Treated|1|||
37919344|NCT00865904|69605976|FG004|Overall Study|Randomized but not Treated|1|||
37919345|NCT00599339|69605992|FG000|Overall Study|Adverse Event|79|||
37919346|NCT00599339|69605992|FG000|Overall Study|Withdrawal by Subject|137|||
37919347|NCT00599339|69605992|FG000|Overall Study|Other Reason|179|||
37919348|NCT00599339|69605992|FG000|Overall Study|Lost to Follow-up|221|||
37919349|NCT00599339|69605992|FG000|Overall Study|No valid data consent|36|||
37919350|NCT00599339|69605992|FG000|Overall Study|Study Termination Status Unknown|12|||
37850285|NCT01288443|69534301|FG002|Overall Study|Adverse Event|1|||
37850286|NCT01288443|69534302|FG003|Overall Study|Adverse Event|1|||
37850287|NCT01288443|69534303|FG004|Overall Study|Adverse Event|3|||
37850288|NCT01288443|69534304|FG005|Overall Study|Adverse Event|1|||
37919351|NCT00599027|69606016|FG000|Overall Study|Withdrawal by Subject|1|||
37919352|NCT00599027|69606017|FG001|Overall Study|Withdrawal by Subject|1|||
37919353|NCT00599027|69606016|FG000|Overall Study|Adverse Event|0|||
37919354|NCT00599027|69606017|FG001|Overall Study|Adverse Event|1|||
37919355|NCT00599027|69606016|FG000|Overall Study|Treatment Failure|0|||
37919356|NCT00599027|69606017|FG001|Overall Study|Treatment Failure|1|||
37919357|NCT02881151|69606032|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
37919358|NCT00689728|69606040|FG000|Double-Blind Treatment|Adverse Event|1|||
37919359|NCT00689728|69606041|FG001|Double-Blind Treatment|Adverse Event|0|||
37919360|NCT00689728|69606042|FG002|Double-Blind Treatment|Adverse Event|0|||
37919361|NCT00689728|69606040|FG000|Double-Blind Treatment|Protocol Violation|0|||
37919362|NCT00689728|69606041|FG001|Double-Blind Treatment|Protocol Violation|0|||
37850289|NCT01288443|69534299|FG000|Overall Study|Poor compliance to protocol|0|||
37850290|NCT01288443|69534300|FG001|Overall Study|Poor compliance to protocol|0|||
37850291|NCT01288443|69534301|FG002|Overall Study|Poor compliance to protocol|0|||
37850292|NCT01288443|69534302|FG003|Overall Study|Poor compliance to protocol|0|||
37734978|NCT00985192|69215335|FG000|Overall Study|Withdrawal by Subject|1|||
37734979|NCT00985192|69215335|FG000|Overall Study|Disease Progression|1|||
38027968|NCT00054717|69713068|FG000|Overall Study|Protocol Violation|18|||
38027969|NCT00054717|69713069|FG001|Overall Study|Protocol Violation|19|||
38027970|NCT00054717|69713068|FG000|Overall Study|Lost to Follow-up|23|||
38027971|NCT00054717|69713069|FG001|Overall Study|Lost to Follow-up|13|||
38027972|NCT00054717|69713068|FG000|Overall Study|Withdrawal by Subject|32|||
38027973|NCT00054717|69713069|FG001|Overall Study|Withdrawal by Subject|20|||
38027974|NCT00054717|69713068|FG000|Overall Study|Other reason not defined above|117|||
38027975|NCT00054717|69713069|FG001|Overall Study|Other reason not defined above|217|||
38027976|NCT03430856|69713078|FG000|Overall Study|Adverse Event|0|||
38027977|NCT03430856|69713079|FG001|Overall Study|Adverse Event|1|||
38027978|NCT03430856|69713080|FG002|Overall Study|Adverse Event|0|||
38027979|NCT03430856|69713078|FG000|Overall Study|Rescue criteria|1|||
38027980|NCT03430856|69713079|FG001|Overall Study|Rescue criteria|1|||
38027981|NCT03430856|69713080|FG002|Overall Study|Rescue criteria|0|||
38027982|NCT03430856|69713078|FG000|Overall Study|Voluntary withdrawal of consent|1|||
38027983|NCT03430856|69713079|FG001|Overall Study|Voluntary withdrawal of consent|1|||
38027984|NCT03430856|69713080|FG002|Overall Study|Voluntary withdrawal of consent|1|||
38027985|NCT03731364|69713096|FG000|Overall Study|Adverse Event|0|||
38027986|NCT03731364|69713097|FG001|Overall Study|Adverse Event|0|||
38027987|NCT03731364|69713098|FG002|Overall Study|Adverse Event|1|||
38027988|NCT03731364|69713099|FG003|Overall Study|Adverse Event|2|||
38027989|NCT03731364|69713100|FG004|Overall Study|Adverse Event|1|||
38027990|NCT03510182|69713112|FG000|Overall Study|Withdrawal by Subject|2|||
38027991|NCT00066807|69713118|FG000|Overall Study|Study was terminated early|14|||
38027992|NCT00066807|69713119|FG001|Overall Study|Study was terminated early|15|||
38027993|NCT03428750|69713127|FG000|Overall Study|Withdrawal by Subject|11|||
38027994|NCT03428750|69713128|FG001|Overall Study|Withdrawal by Subject|10|||
38027995|NCT03428750|69713127|FG000|Overall Study|Lost to Follow-up|3|||
38027996|NCT03428750|69713128|FG001|Overall Study|Lost to Follow-up|9|||
38027997|NCT03428750|69713127|FG000|Overall Study|Adverse Event|9|||
38027998|NCT03428750|69713128|FG001|Overall Study|Adverse Event|1|||
38027999|NCT03428750|69713127|FG000|Overall Study|Protocol Violation|1|||
38028000|NCT03428750|69713128|FG001|Overall Study|Protocol Violation|0|||
38028001|NCT03428750|69713127|FG000|Overall Study|Administrative|0|||
38028002|NCT03428750|69713128|FG001|Overall Study|Administrative|1|||
38028003|NCT03666858|69713157|FG000|Cohort 1|Adverse Event|1|||
38028004|NCT03666858|69713158|FG001|Cohort 1|Adverse Event|0|||
38028005|NCT03666858|69713157|FG000|Cohort 2|Adverse Event|0|||
38028006|NCT03666858|69713158|FG001|Cohort 2|Adverse Event|1|||
38028007|NCT00054639|69713164|FG000|Overall Study|Lack of Efficacy|1|||
38028008|NCT00054639|69713164|FG000|Overall Study|Physician Decision|1|||
38028009|NCT03428360|69713168|FG000|Overall Study|Informed consent withdrawn|5|||
38028010|NCT03428360|69713168|FG000|Overall Study|Withdrawal by Subject|4|||
38028011|NCT03428360|69713168|FG000|Overall Study|Lost to Follow-up|5|||
38028012|NCT03428360|69713168|FG000|Overall Study|Physician Decision|2|||
38028013|NCT03428360|69713168|FG000|Overall Study|Informed consent withdrawn|5|||
38028014|NCT03428360|69713168|FG000|Overall Study|Study terminated by sponsor|10|||
38028015|NCT03428360|69713168|FG000|Overall Study|Non-compliant with study|1|||
38028016|NCT03428360|69713168|FG000|Overall Study|Non-compliant with study drug|3|||
38028017|NCT03428360|69713168|FG000|Overall Study|Death|3|||
38028018|NCT03428360|69713168|FG000|Overall Study|Adverse Event|1|||
38028019|NCT03428360|69713168|FG000|Overall Study|Not on antiepileptic drug|1|||
38028020|NCT03427892|69713176|FG000|Overall Study|Lost to Follow-up|2|||
37850293|NCT01288443|69534303|FG004|Overall Study|Poor compliance to protocol|0|||
37850294|NCT01288443|69534304|FG005|Overall Study|Poor compliance to protocol|1|||
37850295|NCT01288443|69534299|FG000|Overall Study|Participant Moved|0|||
37850296|NCT01288443|69534300|FG001|Overall Study|Participant Moved|0|||
38028021|NCT03595332|69713182|FG000|Overall Study|Lost to Follow-up|16|||
38028022|NCT03595332|69713183|FG001|Overall Study|Lost to Follow-up|22|||
37850297|NCT01288443|69534301|FG002|Overall Study|Participant Moved|0|||
37919363|NCT00689728|69606042|FG002|Double-Blind Treatment|Protocol Violation|1|||
38028023|NCT03595332|69713182|FG000|Overall Study|Unable to retrieve ID from school|0|||
38028024|NCT03595332|69713183|FG001|Overall Study|Unable to retrieve ID from school|2|||
38028025|NCT03427268|69713192|FG000|Overall Study|Progressive disease|25|||
38028026|NCT03427268|69713192|FG000|Overall Study|Never treated|2|||
38028027|NCT03427268|69713192|FG000|Overall Study|Compassionate use|1|||
37919364|NCT00689728|69606040|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
37919365|NCT00689728|69606041|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
37919366|NCT00689728|69606042|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
37919367|NCT00689728|69606040|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
37919368|NCT00689728|69606041|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
37919369|NCT00689728|69606042|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
37919370|NCT00689728|69606040|FG000|Rescue|Adverse Event|0|||
37919371|NCT00689728|69606041|FG001|Rescue|Adverse Event|1|||
37919372|NCT00689728|69606042|FG002|Rescue|Adverse Event|0|||
37919373|NCT00689728|69606040|FG000|Rescue|Withdrawal by Subject|1|||
37919374|NCT00689728|69606041|FG001|Rescue|Withdrawal by Subject|1|||
37919375|NCT00689728|69606042|FG002|Rescue|Withdrawal by Subject|1|||
37919376|NCT00689728|69606040|FG000|Optional Follow-Up|Adverse Event|1|||
37919377|NCT00689728|69606041|FG001|Optional Follow-Up|Adverse Event|0|||
38028028|NCT03427268|69713192|FG000|Overall Study|Withdrawal by Subject|1|||
38028029|NCT03427268|69713192|FG000|Overall Study|Adverse Event|3|||
38028030|NCT03509948|69713196|FG000|Overall Study|Protocol Violation|0|||
37919378|NCT00689728|69606042|FG002|Optional Follow-Up|Adverse Event|0|||
37919379|NCT00689728|69606040|FG000|Optional Follow-Up|Lack of Efficacy|0|||
38028031|NCT03509948|69713197|FG001|Overall Study|Protocol Violation|1|||
37919380|NCT00689728|69606041|FG001|Optional Follow-Up|Lack of Efficacy|1|||
37919381|NCT00689728|69606042|FG002|Optional Follow-Up|Lack of Efficacy|1|||
37919382|NCT00689728|69606040|FG000|Optional Follow-Up|Lost to Follow-up|0|||
38028032|NCT03466658|69713203|FG000|Overall Study|Withdrawal by Subject|3|||
37850298|NCT01288443|69534302|FG003|Overall Study|Participant Moved|1|||
37850299|NCT01288443|69534303|FG004|Overall Study|Participant Moved|2|||
37850300|NCT01288443|69534304|FG005|Overall Study|Participant Moved|1|||
37850301|NCT01288443|69534299|FG000|Overall Study|Consent withdrawn by Participant|0|||
37850302|NCT01288443|69534300|FG001|Overall Study|Consent withdrawn by Participant|0|||
37850303|NCT01288443|69534301|FG002|Overall Study|Consent withdrawn by Participant|0|||
37850304|NCT01288443|69534302|FG003|Overall Study|Consent withdrawn by Participant|0|||
37850305|NCT01288443|69534303|FG004|Overall Study|Consent withdrawn by Participant|0|||
37850306|NCT01288443|69534304|FG005|Overall Study|Consent withdrawn by Participant|1|||
37850307|NCT01288443|69534299|FG000|Overall Study|Lost to Follow-up|0|||
38028033|NCT03425396|69713214|FG000|Overall Study|Lost to Follow-up|2|||
38028034|NCT03425396|69713215|FG001|Overall Study|Lost to Follow-up|5|||
38028035|NCT03425396|69713216|FG002|Overall Study|Lost to Follow-up|2|||
38028036|NCT03425396|69713217|FG003|Overall Study|Lost to Follow-up|0|||
38028037|NCT03425396|69713218|FG004|Overall Study|Lost to Follow-up|0|||
38028038|NCT03425396|69713214|FG000|Overall Study|Withdrawal by Subject|0|||
38028039|NCT03425396|69713215|FG001|Overall Study|Withdrawal by Subject|1|||
38028040|NCT03425396|69713216|FG002|Overall Study|Withdrawal by Subject|0|||
38028041|NCT03425396|69713217|FG003|Overall Study|Withdrawal by Subject|1|||
38028042|NCT03425396|69713218|FG004|Overall Study|Withdrawal by Subject|0|||
38028043|NCT03425396|69713214|FG000|Overall Study|Other|0|||
38028044|NCT03425396|69713215|FG001|Overall Study|Other|1|||
38028045|NCT03425396|69713216|FG002|Overall Study|Other|1|||
38028046|NCT03425396|69713217|FG003|Overall Study|Other|0|||
38028047|NCT03425396|69713218|FG004|Overall Study|Other|1|||
38028048|NCT00032487|69713232|FG000|Overall Study|Withdrawal by Subject|67|||
38028049|NCT00032487|69713233|FG001|Overall Study|Withdrawal by Subject|43|||
38028050|NCT00032487|69713232|FG000|Overall Study|Adverse Event|3|||
38028051|NCT00032487|69713233|FG001|Overall Study|Adverse Event|7|||
38028052|NCT00032487|69713232|FG000|Overall Study|Lost to Follow-up|57|||
38028053|NCT00032487|69713233|FG001|Overall Study|Lost to Follow-up|58|||
38028054|NCT00032487|69713232|FG000|Overall Study|Had other reason|12|||
38028055|NCT00032487|69713233|FG001|Overall Study|Had other reason|12|||
38028056|NCT03641508|69713241|FG000|First Injection|Lost to Follow-up|2|||
38028057|NCT03641508|69713242|FG001|First Injection|Lost to Follow-up|0|||
38028058|NCT03465878|69713250|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
38028059|NCT03465878|69713251|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
38028060|NCT03465878|69713252|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
38028061|NCT03465878|69713253|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
38028062|NCT03465878|69713250|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
38028063|NCT03465878|69713251|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
37850308|NCT01288443|69534300|FG001|Overall Study|Lost to Follow-up|1|||
37850309|NCT01288443|69534301|FG002|Overall Study|Lost to Follow-up|0|||
37850310|NCT01288443|69534302|FG003|Overall Study|Lost to Follow-up|0|||
37850311|NCT01288443|69534303|FG004|Overall Study|Lost to Follow-up|0|||
38028064|NCT03465878|69713252|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
37850312|NCT01288443|69534304|FG005|Overall Study|Lost to Follow-up|0|||
37850313|NCT01288443|69534299|FG000|Overall Study|Study drug auto-injector administration|0|||
37850314|NCT01288443|69534300|FG001|Overall Study|Study drug auto-injector administration|0|||
38028065|NCT03465878|69713253|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
38028066|NCT03465878|69713250|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
38028067|NCT03465878|69713251|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
38028068|NCT03465878|69713252|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
38028069|NCT03465878|69713253|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
38028070|NCT03637374|69713281|FG000|Overall Study|Death|2|||
38028071|NCT03637374|69713282|FG001|Overall Study|Death|0|||
37919383|NCT00689728|69606041|FG001|Optional Follow-Up|Lost to Follow-up|1|||
37919384|NCT00689728|69606042|FG002|Optional Follow-Up|Lost to Follow-up|1|||
37919385|NCT00689728|69606040|FG000|Optional Follow-Up|Protocol Violation|0|||
38028072|NCT03421730|69713288|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
38028073|NCT03421730|69713289|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
38028074|NCT03421730|69713290|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
38028075|NCT03421730|69713291|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
37919386|NCT00689728|69606041|FG001|Optional Follow-Up|Protocol Violation|0|||
37919387|NCT00689728|69606042|FG002|Optional Follow-Up|Protocol Violation|1|||
37919388|NCT00689728|69606040|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
37919389|NCT00689728|69606041|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
38028076|NCT03421730|69713292|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
38028077|NCT03421730|69713293|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
38028078|NCT03421730|69713294|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
38028079|NCT03421730|69713295|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
38028080|NCT03421730|69713296|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
38028081|NCT03421730|69713297|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
38028082|NCT03421730|69713298|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
38028083|NCT03421730|69713299|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
38028084|NCT03421730|69713288|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
38028085|NCT03421730|69713289|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
38028086|NCT03421730|69713290|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
38028087|NCT03421730|69713291|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
38028088|NCT03421730|69713292|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
38028089|NCT03421730|69713293|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
38028090|NCT03421730|69713294|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
38028091|NCT03421730|69713295|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
38028092|NCT03421730|69713296|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
38028093|NCT03421730|69713297|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
38028094|NCT03421730|69713298|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
38028095|NCT03421730|69713299|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
38028096|NCT00054327|69713319|FG000|Overall Study|Engraftment failure|1|||
38028097|NCT00054327|69713320|FG001|Overall Study|Engraftment failure|0|||
38028098|NCT00054327|69713321|FG002|Overall Study|Engraftment failure|0|||
38028099|NCT00054327|69713322|FG003|Overall Study|Engraftment failure|0|||
38028100|NCT00054327|69713323|FG004|Overall Study|Engraftment failure|0|||
38028101|NCT00054327|69713324|FG005|Overall Study|Engraftment failure|0|||
38028102|NCT03503162|69713338|FG000|Overall Study|did not meet eligibility|1|||
38028103|NCT03029650|69713342|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
38028104|NCT03029650|69713343|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
38028105|NCT03029650|69713342|FG000|Washout (1 Week)|Physician Decision|0|||
38028106|NCT03029650|69713343|FG001|Washout (1 Week)|Physician Decision|1|||
38028107|NCT03462680|69713355|FG000|Overall Study|Withdrawal by Subject|3|||
38028108|NCT03462680|69713356|FG001|Overall Study|Withdrawal by Subject|5|||
38028109|NCT03636906|69713365|FG000|Overall Study|Adverse Event|0|||
38028110|NCT03636906|69713366|FG001|Overall Study|Adverse Event|0|||
38028111|NCT03636906|69713367|FG002|Overall Study|Adverse Event|1|||
38028112|NCT03636906|69713365|FG000|Overall Study|Lost to Follow-up|1|||
38028113|NCT03636906|69713366|FG001|Overall Study|Lost to Follow-up|0|||
38028114|NCT03636906|69713367|FG002|Overall Study|Lost to Follow-up|0|||
38028115|NCT03636906|69713365|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
38028116|NCT03636906|69713366|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
38028117|NCT03636906|69713367|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
38028118|NCT03636906|69713365|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
38028119|NCT03636906|69713366|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
38028120|NCT03636906|69713367|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
38028121|NCT03636906|69713365|FG000|Overall Study|Other|0|||
37919390|NCT00689728|69606042|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
37919391|NCT00691054|69606071|FG000|Overall Study|Withdrawal by Subject|1|||
37919392|NCT00598871|69606079|FG000|Overall Study|Adverse Event|0|||
37919393|NCT00598871|69606080|FG001|Overall Study|Adverse Event|1|||
38028122|NCT03636906|69713366|FG001|Overall Study|Other|0|||
38028123|NCT03636906|69713367|FG002|Overall Study|Other|1|||
38028124|NCT03028870|69713385|FG000|Overall Study|Adverse Event|7|||
38028125|NCT03028870|69713386|FG001|Overall Study|Adverse Event|4|||
38028126|NCT03028870|69713387|FG002|Overall Study|Adverse Event|3|||
38028127|NCT03028870|69713388|FG003|Overall Study|Adverse Event|3|||
38028128|NCT03028870|69713385|FG000|Overall Study|Withdrawal by Subject|1|||
37734980|NCT00985192|69215335|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
37850315|NCT01288443|69534301|FG002|Overall Study|Study drug auto-injector administration|0|||
37850316|NCT01288443|69534302|FG003|Overall Study|Study drug auto-injector administration|0|||
37850317|NCT01288443|69534303|FG004|Overall Study|Study drug auto-injector administration|1|||
37850318|NCT01288443|69534304|FG005|Overall Study|Study drug auto-injector administration|1|||
37850319|NCT01288443|69534299|FG000|Overall Study|Other than above|0|||
37850320|NCT01288443|69534300|FG001|Overall Study|Other than above|0|||
37850321|NCT01288443|69534301|FG002|Overall Study|Other than above|0|||
37850322|NCT01288443|69534302|FG003|Overall Study|Other than above|2|||
37850323|NCT01288443|69534303|FG004|Overall Study|Other than above|1|||
37850324|NCT01288443|69534304|FG005|Overall Study|Other than above|0|||
37850325|NCT01288287|69534318|FG000|Overall Study|Lost to Follow-up|8|||
37919394|NCT00690820|69606088|FG000|Period 1|Withdrawal by Subject|0|||
37919395|NCT00690820|69606089|FG001|Period 1|Withdrawal by Subject|1|||
37919396|NCT00689338|69606095|FG000|Overall Study|Death|65|||
37919397|NCT00689338|69606095|FG000|Overall Study|Adverse Event|13|||
37919398|NCT00689338|69606095|FG000|Overall Study|Insufficient Clinical Response|1|||
37919399|NCT00689338|69606095|FG000|Overall Study|Lack of Efficacy|6|||
37919400|NCT00689338|69606095|FG000|Overall Study|Other|8|||
37919401|NCT00689338|69606095|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
37919402|NCT00689338|69606095|FG000|Overall Study|Lost to Follow-up|5|||
37919403|NCT00689338|69606095|FG000|Overall Study|Withdrawal by Subject|3|||
37919404|NCT00689338|69606095|FG000|Overall Study|Protocol Violation|15|||
37919405|NCT00686998|69606102|FG000|Overall Study|Adverse Event|3|||
37734981|NCT00985114|69215341|FG000|Overall Study|Adverse Event|1|||
37734982|NCT00985114|69215342|FG001|Overall Study|Adverse Event|0|||
37734983|NCT00985114|69215341|FG000|Overall Study|Withdrawal by Subject|0|||
37734984|NCT00985114|69215342|FG001|Overall Study|Withdrawal by Subject|2|||
37850326|NCT01288287|69534318|FG000|Overall Study|Withdrawal by Subject|4|||
37850327|NCT01288287|69534318|FG000|Overall Study|Lack of Efficacy|13|||
37919406|NCT00686998|69606103|FG001|Overall Study|Adverse Event|2|||
38028129|NCT03028870|69713386|FG001|Overall Study|Withdrawal by Subject|1|||
38028130|NCT03028870|69713387|FG002|Overall Study|Withdrawal by Subject|1|||
38028131|NCT03028870|69713388|FG003|Overall Study|Withdrawal by Subject|2|||
38028132|NCT03028870|69713385|FG000|Overall Study|Lost to Follow-up|1|||
38028133|NCT03028870|69713386|FG001|Overall Study|Lost to Follow-up|0|||
38028134|NCT03028870|69713387|FG002|Overall Study|Lost to Follow-up|0|||
38028135|NCT03028870|69713388|FG003|Overall Study|Lost to Follow-up|0|||
38028136|NCT03028870|69713385|FG000|Overall Study|Lack of Efficacy|3|||
38028137|NCT03028870|69713386|FG001|Overall Study|Lack of Efficacy|0|||
38028138|NCT03028870|69713387|FG002|Overall Study|Lack of Efficacy|0|||
38028139|NCT03028870|69713388|FG003|Overall Study|Lack of Efficacy|0|||
38028140|NCT03028870|69713385|FG000|Overall Study|Administrative|5|||
38028141|NCT03028870|69713386|FG001|Overall Study|Administrative|5|||
38028142|NCT03028870|69713387|FG002|Overall Study|Administrative|12|||
38028143|NCT03028870|69713388|FG003|Overall Study|Administrative|4|||
38028144|NCT03663582|69713398|FG000|Overall Study|Physician Decision|1|||
38028145|NCT03502616|69713404|FG000|Up to Week 16|Withdrawal by Subject|1|||
38028146|NCT03502616|69713405|FG001|Up to Week 16|Withdrawal by Subject|2|||
38028147|NCT03502616|69713404|FG000|Up to Week 16|Lost to Follow-up|0|||
38028148|NCT03502616|69713405|FG001|Up to Week 16|Lost to Follow-up|1|||
38028149|NCT03502616|69713404|FG000|Up to Week 16|Randomized, but not treated|1|||
38028150|NCT03502616|69713405|FG001|Up to Week 16|Randomized, but not treated|0|||
38028151|NCT03502616|69713404|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
38028152|NCT03502616|69713405|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
38028153|NCT03502616|69713404|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
38028154|NCT03502616|69713405|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
38028155|NCT03028012|69713426|FG000|Overall Study|Lost to Follow-up|2|||
38028156|NCT03028012|69713427|FG001|Overall Study|Lost to Follow-up|3|||
38028157|NCT03028012|69713428|FG002|Overall Study|Lost to Follow-up|3|||
38028158|NCT03635190|69713437|FG000|Overall Study|Lost to Follow-up|4|||
38028159|NCT03635190|69713437|FG000|Overall Study|Death|3|||
38028160|NCT03635190|69713437|FG000|Overall Study|Withdrawal by Subject|1|||
38028161|NCT03635190|69713437|FG000|Overall Study|Patient moved and did not return for follow up|1|||
38028162|NCT03634800|69713444|FG000|Overall Study|Adverse Event|1|||
38028163|NCT03634800|69713444|FG000|Overall Study|Disease Progression|4|||
38028164|NCT03634800|69713444|FG000|Overall Study|Withdrawal by Subject|1|||
38028165|NCT03027466|69713452|FG000|Overall Study|Opting out of the app|1869|||
38028166|NCT03027466|69713453|FG001|Overall Study|Opting out of the app|1819|||
38028167|NCT03027466|69713454|FG002|Overall Study|Opting out of the app|1743|||
38028168|NCT03027466|69713455|FG003|Overall Study|Opting out of the app|1821|||
38028169|NCT03662334|69713467|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
38028170|NCT03662334|69713468|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
38028171|NCT02955186|69713476|FG000|Overall Study|Withdrawal by Subject|6|||
38028172|NCT02955186|69713477|FG001|Overall Study|Withdrawal by Subject|2|||
38028173|NCT02955186|69713476|FG000|Overall Study|Protocol Violation|1|||
38028174|NCT02955186|69713477|FG001|Overall Study|Protocol Violation|0|||
38028175|NCT03502070|69713483|FG000|Overall Study|Withdrawal by Subject|1|||
38028176|NCT03502070|69713483|FG000|Overall Study|Screen Failure|1|||
38028177|NCT03586830|69713491|FG000|Overall Study|Site terminated by Sponsor|1|||
38028178|NCT03586830|69713492|FG001|Overall Study|Site terminated by Sponsor|4|||
38028179|NCT03586830|69713493|FG002|Overall Study|Site terminated by Sponsor|3|||
38028180|NCT03586830|69713494|FG003|Overall Study|Site terminated by Sponsor|3|||
38028181|NCT03586830|69713491|FG000|Overall Study|Lost to Follow-up|0|||
38028182|NCT03586830|69713492|FG001|Overall Study|Lost to Follow-up|2|||
38028183|NCT03586830|69713493|FG002|Overall Study|Lost to Follow-up|2|||
38028184|NCT03586830|69713494|FG003|Overall Study|Lost to Follow-up|1|||
38028185|NCT03586830|69713491|FG000|Overall Study|Withdrawal by Subject|1|||
38028186|NCT03586830|69713492|FG001|Overall Study|Withdrawal by Subject|0|||
38028187|NCT03586830|69713493|FG002|Overall Study|Withdrawal by Subject|3|||
38028188|NCT03586830|69713494|FG003|Overall Study|Withdrawal by Subject|1|||
38028189|NCT03026530|69713506|FG000|Overall Study|Lost to Follow-up|19|||
38028190|NCT03026530|69713507|FG001|Overall Study|Lost to Follow-up|24|||
38028191|NCT03026530|69713506|FG000|Overall Study|Protocol Violation|2|||
38028192|NCT03026530|69713507|FG001|Overall Study|Protocol Violation|5|||
38028193|NCT03418376|69713517|FG000|Overall Study|Musculoskeletal injury|1|||
38028194|NCT03418376|69713518|FG001|Overall Study|Musculoskeletal injury|2|||
38028195|NCT03418376|69713519|FG002|Overall Study|Musculoskeletal injury|1|||
38028196|NCT03418376|69713520|FG003|Overall Study|Musculoskeletal injury|0|||
38028197|NCT03418376|69713517|FG000|Overall Study|Personal reasons|0|||
38028198|NCT03418376|69713518|FG001|Overall Study|Personal reasons|2|||
38028199|NCT03418376|69713519|FG002|Overall Study|Personal reasons|2|||
38028200|NCT03418376|69713520|FG003|Overall Study|Personal reasons|1|||
38028201|NCT03418376|69713517|FG000|Overall Study|Exacerbation|0|||
38028202|NCT03418376|69713518|FG001|Overall Study|Exacerbation|1|||
38028203|NCT03418376|69713519|FG002|Overall Study|Exacerbation|0|||
38028204|NCT03418376|69713520|FG003|Overall Study|Exacerbation|0|||
38028205|NCT03585504|69713532|FG000|Overall Study|Lost to Follow-up|26|||
38028206|NCT03585504|69713533|FG001|Overall Study|Lost to Follow-up|29|||
38028207|NCT03417830|69713541|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
38028208|NCT03417830|69713542|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
38028209|NCT03576768|69713553|FG000|Overall Study|Lost to Follow-up|3|||
38028210|NCT03576768|69713554|FG001|Overall Study|Lost to Follow-up|3|||
38028211|NCT03576768|69713555|FG002|Overall Study|Lost to Follow-up|0|||
38028212|NCT03576768|69713556|FG003|Overall Study|Lost to Follow-up|0|||
38028213|NCT03576066|69713568|FG000|Overall Study|Noncompliance with study drug|0|||
38028214|NCT03576066|69713569|FG001|Overall Study|Noncompliance with study drug|1|||
38028215|NCT03557034|69713581|FG000|Overall Study|Withdrawal by Subject|1|||
38028216|NCT03557034|69713582|FG001|Overall Study|Withdrawal by Subject|0|||
38028217|NCT03583554|69713588|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
38028218|NCT03583554|69713589|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
38028219|NCT03583554|69713590|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
37850328|NCT01288287|69534318|FG000|Overall Study|Other Reason|13|||
37850329|NCT01288287|69534318|FG000|Overall Study|Unknown Reason|1|||
37850330|NCT01288287|69534318|FG000|Overall Study|Unknown Status|7|||
37850331|NCT01288209|69534325|FG000|Overall Study|Withdrawal by Subject|1|||
37850332|NCT01288209|69534326|FG001|Overall Study|Withdrawal by Subject|3|||
37850333|NCT01288209|69534325|FG000|Overall Study|Other|1|||
37850334|NCT01288209|69534326|FG001|Overall Study|Other|0|||
37850335|NCT01288053|69534332|FG000|Overall Study|Death|1|||
37850336|NCT01287195|69534336|FG000|Overall Study|Withdrawal by Subject|2|||
37850337|NCT01287117|69534344|FG000|Overall Study|Adverse Event|2|||
37850338|NCT01287117|69534345|FG001|Overall Study|Adverse Event|1|||
37850339|NCT01287117|69534346|FG002|Overall Study|Adverse Event|1|||
37850340|NCT01287117|69534347|FG003|Overall Study|Adverse Event|1|||
37850341|NCT01287117|69534344|FG000|Overall Study|Lost to Follow-up|1|||
38028220|NCT03948178|69713601|FG000|Overall Study|Protocol Violation|1|||
38028221|NCT03948178|69713601|FG000|Overall Study|Lost to Follow-up|2|||
38028222|NCT03948178|69713601|FG000|Overall Study|Withdrawal by Subject|2|||
38028223|NCT03948178|69713601|FG000|Overall Study|Reason not known|2|||
38028224|NCT03948178|69713601|FG000|Overall Study|Personal reason|14|||
38028225|NCT03948178|69713601|FG000|Overall Study|Disease progression|30|||
38028226|NCT03948178|69713601|FG000|Overall Study|Adverse Event|12|||
38028227|NCT03948178|69713601|FG000|Overall Study|Sponsor terminated study|164|||
38028228|NCT03520920|69713608|FG000|Overall Study|Death|13|||
38028229|NCT03520920|69713609|FG001|Overall Study|Death|1|||
38028230|NCT03520920|69713610|FG002|Overall Study|Death|0|||
38028231|NCT03520920|69713608|FG000|Overall Study|Withdrawal by Subject|2|||
38028232|NCT03520920|69713609|FG001|Overall Study|Withdrawal by Subject|1|||
38028233|NCT03520920|69713610|FG002|Overall Study|Withdrawal by Subject|0|||
38028234|NCT03520920|69713608|FG000|Overall Study|Study Terminated by the Sponsor|5|||
38028235|NCT03520920|69713609|FG001|Overall Study|Study Terminated by the Sponsor|14|||
38028236|NCT03520920|69713610|FG002|Overall Study|Study Terminated by the Sponsor|5|||
38028237|NCT02953340|69713626|FG000|Overall Study|Death|0|||
38028238|NCT02953340|69713627|FG001|Overall Study|Death|1|||
38028239|NCT02953340|69713626|FG000|Overall Study|Investigator Decision|3|||
38028240|NCT02953340|69713627|FG001|Overall Study|Investigator Decision|3|||
38028241|NCT02953340|69713626|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
38028242|NCT02953340|69713627|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
38028243|NCT02953340|69713626|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
38028244|NCT02953340|69713627|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
38028245|NCT02953340|69713626|FG000|Overall Study|Withdrawal by Subject|9|||
38028246|NCT02953340|69713627|FG001|Overall Study|Withdrawal by Subject|9|||
38028247|NCT02953340|69713626|FG000|Overall Study|Sponsor decision|0|||
38028248|NCT02953340|69713627|FG001|Overall Study|Sponsor decision|2|||
38028249|NCT02953340|69713626|FG000|Overall Study|Lost to Follow-up|3|||
38028250|NCT02953340|69713627|FG001|Overall Study|Lost to Follow-up|2|||
38028251|NCT02953340|69713626|FG000|Overall Study|Reason not specified|2|||
38028252|NCT02953340|69713627|FG001|Overall Study|Reason not specified|2|||
38028253|NCT03554772|69713643|FG000|Overall Study|Lost to Follow-up|0|||
38028254|NCT03554772|69713644|FG001|Overall Study|Lost to Follow-up|0|||
38028255|NCT03554772|69713645|FG002|Overall Study|Lost to Follow-up|0|||
38028256|NCT03554772|69713646|FG003|Overall Study|Lost to Follow-up|2|||
38028257|NCT03573804|69713656|FG000|Overall Study|claustrophobia or MRI table problems|10|||
38028258|NCT03417440|69713674|FG000|Overall Study|Lost to Follow-up|0|||
38028259|NCT03417440|69713675|FG001|Overall Study|Lost to Follow-up|1|||
38028260|NCT03417440|69713676|FG002|Overall Study|Lost to Follow-up|0|||
38028261|NCT03417440|69713677|FG003|Overall Study|Lost to Follow-up|0|||
38028262|NCT03417440|69713678|FG004|Overall Study|Lost to Follow-up|1|||
38028263|NCT03417440|69713679|FG005|Overall Study|Lost to Follow-up|0|||
37919407|NCT00686998|69606104|FG002|Overall Study|Adverse Event|1|||
37919408|NCT00686998|69606102|FG000|Overall Study|Withdrawal by Subject|2|||
37919409|NCT00686998|69606103|FG001|Overall Study|Withdrawal by Subject|1|||
38028264|NCT03417440|69713680|FG006|Overall Study|Lost to Follow-up|0|||
38028265|NCT03417440|69713681|FG007|Overall Study|Lost to Follow-up|0|||
38028266|NCT03417440|69713674|FG000|Overall Study|Withdrawal by Subject|2|||
38028267|NCT03417440|69713675|FG001|Overall Study|Withdrawal by Subject|0|||
38028268|NCT03417440|69713676|FG002|Overall Study|Withdrawal by Subject|2|||
38028269|NCT03417440|69713677|FG003|Overall Study|Withdrawal by Subject|1|||
38028270|NCT03417440|69713678|FG004|Overall Study|Withdrawal by Subject|1|||
38028271|NCT03417440|69713679|FG005|Overall Study|Withdrawal by Subject|0|||
38028272|NCT03417440|69713680|FG006|Overall Study|Withdrawal by Subject|0|||
38028273|NCT03417440|69713681|FG007|Overall Study|Withdrawal by Subject|1|||
38028274|NCT03458702|69713704|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
38028275|NCT03458702|69713705|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
38028276|NCT03458702|69713704|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
38028277|NCT03458702|69713705|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
37734985|NCT00984568|69215350|FG000|Overall Study|Withdrawal by Subject|1|||
38028278|NCT03454412|69713711|FG000|Baseline Assesment|Physician Decision|12|||
38028279|NCT03452540|69713715|FG000|Overall Study|Adverse Event|1|||
38028280|NCT03452540|69713715|FG000|Overall Study|Withdrawal by Subject|1|||
38028281|NCT03452540|69713715|FG000|Overall Study|Other SAE and AE|2|||
38028282|NCT03573336|69713722|FG000|Overall Study|Study terminated|2|||
38028283|NCT03573336|69713723|FG001|Overall Study|Study terminated|4|||
38028284|NCT03573336|69713724|FG002|Overall Study|Study terminated|2|||
38028285|NCT03500198|69713734|FG000|Overall Study|Lost to Follow-up|0|||
38028286|NCT03500198|69713735|FG001|Overall Study|Lost to Follow-up|1|||
38028287|NCT03553758|69713743|FG000|Overall Study|Lost to Follow-up|1|||
37734986|NCT00984568|69215351|FG001|Overall Study|Withdrawal by Subject|2|||
38028288|NCT03552198|69713753|FG000|Overall Study|Lost to Follow-up|42|||
37919410|NCT00686998|69606104|FG002|Overall Study|Withdrawal by Subject|2|||
37919411|NCT00686998|69606102|FG000|Overall Study|Lack of Efficacy|7|||
37919412|NCT00686998|69606103|FG001|Overall Study|Lack of Efficacy|5|||
37919413|NCT00686998|69606104|FG002|Overall Study|Lack of Efficacy|0|||
38028289|NCT03552198|69713754|FG001|Overall Study|Lost to Follow-up|48|||
38028290|NCT03552198|69713755|FG002|Overall Study|Lost to Follow-up|15|||
38028291|NCT03552198|69713756|FG003|Overall Study|Lost to Follow-up|19|||
38028292|NCT03552198|69713753|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
38028293|NCT03552198|69713754|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
38028294|NCT03552198|69713755|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
38028295|NCT03552198|69713756|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
38028296|NCT03552198|69713753|FG000|Overall Study|Did not receive air alerts|1|||
38028297|NCT03552198|69713754|FG001|Overall Study|Did not receive air alerts|0|||
38028298|NCT03552198|69713755|FG002|Overall Study|Did not receive air alerts|0|||
38028299|NCT03552198|69713756|FG003|Overall Study|Did not receive air alerts|1|||
38028300|NCT02954354|69713769|FG000|Overall Study|Adverse Event|2|||
38028301|NCT02954354|69713770|FG001|Overall Study|Adverse Event|2|||
38028302|NCT02954354|69713771|FG002|Overall Study|Adverse Event|4|||
38028303|NCT02954354|69713769|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
38028304|NCT02954354|69713770|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
38028305|NCT02954354|69713771|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
38028306|NCT02954354|69713769|FG000|Overall Study|Lack of Efficacy|0|||
38028307|NCT02954354|69713770|FG001|Overall Study|Lack of Efficacy|2|||
38028308|NCT02954354|69713771|FG002|Overall Study|Lack of Efficacy|0|||
37919414|NCT00686998|69606102|FG000|Overall Study|Other|0|||
37919415|NCT00686998|69606103|FG001|Overall Study|Other|0|||
37919416|NCT00686998|69606104|FG002|Overall Study|Other|1|||
37919417|NCT00686998|69606102|FG000|Overall Study|Safety Reasons|1|||
37919418|NCT00686998|69606103|FG001|Overall Study|Safety Reasons|0|||
37919419|NCT00686998|69606104|FG002|Overall Study|Safety Reasons|0|||
37919420|NCT00848718|69606125|FG000|Overall Study|Adverse Event|2|||
37919421|NCT00848718|69606126|FG001|Overall Study|Adverse Event|2|||
37919422|NCT00848718|69606127|FG002|Overall Study|Adverse Event|1|||
37919423|NCT00848718|69606128|FG003|Overall Study|Adverse Event|1|||
37919424|NCT00848718|69606129|FG004|Overall Study|Adverse Event|1|||
37919425|NCT00848718|69606130|FG005|Overall Study|Adverse Event|0|||
37919426|NCT00848718|69606131|FG006|Overall Study|Adverse Event|0|||
37919427|NCT00848718|69606132|FG007|Overall Study|Adverse Event|1|||
37919428|NCT00848718|69606133|FG008|Overall Study|Adverse Event|1|||
38028309|NCT02954354|69713769|FG000|Overall Study|Withdrawal by Subject|17|||
38028310|NCT02954354|69713770|FG001|Overall Study|Withdrawal by Subject|9|||
38028311|NCT02954354|69713771|FG002|Overall Study|Withdrawal by Subject|11|||
37734987|NCT00984568|69215350|FG000|Overall Study|Lack of Efficacy|2|||
37850342|NCT01287117|69534345|FG001|Overall Study|Lost to Follow-up|1|||
37850343|NCT01287117|69534346|FG002|Overall Study|Lost to Follow-up|0|||
37850344|NCT01287117|69534347|FG003|Overall Study|Lost to Follow-up|0|||
37850345|NCT01287117|69534344|FG000|Overall Study|Physician Decision|0|||
37850346|NCT01287117|69534345|FG001|Overall Study|Physician Decision|1|||
37850347|NCT01287117|69534346|FG002|Overall Study|Physician Decision|1|||
37850348|NCT01287117|69534347|FG003|Overall Study|Physician Decision|1|||
37850349|NCT01287117|69534344|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
37850350|NCT01287117|69534345|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
37850351|NCT01287117|69534346|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
37850352|NCT01287117|69534347|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
37850353|NCT01287117|69534344|FG000|Overall Study|Disease Progression|10|||
37850354|NCT01287117|69534345|FG001|Overall Study|Disease Progression|5|||
37850355|NCT01287117|69534346|FG002|Overall Study|Disease Progression|6|||
37850356|NCT01287117|69534347|FG003|Overall Study|Disease Progression|5|||
37850357|NCT01287039|69534359|FG000|Overall Study|Noncompliance with study procedures|0|||
37850358|NCT01287039|69534360|FG001|Overall Study|Noncompliance with study procedures|1|||
37850359|NCT01287039|69534359|FG000|Overall Study|Change of location/residence|0|||
37919429|NCT00848718|69606134|FG009|Overall Study|Adverse Event|0|||
37919430|NCT00848718|69606135|FG010|Overall Study|Adverse Event|0|||
37919431|NCT00848718|69606136|FG011|Overall Study|Adverse Event|0|||
37919432|NCT00848718|69606137|FG012|Overall Study|Adverse Event|2|||
37919433|NCT00848718|69606125|FG000|Overall Study|Lack of Efficacy|0|||
37919434|NCT00848718|69606126|FG001|Overall Study|Lack of Efficacy|0|||
37919435|NCT00848718|69606127|FG002|Overall Study|Lack of Efficacy|1|||
38028312|NCT02954354|69713769|FG000|Overall Study|Lost to Follow-up|12|||
38028313|NCT02954354|69713770|FG001|Overall Study|Lost to Follow-up|5|||
38028314|NCT02954354|69713771|FG002|Overall Study|Lost to Follow-up|0|||
38028315|NCT02954354|69713769|FG000|Overall Study|Miscellaneous|2|||
38028316|NCT02954354|69713770|FG001|Overall Study|Miscellaneous|2|||
38028317|NCT02954354|69713771|FG002|Overall Study|Miscellaneous|1|||
38028318|NCT03519516|69713783|FG000|Overall Study|Adverse Event|0|||
38028319|NCT03519516|69713784|FG001|Overall Study|Adverse Event|1|||
38028320|NCT03519204|69713792|FG000|Overall Study|Lost to Follow-up|3|||
38028321|NCT03519204|69713793|FG001|Overall Study|Lost to Follow-up|8|||
38028322|NCT03519204|69713792|FG000|Overall Study|Withdrawal by Subject|9|||
38028323|NCT03519204|69713793|FG001|Overall Study|Withdrawal by Subject|7|||
38028324|NCT03519204|69713792|FG000|Overall Study|Other Miscellaneous Reasons|1|||
38028325|NCT03519204|69713793|FG001|Overall Study|Other Miscellaneous Reasons|0|||
38028326|NCT03518658|69713805|FG000|Overall Study|Other|51|||
38028327|NCT03518658|69713806|FG001|Overall Study|Other|0|||
38028328|NCT03518112|69713814|FG000|Overall Study|Withdrawal by Subject|1|||
38028329|NCT03706456|69713818|FG000|Overall Study|Lack of Efficacy|1|||
38028330|NCT03706456|69713818|FG000|Overall Study|Ongoing|21|||
38028331|NCT03517566|69713827|FG000|Overall Study|Adverse Event|5|||
38028332|NCT03517566|69713828|FG001|Overall Study|Adverse Event|2|||
38028333|NCT03517566|69713829|FG002|Overall Study|Adverse Event|2|||
37850360|NCT01287039|69534360|FG001|Overall Study|Change of location/residence|3|||
37850361|NCT01287039|69534359|FG000|Overall Study|Elective surgery|0|||
37850362|NCT01287039|69534360|FG001|Overall Study|Elective surgery|1|||
37850363|NCT01287039|69534359|FG000|Overall Study|Protocol Violation|2|||
38028334|NCT03517566|69713830|FG003|Overall Study|Adverse Event|8|||
38028335|NCT03517566|69713831|FG004|Overall Study|Adverse Event|7|||
38028336|NCT03517566|69713827|FG000|Overall Study|Lack of Efficacy|3|||
38028337|NCT03517566|69713828|FG001|Overall Study|Lack of Efficacy|2|||
38028338|NCT03517566|69713829|FG002|Overall Study|Lack of Efficacy|1|||
38028339|NCT03517566|69713830|FG003|Overall Study|Lack of Efficacy|1|||
38028340|NCT03517566|69713831|FG004|Overall Study|Lack of Efficacy|4|||
38028341|NCT03517566|69713827|FG000|Overall Study|Lost to Follow-up|3|||
38028342|NCT03517566|69713828|FG001|Overall Study|Lost to Follow-up|1|||
38028343|NCT03517566|69713829|FG002|Overall Study|Lost to Follow-up|1|||
38028344|NCT03517566|69713830|FG003|Overall Study|Lost to Follow-up|1|||
38028345|NCT03517566|69713831|FG004|Overall Study|Lost to Follow-up|0|||
38028346|NCT03517566|69713827|FG000|Overall Study|Physician Decision|1|||
38028347|NCT03517566|69713828|FG001|Overall Study|Physician Decision|1|||
38028348|NCT03517566|69713829|FG002|Overall Study|Physician Decision|0|||
38028349|NCT03517566|69713830|FG003|Overall Study|Physician Decision|1|||
38028350|NCT03517566|69713831|FG004|Overall Study|Physician Decision|0|||
38028351|NCT03517566|69713827|FG000|Overall Study|Pregnancy|0|||
38028352|NCT03517566|69713828|FG001|Overall Study|Pregnancy|1|||
38028353|NCT03517566|69713829|FG002|Overall Study|Pregnancy|0|||
38028354|NCT03517566|69713830|FG003|Overall Study|Pregnancy|0|||
38028355|NCT03517566|69713831|FG004|Overall Study|Pregnancy|0|||
38028356|NCT03517566|69713827|FG000|Overall Study|Protocol Deviation|0|||
38028357|NCT03517566|69713828|FG001|Overall Study|Protocol Deviation|1|||
38028358|NCT03517566|69713829|FG002|Overall Study|Protocol Deviation|0|||
38028359|NCT03517566|69713830|FG003|Overall Study|Protocol Deviation|1|||
38028360|NCT03517566|69713831|FG004|Overall Study|Protocol Deviation|1|||
38028361|NCT03517566|69713827|FG000|Overall Study|Study terminated by Sponsor|11|||
38028362|NCT03517566|69713828|FG001|Overall Study|Study terminated by Sponsor|5|||
38028363|NCT03517566|69713829|FG002|Overall Study|Study terminated by Sponsor|6|||
38028364|NCT03517566|69713830|FG003|Overall Study|Study terminated by Sponsor|14|||
38028365|NCT03517566|69713831|FG004|Overall Study|Study terminated by Sponsor|12|||
37850364|NCT01287039|69534360|FG001|Overall Study|Protocol Violation|3|||
37850365|NCT01287039|69534359|FG000|Overall Study|Excluded medication taken|1|||
37850366|NCT01287039|69534360|FG001|Overall Study|Excluded medication taken|0|||
37850367|NCT01287039|69534359|FG000|Overall Study|Noncompliance with study medication|0|||
37850368|NCT01287039|69534360|FG001|Overall Study|Noncompliance with study medication|1|||
38028366|NCT03517566|69713827|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
37919436|NCT00848718|69606128|FG003|Overall Study|Lack of Efficacy|0|||
37919437|NCT00848718|69606129|FG004|Overall Study|Lack of Efficacy|0|||
38028367|NCT03517566|69713828|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
37850369|NCT01287039|69534359|FG000|Overall Study|Problem with travel|0|||
37919438|NCT00848718|69606130|FG005|Overall Study|Lack of Efficacy|0|||
38028368|NCT03517566|69713829|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
38028369|NCT03517566|69713830|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
38028370|NCT03517566|69713831|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
38028371|NCT03916744|69713847|FG000|Overall Study|Withdrawal by Subject|0|||
38028372|NCT03916744|69713848|FG001|Overall Study|Withdrawal by Subject|1|||
38028373|NCT03916744|69713849|FG002|Overall Study|Withdrawal by Subject|2|||
38028374|NCT03639610|69713864|FG000|Overall Study|Adverse Event|7|||
38028375|NCT03639610|69713865|FG001|Overall Study|Adverse Event|1|||
38028376|NCT03639610|69713866|FG002|Overall Study|Adverse Event|0|||
38028377|NCT03639610|69713864|FG000|Overall Study|Physician Decision|3|||
38028378|NCT03639610|69713865|FG001|Overall Study|Physician Decision|1|||
38028379|NCT03639610|69713866|FG002|Overall Study|Physician Decision|0|||
38028380|NCT03639610|69713864|FG000|Overall Study|Disease progression|8|||
38028381|NCT03639610|69713865|FG001|Overall Study|Disease progression|5|||
38028382|NCT03639610|69713866|FG002|Overall Study|Disease progression|3|||
38028383|NCT03639610|69713864|FG000|Overall Study|Study terminated by sponsor|2|||
38028384|NCT03639610|69713865|FG001|Overall Study|Study terminated by sponsor|1|||
38028385|NCT03639610|69713866|FG002|Overall Study|Study terminated by sponsor|1|||
38028386|NCT03639610|69713864|FG000|Overall Study|Patient request to stop treatment|1|||
38028387|NCT03639610|69713865|FG001|Overall Study|Patient request to stop treatment|2|||
38028388|NCT03639610|69713866|FG002|Overall Study|Patient request to stop treatment|0|||
38028389|NCT02954406|69713884|FG000|Overall Study|Adverse Event|0|||
38028390|NCT02954406|69713885|FG001|Overall Study|Adverse Event|1|||
38028391|NCT02954406|69713886|FG002|Overall Study|Adverse Event|0|||
38028392|NCT02954406|69713887|FG003|Overall Study|Adverse Event|0|||
38028393|NCT02954406|69713888|FG004|Overall Study|Adverse Event|1|||
38028394|NCT02954406|69713889|FG005|Overall Study|Adverse Event|0|||
38028395|NCT02954406|69713890|FG006|Overall Study|Adverse Event|0|||
38028396|NCT02954406|69713891|FG007|Overall Study|Adverse Event|0|||
38028397|NCT02954406|69713892|FG008|Overall Study|Adverse Event|1|||
38028398|NCT02954406|69713893|FG009|Overall Study|Adverse Event|1|||
38028399|NCT02954406|69713894|FG010|Overall Study|Adverse Event|0|||
38028400|NCT02954406|69713884|FG000|Overall Study|Progressive Disease|3|||
38028401|NCT02954406|69713885|FG001|Overall Study|Progressive Disease|4|||
38028402|NCT02954406|69713886|FG002|Overall Study|Progressive Disease|3|||
38028403|NCT02954406|69713887|FG003|Overall Study|Progressive Disease|4|||
38028404|NCT02954406|69713888|FG004|Overall Study|Progressive Disease|3|||
38028405|NCT02954406|69713889|FG005|Overall Study|Progressive Disease|3|||
38028406|NCT02954406|69713890|FG006|Overall Study|Progressive Disease|2|||
38028407|NCT02954406|69713891|FG007|Overall Study|Progressive Disease|2|||
38028408|NCT02954406|69713892|FG008|Overall Study|Progressive Disease|1|||
38028409|NCT02954406|69713893|FG009|Overall Study|Progressive Disease|1|||
38028410|NCT02954406|69713894|FG010|Overall Study|Progressive Disease|0|||
38028411|NCT02954406|69713884|FG000|Overall Study|Symptomatic Deterioration|0|||
38028412|NCT02954406|69713885|FG001|Overall Study|Symptomatic Deterioration|1|||
38028413|NCT02954406|69713886|FG002|Overall Study|Symptomatic Deterioration|0|||
38028414|NCT02954406|69713887|FG003|Overall Study|Symptomatic Deterioration|0|||
38028415|NCT02954406|69713888|FG004|Overall Study|Symptomatic Deterioration|0|||
38028416|NCT02954406|69713889|FG005|Overall Study|Symptomatic Deterioration|0|||
38028417|NCT02954406|69713890|FG006|Overall Study|Symptomatic Deterioration|0|||
38028418|NCT02954406|69713891|FG007|Overall Study|Symptomatic Deterioration|0|||
38028419|NCT02954406|69713892|FG008|Overall Study|Symptomatic Deterioration|0|||
38028420|NCT02954406|69713893|FG009|Overall Study|Symptomatic Deterioration|0|||
38028421|NCT02954406|69713894|FG010|Overall Study|Symptomatic Deterioration|0|||
38028422|NCT02954406|69713884|FG000|Overall Study|Death|0|||
38028423|NCT02954406|69713885|FG001|Overall Study|Death|0|||
38028424|NCT02954406|69713886|FG002|Overall Study|Death|0|||
38028425|NCT02954406|69713887|FG003|Overall Study|Death|0|||
38028426|NCT02954406|69713888|FG004|Overall Study|Death|1|||
38028427|NCT02954406|69713889|FG005|Overall Study|Death|0|||
38028428|NCT02954406|69713890|FG006|Overall Study|Death|0|||
38028429|NCT02954406|69713891|FG007|Overall Study|Death|0|||
38028430|NCT02954406|69713892|FG008|Overall Study|Death|1|||
38028431|NCT02954406|69713893|FG009|Overall Study|Death|1|||
38028432|NCT02954406|69713894|FG010|Overall Study|Death|0|||
38028433|NCT02954406|69713884|FG000|Overall Study|Reason Not Specified|0|||
38028434|NCT02954406|69713885|FG001|Overall Study|Reason Not Specified|0|||
38028435|NCT02954406|69713886|FG002|Overall Study|Reason Not Specified|3|||
38028436|NCT02954406|69713887|FG003|Overall Study|Reason Not Specified|2|||
38028437|NCT02954406|69713888|FG004|Overall Study|Reason Not Specified|2|||
37734988|NCT00984568|69215351|FG001|Overall Study|Lack of Efficacy|0|||
37734989|NCT00984568|69215350|FG000|Overall Study|Adverse Event|2|||
38028438|NCT02954406|69713889|FG005|Overall Study|Reason Not Specified|0|||
38028439|NCT02954406|69713890|FG006|Overall Study|Reason Not Specified|1|||
38028440|NCT02954406|69713891|FG007|Overall Study|Reason Not Specified|0|||
38028441|NCT02954406|69713892|FG008|Overall Study|Reason Not Specified|1|||
38028442|NCT02954406|69713893|FG009|Overall Study|Reason Not Specified|0|||
38028443|NCT02954406|69713894|FG010|Overall Study|Reason Not Specified|0|||
38028444|NCT03514914|69713924|FG000|Overall Study|Death|3|||
37734990|NCT00984568|69215351|FG001|Overall Study|Adverse Event|0|||
37850370|NCT01287039|69534360|FG001|Overall Study|Problem with travel|1|||
38028445|NCT03514914|69713925|FG001|Overall Study|Death|3|||
38028446|NCT03514914|69713924|FG000|Overall Study|Lost to Follow-up|117|||
38028447|NCT03514914|69713925|FG001|Overall Study|Lost to Follow-up|89|||
38028448|NCT03513588|69713934|FG000|Overall Study|Lost to Follow-up|0|||
38028449|NCT03513588|69713935|FG001|Overall Study|Lost to Follow-up|1|||
38028450|NCT03513588|69713936|FG002|Overall Study|Lost to Follow-up|1|||
38028451|NCT03513588|69713934|FG000|Overall Study|Study dosing paused by sponsor|1|||
38028452|NCT03513588|69713935|FG001|Overall Study|Study dosing paused by sponsor|1|||
38028453|NCT03513588|69713936|FG002|Overall Study|Study dosing paused by sponsor|0|||
38028454|NCT03513588|69713934|FG000|Overall Study|Death|0|||
38028455|NCT03513588|69713935|FG001|Overall Study|Death|0|||
38028456|NCT03513588|69713936|FG002|Overall Study|Death|1|||
38028457|NCT03512028|69713948|FG000|Overall Study|Withdrawal by Subject|2|||
38028458|NCT03512028|69713949|FG001|Overall Study|Withdrawal by Subject|0|||
38028459|NCT03512028|69713948|FG000|Overall Study|Protocol Violation|2|||
38028460|NCT03512028|69713949|FG001|Overall Study|Protocol Violation|0|||
38028461|NCT03511326|69713955|FG000|Overall Study|Withdrawal by Subject|1|||
38028462|NCT03508830|69713961|FG000|Overall Study|Withdrawal by Subject|3|||
38028463|NCT03508830|69713962|FG001|Overall Study|Withdrawal by Subject|4|||
38028464|NCT03508830|69713961|FG000|Overall Study|Physician Decision|2|||
38028465|NCT03508830|69713962|FG001|Overall Study|Physician Decision|2|||
38028466|NCT03508050|69713970|FG000|Overall Study|Pleural adhesions|1|||
38028467|NCT03508050|69713971|FG001|Overall Study|Pleural adhesions|0|||
38028468|NCT03508050|69713970|FG000|Overall Study|Mucus plug|1|||
38028469|NCT03508050|69713971|FG001|Overall Study|Mucus plug|0|||
38028470|NCT03508050|69713970|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
38028471|NCT03508050|69713971|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
38028472|NCT03508050|69713970|FG000|Overall Study|Sustained desaturation|0|||
38028473|NCT03508050|69713971|FG001|Overall Study|Sustained desaturation|1|||
38028474|NCT03569202|69713980|FG000|Part 3|Physician Decision|1|||
38028475|NCT03569202|69713981|FG001|Part 3|Physician Decision|0|||
38028476|NCT03569202|69713980|FG000|Part 3|Other|1|||
38028477|NCT03569202|69713981|FG001|Part 3|Other|1|||
38028478|NCT03568500|69713990|FG000|Overall Study|Lost to Follow-up|1|||
38028479|NCT03568500|69713991|FG001|Overall Study|Lost to Follow-up|1|||
38028480|NCT03568500|69713992|FG002|Overall Study|Lost to Follow-up|2|||
38028481|NCT03568500|69713990|FG000|Overall Study|Adverse Event|1|||
38028482|NCT03568500|69713991|FG001|Overall Study|Adverse Event|1|||
38028483|NCT03568500|69713992|FG002|Overall Study|Adverse Event|2|||
38028484|NCT03568500|69713990|FG000|Overall Study|Physician Decision|1|||
37919439|NCT00848718|69606131|FG006|Overall Study|Lack of Efficacy|1|||
37919440|NCT00848718|69606132|FG007|Overall Study|Lack of Efficacy|0|||
38028485|NCT03568500|69713991|FG001|Overall Study|Physician Decision|0|||
38028486|NCT03568500|69713992|FG002|Overall Study|Physician Decision|0|||
38028487|NCT03568500|69713990|FG000|Overall Study|Withdrawal by Subject|4|||
38028488|NCT03568500|69713991|FG001|Overall Study|Withdrawal by Subject|2|||
38028489|NCT03568500|69713992|FG002|Overall Study|Withdrawal by Subject|0|||
38028490|NCT03568500|69713990|FG000|Overall Study|Technical Problems|2|||
38028491|NCT03568500|69713991|FG001|Overall Study|Technical Problems|1|||
37919441|NCT00848718|69606133|FG008|Overall Study|Lack of Efficacy|0|||
37919442|NCT00848718|69606134|FG009|Overall Study|Lack of Efficacy|0|||
37919443|NCT00848718|69606135|FG010|Overall Study|Lack of Efficacy|0|||
37919444|NCT00848718|69606136|FG011|Overall Study|Lack of Efficacy|0|||
37919445|NCT00848718|69606137|FG012|Overall Study|Lack of Efficacy|0|||
38028492|NCT03568500|69713992|FG002|Overall Study|Technical Problems|0|||
38028493|NCT03568500|69713990|FG000|Overall Study|Participant Noncompliance|1|||
38028494|NCT03568500|69713991|FG001|Overall Study|Participant Noncompliance|1|||
38028495|NCT03568500|69713992|FG002|Overall Study|Participant Noncompliance|0|||
38028496|NCT03504852|69714017|FG000|Overall Study|Withdrawal of informed consent|2|||
38028497|NCT03504852|69714018|FG001|Overall Study|Withdrawal of informed consent|1|||
38028498|NCT03504852|69714019|FG002|Overall Study|Withdrawal of informed consent|0|||
38028499|NCT03504852|69714017|FG000|Overall Study|Withdrawal by Subject|5|||
37850371|NCT01287039|69534359|FG000|Overall Study|Death|1|||
37850372|NCT01287039|69534360|FG001|Overall Study|Death|0|||
37850373|NCT01287039|69534359|FG000|Overall Study|Change of residence|1|||
37850374|NCT01287039|69534360|FG001|Overall Study|Change of residence|0|||
37850375|NCT01287039|69534359|FG000|Overall Study|Adverse Event|7|||
37850376|NCT01287039|69534360|FG001|Overall Study|Adverse Event|4|||
37850377|NCT01287039|69534359|FG000|Overall Study|Withdrawal by Subject|14|||
37850378|NCT01287039|69534360|FG001|Overall Study|Withdrawal by Subject|11|||
37850379|NCT01287039|69534359|FG000|Overall Study|Lost to Follow-up|3|||
37850380|NCT01287039|69534360|FG001|Overall Study|Lost to Follow-up|2|||
37850381|NCT01285401|69534368|FG000|Overall Study|Prematurely withdrawn from the study|17|||
38028500|NCT03504852|69714018|FG001|Overall Study|Withdrawal by Subject|5|||
38028501|NCT03504852|69714019|FG002|Overall Study|Withdrawal by Subject|1|||
38028502|NCT03504852|69714017|FG000|Overall Study|Lost to Follow-up|4|||
38028503|NCT03504852|69714018|FG001|Overall Study|Lost to Follow-up|1|||
37850382|NCT01285401|69534369|FG001|Overall Study|Prematurely withdrawn from the study|29|||
37919446|NCT00848718|69606125|FG000|Overall Study|Physician Decision|0|||
37919447|NCT00848718|69606126|FG001|Overall Study|Physician Decision|1|||
38028504|NCT03504852|69714019|FG002|Overall Study|Lost to Follow-up|0|||
38028505|NCT03504852|69714017|FG000|Overall Study|New therapy for study indication|1|||
38028506|NCT03504852|69714018|FG001|Overall Study|New therapy for study indication|0|||
38028507|NCT03504852|69714019|FG002|Overall Study|New therapy for study indication|0|||
38028508|NCT03504852|69714017|FG000|Overall Study|Lack of Efficacy|1|||
38028509|NCT03504852|69714018|FG001|Overall Study|Lack of Efficacy|2|||
38028510|NCT03504852|69714019|FG002|Overall Study|Lack of Efficacy|0|||
38028511|NCT03504852|69714017|FG000|Overall Study|Death|0|||
38028512|NCT03504852|69714018|FG001|Overall Study|Death|1|||
38028513|NCT03504852|69714019|FG002|Overall Study|Death|0|||
38028514|NCT03504852|69714017|FG000|Overall Study|Adverse Event|4|||
38028515|NCT03504852|69714018|FG001|Overall Study|Adverse Event|8|||
38028516|NCT03504852|69714019|FG002|Overall Study|Adverse Event|2|||
38028517|NCT03025828|69714029|FG000|Overall Study|Lost to Follow-up|1|||
38028518|NCT03546816|69714035|FG000|Overall Study|Adverse Event|5|||
37850383|NCT01285323|69534377|FG000|Overall Study|Adverse Event|9|||
37850384|NCT01285323|69534378|FG001|Overall Study|Adverse Event|8|||
37850385|NCT01285323|69534377|FG000|Overall Study|Lack of Efficacy|4|||
37850386|NCT01285323|69534378|FG001|Overall Study|Lack of Efficacy|2|||
37850387|NCT01285323|69534377|FG000|Overall Study|Withdrawal by Subject|15|||
37850388|NCT01285323|69534378|FG001|Overall Study|Withdrawal by Subject|11|||
37850389|NCT01285323|69534377|FG000|Overall Study|Protocol Violation|1|||
37850390|NCT01285323|69534378|FG001|Overall Study|Protocol Violation|2|||
37850391|NCT01285323|69534377|FG000|Overall Study|Non-compliance with study procedures|2|||
38028519|NCT03546816|69714036|FG001|Overall Study|Adverse Event|3|||
38028520|NCT03546816|69714035|FG000|Overall Study|Lack of Efficacy|2|||
38028521|NCT03546816|69714036|FG001|Overall Study|Lack of Efficacy|4|||
38028522|NCT03546816|69714035|FG000|Overall Study|Pregnancy|1|||
38028523|NCT03546816|69714036|FG001|Overall Study|Pregnancy|0|||
38028524|NCT03546816|69714035|FG000|Overall Study|Physician Decision|2|||
38028525|NCT03546816|69714036|FG001|Overall Study|Physician Decision|0|||
38028526|NCT03546816|69714035|FG000|Overall Study|Withdrawal by Subject|8|||
38028527|NCT03546816|69714036|FG001|Overall Study|Withdrawal by Subject|10|||
38028528|NCT03546816|69714035|FG000|Overall Study|Lost to Follow-up|3|||
38028529|NCT03546816|69714036|FG001|Overall Study|Lost to Follow-up|2|||
38028530|NCT03024970|69714044|FG000|First Intervention|Adverse Event|1|||
38028531|NCT03024970|69714045|FG001|First Intervention|Adverse Event|0|||
38028532|NCT03024970|69714044|FG000|Second Intervention|Lost to Follow-up|1|||
38028533|NCT03024970|69714045|FG001|Second Intervention|Lost to Follow-up|0|||
38028534|NCT03500094|69714051|FG000|Overall Study|Withdrawal by Subject|1|||
38028535|NCT03500094|69714051|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
38028536|NCT03500094|69714051|FG000|Overall Study|Lost to Follow-up|1|||
38028537|NCT03566550|69714059|FG000|Overall Study|Withdrawal by Subject|0|||
38028538|NCT03566550|69714060|FG001|Overall Study|Withdrawal by Subject|1|||
38028539|NCT03566238|69714069|FG000|Overall Study|Adverse Event|0|||
38028540|NCT03566238|69714070|FG001|Overall Study|Adverse Event|1|||
38028541|NCT03566238|69714071|FG002|Overall Study|Adverse Event|0|||
38028542|NCT03566238|69714069|FG000|Overall Study|Lack of Efficacy|4|||
38028543|NCT03566238|69714070|FG001|Overall Study|Lack of Efficacy|2|||
38028544|NCT03566238|69714071|FG002|Overall Study|Lack of Efficacy|5|||
38028545|NCT03566238|69714069|FG000|Overall Study|Other|1|||
38028546|NCT03566238|69714070|FG001|Overall Study|Other|0|||
38028547|NCT03566238|69714071|FG002|Overall Study|Other|0|||
38028548|NCT02894502|69714082|FG000|Baseline|Withdrawal by Subject|24|||
38028549|NCT02894502|69714083|FG001|Baseline|Withdrawal by Subject|31|||
38028550|NCT02894502|69714084|FG002|Baseline|Withdrawal by Subject|36|||
38028551|NCT02894502|69714082|FG000|Baseline|Death|3|||
38028552|NCT02894502|69714083|FG001|Baseline|Death|1|||
38028553|NCT02894502|69714084|FG002|Baseline|Death|9|||
38028554|NCT02894502|69714082|FG000|First Follow up|Withdrawal by Subject|32|||
37850392|NCT01285323|69534378|FG001|Overall Study|Non-compliance with study procedures|3|||
37850393|NCT01285323|69534377|FG000|Overall Study|Lost to Follow-up|1|||
37850394|NCT01285323|69534378|FG001|Overall Study|Lost to Follow-up|1|||
38028555|NCT02894502|69714083|FG001|First Follow up|Withdrawal by Subject|29|||
38028556|NCT02894502|69714084|FG002|First Follow up|Withdrawal by Subject|37|||
38028557|NCT02894502|69714082|FG000|First Follow up|Death|2|||
38028558|NCT02894502|69714083|FG001|First Follow up|Death|2|||
38028559|NCT02894502|69714084|FG002|First Follow up|Death|3|||
38028560|NCT02894502|69714082|FG000|Second Follow up|Withdrawal by Subject|13|||
38028561|NCT02894502|69714083|FG001|Second Follow up|Withdrawal by Subject|15|||
38028562|NCT02894502|69714084|FG002|Second Follow up|Withdrawal by Subject|13|||
38028563|NCT02894502|69714082|FG000|Second Follow up|Death|2|||
38028564|NCT02894502|69714083|FG001|Second Follow up|Death|3|||
38028565|NCT02894502|69714084|FG002|Second Follow up|Death|1|||
38028566|NCT02894502|69714082|FG000|Third Follow up|Withdrawal by Subject|5|||
38028567|NCT02894502|69714083|FG001|Third Follow up|Withdrawal by Subject|6|||
38028568|NCT02894502|69714084|FG002|Third Follow up|Withdrawal by Subject|3|||
38028569|NCT02894502|69714082|FG000|Third Follow up|Death|1|||
38028570|NCT02894502|69714083|FG001|Third Follow up|Death|1|||
38028571|NCT02894502|69714084|FG002|Third Follow up|Death|0|||
38028572|NCT03449030|69714105|FG000|Overall Study|Withdrawal by Subject|0|||
38028573|NCT03449030|69714106|FG001|Overall Study|Withdrawal by Subject|0|||
38028574|NCT03449030|69714107|FG002|Overall Study|Withdrawal by Subject|0|||
38028575|NCT03449030|69714108|FG003|Overall Study|Withdrawal by Subject|1|||
38028576|NCT03449030|69714109|FG004|Overall Study|Withdrawal by Subject|1|||
38028577|NCT03449030|69714110|FG005|Overall Study|Withdrawal by Subject|1|||
38028578|NCT03449030|69714111|FG006|Overall Study|Withdrawal by Subject|1|||
38028579|NCT03449030|69714112|FG007|Overall Study|Withdrawal by Subject|2|||
38028580|NCT03449030|69714113|FG008|Overall Study|Withdrawal by Subject|0|||
37919448|NCT00848718|69606127|FG002|Overall Study|Physician Decision|0|||
37919449|NCT00848718|69606128|FG003|Overall Study|Physician Decision|0|||
37919450|NCT00848718|69606129|FG004|Overall Study|Physician Decision|1|||
37919451|NCT00848718|69606130|FG005|Overall Study|Physician Decision|1|||
38028581|NCT03449030|69714114|FG009|Overall Study|Withdrawal by Subject|0|||
38028582|NCT03449030|69714105|FG000|Overall Study|Symptomatic Deterioration|0|||
38028583|NCT03449030|69714106|FG001|Overall Study|Symptomatic Deterioration|1|||
38028584|NCT03449030|69714107|FG002|Overall Study|Symptomatic Deterioration|0|||
38028585|NCT03449030|69714108|FG003|Overall Study|Symptomatic Deterioration|0|||
38028586|NCT03449030|69714109|FG004|Overall Study|Symptomatic Deterioration|0|||
38028587|NCT03449030|69714110|FG005|Overall Study|Symptomatic Deterioration|1|||
38028588|NCT03449030|69714111|FG006|Overall Study|Symptomatic Deterioration|1|||
38028589|NCT03449030|69714112|FG007|Overall Study|Symptomatic Deterioration|0|||
38028590|NCT03449030|69714113|FG008|Overall Study|Symptomatic Deterioration|2|||
38028591|NCT03449030|69714114|FG009|Overall Study|Symptomatic Deterioration|0|||
38028592|NCT03449030|69714105|FG000|Overall Study|Progressive Disease|1|||
38028593|NCT03449030|69714106|FG001|Overall Study|Progressive Disease|0|||
38028594|NCT03449030|69714107|FG002|Overall Study|Progressive Disease|1|||
38028595|NCT03449030|69714108|FG003|Overall Study|Progressive Disease|4|||
38028596|NCT03449030|69714109|FG004|Overall Study|Progressive Disease|5|||
38028597|NCT03449030|69714110|FG005|Overall Study|Progressive Disease|3|||
37919452|NCT00848718|69606131|FG006|Overall Study|Physician Decision|0|||
37919453|NCT00848718|69606132|FG007|Overall Study|Physician Decision|0|||
38028598|NCT03449030|69714111|FG006|Overall Study|Progressive Disease|0|||
38028599|NCT03449030|69714112|FG007|Overall Study|Progressive Disease|1|||
38028600|NCT03449030|69714113|FG008|Overall Study|Progressive Disease|1|||
38028601|NCT03449030|69714114|FG009|Overall Study|Progressive Disease|1|||
38028602|NCT03449030|69714105|FG000|Overall Study|Adverse Event|0|||
38028603|NCT03449030|69714106|FG001|Overall Study|Adverse Event|0|||
38028604|NCT03449030|69714107|FG002|Overall Study|Adverse Event|0|||
38028605|NCT03449030|69714108|FG003|Overall Study|Adverse Event|0|||
38028606|NCT03449030|69714109|FG004|Overall Study|Adverse Event|0|||
37850395|NCT01285323|69534377|FG000|Overall Study|Other|1|||
37850396|NCT01285323|69534378|FG001|Overall Study|Other|3|||
37919454|NCT00848718|69606133|FG008|Overall Study|Physician Decision|1|||
37919455|NCT00848718|69606134|FG009|Overall Study|Physician Decision|2|||
37919456|NCT00848718|69606135|FG010|Overall Study|Physician Decision|0|||
37919457|NCT00848718|69606136|FG011|Overall Study|Physician Decision|0|||
37919458|NCT00848718|69606137|FG012|Overall Study|Physician Decision|1|||
37919459|NCT00848718|69606125|FG000|Overall Study|Progressive disease before treatment|1|||
37919460|NCT00848718|69606126|FG001|Overall Study|Progressive disease before treatment|5|||
37919461|NCT00848718|69606127|FG002|Overall Study|Progressive disease before treatment|1|||
37919462|NCT00848718|69606128|FG003|Overall Study|Progressive disease before treatment|3|||
37919463|NCT00848718|69606129|FG004|Overall Study|Progressive disease before treatment|4|||
37919464|NCT00848718|69606130|FG005|Overall Study|Progressive disease before treatment|4|||
37919465|NCT00848718|69606131|FG006|Overall Study|Progressive disease before treatment|2|||
37919466|NCT00848718|69606132|FG007|Overall Study|Progressive disease before treatment|1|||
37919467|NCT00848718|69606133|FG008|Overall Study|Progressive disease before treatment|2|||
37919468|NCT00848718|69606134|FG009|Overall Study|Progressive disease before treatment|7|||
37850397|NCT01284621|69534384|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
37850398|NCT01284621|69534385|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
37850399|NCT01284621|69534386|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
37850400|NCT01284621|69534387|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
37850401|NCT01284621|69534388|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
37919469|NCT00848718|69606135|FG010|Overall Study|Progressive disease before treatment|3|||
37919470|NCT00848718|69606136|FG011|Overall Study|Progressive disease before treatment|6|||
37919471|NCT00848718|69606137|FG012|Overall Study|Progressive disease before treatment|2|||
37919472|NCT00848718|69606125|FG000|Overall Study|Protocol Violation|0|||
37850402|NCT01284621|69534389|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
37850403|NCT01283139|69534403|FG000|Overall Study|Lost to Follow-up|5|||
37919473|NCT00848718|69606126|FG001|Overall Study|Protocol Violation|1|||
37919474|NCT00848718|69606127|FG002|Overall Study|Protocol Violation|0|||
37919475|NCT00848718|69606128|FG003|Overall Study|Protocol Violation|0|||
37919476|NCT00848718|69606129|FG004|Overall Study|Protocol Violation|0|||
37919477|NCT00848718|69606130|FG005|Overall Study|Protocol Violation|0|||
37919478|NCT00848718|69606131|FG006|Overall Study|Protocol Violation|0|||
37919479|NCT00848718|69606132|FG007|Overall Study|Protocol Violation|1|||
38028607|NCT03449030|69714110|FG005|Overall Study|Adverse Event|2|||
38028608|NCT03449030|69714111|FG006|Overall Study|Adverse Event|0|||
38028609|NCT03449030|69714112|FG007|Overall Study|Adverse Event|0|||
38028610|NCT03449030|69714113|FG008|Overall Study|Adverse Event|0|||
38028611|NCT03449030|69714114|FG009|Overall Study|Adverse Event|0|||
38028612|NCT03449030|69714105|FG000|Overall Study|Death|0|||
38028613|NCT03449030|69714106|FG001|Overall Study|Death|0|||
38028614|NCT03449030|69714107|FG002|Overall Study|Death|0|||
38028615|NCT03449030|69714108|FG003|Overall Study|Death|0|||
38028616|NCT03449030|69714109|FG004|Overall Study|Death|1|||
38028617|NCT03449030|69714110|FG005|Overall Study|Death|0|||
38028618|NCT03449030|69714111|FG006|Overall Study|Death|0|||
38028619|NCT03449030|69714112|FG007|Overall Study|Death|0|||
38028620|NCT03449030|69714113|FG008|Overall Study|Death|0|||
38028621|NCT03449030|69714114|FG009|Overall Study|Death|0|||
38028622|NCT03448406|69714139|FG000|Overall Study|Noncompliance of scheduled visits|1|||
38028623|NCT03448406|69714140|FG001|Overall Study|Noncompliance of scheduled visits|2|||
38028624|NCT03448406|69714139|FG000|Overall Study|Withdrawal by Subject|1|||
38028625|NCT03448406|69714140|FG001|Overall Study|Withdrawal by Subject|2|||
38028626|NCT03448406|69714139|FG000|Overall Study|Protocol Violation|1|||
38028627|NCT03448406|69714140|FG001|Overall Study|Protocol Violation|0|||
38028628|NCT03448406|69714139|FG000|Overall Study|Adverse Event|8|||
38028629|NCT03448406|69714140|FG001|Overall Study|Adverse Event|9|||
38028630|NCT03499028|69714148|FG000|Overall Study|Lost to Follow-up|12|||
38028631|NCT03499028|69714149|FG001|Overall Study|Lost to Follow-up|9|||
38028632|NCT03499028|69714148|FG000|Overall Study|Withdrawal by Subject|5|||
38028633|NCT03499028|69714149|FG001|Overall Study|Withdrawal by Subject|8|||
38028634|NCT03499028|69714148|FG000|Overall Study|Unplanned SNF discharge|5|||
38028635|NCT03499028|69714149|FG001|Overall Study|Unplanned SNF discharge|8|||
38028636|NCT03498560|69714157|FG000|Overall Study|Found Ineligible|2|||
38028637|NCT03498560|69714157|FG000|Overall Study|Withdrawal by Subject|14|||
38028638|NCT03498560|69714157|FG000|Overall Study|Lost to Follow-up|4|||
38028639|NCT03498560|69714157|FG000|Overall Study|Death|1|||
38028640|NCT00064701|69714165|FG000|One Year Post-transplant|Did not receive study drug|7|||
38028641|NCT00064701|69714166|FG001|One Year Post-transplant|Did not receive study drug|12|||
38028642|NCT00064701|69714167|FG002|One Year Post-transplant|Did not receive study drug|11|||
37850404|NCT01283139|69534404|FG001|Overall Study|Lost to Follow-up|2|||
37850405|NCT01283139|69534405|FG002|Overall Study|Lost to Follow-up|3|||
37850406|NCT01283139|69534406|FG003|Overall Study|Lost to Follow-up|1|||
37850407|NCT01283139|69534403|FG000|Overall Study|Withdrawal by Subject|8|||
37850408|NCT01283139|69534404|FG001|Overall Study|Withdrawal by Subject|8|||
37850409|NCT01283139|69534405|FG002|Overall Study|Withdrawal by Subject|6|||
37850410|NCT01283139|69534406|FG003|Overall Study|Withdrawal by Subject|8|||
37850411|NCT01283139|69534403|FG000|Overall Study|Death|2|||
37850412|NCT01283139|69534404|FG001|Overall Study|Death|0|||
37850413|NCT01283139|69534405|FG002|Overall Study|Death|2|||
37850414|NCT01283139|69534406|FG003|Overall Study|Death|2|||
37850415|NCT01283139|69534403|FG000|Overall Study|Lack of Efficacy|1|||
37850416|NCT01283139|69534404|FG001|Overall Study|Lack of Efficacy|2|||
37850417|NCT01283139|69534405|FG002|Overall Study|Lack of Efficacy|2|||
37850418|NCT01283139|69534406|FG003|Overall Study|Lack of Efficacy|1|||
37850419|NCT01283139|69534403|FG000|Overall Study|Early termination due to AE/SAE|1|||
37850420|NCT01283139|69534404|FG001|Overall Study|Early termination due to AE/SAE|1|||
37850421|NCT01283139|69534405|FG002|Overall Study|Early termination due to AE/SAE|0|||
37850422|NCT01283139|69534406|FG003|Overall Study|Early termination due to AE/SAE|0|||
37850423|NCT01283139|69534403|FG000|Overall Study|Participant's refusal to continue|0|||
37850424|NCT01283139|69534404|FG001|Overall Study|Participant's refusal to continue|3|||
37850425|NCT01283139|69534405|FG002|Overall Study|Participant's refusal to continue|1|||
37850426|NCT01283139|69534406|FG003|Overall Study|Participant's refusal to continue|1|||
37850427|NCT01283139|69534403|FG000|Overall Study|Pregnancy|0|||
37850428|NCT01283139|69534404|FG001|Overall Study|Pregnancy|1|||
37850429|NCT01283139|69534405|FG002|Overall Study|Pregnancy|1|||
37850430|NCT01283139|69534406|FG003|Overall Study|Pregnancy|0|||
37850431|NCT01283139|69534403|FG000|Overall Study|Missed follow-up visit|0|||
38028643|NCT00064701|69714165|FG000|One Year Post-transplant|Adverse Event|23|||
38028644|NCT00064701|69714166|FG001|One Year Post-transplant|Adverse Event|19|||
38028645|NCT00064701|69714167|FG002|One Year Post-transplant|Adverse Event|37|||
38028646|NCT00064701|69714165|FG000|One Year Post-transplant|Rejection|0|||
37850432|NCT01283139|69534404|FG001|Overall Study|Missed follow-up visit|1|||
38028647|NCT00064701|69714166|FG001|One Year Post-transplant|Rejection|1|||
37850433|NCT01283139|69534405|FG002|Overall Study|Missed follow-up visit|2|||
38028648|NCT00064701|69714167|FG002|One Year Post-transplant|Rejection|16|||
37850434|NCT01283139|69534406|FG003|Overall Study|Missed follow-up visit|2|||
37850435|NCT01283139|69534403|FG000|Overall Study|Participant randomized in error|0|||
37850436|NCT01283139|69534404|FG001|Overall Study|Participant randomized in error|0|||
37850437|NCT01283139|69534405|FG002|Overall Study|Participant randomized in error|1|||
38028649|NCT00064701|69714165|FG000|One Year Post-transplant|Non-compliance|4|||
38028650|NCT00064701|69714166|FG001|One Year Post-transplant|Non-compliance|2|||
38028651|NCT00064701|69714167|FG002|One Year Post-transplant|Non-compliance|5|||
38028652|NCT00064701|69714165|FG000|One Year Post-transplant|Graft Failure|3|||
37919480|NCT00848718|69606133|FG008|Overall Study|Protocol Violation|0|||
37734991|NCT00984568|69215350|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
37734992|NCT00984568|69215351|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
37734993|NCT00984568|69215350|FG000|Overall Study|Lost to Follow-up|0|||
37734994|NCT00984568|69215351|FG001|Overall Study|Lost to Follow-up|1|||
37734995|NCT00984568|69215350|FG000|Overall Study|Opportunistic Infection|1|||
37734996|NCT00984568|69215351|FG001|Overall Study|Opportunistic Infection|0|||
37734997|NCT00984568|69215350|FG000|Overall Study|Unknown Reason|1|||
37734998|NCT00984568|69215351|FG001|Overall Study|Unknown Reason|3|||
38028653|NCT00064701|69714166|FG001|One Year Post-transplant|Graft Failure|2|||
38028654|NCT00064701|69714167|FG002|One Year Post-transplant|Graft Failure|1|||
38028655|NCT00064701|69714165|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
38028656|NCT00064701|69714166|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
38028657|NCT00064701|69714167|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
38028658|NCT00064701|69714165|FG000|One Year Post-transplant|Lost to Follow-up|1|||
38028659|NCT00064701|69714166|FG001|One Year Post-transplant|Lost to Follow-up|0|||
38028660|NCT00064701|69714167|FG002|One Year Post-transplant|Lost to Follow-up|0|||
38028661|NCT00064701|69714165|FG000|One Year Post-transplant|Converted to rapamycin|1|||
38028662|NCT00064701|69714166|FG001|One Year Post-transplant|Converted to rapamycin|0|||
38028663|NCT00064701|69714167|FG002|One Year Post-transplant|Converted to rapamycin|0|||
38028664|NCT00064701|69714165|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
38028665|NCT00064701|69714166|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
38028666|NCT00064701|69714167|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
38028667|NCT00064701|69714165|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
38028668|NCT00064701|69714166|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
38028669|NCT00064701|69714167|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
38028670|NCT00064701|69714165|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
38028671|NCT00064701|69714166|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
38028672|NCT00064701|69714167|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
38028673|NCT00064701|69714165|FG000|One Year Post-transplant|Poor absorption|0|||
38028674|NCT00064701|69714166|FG001|One Year Post-transplant|Poor absorption|1|||
38028675|NCT00064701|69714167|FG002|One Year Post-transplant|Poor absorption|0|||
38028676|NCT00064701|69714165|FG000|One Year Post-transplant|Pancreas transplant|0|||
38028677|NCT00064701|69714166|FG001|One Year Post-transplant|Pancreas transplant|0|||
38028678|NCT00064701|69714167|FG002|One Year Post-transplant|Pancreas transplant|1|||
38028679|NCT00064701|69714165|FG000|Clinical Continuation Phase|Adverse Event|12|||
38028680|NCT00064701|69714166|FG001|Clinical Continuation Phase|Adverse Event|21|||
38028681|NCT00064701|69714167|FG002|Clinical Continuation Phase|Adverse Event|14|||
38028682|NCT00064701|69714165|FG000|Clinical Continuation Phase|Non-compliance|8|||
38028683|NCT00064701|69714166|FG001|Clinical Continuation Phase|Non-compliance|6|||
38028684|NCT00064701|69714167|FG002|Clinical Continuation Phase|Non-compliance|7|||
38028685|NCT00064701|69714165|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
38028686|NCT00064701|69714166|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
37850438|NCT01283139|69534406|FG003|Overall Study|Participant randomized in error|0|||
37850439|NCT01282203|69534416|FG000|Overall Study|Adverse Event|1|||
37850440|NCT01281969|69534425|FG000|Overall Study|not randomized didn't meet criteria|0|||
37850441|NCT01281969|69534426|FG001|Overall Study|not randomized didn't meet criteria|0|||
37850442|NCT01281969|69534427|FG002|Overall Study|not randomized didn't meet criteria|7|||
37850443|NCT01281969|69534425|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
37850444|NCT01281969|69534426|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
37850445|NCT01281969|69534427|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
37850446|NCT01281969|69534425|FG000|Overall Study|not randomized, child consent not given|0|||
37734999|NCT00984256|69215359|FG000|Overall Study|Withdrawal by Subject|0|||
38028687|NCT00064701|69714167|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
37735000|NCT00984256|69215360|FG001|Overall Study|Withdrawal by Subject|1|||
38028688|NCT00064701|69714165|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
37850447|NCT01281969|69534426|FG001|Overall Study|not randomized, child consent not given|0|||
37850448|NCT01281969|69534427|FG002|Overall Study|not randomized, child consent not given|2|||
37850449|NCT01281813|69534438|FG000|Overall Study|Adverse Event|0|||
37850450|NCT01281813|69534439|FG001|Overall Study|Adverse Event|0|||
37850451|NCT01281813|69534440|FG002|Overall Study|Adverse Event|10|||
37850452|NCT01281813|69534438|FG000|Overall Study|Lost to Follow-up|0|||
37850453|NCT01281813|69534439|FG001|Overall Study|Lost to Follow-up|0|||
37850454|NCT01281813|69534440|FG002|Overall Study|Lost to Follow-up|31|||
37850455|NCT01281813|69534438|FG000|Overall Study|Withdrawal by Subject|0|||
37850456|NCT01281813|69534439|FG001|Overall Study|Withdrawal by Subject|0|||
37850457|NCT01281813|69534440|FG002|Overall Study|Withdrawal by Subject|13|||
37850458|NCT01281813|69534438|FG000|Overall Study|Subject Non-Compliant|0|||
37850459|NCT01281813|69534439|FG001|Overall Study|Subject Non-Compliant|0|||
37850460|NCT01281813|69534440|FG002|Overall Study|Subject Non-Compliant|6|||
37850461|NCT01281813|69534438|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
37850462|NCT01281813|69534439|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
37850463|NCT01281813|69534440|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
37850464|NCT01281813|69534438|FG000|Overall Study|Sponsor's Decision|4|||
38028689|NCT00064701|69714166|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
38028690|NCT00064701|69714167|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
38028691|NCT00064701|69714165|FG000|Clinical Continuation Phase|Graft Failure|5|||
38028692|NCT00064701|69714166|FG001|Clinical Continuation Phase|Graft Failure|5|||
38028693|NCT00064701|69714167|FG002|Clinical Continuation Phase|Graft Failure|2|||
38028694|NCT00064701|69714165|FG000|Clinical Continuation Phase|Rejection|1|||
38028695|NCT00064701|69714166|FG001|Clinical Continuation Phase|Rejection|2|||
38028696|NCT00064701|69714167|FG002|Clinical Continuation Phase|Rejection|2|||
38028697|NCT00064701|69714165|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
38028698|NCT00064701|69714166|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
38028699|NCT00064701|69714167|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
38028700|NCT00064701|69714165|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
37850465|NCT01281813|69534439|FG001|Overall Study|Sponsor's Decision|3|||
37850466|NCT01281813|69534440|FG002|Overall Study|Sponsor's Decision|7|||
37850467|NCT01281813|69534438|FG000|Overall Study|Switched to Commercially Available Medication|0|||
37850468|NCT01281813|69534439|FG001|Overall Study|Switched to Commercially Available Medication|0|||
37850469|NCT01281813|69534440|FG002|Overall Study|Switched to Commercially Available Medication|26|||
38028701|NCT00064701|69714166|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
38028702|NCT00064701|69714167|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
38028703|NCT00064701|69714165|FG000|Clinical Continuation Phase|Physician Decision|1|||
38028704|NCT00064701|69714166|FG001|Clinical Continuation Phase|Physician Decision|3|||
38028705|NCT00064701|69714167|FG002|Clinical Continuation Phase|Physician Decision|0|||
38028706|NCT00064701|69714165|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
38028707|NCT00064701|69714166|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
38028708|NCT00064701|69714167|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
38028709|NCT00064701|69714165|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
37850470|NCT01281813|69534438|FG000|Overall Study|Other|0|||
37850471|NCT01281813|69534439|FG001|Overall Study|Other|1|||
37850472|NCT01281813|69534440|FG002|Overall Study|Other|39|||
38028710|NCT00064701|69714166|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
38028711|NCT00064701|69714167|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
38028712|NCT00064701|69714165|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
38028713|NCT00064701|69714166|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
38028714|NCT00064701|69714167|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
38028715|NCT00064701|69714165|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
38028716|NCT00064701|69714166|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
38028717|NCT00064701|69714167|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
38028718|NCT00064701|69714165|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
38028719|NCT00064701|69714166|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
38028720|NCT00064701|69714167|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
38028721|NCT00064701|69714165|FG000|Clinical Continuation Phase|Patient opted out|0|||
38028722|NCT00064701|69714166|FG001|Clinical Continuation Phase|Patient opted out|0|||
38028723|NCT00064701|69714167|FG002|Clinical Continuation Phase|Patient opted out|1|||
38028724|NCT00064077|69714179|FG000|Overall Study|Improper prior treatment|1|||
38028725|NCT00064077|69714180|FG001|Overall Study|Improper prior treatment|0|||
38028726|NCT00064077|69714181|FG002|Overall Study|Improper prior treatment|0|||
38028727|NCT00064077|69714182|FG003|Overall Study|Improper prior treatment|0|||
37850473|NCT01090414|69534452|FG000|Study 101-99|Progressive Disease|28|||
37850474|NCT01090414|69534453|FG001|Study 101-99|Progressive Disease|48|||
37850475|NCT01090414|69534454|FG002|Study 101-99|Progressive Disease|10|||
37850476|NCT01090414|69534455|FG003|Study 101-99|Progressive Disease|4|||
38028728|NCT00064077|69714179|FG000|Overall Study|Poor risk|2|||
38028729|NCT00064077|69714180|FG001|Overall Study|Poor risk|0|||
37850477|NCT01090414|69534452|FG000|Study 101-99|Adverse Event|10|||
38028730|NCT00064077|69714181|FG002|Overall Study|Poor risk|1|||
38028731|NCT00064077|69714182|FG003|Overall Study|Poor risk|1|||
38028732|NCT00064077|69714179|FG000|Overall Study|Pathology|10|||
38028733|NCT00064077|69714180|FG001|Overall Study|Pathology|7|||
38028734|NCT00064077|69714181|FG002|Overall Study|Pathology|3|||
38028735|NCT00064077|69714182|FG003|Overall Study|Pathology|4|||
38028736|NCT00064077|69714179|FG000|Overall Study|No surgery|0|||
38028737|NCT00064077|69714180|FG001|Overall Study|No surgery|0|||
38028738|NCT00064077|69714181|FG002|Overall Study|No surgery|1|||
38028739|NCT00064077|69714182|FG003|Overall Study|No surgery|0|||
38028740|NCT00064077|69714179|FG000|Overall Study|No tumor|0|||
38028741|NCT00064077|69714180|FG001|Overall Study|No tumor|0|||
38028742|NCT00064077|69714181|FG002|Overall Study|No tumor|1|||
38028743|NCT00064077|69714182|FG003|Overall Study|No tumor|0|||
38028744|NCT00064077|69714179|FG000|Overall Study|Other reasons|2|||
38028745|NCT00064077|69714180|FG001|Overall Study|Other reasons|2|||
38028746|NCT00064077|69714181|FG002|Overall Study|Other reasons|1|||
38028747|NCT00064077|69714182|FG003|Overall Study|Other reasons|2|||
38028748|NCT00063999|69714194|FG000|Overall Study|Withdrawal by Subject|1|||
38028749|NCT00063999|69714195|FG001|Overall Study|Withdrawal by Subject|0|||
38028750|NCT00063999|69714194|FG000|Overall Study|Ineligible|44|||
38028751|NCT00063999|69714195|FG001|Overall Study|Ineligible|24|||
38028752|NCT03131440|69714240|FG000|Overall Study|Withdrawal by Subject|1|||
38028753|NCT03131440|69714241|FG001|Overall Study|Withdrawal by Subject|3|||
38028754|NCT03131440|69714242|FG002|Overall Study|Withdrawal by Subject|0|||
38028755|NCT03131440|69714243|FG003|Overall Study|Withdrawal by Subject|0|||
38028756|NCT03131440|69714244|FG004|Overall Study|Withdrawal by Subject|1|||
38028757|NCT03131440|69714245|FG005|Overall Study|Withdrawal by Subject|0|||
38028758|NCT03131440|69714246|FG006|Overall Study|Withdrawal by Subject|0|||
38028759|NCT03131440|69714247|FG007|Overall Study|Withdrawal by Subject|1|||
38028760|NCT03131440|69714248|FG008|Overall Study|Withdrawal by Subject|1|||
38028761|NCT03131440|69714249|FG009|Overall Study|Withdrawal by Subject|1|||
38028762|NCT03131440|69714250|FG010|Overall Study|Withdrawal by Subject|0|||
38028763|NCT03131440|69714251|FG011|Overall Study|Withdrawal by Subject|1|||
38028764|NCT03131440|69714252|FG012|Overall Study|Withdrawal by Subject|1|||
38028765|NCT03131440|69714253|FG013|Overall Study|Withdrawal by Subject|0|||
38028766|NCT03131440|69714254|FG014|Overall Study|Withdrawal by Subject|1|||
38028767|NCT03131440|69714255|FG015|Overall Study|Withdrawal by Subject|0|||
38028768|NCT03131440|69714256|FG016|Overall Study|Withdrawal by Subject|0|||
38028769|NCT03131440|69714257|FG017|Overall Study|Withdrawal by Subject|0|||
38028770|NCT03131440|69714258|FG018|Overall Study|Withdrawal by Subject|1|||
38028771|NCT03131440|69714259|FG019|Overall Study|Withdrawal by Subject|0|||
38028772|NCT03131440|69714260|FG020|Overall Study|Withdrawal by Subject|1|||
38028773|NCT03131440|69714261|FG021|Overall Study|Withdrawal by Subject|1|||
38028774|NCT03131440|69714262|FG022|Overall Study|Withdrawal by Subject|1|||
38028775|NCT03131440|69714263|FG023|Overall Study|Withdrawal by Subject|0|||
38028776|NCT03131440|69714264|FG024|Overall Study|Withdrawal by Subject|0|||
38028777|NCT03131440|69714265|FG025|Overall Study|Withdrawal by Subject|0|||
38028778|NCT03131440|69714266|FG026|Overall Study|Withdrawal by Subject|0|||
38028779|NCT03131440|69714267|FG027|Overall Study|Withdrawal by Subject|0|||
38028780|NCT03131440|69714268|FG028|Overall Study|Withdrawal by Subject|0|||
38028781|NCT03131440|69714269|FG029|Overall Study|Withdrawal by Subject|0|||
38028782|NCT03131440|69714270|FG030|Overall Study|Withdrawal by Subject|1|||
38028783|NCT03131440|69714271|FG031|Overall Study|Withdrawal by Subject|0|||
38028784|NCT03131440|69714240|FG000|Overall Study|Lost to Follow-up|0|||
38028785|NCT03131440|69714241|FG001|Overall Study|Lost to Follow-up|0|||
38028786|NCT03131440|69714242|FG002|Overall Study|Lost to Follow-up|0|||
38028787|NCT03131440|69714243|FG003|Overall Study|Lost to Follow-up|0|||
38028788|NCT03131440|69714244|FG004|Overall Study|Lost to Follow-up|0|||
38028789|NCT03131440|69714245|FG005|Overall Study|Lost to Follow-up|1|||
38028790|NCT03131440|69714246|FG006|Overall Study|Lost to Follow-up|0|||
38028791|NCT03131440|69714247|FG007|Overall Study|Lost to Follow-up|0|||
38028792|NCT03131440|69714248|FG008|Overall Study|Lost to Follow-up|0|||
38028793|NCT03131440|69714249|FG009|Overall Study|Lost to Follow-up|0|||
38028794|NCT03131440|69714250|FG010|Overall Study|Lost to Follow-up|0|||
38028795|NCT03131440|69714251|FG011|Overall Study|Lost to Follow-up|0|||
38028796|NCT03131440|69714252|FG012|Overall Study|Lost to Follow-up|0|||
38028797|NCT03131440|69714253|FG013|Overall Study|Lost to Follow-up|0|||
38028798|NCT03131440|69714254|FG014|Overall Study|Lost to Follow-up|0|||
38028799|NCT03131440|69714255|FG015|Overall Study|Lost to Follow-up|0|||
38028800|NCT03131440|69714256|FG016|Overall Study|Lost to Follow-up|0|||
38028801|NCT03131440|69714257|FG017|Overall Study|Lost to Follow-up|0|||
38028802|NCT03131440|69714258|FG018|Overall Study|Lost to Follow-up|0|||
38028803|NCT03131440|69714259|FG019|Overall Study|Lost to Follow-up|2|||
38028804|NCT03131440|69714260|FG020|Overall Study|Lost to Follow-up|1|||
38028805|NCT03131440|69714261|FG021|Overall Study|Lost to Follow-up|0|||
38028806|NCT03131440|69714262|FG022|Overall Study|Lost to Follow-up|1|||
38028807|NCT03131440|69714263|FG023|Overall Study|Lost to Follow-up|0|||
38028808|NCT03131440|69714264|FG024|Overall Study|Lost to Follow-up|1|||
38028809|NCT03131440|69714265|FG025|Overall Study|Lost to Follow-up|0|||
38028810|NCT03131440|69714266|FG026|Overall Study|Lost to Follow-up|0|||
38028811|NCT03131440|69714267|FG027|Overall Study|Lost to Follow-up|2|||
38028812|NCT03131440|69714268|FG028|Overall Study|Lost to Follow-up|0|||
38028813|NCT03131440|69714269|FG029|Overall Study|Lost to Follow-up|2|||
38028814|NCT03131440|69714270|FG030|Overall Study|Lost to Follow-up|0|||
38028815|NCT03131440|69714271|FG031|Overall Study|Lost to Follow-up|0|||
38028816|NCT03131440|69714240|FG000|Overall Study|Death|0|||
38028817|NCT03131440|69714241|FG001|Overall Study|Death|0|||
38028818|NCT03131440|69714242|FG002|Overall Study|Death|0|||
38028819|NCT03131440|69714243|FG003|Overall Study|Death|0|||
38028820|NCT03131440|69714244|FG004|Overall Study|Death|0|||
38028821|NCT03131440|69714245|FG005|Overall Study|Death|0|||
38028822|NCT03131440|69714246|FG006|Overall Study|Death|0|||
38028823|NCT03131440|69714247|FG007|Overall Study|Death|0|||
38028824|NCT03131440|69714248|FG008|Overall Study|Death|0|||
38028825|NCT03131440|69714249|FG009|Overall Study|Death|0|||
38028826|NCT03131440|69714250|FG010|Overall Study|Death|0|||
38028827|NCT03131440|69714251|FG011|Overall Study|Death|0|||
38028828|NCT03131440|69714252|FG012|Overall Study|Death|0|||
38028829|NCT03131440|69714253|FG013|Overall Study|Death|0|||
38028830|NCT03131440|69714254|FG014|Overall Study|Death|0|||
38028831|NCT03131440|69714255|FG015|Overall Study|Death|0|||
38028832|NCT03131440|69714256|FG016|Overall Study|Death|0|||
38028833|NCT03131440|69714257|FG017|Overall Study|Death|0|||
38028834|NCT03131440|69714258|FG018|Overall Study|Death|0|||
38028835|NCT03131440|69714259|FG019|Overall Study|Death|0|||
38028836|NCT03131440|69714260|FG020|Overall Study|Death|0|||
38028837|NCT03131440|69714261|FG021|Overall Study|Death|0|||
38028838|NCT03131440|69714262|FG022|Overall Study|Death|0|||
38028839|NCT03131440|69714263|FG023|Overall Study|Death|0|||
38028840|NCT03131440|69714264|FG024|Overall Study|Death|0|||
38028841|NCT03131440|69714265|FG025|Overall Study|Death|1|||
38028842|NCT03131440|69714266|FG026|Overall Study|Death|0|||
38028843|NCT03131440|69714267|FG027|Overall Study|Death|0|||
38028844|NCT03131440|69714268|FG028|Overall Study|Death|0|||
38028845|NCT03131440|69714269|FG029|Overall Study|Death|0|||
38028846|NCT03131440|69714270|FG030|Overall Study|Death|0|||
38028847|NCT03131440|69714271|FG031|Overall Study|Death|0|||
38028848|NCT02915302|69714316|FG000|Overall Study|Adverse Event|3|||
38028849|NCT02915302|69714317|FG001|Overall Study|Adverse Event|0|||
38028850|NCT02915302|69714316|FG000|Overall Study|Protocol Violation|20|||
38028851|NCT02915302|69714317|FG001|Overall Study|Protocol Violation|27|||
38028852|NCT02915302|69714316|FG000|Overall Study|Lost to Follow-up|19|||
38028853|NCT02915302|69714317|FG001|Overall Study|Lost to Follow-up|22|||
37735001|NCT00984022|69215377|FG000|Overall Study|Lost to Follow-up|10|||
37735002|NCT00984022|69215378|FG001|Overall Study|Lost to Follow-up|14|||
37735003|NCT01890265|69215390|FG000|Overall Study|Other (Unspecified reason)|0|||
37735004|NCT01890265|69215391|FG001|Overall Study|Other (Unspecified reason)|1|||
37735005|NCT01890265|69215392|FG002|Overall Study|Other (Unspecified reason)|0|||
37850478|NCT01090414|69534453|FG001|Study 101-99|Adverse Event|28|||
37850479|NCT01090414|69534454|FG002|Study 101-99|Adverse Event|18|||
37850480|NCT01090414|69534455|FG003|Study 101-99|Adverse Event|0|||
37850481|NCT01090414|69534452|FG000|Study 101-99|Investigator Request|1|||
37735006|NCT01890265|69215393|FG003|Overall Study|Other (Unspecified reason)|0|||
38028854|NCT02915302|69714316|FG000|Overall Study|Withdrawal by Subject|22|||
38028855|NCT02915302|69714317|FG001|Overall Study|Withdrawal by Subject|29|||
38028856|NCT02915302|69714316|FG000|Overall Study|Other|1|||
38028857|NCT02915302|69714317|FG001|Overall Study|Other|0|||
38028858|NCT03023878|69714323|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
38028859|NCT03023878|69714323|FG000|Pre-Study Run-In Period|Death|1|||
38028860|NCT03023878|69714323|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
38028861|NCT03023878|69714323|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
38028862|NCT03023878|69714323|FG000|Treatment Period|Disease Progression|1|||
38028863|NCT03023878|69714323|FG000|Treatment Period|Withdrawal by Subject|1|||
37850482|NCT01090414|69534453|FG001|Study 101-99|Investigator Request|11|||
38028864|NCT03023878|69714323|FG000|Treatment Period|Adverse Event|1|||
38028865|NCT03023878|69714323|FG000|Long Term Follow-Up Period|Death|2|||
38028866|NCT03022630|69714329|FG000|Overall Study|Death|9|||
38028867|NCT03022630|69714330|FG001|Overall Study|Death|7|||
38028868|NCT03022630|69714329|FG000|Overall Study|Withdrawal by Subject|0|||
38028869|NCT03022630|69714330|FG001|Overall Study|Withdrawal by Subject|5|||
38028870|NCT03023722|69714341|FG000|Overall Study|No follow-up assessment|4|||
38028871|NCT03022084|69714347|FG000|Overall Study|Lost to Follow-up|2|||
38028872|NCT03022084|69714348|FG001|Overall Study|Lost to Follow-up|3|||
38028873|NCT03021304|69714354|FG000|Overall Study|Lack of Efficacy|1|||
37735007|NCT01890265|69215394|FG004|Overall Study|Other (Unspecified reason)|0|||
37735008|NCT01890265|69215395|FG005|Overall Study|Other (Unspecified reason)|0|||
37919481|NCT00848718|69606134|FG009|Overall Study|Protocol Violation|0|||
37919482|NCT00848718|69606135|FG010|Overall Study|Protocol Violation|0|||
37919483|NCT00848718|69606136|FG011|Overall Study|Protocol Violation|0|||
37919484|NCT00848718|69606137|FG012|Overall Study|Protocol Violation|1|||
37919485|NCT00848718|69606125|FG000|Overall Study|Withdrawal by Subject|1|||
37919486|NCT00848718|69606126|FG001|Overall Study|Withdrawal by Subject|0|||
37919487|NCT00848718|69606127|FG002|Overall Study|Withdrawal by Subject|0|||
37919488|NCT00848718|69606128|FG003|Overall Study|Withdrawal by Subject|1|||
37919489|NCT00848718|69606129|FG004|Overall Study|Withdrawal by Subject|0|||
37919490|NCT00848718|69606130|FG005|Overall Study|Withdrawal by Subject|0|||
37919491|NCT00848718|69606131|FG006|Overall Study|Withdrawal by Subject|0|||
37919492|NCT00848718|69606132|FG007|Overall Study|Withdrawal by Subject|0|||
37919493|NCT00848718|69606133|FG008|Overall Study|Withdrawal by Subject|0|||
37919494|NCT00848718|69606134|FG009|Overall Study|Withdrawal by Subject|0|||
37919495|NCT00848718|69606135|FG010|Overall Study|Withdrawal by Subject|1|||
37919496|NCT00848718|69606136|FG011|Overall Study|Withdrawal by Subject|0|||
37919497|NCT00848718|69606137|FG012|Overall Study|Withdrawal by Subject|0|||
37919498|NCT00848718|69606125|FG000|Overall Study|Progressive disease during treatment|3|||
37919499|NCT00848718|69606126|FG001|Overall Study|Progressive disease during treatment|0|||
37919500|NCT00848718|69606127|FG002|Overall Study|Progressive disease during treatment|3|||
37919501|NCT00848718|69606128|FG003|Overall Study|Progressive disease during treatment|0|||
38028886|NCT03496298|69714378|FG000|Overall Study|Adverse Event|49|||
38028887|NCT03496298|69714379|FG001|Overall Study|Adverse Event|68|||
38028888|NCT03496298|69714380|FG002|Overall Study|Adverse Event|79|||
38028889|NCT03496298|69714378|FG000|Overall Study|Study terminated by Sponsor|1050|||
38028890|NCT03496298|69714379|FG001|Overall Study|Study terminated by Sponsor|1063|||
37735009|NCT01890265|69215390|FG000|Overall Study|Progressive disease|6|||
37919502|NCT00848718|69606129|FG004|Overall Study|Progressive disease during treatment|0|||
37919503|NCT00848718|69606130|FG005|Overall Study|Progressive disease during treatment|0|||
37919504|NCT00848718|69606131|FG006|Overall Study|Progressive disease during treatment|0|||
37919505|NCT00848718|69606132|FG007|Overall Study|Progressive disease during treatment|2|||
37919506|NCT00848718|69606133|FG008|Overall Study|Progressive disease during treatment|0|||
37919507|NCT00848718|69606134|FG009|Overall Study|Progressive disease during treatment|0|||
37919508|NCT00848718|69606135|FG010|Overall Study|Progressive disease during treatment|0|||
37919509|NCT00848718|69606136|FG011|Overall Study|Progressive disease during treatment|0|||
37919510|NCT00848718|69606137|FG012|Overall Study|Progressive disease during treatment|2|||
37919511|NCT00883337|69606174|FG000|Core Treatment Period|Adverse Event|9|||
37919512|NCT00883337|69606175|FG001|Core Treatment Period|Adverse Event|12|||
37919513|NCT00883337|69606176|FG002|Core Treatment Period|Adverse Event|22|||
37919514|NCT00883337|69606174|FG000|Core Treatment Period|Lack of Efficacy|7|||
37919515|NCT00883337|69606175|FG001|Core Treatment Period|Lack of Efficacy|4|||
37735010|NCT01890265|69215391|FG001|Overall Study|Progressive disease|6|||
37735011|NCT01890265|69215392|FG002|Overall Study|Progressive disease|0|||
37735012|NCT01890265|69215393|FG003|Overall Study|Progressive disease|0|||
37735013|NCT01890265|69215394|FG004|Overall Study|Progressive disease|0|||
37735014|NCT01890265|69215395|FG005|Overall Study|Progressive disease|0|||
38028891|NCT03496298|69714380|FG002|Overall Study|Study terminated by Sponsor|1071|||
37919516|NCT00883337|69606176|FG002|Core Treatment Period|Lack of Efficacy|2|||
37919517|NCT00883337|69606174|FG000|Core Treatment Period|Lost to Follow-up|1|||
37919518|NCT00883337|69606175|FG001|Core Treatment Period|Lost to Follow-up|1|||
37919519|NCT00883337|69606176|FG002|Core Treatment Period|Lost to Follow-up|0|||
37919520|NCT00883337|69606174|FG000|Core Treatment Period|Withdrawal by Subject|2|||
37919521|NCT00883337|69606175|FG001|Core Treatment Period|Withdrawal by Subject|2|||
37919522|NCT00883337|69606176|FG002|Core Treatment Period|Withdrawal by Subject|6|||
37919523|NCT00883337|69606174|FG000|Core Treatment Period|Wish to be pregnant|1|||
37919524|NCT00883337|69606175|FG001|Core Treatment Period|Wish to be pregnant|2|||
37919525|NCT00883337|69606176|FG002|Core Treatment Period|Wish to be pregnant|1|||
37919526|NCT00883337|69606174|FG000|Core Treatment Period|Poor compliance to protocol|0|||
37919527|NCT00883337|69606175|FG001|Core Treatment Period|Poor compliance to protocol|0|||
37919528|NCT00883337|69606176|FG002|Core Treatment Period|Poor compliance to protocol|1|||
37919529|NCT00883337|69606174|FG000|Core Treatment Period|Other than above|0|||
37919530|NCT00883337|69606175|FG001|Core Treatment Period|Other than above|1|||
37919531|NCT00883337|69606176|FG002|Core Treatment Period|Other than above|1|||
37919532|NCT00883337|69606174|FG000|Extension Treatment Period|Adverse Event|8|||
38028892|NCT03496298|69714378|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
38028893|NCT03496298|69714379|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
38028894|NCT03496298|69714380|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
38028895|NCT03496298|69714378|FG000|Overall Study|Withdrawal by Subject|176|||
38028896|NCT03496298|69714379|FG001|Overall Study|Withdrawal by Subject|154|||
38028897|NCT03496298|69714380|FG002|Overall Study|Withdrawal by Subject|151|||
38028898|NCT03496298|69714378|FG000|Overall Study|Other|29|||
38028899|NCT03496298|69714379|FG001|Overall Study|Other|20|||
38028900|NCT03496298|69714380|FG002|Overall Study|Other|23|||
38028901|NCT03496298|69714378|FG000|Overall Study|Randomized and not treated|1|||
38028902|NCT03496298|69714379|FG001|Overall Study|Randomized and not treated|1|||
38028903|NCT03496298|69714380|FG002|Overall Study|Randomized and not treated|1|||
38028904|NCT02914522|69714393|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
38028905|NCT02914522|69714394|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
38028906|NCT02914522|69714395|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
38028907|NCT02914522|69714396|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
38028908|NCT02914522|69714397|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
38028909|NCT02914522|69714398|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
38028910|NCT02914522|69714399|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
38028911|NCT02914522|69714400|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
38028912|NCT02914522|69714401|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
38028913|NCT02914522|69714402|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
38028914|NCT02914522|69714403|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
38028915|NCT02914522|69714393|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
38028916|NCT02914522|69714394|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
38028917|NCT02914522|69714395|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
38028918|NCT02914522|69714396|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
38028919|NCT02914522|69714397|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
38028920|NCT02914522|69714398|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
38028921|NCT02914522|69714399|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
38028922|NCT02914522|69714400|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
38028923|NCT02914522|69714401|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
38028924|NCT02914522|69714402|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
37919533|NCT00883337|69606175|FG001|Extension Treatment Period|Adverse Event|5|||
37919534|NCT00883337|69606176|FG002|Extension Treatment Period|Adverse Event|5|||
37919535|NCT00883337|69606174|FG000|Extension Treatment Period|Lack of Efficacy|8|||
37919536|NCT00883337|69606175|FG001|Extension Treatment Period|Lack of Efficacy|8|||
37919537|NCT00883337|69606176|FG002|Extension Treatment Period|Lack of Efficacy|8|||
37919538|NCT00883337|69606174|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
37919539|NCT00883337|69606175|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
38028925|NCT02914522|69714403|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
38028926|NCT02914522|69714393|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
38028927|NCT02914522|69714394|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
37919540|NCT00883337|69606176|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
37919541|NCT00883337|69606174|FG000|Extension Treatment Period|Lost to Follow-up|1|||
37850483|NCT01090414|69534454|FG002|Study 101-99|Investigator Request|4|||
37850484|NCT01090414|69534455|FG003|Study 101-99|Investigator Request|0|||
37850485|NCT01090414|69534452|FG000|Study 101-99|Death|3|||
37850486|NCT01090414|69534453|FG001|Study 101-99|Death|8|||
37850487|NCT01090414|69534454|FG002|Study 101-99|Death|1|||
37850488|NCT01090414|69534455|FG003|Study 101-99|Death|0|||
37919542|NCT00883337|69606175|FG001|Extension Treatment Period|Lost to Follow-up|0|||
37919543|NCT00883337|69606176|FG002|Extension Treatment Period|Lost to Follow-up|0|||
37919544|NCT00883337|69606174|FG000|Extension Treatment Period|Other than above|10|||
37919545|NCT00883337|69606175|FG001|Extension Treatment Period|Other than above|9|||
38028928|NCT02914522|69714395|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
37850489|NCT01090414|69534452|FG000|Study 101-99|Sponsor Discontinued Study|0|||
37850490|NCT01090414|69534453|FG001|Study 101-99|Sponsor Discontinued Study|7|||
37850491|NCT01090414|69534454|FG002|Study 101-99|Sponsor Discontinued Study|5|||
37850492|NCT01090414|69534455|FG003|Study 101-99|Sponsor Discontinued Study|0|||
37919546|NCT00883337|69606176|FG002|Extension Treatment Period|Other than above|5|||
37919547|NCT00838110|69606192|FG000|Overall Study|Death|0|||
37919548|NCT00838110|69606193|FG001|Overall Study|Death|0|||
37919549|NCT00838110|69606194|FG002|Overall Study|Death|1|||
37919550|NCT00838110|69606195|FG003|Overall Study|Death|2|||
37919551|NCT00838110|69606192|FG000|Overall Study|Adverse Event|11|||
37919552|NCT00838110|69606193|FG001|Overall Study|Adverse Event|10|||
37919553|NCT00838110|69606194|FG002|Overall Study|Adverse Event|8|||
37919554|NCT00838110|69606195|FG003|Overall Study|Adverse Event|7|||
37919555|NCT00838110|69606192|FG000|Overall Study|Withdrawal by Subject|5|||
37919556|NCT00838110|69606193|FG001|Overall Study|Withdrawal by Subject|6|||
37919557|NCT00838110|69606194|FG002|Overall Study|Withdrawal by Subject|3|||
37919558|NCT00838110|69606195|FG003|Overall Study|Withdrawal by Subject|4|||
37919559|NCT00838110|69606192|FG000|Overall Study|Other|3|||
37919560|NCT00838110|69606193|FG001|Overall Study|Other|3|||
37919561|NCT00838110|69606194|FG002|Overall Study|Other|3|||
37919562|NCT00838110|69606195|FG003|Overall Study|Other|2|||
37919563|NCT00838110|69606192|FG000|Overall Study|Protocol Violation|0|||
37919564|NCT00838110|69606193|FG001|Overall Study|Protocol Violation|2|||
37919565|NCT00838110|69606194|FG002|Overall Study|Protocol Violation|1|||
37919566|NCT00838110|69606195|FG003|Overall Study|Protocol Violation|1|||
37919567|NCT00838110|69606192|FG000|Overall Study|Lost to Follow-up|3|||
37919568|NCT00838110|69606193|FG001|Overall Study|Lost to Follow-up|0|||
38028929|NCT02914522|69714396|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
38028930|NCT02914522|69714397|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
38028931|NCT02914522|69714398|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
38028932|NCT02914522|69714399|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
38028933|NCT02914522|69714400|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
38028934|NCT02914522|69714401|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
38028935|NCT02914522|69714402|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
38028936|NCT02914522|69714403|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
38028937|NCT02914522|69714393|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
38028938|NCT02914522|69714394|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
38028939|NCT02914522|69714395|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
37735015|NCT01890265|69215390|FG000|Overall Study|Adverse Event|2|||
37735016|NCT01890265|69215391|FG001|Overall Study|Adverse Event|1|||
37919569|NCT00838110|69606194|FG002|Overall Study|Lost to Follow-up|0|||
37919570|NCT00838110|69606195|FG003|Overall Study|Lost to Follow-up|0|||
38028940|NCT02914522|69714396|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
38028941|NCT02914522|69714397|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
38028942|NCT02914522|69714398|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
38028943|NCT02914522|69714399|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
37735017|NCT01890265|69215392|FG002|Overall Study|Adverse Event|0|||
37919571|NCT00838110|69606192|FG000|Overall Study|Did not meet eligibility criteria|0|||
37850493|NCT01090414|69534452|FG000|Study 101-99|Other (Unknown Reasons)|3|||
37850494|NCT01090414|69534453|FG001|Study 101-99|Other (Unknown Reasons)|3|||
37850495|NCT01090414|69534454|FG002|Study 101-99|Other (Unknown Reasons)|0|||
37850496|NCT01090414|69534455|FG003|Study 101-99|Other (Unknown Reasons)|0|||
37850497|NCT01090414|69534452|FG000|Study 101-99|Withdrew Consent|0|||
37919572|NCT00838110|69606193|FG001|Overall Study|Did not meet eligibility criteria|0|||
37919573|NCT00838110|69606194|FG002|Overall Study|Did not meet eligibility criteria|1|||
37919574|NCT00838110|69606195|FG003|Overall Study|Did not meet eligibility criteria|2|||
37919575|NCT00838110|69606192|FG000|Overall Study|Randomized but not treated|0|||
37919576|NCT00838110|69606193|FG001|Overall Study|Randomized but not treated|1|||
37919577|NCT00838110|69606194|FG002|Overall Study|Randomized but not treated|0|||
37919578|NCT00838110|69606195|FG003|Overall Study|Randomized but not treated|0|||
37919579|NCT00837876|69606205|FG000|Overall Study|Death|2|||
37919580|NCT00837876|69606205|FG000|Overall Study|Adverse Event|7|||
37919581|NCT00837876|69606205|FG000|Overall Study|Physician Decision|1|||
37919582|NCT00837876|69606205|FG000|Overall Study|Withdrawal by Subject|3|||
37919583|NCT00837876|69606205|FG000|Overall Study|disease progression|24|||
37919584|NCT02637713|69606209|FG000|Overall Study|Screen Failure|2|||
37919585|NCT00686920|69606215|FG000|Overall Study|Death|45|||
37919586|NCT00686920|69606216|FG001|Overall Study|Death|14|||
37919587|NCT00686920|69606215|FG000|Overall Study|Liver Transplant|23|||
37850498|NCT01090414|69534453|FG001|Study 101-99|Withdrew Consent|2|||
37735018|NCT01890265|69215393|FG003|Overall Study|Adverse Event|0|||
37850499|NCT01090414|69534454|FG002|Study 101-99|Withdrew Consent|3|||
37850500|NCT01090414|69534455|FG003|Study 101-99|Withdrew Consent|1|||
37850501|NCT01090414|69534452|FG000|Study 101-99|Participant Request|3|||
37919588|NCT00686920|69606216|FG001|Overall Study|Liver Transplant|8|||
37919589|NCT00686920|69606215|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
37919590|NCT00686920|69606216|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
38028944|NCT02914522|69714400|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
38028945|NCT02914522|69714401|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
38028946|NCT02914522|69714402|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
38028947|NCT02914522|69714403|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
38028948|NCT02914522|69714393|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
38028949|NCT02914522|69714394|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
38028950|NCT02914522|69714395|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
38028951|NCT02914522|69714396|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
38028952|NCT02914522|69714397|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
38028953|NCT02914522|69714398|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
38028954|NCT02914522|69714399|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
38028955|NCT02914522|69714400|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
38028956|NCT02914522|69714401|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
38028957|NCT02914522|69714402|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
38028958|NCT02914522|69714403|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
38028959|NCT02914522|69714393|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
38028960|NCT02914522|69714394|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
38028961|NCT02914522|69714395|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
38028962|NCT02914522|69714396|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
38028963|NCT02914522|69714397|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
38028964|NCT02914522|69714398|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
37735019|NCT01890265|69215394|FG004|Overall Study|Adverse Event|0|||
37735020|NCT01890265|69215395|FG005|Overall Study|Adverse Event|0|||
37735021|NCT01890265|69215390|FG000|Overall Study|Death|2|||
37735022|NCT01890265|69215391|FG001|Overall Study|Death|3|||
37735023|NCT01890265|69215392|FG002|Overall Study|Death|1|||
37735024|NCT01890265|69215393|FG003|Overall Study|Death|0|||
37735025|NCT01890265|69215394|FG004|Overall Study|Death|0|||
37735026|NCT01890265|69215395|FG005|Overall Study|Death|0|||
37735027|NCT01890265|69215390|FG000|Overall Study|Withdrawal by Subject|0|||
37735028|NCT01890265|69215391|FG001|Overall Study|Withdrawal by Subject|2|||
37735029|NCT01890265|69215392|FG002|Overall Study|Withdrawal by Subject|3|||
37735030|NCT01890265|69215393|FG003|Overall Study|Withdrawal by Subject|0|||
37735031|NCT01890265|69215394|FG004|Overall Study|Withdrawal by Subject|2|||
37735032|NCT01890265|69215395|FG005|Overall Study|Withdrawal by Subject|0|||
37735033|NCT01928329|69215416|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
37735034|NCT01928329|69215417|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
37735035|NCT01928329|69215416|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
37735036|NCT01928329|69215417|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
37735037|NCT01928329|69215416|FG000|Overall Study|Adverse Event|5|||
37735038|NCT01928329|69215417|FG001|Overall Study|Adverse Event|3|||
37735039|NCT01928329|69215416|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
38028965|NCT02914522|69714399|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
38028966|NCT02914522|69714400|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
38028967|NCT02914522|69714401|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
38028968|NCT02914522|69714402|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
38028969|NCT02914522|69714403|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
38028970|NCT02914522|69714393|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
38028971|NCT02914522|69714394|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
38028972|NCT02914522|69714395|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
38028973|NCT02914522|69714396|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
38028974|NCT02914522|69714397|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
38028975|NCT02914522|69714398|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
38028976|NCT02914522|69714399|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
38028977|NCT02914522|69714400|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
38028978|NCT02914522|69714401|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
38028979|NCT02914522|69714402|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
38028980|NCT02914522|69714403|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
38028981|NCT02914522|69714393|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
38028982|NCT02914522|69714394|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
38028983|NCT02914522|69714395|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
38028984|NCT02914522|69714396|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
38028985|NCT02914522|69714397|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
38028986|NCT02914522|69714398|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
38028987|NCT02914522|69714399|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
38028988|NCT02914522|69714400|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
38028989|NCT02914522|69714401|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
38028990|NCT02914522|69714402|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
38028991|NCT02914522|69714403|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
37735040|NCT01928329|69215417|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
37735041|NCT01928329|69215416|FG000|Overall Study|Withdrawal by Subject|1|||
38043581|NCT02657434|69731755|FG000|Overall Study|Randomization by Error|2|||
38028992|NCT02914522|69714393|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
38028993|NCT02914522|69714394|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
38028994|NCT02914522|69714395|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
38028995|NCT02914522|69714396|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
38028996|NCT02914522|69714397|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
38028997|NCT02914522|69714398|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
38028998|NCT02914522|69714399|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
38028999|NCT02914522|69714400|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
38029000|NCT02914522|69714401|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
38029001|NCT02914522|69714402|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
38029002|NCT02914522|69714403|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
38029003|NCT02914522|69714393|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
38029004|NCT02914522|69714394|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
38029005|NCT02914522|69714395|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
38029006|NCT02914522|69714396|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
38029007|NCT02914522|69714397|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
38029008|NCT02914522|69714398|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
38029009|NCT02914522|69714399|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
38029010|NCT02914522|69714400|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
38029011|NCT02914522|69714401|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
38029012|NCT02914522|69714402|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
38029013|NCT02914522|69714403|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
38029014|NCT02914522|69714393|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
38029015|NCT02914522|69714394|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
38029016|NCT02914522|69714395|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
38029017|NCT02914522|69714396|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
38029018|NCT02914522|69714397|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
38029019|NCT02914522|69714398|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
38029020|NCT02914522|69714399|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
38029021|NCT02914522|69714400|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
38029022|NCT02914522|69714401|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
38029023|NCT02914522|69714402|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
38029024|NCT02914522|69714403|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
38029025|NCT02914522|69714393|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
38029026|NCT02914522|69714394|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
38029027|NCT02914522|69714395|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
38029028|NCT02914522|69714396|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
38029029|NCT02914522|69714397|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
38029030|NCT02914522|69714398|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
38029031|NCT02914522|69714399|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
38029032|NCT02914522|69714400|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
38029033|NCT02914522|69714401|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
38029034|NCT02914522|69714402|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
38029035|NCT02914522|69714403|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
38029036|NCT02914522|69714393|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
38029037|NCT02914522|69714394|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
38029038|NCT02914522|69714395|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
38029039|NCT02914522|69714396|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
37735042|NCT01928329|69215417|FG001|Overall Study|Withdrawal by Subject|5|||
37850502|NCT01090414|69534453|FG001|Study 101-99|Participant Request|1|||
37850503|NCT01090414|69534454|FG002|Study 101-99|Participant Request|0|||
37850504|NCT01090414|69534455|FG003|Study 101-99|Participant Request|0|||
37850505|NCT01090102|69534479|FG000|First 12 Weeks|Withdrawal by Subject|1|||
37850506|NCT01090102|69534480|FG001|First 12 Weeks|Withdrawal by Subject|1|||
37850507|NCT01090102|69534479|FG000|First 12 Weeks|Adverse Event|2|||
37850508|NCT01090102|69534480|FG001|First 12 Weeks|Adverse Event|0|||
37850509|NCT01090102|69534479|FG000|First 12 Weeks|Death|1|||
37735043|NCT01928329|69215416|FG000|Overall Study|Physician Decision|1|||
37850510|NCT01090102|69534480|FG001|First 12 Weeks|Death|1|||
38029040|NCT02914522|69714397|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
38029041|NCT02914522|69714398|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
38029042|NCT02914522|69714399|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
38029043|NCT02914522|69714400|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
38029044|NCT02914522|69714401|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
38029045|NCT02914522|69714402|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
37850511|NCT01090102|69534479|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
37850512|NCT01090102|69534480|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
37850513|NCT01287897|69534490|FG000|Overall Study|Adverse Event|5|||
37850514|NCT01287897|69534491|FG001|Overall Study|Adverse Event|3|||
37850515|NCT01287897|69534492|FG002|Overall Study|Adverse Event|6|||
37850516|NCT01287897|69534493|FG003|Overall Study|Adverse Event|4|||
37850517|NCT01287897|69534490|FG000|Overall Study|Lack of Efficacy|2|||
37850518|NCT01287897|69534491|FG001|Overall Study|Lack of Efficacy|0|||
37919591|NCT00686920|69606215|FG000|Overall Study|Withdrawal by Subject|23|||
37919592|NCT00686920|69606216|FG001|Overall Study|Withdrawal by Subject|5|||
37919593|NCT00686920|69606215|FG000|Overall Study|Protocol Violation|2|||
37919594|NCT00686920|69606216|FG001|Overall Study|Protocol Violation|1|||
37919595|NCT00686920|69606215|FG000|Overall Study|Adverse Event|10|||
37850519|NCT01287897|69534492|FG002|Overall Study|Lack of Efficacy|0|||
37919596|NCT00686920|69606216|FG001|Overall Study|Adverse Event|2|||
37919597|NCT00686920|69606215|FG000|Overall Study|Personal Reason|0|||
37735044|NCT01928329|69215417|FG001|Overall Study|Physician Decision|1|||
37919598|NCT00686920|69606216|FG001|Overall Study|Personal Reason|1|||
37919599|NCT00686920|69606215|FG000|Overall Study|Lost to Follow-up|15|||
37919600|NCT00686920|69606216|FG001|Overall Study|Lost to Follow-up|3|||
37919601|NCT00686920|69606215|FG000|Overall Study|Moved to Another State|1|||
37919602|NCT00686920|69606216|FG001|Overall Study|Moved to Another State|0|||
37919603|NCT00686920|69606215|FG000|Overall Study|Transferred to Nursing Home|1|||
37919604|NCT00686920|69606216|FG001|Overall Study|Transferred to Nursing Home|0|||
37919605|NCT00686920|69606215|FG000|Overall Study|Noncompliance|9|||
37919606|NCT00686920|69606216|FG001|Overall Study|Noncompliance|0|||
37735045|NCT01890109|69215425|FG000|Overall Study|Withdrawal by Subject|0|||
37735046|NCT01890109|69215426|FG001|Overall Study|Withdrawal by Subject|3|||
37735047|NCT01890109|69215425|FG000|Overall Study|Lost to Follow-up|1|||
37735048|NCT01890109|69215426|FG001|Overall Study|Lost to Follow-up|2|||
38029046|NCT02914522|69714403|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
38029047|NCT02914522|69714393|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
38029048|NCT02914522|69714394|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
38029049|NCT02914522|69714395|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
38029050|NCT02914522|69714396|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
38029051|NCT02914522|69714397|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
38029052|NCT02914522|69714398|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
38029053|NCT02914522|69714399|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
38029054|NCT02914522|69714400|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
38029055|NCT02914522|69714401|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
38029056|NCT02914522|69714402|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
38029057|NCT02914522|69714403|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
38029058|NCT02914522|69714393|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
38029059|NCT02914522|69714394|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
37919607|NCT00686920|69606215|FG000|Overall Study|Principal Investigator Decision|2|||
37919608|NCT00686920|69606216|FG001|Overall Study|Principal Investigator Decision|0|||
37919609|NCT00845832|69606225|FG000|Treatment Period|Adverse Event|0|||
37919610|NCT00845832|69606226|FG001|Treatment Period|Adverse Event|2|||
37919611|NCT00845832|69606227|FG002|Treatment Period|Adverse Event|0|||
37919612|NCT00845832|69606225|FG000|Treatment Period|Protocol Violation|1|||
38029060|NCT02914522|69714395|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
38029061|NCT02914522|69714396|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
38029062|NCT02914522|69714397|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
38029063|NCT02914522|69714398|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
38029064|NCT02914522|69714399|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
38029065|NCT02914522|69714400|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
38029066|NCT02914522|69714401|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
37850520|NCT01287897|69534493|FG003|Overall Study|Lack of Efficacy|0|||
37850521|NCT01287897|69534490|FG000|Overall Study|Protocol Violation|1|||
37850522|NCT01287897|69534491|FG001|Overall Study|Protocol Violation|1|||
37850523|NCT01287897|69534492|FG002|Overall Study|Protocol Violation|0|||
37850524|NCT01287897|69534493|FG003|Overall Study|Protocol Violation|1|||
37850525|NCT01287897|69534490|FG000|Overall Study|Lost to Follow-up|0|||
37850526|NCT01287897|69534491|FG001|Overall Study|Lost to Follow-up|0|||
37850527|NCT01287897|69534492|FG002|Overall Study|Lost to Follow-up|2|||
37850528|NCT01287897|69534493|FG003|Overall Study|Lost to Follow-up|0|||
37850529|NCT01287897|69534490|FG000|Overall Study|Withdrawal by Subject|1|||
37850530|NCT01287897|69534491|FG001|Overall Study|Withdrawal by Subject|5|||
37850531|NCT01287897|69534492|FG002|Overall Study|Withdrawal by Subject|3|||
37850532|NCT01287897|69534493|FG003|Overall Study|Withdrawal by Subject|2|||
37850533|NCT01287897|69534490|FG000|Overall Study|Not consented properly|0|||
37850534|NCT01287897|69534491|FG001|Overall Study|Not consented properly|1|||
37919613|NCT00845832|69606226|FG001|Treatment Period|Protocol Violation|1|||
37850535|NCT01287897|69534492|FG002|Overall Study|Not consented properly|0|||
37919614|NCT00845832|69606227|FG002|Treatment Period|Protocol Violation|0|||
37919615|NCT00845832|69606225|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
37919616|NCT00845832|69606226|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
37919617|NCT00845832|69606227|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
37919618|NCT00845832|69606225|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
37919619|NCT00845832|69606226|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
38029067|NCT02914522|69714402|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
38029068|NCT02914522|69714403|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
38029069|NCT02914522|69714393|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
38029070|NCT02914522|69714394|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
38029071|NCT02914522|69714395|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
37850536|NCT01287897|69534493|FG003|Overall Study|Not consented properly|0|||
37850537|NCT01287897|69534490|FG000|Overall Study|Not meeting entrance criteria|1|||
37850538|NCT01287897|69534491|FG001|Overall Study|Not meeting entrance criteria|1|||
37850539|NCT01287897|69534492|FG002|Overall Study|Not meeting entrance criteria|0|||
37919620|NCT00845832|69606227|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
37919621|NCT00591864|69606235|FG000|Overall Study|Incomplete Imaging|5|||
38029072|NCT02914522|69714396|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
38029073|NCT02914522|69714397|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
38029074|NCT02914522|69714398|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
38029075|NCT02914522|69714399|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
38029076|NCT02914522|69714400|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
38029077|NCT02914522|69714401|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
37919622|NCT00885755|69606243|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
37919623|NCT00885755|69606244|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
37919624|NCT00885755|69606245|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
37919625|NCT00885755|69606243|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
37919626|NCT00885755|69606244|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
37919627|NCT00885755|69606245|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
37919628|NCT00885755|69606243|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
37850540|NCT01287897|69534493|FG003|Overall Study|Not meeting entrance criteria|0|||
37850541|NCT01287897|69534490|FG000|Overall Study|Other|1|||
37850542|NCT01287897|69534491|FG001|Overall Study|Other|0|||
37850543|NCT01287897|69534492|FG002|Overall Study|Other|1|||
37919629|NCT00885755|69606244|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
37919630|NCT00885755|69606245|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
37919631|NCT00885755|69606243|FG000|Part I: Trastuzumab+Taxane|Death|0|||
37919632|NCT00885755|69606244|FG001|Part I: Trastuzumab+Taxane|Death|0|||
37919633|NCT00885755|69606245|FG002|Part I: Trastuzumab+Taxane|Death|1|||
37919634|NCT00885755|69606243|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
37919635|NCT00885755|69606244|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
38029078|NCT02914522|69714402|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
38029079|NCT02914522|69714403|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
38029080|NCT02924428|69714432|FG000|Overall Study|Adverse Event|1|||
38029081|NCT02924428|69714433|FG001|Overall Study|Adverse Event|0|||
38029082|NCT02924428|69714432|FG000|Overall Study|Physician Decision|1|||
38029083|NCT02924428|69714433|FG001|Overall Study|Physician Decision|0|||
38029084|NCT02924428|69714432|FG000|Overall Study|Lost to Follow-up|2|||
38029085|NCT02924428|69714433|FG001|Overall Study|Lost to Follow-up|4|||
38029086|NCT02924428|69714432|FG000|Overall Study|Pregnancy|0|||
38029087|NCT02924428|69714433|FG001|Overall Study|Pregnancy|1|||
38029088|NCT00062751|69714444|FG000|Overall Study|Disease progression|24|||
38029089|NCT00062751|69714445|FG001|Overall Study|Disease progression|17|||
38029090|NCT00062751|69714446|FG002|Overall Study|Disease progression|24|||
38029091|NCT00062751|69714447|FG003|Overall Study|Disease progression|2|||
38029092|NCT00062751|69714448|FG004|Overall Study|Disease progression|2|||
38029093|NCT00062751|69714444|FG000|Overall Study|Adverse Event|4|||
38029094|NCT00062751|69714445|FG001|Overall Study|Adverse Event|7|||
38029095|NCT00062751|69714446|FG002|Overall Study|Adverse Event|2|||
38029096|NCT00062751|69714447|FG003|Overall Study|Adverse Event|2|||
38029097|NCT00062751|69714448|FG004|Overall Study|Adverse Event|2|||
38029098|NCT00062751|69714444|FG000|Overall Study|Other|2|||
38029099|NCT00062751|69714445|FG001|Overall Study|Other|3|||
38029100|NCT00062751|69714446|FG002|Overall Study|Other|1|||
38029101|NCT00062751|69714447|FG003|Overall Study|Other|0|||
38029102|NCT00062751|69714448|FG004|Overall Study|Other|1|||
38029103|NCT00062751|69714444|FG000|Overall Study|Withdrawal by Subject|1|||
38029104|NCT00062751|69714445|FG001|Overall Study|Withdrawal by Subject|2|||
38029105|NCT00062751|69714446|FG002|Overall Study|Withdrawal by Subject|2|||
38029106|NCT00062751|69714447|FG003|Overall Study|Withdrawal by Subject|1|||
38029107|NCT00062751|69714448|FG004|Overall Study|Withdrawal by Subject|0|||
38029108|NCT00062751|69714444|FG000|Overall Study|Symptomatic deterioration|1|||
38029109|NCT00062751|69714445|FG001|Overall Study|Symptomatic deterioration|1|||
37850544|NCT01287897|69534493|FG003|Overall Study|Other|0|||
38029110|NCT00062751|69714446|FG002|Overall Study|Symptomatic deterioration|0|||
38029111|NCT00062751|69714447|FG003|Overall Study|Symptomatic deterioration|0|||
38029112|NCT00062751|69714448|FG004|Overall Study|Symptomatic deterioration|1|||
38029113|NCT00062751|69714444|FG000|Overall Study|Death|1|||
38029114|NCT00062751|69714445|FG001|Overall Study|Death|0|||
38029115|NCT00062751|69714446|FG002|Overall Study|Death|1|||
38029116|NCT00062751|69714447|FG003|Overall Study|Death|0|||
38029117|NCT00062751|69714448|FG004|Overall Study|Death|0|||
37850545|NCT01090024|69534507|FG000|Period 1|Met exclusion criteria|0|||
37850546|NCT01090024|69534508|FG001|Period 1|Met exclusion criteria|0|||
37850547|NCT01090024|69534509|FG002|Period 1|Met exclusion criteria|0|||
37850548|NCT01090024|69534510|FG003|Period 1|Met exclusion criteria|0|||
37850549|NCT01090024|69534511|FG004|Period 1|Met exclusion criteria|0|||
37850550|NCT01090024|69534512|FG005|Period 1|Met exclusion criteria|0|||
37850551|NCT01090024|69534513|FG006|Period 1|Met exclusion criteria|0|||
37850552|NCT01090024|69534514|FG007|Period 1|Met exclusion criteria|0|||
37850553|NCT01090024|69534515|FG008|Period 1|Met exclusion criteria|0|||
37850554|NCT01090024|69534516|FG009|Period 1|Met exclusion criteria|0|||
37850555|NCT01090024|69534517|FG010|Period 1|Met exclusion criteria|0|||
37850556|NCT01090024|69534518|FG011|Period 1|Met exclusion criteria|0|||
37850557|NCT01090024|69534519|FG012|Period 1|Met exclusion criteria|0|||
37850558|NCT01090024|69534520|FG013|Period 1|Met exclusion criteria|0|||
37850559|NCT01090024|69534521|FG014|Period 1|Met exclusion criteria|1|||
38029118|NCT00062439|69714465|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
38029119|NCT00062439|69714465|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
38029120|NCT00062439|69714465|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
38029121|NCT00062439|69714465|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
38029122|NCT00062439|69714465|FG000|Post Chemoradiation Assessment|Death|1|||
38029123|NCT00062439|69714465|FG000|Post Chemoradiation Assessment|Disease progression|2|||
38029124|NCT00062439|69714465|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
38029125|NCT00062439|69714465|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
38029126|NCT00062439|69714465|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
38029127|NCT00062439|69714465|FG000|Surgery|Physician Decision|4|||
38029128|NCT00062439|69714465|FG000|Surgery|Death|1|||
38029129|NCT00062439|69714465|FG000|Surgery|Adverse Event|2|||
38029130|NCT00062439|69714465|FG000|Consolidation Chemotherapy|Adverse Event|2|||
37850560|NCT01090024|69534522|FG015|Period 1|Met exclusion criteria|0|||
37850561|NCT01090024|69534523|FG016|Period 1|Met exclusion criteria|0|||
37850562|NCT01090024|69534524|FG017|Period 1|Met exclusion criteria|0|||
37850563|NCT01090024|69534507|FG000|Period 1|Adverse Event|0|||
37850564|NCT01090024|69534508|FG001|Period 1|Adverse Event|0|||
37850565|NCT01090024|69534509|FG002|Period 1|Adverse Event|0|||
37850566|NCT01090024|69534510|FG003|Period 1|Adverse Event|0|||
37850567|NCT01090024|69534511|FG004|Period 1|Adverse Event|0|||
37850568|NCT01090024|69534512|FG005|Period 1|Adverse Event|0|||
38029131|NCT00051363|69714476|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
38029132|NCT00051363|69714477|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
38029133|NCT00051363|69714476|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
38029134|NCT00051363|69714477|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
38029135|NCT00051363|69714476|FG000|Overall Study|Death|2|||
38029136|NCT00051363|69714477|FG001|Overall Study|Death|2|||
38029137|NCT00051363|69714476|FG000|Overall Study|Excluded Pre-Randomization|2|||
38029138|NCT00051363|69714477|FG001|Overall Study|Excluded Pre-Randomization|5|||
38029139|NCT00031551|69714485|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
38029140|NCT00031551|69714486|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
38029141|NCT00049257|69714496|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
38029142|NCT00049257|69714496|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
38029143|NCT00049257|69714496|FG000|Carboplatin, Paclitaxel|Death|2|||
38029144|NCT00049257|69714496|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
38029145|NCT03020992|69714500|FG000|Overall Study|Adverse Event|5|||
38029146|NCT03020992|69714500|FG000|Overall Study|Withdrawal by Subject|1|||
37735049|NCT00982930|69215433|FG000|Overall Study|Adverse Event|1|||
37735050|NCT00982930|69215433|FG000|Overall Study|Withdrawal by Subject|1|||
37735051|NCT00982930|69215433|FG000|Overall Study|Administrative Problems|2|||
37850569|NCT01090024|69534513|FG006|Period 1|Adverse Event|0|||
37850570|NCT01090024|69534514|FG007|Period 1|Adverse Event|0|||
37850571|NCT01090024|69534515|FG008|Period 1|Adverse Event|0|||
37850572|NCT01090024|69534516|FG009|Period 1|Adverse Event|1|||
37850573|NCT01090024|69534517|FG010|Period 1|Adverse Event|0|||
37850574|NCT01090024|69534518|FG011|Period 1|Adverse Event|1|||
37850575|NCT01090024|69534519|FG012|Period 1|Adverse Event|0|||
37850576|NCT01090024|69534520|FG013|Period 1|Adverse Event|0|||
37919636|NCT00885755|69606245|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
37919637|NCT00837486|69606255|FG000|Blinded-treatment Phase|Physician Decision|1|||
37919638|NCT00837486|69606256|FG001|Blinded-treatment Phase|Physician Decision|0|||
37919639|NCT00837486|69606255|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
37919640|NCT00837486|69606256|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
37919641|NCT00837486|69606255|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
37919642|NCT00837486|69606256|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
37919643|NCT00837486|69606255|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
37919644|NCT00837486|69606256|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
37919645|NCT00845676|69606264|FG000|Overall Study|Virologic breakthrough at week 20|1|||
37919646|NCT00845676|69606264|FG000|Overall Study|Adverse Event|1|||
37919647|NCT00883181|69606269|FG000|Overall Study|Hematological Adverse Event|26|||
37919648|NCT00883181|69606269|FG000|Overall Study|Non-hematological Adverse Event|55|||
37919649|NCT00883181|69606269|FG000|Overall Study|Disease Progression|94|||
37919650|NCT00883181|69606269|FG000|Overall Study|Administrative Reason|24|||
37919651|NCT00883181|69606269|FG000|Overall Study|Withdrawal by Subject|4|||
37919652|NCT00883181|69606269|FG000|Overall Study|Death|31|||
37919653|NCT00883181|69606269|FG000|Overall Study|Other|38|||
37919654|NCT00883181|69606269|FG000|Overall Study|Protocol Deviation|3|||
37919655|NCT00883181|69606269|FG000|Overall Study|Noncompliance|3|||
38029147|NCT03020914|69714507|FG000|Overall Study|Surgery Cancelled|1|||
37735052|NCT00981682|69215437|FG000|Overall Study|Adverse Event|48|||
37850577|NCT01090024|69534521|FG014|Period 1|Adverse Event|0|||
38029148|NCT03020914|69714508|FG001|Overall Study|Surgery Cancelled|0|||
38029149|NCT03018340|69714516|FG000|Overall Study|Adverse Event|1|||
37850578|NCT01090024|69534522|FG015|Period 1|Adverse Event|0|||
37850579|NCT01090024|69534523|FG016|Period 1|Adverse Event|0|||
37850580|NCT01090024|69534524|FG017|Period 1|Adverse Event|1|||
37850581|NCT01090024|69534507|FG000|Period 1|Withdrawal by Subject|0|||
37850582|NCT01090024|69534508|FG001|Period 1|Withdrawal by Subject|0|||
37850583|NCT01090024|69534509|FG002|Period 1|Withdrawal by Subject|0|||
37850584|NCT01090024|69534510|FG003|Period 1|Withdrawal by Subject|1|||
37850585|NCT01090024|69534511|FG004|Period 1|Withdrawal by Subject|0|||
38029150|NCT03018340|69714517|FG001|Overall Study|Adverse Event|2|||
38029151|NCT03018340|69714516|FG000|Overall Study|Withdrawal by Subject|0|||
38029152|NCT03018340|69714517|FG001|Overall Study|Withdrawal by Subject|8|||
38029153|NCT03018340|69714516|FG000|Overall Study|Lack of Efficacy|0|||
38029154|NCT03018340|69714517|FG001|Overall Study|Lack of Efficacy|1|||
38029155|NCT03018340|69714516|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
38029156|NCT03018340|69714517|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
38029157|NCT03018340|69714516|FG000|Overall Study|Lost to Follow-up|1|||
38029158|NCT03018340|69714517|FG001|Overall Study|Lost to Follow-up|7|||
38029159|NCT03018340|69714516|FG000|Overall Study|Protocol Violation|3|||
38029160|NCT03018340|69714517|FG001|Overall Study|Protocol Violation|7|||
38029161|NCT03018340|69714516|FG000|Overall Study|Not further specified|0|||
38029162|NCT03018340|69714517|FG001|Overall Study|Not further specified|1|||
38029163|NCT03016078|69714527|FG000|Overall Study|Protocol Violation|1|||
38029164|NCT03016078|69714527|FG000|Overall Study|Protocol Violation|1|||
38029165|NCT00048165|69714533|FG000|Completed 6 Months Study|Administration/Other|8|||
38029166|NCT00048165|69714534|FG001|Completed 6 Months Study|Administration/Other|8|||
38029167|NCT00048165|69714533|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
38029168|NCT00048165|69714534|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
38029169|NCT00048165|69714533|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
38029170|NCT00048165|69714534|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
38029171|NCT00048165|69714533|FG000|Completed 6 Months Study|Death|12|||
38029172|NCT00048165|69714534|FG001|Completed 6 Months Study|Death|6|||
38029173|NCT00048165|69714533|FG000|Completed 6 Months Study|Insufficient therapy|1|||
37735053|NCT00981682|69215437|FG000|Overall Study|Withdrawal by Subject|52|||
37735054|NCT00981682|69215437|FG000|Overall Study|Lost to Follow-up|14|||
37735055|NCT00981682|69215437|FG000|Overall Study|Lack of Efficacy|13|||
38029174|NCT00048165|69714534|FG001|Completed 6 Months Study|Insufficient therapy|4|||
37735056|NCT00981682|69215437|FG000|Overall Study|Protocol Violation|6|||
37735057|NCT00981682|69215437|FG000|Overall Study|administrative|9|||
37735058|NCT01903993|69215443|FG000|Overall Study|Death|118|||
37850586|NCT01090024|69534512|FG005|Period 1|Withdrawal by Subject|0|||
37850587|NCT01090024|69534513|FG006|Period 1|Withdrawal by Subject|0|||
37850588|NCT01090024|69534514|FG007|Period 1|Withdrawal by Subject|0|||
37850589|NCT01090024|69534515|FG008|Period 1|Withdrawal by Subject|0|||
37850590|NCT01090024|69534516|FG009|Period 1|Withdrawal by Subject|0|||
38029175|NCT00048165|69714533|FG000|Completed 6 Months Study|Other violation|4|||
38029176|NCT00048165|69714534|FG001|Completed 6 Months Study|Other violation|6|||
38029177|NCT00048165|69714533|FG000|Completed 6 Months Study|Refused treatment|5|||
38029178|NCT00048165|69714534|FG001|Completed 6 Months Study|Refused treatment|5|||
38029179|NCT00048165|69714533|FG000|Completed 6 Months Study|Violation criteria|0|||
38029180|NCT00048165|69714534|FG001|Completed 6 Months Study|Violation criteria|2|||
38029181|NCT00048165|69714533|FG000|Completed 6 Months Study|Did not receive study drug|6|||
38029182|NCT00048165|69714534|FG001|Completed 6 Months Study|Did not receive study drug|6|||
38029183|NCT00048165|69714533|FG000|Completed 12 Months Study|Administration/Other|0|||
38029184|NCT00048165|69714534|FG001|Completed 12 Months Study|Administration/Other|2|||
38029185|NCT00048165|69714533|FG000|Completed 12 Months Study|Death|2|||
38029186|NCT00048165|69714534|FG001|Completed 12 Months Study|Death|1|||
38029187|NCT00048165|69714533|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
38029188|NCT00048165|69714534|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
38029189|NCT00059787|69714542|FG000|Overall Study|Adverse Event|13|||
38029190|NCT00059787|69714542|FG000|Overall Study|disease progression|2|||
38029191|NCT00059787|69714542|FG000|Overall Study|ineligible|1|||
38029192|NCT00059787|69714542|FG000|Overall Study|Other|4|||
38029193|NCT00058539|69714547|FG000|Overall Study|Disease progression|24|||
38029194|NCT00058539|69714547|FG000|Overall Study|Adverse Event|3|||
38029195|NCT00058539|69714547|FG000|Overall Study|Withdrawal by Subject|5|||
38029196|NCT00058539|69714547|FG000|Overall Study|Physician Decision|9|||
38029197|NCT00058539|69714547|FG000|Overall Study|Death|1|||
38029198|NCT03015532|69714559|FG000|Overall Study|Adverse Event|0|||
38029199|NCT03015532|69714560|FG001|Overall Study|Adverse Event|0|||
38029200|NCT03015532|69714561|FG002|Overall Study|Adverse Event|0|||
38029201|NCT03015532|69714562|FG003|Overall Study|Adverse Event|0|||
38029202|NCT03015532|69714563|FG004|Overall Study|Adverse Event|0|||
38029203|NCT03015532|69714564|FG005|Overall Study|Adverse Event|2|||
38029204|NCT03015532|69714565|FG006|Overall Study|Adverse Event|1|||
38029205|NCT03015532|69714566|FG007|Overall Study|Adverse Event|0|||
38029206|NCT03015532|69714559|FG000|Overall Study|Withdrawal by Subject|0|||
38029207|NCT03015532|69714560|FG001|Overall Study|Withdrawal by Subject|0|||
38029208|NCT03015532|69714561|FG002|Overall Study|Withdrawal by Subject|0|||
37735059|NCT01903993|69215444|FG001|Overall Study|Death|121|||
38029209|NCT03015532|69714562|FG003|Overall Study|Withdrawal by Subject|0|||
38029210|NCT03015532|69714563|FG004|Overall Study|Withdrawal by Subject|0|||
38029211|NCT03015532|69714564|FG005|Overall Study|Withdrawal by Subject|0|||
38029212|NCT03015532|69714565|FG006|Overall Study|Withdrawal by Subject|1|||
38029213|NCT03015532|69714566|FG007|Overall Study|Withdrawal by Subject|0|||
38029214|NCT00047463|69714588|FG000|Overall Study|Withdrawal by Subject|0|||
38029215|NCT00047463|69714589|FG001|Overall Study|Withdrawal by Subject|3|||
38029216|NCT03015220|69714602|FG000|Overall Study|Withdrawal by Subject|3|||
38029217|NCT03015220|69714603|FG001|Overall Study|Withdrawal by Subject|2|||
37735060|NCT01903993|69215443|FG000|Overall Study|Withdrawal by Subject|15|||
38029218|NCT03015220|69714604|FG002|Overall Study|Withdrawal by Subject|2|||
38029219|NCT03015220|69714605|FG003|Overall Study|Withdrawal by Subject|2|||
38029220|NCT03015220|69714602|FG000|Overall Study|Lost to Follow-up|0|||
38029221|NCT03015220|69714603|FG001|Overall Study|Lost to Follow-up|0|||
38029222|NCT03015220|69714604|FG002|Overall Study|Lost to Follow-up|1|||
38029223|NCT03015220|69714605|FG003|Overall Study|Lost to Follow-up|0|||
38029224|NCT00022659|69714615|FG000|Overall Study|Ineligible: wrong primary|1|||
38029225|NCT00022659|69714615|FG000|Overall Study|Never treated|1|||
38029226|NCT03014674|69714626|FG000|Overall Study|Withdrawal by Subject|1|||
38029227|NCT03014674|69714627|FG001|Overall Study|Withdrawal by Subject|0|||
38029228|NCT03014674|69714628|FG002|Overall Study|Withdrawal by Subject|0|||
38029229|NCT03018106|69714638|FG000|Overall Study|Lost to Follow-up|0|||
37735061|NCT01903993|69215444|FG001|Overall Study|Withdrawal by Subject|4|||
37735062|NCT01903993|69215443|FG000|Overall Study|Lost to Follow-up|2|||
37735063|NCT01903993|69215444|FG001|Overall Study|Lost to Follow-up|3|||
37735064|NCT01903993|69215443|FG000|Overall Study|Study Terminated by Sponsor|8|||
37735065|NCT01903993|69215444|FG001|Overall Study|Study Terminated by Sponsor|14|||
37735066|NCT01903993|69215443|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
37735067|NCT01903993|69215444|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
37735068|NCT00981292|69215457|FG000|Day 1|Protocol Violation|1|||
37735069|NCT00981292|69215458|FG001|Day 1|Protocol Violation|0|||
37735070|NCT00981292|69215459|FG002|Day 1|Protocol Violation|0|||
37735071|NCT00981292|69215460|FG003|Day 1|Protocol Violation|0|||
37735072|NCT00981292|69215461|FG004|Day 1|Protocol Violation|0|||
37735073|NCT00981292|69215462|FG005|Day 1|Protocol Violation|2|||
37735074|NCT00981292|69215457|FG000|Day 2|Protocol Violation|2|||
37850591|NCT01090024|69534517|FG010|Period 1|Withdrawal by Subject|0|||
37850592|NCT01090024|69534518|FG011|Period 1|Withdrawal by Subject|0|||
38029230|NCT03018106|69714639|FG001|Overall Study|Lost to Follow-up|1|||
38029231|NCT03018028|69714648|FG000|Overall Study|Withdrawal by Subject|3|||
38029232|NCT03018028|69714649|FG001|Overall Study|Withdrawal by Subject|0|||
38029233|NCT03018028|69714650|FG002|Overall Study|Withdrawal by Subject|1|||
38029234|NCT03018028|69714651|FG003|Overall Study|Withdrawal by Subject|2|||
38029235|NCT03018028|69714652|FG004|Overall Study|Withdrawal by Subject|0|||
38029236|NCT03010462|69714666|FG000|Overall Study|Withdrawal by Subject|3|||
38029237|NCT03010462|69714667|FG001|Overall Study|Withdrawal by Subject|1|||
38029238|NCT00021255|69714676|FG000|Overall Study|Death|1|||
38029239|NCT00021255|69714677|FG001|Overall Study|Death|0|||
38029240|NCT00021255|69714678|FG002|Overall Study|Death|2|||
38029241|NCT00021255|69714676|FG000|Overall Study|Breast cancer relapse|5|||
38029242|NCT00021255|69714677|FG001|Overall Study|Breast cancer relapse|18|||
38029243|NCT00021255|69714678|FG002|Overall Study|Breast cancer relapse|11|||
38029244|NCT00021255|69714676|FG000|Overall Study|Second primary malignancy|0|||
38029245|NCT00021255|69714677|FG001|Overall Study|Second primary malignancy|4|||
38029246|NCT00021255|69714678|FG002|Overall Study|Second primary malignancy|1|||
38029247|NCT00021255|69714676|FG000|Overall Study|Withdrawal by Subject|41|||
38029248|NCT00021255|69714677|FG001|Overall Study|Withdrawal by Subject|64|||
38029249|NCT00021255|69714678|FG002|Overall Study|Withdrawal by Subject|26|||
38029250|NCT00021255|69714676|FG000|Overall Study|Lost to Follow-up|0|||
38029251|NCT00021255|69714677|FG001|Overall Study|Lost to Follow-up|2|||
38029252|NCT00021255|69714678|FG002|Overall Study|Lost to Follow-up|3|||
37850593|NCT01090024|69534519|FG012|Period 1|Withdrawal by Subject|0|||
37850594|NCT01090024|69534520|FG013|Period 1|Withdrawal by Subject|0|||
37850595|NCT01090024|69534521|FG014|Period 1|Withdrawal by Subject|0|||
37850596|NCT01090024|69534522|FG015|Period 1|Withdrawal by Subject|0|||
37850597|NCT01090024|69534523|FG016|Period 1|Withdrawal by Subject|0|||
38029253|NCT00021255|69714676|FG000|Overall Study|Cardiac toxicity|0|||
38029254|NCT00021255|69714677|FG001|Overall Study|Cardiac toxicity|61|||
38029255|NCT00021255|69714678|FG002|Overall Study|Cardiac toxicity|32|||
38029256|NCT00021255|69714676|FG000|Overall Study|Herceptin toxicity|0|||
38029257|NCT00021255|69714677|FG001|Overall Study|Herceptin toxicity|22|||
38029258|NCT00021255|69714678|FG002|Overall Study|Herceptin toxicity|6|||
38029259|NCT00021255|69714676|FG000|Overall Study|Adverse Event|46|||
38029260|NCT00021255|69714677|FG001|Overall Study|Adverse Event|30|||
38029261|NCT00021255|69714678|FG002|Overall Study|Adverse Event|18|||
38029262|NCT00021255|69714676|FG000|Overall Study|Protocol Violation|0|||
38029263|NCT00021255|69714677|FG001|Overall Study|Protocol Violation|2|||
38029264|NCT00021255|69714678|FG002|Overall Study|Protocol Violation|0|||
37850598|NCT01090024|69534524|FG017|Period 1|Withdrawal by Subject|0|||
37850599|NCT01090024|69534507|FG000|Period 1|Lost to Follow-up|0|||
38029265|NCT00021255|69714676|FG000|Overall Study|Other than specified above|0|||
38029266|NCT00021255|69714677|FG001|Overall Study|Other than specified above|38|||
38029267|NCT00021255|69714678|FG002|Overall Study|Other than specified above|19|||
38029268|NCT00021255|69714676|FG000|Overall Study|Missing|0|||
38029269|NCT00021255|69714677|FG001|Overall Study|Missing|27|||
38029270|NCT00021255|69714678|FG002|Overall Study|Missing|13|||
38029271|NCT00021255|69714676|FG000|Overall Study|Randomized but not treated|28|||
37735075|NCT00981292|69215458|FG001|Day 2|Protocol Violation|0|||
37850600|NCT01090024|69534508|FG001|Period 1|Lost to Follow-up|1|||
37735076|NCT00981292|69215459|FG002|Day 2|Protocol Violation|0|||
37735077|NCT00981292|69215460|FG003|Day 2|Protocol Violation|0|||
37735078|NCT00981292|69215461|FG004|Day 2|Protocol Violation|0|||
37735079|NCT00981292|69215462|FG005|Day 2|Protocol Violation|0|||
37735080|NCT00981292|69215457|FG000|Day 3|Protocol Violation|0|||
37735081|NCT00981292|69215458|FG001|Day 3|Protocol Violation|0|||
37735082|NCT00981292|69215459|FG002|Day 3|Protocol Violation|0|||
37735083|NCT00981292|69215460|FG003|Day 3|Protocol Violation|0|||
37735084|NCT00981292|69215461|FG004|Day 3|Protocol Violation|0|||
37735085|NCT00981292|69215462|FG005|Day 3|Protocol Violation|1|||
37735086|NCT00980044|69215477|FG000|Overall Study|Withdrawal by Subject|5|||
37735087|NCT00980044|69215478|FG001|Overall Study|Withdrawal by Subject|7|||
37735088|NCT00980044|69215479|FG002|Overall Study|Withdrawal by Subject|3|||
37735089|NCT00980044|69215477|FG000|Overall Study|Protocol Violation|0|||
37735090|NCT00980044|69215478|FG001|Overall Study|Protocol Violation|0|||
37735091|NCT00980044|69215479|FG002|Overall Study|Protocol Violation|2|||
37735092|NCT01903837|69215494|FG000|Part A|Withdrawal by Subject|4|||
37850601|NCT01090024|69534509|FG002|Period 1|Lost to Follow-up|0|||
37850602|NCT01090024|69534510|FG003|Period 1|Lost to Follow-up|0|||
37850603|NCT01090024|69534511|FG004|Period 1|Lost to Follow-up|0|||
37850604|NCT01090024|69534512|FG005|Period 1|Lost to Follow-up|0|||
37850605|NCT01090024|69534513|FG006|Period 1|Lost to Follow-up|0|||
37850606|NCT01090024|69534514|FG007|Period 1|Lost to Follow-up|0|||
37850607|NCT01090024|69534515|FG008|Period 1|Lost to Follow-up|0|||
37850608|NCT01090024|69534516|FG009|Period 1|Lost to Follow-up|0|||
37735093|NCT01903837|69215495|FG001|Part A|Withdrawal by Subject|9|||
37735094|NCT01903837|69215496|FG002|Part A|Withdrawal by Subject|8|||
37735095|NCT01903837|69215497|FG003|Part A|Withdrawal by Subject|5|||
37735096|NCT01903837|69215494|FG000|Part A|Adverse Event|3|||
37735097|NCT01903837|69215495|FG001|Part A|Adverse Event|6|||
37735098|NCT01903837|69215496|FG002|Part A|Adverse Event|9|||
37850609|NCT01090024|69534517|FG010|Period 1|Lost to Follow-up|0|||
37850610|NCT01090024|69534518|FG011|Period 1|Lost to Follow-up|0|||
37850611|NCT01090024|69534519|FG012|Period 1|Lost to Follow-up|0|||
37735099|NCT01903837|69215497|FG003|Part A|Adverse Event|6|||
37850612|NCT01090024|69534520|FG013|Period 1|Lost to Follow-up|0|||
37850613|NCT01090024|69534521|FG014|Period 1|Lost to Follow-up|0|||
37735100|NCT01903837|69215494|FG000|Part A|Lost to Follow-up|9|||
37735101|NCT01903837|69215495|FG001|Part A|Lost to Follow-up|7|||
37735102|NCT01903837|69215496|FG002|Part A|Lost to Follow-up|7|||
37850614|NCT01090024|69534522|FG015|Period 1|Lost to Follow-up|0|||
38029272|NCT00021255|69714677|FG001|Overall Study|Randomized but not treated|2|||
38029273|NCT00021255|69714678|FG002|Overall Study|Randomized but not treated|18|||
38029274|NCT03012334|69714696|FG000|Period 1|Withdrawal by Subject|0|||
38029275|NCT03012334|69714697|FG001|Period 1|Withdrawal by Subject|0|||
38029276|NCT03012334|69714698|FG002|Period 1|Withdrawal by Subject|0|||
38029277|NCT03012334|69714699|FG003|Period 1|Withdrawal by Subject|0|||
38029278|NCT03012334|69714700|FG004|Period 1|Withdrawal by Subject|0|||
38029279|NCT03012334|69714701|FG005|Period 1|Withdrawal by Subject|0|||
38029280|NCT03012334|69714702|FG006|Period 1|Withdrawal by Subject|0|||
38029281|NCT03012334|69714703|FG007|Period 1|Withdrawal by Subject|0|||
37735103|NCT01903837|69215497|FG003|Part A|Lost to Follow-up|2|||
37735104|NCT01903837|69215494|FG000|Part A|Non-compliance with study drug|1|||
37850615|NCT01090024|69534523|FG016|Period 1|Lost to Follow-up|0|||
37850616|NCT01090024|69534524|FG017|Period 1|Lost to Follow-up|0|||
37850617|NCT01090024|69534507|FG000|Period 2|Lost to Follow-up|0|||
37850618|NCT01090024|69534508|FG001|Period 2|Lost to Follow-up|0|||
37850619|NCT01090024|69534509|FG002|Period 2|Lost to Follow-up|0|||
37850620|NCT01090024|69534510|FG003|Period 2|Lost to Follow-up|1|||
37850621|NCT01090024|69534511|FG004|Period 2|Lost to Follow-up|0|||
37850622|NCT01090024|69534512|FG005|Period 2|Lost to Follow-up|0|||
37850623|NCT01090024|69534513|FG006|Period 2|Lost to Follow-up|0|||
38029282|NCT03012334|69714704|FG008|Period 1|Withdrawal by Subject|0|||
38029283|NCT03012334|69714705|FG009|Period 1|Withdrawal by Subject|1|||
37850624|NCT01090024|69534514|FG007|Period 2|Lost to Follow-up|0|||
37850625|NCT01090024|69534515|FG008|Period 2|Lost to Follow-up|0|||
37850626|NCT01090024|69534516|FG009|Period 2|Lost to Follow-up|0|||
37850627|NCT01090024|69534517|FG010|Period 2|Lost to Follow-up|0|||
37850628|NCT01090024|69534518|FG011|Period 2|Lost to Follow-up|0|||
37735105|NCT01903837|69215495|FG001|Part A|Non-compliance with study drug|4|||
37850629|NCT01090024|69534519|FG012|Period 2|Lost to Follow-up|0|||
37850630|NCT01090024|69534520|FG013|Period 2|Lost to Follow-up|0|||
38029284|NCT03012334|69714696|FG000|Period 2|Withdrawal by Subject|0|||
38029285|NCT03012334|69714697|FG001|Period 2|Withdrawal by Subject|1|||
38029286|NCT03012334|69714698|FG002|Period 2|Withdrawal by Subject|0|||
37850631|NCT01090024|69534521|FG014|Period 2|Lost to Follow-up|0|||
37850632|NCT01090024|69534522|FG015|Period 2|Lost to Follow-up|0|||
37919656|NCT00845520|69606289|FG000|Overall Study|Death|1|||
37919657|NCT00845520|69606290|FG001|Overall Study|Death|2|||
37919658|NCT00845520|69606291|FG002|Overall Study|Death|0|||
37919659|NCT00845520|69606289|FG000|Overall Study|Lost to Follow-up|1|||
37919660|NCT00845520|69606290|FG001|Overall Study|Lost to Follow-up|0|||
37919661|NCT00845520|69606291|FG002|Overall Study|Lost to Follow-up|0|||
37919662|NCT00845520|69606289|FG000|Overall Study|Adverse Event|0|||
37919663|NCT00845520|69606290|FG001|Overall Study|Adverse Event|0|||
37919664|NCT00845520|69606291|FG002|Overall Study|Adverse Event|1|||
37919665|NCT00844896|69606307|FG000|Overall Study|Lost to Follow-up|12|||
37919666|NCT00844896|69606308|FG001|Overall Study|Lost to Follow-up|16|||
37919667|NCT00844896|69606307|FG000|Overall Study|Parents did not have time to complete|0|||
37919668|NCT00844896|69606308|FG001|Overall Study|Parents did not have time to complete|1|||
38029287|NCT03012334|69714699|FG003|Period 2|Withdrawal by Subject|0|||
38029288|NCT03012334|69714700|FG004|Period 2|Withdrawal by Subject|0|||
38029289|NCT03012334|69714701|FG005|Period 2|Withdrawal by Subject|0|||
38029290|NCT03012334|69714702|FG006|Period 2|Withdrawal by Subject|0|||
38029291|NCT03012334|69714703|FG007|Period 2|Withdrawal by Subject|0|||
38029292|NCT03012334|69714704|FG008|Period 2|Withdrawal by Subject|0|||
38029293|NCT03012334|69714705|FG009|Period 2|Withdrawal by Subject|0|||
37850633|NCT01090024|69534523|FG016|Period 2|Lost to Follow-up|0|||
37850634|NCT01090024|69534524|FG017|Period 2|Lost to Follow-up|0|||
37850635|NCT01090024|69534507|FG000|Period 2|Adverse Event|1|||
37850636|NCT01090024|69534508|FG001|Period 2|Adverse Event|0|||
37850637|NCT01090024|69534509|FG002|Period 2|Adverse Event|0|||
37850638|NCT01090024|69534510|FG003|Period 2|Adverse Event|0|||
37850639|NCT01090024|69534511|FG004|Period 2|Adverse Event|0|||
37850640|NCT01090024|69534512|FG005|Period 2|Adverse Event|0|||
37850641|NCT01090024|69534513|FG006|Period 2|Adverse Event|0|||
37850642|NCT01090024|69534514|FG007|Period 2|Adverse Event|0|||
37850643|NCT01090024|69534515|FG008|Period 2|Adverse Event|0|||
37850644|NCT01090024|69534516|FG009|Period 2|Adverse Event|0|||
37919669|NCT00827502|69606315|FG000|Overall Study|randomized but not treated|11|||
37919670|NCT00827502|69606315|FG000|Overall Study|Adverse Event|1|||
37919671|NCT00827502|69606315|FG000|Overall Study|Lost to Follow-up|4|||
37919672|NCT00827502|69606315|FG000|Overall Study|Withdrawal by Subject|5|||
37919673|NCT00837330|69606321|FG000|Overall Study|Lost to Follow-up|1|||
37919674|NCT00837330|69606322|FG001|Overall Study|Lost to Follow-up|3|||
37919675|NCT00837096|69606330|FG000|Overall Study|Physician Decision|1|||
37919676|NCT00837096|69606331|FG001|Overall Study|Physician Decision|1|||
37919677|NCT00837096|69606330|FG000|Overall Study|Not reported|9|||
37919678|NCT00837096|69606331|FG001|Overall Study|Not reported|8|||
37919679|NCT00885677|69606339|FG000|Overall Study|Death|40|||
37919680|NCT00885677|69606340|FG001|Overall Study|Death|34|||
37919681|NCT00885677|69606339|FG000|Overall Study|Lost to Follow-up|15|||
37850645|NCT01090024|69534517|FG010|Period 2|Adverse Event|0|||
37919682|NCT00885677|69606340|FG001|Overall Study|Lost to Follow-up|13|||
37919683|NCT00885677|69606339|FG000|Overall Study|Protocol Violation|54|||
37850646|NCT01090024|69534518|FG011|Period 2|Adverse Event|0|||
37850647|NCT01090024|69534519|FG012|Period 2|Adverse Event|0|||
37850648|NCT01090024|69534520|FG013|Period 2|Adverse Event|0|||
37850649|NCT01090024|69534521|FG014|Period 2|Adverse Event|0|||
37850650|NCT01090024|69534522|FG015|Period 2|Adverse Event|0|||
37850651|NCT01090024|69534523|FG016|Period 2|Adverse Event|0|||
37850652|NCT01090024|69534524|FG017|Period 2|Adverse Event|0|||
37850653|NCT01090024|69534507|FG000|Period 3|Withdrawal by Subject|0|||
38029294|NCT03012334|69714696|FG000|Period 2|Protocol Violation|0|||
38029295|NCT03012334|69714697|FG001|Period 2|Protocol Violation|0|||
37919684|NCT00885677|69606340|FG001|Overall Study|Protocol Violation|54|||
38029296|NCT03012334|69714698|FG002|Period 2|Protocol Violation|1|||
38029297|NCT03012334|69714699|FG003|Period 2|Protocol Violation|0|||
37850654|NCT01090024|69534508|FG001|Period 3|Withdrawal by Subject|0|||
37850655|NCT01090024|69534509|FG002|Period 3|Withdrawal by Subject|0|||
37850656|NCT01090024|69534510|FG003|Period 3|Withdrawal by Subject|0|||
37919685|NCT00885677|69606339|FG000|Overall Study|premature study closure|41|||
37919686|NCT00885677|69606340|FG001|Overall Study|premature study closure|44|||
37919687|NCT00885677|69606339|FG000|Overall Study|device/lead revision or replacement|7|||
37919688|NCT00885677|69606340|FG001|Overall Study|device/lead revision or replacement|6|||
37919689|NCT00885677|69606339|FG000|Overall Study|Heart transplantation|1|||
37919690|NCT00885677|69606340|FG001|Overall Study|Heart transplantation|0|||
38029298|NCT03012334|69714700|FG004|Period 2|Protocol Violation|0|||
38029299|NCT03012334|69714701|FG005|Period 2|Protocol Violation|0|||
38029300|NCT03012334|69714702|FG006|Period 2|Protocol Violation|0|||
38029301|NCT03012334|69714703|FG007|Period 2|Protocol Violation|1|||
38029302|NCT03012334|69714704|FG008|Period 2|Protocol Violation|0|||
38029303|NCT03012334|69714705|FG009|Period 2|Protocol Violation|0|||
38029304|NCT03012334|69714696|FG000|Period 4|Non-Compliance|0|||
38029305|NCT03012334|69714697|FG001|Period 4|Non-Compliance|0|||
38029306|NCT03012334|69714698|FG002|Period 4|Non-Compliance|0|||
38029307|NCT03012334|69714699|FG003|Period 4|Non-Compliance|0|||
37919691|NCT00885677|69606339|FG000|Overall Study|Inclusion/exclusion not met|25|||
37919692|NCT00885677|69606340|FG001|Overall Study|Inclusion/exclusion not met|27|||
37919693|NCT00885365|69606348|FG000|4 Weeks ON Treatment|Adverse Event|2|||
37919694|NCT00885365|69606349|FG001|4 Weeks ON Treatment|Adverse Event|4|||
37919695|NCT00885365|69606348|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
37919696|NCT00885365|69606349|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
37919697|NCT00885365|69606348|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
37919698|NCT00885365|69606349|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
37919699|NCT00827112|69606357|FG000|Overall Study|Adverse Event|2|||
37919700|NCT00827112|69606358|FG001|Overall Study|Adverse Event|0|||
37919701|NCT00827112|69606357|FG000|Overall Study|Lack of Efficacy|2|||
37919702|NCT00827112|69606358|FG001|Overall Study|Lack of Efficacy|0|||
37919703|NCT00827112|69606357|FG000|Overall Study|Lost to Follow-up|3|||
37919704|NCT00827112|69606358|FG001|Overall Study|Lost to Follow-up|2|||
37919705|NCT00827112|69606357|FG000|Overall Study|Pregnancy|0|||
37919706|NCT00827112|69606358|FG001|Overall Study|Pregnancy|1|||
37919707|NCT00827112|69606357|FG000|Overall Study|Protocol Violation|0|||
37919708|NCT00827112|69606358|FG001|Overall Study|Protocol Violation|2|||
38029308|NCT03012334|69714700|FG004|Period 4|Non-Compliance|0|||
38029309|NCT03012334|69714701|FG005|Period 4|Non-Compliance|0|||
38029310|NCT03012334|69714702|FG006|Period 4|Non-Compliance|1|||
38029311|NCT03012334|69714703|FG007|Period 4|Non-Compliance|0|||
38029312|NCT03012334|69714704|FG008|Period 4|Non-Compliance|0|||
38029313|NCT03012334|69714705|FG009|Period 4|Non-Compliance|0|||
38029314|NCT03012334|69714696|FG000|Period 4|Adverse Event|0|||
38029315|NCT03012334|69714697|FG001|Period 4|Adverse Event|0|||
38029316|NCT03012334|69714698|FG002|Period 4|Adverse Event|0|||
38029317|NCT03012334|69714699|FG003|Period 4|Adverse Event|0|||
38029318|NCT03012334|69714700|FG004|Period 4|Adverse Event|0|||
38029319|NCT03012334|69714701|FG005|Period 4|Adverse Event|0|||
38029320|NCT03012334|69714702|FG006|Period 4|Adverse Event|0|||
38029321|NCT03012334|69714703|FG007|Period 4|Adverse Event|0|||
38029322|NCT03012334|69714704|FG008|Period 4|Adverse Event|1|||
38029323|NCT03012334|69714705|FG009|Period 4|Adverse Event|0|||
38029324|NCT03565068|69714727|FG000|Overall Study|Protocol Violation|0|||
38029325|NCT03565068|69714728|FG001|Overall Study|Protocol Violation|0|||
38029326|NCT03565068|69714729|FG002|Overall Study|Protocol Violation|0|||
38029327|NCT03565068|69714730|FG003|Overall Study|Protocol Violation|0|||
38029328|NCT03565068|69714731|FG004|Overall Study|Protocol Violation|1|||
38029329|NCT03565068|69714732|FG005|Overall Study|Protocol Violation|0|||
38029330|NCT03565068|69714733|FG006|Overall Study|Protocol Violation|0|||
38029331|NCT03565068|69714734|FG007|Overall Study|Protocol Violation|1|||
38029332|NCT03565068|69714735|FG008|Overall Study|Protocol Violation|0|||
38029333|NCT03565068|69714727|FG000|Overall Study|Sponsor decision|0|||
38029334|NCT03565068|69714728|FG001|Overall Study|Sponsor decision|0|||
38029335|NCT03565068|69714729|FG002|Overall Study|Sponsor decision|0|||
37850657|NCT01090024|69534511|FG004|Period 3|Withdrawal by Subject|0|||
37850658|NCT01090024|69534512|FG005|Period 3|Withdrawal by Subject|0|||
37850659|NCT01090024|69534513|FG006|Period 3|Withdrawal by Subject|0|||
37850660|NCT01090024|69534514|FG007|Period 3|Withdrawal by Subject|0|||
37850661|NCT01090024|69534515|FG008|Period 3|Withdrawal by Subject|0|||
37850662|NCT01090024|69534516|FG009|Period 3|Withdrawal by Subject|0|||
37850663|NCT01090024|69534517|FG010|Period 3|Withdrawal by Subject|0|||
37850664|NCT01090024|69534518|FG011|Period 3|Withdrawal by Subject|0|||
37850665|NCT01090024|69534519|FG012|Period 3|Withdrawal by Subject|0|||
38029336|NCT03565068|69714730|FG003|Overall Study|Sponsor decision|0|||
38029337|NCT03565068|69714731|FG004|Overall Study|Sponsor decision|1|||
38029338|NCT03565068|69714732|FG005|Overall Study|Sponsor decision|1|||
38029339|NCT03565068|69714733|FG006|Overall Study|Sponsor decision|0|||
38029340|NCT03565068|69714734|FG007|Overall Study|Sponsor decision|0|||
38029341|NCT03565068|69714735|FG008|Overall Study|Sponsor decision|0|||
38029342|NCT03565068|69714727|FG000|Overall Study|Withdrawal by Subject|0|||
37919709|NCT00827112|69606357|FG000|Overall Study|Withdrawal by Subject|2|||
37919710|NCT00827112|69606358|FG001|Overall Study|Withdrawal by Subject|1|||
37919711|NCT00827112|69606357|FG000|Overall Study|Randomized but not treated|5|||
37850666|NCT01090024|69534520|FG013|Period 3|Withdrawal by Subject|0|||
37850667|NCT01090024|69534521|FG014|Period 3|Withdrawal by Subject|0|||
38029343|NCT03565068|69714728|FG001|Overall Study|Withdrawal by Subject|0|||
38029344|NCT03565068|69714729|FG002|Overall Study|Withdrawal by Subject|1|||
38029345|NCT03565068|69714730|FG003|Overall Study|Withdrawal by Subject|0|||
38029346|NCT03565068|69714731|FG004|Overall Study|Withdrawal by Subject|2|||
38029347|NCT03565068|69714732|FG005|Overall Study|Withdrawal by Subject|0|||
37919712|NCT00827112|69606358|FG001|Overall Study|Randomized but not treated|3|||
38029348|NCT03565068|69714733|FG006|Overall Study|Withdrawal by Subject|1|||
38029349|NCT03565068|69714734|FG007|Overall Study|Withdrawal by Subject|5|||
38029350|NCT03565068|69714735|FG008|Overall Study|Withdrawal by Subject|1|||
38029351|NCT03565068|69714727|FG000|Overall Study|Physician Decision|0|||
38029352|NCT03565068|69714728|FG001|Overall Study|Physician Decision|0|||
38029353|NCT03565068|69714729|FG002|Overall Study|Physician Decision|0|||
38029354|NCT03565068|69714730|FG003|Overall Study|Physician Decision|0|||
38029355|NCT03565068|69714731|FG004|Overall Study|Physician Decision|0|||
38029356|NCT03565068|69714732|FG005|Overall Study|Physician Decision|0|||
38029357|NCT03565068|69714733|FG006|Overall Study|Physician Decision|0|||
38029358|NCT03565068|69714734|FG007|Overall Study|Physician Decision|1|||
38029359|NCT03565068|69714735|FG008|Overall Study|Physician Decision|0|||
38029360|NCT03565068|69714727|FG000|Overall Study|Lost to Follow-up|0|||
38029361|NCT03565068|69714728|FG001|Overall Study|Lost to Follow-up|0|||
37850668|NCT01090024|69534522|FG015|Period 3|Withdrawal by Subject|1|||
37850669|NCT01090024|69534523|FG016|Period 3|Withdrawal by Subject|0|||
38029362|NCT03565068|69714729|FG002|Overall Study|Lost to Follow-up|0|||
38029363|NCT03565068|69714730|FG003|Overall Study|Lost to Follow-up|0|||
38029364|NCT03565068|69714731|FG004|Overall Study|Lost to Follow-up|0|||
38029365|NCT03565068|69714732|FG005|Overall Study|Lost to Follow-up|0|||
38029366|NCT03565068|69714733|FG006|Overall Study|Lost to Follow-up|0|||
38029367|NCT03565068|69714734|FG007|Overall Study|Lost to Follow-up|1|||
38029368|NCT03565068|69714735|FG008|Overall Study|Lost to Follow-up|0|||
38029369|NCT00010803|69714794|FG000|Overall Study|Withdrawal by Subject|97|||
38029370|NCT00010803|69714795|FG001|Overall Study|Withdrawal by Subject|98|||
38029371|NCT02914834|69714803|FG000|Overall Study|Study halted due to COVID|1|||
38029372|NCT02914834|69714804|FG001|Overall Study|Study halted due to COVID|1|||
38029373|NCT02914834|69714803|FG000|Overall Study|1 subject withdrew|0|||
38029374|NCT02914834|69714804|FG001|Overall Study|1 subject withdrew|1|||
37850670|NCT01090024|69534524|FG017|Period 3|Withdrawal by Subject|0|||
37850671|NCT01090024|69534507|FG000|Period 3|Protocol Violation|0|||
37850672|NCT01090024|69534508|FG001|Period 3|Protocol Violation|0|||
37850673|NCT01090024|69534509|FG002|Period 3|Protocol Violation|0|||
37850674|NCT01090024|69534510|FG003|Period 3|Protocol Violation|0|||
37850675|NCT01090024|69534511|FG004|Period 3|Protocol Violation|0|||
37850676|NCT01090024|69534512|FG005|Period 3|Protocol Violation|0|||
37850677|NCT01090024|69534513|FG006|Period 3|Protocol Violation|0|||
37850678|NCT01090024|69534514|FG007|Period 3|Protocol Violation|0|||
37850679|NCT01090024|69534515|FG008|Period 3|Protocol Violation|1|||
37850680|NCT01090024|69534516|FG009|Period 3|Protocol Violation|0|||
37850681|NCT01090024|69534517|FG010|Period 3|Protocol Violation|0|||
37850682|NCT01090024|69534518|FG011|Period 3|Protocol Violation|0|||
37850683|NCT01090024|69534519|FG012|Period 3|Protocol Violation|0|||
37850684|NCT01090024|69534520|FG013|Period 3|Protocol Violation|0|||
37850685|NCT01090024|69534521|FG014|Period 3|Protocol Violation|0|||
37850686|NCT01090024|69534522|FG015|Period 3|Protocol Violation|0|||
38029375|NCT03497130|69714812|FG000|Overall Study|Lost to Follow-up|1|||
38029376|NCT03497130|69714813|FG001|Overall Study|Lost to Follow-up|1|||
38029377|NCT03006562|69714821|FG000|Overall Study|Lost to Follow-up|0|||
38029378|NCT03006562|69714822|FG001|Overall Study|Lost to Follow-up|1|||
37850687|NCT01090024|69534523|FG016|Period 3|Protocol Violation|0|||
37850688|NCT01090024|69534524|FG017|Period 3|Protocol Violation|0|||
37850689|NCT01090024|69534507|FG000|Period 3|Adverse Event|0|||
37850690|NCT01090024|69534508|FG001|Period 3|Adverse Event|0|||
37850691|NCT01090024|69534509|FG002|Period 3|Adverse Event|0|||
37850692|NCT01090024|69534510|FG003|Period 3|Adverse Event|0|||
37850693|NCT01090024|69534511|FG004|Period 3|Adverse Event|0|||
37850694|NCT01090024|69534512|FG005|Period 3|Adverse Event|1|||
37850695|NCT01090024|69534513|FG006|Period 3|Adverse Event|0|||
37850696|NCT01090024|69534514|FG007|Period 3|Adverse Event|0|||
38029379|NCT03007966|69714830|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
38029380|NCT03007966|69714831|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
38029381|NCT03007888|69714838|FG000|First Intervention (14 Days)|Adverse Event|1|||
38029382|NCT03007888|69714839|FG001|First Intervention (14 Days)|Adverse Event|0|||
38029383|NCT03541044|69714848|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
38029384|NCT03541044|69714849|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
38029385|NCT03541044|69714848|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
38029386|NCT03541044|69714849|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
38029387|NCT00009945|69714859|FG000|Overall Study|no follow up data|7|||
38029388|NCT00009945|69714860|FG001|Overall Study|no follow up data|5|||
38029389|NCT03540030|69714868|FG000|Overall Study|Withdrawal by Subject|2|||
38029390|NCT03540030|69714869|FG001|Overall Study|Withdrawal by Subject|1|||
38029391|NCT03540030|69714868|FG000|Overall Study|screen fail|7|||
38029392|NCT03540030|69714869|FG001|Overall Study|screen fail|1|||
38029393|NCT03540030|69714868|FG000|Overall Study|never had surgery after signing consent|9|||
38029394|NCT03540030|69714869|FG001|Overall Study|never had surgery after signing consent|1|||
38029395|NCT03003676|69714877|FG000|Overall Study|Lack of Efficacy|5|||
38029396|NCT03003676|69714878|FG001|Overall Study|Lack of Efficacy|7|||
38029397|NCT03003676|69714877|FG000|Overall Study|Withdrawal by Subject|0|||
38029398|NCT03003676|69714878|FG001|Overall Study|Withdrawal by Subject|1|||
38029399|NCT03003676|69714877|FG000|Overall Study|Hepatitis B infection|1|||
38029400|NCT03003676|69714878|FG001|Overall Study|Hepatitis B infection|0|||
38029401|NCT00047385|69714888|FG000|Overall Study|Death before any screening|2|||
38029402|NCT00047385|69714889|FG001|Overall Study|Death before any screening|5|||
38029403|NCT00047385|69714888|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
38029404|NCT00047385|69714889|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
38029405|NCT00047385|69714888|FG000|Overall Study|Eligible for screening but had no screen|260|||
38029406|NCT00047385|69714889|FG001|Overall Study|Eligible for screening but had no screen|492|||
38029407|NCT03002818|69714895|FG000|Overall Study|Decision of the investigator|1|||
38029408|NCT03002194|69714899|FG000|Overall Study|Lost to Follow-up|6|||
38029409|NCT03002194|69714899|FG000|Overall Study|Adverse Event|1|||
38029410|NCT03002194|69714899|FG000|Overall Study|Lack of Efficacy|1|||
38029411|NCT03002194|69714899|FG000|Overall Study|Withdrawal by Subject|2|||
38029412|NCT02912650|69714907|FG000|Overall Study|Withdrawal by Subject|1|||
38029413|NCT02912650|69714908|FG001|Overall Study|Withdrawal by Subject|0|||
38029414|NCT02912650|69714909|FG002|Overall Study|Withdrawal by Subject|1|||
38029415|NCT02912650|69714910|FG003|Overall Study|Withdrawal by Subject|5|||
38029416|NCT02912650|69714907|FG000|Overall Study|Adverse Event|0|||
38029417|NCT02912650|69714908|FG001|Overall Study|Adverse Event|0|||
38029418|NCT02912650|69714909|FG002|Overall Study|Adverse Event|1|||
38029419|NCT02912650|69714910|FG003|Overall Study|Adverse Event|0|||
38029420|NCT03004924|69714923|FG000|Overall Study|Adverse Event|6|||
38029421|NCT03004924|69714924|FG001|Overall Study|Adverse Event|5|||
38029422|NCT03004924|69714925|FG002|Overall Study|Adverse Event|10|||
38029423|NCT03004924|69714923|FG000|Overall Study|Protocol Violation|4|||
38029424|NCT03004924|69714924|FG001|Overall Study|Protocol Violation|0|||
38029425|NCT03004924|69714925|FG002|Overall Study|Protocol Violation|1|||
38029426|NCT03004924|69714923|FG000|Overall Study|Withdrawal by Subject|5|||
38029427|NCT03004924|69714924|FG001|Overall Study|Withdrawal by Subject|3|||
38029428|NCT03004924|69714925|FG002|Overall Study|Withdrawal by Subject|5|||
38029429|NCT03004924|69714923|FG000|Overall Study|Lost to Follow-up|6|||
38029430|NCT03004924|69714924|FG001|Overall Study|Lost to Follow-up|1|||
38029431|NCT03004924|69714925|FG002|Overall Study|Lost to Follow-up|4|||
38029432|NCT03004924|69714923|FG000|Overall Study|Lack of Efficacy|2|||
38029433|NCT03004924|69714924|FG001|Overall Study|Lack of Efficacy|4|||
38029434|NCT03004924|69714925|FG002|Overall Study|Lack of Efficacy|2|||
38029435|NCT03004924|69714923|FG000|Overall Study|Physician Decision|1|||
38029436|NCT03004924|69714924|FG001|Overall Study|Physician Decision|0|||
38029437|NCT03004924|69714925|FG002|Overall Study|Physician Decision|1|||
38029438|NCT03004924|69714923|FG000|Overall Study|Withdrawal by parent/guardian|1|||
38029439|NCT03004924|69714924|FG001|Overall Study|Withdrawal by parent/guardian|0|||
38029440|NCT03004924|69714925|FG002|Overall Study|Withdrawal by parent/guardian|2|||
38029441|NCT03004924|69714923|FG000|Overall Study|Screen Failure|1|||
38029442|NCT03004924|69714924|FG001|Overall Study|Screen Failure|0|||
38029443|NCT03004924|69714925|FG002|Overall Study|Screen Failure|0|||
38029444|NCT03004924|69714923|FG000|Overall Study|Pregnancy|0|||
38029445|NCT03004924|69714924|FG001|Overall Study|Pregnancy|1|||
38029446|NCT03004924|69714925|FG002|Overall Study|Pregnancy|0|||
37919713|NCT00827112|69606357|FG000|Overall Study|Other|1|||
37919714|NCT00827112|69606358|FG001|Overall Study|Other|3|||
37919715|NCT00689104|69606368|FG000|Overall Study|Eligibility criterion not met|5|||
37919716|NCT00689104|69606369|FG001|Overall Study|Eligibility criterion not met|8|||
37919717|NCT00689104|69606370|FG002|Overall Study|Eligibility criterion not met|0|||
37919718|NCT00689104|69606371|FG003|Overall Study|Eligibility criterion not met|4|||
37919719|NCT00689104|69606368|FG000|Overall Study|Adverse Event|13|||
37919720|NCT00689104|69606369|FG001|Overall Study|Adverse Event|25|||
37919721|NCT00689104|69606370|FG002|Overall Study|Adverse Event|16|||
37919722|NCT00689104|69606371|FG003|Overall Study|Adverse Event|24|||
37919723|NCT00689104|69606368|FG000|Overall Study|Lack of Efficacy|5|||
37919724|NCT00689104|69606369|FG001|Overall Study|Lack of Efficacy|6|||
37919725|NCT00689104|69606370|FG002|Overall Study|Lack of Efficacy|2|||
38029447|NCT03004924|69714923|FG000|Overall Study|Terminated by Sponsor|0|||
38029448|NCT03004924|69714924|FG001|Overall Study|Terminated by Sponsor|0|||
38029449|NCT03004924|69714925|FG002|Overall Study|Terminated by Sponsor|1|||
38029450|NCT03004924|69714923|FG000|Overall Study|Missed Study Visit|0|||
38029451|NCT03004924|69714924|FG001|Overall Study|Missed Study Visit|0|||
38029452|NCT03004924|69714925|FG002|Overall Study|Missed Study Visit|2|||
38029453|NCT03004924|69714923|FG000|Overall Study|HSV1 Positive|1|||
38029454|NCT03004924|69714924|FG001|Overall Study|HSV1 Positive|0|||
38029455|NCT03004924|69714925|FG002|Overall Study|HSV1 Positive|0|||
38029456|NCT03002038|69714936|FG000|Overall Study|Adverse Event|3|||
38029457|NCT03002038|69714937|FG001|Overall Study|Adverse Event|1|||
37850697|NCT01090024|69534515|FG008|Period 3|Adverse Event|0|||
38029458|NCT03002038|69714936|FG000|Overall Study|Withdrawal by Subject|8|||
38029459|NCT03002038|69714937|FG001|Overall Study|Withdrawal by Subject|4|||
37850698|NCT01090024|69534516|FG009|Period 3|Adverse Event|0|||
37850699|NCT01090024|69534517|FG010|Period 3|Adverse Event|0|||
37850700|NCT01090024|69534518|FG011|Period 3|Adverse Event|0|||
37850701|NCT01090024|69534519|FG012|Period 3|Adverse Event|0|||
37850702|NCT01090024|69534520|FG013|Period 3|Adverse Event|0|||
37850703|NCT01090024|69534521|FG014|Period 3|Adverse Event|0|||
37850704|NCT01090024|69534522|FG015|Period 3|Adverse Event|0|||
37850705|NCT01090024|69534523|FG016|Period 3|Adverse Event|0|||
37850706|NCT01090024|69534524|FG017|Period 3|Adverse Event|0|||
37850707|NCT04868890|69534536|FG000|Overall Study|Death|2|||
38029460|NCT03002038|69714936|FG000|Overall Study|Immigration to another region|0|||
38029461|NCT03002038|69714937|FG001|Overall Study|Immigration to another region|2|||
38029462|NCT02911948|69714945|FG000|Overall Study|Protocol Violation|0|||
38029463|NCT02911948|69714946|FG001|Overall Study|Protocol Violation|1|||
38029464|NCT02911948|69714945|FG000|Overall Study|Withdrawal by Subject|0|||
38029465|NCT02911948|69714946|FG001|Overall Study|Withdrawal by Subject|2|||
38029466|NCT02911948|69714945|FG000|Overall Study|Lack of Efficacy|0|||
38029467|NCT02911948|69714946|FG001|Overall Study|Lack of Efficacy|1|||
38029468|NCT02911948|69714945|FG000|Overall Study|Unclassified|0|||
38029469|NCT02911948|69714946|FG001|Overall Study|Unclassified|3|||
38029470|NCT02996968|69714954|FG000|Overall Study|Withdrawal by Subject|1|||
38029471|NCT02996968|69714955|FG001|Overall Study|Withdrawal by Subject|0|||
38029472|NCT00027027|69714966|FG000|Overall Study|Adverse Event|0|||
37919726|NCT00689104|69606371|FG003|Overall Study|Lack of Efficacy|3|||
37919727|NCT00689104|69606368|FG000|Overall Study|Withdrawal by Subject|12|||
37919728|NCT00689104|69606369|FG001|Overall Study|Withdrawal by Subject|11|||
37919729|NCT00689104|69606370|FG002|Overall Study|Withdrawal by Subject|18|||
37735106|NCT01903837|69215496|FG002|Part A|Non-compliance with study drug|4|||
37735107|NCT01903837|69215497|FG003|Part A|Non-compliance with study drug|0|||
37735108|NCT01903837|69215494|FG000|Part A|Physician Decision|1|||
37735109|NCT01903837|69215495|FG001|Part A|Physician Decision|1|||
37735110|NCT01903837|69215496|FG002|Part A|Physician Decision|0|||
37735111|NCT01903837|69215497|FG003|Part A|Physician Decision|0|||
37735112|NCT01903837|69215494|FG000|Part A|Protocol Violation|1|||
37735113|NCT01903837|69215495|FG001|Part A|Protocol Violation|1|||
37735114|NCT01903837|69215496|FG002|Part A|Protocol Violation|0|||
37735115|NCT01903837|69215497|FG003|Part A|Protocol Violation|0|||
37735116|NCT01903837|69215494|FG000|Part B|Lost to Follow-up|0|||
37919730|NCT00689104|69606371|FG003|Overall Study|Withdrawal by Subject|11|||
37919731|NCT00689104|69606368|FG000|Overall Study|Lost to Follow-up|4|||
37919732|NCT00689104|69606369|FG001|Overall Study|Lost to Follow-up|3|||
37919733|NCT00689104|69606370|FG002|Overall Study|Lost to Follow-up|2|||
37919734|NCT00689104|69606371|FG003|Overall Study|Lost to Follow-up|5|||
37919735|NCT00689104|69606368|FG000|Overall Study|Protocol Violation|2|||
37919736|NCT00689104|69606369|FG001|Overall Study|Protocol Violation|3|||
37919737|NCT00689104|69606370|FG002|Overall Study|Protocol Violation|5|||
37919738|NCT00689104|69606371|FG003|Overall Study|Protocol Violation|3|||
37919739|NCT00689104|69606368|FG000|Overall Study|Randomized but never received study drug|2|||
37919740|NCT00689104|69606369|FG001|Overall Study|Randomized but never received study drug|1|||
37919741|NCT00689104|69606370|FG002|Overall Study|Randomized but never received study drug|1|||
37919742|NCT00689104|69606371|FG003|Overall Study|Randomized but never received study drug|0|||
37919743|NCT00689104|69606368|FG000|Overall Study|Physician Decision|1|||
37919744|NCT00689104|69606369|FG001|Overall Study|Physician Decision|0|||
37735117|NCT01903837|69215495|FG001|Part B|Lost to Follow-up|3|||
37735118|NCT01903837|69215496|FG002|Part B|Lost to Follow-up|3|||
37919745|NCT00689104|69606370|FG002|Overall Study|Physician Decision|0|||
37919746|NCT00689104|69606371|FG003|Overall Study|Physician Decision|0|||
37919747|NCT00689104|69606368|FG000|Overall Study|Non-compliance with study procedures|0|||
37919748|NCT00689104|69606369|FG001|Overall Study|Non-compliance with study procedures|0|||
37735119|NCT01903837|69215497|FG003|Part B|Lost to Follow-up|4|||
37919749|NCT00689104|69606370|FG002|Overall Study|Non-compliance with study procedures|1|||
37919750|NCT00689104|69606371|FG003|Overall Study|Non-compliance with study procedures|0|||
38029473|NCT00027027|69714967|FG001|Overall Study|Adverse Event|0|||
38029474|NCT00027027|69714968|FG002|Overall Study|Adverse Event|1|||
38029475|NCT00027027|69714969|FG003|Overall Study|Adverse Event|0|||
38029476|NCT00027027|69714970|FG004|Overall Study|Adverse Event|1|||
38029477|NCT00027027|69714966|FG000|Overall Study|Admitted for Signs of PD|0|||
38029478|NCT00027027|69714967|FG001|Overall Study|Admitted for Signs of PD|0|||
38029479|NCT00027027|69714968|FG002|Overall Study|Admitted for Signs of PD|0|||
38029480|NCT00027027|69714969|FG003|Overall Study|Admitted for Signs of PD|0|||
38029481|NCT00027027|69714970|FG004|Overall Study|Admitted for Signs of PD|1|||
38029482|NCT00027027|69714966|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
38029483|NCT00027027|69714967|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
38029484|NCT00027027|69714968|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
38029485|NCT00027027|69714969|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
38029486|NCT00027027|69714970|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
38029487|NCT00027027|69714966|FG000|Overall Study|PD Requiring Surgery|0|||
38029488|NCT00027027|69714967|FG001|Overall Study|PD Requiring Surgery|0|||
38029489|NCT00027027|69714968|FG002|Overall Study|PD Requiring Surgery|1|||
38029490|NCT00027027|69714969|FG003|Overall Study|PD Requiring Surgery|0|||
38029491|NCT00027027|69714970|FG004|Overall Study|PD Requiring Surgery|0|||
38029492|NCT00027027|69714966|FG000|Overall Study|Physician Decision Due To PD|2|||
38029493|NCT00027027|69714967|FG001|Overall Study|Physician Decision Due To PD|3|||
38029494|NCT00027027|69714968|FG002|Overall Study|Physician Decision Due To PD|2|||
38029495|NCT00027027|69714969|FG003|Overall Study|Physician Decision Due To PD|3|||
38029496|NCT00027027|69714970|FG004|Overall Study|Physician Decision Due To PD|5|||
38029497|NCT00027027|69714966|FG000|Overall Study|Withdrawal by Subject|0|||
38029498|NCT00027027|69714967|FG001|Overall Study|Withdrawal by Subject|0|||
38029499|NCT00027027|69714968|FG002|Overall Study|Withdrawal by Subject|0|||
38029500|NCT00027027|69714969|FG003|Overall Study|Withdrawal by Subject|0|||
38029501|NCT00027027|69714970|FG004|Overall Study|Withdrawal by Subject|1|||
38029502|NCT00046839|69714988|FG000|Overall Study|Ineligible / No protocol treatment|0|||
38029503|NCT00046839|69714989|FG001|Overall Study|Ineligible / No protocol treatment|2|||
38029504|NCT00046839|69714988|FG000|Overall Study|Withdrawal of consent|1|||
38029505|NCT00046839|69714989|FG001|Overall Study|Withdrawal of consent|0|||
38029506|NCT00006903|69714998|FG000|Overall Study|Still receiving treatment|0|||
38029507|NCT00006903|69714999|FG001|Overall Study|Still receiving treatment|0|||
38029508|NCT00006903|69715000|FG002|Overall Study|Still receiving treatment|1|||
38029509|NCT00006903|69714998|FG000|Overall Study|Refused further treatment|0|||
38029510|NCT00006903|69714999|FG001|Overall Study|Refused further treatment|2|||
38029511|NCT00006903|69715000|FG002|Overall Study|Refused further treatment|1|||
38029512|NCT00006903|69714998|FG000|Overall Study|Adverse Event|0|||
38029513|NCT00006903|69714999|FG001|Overall Study|Adverse Event|0|||
37850708|NCT04868890|69534537|FG001|Overall Study|Death|1|||
37850709|NCT04868890|69534536|FG000|Overall Study|Withdrawal by Subject|1|||
37850710|NCT04868890|69534537|FG001|Overall Study|Withdrawal by Subject|5|||
37850711|NCT01281189|69534545|FG000|Overall Study|Adverse Event|7|||
37850712|NCT01281189|69534546|FG001|Overall Study|Adverse Event|9|||
37850713|NCT01281189|69534545|FG000|Overall Study|Lost to Follow-up|6|||
37850714|NCT01281189|69534546|FG001|Overall Study|Lost to Follow-up|4|||
37850715|NCT01281189|69534545|FG000|Overall Study|Withdrawal by Subject|21|||
37850716|NCT01281189|69534546|FG001|Overall Study|Withdrawal by Subject|24|||
37850717|NCT01281189|69534545|FG000|Overall Study|Physician Decision|2|||
37850718|NCT01281189|69534546|FG001|Overall Study|Physician Decision|3|||
37919751|NCT00689026|69606383|FG000|Overall Study|Withdrawal by Subject|13|||
38029514|NCT00006903|69715000|FG002|Overall Study|Adverse Event|1|||
37850719|NCT01281189|69534545|FG000|Overall Study|Death|103|||
37850720|NCT01281189|69534546|FG001|Overall Study|Death|91|||
38029515|NCT00006903|69714998|FG000|Overall Study|Death|0|||
38029516|NCT00006903|69714999|FG001|Overall Study|Death|1|||
38029517|NCT00006903|69715000|FG002|Overall Study|Death|0|||
38029518|NCT00006903|69714998|FG000|Overall Study|Patient never treated|0|||
38029519|NCT00006903|69714999|FG001|Overall Study|Patient never treated|0|||
37850721|NCT01281189|69534545|FG000|Overall Study|Other|8|||
37850722|NCT01281189|69534546|FG001|Overall Study|Other|12|||
37850723|NCT01280955|69534552|FG000|Overall Study|Death|2|||
37850724|NCT01280955|69534552|FG000|Overall Study|Withdrawal by Subject|1|||
38029520|NCT00006903|69715000|FG002|Overall Study|Patient never treated|1|||
38029521|NCT00006903|69714998|FG000|Overall Study|Ineligible|10|||
38029522|NCT00006903|69714999|FG001|Overall Study|Ineligible|1|||
38029523|NCT00006903|69715000|FG002|Overall Study|Ineligible|2|||
38029524|NCT00026793|69715008|FG000|Overall Study|Death on study due to underlying disease|4|||
37735120|NCT01903837|69215494|FG000|Part B|Withdrawal by Subject|1|||
37735121|NCT01903837|69215495|FG001|Part B|Withdrawal by Subject|2|||
37735122|NCT01903837|69215496|FG002|Part B|Withdrawal by Subject|0|||
37850725|NCT01280721|69534558|FG000|Overall Study|Adverse Event|4|||
37850726|NCT01280721|69534558|FG000|Overall Study|Physician Decision|3|||
37850727|NCT01280721|69534558|FG000|Overall Study|Withdrawal by Subject|6|||
37850728|NCT01280721|69534558|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
37850729|NCT01280721|69534558|FG000|Overall Study|No tolerability for the lowest dose|2|||
37850730|NCT01087762|69534576|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
37850731|NCT01087762|69534577|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
37850732|NCT01087762|69534578|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
37850733|NCT01087762|69534579|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
37850734|NCT01087762|69534580|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
37850735|NCT01087762|69534576|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
37850736|NCT01087762|69534577|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
37735123|NCT01903837|69215497|FG003|Part B|Withdrawal by Subject|3|||
37735124|NCT01903837|69215494|FG000|Part B|Adverse Event|3|||
37735125|NCT01903837|69215495|FG001|Part B|Adverse Event|0|||
37735126|NCT01903837|69215496|FG002|Part B|Adverse Event|2|||
37735127|NCT01903837|69215497|FG003|Part B|Adverse Event|0|||
37735128|NCT01903837|69215494|FG000|Part B|Non-compliance with study drug|2|||
37735129|NCT01903837|69215495|FG001|Part B|Non-compliance with study drug|0|||
37735130|NCT01903837|69215496|FG002|Part B|Non-compliance with study drug|0|||
37735131|NCT01903837|69215497|FG003|Part B|Non-compliance with study drug|1|||
37735132|NCT01903837|69215494|FG000|Part B|Incarceration|2|||
37735133|NCT01903837|69215495|FG001|Part B|Incarceration|0|||
37735134|NCT01903837|69215496|FG002|Part B|Incarceration|0|||
37735135|NCT01903837|69215497|FG003|Part B|Incarceration|1|||
37735136|NCT01903837|69215494|FG000|Part B|Physician Decision|1|||
37735137|NCT01903837|69215495|FG001|Part B|Physician Decision|0|||
37735138|NCT01903837|69215496|FG002|Part B|Physician Decision|0|||
37735139|NCT01903837|69215497|FG003|Part B|Physician Decision|2|||
37735140|NCT01903837|69215494|FG000|Part B|Lack of Efficacy|0|||
37735141|NCT01903837|69215495|FG001|Part B|Lack of Efficacy|1|||
37735142|NCT01903837|69215496|FG002|Part B|Lack of Efficacy|0|||
37735143|NCT01903837|69215497|FG003|Part B|Lack of Efficacy|0|||
37735144|NCT01903525|69215530|FG000|Overall Study|Lost to Follow-up|5|||
37735145|NCT01903525|69215531|FG001|Overall Study|Lost to Follow-up|9|||
37735146|NCT01903525|69215530|FG000|Overall Study|Adverse Event|0|||
37735147|NCT01903525|69215531|FG001|Overall Study|Adverse Event|1|||
37735148|NCT00981526|69215539|FG000|Overall Study|Withdrawal by Subject|0|||
37735149|NCT00981526|69215540|FG001|Overall Study|Withdrawal by Subject|2|||
37735150|NCT00981526|69215539|FG000|Overall Study|Physician Decision|4|||
37735151|NCT00981526|69215540|FG001|Overall Study|Physician Decision|4|||
37735152|NCT01927861|69215550|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
37735153|NCT01927861|69215551|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
37735154|NCT01927861|69215550|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
37735155|NCT01927861|69215551|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
37735156|NCT01927627|69215557|FG000|Overall Study|Adverse Event|3|||
37735157|NCT01927627|69215557|FG000|Overall Study|Lack of Efficacy|1|||
37735158|NCT01927627|69215557|FG000|Overall Study|Financial Concerns|1|||
37735159|NCT01889251|69215563|FG000|Overall Study|Adverse Event|1|||
37735160|NCT01889251|69215564|FG001|Overall Study|Adverse Event|0|||
37735161|NCT01616563|69215570|FG000|Overall Study|Lost to Follow-up|40|||
37735162|NCT01616173|69215578|FG000|Overall Study|Lost to Follow-up|0|||
37735163|NCT01616173|69215579|FG001|Overall Study|Lost to Follow-up|2|||
37735164|NCT01616173|69215580|FG002|Overall Study|Lost to Follow-up|0|||
37735165|NCT01544595|69215594|FG000|Status at Week 68|Adverse Event|3|||
37735166|NCT01544595|69215595|FG001|Status at Week 68|Adverse Event|2|||
37850737|NCT01087762|69534578|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
37850738|NCT01087762|69534579|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
37919752|NCT00689026|69606384|FG001|Overall Study|Withdrawal by Subject|6|||
37919753|NCT00598559|69606393|FG000|Overall Study|Adverse Event|11|||
37735167|NCT01544595|69215596|FG002|Status at Week 68|Adverse Event|1|||
37735168|NCT01544595|69215597|FG003|Status at Week 68|Adverse Event|0|||
37735169|NCT01544595|69215598|FG004|Status at Week 68|Adverse Event|0|||
37735170|NCT01544595|69215599|FG005|Status at Week 68|Adverse Event|0|||
37735171|NCT01544595|69215594|FG000|Status at Week 68|Lack of Efficacy|1|||
37735172|NCT01544595|69215595|FG001|Status at Week 68|Lack of Efficacy|0|||
37735173|NCT01544595|69215596|FG002|Status at Week 68|Lack of Efficacy|0|||
37735174|NCT01544595|69215597|FG003|Status at Week 68|Lack of Efficacy|0|||
37735175|NCT01544595|69215598|FG004|Status at Week 68|Lack of Efficacy|0|||
37850739|NCT01087762|69534580|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
37919754|NCT00598559|69606394|FG001|Overall Study|Adverse Event|7|||
38029525|NCT00026793|69715008|FG000|Overall Study|Physician Decision|2|||
38029526|NCT00026793|69715008|FG000|Overall Study|Off study|2|||
38029527|NCT03539484|69715019|FG000|Overall Study|Death|1|||
38029528|NCT03539484|69715020|FG001|Overall Study|Death|0|||
38029529|NCT03539484|69715021|FG002|Overall Study|Death|0|||
38029530|NCT03539484|69715022|FG003|Overall Study|Death|2|||
38029531|NCT03539484|69715023|FG004|Overall Study|Death|8|||
38029532|NCT03539484|69715024|FG005|Overall Study|Death|3|||
38029533|NCT03539484|69715025|FG006|Overall Study|Death|0|||
38029534|NCT03539484|69715019|FG000|Overall Study|Lost to Follow-up|0|||
38029535|NCT03539484|69715020|FG001|Overall Study|Lost to Follow-up|1|||
38029536|NCT03539484|69715021|FG002|Overall Study|Lost to Follow-up|0|||
38029537|NCT03539484|69715022|FG003|Overall Study|Lost to Follow-up|0|||
38029538|NCT03539484|69715023|FG004|Overall Study|Lost to Follow-up|1|||
38029539|NCT03539484|69715024|FG005|Overall Study|Lost to Follow-up|0|||
38029540|NCT03539484|69715025|FG006|Overall Study|Lost to Follow-up|0|||
38029541|NCT03539484|69715019|FG000|Overall Study|Withdrawal by Subject|0|||
38029542|NCT03539484|69715020|FG001|Overall Study|Withdrawal by Subject|0|||
38029543|NCT03539484|69715021|FG002|Overall Study|Withdrawal by Subject|0|||
37735176|NCT01544595|69215599|FG005|Status at Week 68|Lack of Efficacy|0|||
37735177|NCT01544595|69215594|FG000|Status at Week 68|Lost to Follow-up|1|||
37735178|NCT01544595|69215595|FG001|Status at Week 68|Lost to Follow-up|1|||
37735179|NCT01544595|69215596|FG002|Status at Week 68|Lost to Follow-up|0|||
37735180|NCT01544595|69215597|FG003|Status at Week 68|Lost to Follow-up|0|||
37735181|NCT01544595|69215598|FG004|Status at Week 68|Lost to Follow-up|0|||
37735182|NCT01544595|69215599|FG005|Status at Week 68|Lost to Follow-up|0|||
37735183|NCT01544595|69215594|FG000|Status at Week 68|Non-compliance with study treatment|1|||
37735184|NCT01544595|69215595|FG001|Status at Week 68|Non-compliance with study treatment|0|||
37735185|NCT01544595|69215596|FG002|Status at Week 68|Non-compliance with study treatment|0|||
37735186|NCT01544595|69215597|FG003|Status at Week 68|Non-compliance with study treatment|1|||
37735187|NCT01544595|69215598|FG004|Status at Week 68|Non-compliance with study treatment|0|||
37735188|NCT01544595|69215599|FG005|Status at Week 68|Non-compliance with study treatment|0|||
37735189|NCT01544595|69215594|FG000|Status at Week 68|Protocol Violation|2|||
37735190|NCT01544595|69215595|FG001|Status at Week 68|Protocol Violation|0|||
37735191|NCT01544595|69215596|FG002|Status at Week 68|Protocol Violation|1|||
37735192|NCT01544595|69215597|FG003|Status at Week 68|Protocol Violation|1|||
37735193|NCT01544595|69215598|FG004|Status at Week 68|Protocol Violation|0|||
37735194|NCT01544595|69215599|FG005|Status at Week 68|Protocol Violation|0|||
37735195|NCT01544595|69215594|FG000|Status at Week 68|Technical problems|1|||
37735196|NCT01544595|69215595|FG001|Status at Week 68|Technical problems|0|||
37735197|NCT01544595|69215596|FG002|Status at Week 68|Technical problems|0|||
37735198|NCT01544595|69215597|FG003|Status at Week 68|Technical problems|1|||
37735199|NCT01544595|69215598|FG004|Status at Week 68|Technical problems|0|||
37735200|NCT01544595|69215599|FG005|Status at Week 68|Technical problems|0|||
37735201|NCT01544595|69215594|FG000|Status at Week 68|Withdrawal by Subject|0|||
37735202|NCT01544595|69215595|FG001|Status at Week 68|Withdrawal by Subject|1|||
37735203|NCT01544595|69215596|FG002|Status at Week 68|Withdrawal by Subject|1|||
37735204|NCT01544595|69215597|FG003|Status at Week 68|Withdrawal by Subject|2|||
37735205|NCT01544595|69215598|FG004|Status at Week 68|Withdrawal by Subject|0|||
37735206|NCT01544595|69215599|FG005|Status at Week 68|Withdrawal by Subject|0|||
37735207|NCT01544595|69215594|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
37735208|NCT01544595|69215595|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
37735209|NCT01544595|69215596|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
37735210|NCT01544595|69215597|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
37735211|NCT01544595|69215598|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
37735212|NCT01544595|69215599|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
37735213|NCT01544595|69215594|FG000|Status at Week 156|Withdrawal by Subject|9|||
37735214|NCT01544595|69215595|FG001|Status at Week 156|Withdrawal by Subject|10|||
37735215|NCT01544595|69215596|FG002|Status at Week 156|Withdrawal by Subject|4|||
37735216|NCT01544595|69215597|FG003|Status at Week 156|Withdrawal by Subject|9|||
37735217|NCT01544595|69215598|FG004|Status at Week 156|Withdrawal by Subject|20|||
37735218|NCT01544595|69215599|FG005|Status at Week 156|Withdrawal by Subject|6|||
37735219|NCT01544595|69215594|FG000|Status at Week 156|Adverse Event|9|||
37735220|NCT01544595|69215595|FG001|Status at Week 156|Adverse Event|11|||
37735221|NCT01544595|69215596|FG002|Status at Week 156|Adverse Event|1|||
37735222|NCT01544595|69215597|FG003|Status at Week 156|Adverse Event|3|||
37735223|NCT01544595|69215598|FG004|Status at Week 156|Adverse Event|4|||
37735224|NCT01544595|69215599|FG005|Status at Week 156|Adverse Event|2|||
37735225|NCT01544595|69215594|FG000|Status at Week 156|Lost to Follow-up|4|||
37735226|NCT01544595|69215595|FG001|Status at Week 156|Lost to Follow-up|4|||
37850740|NCT01087762|69534576|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
37850741|NCT01087762|69534577|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
37850742|NCT01087762|69534578|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
37850743|NCT01087762|69534579|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
37850744|NCT01087762|69534580|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
37919755|NCT00598559|69606395|FG002|Overall Study|Adverse Event|0|||
37919756|NCT00598559|69606393|FG000|Overall Study|Withdrawal by Subject|2|||
37919757|NCT00598559|69606394|FG001|Overall Study|Withdrawal by Subject|2|||
37919758|NCT00598559|69606395|FG002|Overall Study|Withdrawal by Subject|0|||
37919759|NCT00598559|69606393|FG000|Overall Study|Protocol Non-compliance|1|||
37919760|NCT00598559|69606394|FG001|Overall Study|Protocol Non-compliance|0|||
37919761|NCT00598559|69606395|FG002|Overall Study|Protocol Non-compliance|0|||
37919762|NCT00598559|69606393|FG000|Overall Study|Early discharge from hospital|9|||
37919763|NCT00598559|69606394|FG001|Overall Study|Early discharge from hospital|12|||
37919764|NCT00598559|69606395|FG002|Overall Study|Early discharge from hospital|3|||
37919765|NCT00598559|69606393|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
37919766|NCT00598559|69606394|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
37919767|NCT00598559|69606395|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
37919768|NCT00686686|69606403|FG000|Overall Study|Non-compliance|1|||
37919769|NCT00686686|69606403|FG000|Overall Study|Adverse Event|2|||
37919770|NCT00686686|69606403|FG000|Overall Study|Lost to Follow-up|3|||
37919771|NCT04160195|69606409|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
37919772|NCT04160195|69606410|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
37919773|NCT00686374|69606418|FG000|Overall Study|Lack of Efficacy|10|||
37919774|NCT00686374|69606418|FG000|Overall Study|Adverse Event|8|||
37919775|NCT00686374|69606418|FG000|Overall Study|Withdrew consent|5|||
37850745|NCT01087762|69534576|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
37850746|NCT01087762|69534577|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
37850747|NCT01087762|69534578|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
37850748|NCT01087762|69534579|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
37735227|NCT01544595|69215596|FG002|Status at Week 156|Lost to Follow-up|0|||
37735228|NCT01544595|69215597|FG003|Status at Week 156|Lost to Follow-up|1|||
37735229|NCT01544595|69215598|FG004|Status at Week 156|Lost to Follow-up|4|||
37735230|NCT01544595|69215599|FG005|Status at Week 156|Lost to Follow-up|1|||
37850749|NCT01087762|69534580|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
37850750|NCT01087762|69534576|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
37850751|NCT01087762|69534577|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
37735231|NCT01544595|69215594|FG000|Status at Week 156|Non-compliance with study treatement|0|||
37735232|NCT01544595|69215595|FG001|Status at Week 156|Non-compliance with study treatement|1|||
37850752|NCT01087762|69534578|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
37850753|NCT01087762|69534579|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
37850754|NCT01087762|69534580|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
37850755|NCT01087762|69534576|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
37850756|NCT01087762|69534577|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
37850757|NCT01087762|69534578|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
37850758|NCT01087762|69534579|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
37850759|NCT01087762|69534580|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
37850760|NCT01087762|69534576|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
37850761|NCT01087762|69534577|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
37850762|NCT01087762|69534578|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
37850763|NCT01087762|69534579|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
37850764|NCT01087762|69534580|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
37850765|NCT01087762|69534576|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
37850766|NCT01087762|69534577|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
37850767|NCT01087762|69534578|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
37850768|NCT01087762|69534579|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
37850769|NCT01087762|69534580|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
37735233|NCT01544595|69215596|FG002|Status at Week 156|Non-compliance with study treatement|0|||
37735234|NCT01544595|69215597|FG003|Status at Week 156|Non-compliance with study treatement|1|||
37735235|NCT01544595|69215598|FG004|Status at Week 156|Non-compliance with study treatement|0|||
37735236|NCT01544595|69215599|FG005|Status at Week 156|Non-compliance with study treatement|1|||
37735237|NCT01544595|69215594|FG000|Status at Week 156|Physician Decision|0|||
37735238|NCT01544595|69215595|FG001|Status at Week 156|Physician Decision|3|||
37735239|NCT01544595|69215596|FG002|Status at Week 156|Physician Decision|1|||
37735240|NCT01544595|69215597|FG003|Status at Week 156|Physician Decision|0|||
37735241|NCT01544595|69215598|FG004|Status at Week 156|Physician Decision|0|||
37735242|NCT01544595|69215599|FG005|Status at Week 156|Physician Decision|0|||
37735243|NCT01544595|69215594|FG000|Status at Week 156|Pregnancy|2|||
37850770|NCT01087762|69534576|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
37850771|NCT01087762|69534577|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
37850772|NCT01087762|69534578|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
37850773|NCT01087762|69534579|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
37850774|NCT01087762|69534580|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
37850775|NCT01087762|69534576|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
37850776|NCT01087762|69534577|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
37850777|NCT01087762|69534578|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
37850778|NCT01087762|69534579|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
37850779|NCT01087762|69534580|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
37850780|NCT01087762|69534576|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
37850781|NCT01087762|69534577|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
37850782|NCT01087762|69534578|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
37850783|NCT01087762|69534579|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
37850784|NCT01087762|69534580|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
37850785|NCT01087762|69534576|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
37850786|NCT01087762|69534577|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
37850787|NCT01087762|69534578|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
37850788|NCT01087762|69534579|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
37850789|NCT01087762|69534580|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
37850790|NCT01087762|69534576|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
37850791|NCT01087762|69534577|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
37850792|NCT01087762|69534578|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
37850793|NCT01087762|69534579|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
37850794|NCT01087762|69534580|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
37850795|NCT01078168|69534592|FG000|Overall Study|Physician Decision|0|||
37850796|NCT01078168|69534593|FG001|Overall Study|Physician Decision|1|||
37850797|NCT01086358|69534599|FG000|First Intervention|Lost to Follow-up|9|||
37850798|NCT01086358|69534600|FG001|First Intervention|Lost to Follow-up|4|||
37850799|NCT01086358|69534599|FG000|First Intervention|Withdrawal by Subject|0|||
37850800|NCT01086358|69534600|FG001|First Intervention|Withdrawal by Subject|1|||
37850801|NCT01086358|69534599|FG000|Second Intervention|Lost to Follow-up|4|||
37850802|NCT01086358|69534600|FG001|Second Intervention|Lost to Follow-up|4|||
37850803|NCT01277601|69534610|FG000|Overall Study|Adverse Event|5|||
37850804|NCT01277601|69534611|FG001|Overall Study|Adverse Event|3|||
37850805|NCT01277601|69534612|FG002|Overall Study|Adverse Event|0|||
37850806|NCT01277601|69534613|FG003|Overall Study|Adverse Event|7|||
37850807|NCT01277601|69534610|FG000|Overall Study|Withdrawal by Subject|18|||
37850808|NCT01277601|69534611|FG001|Overall Study|Withdrawal by Subject|21|||
37850809|NCT01277601|69534612|FG002|Overall Study|Withdrawal by Subject|8|||
38029544|NCT03539484|69715022|FG003|Overall Study|Withdrawal by Subject|0|||
38029545|NCT03539484|69715023|FG004|Overall Study|Withdrawal by Subject|2|||
38029546|NCT03539484|69715024|FG005|Overall Study|Withdrawal by Subject|0|||
38029547|NCT03539484|69715025|FG006|Overall Study|Withdrawal by Subject|1|||
38029548|NCT03539484|69715019|FG000|Overall Study|Study Terminated by Sponsor|0|||
37850810|NCT01277601|69534613|FG003|Overall Study|Withdrawal by Subject|17|||
38029549|NCT03539484|69715020|FG001|Overall Study|Study Terminated by Sponsor|0|||
38029550|NCT03539484|69715021|FG002|Overall Study|Study Terminated by Sponsor|1|||
38029551|NCT03539484|69715022|FG003|Overall Study|Study Terminated by Sponsor|1|||
38029552|NCT03539484|69715023|FG004|Overall Study|Study Terminated by Sponsor|2|||
38029553|NCT03539484|69715024|FG005|Overall Study|Study Terminated by Sponsor|2|||
38029554|NCT03539484|69715025|FG006|Overall Study|Study Terminated by Sponsor|1|||
38029555|NCT03561090|69715048|FG000|Overall Study|Adverse Event|11|||
38029556|NCT03561090|69715049|FG001|Overall Study|Adverse Event|7|||
38029557|NCT03561090|69715048|FG000|Overall Study|Non-Compliance With Study Drug|2|||
38029558|NCT03561090|69715049|FG001|Overall Study|Non-Compliance With Study Drug|0|||
38029559|NCT03561090|69715048|FG000|Overall Study|Protocol Violation|2|||
38029560|NCT03561090|69715049|FG001|Overall Study|Protocol Violation|2|||
38029561|NCT03561090|69715048|FG000|Overall Study|Withdrawal by Subject|7|||
38029562|NCT03561090|69715049|FG001|Overall Study|Withdrawal by Subject|7|||
38029563|NCT03561090|69715048|FG000|Overall Study|Lost to Follow-up|7|||
37735244|NCT01544595|69215595|FG001|Status at Week 156|Pregnancy|3|||
37919776|NCT00686374|69606418|FG000|Overall Study|Lost to Follow-up|1|||
37919777|NCT00686374|69606418|FG000|Overall Study|Missing reason|33|||
37919778|NCT00686374|69606418|FG000|Overall Study|Other, not specified|4|||
37919779|NCT00571948|69606424|FG000|Overall Study|Lost to Follow-up|2|||
37919780|NCT00571948|69606425|FG001|Overall Study|Lost to Follow-up|0|||
37919781|NCT00571948|69606424|FG000|Overall Study|Withdrawal by Subject|1|||
37919782|NCT00571948|69606425|FG001|Overall Study|Withdrawal by Subject|2|||
37919783|NCT00571948|69606424|FG000|Overall Study|Protocol Violation|3|||
37919784|NCT00571948|69606425|FG001|Overall Study|Protocol Violation|3|||
37919785|NCT00571948|69606424|FG000|Overall Study|infant refused study meal|3|||
37919786|NCT00571948|69606425|FG001|Overall Study|infant refused study meal|4|||
37919787|NCT00571948|69606424|FG000|Overall Study|Parent were afraid of blood colection|2|||
37919788|NCT00571948|69606425|FG001|Overall Study|Parent were afraid of blood colection|5|||
37919789|NCT00684424|69606431|FG000|Overall Study|Adverse Event|1|||
37919790|NCT00684424|69606431|FG000|Overall Study|Lost to Follow-up|2|||
37919791|NCT00684424|69606431|FG000|Overall Study|Other|2|||
37919792|NCT00685750|69606443|FG000|Overall Study|Tumor sampling failure|0|||
37919793|NCT00685750|69606444|FG001|Overall Study|Tumor sampling failure|0|||
37919794|NCT00685750|69606445|FG002|Overall Study|Tumor sampling failure|1|||
37919795|NCT00685750|69606446|FG003|Overall Study|Tumor sampling failure|0|||
37919796|NCT00685750|69606447|FG004|Overall Study|Tumor sampling failure|0|||
37919797|NCT00685750|69606448|FG005|Overall Study|Tumor sampling failure|0|||
37735245|NCT01544595|69215596|FG002|Status at Week 156|Pregnancy|0|||
37735246|NCT01544595|69215597|FG003|Status at Week 156|Pregnancy|0|||
37735247|NCT01544595|69215598|FG004|Status at Week 156|Pregnancy|0|||
37735248|NCT01544595|69215599|FG005|Status at Week 156|Pregnancy|0|||
37735249|NCT01544595|69215594|FG000|Status at Week 156|Protocol Violation|3|||
37735250|NCT01544595|69215595|FG001|Status at Week 156|Protocol Violation|1|||
37735251|NCT01544595|69215596|FG002|Status at Week 156|Protocol Violation|2|||
37735252|NCT01544595|69215597|FG003|Status at Week 156|Protocol Violation|2|||
37735253|NCT01544595|69215598|FG004|Status at Week 156|Protocol Violation|0|||
37735254|NCT01544595|69215599|FG005|Status at Week 156|Protocol Violation|0|||
37735255|NCT01544595|69215594|FG000|Status at Week 156|Technical problems|3|||
37735256|NCT01544595|69215595|FG001|Status at Week 156|Technical problems|1|||
37735257|NCT01544595|69215596|FG002|Status at Week 156|Technical problems|0|||
37735258|NCT01544595|69215597|FG003|Status at Week 156|Technical problems|1|||
37919798|NCT00685750|69606449|FG006|Overall Study|Tumor sampling failure|0|||
37919799|NCT00685750|69606443|FG000|Overall Study|Patient didn't receive the treatment|0|||
37919800|NCT00685750|69606444|FG001|Overall Study|Patient didn't receive the treatment|0|||
37735259|NCT01544595|69215598|FG004|Status at Week 156|Technical problems|0|||
37735260|NCT01544595|69215599|FG005|Status at Week 156|Technical problems|0|||
37735261|NCT01544595|69215594|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
37735262|NCT01544595|69215595|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
37735263|NCT01544595|69215596|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
37735264|NCT01544595|69215597|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
37735265|NCT01544595|69215598|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
37735266|NCT01544595|69215599|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
37735267|NCT01544595|69215594|FG000|Status at Week 156|Lack of Efficacy|1|||
37735268|NCT01544595|69215595|FG001|Status at Week 156|Lack of Efficacy|0|||
37735269|NCT01544595|69215596|FG002|Status at Week 156|Lack of Efficacy|1|||
37735270|NCT01544595|69215597|FG003|Status at Week 156|Lack of Efficacy|4|||
37735271|NCT01544595|69215598|FG004|Status at Week 156|Lack of Efficacy|10|||
37735272|NCT01544595|69215599|FG005|Status at Week 156|Lack of Efficacy|5|||
37735273|NCT01539525|69215620|FG000|Overall Study|Lost to Follow-up|19|||
37735274|NCT01539525|69215621|FG001|Overall Study|Lost to Follow-up|12|||
37735275|NCT01539525|69215622|FG002|Overall Study|Lost to Follow-up|11|||
37735276|NCT01539525|69215620|FG000|Overall Study|Withdrawal by Subject|0|||
37735277|NCT01539525|69215621|FG001|Overall Study|Withdrawal by Subject|3|||
37735278|NCT01539525|69215622|FG002|Overall Study|Withdrawal by Subject|2|||
37735279|NCT01539525|69215620|FG000|Overall Study|Protocol Violation|1|||
37919801|NCT00685750|69606445|FG002|Overall Study|Patient didn't receive the treatment|0|||
37919802|NCT00685750|69606446|FG003|Overall Study|Patient didn't receive the treatment|0|||
37919803|NCT00685750|69606447|FG004|Overall Study|Patient didn't receive the treatment|0|||
37919804|NCT00685750|69606448|FG005|Overall Study|Patient didn't receive the treatment|0|||
37919805|NCT00685750|69606449|FG006|Overall Study|Patient didn't receive the treatment|1|||
37919806|NCT00685750|69606443|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
37919807|NCT00685750|69606444|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
37919808|NCT00685750|69606445|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
37919809|NCT00685750|69606446|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
37919810|NCT00685750|69606447|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
37919811|NCT00685750|69606448|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
37919812|NCT00685750|69606449|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
37919813|NCT00576628|69606469|FG000|Overall Study|Adverse Event|11|||
37919814|NCT00576628|69606469|FG000|Overall Study|Death|2|||
37919815|NCT00576628|69606469|FG000|Overall Study|Failure to return|1|||
37919816|NCT00576628|69606469|FG000|Overall Study|Refused Treatment|8|||
37919817|NCT00576628|69606469|FG000|Overall Study|Pregnancy|1|||
37919818|NCT00576628|69606469|FG000|Overall Study|RBC transfusion|1|||
37919819|NCT00576628|69606469|FG000|Overall Study|Progression of Kidney Disease|1|||
37919820|NCT00576628|69606469|FG000|Overall Study|Progression of Renal Failure|1|||
37735280|NCT01539525|69215621|FG001|Overall Study|Protocol Violation|1|||
37735281|NCT01539525|69215622|FG002|Overall Study|Protocol Violation|4|||
37735282|NCT01513551|69215636|FG000|Overall Study|Death|0|||
37735283|NCT01513551|69215637|FG001|Overall Study|Death|1|||
37735284|NCT01513551|69215638|FG002|Overall Study|Death|0|||
37735285|NCT01513551|69215636|FG000|Overall Study|Lost to Follow-up|3|||
37735286|NCT01513551|69215637|FG001|Overall Study|Lost to Follow-up|5|||
37735287|NCT01513551|69215638|FG002|Overall Study|Lost to Follow-up|2|||
37735288|NCT01513551|69215636|FG000|Overall Study|Withdrawal by Subject|1|||
37735289|NCT01513551|69215637|FG001|Overall Study|Withdrawal by Subject|0|||
37735290|NCT01513551|69215638|FG002|Overall Study|Withdrawal by Subject|2|||
37735291|NCT01513551|69215636|FG000|Overall Study|Randomized but not vaccinated|0|||
37735292|NCT01513551|69215637|FG001|Overall Study|Randomized but not vaccinated|0|||
37735293|NCT01513551|69215638|FG002|Overall Study|Randomized but not vaccinated|1|||
37735294|NCT01513473|69215648|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
37735295|NCT01513473|69215649|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
37735296|NCT01513473|69215648|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
37850811|NCT01277601|69534610|FG000|Overall Study|Lost to Follow-up|7|||
37850812|NCT01277601|69534611|FG001|Overall Study|Lost to Follow-up|9|||
37850813|NCT01277601|69534612|FG002|Overall Study|Lost to Follow-up|4|||
37850814|NCT01277601|69534613|FG003|Overall Study|Lost to Follow-up|2|||
37850815|NCT01277601|69534610|FG000|Overall Study|Physician Decision|3|||
37850816|NCT01277601|69534611|FG001|Overall Study|Physician Decision|5|||
37850817|NCT01277601|69534612|FG002|Overall Study|Physician Decision|1|||
37850818|NCT01277601|69534613|FG003|Overall Study|Physician Decision|6|||
37850819|NCT01277601|69534610|FG000|Overall Study|Pregnancy|2|||
37919821|NCT00576628|69606469|FG000|Overall Study|The patient move into other town|1|||
37735297|NCT01513473|69215649|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
37735298|NCT01513473|69215648|FG000|Main Trial (26 Weeks)|Unclassified|0|||
37735299|NCT01513473|69215649|FG001|Main Trial (26 Weeks)|Unclassified|2|||
37735300|NCT01513473|69215648|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
37735301|NCT01513473|69215649|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
37850820|NCT01277601|69534611|FG001|Overall Study|Pregnancy|2|||
37735302|NCT01513473|69215648|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
37735303|NCT01513473|69215649|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
37919822|NCT00576628|69606469|FG000|Overall Study|Transplantation|1|||
37919823|NCT00576628|69606469|FG000|Overall Study|Dialysis|15|||
37735304|NCT01513317|69215657|FG000|Overall Study|Withdrawal by Subject|15|||
37735305|NCT01513317|69215658|FG001|Overall Study|Withdrawal by Subject|4|||
37735306|NCT01513317|69215657|FG000|Overall Study|Death|1|||
37735307|NCT01513317|69215658|FG001|Overall Study|Death|1|||
37735308|NCT01513317|69215657|FG000|Overall Study|Study terminated by sponsor|18|||
37735309|NCT01513317|69215658|FG001|Overall Study|Study terminated by sponsor|18|||
37919824|NCT00683878|69606477|FG000|Overall Study|Lack of Efficacy|3|||
37919825|NCT00683878|69606478|FG001|Overall Study|Lack of Efficacy|0|||
37919826|NCT00683878|69606479|FG002|Overall Study|Lack of Efficacy|1|||
37919827|NCT00683878|69606477|FG000|Overall Study|Adverse Event|4|||
37919828|NCT00683878|69606478|FG001|Overall Study|Adverse Event|3|||
37919829|NCT00683878|69606479|FG002|Overall Study|Adverse Event|3|||
37919830|NCT00683878|69606477|FG000|Overall Study|Withdrawal by Subject|9|||
37919831|NCT00683878|69606478|FG001|Overall Study|Withdrawal by Subject|8|||
37919832|NCT00683878|69606479|FG002|Overall Study|Withdrawal by Subject|6|||
37735310|NCT01513317|69215657|FG000|Overall Study|Other|0|||
37735311|NCT01513317|69215658|FG001|Overall Study|Other|1|||
37735312|NCT03824392|69215668|FG000|Overall Study|Adverse Event|1|||
37735313|NCT03824392|69215669|FG001|Overall Study|Adverse Event|0|||
37735314|NCT03824392|69215670|FG002|Overall Study|Adverse Event|0|||
38029564|NCT03561090|69715049|FG001|Overall Study|Lost to Follow-up|2|||
38029565|NCT03561090|69715048|FG000|Overall Study|Study Terminated by Sponsor|10|||
38029566|NCT03561090|69715049|FG001|Overall Study|Study Terminated by Sponsor|15|||
38029567|NCT03561090|69715048|FG000|Overall Study|Randomized by Mistake|1|||
38029568|NCT03561090|69715049|FG001|Overall Study|Randomized by Mistake|1|||
38029569|NCT03561090|69715048|FG000|Overall Study|Other Not Specified|0|||
38029570|NCT03561090|69715049|FG001|Overall Study|Other Not Specified|2|||
38029571|NCT02996500|69715063|FG000|Overall Study|Adverse Event|1|||
38029572|NCT02996500|69715064|FG001|Overall Study|Adverse Event|1|||
38029573|NCT02996500|69715065|FG002|Overall Study|Adverse Event|4|||
38029574|NCT02996500|69715066|FG003|Overall Study|Adverse Event|3|||
38029575|NCT02996500|69715067|FG004|Overall Study|Adverse Event|1|||
38029576|NCT02996500|69715068|FG005|Overall Study|Adverse Event|2|||
38029577|NCT02996500|69715063|FG000|Overall Study|Lack of Efficacy|0|||
38029578|NCT02996500|69715064|FG001|Overall Study|Lack of Efficacy|0|||
38029579|NCT02996500|69715065|FG002|Overall Study|Lack of Efficacy|0|||
37735315|NCT03824392|69215671|FG003|Overall Study|Adverse Event|0|||
37735316|NCT03824392|69215668|FG000|Overall Study|Investigator Decision|0|||
37735317|NCT03824392|69215669|FG001|Overall Study|Investigator Decision|1|||
37735318|NCT03824392|69215670|FG002|Overall Study|Investigator Decision|0|||
37735319|NCT03824392|69215671|FG003|Overall Study|Investigator Decision|0|||
37735320|NCT03824392|69215668|FG000|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|2|||
37735321|NCT03824392|69215669|FG001|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
37735322|NCT03824392|69215670|FG002|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|3|||
37735323|NCT03824392|69215671|FG003|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
37735324|NCT01901653|69215694|FG000|Overall Study|Death|2|||
37735325|NCT01901653|69215695|FG001|Overall Study|Death|1|||
37735326|NCT01901653|69215696|FG002|Overall Study|Death|8|||
38029580|NCT02996500|69715066|FG003|Overall Study|Lack of Efficacy|0|||
37850821|NCT01277601|69534612|FG002|Overall Study|Pregnancy|4|||
37850822|NCT01277601|69534613|FG003|Overall Study|Pregnancy|1|||
37850823|NCT01277601|69534610|FG000|Overall Study|Noncompliance with Study Drug|1|||
37850824|NCT01277601|69534611|FG001|Overall Study|Noncompliance with Study Drug|3|||
37850825|NCT01277601|69534612|FG002|Overall Study|Noncompliance with Study Drug|2|||
38029581|NCT02996500|69715067|FG004|Overall Study|Lack of Efficacy|2|||
37850826|NCT01277601|69534613|FG003|Overall Study|Noncompliance with Study Drug|0|||
37850827|NCT01277601|69534610|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
37850828|NCT01277601|69534611|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
37850829|NCT01277601|69534612|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
37919833|NCT00683878|69606477|FG000|Overall Study|Death|0|||
37919834|NCT00683878|69606478|FG001|Overall Study|Death|1|||
37919835|NCT00683878|69606479|FG002|Overall Study|Death|0|||
37919836|NCT00683878|69606477|FG000|Overall Study|Lost to Follow-up|4|||
38029582|NCT02996500|69715068|FG005|Overall Study|Lack of Efficacy|0|||
38029583|NCT02996500|69715063|FG000|Overall Study|Lost to Follow-up|1|||
38029584|NCT02996500|69715064|FG001|Overall Study|Lost to Follow-up|0|||
38029585|NCT02996500|69715065|FG002|Overall Study|Lost to Follow-up|0|||
38029586|NCT02996500|69715066|FG003|Overall Study|Lost to Follow-up|0|||
37919837|NCT00683878|69606478|FG001|Overall Study|Lost to Follow-up|2|||
37919838|NCT00683878|69606479|FG002|Overall Study|Lost to Follow-up|4|||
37919839|NCT00683878|69606477|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
37919840|NCT00683878|69606478|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
38029587|NCT02996500|69715067|FG004|Overall Study|Lost to Follow-up|0|||
38029588|NCT02996500|69715068|FG005|Overall Study|Lost to Follow-up|1|||
38029589|NCT02996500|69715063|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
37919841|NCT00683878|69606479|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
37919842|NCT00884741|69606490|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
37919843|NCT00884741|69606491|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
37919844|NCT00884741|69606492|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
37919845|NCT00884741|69606493|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
37919846|NCT00884741|69606490|FG000|Step 1 Registration: Tissue Screening|Death|3|||
37919847|NCT00884741|69606491|FG001|Step 1 Registration: Tissue Screening|Death|0|||
37919848|NCT00884741|69606492|FG002|Step 1 Registration: Tissue Screening|Death|0|||
37919849|NCT00884741|69606493|FG003|Step 1 Registration: Tissue Screening|Death|0|||
37919850|NCT00884741|69606490|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
37919851|NCT00884741|69606491|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
37919852|NCT00884741|69606492|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
37919853|NCT00884741|69606493|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
37919854|NCT00884741|69606490|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
37919855|NCT00884741|69606491|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
37919856|NCT00884741|69606492|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
37919857|NCT00884741|69606493|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
37919858|NCT00884741|69606490|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
37919859|NCT00884741|69606491|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
37919860|NCT00884741|69606492|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
37919861|NCT00884741|69606493|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
37919862|NCT00884741|69606490|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
37919863|NCT00884741|69606491|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
37919864|NCT00884741|69606492|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
37919865|NCT00884741|69606493|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
37919866|NCT00884741|69606490|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
37919867|NCT00884741|69606491|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
37919868|NCT00884741|69606492|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
37919869|NCT00884741|69606493|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
37919870|NCT00884741|69606490|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
37919871|NCT00884741|69606491|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
37919872|NCT00884741|69606492|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
37919873|NCT00884741|69606493|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
37919874|NCT00884741|69606490|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
37919875|NCT00884741|69606491|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
37919876|NCT00884741|69606492|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
37919877|NCT00884741|69606493|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
37919878|NCT00884741|69606490|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
37919879|NCT00884741|69606491|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
37919880|NCT00884741|69606492|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
37919881|NCT00884741|69606493|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
37919882|NCT00884741|69606490|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
37919883|NCT00884741|69606491|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
37919884|NCT00884741|69606492|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
37919885|NCT00884741|69606493|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
37919886|NCT00884741|69606490|FG000|Randomization|Protocol Violation|0|||
37919887|NCT00884741|69606491|FG001|Randomization|Protocol Violation|0|||
37919888|NCT00884741|69606492|FG002|Randomization|Protocol Violation|8|||
37919889|NCT00884741|69606493|FG003|Randomization|Protocol Violation|8|||
37919890|NCT00880763|69606504|FG000|Extension Period (Part 2)|Adverse Event|0|||
37919891|NCT00880763|69606505|FG001|Extension Period (Part 2)|Adverse Event|0|||
37919892|NCT00880763|69606506|FG002|Extension Period (Part 2)|Adverse Event|1|||
37735327|NCT01901653|69215697|FG003|Overall Study|Death|3|||
37735328|NCT01901653|69215698|FG004|Overall Study|Death|2|||
37735329|NCT01901653|69215699|FG005|Overall Study|Death|2|||
37735330|NCT01901653|69215700|FG006|Overall Study|Death|6|||
37850830|NCT01277601|69534613|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
37850831|NCT01277601|69534610|FG000|Overall Study|Protocol Violation|0|||
37850832|NCT01277601|69534611|FG001|Overall Study|Protocol Violation|2|||
37850833|NCT01277601|69534612|FG002|Overall Study|Protocol Violation|5|||
37850834|NCT01277601|69534613|FG003|Overall Study|Protocol Violation|0|||
37850835|NCT01277601|69534610|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
37850836|NCT01277601|69534611|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
37919893|NCT00880763|69606507|FG003|Extension Period (Part 2)|Adverse Event|1|||
37919894|NCT00880763|69606504|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
37735331|NCT01901653|69215701|FG007|Overall Study|Death|9|||
37735332|NCT01901653|69215702|FG008|Overall Study|Death|1|||
37850837|NCT01277601|69534612|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
37850838|NCT01277601|69534613|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
37850839|NCT01277523|69534643|FG000|Overall Study|Adverse Event|1|||
37850840|NCT01277523|69534644|FG001|Overall Study|Adverse Event|0|||
38029590|NCT02996500|69715064|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
38029591|NCT02996500|69715065|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
38029592|NCT02996500|69715066|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
38029593|NCT02996500|69715067|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
38029594|NCT02996500|69715068|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
38029595|NCT02996500|69715063|FG000|Overall Study|Non-Compliance With Study Drug|0|||
38029596|NCT02996500|69715064|FG001|Overall Study|Non-Compliance With Study Drug|0|||
38029597|NCT02996500|69715065|FG002|Overall Study|Non-Compliance With Study Drug|0|||
38029598|NCT02996500|69715066|FG003|Overall Study|Non-Compliance With Study Drug|0|||
38029599|NCT02996500|69715067|FG004|Overall Study|Non-Compliance With Study Drug|0|||
38029600|NCT02996500|69715068|FG005|Overall Study|Non-Compliance With Study Drug|1|||
38029601|NCT02996500|69715063|FG000|Overall Study|Progressive Disease|1|||
38029602|NCT02996500|69715064|FG001|Overall Study|Progressive Disease|0|||
38029603|NCT02996500|69715065|FG002|Overall Study|Progressive Disease|0|||
38029604|NCT02996500|69715066|FG003|Overall Study|Progressive Disease|0|||
38029605|NCT02996500|69715067|FG004|Overall Study|Progressive Disease|0|||
38029606|NCT02996500|69715068|FG005|Overall Study|Progressive Disease|0|||
38029607|NCT02996500|69715063|FG000|Overall Study|Other|2|||
38029608|NCT02996500|69715064|FG001|Overall Study|Other|0|||
38029609|NCT02996500|69715065|FG002|Overall Study|Other|2|||
38029610|NCT02996500|69715066|FG003|Overall Study|Other|0|||
38029611|NCT02996500|69715067|FG004|Overall Study|Other|0|||
38029612|NCT02996500|69715068|FG005|Overall Study|Other|0|||
38029613|NCT02996500|69715063|FG000|Overall Study|Protocol Violation|0|||
38029614|NCT02996500|69715064|FG001|Overall Study|Protocol Violation|0|||
38029615|NCT02996500|69715065|FG002|Overall Study|Protocol Violation|0|||
38029616|NCT02996500|69715066|FG003|Overall Study|Protocol Violation|1|||
38029617|NCT02996500|69715067|FG004|Overall Study|Protocol Violation|0|||
38029618|NCT02996500|69715068|FG005|Overall Study|Protocol Violation|0|||
38029619|NCT02996500|69715063|FG000|Overall Study|Withdrawal by Subject|3|||
38029620|NCT02996500|69715064|FG001|Overall Study|Withdrawal by Subject|0|||
38029621|NCT02996500|69715065|FG002|Overall Study|Withdrawal by Subject|3|||
38029622|NCT02996500|69715066|FG003|Overall Study|Withdrawal by Subject|0|||
38029623|NCT02996500|69715067|FG004|Overall Study|Withdrawal by Subject|2|||
38029624|NCT02996500|69715068|FG005|Overall Study|Withdrawal by Subject|0|||
38029625|NCT00006489|69715090|FG000|Overall Study|Adverse Event|3|||
38029626|NCT00006489|69715091|FG001|Overall Study|Adverse Event|2|||
38029627|NCT00006489|69715092|FG002|Overall Study|Adverse Event|4|||
38029628|NCT00006489|69715093|FG003|Overall Study|Adverse Event|3|||
38029629|NCT00006489|69715090|FG000|Overall Study|Withdrawal by Subject|10|||
38029630|NCT00006489|69715091|FG001|Overall Study|Withdrawal by Subject|9|||
38029631|NCT00006489|69715092|FG002|Overall Study|Withdrawal by Subject|9|||
38029632|NCT00006489|69715093|FG003|Overall Study|Withdrawal by Subject|6|||
38029633|NCT00006489|69715090|FG000|Overall Study|Scheduling Conflict|0|||
38029634|NCT00006489|69715091|FG001|Overall Study|Scheduling Conflict|3|||
38029635|NCT00006489|69715092|FG002|Overall Study|Scheduling Conflict|2|||
38029636|NCT00006489|69715093|FG003|Overall Study|Scheduling Conflict|1|||
38029637|NCT00006489|69715090|FG000|Overall Study|Death|0|||
38029638|NCT00006489|69715091|FG001|Overall Study|Death|0|||
38029639|NCT00006489|69715092|FG002|Overall Study|Death|0|||
38029640|NCT00006489|69715093|FG003|Overall Study|Death|1|||
38029641|NCT03535974|69715106|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
38029642|NCT03535974|69715107|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
38029643|NCT03535974|69715108|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
38029644|NCT03535974|69715106|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
38029645|NCT03535974|69715107|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
38029646|NCT03535974|69715108|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
38029647|NCT00025233|69715116|FG000|Overall Study|Ineligible: wrong cell type|1|||
38029648|NCT00025233|69715116|FG000|Overall Study|Ineligible: wrong primary|1|||
38029649|NCT00025233|69715116|FG000|Overall Study|Ineligible: improper prior treatment|1|||
38029650|NCT00025233|69715116|FG000|Overall Study|Never treated|1|||
38029651|NCT00025155|69715126|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
38029652|NCT00025155|69715126|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
38029653|NCT02998996|69715141|FG000|Overall Study|Lost to Follow-up|0|||
38029654|NCT02998996|69715142|FG001|Overall Study|Lost to Follow-up|0|||
38029655|NCT02998996|69715143|FG002|Overall Study|Lost to Follow-up|1|||
38029656|NCT02998996|69715144|FG003|Overall Study|Lost to Follow-up|0|||
38029657|NCT02998996|69715145|FG004|Overall Study|Lost to Follow-up|0|||
38029658|NCT02998996|69715146|FG005|Overall Study|Lost to Follow-up|0|||
38029659|NCT02998996|69715141|FG000|Overall Study|Pregnancy|0|||
38029660|NCT02998996|69715142|FG001|Overall Study|Pregnancy|1|||
38029661|NCT02998996|69715143|FG002|Overall Study|Pregnancy|0|||
38029662|NCT02998996|69715144|FG003|Overall Study|Pregnancy|0|||
38029663|NCT02998996|69715145|FG004|Overall Study|Pregnancy|0|||
38029664|NCT02998996|69715146|FG005|Overall Study|Pregnancy|0|||
38029665|NCT02998996|69715141|FG000|Overall Study|Family reasons|0|||
38029666|NCT02998996|69715142|FG001|Overall Study|Family reasons|0|||
38029667|NCT02998996|69715143|FG002|Overall Study|Family reasons|0|||
38029668|NCT02998996|69715144|FG003|Overall Study|Family reasons|0|||
38029669|NCT02998996|69715145|FG004|Overall Study|Family reasons|1|||
38029670|NCT02998996|69715146|FG005|Overall Study|Family reasons|0|||
38029671|NCT02994940|69715162|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
38029672|NCT02994940|69715163|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
38029673|NCT02994940|69715162|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
38029674|NCT02994940|69715163|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
38029675|NCT02994940|69715162|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
38029676|NCT02994940|69715163|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
38029677|NCT02994394|69715171|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
38029678|NCT02994394|69715172|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
38029679|NCT02994394|69715173|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
38029680|NCT02994394|69715174|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
38029681|NCT02994394|69715175|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
38029682|NCT02994394|69715176|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
38029683|NCT02994394|69715171|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
38029684|NCT02994394|69715172|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
38029685|NCT02994394|69715173|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
38029686|NCT02994394|69715174|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
38029687|NCT02994394|69715175|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
38029688|NCT02994394|69715176|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
38029689|NCT02998840|69715194|FG000|Overall Study|Lost to Follow-up|1|||
38029690|NCT02998840|69715195|FG001|Overall Study|Lost to Follow-up|1|||
38029691|NCT02998840|69715196|FG002|Overall Study|Lost to Follow-up|2|||
38029692|NCT02998840|69715197|FG003|Overall Study|Lost to Follow-up|3|||
38029693|NCT02998840|69715194|FG000|Overall Study|Withdrawal by Subject|1|||
38029694|NCT02998840|69715195|FG001|Overall Study|Withdrawal by Subject|1|||
38029695|NCT02998840|69715196|FG002|Overall Study|Withdrawal by Subject|0|||
38029696|NCT02998840|69715197|FG003|Overall Study|Withdrawal by Subject|1|||
38029697|NCT02998840|69715194|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
38029698|NCT02998840|69715195|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
37850841|NCT01277523|69534645|FG002|Overall Study|Adverse Event|0|||
37850842|NCT01277523|69534643|FG000|Overall Study|Protocol Violation|2|||
37850843|NCT01277523|69534644|FG001|Overall Study|Protocol Violation|0|||
37850844|NCT01277523|69534645|FG002|Overall Study|Protocol Violation|0|||
37850845|NCT01277523|69534643|FG000|Overall Study|Other Reason not Defined|0|||
37850846|NCT01277523|69534644|FG001|Overall Study|Other Reason not Defined|1|||
37850847|NCT01277523|69534645|FG002|Overall Study|Other Reason not Defined|0|||
37850848|NCT01081834|69534658|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
37850849|NCT01081834|69534659|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
38029699|NCT02998840|69715196|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
38029700|NCT02998840|69715197|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
38029701|NCT00023673|69715208|FG000|Overall Study|Ineligible / no protocol treatment|0|||
38029702|NCT00023673|69715209|FG001|Overall Study|Ineligible / no protocol treatment|0|||
38029703|NCT00023673|69715210|FG002|Overall Study|Ineligible / no protocol treatment|0|||
38029704|NCT00023673|69715211|FG003|Overall Study|Ineligible / no protocol treatment|1|||
38029705|NCT00023673|69715208|FG000|Overall Study|Patient withdrew consent|0|||
38029706|NCT00023673|69715209|FG001|Overall Study|Patient withdrew consent|0|||
38029707|NCT00023673|69715210|FG002|Overall Study|Patient withdrew consent|0|||
37850850|NCT01081834|69534660|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
37850851|NCT01081834|69534661|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
37850852|NCT01081834|69534662|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
38029708|NCT00023673|69715211|FG003|Overall Study|Patient withdrew consent|1|||
38029709|NCT01069900|69715223|FG000|Overall Study|Technical problems|0|||
38029710|NCT01069900|69715224|FG001|Overall Study|Technical problems|1|||
38029711|NCT01069900|69715223|FG000|Overall Study|Lost to Follow-up|7|||
38029712|NCT01069900|69715224|FG001|Overall Study|Lost to Follow-up|1|||
38029713|NCT01069900|69715223|FG000|Overall Study|Withdrawal by Subject|6|||
38029714|NCT01069900|69715224|FG001|Overall Study|Withdrawal by Subject|1|||
38029715|NCT01069900|69715223|FG000|Overall Study|Protocol Violation|4|||
38029716|NCT01069900|69715224|FG001|Overall Study|Protocol Violation|1|||
38029717|NCT01069900|69715223|FG000|Overall Study|Insufficient Therapeutic effect|1|||
38029718|NCT01069900|69715224|FG001|Overall Study|Insufficient Therapeutic effect|0|||
38029719|NCT01069120|69715232|FG000|Overall Study|Study prematurely terminated|27|||
38029720|NCT00006237|69715240|FG000|Overall Study|Adverse Event|39|||
38029721|NCT00006237|69715241|FG001|Overall Study|Adverse Event|29|||
38029722|NCT00006237|69715240|FG000|Overall Study|Death|1|||
38029723|NCT00006237|69715241|FG001|Overall Study|Death|0|||
38029724|NCT00006237|69715240|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
38029725|NCT00006237|69715241|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
38029726|NCT00006237|69715240|FG000|Overall Study|Progression/relapse|54|||
38029727|NCT00006237|69715241|FG001|Overall Study|Progression/relapse|2|||
38029728|NCT00006237|69715240|FG000|Overall Study|Not eligible|9|||
38029729|NCT00006237|69715241|FG001|Overall Study|Not eligible|20|||
37850853|NCT01081834|69534658|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
37850854|NCT01081834|69534659|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
37850855|NCT01081834|69534660|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
37850856|NCT01081834|69534661|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
37850857|NCT01081834|69534662|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
37850858|NCT01081834|69534658|FG000|Core Period: Baseline to Week 26|Death|1|||
37850859|NCT01081834|69534659|FG001|Core Period: Baseline to Week 26|Death|0|||
37850860|NCT01081834|69534660|FG002|Core Period: Baseline to Week 26|Death|0|||
37850861|NCT01081834|69534661|FG003|Core Period: Baseline to Week 26|Death|0|||
37850862|NCT01081834|69534662|FG004|Core Period: Baseline to Week 26|Death|0|||
37850863|NCT01081834|69534658|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
37850864|NCT01081834|69534659|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
37850865|NCT01081834|69534660|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
37850866|NCT01081834|69534661|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
37850867|NCT01081834|69534662|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
37850868|NCT01081834|69534658|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
37850869|NCT01081834|69534659|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
37850870|NCT01081834|69534660|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
37850871|NCT01081834|69534661|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
37850872|NCT01081834|69534662|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
37850873|NCT01081834|69534658|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
37850874|NCT01081834|69534659|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
37850875|NCT01081834|69534660|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
37850876|NCT01081834|69534661|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
37850877|NCT01081834|69534662|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
37850878|NCT01081834|69534658|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
37850879|NCT01081834|69534659|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
37850880|NCT01081834|69534660|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
37850881|NCT01081834|69534661|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
37850882|NCT01081834|69534662|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
37850883|NCT01081834|69534658|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
37850884|NCT01081834|69534659|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
37850885|NCT01081834|69534660|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
37850886|NCT01081834|69534661|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
37919895|NCT00880763|69606505|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
38029730|NCT00006237|69715240|FG000|Overall Study|Withdrawal by Subject|0|||
38029731|NCT00006237|69715241|FG001|Overall Study|Withdrawal by Subject|1|||
38029732|NCT00006237|69715240|FG000|Overall Study|Not protocol specified|14|||
38029733|NCT00006237|69715241|FG001|Overall Study|Not protocol specified|5|||
38029734|NCT02993926|69715250|FG000|Enantone Treatment Phase|Adverse Event|1|||
38029735|NCT02993926|69715251|FG001|Enantone Treatment Phase|Adverse Event|0|||
38029736|NCT02993926|69715252|FG002|Enantone Treatment Phase|Adverse Event|0|||
38029737|NCT02993926|69715250|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
38029738|NCT02993926|69715251|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
38029739|NCT02993926|69715252|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
38029740|NCT02993926|69715250|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
38029741|NCT02993926|69715251|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
38029742|NCT02993926|69715252|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
37850887|NCT01081834|69534662|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
37850888|NCT01081834|69534658|FG000|Core Period: Baseline to Week 26|Other|4|||
37850889|NCT01081834|69534659|FG001|Core Period: Baseline to Week 26|Other|4|||
37850890|NCT01081834|69534660|FG002|Core Period: Baseline to Week 26|Other|3|||
37850891|NCT01081834|69534661|FG003|Core Period: Baseline to Week 26|Other|1|||
37850892|NCT01081834|69534662|FG004|Core Period: Baseline to Week 26|Other|0|||
37850893|NCT01081834|69534658|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
38029743|NCT02993926|69715250|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
38029744|NCT02993926|69715251|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
38029745|NCT02993926|69715252|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
38029746|NCT02993224|69715262|FG000|Core Phase - Period 1|Adverse Event|4|||
38029747|NCT02993224|69715262|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
38029748|NCT02993224|69715262|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
38029749|NCT02993224|69715262|FG000|Core Phase- Period 2|Adverse Event|1|||
38029750|NCT02993224|69715262|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
38029751|NCT02993224|69715262|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
38029752|NCT02993224|69715262|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
38029753|NCT02993224|69715262|FG000|Extension Phase|Adverse Event|3|||
38029754|NCT02993224|69715262|FG000|Extension Phase|Withdrawal by Subject|3|||
38029755|NCT02993224|69715262|FG000|Extension Phase|Lost to Follow-up|2|||
38029756|NCT02993224|69715262|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
38029757|NCT03495908|69715270|FG000|Overall Study|Withdrawal by Subject|3|||
38029758|NCT03495908|69715271|FG001|Overall Study|Withdrawal by Subject|1|||
38029759|NCT03495908|69715270|FG000|Overall Study|Lost to Follow-up|1|||
38029760|NCT03495908|69715271|FG001|Overall Study|Lost to Follow-up|4|||
38029761|NCT03495908|69715270|FG000|Overall Study|Adverse Event|0|||
38029762|NCT03495908|69715271|FG001|Overall Study|Adverse Event|2|||
38029763|NCT03495908|69715270|FG000|Overall Study|Death|1|||
38029764|NCT03495908|69715271|FG001|Overall Study|Death|0|||
38029765|NCT03495908|69715270|FG000|Overall Study|Physician Decision|5|||
38029766|NCT03495908|69715271|FG001|Overall Study|Physician Decision|4|||
38029767|NCT03495908|69715270|FG000|Overall Study|No documented reason|0|||
38029768|NCT03495908|69715271|FG001|Overall Study|No documented reason|2|||
38029769|NCT02992288|69715283|FG000|Overall Study|Adverse Event|8|||
38029770|NCT02992288|69715284|FG001|Overall Study|Adverse Event|2|||
38029771|NCT02992288|69715285|FG002|Overall Study|Adverse Event|2|||
38029772|NCT02992288|69715286|FG003|Overall Study|Adverse Event|2|||
38029773|NCT02992288|69715287|FG004|Overall Study|Adverse Event|2|||
38029774|NCT02992288|69715288|FG005|Overall Study|Adverse Event|7|||
37850894|NCT01081834|69534659|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
37850895|NCT01081834|69534660|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
37850896|NCT01081834|69534661|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
37850897|NCT01081834|69534662|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
37850898|NCT01081834|69534658|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
37850899|NCT01081834|69534659|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
37850900|NCT01081834|69534660|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
37850901|NCT01081834|69534661|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
37850902|NCT01081834|69534662|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
37850903|NCT01081834|69534658|FG000|Extension Period: Week 26 to Week 52|Death|1|||
37850904|NCT01081834|69534659|FG001|Extension Period: Week 26 to Week 52|Death|0|||
37850905|NCT01081834|69534660|FG002|Extension Period: Week 26 to Week 52|Death|0|||
37850906|NCT01081834|69534661|FG003|Extension Period: Week 26 to Week 52|Death|0|||
37850907|NCT01081834|69534662|FG004|Extension Period: Week 26 to Week 52|Death|0|||
37850908|NCT01081834|69534658|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
37850909|NCT01081834|69534659|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
37850910|NCT01081834|69534660|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
37850911|NCT01081834|69534661|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
37850912|NCT01081834|69534662|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
37850913|NCT01081834|69534658|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
37850914|NCT01081834|69534659|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
37850915|NCT01081834|69534660|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
38029775|NCT02992288|69715283|FG000|Overall Study|Non-compliance with study drug|0|||
38029776|NCT02992288|69715284|FG001|Overall Study|Non-compliance with study drug|1|||
37850916|NCT01081834|69534661|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
37850917|NCT01081834|69534662|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
37850918|NCT01081834|69534658|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
37850919|NCT01081834|69534659|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
37850920|NCT01081834|69534660|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
37850921|NCT01081834|69534661|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
38029777|NCT02992288|69715285|FG002|Overall Study|Non-compliance with study drug|1|||
38029778|NCT02992288|69715286|FG003|Overall Study|Non-compliance with study drug|0|||
38029779|NCT02992288|69715287|FG004|Overall Study|Non-compliance with study drug|1|||
38029780|NCT02992288|69715288|FG005|Overall Study|Non-compliance with study drug|0|||
38029781|NCT02992288|69715283|FG000|Overall Study|Physician Decision|3|||
38029782|NCT02992288|69715284|FG001|Overall Study|Physician Decision|0|||
38029783|NCT02992288|69715285|FG002|Overall Study|Physician Decision|1|||
37850922|NCT01081834|69534662|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
37850923|NCT01081834|69534658|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
37850924|NCT01081834|69534659|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
37850925|NCT01081834|69534660|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
37850926|NCT01081834|69534661|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
37850927|NCT01081834|69534662|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
37850928|NCT01081834|69534658|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
37850929|NCT01081834|69534659|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
37850930|NCT01081834|69534660|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
37850931|NCT01081834|69534661|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
37850932|NCT01081834|69534662|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
37850933|NCT01081834|69534658|FG000|Extension Period: Week 26 to Week 52|Other|4|||
37850934|NCT01081834|69534659|FG001|Extension Period: Week 26 to Week 52|Other|5|||
37850935|NCT01081834|69534660|FG002|Extension Period: Week 26 to Week 52|Other|4|||
37850936|NCT01081834|69534661|FG003|Extension Period: Week 26 to Week 52|Other|0|||
37850937|NCT01081834|69534662|FG004|Extension Period: Week 26 to Week 52|Other|0|||
37850938|NCT01081834|69534658|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
37850939|NCT01081834|69534659|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
37850940|NCT01081834|69534660|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
37850941|NCT01081834|69534661|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
37850942|NCT01081834|69534662|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
37850943|NCT01081834|69534658|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
37850944|NCT01081834|69534659|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
37850945|NCT01081834|69534660|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
37850946|NCT01081834|69534661|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
37850947|NCT01081834|69534662|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
37850948|NCT01276509|69534685|FG000|Overall Study|Adverse Event|9|||
37850949|NCT01276509|69534686|FG001|Overall Study|Adverse Event|8|||
37919896|NCT00880763|69606506|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
37919897|NCT00880763|69606507|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
37919898|NCT00880763|69606504|FG000|Extension Period (Part 2)|Physician Decision|0|||
37735333|NCT01901653|69215703|FG009|Overall Study|Death|16|||
37919899|NCT00880763|69606505|FG001|Extension Period (Part 2)|Physician Decision|1|||
37919900|NCT00880763|69606506|FG002|Extension Period (Part 2)|Physician Decision|1|||
37919901|NCT00880763|69606507|FG003|Extension Period (Part 2)|Physician Decision|0|||
37919902|NCT00880763|69606504|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
37919903|NCT00880763|69606505|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
37919904|NCT00880763|69606506|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
38029784|NCT02992288|69715286|FG003|Overall Study|Physician Decision|0|||
38029785|NCT02992288|69715287|FG004|Overall Study|Physician Decision|0|||
38029786|NCT02992288|69715288|FG005|Overall Study|Physician Decision|1|||
38029787|NCT02992288|69715283|FG000|Overall Study|Death|2|||
38029788|NCT02992288|69715284|FG001|Overall Study|Death|0|||
38029789|NCT02992288|69715285|FG002|Overall Study|Death|2|||
38029790|NCT02992288|69715286|FG003|Overall Study|Death|1|||
38029791|NCT02992288|69715287|FG004|Overall Study|Death|2|||
38029792|NCT02992288|69715288|FG005|Overall Study|Death|0|||
38029793|NCT02992288|69715283|FG000|Overall Study|Lost to Follow-up|0|||
38029794|NCT02992288|69715284|FG001|Overall Study|Lost to Follow-up|0|||
38029795|NCT02992288|69715285|FG002|Overall Study|Lost to Follow-up|0|||
38029796|NCT02992288|69715286|FG003|Overall Study|Lost to Follow-up|1|||
38029797|NCT02992288|69715287|FG004|Overall Study|Lost to Follow-up|0|||
38029798|NCT02992288|69715288|FG005|Overall Study|Lost to Follow-up|0|||
38029799|NCT02992288|69715283|FG000|Overall Study|Protocol Violation|0|||
38029800|NCT02992288|69715284|FG001|Overall Study|Protocol Violation|0|||
38029801|NCT02992288|69715285|FG002|Overall Study|Protocol Violation|0|||
38029802|NCT02992288|69715286|FG003|Overall Study|Protocol Violation|0|||
38029803|NCT02992288|69715287|FG004|Overall Study|Protocol Violation|0|||
38029804|NCT02992288|69715288|FG005|Overall Study|Protocol Violation|1|||
38029805|NCT02992288|69715283|FG000|Overall Study|Withdrawal by Subject|4|||
38029806|NCT02992288|69715284|FG001|Overall Study|Withdrawal by Subject|2|||
38029807|NCT02992288|69715285|FG002|Overall Study|Withdrawal by Subject|1|||
37735334|NCT01901653|69215704|FG010|Overall Study|Death|2|||
37735335|NCT01901653|69215705|FG011|Overall Study|Death|15|||
38029808|NCT02992288|69715286|FG003|Overall Study|Withdrawal by Subject|5|||
38029809|NCT02992288|69715287|FG004|Overall Study|Withdrawal by Subject|3|||
38029810|NCT02992288|69715288|FG005|Overall Study|Withdrawal by Subject|4|||
38029811|NCT02992132|69715305|FG000|Overall Study|Adverse Event|4|||
38029812|NCT02992132|69715306|FG001|Overall Study|Adverse Event|1|||
38029813|NCT02992132|69715307|FG002|Overall Study|Adverse Event|3|||
38029814|NCT02992132|69715305|FG000|Overall Study|Lack of Efficacy|2|||
38029815|NCT02992132|69715306|FG001|Overall Study|Lack of Efficacy|0|||
38029816|NCT02992132|69715307|FG002|Overall Study|Lack of Efficacy|0|||
38029817|NCT02992132|69715305|FG000|Overall Study|Non-compliance with study drug|2|||
38029818|NCT02992132|69715306|FG001|Overall Study|Non-compliance with study drug|0|||
38029819|NCT02992132|69715307|FG002|Overall Study|Non-compliance with study drug|0|||
38029820|NCT02992132|69715305|FG000|Overall Study|Progressive disease|1|||
38029821|NCT02992132|69715306|FG001|Overall Study|Progressive disease|0|||
38029822|NCT02992132|69715307|FG002|Overall Study|Progressive disease|0|||
38029823|NCT02992132|69715305|FG000|Overall Study|Protocol Violation|2|||
38029824|NCT02992132|69715306|FG001|Overall Study|Protocol Violation|2|||
38029825|NCT02992132|69715307|FG002|Overall Study|Protocol Violation|0|||
37735336|NCT01901653|69215706|FG012|Overall Study|Death|4|||
37735337|NCT01901653|69215694|FG000|Overall Study|Lost to Follow-up|1|||
37735338|NCT01901653|69215695|FG001|Overall Study|Lost to Follow-up|0|||
37735339|NCT01901653|69215696|FG002|Overall Study|Lost to Follow-up|2|||
38029826|NCT02992132|69715305|FG000|Overall Study|Caregiver withdrew consent|2|||
38029827|NCT02992132|69715306|FG001|Overall Study|Caregiver withdrew consent|3|||
38029828|NCT02992132|69715307|FG002|Overall Study|Caregiver withdrew consent|2|||
38029829|NCT02992132|69715305|FG000|Overall Study|Withdrawal by Subject|0|||
38029830|NCT02992132|69715306|FG001|Overall Study|Withdrawal by Subject|2|||
38029831|NCT02992132|69715307|FG002|Overall Study|Withdrawal by Subject|1|||
38029832|NCT02992132|69715305|FG000|Overall Study|Physician Decision|0|||
38029833|NCT02992132|69715306|FG001|Overall Study|Physician Decision|0|||
38029834|NCT02992132|69715307|FG002|Overall Study|Physician Decision|1|||
37735340|NCT01901653|69215697|FG003|Overall Study|Lost to Follow-up|0|||
37735341|NCT01901653|69215698|FG004|Overall Study|Lost to Follow-up|0|||
37735342|NCT01901653|69215699|FG005|Overall Study|Lost to Follow-up|1|||
37735343|NCT01901653|69215700|FG006|Overall Study|Lost to Follow-up|0|||
38029835|NCT03444584|69715317|FG000|Overall Study|Withdrawal by Subject|0|||
37735344|NCT01901653|69215701|FG007|Overall Study|Lost to Follow-up|1|||
37735345|NCT01901653|69215702|FG008|Overall Study|Lost to Follow-up|0|||
37735346|NCT01901653|69215703|FG009|Overall Study|Lost to Follow-up|0|||
37850950|NCT01276509|69534687|FG002|Overall Study|Adverse Event|4|||
37850951|NCT01276509|69534688|FG003|Overall Study|Adverse Event|3|||
37850952|NCT01276509|69534685|FG000|Overall Study|Lack of Efficacy|2|||
37850953|NCT01276509|69534686|FG001|Overall Study|Lack of Efficacy|1|||
37850954|NCT01276509|69534687|FG002|Overall Study|Lack of Efficacy|1|||
37850955|NCT01276509|69534688|FG003|Overall Study|Lack of Efficacy|2|||
37850956|NCT01276509|69534685|FG000|Overall Study|Pregnancy|1|||
37850957|NCT01276509|69534686|FG001|Overall Study|Pregnancy|0|||
37850958|NCT01276509|69534687|FG002|Overall Study|Pregnancy|0|||
38029836|NCT03444584|69715318|FG001|Overall Study|Withdrawal by Subject|1|||
38029837|NCT03444584|69715317|FG000|Overall Study|Other|0|||
38029838|NCT03444584|69715318|FG001|Overall Study|Other|1|||
38029839|NCT02989168|69715327|FG000|Overall Study|Withdrawal by Subject|2|||
38029840|NCT02989168|69715328|FG001|Overall Study|Withdrawal by Subject|0|||
38029841|NCT02989168|69715327|FG000|Overall Study|Physician Decision|0|||
37735347|NCT01901653|69215704|FG010|Overall Study|Lost to Follow-up|0|||
37735348|NCT01901653|69215705|FG011|Overall Study|Lost to Follow-up|0|||
37735349|NCT01901653|69215706|FG012|Overall Study|Lost to Follow-up|0|||
37850959|NCT01276509|69534688|FG003|Overall Study|Pregnancy|0|||
38029842|NCT02989168|69715328|FG001|Overall Study|Physician Decision|1|||
38029843|NCT02989168|69715327|FG000|Overall Study|Adverse Event|1|||
37735350|NCT01901653|69215694|FG000|Overall Study|Withdrawal by Subject|0|||
37735351|NCT01901653|69215695|FG001|Overall Study|Withdrawal by Subject|0|||
37735352|NCT01901653|69215696|FG002|Overall Study|Withdrawal by Subject|0|||
37735353|NCT01901653|69215697|FG003|Overall Study|Withdrawal by Subject|0|||
37735354|NCT01901653|69215698|FG004|Overall Study|Withdrawal by Subject|0|||
37735355|NCT01901653|69215699|FG005|Overall Study|Withdrawal by Subject|0|||
37735356|NCT01901653|69215700|FG006|Overall Study|Withdrawal by Subject|1|||
37735357|NCT01901653|69215701|FG007|Overall Study|Withdrawal by Subject|0|||
37735358|NCT01901653|69215702|FG008|Overall Study|Withdrawal by Subject|0|||
37735359|NCT01901653|69215703|FG009|Overall Study|Withdrawal by Subject|0|||
37735360|NCT01901653|69215704|FG010|Overall Study|Withdrawal by Subject|0|||
37735361|NCT01901653|69215705|FG011|Overall Study|Withdrawal by Subject|0|||
37735362|NCT01901653|69215706|FG012|Overall Study|Withdrawal by Subject|0|||
37735363|NCT01901653|69215694|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
38029844|NCT02989168|69715328|FG001|Overall Study|Adverse Event|2|||
38029845|NCT02989168|69715327|FG000|Overall Study|Sponsor stopped study.|1|||
38029846|NCT02989168|69715328|FG001|Overall Study|Sponsor stopped study.|0|||
38029847|NCT02988622|69715336|FG000|Overall Study|Lost to Follow-up|17|||
38029848|NCT03412604|69715342|FG000|Overall Study|Withdrawal by Subject|1|||
38029849|NCT02991430|69715349|FG000|Treatment Period 1|Adverse Event|1|||
38029850|NCT02991430|69715350|FG001|Treatment Period 1|Adverse Event|0|||
38029851|NCT02991430|69715351|FG002|Treatment Period 1|Adverse Event|2|||
38029852|NCT02991430|69715349|FG000|Treatment Period 1|Withdrawal by Subject|0|||
38029853|NCT02991430|69715350|FG001|Treatment Period 1|Withdrawal by Subject|4|||
38029854|NCT02991430|69715351|FG002|Treatment Period 1|Withdrawal by Subject|0|||
38029855|NCT02991430|69715349|FG000|Treatment Period 2|Study Termination|6|||
38029856|NCT02991430|69715350|FG001|Treatment Period 2|Study Termination|3|||
38029857|NCT02991430|69715351|FG002|Treatment Period 2|Study Termination|3|||
38029858|NCT02991430|69715349|FG000|Treatment Period 2|Lost to Follow-up|0|||
38029859|NCT02991430|69715350|FG001|Treatment Period 2|Lost to Follow-up|0|||
38029860|NCT02991430|69715351|FG002|Treatment Period 2|Lost to Follow-up|1|||
38029861|NCT02991430|69715349|FG000|Post-treatment Observation Period|Study Termination|3|||
38029862|NCT02991430|69715350|FG001|Post-treatment Observation Period|Study Termination|6|||
38029863|NCT02991430|69715351|FG002|Post-treatment Observation Period|Study Termination|5|||
38029864|NCT03411902|69715361|FG000|Overall Study|Lost to Follow-up|3|||
38029865|NCT03411902|69715362|FG001|Overall Study|Lost to Follow-up|0|||
38029866|NCT03494816|69715368|FG000|Overall Study|Protocol Violation|2|||
37735364|NCT01901653|69215695|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
37735365|NCT01901653|69215696|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
37735366|NCT01901653|69215697|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
37735367|NCT01901653|69215698|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
37850960|NCT01276509|69534685|FG000|Overall Study|Withdrawal by Subject|1|||
37919905|NCT00880763|69606507|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
37919906|NCT00884273|69606519|FG000|Overall Study|Adverse Event|0|||
37735368|NCT01901653|69215699|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
37850961|NCT01276509|69534686|FG001|Overall Study|Withdrawal by Subject|2|||
37850962|NCT01276509|69534687|FG002|Overall Study|Withdrawal by Subject|0|||
37850963|NCT01276509|69534688|FG003|Overall Study|Withdrawal by Subject|0|||
37850964|NCT01276509|69534685|FG000|Overall Study|Other|0|||
37850965|NCT01276509|69534686|FG001|Overall Study|Other|1|||
37850966|NCT01276509|69534687|FG002|Overall Study|Other|0|||
37850967|NCT01276509|69534688|FG003|Overall Study|Other|0|||
37850968|NCT01079962|69534700|FG000|Overall Study|Adverse Event|2|||
37850969|NCT01079962|69534701|FG001|Overall Study|Adverse Event|2|||
37850970|NCT01079962|69534700|FG000|Overall Study|Withdrawal by Subject|5|||
37850971|NCT01079962|69534701|FG001|Overall Study|Withdrawal by Subject|7|||
37850972|NCT01079962|69534700|FG000|Overall Study|Protocol Violation|2|||
37919907|NCT00884273|69606520|FG001|Overall Study|Adverse Event|2|||
37919908|NCT00884273|69606519|FG000|Overall Study|Protocol Violation|1|||
37850973|NCT01079962|69534701|FG001|Overall Study|Protocol Violation|2|||
37850974|NCT01079962|69534700|FG000|Overall Study|No blood pressure (BP) control|3|||
37919909|NCT00884273|69606520|FG001|Overall Study|Protocol Violation|3|||
37919910|NCT00884273|69606519|FG000|Overall Study|Practical reasons|1|||
37919911|NCT00884273|69606520|FG001|Overall Study|Practical reasons|0|||
37919912|NCT00884117|69606526|FG000|Overall Study|Adverse Event|2|||
37919913|NCT00884117|69606526|FG000|Overall Study|Withdrawal by Subject|89|||
37919914|NCT00884117|69606526|FG000|Overall Study|Death|3|||
37919915|NCT00884117|69606526|FG000|Overall Study|Lost to Follow-up|143|||
37919916|NCT00884117|69606526|FG000|Overall Study|Other|12|||
37919917|NCT00884039|69606545|FG000|Overall Study|Withdrawal by Subject|0|||
37919918|NCT00884039|69606546|FG001|Overall Study|Withdrawal by Subject|1|||
37919919|NCT00884039|69606545|FG000|Overall Study|Lack of Efficacy|2|||
37919920|NCT00884039|69606546|FG001|Overall Study|Lack of Efficacy|0|||
37919921|NCT00835770|69606554|FG000|Overall Study|MS Relapse|17|||
37919922|NCT00835770|69606555|FG001|Overall Study|MS Relapse|23|||
37919923|NCT00835770|69606554|FG000|Overall Study|MS Progression|14|||
37919924|NCT00835770|69606555|FG001|Overall Study|MS Progression|9|||
38029867|NCT03494816|69715368|FG000|Overall Study|Physician Decision|2|||
38029868|NCT03494816|69715368|FG000|Overall Study|Did not start trial treatment|1|||
38029869|NCT03494816|69715368|FG000|Overall Study|Adverse Event|1|||
38029870|NCT03492554|69715378|FG000|Overall Study|Protocol Violation|0|||
38029871|NCT03492554|69715379|FG001|Overall Study|Protocol Violation|14|||
37919925|NCT00835770|69606554|FG000|Overall Study|Adverse Event|113|||
37919926|NCT00835770|69606555|FG001|Overall Study|Adverse Event|124|||
37919927|NCT00835770|69606554|FG000|Overall Study|Lost to Follow-up|22|||
37919928|NCT00835770|69606555|FG001|Overall Study|Lost to Follow-up|19|||
37919929|NCT00835770|69606554|FG000|Overall Study|Consent Withdrawn|144|||
37919930|NCT00835770|69606555|FG001|Overall Study|Consent Withdrawn|156|||
37919931|NCT00835770|69606554|FG000|Overall Study|Investigator Decision|42|||
37919932|NCT00835770|69606555|FG001|Overall Study|Investigator Decision|42|||
37919933|NCT00835770|69606554|FG000|Overall Study|Participant Non-Compliance|11|||
37919934|NCT00835770|69606555|FG001|Overall Study|Participant Non-Compliance|9|||
37919935|NCT00835770|69606554|FG000|Overall Study|Death|4|||
37919936|NCT00835770|69606555|FG001|Overall Study|Death|6|||
37919937|NCT00835770|69606554|FG000|Overall Study|Other|115|||
37919938|NCT00835770|69606555|FG001|Overall Study|Other|104|||
37919939|NCT00835770|69606554|FG000|Overall Study|Other|2|||
37919940|NCT00835770|69606555|FG001|Overall Study|Other|1|||
37919941|NCT00880685|69606567|FG000|Memantine 10mg|Lost to Follow-up|2|||
38029872|NCT04936334|69715424|FG000|Overall Study|Metastatic disease found on PSMA-PET, surgery cancelled|1|||
38029873|NCT04822597|69715434|FG000|Overall Study|Withdrawal by Subject|0|||
38029874|NCT04822597|69715435|FG001|Overall Study|Withdrawal by Subject|1|||
38029875|NCT04822597|69715436|FG002|Overall Study|Withdrawal by Subject|1|||
38029876|NCT04822597|69715437|FG003|Overall Study|Withdrawal by Subject|0|||
38029877|NCT04822597|69715434|FG000|Overall Study|Physician Decision|0|||
38029878|NCT04822597|69715435|FG001|Overall Study|Physician Decision|0|||
38029879|NCT04822597|69715436|FG002|Overall Study|Physician Decision|1|||
38029880|NCT04822597|69715437|FG003|Overall Study|Physician Decision|1|||
38029881|NCT04822597|69715434|FG000|Overall Study|Subject withdrawn after enrollment|0|||
38029882|NCT04822597|69715435|FG001|Overall Study|Subject withdrawn after enrollment|1|||
38029883|NCT04822597|69715436|FG002|Overall Study|Subject withdrawn after enrollment|0|||
38029884|NCT04822597|69715437|FG003|Overall Study|Subject withdrawn after enrollment|1|||
38029885|NCT04822597|69715434|FG000|Overall Study|Surgery Re-scheduled, missed by study team|1|||
38029886|NCT04822597|69715435|FG001|Overall Study|Surgery Re-scheduled, missed by study team|0|||
38029887|NCT04822597|69715436|FG002|Overall Study|Surgery Re-scheduled, missed by study team|0|||
38029888|NCT04822597|69715437|FG003|Overall Study|Surgery Re-scheduled, missed by study team|0|||
38029889|NCT04639245|69715447|FG000|Overall Study|Death|1|||
38029890|NCT04599465|69715451|FG000|Overall Study|Physician Decision|1|||
38029891|NCT04599465|69715451|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
38029892|NCT04104646|69715498|FG000|Overall Study|Withdrawal by Subject|1|||
38029893|NCT04104646|69715499|FG001|Overall Study|Withdrawal by Subject|1|||
38029894|NCT04104646|69715498|FG000|Overall Study|Lost to Follow-up|1|||
37850975|NCT01079962|69534701|FG001|Overall Study|No blood pressure (BP) control|0|||
37850976|NCT01079962|69534700|FG000|Overall Study|Inclusion/exclusion criteria|1|||
37850977|NCT01079962|69534701|FG001|Overall Study|Inclusion/exclusion criteria|3|||
37850978|NCT01079962|69534700|FG000|Overall Study|Participant not returning for next visit|1|||
37850979|NCT01079962|69534701|FG001|Overall Study|Participant not returning for next visit|0|||
37850980|NCT01079962|69534700|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
37850981|NCT01079962|69534701|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
37850982|NCT01274637|69534709|FG000|Overall Study|Withdrawal by Subject|0|||
37850983|NCT01274637|69534710|FG001|Overall Study|Withdrawal by Subject|1|||
37850984|NCT01274637|69534709|FG000|Overall Study|Lost to Follow-up|0|||
37850985|NCT01274637|69534710|FG001|Overall Study|Lost to Follow-up|1|||
37850986|NCT01079806|69534718|FG000|Day 1 to Week 96|Adverse Event|0|||
37850987|NCT01079806|69534719|FG001|Day 1 to Week 96|Adverse Event|3|||
37850988|NCT01079806|69534718|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
37850989|NCT01079806|69534719|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
37919942|NCT00880685|69606567|FG000|Memantine 20mg|Withdrawal by Subject|1|||
37919943|NCT00835380|69606574|FG000|Overall Study|Withdrawal by Subject|2|||
37919944|NCT00880607|69606580|FG000|Overall Study|Physician Decision|2|||
37919945|NCT00880607|69606581|FG001|Overall Study|Physician Decision|2|||
37919946|NCT00880607|69606580|FG000|Overall Study|Protocol Violation|2|||
37919947|NCT00880607|69606581|FG001|Overall Study|Protocol Violation|1|||
37919948|NCT00880607|69606580|FG000|Overall Study|surgery did not extend past L1 level|3|||
38029895|NCT04104646|69715499|FG001|Overall Study|Lost to Follow-up|0|||
38029896|NCT04104646|69715498|FG000|Overall Study|Physician Decision|2|||
38029897|NCT04104646|69715499|FG001|Overall Study|Physician Decision|0|||
38029898|NCT03919669|69715510|FG000|Overall Study|Withdrawal by Subject|1|||
38029899|NCT03919669|69715511|FG001|Overall Study|Withdrawal by Subject|0|||
38029900|NCT03919669|69715512|FG002|Overall Study|Withdrawal by Subject|0|||
38029901|NCT03772665|69715523|FG000|Overall Study|Protocol Violation|1|||
37919949|NCT00880607|69606581|FG001|Overall Study|surgery did not extend past L1 level|0|||
37919950|NCT00835068|69606591|FG000|Overall Study|Death|1|||
38029902|NCT03772665|69715524|FG001|Overall Study|Protocol Violation|0|||
38029903|NCT03594110|69715541|FG000|Overall Study|Participant concerned about study treatment|23|||
38029904|NCT03594110|69715542|FG001|Overall Study|Participant concerned about study treatment|28|||
38029905|NCT03594110|69715541|FG000|Overall Study|Doctor advice|38|||
38029906|NCT03594110|69715542|FG001|Overall Study|Doctor advice|40|||
38029907|NCT03594110|69715541|FG000|Overall Study|Participants' wish|89|||
38029908|NCT03594110|69715542|FG001|Overall Study|Participants' wish|68|||
38029909|NCT03594110|69715541|FG000|Overall Study|Adverse Event|119|||
37919951|NCT00835068|69606592|FG001|Overall Study|Death|0|||
37919952|NCT00835068|69606591|FG000|Overall Study|Adverse Event|0|||
37919953|NCT00835068|69606592|FG001|Overall Study|Adverse Event|1|||
37919954|NCT00835068|69606591|FG000|Overall Study|Other|8|||
38029910|NCT03594110|69715542|FG001|Overall Study|Adverse Event|116|||
38029911|NCT03594110|69715541|FG000|Overall Study|Study drug stopped, reason missing|337|||
38029912|NCT03594110|69715542|FG001|Overall Study|Study drug stopped, reason missing|295|||
38029913|NCT03594110|69715541|FG000|Overall Study|Cannot attend clinic because of personal problems|8|||
37850990|NCT01079806|69534718|FG000|Day 1 to Week 96|Pregnancy|0|||
37919955|NCT00835068|69606592|FG001|Overall Study|Other|0|||
37919956|NCT00835068|69606591|FG000|Overall Study|Withdrawal by Subject|1|||
37919957|NCT00835068|69606592|FG001|Overall Study|Withdrawal by Subject|0|||
38029914|NCT03594110|69715542|FG001|Overall Study|Cannot attend clinic because of personal problems|16|||
37735369|NCT01901653|69215700|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
37735370|NCT01901653|69215701|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
37850991|NCT01079806|69534719|FG001|Day 1 to Week 96|Pregnancy|1|||
37850992|NCT01079806|69534718|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
37850993|NCT01079806|69534719|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
37850994|NCT01079806|69534718|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
37735371|NCT01901653|69215702|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
37735372|NCT01901653|69215703|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
37735373|NCT01901653|69215704|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
37735374|NCT01901653|69215705|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
37735375|NCT01901653|69215706|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
37735376|NCT01925989|69215734|FG000|Period 1|Sponsor Decision|1|||
37735377|NCT01925989|69215735|FG001|Period 1|Sponsor Decision|1|||
37735378|NCT01925989|69215736|FG002|Period 1|Sponsor Decision|0|||
37735379|NCT01925989|69215734|FG000|Period 1|Withdrawal by Subject|0|||
37735380|NCT01925989|69215735|FG001|Period 1|Withdrawal by Subject|1|||
37735381|NCT01925989|69215736|FG002|Period 1|Withdrawal by Subject|0|||
37735382|NCT01901419|69215750|FG000|Overall Study|Protocol Violation|2|||
37735383|NCT01901419|69215751|FG001|Overall Study|Protocol Violation|6|||
37735384|NCT01901419|69215750|FG000|Overall Study|unavailable researchers|6|||
37735385|NCT01901419|69215751|FG001|Overall Study|unavailable researchers|3|||
37735386|NCT01901341|69215778|FG000|Overall Study|Adverse Event|4|||
37735387|NCT01901341|69215779|FG001|Overall Study|Adverse Event|2|||
37735388|NCT01901341|69215778|FG000|Overall Study|Lack of Efficacy|0|||
37735389|NCT01901341|69215779|FG001|Overall Study|Lack of Efficacy|2|||
37735390|NCT01901341|69215778|FG000|Overall Study|Lost to Follow-up|0|||
37735391|NCT01901341|69215779|FG001|Overall Study|Lost to Follow-up|1|||
37735392|NCT01901341|69215778|FG000|Overall Study|Protocol Violation|2|||
37735393|NCT01901341|69215779|FG001|Overall Study|Protocol Violation|0|||
37850995|NCT01079806|69534719|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
37850996|NCT01079806|69534718|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
37850997|NCT01079806|69534719|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
37850998|NCT01079806|69534718|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
37850999|NCT01079806|69534719|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
37851000|NCT01079806|69534718|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
37851001|NCT01079806|69534719|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
37851002|NCT01079806|69534718|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
37851003|NCT01079806|69534719|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
37919958|NCT00834912|69606604|FG000|Treatment Period 1|Adverse Event|0|||
37919959|NCT00834912|69606605|FG001|Treatment Period 1|Adverse Event|1|||
37919960|NCT00834912|69606606|FG002|Treatment Period 1|Adverse Event|0|||
37919961|NCT00834912|69606607|FG003|Treatment Period 1|Adverse Event|1|||
37735394|NCT01901341|69215778|FG000|Overall Study|Study Terminated by Sponsor|13|||
37735395|NCT01901341|69215779|FG001|Overall Study|Study Terminated by Sponsor|15|||
37735396|NCT01901341|69215778|FG000|Overall Study|Withdrawal by Subject|1|||
38029915|NCT03594110|69715541|FG000|Overall Study|Cannot attend clinic because moving out of the area|15|||
38029916|NCT03594110|69715542|FG001|Overall Study|Cannot attend clinic because moving out of the area|9|||
38029917|NCT03594110|69715541|FG000|Overall Study|Contraindicated drug started|32|||
38029918|NCT03594110|69715542|FG001|Overall Study|Contraindicated drug started|18|||
38029919|NCT03594110|69715541|FG000|Overall Study|Other reasons (include any category with a frequency <20 patients in total)|58|||
38029920|NCT03594110|69715542|FG001|Overall Study|Other reasons (include any category with a frequency <20 patients in total)|45|||
37735397|NCT01901341|69215779|FG001|Overall Study|Withdrawal by Subject|1|||
37735398|NCT01615939|69215788|FG000|Overall Study|Lost to Follow-up|5|||
37735399|NCT01615939|69215789|FG001|Overall Study|Lost to Follow-up|0|||
37735400|NCT01901185|69215795|FG000|Overall Study|Withdrawal by Subject|2|||
37735401|NCT01888003|69215802|FG000|Overall Study|Study Terminated|5|||
37735402|NCT01888003|69215803|FG001|Overall Study|Study Terminated|6|||
37919962|NCT00834912|69606608|FG004|Treatment Period 1|Adverse Event|0|||
37919963|NCT00834912|69606609|FG005|Treatment Period 1|Adverse Event|0|||
37919964|NCT00834912|69606604|FG000|Treatment Period 2|Withdrawal by Subject|0|||
37919965|NCT00834912|69606605|FG001|Treatment Period 2|Withdrawal by Subject|0|||
37919966|NCT00834912|69606606|FG002|Treatment Period 2|Withdrawal by Subject|1|||
37919967|NCT00834912|69606607|FG003|Treatment Period 2|Withdrawal by Subject|0|||
37919968|NCT00834912|69606608|FG004|Treatment Period 2|Withdrawal by Subject|1|||
37919969|NCT00834912|69606609|FG005|Treatment Period 2|Withdrawal by Subject|0|||
37919970|NCT00883493|69606619|FG000|Overall Study|Adverse Event|11|||
37919971|NCT00883493|69606620|FG001|Overall Study|Adverse Event|12|||
37919972|NCT00883493|69606619|FG000|Overall Study|Lack of Efficacy|4|||
37735403|NCT01888003|69215804|FG002|Overall Study|Study Terminated|40|||
37919973|NCT00883493|69606620|FG001|Overall Study|Lack of Efficacy|3|||
37735404|NCT02775214|69215814|FG000|Overall Study|Withdrawal by Subject|2|||
37851004|NCT01079806|69534718|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
37851005|NCT01079806|69534719|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
37851006|NCT01078090|69534727|FG000|Overall Study|Lost to Follow-up|2363|||
37851007|NCT01078090|69534727|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
37851008|NCT01078090|69534727|FG000|Overall Study|Lack of Efficacy|1193|||
37851009|NCT01078090|69534727|FG000|Overall Study|ADR and lack of efficacy|61|||
37851010|NCT01078090|69534727|FG000|Overall Study|Other|523|||
37851011|NCT01077622|69534745|FG000|Overall Study|Physician Decision|2|||
37851012|NCT01077622|69534745|FG000|Overall Study|Withdrawal by Subject|1|||
37919974|NCT00883493|69606619|FG000|Overall Study|Lost to Follow-up|7|||
37919975|NCT00883493|69606620|FG001|Overall Study|Lost to Follow-up|6|||
37919976|NCT00883493|69606619|FG000|Overall Study|Withdrawal by Subject|11|||
37919977|NCT00883493|69606620|FG001|Overall Study|Withdrawal by Subject|20|||
37919978|NCT00883493|69606619|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
37919979|NCT00883493|69606620|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
37919980|NCT00883493|69606619|FG000|Overall Study|Study specific disc. criteria|2|||
37919981|NCT00883493|69606620|FG001|Overall Study|Study specific disc. criteria|0|||
37919982|NCT00883493|69606619|FG000|Overall Study|Other|5|||
37919983|NCT00883493|69606620|FG001|Overall Study|Other|3|||
37919984|NCT04887922|69606635|FG000|1st Randomization|Decided not to have surgery|0|||
37919985|NCT04887922|69606636|FG001|1st Randomization|Decided not to have surgery|1|||
37919986|NCT04887922|69606637|FG002|1st Randomization|Decided not to have surgery|0|||
37919987|NCT04887922|69606638|FG003|1st Randomization|Decided not to have surgery|0|||
37919988|NCT04887922|69606639|FG004|1st Randomization|Decided not to have surgery|0|||
37919989|NCT04771403|69606662|FG000|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|0|||
37919990|NCT04771403|69606663|FG001|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|1|||
37919991|NCT04771403|69606662|FG000|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|1|||
37919992|NCT04771403|69606663|FG001|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|0|||
37919993|NCT04771403|69606662|FG000|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|1|||
37919994|NCT04771403|69606663|FG001|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|0|||
37919995|NCT04771403|69606662|FG000|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|1|||
37919996|NCT04771403|69606663|FG001|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|0|||
37919997|NCT04771403|69606662|FG000|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|1|||
37919998|NCT04771403|69606663|FG001|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|0|||
37919999|NCT04771403|69606662|FG000|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|0|||
37920000|NCT04771403|69606663|FG001|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|1|||
37920001|NCT04771403|69606662|FG000|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|1|||
37920002|NCT04771403|69606663|FG001|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|0|||
37920003|NCT04771403|69606662|FG000|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|1|||
37920004|NCT04771403|69606663|FG001|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|0|||
37920005|NCT04698525|69606672|FG000|Overall Study|Lost to Follow-up|1|||
37920006|NCT04698525|69606673|FG001|Overall Study|Lost to Follow-up|2|||
37920007|NCT04698525|69606672|FG000|Overall Study|Three suffered of Covid-19|2|||
37920008|NCT04698525|69606673|FG001|Overall Study|Three suffered of Covid-19|1|||
38029921|NCT03594110|69715541|FG000|Overall Study|Death|129|||
38029922|NCT03594110|69715542|FG001|Overall Study|Death|120|||
38029923|NCT03024996|69715571|FG000|Overall Study|Death|57|||
38029924|NCT03024996|69715572|FG001|Overall Study|Death|55|||
38029925|NCT03024996|69715571|FG000|Overall Study|Disease relapse|1|||
38029926|NCT03024996|69715572|FG001|Overall Study|Disease relapse|0|||
38029927|NCT03024996|69715571|FG000|Overall Study|Lost to Follow-up|5|||
38029928|NCT03024996|69715572|FG001|Overall Study|Lost to Follow-up|10|||
38029929|NCT03024996|69715571|FG000|Overall Study|Other|3|||
38029930|NCT03024996|69715572|FG001|Overall Study|Other|3|||
38029931|NCT03024996|69715571|FG000|Overall Study|Physician Decision|0|||
38029932|NCT03024996|69715572|FG001|Overall Study|Physician Decision|1|||
37851013|NCT01313676|69534753|FG000|Overall Study|Adverse Event|395|||
37851014|NCT01313676|69534754|FG001|Overall Study|Adverse Event|365|||
37851015|NCT01313676|69534755|FG002|Overall Study|Adverse Event|372|||
37851016|NCT01313676|69534756|FG003|Overall Study|Adverse Event|333|||
37851017|NCT01313676|69534753|FG000|Overall Study|Lack of Efficacy|98|||
37851018|NCT01313676|69534754|FG001|Overall Study|Lack of Efficacy|90|||
37851019|NCT01313676|69534755|FG002|Overall Study|Lack of Efficacy|65|||
37851020|NCT01313676|69534756|FG003|Overall Study|Lack of Efficacy|46|||
38029933|NCT03024996|69715571|FG000|Overall Study|Study terminated by sponsor|303|||
38029934|NCT03024996|69715572|FG001|Overall Study|Study terminated by sponsor|283|||
37920009|NCT04510675|69606687|FG000|Overall Study|Withdrawal by Subject|5|||
37920010|NCT04228783|69606709|FG000|Overall Study|Adverse Event|1|||
37920011|NCT04228783|69606710|FG001|Overall Study|Adverse Event|0|||
37920012|NCT04228783|69606711|FG002|Overall Study|Adverse Event|2|||
38029935|NCT03024996|69715571|FG000|Overall Study|Withdrawal by Subject|21|||
38029936|NCT03024996|69715572|FG001|Overall Study|Withdrawal by Subject|36|||
38029937|NCT02642965|69715596|FG000|Overall Study|Lack of Efficacy|4|||
38029938|NCT02642965|69715596|FG000|Overall Study|Physician Decision|9|||
38029939|NCT01320085|69715613|FG000|Overall Study|Treatment Ongoing|0|||
38029940|NCT01320085|69715614|FG001|Overall Study|Treatment Ongoing|13|||
38029941|NCT01320085|69715615|FG002|Overall Study|Treatment Ongoing|2|||
38029942|NCT01320085|69715613|FG000|Overall Study|Disease Progression|26|||
38029943|NCT01320085|69715614|FG001|Overall Study|Disease Progression|86|||
38029944|NCT01320085|69715615|FG002|Overall Study|Disease Progression|16|||
38029945|NCT01320085|69715613|FG000|Overall Study|Adverse Event|12|||
38029946|NCT01320085|69715614|FG001|Overall Study|Adverse Event|14|||
38029947|NCT01320085|69715615|FG002|Overall Study|Adverse Event|5|||
38029948|NCT01320085|69715613|FG000|Overall Study|Withdrawal by Subject|2|||
38029949|NCT01320085|69715614|FG001|Overall Study|Withdrawal by Subject|4|||
38029950|NCT01320085|69715615|FG002|Overall Study|Withdrawal by Subject|1|||
38029951|NCT01320085|69715613|FG000|Overall Study|Protocol Deviation|1|||
38029952|NCT01320085|69715614|FG001|Overall Study|Protocol Deviation|0|||
38029953|NCT01320085|69715615|FG002|Overall Study|Protocol Deviation|1|||
38029954|NCT01038778|69715638|FG000|Overall Study|Withdrawal by Subject|0|||
38029955|NCT01038778|69715639|FG001|Overall Study|Withdrawal by Subject|2|||
38029956|NCT01038778|69715640|FG002|Overall Study|Withdrawal by Subject|3|||
38029957|NCT03443414|69715667|FG000|Overall Study|Adverse Event|6|||
38029958|NCT03443414|69715668|FG001|Overall Study|Adverse Event|0|||
38029959|NCT03443414|69715669|FG002|Overall Study|Adverse Event|4|||
38029960|NCT03443414|69715670|FG003|Overall Study|Adverse Event|2|||
38029961|NCT03443414|69715671|FG004|Overall Study|Adverse Event|3|||
38029962|NCT03443414|69715667|FG000|Overall Study|Withdrawal by Subject|3|||
38029963|NCT03443414|69715668|FG001|Overall Study|Withdrawal by Subject|2|||
38029964|NCT03443414|69715669|FG002|Overall Study|Withdrawal by Subject|2|||
38029965|NCT03443414|69715670|FG003|Overall Study|Withdrawal by Subject|2|||
38029966|NCT03443414|69715671|FG004|Overall Study|Withdrawal by Subject|1|||
38029967|NCT03443414|69715667|FG000|Overall Study|Death|0|||
37851021|NCT01313676|69534753|FG000|Overall Study|Protocol Violation|37|||
38029968|NCT03443414|69715668|FG001|Overall Study|Death|1|||
38029969|NCT03443414|69715669|FG002|Overall Study|Death|0|||
38029970|NCT03443414|69715670|FG003|Overall Study|Death|1|||
38029971|NCT03443414|69715671|FG004|Overall Study|Death|0|||
38029972|NCT03443414|69715667|FG000|Overall Study|Reason not specified|2|||
38029973|NCT03443414|69715668|FG001|Overall Study|Reason not specified|0|||
38029974|NCT03443414|69715669|FG002|Overall Study|Reason not specified|0|||
38029975|NCT03443414|69715670|FG003|Overall Study|Reason not specified|0|||
38029976|NCT03443414|69715671|FG004|Overall Study|Reason not specified|1|||
38029977|NCT02991118|69715685|FG000|Overall Study|Death|3|||
38029978|NCT02991118|69715686|FG001|Overall Study|Death|8|||
37735405|NCT02775214|69215815|FG001|Overall Study|Withdrawal by Subject|0|||
37851022|NCT01313676|69534754|FG001|Overall Study|Protocol Violation|44|||
37851023|NCT01313676|69534755|FG002|Overall Study|Protocol Violation|46|||
37851024|NCT01313676|69534756|FG003|Overall Study|Protocol Violation|44|||
37851025|NCT01313676|69534753|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
37851026|NCT01313676|69534754|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
37851027|NCT01313676|69534755|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
37851028|NCT01313676|69534756|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
37851029|NCT01313676|69534753|FG000|Overall Study|Study Closed/terminated|7|||
37851030|NCT01313676|69534754|FG001|Overall Study|Study Closed/terminated|6|||
37920013|NCT04228783|69606712|FG003|Overall Study|Adverse Event|0|||
37920014|NCT04228783|69606713|FG004|Overall Study|Adverse Event|0|||
37920015|NCT04228783|69606714|FG005|Overall Study|Adverse Event|1|||
37920016|NCT04228783|69606709|FG000|Overall Study|Death|0|||
38029979|NCT02991118|69715685|FG000|Overall Study|Protocol Violation|0|||
38029980|NCT02991118|69715686|FG001|Overall Study|Protocol Violation|3|||
38029981|NCT02991118|69715685|FG000|Overall Study|Physician Decision|0|||
38029982|NCT02991118|69715686|FG001|Overall Study|Physician Decision|1|||
38029983|NCT02991118|69715685|FG000|Overall Study|Moved out of the country|0|||
38029984|NCT02991118|69715686|FG001|Overall Study|Moved out of the country|1|||
38029985|NCT02991118|69715685|FG000|Overall Study|Adverse Event|2|||
38029986|NCT02991118|69715686|FG001|Overall Study|Adverse Event|2|||
38029987|NCT02991118|69715685|FG000|Overall Study|Withdrawal by Subject|1|||
37920017|NCT04228783|69606710|FG001|Overall Study|Death|0|||
37920018|NCT04228783|69606711|FG002|Overall Study|Death|0|||
37920019|NCT04228783|69606712|FG003|Overall Study|Death|0|||
37920020|NCT04228783|69606713|FG004|Overall Study|Death|1|||
37920021|NCT04228783|69606714|FG005|Overall Study|Death|0|||
37920022|NCT04228783|69606709|FG000|Overall Study|Lost to Follow-up|36|||
38029988|NCT02991118|69715686|FG001|Overall Study|Withdrawal by Subject|7|||
38029989|NCT02991118|69715685|FG000|Overall Study|Could not attend study visits|0|||
37851031|NCT01313676|69534755|FG002|Overall Study|Study Closed/terminated|9|||
37851032|NCT01313676|69534756|FG003|Overall Study|Study Closed/terminated|9|||
37851033|NCT01313676|69534753|FG000|Overall Study|Lost to Follow-up|0|||
37851034|NCT01313676|69534754|FG001|Overall Study|Lost to Follow-up|0|||
37851035|NCT01313676|69534755|FG002|Overall Study|Lost to Follow-up|1|||
37851036|NCT01313676|69534756|FG003|Overall Study|Lost to Follow-up|0|||
37851037|NCT01313676|69534753|FG000|Overall Study|Physician Decision|53|||
37851038|NCT01313676|69534754|FG001|Overall Study|Physician Decision|64|||
37851039|NCT01313676|69534755|FG002|Overall Study|Physician Decision|62|||
37851040|NCT01313676|69534756|FG003|Overall Study|Physician Decision|48|||
37851041|NCT01313676|69534753|FG000|Overall Study|Decision by Participant or Proxy|643|||
37851042|NCT01313676|69534754|FG001|Overall Study|Decision by Participant or Proxy|527|||
37851043|NCT01313676|69534755|FG002|Overall Study|Decision by Participant or Proxy|515|||
37851044|NCT01313676|69534756|FG003|Overall Study|Decision by Participant or Proxy|492|||
37851045|NCT01313676|69534753|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
37851046|NCT01313676|69534754|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
37851047|NCT01313676|69534755|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
37851048|NCT01313676|69534756|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
37851049|NCT01313676|69534753|FG000|Overall Study|Investigator Site Closed|12|||
37851050|NCT01313676|69534754|FG001|Overall Study|Investigator Site Closed|11|||
37851051|NCT01313676|69534755|FG002|Overall Study|Investigator Site Closed|15|||
37851052|NCT01313676|69534756|FG003|Overall Study|Investigator Site Closed|10|||
37851053|NCT01313676|69534753|FG000|Overall Study|Missing|1|||
38029990|NCT02991118|69715686|FG001|Overall Study|Could not attend study visits|1|||
37920023|NCT04228783|69606710|FG001|Overall Study|Lost to Follow-up|36|||
37920024|NCT04228783|69606711|FG002|Overall Study|Lost to Follow-up|28|||
38029991|NCT02991118|69715685|FG000|Overall Study|Lost to Follow-up|1|||
38029992|NCT02991118|69715686|FG001|Overall Study|Lost to Follow-up|9|||
38029993|NCT03491150|69715694|FG000|Overall Study|Adverse Event|1|||
38029994|NCT03491150|69715695|FG001|Overall Study|Adverse Event|0|||
37920025|NCT04228783|69606712|FG003|Overall Study|Lost to Follow-up|6|||
37920026|NCT04228783|69606713|FG004|Overall Study|Lost to Follow-up|14|||
37920027|NCT04228783|69606714|FG005|Overall Study|Lost to Follow-up|3|||
38029995|NCT03491150|69715694|FG000|Overall Study|Study Terminated by Sponsor|74|||
37920028|NCT04228783|69606709|FG000|Overall Study|Physician Decision|1|||
37920029|NCT04228783|69606710|FG001|Overall Study|Physician Decision|2|||
37920030|NCT04228783|69606711|FG002|Overall Study|Physician Decision|0|||
37920031|NCT04228783|69606712|FG003|Overall Study|Physician Decision|0|||
37920032|NCT04228783|69606713|FG004|Overall Study|Physician Decision|0|||
37920033|NCT04228783|69606714|FG005|Overall Study|Physician Decision|0|||
37920034|NCT04228783|69606709|FG000|Overall Study|Protocol Violation|0|||
37920035|NCT04228783|69606710|FG001|Overall Study|Protocol Violation|0|||
37920036|NCT04228783|69606711|FG002|Overall Study|Protocol Violation|0|||
37920037|NCT04228783|69606712|FG003|Overall Study|Protocol Violation|1|||
37920038|NCT04228783|69606713|FG004|Overall Study|Protocol Violation|0|||
37920039|NCT04228783|69606714|FG005|Overall Study|Protocol Violation|0|||
37920040|NCT04228783|69606709|FG000|Overall Study|Withdrawal by Subject|6|||
37920041|NCT04228783|69606710|FG001|Overall Study|Withdrawal by Subject|10|||
37920042|NCT04228783|69606711|FG002|Overall Study|Withdrawal by Subject|19|||
37920043|NCT04228783|69606712|FG003|Overall Study|Withdrawal by Subject|1|||
37920044|NCT04228783|69606713|FG004|Overall Study|Withdrawal by Subject|2|||
37920045|NCT04228783|69606714|FG005|Overall Study|Withdrawal by Subject|0|||
37920046|NCT04228783|69606709|FG000|Overall Study|Other|4|||
37920047|NCT04228783|69606710|FG001|Overall Study|Other|3|||
38029996|NCT03491150|69715695|FG001|Overall Study|Study Terminated by Sponsor|70|||
38029997|NCT03491150|69715694|FG000|Overall Study|Other|0|||
38029998|NCT03491150|69715695|FG001|Overall Study|Other|1|||
38029999|NCT03491150|69715694|FG000|Overall Study|Withdrawal by Subject|1|||
38030000|NCT03491150|69715695|FG001|Overall Study|Withdrawal by Subject|2|||
38030001|NCT02991040|69715701|FG000|Overall Study|Withdrawal by Subject|2|||
38030002|NCT02991040|69715701|FG000|Overall Study|Lost to Follow-up|2|||
38030003|NCT02910466|69715707|FG000|Overall Study|Adverse Event|1|||
38030004|NCT02910466|69715707|FG000|Overall Study|Withdrawal by Subject|3|||
38030005|NCT02910466|69715707|FG000|Overall Study|Lost to Follow-up|5|||
38030006|NCT02910466|69715707|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
38030007|NCT02910466|69715707|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
37920048|NCT04228783|69606711|FG002|Overall Study|Other|2|||
37920049|NCT04228783|69606712|FG003|Overall Study|Other|1|||
37920050|NCT04228783|69606713|FG004|Overall Study|Other|0|||
37920051|NCT04228783|69606714|FG005|Overall Study|Other|0|||
37920052|NCT03950674|69606730|FG000|Overall Study|Death|3|||
37851054|NCT01313676|69534754|FG001|Overall Study|Missing|1|||
37851055|NCT01313676|69534755|FG002|Overall Study|Missing|1|||
37851056|NCT01313676|69534756|FG003|Overall Study|Missing|0|||
37851057|NCT01313286|69534767|FG000|Period 1|Withdrawal by Subject|2|||
37851058|NCT01313286|69534768|FG001|Period 1|Withdrawal by Subject|0|||
37851059|NCT01313208|69534776|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
37851060|NCT01313208|69534777|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
37851061|NCT01313208|69534776|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
37851062|NCT01313208|69534777|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
37851063|NCT01313208|69534776|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
37920053|NCT03950674|69606731|FG001|Overall Study|Death|7|||
37920054|NCT03950674|69606730|FG000|Overall Study|Ongoing in Study|22|||
38030008|NCT03415178|69715713|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
37920055|NCT03950674|69606731|FG001|Overall Study|Ongoing in Study|8|||
37920056|NCT03702621|69606740|FG000|Overall Study|Physician Decision|6|||
37920057|NCT03702621|69606741|FG001|Overall Study|Physician Decision|6|||
37920058|NCT03577990|69606749|FG000|Overall Study|Lost to Follow-up|4|||
37920059|NCT03577990|69606750|FG001|Overall Study|Lost to Follow-up|6|||
37920060|NCT03577990|69606749|FG000|Overall Study|Withdrawal by Subject|4|||
37920061|NCT03577990|69606750|FG001|Overall Study|Withdrawal by Subject|7|||
37920062|NCT03565497|69606760|FG000|Overall Study|COVID-19 halt to human subjects research|0|||
37920063|NCT03565497|69606761|FG001|Overall Study|COVID-19 halt to human subjects research|1|||
38030009|NCT03415178|69715714|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
37920064|NCT03565497|69606762|FG002|Overall Study|COVID-19 halt to human subjects research|1|||
38030010|NCT03415178|69715713|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
38030011|NCT03415178|69715714|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
38030012|NCT01068730|69715724|FG000|Period 3|Personal reason|1|||
38030013|NCT01068730|69715725|FG001|Period 3|Personal reason|0|||
38030014|NCT01068730|69715726|FG002|Period 3|Personal reason|0|||
38030015|NCT01068730|69715727|FG003|Period 3|Personal reason|0|||
38030016|NCT01068730|69715724|FG000|Period 4|Family emergency|0|||
38030017|NCT01068730|69715725|FG001|Period 4|Family emergency|1|||
38030018|NCT01068730|69715726|FG002|Period 4|Family emergency|0|||
38030019|NCT01068730|69715727|FG003|Period 4|Family emergency|0|||
38030020|NCT01068652|69715746|FG000|Overall Study|Adverse Event|4|||
38030021|NCT01068652|69715747|FG001|Overall Study|Adverse Event|0|||
38030022|NCT01068652|69715746|FG000|Overall Study|Lack of Efficacy|0|||
38030023|NCT01068652|69715747|FG001|Overall Study|Lack of Efficacy|2|||
38030024|NCT01068652|69715746|FG000|Overall Study|Lost to Follow-up|2|||
38030025|NCT01068652|69715747|FG001|Overall Study|Lost to Follow-up|1|||
38030026|NCT01068652|69715746|FG000|Overall Study|Protocol Violation|3|||
38030027|NCT01068652|69715747|FG001|Overall Study|Protocol Violation|6|||
38030028|NCT01068652|69715746|FG000|Overall Study|Withdrawal criteria|1|||
38030029|NCT01068652|69715747|FG001|Overall Study|Withdrawal criteria|2|||
38030030|NCT01068652|69715746|FG000|Overall Study|Patient was not eligible|1|||
38030031|NCT01068652|69715747|FG001|Overall Study|Patient was not eligible|0|||
38030032|NCT01068652|69715746|FG000|Overall Study|Unclassified|7|||
38030033|NCT01068652|69715747|FG001|Overall Study|Unclassified|4|||
38030034|NCT02921776|69715759|FG000|Overall Study|patient deterioration, fatigue|2|||
38030035|NCT02921776|69715760|FG001|Overall Study|patient deterioration, fatigue|6|||
38030036|NCT02921776|69715761|FG002|Overall Study|patient deterioration, fatigue|0|||
38030037|NCT02921776|69715762|FG003|Overall Study|patient deterioration, fatigue|0|||
38030038|NCT02921776|69715763|FG004|Overall Study|patient deterioration, fatigue|0|||
38030039|NCT02921776|69715764|FG005|Overall Study|patient deterioration, fatigue|0|||
38030040|NCT02921776|69715765|FG006|Overall Study|patient deterioration, fatigue|0|||
38030041|NCT02921776|69715766|FG007|Overall Study|patient deterioration, fatigue|0|||
38030042|NCT02921776|69715759|FG000|Overall Study|Withdrawal by Subject|0|||
38030043|NCT02921776|69715760|FG001|Overall Study|Withdrawal by Subject|2|||
38030044|NCT02921776|69715761|FG002|Overall Study|Withdrawal by Subject|0|||
38030045|NCT02921776|69715762|FG003|Overall Study|Withdrawal by Subject|1|||
38030046|NCT02921776|69715763|FG004|Overall Study|Withdrawal by Subject|1|||
38030047|NCT02921776|69715764|FG005|Overall Study|Withdrawal by Subject|0|||
38030048|NCT02921776|69715765|FG006|Overall Study|Withdrawal by Subject|8|||
38030049|NCT02921776|69715766|FG007|Overall Study|Withdrawal by Subject|1|||
38030050|NCT02921776|69715759|FG000|Overall Study|Death|0|||
38030051|NCT02921776|69715760|FG001|Overall Study|Death|0|||
38030052|NCT02921776|69715761|FG002|Overall Study|Death|0|||
38030053|NCT02921776|69715762|FG003|Overall Study|Death|2|||
38030054|NCT02921776|69715763|FG004|Overall Study|Death|0|||
38030055|NCT02921776|69715764|FG005|Overall Study|Death|0|||
37851064|NCT01313208|69534777|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
37851065|NCT01313208|69534776|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
37851066|NCT01313208|69534777|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
37851067|NCT01313208|69534776|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
37851068|NCT01313208|69534777|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
37851069|NCT01313208|69534776|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
37851070|NCT01313208|69534777|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
37851071|NCT01313208|69534776|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
37851072|NCT01313208|69534777|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
37851073|NCT01313208|69534776|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
37851074|NCT01313208|69534777|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
37851075|NCT01313208|69534776|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
37851076|NCT01313208|69534777|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
37851077|NCT01312428|69534787|FG000|Overall Study|Study Termination|3|||
37920065|NCT03565497|69606760|FG000|Overall Study|Lost to Follow-up|1|||
38030056|NCT02921776|69715765|FG006|Overall Study|Death|0|||
38030057|NCT02921776|69715766|FG007|Overall Study|Death|0|||
38030058|NCT02921776|69715759|FG000|Overall Study|extubation or early discharge|0|||
38030059|NCT02921776|69715760|FG001|Overall Study|extubation or early discharge|0|||
38030060|NCT02921776|69715761|FG002|Overall Study|extubation or early discharge|0|||
38030061|NCT02921776|69715762|FG003|Overall Study|extubation or early discharge|5|||
38030062|NCT02921776|69715763|FG004|Overall Study|extubation or early discharge|5|||
38030063|NCT02921776|69715764|FG005|Overall Study|extubation or early discharge|0|||
38030064|NCT02921776|69715765|FG006|Overall Study|extubation or early discharge|0|||
38030065|NCT02921776|69715766|FG007|Overall Study|extubation or early discharge|0|||
38030066|NCT02921776|69715759|FG000|Overall Study|Lost to Follow-up|0|||
38030067|NCT02921776|69715760|FG001|Overall Study|Lost to Follow-up|0|||
38030068|NCT02921776|69715761|FG002|Overall Study|Lost to Follow-up|0|||
38030069|NCT02921776|69715762|FG003|Overall Study|Lost to Follow-up|0|||
38030070|NCT02921776|69715763|FG004|Overall Study|Lost to Follow-up|0|||
38030071|NCT02921776|69715764|FG005|Overall Study|Lost to Follow-up|2|||
38030072|NCT02921776|69715765|FG006|Overall Study|Lost to Follow-up|3|||
38030073|NCT02921776|69715766|FG007|Overall Study|Lost to Follow-up|6|||
38030074|NCT02922634|69715790|FG000|Overall Study|Withdrawal by Subject|5|||
38030075|NCT02922634|69715790|FG000|Overall Study|Did not have their surgery|5|||
38030076|NCT00023595|69715806|FG000|5 Year Follow up|Lost to Follow-up|2|||
38030077|NCT00023595|69715807|FG001|5 Year Follow up|Lost to Follow-up|2|||
38030078|NCT00023595|69715808|FG002|5 Year Follow up|Lost to Follow-up|1|||
38030079|NCT00023595|69715809|FG003|5 Year Follow up|Lost to Follow-up|7|||
38030080|NCT00023595|69715810|FG004|5 Year Follow up|Lost to Follow-up|3|||
38030081|NCT00023595|69715806|FG000|10 Year Follow up|Lost to Follow-up|12|||
37851078|NCT01312428|69534788|FG001|Overall Study|Study Termination|4|||
37851079|NCT01075984|69534801|FG000|Treatment Phase|Adverse Event|0|||
37851080|NCT01075984|69534802|FG001|Treatment Phase|Adverse Event|1|||
37851081|NCT01075984|69534803|FG002|Treatment Phase|Adverse Event|3|||
37851082|NCT01075984|69534804|FG003|Treatment Phase|Adverse Event|7|||
37851083|NCT01075984|69534805|FG004|Treatment Phase|Adverse Event|35|||
37851084|NCT01075984|69534801|FG000|Treatment Phase|Protocol Violation|0|||
37851085|NCT01075984|69534802|FG001|Treatment Phase|Protocol Violation|0|||
37851086|NCT01075984|69534803|FG002|Treatment Phase|Protocol Violation|1|||
37851087|NCT01075984|69534804|FG003|Treatment Phase|Protocol Violation|0|||
37851088|NCT01075984|69534805|FG004|Treatment Phase|Protocol Violation|3|||
37851089|NCT01075984|69534801|FG000|Treatment Phase|Withdrawal by Subject|0|||
37851090|NCT01075984|69534802|FG001|Treatment Phase|Withdrawal by Subject|0|||
37851091|NCT01075984|69534803|FG002|Treatment Phase|Withdrawal by Subject|2|||
37851092|NCT01075984|69534804|FG003|Treatment Phase|Withdrawal by Subject|0|||
37851093|NCT01075984|69534805|FG004|Treatment Phase|Withdrawal by Subject|15|||
37851094|NCT01075984|69534801|FG000|Treatment Phase|Treatment Failure|0|||
37851095|NCT01075984|69534802|FG001|Treatment Phase|Treatment Failure|0|||
37851096|NCT01075984|69534803|FG002|Treatment Phase|Treatment Failure|1|||
37851097|NCT01075984|69534804|FG003|Treatment Phase|Treatment Failure|0|||
37851098|NCT01075984|69534805|FG004|Treatment Phase|Treatment Failure|5|||
37851099|NCT01075984|69534801|FG000|Treatment Phase|Progression of disease|0|||
37851100|NCT01075984|69534802|FG001|Treatment Phase|Progression of disease|0|||
37851101|NCT01075984|69534803|FG002|Treatment Phase|Progression of disease|0|||
37851102|NCT01075984|69534804|FG003|Treatment Phase|Progression of disease|0|||
37851103|NCT01075984|69534805|FG004|Treatment Phase|Progression of disease|2|||
37851104|NCT01075984|69534801|FG000|Follow-up Phase|Protocol Violation|0|||
37851105|NCT01075984|69534802|FG001|Follow-up Phase|Protocol Violation|0|||
37851106|NCT01075984|69534803|FG002|Follow-up Phase|Protocol Violation|1|||
37851107|NCT01075984|69534804|FG003|Follow-up Phase|Protocol Violation|0|||
37851108|NCT01075984|69534805|FG004|Follow-up Phase|Protocol Violation|3|||
37851109|NCT01075984|69534801|FG000|Follow-up Phase|Adverse Event|0|||
37851110|NCT01075984|69534802|FG001|Follow-up Phase|Adverse Event|0|||
37851111|NCT01075984|69534803|FG002|Follow-up Phase|Adverse Event|0|||
37851112|NCT01075984|69534804|FG003|Follow-up Phase|Adverse Event|2|||
37851113|NCT01075984|69534805|FG004|Follow-up Phase|Adverse Event|27|||
37851114|NCT01075984|69534801|FG000|Follow-up Phase|Administrative|0|||
37851115|NCT01075984|69534802|FG001|Follow-up Phase|Administrative|0|||
37851116|NCT01075984|69534803|FG002|Follow-up Phase|Administrative|0|||
37851117|NCT01075984|69534804|FG003|Follow-up Phase|Administrative|0|||
37851118|NCT01075984|69534805|FG004|Follow-up Phase|Administrative|1|||
37851119|NCT01075984|69534801|FG000|Follow-up Phase|Withdrawal by Subject|0|||
37851120|NCT01075984|69534802|FG001|Follow-up Phase|Withdrawal by Subject|0|||
37851121|NCT01075984|69534803|FG002|Follow-up Phase|Withdrawal by Subject|0|||
37851122|NCT01075984|69534804|FG003|Follow-up Phase|Withdrawal by Subject|0|||
38030082|NCT00023595|69715807|FG001|10 Year Follow up|Lost to Follow-up|10|||
38030083|NCT00023595|69715808|FG002|10 Year Follow up|Lost to Follow-up|3|||
37851123|NCT01075984|69534805|FG004|Follow-up Phase|Withdrawal by Subject|10|||
37851124|NCT01075984|69534801|FG000|Follow-up Phase|Progression of disease|0|||
37851125|NCT01075984|69534802|FG001|Follow-up Phase|Progression of disease|0|||
37851126|NCT01075984|69534803|FG002|Follow-up Phase|Progression of disease|0|||
37851127|NCT01075984|69534804|FG003|Follow-up Phase|Progression of disease|0|||
37851128|NCT01075984|69534805|FG004|Follow-up Phase|Progression of disease|2|||
38030084|NCT00023595|69715809|FG003|10 Year Follow up|Lost to Follow-up|0|||
38030085|NCT00023595|69715810|FG004|10 Year Follow up|Lost to Follow-up|0|||
38030086|NCT02920528|69715836|FG000|Overall Study|Incomplete Data|1|||
37851129|NCT01075984|69534801|FG000|Follow-up Phase|Treatment failure|0|||
37851130|NCT01075984|69534802|FG001|Follow-up Phase|Treatment failure|0|||
38030087|NCT02920528|69715837|FG001|Overall Study|Incomplete Data|1|||
38030088|NCT02920528|69715838|FG002|Overall Study|Incomplete Data|1|||
38030089|NCT02920528|69715836|FG000|Overall Study|Adverse Event|0|||
38030090|NCT02920528|69715837|FG001|Overall Study|Adverse Event|0|||
38030091|NCT02920528|69715838|FG002|Overall Study|Adverse Event|3|||
38030092|NCT02920528|69715836|FG000|Overall Study|Did not meet inclusion criteria|2|||
38030093|NCT02920528|69715837|FG001|Overall Study|Did not meet inclusion criteria|0|||
38030094|NCT02920528|69715838|FG002|Overall Study|Did not meet inclusion criteria|1|||
38030095|NCT01068418|69715846|FG000|Overall Study|Physician Decision|12|||
38030096|NCT01068262|69715854|FG000|Overall Study|Adverse Event|2|||
38030097|NCT01068262|69715855|FG001|Overall Study|Adverse Event|0|||
38030098|NCT01068262|69715856|FG002|Overall Study|Adverse Event|1|||
38030099|NCT01068262|69715857|FG003|Overall Study|Adverse Event|0|||
38030100|NCT01068262|69715854|FG000|Overall Study|Protocol Violation|1|||
38030101|NCT01068262|69715855|FG001|Overall Study|Protocol Violation|0|||
38030102|NCT01068262|69715856|FG002|Overall Study|Protocol Violation|0|||
38030103|NCT01068262|69715857|FG003|Overall Study|Protocol Violation|0|||
38030104|NCT01068262|69715854|FG000|Overall Study|Withdrawal by Subject|0|||
38030105|NCT01068262|69715855|FG001|Overall Study|Withdrawal by Subject|1|||
38030106|NCT01068262|69715856|FG002|Overall Study|Withdrawal by Subject|0|||
38030107|NCT01068262|69715857|FG003|Overall Study|Withdrawal by Subject|0|||
38030108|NCT02920450|69715870|FG000|Overall Study|Death|1|||
38030109|NCT02920450|69715871|FG001|Overall Study|Death|0|||
38030110|NCT02920450|69715872|FG002|Overall Study|Death|0|||
38030111|NCT02920450|69715873|FG003|Overall Study|Death|0|||
38030112|NCT02920450|69715870|FG000|Overall Study|Withdrawal by Subject|1|||
38030113|NCT02920450|69715871|FG001|Overall Study|Withdrawal by Subject|0|||
38030114|NCT02920450|69715872|FG002|Overall Study|Withdrawal by Subject|0|||
38030115|NCT02920450|69715873|FG003|Overall Study|Withdrawal by Subject|0|||
38030116|NCT01066936|69715884|FG000|Overall Study|Death|2|||
38030117|NCT01066936|69715884|FG000|Overall Study|Device revised/removed|1|||
38030118|NCT01066936|69715884|FG000|Overall Study|Lost to Follow-up|3|||
38030119|NCT01066936|69715884|FG000|Overall Study|Withdrawal by Subject|4|||
38030120|NCT02919436|69715892|FG000|Overall Study|Did not undergo surgery|16|||
38030121|NCT02919436|69715893|FG001|Overall Study|Did not undergo surgery|20|||
38030122|NCT02919436|69715892|FG000|Overall Study|Enrolled before trial registration|44|||
38030123|NCT02919436|69715893|FG001|Overall Study|Enrolled before trial registration|33|||
38030124|NCT03804879|69715903|FG000|Overall Study|Adverse Event|3|||
38030125|NCT03804879|69715904|FG001|Overall Study|Adverse Event|0|||
38030126|NCT03804879|69715903|FG000|Overall Study|Study Terminated By Sponsor|10|||
38030127|NCT03804879|69715904|FG001|Overall Study|Study Terminated By Sponsor|12|||
38030128|NCT03804879|69715903|FG000|Overall Study|Withdrawal by Subject|3|||
38030129|NCT03804879|69715904|FG001|Overall Study|Withdrawal by Subject|1|||
38030130|NCT03803475|69715911|FG000|Overall Study|Physician Decision|1|||
38030131|NCT00005937|69715915|FG000|Overall Study|Lack of Efficacy|5|||
38030132|NCT03443024|69715923|FG000|Overall Study|Adverse Event|2|||
38030133|NCT03443024|69715924|FG001|Overall Study|Adverse Event|4|||
38030134|NCT03443024|69715925|FG002|Overall Study|Adverse Event|3|||
38030135|NCT03443024|69715926|FG003|Overall Study|Adverse Event|1|||
38030136|NCT03443024|69715923|FG000|Overall Study|Lost to Follow-up|9|||
38030137|NCT03443024|69715924|FG001|Overall Study|Lost to Follow-up|9|||
38030138|NCT03443024|69715925|FG002|Overall Study|Lost to Follow-up|7|||
38030139|NCT03443024|69715926|FG003|Overall Study|Lost to Follow-up|5|||
38030140|NCT03443024|69715923|FG000|Overall Study|Withdrawal by Subject|8|||
38030141|NCT03443024|69715924|FG001|Overall Study|Withdrawal by Subject|15|||
38030142|NCT03443024|69715925|FG002|Overall Study|Withdrawal by Subject|9|||
38030143|NCT03443024|69715926|FG003|Overall Study|Withdrawal by Subject|23|||
38030144|NCT03443024|69715923|FG000|Overall Study|Physician Decision|1|||
38030145|NCT03443024|69715924|FG001|Overall Study|Physician Decision|2|||
38030146|NCT03443024|69715925|FG002|Overall Study|Physician Decision|0|||
38030147|NCT03443024|69715926|FG003|Overall Study|Physician Decision|1|||
38030148|NCT03443024|69715923|FG000|Overall Study|Sponsor Decision|1|||
37851131|NCT01075984|69534803|FG002|Follow-up Phase|Treatment failure|0|||
38030149|NCT03443024|69715924|FG001|Overall Study|Sponsor Decision|1|||
38030150|NCT03443024|69715925|FG002|Overall Study|Sponsor Decision|0|||
38030151|NCT03443024|69715926|FG003|Overall Study|Sponsor Decision|0|||
38030152|NCT03443024|69715923|FG000|Overall Study|Protocol Deviation|0|||
38030153|NCT03443024|69715924|FG001|Overall Study|Protocol Deviation|0|||
38030154|NCT03443024|69715925|FG002|Overall Study|Protocol Deviation|0|||
38030155|NCT03443024|69715926|FG003|Overall Study|Protocol Deviation|2|||
38030156|NCT02908516|69715938|FG000|Overall Study|Study Terminated|3|||
38030157|NCT02908516|69715939|FG001|Overall Study|Study Terminated|3|||
38030158|NCT02907892|69715947|FG000|Overall Study|Lost to Follow-up|27|||
38030159|NCT02907892|69715948|FG001|Overall Study|Lost to Follow-up|40|||
38030160|NCT02906644|69715956|FG000|First 2 Weeks|Withdrawal by Subject|0|||
38030161|NCT02906644|69715957|FG001|First 2 Weeks|Withdrawal by Subject|2|||
38030162|NCT02906644|69715956|FG000|First 2 Weeks|Physician Decision|1|||
38030163|NCT02906644|69715957|FG001|First 2 Weeks|Physician Decision|1|||
37920066|NCT03565497|69606761|FG001|Overall Study|Lost to Follow-up|1|||
38030164|NCT02906644|69715956|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
38030165|NCT02906644|69715957|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
38030166|NCT02906644|69715956|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
38030167|NCT02906644|69715957|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
38030168|NCT03410108|69715964|FG000|Overall Study|Ongoing|41|||
38030169|NCT03410108|69715964|FG000|Overall Study|Adverse Event|4|||
38030170|NCT03410108|69715964|FG000|Overall Study|Progressive Disease|58|||
37851132|NCT01075984|69534804|FG003|Follow-up Phase|Treatment failure|0|||
37851133|NCT01075984|69534805|FG004|Follow-up Phase|Treatment failure|4|||
37851134|NCT01024231|69534824|FG000|Overall Study|Other Reasons|1|||
37851135|NCT01024231|69534825|FG001|Overall Study|Other Reasons|2|||
37851136|NCT01024231|69534826|FG002|Overall Study|Other Reasons|0|||
37851137|NCT01024231|69534827|FG003|Overall Study|Other Reasons|0|||
37851138|NCT01024231|69534828|FG004|Overall Study|Other Reasons|2|||
37851139|NCT01024231|69534829|FG005|Overall Study|Other Reasons|0|||
37851140|NCT01024231|69534830|FG006|Overall Study|Other Reasons|1|||
37851141|NCT01024231|69534824|FG000|Overall Study|Maximum Clinical Benefit|1|||
37851142|NCT01024231|69534825|FG001|Overall Study|Maximum Clinical Benefit|2|||
37851143|NCT01024231|69534826|FG002|Overall Study|Maximum Clinical Benefit|0|||
37851144|NCT01024231|69534827|FG003|Overall Study|Maximum Clinical Benefit|1|||
37851145|NCT01024231|69534828|FG004|Overall Study|Maximum Clinical Benefit|1|||
37851146|NCT01024231|69534829|FG005|Overall Study|Maximum Clinical Benefit|0|||
37920067|NCT03565497|69606762|FG002|Overall Study|Lost to Follow-up|2|||
37920068|NCT03565497|69606760|FG000|Overall Study|Withdrawal by Subject|1|||
37920069|NCT03565497|69606761|FG001|Overall Study|Withdrawal by Subject|1|||
37920070|NCT03565497|69606762|FG002|Overall Study|Withdrawal by Subject|1|||
37920071|NCT03362931|69606770|FG000|Overall Study|Adverse Event|1|||
37920072|NCT03362931|69606770|FG000|Overall Study|Death|2|||
37920073|NCT03360019|69606777|FG000|Overall Study|Withdrawal by Subject|2|||
37920074|NCT03360019|69606778|FG001|Overall Study|Withdrawal by Subject|0|||
37920075|NCT03360019|69606779|FG002|Overall Study|Withdrawal by Subject|0|||
37920076|NCT03360019|69606777|FG000|Overall Study|Pandemic caused suspension of study activities|6|||
37920077|NCT03360019|69606778|FG001|Overall Study|Pandemic caused suspension of study activities|0|||
37920078|NCT03360019|69606779|FG002|Overall Study|Pandemic caused suspension of study activities|0|||
37920079|NCT03245008|69606796|FG000|Overall Study|Adverse Event|15|||
37920080|NCT03245008|69606797|FG001|Overall Study|Adverse Event|18|||
37920081|NCT03245008|69606798|FG002|Overall Study|Adverse Event|15|||
37920082|NCT03245008|69606799|FG003|Overall Study|Adverse Event|0|||
37920083|NCT03245008|69606800|FG004|Overall Study|Adverse Event|1|||
37920084|NCT03245008|69606796|FG000|Overall Study|Lack of Efficacy|0|||
37920085|NCT03245008|69606797|FG001|Overall Study|Lack of Efficacy|1|||
37920086|NCT03245008|69606798|FG002|Overall Study|Lack of Efficacy|0|||
37920087|NCT03245008|69606799|FG003|Overall Study|Lack of Efficacy|0|||
37920088|NCT03245008|69606800|FG004|Overall Study|Lack of Efficacy|0|||
37920089|NCT03245008|69606796|FG000|Overall Study|Lost to Follow-up|4|||
37920090|NCT03245008|69606797|FG001|Overall Study|Lost to Follow-up|1|||
37920091|NCT03245008|69606798|FG002|Overall Study|Lost to Follow-up|0|||
37920092|NCT03245008|69606799|FG003|Overall Study|Lost to Follow-up|0|||
37920093|NCT03245008|69606800|FG004|Overall Study|Lost to Follow-up|1|||
37920094|NCT03245008|69606796|FG000|Overall Study|Physician Decision|1|||
37920095|NCT03245008|69606797|FG001|Overall Study|Physician Decision|3|||
38030171|NCT03410108|69715964|FG000|Overall Study|Withdrawal by Subject|1|||
37920096|NCT03245008|69606798|FG002|Overall Study|Physician Decision|4|||
37920097|NCT03245008|69606799|FG003|Overall Study|Physician Decision|0|||
37920098|NCT03245008|69606800|FG004|Overall Study|Physician Decision|0|||
38030172|NCT02982772|69715973|FG000|Intervention|Lost to Follow-up|19|||
37920099|NCT03245008|69606796|FG000|Overall Study|Protocol Violation|0|||
37920100|NCT03245008|69606797|FG001|Overall Study|Protocol Violation|1|||
37920101|NCT03245008|69606798|FG002|Overall Study|Protocol Violation|0|||
37920102|NCT03245008|69606799|FG003|Overall Study|Protocol Violation|0|||
37920103|NCT03245008|69606800|FG004|Overall Study|Protocol Violation|0|||
37851147|NCT01024231|69534830|FG006|Overall Study|Maximum Clinical Benefit|0|||
37920104|NCT03245008|69606796|FG000|Overall Study|Withdrawal by Subject|20|||
37920105|NCT03245008|69606797|FG001|Overall Study|Withdrawal by Subject|19|||
37920106|NCT03245008|69606798|FG002|Overall Study|Withdrawal by Subject|11|||
37920107|NCT03245008|69606799|FG003|Overall Study|Withdrawal by Subject|0|||
37920108|NCT03245008|69606800|FG004|Overall Study|Withdrawal by Subject|0|||
37920109|NCT03245008|69606796|FG000|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
37920110|NCT03245008|69606797|FG001|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
37920111|NCT03245008|69606798|FG002|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
38030173|NCT02982772|69715974|FG001|Intervention|Lost to Follow-up|13|||
38030174|NCT02982772|69715973|FG000|1M Follow-Up|Lost to Follow-up|21|||
37851148|NCT01024231|69534824|FG000|Overall Study|Disease Progression|3|||
38030175|NCT02982772|69715974|FG001|1M Follow-Up|Lost to Follow-up|18|||
38030176|NCT02982772|69715973|FG000|3M Follow-Up|Lost to Follow-up|17|||
37920112|NCT03245008|69606799|FG003|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
37920113|NCT03245008|69606800|FG004|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
37920114|NCT03245008|69606796|FG000|Overall Study|Failure to meet randomization criteria|0|||
37920115|NCT03245008|69606797|FG001|Overall Study|Failure to meet randomization criteria|1|||
37920116|NCT03245008|69606798|FG002|Overall Study|Failure to meet randomization criteria|0|||
37920117|NCT03245008|69606799|FG003|Overall Study|Failure to meet randomization criteria|1|||
38030177|NCT02982772|69715974|FG001|3M Follow-Up|Lost to Follow-up|11|||
38030178|NCT02982772|69715973|FG000|6M Follow-Up|Lost to Follow-up|11|||
38030179|NCT02982772|69715974|FG001|6M Follow-Up|Lost to Follow-up|9|||
38030180|NCT02982772|69715973|FG000|12M Follow-Up|Lost to Follow-up|11|||
38030181|NCT02982772|69715974|FG001|12M Follow-Up|Lost to Follow-up|5|||
38030182|NCT03488108|69715984|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
38030183|NCT03488108|69715985|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
38030184|NCT03488108|69715984|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
38030185|NCT03488108|69715985|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
38030186|NCT03440918|69715995|FG000|Overall Study|Protocol Violation|0|||
38030187|NCT03440918|69715996|FG001|Overall Study|Protocol Violation|16|||
38030188|NCT03486392|69716007|FG000|Overall Study|Lost to Follow-up|0|||
38030189|NCT03486392|69716008|FG001|Overall Study|Lost to Follow-up|0|||
38030190|NCT03486392|69716009|FG002|Overall Study|Lost to Follow-up|8|||
37920118|NCT03245008|69606800|FG004|Overall Study|Failure to meet randomization criteria|0|||
37920119|NCT03203473|69606822|FG000|Induction Phase|Never started primary treatment|2|||
37920120|NCT03203473|69606823|FG001|Induction Phase|Never started primary treatment|0|||
37920121|NCT03203473|69606824|FG002|Induction Phase|Never started primary treatment|0|||
37920122|NCT03203473|69606822|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
37920123|NCT03203473|69606823|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
38030191|NCT03486392|69716010|FG003|Overall Study|Lost to Follow-up|5|||
38030192|NCT03486392|69716011|FG004|Overall Study|Lost to Follow-up|2|||
38030193|NCT03486392|69716007|FG000|Overall Study|Withdrawal by Subject|3|||
38030194|NCT03486392|69716008|FG001|Overall Study|Withdrawal by Subject|0|||
37920124|NCT03203473|69606824|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
38030195|NCT03486392|69716009|FG002|Overall Study|Withdrawal by Subject|6|||
38030196|NCT03486392|69716010|FG003|Overall Study|Withdrawal by Subject|4|||
38030197|NCT03486392|69716011|FG004|Overall Study|Withdrawal by Subject|1|||
38030198|NCT03486392|69716007|FG000|Overall Study|Death|0|||
38030199|NCT03486392|69716008|FG001|Overall Study|Death|0|||
38030200|NCT03486392|69716009|FG002|Overall Study|Death|0|||
37851149|NCT01024231|69534825|FG001|Overall Study|Disease Progression|1|||
37851150|NCT01024231|69534826|FG002|Overall Study|Disease Progression|3|||
37851151|NCT01024231|69534827|FG003|Overall Study|Disease Progression|0|||
37851152|NCT01024231|69534828|FG004|Overall Study|Disease Progression|4|||
37851153|NCT01024231|69534829|FG005|Overall Study|Disease Progression|11|||
37851154|NCT01024231|69534830|FG006|Overall Study|Disease Progression|6|||
37851155|NCT01024231|69534824|FG000|Overall Study|AE unrelated to Study Drug|0|||
37851156|NCT01024231|69534825|FG001|Overall Study|AE unrelated to Study Drug|1|||
37851157|NCT01024231|69534826|FG002|Overall Study|AE unrelated to Study Drug|0|||
37851158|NCT01024231|69534827|FG003|Overall Study|AE unrelated to Study Drug|0|||
37851159|NCT01024231|69534828|FG004|Overall Study|AE unrelated to Study Drug|0|||
37851160|NCT01024231|69534829|FG005|Overall Study|AE unrelated to Study Drug|0|||
37851161|NCT01024231|69534830|FG006|Overall Study|AE unrelated to Study Drug|0|||
37851162|NCT01024231|69534824|FG000|Overall Study|No longer meets criteria|0|||
37851163|NCT01024231|69534825|FG001|Overall Study|No longer meets criteria|0|||
37851164|NCT01024231|69534826|FG002|Overall Study|No longer meets criteria|0|||
37851165|NCT01024231|69534827|FG003|Overall Study|No longer meets criteria|0|||
37851166|NCT01024231|69534828|FG004|Overall Study|No longer meets criteria|1|||
37851167|NCT01024231|69534829|FG005|Overall Study|No longer meets criteria|0|||
37851168|NCT01024231|69534830|FG006|Overall Study|No longer meets criteria|1|||
37851169|NCT01024231|69534824|FG000|Overall Study|Study Drug Toxicity|1|||
37920125|NCT03203473|69606822|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
37920126|NCT03203473|69606823|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
38030201|NCT03486392|69716010|FG003|Overall Study|Death|0|||
38030202|NCT03486392|69716011|FG004|Overall Study|Death|1|||
37851170|NCT01024231|69534825|FG001|Overall Study|Study Drug Toxicity|6|||
37851171|NCT01024231|69534826|FG002|Overall Study|Study Drug Toxicity|6|||
38030203|NCT02981602|69716028|FG000|Overall Study|Adverse Event|0|||
38030204|NCT02981602|69716029|FG001|Overall Study|Adverse Event|0|||
37851172|NCT01024231|69534827|FG003|Overall Study|Study Drug Toxicity|4|||
37851173|NCT01024231|69534828|FG004|Overall Study|Study Drug Toxicity|2|||
37851174|NCT01024231|69534829|FG005|Overall Study|Study Drug Toxicity|0|||
38030205|NCT02981602|69716030|FG002|Overall Study|Adverse Event|0|||
38030206|NCT02981602|69716031|FG003|Overall Study|Adverse Event|1|||
38030207|NCT02981602|69716032|FG004|Overall Study|Adverse Event|0|||
38030208|NCT02981524|69716045|FG000|Overall Study|Progressive Disease|14|||
38030209|NCT02981524|69716045|FG000|Overall Study|Death (unrelated)|1|||
38030210|NCT02981524|69716045|FG000|Overall Study|Treatment Related Toxicity|1|||
38030211|NCT02981524|69716045|FG000|Overall Study|Withdrawal by Subject|1|||
37920127|NCT03203473|69606824|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
37920128|NCT03203473|69606822|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
37920129|NCT03203473|69606823|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
37920130|NCT03203473|69606824|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
37920131|NCT03203473|69606822|FG000|Arm Allocation Phase|started salvage therapy|0|||
37920132|NCT03203473|69606823|FG001|Arm Allocation Phase|started salvage therapy|5|||
38030212|NCT03486314|69716049|FG000|Part A|Adverse Event|1|||
38030213|NCT03486314|69716050|FG001|Part A|Adverse Event|0|||
38030214|NCT03486314|69716051|FG002|Part A|Adverse Event|0|||
38030215|NCT03486314|69716049|FG000|Part A|Symptomatic Deterioration|2|||
38030216|NCT03486314|69716050|FG001|Part A|Symptomatic Deterioration|0|||
38030217|NCT03486314|69716051|FG002|Part A|Symptomatic Deterioration|0|||
38030218|NCT02905006|69716065|FG000|Overall Study|Adverse Event|1|||
38030219|NCT02905006|69716066|FG001|Overall Study|Adverse Event|1|||
38030220|NCT02905006|69716067|FG002|Overall Study|Adverse Event|1|||
38030221|NCT02905006|69716068|FG003|Overall Study|Adverse Event|1|||
38030222|NCT02905006|69716069|FG004|Overall Study|Adverse Event|0|||
38030223|NCT02905006|69716070|FG005|Overall Study|Adverse Event|1|||
38030224|NCT02905006|69716065|FG000|Overall Study|Lack of Efficacy|1|||
38030225|NCT02905006|69716066|FG001|Overall Study|Lack of Efficacy|0|||
38030226|NCT02905006|69716067|FG002|Overall Study|Lack of Efficacy|0|||
38030227|NCT02905006|69716068|FG003|Overall Study|Lack of Efficacy|0|||
38030228|NCT02905006|69716069|FG004|Overall Study|Lack of Efficacy|0|||
38030229|NCT02905006|69716070|FG005|Overall Study|Lack of Efficacy|0|||
38030230|NCT02905006|69716065|FG000|Overall Study|Protocol Violation|2|||
38030231|NCT02905006|69716066|FG001|Overall Study|Protocol Violation|0|||
38030232|NCT02905006|69716067|FG002|Overall Study|Protocol Violation|0|||
38030233|NCT02905006|69716068|FG003|Overall Study|Protocol Violation|0|||
38030234|NCT02905006|69716069|FG004|Overall Study|Protocol Violation|0|||
38030235|NCT02905006|69716070|FG005|Overall Study|Protocol Violation|0|||
38030236|NCT02905006|69716065|FG000|Overall Study|Lost to Follow-up|0|||
38030237|NCT02905006|69716066|FG001|Overall Study|Lost to Follow-up|0|||
38030238|NCT02905006|69716067|FG002|Overall Study|Lost to Follow-up|0|||
38030239|NCT02905006|69716068|FG003|Overall Study|Lost to Follow-up|1|||
38030240|NCT02905006|69716069|FG004|Overall Study|Lost to Follow-up|1|||
37851175|NCT01024231|69534830|FG006|Overall Study|Study Drug Toxicity|7|||
37851176|NCT01024231|69534824|FG000|Overall Study|Death|6|||
37851177|NCT01024231|69534825|FG001|Overall Study|Death|2|||
37851178|NCT01024231|69534826|FG002|Overall Study|Death|1|||
37920133|NCT03203473|69606824|FG002|Arm Allocation Phase|started salvage therapy|0|||
37920134|NCT03203473|69606822|FG000|Arm Allocation Phase|Disease progression|0|||
37920135|NCT03203473|69606823|FG001|Arm Allocation Phase|Disease progression|0|||
37920136|NCT03203473|69606824|FG002|Arm Allocation Phase|Disease progression|37|||
37920137|NCT03203473|69606822|FG000|Arm Allocation Phase|Adverse Event|0|||
37920138|NCT03203473|69606823|FG001|Arm Allocation Phase|Adverse Event|0|||
37920139|NCT03203473|69606824|FG002|Arm Allocation Phase|Adverse Event|11|||
37920140|NCT03203473|69606822|FG000|Arm Allocation Phase|Physician Decision|0|||
37920141|NCT03203473|69606823|FG001|Arm Allocation Phase|Physician Decision|0|||
37920142|NCT03203473|69606824|FG002|Arm Allocation Phase|Physician Decision|3|||
37920143|NCT03203473|69606822|FG000|Arm Allocation Phase|Death|0|||
37920144|NCT03203473|69606823|FG001|Arm Allocation Phase|Death|0|||
38030241|NCT02905006|69716070|FG005|Overall Study|Lost to Follow-up|0|||
37851179|NCT01024231|69534827|FG003|Overall Study|Death|0|||
37851180|NCT01024231|69534828|FG004|Overall Study|Death|4|||
37851181|NCT01024231|69534829|FG005|Overall Study|Death|3|||
37851182|NCT01024231|69534830|FG006|Overall Study|Death|5|||
37851183|NCT01024231|69534824|FG000|Overall Study|Lost to Follow-up|0|||
37851184|NCT01024231|69534825|FG001|Overall Study|Lost to Follow-up|0|||
37920145|NCT03203473|69606824|FG002|Arm Allocation Phase|Death|1|||
37920146|NCT03203473|69606822|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
37920147|NCT03203473|69606823|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
38030242|NCT02905006|69716065|FG000|Overall Study|Withdrawal by Subject|0|||
38030243|NCT02905006|69716066|FG001|Overall Study|Withdrawal by Subject|0|||
38030244|NCT02905006|69716067|FG002|Overall Study|Withdrawal by Subject|1|||
38030245|NCT02905006|69716068|FG003|Overall Study|Withdrawal by Subject|1|||
38030246|NCT02905006|69716069|FG004|Overall Study|Withdrawal by Subject|0|||
38030247|NCT02905006|69716070|FG005|Overall Study|Withdrawal by Subject|1|||
37851185|NCT01024231|69534826|FG002|Overall Study|Lost to Follow-up|0|||
38030248|NCT02905006|69716065|FG000|Overall Study|Screening exclusion criteria met|1|||
38030249|NCT02905006|69716066|FG001|Overall Study|Screening exclusion criteria met|0|||
38030250|NCT02905006|69716067|FG002|Overall Study|Screening exclusion criteria met|0|||
37851186|NCT01024231|69534827|FG003|Overall Study|Lost to Follow-up|0|||
38030251|NCT02905006|69716068|FG003|Overall Study|Screening exclusion criteria met|0|||
38030252|NCT02905006|69716069|FG004|Overall Study|Screening exclusion criteria met|0|||
38030253|NCT02905006|69716070|FG005|Overall Study|Screening exclusion criteria met|0|||
38030254|NCT02905006|69716065|FG000|Overall Study|Lab withdrawal criterion met|0|||
38030255|NCT02905006|69716066|FG001|Overall Study|Lab withdrawal criterion met|1|||
38030256|NCT02905006|69716067|FG002|Overall Study|Lab withdrawal criterion met|2|||
38030257|NCT02905006|69716068|FG003|Overall Study|Lab withdrawal criterion met|2|||
38030258|NCT02905006|69716069|FG004|Overall Study|Lab withdrawal criterion met|2|||
38030259|NCT02905006|69716070|FG005|Overall Study|Lab withdrawal criterion met|1|||
38030260|NCT02905006|69716065|FG000|Overall Study|Positive for Tuberculosis|0|||
37735406|NCT01925209|69215870|FG000|Treatment Epoch|Physician Decision|1|||
37735407|NCT01925209|69215871|FG001|Treatment Epoch|Physician Decision|0|||
37851187|NCT01024231|69534828|FG004|Overall Study|Lost to Follow-up|0|||
37851188|NCT01024231|69534829|FG005|Overall Study|Lost to Follow-up|0|||
37735408|NCT01925209|69215872|FG002|Treatment Epoch|Physician Decision|0|||
37735409|NCT01925209|69215873|FG003|Treatment Epoch|Physician Decision|0|||
37851189|NCT01024231|69534830|FG006|Overall Study|Lost to Follow-up|1|||
37851190|NCT01024231|69534824|FG000|Overall Study|Withdrew Consent|0|||
37851191|NCT01024231|69534825|FG001|Overall Study|Withdrew Consent|1|||
37851192|NCT01024231|69534826|FG002|Overall Study|Withdrew Consent|0|||
37851193|NCT01024231|69534827|FG003|Overall Study|Withdrew Consent|0|||
37851194|NCT01024231|69534828|FG004|Overall Study|Withdrew Consent|0|||
37851195|NCT01024231|69534829|FG005|Overall Study|Withdrew Consent|0|||
37851196|NCT01024231|69534830|FG006|Overall Study|Withdrew Consent|0|||
37920148|NCT03203473|69606824|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
37851197|NCT01024231|69534824|FG000|Overall Study|Continuing on Treatment|0|||
37851198|NCT01024231|69534825|FG001|Overall Study|Continuing on Treatment|0|||
37851199|NCT01024231|69534826|FG002|Overall Study|Continuing on Treatment|0|||
38030261|NCT02905006|69716066|FG001|Overall Study|Positive for Tuberculosis|1|||
38030262|NCT02905006|69716067|FG002|Overall Study|Positive for Tuberculosis|0|||
38030263|NCT02905006|69716068|FG003|Overall Study|Positive for Tuberculosis|0|||
38030264|NCT02905006|69716069|FG004|Overall Study|Positive for Tuberculosis|0|||
38030265|NCT02905006|69716070|FG005|Overall Study|Positive for Tuberculosis|0|||
37851200|NCT01024231|69534827|FG003|Overall Study|Continuing on Treatment|0|||
37920149|NCT03203473|69606822|FG000|Arm Allocation Phase|Intercurrent illness|0|||
37920150|NCT03203473|69606823|FG001|Arm Allocation Phase|Intercurrent illness|0|||
37920151|NCT03203473|69606824|FG002|Arm Allocation Phase|Intercurrent illness|1|||
37920152|NCT03203473|69606822|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
37920153|NCT03203473|69606823|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
37920154|NCT03203473|69606824|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
37920155|NCT03158051|69606837|FG000|Overall Study|Lost to Follow-up|41|||
37851201|NCT01024231|69534828|FG004|Overall Study|Continuing on Treatment|3|||
37851202|NCT01024231|69534829|FG005|Overall Study|Continuing on Treatment|2|||
37851203|NCT01024231|69534830|FG006|Overall Study|Continuing on Treatment|0|||
37851204|NCT01077544|69534853|FG000|Overall Study|New Cancer Therapy|3|||
37851205|NCT01077544|69534854|FG001|Overall Study|New Cancer Therapy|3|||
37851206|NCT01077544|69534853|FG000|Overall Study|Adverse Event|0|||
37851207|NCT01077544|69534854|FG001|Overall Study|Adverse Event|1|||
37851208|NCT01077544|69534853|FG000|Overall Study|Disease Progression|0|||
37851209|NCT01077544|69534854|FG001|Overall Study|Disease Progression|1|||
37920156|NCT03158051|69606838|FG001|Overall Study|Lost to Follow-up|47|||
37920157|NCT03158051|69606837|FG000|Overall Study|Physician Decision|6|||
37920158|NCT03158051|69606838|FG001|Overall Study|Physician Decision|7|||
37920159|NCT03158051|69606837|FG000|Overall Study|Withdrawal by Subject|24|||
37920160|NCT03158051|69606838|FG001|Overall Study|Withdrawal by Subject|15|||
37920161|NCT03158051|69606837|FG000|Overall Study|Death|0|||
37920162|NCT03158051|69606838|FG001|Overall Study|Death|1|||
38030266|NCT02905006|69716065|FG000|Overall Study|Subject positive for Hep B|0|||
37851210|NCT01075516|69534862|FG000|Overall Study|Death|5|||
37851211|NCT01075516|69534863|FG001|Overall Study|Death|9|||
37851212|NCT01075516|69534862|FG000|Overall Study|Lost to Follow-up|10|||
37851213|NCT01075516|69534863|FG001|Overall Study|Lost to Follow-up|2|||
37851214|NCT01075516|69534862|FG000|Overall Study|Withdrawal by Subject|3|||
37851215|NCT01075516|69534863|FG001|Overall Study|Withdrawal by Subject|5|||
37851216|NCT01012999|69534869|FG000|Overall Study|Protocol Violation|1|||
37851217|NCT01017601|69534875|FG000|Overall Study|Disease Progression|12|||
37851218|NCT01017601|69534876|FG001|Overall Study|Disease Progression|12|||
37851219|NCT01017601|69534875|FG000|Overall Study|Withdrawal by Subject|0|||
37851220|NCT01017601|69534876|FG001|Overall Study|Withdrawal by Subject|1|||
37851221|NCT01016977|69534884|FG000|Overall Study|Lost to Follow-up|1|||
37851222|NCT01016977|69534885|FG001|Overall Study|Lost to Follow-up|0|||
37851223|NCT01016977|69534884|FG000|Overall Study|Withdrawal by Subject|2|||
37851224|NCT01016977|69534885|FG001|Overall Study|Withdrawal by Subject|2|||
37851225|NCT01012765|69534894|FG000|Treatment Period 1|Adverse Event|1|||
37851226|NCT01012765|69534895|FG001|Treatment Period 1|Adverse Event|0|||
37851227|NCT01012765|69534896|FG002|Treatment Period 1|Adverse Event|1|||
37851228|NCT01012765|69534897|FG003|Treatment Period 1|Adverse Event|0|||
37851229|NCT01012765|69534898|FG004|Treatment Period 1|Adverse Event|0|||
37851230|NCT01012765|69534899|FG005|Treatment Period 1|Adverse Event|0|||
37851231|NCT01012765|69534894|FG000|Treatment Period 1|Withdrawal by Subject|2|||
37851232|NCT01012765|69534895|FG001|Treatment Period 1|Withdrawal by Subject|0|||
37851233|NCT01012765|69534896|FG002|Treatment Period 1|Withdrawal by Subject|0|||
37851234|NCT01012765|69534897|FG003|Treatment Period 1|Withdrawal by Subject|0|||
37851235|NCT01012765|69534898|FG004|Treatment Period 1|Withdrawal by Subject|0|||
37920163|NCT02971761|69606853|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
37920164|NCT02724878|69606857|FG000|Overall Study|Still on Active Therapy|15|||
37920165|NCT02724878|69606857|FG000|Overall Study|Disease Progression|31|||
38030267|NCT02905006|69716066|FG001|Overall Study|Subject positive for Hep B|0|||
37851236|NCT01012765|69534899|FG005|Treatment Period 1|Withdrawal by Subject|0|||
38030268|NCT02905006|69716067|FG002|Overall Study|Subject positive for Hep B|1|||
37851237|NCT01012765|69534894|FG000|Treatment Period 1|Administrative problems|0|||
37851238|NCT01012765|69534895|FG001|Treatment Period 1|Administrative problems|0|||
37851239|NCT01012765|69534896|FG002|Treatment Period 1|Administrative problems|1|||
37851240|NCT01012765|69534897|FG003|Treatment Period 1|Administrative problems|1|||
37851241|NCT01012765|69534898|FG004|Treatment Period 1|Administrative problems|1|||
37851242|NCT01012765|69534899|FG005|Treatment Period 1|Administrative problems|0|||
37920166|NCT02724878|69606857|FG000|Overall Study|Toxicity|5|||
37920167|NCT02724878|69606857|FG000|Overall Study|Death|1|||
37920168|NCT02724878|69606857|FG000|Overall Study|Withdrawal by Subject|4|||
37920169|NCT02724878|69606857|FG000|Overall Study|Lost to Follow-up|2|||
37920170|NCT02724878|69606857|FG000|Overall Study|Protocol Violation|1|||
37920171|NCT02724878|69606857|FG000|Overall Study|Ineligible for Study Drug|5|||
37920172|NCT02724878|69606857|FG000|Overall Study|not started|1|||
37920173|NCT02600507|69606864|FG000|Overall Study|Adverse Event|3|||
37920174|NCT02600507|69606865|FG001|Overall Study|Adverse Event|15|||
37920175|NCT02600507|69606866|FG002|Overall Study|Adverse Event|5|||
37920176|NCT02600507|69606864|FG000|Overall Study|Lack of Efficacy|3|||
37920177|NCT02600507|69606865|FG001|Overall Study|Lack of Efficacy|8|||
37920178|NCT02600507|69606866|FG002|Overall Study|Lack of Efficacy|5|||
37920179|NCT02600507|69606864|FG000|Overall Study|Lost to Follow-up|3|||
37920180|NCT02600507|69606865|FG001|Overall Study|Lost to Follow-up|5|||
37920181|NCT02600507|69606866|FG002|Overall Study|Lost to Follow-up|2|||
37920182|NCT02600507|69606864|FG000|Overall Study|Protocol Violation|12|||
37920183|NCT02600507|69606865|FG001|Overall Study|Protocol Violation|4|||
37920184|NCT02600507|69606866|FG002|Overall Study|Protocol Violation|4|||
37920185|NCT02600507|69606864|FG000|Overall Study|Physician Decision|1|||
37920186|NCT02600507|69606865|FG001|Overall Study|Physician Decision|0|||
37920187|NCT02600507|69606866|FG002|Overall Study|Physician Decision|1|||
37920188|NCT02600507|69606864|FG000|Overall Study|Withdrawal by Subject|7|||
37920189|NCT02600507|69606865|FG001|Overall Study|Withdrawal by Subject|11|||
37920190|NCT02600507|69606866|FG002|Overall Study|Withdrawal by Subject|7|||
37920191|NCT02600507|69606864|FG000|Overall Study|Other|0|||
37920192|NCT02600507|69606865|FG001|Overall Study|Other|1|||
37920193|NCT02600507|69606866|FG002|Overall Study|Other|1|||
37920194|NCT02578680|69606876|FG000|Overall Study|Death|124|||
37920195|NCT02578680|69606877|FG001|Overall Study|Death|104|||
37920196|NCT02578680|69606876|FG000|Overall Study|Protocol Violation|1|||
37920197|NCT02578680|69606877|FG001|Overall Study|Protocol Violation|1|||
37920198|NCT02578680|69606876|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
37920199|NCT02578680|69606877|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
37920200|NCT02578680|69606876|FG000|Overall Study|Withdrawal by Subject|8|||
37920201|NCT02578680|69606877|FG001|Overall Study|Withdrawal by Subject|5|||
37920202|NCT02578680|69606876|FG000|Overall Study|Ongoing in Study|276|||
37920203|NCT02578680|69606877|FG001|Overall Study|Ongoing in Study|96|||
37920204|NCT02385266|69606885|FG000|Overall Study|Withdrawal by Subject|1|||
37920205|NCT02385266|69606886|FG001|Overall Study|Withdrawal by Subject|3|||
37920206|NCT02379988|69606892|FG000|Overall Study|Not eligible|1|||
37920207|NCT02006069|69606907|FG000|Overall Study|MPP other programming|239|||
38030269|NCT02905006|69716068|FG003|Overall Study|Subject positive for Hep B|0|||
38030270|NCT02905006|69716069|FG004|Overall Study|Subject positive for Hep B|0|||
38030271|NCT02905006|69716070|FG005|Overall Study|Subject positive for Hep B|0|||
38030272|NCT02905006|69716065|FG000|Overall Study|Patient moved abroad|0|||
38030273|NCT02905006|69716066|FG001|Overall Study|Patient moved abroad|0|||
38030274|NCT02905006|69716067|FG002|Overall Study|Patient moved abroad|0|||
37851243|NCT01012765|69534894|FG000|Treatment Period 1|Protocol Violation|0|||
37851244|NCT01012765|69534895|FG001|Treatment Period 1|Protocol Violation|0|||
37851245|NCT01012765|69534896|FG002|Treatment Period 1|Protocol Violation|0|||
37851246|NCT01012765|69534897|FG003|Treatment Period 1|Protocol Violation|2|||
37851247|NCT01012765|69534898|FG004|Treatment Period 1|Protocol Violation|1|||
37851248|NCT01012765|69534899|FG005|Treatment Period 1|Protocol Violation|0|||
37851249|NCT01012765|69534894|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
37851250|NCT01012765|69534895|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
37851251|NCT01012765|69534896|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
37920208|NCT02006069|69606908|FG001|Overall Study|MPP other programming|0|||
37920209|NCT02006069|69606907|FG000|Overall Study|RV only pacing|0|||
37920210|NCT02006069|69606908|FG001|Overall Study|RV only pacing|3|||
37920211|NCT01985867|69606916|FG000|Overall Study|Lost to Follow-up|3|||
37920212|NCT01985867|69606917|FG001|Overall Study|Lost to Follow-up|4|||
37920213|NCT01985867|69606916|FG000|Overall Study|Adverse Event|3|||
37920214|NCT01985867|69606917|FG001|Overall Study|Adverse Event|2|||
37920215|NCT01985867|69606916|FG000|Overall Study|Lack of Efficacy|1|||
37920216|NCT01985867|69606917|FG001|Overall Study|Lack of Efficacy|0|||
37920217|NCT01367002|69606925|FG000|Overall Study|Withdrawal by Subject|1|||
37920218|NCT01367002|69606926|FG001|Overall Study|Withdrawal by Subject|0|||
37920219|NCT01367002|69606925|FG000|Overall Study|Physician Decision|0|||
37920220|NCT01367002|69606926|FG001|Overall Study|Physician Decision|2|||
37920221|NCT00858273|69606934|FG000|Overall Study|Protocol Violation|3|||
37920222|NCT00858273|69606935|FG001|Overall Study|Protocol Violation|5|||
38030275|NCT02905006|69716068|FG003|Overall Study|Patient moved abroad|1|||
38030276|NCT02905006|69716069|FG004|Overall Study|Patient moved abroad|0|||
37851252|NCT01012765|69534897|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
37920223|NCT00844428|69606966|FG000|Screening Period|Screen Failure|3|||
37920224|NCT00844428|69606966|FG000|Extension Treatment Period|Death|1|||
38030277|NCT02905006|69716070|FG005|Overall Study|Patient moved abroad|0|||
38030278|NCT02905006|69716065|FG000|Overall Study|Patient randomized by mistake|0|||
38030279|NCT02905006|69716066|FG001|Overall Study|Patient randomized by mistake|0|||
38030280|NCT02905006|69716067|FG002|Overall Study|Patient randomized by mistake|0|||
38030281|NCT02905006|69716068|FG003|Overall Study|Patient randomized by mistake|0|||
38030282|NCT02905006|69716069|FG004|Overall Study|Patient randomized by mistake|0|||
37920225|NCT00844428|69606966|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
37920226|NCT00834834|69606972|FG000|Overall Study|Withdrawal by Subject|4|||
37920227|NCT00834834|69606973|FG001|Overall Study|Withdrawal by Subject|3|||
37920228|NCT00834366|69606981|FG000|Treatment Period 1|Adverse Event|1|||
37920229|NCT00834366|69606982|FG001|Treatment Period 1|Adverse Event|1|||
37920230|NCT00844194|69606990|FG000|Overall Study|Adverse Event|17|||
37920231|NCT00844194|69606991|FG001|Overall Study|Adverse Event|5|||
37920232|NCT00844194|69606990|FG000|Overall Study|Protocol Violation|1|||
37920233|NCT00844194|69606991|FG001|Overall Study|Protocol Violation|1|||
37920234|NCT00844194|69606990|FG000|Overall Study|Lost to Follow-up|1|||
37920235|NCT00844194|69606991|FG001|Overall Study|Lost to Follow-up|1|||
38030283|NCT02905006|69716070|FG005|Overall Study|Patient randomized by mistake|1|||
38030284|NCT01066780|69716108|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
38030285|NCT01066780|69716109|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
38030286|NCT02975206|69716116|FG000|Overall Study|Withdrawal by Subject|14|||
38030287|NCT02975206|69716117|FG001|Overall Study|Withdrawal by Subject|11|||
38030288|NCT02975206|69716118|FG002|Overall Study|Withdrawal by Subject|11|||
38030289|NCT02975206|69716116|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
38030290|NCT02975206|69716117|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
38030291|NCT02975206|69716118|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
38030292|NCT01066156|69716126|FG000|Overall Study|ineligible|2|||
38030293|NCT01066156|69716126|FG000|Overall Study|Lost to Follow-up|7|||
38030294|NCT01066156|69716126|FG000|Overall Study|Withdrawal by Subject|1|||
38030295|NCT02980042|69716132|FG000|Overall Study|Lost to Follow-up|5|||
38030296|NCT02980042|69716133|FG001|Overall Study|Lost to Follow-up|0|||
38030297|NCT02980042|69716132|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
38030298|NCT02980042|69716133|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
38030299|NCT01066000|69716151|FG000|Overall Study|Protocol Violation|4|||
38030300|NCT01066000|69716151|FG000|Overall Study|Death|3|||
38030301|NCT01066000|69716151|FG000|Overall Study|Withdrawal by Subject|1|||
38030302|NCT01066000|69716151|FG000|Overall Study|Adverse Event|1|||
38030303|NCT01065844|69716155|FG000|Overall Study|Adverse Event|5|||
38030304|NCT00004635|69716161|FG000|Period One|refused|2|||
38030305|NCT00004635|69716162|FG001|Period One|refused|1|||
38030306|NCT00004635|69716161|FG000|Period One|Withdrawal by Subject|1|||
38030307|NCT00004635|69716162|FG001|Period One|Withdrawal by Subject|1|||
38030308|NCT00004635|69716161|FG000|Period One|Protocol Violation|1|||
38030309|NCT00004635|69716162|FG001|Period One|Protocol Violation|0|||
38030310|NCT00004635|69716161|FG000|Period One|PSA did not go <5 ng/mL|1|||
38030311|NCT00004635|69716162|FG001|Period One|PSA did not go <5 ng/mL|0|||
38030312|NCT00004635|69716161|FG000|Period One|second malignancy|1|||
38030313|NCT00004635|69716162|FG001|Period One|second malignancy|0|||
38030314|NCT00004635|69716161|FG000|Period One|progressed|0|||
38030315|NCT00004635|69716162|FG001|Period One|progressed|2|||
38030316|NCT00004635|69716161|FG000|Period One|health problem|0|||
38030317|NCT00004635|69716162|FG001|Period One|health problem|1|||
38030318|NCT00004635|69716161|FG000|Period One|discrepancy in data entry|0|||
38030319|NCT00004635|69716162|FG001|Period One|discrepancy in data entry|1|||
37851253|NCT01012765|69534898|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
37851254|NCT01012765|69534899|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
37851255|NCT01012765|69534894|FG000|Treatment Period 2|Withdrawal by Subject|1|||
37851256|NCT01012765|69534895|FG001|Treatment Period 2|Withdrawal by Subject|0|||
37851257|NCT01012765|69534896|FG002|Treatment Period 2|Withdrawal by Subject|1|||
37851258|NCT01012765|69534897|FG003|Treatment Period 2|Withdrawal by Subject|0|||
37851259|NCT01012765|69534898|FG004|Treatment Period 2|Withdrawal by Subject|1|||
37851260|NCT01012765|69534899|FG005|Treatment Period 2|Withdrawal by Subject|0|||
37851261|NCT01012765|69534894|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
37851262|NCT01012765|69534895|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
37851263|NCT01012765|69534896|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
37920236|NCT00844194|69606990|FG000|Overall Study|Withdrawal by Subject|2|||
37920237|NCT00844194|69606991|FG001|Overall Study|Withdrawal by Subject|1|||
38030320|NCT00004635|69716161|FG000|Period Two|progression|2|||
38030321|NCT00004635|69716162|FG001|Period Two|progression|3|||
38030322|NCT00004635|69716161|FG000|Period Two|Adverse Event|1|||
38030323|NCT00004635|69716162|FG001|Period Two|Adverse Event|0|||
38030324|NCT00004635|69716161|FG000|Period Two|refused|0|||
38030325|NCT00004635|69716162|FG001|Period Two|refused|2|||
38030326|NCT00004635|69716161|FG000|Period Two|health problem|1|||
38030327|NCT00004635|69716162|FG001|Period Two|health problem|1|||
38030328|NCT00004635|69716161|FG000|Period Two|travel issues|0|||
38030329|NCT00004635|69716162|FG001|Period Two|travel issues|1|||
38030330|NCT00004635|69716161|FG000|Period Two|secondary malignancy|1|||
38030331|NCT00004635|69716162|FG001|Period Two|secondary malignancy|1|||
38030332|NCT00004635|69716161|FG000|Period Two|Lost to Follow-up|1|||
38030333|NCT00004635|69716162|FG001|Period Two|Lost to Follow-up|0|||
38030334|NCT00004635|69716161|FG000|Period Two|discrepancy in data entry|0|||
38030335|NCT00004635|69716162|FG001|Period Two|discrepancy in data entry|1|||
38030336|NCT00004563|69716173|FG000|Overall Study|Withdrawal by Subject|20|||
38030337|NCT00004563|69716174|FG001|Overall Study|Withdrawal by Subject|16|||
38030338|NCT00004563|69716173|FG000|Overall Study|Lack of Efficacy|3|||
38030339|NCT00004563|69716174|FG001|Overall Study|Lack of Efficacy|5|||
38030340|NCT00004563|69716173|FG000|Overall Study|Death|2|||
38030341|NCT00004563|69716174|FG001|Overall Study|Death|3|||
38030342|NCT00003645|69716182|FG000|Overall Study|Death|4|||
38030343|NCT00003645|69716183|FG001|Overall Study|Death|1|||
38030344|NCT00003645|69716182|FG000|Overall Study|Lost to Follow-up|7|||
38030345|NCT00003645|69716183|FG001|Overall Study|Lost to Follow-up|8|||
38030346|NCT00003645|69716182|FG000|Overall Study|Withdrawal by Subject|1|||
38030347|NCT00003645|69716183|FG001|Overall Study|Withdrawal by Subject|3|||
38030348|NCT00003537|69716191|FG000|Overall Study|Not evalauable|1|||
38030349|NCT00003531|69716195|FG000|Overall Study|Not evaluable|10|||
38030350|NCT02918968|69716201|FG000|1st Line AAT|Progressive disease|9|||
38030351|NCT02918968|69716202|FG001|1st Line AAT|Progressive disease|4|||
38030352|NCT02918968|69716201|FG000|1st Line AAT|Adverse Event|12|||
38030353|NCT02918968|69716202|FG001|1st Line AAT|Adverse Event|3|||
38030354|NCT02918968|69716201|FG000|1st Line AAT|Physician Decision|4|||
38030355|NCT02918968|69716202|FG001|1st Line AAT|Physician Decision|2|||
38030356|NCT02918968|69716201|FG000|1st Line AAT|Withdrawal by Subject|2|||
38030357|NCT02918968|69716202|FG001|1st Line AAT|Withdrawal by Subject|1|||
37920238|NCT00844194|69606990|FG000|Overall Study|Lack of Efficacy|3|||
37920239|NCT00844194|69606991|FG001|Overall Study|Lack of Efficacy|0|||
37920240|NCT00844194|69606990|FG000|Overall Study|Other reason (not specified)|1|||
37920241|NCT00844194|69606991|FG001|Overall Study|Other reason (not specified)|0|||
38030358|NCT02918968|69716201|FG000|1st Line AAT|Lost to Follow-up|0|||
37735410|NCT01925209|69215870|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
37735411|NCT01925209|69215871|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
37735412|NCT01925209|69215872|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
37735413|NCT01925209|69215873|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
37735414|NCT01925209|69215870|FG000|Treatment Epoch|Death|1|||
37735415|NCT01925209|69215871|FG001|Treatment Epoch|Death|0|||
37735416|NCT01925209|69215872|FG002|Treatment Epoch|Death|0|||
37735417|NCT01925209|69215873|FG003|Treatment Epoch|Death|0|||
38030359|NCT02918968|69716202|FG001|1st Line AAT|Lost to Follow-up|1|||
38030360|NCT02918968|69716201|FG000|1st Line AAT|Death|1|||
37851264|NCT01012765|69534897|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
37851265|NCT01012765|69534898|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
37851266|NCT01012765|69534899|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
37851267|NCT01012765|69534894|FG000|Treatment Period 2|Adverse Event|0|||
37851268|NCT01012765|69534895|FG001|Treatment Period 2|Adverse Event|1|||
37851269|NCT01012765|69534896|FG002|Treatment Period 2|Adverse Event|1|||
37851270|NCT01012765|69534897|FG003|Treatment Period 2|Adverse Event|0|||
37920242|NCT00826176|69607003|FG000|Overall Study|Lost to Follow-up|1|||
37920243|NCT00826176|69607004|FG001|Overall Study|Lost to Follow-up|0|||
37920244|NCT00826176|69607003|FG000|Overall Study|Subject Withdrew Consent|3|||
37920245|NCT00826176|69607004|FG001|Overall Study|Subject Withdrew Consent|0|||
37920246|NCT00826176|69607003|FG000|Overall Study|Administrative|9|||
37920247|NCT00826176|69607004|FG001|Overall Study|Administrative|0|||
37920248|NCT00878969|69607013|FG000|Overall Study|Physician Decision|5|||
37920249|NCT00878969|69607014|FG001|Overall Study|Physician Decision|3|||
37920250|NCT00878969|69607015|FG002|Overall Study|Physician Decision|2|||
38030361|NCT02918968|69716202|FG001|1st Line AAT|Death|0|||
38030362|NCT02918968|69716201|FG000|1st Line AAT|Miscellaneous|1|||
38030363|NCT02918968|69716202|FG001|1st Line AAT|Miscellaneous|0|||
37735418|NCT01925209|69215870|FG000|Treatment Epoch|Protocol deviation|0|||
37851271|NCT01012765|69534898|FG004|Treatment Period 2|Adverse Event|0|||
37851272|NCT01012765|69534899|FG005|Treatment Period 2|Adverse Event|0|||
37920251|NCT00878969|69607013|FG000|Overall Study|Withdrawal by Subject|1|||
37920252|NCT00878969|69607014|FG001|Overall Study|Withdrawal by Subject|6|||
37920253|NCT00878969|69607015|FG002|Overall Study|Withdrawal by Subject|3|||
37920254|NCT00878969|69607013|FG000|Overall Study|kidney transplant|2|||
37920255|NCT00878969|69607014|FG001|Overall Study|kidney transplant|3|||
38030364|NCT02918968|69716201|FG000|2nd Line AAT|Progressive disease|21|||
38030365|NCT02918968|69716202|FG001|2nd Line AAT|Progressive disease|3|||
38030366|NCT02918968|69716201|FG000|2nd Line AAT|Adverse Event|2|||
38030367|NCT02918968|69716202|FG001|2nd Line AAT|Adverse Event|5|||
38030368|NCT02918968|69716201|FG000|2nd Line AAT|Physician Decision|0|||
38030369|NCT02918968|69716202|FG001|2nd Line AAT|Physician Decision|1|||
38030370|NCT02918968|69716201|FG000|2nd Line AAT|Withdrawal by Subject|2|||
38030371|NCT02918968|69716202|FG001|2nd Line AAT|Withdrawal by Subject|2|||
38030372|NCT02918968|69716201|FG000|2nd Line AAT|Death|0|||
38030373|NCT02918968|69716202|FG001|2nd Line AAT|Death|1|||
37920256|NCT00878969|69607015|FG002|Overall Study|kidney transplant|2|||
37920257|NCT00878969|69607013|FG000|Overall Study|Adverse Event|3|||
37920258|NCT00878969|69607014|FG001|Overall Study|Adverse Event|1|||
37920259|NCT00878969|69607015|FG002|Overall Study|Adverse Event|2|||
37920260|NCT00878969|69607013|FG000|Overall Study|Lost to Follow-up|2|||
37920261|NCT00878969|69607014|FG001|Overall Study|Lost to Follow-up|1|||
37920262|NCT00878969|69607015|FG002|Overall Study|Lost to Follow-up|0|||
37920263|NCT00878969|69607013|FG000|Overall Study|Protocol Violation|2|||
37920264|NCT00878969|69607014|FG001|Overall Study|Protocol Violation|0|||
37920265|NCT00878969|69607015|FG002|Overall Study|Protocol Violation|0|||
37920266|NCT00878969|69607013|FG000|Overall Study|Death|0|||
37920267|NCT00878969|69607014|FG001|Overall Study|Death|0|||
37920268|NCT00878969|69607015|FG002|Overall Study|Death|2|||
37920269|NCT00878969|69607013|FG000|Overall Study|Pregnancy|0|||
37920270|NCT00878969|69607014|FG001|Overall Study|Pregnancy|1|||
37920271|NCT00878969|69607015|FG002|Overall Study|Pregnancy|0|||
37920272|NCT00843726|69607029|FG000|Overall Study|Death|1|||
37920273|NCT00843726|69607030|FG001|Overall Study|Death|0|||
37920274|NCT00843726|69607029|FG000|Overall Study|Withdrawal by Subject|0|||
37920275|NCT00843726|69607030|FG001|Overall Study|Withdrawal by Subject|1|||
37920276|NCT00843492|69607039|FG000|Overall Study|Adverse Event|0|||
37920277|NCT00843492|69607040|FG001|Overall Study|Adverse Event|3|||
37920278|NCT00843492|69607039|FG000|Overall Study|Lost to Follow-up|4|||
37920279|NCT00843492|69607040|FG001|Overall Study|Lost to Follow-up|4|||
37920280|NCT00843492|69607039|FG000|Overall Study|Withdrawal by Subject|0|||
37851273|NCT01012765|69534894|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
37851274|NCT01012765|69534895|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
37851275|NCT01012765|69534896|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
37851276|NCT01012765|69534897|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
37851277|NCT01012765|69534898|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
37920281|NCT00843492|69607040|FG001|Overall Study|Withdrawal by Subject|4|||
37735419|NCT01925209|69215871|FG001|Treatment Epoch|Protocol deviation|0|||
37851278|NCT01012765|69534899|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
37851279|NCT01010503|69534907|FG000|Overall Study|Adverse Event|1|||
37851280|NCT01010503|69534907|FG000|Overall Study|Death|1|||
37851281|NCT01006291|69534914|FG000|Overall Study|Adverse Event|2|||
37851282|NCT01006291|69534915|FG001|Overall Study|Adverse Event|1|||
37851283|NCT01006291|69534916|FG002|Overall Study|Adverse Event|2|||
37851284|NCT01006291|69534914|FG000|Overall Study|Lack of Efficacy|2|||
37851285|NCT01006291|69534915|FG001|Overall Study|Lack of Efficacy|2|||
37851286|NCT01006291|69534916|FG002|Overall Study|Lack of Efficacy|1|||
37851287|NCT01006291|69534914|FG000|Overall Study|Protocol Violation|3|||
37851288|NCT01006291|69534915|FG001|Overall Study|Protocol Violation|3|||
37851289|NCT01006291|69534916|FG002|Overall Study|Protocol Violation|3|||
37851290|NCT01006291|69534914|FG000|Overall Study|Withdrawal criteria|5|||
37851291|NCT01006291|69534915|FG001|Overall Study|Withdrawal criteria|4|||
37851292|NCT01006291|69534916|FG002|Overall Study|Withdrawal criteria|4|||
37851293|NCT01006291|69534914|FG000|Overall Study|Other|14|||
37851294|NCT01006291|69534915|FG001|Overall Study|Other|14|||
37851295|NCT01006291|69534916|FG002|Overall Study|Other|17|||
37851296|NCT01006135|69534924|FG000|Overall Study|Adverse Event|22|||
37851297|NCT01006135|69534924|FG000|Overall Study|Protocol Violation|14|||
37851298|NCT01006135|69534924|FG000|Overall Study|Lost to Follow-up|32|||
37851299|NCT01006135|69534924|FG000|Overall Study|Other|72|||
37851300|NCT01012609|69534930|FG000|Overall Study|Withdrawal by Subject|1|||
37851301|NCT01012609|69534931|FG001|Overall Study|Withdrawal by Subject|1|||
37851302|NCT01012219|69534938|FG000|Period 1|Withdrawal by Subject|1|||
37851303|NCT01012219|69534938|FG000|Period 2|Withdrawal by Subject|1|||
37851304|NCT01011907|69534947|FG000|Overall Study|Withdrawal by Subject|13|||
37851305|NCT01011907|69534948|FG001|Overall Study|Withdrawal by Subject|11|||
37851306|NCT01011907|69534947|FG000|Overall Study|Adverse Event|1|||
37920282|NCT00843492|69607039|FG000|Overall Study|Immobilization Stopped|1|||
37920283|NCT00843492|69607040|FG001|Overall Study|Immobilization Stopped|0|||
37920284|NCT00843492|69607039|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
37735420|NCT01925209|69215872|FG002|Treatment Epoch|Protocol deviation|1|||
37735421|NCT01925209|69215873|FG003|Treatment Epoch|Protocol deviation|1|||
37735422|NCT01925209|69215870|FG000|Treatment Epoch|Withdrawal by Subject|4|||
37851307|NCT01011907|69534948|FG001|Overall Study|Adverse Event|4|||
37851308|NCT01011673|69534956|FG000|Randomized|Secondary headache|2|||
37851309|NCT01011673|69534957|FG001|Randomized|Secondary headache|1|||
37851310|NCT01011673|69534956|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
37920285|NCT00843492|69607040|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
37920286|NCT00843492|69607039|FG000|Overall Study|Orthopedic Surgery|0|||
37920287|NCT00843492|69607040|FG001|Overall Study|Orthopedic Surgery|2|||
37851311|NCT01011673|69534957|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
37851312|NCT01311648|69534966|FG000|Main Study|Protocol Violation|0|||
37851313|NCT01311648|69534967|FG001|Main Study|Protocol Violation|1|||
37920288|NCT00843492|69607039|FG000|Overall Study|Visit Not Performed|1|||
37920289|NCT00843492|69607040|FG001|Overall Study|Visit Not Performed|0|||
37920290|NCT00843492|69607039|FG000|Overall Study|Deep-vein Thrombosis|1|||
37920291|NCT00843492|69607040|FG001|Overall Study|Deep-vein Thrombosis|0|||
37920292|NCT00833976|69607046|FG000|Overall Study|Withdrawal by Subject|5|||
37920293|NCT00833976|69607046|FG000|Overall Study|Lost to Follow-up|4|||
37920294|NCT00833976|69607046|FG000|Overall Study|Did not meet eligibility criteria|41|||
37851314|NCT01311648|69534966|FG000|Main Study|Adverse Event|0|||
37851315|NCT01311648|69534967|FG001|Main Study|Adverse Event|1|||
37851316|NCT01311648|69534966|FG000|Main Study|Inhibitor management|0|||
37851317|NCT01311648|69534967|FG001|Main Study|Inhibitor management|17|||
37851318|NCT01311648|69534966|FG000|Main Study|Withdrawal by Subject|0|||
37851319|NCT01311648|69534967|FG001|Main Study|Withdrawal by Subject|2|||
37851320|NCT01311648|69534966|FG000|Extension Study|Physician Decision|0|||
37851321|NCT01311648|69534967|FG001|Extension Study|Physician Decision|1|||
37851322|NCT01311648|69534966|FG000|Extension Study|ITI therapy with marketed product|0|||
37851323|NCT01311648|69534967|FG001|Extension Study|ITI therapy with marketed product|1|||
37851324|NCT01311648|69534966|FG000|Extension Study|Incorrect visit planning|0|||
37851325|NCT01311648|69534967|FG001|Extension Study|Incorrect visit planning|1|||
37851326|NCT01311648|69534966|FG000|Extension Study|Family's decision|0|||
37851327|NCT01311648|69534967|FG001|Extension Study|Family's decision|1|||
37851328|NCT01311648|69534966|FG000|Extension Study|Failure of ITI therapy|0|||
37851329|NCT01311648|69534967|FG001|Extension Study|Failure of ITI therapy|3|||
37851330|NCT01311648|69534966|FG000|Extension Study|Long travel|0|||
37851331|NCT01311648|69534967|FG001|Extension Study|Long travel|1|||
37851332|NCT01311648|69534966|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
37851333|NCT01311648|69534967|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
37851334|NCT01311648|69534966|FG000|Extension Study|Withdrawal by Subject|0|||
37851335|NCT01311648|69534967|FG001|Extension Study|Withdrawal by Subject|1|||
37851336|NCT01311648|69534966|FG000|Extension Study|Inhibitor management|0|||
37851337|NCT01311648|69534967|FG001|Extension Study|Inhibitor management|2|||
37851338|NCT01011439|69534980|FG000|Overall Study|Death|37|||
37851339|NCT01011439|69534980|FG000|Overall Study|Lost to Follow-up|4|||
37851340|NCT01011439|69534980|FG000|Overall Study|Withdrawal by Subject|1|||
37851341|NCT01011439|69534980|FG000|Overall Study|Sponsor's decision|15|||
37851342|NCT01311024|69534987|FG000|Overall Study|Protocol Violation|35|||
37851343|NCT01311024|69534988|FG001|Overall Study|Protocol Violation|22|||
37851344|NCT01310868|69534994|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
37851345|NCT01273155|69535002|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
37851346|NCT01273155|69535003|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
37851347|NCT01273155|69535004|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
37851348|NCT01273155|69535005|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
37851349|NCT01273155|69535006|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
37851350|NCT01273155|69535007|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
37851351|NCT01273155|69535008|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
37851352|NCT01273155|69535002|FG000|Overall Study|Change in liver function/no longer eval.|0|||
37851353|NCT01273155|69535003|FG001|Overall Study|Change in liver function/no longer eval.|1|||
37851354|NCT01273155|69535004|FG002|Overall Study|Change in liver function/no longer eval.|0|||
37851355|NCT01273155|69535005|FG003|Overall Study|Change in liver function/no longer eval.|0|||
37851356|NCT01273155|69535006|FG004|Overall Study|Change in liver function/no longer eval.|1|||
37851357|NCT01273155|69535007|FG005|Overall Study|Change in liver function/no longer eval.|0|||
37851358|NCT01273155|69535008|FG006|Overall Study|Change in liver function/no longer eval.|0|||
37851359|NCT01273155|69535002|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
37920295|NCT00833976|69607046|FG000|Overall Study|Physician Decision|1|||
37920296|NCT00833898|69607052|FG000|Overall Study|Withdrawal by Subject|33|||
37851360|NCT01273155|69535003|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
37851361|NCT01273155|69535004|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
37851362|NCT01273155|69535005|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
37851363|NCT01273155|69535006|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
37851364|NCT01273155|69535007|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
37920297|NCT00833898|69607053|FG001|Overall Study|Withdrawal by Subject|27|||
37920298|NCT00833898|69607052|FG000|Overall Study|Lost to Follow-up|7|||
37920299|NCT00833898|69607053|FG001|Overall Study|Lost to Follow-up|7|||
37920300|NCT00833898|69607052|FG000|Overall Study|Patient did not receive transplant|0|||
37920301|NCT00833898|69607053|FG001|Overall Study|Patient did not receive transplant|2|||
37920302|NCT00825162|69607062|FG000|Overall Study|Withdrawal by Subject|11|||
37851365|NCT01273155|69535008|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
37851366|NCT01273155|69535002|FG000|Overall Study|Died during Cycle 1|0|||
37851367|NCT01273155|69535003|FG001|Overall Study|Died during Cycle 1|0|||
37920303|NCT00825162|69607063|FG001|Overall Study|Withdrawal by Subject|13|||
37920304|NCT00825162|69607064|FG002|Overall Study|Withdrawal by Subject|3|||
37920305|NCT00825162|69607062|FG000|Overall Study|Lost to Follow-up|9|||
37920306|NCT00825162|69607063|FG001|Overall Study|Lost to Follow-up|6|||
37920307|NCT00825162|69607064|FG002|Overall Study|Lost to Follow-up|3|||
37920308|NCT00825162|69607062|FG000|Overall Study|Physician Decision|2|||
37920309|NCT00825162|69607063|FG001|Overall Study|Physician Decision|0|||
37920310|NCT00825162|69607064|FG002|Overall Study|Physician Decision|0|||
37920311|NCT00825162|69607062|FG000|Overall Study|Move away from the study area|1|||
37920312|NCT00825162|69607063|FG001|Overall Study|Move away from the study area|0|||
37920313|NCT00825162|69607064|FG002|Overall Study|Move away from the study area|0|||
37920314|NCT00825162|69607062|FG000|Overall Study|Unable to attend the study visit|5|||
37920315|NCT00825162|69607063|FG001|Overall Study|Unable to attend the study visit|2|||
37920316|NCT00825162|69607064|FG002|Overall Study|Unable to attend the study visit|0|||
37920317|NCT00824850|69607079|FG000|Overall Study|Withdrawal by Subject|0|||
37920318|NCT00824850|69607080|FG001|Overall Study|Withdrawal by Subject|1|||
37920319|NCT00596687|69607094|FG000|Overall Study|< 24 hours of insulin treatment|8|||
37920320|NCT00596687|69607095|FG001|Overall Study|< 24 hours of insulin treatment|6|||
37920321|NCT00596687|69607094|FG000|Overall Study|continuous insulin infusion during TPN|2|||
37920322|NCT00596687|69607095|FG001|Overall Study|continuous insulin infusion during TPN|1|||
37920323|NCT00596687|69607094|FG000|Overall Study|Withdrawal by Subject|3|||
37920324|NCT00596687|69607095|FG001|Overall Study|Withdrawal by Subject|1|||
37920325|NCT00596687|69607094|FG000|Overall Study|cancelled surgery|1|||
37920326|NCT00596687|69607095|FG001|Overall Study|cancelled surgery|1|||
37920327|NCT00824772|69607101|FG000|Overall Study|Withdrawal by Subject|8|||
37920328|NCT00824616|69607107|FG000|Overall Study|Adverse Event|2|||
37920329|NCT00824616|69607108|FG001|Overall Study|Adverse Event|1|||
37920330|NCT00824616|69607107|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
37920331|NCT00824616|69607108|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
37920332|NCT00824616|69607107|FG000|Overall Study|Hyperglycemia|1|||
37920333|NCT00824616|69607108|FG001|Overall Study|Hyperglycemia|1|||
37920334|NCT00824616|69607107|FG000|Overall Study|Lack of Efficacy|2|||
37920335|NCT00824616|69607108|FG001|Overall Study|Lack of Efficacy|1|||
37920336|NCT00824616|69607107|FG000|Overall Study|Lost to Follow-up|0|||
37920337|NCT00824616|69607108|FG001|Overall Study|Lost to Follow-up|1|||
37920338|NCT00824616|69607107|FG000|Overall Study|Withdrawal by Subject|1|||
37920339|NCT00824616|69607108|FG001|Overall Study|Withdrawal by Subject|1|||
37920340|NCT00824382|69607118|FG000|Overall Study|Adverse Event|4|||
37920341|NCT00824382|69607119|FG001|Overall Study|Adverse Event|1|||
37920342|NCT00824382|69607120|FG002|Overall Study|Adverse Event|1|||
37920343|NCT00824382|69607121|FG003|Overall Study|Adverse Event|4|||
37920344|NCT00824382|69607118|FG000|Overall Study|Protocol Violation|1|||
37851368|NCT01273155|69535004|FG002|Overall Study|Died during Cycle 1|1|||
37851369|NCT01273155|69535005|FG003|Overall Study|Died during Cycle 1|1|||
37851370|NCT01273155|69535006|FG004|Overall Study|Died during Cycle 1|0|||
37851371|NCT01273155|69535007|FG005|Overall Study|Died during Cycle 1|2|||
37851372|NCT01273155|69535008|FG006|Overall Study|Died during Cycle 1|2|||
37851373|NCT01273155|69535002|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
37851374|NCT01273155|69535003|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
37851375|NCT01273155|69535004|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
37851376|NCT01273155|69535005|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
37851377|NCT01273155|69535006|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
37851378|NCT01273155|69535007|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
37851379|NCT01273155|69535008|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
37851380|NCT01005901|69535033|FG000|Overall Study|Withdrawal by Subject|38|||
37851381|NCT01005901|69535034|FG001|Overall Study|Withdrawal by Subject|14|||
37851382|NCT01005901|69535033|FG000|Overall Study|Adverse Event|30|||
37851383|NCT01005901|69535034|FG001|Overall Study|Adverse Event|16|||
37851384|NCT01005901|69535033|FG000|Overall Study|Administrative problems|21|||
37851385|NCT01005901|69535034|FG001|Overall Study|Administrative problems|13|||
37851386|NCT01005901|69535033|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
37920345|NCT00824382|69607119|FG001|Overall Study|Protocol Violation|0|||
37920346|NCT00824382|69607120|FG002|Overall Study|Protocol Violation|0|||
37851387|NCT01005901|69535034|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
37920347|NCT00824382|69607121|FG003|Overall Study|Protocol Violation|1|||
37920348|NCT00824382|69607118|FG000|Overall Study|Investigator's decision|0|||
37920349|NCT00824382|69607119|FG001|Overall Study|Investigator's decision|1|||
37920350|NCT00824382|69607120|FG002|Overall Study|Investigator's decision|2|||
37920351|NCT00824382|69607121|FG003|Overall Study|Investigator's decision|0|||
37851388|NCT01005901|69535033|FG000|Overall Study|Protocol Violation|4|||
37851389|NCT01005901|69535034|FG001|Overall Study|Protocol Violation|3|||
37851390|NCT01005901|69535033|FG000|Overall Study|Death|2|||
37920352|NCT00833040|69607133|FG000|Overall Study|Adverse Event|0|||
38030374|NCT01065766|69716210|FG000|Overall Study|Assessed before the contracted date|1|||
38030375|NCT01065766|69716210|FG000|Overall Study|Contraindication to administration|6|||
38030376|NCT01065766|69716210|FG000|Overall Study|Violated dosage/administration|25|||
38030377|NCT01063972|69716216|FG000|Overall Study|Death|12|||
38030378|NCT01063972|69716217|FG001|Overall Study|Death|11|||
38030379|NCT01063972|69716216|FG000|Overall Study|Incarcerated|2|||
38030380|NCT01063972|69716217|FG001|Overall Study|Incarcerated|1|||
38030381|NCT00003483|69716223|FG000|Overall Study|Not evaluable|1|||
38030382|NCT00003477|69716227|FG000|Overall Study|Not evalauable|4|||
38030383|NCT00003471|69716231|FG000|Overall Study|Not evaluable|4|||
38030384|NCT04185220|69716237|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
38030385|NCT04185220|69716238|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
38030386|NCT04185220|69716237|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
38030387|NCT04185220|69716238|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
38030388|NCT00002931|69716245|FG000|Overall Study|rapidly progressing disease during|2|||
38030389|NCT02918266|69716260|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
38030390|NCT02918266|69716261|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
38030391|NCT02918266|69716262|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
37735423|NCT01925209|69215871|FG001|Treatment Epoch|Withdrawal by Subject|3|||
37735424|NCT01925209|69215872|FG002|Treatment Epoch|Withdrawal by Subject|3|||
37735425|NCT01925209|69215873|FG003|Treatment Epoch|Withdrawal by Subject|2|||
38030392|NCT02918266|69716263|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
38030393|NCT02918266|69716264|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
38030394|NCT02918266|69716265|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
38030395|NCT02918266|69716266|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
38030396|NCT02918266|69716267|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
38030397|NCT02918266|69716268|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
38030398|NCT02918266|69716269|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
38030399|NCT02918266|69716270|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
38030400|NCT00041067|69716290|FG000|Overall Study|Adverse Event|20|||
38030401|NCT00041067|69716290|FG000|Overall Study|Progression|19|||
37735426|NCT01925209|69215870|FG000|Treatment Epoch|Adverse Event|3|||
37735427|NCT01925209|69215871|FG001|Treatment Epoch|Adverse Event|5|||
37735428|NCT01925209|69215872|FG002|Treatment Epoch|Adverse Event|3|||
37735429|NCT01925209|69215873|FG003|Treatment Epoch|Adverse Event|1|||
37735430|NCT01925209|69215870|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
37851391|NCT01005901|69535034|FG001|Overall Study|Death|3|||
37851392|NCT01005901|69535033|FG000|Overall Study|Lost to Follow-up|1|||
37851393|NCT01005901|69535034|FG001|Overall Study|Lost to Follow-up|2|||
37851394|NCT01005901|69535033|FG000|Overall Study|Patient's inability to use the device|1|||
37851395|NCT01005901|69535034|FG001|Overall Study|Patient's inability to use the device|1|||
37851396|NCT01005901|69535033|FG000|Overall Study|No longer requires study drug|0|||
37851397|NCT01005901|69535034|FG001|Overall Study|No longer requires study drug|1|||
37851398|NCT04968925|69535042|FG000|Phase I- Period 1|COVID-19 related|0|||
37851399|NCT04968925|69535043|FG001|Phase I- Period 1|COVID-19 related|1|||
37851400|NCT04968925|69535044|FG002|Phase I- Period 1|COVID-19 related|0|||
37851401|NCT04968925|69535045|FG003|Phase I- Period 1|COVID-19 related|0|||
37851402|NCT04968925|69535042|FG000|Phase I- Period 1|Subject enrolled in error|1|||
37851403|NCT04968925|69535043|FG001|Phase I- Period 1|Subject enrolled in error|1|||
37851404|NCT04968925|69535044|FG002|Phase I- Period 1|Subject enrolled in error|0|||
37851405|NCT04968925|69535045|FG003|Phase I- Period 1|Subject enrolled in error|0|||
37851406|NCT04968925|69535042|FG000|Phase II- Period 1|COVID-19 Related|0|||
37851407|NCT04968925|69535043|FG001|Phase II- Period 1|COVID-19 Related|0|||
37851408|NCT04968925|69535044|FG002|Phase II- Period 1|COVID-19 Related|6|||
37851409|NCT04968925|69535045|FG003|Phase II- Period 1|COVID-19 Related|6|||
37851410|NCT04968925|69535042|FG000|Phase II- Period 1|Subject enrolled in error|0|||
37851411|NCT04968925|69535043|FG001|Phase II- Period 1|Subject enrolled in error|0|||
37851412|NCT04968925|69535044|FG002|Phase II- Period 1|Subject enrolled in error|1|||
37851413|NCT04968925|69535045|FG003|Phase II- Period 1|Subject enrolled in error|0|||
37851414|NCT04968925|69535042|FG000|Phase II -Period 2|COVID-19 related|0|||
37851415|NCT04968925|69535043|FG001|Phase II -Period 2|COVID-19 related|0|||
37851416|NCT04968925|69535044|FG002|Phase II -Period 2|COVID-19 related|4|||
37851417|NCT04968925|69535045|FG003|Phase II -Period 2|COVID-19 related|3|||
37851418|NCT04968925|69535042|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
37851419|NCT04968925|69535043|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
38030402|NCT00041067|69716290|FG000|Overall Study|Patient refusal|12|||
38030403|NCT00041067|69716290|FG000|Overall Study|Other reasons|23|||
38030404|NCT00041067|69716290|FG000|Overall Study|Ineligible|2|||
38030405|NCT01063036|69716295|FG000|Participants Treated With Study Drug|Adverse Event|1|||
38030406|NCT01063036|69716295|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
38030407|NCT01063036|69716295|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
38030408|NCT01063036|69716295|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
38030409|NCT01063036|69716295|FG000|Participants Treated With Study Drug|Pregnancy|1|||
38030410|NCT01063036|69716295|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
38030411|NCT01063036|69716295|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
38030412|NCT01063036|69716295|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
38030413|NCT00040365|69716299|FG000|Overall Study|Death|1|||
38030414|NCT00040365|69716299|FG000|Overall Study|Progressive disease|7|||
38030415|NCT00040365|69716299|FG000|Overall Study|Lost to Follow-up|3|||
38030416|NCT02974114|69716306|FG000|Overall Study|Other (Not specified)|0|||
38030417|NCT02974114|69716307|FG001|Overall Study|Other (Not specified)|1|||
38030418|NCT02974114|69716308|FG002|Overall Study|Other (Not specified)|2|||
38030419|NCT00001959|69716318|FG000|Overall Study|newly diagnosed colon cancer|1|||
38030420|NCT00001959|69716318|FG000|Overall Study|disabling sedation|1|||
38030421|NCT00001959|69716318|FG000|Overall Study|non-compliance|1|||
37851420|NCT04968925|69535044|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
37851421|NCT04968925|69535045|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
37851422|NCT01266993|69535057|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
37851423|NCT01266993|69535058|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
38030422|NCT00001941|69716322|FG000|Overall Study|not treated- rapidly progressing disease|0|||
37851424|NCT01266993|69535057|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
38030423|NCT00001941|69716323|FG001|Overall Study|not treated- rapidly progressing disease|0|||
38030424|NCT00001941|69716324|FG002|Overall Study|not treated- rapidly progressing disease|0|||
38030425|NCT00001941|69716325|FG003|Overall Study|not treated- rapidly progressing disease|0|||
38030426|NCT00001941|69716326|FG004|Overall Study|not treated- rapidly progressing disease|1|||
38030427|NCT02978326|69716334|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
38030428|NCT02978326|69716335|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
38030429|NCT02978326|69716336|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
38030430|NCT02978326|69716334|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
38030431|NCT02978326|69716335|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
38030432|NCT02978326|69716336|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
38030433|NCT02978326|69716334|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
38030434|NCT02978326|69716335|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
38030435|NCT02978326|69716336|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
38030436|NCT02978326|69716334|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
38030437|NCT02978326|69716335|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
38030438|NCT02978326|69716336|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
38030439|NCT01061866|69716346|FG000|Overall Study|Adverse Event|2|||
38030440|NCT01061008|69716352|FG000|Overall Study|Badiocephalic fistula failed|3|||
38030441|NCT01061008|69716353|FG001|Overall Study|Badiocephalic fistula failed|2|||
38030442|NCT01061008|69716352|FG000|Overall Study|Death|1|||
38030443|NCT01061008|69716353|FG001|Overall Study|Death|0|||
38030444|NCT01061008|69716352|FG000|Overall Study|Withdrawal by Subject|1|||
38030445|NCT01061008|69716353|FG001|Overall Study|Withdrawal by Subject|3|||
38030446|NCT01061008|69716352|FG000|Overall Study|Unable to exercise following surgery|1|||
38030447|NCT01061008|69716353|FG001|Overall Study|Unable to exercise following surgery|0|||
37735431|NCT01925209|69215871|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
37735432|NCT01925209|69215872|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
37735433|NCT01925209|69215873|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
37851425|NCT01266993|69535058|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
37851426|NCT01309386|69535066|FG000|Overall Study|Other|2|||
37851427|NCT01309386|69535067|FG001|Overall Study|Other|0|||
37851428|NCT01309386|69535066|FG000|Overall Study|Withdrawal by Subject|2|||
38030448|NCT01061008|69716352|FG000|Overall Study|Adverse Event|0|||
37735434|NCT01925209|69215870|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
37851429|NCT01309386|69535067|FG001|Overall Study|Withdrawal by Subject|0|||
38030449|NCT01061008|69716353|FG001|Overall Study|Adverse Event|1|||
37851430|NCT01309386|69535066|FG000|Overall Study|Progressive disease|9|||
37851431|NCT01309386|69535067|FG001|Overall Study|Progressive disease|11|||
37851432|NCT01309386|69535066|FG000|Overall Study|Physician Decision|1|||
37851433|NCT01309386|69535067|FG001|Overall Study|Physician Decision|1|||
37851434|NCT01309386|69535066|FG000|Overall Study|Lack of Efficacy|3|||
37851435|NCT01309386|69535067|FG001|Overall Study|Lack of Efficacy|1|||
37851436|NCT01309386|69535066|FG000|Overall Study|Adverse Event|5|||
37851437|NCT01309386|69535067|FG001|Overall Study|Adverse Event|8|||
37851438|NCT01266603|69535073|FG000|Overall Study|Adverse Event|1|||
38030450|NCT00039741|69716363|FG000|Overall Study|Death|0|||
37735435|NCT01925209|69215871|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
37851439|NCT01266603|69535073|FG000|Overall Study|Lack of Efficacy|14|||
37851440|NCT01266603|69535073|FG000|Overall Study|Withdrawal by Subject|1|||
37851441|NCT01266603|69535073|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
38030451|NCT00039741|69716364|FG001|Overall Study|Death|1|||
38030452|NCT00039741|69716365|FG002|Overall Study|Death|0|||
38030453|NCT00039741|69716366|FG003|Overall Study|Death|0|||
38030454|NCT00039741|69716363|FG000|Overall Study|Lost to Follow-up|3|||
38030455|NCT00039741|69716364|FG001|Overall Study|Lost to Follow-up|1|||
38030456|NCT00039741|69716365|FG002|Overall Study|Lost to Follow-up|5|||
38030457|NCT00039741|69716366|FG003|Overall Study|Lost to Follow-up|2|||
38030458|NCT00039741|69716363|FG000|Overall Study|Confounding medical condition|1|||
38030459|NCT00039741|69716364|FG001|Overall Study|Confounding medical condition|0|||
38030460|NCT00039741|69716365|FG002|Overall Study|Confounding medical condition|0|||
38030461|NCT00039741|69716366|FG003|Overall Study|Confounding medical condition|0|||
38030462|NCT00039741|69716363|FG000|Overall Study|Not able to get to clinic|5|||
38030463|NCT00039741|69716364|FG001|Overall Study|Not able to get to clinic|2|||
38030464|NCT00039741|69716365|FG002|Overall Study|Not able to get to clinic|0|||
38030465|NCT00039741|69716366|FG003|Overall Study|Not able to get to clinic|3|||
38030466|NCT00039741|69716363|FG000|Overall Study|Moved|3|||
38030467|NCT00039741|69716364|FG001|Overall Study|Moved|2|||
38030468|NCT00039741|69716365|FG002|Overall Study|Moved|3|||
38030469|NCT00039741|69716366|FG003|Overall Study|Moved|6|||
38030470|NCT00039741|69716363|FG000|Overall Study|Non-compliance with protocol|1|||
38030471|NCT00039741|69716364|FG001|Overall Study|Non-compliance with protocol|0|||
38030472|NCT00039741|69716365|FG002|Overall Study|Non-compliance with protocol|1|||
38030473|NCT00039741|69716366|FG003|Overall Study|Non-compliance with protocol|0|||
38030474|NCT00039741|69716363|FG000|Overall Study|Withdrew consent|0|||
38030475|NCT00039741|69716364|FG001|Overall Study|Withdrew consent|5|||
38030476|NCT00039741|69716365|FG002|Overall Study|Withdrew consent|0|||
38030477|NCT00039741|69716366|FG003|Overall Study|Withdrew consent|1|||
38030478|NCT00039741|69716363|FG000|Overall Study|Missed final visit|2|||
38030479|NCT00039741|69716364|FG001|Overall Study|Missed final visit|1|||
38030480|NCT00039741|69716365|FG002|Overall Study|Missed final visit|2|||
38030481|NCT00039741|69716366|FG003|Overall Study|Missed final visit|2|||
38030482|NCT02973802|69716376|FG000|Overall Study|Lost to Follow-up|1|||
38030483|NCT02973802|69716376|FG000|Overall Study|Withdrawal by Subject|1|||
38030484|NCT02973100|69716385|FG000|Overall Study|Adverse Event|1|||
38030485|NCT02973100|69716386|FG001|Overall Study|Adverse Event|2|||
38030486|NCT02973100|69716387|FG002|Overall Study|Adverse Event|1|||
38030487|NCT02973100|69716388|FG003|Overall Study|Adverse Event|2|||
38030488|NCT02973100|69716385|FG000|Overall Study|Lost to Follow-up|3|||
38030489|NCT02973100|69716386|FG001|Overall Study|Lost to Follow-up|1|||
38030490|NCT02973100|69716387|FG002|Overall Study|Lost to Follow-up|1|||
38030491|NCT02973100|69716388|FG003|Overall Study|Lost to Follow-up|0|||
38030492|NCT02973100|69716385|FG000|Overall Study|Withdrawal by Subject|3|||
38030493|NCT02973100|69716386|FG001|Overall Study|Withdrawal by Subject|5|||
38030494|NCT02973100|69716387|FG002|Overall Study|Withdrawal by Subject|1|||
38030495|NCT02973100|69716388|FG003|Overall Study|Withdrawal by Subject|4|||
38030496|NCT02973100|69716385|FG000|Overall Study|Notification of change in address|0|||
38030497|NCT02973100|69716386|FG001|Overall Study|Notification of change in address|0|||
38030498|NCT02973100|69716387|FG002|Overall Study|Notification of change in address|0|||
38030499|NCT02973100|69716388|FG003|Overall Study|Notification of change in address|1|||
38030500|NCT02973100|69716385|FG000|Overall Study|Failed to attend Safety followup period|0|||
38030501|NCT02973100|69716386|FG001|Overall Study|Failed to attend Safety followup period|0|||
38030502|NCT02973100|69716387|FG002|Overall Study|Failed to attend Safety followup period|1|||
38030503|NCT02973100|69716388|FG003|Overall Study|Failed to attend Safety followup period|0|||
38030504|NCT01060540|69716403|FG000|Overall Study|Withdrawal by Subject|10|||
38030505|NCT01060540|69716404|FG001|Overall Study|Withdrawal by Subject|20|||
38030506|NCT01060540|69716403|FG000|Overall Study|Lost to Follow-up|52|||
38030507|NCT01060540|69716404|FG001|Overall Study|Lost to Follow-up|43|||
37920353|NCT00833040|69607134|FG001|Overall Study|Adverse Event|0|||
37920354|NCT00833040|69607135|FG002|Overall Study|Adverse Event|0|||
37920355|NCT00833040|69607136|FG003|Overall Study|Adverse Event|0|||
37920356|NCT00833040|69607137|FG004|Overall Study|Adverse Event|0|||
37920357|NCT00833040|69607138|FG005|Overall Study|Adverse Event|1|||
37920358|NCT00843024|69607147|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
37920359|NCT00843024|69607148|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
37920360|NCT00843024|69607149|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
38030508|NCT01060540|69716403|FG000|Overall Study|Death|2|||
38030509|NCT01060540|69716404|FG001|Overall Study|Death|1|||
38030510|NCT01060540|69716403|FG000|Overall Study|Physician Decision|0|||
37735436|NCT01925209|69215872|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
38030511|NCT01060540|69716404|FG001|Overall Study|Physician Decision|1|||
38030512|NCT02972632|69716429|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
38030513|NCT02972632|69716429|FG000|Overall Study|Lost to Follow-up|4|||
38030514|NCT02972632|69716429|FG000|Overall Study|Voluntary Withdrawal|10|||
38030515|NCT01060150|69716433|FG000|Overall Study|Adverse Event|6|||
38030516|NCT01060150|69716433|FG000|Overall Study|Lost to Follow-up|1|||
38030517|NCT01060150|69716433|FG000|Overall Study|Protocol Violation|6|||
38030518|NCT01060150|69716433|FG000|Overall Study|Withdrawal by Subject|8|||
38030519|NCT01060150|69716433|FG000|Overall Study|Enrolled, but not treated|2|||
37735437|NCT01925209|69215873|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
38030520|NCT02972242|69716439|FG000|Overall Study|Withdrawal by Subject|1|||
38030521|NCT02972242|69716440|FG001|Overall Study|Withdrawal by Subject|0|||
38030522|NCT02970292|69716448|FG000|Overall Study|Physician Decision|1|||
38030523|NCT02970292|69716449|FG001|Overall Study|Physician Decision|1|||
38030524|NCT02970292|69716448|FG000|Overall Study|Withdrawal by Subject|11|||
38030525|NCT02970292|69716449|FG001|Overall Study|Withdrawal by Subject|5|||
38030526|NCT02970292|69716448|FG000|Overall Study|Noncompliance with study drug|2|||
38030527|NCT02970292|69716449|FG001|Overall Study|Noncompliance with study drug|2|||
38030528|NCT02970292|69716448|FG000|Overall Study|Adverse Event|5|||
38030529|NCT02970292|69716449|FG001|Overall Study|Adverse Event|0|||
38030530|NCT02970292|69716448|FG000|Overall Study|Lack of Efficacy|1|||
38030531|NCT02970292|69716449|FG001|Overall Study|Lack of Efficacy|0|||
38030532|NCT02970292|69716448|FG000|Overall Study|Lost to Follow-up|1|||
38030533|NCT02970292|69716449|FG001|Overall Study|Lost to Follow-up|0|||
38030534|NCT02970292|69716448|FG000|Overall Study|Protocol Violation|2|||
37851442|NCT01309308|69535079|FG000|Overall Study|Lost to Follow-up|6|||
37851443|NCT01309308|69535080|FG001|Overall Study|Lost to Follow-up|4|||
37851444|NCT01266291|69535086|FG000|Overall Study|Adverse Event|1|||
37851445|NCT01004263|69535090|FG000|Overall Study|Adverse Event|15|||
38030535|NCT02970292|69716449|FG001|Overall Study|Protocol Violation|0|||
37851446|NCT01004263|69535090|FG000|Overall Study|Withdrawal by Subject|58|||
37851447|NCT01004263|69535090|FG000|Overall Study|Protocol Violation|10|||
38030536|NCT02970292|69716448|FG000|Overall Study|Other|1|||
38030537|NCT02970292|69716449|FG001|Overall Study|Other|0|||
38030538|NCT02971228|69716455|FG000|Overall Study|Withdrawal by Subject|1|||
38030539|NCT02971228|69716456|FG001|Overall Study|Withdrawal by Subject|1|||
37851448|NCT01004263|69535090|FG000|Overall Study|Lost to Follow-up|64|||
37851449|NCT01004263|69535090|FG000|Overall Study|Lack of Efficacy|13|||
37851450|NCT01004263|69535090|FG000|Overall Study|Pregnancy|2|||
38030540|NCT02971228|69716457|FG002|Overall Study|Withdrawal by Subject|0|||
38030541|NCT02971228|69716458|FG003|Overall Study|Withdrawal by Subject|0|||
38030542|NCT02971228|69716459|FG004|Overall Study|Withdrawal by Subject|0|||
37920361|NCT00843024|69607150|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
37920362|NCT00843024|69607151|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
37920363|NCT00843024|69607152|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
37920364|NCT00843024|69607147|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
37920365|NCT00843024|69607148|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
37920366|NCT00843024|69607149|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
37920367|NCT00843024|69607150|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
37920368|NCT00843024|69607151|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
37920369|NCT00843024|69607152|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
37920370|NCT00843024|69607147|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
37920371|NCT00843024|69607148|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
37920372|NCT00843024|69607149|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
37920373|NCT00843024|69607150|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
37920374|NCT00843024|69607151|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
37920375|NCT00843024|69607152|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
37920376|NCT00843024|69607147|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
37920377|NCT00843024|69607148|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
38030543|NCT02971228|69716455|FG000|Overall Study|Logistical challenges|0|||
37920378|NCT00843024|69607149|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
38030544|NCT02971228|69716456|FG001|Overall Study|Logistical challenges|1|||
38030545|NCT02971228|69716457|FG002|Overall Study|Logistical challenges|0|||
38030546|NCT02971228|69716458|FG003|Overall Study|Logistical challenges|0|||
38030547|NCT02971228|69716459|FG004|Overall Study|Logistical challenges|0|||
38030548|NCT01060072|69716472|FG000|Overall Study|Adverse Event|1|||
38030549|NCT01060072|69716473|FG001|Overall Study|Adverse Event|1|||
38030550|NCT01060072|69716472|FG000|Overall Study|Physician Decision|0|||
38030551|NCT01060072|69716473|FG001|Overall Study|Physician Decision|2|||
38030552|NCT01060072|69716472|FG000|Overall Study|Protocol Violation|0|||
38030553|NCT01060072|69716473|FG001|Overall Study|Protocol Violation|1|||
38030554|NCT01060072|69716472|FG000|Overall Study|Acute cholecystitis|1|||
38030555|NCT01060072|69716473|FG001|Overall Study|Acute cholecystitis|0|||
37920379|NCT00843024|69607150|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
37920380|NCT00843024|69607151|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
37920381|NCT00843024|69607152|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
37920382|NCT00843024|69607147|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
37920383|NCT00843024|69607148|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
37920384|NCT00843024|69607149|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
37920385|NCT00843024|69607150|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
37920386|NCT00843024|69607151|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
37920387|NCT00843024|69607152|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
37920388|NCT00843024|69607147|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
37920389|NCT00843024|69607148|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
37920390|NCT00843024|69607149|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
37920391|NCT00843024|69607150|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
37920392|NCT00843024|69607151|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
37920393|NCT00843024|69607152|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
37920394|NCT00843024|69607147|FG000|Single-blind Placebo Run-In Phase|Other|0|||
37920395|NCT00843024|69607148|FG001|Single-blind Placebo Run-In Phase|Other|1|||
37920396|NCT00843024|69607149|FG002|Single-blind Placebo Run-In Phase|Other|0|||
37920397|NCT00843024|69607150|FG003|Single-blind Placebo Run-In Phase|Other|0|||
37920398|NCT00843024|69607151|FG004|Single-blind Placebo Run-In Phase|Other|0|||
37920399|NCT00843024|69607152|FG005|Single-blind Placebo Run-In Phase|Other|0|||
37920400|NCT00843024|69607147|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
37920401|NCT00843024|69607148|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
37920402|NCT00843024|69607149|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
37920403|NCT00843024|69607150|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
37920404|NCT00843024|69607151|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
37920405|NCT00843024|69607152|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
37920406|NCT00843024|69607147|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
37920407|NCT00843024|69607148|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
37920408|NCT00843024|69607149|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
37920409|NCT00843024|69607150|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
37920410|NCT00843024|69607151|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
37920411|NCT00843024|69607152|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
37920412|NCT00843024|69607147|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
37920413|NCT00843024|69607148|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
37920414|NCT00843024|69607149|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
37920415|NCT00843024|69607150|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
37920416|NCT00843024|69607151|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
37920417|NCT00843024|69607152|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
37920418|NCT00843024|69607147|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
37920419|NCT00843024|69607148|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
37920420|NCT00843024|69607149|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
37920421|NCT00843024|69607150|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
37920422|NCT00843024|69607151|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
37920423|NCT00843024|69607152|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
37920424|NCT00843024|69607147|FG000|Double-blind Treatment Phase|Physician Decision|0|||
37920425|NCT00843024|69607148|FG001|Double-blind Treatment Phase|Physician Decision|0|||
37920426|NCT00843024|69607149|FG002|Double-blind Treatment Phase|Physician Decision|0|||
37920427|NCT00843024|69607150|FG003|Double-blind Treatment Phase|Physician Decision|3|||
37920428|NCT00843024|69607151|FG004|Double-blind Treatment Phase|Physician Decision|1|||
37920429|NCT00843024|69607152|FG005|Double-blind Treatment Phase|Physician Decision|1|||
37920430|NCT00843024|69607147|FG000|Double-blind Treatment Phase|Adverse Event|0|||
37920431|NCT00843024|69607148|FG001|Double-blind Treatment Phase|Adverse Event|0|||
37920432|NCT00843024|69607149|FG002|Double-blind Treatment Phase|Adverse Event|0|||
38030556|NCT01060072|69716472|FG000|Overall Study|Excluded Medications|0|||
38030557|NCT01060072|69716473|FG001|Overall Study|Excluded Medications|1|||
38030558|NCT02969590|69716481|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
38030559|NCT02969590|69716482|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
37920433|NCT00843024|69607150|FG003|Double-blind Treatment Phase|Adverse Event|0|||
37920434|NCT00843024|69607151|FG004|Double-blind Treatment Phase|Adverse Event|1|||
38030560|NCT02969590|69716483|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
38030561|NCT03345849|69716495|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
38030562|NCT03345849|69716496|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
38030563|NCT03345849|69716497|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
38030564|NCT03345849|69716498|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
38030565|NCT03345849|69716495|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
38030566|NCT03345849|69716496|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
38030567|NCT03345849|69716497|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
38030568|NCT03345849|69716498|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
38030569|NCT03345849|69716495|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
38030570|NCT03345849|69716496|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
38030571|NCT03345849|69716497|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
38030572|NCT03345849|69716498|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
38030573|NCT03345849|69716495|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
38030574|NCT03345849|69716496|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
38030575|NCT03345849|69716497|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
38030576|NCT03345849|69716498|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
38030577|NCT03345849|69716495|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
38030578|NCT03345849|69716496|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
38030579|NCT03345849|69716497|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
38030580|NCT03345849|69716498|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
38030581|NCT03345849|69716495|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
38030582|NCT03345849|69716496|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
38030583|NCT03345849|69716497|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
38030584|NCT03345849|69716498|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
38030585|NCT03345849|69716495|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
38030586|NCT03345849|69716496|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
38030587|NCT03345849|69716497|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
38030588|NCT03345849|69716498|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
38030589|NCT03345849|69716495|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
38030590|NCT03345849|69716496|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
38030591|NCT03345849|69716497|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
38030592|NCT03345849|69716498|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
38030593|NCT03345849|69716495|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
38030594|NCT03345849|69716496|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
37851451|NCT01004263|69535090|FG000|Overall Study|Physician Decision|15|||
37851452|NCT01004263|69535090|FG000|Overall Study|Lack of Qualifying Event|2|||
37851453|NCT01308762|69535097|FG000|Overall Study|Protocol Violation|0|||
37851454|NCT01308762|69535098|FG001|Overall Study|Protocol Violation|1|||
37851455|NCT01308762|69535099|FG002|Overall Study|Protocol Violation|0|||
37851456|NCT01265823|69535110|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
37920435|NCT00843024|69607152|FG005|Double-blind Treatment Phase|Adverse Event|1|||
37920436|NCT00843024|69607147|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
37920437|NCT00843024|69607148|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
37920438|NCT00843024|69607149|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
37920439|NCT00843024|69607150|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
37920440|NCT00843024|69607151|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
37920441|NCT00843024|69607152|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
37920442|NCT00832650|69607168|FG000|Overall Study|Randomized but not treated|0|||
37920443|NCT00832650|69607169|FG001|Overall Study|Randomized but not treated|0|||
37920444|NCT00832650|69607170|FG002|Overall Study|Randomized but not treated|1|||
37920445|NCT00595517|69607178|FG000|Overall Study|Adverse Event|6|||
37920446|NCT00595517|69607178|FG000|Overall Study|Withdrawal by Subject|4|||
37920447|NCT00595517|69607178|FG000|Overall Study|Protocol Violation|2|||
37851457|NCT01265823|69535110|FG000|Overall Study|Failure to Return|4|||
37920448|NCT00595517|69607178|FG000|Overall Study|Recurrence of ulcer|5|||
37735438|NCT01925209|69215870|FG000|Follow-up|Adverse Event|1|||
37851458|NCT01265823|69535110|FG000|Overall Study|Protocol Violation|1|||
37920449|NCT00595517|69607178|FG000|Overall Study|usage of prohibited treatment|1|||
38030595|NCT03345849|69716497|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
38030596|NCT03345849|69716498|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
38030597|NCT03345849|69716495|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
38030598|NCT03345849|69716496|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
38030599|NCT03345849|69716497|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
37735439|NCT01925209|69215871|FG001|Follow-up|Adverse Event|4|||
37920450|NCT00595517|69607178|FG000|Overall Study|No intention to attend regularly|1|||
37920451|NCT00823836|69607184|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
37920452|NCT00823836|69607185|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
37920453|NCT00823836|69607184|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
37920454|NCT00823836|69607185|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
38030600|NCT03345849|69716498|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
38030601|NCT03345849|69716495|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
38030602|NCT03345849|69716496|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
38030603|NCT03345849|69716497|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
38030604|NCT03345849|69716498|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
38030605|NCT03011307|69716508|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
38030606|NCT03011307|69716509|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
38030607|NCT03011307|69716508|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
38030608|NCT03011307|69716509|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
38030609|NCT03011307|69716508|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
38030610|NCT03011307|69716509|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
38030611|NCT03798717|69716521|FG000|Overall Study|Failed Screening|0|||
38030612|NCT03798717|69716522|FG001|Overall Study|Failed Screening|0|||
38030613|NCT03798717|69716523|FG002|Overall Study|Failed Screening|0|||
38030614|NCT03798717|69716524|FG003|Overall Study|Failed Screening|0|||
38030615|NCT03798717|69716525|FG004|Overall Study|Failed Screening|0|||
38030616|NCT03798717|69716526|FG005|Overall Study|Failed Screening|1|||
38030617|NCT03798717|69716521|FG000|Overall Study|Physician Decision|1|||
38030618|NCT03798717|69716522|FG001|Overall Study|Physician Decision|0|||
38030619|NCT03798717|69716523|FG002|Overall Study|Physician Decision|1|||
38030620|NCT03798717|69716524|FG003|Overall Study|Physician Decision|0|||
38030621|NCT03798717|69716525|FG004|Overall Study|Physician Decision|0|||
38030622|NCT03798717|69716526|FG005|Overall Study|Physician Decision|0|||
38030623|NCT03798717|69716521|FG000|Overall Study|Withdrawal by Subject|0|||
38030624|NCT03798717|69716522|FG001|Overall Study|Withdrawal by Subject|0|||
38030625|NCT03798717|69716523|FG002|Overall Study|Withdrawal by Subject|0|||
38030626|NCT03798717|69716524|FG003|Overall Study|Withdrawal by Subject|1|||
38030627|NCT03798717|69716525|FG004|Overall Study|Withdrawal by Subject|0|||
38030628|NCT03798717|69716526|FG005|Overall Study|Withdrawal by Subject|0|||
38030629|NCT03798717|69716521|FG000|Overall Study|Lost to Follow-up|1|||
38030630|NCT03798717|69716522|FG001|Overall Study|Lost to Follow-up|0|||
38030631|NCT03798717|69716523|FG002|Overall Study|Lost to Follow-up|0|||
38030632|NCT03798717|69716524|FG003|Overall Study|Lost to Follow-up|1|||
38030633|NCT03798717|69716525|FG004|Overall Study|Lost to Follow-up|0|||
38030634|NCT03798717|69716526|FG005|Overall Study|Lost to Follow-up|0|||
38030635|NCT03798717|69716521|FG000|Overall Study|Adverse Event|0|||
38030636|NCT03798717|69716522|FG001|Overall Study|Adverse Event|1|||
38030637|NCT03798717|69716523|FG002|Overall Study|Adverse Event|0|||
38030638|NCT03798717|69716524|FG003|Overall Study|Adverse Event|0|||
38030639|NCT03798717|69716525|FG004|Overall Study|Adverse Event|0|||
37920455|NCT00823836|69607184|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
37920456|NCT00823836|69607185|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
38030640|NCT03798717|69716526|FG005|Overall Study|Adverse Event|0|||
38030641|NCT03798717|69716521|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
38030642|NCT03798717|69716522|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
38030643|NCT03798717|69716523|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
38030644|NCT03798717|69716524|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
38030645|NCT03798717|69716525|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
38030646|NCT03798717|69716526|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
38030647|NCT03798483|69716535|FG000|Overall Study|Lost to Follow-up|2|||
38030648|NCT03792477|69716548|FG000|Overall Study|Adverse Event|0|||
38030649|NCT03792477|69716549|FG001|Overall Study|Adverse Event|0|||
38030650|NCT03792477|69716550|FG002|Overall Study|Adverse Event|0|||
38030651|NCT03792477|69716551|FG003|Overall Study|Adverse Event|1|||
38030652|NCT03792477|69716552|FG004|Overall Study|Adverse Event|0|||
38030653|NCT03792477|69716548|FG000|Overall Study|Lost to Follow-up|0|||
38030654|NCT03792477|69716549|FG001|Overall Study|Lost to Follow-up|0|||
38030655|NCT03792477|69716550|FG002|Overall Study|Lost to Follow-up|2|||
38030656|NCT03792477|69716551|FG003|Overall Study|Lost to Follow-up|0|||
38030657|NCT03792477|69716552|FG004|Overall Study|Lost to Follow-up|0|||
38030658|NCT03792477|69716548|FG000|Overall Study|Other|0|||
38030659|NCT03792477|69716549|FG001|Overall Study|Other|0|||
38030660|NCT03792477|69716550|FG002|Overall Study|Other|0|||
38030661|NCT03792477|69716551|FG003|Overall Study|Other|0|||
38030662|NCT03792477|69716552|FG004|Overall Study|Other|1|||
38030663|NCT03790917|69716558|FG000|Overall Study|Death|1|||
38030664|NCT03788967|69716565|FG000|Overall Study|Lost to Follow-up|14|||
38030665|NCT03788967|69716566|FG001|Overall Study|Lost to Follow-up|10|||
38030666|NCT03788967|69716565|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
38030667|NCT03788967|69716566|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
38030668|NCT03788967|69716565|FG000|Overall Study|Participant Withdrawal of Consent|13|||
38030669|NCT03788967|69716566|FG001|Overall Study|Participant Withdrawal of Consent|5|||
38030670|NCT03788967|69716565|FG000|Overall Study|Adverse Event|1|||
38030671|NCT03788967|69716566|FG001|Overall Study|Adverse Event|1|||
38030672|NCT03788967|69716565|FG000|Overall Study|COVID-19|1|||
38030673|NCT03788967|69716566|FG001|Overall Study|COVID-19|2|||
38030674|NCT03782571|69716574|FG000|Period 1|Withdrawal by Subject|1|||
38030675|NCT03782571|69716575|FG001|Period 1|Withdrawal by Subject|0|||
38030676|NCT03782571|69716576|FG002|Period 1|Withdrawal by Subject|0|||
38030677|NCT03782571|69716577|FG003|Period 1|Withdrawal by Subject|0|||
38030678|NCT03782571|69716574|FG000|Period 3|Subject Unable to Attend V5|1|||
37920457|NCT00823836|69607184|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
37920458|NCT00823836|69607185|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
38030679|NCT03782571|69716575|FG001|Period 3|Subject Unable to Attend V5|0|||
38030680|NCT03782571|69716576|FG002|Period 3|Subject Unable to Attend V5|0|||
38030681|NCT03782571|69716577|FG003|Period 3|Subject Unable to Attend V5|0|||
38030682|NCT03782571|69716574|FG000|Period 3|Adverse Event|1|||
38030683|NCT03782571|69716575|FG001|Period 3|Adverse Event|0|||
38030684|NCT03782571|69716576|FG002|Period 3|Adverse Event|0|||
38030685|NCT03782571|69716577|FG003|Period 3|Adverse Event|0|||
38030686|NCT03783039|69716591|FG000|Overall Study|Death|2|||
38030687|NCT03783039|69716592|FG001|Overall Study|Death|1|||
38030688|NCT03776175|69716602|FG000|Treatment Period (42 Days)|Adverse Event|0|||
38030689|NCT03776175|69716603|FG001|Treatment Period (42 Days)|Adverse Event|1|||
37851459|NCT01265823|69535110|FG000|Overall Study|Participant Request|1|||
37851460|NCT01004185|69535120|FG000|Overall Study|Adverse Event|1|||
37851461|NCT01004185|69535121|FG001|Overall Study|Adverse Event|1|||
37851462|NCT01004185|69535120|FG000|Overall Study|Lost to Follow-up|0|||
37851463|NCT01004185|69535121|FG001|Overall Study|Lost to Follow-up|1|||
37851464|NCT01004185|69535120|FG000|Overall Study|Lack of Efficacy|2|||
37851465|NCT01004185|69535121|FG001|Overall Study|Lack of Efficacy|1|||
38030690|NCT03776175|69716604|FG002|Treatment Period (42 Days)|Adverse Event|1|||
38030691|NCT03776175|69716605|FG003|Treatment Period (42 Days)|Adverse Event|0|||
37851466|NCT01004185|69535120|FG000|Overall Study|Sponsor Terminated Study|4|||
37851467|NCT01004185|69535121|FG001|Overall Study|Sponsor Terminated Study|5|||
37920459|NCT00823836|69607184|FG000|Long-term Phase|Adverse Event|3|||
38030692|NCT03776175|69716602|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
38030693|NCT03776175|69716603|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
38030694|NCT03776175|69716604|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
38030695|NCT03776175|69716605|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
38030696|NCT03776175|69716602|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
38030697|NCT03776175|69716603|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
38030698|NCT03776175|69716604|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
37851468|NCT01004185|69535120|FG000|Overall Study|Withdrawal by Subject|2|||
38030699|NCT03776175|69716605|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
38030700|NCT03776175|69716602|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
38030701|NCT03776175|69716603|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
37920460|NCT00823836|69607185|FG001|Long-term Phase|Adverse Event|2|||
37920461|NCT00823836|69607184|FG000|Long-term Phase|Physician Decision|1|||
37920462|NCT00823836|69607185|FG001|Long-term Phase|Physician Decision|2|||
37920463|NCT00823836|69607184|FG000|Long-term Phase|Withdrawal by Subject|1|||
37920464|NCT00823836|69607185|FG001|Long-term Phase|Withdrawal by Subject|1|||
38030702|NCT03776175|69716604|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
38030703|NCT03776175|69716605|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
38030704|NCT03776175|69716602|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
38030705|NCT03776175|69716603|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
38030706|NCT03776175|69716604|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
38030707|NCT03776175|69716605|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
38030708|NCT03776175|69716602|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
38030709|NCT03776175|69716603|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
38030710|NCT03776175|69716604|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
38030711|NCT03776175|69716605|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
38030712|NCT02903914|69716623|FG000|Overall Study|Adverse Event|0|||
38030713|NCT02903914|69716624|FG001|Overall Study|Adverse Event|0|||
38030714|NCT02903914|69716625|FG002|Overall Study|Adverse Event|1|||
38030715|NCT02903914|69716626|FG003|Overall Study|Adverse Event|0|||
38030716|NCT02903914|69716627|FG004|Overall Study|Adverse Event|0|||
38030717|NCT02903914|69716628|FG005|Overall Study|Adverse Event|1|||
38030718|NCT02903914|69716629|FG006|Overall Study|Adverse Event|2|||
38030719|NCT02903914|69716630|FG007|Overall Study|Adverse Event|1|||
38030720|NCT02903914|69716623|FG000|Overall Study|Withdrawal by Subject|3|||
38030721|NCT02903914|69716624|FG001|Overall Study|Withdrawal by Subject|1|||
38030722|NCT02903914|69716625|FG002|Overall Study|Withdrawal by Subject|28|||
38030723|NCT02903914|69716626|FG003|Overall Study|Withdrawal by Subject|0|||
38030724|NCT02903914|69716627|FG004|Overall Study|Withdrawal by Subject|1|||
38030725|NCT02903914|69716628|FG005|Overall Study|Withdrawal by Subject|1|||
38030726|NCT02903914|69716629|FG006|Overall Study|Withdrawal by Subject|12|||
38030727|NCT02903914|69716630|FG007|Overall Study|Withdrawal by Subject|0|||
38030728|NCT02903914|69716623|FG000|Overall Study|Progressive Disease|1|||
38030729|NCT02903914|69716624|FG001|Overall Study|Progressive Disease|0|||
38030730|NCT02903914|69716625|FG002|Overall Study|Progressive Disease|4|||
38030731|NCT02903914|69716626|FG003|Overall Study|Progressive Disease|0|||
38030732|NCT02903914|69716627|FG004|Overall Study|Progressive Disease|0|||
38030733|NCT02903914|69716628|FG005|Overall Study|Progressive Disease|0|||
38030734|NCT02903914|69716629|FG006|Overall Study|Progressive Disease|2|||
38030735|NCT02903914|69716630|FG007|Overall Study|Progressive Disease|4|||
38030736|NCT02903914|69716623|FG000|Overall Study|Death|0|||
38030737|NCT02903914|69716624|FG001|Overall Study|Death|0|||
38030738|NCT02903914|69716625|FG002|Overall Study|Death|9|||
37851469|NCT01004185|69535121|FG001|Overall Study|Withdrawal by Subject|1|||
37851470|NCT01265511|69535129|FG000|Overall Study|Lack of Efficacy|2|||
37851471|NCT01265511|69535130|FG001|Overall Study|Lack of Efficacy|1|||
37851472|NCT01265511|69535129|FG000|Overall Study|Met stopping rules|0|||
37851473|NCT01265511|69535130|FG001|Overall Study|Met stopping rules|2|||
37851474|NCT01264965|69535136|FG000|Overall Study|Withdrawal by Subject|10|||
37851475|NCT01264887|69535140|FG000|Overall Study|Adverse Event|5|||
37851476|NCT01264887|69535140|FG000|Overall Study|Death|7|||
37851477|NCT01264887|69535140|FG000|Overall Study|Lack of Efficacy|5|||
37851478|NCT01264887|69535140|FG000|Overall Study|Physician Decision|4|||
37851479|NCT01264887|69535140|FG000|Overall Study|Withdrawal by Subject|6|||
37920465|NCT00879437|69607194|FG000|Overall Study|Protocol Violation|0|||
37920466|NCT00879437|69607195|FG001|Overall Study|Protocol Violation|1|||
38030739|NCT02903914|69716626|FG003|Overall Study|Death|0|||
38030740|NCT02903914|69716627|FG004|Overall Study|Death|1|||
38030741|NCT02903914|69716628|FG005|Overall Study|Death|3|||
38030742|NCT02903914|69716629|FG006|Overall Study|Death|24|||
38030743|NCT02903914|69716630|FG007|Overall Study|Death|0|||
38030744|NCT02903914|69716623|FG000|Overall Study|Lost to Follow-up|0|||
38030745|NCT02903914|69716624|FG001|Overall Study|Lost to Follow-up|1|||
38030746|NCT02903914|69716625|FG002|Overall Study|Lost to Follow-up|0|||
38030747|NCT02903914|69716626|FG003|Overall Study|Lost to Follow-up|0|||
37920467|NCT00879437|69607194|FG000|Overall Study|Death|1|||
38030748|NCT02903914|69716627|FG004|Overall Study|Lost to Follow-up|2|||
38030749|NCT02903914|69716628|FG005|Overall Study|Lost to Follow-up|0|||
38030750|NCT02903914|69716629|FG006|Overall Study|Lost to Follow-up|1|||
38030751|NCT02903914|69716630|FG007|Overall Study|Lost to Follow-up|0|||
38030752|NCT02903914|69716623|FG000|Overall Study|Physician Decision|0|||
38030753|NCT02903914|69716624|FG001|Overall Study|Physician Decision|0|||
38030754|NCT02903914|69716625|FG002|Overall Study|Physician Decision|1|||
38030755|NCT02903914|69716626|FG003|Overall Study|Physician Decision|0|||
38030756|NCT02903914|69716627|FG004|Overall Study|Physician Decision|0|||
38030757|NCT02903914|69716628|FG005|Overall Study|Physician Decision|0|||
38030758|NCT02903914|69716629|FG006|Overall Study|Physician Decision|1|||
38030759|NCT02903914|69716630|FG007|Overall Study|Physician Decision|0|||
38030760|NCT02903914|69716623|FG000|Overall Study|Symptomatic Deterioration|0|||
38030761|NCT02903914|69716624|FG001|Overall Study|Symptomatic Deterioration|0|||
38030762|NCT02903914|69716625|FG002|Overall Study|Symptomatic Deterioration|1|||
38030763|NCT02903914|69716626|FG003|Overall Study|Symptomatic Deterioration|0|||
38030764|NCT02903914|69716627|FG004|Overall Study|Symptomatic Deterioration|0|||
38030765|NCT02903914|69716628|FG005|Overall Study|Symptomatic Deterioration|0|||
38030766|NCT02903914|69716629|FG006|Overall Study|Symptomatic Deterioration|0|||
38030767|NCT02903914|69716630|FG007|Overall Study|Symptomatic Deterioration|0|||
38030768|NCT02903914|69716623|FG000|Overall Study|New Cancer Therapy|2|||
38030769|NCT02903914|69716624|FG001|Overall Study|New Cancer Therapy|2|||
38030770|NCT02903914|69716625|FG002|Overall Study|New Cancer Therapy|21|||
38030771|NCT02903914|69716626|FG003|Overall Study|New Cancer Therapy|4|||
38030772|NCT02903914|69716627|FG004|Overall Study|New Cancer Therapy|3|||
38030773|NCT02903914|69716628|FG005|Overall Study|New Cancer Therapy|6|||
38030774|NCT02903914|69716629|FG006|Overall Study|New Cancer Therapy|55|||
38030775|NCT02903914|69716630|FG007|Overall Study|New Cancer Therapy|0|||
37920468|NCT00879437|69607195|FG001|Overall Study|Death|0|||
38030776|NCT02903914|69716623|FG000|Overall Study|Reasoning not specified|2|||
38030777|NCT02903914|69716624|FG001|Overall Study|Reasoning not specified|3|||
38030778|NCT02903914|69716625|FG002|Overall Study|Reasoning not specified|20|||
38030779|NCT02903914|69716626|FG003|Overall Study|Reasoning not specified|3|||
38030780|NCT02903914|69716627|FG004|Overall Study|Reasoning not specified|3|||
38030781|NCT02903914|69716628|FG005|Overall Study|Reasoning not specified|3|||
38030782|NCT02903914|69716629|FG006|Overall Study|Reasoning not specified|20|||
38030783|NCT02903914|69716630|FG007|Overall Study|Reasoning not specified|0|||
38030784|NCT02969044|69716652|FG000|Overall Study|Withdrawal by Subject|2|||
38030785|NCT02969044|69716653|FG001|Overall Study|Withdrawal by Subject|6|||
38030786|NCT02969044|69716652|FG000|Overall Study|Adverse Event|3|||
37735440|NCT01925209|69215872|FG002|Follow-up|Adverse Event|0|||
38030787|NCT02969044|69716653|FG001|Overall Study|Adverse Event|0|||
38030788|NCT02967562|69716661|FG000|Overall Study|Consent not obtained|1|||
37735441|NCT01925209|69215873|FG003|Follow-up|Adverse Event|1|||
37735442|NCT01925209|69215870|FG000|Follow-up|Physician Decision|0|||
37851480|NCT01264887|69535140|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
37851481|NCT01264887|69535140|FG000|Overall Study|Other|2|||
37851482|NCT01306968|69535150|FG000|Overall Study|Lost to Follow-up|1|||
37851483|NCT01306968|69535151|FG001|Overall Study|Lost to Follow-up|1|||
37851484|NCT01306968|69535152|FG002|Overall Study|Lost to Follow-up|0|||
37851485|NCT01306968|69535153|FG003|Overall Study|Lost to Follow-up|0|||
37851486|NCT01306968|69535150|FG000|Overall Study|Physician Decision|0|||
37851487|NCT01306968|69535151|FG001|Overall Study|Physician Decision|1|||
37851488|NCT01306968|69535152|FG002|Overall Study|Physician Decision|0|||
37851489|NCT01306968|69535153|FG003|Overall Study|Physician Decision|0|||
37851490|NCT01306968|69535150|FG000|Overall Study|Relocated and left active duty|0|||
37851491|NCT01306968|69535151|FG001|Overall Study|Relocated and left active duty|1|||
37851492|NCT01306968|69535152|FG002|Overall Study|Relocated and left active duty|1|||
37851493|NCT01306968|69535153|FG003|Overall Study|Relocated and left active duty|1|||
37851494|NCT01306968|69535150|FG000|Overall Study|Withdrew - time commitment|0|||
37851495|NCT01306968|69535151|FG001|Overall Study|Withdrew - time commitment|0|||
37851496|NCT01306968|69535152|FG002|Overall Study|Withdrew - time commitment|0|||
38030789|NCT02967562|69716662|FG001|Overall Study|Consent not obtained|0|||
38030790|NCT02967562|69716661|FG000|Overall Study|High leak precluding analysis|1|||
38030791|NCT02967562|69716662|FG001|Overall Study|High leak precluding analysis|1|||
37851497|NCT01306968|69535153|FG003|Overall Study|Withdrew - time commitment|2|||
37851498|NCT01306968|69535150|FG000|Overall Study|Withdrew over privacy concerns|0|||
38030792|NCT02968576|69716668|FG000|Overall Study|Pregnancy|0|||
37735443|NCT01925209|69215871|FG001|Follow-up|Physician Decision|0|||
38030793|NCT02968576|69716669|FG001|Overall Study|Pregnancy|1|||
38030794|NCT02966002|69716673|FG000|Overall Study|Withdrawal by Subject|2|||
38030795|NCT02966002|69716673|FG000|Overall Study|Adverse Event|1|||
38030796|NCT02966002|69716673|FG000|Overall Study|Lost to Follow-up|1|||
38030797|NCT02965846|69716680|FG000|Overall Study|Lost to Follow-up|1|||
38030798|NCT02965846|69716681|FG001|Overall Study|Lost to Follow-up|0|||
38030799|NCT02965846|69716682|FG002|Overall Study|Lost to Follow-up|0|||
38030800|NCT02965846|69716680|FG000|Overall Study|Withdrawal by Subject|0|||
38030801|NCT02965846|69716681|FG001|Overall Study|Withdrawal by Subject|1|||
38030802|NCT02965846|69716682|FG002|Overall Study|Withdrawal by Subject|0|||
38030803|NCT02965846|69716680|FG000|Overall Study|Study Terminated By Sponsor|4|||
38030804|NCT02965846|69716681|FG001|Overall Study|Study Terminated By Sponsor|4|||
38030805|NCT02965846|69716682|FG002|Overall Study|Study Terminated By Sponsor|0|||
38030806|NCT02965846|69716680|FG000|Overall Study|Participants not randomized|0|||
38030807|NCT02965846|69716681|FG001|Overall Study|Participants not randomized|0|||
38030808|NCT02965846|69716682|FG002|Overall Study|Participants not randomized|33|||
38030809|NCT02900170|69716688|FG000|Overall Study|Lost to Follow-up|8|||
38030810|NCT02900092|69716692|FG000|Overall Study|Adverse Event|1|||
38030811|NCT02902120|69716700|FG000|Overall Study|Lack of Efficacy|1|||
38030812|NCT02965456|69716706|FG000|Overall Study|Lost to Follow-up|40|||
38030813|NCT02965456|69716707|FG001|Overall Study|Lost to Follow-up|18|||
38030814|NCT02965456|69716706|FG000|Overall Study|Subject Request|22|||
38030815|NCT02965456|69716707|FG001|Overall Study|Subject Request|13|||
38030816|NCT02965456|69716706|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
38030817|NCT02965456|69716707|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
38030818|NCT02965456|69716706|FG000|Overall Study|Adverse Event|3|||
38030819|NCT02965456|69716707|FG001|Overall Study|Adverse Event|0|||
38030820|NCT02965456|69716706|FG000|Overall Study|Noncompliance with Study Drug|1|||
37851499|NCT01306968|69535151|FG001|Overall Study|Withdrew over privacy concerns|0|||
37851500|NCT01306968|69535152|FG002|Overall Study|Withdrew over privacy concerns|0|||
37920469|NCT00877799|69607208|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
37920470|NCT00877799|69607209|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
37920471|NCT00877799|69607210|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
37920472|NCT00877799|69607211|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
37920473|NCT00877799|69607212|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
37920474|NCT00877799|69607208|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
37920475|NCT00877799|69607209|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
37920476|NCT00877799|69607210|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
37920477|NCT00877799|69607211|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
37920478|NCT00877799|69607212|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
37920479|NCT00877799|69607208|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
37920480|NCT00877799|69607209|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
37920481|NCT00877799|69607210|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
37920482|NCT00877799|69607211|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
37851501|NCT01306968|69535153|FG003|Overall Study|Withdrew over privacy concerns|1|||
37851502|NCT01264419|69535165|FG000|Overall Study|Lost to Follow-up|3|||
37851503|NCT01263873|69535171|FG000|Overall Study|One provider unable to complete numbers|1|||
37851504|NCT01263873|69535172|FG001|Overall Study|One provider unable to complete numbers|1|||
37851505|NCT01263639|69535180|FG000|Overall Study|Lost to Follow-up|66|||
37851506|NCT01263639|69535181|FG001|Overall Study|Lost to Follow-up|70|||
37851507|NCT01263639|69535180|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
37851508|NCT01263639|69535181|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
37851509|NCT01011283|69535189|FG000|Overall Study|Adverse Event|4|||
37851510|NCT01011283|69535190|FG001|Overall Study|Adverse Event|2|||
37851511|NCT01011283|69535189|FG000|Overall Study|Progressive Disease|0|||
37851512|NCT01011283|69535190|FG001|Overall Study|Progressive Disease|2|||
37851513|NCT01011283|69535189|FG000|Overall Study|Terminated by Sponsor|5|||
37851514|NCT01011283|69535190|FG001|Overall Study|Terminated by Sponsor|5|||
37851515|NCT01011283|69535189|FG000|Overall Study|Other|2|||
37851516|NCT01011283|69535190|FG001|Overall Study|Other|2|||
37851517|NCT01263561|69535198|FG000|Overall Study|Death|1|||
37851518|NCT01263561|69535199|FG001|Overall Study|Death|2|||
38030821|NCT02965456|69716707|FG001|Overall Study|Noncompliance with Study Drug|1|||
37851519|NCT01009099|69535207|FG000|Overall Study|Lost to Follow-up|1|||
37851520|NCT01009099|69535208|FG001|Overall Study|Lost to Follow-up|0|||
37851521|NCT01009099|69535207|FG000|Overall Study|Physician Decision|3|||
37851522|NCT01009099|69535208|FG001|Overall Study|Physician Decision|2|||
38030822|NCT02965456|69716706|FG000|Overall Study|Worsening Condition|0|||
38030823|NCT02965456|69716707|FG001|Overall Study|Worsening Condition|2|||
38030824|NCT02965456|69716706|FG000|Overall Study|Lack of Efficacy|1|||
38030825|NCT02965456|69716707|FG001|Overall Study|Lack of Efficacy|0|||
38030826|NCT02965456|69716706|FG000|Overall Study|Physician Decision|0|||
37920483|NCT00877799|69607212|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
37920484|NCT00877799|69607208|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
37920485|NCT00877799|69607209|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
37920486|NCT00877799|69607210|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
37920487|NCT00877799|69607211|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
37920488|NCT00877799|69607212|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
37920489|NCT00877799|69607208|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
37920490|NCT00877799|69607209|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
37920491|NCT00877799|69607210|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
37920492|NCT00877799|69607211|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
37920493|NCT00877799|69607212|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
37920494|NCT00595127|69607223|FG000|Overall Study|Death|6|||
37920495|NCT00595127|69607223|FG000|Overall Study|Relapsed|3|||
37920496|NCT00595127|69607223|FG000|Overall Study|joined another trial|1|||
37920497|NCT00877487|69607227|FG000|Open-label Treatment Phase|Adverse Event|1|||
37920498|NCT00877487|69607228|FG001|Open-label Treatment Phase|Adverse Event|0|||
37920499|NCT00877487|69607227|FG000|Open-label Treatment Phase|Protocol Violation|3|||
37920500|NCT00877487|69607228|FG001|Open-label Treatment Phase|Protocol Violation|0|||
37920501|NCT00877487|69607227|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
37920502|NCT00877487|69607228|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
37920503|NCT00877487|69607227|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
37920504|NCT00877487|69607228|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
37920505|NCT00877487|69607227|FG000|Open-label Treatment Phase|Out of country for business|1|||
37851523|NCT01009099|69535207|FG000|Overall Study|Withdrawal by Subject|1|||
37851524|NCT01009099|69535208|FG001|Overall Study|Withdrawal by Subject|1|||
37851525|NCT01009099|69535207|FG000|Overall Study|Death|0|||
37851526|NCT01009099|69535208|FG001|Overall Study|Death|1|||
37851527|NCT01263483|69535217|FG000|Overall Study|Adverse Event|4|||
37851528|NCT01263483|69535218|FG001|Overall Study|Adverse Event|0|||
37851529|NCT01263483|69535219|FG002|Overall Study|Adverse Event|3|||
37851530|NCT01263483|69535217|FG000|Overall Study|Withdrawal by Subject|1|||
37851531|NCT01263483|69535218|FG001|Overall Study|Withdrawal by Subject|0|||
37851532|NCT01263483|69535219|FG002|Overall Study|Withdrawal by Subject|0|||
37851533|NCT01263483|69535217|FG000|Overall Study|Lack of Efficacy|2|||
37851534|NCT01263483|69535218|FG001|Overall Study|Lack of Efficacy|0|||
37851535|NCT01263483|69535219|FG002|Overall Study|Lack of Efficacy|0|||
37851536|NCT01263483|69535217|FG000|Overall Study|Protocol Violation|0|||
37851537|NCT01263483|69535218|FG001|Overall Study|Protocol Violation|1|||
37851538|NCT01263483|69535219|FG002|Overall Study|Protocol Violation|1|||
37851539|NCT01263483|69535217|FG000|Overall Study|Participant Unavailability|0|||
37851540|NCT01263483|69535218|FG001|Overall Study|Participant Unavailability|1|||
37851541|NCT01263483|69535219|FG002|Overall Study|Participant Unavailability|1|||
37851542|NCT01306890|69535227|FG000|Overall Study|Adverse Event|2|||
37851543|NCT01306890|69535227|FG000|Overall Study|Death|1223|||
37851544|NCT01306890|69535227|FG000|Overall Study|Lost to Follow-up|58|||
37851545|NCT01306890|69535227|FG000|Overall Study|Withdrawal by Subject|88|||
37851546|NCT01306890|69535227|FG000|Overall Study|Unspecified reasons|104|||
37851547|NCT01306890|69535227|FG000|Overall Study|Study Termination|3|||
37851548|NCT01306890|69535227|FG000|Overall Study|No discontinuation documentation|41|||
37851549|NCT01011049|69535235|FG000|Overall Study|Protocol Violation|0|||
37851550|NCT01011049|69535236|FG001|Overall Study|Protocol Violation|0|||
37851551|NCT01011049|69535237|FG002|Overall Study|Protocol Violation|2|||
37851552|NCT01011049|69535238|FG003|Overall Study|Protocol Violation|0|||
37851553|NCT01011049|69535235|FG000|Overall Study|Lost to Follow-up|1|||
37851554|NCT01011049|69535236|FG001|Overall Study|Lost to Follow-up|2|||
37851555|NCT01011049|69535237|FG002|Overall Study|Lost to Follow-up|1|||
37851556|NCT01011049|69535238|FG003|Overall Study|Lost to Follow-up|0|||
37851557|NCT01011049|69535235|FG000|Overall Study|Withdrawal by Subject|0|||
37920506|NCT00877487|69607228|FG001|Open-label Treatment Phase|Out of country for business|0|||
37920507|NCT00877487|69607227|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
37920508|NCT00877487|69607228|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
37920509|NCT00877487|69607227|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
38030827|NCT02965456|69716707|FG001|Overall Study|Physician Decision|1|||
38030828|NCT02965456|69716706|FG000|Overall Study|Pregnancy|1|||
37851558|NCT01011049|69535236|FG001|Overall Study|Withdrawal by Subject|0|||
37851559|NCT01011049|69535237|FG002|Overall Study|Withdrawal by Subject|1|||
37851560|NCT01011049|69535238|FG003|Overall Study|Withdrawal by Subject|0|||
37851561|NCT01263093|69535250|FG000|Washout|Physician Decision|1|||
37851562|NCT01263093|69535251|FG001|Washout|Physician Decision|0|||
37851563|NCT01263093|69535250|FG000|Period 2|Adverse Event|1|||
37851564|NCT01263093|69535251|FG001|Period 2|Adverse Event|0|||
37851565|NCT01010971|69535261|FG000|Overall Study|Adverse Event|2|||
37851566|NCT01010971|69535262|FG001|Overall Study|Adverse Event|4|||
37851567|NCT01010971|69535263|FG002|Overall Study|Adverse Event|3|||
37851568|NCT01010971|69535261|FG000|Overall Study|Withdrawal by Subject|0|||
37920510|NCT00877487|69607228|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
37920511|NCT00877487|69607227|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
37920512|NCT00877487|69607228|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
37920513|NCT00877487|69607227|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
37920514|NCT00877487|69607228|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
37920515|NCT00878501|69607237|FG000|Overall Study|Adverse Event|11|||
37920516|NCT00878501|69607238|FG001|Overall Study|Adverse Event|3|||
37920517|NCT00878501|69607239|FG002|Overall Study|Adverse Event|3|||
38030829|NCT02965456|69716707|FG001|Overall Study|Pregnancy|0|||
38030830|NCT02965456|69716706|FG000|Overall Study|Protocol Violation|0|||
38030831|NCT02965456|69716707|FG001|Overall Study|Protocol Violation|1|||
37920518|NCT00878501|69607237|FG000|Overall Study|Lack of Efficacy|2|||
38030832|NCT02965456|69716706|FG000|Overall Study|Participant ran out of study drug|0|||
38030833|NCT02965456|69716707|FG001|Overall Study|Participant ran out of study drug|1|||
37920519|NCT00878501|69607238|FG001|Overall Study|Lack of Efficacy|1|||
37920520|NCT00878501|69607239|FG002|Overall Study|Lack of Efficacy|0|||
38030834|NCT02965378|69716715|FG000|Overall Study|Progression|16|||
38030835|NCT02965378|69716716|FG001|Overall Study|Progression|4|||
38030836|NCT02965378|69716715|FG000|Overall Study|Adverse Event|5|||
38030837|NCT02965378|69716716|FG001|Overall Study|Adverse Event|2|||
38030838|NCT02965378|69716715|FG000|Overall Study|Death|2|||
38030839|NCT02965378|69716716|FG001|Overall Study|Death|0|||
38030840|NCT02965378|69716715|FG000|Overall Study|Refusal|2|||
38030841|NCT02965378|69716716|FG001|Overall Study|Refusal|1|||
38030842|NCT02965378|69716715|FG000|Overall Study|Not protocol specified|0|||
38030843|NCT02965378|69716716|FG001|Overall Study|Not protocol specified|2|||
38030844|NCT03772041|69716724|FG000|Overall Study|Adverse Event|8|||
38030845|NCT03772041|69716725|FG001|Overall Study|Adverse Event|3|||
38030846|NCT03772041|69716724|FG000|Overall Study|Withdrawal by Subject|0|||
38030847|NCT03772041|69716725|FG001|Overall Study|Withdrawal by Subject|2|||
38030848|NCT03772041|69716724|FG000|Overall Study|Protocol Violation|4|||
38030849|NCT03772041|69716725|FG001|Overall Study|Protocol Violation|2|||
38030850|NCT03772041|69716724|FG000|Overall Study|Physician Decision|2|||
38030851|NCT03772041|69716725|FG001|Overall Study|Physician Decision|3|||
38030852|NCT02899156|69716733|FG000|Overall Study|Death|1|||
38030853|NCT02899156|69716734|FG001|Overall Study|Death|0|||
38030854|NCT02899156|69716733|FG000|Overall Study|Physician Decision|0|||
38030855|NCT02899156|69716734|FG001|Overall Study|Physician Decision|1|||
38030856|NCT03773133|69716740|FG000|Overall Study|Screen Failure|8|||
38030857|NCT02969356|69716745|FG000|Overall Study|Adverse Event|7|||
38030858|NCT02969356|69716745|FG000|Overall Study|Consent withdrawn|2|||
38030859|NCT02969356|69716745|FG000|Overall Study|Lost to Follow-up|3|||
38030860|NCT02969356|69716745|FG000|Overall Study|Did not need to be reinjected|6|||
37920521|NCT00878501|69607237|FG000|Overall Study|Withdrawal by Subject|2|||
37920522|NCT00878501|69607238|FG001|Overall Study|Withdrawal by Subject|1|||
37920523|NCT00878501|69607239|FG002|Overall Study|Withdrawal by Subject|2|||
37920524|NCT00878501|69607237|FG000|Overall Study|Protocol Violation|0|||
37920525|NCT00878501|69607238|FG001|Overall Study|Protocol Violation|0|||
37920526|NCT00878501|69607239|FG002|Overall Study|Protocol Violation|1|||
37920527|NCT00878501|69607237|FG000|Overall Study|Incorrect enrolment|1|||
37920528|NCT00878501|69607238|FG001|Overall Study|Incorrect enrolment|2|||
37920529|NCT00878501|69607239|FG002|Overall Study|Incorrect enrolment|0|||
37920530|NCT00878501|69607237|FG000|Overall Study|Intake of prohibited concom. medication|0|||
37920531|NCT00878501|69607238|FG001|Overall Study|Intake of prohibited concom. medication|0|||
37920532|NCT00878501|69607239|FG002|Overall Study|Intake of prohibited concom. medication|1|||
37920533|NCT00878501|69607237|FG000|Overall Study|Mis-randomisation of patient|1|||
37920534|NCT00878501|69607238|FG001|Overall Study|Mis-randomisation of patient|0|||
37920535|NCT00878501|69607239|FG002|Overall Study|Mis-randomisation of patient|0|||
37920536|NCT00878501|69607237|FG000|Overall Study|Administrative|0|||
37920537|NCT00878501|69607238|FG001|Overall Study|Administrative|0|||
37920538|NCT00878501|69607239|FG002|Overall Study|Administrative|1|||
37920539|NCT00882713|69607247|FG000|Overall Study|Adverse Event|2|||
37920540|NCT00882713|69607247|FG000|Overall Study|Death|3|||
37920541|NCT00882713|69607247|FG000|Overall Study|Administrative reasons|4|||
38030861|NCT02969356|69716745|FG000|Overall Study|Personal reasons|5|||
38030862|NCT02898454|69716752|FG000|Overall Study|Adverse Event|4|||
38030863|NCT02898454|69716753|FG001|Overall Study|Adverse Event|1|||
37920542|NCT00882713|69607247|FG000|Overall Study|refused treatment/withdrew consent|4|||
37920543|NCT00882713|69607247|FG000|Overall Study|Blood transfusion|2|||
37920544|NCT00882713|69607247|FG000|Overall Study|Insufficient therapeutic response|3|||
37920545|NCT00882713|69607247|FG000|Overall Study|Failure to return|2|||
37920546|NCT00882713|69607247|FG000|Overall Study|Other - Reasons|2|||
38030864|NCT02898454|69716754|FG002|Overall Study|Adverse Event|2|||
38030865|NCT02898454|69716752|FG000|Overall Study|Protocol Violation|1|||
38030866|NCT02898454|69716753|FG001|Overall Study|Protocol Violation|0|||
38030867|NCT02898454|69716754|FG002|Overall Study|Protocol Violation|1|||
38030868|NCT02898454|69716752|FG000|Overall Study|Lack of Efficacy|4|||
38030869|NCT02898454|69716753|FG001|Overall Study|Lack of Efficacy|1|||
37920547|NCT00809133|69607266|FG000|Overall Study|Progressive disease|2|||
37920548|NCT00809133|69607267|FG001|Overall Study|Progressive disease|5|||
37920549|NCT00809133|69607268|FG002|Overall Study|Progressive disease|5|||
37920550|NCT00809133|69607269|FG003|Overall Study|Progressive disease|3|||
37920551|NCT00809133|69607270|FG004|Overall Study|Progressive disease|4|||
37920552|NCT00809133|69607271|FG005|Overall Study|Progressive disease|1|||
37920553|NCT00809133|69607272|FG006|Overall Study|Progressive disease|3|||
37851569|NCT01010971|69535262|FG001|Overall Study|Withdrawal by Subject|2|||
37851570|NCT01010971|69535263|FG002|Overall Study|Withdrawal by Subject|5|||
37851571|NCT01010971|69535261|FG000|Overall Study|Lost to Follow-up|0|||
37851572|NCT01010971|69535262|FG001|Overall Study|Lost to Follow-up|2|||
37851573|NCT01010971|69535263|FG002|Overall Study|Lost to Follow-up|3|||
37851574|NCT01010971|69535261|FG000|Overall Study|Other|1|||
37851575|NCT01010971|69535262|FG001|Overall Study|Other|0|||
37851576|NCT01010971|69535263|FG002|Overall Study|Other|2|||
37851577|NCT01306656|69535273|FG000|Overall Study|Lost to Follow-up|1|||
37851578|NCT01306656|69535274|FG001|Overall Study|Lost to Follow-up|0|||
37851579|NCT01008943|69535282|FG000|Overall Study|Withdrawal by Subject|1|||
37920554|NCT00809133|69607273|FG007|Overall Study|Progressive disease|3|||
37920555|NCT00809133|69607274|FG008|Overall Study|Progressive disease|3|||
37920556|NCT00809133|69607275|FG009|Overall Study|Progressive disease|9|||
37920557|NCT00809133|69607276|FG010|Overall Study|Progressive disease|5|||
37920558|NCT00809133|69607277|FG011|Overall Study|Progressive disease|7|||
37920559|NCT00809133|69607278|FG012|Overall Study|Progressive disease|5|||
37920560|NCT00809133|69607279|FG013|Overall Study|Progressive disease|4|||
37920561|NCT00809133|69607266|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
37920562|NCT00809133|69607267|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
37920563|NCT00809133|69607268|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
37920564|NCT00809133|69607269|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
37920565|NCT00809133|69607270|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
37920566|NCT00809133|69607271|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
37920567|NCT00809133|69607272|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
37920568|NCT00809133|69607273|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
37920569|NCT00809133|69607274|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
37920570|NCT00809133|69607275|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
37920571|NCT00809133|69607276|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
37920572|NCT00809133|69607277|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
37920573|NCT00809133|69607278|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
37920574|NCT00809133|69607279|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
37920575|NCT00809133|69607266|FG000|Overall Study|Other adverse event|1|||
37920576|NCT00809133|69607267|FG001|Overall Study|Other adverse event|1|||
37920577|NCT00809133|69607268|FG002|Overall Study|Other adverse event|1|||
37920578|NCT00809133|69607269|FG003|Overall Study|Other adverse event|0|||
37920579|NCT00809133|69607270|FG004|Overall Study|Other adverse event|0|||
37920580|NCT00809133|69607271|FG005|Overall Study|Other adverse event|3|||
37920581|NCT00809133|69607272|FG006|Overall Study|Other adverse event|2|||
37920582|NCT00809133|69607273|FG007|Overall Study|Other adverse event|4|||
37920583|NCT00809133|69607274|FG008|Overall Study|Other adverse event|0|||
37920584|NCT00809133|69607275|FG009|Overall Study|Other adverse event|0|||
37851580|NCT01003639|69535288|FG000|Overall Study|Lost to Follow-up|6|||
37851581|NCT01003639|69535289|FG001|Overall Study|Lost to Follow-up|9|||
37851582|NCT01003639|69535288|FG000|Overall Study|Withdrawal by Subject|9|||
37851583|NCT01003639|69535289|FG001|Overall Study|Withdrawal by Subject|5|||
37851584|NCT01003639|69535288|FG000|Overall Study|Lack of Efficacy|1|||
37920585|NCT00809133|69607276|FG010|Overall Study|Other adverse event|1|||
37851585|NCT01003639|69535289|FG001|Overall Study|Lack of Efficacy|6|||
37851586|NCT01003639|69535288|FG000|Overall Study|Adverse Event|0|||
37851587|NCT01003639|69535289|FG001|Overall Study|Adverse Event|1|||
37851588|NCT01003639|69535288|FG000|Overall Study|Protocol Violation|0|||
37851589|NCT01003639|69535289|FG001|Overall Study|Protocol Violation|1|||
37920586|NCT00809133|69607277|FG011|Overall Study|Other adverse event|1|||
37920587|NCT00809133|69607278|FG012|Overall Study|Other adverse event|0|||
37920588|NCT00809133|69607279|FG013|Overall Study|Other adverse event|1|||
37920589|NCT00809133|69607266|FG000|Overall Study|Lost to Follow-up|0|||
37920590|NCT00809133|69607267|FG001|Overall Study|Lost to Follow-up|0|||
37920591|NCT00809133|69607268|FG002|Overall Study|Lost to Follow-up|0|||
37851590|NCT01003639|69535288|FG000|Overall Study|Physician Decision|1|||
37851591|NCT01003639|69535289|FG001|Overall Study|Physician Decision|0|||
37920592|NCT00809133|69607269|FG003|Overall Study|Lost to Follow-up|0|||
37851592|NCT01003249|69535295|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
37920593|NCT00809133|69607270|FG004|Overall Study|Lost to Follow-up|0|||
37920594|NCT00809133|69607271|FG005|Overall Study|Lost to Follow-up|1|||
37920595|NCT00809133|69607272|FG006|Overall Study|Lost to Follow-up|0|||
37920596|NCT00809133|69607273|FG007|Overall Study|Lost to Follow-up|0|||
37920597|NCT00809133|69607274|FG008|Overall Study|Lost to Follow-up|0|||
37920598|NCT00809133|69607275|FG009|Overall Study|Lost to Follow-up|0|||
37920599|NCT00809133|69607276|FG010|Overall Study|Lost to Follow-up|0|||
37735444|NCT01925209|69215872|FG002|Follow-up|Physician Decision|1|||
37735445|NCT01925209|69215873|FG003|Follow-up|Physician Decision|0|||
37735446|NCT01925209|69215870|FG000|Follow-up|Non-compliance with study treatment|0|||
37735447|NCT01925209|69215871|FG001|Follow-up|Non-compliance with study treatment|0|||
37735448|NCT01925209|69215872|FG002|Follow-up|Non-compliance with study treatment|0|||
37735449|NCT01925209|69215873|FG003|Follow-up|Non-compliance with study treatment|1|||
37735450|NCT01925209|69215870|FG000|Follow-up|Withdrawal by Subject|0|||
37735451|NCT01925209|69215871|FG001|Follow-up|Withdrawal by Subject|2|||
37735452|NCT01925209|69215872|FG002|Follow-up|Withdrawal by Subject|0|||
37735453|NCT01925209|69215873|FG003|Follow-up|Withdrawal by Subject|2|||
37735454|NCT01614925|69215885|FG000|Overall Study|Withdrawal by Subject|1|||
37735455|NCT01614925|69215886|FG001|Overall Study|Withdrawal by Subject|0|||
37735456|NCT01614925|69215885|FG000|Overall Study|Protocol Violation|3|||
37735457|NCT01614925|69215886|FG001|Overall Study|Protocol Violation|2|||
37735458|NCT01886833|69215892|FG000|Overall Study|IgA not available from both periods|204|||
37735459|NCT01898923|69215901|FG000|Overall Study|Lack of Efficacy|5|||
37735460|NCT01898923|69215902|FG001|Overall Study|Lack of Efficacy|6|||
37851593|NCT01003249|69535296|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
37851594|NCT01003249|69535295|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
37851595|NCT01003249|69535296|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
37851596|NCT01003249|69535295|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
37851597|NCT01003249|69535296|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
37851598|NCT01003249|69535295|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
37851599|NCT01003249|69535296|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
37851600|NCT01001767|69535308|FG000|Overall Study|no baseline study performed|1|||
37851601|NCT01001767|69535309|FG001|Overall Study|no baseline study performed|0|||
37851602|NCT01001767|69535308|FG000|Overall Study|Protocol Violation|1|||
37851603|NCT01001767|69535309|FG001|Overall Study|Protocol Violation|0|||
37851604|NCT01001767|69535308|FG000|Overall Study|Lost to Follow-up|1|||
37851605|NCT01001767|69535309|FG001|Overall Study|Lost to Follow-up|0|||
37851606|NCT01001767|69535308|FG000|Overall Study|Physician Decision|1|||
37851607|NCT01001767|69535309|FG001|Overall Study|Physician Decision|0|||
37851608|NCT01306032|69535321|FG000|First Intervention|Adverse Event|1|||
37851609|NCT01306032|69535322|FG001|First Intervention|Adverse Event|0|||
37851610|NCT01306032|69535323|FG002|First Intervention|Adverse Event|1|||
37851611|NCT01306032|69535324|FG003|First Intervention|Adverse Event|0|||
37851612|NCT01306032|69535325|FG004|First Intervention|Adverse Event|0|||
37851613|NCT01306032|69535326|FG005|First Intervention|Adverse Event|1|||
37851614|NCT01306032|69535321|FG000|First Intervention|Withdrawal by Subject|0|||
37851615|NCT01306032|69535322|FG001|First Intervention|Withdrawal by Subject|2|||
37851616|NCT01306032|69535323|FG002|First Intervention|Withdrawal by Subject|0|||
37851617|NCT01306032|69535324|FG003|First Intervention|Withdrawal by Subject|1|||
37851618|NCT01306032|69535325|FG004|First Intervention|Withdrawal by Subject|0|||
37851619|NCT01306032|69535326|FG005|First Intervention|Withdrawal by Subject|0|||
37920600|NCT00809133|69607277|FG011|Overall Study|Lost to Follow-up|0|||
37735461|NCT01898923|69215901|FG000|Overall Study|Adverse Event|3|||
37735462|NCT01898923|69215902|FG001|Overall Study|Adverse Event|1|||
37920601|NCT00809133|69607278|FG012|Overall Study|Lost to Follow-up|0|||
37920602|NCT00809133|69607279|FG013|Overall Study|Lost to Follow-up|0|||
37920603|NCT00809133|69607266|FG000|Overall Study|Consent withdrawn|0|||
37920604|NCT00809133|69607267|FG001|Overall Study|Consent withdrawn|0|||
37735463|NCT01898923|69215901|FG000|Overall Study|Lost to Follow-up|0|||
37851620|NCT01306032|69535321|FG000|First Intervention|Death|0|||
37851621|NCT01306032|69535322|FG001|First Intervention|Death|0|||
37851622|NCT01306032|69535323|FG002|First Intervention|Death|1|||
37735464|NCT01898923|69215902|FG001|Overall Study|Lost to Follow-up|1|||
37735465|NCT01898923|69215901|FG000|Overall Study|Withdrawal by Subject|4|||
37735466|NCT01898923|69215902|FG001|Overall Study|Withdrawal by Subject|7|||
37735467|NCT01898923|69215901|FG000|Overall Study|Physician Decision|3|||
37735468|NCT01898923|69215902|FG001|Overall Study|Physician Decision|4|||
37735469|NCT01898923|69215901|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
37735470|NCT01898923|69215902|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
37851623|NCT01306032|69535324|FG003|First Intervention|Death|0|||
37851624|NCT01306032|69535325|FG004|First Intervention|Death|0|||
37920605|NCT00809133|69607268|FG002|Overall Study|Consent withdrawn|0|||
37851625|NCT01306032|69535326|FG005|First Intervention|Death|0|||
37851626|NCT01306032|69535321|FG000|First Intervention|Ineligible|0|||
37851627|NCT01306032|69535322|FG001|First Intervention|Ineligible|0|||
37920606|NCT00809133|69607269|FG003|Overall Study|Consent withdrawn|0|||
37920607|NCT00809133|69607270|FG004|Overall Study|Consent withdrawn|1|||
37920608|NCT00809133|69607271|FG005|Overall Study|Consent withdrawn|0|||
37920609|NCT00809133|69607272|FG006|Overall Study|Consent withdrawn|0|||
37920610|NCT00809133|69607273|FG007|Overall Study|Consent withdrawn|0|||
37920611|NCT00809133|69607274|FG008|Overall Study|Consent withdrawn|0|||
37920612|NCT00809133|69607275|FG009|Overall Study|Consent withdrawn|0|||
37920613|NCT00809133|69607276|FG010|Overall Study|Consent withdrawn|0|||
37920614|NCT00809133|69607277|FG011|Overall Study|Consent withdrawn|0|||
37920615|NCT00809133|69607278|FG012|Overall Study|Consent withdrawn|0|||
37851628|NCT01306032|69535323|FG002|First Intervention|Ineligible|0|||
37851629|NCT01306032|69535324|FG003|First Intervention|Ineligible|0|||
37851630|NCT01306032|69535325|FG004|First Intervention|Ineligible|0|||
37851631|NCT01306032|69535326|FG005|First Intervention|Ineligible|1|||
37851632|NCT01306032|69535321|FG000|First Intervention|Progressive disease|0|||
37851633|NCT01306032|69535322|FG001|First Intervention|Progressive disease|0|||
37851634|NCT01306032|69535323|FG002|First Intervention|Progressive disease|0|||
37851635|NCT01306032|69535324|FG003|First Intervention|Progressive disease|0|||
37851636|NCT01306032|69535325|FG004|First Intervention|Progressive disease|2|||
37851637|NCT01306032|69535326|FG005|First Intervention|Progressive disease|0|||
37851638|NCT01306032|69535321|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
37851639|NCT01306032|69535322|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
37851640|NCT01306032|69535323|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
37851641|NCT01306032|69535324|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
37851642|NCT01306032|69535325|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
37851643|NCT01306032|69535326|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
37851644|NCT01306032|69535321|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
37851645|NCT01306032|69535322|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
37851646|NCT01306032|69535323|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
37851647|NCT01306032|69535324|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
37851648|NCT01306032|69535325|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
37851649|NCT01306032|69535326|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
37851650|NCT01263015|69535354|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
37851651|NCT01263015|69535355|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
37920616|NCT00809133|69607279|FG013|Overall Study|Consent withdrawn|0|||
37920617|NCT00809133|69607266|FG000|Overall Study|Other not mentioned above|0|||
37851652|NCT01263015|69535354|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
37851653|NCT01263015|69535355|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
37851654|NCT01263015|69535354|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
37851655|NCT01263015|69535355|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
37920618|NCT00809133|69607267|FG001|Overall Study|Other not mentioned above|1|||
37735471|NCT01924429|69215910|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
37735472|NCT01924429|69215911|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
37735473|NCT01898299|69215921|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
37735474|NCT01898299|69215922|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
37735475|NCT01886287|69215928|FG000|Overall Study|Radiographic disease progression|1|||
37735476|NCT01886287|69215928|FG000|Overall Study|Clinical progression due to disease|1|||
37735477|NCT01885195|69215932|FG000|Overall Study|Adverse Event|29|||
37735478|NCT01885195|69215932|FG000|Overall Study|Death|1|||
37851656|NCT01263015|69535354|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
37920619|NCT00809133|69607268|FG002|Overall Study|Other not mentioned above|0|||
37920620|NCT00809133|69607269|FG003|Overall Study|Other not mentioned above|0|||
37920621|NCT00809133|69607270|FG004|Overall Study|Other not mentioned above|0|||
37920622|NCT00809133|69607271|FG005|Overall Study|Other not mentioned above|1|||
37920623|NCT00809133|69607272|FG006|Overall Study|Other not mentioned above|0|||
37920624|NCT00809133|69607273|FG007|Overall Study|Other not mentioned above|0|||
37920625|NCT00809133|69607274|FG008|Overall Study|Other not mentioned above|0|||
37920626|NCT00809133|69607275|FG009|Overall Study|Other not mentioned above|0|||
37920627|NCT00809133|69607276|FG010|Overall Study|Other not mentioned above|0|||
37920628|NCT00809133|69607277|FG011|Overall Study|Other not mentioned above|0|||
37920629|NCT00809133|69607278|FG012|Overall Study|Other not mentioned above|0|||
37920630|NCT00809133|69607279|FG013|Overall Study|Other not mentioned above|0|||
37920631|NCT00882557|69607324|FG000|Overall Study|Withdrawal by Subject|1|||
37920632|NCT00882557|69607325|FG001|Overall Study|Withdrawal by Subject|0|||
37920633|NCT00882557|69607324|FG000|Overall Study|Trouble with Vein Access|1|||
37920634|NCT00882557|69607325|FG001|Overall Study|Trouble with Vein Access|0|||
37920635|NCT00882557|69607324|FG000|Overall Study|Randomized Not Treated|0|||
37920636|NCT00882557|69607325|FG001|Overall Study|Randomized Not Treated|1|||
37920637|NCT00808899|69607331|FG000|Overall Study|Death|1|||
37920638|NCT00808899|69607331|FG000|Overall Study|Physician Decision|3|||
37920639|NCT00808665|69607337|FG000|Overall Study|Withdrawal by Subject|1|||
37920640|NCT00808665|69607338|FG001|Overall Study|Withdrawal by Subject|0|||
37920641|NCT00808665|69607337|FG000|Overall Study|only required minimally invasive surgery|1|||
37920642|NCT00808665|69607338|FG001|Overall Study|only required minimally invasive surgery|0|||
37920643|NCT00808665|69607337|FG000|Overall Study|surgery cancelled|1|||
37920644|NCT00808665|69607338|FG001|Overall Study|surgery cancelled|0|||
37851657|NCT01263015|69535355|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
37851658|NCT01263015|69535354|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
37851659|NCT01263015|69535355|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
37851660|NCT01263015|69535354|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
37851661|NCT01263015|69535355|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
37851662|NCT01263015|69535354|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
37851663|NCT01263015|69535355|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
37851664|NCT01263015|69535354|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
37851665|NCT01263015|69535355|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
37851666|NCT01263015|69535354|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
37851667|NCT01263015|69535355|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
37851668|NCT01263015|69535354|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
37851669|NCT01263015|69535355|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
37851670|NCT01263015|69535354|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
37851671|NCT01263015|69535355|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
37851672|NCT01263015|69535354|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
37851673|NCT01263015|69535355|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
37851674|NCT01305564|69535361|FG000|Overall Study|Death|21|||
37851675|NCT01305564|69535361|FG000|Overall Study|Lost to Follow-up|12|||
37851676|NCT01305564|69535361|FG000|Overall Study|Withdrawal by Subject|1|||
37851677|NCT01305564|69535361|FG000|Overall Study|Physician Decision|3|||
37851678|NCT01305408|69535378|FG000|Overall Study|Adverse Event|10|||
37851679|NCT01305408|69535379|FG001|Overall Study|Adverse Event|7|||
37851680|NCT01305408|69535378|FG000|Overall Study|Lack of Efficacy|3|||
37851681|NCT01305408|69535379|FG001|Overall Study|Lack of Efficacy|4|||
37851682|NCT01305408|69535378|FG000|Overall Study|Withdrawal by Subject|9|||
37920645|NCT00808665|69607337|FG000|Overall Study|required an additional procedure|0|||
37920646|NCT00808665|69607338|FG001|Overall Study|required an additional procedure|1|||
37851683|NCT01305408|69535379|FG001|Overall Study|Withdrawal by Subject|9|||
37920647|NCT00808665|69607337|FG000|Overall Study|Physician Decision|3|||
37920648|NCT00808665|69607338|FG001|Overall Study|Physician Decision|1|||
38030870|NCT02898454|69716754|FG002|Overall Study|Lack of Efficacy|0|||
38030871|NCT02898454|69716752|FG000|Overall Study|Withdrawal by Subject|6|||
38030872|NCT02898454|69716753|FG001|Overall Study|Withdrawal by Subject|3|||
38030873|NCT02898454|69716754|FG002|Overall Study|Withdrawal by Subject|3|||
38030874|NCT02898454|69716752|FG000|Overall Study|Lost to Follow-up|1|||
37851684|NCT01305408|69535378|FG000|Overall Study|Protocol Violation|4|||
37851685|NCT01305408|69535379|FG001|Overall Study|Protocol Violation|6|||
37851686|NCT01305408|69535378|FG000|Overall Study|Lost to Follow-up|5|||
37851687|NCT01305408|69535379|FG001|Overall Study|Lost to Follow-up|3|||
37851688|NCT01305408|69535378|FG000|Overall Study|Noncompliance with study medication|0|||
37851689|NCT01305408|69535379|FG001|Overall Study|Noncompliance with study medication|1|||
37851690|NCT01305408|69535378|FG000|Overall Study|Noncompliance with study procedures|0|||
37851691|NCT01305408|69535379|FG001|Overall Study|Noncompliance with study procedures|1|||
37851692|NCT01305408|69535378|FG000|Overall Study|Other|1|||
37851693|NCT01305408|69535379|FG001|Overall Study|Other|0|||
37851694|NCT01304940|69535387|FG000|Overall Study|not meet symptom severity requirement|3|||
37851695|NCT01304940|69535388|FG001|Overall Study|not meet symptom severity requirement|0|||
37851696|NCT01261611|69535397|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
37851697|NCT01261611|69535398|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
37851698|NCT01261611|69535399|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
37851699|NCT01261611|69535397|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
37851700|NCT01261611|69535398|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
37851701|NCT01261611|69535399|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
37851702|NCT01261611|69535397|FG000|Treatment Cycle 1|Adverse Event|0|||
37851703|NCT01261611|69535398|FG001|Treatment Cycle 1|Adverse Event|1|||
37851704|NCT01261611|69535399|FG002|Treatment Cycle 1|Adverse Event|0|||
37851705|NCT01261611|69535397|FG000|Treatment Cycle 1|Protocol Violation|0|||
37851706|NCT01261611|69535398|FG001|Treatment Cycle 1|Protocol Violation|0|||
37851707|NCT01261611|69535399|FG002|Treatment Cycle 1|Protocol Violation|2|||
37851708|NCT01261611|69535397|FG000|Treatment Cycle 2|Completed study|4|||
37851709|NCT01261611|69535398|FG001|Treatment Cycle 2|Completed study|0|||
37851710|NCT01261611|69535399|FG002|Treatment Cycle 2|Completed study|0|||
37851711|NCT01261611|69535397|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
37851712|NCT01261611|69535398|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
37851713|NCT01261611|69535399|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
37851714|NCT01261611|69535397|FG000|Treatment Cycle 2|Adverse Event|1|||
37851715|NCT01261611|69535398|FG001|Treatment Cycle 2|Adverse Event|0|||
37851716|NCT01261611|69535399|FG002|Treatment Cycle 2|Adverse Event|0|||
37851717|NCT01261611|69535397|FG000|Treatment Cycle 2|Protocol Violation|2|||
37851718|NCT01261611|69535398|FG001|Treatment Cycle 2|Protocol Violation|0|||
37851719|NCT01261611|69535399|FG002|Treatment Cycle 2|Protocol Violation|0|||
37851720|NCT01261611|69535397|FG000|Treatment Cycle 2|Not otherwise specified|2|||
37851721|NCT01261611|69535398|FG001|Treatment Cycle 2|Not otherwise specified|0|||
37851722|NCT01261611|69535399|FG002|Treatment Cycle 2|Not otherwise specified|0|||
37851723|NCT01261611|69535397|FG000|Treatment Cycle 3|Completed study|24|||
37851724|NCT01261611|69535398|FG001|Treatment Cycle 3|Completed study|0|||
37851725|NCT01261611|69535399|FG002|Treatment Cycle 3|Completed study|0|||
37851726|NCT01261611|69535397|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
37851727|NCT01261611|69535398|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
37851728|NCT01261611|69535399|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
37851729|NCT01261611|69535397|FG000|Treatment Cycle 3|Adverse Event|1|||
38030875|NCT02898454|69716753|FG001|Overall Study|Lost to Follow-up|0|||
37851730|NCT01261611|69535398|FG001|Treatment Cycle 3|Adverse Event|0|||
37851731|NCT01261611|69535399|FG002|Treatment Cycle 3|Adverse Event|0|||
37851732|NCT01261611|69535397|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
37851733|NCT01261611|69535398|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
38030876|NCT02898454|69716754|FG002|Overall Study|Lost to Follow-up|0|||
37851734|NCT01261611|69535399|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
37851735|NCT01261611|69535397|FG000|Treatment Cycle 4|Completed study|87|||
37851736|NCT01261611|69535398|FG001|Treatment Cycle 4|Completed study|0|||
37851737|NCT01261611|69535399|FG002|Treatment Cycle 4|Completed study|0|||
37851738|NCT01261611|69535397|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
37851739|NCT01261611|69535398|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
38030877|NCT02898454|69716752|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
37851740|NCT01261611|69535399|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
38030878|NCT02898454|69716753|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
38030879|NCT02898454|69716754|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
38030880|NCT03772587|69716772|FG000|Overall Study|COVID-19|0|||
38030881|NCT03772587|69716773|FG001|Overall Study|COVID-19|0|||
38030882|NCT03772587|69716774|FG002|Overall Study|COVID-19|1|||
38030883|NCT03772587|69716775|FG003|Overall Study|COVID-19|1|||
38030884|NCT03772587|69716776|FG004|Overall Study|COVID-19|0|||
38030885|NCT03772587|69716772|FG000|Overall Study|Withdrawal by Subject|1|||
38030886|NCT03772587|69716773|FG001|Overall Study|Withdrawal by Subject|0|||
38030887|NCT03772587|69716774|FG002|Overall Study|Withdrawal by Subject|0|||
38030888|NCT03772587|69716775|FG003|Overall Study|Withdrawal by Subject|0|||
38030889|NCT03772587|69716776|FG004|Overall Study|Withdrawal by Subject|0|||
38030890|NCT02963506|69716803|FG000|Double-Blind Period|Adverse Event|0|||
38030891|NCT02963506|69716804|FG001|Double-Blind Period|Adverse Event|0|||
38030892|NCT02963506|69716805|FG002|Double-Blind Period|Adverse Event|1|||
37851741|NCT01261611|69535397|FG000|Treatment Cycle 4|Adverse Event|1|||
37851742|NCT01261611|69535398|FG001|Treatment Cycle 4|Adverse Event|0|||
37851743|NCT01261611|69535399|FG002|Treatment Cycle 4|Adverse Event|0|||
37920649|NCT00808665|69607337|FG000|Overall Study|Medication stopped by resident|0|||
37920650|NCT00808665|69607338|FG001|Overall Study|Medication stopped by resident|1|||
38030893|NCT02963506|69716806|FG003|Double-Blind Period|Adverse Event|0|||
38030894|NCT02963506|69716807|FG004|Double-Blind Period|Adverse Event|0|||
38030895|NCT02963506|69716808|FG005|Double-Blind Period|Adverse Event|0|||
38030896|NCT02963506|69716809|FG006|Double-Blind Period|Adverse Event|0|||
38030897|NCT02963506|69716810|FG007|Double-Blind Period|Adverse Event|0|||
38030898|NCT02963506|69716811|FG008|Double-Blind Period|Adverse Event|0|||
38030899|NCT02963506|69716812|FG009|Double-Blind Period|Adverse Event|0|||
38030900|NCT02963506|69716813|FG010|Double-Blind Period|Adverse Event|0|||
38030901|NCT02963506|69716814|FG011|Double-Blind Period|Adverse Event|0|||
38030902|NCT02963506|69716815|FG012|Double-Blind Period|Adverse Event|0|||
38030903|NCT02963506|69716803|FG000|Double-Blind Period|Death|0|||
38030904|NCT02963506|69716804|FG001|Double-Blind Period|Death|0|||
38030905|NCT02963506|69716805|FG002|Double-Blind Period|Death|0|||
37851744|NCT01261611|69535397|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
37851745|NCT01261611|69535398|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
37851746|NCT01261611|69535399|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
37851747|NCT01261611|69535397|FG000|Treatment Cycle 4|Not otherwise specified|3|||
37851748|NCT01261611|69535398|FG001|Treatment Cycle 4|Not otherwise specified|0|||
37851749|NCT01261611|69535399|FG002|Treatment Cycle 4|Not otherwise specified|0|||
37920651|NCT00808509|69607346|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
37920652|NCT00808509|69607347|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
37920653|NCT00808509|69607346|FG000|Randomized Phase|Reduced methotrexate dose|1|||
37920654|NCT00808509|69607347|FG001|Randomized Phase|Reduced methotrexate dose|2|||
37920655|NCT00808509|69607346|FG000|Randomized Phase|Patient refused rescue therapy|0|||
37920656|NCT00808509|69607347|FG001|Randomized Phase|Patient refused rescue therapy|3|||
37920657|NCT00807885|69607364|FG000|Overall Study|Lost to Follow-up|0|||
37920658|NCT00807885|69607365|FG001|Overall Study|Lost to Follow-up|0|||
37920659|NCT00807885|69607366|FG002|Overall Study|Lost to Follow-up|0|||
37920660|NCT00807885|69607367|FG003|Overall Study|Lost to Follow-up|0|||
37920661|NCT00807885|69607368|FG004|Overall Study|Lost to Follow-up|0|||
37920662|NCT00807885|69607369|FG005|Overall Study|Lost to Follow-up|1|||
37920663|NCT00807885|69607370|FG006|Overall Study|Lost to Follow-up|0|||
37920664|NCT00807885|69607371|FG007|Overall Study|Lost to Follow-up|0|||
37920665|NCT00807885|69607372|FG008|Overall Study|Lost to Follow-up|0|||
38030906|NCT02963506|69716806|FG003|Double-Blind Period|Death|1|||
38030907|NCT02963506|69716807|FG004|Double-Blind Period|Death|0|||
38030908|NCT02963506|69716808|FG005|Double-Blind Period|Death|0|||
38030909|NCT02963506|69716809|FG006|Double-Blind Period|Death|0|||
38030910|NCT02963506|69716810|FG007|Double-Blind Period|Death|0|||
38030911|NCT02963506|69716811|FG008|Double-Blind Period|Death|0|||
38030912|NCT02963506|69716812|FG009|Double-Blind Period|Death|0|||
37920666|NCT00807573|69607392|FG000|Overall Study|Withdrawal by Subject|1|||
38030913|NCT02963506|69716813|FG010|Double-Blind Period|Death|0|||
38030914|NCT02963506|69716814|FG011|Double-Blind Period|Death|0|||
38030915|NCT02963506|69716815|FG012|Double-Blind Period|Death|0|||
38030916|NCT02963506|69716803|FG000|Double-Blind Period|Lost to Follow-up|0|||
38030917|NCT02963506|69716804|FG001|Double-Blind Period|Lost to Follow-up|1|||
38030918|NCT02963506|69716805|FG002|Double-Blind Period|Lost to Follow-up|0|||
38030919|NCT02963506|69716806|FG003|Double-Blind Period|Lost to Follow-up|0|||
38030920|NCT02963506|69716807|FG004|Double-Blind Period|Lost to Follow-up|0|||
38030921|NCT02963506|69716808|FG005|Double-Blind Period|Lost to Follow-up|0|||
38030922|NCT02963506|69716809|FG006|Double-Blind Period|Lost to Follow-up|0|||
38030923|NCT02963506|69716810|FG007|Double-Blind Period|Lost to Follow-up|0|||
38030924|NCT02963506|69716811|FG008|Double-Blind Period|Lost to Follow-up|0|||
38030925|NCT02963506|69716812|FG009|Double-Blind Period|Lost to Follow-up|0|||
37851750|NCT01261611|69535397|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
37851751|NCT01261611|69535398|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
37851752|NCT01261611|69535399|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
37851753|NCT01261611|69535397|FG000|Treatment Cycle 5|Adverse Event|1|||
37851754|NCT01261611|69535398|FG001|Treatment Cycle 5|Adverse Event|0|||
37851755|NCT01261611|69535399|FG002|Treatment Cycle 5|Adverse Event|0|||
37851756|NCT01261611|69535397|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
37851757|NCT01261611|69535398|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
37851758|NCT01261611|69535399|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
37851759|NCT01304706|69535411|FG000|Overall Study|Adverse Event|2|||
37851760|NCT01304706|69535411|FG000|Overall Study|Lack of Efficacy|1|||
37851761|NCT01304706|69535411|FG000|Overall Study|Death|3|||
37851762|NCT01304706|69535411|FG000|Overall Study|Withdrawal by Subject|3|||
37851763|NCT01304706|69535411|FG000|Overall Study|Lost to Follow-up|7|||
37851764|NCT01304706|69535411|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
37851765|NCT01303380|69535415|FG000|Overall Study|Lack of compliance to study procedures|1|||
37851766|NCT01008553|69535419|FG000|Period 1 (Titration Period)|Physician Decision|2|||
37851767|NCT01008553|69535420|FG001|Period 1 (Titration Period)|Physician Decision|0|||
37851768|NCT01008553|69535421|FG002|Period 1 (Titration Period)|Physician Decision|0|||
37851769|NCT01008553|69535419|FG000|Period 1 (Titration Period)|Adverse Event|33|||
37851770|NCT01008553|69535420|FG001|Period 1 (Titration Period)|Adverse Event|0|||
37920667|NCT00807573|69607392|FG000|Overall Study|Adverse Event|1|||
37920668|NCT00842712|69607403|FG000|Safety Run-in Part|Adverse Event|0|||
37920669|NCT00842712|69607404|FG001|Safety Run-in Part|Adverse Event|1|||
37920670|NCT00842712|69607405|FG002|Safety Run-in Part|Adverse Event|0|||
37920671|NCT00842712|69607406|FG003|Safety Run-in Part|Adverse Event|0|||
37920672|NCT00842712|69607407|FG004|Safety Run-in Part|Adverse Event|0|||
37920673|NCT00842712|69607408|FG005|Safety Run-in Part|Adverse Event|0|||
37920674|NCT00842712|69607409|FG006|Safety Run-in Part|Adverse Event|0|||
37920675|NCT00842712|69607403|FG000|Safety Run-in Part|Progressive disease|3|||
37920676|NCT00842712|69607404|FG001|Safety Run-in Part|Progressive disease|1|||
37920677|NCT00842712|69607405|FG002|Safety Run-in Part|Progressive disease|0|||
37920678|NCT00842712|69607406|FG003|Safety Run-in Part|Progressive disease|1|||
37920679|NCT00842712|69607407|FG004|Safety Run-in Part|Progressive disease|0|||
37920680|NCT00842712|69607408|FG005|Safety Run-in Part|Progressive disease|0|||
37920681|NCT00842712|69607409|FG006|Safety Run-in Part|Progressive disease|0|||
37920682|NCT00842712|69607403|FG000|Randomized Part|Randomized but not treated|0|||
37851771|NCT01008553|69535421|FG002|Period 1 (Titration Period)|Adverse Event|0|||
37851772|NCT01008553|69535419|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
37851773|NCT01008553|69535420|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
37851774|NCT01008553|69535421|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
37851775|NCT01008553|69535419|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
37851776|NCT01008553|69535420|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
37851777|NCT01008553|69535421|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
37851778|NCT01008553|69535419|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
37851779|NCT01008553|69535420|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
37920683|NCT00842712|69607404|FG001|Randomized Part|Randomized but not treated|0|||
37851780|NCT01008553|69535421|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
37851781|NCT01008553|69535419|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
37920684|NCT00842712|69607405|FG002|Randomized Part|Randomized but not treated|0|||
37920685|NCT00842712|69607406|FG003|Randomized Part|Randomized but not treated|0|||
37920686|NCT00842712|69607407|FG004|Randomized Part|Randomized but not treated|0|||
37920687|NCT00842712|69607408|FG005|Randomized Part|Randomized but not treated|1|||
38030926|NCT02963506|69716813|FG010|Double-Blind Period|Lost to Follow-up|0|||
38030927|NCT02963506|69716814|FG011|Double-Blind Period|Lost to Follow-up|0|||
37920688|NCT00842712|69607409|FG006|Randomized Part|Randomized but not treated|4|||
37920689|NCT00842712|69607403|FG000|Randomized Part|Ongoing at cut-off date|0|||
37920690|NCT00842712|69607404|FG001|Randomized Part|Ongoing at cut-off date|0|||
37920691|NCT00842712|69607405|FG002|Randomized Part|Ongoing at cut-off date|0|||
37920692|NCT00842712|69607406|FG003|Randomized Part|Ongoing at cut-off date|0|||
37920693|NCT00842712|69607407|FG004|Randomized Part|Ongoing at cut-off date|0|||
37920694|NCT00842712|69607408|FG005|Randomized Part|Ongoing at cut-off date|0|||
37920695|NCT00842712|69607409|FG006|Randomized Part|Ongoing at cut-off date|2|||
37920696|NCT00842244|69607425|FG000|Overall Study|Death|3|||
37920697|NCT00842244|69607425|FG000|Overall Study|Withdrawal by Subject|1|||
37920698|NCT00842244|69607425|FG000|Overall Study|Other|17|||
37920699|NCT00832416|69607436|FG000|Overall Study|Lack of Efficacy|17|||
37920700|NCT00832416|69607437|FG001|Overall Study|Lack of Efficacy|15|||
37920701|NCT00832416|69607438|FG002|Overall Study|Lack of Efficacy|13|||
37920702|NCT00832416|69607439|FG003|Overall Study|Lack of Efficacy|52|||
37920703|NCT00832416|69607436|FG000|Overall Study|Withdrawal by Subject|5|||
37920704|NCT00832416|69607437|FG001|Overall Study|Withdrawal by Subject|7|||
37920705|NCT00832416|69607438|FG002|Overall Study|Withdrawal by Subject|2|||
37920706|NCT00832416|69607439|FG003|Overall Study|Withdrawal by Subject|10|||
37920707|NCT00832416|69607436|FG000|Overall Study|Physician Decision|2|||
37920708|NCT00832416|69607437|FG001|Overall Study|Physician Decision|12|||
37920709|NCT00832416|69607438|FG002|Overall Study|Physician Decision|5|||
37920710|NCT00832416|69607439|FG003|Overall Study|Physician Decision|10|||
37920711|NCT00832416|69607436|FG000|Overall Study|Administrative|0|||
38030928|NCT02963506|69716815|FG012|Double-Blind Period|Lost to Follow-up|0|||
38030929|NCT02963506|69716803|FG000|Double-Blind Period|Withdrawal by Subject|0|||
38030930|NCT02963506|69716804|FG001|Double-Blind Period|Withdrawal by Subject|0|||
38030931|NCT02963506|69716805|FG002|Double-Blind Period|Withdrawal by Subject|1|||
38030932|NCT02963506|69716806|FG003|Double-Blind Period|Withdrawal by Subject|1|||
38030933|NCT02963506|69716807|FG004|Double-Blind Period|Withdrawal by Subject|0|||
37920712|NCT00832416|69607437|FG001|Overall Study|Administrative|0|||
37920713|NCT00832416|69607438|FG002|Overall Study|Administrative|0|||
37920714|NCT00832416|69607439|FG003|Overall Study|Administrative|1|||
38030934|NCT02963506|69716808|FG005|Double-Blind Period|Withdrawal by Subject|0|||
38030935|NCT02963506|69716809|FG006|Double-Blind Period|Withdrawal by Subject|0|||
37920715|NCT00832416|69607436|FG000|Overall Study|Adverse Event|21|||
37920716|NCT00832416|69607437|FG001|Overall Study|Adverse Event|19|||
37920717|NCT00832416|69607438|FG002|Overall Study|Adverse Event|41|||
37920718|NCT00832416|69607439|FG003|Overall Study|Adverse Event|10|||
37920719|NCT00832416|69607436|FG000|Overall Study|Death|1|||
37920720|NCT00832416|69607437|FG001|Overall Study|Death|0|||
37920721|NCT00832416|69607438|FG002|Overall Study|Death|0|||
37920722|NCT00832416|69607439|FG003|Overall Study|Death|0|||
37920723|NCT00841776|69607451|FG000|Overall Study|Lack of Efficacy|0|||
37920724|NCT00841776|69607452|FG001|Overall Study|Lack of Efficacy|1|||
37920725|NCT00841776|69607451|FG000|Overall Study|Lost to Follow-up|2|||
37920726|NCT00841776|69607452|FG001|Overall Study|Lost to Follow-up|1|||
37920727|NCT00841776|69607451|FG000|Overall Study|Withdrawal by Subject|0|||
37920728|NCT00841776|69607452|FG001|Overall Study|Withdrawal by Subject|1|||
37920729|NCT00683800|69607460|FG000|Overall Study|Adverse Event|195|||
37920730|NCT00683800|69607461|FG001|Overall Study|Adverse Event|102|||
37920731|NCT00683800|69607460|FG000|Overall Study|Death|0|||
37920732|NCT00683800|69607461|FG001|Overall Study|Death|1|||
37920733|NCT00683800|69607460|FG000|Overall Study|Lost to Follow-up|57|||
37920734|NCT00683800|69607461|FG001|Overall Study|Lost to Follow-up|44|||
37920735|NCT00683800|69607460|FG000|Overall Study|Other|5|||
37920736|NCT00683800|69607461|FG001|Overall Study|Other|2|||
37920737|NCT00683800|69607460|FG000|Overall Study|Protocol Violation|13|||
37920738|NCT00683800|69607461|FG001|Overall Study|Protocol Violation|16|||
37920739|NCT00683800|69607460|FG000|Overall Study|Withdrawal by Subject|66|||
37920740|NCT00683800|69607461|FG001|Overall Study|Withdrawal by Subject|64|||
37920741|NCT00683800|69607460|FG000|Overall Study|Lack of Efficacy|61|||
37920742|NCT00683800|69607461|FG001|Overall Study|Lack of Efficacy|104|||
37920743|NCT00683800|69607460|FG000|Overall Study|Randomized, not treated|35|||
37920744|NCT00683800|69607461|FG001|Overall Study|Randomized, not treated|33|||
37920745|NCT00683644|69607469|FG000|Overall Study|Withdrawal by Subject|4|||
37920746|NCT00683644|69607470|FG001|Overall Study|Withdrawal by Subject|2|||
37920747|NCT00683644|69607469|FG000|Overall Study|Lost to Follow-up|1|||
37920748|NCT00683644|69607470|FG001|Overall Study|Lost to Follow-up|4|||
37920749|NCT00683644|69607469|FG000|Overall Study|Adverse Event|1|||
38030936|NCT02963506|69716810|FG007|Double-Blind Period|Withdrawal by Subject|0|||
38030937|NCT02963506|69716811|FG008|Double-Blind Period|Withdrawal by Subject|0|||
37920750|NCT00683644|69607470|FG001|Overall Study|Adverse Event|2|||
37920751|NCT00683644|69607469|FG000|Overall Study|Low copper, other health problems,|7|||
37920752|NCT00683644|69607470|FG001|Overall Study|Low copper, other health problems,|6|||
37920753|NCT00685360|69607483|FG000|Overall Study|Lost to Follow-up|0|||
37920754|NCT00685360|69607484|FG001|Overall Study|Lost to Follow-up|1|||
37920755|NCT00685360|69607485|FG002|Overall Study|Lost to Follow-up|2|||
37920756|NCT00685360|69607483|FG000|Overall Study|Adverse Event|4|||
37920757|NCT00685360|69607484|FG001|Overall Study|Adverse Event|6|||
37920758|NCT00685360|69607485|FG002|Overall Study|Adverse Event|4|||
37920759|NCT00685360|69607483|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
38030938|NCT02963506|69716812|FG009|Double-Blind Period|Withdrawal by Subject|0|||
38030939|NCT02963506|69716813|FG010|Double-Blind Period|Withdrawal by Subject|0|||
38030940|NCT02963506|69716814|FG011|Double-Blind Period|Withdrawal by Subject|0|||
38030941|NCT02963506|69716815|FG012|Double-Blind Period|Withdrawal by Subject|0|||
38030942|NCT02963506|69716803|FG000|Double-Blind Period|No compliance|0|||
38030943|NCT02963506|69716804|FG001|Double-Blind Period|No compliance|1|||
38030944|NCT02963506|69716805|FG002|Double-Blind Period|No compliance|0|||
38030945|NCT02963506|69716806|FG003|Double-Blind Period|No compliance|0|||
38030946|NCT02963506|69716807|FG004|Double-Blind Period|No compliance|0|||
38030947|NCT02963506|69716808|FG005|Double-Blind Period|No compliance|0|||
38030948|NCT02963506|69716809|FG006|Double-Blind Period|No compliance|0|||
38030949|NCT02963506|69716810|FG007|Double-Blind Period|No compliance|0|||
38030950|NCT02963506|69716811|FG008|Double-Blind Period|No compliance|0|||
38030951|NCT02963506|69716812|FG009|Double-Blind Period|No compliance|0|||
38030952|NCT02963506|69716813|FG010|Double-Blind Period|No compliance|0|||
38030953|NCT02963506|69716814|FG011|Double-Blind Period|No compliance|0|||
38030954|NCT02963506|69716815|FG012|Double-Blind Period|No compliance|0|||
37851782|NCT01008553|69535420|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
37851783|NCT01008553|69535421|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
37851784|NCT01008553|69535419|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
37851785|NCT01008553|69535420|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
37851786|NCT01008553|69535421|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
37851787|NCT01008553|69535419|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
37851788|NCT01008553|69535420|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
37851789|NCT01008553|69535421|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
37851790|NCT01008553|69535419|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
37851791|NCT01008553|69535420|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
37851792|NCT01008553|69535421|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
37851793|NCT01008553|69535419|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
37851794|NCT01008553|69535420|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
37920760|NCT00685360|69607484|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
37920761|NCT00685360|69607485|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
37920762|NCT00685360|69607483|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
37920763|NCT00685360|69607484|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
37920764|NCT00685360|69607485|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
37920765|NCT00685360|69607483|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
37920766|NCT00685360|69607484|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
37920767|NCT00685360|69607485|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
37920768|NCT00685360|69607483|FG000|Overall Study|Protocol Deviation|0|||
37920769|NCT00685360|69607484|FG001|Overall Study|Protocol Deviation|1|||
37920770|NCT00685360|69607485|FG002|Overall Study|Protocol Deviation|1|||
37920771|NCT00684814|69607493|FG000|Washout Period of 7 Days|Adverse Event|1|||
37920772|NCT00684814|69607494|FG001|Washout Period of 7 Days|Adverse Event|2|||
37920773|NCT00684814|69607493|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
37920774|NCT00684814|69607494|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
37920775|NCT00684814|69607493|FG000|Second Intervention|Adverse Event|1|||
37920776|NCT00684814|69607494|FG001|Second Intervention|Adverse Event|0|||
38030955|NCT02963506|69716803|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
37735479|NCT01885195|69215932|FG000|Overall Study|Disease Progression|67|||
37851795|NCT01008553|69535421|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
37851796|NCT01008553|69535419|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
37851797|NCT01008553|69535420|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
37851798|NCT01008553|69535421|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
37851799|NCT01008553|69535419|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
37851800|NCT01008553|69535420|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
37851801|NCT01008553|69535421|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
37920777|NCT00576472|69607515|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
37920778|NCT00576472|69607516|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
38030956|NCT02963506|69716804|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
38030957|NCT02963506|69716805|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
38030958|NCT02963506|69716806|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
38030959|NCT02963506|69716807|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
38030960|NCT02963506|69716808|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
38030961|NCT02963506|69716809|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
38030962|NCT02963506|69716810|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
38030963|NCT02963506|69716811|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
38030964|NCT02963506|69716812|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
37735480|NCT01885195|69215932|FG000|Overall Study|Protocol Deviation|2|||
38030965|NCT02963506|69716813|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
38030966|NCT02963506|69716814|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
38030967|NCT02963506|69716815|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
38030968|NCT02963506|69716803|FG000|Dose-Blind Period|Adverse Event|0|||
38030969|NCT02963506|69716804|FG001|Dose-Blind Period|Adverse Event|0|||
38030970|NCT02963506|69716805|FG002|Dose-Blind Period|Adverse Event|0|||
38030971|NCT02963506|69716806|FG003|Dose-Blind Period|Adverse Event|0|||
38030972|NCT02963506|69716807|FG004|Dose-Blind Period|Adverse Event|0|||
38030973|NCT02963506|69716808|FG005|Dose-Blind Period|Adverse Event|1|||
38030974|NCT02963506|69716809|FG006|Dose-Blind Period|Adverse Event|3|||
38030975|NCT02963506|69716810|FG007|Dose-Blind Period|Adverse Event|2|||
38030976|NCT02963506|69716811|FG008|Dose-Blind Period|Adverse Event|2|||
38030977|NCT02963506|69716812|FG009|Dose-Blind Period|Adverse Event|2|||
38030978|NCT02963506|69716813|FG010|Dose-Blind Period|Adverse Event|1|||
37920779|NCT00576472|69607517|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
37920780|NCT00576472|69607518|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
37920781|NCT00576472|69607519|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
37920782|NCT00576472|69607520|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
37920783|NCT00576472|69607521|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
37920784|NCT00576472|69607522|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
37920785|NCT00576472|69607523|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
38030979|NCT02963506|69716814|FG011|Dose-Blind Period|Adverse Event|1|||
38030980|NCT02963506|69716815|FG012|Dose-Blind Period|Adverse Event|6|||
38030981|NCT02963506|69716803|FG000|Dose-Blind Period|Lack of Efficacy|0|||
38030982|NCT02963506|69716804|FG001|Dose-Blind Period|Lack of Efficacy|0|||
38030983|NCT02963506|69716805|FG002|Dose-Blind Period|Lack of Efficacy|0|||
38030984|NCT02963506|69716806|FG003|Dose-Blind Period|Lack of Efficacy|0|||
38030985|NCT02963506|69716807|FG004|Dose-Blind Period|Lack of Efficacy|0|||
38030986|NCT02963506|69716808|FG005|Dose-Blind Period|Lack of Efficacy|0|||
38030987|NCT02963506|69716809|FG006|Dose-Blind Period|Lack of Efficacy|0|||
38030988|NCT02963506|69716810|FG007|Dose-Blind Period|Lack of Efficacy|1|||
38030989|NCT02963506|69716811|FG008|Dose-Blind Period|Lack of Efficacy|0|||
38030990|NCT02963506|69716812|FG009|Dose-Blind Period|Lack of Efficacy|1|||
38030991|NCT02963506|69716813|FG010|Dose-Blind Period|Lack of Efficacy|0|||
38030992|NCT02963506|69716814|FG011|Dose-Blind Period|Lack of Efficacy|0|||
38030993|NCT02963506|69716815|FG012|Dose-Blind Period|Lack of Efficacy|0|||
38030994|NCT02963506|69716803|FG000|Dose-Blind Period|Lost to Follow-up|0|||
38030995|NCT02963506|69716804|FG001|Dose-Blind Period|Lost to Follow-up|0|||
38030996|NCT02963506|69716805|FG002|Dose-Blind Period|Lost to Follow-up|0|||
38030997|NCT02963506|69716806|FG003|Dose-Blind Period|Lost to Follow-up|0|||
38030998|NCT02963506|69716807|FG004|Dose-Blind Period|Lost to Follow-up|0|||
38030999|NCT02963506|69716808|FG005|Dose-Blind Period|Lost to Follow-up|1|||
38031000|NCT02963506|69716809|FG006|Dose-Blind Period|Lost to Follow-up|0|||
38031001|NCT02963506|69716810|FG007|Dose-Blind Period|Lost to Follow-up|0|||
38031002|NCT02963506|69716811|FG008|Dose-Blind Period|Lost to Follow-up|1|||
38031003|NCT02963506|69716812|FG009|Dose-Blind Period|Lost to Follow-up|0|||
38031004|NCT02963506|69716813|FG010|Dose-Blind Period|Lost to Follow-up|0|||
38031005|NCT02963506|69716814|FG011|Dose-Blind Period|Lost to Follow-up|1|||
38031006|NCT02963506|69716815|FG012|Dose-Blind Period|Lost to Follow-up|0|||
38031007|NCT02963506|69716803|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
37735481|NCT01885195|69215932|FG000|Overall Study|Physician Decision|3|||
38031008|NCT02963506|69716804|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
38031009|NCT02963506|69716805|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
38031010|NCT02963506|69716806|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
38031011|NCT02963506|69716807|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
38031012|NCT02963506|69716808|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
38031013|NCT02963506|69716809|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
38031014|NCT02963506|69716810|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
38031015|NCT02963506|69716811|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
38031016|NCT02963506|69716812|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
37735482|NCT01885195|69215932|FG000|Overall Study|Patient/guardian decision|8|||
37735483|NCT01896895|69215939|FG000|Double-blind MP|Physician Decision|0|||
37920786|NCT00576472|69607524|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
37920787|NCT00576472|69607525|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
37920788|NCT00576472|69607526|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
37920789|NCT00576472|69607527|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
37920790|NCT00576472|69607528|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
37920791|NCT00576472|69607529|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
37920792|NCT00576472|69607515|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
37920793|NCT00576472|69607516|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
37735484|NCT01896895|69215940|FG001|Double-blind MP|Physician Decision|0|||
37920794|NCT00576472|69607517|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
37920795|NCT00576472|69607518|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
37920796|NCT00576472|69607519|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
37920797|NCT00576472|69607520|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
37920798|NCT00576472|69607521|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
37920799|NCT00576472|69607522|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
37920800|NCT00576472|69607523|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
37920801|NCT00576472|69607524|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
37920802|NCT00576472|69607525|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
37920803|NCT00576472|69607526|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
37920804|NCT00576472|69607527|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
37920805|NCT00576472|69607528|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
37920806|NCT00576472|69607529|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
37920807|NCT00576472|69607515|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
37735485|NCT01896895|69215941|FG002|Double-blind MP|Physician Decision|1|||
38031017|NCT02963506|69716813|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
38031018|NCT02963506|69716814|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
38031019|NCT02963506|69716815|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
38031020|NCT02963506|69716803|FG000|Dose-Blind Period|Sponsor decision|0|||
38031021|NCT02963506|69716804|FG001|Dose-Blind Period|Sponsor decision|0|||
38031022|NCT02963506|69716805|FG002|Dose-Blind Period|Sponsor decision|0|||
38031023|NCT02963506|69716806|FG003|Dose-Blind Period|Sponsor decision|0|||
38031024|NCT02963506|69716807|FG004|Dose-Blind Period|Sponsor decision|0|||
38031025|NCT02963506|69716808|FG005|Dose-Blind Period|Sponsor decision|1|||
38031026|NCT02963506|69716809|FG006|Dose-Blind Period|Sponsor decision|0|||
38031027|NCT02963506|69716810|FG007|Dose-Blind Period|Sponsor decision|0|||
38031028|NCT02963506|69716811|FG008|Dose-Blind Period|Sponsor decision|0|||
38031029|NCT02963506|69716812|FG009|Dose-Blind Period|Sponsor decision|0|||
38031030|NCT02963506|69716813|FG010|Dose-Blind Period|Sponsor decision|0|||
38031031|NCT02963506|69716814|FG011|Dose-Blind Period|Sponsor decision|0|||
38031032|NCT02963506|69716815|FG012|Dose-Blind Period|Sponsor decision|0|||
38031033|NCT02963506|69716803|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
38031034|NCT02963506|69716804|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
38031035|NCT02963506|69716805|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
38031036|NCT02963506|69716806|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
38031037|NCT02963506|69716807|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
38031038|NCT02963506|69716808|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
38031039|NCT02963506|69716809|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
38031040|NCT02963506|69716810|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
37920808|NCT00576472|69607516|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
37920809|NCT00576472|69607517|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
38031041|NCT02963506|69716811|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
38031042|NCT02963506|69716812|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
38031043|NCT02963506|69716813|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
38031044|NCT02963506|69716814|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
38031045|NCT02963506|69716815|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
38031046|NCT01345162|69716834|FG000|Overall Study|Protocol Violation|2|||
38031047|NCT01345162|69716835|FG001|Overall Study|Protocol Violation|4|||
38031048|NCT01345318|69716841|FG000|Overall Study|Adverse Event|16|||
38031049|NCT01345318|69716841|FG000|Overall Study|Lack of Efficacy|17|||
38031050|NCT01345318|69716841|FG000|Overall Study|Lost to Follow-up|2|||
38031051|NCT01345318|69716841|FG000|Overall Study|Protocol Violation|1|||
38031052|NCT01345318|69716841|FG000|Overall Study|Withdrawal by Subject|41|||
38031053|NCT01345318|69716841|FG000|Overall Study|Other|3|||
38031054|NCT02961244|69716848|FG000|Overall Study|Protocol Violation|0|||
38031055|NCT02961244|69716849|FG001|Overall Study|Protocol Violation|1|||
38031056|NCT02961244|69716848|FG000|Overall Study|Withdrawal by Subject|1|||
38031057|NCT02961244|69716849|FG001|Overall Study|Withdrawal by Subject|2|||
38031058|NCT02961244|69716848|FG000|Overall Study|Surgery plan change after study approval|0|||
38031059|NCT02961244|69716849|FG001|Overall Study|Surgery plan change after study approval|2|||
38031060|NCT02961244|69716848|FG000|Overall Study|Lost to Follow-up|0|||
38031061|NCT02961244|69716849|FG001|Overall Study|Lost to Follow-up|2|||
37920810|NCT00576472|69607518|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
37920811|NCT00576472|69607519|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
38031062|NCT02961244|69716848|FG000|Overall Study|İnadequate data|0|||
38031063|NCT02961244|69716849|FG001|Overall Study|İnadequate data|2|||
38031064|NCT03771963|69716855|FG000|Overall Study|Lost to Follow-up|22|||
37920812|NCT00576472|69607520|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
37920813|NCT00576472|69607521|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
37920814|NCT00576472|69607522|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
38031065|NCT03771963|69716855|FG000|Overall Study|Withdrawal of Consent|10|||
38031066|NCT02962648|69716859|FG000|Overall Study|Withdrawal by Subject|3|||
38031067|NCT02962648|69716859|FG000|Overall Study|Lost to Follow-up|3|||
37920815|NCT00576472|69607523|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
37920816|NCT00576472|69607524|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
37920817|NCT00576472|69607525|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
37920818|NCT00576472|69607526|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
38031068|NCT02962648|69716859|FG000|Overall Study|Physician Decision|1|||
38031069|NCT02962648|69716859|FG000|Overall Study|Subject had problems with transportation|2|||
38031070|NCT02962882|69716863|FG000|Overall Study|Adverse Event|2|||
38031071|NCT02962882|69716863|FG000|Overall Study|Withdrawal by Subject|2|||
38031072|NCT02962882|69716863|FG000|Overall Study|Transfer from ICU|32|||
38031073|NCT02961790|69716872|FG000|Overall Study|Canceled|4|||
38031074|NCT02961790|69716873|FG001|Overall Study|Canceled|5|||
38031075|NCT02961790|69716874|FG002|Overall Study|Canceled|1|||
38031076|NCT02961790|69716875|FG003|Overall Study|Canceled|4|||
38031077|NCT02961790|69716872|FG000|Overall Study|without baseline data|4|||
37920819|NCT00576472|69607527|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
37920820|NCT00576472|69607528|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
37920821|NCT00576472|69607529|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
37920822|NCT00576472|69607515|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
38031078|NCT02961790|69716873|FG001|Overall Study|without baseline data|0|||
38031079|NCT02961790|69716874|FG002|Overall Study|without baseline data|1|||
38031080|NCT02961790|69716875|FG003|Overall Study|without baseline data|0|||
38031081|NCT02961790|69716872|FG000|Overall Study|without post baseline data|7|||
37851802|NCT01008553|69535419|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
37851803|NCT01008553|69535420|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
37851804|NCT01008553|69535421|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
37851805|NCT01008553|69535419|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
37851806|NCT01008553|69535420|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
37851807|NCT01008553|69535421|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
37851808|NCT01259115|69535430|FG000|Period 1|Adverse Event|1|||
37851809|NCT01259115|69535431|FG001|Period 1|Adverse Event|0|||
37851810|NCT01259115|69535430|FG000|Period 1|Protocol Violation|2|||
37851811|NCT01259115|69535431|FG001|Period 1|Protocol Violation|0|||
38031082|NCT02961790|69716873|FG001|Overall Study|without post baseline data|6|||
38031083|NCT02961790|69716874|FG002|Overall Study|without post baseline data|4|||
38031084|NCT02961790|69716875|FG003|Overall Study|without post baseline data|1|||
37851812|NCT01259115|69535430|FG000|Period 1|Lost to Follow-up|0|||
37851813|NCT01259115|69535431|FG001|Period 1|Lost to Follow-up|1|||
37851814|NCT01259115|69535430|FG000|Period 2|Adverse Event|1|||
38031085|NCT02960854|69716897|FG000|Overall Study|Not Disclosed|2|||
37851815|NCT01259115|69535431|FG001|Period 2|Adverse Event|0|||
37851816|NCT01302366|69535442|FG000|Overall Study|patient choice or noncompliance|5|||
37851817|NCT01302054|69535446|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
37851818|NCT01302054|69535447|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
37851819|NCT01302054|69535448|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
37851820|NCT01302054|69535446|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
37851821|NCT01302054|69535447|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
37851822|NCT01302054|69535448|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
37851823|NCT01302054|69535446|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
38031086|NCT02960854|69716898|FG001|Overall Study|Not Disclosed|2|||
38031087|NCT02960854|69716897|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
38031088|NCT02960854|69716898|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
38031089|NCT02960854|69716897|FG000|Overall Study|Subject Withdrew Consent|0|||
38031090|NCT02960854|69716898|FG001|Overall Study|Subject Withdrew Consent|1|||
38031091|NCT02960854|69716897|FG000|Overall Study|Death|4|||
38031092|NCT02960854|69716898|FG001|Overall Study|Death|6|||
37851824|NCT01302054|69535447|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
37851825|NCT01302054|69535448|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
37851826|NCT01302054|69535446|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
37851827|NCT01302054|69535447|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
37920823|NCT00576472|69607516|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
37920824|NCT00576472|69607517|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
37920825|NCT00576472|69607518|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
37920826|NCT00576472|69607519|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
37920827|NCT00576472|69607520|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
37920828|NCT00576472|69607521|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
37920829|NCT00576472|69607522|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
37920830|NCT00576472|69607523|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
37920831|NCT00576472|69607524|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
37851828|NCT01302054|69535448|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
37851829|NCT01302054|69535446|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
37851830|NCT01302054|69535447|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
37851831|NCT01302054|69535448|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
37851832|NCT01302054|69535446|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
37920832|NCT00576472|69607525|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
37920833|NCT00576472|69607526|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
37851833|NCT01302054|69535447|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
37920834|NCT00576472|69607527|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
38031093|NCT01344538|69716906|FG000|Overall Study|Adverse Event|1|||
38031094|NCT01344538|69716907|FG001|Overall Study|Adverse Event|1|||
38031095|NCT01344538|69716906|FG000|Overall Study|Lost to Follow-up|1|||
38031096|NCT01344538|69716907|FG001|Overall Study|Lost to Follow-up|0|||
38031097|NCT01344460|69716913|FG000|Overall Study|Withdrawal by Subject|1|||
38031098|NCT01344460|69716913|FG000|Overall Study|Lost to Follow-up|2|||
38031099|NCT03764631|69716923|FG000|Overall Study|Personal Reasons|3|||
38031100|NCT03764631|69716924|FG001|Overall Study|Personal Reasons|2|||
38031101|NCT03764631|69716923|FG000|Overall Study|Switching Therapy|3|||
38031102|NCT03764631|69716924|FG001|Overall Study|Switching Therapy|3|||
38031103|NCT03764631|69716923|FG000|Overall Study|Adverse Event|0|||
38031104|NCT03764631|69716924|FG001|Overall Study|Adverse Event|1|||
38031105|NCT03764631|69716923|FG000|Overall Study|Lost to Follow-up|33|||
38031106|NCT03764631|69716924|FG001|Overall Study|Lost to Follow-up|41|||
38031107|NCT03764631|69716923|FG000|Overall Study|No data as study site was closed|2|||
38031108|NCT03764631|69716924|FG001|Overall Study|No data as study site was closed|6|||
38031109|NCT02956486|69716943|FG000|Core Phase|Adverse Event|51|||
38031110|NCT02956486|69716944|FG001|Core Phase|Adverse Event|88|||
38031111|NCT02956486|69716945|FG002|Core Phase|Adverse Event|0|||
38031112|NCT02956486|69716943|FG000|Core Phase|Lost to Follow-up|8|||
38031113|NCT02956486|69716944|FG001|Core Phase|Lost to Follow-up|6|||
37920835|NCT00576472|69607528|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
37920836|NCT00576472|69607529|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
37920837|NCT00576472|69607515|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
37920838|NCT00576472|69607516|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
37920839|NCT00576472|69607517|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
37920840|NCT00576472|69607518|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
37920841|NCT00576472|69607519|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
37920842|NCT00576472|69607520|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
37920843|NCT00576472|69607521|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
37920844|NCT00576472|69607522|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
37920845|NCT00576472|69607523|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
37920846|NCT00576472|69607524|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
37920847|NCT00576472|69607525|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
37920848|NCT00576472|69607526|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
37920849|NCT00576472|69607527|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
37920850|NCT00576472|69607528|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
37920851|NCT00576472|69607529|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
37920852|NCT00576472|69607515|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
37920853|NCT00576472|69607516|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
37920854|NCT00576472|69607517|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
37920855|NCT00576472|69607518|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
38031114|NCT02956486|69716945|FG002|Core Phase|Lost to Follow-up|0|||
37920856|NCT00576472|69607519|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
37920857|NCT00576472|69607520|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
37920858|NCT00576472|69607521|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
37920859|NCT00576472|69607522|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
38031115|NCT02956486|69716943|FG000|Core Phase|Inadequate therapeutic effect|4|||
38031116|NCT02956486|69716944|FG001|Core Phase|Inadequate therapeutic effect|5|||
38031117|NCT02956486|69716945|FG002|Core Phase|Inadequate therapeutic effect|0|||
38031118|NCT02956486|69716943|FG000|Core Phase|Withdrawal by Subject|101|||
37851834|NCT01302054|69535448|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
37851835|NCT01302054|69535446|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
37851836|NCT01302054|69535447|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
37851837|NCT01302054|69535448|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
37920860|NCT00576472|69607523|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
37920861|NCT00576472|69607524|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
37920862|NCT00576472|69607525|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
37920863|NCT00576472|69607526|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
38031119|NCT02956486|69716944|FG001|Core Phase|Withdrawal by Subject|104|||
38031120|NCT02956486|69716945|FG002|Core Phase|Withdrawal by Subject|0|||
38031121|NCT02956486|69716943|FG000|Core Phase|Study terminated by sponsor|888|||
38031122|NCT02956486|69716944|FG001|Core Phase|Study terminated by sponsor|848|||
38031123|NCT02956486|69716945|FG002|Core Phase|Study terminated by sponsor|0|||
38031124|NCT02956486|69716943|FG000|Core Phase|Other|27|||
38031125|NCT02956486|69716944|FG001|Core Phase|Other|18|||
38031126|NCT02956486|69716945|FG002|Core Phase|Other|0|||
38031127|NCT02956486|69716943|FG000|Core Phase|Not treated|0|||
38031128|NCT02956486|69716944|FG001|Core Phase|Not treated|3|||
38031129|NCT02956486|69716945|FG002|Core Phase|Not treated|0|||
38031130|NCT02956486|69716943|FG000|Extension Phase|Adverse Event|0|||
38031131|NCT02956486|69716944|FG001|Extension Phase|Adverse Event|0|||
38031132|NCT02956486|69716945|FG002|Extension Phase|Adverse Event|2|||
38031133|NCT02956486|69716943|FG000|Extension Phase|Study terminated by sponsor|0|||
38031134|NCT02956486|69716944|FG001|Extension Phase|Study terminated by sponsor|0|||
38031135|NCT02956486|69716945|FG002|Extension Phase|Study terminated by sponsor|16|||
38031136|NCT02956486|69716943|FG000|Extension Phase|Not Treated|0|||
38031137|NCT02956486|69716944|FG001|Extension Phase|Not Treated|0|||
38031138|NCT02956486|69716945|FG002|Extension Phase|Not Treated|1|||
38031139|NCT03445533|69716960|FG000|Overall Study|Progressive Disease|48|||
38031140|NCT03445533|69716961|FG001|Overall Study|Progressive Disease|81|||
38031141|NCT03445533|69716960|FG000|Overall Study|Adverse Event|60|||
38031142|NCT03445533|69716961|FG001|Overall Study|Adverse Event|64|||
38031143|NCT03445533|69716960|FG000|Overall Study|Death|9|||
38031144|NCT03445533|69716961|FG001|Overall Study|Death|19|||
38031145|NCT03445533|69716960|FG000|Overall Study|Miscellaneous|0|||
38031146|NCT03445533|69716961|FG001|Overall Study|Miscellaneous|16|||
38031147|NCT03445533|69716960|FG000|Overall Study|Withdrawal by Subject|3|||
38031148|NCT03445533|69716961|FG001|Overall Study|Withdrawal by Subject|4|||
38031149|NCT03445533|69716960|FG000|Overall Study|Physician Decision|1|||
38031150|NCT03445533|69716961|FG001|Overall Study|Physician Decision|3|||
38031151|NCT03445533|69716960|FG000|Overall Study|Sponsor Decision|0|||
38031152|NCT03445533|69716961|FG001|Overall Study|Sponsor Decision|1|||
38031153|NCT03445533|69716960|FG000|Overall Study|Lost to Follow-up|0|||
38031154|NCT03445533|69716961|FG001|Overall Study|Lost to Follow-up|1|||
38031155|NCT03445533|69716960|FG000|Overall Study|Never Received any Study Treatment|7|||
37851838|NCT01302054|69535446|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
37851839|NCT01302054|69535447|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
37851840|NCT01302054|69535448|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
37851841|NCT01302054|69535446|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
37851842|NCT01302054|69535447|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
37851843|NCT01302054|69535448|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
37851844|NCT01302054|69535446|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
37851845|NCT01302054|69535447|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
37851846|NCT01302054|69535448|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
37851847|NCT01302054|69535446|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
37851848|NCT01302054|69535447|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
38031156|NCT03445533|69716961|FG001|Overall Study|Never Received any Study Treatment|4|||
37851849|NCT01302054|69535448|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
37851850|NCT01302054|69535446|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
37851851|NCT01302054|69535447|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
38031157|NCT01337050|69716970|FG000|Overall Study|Death|0|||
38031158|NCT01337050|69716971|FG001|Overall Study|Death|0|||
38031159|NCT01337050|69716972|FG002|Overall Study|Death|4|||
38031160|NCT01337050|69716970|FG000|Overall Study|Other|4|||
38031161|NCT01337050|69716971|FG001|Overall Study|Other|6|||
38031162|NCT01337050|69716972|FG002|Overall Study|Other|8|||
38031163|NCT01337050|69716970|FG000|Overall Study|Participants refused further follow-up|0|||
38031164|NCT01337050|69716971|FG001|Overall Study|Participants refused further follow-up|7|||
37735486|NCT01896895|69215942|FG003|Double-blind MP|Physician Decision|0|||
37735487|NCT01896895|69215939|FG000|Double-blind MP|Withdrawal by Subject|0|||
37735488|NCT01896895|69215940|FG001|Double-blind MP|Withdrawal by Subject|2|||
37735489|NCT01896895|69215941|FG002|Double-blind MP|Withdrawal by Subject|1|||
37851852|NCT01302054|69535448|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
37851853|NCT01302054|69535446|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
37851854|NCT01302054|69535447|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
37920864|NCT00576472|69607527|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
37920865|NCT00576472|69607528|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
37920866|NCT00576472|69607529|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
37920867|NCT00576472|69607515|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
37920868|NCT00576472|69607516|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
37920869|NCT00576472|69607517|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
37920870|NCT00576472|69607518|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
37920871|NCT00576472|69607519|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
37920872|NCT00576472|69607520|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
37920873|NCT00576472|69607521|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
37920874|NCT00576472|69607522|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
37920875|NCT00576472|69607523|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
37920876|NCT00576472|69607524|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
37920877|NCT00576472|69607525|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
37920878|NCT00576472|69607526|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
37920879|NCT00576472|69607527|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
37920880|NCT00576472|69607528|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
37920881|NCT00576472|69607529|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
37920882|NCT00576472|69607515|FG000|MPH Cross Over Phase|Physician Decision|0|||
37920883|NCT00576472|69607516|FG001|MPH Cross Over Phase|Physician Decision|0|||
37920884|NCT00576472|69607517|FG002|MPH Cross Over Phase|Physician Decision|0|||
37920885|NCT00576472|69607518|FG003|MPH Cross Over Phase|Physician Decision|0|||
37920886|NCT00576472|69607519|FG004|MPH Cross Over Phase|Physician Decision|0|||
37920887|NCT00576472|69607520|FG005|MPH Cross Over Phase|Physician Decision|0|||
37920888|NCT00576472|69607521|FG006|MPH Cross Over Phase|Physician Decision|4|||
37920889|NCT00576472|69607522|FG007|MPH Cross Over Phase|Physician Decision|0|||
37920890|NCT00576472|69607523|FG008|MPH Cross Over Phase|Physician Decision|0|||
37920891|NCT00576472|69607524|FG009|MPH Cross Over Phase|Physician Decision|0|||
37920892|NCT00576472|69607525|FG010|MPH Cross Over Phase|Physician Decision|0|||
37920893|NCT00576472|69607526|FG011|MPH Cross Over Phase|Physician Decision|0|||
37920894|NCT00576472|69607527|FG012|MPH Cross Over Phase|Physician Decision|0|||
37920895|NCT00576472|69607528|FG013|MPH Cross Over Phase|Physician Decision|0|||
37920896|NCT00576472|69607529|FG014|MPH Cross Over Phase|Physician Decision|0|||
37920897|NCT00576472|69607515|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
37920898|NCT00576472|69607516|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
37920899|NCT00576472|69607517|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
37920900|NCT00576472|69607518|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
37920901|NCT00576472|69607519|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
37920902|NCT00576472|69607520|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
37851855|NCT01302054|69535448|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
37851856|NCT01302054|69535446|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
37851857|NCT01302054|69535447|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
37851858|NCT01302054|69535448|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
37851859|NCT01302054|69535446|FG000|Double-Blind Treatment Phase|Other|0|||
37851860|NCT01302054|69535447|FG001|Double-Blind Treatment Phase|Other|4|||
37920903|NCT00576472|69607521|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
37920904|NCT00576472|69607522|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
37920905|NCT00576472|69607523|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
37920906|NCT00576472|69607524|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
37920907|NCT00576472|69607525|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
37920908|NCT00576472|69607526|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
37920909|NCT00576472|69607527|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
38031165|NCT01337050|69716972|FG002|Overall Study|Participants refused further follow-up|7|||
37735490|NCT01896895|69215942|FG003|Double-blind MP|Withdrawal by Subject|0|||
37735491|NCT01896895|69215939|FG000|Double-blind MP|Lost to Follow-up|1|||
37851861|NCT01302054|69535448|FG002|Double-Blind Treatment Phase|Other|9|||
37851862|NCT01301508|69535459|FG000|Overall Study|Withdrawal by Subject|1|||
37920910|NCT00576472|69607528|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
37920911|NCT00576472|69607529|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
37920912|NCT00576472|69607515|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
37920913|NCT00576472|69607516|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
37920914|NCT00576472|69607517|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
37920915|NCT00576472|69607518|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
37920916|NCT00576472|69607519|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
37920917|NCT00576472|69607520|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
37920918|NCT00576472|69607521|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
37920919|NCT00576472|69607522|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
37920920|NCT00576472|69607523|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
37920921|NCT00576472|69607524|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
37920922|NCT00576472|69607525|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
37920923|NCT00576472|69607526|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
37920924|NCT00576472|69607527|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
37920925|NCT00576472|69607528|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
37920926|NCT00576472|69607529|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
37920927|NCT00576472|69607515|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
37920928|NCT00576472|69607516|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
37735492|NCT01896895|69215940|FG001|Double-blind MP|Lost to Follow-up|0|||
37735493|NCT01896895|69215941|FG002|Double-blind MP|Lost to Follow-up|1|||
37735494|NCT01896895|69215942|FG003|Double-blind MP|Lost to Follow-up|0|||
37735495|NCT01923181|69215978|FG000|Overall Study|Protocol Violation|2|||
37735496|NCT01923181|69215979|FG001|Overall Study|Protocol Violation|2|||
37735497|NCT01923181|69215980|FG002|Overall Study|Protocol Violation|0|||
37735498|NCT01923181|69215981|FG003|Overall Study|Protocol Violation|2|||
37735499|NCT01923181|69215982|FG004|Overall Study|Protocol Violation|2|||
37920929|NCT00576472|69607517|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
37920930|NCT00576472|69607518|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
37920931|NCT00576472|69607519|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
37920932|NCT00576472|69607520|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
37920933|NCT00576472|69607521|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
37920934|NCT00576472|69607522|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
37920935|NCT00576472|69607523|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
38031166|NCT01336972|69716984|FG000|Overall Study|Adverse Event|1|||
38031167|NCT01336972|69716985|FG001|Overall Study|Adverse Event|1|||
38031168|NCT01336972|69716986|FG002|Overall Study|Adverse Event|0|||
38031169|NCT03762681|69717003|FG000|Part 1|Withdrawal by Subject|0|||
37735500|NCT01923181|69215983|FG005|Overall Study|Protocol Violation|1|||
37735501|NCT01923181|69215984|FG006|Overall Study|Protocol Violation|1|||
37735502|NCT01923181|69215985|FG007|Overall Study|Protocol Violation|2|||
37735503|NCT01923181|69215986|FG008|Overall Study|Protocol Violation|1|||
37735504|NCT01923181|69215978|FG000|Overall Study|Withdrawal by Subject|0|||
37735505|NCT01923181|69215979|FG001|Overall Study|Withdrawal by Subject|1|||
37735506|NCT01923181|69215980|FG002|Overall Study|Withdrawal by Subject|0|||
37735507|NCT01923181|69215981|FG003|Overall Study|Withdrawal by Subject|1|||
37851863|NCT01301508|69535460|FG001|Overall Study|Withdrawal by Subject|2|||
37851864|NCT01301508|69535459|FG000|Overall Study|Lost to Follow-up|0|||
37851865|NCT01301508|69535460|FG001|Overall Study|Lost to Follow-up|1|||
37851866|NCT01301274|69535468|FG000|Overall Study|Physician Decision|2|||
37851867|NCT01301274|69535469|FG001|Overall Study|Physician Decision|1|||
37851868|NCT01300650|69535480|FG000|Overall Study|Adverse Event|1|||
37851869|NCT01300572|69535485|FG000|Overall Study|HAMA + post dosimetry|1|||
37851870|NCT01077154|69535492|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
37920936|NCT00576472|69607524|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
38031170|NCT03762681|69717004|FG001|Part 1|Withdrawal by Subject|0|||
38031171|NCT03762681|69717005|FG002|Part 1|Withdrawal by Subject|0|||
38031172|NCT03762681|69717006|FG003|Part 1|Withdrawal by Subject|1|||
38031173|NCT03762681|69717007|FG004|Part 1|Withdrawal by Subject|0|||
37735508|NCT01923181|69215982|FG004|Overall Study|Withdrawal by Subject|4|||
37920937|NCT00576472|69607525|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
38031174|NCT03762681|69717008|FG005|Part 1|Withdrawal by Subject|0|||
38031175|NCT03762681|69717009|FG006|Part 1|Withdrawal by Subject|0|||
37735509|NCT01923181|69215983|FG005|Overall Study|Withdrawal by Subject|2|||
37851871|NCT01077154|69535493|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
37851872|NCT01077154|69535492|FG000|Overall Study|Withdrawal by Subject|369|||
37851873|NCT01077154|69535493|FG001|Overall Study|Withdrawal by Subject|385|||
37851874|NCT01077154|69535492|FG000|Overall Study|Death|215|||
37851875|NCT01077154|69535493|FG001|Overall Study|Death|214|||
37851876|NCT01077154|69535492|FG000|Overall Study|Lost to Follow-up|43|||
37851877|NCT01077154|69535493|FG001|Overall Study|Lost to Follow-up|35|||
37851878|NCT01077154|69535492|FG000|Overall Study|Noncompliance|22|||
37851879|NCT01077154|69535493|FG001|Overall Study|Noncompliance|20|||
37851880|NCT01077154|69535492|FG000|Overall Study|Disease Progression|18|||
38031176|NCT03762681|69717010|FG007|Part 1|Withdrawal by Subject|0|||
37851881|NCT01077154|69535493|FG001|Overall Study|Disease Progression|20|||
37851882|NCT01077154|69535492|FG000|Overall Study|Ineligibility Determined|10|||
37851883|NCT01077154|69535493|FG001|Overall Study|Ineligibility Determined|14|||
37851884|NCT01077154|69535492|FG000|Overall Study|Other|14|||
37851885|NCT01077154|69535493|FG001|Overall Study|Other|11|||
37920938|NCT00576472|69607526|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
37920939|NCT00576472|69607527|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
37920940|NCT00576472|69607528|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
37920941|NCT00576472|69607529|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
37920942|NCT00576472|69607515|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
37920943|NCT00576472|69607516|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
37920944|NCT00576472|69607517|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
37920945|NCT00576472|69607518|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
37920946|NCT00576472|69607519|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
37920947|NCT00576472|69607520|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
37920948|NCT00576472|69607521|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
37920949|NCT00576472|69607522|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
37920950|NCT00576472|69607523|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
37920951|NCT00576472|69607524|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
37920952|NCT00576472|69607525|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
37920953|NCT00576472|69607526|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
37920954|NCT00576472|69607527|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
37920955|NCT00576472|69607528|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
37920956|NCT00576472|69607529|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
37920957|NCT00576472|69607515|FG000|MPH Home Maintenance Phase|Side effects|0|||
37920958|NCT00576472|69607516|FG001|MPH Home Maintenance Phase|Side effects|0|||
37920959|NCT00576472|69607517|FG002|MPH Home Maintenance Phase|Side effects|0|||
37920960|NCT00576472|69607518|FG003|MPH Home Maintenance Phase|Side effects|0|||
37920961|NCT00576472|69607519|FG004|MPH Home Maintenance Phase|Side effects|0|||
37920962|NCT00576472|69607520|FG005|MPH Home Maintenance Phase|Side effects|0|||
37920963|NCT00576472|69607521|FG006|MPH Home Maintenance Phase|Side effects|0|||
37920964|NCT00576472|69607522|FG007|MPH Home Maintenance Phase|Side effects|0|||
38031177|NCT03762681|69717003|FG000|Part 2a|Pandemic Travel Restrictions|0|||
38031178|NCT03762681|69717004|FG001|Part 2a|Pandemic Travel Restrictions|0|||
38031179|NCT03762681|69717005|FG002|Part 2a|Pandemic Travel Restrictions|0|||
38031180|NCT03762681|69717006|FG003|Part 2a|Pandemic Travel Restrictions|0|||
38031181|NCT03762681|69717007|FG004|Part 2a|Pandemic Travel Restrictions|0|||
38031182|NCT03762681|69717008|FG005|Part 2a|Pandemic Travel Restrictions|0|||
38031183|NCT03762681|69717009|FG006|Part 2a|Pandemic Travel Restrictions|0|||
38031184|NCT03762681|69717010|FG007|Part 2a|Pandemic Travel Restrictions|1|||
38031185|NCT03764475|69717039|FG000|Overall Study|Adverse Event|11|||
37851886|NCT01077154|69535492|FG000|Overall Study|Adverse Event|9|||
37851887|NCT01077154|69535493|FG001|Overall Study|Adverse Event|9|||
37851888|NCT01077154|69535492|FG000|Overall Study|Administrative Decision|1|||
37851889|NCT01077154|69535493|FG001|Overall Study|Administrative Decision|6|||
37851890|NCT01077154|69535492|FG000|Overall Study|Protocol Deviation|1|||
37851891|NCT01077154|69535493|FG001|Overall Study|Protocol Deviation|0|||
37851892|NCT01258101|69535503|FG000|Overall Study|Adverse Event|5|||
37851893|NCT01258101|69535504|FG001|Overall Study|Adverse Event|6|||
37851894|NCT01258101|69535505|FG002|Overall Study|Adverse Event|0|||
37851895|NCT01258101|69535506|FG003|Overall Study|Adverse Event|0|||
37851896|NCT01258101|69535503|FG000|Overall Study|Extra exclusion criterion amended|2|||
37851897|NCT01258101|69535504|FG001|Overall Study|Extra exclusion criterion amended|1|||
37851898|NCT01258101|69535505|FG002|Overall Study|Extra exclusion criterion amended|1|||
37851899|NCT01258101|69535506|FG003|Overall Study|Extra exclusion criterion amended|1|||
37851900|NCT01258101|69535503|FG000|Overall Study|Informed consent has been withdrawn|2|||
37851901|NCT01258101|69535504|FG001|Overall Study|Informed consent has been withdrawn|2|||
37851902|NCT01258101|69535505|FG002|Overall Study|Informed consent has been withdrawn|1|||
37851903|NCT01258101|69535506|FG003|Overall Study|Informed consent has been withdrawn|1|||
37851904|NCT01258101|69535503|FG000|Overall Study|Patient is not able to attend visits|8|||
37851905|NCT01258101|69535504|FG001|Overall Study|Patient is not able to attend visits|9|||
37851906|NCT01258101|69535505|FG002|Overall Study|Patient is not able to attend visits|7|||
37851907|NCT01258101|69535506|FG003|Overall Study|Patient is not able to attend visits|6|||
37851908|NCT01258101|69535503|FG000|Overall Study|Patient´s compliance|4|||
37920965|NCT00576472|69607523|FG008|MPH Home Maintenance Phase|Side effects|0|||
37920966|NCT00576472|69607524|FG009|MPH Home Maintenance Phase|Side effects|0|||
37920967|NCT00576472|69607525|FG010|MPH Home Maintenance Phase|Side effects|0|||
37920968|NCT00576472|69607526|FG011|MPH Home Maintenance Phase|Side effects|0|||
37920969|NCT00576472|69607527|FG012|MPH Home Maintenance Phase|Side effects|0|||
38031186|NCT03764475|69717040|FG001|Overall Study|Adverse Event|2|||
38031187|NCT03764475|69717039|FG000|Overall Study|Lost to Follow-up|24|||
37851909|NCT01258101|69535504|FG001|Overall Study|Patient´s compliance|3|||
38031188|NCT03764475|69717040|FG001|Overall Study|Lost to Follow-up|10|||
37851910|NCT01258101|69535505|FG002|Overall Study|Patient´s compliance|1|||
37851911|NCT01258101|69535506|FG003|Overall Study|Patient´s compliance|2|||
37851912|NCT01258101|69535503|FG000|Overall Study|Lost to Follow-up|5|||
37851913|NCT01258101|69535504|FG001|Overall Study|Lost to Follow-up|5|||
37851914|NCT01258101|69535505|FG002|Overall Study|Lost to Follow-up|0|||
37851915|NCT01258101|69535506|FG003|Overall Study|Lost to Follow-up|6|||
37851916|NCT01258101|69535503|FG000|Overall Study|PCR positive at week 24|0|||
37851917|NCT01258101|69535504|FG001|Overall Study|PCR positive at week 24|0|||
37851918|NCT01258101|69535505|FG002|Overall Study|PCR positive at week 24|0|||
37851919|NCT01258101|69535506|FG003|Overall Study|PCR positive at week 24|1|||
37851920|NCT01258101|69535503|FG000|Overall Study|Other reason|7|||
37851921|NCT01258101|69535504|FG001|Overall Study|Other reason|8|||
38031189|NCT03764475|69717039|FG000|Overall Study|Withdrawal by Subject|26|||
38031190|NCT03764475|69717040|FG001|Overall Study|Withdrawal by Subject|10|||
38031191|NCT03764475|69717039|FG000|Overall Study|Lack of Efficacy|3|||
38031192|NCT03764475|69717040|FG001|Overall Study|Lack of Efficacy|0|||
38031193|NCT03764475|69717039|FG000|Overall Study|COVID-19 Disruption|2|||
38031194|NCT03764475|69717040|FG001|Overall Study|COVID-19 Disruption|0|||
38031195|NCT02872012|69717055|FG000|Overall Study|Withdrawal by Subject|1|||
38031196|NCT02872012|69717056|FG001|Overall Study|Withdrawal by Subject|0|||
38031197|NCT02872012|69717057|FG002|Overall Study|Withdrawal by Subject|0|||
38031198|NCT02872012|69717058|FG003|Overall Study|Withdrawal by Subject|0|||
38031199|NCT02872012|69717059|FG004|Overall Study|Withdrawal by Subject|0|||
38031200|NCT02959138|69717076|FG000|Overall Study|Enrolled but Never Treated|0|||
38031201|NCT02959138|69717077|FG001|Overall Study|Enrolled but Never Treated|1|||
38031202|NCT02959138|69717078|FG002|Overall Study|Enrolled but Never Treated|0|||
38031203|NCT01344226|69717090|FG000|Overall Study|Protocol Violation|2|||
38031204|NCT01344226|69717090|FG000|Overall Study|Withdrawal by Subject|3|||
38031205|NCT01344226|69717090|FG000|Overall Study|Lack of Efficacy|3|||
38031206|NCT02869438|69717096|FG000|Overall Study|Lost to Follow-up|1|||
38031207|NCT02869438|69717097|FG001|Overall Study|Lost to Follow-up|0|||
38031208|NCT02869438|69717096|FG000|Overall Study|Adverse Event|1|||
38031209|NCT02869438|69717097|FG001|Overall Study|Adverse Event|0|||
38031210|NCT02869438|69717096|FG000|Overall Study|Withdrawal by Subject|1|||
37851922|NCT01258101|69535505|FG002|Overall Study|Other reason|1|||
37851923|NCT01258101|69535506|FG003|Overall Study|Other reason|8|||
37851924|NCT01300338|69535518|FG000|Overall Study|Lost to Follow-up|5|||
37851925|NCT01300338|69535519|FG001|Overall Study|Lost to Follow-up|0|||
37851926|NCT01300260|69535527|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
37851927|NCT01300260|69535528|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
37851928|NCT01300260|69535527|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
37851929|NCT01300260|69535528|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
37851930|NCT01300260|69535527|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
38031211|NCT02869438|69717097|FG001|Overall Study|Withdrawal by Subject|2|||
38031212|NCT02868892|69717103|FG000|Overall Study|Investigator left site and no follow-up|6|||
38031213|NCT03352557|69717112|FG000|PC Period: Day 1 to Week 78|Death|1|||
38031214|NCT03352557|69717113|FG001|PC Period: Day 1 to Week 78|Death|1|||
38031215|NCT03352557|69717114|FG002|PC Period: Day 1 to Week 78|Death|0|||
38031216|NCT03352557|69717115|FG003|PC Period: Day 1 to Week 78|Death|0|||
37735510|NCT01923181|69215984|FG006|Overall Study|Withdrawal by Subject|4|||
37735511|NCT01923181|69215985|FG007|Overall Study|Withdrawal by Subject|3|||
37735512|NCT01923181|69215986|FG008|Overall Study|Withdrawal by Subject|1|||
37735513|NCT01923181|69215978|FG000|Overall Study|Other|1|||
37735514|NCT01923181|69215979|FG001|Overall Study|Other|0|||
37735515|NCT01923181|69215980|FG002|Overall Study|Other|0|||
37735516|NCT01923181|69215981|FG003|Overall Study|Other|1|||
37735517|NCT01923181|69215982|FG004|Overall Study|Other|0|||
37735518|NCT01923181|69215983|FG005|Overall Study|Other|0|||
37851931|NCT01300260|69535528|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
37735519|NCT01923181|69215984|FG006|Overall Study|Other|0|||
37851932|NCT01256385|69535547|FG000|Overall Study|Physician Decision|1|||
37851933|NCT01256385|69535548|FG001|Overall Study|Physician Decision|1|||
37851934|NCT01256385|69535547|FG000|Overall Study|Withdrawal by Subject|2|||
37851935|NCT01256385|69535548|FG001|Overall Study|Withdrawal by Subject|2|||
37851936|NCT01298778|69535556|FG000|Overall Study|Lost to Follow-up|2|||
37851937|NCT01298778|69535557|FG001|Overall Study|Lost to Follow-up|3|||
37851938|NCT01298778|69535556|FG000|Overall Study|Incorrect use of VAS|1|||
37851939|NCT01298778|69535557|FG001|Overall Study|Incorrect use of VAS|0|||
37851940|NCT01298778|69535556|FG000|Overall Study|Withdrawal by Subject|0|||
37851941|NCT01298778|69535557|FG001|Overall Study|Withdrawal by Subject|1|||
37851942|NCT01298778|69535556|FG000|Overall Study|Protocol Violation|0|||
37735520|NCT01923181|69215985|FG007|Overall Study|Other|0|||
37735521|NCT01923181|69215986|FG008|Overall Study|Other|0|||
37851943|NCT01298778|69535557|FG001|Overall Study|Protocol Violation|1|||
37851944|NCT01298778|69535556|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
37851945|NCT01298778|69535557|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
37851946|NCT01298700|69535567|FG000|Overall Study|Adverse Event|50|||
37920970|NCT00576472|69607528|FG013|MPH Home Maintenance Phase|Side effects|0|||
37920971|NCT00576472|69607529|FG014|MPH Home Maintenance Phase|Side effects|8|||
37920972|NCT00576472|69607515|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
37920973|NCT00576472|69607516|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
37920974|NCT00576472|69607517|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
37920975|NCT00576472|69607518|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
37920976|NCT00576472|69607519|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
37920977|NCT00576472|69607520|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
37851947|NCT01298700|69535568|FG001|Overall Study|Adverse Event|51|||
37851948|NCT01298700|69535567|FG000|Overall Study|Lack of Efficacy|9|||
37851949|NCT01298700|69535568|FG001|Overall Study|Lack of Efficacy|14|||
37851950|NCT01298700|69535567|FG000|Overall Study|Lost to Follow-up|5|||
37920978|NCT00576472|69607521|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
37920979|NCT00576472|69607522|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
37920980|NCT00576472|69607523|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
37920981|NCT00576472|69607524|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
37920982|NCT00576472|69607525|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
37920983|NCT00576472|69607526|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
37920984|NCT00576472|69607527|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
37920985|NCT00576472|69607528|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
37920986|NCT00576472|69607529|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
37920987|NCT00576472|69607515|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
37920988|NCT00576472|69607516|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
37920989|NCT00576472|69607517|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
37920990|NCT00576472|69607518|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
37920991|NCT00576472|69607519|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
37920992|NCT00576472|69607520|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
37920993|NCT00576472|69607521|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
37920994|NCT00576472|69607522|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
37920995|NCT00576472|69607523|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
37920996|NCT00576472|69607524|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
37920997|NCT00576472|69607525|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
37920998|NCT00576472|69607526|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
37920999|NCT00576472|69607527|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
37921000|NCT00576472|69607528|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
37921001|NCT00576472|69607529|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
38031217|NCT03352557|69717116|FG004|PC Period: Day 1 to Week 78|Death|1|||
38031218|NCT03352557|69717117|FG005|PC Period: Day 1 to Week 78|Death|0|||
38031219|NCT03352557|69717118|FG006|PC Period: Day 1 to Week 78|Death|0|||
38031220|NCT03352557|69717119|FG007|PC Period: Day 1 to Week 78|Death|0|||
38031221|NCT03352557|69717120|FG008|PC Period: Day 1 to Week 78|Death|0|||
38031222|NCT03352557|69717121|FG009|PC Period: Day 1 to Week 78|Death|0|||
38031223|NCT03352557|69717112|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
38031224|NCT03352557|69717113|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
38031225|NCT03352557|69717114|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
38031226|NCT03352557|69717115|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
38031227|NCT03352557|69717116|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
38031228|NCT03352557|69717117|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
38031229|NCT03352557|69717118|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
38031230|NCT03352557|69717119|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
38031231|NCT03352557|69717120|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
37851951|NCT01298700|69535568|FG001|Overall Study|Lost to Follow-up|2|||
37851952|NCT01298700|69535567|FG000|Overall Study|Withdrawal by Subject|12|||
37921002|NCT00576472|69607515|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
37921003|NCT00576472|69607516|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
37921004|NCT00576472|69607517|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
38031232|NCT03352557|69717121|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
37851953|NCT01298700|69535568|FG001|Overall Study|Withdrawal by Subject|9|||
37921005|NCT00576472|69607518|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
37851954|NCT01298700|69535567|FG000|Overall Study|Protocol Violation|6|||
38031233|NCT03352557|69717112|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
38031234|NCT03352557|69717113|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
38031235|NCT03352557|69717114|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
38031236|NCT03352557|69717115|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
37735522|NCT01923181|69215978|FG000|Overall Study|Lost to Follow-up|0|||
37851955|NCT01298700|69535568|FG001|Overall Study|Protocol Violation|4|||
37851956|NCT01298700|69535567|FG000|Overall Study|Other Miscellaneous Reasons|16|||
37851957|NCT01298700|69535568|FG001|Overall Study|Other Miscellaneous Reasons|15|||
37851958|NCT01298700|69535567|FG000|Overall Study|Did not Receive Study Drug|3|||
37851959|NCT01298700|69535568|FG001|Overall Study|Did not Receive Study Drug|5|||
37851960|NCT01297920|69535577|FG000|Overall Study|Adverse Event|42|||
37851961|NCT01297920|69535578|FG001|Overall Study|Adverse Event|10|||
37851962|NCT01297920|69535579|FG002|Overall Study|Adverse Event|38|||
37851963|NCT01297920|69535577|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
37851964|NCT01297920|69535578|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
37851965|NCT01297920|69535579|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
37851966|NCT01297920|69535577|FG000|Overall Study|Noncompliance|1|||
37851967|NCT01297920|69535578|FG001|Overall Study|Noncompliance|0|||
37851968|NCT01297920|69535579|FG002|Overall Study|Noncompliance|0|||
37851969|NCT01297920|69535577|FG000|Overall Study|Protocol Violation|1|||
37851970|NCT01297920|69535578|FG001|Overall Study|Protocol Violation|3|||
37851971|NCT01297920|69535579|FG002|Overall Study|Protocol Violation|0|||
37851972|NCT01297920|69535577|FG000|Overall Study|Inadequate Control of IOP|7|||
37851973|NCT01297920|69535578|FG001|Overall Study|Inadequate Control of IOP|9|||
37851974|NCT01297920|69535579|FG002|Overall Study|Inadequate Control of IOP|17|||
37851975|NCT01297920|69535577|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
37851976|NCT01297920|69535578|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
37851977|NCT01297920|69535579|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
37851978|NCT01255761|69535589|FG000|Overall Study|Adverse Event|29|||
37851979|NCT01255761|69535590|FG001|Overall Study|Adverse Event|43|||
37851980|NCT01255761|69535589|FG000|Overall Study|Lack of Efficacy|86|||
37851981|NCT01255761|69535590|FG001|Overall Study|Lack of Efficacy|74|||
37851982|NCT01255761|69535589|FG000|Overall Study|Protocol Violation|9|||
37851983|NCT01255761|69535590|FG001|Overall Study|Protocol Violation|5|||
37851984|NCT01255761|69535589|FG000|Overall Study|Lost to Follow-up|10|||
37851985|NCT01255761|69535590|FG001|Overall Study|Lost to Follow-up|8|||
37851986|NCT01255761|69535589|FG000|Overall Study|Withdrawal by Subject|11|||
37851987|NCT01255761|69535590|FG001|Overall Study|Withdrawal by Subject|27|||
37851988|NCT01255761|69535589|FG000|Overall Study|Other Reasons|37|||
37851989|NCT01255761|69535590|FG001|Overall Study|Other Reasons|18|||
37851990|NCT01297062|69535602|FG000|Overall Study|Adverse Event|2|||
37851991|NCT01297062|69535603|FG001|Overall Study|Adverse Event|0|||
37921006|NCT00576472|69607519|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
37921007|NCT00576472|69607520|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
37851992|NCT01297062|69535604|FG002|Overall Study|Adverse Event|1|||
37851993|NCT01297062|69535605|FG003|Overall Study|Adverse Event|0|||
37851994|NCT01297062|69535606|FG004|Overall Study|Adverse Event|0|||
37851995|NCT01297062|69535607|FG005|Overall Study|Adverse Event|0|||
37851996|NCT01297062|69535608|FG006|Overall Study|Adverse Event|0|||
37851997|NCT01297062|69535602|FG000|Overall Study|Physician Decision|1|||
37851998|NCT01297062|69535603|FG001|Overall Study|Physician Decision|0|||
37851999|NCT01297062|69535604|FG002|Overall Study|Physician Decision|1|||
37852000|NCT01297062|69535605|FG003|Overall Study|Physician Decision|0|||
37852001|NCT01297062|69535606|FG004|Overall Study|Physician Decision|0|||
37852002|NCT01297062|69535607|FG005|Overall Study|Physician Decision|0|||
37852003|NCT01297062|69535608|FG006|Overall Study|Physician Decision|6|||
37852004|NCT01297062|69535602|FG000|Overall Study|Protocol Violation|0|||
37852005|NCT01297062|69535603|FG001|Overall Study|Protocol Violation|0|||
37852006|NCT01297062|69535604|FG002|Overall Study|Protocol Violation|0|||
37852007|NCT01297062|69535605|FG003|Overall Study|Protocol Violation|0|||
37852008|NCT01297062|69535606|FG004|Overall Study|Protocol Violation|1|||
37852009|NCT01297062|69535607|FG005|Overall Study|Protocol Violation|0|||
37852010|NCT01297062|69535608|FG006|Overall Study|Protocol Violation|0|||
37852011|NCT01297062|69535602|FG000|Overall Study|Subject Decision|1|||
37852012|NCT01297062|69535603|FG001|Overall Study|Subject Decision|1|||
37852013|NCT01297062|69535604|FG002|Overall Study|Subject Decision|0|||
37852014|NCT01297062|69535605|FG003|Overall Study|Subject Decision|1|||
37852015|NCT01297062|69535606|FG004|Overall Study|Subject Decision|1|||
37852016|NCT01297062|69535607|FG005|Overall Study|Subject Decision|1|||
37852017|NCT01297062|69535608|FG006|Overall Study|Subject Decision|2|||
37852018|NCT01254747|69535620|FG000|Overall Study|Unacceptable subjective vision|0|||
37852019|NCT01254747|69535621|FG001|Overall Study|Unacceptable subjective vision|0|||
37852020|NCT01254747|69535622|FG002|Overall Study|Unacceptable subjective vision|0|||
37852021|NCT01254747|69535623|FG003|Overall Study|Unacceptable subjective vision|2|||
37852022|NCT01254747|69535620|FG000|Overall Study|Difficult removal handling|0|||
37852023|NCT01254747|69535621|FG001|Overall Study|Difficult removal handling|0|||
37852024|NCT01254747|69535622|FG002|Overall Study|Difficult removal handling|1|||
37852025|NCT01254747|69535623|FG003|Overall Study|Difficult removal handling|0|||
37852026|NCT01254747|69535620|FG000|Overall Study|Symptoms and problems|0|||
37852027|NCT01254747|69535621|FG001|Overall Study|Symptoms and problems|2|||
37852028|NCT01254747|69535622|FG002|Overall Study|Symptoms and problems|1|||
37852029|NCT01254747|69535623|FG003|Overall Study|Symptoms and problems|0|||
37852030|NCT01254747|69535620|FG000|Overall Study|Lost to Follow-up|0|||
37852031|NCT01254747|69535621|FG001|Overall Study|Lost to Follow-up|0|||
37852032|NCT01254747|69535622|FG002|Overall Study|Lost to Follow-up|1|||
37852033|NCT01254747|69535623|FG003|Overall Study|Lost to Follow-up|0|||
37852034|NCT01254747|69535620|FG000|Overall Study|Biomicroscopy|0|||
37852035|NCT01254747|69535621|FG001|Overall Study|Biomicroscopy|0|||
37852036|NCT01254747|69535622|FG002|Overall Study|Biomicroscopy|1|||
37852037|NCT01254747|69535623|FG003|Overall Study|Biomicroscopy|0|||
37852038|NCT01254747|69535620|FG000|Overall Study|Discomfort|0|||
37921008|NCT00576472|69607521|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
37921009|NCT00576472|69607522|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
37921010|NCT00576472|69607523|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
37921011|NCT00576472|69607524|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
37921012|NCT00576472|69607525|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
37921013|NCT00576472|69607526|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
37921014|NCT00576472|69607527|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
37921015|NCT00576472|69607528|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
37921016|NCT00576472|69607529|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
37921017|NCT00823212|69607562|FG000|Overall Study|Death|8|||
37921018|NCT00823212|69607563|FG001|Overall Study|Death|10|||
37921019|NCT00823212|69607562|FG000|Overall Study|Withdrawal by Subject|6|||
37921020|NCT00823212|69607563|FG001|Overall Study|Withdrawal by Subject|1|||
37921021|NCT00823212|69607562|FG000|Overall Study|Incarcerated|0|||
37921022|NCT00823212|69607563|FG001|Overall Study|Incarcerated|1|||
37921023|NCT00823212|69607562|FG000|Overall Study|Missed 12-month visit|21|||
37921024|NCT00823212|69607563|FG001|Overall Study|Missed 12-month visit|21|||
37921025|NCT00807495|69607576|FG000|Overall Study|Adverse Event|6|||
37852039|NCT01254747|69535621|FG001|Overall Study|Discomfort|4|||
37852040|NCT01254747|69535622|FG002|Overall Study|Discomfort|0|||
37852041|NCT01254747|69535623|FG003|Overall Study|Discomfort|0|||
37852042|NCT01296672|69535635|FG000|Overall Study|Lost to Follow-up|73|||
37852043|NCT01296672|69535636|FG001|Overall Study|Lost to Follow-up|18|||
37852044|NCT01254669|69535646|FG000|Overall Study|Withdrawal by Subject|0|||
37852045|NCT01254669|69535647|FG001|Overall Study|Withdrawal by Subject|1|||
37852046|NCT01254669|69535646|FG000|Overall Study|time constraint|2|||
37852047|NCT01254669|69535647|FG001|Overall Study|time constraint|2|||
37852048|NCT01254669|69535646|FG000|Overall Study|called to clinic during intervention|1|||
37921026|NCT00807495|69607577|FG001|Overall Study|Adverse Event|3|||
37852049|NCT01254669|69535647|FG001|Overall Study|called to clinic during intervention|1|||
37852050|NCT01295814|69535657|FG000|Overall Study|Lack of Efficacy|0|||
37921027|NCT00807495|69607578|FG002|Overall Study|Adverse Event|1|||
37921028|NCT00807495|69607579|FG003|Overall Study|Adverse Event|1|||
37921029|NCT00807495|69607580|FG004|Overall Study|Adverse Event|2|||
37921030|NCT00807495|69607576|FG000|Overall Study|Withdrawal by Patient|2|||
37921031|NCT00807495|69607577|FG001|Overall Study|Withdrawal by Patient|0|||
37921032|NCT00807495|69607578|FG002|Overall Study|Withdrawal by Patient|1|||
37921033|NCT00807495|69607579|FG003|Overall Study|Withdrawal by Patient|0|||
37921034|NCT00807495|69607580|FG004|Overall Study|Withdrawal by Patient|0|||
37921035|NCT00807495|69607576|FG000|Overall Study|Reason Not Specified|0|||
37921036|NCT00807495|69607577|FG001|Overall Study|Reason Not Specified|3|||
37921037|NCT00807495|69607578|FG002|Overall Study|Reason Not Specified|2|||
37921038|NCT00807495|69607579|FG003|Overall Study|Reason Not Specified|0|||
37921039|NCT00807495|69607580|FG004|Overall Study|Reason Not Specified|3|||
37921040|NCT05074433|69607596|FG000|Overall Study|Adverse Event|0|||
38031237|NCT03352557|69717116|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
38031238|NCT03352557|69717117|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
37852051|NCT01295814|69535658|FG001|Overall Study|Lack of Efficacy|2|||
37852052|NCT01295814|69535657|FG000|Overall Study|Withdrawal by Subject|2|||
37852053|NCT01295814|69535658|FG001|Overall Study|Withdrawal by Subject|0|||
37852054|NCT01254045|69535664|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
37852055|NCT01254045|69535665|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
37852056|NCT01254045|69535666|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
38031239|NCT03352557|69717118|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
37852057|NCT01254045|69535667|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
37852058|NCT01254045|69535668|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
37852059|NCT01254045|69535669|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
37852060|NCT01075282|69535682|FG000|Overall Study|Withdrawal by Subject|11|||
37852061|NCT01075282|69535683|FG001|Overall Study|Withdrawal by Subject|7|||
37852062|NCT01075282|69535684|FG002|Overall Study|Withdrawal by Subject|11|||
37852063|NCT01075282|69535682|FG000|Overall Study|Adverse Event|9|||
37852064|NCT01075282|69535683|FG001|Overall Study|Adverse Event|8|||
37852065|NCT01075282|69535684|FG002|Overall Study|Adverse Event|5|||
37852066|NCT01075282|69535682|FG000|Overall Study|Entry Criteria Not Met|3|||
37852067|NCT01075282|69535683|FG001|Overall Study|Entry Criteria Not Met|2|||
37852068|NCT01075282|69535684|FG002|Overall Study|Entry Criteria Not Met|0|||
37852069|NCT01075282|69535682|FG000|Overall Study|Lost to Follow-up|3|||
37852070|NCT01075282|69535683|FG001|Overall Study|Lost to Follow-up|3|||
37852071|NCT01075282|69535684|FG002|Overall Study|Lost to Follow-up|3|||
37852072|NCT01075282|69535682|FG000|Overall Study|Physician Decision|3|||
37852073|NCT01075282|69535683|FG001|Overall Study|Physician Decision|3|||
37852074|NCT01075282|69535684|FG002|Overall Study|Physician Decision|3|||
37852075|NCT01075282|69535682|FG000|Overall Study|Lack of Efficacy|1|||
37852076|NCT01075282|69535683|FG001|Overall Study|Lack of Efficacy|1|||
37852077|NCT01075282|69535684|FG002|Overall Study|Lack of Efficacy|0|||
37852078|NCT01075282|69535682|FG000|Overall Study|Treatment Non-compliance|1|||
37852079|NCT01075282|69535683|FG001|Overall Study|Treatment Non-compliance|2|||
37852080|NCT01075282|69535684|FG002|Overall Study|Treatment Non-compliance|2|||
37852081|NCT01075282|69535682|FG000|Overall Study|Protocol Violation|0|||
37852082|NCT01075282|69535683|FG001|Overall Study|Protocol Violation|2|||
37852083|NCT01075282|69535684|FG002|Overall Study|Protocol Violation|1|||
37852084|NCT01075282|69535682|FG000|Overall Study|Death|0|||
37852085|NCT01075282|69535683|FG001|Overall Study|Death|1|||
37852086|NCT01075282|69535684|FG002|Overall Study|Death|2|||
37852087|NCT01253811|69535693|FG000|Overall Study|Withdrawal criteria|1|||
37852088|NCT01295580|69535699|FG000|Overall Study|Protocol Violation|4|||
37852089|NCT01295580|69535700|FG001|Overall Study|Protocol Violation|2|||
37852090|NCT01295580|69535699|FG000|Overall Study|Withdrawal by Subject|1|||
37852091|NCT01295580|69535700|FG001|Overall Study|Withdrawal by Subject|4|||
37852092|NCT01295580|69535699|FG000|Overall Study|Adverse Event|2|||
37852093|NCT01295580|69535700|FG001|Overall Study|Adverse Event|1|||
37852094|NCT01295580|69535699|FG000|Overall Study|Lost to Follow-up|1|||
37852095|NCT01295580|69535700|FG001|Overall Study|Lost to Follow-up|0|||
37852096|NCT01295580|69535699|FG000|Overall Study|Lack of Efficacy|1|||
37852097|NCT01295580|69535700|FG001|Overall Study|Lack of Efficacy|0|||
37921041|NCT05074433|69607597|FG001|Overall Study|Adverse Event|2|||
37921042|NCT05074433|69607598|FG002|Overall Study|Adverse Event|0|||
37921043|NCT05074433|69607599|FG003|Overall Study|Adverse Event|1|||
38031240|NCT03352557|69717119|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
37852098|NCT01295580|69535699|FG000|Overall Study|Other: inconvenience|1|||
37852099|NCT01295580|69535700|FG001|Overall Study|Other: inconvenience|0|||
37852100|NCT01295580|69535699|FG000|Overall Study|Other: family objection|0|||
37852101|NCT01295580|69535700|FG001|Overall Study|Other: family objection|1|||
38031241|NCT03352557|69717120|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
37852102|NCT01253577|69535706|FG000|Overall Study|Lost to Follow-up|3|||
37852103|NCT01295034|69535714|FG000|Overall Study|Lost to Follow-up|5|||
37852104|NCT01295034|69535715|FG001|Overall Study|Lost to Follow-up|5|||
37852105|NCT01253421|69535726|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
37852106|NCT01253421|69535727|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
37852107|NCT01253421|69535728|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
37852108|NCT01253421|69535729|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
37852109|NCT01253421|69535730|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
37852110|NCT01253421|69535726|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
37852111|NCT01253421|69535727|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
37852112|NCT01253421|69535728|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
37852113|NCT01253421|69535729|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
37852114|NCT01253421|69535730|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
37852115|NCT01253421|69535726|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
37852116|NCT01253421|69535727|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
37852117|NCT01253421|69535728|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
37852118|NCT01253421|69535729|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
37852119|NCT01253421|69535730|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
37852120|NCT01253421|69535726|FG000|Assessment and Scheduling|Physician Decision|1|||
37852121|NCT01253421|69535727|FG001|Assessment and Scheduling|Physician Decision|0|||
37852122|NCT01253421|69535728|FG002|Assessment and Scheduling|Physician Decision|0|||
37852123|NCT01253421|69535729|FG003|Assessment and Scheduling|Physician Decision|0|||
37852124|NCT01253421|69535730|FG004|Assessment and Scheduling|Physician Decision|0|||
37852125|NCT01253421|69535726|FG000|Drug+Scanning Visit|Physician Decision|0|||
37852126|NCT01253421|69535727|FG001|Drug+Scanning Visit|Physician Decision|0|||
37852127|NCT01253421|69535728|FG002|Drug+Scanning Visit|Physician Decision|0|||
37852128|NCT01253421|69535729|FG003|Drug+Scanning Visit|Physician Decision|0|||
37852129|NCT01253421|69535730|FG004|Drug+Scanning Visit|Physician Decision|1|||
37852130|NCT01077076|69535740|FG000|First Intervention|Withdrawal by Subject|1|||
37852131|NCT01077076|69535741|FG001|First Intervention|Withdrawal by Subject|0|||
37852132|NCT01077076|69535742|FG002|First Intervention|Withdrawal by Subject|0|||
37852133|NCT01077076|69535743|FG003|First Intervention|Withdrawal by Subject|0|||
37852134|NCT01077076|69535744|FG004|First Intervention|Withdrawal by Subject|0|||
37852135|NCT01077076|69535745|FG005|First Intervention|Withdrawal by Subject|0|||
37852136|NCT01077076|69535740|FG000|Third Intervention|Death in the participant's family|0|||
37852137|NCT01077076|69535741|FG001|Third Intervention|Death in the participant's family|0|||
37852138|NCT01077076|69535742|FG002|Third Intervention|Death in the participant's family|0|||
37852139|NCT01077076|69535743|FG003|Third Intervention|Death in the participant's family|0|||
37852140|NCT01077076|69535744|FG004|Third Intervention|Death in the participant's family|0|||
37852141|NCT01077076|69535745|FG005|Third Intervention|Death in the participant's family|1|||
37852142|NCT01294800|69535757|FG000|Overall Study|Adverse Event|7|||
37852143|NCT01294800|69535758|FG001|Overall Study|Adverse Event|6|||
37852144|NCT01294800|69535759|FG002|Overall Study|Adverse Event|12|||
37852145|NCT01294800|69535760|FG003|Overall Study|Adverse Event|5|||
37852146|NCT01294800|69535757|FG000|Overall Study|Subject Withdrew Consent|2|||
37852147|NCT01294800|69535758|FG001|Overall Study|Subject Withdrew Consent|2|||
37852148|NCT01294800|69535759|FG002|Overall Study|Subject Withdrew Consent|2|||
37852149|NCT01294800|69535760|FG003|Overall Study|Subject Withdrew Consent|11|||
37921044|NCT05074433|69607596|FG000|Overall Study|Sponsor Request|0|||
37921045|NCT05074433|69607597|FG001|Overall Study|Sponsor Request|1|||
37921046|NCT05074433|69607598|FG002|Overall Study|Sponsor Request|1|||
37921047|NCT05074433|69607599|FG003|Overall Study|Sponsor Request|0|||
37921048|NCT05074433|69607596|FG000|Overall Study|Death|1|||
37921049|NCT05074433|69607597|FG001|Overall Study|Death|0|||
37921050|NCT05074433|69607598|FG002|Overall Study|Death|0|||
37921051|NCT05074433|69607599|FG003|Overall Study|Death|0|||
37921052|NCT05074433|69607596|FG000|Overall Study|Lost to Follow-up|0|||
37921053|NCT05074433|69607597|FG001|Overall Study|Lost to Follow-up|0|||
37921054|NCT05074433|69607598|FG002|Overall Study|Lost to Follow-up|2|||
37921055|NCT05074433|69607599|FG003|Overall Study|Lost to Follow-up|0|||
37921056|NCT05074433|69607596|FG000|Overall Study|Subject Decision|8|||
37921057|NCT05074433|69607597|FG001|Overall Study|Subject Decision|6|||
37921058|NCT05074433|69607598|FG002|Overall Study|Subject Decision|4|||
37921059|NCT05074433|69607599|FG003|Overall Study|Subject Decision|5|||
37852150|NCT01294800|69535757|FG000|Overall Study|Lost to Follow-up|0|||
37852151|NCT01294800|69535758|FG001|Overall Study|Lost to Follow-up|0|||
37852152|NCT01294800|69535759|FG002|Overall Study|Lost to Follow-up|1|||
37921060|NCT04922021|69607623|FG000|Overall Study|Withdrawal by Subject|4|||
37921061|NCT04922021|69607624|FG001|Overall Study|Withdrawal by Subject|10|||
37852153|NCT01294800|69535760|FG003|Overall Study|Lost to Follow-up|0|||
37921062|NCT04922021|69607623|FG000|Overall Study|Adverse Event|2|||
37852154|NCT01294800|69535757|FG000|Overall Study|Non-compliance With Protocol|0|||
37852155|NCT01294800|69535758|FG001|Overall Study|Non-compliance With Protocol|1|||
37921063|NCT04922021|69607624|FG001|Overall Study|Adverse Event|2|||
37921064|NCT04922021|69607623|FG000|Overall Study|Lack of Efficacy|0|||
37921065|NCT04922021|69607624|FG001|Overall Study|Lack of Efficacy|1|||
37921066|NCT04922021|69607623|FG000|Overall Study|Multiple reasons|1|||
37921067|NCT04922021|69607624|FG001|Overall Study|Multiple reasons|0|||
37735523|NCT01923181|69215979|FG001|Overall Study|Lost to Follow-up|3|||
37735524|NCT01923181|69215980|FG002|Overall Study|Lost to Follow-up|2|||
37852156|NCT01294800|69535759|FG002|Overall Study|Non-compliance With Protocol|1|||
37852157|NCT01294800|69535760|FG003|Overall Study|Non-compliance With Protocol|0|||
37852158|NCT01294800|69535757|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
37852159|NCT01294800|69535758|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
37852160|NCT01294800|69535759|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
37852161|NCT01294800|69535760|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
37852162|NCT01294644|69535773|FG000|Overall Study|Adverse Event|2|||
37852163|NCT01294644|69535774|FG001|Overall Study|Adverse Event|0|||
37852164|NCT01294644|69535775|FG002|Overall Study|Adverse Event|1|||
37852165|NCT01294644|69535773|FG000|Overall Study|Withdrawal by Subject|3|||
37852166|NCT01294644|69535774|FG001|Overall Study|Withdrawal by Subject|7|||
37852167|NCT01294644|69535775|FG002|Overall Study|Withdrawal by Subject|4|||
37852168|NCT01294644|69535773|FG000|Overall Study|Lost to Follow-up|3|||
37852169|NCT01294644|69535774|FG001|Overall Study|Lost to Follow-up|2|||
37852170|NCT01294644|69535775|FG002|Overall Study|Lost to Follow-up|5|||
38031242|NCT03352557|69717121|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
38031243|NCT03352557|69717112|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
38031244|NCT03352557|69717113|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
37852171|NCT01294644|69535773|FG000|Overall Study|Miscellaneous Reason|2|||
37852172|NCT01294644|69535774|FG001|Overall Study|Miscellaneous Reason|1|||
37852173|NCT01294644|69535775|FG002|Overall Study|Miscellaneous Reason|4|||
37852174|NCT01293240|69535783|FG000|Overall Study|Noncompliance|2|||
37852175|NCT01253265|69535792|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
37852176|NCT01253265|69535793|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
37852177|NCT01253265|69535794|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
37852178|NCT01253265|69535795|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
37852179|NCT01253265|69535796|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
37852180|NCT01253265|69535792|FG000|Overall Study|Withdrawal by Subject|0|||
37852181|NCT01253265|69535793|FG001|Overall Study|Withdrawal by Subject|0|||
37852182|NCT01253265|69535794|FG002|Overall Study|Withdrawal by Subject|0|||
37852183|NCT01253265|69535795|FG003|Overall Study|Withdrawal by Subject|0|||
37852184|NCT01253265|69535796|FG004|Overall Study|Withdrawal by Subject|1|||
37852185|NCT01293084|69535808|FG000|Overall Study|Physician Decision|3|||
37852186|NCT01293084|69535808|FG000|Overall Study|Withdrawal by Subject|2|||
37852187|NCT01293006|69535818|FG000|Period 2|Lost to Follow-up|1|||
37921068|NCT04233580|69607675|FG000|Overall Study|Adverse Event|3|||
37852188|NCT01293006|69535819|FG001|Period 2|Lost to Follow-up|0|||
37852189|NCT01293006|69535820|FG002|Period 2|Lost to Follow-up|0|||
37852190|NCT01293006|69535821|FG003|Period 2|Lost to Follow-up|0|||
37852191|NCT01253187|69535840|FG000|Period 2|Withdrawal by Subject|0|||
37921069|NCT04233580|69607676|FG001|Overall Study|Adverse Event|3|||
37852192|NCT01253187|69535841|FG001|Period 2|Withdrawal by Subject|0|||
37735525|NCT01923181|69215981|FG003|Overall Study|Lost to Follow-up|1|||
37852193|NCT01253187|69535842|FG002|Period 2|Withdrawal by Subject|0|||
37852194|NCT01253187|69535843|FG003|Period 2|Withdrawal by Subject|0|||
38031245|NCT03352557|69717114|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
37921070|NCT04233580|69607675|FG000|Overall Study|Withdrawal by Subject|2|||
37921071|NCT04233580|69607676|FG001|Overall Study|Withdrawal by Subject|1|||
37921072|NCT04016805|69607696|FG000|Overall Study|Sponsor's Discretion|30|||
37921073|NCT04016805|69607697|FG001|Overall Study|Sponsor's Discretion|6|||
37921074|NCT04016805|69607698|FG002|Overall Study|Sponsor's Discretion|5|||
37921075|NCT03982199|69607708|FG000|Overall Study|Site terminated by sponsor|14|||
37852195|NCT01253187|69535844|FG004|Period 2|Withdrawal by Subject|1|||
37852196|NCT01253187|69535845|FG005|Period 2|Withdrawal by Subject|0|||
37852197|NCT01253187|69535840|FG000|Period 3|Pregnancy|1|||
38031246|NCT03352557|69717115|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
38031247|NCT03352557|69717116|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
37852198|NCT01253187|69535841|FG001|Period 3|Pregnancy|0|||
37852199|NCT01253187|69535842|FG002|Period 3|Pregnancy|0|||
37852200|NCT01253187|69535843|FG003|Period 3|Pregnancy|0|||
37852201|NCT01253187|69535844|FG004|Period 3|Pregnancy|0|||
37852202|NCT01253187|69535845|FG005|Period 3|Pregnancy|0|||
37852203|NCT01253187|69535840|FG000|Period 3|difficulty with blood sampling|0|||
37852204|NCT01253187|69535841|FG001|Period 3|difficulty with blood sampling|1|||
37852205|NCT01253187|69535842|FG002|Period 3|difficulty with blood sampling|0|||
37852206|NCT01253187|69535843|FG003|Period 3|difficulty with blood sampling|0|||
37852207|NCT01253187|69535844|FG004|Period 3|difficulty with blood sampling|0|||
37852208|NCT01253187|69535845|FG005|Period 3|difficulty with blood sampling|0|||
37852209|NCT01253187|69535840|FG000|Period 3|non-compliance|0|||
37921076|NCT03982199|69607709|FG001|Overall Study|Site terminated by sponsor|17|||
37921077|NCT03982199|69607708|FG000|Overall Study|Lost to Follow-up|137|||
37921078|NCT03982199|69607709|FG001|Overall Study|Lost to Follow-up|142|||
37921079|NCT03982199|69607708|FG000|Overall Study|Physician Decision|38|||
37921080|NCT03982199|69607709|FG001|Overall Study|Physician Decision|33|||
37921081|NCT03982199|69607708|FG000|Overall Study|Withdrawal by Subject|514|||
37921082|NCT03982199|69607709|FG001|Overall Study|Withdrawal by Subject|496|||
37921083|NCT03982199|69607708|FG000|Overall Study|Adverse Event|10|||
37921084|NCT03982199|69607709|FG001|Overall Study|Adverse Event|14|||
38031248|NCT03352557|69717117|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
38031249|NCT03352557|69717118|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
37852210|NCT01253187|69535841|FG001|Period 3|non-compliance|0|||
37852211|NCT01253187|69535842|FG002|Period 3|non-compliance|0|||
37852212|NCT01253187|69535843|FG003|Period 3|non-compliance|0|||
37852213|NCT01253187|69535844|FG004|Period 3|non-compliance|1|||
37852214|NCT01253187|69535845|FG005|Period 3|non-compliance|0|||
37852215|NCT01252563|69535856|FG000|Overall Study|Contract Deviation|41|||
37852216|NCT01252563|69535856|FG000|Overall Study|Centralized Registration Deviation|30|||
37852217|NCT01252563|69535856|FG000|Overall Study|Lost to Follow-up|161|||
37852218|NCT01252563|69535856|FG000|Overall Study|No visit after first day of treatment|194|||
37852219|NCT01252563|69535856|FG000|Overall Study|No drug administration|6|||
37852220|NCT01292226|69535891|FG000|Overall Study|Adverse Event|5|||
37852221|NCT01292226|69535891|FG000|Overall Study|Death|1|||
37852222|NCT01292226|69535891|FG000|Overall Study|Graft loss|1|||
37852223|NCT01292226|69535891|FG000|Overall Study|Protocol Violation|3|||
37852224|NCT01292226|69535891|FG000|Overall Study|Withdrawal by Subject|1|||
37852225|NCT01292226|69535891|FG000|Overall Study|Other|2|||
37852226|NCT01290822|69535895|FG000|Overall Study|Withdrawal by Subject|1|||
37852227|NCT01290822|69535895|FG000|Overall Study|Physician Decision|10|||
37852228|NCT01075048|69535902|FG000|Overall Study|Death|4|||
38031250|NCT03352557|69717119|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
38031251|NCT03352557|69717120|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
38031252|NCT03352557|69717121|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
38031253|NCT03352557|69717112|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
38031254|NCT03352557|69717113|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
38031255|NCT03352557|69717114|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
38031256|NCT03352557|69717115|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
38031257|NCT03352557|69717116|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
38031258|NCT03352557|69717117|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
38031259|NCT03352557|69717118|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
38031260|NCT03352557|69717119|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
37852229|NCT01075048|69535903|FG001|Overall Study|Death|17|||
37852230|NCT01075048|69535904|FG002|Overall Study|Death|12|||
38031261|NCT03352557|69717120|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
38031262|NCT03352557|69717121|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
37852231|NCT01075048|69535902|FG000|Overall Study|Start of other or new therapy|4|||
37852232|NCT01075048|69535903|FG001|Overall Study|Start of other or new therapy|36|||
37852233|NCT01075048|69535904|FG002|Overall Study|Start of other or new therapy|46|||
37852234|NCT01075048|69535902|FG000|Overall Study|Withdrawal by Subject|1|||
37852235|NCT01075048|69535903|FG001|Overall Study|Withdrawal by Subject|6|||
37921085|NCT03982199|69607708|FG000|Overall Study|Technical Problems|9|||
37852236|NCT01075048|69535904|FG002|Overall Study|Withdrawal by Subject|3|||
37852237|NCT01075048|69535902|FG000|Overall Study|Lost to Follow-up|0|||
37735526|NCT01923181|69215982|FG004|Overall Study|Lost to Follow-up|2|||
37735527|NCT01923181|69215983|FG005|Overall Study|Lost to Follow-up|1|||
37735528|NCT01923181|69215984|FG006|Overall Study|Lost to Follow-up|3|||
37735529|NCT01923181|69215985|FG007|Overall Study|Lost to Follow-up|3|||
37735530|NCT01923181|69215986|FG008|Overall Study|Lost to Follow-up|1|||
37735531|NCT01896271|69216009|FG000|Overall Study|Physician Decision|10|||
37735532|NCT01884571|69216013|FG000|Overall Study|Adverse Event|1|||
37735533|NCT01884571|69216013|FG000|Overall Study|Death|2|||
37735534|NCT01884571|69216013|FG000|Overall Study|Withdrawal by Subject|2|||
37735535|NCT01884571|69216013|FG000|Overall Study|Disease progression|3|||
37852238|NCT01075048|69535903|FG001|Overall Study|Lost to Follow-up|1|||
37852239|NCT01075048|69535904|FG002|Overall Study|Lost to Follow-up|1|||
37852240|NCT01290666|69535915|FG000|Overall Study|Lost to Follow-up|11|||
37852241|NCT01290666|69535915|FG000|Overall Study|Withdrawal by Subject|23|||
37852242|NCT01290666|69535915|FG000|Overall Study|Early Termination of Study|4|||
37735536|NCT01884337|69216019|FG000|Treatment|Adverse Event|2|||
37852243|NCT01252251|69535919|FG000|Overall Study|Withdrawal by Subject|1|||
37852244|NCT01289574|69535926|FG000|Overall Study|Lack of Efficacy|4|||
37921086|NCT03982199|69607709|FG001|Overall Study|Technical Problems|8|||
38031263|NCT03352557|69717112|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
38031264|NCT03352557|69717113|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
38031265|NCT03352557|69717114|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
38031266|NCT03352557|69717115|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
38031267|NCT03352557|69717116|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
37735537|NCT01884337|69216020|FG001|Treatment|Adverse Event|2|||
38031268|NCT03352557|69717117|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
38031269|NCT03352557|69717118|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
38031270|NCT03352557|69717119|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
38031271|NCT03352557|69717120|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
38031272|NCT03352557|69717121|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
38031273|NCT03352557|69717112|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
38031274|NCT03352557|69717113|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
38031275|NCT03352557|69717114|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
38031276|NCT03352557|69717115|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
38031277|NCT03352557|69717116|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
38031278|NCT03352557|69717117|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
38031279|NCT03352557|69717118|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
38031280|NCT03352557|69717119|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
38031281|NCT03352557|69717120|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
38031282|NCT03352557|69717121|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
38031283|NCT03352557|69717112|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
38031284|NCT03352557|69717113|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
38043582|NCT02657434|69731756|FG001|Overall Study|Randomization by Error|0|||
37852245|NCT01289574|69535927|FG001|Overall Study|Lack of Efficacy|0|||
37735538|NCT01884337|69216019|FG000|Treatment|Subj. request to discont. treatment|2|||
37735539|NCT01884337|69216020|FG001|Treatment|Subj. request to discont. treatment|0|||
37735540|NCT01884337|69216019|FG000|Follow-up Period|Lost to Follow-up|1|||
37735541|NCT01884337|69216020|FG001|Follow-up Period|Lost to Follow-up|1|||
37735542|NCT01922089|69216028|FG000|Overall Study|Adverse Event|18|||
37735543|NCT01922089|69216029|FG001|Overall Study|Adverse Event|13|||
37735544|NCT01922089|69216028|FG000|Overall Study|Protocol Deviation|10|||
37735545|NCT01922089|69216029|FG001|Overall Study|Protocol Deviation|7|||
37735546|NCT01922089|69216028|FG000|Overall Study|Withdrawal by Subject|3|||
37735547|NCT01922089|69216029|FG001|Overall Study|Withdrawal by Subject|4|||
37735548|NCT01922089|69216028|FG000|Overall Study|administrative problems|4|||
37735549|NCT01922089|69216029|FG001|Overall Study|administrative problems|1|||
37735550|NCT01922089|69216028|FG000|Overall Study|Physician Decision|2|||
37735551|NCT01922089|69216029|FG001|Overall Study|Physician Decision|3|||
37735552|NCT01922089|69216028|FG000|Overall Study|Death|2|||
37735553|NCT01922089|69216029|FG001|Overall Study|Death|1|||
37735554|NCT01922089|69216028|FG000|Overall Study|Lost to Follow-up|0|||
38031285|NCT03352557|69717114|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
38031286|NCT03352557|69717115|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
37735555|NCT01922089|69216029|FG001|Overall Study|Lost to Follow-up|1|||
37735556|NCT01884025|69216037|FG000|Overall Study|Lost to Follow-up|3|||
37735557|NCT01884025|69216038|FG001|Overall Study|Lost to Follow-up|4|||
37921087|NCT03982199|69607708|FG000|Overall Study|Death|40|||
37921088|NCT03982199|69607709|FG001|Overall Study|Death|40|||
37735558|NCT01896193|69216048|FG000|Overall Study|Lack of Efficacy|20|||
37735559|NCT01896193|69216049|FG001|Overall Study|Lack of Efficacy|11|||
37735560|NCT01896193|69216048|FG000|Overall Study|Protocol Violation|0|||
37921089|NCT03982199|69607708|FG000|Overall Study|Study terminated by sponsor|2|||
37735561|NCT01896193|69216049|FG001|Overall Study|Protocol Violation|1|||
37735562|NCT01896193|69216048|FG000|Overall Study|Withdrew Consent|1|||
37735563|NCT01896193|69216049|FG001|Overall Study|Withdrew Consent|0|||
37735564|NCT01922011|69216059|FG000|Overall Study|Protocol Violation|0|||
37735565|NCT01922011|69216060|FG001|Overall Study|Protocol Violation|1|||
37921090|NCT03982199|69607709|FG001|Overall Study|Study terminated by sponsor|1|||
37921091|NCT03982199|69607708|FG000|Overall Study|Other|76|||
37921092|NCT03982199|69607709|FG001|Overall Study|Other|81|||
37735566|NCT01922011|69216059|FG000|Overall Study|Physician Decision|0|||
37735567|NCT01922011|69216060|FG001|Overall Study|Physician Decision|1|||
37735568|NCT01922011|69216059|FG000|Overall Study|Parent/Guardian Decision|3|||
37921093|NCT03982199|69607708|FG000|Overall Study|Ongoing|743|||
37921094|NCT03982199|69607709|FG001|Overall Study|Ongoing|799|||
37735569|NCT01922011|69216060|FG001|Overall Study|Parent/Guardian Decision|0|||
37735570|NCT01922011|69216059|FG000|Overall Study|Lost to Follow-up|0|||
37735571|NCT01922011|69216060|FG001|Overall Study|Lost to Follow-up|1|||
37852246|NCT01289574|69535928|FG002|Overall Study|Lack of Efficacy|1|||
37852247|NCT01289574|69535926|FG000|Overall Study|Lost to Follow-up|2|||
37852248|NCT01289574|69535927|FG001|Overall Study|Lost to Follow-up|0|||
37852249|NCT01289574|69535928|FG002|Overall Study|Lost to Follow-up|1|||
37852250|NCT01289574|69535926|FG000|Overall Study|Withdrawal by Subject|1|||
37852251|NCT01289574|69535927|FG001|Overall Study|Withdrawal by Subject|1|||
37852252|NCT01289574|69535928|FG002|Overall Study|Withdrawal by Subject|1|||
37852253|NCT01289574|69535926|FG000|Overall Study|Adverse Event|0|||
37852254|NCT01289574|69535927|FG001|Overall Study|Adverse Event|1|||
37852255|NCT01289574|69535928|FG002|Overall Study|Adverse Event|0|||
37735572|NCT01922011|69216059|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
37735573|NCT01922011|69216060|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
37735574|NCT01922011|69216059|FG000|Overall Study|Not Treated|1|||
37735575|NCT01922011|69216060|FG001|Overall Study|Not Treated|0|||
37735576|NCT01922011|69216059|FG000|Overall Study|Lack of willing home health agency|1|||
37735577|NCT01922011|69216060|FG001|Overall Study|Lack of willing home health agency|0|||
37921095|NCT03982199|69607708|FG000|Overall Study|Randomized but not vaccinated|18|||
37921096|NCT03982199|69607709|FG001|Overall Study|Randomized but not vaccinated|15|||
37735578|NCT01922011|69216059|FG000|Overall Study|Randomized in error|1|||
37735579|NCT01922011|69216060|FG001|Overall Study|Randomized in error|0|||
37735580|NCT01883635|69216074|FG000|Overall Study|Withdrawal by Subject|4|||
37735581|NCT01883635|69216075|FG001|Overall Study|Withdrawal by Subject|0|||
37735582|NCT01921387|69216083|FG000|Overall Study|Adverse Event|1|||
37735583|NCT01895335|69216087|FG000|Overall Study|Adverse Event|106|||
37735584|NCT01895335|69216087|FG000|Overall Study|Lack of Efficacy|53|||
37921097|NCT03828448|69607715|FG000|Overall Study|Sponsor's Discretion|34|||
37921098|NCT03713593|69607725|FG000|Overall Study|Participants Ongoing|140|||
37921099|NCT03713593|69607726|FG001|Overall Study|Participants Ongoing|114|||
37921100|NCT03713593|69607725|FG000|Overall Study|Withdrawal by Subject|3|||
37921101|NCT03713593|69607726|FG001|Overall Study|Withdrawal by Subject|6|||
37921102|NCT03713593|69607725|FG000|Overall Study|Death|252|||
37921103|NCT03713593|69607726|FG001|Overall Study|Death|279|||
37921104|NCT03580369|69607736|FG000|Overall Study|No treatment due to mis-randomization|1|||
37921105|NCT03580369|69607737|FG001|Overall Study|No treatment due to mis-randomization|0|||
37921106|NCT03580369|69607738|FG002|Overall Study|No treatment due to mis-randomization|0|||
37921107|NCT03580369|69607739|FG003|Overall Study|No treatment due to mis-randomization|0|||
37921108|NCT03580369|69607740|FG004|Overall Study|No treatment due to mis-randomization|3|||
37921109|NCT03580369|69607741|FG005|Overall Study|No treatment due to mis-randomization|0|||
37921110|NCT03580369|69607742|FG006|Overall Study|No treatment due to mis-randomization|0|||
37921111|NCT03580369|69607743|FG007|Overall Study|No treatment due to mis-randomization|0|||
37921112|NCT03580369|69607736|FG000|Overall Study|Reason unknown|0|||
37921113|NCT03580369|69607737|FG001|Overall Study|Reason unknown|0|||
37921114|NCT03580369|69607738|FG002|Overall Study|Reason unknown|1|||
37921115|NCT03580369|69607739|FG003|Overall Study|Reason unknown|0|||
37921116|NCT03580369|69607740|FG004|Overall Study|Reason unknown|0|||
38031287|NCT03352557|69717116|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
38031288|NCT03352557|69717117|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
38031289|NCT03352557|69717118|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
37852256|NCT01289574|69535926|FG000|Overall Study|Subject wanted alternate treatment|0|||
37852257|NCT01289574|69535927|FG001|Overall Study|Subject wanted alternate treatment|1|||
37852258|NCT01289574|69535928|FG002|Overall Study|Subject wanted alternate treatment|0|||
37852259|NCT01252095|69535939|FG000|Overall Study|Disease progression|1|||
37852260|NCT01252095|69535940|FG001|Overall Study|Disease progression|0|||
37852261|NCT01289418|69535949|FG000|Day 8 Survey|email address invalid|283|||
37852262|NCT01289418|69535949|FG000|Day 8 Survey|participants did not complete the survey|1935|||
37852263|NCT01289418|69535949|FG000|Day 29 Survey|email address invalid|283|||
37852264|NCT01289418|69535949|FG000|Day 29 Survey|participants did not complete the survey|2185|||
37852265|NCT01074658|69535955|FG000|Overall Study|No implant attempted|19|||
37852266|NCT01074502|69535959|FG000|Overall Study|Withdrawal by Subject|1|||
37852267|NCT01289028|69535963|FG000|Overall Study|Progressive Disease|49|||
37852268|NCT01289028|69535963|FG000|Overall Study|Adverse Event|14|||
38043583|NCT02657434|69731755|FG000|Overall Study|Withdrawal by Subject|28|||
37852269|NCT01289028|69535963|FG000|Overall Study|Withdrawal by Subject|6|||
37852270|NCT01289028|69535963|FG000|Overall Study|Death|4|||
37852271|NCT01289028|69535963|FG000|Overall Study|Lack of Efficacy|2|||
37852272|NCT01289028|69535963|FG000|Overall Study|No longer required|2|||
37852273|NCT01289028|69535963|FG000|Overall Study|Lost to Follow-up|2|||
37852274|NCT01289028|69535963|FG000|Overall Study|New Cancer Therapy|2|||
37852275|NCT01289028|69535963|FG000|Overall Study|Abnormal Lab Value|1|||
37852276|NCT01289028|69535963|FG000|Overall Study|Missing reason for discon|1|||
37852277|NCT01250925|69535972|FG000|Overall Study|Lost to Follow-up|1|||
37852278|NCT01250925|69535973|FG001|Overall Study|Lost to Follow-up|1|||
37852279|NCT01250925|69535974|FG002|Overall Study|Lost to Follow-up|0|||
37852280|NCT01250925|69535972|FG000|Overall Study|Withdrawal by Subject|2|||
37852281|NCT01250925|69535973|FG001|Overall Study|Withdrawal by Subject|0|||
37852282|NCT01250925|69535974|FG002|Overall Study|Withdrawal by Subject|0|||
37852283|NCT01250925|69535972|FG000|Overall Study|Protocol Violation|2|||
37852284|NCT01250925|69535973|FG001|Overall Study|Protocol Violation|0|||
37852285|NCT01250925|69535974|FG002|Overall Study|Protocol Violation|0|||
37852286|NCT01250925|69535972|FG000|Overall Study|Physician Decision|0|||
37852287|NCT01250925|69535973|FG001|Overall Study|Physician Decision|2|||
37852288|NCT01250925|69535974|FG002|Overall Study|Physician Decision|1|||
37852289|NCT01250925|69535972|FG000|Overall Study|Adverse Event|0|||
37852290|NCT01250925|69535973|FG001|Overall Study|Adverse Event|0|||
37852291|NCT01250925|69535974|FG002|Overall Study|Adverse Event|1|||
37852292|NCT01285908|69535982|FG000|Baseline Measurement|unable to insert catheter|1|||
37852293|NCT01285908|69535983|FG001|Baseline Measurement|unable to insert catheter|0|||
37852294|NCT01285908|69535984|FG002|Baseline Measurement|unable to insert catheter|0|||
37852295|NCT01285908|69535982|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
37852296|NCT01285908|69535983|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
37852297|NCT01285908|69535984|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
37852298|NCT01285908|69535982|FG000|Baseline Measurement|unable to tolerate procedure|1|||
37852299|NCT01285908|69535983|FG001|Baseline Measurement|unable to tolerate procedure|0|||
37852300|NCT01285908|69535984|FG002|Baseline Measurement|unable to tolerate procedure|0|||
37852301|NCT01250769|69536018|FG000|Overall Study|Withdrawal by Subject|0|||
37852302|NCT01250769|69536019|FG001|Overall Study|Withdrawal by Subject|1|||
37735585|NCT01895335|69216087|FG000|Overall Study|Poor Compliance to Protocol|11|||
37735586|NCT01895335|69216087|FG000|Overall Study|Included But Not treated|1|||
37735587|NCT01895335|69216087|FG000|Overall Study|Other than Specified Above|44|||
37921117|NCT03580369|69607741|FG005|Overall Study|Reason unknown|0|||
38031290|NCT03352557|69717119|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
38031291|NCT03352557|69717120|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
38031292|NCT03352557|69717121|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
37735588|NCT01617655|69216093|FG000|Overall Study|Adverse Event|2|||
37921118|NCT03580369|69607742|FG006|Overall Study|Reason unknown|0|||
37735589|NCT01617655|69216094|FG001|Overall Study|Adverse Event|3|||
37735590|NCT01617655|69216093|FG000|Overall Study|Poor compliance to protocol|1|||
37735591|NCT01617655|69216094|FG001|Overall Study|Poor compliance to protocol|4|||
37735592|NCT01617655|69216093|FG000|Overall Study|Participants moved|0|||
37852303|NCT01250769|69536020|FG002|Overall Study|Withdrawal by Subject|1|||
37735593|NCT01617655|69216094|FG001|Overall Study|Participants moved|4|||
37852304|NCT01250769|69536021|FG003|Overall Study|Withdrawal by Subject|0|||
37852305|NCT01250769|69536018|FG000|Overall Study|Adverse Event|0|||
37852306|NCT01250769|69536019|FG001|Overall Study|Adverse Event|0|||
37921119|NCT03580369|69607743|FG007|Overall Study|Reason unknown|0|||
37921120|NCT03580369|69607736|FG000|Overall Study|Technical problems|0|||
37921121|NCT03580369|69607737|FG001|Overall Study|Technical problems|0|||
37852307|NCT01250769|69536020|FG002|Overall Study|Adverse Event|1|||
37852308|NCT01250769|69536021|FG003|Overall Study|Adverse Event|0|||
37852309|NCT01074268|69536033|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
37735594|NCT01617655|69216093|FG000|Overall Study|Consent withdrawn by participant|1|||
37735595|NCT01617655|69216094|FG001|Overall Study|Consent withdrawn by participant|1|||
37735596|NCT01617655|69216093|FG000|Overall Study|Last visit outside protocol visit window|1|||
37852310|NCT01074268|69536034|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
37852311|NCT01074268|69536033|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
37852312|NCT01074268|69536034|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
37852313|NCT01074268|69536033|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
37852314|NCT01074268|69536034|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
37852315|NCT01074268|69536033|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
37852316|NCT01074268|69536034|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
37921122|NCT03580369|69607738|FG002|Overall Study|Technical problems|0|||
37921123|NCT03580369|69607739|FG003|Overall Study|Technical problems|0|||
37852317|NCT01074268|69536033|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
37852318|NCT01074268|69536034|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
37735597|NCT01617655|69216094|FG001|Overall Study|Last visit outside protocol visit window|10|||
37852319|NCT01074268|69536033|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
37735598|NCT01617655|69216093|FG000|Overall Study|Site closure|3|||
37735599|NCT01617655|69216094|FG001|Overall Study|Site closure|5|||
37735600|NCT01617655|69216093|FG000|Overall Study|Other than specified above|1|||
37735601|NCT01617655|69216094|FG001|Overall Study|Other than specified above|2|||
37735602|NCT01895101|69216105|FG000|Overall Study|OPCAB procedure|1|||
37735603|NCT01895101|69216106|FG001|Overall Study|OPCAB procedure|1|||
37735604|NCT01895101|69216107|FG002|Overall Study|OPCAB procedure|3|||
37735605|NCT01895101|69216105|FG000|Overall Study|Withdrawal by Subject|0|||
37735606|NCT01895101|69216106|FG001|Overall Study|Withdrawal by Subject|1|||
37735607|NCT01895101|69216107|FG002|Overall Study|Withdrawal by Subject|2|||
37735608|NCT01895101|69216105|FG000|Overall Study|another study, enrolled in other study|0|||
37735609|NCT01895101|69216106|FG001|Overall Study|another study, enrolled in other study|1|||
37735610|NCT01895101|69216107|FG002|Overall Study|another study, enrolled in other study|0|||
37735611|NCT01895101|69216105|FG000|Overall Study|Death|0|||
37735612|NCT01895101|69216106|FG001|Overall Study|Death|1|||
37735613|NCT01895101|69216107|FG002|Overall Study|Death|0|||
37735614|NCT01895101|69216105|FG000|Overall Study|coagulation disorder|0|||
37735615|NCT01895101|69216106|FG001|Overall Study|coagulation disorder|1|||
37735616|NCT01895101|69216107|FG002|Overall Study|coagulation disorder|0|||
37735617|NCT01894477|69216117|FG000|Overall Study|Protocol Violation|0|||
37735618|NCT01894477|69216118|FG001|Overall Study|Protocol Violation|1|||
37735619|NCT01894477|69216117|FG000|Overall Study|protocol changed due SC changed to cord|0|||
37735620|NCT01894477|69216118|FG001|Overall Study|protocol changed due SC changed to cord|1|||
37735621|NCT01894243|69216127|FG000|Overall Study|Adverse Event|0|||
38031293|NCT03352557|69717112|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
38031294|NCT03352557|69717113|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
37735622|NCT01894243|69216128|FG001|Overall Study|Adverse Event|1|||
37735623|NCT01894243|69216129|FG002|Overall Study|Adverse Event|2|||
37735624|NCT01894243|69216127|FG000|Overall Study|Death|0|||
37735625|NCT01894243|69216128|FG001|Overall Study|Death|0|||
37735626|NCT01894243|69216129|FG002|Overall Study|Death|3|||
37735627|NCT01894243|69216127|FG000|Overall Study|Lack of Efficacy|3|||
37735628|NCT01894243|69216128|FG001|Overall Study|Lack of Efficacy|3|||
37735629|NCT01894243|69216129|FG002|Overall Study|Lack of Efficacy|1|||
37735630|NCT01894243|69216127|FG000|Overall Study|Condition under investigation worsened|8|||
37735631|NCT01894243|69216128|FG001|Overall Study|Condition under investigation worsened|6|||
37735632|NCT01894243|69216129|FG002|Overall Study|Condition under investigation worsened|2|||
37735633|NCT01894243|69216127|FG000|Overall Study|Subject decision|1|||
37735634|NCT01894243|69216128|FG001|Overall Study|Subject decision|0|||
37735635|NCT01894243|69216129|FG002|Overall Study|Subject decision|0|||
37735636|NCT01894243|69216127|FG000|Overall Study|Other|1|||
37735637|NCT01894243|69216128|FG001|Overall Study|Other|0|||
37735638|NCT01894243|69216129|FG002|Overall Study|Other|0|||
37735639|NCT03822832|69216146|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
37735640|NCT03822832|69216147|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
37735641|NCT03822832|69216146|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
37735642|NCT03822832|69216147|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
37735643|NCT03822832|69216146|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
37735644|NCT03822832|69216147|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
37735645|NCT03822832|69216146|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
37735646|NCT03822832|69216147|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
37735647|NCT03822832|69216146|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
37735648|NCT03822832|69216147|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
37735649|NCT03822832|69216146|FG000|Re-allocation|Not re-allocated to open label period|2|||
37735650|NCT03822832|69216147|FG001|Re-allocation|Not re-allocated to open label period|6|||
37735651|NCT03822832|69216146|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
37735652|NCT03822832|69216147|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
37735653|NCT03822832|69216146|FG000|Period 2 - Open Label Period|Adverse Event|0|||
37735654|NCT03822832|69216147|FG001|Period 2 - Open Label Period|Adverse Event|3|||
37735655|NCT01513239|69216157|FG000|Period 1: Main Phase|Adverse Event|1|||
37735656|NCT01513239|69216158|FG001|Period 1: Main Phase|Adverse Event|1|||
37735657|NCT01513239|69216159|FG002|Period 1: Main Phase|Adverse Event|2|||
37735658|NCT01513239|69216160|FG003|Period 1: Main Phase|Adverse Event|0|||
37735659|NCT01513239|69216161|FG004|Period 1: Main Phase|Adverse Event|0|||
37735660|NCT01513239|69216162|FG005|Period 1: Main Phase|Adverse Event|0|||
37735661|NCT01513239|69216157|FG000|Period 1: Main Phase|Death|29|||
38031295|NCT03352557|69717114|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
38031296|NCT03352557|69717115|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
38031297|NCT03352557|69717116|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
38031298|NCT03352557|69717117|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
38031299|NCT03352557|69717118|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
38031300|NCT03352557|69717119|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
38031301|NCT03352557|69717120|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
38031302|NCT03352557|69717121|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
38031303|NCT03352557|69717112|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
38031304|NCT03352557|69717113|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
38031305|NCT03352557|69717114|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
38031306|NCT03352557|69717115|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
38031307|NCT03352557|69717116|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
38031308|NCT03352557|69717117|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
37735662|NCT01513239|69216158|FG001|Period 1: Main Phase|Death|22|||
37735663|NCT01513239|69216159|FG002|Period 1: Main Phase|Death|32|||
37921124|NCT03580369|69607740|FG004|Overall Study|Technical problems|1|||
38043584|NCT02657434|69731756|FG001|Overall Study|Withdrawal by Subject|17|||
37735664|NCT01513239|69216160|FG003|Period 1: Main Phase|Death|0|||
37735665|NCT01513239|69216161|FG004|Period 1: Main Phase|Death|0|||
37852320|NCT01074268|69536034|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
37852321|NCT01074268|69536033|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
37852322|NCT01074268|69536034|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
37735666|NCT01513239|69216162|FG005|Period 1: Main Phase|Death|0|||
38043585|NCT02657434|69731755|FG000|Overall Study|Protocol Violation|1|||
37735667|NCT01513239|69216157|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
37735668|NCT01513239|69216158|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
37735669|NCT01513239|69216159|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
37735670|NCT01513239|69216160|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
37735671|NCT01513239|69216161|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
37735672|NCT01513239|69216162|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
37735673|NCT01513239|69216157|FG000|Period 1: Main Phase|Physician Decision|4|||
37735674|NCT01513239|69216158|FG001|Period 1: Main Phase|Physician Decision|4|||
37852323|NCT01074268|69536033|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
37852324|NCT01074268|69536034|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
37852325|NCT01074268|69536033|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
37852326|NCT01074268|69536034|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
37852327|NCT01074190|69536043|FG000|Overall Study|Emergency Cesarean Delivery|1|||
38031309|NCT03352557|69717118|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
37852328|NCT01074190|69536044|FG001|Overall Study|Emergency Cesarean Delivery|2|||
37852329|NCT01074190|69536045|FG002|Overall Study|Emergency Cesarean Delivery|1|||
37852330|NCT01074190|69536043|FG000|Overall Study|Protocol Violation|2|||
37852331|NCT01074190|69536044|FG001|Overall Study|Protocol Violation|1|||
37852332|NCT01074190|69536045|FG002|Overall Study|Protocol Violation|0|||
37852333|NCT01074190|69536043|FG000|Overall Study|Delivered in under 90 minutes|0|||
37852334|NCT01074190|69536044|FG001|Overall Study|Delivered in under 90 minutes|2|||
37852335|NCT01074190|69536045|FG002|Overall Study|Delivered in under 90 minutes|1|||
37852336|NCT01074190|69536043|FG000|Overall Study|Subject withdrew consent|1|||
37852337|NCT01074190|69536044|FG001|Overall Study|Subject withdrew consent|1|||
37852338|NCT01074190|69536045|FG002|Overall Study|Subject withdrew consent|1|||
37852339|NCT01073566|69536058|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
37852340|NCT01073566|69536059|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
37852341|NCT01072396|69536067|FG000|Period One|Adverse Event|1|||
37852342|NCT01072396|69536068|FG001|Period One|Adverse Event|1|||
37852343|NCT01072396|69536067|FG000|Period One|Protocol Violation|2|||
37852344|NCT01072396|69536068|FG001|Period One|Protocol Violation|1|||
37852345|NCT01072396|69536067|FG000|Period One|Withdrawal by Subject|2|||
37852346|NCT01072396|69536068|FG001|Period One|Withdrawal by Subject|0|||
37852347|NCT01072396|69536067|FG000|Washout Period|Missing termination information|0|||
37852348|NCT01072396|69536068|FG001|Washout Period|Missing termination information|1|||
37852349|NCT01072396|69536067|FG000|Period Two|Adverse Event|0|||
37852350|NCT01072396|69536068|FG001|Period Two|Adverse Event|3|||
37852351|NCT01072396|69536067|FG000|Period Two|Lost to Follow-up|1|||
37852352|NCT01072396|69536068|FG001|Period Two|Lost to Follow-up|0|||
37852353|NCT01045096|69536077|FG000|Overall Study|Withdrawal by Subject|2|||
37852354|NCT01045096|69536078|FG001|Overall Study|Withdrawal by Subject|0|||
37852355|NCT01045096|69536079|FG002|Overall Study|Withdrawal by Subject|0|||
37735675|NCT01513239|69216159|FG002|Period 1: Main Phase|Physician Decision|4|||
37735676|NCT01513239|69216160|FG003|Period 1: Main Phase|Physician Decision|0|||
37735677|NCT01513239|69216161|FG004|Period 1: Main Phase|Physician Decision|0|||
37735678|NCT01513239|69216162|FG005|Period 1: Main Phase|Physician Decision|0|||
37735679|NCT01513239|69216157|FG000|Period 1: Main Phase|Protocol Violation|2|||
37735680|NCT01513239|69216158|FG001|Period 1: Main Phase|Protocol Violation|2|||
37735681|NCT01513239|69216159|FG002|Period 1: Main Phase|Protocol Violation|2|||
37735682|NCT01513239|69216160|FG003|Period 1: Main Phase|Protocol Violation|0|||
37735683|NCT01513239|69216161|FG004|Period 1: Main Phase|Protocol Violation|0|||
37735684|NCT01513239|69216162|FG005|Period 1: Main Phase|Protocol Violation|0|||
37735685|NCT01513239|69216157|FG000|Period 1: Main Phase|Technical Problems|1|||
37735686|NCT01513239|69216158|FG001|Period 1: Main Phase|Technical Problems|2|||
37735687|NCT01513239|69216159|FG002|Period 1: Main Phase|Technical Problems|0|||
37735688|NCT01513239|69216160|FG003|Period 1: Main Phase|Technical Problems|0|||
37735689|NCT01513239|69216161|FG004|Period 1: Main Phase|Technical Problems|0|||
37735690|NCT01513239|69216162|FG005|Period 1: Main Phase|Technical Problems|0|||
37735691|NCT01513239|69216157|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
37735692|NCT01513239|69216158|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
37735693|NCT01513239|69216159|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
37735694|NCT01513239|69216160|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
37852356|NCT01045096|69536077|FG000|Overall Study|Other|1|||
37852357|NCT01045096|69536078|FG001|Overall Study|Other|0|||
37852358|NCT01045096|69536079|FG002|Overall Study|Other|0|||
37852359|NCT01285518|69536095|FG000|Overall Study|Lost to Follow-up|0|||
37921125|NCT03580369|69607741|FG005|Overall Study|Technical problems|0|||
37921126|NCT03580369|69607742|FG006|Overall Study|Technical problems|2|||
37921127|NCT03580369|69607743|FG007|Overall Study|Technical problems|0|||
37921128|NCT03580369|69607736|FG000|Overall Study|Pregnancy|2|||
38043586|NCT02657434|69731756|FG001|Overall Study|Protocol Violation|0|||
37921129|NCT03580369|69607737|FG001|Overall Study|Pregnancy|0|||
37921130|NCT03580369|69607738|FG002|Overall Study|Pregnancy|3|||
37921131|NCT03580369|69607739|FG003|Overall Study|Pregnancy|0|||
37852360|NCT01285518|69536096|FG001|Overall Study|Lost to Follow-up|0|||
37852361|NCT01285518|69536097|FG002|Overall Study|Lost to Follow-up|0|||
37852362|NCT01285518|69536098|FG003|Overall Study|Lost to Follow-up|0|||
37852363|NCT01285518|69536099|FG004|Overall Study|Lost to Follow-up|0|||
37852364|NCT01285518|69536100|FG005|Overall Study|Lost to Follow-up|1|||
37852365|NCT01285518|69536101|FG006|Overall Study|Lost to Follow-up|0|||
37852366|NCT01285518|69536102|FG007|Overall Study|Lost to Follow-up|0|||
37852367|NCT01073020|69536125|FG000|Overall Study|Withdrawal by Subject|6|||
37852368|NCT01073020|69536126|FG001|Overall Study|Withdrawal by Subject|4|||
37852369|NCT01073020|69536127|FG002|Overall Study|Withdrawal by Subject|1|||
38031310|NCT03352557|69717119|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
37735695|NCT01513239|69216161|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
37735696|NCT01513239|69216162|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
37735697|NCT01513239|69216157|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
37735698|NCT01513239|69216158|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
37735699|NCT01513239|69216159|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
37735700|NCT01513239|69216160|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
37852370|NCT01073020|69536128|FG003|Overall Study|Withdrawal by Subject|2|||
37852371|NCT01073020|69536125|FG000|Overall Study|Physician Decision|1|||
37852372|NCT01073020|69536126|FG001|Overall Study|Physician Decision|0|||
37735701|NCT01513239|69216161|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
37735702|NCT01513239|69216162|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
37735703|NCT01513239|69216157|FG000|Period 2: 9 Month Extension Phase|Death|0|||
37735704|NCT01513239|69216158|FG001|Period 2: 9 Month Extension Phase|Death|0|||
37735705|NCT01513239|69216159|FG002|Period 2: 9 Month Extension Phase|Death|0|||
37735706|NCT01513239|69216160|FG003|Period 2: 9 Month Extension Phase|Death|2|||
37735707|NCT01513239|69216161|FG004|Period 2: 9 Month Extension Phase|Death|5|||
37852373|NCT01073020|69536127|FG002|Overall Study|Physician Decision|2|||
37852374|NCT01073020|69536128|FG003|Overall Study|Physician Decision|0|||
37852375|NCT01073020|69536125|FG000|Overall Study|Death|0|||
37852376|NCT01073020|69536126|FG001|Overall Study|Death|1|||
37852377|NCT01073020|69536127|FG002|Overall Study|Death|0|||
37852378|NCT01073020|69536128|FG003|Overall Study|Death|0|||
37852379|NCT01284114|69536138|FG000|Overall Study|viral infection|1|||
37852380|NCT01284114|69536138|FG000|Overall Study|From the results of ALLTITUDE study|1|||
37852381|NCT01284114|69536138|FG000|Overall Study|Symptomatic hypotension|1|||
37852382|NCT01284114|69536138|FG000|Overall Study|dizziness|1|||
37852383|NCT01283334|69536143|FG000|Overall Study|Withdrawal by Subject|1|||
37852384|NCT01283334|69536143|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
37852385|NCT01283334|69536143|FG000|Overall Study|Adverse Event|4|||
37852386|NCT01283334|69536143|FG000|Overall Study|Physician Decision|1|||
37852387|NCT01282866|69536149|FG000|Overall Study|Adverse Event|1|||
37852388|NCT01071070|69536155|FG000|Overall Study|Adverse Event|0|||
37852389|NCT01071070|69536156|FG001|Overall Study|Adverse Event|3|||
37852390|NCT01071070|69536155|FG000|Overall Study|Withdrawal by Subject|1|||
37852391|NCT01071070|69536156|FG001|Overall Study|Withdrawal by Subject|0|||
37852392|NCT01071070|69536155|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
37852393|NCT01071070|69536156|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
37852394|NCT01071070|69536155|FG000|Overall Study|Hypercalcemia|1|||
37852395|NCT01071070|69536156|FG001|Overall Study|Hypercalcemia|0|||
37852396|NCT01282476|69536162|FG000|Overall Study|Death|11|||
37852397|NCT01282164|69536168|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
37852398|NCT01282164|69536169|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
37852399|NCT01250379|69536185|FG000|Overall Study|Death|141|||
37852400|NCT01250379|69536186|FG001|Overall Study|Death|148|||
37852401|NCT01250379|69536185|FG000|Overall Study|Withdrawal by Subject|32|||
37852402|NCT01250379|69536186|FG001|Overall Study|Withdrawal by Subject|20|||
37852403|NCT01250379|69536185|FG000|Overall Study|Physician Decision|11|||
37852404|NCT01250379|69536186|FG001|Overall Study|Physician Decision|3|||
37852405|NCT01250379|69536185|FG000|Overall Study|Protocol Violation|2|||
37852406|NCT01250379|69536186|FG001|Overall Study|Protocol Violation|8|||
37735708|NCT01513239|69216162|FG005|Period 2: 9 Month Extension Phase|Death|2|||
37735709|NCT01513239|69216157|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
37735710|NCT01513239|69216158|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
37735711|NCT01513239|69216159|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
37735712|NCT01513239|69216160|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
37735713|NCT01513239|69216161|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
37735714|NCT01513239|69216162|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
37852407|NCT01250379|69536185|FG000|Overall Study|Lost to Follow-up|9|||
37852408|NCT01250379|69536186|FG001|Overall Study|Lost to Follow-up|6|||
37852409|NCT01250379|69536185|FG000|Overall Study|Adverse Event|5|||
37852410|NCT01250379|69536186|FG001|Overall Study|Adverse Event|4|||
37735715|NCT01513239|69216157|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
37735716|NCT01513239|69216158|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
37735717|NCT01513239|69216159|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
37735718|NCT01513239|69216160|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
37735719|NCT01513239|69216161|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
37735720|NCT01513239|69216162|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
37735721|NCT01513239|69216157|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
37735722|NCT01513239|69216158|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
37735723|NCT01513239|69216159|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
37735724|NCT01513239|69216160|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
37735725|NCT01513239|69216161|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
37735726|NCT01513239|69216162|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
37735727|NCT01544127|69216177|FG000|Overall Study|Lost to Follow-up|4|||
37735728|NCT01544127|69216178|FG001|Overall Study|Lost to Follow-up|2|||
37735729|NCT01544127|69216179|FG002|Overall Study|Lost to Follow-up|9|||
37735730|NCT01544127|69216177|FG000|Overall Study|Withdrawal by Subject|2|||
37735731|NCT01544127|69216178|FG001|Overall Study|Withdrawal by Subject|2|||
37735732|NCT01544127|69216179|FG002|Overall Study|Withdrawal by Subject|1|||
37735733|NCT01544127|69216177|FG000|Overall Study|Discharged out of catchment area|1|||
37735734|NCT01544127|69216178|FG001|Overall Study|Discharged out of catchment area|1|||
37735735|NCT01544127|69216179|FG002|Overall Study|Discharged out of catchment area|1|||
37735736|NCT01544127|69216177|FG000|Overall Study|Death|1|||
37735737|NCT01544127|69216178|FG001|Overall Study|Death|0|||
37735738|NCT01544127|69216179|FG002|Overall Study|Death|0|||
37735739|NCT01544127|69216177|FG000|Overall Study|Jail or Prison|1|||
37735740|NCT01544127|69216178|FG001|Overall Study|Jail or Prison|1|||
37735741|NCT01544127|69216179|FG002|Overall Study|Jail or Prison|2|||
37735742|NCT01544127|69216177|FG000|Overall Study|Became Psychotic|1|||
37735743|NCT01544127|69216178|FG001|Overall Study|Became Psychotic|0|||
37735744|NCT01544127|69216179|FG002|Overall Study|Became Psychotic|0|||
37735745|NCT01544127|69216177|FG000|Overall Study|Researcher withdrew|1|||
37735746|NCT01544127|69216178|FG001|Overall Study|Researcher withdrew|0|||
37735747|NCT01544127|69216179|FG002|Overall Study|Researcher withdrew|0|||
37735748|NCT01544127|69216177|FG000|Overall Study|Went active duty|0|||
37852411|NCT01250379|69536185|FG000|Overall Study|Other|0|||
37735749|NCT01544127|69216178|FG001|Overall Study|Went active duty|0|||
37852412|NCT01250379|69536186|FG001|Overall Study|Other|4|||
37852413|NCT01250379|69536185|FG000|Overall Study|Participant noncompliance|2|||
37735750|NCT01544127|69216179|FG002|Overall Study|Went active duty|1|||
37735751|NCT01512693|69216190|FG000|Overall Study|Withdrawal by Subject|0|||
37735752|NCT01512693|69216191|FG001|Overall Study|Withdrawal by Subject|1|||
37921132|NCT03580369|69607740|FG004|Overall Study|Pregnancy|2|||
37735753|NCT01458340|69216200|FG000|Overall Study|Adverse Event|5|||
37735754|NCT01458340|69216201|FG001|Overall Study|Adverse Event|4|||
37735755|NCT01458340|69216202|FG002|Overall Study|Adverse Event|2|||
37735756|NCT01458340|69216200|FG000|Overall Study|Lost to Follow-up|3|||
37735757|NCT01458340|69216201|FG001|Overall Study|Lost to Follow-up|3|||
37735758|NCT01458340|69216202|FG002|Overall Study|Lost to Follow-up|10|||
37735759|NCT01458340|69216200|FG000|Overall Study|Miscellaneous|0|||
38031311|NCT03352557|69717120|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
38031312|NCT03352557|69717121|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
38031313|NCT03352557|69717112|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
38031314|NCT03352557|69717113|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
38031315|NCT03352557|69717114|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
38031316|NCT03352557|69717115|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
38031317|NCT03352557|69717116|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
37735760|NCT01458340|69216201|FG001|Overall Study|Miscellaneous|1|||
37735761|NCT01458340|69216202|FG002|Overall Study|Miscellaneous|0|||
37735762|NCT01458340|69216200|FG000|Overall Study|Physician Decision|1|||
37735763|NCT01458340|69216201|FG001|Overall Study|Physician Decision|1|||
37735764|NCT01458340|69216202|FG002|Overall Study|Physician Decision|2|||
37735765|NCT01458340|69216200|FG000|Overall Study|Protocol Violation|6|||
37852414|NCT01250379|69536186|FG001|Overall Study|Participant noncompliance|0|||
37852415|NCT01072630|69536195|FG000|Overall Study|Adverse Event|11|||
37852416|NCT01072630|69536196|FG001|Overall Study|Adverse Event|19|||
37852417|NCT01072630|69536197|FG002|Overall Study|Adverse Event|2|||
37735766|NCT01458340|69216201|FG001|Overall Study|Protocol Violation|6|||
37735767|NCT01458340|69216202|FG002|Overall Study|Protocol Violation|5|||
37735768|NCT01458340|69216200|FG000|Overall Study|Withdrawal by Subject|12|||
37735769|NCT01458340|69216201|FG001|Overall Study|Withdrawal by Subject|6|||
37735770|NCT01458340|69216202|FG002|Overall Study|Withdrawal by Subject|4|||
37735771|NCT01539291|69216248|FG000|Study GS-US-312-0116|Adverse Event|9|||
37852418|NCT01072630|69536195|FG000|Overall Study|Lack of Efficacy|10|||
37852419|NCT01072630|69536196|FG001|Overall Study|Lack of Efficacy|10|||
37852420|NCT01072630|69536197|FG002|Overall Study|Lack of Efficacy|1|||
37852421|NCT01072630|69536195|FG000|Overall Study|Withdrawal by Subject|8|||
37852422|NCT01072630|69536196|FG001|Overall Study|Withdrawal by Subject|7|||
37852423|NCT01072630|69536197|FG002|Overall Study|Withdrawal by Subject|2|||
37852424|NCT01072630|69536195|FG000|Overall Study|Protocol Violation|10|||
37852425|NCT01072630|69536196|FG001|Overall Study|Protocol Violation|8|||
37852426|NCT01072630|69536197|FG002|Overall Study|Protocol Violation|4|||
37852427|NCT01072630|69536195|FG000|Overall Study|Lost to Follow-up|11|||
37852428|NCT01072630|69536196|FG001|Overall Study|Lost to Follow-up|11|||
37852429|NCT01072630|69536197|FG002|Overall Study|Lost to Follow-up|1|||
37852430|NCT01072630|69536195|FG000|Overall Study|Noncompliance with study medication|1|||
37852431|NCT01072630|69536196|FG001|Overall Study|Noncompliance with study medication|1|||
37852432|NCT01072630|69536197|FG002|Overall Study|Noncompliance with study medication|1|||
37852433|NCT01072630|69536195|FG000|Overall Study|Noncompliance with study procedures|1|||
37852434|NCT01072630|69536196|FG001|Overall Study|Noncompliance with study procedures|2|||
37852435|NCT01072630|69536197|FG002|Overall Study|Noncompliance with study procedures|1|||
37852436|NCT01072630|69536195|FG000|Overall Study|Other|3|||
37852437|NCT01072630|69536196|FG001|Overall Study|Other|2|||
37735772|NCT01539291|69216249|FG001|Study GS-US-312-0116|Adverse Event|0|||
37735773|NCT01539291|69216250|FG002|Study GS-US-312-0116|Adverse Event|0|||
37735774|NCT01539291|69216251|FG003|Study GS-US-312-0116|Adverse Event|0|||
37735775|NCT01539291|69216248|FG000|Study GS-US-312-0116|Physician Decision|1|||
37735776|NCT01539291|69216249|FG001|Study GS-US-312-0116|Physician Decision|0|||
37735777|NCT01539291|69216250|FG002|Study GS-US-312-0116|Physician Decision|0|||
37735778|NCT01539291|69216251|FG003|Study GS-US-312-0116|Physician Decision|0|||
37852438|NCT01072630|69536197|FG002|Overall Study|Other|1|||
38043587|NCT02657434|69731755|FG000|Overall Study|Physician Decision|0|||
37852439|NCT01281306|69536213|FG000|Overall Study|Lack of Efficacy|0|||
37735779|NCT01539291|69216248|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
37735780|NCT01539291|69216249|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
37852440|NCT01281306|69536214|FG001|Overall Study|Lack of Efficacy|1|||
37852441|NCT01281306|69536215|FG002|Overall Study|Lack of Efficacy|3|||
37852442|NCT01281306|69536216|FG003|Overall Study|Lack of Efficacy|0|||
37852443|NCT01281306|69536217|FG004|Overall Study|Lack of Efficacy|2|||
37852444|NCT01281306|69536218|FG005|Overall Study|Lack of Efficacy|0|||
37852445|NCT01281306|69536219|FG006|Overall Study|Lack of Efficacy|1|||
37852446|NCT01281306|69536213|FG000|Overall Study|Withdrawal by Subject|1|||
37852447|NCT01281306|69536214|FG001|Overall Study|Withdrawal by Subject|0|||
37852448|NCT01281306|69536215|FG002|Overall Study|Withdrawal by Subject|2|||
37852449|NCT01281306|69536216|FG003|Overall Study|Withdrawal by Subject|4|||
37852450|NCT01281306|69536217|FG004|Overall Study|Withdrawal by Subject|1|||
37852451|NCT01281306|69536218|FG005|Overall Study|Withdrawal by Subject|3|||
37852452|NCT01281306|69536219|FG006|Overall Study|Withdrawal by Subject|1|||
37852453|NCT01281306|69536213|FG000|Overall Study|Protocol deviation|0|||
37852454|NCT01281306|69536214|FG001|Overall Study|Protocol deviation|1|||
37852455|NCT01281306|69536215|FG002|Overall Study|Protocol deviation|1|||
38043541|NCT03366844|69731681|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
37735781|NCT01539291|69216250|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
37852456|NCT01281306|69536216|FG003|Overall Study|Protocol deviation|1|||
37852457|NCT01281306|69536217|FG004|Overall Study|Protocol deviation|1|||
37852458|NCT01281306|69536218|FG005|Overall Study|Protocol deviation|0|||
37852459|NCT01281306|69536219|FG006|Overall Study|Protocol deviation|0|||
37852460|NCT01281306|69536213|FG000|Overall Study|Condition no longer requires study drug|1|||
37852461|NCT01281306|69536214|FG001|Overall Study|Condition no longer requires study drug|0|||
37852462|NCT01281306|69536215|FG002|Overall Study|Condition no longer requires study drug|0|||
37852463|NCT01281306|69536216|FG003|Overall Study|Condition no longer requires study drug|0|||
37852464|NCT01281306|69536217|FG004|Overall Study|Condition no longer requires study drug|0|||
37852465|NCT01281306|69536218|FG005|Overall Study|Condition no longer requires study drug|1|||
37852466|NCT01281306|69536219|FG006|Overall Study|Condition no longer requires study drug|1|||
37852467|NCT01281306|69536213|FG000|Overall Study|Lost to Follow-up|1|||
37852468|NCT01281306|69536214|FG001|Overall Study|Lost to Follow-up|0|||
37852469|NCT01281306|69536215|FG002|Overall Study|Lost to Follow-up|0|||
37852470|NCT01281306|69536216|FG003|Overall Study|Lost to Follow-up|2|||
37852471|NCT01281306|69536217|FG004|Overall Study|Lost to Follow-up|0|||
37852472|NCT01281306|69536218|FG005|Overall Study|Lost to Follow-up|0|||
37852473|NCT01281306|69536219|FG006|Overall Study|Lost to Follow-up|1|||
37852474|NCT01281306|69536213|FG000|Overall Study|Death|1|||
37852475|NCT01281306|69536214|FG001|Overall Study|Death|0|||
37852476|NCT01281306|69536215|FG002|Overall Study|Death|0|||
37852477|NCT01281306|69536216|FG003|Overall Study|Death|0|||
37852478|NCT01281306|69536217|FG004|Overall Study|Death|0|||
37852479|NCT01281306|69536218|FG005|Overall Study|Death|0|||
37852480|NCT01281306|69536219|FG006|Overall Study|Death|0|||
37852481|NCT01281306|69536213|FG000|Overall Study|Adverse Event|3|||
37852482|NCT01281306|69536214|FG001|Overall Study|Adverse Event|2|||
37852483|NCT01281306|69536215|FG002|Overall Study|Adverse Event|2|||
37852484|NCT01281306|69536216|FG003|Overall Study|Adverse Event|3|||
37852485|NCT01281306|69536217|FG004|Overall Study|Adverse Event|5|||
37852486|NCT01281306|69536218|FG005|Overall Study|Adverse Event|3|||
37852487|NCT01281306|69536219|FG006|Overall Study|Adverse Event|3|||
38031318|NCT03352557|69717117|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
38031319|NCT03352557|69717118|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
38031320|NCT03352557|69717119|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
38031321|NCT03352557|69717120|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
38031322|NCT03352557|69717121|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
38043542|NCT03238248|69731701|FG000|Overall Study|Death|5|||
37852488|NCT01281306|69536213|FG000|Overall Study|Randomized in error|1|||
37852489|NCT01281306|69536214|FG001|Overall Study|Randomized in error|0|||
37852490|NCT01281306|69536215|FG002|Overall Study|Randomized in error|0|||
37852491|NCT01281306|69536216|FG003|Overall Study|Randomized in error|1|||
37852492|NCT01281306|69536217|FG004|Overall Study|Randomized in error|0|||
37677375|NCT01659255|69152292|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
37677376|NCT01659255|69152293|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
37677377|NCT01659255|69152294|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
37677378|NCT01659255|69152295|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
37677379|NCT01659255|69152296|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
37677380|NCT01659255|69152297|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
37677381|NCT01659255|69152298|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
37677382|NCT01659255|69152299|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
37677383|NCT01659255|69152300|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
37677384|NCT01659255|69152301|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
37677385|NCT01659255|69152302|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
37677386|NCT01659255|69152303|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
37677387|NCT01659255|69152304|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
37677388|NCT02637037|69152344|FG000|Overall Study|Positive drug screen at admission|1|||
37677389|NCT02637037|69152345|FG001|Overall Study|Positive drug screen at admission|0|||
37677390|NCT02637037|69152344|FG000|Overall Study|Withdrawal by Subject|2|||
37677391|NCT02637037|69152345|FG001|Overall Study|Withdrawal by Subject|1|||
37677392|NCT02637037|69152344|FG000|Overall Study|Adverse Event|1|||
37677393|NCT02637037|69152345|FG001|Overall Study|Adverse Event|0|||
37677394|NCT02637895|69152365|FG000|Overall Study|Lost to Follow-up|4|||
37677395|NCT02637895|69152366|FG001|Overall Study|Lost to Follow-up|0|||
37677396|NCT02637895|69152365|FG000|Overall Study|Protocol Violation|0|||
37677397|NCT02637895|69152366|FG001|Overall Study|Protocol Violation|1|||
37677398|NCT02637895|69152365|FG000|Overall Study|Lack of Efficacy|1|||
37677399|NCT02637895|69152366|FG001|Overall Study|Lack of Efficacy|0|||
37677400|NCT02637895|69152365|FG000|Overall Study|Withdrawal by Subject|1|||
37677401|NCT02637895|69152366|FG001|Overall Study|Withdrawal by Subject|1|||
37852493|NCT01281306|69536218|FG005|Overall Study|Randomized in error|0|||
37852494|NCT01281306|69536219|FG006|Overall Study|Randomized in error|0|||
37735782|NCT01539291|69216251|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
37852495|NCT01250145|69536237|FG000|Overall Study|Adverse Event|2|||
38031323|NCT03352557|69717112|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
37735783|NCT01539291|69216248|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
37735784|NCT01539291|69216249|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
37735785|NCT01539291|69216250|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
37735786|NCT01539291|69216251|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
37735787|NCT01539291|69216248|FG000|Study GS-US-312-0116|Other|1|||
37735788|NCT01539291|69216249|FG001|Study GS-US-312-0116|Other|0|||
37735789|NCT01539291|69216250|FG002|Study GS-US-312-0116|Other|0|||
37735790|NCT01539291|69216251|FG003|Study GS-US-312-0116|Other|0|||
37735791|NCT01539291|69216248|FG000|Study GS-US-312-0117|Adverse Event|22|||
37735792|NCT01539291|69216249|FG001|Study GS-US-312-0117|Adverse Event|1|||
37735793|NCT01539291|69216250|FG002|Study GS-US-312-0117|Adverse Event|9|||
37735794|NCT01539291|69216251|FG003|Study GS-US-312-0117|Adverse Event|12|||
37735795|NCT01539291|69216248|FG000|Study GS-US-312-0117|Physician Decision|9|||
37735796|NCT01539291|69216249|FG001|Study GS-US-312-0117|Physician Decision|0|||
37735797|NCT01539291|69216250|FG002|Study GS-US-312-0117|Physician Decision|6|||
37735798|NCT01539291|69216251|FG003|Study GS-US-312-0117|Physician Decision|4|||
37921133|NCT03580369|69607741|FG005|Overall Study|Pregnancy|0|||
37921134|NCT03580369|69607742|FG006|Overall Study|Pregnancy|0|||
37921135|NCT03580369|69607743|FG007|Overall Study|Pregnancy|0|||
37735799|NCT01539291|69216248|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
37735800|NCT01539291|69216249|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
37735801|NCT01539291|69216250|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
37735802|NCT01539291|69216251|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
37735803|NCT01539291|69216248|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
37735804|NCT01539291|69216249|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
37735805|NCT01539291|69216250|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
37735806|NCT01539291|69216251|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
37735807|NCT01539291|69216248|FG000|Study GS-US-312-0117|Other|2|||
37735808|NCT01539291|69216249|FG001|Study GS-US-312-0117|Other|1|||
37735809|NCT01539291|69216250|FG002|Study GS-US-312-0117|Other|1|||
37735810|NCT01539291|69216251|FG003|Study GS-US-312-0117|Other|1|||
37735811|NCT01538199|69216274|FG000|Overall Study|Lost to Follow-up|1|||
37735812|NCT01538199|69216275|FG001|Overall Study|Lost to Follow-up|2|||
37735813|NCT01538199|69216276|FG002|Overall Study|Lost to Follow-up|1|||
37852496|NCT01250145|69536238|FG001|Overall Study|Adverse Event|1|||
37852497|NCT01250145|69536237|FG000|Overall Study|Withdrawal by Subject|0|||
37735814|NCT01538199|69216277|FG003|Overall Study|Lost to Follow-up|0|||
37921136|NCT03580369|69607736|FG000|Overall Study|Lost to Follow-up|2|||
37735815|NCT01538199|69216274|FG000|Overall Study|participant did not have time|1|||
38031324|NCT03352557|69717113|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
38031325|NCT03352557|69717114|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
38031326|NCT03352557|69717115|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
38031327|NCT03352557|69717116|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
38031328|NCT03352557|69717117|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
38031329|NCT03352557|69717118|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
38031330|NCT03352557|69717119|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
37735816|NCT01538199|69216275|FG001|Overall Study|participant did not have time|0|||
37735817|NCT01538199|69216276|FG002|Overall Study|participant did not have time|0|||
37735818|NCT01538199|69216277|FG003|Overall Study|participant did not have time|2|||
38031331|NCT03352557|69717120|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
38031332|NCT03352557|69717121|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
38031333|NCT03352557|69717112|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
38031334|NCT03352557|69717113|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
38031335|NCT03352557|69717114|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
38031336|NCT03352557|69717115|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
37735819|NCT01538199|69216274|FG000|Overall Study|Lack of Efficacy|0|||
37735820|NCT01538199|69216275|FG001|Overall Study|Lack of Efficacy|1|||
37735821|NCT01538199|69216276|FG002|Overall Study|Lack of Efficacy|0|||
37735822|NCT01538199|69216277|FG003|Overall Study|Lack of Efficacy|0|||
37735823|NCT01511445|69216296|FG000|Overall Study|Lost to Follow-up|3|||
37735824|NCT01511445|69216297|FG001|Overall Study|Lost to Follow-up|1|||
37735825|NCT01511445|69216296|FG000|Overall Study|Protocol Violation|1|||
37735826|NCT01511445|69216297|FG001|Overall Study|Protocol Violation|3|||
37735827|NCT01511445|69216296|FG000|Overall Study|Protocol Violation|1|||
37735828|NCT01511445|69216297|FG001|Overall Study|Protocol Violation|0|||
37735829|NCT01543503|69216305|FG000|Overall Study|Lost to Follow-up|32|||
37735830|NCT01543503|69216306|FG001|Overall Study|Lost to Follow-up|36|||
37735831|NCT01543503|69216305|FG000|Overall Study|Adverse Event|9|||
37735832|NCT01543503|69216306|FG001|Overall Study|Adverse Event|13|||
37852498|NCT01250145|69536238|FG001|Overall Study|Withdrawal by Subject|4|||
37735833|NCT01543503|69216305|FG000|Overall Study|Lack of Efficacy|4|||
37921137|NCT03580369|69607737|FG001|Overall Study|Lost to Follow-up|0|||
37921138|NCT03580369|69607738|FG002|Overall Study|Lost to Follow-up|2|||
37921139|NCT03580369|69607739|FG003|Overall Study|Lost to Follow-up|0|||
37735834|NCT01543503|69216306|FG001|Overall Study|Lack of Efficacy|16|||
37735835|NCT01543503|69216305|FG000|Overall Study|Participant withdrew informed consent|8|||
37735836|NCT01543503|69216306|FG001|Overall Study|Participant withdrew informed consent|10|||
37735837|NCT01543503|69216305|FG000|Overall Study|Change of jobs|0|||
37735838|NCT01543503|69216306|FG001|Overall Study|Change of jobs|1|||
37735839|NCT01543503|69216305|FG000|Overall Study|Intolerance to the biologic treatment|0|||
37735840|NCT01543503|69216306|FG001|Overall Study|Intolerance to the biologic treatment|1|||
37735841|NCT01543503|69216305|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
37735842|NCT01543503|69216306|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
37735843|NCT01543503|69216305|FG000|Overall Study|Participant did not complete last visit|0|||
37735844|NCT01543503|69216306|FG001|Overall Study|Participant did not complete last visit|2|||
37735845|NCT01543503|69216305|FG000|Overall Study|Refused to continue treatment|7|||
37735846|NCT01543503|69216306|FG001|Overall Study|Refused to continue treatment|0|||
37735847|NCT01543503|69216305|FG000|Overall Study|Incorrect medication received|1|||
37735848|NCT01543503|69216306|FG001|Overall Study|Incorrect medication received|0|||
37735849|NCT01543503|69216305|FG000|Overall Study|Participant moved to another city|2|||
37735850|NCT01543503|69216306|FG001|Overall Study|Participant moved to another city|0|||
37735851|NCT01543503|69216305|FG000|Overall Study|Participant will not return for visits|0|||
37735852|NCT01543503|69216306|FG001|Overall Study|Participant will not return for visits|2|||
37735853|NCT01543503|69216305|FG000|Overall Study|Participant transferred to another city|1|||
37735854|NCT01543503|69216306|FG001|Overall Study|Participant transferred to another city|0|||
37735855|NCT01543503|69216305|FG000|Overall Study|Participant moved to Scotland|1|||
37735856|NCT01543503|69216306|FG001|Overall Study|Participant moved to Scotland|0|||
37735857|NCT01543503|69216305|FG000|Overall Study|Participant decision to stop treatment|1|||
37735858|NCT01543503|69216306|FG001|Overall Study|Participant decision to stop treatment|0|||
37735859|NCT01543503|69216305|FG000|Overall Study|Investigator did not wish to participate|1|||
37735860|NCT01543503|69216306|FG001|Overall Study|Investigator did not wish to participate|1|||
37735861|NCT01543503|69216305|FG000|Overall Study|Participant recruited after closing date|0|||
37735862|NCT01543503|69216306|FG001|Overall Study|Participant recruited after closing date|1|||
37735863|NCT01543503|69216305|FG000|Overall Study|Site stopped participation|5|||
37735864|NCT01543503|69216306|FG001|Overall Study|Site stopped participation|1|||
37735865|NCT01543503|69216305|FG000|Overall Study|Participant did not attend a visit|1|||
37735866|NCT01543503|69216306|FG001|Overall Study|Participant did not attend a visit|0|||
37735867|NCT01543503|69216305|FG000|Overall Study|Moved to other rheumatologic site|0|||
37735868|NCT01543503|69216306|FG001|Overall Study|Moved to other rheumatologic site|1|||
37735869|NCT01543503|69216305|FG000|Overall Study|Participant consented to another study|0|||
37735870|NCT01543503|69216306|FG001|Overall Study|Participant consented to another study|2|||
37735871|NCT01543503|69216305|FG000|Overall Study|Participant went to United States|1|||
37735872|NCT01543503|69216306|FG001|Overall Study|Participant went to United States|0|||
37735873|NCT01543503|69216305|FG000|Overall Study|Screen failure|1|||
37735874|NCT01543503|69216306|FG001|Overall Study|Screen failure|0|||
37735875|NCT01511055|69216312|FG000|Overall Study|Withdrawal by Subject|6|||
37735876|NCT01537887|69216316|FG000|Period 1|Physician Decision|0|||
37735877|NCT01537887|69216317|FG001|Period 1|Physician Decision|0|||
37735878|NCT01537887|69216318|FG002|Period 1|Physician Decision|0|||
37735879|NCT01537887|69216319|FG003|Period 1|Physician Decision|0|||
37735880|NCT01537887|69216320|FG004|Period 1|Physician Decision|1|||
37735881|NCT01537887|69216321|FG005|Period 1|Physician Decision|1|||
37735882|NCT01537887|69216316|FG000|Period 1|Did not receive treatment|0|||
37735883|NCT01537887|69216317|FG001|Period 1|Did not receive treatment|0|||
37735884|NCT01537887|69216318|FG002|Period 1|Did not receive treatment|1|||
37735885|NCT01537887|69216319|FG003|Period 1|Did not receive treatment|0|||
37735886|NCT01537887|69216320|FG004|Period 1|Did not receive treatment|0|||
37735887|NCT01537887|69216321|FG005|Period 1|Did not receive treatment|0|||
37735888|NCT01537887|69216316|FG000|Period 2|Withdrawal by Subject|0|||
37735889|NCT01537887|69216317|FG001|Period 2|Withdrawal by Subject|1|||
37735890|NCT01537887|69216318|FG002|Period 2|Withdrawal by Subject|0|||
37735891|NCT01537887|69216319|FG003|Period 2|Withdrawal by Subject|0|||
37735892|NCT01537887|69216320|FG004|Period 2|Withdrawal by Subject|0|||
37735893|NCT01537887|69216321|FG005|Period 2|Withdrawal by Subject|0|||
37735894|NCT01537887|69216316|FG000|Period 3|Adverse Event|0|||
37735895|NCT01537887|69216317|FG001|Period 3|Adverse Event|0|||
37735896|NCT01537887|69216318|FG002|Period 3|Adverse Event|1|||
37735897|NCT01537887|69216319|FG003|Period 3|Adverse Event|0|||
37735898|NCT01537887|69216320|FG004|Period 3|Adverse Event|0|||
37735899|NCT01537887|69216321|FG005|Period 3|Adverse Event|0|||
37735900|NCT01537887|69216316|FG000|Period 3|Withdrawal by Subject|0|||
37735901|NCT01537887|69216317|FG001|Period 3|Withdrawal by Subject|1|||
37735902|NCT01537887|69216318|FG002|Period 3|Withdrawal by Subject|0|||
37921140|NCT03580369|69607740|FG004|Overall Study|Lost to Follow-up|3|||
37921141|NCT03580369|69607741|FG005|Overall Study|Lost to Follow-up|0|||
37921142|NCT03580369|69607742|FG006|Overall Study|Lost to Follow-up|1|||
38031337|NCT03352557|69717116|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
37735903|NCT01537887|69216319|FG003|Period 3|Withdrawal by Subject|0|||
37735904|NCT01537887|69216320|FG004|Period 3|Withdrawal by Subject|0|||
37735905|NCT01537887|69216321|FG005|Period 3|Withdrawal by Subject|0|||
37921143|NCT03580369|69607743|FG007|Overall Study|Lost to Follow-up|0|||
37921144|NCT03580369|69607736|FG000|Overall Study|Physician Decision|4|||
37921145|NCT03580369|69607737|FG001|Overall Study|Physician Decision|0|||
37735906|NCT01489527|69216331|FG000|Overall Study|Pregnancy|9|||
37735907|NCT01489527|69216332|FG001|Overall Study|Pregnancy|14|||
37735908|NCT01489527|69216331|FG000|Overall Study|Participant moved|6|||
37735909|NCT01489527|69216332|FG001|Overall Study|Participant moved|7|||
38031338|NCT03352557|69717117|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
38031339|NCT03352557|69717118|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
38031340|NCT03352557|69717119|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
37735910|NCT01489527|69216331|FG000|Overall Study|Withdrawal by Subject|0|||
37735911|NCT01489527|69216332|FG001|Overall Study|Withdrawal by Subject|4|||
37735912|NCT01489527|69216331|FG000|Overall Study|Lost to Follow-up|5|||
37921146|NCT03580369|69607738|FG002|Overall Study|Physician Decision|4|||
37735913|NCT01489527|69216332|FG001|Overall Study|Lost to Follow-up|1|||
37735914|NCT01489527|69216331|FG000|Overall Study|Procedures|1|||
37735915|NCT01489527|69216332|FG001|Overall Study|Procedures|0|||
37735916|NCT01489527|69216331|FG000|Overall Study|Not compliant|1|||
37735917|NCT01489527|69216332|FG001|Overall Study|Not compliant|0|||
37735918|NCT01487577|69216345|FG000|Overall Study|Became ineligible after signing consent|1|||
37735919|NCT01536951|69216351|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
37735920|NCT01536951|69216352|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
37735921|NCT01536951|69216353|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
37735922|NCT01536951|69216354|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
37735923|NCT01536951|69216355|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
37735924|NCT01536951|69216356|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
37735925|NCT01536951|69216357|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
37735926|NCT01536951|69216358|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
37735927|NCT01536951|69216359|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
37735928|NCT01536951|69216351|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
37735929|NCT01536951|69216352|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
37735930|NCT01536951|69216353|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
37735931|NCT01536951|69216354|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
37735932|NCT01536951|69216355|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
37735933|NCT01536951|69216356|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
37735934|NCT01536951|69216357|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
37735935|NCT01536951|69216358|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
37735936|NCT01536951|69216359|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
37735937|NCT01536795|69216384|FG000|Overall Study|Lost to Follow-up|0|||
37735938|NCT01536795|69216385|FG001|Overall Study|Lost to Follow-up|2|||
37735939|NCT01536795|69216384|FG000|Overall Study|Lack of Efficacy|1|||
37735940|NCT01536795|69216385|FG001|Overall Study|Lack of Efficacy|0|||
37735941|NCT01536561|69216395|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
37735942|NCT01536561|69216395|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
37735943|NCT01536561|69216395|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
37735944|NCT01536561|69216395|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
37735945|NCT01536561|69216395|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
37735946|NCT01536561|69216395|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
37735947|NCT01536405|69216413|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
37852499|NCT01067326|69536260|FG000|Overall Study|Adverse Event|0|||
37852500|NCT01067326|69536261|FG001|Overall Study|Adverse Event|2|||
37852501|NCT01067326|69536260|FG000|Overall Study|Withdrawal by Subject|1|||
37735948|NCT01536405|69216414|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
37735949|NCT01536405|69216413|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
37735950|NCT01536405|69216414|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
37735951|NCT01536405|69216413|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
37735952|NCT01536405|69216414|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
37735953|NCT01536405|69216413|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
37735954|NCT01536405|69216414|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
37735955|NCT01536405|69216413|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
37735956|NCT01536405|69216414|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
37735957|NCT01536405|69216413|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
37735958|NCT01536405|69216414|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
37735959|NCT01536405|69216413|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
37735960|NCT01536405|69216414|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
37735961|NCT01536405|69216413|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
37735962|NCT01536405|69216414|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
37735963|NCT01536405|69216413|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
37735964|NCT01536405|69216414|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
37735965|NCT01536405|69216413|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
37735966|NCT01536405|69216414|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
37735967|NCT01536405|69216413|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
37735968|NCT01536405|69216414|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
37735969|NCT01536405|69216413|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
37735970|NCT01536405|69216414|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
37735971|NCT01536405|69216413|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
37735972|NCT01536405|69216414|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
37735973|NCT01487265|69216420|FG000|Overall Study|Adverse Event|8|||
37735974|NCT01487265|69216420|FG000|Overall Study|Withdrawal by Subject|5|||
37735975|NCT01487265|69216420|FG000|Overall Study|Disease Progression|21|||
37735976|NCT01487265|69216420|FG000|Overall Study|Death|2|||
37735977|NCT01487265|69216420|FG000|Overall Study|Still on Treatment|1|||
37735978|NCT01485627|69216426|FG000|Overall Study|Patient withdrew|6|||
37735979|NCT01485627|69216427|FG001|Overall Study|Patient withdrew|5|||
37735980|NCT01485627|69216426|FG000|Overall Study|Patient died|3|||
37735981|NCT01485627|69216427|FG001|Overall Study|Patient died|1|||
37735982|NCT01485627|69216426|FG000|Overall Study|Patient lost to followup|0|||
37735983|NCT01485627|69216427|FG001|Overall Study|Patient lost to followup|1|||
37921147|NCT03580369|69607739|FG003|Overall Study|Physician Decision|1|||
37921148|NCT03580369|69607740|FG004|Overall Study|Physician Decision|1|||
37921149|NCT03580369|69607741|FG005|Overall Study|Physician Decision|0|||
37852502|NCT01067326|69536261|FG001|Overall Study|Withdrawal by Subject|0|||
38031341|NCT03352557|69717120|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
38031342|NCT03352557|69717121|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
38031343|NCT03352557|69717112|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
38031344|NCT03352557|69717113|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
38031345|NCT03352557|69717114|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
38031346|NCT03352557|69717115|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
37735984|NCT01485627|69216426|FG000|Overall Study|Caregiver withdrew|3|||
37735985|NCT01485627|69216427|FG001|Overall Study|Caregiver withdrew|3|||
37735986|NCT01485627|69216426|FG000|Overall Study|Caregiver lost to follow up|11|||
37735987|NCT01485627|69216427|FG001|Overall Study|Caregiver lost to follow up|12|||
38031347|NCT03352557|69717116|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
38031348|NCT03352557|69717117|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
38031349|NCT03352557|69717118|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
38031350|NCT03352557|69717119|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
38031351|NCT03352557|69717120|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
38031352|NCT03352557|69717121|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
38031353|NCT03352557|69717112|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
38031354|NCT03352557|69717113|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
37735988|NCT01485627|69216426|FG000|Overall Study|Caregiver died|1|||
37735989|NCT01485627|69216427|FG001|Overall Study|Caregiver died|0|||
37735990|NCT01485627|69216426|FG000|Overall Study|caregiver was not bereaved|42|||
37735991|NCT01485627|69216427|FG001|Overall Study|caregiver was not bereaved|35|||
37921150|NCT03580369|69607742|FG006|Overall Study|Physician Decision|0|||
37921151|NCT03580369|69607743|FG007|Overall Study|Physician Decision|0|||
37921152|NCT03580369|69607736|FG000|Overall Study|Lack of Efficacy|3|||
37921153|NCT03580369|69607737|FG001|Overall Study|Lack of Efficacy|0|||
37735992|NCT01508325|69216450|FG000|Overall Study|Withdrawal by Subject|8|||
37735993|NCT01508325|69216451|FG001|Overall Study|Withdrawal by Subject|9|||
37735994|NCT01508325|69216450|FG000|Overall Study|Protocol Violation|0|||
37735995|NCT01508325|69216451|FG001|Overall Study|Protocol Violation|3|||
37735996|NCT01508325|69216450|FG000|Overall Study|Physician Decision|2|||
37735997|NCT01508325|69216451|FG001|Overall Study|Physician Decision|1|||
37735998|NCT01508325|69216450|FG000|Overall Study|Adverse Event|1|||
37735999|NCT01508325|69216451|FG001|Overall Study|Adverse Event|0|||
37736000|NCT01508325|69216450|FG000|Overall Study|Lost to Follow-up|5|||
37736001|NCT01508325|69216451|FG001|Overall Study|Lost to Follow-up|6|||
37736002|NCT01508325|69216450|FG000|Overall Study|Other|2|||
37736003|NCT01508325|69216451|FG001|Overall Study|Other|2|||
37736004|NCT01508169|69216459|FG000|Overall Study|Adverse Event|1|||
37736005|NCT01508169|69216460|FG001|Overall Study|Adverse Event|0|||
37736006|NCT01508169|69216459|FG000|Overall Study|Withdrawal by Subject|1|||
37736007|NCT01508169|69216460|FG001|Overall Study|Withdrawal by Subject|0|||
37736008|NCT01508169|69216459|FG000|Overall Study|Lost to Follow-up|1|||
37736009|NCT01508169|69216460|FG001|Overall Study|Lost to Follow-up|2|||
37736010|NCT01536171|69216472|FG000|Overall Study|Withdrawal by Subject|1|||
37736011|NCT01536093|69216479|FG000|Overall Study|Death|1|||
37736012|NCT01536093|69216480|FG001|Overall Study|Death|2|||
37736013|NCT01536093|69216479|FG000|Overall Study|absence of maternal colostrum|2|||
37736014|NCT01536093|69216480|FG001|Overall Study|absence of maternal colostrum|0|||
37736015|NCT01536093|69216479|FG000|Overall Study|Withdrawal by Subject|0|||
37736016|NCT01536093|69216480|FG001|Overall Study|Withdrawal by Subject|1|||
37736017|NCT01536015|69216488|FG000|Overall Study|Adverse Event|1|||
37736018|NCT01536015|69216489|FG001|Overall Study|Adverse Event|4|||
37736019|NCT01536015|69216488|FG000|Overall Study|Lost to Follow-up|0|||
38031355|NCT03352557|69717114|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
38031356|NCT03352557|69717115|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
37736020|NCT01536015|69216489|FG001|Overall Study|Lost to Follow-up|1|||
37736021|NCT01536015|69216488|FG000|Overall Study|Inclusion Criterion not met|2|||
37736022|NCT01536015|69216489|FG001|Overall Study|Inclusion Criterion not met|0|||
37736023|NCT01536015|69216488|FG000|Overall Study|Study closure|5|||
37736024|NCT01536015|69216489|FG001|Overall Study|Study closure|5|||
37736025|NCT01484691|69216498|FG000|Overall Study|Withdrawal by Subject|1|||
37736026|NCT01484691|69216499|FG001|Overall Study|Withdrawal by Subject|1|||
38031357|NCT03352557|69717116|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
38031358|NCT03352557|69717117|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
38031359|NCT03352557|69717118|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
38031360|NCT03352557|69717119|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
37736027|NCT01484691|69216500|FG002|Overall Study|Withdrawal by Subject|1|||
37736028|NCT01484691|69216498|FG000|Overall Study|Physician Decision|0|||
37736029|NCT01484691|69216499|FG001|Overall Study|Physician Decision|2|||
37736030|NCT01484691|69216500|FG002|Overall Study|Physician Decision|1|||
37736031|NCT01535235|69216511|FG000|Overall Study|Adverse Event|1|||
37736032|NCT01535235|69216512|FG001|Overall Study|Adverse Event|0|||
37736033|NCT01483599|69216556|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
37736034|NCT01483599|69216557|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
37736035|NCT01483599|69216558|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
37736036|NCT01483599|69216559|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
37736037|NCT01483599|69216560|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
37736038|NCT01483599|69216561|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
37736039|NCT01483599|69216562|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
37736040|NCT01483599|69216563|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
37736041|NCT01483599|69216564|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
37736042|NCT01483599|69216565|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
37736043|NCT01483599|69216566|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
37736044|NCT01483599|69216567|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
37736045|NCT01483599|69216568|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
37736046|NCT01483599|69216569|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
37736047|NCT01483599|69216556|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
37736048|NCT01483599|69216557|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
37736049|NCT01483599|69216558|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
37736050|NCT01483599|69216559|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
37736051|NCT01483599|69216560|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
37736052|NCT01483599|69216561|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
37736053|NCT01483599|69216562|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
37736054|NCT01483599|69216563|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
37736055|NCT01483599|69216564|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
37736056|NCT01483599|69216565|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
37736057|NCT01483599|69216566|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
37736058|NCT01483599|69216567|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
37736059|NCT01483599|69216568|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
37736060|NCT01483599|69216569|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
37852503|NCT01067326|69536260|FG000|Overall Study|Early Study Termination|1|||
37852504|NCT01067326|69536261|FG001|Overall Study|Early Study Termination|1|||
37852505|NCT01279200|69536269|FG000|Overall Study|Withdrawal by Subject|1|||
37852506|NCT01279200|69536270|FG001|Overall Study|Withdrawal by Subject|3|||
37852507|NCT01279200|69536269|FG000|Overall Study|Patient withdrawal due to high cost|0|||
37852508|NCT01279200|69536270|FG001|Overall Study|Patient withdrawal due to high cost|1|||
37852509|NCT01279200|69536269|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
38031361|NCT03352557|69717120|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
38043543|NCT03238248|69731701|FG000|Overall Study|Withdrawal by Subject|7|||
37736061|NCT01483599|69216556|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
37736062|NCT01483599|69216557|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
37736063|NCT01483599|69216558|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
37736064|NCT01483599|69216559|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
37736065|NCT01483599|69216560|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
37852510|NCT01279200|69536270|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
37852511|NCT01279200|69536269|FG000|Overall Study|ultrasound screening failure|0|||
37852512|NCT01279200|69536270|FG001|Overall Study|ultrasound screening failure|1|||
37852513|NCT01279200|69536269|FG000|Overall Study|Lost to Follow-up|0|||
37852514|NCT01279200|69536270|FG001|Overall Study|Lost to Follow-up|1|||
37852515|NCT01279200|69536269|FG000|Overall Study|Adverse Event|1|||
37852516|NCT01279200|69536270|FG001|Overall Study|Adverse Event|0|||
37852517|NCT01273818|69536279|FG000|Overall Study|Physician Decision|13|||
37852518|NCT01273818|69536280|FG001|Overall Study|Physician Decision|2|||
38031362|NCT03352557|69717121|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
38031363|NCT03352557|69717112|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
37852519|NCT01273818|69536281|FG002|Overall Study|Physician Decision|9|||
38031364|NCT03352557|69717113|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
38031365|NCT03352557|69717114|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
38031366|NCT03352557|69717115|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
37736066|NCT01483599|69216561|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
37852520|NCT01245387|69536289|FG000|Overall Study|Lost to Follow-up|106|||
37852521|NCT01245387|69536289|FG000|Overall Study|Lack of Efficacy|195|||
37852522|NCT01245387|69536289|FG000|Overall Study|Adverse Event|9|||
37852523|NCT01245387|69536289|FG000|Overall Study|Death|3|||
38043544|NCT03238248|69731701|FG000|Overall Study|Participant proceeding to transplant|10|||
37736067|NCT01483599|69216562|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
37736068|NCT01483599|69216563|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
37736069|NCT01483599|69216564|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
37736070|NCT01483599|69216565|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
38031367|NCT03352557|69717116|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
38031368|NCT03352557|69717117|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
38031369|NCT03352557|69717118|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
38031370|NCT03352557|69717119|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
38043545|NCT03238248|69731701|FG000|Overall Study|Lack of Efficacy|4|||
37736071|NCT01483599|69216566|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
37736072|NCT01483599|69216567|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
37852524|NCT01245387|69536289|FG000|Overall Study|Other|131|||
38043546|NCT03238248|69731701|FG000|Overall Study|Physician Decision|3|||
37736073|NCT01483599|69216568|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
37736074|NCT01483599|69216569|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
37736075|NCT01483599|69216556|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
37736076|NCT01483599|69216557|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
37736077|NCT01483599|69216558|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
37736078|NCT01483599|69216559|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
37736079|NCT01483599|69216560|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
37736080|NCT01483599|69216561|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
37736081|NCT01483599|69216562|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
37736082|NCT01483599|69216563|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
37736083|NCT01483599|69216564|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
37736084|NCT01483599|69216565|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
37736085|NCT01483599|69216566|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
37736086|NCT01483599|69216567|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
37736087|NCT01483599|69216568|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
37736088|NCT01483599|69216569|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
37736089|NCT01483599|69216556|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
37736090|NCT01483599|69216557|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
37736091|NCT01483599|69216558|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
38031371|NCT03352557|69717120|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
38043547|NCT03238248|69731701|FG000|Overall Study|Transitioning to another study|1|||
37736092|NCT01483599|69216559|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
37736093|NCT01483599|69216560|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
37736094|NCT01483599|69216561|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
37736095|NCT01483599|69216562|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
37736096|NCT01483599|69216563|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
37736097|NCT01483599|69216564|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
37736098|NCT01483599|69216565|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
37736099|NCT01483599|69216566|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
37736100|NCT01483599|69216567|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
37736101|NCT01483599|69216568|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
37736102|NCT01483599|69216569|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
37736103|NCT01483599|69216556|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
37736104|NCT01483599|69216557|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
37736105|NCT01483599|69216558|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
37736106|NCT01483599|69216559|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
37736107|NCT01483599|69216560|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
37736108|NCT01483599|69216561|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
37736109|NCT01483599|69216562|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
37736110|NCT01483599|69216563|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
37736111|NCT01483599|69216564|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
37736112|NCT01483599|69216565|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
37736113|NCT01483599|69216566|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
37736114|NCT01483599|69216567|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
37736115|NCT01483599|69216568|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
37736116|NCT01483599|69216569|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
37736117|NCT01483599|69216556|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
37736118|NCT01483599|69216557|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
37736119|NCT01483599|69216558|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
37736120|NCT01483599|69216559|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
37736121|NCT01483599|69216560|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
37736122|NCT01483599|69216561|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
37736123|NCT01483599|69216562|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
37736124|NCT01483599|69216563|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
37736125|NCT01483599|69216564|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
37736126|NCT01483599|69216565|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
37736127|NCT01483599|69216566|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
37736128|NCT01483599|69216567|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
37736129|NCT01483599|69216568|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
37736130|NCT01483599|69216569|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
37736131|NCT01483599|69216556|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
37736132|NCT01483599|69216557|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
37736133|NCT01483599|69216558|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
37736134|NCT01483599|69216559|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
37736135|NCT01483599|69216560|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
37736136|NCT01483599|69216561|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
37736137|NCT01483599|69216562|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
37852525|NCT01245387|69536289|FG000|Overall Study|Missing discontinuation status|369|||
37736138|NCT01483599|69216563|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
37736139|NCT01483599|69216564|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
37736140|NCT01483599|69216565|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
37736141|NCT01483599|69216566|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
37736142|NCT01483599|69216567|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
37736143|NCT01483599|69216568|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
37736144|NCT01483599|69216569|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
37736145|NCT01483599|69216556|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
37736146|NCT01483599|69216557|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
37736147|NCT01483599|69216558|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
37736148|NCT01483599|69216559|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
37736149|NCT01483599|69216560|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
37736150|NCT01483599|69216561|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
37736151|NCT01483599|69216562|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
37736152|NCT01483599|69216563|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
37736153|NCT01483599|69216564|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
37736154|NCT01483599|69216565|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
37736155|NCT01483599|69216566|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
37736156|NCT01483599|69216567|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
37736157|NCT01483599|69216568|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
37852526|NCT01037218|69536297|FG000|Overall Study|Adverse Event|4|||
37852527|NCT01037218|69536298|FG001|Overall Study|Adverse Event|2|||
37852528|NCT01037218|69536299|FG002|Overall Study|Adverse Event|2|||
37852529|NCT01037218|69536300|FG003|Overall Study|Adverse Event|1|||
37852530|NCT01037218|69536297|FG000|Overall Study|Lack of Efficacy|0|||
37852531|NCT01037218|69536298|FG001|Overall Study|Lack of Efficacy|2|||
37921154|NCT03580369|69607738|FG002|Overall Study|Lack of Efficacy|7|||
37921155|NCT03580369|69607739|FG003|Overall Study|Lack of Efficacy|0|||
37852532|NCT01037218|69536299|FG002|Overall Study|Lack of Efficacy|1|||
37852533|NCT01037218|69536300|FG003|Overall Study|Lack of Efficacy|5|||
37852534|NCT01037218|69536297|FG000|Overall Study|Lost to Follow-up|3|||
37852535|NCT01037218|69536298|FG001|Overall Study|Lost to Follow-up|5|||
37921156|NCT03580369|69607740|FG004|Overall Study|Lack of Efficacy|2|||
37921157|NCT03580369|69607741|FG005|Overall Study|Lack of Efficacy|0|||
38031372|NCT03352557|69717121|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
38031373|NCT03352557|69717112|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
38031374|NCT03352557|69717113|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
38031375|NCT03352557|69717114|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
38031376|NCT03352557|69717115|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
38031377|NCT03352557|69717116|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
38031378|NCT03352557|69717117|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
38031379|NCT03352557|69717118|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
38031380|NCT03352557|69717119|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
38031381|NCT03352557|69717120|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
38031382|NCT03352557|69717121|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
38031383|NCT03352557|69717112|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
38031384|NCT03352557|69717113|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
38031385|NCT03352557|69717114|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
38031386|NCT03352557|69717115|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
38031387|NCT03352557|69717116|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
38031388|NCT03352557|69717117|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
38031389|NCT03352557|69717118|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
38031390|NCT03352557|69717119|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
38031391|NCT03352557|69717120|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
37736158|NCT01483599|69216569|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
37921158|NCT03580369|69607742|FG006|Overall Study|Lack of Efficacy|3|||
37921159|NCT03580369|69607743|FG007|Overall Study|Lack of Efficacy|0|||
37921160|NCT03580369|69607736|FG000|Overall Study|Protocol Violation|6|||
37921161|NCT03580369|69607737|FG001|Overall Study|Protocol Violation|0|||
37921162|NCT03580369|69607738|FG002|Overall Study|Protocol Violation|6|||
38031392|NCT03352557|69717121|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
37736159|NCT01483599|69216556|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
37852536|NCT01037218|69536299|FG002|Overall Study|Lost to Follow-up|4|||
37852537|NCT01037218|69536300|FG003|Overall Study|Lost to Follow-up|2|||
37852538|NCT01037218|69536297|FG000|Overall Study|Withdrawal by Subject|6|||
37852539|NCT01037218|69536298|FG001|Overall Study|Withdrawal by Subject|7|||
37921163|NCT03580369|69607739|FG003|Overall Study|Protocol Violation|1|||
37921164|NCT03580369|69607740|FG004|Overall Study|Protocol Violation|8|||
37921165|NCT03580369|69607741|FG005|Overall Study|Protocol Violation|2|||
37921166|NCT03580369|69607742|FG006|Overall Study|Protocol Violation|1|||
37736160|NCT01483599|69216557|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
37736161|NCT01483599|69216558|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
37736162|NCT01483599|69216559|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
37736163|NCT01483599|69216560|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
37736164|NCT01483599|69216561|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
37736165|NCT01483599|69216562|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
37736166|NCT01483599|69216563|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
37736167|NCT01483599|69216564|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
37736168|NCT01483599|69216565|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
37736169|NCT01483599|69216566|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
37736170|NCT01483599|69216567|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
37736171|NCT01483599|69216568|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
37736172|NCT01483599|69216569|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
37736173|NCT01507545|69216645|FG000|Overall Study|Withdrawal by Subject|6|||
37736174|NCT01507545|69216646|FG001|Overall Study|Withdrawal by Subject|2|||
37736175|NCT01507545|69216645|FG000|Overall Study|Lost to Follow-up|1|||
37736176|NCT01507545|69216646|FG001|Overall Study|Lost to Follow-up|0|||
37736177|NCT01507545|69216645|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
37736178|NCT01507545|69216646|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
37736179|NCT01507545|69216645|FG000|Overall Study|Progressive disease|60|||
37736180|NCT01507545|69216646|FG001|Overall Study|Progressive disease|27|||
37736181|NCT01507545|69216645|FG000|Overall Study|Other|6|||
37736182|NCT01507545|69216646|FG001|Overall Study|Other|4|||
37736183|NCT01482819|69216652|FG000|Overall Study|Lost to Follow-up|2|||
37736184|NCT01534533|69216664|FG000|Overall Study|Lost to Follow-up|3|||
37736185|NCT01534533|69216665|FG001|Overall Study|Lost to Follow-up|0|||
37736186|NCT01534533|69216666|FG002|Overall Study|Lost to Follow-up|4|||
37736187|NCT01534533|69216667|FG003|Overall Study|Lost to Follow-up|3|||
37736188|NCT01534533|69216664|FG000|Overall Study|Withdrawal by Subject|5|||
37736189|NCT01534533|69216665|FG001|Overall Study|Withdrawal by Subject|3|||
37736190|NCT01534533|69216666|FG002|Overall Study|Withdrawal by Subject|4|||
37736191|NCT01534533|69216667|FG003|Overall Study|Withdrawal by Subject|1|||
37736192|NCT01506609|69216801|FG000|Overall Study|Adverse Event Related to Progression|0|||
37736193|NCT01506609|69216802|FG001|Overall Study|Adverse Event Related to Progression|0|||
37736194|NCT01506609|69216803|FG002|Overall Study|Adverse Event Related to Progression|0|||
37736195|NCT01506609|69216804|FG003|Overall Study|Adverse Event Related to Progression|3|||
37736196|NCT01506609|69216805|FG004|Overall Study|Adverse Event Related to Progression|7|||
37736197|NCT01506609|69216806|FG005|Overall Study|Adverse Event Related to Progression|3|||
37736198|NCT01506609|69216801|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
37736199|NCT01506609|69216802|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
37736200|NCT01506609|69216803|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
37736201|NCT01506609|69216804|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
37736202|NCT01506609|69216805|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
37736203|NCT01506609|69216806|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
37736204|NCT01506609|69216801|FG000|Overall Study|Withdrawal by Subject|0|||
37736205|NCT01506609|69216802|FG001|Overall Study|Withdrawal by Subject|0|||
37736206|NCT01506609|69216803|FG002|Overall Study|Withdrawal by Subject|0|||
37736207|NCT01506609|69216804|FG003|Overall Study|Withdrawal by Subject|9|||
37736208|NCT01506609|69216805|FG004|Overall Study|Withdrawal by Subject|7|||
37736209|NCT01506609|69216806|FG005|Overall Study|Withdrawal by Subject|7|||
37736210|NCT01506609|69216801|FG000|Overall Study|Lost to Follow-up|0|||
37736211|NCT01506609|69216802|FG001|Overall Study|Lost to Follow-up|0|||
37736212|NCT01506609|69216803|FG002|Overall Study|Lost to Follow-up|0|||
37852540|NCT01037218|69536299|FG002|Overall Study|Withdrawal by Subject|7|||
38031393|NCT03352557|69717112|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
38031394|NCT03352557|69717113|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
38031395|NCT03352557|69717114|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
38031396|NCT03352557|69717115|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
38031397|NCT03352557|69717116|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
38031398|NCT03352557|69717117|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
37736213|NCT01506609|69216804|FG003|Overall Study|Lost to Follow-up|1|||
37736214|NCT01506609|69216805|FG004|Overall Study|Lost to Follow-up|2|||
37736215|NCT01506609|69216806|FG005|Overall Study|Lost to Follow-up|0|||
37736216|NCT01506609|69216801|FG000|Overall Study|Sponsor Discontinued Study|0|||
37736217|NCT01506609|69216802|FG001|Overall Study|Sponsor Discontinued Study|0|||
37736218|NCT01506609|69216803|FG002|Overall Study|Sponsor Discontinued Study|0|||
37736219|NCT01506609|69216804|FG003|Overall Study|Sponsor Discontinued Study|2|||
37736220|NCT01506609|69216805|FG004|Overall Study|Sponsor Discontinued Study|2|||
37736221|NCT01506609|69216806|FG005|Overall Study|Sponsor Discontinued Study|0|||
37921167|NCT03580369|69607743|FG007|Overall Study|Protocol Violation|0|||
37852541|NCT01037218|69536300|FG003|Overall Study|Withdrawal by Subject|4|||
37852542|NCT01037218|69536297|FG000|Overall Study|Partner Withdrew Consent|0|||
37852543|NCT01037218|69536298|FG001|Overall Study|Partner Withdrew Consent|3|||
37852544|NCT01037218|69536299|FG002|Overall Study|Partner Withdrew Consent|2|||
37921168|NCT03580369|69607736|FG000|Overall Study|Adverse Event|7|||
37921169|NCT03580369|69607737|FG001|Overall Study|Adverse Event|0|||
37921170|NCT03580369|69607738|FG002|Overall Study|Adverse Event|14|||
37921171|NCT03580369|69607739|FG003|Overall Study|Adverse Event|1|||
37921172|NCT03580369|69607740|FG004|Overall Study|Adverse Event|6|||
37736222|NCT01506609|69216801|FG000|Overall Study|Progressive Disease per Protocol|1|||
37852545|NCT01037218|69536300|FG003|Overall Study|Partner Withdrew Consent|1|||
37852546|NCT01037218|69536297|FG000|Overall Study|Protocol Violation|0|||
37852547|NCT01037218|69536298|FG001|Overall Study|Protocol Violation|0|||
37852548|NCT01037218|69536299|FG002|Overall Study|Protocol Violation|2|||
38031399|NCT03352557|69717118|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
38031400|NCT03352557|69717119|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
38031401|NCT03352557|69717120|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
37736223|NCT01506609|69216802|FG001|Overall Study|Progressive Disease per Protocol|0|||
37736224|NCT01506609|69216803|FG002|Overall Study|Progressive Disease per Protocol|0|||
37736225|NCT01506609|69216804|FG003|Overall Study|Progressive Disease per Protocol|64|||
37736226|NCT01506609|69216805|FG004|Overall Study|Progressive Disease per Protocol|57|||
37736227|NCT01506609|69216806|FG005|Overall Study|Progressive Disease per Protocol|74|||
37736228|NCT01506609|69216801|FG000|Overall Study|Other, Not Specified|0|||
37736229|NCT01506609|69216802|FG001|Overall Study|Other, Not Specified|0|||
37736230|NCT01506609|69216803|FG002|Overall Study|Other, Not Specified|0|||
37852549|NCT01037218|69536300|FG003|Overall Study|Protocol Violation|2|||
37921173|NCT03580369|69607741|FG005|Overall Study|Adverse Event|0|||
37852550|NCT01037218|69536297|FG000|Overall Study|Various|3|||
37921174|NCT03580369|69607742|FG006|Overall Study|Adverse Event|1|||
37852551|NCT01037218|69536298|FG001|Overall Study|Various|2|||
37852552|NCT01037218|69536299|FG002|Overall Study|Various|3|||
37852553|NCT01037218|69536300|FG003|Overall Study|Various|1|||
37852554|NCT01038856|69536310|FG000|Overall Study|Adverse Event|2|||
37852555|NCT01066546|69536316|FG000|Overall Study|Study terminated by sponsor|5|||
37852556|NCT01272804|69536326|FG000|Overall Study|Adverse Event|1|||
37921175|NCT03580369|69607743|FG007|Overall Study|Adverse Event|0|||
37921176|NCT03580369|69607736|FG000|Overall Study|Withdrawal by Subject|19|||
37921177|NCT03580369|69607737|FG001|Overall Study|Withdrawal by Subject|0|||
37736231|NCT01506609|69216804|FG003|Overall Study|Other, Not Specified|10|||
37736232|NCT01506609|69216805|FG004|Overall Study|Other, Not Specified|7|||
37736233|NCT01506609|69216806|FG005|Overall Study|Other, Not Specified|3|||
37736234|NCT01506609|69216801|FG000|Overall Study|Missing / Unknown Reason|1|||
37736235|NCT01506609|69216802|FG001|Overall Study|Missing / Unknown Reason|0|||
37736236|NCT01506609|69216803|FG002|Overall Study|Missing / Unknown Reason|1|||
37736237|NCT01506609|69216804|FG003|Overall Study|Missing / Unknown Reason|4|||
37736238|NCT01506609|69216805|FG004|Overall Study|Missing / Unknown Reason|4|||
37736239|NCT01506609|69216806|FG005|Overall Study|Missing / Unknown Reason|2|||
37736240|NCT01506453|69216830|FG000|Overall Study|Withdrawal prior to treatment|0|||
37736241|NCT01506453|69216831|FG001|Overall Study|Withdrawal prior to treatment|2|||
37852557|NCT01272804|69536327|FG001|Overall Study|Adverse Event|0|||
37736242|NCT01482429|69216839|FG000|Care Usual|Protocol Violation|0|||
37736243|NCT01482429|69216840|FG001|Care Usual|Protocol Violation|172|||
38031402|NCT03352557|69717121|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
37736244|NCT01482429|69216839|FG000|Care Usual|Lost to Follow-up|0|||
37736245|NCT01482429|69216840|FG001|Care Usual|Lost to Follow-up|1|||
37736246|NCT01482429|69216839|FG000|Protocol|Protocol Violation|275|||
37736247|NCT01482429|69216840|FG001|Protocol|Protocol Violation|0|||
37852558|NCT01272804|69536328|FG002|Overall Study|Adverse Event|0|||
37852559|NCT01272804|69536329|FG003|Overall Study|Adverse Event|0|||
37852560|NCT01272804|69536330|FG004|Overall Study|Adverse Event|2|||
37736248|NCT01504971|69216846|FG000|Overall Study|Physician Decision|13|||
37736249|NCT01479777|69216854|FG000|Overall Study|Physician Decision|2|||
37852561|NCT01272804|69536331|FG005|Overall Study|Adverse Event|1|||
37852562|NCT01269918|69536347|FG000|Overall Study|Did not receive study drug|0|||
37852563|NCT01269918|69536348|FG001|Overall Study|Did not receive study drug|3|||
37736250|NCT01479621|69216864|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
37736251|NCT01479621|69216865|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
37736252|NCT01479621|69216866|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
37736253|NCT01479621|69216867|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
37852564|NCT01036594|69536354|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
37852565|NCT01036594|69536355|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
37852566|NCT01036594|69536354|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
37736254|NCT01479621|69216868|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
37736255|NCT01479621|69216869|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
38031403|NCT03352557|69717112|FG000|PC Period: Day 1 to Week 78|Other|5|||
38031404|NCT03352557|69717113|FG001|PC Period: Day 1 to Week 78|Other|1|||
37921178|NCT03580369|69607738|FG002|Overall Study|Withdrawal by Subject|17|||
37921179|NCT03580369|69607739|FG003|Overall Study|Withdrawal by Subject|0|||
37921180|NCT03580369|69607740|FG004|Overall Study|Withdrawal by Subject|16|||
37921181|NCT03580369|69607741|FG005|Overall Study|Withdrawal by Subject|1|||
37921182|NCT03580369|69607742|FG006|Overall Study|Withdrawal by Subject|7|||
37921183|NCT03580369|69607743|FG007|Overall Study|Withdrawal by Subject|0|||
37921184|NCT03215810|69607780|FG000|Overall Study|Still responding to nivolumab|1|||
37921185|NCT03215810|69607780|FG000|Overall Study|Insufficient TIL growth|1|||
37736256|NCT01479621|69216870|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
37736257|NCT01479621|69216864|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
37852567|NCT01036594|69536355|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
37852568|NCT01036594|69536354|FG000|Week 12 Evaluation|Adverse Event|5|||
37852569|NCT01036594|69536355|FG001|Week 12 Evaluation|Adverse Event|0|||
37852570|NCT01036594|69536354|FG000|Week 12 Evaluation|Physician Decision|1|||
37852571|NCT01036594|69536355|FG001|Week 12 Evaluation|Physician Decision|0|||
37852572|NCT01036594|69536354|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
37852573|NCT01036594|69536355|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
37852574|NCT01036594|69536354|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
37921186|NCT03215810|69607780|FG000|Overall Study|Decline in performance status|1|||
37736258|NCT01479621|69216865|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
37736259|NCT01479621|69216866|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
37852575|NCT01036594|69536355|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
37921187|NCT03215810|69607780|FG000|Overall Study|Withdrawal by Subject|1|||
37736260|NCT01479621|69216867|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
37736261|NCT01479621|69216868|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
37736262|NCT01479621|69216869|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
37736263|NCT01479621|69216870|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
37736264|NCT01479621|69216864|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
37736265|NCT01479621|69216865|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
37736266|NCT01479621|69216866|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
37736267|NCT01479621|69216867|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
37736268|NCT01479621|69216868|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
37736269|NCT01479621|69216869|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
37736270|NCT01479621|69216870|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
37736271|NCT01479621|69216864|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
37736272|NCT01479621|69216865|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
37736273|NCT01479621|69216866|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
37736274|NCT01479621|69216867|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
37736275|NCT01479621|69216868|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
37736276|NCT01479621|69216869|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
37736277|NCT01479621|69216870|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
37736278|NCT01479621|69216864|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
37736279|NCT01479621|69216865|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
37736280|NCT01479621|69216866|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
37736281|NCT01479621|69216867|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
37736282|NCT01479621|69216868|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
37736283|NCT01479621|69216869|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
37736284|NCT01479621|69216870|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
37736285|NCT01479621|69216864|FG000|Treatment Period|Adverse Event|0|||
37736286|NCT01479621|69216865|FG001|Treatment Period|Adverse Event|0|||
37736287|NCT01479621|69216866|FG002|Treatment Period|Adverse Event|0|||
37736288|NCT01479621|69216867|FG003|Treatment Period|Adverse Event|0|||
37736289|NCT01479621|69216868|FG004|Treatment Period|Adverse Event|1|||
37736290|NCT01479621|69216869|FG005|Treatment Period|Adverse Event|2|||
37736291|NCT01479621|69216870|FG006|Treatment Period|Adverse Event|2|||
37736292|NCT01479621|69216864|FG000|Treatment Period|Withdrawal by Subject|0|||
37736293|NCT01479621|69216865|FG001|Treatment Period|Withdrawal by Subject|4|||
37736294|NCT01479621|69216866|FG002|Treatment Period|Withdrawal by Subject|2|||
37736295|NCT01479621|69216867|FG003|Treatment Period|Withdrawal by Subject|2|||
37736296|NCT01479621|69216868|FG004|Treatment Period|Withdrawal by Subject|5|||
37736297|NCT01479621|69216869|FG005|Treatment Period|Withdrawal by Subject|5|||
37736298|NCT01479621|69216870|FG006|Treatment Period|Withdrawal by Subject|1|||
37736299|NCT01479621|69216864|FG000|Treatment Period|Physician Decision|0|||
37736300|NCT01479621|69216865|FG001|Treatment Period|Physician Decision|0|||
37736301|NCT01479621|69216866|FG002|Treatment Period|Physician Decision|0|||
37736302|NCT01479621|69216867|FG003|Treatment Period|Physician Decision|0|||
37736303|NCT01479621|69216868|FG004|Treatment Period|Physician Decision|1|||
37852576|NCT01036594|69536354|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
38031405|NCT03352557|69717114|FG002|PC Period: Day 1 to Week 78|Other|0|||
38031406|NCT03352557|69717115|FG003|PC Period: Day 1 to Week 78|Other|3|||
37736304|NCT01479621|69216869|FG005|Treatment Period|Physician Decision|1|||
37736305|NCT01479621|69216870|FG006|Treatment Period|Physician Decision|0|||
37736306|NCT01479621|69216864|FG000|Treatment Period|Non-compliance to study drug|0|||
37852577|NCT01036594|69536355|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
38031407|NCT03352557|69717116|FG004|PC Period: Day 1 to Week 78|Other|0|||
38031408|NCT03352557|69717117|FG005|PC Period: Day 1 to Week 78|Other|0|||
37736307|NCT01479621|69216865|FG001|Treatment Period|Non-compliance to study drug|1|||
37736308|NCT01479621|69216866|FG002|Treatment Period|Non-compliance to study drug|0|||
37736309|NCT01479621|69216867|FG003|Treatment Period|Non-compliance to study drug|0|||
37736310|NCT01479621|69216868|FG004|Treatment Period|Non-compliance to study drug|0|||
37736311|NCT01479621|69216869|FG005|Treatment Period|Non-compliance to study drug|0|||
37736312|NCT01479621|69216870|FG006|Treatment Period|Non-compliance to study drug|1|||
37736313|NCT01479621|69216864|FG000|Treatment Period|Protocol Violation|0|||
37736314|NCT01479621|69216865|FG001|Treatment Period|Protocol Violation|9|||
37736315|NCT01479621|69216866|FG002|Treatment Period|Protocol Violation|6|||
37736316|NCT01479621|69216867|FG003|Treatment Period|Protocol Violation|5|||
37736317|NCT01479621|69216868|FG004|Treatment Period|Protocol Violation|2|||
37736318|NCT01479621|69216869|FG005|Treatment Period|Protocol Violation|10|||
37736319|NCT01479621|69216870|FG006|Treatment Period|Protocol Violation|6|||
37736320|NCT01479621|69216864|FG000|Treatment Period|Pregnancy|0|||
37736321|NCT01479621|69216865|FG001|Treatment Period|Pregnancy|0|||
37736322|NCT01479621|69216866|FG002|Treatment Period|Pregnancy|2|||
37736323|NCT01479621|69216867|FG003|Treatment Period|Pregnancy|0|||
37736324|NCT01479621|69216868|FG004|Treatment Period|Pregnancy|0|||
37736325|NCT01479621|69216869|FG005|Treatment Period|Pregnancy|0|||
37736326|NCT01479621|69216870|FG006|Treatment Period|Pregnancy|0|||
37736327|NCT01479621|69216864|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
37736328|NCT01479621|69216865|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
37736329|NCT01479621|69216866|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
37736330|NCT01479621|69216867|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
37736331|NCT01479621|69216868|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
37852578|NCT01036594|69536354|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
37736332|NCT01479621|69216869|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
37736333|NCT01479621|69216870|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
37736334|NCT01479621|69216864|FG000|Treatment Period|Lost to Follow-up|0|||
37736335|NCT01479621|69216865|FG001|Treatment Period|Lost to Follow-up|0|||
37852579|NCT01036594|69536355|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
37852580|NCT01036594|69536354|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
37852581|NCT01036594|69536355|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
37852582|NCT01036438|69536363|FG000|Overall Study|Adverse Event|7|||
37852583|NCT01036438|69536364|FG001|Overall Study|Adverse Event|8|||
37852584|NCT01036438|69536363|FG000|Overall Study|Death|0|||
37852585|NCT01036438|69536364|FG001|Overall Study|Death|1|||
37852586|NCT01036438|69536363|FG000|Overall Study|No effect of study treatment|3|||
37852587|NCT01036438|69536364|FG001|Overall Study|No effect of study treatment|1|||
37852588|NCT01268046|69536374|FG000|Overall Study|Withdrawal by Subject|1|||
37852589|NCT01268046|69536375|FG001|Overall Study|Withdrawal by Subject|0|||
37852590|NCT01268046|69536376|FG002|Overall Study|Withdrawal by Subject|0|||
37852591|NCT01268046|69536377|FG003|Overall Study|Withdrawal by Subject|1|||
37921188|NCT02677922|69607803|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
37921189|NCT02677922|69607804|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
37921190|NCT02677922|69607805|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
37736336|NCT01479621|69216866|FG002|Treatment Period|Lost to Follow-up|1|||
37736337|NCT01479621|69216867|FG003|Treatment Period|Lost to Follow-up|0|||
37736338|NCT01479621|69216868|FG004|Treatment Period|Lost to Follow-up|2|||
37736339|NCT01479621|69216869|FG005|Treatment Period|Lost to Follow-up|2|||
37736340|NCT01479621|69216870|FG006|Treatment Period|Lost to Follow-up|1|||
37736341|NCT01479621|69216864|FG000|Treatment Period|Met stopping criteria|0|||
37736342|NCT01479621|69216865|FG001|Treatment Period|Met stopping criteria|8|||
37736343|NCT01479621|69216866|FG002|Treatment Period|Met stopping criteria|7|||
37736344|NCT01479621|69216867|FG003|Treatment Period|Met stopping criteria|4|||
37736345|NCT01479621|69216868|FG004|Treatment Period|Met stopping criteria|9|||
37736346|NCT01479621|69216869|FG005|Treatment Period|Met stopping criteria|20|||
37736347|NCT01479621|69216870|FG006|Treatment Period|Met stopping criteria|6|||
37852592|NCT01268046|69536374|FG000|Overall Study|Lost to Follow-up|0|||
37921191|NCT02677922|69607806|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
37921192|NCT02677922|69607807|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
37921193|NCT02677922|69607808|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
37921194|NCT02677922|69607803|FG000|Treatment Period|Adverse Event|0|||
37921195|NCT02677922|69607804|FG001|Treatment Period|Adverse Event|0|||
37921196|NCT02677922|69607805|FG002|Treatment Period|Adverse Event|1|||
37921197|NCT02677922|69607806|FG003|Treatment Period|Adverse Event|3|||
37852593|NCT01268046|69536375|FG001|Overall Study|Lost to Follow-up|0|||
37852594|NCT01268046|69536376|FG002|Overall Study|Lost to Follow-up|1|||
37852595|NCT01268046|69536377|FG003|Overall Study|Lost to Follow-up|0|||
37852596|NCT01267266|69536387|FG000|Enrollment Phase|Withdrawal by Subject|2|||
37852597|NCT01267266|69536388|FG001|Enrollment Phase|Withdrawal by Subject|0|||
37852598|NCT01267266|69536387|FG000|Lead-in Phase|Lack of Efficacy|20|||
37852599|NCT01267266|69536388|FG001|Lead-in Phase|Lack of Efficacy|0|||
37852600|NCT01267266|69536387|FG000|Lead-in Phase|Adverse Event|2|||
37852601|NCT01267266|69536388|FG001|Lead-in Phase|Adverse Event|0|||
37852602|NCT01267266|69536387|FG000|Lead-in Phase|Withdrawal by Subject|1|||
37852603|NCT01267266|69536388|FG001|Lead-in Phase|Withdrawal by Subject|0|||
37852604|NCT01034176|69536399|FG000|Overall Study|Physician Decision|2|||
37852605|NCT01034176|69536400|FG001|Overall Study|Physician Decision|0|||
37852606|NCT01034176|69536399|FG000|Overall Study|Withdrawal by Subject|0|||
37852607|NCT01034176|69536400|FG001|Overall Study|Withdrawal by Subject|1|||
37852608|NCT01034176|69536399|FG000|Overall Study|Lost to Follow-up|0|||
37852609|NCT01034176|69536400|FG001|Overall Study|Lost to Follow-up|1|||
37852610|NCT01033942|69536409|FG000|Overall Study|Withdrawal by Subject|1|||
37852611|NCT01033942|69536410|FG001|Overall Study|Withdrawal by Subject|1|||
37852612|NCT01033942|69536411|FG002|Overall Study|Withdrawal by Subject|1|||
37852613|NCT01033942|69536409|FG000|Overall Study|Lost to Follow-up|1|||
37852614|NCT01033942|69536410|FG001|Overall Study|Lost to Follow-up|0|||
37852615|NCT01033942|69536411|FG002|Overall Study|Lost to Follow-up|0|||
37852616|NCT01033942|69536409|FG000|Overall Study|Enrolled in Extension Study|0|||
37852617|NCT01033942|69536410|FG001|Overall Study|Enrolled in Extension Study|3|||
37852618|NCT01033942|69536411|FG002|Overall Study|Enrolled in Extension Study|0|||
37852619|NCT01062256|69536424|FG000|Overall Study|Adverse Event|1|||
37852620|NCT01062256|69536425|FG001|Overall Study|Adverse Event|0|||
37852621|NCT01062256|69536426|FG002|Overall Study|Adverse Event|0|||
37852622|NCT01062256|69536424|FG000|Overall Study|Withdrawal by Subject|1|||
37852623|NCT01062256|69536425|FG001|Overall Study|Withdrawal by Subject|1|||
37852624|NCT01062256|69536426|FG002|Overall Study|Withdrawal by Subject|1|||
37736348|NCT01479465|69216918|FG000|Overall Study|Disease Progression|9|||
37736349|NCT01479465|69216919|FG001|Overall Study|Disease Progression|61|||
37736350|NCT01479465|69216920|FG002|Overall Study|Disease Progression|65|||
37736351|NCT01479465|69216921|FG003|Overall Study|Disease Progression|70|||
37736352|NCT01479465|69216918|FG000|Overall Study|Study Discontinued by Sponsor|0|||
37736353|NCT01479465|69216919|FG001|Overall Study|Study Discontinued by Sponsor|7|||
37736354|NCT01479465|69216920|FG002|Overall Study|Study Discontinued by Sponsor|5|||
37736355|NCT01479465|69216921|FG003|Overall Study|Study Discontinued by Sponsor|3|||
37736356|NCT01479465|69216918|FG000|Overall Study|Adverse Event|0|||
37736357|NCT01479465|69216919|FG001|Overall Study|Adverse Event|3|||
37736358|NCT01479465|69216920|FG002|Overall Study|Adverse Event|6|||
37736359|NCT01479465|69216921|FG003|Overall Study|Adverse Event|4|||
37736360|NCT01479465|69216918|FG000|Overall Study|Investigator Discretion|1|||
37736361|NCT01479465|69216919|FG001|Overall Study|Investigator Discretion|4|||
37736362|NCT01479465|69216920|FG002|Overall Study|Investigator Discretion|2|||
37736363|NCT01479465|69216921|FG003|Overall Study|Investigator Discretion|4|||
37736364|NCT01479465|69216918|FG000|Overall Study|Subject Request|1|||
37736365|NCT01479465|69216919|FG001|Overall Study|Subject Request|3|||
37736366|NCT01479465|69216920|FG002|Overall Study|Subject Request|4|||
37736367|NCT01479465|69216921|FG003|Overall Study|Subject Request|2|||
37736368|NCT01479465|69216918|FG000|Overall Study|Subject Withdrew Consent|0|||
37736369|NCT01479465|69216919|FG001|Overall Study|Subject Withdrew Consent|5|||
37736370|NCT01479465|69216920|FG002|Overall Study|Subject Withdrew Consent|2|||
37736371|NCT01479465|69216921|FG003|Overall Study|Subject Withdrew Consent|1|||
37736372|NCT01479465|69216918|FG000|Overall Study|Protocol Violation|0|||
37736373|NCT01479465|69216919|FG001|Overall Study|Protocol Violation|1|||
37736374|NCT01479465|69216920|FG002|Overall Study|Protocol Violation|1|||
37736375|NCT01479465|69216921|FG003|Overall Study|Protocol Violation|0|||
37736376|NCT01479465|69216918|FG000|Overall Study|Death|0|||
37736377|NCT01479465|69216919|FG001|Overall Study|Death|0|||
37736378|NCT01479465|69216920|FG002|Overall Study|Death|0|||
37736379|NCT01479465|69216921|FG003|Overall Study|Death|1|||
37736380|NCT01479465|69216918|FG000|Overall Study|Lost to Follow-up|0|||
37736381|NCT01479465|69216919|FG001|Overall Study|Lost to Follow-up|0|||
37736382|NCT01479465|69216920|FG002|Overall Study|Lost to Follow-up|1|||
37736383|NCT01479465|69216921|FG003|Overall Study|Lost to Follow-up|0|||
37736384|NCT01503021|69216975|FG000|Overall Study|Adverse Event|7|||
37736385|NCT01503021|69216976|FG001|Overall Study|Adverse Event|6|||
37736386|NCT01503021|69216975|FG000|Overall Study|Death|0|||
37736387|NCT01503021|69216976|FG001|Overall Study|Death|2|||
37736388|NCT01503021|69216975|FG000|Overall Study|Lost to Follow-up|2|||
37736389|NCT01503021|69216976|FG001|Overall Study|Lost to Follow-up|0|||
37736390|NCT01503021|69216975|FG000|Overall Study|Physician Decision|3|||
37736391|NCT01503021|69216976|FG001|Overall Study|Physician Decision|0|||
37736392|NCT01503021|69216975|FG000|Overall Study|Protocol Violation|1|||
37736393|NCT01503021|69216976|FG001|Overall Study|Protocol Violation|3|||
37736394|NCT01503021|69216975|FG000|Overall Study|Withdrawal by Subject|9|||
37736395|NCT01503021|69216976|FG001|Overall Study|Withdrawal by Subject|8|||
37736396|NCT01503021|69216975|FG000|Overall Study|Moved, received transplant, etc.|5|||
37736397|NCT01503021|69216976|FG001|Overall Study|Moved, received transplant, etc.|7|||
37736398|NCT01531725|69216987|FG000|Overall Study|Protocol Violation|5|||
37736399|NCT01478373|69216991|FG000|Treatment Phase|Protocol Violation|1|||
37852625|NCT01062256|69536424|FG000|Overall Study|Ineligible|1|||
37852626|NCT01062256|69536425|FG001|Overall Study|Ineligible|4|||
37852627|NCT01062256|69536426|FG002|Overall Study|Ineligible|3|||
37852628|NCT01062256|69536424|FG000|Overall Study|Administrative|0|||
37852629|NCT01062256|69536425|FG001|Overall Study|Administrative|2|||
37852630|NCT01062256|69536426|FG002|Overall Study|Administrative|0|||
37852631|NCT01029886|69536436|FG000|Overall Study|Adverse Event|12|||
37852632|NCT01029886|69536437|FG001|Overall Study|Adverse Event|25|||
37852633|NCT01029886|69536436|FG000|Overall Study|Lost to Follow-up|1|||
37736400|NCT01478373|69216991|FG000|Survival Phase|Adverse Event|8|||
37736401|NCT01478373|69216991|FG000|Survival Phase|Protocol Violation|1|||
37736402|NCT01478373|69216991|FG000|Survival Phase|crossover to another study|2|||
37736403|NCT01478373|69216991|FG000|Survival Phase|Progressive Disease|27|||
37736404|NCT01502709|69216997|FG000|Overall Study|Lost to Follow-up|4|||
37852634|NCT01029886|69536437|FG001|Overall Study|Lost to Follow-up|0|||
37736405|NCT01502709|69216998|FG001|Overall Study|Lost to Follow-up|0|||
37736406|NCT01477749|69217005|FG000|Overall Study|Physician Decision|4|||
37736407|NCT01502631|69217035|FG000|Overall Study|Adverse Event|5|||
37852635|NCT01029886|69536436|FG000|Overall Study|Physician Decision|2|||
37852636|NCT01029886|69536437|FG001|Overall Study|Physician Decision|6|||
37852637|NCT01029886|69536436|FG000|Overall Study|Protocol Violation|17|||
37736408|NCT01502631|69217036|FG001|Overall Study|Adverse Event|8|||
37736409|NCT01502631|69217035|FG000|Overall Study|Lost to Follow-up|2|||
37736410|NCT01502631|69217036|FG001|Overall Study|Lost to Follow-up|2|||
37736411|NCT01502631|69217035|FG000|Overall Study|Participant withdrew consent|2|||
37736412|NCT01502631|69217036|FG001|Overall Study|Participant withdrew consent|4|||
37852638|NCT01029886|69536437|FG001|Overall Study|Protocol Violation|5|||
37852639|NCT01029886|69536436|FG000|Overall Study|Withdrawal by Subject|8|||
37852640|NCT01029886|69536437|FG001|Overall Study|Withdrawal by Subject|18|||
37852641|NCT01029886|69536436|FG000|Overall Study|Entry Criteria Not Met|13|||
37852642|NCT01029886|69536437|FG001|Overall Study|Entry Criteria Not Met|5|||
37852643|NCT01029886|69536436|FG000|Overall Study|Sponsor Decision|1|||
37852644|NCT01029886|69536437|FG001|Overall Study|Sponsor Decision|0|||
37852645|NCT01029886|69536436|FG000|Overall Study|Loss Glucose Control|7|||
37852646|NCT01029886|69536437|FG001|Overall Study|Loss Glucose Control|1|||
37852647|NCT01244763|69536453|FG000|Overall Study|Adverse Event|1|||
37852648|NCT01244763|69536454|FG001|Overall Study|Adverse Event|0|||
37852649|NCT01244763|69536455|FG002|Overall Study|Adverse Event|0|||
37852650|NCT01244763|69536456|FG003|Overall Study|Adverse Event|0|||
38031409|NCT03352557|69717118|FG006|PC Period: Day 1 to Week 78|Other|0|||
37852651|NCT01244763|69536457|FG004|Overall Study|Adverse Event|0|||
37736413|NCT01502631|69217035|FG000|Overall Study|Participant non-compliant|1|||
37736414|NCT01502631|69217036|FG001|Overall Study|Participant non-compliant|0|||
37736415|NCT01502631|69217035|FG000|Overall Study|Investigator's decision|0|||
37736416|NCT01502631|69217036|FG001|Overall Study|Investigator's decision|1|||
37736417|NCT01502631|69217035|FG000|Overall Study|Other|10|||
37736418|NCT01502631|69217036|FG001|Overall Study|Other|5|||
37736419|NCT01475721|69217092|FG000|Overall Study|Death|3|||
37921198|NCT02677922|69607807|FG004|Treatment Period|Adverse Event|5|||
37921199|NCT02677922|69607808|FG005|Treatment Period|Adverse Event|2|||
37736420|NCT01475721|69217093|FG001|Overall Study|Death|6|||
37736421|NCT01475721|69217092|FG000|Overall Study|Withdrawal by Subject|8|||
37736422|NCT01475721|69217093|FG001|Overall Study|Withdrawal by Subject|8|||
37736423|NCT01530087|69217117|FG000|Overall Study|Physician Decision|2|||
37736424|NCT01475487|69217135|FG000|Overall Study|had to leave early for personal reasons|2|||
37736425|NCT01475487|69217136|FG001|Overall Study|had to leave early for personal reasons|1|||
37736426|NCT01475331|69217144|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
37736427|NCT01475331|69217145|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
37736428|NCT01475331|69217144|FG000|Overall Study|excessive main duct communication|1|||
37736429|NCT01475331|69217145|FG001|Overall Study|excessive main duct communication|1|||
37736430|NCT01475331|69217144|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
37736431|NCT01475331|69217145|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
37736432|NCT01475331|69217144|FG000|Overall Study|Sign of malignancy during the procedure|2|||
37736433|NCT01475331|69217145|FG001|Overall Study|Sign of malignancy during the procedure|0|||
37736434|NCT01475331|69217144|FG000|Overall Study|cyst found to be prohibitively small|0|||
37736435|NCT01475331|69217145|FG001|Overall Study|cyst found to be prohibitively small|1|||
37736436|NCT01500213|69217153|FG000|Overall Study|Adverse Event|35|||
37736437|NCT01500213|69217154|FG001|Overall Study|Adverse Event|35|||
37736438|NCT01500213|69217153|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
37736439|NCT01500213|69217154|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
37736440|NCT01500213|69217153|FG000|Overall Study|Withdrawal by Subject|28|||
37736441|NCT01500213|69217154|FG001|Overall Study|Withdrawal by Subject|37|||
37736442|NCT01500213|69217153|FG000|Overall Study|Death|7|||
37736443|NCT01500213|69217154|FG001|Overall Study|Death|3|||
37736444|NCT01500213|69217153|FG000|Overall Study|Disease Progression|13|||
37736445|NCT01500213|69217154|FG001|Overall Study|Disease Progression|21|||
37852652|NCT01244763|69536458|FG005|Overall Study|Adverse Event|1|||
37852653|NCT01244763|69536453|FG000|Overall Study|Death|1|||
37736446|NCT01500213|69217153|FG000|Overall Study|Protocol Violation|19|||
37736447|NCT01500213|69217154|FG001|Overall Study|Protocol Violation|19|||
37736448|NCT01500213|69217153|FG000|Overall Study|Physician Decision|12|||
37736449|NCT01500213|69217154|FG001|Overall Study|Physician Decision|10|||
37736450|NCT01500213|69217153|FG000|Overall Study|Lack of Efficacy|9|||
37852654|NCT01244763|69536454|FG001|Overall Study|Death|0|||
37736451|NCT01500213|69217154|FG001|Overall Study|Lack of Efficacy|7|||
37736452|NCT01500213|69217153|FG000|Overall Study|Lost to Follow-up|3|||
37736453|NCT01500213|69217154|FG001|Overall Study|Lost to Follow-up|6|||
37736454|NCT01500213|69217153|FG000|Overall Study|Other Reasons|7|||
37852655|NCT01244763|69536455|FG002|Overall Study|Death|1|||
37852656|NCT01244763|69536456|FG003|Overall Study|Death|0|||
38031410|NCT03352557|69717119|FG007|PC Period: Day 1 to Week 78|Other|0|||
38031411|NCT03352557|69717120|FG008|PC Period: Day 1 to Week 78|Other|0|||
38031412|NCT03352557|69717121|FG009|PC Period: Day 1 to Week 78|Other|0|||
38031413|NCT03352557|69717112|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
38031414|NCT03352557|69717113|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
37736455|NCT01500213|69217154|FG001|Overall Study|Other Reasons|5|||
37736456|NCT01475253|69217184|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
37736457|NCT01475253|69217185|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
37736458|NCT01475253|69217186|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
37736459|NCT01475253|69217187|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
37736460|NCT01475253|69217184|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
37736461|NCT01475253|69217185|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
37736462|NCT01475253|69217186|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
37736463|NCT01475253|69217187|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
37736464|NCT01500135|69217245|FG000|Overall Study|Withdrawal of Consent|4|||
37736465|NCT01500135|69217246|FG001|Overall Study|Withdrawal of Consent|0|||
37736466|NCT01500135|69217245|FG000|Overall Study|Lost to Follow-up|6|||
37736467|NCT01500135|69217246|FG001|Overall Study|Lost to Follow-up|4|||
37736468|NCT01500135|69217245|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
37736469|NCT01500135|69217246|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
37736470|NCT01500135|69217245|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
37736471|NCT01500135|69217246|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
37736472|NCT01500135|69217245|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
37736473|NCT01500135|69217246|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
37736474|NCT01500135|69217245|FG000|Overall Study|Participant was a Safety Concern|1|||
37736475|NCT01500135|69217246|FG001|Overall Study|Participant was a Safety Concern|0|||
37736476|NCT01500135|69217245|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
37736477|NCT01500135|69217246|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
37736478|NCT01475097|69217258|FG000|Overall Study|Protocol Violation|1|||
37736479|NCT01475097|69217259|FG001|Overall Study|Protocol Violation|1|||
37736480|NCT01529385|69217267|FG000|Overall Study|Lost to Follow-up|2|||
37736481|NCT01529385|69217268|FG001|Overall Study|Lost to Follow-up|1|||
37921200|NCT02677922|69607803|FG000|Treatment Period|Progressive Disease|1|||
37921201|NCT02677922|69607804|FG001|Treatment Period|Progressive Disease|1|||
37736482|NCT01474551|69217274|FG000|Overall Study|Death|1|||
37736483|NCT01500057|69217309|FG000|Overall Study|Lost to Follow-up|6|||
37736484|NCT01500057|69217310|FG001|Overall Study|Lost to Follow-up|4|||
37736485|NCT01499667|69217328|FG000|Overall Study|administrative problems|4|||
37736486|NCT01499667|69217329|FG001|Overall Study|administrative problems|5|||
37736487|NCT01499667|69217330|FG002|Overall Study|administrative problems|5|||
37736488|NCT01499667|69217328|FG000|Overall Study|Protocol Violation|1|||
37736489|NCT01499667|69217329|FG001|Overall Study|Protocol Violation|3|||
37736490|NCT01499667|69217330|FG002|Overall Study|Protocol Violation|2|||
37736491|NCT01499667|69217328|FG000|Overall Study|Adverse Event|0|||
37736492|NCT01499667|69217329|FG001|Overall Study|Adverse Event|2|||
37736493|NCT01499667|69217330|FG002|Overall Study|Adverse Event|2|||
37736494|NCT01499667|69217328|FG000|Overall Study|Withdrawal by Subject|2|||
37736495|NCT01499667|69217329|FG001|Overall Study|Withdrawal by Subject|1|||
37736496|NCT01499667|69217330|FG002|Overall Study|Withdrawal by Subject|1|||
37736497|NCT01499667|69217328|FG000|Overall Study|Lack of Efficacy|2|||
37736498|NCT01499667|69217329|FG001|Overall Study|Lack of Efficacy|0|||
37736499|NCT01499667|69217330|FG002|Overall Study|Lack of Efficacy|0|||
37736500|NCT01499511|69217340|FG000|Overall Study|Death|1|||
37736501|NCT01499511|69217341|FG001|Overall Study|Death|0|||
37736502|NCT01474317|69217361|FG000|Overall Study|Adverse Event|1|||
37736503|NCT01474317|69217361|FG000|Overall Study|Subject ineligible for study|1|||
37736504|NCT01499355|69217457|FG000|Run-In Period|Study Termination|15|||
37736505|NCT01499355|69217458|FG001|Run-In Period|Study Termination|0|||
37736506|NCT01499355|69217459|FG002|Run-In Period|Study Termination|0|||
38031415|NCT03352557|69717114|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
38031416|NCT03352557|69717115|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
38031417|NCT03352557|69717116|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
38031418|NCT03352557|69717117|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
38031419|NCT03352557|69717118|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
38031420|NCT03352557|69717119|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
38031421|NCT03352557|69717120|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
38031422|NCT03352557|69717121|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
38031423|NCT03352557|69717112|FG000|LTE Period: Week 80 to Week 173|Death|0|||
38031424|NCT03352557|69717113|FG001|LTE Period: Week 80 to Week 173|Death|0|||
38031425|NCT03352557|69717114|FG002|LTE Period: Week 80 to Week 173|Death|0|||
38031426|NCT03352557|69717115|FG003|LTE Period: Week 80 to Week 173|Death|0|||
38031427|NCT03352557|69717116|FG004|LTE Period: Week 80 to Week 173|Death|0|||
38031428|NCT03352557|69717117|FG005|LTE Period: Week 80 to Week 173|Death|1|||
38031429|NCT03352557|69717118|FG006|LTE Period: Week 80 to Week 173|Death|0|||
38031430|NCT03352557|69717119|FG007|LTE Period: Week 80 to Week 173|Death|1|||
37736507|NCT01499355|69217460|FG003|Run-In Period|Study Termination|0|||
37736508|NCT01499355|69217457|FG000|Run-In Period|Other|3|||
37736509|NCT01499355|69217458|FG001|Run-In Period|Other|0|||
37736510|NCT01499355|69217459|FG002|Run-In Period|Other|0|||
37736511|NCT01499355|69217460|FG003|Run-In Period|Other|0|||
37736512|NCT01499355|69217457|FG000|Run-In Period|Death|2|||
37736513|NCT01499355|69217458|FG001|Run-In Period|Death|0|||
37736514|NCT01499355|69217459|FG002|Run-In Period|Death|0|||
37736515|NCT01499355|69217460|FG003|Run-In Period|Death|0|||
37736516|NCT01499355|69217457|FG000|Run-In Period|Investigator Decision|2|||
37736517|NCT01499355|69217458|FG001|Run-In Period|Investigator Decision|0|||
37736518|NCT01499355|69217459|FG002|Run-In Period|Investigator Decision|0|||
37736519|NCT01499355|69217460|FG003|Run-In Period|Investigator Decision|0|||
37736520|NCT01499355|69217457|FG000|Run-In Period|Consent Withdrawn|1|||
37736521|NCT01499355|69217458|FG001|Run-In Period|Consent Withdrawn|0|||
37736522|NCT01499355|69217459|FG002|Run-In Period|Consent Withdrawn|0|||
37852657|NCT01244763|69536457|FG004|Overall Study|Death|2|||
38031431|NCT03352557|69717120|FG008|LTE Period: Week 80 to Week 173|Death|1|||
37736523|NCT01499355|69217460|FG003|Run-In Period|Consent Withdrawn|0|||
37736524|NCT01499355|69217457|FG000|Run-In Period|Adverse Event|8|||
37736525|NCT01499355|69217458|FG001|Run-In Period|Adverse Event|0|||
37736526|NCT01499355|69217459|FG002|Run-In Period|Adverse Event|0|||
37736527|NCT01499355|69217460|FG003|Run-In Period|Adverse Event|0|||
37736528|NCT01499355|69217457|FG000|Double-Blind Period|Adverse Event|0|||
37736529|NCT01499355|69217458|FG001|Double-Blind Period|Adverse Event|2|||
37736530|NCT01499355|69217459|FG002|Double-Blind Period|Adverse Event|3|||
37736531|NCT01499355|69217460|FG003|Double-Blind Period|Adverse Event|2|||
37736532|NCT01499355|69217457|FG000|Double-Blind Period|Study Termination|0|||
37736533|NCT01499355|69217458|FG001|Double-Blind Period|Study Termination|18|||
37736534|NCT01499355|69217459|FG002|Double-Blind Period|Study Termination|16|||
37736535|NCT01499355|69217460|FG003|Double-Blind Period|Study Termination|14|||
37736536|NCT01499355|69217457|FG000|Double-Blind Period|Other|0|||
37736537|NCT01499355|69217458|FG001|Double-Blind Period|Other|1|||
37736538|NCT01499355|69217459|FG002|Double-Blind Period|Other|2|||
37736539|NCT01499355|69217460|FG003|Double-Blind Period|Other|2|||
37736540|NCT01499355|69217457|FG000|Double-Blind Period|Death|0|||
37736541|NCT01499355|69217458|FG001|Double-Blind Period|Death|1|||
37736542|NCT01499355|69217459|FG002|Double-Blind Period|Death|0|||
37736543|NCT01499355|69217460|FG003|Double-Blind Period|Death|0|||
37736544|NCT01499355|69217457|FG000|Double-Blind Period|Investigator Decision|0|||
37736545|NCT01499355|69217458|FG001|Double-Blind Period|Investigator Decision|0|||
37736546|NCT01499355|69217459|FG002|Double-Blind Period|Investigator Decision|3|||
37852658|NCT01244763|69536458|FG005|Overall Study|Death|0|||
37852659|NCT01244763|69536453|FG000|Overall Study|Physician Decision|0|||
37852660|NCT01244763|69536454|FG001|Overall Study|Physician Decision|0|||
37852661|NCT01244763|69536455|FG002|Overall Study|Physician Decision|1|||
37852662|NCT01244763|69536456|FG003|Overall Study|Physician Decision|0|||
37852663|NCT01244763|69536457|FG004|Overall Study|Physician Decision|0|||
37852664|NCT01244763|69536458|FG005|Overall Study|Physician Decision|0|||
37852665|NCT01244763|69536453|FG000|Overall Study|Withdrawal by Subject|1|||
37852666|NCT01244763|69536454|FG001|Overall Study|Withdrawal by Subject|2|||
37852667|NCT01244763|69536455|FG002|Overall Study|Withdrawal by Subject|0|||
37852668|NCT01244763|69536456|FG003|Overall Study|Withdrawal by Subject|1|||
37852669|NCT01244763|69536457|FG004|Overall Study|Withdrawal by Subject|1|||
37852670|NCT01244763|69536458|FG005|Overall Study|Withdrawal by Subject|2|||
37852671|NCT01244763|69536453|FG000|Overall Study|Lost to Follow-up|0|||
37852672|NCT01244763|69536454|FG001|Overall Study|Lost to Follow-up|1|||
37852673|NCT01244763|69536455|FG002|Overall Study|Lost to Follow-up|0|||
37852674|NCT01244763|69536456|FG003|Overall Study|Lost to Follow-up|0|||
37852675|NCT01244763|69536457|FG004|Overall Study|Lost to Follow-up|0|||
37852676|NCT01244763|69536458|FG005|Overall Study|Lost to Follow-up|0|||
37852677|NCT01244763|69536453|FG000|Overall Study|Enrolled into the Extension Study|0|||
37852678|NCT01244763|69536454|FG001|Overall Study|Enrolled into the Extension Study|0|||
37852679|NCT01244763|69536455|FG002|Overall Study|Enrolled into the Extension Study|0|||
37852680|NCT01244763|69536456|FG003|Overall Study|Enrolled into the Extension Study|0|||
37852681|NCT01244763|69536457|FG004|Overall Study|Enrolled into the Extension Study|0|||
37852682|NCT01244763|69536458|FG005|Overall Study|Enrolled into the Extension Study|1|||
37852683|NCT01244061|69536474|FG000|Overall Study|Death|1|||
37852684|NCT01244061|69536475|FG001|Overall Study|Death|0|||
37852685|NCT01244061|69536474|FG000|Overall Study|Did not meet entrance criteria|1|||
37852686|NCT01244061|69536475|FG001|Overall Study|Did not meet entrance criteria|0|||
37852687|NCT01244061|69536474|FG000|Overall Study|Lack of Efficacy|1|||
37852688|NCT01244061|69536475|FG001|Overall Study|Lack of Efficacy|3|||
37852689|NCT01244061|69536474|FG000|Overall Study|Lost to Follow-up|34|||
37852690|NCT01244061|69536475|FG001|Overall Study|Lost to Follow-up|30|||
37852691|NCT01244061|69536474|FG000|Overall Study|Withdrawal by Subject|29|||
37852692|NCT01244061|69536475|FG001|Overall Study|Withdrawal by Subject|46|||
37852693|NCT01244061|69536474|FG000|Overall Study|Other|8|||
37852694|NCT01244061|69536475|FG001|Overall Study|Other|19|||
37852695|NCT01244061|69536474|FG000|Overall Study|Protocol Violation|1|||
37852696|NCT01244061|69536475|FG001|Overall Study|Protocol Violation|1|||
37852697|NCT01244061|69536474|FG000|Overall Study|Adverse Event|5|||
37852698|NCT01244061|69536475|FG001|Overall Study|Adverse Event|2|||
37852699|NCT01244061|69536474|FG000|Overall Study|Randomized but not treated|2|||
37852700|NCT01244061|69536475|FG001|Overall Study|Randomized but not treated|2|||
37852701|NCT01243671|69536481|FG000|Overall Study|Adverse Event|3|||
37852702|NCT01243671|69536481|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
37852703|NCT01243671|69536481|FG000|Overall Study|Other|1|||
37852704|NCT01240785|69536487|FG000|Overall Study|Lost to Follow-up|1|||
37736547|NCT01499355|69217460|FG003|Double-Blind Period|Investigator Decision|3|||
37852705|NCT01240785|69536488|FG001|Overall Study|Lost to Follow-up|0|||
37736548|NCT01499355|69217457|FG000|Double-Blind Period|Consent Withdrawn|0|||
37736549|NCT01499355|69217458|FG001|Double-Blind Period|Consent Withdrawn|0|||
37736550|NCT01499355|69217459|FG002|Double-Blind Period|Consent Withdrawn|1|||
37852706|NCT01240785|69536487|FG000|Overall Study|Protocol Violation|0|||
37852707|NCT01240785|69536488|FG001|Overall Study|Protocol Violation|3|||
37852708|NCT01240551|69536496|FG000|Overall Study|Refused further treatment|3|||
37852709|NCT01240551|69536497|FG001|Overall Study|Refused further treatment|2|||
37852710|NCT01240551|69536496|FG000|Overall Study|Lost to Follow-up|1|||
37852711|NCT01240551|69536497|FG001|Overall Study|Lost to Follow-up|1|||
37852712|NCT01239381|69536503|FG000|Overall Study|Protocol Violation|1|||
37852713|NCT01239381|69536503|FG000|Overall Study|Withdrawal by Subject|1|||
37852714|NCT01266876|69536513|FG000|Overall Study|Adverse Event|0|||
37852715|NCT01266876|69536514|FG001|Overall Study|Adverse Event|0|||
37852716|NCT01266876|69536515|FG002|Overall Study|Adverse Event|0|||
38031432|NCT03352557|69717121|FG009|LTE Period: Week 80 to Week 173|Death|1|||
37736551|NCT01499355|69217460|FG003|Double-Blind Period|Consent Withdrawn|2|||
37736552|NCT01499355|69217457|FG000|Double-Blind Period|Lost to Follow-up|0|||
37736553|NCT01499355|69217458|FG001|Double-Blind Period|Lost to Follow-up|1|||
37921202|NCT02677922|69607805|FG002|Treatment Period|Progressive Disease|0|||
37736554|NCT01499355|69217459|FG002|Double-Blind Period|Lost to Follow-up|0|||
37736555|NCT01499355|69217460|FG003|Double-Blind Period|Lost to Follow-up|0|||
37736556|NCT01474239|69217481|FG000|Overall Study|Disease Progression|37|||
37736557|NCT01474239|69217482|FG001|Overall Study|Disease Progression|25|||
37736558|NCT01474239|69217481|FG000|Overall Study|Adverse Event|12|||
37921203|NCT02677922|69607806|FG003|Treatment Period|Progressive Disease|0|||
37736559|NCT01474239|69217482|FG001|Overall Study|Adverse Event|3|||
37736560|NCT01474239|69217481|FG000|Overall Study|Withdrawal by Subject|1|||
37921204|NCT02677922|69607807|FG004|Treatment Period|Progressive Disease|8|||
37921205|NCT02677922|69607808|FG005|Treatment Period|Progressive Disease|7|||
37921206|NCT02677922|69607803|FG000|Treatment Period|Lack of Efficacy|0|||
37921207|NCT02677922|69607804|FG001|Treatment Period|Lack of Efficacy|0|||
37736561|NCT01474239|69217482|FG001|Overall Study|Withdrawal by Subject|2|||
37736562|NCT01474239|69217481|FG000|Overall Study|Death|1|||
37736563|NCT01474239|69217482|FG001|Overall Study|Death|1|||
37736564|NCT01474239|69217481|FG000|Overall Study|Clinical Disease Progression|7|||
37921208|NCT02677922|69607805|FG002|Treatment Period|Lack of Efficacy|0|||
37736565|NCT01474239|69217482|FG001|Overall Study|Clinical Disease Progression|1|||
37736566|NCT01474239|69217481|FG000|Overall Study|Withdrawal for Economic Reason|1|||
37736567|NCT01474239|69217482|FG001|Overall Study|Withdrawal for Economic Reason|0|||
37736568|NCT01473381|69217492|FG000|Overall Study|Adverse Event|8|||
37736569|NCT01473381|69217493|FG001|Overall Study|Adverse Event|20|||
37736570|NCT01473381|69217494|FG002|Overall Study|Adverse Event|25|||
37736571|NCT01473381|69217495|FG003|Overall Study|Adverse Event|17|||
37736572|NCT01473381|69217492|FG000|Overall Study|Insufficient Therapeutic Response|10|||
37736573|NCT01473381|69217493|FG001|Overall Study|Insufficient Therapeutic Response|1|||
37736574|NCT01473381|69217494|FG002|Overall Study|Insufficient Therapeutic Response|2|||
37736575|NCT01473381|69217495|FG003|Overall Study|Insufficient Therapeutic Response|3|||
37736576|NCT01473381|69217492|FG000|Overall Study|Protocol Violation|17|||
37736577|NCT01473381|69217493|FG001|Overall Study|Protocol Violation|23|||
37736578|NCT01473381|69217494|FG002|Overall Study|Protocol Violation|19|||
37736579|NCT01473381|69217495|FG003|Overall Study|Protocol Violation|17|||
37736580|NCT01473381|69217492|FG000|Overall Study|Withdrawal of Consent|20|||
37736581|NCT01473381|69217493|FG001|Overall Study|Withdrawal of Consent|21|||
37736582|NCT01473381|69217494|FG002|Overall Study|Withdrawal of Consent|20|||
37736583|NCT01473381|69217495|FG003|Overall Study|Withdrawal of Consent|26|||
37736584|NCT01473381|69217492|FG000|Overall Study|Lost to Follow-up|25|||
37736585|NCT01473381|69217493|FG001|Overall Study|Lost to Follow-up|28|||
37736586|NCT01473381|69217494|FG002|Overall Study|Lost to Follow-up|35|||
37736587|NCT01473381|69217495|FG003|Overall Study|Lost to Follow-up|23|||
37736588|NCT01473381|69217492|FG000|Overall Study|Other Reasons|0|||
37736589|NCT01473381|69217493|FG001|Overall Study|Other Reasons|0|||
37736590|NCT01473381|69217494|FG002|Overall Study|Other Reasons|1|||
37736591|NCT01473381|69217495|FG003|Overall Study|Other Reasons|3|||
37736592|NCT01499277|69217537|FG000|Overall Study|Adverse Event|3|||
37736593|NCT01499277|69217538|FG001|Overall Study|Adverse Event|6|||
37736594|NCT01499277|69217537|FG000|Overall Study|Death|3|||
37736595|NCT01499277|69217538|FG001|Overall Study|Death|2|||
37736596|NCT01499277|69217537|FG000|Overall Study|Lost to Follow-up|15|||
37736597|NCT01499277|69217538|FG001|Overall Study|Lost to Follow-up|8|||
37736598|NCT01499277|69217537|FG000|Overall Study|Protocol Violation|2|||
37736599|NCT01499277|69217538|FG001|Overall Study|Protocol Violation|3|||
37736600|NCT01499277|69217537|FG000|Overall Study|Withdrawal by Subject|16|||
37736601|NCT01499277|69217538|FG001|Overall Study|Withdrawal by Subject|6|||
37736602|NCT01499277|69217537|FG000|Overall Study|Lack of therapeutic response and other|8|||
37736603|NCT01499277|69217538|FG001|Overall Study|Lack of therapeutic response and other|7|||
37736604|NCT01499199|69217563|FG000|Overall Study|Adverse Event|1|||
37736605|NCT01499199|69217563|FG000|Overall Study|Lack of Efficacy|1|||
38031433|NCT03352557|69717112|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
38031434|NCT03352557|69717113|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
38031435|NCT03352557|69717114|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
38031436|NCT03352557|69717115|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
37736606|NCT01499043|69217567|FG000|Overall Study|Progressive disease (radiographic)|2|||
37736607|NCT01499043|69217567|FG000|Overall Study|Progressive disease (clinical)|1|||
37736608|NCT01499043|69217567|FG000|Overall Study|Withdrawal by Subject|2|||
38031437|NCT03352557|69717116|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
38031438|NCT03352557|69717117|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
37736609|NCT01499043|69217567|FG000|Overall Study|Adverse Event|1|||
37736610|NCT01498887|69217641|FG000|Overall Study|Administrative problems|1|||
37736611|NCT01498887|69217642|FG001|Overall Study|Administrative problems|0|||
37852717|NCT01266876|69536516|FG003|Overall Study|Adverse Event|1|||
37852718|NCT01266876|69536517|FG004|Overall Study|Adverse Event|0|||
37852719|NCT01033240|69536532|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
37852720|NCT01033240|69536533|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
37852721|NCT01033240|69536534|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
37852722|NCT01033240|69536532|FG000|Overall Study|Death|2|||
37852723|NCT01033240|69536533|FG001|Overall Study|Death|0|||
37852724|NCT01033240|69536534|FG002|Overall Study|Death|0|||
37852725|NCT01033240|69536532|FG000|Overall Study|Withdrew Consent|2|||
37852726|NCT01033240|69536533|FG001|Overall Study|Withdrew Consent|9|||
37852727|NCT01033240|69536534|FG002|Overall Study|Withdrew Consent|2|||
37852728|NCT01033240|69536532|FG000|Overall Study|Disease Progression|35|||
37852729|NCT01033240|69536533|FG001|Overall Study|Disease Progression|32|||
37852730|NCT01033240|69536534|FG002|Overall Study|Disease Progression|41|||
38031439|NCT03352557|69717118|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
38031440|NCT03352557|69717119|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
38031441|NCT03352557|69717120|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
37852731|NCT01033240|69536532|FG000|Overall Study|Investigator Discretion|0|||
38031442|NCT03352557|69717121|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
37921209|NCT02677922|69607806|FG003|Treatment Period|Lack of Efficacy|1|||
37921210|NCT02677922|69607807|FG004|Treatment Period|Lack of Efficacy|1|||
38031443|NCT03352557|69717112|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
37921211|NCT02677922|69607808|FG005|Treatment Period|Lack of Efficacy|6|||
37921212|NCT02677922|69607803|FG000|Treatment Period|Withdrawal by Subject|0|||
37921213|NCT02677922|69607804|FG001|Treatment Period|Withdrawal by Subject|0|||
37852732|NCT01033240|69536533|FG001|Overall Study|Investigator Discretion|0|||
37852733|NCT01033240|69536534|FG002|Overall Study|Investigator Discretion|2|||
37852734|NCT01033240|69536532|FG000|Overall Study|Other|0|||
37852735|NCT01033240|69536533|FG001|Overall Study|Other|1|||
38031444|NCT03352557|69717113|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
37736612|NCT01498887|69217641|FG000|Overall Study|Lost to Follow-up|1|||
37736613|NCT01498887|69217642|FG001|Overall Study|Lost to Follow-up|1|||
37736614|NCT01498887|69217641|FG000|Overall Study|Withdrawal by Subject|1|||
37736615|NCT01498887|69217642|FG001|Overall Study|Withdrawal by Subject|0|||
37736616|NCT01498887|69217641|FG000|Overall Study|Protocol Violation|1|||
37736617|NCT01498887|69217642|FG001|Overall Study|Protocol Violation|3|||
37736618|NCT01498887|69217641|FG000|Overall Study|Lack of Efficacy|5|||
37736619|NCT01498887|69217642|FG001|Overall Study|Lack of Efficacy|3|||
37736620|NCT01498887|69217641|FG000|Overall Study|Abnormal result from test procedure|1|||
37736621|NCT01498887|69217642|FG001|Overall Study|Abnormal result from test procedure|1|||
37736622|NCT01498887|69217641|FG000|Overall Study|Abnormal laboratory value|2|||
37736623|NCT01498887|69217642|FG001|Overall Study|Abnormal laboratory value|2|||
37736624|NCT01498887|69217641|FG000|Overall Study|Adverse Event|4|||
37736625|NCT01498887|69217642|FG001|Overall Study|Adverse Event|1|||
37736626|NCT01498653|69217651|FG000|Overall Study|Adverse Event|2|||
37736627|NCT01498653|69217652|FG001|Overall Study|Adverse Event|2|||
37736628|NCT01498653|69217651|FG000|Overall Study|Lack of Efficacy|12|||
37736629|NCT01498653|69217652|FG001|Overall Study|Lack of Efficacy|26|||
37736630|NCT01498653|69217651|FG000|Overall Study|Protocol Violation|0|||
37736631|NCT01498653|69217652|FG001|Overall Study|Protocol Violation|4|||
38043588|NCT02657434|69731756|FG001|Overall Study|Physician Decision|1|||
37852736|NCT01033240|69536534|FG002|Overall Study|Other|2|||
37852737|NCT01266018|69536542|FG000|Overall Study|Physician Decision|1|||
37736632|NCT01498653|69217651|FG000|Overall Study|Lost to Follow-up|1|||
37736633|NCT01498653|69217652|FG001|Overall Study|Lost to Follow-up|0|||
37736634|NCT01498653|69217651|FG000|Overall Study|Physician Decision|2|||
37852738|NCT01266018|69536543|FG001|Overall Study|Physician Decision|0|||
37852739|NCT01266018|69536542|FG000|Overall Study|Progressive disease|0|||
37852740|NCT01266018|69536543|FG001|Overall Study|Progressive disease|1|||
37852741|NCT01032382|69536551|FG000|Overall Study|Disease dissemination|1|||
37852742|NCT01032382|69536552|FG001|Overall Study|Disease dissemination|1|||
37852743|NCT01032382|69536551|FG000|Overall Study|Treatment failure|3|||
37852744|NCT01032382|69536552|FG001|Overall Study|Treatment failure|1|||
37852745|NCT01032382|69536551|FG000|Overall Study|Index lesion relapse|1|||
37852746|NCT01032382|69536552|FG001|Overall Study|Index lesion relapse|3|||
37852747|NCT01029652|69536560|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
37852748|NCT01029652|69536561|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
37852749|NCT01029652|69536560|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
37852750|NCT01029652|69536561|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
37852751|NCT01029652|69536560|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
37921214|NCT02677922|69607805|FG002|Treatment Period|Withdrawal by Subject|1|||
37921215|NCT02677922|69607806|FG003|Treatment Period|Withdrawal by Subject|3|||
37852752|NCT01029652|69536561|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
37852753|NCT01029652|69536560|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
37921216|NCT02677922|69607807|FG004|Treatment Period|Withdrawal by Subject|5|||
37736635|NCT01498653|69217652|FG001|Overall Study|Physician Decision|0|||
37736636|NCT01498653|69217651|FG000|Overall Study|Withdrawal by Subject|2|||
37736637|NCT01498653|69217652|FG001|Overall Study|Withdrawal by Subject|3|||
37736638|NCT01498575|69217660|FG000|Overall Sample|Withdrawal by Subject|60|||
37736639|NCT01498575|69217661|FG001|Overall Sample|Withdrawal by Subject|14|||
37852754|NCT01029652|69536561|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
37852755|NCT01029652|69536560|FG000|Core Study (0-12 Weeks)|Death|0|||
37852756|NCT01029652|69536561|FG001|Core Study (0-12 Weeks)|Death|1|||
37852757|NCT01029652|69536560|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
37852758|NCT01029652|69536561|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
37852759|NCT01029652|69536560|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
37852760|NCT01029652|69536561|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
37852761|NCT01029652|69536560|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
37852762|NCT01029652|69536561|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
37736640|NCT01498575|69217660|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
37736641|NCT01498575|69217661|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
37736642|NCT01498575|69217660|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
37852763|NCT01029652|69536560|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
37736643|NCT01498575|69217661|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
38043589|NCT02656290|69731763|FG000|Overall Study|Lost to Follow-up|1|||
37852764|NCT01029652|69536561|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
37852765|NCT01029652|69536560|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
37852766|NCT01029652|69536561|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
38043590|NCT02656290|69731763|FG000|Overall Study|Reintervention|3|||
37736644|NCT01498185|69217672|FG000|Overall Study|Adverse Event|0|||
37921217|NCT02677922|69607808|FG005|Treatment Period|Withdrawal by Subject|5|||
38043591|NCT02603146|69731777|FG000|Overall Study|Lost to Follow-up|5|||
37736645|NCT01498185|69217673|FG001|Overall Study|Adverse Event|0|||
37736646|NCT01498185|69217674|FG002|Overall Study|Adverse Event|0|||
37736647|NCT01498185|69217675|FG003|Overall Study|Adverse Event|1|||
37736648|NCT01498185|69217676|FG004|Overall Study|Adverse Event|0|||
37736649|NCT01498185|69217672|FG000|Overall Study|Withdrawal by Subject|1|||
37736650|NCT01498185|69217673|FG001|Overall Study|Withdrawal by Subject|1|||
37736651|NCT01498185|69217674|FG002|Overall Study|Withdrawal by Subject|0|||
37736652|NCT01498185|69217675|FG003|Overall Study|Withdrawal by Subject|2|||
37852767|NCT01029652|69536560|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
37852768|NCT01029652|69536561|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
37736653|NCT01498185|69217676|FG004|Overall Study|Withdrawal by Subject|1|||
37852769|NCT01029652|69536560|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
37852770|NCT01029652|69536561|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
37852771|NCT01029340|69536590|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
37852772|NCT01029340|69536591|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
38043592|NCT02603146|69731778|FG001|Overall Study|Lost to Follow-up|6|||
37921218|NCT02677922|69607803|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
37921219|NCT02677922|69607804|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
37921220|NCT02677922|69607805|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
38031445|NCT03352557|69717114|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
37736654|NCT01498185|69217672|FG000|Overall Study|No longer met criteria, etc|0|||
37736655|NCT01498185|69217673|FG001|Overall Study|No longer met criteria, etc|0|||
37736656|NCT01498185|69217674|FG002|Overall Study|No longer met criteria, etc|0|||
37736657|NCT01498185|69217675|FG003|Overall Study|No longer met criteria, etc|0|||
37736658|NCT01498185|69217676|FG004|Overall Study|No longer met criteria, etc|2|||
37736659|NCT01528605|69217698|FG000|Overall Study|Lost to Follow-up|1|||
37736660|NCT01528605|69217699|FG001|Overall Study|Lost to Follow-up|0|||
37736661|NCT01528605|69217700|FG002|Overall Study|Lost to Follow-up|1|||
37736662|NCT01528605|69217701|FG003|Overall Study|Lost to Follow-up|1|||
37736663|NCT01528605|69217702|FG004|Overall Study|Lost to Follow-up|0|||
37736664|NCT01528605|69217703|FG005|Overall Study|Lost to Follow-up|0|||
37736665|NCT01528605|69217698|FG000|Overall Study|Death|1|||
37736666|NCT01528605|69217699|FG001|Overall Study|Death|0|||
37736667|NCT01528605|69217700|FG002|Overall Study|Death|0|||
37736668|NCT01528605|69217701|FG003|Overall Study|Death|0|||
37736669|NCT01528605|69217702|FG004|Overall Study|Death|0|||
37736670|NCT01528605|69217703|FG005|Overall Study|Death|0|||
37736671|NCT01528215|69217719|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
37736672|NCT01528215|69217720|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
37736673|NCT01528215|69217719|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
37736674|NCT01528215|69217720|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
37736675|NCT01528215|69217719|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
37736676|NCT01528215|69217720|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
37736677|NCT01528215|69217719|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
37736678|NCT01528215|69217720|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
37736679|NCT01527357|69217728|FG000|Overall Study|Death|8|||
37736680|NCT01527357|69217729|FG001|Overall Study|Death|2|||
37736681|NCT01527357|69217728|FG000|Overall Study|Lost to Follow-up|6|||
37736682|NCT01527357|69217729|FG001|Overall Study|Lost to Follow-up|4|||
37736683|NCT01527357|69217728|FG000|Overall Study|Withdrew Consent|1|||
37736684|NCT01527357|69217729|FG001|Overall Study|Withdrew Consent|1|||
37736685|NCT01527357|69217728|FG000|Overall Study|Non-compliance|0|||
37736686|NCT01527357|69217729|FG001|Overall Study|Non-compliance|1|||
37736687|NCT01527357|69217728|FG000|Overall Study|No Day 29 Visit|0|||
37736688|NCT01527357|69217729|FG001|Overall Study|No Day 29 Visit|1|||
37736689|NCT01527357|69217728|FG000|Overall Study|Did Not Receive Treatment|2|||
37736690|NCT01527357|69217729|FG001|Overall Study|Did Not Receive Treatment|0|||
37736691|NCT01526889|69217748|FG000|Treatment Period|Adverse Event|2|||
37736692|NCT01526889|69217749|FG001|Treatment Period|Adverse Event|0|||
37736693|NCT01526889|69217748|FG000|Treatment Extension Period|Administrative problems|1|||
37736694|NCT01526889|69217749|FG001|Treatment Extension Period|Administrative problems|0|||
37736695|NCT01472835|69217761|FG000|Overall Study|Lost to Follow-up|2|||
37736696|NCT01472835|69217762|FG001|Overall Study|Lost to Follow-up|0|||
37736697|NCT01526733|69217775|FG000|Phase 1|Protocol Violation|1|||
37736698|NCT01526733|69217776|FG001|Phase 1|Protocol Violation|0|||
37736699|NCT01526733|69217775|FG000|Phase 1|Withdrawal by Subject|1|||
37736700|NCT01526733|69217776|FG001|Phase 1|Withdrawal by Subject|1|||
37736701|NCT01472757|69217821|FG000|Overall Study|Withdrawal by Subject|1|||
37736702|NCT01472757|69217822|FG001|Overall Study|Withdrawal by Subject|2|||
37736703|NCT01472757|69217823|FG002|Overall Study|Withdrawal by Subject|2|||
37736704|NCT01472757|69217824|FG003|Overall Study|Withdrawal by Subject|0|||
37736705|NCT01472757|69217821|FG000|Overall Study|Asthma exacerbation|4|||
37736706|NCT01472757|69217822|FG001|Overall Study|Asthma exacerbation|1|||
37736707|NCT01472757|69217823|FG002|Overall Study|Asthma exacerbation|2|||
37736708|NCT01472757|69217824|FG003|Overall Study|Asthma exacerbation|1|||
37736709|NCT01472757|69217821|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
37736710|NCT01472757|69217822|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
37736711|NCT01472757|69217823|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
37736712|NCT01472757|69217824|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
37736713|NCT01472757|69217821|FG000|Overall Study|Protocol Violation|3|||
37736714|NCT01472757|69217822|FG001|Overall Study|Protocol Violation|2|||
37736715|NCT01472757|69217823|FG002|Overall Study|Protocol Violation|4|||
37736716|NCT01472757|69217824|FG003|Overall Study|Protocol Violation|4|||
37736717|NCT01472757|69217821|FG000|Overall Study|Other reasons|1|||
37736718|NCT01472757|69217822|FG001|Overall Study|Other reasons|0|||
37736719|NCT01472757|69217823|FG002|Overall Study|Other reasons|2|||
37736720|NCT01472757|69217824|FG003|Overall Study|Other reasons|2|||
37736721|NCT01472289|69217843|FG000|Overall Study|Death|2|||
37736722|NCT01525875|69217862|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
37736723|NCT01525875|69217863|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
37736724|NCT01525875|69217862|FG000|Open-label Period|Lost to Follow-up|0|||
37736725|NCT01525875|69217863|FG001|Open-label Period|Lost to Follow-up|2|||
37736726|NCT01525641|69217869|FG000|Overall Study|Case report form not collected|25|||
37736727|NCT01525641|69217869|FG000|Overall Study|No visit since the first visit|16|||
37736728|NCT01525641|69217869|FG000|Overall Study|Adverse Event|73|||
37736729|NCT01525641|69217869|FG000|Overall Study|Lack of Efficacy|24|||
37736730|NCT01525641|69217869|FG000|Overall Study|Improvement|5|||
37736731|NCT01525641|69217869|FG000|Overall Study|Lost to follow-up (relocation)|1|||
37736732|NCT01525641|69217869|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
37736733|NCT01525641|69217869|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
37736734|NCT01525641|69217869|FG000|Overall Study|Other than stated above|7|||
37736735|NCT01496469|69217884|FG000|Overall Study|Adverse Event|1|||
37736736|NCT01496469|69217885|FG001|Overall Study|Adverse Event|0|||
37736737|NCT01496469|69217884|FG000|Overall Study|Protocol Violation|2|||
37736738|NCT01496469|69217885|FG001|Overall Study|Protocol Violation|0|||
37736739|NCT01496469|69217884|FG000|Overall Study|Lost to Follow-up|1|||
37736740|NCT01496469|69217885|FG001|Overall Study|Lost to Follow-up|1|||
37736741|NCT01496469|69217884|FG000|Overall Study|Withdrawal by Subject|4|||
37736742|NCT01496469|69217885|FG001|Overall Study|Withdrawal by Subject|4|||
37736743|NCT01496469|69217884|FG000|Overall Study|BP exceeds protocol limits|1|||
37736744|NCT01496469|69217885|FG001|Overall Study|BP exceeds protocol limits|2|||
37736745|NCT01496469|69217884|FG000|Overall Study|Other|1|||
37736746|NCT01496469|69217885|FG001|Overall Study|Other|1|||
37736747|NCT01471353|69217900|FG000|Overall Study|remain on study|3|||
37736748|NCT01525407|69217906|FG000|Overall Study|Change in recipient treatment plan|2|||
37736749|NCT01525407|69217907|FG001|Overall Study|Change in recipient treatment plan|2|||
37736750|NCT01525407|69217906|FG000|Overall Study|Withdrawal by Subject|0|||
37736751|NCT01525407|69217907|FG001|Overall Study|Withdrawal by Subject|1|||
37736752|NCT01525407|69217906|FG000|Overall Study|Transplant was delayed|0|||
37736753|NCT01525407|69217907|FG001|Overall Study|Transplant was delayed|1|||
37736754|NCT01525407|69217906|FG000|Overall Study|Delay in Transplant|1|||
37852773|NCT01029340|69536592|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
37736755|NCT01525407|69217907|FG001|Overall Study|Delay in Transplant|0|||
37736756|NCT01471197|69217915|FG000|Overall Study|Disease Progression|4|||
37736757|NCT01471197|69217916|FG001|Overall Study|Disease Progression|2|||
37736758|NCT01471197|69217915|FG000|Overall Study|Death|1|||
37852774|NCT01029340|69536593|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
37852775|NCT01029340|69536594|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
37852776|NCT01029340|69536595|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
37736759|NCT01471197|69217916|FG001|Overall Study|Death|0|||
37736760|NCT01471197|69217915|FG000|Overall Study|Study Drug Toxicity|1|||
37736761|NCT01471197|69217916|FG001|Overall Study|Study Drug Toxicity|0|||
37736762|NCT01524783|69217950|FG000|Blinded Period|Adverse Event|64|||
37736763|NCT01524783|69217951|FG001|Blinded Period|Adverse Event|7|||
37736764|NCT01524783|69217952|FG002|Blinded Period|Adverse Event|0|||
37736765|NCT01524783|69217950|FG000|Blinded Period|Disease Progression|89|||
37736766|NCT01524783|69217951|FG001|Blinded Period|Disease Progression|75|||
37736767|NCT01524783|69217952|FG002|Blinded Period|Disease Progression|0|||
37736768|NCT01524783|69217950|FG000|Blinded Period|Withdrawal by Subject|19|||
37736769|NCT01524783|69217951|FG001|Blinded Period|Withdrawal by Subject|6|||
37736770|NCT01524783|69217952|FG002|Blinded Period|Withdrawal by Subject|0|||
37736771|NCT01524783|69217950|FG000|Blinded Period|Protocol deviation|2|||
37736772|NCT01524783|69217951|FG001|Blinded Period|Protocol deviation|1|||
37736773|NCT01524783|69217952|FG002|Blinded Period|Protocol deviation|0|||
37736774|NCT01524783|69217950|FG000|Blinded Period|Death|5|||
37736775|NCT01524783|69217951|FG001|Blinded Period|Death|2|||
37736776|NCT01524783|69217952|FG002|Blinded Period|Death|0|||
37736777|NCT01524783|69217950|FG000|Open-label Period|Disease progression|13|||
37736778|NCT01524783|69217951|FG001|Open-label Period|Disease progression|0|||
37736779|NCT01524783|69217952|FG002|Open-label Period|Disease progression|2|||
37736780|NCT01524783|69217950|FG000|Open-label Period|Administrative problems|5|||
37736781|NCT01524783|69217951|FG001|Open-label Period|Administrative problems|0|||
37736782|NCT01524783|69217952|FG002|Open-label Period|Administrative problems|2|||
37736783|NCT01524783|69217950|FG000|Open-label Period|Adverse Event|5|||
37736784|NCT01524783|69217951|FG001|Open-label Period|Adverse Event|0|||
37736785|NCT01524783|69217952|FG002|Open-label Period|Adverse Event|1|||
37736786|NCT01524783|69217950|FG000|Open-label Period|Withdrawal by Subject|2|||
37852777|NCT01029340|69536590|FG000|Part B Treatment Period|Protocol Violation|0|||
37852778|NCT01029340|69536591|FG001|Part B Treatment Period|Protocol Violation|0|||
37852779|NCT01029340|69536592|FG002|Part B Treatment Period|Protocol Violation|1|||
37852780|NCT01029340|69536593|FG003|Part B Treatment Period|Protocol Violation|0|||
37852781|NCT01029340|69536594|FG004|Part B Treatment Period|Protocol Violation|0|||
37852782|NCT01029340|69536595|FG005|Part B Treatment Period|Protocol Violation|0|||
37852783|NCT01029340|69536590|FG000|Extension Period|Adverse Event|0|||
37852784|NCT01029340|69536591|FG001|Extension Period|Adverse Event|0|||
37852785|NCT01029340|69536592|FG002|Extension Period|Adverse Event|0|||
37852786|NCT01029340|69536593|FG003|Extension Period|Adverse Event|0|||
37852787|NCT01029340|69536594|FG004|Extension Period|Adverse Event|0|||
37852788|NCT01029340|69536595|FG005|Extension Period|Adverse Event|1|||
37852789|NCT01029340|69536590|FG000|Extension Period|starting another study|0|||
37852790|NCT01029340|69536591|FG001|Extension Period|starting another study|0|||
37852791|NCT01029340|69536592|FG002|Extension Period|starting another study|0|||
37736787|NCT01524783|69217951|FG001|Open-label Period|Withdrawal by Subject|0|||
37736788|NCT01524783|69217952|FG002|Open-label Period|Withdrawal by Subject|1|||
37736789|NCT01524783|69217950|FG000|Open-label Period|Protocol deviation|1|||
37736790|NCT01524783|69217951|FG001|Open-label Period|Protocol deviation|0|||
37736791|NCT01524783|69217952|FG002|Open-label Period|Protocol deviation|0|||
37736792|NCT01494987|69217966|FG000|Overall Study|Adverse Event|6|||
37736793|NCT01494987|69217967|FG001|Overall Study|Adverse Event|5|||
37736794|NCT01494987|69217966|FG000|Overall Study|Hyperglycemia|6|||
37736795|NCT01494987|69217967|FG001|Overall Study|Hyperglycemia|4|||
37736796|NCT01494987|69217966|FG000|Overall Study|Investigator's Discretion|1|||
37736797|NCT01494987|69217967|FG001|Overall Study|Investigator's Discretion|2|||
37736798|NCT01494987|69217966|FG000|Overall Study|Lost to Follow-up|1|||
37736799|NCT01494987|69217967|FG001|Overall Study|Lost to Follow-up|1|||
37736800|NCT01494987|69217966|FG000|Overall Study|Protocol Violation|3|||
37852792|NCT01029340|69536593|FG003|Extension Period|starting another study|0|||
37852793|NCT01029340|69536594|FG004|Extension Period|starting another study|0|||
37736801|NCT01494987|69217967|FG001|Overall Study|Protocol Violation|3|||
37736802|NCT01494987|69217966|FG000|Overall Study|Subject Non-Compliance|9|||
37736803|NCT01494987|69217967|FG001|Overall Study|Subject Non-Compliance|10|||
37736804|NCT01494987|69217966|FG000|Overall Study|Subject Withdrew Consent|2|||
37852794|NCT01029340|69536595|FG005|Extension Period|starting another study|8|||
37736805|NCT01494987|69217967|FG001|Overall Study|Subject Withdrew Consent|3|||
37736806|NCT01524627|69217975|FG000|Overall Study|Physician Decision|0|||
37736807|NCT01524627|69217976|FG001|Overall Study|Physician Decision|1|||
37852795|NCT01029340|69536590|FG000|Extension Period|non-compliance|0|||
37852796|NCT01029340|69536591|FG001|Extension Period|non-compliance|0|||
37852797|NCT01029340|69536592|FG002|Extension Period|non-compliance|0|||
37852798|NCT01029340|69536593|FG003|Extension Period|non-compliance|0|||
37736808|NCT01524627|69217975|FG000|Overall Study|Lost to Follow-up|1|||
37736809|NCT01524627|69217976|FG001|Overall Study|Lost to Follow-up|1|||
37736810|NCT01469637|69217984|FG000|First Intervention|Unacceptable behavior|0|||
37736811|NCT01469637|69217985|FG001|First Intervention|Unacceptable behavior|1|||
37852799|NCT01029340|69536594|FG004|Extension Period|non-compliance|0|||
37852800|NCT01029340|69536595|FG005|Extension Period|non-compliance|1|||
37852801|NCT01029340|69536590|FG000|Extension Period|Withdrawal by Subject|0|||
38031446|NCT03352557|69717115|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
37921221|NCT02677922|69607806|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
37921222|NCT02677922|69607807|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
37852802|NCT01029340|69536591|FG001|Extension Period|Withdrawal by Subject|0|||
37852803|NCT01029340|69536592|FG002|Extension Period|Withdrawal by Subject|0|||
37852804|NCT01029340|69536593|FG003|Extension Period|Withdrawal by Subject|0|||
37852805|NCT01029340|69536594|FG004|Extension Period|Withdrawal by Subject|0|||
37852806|NCT01029340|69536595|FG005|Extension Period|Withdrawal by Subject|1|||
37852807|NCT01029340|69536590|FG000|Extension Period|Physician Decision|0|||
37736812|NCT01469637|69217984|FG000|Second Intervention|Incarcerated|1|||
37852808|NCT01029340|69536591|FG001|Extension Period|Physician Decision|0|||
37921223|NCT02677922|69607808|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
37921224|NCT02677922|69607803|FG000|Treatment Period|Disease Relapse|0|||
38031447|NCT03352557|69717116|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
38031448|NCT03352557|69717117|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
38031449|NCT03352557|69717118|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
38031450|NCT03352557|69717119|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
38031451|NCT03352557|69717120|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
38031452|NCT03352557|69717121|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
37921225|NCT02677922|69607804|FG001|Treatment Period|Disease Relapse|0|||
37921226|NCT02677922|69607805|FG002|Treatment Period|Disease Relapse|0|||
37921227|NCT02677922|69607806|FG003|Treatment Period|Disease Relapse|3|||
37921228|NCT02677922|69607807|FG004|Treatment Period|Disease Relapse|6|||
37852809|NCT01029340|69536592|FG002|Extension Period|Physician Decision|0|||
37852810|NCT01029340|69536593|FG003|Extension Period|Physician Decision|0|||
37852811|NCT01029340|69536594|FG004|Extension Period|Physician Decision|0|||
37852812|NCT01029340|69536595|FG005|Extension Period|Physician Decision|1|||
37852813|NCT01265550|69536612|FG000|Pre Randomization|Withdrawal by Subject|0|||
37852814|NCT01265550|69536613|FG001|Pre Randomization|Withdrawal by Subject|0|||
37736813|NCT01469637|69217985|FG001|Second Intervention|Incarcerated|0|||
37736814|NCT04842747|69218409|FG000|Overall Study|Withdrawal by Subject|6|||
37736815|NCT04842747|69218410|FG001|Overall Study|Withdrawal by Subject|2|||
37852815|NCT01265550|69536614|FG002|Pre Randomization|Withdrawal by Subject|0|||
37852816|NCT01265550|69536615|FG003|Pre Randomization|Withdrawal by Subject|70|||
37852817|NCT01265550|69536612|FG000|Pre Randomization|Technical Exclusions|0|||
37736816|NCT04842747|69218409|FG000|Overall Study|Lost to Follow-up|1|||
37736817|NCT04842747|69218410|FG001|Overall Study|Lost to Follow-up|2|||
37852818|NCT01265550|69536613|FG001|Pre Randomization|Technical Exclusions|0|||
37852819|NCT01265550|69536614|FG002|Pre Randomization|Technical Exclusions|0|||
37736818|NCT04842747|69218409|FG000|Overall Study|Physician Decision|1|||
37736819|NCT04842747|69218410|FG001|Overall Study|Physician Decision|0|||
37736820|NCT04842747|69218409|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
37736821|NCT04842747|69218410|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
37736822|NCT04810481|69218418|FG000|Overall Study|Disqualified data sets|10|||
37736823|NCT04810481|69218419|FG001|Overall Study|Disqualified data sets|28|||
37736824|NCT04755231|69218438|FG000|Overall Study|Lost to Follow-up|5|||
37736825|NCT04755231|69218438|FG000|Overall Study|Withdrawal by Subject|5|||
37736826|NCT04664400|69218451|FG000|Overall Study|Withdrawal by Subject|2|||
37736827|NCT04657770|69218456|FG000|Overall Study|Withdrawal by Subject|3|||
37736828|NCT04657770|69218456|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
37736829|NCT04496453|69218460|FG000|Overall Study|Lost to Follow-up|6|||
37736830|NCT04440163|69218472|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
37736831|NCT04440163|69218473|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
37736832|NCT04440163|69218474|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
37736833|NCT04440163|69218475|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
37736834|NCT04440163|69218476|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
37736835|NCT04440163|69218477|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
37736836|NCT04440163|69218478|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
37736837|NCT04440163|69218479|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
37736838|NCT04440163|69218472|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
37736839|NCT04440163|69218473|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
37736840|NCT04440163|69218474|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
37736841|NCT04440163|69218475|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
37736842|NCT04440163|69218476|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
37736843|NCT04440163|69218477|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
38031453|NCT03352557|69717112|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
38031454|NCT03352557|69717113|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
38031455|NCT03352557|69717114|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
38031456|NCT03352557|69717115|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
38031457|NCT03352557|69717116|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
37736844|NCT04440163|69218478|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
37736845|NCT04440163|69218479|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
37736846|NCT04440163|69218472|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
37852820|NCT01265550|69536615|FG003|Pre Randomization|Technical Exclusions|54|||
37852821|NCT01265550|69536612|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
37852822|NCT01265550|69536613|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
37852823|NCT01265550|69536614|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
37852824|NCT01265550|69536615|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
37852825|NCT01265550|69536612|FG000|Pre Randomization|Non-GERD organic disorders|0|||
37852826|NCT01265550|69536613|FG001|Pre Randomization|Non-GERD organic disorders|0|||
38031458|NCT03352557|69717117|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
38031459|NCT03352557|69717118|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
38031460|NCT03352557|69717119|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
37736847|NCT04440163|69218473|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
37736848|NCT04440163|69218474|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
37736849|NCT04440163|69218475|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
37736850|NCT04440163|69218476|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
37736851|NCT04440163|69218477|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
37736852|NCT04440163|69218478|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
37736853|NCT04440163|69218479|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
37736854|NCT04440163|69218472|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
37736855|NCT04440163|69218473|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
37736856|NCT04440163|69218474|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
37736857|NCT04440163|69218475|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
37736858|NCT04440163|69218476|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
37736859|NCT04440163|69218477|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
37736860|NCT04440163|69218478|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
37736861|NCT04440163|69218479|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
37736862|NCT04440163|69218472|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
37736863|NCT04440163|69218473|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
37736864|NCT04440163|69218474|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
37736865|NCT04440163|69218475|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
37736866|NCT04440163|69218476|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
37736867|NCT04440163|69218477|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
37736868|NCT04440163|69218478|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
37736869|NCT04440163|69218479|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
37736870|NCT04440163|69218472|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
37736871|NCT04440163|69218473|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
37852827|NCT01265550|69536614|FG002|Pre Randomization|Non-GERD organic disorders|0|||
37921229|NCT02677922|69607808|FG005|Treatment Period|Disease Relapse|1|||
37852828|NCT01265550|69536615|FG003|Pre Randomization|Non-GERD organic disorders|23|||
38031461|NCT03352557|69717120|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
37736872|NCT04440163|69218474|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
37736873|NCT04440163|69218475|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
37852829|NCT01265550|69536612|FG000|Pre Randomization|Functional heartburn|0|||
37852830|NCT01265550|69536613|FG001|Pre Randomization|Functional heartburn|0|||
37852831|NCT01265550|69536614|FG002|Pre Randomization|Functional heartburn|0|||
37852832|NCT01265550|69536615|FG003|Pre Randomization|Functional heartburn|99|||
37736874|NCT04440163|69218476|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
37736875|NCT04440163|69218477|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
37736876|NCT04440163|69218478|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
37852833|NCT01265394|69536629|FG000|Overall Study|Subjects withdrawn|37|||
37852834|NCT01029262|69536636|FG000|Overall Study|Adverse Event|9|||
37852835|NCT01029262|69536637|FG001|Overall Study|Adverse Event|52|||
37852836|NCT01029262|69536636|FG000|Overall Study|Lack of therapeutic effect|57|||
37852837|NCT01029262|69536637|FG001|Overall Study|Lack of therapeutic effect|76|||
37852838|NCT01029262|69536636|FG000|Overall Study|Withdrawal by Subject|10|||
37852839|NCT01029262|69536637|FG001|Overall Study|Withdrawal by Subject|17|||
37852840|NCT01029262|69536636|FG000|Overall Study|Protocol Violation|2|||
37852841|NCT01029262|69536637|FG001|Overall Study|Protocol Violation|3|||
37852842|NCT01029262|69536636|FG000|Overall Study|Miscellaneous|1|||
37852843|NCT01029262|69536637|FG001|Overall Study|Miscellaneous|9|||
37852844|NCT01029262|69536636|FG000|Overall Study|Death|0|||
37852845|NCT01029262|69536637|FG001|Overall Study|Death|3|||
37736877|NCT04440163|69218479|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
37852846|NCT01028560|69536650|FG000|Overall Study|Lack of Efficacy|3|||
37852847|NCT01028560|69536651|FG001|Overall Study|Lack of Efficacy|6|||
37852848|NCT01028560|69536650|FG000|Overall Study|Withdrawal by Subject|7|||
37852849|NCT01028560|69536651|FG001|Overall Study|Withdrawal by Subject|12|||
37852850|NCT01061710|69536658|FG000|Overall Study|Protocol Violation|14|||
37852851|NCT01028014|69536668|FG000|Overall Study|Lost to Follow-up|1|||
37852852|NCT01028014|69536669|FG001|Overall Study|Lost to Follow-up|2|||
38031462|NCT03352557|69717121|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
37736878|NCT04440163|69218472|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
37736879|NCT04440163|69218473|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
37736880|NCT04440163|69218474|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
37736881|NCT04440163|69218475|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
37852853|NCT01028014|69536670|FG002|Overall Study|Lost to Follow-up|0|||
37736882|NCT04440163|69218476|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
37736883|NCT04440163|69218477|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
37736884|NCT04440163|69218478|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
37852854|NCT01028014|69536671|FG003|Overall Study|Lost to Follow-up|1|||
37736885|NCT04440163|69218479|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
37736886|NCT04440163|69218472|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
37736887|NCT04440163|69218473|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
37736888|NCT04440163|69218474|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
37736889|NCT04440163|69218475|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
37736890|NCT04440163|69218476|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
37736891|NCT04440163|69218477|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
37736892|NCT04440163|69218478|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
37736893|NCT04440163|69218479|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
37736894|NCT04440163|69218472|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
37736895|NCT04440163|69218473|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
37736896|NCT04440163|69218474|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
37736897|NCT04440163|69218475|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
37736898|NCT04440163|69218476|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
37736899|NCT04440163|69218477|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
37736900|NCT04440163|69218478|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
37736901|NCT04440163|69218479|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
37736902|NCT04440163|69218472|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
37736903|NCT04440163|69218473|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
37736904|NCT04440163|69218474|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
37736905|NCT04440163|69218475|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
37736906|NCT04440163|69218476|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
37736907|NCT04440163|69218477|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
37736908|NCT04440163|69218478|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
37736909|NCT04440163|69218479|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
37736910|NCT04440163|69218472|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
37736911|NCT04440163|69218473|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
37736912|NCT04440163|69218474|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
37736913|NCT04440163|69218475|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
37736914|NCT04440163|69218476|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
37736915|NCT04440163|69218477|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
37736916|NCT04440163|69218478|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
37736917|NCT04440163|69218479|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
37736918|NCT04440163|69218472|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
37736919|NCT04440163|69218473|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
37736920|NCT04440163|69218474|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
37736921|NCT04440163|69218475|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
37736922|NCT04440163|69218476|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
37736923|NCT04440163|69218477|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
37736924|NCT04440163|69218478|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
37736925|NCT04440163|69218479|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
37736926|NCT04304508|69218510|FG000|Overall Study|Subject Decision|29|||
37736927|NCT04304508|69218511|FG001|Overall Study|Subject Decision|39|||
37736928|NCT04304508|69218512|FG002|Overall Study|Subject Decision|37|||
37736929|NCT04304508|69218513|FG003|Overall Study|Subject Decision|48|||
37736930|NCT04304508|69218510|FG000|Overall Study|Death|6|||
37736931|NCT04304508|69218511|FG001|Overall Study|Death|1|||
37736932|NCT04304508|69218512|FG002|Overall Study|Death|8|||
37736933|NCT04304508|69218513|FG003|Overall Study|Death|5|||
37736934|NCT04304508|69218510|FG000|Overall Study|Non-compliance With Study Drug|3|||
37736935|NCT04304508|69218511|FG001|Overall Study|Non-compliance With Study Drug|1|||
37736936|NCT04304508|69218512|FG002|Overall Study|Non-compliance With Study Drug|2|||
37736937|NCT04304508|69218513|FG003|Overall Study|Non-compliance With Study Drug|0|||
37736938|NCT04304508|69218510|FG000|Overall Study|Switching To Other Therapy|1|||
37736939|NCT04304508|69218511|FG001|Overall Study|Switching To Other Therapy|1|||
37736940|NCT04304508|69218512|FG002|Overall Study|Switching To Other Therapy|1|||
37736941|NCT04304508|69218513|FG003|Overall Study|Switching To Other Therapy|2|||
37736942|NCT04304508|69218510|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
37736943|NCT04304508|69218511|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
37736944|NCT04304508|69218512|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
38031463|NCT03352557|69717112|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
37852855|NCT01028014|69536672|FG004|Overall Study|Lost to Follow-up|1|||
37852856|NCT01028014|69536673|FG005|Overall Study|Lost to Follow-up|2|||
37852857|NCT01264770|69536693|FG000|Overall Study|Not reported|0|||
37852858|NCT01264770|69536694|FG001|Overall Study|Not reported|0|||
37852859|NCT01264770|69536695|FG002|Overall Study|Not reported|1|||
37736945|NCT04304508|69218513|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
37736946|NCT04304508|69218510|FG000|Overall Study|Withdrawal by Subject|7|||
37736947|NCT04304508|69218511|FG001|Overall Study|Withdrawal by Subject|5|||
37736948|NCT04304508|69218512|FG002|Overall Study|Withdrawal by Subject|11|||
37736949|NCT04304508|69218513|FG003|Overall Study|Withdrawal by Subject|6|||
38031464|NCT03352557|69717113|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
38043548|NCT03238248|69731701|FG000|Overall Study|No longer benefiting|1|||
37736950|NCT04304508|69218510|FG000|Overall Study|Logistical Difficulties|2|||
37736951|NCT04304508|69218511|FG001|Overall Study|Logistical Difficulties|2|||
38031465|NCT03352557|69717114|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
38031466|NCT03352557|69717115|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
38031467|NCT03352557|69717116|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
38031468|NCT03352557|69717117|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
38031469|NCT03352557|69717118|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
37852860|NCT01264770|69536696|FG003|Overall Study|Not reported|0|||
37852861|NCT01264770|69536697|FG004|Overall Study|Not reported|0|||
37852862|NCT01264770|69536698|FG005|Overall Study|Not reported|0|||
37852863|NCT01264770|69536693|FG000|Overall Study|e.g., change in circumstances|8|||
37852864|NCT01264770|69536694|FG001|Overall Study|e.g., change in circumstances|3|||
37921230|NCT02677922|69607803|FG000|Treatment Period|Allogeneic HSCT|1|||
37921231|NCT02677922|69607804|FG001|Treatment Period|Allogeneic HSCT|0|||
37921232|NCT02677922|69607805|FG002|Treatment Period|Allogeneic HSCT|0|||
37921233|NCT02677922|69607806|FG003|Treatment Period|Allogeneic HSCT|1|||
37921234|NCT02677922|69607807|FG004|Treatment Period|Allogeneic HSCT|4|||
37852865|NCT01264770|69536695|FG002|Overall Study|e.g., change in circumstances|3|||
37921235|NCT02677922|69607808|FG005|Treatment Period|Allogeneic HSCT|1|||
37921236|NCT02677922|69607803|FG000|Treatment Period|Other Reasons|0|||
37921237|NCT02677922|69607804|FG001|Treatment Period|Other Reasons|0|||
37921238|NCT02677922|69607805|FG002|Treatment Period|Other Reasons|0|||
37921239|NCT02677922|69607806|FG003|Treatment Period|Other Reasons|1|||
37921240|NCT02677922|69607807|FG004|Treatment Period|Other Reasons|3|||
37921241|NCT02677922|69607808|FG005|Treatment Period|Other Reasons|5|||
37921242|NCT02677922|69607803|FG000|Treatment Period|Death|0|||
37921243|NCT02677922|69607804|FG001|Treatment Period|Death|0|||
37921244|NCT02677922|69607805|FG002|Treatment Period|Death|0|||
37921245|NCT02677922|69607806|FG003|Treatment Period|Death|0|||
37921246|NCT02677922|69607807|FG004|Treatment Period|Death|12|||
37921247|NCT02677922|69607808|FG005|Treatment Period|Death|1|||
37921248|NCT02677922|69607803|FG000|Treatment Period|Non-compliance with Study Drug|0|||
37852866|NCT01264770|69536696|FG003|Overall Study|e.g., change in circumstances|3|||
37852867|NCT01264770|69536697|FG004|Overall Study|e.g., change in circumstances|4|||
38031470|NCT03352557|69717119|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
38031471|NCT03352557|69717120|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
38031472|NCT03352557|69717121|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
38031473|NCT03352557|69717112|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
38031474|NCT03352557|69717113|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
38031475|NCT03352557|69717114|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
38031476|NCT03352557|69717115|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
38031477|NCT03352557|69717116|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
38031478|NCT03352557|69717117|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
38031479|NCT03352557|69717118|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
38031480|NCT03352557|69717119|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
38031481|NCT03352557|69717120|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
38031482|NCT03352557|69717121|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
38031483|NCT03352557|69717112|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
38031484|NCT03352557|69717113|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
38031485|NCT03352557|69717114|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
38031486|NCT03352557|69717115|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
38031487|NCT03352557|69717116|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
38031488|NCT03352557|69717117|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
38031489|NCT03352557|69717118|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
38031490|NCT03352557|69717119|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
38031491|NCT03352557|69717120|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
38031492|NCT03352557|69717121|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
38031493|NCT03352557|69717112|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
38031494|NCT03352557|69717113|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
38031495|NCT03352557|69717114|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
38031496|NCT03352557|69717115|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
38031497|NCT03352557|69717116|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
38031498|NCT03352557|69717117|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
38031499|NCT03352557|69717118|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
38031500|NCT03352557|69717119|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
38031501|NCT03352557|69717120|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
38031502|NCT03352557|69717121|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
38031503|NCT03352557|69717112|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
38031504|NCT03352557|69717113|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
38031505|NCT03352557|69717114|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
38031506|NCT03352557|69717115|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
38031507|NCT03352557|69717116|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
38031508|NCT03352557|69717117|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
38031509|NCT03352557|69717118|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
38031510|NCT03352557|69717119|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
38031511|NCT03352557|69717120|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
38031512|NCT03352557|69717121|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
38031513|NCT03352557|69717112|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
38031514|NCT03352557|69717113|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
38031515|NCT03352557|69717114|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
38031516|NCT03352557|69717115|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
38031517|NCT03352557|69717116|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
38031518|NCT03352557|69717117|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
38031519|NCT03352557|69717118|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
38031520|NCT03352557|69717119|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
37852868|NCT01264770|69536698|FG005|Overall Study|e.g., change in circumstances|4|||
37852869|NCT01264770|69536693|FG000|Overall Study|Severe non-compliance to protocol|0|||
37852870|NCT01264770|69536694|FG001|Overall Study|Severe non-compliance to protocol|0|||
37852871|NCT01264770|69536695|FG002|Overall Study|Severe non-compliance to protocol|1|||
37852872|NCT01264770|69536696|FG003|Overall Study|Severe non-compliance to protocol|1|||
38031521|NCT03352557|69717120|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
38031522|NCT03352557|69717121|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
37852873|NCT01264770|69536697|FG004|Overall Study|Severe non-compliance to protocol|0|||
37852874|NCT01264770|69536698|FG005|Overall Study|Severe non-compliance to protocol|0|||
37852875|NCT01264770|69536693|FG000|Overall Study|Lack of therapeutic response|1|||
37852876|NCT01264770|69536694|FG001|Overall Study|Lack of therapeutic response|0|||
37852877|NCT01264770|69536695|FG002|Overall Study|Lack of therapeutic response|2|||
37852878|NCT01264770|69536696|FG003|Overall Study|Lack of therapeutic response|1|||
37852879|NCT01264770|69536697|FG004|Overall Study|Lack of therapeutic response|1|||
37852880|NCT01264770|69536698|FG005|Overall Study|Lack of therapeutic response|0|||
37852881|NCT01264770|69536693|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
37736952|NCT04304508|69218512|FG002|Overall Study|Logistical Difficulties|3|||
37736953|NCT04304508|69218513|FG003|Overall Study|Logistical Difficulties|2|||
37736954|NCT04304508|69218510|FG000|Overall Study|Missing Information|1|||
37736955|NCT04304508|69218511|FG001|Overall Study|Missing Information|2|||
37736956|NCT04304508|69218512|FG002|Overall Study|Missing Information|1|||
37736957|NCT04304508|69218513|FG003|Overall Study|Missing Information|3|||
37736958|NCT04304508|69218510|FG000|Overall Study|Other|7|||
37736959|NCT04304508|69218511|FG001|Overall Study|Other|6|||
37736960|NCT04304508|69218512|FG002|Overall Study|Other|5|||
37736961|NCT04304508|69218513|FG003|Overall Study|Other|4|||
37736962|NCT04304508|69218510|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
37736963|NCT04304508|69218511|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
37736964|NCT04304508|69218512|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
37736965|NCT04304508|69218513|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
37736966|NCT04304508|69218510|FG000|Overall Study|Physician Decision|3|||
37736967|NCT04304508|69218511|FG001|Overall Study|Physician Decision|4|||
37736968|NCT04304508|69218512|FG002|Overall Study|Physician Decision|9|||
37736969|NCT04304508|69218513|FG003|Overall Study|Physician Decision|7|||
37736970|NCT04304508|69218510|FG000|Overall Study|Study drug never administered|10|||
37736971|NCT04304508|69218511|FG001|Overall Study|Study drug never administered|4|||
37736972|NCT04304508|69218512|FG002|Overall Study|Study drug never administered|4|||
37736973|NCT04304508|69218513|FG003|Overall Study|Study drug never administered|4|||
37736974|NCT04304508|69218510|FG000|Overall Study|Adverse Event|49|||
37736975|NCT04304508|69218511|FG001|Overall Study|Adverse Event|50|||
37736976|NCT04304508|69218512|FG002|Overall Study|Adverse Event|51|||
37736977|NCT04304508|69218513|FG003|Overall Study|Adverse Event|56|||
37736978|NCT04304508|69218510|FG000|Overall Study|Lost to Follow-up|1|||
37736979|NCT04304508|69218511|FG001|Overall Study|Lost to Follow-up|5|||
37736980|NCT04304508|69218512|FG002|Overall Study|Lost to Follow-up|2|||
37736981|NCT04304508|69218513|FG003|Overall Study|Lost to Follow-up|3|||
37736982|NCT04206332|69218542|FG000|Part A|Lost to Follow-up|0|||
37736983|NCT04206332|69218543|FG001|Part A|Lost to Follow-up|1|||
37736984|NCT04206332|69218544|FG002|Part A|Lost to Follow-up|0|||
37736985|NCT04206332|69218545|FG003|Part A|Lost to Follow-up|0|||
37736986|NCT04206332|69218546|FG004|Part A|Lost to Follow-up|0|||
37736987|NCT04206332|69218547|FG005|Part A|Lost to Follow-up|0|||
37736988|NCT04206332|69218548|FG006|Part A|Lost to Follow-up|0|||
37736989|NCT04206332|69218549|FG007|Part A|Lost to Follow-up|0|||
37736990|NCT04206332|69218550|FG008|Part A|Lost to Follow-up|0|||
37736991|NCT04206332|69218551|FG009|Part A|Lost to Follow-up|0|||
37736992|NCT04206332|69218552|FG010|Part A|Lost to Follow-up|0|||
37736993|NCT04206332|69218553|FG011|Part A|Lost to Follow-up|0|||
37736994|NCT04206332|69218554|FG012|Part A|Lost to Follow-up|0|||
37736995|NCT04206332|69218555|FG013|Part A|Lost to Follow-up|0|||
37736996|NCT04206332|69218556|FG014|Part A|Lost to Follow-up|0|||
37736997|NCT04206332|69218557|FG015|Part A|Lost to Follow-up|0|||
37736998|NCT04206332|69218558|FG016|Part A|Lost to Follow-up|0|||
37736999|NCT04206332|69218542|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
37737000|NCT04206332|69218543|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
37737001|NCT04206332|69218544|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
37737002|NCT04206332|69218545|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
37737003|NCT04206332|69218546|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
37737004|NCT04206332|69218547|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
37852882|NCT01264770|69536694|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
37852883|NCT01264770|69536695|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
37852884|NCT01264770|69536696|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
37852885|NCT01264770|69536697|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
37852886|NCT01264770|69536698|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
37921249|NCT02677922|69607804|FG001|Treatment Period|Non-compliance with Study Drug|0|||
37921250|NCT02677922|69607805|FG002|Treatment Period|Non-compliance with Study Drug|0|||
37921251|NCT02677922|69607806|FG003|Treatment Period|Non-compliance with Study Drug|0|||
37852887|NCT01264770|69536693|FG000|Overall Study|Lost to Follow-up|0|||
37921252|NCT02677922|69607807|FG004|Treatment Period|Non-compliance with Study Drug|1|||
37921253|NCT02677922|69607808|FG005|Treatment Period|Non-compliance with Study Drug|0|||
37921254|NCT02677922|69607803|FG000|Treatment Period|Physician Decision|0|||
37921255|NCT02677922|69607804|FG001|Treatment Period|Physician Decision|0|||
37852888|NCT01264770|69536694|FG001|Overall Study|Lost to Follow-up|0|||
37852889|NCT01264770|69536695|FG002|Overall Study|Lost to Follow-up|1|||
37852890|NCT01264770|69536696|FG003|Overall Study|Lost to Follow-up|1|||
37852891|NCT01264770|69536697|FG004|Overall Study|Lost to Follow-up|0|||
38043549|NCT03238248|69731701|FG000|Overall Study|Other complicating disease|1|||
37921256|NCT02677922|69607805|FG002|Treatment Period|Physician Decision|0|||
37921257|NCT02677922|69607806|FG003|Treatment Period|Physician Decision|0|||
37921258|NCT02677922|69607807|FG004|Treatment Period|Physician Decision|0|||
37921259|NCT02677922|69607808|FG005|Treatment Period|Physician Decision|1|||
37852892|NCT01264770|69536698|FG005|Overall Study|Lost to Follow-up|0|||
37852893|NCT01264770|69536693|FG000|Overall Study|Adverse Event|7|||
37852894|NCT01264770|69536694|FG001|Overall Study|Adverse Event|7|||
37852895|NCT01264770|69536695|FG002|Overall Study|Adverse Event|8|||
37852896|NCT01264770|69536696|FG003|Overall Study|Adverse Event|0|||
37852897|NCT01264770|69536697|FG004|Overall Study|Adverse Event|2|||
37852898|NCT01264770|69536698|FG005|Overall Study|Adverse Event|1|||
37852899|NCT01027702|69536718|FG000|Overall Study|Received subsequent therapy|1|||
37852900|NCT01027702|69536719|FG001|Overall Study|Received subsequent therapy|2|||
37852901|NCT01027702|69536720|FG002|Overall Study|Received subsequent therapy|0|||
37852902|NCT01027702|69536721|FG003|Overall Study|Received subsequent therapy|4|||
37852903|NCT01027702|69536722|FG004|Overall Study|Received subsequent therapy|1|||
37852904|NCT01027702|69536723|FG005|Overall Study|Received subsequent therapy|0|||
37921260|NCT02677922|69607803|FG000|Treatment Period|Symptomatic Deterioration|0|||
37921261|NCT02677922|69607804|FG001|Treatment Period|Symptomatic Deterioration|0|||
37921262|NCT02677922|69607805|FG002|Treatment Period|Symptomatic Deterioration|0|||
37921263|NCT02677922|69607806|FG003|Treatment Period|Symptomatic Deterioration|0|||
37921264|NCT02677922|69607807|FG004|Treatment Period|Symptomatic Deterioration|1|||
37921265|NCT02677922|69607808|FG005|Treatment Period|Symptomatic Deterioration|0|||
37921266|NCT02634710|69607841|FG000|Overall Study|Death|4|||
37852905|NCT01027702|69536724|FG006|Overall Study|Received subsequent therapy|1|||
37852906|NCT01027702|69536718|FG000|Overall Study|Death|0|||
37852907|NCT01027702|69536719|FG001|Overall Study|Death|0|||
37852908|NCT01027702|69536720|FG002|Overall Study|Death|1|||
37852909|NCT01027702|69536721|FG003|Overall Study|Death|0|||
37852910|NCT01027702|69536722|FG004|Overall Study|Death|0|||
37737005|NCT04206332|69218548|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
37737006|NCT04206332|69218549|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
37852911|NCT01027702|69536723|FG005|Overall Study|Death|0|||
37852912|NCT01027702|69536724|FG006|Overall Study|Death|0|||
37852913|NCT01302080|69536738|FG000|Overall Study|Withdrew Consent|92|||
37852914|NCT01302080|69536739|FG001|Overall Study|Withdrew Consent|39|||
37852915|NCT01302080|69536738|FG000|Overall Study|Patient/Family Moved|28|||
37852916|NCT01302080|69536739|FG001|Overall Study|Patient/Family Moved|3|||
37852917|NCT01302080|69536738|FG000|Overall Study|Lost to Follow-up|192|||
37852918|NCT01302080|69536739|FG001|Overall Study|Lost to Follow-up|93|||
37852919|NCT01302080|69536738|FG000|Overall Study|Death|1|||
37852920|NCT01302080|69536739|FG001|Overall Study|Death|0|||
37852921|NCT01302080|69536738|FG000|Overall Study|Other|52|||
37852922|NCT01302080|69536739|FG001|Overall Study|Other|8|||
37737007|NCT04206332|69218550|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
37852923|NCT01302080|69536738|FG000|Overall Study|Reason Missing For Discontinuation|1|||
37737008|NCT04206332|69218551|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
37737009|NCT04206332|69218552|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
37737010|NCT04206332|69218553|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
37921267|NCT02540993|69607856|FG000|Overall Study|Lost to Follow-up|5|||
37852924|NCT01302080|69536739|FG001|Overall Study|Reason Missing For Discontinuation|0|||
37852925|NCT01238991|69536779|FG000|Overall Study|Adverse Event|1|||
37852926|NCT01238991|69536780|FG001|Overall Study|Adverse Event|0|||
37852927|NCT01238991|69536781|FG002|Overall Study|Adverse Event|3|||
37852928|NCT01238991|69536782|FG003|Overall Study|Adverse Event|1|||
37852929|NCT01238991|69536783|FG004|Overall Study|Adverse Event|1|||
37921268|NCT02540993|69607857|FG001|Overall Study|Lost to Follow-up|3|||
37852930|NCT01238991|69536784|FG005|Overall Study|Adverse Event|0|||
37852931|NCT01238991|69536785|FG006|Overall Study|Adverse Event|1|||
37921269|NCT02540993|69607856|FG000|Overall Study|Withdrawal by Subject|4|||
37737011|NCT04206332|69218554|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
37852932|NCT01238991|69536786|FG007|Overall Study|Adverse Event|1|||
37852933|NCT01238991|69536787|FG008|Overall Study|Adverse Event|0|||
37852934|NCT01238991|69536788|FG009|Overall Study|Adverse Event|0|||
37737012|NCT04206332|69218555|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
37737013|NCT04206332|69218556|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
37737014|NCT04206332|69218557|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
37737015|NCT04206332|69218558|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
37737016|NCT04206332|69218542|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
37737017|NCT04206332|69218543|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
37737018|NCT04206332|69218544|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
37737019|NCT04206332|69218545|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
37737020|NCT04206332|69218546|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
37737021|NCT04206332|69218547|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
37737022|NCT04206332|69218548|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
37737023|NCT04206332|69218549|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
37737024|NCT04206332|69218550|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
37737025|NCT04206332|69218551|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
37737026|NCT04206332|69218552|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
37737027|NCT04206332|69218553|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
37737028|NCT04206332|69218554|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
37737029|NCT04206332|69218555|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
37737030|NCT04206332|69218556|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
37737031|NCT04206332|69218557|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
37737032|NCT04206332|69218558|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
37737033|NCT04206332|69218542|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
37737034|NCT04206332|69218543|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
37737035|NCT04206332|69218544|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
37737036|NCT04206332|69218545|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
37737037|NCT04206332|69218546|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
38043550|NCT03238248|69731701|FG000|Overall Study|Adverse Event|5|||
37921270|NCT02540993|69607857|FG001|Overall Study|Withdrawal by Subject|6|||
37852935|NCT01238991|69536779|FG000|Overall Study|Death|0|||
37852936|NCT01238991|69536780|FG001|Overall Study|Death|0|||
37852937|NCT01238991|69536781|FG002|Overall Study|Death|0|||
37852938|NCT01238991|69536782|FG003|Overall Study|Death|1|||
37852939|NCT01238991|69536783|FG004|Overall Study|Death|0|||
37852940|NCT01238991|69536784|FG005|Overall Study|Death|0|||
37737038|NCT04206332|69218547|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
37852941|NCT01238991|69536785|FG006|Overall Study|Death|0|||
38031523|NCT03352557|69717112|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
38031524|NCT03352557|69717113|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
38031525|NCT03352557|69717114|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
38031526|NCT03352557|69717115|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
38031527|NCT03352557|69717116|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
38031528|NCT03352557|69717117|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
38031529|NCT03352557|69717118|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
38031530|NCT03352557|69717119|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
38031531|NCT03352557|69717120|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
38031532|NCT03352557|69717121|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
38031533|NCT03352557|69717112|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
38031534|NCT03352557|69717113|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
38031535|NCT03352557|69717114|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
38031536|NCT03352557|69717115|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
38031537|NCT03352557|69717116|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
38031538|NCT03352557|69717117|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
38031539|NCT03352557|69717118|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
38031540|NCT03352557|69717119|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
38031541|NCT03352557|69717120|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
38031542|NCT03352557|69717121|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
38031543|NCT03352557|69717112|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
38031544|NCT03352557|69717113|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
38031545|NCT03352557|69717114|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
37737039|NCT04206332|69218548|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
37737040|NCT04206332|69218549|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
37737041|NCT04206332|69218550|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
37737042|NCT04206332|69218551|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
37737043|NCT04206332|69218552|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
37737044|NCT04206332|69218553|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
37737045|NCT04206332|69218554|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
37737046|NCT04206332|69218555|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
37737047|NCT04206332|69218556|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
37737048|NCT04206332|69218557|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
37737049|NCT04206332|69218558|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
37737050|NCT04206332|69218542|FG000|Part C|Withdrawal by Subject|0|||
37737051|NCT04206332|69218543|FG001|Part C|Withdrawal by Subject|0|||
37737052|NCT04206332|69218544|FG002|Part C|Withdrawal by Subject|0|||
37737053|NCT04206332|69218545|FG003|Part C|Withdrawal by Subject|0|||
37737054|NCT04206332|69218546|FG004|Part C|Withdrawal by Subject|0|||
37737055|NCT04206332|69218547|FG005|Part C|Withdrawal by Subject|0|||
37852942|NCT01238991|69536786|FG007|Overall Study|Death|0|||
37852943|NCT01238991|69536787|FG008|Overall Study|Death|0|||
37852944|NCT01238991|69536788|FG009|Overall Study|Death|0|||
37737056|NCT04206332|69218548|FG006|Part C|Withdrawal by Subject|0|||
37852945|NCT01238991|69536779|FG000|Overall Study|Lack of Efficacy|0|||
38031546|NCT03352557|69717115|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
38031547|NCT03352557|69717116|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
38031548|NCT03352557|69717117|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
37921271|NCT02540993|69607856|FG000|Overall Study|GCP violations|33|||
38031549|NCT03352557|69717118|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
38031550|NCT03352557|69717119|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
38031551|NCT03352557|69717120|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
37852946|NCT01238991|69536780|FG001|Overall Study|Lack of Efficacy|0|||
37852947|NCT01238991|69536781|FG002|Overall Study|Lack of Efficacy|1|||
37852948|NCT01238991|69536782|FG003|Overall Study|Lack of Efficacy|0|||
37852949|NCT01238991|69536783|FG004|Overall Study|Lack of Efficacy|0|||
37852950|NCT01238991|69536784|FG005|Overall Study|Lack of Efficacy|0|||
37921272|NCT02540993|69607857|FG001|Overall Study|GCP violations|27|||
37921273|NCT02449239|69607892|FG000|Induction Phase|Lack of Efficacy|64|||
37921274|NCT02449239|69607892|FG000|Induction Phase|Adverse Event|1|||
37737057|NCT04206332|69218549|FG007|Part C|Withdrawal by Subject|0|||
37737058|NCT04206332|69218550|FG008|Part C|Withdrawal by Subject|0|||
37737059|NCT04206332|69218551|FG009|Part C|Withdrawal by Subject|0|||
37737060|NCT04206332|69218552|FG010|Part C|Withdrawal by Subject|0|||
37737061|NCT04206332|69218553|FG011|Part C|Withdrawal by Subject|0|||
37737062|NCT04206332|69218554|FG012|Part C|Withdrawal by Subject|0|||
37737063|NCT04206332|69218555|FG013|Part C|Withdrawal by Subject|0|||
37737064|NCT04206332|69218556|FG014|Part C|Withdrawal by Subject|2|||
37737065|NCT04206332|69218557|FG015|Part C|Withdrawal by Subject|0|||
37737066|NCT04206332|69218558|FG016|Part C|Withdrawal by Subject|0|||
38031552|NCT03352557|69717121|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
38031553|NCT03352557|69717112|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
38031554|NCT03352557|69717113|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
38031555|NCT03352557|69717114|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
38031556|NCT03352557|69717115|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
37737067|NCT03790111|69218641|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
37737068|NCT03780543|69218648|FG000|Overall Study|Adverse Event|1|||
37737069|NCT03780543|69218649|FG001|Overall Study|Adverse Event|0|||
37737070|NCT03780543|69218650|FG002|Overall Study|Adverse Event|2|||
37737071|NCT03780543|69218648|FG000|Overall Study|Lost to Follow-up|2|||
37737072|NCT03780543|69218649|FG001|Overall Study|Lost to Follow-up|0|||
37737073|NCT03780543|69218650|FG002|Overall Study|Lost to Follow-up|1|||
37737074|NCT03780543|69218648|FG000|Overall Study|Study terminated by Sponsor|8|||
37737075|NCT03780543|69218649|FG001|Overall Study|Study terminated by Sponsor|7|||
37737076|NCT03780543|69218650|FG002|Overall Study|Study terminated by Sponsor|13|||
37737077|NCT03780543|69218648|FG000|Overall Study|Withdrawal by Subject|1|||
37737078|NCT03780543|69218649|FG001|Overall Study|Withdrawal by Subject|8|||
37737079|NCT03780543|69218650|FG002|Overall Study|Withdrawal by Subject|1|||
37737080|NCT03780543|69218648|FG000|Overall Study|Noncompliance with study drug|1|||
37737081|NCT03780543|69218649|FG001|Overall Study|Noncompliance with study drug|0|||
37737082|NCT03780543|69218650|FG002|Overall Study|Noncompliance with study drug|0|||
37737083|NCT03745820|69218663|FG000|Overall Study|Adverse Event|0|||
37737084|NCT03745820|69218664|FG001|Overall Study|Adverse Event|3|||
37737085|NCT03745820|69218665|FG002|Overall Study|Adverse Event|2|||
37737086|NCT03745820|69218663|FG000|Overall Study|Non-Compliance with Study Drug|4|||
37737087|NCT03745820|69218664|FG001|Overall Study|Non-Compliance with Study Drug|3|||
37737088|NCT03745820|69218665|FG002|Overall Study|Non-Compliance with Study Drug|0|||
37737089|NCT03745820|69218663|FG000|Overall Study|Withdrawal by Subject|4|||
37737090|NCT03745820|69218664|FG001|Overall Study|Withdrawal by Subject|4|||
38031557|NCT03352557|69717116|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
37737091|NCT03745820|69218665|FG002|Overall Study|Withdrawal by Subject|4|||
37737092|NCT03745820|69218663|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
37737093|NCT03745820|69218664|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
37737094|NCT03745820|69218665|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
37737095|NCT03745820|69218663|FG000|Overall Study|Lost to Follow-up|2|||
37737096|NCT03745820|69218664|FG001|Overall Study|Lost to Follow-up|0|||
37737097|NCT03745820|69218665|FG002|Overall Study|Lost to Follow-up|3|||
37737098|NCT03745820|69218663|FG000|Overall Study|Reason not Specified|2|||
37737099|NCT03745820|69218664|FG001|Overall Study|Reason not Specified|4|||
38031558|NCT03352557|69717117|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
37737100|NCT03745820|69218665|FG002|Overall Study|Reason not Specified|1|||
37737101|NCT03699631|69218673|FG000|Overall Study|Adverse Event|3|||
37737102|NCT03686150|69218683|FG000|Overall Study|Withdrawal by Subject|1|||
37737103|NCT03686150|69218684|FG001|Overall Study|Withdrawal by Subject|1|||
37737104|NCT03686150|69218685|FG002|Overall Study|Withdrawal by Subject|1|||
37737105|NCT03686150|69218686|FG003|Overall Study|Withdrawal by Subject|0|||
37737106|NCT03686150|69218687|FG004|Overall Study|Withdrawal by Subject|1|||
37737107|NCT03686150|69218688|FG005|Overall Study|Withdrawal by Subject|2|||
37737108|NCT03686150|69218683|FG000|Overall Study|Physician Decision|1|||
37737109|NCT03686150|69218684|FG001|Overall Study|Physician Decision|0|||
37737110|NCT03686150|69218685|FG002|Overall Study|Physician Decision|0|||
37737111|NCT03686150|69218686|FG003|Overall Study|Physician Decision|0|||
37737112|NCT03686150|69218687|FG004|Overall Study|Physician Decision|0|||
37737113|NCT03686150|69218688|FG005|Overall Study|Physician Decision|1|||
37737114|NCT03686150|69218683|FG000|Overall Study|Lost to Follow-up|0|||
37737115|NCT03686150|69218684|FG001|Overall Study|Lost to Follow-up|1|||
37737116|NCT03686150|69218685|FG002|Overall Study|Lost to Follow-up|0|||
37737117|NCT03686150|69218686|FG003|Overall Study|Lost to Follow-up|0|||
37737118|NCT03686150|69218687|FG004|Overall Study|Lost to Follow-up|0|||
37737119|NCT03686150|69218688|FG005|Overall Study|Lost to Follow-up|0|||
37737120|NCT03604172|69218705|FG000|Overall Study|Lost to Follow-up|1|||
37737121|NCT03604172|69218706|FG001|Overall Study|Lost to Follow-up|2|||
37737122|NCT03496207|69218715|FG000|Base Study|Adverse Event|0|||
37737123|NCT03496207|69218716|FG001|Base Study|Adverse Event|0|||
37737124|NCT03496207|69218717|FG002|Base Study|Adverse Event|1|||
37737125|NCT03496207|69218718|FG003|Base Study|Adverse Event|1|||
37737126|NCT03496207|69218719|FG004|Base Study|Adverse Event|4|||
37737127|NCT03496207|69218715|FG000|Base Study|Death|0|||
37737128|NCT03496207|69218716|FG001|Base Study|Death|0|||
37737129|NCT03496207|69218717|FG002|Base Study|Death|0|||
37737130|NCT03496207|69218718|FG003|Base Study|Death|0|||
37737131|NCT03496207|69218719|FG004|Base Study|Death|1|||
37737132|NCT03496207|69218715|FG000|Base Study|Withdrawal by Subject|0|||
37737133|NCT03496207|69218716|FG001|Base Study|Withdrawal by Subject|0|||
37737134|NCT03496207|69218717|FG002|Base Study|Withdrawal by Subject|1|||
37737135|NCT03496207|69218718|FG003|Base Study|Withdrawal by Subject|0|||
37737136|NCT03496207|69218719|FG004|Base Study|Withdrawal by Subject|1|||
37737137|NCT03496207|69218715|FG000|Extension Period|Adverse Event|0|||
37737138|NCT03496207|69218716|FG001|Extension Period|Adverse Event|0|||
37737139|NCT03496207|69218717|FG002|Extension Period|Adverse Event|0|||
37737140|NCT03496207|69218718|FG003|Extension Period|Adverse Event|1|||
37737141|NCT03496207|69218719|FG004|Extension Period|Adverse Event|1|||
37737142|NCT03496207|69218715|FG000|Extension Period|Death|1|||
37737143|NCT03496207|69218716|FG001|Extension Period|Death|0|||
37737144|NCT03496207|69218717|FG002|Extension Period|Death|0|||
37737145|NCT03496207|69218718|FG003|Extension Period|Death|1|||
37737146|NCT03496207|69218719|FG004|Extension Period|Death|2|||
37737147|NCT03496207|69218715|FG000|Extension Period|Withdrawal by Subject|1|||
37737148|NCT03496207|69218716|FG001|Extension Period|Withdrawal by Subject|0|||
37737149|NCT03496207|69218717|FG002|Extension Period|Withdrawal by Subject|0|||
37737150|NCT03496207|69218718|FG003|Extension Period|Withdrawal by Subject|1|||
37737151|NCT03496207|69218719|FG004|Extension Period|Withdrawal by Subject|1|||
37737152|NCT03496207|69218715|FG000|Extension Period|Elevated hemoglobin levels|0|||
37737153|NCT03496207|69218716|FG001|Extension Period|Elevated hemoglobin levels|0|||
37737154|NCT03496207|69218717|FG002|Extension Period|Elevated hemoglobin levels|0|||
37737155|NCT03496207|69218718|FG003|Extension Period|Elevated hemoglobin levels|0|||
37737156|NCT03496207|69218719|FG004|Extension Period|Elevated hemoglobin levels|1|||
37852951|NCT01238991|69536785|FG006|Overall Study|Lack of Efficacy|0|||
37852952|NCT01238991|69536786|FG007|Overall Study|Lack of Efficacy|0|||
37737161|NCT03112590|69218756|FG000|Overall Study|Adverse Event|0|||
37737162|NCT03112590|69218757|FG001|Overall Study|Adverse Event|1|||
37737163|NCT03112590|69218758|FG002|Overall Study|Adverse Event|0|||
37737164|NCT03060629|69218768|FG000|Overall Study|Death|4|||
37737165|NCT03060629|69218769|FG001|Overall Study|Death|5|||
37852953|NCT01238991|69536787|FG008|Overall Study|Lack of Efficacy|1|||
37852954|NCT01238991|69536788|FG009|Overall Study|Lack of Efficacy|0|||
37852955|NCT01238991|69536779|FG000|Overall Study|Withdrawal by Subject|0|||
37852956|NCT01238991|69536780|FG001|Overall Study|Withdrawal by Subject|0|||
37852957|NCT01238991|69536781|FG002|Overall Study|Withdrawal by Subject|1|||
37852958|NCT01238991|69536782|FG003|Overall Study|Withdrawal by Subject|0|||
37737166|NCT03060629|69218768|FG000|Overall Study|Withdrawal by Subject|50|||
37737167|NCT03060629|69218769|FG001|Overall Study|Withdrawal by Subject|35|||
37737168|NCT03060629|69218768|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
37737169|NCT03060629|69218769|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
37737170|NCT03060629|69218768|FG000|Overall Study|Participant Relocate|15|||
37737171|NCT03060629|69218769|FG001|Overall Study|Participant Relocate|15|||
37737172|NCT03060629|69218768|FG000|Overall Study|Unable to Contact Participant|34|||
37737173|NCT03060629|69218769|FG001|Overall Study|Unable to Contact Participant|23|||
37737174|NCT03060629|69218768|FG000|Overall Study|Investigator Decision|7|||
37737175|NCT03060629|69218769|FG001|Overall Study|Investigator Decision|7|||
37737176|NCT03060629|69218768|FG000|Overall Study|Study Terminated by Sponsor|1100|||
37737177|NCT03060629|69218769|FG001|Overall Study|Study Terminated by Sponsor|1123|||
37737178|NCT03060629|69218768|FG000|Overall Study|Other|4|||
37737179|NCT03060629|69218769|FG001|Overall Study|Other|4|||
37737180|NCT03021486|69218778|FG000|Overall Study|Withdrawal by Subject|1|||
37737181|NCT03021486|69218779|FG001|Overall Study|Withdrawal by Subject|1|||
37737182|NCT03021486|69218780|FG002|Overall Study|Withdrawal by Subject|3|||
37737183|NCT03021486|69218778|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
37737184|NCT03021486|69218779|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
37737185|NCT03021486|69218780|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
37921275|NCT02449239|69607892|FG000|Induction Phase|Lost to Follow-up|1|||
37737186|NCT02999789|69218792|FG000|Overall Study|Withdrawal by Subject|0|||
37737187|NCT02999789|69218793|FG001|Overall Study|Withdrawal by Subject|1|||
37737188|NCT02999789|69218792|FG000|Overall Study|Became ineligible|1|||
37737189|NCT02999789|69218793|FG001|Overall Study|Became ineligible|2|||
37737190|NCT02949128|69218800|FG000|Initial Evaluation Period|Failed to Meet Eligibility Criteria|2|||
37737191|NCT02949128|69218800|FG000|Initial Evaluation Period|Adverse Event|3|||
37737192|NCT02949128|69218800|FG000|Initial Evaluation Period|Death|2|||
37737193|NCT02949128|69218800|FG000|Initial Evaluation Period|Physician Decision|1|||
37737194|NCT02949128|69218800|FG000|Initial Evaluation Period|Protocol Violation|1|||
37737195|NCT02949128|69218800|FG000|Extension Period|Withdrawal by Subject|5|||
37737196|NCT02949128|69218800|FG000|Extension Period|Protocol Violation|1|||
37737197|NCT02949128|69218800|FG000|Extension Period|Physician Decision|2|||
37737198|NCT02949128|69218800|FG000|Extension Period|Ongoing in Extension Period as of 07/02/2019|41|||
37737199|NCT02923115|69218819|FG000|Overall Study|Lost to Follow-up|0|||
37737200|NCT02923115|69218820|FG001|Overall Study|Lost to Follow-up|0|||
38031559|NCT03352557|69717118|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
38031560|NCT03352557|69717119|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
38031561|NCT03352557|69717120|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
38031562|NCT03352557|69717121|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
38031563|NCT03352557|69717112|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
38031564|NCT03352557|69717113|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
38031565|NCT03352557|69717114|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
38031566|NCT03352557|69717115|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
38031567|NCT03352557|69717116|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
38031568|NCT03352557|69717117|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
38031569|NCT03352557|69717118|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
38031570|NCT03352557|69717119|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
38031571|NCT03352557|69717120|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
38031572|NCT03352557|69717121|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
38031573|NCT03352557|69717112|FG000|LTE Period: Week 80 to Week 173|Other|0|||
38031574|NCT03352557|69717113|FG001|LTE Period: Week 80 to Week 173|Other|0|||
38031575|NCT03352557|69717114|FG002|LTE Period: Week 80 to Week 173|Other|0|||
38031576|NCT03352557|69717115|FG003|LTE Period: Week 80 to Week 173|Other|0|||
38031577|NCT03352557|69717116|FG004|LTE Period: Week 80 to Week 173|Other|0|||
38031578|NCT03352557|69717117|FG005|LTE Period: Week 80 to Week 173|Other|0|||
38031579|NCT03352557|69717118|FG006|LTE Period: Week 80 to Week 173|Other|0|||
38031580|NCT03352557|69717119|FG007|LTE Period: Week 80 to Week 173|Other|1|||
37737201|NCT02923115|69218821|FG002|Overall Study|Lost to Follow-up|0|||
37737202|NCT02923115|69218822|FG003|Overall Study|Lost to Follow-up|1|||
37737203|NCT02923115|69218823|FG004|Overall Study|Lost to Follow-up|0|||
37737204|NCT02923115|69218824|FG005|Overall Study|Lost to Follow-up|0|||
37737205|NCT02923115|69218819|FG000|Overall Study|Withdrawal by Subject|0|||
37737206|NCT02923115|69218820|FG001|Overall Study|Withdrawal by Subject|1|||
37737207|NCT02923115|69218821|FG002|Overall Study|Withdrawal by Subject|0|||
37737208|NCT02923115|69218822|FG003|Overall Study|Withdrawal by Subject|0|||
37737209|NCT02923115|69218823|FG004|Overall Study|Withdrawal by Subject|0|||
37737210|NCT02923115|69218824|FG005|Overall Study|Withdrawal by Subject|0|||
37737211|NCT02923115|69218819|FG000|Overall Study|Randomized, but not dosed|0|||
37737212|NCT02923115|69218820|FG001|Overall Study|Randomized, but not dosed|0|||
37737213|NCT02923115|69218821|FG002|Overall Study|Randomized, but not dosed|3|||
37737214|NCT02923115|69218822|FG003|Overall Study|Randomized, but not dosed|1|||
37737215|NCT02923115|69218823|FG004|Overall Study|Randomized, but not dosed|5|||
37737216|NCT02923115|69218824|FG005|Overall Study|Randomized, but not dosed|0|||
37737217|NCT02910583|69218840|FG000|Overall Study|Withdrawal by Subject|6|||
37737218|NCT02910583|69218841|FG001|Overall Study|Withdrawal by Subject|7|||
37737219|NCT02910583|69218840|FG000|Overall Study|Other, Not Specified|1|||
37737220|NCT02910583|69218841|FG001|Overall Study|Other, Not Specified|0|||
37737221|NCT02487394|69218886|FG000|Phase 1|Withdrawal by Subject|0|||
37737222|NCT02487394|69218887|FG001|Phase 1|Withdrawal by Subject|1|||
37737223|NCT02029846|69218908|FG000|Overall Study|n=1 each arm|1|||
37737224|NCT02029846|69218909|FG001|Overall Study|n=1 each arm|1|||
37737225|NCT05889039|69218919|FG000|Overall Study|error in completing survey|0|||
37737226|NCT05889039|69218920|FG001|Overall Study|error in completing survey|2|||
37737227|NCT05889039|69218921|FG002|Overall Study|error in completing survey|0|||
37737228|NCT05889039|69218922|FG003|Overall Study|error in completing survey|0|||
37737229|NCT05889039|69218919|FG000|Overall Study|Lost to Follow-up|4|||
37737230|NCT05889039|69218920|FG001|Overall Study|Lost to Follow-up|0|||
37737231|NCT05889039|69218921|FG002|Overall Study|Lost to Follow-up|0|||
37737232|NCT05889039|69218922|FG003|Overall Study|Lost to Follow-up|0|||
37737233|NCT05790408|69218932|FG000|Overall Study|Did not undergo surgery or did not undergo imaging at the time of surgery|3|||
37737234|NCT04944992|69218981|FG000|Overall Study|Lost to Follow-up|1|||
37737235|NCT04944992|69218982|FG001|Overall Study|Lost to Follow-up|1|||
37737236|NCT04944992|69218981|FG000|Overall Study|Physician Decision|1|||
37737237|NCT04944992|69218982|FG001|Overall Study|Physician Decision|0|||
37737238|NCT04944992|69218981|FG000|Overall Study|Withdrawal by Subject|6|||
37737239|NCT04944992|69218982|FG001|Overall Study|Withdrawal by Subject|1|||
37737240|NCT04820530|69218988|FG000|Extension Treatment Period|Ongoing at the time of the data cut-off date 2022-11-02|32|||
37737241|NCT04535583|69219009|FG000|Overall Study|Lost to Follow-up|1|||
37737242|NCT04535583|69219009|FG000|Overall Study|Physician Decision|1|||
37737243|NCT04535583|69219009|FG000|Overall Study|Withdrawal by Subject|1|||
37737244|NCT04484935|69219024|FG000|Overall Study|Other|0|||
37737245|NCT04484935|69219025|FG001|Overall Study|Other|1|||
37737246|NCT04484935|69219024|FG000|Overall Study|Withdrawal by parent/guardian|0|||
37737247|NCT04484935|69219025|FG001|Overall Study|Withdrawal by parent/guardian|1|||
37737248|NCT04484935|69219024|FG000|Overall Study|Lost to Follow-up|1|||
37737249|NCT04484935|69219025|FG001|Overall Study|Lost to Follow-up|0|||
37737250|NCT04484935|69219024|FG000|Overall Study|Death|2|||
37737251|NCT04484935|69219025|FG001|Overall Study|Death|1|||
37737252|NCT04458922|69219035|FG000|Overall Study|Withdrawal by Subject|1|||
37737253|NCT04458922|69219036|FG001|Overall Study|Withdrawal by Subject|0|||
37737254|NCT04458922|69219037|FG002|Overall Study|Withdrawal by Subject|2|||
37737255|NCT04458922|69219035|FG000|Overall Study|Protocol -specified withdrawal criterion met|0|||
37737256|NCT04458922|69219036|FG001|Overall Study|Protocol -specified withdrawal criterion met|0|||
37737257|NCT04458922|69219037|FG002|Overall Study|Protocol -specified withdrawal criterion met|1|||
37737258|NCT04458922|69219035|FG000|Overall Study|Adverse Event|1|||
37737259|NCT04458922|69219036|FG001|Overall Study|Adverse Event|0|||
37737260|NCT04458922|69219037|FG002|Overall Study|Adverse Event|0|||
37737261|NCT04458922|69219035|FG000|Overall Study|Started new study|0|||
37737262|NCT04458922|69219036|FG001|Overall Study|Started new study|0|||
37737263|NCT04458922|69219037|FG002|Overall Study|Started new study|1|||
37852959|NCT01238991|69536783|FG004|Overall Study|Withdrawal by Subject|0|||
37737264|NCT04458922|69219035|FG000|Overall Study|Progressive disease|6|||
37737265|NCT04458922|69219036|FG001|Overall Study|Progressive disease|8|||
37737266|NCT04458922|69219037|FG002|Overall Study|Progressive disease|2|||
37737267|NCT04458922|69219035|FG000|Overall Study|Death|1|||
37737268|NCT04458922|69219036|FG001|Overall Study|Death|0|||
37737269|NCT04458922|69219037|FG002|Overall Study|Death|2|||
37737270|NCT04458922|69219035|FG000|Overall Study|Participant started chemotherapy|0|||
37737271|NCT04458922|69219036|FG001|Overall Study|Participant started chemotherapy|1|||
38043551|NCT03238248|69731701|FG000|Overall Study|Disease progression|26|||
37852960|NCT01238991|69536784|FG005|Overall Study|Withdrawal by Subject|0|||
37852961|NCT01238991|69536785|FG006|Overall Study|Withdrawal by Subject|0|||
37852962|NCT01238991|69536786|FG007|Overall Study|Withdrawal by Subject|0|||
37852963|NCT01238991|69536787|FG008|Overall Study|Withdrawal by Subject|0|||
37852964|NCT01238991|69536788|FG009|Overall Study|Withdrawal by Subject|0|||
37737272|NCT04458922|69219037|FG002|Overall Study|Participant started chemotherapy|0|||
37737273|NCT04262882|69219047|FG000|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|14|||
37737274|NCT04262882|69219048|FG001|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|6|||
37737275|NCT04262882|69219047|FG000|Overall Study|Lost to Follow-up|1|||
37737276|NCT04262882|69219048|FG001|Overall Study|Lost to Follow-up|0|||
37737277|NCT04135859|69219056|FG000|Overall Study|Withdrawal by Subject|1|||
37737278|NCT04135859|69219057|FG001|Overall Study|Withdrawal by Subject|0|||
37737279|NCT04135859|69219056|FG000|Overall Study|Withdrawal due to screening failure|1|||
37737280|NCT04135859|69219057|FG001|Overall Study|Withdrawal due to screening failure|2|||
37737281|NCT04135859|69219056|FG000|Overall Study|Did not complete stress test|3|||
37737282|NCT04135859|69219057|FG001|Overall Study|Did not complete stress test|3|||
37737283|NCT04135859|69219056|FG000|Overall Study|Did not wear accelerometer and did not complete stress test|0|||
37737284|NCT04135859|69219057|FG001|Overall Study|Did not wear accelerometer and did not complete stress test|2|||
37737285|NCT04068610|69219075|FG000|Overall Study|Death|4|||
37737286|NCT04068610|69219076|FG001|Overall Study|Death|8|||
37737287|NCT04068610|69219077|FG002|Overall Study|Death|13|||
37737288|NCT04068610|69219075|FG000|Overall Study|Lost to Follow-up|0|||
37737289|NCT04068610|69219076|FG001|Overall Study|Lost to Follow-up|2|||
37737290|NCT04068610|69219077|FG002|Overall Study|Lost to Follow-up|0|||
37737291|NCT04068610|69219075|FG000|Overall Study|Withdrawal by Subject|0|||
37737292|NCT04068610|69219076|FG001|Overall Study|Withdrawal by Subject|4|||
37737293|NCT04068610|69219077|FG002|Overall Study|Withdrawal by Subject|2|||
37737294|NCT04068610|69219075|FG000|Overall Study|Other|3|||
37737295|NCT04068610|69219076|FG001|Overall Study|Other|12|||
37737296|NCT04068610|69219077|FG002|Overall Study|Other|11|||
37737297|NCT03860844|69219088|FG000|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
37737298|NCT03860844|69219089|FG001|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|2|||
37737299|NCT03860844|69219090|FG002|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
37737300|NCT03860844|69219088|FG000|Overall Study|Progressive disease|5|||
38031581|NCT03352557|69717120|FG008|LTE Period: Week 80 to Week 173|Other|0|||
38031582|NCT03352557|69717121|FG009|LTE Period: Week 80 to Week 173|Other|0|||
37737301|NCT03860844|69219089|FG001|Overall Study|Progressive disease|3|||
37852965|NCT01238991|69536779|FG000|Overall Study|Study Terminated by Sponsor|0|||
38031583|NCT02866942|69717146|FG000|Overall Study|Invalid consent|1|||
37737302|NCT03860844|69219090|FG002|Overall Study|Progressive disease|4|||
37852966|NCT01238991|69536780|FG001|Overall Study|Study Terminated by Sponsor|0|||
37921276|NCT02449239|69607892|FG000|Induction Phase|Protocol Violation|1|||
37921277|NCT02449239|69607892|FG000|Induction Phase|Physician Decision|1|||
37921278|NCT02449239|69607892|FG000|Induction Phase|Patient was determined by the sponsor to be ineligible for enrollment|1|||
37921279|NCT02449239|69607892|FG000|Induction Phase|Withdrawal by Subject|1|||
37921280|NCT02449239|69607892|FG000|Maintenance Month 3|Lack of Efficacy|14|||
37737303|NCT03860844|69219088|FG000|Overall Study|Other, Not related to COVID-19|0|||
37921281|NCT02449239|69607892|FG000|Maintenance Month 6|Lack of Efficacy|10|||
38031584|NCT01336894|69717200|FG000|Follow-up|Study terminated prematurely|2|||
38031585|NCT01336894|69717201|FG001|Follow-up|Study terminated prematurely|7|||
38031586|NCT02572167|69717210|FG000|Overall Study|Withdrawal by Subject|0|||
37921282|NCT02449239|69607892|FG000|Maintenance Month 6|Adverse Event|2|||
38031587|NCT02572167|69717211|FG001|Overall Study|Withdrawal by Subject|3|||
38031588|NCT02572167|69717212|FG002|Overall Study|Withdrawal by Subject|0|||
37852967|NCT01238991|69536781|FG002|Overall Study|Study Terminated by Sponsor|0|||
37737304|NCT03860844|69219089|FG001|Overall Study|Other, Not related to COVID-19|1|||
37737305|NCT03860844|69219090|FG002|Overall Study|Other, Not related to COVID-19|0|||
37737306|NCT03692052|69219100|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
37737307|NCT03692052|69219100|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
37737308|NCT03692052|69219100|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
37737309|NCT03692052|69219100|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
37737310|NCT03459846|69219106|FG000|Overall Study|Death|52|||
37737311|NCT03459846|69219107|FG001|Overall Study|Death|46|||
37737312|NCT03459846|69219106|FG000|Overall Study|Study terminated by sponsor|24|||
37737313|NCT03459846|69219107|FG001|Overall Study|Study terminated by sponsor|28|||
37737314|NCT03459846|69219106|FG000|Overall Study|Withdrawal by Subject|2|||
37737315|NCT03459846|69219107|FG001|Overall Study|Withdrawal by Subject|2|||
37737316|NCT03298984|69219117|FG000|Overall Study|Physician Decision|1|||
37737317|NCT03298984|69219118|FG001|Overall Study|Physician Decision|0|||
37737318|NCT03298984|69219119|FG002|Overall Study|Physician Decision|0|||
37737319|NCT03298984|69219120|FG003|Overall Study|Physician Decision|6|||
37737320|NCT03298984|69219117|FG000|Overall Study|Lack of Efficacy|0|||
37737321|NCT03298984|69219118|FG001|Overall Study|Lack of Efficacy|1|||
37737322|NCT03298984|69219119|FG002|Overall Study|Lack of Efficacy|1|||
37737323|NCT03298984|69219120|FG003|Overall Study|Lack of Efficacy|4|||
37737324|NCT03298984|69219117|FG000|Overall Study|Relapsed disease (following remission)|0|||
37737325|NCT03298984|69219118|FG001|Overall Study|Relapsed disease (following remission)|0|||
37737326|NCT03298984|69219119|FG002|Overall Study|Relapsed disease (following remission)|1|||
37737327|NCT03298984|69219120|FG003|Overall Study|Relapsed disease (following remission)|1|||
37737328|NCT03298984|69219117|FG000|Overall Study|Adverse Event|0|||
37737329|NCT03298984|69219118|FG001|Overall Study|Adverse Event|0|||
37737330|NCT03298984|69219119|FG002|Overall Study|Adverse Event|0|||
37737331|NCT03298984|69219120|FG003|Overall Study|Adverse Event|1|||
37737332|NCT03298984|69219117|FG000|Overall Study|Death|0|||
37737333|NCT03298984|69219118|FG001|Overall Study|Death|0|||
37737334|NCT03298984|69219119|FG002|Overall Study|Death|0|||
37737335|NCT03298984|69219120|FG003|Overall Study|Death|2|||
37737336|NCT03298984|69219117|FG000|Overall Study|Insurance Company Decision|0|||
37737337|NCT03298984|69219118|FG001|Overall Study|Insurance Company Decision|0|||
37737338|NCT03298984|69219119|FG002|Overall Study|Insurance Company Decision|0|||
37737339|NCT03298984|69219120|FG003|Overall Study|Insurance Company Decision|1|||
37737340|NCT03248492|69219136|FG000|Overall Study|Ongoing|23|||
37737341|NCT03248492|69219137|FG001|Overall Study|Ongoing|26|||
37737342|NCT03248492|69219138|FG002|Overall Study|Ongoing|3|||
37737343|NCT03248492|69219139|FG003|Overall Study|Ongoing|85|||
37737344|NCT03248492|69219140|FG004|Overall Study|Ongoing|2|||
37737345|NCT03248492|69219136|FG000|Overall Study|Progressive disease per RECIST v1.1|16|||
37737346|NCT03248492|69219137|FG001|Overall Study|Progressive disease per RECIST v1.1|12|||
37737347|NCT03248492|69219138|FG002|Overall Study|Progressive disease per RECIST v1.1|9|||
37737348|NCT03248492|69219139|FG003|Overall Study|Progressive disease per RECIST v1.1|22|||
37737349|NCT03248492|69219140|FG004|Overall Study|Progressive disease per RECIST v1.1|0|||
37852968|NCT01238991|69536782|FG003|Overall Study|Study Terminated by Sponsor|0|||
37737350|NCT03248492|69219136|FG000|Overall Study|Adverse Event|6|||
37737351|NCT03248492|69219137|FG001|Overall Study|Adverse Event|6|||
37737352|NCT03248492|69219138|FG002|Overall Study|Adverse Event|8|||
37737353|NCT03248492|69219139|FG003|Overall Study|Adverse Event|8|||
37737354|NCT03248492|69219140|FG004|Overall Study|Adverse Event|1|||
37737355|NCT03248492|69219136|FG000|Overall Study|Withdrawal by Subject|3|||
37737356|NCT03248492|69219137|FG001|Overall Study|Withdrawal by Subject|3|||
37737357|NCT03248492|69219138|FG002|Overall Study|Withdrawal by Subject|0|||
37737358|NCT03248492|69219139|FG003|Overall Study|Withdrawal by Subject|3|||
37737359|NCT03248492|69219140|FG004|Overall Study|Withdrawal by Subject|1|||
37737360|NCT03248492|69219136|FG000|Overall Study|Physician Decision|1|||
37737361|NCT03248492|69219137|FG001|Overall Study|Physician Decision|0|||
37737362|NCT03248492|69219138|FG002|Overall Study|Physician Decision|1|||
37737363|NCT03248492|69219139|FG003|Overall Study|Physician Decision|2|||
37737364|NCT03248492|69219140|FG004|Overall Study|Physician Decision|0|||
37737365|NCT03248492|69219136|FG000|Overall Study|Death|1|||
37852969|NCT01238991|69536783|FG004|Overall Study|Study Terminated by Sponsor|1|||
37737366|NCT03248492|69219137|FG001|Overall Study|Death|0|||
37737367|NCT03248492|69219138|FG002|Overall Study|Death|0|||
38031589|NCT02572167|69717210|FG000|Overall Study|Lost to Follow-up|2|||
37737368|NCT03248492|69219139|FG003|Overall Study|Death|6|||
37921283|NCT02449239|69607892|FG000|Maintenance Month 6|Physician Decision|1|||
37921284|NCT02449239|69607892|FG000|Maintenance Month 9|Lack of Efficacy|2|||
37921285|NCT02449239|69607892|FG000|Maintenance Month 9|Started ibrutinib for CLL|1|||
37921286|NCT02449239|69607892|FG000|Maintenance Month 12|Lack of Efficacy|5|||
37921287|NCT02449239|69607892|FG000|Maintenance Month 12|Withdrawal by Subject|1|||
37921288|NCT02449239|69607892|FG000|Maintenance Month 12|Subject moved from area|1|||
37921289|NCT02449239|69607892|FG000|Maintenance Month 15|Lack of Efficacy|1|||
37921290|NCT02449239|69607892|FG000|Maintenance Month 21|Lack of Efficacy|1|||
37921291|NCT02449239|69607892|FG000|Maintenance Month 21|Sponsor decision|1|||
37921292|NCT01292928|69607896|FG000|Overall Study|Death|8|||
37921293|NCT01292928|69607896|FG000|Overall Study|Withdrawal by Subject|8|||
37921294|NCT01292928|69607896|FG000|Overall Study|Lost to Follow-up|6|||
37921295|NCT01292928|69607896|FG000|Overall Study|Physician Decision|2|||
37921296|NCT00581828|69607928|FG000|Overall Study|Protocol Violation|1|||
37921297|NCT00220337|69607977|FG000|Overall Study|Adverse Event|70|||
37921298|NCT00220337|69607977|FG000|Overall Study|Lack of Efficacy|17|||
37921299|NCT00220337|69607977|FG000|Overall Study|Withdrawal by Subject|68|||
37921300|NCT00220337|69607977|FG000|Overall Study|Protocol Violation|2|||
37921301|NCT00220337|69607977|FG000|Overall Study|Lost to Follow-up|5|||
37921302|NCT00220337|69607977|FG000|Overall Study|Other|12|||
37921303|NCT00220337|69607977|FG000|Overall Study|Unsatisfactory compliance|5|||
37921304|NCT00576316|69607981|FG000|Overall Study|Adverse Event|9|||
37921305|NCT00576316|69607981|FG000|Overall Study|Withdrawal by Subject|2|||
37921306|NCT00576316|69607981|FG000|Overall Study|Protocol Violation|9|||
37921307|NCT00823134|69607985|FG000|Overall Study|Invalid measurement|1|||
37921308|NCT00831792|69607990|FG000|Overall Study|Not Eligible|3|||
37921309|NCT00831792|69607990|FG000|Overall Study|Adverse Event|1|||
37921310|NCT00831792|69607990|FG000|Overall Study|Death|1|||
37921311|NCT00831792|69607990|FG000|Overall Study|Lack of Efficacy|1|||
37921312|NCT00575380|69607996|FG000|Overall Study|Withdrawal by Subject|1|||
37921313|NCT00575380|69607997|FG001|Overall Study|Withdrawal by Subject|0|||
37921314|NCT00575380|69607996|FG000|Overall Study|Adverse Event|0|||
37921315|NCT00575380|69607997|FG001|Overall Study|Adverse Event|1|||
37921316|NCT00575380|69607996|FG000|Overall Study|Various|0|||
37921317|NCT00575380|69607997|FG001|Overall Study|Various|2|||
37921318|NCT00840996|69608005|FG000|Overall Study|Withdrawal by Subject|1|||
37921319|NCT00840996|69608006|FG001|Overall Study|Withdrawal by Subject|0|||
37921320|NCT00680914|69608014|FG000|Overall Study|Consent withdrawal|6|||
37921321|NCT00680914|69608015|FG001|Overall Study|Consent withdrawal|3|||
37921322|NCT00680914|69608014|FG000|Overall Study|Lost to Follow-up|4|||
37921323|NCT00680914|69608015|FG001|Overall Study|Lost to Follow-up|0|||
37921324|NCT00680914|69608014|FG000|Overall Study|serious adverse event (SAE)|0|||
37921325|NCT00680914|69608015|FG001|Overall Study|serious adverse event (SAE)|1|||
37921326|NCT00680836|69608023|FG000|Overall Study|Withdrawal by Subject|3|||
37921327|NCT00680836|69608024|FG001|Overall Study|Withdrawal by Subject|0|||
37921328|NCT00680836|69608023|FG000|Overall Study|Lost to Follow-up|3|||
37921329|NCT00680836|69608024|FG001|Overall Study|Lost to Follow-up|1|||
37921330|NCT00680836|69608023|FG000|Overall Study|Physician Decision|2|||
37921331|NCT00680836|69608024|FG001|Overall Study|Physician Decision|1|||
38031590|NCT02572167|69717211|FG001|Overall Study|Lost to Follow-up|5|||
37921332|NCT00679432|69608035|FG000|Overall Study|Adverse Event|5|||
37921333|NCT00679432|69608036|FG001|Overall Study|Adverse Event|6|||
37921334|NCT00679432|69608037|FG002|Overall Study|Adverse Event|10|||
37921335|NCT00679432|69608038|FG003|Overall Study|Adverse Event|7|||
37921336|NCT00679432|69608035|FG000|Overall Study|Protocol Violation|1|||
37921337|NCT00679432|69608036|FG001|Overall Study|Protocol Violation|1|||
37921338|NCT00679432|69608037|FG002|Overall Study|Protocol Violation|2|||
37921339|NCT00679432|69608038|FG003|Overall Study|Protocol Violation|1|||
37921340|NCT00679432|69608035|FG000|Overall Study|Withdrawal by Subject|8|||
37921341|NCT00679432|69608036|FG001|Overall Study|Withdrawal by Subject|11|||
37921342|NCT00679432|69608037|FG002|Overall Study|Withdrawal by Subject|10|||
37921343|NCT00679432|69608038|FG003|Overall Study|Withdrawal by Subject|9|||
37921344|NCT00679432|69608035|FG000|Overall Study|Lost to Follow-up|1|||
37921345|NCT00679432|69608036|FG001|Overall Study|Lost to Follow-up|5|||
37921346|NCT00679432|69608037|FG002|Overall Study|Lost to Follow-up|4|||
37921347|NCT00679432|69608038|FG003|Overall Study|Lost to Follow-up|2|||
37921348|NCT00679432|69608035|FG000|Overall Study|Physician Decision|3|||
37921349|NCT00679432|69608036|FG001|Overall Study|Physician Decision|2|||
37921350|NCT00679432|69608037|FG002|Overall Study|Physician Decision|2|||
37921351|NCT00679432|69608038|FG003|Overall Study|Physician Decision|2|||
37921352|NCT00679432|69608035|FG000|Overall Study|Sponsor decision|1|||
37921353|NCT00679432|69608036|FG001|Overall Study|Sponsor decision|0|||
37921354|NCT00679432|69608037|FG002|Overall Study|Sponsor decision|0|||
37921355|NCT00679432|69608038|FG003|Overall Study|Sponsor decision|0|||
37921356|NCT00679432|69608035|FG000|Overall Study|Lack of Efficacy|13|||
37921357|NCT00679432|69608036|FG001|Overall Study|Lack of Efficacy|9|||
37921358|NCT00679432|69608037|FG002|Overall Study|Lack of Efficacy|14|||
37921359|NCT00679432|69608038|FG003|Overall Study|Lack of Efficacy|8|||
37921360|NCT00679432|69608035|FG000|Overall Study|Infectious colitis, normal histology|5|||
37921361|NCT00679432|69608036|FG001|Overall Study|Infectious colitis, normal histology|4|||
37921362|NCT00679432|69608037|FG002|Overall Study|Infectious colitis, normal histology|8|||
37921363|NCT00679432|69608038|FG003|Overall Study|Infectious colitis, normal histology|3|||
37921364|NCT00679432|69608035|FG000|Overall Study|Randomization error, return to prior Rx|0|||
37921365|NCT00679432|69608036|FG001|Overall Study|Randomization error, return to prior Rx|0|||
37921366|NCT00679432|69608037|FG002|Overall Study|Randomization error, return to prior Rx|3|||
37921367|NCT00679432|69608038|FG003|Overall Study|Randomization error, return to prior Rx|0|||
37921368|NCT00679354|69608048|FG000|Overall Study|Death|3|||
37921369|NCT00679354|69608048|FG000|Overall Study|Lack of Efficacy|22|||
37921370|NCT00679354|69608048|FG000|Overall Study|Physician Decision|4|||
37921371|NCT00679354|69608048|FG000|Overall Study|Ineligible|1|||
37921372|NCT00822900|69608055|FG000|Overall Study|Withdrawal by Subject|14|||
37921373|NCT00822900|69608056|FG001|Overall Study|Withdrawal by Subject|14|||
37921374|NCT00822900|69608055|FG000|Overall Study|Lost to Follow-up|9|||
37921375|NCT00822900|69608056|FG001|Overall Study|Lost to Follow-up|9|||
37921376|NCT00822900|69608055|FG000|Overall Study|Death|83|||
37921377|NCT00822900|69608056|FG001|Overall Study|Death|69|||
37921378|NCT00822900|69608055|FG000|Overall Study|Became a ward of the state|2|||
37921379|NCT00822900|69608056|FG001|Overall Study|Became a ward of the state|1|||
37921380|NCT00682786|69608064|FG000|Overall Study|Withdrawal by Subject|2|||
37921381|NCT00682786|69608065|FG001|Overall Study|Withdrawal by Subject|2|||
37921382|NCT00682786|69608064|FG000|Overall Study|Did not receive irinotecan|0|||
37921383|NCT00682786|69608065|FG001|Overall Study|Did not receive irinotecan|1|||
37921384|NCT00840450|69608077|FG000|Overall Study|Adverse Event|1|||
37921385|NCT00840450|69608077|FG000|Overall Study|Lack of Efficacy|2|||
37921386|NCT00840294|69608083|FG000|Overall Study|Withdrawal by Subject|2|||
37921387|NCT00840294|69608084|FG001|Overall Study|Withdrawal by Subject|1|||
37921388|NCT00840294|69608083|FG000|Overall Study|Protocol Violation|1|||
37852970|NCT01238991|69536784|FG005|Overall Study|Study Terminated by Sponsor|0|||
37852971|NCT01238991|69536785|FG006|Overall Study|Study Terminated by Sponsor|7|||
37852972|NCT01238991|69536786|FG007|Overall Study|Study Terminated by Sponsor|4|||
37852973|NCT01238991|69536787|FG008|Overall Study|Study Terminated by Sponsor|2|||
37852974|NCT01238991|69536788|FG009|Overall Study|Study Terminated by Sponsor|2|||
37852975|NCT01238991|69536779|FG000|Overall Study|Caregiver's request|0|||
37852976|NCT01238991|69536780|FG001|Overall Study|Caregiver's request|0|||
37852977|NCT01238991|69536781|FG002|Overall Study|Caregiver's request|0|||
37852978|NCT01238991|69536782|FG003|Overall Study|Caregiver's request|0|||
37852979|NCT01238991|69536783|FG004|Overall Study|Caregiver's request|0|||
37852980|NCT01238991|69536784|FG005|Overall Study|Caregiver's request|0|||
37852981|NCT01238991|69536785|FG006|Overall Study|Caregiver's request|0|||
37852982|NCT01238991|69536786|FG007|Overall Study|Caregiver's request|0|||
37852983|NCT01238991|69536787|FG008|Overall Study|Caregiver's request|1|||
37852984|NCT01238991|69536788|FG009|Overall Study|Caregiver's request|0|||
37852985|NCT01238991|69536779|FG000|Overall Study|Admission to a nursing home|1|||
38031591|NCT02572167|69717212|FG002|Overall Study|Lost to Follow-up|3|||
38031592|NCT02572167|69717210|FG000|Overall Study|Death|0|||
38031593|NCT02572167|69717211|FG001|Overall Study|Death|8|||
37737369|NCT03248492|69219140|FG004|Overall Study|Death|0|||
37921389|NCT00840294|69608084|FG001|Overall Study|Protocol Violation|3|||
37921390|NCT00840294|69608083|FG000|Overall Study|Illness|0|||
37921391|NCT00840294|69608084|FG001|Overall Study|Illness|1|||
37921392|NCT00680368|69608090|FG000|Overall Study|not supervised, not eligible|15|||
37737370|NCT03248492|69219136|FG000|Overall Study|Other|0|||
37921393|NCT00680056|69608098|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
37921394|NCT00680056|69608099|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
37921395|NCT00680056|69608098|FG000|Second Intervention|Protocol Violation|3|||
37921396|NCT00680056|69608099|FG001|Second Intervention|Protocol Violation|1|||
37921397|NCT00680992|69608109|FG000|Overall Study|Complete Resection (as per protocol)|25|||
37921398|NCT00680992|69608110|FG001|Overall Study|Complete Resection (as per protocol)|121|||
37921399|NCT00680992|69608111|FG002|Overall Study|Complete Resection (as per protocol)|0|||
37921400|NCT00680992|69608109|FG000|Overall Study|Administrative Decision|83|||
37921401|NCT00680992|69608110|FG001|Overall Study|Administrative Decision|42|||
37921402|NCT00680992|69608111|FG002|Overall Study|Administrative Decision|5|||
37921403|NCT00680992|69608109|FG000|Overall Study|End of Trial|32|||
37737371|NCT03248492|69219137|FG001|Overall Study|Other|1|||
37737372|NCT03248492|69219138|FG002|Overall Study|Other|0|||
37737373|NCT03248492|69219139|FG003|Overall Study|Other|4|||
37737374|NCT03248492|69219140|FG004|Overall Study|Other|0|||
37737375|NCT03224468|69219162|FG000|Overall Study|Did not obtain MM card|53|||
37921404|NCT00680992|69608110|FG001|Overall Study|End of Trial|12|||
37921405|NCT00680992|69608111|FG002|Overall Study|End of Trial|3|||
37921406|NCT00680992|69608109|FG000|Overall Study|Withdrawal by Subject|33|||
37921407|NCT00680992|69608110|FG001|Overall Study|Withdrawal by Subject|11|||
38031594|NCT02572167|69717212|FG002|Overall Study|Death|3|||
37852986|NCT01238991|69536780|FG001|Overall Study|Admission to a nursing home|0|||
37852987|NCT01238991|69536781|FG002|Overall Study|Admission to a nursing home|1|||
37852988|NCT01238991|69536782|FG003|Overall Study|Admission to a nursing home|0|||
37852989|NCT01238991|69536783|FG004|Overall Study|Admission to a nursing home|0|||
37852990|NCT01238991|69536784|FG005|Overall Study|Admission to a nursing home|0|||
37852991|NCT01238991|69536785|FG006|Overall Study|Admission to a nursing home|0|||
37852992|NCT01238991|69536786|FG007|Overall Study|Admission to a nursing home|0|||
37852993|NCT01238991|69536787|FG008|Overall Study|Admission to a nursing home|0|||
37921408|NCT00680992|69608111|FG002|Overall Study|Withdrawal by Subject|1|||
37852994|NCT01238991|69536788|FG009|Overall Study|Admission to a nursing home|0|||
37852995|NCT01238835|69536813|FG000|Overall Study|Death|124|||
37921409|NCT00680992|69608109|FG000|Overall Study|Adverse Event|21|||
37737376|NCT03224468|69219163|FG001|Overall Study|Did not obtain MM card|0|||
37737377|NCT03224468|69219162|FG000|Overall Study|Lost to Follow-up|4|||
37737378|NCT03224468|69219163|FG001|Overall Study|Lost to Follow-up|11|||
37737379|NCT03224468|69219162|FG000|Overall Study|Cannabis Use Disorder at Baseline|11|||
37737380|NCT03224468|69219163|FG001|Overall Study|Cannabis Use Disorder at Baseline|4|||
37737381|NCT03149003|69219172|FG000|Overall Study|Randomized but not treated|0|||
37737382|NCT03149003|69219173|FG001|Overall Study|Randomized but not treated|1|||
37737383|NCT03149003|69219174|FG002|Overall Study|Randomized but not treated|18|||
37737384|NCT03093974|69219188|FG000|Overall Study|Withdrawal by Subject|32|||
37737385|NCT03093974|69219189|FG001|Overall Study|Withdrawal by Subject|27|||
37737386|NCT03093974|69219188|FG000|Overall Study|Adverse Event|17|||
37737387|NCT03093974|69219189|FG001|Overall Study|Adverse Event|24|||
37737388|NCT03093974|69219188|FG000|Overall Study|Death|0|||
37737389|NCT03093974|69219189|FG001|Overall Study|Death|1|||
37737390|NCT03093974|69219188|FG000|Overall Study|Non-Compliance with Study Drug|1|||
37737391|NCT03093974|69219189|FG001|Overall Study|Non-Compliance with Study Drug|0|||
37737392|NCT03093974|69219188|FG000|Overall Study|Protocol-Specified withdrawal criterion met|3|||
37737393|NCT03093974|69219189|FG001|Overall Study|Protocol-Specified withdrawal criterion met|16|||
37737394|NCT03093974|69219188|FG000|Overall Study|Lost to Follow-up|0|||
37737395|NCT03093974|69219189|FG001|Overall Study|Lost to Follow-up|1|||
37737396|NCT03093974|69219188|FG000|Overall Study|Other|1|||
37737397|NCT03093974|69219189|FG001|Overall Study|Other|2|||
37737398|NCT03089606|69219195|FG000|Overall Study|Progression after Cycle 1|1|||
37737399|NCT03023332|69219211|FG000|Overall Study|Withdrawal by Subject|10|||
37737400|NCT03023332|69219212|FG001|Overall Study|Withdrawal by Subject|5|||
37737401|NCT03023332|69219213|FG002|Overall Study|Withdrawal by Subject|4|||
37737402|NCT03023332|69219214|FG003|Overall Study|Withdrawal by Subject|7|||
37737403|NCT03023332|69219211|FG000|Overall Study|Lost to Follow-up|13|||
37737404|NCT03023332|69219212|FG001|Overall Study|Lost to Follow-up|16|||
37737405|NCT03023332|69219213|FG002|Overall Study|Lost to Follow-up|8|||
37737406|NCT03023332|69219214|FG003|Overall Study|Lost to Follow-up|13|||
37737407|NCT03023332|69219211|FG000|Overall Study|Death|1|||
37737408|NCT03023332|69219212|FG001|Overall Study|Death|0|||
37737409|NCT03023332|69219213|FG002|Overall Study|Death|0|||
37737410|NCT03023332|69219214|FG003|Overall Study|Death|0|||
37737411|NCT02993731|69219243|FG000|Overall Study|Study Termination|101|||
37737412|NCT02993731|69219244|FG001|Overall Study|Study Termination|105|||
37737413|NCT02985957|69219267|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
37737414|NCT02985957|69219268|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
37737415|NCT02985957|69219269|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
37737416|NCT02985957|69219270|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
37737417|NCT02985957|69219271|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
37737418|NCT02985957|69219272|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
37737419|NCT02985957|69219273|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
37737420|NCT02985957|69219267|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
37737421|NCT02985957|69219268|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
37737422|NCT02985957|69219269|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
37737423|NCT02985957|69219270|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
37737424|NCT02985957|69219271|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
37737425|NCT02985957|69219272|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
37737426|NCT02985957|69219273|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
37737427|NCT02985957|69219267|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
37737428|NCT02985957|69219268|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
37737429|NCT02985957|69219269|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
37737430|NCT02985957|69219270|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
37737431|NCT02985957|69219271|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
37737432|NCT02985957|69219272|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
37737433|NCT02985957|69219273|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
37737434|NCT02985957|69219267|FG000|Treatment Period|Death|0|||
37737435|NCT02985957|69219268|FG001|Treatment Period|Death|0|||
37737436|NCT02985957|69219269|FG002|Treatment Period|Death|0|||
37737437|NCT02985957|69219270|FG003|Treatment Period|Death|0|||
37737438|NCT02985957|69219271|FG004|Treatment Period|Death|1|||
37737439|NCT02985957|69219272|FG005|Treatment Period|Death|0|||
37737440|NCT02985957|69219273|FG006|Treatment Period|Death|0|||
37737441|NCT02985957|69219267|FG000|Treatment Period|Participant withdrew consent|0|||
37921410|NCT00680992|69608110|FG001|Overall Study|Adverse Event|19|||
37921411|NCT00680992|69608111|FG002|Overall Study|Adverse Event|1|||
37921412|NCT00680992|69608109|FG000|Overall Study|Other|19|||
37737442|NCT02985957|69219268|FG001|Treatment Period|Participant withdrew consent|0|||
37737443|NCT02985957|69219269|FG002|Treatment Period|Participant withdrew consent|0|||
37737444|NCT02985957|69219270|FG003|Treatment Period|Participant withdrew consent|1|||
37737445|NCT02985957|69219271|FG004|Treatment Period|Participant withdrew consent|3|||
37921413|NCT00680992|69608110|FG001|Overall Study|Other|14|||
37737446|NCT02985957|69219272|FG005|Treatment Period|Participant withdrew consent|0|||
37737447|NCT02985957|69219273|FG006|Treatment Period|Participant withdrew consent|1|||
37737448|NCT02985957|69219267|FG000|Treatment Period|Lost to Follow-up|0|||
37737449|NCT02985957|69219268|FG001|Treatment Period|Lost to Follow-up|0|||
37737450|NCT02985957|69219269|FG002|Treatment Period|Lost to Follow-up|0|||
37737451|NCT02985957|69219270|FG003|Treatment Period|Lost to Follow-up|0|||
37737452|NCT02985957|69219271|FG004|Treatment Period|Lost to Follow-up|1|||
37737453|NCT02985957|69219272|FG005|Treatment Period|Lost to Follow-up|0|||
37737454|NCT02985957|69219273|FG006|Treatment Period|Lost to Follow-up|0|||
37737455|NCT02985957|69219267|FG000|Treatment Period|Other reasons|0|||
37737456|NCT02985957|69219268|FG001|Treatment Period|Other reasons|0|||
37737457|NCT02985957|69219269|FG002|Treatment Period|Other reasons|1|||
37737458|NCT02985957|69219270|FG003|Treatment Period|Other reasons|3|||
37737459|NCT02985957|69219271|FG004|Treatment Period|Other reasons|6|||
37737460|NCT02985957|69219272|FG005|Treatment Period|Other reasons|0|||
37737461|NCT02985957|69219273|FG006|Treatment Period|Other reasons|1|||
37737462|NCT02985957|69219267|FG000|Treatment Period|Not reported|0|||
37737463|NCT02985957|69219268|FG001|Treatment Period|Not reported|1|||
37737464|NCT02985957|69219269|FG002|Treatment Period|Not reported|2|||
37737465|NCT02985957|69219270|FG003|Treatment Period|Not reported|5|||
37737466|NCT02985957|69219271|FG004|Treatment Period|Not reported|0|||
37921414|NCT00680992|69608111|FG002|Overall Study|Other|1|||
37737467|NCT02985957|69219272|FG005|Treatment Period|Not reported|0|||
37737468|NCT02985957|69219273|FG006|Treatment Period|Not reported|0|||
37737469|NCT02985957|69219267|FG000|Treatment Period|Maximum clinical benefit|0|||
37737470|NCT02985957|69219268|FG001|Treatment Period|Maximum clinical benefit|0|||
37737471|NCT02985957|69219269|FG002|Treatment Period|Maximum clinical benefit|1|||
37737472|NCT02985957|69219270|FG003|Treatment Period|Maximum clinical benefit|1|||
37737473|NCT02985957|69219271|FG004|Treatment Period|Maximum clinical benefit|0|||
37737474|NCT02985957|69219272|FG005|Treatment Period|Maximum clinical benefit|0|||
37737475|NCT02985957|69219273|FG006|Treatment Period|Maximum clinical benefit|2|||
38031595|NCT02572167|69717210|FG000|Overall Study|Did not meet inclusion criteria|0|||
37737476|NCT02985957|69219267|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
37737477|NCT02985957|69219268|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
37737478|NCT02985957|69219269|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
37737479|NCT02985957|69219270|FG003|Treatment Period|Adverse event unrelated to study drug|3|||
37737480|NCT02985957|69219271|FG004|Treatment Period|Adverse event unrelated to study drug|7|||
37921415|NCT00680992|69608109|FG000|Overall Study|Disease Progression|21|||
37921416|NCT00680992|69608110|FG001|Overall Study|Disease Progression|9|||
37921417|NCT00680992|69608111|FG002|Overall Study|Disease Progression|0|||
37921418|NCT00680992|69608109|FG000|Overall Study|Lost to Follow-up|12|||
37921419|NCT00680992|69608110|FG001|Overall Study|Lost to Follow-up|14|||
37921420|NCT00680992|69608111|FG002|Overall Study|Lost to Follow-up|0|||
37921421|NCT00680992|69608109|FG000|Overall Study|Noncompliance|4|||
37921422|NCT00680992|69608110|FG001|Overall Study|Noncompliance|6|||
37921423|NCT00680992|69608111|FG002|Overall Study|Noncompliance|0|||
37921424|NCT00680992|69608109|FG000|Overall Study|Requirement for Alternative Therapy|8|||
37921425|NCT00680992|69608110|FG001|Overall Study|Requirement for Alternative Therapy|2|||
37921426|NCT00680992|69608111|FG002|Overall Study|Requirement for Alternative Therapy|0|||
37921427|NCT00680992|69608109|FG000|Overall Study|Pregnancy|5|||
37921428|NCT00680992|69608110|FG001|Overall Study|Pregnancy|0|||
37921429|NCT00680992|69608111|FG002|Overall Study|Pregnancy|1|||
37921430|NCT00680992|69608109|FG000|Overall Study|Death|5|||
37737481|NCT02985957|69219272|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
37737482|NCT02985957|69219273|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
37921431|NCT00680992|69608110|FG001|Overall Study|Death|1|||
37737483|NCT02985957|69219267|FG000|Treatment Period|Study drug toxicity|1|||
37921432|NCT00680992|69608111|FG002|Overall Study|Death|0|||
37921433|NCT00680992|69608109|FG000|Overall Study|Ineligibility Determined|0|||
37737484|NCT02985957|69219268|FG001|Treatment Period|Study drug toxicity|23|||
37737485|NCT02985957|69219269|FG002|Treatment Period|Study drug toxicity|20|||
37737486|NCT02985957|69219270|FG003|Treatment Period|Study drug toxicity|11|||
37921434|NCT00680992|69608110|FG001|Overall Study|Ineligibility Determined|1|||
37921435|NCT00680992|69608111|FG002|Overall Study|Ineligibility Determined|0|||
37921436|NCT00805389|69608125|FG000|Overall Study|Adverse Event|0|||
37921437|NCT00805389|69608126|FG001|Overall Study|Adverse Event|0|||
37737487|NCT02985957|69219271|FG004|Treatment Period|Study drug toxicity|19|||
37737488|NCT02985957|69219272|FG005|Treatment Period|Study drug toxicity|3|||
37852996|NCT01238835|69536813|FG000|Overall Study|Withdrawal by Subject|9|||
37737489|NCT02985957|69219273|FG006|Treatment Period|Study drug toxicity|5|||
37737490|NCT02985957|69219267|FG000|Treatment Period|Disease progression|0|||
37737491|NCT02985957|69219268|FG001|Treatment Period|Disease progression|16|||
37852997|NCT01238835|69536813|FG000|Overall Study|Lost to Follow-up|1|||
37852998|NCT01238835|69536813|FG000|Overall Study|Site early discontinuation|2|||
37852999|NCT01032070|69536819|FG000|Overall Study|Disease progression|13|||
38031596|NCT02572167|69717211|FG001|Overall Study|Did not meet inclusion criteria|0|||
38031597|NCT02572167|69717212|FG002|Overall Study|Did not meet inclusion criteria|1|||
37737492|NCT02985957|69219269|FG002|Treatment Period|Disease progression|20|||
37853000|NCT01032070|69536820|FG001|Overall Study|Disease progression|8|||
37853001|NCT01032070|69536819|FG000|Overall Study|Medical or ethical reasons|0|||
37853002|NCT01032070|69536820|FG001|Overall Study|Medical or ethical reasons|2|||
37853003|NCT01032070|69536819|FG000|Overall Study|Withdrawal by Subject|0|||
37853004|NCT01032070|69536820|FG001|Overall Study|Withdrawal by Subject|2|||
37737493|NCT02985957|69219270|FG003|Treatment Period|Disease progression|39|||
37737494|NCT02985957|69219271|FG004|Treatment Period|Disease progression|29|||
37737495|NCT02985957|69219272|FG005|Treatment Period|Disease progression|11|||
37737496|NCT02985957|69219273|FG006|Treatment Period|Disease progression|28|||
37737497|NCT02985957|69219267|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
37737498|NCT02985957|69219268|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
37737499|NCT02985957|69219269|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
37737500|NCT02985957|69219270|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
37737501|NCT02985957|69219271|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
37737502|NCT02985957|69219272|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
37737503|NCT02985957|69219273|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
37737504|NCT02985957|69219267|FG000|Treatment Period|Poor/Non-Compliance|0|||
37737505|NCT02985957|69219268|FG001|Treatment Period|Poor/Non-Compliance|0|||
37737506|NCT02985957|69219269|FG002|Treatment Period|Poor/Non-Compliance|0|||
37737507|NCT02985957|69219270|FG003|Treatment Period|Poor/Non-Compliance|0|||
37737508|NCT02985957|69219271|FG004|Treatment Period|Poor/Non-Compliance|1|||
37737509|NCT02985957|69219272|FG005|Treatment Period|Poor/Non-Compliance|1|||
37737510|NCT02985957|69219273|FG006|Treatment Period|Poor/Non-Compliance|0|||
37737511|NCT02985957|69219267|FG000|Treatment Period|Continuing in Treatment Period|0|||
37737512|NCT02985957|69219268|FG001|Treatment Period|Continuing in Treatment Period|1|||
37737513|NCT02985957|69219269|FG002|Treatment Period|Continuing in Treatment Period|0|||
37737514|NCT02985957|69219270|FG003|Treatment Period|Continuing in Treatment Period|4|||
37737515|NCT02985957|69219271|FG004|Treatment Period|Continuing in Treatment Period|4|||
37737516|NCT02985957|69219272|FG005|Treatment Period|Continuing in Treatment Period|0|||
37737517|NCT02985957|69219273|FG006|Treatment Period|Continuing in Treatment Period|0|||
37737518|NCT02903368|69219297|FG000|Part 1|Adverse Event|3|||
37737519|NCT02903368|69219298|FG001|Part 1|Adverse Event|0|||
37737520|NCT02903368|69219299|FG002|Part 1|Adverse Event|0|||
37737521|NCT02903368|69219300|FG003|Part 1|Adverse Event|0|||
37737522|NCT02903368|69219297|FG000|Part 1|Withdrawal by Subject|1|||
37737523|NCT02903368|69219298|FG001|Part 1|Withdrawal by Subject|0|||
37737524|NCT02903368|69219299|FG002|Part 1|Withdrawal by Subject|0|||
37737525|NCT02903368|69219300|FG003|Part 1|Withdrawal by Subject|0|||
37737526|NCT02903368|69219297|FG000|Part 2|Adverse Event|0|||
37737527|NCT02903368|69219298|FG001|Part 2|Adverse Event|0|||
37737528|NCT02903368|69219299|FG002|Part 2|Adverse Event|5|||
37737529|NCT02903368|69219300|FG003|Part 2|Adverse Event|0|||
37737530|NCT02903368|69219297|FG000|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
37737531|NCT02903368|69219298|FG001|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
37737532|NCT02903368|69219299|FG002|Part 2|Subject withdrew after 6 cycles of protocol therapy.|1|||
37737533|NCT02903368|69219300|FG003|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
37737534|NCT02903368|69219297|FG000|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
37737535|NCT02903368|69219298|FG001|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
37737536|NCT02903368|69219299|FG002|Part 2|Subject withdrew after part-2 randomization and remained on observation.|4|||
37737537|NCT02903368|69219300|FG003|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
37737538|NCT02903368|69219297|FG000|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
37737539|NCT02903368|69219298|FG001|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
37737540|NCT02903368|69219299|FG002|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|1|||
37737541|NCT02903368|69219300|FG003|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|2|||
37737542|NCT02753127|69219320|FG000|Overall Study|Lost to Follow-up|13|||
37737543|NCT02753127|69219321|FG001|Overall Study|Lost to Follow-up|11|||
37737544|NCT02753127|69219320|FG000|Overall Study|Withdrawal by Subject|37|||
37737545|NCT02753127|69219321|FG001|Overall Study|Withdrawal by Subject|47|||
37737546|NCT02753127|69219320|FG000|Overall Study|Other|3|||
37737547|NCT02753127|69219321|FG001|Overall Study|Other|8|||
37737548|NCT02753127|69219320|FG000|Overall Study|Hospice|0|||
37737549|NCT02753127|69219321|FG001|Overall Study|Hospice|2|||
37737550|NCT02657551|69219335|FG000|Overall Study|Adverse Event|2|||
37737551|NCT02657551|69219335|FG000|Overall Study|Withdrawal by Subject|1|||
37853005|NCT01237899|69536837|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
37853006|NCT01237899|69536838|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
37853007|NCT01237899|69536839|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
37853008|NCT01237899|69536840|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
37921438|NCT00805389|69608127|FG002|Overall Study|Adverse Event|1|||
38031598|NCT02572167|69717210|FG000|Overall Study|Study closure by Sponsor|4|||
38031599|NCT02572167|69717211|FG001|Overall Study|Study closure by Sponsor|40|||
37921439|NCT00805389|69608128|FG003|Overall Study|Adverse Event|2|||
37921440|NCT00805389|69608129|FG004|Overall Study|Adverse Event|0|||
38031600|NCT02572167|69717212|FG002|Overall Study|Study closure by Sponsor|24|||
38031601|NCT01336738|69717226|FG000|Overall Study|Adverse Event|0|||
38031602|NCT01336738|69717227|FG001|Overall Study|Adverse Event|3|||
38031603|NCT01336738|69717228|FG002|Overall Study|Adverse Event|2|||
38031604|NCT01336738|69717229|FG003|Overall Study|Adverse Event|1|||
38031605|NCT01336738|69717230|FG004|Overall Study|Adverse Event|3|||
38031606|NCT01336738|69717226|FG000|Overall Study|Lost to Follow-up|2|||
38031607|NCT01336738|69717227|FG001|Overall Study|Lost to Follow-up|1|||
38031608|NCT01336738|69717228|FG002|Overall Study|Lost to Follow-up|2|||
38031609|NCT01336738|69717229|FG003|Overall Study|Lost to Follow-up|2|||
38031610|NCT01336738|69717230|FG004|Overall Study|Lost to Follow-up|2|||
38031611|NCT01336738|69717226|FG000|Overall Study|Did not meet entrance criteria|0|||
38031612|NCT01336738|69717227|FG001|Overall Study|Did not meet entrance criteria|1|||
38031613|NCT01336738|69717228|FG002|Overall Study|Did not meet entrance criteria|0|||
38031614|NCT01336738|69717229|FG003|Overall Study|Did not meet entrance criteria|0|||
38031615|NCT01336738|69717230|FG004|Overall Study|Did not meet entrance criteria|0|||
38031616|NCT01336738|69717226|FG000|Overall Study|Protocol Violation|0|||
38031617|NCT01336738|69717227|FG001|Overall Study|Protocol Violation|1|||
38031618|NCT01336738|69717228|FG002|Overall Study|Protocol Violation|0|||
38031619|NCT01336738|69717229|FG003|Overall Study|Protocol Violation|0|||
38031620|NCT01336738|69717230|FG004|Overall Study|Protocol Violation|0|||
38031621|NCT01336738|69717226|FG000|Overall Study|Withdrawal by Subject|2|||
38031622|NCT01336738|69717227|FG001|Overall Study|Withdrawal by Subject|0|||
38031623|NCT01336738|69717228|FG002|Overall Study|Withdrawal by Subject|2|||
38031624|NCT01336738|69717229|FG003|Overall Study|Withdrawal by Subject|1|||
38031625|NCT01336738|69717230|FG004|Overall Study|Withdrawal by Subject|1|||
38031626|NCT01336738|69717226|FG000|Overall Study|Other|3|||
38031627|NCT01336738|69717227|FG001|Overall Study|Other|3|||
38031628|NCT01336738|69717228|FG002|Overall Study|Other|2|||
38031629|NCT01336738|69717229|FG003|Overall Study|Other|3|||
38031630|NCT01336738|69717230|FG004|Overall Study|Other|4|||
38031631|NCT02865538|69717247|FG000|Overall Study|Withdrawal by Subject|0|||
38031632|NCT02865538|69717248|FG001|Overall Study|Withdrawal by Subject|0|||
38031633|NCT02865538|69717249|FG002|Overall Study|Withdrawal by Subject|1|||
38031634|NCT02865538|69717250|FG003|Overall Study|Withdrawal by Subject|0|||
38031635|NCT02865538|69717251|FG004|Overall Study|Withdrawal by Subject|0|||
38031636|NCT02865538|69717247|FG000|Overall Study|Lost to Follow-up|1|||
38031637|NCT02865538|69717248|FG001|Overall Study|Lost to Follow-up|0|||
38031638|NCT02865538|69717249|FG002|Overall Study|Lost to Follow-up|0|||
38031639|NCT02865538|69717250|FG003|Overall Study|Lost to Follow-up|0|||
38031640|NCT02865538|69717251|FG004|Overall Study|Lost to Follow-up|0|||
38031641|NCT02860546|69717263|FG000|Overall Study|Clinical Progression|6|||
38031642|NCT02860546|69717263|FG000|Overall Study|Radiological Progression|12|||
38031643|NCT01982955|69717272|FG000|Overall Study|Randomized but not treated|0|||
38031644|NCT01982955|69717273|FG001|Overall Study|Randomized but not treated|0|||
37921441|NCT00805389|69608125|FG000|Overall Study|Lost to Follow-up|4|||
37921442|NCT00805389|69608126|FG001|Overall Study|Lost to Follow-up|3|||
37921443|NCT00805389|69608127|FG002|Overall Study|Lost to Follow-up|6|||
37921444|NCT00805389|69608128|FG003|Overall Study|Lost to Follow-up|10|||
37921445|NCT00805389|69608129|FG004|Overall Study|Lost to Follow-up|9|||
37921446|NCT00805389|69608125|FG000|Overall Study|Protocol Violation|0|||
37921447|NCT00805389|69608126|FG001|Overall Study|Protocol Violation|0|||
37921448|NCT00805389|69608127|FG002|Overall Study|Protocol Violation|1|||
37921449|NCT00805389|69608128|FG003|Overall Study|Protocol Violation|0|||
38031645|NCT01982955|69717274|FG002|Overall Study|Randomized but not treated|0|||
38031646|NCT01982955|69717275|FG003|Overall Study|Randomized but not treated|1|||
38031647|NCT01982955|69717276|FG004|Overall Study|Randomized but not treated|0|||
38031648|NCT00396279|69717289|FG000|Overall Study|Ongoing in study|26|||
38031649|NCT00396279|69717289|FG000|Overall Study|Disease progression|2|||
38031650|NCT00396279|69717289|FG000|Overall Study|Withdrawal by Subject|1|||
38031651|NCT00396279|69717289|FG000|Overall Study|Physician Decision|1|||
38031652|NCT01347866|69717310|FG000|Overall Study|Death|0|||
38031653|NCT01347866|69717311|FG001|Overall Study|Death|0|||
38031654|NCT01347866|69717312|FG002|Overall Study|Death|0|||
37921450|NCT00805389|69608129|FG004|Overall Study|Protocol Violation|0|||
38031655|NCT01347866|69717313|FG003|Overall Study|Death|1|||
38031656|NCT01347866|69717314|FG004|Overall Study|Death|2|||
38031657|NCT01347866|69717315|FG005|Overall Study|Death|2|||
38031658|NCT01347866|69717316|FG006|Overall Study|Death|1|||
38031659|NCT01347866|69717317|FG007|Overall Study|Death|0|||
38031660|NCT01347866|69717318|FG008|Overall Study|Death|4|||
38031661|NCT01347866|69717319|FG009|Overall Study|Death|1|||
38031662|NCT01347866|69717320|FG010|Overall Study|Death|3|||
38031663|NCT01347866|69717321|FG011|Overall Study|Death|1|||
38031664|NCT01347866|69717322|FG012|Overall Study|Death|2|||
38031665|NCT01347866|69717323|FG013|Overall Study|Death|0|||
38031666|NCT01347866|69717324|FG014|Overall Study|Death|0|||
38031667|NCT01347866|69717325|FG015|Overall Study|Death|1|||
38031668|NCT01347866|69717326|FG016|Overall Study|Death|0|||
38031669|NCT01347866|69717310|FG000|Overall Study|Lost to Follow-up|0|||
38031670|NCT01347866|69717311|FG001|Overall Study|Lost to Follow-up|0|||
38031671|NCT01347866|69717312|FG002|Overall Study|Lost to Follow-up|0|||
38031672|NCT01347866|69717313|FG003|Overall Study|Lost to Follow-up|0|||
38031673|NCT01347866|69717314|FG004|Overall Study|Lost to Follow-up|0|||
38031674|NCT01347866|69717315|FG005|Overall Study|Lost to Follow-up|0|||
38031675|NCT01347866|69717316|FG006|Overall Study|Lost to Follow-up|0|||
38031676|NCT01347866|69717317|FG007|Overall Study|Lost to Follow-up|1|||
38031677|NCT01347866|69717318|FG008|Overall Study|Lost to Follow-up|1|||
38031678|NCT01347866|69717319|FG009|Overall Study|Lost to Follow-up|0|||
38031679|NCT01347866|69717320|FG010|Overall Study|Lost to Follow-up|0|||
38031680|NCT01347866|69717321|FG011|Overall Study|Lost to Follow-up|0|||
38031681|NCT01347866|69717322|FG012|Overall Study|Lost to Follow-up|0|||
38031682|NCT01347866|69717323|FG013|Overall Study|Lost to Follow-up|0|||
38031683|NCT01347866|69717324|FG014|Overall Study|Lost to Follow-up|0|||
38031684|NCT01347866|69717325|FG015|Overall Study|Lost to Follow-up|0|||
38031685|NCT01347866|69717326|FG016|Overall Study|Lost to Follow-up|0|||
38031686|NCT01347866|69717310|FG000|Overall Study|Other|3|||
38031687|NCT01347866|69717311|FG001|Overall Study|Other|1|||
38031688|NCT01347866|69717312|FG002|Overall Study|Other|1|||
38031689|NCT01347866|69717313|FG003|Overall Study|Other|4|||
38031690|NCT01347866|69717314|FG004|Overall Study|Other|5|||
38031691|NCT01347866|69717315|FG005|Overall Study|Other|0|||
38031692|NCT01347866|69717316|FG006|Overall Study|Other|5|||
38031693|NCT01347866|69717317|FG007|Overall Study|Other|3|||
38031694|NCT01347866|69717318|FG008|Overall Study|Other|22|||
38031695|NCT01347866|69717319|FG009|Overall Study|Other|5|||
38031696|NCT01347866|69717320|FG010|Overall Study|Other|0|||
38031697|NCT01347866|69717321|FG011|Overall Study|Other|3|||
38031698|NCT01347866|69717322|FG012|Overall Study|Other|4|||
38031699|NCT01347866|69717323|FG013|Overall Study|Other|4|||
38031700|NCT01347866|69717324|FG014|Overall Study|Other|2|||
38031701|NCT01347866|69717325|FG015|Overall Study|Other|3|||
38031702|NCT01347866|69717326|FG016|Overall Study|Other|0|||
38031703|NCT01347866|69717310|FG000|Overall Study|Subject refused further follow-up|2|||
38031704|NCT01347866|69717311|FG001|Overall Study|Subject refused further follow-up|0|||
38031705|NCT01347866|69717312|FG002|Overall Study|Subject refused further follow-up|0|||
37853009|NCT01237899|69536841|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
37853010|NCT01237899|69536842|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
37853011|NCT01237899|69536843|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
38031706|NCT01347866|69717313|FG003|Overall Study|Subject refused further follow-up|2|||
38031707|NCT01347866|69717314|FG004|Overall Study|Subject refused further follow-up|0|||
38031708|NCT01347866|69717315|FG005|Overall Study|Subject refused further follow-up|1|||
38031709|NCT01347866|69717316|FG006|Overall Study|Subject refused further follow-up|0|||
38031710|NCT01347866|69717317|FG007|Overall Study|Subject refused further follow-up|0|||
38031711|NCT01347866|69717318|FG008|Overall Study|Subject refused further follow-up|4|||
38031712|NCT01347866|69717319|FG009|Overall Study|Subject refused further follow-up|1|||
38031713|NCT01347866|69717320|FG010|Overall Study|Subject refused further follow-up|0|||
37853012|NCT01237899|69536844|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
37853013|NCT01237899|69536845|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
37853014|NCT01237899|69536846|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
38031714|NCT01347866|69717321|FG011|Overall Study|Subject refused further follow-up|0|||
38031715|NCT01347866|69717322|FG012|Overall Study|Subject refused further follow-up|1|||
38031716|NCT01347866|69717323|FG013|Overall Study|Subject refused further follow-up|3|||
38031717|NCT01347866|69717324|FG014|Overall Study|Subject refused further follow-up|1|||
38031718|NCT01347866|69717325|FG015|Overall Study|Subject refused further follow-up|0|||
38031719|NCT01347866|69717326|FG016|Overall Study|Subject refused further follow-up|2|||
38031720|NCT01347710|69717397|FG000|Overall Study|Withdrawal by Subject|2|||
38031721|NCT01347710|69717397|FG000|Overall Study|Adverse Event|4|||
38031722|NCT01347710|69717397|FG000|Overall Study|Angio or SPECT not completed|18|||
38031723|NCT01347710|69717397|FG000|Overall Study|issue with vitals prior to dosing|1|||
38031724|NCT01347710|69717397|FG000|Overall Study|Lost to Follow-up|1|||
37737552|NCT02657551|69219335|FG000|Overall Study|Non-Compliance|1|||
37737553|NCT02657551|69219335|FG000|Overall Study|Progression / Relapse|4|||
37737554|NCT02577406|69219341|FG000|Randomized Period|Death|1|||
38031725|NCT01347710|69717397|FG000|Overall Study|Physician Decision|2|||
38031726|NCT01347710|69717397|FG000|Overall Study|Other|3|||
38031727|NCT03485222|69717407|FG000|Overall Study|Death|0|||
38031728|NCT03485222|69717408|FG001|Overall Study|Death|1|||
38031729|NCT03485222|69717407|FG000|Overall Study|Lost to Follow-up|2|||
38031730|NCT03485222|69717408|FG001|Overall Study|Lost to Follow-up|1|||
38031731|NCT01347554|69717416|FG000|Overall Study|Lack of Efficacy|7|||
38031732|NCT01347554|69717417|FG001|Overall Study|Lack of Efficacy|11|||
38031733|NCT03482882|69717423|FG000|Overall Study|Adverse Event|3|||
38031734|NCT03482882|69717423|FG000|Overall Study|Lost to Follow-up|1|||
38031735|NCT03482882|69717423|FG000|Overall Study|Protocol Violation|2|||
38031736|NCT03482882|69717423|FG000|Overall Study|Not further specified|1|||
38031737|NCT03480932|69717430|FG000|Overall Study|Death|1|||
38031738|NCT03480932|69717431|FG001|Overall Study|Death|1|||
38031739|NCT03480932|69717432|FG002|Overall Study|Death|0|||
38031740|NCT03480932|69717430|FG000|Overall Study|Lost to Follow-up|0|||
38031741|NCT03480932|69717431|FG001|Overall Study|Lost to Follow-up|2|||
38031742|NCT03480932|69717432|FG002|Overall Study|Lost to Follow-up|3|||
38031743|NCT03480932|69717430|FG000|Overall Study|Incarcerated|2|||
38031744|NCT03480932|69717431|FG001|Overall Study|Incarcerated|2|||
38031745|NCT03480932|69717432|FG002|Overall Study|Incarcerated|2|||
38031746|NCT03387020|69717443|FG000|Overall Study|Adverse Event|0|||
38031747|NCT03387020|69717444|FG001|Overall Study|Adverse Event|2|||
38031748|NCT03387020|69717445|FG002|Overall Study|Adverse Event|0|||
37737555|NCT02577406|69219342|FG001|Randomized Period|Death|0|||
37737556|NCT02577406|69219341|FG000|Randomized Period|Other reasons|0|||
38031749|NCT03387020|69717443|FG000|Overall Study|Withdrawal by Subject|2|||
38031750|NCT03387020|69717444|FG001|Overall Study|Withdrawal by Subject|0|||
38031751|NCT03387020|69717445|FG002|Overall Study|Withdrawal by Subject|0|||
38031752|NCT03386474|69717465|FG000|Overall Study|Death|1|||
37921451|NCT00805389|69608125|FG000|Overall Study|Withdrawal by Subject|3|||
37921452|NCT00805389|69608126|FG001|Overall Study|Withdrawal by Subject|2|||
37921453|NCT00805389|69608127|FG002|Overall Study|Withdrawal by Subject|4|||
37921454|NCT00805389|69608128|FG003|Overall Study|Withdrawal by Subject|5|||
37921455|NCT00805389|69608129|FG004|Overall Study|Withdrawal by Subject|4|||
37921456|NCT00678886|69608153|FG000|Overall Study|Withdrawal by Subject|0|||
37921457|NCT00678886|69608154|FG001|Overall Study|Withdrawal by Subject|0|||
37921458|NCT00678886|69608155|FG002|Overall Study|Withdrawal by Subject|4|||
37921459|NCT00678886|69608156|FG003|Overall Study|Withdrawal by Subject|6|||
37921460|NCT00678886|69608153|FG000|Overall Study|Physician Decision|0|||
37921461|NCT00678886|69608154|FG001|Overall Study|Physician Decision|0|||
37921462|NCT00678886|69608155|FG002|Overall Study|Physician Decision|1|||
37921463|NCT00678886|69608156|FG003|Overall Study|Physician Decision|1|||
37921464|NCT00678886|69608153|FG000|Overall Study|Lost to Follow-up|0|||
37921465|NCT00678886|69608154|FG001|Overall Study|Lost to Follow-up|0|||
37921466|NCT00678886|69608155|FG002|Overall Study|Lost to Follow-up|3|||
37921467|NCT00678886|69608156|FG003|Overall Study|Lost to Follow-up|2|||
37737557|NCT02577406|69219342|FG001|Randomized Period|Other reasons|20|||
37853015|NCT01237899|69536847|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
37853016|NCT01264380|69536865|FG000|Period C|Disease Progression|0|||
37853017|NCT01264380|69536866|FG001|Period C|Disease Progression|0|||
37853018|NCT01264380|69536867|FG002|Period C|Disease Progression|4|||
37853019|NCT01264380|69536865|FG000|Period C|Death|0|||
37853020|NCT01264380|69536866|FG001|Period C|Death|0|||
37853021|NCT01264380|69536867|FG002|Period C|Death|2|||
37853022|NCT01264380|69536865|FG000|Period C|Follow-up for survival status|0|||
37853023|NCT01264380|69536866|FG001|Period C|Follow-up for survival status|0|||
37853024|NCT01264380|69536867|FG002|Period C|Follow-up for survival status|6|||
37737558|NCT02577406|69219341|FG000|Treatment Period|Transition to commercially available treatment|1|||
37853025|NCT01264380|69536865|FG000|Period C|Withdrawal by Subject|0|||
37853026|NCT01264380|69536866|FG001|Period C|Withdrawal by Subject|0|||
37853027|NCT01264380|69536867|FG002|Period C|Withdrawal by Subject|1|||
37853028|NCT01264380|69536865|FG000|Period C|Adverse Event|0|||
37853029|NCT01264380|69536866|FG001|Period C|Adverse Event|0|||
37853030|NCT01264380|69536867|FG002|Period C|Adverse Event|1|||
37853031|NCT01263444|69536875|FG000|Overall Study|Adverse Event|8|||
37853032|NCT01263444|69536875|FG000|Overall Study|Withdrawal by Subject|1|||
37853033|NCT01263444|69536875|FG000|Overall Study|Protocol Violation|1|||
37737559|NCT02577406|69219342|FG001|Treatment Period|Transition to commercially available treatment|0|||
37737560|NCT02577406|69219341|FG000|Treatment Period|Progressive disease|47|||
37921468|NCT00678886|69608153|FG000|Overall Study|Other|0|||
37853034|NCT01263054|69536881|FG000|Overall Study|Death|1|||
37853035|NCT01263054|69536882|FG001|Overall Study|Death|0|||
38031753|NCT03386474|69717466|FG001|Overall Study|Death|0|||
37737561|NCT02577406|69219342|FG001|Treatment Period|Progressive disease|36|||
37737562|NCT02577406|69219341|FG000|Treatment Period|Death|36|||
37737563|NCT02577406|69219342|FG001|Treatment Period|Death|23|||
37921469|NCT00678886|69608154|FG001|Overall Study|Other|0|||
37737564|NCT02577406|69219341|FG000|Treatment Period|Other reasons|3|||
37921470|NCT00678886|69608155|FG002|Overall Study|Other|1|||
37921471|NCT00678886|69608156|FG003|Overall Study|Other|0|||
37921472|NCT00804843|69608167|FG000|Overall Study|Protocol Violation|1|||
37737565|NCT02577406|69219342|FG001|Treatment Period|Other reasons|37|||
37921473|NCT00804843|69608168|FG001|Overall Study|Protocol Violation|0|||
37921474|NCT00804843|69608167|FG000|Overall Study|Adverse Event|8|||
37921475|NCT00804843|69608168|FG001|Overall Study|Adverse Event|5|||
37921476|NCT00804843|69608167|FG000|Overall Study|Withdrawal by Subject|1|||
37921477|NCT00804843|69608168|FG001|Overall Study|Withdrawal by Subject|2|||
38031754|NCT03386474|69717465|FG000|Overall Study|Adverse Event|0|||
37737566|NCT02577406|69219341|FG000|Treatment Period|Withdrawal by Subject|10|||
37737567|NCT02577406|69219342|FG001|Treatment Period|Withdrawal by Subject|24|||
37737568|NCT02577406|69219341|FG000|Treatment Period|Adverse Event|17|||
38031755|NCT03386474|69717466|FG001|Overall Study|Adverse Event|1|||
37737569|NCT02577406|69219342|FG001|Treatment Period|Adverse Event|12|||
37737570|NCT02577406|69219341|FG000|Treatment Period|Disease relapse|27|||
37737571|NCT02577406|69219342|FG001|Treatment Period|Disease relapse|1|||
37737572|NCT02577406|69219341|FG000|Treatment Period|HSCT|6|||
37737573|NCT02577406|69219342|FG001|Treatment Period|HSCT|2|||
37737574|NCT02577406|69219341|FG000|Treatment Period|Lost to Follow-up|0|||
37737575|NCT02577406|69219342|FG001|Treatment Period|Lost to Follow-up|1|||
37737576|NCT02577406|69219341|FG000|Treatment Period|Protocol Violation|0|||
37737577|NCT02577406|69219342|FG001|Treatment Period|Protocol Violation|1|||
37737578|NCT02527434|69219364|FG000|Overall Study|Lost to Follow-up|2|||
37737579|NCT02527434|69219365|FG001|Overall Study|Lost to Follow-up|2|||
37737580|NCT02527434|69219366|FG002|Overall Study|Lost to Follow-up|0|||
37737581|NCT02527434|69219364|FG000|Overall Study|Death|19|||
37737582|NCT02527434|69219365|FG001|Overall Study|Death|6|||
37737583|NCT02527434|69219366|FG002|Overall Study|Death|17|||
37737584|NCT02527434|69219364|FG000|Overall Study|Withdrawal by Subject|5|||
37737585|NCT02527434|69219365|FG001|Overall Study|Withdrawal by Subject|3|||
37737586|NCT02527434|69219366|FG002|Overall Study|Withdrawal by Subject|3|||
37737587|NCT02527434|69219364|FG000|Overall Study|Reason Not Specified|1|||
37737588|NCT02527434|69219365|FG001|Overall Study|Reason Not Specified|0|||
37737589|NCT02527434|69219366|FG002|Overall Study|Reason Not Specified|0|||
37737590|NCT02527434|69219364|FG000|Overall Study|Site closure|1|||
37737591|NCT02527434|69219365|FG001|Overall Study|Site closure|0|||
37737592|NCT02527434|69219366|FG002|Overall Study|Site closure|0|||
37737593|NCT02476916|69219386|FG000|Core Period|Adverse Event|2|||
37737594|NCT02476916|69219387|FG001|Core Period|Adverse Event|2|||
37737595|NCT02476916|69219386|FG000|Core Period|Investigator decision|1|||
37737596|NCT02476916|69219387|FG001|Core Period|Investigator decision|1|||
37737597|NCT02476916|69219386|FG000|Core Period|Withdrawal by Subject|3|||
37737598|NCT02476916|69219387|FG001|Core Period|Withdrawal by Subject|0|||
37853036|NCT01263054|69536881|FG000|Overall Study|Lost to Follow-up|2|||
37853037|NCT01263054|69536882|FG001|Overall Study|Lost to Follow-up|2|||
38031756|NCT03405818|69717477|FG000|Overall Study|Withdrawal by Subject|4|||
37737599|NCT02476916|69219386|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
37853038|NCT01263054|69536881|FG000|Overall Study|Withdrawal by Subject|1|||
37853039|NCT01263054|69536882|FG001|Overall Study|Withdrawal by Subject|3|||
37853040|NCT01263054|69536881|FG000|Overall Study|Qualification Violation|1|||
37921478|NCT00822120|69608177|FG000|Initial Registration|Adverse Event|1|||
37921479|NCT00822120|69608178|FG001|Initial Registration|Adverse Event|0|||
37921480|NCT00822120|69608179|FG002|Initial Registration|Adverse Event|0|||
37737600|NCT02476916|69219387|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
37737601|NCT02476916|69219386|FG000|Extension Period|On Treatment|12|||
37737602|NCT02476916|69219387|FG001|Extension Period|On Treatment|17|||
37737603|NCT02460835|69219394|FG000|Overall Study|Disease progression prior to treatment|3|||
37737604|NCT02460835|69219394|FG000|Overall Study|Unable to complete planning scans|2|||
37737605|NCT02460835|69219394|FG000|Overall Study|Decrease in performance status|1|||
37737606|NCT02460835|69219394|FG000|Overall Study|Withdrawal by Subject|3|||
37737607|NCT02460835|69219394|FG000|Overall Study|Underwent fractionated RT|10|||
37737608|NCT02460835|69219394|FG000|Overall Study|Unable to complete follow-up lab draws|2|||
37737609|NCT02231749|69219430|FG000|Overall Study|Disease progression|229|||
37737610|NCT02231749|69219431|FG001|Overall Study|Disease progression|297|||
37737611|NCT02231749|69219430|FG000|Overall Study|Study Drug Toxicity|134|||
37737612|NCT02231749|69219431|FG001|Overall Study|Study Drug Toxicity|63|||
37737613|NCT02231749|69219430|FG000|Overall Study|Death|1|||
37737614|NCT02231749|69219431|FG001|Overall Study|Death|1|||
37737615|NCT02231749|69219430|FG000|Overall Study|AE unrelated to Study drug|32|||
37737616|NCT02231749|69219431|FG001|Overall Study|AE unrelated to Study drug|31|||
37737617|NCT02231749|69219430|FG000|Overall Study|Participant's request to discontinue|10|||
37737618|NCT02231749|69219431|FG001|Overall Study|Participant's request to discontinue|21|||
37737619|NCT02231749|69219430|FG000|Overall Study|Participant withdrew Consent|8|||
37737620|NCT02231749|69219431|FG001|Overall Study|Participant withdrew Consent|15|||
37737621|NCT02231749|69219430|FG000|Overall Study|Lost to Follow-up|1|||
37737622|NCT02231749|69219431|FG001|Overall Study|Lost to Follow-up|2|||
37737623|NCT02231749|69219430|FG000|Overall Study|Maximum Clinical Benefit|5|||
37737624|NCT02231749|69219431|FG001|Overall Study|Maximum Clinical Benefit|8|||
37737625|NCT02231749|69219430|FG000|Overall Study|Poor/Non-Compliance|0|||
37737626|NCT02231749|69219431|FG001|Overall Study|Poor/Non-Compliance|3|||
37737627|NCT02231749|69219430|FG000|Overall Study|Pregnancy|1|||
37737628|NCT02231749|69219431|FG001|Overall Study|Pregnancy|0|||
37737629|NCT02231749|69219430|FG000|Overall Study|other|0|||
37737630|NCT02231749|69219431|FG001|Overall Study|other|8|||
37737631|NCT02231749|69219430|FG000|Overall Study|No longer meets Study Criteria|1|||
37737632|NCT02231749|69219431|FG001|Overall Study|No longer meets Study Criteria|0|||
37737633|NCT01776307|69219496|FG000|Overall Study|Not dosed|0|||
37737634|NCT01776307|69219497|FG001|Overall Study|Not dosed|0|||
37737635|NCT01776307|69219498|FG002|Overall Study|Not dosed|1|||
37737636|NCT00598481|69219558|FG000|Treatment|Physician Decision|1|||
37737637|NCT05419908|69219567|FG000|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|1|||
37737638|NCT05419908|69219568|FG001|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|0|||
37737639|NCT05419908|69219567|FG000|Overall Study|Serious Adverse Event|0|||
37737640|NCT05419908|69219568|FG001|Overall Study|Serious Adverse Event|2|||
37737641|NCT05419908|69219567|FG000|Overall Study|Withdrawal by Subject|2|||
37737642|NCT05419908|69219568|FG001|Overall Study|Withdrawal by Subject|0|||
37737643|NCT05419908|69219567|FG000|Overall Study|Miscellaneous|1|||
37737644|NCT05419908|69219568|FG001|Overall Study|Miscellaneous|1|||
37737645|NCT05091060|69219574|FG000|Overall Study|Lost to Follow-up|1|||
37737646|NCT05056311|69219578|FG000|Overall Study|Lost to Follow-up|14|||
37737647|NCT05056311|69219578|FG000|Overall Study|Withdrawal by Subject|1|||
37737648|NCT05056311|69219578|FG000|Overall Study|Dropped from study due to no Hypospadias|23|||
37737649|NCT05020899|69219585|FG000|8 Week Follow-up|Lost to Follow-up|3|||
37737650|NCT05020899|69219586|FG001|8 Week Follow-up|Lost to Follow-up|6|||
37737651|NCT05020899|69219585|FG000|12 Week Follow-up|Lost to Follow-up|1|||
37737652|NCT05020899|69219586|FG001|12 Week Follow-up|Lost to Follow-up|0|||
37737653|NCT05020899|69219585|FG000|12 Week Follow-up|Death|0|||
37737654|NCT05020899|69219586|FG001|12 Week Follow-up|Death|1|||
37737655|NCT04806503|69219625|FG000|Overall Study|Lost to Follow-up|0|||
37737656|NCT04806503|69219626|FG001|Overall Study|Lost to Follow-up|0|||
37737657|NCT04806503|69219627|FG002|Overall Study|Lost to Follow-up|1|||
37737658|NCT04806503|69219628|FG003|Overall Study|Lost to Follow-up|0|||
37737659|NCT04806503|69219629|FG004|Overall Study|Lost to Follow-up|0|||
37853041|NCT01263054|69536882|FG001|Overall Study|Qualification Violation|0|||
37853042|NCT01263054|69536881|FG000|Overall Study|Other|0|||
37737660|NCT04806503|69219625|FG000|Overall Study|Withdrawal by Subject|1|||
37737661|NCT04806503|69219626|FG001|Overall Study|Withdrawal by Subject|0|||
37737662|NCT04806503|69219627|FG002|Overall Study|Withdrawal by Subject|1|||
37737663|NCT04806503|69219628|FG003|Overall Study|Withdrawal by Subject|1|||
37737664|NCT04806503|69219629|FG004|Overall Study|Withdrawal by Subject|1|||
37737665|NCT04806503|69219625|FG000|Overall Study|Adverse Event|1|||
37853043|NCT01263054|69536882|FG001|Overall Study|Other|1|||
37737666|NCT04806503|69219626|FG001|Overall Study|Adverse Event|1|||
37737667|NCT04806503|69219627|FG002|Overall Study|Adverse Event|0|||
37737668|NCT04806503|69219628|FG003|Overall Study|Adverse Event|1|||
37737669|NCT04806503|69219629|FG004|Overall Study|Adverse Event|0|||
37737670|NCT04508751|69219645|FG000|Overall Study|Discontinued study early due to maternal discomfort|0|||
37737671|NCT04508751|69219646|FG001|Overall Study|Discontinued study early due to maternal discomfort|0|||
37737672|NCT04508751|69219647|FG002|Overall Study|Discontinued study early due to maternal discomfort|2|||
37737673|NCT04473482|69219657|FG000|Overall Study|Death|0|||
37737674|NCT04473482|69219658|FG001|Overall Study|Death|3|||
37737675|NCT04473482|69219657|FG000|Overall Study|Lost to Follow-up|9|||
37737676|NCT04473482|69219658|FG001|Overall Study|Lost to Follow-up|7|||
37737677|NCT04473482|69219657|FG000|Overall Study|Withdrawal by Subject|2|||
37737678|NCT04473482|69219658|FG001|Overall Study|Withdrawal by Subject|1|||
37737679|NCT03919799|69219668|FG000|DB Period (28 Weeks)|Randomized not treated|1|||
37737680|NCT03919799|69219669|FG001|DB Period (28 Weeks)|Randomized not treated|0|||
37737681|NCT03919799|69219670|FG002|DB Period (28 Weeks)|Randomized not treated|0|||
37737682|NCT03919799|69219671|FG003|DB Period (28 Weeks)|Randomized not treated|0|||
37737683|NCT03919799|69219672|FG004|DB Period (28 Weeks)|Randomized not treated|0|||
37737684|NCT03919799|69219668|FG000|DB Period (28 Weeks)|Adverse Event|1|||
37737685|NCT03919799|69219669|FG001|DB Period (28 Weeks)|Adverse Event|1|||
37737686|NCT03919799|69219670|FG002|DB Period (28 Weeks)|Adverse Event|1|||
37737687|NCT03919799|69219671|FG003|DB Period (28 Weeks)|Adverse Event|0|||
37737688|NCT03919799|69219672|FG004|DB Period (28 Weeks)|Adverse Event|0|||
38031757|NCT03405818|69717477|FG000|Overall Study|Lost to Follow-up|4|||
38031758|NCT03403634|69717481|FG000|Overall Study|Disease progression|3|||
38031759|NCT03403634|69717481|FG000|Overall Study|Did not meet eligibility criteria|4|||
38031760|NCT03403400|69717488|FG000|Overall Study|Lost to Follow-up|1|||
38031761|NCT03403400|69717489|FG001|Overall Study|Lost to Follow-up|0|||
38031762|NCT03403400|69717490|FG002|Overall Study|Lost to Follow-up|1|||
38031763|NCT03403400|69717488|FG000|Overall Study|Hospitalization|1|||
38031764|NCT03403400|69717489|FG001|Overall Study|Hospitalization|0|||
38031765|NCT03403400|69717490|FG002|Overall Study|Hospitalization|0|||
38031766|NCT03403400|69717488|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
38031767|NCT03403400|69717489|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
38031768|NCT03403400|69717490|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
38031769|NCT02863354|69717515|FG000|Year 1|Lost to Follow-up|1|||
38031770|NCT02863354|69717516|FG001|Year 1|Lost to Follow-up|1|||
38031771|NCT02863354|69717515|FG000|Year 1|Withdrawal by Subject|3|||
38031772|NCT02863354|69717516|FG001|Year 1|Withdrawal by Subject|0|||
38031773|NCT02863354|69717515|FG000|Year 1|Death|0|||
38031774|NCT02863354|69717516|FG001|Year 1|Death|1|||
38031775|NCT02863354|69717515|FG000|Year 2|Lost to Follow-up|2|||
38031776|NCT02863354|69717516|FG001|Year 2|Lost to Follow-up|2|||
38031777|NCT03480152|69717524|FG000|Phase I|Signed consent. Died before treatment.|1|||
38031778|NCT03480152|69717525|FG001|Phase I|Signed consent. Died before treatment.|0|||
38031779|NCT03480152|69717526|FG002|Phase I|Signed consent. Died before treatment.|0|||
38031780|NCT02859454|69717534|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
38031781|NCT02862730|69717541|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
38031782|NCT02862730|69717542|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
38031783|NCT02862730|69717543|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
38031784|NCT02862730|69717544|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
37737689|NCT03919799|69219668|FG000|DB Period (28 Weeks)|Withdrawal by Subject|0|||
37853044|NCT01031836|69536894|FG000|Stage I|Adverse Event|1|||
37853045|NCT01031836|69536895|FG001|Stage I|Adverse Event|1|||
37853046|NCT01031836|69536896|FG002|Stage I|Adverse Event|0|||
37853047|NCT01031836|69536897|FG003|Stage I|Adverse Event|0|||
38031785|NCT02862730|69717545|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
38031786|NCT02862730|69717546|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
37853048|NCT01031836|69536898|FG004|Stage I|Adverse Event|0|||
38031787|NCT02862730|69717547|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
37737690|NCT03919799|69219669|FG001|DB Period (28 Weeks)|Withdrawal by Subject|1|||
37737691|NCT03919799|69219670|FG002|DB Period (28 Weeks)|Withdrawal by Subject|0|||
37737692|NCT03919799|69219671|FG003|DB Period (28 Weeks)|Withdrawal by Subject|0|||
37737693|NCT03919799|69219672|FG004|DB Period (28 Weeks)|Withdrawal by Subject|0|||
37737694|NCT03919799|69219668|FG000|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
37737695|NCT03919799|69219669|FG001|OLE Period (24 Weeks)|Withdrawal by Subject|2|||
37737696|NCT03919799|69219670|FG002|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
37737697|NCT03919799|69219671|FG003|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
37737698|NCT03919799|69219672|FG004|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
37737699|NCT03919799|69219668|FG000|OLE Period (24 Weeks)|Other-unspecified|0|||
37737700|NCT03919799|69219669|FG001|OLE Period (24 Weeks)|Other-unspecified|1|||
37737701|NCT03919799|69219670|FG002|OLE Period (24 Weeks)|Other-unspecified|0|||
37737702|NCT03919799|69219671|FG003|OLE Period (24 Weeks)|Other-unspecified|0|||
37737703|NCT03919799|69219672|FG004|OLE Period (24 Weeks)|Other-unspecified|0|||
37737704|NCT03621735|69219717|FG000|Overall Study|Withdrawal by Subject|13|||
37737705|NCT03621735|69219718|FG001|Overall Study|Withdrawal by Subject|13|||
37737706|NCT03245151|69219778|FG000|Overall Study|Withdrawal by Subject|2|||
37737707|NCT03245151|69219779|FG001|Overall Study|Withdrawal by Subject|0|||
37737708|NCT03245151|69219780|FG002|Overall Study|Withdrawal by Subject|0|||
37737709|NCT03245151|69219781|FG003|Overall Study|Withdrawal by Subject|2|||
37737710|NCT03245151|69219782|FG004|Overall Study|Withdrawal by Subject|1|||
37737711|NCT03245151|69219778|FG000|Overall Study|Death|3|||
37737712|NCT03245151|69219779|FG001|Overall Study|Death|14|||
37737713|NCT03245151|69219780|FG002|Overall Study|Death|9|||
37737714|NCT03245151|69219781|FG003|Overall Study|Death|16|||
37737715|NCT03245151|69219782|FG004|Overall Study|Death|7|||
37737716|NCT03245151|69219778|FG000|Overall Study|Sponsor's decision|0|||
37737717|NCT03245151|69219779|FG001|Overall Study|Sponsor's decision|1|||
37737718|NCT03245151|69219780|FG002|Overall Study|Sponsor's decision|0|||
37737719|NCT03245151|69219781|FG003|Overall Study|Sponsor's decision|0|||
37737720|NCT03245151|69219782|FG004|Overall Study|Sponsor's decision|0|||
37737721|NCT03075527|69219795|FG000|Overall Study|Ongoing treatment|2|||
37737722|NCT02227199|69219820|FG000|Overall Study|Physician Decision|0|||
37737723|NCT02227199|69219821|FG001|Overall Study|Physician Decision|0|||
37853049|NCT01031836|69536899|FG005|Stage I|Adverse Event|0|||
37737724|NCT02227199|69219822|FG002|Overall Study|Physician Decision|1|||
37737725|NCT02227199|69219820|FG000|Overall Study|Adverse Event|0|||
37737726|NCT02227199|69219821|FG001|Overall Study|Adverse Event|0|||
37737727|NCT02227199|69219822|FG002|Overall Study|Adverse Event|3|||
37853050|NCT01031836|69536894|FG000|Stage I|Other|0|||
37737728|NCT02087865|69219837|FG000|Overall Study|Withdrawal by Subject|6|||
37853051|NCT01031836|69536895|FG001|Stage I|Other|1|||
37737729|NCT02087865|69219838|FG001|Overall Study|Withdrawal by Subject|0|||
37737730|NCT02087865|69219839|FG002|Overall Study|Withdrawal by Subject|1|||
37737731|NCT02087865|69219837|FG000|Overall Study|Lost to Follow-up|0|||
37737732|NCT02087865|69219838|FG001|Overall Study|Lost to Follow-up|0|||
37737733|NCT02087865|69219839|FG002|Overall Study|Lost to Follow-up|1|||
37737734|NCT02087865|69219837|FG000|Overall Study|Drug Non-compliance|0|||
37737735|NCT02087865|69219838|FG001|Overall Study|Drug Non-compliance|2|||
37737736|NCT02087865|69219839|FG002|Overall Study|Drug Non-compliance|0|||
37737737|NCT02087865|69219837|FG000|Overall Study|Not analyzed due to anatomical abnormalities|0|||
37737738|NCT02087865|69219838|FG001|Overall Study|Not analyzed due to anatomical abnormalities|1|||
37737739|NCT02087865|69219839|FG002|Overall Study|Not analyzed due to anatomical abnormalities|1|||
37737740|NCT01682083|69219859|FG000|Overall Study|Lost to Follow-up|11|||
37737741|NCT01682083|69219860|FG001|Overall Study|Lost to Follow-up|18|||
37737742|NCT01682083|69219859|FG000|Overall Study|Withdrawal by Subject|31|||
37737743|NCT01682083|69219860|FG001|Overall Study|Withdrawal by Subject|40|||
37737744|NCT01682083|69219859|FG000|Overall Study|Death|60|||
37737745|NCT01682083|69219860|FG001|Overall Study|Death|93|||
37737746|NCT01682083|69219859|FG000|Overall Study|Physician Decision|5|||
37737747|NCT01682083|69219860|FG001|Overall Study|Physician Decision|4|||
37737748|NCT01180790|69219877|FG000|Overall Study|Adverse Event|1|||
37737749|NCT01180790|69219878|FG001|Overall Study|Adverse Event|1|||
37737750|NCT01180790|69219879|FG002|Overall Study|Adverse Event|2|||
37737751|NCT01180790|69219880|FG003|Overall Study|Adverse Event|0|||
37737752|NCT01180790|69219881|FG004|Overall Study|Adverse Event|1|||
37737753|NCT01180790|69219882|FG005|Overall Study|Adverse Event|3|||
37737754|NCT01180790|69219883|FG006|Overall Study|Adverse Event|0|||
37737755|NCT01180790|69219877|FG000|Overall Study|Withdrawal by Subject|3|||
37737756|NCT01180790|69219878|FG001|Overall Study|Withdrawal by Subject|0|||
37737757|NCT01180790|69219879|FG002|Overall Study|Withdrawal by Subject|5|||
37737758|NCT01180790|69219880|FG003|Overall Study|Withdrawal by Subject|0|||
37737759|NCT01180790|69219881|FG004|Overall Study|Withdrawal by Subject|2|||
37737760|NCT01180790|69219882|FG005|Overall Study|Withdrawal by Subject|1|||
37737761|NCT01180790|69219883|FG006|Overall Study|Withdrawal by Subject|0|||
37737762|NCT01180790|69219877|FG000|Overall Study|Lost to Follow-up|3|||
37737763|NCT01180790|69219878|FG001|Overall Study|Lost to Follow-up|1|||
37737764|NCT01180790|69219879|FG002|Overall Study|Lost to Follow-up|0|||
37737765|NCT01180790|69219880|FG003|Overall Study|Lost to Follow-up|2|||
37737766|NCT01180790|69219881|FG004|Overall Study|Lost to Follow-up|1|||
37737767|NCT01180790|69219882|FG005|Overall Study|Lost to Follow-up|0|||
37737768|NCT01180790|69219883|FG006|Overall Study|Lost to Follow-up|1|||
37737769|NCT01180790|69219877|FG000|Overall Study|Physician Decision|1|||
37737770|NCT01180790|69219878|FG001|Overall Study|Physician Decision|0|||
37737771|NCT01180790|69219879|FG002|Overall Study|Physician Decision|0|||
37737772|NCT01180790|69219880|FG003|Overall Study|Physician Decision|1|||
37737773|NCT01180790|69219881|FG004|Overall Study|Physician Decision|0|||
37737774|NCT01180790|69219882|FG005|Overall Study|Physician Decision|0|||
37737775|NCT01180790|69219883|FG006|Overall Study|Physician Decision|0|||
37737776|NCT01180790|69219877|FG000|Overall Study|Lack of Efficacy|1|||
37737777|NCT01180790|69219878|FG001|Overall Study|Lack of Efficacy|2|||
37737778|NCT01180790|69219879|FG002|Overall Study|Lack of Efficacy|5|||
37737779|NCT01180790|69219880|FG003|Overall Study|Lack of Efficacy|6|||
37737780|NCT01180790|69219881|FG004|Overall Study|Lack of Efficacy|1|||
37737781|NCT01180790|69219882|FG005|Overall Study|Lack of Efficacy|3|||
37737782|NCT01180790|69219883|FG006|Overall Study|Lack of Efficacy|0|||
37737783|NCT01180790|69219877|FG000|Overall Study|compliance|0|||
37737784|NCT01180790|69219878|FG001|Overall Study|compliance|1|||
37737785|NCT01180790|69219879|FG002|Overall Study|compliance|0|||
37921481|NCT00822120|69608180|FG003|Initial Registration|Adverse Event|0|||
37737786|NCT01180790|69219880|FG003|Overall Study|compliance|0|||
37737787|NCT01180790|69219881|FG004|Overall Study|compliance|0|||
38031788|NCT02862730|69717541|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
38031789|NCT02862730|69717542|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
38031790|NCT02862730|69717543|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
38031791|NCT02862730|69717544|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
38031792|NCT02862730|69717545|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
38031793|NCT02862730|69717546|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
38031794|NCT02862730|69717547|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
37737788|NCT01180790|69219882|FG005|Overall Study|compliance|0|||
37737789|NCT01180790|69219883|FG006|Overall Study|compliance|0|||
37853052|NCT01031836|69536896|FG002|Stage I|Other|0|||
37737790|NCT01180790|69219877|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
37737791|NCT01180790|69219878|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
37737792|NCT01180790|69219879|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
37853053|NCT01031836|69536897|FG003|Stage I|Other|0|||
37853054|NCT01031836|69536898|FG004|Stage I|Other|0|||
37737793|NCT01180790|69219880|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
37853055|NCT01031836|69536899|FG005|Stage I|Other|1|||
38031795|NCT02862730|69717541|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
38031796|NCT02862730|69717542|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
38031797|NCT02862730|69717543|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
38031798|NCT02862730|69717544|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
38031799|NCT02862730|69717545|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
38031800|NCT02862730|69717546|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
38031801|NCT02862730|69717547|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
38031802|NCT02862730|69717541|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
38031803|NCT02862730|69717542|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
37853056|NCT01031836|69536894|FG000|Stage II|Adverse Event|0|||
37853057|NCT01031836|69536895|FG001|Stage II|Adverse Event|0|||
38031804|NCT02862730|69717543|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
38031805|NCT02862730|69717544|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
38031806|NCT02862730|69717545|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
38031807|NCT02862730|69717546|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
38031808|NCT02862730|69717547|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
38031809|NCT03402386|69717562|FG000|Overall Study|Adverse Event|3|||
38031810|NCT03402386|69717562|FG000|Overall Study|Physician Decision|1|||
38031811|NCT03402386|69717562|FG000|Overall Study|Difficult to control Hb|2|||
38031812|NCT03353792|69717568|FG000|Overall Study|Lost to Follow-up|1|||
38031813|NCT03353792|69717569|FG001|Overall Study|Lost to Follow-up|0|||
38031814|NCT03353792|69717568|FG000|Overall Study|Participant Unable to Manage Device|1|||
38031815|NCT03353792|69717569|FG001|Overall Study|Participant Unable to Manage Device|0|||
38031816|NCT02862574|69717578|FG000|Double-Blind Treatment Period|Adverse Event|0|||
38031817|NCT02862574|69717579|FG001|Double-Blind Treatment Period|Adverse Event|1|||
37737794|NCT01180790|69219881|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
37737795|NCT01180790|69219882|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
37737796|NCT01180790|69219883|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
37737797|NCT01112306|69219928|FG000|Overall Study|Death|175|||
37737798|NCT01112306|69219928|FG000|Overall Study|Lost to Follow-up|9|||
37737799|NCT01112306|69219928|FG000|Overall Study|Withdrawal by Subject|31|||
37737800|NCT01112306|69219928|FG000|Overall Study|Other|70|||
37737801|NCT00679042|69219936|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
37737802|NCT00679042|69219936|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
37853058|NCT01031836|69536896|FG002|Stage II|Adverse Event|2|||
37853059|NCT01031836|69536897|FG003|Stage II|Adverse Event|2|||
37853060|NCT01031836|69536898|FG004|Stage II|Adverse Event|1|||
37853061|NCT01031836|69536899|FG005|Stage II|Adverse Event|1|||
37853062|NCT01031836|69536894|FG000|Stage II|Other|2|||
37853063|NCT01031836|69536895|FG001|Stage II|Other|0|||
37853064|NCT01031836|69536896|FG002|Stage II|Other|0|||
37853065|NCT01031836|69536897|FG003|Stage II|Other|1|||
37853066|NCT01031836|69536898|FG004|Stage II|Other|1|||
37853067|NCT01031836|69536899|FG005|Stage II|Other|0|||
37737803|NCT00679042|69219936|FG000|5-Year Follow Up|Death|1|||
37853068|NCT01237587|69536915|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
37921482|NCT00822120|69608181|FG004|Initial Registration|Adverse Event|0|||
37921483|NCT00822120|69608182|FG005|Initial Registration|Adverse Event|0|||
37921484|NCT00822120|69608177|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
37921485|NCT00822120|69608178|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
37921486|NCT00822120|69608179|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
37921487|NCT00822120|69608180|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
37921488|NCT00822120|69608181|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
37921489|NCT00822120|69608182|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
37921490|NCT00822120|69608177|FG000|Initial Registration|Reasons not Protocol Specified|2|||
37921491|NCT00822120|69608178|FG001|Initial Registration|Reasons not Protocol Specified|0|||
38031818|NCT02862574|69717580|FG002|Double-Blind Treatment Period|Adverse Event|0|||
37737804|NCT00679042|69219936|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
37853069|NCT01237587|69536916|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
37853070|NCT01237587|69536915|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
37853071|NCT01237587|69536916|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
37853072|NCT01237587|69536915|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
37853073|NCT01237587|69536916|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
37853074|NCT01237587|69536915|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
37853075|NCT01237587|69536916|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
37853076|NCT01237587|69536915|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
37853077|NCT01237587|69536916|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
37853078|NCT01237587|69536915|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
37853079|NCT01237587|69536916|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
37853080|NCT01237587|69536915|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
37853081|NCT01237587|69536916|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
37921492|NCT00822120|69608179|FG002|Initial Registration|Reasons not Protocol Specified|0|||
37737805|NCT00679042|69219936|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
37921493|NCT00822120|69608180|FG003|Initial Registration|Reasons not Protocol Specified|0|||
37921494|NCT00822120|69608181|FG004|Initial Registration|Reasons not Protocol Specified|0|||
37737806|NCT00350272|69219966|FG000|Blinded 12-Week Treatment|Adverse Event|1|||
37737807|NCT00350272|69219967|FG001|Blinded 12-Week Treatment|Adverse Event|0|||
37737808|NCT00350272|69219966|FG000|Blinded 12-Week Treatment|Death|1|||
37737809|NCT00350272|69219967|FG001|Blinded 12-Week Treatment|Death|0|||
37853082|NCT01237587|69536915|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
37853083|NCT01237587|69536916|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
37853084|NCT01237587|69536915|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
37853085|NCT01237587|69536916|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
37853086|NCT01237587|69536915|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
37853087|NCT01237587|69536916|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
37853088|NCT01237587|69536915|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
37853089|NCT01237587|69536916|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
37853090|NCT01237587|69536915|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
37853091|NCT01237587|69536916|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
37853092|NCT01237587|69536915|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
37853093|NCT01237587|69536916|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
37853094|NCT01237587|69536915|FG000|Taper Phase|Adverse Event|0|||
37853095|NCT01237587|69536916|FG001|Taper Phase|Adverse Event|2|||
37853096|NCT01237587|69536915|FG000|Taper Phase|Protocol Violation|2|||
37853097|NCT01237587|69536916|FG001|Taper Phase|Protocol Violation|0|||
37853098|NCT01237587|69536915|FG000|Taper Phase|Lack of Efficacy|2|||
37853099|NCT01237587|69536916|FG001|Taper Phase|Lack of Efficacy|5|||
37853100|NCT01237587|69536915|FG000|Taper Phase|Parent/Guardian Decision|0|||
37853101|NCT01237587|69536916|FG001|Taper Phase|Parent/Guardian Decision|2|||
37853102|NCT01237587|69536915|FG000|Taper Phase|Sponsor Decision|1|||
37853103|NCT01237587|69536916|FG001|Taper Phase|Sponsor Decision|0|||
37853104|NCT01237587|69536915|FG000|Taper Phase|Withdrawal by Subject|0|||
37853105|NCT01237587|69536916|FG001|Taper Phase|Withdrawal by Subject|1|||
37853106|NCT01031680|69536931|FG000|Overall Study|Adverse Event|8|||
37853107|NCT01031680|69536932|FG001|Overall Study|Adverse Event|3|||
37853108|NCT01031680|69536931|FG000|Overall Study|Lost to Follow-up|2|||
37853109|NCT01031680|69536932|FG001|Overall Study|Lost to Follow-up|10|||
37853110|NCT01031680|69536931|FG000|Overall Study|Withdrawal by Subject|12|||
37853111|NCT01031680|69536932|FG001|Overall Study|Withdrawal by Subject|16|||
37853112|NCT01031680|69536931|FG000|Overall Study|Death|2|||
37853113|NCT01031680|69536932|FG001|Overall Study|Death|1|||
37853114|NCT01031680|69536931|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
37853115|NCT01031680|69536932|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
37853116|NCT01031680|69536931|FG000|Overall Study|Poor/Non-compliance|5|||
37853117|NCT01031680|69536932|FG001|Overall Study|Poor/Non-compliance|6|||
37853118|NCT01031680|69536931|FG000|Overall Study|Safety|1|||
37853119|NCT01031680|69536932|FG001|Overall Study|Safety|0|||
37921495|NCT00822120|69608182|FG005|Initial Registration|Reasons not Protocol Specified|0|||
37921496|NCT00822120|69608177|FG000|Initial Registration|Ineligible|22|||
37921497|NCT00822120|69608178|FG001|Initial Registration|Ineligible|1|||
37921498|NCT00822120|69608179|FG002|Initial Registration|Ineligible|0|||
37921499|NCT00822120|69608180|FG003|Initial Registration|Ineligible|0|||
37921500|NCT00822120|69608181|FG004|Initial Registration|Ineligible|0|||
37921501|NCT00822120|69608182|FG005|Initial Registration|Ineligible|0|||
37921502|NCT00822120|69608177|FG000|PET-directed Therapy|Adverse Event|0|||
37921503|NCT00822120|69608178|FG001|PET-directed Therapy|Adverse Event|0|||
37921504|NCT00822120|69608179|FG002|PET-directed Therapy|Adverse Event|0|||
37853120|NCT01031680|69536931|FG000|Overall Study|Incorrect Enrolment|1|||
37853121|NCT01031680|69536932|FG001|Overall Study|Incorrect Enrolment|2|||
37853122|NCT01031680|69536931|FG000|Overall Study|Administrative Reason by Sponsor|0|||
37921505|NCT00822120|69608180|FG003|PET-directed Therapy|Adverse Event|1|||
37921506|NCT00822120|69608181|FG004|PET-directed Therapy|Adverse Event|0|||
37853123|NCT01031680|69536932|FG001|Overall Study|Administrative Reason by Sponsor|1|||
38031819|NCT02862574|69717578|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
38031820|NCT02862574|69717579|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
38031821|NCT02862574|69717580|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
37737810|NCT00350272|69219966|FG000|Blinded 12-Week Treatment|Lost to Follow-up|2|||
37737811|NCT00350272|69219967|FG001|Blinded 12-Week Treatment|Lost to Follow-up|0|||
37737812|NCT00350272|69219966|FG000|Blinded 12-Week Treatment|Withdrawal by Subject|3|||
37737813|NCT00350272|69219967|FG001|Blinded 12-Week Treatment|Withdrawal by Subject|0|||
37737814|NCT00350272|69219966|FG000|Blinded 12-Week Treatment|Physician Decision|2|||
37737815|NCT00350272|69219967|FG001|Blinded 12-Week Treatment|Physician Decision|1|||
37737816|NCT00350272|69219966|FG000|Blinded 12-Week Treatment|Sponsor decision|0|||
37737817|NCT00350272|69219967|FG001|Blinded 12-Week Treatment|Sponsor decision|1|||
37737818|NCT00350272|69219966|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
37737819|NCT00350272|69219967|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
37737820|NCT00350272|69219966|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
37737821|NCT00350272|69219967|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
37737822|NCT00350272|69219966|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
37737823|NCT00350272|69219967|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
37737824|NCT00350272|69219966|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
37737825|NCT00350272|69219967|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
37737826|NCT00350272|69219966|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
37737827|NCT00350272|69219967|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
37737828|NCT02028884|69219978|FG000|Double-blind Period|Adverse Event|5|||
37737829|NCT02028884|69219979|FG001|Double-blind Period|Adverse Event|3|||
37737830|NCT02028884|69219980|FG002|Double-blind Period|Adverse Event|0|||
37737831|NCT02028884|69219978|FG000|Double-blind Period|Eligibility Violation|1|||
37737832|NCT02028884|69219979|FG001|Double-blind Period|Eligibility Violation|0|||
37737833|NCT02028884|69219980|FG002|Double-blind Period|Eligibility Violation|0|||
37737834|NCT02028884|69219978|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
37737835|NCT02028884|69219979|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
37737836|NCT02028884|69219980|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
37737837|NCT02028884|69219978|FG000|Double-blind Period|Withdrawal by Subject|2|||
37737838|NCT02028884|69219979|FG001|Double-blind Period|Withdrawal by Subject|0|||
37737839|NCT02028884|69219980|FG002|Double-blind Period|Withdrawal by Subject|0|||
37737840|NCT02028884|69219978|FG000|Open-label Extension Period|Adverse Event|3|||
37737841|NCT02028884|69219979|FG001|Open-label Extension Period|Adverse Event|1|||
37737842|NCT02028884|69219980|FG002|Open-label Extension Period|Adverse Event|0|||
37737843|NCT02028884|69219978|FG000|Open-label Extension Period|Lack of Efficacy|3|||
37737844|NCT02028884|69219979|FG001|Open-label Extension Period|Lack of Efficacy|0|||
37737845|NCT02028884|69219980|FG002|Open-label Extension Period|Lack of Efficacy|0|||
37737846|NCT02028884|69219978|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
37737847|NCT02028884|69219979|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
37737848|NCT02028884|69219980|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
37737849|NCT02028884|69219978|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
37737850|NCT02028884|69219979|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
37737851|NCT02028884|69219980|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
37737852|NCT02028884|69219978|FG000|Open-label Extension Period|Switched to another treatment option|3|||
37737853|NCT02028884|69219979|FG001|Open-label Extension Period|Switched to another treatment option|0|||
37737854|NCT02028884|69219980|FG002|Open-label Extension Period|Switched to another treatment option|0|||
37737855|NCT01467427|69220032|FG000|Overall Study|Withdrawal by Subject|1|||
37737856|NCT01467427|69220033|FG001|Overall Study|Withdrawal by Subject|0|||
37737857|NCT01467427|69220032|FG000|Overall Study|Entered extension phase|11|||
37737858|NCT01467427|69220033|FG001|Overall Study|Entered extension phase|11|||
37737859|NCT01467427|69220032|FG000|Overall Study|Not continuing in extension phase|0|||
37737860|NCT01467427|69220033|FG001|Overall Study|Not continuing in extension phase|2|||
37737861|NCT01422187|69220042|FG000|Overall Study|Personal reason|1|||
37737862|NCT01422187|69220043|FG001|Overall Study|Personal reason|0|||
37737863|NCT01422187|69220044|FG002|Overall Study|Personal reason|0|||
37737864|NCT01422187|69220042|FG000|Overall Study|Lost to Follow-up|0|||
37737865|NCT01422187|69220043|FG001|Overall Study|Lost to Follow-up|1|||
37737866|NCT01422187|69220044|FG002|Overall Study|Lost to Follow-up|0|||
37737867|NCT00472212|69220054|FG000|Overall Study|Lost to Follow-up|6|||
37737868|NCT00472212|69220055|FG001|Overall Study|Lost to Follow-up|4|||
37737869|NCT00378105|69220063|FG000|Overall Study|Adverse Event|3|||
37737870|NCT00378105|69220064|FG001|Overall Study|Adverse Event|1|||
37737871|NCT00378105|69220063|FG000|Overall Study|Withdrawal by Subject|3|||
37737872|NCT00378105|69220064|FG001|Overall Study|Withdrawal by Subject|3|||
37737873|NCT00378105|69220063|FG000|Overall Study|Death|1|||
37737874|NCT00378105|69220064|FG001|Overall Study|Death|0|||
37737875|NCT00378105|69220063|FG000|Overall Study|Going to transplant|7|||
37737876|NCT00378105|69220064|FG001|Overall Study|Going to transplant|8|||
37737877|NCT00378105|69220063|FG000|Overall Study|Progressive disease|3|||
37737878|NCT00378105|69220064|FG001|Overall Study|Progressive disease|3|||
37737879|NCT00378105|69220063|FG000|Overall Study|remain on study|3|||
37737880|NCT00378105|69220064|FG001|Overall Study|remain on study|11|||
37737881|NCT00378105|69220063|FG000|Overall Study|Physician Decision|0|||
37737882|NCT00378105|69220064|FG001|Overall Study|Physician Decision|2|||
37737883|NCT00378105|69220063|FG000|Overall Study|Going non-protocol therapy|0|||
37737884|NCT00378105|69220064|FG001|Overall Study|Going non-protocol therapy|1|||
37737885|NCT00378105|69220063|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
37737886|NCT00378105|69220064|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
37737887|NCT00139477|69220073|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
37737888|NCT00139477|69220074|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
37737889|NCT00139477|69220073|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
37737890|NCT00139477|69220074|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
37737891|NCT00139477|69220073|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
37737892|NCT00139477|69220074|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
37737893|NCT00139477|69220073|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
37737894|NCT00139477|69220074|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
37737895|NCT00139477|69220073|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
37737896|NCT00139477|69220074|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
37737897|NCT00139477|69220073|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
37737898|NCT00139477|69220074|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
37737899|NCT00139477|69220073|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
37737900|NCT00139477|69220074|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
37737901|NCT01469013|69220394|FG000|Part A (Treatment Period)|Adverse Event|1|||
37737902|NCT01469013|69220395|FG001|Part A (Treatment Period)|Adverse Event|0|||
37737903|NCT01469013|69220396|FG002|Part A (Treatment Period)|Adverse Event|0|||
37737904|NCT01469013|69220397|FG003|Part A (Treatment Period)|Adverse Event|0|||
37737905|NCT01469013|69220398|FG004|Part A (Treatment Period)|Adverse Event|1|||
37737906|NCT01469013|69220399|FG005|Part A (Treatment Period)|Adverse Event|0|||
37737907|NCT01469013|69220400|FG006|Part A (Treatment Period)|Adverse Event|0|||
37737908|NCT01469013|69220401|FG007|Part A (Treatment Period)|Adverse Event|0|||
37737909|NCT01469013|69220402|FG008|Part A (Treatment Period)|Adverse Event|0|||
37737910|NCT01469013|69220403|FG009|Part A (Treatment Period)|Adverse Event|0|||
37737911|NCT01469013|69220404|FG010|Part A (Treatment Period)|Adverse Event|0|||
37737912|NCT01469013|69220405|FG011|Part A (Treatment Period)|Adverse Event|0|||
37737913|NCT01469013|69220406|FG012|Part A (Treatment Period)|Adverse Event|0|||
37737914|NCT01469013|69220394|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
37737915|NCT01469013|69220395|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
37737916|NCT01469013|69220396|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
37737917|NCT01469013|69220397|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
38031822|NCT02862574|69717578|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
38031823|NCT02862574|69717579|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
37737918|NCT01469013|69220398|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
37737919|NCT01469013|69220399|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
37737920|NCT01469013|69220400|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
37737921|NCT01469013|69220401|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
37737922|NCT01469013|69220402|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
37737923|NCT01469013|69220403|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
37737924|NCT01469013|69220404|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
37737925|NCT01469013|69220405|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
37737926|NCT01469013|69220406|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
37737927|NCT01469013|69220394|FG000|Part B (Extension Period)|Adverse Event|0|||
37628973|NCT00157248|69095127|FG000|Overall Study|Adverse Event|36|||
37628974|NCT00157248|69095128|FG001|Overall Study|Adverse Event|25|||
37628975|NCT00157248|69095129|FG002|Overall Study|Adverse Event|13|||
37628976|NCT00157248|69095130|FG003|Overall Study|Adverse Event|33|||
37628977|NCT00157248|69095127|FG000|Overall Study|Protocol Violation|4|||
37628978|NCT00157248|69095128|FG001|Overall Study|Protocol Violation|0|||
37628979|NCT00157248|69095129|FG002|Overall Study|Protocol Violation|2|||
37628980|NCT00157248|69095130|FG003|Overall Study|Protocol Violation|2|||
37628981|NCT00157248|69095127|FG000|Overall Study|Lost to Follow-up|0|||
37628982|NCT00157248|69095128|FG001|Overall Study|Lost to Follow-up|1|||
37628983|NCT00157248|69095129|FG002|Overall Study|Lost to Follow-up|0|||
37628984|NCT00157248|69095130|FG003|Overall Study|Lost to Follow-up|0|||
37628985|NCT00157248|69095127|FG000|Overall Study|Withdrawal by Subject|1|||
37628986|NCT00157248|69095128|FG001|Overall Study|Withdrawal by Subject|4|||
37628987|NCT00157248|69095129|FG002|Overall Study|Withdrawal by Subject|3|||
37628988|NCT00157248|69095130|FG003|Overall Study|Withdrawal by Subject|3|||
37628989|NCT00157248|69095127|FG000|Overall Study|site closures, subject moving|7|||
37628990|NCT00157248|69095128|FG001|Overall Study|site closures, subject moving|7|||
37628991|NCT00157248|69095129|FG002|Overall Study|site closures, subject moving|3|||
37628992|NCT00157248|69095130|FG003|Overall Study|site closures, subject moving|9|||
37628993|NCT02504580|69095152|FG000|Overall Study|Other|1|||
37628994|NCT02504580|69095153|FG001|Overall Study|Other|0|||
37628995|NCT02504580|69095154|FG002|Overall Study|Other|0|||
37628996|NCT02504580|69095155|FG003|Overall Study|Other|2|||
37628997|NCT02504580|69095156|FG004|Overall Study|Other|1|||
37628998|NCT02504580|69095157|FG005|Overall Study|Other|1|||
37628999|NCT02504580|69095158|FG006|Overall Study|Other|1|||
37629000|NCT02504580|69095159|FG007|Overall Study|Other|2|||
37629001|NCT02504580|69095160|FG008|Overall Study|Other|0|||
37629002|NCT02504580|69095161|FG009|Overall Study|Other|0|||
37629003|NCT02504580|69095162|FG010|Overall Study|Other|0|||
37629004|NCT02504580|69095163|FG011|Overall Study|Other|2|||
37629005|NCT02504580|69095152|FG000|Overall Study|Subject refusal to continue|0|||
37629006|NCT02504580|69095153|FG001|Overall Study|Subject refusal to continue|1|||
37629007|NCT02504580|69095154|FG002|Overall Study|Subject refusal to continue|0|||
37629008|NCT02504580|69095155|FG003|Overall Study|Subject refusal to continue|0|||
37629009|NCT02504580|69095156|FG004|Overall Study|Subject refusal to continue|0|||
37629010|NCT02504580|69095157|FG005|Overall Study|Subject refusal to continue|0|||
37629011|NCT02504580|69095158|FG006|Overall Study|Subject refusal to continue|0|||
37629012|NCT02504580|69095159|FG007|Overall Study|Subject refusal to continue|0|||
37629013|NCT02504580|69095160|FG008|Overall Study|Subject refusal to continue|0|||
37629014|NCT02504580|69095161|FG009|Overall Study|Subject refusal to continue|0|||
37629015|NCT02504580|69095162|FG010|Overall Study|Subject refusal to continue|0|||
37629016|NCT02504580|69095163|FG011|Overall Study|Subject refusal to continue|0|||
37629017|NCT01328756|69095185|FG000|Overall Study|Protocol Violation|4|||
37629018|NCT01328756|69095185|FG000|Overall Study|Adverse Event|39|||
37629019|NCT01328756|69095185|FG000|Overall Study|Lack of Efficacy|5|||
37629020|NCT01328756|69095185|FG000|Overall Study|Withdrawal by Subject|41|||
37629021|NCT01328756|69095185|FG000|Overall Study|Lost to Follow-up|5|||
37629022|NCT01328756|69095185|FG000|Overall Study|Other|29|||
37629023|NCT03922308|69095192|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
37629024|NCT03922308|69095193|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
37629025|NCT03922308|69095194|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
37629026|NCT03922308|69095192|FG000|Overall Study|Lost to Follow-up|1|||
37629027|NCT03922308|69095193|FG001|Overall Study|Lost to Follow-up|0|||
37629028|NCT03922308|69095194|FG002|Overall Study|Lost to Follow-up|0|||
37629029|NCT03922308|69095192|FG000|Overall Study|Reason not Specified|0|||
37629030|NCT03922308|69095193|FG001|Overall Study|Reason not Specified|2|||
37629031|NCT03922308|69095194|FG002|Overall Study|Reason not Specified|1|||
37629032|NCT02607930|69095207|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
37629033|NCT02607930|69095208|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
37629034|NCT02607930|69095209|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
37629035|NCT02607930|69095210|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
37629036|NCT02607930|69095207|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
37629037|NCT02607930|69095208|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
37629038|NCT02607930|69095209|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
37629039|NCT02607930|69095210|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
37629040|NCT02607930|69095207|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
37629041|NCT02607930|69095208|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
37629042|NCT02607930|69095209|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
37629043|NCT02607930|69095210|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
37629044|NCT02607930|69095207|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
37629045|NCT02607930|69095208|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
37629046|NCT02607930|69095209|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
37629047|NCT02607930|69095210|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
37629048|NCT02607930|69095207|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
37629049|NCT02607930|69095208|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
37629050|NCT02607930|69095209|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
37629051|NCT02607930|69095210|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
37629052|NCT02607930|69095207|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
37629053|NCT02607930|69095208|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
37629054|NCT02607930|69095209|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
37629055|NCT02607930|69095210|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
37629056|NCT02607930|69095207|FG000|Double-Blinded Treatment Phase|Death|2|||
37629057|NCT02607930|69095208|FG001|Double-Blinded Treatment Phase|Death|1|||
37629058|NCT02607930|69095209|FG002|Double-Blinded Treatment Phase|Death|0|||
37629059|NCT02607930|69095210|FG003|Double-Blinded Treatment Phase|Death|0|||
37629060|NCT02607930|69095207|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
37629061|NCT02607930|69095208|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
37629062|NCT02607930|69095209|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
37629063|NCT02607930|69095210|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
37629064|NCT02607930|69095207|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
37629065|NCT02607930|69095208|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
37629066|NCT02607930|69095209|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
37629067|NCT02607930|69095210|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
37629068|NCT02607930|69095207|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
37629069|NCT02607930|69095208|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
37629070|NCT02607930|69095209|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
37629071|NCT02607930|69095210|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
37629072|NCT02607930|69095207|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
37629073|NCT02607930|69095208|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
37629074|NCT02607930|69095209|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
37629075|NCT02607930|69095210|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
37629076|NCT02607930|69095207|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
37629077|NCT02607930|69095208|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
37629078|NCT02607930|69095209|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
37629079|NCT02607930|69095210|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
37629080|NCT02607930|69095207|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
37629081|NCT02607930|69095208|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
37629082|NCT02607930|69095209|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
37629083|NCT02607930|69095210|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
37629084|NCT02607930|69095207|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
37629085|NCT02607930|69095208|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
37629086|NCT02607930|69095209|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
37629087|NCT02607930|69095210|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
37629088|NCT02607930|69095207|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
37629089|NCT02607930|69095208|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
37629090|NCT02607930|69095209|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
37629091|NCT02607930|69095210|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
37629092|NCT02607930|69095207|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
37629093|NCT02607930|69095208|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
37629094|NCT02607930|69095209|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
37629095|NCT02607930|69095210|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
37629096|NCT02736188|69095241|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
37629097|NCT02736188|69095241|FG000|Overall Study|Adverse Event|1|||
37629098|NCT02736188|69095241|FG000|Overall Study|Withdrawal by Subject|1|||
37629099|NCT02736188|69095241|FG000|Overall Study|Other|6|||
37629100|NCT00154284|69095249|FG000|Overall Study|Adverse Event|6|||
37629101|NCT00154284|69095250|FG001|Overall Study|Adverse Event|9|||
37629102|NCT00154284|69095249|FG000|Overall Study|Abnormal laboratory value(s)|0|||
37853124|NCT01031680|69536931|FG000|Overall Study|Various|0|||
37853125|NCT01031680|69536932|FG001|Overall Study|Various|2|||
37853126|NCT01031446|69536938|FG000|Overall Study|Disease Progression|38|||
37629103|NCT00154284|69095250|FG001|Overall Study|Abnormal laboratory value(s)|1|||
37853127|NCT01031446|69536938|FG000|Overall Study|Adverse Event|9|||
37853128|NCT01031446|69536938|FG000|Overall Study|Physician Decision|4|||
37853129|NCT01031446|69536938|FG000|Overall Study|Withdrawal by Subject|3|||
37853130|NCT01031446|69536938|FG000|Overall Study|Still on treatment|1|||
37629104|NCT00154284|69095249|FG000|Overall Study|Lack of Efficacy|1|||
37629105|NCT00154284|69095250|FG001|Overall Study|Lack of Efficacy|2|||
37629106|NCT00154284|69095249|FG000|Overall Study|Protocol Violation|0|||
37629107|NCT00154284|69095250|FG001|Overall Study|Protocol Violation|1|||
37629108|NCT02735096|69095258|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
37629109|NCT00905346|69095271|FG000|Period 1|Withdrawal by Subject|1|||
37629110|NCT00905346|69095272|FG001|Period 1|Withdrawal by Subject|0|||
37629111|NCT01328444|69095285|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
37629112|NCT01328444|69095286|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
37629113|NCT01328444|69095287|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
37629114|NCT01328444|69095288|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
37629115|NCT01328444|69095289|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
37629116|NCT01328444|69095290|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
37629117|NCT01328444|69095285|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
37629118|NCT01328444|69095286|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
37629119|NCT01328444|69095287|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
37629120|NCT01328444|69095288|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
37629121|NCT01328444|69095289|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
37629122|NCT01328444|69095290|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
37629123|NCT01328444|69095285|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
37629124|NCT01328444|69095286|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
37629125|NCT01328444|69095287|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
37629126|NCT01328444|69095288|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
37629127|NCT01328444|69095289|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
37629128|NCT01328444|69095290|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
37629129|NCT01328444|69095285|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
37629130|NCT01328444|69095286|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
37629131|NCT01328444|69095287|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
37629132|NCT01328444|69095288|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
37629133|NCT01328444|69095289|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
37629134|NCT01328444|69095290|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
37629135|NCT01328444|69095285|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
37629136|NCT01328444|69095286|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
37629137|NCT01328444|69095287|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
37629138|NCT01328444|69095288|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
37629139|NCT01328444|69095289|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
37629140|NCT01328444|69095290|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
37629141|NCT01328444|69095285|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
37629142|NCT01328444|69095286|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
37629143|NCT01328444|69095287|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
37629144|NCT01328444|69095288|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
37629145|NCT01328444|69095289|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
37629146|NCT01328444|69095290|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
37629147|NCT01328444|69095285|FG000|Washout Period (14 Days)|Adverse Event|1|||
37629148|NCT01328444|69095286|FG001|Washout Period (14 Days)|Adverse Event|1|||
37629149|NCT01328444|69095287|FG002|Washout Period (14 Days)|Adverse Event|0|||
37629150|NCT01328444|69095288|FG003|Washout Period (14 Days)|Adverse Event|1|||
37629151|NCT01328444|69095289|FG004|Washout Period (14 Days)|Adverse Event|1|||
37629152|NCT01328444|69095290|FG005|Washout Period (14 Days)|Adverse Event|2|||
37629153|NCT01328444|69095285|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
37629154|NCT01328444|69095286|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
37629155|NCT01328444|69095287|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
37629156|NCT01328444|69095288|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
37629157|NCT01328444|69095289|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
37629158|NCT01328444|69095290|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
37629159|NCT01328444|69095285|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
37629160|NCT01328444|69095286|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
37629161|NCT01328444|69095287|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
37629162|NCT01328444|69095288|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
37629163|NCT01328444|69095289|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
37629164|NCT01328444|69095290|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
37629165|NCT01328444|69095285|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
37629166|NCT01328444|69095286|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
37629167|NCT01328444|69095287|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
37629168|NCT01328444|69095288|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
37629169|NCT01328444|69095289|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
37629170|NCT01328444|69095290|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
37629171|NCT01328444|69095285|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
37629172|NCT01328444|69095286|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
37737928|NCT01469013|69220395|FG001|Part B (Extension Period)|Adverse Event|0|||
37629173|NCT01328444|69095287|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
37629174|NCT01328444|69095288|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
37629175|NCT01328444|69095289|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
37629176|NCT01328444|69095290|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
37629177|NCT01328444|69095285|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
37629178|NCT01328444|69095286|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
37629179|NCT01328444|69095287|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
37629180|NCT01328444|69095288|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
37629181|NCT01328444|69095289|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
37629182|NCT01328444|69095290|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
37629183|NCT01328444|69095285|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
37629184|NCT01328444|69095286|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
37629185|NCT01328444|69095287|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
37629186|NCT01328444|69095288|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
37629187|NCT01328444|69095289|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
37629188|NCT01328444|69095290|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
37629189|NCT01328444|69095285|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
37629190|NCT01328444|69095286|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
37629191|NCT01328444|69095287|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
37629192|NCT01328444|69095288|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
37629193|NCT01328444|69095289|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
37629194|NCT01328444|69095290|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
37629195|NCT01328444|69095285|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
37629196|NCT01328444|69095286|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
37629197|NCT01328444|69095287|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
37629198|NCT01328444|69095288|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
37629199|NCT01328444|69095289|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
37629200|NCT01328444|69095290|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
37629201|NCT00887250|69095307|FG000|Overall Study|Adverse Event|3|||
37629202|NCT00887250|69095308|FG001|Overall Study|Adverse Event|0|||
37629203|NCT00887250|69095309|FG002|Overall Study|Adverse Event|7|||
37629204|NCT00887250|69095307|FG000|Overall Study|Lack of Efficacy|9|||
37629205|NCT00887250|69095308|FG001|Overall Study|Lack of Efficacy|6|||
37629206|NCT00887250|69095309|FG002|Overall Study|Lack of Efficacy|1|||
37629207|NCT00887250|69095307|FG000|Overall Study|Lost to Follow-up|2|||
37629208|NCT00887250|69095308|FG001|Overall Study|Lost to Follow-up|3|||
37629209|NCT00887250|69095309|FG002|Overall Study|Lost to Follow-up|1|||
37629210|NCT00887250|69095307|FG000|Overall Study|Protocol Violation|2|||
37629211|NCT00887250|69095308|FG001|Overall Study|Protocol Violation|2|||
37629212|NCT00887250|69095309|FG002|Overall Study|Protocol Violation|1|||
37629213|NCT00887250|69095307|FG000|Overall Study|Withdrawal by Subject|2|||
37629214|NCT00887250|69095308|FG001|Overall Study|Withdrawal by Subject|1|||
37629215|NCT00887250|69095309|FG002|Overall Study|Withdrawal by Subject|2|||
37629216|NCT00887250|69095307|FG000|Overall Study|Patient uncooperative|0|||
37629217|NCT00887250|69095308|FG001|Overall Study|Patient uncooperative|0|||
37629218|NCT00887250|69095309|FG002|Overall Study|Patient uncooperative|1|||
37629219|NCT02599402|69095314|FG000|Overall Study|Disease progression|153|||
37629220|NCT02599402|69095314|FG000|Overall Study|Study drug toxicity|201|||
37629221|NCT02599402|69095314|FG000|Overall Study|Death|26|||
37629222|NCT02599402|69095314|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
37629223|NCT02599402|69095314|FG000|Overall Study|Participant request to discontinue study treatment|13|||
37629224|NCT02599402|69095314|FG000|Overall Study|Participant withdrew consent|5|||
37629225|NCT02599402|69095314|FG000|Overall Study|Lost to Follow-up|1|||
37629226|NCT02599402|69095314|FG000|Overall Study|Maximum Clinical Benefit|7|||
37629227|NCT02599402|69095314|FG000|Overall Study|Poor/non-compliance|1|||
37629228|NCT02599402|69095314|FG000|Overall Study|Pregnancy|1|||
37629229|NCT02599402|69095314|FG000|Overall Study|Participant no longer met study criteria|7|||
37629230|NCT02599402|69095314|FG000|Overall Study|Other Reasons|95|||
37629231|NCT02734862|69095354|FG000|Part A|Death|3|||
37629232|NCT02734862|69095355|FG001|Part A|Death|4|||
37629233|NCT02734862|69095356|FG002|Part A|Death|6|||
37629234|NCT02734862|69095354|FG000|Part A|Lost to Follow-up|2|||
37629235|NCT02734862|69095355|FG001|Part A|Lost to Follow-up|1|||
37629236|NCT02734862|69095356|FG002|Part A|Lost to Follow-up|1|||
37629237|NCT02734862|69095354|FG000|Part A|Withdrawal by Subject|1|||
37629238|NCT02734862|69095355|FG001|Part A|Withdrawal by Subject|1|||
37629239|NCT02734862|69095356|FG002|Part A|Withdrawal by Subject|2|||
37629240|NCT02734862|69095354|FG000|Part A|Physician Decision|2|||
37629241|NCT02734862|69095355|FG001|Part A|Physician Decision|0|||
37629242|NCT02734862|69095356|FG002|Part A|Physician Decision|1|||
37629243|NCT02734862|69095354|FG000|Part A|Adverse Event|2|||
37629244|NCT02734862|69095355|FG001|Part A|Adverse Event|0|||
37629245|NCT02734862|69095356|FG002|Part A|Adverse Event|1|||
37629246|NCT02734862|69095354|FG000|Part A|Noncompliance|1|||
37629247|NCT02734862|69095355|FG001|Part A|Noncompliance|1|||
37629248|NCT02734862|69095356|FG002|Part A|Noncompliance|0|||
37629249|NCT02734862|69095354|FG000|Part A|Other|1|||
37629250|NCT02734862|69095355|FG001|Part A|Other|1|||
37629251|NCT02734862|69095356|FG002|Part A|Other|3|||
37629252|NCT02734862|69095354|FG000|Part B|Death|8|||
37629253|NCT02734862|69095355|FG001|Part B|Death|3|||
37629254|NCT02734862|69095356|FG002|Part B|Death|5|||
37629255|NCT02734862|69095354|FG000|Part B|Lost to Follow-up|2|||
37629256|NCT02734862|69095355|FG001|Part B|Lost to Follow-up|2|||
37629257|NCT02734862|69095356|FG002|Part B|Lost to Follow-up|0|||
37629258|NCT02734862|69095354|FG000|Part B|Withdrawal by Subject|3|||
37629259|NCT02734862|69095355|FG001|Part B|Withdrawal by Subject|1|||
37629260|NCT02734862|69095356|FG002|Part B|Withdrawal by Subject|0|||
37629261|NCT02734862|69095354|FG000|Part B|Other|0|||
37629262|NCT02734862|69095355|FG001|Part B|Other|1|||
37629263|NCT02734862|69095356|FG002|Part B|Other|0|||
37629264|NCT00858702|69095367|FG000|Overall Study|Lack of Efficacy|1|||
37629265|NCT00858702|69095368|FG001|Overall Study|Lack of Efficacy|0|||
37629266|NCT00858702|69095367|FG000|Overall Study|Protocol Violation|1|||
37629267|NCT00858702|69095368|FG001|Overall Study|Protocol Violation|1|||
37629268|NCT00858702|69095367|FG000|Overall Study|Other|2|||
37629269|NCT00858702|69095368|FG001|Overall Study|Other|1|||
37629270|NCT00858702|69095367|FG000|Overall Study|Withdrawal by Subject|1|||
37629271|NCT00858702|69095368|FG001|Overall Study|Withdrawal by Subject|0|||
37629272|NCT02598934|69095376|FG000|Overall Study|Adverse Event|11|||
37629273|NCT02598934|69095377|FG001|Overall Study|Adverse Event|13|||
37629274|NCT02598934|69095376|FG000|Overall Study|Failure to Return|3|||
37629275|NCT02598934|69095377|FG001|Overall Study|Failure to Return|3|||
37629276|NCT02598934|69095376|FG000|Overall Study|Withdrawal by Subject|2|||
37629277|NCT02598934|69095377|FG001|Overall Study|Withdrawal by Subject|3|||
37629278|NCT02598934|69095376|FG000|Overall Study|Administrative|2|||
37629279|NCT02598934|69095377|FG001|Overall Study|Administrative|1|||
37629280|NCT02598934|69095376|FG000|Overall Study|Protocol Violation|1|||
37629281|NCT02598934|69095377|FG001|Overall Study|Protocol Violation|2|||
37629282|NCT02598622|69095385|FG000|Overall Study|Withdrawal by Subject|3|||
37629283|NCT02598622|69095386|FG001|Overall Study|Withdrawal by Subject|0|||
37629284|NCT02598622|69095385|FG000|Overall Study|Physician Decision|3|||
37629285|NCT02598622|69095386|FG001|Overall Study|Physician Decision|0|||
37629286|NCT00841698|69095394|FG000|First Intervention|Withdrawal by Subject|1|||
37629287|NCT00841698|69095395|FG001|First Intervention|Withdrawal by Subject|0|||
37629288|NCT00841542|69095401|FG000|Period 1|Adverse Event|1|||
37629289|NCT00841542|69095402|FG001|Period 1|Adverse Event|0|||
37629290|NCT00840216|69095424|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
37629291|NCT00840216|69095425|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
37629292|NCT00836706|69095435|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
37629293|NCT00836706|69095436|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
37629294|NCT00836472|69095442|FG000|Washout|Adverse Event|1|||
37629295|NCT00836472|69095443|FG001|Washout|Adverse Event|2|||
37629296|NCT00836472|69095442|FG000|Washout|Withdrawal by Subject|1|||
37629297|NCT00836472|69095443|FG001|Washout|Withdrawal by Subject|1|||
37629298|NCT02598388|69095459|FG000|Overall Study|Lost to Follow-up|1|||
37629299|NCT02598388|69095460|FG001|Overall Study|Lost to Follow-up|0|||
37921507|NCT00822120|69608182|FG005|PET-directed Therapy|Adverse Event|0|||
37921508|NCT00822120|69608177|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
37921509|NCT00822120|69608178|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
37629300|NCT02598388|69095461|FG002|Overall Study|Lost to Follow-up|1|||
37629301|NCT02598388|69095462|FG003|Overall Study|Lost to Follow-up|0|||
37629302|NCT02598388|69095463|FG004|Overall Study|Lost to Follow-up|5|||
37629303|NCT02598388|69095464|FG005|Overall Study|Lost to Follow-up|1|||
37629304|NCT02598388|69095465|FG006|Overall Study|Lost to Follow-up|2|||
37629305|NCT02598388|69095466|FG007|Overall Study|Lost to Follow-up|1|||
37629306|NCT02598388|69095467|FG008|Overall Study|Lost to Follow-up|0|||
37629307|NCT02598388|69095468|FG009|Overall Study|Lost to Follow-up|0|||
37629308|NCT02598388|69095469|FG010|Overall Study|Lost to Follow-up|1|||
37629309|NCT02598388|69095470|FG011|Overall Study|Lost to Follow-up|0|||
37921510|NCT00822120|69608179|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
37921511|NCT00822120|69608180|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
37921512|NCT00822120|69608181|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
37921513|NCT00822120|69608182|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
37921514|NCT00822120|69608177|FG000|PET-directed Therapy|Death|0|||
37921515|NCT00822120|69608178|FG001|PET-directed Therapy|Death|0|||
37921516|NCT00822120|69608179|FG002|PET-directed Therapy|Death|0|||
37921517|NCT00822120|69608180|FG003|PET-directed Therapy|Death|2|||
37629310|NCT02598388|69095459|FG000|Overall Study|Withdrawal by Subject|0|||
37629311|NCT02598388|69095460|FG001|Overall Study|Withdrawal by Subject|0|||
37629312|NCT02598388|69095461|FG002|Overall Study|Withdrawal by Subject|0|||
37629313|NCT02598388|69095462|FG003|Overall Study|Withdrawal by Subject|0|||
37629314|NCT02598388|69095463|FG004|Overall Study|Withdrawal by Subject|2|||
37629315|NCT02598388|69095464|FG005|Overall Study|Withdrawal by Subject|0|||
37629316|NCT02598388|69095465|FG006|Overall Study|Withdrawal by Subject|2|||
37629317|NCT02598388|69095466|FG007|Overall Study|Withdrawal by Subject|0|||
37629318|NCT02598388|69095467|FG008|Overall Study|Withdrawal by Subject|0|||
37629319|NCT02598388|69095468|FG009|Overall Study|Withdrawal by Subject|1|||
37629320|NCT02598388|69095469|FG010|Overall Study|Withdrawal by Subject|0|||
37629321|NCT02598388|69095470|FG011|Overall Study|Withdrawal by Subject|0|||
37629322|NCT02598388|69095459|FG000|Overall Study|Other|0|||
37629323|NCT02598388|69095460|FG001|Overall Study|Other|0|||
37629324|NCT02598388|69095461|FG002|Overall Study|Other|1|||
37629325|NCT02598388|69095462|FG003|Overall Study|Other|0|||
37629326|NCT02598388|69095463|FG004|Overall Study|Other|3|||
37629327|NCT02598388|69095464|FG005|Overall Study|Other|0|||
37629328|NCT02598388|69095465|FG006|Overall Study|Other|1|||
37629329|NCT02598388|69095466|FG007|Overall Study|Other|0|||
37629330|NCT02598388|69095467|FG008|Overall Study|Other|0|||
37629331|NCT02598388|69095468|FG009|Overall Study|Other|0|||
37629332|NCT02598388|69095469|FG010|Overall Study|Other|0|||
37629333|NCT02598388|69095470|FG011|Overall Study|Other|0|||
37629334|NCT00835692|69095510|FG000|First Intervention|Withdrawal by Subject|1|||
37629335|NCT00835692|69095511|FG001|First Intervention|Withdrawal by Subject|0|||
37629336|NCT00835536|69095524|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
37629337|NCT00835536|69095525|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
37629338|NCT03865316|69095529|FG000|Overall Study|Procedure Cancelled|4|||
37629339|NCT03865316|69095529|FG000|Overall Study|Equipment failure|4|||
37629340|NCT02598076|69095535|FG000|Overall Study|Lost to Follow-up|2|||
37629341|NCT02598076|69095536|FG001|Overall Study|Lost to Follow-up|3|||
37629342|NCT02602288|69095544|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
37629343|NCT02602288|69095545|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
37629344|NCT02602288|69095544|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
37629345|NCT02602288|69095545|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
37629346|NCT02602288|69095544|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
37629347|NCT02602288|69095545|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
37629348|NCT02602288|69095544|FG000|12 Month Follow-up|Lost to Follow-up|0|||
37629349|NCT02602288|69095545|FG001|12 Month Follow-up|Lost to Follow-up|4|||
37629350|NCT02602288|69095544|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
37629351|NCT02602288|69095545|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
37629352|NCT02601820|69095551|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
37629353|NCT02601820|69095551|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
37629354|NCT02601820|69095551|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
37629355|NCT02601820|69095551|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
37629356|NCT02807454|69095570|FG000|Overall Study|Adverse Event|1|||
37629357|NCT02807454|69095571|FG001|Overall Study|Adverse Event|0|||
37629358|NCT02807454|69095570|FG000|Overall Study|Withdrawal by Subject|0|||
37629359|NCT02807454|69095571|FG001|Overall Study|Withdrawal by Subject|1|||
37629360|NCT02807454|69095570|FG000|Overall Study|Progressive Disease|30|||
37629361|NCT02807454|69095571|FG001|Overall Study|Progressive Disease|3|||
37629362|NCT02807454|69095570|FG000|Overall Study|Other Reasons|1|||
37629363|NCT02807454|69095571|FG001|Overall Study|Other Reasons|1|||
37629364|NCT02597920|69095586|FG000|Overall Study|Worsening of other pre-existing disease|0|||
37629365|NCT02597920|69095587|FG001|Overall Study|Worsening of other pre-existing disease|1|||
37629366|NCT02597920|69095588|FG002|Overall Study|Worsening of other pre-existing disease|0|||
37629367|NCT02597920|69095586|FG000|Overall Study|Other adverse event|20|||
37629368|NCT02597920|69095587|FG001|Overall Study|Other adverse event|30|||
37629369|NCT02597920|69095588|FG002|Overall Study|Other adverse event|0|||
37629370|NCT02597920|69095586|FG000|Overall Study|Lost to Follow-up|7|||
37629371|NCT02597920|69095587|FG001|Overall Study|Lost to Follow-up|9|||
37629372|NCT02597920|69095588|FG002|Overall Study|Lost to Follow-up|0|||
37629373|NCT02597920|69095586|FG000|Overall Study|Refuse to continue in the study|3|||
37629374|NCT02597920|69095587|FG001|Overall Study|Refuse to continue in the study|13|||
37629375|NCT02597920|69095588|FG002|Overall Study|Refuse to continue in the study|1|||
37629376|NCT02597920|69095586|FG000|Overall Study|Other than specified|10|||
37629377|NCT02597920|69095587|FG001|Overall Study|Other than specified|31|||
37629378|NCT02597920|69095588|FG002|Overall Study|Other than specified|5|||
37629379|NCT02597920|69095586|FG000|Overall Study|Other|1|||
37629380|NCT02597920|69095587|FG001|Overall Study|Other|0|||
37629381|NCT02597920|69095588|FG002|Overall Study|Other|0|||
37629382|NCT01235234|69095608|FG000|Overall Study|Adverse Event|2|||
37629383|NCT01235234|69095609|FG001|Overall Study|Adverse Event|2|||
37629384|NCT01235234|69095610|FG002|Overall Study|Adverse Event|1|||
37629385|NCT02597452|69095625|FG000|Overall Study|testing incomplete|30|||
37629386|NCT00834756|69095631|FG000|First Intervention|Adverse Event|1|||
37629387|NCT00834756|69095632|FG001|First Intervention|Adverse Event|0|||
37629388|NCT00834756|69095631|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
37629389|NCT00834756|69095632|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
37629390|NCT00828854|69095636|FG000|Overall Study|Disease Progression|17|||
37629391|NCT00828854|69095636|FG000|Overall Study|Adverse Event|9|||
37629392|NCT00828854|69095636|FG000|Overall Study|Reason not Specified|1|||
37629393|NCT00834522|69095642|FG000|Washout|Adverse Event|1|||
37629394|NCT00834522|69095643|FG001|Washout|Adverse Event|0|||
37629395|NCT00834522|69095642|FG000|Washout|Withdrawal by Subject|2|||
37629396|NCT00834522|69095643|FG001|Washout|Withdrawal by Subject|1|||
37629397|NCT00834444|69095649|FG000|First Intervention|Adverse Event|1|||
37629398|NCT00834444|69095650|FG001|First Intervention|Adverse Event|0|||
37629399|NCT00834444|69095649|FG000|First Intervention|Intolerance to Venopuncture|0|||
37629400|NCT00834444|69095650|FG001|First Intervention|Intolerance to Venopuncture|1|||
37629401|NCT00834444|69095649|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
37629402|NCT00834444|69095650|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
37629403|NCT00834444|69095649|FG000|Second Intervention|Adverse Event|1|||
37629404|NCT00834444|69095650|FG001|Second Intervention|Adverse Event|0|||
37629405|NCT02605954|69095670|FG000|Overall Study|Adverse Event|5|||
37629406|NCT02605954|69095671|FG001|Overall Study|Adverse Event|1|||
37629407|NCT02605954|69095670|FG000|Overall Study|Investigator's Discretion|1|||
37629408|NCT02605954|69095671|FG001|Overall Study|Investigator's Discretion|0|||
37629409|NCT02605954|69095670|FG000|Overall Study|Non-Compliance with Study Drug|1|||
37629410|NCT02605954|69095671|FG001|Overall Study|Non-Compliance with Study Drug|0|||
37629411|NCT02605954|69095670|FG000|Overall Study|Withdrew Consent|2|||
37629412|NCT02605954|69095671|FG001|Overall Study|Withdrew Consent|2|||
37629413|NCT02605954|69095670|FG000|Overall Study|Lost to Follow-up|3|||
37629414|NCT02605954|69095671|FG001|Overall Study|Lost to Follow-up|0|||
37629415|NCT02605954|69095670|FG000|Overall Study|Randomized but not treated|0|||
37629416|NCT02605954|69095671|FG001|Overall Study|Randomized but not treated|1|||
37629417|NCT00724698|69095680|FG000|Overall Study|Adverse Event|9|||
37629418|NCT00724698|69095680|FG000|Overall Study|Failure of Therapy|4|||
37629419|NCT00724698|69095680|FG000|Overall Study|Poor Compliance|16|||
37629420|NCT00724698|69095680|FG000|Overall Study|Lost to Follow-up|36|||
37629421|NCT00724698|69095680|FG000|Overall Study|No Info|25|||
37629422|NCT00829998|69095685|FG000|Washout|Adverse Event|0|||
37629423|NCT00829998|69095686|FG001|Washout|Adverse Event|1|||
37629424|NCT00829764|69095697|FG000|First Intervention|Adverse Event|1|||
37629425|NCT00829764|69095698|FG001|First Intervention|Adverse Event|0|||
37629426|NCT00829764|69095697|FG000|First Intervention|Withdrawal by Subject|1|||
37629427|NCT00829764|69095698|FG001|First Intervention|Withdrawal by Subject|1|||
37629428|NCT00829530|69095720|FG000|First Intervention|Adverse Event|0|||
37629429|NCT00829530|69095721|FG001|First Intervention|Adverse Event|1|||
37629430|NCT00829530|69095720|FG000|First Intervention|Intolerance to Venopuncture|0|||
37629431|NCT00829530|69095721|FG001|First Intervention|Intolerance to Venopuncture|1|||
37629432|NCT00829530|69095720|FG000|Second Intervention|Intolerance to Venopuncture|1|||
37629433|NCT00829530|69095721|FG001|Second Intervention|Intolerance to Venopuncture|0|||
37629434|NCT01377194|69095728|FG000|Overall Study|Adverse Event|3|||
37629435|NCT01377194|69095729|FG001|Overall Study|Adverse Event|12|||
37629436|NCT01377194|69095730|FG002|Overall Study|Adverse Event|19|||
37629437|NCT01377194|69095728|FG000|Overall Study|Lack of Efficacy|3|||
37629438|NCT01377194|69095729|FG001|Overall Study|Lack of Efficacy|3|||
37629439|NCT01377194|69095730|FG002|Overall Study|Lack of Efficacy|3|||
37629440|NCT01377194|69095728|FG000|Overall Study|Protocol Violation|4|||
37629441|NCT01377194|69095729|FG001|Overall Study|Protocol Violation|10|||
37629442|NCT01377194|69095730|FG002|Overall Study|Protocol Violation|6|||
37629443|NCT01377194|69095728|FG000|Overall Study|Withdrawal by Subject|8|||
37629444|NCT01377194|69095729|FG001|Overall Study|Withdrawal by Subject|10|||
37629445|NCT01377194|69095730|FG002|Overall Study|Withdrawal by Subject|7|||
37629446|NCT01377194|69095728|FG000|Overall Study|Lost to Follow-up|14|||
37629447|NCT01377194|69095729|FG001|Overall Study|Lost to Follow-up|8|||
37629448|NCT01377194|69095730|FG002|Overall Study|Lost to Follow-up|11|||
37629449|NCT00829452|69095743|FG000|First Intervention|Withdrawal by Subject|0|||
37629450|NCT00829452|69095744|FG001|First Intervention|Withdrawal by Subject|1|||
37629451|NCT00829452|69095743|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
37629452|NCT00829452|69095744|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
37629453|NCT00829452|69095743|FG000|Second Intervention|Physician Decision|0|||
37629454|NCT00829452|69095744|FG001|Second Intervention|Physician Decision|1|||
37629455|NCT04600076|69095748|FG000|Overall Study|Lost to Follow-up|3|||
37629456|NCT02064387|69095764|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
37629457|NCT02064387|69095765|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
37629458|NCT02064387|69095766|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
37921518|NCT00822120|69608181|FG004|PET-directed Therapy|Death|0|||
37629459|NCT02064387|69095767|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
37629460|NCT02064387|69095768|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
37629461|NCT02064387|69095769|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
37629462|NCT02064387|69095770|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
37629463|NCT02064387|69095771|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
37629464|NCT02064387|69095772|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
37921519|NCT00822120|69608182|FG005|PET-directed Therapy|Death|0|||
37629465|NCT02064387|69095773|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
37629466|NCT02064387|69095774|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
37629467|NCT02064387|69095775|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
37629468|NCT02064387|69095764|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
38031824|NCT02862574|69717580|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
38031825|NCT02862106|69717595|FG000|Overall Study|Adverse Event|4|||
38031826|NCT02862106|69717596|FG001|Overall Study|Adverse Event|0|||
38031827|NCT02862106|69717595|FG000|Overall Study|Protocol Violation|16|||
38031828|NCT02862106|69717596|FG001|Overall Study|Protocol Violation|1|||
37629469|NCT02064387|69095765|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
37629470|NCT02064387|69095766|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
37629471|NCT02064387|69095767|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
37629472|NCT02064387|69095768|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
37629473|NCT02064387|69095769|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
37629474|NCT02064387|69095770|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
37629475|NCT02064387|69095771|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
37629476|NCT02064387|69095772|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
37629477|NCT02064387|69095773|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
37629478|NCT02064387|69095774|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
37629479|NCT02064387|69095775|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
37629480|NCT02064387|69095764|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
37629481|NCT02064387|69095765|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
37629482|NCT02064387|69095766|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
37629483|NCT02064387|69095767|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
37629484|NCT02064387|69095768|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
37629485|NCT02064387|69095769|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
37629486|NCT02064387|69095770|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
37629487|NCT02064387|69095771|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
37629488|NCT02064387|69095772|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
37629489|NCT02064387|69095773|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
37629490|NCT02064387|69095774|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
37629491|NCT02064387|69095775|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
37629492|NCT02064387|69095764|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
37629493|NCT02064387|69095765|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
37629494|NCT02064387|69095766|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
37629495|NCT02064387|69095767|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
37629496|NCT02064387|69095768|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
37629497|NCT02064387|69095769|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
37629498|NCT02064387|69095770|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
37629499|NCT02064387|69095771|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
37629500|NCT02064387|69095772|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
37629501|NCT02064387|69095773|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
37629502|NCT02064387|69095774|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
37629503|NCT02064387|69095775|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
37629504|NCT02064387|69095764|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
37629505|NCT02064387|69095765|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
37629506|NCT02064387|69095766|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
37629507|NCT02064387|69095767|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
37853131|NCT01030900|69536944|FG000|Overall Study|Not treated due to congestive heart failure|1|||
37853132|NCT01030900|69536944|FG000|Overall Study|Not treated due to rapid disease|1|||
37629508|NCT02064387|69095768|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
37629509|NCT02064387|69095769|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
37629510|NCT02064387|69095770|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
37629511|NCT02064387|69095771|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
37629512|NCT02064387|69095772|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
37629513|NCT02064387|69095773|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
37629514|NCT02064387|69095774|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
37853133|NCT01030822|69536951|FG000|Overall Study|Moved/migrated from study area|6|||
37853134|NCT01030822|69536952|FG001|Overall Study|Moved/migrated from study area|7|||
37853135|NCT01030822|69536953|FG002|Overall Study|Moved/migrated from study area|3|||
37853136|NCT01030822|69536951|FG000|Overall Study|Withdrawal by Subject|16|||
37853137|NCT01030822|69536952|FG001|Overall Study|Withdrawal by Subject|13|||
37853138|NCT01030822|69536953|FG002|Overall Study|Withdrawal by Subject|16|||
37853139|NCT01030822|69536951|FG000|Overall Study|Lost to Follow-up|9|||
37853140|NCT01030822|69536952|FG001|Overall Study|Lost to Follow-up|4|||
37853141|NCT01030822|69536953|FG002|Overall Study|Lost to Follow-up|7|||
37853142|NCT01026454|69536964|FG000|Second Intervention|Pregnancy|1|||
37853143|NCT01026454|69536965|FG001|Second Intervention|Pregnancy|1|||
37853144|NCT01026220|69536971|FG000|Induction|Death|1|||
37853145|NCT01026220|69536972|FG001|Induction|Death|0|||
38031829|NCT02862106|69717595|FG000|Overall Study|Lost to Follow-up|15|||
37629515|NCT02064387|69095775|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
37629516|NCT01328366|69095814|FG000|Overall Study|Death|1|||
37629517|NCT01328366|69095814|FG000|Overall Study|Withdrawal by Subject|2|||
37629518|NCT01328366|69095814|FG000|Overall Study|Lost to Follow-up|7|||
37629519|NCT03256344|69095820|FG000|Overall Study|Death|6|||
37629520|NCT03256344|69095821|FG001|Overall Study|Death|22|||
37629521|NCT03256344|69095820|FG000|Overall Study|Withdrawal by Subject|3|||
37629522|NCT03256344|69095821|FG001|Overall Study|Withdrawal by Subject|3|||
37629523|NCT03256344|69095820|FG000|Overall Study|Sponsor Decision|1|||
37629524|NCT03256344|69095821|FG001|Overall Study|Sponsor Decision|0|||
37629525|NCT01370499|69095829|FG000|Overall Study|Adverse Event|38|||
37629526|NCT01370499|69095830|FG001|Overall Study|Adverse Event|12|||
37629527|NCT01370499|69095829|FG000|Overall Study|Lack of Efficacy|4|||
37629528|NCT01370499|69095830|FG001|Overall Study|Lack of Efficacy|2|||
37629529|NCT01370499|69095829|FG000|Overall Study|Lost to Follow-up|2|||
37629530|NCT01370499|69095830|FG001|Overall Study|Lost to Follow-up|1|||
37629531|NCT01370499|69095829|FG000|Overall Study|Physician Decision|3|||
37629532|NCT01370499|69095830|FG001|Overall Study|Physician Decision|3|||
37629533|NCT01370499|69095829|FG000|Overall Study|Protocol Violation|5|||
37629534|NCT01370499|69095830|FG001|Overall Study|Protocol Violation|4|||
37629535|NCT01370499|69095829|FG000|Overall Study|Withdrawal by Subject|18|||
37629536|NCT01370499|69095830|FG001|Overall Study|Withdrawal by Subject|7|||
37629537|NCT01370499|69095829|FG000|Overall Study|Sponsor Decision|41|||
37629538|NCT01370499|69095830|FG001|Overall Study|Sponsor Decision|15|||
37629539|NCT01370265|69095838|FG000|First Intervention|Adverse Event|1|||
37629540|NCT01370265|69095839|FG001|First Intervention|Adverse Event|1|||
37629541|NCT02792829|69095877|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
37629542|NCT02792829|69095878|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
37629543|NCT02792829|69095879|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
37629544|NCT02792829|69095880|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
37629545|NCT02792829|69095881|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
37629546|NCT02792829|69095882|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
37737929|NCT01469013|69220396|FG002|Part B (Extension Period)|Adverse Event|0|||
37737930|NCT01469013|69220397|FG003|Part B (Extension Period)|Adverse Event|0|||
37737931|NCT01469013|69220398|FG004|Part B (Extension Period)|Adverse Event|0|||
37737932|NCT01469013|69220399|FG005|Part B (Extension Period)|Adverse Event|2|||
37737933|NCT01469013|69220400|FG006|Part B (Extension Period)|Adverse Event|5|||
37737934|NCT01469013|69220401|FG007|Part B (Extension Period)|Adverse Event|5|||
37737935|NCT01469013|69220402|FG008|Part B (Extension Period)|Adverse Event|3|||
37737936|NCT01469013|69220403|FG009|Part B (Extension Period)|Adverse Event|3|||
37737937|NCT01469013|69220404|FG010|Part B (Extension Period)|Adverse Event|1|||
37737938|NCT01469013|69220405|FG011|Part B (Extension Period)|Adverse Event|6|||
37737939|NCT01469013|69220406|FG012|Part B (Extension Period)|Adverse Event|3|||
37737940|NCT01469013|69220394|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
37737941|NCT01469013|69220395|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
37737942|NCT01469013|69220396|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
37737943|NCT01469013|69220397|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
37737944|NCT01469013|69220398|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
37737945|NCT01469013|69220399|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
37737946|NCT01469013|69220400|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
37737947|NCT01469013|69220401|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
37737948|NCT01469013|69220402|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
37737949|NCT01469013|69220403|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
37737950|NCT01469013|69220404|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
37737951|NCT01469013|69220405|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
37737952|NCT01469013|69220406|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
37737953|NCT01493427|69220433|FG000|Overall Study|Adverse Event|10|||
37737954|NCT01493427|69220433|FG000|Overall Study|Personal Reasons|4|||
37737955|NCT01493427|69220433|FG000|Overall Study|Lost to Follow-up|2|||
37737956|NCT01493427|69220433|FG000|Overall Study|Inability to Follow Instructions|2|||
37737957|NCT01493427|69220433|FG000|Overall Study|Other|2|||
37737958|NCT01523457|69220439|FG000|Overall Study|Withdrawal by Subject|7|||
37737959|NCT01523457|69220440|FG001|Overall Study|Withdrawal by Subject|2|||
37853146|NCT01026220|69536973|FG002|Induction|Death|0|||
37629547|NCT02792829|69095883|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
37629548|NCT02792829|69095884|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
37737960|NCT01523301|69220448|FG000|Overall Study|Adverse Event|25|||
37737961|NCT01523301|69220449|FG001|Overall Study|Adverse Event|16|||
37737962|NCT01523301|69220448|FG000|Overall Study|Lack of Efficacy|0|||
37629549|NCT02792829|69095877|FG000|Treatment Period 2|Adverse Event|0|||
37629550|NCT02792829|69095878|FG001|Treatment Period 2|Adverse Event|0|||
37629551|NCT02792829|69095879|FG002|Treatment Period 2|Adverse Event|0|||
37629552|NCT02792829|69095880|FG003|Treatment Period 2|Adverse Event|0|||
37737963|NCT01523301|69220449|FG001|Overall Study|Lack of Efficacy|2|||
37737964|NCT01523301|69220448|FG000|Overall Study|Protocol Violation|3|||
37629553|NCT02792829|69095881|FG004|Treatment Period 2|Adverse Event|1|||
37629554|NCT02792829|69095882|FG005|Treatment Period 2|Adverse Event|0|||
37629555|NCT02792829|69095883|FG006|Treatment Period 2|Adverse Event|1|||
37629556|NCT02792829|69095884|FG007|Treatment Period 2|Adverse Event|1|||
37629557|NCT02792829|69095877|FG000|Treatment Period 2|Use of proscribed medications|0|||
37629558|NCT02792829|69095878|FG001|Treatment Period 2|Use of proscribed medications|0|||
37629559|NCT02792829|69095879|FG002|Treatment Period 2|Use of proscribed medications|0|||
37853147|NCT01026220|69536971|FG000|Induction|Lack of Efficacy|2|||
37853148|NCT01026220|69536972|FG001|Induction|Lack of Efficacy|0|||
37853149|NCT01026220|69536973|FG002|Induction|Lack of Efficacy|0|||
37853150|NCT01026220|69536971|FG000|Induction|Physician Decision|12|||
37853151|NCT01026220|69536972|FG001|Induction|Physician Decision|0|||
37853152|NCT01026220|69536973|FG002|Induction|Physician Decision|0|||
37853153|NCT01026220|69536971|FG000|Induction|Withdrawal by Subject|9|||
37853154|NCT01026220|69536972|FG001|Induction|Withdrawal by Subject|0|||
37853155|NCT01026220|69536973|FG002|Induction|Withdrawal by Subject|0|||
37853156|NCT01026220|69536971|FG000|Induction|Ineligible|1|||
37853157|NCT01026220|69536972|FG001|Induction|Ineligible|0|||
37853158|NCT01026220|69536973|FG002|Induction|Ineligible|0|||
37853159|NCT01026220|69536971|FG000|Consolidation Maintenance|Death|0|||
37853160|NCT01026220|69536972|FG001|Consolidation Maintenance|Death|1|||
37853161|NCT01026220|69536973|FG002|Consolidation Maintenance|Death|0|||
37853162|NCT01026220|69536971|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
37853163|NCT01026220|69536972|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
37853164|NCT01026220|69536973|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
37853165|NCT01026220|69536971|FG000|Consolidation Maintenance|Physician Decision|0|||
37853166|NCT01026220|69536972|FG001|Consolidation Maintenance|Physician Decision|2|||
37853167|NCT01026220|69536973|FG002|Consolidation Maintenance|Physician Decision|7|||
37853168|NCT01026220|69536971|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
37853169|NCT01026220|69536972|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
37853170|NCT01026220|69536973|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
37853171|NCT01026142|69536990|FG000|Overall Study|Death|136|||
37853172|NCT01026142|69536991|FG001|Overall Study|Death|134|||
37853173|NCT01026142|69536990|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
37853174|NCT01026142|69536991|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
37853175|NCT04615403|69537006|FG000|Overall Study|Death|1|||
37853176|NCT04368429|69537016|FG000|Overall Study|Adverse Event|1|||
37853177|NCT04368429|69537017|FG001|Overall Study|Adverse Event|0|||
37853178|NCT04091438|69537034|FG000|Treatment Period 1 (1 Day)|Other|1|||
37853179|NCT04091438|69537035|FG001|Treatment Period 1 (1 Day)|Other|0|||
37853180|NCT04091438|69537034|FG000|Washout Period (1 Day)|Protocol deviation|0|||
37853181|NCT04091438|69537035|FG001|Washout Period (1 Day)|Protocol deviation|1|||
37853182|NCT04091438|69537034|FG000|Washout Period (1 Day)|Other|0|||
37853183|NCT04091438|69537035|FG001|Washout Period (1 Day)|Other|1|||
37853184|NCT04084769|69537047|FG000|Overall Study|Protocol Violation|1|||
37853185|NCT04084769|69537048|FG001|Overall Study|Protocol Violation|3|||
37853186|NCT04084769|69537049|FG002|Overall Study|Protocol Violation|0|||
37853187|NCT04084769|69537050|FG003|Overall Study|Protocol Violation|1|||
37853188|NCT04084769|69537047|FG000|Overall Study|Withdrawal by Subject|0|||
37853189|NCT04084769|69537048|FG001|Overall Study|Withdrawal by Subject|1|||
37853190|NCT04084769|69537049|FG002|Overall Study|Withdrawal by Subject|0|||
37853191|NCT04084769|69537050|FG003|Overall Study|Withdrawal by Subject|0|||
37853192|NCT04084769|69537047|FG000|Overall Study|Withdrawal by parent/guardian|1|||
37853193|NCT04084769|69537048|FG001|Overall Study|Withdrawal by parent/guardian|0|||
37629560|NCT02792829|69095880|FG003|Treatment Period 2|Use of proscribed medications|0|||
37629561|NCT02792829|69095881|FG004|Treatment Period 2|Use of proscribed medications|0|||
37629562|NCT02792829|69095882|FG005|Treatment Period 2|Use of proscribed medications|0|||
37629563|NCT02792829|69095883|FG006|Treatment Period 2|Use of proscribed medications|0|||
37629564|NCT02792829|69095884|FG007|Treatment Period 2|Use of proscribed medications|1|||
37629565|NCT02867592|69095916|FG000|Overall Study|Adverse Event|3|||
37629566|NCT02867592|69095917|FG001|Overall Study|Adverse Event|0|||
37629567|NCT02867592|69095918|FG002|Overall Study|Adverse Event|2|||
37629568|NCT02867592|69095919|FG003|Overall Study|Adverse Event|1|||
37629569|NCT02867592|69095920|FG004|Overall Study|Adverse Event|1|||
37629570|NCT02867592|69095921|FG005|Overall Study|Adverse Event|5|||
37629571|NCT02867592|69095916|FG000|Overall Study|Death|0|||
37853194|NCT04084769|69537049|FG002|Overall Study|Withdrawal by parent/guardian|0|||
37853195|NCT04084769|69537050|FG003|Overall Study|Withdrawal by parent/guardian|1|||
37853196|NCT04084769|69537047|FG000|Overall Study|Lost to Follow-up|2|||
37853197|NCT04084769|69537048|FG001|Overall Study|Lost to Follow-up|0|||
37853198|NCT04084769|69537049|FG002|Overall Study|Lost to Follow-up|0|||
37853199|NCT04084769|69537050|FG003|Overall Study|Lost to Follow-up|0|||
37921520|NCT00822120|69608177|FG000|PET-directed Therapy|Protocol Violation|0|||
37629572|NCT02867592|69095917|FG001|Overall Study|Death|0|||
37629573|NCT02867592|69095918|FG002|Overall Study|Death|0|||
37629574|NCT02867592|69095919|FG003|Overall Study|Death|1|||
37629575|NCT02867592|69095920|FG004|Overall Study|Death|0|||
37629576|NCT02867592|69095921|FG005|Overall Study|Death|1|||
37629577|NCT02867592|69095916|FG000|Overall Study|Lack of Efficacy|8|||
37629578|NCT02867592|69095917|FG001|Overall Study|Lack of Efficacy|10|||
37629579|NCT02867592|69095918|FG002|Overall Study|Lack of Efficacy|8|||
37629580|NCT02867592|69095919|FG003|Overall Study|Lack of Efficacy|8|||
37629581|NCT02867592|69095920|FG004|Overall Study|Lack of Efficacy|12|||
37629582|NCT02867592|69095921|FG005|Overall Study|Lack of Efficacy|17|||
37629583|NCT02867592|69095916|FG000|Overall Study|Physician Decision|1|||
37629584|NCT02867592|69095917|FG001|Overall Study|Physician Decision|2|||
37629585|NCT02867592|69095918|FG002|Overall Study|Physician Decision|2|||
37629586|NCT02867592|69095919|FG003|Overall Study|Physician Decision|0|||
37629587|NCT02867592|69095920|FG004|Overall Study|Physician Decision|5|||
37629588|NCT02867592|69095921|FG005|Overall Study|Physician Decision|1|||
37629589|NCT02867592|69095916|FG000|Overall Study|Protocol Violation|0|||
37629590|NCT02867592|69095917|FG001|Overall Study|Protocol Violation|0|||
37629591|NCT02867592|69095918|FG002|Overall Study|Protocol Violation|0|||
37629592|NCT02867592|69095919|FG003|Overall Study|Protocol Violation|0|||
37629593|NCT02867592|69095920|FG004|Overall Study|Protocol Violation|1|||
37629594|NCT02867592|69095921|FG005|Overall Study|Protocol Violation|1|||
37629595|NCT02867592|69095916|FG000|Overall Study|Withdrawal by Subject|0|||
37629596|NCT02867592|69095917|FG001|Overall Study|Withdrawal by Subject|1|||
37629597|NCT02867592|69095918|FG002|Overall Study|Withdrawal by Subject|0|||
37629598|NCT02867592|69095919|FG003|Overall Study|Withdrawal by Subject|1|||
37629599|NCT02867592|69095920|FG004|Overall Study|Withdrawal by Subject|3|||
37629600|NCT02867592|69095921|FG005|Overall Study|Withdrawal by Subject|3|||
37629601|NCT02867592|69095916|FG000|Overall Study|Ineligible|1|||
37629602|NCT02867592|69095917|FG001|Overall Study|Ineligible|1|||
37629603|NCT02867592|69095918|FG002|Overall Study|Ineligible|0|||
37629604|NCT02867592|69095919|FG003|Overall Study|Ineligible|0|||
37629605|NCT02867592|69095920|FG004|Overall Study|Ineligible|2|||
37629606|NCT02867592|69095921|FG005|Overall Study|Ineligible|0|||
37629607|NCT02867592|69095916|FG000|Overall Study|No Treatment|1|||
37629608|NCT02867592|69095917|FG001|Overall Study|No Treatment|0|||
37629609|NCT02867592|69095918|FG002|Overall Study|No Treatment|0|||
37629610|NCT02867592|69095919|FG003|Overall Study|No Treatment|0|||
37629611|NCT02867592|69095920|FG004|Overall Study|No Treatment|0|||
37629612|NCT02867592|69095921|FG005|Overall Study|No Treatment|0|||
37629613|NCT02867592|69095916|FG000|Overall Study|Still on Therapy|0|||
37629614|NCT02867592|69095917|FG001|Overall Study|Still on Therapy|0|||
37629615|NCT02867592|69095918|FG002|Overall Study|Still on Therapy|0|||
37629616|NCT02867592|69095919|FG003|Overall Study|Still on Therapy|0|||
37629617|NCT02867592|69095920|FG004|Overall Study|Still on Therapy|1|||
37629618|NCT02867592|69095921|FG005|Overall Study|Still on Therapy|0|||
37629619|NCT02867592|69095916|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
37629620|NCT02867592|69095917|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
37629621|NCT02867592|69095918|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
37629622|NCT02867592|69095919|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
37629623|NCT02867592|69095920|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
37629624|NCT02867592|69095921|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
37629625|NCT02867592|69095916|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
37629626|NCT02867592|69095917|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
37629627|NCT02867592|69095918|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
37629628|NCT02867592|69095919|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
37629629|NCT02867592|69095920|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
37737965|NCT01523301|69220449|FG001|Overall Study|Protocol Violation|4|||
37737966|NCT01523301|69220448|FG000|Overall Study|Lost to Follow-up|1|||
37737967|NCT01523301|69220449|FG001|Overall Study|Lost to Follow-up|0|||
37737968|NCT01523301|69220448|FG000|Overall Study|Withdrawal by Subject|6|||
37737969|NCT01523301|69220449|FG001|Overall Study|Withdrawal by Subject|8|||
37737970|NCT01523301|69220448|FG000|Overall Study|Other Reason|0|||
37737971|NCT01523301|69220449|FG001|Overall Study|Other Reason|2|||
37737972|NCT01806506|69220457|FG000|Overall Study|Lost to Follow-up|2|||
37629630|NCT02867592|69095921|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
37629631|NCT00676494|69095937|FG000|Overall Study|Missed Visit|8|||
37629632|NCT00676494|69095937|FG000|Overall Study|Withdrawal by Subject|6|||
37629633|NCT02605642|69095942|FG000|Overall Study|Other|11|||
37737973|NCT01806506|69220458|FG001|Overall Study|Lost to Follow-up|1|||
37737974|NCT01766336|69220466|FG000|Overall Study|Adverse Event|11|||
37737975|NCT01766336|69220467|FG001|Overall Study|Adverse Event|8|||
38031830|NCT02862106|69717596|FG001|Overall Study|Lost to Follow-up|5|||
37737976|NCT01766336|69220466|FG000|Overall Study|Death|4|||
37629634|NCT02605642|69095943|FG001|Overall Study|Other|1|||
37737977|NCT01766336|69220467|FG001|Overall Study|Death|3|||
37737978|NCT01766336|69220466|FG000|Overall Study|Lost to Follow-up|1|||
37629635|NCT02605642|69095942|FG000|Overall Study|Participant non-compliance|2|||
37629636|NCT02605642|69095943|FG001|Overall Study|Participant non-compliance|4|||
37629637|NCT02605642|69095942|FG000|Overall Study|Physician Decision|10|||
37629638|NCT02605642|69095943|FG001|Overall Study|Physician Decision|0|||
37629639|NCT02605642|69095942|FG000|Overall Study|Lost to Follow-up|12|||
37629640|NCT02605642|69095943|FG001|Overall Study|Lost to Follow-up|1|||
37629641|NCT02605642|69095942|FG000|Overall Study|Adverse Event|14|||
37629642|NCT02605642|69095943|FG001|Overall Study|Adverse Event|2|||
37629643|NCT02605642|69095942|FG000|Overall Study|Withdrawal by Subject|23|||
37629644|NCT02605642|69095943|FG001|Overall Study|Withdrawal by Subject|2|||
37629645|NCT02605642|69095942|FG000|Overall Study|Lack of response|24|||
37629646|NCT02605642|69095943|FG001|Overall Study|Lack of response|11|||
37629647|NCT02253810|69095951|FG000|Overall Study|Withdrawal by Subject|2|||
37629648|NCT02253810|69095952|FG001|Overall Study|Withdrawal by Subject|1|||
37629649|NCT02253810|69095951|FG000|Overall Study|Unknown concomitant procedure|3|||
37629650|NCT02253810|69095952|FG001|Overall Study|Unknown concomitant procedure|2|||
37629651|NCT02732912|69095976|FG000|Overall Study|Discharged before night|2|||
37629652|NCT02732912|69095977|FG001|Overall Study|Discharged before night|6|||
37629653|NCT02732912|69095976|FG000|Overall Study|Incomplete completion of questionnaire|2|||
37629654|NCT02732912|69095977|FG001|Overall Study|Incomplete completion of questionnaire|3|||
37629655|NCT02732912|69095976|FG000|Overall Study|No outcome; discharged or refused|6|||
37629656|NCT02732912|69095977|FG001|Overall Study|No outcome; discharged or refused|9|||
37629657|NCT02792517|69095983|FG000|Overall Study|Withdrawal by Subject|10|||
37629658|NCT02792517|69095983|FG000|Overall Study|Decision by Sponsor|7|||
37629659|NCT02792517|69095983|FG000|Overall Study|Lost to Follow-up|3|||
37629660|NCT01369485|69096018|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
37629661|NCT01369485|69096019|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
37629662|NCT01369485|69096018|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
37629663|NCT01369485|69096019|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
37629664|NCT01369485|69096018|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
37629665|NCT01369485|69096019|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
37629666|NCT01369485|69096018|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
37629667|NCT01369485|69096019|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
37629668|NCT01369485|69096018|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
37629669|NCT01369485|69096019|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
37629670|NCT01369485|69096018|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
37629671|NCT01369485|69096019|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
37629672|NCT01369485|69096018|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
37629673|NCT01369485|69096019|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
37737979|NCT01766336|69220467|FG001|Overall Study|Lost to Follow-up|3|||
37737980|NCT01766336|69220466|FG000|Overall Study|Physician Decision|4|||
37737981|NCT01766336|69220467|FG001|Overall Study|Physician Decision|2|||
37737982|NCT01766336|69220466|FG000|Overall Study|Protocol Violation|0|||
37737983|NCT01766336|69220467|FG001|Overall Study|Protocol Violation|1|||
37737984|NCT01766336|69220466|FG000|Overall Study|Sponsor Decision|52|||
37737985|NCT01766336|69220467|FG001|Overall Study|Sponsor Decision|43|||
37737986|NCT01766336|69220466|FG000|Overall Study|Withdrawal by Subject|18|||
37737987|NCT01766336|69220467|FG001|Overall Study|Withdrawal by Subject|15|||
37737988|NCT01797536|69220477|FG000|Overall Study|Adverse Event|0|||
37737989|NCT01797536|69220478|FG001|Overall Study|Adverse Event|1|||
37737990|NCT01797536|69220479|FG002|Overall Study|Adverse Event|0|||
37737991|NCT01797536|69220480|FG003|Overall Study|Adverse Event|0|||
37737992|NCT01797302|69220493|FG000|Overall Study|Lost to Follow-up|16|||
37737993|NCT01797302|69220494|FG001|Overall Study|Lost to Follow-up|23|||
37737994|NCT01797302|69220495|FG002|Overall Study|Lost to Follow-up|22|||
37737995|NCT01797302|69220493|FG000|Overall Study|Withdrawal by Subject|1|||
37853200|NCT03890367|69537068|FG000|Overall Study|Withdrawal by parent/guardian|1|||
37629674|NCT01369485|69096018|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
37629675|NCT01369485|69096019|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
37629676|NCT01369485|69096018|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
37629677|NCT01369485|69096019|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
37629678|NCT01369485|69096018|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
37629679|NCT01369485|69096019|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
37737996|NCT01797302|69220494|FG001|Overall Study|Withdrawal by Subject|3|||
37853201|NCT03890367|69537069|FG001|Overall Study|Withdrawal by parent/guardian|3|||
37853202|NCT03890367|69537070|FG002|Overall Study|Withdrawal by parent/guardian|0|||
37853203|NCT03890367|69537068|FG000|Overall Study|Protocol deviation|2|||
37629680|NCT02886572|69096046|FG000|Overall Study|Death|8|||
37629681|NCT02741700|69096059|FG000|Overall Study|Lost to Follow-up|17|||
37853204|NCT03890367|69537069|FG001|Overall Study|Protocol deviation|2|||
37853205|NCT03890367|69537070|FG002|Overall Study|Protocol deviation|1|||
37737997|NCT01797302|69220495|FG002|Overall Study|Withdrawal by Subject|4|||
37737998|NCT01805180|69220505|FG000|Lead-in Donor Phase|screen failure|1|||
37921521|NCT00822120|69608178|FG001|PET-directed Therapy|Protocol Violation|0|||
37921522|NCT00822120|69608179|FG002|PET-directed Therapy|Protocol Violation|0|||
37921523|NCT00822120|69608180|FG003|PET-directed Therapy|Protocol Violation|6|||
37921524|NCT00822120|69608181|FG004|PET-directed Therapy|Protocol Violation|0|||
37921525|NCT00822120|69608182|FG005|PET-directed Therapy|Protocol Violation|0|||
37921526|NCT00804687|69608203|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
37921527|NCT00804687|69608204|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
37921528|NCT00804687|69608205|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
37921529|NCT00804687|69608206|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
37921530|NCT00804687|69608207|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
37921531|NCT00804687|69608208|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
37921532|NCT00804687|69608203|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
37921533|NCT00804687|69608204|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
37921534|NCT00804687|69608205|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
37921535|NCT00804687|69608206|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
37921536|NCT00804687|69608207|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
37921537|NCT00804687|69608208|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
37921538|NCT00804687|69608203|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
37921539|NCT00804687|69608204|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
37921540|NCT00804687|69608205|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
37921541|NCT00804687|69608206|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
37921542|NCT00804687|69608207|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
37921543|NCT00804687|69608208|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
37921544|NCT00804687|69608203|FG000|Period 5: Treatment Period|Positive drug test|1|||
37921545|NCT00804687|69608204|FG001|Period 5: Treatment Period|Positive drug test|0|||
37921546|NCT00804687|69608205|FG002|Period 5: Treatment Period|Positive drug test|0|||
37921547|NCT00804687|69608206|FG003|Period 5: Treatment Period|Positive drug test|0|||
37921548|NCT00804687|69608207|FG004|Period 5: Treatment Period|Positive drug test|0|||
37921549|NCT00804687|69608208|FG005|Period 5: Treatment Period|Positive drug test|0|||
37921550|NCT00678652|69608220|FG000|Overall Study|Protocol Violation|2|||
37921551|NCT00678652|69608221|FG001|Overall Study|Protocol Violation|0|||
37921552|NCT00678652|69608222|FG002|Overall Study|Protocol Violation|0|||
37921553|NCT00678652|69608223|FG003|Overall Study|Protocol Violation|0|||
37921554|NCT00678652|69608220|FG000|Overall Study|Pregnancy|0|||
37921555|NCT00678652|69608221|FG001|Overall Study|Pregnancy|0|||
37921556|NCT00678652|69608222|FG002|Overall Study|Pregnancy|1|||
37921557|NCT00678652|69608223|FG003|Overall Study|Pregnancy|0|||
37921558|NCT00678652|69608220|FG000|Overall Study|Relocation|1|||
37921559|NCT00678652|69608221|FG001|Overall Study|Relocation|0|||
37921560|NCT00678652|69608222|FG002|Overall Study|Relocation|0|||
37921561|NCT00678652|69608223|FG003|Overall Study|Relocation|0|||
37921562|NCT00840060|69608244|FG000|Overall Study|Withdrawal by Subject|1|||
37921563|NCT00840060|69608245|FG001|Overall Study|Withdrawal by Subject|0|||
37921564|NCT00840060|69608244|FG000|Overall Study|Change in emotional/behavioral status|0|||
37921565|NCT00840060|69608245|FG001|Overall Study|Change in emotional/behavioral status|1|||
37921566|NCT00574912|69608251|FG000|Overall Study|Could not place IV lines.|3|||
37921567|NCT00574912|69608251|FG000|Overall Study|scheduling conflicts|3|||
37921568|NCT00574912|69608251|FG000|Overall Study|Physician Decision|2|||
37921569|NCT00674128|69608265|FG000|Overall Study|Withdrawal by Subject|25|||
37921570|NCT00674128|69608266|FG001|Overall Study|Withdrawal by Subject|23|||
37921571|NCT00804141|69608272|FG000|Overall Study|Adverse Event|157|||
37921572|NCT00804141|69608272|FG000|Overall Study|Death|4|||
37921573|NCT00804141|69608272|FG000|Overall Study|Failed to return|96|||
37921574|NCT00804141|69608272|FG000|Overall Study|Investigator request|8|||
37737999|NCT01805180|69220506|FG001|Lead-in Donor Phase|screen failure|0|||
37738000|NCT01805180|69220507|FG002|Lead-in Donor Phase|screen failure|0|||
37738001|NCT01804946|69220517|FG000|Overall Study|Protocol Violation|1|||
37738002|NCT01804946|69220518|FG001|Overall Study|Protocol Violation|0|||
37738003|NCT01804946|69220517|FG000|Overall Study|Adverse Event|0|||
37853206|NCT03890367|69537068|FG000|Overall Study|Lost to Follow-up|1|||
37853207|NCT03890367|69537069|FG001|Overall Study|Lost to Follow-up|1|||
37853208|NCT03890367|69537070|FG002|Overall Study|Lost to Follow-up|0|||
37853209|NCT03868124|69537081|FG000|Overall Study|Withdrawal by Subject|4|||
37853210|NCT03868124|69537082|FG001|Overall Study|Withdrawal by Subject|0|||
37853211|NCT03868124|69537083|FG002|Overall Study|Withdrawal by Subject|1|||
37853212|NCT03868124|69537081|FG000|Overall Study|Physician Decision|1|||
37853213|NCT03868124|69537082|FG001|Overall Study|Physician Decision|0|||
37853214|NCT03868124|69537083|FG002|Overall Study|Physician Decision|1|||
37853215|NCT03868124|69537081|FG000|Overall Study|Lost to Follow-up|1|||
37853216|NCT03868124|69537082|FG001|Overall Study|Lost to Follow-up|1|||
37853217|NCT03868124|69537083|FG002|Overall Study|Lost to Follow-up|2|||
37921575|NCT00804141|69608272|FG000|Overall Study|Protocol Violation|85|||
37921576|NCT00804141|69608272|FG000|Overall Study|Withdrawal by Subject|131|||
37921577|NCT00804141|69608272|FG000|Overall Study|Lack of Efficacy|46|||
37921578|NCT00804141|69608272|FG000|Overall Study|Other than specified|30|||
37921579|NCT00804141|69608272|FG000|Overall Study|Enrolled but not treated|6|||
37921580|NCT00677092|69608276|FG000|Overall Study|Adverse Event|1|||
37921581|NCT00677092|69608276|FG000|Overall Study|Lost to Follow-up|1|||
37921582|NCT00677092|69608276|FG000|Overall Study|Withdrawal by Subject|3|||
37921583|NCT00677092|69608276|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
37921584|NCT00677014|69608284|FG000|Overall Study|Lost to Follow-up|20|||
37921585|NCT00677014|69608285|FG001|Overall Study|Lost to Follow-up|12|||
37921586|NCT00677014|69608286|FG002|Overall Study|Lost to Follow-up|24|||
37921587|NCT00677014|69608284|FG000|Overall Study|Death|6|||
37921588|NCT00677014|69608285|FG001|Overall Study|Death|15|||
37921589|NCT00677014|69608286|FG002|Overall Study|Death|7|||
37921590|NCT00677014|69608284|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
37921591|NCT00677014|69608285|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
37921592|NCT00677014|69608286|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
37921593|NCT00839436|69608297|FG000|Overall Study|Developed exclusionary condition|1|||
37921594|NCT00839436|69608298|FG001|Overall Study|Developed exclusionary condition|0|||
37921595|NCT00839436|69608299|FG002|Overall Study|Developed exclusionary condition|0|||
37921596|NCT00839436|69608297|FG000|Overall Study|Withdrawal by Subject|0|||
37921597|NCT00839436|69608298|FG001|Overall Study|Withdrawal by Subject|1|||
37921598|NCT00839436|69608299|FG002|Overall Study|Withdrawal by Subject|0|||
37921599|NCT00839436|69608297|FG000|Overall Study|Study drug no longer available|0|||
37921600|NCT00839436|69608298|FG001|Overall Study|Study drug no longer available|0|||
37921601|NCT00839436|69608299|FG002|Overall Study|Study drug no longer available|1|||
37921602|NCT00675766|69608311|FG000|Overall Study|Lost to Follow-up|6|||
37921603|NCT00675766|69608312|FG001|Overall Study|Lost to Follow-up|5|||
37921604|NCT00675766|69608313|FG002|Overall Study|Lost to Follow-up|21|||
37921605|NCT00675766|69608314|FG003|Overall Study|Lost to Follow-up|26|||
37921606|NCT00673894|69608326|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
37921607|NCT00673894|69608327|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
37921608|NCT00673894|69608326|FG000|First Intervention 4 Weeks|Adverse Event|1|||
37921609|NCT00673894|69608327|FG001|First Intervention 4 Weeks|Adverse Event|0|||
37921610|NCT00674986|69608335|FG000|Overall Study|Adverse Event|2|||
37921611|NCT00674986|69608336|FG001|Overall Study|Adverse Event|1|||
37921612|NCT00674986|69608335|FG000|Overall Study|Subject withdrew consent|12|||
37921613|NCT00674986|69608336|FG001|Overall Study|Subject withdrew consent|19|||
37921614|NCT00674986|69608335|FG000|Overall Study|Lost to Follow-up|25|||
37921615|NCT00674986|69608336|FG001|Overall Study|Lost to Follow-up|53|||
37921616|NCT00674986|69608335|FG000|Overall Study|Other reasons|4|||
37921617|NCT00674986|69608336|FG001|Overall Study|Other reasons|8|||
37921618|NCT00673816|69608343|FG000|Overall Study|Adverse Event|1|||
37921619|NCT00673816|69608343|FG000|Overall Study|Withdrawal by Subject|1|||
37921620|NCT00673660|69608348|FG000|Overall Study|Lost to Follow-up|107|||
37921621|NCT00672958|69608359|FG000|Overall Study|Adverse Event|11|||
37921622|NCT00672958|69608360|FG001|Overall Study|Adverse Event|9|||
37921623|NCT00672958|69608359|FG000|Overall Study|Lack of Efficacy|6|||
37921624|NCT00672958|69608360|FG001|Overall Study|Lack of Efficacy|11|||
37921625|NCT00672958|69608359|FG000|Overall Study|Non-compliance with study drug|2|||
37921626|NCT00672958|69608360|FG001|Overall Study|Non-compliance with study drug|3|||
37921627|NCT00672958|69608359|FG000|Overall Study|Protocol deviations|11|||
37921628|NCT00672958|69608360|FG001|Overall Study|Protocol deviations|5|||
37921629|NCT00672958|69608359|FG000|Overall Study|Voluntary withdrawal|12|||
37921630|NCT00672958|69608360|FG001|Overall Study|Voluntary withdrawal|8|||
37921631|NCT00672958|69608359|FG000|Overall Study|Lost to Follow-up|22|||
37921632|NCT00672958|69608360|FG001|Overall Study|Lost to Follow-up|17|||
37738004|NCT01804946|69220518|FG001|Overall Study|Adverse Event|1|||
37738005|NCT01804946|69220517|FG000|Overall Study|Insufficient data available|0|||
37738006|NCT01804946|69220518|FG001|Overall Study|Insufficient data available|1|||
37738007|NCT01804946|69220517|FG000|Overall Study|Do not meet inclusion criteria|1|||
37738008|NCT01804946|69220518|FG001|Overall Study|Do not meet inclusion criteria|2|||
37738009|NCT01737398|69220528|FG000|Overall Study|Adverse event or SAE|16|||
37738010|NCT01737398|69220529|FG001|Overall Study|Adverse event or SAE|1|||
37738011|NCT01737398|69220528|FG000|Overall Study|Stopping rule met|2|||
37738012|NCT01737398|69220529|FG001|Overall Study|Stopping rule met|1|||
37921633|NCT00672958|69608359|FG000|Overall Study|Reason not specified|0|||
37921634|NCT00672958|69608360|FG001|Overall Study|Reason not specified|3|||
37921635|NCT00672646|69608369|FG000|Overall Study|Lost to Follow-up|0|||
37921636|NCT00672646|69608370|FG001|Overall Study|Lost to Follow-up|1|||
37921637|NCT00672646|69608371|FG002|Overall Study|Lost to Follow-up|2|||
37921638|NCT00672646|69608369|FG000|Overall Study|Withdrawal by Subject|0|||
37921639|NCT00672646|69608370|FG001|Overall Study|Withdrawal by Subject|0|||
37921640|NCT00672646|69608371|FG002|Overall Study|Withdrawal by Subject|1|||
37921641|NCT00672490|69608381|FG000|Overall Study|Withdrawal by Subject|8|||
37921642|NCT00672490|69608382|FG001|Overall Study|Withdrawal by Subject|8|||
37921643|NCT00672490|69608381|FG000|Overall Study|Lack of Compliance|2|||
37738013|NCT01737398|69220528|FG000|Overall Study|Voluntary withdrawal|2|||
37921644|NCT00672490|69608382|FG001|Overall Study|Lack of Compliance|7|||
37921645|NCT00672490|69608381|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
37921646|NCT00672490|69608382|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
37921647|NCT00672490|69608381|FG000|Overall Study|Adverse Event|5|||
37921648|NCT00672490|69608382|FG001|Overall Study|Adverse Event|8|||
37921649|NCT00672490|69608381|FG000|Overall Study|Violation of Concomitant Medicine|1|||
37629682|NCT02741700|69096060|FG001|Overall Study|Lost to Follow-up|8|||
37629683|NCT02741700|69096059|FG000|Overall Study|Withdrawal by Subject|2|||
37629684|NCT02741700|69096060|FG001|Overall Study|Withdrawal by Subject|5|||
37629685|NCT02741700|69096059|FG000|Overall Study|Physician Decision|3|||
37629686|NCT02741700|69096060|FG001|Overall Study|Physician Decision|0|||
37629687|NCT02741700|69096059|FG000|Overall Study|Moved out of State|0|||
37629688|NCT02741700|69096060|FG001|Overall Study|Moved out of State|1|||
37629689|NCT02741700|69096059|FG000|Overall Study|Death|4|||
37629690|NCT02741700|69096060|FG001|Overall Study|Death|5|||
37629691|NCT00430950|69096068|FG000|Overall Study|Adverse Event|7|||
37629692|NCT00430950|69096069|FG001|Overall Study|Adverse Event|6|||
37629693|NCT00430950|69096068|FG000|Overall Study|Withdrawal by Subject|1|||
37629694|NCT00430950|69096069|FG001|Overall Study|Withdrawal by Subject|0|||
37629695|NCT00430950|69096068|FG000|Overall Study|concomitant medication,etc.|5|||
37629696|NCT00430950|69096069|FG001|Overall Study|concomitant medication,etc.|7|||
37629697|NCT02081391|69096077|FG000|12-hour Treatment|Withdrawal by Subject|3|||
37629698|NCT02081391|69096078|FG001|12-hour Treatment|Withdrawal by Subject|2|||
37629699|NCT02081391|69096079|FG002|12-hour Treatment|Withdrawal by Subject|0|||
37629700|NCT02081391|69096080|FG003|12-hour Treatment|Withdrawal by Subject|0|||
37629701|NCT02081391|69096077|FG000|12-hour Treatment|Physician Decision|4|||
37629702|NCT02081391|69096078|FG001|12-hour Treatment|Physician Decision|1|||
37629703|NCT02081391|69096079|FG002|12-hour Treatment|Physician Decision|0|||
37629704|NCT02081391|69096080|FG003|12-hour Treatment|Physician Decision|0|||
37629705|NCT02081391|69096077|FG000|12-hour Treatment|Lack of Efficacy|3|||
37629706|NCT02081391|69096078|FG001|12-hour Treatment|Lack of Efficacy|0|||
37629707|NCT02081391|69096079|FG002|12-hour Treatment|Lack of Efficacy|0|||
37629708|NCT02081391|69096080|FG003|12-hour Treatment|Lack of Efficacy|0|||
37629709|NCT02081391|69096077|FG000|12-hour Treatment|Adverse Event|4|||
37629710|NCT02081391|69096078|FG001|12-hour Treatment|Adverse Event|2|||
37629711|NCT02081391|69096079|FG002|12-hour Treatment|Adverse Event|0|||
37629712|NCT02081391|69096080|FG003|12-hour Treatment|Adverse Event|0|||
37629713|NCT02081391|69096077|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
37629714|NCT02081391|69096078|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
37629715|NCT02081391|69096079|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
37629716|NCT02081391|69096080|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
37629717|NCT02081391|69096077|FG000|12-hour Treatment|Further reasons|2|||
37629718|NCT02081391|69096078|FG001|12-hour Treatment|Further reasons|1|||
37629719|NCT02081391|69096079|FG002|12-hour Treatment|Further reasons|0|||
37629720|NCT02081391|69096080|FG003|12-hour Treatment|Further reasons|0|||
37629721|NCT02081391|69096077|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
37629722|NCT02081391|69096078|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
37629723|NCT02081391|69096079|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
37629724|NCT02081391|69096080|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
37629725|NCT02081391|69096077|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
37629726|NCT02081391|69096078|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
37629727|NCT02081391|69096079|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
37629728|NCT02081391|69096080|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
37629729|NCT02081391|69096077|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
37629730|NCT02081391|69096078|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
37629731|NCT02081391|69096079|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
37629732|NCT02081391|69096080|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
37629733|NCT02081391|69096077|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
37629734|NCT02081391|69096078|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
37629735|NCT02081391|69096079|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
37629736|NCT02081391|69096080|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
37629737|NCT02081391|69096077|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
37629738|NCT02081391|69096078|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
37629739|NCT02081391|69096079|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
37629740|NCT02081391|69096080|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
37629741|NCT02081391|69096077|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
37629742|NCT02081391|69096078|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
37629743|NCT02081391|69096079|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
37629744|NCT02081391|69096080|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
37921650|NCT00672490|69608382|FG001|Overall Study|Violation of Concomitant Medicine|0|||
37629745|NCT00430092|69096103|FG000|Overall Study|Adverse Event|0|||
37629746|NCT00430092|69096104|FG001|Overall Study|Adverse Event|0|||
37629747|NCT00430092|69096105|FG002|Overall Study|Adverse Event|1|||
37629748|NCT00430092|69096103|FG000|Overall Study|Lack of Efficacy|5|||
37629749|NCT00430092|69096104|FG001|Overall Study|Lack of Efficacy|2|||
37629750|NCT00430092|69096105|FG002|Overall Study|Lack of Efficacy|54|||
37629751|NCT00430092|69096103|FG000|Overall Study|Lost to Follow-up|1|||
37629752|NCT00430092|69096104|FG001|Overall Study|Lost to Follow-up|0|||
37629753|NCT00430092|69096105|FG002|Overall Study|Lost to Follow-up|0|||
37629754|NCT00430092|69096103|FG000|Overall Study|Protocol Violation|0|||
37629755|NCT00430092|69096104|FG001|Overall Study|Protocol Violation|1|||
37629756|NCT00430092|69096105|FG002|Overall Study|Protocol Violation|1|||
37629757|NCT00430092|69096103|FG000|Overall Study|Withdrawal by Subject|0|||
37629758|NCT00430092|69096104|FG001|Overall Study|Withdrawal by Subject|1|||
37629759|NCT00430092|69096105|FG002|Overall Study|Withdrawal by Subject|1|||
37629760|NCT00425100|69096110|FG000|Overall Study|Adverse Event|36|||
37629761|NCT00425100|69096110|FG000|Overall Study|Lack of Efficacy|4|||
37629762|NCT00425100|69096110|FG000|Overall Study|Lost to Follow-up|2|||
37629763|NCT00425100|69096110|FG000|Overall Study|Protocol Violation|4|||
37629764|NCT00425100|69096110|FG000|Overall Study|Withdrawal by Subject|7|||
37629765|NCT00412932|69096115|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
37629766|NCT00412932|69096115|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
37629767|NCT00412932|69096115|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
37629768|NCT00412932|69096115|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
37629769|NCT00412932|69096115|FG000|Olmesartan (Olm) 20 mg|Other|1|||
37629770|NCT00412932|69096115|FG000|Olmesartan 40 mg|Adverse Event|4|||
37629771|NCT00412932|69096115|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
37629772|NCT00412932|69096115|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
37629773|NCT00412932|69096115|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
37629774|NCT00412932|69096115|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
37629775|NCT00412932|69096115|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
37629776|NCT00412932|69096115|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
37629777|NCT02696031|69096121|FG000|Up to Week 24|Adverse Event|2|||
37629778|NCT02696031|69096122|FG001|Up to Week 24|Adverse Event|4|||
37629779|NCT02696031|69096123|FG002|Up to Week 24|Adverse Event|2|||
37629780|NCT02696031|69096124|FG003|Up to Week 24|Adverse Event|0|||
37629781|NCT02696031|69096125|FG004|Up to Week 24|Adverse Event|0|||
37629782|NCT02696031|69096126|FG005|Up to Week 24|Adverse Event|0|||
37629783|NCT02696031|69096121|FG000|Up to Week 24|Lack of Efficacy|2|||
37629784|NCT02696031|69096122|FG001|Up to Week 24|Lack of Efficacy|1|||
37629785|NCT02696031|69096123|FG002|Up to Week 24|Lack of Efficacy|2|||
37629786|NCT02696031|69096124|FG003|Up to Week 24|Lack of Efficacy|0|||
37629787|NCT02696031|69096125|FG004|Up to Week 24|Lack of Efficacy|0|||
37629788|NCT02696031|69096126|FG005|Up to Week 24|Lack of Efficacy|0|||
37629789|NCT02696031|69096121|FG000|Up to Week 24|Lost to Follow-up|0|||
37629790|NCT02696031|69096122|FG001|Up to Week 24|Lost to Follow-up|1|||
37629791|NCT02696031|69096123|FG002|Up to Week 24|Lost to Follow-up|1|||
37629792|NCT02696031|69096124|FG003|Up to Week 24|Lost to Follow-up|0|||
37629793|NCT02696031|69096125|FG004|Up to Week 24|Lost to Follow-up|0|||
37629794|NCT02696031|69096126|FG005|Up to Week 24|Lost to Follow-up|0|||
37629795|NCT02696031|69096121|FG000|Up to Week 24|Physician Decision|1|||
37629796|NCT02696031|69096122|FG001|Up to Week 24|Physician Decision|0|||
37629797|NCT02696031|69096123|FG002|Up to Week 24|Physician Decision|1|||
37629798|NCT02696031|69096124|FG003|Up to Week 24|Physician Decision|0|||
37629799|NCT02696031|69096125|FG004|Up to Week 24|Physician Decision|0|||
37629800|NCT02696031|69096126|FG005|Up to Week 24|Physician Decision|0|||
37629801|NCT02696031|69096121|FG000|Up to Week 24|Protocol Violation|1|||
37629802|NCT02696031|69096122|FG001|Up to Week 24|Protocol Violation|0|||
37629803|NCT02696031|69096123|FG002|Up to Week 24|Protocol Violation|0|||
37629804|NCT02696031|69096124|FG003|Up to Week 24|Protocol Violation|0|||
37629805|NCT02696031|69096125|FG004|Up to Week 24|Protocol Violation|0|||
37629806|NCT02696031|69096126|FG005|Up to Week 24|Protocol Violation|0|||
37629807|NCT02696031|69096121|FG000|Up to Week 24|Withdrawal by Subject|4|||
37629808|NCT02696031|69096122|FG001|Up to Week 24|Withdrawal by Subject|1|||
37629809|NCT02696031|69096123|FG002|Up to Week 24|Withdrawal by Subject|5|||
37629810|NCT02696031|69096124|FG003|Up to Week 24|Withdrawal by Subject|0|||
37921651|NCT00672490|69608381|FG000|Overall Study|Intolerance|0|||
37921652|NCT00672490|69608382|FG001|Overall Study|Intolerance|2|||
37629811|NCT02696031|69096125|FG004|Up to Week 24|Withdrawal by Subject|0|||
37629812|NCT02696031|69096126|FG005|Up to Week 24|Withdrawal by Subject|0|||
37629813|NCT02696031|69096121|FG000|Up to Week 52|Adverse Event|4|||
37629814|NCT02696031|69096122|FG001|Up to Week 52|Adverse Event|5|||
37629815|NCT02696031|69096123|FG002|Up to Week 52|Adverse Event|3|||
37629816|NCT02696031|69096124|FG003|Up to Week 52|Adverse Event|0|||
37629817|NCT02696031|69096125|FG004|Up to Week 52|Adverse Event|0|||
37629818|NCT02696031|69096126|FG005|Up to Week 52|Adverse Event|0|||
37629819|NCT02696031|69096121|FG000|Up to Week 52|Lack of Efficacy|10|||
37629820|NCT02696031|69096122|FG001|Up to Week 52|Lack of Efficacy|7|||
37629821|NCT02696031|69096123|FG002|Up to Week 52|Lack of Efficacy|11|||
37629822|NCT02696031|69096124|FG003|Up to Week 52|Lack of Efficacy|0|||
37629823|NCT02696031|69096125|FG004|Up to Week 52|Lack of Efficacy|0|||
37629824|NCT02696031|69096126|FG005|Up to Week 52|Lack of Efficacy|0|||
37629825|NCT02696031|69096121|FG000|Up to Week 52|Lost to Follow-up|1|||
37853218|NCT03868124|69537081|FG000|Overall Study|Death|1|||
37853219|NCT03868124|69537082|FG001|Overall Study|Death|1|||
37853220|NCT03868124|69537083|FG002|Overall Study|Death|2|||
37853221|NCT03868124|69537081|FG000|Overall Study|Adverse Event|0|||
37853222|NCT03868124|69537082|FG001|Overall Study|Adverse Event|0|||
37853223|NCT03868124|69537083|FG002|Overall Study|Adverse Event|3|||
38031831|NCT02862106|69717595|FG000|Overall Study|Withdrawal by Subject|2|||
37629826|NCT02696031|69096122|FG001|Up to Week 52|Lost to Follow-up|1|||
37629827|NCT02696031|69096123|FG002|Up to Week 52|Lost to Follow-up|1|||
37629828|NCT02696031|69096124|FG003|Up to Week 52|Lost to Follow-up|0|||
37629829|NCT02696031|69096125|FG004|Up to Week 52|Lost to Follow-up|0|||
37629830|NCT02696031|69096126|FG005|Up to Week 52|Lost to Follow-up|0|||
37629831|NCT02696031|69096121|FG000|Up to Week 52|Physician Decision|1|||
37629832|NCT02696031|69096122|FG001|Up to Week 52|Physician Decision|1|||
37629833|NCT02696031|69096123|FG002|Up to Week 52|Physician Decision|2|||
37629834|NCT02696031|69096124|FG003|Up to Week 52|Physician Decision|0|||
37629835|NCT02696031|69096125|FG004|Up to Week 52|Physician Decision|0|||
37629836|NCT02696031|69096126|FG005|Up to Week 52|Physician Decision|0|||
37629837|NCT02696031|69096121|FG000|Up to Week 52|Pregnancy|0|||
37629838|NCT02696031|69096122|FG001|Up to Week 52|Pregnancy|2|||
37629839|NCT02696031|69096123|FG002|Up to Week 52|Pregnancy|0|||
37629840|NCT02696031|69096124|FG003|Up to Week 52|Pregnancy|0|||
37629841|NCT02696031|69096125|FG004|Up to Week 52|Pregnancy|0|||
37629842|NCT02696031|69096126|FG005|Up to Week 52|Pregnancy|0|||
37629843|NCT02696031|69096121|FG000|Up to Week 52|Protocol Violation|1|||
37629844|NCT02696031|69096122|FG001|Up to Week 52|Protocol Violation|0|||
37629845|NCT02696031|69096123|FG002|Up to Week 52|Protocol Violation|0|||
37629846|NCT02696031|69096124|FG003|Up to Week 52|Protocol Violation|0|||
37629847|NCT02696031|69096125|FG004|Up to Week 52|Protocol Violation|0|||
37629848|NCT02696031|69096126|FG005|Up to Week 52|Protocol Violation|0|||
37629849|NCT02696031|69096121|FG000|Up to Week 52|Withdrawal by Subject|12|||
37629850|NCT02696031|69096122|FG001|Up to Week 52|Withdrawal by Subject|3|||
37629851|NCT02696031|69096123|FG002|Up to Week 52|Withdrawal by Subject|9|||
37629852|NCT02696031|69096124|FG003|Up to Week 52|Withdrawal by Subject|0|||
37629853|NCT02696031|69096125|FG004|Up to Week 52|Withdrawal by Subject|0|||
37629854|NCT02696031|69096126|FG005|Up to Week 52|Withdrawal by Subject|0|||
37629855|NCT02696031|69096121|FG000|Up to Week 104|Pregnancy|0|||
37629856|NCT02696031|69096122|FG001|Up to Week 104|Pregnancy|2|||
37629857|NCT02696031|69096123|FG002|Up to Week 104|Pregnancy|1|||
37629858|NCT02696031|69096124|FG003|Up to Week 104|Pregnancy|0|||
37629859|NCT02696031|69096125|FG004|Up to Week 104|Pregnancy|0|||
37629860|NCT02696031|69096126|FG005|Up to Week 104|Pregnancy|0|||
37629861|NCT02696031|69096121|FG000|Up to Week 104|Withdrawal by Subject|15|||
37629862|NCT02696031|69096122|FG001|Up to Week 104|Withdrawal by Subject|10|||
37629863|NCT02696031|69096123|FG002|Up to Week 104|Withdrawal by Subject|16|||
37629864|NCT02696031|69096124|FG003|Up to Week 104|Withdrawal by Subject|0|||
37629865|NCT02696031|69096125|FG004|Up to Week 104|Withdrawal by Subject|0|||
37629866|NCT02696031|69096126|FG005|Up to Week 104|Withdrawal by Subject|0|||
37629867|NCT02696031|69096121|FG000|Up to Week 104|Protocol Violation|1|||
37629868|NCT02696031|69096122|FG001|Up to Week 104|Protocol Violation|0|||
37629869|NCT02696031|69096123|FG002|Up to Week 104|Protocol Violation|0|||
37629870|NCT02696031|69096124|FG003|Up to Week 104|Protocol Violation|0|||
37629871|NCT02696031|69096125|FG004|Up to Week 104|Protocol Violation|0|||
37629872|NCT02696031|69096126|FG005|Up to Week 104|Protocol Violation|0|||
37629873|NCT02696031|69096121|FG000|Up to Week 104|Physician Decision|1|||
37629874|NCT02696031|69096122|FG001|Up to Week 104|Physician Decision|2|||
37629875|NCT02696031|69096123|FG002|Up to Week 104|Physician Decision|3|||
37629876|NCT02696031|69096124|FG003|Up to Week 104|Physician Decision|0|||
37629877|NCT02696031|69096125|FG004|Up to Week 104|Physician Decision|0|||
37629878|NCT02696031|69096126|FG005|Up to Week 104|Physician Decision|0|||
37629879|NCT02696031|69096121|FG000|Up to Week 104|Lost to Follow-up|2|||
37629880|NCT02696031|69096122|FG001|Up to Week 104|Lost to Follow-up|3|||
37629881|NCT02696031|69096123|FG002|Up to Week 104|Lost to Follow-up|1|||
37629882|NCT02696031|69096124|FG003|Up to Week 104|Lost to Follow-up|0|||
37853224|NCT03868124|69537081|FG000|Overall Study|Explanted|2|||
38031832|NCT02862106|69717596|FG001|Overall Study|Withdrawal by Subject|0|||
38031833|NCT02862106|69717595|FG000|Overall Study|Subjects moved to other city|1|||
38031834|NCT02862106|69717596|FG001|Overall Study|Subjects moved to other city|0|||
37629883|NCT02696031|69096125|FG004|Up to Week 104|Lost to Follow-up|0|||
37853225|NCT03868124|69537082|FG001|Overall Study|Explanted|1|||
37853226|NCT03868124|69537083|FG002|Overall Study|Explanted|0|||
37629884|NCT02696031|69096126|FG005|Up to Week 104|Lost to Follow-up|0|||
37629885|NCT02696031|69096121|FG000|Up to Week 104|Lack of Efficacy|13|||
37629886|NCT02696031|69096122|FG001|Up to Week 104|Lack of Efficacy|12|||
37629887|NCT02696031|69096123|FG002|Up to Week 104|Lack of Efficacy|11|||
37853227|NCT03868124|69537081|FG000|Overall Study|Ongoing in study|176|||
37629888|NCT02696031|69096124|FG003|Up to Week 104|Lack of Efficacy|0|||
37629889|NCT02696031|69096125|FG004|Up to Week 104|Lack of Efficacy|0|||
37629890|NCT02696031|69096126|FG005|Up to Week 104|Lack of Efficacy|0|||
37629891|NCT02696031|69096121|FG000|Up to Week 104|Adverse Event|7|||
37629892|NCT02696031|69096122|FG001|Up to Week 104|Adverse Event|11|||
37629893|NCT02696031|69096123|FG002|Up to Week 104|Adverse Event|5|||
37629894|NCT02696031|69096124|FG003|Up to Week 104|Adverse Event|0|||
37629895|NCT02696031|69096125|FG004|Up to Week 104|Adverse Event|0|||
37629896|NCT02696031|69096126|FG005|Up to Week 104|Adverse Event|0|||
37629897|NCT02696031|69096121|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
37629898|NCT02696031|69096122|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
37629899|NCT02696031|69096123|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
37629900|NCT02696031|69096124|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
37629901|NCT02696031|69096125|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
37629902|NCT02696031|69096126|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
37629903|NCT02696031|69096121|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
37629904|NCT02696031|69096122|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
37629905|NCT02696031|69096123|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
37629906|NCT02696031|69096124|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
37629907|NCT02696031|69096125|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
37629908|NCT02696031|69096126|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
37629909|NCT02696031|69096121|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
37629910|NCT02696031|69096122|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
37629911|NCT02696031|69096123|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
37629912|NCT02696031|69096124|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
37629913|NCT02696031|69096125|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
37629914|NCT02696031|69096126|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
37629915|NCT02696031|69096121|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
37738014|NCT01737398|69220529|FG001|Overall Study|Voluntary withdrawal|3|||
37738015|NCT01737398|69220528|FG000|Overall Study|Ineligibility|1|||
37738016|NCT01737398|69220529|FG001|Overall Study|Ineligibility|0|||
37738017|NCT01737398|69220528|FG000|Overall Study|Liver transplant|1|||
37738018|NCT01737398|69220529|FG001|Overall Study|Liver transplant|0|||
37738019|NCT01737398|69220528|FG000|Overall Study|Disease progression|2|||
37738020|NCT01737398|69220529|FG001|Overall Study|Disease progression|3|||
37738021|NCT01737398|69220528|FG000|Overall Study|Sponsor's decision|2|||
37738022|NCT01737398|69220529|FG001|Overall Study|Sponsor's decision|0|||
37738023|NCT01795898|69220538|FG000|Overall Study|Adverse Event|27|||
37738024|NCT01795898|69220538|FG000|Overall Study|Lost to Follow-up|20|||
37738025|NCT01795898|69220538|FG000|Overall Study|Withdrawal of consent|6|||
37738026|NCT01795898|69220538|FG000|Overall Study|Diagnosed with metastasis|1|||
37738027|NCT01795898|69220538|FG000|Overall Study|No pain|1|||
37738028|NCT01795898|69220538|FG000|Overall Study|Death|1|||
37738029|NCT01795898|69220538|FG000|Overall Study|Withdrew consent & had adverse events|3|||
37738030|NCT01795898|69220538|FG000|Overall Study|Physician Decision|1|||
37738031|NCT01736696|69220549|FG000|Overall Study|Withdrawal by Subject|0|||
37738032|NCT01736696|69220550|FG001|Overall Study|Withdrawal by Subject|0|||
37738033|NCT01736696|69220551|FG002|Overall Study|Withdrawal by Subject|1|||
37738034|NCT01736696|69220552|FG003|Overall Study|Withdrawal by Subject|0|||
37738035|NCT01736696|69220553|FG004|Overall Study|Withdrawal by Subject|0|||
37738036|NCT01736696|69220554|FG005|Overall Study|Withdrawal by Subject|0|||
37738037|NCT01736696|69220555|FG006|Overall Study|Withdrawal by Subject|0|||
37738038|NCT01736540|69220579|FG000|Overall Study|Did not complete scan within 45 days|2|||
37738039|NCT01736540|69220579|FG000|Overall Study|Death|1|||
37738040|NCT01736540|69220579|FG000|Overall Study|Abnormal test procedure|1|||
37738041|NCT01736540|69220579|FG000|Overall Study|Withdrawal by Subject|5|||
37738042|NCT01736540|69220579|FG000|Overall Study|Protocol Violation|1|||
37738043|NCT01736540|69220579|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
37738044|NCT01736540|69220579|FG000|Overall Study|No show for MRI appointment|1|||
37738045|NCT01736540|69220579|FG000|Overall Study|Unable to make MRI appointment|3|||
37738046|NCT01794338|69220592|FG000|Overall Study|Death|2|||
37738047|NCT01794338|69220593|FG001|Overall Study|Death|0|||
37738048|NCT01794338|69220592|FG000|Overall Study|Lost to Follow-up|6|||
37738049|NCT01794338|69220593|FG001|Overall Study|Lost to Follow-up|9|||
37738050|NCT01609478|69220602|FG000|Overall Study|Adverse Event|3|||
37738051|NCT01609478|69220603|FG001|Overall Study|Adverse Event|1|||
37738052|NCT01609478|69220604|FG002|Overall Study|Adverse Event|5|||
37738053|NCT01609478|69220602|FG000|Overall Study|Protocol Deviation|0|||
37738054|NCT01609478|69220603|FG001|Overall Study|Protocol Deviation|1|||
37738055|NCT01609478|69220604|FG002|Overall Study|Protocol Deviation|1|||
37738056|NCT01609478|69220602|FG000|Overall Study|Non-Compliance with study treatment|1|||
37738057|NCT01609478|69220603|FG001|Overall Study|Non-Compliance with study treatment|0|||
37738058|NCT01609478|69220604|FG002|Overall Study|Non-Compliance with study treatment|0|||
37738059|NCT01609478|69220602|FG000|Overall Study|Physician Decision|1|||
37738060|NCT01609478|69220603|FG001|Overall Study|Physician Decision|0|||
37738061|NCT01609478|69220604|FG002|Overall Study|Physician Decision|1|||
37738062|NCT01609478|69220602|FG000|Overall Study|Withdrawal by Subject|2|||
37738063|NCT01609478|69220603|FG001|Overall Study|Withdrawal by Subject|0|||
37629916|NCT02696031|69096122|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
37629917|NCT02696031|69096123|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
37629918|NCT02696031|69096124|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
37629919|NCT02696031|69096125|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
37629920|NCT02696031|69096126|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
37629921|NCT02696031|69096121|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
37629922|NCT02696031|69096122|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
37629923|NCT02696031|69096123|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
37629924|NCT02696031|69096124|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
37629925|NCT02696031|69096125|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
37629926|NCT02696031|69096126|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
37629927|NCT02696031|69096121|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
37629928|NCT02696031|69096122|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
37629929|NCT02696031|69096123|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
37629930|NCT02696031|69096124|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
37629931|NCT02696031|69096125|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
37629932|NCT02696031|69096126|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
37629933|NCT02696031|69096121|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
37629934|NCT02696031|69096122|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
37629935|NCT02696031|69096123|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
37629936|NCT02696031|69096124|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
37629937|NCT02696031|69096125|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
37629938|NCT02696031|69096126|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
37629939|NCT00397254|69096135|FG000|Overall Study|Lost to Follow-up|2|||
37629940|NCT00397254|69096136|FG001|Overall Study|Lost to Follow-up|2|||
37629941|NCT01369641|69096140|FG000|Overall Study|Withdrawal by Subject|1|||
37629942|NCT00529152|69096144|FG000|Overall Study|Adverse Event|2|||
37629943|NCT00529152|69096144|FG000|Overall Study|Withdrawal by Subject|2|||
37629944|NCT00529152|69096144|FG000|Overall Study|Lost to Follow-up|1|||
37629945|NCT02605174|69096151|FG000|Overall Study|Adverse Event|0|||
37629946|NCT02605174|69096152|FG001|Overall Study|Adverse Event|0|||
37629947|NCT02605174|69096153|FG002|Overall Study|Adverse Event|1|||
37629948|NCT02605174|69096154|FG003|Overall Study|Adverse Event|0|||
37629949|NCT02605174|69096155|FG004|Overall Study|Adverse Event|4|||
37629950|NCT02605174|69096156|FG005|Overall Study|Adverse Event|0|||
37629951|NCT02605174|69096157|FG006|Overall Study|Adverse Event|0|||
37629952|NCT02605174|69096151|FG000|Overall Study|Lost to Follow-up|20|||
37629953|NCT02605174|69096152|FG001|Overall Study|Lost to Follow-up|7|||
37629954|NCT02605174|69096153|FG002|Overall Study|Lost to Follow-up|27|||
37629955|NCT02605174|69096154|FG003|Overall Study|Lost to Follow-up|10|||
37629956|NCT02605174|69096155|FG004|Overall Study|Lost to Follow-up|20|||
37629957|NCT02605174|69096156|FG005|Overall Study|Lost to Follow-up|10|||
37629958|NCT02605174|69096157|FG006|Overall Study|Lost to Follow-up|29|||
37629959|NCT02605174|69096151|FG000|Overall Study|Protocol Violation|10|||
37629960|NCT02605174|69096152|FG001|Overall Study|Protocol Violation|4|||
37629961|NCT02605174|69096153|FG002|Overall Study|Protocol Violation|14|||
37629962|NCT02605174|69096154|FG003|Overall Study|Protocol Violation|6|||
37629963|NCT02605174|69096155|FG004|Overall Study|Protocol Violation|7|||
37629964|NCT02605174|69096156|FG005|Overall Study|Protocol Violation|7|||
37629965|NCT02605174|69096157|FG006|Overall Study|Protocol Violation|12|||
37629966|NCT02605174|69096151|FG000|Overall Study|Pregnancy|1|||
37629967|NCT02605174|69096152|FG001|Overall Study|Pregnancy|0|||
37629968|NCT02605174|69096153|FG002|Overall Study|Pregnancy|0|||
37629969|NCT02605174|69096154|FG003|Overall Study|Pregnancy|2|||
37629970|NCT02605174|69096155|FG004|Overall Study|Pregnancy|0|||
37629971|NCT02605174|69096156|FG005|Overall Study|Pregnancy|0|||
37629972|NCT02605174|69096157|FG006|Overall Study|Pregnancy|0|||
37629973|NCT02605174|69096151|FG000|Overall Study|Withdrawal by Subject|9|||
37629974|NCT02605174|69096152|FG001|Overall Study|Withdrawal by Subject|6|||
37629975|NCT02605174|69096153|FG002|Overall Study|Withdrawal by Subject|14|||
37629976|NCT02605174|69096154|FG003|Overall Study|Withdrawal by Subject|11|||
37629977|NCT02605174|69096155|FG004|Overall Study|Withdrawal by Subject|6|||
37629978|NCT02605174|69096156|FG005|Overall Study|Withdrawal by Subject|4|||
37629979|NCT02605174|69096157|FG006|Overall Study|Withdrawal by Subject|15|||
37853228|NCT03868124|69537082|FG001|Overall Study|Ongoing in study|180|||
37853229|NCT03868124|69537083|FG002|Overall Study|Ongoing in study|183|||
37629980|NCT02605174|69096151|FG000|Overall Study|Physician Decision|2|||
37629981|NCT02605174|69096152|FG001|Overall Study|Physician Decision|0|||
37629982|NCT02605174|69096153|FG002|Overall Study|Physician Decision|0|||
37629983|NCT02605174|69096154|FG003|Overall Study|Physician Decision|0|||
37629984|NCT02605174|69096155|FG004|Overall Study|Physician Decision|0|||
37629985|NCT02605174|69096156|FG005|Overall Study|Physician Decision|0|||
37629986|NCT02605174|69096157|FG006|Overall Study|Physician Decision|3|||
37629987|NCT02605174|69096151|FG000|Overall Study|Randomization Failure|22|||
37629988|NCT02605174|69096152|FG001|Overall Study|Randomization Failure|6|||
37629989|NCT02605174|69096153|FG002|Overall Study|Randomization Failure|20|||
37629990|NCT02605174|69096154|FG003|Overall Study|Randomization Failure|7|||
37629991|NCT02605174|69096155|FG004|Overall Study|Randomization Failure|16|||
37629992|NCT02605174|69096156|FG005|Overall Study|Randomization Failure|11|||
37629993|NCT02605174|69096157|FG006|Overall Study|Randomization Failure|30|||
37629994|NCT02604550|69096185|FG000|Overall Study|Lost to Follow-up|7|||
37629995|NCT02604550|69096186|FG001|Overall Study|Lost to Follow-up|6|||
37629996|NCT02604550|69096185|FG000|Overall Study|Withdrawal by Subject|0|||
37629997|NCT02604550|69096186|FG001|Overall Study|Withdrawal by Subject|1|||
37629998|NCT02604550|69096185|FG000|Overall Study|Incomplete data using paper journal|18|||
37629999|NCT02604550|69096186|FG001|Overall Study|Incomplete data using paper journal|19|||
37630000|NCT02591290|69096192|FG000|Overall Study|Withdrawal by Subject|2|||
37630001|NCT02791893|69096198|FG000|Blinded Phase|Lost to Follow-up|2|||
37630002|NCT02791893|69096199|FG001|Blinded Phase|Lost to Follow-up|2|||
37630003|NCT02791893|69096198|FG000|Blinded Phase|Withdrawal by Subject|1|||
37630004|NCT02791893|69096199|FG001|Blinded Phase|Withdrawal by Subject|2|||
37630005|NCT02791893|69096198|FG000|Open Label Phase|Lost to Follow-up|3|||
37630006|NCT02791893|69096199|FG001|Open Label Phase|Lost to Follow-up|0|||
37630007|NCT02791893|69096198|FG000|Open Label Phase|Withdrawal by Subject|0|||
37630008|NCT02791893|69096199|FG001|Open Label Phase|Withdrawal by Subject|2|||
37630009|NCT00120042|69096208|FG000|Overall Study|all completed protocl|0|||
37630010|NCT00120042|69096209|FG001|Overall Study|all completed protocl|0|||
37630011|NCT00120042|69096210|FG002|Overall Study|all completed protocl|0|||
37853230|NCT03733249|69537091|FG000|Overall Study|Death|7|||
37630012|NCT02476851|69096217|FG000|Overall Study|Protocol Violation|1|||
37630013|NCT02476851|69096218|FG001|Overall Study|Protocol Violation|1|||
37630014|NCT02595970|69096224|FG000|Overall Study|Withdrawal by Subject|2|||
37630015|NCT02595970|69096224|FG000|Overall Study|Physician Decision|2|||
37630016|NCT02595970|69096224|FG000|Overall Study|Protocol Violation|4|||
37630017|NCT02595970|69096224|FG000|Overall Study|Adverse Event|5|||
37630018|NCT02595970|69096224|FG000|Overall Study|Lack of Efficacy|7|||
37630019|NCT01866111|69096232|FG000|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|14|||
37630020|NCT01866111|69096233|FG001|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|13|||
37630021|NCT01866111|69096234|FG002|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|20|||
37630022|NCT01866111|69096235|FG003|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|30|||
37630023|NCT01866111|69096232|FG000|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|65|||
37630024|NCT01866111|69096233|FG001|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|67|||
37630025|NCT01866111|69096234|FG002|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|63|||
37630026|NCT01866111|69096235|FG003|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|52|||
37630027|NCT02595502|69096245|FG000|Period 1|Adverse Event|0|||
37630028|NCT02595502|69096246|FG001|Period 1|Adverse Event|1|||
37630029|NCT02595502|69096245|FG000|Period 1|Withdrawal by Subject|1|||
37630030|NCT02595502|69096246|FG001|Period 1|Withdrawal by Subject|0|||
37630031|NCT02595502|69096245|FG000|Period 1|Lost to Follow-up|0|||
37630032|NCT02595502|69096246|FG001|Period 1|Lost to Follow-up|1|||
37630033|NCT02595502|69096245|FG000|Period 2|Adverse Event|1|||
37630034|NCT02595502|69096246|FG001|Period 2|Adverse Event|1|||
37630035|NCT02595502|69096245|FG000|Period 2|Received incorrect lens at Period 1|0|||
37630036|NCT02595502|69096246|FG001|Period 2|Received incorrect lens at Period 1|1|||
37630037|NCT02595502|69096245|FG000|Period 3|Protocol Violation|0|||
37630038|NCT02595502|69096246|FG001|Period 3|Protocol Violation|1|||
37630039|NCT02595502|69096245|FG000|Period 3|Lost to Follow-up|1|||
37630040|NCT02595502|69096246|FG001|Period 3|Lost to Follow-up|0|||
37630041|NCT02595502|69096245|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
37630042|NCT02595502|69096246|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
37630043|NCT01369329|69096255|FG000|Overall Study|Withdrawal by Subject|8|||
37630044|NCT01369329|69096256|FG001|Overall Study|Withdrawal by Subject|6|||
37630045|NCT01369329|69096257|FG002|Overall Study|Withdrawal by Subject|10|||
37630046|NCT01369329|69096255|FG000|Overall Study|Lost to Follow-up|2|||
37630047|NCT01369329|69096256|FG001|Overall Study|Lost to Follow-up|2|||
37630048|NCT01369329|69096257|FG002|Overall Study|Lost to Follow-up|2|||
37630049|NCT01369329|69096255|FG000|Overall Study|Other|2|||
37630050|NCT01369329|69096256|FG001|Overall Study|Other|3|||
37630051|NCT01369329|69096257|FG002|Overall Study|Other|2|||
37630052|NCT02791659|69096267|FG000|Overall Study|Protocol Violation|0|||
37630053|NCT02791659|69096268|FG001|Overall Study|Protocol Violation|1|||
37630054|NCT02594098|69096276|FG000|Overall Study|Lack of Efficacy|17|||
37630055|NCT02594098|69096277|FG001|Overall Study|Lack of Efficacy|6|||
37853231|NCT03733249|69537091|FG000|Overall Study|Disease relapse|16|||
37853232|NCT03733249|69537091|FG000|Overall Study|Lost to Follow-up|4|||
37630056|NCT02594098|69096276|FG000|Overall Study|Withdrawal by Subject|1|||
37630057|NCT02594098|69096277|FG001|Overall Study|Withdrawal by Subject|3|||
37630058|NCT02594098|69096276|FG000|Overall Study|Terminated participation|6|||
37853233|NCT03733249|69537091|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
37630059|NCT02594098|69096277|FG001|Overall Study|Terminated participation|2|||
37630060|NCT02594098|69096276|FG000|Overall Study|Seek alternative treatment|2|||
37630061|NCT02594098|69096277|FG001|Overall Study|Seek alternative treatment|1|||
37630062|NCT02594098|69096276|FG000|Overall Study|Other|0|||
37630063|NCT02594098|69096277|FG001|Overall Study|Other|1|||
37630064|NCT02593864|69096285|FG000|Overall Study|Withdrawal by Subject|3|||
37630065|NCT02593864|69096285|FG000|Overall Study|Lost to Follow-up|3|||
37630066|NCT02590588|69096289|FG000|Overall Study|Adverse Event|1|||
37630067|NCT01434602|69096298|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
37630068|NCT01434602|69096299|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
37630069|NCT01434602|69096300|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
37630070|NCT01434602|69096301|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
37630071|NCT01434602|69096302|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
37630072|NCT01434602|69096298|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
37630073|NCT01434602|69096299|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
37630074|NCT01434602|69096300|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
37630075|NCT01434602|69096301|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
37630076|NCT01434602|69096302|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
37630077|NCT01434602|69096298|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
37630078|NCT01434602|69096299|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
37630079|NCT01434602|69096300|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
37630080|NCT01434602|69096301|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
37630081|NCT01434602|69096302|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
37630082|NCT01434602|69096298|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
37630083|NCT01434602|69096299|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
37630084|NCT01434602|69096300|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
37630085|NCT01434602|69096301|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
37630086|NCT01434602|69096302|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
37630087|NCT01434602|69096298|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
37630088|NCT01434602|69096299|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
37630089|NCT01434602|69096300|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
37630090|NCT01434602|69096301|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
37630091|NCT01434602|69096302|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
37630092|NCT01434602|69096298|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
37630093|NCT01434602|69096299|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
37630094|NCT01434602|69096300|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
37630095|NCT01434602|69096301|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
37630096|NCT01434602|69096302|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
37630097|NCT01434602|69096298|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
37630098|NCT01434602|69096299|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
37630099|NCT01434602|69096300|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
37630100|NCT01434602|69096301|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
37630101|NCT01434602|69096302|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
37630102|NCT01434602|69096298|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
37630103|NCT01434602|69096299|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
37630104|NCT01434602|69096300|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
37630105|NCT01434602|69096301|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
37630106|NCT01434602|69096302|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
37630107|NCT01434602|69096298|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
37630108|NCT01434602|69096299|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
37630109|NCT01434602|69096300|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
37630110|NCT01434602|69096301|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
37630111|NCT01434602|69096302|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
37630112|NCT01434602|69096298|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
37630113|NCT01434602|69096299|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
37630114|NCT01434602|69096300|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
37630115|NCT01434602|69096301|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
37630116|NCT01434602|69096302|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
37630117|NCT01767129|69096324|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
37630118|NCT01767129|69096325|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
37630119|NCT02791269|69096334|FG000|Overall Study|Lost to Follow-up|0|||
37630120|NCT02791269|69096335|FG001|Overall Study|Lost to Follow-up|1|||
37630121|NCT02696564|69096345|FG000|Overall Study|Death|1|||
37630122|NCT02696564|69096346|FG001|Overall Study|Death|2|||
37630123|NCT02696564|69096345|FG000|Overall Study|Withdrawal by Subject|3|||
37630124|NCT02696564|69096346|FG001|Overall Study|Withdrawal by Subject|2|||
37630125|NCT02696564|69096345|FG000|Overall Study|Lost to Follow-up|3|||
37630126|NCT02696564|69096346|FG001|Overall Study|Lost to Follow-up|3|||
37630127|NCT02696564|69096345|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
37630128|NCT02696564|69096346|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
37630129|NCT02696564|69096345|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
37630130|NCT02696564|69096346|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
37630131|NCT02696564|69096345|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
37630132|NCT02696564|69096346|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
37630133|NCT02696564|69096345|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
37630134|NCT02696564|69096346|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
37630135|NCT02696564|69096345|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
37630136|NCT02696564|69096346|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
37630137|NCT02640950|69096352|FG000|Overall Study|Adverse Event|1|||
37630138|NCT02640950|69096352|FG000|Overall Study|Withdrawal by Subject|1|||
37630139|NCT02593786|69096360|FG000|Overall Study|Disease progression|12|||
37630140|NCT02593786|69096361|FG001|Overall Study|Disease progression|16|||
37630141|NCT02593786|69096362|FG002|Overall Study|Disease progression|10|||
37630142|NCT02593786|69096363|FG003|Overall Study|Disease progression|7|||
37630143|NCT02593786|69096360|FG000|Overall Study|Study drug toxicity|1|||
37630144|NCT02593786|69096361|FG001|Overall Study|Study drug toxicity|0|||
37630145|NCT02593786|69096362|FG002|Overall Study|Study drug toxicity|0|||
37630146|NCT02593786|69096363|FG003|Overall Study|Study drug toxicity|0|||
37630147|NCT02593786|69096360|FG000|Overall Study|Adverse event unrelated to study drug|1|||
37630148|NCT02593786|69096361|FG001|Overall Study|Adverse event unrelated to study drug|1|||
37630149|NCT02593786|69096362|FG002|Overall Study|Adverse event unrelated to study drug|1|||
37630150|NCT02593786|69096363|FG003|Overall Study|Adverse event unrelated to study drug|0|||
37630151|NCT02593786|69096360|FG000|Overall Study|Participant request to discontinue study therapy|0|||
37630152|NCT02593786|69096361|FG001|Overall Study|Participant request to discontinue study therapy|2|||
37630153|NCT02593786|69096362|FG002|Overall Study|Participant request to discontinue study therapy|0|||
37630154|NCT02593786|69096363|FG003|Overall Study|Participant request to discontinue study therapy|0|||
37630155|NCT02593786|69096360|FG000|Overall Study|Other reasons|1|||
37630156|NCT02593786|69096361|FG001|Overall Study|Other reasons|1|||
37630157|NCT02593786|69096362|FG002|Overall Study|Other reasons|0|||
37630158|NCT02593786|69096363|FG003|Overall Study|Other reasons|5|||
37630159|NCT04829331|69096385|FG000|Overall Study|Lost to Follow-up|1|||
37630160|NCT04829331|69096386|FG001|Overall Study|Lost to Follow-up|0|||
37630161|NCT04602546|69096401|FG000|Overall Study|Training|2|||
37630162|NCT04602546|69096402|FG001|Overall Study|Training|2|||
37630163|NCT04602546|69096403|FG002|Overall Study|Training|1|||
37630164|NCT04602546|69096404|FG003|Overall Study|Training|2|||
37630165|NCT04602546|69096405|FG004|Overall Study|Training|0|||
37630166|NCT04602546|69096401|FG000|Overall Study|Randomized with disqualified data|2|||
37630167|NCT04602546|69096402|FG001|Overall Study|Randomized with disqualified data|0|||
37630168|NCT04602546|69096403|FG002|Overall Study|Randomized with disqualified data|2|||
37630169|NCT04602546|69096404|FG003|Overall Study|Randomized with disqualified data|5|||
37630170|NCT04602546|69096405|FG004|Overall Study|Randomized with disqualified data|3|||
37630171|NCT04102189|69096435|FG000|Overall Study|Withdrawal by Subject|1|||
37738064|NCT01609478|69220604|FG002|Overall Study|Withdrawal by Subject|2|||
37738065|NCT01764854|69220616|FG000|Overall Study|Adverse Event|0|||
37738066|NCT01764854|69220617|FG001|Overall Study|Adverse Event|0|||
37630172|NCT04102189|69096436|FG001|Overall Study|Withdrawal by Subject|2|||
37630173|NCT04102189|69096435|FG000|Overall Study|Withdrawal by parent/guardian|0|||
37630174|NCT04102189|69096436|FG001|Overall Study|Withdrawal by parent/guardian|1|||
37630175|NCT04102189|69096435|FG000|Overall Study|Lost to Follow-up|1|||
37630176|NCT04102189|69096436|FG001|Overall Study|Lost to Follow-up|0|||
37630177|NCT04004988|69096474|FG000|Period 1|Physician Decision|2|||
37630178|NCT04004988|69096475|FG001|Period 1|Physician Decision|0|||
37630179|NCT04004988|69096474|FG000|Period 1|Withdrawal by Subject|0|||
37630180|NCT04004988|69096475|FG001|Period 1|Withdrawal by Subject|1|||
37630181|NCT04004988|69096474|FG000|Period 1|Adverse Event|1|||
37630182|NCT04004988|69096475|FG001|Period 1|Adverse Event|2|||
37630183|NCT03898700|69096482|FG000|Overall Study|Withdrawal by Subject|2|||
37630184|NCT03586973|69096497|FG000|Overall Study|Death|15|||
37738067|NCT01764854|69220618|FG002|Overall Study|Adverse Event|2|||
37738068|NCT01764854|69220619|FG003|Overall Study|Adverse Event|0|||
37738069|NCT01764854|69220616|FG000|Overall Study|Withdrawal by Subject|0|||
37630185|NCT03586973|69096498|FG001|Overall Study|Death|8|||
37630186|NCT03586973|69096497|FG000|Overall Study|Site Terminated by Sponsor|3|||
37738070|NCT01764854|69220617|FG001|Overall Study|Withdrawal by Subject|0|||
37738071|NCT01764854|69220618|FG002|Overall Study|Withdrawal by Subject|1|||
37738072|NCT01764854|69220619|FG003|Overall Study|Withdrawal by Subject|0|||
37738073|NCT01764854|69220616|FG000|Overall Study|relocation|0|||
37738074|NCT01764854|69220617|FG001|Overall Study|relocation|0|||
37738075|NCT01764854|69220618|FG002|Overall Study|relocation|2|||
37738076|NCT01764854|69220619|FG003|Overall Study|relocation|0|||
37738077|NCT01764854|69220616|FG000|Overall Study|Protocol Violation|0|||
37738078|NCT01764854|69220617|FG001|Overall Study|Protocol Violation|0|||
37738079|NCT01764854|69220618|FG002|Overall Study|Protocol Violation|1|||
37738080|NCT01764854|69220619|FG003|Overall Study|Protocol Violation|2|||
37738081|NCT01764464|69220631|FG000|First Intervention|Withdrawal by Subject|1|||
37738082|NCT01764464|69220632|FG001|First Intervention|Withdrawal by Subject|0|||
37738083|NCT01764464|69220631|FG000|First Intervention|Lost to Follow-up|1|||
37738084|NCT01764464|69220632|FG001|First Intervention|Lost to Follow-up|0|||
37738085|NCT01764464|69220631|FG000|First Intervention|Adverse Event|0|||
37738086|NCT01764464|69220632|FG001|First Intervention|Adverse Event|2|||
37738087|NCT01764464|69220631|FG000|First Intervention|did not receive study drug|0|||
37738088|NCT01764464|69220632|FG001|First Intervention|did not receive study drug|1|||
37738089|NCT01764464|69220631|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
37738090|NCT01764464|69220632|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
37738091|NCT01764386|69220640|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
37738092|NCT01764386|69220641|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
37738093|NCT01764386|69220640|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
37738094|NCT01764386|69220641|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
37738095|NCT01764386|69220640|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
37738096|NCT01764386|69220641|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
37738097|NCT01764386|69220640|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
37738098|NCT01764386|69220641|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
37738099|NCT01764386|69220640|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
37738100|NCT01764386|69220641|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
37738101|NCT01764386|69220640|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
37738102|NCT01764386|69220641|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
37738103|NCT01764386|69220640|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
37738104|NCT01764386|69220641|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
37738105|NCT01764386|69220640|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
37738106|NCT01764386|69220641|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
37738107|NCT01763918|69220652|FG000|Overall Study|Withdrawal by Subject|2|||
37738108|NCT01763918|69220653|FG001|Overall Study|Withdrawal by Subject|1|||
37738109|NCT01763918|69220654|FG002|Overall Study|Withdrawal by Subject|1|||
37738110|NCT01763918|69220655|FG003|Overall Study|Withdrawal by Subject|2|||
37738111|NCT01763918|69220652|FG000|Overall Study|Sponsor Decision|4|||
37738112|NCT01763918|69220653|FG001|Overall Study|Sponsor Decision|0|||
37738113|NCT01763918|69220654|FG002|Overall Study|Sponsor Decision|9|||
37738114|NCT01763918|69220655|FG003|Overall Study|Sponsor Decision|0|||
37738115|NCT01763684|69220667|FG000|Overall Study|Study terminated early due to low enrollment|126|||
37738116|NCT01763684|69220668|FG001|Overall Study|Study terminated early due to low enrollment|127|||
37738117|NCT01763684|69220667|FG000|Overall Study|Study surgery not performed|7|||
37738118|NCT01763684|69220668|FG001|Overall Study|Study surgery not performed|6|||
37738119|NCT01606748|69220676|FG000|Overall Study|Adverse Event|1|||
37738120|NCT01606748|69220677|FG001|Overall Study|Adverse Event|0|||
37738121|NCT01606748|69220676|FG000|Overall Study|Progressive Disease|1|||
37738122|NCT01606748|69220677|FG001|Overall Study|Progressive Disease|0|||
37738123|NCT01606748|69220676|FG000|Overall Study|Withdrawal by Subject|1|||
37738124|NCT01606748|69220677|FG001|Overall Study|Withdrawal by Subject|0|||
37738125|NCT01597622|69220695|FG000|Overall Study|Adverse Event|7|||
37738126|NCT01597622|69220695|FG000|Overall Study|Lack of Efficacy|3|||
37738127|NCT01597622|69220695|FG000|Overall Study|Protocol Violation|1|||
37738128|NCT01597622|69220695|FG000|Overall Study|Lost to Follow-up|1|||
37630187|NCT03586973|69096498|FG001|Overall Study|Site Terminated by Sponsor|6|||
37630188|NCT03586973|69096497|FG000|Overall Study|Withdrawal by Subject|1|||
37738129|NCT01597622|69220695|FG000|Overall Study|Investigator Discretion|5|||
37853234|NCT03733249|69537091|FG000|Overall Study|Withdrawal by Subject|1|||
37853235|NCT03469271|69537103|FG000|Overall Study|Withdrawal by Subject|2|||
37738130|NCT01597622|69220695|FG000|Overall Study|Withdrawal by Subject|20|||
37738131|NCT01597622|69220695|FG000|Overall Study|Death|1|||
37738132|NCT01761266|69220701|FG000|Overall Study|Death|415|||
37738133|NCT01761266|69220702|FG001|Overall Study|Death|402|||
37738134|NCT01761266|69220701|FG000|Overall Study|Lost to Follow-up|8|||
37738135|NCT01761266|69220702|FG001|Overall Study|Lost to Follow-up|12|||
37853236|NCT03469271|69537104|FG001|Overall Study|Withdrawal by Subject|0|||
37630189|NCT03586973|69096498|FG001|Overall Study|Withdrawal by Subject|0|||
37630190|NCT03586973|69096497|FG000|Overall Study|Lost to Follow-up|1|||
37630191|NCT03586973|69096498|FG001|Overall Study|Lost to Follow-up|0|||
37630192|NCT02669212|69096506|FG000|Overall Study|Lost to Follow-up|1|||
37630193|NCT02669212|69096507|FG001|Overall Study|Lost to Follow-up|0|||
37630194|NCT02669212|69096506|FG000|Overall Study|Medical Condition|3|||
37630195|NCT02669212|69096507|FG001|Overall Study|Medical Condition|4|||
37630196|NCT02669212|69096506|FG000|Overall Study|Withdrawal by Subject|0|||
37630197|NCT02669212|69096507|FG001|Overall Study|Withdrawal by Subject|2|||
37630198|NCT02669212|69096506|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
37630199|NCT02669212|69096507|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
37630200|NCT02536664|69096529|FG000|Overall Study|Inadequate completion of documentation|2|||
37630201|NCT02536664|69096530|FG001|Overall Study|Inadequate completion of documentation|4|||
37630202|NCT02536664|69096529|FG000|Overall Study|Progression|13|||
37630203|NCT02536664|69096530|FG001|Overall Study|Progression|18|||
37630204|NCT02536664|69096529|FG000|Overall Study|Death due to lymphoma|2|||
37630205|NCT02536664|69096530|FG001|Overall Study|Death due to lymphoma|1|||
37630206|NCT02536664|69096529|FG000|Overall Study|Death due to other reason|3|||
37630207|NCT02536664|69096530|FG001|Overall Study|Death due to other reason|2|||
37630208|NCT02536664|69096529|FG000|Overall Study|Intolerability|8|||
37630209|NCT02536664|69096530|FG001|Overall Study|Intolerability|6|||
37630210|NCT02536664|69096529|FG000|Overall Study|Withdrawal by Subject|8|||
37630211|NCT02536664|69096530|FG001|Overall Study|Withdrawal by Subject|5|||
37630212|NCT02536664|69096529|FG000|Overall Study|Other|18|||
37630213|NCT02536664|69096530|FG001|Overall Study|Other|24|||
37630214|NCT02536664|69096529|FG000|Overall Study|Missing|53|||
37630215|NCT02536664|69096530|FG001|Overall Study|Missing|20|||
37630216|NCT02426892|69096536|FG000|Overall Study|Adverse Event|2|||
37630217|NCT02426892|69096536|FG000|Overall Study|Lack of Efficacy|17|||
37630218|NCT02426892|69096536|FG000|Overall Study|Withdrawal by Subject|1|||
37630219|NCT02312687|69096540|FG000|Overall Study|Other, Not Specified|1|||
37630220|NCT02304367|69096544|FG000|Overall Study|Lack of Response to Bruosumab|1|||
38031835|NCT04157296|69717611|FG000|Overall Study|Withdrawal by Subject|0|||
38031836|NCT04157296|69717612|FG001|Overall Study|Withdrawal by Subject|1|||
38031837|NCT04157296|69717611|FG000|Overall Study|Did not obtain second fMRI.|0|||
38031838|NCT04157296|69717612|FG001|Overall Study|Did not obtain second fMRI.|1|||
37630221|NCT02304367|69096544|FG000|Overall Study|Sponsor Decision|3|||
37630222|NCT02304367|69096544|FG000|Overall Study|Death|2|||
37630223|NCT02304367|69096544|FG000|Overall Study|Physician Decision|1|||
37630224|NCT02304367|69096544|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
37630225|NCT02054520|69096561|FG000|Overall Study|Adverse Event|1|||
37630226|NCT02054520|69096562|FG001|Overall Study|Adverse Event|4|||
37630227|NCT02054520|69096563|FG002|Overall Study|Adverse Event|2|||
37630228|NCT02054520|69096564|FG003|Overall Study|Adverse Event|1|||
37630229|NCT02054520|69096565|FG004|Overall Study|Adverse Event|1|||
37630230|NCT02054520|69096566|FG005|Overall Study|Adverse Event|0|||
37630231|NCT02054520|69096561|FG000|Overall Study|Lack of Efficacy|7|||
37630232|NCT02054520|69096562|FG001|Overall Study|Lack of Efficacy|0|||
37630233|NCT02054520|69096563|FG002|Overall Study|Lack of Efficacy|2|||
37630234|NCT02054520|69096564|FG003|Overall Study|Lack of Efficacy|1|||
37630235|NCT02054520|69096565|FG004|Overall Study|Lack of Efficacy|3|||
37630236|NCT02054520|69096566|FG005|Overall Study|Lack of Efficacy|2|||
37630237|NCT02054520|69096561|FG000|Overall Study|Withdrawal by Subject|1|||
37630238|NCT02054520|69096562|FG001|Overall Study|Withdrawal by Subject|0|||
37630239|NCT02054520|69096563|FG002|Overall Study|Withdrawal by Subject|0|||
37630240|NCT02054520|69096564|FG003|Overall Study|Withdrawal by Subject|2|||
37630241|NCT02054520|69096565|FG004|Overall Study|Withdrawal by Subject|1|||
37630242|NCT02054520|69096566|FG005|Overall Study|Withdrawal by Subject|0|||
37630243|NCT02054520|69096561|FG000|Overall Study|Physician Decision|0|||
37630244|NCT02054520|69096562|FG001|Overall Study|Physician Decision|1|||
37630245|NCT02054520|69096563|FG002|Overall Study|Physician Decision|0|||
37630246|NCT02054520|69096564|FG003|Overall Study|Physician Decision|1|||
37630247|NCT02054520|69096565|FG004|Overall Study|Physician Decision|0|||
37630248|NCT02054520|69096566|FG005|Overall Study|Physician Decision|1|||
38031839|NCT04157296|69717611|FG000|Overall Study|MRI failed/no second fMRI|0|||
38031840|NCT04157296|69717612|FG001|Overall Study|MRI failed/no second fMRI|1|||
38031841|NCT02859142|69717620|FG000|Overall Study|Adverse Event|1|||
37630249|NCT02054520|69096561|FG000|Overall Study|Study terminated by Sponsor|0|||
37630250|NCT02054520|69096562|FG001|Overall Study|Study terminated by Sponsor|0|||
38031842|NCT02859142|69717621|FG001|Overall Study|Adverse Event|2|||
38031843|NCT02859142|69717620|FG000|Overall Study|Lost to Follow-up|1|||
38031844|NCT02859142|69717621|FG001|Overall Study|Lost to Follow-up|4|||
37630251|NCT02054520|69096563|FG002|Overall Study|Study terminated by Sponsor|2|||
37630252|NCT02054520|69096564|FG003|Overall Study|Study terminated by Sponsor|1|||
37630253|NCT02054520|69096565|FG004|Overall Study|Study terminated by Sponsor|0|||
37630254|NCT02054520|69096566|FG005|Overall Study|Study terminated by Sponsor|0|||
37630255|NCT01546987|69096595|FG000|Overall Study|Protocol Violation|3|||
37630256|NCT01546987|69096596|FG001|Overall Study|Protocol Violation|4|||
37921653|NCT00672490|69608381|FG000|Overall Study|Lost to Follow-up|1|||
37630257|NCT00261443|69096619|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
37630258|NCT00261443|69096620|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
37630259|NCT00261443|69096621|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
37630260|NCT00261443|69096619|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
37630261|NCT00261443|69096620|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
37630262|NCT00261443|69096621|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
37630263|NCT00261443|69096619|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
37630264|NCT00261443|69096620|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
37630265|NCT00261443|69096621|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
37630266|NCT00261443|69096619|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
37630267|NCT00261443|69096620|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
37630268|NCT00261443|69096621|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
37630269|NCT00261443|69096619|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
37630270|NCT00261443|69096620|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
37630271|NCT00261443|69096621|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
37630272|NCT00261443|69096619|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
37630273|NCT00261443|69096620|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
37630274|NCT00261443|69096621|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
37630275|NCT00261443|69096619|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
37630276|NCT00261443|69096620|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
37630277|NCT00261443|69096621|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
37630278|NCT00261443|69096619|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
37630279|NCT00261443|69096620|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
37630280|NCT00261443|69096621|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
37630281|NCT00261443|69096619|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
37630282|NCT00261443|69096620|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
37630283|NCT00261443|69096621|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
37630284|NCT00261443|69096619|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
37630285|NCT00261443|69096620|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
37630286|NCT00261443|69096621|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
37630287|NCT00261443|69096619|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
37630288|NCT00261443|69096620|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
37630289|NCT00261443|69096621|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
37630290|NCT00261443|69096619|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
37630291|NCT00261443|69096620|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
37630292|NCT00261443|69096621|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
37630293|NCT00261443|69096619|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
37630294|NCT00261443|69096620|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
37630295|NCT00261443|69096621|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
37630296|NCT00261443|69096619|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
37630297|NCT00261443|69096620|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
37630298|NCT00261443|69096621|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
37630299|NCT00261443|69096619|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
37630300|NCT00261443|69096620|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
37630301|NCT00261443|69096621|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
37630302|NCT00261443|69096619|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
37630303|NCT00261443|69096620|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
37630304|NCT00261443|69096621|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
37630305|NCT00261443|69096619|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
37630306|NCT00261443|69096620|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
37630307|NCT00261443|69096621|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
37630308|NCT00261443|69096619|FG000|3: Assessment of Relapse|Adverse Event|0|||
37630309|NCT00261443|69096620|FG001|3: Assessment of Relapse|Adverse Event|15|||
37630310|NCT00261443|69096621|FG002|3: Assessment of Relapse|Adverse Event|19|||
37630311|NCT00261443|69096619|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
37630312|NCT00261443|69096620|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
37630313|NCT00261443|69096621|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
37630314|NCT00261443|69096619|FG000|3: Assessment of Relapse|Death|0|||
37630315|NCT00261443|69096620|FG001|3: Assessment of Relapse|Death|0|||
37630316|NCT00261443|69096621|FG002|3: Assessment of Relapse|Death|1|||
37630317|NCT00261443|69096619|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
37921654|NCT00672490|69608382|FG001|Overall Study|Lost to Follow-up|5|||
37921655|NCT00672490|69608381|FG000|Overall Study|No reason was provided|6|||
37921656|NCT00672490|69608382|FG001|Overall Study|No reason was provided|2|||
37921657|NCT00670930|69608390|FG000|Overall Study|Adminstrative Problem|0|||
37921658|NCT00670930|69608391|FG001|Overall Study|Adminstrative Problem|1|||
37630318|NCT00261443|69096620|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
37630319|NCT00261443|69096621|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
37630320|NCT00261443|69096619|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
37630321|NCT00261443|69096620|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
37630322|NCT00261443|69096621|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
37630323|NCT00261443|69096619|FG000|3: Assessment of Relapse|Pregnancy|0|||
37630324|NCT00261443|69096620|FG001|3: Assessment of Relapse|Pregnancy|2|||
37630325|NCT00261443|69096621|FG002|3: Assessment of Relapse|Pregnancy|1|||
37630326|NCT00261443|69096619|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
37630327|NCT00261443|69096620|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
37630328|NCT00261443|69096621|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
37630329|NCT00261443|69096619|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
37738136|NCT01761266|69220701|FG000|Overall Study|Withdrawal by Subject|14|||
37738137|NCT01761266|69220702|FG001|Overall Study|Withdrawal by Subject|10|||
37738138|NCT01761266|69220701|FG000|Overall Study|Sponsor Decision|41|||
37738139|NCT01761266|69220702|FG001|Overall Study|Sponsor Decision|52|||
37738140|NCT01760954|69220715|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
37738141|NCT01760954|69220716|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
37738142|NCT01760954|69220717|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
37738143|NCT01760954|69220718|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
37738144|NCT01760954|69220715|FG000|Treatment Period (6 Months)|Adverse Event|5|||
37738145|NCT01760954|69220716|FG001|Treatment Period (6 Months)|Adverse Event|3|||
37738146|NCT01760954|69220717|FG002|Treatment Period (6 Months)|Adverse Event|4|||
37738147|NCT01760954|69220718|FG003|Treatment Period (6 Months)|Adverse Event|10|||
37738148|NCT01760954|69220715|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
37738149|NCT01760954|69220716|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
37738150|NCT01760954|69220717|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
37738151|NCT01760954|69220718|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
37738152|NCT01760954|69220715|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
37738153|NCT01760954|69220716|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
37738154|NCT01760954|69220717|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
37738155|NCT01760954|69220718|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
37738156|NCT01760954|69220715|FG000|Treatment Period (6 Months)|Pregnancy|5|||
37738157|NCT01760954|69220716|FG001|Treatment Period (6 Months)|Pregnancy|0|||
37738158|NCT01760954|69220717|FG002|Treatment Period (6 Months)|Pregnancy|3|||
37738159|NCT01760954|69220718|FG003|Treatment Period (6 Months)|Pregnancy|2|||
37738160|NCT01760954|69220715|FG000|Treatment Period (6 Months)|Non-compliance|1|||
37738161|NCT01760954|69220716|FG001|Treatment Period (6 Months)|Non-compliance|4|||
37738162|NCT01760954|69220717|FG002|Treatment Period (6 Months)|Non-compliance|0|||
37738163|NCT01760954|69220718|FG003|Treatment Period (6 Months)|Non-compliance|3|||
37738164|NCT01760954|69220715|FG000|Treatment Period (6 Months)|Other|0|||
37738165|NCT01760954|69220716|FG001|Treatment Period (6 Months)|Other|3|||
37738166|NCT01760954|69220717|FG002|Treatment Period (6 Months)|Other|3|||
37738167|NCT01760954|69220718|FG003|Treatment Period (6 Months)|Other|1|||
37738168|NCT01760954|69220715|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
37630330|NCT00261443|69096620|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
37630331|NCT00261443|69096621|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
37630332|NCT00261443|69096619|FG000|3: Assessment of Relapse|Other Reasons|0|||
37630333|NCT00261443|69096620|FG001|3: Assessment of Relapse|Other Reasons|4|||
37630334|NCT00261443|69096621|FG002|3: Assessment of Relapse|Other Reasons|3|||
37630335|NCT00261443|69096619|FG000|4: Extension Phase|Adverse Event|0|||
37630336|NCT00261443|69096620|FG001|4: Extension Phase|Adverse Event|1|||
37630337|NCT00261443|69096621|FG002|4: Extension Phase|Adverse Event|0|||
37630338|NCT00261443|69096619|FG000|4: Extension Phase|Withdrawal by Subject|0|||
37630339|NCT00261443|69096620|FG001|4: Extension Phase|Withdrawal by Subject|1|||
37630340|NCT00261443|69096621|FG002|4: Extension Phase|Withdrawal by Subject|2|||
37630341|NCT00261443|69096619|FG000|4: Extension Phase|Lost to Follow-up|0|||
37630342|NCT00261443|69096620|FG001|4: Extension Phase|Lost to Follow-up|1|||
37630343|NCT00261443|69096621|FG002|4: Extension Phase|Lost to Follow-up|0|||
37630344|NCT02593318|69096638|FG000|Overall Study|Withdrawal by Subject|1|||
37630345|NCT02593318|69096639|FG001|Overall Study|Withdrawal by Subject|1|||
37630346|NCT02343302|69096653|FG000|Overall Study|Physician Decision|1|||
37630347|NCT02343302|69096654|FG001|Overall Study|Physician Decision|1|||
37630348|NCT02590432|69096662|FG000|Open-label Treatment Period|Adverse Event|97|||
37630349|NCT02590432|69096663|FG001|Open-label Treatment Period|Adverse Event|79|||
37630350|NCT02590432|69096664|FG002|Open-label Treatment Period|Adverse Event|0|||
37630351|NCT02590432|69096665|FG003|Open-label Treatment Period|Adverse Event|0|||
37630352|NCT02590432|69096666|FG004|Open-label Treatment Period|Adverse Event|0|||
37630353|NCT02590432|69096667|FG005|Open-label Treatment Period|Adverse Event|0|||
37630354|NCT02590432|69096668|FG006|Open-label Treatment Period|Adverse Event|0|||
37630355|NCT02590432|69096669|FG007|Open-label Treatment Period|Adverse Event|0|||
37630356|NCT02590432|69096670|FG008|Open-label Treatment Period|Adverse Event|0|||
37630357|NCT02590432|69096662|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
37630358|NCT02590432|69096663|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
37630359|NCT02590432|69096664|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
37630360|NCT02590432|69096665|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
37630361|NCT02590432|69096666|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
37630362|NCT02590432|69096667|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
37630363|NCT02590432|69096668|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
37630364|NCT02590432|69096669|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
37630365|NCT02590432|69096670|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
37630366|NCT02590432|69096662|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
37630367|NCT02590432|69096663|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
37630368|NCT02590432|69096664|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
37630369|NCT02590432|69096665|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
37630370|NCT02590432|69096666|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
37630371|NCT02590432|69096667|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
37630372|NCT02590432|69096668|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
37630373|NCT02590432|69096669|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
37630374|NCT02590432|69096670|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
37630375|NCT02590432|69096662|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
37630376|NCT02590432|69096663|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
37630377|NCT02590432|69096664|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
37630378|NCT02590432|69096665|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
37630379|NCT02590432|69096666|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
37630380|NCT02590432|69096667|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
37630381|NCT02590432|69096668|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
37630382|NCT02590432|69096669|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
37630383|NCT02590432|69096670|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
37630384|NCT02590432|69096662|FG000|Open-label Treatment Period|Protocol Violation|10|||
37630385|NCT02590432|69096663|FG001|Open-label Treatment Period|Protocol Violation|4|||
37630386|NCT02590432|69096664|FG002|Open-label Treatment Period|Protocol Violation|0|||
37630387|NCT02590432|69096665|FG003|Open-label Treatment Period|Protocol Violation|0|||
37630388|NCT02590432|69096666|FG004|Open-label Treatment Period|Protocol Violation|0|||
37630389|NCT02590432|69096667|FG005|Open-label Treatment Period|Protocol Violation|0|||
37630390|NCT02590432|69096668|FG006|Open-label Treatment Period|Protocol Violation|0|||
37630391|NCT02590432|69096669|FG007|Open-label Treatment Period|Protocol Violation|0|||
37630392|NCT02590432|69096670|FG008|Open-label Treatment Period|Protocol Violation|0|||
37630393|NCT02590432|69096662|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
37630394|NCT02590432|69096663|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
37630395|NCT02590432|69096664|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
37630396|NCT02590432|69096665|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
37630397|NCT02590432|69096666|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
37630398|NCT02590432|69096667|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
37630399|NCT02590432|69096668|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
37630400|NCT02590432|69096669|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
37630401|NCT02590432|69096670|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
37630402|NCT02590432|69096662|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
37630403|NCT02590432|69096663|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
37630404|NCT02590432|69096664|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
37630405|NCT02590432|69096665|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
37630406|NCT02590432|69096666|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
37630407|NCT02590432|69096667|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
37630408|NCT02590432|69096668|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
37630409|NCT02590432|69096669|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
37630410|NCT02590432|69096670|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
37630411|NCT02590432|69096662|FG000|Double-blind Treatment Period|Adverse Event|0|||
37630412|NCT02590432|69096663|FG001|Double-blind Treatment Period|Adverse Event|0|||
37630413|NCT02590432|69096664|FG002|Double-blind Treatment Period|Adverse Event|14|||
37630414|NCT02590432|69096665|FG003|Double-blind Treatment Period|Adverse Event|12|||
37630415|NCT02590432|69096666|FG004|Double-blind Treatment Period|Adverse Event|6|||
37630416|NCT02590432|69096667|FG005|Double-blind Treatment Period|Adverse Event|22|||
37630417|NCT02590432|69096668|FG006|Double-blind Treatment Period|Adverse Event|20|||
37630418|NCT02590432|69096669|FG007|Double-blind Treatment Period|Adverse Event|0|||
37630419|NCT02590432|69096670|FG008|Double-blind Treatment Period|Adverse Event|0|||
37630420|NCT02590432|69096662|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
37630421|NCT02590432|69096663|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
37630422|NCT02590432|69096664|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
37630423|NCT02590432|69096665|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
37630424|NCT02590432|69096666|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
37630425|NCT02590432|69096667|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
37630426|NCT02590432|69096668|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
37630427|NCT02590432|69096669|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
37630428|NCT02590432|69096670|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
37630429|NCT02590432|69096662|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
37630430|NCT02590432|69096663|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
37630431|NCT02590432|69096664|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
37630432|NCT02590432|69096665|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
37630433|NCT02590432|69096666|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
37630434|NCT02590432|69096667|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
37630435|NCT02590432|69096668|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
37630436|NCT02590432|69096669|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
37630437|NCT02590432|69096670|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
37630438|NCT02590432|69096662|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
37630439|NCT02590432|69096663|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
37630440|NCT02590432|69096664|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
37630441|NCT02590432|69096665|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
37630442|NCT02590432|69096666|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
37630443|NCT02590432|69096667|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
37630444|NCT02590432|69096668|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
37630445|NCT02590432|69096669|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
37630446|NCT02590432|69096670|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
37630447|NCT02590432|69096662|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
37630448|NCT02590432|69096663|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
37630449|NCT02590432|69096664|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
37630450|NCT02590432|69096665|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
37630451|NCT02590432|69096666|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
37630452|NCT02590432|69096667|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
37630453|NCT02590432|69096668|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
37630454|NCT02590432|69096669|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
37630455|NCT02590432|69096670|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
37630456|NCT02590432|69096662|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
37630457|NCT02590432|69096663|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
37630458|NCT02590432|69096664|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
37630459|NCT02590432|69096665|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
37630460|NCT02590432|69096666|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
37630461|NCT02590432|69096667|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
37630462|NCT02590432|69096668|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
37630463|NCT02590432|69096669|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
37630464|NCT02590432|69096670|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
37630465|NCT02590432|69096662|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
37630466|NCT02590432|69096663|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
37630467|NCT02590432|69096664|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
37630468|NCT02590432|69096665|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
37630469|NCT02590432|69096666|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
37630470|NCT02590432|69096667|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
37630471|NCT02590432|69096668|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
37630472|NCT02590432|69096669|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
37630473|NCT02590432|69096670|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
37630474|NCT02590432|69096662|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
37630475|NCT02590432|69096663|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
37630476|NCT02590432|69096664|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
37630477|NCT02590432|69096665|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
37630478|NCT02590432|69096666|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
37630479|NCT02590432|69096667|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
37630480|NCT02590432|69096668|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
37630481|NCT02590432|69096669|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
37630482|NCT02590432|69096670|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
37630483|NCT02590432|69096662|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
37630484|NCT02590432|69096663|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
37630485|NCT02590432|69096664|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
37853237|NCT03469271|69537105|FG002|Overall Study|Withdrawal by Subject|0|||
37630486|NCT02590432|69096665|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
37630487|NCT02590432|69096666|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
37630488|NCT02590432|69096667|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
37630489|NCT02590432|69096668|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
37630490|NCT02590432|69096669|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
37630491|NCT02590432|69096670|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
37630492|NCT02590432|69096662|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
37630493|NCT02590432|69096663|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
37630494|NCT02590432|69096664|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
37630495|NCT02590432|69096665|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
37630496|NCT02590432|69096666|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
37630497|NCT02590432|69096667|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
37630498|NCT02590432|69096668|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
37630499|NCT02590432|69096669|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
37630500|NCT02590432|69096670|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
37630501|NCT02590432|69096662|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
37630502|NCT02590432|69096663|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
37630503|NCT02590432|69096664|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
37630504|NCT02590432|69096665|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
37630505|NCT02590432|69096666|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
37630506|NCT02590432|69096667|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
37630507|NCT02590432|69096668|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
37630508|NCT02590432|69096669|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
37630509|NCT02590432|69096670|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
37630510|NCT02590432|69096662|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
37630511|NCT02590432|69096663|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
37630512|NCT02590432|69096664|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
37630513|NCT02590432|69096665|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
37630514|NCT02590432|69096666|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
37630515|NCT02590432|69096667|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
37630516|NCT02590432|69096668|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
37630517|NCT02590432|69096669|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
37630518|NCT02590432|69096670|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
37630519|NCT02590354|69096682|FG000|Phase 1|Active hepatitis B or C infection|1|||
37630520|NCT02590354|69096682|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
37630521|NCT02590354|69096682|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
37630522|NCT02590354|69096682|FG000|Phase 1|Subject does not want to participate|20|||
37630523|NCT02590354|69096682|FG000|Phase 1|Lost to Follow-up|1|||
37630524|NCT02590354|69096682|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
37630525|NCT01667224|69096689|FG000|Overall Study|Withdrawal by Subject|3|||
37630526|NCT01667224|69096690|FG001|Overall Study|Withdrawal by Subject|1|||
37630527|NCT01667224|69096689|FG000|Overall Study|Protocol Violation|1|||
37630528|NCT01667224|69096690|FG001|Overall Study|Protocol Violation|1|||
37630529|NCT03923738|69096698|FG000|Period 1|Adverse Event|1|||
37630530|NCT03923738|69096698|FG000|Period 1|Withdrawal by Subject|1|||
37630531|NCT02588248|69096706|FG000|Overall Study|Physician Decision|4|||
37630532|NCT02588248|69096707|FG001|Overall Study|Physician Decision|3|||
37630533|NCT01328054|69096718|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
37630534|NCT01328054|69096719|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
37630535|NCT01328054|69096718|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
37630536|NCT01328054|69096719|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
37630537|NCT01328054|69096718|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
37630538|NCT01328054|69096719|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
37630539|NCT01849250|69096742|FG000|Overall Study|Withdrawal by Subject|1|||
37630540|NCT01849250|69096743|FG001|Overall Study|Withdrawal by Subject|0|||
37630541|NCT01849250|69096742|FG000|Overall Study|Not Evaluable|5|||
37630542|NCT01849250|69096743|FG001|Overall Study|Not Evaluable|3|||
37630543|NCT01849250|69096742|FG000|Overall Study|Screen Failure|1|||
37630544|NCT01849250|69096743|FG001|Overall Study|Screen Failure|0|||
37630545|NCT02791191|69096753|FG000|Overall Study|Adverse Event|2|||
37630546|NCT02791191|69096754|FG001|Overall Study|Adverse Event|4|||
38031845|NCT02859142|69717620|FG000|Overall Study|Withdrawal by Subject|2|||
38031846|NCT02859142|69717621|FG001|Overall Study|Withdrawal by Subject|0|||
38031847|NCT02859142|69717620|FG000|Overall Study|Scheduling difficulties|0|||
38031848|NCT02859142|69717621|FG001|Overall Study|Scheduling difficulties|3|||
38031849|NCT03351608|69717632|FG000|Overall Study|Lost to Follow-up|0|||
37630547|NCT02791191|69096755|FG002|Overall Study|Adverse Event|5|||
37630548|NCT02791191|69096753|FG000|Overall Study|Lack of Efficacy|0|||
37630549|NCT02791191|69096754|FG001|Overall Study|Lack of Efficacy|1|||
37630550|NCT02791191|69096755|FG002|Overall Study|Lack of Efficacy|0|||
37630551|NCT02791191|69096753|FG000|Overall Study|Study Drug Non-Compliance|0|||
37630552|NCT02791191|69096754|FG001|Overall Study|Study Drug Non-Compliance|2|||
37630553|NCT02791191|69096755|FG002|Overall Study|Study Drug Non-Compliance|0|||
37630554|NCT02791191|69096753|FG000|Overall Study|Site Closed by Sponsor|1|||
37630555|NCT02791191|69096754|FG001|Overall Study|Site Closed by Sponsor|1|||
37630556|NCT02791191|69096755|FG002|Overall Study|Site Closed by Sponsor|3|||
37630557|NCT02791191|69096753|FG000|Overall Study|Progressive Disease|1|||
37630558|NCT02791191|69096754|FG001|Overall Study|Progressive Disease|0|||
37630559|NCT02791191|69096755|FG002|Overall Study|Progressive Disease|0|||
37630560|NCT02791191|69096753|FG000|Overall Study|Study Terminated by Sponsor|29|||
37630561|NCT02791191|69096754|FG001|Overall Study|Study Terminated by Sponsor|101|||
37630562|NCT02791191|69096755|FG002|Overall Study|Study Terminated by Sponsor|109|||
37630563|NCT02791191|69096753|FG000|Overall Study|Withdrawal by Subject|3|||
37630564|NCT02791191|69096754|FG001|Overall Study|Withdrawal by Subject|1|||
37630565|NCT02791191|69096755|FG002|Overall Study|Withdrawal by Subject|3|||
37630566|NCT02791191|69096753|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
37630567|NCT02791191|69096754|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
37630568|NCT02791191|69096755|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
37630569|NCT02114697|69096778|FG000|Overall Study|Study terminated|5|||
37630570|NCT02114697|69096779|FG001|Overall Study|Study terminated|4|||
37630571|NCT01330017|69096790|FG000|Overall Study|Adverse Event|0|||
37630572|NCT01330017|69096791|FG001|Overall Study|Adverse Event|1|||
37630573|NCT01330017|69096792|FG002|Overall Study|Adverse Event|1|||
37630574|NCT01330017|69096793|FG003|Overall Study|Adverse Event|4|||
37630575|NCT01330017|69096794|FG004|Overall Study|Adverse Event|0|||
37630576|NCT01330017|69096790|FG000|Overall Study|Withdrawal by Subject|0|||
37630577|NCT01330017|69096791|FG001|Overall Study|Withdrawal by Subject|0|||
37630578|NCT01330017|69096792|FG002|Overall Study|Withdrawal by Subject|1|||
37630579|NCT01330017|69096793|FG003|Overall Study|Withdrawal by Subject|0|||
37630580|NCT01330017|69096794|FG004|Overall Study|Withdrawal by Subject|1|||
37630581|NCT01330017|69096790|FG000|Overall Study|Lost to Follow-up|0|||
37630582|NCT01330017|69096791|FG001|Overall Study|Lost to Follow-up|0|||
37630583|NCT01330017|69096792|FG002|Overall Study|Lost to Follow-up|1|||
37630584|NCT01330017|69096793|FG003|Overall Study|Lost to Follow-up|0|||
37630585|NCT01330017|69096794|FG004|Overall Study|Lost to Follow-up|0|||
37630586|NCT01330017|69096790|FG000|Overall Study|Protocol Violation|0|||
37630587|NCT01330017|69096791|FG001|Overall Study|Protocol Violation|0|||
37630588|NCT01330017|69096792|FG002|Overall Study|Protocol Violation|0|||
37630589|NCT01330017|69096793|FG003|Overall Study|Protocol Violation|1|||
37630590|NCT01330017|69096794|FG004|Overall Study|Protocol Violation|0|||
37630591|NCT01330017|69096790|FG000|Overall Study|Unknown Reason|5|||
37630592|NCT01330017|69096791|FG001|Overall Study|Unknown Reason|3|||
37630593|NCT01330017|69096792|FG002|Overall Study|Unknown Reason|5|||
37630594|NCT01330017|69096793|FG003|Overall Study|Unknown Reason|7|||
37630595|NCT01330017|69096794|FG004|Overall Study|Unknown Reason|2|||
37630596|NCT00150462|69096817|FG000|Overall Study|Disease Progression or Relapse|3|||
37630597|NCT00150462|69096818|FG001|Overall Study|Disease Progression or Relapse|1|||
37630598|NCT00150462|69096819|FG002|Overall Study|Disease Progression or Relapse|2|||
37630599|NCT00150462|69096820|FG003|Overall Study|Disease Progression or Relapse|1|||
37630600|NCT00150462|69096821|FG004|Overall Study|Disease Progression or Relapse|2|||
37630601|NCT00150462|69096822|FG005|Overall Study|Disease Progression or Relapse|2|||
37630602|NCT00150462|69096823|FG006|Overall Study|Disease Progression or Relapse|3|||
37630603|NCT00150462|69096824|FG007|Overall Study|Disease Progression or Relapse|5|||
37630604|NCT00150462|69096825|FG008|Overall Study|Disease Progression or Relapse|5|||
37630605|NCT00150462|69096826|FG009|Overall Study|Disease Progression or Relapse|3|||
37630606|NCT00150462|69096827|FG010|Overall Study|Disease Progression or Relapse|2|||
37630607|NCT00150462|69096817|FG000|Overall Study|Withdrawal by Subject|0|||
37630608|NCT00150462|69096818|FG001|Overall Study|Withdrawal by Subject|1|||
37630609|NCT00150462|69096819|FG002|Overall Study|Withdrawal by Subject|1|||
37630610|NCT00150462|69096820|FG003|Overall Study|Withdrawal by Subject|0|||
37630611|NCT00150462|69096821|FG004|Overall Study|Withdrawal by Subject|1|||
37630612|NCT00150462|69096822|FG005|Overall Study|Withdrawal by Subject|2|||
37630613|NCT00150462|69096823|FG006|Overall Study|Withdrawal by Subject|0|||
37630614|NCT00150462|69096824|FG007|Overall Study|Withdrawal by Subject|1|||
37630615|NCT00150462|69096825|FG008|Overall Study|Withdrawal by Subject|0|||
37630616|NCT00150462|69096826|FG009|Overall Study|Withdrawal by Subject|1|||
37630617|NCT00150462|69096827|FG010|Overall Study|Withdrawal by Subject|0|||
37630618|NCT00150462|69096817|FG000|Overall Study|Death|0|||
37630619|NCT00150462|69096818|FG001|Overall Study|Death|1|||
37630620|NCT00150462|69096819|FG002|Overall Study|Death|0|||
37853238|NCT03469271|69537106|FG003|Overall Study|Withdrawal by Subject|1|||
38031850|NCT03351608|69717633|FG001|Overall Study|Lost to Follow-up|1|||
37630621|NCT00150462|69096820|FG003|Overall Study|Death|0|||
37630622|NCT00150462|69096821|FG004|Overall Study|Death|0|||
37630623|NCT00150462|69096822|FG005|Overall Study|Death|0|||
37630624|NCT00150462|69096823|FG006|Overall Study|Death|0|||
37630625|NCT00150462|69096824|FG007|Overall Study|Death|0|||
37630626|NCT00150462|69096825|FG008|Overall Study|Death|1|||
37630627|NCT00150462|69096826|FG009|Overall Study|Death|0|||
37630628|NCT00150462|69096827|FG010|Overall Study|Death|0|||
37630629|NCT00150462|69096817|FG000|Overall Study|Adverse Event|0|||
37630630|NCT00150462|69096818|FG001|Overall Study|Adverse Event|0|||
37630631|NCT00150462|69096819|FG002|Overall Study|Adverse Event|0|||
37630632|NCT00150462|69096820|FG003|Overall Study|Adverse Event|1|||
37630633|NCT00150462|69096821|FG004|Overall Study|Adverse Event|0|||
37630634|NCT00150462|69096822|FG005|Overall Study|Adverse Event|0|||
37630635|NCT00150462|69096823|FG006|Overall Study|Adverse Event|0|||
37630636|NCT00150462|69096824|FG007|Overall Study|Adverse Event|2|||
37630637|NCT00150462|69096825|FG008|Overall Study|Adverse Event|0|||
37630638|NCT00150462|69096826|FG009|Overall Study|Adverse Event|1|||
37630639|NCT00150462|69096827|FG010|Overall Study|Adverse Event|0|||
37630640|NCT00150462|69096817|FG000|Overall Study|Physician Decision|0|||
37630641|NCT00150462|69096818|FG001|Overall Study|Physician Decision|0|||
37630642|NCT00150462|69096819|FG002|Overall Study|Physician Decision|1|||
37630643|NCT00150462|69096820|FG003|Overall Study|Physician Decision|1|||
37630644|NCT00150462|69096821|FG004|Overall Study|Physician Decision|0|||
37630645|NCT00150462|69096822|FG005|Overall Study|Physician Decision|0|||
37630646|NCT00150462|69096823|FG006|Overall Study|Physician Decision|0|||
37630647|NCT00150462|69096824|FG007|Overall Study|Physician Decision|0|||
37630648|NCT00150462|69096825|FG008|Overall Study|Physician Decision|0|||
37630649|NCT00150462|69096826|FG009|Overall Study|Physician Decision|0|||
37630650|NCT00150462|69096827|FG010|Overall Study|Physician Decision|0|||
37630651|NCT00150462|69096817|FG000|Overall Study|Other|0|||
37630652|NCT00150462|69096818|FG001|Overall Study|Other|0|||
37630653|NCT00150462|69096819|FG002|Overall Study|Other|0|||
37630654|NCT00150462|69096820|FG003|Overall Study|Other|0|||
37630655|NCT00150462|69096821|FG004|Overall Study|Other|0|||
37630656|NCT00150462|69096822|FG005|Overall Study|Other|0|||
37630657|NCT00150462|69096823|FG006|Overall Study|Other|0|||
37630658|NCT00150462|69096824|FG007|Overall Study|Other|0|||
37630659|NCT00150462|69096825|FG008|Overall Study|Other|0|||
37630660|NCT00150462|69096826|FG009|Overall Study|Other|1|||
37630661|NCT00150462|69096827|FG010|Overall Study|Other|1|||
37630662|NCT01368081|69096867|FG000|Overall Study|Adverse Event|4|||
37630663|NCT01368081|69096868|FG001|Overall Study|Adverse Event|4|||
37630664|NCT01368081|69096869|FG002|Overall Study|Adverse Event|3|||
37630665|NCT01368081|69096870|FG003|Overall Study|Adverse Event|2|||
37630666|NCT01368081|69096871|FG004|Overall Study|Adverse Event|2|||
37630667|NCT01368081|69096872|FG005|Overall Study|Adverse Event|5|||
37630668|NCT01368081|69096873|FG006|Overall Study|Adverse Event|6|||
37630669|NCT01368081|69096874|FG007|Overall Study|Adverse Event|2|||
37630670|NCT01368081|69096875|FG008|Overall Study|Adverse Event|3|||
37630671|NCT01368081|69096876|FG009|Overall Study|Adverse Event|5|||
37630672|NCT01368081|69096877|FG010|Overall Study|Adverse Event|6|||
37630673|NCT01368081|69096878|FG011|Overall Study|Adverse Event|1|||
37630674|NCT01368081|69096879|FG012|Overall Study|Adverse Event|3|||
37630675|NCT01368081|69096867|FG000|Overall Study|Lack of Efficacy|0|||
37630676|NCT01368081|69096868|FG001|Overall Study|Lack of Efficacy|1|||
37630677|NCT01368081|69096869|FG002|Overall Study|Lack of Efficacy|0|||
37630678|NCT01368081|69096870|FG003|Overall Study|Lack of Efficacy|1|||
37630679|NCT01368081|69096871|FG004|Overall Study|Lack of Efficacy|0|||
37630680|NCT01368081|69096872|FG005|Overall Study|Lack of Efficacy|0|||
37630681|NCT01368081|69096873|FG006|Overall Study|Lack of Efficacy|0|||
37630682|NCT01368081|69096874|FG007|Overall Study|Lack of Efficacy|2|||
37630683|NCT01368081|69096875|FG008|Overall Study|Lack of Efficacy|0|||
37630684|NCT01368081|69096876|FG009|Overall Study|Lack of Efficacy|0|||
37738169|NCT01760954|69220716|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
37738170|NCT01760954|69220717|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
37738171|NCT01760954|69220718|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
37738172|NCT01760954|69220715|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
37738173|NCT01760954|69220716|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
37630685|NCT01368081|69096877|FG010|Overall Study|Lack of Efficacy|0|||
37630686|NCT01368081|69096878|FG011|Overall Study|Lack of Efficacy|0|||
37630687|NCT01368081|69096879|FG012|Overall Study|Lack of Efficacy|0|||
37630688|NCT01368081|69096867|FG000|Overall Study|Protocol Violation|0|||
37630689|NCT01368081|69096868|FG001|Overall Study|Protocol Violation|0|||
37630690|NCT01368081|69096869|FG002|Overall Study|Protocol Violation|0|||
37630691|NCT01368081|69096870|FG003|Overall Study|Protocol Violation|0|||
37853239|NCT03302234|69537122|FG000|Overall Study|Death|191|||
37630692|NCT01368081|69096871|FG004|Overall Study|Protocol Violation|0|||
37630693|NCT01368081|69096872|FG005|Overall Study|Protocol Violation|1|||
37630694|NCT01368081|69096873|FG006|Overall Study|Protocol Violation|0|||
37630695|NCT01368081|69096874|FG007|Overall Study|Protocol Violation|1|||
37630696|NCT01368081|69096875|FG008|Overall Study|Protocol Violation|0|||
37630697|NCT01368081|69096876|FG009|Overall Study|Protocol Violation|0|||
37630698|NCT01368081|69096877|FG010|Overall Study|Protocol Violation|0|||
37630699|NCT01368081|69096878|FG011|Overall Study|Protocol Violation|0|||
37630700|NCT01368081|69096879|FG012|Overall Study|Protocol Violation|0|||
37630701|NCT01368081|69096867|FG000|Overall Study|Lost to Follow-up|0|||
37630702|NCT01368081|69096868|FG001|Overall Study|Lost to Follow-up|0|||
37630703|NCT01368081|69096869|FG002|Overall Study|Lost to Follow-up|0|||
37630704|NCT01368081|69096870|FG003|Overall Study|Lost to Follow-up|0|||
37738174|NCT01760954|69220717|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
37738175|NCT01760954|69220718|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
37738176|NCT01760954|69220715|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
37738177|NCT01760954|69220716|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
37738178|NCT01760954|69220717|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
37738179|NCT01760954|69220718|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
37738180|NCT01760954|69220715|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
37738181|NCT01760954|69220716|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
37738182|NCT01760954|69220717|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
37738183|NCT01760954|69220718|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
37738184|NCT01760954|69220715|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
37738185|NCT01760954|69220716|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
37738186|NCT01760954|69220717|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
37738187|NCT01760954|69220718|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
37738188|NCT01760954|69220715|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
37738189|NCT01760954|69220716|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
37738190|NCT01760954|69220717|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
37738191|NCT01760954|69220718|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
37738192|NCT01760954|69220715|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
37738193|NCT01760954|69220716|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
37738194|NCT01760954|69220717|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
37738195|NCT01760954|69220718|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
37738196|NCT01760954|69220715|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
37738197|NCT01760954|69220716|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
37738198|NCT01760954|69220717|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
37738199|NCT01760954|69220718|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
37738200|NCT01760876|69220728|FG000|Overall Study|Non-cardiac death (head injury)|1|||
37738201|NCT01760876|69220728|FG000|Overall Study|Carcinoma of prostate|1|||
37738202|NCT01760876|69220728|FG000|Overall Study|Impaired renal function|1|||
37738203|NCT01760876|69220728|FG000|Overall Study|Major depression|1|||
37738204|NCT01760876|69220728|FG000|Overall Study|Very poor baseline OCT quality|2|||
37738205|NCT01759862|69220734|FG000|Overall Study|Physician Decision|3|||
37738206|NCT01759862|69220735|FG001|Overall Study|Physician Decision|1|||
37738207|NCT01759862|69220734|FG000|Overall Study|Adverse Event|0|||
37738208|NCT01759862|69220735|FG001|Overall Study|Adverse Event|1|||
37738209|NCT01606670|69220741|FG000|Overall Study|Adverse Event|6|||
37738210|NCT01606670|69220741|FG000|Overall Study|Lack of Efficacy|2|||
37738211|NCT01606670|69220741|FG000|Overall Study|Lost to Follow-up|3|||
37738212|NCT01606670|69220741|FG000|Overall Study|Withdrawal by Subject|3|||
37738213|NCT01606670|69220741|FG000|Overall Study|Other Reason|2|||
37738214|NCT01793792|69220745|FG000|Overall Study|Death|5|||
37738215|NCT01793792|69220745|FG000|Overall Study|Lost to Follow-up|5|||
37738216|NCT01793792|69220745|FG000|Overall Study|Withdrawal by Subject|1|||
37738217|NCT01793792|69220745|FG000|Overall Study|Device Not Implanted|1|||
37738218|NCT01790984|69220751|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
37738219|NCT01790984|69220752|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
37738220|NCT01790984|69220753|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
37738221|NCT01790984|69220754|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
37738222|NCT01735994|69220779|FG000|Overall Study|Withdrawal by Subject|6|||
37738223|NCT01735994|69220780|FG001|Overall Study|Withdrawal by Subject|4|||
37738224|NCT01735994|69220779|FG000|Overall Study|Injury|2|||
37738225|NCT01735994|69220780|FG001|Overall Study|Injury|0|||
37738226|NCT01735994|69220779|FG000|Overall Study|Kicked off team|5|||
37738227|NCT01735994|69220780|FG001|Overall Study|Kicked off team|0|||
37738228|NCT01735994|69220779|FG000|Overall Study|Lost to Follow-up|50|||
37738229|NCT01735994|69220780|FG001|Overall Study|Lost to Follow-up|62|||
37738230|NCT01790828|69220786|FG000|Overall Study|Other|34|||
37738231|NCT01790594|69220792|FG000|Overall Study|Death|1|||
37738232|NCT01790594|69220793|FG001|Overall Study|Death|0|||
37738233|NCT01790594|69220794|FG002|Overall Study|Death|0|||
37738234|NCT01790594|69220792|FG000|Overall Study|Physician Decision|2|||
37738235|NCT01790594|69220793|FG001|Overall Study|Physician Decision|1|||
37630705|NCT01368081|69096871|FG004|Overall Study|Lost to Follow-up|0|||
37630706|NCT01368081|69096872|FG005|Overall Study|Lost to Follow-up|0|||
37738236|NCT01790594|69220794|FG002|Overall Study|Physician Decision|0|||
37738237|NCT01790594|69220792|FG000|Overall Study|Withdrawal by Subject|2|||
37738238|NCT01790594|69220793|FG001|Overall Study|Withdrawal by Subject|0|||
37630707|NCT01368081|69096873|FG006|Overall Study|Lost to Follow-up|0|||
37630708|NCT01368081|69096874|FG007|Overall Study|Lost to Follow-up|0|||
37630709|NCT01368081|69096875|FG008|Overall Study|Lost to Follow-up|0|||
37630710|NCT01368081|69096876|FG009|Overall Study|Lost to Follow-up|0|||
37630711|NCT01368081|69096877|FG010|Overall Study|Lost to Follow-up|0|||
37630712|NCT01368081|69096878|FG011|Overall Study|Lost to Follow-up|0|||
37630713|NCT01368081|69096879|FG012|Overall Study|Lost to Follow-up|1|||
37630714|NCT01368081|69096867|FG000|Overall Study|Withdrawal by Subject|4|||
37630715|NCT01368081|69096868|FG001|Overall Study|Withdrawal by Subject|4|||
37630716|NCT01368081|69096869|FG002|Overall Study|Withdrawal by Subject|1|||
37630717|NCT01368081|69096870|FG003|Overall Study|Withdrawal by Subject|1|||
37630718|NCT01368081|69096871|FG004|Overall Study|Withdrawal by Subject|0|||
37630719|NCT01368081|69096872|FG005|Overall Study|Withdrawal by Subject|3|||
37630720|NCT01368081|69096873|FG006|Overall Study|Withdrawal by Subject|4|||
37630721|NCT01368081|69096874|FG007|Overall Study|Withdrawal by Subject|2|||
37630722|NCT01368081|69096875|FG008|Overall Study|Withdrawal by Subject|5|||
37630723|NCT01368081|69096876|FG009|Overall Study|Withdrawal by Subject|4|||
37630724|NCT01368081|69096877|FG010|Overall Study|Withdrawal by Subject|3|||
37630725|NCT01368081|69096878|FG011|Overall Study|Withdrawal by Subject|2|||
37630726|NCT01368081|69096879|FG012|Overall Study|Withdrawal by Subject|0|||
37921659|NCT00670930|69608390|FG000|Overall Study|Lost to Follow-up|1|||
37921660|NCT00670930|69608391|FG001|Overall Study|Lost to Follow-up|0|||
37921661|NCT00670540|69608397|FG000|Overall Study|ineligible|17|||
37921662|NCT00670540|69608397|FG000|Overall Study|not living in France|348|||
37921663|NCT00670540|69608397|FG000|Overall Study|refused to participate|189|||
37921664|NCT00670540|69608397|FG000|Overall Study|controls randomised for no follow up|2770|||
37921665|NCT00670540|69608397|FG000|Overall Study|missing information inclusion criteria|1|||
37921666|NCT00591786|69608411|FG000|Overall Study|Withdrawal of Informed Consent|0|||
37921667|NCT00591786|69608412|FG001|Overall Study|Withdrawal of Informed Consent|0|||
37921668|NCT00591786|69608413|FG002|Overall Study|Withdrawal of Informed Consent|1|||
37921669|NCT00591786|69608414|FG003|Overall Study|Withdrawal of Informed Consent|0|||
37921670|NCT00591786|69608415|FG004|Overall Study|Withdrawal of Informed Consent|0|||
37921671|NCT00591786|69608416|FG005|Overall Study|Withdrawal of Informed Consent|0|||
37921672|NCT00591786|69608417|FG006|Overall Study|Withdrawal of Informed Consent|0|||
37921673|NCT00591786|69608418|FG007|Overall Study|Withdrawal of Informed Consent|0|||
37921674|NCT00591786|69608419|FG008|Overall Study|Withdrawal of Informed Consent|0|||
37921675|NCT00591786|69608420|FG009|Overall Study|Withdrawal of Informed Consent|0|||
37921676|NCT00674362|69608444|FG000|Double Blind|Adverse Event|6|||
37921677|NCT00674362|69608445|FG001|Double Blind|Adverse Event|6|||
37921678|NCT00674362|69608444|FG000|Double Blind|Lack of Efficacy|2|||
37921679|NCT00674362|69608445|FG001|Double Blind|Lack of Efficacy|6|||
37921680|NCT00674362|69608444|FG000|Double Blind|Loss of efficacy|0|||
37921681|NCT00674362|69608445|FG001|Double Blind|Loss of efficacy|1|||
37921682|NCT00674362|69608444|FG000|Double Blind|Withdrawal by Subject|4|||
37921683|NCT00674362|69608445|FG001|Double Blind|Withdrawal by Subject|3|||
37921684|NCT00674362|69608444|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
37921685|NCT00674362|69608445|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
37921686|NCT00674362|69608444|FG000|Double Blind|Other: Surgery|0|||
37921687|NCT00674362|69608445|FG001|Double Blind|Other: Surgery|1|||
37921688|NCT00674362|69608444|FG000|Open Label|Adverse Event|1|||
37921689|NCT00674362|69608445|FG001|Open Label|Adverse Event|0|||
37921690|NCT00674362|69608444|FG000|Open Label|Other: Subject moved to extension study|1|||
37921691|NCT00674362|69608445|FG001|Open Label|Other: Subject moved to extension study|0|||
37630727|NCT01368081|69096867|FG000|Overall Study|Other reason not defined above|2|||
37630728|NCT01368081|69096868|FG001|Overall Study|Other reason not defined above|0|||
37630729|NCT01368081|69096869|FG002|Overall Study|Other reason not defined above|0|||
37630730|NCT01368081|69096870|FG003|Overall Study|Other reason not defined above|1|||
37630731|NCT01368081|69096871|FG004|Overall Study|Other reason not defined above|0|||
37630732|NCT01368081|69096872|FG005|Overall Study|Other reason not defined above|1|||
37630733|NCT01368081|69096873|FG006|Overall Study|Other reason not defined above|2|||
37630734|NCT01368081|69096874|FG007|Overall Study|Other reason not defined above|0|||
37738239|NCT01790594|69220794|FG002|Overall Study|Withdrawal by Subject|0|||
37738240|NCT01790594|69220792|FG000|Overall Study|Transplant was not done|0|||
37738241|NCT01790594|69220793|FG001|Overall Study|Transplant was not done|0|||
37921692|NCT00820950|69608457|FG000|Overall Study|Scheduling Conflict|0|||
37921693|NCT00820950|69608458|FG001|Overall Study|Scheduling Conflict|0|||
37921694|NCT00820950|69608459|FG002|Overall Study|Scheduling Conflict|0|||
37921695|NCT00820950|69608460|FG003|Overall Study|Scheduling Conflict|0|||
37921696|NCT00820950|69608461|FG004|Overall Study|Scheduling Conflict|0|||
37921697|NCT00820950|69608462|FG005|Overall Study|Scheduling Conflict|0|||
37630735|NCT01368081|69096875|FG008|Overall Study|Other reason not defined above|0|||
37630736|NCT01368081|69096876|FG009|Overall Study|Other reason not defined above|1|||
37630737|NCT01368081|69096877|FG010|Overall Study|Other reason not defined above|0|||
37630738|NCT01368081|69096878|FG011|Overall Study|Other reason not defined above|0|||
37630739|NCT01368081|69096879|FG012|Overall Study|Other reason not defined above|3|||
37630740|NCT00303498|69096909|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
37630741|NCT00303498|69096910|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
37630742|NCT00303498|69096909|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
37630743|NCT00303498|69096910|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
37630744|NCT00303498|69096909|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
37630745|NCT00303498|69096910|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
37630746|NCT00303498|69096909|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
37630747|NCT00303498|69096910|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
37630748|NCT00303498|69096909|FG000|Run-In-Phase (10 Weeks)|Other|4|||
37630749|NCT00303498|69096910|FG001|Run-In-Phase (10 Weeks)|Other|1|||
37630750|NCT00303498|69096909|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
37630751|NCT00303498|69096910|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
37630752|NCT00303498|69096909|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
37630753|NCT00303498|69096910|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
37630754|NCT00303498|69096909|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
37630755|NCT00303498|69096910|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
37630756|NCT00303498|69096909|FG000|Maintenance Phase (24 Weeks)|Death|1|||
37630757|NCT00303498|69096910|FG001|Maintenance Phase (24 Weeks)|Death|0|||
37630758|NCT00303498|69096909|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
37630759|NCT00303498|69096910|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
37630760|NCT00303498|69096909|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
37630761|NCT00303498|69096910|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
37630762|NCT00303498|69096909|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
37630763|NCT00303498|69096910|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
37630764|NCT00303498|69096909|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
37630765|NCT00303498|69096910|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
37630766|NCT00303498|69096909|FG000|Maintenance Phase (24 Weeks)|Other|1|||
37630767|NCT00303498|69096910|FG001|Maintenance Phase (24 Weeks)|Other|0|||
37630768|NCT00303498|69096909|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
37630769|NCT00303498|69096910|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
37630770|NCT00303498|69096909|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
37630771|NCT00303498|69096910|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
37630772|NCT02588092|69096926|FG000|Overall Study|Death|4|||
37630773|NCT02588092|69096927|FG001|Overall Study|Death|3|||
37630774|NCT02588092|69096928|FG002|Overall Study|Death|3|||
37630775|NCT02588092|69096929|FG003|Overall Study|Death|3|||
37630776|NCT02588092|69096930|FG004|Overall Study|Death|2|||
37630777|NCT02588092|69096931|FG005|Overall Study|Death|2|||
37630778|NCT02588092|69096932|FG006|Overall Study|Death|2|||
37630779|NCT02588092|69096933|FG007|Overall Study|Death|1|||
37630780|NCT02588092|69096934|FG008|Overall Study|Death|5|||
37630781|NCT02588092|69096935|FG009|Overall Study|Death|2|||
37630782|NCT02588092|69096926|FG000|Overall Study|Withdrawal by Subject|0|||
37630783|NCT02588092|69096927|FG001|Overall Study|Withdrawal by Subject|0|||
37630784|NCT02588092|69096928|FG002|Overall Study|Withdrawal by Subject|0|||
37630785|NCT02588092|69096929|FG003|Overall Study|Withdrawal by Subject|0|||
37630786|NCT02588092|69096930|FG004|Overall Study|Withdrawal by Subject|0|||
37630787|NCT02588092|69096931|FG005|Overall Study|Withdrawal by Subject|1|||
37630788|NCT02588092|69096932|FG006|Overall Study|Withdrawal by Subject|1|||
37630789|NCT02588092|69096933|FG007|Overall Study|Withdrawal by Subject|2|||
37630790|NCT02588092|69096934|FG008|Overall Study|Withdrawal by Subject|0|||
37630791|NCT02588092|69096935|FG009|Overall Study|Withdrawal by Subject|0|||
37630792|NCT02588092|69096926|FG000|Overall Study|Started Another Treatment|0|||
37630793|NCT02588092|69096927|FG001|Overall Study|Started Another Treatment|0|||
37630794|NCT02588092|69096928|FG002|Overall Study|Started Another Treatment|0|||
37630795|NCT02588092|69096929|FG003|Overall Study|Started Another Treatment|0|||
37630796|NCT02588092|69096930|FG004|Overall Study|Started Another Treatment|1|||
37630797|NCT02588092|69096931|FG005|Overall Study|Started Another Treatment|0|||
37630798|NCT02588092|69096932|FG006|Overall Study|Started Another Treatment|0|||
37630799|NCT02588092|69096933|FG007|Overall Study|Started Another Treatment|1|||
37630800|NCT02588092|69096934|FG008|Overall Study|Started Another Treatment|0|||
37630801|NCT02588092|69096935|FG009|Overall Study|Started Another Treatment|0|||
37630802|NCT02588092|69096926|FG000|Overall Study|Sponsor Decision|0|||
37630803|NCT02588092|69096927|FG001|Overall Study|Sponsor Decision|0|||
37630804|NCT02588092|69096928|FG002|Overall Study|Sponsor Decision|0|||
37630805|NCT02588092|69096929|FG003|Overall Study|Sponsor Decision|0|||
37630806|NCT02588092|69096930|FG004|Overall Study|Sponsor Decision|0|||
37630807|NCT02588092|69096931|FG005|Overall Study|Sponsor Decision|0|||
37630808|NCT02588092|69096932|FG006|Overall Study|Sponsor Decision|0|||
37630809|NCT02588092|69096933|FG007|Overall Study|Sponsor Decision|0|||
37630810|NCT02588092|69096934|FG008|Overall Study|Sponsor Decision|1|||
37630811|NCT02588092|69096935|FG009|Overall Study|Sponsor Decision|1|||
37630812|NCT01367847|69096963|FG000|Overall Study|Withdrawal by Subject|2|||
37630813|NCT01367847|69096964|FG001|Overall Study|Withdrawal by Subject|2|||
37630814|NCT00150618|69096976|FG000|Overall Study|Adverse Event|2|||
37630815|NCT00150618|69096977|FG001|Overall Study|Adverse Event|2|||
37630816|NCT00150618|69096978|FG002|Overall Study|Adverse Event|6|||
37630817|NCT00150618|69096979|FG003|Overall Study|Adverse Event|9|||
37630818|NCT00150618|69096980|FG004|Overall Study|Adverse Event|5|||
37630819|NCT00150618|69096976|FG000|Overall Study|Withdrawal by Subject|6|||
38031851|NCT03351608|69717634|FG002|Overall Study|Lost to Follow-up|1|||
38031852|NCT03351608|69717635|FG003|Overall Study|Lost to Follow-up|1|||
37630820|NCT00150618|69096977|FG001|Overall Study|Withdrawal by Subject|8|||
37630821|NCT00150618|69096978|FG002|Overall Study|Withdrawal by Subject|8|||
37630822|NCT00150618|69096979|FG003|Overall Study|Withdrawal by Subject|4|||
37630823|NCT00150618|69096980|FG004|Overall Study|Withdrawal by Subject|5|||
37630824|NCT00150618|69096976|FG000|Overall Study|Lost to Follow-up|4|||
37630825|NCT00150618|69096977|FG001|Overall Study|Lost to Follow-up|1|||
37630826|NCT00150618|69096978|FG002|Overall Study|Lost to Follow-up|5|||
37630827|NCT00150618|69096979|FG003|Overall Study|Lost to Follow-up|8|||
37630828|NCT00150618|69096980|FG004|Overall Study|Lost to Follow-up|4|||
37630829|NCT00150618|69096976|FG000|Overall Study|Protocol Violation|1|||
37630830|NCT00150618|69096977|FG001|Overall Study|Protocol Violation|0|||
37630831|NCT00150618|69096978|FG002|Overall Study|Protocol Violation|0|||
37630832|NCT00150618|69096979|FG003|Overall Study|Protocol Violation|0|||
37630833|NCT00150618|69096980|FG004|Overall Study|Protocol Violation|1|||
37630834|NCT00150618|69096976|FG000|Overall Study|Lack of Efficacy|1|||
37630835|NCT00150618|69096977|FG001|Overall Study|Lack of Efficacy|4|||
37630836|NCT00150618|69096978|FG002|Overall Study|Lack of Efficacy|7|||
37630837|NCT00150618|69096979|FG003|Overall Study|Lack of Efficacy|4|||
37630838|NCT00150618|69096980|FG004|Overall Study|Lack of Efficacy|6|||
37630839|NCT00150618|69096976|FG000|Overall Study|No study meds|0|||
37630840|NCT00150618|69096977|FG001|Overall Study|No study meds|0|||
37630841|NCT00150618|69096978|FG002|Overall Study|No study meds|0|||
37630842|NCT00150618|69096979|FG003|Overall Study|No study meds|0|||
37630843|NCT00150618|69096980|FG004|Overall Study|No study meds|2|||
37630844|NCT00150618|69096976|FG000|Overall Study|Physician Decision|0|||
37630845|NCT00150618|69096977|FG001|Overall Study|Physician Decision|2|||
37630846|NCT00150618|69096978|FG002|Overall Study|Physician Decision|0|||
37630847|NCT00150618|69096979|FG003|Overall Study|Physician Decision|0|||
37630848|NCT00150618|69096980|FG004|Overall Study|Physician Decision|1|||
37630849|NCT00150618|69096976|FG000|Overall Study|Lack of compliance|2|||
37630850|NCT00150618|69096977|FG001|Overall Study|Lack of compliance|1|||
37630851|NCT00150618|69096978|FG002|Overall Study|Lack of compliance|1|||
37630852|NCT00150618|69096979|FG003|Overall Study|Lack of compliance|0|||
37630853|NCT00150618|69096980|FG004|Overall Study|Lack of compliance|1|||
37630854|NCT00150618|69096976|FG000|Overall Study|Abnormal ECG|1|||
37630855|NCT00150618|69096977|FG001|Overall Study|Abnormal ECG|0|||
37630856|NCT00150618|69096978|FG002|Overall Study|Abnormal ECG|0|||
37630857|NCT00150618|69096979|FG003|Overall Study|Abnormal ECG|0|||
37630858|NCT00150618|69096980|FG004|Overall Study|Abnormal ECG|0|||
37630859|NCT00150618|69096976|FG000|Overall Study|Sponsor's decision|0|||
37630860|NCT00150618|69096977|FG001|Overall Study|Sponsor's decision|0|||
37630861|NCT00150618|69096978|FG002|Overall Study|Sponsor's decision|0|||
37630862|NCT00150618|69096979|FG003|Overall Study|Sponsor's decision|1|||
37630863|NCT00150618|69096980|FG004|Overall Study|Sponsor's decision|0|||
37630864|NCT01359046|69096994|FG000|Overall Study|Did not receive allocated intervention|6|||
37630865|NCT01359046|69096995|FG001|Overall Study|Did not receive allocated intervention|6|||
37630866|NCT01359046|69096994|FG000|Overall Study|Physician Decision|1|||
37630867|NCT01359046|69096995|FG001|Overall Study|Physician Decision|11|||
37630868|NCT02741310|69097003|FG000|Overall Study|Sponsor Decision|2|||
37630869|NCT02741310|69097004|FG001|Overall Study|Sponsor Decision|2|||
37630870|NCT01367457|69097021|FG000|Overall Study|Death|2|||
37630871|NCT01367457|69097022|FG001|Overall Study|Death|0|||
37630872|NCT01367457|69097023|FG002|Overall Study|Death|0|||
37630873|NCT01367457|69097021|FG000|Overall Study|Investigator's decision|2|||
37630874|NCT01367457|69097022|FG001|Overall Study|Investigator's decision|0|||
37853240|NCT03302234|69537123|FG001|Overall Study|Death|192|||
37853241|NCT03302234|69537122|FG000|Overall Study|Withdrawal by Subject|2|||
37853242|NCT03302234|69537123|FG001|Overall Study|Withdrawal by Subject|2|||
37853243|NCT03302234|69537122|FG000|Overall Study|Sponsor Decision|90|||
37853244|NCT03302234|69537123|FG001|Overall Study|Sponsor Decision|89|||
37853245|NCT03302234|69537122|FG000|Overall Study|Laryngeal carcinoma|0|||
37853246|NCT03302234|69537123|FG001|Overall Study|Laryngeal carcinoma|1|||
37630875|NCT01367457|69097023|FG002|Overall Study|Investigator's decision|0|||
37630876|NCT01367457|69097021|FG000|Overall Study|Clinical decline (CD)|2|||
37630877|NCT01367457|69097022|FG001|Overall Study|Clinical decline (CD)|0|||
37853247|NCT03302234|69537122|FG000|Overall Study|Not Reported|1|||
38031853|NCT03351608|69717636|FG004|Overall Study|Lost to Follow-up|1|||
37630878|NCT01367457|69097023|FG002|Overall Study|Clinical decline (CD)|0|||
37630879|NCT01367457|69097021|FG000|Overall Study|Progression and death|8|||
38031854|NCT03351608|69717632|FG000|Overall Study|Physician Decision|1|||
37630880|NCT01367457|69097022|FG001|Overall Study|Progression and death|0|||
37630881|NCT01367457|69097023|FG002|Overall Study|Progression and death|0|||
37630882|NCT01367457|69097021|FG000|Overall Study|Toxicity|16|||
37630883|NCT01367457|69097022|FG001|Overall Study|Toxicity|0|||
37630884|NCT01367457|69097023|FG002|Overall Study|Toxicity|0|||
37630885|NCT01367457|69097021|FG000|Overall Study|Progression|137|||
37630886|NCT01367457|69097022|FG001|Overall Study|Progression|0|||
37630887|NCT01367457|69097023|FG002|Overall Study|Progression|0|||
37630888|NCT01367457|69097021|FG000|Overall Study|Patient asks for rest + slow progression|1|||
37630889|NCT01367457|69097022|FG001|Overall Study|Patient asks for rest + slow progression|0|||
37630890|NCT01367457|69097023|FG002|Overall Study|Patient asks for rest + slow progression|0|||
37630891|NCT01367457|69097021|FG000|Overall Study|Investigator's opinion, stable disease|1|||
37630892|NCT01367457|69097022|FG001|Overall Study|Investigator's opinion, stable disease|0|||
37630893|NCT01367457|69097023|FG002|Overall Study|Investigator's opinion, stable disease|0|||
37630894|NCT01367457|69097021|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
37630895|NCT01367457|69097022|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
37630896|NCT01367457|69097023|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
37630897|NCT01367457|69097021|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
37630898|NCT01367457|69097022|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
37630899|NCT01367457|69097023|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
37630900|NCT01367457|69097021|FG000|Overall Study|low grade toxicities + stable disease|1|||
37630901|NCT01367457|69097022|FG001|Overall Study|low grade toxicities + stable disease|0|||
37630902|NCT01367457|69097023|FG002|Overall Study|low grade toxicities + stable disease|0|||
37630903|NCT01367457|69097021|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
37630904|NCT01367457|69097022|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
37853248|NCT03302234|69537123|FG001|Overall Study|Not Reported|0|||
37630905|NCT01367457|69097023|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
37630906|NCT01367457|69097021|FG000|Overall Study|Withdrawal by Subject|1|||
37630907|NCT01367457|69097022|FG001|Overall Study|Withdrawal by Subject|0|||
37630908|NCT01367457|69097023|FG002|Overall Study|Withdrawal by Subject|0|||
37630909|NCT01367457|69097021|FG000|Overall Study|CD, associated leukaemia|1|||
37630910|NCT01367457|69097022|FG001|Overall Study|CD, associated leukaemia|0|||
37630911|NCT01367457|69097023|FG002|Overall Study|CD, associated leukaemia|0|||
37630912|NCT01367457|69097021|FG000|Overall Study|Uncontrolled pain|1|||
37630913|NCT01367457|69097022|FG001|Overall Study|Uncontrolled pain|0|||
37630914|NCT01367457|69097023|FG002|Overall Study|Uncontrolled pain|0|||
37630915|NCT01367457|69097021|FG000|Overall Study|Overall status worsens to grade 4|1|||
37630916|NCT01367457|69097022|FG001|Overall Study|Overall status worsens to grade 4|0|||
37630917|NCT01367457|69097023|FG002|Overall Study|Overall status worsens to grade 4|0|||
37630918|NCT01367457|69097021|FG000|Overall Study|Stabilisation + frequent infections|1|||
37630919|NCT01367457|69097022|FG001|Overall Study|Stabilisation + frequent infections|0|||
37630920|NCT01367457|69097023|FG002|Overall Study|Stabilisation + frequent infections|0|||
37630921|NCT01367457|69097021|FG000|Overall Study|No clinical benefit|1|||
37630922|NCT01367457|69097022|FG001|Overall Study|No clinical benefit|0|||
37630923|NCT01367457|69097023|FG002|Overall Study|No clinical benefit|0|||
37630924|NCT01367457|69097021|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
37630925|NCT01367457|69097022|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
37630926|NCT01367457|69097023|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
37630927|NCT01367457|69097021|FG000|Overall Study|Overall decline|1|||
37630928|NCT01367457|69097022|FG001|Overall Study|Overall decline|0|||
37630929|NCT01367457|69097023|FG002|Overall Study|Overall decline|0|||
37630930|NCT01367457|69097021|FG000|Overall Study|Rejection of treatment|1|||
37630931|NCT01367457|69097022|FG001|Overall Study|Rejection of treatment|0|||
37630932|NCT01367457|69097023|FG002|Overall Study|Rejection of treatment|0|||
37630933|NCT01367457|69097021|FG000|Overall Study|Lost to Follow-up|1|||
37630934|NCT01367457|69097022|FG001|Overall Study|Lost to Follow-up|0|||
37630935|NCT01367457|69097023|FG002|Overall Study|Lost to Follow-up|0|||
37630936|NCT01367457|69097021|FG000|Overall Study|Death from septic shock|1|||
37630937|NCT01367457|69097022|FG001|Overall Study|Death from septic shock|0|||
37630938|NCT01367457|69097023|FG002|Overall Study|Death from septic shock|0|||
37630939|NCT01367457|69097021|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
37630940|NCT01367457|69097022|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
37630941|NCT01367457|69097023|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
37630942|NCT01367457|69097021|FG000|Overall Study|Patient's Wish|1|||
37630943|NCT01367457|69097022|FG001|Overall Study|Patient's Wish|0|||
37630944|NCT01367457|69097023|FG002|Overall Study|Patient's Wish|0|||
37630945|NCT01367457|69097021|FG000|Overall Study|Palliative. Overall decline|1|||
37630946|NCT01367457|69097022|FG001|Overall Study|Palliative. Overall decline|0|||
37630947|NCT01367457|69097023|FG002|Overall Study|Palliative. Overall decline|0|||
37630948|NCT01367457|69097021|FG000|Overall Study|Suspected DP/suspected active infection|1|||
37630949|NCT01367457|69097022|FG001|Overall Study|Suspected DP/suspected active infection|0|||
37853249|NCT02754596|69537155|FG000|Overall Study|Withdrawal by Subject|3|||
37853250|NCT02754596|69537156|FG001|Overall Study|Withdrawal by Subject|4|||
37853251|NCT02754596|69537157|FG002|Overall Study|Withdrawal by Subject|0|||
37853252|NCT02754596|69537155|FG000|Overall Study|Physician Decision|1|||
37630950|NCT01367457|69097023|FG002|Overall Study|Suspected DP/suspected active infection|0|||
37630951|NCT00235326|69097033|FG000|Overall Study|Lost to Follow-up|746|||
37630952|NCT00235326|69097034|FG001|Overall Study|Lost to Follow-up|1400|||
37630953|NCT00162942|69097044|FG000|Overall Study|Adverse Event|10|||
37630954|NCT00162942|69097045|FG001|Overall Study|Adverse Event|6|||
37630955|NCT00162942|69097044|FG000|Overall Study|Death|1|||
37630956|NCT00162942|69097045|FG001|Overall Study|Death|0|||
37630957|NCT00162942|69097044|FG000|Overall Study|Withdrawal by Subject|3|||
37630958|NCT00162942|69097045|FG001|Overall Study|Withdrawal by Subject|6|||
37630959|NCT00162942|69097044|FG000|Overall Study|Physician Decision|1|||
37630960|NCT00162942|69097045|FG001|Overall Study|Physician Decision|0|||
37630961|NCT00162942|69097044|FG000|Overall Study|Enter Open-Label Study|76|||
37630962|NCT00162942|69097045|FG001|Overall Study|Enter Open-Label Study|35|||
37630963|NCT00162942|69097044|FG000|Overall Study|Alternate Therapy|6|||
37630964|NCT00162942|69097045|FG001|Overall Study|Alternate Therapy|2|||
37630965|NCT00162942|69097044|FG000|Overall Study|Lack of Efficacy|1|||
37630966|NCT00162942|69097045|FG001|Overall Study|Lack of Efficacy|0|||
37630967|NCT00162942|69097044|FG000|Overall Study|Flare During Active Treatment|7|||
37630968|NCT00162942|69097045|FG001|Overall Study|Flare During Active Treatment|3|||
37630969|NCT00162942|69097044|FG000|Overall Study|2 or more consecutive treatments missed|1|||
37630970|NCT00162942|69097045|FG001|Overall Study|2 or more consecutive treatments missed|0|||
37630971|NCT02786901|69097075|FG000|Overall Study|Adverse Event|1|||
37630972|NCT02786901|69097076|FG001|Overall Study|Adverse Event|1|||
37630973|NCT02786901|69097077|FG002|Overall Study|Adverse Event|2|||
37630974|NCT02786901|69097075|FG000|Overall Study|Physician Decision|1|||
37630975|NCT02786901|69097076|FG001|Overall Study|Physician Decision|0|||
37630976|NCT02786901|69097077|FG002|Overall Study|Physician Decision|0|||
37630977|NCT02786901|69097075|FG000|Overall Study|Rescue Therapy Use|71|||
37630978|NCT02786901|69097076|FG001|Overall Study|Rescue Therapy Use|49|||
37630979|NCT02786901|69097077|FG002|Overall Study|Rescue Therapy Use|33|||
37630980|NCT02786901|69097075|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
37630981|NCT02786901|69097076|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
37630982|NCT02786901|69097077|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
37630983|NCT02786901|69097075|FG000|Overall Study|Disallowed medication|1|||
37630984|NCT02786901|69097076|FG001|Overall Study|Disallowed medication|1|||
37630985|NCT02786901|69097077|FG002|Overall Study|Disallowed medication|0|||
37630986|NCT02786901|69097075|FG000|Overall Study|Randomized in error|2|||
37630987|NCT02786901|69097076|FG001|Overall Study|Randomized in error|0|||
37630988|NCT02786901|69097077|FG002|Overall Study|Randomized in error|1|||
37630989|NCT02137239|69097087|FG000|Overall Study|Discontinued Study Treatment|0|||
37630990|NCT02137239|69097088|FG001|Overall Study|Discontinued Study Treatment|3|||
37630991|NCT02137239|69097087|FG000|Overall Study|Withdrew Consent|1|||
37630992|NCT02137239|69097088|FG001|Overall Study|Withdrew Consent|1|||
37630993|NCT02137239|69097087|FG000|Overall Study|Adverse Event|2|||
37630994|NCT02137239|69097088|FG001|Overall Study|Adverse Event|2|||
37630995|NCT02741076|69097107|FG000|Overall Study|Adverse Event|0|||
37630996|NCT02741076|69097108|FG001|Overall Study|Adverse Event|1|||
37630997|NCT02741076|69097109|FG002|Overall Study|Adverse Event|1|||
37630998|NCT02741076|69097110|FG003|Overall Study|Adverse Event|0|||
37630999|NCT02741076|69097107|FG000|Overall Study|Lack of Efficacy|1|||
37631000|NCT02741076|69097108|FG001|Overall Study|Lack of Efficacy|0|||
37631001|NCT02741076|69097109|FG002|Overall Study|Lack of Efficacy|0|||
37631002|NCT02741076|69097110|FG003|Overall Study|Lack of Efficacy|0|||
37631003|NCT02741076|69097107|FG000|Overall Study|Withdrawal by Subject|0|||
37631004|NCT02741076|69097108|FG001|Overall Study|Withdrawal by Subject|1|||
37631005|NCT02741076|69097109|FG002|Overall Study|Withdrawal by Subject|0|||
37631006|NCT02741076|69097110|FG003|Overall Study|Withdrawal by Subject|0|||
37631007|NCT02741076|69097107|FG000|Overall Study|Sponsor Request|2|||
37631008|NCT02741076|69097108|FG001|Overall Study|Sponsor Request|3|||
37631009|NCT02741076|69097109|FG002|Overall Study|Sponsor Request|0|||
37631010|NCT02741076|69097110|FG003|Overall Study|Sponsor Request|1|||
37631011|NCT02741076|69097107|FG000|Overall Study|No additional information available|0|||
37631012|NCT02741076|69097108|FG001|Overall Study|No additional information available|0|||
37631013|NCT02741076|69097109|FG002|Overall Study|No additional information available|1|||
37631014|NCT02741076|69097110|FG003|Overall Study|No additional information available|1|||
37631015|NCT01666444|69097123|FG000|Overall Study|Did not initiate treatment|2|||
37631016|NCT01666444|69097124|FG001|Overall Study|Did not initiate treatment|1|||
37631017|NCT05159622|69097132|FG000|Overall Study|Lost to Follow-up|4|||
37631018|NCT05159622|69097133|FG001|Overall Study|Lost to Follow-up|5|||
37631019|NCT01665430|69097145|FG000|Overall Study|Adverse Event|1|||
37631020|NCT01665430|69097145|FG000|Overall Study|Withdrawal by Subject|6|||
37631021|NCT01665430|69097145|FG000|Overall Study|Other Unspecified|2|||
37631022|NCT02739594|69097151|FG000|Overall Study|Undesired Event|3|||
37631023|NCT02739594|69097152|FG001|Overall Study|Undesired Event|4|||
37631024|NCT02739594|69097151|FG000|Overall Study|Violation of Eligibility Criteria|1|||
37631025|NCT02739594|69097152|FG001|Overall Study|Violation of Eligibility Criteria|2|||
37631026|NCT02739594|69097151|FG000|Overall Study|Protocol Violation|5|||
37631027|NCT02739594|69097152|FG001|Overall Study|Protocol Violation|6|||
37631028|NCT02739594|69097151|FG000|Overall Study|Death|4|||
37631029|NCT02739594|69097152|FG001|Overall Study|Death|2|||
37631030|NCT02739594|69097151|FG000|Overall Study|Renal Insufficiency|4|||
37631031|NCT02739594|69097152|FG001|Overall Study|Renal Insufficiency|6|||
37631032|NCT02739594|69097151|FG000|Overall Study|Administrative Reasons|1|||
37631033|NCT02739594|69097152|FG001|Overall Study|Administrative Reasons|3|||
37631034|NCT02739594|69097151|FG000|Overall Study|Withdrawal by Subject|1|||
37631035|NCT02739594|69097152|FG001|Overall Study|Withdrawal by Subject|1|||
37631036|NCT02739594|69097151|FG000|Overall Study|Lost to Follow-up|0|||
37631037|NCT02739594|69097152|FG001|Overall Study|Lost to Follow-up|1|||
37631038|NCT02739594|69097151|FG000|Overall Study|Elevated Serum Creatinine|0|||
37631039|NCT02739594|69097152|FG001|Overall Study|Elevated Serum Creatinine|1|||
37631040|NCT02739594|69097151|FG000|Overall Study|Other|6|||
37631041|NCT02739594|69097152|FG001|Overall Study|Other|2|||
37631042|NCT03989232|69097161|FG000|Overall Study|Lost to Follow-up|3|||
37631043|NCT03989232|69097162|FG001|Overall Study|Lost to Follow-up|10|||
37631044|NCT03989232|69097161|FG000|Overall Study|Withdrawal by Subject|6|||
37631045|NCT03989232|69097162|FG001|Overall Study|Withdrawal by Subject|6|||
37631046|NCT03989232|69097161|FG000|Overall Study|Death|1|||
37631047|NCT03989232|69097162|FG001|Overall Study|Death|2|||
37631048|NCT02585830|69097168|FG000|Overall Study|Withdrawal by Subject|3|||
37631049|NCT02584504|69097175|FG000|Double-blind Treatment|Participant withdrew consent|0|||
37631050|NCT02584504|69097176|FG001|Double-blind Treatment|Participant withdrew consent|0|||
37631051|NCT02584504|69097177|FG002|Double-blind Treatment|Participant withdrew consent|1|||
37631052|NCT02584504|69097175|FG000|Double-blind Treatment|Adverse Event|0|||
37631053|NCT02584504|69097176|FG001|Double-blind Treatment|Adverse Event|1|||
37631054|NCT02584504|69097177|FG002|Double-blind Treatment|Adverse Event|0|||
37631055|NCT02584504|69097175|FG000|Double-blind Treatment|Family Matter|0|||
37631056|NCT02584504|69097176|FG001|Double-blind Treatment|Family Matter|1|||
37631057|NCT02584504|69097177|FG002|Double-blind Treatment|Family Matter|0|||
37631058|NCT02584504|69097175|FG000|Open-label Treatment|Participant withdrew consent|0|||
37631059|NCT02584504|69097176|FG001|Open-label Treatment|Participant withdrew consent|0|||
37631060|NCT02584504|69097177|FG002|Open-label Treatment|Participant withdrew consent|4|||
37631061|NCT02584504|69097175|FG000|Open-label Treatment|Adverse Event|2|||
37631062|NCT02584504|69097176|FG001|Open-label Treatment|Adverse Event|2|||
37631063|NCT02584504|69097177|FG002|Open-label Treatment|Adverse Event|3|||
37631064|NCT02584504|69097175|FG000|Open-label Treatment|Physician Decision|0|||
37631065|NCT02584504|69097176|FG001|Open-label Treatment|Physician Decision|1|||
37631066|NCT02584504|69097177|FG002|Open-label Treatment|Physician Decision|0|||
37631067|NCT02584504|69097175|FG000|Open-label Treatment|Entered but not treated|0|||
37631068|NCT02584504|69097176|FG001|Open-label Treatment|Entered but not treated|1|||
37631069|NCT02584504|69097177|FG002|Open-label Treatment|Entered but not treated|1|||
37631070|NCT04447755|69097196|FG000|Overall Study|Death|8|||
37631071|NCT04447755|69097197|FG001|Overall Study|Death|14|||
37631072|NCT04447755|69097198|FG002|Overall Study|Death|8|||
37631073|NCT04447755|69097199|FG003|Overall Study|Death|9|||
37631074|NCT04447755|69097200|FG004|Overall Study|Death|7|||
37631075|NCT04447755|69097201|FG005|Overall Study|Death|7|||
37631076|NCT04447755|69097202|FG006|Overall Study|Death|40|||
37631077|NCT04447755|69097196|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
37631078|NCT04447755|69097197|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
37631079|NCT04447755|69097198|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
37631080|NCT04447755|69097199|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
37631081|NCT04447755|69097200|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
37631082|NCT04447755|69097201|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
37631083|NCT04447755|69097202|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
37631084|NCT04447755|69097196|FG000|Overall Study|Ongoing in Study|1|||
37631085|NCT04447755|69097197|FG001|Overall Study|Ongoing in Study|2|||
37738242|NCT01790594|69220794|FG002|Overall Study|Transplant was not done|3|||
37738243|NCT01790594|69220792|FG000|Overall Study|Terminated prior to week 76|0|||
37631086|NCT04447755|69097198|FG002|Overall Study|Ongoing in Study|0|||
37631087|NCT04447755|69097199|FG003|Overall Study|Ongoing in Study|0|||
37631088|NCT04447755|69097200|FG004|Overall Study|Ongoing in Study|2|||
37631089|NCT04447755|69097201|FG005|Overall Study|Ongoing in Study|2|||
37631090|NCT04447755|69097202|FG006|Overall Study|Ongoing in Study|26|||
37631091|NCT04354155|69097233|FG000|Overall Study|Withdrawal by Subject|1|||
37631092|NCT04354155|69097233|FG000|Overall Study|Did not meet criteria for study intervention|1|||
37631093|NCT02586064|69097239|FG000|Overall Study|Other Obligations|6|||
37631094|NCT02586064|69097240|FG001|Overall Study|Other Obligations|6|||
37631095|NCT02586064|69097239|FG000|Overall Study|Other|3|||
37631096|NCT02586064|69097240|FG001|Overall Study|Other|7|||
37631097|NCT02586064|69097239|FG000|Overall Study|Never Started|3|||
37631098|NCT02586064|69097240|FG001|Overall Study|Never Started|3|||
37631099|NCT02586064|69097239|FG000|Overall Study|Lost Interest|1|||
37631100|NCT02586064|69097240|FG001|Overall Study|Lost Interest|4|||
37631101|NCT02586064|69097239|FG000|Overall Study|Miscellaneous Life Issues|0|||
37631102|NCT02586064|69097240|FG001|Overall Study|Miscellaneous Life Issues|5|||
37631103|NCT02586064|69097239|FG000|Overall Study|Infrequent Attendance|2|||
37631104|NCT02586064|69097240|FG001|Overall Study|Infrequent Attendance|1|||
37631105|NCT02586064|69097239|FG000|Overall Study|Timed Out|2|||
37631106|NCT02586064|69097240|FG001|Overall Study|Timed Out|0|||
37631107|NCT02586064|69097239|FG000|Overall Study|AUD relapse|0|||
37631108|NCT02586064|69097240|FG001|Overall Study|AUD relapse|2|||
37631109|NCT02586064|69097239|FG000|Overall Study|Legal Issue|1|||
37631110|NCT02586064|69097240|FG001|Overall Study|Legal Issue|0|||
37631111|NCT03810495|69097249|FG000|Overall Study|Lost to Follow-up|2|||
37631112|NCT03810495|69097249|FG000|Overall Study|Withdrawal by Subject|1|||
37631113|NCT02782923|69097253|FG000|Overall Study|Lost to Follow-up|15|||
37631114|NCT03760458|69097262|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
37631115|NCT03760458|69097263|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
37631116|NCT03760458|69097264|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
37631117|NCT03760458|69097265|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
37631118|NCT03760458|69097266|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
37631119|NCT02066415|69097281|FG000|Overall Study|Decision by Sponsor|5|||
37631120|NCT02066415|69097282|FG001|Overall Study|Decision by Sponsor|4|||
37631121|NCT02066415|69097283|FG002|Overall Study|Decision by Sponsor|2|||
37631122|NCT02066415|69097281|FG000|Overall Study|Withdrawal by Subject|9|||
37631123|NCT02066415|69097282|FG001|Overall Study|Withdrawal by Subject|1|||
37631124|NCT02066415|69097283|FG002|Overall Study|Withdrawal by Subject|4|||
37631125|NCT02066415|69097281|FG000|Overall Study|Lost to Follow-up|7|||
37631126|NCT02066415|69097282|FG001|Overall Study|Lost to Follow-up|2|||
37631127|NCT02066415|69097283|FG002|Overall Study|Lost to Follow-up|2|||
37631128|NCT02583256|69097295|FG000|Overall Study|Withdrawal by Subject|0|||
37631129|NCT02583256|69097296|FG001|Overall Study|Withdrawal by Subject|1|||
37631130|NCT02583256|69097297|FG002|Overall Study|Withdrawal by Subject|1|||
37631131|NCT02583256|69097298|FG003|Overall Study|Withdrawal by Subject|0|||
37631132|NCT02583256|69097295|FG000|Overall Study|Lost to Follow-up|1|||
37631133|NCT02583256|69097296|FG001|Overall Study|Lost to Follow-up|1|||
37631134|NCT02583256|69097297|FG002|Overall Study|Lost to Follow-up|0|||
37631135|NCT02583256|69097298|FG003|Overall Study|Lost to Follow-up|1|||
37631136|NCT02583256|69097295|FG000|Overall Study|Administrative/Other|2|||
37738244|NCT01790594|69220793|FG001|Overall Study|Terminated prior to week 76|2|||
37738245|NCT01790594|69220794|FG002|Overall Study|Terminated prior to week 76|0|||
37738246|NCT01790516|69220803|FG000|Overall Study|Physician Decision|1|||
37738247|NCT01790516|69220804|FG001|Overall Study|Physician Decision|0|||
37738248|NCT01790438|69220812|FG000|Overall Study|Adverse Event|3|||
37738249|NCT01790438|69220813|FG001|Overall Study|Adverse Event|2|||
37738250|NCT01790438|69220812|FG000|Overall Study|Death|4|||
37738251|NCT01790438|69220813|FG001|Overall Study|Death|0|||
37738252|NCT01790438|69220812|FG000|Overall Study|Lost to Follow-up|5|||
37738253|NCT01790438|69220813|FG001|Overall Study|Lost to Follow-up|2|||
37738254|NCT01790438|69220812|FG000|Overall Study|Withdrawal by Subject|13|||
37738255|NCT01790438|69220813|FG001|Overall Study|Withdrawal by Subject|2|||
37738256|NCT01790438|69220812|FG000|Overall Study|Physician Decision|3|||
37738257|NCT01790438|69220813|FG001|Overall Study|Physician Decision|1|||
37738258|NCT01790438|69220812|FG000|Overall Study|Sponsor Decision|0|||
37738259|NCT01790438|69220813|FG001|Overall Study|Sponsor Decision|3|||
37738260|NCT01790438|69220812|FG000|Overall Study|Protocol Required Discontinuation|7|||
37738261|NCT01790438|69220813|FG001|Overall Study|Protocol Required Discontinuation|1|||
37738262|NCT01735916|69220824|FG000|Overall Study|Subject not eligible to be randomized|11|||
37738263|NCT01735916|69220825|FG001|Overall Study|Subject not eligible to be randomized|0|||
37738264|NCT01735916|69220826|FG002|Overall Study|Subject not eligible to be randomized|0|||
37738265|NCT01735916|69220824|FG000|Overall Study|Early termination of study by sponsor|4|||
37853253|NCT02754596|69537156|FG001|Overall Study|Physician Decision|1|||
37631137|NCT02583256|69097296|FG001|Overall Study|Administrative/Other|0|||
37631138|NCT02583256|69097297|FG002|Overall Study|Administrative/Other|1|||
37631139|NCT02583256|69097298|FG003|Overall Study|Administrative/Other|2|||
37631140|NCT02584660|69097321|FG000|Overall Study|Adverse Event|4|||
37631141|NCT02584660|69097322|FG001|Overall Study|Adverse Event|0|||
37631142|NCT02584660|69097321|FG000|Overall Study|Lost to Follow-up|3|||
37631143|NCT02584660|69097322|FG001|Overall Study|Lost to Follow-up|4|||
37631144|NCT02584660|69097321|FG000|Overall Study|Protocol Violation|0|||
37631145|NCT02584660|69097322|FG001|Overall Study|Protocol Violation|1|||
37631146|NCT02584660|69097321|FG000|Overall Study|Withdrawal by Subject|0|||
37631147|NCT02584660|69097322|FG001|Overall Study|Withdrawal by Subject|2|||
37631148|NCT02584660|69097321|FG000|Overall Study|Other|0|||
37631149|NCT02584660|69097322|FG001|Overall Study|Other|1|||
37631150|NCT02582632|69097344|FG000|Overall Study|Other|1|||
37738266|NCT01735916|69220825|FG001|Overall Study|Early termination of study by sponsor|19|||
37738267|NCT01735916|69220826|FG002|Overall Study|Early termination of study by sponsor|7|||
37738268|NCT01735916|69220824|FG000|Overall Study|Withdrawal by Subject|3|||
37738269|NCT01735916|69220825|FG001|Overall Study|Withdrawal by Subject|0|||
37738270|NCT01735916|69220826|FG002|Overall Study|Withdrawal by Subject|0|||
37631151|NCT02178722|69097362|FG000|Overall Study|Withdrawal by Subject|0|||
37631152|NCT02178722|69097363|FG001|Overall Study|Withdrawal by Subject|0|||
37631153|NCT02178722|69097364|FG002|Overall Study|Withdrawal by Subject|0|||
37631154|NCT02178722|69097365|FG003|Overall Study|Withdrawal by Subject|2|||
37631155|NCT02178722|69097366|FG004|Overall Study|Withdrawal by Subject|33|||
37631156|NCT02178722|69097362|FG000|Overall Study|Death|2|||
37631157|NCT02178722|69097363|FG001|Overall Study|Death|13|||
37631158|NCT02178722|69097364|FG002|Overall Study|Death|12|||
37631159|NCT02178722|69097365|FG003|Overall Study|Death|12|||
37631160|NCT02178722|69097366|FG004|Overall Study|Death|205|||
37631161|NCT02178722|69097362|FG000|Overall Study|Lost to Follow-up|0|||
37631162|NCT02178722|69097363|FG001|Overall Study|Lost to Follow-up|0|||
37631163|NCT02178722|69097364|FG002|Overall Study|Lost to Follow-up|0|||
37631164|NCT02178722|69097365|FG003|Overall Study|Lost to Follow-up|2|||
37631165|NCT02178722|69097366|FG004|Overall Study|Lost to Follow-up|11|||
37631166|NCT02178722|69097362|FG000|Overall Study|Study terminated by Sponsor|2|||
37631167|NCT02178722|69097363|FG001|Overall Study|Study terminated by Sponsor|7|||
37631168|NCT02178722|69097364|FG002|Overall Study|Study terminated by Sponsor|6|||
37631169|NCT02178722|69097365|FG003|Overall Study|Study terminated by Sponsor|4|||
37631170|NCT02178722|69097366|FG004|Overall Study|Study terminated by Sponsor|128|||
37631171|NCT02178722|69097362|FG000|Overall Study|Physician Decision|0|||
37631172|NCT02178722|69097363|FG001|Overall Study|Physician Decision|0|||
37631173|NCT02178722|69097364|FG002|Overall Study|Physician Decision|0|||
37631174|NCT02178722|69097365|FG003|Overall Study|Physician Decision|0|||
37631175|NCT02178722|69097366|FG004|Overall Study|Physician Decision|3|||
37631176|NCT02178722|69097362|FG000|Overall Study|Other|0|||
37631177|NCT02178722|69097363|FG001|Overall Study|Other|0|||
37631178|NCT02178722|69097364|FG002|Overall Study|Other|0|||
37631179|NCT02178722|69097365|FG003|Overall Study|Other|0|||
37631180|NCT02178722|69097366|FG004|Overall Study|Other|2|||
37631181|NCT00972309|69097383|FG000|Overall Study|Switched to alternative treatment|0|||
37631182|NCT00972309|69097384|FG001|Overall Study|Switched to alternative treatment|2|||
37631183|NCT00972309|69097383|FG000|Overall Study|Refused further treatment|0|||
37631184|NCT00972309|69097384|FG001|Overall Study|Refused further treatment|1|||
37631185|NCT00972309|69097383|FG000|Overall Study|Late determination of ineligibility|0|||
37631186|NCT00972309|69097384|FG001|Overall Study|Late determination of ineligibility|1|||
37631187|NCT00972309|69097383|FG000|Overall Study|Second malignancy|1|||
37631188|NCT00972309|69097384|FG001|Overall Study|Second malignancy|1|||
37631189|NCT00972309|69097383|FG000|Overall Study|Visa issues|0|||
37631190|NCT00972309|69097384|FG001|Overall Study|Visa issues|1|||
37631191|NCT00972309|69097383|FG000|Overall Study|Secondary cancer (SCC)|0|||
37631192|NCT00972309|69097384|FG001|Overall Study|Secondary cancer (SCC)|1|||
37631193|NCT00972309|69097383|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
37631194|NCT00972309|69097384|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
37631195|NCT00972309|69097383|FG000|Overall Study|Lost to Follow-up|1|||
37631196|NCT00972309|69097384|FG001|Overall Study|Lost to Follow-up|1|||
37631197|NCT00972309|69097383|FG000|Overall Study|Disease progression on study|10|||
37631198|NCT00972309|69097384|FG001|Overall Study|Disease progression on study|4|||
37631199|NCT02582242|69097403|FG000|Overall Study|Adverse Event|4|||
37631200|NCT02582242|69097404|FG001|Overall Study|Adverse Event|3|||
37631201|NCT02582242|69097403|FG000|Overall Study|Protocol Violation|3|||
37631202|NCT02582242|69097404|FG001|Overall Study|Protocol Violation|1|||
37631203|NCT02582242|69097403|FG000|Overall Study|Lost to Follow-up|0|||
37631204|NCT02582242|69097404|FG001|Overall Study|Lost to Follow-up|1|||
37631205|NCT02582242|69097403|FG000|Overall Study|Withdrawal by Subject|11|||
37631206|NCT02582242|69097404|FG001|Overall Study|Withdrawal by Subject|11|||
37631207|NCT02582242|69097403|FG000|Overall Study|Unclassified|2|||
37631208|NCT02582242|69097404|FG001|Overall Study|Unclassified|1|||
37631209|NCT00663351|69097412|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
37631210|NCT00663351|69097413|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
37631211|NCT00663351|69097412|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
37631212|NCT00663351|69097413|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
37631213|NCT00663351|69097412|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
37631214|NCT00663351|69097413|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
37631215|NCT00663351|69097412|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
37631216|NCT00663351|69097413|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
37631217|NCT00663351|69097412|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
37631218|NCT00663351|69097413|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
37631219|NCT00663351|69097412|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
37631220|NCT00663351|69097413|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
37631221|NCT00616941|69097422|FG000|Overall Study|Progressive Disease|1|||
37631222|NCT00616941|69097423|FG001|Overall Study|Progressive Disease|2|||
37631223|NCT00616941|69097424|FG002|Overall Study|Progressive Disease|1|||
37631224|NCT00616941|69097422|FG000|Overall Study|Adverse Event|0|||
37631225|NCT00616941|69097423|FG001|Overall Study|Adverse Event|1|||
37631226|NCT00616941|69097424|FG002|Overall Study|Adverse Event|1|||
37631227|NCT00616941|69097422|FG000|Overall Study|Subject Non-compliance|0|||
37631228|NCT00616941|69097423|FG001|Overall Study|Subject Non-compliance|0|||
37631229|NCT00616941|69097424|FG002|Overall Study|Subject Non-compliance|1|||
37631230|NCT00616941|69097422|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
37631231|NCT00616941|69097423|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
37631232|NCT00616941|69097424|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
37631233|NCT00616941|69097422|FG000|Overall Study|Vaccination Suspended|0|||
37631234|NCT00616941|69097423|FG001|Overall Study|Vaccination Suspended|0|||
37631235|NCT00616941|69097424|FG002|Overall Study|Vaccination Suspended|3|||
37631236|NCT00105560|69097432|FG000|Overall Study|Lost to Follow-up|1|||
37631237|NCT02577718|69097445|FG000|Overall Study|Death|6|||
37631238|NCT02577718|69097445|FG000|Overall Study|Withdrawal by Subject|2|||
37631239|NCT00520533|69097451|FG000|Overall Study|Death|1|||
37631240|NCT00520533|69097451|FG000|Overall Study|Suspension of the study for safety reasons|1|||
37631241|NCT00520533|69097451|FG000|Overall Study|Withdrawal by Subject|1|||
37631242|NCT00520533|69097451|FG000|Overall Study|Physician Decision|1|||
37631243|NCT01664104|69097460|FG000|Overall Study|Adverse Event|6|||
37631244|NCT01664104|69097460|FG000|Overall Study|Lack of Efficacy|2|||
37631245|NCT01664104|69097460|FG000|Overall Study|Withdrawal by Subject|1|||
37631246|NCT01664104|69097460|FG000|Overall Study|Lost to Follow-up|4|||
37631247|NCT01664104|69097460|FG000|Overall Study|Other|1|||
37631248|NCT01664104|69097460|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
37631249|NCT02739984|69097468|FG000|Overall Study|Sponsor Decision|1|||
37631250|NCT02739984|69097469|FG001|Overall Study|Sponsor Decision|0|||
37631251|NCT02739984|69097468|FG000|Overall Study|Withdrawal by Subject|1|||
37631252|NCT02739984|69097469|FG001|Overall Study|Withdrawal by Subject|1|||
37631253|NCT02739984|69097468|FG000|Overall Study|Death|0|||
37631254|NCT02739984|69097469|FG001|Overall Study|Death|1|||
37631255|NCT02739984|69097468|FG000|Overall Study|Lost to Follow-up|3|||
37631256|NCT02739984|69097469|FG001|Overall Study|Lost to Follow-up|0|||
37631257|NCT00496730|69097477|FG000|Overall Study|Lost to Follow-up|4|||
37631258|NCT00496730|69097478|FG001|Overall Study|Lost to Follow-up|3|||
37631259|NCT00496730|69097477|FG000|Overall Study|Withdrawal by Subject|2|||
37631260|NCT00496730|69097478|FG001|Overall Study|Withdrawal by Subject|2|||
37631261|NCT02739828|69097484|FG000|Overall Study|Adverse Event|1|||
37631262|NCT02739828|69097484|FG000|Overall Study|Lost to Follow-up|4|||
37631263|NCT04435808|69097499|FG000|Overall Study|Study stopped by DSMB|0|||
37631264|NCT04435808|69097500|FG001|Overall Study|Study stopped by DSMB|1|||
37631265|NCT01664494|69097523|FG000|Overall Study|Withdrawal by Subject|27|||
37631266|NCT01664494|69097523|FG000|Overall Study|Death|18|||
37631267|NCT01664494|69097523|FG000|Overall Study|Other|49|||
37631268|NCT01664494|69097523|FG000|Overall Study|Lost to Follow-up|99|||
37631269|NCT02577016|69097529|FG000|Overall Study|Adverse Event|2|||
37631270|NCT02577016|69097530|FG001|Overall Study|Adverse Event|1|||
37631271|NCT02577016|69097529|FG000|Overall Study|Physician Decision|0|||
37631272|NCT02577016|69097530|FG001|Overall Study|Physician Decision|1|||
37631273|NCT05101252|69097538|FG000|Overall Study|Unsatisfactory Test Article|1|||
37631274|NCT05101252|69097539|FG001|Overall Study|Unsatisfactory Test Article|0|||
37631275|NCT05101252|69097538|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
37631276|NCT05101252|69097539|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
37631277|NCT05101252|69097538|FG000|Overall Study|Withdrew Consent during study|0|||
37631278|NCT05101252|69097539|FG001|Overall Study|Withdrew Consent during study|1|||
37631279|NCT05101252|69097538|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
37631280|NCT05101252|69097539|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
37631281|NCT03316586|69097545|FG000|Overall Study|Adverse Event|2|||
37631282|NCT03316586|69097545|FG000|Overall Study|Physician Decision|3|||
37631283|NCT03316586|69097545|FG000|Overall Study|Lack of Efficacy|10|||
37631284|NCT03316586|69097545|FG000|Overall Study|still on treatment|1|||
37631285|NCT03316586|69097545|FG000|Overall Study|Patient needed radiation therapy|1|||
37631286|NCT03316586|69097545|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
37631287|NCT00107991|69097549|FG000|Eligibility Assessment|Disease not severe enough|7|||
37631288|NCT00107991|69097549|FG000|Eligibility Assessment|Unwilling to participate|7|||
37631289|NCT00107991|69097549|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
37631290|NCT00107991|69097549|FG000|Eligibility Assessment|Abnormal labs|2|||
37631291|NCT00107991|69097549|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
37631292|NCT00107991|69097549|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
37631293|NCT00107991|69097549|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
37631294|NCT00107991|69097549|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
37631295|NCT00107991|69097549|FG000|12 Week Treatment Period|Adverse Event|1|||
37631296|NCT00107991|69097549|FG000|12 Week Treatment Period|Protocol Violation|1|||
37631297|NCT00107991|69097549|FG000|12 Week Treatment Period|Incarcerated|1|||
37631298|NCT00107991|69097549|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
37631299|NCT00492856|69097553|FG000|Induction|Adverse Event|2|||
37631300|NCT00492856|69097554|FG001|Induction|Adverse Event|0|||
37631301|NCT00492856|69097555|FG002|Induction|Adverse Event|0|||
37631302|NCT00492856|69097556|FG003|Induction|Adverse Event|0|||
37631303|NCT00492856|69097553|FG000|Induction|Withdrawal by Subject|1|||
37631304|NCT00492856|69097554|FG001|Induction|Withdrawal by Subject|0|||
37631305|NCT00492856|69097555|FG002|Induction|Withdrawal by Subject|0|||
37631306|NCT00492856|69097556|FG003|Induction|Withdrawal by Subject|0|||
37631307|NCT00492856|69097553|FG000|Induction|Death|3|||
37631308|NCT00492856|69097554|FG001|Induction|Death|0|||
37631309|NCT00492856|69097555|FG002|Induction|Death|0|||
37631310|NCT00492856|69097556|FG003|Induction|Death|0|||
37631311|NCT00492856|69097553|FG000|Consolidation|Adverse Event|6|||
37631312|NCT00492856|69097554|FG001|Consolidation|Adverse Event|0|||
37631313|NCT00492856|69097555|FG002|Consolidation|Adverse Event|0|||
37631314|NCT00492856|69097556|FG003|Consolidation|Adverse Event|0|||
37631315|NCT00492856|69097553|FG000|Consolidation|Not protocol specified|2|||
37631316|NCT00492856|69097554|FG001|Consolidation|Not protocol specified|0|||
37631317|NCT00492856|69097555|FG002|Consolidation|Not protocol specified|0|||
37631318|NCT00492856|69097556|FG003|Consolidation|Not protocol specified|0|||
37631319|NCT00492856|69097553|FG000|Consolidation|Lost to Follow-up|1|||
37631320|NCT00492856|69097554|FG001|Consolidation|Lost to Follow-up|0|||
37631321|NCT00492856|69097555|FG002|Consolidation|Lost to Follow-up|0|||
37631322|NCT00492856|69097556|FG003|Consolidation|Lost to Follow-up|0|||
37631323|NCT00492856|69097553|FG000|Post-consolidation|Adverse Event|0|||
37631324|NCT00492856|69097554|FG001|Post-consolidation|Adverse Event|4|||
37631325|NCT00492856|69097555|FG002|Post-consolidation|Adverse Event|0|||
37631326|NCT00492856|69097556|FG003|Post-consolidation|Adverse Event|1|||
37631327|NCT00492856|69097553|FG000|Post-consolidation|Withdrawal by Subject|0|||
37631328|NCT00492856|69097554|FG001|Post-consolidation|Withdrawal by Subject|4|||
37631329|NCT00492856|69097555|FG002|Post-consolidation|Withdrawal by Subject|0|||
37631330|NCT00492856|69097556|FG003|Post-consolidation|Withdrawal by Subject|0|||
37631331|NCT00492856|69097553|FG000|Post-consolidation|Death|0|||
37631332|NCT00492856|69097554|FG001|Post-consolidation|Death|1|||
37631333|NCT00492856|69097555|FG002|Post-consolidation|Death|0|||
37631334|NCT00492856|69097556|FG003|Post-consolidation|Death|0|||
37631335|NCT00492856|69097553|FG000|Post-consolidation|Not protocol specified|0|||
37631336|NCT00492856|69097554|FG001|Post-consolidation|Not protocol specified|1|||
37631337|NCT00492856|69097555|FG002|Post-consolidation|Not protocol specified|0|||
37631338|NCT00492856|69097556|FG003|Post-consolidation|Not protocol specified|0|||
37631339|NCT00492856|69097553|FG000|Post-consolidation|Lost to Follow-up|0|||
37631340|NCT00492856|69097554|FG001|Post-consolidation|Lost to Follow-up|2|||
37631341|NCT00492856|69097555|FG002|Post-consolidation|Lost to Follow-up|0|||
37631342|NCT00492856|69097556|FG003|Post-consolidation|Lost to Follow-up|0|||
37631343|NCT00492856|69097553|FG000|Post-consolidation|Observation Arm|0|||
37631344|NCT00492856|69097554|FG001|Post-consolidation|Observation Arm|0|||
37631345|NCT00492856|69097555|FG002|Post-consolidation|Observation Arm|27|||
37631346|NCT00492856|69097556|FG003|Post-consolidation|Observation Arm|0|||
37631347|NCT02782377|69097568|FG000|Overall Study|Physician Decision|5|||
37631348|NCT02410629|69097575|FG000|Overall Study|Family cannot commit to the study|2|||
37631349|NCT02410629|69097576|FG001|Overall Study|Family cannot commit to the study|1|||
37631350|NCT02410629|69097575|FG000|Overall Study|Subject returned to work|1|||
37631351|NCT02410629|69097576|FG001|Overall Study|Subject returned to work|0|||
37631352|NCT02410629|69097575|FG000|Overall Study|Subject moved back to home country|0|||
37631353|NCT02410629|69097576|FG001|Overall Study|Subject moved back to home country|1|||
37631354|NCT02410629|69097575|FG000|Overall Study|Subject underwent heart surgery|0|||
37631355|NCT02410629|69097576|FG001|Overall Study|Subject underwent heart surgery|1|||
37631356|NCT02252211|69097584|FG000|Overall Study|Adverse Event|0|||
37631357|NCT02252211|69097585|FG001|Overall Study|Adverse Event|1|||
37631358|NCT02252211|69097586|FG002|Overall Study|Adverse Event|0|||
37631359|NCT02252211|69097584|FG000|Overall Study|Progressive disease|3|||
37631360|NCT02252211|69097585|FG001|Overall Study|Progressive disease|2|||
37631361|NCT02252211|69097586|FG002|Overall Study|Progressive disease|0|||
37631362|NCT02252211|69097584|FG000|Overall Study|Withdrawal by Subject|1|||
37631363|NCT02252211|69097585|FG001|Overall Study|Withdrawal by Subject|0|||
37631364|NCT02252211|69097586|FG002|Overall Study|Withdrawal by Subject|0|||
37631365|NCT02252211|69097584|FG000|Overall Study|Serious Adverse Event During Screening|1|||
37853254|NCT02754596|69537157|FG002|Overall Study|Physician Decision|1|||
37631366|NCT02252211|69097585|FG001|Overall Study|Serious Adverse Event During Screening|0|||
37631367|NCT02252211|69097586|FG002|Overall Study|Serious Adverse Event During Screening|1|||
37631368|NCT02776683|69097593|FG000|Pre-switch Period|Protocol Violation|1|||
37631369|NCT02776683|69097594|FG001|Pre-switch Period|Protocol Violation|0|||
37631370|NCT02776683|69097593|FG000|Pre-switch Period|Adverse Event|21|||
37631371|NCT02776683|69097594|FG001|Pre-switch Period|Adverse Event|0|||
37631372|NCT02776683|69097593|FG000|Pre-switch Period|Withdrawal by Subject|9|||
37631373|NCT02776683|69097594|FG001|Pre-switch Period|Withdrawal by Subject|0|||
37631374|NCT02776683|69097593|FG000|Pre-switch Period|Physician Decision|7|||
37631375|NCT02776683|69097594|FG001|Pre-switch Period|Physician Decision|0|||
37631376|NCT02776683|69097593|FG000|Pre-switch Period|Progressive disease|39|||
37631377|NCT02776683|69097594|FG001|Pre-switch Period|Progressive disease|0|||
37853255|NCT02754596|69537155|FG000|Overall Study|Lost to Follow-up|1|||
37631378|NCT02776683|69097593|FG000|Pre-switch Period|Other than listed|3|||
37631379|NCT02776683|69097594|FG001|Pre-switch Period|Other than listed|0|||
37631380|NCT02776683|69097593|FG000|Post-switch Period|Adverse Event|0|||
37631381|NCT02776683|69097594|FG001|Post-switch Period|Adverse Event|3|||
37631382|NCT02776683|69097593|FG000|Post-switch Period|Withdrawal by Subject|0|||
37631383|NCT02776683|69097594|FG001|Post-switch Period|Withdrawal by Subject|2|||
37631384|NCT02776683|69097593|FG000|Post-switch Period|Physician Decision|0|||
37631385|NCT02776683|69097594|FG001|Post-switch Period|Physician Decision|3|||
37631386|NCT02776683|69097593|FG000|Post-switch Period|Progressive disease|0|||
37631387|NCT02776683|69097594|FG001|Post-switch Period|Progressive disease|20|||
37631388|NCT02776683|69097593|FG000|Post-switch Period|Other than listed|0|||
37631389|NCT02776683|69097594|FG001|Post-switch Period|Other than listed|15|||
37631390|NCT02731742|69097602|FG000|Overall Study|Death|1|||
37631391|NCT02731742|69097603|FG001|Overall Study|Death|2|||
37631392|NCT02731742|69097604|FG002|Overall Study|Death|5|||
37631393|NCT02731742|69097605|FG003|Overall Study|Death|0|||
37631394|NCT02731742|69097602|FG000|Overall Study|Physician Decision|0|||
37631395|NCT02731742|69097603|FG001|Overall Study|Physician Decision|0|||
37631396|NCT02731742|69097604|FG002|Overall Study|Physician Decision|0|||
37631397|NCT02731742|69097605|FG003|Overall Study|Physician Decision|1|||
37631398|NCT02731742|69097602|FG000|Overall Study|Study Terminated by Sponsor|2|||
37631399|NCT02731742|69097603|FG001|Overall Study|Study Terminated by Sponsor|1|||
37631400|NCT02731742|69097604|FG002|Overall Study|Study Terminated by Sponsor|1|||
37631401|NCT02731742|69097605|FG003|Overall Study|Study Terminated by Sponsor|1|||
37631402|NCT00104871|69097628|FG000|Overall Study|Not evaluable|1|||
37631403|NCT03487796|69097636|FG000|Overall Study|Lost to Follow-up|18|||
37631404|NCT03487796|69097637|FG001|Overall Study|Lost to Follow-up|6|||
37631405|NCT02148705|69097652|FG000|Overall Study|Death|2|||
37631406|NCT02148705|69097653|FG001|Overall Study|Death|0|||
37631407|NCT02148705|69097654|FG002|Overall Study|Death|0|||
37631408|NCT02148705|69097652|FG000|Overall Study|Lost to Follow-up|13|||
37631409|NCT02148705|69097653|FG001|Overall Study|Lost to Follow-up|4|||
37631410|NCT02148705|69097654|FG002|Overall Study|Lost to Follow-up|10|||
37631411|NCT02148705|69097652|FG000|Overall Study|Withdrawal by Subject|3|||
37631412|NCT02148705|69097653|FG001|Overall Study|Withdrawal by Subject|0|||
37631413|NCT02148705|69097654|FG002|Overall Study|Withdrawal by Subject|2|||
37631414|NCT02148705|69097652|FG000|Overall Study|Not Treated|0|||
37631415|NCT02148705|69097653|FG001|Overall Study|Not Treated|1|||
37631416|NCT02148705|69097654|FG002|Overall Study|Not Treated|5|||
37631417|NCT03446612|69097664|FG000|Overall Study|Protocol defined stopping criteria|0|||
37631418|NCT03446612|69097665|FG001|Overall Study|Protocol defined stopping criteria|1|||
37631419|NCT02730728|69097676|FG000|Overall Study|Withdrawal by Subject|0|||
37631420|NCT02730728|69097677|FG001|Overall Study|Withdrawal by Subject|1|||
37631421|NCT02730728|69097678|FG002|Overall Study|Withdrawal by Subject|0|||
37631422|NCT02730728|69097676|FG000|Overall Study|Lack of Efficacy|0|||
37631423|NCT02730728|69097677|FG001|Overall Study|Lack of Efficacy|1|||
37631424|NCT02730728|69097678|FG002|Overall Study|Lack of Efficacy|1|||
37631425|NCT00104637|69097686|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
37631426|NCT00104637|69097687|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
37631427|NCT02768103|69097696|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
37631428|NCT02767323|69097705|FG000|Overall Study|Withdrawal by Subject|17|||
37631429|NCT02767323|69097706|FG001|Overall Study|Withdrawal by Subject|5|||
37631430|NCT02767323|69097707|FG002|Overall Study|Withdrawal by Subject|13|||
37631431|NCT02767323|69097708|FG003|Overall Study|Withdrawal by Subject|0|||
37631432|NCT02767323|69097705|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
37631433|NCT02767323|69097706|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
37631434|NCT02767323|69097707|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
37631435|NCT02767323|69097708|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
37631436|NCT04304950|69097723|FG000|Overall Study|Lost to Follow-up|1|||
37631437|NCT04304950|69097724|FG001|Overall Study|Lost to Follow-up|1|||
37631438|NCT02780115|69097738|FG000|Overall Study|Withdrawal by Subject|0|||
37631439|NCT02780115|69097739|FG001|Overall Study|Withdrawal by Subject|1|||
37631440|NCT02780115|69097740|FG002|Overall Study|Withdrawal by Subject|1|||
37631441|NCT02780115|69097741|FG003|Overall Study|Withdrawal by Subject|0|||
37631442|NCT02780115|69097742|FG004|Overall Study|Withdrawal by Subject|0|||
37631443|NCT02780115|69097738|FG000|Overall Study|Adverse Event|0|||
37631444|NCT02780115|69097739|FG001|Overall Study|Adverse Event|0|||
37631445|NCT02780115|69097740|FG002|Overall Study|Adverse Event|0|||
37631446|NCT02780115|69097741|FG003|Overall Study|Adverse Event|1|||
37631447|NCT02780115|69097742|FG004|Overall Study|Adverse Event|1|||
37631448|NCT02766777|69097754|FG000|Overall Study|Adverse Event|12|||
37631449|NCT02766777|69097754|FG000|Overall Study|Lost to Follow-up|16|||
37631450|NCT02766777|69097754|FG000|Overall Study|Non-Compliance With Study Drug|1|||
37631451|NCT02766777|69097754|FG000|Overall Study|Protocol Violation|1|||
37631452|NCT02766777|69097754|FG000|Overall Study|Withdrawal by Subject|4|||
37631453|NCT00157014|69097762|FG000|Overall Study|Death|4|||
37631454|NCT00157014|69097763|FG001|Overall Study|Death|2|||
37631455|NCT00157014|69097764|FG002|Overall Study|Death|1|||
37631456|NCT00157014|69097765|FG003|Overall Study|Death|1|||
37631457|NCT00157014|69097762|FG000|Overall Study|Physician Decision|0|||
37631458|NCT00157014|69097763|FG001|Overall Study|Physician Decision|1|||
37631459|NCT00157014|69097764|FG002|Overall Study|Physician Decision|0|||
37631460|NCT00157014|69097765|FG003|Overall Study|Physician Decision|0|||
37631461|NCT00157014|69097762|FG000|Overall Study|Medications withdrawn on family request|0|||
37631462|NCT00157014|69097763|FG001|Overall Study|Medications withdrawn on family request|1|||
37631463|NCT00157014|69097764|FG002|Overall Study|Medications withdrawn on family request|0|||
37631464|NCT00157014|69097765|FG003|Overall Study|Medications withdrawn on family request|0|||
37631465|NCT00157014|69097762|FG000|Overall Study|Patient withdrawn by investigator|1|||
37631466|NCT00157014|69097763|FG001|Overall Study|Patient withdrawn by investigator|0|||
37631467|NCT00157014|69097764|FG002|Overall Study|Patient withdrawn by investigator|0|||
37631468|NCT00157014|69097765|FG003|Overall Study|Patient withdrawn by investigator|0|||
37631469|NCT00157014|69097762|FG000|Overall Study|Patient unable to return in nursing home|1|||
37631470|NCT00157014|69097763|FG001|Overall Study|Patient unable to return in nursing home|0|||
37631471|NCT00157014|69097764|FG002|Overall Study|Patient unable to return in nursing home|0|||
37631472|NCT00157014|69097765|FG003|Overall Study|Patient unable to return in nursing home|0|||
37631473|NCT00157014|69097762|FG000|Overall Study|Patient would not receive transplant|0|||
37631474|NCT00157014|69097763|FG001|Overall Study|Patient would not receive transplant|1|||
37631475|NCT00157014|69097764|FG002|Overall Study|Patient would not receive transplant|0|||
37631476|NCT00157014|69097765|FG003|Overall Study|Patient would not receive transplant|0|||
37631477|NCT00157014|69097762|FG000|Overall Study|Withdrawal by Subject|1|||
37631478|NCT00157014|69097763|FG001|Overall Study|Withdrawal by Subject|0|||
37631479|NCT00157014|69097764|FG002|Overall Study|Withdrawal by Subject|0|||
37631480|NCT00157014|69097765|FG003|Overall Study|Withdrawal by Subject|0|||
37631481|NCT02778867|69097777|FG000|Phase 1|Withdrawal by Subject|2|||
37631482|NCT02778867|69097778|FG001|Phase 1|Withdrawal by Subject|3|||
37631483|NCT02778867|69097779|FG002|Phase 1|Withdrawal by Subject|0|||
37631484|NCT02778867|69097780|FG003|Phase 1|Withdrawal by Subject|0|||
37631485|NCT02778867|69097777|FG000|Phase 2|Withdrawal by Subject|0|||
37631486|NCT02778867|69097778|FG001|Phase 2|Withdrawal by Subject|0|||
37631487|NCT02778867|69097779|FG002|Phase 2|Withdrawal by Subject|1|||
37631488|NCT02778867|69097780|FG003|Phase 2|Withdrawal by Subject|0|||
37631489|NCT02778867|69097777|FG000|Phase 2|Physician Decision|0|||
37631490|NCT02778867|69097778|FG001|Phase 2|Physician Decision|0|||
37631491|NCT02778867|69097779|FG002|Phase 2|Physician Decision|0|||
37631492|NCT02778867|69097780|FG003|Phase 2|Physician Decision|1|||
37631493|NCT02778867|69097777|FG000|Phase 2|Adverse Event|0|||
37631494|NCT02778867|69097778|FG001|Phase 2|Adverse Event|0|||
37631495|NCT02778867|69097779|FG002|Phase 2|Adverse Event|0|||
37631496|NCT02778867|69097780|FG003|Phase 2|Adverse Event|1|||
37631497|NCT02778555|69097793|FG000|Overall Study|Withdrawal by Subject|55|||
37631498|NCT02778555|69097794|FG001|Overall Study|Withdrawal by Subject|32|||
37631499|NCT02778555|69097795|FG002|Overall Study|Withdrawal by Subject|107|||
37631500|NCT02778399|69097809|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
37631501|NCT02778399|69097810|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
37631502|NCT02778399|69097811|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
37631503|NCT02778399|69097812|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
37631504|NCT02778399|69097813|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
37631505|NCT02778399|69097814|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
37631506|NCT02778399|69097809|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
37631507|NCT02778399|69097810|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
37631508|NCT02778399|69097811|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
37631509|NCT02778399|69097812|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
37631510|NCT02778399|69097813|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
37631511|NCT02778399|69097814|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
37631512|NCT02778399|69097809|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
37631513|NCT02778399|69097810|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
37631514|NCT02778399|69097811|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
37631515|NCT02778399|69097812|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
37631516|NCT02778399|69097813|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
37631517|NCT02778399|69097814|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
37631518|NCT02778399|69097809|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
37631519|NCT02778399|69097810|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
37631520|NCT02778399|69097811|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
37631521|NCT02778399|69097812|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
37631522|NCT02778399|69097813|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
37631523|NCT02778399|69097814|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
37631524|NCT02778399|69097809|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
37631525|NCT02778399|69097810|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
37631526|NCT02778399|69097811|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
37738271|NCT01790126|69220836|FG000|Overall Study|PSA Progression|12|||
37631527|NCT02778399|69097812|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
37631528|NCT02778399|69097813|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
37631529|NCT02778399|69097814|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
37631530|NCT02778399|69097809|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
37631531|NCT02778399|69097810|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
37631532|NCT02778399|69097811|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
37631533|NCT02778399|69097812|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
37631534|NCT02778399|69097813|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
37631535|NCT02778399|69097814|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
37631536|NCT02778399|69097809|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
37631537|NCT02778399|69097810|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
37631538|NCT02778399|69097811|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
37631539|NCT02778399|69097812|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
37631540|NCT02778399|69097813|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
37631541|NCT02778399|69097814|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
37631542|NCT02778399|69097809|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
37631543|NCT02778399|69097810|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
37631544|NCT02778399|69097811|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
37631545|NCT02778399|69097812|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
37631546|NCT02778399|69097813|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
37631547|NCT02778399|69097814|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
37631548|NCT02778399|69097809|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
37631549|NCT02778399|69097810|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
37631550|NCT02778399|69097811|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
37631551|NCT02778399|69097812|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
37631552|NCT02778399|69097813|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
37631553|NCT02778399|69097814|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
37631554|NCT02778399|69097809|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
37631555|NCT02778399|69097810|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
37631556|NCT02778399|69097811|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
37631557|NCT02778399|69097812|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
37631558|NCT02778399|69097813|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
37631559|NCT02778399|69097814|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
37631560|NCT02778399|69097809|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
37631561|NCT02778399|69097810|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
37631562|NCT02778399|69097811|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
37631563|NCT02778399|69097812|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
37631564|NCT02778399|69097813|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
37631565|NCT02778399|69097814|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
37631566|NCT03656744|69097863|FG000|Overall Study|Adverse Event|1|||
37631567|NCT03656744|69097864|FG001|Overall Study|Adverse Event|4|||
37631568|NCT03656744|69097865|FG002|Overall Study|Adverse Event|1|||
37631569|NCT03656744|69097863|FG000|Overall Study|Protocol Violation|1|||
37631570|NCT03656744|69097864|FG001|Overall Study|Protocol Violation|0|||
37631571|NCT03656744|69097865|FG002|Overall Study|Protocol Violation|0|||
37631572|NCT03656744|69097863|FG000|Overall Study|Lost to Follow-up|2|||
37631573|NCT03656744|69097864|FG001|Overall Study|Lost to Follow-up|2|||
37631574|NCT03656744|69097865|FG002|Overall Study|Lost to Follow-up|0|||
37631575|NCT03656744|69097863|FG000|Overall Study|Withdrawal by Subject|0|||
37631576|NCT03656744|69097864|FG001|Overall Study|Withdrawal by Subject|1|||
37631577|NCT03656744|69097865|FG002|Overall Study|Withdrawal by Subject|0|||
37631578|NCT03656744|69097863|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
37631579|NCT03656744|69097864|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
37631580|NCT03656744|69097865|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
37631581|NCT02739360|69097873|FG000|Overall Study|Adverse Event|1|||
37631582|NCT02739360|69097873|FG000|Overall Study|Study terminated by Sponsor|2|||
37631583|NCT01822522|69097883|FG000|Overall Study|Adverse Event|1|||
37631584|NCT01822522|69097884|FG001|Overall Study|Adverse Event|1|||
37631585|NCT01822522|69097885|FG002|Overall Study|Adverse Event|1|||
37631586|NCT01822522|69097886|FG003|Overall Study|Adverse Event|0|||
37631587|NCT01822522|69097887|FG004|Overall Study|Adverse Event|0|||
37631588|NCT01822522|69097888|FG005|Overall Study|Adverse Event|1|||
37631589|NCT01822522|69097883|FG000|Overall Study|Death|3|||
37631590|NCT01822522|69097884|FG001|Overall Study|Death|0|||
37631591|NCT01822522|69097885|FG002|Overall Study|Death|2|||
37631592|NCT01822522|69097886|FG003|Overall Study|Death|0|||
37631593|NCT01822522|69097887|FG004|Overall Study|Death|0|||
37921698|NCT00820950|69608463|FG006|Overall Study|Scheduling Conflict|1|||
38031855|NCT03351608|69717633|FG001|Overall Study|Physician Decision|0|||
38031856|NCT03351608|69717634|FG002|Overall Study|Physician Decision|0|||
37738272|NCT01790126|69220837|FG001|Overall Study|PSA Progression|16|||
37738273|NCT01790126|69220838|FG002|Overall Study|PSA Progression|16|||
37738274|NCT01790126|69220836|FG000|Overall Study|Other|5|||
37738275|NCT01790126|69220837|FG001|Overall Study|Other|4|||
37738276|NCT01790126|69220838|FG002|Overall Study|Other|8|||
37738277|NCT01790126|69220836|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
37738278|NCT01790126|69220837|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
37738279|NCT01790126|69220838|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
37738280|NCT01790126|69220836|FG000|Overall Study|Withdrawal by Physician|1|||
37738281|NCT01790126|69220837|FG001|Overall Study|Withdrawal by Physician|1|||
37738282|NCT01790126|69220838|FG002|Overall Study|Withdrawal by Physician|2|||
37738283|NCT01790126|69220836|FG000|Overall Study|Withdrawal by Subject|3|||
37853256|NCT02754596|69537156|FG001|Overall Study|Lost to Follow-up|1|||
37853257|NCT02754596|69537157|FG002|Overall Study|Lost to Follow-up|2|||
37853258|NCT02754596|69537155|FG000|Overall Study|Death|0|||
37631594|NCT01822522|69097888|FG005|Overall Study|Death|0|||
37738284|NCT01790126|69220837|FG001|Overall Study|Withdrawal by Subject|1|||
37738285|NCT01790126|69220838|FG002|Overall Study|Withdrawal by Subject|2|||
37738286|NCT01790126|69220836|FG000|Overall Study|Lost to Follow-up|1|||
37738287|NCT01790126|69220837|FG001|Overall Study|Lost to Follow-up|0|||
37738288|NCT01790126|69220838|FG002|Overall Study|Lost to Follow-up|1|||
37738289|NCT01790126|69220836|FG000|Overall Study|Adverse Event|0|||
37738290|NCT01790126|69220837|FG001|Overall Study|Adverse Event|2|||
37738291|NCT01790126|69220838|FG002|Overall Study|Adverse Event|0|||
37738292|NCT01790126|69220836|FG000|Overall Study|Death|2|||
37738293|NCT01790126|69220837|FG001|Overall Study|Death|0|||
37738294|NCT01790126|69220838|FG002|Overall Study|Death|0|||
37738295|NCT01790126|69220836|FG000|Overall Study|Radiographic Progression|3|||
37738296|NCT01790126|69220837|FG001|Overall Study|Radiographic Progression|1|||
37738297|NCT01790126|69220838|FG002|Overall Study|Radiographic Progression|0|||
37738298|NCT01734902|69220849|FG000|Overall Study|Other than listed|0|||
37738299|NCT01734902|69220850|FG001|Overall Study|Other than listed|2|||
37738300|NCT01790048|69220858|FG000|Overall Study|Incorrect Age|9|||
37738301|NCT01790048|69220859|FG001|Overall Study|Incorrect Age|14|||
37738302|NCT01790048|69220858|FG000|Overall Study|data entry error|0|||
37738303|NCT01790048|69220859|FG001|Overall Study|data entry error|1|||
37738304|NCT01790048|69220858|FG000|Overall Study|Other|0|||
37738305|NCT01790048|69220859|FG001|Overall Study|Other|2|||
37738306|NCT01790048|69220858|FG000|Overall Study|SAM at Enrollment|2|||
37738307|NCT01790048|69220859|FG001|Overall Study|SAM at Enrollment|0|||
37738308|NCT01790048|69220858|FG000|Overall Study|Measurement error|1|||
37738309|NCT01790048|69220859|FG001|Overall Study|Measurement error|0|||
37738310|NCT01789970|69220869|FG000|Open-label Titration Period|Adverse Event|68|||
37738311|NCT01789970|69220870|FG001|Open-label Titration Period|Adverse Event|0|||
37738312|NCT01789970|69220871|FG002|Open-label Titration Period|Adverse Event|0|||
37738313|NCT01789970|69220869|FG000|Open-label Titration Period|Lack of Efficacy|31|||
37738314|NCT01789970|69220870|FG001|Open-label Titration Period|Lack of Efficacy|0|||
37738315|NCT01789970|69220871|FG002|Open-label Titration Period|Lack of Efficacy|0|||
37738316|NCT01789970|69220869|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
37853259|NCT02754596|69537156|FG001|Overall Study|Death|2|||
37853260|NCT02754596|69537157|FG002|Overall Study|Death|0|||
37631595|NCT01822522|69097883|FG000|Overall Study|Lost to Follow-up|0|||
37631596|NCT01822522|69097884|FG001|Overall Study|Lost to Follow-up|0|||
37631597|NCT01822522|69097885|FG002|Overall Study|Lost to Follow-up|1|||
37631598|NCT01822522|69097886|FG003|Overall Study|Lost to Follow-up|1|||
37631599|NCT01822522|69097887|FG004|Overall Study|Lost to Follow-up|0|||
37631600|NCT01822522|69097888|FG005|Overall Study|Lost to Follow-up|1|||
37631601|NCT01822522|69097883|FG000|Overall Study|Withdrawal by Subject|0|||
37631602|NCT01822522|69097884|FG001|Overall Study|Withdrawal by Subject|0|||
37631603|NCT01822522|69097885|FG002|Overall Study|Withdrawal by Subject|0|||
37631604|NCT01822522|69097886|FG003|Overall Study|Withdrawal by Subject|1|||
37631605|NCT01822522|69097887|FG004|Overall Study|Withdrawal by Subject|0|||
37738317|NCT01789970|69220870|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
37738318|NCT01789970|69220871|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
37738319|NCT01789970|69220869|FG000|Open-label Titration Period|Protocol Violation|18|||
37738320|NCT01789970|69220870|FG001|Open-label Titration Period|Protocol Violation|0|||
37738321|NCT01789970|69220871|FG002|Open-label Titration Period|Protocol Violation|0|||
37738322|NCT01789970|69220869|FG000|Open-label Titration Period|Lost to Follow-up|5|||
37738323|NCT01789970|69220870|FG001|Open-label Titration Period|Lost to Follow-up|0|||
37853261|NCT02754596|69537155|FG000|Overall Study|Adverse Event|1|||
37631606|NCT01822522|69097888|FG005|Overall Study|Withdrawal by Subject|0|||
37631607|NCT01822522|69097883|FG000|Overall Study|Lack of Efficacy|0|||
37738324|NCT01789970|69220871|FG002|Open-label Titration Period|Lost to Follow-up|0|||
37738325|NCT01789970|69220869|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
37738326|NCT01789970|69220870|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
37853262|NCT02754596|69537156|FG001|Overall Study|Adverse Event|0|||
37853263|NCT02754596|69537157|FG002|Overall Study|Adverse Event|1|||
37631608|NCT01822522|69097884|FG001|Overall Study|Lack of Efficacy|0|||
37631609|NCT01822522|69097885|FG002|Overall Study|Lack of Efficacy|0|||
37921699|NCT00820950|69608464|FG007|Overall Study|Scheduling Conflict|1|||
37921700|NCT00820950|69608465|FG008|Overall Study|Scheduling Conflict|0|||
37921701|NCT00820950|69608466|FG009|Overall Study|Scheduling Conflict|0|||
37921702|NCT00820950|69608457|FG000|Overall Study|Protocol Violation|1|||
37631610|NCT01822522|69097886|FG003|Overall Study|Lack of Efficacy|0|||
37631611|NCT01822522|69097887|FG004|Overall Study|Lack of Efficacy|0|||
37631612|NCT01822522|69097888|FG005|Overall Study|Lack of Efficacy|2|||
37631613|NCT00102687|69097932|FG000|Initial Period|Withdrawal by Subject|6|||
37631614|NCT00102687|69097933|FG001|Initial Period|Withdrawal by Subject|3|||
37631615|NCT00102687|69097934|FG002|Initial Period|Withdrawal by Subject|5|||
37631616|NCT00102687|69097935|FG003|Initial Period|Withdrawal by Subject|0|||
37631617|NCT00102687|69097936|FG004|Initial Period|Withdrawal by Subject|0|||
37631618|NCT00102687|69097932|FG000|Initial Period|Adverse Event|4|||
37631619|NCT00102687|69097933|FG001|Initial Period|Adverse Event|7|||
37631620|NCT00102687|69097934|FG002|Initial Period|Adverse Event|9|||
37631621|NCT00102687|69097935|FG003|Initial Period|Adverse Event|0|||
37631622|NCT00102687|69097936|FG004|Initial Period|Adverse Event|0|||
37631623|NCT00102687|69097932|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
37631624|NCT00102687|69097933|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
37631625|NCT00102687|69097934|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
37631626|NCT00102687|69097935|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
37631627|NCT00102687|69097936|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
37738327|NCT01789970|69220871|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
37738328|NCT01789970|69220869|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
37738329|NCT01789970|69220870|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
37738330|NCT01789970|69220871|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
37738331|NCT01789970|69220869|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
37738332|NCT01789970|69220870|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
37738333|NCT01789970|69220871|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
37738334|NCT01789970|69220869|FG000|Open-label Titration Period|Pregnancy|2|||
37738335|NCT01789970|69220870|FG001|Open-label Titration Period|Pregnancy|0|||
37738336|NCT01789970|69220871|FG002|Open-label Titration Period|Pregnancy|0|||
37738337|NCT01789970|69220869|FG000|Open-label Titration Period|Other|76|||
37738338|NCT01789970|69220870|FG001|Open-label Titration Period|Other|0|||
37738339|NCT01789970|69220871|FG002|Open-label Titration Period|Other|0|||
37738340|NCT01789970|69220869|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
37738341|NCT01789970|69220870|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
37738342|NCT01789970|69220871|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
37738343|NCT01789970|69220869|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
37738344|NCT01789970|69220870|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
37738345|NCT01789970|69220871|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
37738346|NCT01789970|69220869|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
37738347|NCT01789970|69220870|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
37738348|NCT01789970|69220871|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
37738349|NCT01789970|69220869|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
37738350|NCT01789970|69220870|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
37738351|NCT01789970|69220871|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
37738352|NCT01789970|69220869|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
37738353|NCT01789970|69220870|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
37738354|NCT01789970|69220871|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
37738355|NCT01789970|69220869|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
37738356|NCT01789970|69220870|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
37738357|NCT01789970|69220871|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
37738358|NCT01789970|69220869|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
37738359|NCT01789970|69220870|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
37738360|NCT01789970|69220871|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
37738361|NCT01789970|69220869|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
37738362|NCT01789970|69220870|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
37738363|NCT01789970|69220871|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
37738364|NCT01789970|69220869|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
37738365|NCT01789970|69220870|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
37738366|NCT01789970|69220871|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
37921703|NCT00820950|69608458|FG001|Overall Study|Protocol Violation|1|||
37631628|NCT00102687|69097932|FG000|Initial Period|Protocol Violation|0|||
37631629|NCT00102687|69097933|FG001|Initial Period|Protocol Violation|0|||
37631630|NCT00102687|69097934|FG002|Initial Period|Protocol Violation|2|||
37631631|NCT00102687|69097935|FG003|Initial Period|Protocol Violation|0|||
37631632|NCT00102687|69097936|FG004|Initial Period|Protocol Violation|0|||
37631633|NCT00102687|69097932|FG000|Initial Period|Physician Decision|2|||
37631634|NCT00102687|69097933|FG001|Initial Period|Physician Decision|9|||
37738367|NCT01789970|69220869|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
37738368|NCT01789970|69220870|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
37738369|NCT01789970|69220871|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
37738370|NCT01789970|69220869|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
37738371|NCT01789970|69220870|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
37738372|NCT01789970|69220871|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
37738373|NCT01734434|69220889|FG000|Overall Study|Death Infant|3|||
37738374|NCT01734434|69220890|FG001|Overall Study|Death Infant|1|||
37738375|NCT01734434|69220891|FG002|Overall Study|Death Infant|17|||
37738376|NCT01734434|69220892|FG003|Overall Study|Death Infant|5|||
37738377|NCT01734434|69220889|FG000|Overall Study|Lost to Follow-up|2|||
37738378|NCT01734434|69220890|FG001|Overall Study|Lost to Follow-up|9|||
37738379|NCT01734434|69220891|FG002|Overall Study|Lost to Follow-up|67|||
37738380|NCT01734434|69220892|FG003|Overall Study|Lost to Follow-up|11|||
37738381|NCT01734434|69220889|FG000|Overall Study|No Live Birth|1|||
37738382|NCT01734434|69220890|FG001|Overall Study|No Live Birth|2|||
37738383|NCT01734434|69220891|FG002|Overall Study|No Live Birth|32|||
37738384|NCT01734434|69220892|FG003|Overall Study|No Live Birth|6|||
37738385|NCT01734434|69220889|FG000|Overall Study|Withdrawal by Subject|4|||
37738386|NCT01734434|69220890|FG001|Overall Study|Withdrawal by Subject|0|||
37738387|NCT01734434|69220891|FG002|Overall Study|Withdrawal by Subject|8|||
37738388|NCT01734434|69220892|FG003|Overall Study|Withdrawal by Subject|1|||
37738389|NCT01734434|69220889|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
37738390|NCT01734434|69220890|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
37738391|NCT01734434|69220891|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
37738392|NCT01734434|69220892|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
37738393|NCT01734434|69220889|FG000|Overall Study|Subject Not Reachable|0|||
37738394|NCT01734434|69220890|FG001|Overall Study|Subject Not Reachable|0|||
37738395|NCT01734434|69220891|FG002|Overall Study|Subject Not Reachable|1|||
37738396|NCT01734434|69220892|FG003|Overall Study|Subject Not Reachable|0|||
37738397|NCT01734434|69220889|FG000|Overall Study|Treatment Defaulter|0|||
37738398|NCT01734434|69220890|FG001|Overall Study|Treatment Defaulter|0|||
37738399|NCT01734434|69220891|FG002|Overall Study|Treatment Defaulter|1|||
37738400|NCT01734434|69220892|FG003|Overall Study|Treatment Defaulter|0|||
37738401|NCT01734434|69220889|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
37738402|NCT01734434|69220890|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
37738403|NCT01734434|69220891|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
37738404|NCT01734434|69220892|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
37738405|NCT01734434|69220889|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
37738406|NCT01734434|69220890|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
37738407|NCT01734434|69220891|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
37738408|NCT01734434|69220892|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
37738409|NCT01788566|69220910|FG000|Overall Study|Death|4|||
37738410|NCT01788566|69220910|FG000|Overall Study|Adverse Event|1|||
37738411|NCT01788566|69220910|FG000|Overall Study|Clinical Progressive Disease|3|||
37738412|NCT01733732|69220916|FG000|Overall Study|Adverse Event|1|||
37738413|NCT01733732|69220917|FG001|Overall Study|Adverse Event|0|||
37738414|NCT01733732|69220916|FG000|Overall Study|Did not attend all study visits|1|||
37738415|NCT01733732|69220917|FG001|Overall Study|Did not attend all study visits|0|||
37738416|NCT01732874|69220935|FG000|Overall Study|Withdrawal by Subject|5|||
37738417|NCT01732874|69220936|FG001|Overall Study|Withdrawal by Subject|1|||
37738418|NCT01732874|69220935|FG000|Overall Study|Death of Infant|3|||
37738419|NCT01732874|69220936|FG001|Overall Study|Death of Infant|2|||
37738420|NCT01732796|69220945|FG000|Overall Study|Adverse Event|16|||
37738421|NCT01732796|69220946|FG001|Overall Study|Adverse Event|16|||
37631635|NCT00102687|69097934|FG002|Initial Period|Physician Decision|6|||
37631636|NCT00102687|69097935|FG003|Initial Period|Physician Decision|0|||
37631637|NCT00102687|69097936|FG004|Initial Period|Physician Decision|0|||
37631638|NCT00102687|69097932|FG000|Initial Period|Sponsor's decision|0|||
37631639|NCT00102687|69097933|FG001|Initial Period|Sponsor's decision|1|||
37631640|NCT00102687|69097934|FG002|Initial Period|Sponsor's decision|1|||
37631641|NCT00102687|69097935|FG003|Initial Period|Sponsor's decision|0|||
37631642|NCT00102687|69097936|FG004|Initial Period|Sponsor's decision|0|||
37631643|NCT00102687|69097932|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
37738422|NCT01732796|69220947|FG002|Overall Study|Adverse Event|4|||
37738423|NCT01732796|69220945|FG000|Overall Study|Lack of Efficacy|21|||
37738424|NCT01732796|69220946|FG001|Overall Study|Lack of Efficacy|18|||
37738425|NCT01732796|69220947|FG002|Overall Study|Lack of Efficacy|5|||
37738426|NCT01732796|69220945|FG000|Overall Study|Lost to Follow-up|2|||
37738427|NCT01732796|69220946|FG001|Overall Study|Lost to Follow-up|0|||
37738428|NCT01732796|69220947|FG002|Overall Study|Lost to Follow-up|0|||
37631644|NCT00102687|69097933|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
37631645|NCT00102687|69097934|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
37631646|NCT00102687|69097935|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
37631647|NCT00102687|69097936|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
37631648|NCT00102687|69097932|FG000|Initial Period|Death|1|||
37631649|NCT00102687|69097933|FG001|Initial Period|Death|1|||
37631650|NCT00102687|69097934|FG002|Initial Period|Death|1|||
37631651|NCT00102687|69097935|FG003|Initial Period|Death|0|||
37631652|NCT00102687|69097936|FG004|Initial Period|Death|0|||
37631653|NCT00102687|69097932|FG000|Maintenance Period|Withdrawal by Subject|4|||
37631654|NCT00102687|69097933|FG001|Maintenance Period|Withdrawal by Subject|0|||
37631655|NCT00102687|69097934|FG002|Maintenance Period|Withdrawal by Subject|2|||
37631656|NCT00102687|69097935|FG003|Maintenance Period|Withdrawal by Subject|3|||
37631657|NCT00102687|69097936|FG004|Maintenance Period|Withdrawal by Subject|1|||
37631658|NCT00102687|69097932|FG000|Maintenance Period|Adverse Event|1|||
37853264|NCT02754596|69537155|FG000|Overall Study|Other|1|||
37853265|NCT02754596|69537156|FG001|Overall Study|Other|0|||
37853266|NCT02754596|69537157|FG002|Overall Study|Other|0|||
37631659|NCT00102687|69097933|FG001|Maintenance Period|Adverse Event|0|||
37631660|NCT00102687|69097934|FG002|Maintenance Period|Adverse Event|0|||
37631661|NCT00102687|69097935|FG003|Maintenance Period|Adverse Event|1|||
37631662|NCT00102687|69097936|FG004|Maintenance Period|Adverse Event|3|||
37631663|NCT00102687|69097932|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
37631664|NCT00102687|69097933|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
37631665|NCT00102687|69097934|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
37631666|NCT00102687|69097935|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
37631667|NCT00102687|69097936|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
37631668|NCT00102687|69097932|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
37631669|NCT00102687|69097933|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
37738429|NCT01732796|69220945|FG000|Overall Study|Withdrawal by Subject|6|||
37738430|NCT01732796|69220946|FG001|Overall Study|Withdrawal by Subject|8|||
37738431|NCT01732796|69220947|FG002|Overall Study|Withdrawal by Subject|2|||
37631670|NCT00102687|69097934|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
37631671|NCT00102687|69097935|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
37738432|NCT01732796|69220945|FG000|Overall Study|Other reason not defined above|1|||
37738433|NCT01732796|69220946|FG001|Overall Study|Other reason not defined above|0|||
37738434|NCT01732796|69220947|FG002|Overall Study|Other reason not defined above|2|||
37738435|NCT01732640|69220957|FG000|Overall Study|Adverse Event|0|||
37738436|NCT01732640|69220958|FG001|Overall Study|Adverse Event|1|||
37738437|NCT01732640|69220957|FG000|Overall Study|Death|0|||
37738438|NCT01732640|69220958|FG001|Overall Study|Death|1|||
37738439|NCT01732484|69220968|FG000|Overall Study|Death|7|||
37738440|NCT01732484|69220968|FG000|Overall Study|Lost to Follow-up|14|||
37738441|NCT01732484|69220968|FG000|Overall Study|chronical illness|5|||
37738442|NCT01786148|69220976|FG000|Overall Study|Lost to Follow-up|21|||
37738443|NCT01786148|69220977|FG001|Overall Study|Lost to Follow-up|13|||
37738444|NCT01786148|69220976|FG000|Overall Study|Death|0|||
37738445|NCT01786148|69220977|FG001|Overall Study|Death|1|||
37738446|NCT01786148|69220976|FG000|Overall Study|Withdrawal by Subject|0|||
37738447|NCT01786148|69220977|FG001|Overall Study|Withdrawal by Subject|7|||
37738448|NCT01786148|69220976|FG000|Overall Study|Incarceration|1|||
37738449|NCT01786148|69220977|FG001|Overall Study|Incarceration|1|||
37738450|NCT01785602|69220989|FG000|Overall Study|Withdrawal by Subject|2|||
37738451|NCT01785602|69220990|FG001|Overall Study|Withdrawal by Subject|0|||
37738452|NCT01785602|69220989|FG000|Overall Study|Lost to Follow-up|1|||
37738453|NCT01785602|69220990|FG001|Overall Study|Lost to Follow-up|1|||
37738454|NCT01785602|69220989|FG000|Overall Study|Adverse Event|3|||
37738455|NCT01785602|69220990|FG001|Overall Study|Adverse Event|5|||
37853267|NCT02744898|69537165|FG000|Overall Study|Progressive Disease|2|||
37853268|NCT02744898|69537165|FG000|Overall Study|Physician Decision|1|||
37853269|NCT02744898|69537165|FG000|Overall Study|Toxicity|1|||
37853270|NCT02095132|69537178|FG000|Overall Study|Adverse Event|0|||
37853271|NCT02095132|69537179|FG001|Overall Study|Adverse Event|0|||
37853272|NCT02095132|69537180|FG002|Overall Study|Adverse Event|0|||
37853273|NCT02095132|69537181|FG003|Overall Study|Adverse Event|0|||
37853274|NCT02095132|69537182|FG004|Overall Study|Adverse Event|1|||
37853275|NCT02095132|69537183|FG005|Overall Study|Adverse Event|0|||
37853276|NCT02095132|69537184|FG006|Overall Study|Adverse Event|1|||
37631672|NCT00102687|69097936|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
37631673|NCT00102687|69097932|FG000|Maintenance Period|Death|0|||
37738456|NCT01785602|69220989|FG000|Overall Study|Administrative problems|7|||
37738457|NCT01785602|69220990|FG001|Overall Study|Administrative problems|3|||
37738458|NCT01785524|69220998|FG000|Overall Study|Withdrawal by Subject|2|||
37738459|NCT01785524|69220999|FG001|Overall Study|Withdrawal by Subject|2|||
37738460|NCT01757288|69221008|FG000|Overall Study|Consent withdrawal|0|||
37853277|NCT02095132|69537185|FG007|Overall Study|Adverse Event|0|||
37853278|NCT02095132|69537186|FG008|Overall Study|Adverse Event|0|||
37853279|NCT02095132|69537178|FG000|Overall Study|Death|0|||
37631674|NCT00102687|69097933|FG001|Maintenance Period|Death|0|||
37631675|NCT00102687|69097934|FG002|Maintenance Period|Death|0|||
37631676|NCT00102687|69097935|FG003|Maintenance Period|Death|1|||
37631677|NCT00102687|69097936|FG004|Maintenance Period|Death|1|||
37631678|NCT00102687|69097932|FG000|Maintenance Period|Physician Decision|1|||
37631679|NCT00102687|69097933|FG001|Maintenance Period|Physician Decision|2|||
37631680|NCT00102687|69097934|FG002|Maintenance Period|Physician Decision|3|||
37631681|NCT00102687|69097935|FG003|Maintenance Period|Physician Decision|0|||
37631682|NCT00102687|69097936|FG004|Maintenance Period|Physician Decision|4|||
37631683|NCT00102531|69097954|FG000|Overall Study|Adverse Event|0|||
37631684|NCT00102531|69097955|FG001|Overall Study|Adverse Event|1|||
37631685|NCT00102531|69097954|FG000|Overall Study|Disease Progression|5|||
37631686|NCT00102531|69097955|FG001|Overall Study|Disease Progression|9|||
37631687|NCT00102531|69097954|FG000|Overall Study|Physician Decision|0|||
37631688|NCT00102531|69097955|FG001|Overall Study|Physician Decision|1|||
37631689|NCT02771145|69097961|FG000|Overall Study|Adverse Event|3|||
37631690|NCT02771145|69097961|FG000|Overall Study|Lost to Follow-up|1|||
37631691|NCT02578186|69097981|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
37631692|NCT02578186|69097982|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
37631693|NCT02578186|69097981|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
37631694|NCT02578186|69097982|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
37631695|NCT00103311|69097990|FG000|Overall Study|Lost to Follow-up|1|||
37631696|NCT00103311|69097991|FG001|Overall Study|Lost to Follow-up|0|||
37631697|NCT00103311|69097990|FG000|Overall Study|Withdrawal by Subject|2|||
37631698|NCT00103311|69097991|FG001|Overall Study|Withdrawal by Subject|1|||
37631699|NCT00103311|69097990|FG000|Overall Study|Adverse Event|1|||
37631700|NCT00103311|69097991|FG001|Overall Study|Adverse Event|0|||
37631701|NCT02576938|69098004|FG000|Overall Study|Adverse Event|5|||
37631702|NCT02576938|69098005|FG001|Overall Study|Adverse Event|3|||
37631703|NCT02576938|69098006|FG002|Overall Study|Adverse Event|6|||
37631704|NCT02576938|69098004|FG000|Overall Study|Protocol Violation|1|||
37631705|NCT02576938|69098005|FG001|Overall Study|Protocol Violation|1|||
37631706|NCT02576938|69098006|FG002|Overall Study|Protocol Violation|1|||
37631707|NCT02576938|69098004|FG000|Overall Study|Withdrawal by Subject|3|||
37631708|NCT02576938|69098005|FG001|Overall Study|Withdrawal by Subject|2|||
37631709|NCT02576938|69098006|FG002|Overall Study|Withdrawal by Subject|4|||
37631710|NCT02576938|69098004|FG000|Overall Study|Lack of Efficacy|9|||
37631711|NCT02576938|69098005|FG001|Overall Study|Lack of Efficacy|4|||
37631712|NCT02576938|69098006|FG002|Overall Study|Lack of Efficacy|0|||
37631713|NCT02576938|69098004|FG000|Overall Study|Lost to Follow-up|2|||
37631714|NCT02576938|69098005|FG001|Overall Study|Lost to Follow-up|0|||
37631715|NCT02576938|69098006|FG002|Overall Study|Lost to Follow-up|1|||
37631716|NCT02576938|69098004|FG000|Overall Study|Physician Decision|0|||
37631717|NCT02576938|69098005|FG001|Overall Study|Physician Decision|1|||
37631718|NCT02576938|69098006|FG002|Overall Study|Physician Decision|0|||
37631719|NCT02576938|69098004|FG000|Overall Study|Met Exclusion Criteria|0|||
37631720|NCT02576938|69098005|FG001|Overall Study|Met Exclusion Criteria|1|||
37631721|NCT02576938|69098006|FG002|Overall Study|Met Exclusion Criteria|0|||
37631722|NCT02576860|69098018|FG000|Overall Study|Adverse Event|6|||
37631723|NCT02576860|69098019|FG001|Overall Study|Adverse Event|6|||
37631724|NCT02576860|69098018|FG000|Overall Study|Lost to Follow-up|5|||
37631725|NCT02576860|69098019|FG001|Overall Study|Lost to Follow-up|7|||
37631726|NCT02576860|69098018|FG000|Overall Study|Physician Decision|0|||
37631727|NCT02576860|69098019|FG001|Overall Study|Physician Decision|1|||
37631728|NCT02576860|69098018|FG000|Overall Study|Protocol Violation|0|||
37631729|NCT02576860|69098019|FG001|Overall Study|Protocol Violation|2|||
37853280|NCT02095132|69537179|FG001|Overall Study|Death|0|||
37853281|NCT02095132|69537180|FG002|Overall Study|Death|0|||
37853282|NCT02095132|69537181|FG003|Overall Study|Death|0|||
37853283|NCT02095132|69537182|FG004|Overall Study|Death|0|||
37853284|NCT02095132|69537183|FG005|Overall Study|Death|0|||
37631730|NCT02576860|69098018|FG000|Overall Study|Withdrawal by Subject|13|||
37631731|NCT02576860|69098019|FG001|Overall Study|Withdrawal by Subject|8|||
37631732|NCT02576860|69098018|FG000|Overall Study|Disallowed medication|1|||
37631733|NCT02576860|69098019|FG001|Overall Study|Disallowed medication|0|||
37631734|NCT02572570|69098026|FG000|Overall Study|Study Terminated|27|||
37631735|NCT00709202|69098035|FG000|Overall Study|Withdrawal by Subject|6|||
37631736|NCT00709202|69098036|FG001|Overall Study|Withdrawal by Subject|6|||
37631737|NCT00709124|69098045|FG000|Overall Study|Death|3|||
37631738|NCT00709124|69098046|FG001|Overall Study|Death|1|||
37631739|NCT00709124|69098045|FG000|Overall Study|encephalopathy; can't do assessment|1|||
37631740|NCT00709124|69098046|FG001|Overall Study|encephalopathy; can't do assessment|0|||
37853285|NCT02095132|69537184|FG006|Overall Study|Death|1|||
37631741|NCT02738580|69098058|FG000|Overall Study|Adverse Event|1|||
37631742|NCT02738580|69098059|FG001|Overall Study|Adverse Event|0|||
37631743|NCT02738580|69098058|FG000|Overall Study|Lack of Efficacy|3|||
37631744|NCT02738580|69098059|FG001|Overall Study|Lack of Efficacy|2|||
37853286|NCT02095132|69537185|FG007|Overall Study|Death|0|||
37853287|NCT02095132|69537186|FG008|Overall Study|Death|0|||
37631745|NCT02738580|69098058|FG000|Overall Study|Withdrawal by Subject|0|||
37631746|NCT02738580|69098059|FG001|Overall Study|Withdrawal by Subject|1|||
37631747|NCT02738580|69098058|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
37631748|NCT02738580|69098059|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
37631749|NCT02571244|69098067|FG000|Overall Study|Lost to Follow-up|0|||
37631750|NCT02571244|69098068|FG001|Overall Study|Lost to Follow-up|1|||
37631751|NCT02571244|69098067|FG000|Overall Study|Unable to reach out post discharge|3|||
37631752|NCT02571244|69098068|FG001|Overall Study|Unable to reach out post discharge|0|||
37631753|NCT02573350|69098079|FG000|Overall Study|Lost to Follow-up|2|||
37631754|NCT02573350|69098080|FG001|Overall Study|Lost to Follow-up|1|||
37631755|NCT02573350|69098079|FG000|Overall Study|Adverse Event|3|||
37631756|NCT02573350|69098080|FG001|Overall Study|Adverse Event|4|||
37631757|NCT02573350|69098079|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
37631758|NCT02573350|69098080|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
37631759|NCT02573350|69098079|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
37631760|NCT02573350|69098080|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
37631761|NCT02573350|69098079|FG000|Overall Study|Subject withdrew consent to participate|6|||
37631762|NCT02573350|69098080|FG001|Overall Study|Subject withdrew consent to participate|1|||
37631763|NCT02573350|69098079|FG000|Overall Study|Protocol Deviation|1|||
37631764|NCT02573350|69098080|FG001|Overall Study|Protocol Deviation|1|||
37631765|NCT01376804|69098089|FG000|Treatment Period|Withdrawal by Subject|1|||
37631766|NCT01376804|69098089|FG000|Treatment Period|Adverse Event|6|||
37631767|NCT01376804|69098089|FG000|Treatment Period|Patient did not receive study drug|1|||
37631768|NCT02574520|69098097|FG000|Overall Study|Not dosed|2|||
37631769|NCT02574520|69098098|FG001|Overall Study|Not dosed|0|||
37631770|NCT02574520|69098099|FG002|Overall Study|Not dosed|5|||
37631771|NCT02574520|69098100|FG003|Overall Study|Not dosed|4|||
37631772|NCT02574520|69098097|FG000|Overall Study|Adverse Event|0|||
37631773|NCT02574520|69098098|FG001|Overall Study|Adverse Event|0|||
37631774|NCT02574520|69098099|FG002|Overall Study|Adverse Event|0|||
37631775|NCT02574520|69098100|FG003|Overall Study|Adverse Event|1|||
37631776|NCT02574520|69098097|FG000|Overall Study|Withdrawal by Subject|0|||
37631777|NCT02574520|69098098|FG001|Overall Study|Withdrawal by Subject|0|||
37631778|NCT02574520|69098099|FG002|Overall Study|Withdrawal by Subject|0|||
37631779|NCT02574520|69098100|FG003|Overall Study|Withdrawal by Subject|1|||
37631780|NCT02574520|69098097|FG000|Overall Study|Other|0|||
37631781|NCT02574520|69098098|FG001|Overall Study|Other|0|||
37631782|NCT02574520|69098099|FG002|Overall Study|Other|0|||
37631783|NCT02574520|69098100|FG003|Overall Study|Other|2|||
37631784|NCT00709592|69098112|FG000|Overall Study|Unable to proceed to transplant|0|||
37631785|NCT00709592|69098113|FG001|Overall Study|Unable to proceed to transplant|1|||
37631786|NCT02570152|69098119|FG000|Overall Study|Protocol Violation|2|||
37631787|NCT02570152|69098119|FG000|Overall Study|Migrated/moved from study area|13|||
37631788|NCT02570074|69098125|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
37631789|NCT02570074|69098126|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
37631790|NCT02569996|69098144|FG000|Overall Study|Adverse Event|6|||
37631791|NCT02569996|69098144|FG000|Overall Study|Physician Decision|3|||
37631792|NCT02569996|69098144|FG000|Overall Study|Progression of the disease|18|||
37631793|NCT02569996|69098144|FG000|Overall Study|New anti-lymphoma treatment|1|||
37631794|NCT02569996|69098144|FG000|Overall Study|Non-compliance|9|||
37631795|NCT02569996|69098144|FG000|Overall Study|Withdrawal by Subject|5|||
37631796|NCT02569996|69098144|FG000|Overall Study|Lost to Follow-up|5|||
37631797|NCT02569996|69098144|FG000|Overall Study|Complete remission|7|||
37631798|NCT02569996|69098144|FG000|Overall Study|Unknown reason|1|||
37631799|NCT02572882|69098148|FG000|Overall Study|Withdrawal by Subject|1|||
37631800|NCT02572882|69098148|FG000|Overall Study|Participant received kidney transplant|1|||
37631801|NCT00708500|69098178|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
37631802|NCT00708500|69098179|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
37631803|NCT00708500|69098180|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
37631804|NCT00708500|69098178|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
37631805|NCT00708500|69098179|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
37631806|NCT00708500|69098180|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
37631807|NCT00708500|69098178|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
37631808|NCT00708500|69098179|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
37631809|NCT00708500|69098180|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
37631810|NCT00708500|69098178|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
37921704|NCT00820950|69608459|FG002|Overall Study|Protocol Violation|0|||
37631811|NCT00708500|69098179|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
37921705|NCT00820950|69608460|FG003|Overall Study|Protocol Violation|0|||
37631812|NCT00708500|69098180|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
37631813|NCT00708500|69098178|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
37631814|NCT00708500|69098179|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
37631815|NCT00708500|69098180|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
37631816|NCT00708500|69098178|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
37631817|NCT00708500|69098179|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
37631818|NCT00708500|69098180|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
37631819|NCT00708500|69098178|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
37631820|NCT00708500|69098179|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
37631821|NCT00708500|69098180|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
37631822|NCT00708500|69098178|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
37631823|NCT00708500|69098179|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
37631824|NCT00708500|69098180|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
37631825|NCT00708500|69098178|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
37738461|NCT01757288|69221009|FG001|Overall Study|Consent withdrawal|4|||
37738462|NCT01757288|69221010|FG002|Overall Study|Consent withdrawal|4|||
37738463|NCT01757288|69221008|FG000|Overall Study|Patient off study, IRB hold.|0|||
37738464|NCT01757288|69221009|FG001|Overall Study|Patient off study, IRB hold.|0|||
37738465|NCT01757288|69221010|FG002|Overall Study|Patient off study, IRB hold.|1|||
37738466|NCT01757288|69221008|FG000|Overall Study|Patient death prior to starting treatment|0|||
37738467|NCT01757288|69221009|FG001|Overall Study|Patient death prior to starting treatment|0|||
37738468|NCT01757288|69221010|FG002|Overall Study|Patient death prior to starting treatment|1|||
37738469|NCT01757288|69221008|FG000|Overall Study|Wrong medication administered|0|||
37738470|NCT01757288|69221009|FG001|Overall Study|Wrong medication administered|1|||
37738471|NCT01757288|69221010|FG002|Overall Study|Wrong medication administered|0|||
37738472|NCT01757288|69221008|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
37738473|NCT01757288|69221009|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
37738474|NCT01757288|69221010|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
37631826|NCT00708500|69098179|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
37631827|NCT00708500|69098180|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
37631828|NCT00708500|69098178|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
37631829|NCT00708500|69098179|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
37631830|NCT00708500|69098180|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
37631831|NCT00708500|69098178|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
37631832|NCT00708500|69098179|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
37631833|NCT00708500|69098180|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
37631834|NCT00708500|69098178|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
37631835|NCT00708500|69098179|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
37631836|NCT00708500|69098180|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
37631837|NCT00708500|69098178|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
37631838|NCT00708500|69098179|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
37631839|NCT00708500|69098180|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
37631840|NCT00708500|69098178|FG000|FOLLOWUP|Adverse Event|0|||
37631841|NCT00708500|69098179|FG001|FOLLOWUP|Adverse Event|1|||
37631842|NCT00708500|69098180|FG002|FOLLOWUP|Adverse Event|0|||
37631843|NCT00708500|69098178|FG000|FOLLOWUP|Lost to Follow-up|1|||
37631844|NCT00708500|69098179|FG001|FOLLOWUP|Lost to Follow-up|6|||
37631845|NCT00708500|69098180|FG002|FOLLOWUP|Lost to Follow-up|4|||
37631846|NCT00708500|69098178|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
37631847|NCT00708500|69098179|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
37631848|NCT00708500|69098180|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
37631849|NCT00708500|69098178|FG000|FOLLOWUP|Subject withdrew consent|31|||
37631850|NCT00708500|69098179|FG001|FOLLOWUP|Subject withdrew consent|4|||
37738475|NCT01757288|69221008|FG000|Overall Study|Not meeting protocol constraints|0|||
38031857|NCT03351608|69717635|FG003|Overall Study|Physician Decision|2|||
38031858|NCT03351608|69717636|FG004|Overall Study|Physician Decision|1|||
38031859|NCT03351608|69717632|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
38031860|NCT03351608|69717633|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
38031861|NCT03351608|69717634|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
38031862|NCT03351608|69717635|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
38031863|NCT03351608|69717636|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
37631851|NCT00708500|69098180|FG002|FOLLOWUP|Subject withdrew consent|5|||
37738476|NCT01757288|69221009|FG001|Overall Study|Not meeting protocol constraints|1|||
37738477|NCT01757288|69221010|FG002|Overall Study|Not meeting protocol constraints|1|||
37738478|NCT01757288|69221008|FG000|Overall Study|Multiple missed appointments|0|||
37738479|NCT01757288|69221009|FG001|Overall Study|Multiple missed appointments|1|||
37738480|NCT01757288|69221010|FG002|Overall Study|Multiple missed appointments|0|||
37631852|NCT00708500|69098178|FG000|FOLLOWUP|Non-compliance with protocol|5|||
37631853|NCT00708500|69098179|FG001|FOLLOWUP|Non-compliance with protocol|0|||
37631854|NCT00708500|69098180|FG002|FOLLOWUP|Non-compliance with protocol|1|||
37631855|NCT00708734|69098197|FG000|Overall Study|scheduling conflict|2|||
37738481|NCT01757288|69221008|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
37631856|NCT00708734|69098197|FG000|Overall Study|moved|1|||
37631857|NCT00708734|69098197|FG000|Overall Study|leg injury|1|||
37631858|NCT00708734|69098197|FG000|Overall Study|knee replacement|1|||
37631859|NCT00708734|69098197|FG000|Overall Study|vertigo|1|||
37631860|NCT00708734|69098197|FG000|Overall Study|leg fracture|1|||
37631861|NCT04834362|69098203|FG000|Overall Study|Death|1|||
37631862|NCT04834362|69098204|FG001|Overall Study|Death|2|||
37631863|NCT00101907|69098216|FG000|Overall Study|Adverse Event|1|||
37631864|NCT00101907|69098217|FG001|Overall Study|Adverse Event|0|||
37631865|NCT00101907|69098218|FG002|Overall Study|Adverse Event|0|||
37631866|NCT00101907|69098219|FG003|Overall Study|Adverse Event|0|||
37631867|NCT00101907|69098220|FG004|Overall Study|Adverse Event|0|||
37631868|NCT00101907|69098221|FG005|Overall Study|Adverse Event|0|||
37631869|NCT00101907|69098216|FG000|Overall Study|Death|0|||
37631870|NCT00101907|69098217|FG001|Overall Study|Death|1|||
37631871|NCT00101907|69098218|FG002|Overall Study|Death|0|||
37631872|NCT00101907|69098219|FG003|Overall Study|Death|0|||
37631873|NCT00101907|69098220|FG004|Overall Study|Death|3|||
37631874|NCT00101907|69098221|FG005|Overall Study|Death|0|||
37631875|NCT00101907|69098216|FG000|Overall Study|Physician Decision|0|||
37631876|NCT00101907|69098217|FG001|Overall Study|Physician Decision|0|||
37631877|NCT00101907|69098218|FG002|Overall Study|Physician Decision|0|||
37631878|NCT00101907|69098219|FG003|Overall Study|Physician Decision|1|||
37631879|NCT00101907|69098220|FG004|Overall Study|Physician Decision|1|||
37631880|NCT00101907|69098221|FG005|Overall Study|Physician Decision|0|||
37631881|NCT00101907|69098216|FG000|Overall Study|Withdrawal by Subject|1|||
37631882|NCT00101907|69098217|FG001|Overall Study|Withdrawal by Subject|0|||
37631883|NCT00101907|69098218|FG002|Overall Study|Withdrawal by Subject|1|||
37631884|NCT00101907|69098219|FG003|Overall Study|Withdrawal by Subject|0|||
37631885|NCT00101907|69098220|FG004|Overall Study|Withdrawal by Subject|1|||
37631886|NCT00101907|69098221|FG005|Overall Study|Withdrawal by Subject|0|||
37631887|NCT02565784|69098242|FG000|First Treatment|Adverse Event|1|||
37631888|NCT02565784|69098242|FG000|First Treatment|Withdrawal by Subject|1|||
37631889|NCT02565784|69098242|FG000|Second Treatment|Withdrawal by Subject|2|||
37631890|NCT04650204|69098289|FG000|Overall Study|Study was Terminated|2|||
37631891|NCT04650204|69098290|FG001|Overall Study|Study was Terminated|1|||
37631892|NCT02761629|69098298|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
37631893|NCT02761629|69098299|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
37631894|NCT02761629|69098298|FG000|Overall Study|Insufficient Therapeutic Response|2|||
37631895|NCT02761629|69098299|FG001|Overall Study|Insufficient Therapeutic Response|7|||
37631896|NCT02761629|69098298|FG000|Overall Study|Failure to Return|2|||
37631897|NCT02761629|69098299|FG001|Overall Study|Failure to Return|4|||
37631898|NCT02761629|69098298|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
37631899|NCT02761629|69098299|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
37631900|NCT02761629|69098298|FG000|Overall Study|Protocol Violation|2|||
37631901|NCT02761629|69098299|FG001|Overall Study|Protocol Violation|2|||
37631902|NCT02761629|69098298|FG000|Overall Study|Withdrawal by Subject|0|||
37631903|NCT02761629|69098299|FG001|Overall Study|Withdrawal by Subject|3|||
37631904|NCT02761629|69098298|FG000|Overall Study|Other|0|||
37631905|NCT02761629|69098299|FG001|Overall Study|Other|2|||
37631906|NCT02761629|69098298|FG000|Overall Study|Lost to Follow-up|4|||
37631907|NCT02761629|69098299|FG001|Overall Study|Lost to Follow-up|1|||
37853288|NCT02095132|69537178|FG000|Overall Study|Lack of Efficacy|3|||
37853289|NCT02095132|69537179|FG001|Overall Study|Lack of Efficacy|5|||
37853290|NCT02095132|69537180|FG002|Overall Study|Lack of Efficacy|2|||
37853291|NCT02095132|69537181|FG003|Overall Study|Lack of Efficacy|8|||
37853292|NCT02095132|69537182|FG004|Overall Study|Lack of Efficacy|3|||
37853293|NCT02095132|69537183|FG005|Overall Study|Lack of Efficacy|6|||
37853294|NCT02095132|69537184|FG006|Overall Study|Lack of Efficacy|10|||
37853295|NCT02095132|69537185|FG007|Overall Study|Lack of Efficacy|9|||
37853296|NCT02095132|69537186|FG008|Overall Study|Lack of Efficacy|8|||
37853297|NCT02095132|69537178|FG000|Overall Study|Physician Decision|1|||
37853298|NCT02095132|69537179|FG001|Overall Study|Physician Decision|0|||
37853299|NCT02095132|69537180|FG002|Overall Study|Physician Decision|0|||
37853300|NCT02095132|69537181|FG003|Overall Study|Physician Decision|0|||
37853301|NCT02095132|69537182|FG004|Overall Study|Physician Decision|0|||
37631908|NCT02761629|69098298|FG000|Overall Study|Randomized But Not Treated|8|||
37631909|NCT02761629|69098299|FG001|Overall Study|Randomized But Not Treated|4|||
37631910|NCT02760927|69098305|FG000|Overall Study|Tube Slippage from Device|1|||
37631911|NCT00101439|69098311|FG000|Period 2|Withdrawal by Subject|0|||
37631912|NCT00101439|69098312|FG001|Period 2|Withdrawal by Subject|2|||
37631913|NCT04033068|69098322|FG000|Overall Study|Withdrawal by Subject|0|||
37631914|NCT04033068|69098323|FG001|Overall Study|Withdrawal by Subject|0|||
37631915|NCT04033068|69098324|FG002|Overall Study|Withdrawal by Subject|1|||
37631916|NCT04033068|69098325|FG003|Overall Study|Withdrawal by Subject|0|||
37631917|NCT04033068|69098322|FG000|Overall Study|Lost to Follow-up|0|||
37631918|NCT04033068|69098323|FG001|Overall Study|Lost to Follow-up|1|||
37853302|NCT02095132|69537183|FG005|Overall Study|Physician Decision|0|||
37853303|NCT02095132|69537184|FG006|Overall Study|Physician Decision|1|||
37631919|NCT04033068|69098324|FG002|Overall Study|Lost to Follow-up|0|||
37631920|NCT04033068|69098325|FG003|Overall Study|Lost to Follow-up|0|||
37631921|NCT04033068|69098322|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
37631922|NCT04033068|69098323|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
37631923|NCT04033068|69098324|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
37631924|NCT04033068|69098325|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
37631925|NCT02762565|69098335|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
37631926|NCT02757963|69098348|FG000|Overall Study|Adverse Event|3|||
37631927|NCT02757963|69098348|FG000|Overall Study|Reached Stopping Criteria|1054|||
37631928|NCT02757963|69098348|FG000|Overall Study|Lost to Follow-up|5|||
37631929|NCT02757963|69098348|FG000|Overall Study|Physician Decision|1|||
37631930|NCT02757963|69098348|FG000|Overall Study|Withdrawal by Subject|34|||
37631931|NCT03111732|69098363|FG000|Overall Study|Enrolled in different study|1|||
37631932|NCT03111732|69098363|FG000|Overall Study|Progressive disease|3|||
37631933|NCT03111732|69098363|FG000|Overall Study|Withdrawal by Subject|1|||
37631934|NCT01663714|69098372|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
37631935|NCT01663714|69098372|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
37631936|NCT01663714|69098372|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
37631937|NCT01663714|69098372|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
37631938|NCT01663714|69098372|FG000|Long-Term Follow-Up|Death|4|||
37738482|NCT01757288|69221009|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
37738483|NCT01757288|69221010|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
37738484|NCT01757288|69221008|FG000|Overall Study|>2 weeks treatment break|0|||
37738485|NCT01757288|69221009|FG001|Overall Study|>2 weeks treatment break|0|||
37738486|NCT01757288|69221010|FG002|Overall Study|>2 weeks treatment break|1|||
37738487|NCT01756898|69221023|FG000|Overall Study|Adverse Event|7|||
37738488|NCT01756898|69221024|FG001|Overall Study|Adverse Event|1|||
37738489|NCT01756898|69221025|FG002|Overall Study|Adverse Event|0|||
37738490|NCT01756898|69221026|FG003|Overall Study|Adverse Event|0|||
37738491|NCT01756898|69221023|FG000|Overall Study|Lack of Efficacy|4|||
37738492|NCT01756898|69221024|FG001|Overall Study|Lack of Efficacy|7|||
37738493|NCT01756898|69221025|FG002|Overall Study|Lack of Efficacy|6|||
37738494|NCT01756898|69221026|FG003|Overall Study|Lack of Efficacy|6|||
37738495|NCT01756898|69221023|FG000|Overall Study|Lost to Follow-up|2|||
37738496|NCT01756898|69221024|FG001|Overall Study|Lost to Follow-up|4|||
37738497|NCT01756898|69221025|FG002|Overall Study|Lost to Follow-up|2|||
37738498|NCT01756898|69221026|FG003|Overall Study|Lost to Follow-up|3|||
37738499|NCT01756898|69221023|FG000|Overall Study|Protocol Violation|1|||
37738500|NCT01756898|69221024|FG001|Overall Study|Protocol Violation|2|||
37738501|NCT01756898|69221025|FG002|Overall Study|Protocol Violation|2|||
37738502|NCT01756898|69221026|FG003|Overall Study|Protocol Violation|1|||
37738503|NCT01756898|69221023|FG000|Overall Study|Withdrew Consent|5|||
37738504|NCT01756898|69221024|FG001|Overall Study|Withdrew Consent|3|||
37738505|NCT01756898|69221025|FG002|Overall Study|Withdrew Consent|5|||
37738506|NCT01756898|69221026|FG003|Overall Study|Withdrew Consent|6|||
37738507|NCT01756898|69221023|FG000|Overall Study|Other|0|||
37738508|NCT01756898|69221024|FG001|Overall Study|Other|2|||
37738509|NCT01756898|69221025|FG002|Overall Study|Other|2|||
37853304|NCT02095132|69537185|FG007|Overall Study|Physician Decision|0|||
37853305|NCT02095132|69537186|FG008|Overall Study|Physician Decision|2|||
37853306|NCT02095132|69537178|FG000|Overall Study|Withdrawal by Subject|0|||
37853307|NCT02095132|69537179|FG001|Overall Study|Withdrawal by Subject|0|||
37853308|NCT02095132|69537180|FG002|Overall Study|Withdrawal by Subject|2|||
37853309|NCT02095132|69537181|FG003|Overall Study|Withdrawal by Subject|2|||
37631939|NCT01663714|69098372|FG000|Long-Term Follow-Up|Non-compliance|1|||
37631940|NCT01663636|69098394|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
37631941|NCT01663636|69098395|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
37738510|NCT01756898|69221026|FG003|Overall Study|Other|0|||
37738511|NCT01731938|69221043|FG000|Preliminary Part I|Withdrawal by Subject|2|||
37738512|NCT01731938|69221044|FG001|Preliminary Part I|Withdrawal by Subject|2|||
37738513|NCT01731938|69221043|FG000|Preliminary Part I|Physician Decision|1|||
37738514|NCT01731938|69221044|FG001|Preliminary Part I|Physician Decision|0|||
37738515|NCT01731938|69221043|FG000|Preliminary Part I|Lost to Follow-up|0|||
37853310|NCT02095132|69537182|FG004|Overall Study|Withdrawal by Subject|3|||
37853311|NCT02095132|69537183|FG005|Overall Study|Withdrawal by Subject|0|||
37631942|NCT03065244|69098403|FG000|Overall Study|Lost to Follow-up|1|||
37631943|NCT03065244|69098404|FG001|Overall Study|Lost to Follow-up|1|||
37631944|NCT03065244|69098403|FG000|Overall Study|Diagnosed with a different disease|1|||
37738516|NCT01731938|69221044|FG001|Preliminary Part I|Lost to Follow-up|3|||
37738517|NCT01731938|69221043|FG000|Preliminary Part I|Missed Week 6 visit|0|||
37738518|NCT01731938|69221044|FG001|Preliminary Part I|Missed Week 6 visit|3|||
37738519|NCT01731938|69221043|FG000|Primary Part II|Withdrawal by Subject|5|||
37738520|NCT01731938|69221044|FG001|Primary Part II|Withdrawal by Subject|4|||
37738521|NCT01731938|69221043|FG000|Primary Part II|Lost to Follow-up|4|||
37738522|NCT01731938|69221044|FG001|Primary Part II|Lost to Follow-up|5|||
37738523|NCT01731938|69221043|FG000|Primary Part II|Death|2|||
37738524|NCT01731938|69221044|FG001|Primary Part II|Death|1|||
37631945|NCT03065244|69098404|FG001|Overall Study|Diagnosed with a different disease|1|||
37631946|NCT03065244|69098403|FG000|Overall Study|Protocol Violation|0|||
37631947|NCT03065244|69098404|FG001|Overall Study|Protocol Violation|1|||
37631948|NCT03065244|69098403|FG000|Overall Study|Withdrawal by Subject|1|||
37631949|NCT03065244|69098404|FG001|Overall Study|Withdrawal by Subject|1|||
37631950|NCT00100815|69098410|FG000|Overall Study|Progression|24|||
37631951|NCT00100815|69098410|FG000|Overall Study|Adverse Event|18|||
37631952|NCT00100815|69098410|FG000|Overall Study|Death|4|||
37631953|NCT00100815|69098410|FG000|Overall Study|Other|3|||
37631954|NCT00708422|69098416|FG000|Overall Study|Adverse Event|3|||
37631955|NCT00708422|69098417|FG001|Overall Study|Adverse Event|1|||
37631956|NCT00708422|69098416|FG000|Overall Study|Withdrawal by Subject|1|||
37631957|NCT00708422|69098417|FG001|Overall Study|Withdrawal by Subject|0|||
37631958|NCT02760069|69098426|FG000|Overall Study|Withdrawal by Subject|0|||
37631959|NCT02760069|69098427|FG001|Overall Study|Withdrawal by Subject|1|||
37631960|NCT02760069|69098428|FG002|Overall Study|Withdrawal by Subject|1|||
37631961|NCT00707486|69098436|FG000|Overall Study|Withdrawal by Subject|1|||
37631962|NCT02759055|69098444|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
37631963|NCT02759055|69098445|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
37631964|NCT00708032|69098453|FG000|Overall Study|Adverse Event|0|||
37631965|NCT00708032|69098454|FG001|Overall Study|Adverse Event|2|||
37631966|NCT00708032|69098453|FG000|Overall Study|Lost to Follow-up|1|||
37631967|NCT00708032|69098454|FG001|Overall Study|Lost to Follow-up|2|||
37631968|NCT00708032|69098453|FG000|Overall Study|Pregnancy|0|||
37631969|NCT00708032|69098454|FG001|Overall Study|Pregnancy|1|||
37631970|NCT00708032|69098453|FG000|Overall Study|Poor vision|0|||
37631971|NCT00708032|69098454|FG001|Overall Study|Poor vision|6|||
37631972|NCT00708032|69098453|FG000|Overall Study|Visit out of range at month 12|4|||
37631973|NCT00708032|69098454|FG001|Overall Study|Visit out of range at month 12|1|||
37631974|NCT00708032|69098453|FG000|Overall Study|Did not meet protocol criteria|1|||
37631975|NCT00708032|69098454|FG001|Overall Study|Did not meet protocol criteria|2|||
37631976|NCT00708032|69098453|FG000|Overall Study|Protocol Violation|4|||
37631977|NCT00708032|69098454|FG001|Overall Study|Protocol Violation|1|||
37631978|NCT00708032|69098453|FG000|Overall Study|Withdrawal by Subject|0|||
37631979|NCT00708032|69098454|FG001|Overall Study|Withdrawal by Subject|1|||
37631980|NCT00707174|69098462|FG000|Overall Study|Adverse Event|1|||
37631981|NCT00707174|69098463|FG001|Overall Study|Adverse Event|6|||
37631982|NCT00707174|69098462|FG000|Overall Study|Withdrawal by Subject|4|||
37631983|NCT00707174|69098463|FG001|Overall Study|Withdrawal by Subject|1|||
37631984|NCT02756403|69098473|FG000|Overall Study|Unable to swallow medication|0|||
37631985|NCT02756403|69098474|FG001|Overall Study|Unable to swallow medication|1|||
37631986|NCT02756403|69098475|FG002|Overall Study|Unable to swallow medication|1|||
37631987|NCT02756403|69098476|FG003|Overall Study|Unable to swallow medication|1|||
37631988|NCT02756403|69098473|FG000|Overall Study|Did not complete Procedure|0|||
37631989|NCT02756403|69098474|FG001|Overall Study|Did not complete Procedure|1|||
37631990|NCT02756403|69098475|FG002|Overall Study|Did not complete Procedure|0|||
37631991|NCT02756403|69098476|FG003|Overall Study|Did not complete Procedure|0|||
37631992|NCT02756403|69098473|FG000|Overall Study|Changed Mind About Procedure|0|||
37631993|NCT02756403|69098474|FG001|Overall Study|Changed Mind About Procedure|0|||
37631994|NCT02756403|69098475|FG002|Overall Study|Changed Mind About Procedure|1|||
37631995|NCT02756403|69098476|FG003|Overall Study|Changed Mind About Procedure|0|||
37631996|NCT02756403|69098473|FG000|Overall Study|Protocol Violation|0|||
37631997|NCT02756403|69098474|FG001|Overall Study|Protocol Violation|1|||
37631998|NCT02756403|69098475|FG002|Overall Study|Protocol Violation|0|||
37631999|NCT02756403|69098476|FG003|Overall Study|Protocol Violation|1|||
37632000|NCT02753595|69098488|FG000|Overall Study|Sponsor termination|2|||
37632001|NCT02753595|69098489|FG001|Overall Study|Sponsor termination|2|||
37632002|NCT00707954|69098512|FG000|Overall Study|Physician Decision|0|||
37632003|NCT00707954|69098513|FG001|Overall Study|Physician Decision|0|||
37632004|NCT00707954|69098514|FG002|Overall Study|Physician Decision|0|||
37632005|NCT00707954|69098515|FG003|Overall Study|Physician Decision|0|||
37632006|NCT00707954|69098516|FG004|Overall Study|Physician Decision|1|||
37632007|NCT02561962|69098537|FG000|Overall Study|Ongoing in study|1|||
37632008|NCT02561962|69098538|FG001|Overall Study|Ongoing in study|0|||
37632009|NCT02561962|69098539|FG002|Overall Study|Ongoing in study|0|||
37632010|NCT02561962|69098540|FG003|Overall Study|Ongoing in study|1|||
37632011|NCT02561962|69098541|FG004|Overall Study|Ongoing in study|0|||
37632012|NCT02561962|69098542|FG005|Overall Study|Ongoing in study|1|||
37632013|NCT02561962|69098543|FG006|Overall Study|Ongoing in study|0|||
37632014|NCT02561962|69098544|FG007|Overall Study|Ongoing in study|4|||
37632015|NCT02561962|69098545|FG008|Overall Study|Ongoing in study|1|||
37632016|NCT02561962|69098537|FG000|Overall Study|Withdrawal by Subject|1|||
37632017|NCT02561962|69098538|FG001|Overall Study|Withdrawal by Subject|0|||
37632018|NCT02561962|69098539|FG002|Overall Study|Withdrawal by Subject|0|||
37632019|NCT02561962|69098540|FG003|Overall Study|Withdrawal by Subject|0|||
37632020|NCT02561962|69098541|FG004|Overall Study|Withdrawal by Subject|1|||
37632021|NCT02561962|69098542|FG005|Overall Study|Withdrawal by Subject|1|||
37632022|NCT02561962|69098543|FG006|Overall Study|Withdrawal by Subject|2|||
37632023|NCT02561962|69098544|FG007|Overall Study|Withdrawal by Subject|1|||
37632024|NCT02561962|69098545|FG008|Overall Study|Withdrawal by Subject|0|||
37632025|NCT02561962|69098537|FG000|Overall Study|Decision by sponsor|0|||
37632026|NCT02561962|69098538|FG001|Overall Study|Decision by sponsor|0|||
37632027|NCT02561962|69098539|FG002|Overall Study|Decision by sponsor|0|||
37632028|NCT02561962|69098540|FG003|Overall Study|Decision by sponsor|0|||
37632029|NCT02561962|69098541|FG004|Overall Study|Decision by sponsor|1|||
37632030|NCT02561962|69098542|FG005|Overall Study|Decision by sponsor|1|||
37632031|NCT02561962|69098543|FG006|Overall Study|Decision by sponsor|0|||
37632032|NCT02561962|69098544|FG007|Overall Study|Decision by sponsor|3|||
37632033|NCT02561962|69098545|FG008|Overall Study|Decision by sponsor|0|||
37632034|NCT02561962|69098537|FG000|Overall Study|Lost to Follow-up|0|||
37632035|NCT02561962|69098538|FG001|Overall Study|Lost to Follow-up|0|||
37632036|NCT02561962|69098539|FG002|Overall Study|Lost to Follow-up|0|||
37632037|NCT02561962|69098540|FG003|Overall Study|Lost to Follow-up|0|||
37632038|NCT02561962|69098541|FG004|Overall Study|Lost to Follow-up|0|||
37632039|NCT02561962|69098542|FG005|Overall Study|Lost to Follow-up|1|||
37632040|NCT02561962|69098543|FG006|Overall Study|Lost to Follow-up|0|||
37632041|NCT02561962|69098544|FG007|Overall Study|Lost to Follow-up|0|||
37632042|NCT02561962|69098545|FG008|Overall Study|Lost to Follow-up|0|||
37632043|NCT02565706|69098569|FG000|Overall Study|Withdrawal by Subject|5|||
37632044|NCT02565706|69098570|FG001|Overall Study|Withdrawal by Subject|7|||
37632045|NCT02565706|69098571|FG002|Overall Study|Withdrawal by Subject|7|||
37632046|NCT02565706|69098572|FG003|Overall Study|Withdrawal by Subject|11|||
37632047|NCT02565706|69098569|FG000|Overall Study|Lost to Follow-up|72|||
37632048|NCT02565706|69098570|FG001|Overall Study|Lost to Follow-up|75|||
37632049|NCT02565706|69098571|FG002|Overall Study|Lost to Follow-up|82|||
37632050|NCT02565706|69098572|FG003|Overall Study|Lost to Follow-up|74|||
37632051|NCT00706628|69098591|FG000|Overall Study|Other Adverse Event|16|||
37853312|NCT02095132|69537184|FG006|Overall Study|Withdrawal by Subject|5|||
37853313|NCT02095132|69537185|FG007|Overall Study|Withdrawal by Subject|0|||
37853314|NCT02095132|69537186|FG008|Overall Study|Withdrawal by Subject|0|||
37853315|NCT02025010|69537209|FG000|Overall Study|Symptomatic or radiographic progression|36|||
37853316|NCT02025010|69537209|FG000|Overall Study|Adverse Event|6|||
37853317|NCT02025010|69537209|FG000|Overall Study|Physician Decision|7|||
37853318|NCT02025010|69537209|FG000|Overall Study|Withdrawal by Subject|3|||
37853319|NCT02025010|69537209|FG000|Overall Study|Intercurrent illness|3|||
37853320|NCT02025010|69537209|FG000|Overall Study|Patients still on treatment|3|||
37632052|NCT00706628|69098592|FG001|Overall Study|Other Adverse Event|5|||
37632053|NCT00706628|69098593|FG002|Overall Study|Other Adverse Event|5|||
37632054|NCT00706628|69098594|FG003|Overall Study|Other Adverse Event|2|||
37632055|NCT00706628|69098591|FG000|Overall Study|Non compliant with protocol|0|||
37632056|NCT00706628|69098592|FG001|Overall Study|Non compliant with protocol|1|||
37632057|NCT00706628|69098593|FG002|Overall Study|Non compliant with protocol|0|||
37632058|NCT00706628|69098594|FG003|Overall Study|Non compliant with protocol|0|||
37632059|NCT00706628|69098591|FG000|Overall Study|Consent withdrawn|6|||
37632060|NCT00706628|69098592|FG001|Overall Study|Consent withdrawn|1|||
37632061|NCT00706628|69098593|FG002|Overall Study|Consent withdrawn|3|||
37632062|NCT00706628|69098594|FG003|Overall Study|Consent withdrawn|0|||
37632063|NCT00706628|69098591|FG000|Overall Study|Progressive disease|20|||
37632064|NCT00706628|69098592|FG001|Overall Study|Progressive disease|13|||
37632065|NCT00706628|69098593|FG002|Overall Study|Progressive disease|8|||
37632066|NCT00706628|69098594|FG003|Overall Study|Progressive disease|1|||
37632067|NCT00706628|69098591|FG000|Overall Study|Other than those stated above|4|||
37632068|NCT00706628|69098592|FG001|Overall Study|Other than those stated above|0|||
37738525|NCT01731938|69221043|FG000|Primary Part II|Missed Week 6 visit|2|||
37738526|NCT01731938|69221044|FG001|Primary Part II|Missed Week 6 visit|3|||
37853321|NCT02025010|69537209|FG000|Overall Study|Never initiate the treatment|2|||
37853322|NCT01867333|69537217|FG000|Overall Study|Withdrawal by Subject|1|||
37632069|NCT00706628|69098593|FG002|Overall Study|Other than those stated above|0|||
37632070|NCT00706628|69098594|FG003|Overall Study|Other than those stated above|0|||
37632071|NCT00706628|69098591|FG000|Overall Study|Not treated|1|||
37632072|NCT00706628|69098592|FG001|Overall Study|Not treated|1|||
37632073|NCT00706628|69098593|FG002|Overall Study|Not treated|0|||
37853323|NCT01867333|69537218|FG001|Overall Study|Withdrawal by Subject|0|||
37632074|NCT00706628|69098594|FG003|Overall Study|Not treated|0|||
37632075|NCT02561806|69098609|FG000|Induction Period|Adverse Event|0|||
37632076|NCT02561806|69098610|FG001|Induction Period|Adverse Event|2|||
37632077|NCT02561806|69098609|FG000|Induction Period|Lack of Efficacy|1|||
37632078|NCT02561806|69098610|FG001|Induction Period|Lack of Efficacy|0|||
37632079|NCT02561806|69098609|FG000|Induction Period|Withdrawal by Subject|0|||
37632080|NCT02561806|69098610|FG001|Induction Period|Withdrawal by Subject|2|||
37632081|NCT02561806|69098609|FG000|Induction Period|Site staff became unblinded|1|||
37632082|NCT02561806|69098610|FG001|Induction Period|Site staff became unblinded|0|||
37632083|NCT02561806|69098609|FG000|Induction Period|Randomized but not treated|0|||
37632084|NCT02561806|69098610|FG001|Induction Period|Randomized but not treated|1|||
37738527|NCT01731470|69221051|FG000|Overall Study|Withdrawal by Subject|1|||
37632085|NCT02561806|69098609|FG000|Maintenance Period|Adverse Event|2|||
37632086|NCT02561806|69098610|FG001|Maintenance Period|Adverse Event|1|||
37632087|NCT02561806|69098609|FG000|Maintenance Period|Lack of Efficacy|3|||
37632088|NCT02561806|69098610|FG001|Maintenance Period|Lack of Efficacy|1|||
37632089|NCT02561806|69098609|FG000|Maintenance Period|Lost to Follow-up|2|||
37632090|NCT02561806|69098610|FG001|Maintenance Period|Lost to Follow-up|2|||
37632091|NCT02561806|69098609|FG000|Maintenance Period|Protocol Violation|1|||
37632092|NCT02561806|69098610|FG001|Maintenance Period|Protocol Violation|0|||
37632093|NCT02561806|69098609|FG000|Maintenance Period|Withdrawal by Subject|5|||
37632094|NCT02561806|69098610|FG001|Maintenance Period|Withdrawal by Subject|3|||
37632095|NCT02561806|69098609|FG000|Maintenance Period|Site staff became unblinded|0|||
37632096|NCT02561806|69098610|FG001|Maintenance Period|Site staff became unblinded|1|||
37632097|NCT02561806|69098609|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
37632098|NCT02561806|69098610|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
37632099|NCT02561806|69098609|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
37632100|NCT02561806|69098610|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
37632101|NCT02561572|69098633|FG000|Overall Study|Inadequate time before surgery|2|||
37632102|NCT02561572|69098634|FG001|Overall Study|Inadequate time before surgery|1|||
37632103|NCT02561572|69098633|FG000|Overall Study|Protocol Violation|0|||
37632104|NCT02561572|69098634|FG001|Overall Study|Protocol Violation|1|||
37632105|NCT02180217|69098643|FG000|Overall Study|Adverse Event|3|||
37632106|NCT02180217|69098644|FG001|Overall Study|Adverse Event|2|||
37632107|NCT02180217|69098645|FG002|Overall Study|Adverse Event|22|||
37632108|NCT02180217|69098643|FG000|Overall Study|Death|1|||
37632109|NCT02180217|69098644|FG001|Overall Study|Death|1|||
37632110|NCT02180217|69098645|FG002|Overall Study|Death|0|||
37632111|NCT02180217|69098643|FG000|Overall Study|Withdrawal by Subject|1|||
37632112|NCT02180217|69098644|FG001|Overall Study|Withdrawal by Subject|1|||
37632113|NCT02180217|69098645|FG002|Overall Study|Withdrawal by Subject|4|||
37632114|NCT02180217|69098643|FG000|Overall Study|Subject/Guardian decision|5|||
37632115|NCT02180217|69098644|FG001|Overall Study|Subject/Guardian decision|3|||
37632116|NCT02180217|69098645|FG002|Overall Study|Subject/Guardian decision|6|||
37632117|NCT02180217|69098643|FG000|Overall Study|Physician Decision|1|||
37632118|NCT02180217|69098644|FG001|Overall Study|Physician Decision|1|||
37632119|NCT02180217|69098645|FG002|Overall Study|Physician Decision|6|||
37632120|NCT02180217|69098643|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
37632121|NCT02180217|69098644|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
37632122|NCT02180217|69098645|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
37632123|NCT02560558|69098662|FG000|Overall Study|Adverse Event|1|||
37632124|NCT02560558|69098663|FG001|Overall Study|Adverse Event|0|||
37632125|NCT02560558|69098662|FG000|Overall Study|Death|0|||
37632126|NCT02560558|69098663|FG001|Overall Study|Death|2|||
37632127|NCT02560558|69098662|FG000|Overall Study|Lost to Follow-up|0|||
37632128|NCT02560558|69098663|FG001|Overall Study|Lost to Follow-up|4|||
37632129|NCT02560558|69098662|FG000|Overall Study|Protocol Violation|3|||
37632130|NCT02560558|69098663|FG001|Overall Study|Protocol Violation|0|||
37632131|NCT02560558|69098662|FG000|Overall Study|Withdrawal by Subject|3|||
37632132|NCT02560558|69098663|FG001|Overall Study|Withdrawal by Subject|0|||
37632133|NCT02568046|69098671|FG000|Overall Study|Adverse Event|0|||
37632134|NCT02568046|69098672|FG001|Overall Study|Adverse Event|1|||
37632135|NCT02568046|69098671|FG000|Overall Study|Death|2|||
37632136|NCT02568046|69098672|FG001|Overall Study|Death|0|||
37632137|NCT02568046|69098671|FG000|Overall Study|Progressive Disease|1|||
37632138|NCT02568046|69098672|FG001|Overall Study|Progressive Disease|0|||
37632139|NCT02568046|69098671|FG000|Overall Study|Withdrawal by Subject|2|||
37632140|NCT02568046|69098672|FG001|Overall Study|Withdrawal by Subject|1|||
37632141|NCT02568046|69098671|FG000|Overall Study|Other Events|0|||
37632142|NCT02568046|69098672|FG001|Overall Study|Other Events|1|||
37632143|NCT02567656|69098684|FG000|Overall Study|Premature discontinuation due to PD|1|||
37632144|NCT02567656|69098685|FG001|Overall Study|Premature discontinuation due to PD|1|||
37738528|NCT01731470|69221051|FG000|Overall Study|Did not meet study criteria|1|||
37738529|NCT01756352|69221055|FG000|Overall Study|moved away and lost to followup|1|||
37738530|NCT01756274|69221059|FG000|Overall Study|Protocol Violation|2|||
37921706|NCT00820950|69608461|FG004|Overall Study|Protocol Violation|0|||
37632145|NCT02567656|69098686|FG002|Overall Study|Premature discontinuation due to PD|2|||
37632146|NCT02567656|69098687|FG003|Overall Study|Premature discontinuation due to PD|0|||
37632147|NCT02567656|69098688|FG004|Overall Study|Premature discontinuation due to PD|0|||
37632148|NCT02567656|69098689|FG005|Overall Study|Premature discontinuation due to PD|0|||
37632149|NCT02560012|69098703|FG000|Overall Study|Study Terminated|2|||
37632150|NCT02567266|69098710|FG000|Overall Study|Withdrawal by Subject|10|||
37632151|NCT02567266|69098711|FG001|Overall Study|Withdrawal by Subject|7|||
37632152|NCT02567266|69098712|FG002|Overall Study|Withdrawal by Subject|6|||
37632153|NCT02567266|69098710|FG000|Overall Study|Lost to Follow-up|13|||
37632154|NCT02567266|69098711|FG001|Overall Study|Lost to Follow-up|8|||
37632155|NCT02567266|69098712|FG002|Overall Study|Lost to Follow-up|10|||
37632156|NCT02567188|69098720|FG000|Overall Study|Death|10|||
37738531|NCT01756274|69221059|FG000|Overall Study|Laboratory error|1|||
37632157|NCT02567188|69098720|FG000|Overall Study|Terminated Mircera Treatment|9|||
37632158|NCT02567188|69098720|FG000|Overall Study|Lost to Follow-up|5|||
37632159|NCT02567188|69098720|FG000|Overall Study|Adverse Event|1|||
37632160|NCT02567188|69098720|FG000|Overall Study|Withdrawal by Subject|1|||
37632161|NCT02567188|69098720|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
37632162|NCT02567188|69098720|FG000|Overall Study|Moved and Changed Clinic|1|||
37632163|NCT02567188|69098720|FG000|Overall Study|Started Hemodialysis|2|||
37632164|NCT02567188|69098720|FG000|Overall Study|Protocol Violation|5|||
37632165|NCT00706238|69098725|FG000|Overall Study|Disease progression|4|||
37632166|NCT00706238|69098725|FG000|Overall Study|Other|1|||
37632167|NCT03321968|69098732|FG000|Overall Study|Withdrawal by Subject|1|||
37632168|NCT03321968|69098733|FG001|Overall Study|Withdrawal by Subject|2|||
37632169|NCT03321968|69098734|FG002|Overall Study|Withdrawal by Subject|1|||
37632170|NCT03321968|69098732|FG000|Overall Study|Lost to Follow-up|2|||
37632171|NCT03321968|69098733|FG001|Overall Study|Lost to Follow-up|0|||
37632172|NCT03321968|69098734|FG002|Overall Study|Lost to Follow-up|1|||
37632173|NCT03321968|69098732|FG000|Overall Study|Other than specified|0|||
37632174|NCT03321968|69098733|FG001|Overall Study|Other than specified|0|||
37632175|NCT03321968|69098734|FG002|Overall Study|Other than specified|1|||
37632176|NCT05338333|69098748|FG000|Period 1, Approximately 30 Days|Adverse Event|1|||
37632177|NCT05338333|69098749|FG001|Period 1, Approximately 30 Days|Adverse Event|0|||
37632178|NCT05051579|69098765|FG000|Overall Study|Withdrawal by Subject|3|||
37632179|NCT05051579|69098766|FG001|Overall Study|Withdrawal by Subject|5|||
37632180|NCT05051579|69098767|FG002|Overall Study|Withdrawal by Subject|2|||
37632181|NCT05051579|69098768|FG003|Overall Study|Withdrawal by Subject|1|||
37632182|NCT05051579|69098769|FG004|Overall Study|Withdrawal by Subject|4|||
37632183|NCT05051579|69098770|FG005|Overall Study|Withdrawal by Subject|0|||
37632184|NCT05051579|69098771|FG006|Overall Study|Withdrawal by Subject|4|||
37632185|NCT05051579|69098765|FG000|Overall Study|Lost to Follow-up|1|||
37632186|NCT05051579|69098766|FG001|Overall Study|Lost to Follow-up|0|||
37632187|NCT05051579|69098767|FG002|Overall Study|Lost to Follow-up|0|||
37632188|NCT05051579|69098768|FG003|Overall Study|Lost to Follow-up|0|||
37632189|NCT05051579|69098769|FG004|Overall Study|Lost to Follow-up|1|||
37632190|NCT05051579|69098770|FG005|Overall Study|Lost to Follow-up|0|||
37632191|NCT05051579|69098771|FG006|Overall Study|Lost to Follow-up|1|||
37632192|NCT05051579|69098765|FG000|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
37632193|NCT05051579|69098766|FG001|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
37632194|NCT05051579|69098767|FG002|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
37632195|NCT05051579|69098768|FG003|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
37632196|NCT05051579|69098769|FG004|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
37632197|NCT05051579|69098770|FG005|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
37632198|NCT05051579|69098771|FG006|Overall Study|Subject Unable to Visit Due to Working Out of Town|1|||
37632199|NCT05051579|69098765|FG000|Overall Study|Adverse Event|2|||
37632200|NCT05051579|69098766|FG001|Overall Study|Adverse Event|1|||
37632201|NCT05051579|69098767|FG002|Overall Study|Adverse Event|0|||
37632202|NCT05051579|69098768|FG003|Overall Study|Adverse Event|4|||
37632203|NCT05051579|69098769|FG004|Overall Study|Adverse Event|1|||
37632204|NCT05051579|69098770|FG005|Overall Study|Adverse Event|2|||
37632205|NCT05051579|69098771|FG006|Overall Study|Adverse Event|0|||
37632206|NCT05051579|69098765|FG000|Overall Study|Inadvertent Enrollment|0|||
37632207|NCT05051579|69098766|FG001|Overall Study|Inadvertent Enrollment|0|||
37632208|NCT05051579|69098767|FG002|Overall Study|Inadvertent Enrollment|0|||
37632209|NCT05051579|69098768|FG003|Overall Study|Inadvertent Enrollment|0|||
37632210|NCT05051579|69098769|FG004|Overall Study|Inadvertent Enrollment|0|||
37632211|NCT05051579|69098770|FG005|Overall Study|Inadvertent Enrollment|0|||
37632212|NCT05051579|69098771|FG006|Overall Study|Inadvertent Enrollment|1|||
37632213|NCT05051579|69098765|FG000|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
37632214|NCT05051579|69098766|FG001|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|1|||
37632215|NCT05051579|69098767|FG002|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
37632216|NCT05051579|69098768|FG003|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
37632217|NCT05051579|69098769|FG004|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
37632218|NCT05051579|69098770|FG005|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
37853324|NCT01867333|69537217|FG000|Overall Study|Adverse Event|1|||
37853325|NCT01867333|69537218|FG001|Overall Study|Adverse Event|0|||
37853326|NCT01867333|69537217|FG000|Overall Study|Participant choice|1|||
37853327|NCT01867333|69537218|FG001|Overall Study|Participant choice|2|||
37632219|NCT05051579|69098771|FG006|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
37632220|NCT05051579|69098765|FG000|Overall Study|Sponsor Decision|0|||
37632221|NCT05051579|69098766|FG001|Overall Study|Sponsor Decision|0|||
37632222|NCT05051579|69098767|FG002|Overall Study|Sponsor Decision|0|||
37632223|NCT05051579|69098768|FG003|Overall Study|Sponsor Decision|0|||
37632224|NCT05051579|69098769|FG004|Overall Study|Sponsor Decision|1|||
37921707|NCT00820950|69608462|FG005|Overall Study|Protocol Violation|0|||
37632225|NCT05051579|69098770|FG005|Overall Study|Sponsor Decision|0|||
37632226|NCT05051579|69098771|FG006|Overall Study|Sponsor Decision|0|||
37632227|NCT05051579|69098765|FG000|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
37632228|NCT05051579|69098766|FG001|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
37632229|NCT05051579|69098767|FG002|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
37632230|NCT05051579|69098768|FG003|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
37632231|NCT05051579|69098769|FG004|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|1|||
37632232|NCT05051579|69098770|FG005|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
37632233|NCT05051579|69098771|FG006|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
37632238|NCT04964128|69098799|FG000|Phase 1 (Software Release Tag 1.0)|Withdrawal by Subject|1|||
37632239|NCT04964128|69098799|FG000|Phase 2 (Software Release Tag 2.0)|Physician Decision|1|||
37632240|NCT04881760|69098814|FG000|Overall Study|Adverse Event|0|||
37632241|NCT04881760|69098815|FG001|Overall Study|Adverse Event|1|||
37632242|NCT04881760|69098816|FG002|Overall Study|Adverse Event|1|||
37632243|NCT04881760|69098817|FG003|Overall Study|Adverse Event|0|||
37632244|NCT04881760|69098818|FG004|Overall Study|Adverse Event|1|||
37632245|NCT04881760|69098819|FG005|Overall Study|Adverse Event|1|||
37632246|NCT04881760|69098820|FG006|Overall Study|Adverse Event|2|||
37632247|NCT04881760|69098814|FG000|Overall Study|Death|0|||
37632248|NCT04881760|69098815|FG001|Overall Study|Death|0|||
37632249|NCT04881760|69098816|FG002|Overall Study|Death|0|||
37632250|NCT04881760|69098817|FG003|Overall Study|Death|1|||
37632251|NCT04881760|69098818|FG004|Overall Study|Death|0|||
37632252|NCT04881760|69098819|FG005|Overall Study|Death|0|||
37632253|NCT04881760|69098820|FG006|Overall Study|Death|0|||
37632254|NCT04881760|69098814|FG000|Overall Study|Lost to Follow-up|5|||
37632255|NCT04881760|69098815|FG001|Overall Study|Lost to Follow-up|7|||
37632256|NCT04881760|69098816|FG002|Overall Study|Lost to Follow-up|5|||
37632257|NCT04881760|69098817|FG003|Overall Study|Lost to Follow-up|1|||
37632258|NCT04881760|69098818|FG004|Overall Study|Lost to Follow-up|2|||
37632259|NCT04881760|69098819|FG005|Overall Study|Lost to Follow-up|4|||
37632260|NCT04881760|69098820|FG006|Overall Study|Lost to Follow-up|4|||
37632261|NCT04881760|69098814|FG000|Overall Study|Withdrawal by Subject|13|||
37632262|NCT04881760|69098815|FG001|Overall Study|Withdrawal by Subject|1|||
37632263|NCT04881760|69098816|FG002|Overall Study|Withdrawal by Subject|1|||
37632264|NCT04881760|69098817|FG003|Overall Study|Withdrawal by Subject|4|||
37632265|NCT04881760|69098818|FG004|Overall Study|Withdrawal by Subject|2|||
37632266|NCT04881760|69098819|FG005|Overall Study|Withdrawal by Subject|1|||
37632267|NCT04881760|69098820|FG006|Overall Study|Withdrawal by Subject|2|||
37632268|NCT04881760|69098814|FG000|Overall Study|Randomized but Never Treated|0|||
37632269|NCT04881760|69098815|FG001|Overall Study|Randomized but Never Treated|0|||
37632270|NCT04881760|69098816|FG002|Overall Study|Randomized but Never Treated|0|||
37632271|NCT04881760|69098817|FG003|Overall Study|Randomized but Never Treated|1|||
37632272|NCT04881760|69098818|FG004|Overall Study|Randomized but Never Treated|0|||
37632273|NCT04881760|69098819|FG005|Overall Study|Randomized but Never Treated|0|||
37632274|NCT04881760|69098820|FG006|Overall Study|Randomized but Never Treated|0|||
37632275|NCT04881760|69098814|FG000|Overall Study|Inadvertent Enrollment|2|||
37632276|NCT04881760|69098815|FG001|Overall Study|Inadvertent Enrollment|0|||
37632277|NCT04881760|69098816|FG002|Overall Study|Inadvertent Enrollment|0|||
37632278|NCT04881760|69098817|FG003|Overall Study|Inadvertent Enrollment|0|||
37632279|NCT04881760|69098818|FG004|Overall Study|Inadvertent Enrollment|0|||
37632280|NCT04881760|69098819|FG005|Overall Study|Inadvertent Enrollment|0|||
37632281|NCT04881760|69098820|FG006|Overall Study|Inadvertent Enrollment|0|||
37632282|NCT04881760|69098814|FG000|Overall Study|Site Closure|0|||
37632283|NCT04881760|69098815|FG001|Overall Study|Site Closure|0|||
37632284|NCT04881760|69098816|FG002|Overall Study|Site Closure|0|||
37632285|NCT04881760|69098817|FG003|Overall Study|Site Closure|1|||
37921708|NCT00820950|69608463|FG006|Overall Study|Protocol Violation|0|||
37921709|NCT00820950|69608464|FG007|Overall Study|Protocol Violation|0|||
38031864|NCT03351608|69717632|FG000|Overall Study|Withdrawal by parent/guardian|0|||
38031865|NCT03351608|69717633|FG001|Overall Study|Withdrawal by parent/guardian|0|||
37632286|NCT04881760|69098818|FG004|Overall Study|Site Closure|0|||
37632287|NCT04881760|69098819|FG005|Overall Study|Site Closure|0|||
37632288|NCT04881760|69098820|FG006|Overall Study|Site Closure|0|||
37632289|NCT04749797|69098839|FG000|Overall Study|Did not meet I/E criteria after surgery|1|||
37632290|NCT04749797|69098840|FG001|Overall Study|Did not meet I/E criteria after surgery|0|||
37632291|NCT04749797|69098841|FG002|Overall Study|Did not meet I/E criteria after surgery|0|||
37632292|NCT04747275|69098851|FG000|Overall Study|Study terminated|0|||
38031866|NCT03351608|69717634|FG002|Overall Study|Withdrawal by parent/guardian|1|||
37632293|NCT04747275|69098852|FG001|Overall Study|Study terminated|1|||
37632294|NCT04654468|69098858|FG000|Overall Study|Death|1|||
37632295|NCT04654468|69098858|FG000|Overall Study|Ongoing in the Study|50|||
37632296|NCT04556552|69098864|FG000|Overall Study|Lost to Follow-up|1|||
37632297|NCT04556552|69098865|FG001|Overall Study|Lost to Follow-up|0|||
37632298|NCT04556552|69098864|FG000|Overall Study|Claustrophobia|0|||
37632299|NCT04556552|69098865|FG001|Overall Study|Claustrophobia|1|||
37632300|NCT04556552|69098864|FG000|Overall Study|Inability to continue|0|||
37632301|NCT04556552|69098865|FG001|Overall Study|Inability to continue|1|||
37632302|NCT04496167|69098873|FG000|Overall Study|Adverse Event|6|||
37632303|NCT04496167|69098874|FG001|Overall Study|Adverse Event|2|||
37632304|NCT04496167|69098873|FG000|Overall Study|Withdrawal by Subject|7|||
37632305|NCT04496167|69098874|FG001|Overall Study|Withdrawal by Subject|6|||
37632306|NCT04496167|69098873|FG000|Overall Study|Lost to Follow-up|3|||
37632307|NCT04496167|69098874|FG001|Overall Study|Lost to Follow-up|5|||
37632308|NCT04496167|69098873|FG000|Overall Study|Not Treated|1|||
37632309|NCT04496167|69098874|FG001|Overall Study|Not Treated|2|||
37632310|NCT04496167|69098873|FG000|Overall Study|Other Than Specified|1|||
37632311|NCT04496167|69098874|FG001|Overall Study|Other Than Specified|1|||
37632312|NCT04238481|69098917|FG000|Overall Study|Miscellaneous|0|||
37632313|NCT04238481|69098918|FG001|Overall Study|Miscellaneous|1|||
37632314|NCT04238481|69098919|FG002|Overall Study|Miscellaneous|0|||
37632315|NCT04238481|69098920|FG003|Overall Study|Miscellaneous|0|||
37632316|NCT04145700|69098932|FG000|Overall Study|Withdrawal by Subject|8|||
37632317|NCT04145700|69098933|FG001|Overall Study|Withdrawal by Subject|3|||
37632318|NCT04079738|69098939|FG000|Study Treatment|Death|1|||
37632319|NCT04079738|69098940|FG001|Study Treatment|Death|0|||
37632320|NCT04079738|69098941|FG002|Study Treatment|Death|0|||
37632321|NCT04079738|69098942|FG003|Study Treatment|Death|0|||
37632322|NCT04079738|69098939|FG000|Study Treatment|Adverse Event|2|||
37632323|NCT04079738|69098940|FG001|Study Treatment|Adverse Event|0|||
37632324|NCT04079738|69098941|FG002|Study Treatment|Adverse Event|0|||
37632325|NCT04079738|69098942|FG003|Study Treatment|Adverse Event|0|||
37632326|NCT04079738|69098939|FG000|Study Treatment|withdrawal before treatment|1|||
37632327|NCT04079738|69098940|FG001|Study Treatment|withdrawal before treatment|0|||
37632328|NCT04079738|69098941|FG002|Study Treatment|withdrawal before treatment|0|||
37632329|NCT04079738|69098942|FG003|Study Treatment|withdrawal before treatment|0|||
37632330|NCT04079738|69098939|FG000|Study Treatment|symptomatic deterioration|2|||
37632331|NCT04079738|69098940|FG001|Study Treatment|symptomatic deterioration|0|||
37632332|NCT04079738|69098941|FG002|Study Treatment|symptomatic deterioration|0|||
37632333|NCT04079738|69098942|FG003|Study Treatment|symptomatic deterioration|0|||
37632334|NCT04079738|69098939|FG000|Study Treatment|Disease Progression|1|||
37632335|NCT04079738|69098940|FG001|Study Treatment|Disease Progression|0|||
37632336|NCT04079738|69098941|FG002|Study Treatment|Disease Progression|0|||
37632337|NCT04079738|69098942|FG003|Study Treatment|Disease Progression|0|||
37632338|NCT04079738|69098939|FG000|Study Treatment|withdrawal after treatment|1|||
37632339|NCT04079738|69098940|FG001|Study Treatment|withdrawal after treatment|0|||
37632340|NCT04079738|69098941|FG002|Study Treatment|withdrawal after treatment|0|||
37632341|NCT04079738|69098942|FG003|Study Treatment|withdrawal after treatment|0|||
37632342|NCT04079738|69098939|FG000|Follow up|Withdrawal by Subject|3|||
37632343|NCT04079738|69098940|FG001|Follow up|Withdrawal by Subject|0|||
37632344|NCT04079738|69098941|FG002|Follow up|Withdrawal by Subject|0|||
37632345|NCT04079738|69098942|FG003|Follow up|Withdrawal by Subject|0|||
37632346|NCT04079738|69098939|FG000|Follow up|Death|5|||
37632347|NCT04079738|69098940|FG001|Follow up|Death|0|||
37632348|NCT04079738|69098941|FG002|Follow up|Death|0|||
37632349|NCT04079738|69098942|FG003|Follow up|Death|0|||
37632350|NCT04054635|69098951|FG000|Second Visit (First Follow-up)|Lost to Follow-up|0|||
37632351|NCT04054635|69098952|FG001|Second Visit (First Follow-up)|Lost to Follow-up|1|||
37632352|NCT04054635|69098953|FG002|Second Visit (First Follow-up)|Lost to Follow-up|0|||
37632353|NCT04054635|69098951|FG000|Third Visit (Second Follow-up)|Lost to Follow-up|1|||
37632354|NCT04054635|69098952|FG001|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
37853328|NCT01867333|69537217|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
37853329|NCT01867333|69537218|FG001|Overall Study|Complicating disease/intercurrent illness|0|||
37632355|NCT04054635|69098953|FG002|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
37632356|NCT03820726|69098961|FG000|Overall Study|Other than listed|23|||
37632357|NCT03820726|69098961|FG000|Overall Study|Withdrawal by Subject|37|||
37632358|NCT03820726|69098961|FG000|Overall Study|Lost to Follow-up|3|||
37632359|NCT03820726|69098961|FG000|Overall Study|Protocol deviation|1|||
37632360|NCT03820726|69098961|FG000|Overall Study|Adverse Event|146|||
37632361|NCT03820726|69098961|FG000|Overall Study|Not treated|1|||
37632362|NCT03744312|69098967|FG000|Overall Study|Withdrawal by Subject|0|||
37632363|NCT03744312|69098968|FG001|Overall Study|Withdrawal by Subject|1|||
37632364|NCT03744312|69098967|FG000|Overall Study|Screen fail|0|||
37632365|NCT03744312|69098968|FG001|Overall Study|Screen fail|1|||
37632366|NCT03737123|69098976|FG000|Study Treatment|Adverse Event|2|||
37632367|NCT03737123|69098977|FG001|Study Treatment|Adverse Event|0|||
37632368|NCT03737123|69098976|FG000|Study Treatment|Disease Progression|2|||
37632369|NCT03737123|69098977|FG001|Study Treatment|Disease Progression|0|||
37632370|NCT03737123|69098976|FG000|Study Treatment|Withdrawal by Subject|2|||
37632371|NCT03737123|69098977|FG001|Study Treatment|Withdrawal by Subject|0|||
37632372|NCT03737123|69098976|FG000|Follow up|Death|1|||
37632373|NCT03737123|69098977|FG001|Follow up|Death|0|||
37632374|NCT03737123|69098976|FG000|Follow up|Withdrawal by Subject|1|||
37632375|NCT03737123|69098977|FG001|Follow up|Withdrawal by Subject|0|||
37632376|NCT03737123|69098976|FG000|Follow up|Termination of study|4|||
37632377|NCT03737123|69098977|FG001|Follow up|Termination of study|0|||
37632378|NCT03502707|69099009|FG000|Overall Study|Adverse Event|0|||
37632379|NCT03502707|69099010|FG001|Overall Study|Adverse Event|0|||
37632380|NCT03502707|69099011|FG002|Overall Study|Adverse Event|0|||
37632381|NCT03502707|69099012|FG003|Overall Study|Adverse Event|0|||
37632382|NCT03502707|69099013|FG004|Overall Study|Adverse Event|0|||
37632383|NCT03502707|69099014|FG005|Overall Study|Adverse Event|0|||
37632384|NCT03502707|69099015|FG006|Overall Study|Adverse Event|0|||
37632385|NCT03502707|69099016|FG007|Overall Study|Adverse Event|0|||
37632386|NCT03502707|69099017|FG008|Overall Study|Adverse Event|0|||
37632387|NCT03502707|69099018|FG009|Overall Study|Adverse Event|0|||
37632388|NCT03502707|69099019|FG010|Overall Study|Adverse Event|0|||
37632389|NCT03502707|69099020|FG011|Overall Study|Adverse Event|0|||
37632390|NCT03502707|69099021|FG012|Overall Study|Adverse Event|0|||
37632391|NCT03502707|69099022|FG013|Overall Study|Adverse Event|0|||
37632392|NCT03502707|69099023|FG014|Overall Study|Adverse Event|0|||
37632393|NCT03502707|69099024|FG015|Overall Study|Adverse Event|1|||
37632394|NCT03502707|69099025|FG016|Overall Study|Adverse Event|5|||
37632395|NCT03502707|69099026|FG017|Overall Study|Adverse Event|0|||
37632396|NCT03502707|69099009|FG000|Overall Study|Death|0|||
37632397|NCT03502707|69099010|FG001|Overall Study|Death|0|||
37632398|NCT03502707|69099011|FG002|Overall Study|Death|0|||
37632399|NCT03502707|69099012|FG003|Overall Study|Death|1|||
37632400|NCT03502707|69099013|FG004|Overall Study|Death|0|||
37632401|NCT03502707|69099014|FG005|Overall Study|Death|0|||
37632402|NCT03502707|69099015|FG006|Overall Study|Death|0|||
37632403|NCT03502707|69099016|FG007|Overall Study|Death|0|||
37632404|NCT03502707|69099017|FG008|Overall Study|Death|1|||
37632405|NCT03502707|69099018|FG009|Overall Study|Death|1|||
37632406|NCT03502707|69099019|FG010|Overall Study|Death|0|||
37632407|NCT03502707|69099020|FG011|Overall Study|Death|0|||
37632408|NCT03502707|69099021|FG012|Overall Study|Death|1|||
37632409|NCT03502707|69099022|FG013|Overall Study|Death|0|||
37632410|NCT03502707|69099023|FG014|Overall Study|Death|0|||
37632411|NCT03502707|69099024|FG015|Overall Study|Death|1|||
37632412|NCT03502707|69099025|FG016|Overall Study|Death|0|||
37632413|NCT03502707|69099026|FG017|Overall Study|Death|0|||
37632414|NCT03502707|69099009|FG000|Overall Study|Lost to Follow-up|0|||
37632415|NCT03502707|69099010|FG001|Overall Study|Lost to Follow-up|0|||
37632416|NCT03502707|69099011|FG002|Overall Study|Lost to Follow-up|0|||
37632417|NCT03502707|69099012|FG003|Overall Study|Lost to Follow-up|0|||
37632418|NCT03502707|69099013|FG004|Overall Study|Lost to Follow-up|0|||
37632419|NCT03502707|69099014|FG005|Overall Study|Lost to Follow-up|0|||
37632420|NCT03502707|69099015|FG006|Overall Study|Lost to Follow-up|0|||
37632421|NCT03502707|69099016|FG007|Overall Study|Lost to Follow-up|5|||
37632422|NCT03502707|69099017|FG008|Overall Study|Lost to Follow-up|0|||
37632423|NCT03502707|69099018|FG009|Overall Study|Lost to Follow-up|2|||
37632424|NCT03502707|69099019|FG010|Overall Study|Lost to Follow-up|1|||
37632425|NCT03502707|69099020|FG011|Overall Study|Lost to Follow-up|2|||
37632426|NCT03502707|69099021|FG012|Overall Study|Lost to Follow-up|1|||
37632427|NCT03502707|69099022|FG013|Overall Study|Lost to Follow-up|1|||
37632428|NCT03502707|69099023|FG014|Overall Study|Lost to Follow-up|0|||
37632429|NCT03502707|69099024|FG015|Overall Study|Lost to Follow-up|4|||
37632430|NCT03502707|69099025|FG016|Overall Study|Lost to Follow-up|9|||
37632431|NCT03502707|69099026|FG017|Overall Study|Lost to Follow-up|2|||
37632432|NCT03502707|69099009|FG000|Overall Study|Physician Decision|0|||
37632433|NCT03502707|69099010|FG001|Overall Study|Physician Decision|0|||
37632434|NCT03502707|69099011|FG002|Overall Study|Physician Decision|0|||
37632435|NCT03502707|69099012|FG003|Overall Study|Physician Decision|0|||
37853330|NCT01867333|69537217|FG000|Overall Study|Death|0|||
37853331|NCT01867333|69537218|FG001|Overall Study|Death|1|||
37853332|NCT01867333|69537217|FG000|Overall Study|Physician Decision|3|||
37632436|NCT03502707|69099013|FG004|Overall Study|Physician Decision|0|||
37853333|NCT01867333|69537218|FG001|Overall Study|Physician Decision|2|||
37632437|NCT03502707|69099014|FG005|Overall Study|Physician Decision|0|||
37632438|NCT03502707|69099015|FG006|Overall Study|Physician Decision|0|||
37853334|NCT01867333|69537217|FG000|Overall Study|Switched to alternative treatment|1|||
37853335|NCT01867333|69537218|FG001|Overall Study|Switched to alternative treatment|0|||
37632439|NCT03502707|69099016|FG007|Overall Study|Physician Decision|0|||
37632440|NCT03502707|69099017|FG008|Overall Study|Physician Decision|2|||
37632441|NCT03502707|69099018|FG009|Overall Study|Physician Decision|1|||
37632442|NCT03502707|69099019|FG010|Overall Study|Physician Decision|0|||
37632443|NCT03502707|69099020|FG011|Overall Study|Physician Decision|0|||
37632444|NCT03502707|69099021|FG012|Overall Study|Physician Decision|0|||
37632445|NCT03502707|69099022|FG013|Overall Study|Physician Decision|0|||
37632446|NCT03502707|69099023|FG014|Overall Study|Physician Decision|1|||
37632447|NCT03502707|69099024|FG015|Overall Study|Physician Decision|3|||
37632448|NCT03502707|69099025|FG016|Overall Study|Physician Decision|0|||
37632449|NCT03502707|69099026|FG017|Overall Study|Physician Decision|0|||
37632450|NCT03502707|69099009|FG000|Overall Study|Protocol Violation|0|||
37632451|NCT03502707|69099010|FG001|Overall Study|Protocol Violation|0|||
37632452|NCT03502707|69099011|FG002|Overall Study|Protocol Violation|0|||
37632453|NCT03502707|69099012|FG003|Overall Study|Protocol Violation|0|||
37632454|NCT03502707|69099013|FG004|Overall Study|Protocol Violation|0|||
37632455|NCT03502707|69099014|FG005|Overall Study|Protocol Violation|0|||
37632456|NCT03502707|69099015|FG006|Overall Study|Protocol Violation|0|||
37632457|NCT03502707|69099016|FG007|Overall Study|Protocol Violation|0|||
37632458|NCT03502707|69099017|FG008|Overall Study|Protocol Violation|0|||
37632459|NCT03502707|69099018|FG009|Overall Study|Protocol Violation|0|||
37632460|NCT03502707|69099019|FG010|Overall Study|Protocol Violation|0|||
37632461|NCT03502707|69099020|FG011|Overall Study|Protocol Violation|0|||
37632462|NCT03502707|69099021|FG012|Overall Study|Protocol Violation|0|||
37632463|NCT03502707|69099022|FG013|Overall Study|Protocol Violation|0|||
37632464|NCT03502707|69099023|FG014|Overall Study|Protocol Violation|0|||
37632465|NCT03502707|69099024|FG015|Overall Study|Protocol Violation|1|||
37632466|NCT03502707|69099025|FG016|Overall Study|Protocol Violation|0|||
37632467|NCT03502707|69099026|FG017|Overall Study|Protocol Violation|0|||
37632468|NCT03502707|69099009|FG000|Overall Study|Withdrawal by Subject|1|||
37632469|NCT03502707|69099010|FG001|Overall Study|Withdrawal by Subject|1|||
37632470|NCT03502707|69099011|FG002|Overall Study|Withdrawal by Subject|0|||
37632471|NCT03502707|69099012|FG003|Overall Study|Withdrawal by Subject|0|||
37632472|NCT03502707|69099013|FG004|Overall Study|Withdrawal by Subject|0|||
37632473|NCT03502707|69099014|FG005|Overall Study|Withdrawal by Subject|2|||
37632474|NCT03502707|69099015|FG006|Overall Study|Withdrawal by Subject|0|||
37632475|NCT03502707|69099016|FG007|Overall Study|Withdrawal by Subject|3|||
37632476|NCT03502707|69099017|FG008|Overall Study|Withdrawal by Subject|1|||
37632477|NCT03502707|69099018|FG009|Overall Study|Withdrawal by Subject|2|||
37632478|NCT03502707|69099019|FG010|Overall Study|Withdrawal by Subject|12|||
37632479|NCT03502707|69099020|FG011|Overall Study|Withdrawal by Subject|23|||
37632480|NCT03502707|69099021|FG012|Overall Study|Withdrawal by Subject|5|||
37632481|NCT03502707|69099022|FG013|Overall Study|Withdrawal by Subject|3|||
37632482|NCT03502707|69099023|FG014|Overall Study|Withdrawal by Subject|3|||
37632483|NCT03502707|69099024|FG015|Overall Study|Withdrawal by Subject|43|||
37632484|NCT03502707|69099025|FG016|Overall Study|Withdrawal by Subject|44|||
37632485|NCT03502707|69099026|FG017|Overall Study|Withdrawal by Subject|18|||
37632486|NCT03502707|69099009|FG000|Overall Study|Sponsor's Decision|1|||
37632487|NCT03502707|69099010|FG001|Overall Study|Sponsor's Decision|0|||
37632488|NCT03502707|69099011|FG002|Overall Study|Sponsor's Decision|0|||
37632489|NCT03502707|69099012|FG003|Overall Study|Sponsor's Decision|0|||
37632490|NCT03502707|69099013|FG004|Overall Study|Sponsor's Decision|0|||
37632491|NCT03502707|69099014|FG005|Overall Study|Sponsor's Decision|0|||
37632492|NCT03502707|69099015|FG006|Overall Study|Sponsor's Decision|0|||
37632493|NCT03502707|69099016|FG007|Overall Study|Sponsor's Decision|0|||
37632494|NCT03502707|69099017|FG008|Overall Study|Sponsor's Decision|0|||
37632495|NCT03502707|69099018|FG009|Overall Study|Sponsor's Decision|1|||
37632496|NCT03502707|69099019|FG010|Overall Study|Sponsor's Decision|0|||
37632497|NCT03502707|69099020|FG011|Overall Study|Sponsor's Decision|0|||
37632498|NCT03502707|69099021|FG012|Overall Study|Sponsor's Decision|0|||
37632499|NCT03502707|69099022|FG013|Overall Study|Sponsor's Decision|0|||
37632500|NCT03502707|69099023|FG014|Overall Study|Sponsor's Decision|0|||
37632501|NCT03502707|69099024|FG015|Overall Study|Sponsor's Decision|2|||
37632502|NCT03502707|69099025|FG016|Overall Study|Sponsor's Decision|1|||
37632503|NCT03502707|69099026|FG017|Overall Study|Sponsor's Decision|0|||
37632504|NCT03502707|69099009|FG000|Overall Study|Initiated Prohibited Medication|0|||
37632505|NCT03502707|69099010|FG001|Overall Study|Initiated Prohibited Medication|0|||
37853336|NCT01534494|69537224|FG000|Overall Study|Withdrawal by Subject|1|||
37853337|NCT00788671|69537237|FG000|Overall Study|Death|2|||
37853338|NCT00788671|69537237|FG000|Overall Study|Unable to biopsy|1|||
37853339|NCT00788671|69537237|FG000|Overall Study|Withdrawal by Subject|4|||
37853340|NCT00788671|69537237|FG000|Overall Study|IUD expulsed|1|||
37853341|NCT00788671|69537237|FG000|Overall Study|Lost to follow up|2|||
37853342|NCT00602797|69537241|FG000|Overall Study|Adverse Event|1|||
37853343|NCT00550615|69537248|FG000|Overall Study|Withdrawal by Subject|0|||
37632506|NCT03502707|69099011|FG002|Overall Study|Initiated Prohibited Medication|0|||
37632507|NCT03502707|69099012|FG003|Overall Study|Initiated Prohibited Medication|0|||
37632508|NCT03502707|69099013|FG004|Overall Study|Initiated Prohibited Medication|0|||
37632509|NCT03502707|69099014|FG005|Overall Study|Initiated Prohibited Medication|0|||
37632510|NCT03502707|69099015|FG006|Overall Study|Initiated Prohibited Medication|0|||
37632511|NCT03502707|69099016|FG007|Overall Study|Initiated Prohibited Medication|0|||
37632512|NCT03502707|69099017|FG008|Overall Study|Initiated Prohibited Medication|0|||
37632513|NCT03502707|69099018|FG009|Overall Study|Initiated Prohibited Medication|0|||
37632514|NCT03502707|69099019|FG010|Overall Study|Initiated Prohibited Medication|0|||
37853344|NCT00550615|69537249|FG001|Overall Study|Withdrawal by Subject|0|||
37853345|NCT00550615|69537250|FG002|Overall Study|Withdrawal by Subject|2|||
37853346|NCT00550615|69537251|FG003|Overall Study|Withdrawal by Subject|3|||
37853347|NCT00550615|69537248|FG000|Overall Study|Not evaluable|0|||
37853348|NCT00550615|69537249|FG001|Overall Study|Not evaluable|0|||
37853349|NCT00550615|69537250|FG002|Overall Study|Not evaluable|2|||
37853350|NCT00550615|69537251|FG003|Overall Study|Not evaluable|7|||
37853351|NCT00006721|69537264|FG000|Overall Study|Adverse Event|0|||
37853352|NCT00006721|69537265|FG001|Overall Study|Adverse Event|4|||
37853353|NCT00006721|69537266|FG002|Overall Study|Adverse Event|4|||
37632515|NCT03502707|69099020|FG011|Overall Study|Initiated Prohibited Medication|0|||
37632516|NCT03502707|69099021|FG012|Overall Study|Initiated Prohibited Medication|0|||
37632517|NCT03502707|69099022|FG013|Overall Study|Initiated Prohibited Medication|0|||
37632518|NCT03502707|69099023|FG014|Overall Study|Initiated Prohibited Medication|0|||
37632519|NCT03502707|69099024|FG015|Overall Study|Initiated Prohibited Medication|0|||
37632520|NCT03502707|69099025|FG016|Overall Study|Initiated Prohibited Medication|1|||
37632521|NCT03502707|69099026|FG017|Overall Study|Initiated Prohibited Medication|0|||
37632522|NCT03502707|69099009|FG000|Overall Study|Other|0|||
37632523|NCT03502707|69099010|FG001|Overall Study|Other|0|||
37632524|NCT03502707|69099011|FG002|Overall Study|Other|0|||
37632525|NCT03502707|69099012|FG003|Overall Study|Other|0|||
37632526|NCT03502707|69099013|FG004|Overall Study|Other|0|||
37632527|NCT03502707|69099014|FG005|Overall Study|Other|0|||
37632528|NCT03502707|69099015|FG006|Overall Study|Other|0|||
37632529|NCT03502707|69099016|FG007|Overall Study|Other|0|||
37632530|NCT03502707|69099017|FG008|Overall Study|Other|1|||
37632531|NCT03502707|69099018|FG009|Overall Study|Other|1|||
37632532|NCT03502707|69099019|FG010|Overall Study|Other|2|||
37632533|NCT03502707|69099020|FG011|Overall Study|Other|0|||
37632534|NCT03502707|69099021|FG012|Overall Study|Other|0|||
37632535|NCT03502707|69099022|FG013|Overall Study|Other|0|||
37632536|NCT03502707|69099023|FG014|Overall Study|Other|0|||
37632537|NCT03502707|69099024|FG015|Overall Study|Other|4|||
37632538|NCT03502707|69099025|FG016|Overall Study|Other|1|||
37632539|NCT03502707|69099026|FG017|Overall Study|Other|0|||
37632540|NCT03502707|69099009|FG000|Overall Study|Randomized but not vaccinated|0|||
37632541|NCT03502707|69099010|FG001|Overall Study|Randomized but not vaccinated|0|||
37632542|NCT03502707|69099011|FG002|Overall Study|Randomized but not vaccinated|0|||
37632543|NCT03502707|69099012|FG003|Overall Study|Randomized but not vaccinated|0|||
37632544|NCT03502707|69099013|FG004|Overall Study|Randomized but not vaccinated|0|||
37632545|NCT03502707|69099014|FG005|Overall Study|Randomized but not vaccinated|0|||
37632546|NCT03502707|69099015|FG006|Overall Study|Randomized but not vaccinated|0|||
37632547|NCT03502707|69099016|FG007|Overall Study|Randomized but not vaccinated|0|||
37632548|NCT03502707|69099017|FG008|Overall Study|Randomized but not vaccinated|0|||
37632549|NCT03502707|69099018|FG009|Overall Study|Randomized but not vaccinated|0|||
37632550|NCT03502707|69099019|FG010|Overall Study|Randomized but not vaccinated|0|||
37632551|NCT03502707|69099020|FG011|Overall Study|Randomized but not vaccinated|1|||
37632552|NCT03502707|69099021|FG012|Overall Study|Randomized but not vaccinated|0|||
37632553|NCT03502707|69099022|FG013|Overall Study|Randomized but not vaccinated|0|||
37632554|NCT03502707|69099023|FG014|Overall Study|Randomized but not vaccinated|0|||
37632555|NCT03502707|69099024|FG015|Overall Study|Randomized but not vaccinated|0|||
37632556|NCT03502707|69099025|FG016|Overall Study|Randomized but not vaccinated|0|||
37632557|NCT03502707|69099026|FG017|Overall Study|Randomized but not vaccinated|1|||
37632558|NCT03425006|69099076|FG000|Overall Study|Withdrawal by Subject|1|||
37632559|NCT03425006|69099076|FG000|Overall Study|Physician Decision|1|||
37632560|NCT03425006|69099076|FG000|Overall Study|Death|1|||
37632561|NCT03401073|69099082|FG000|Overall Study|Lost to Follow-up|1|||
37632562|NCT03401073|69099083|FG001|Overall Study|Lost to Follow-up|2|||
37632563|NCT03299049|69099091|FG000|Overall Study|On-going|486|||
37632564|NCT03299049|69099092|FG001|Overall Study|On-going|481|||
37632565|NCT03299049|69099091|FG000|Overall Study|Withdrawal by Subject|6|||
37632566|NCT03299049|69099092|FG001|Overall Study|Withdrawal by Subject|21|||
37632567|NCT03299049|69099091|FG000|Overall Study|Physician Decision|5|||
37632568|NCT03299049|69099092|FG001|Overall Study|Physician Decision|1|||
37632569|NCT03299049|69099091|FG000|Overall Study|Lost to Follow-up|2|||
37632570|NCT03299049|69099092|FG001|Overall Study|Lost to Follow-up|0|||
37632571|NCT03299049|69099091|FG000|Overall Study|Pregnancy|1|||
37632572|NCT03299049|69099092|FG001|Overall Study|Pregnancy|3|||
37632573|NCT03299049|69099091|FG000|Overall Study|Protocol Violation|1|||
37632574|NCT03299049|69099092|FG001|Overall Study|Protocol Violation|1|||
37632575|NCT03299049|69099091|FG000|Overall Study|Lack of Efficacy|9|||
37632576|NCT03299049|69099092|FG001|Overall Study|Lack of Efficacy|3|||
37632577|NCT03299049|69099091|FG000|Overall Study|Adverse Event|12|||
37632578|NCT03299049|69099092|FG001|Overall Study|Adverse Event|13|||
37853354|NCT00006721|69537264|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
37853355|NCT00006721|69537265|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
37853356|NCT00006721|69537266|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
37632579|NCT03173560|69099111|FG000|Overall Study|Ongoing on Treatment|38|||
37632580|NCT03173560|69099112|FG001|Overall Study|Ongoing on Treatment|50|||
37632581|NCT03173560|69099111|FG000|Overall Study|Ongoing Survival Follow-up|56|||
37632582|NCT03173560|69099112|FG001|Overall Study|Ongoing Survival Follow-up|57|||
37632583|NCT03173560|69099111|FG000|Overall Study|Lost to Follow-up|1|||
37632584|NCT03173560|69099112|FG001|Overall Study|Lost to Follow-up|4|||
37632585|NCT03173560|69099111|FG000|Overall Study|Withdrawal by Subject|10|||
37632586|NCT03173560|69099112|FG001|Overall Study|Withdrawal by Subject|5|||
37632587|NCT03173560|69099111|FG000|Overall Study|Other|0|||
37632588|NCT03173560|69099112|FG001|Overall Study|Other|1|||
37632589|NCT02915263|69099133|FG000|Overall Study|Covid|3|||
37632590|NCT02915263|69099134|FG001|Overall Study|Covid|2|||
37632591|NCT02343952|69099140|FG000|Study Treatment|Disease Progression|23|||
37632592|NCT02343952|69099140|FG000|Study Treatment|Death|3|||
37632593|NCT02343952|69099140|FG000|Study Treatment|Adverse Event|19|||
37632594|NCT02343952|69099140|FG000|Study Treatment|Withdrawal by Subject|7|||
37632595|NCT02343952|69099140|FG000|Study Treatment|other complicating Diseases|1|||
37632596|NCT02343952|69099140|FG000|Follow up|Withdrawal by Subject|3|||
37632597|NCT02343952|69099140|FG000|Follow up|Death|33|||
37632598|NCT02343952|69099140|FG000|Follow up|Patient does not meet eligibility for study.|1|||
37632599|NCT02343952|69099140|FG000|Follow up|Research department closed by the practice.|5|||
37632600|NCT02343952|69099140|FG000|Follow up|Patient went home to Russia|1|||
37632601|NCT02343952|69099140|FG000|Follow up|Disease Progression|1|||
37632602|NCT02343952|69099140|FG000|Follow up|study terminated|1|||
37632603|NCT01592370|69099151|FG000|Overall Study|Disease Progression|62|||
37632604|NCT01592370|69099152|FG001|Overall Study|Disease Progression|16|||
37632605|NCT01592370|69099153|FG002|Overall Study|Disease Progression|52|||
37632606|NCT01592370|69099154|FG003|Overall Study|Disease Progression|3|||
37632607|NCT01592370|69099155|FG004|Overall Study|Disease Progression|3|||
37632608|NCT01592370|69099156|FG005|Overall Study|Disease Progression|31|||
37632609|NCT01592370|69099157|FG006|Overall Study|Disease Progression|14|||
37632610|NCT01592370|69099151|FG000|Overall Study|Study Drug Toxicity|14|||
37632611|NCT01592370|69099152|FG001|Overall Study|Study Drug Toxicity|3|||
37632612|NCT01592370|69099153|FG002|Overall Study|Study Drug Toxicity|0|||
37632613|NCT01592370|69099154|FG003|Overall Study|Study Drug Toxicity|0|||
37632614|NCT01592370|69099155|FG004|Overall Study|Study Drug Toxicity|0|||
37632615|NCT01592370|69099156|FG005|Overall Study|Study Drug Toxicity|0|||
37632616|NCT01592370|69099157|FG006|Overall Study|Study Drug Toxicity|1|||
37632617|NCT01592370|69099151|FG000|Overall Study|AE unrelated to study drug|4|||
37632618|NCT01592370|69099152|FG001|Overall Study|AE unrelated to study drug|3|||
37632619|NCT01592370|69099153|FG002|Overall Study|AE unrelated to study drug|0|||
37632620|NCT01592370|69099154|FG003|Overall Study|AE unrelated to study drug|0|||
37632621|NCT01592370|69099155|FG004|Overall Study|AE unrelated to study drug|0|||
37632622|NCT01592370|69099156|FG005|Overall Study|AE unrelated to study drug|0|||
37632623|NCT01592370|69099157|FG006|Overall Study|AE unrelated to study drug|1|||
37632624|NCT01592370|69099151|FG000|Overall Study|Request to discontinue study treatment|5|||
37632625|NCT01592370|69099152|FG001|Overall Study|Request to discontinue study treatment|0|||
37632626|NCT01592370|69099153|FG002|Overall Study|Request to discontinue study treatment|2|||
37632627|NCT01592370|69099154|FG003|Overall Study|Request to discontinue study treatment|0|||
37632628|NCT01592370|69099155|FG004|Overall Study|Request to discontinue study treatment|1|||
37632629|NCT01592370|69099156|FG005|Overall Study|Request to discontinue study treatment|2|||
37632630|NCT01592370|69099157|FG006|Overall Study|Request to discontinue study treatment|0|||
37632631|NCT01592370|69099151|FG000|Overall Study|Withdrew consent|1|||
37632632|NCT01592370|69099152|FG001|Overall Study|Withdrew consent|2|||
37632633|NCT01592370|69099153|FG002|Overall Study|Withdrew consent|1|||
37632634|NCT01592370|69099154|FG003|Overall Study|Withdrew consent|1|||
37632635|NCT01592370|69099155|FG004|Overall Study|Withdrew consent|0|||
37853357|NCT00006721|69537264|FG000|Overall Study|Progression/Relapse|0|||
37853358|NCT00006721|69537265|FG001|Overall Study|Progression/Relapse|1|||
37853359|NCT00006721|69537266|FG002|Overall Study|Progression/Relapse|2|||
37853360|NCT00006721|69537264|FG000|Overall Study|Death|0|||
37921710|NCT00820950|69608465|FG008|Overall Study|Protocol Violation|0|||
37921711|NCT00820950|69608466|FG009|Overall Study|Protocol Violation|0|||
37853361|NCT00006721|69537265|FG001|Overall Study|Death|1|||
37853362|NCT00006721|69537266|FG002|Overall Study|Death|2|||
37853363|NCT00006721|69537264|FG000|Overall Study|Other - Not Protocol Specified|0|||
37853364|NCT00006721|69537265|FG001|Overall Study|Other - Not Protocol Specified|7|||
37853365|NCT00006721|69537266|FG002|Overall Study|Other - Not Protocol Specified|7|||
37853366|NCT00006721|69537264|FG000|Overall Study|Ineligible|2|||
37853367|NCT00006721|69537265|FG001|Overall Study|Ineligible|12|||
37853368|NCT00006721|69537266|FG002|Overall Study|Ineligible|10|||
37921712|NCT00670306|69608506|FG000|Overall Study|Adverse Event|8|||
37853369|NCT00006721|69537264|FG000|Overall Study|Eligible but no Treatment Received|1|||
37853370|NCT00006721|69537265|FG001|Overall Study|Eligible but no Treatment Received|0|||
37632636|NCT01592370|69099156|FG005|Overall Study|Withdrew consent|0|||
37632637|NCT01592370|69099157|FG006|Overall Study|Withdrew consent|0|||
37632638|NCT01592370|69099151|FG000|Overall Study|Maximum clinical benefit|11|||
37632639|NCT01592370|69099152|FG001|Overall Study|Maximum clinical benefit|1|||
37853371|NCT00006721|69537266|FG002|Overall Study|Eligible but no Treatment Received|0|||
37921713|NCT00670306|69608506|FG000|Overall Study|Lack of Efficacy|10|||
37853372|NCT01030666|69537278|FG000|Overall Study|Lost to Follow-up|3|||
37853373|NCT01030666|69537279|FG001|Overall Study|Lost to Follow-up|2|||
37853374|NCT01025752|69537288|FG000|Overall Study|Lost to Follow-up|7|||
37853375|NCT01025752|69537289|FG001|Overall Study|Lost to Follow-up|10|||
37853376|NCT01025752|69537288|FG000|Overall Study|Physician Decision|1|||
37853377|NCT01025752|69537289|FG001|Overall Study|Physician Decision|3|||
37853378|NCT01030198|69537297|FG000|Overall Study|Could not measure efficacy accurately|0|||
37853379|NCT01030198|69537298|FG001|Overall Study|Could not measure efficacy accurately|7|||
37853380|NCT01301456|69537316|FG000|Stage 1|Withdrawal by Subject|0|||
37853381|NCT01301456|69537317|FG001|Stage 1|Withdrawal by Subject|0|||
37853382|NCT01301456|69537318|FG002|Stage 1|Withdrawal by Subject|1|||
37853383|NCT01301456|69537319|FG003|Stage 1|Withdrawal by Subject|0|||
37853384|NCT01301456|69537320|FG004|Stage 1|Withdrawal by Subject|1|||
37853385|NCT01301456|69537321|FG005|Stage 1|Withdrawal by Subject|0|||
37853386|NCT01301456|69537322|FG006|Stage 1|Withdrawal by Subject|0|||
37853387|NCT01301456|69537323|FG007|Stage 1|Withdrawal by Subject|0|||
37853388|NCT01301456|69537324|FG008|Stage 1|Withdrawal by Subject|0|||
37853389|NCT01301456|69537325|FG009|Stage 1|Withdrawal by Subject|0|||
37853390|NCT01301456|69537326|FG010|Stage 1|Withdrawal by Subject|0|||
37853391|NCT01301456|69537327|FG011|Stage 1|Withdrawal by Subject|0|||
37853392|NCT01301456|69537316|FG000|Stage 1|Randomized but not treated|0|||
37632640|NCT01592370|69099153|FG002|Overall Study|Maximum clinical benefit|7|||
37632641|NCT01592370|69099154|FG003|Overall Study|Maximum clinical benefit|1|||
37632642|NCT01592370|69099155|FG004|Overall Study|Maximum clinical benefit|0|||
37738532|NCT01731002|69221067|FG000|Overall Study|Adverse Event|0|||
37738533|NCT01731002|69221068|FG001|Overall Study|Adverse Event|2|||
37738534|NCT01731002|69221069|FG002|Overall Study|Adverse Event|2|||
37738535|NCT01731002|69221067|FG000|Overall Study|Non-Compliant|0|||
37738536|NCT01731002|69221068|FG001|Overall Study|Non-Compliant|1|||
37738537|NCT01731002|69221069|FG002|Overall Study|Non-Compliant|0|||
37738538|NCT01731002|69221067|FG000|Overall Study|Lost to Follow-up|1|||
37738539|NCT01731002|69221068|FG001|Overall Study|Lost to Follow-up|0|||
37738540|NCT01731002|69221069|FG002|Overall Study|Lost to Follow-up|0|||
37738541|NCT01731002|69221067|FG000|Overall Study|Test Agent Discontinuation|0|||
37738542|NCT01731002|69221068|FG001|Overall Study|Test Agent Discontinuation|1|||
37738543|NCT01731002|69221069|FG002|Overall Study|Test Agent Discontinuation|0|||
37738544|NCT01731002|69221067|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
37738545|NCT01731002|69221068|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
37738546|NCT01731002|69221069|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
37738547|NCT01731002|69221067|FG000|Overall Study|Elevated IOP|1|||
37738548|NCT01731002|69221068|FG001|Overall Study|Elevated IOP|0|||
37738549|NCT01731002|69221069|FG002|Overall Study|Elevated IOP|0|||
37738550|NCT01731002|69221067|FG000|Overall Study|Inappropriate use of study medications|0|||
37738551|NCT01731002|69221068|FG001|Overall Study|Inappropriate use of study medications|0|||
37738552|NCT01731002|69221069|FG002|Overall Study|Inappropriate use of study medications|1|||
37738553|NCT01783886|69221080|FG000|Overall Study|Lost to Follow-up|0|||
37738554|NCT01783886|69221081|FG001|Overall Study|Lost to Follow-up|3|||
37738555|NCT01783886|69221082|FG002|Overall Study|Lost to Follow-up|0|||
37738556|NCT01783886|69221080|FG000|Overall Study|Protocol deviation|0|||
37738557|NCT01783886|69221081|FG001|Overall Study|Protocol deviation|0|||
37738558|NCT01783886|69221082|FG002|Overall Study|Protocol deviation|2|||
37738559|NCT01783886|69221080|FG000|Overall Study|Withdrawal of consent by participant|1|||
37738560|NCT01783886|69221081|FG001|Overall Study|Withdrawal of consent by participant|3|||
37738561|NCT01783886|69221082|FG002|Overall Study|Withdrawal of consent by participant|4|||
37738562|NCT01783886|69221080|FG000|Overall Study|Adverse Event|4|||
37738563|NCT01783886|69221081|FG001|Overall Study|Adverse Event|5|||
37738564|NCT01783886|69221082|FG002|Overall Study|Adverse Event|4|||
37738565|NCT01609556|69221106|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
37738566|NCT01609556|69221107|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
37738567|NCT01609556|69221108|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
37853393|NCT01301456|69537317|FG001|Stage 1|Randomized but not treated|0|||
37853394|NCT01301456|69537318|FG002|Stage 1|Randomized but not treated|0|||
37632643|NCT01592370|69099156|FG005|Overall Study|Maximum clinical benefit|0|||
37921714|NCT00670306|69608506|FG000|Overall Study|Withdrawal by Subject|9|||
37921715|NCT00670306|69608506|FG000|Overall Study|Physician Decision|1|||
37921716|NCT00670306|69608506|FG000|Overall Study|Lost to Follow-up|8|||
37738568|NCT01609556|69221109|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
37738569|NCT01609556|69221110|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
37738570|NCT01609556|69221111|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
37738571|NCT01609556|69221112|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
37738572|NCT01609556|69221113|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
37738573|NCT01609556|69221114|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
37738574|NCT01609556|69221115|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
37738575|NCT01609556|69221116|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
37738576|NCT01609556|69221117|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
37632644|NCT01592370|69099157|FG006|Overall Study|Maximum clinical benefit|0|||
37632645|NCT01592370|69099151|FG000|Overall Study|No longer meets study criteria|1|||
37632646|NCT01592370|69099152|FG001|Overall Study|No longer meets study criteria|0|||
37632647|NCT01592370|69099153|FG002|Overall Study|No longer meets study criteria|0|||
37853395|NCT01301456|69537319|FG003|Stage 1|Randomized but not treated|0|||
37853396|NCT01301456|69537320|FG004|Stage 1|Randomized but not treated|0|||
37853397|NCT01301456|69537321|FG005|Stage 1|Randomized but not treated|0|||
37853398|NCT01301456|69537322|FG006|Stage 1|Randomized but not treated|1|||
37853399|NCT01301456|69537323|FG007|Stage 1|Randomized but not treated|0|||
37853400|NCT01301456|69537324|FG008|Stage 1|Randomized but not treated|0|||
37853401|NCT01301456|69537325|FG009|Stage 1|Randomized but not treated|0|||
37853402|NCT01301456|69537326|FG010|Stage 1|Randomized but not treated|0|||
37853403|NCT01301456|69537327|FG011|Stage 1|Randomized but not treated|0|||
37853404|NCT01301456|69537316|FG000|Stage 2|Adverse Event|0|||
37853405|NCT01301456|69537317|FG001|Stage 2|Adverse Event|0|||
37853406|NCT01301456|69537318|FG002|Stage 2|Adverse Event|0|||
37632648|NCT01592370|69099154|FG003|Overall Study|No longer meets study criteria|0|||
37632649|NCT01592370|69099155|FG004|Overall Study|No longer meets study criteria|0|||
37632650|NCT01592370|69099156|FG005|Overall Study|No longer meets study criteria|0|||
37632651|NCT01592370|69099157|FG006|Overall Study|No longer meets study criteria|0|||
37632652|NCT01592370|69099151|FG000|Overall Study|Other Reasons|6|||
37632653|NCT01592370|69099152|FG001|Overall Study|Other Reasons|0|||
37632654|NCT01592370|69099153|FG002|Overall Study|Other Reasons|10|||
37632655|NCT01592370|69099154|FG003|Overall Study|Other Reasons|0|||
37632656|NCT01592370|69099155|FG004|Overall Study|Other Reasons|0|||
37632657|NCT01592370|69099156|FG005|Overall Study|Other Reasons|1|||
37632658|NCT01592370|69099157|FG006|Overall Study|Other Reasons|0|||
37632659|NCT00777036|69099185|FG000|On Treatment|Reason Not Specified|4|||
37632660|NCT00777036|69099186|FG001|On Treatment|Reason Not Specified|7|||
37632661|NCT00777036|69099187|FG002|On Treatment|Reason Not Specified|12|||
37632662|NCT00777036|69099185|FG000|On Treatment|Failure to Meet Study Criteria|0|||
37632663|NCT00777036|69099186|FG001|On Treatment|Failure to Meet Study Criteria|1|||
37632664|NCT00777036|69099187|FG002|On Treatment|Failure to Meet Study Criteria|0|||
37632665|NCT00777036|69099185|FG000|On Treatment|Non-compliance with Study Drug|1|||
37632666|NCT00777036|69099186|FG001|On Treatment|Non-compliance with Study Drug|0|||
37632667|NCT00777036|69099187|FG002|On Treatment|Non-compliance with Study Drug|0|||
37632668|NCT00777036|69099185|FG000|On Treatment|Maximum Clinical Benefit|2|||
37632669|NCT00777036|69099186|FG001|On Treatment|Maximum Clinical Benefit|0|||
37632670|NCT00777036|69099187|FG002|On Treatment|Maximum Clinical Benefit|1|||
37632671|NCT00777036|69099185|FG000|On Treatment|Withdrawal by Subject|3|||
37632672|NCT00777036|69099186|FG001|On Treatment|Withdrawal by Subject|2|||
37632673|NCT00777036|69099187|FG002|On Treatment|Withdrawal by Subject|3|||
37632674|NCT00777036|69099185|FG000|On Treatment|Death|0|||
37632675|NCT00777036|69099186|FG001|On Treatment|Death|2|||
37632676|NCT00777036|69099187|FG002|On Treatment|Death|0|||
37632677|NCT00777036|69099185|FG000|On Treatment|Study Drug Toxicity|0|||
37632678|NCT00777036|69099186|FG001|On Treatment|Study Drug Toxicity|0|||
37632679|NCT00777036|69099187|FG002|On Treatment|Study Drug Toxicity|1|||
37632680|NCT00777036|69099185|FG000|On Treatment|Progressive Disease|5|||
37632681|NCT00777036|69099186|FG001|On Treatment|Progressive Disease|4|||
37632682|NCT00777036|69099187|FG002|On Treatment|Progressive Disease|6|||
37632683|NCT00777036|69099185|FG000|Follow-Up|Lost to Follow-up|1|||
37632684|NCT00777036|69099186|FG001|Follow-Up|Lost to Follow-up|0|||
37632685|NCT00777036|69099187|FG002|Follow-Up|Lost to Follow-up|0|||
37632686|NCT00777036|69099185|FG000|Follow-Up|Reason Not Specified|2|||
37632687|NCT00777036|69099186|FG001|Follow-Up|Reason Not Specified|0|||
37632688|NCT00777036|69099187|FG002|Follow-Up|Reason Not Specified|0|||
37632689|NCT00777036|69099185|FG000|Follow-Up|Withdrawal by Subject|1|||
37632690|NCT00777036|69099186|FG001|Follow-Up|Withdrawal by Subject|0|||
37632691|NCT00777036|69099187|FG002|Follow-Up|Withdrawal by Subject|4|||
37632692|NCT00777036|69099185|FG000|Follow-Up|Death|1|||
37921717|NCT00670306|69608506|FG000|Overall Study|incl/excl criterias did not meet|19|||
37853407|NCT01301456|69537319|FG003|Stage 2|Adverse Event|0|||
38031867|NCT03351608|69717635|FG003|Overall Study|Withdrawal by parent/guardian|1|||
37632693|NCT00777036|69099186|FG001|Follow-Up|Death|8|||
37632694|NCT00777036|69099187|FG002|Follow-Up|Death|0|||
37632695|NCT00176644|69099202|FG000|Overall Study|Withdrawal by Subject|1|||
37632696|NCT04649164|69099220|FG000|Overall Study|Withdrawal by Subject|1|||
37632697|NCT04649164|69099221|FG001|Overall Study|Withdrawal by Subject|1|||
37632698|NCT04649164|69099222|FG002|Overall Study|Withdrawal by Subject|2|||
37632699|NCT04649164|69099220|FG000|Overall Study|Participant's care recipient expired|0|||
37632700|NCT04649164|69099221|FG001|Overall Study|Participant's care recipient expired|0|||
37632701|NCT04649164|69099222|FG002|Overall Study|Participant's care recipient expired|2|||
37632702|NCT00706004|69099263|FG000|Overall Study|Did not meet eligibility criteria|2|||
37632703|NCT02724644|69099270|FG000|Overall Study|Adverse Event|7|||
37853408|NCT01301456|69537320|FG004|Stage 2|Adverse Event|0|||
37853409|NCT01301456|69537321|FG005|Stage 2|Adverse Event|0|||
37632704|NCT02724644|69099271|FG001|Overall Study|Adverse Event|1|||
37632705|NCT02724644|69099270|FG000|Overall Study|Lost to Follow-up|6|||
37632706|NCT02724644|69099271|FG001|Overall Study|Lost to Follow-up|2|||
37632707|NCT02724644|69099270|FG000|Overall Study|Withdrawal by Subject|7|||
37632708|NCT02724644|69099271|FG001|Overall Study|Withdrawal by Subject|1|||
37632709|NCT02724644|69099270|FG000|Overall Study|Administrative|1|||
37632710|NCT02724644|69099271|FG001|Overall Study|Administrative|0|||
37632711|NCT02725268|69099281|FG000|Overall Study|Death|58|||
37632712|NCT02725268|69099282|FG001|Overall Study|Death|59|||
37632713|NCT02725268|69099283|FG002|Overall Study|Death|30|||
37632714|NCT02725268|69099284|FG003|Overall Study|Death|16|||
37632715|NCT02725268|69099281|FG000|Overall Study|Lost to Follow-up|4|||
37632716|NCT02725268|69099282|FG001|Overall Study|Lost to Follow-up|3|||
37632717|NCT02725268|69099283|FG002|Overall Study|Lost to Follow-up|0|||
37632718|NCT02725268|69099284|FG003|Overall Study|Lost to Follow-up|1|||
37632719|NCT02725268|69099281|FG000|Overall Study|Site Terminated by Sponsor|0|||
37632720|NCT02725268|69099282|FG001|Overall Study|Site Terminated by Sponsor|1|||
37632721|NCT02725268|69099283|FG002|Overall Study|Site Terminated by Sponsor|0|||
37632722|NCT02725268|69099284|FG003|Overall Study|Site Terminated by Sponsor|0|||
37632723|NCT02725268|69099281|FG000|Overall Study|Withdrawal by Subject|8|||
37632724|NCT02725268|69099282|FG001|Overall Study|Withdrawal by Subject|6|||
37632725|NCT02725268|69099283|FG002|Overall Study|Withdrawal by Subject|8|||
37632726|NCT02725268|69099284|FG003|Overall Study|Withdrawal by Subject|1|||
37632727|NCT02725268|69099281|FG000|Overall Study|Reason not Specified|2|||
37632728|NCT02725268|69099282|FG001|Overall Study|Reason not Specified|1|||
37632729|NCT02725268|69099283|FG002|Overall Study|Reason not Specified|0|||
37632730|NCT02725268|69099284|FG003|Overall Study|Reason not Specified|0|||
37632731|NCT02724956|69099296|FG000|Overall Study|Physician Decision|1|||
37632732|NCT02724956|69099297|FG001|Overall Study|Physician Decision|0|||
37632733|NCT02724956|69099296|FG000|Overall Study|Lack of Efficacy|0|||
37632734|NCT02724956|69099297|FG001|Overall Study|Lack of Efficacy|1|||
37632735|NCT02724956|69099296|FG000|Overall Study|Withdrawal by Subject|0|||
37632736|NCT02724956|69099297|FG001|Overall Study|Withdrawal by Subject|1|||
37632737|NCT00705536|69099305|FG000|Start Period 1|Withdrawal by Subject|0|||
37632738|NCT00705536|69099306|FG001|Start Period 1|Withdrawal by Subject|0|||
37632739|NCT00705536|69099307|FG002|Start Period 1|Withdrawal by Subject|0|||
37632740|NCT00705536|69099308|FG003|Start Period 1|Withdrawal by Subject|1|||
37632741|NCT02724020|69099330|FG000|Overall Study|Death|16|||
37632742|NCT02724020|69099331|FG001|Overall Study|Death|18|||
37632743|NCT02724020|69099332|FG002|Overall Study|Death|19|||
37632744|NCT02724020|69099330|FG000|Overall Study|Lost to Follow-up|0|||
37632745|NCT02724020|69099331|FG001|Overall Study|Lost to Follow-up|3|||
37632746|NCT02724020|69099332|FG002|Overall Study|Lost to Follow-up|0|||
37632747|NCT02724020|69099330|FG000|Overall Study|Site Terminated by Sponsor|15|||
37632748|NCT02724020|69099331|FG001|Overall Study|Site Terminated by Sponsor|8|||
37632749|NCT02724020|69099332|FG002|Overall Study|Site Terminated by Sponsor|8|||
37632750|NCT02724020|69099330|FG000|Overall Study|Withdrawal by Subject|1|||
37632751|NCT02724020|69099331|FG001|Overall Study|Withdrawal by Subject|3|||
37632752|NCT02724020|69099332|FG002|Overall Study|Withdrawal by Subject|5|||
37632753|NCT02660034|69099354|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
37632754|NCT02660034|69099355|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
37632755|NCT02660034|69099356|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
37632756|NCT02660034|69099357|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
37632757|NCT02660034|69099358|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
37632758|NCT02660034|69099359|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
37632759|NCT02660034|69099360|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
37632760|NCT02660034|69099361|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
37632761|NCT02660034|69099362|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
37632762|NCT02660034|69099363|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
37632763|NCT02660034|69099364|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
37632764|NCT02660034|69099365|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
37632765|NCT02660034|69099366|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
37632766|NCT02660034|69099367|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
37632767|NCT02660034|69099354|FG000|Overall Study|Progressive Disease (Clinical)|7|||
37632768|NCT02660034|69099355|FG001|Overall Study|Progressive Disease (Clinical)|8|||
37632769|NCT02660034|69099356|FG002|Overall Study|Progressive Disease (Clinical)|3|||
37632770|NCT02660034|69099357|FG003|Overall Study|Progressive Disease (Clinical)|9|||
37632771|NCT02660034|69099358|FG004|Overall Study|Progressive Disease (Clinical)|3|||
37632772|NCT02660034|69099359|FG005|Overall Study|Progressive Disease (Clinical)|0|||
37632773|NCT02660034|69099360|FG006|Overall Study|Progressive Disease (Clinical)|0|||
37632774|NCT02660034|69099361|FG007|Overall Study|Progressive Disease (Clinical)|0|||
37632775|NCT02660034|69099362|FG008|Overall Study|Progressive Disease (Clinical)|0|||
37632776|NCT02660034|69099363|FG009|Overall Study|Progressive Disease (Clinical)|0|||
37632777|NCT02660034|69099364|FG010|Overall Study|Progressive Disease (Clinical)|0|||
37632778|NCT02660034|69099365|FG011|Overall Study|Progressive Disease (Clinical)|0|||
37853410|NCT01301456|69537322|FG006|Stage 2|Adverse Event|0|||
37632779|NCT02660034|69099366|FG012|Overall Study|Progressive Disease (Clinical)|0|||
37632780|NCT02660034|69099367|FG013|Overall Study|Progressive Disease (Clinical)|0|||
37632781|NCT02660034|69099354|FG000|Overall Study|Lost to Follow-up|0|||
37632782|NCT02660034|69099355|FG001|Overall Study|Lost to Follow-up|0|||
37632783|NCT02660034|69099356|FG002|Overall Study|Lost to Follow-up|1|||
37632784|NCT02660034|69099357|FG003|Overall Study|Lost to Follow-up|1|||
37632785|NCT02660034|69099358|FG004|Overall Study|Lost to Follow-up|0|||
37632786|NCT02660034|69099359|FG005|Overall Study|Lost to Follow-up|0|||
37632787|NCT02660034|69099360|FG006|Overall Study|Lost to Follow-up|0|||
37632788|NCT02660034|69099361|FG007|Overall Study|Lost to Follow-up|0|||
37632789|NCT02660034|69099362|FG008|Overall Study|Lost to Follow-up|0|||
37632790|NCT02660034|69099363|FG009|Overall Study|Lost to Follow-up|1|||
37632791|NCT02660034|69099364|FG010|Overall Study|Lost to Follow-up|1|||
37632792|NCT02660034|69099365|FG011|Overall Study|Lost to Follow-up|1|||
37632793|NCT02660034|69099366|FG012|Overall Study|Lost to Follow-up|0|||
37632794|NCT02660034|69099367|FG013|Overall Study|Lost to Follow-up|0|||
37632795|NCT02660034|69099354|FG000|Overall Study|Participant moved into special access scheme|1|||
37632796|NCT02660034|69099355|FG001|Overall Study|Participant moved into special access scheme|2|||
37632797|NCT02660034|69099356|FG002|Overall Study|Participant moved into special access scheme|0|||
37632798|NCT02660034|69099357|FG003|Overall Study|Participant moved into special access scheme|0|||
37632799|NCT02660034|69099358|FG004|Overall Study|Participant moved into special access scheme|0|||
37632800|NCT02660034|69099359|FG005|Overall Study|Participant moved into special access scheme|0|||
37632801|NCT02660034|69099360|FG006|Overall Study|Participant moved into special access scheme|0|||
37632802|NCT02660034|69099361|FG007|Overall Study|Participant moved into special access scheme|0|||
37632803|NCT02660034|69099362|FG008|Overall Study|Participant moved into special access scheme|0|||
37632804|NCT02660034|69099363|FG009|Overall Study|Participant moved into special access scheme|0|||
37632805|NCT02660034|69099364|FG010|Overall Study|Participant moved into special access scheme|0|||
37632806|NCT02660034|69099365|FG011|Overall Study|Participant moved into special access scheme|0|||
37632807|NCT02660034|69099366|FG012|Overall Study|Participant moved into special access scheme|0|||
37632808|NCT02660034|69099367|FG013|Overall Study|Participant moved into special access scheme|0|||
37632809|NCT02660034|69099354|FG000|Overall Study|Adverse Event|1|||
37632810|NCT02660034|69099355|FG001|Overall Study|Adverse Event|0|||
37632811|NCT02660034|69099356|FG002|Overall Study|Adverse Event|0|||
37632812|NCT02660034|69099357|FG003|Overall Study|Adverse Event|0|||
37632813|NCT02660034|69099358|FG004|Overall Study|Adverse Event|0|||
37632814|NCT02660034|69099359|FG005|Overall Study|Adverse Event|0|||
37632815|NCT02660034|69099360|FG006|Overall Study|Adverse Event|0|||
37632816|NCT02660034|69099361|FG007|Overall Study|Adverse Event|0|||
37632817|NCT02660034|69099362|FG008|Overall Study|Adverse Event|0|||
37632818|NCT02660034|69099363|FG009|Overall Study|Adverse Event|0|||
37632819|NCT02660034|69099364|FG010|Overall Study|Adverse Event|0|||
37632820|NCT02660034|69099365|FG011|Overall Study|Adverse Event|0|||
37632821|NCT02660034|69099366|FG012|Overall Study|Adverse Event|0|||
37632822|NCT02660034|69099367|FG013|Overall Study|Adverse Event|0|||
37632823|NCT02660034|69099354|FG000|Overall Study|Sponsor Decision|0|||
37632824|NCT02660034|69099355|FG001|Overall Study|Sponsor Decision|1|||
37632825|NCT02660034|69099356|FG002|Overall Study|Sponsor Decision|2|||
37632826|NCT02660034|69099357|FG003|Overall Study|Sponsor Decision|2|||
37632827|NCT02660034|69099358|FG004|Overall Study|Sponsor Decision|3|||
37632828|NCT02660034|69099359|FG005|Overall Study|Sponsor Decision|0|||
37632829|NCT02660034|69099360|FG006|Overall Study|Sponsor Decision|0|||
37632830|NCT02660034|69099361|FG007|Overall Study|Sponsor Decision|0|||
37632831|NCT02660034|69099362|FG008|Overall Study|Sponsor Decision|0|||
37632832|NCT02660034|69099363|FG009|Overall Study|Sponsor Decision|0|||
37632833|NCT02660034|69099364|FG010|Overall Study|Sponsor Decision|0|||
37632834|NCT02660034|69099365|FG011|Overall Study|Sponsor Decision|0|||
37632835|NCT02660034|69099366|FG012|Overall Study|Sponsor Decision|0|||
37632836|NCT02660034|69099367|FG013|Overall Study|Sponsor Decision|1|||
37632837|NCT02660034|69099354|FG000|Overall Study|Withdrawal by Subject|0|||
37632838|NCT02660034|69099355|FG001|Overall Study|Withdrawal by Subject|0|||
37632839|NCT02660034|69099356|FG002|Overall Study|Withdrawal by Subject|0|||
37921718|NCT00672256|69608510|FG000|Overall Study|PI dropped, bad data|44|||
37632840|NCT02660034|69099357|FG003|Overall Study|Withdrawal by Subject|0|||
37632841|NCT02660034|69099358|FG004|Overall Study|Withdrawal by Subject|0|||
37632842|NCT02660034|69099359|FG005|Overall Study|Withdrawal by Subject|0|||
37632843|NCT02660034|69099360|FG006|Overall Study|Withdrawal by Subject|1|||
37632844|NCT02660034|69099361|FG007|Overall Study|Withdrawal by Subject|1|||
37632845|NCT02660034|69099362|FG008|Overall Study|Withdrawal by Subject|1|||
37632846|NCT02660034|69099363|FG009|Overall Study|Withdrawal by Subject|0|||
37921719|NCT00591630|69608518|FG000|Overall Study|Death|0|||
37632847|NCT02660034|69099364|FG010|Overall Study|Withdrawal by Subject|0|||
37632848|NCT02660034|69099365|FG011|Overall Study|Withdrawal by Subject|1|||
37632849|NCT02660034|69099366|FG012|Overall Study|Withdrawal by Subject|2|||
37632850|NCT02660034|69099367|FG013|Overall Study|Withdrawal by Subject|0|||
37632851|NCT02660034|69099354|FG000|Overall Study|Death|0|||
37632852|NCT02660034|69099355|FG001|Overall Study|Death|0|||
37632853|NCT02660034|69099356|FG002|Overall Study|Death|0|||
37632854|NCT02660034|69099357|FG003|Overall Study|Death|0|||
37632855|NCT02660034|69099358|FG004|Overall Study|Death|0|||
37632856|NCT02660034|69099359|FG005|Overall Study|Death|13|||
37632857|NCT02660034|69099360|FG006|Overall Study|Death|14|||
37632858|NCT02660034|69099361|FG007|Overall Study|Death|10|||
37632859|NCT02660034|69099362|FG008|Overall Study|Death|9|||
37632860|NCT02660034|69099363|FG009|Overall Study|Death|21|||
37632861|NCT02660034|69099364|FG010|Overall Study|Death|17|||
37632862|NCT02660034|69099365|FG011|Overall Study|Death|15|||
37632863|NCT02660034|69099366|FG012|Overall Study|Death|18|||
37632864|NCT02660034|69099367|FG013|Overall Study|Death|7|||
37632865|NCT02660034|69099354|FG000|Overall Study|Physician Decision|0|||
37632866|NCT02660034|69099355|FG001|Overall Study|Physician Decision|0|||
37632867|NCT02660034|69099356|FG002|Overall Study|Physician Decision|0|||
37632868|NCT02660034|69099357|FG003|Overall Study|Physician Decision|0|||
37632869|NCT02660034|69099358|FG004|Overall Study|Physician Decision|0|||
37632870|NCT02660034|69099359|FG005|Overall Study|Physician Decision|0|||
37632871|NCT02660034|69099360|FG006|Overall Study|Physician Decision|0|||
37632872|NCT02660034|69099361|FG007|Overall Study|Physician Decision|0|||
37632873|NCT02660034|69099362|FG008|Overall Study|Physician Decision|0|||
37632874|NCT02660034|69099363|FG009|Overall Study|Physician Decision|0|||
37632875|NCT02660034|69099364|FG010|Overall Study|Physician Decision|0|||
37632876|NCT02660034|69099365|FG011|Overall Study|Physician Decision|0|||
37632877|NCT02660034|69099366|FG012|Overall Study|Physician Decision|0|||
37632878|NCT02660034|69099367|FG013|Overall Study|Physician Decision|1|||
37632879|NCT02660034|69099354|FG000|Overall Study|Participants transferred to LTE|0|||
37632880|NCT02660034|69099355|FG001|Overall Study|Participants transferred to LTE|0|||
37632881|NCT02660034|69099356|FG002|Overall Study|Participants transferred to LTE|0|||
37632882|NCT02660034|69099357|FG003|Overall Study|Participants transferred to LTE|0|||
37632883|NCT02660034|69099358|FG004|Overall Study|Participants transferred to LTE|0|||
37632884|NCT02660034|69099359|FG005|Overall Study|Participants transferred to LTE|10|||
37632885|NCT02660034|69099360|FG006|Overall Study|Participants transferred to LTE|8|||
37632886|NCT02660034|69099361|FG007|Overall Study|Participants transferred to LTE|8|||
37632887|NCT02660034|69099362|FG008|Overall Study|Participants transferred to LTE|10|||
37632888|NCT02660034|69099363|FG009|Overall Study|Participants transferred to LTE|1|||
37632889|NCT02660034|69099364|FG010|Overall Study|Participants transferred to LTE|2|||
37632890|NCT02660034|69099365|FG011|Overall Study|Participants transferred to LTE|4|||
37632891|NCT02660034|69099366|FG012|Overall Study|Participants transferred to LTE|1|||
37632892|NCT02660034|69099367|FG013|Overall Study|Participants transferred to LTE|1|||
37632893|NCT02193867|69099410|FG000|Overall Study|Death|2|||
37632894|NCT02193867|69099410|FG000|Overall Study|Sponsor Study Termination|2|||
37632895|NCT02200770|69099438|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
37632896|NCT02200770|69099439|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
37632897|NCT02200770|69099438|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
37632898|NCT02200770|69099439|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
37632899|NCT02200770|69099438|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
37632900|NCT02200770|69099439|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
37632901|NCT02200770|69099438|FG000|Randomized-controlled Period (RCP)|Other|1|||
37632902|NCT02200770|69099439|FG001|Randomized-controlled Period (RCP)|Other|2|||
37632903|NCT02200770|69099438|FG000|Open-label Period (OLP)|Adverse Event|1|||
37632904|NCT02200770|69099439|FG001|Open-label Period (OLP)|Adverse Event|2|||
37632905|NCT02200770|69099438|FG000|Open-label Period (OLP)|Death|1|||
37632906|NCT02200770|69099439|FG001|Open-label Period (OLP)|Death|2|||
37632907|NCT02200770|69099438|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
37632908|NCT02200770|69099439|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
37632909|NCT02200770|69099438|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
37632910|NCT02200770|69099439|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
37632911|NCT02200770|69099438|FG000|Open-label Period (OLP)|Other|6|||
37632912|NCT02200770|69099439|FG001|Open-label Period (OLP)|Other|15|||
37632913|NCT01186848|69099461|FG000|Overall Study|Lost to Follow-up|4|||
37632914|NCT01186848|69099461|FG000|Overall Study|Withdrawal by Subject|2|||
37632915|NCT01186848|69099461|FG000|Overall Study|Adverse Event|2|||
37632916|NCT01024608|69099469|FG000|Overall Study|Adverse Event|1|||
37632917|NCT01024608|69099470|FG001|Overall Study|Adverse Event|0|||
37632918|NCT01024608|69099469|FG000|Overall Study|Withdrawal by Subject|1|||
37632919|NCT01024608|69099470|FG001|Overall Study|Withdrawal by Subject|0|||
37632920|NCT01024608|69099469|FG000|Overall Study|Lost to Follow-up|0|||
37632921|NCT01024608|69099470|FG001|Overall Study|Lost to Follow-up|1|||
37632922|NCT01024608|69099469|FG000|Overall Study|Protocol Violation|0|||
37632923|NCT01024608|69099470|FG001|Overall Study|Protocol Violation|3|||
37632924|NCT01024608|69099469|FG000|Overall Study|Never received study treatment|2|||
37632925|NCT01024608|69099470|FG001|Overall Study|Never received study treatment|0|||
37632926|NCT00910650|69099476|FG000|Overall Study|Death|2|||
37632927|NCT03996876|69099511|FG000|Overall Study|Incomplete Data|2|||
37632928|NCT03996876|69099512|FG001|Overall Study|Incomplete Data|4|||
37632929|NCT01460160|69099519|FG000|Treatment Phase|Lack of Efficacy|3|||
37632930|NCT01460160|69099519|FG000|Treatment Phase|Study Drug Toxicity|2|||
37632931|NCT01460160|69099519|FG000|Treatment Phase|Adverse Event|8|||
37632932|NCT01460160|69099519|FG000|Treatment Phase|Withdrawal by Subject|4|||
37632933|NCT01460160|69099519|FG000|Treatment Phase|Death|2|||
37632934|NCT01460160|69099519|FG000|Treatment Phase|Other reasons|9|||
37632935|NCT01460160|69099519|FG000|Follow-up Phase|Withdrawal by Subject|4|||
37632936|NCT01460160|69099519|FG000|Follow-up Phase|Death|14|||
37632937|NCT01460160|69099519|FG000|Follow-up Phase|Lost to Follow-up|7|||
37632938|NCT01460160|69099519|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
37632939|NCT01460160|69099519|FG000|Follow-up Phase|Other and not reported reasons|5|||
37632940|NCT01170702|69099527|FG000|Overall Study|Exclusion criteria met after consent|1|||
37632941|NCT01170702|69099528|FG001|Overall Study|Exclusion criteria met after consent|2|||
37632942|NCT01170702|69099529|FG002|Overall Study|Exclusion criteria met after consent|0|||
37632943|NCT01170702|69099530|FG003|Overall Study|Exclusion criteria met after consent|2|||
37632944|NCT02723864|69099569|FG000|Overall Study|Refused further treatment|1|||
37738577|NCT01609556|69221118|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
37738578|NCT01609556|69221119|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
37738579|NCT01609556|69221120|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
37738580|NCT01609556|69221121|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
37738581|NCT01609556|69221106|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
37738582|NCT01609556|69221107|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
37738583|NCT01609556|69221108|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
37738584|NCT01609556|69221109|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
37738585|NCT01609556|69221110|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
37738586|NCT01609556|69221111|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
37853411|NCT01301456|69537323|FG007|Stage 2|Adverse Event|0|||
37853412|NCT01301456|69537324|FG008|Stage 2|Adverse Event|0|||
37853413|NCT01301456|69537325|FG009|Stage 2|Adverse Event|0|||
37853414|NCT01301456|69537326|FG010|Stage 2|Adverse Event|1|||
37853415|NCT01301456|69537327|FG011|Stage 2|Adverse Event|0|||
37853416|NCT01023256|69537375|FG000|Overall Study|Protocol Violation|2|||
37853417|NCT01023256|69537376|FG001|Overall Study|Protocol Violation|3|||
37853418|NCT01023256|69537377|FG002|Overall Study|Protocol Violation|0|||
37853419|NCT01023256|69537378|FG003|Overall Study|Protocol Violation|0|||
37853420|NCT01023256|69537375|FG000|Overall Study|Randomized but not treated|1|||
37853421|NCT01023256|69537376|FG001|Overall Study|Randomized but not treated|0|||
37853422|NCT01023256|69537377|FG002|Overall Study|Randomized but not treated|1|||
37853423|NCT01023256|69537378|FG003|Overall Study|Randomized but not treated|0|||
37853424|NCT01023256|69537375|FG000|Overall Study|Other|1|||
37853425|NCT01023256|69537376|FG001|Overall Study|Other|0|||
37853426|NCT01023256|69537377|FG002|Overall Study|Other|0|||
37853427|NCT01023256|69537378|FG003|Overall Study|Other|2|||
37853428|NCT01023256|69537375|FG000|Overall Study|Adverse Event|0|||
37853429|NCT01023256|69537376|FG001|Overall Study|Adverse Event|0|||
37853430|NCT01023256|69537377|FG002|Overall Study|Adverse Event|0|||
37853431|NCT01023256|69537378|FG003|Overall Study|Adverse Event|1|||
37853432|NCT01023256|69537375|FG000|Overall Study|Withdrawal by Subject|0|||
37853433|NCT01023256|69537376|FG001|Overall Study|Withdrawal by Subject|0|||
37853434|NCT01023256|69537377|FG002|Overall Study|Withdrawal by Subject|0|||
37853435|NCT01023256|69537378|FG003|Overall Study|Withdrawal by Subject|2|||
37853436|NCT01023022|69537391|FG000|Overall Study|Death|5|||
37853437|NCT01023022|69537391|FG000|Overall Study|Lost to Follow-up|7|||
37853438|NCT01023022|69537391|FG000|Overall Study|due to technical issues|2|||
37853439|NCT01058668|69537398|FG000|Double-blind Treatment Phase|Adverse Event|8|||
37853440|NCT01058668|69537399|FG001|Double-blind Treatment Phase|Adverse Event|15|||
37853441|NCT01058668|69537400|FG002|Double-blind Treatment Phase|Adverse Event|25|||
37853442|NCT01058668|69537398|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
37853443|NCT01058668|69537399|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
37853444|NCT01058668|69537400|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
37853445|NCT01058668|69537398|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
37853446|NCT01058668|69537399|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
37853447|NCT01058668|69537400|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
37853448|NCT01058668|69537398|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
37921720|NCT00591630|69608519|FG001|Overall Study|Death|0|||
37632945|NCT02723864|69099570|FG001|Overall Study|Refused further treatment|0|||
37632946|NCT02723864|69099571|FG002|Overall Study|Refused further treatment|0|||
37853449|NCT01058668|69537399|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
37853450|NCT01058668|69537400|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
37853451|NCT01058668|69537398|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
37853452|NCT01058668|69537399|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
37853453|NCT01058668|69537400|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
37853454|NCT01058668|69537398|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
37853455|NCT01058668|69537399|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
37632947|NCT02723864|69099572|FG003|Overall Study|Refused further treatment|0|||
37632948|NCT02723864|69099573|FG004|Overall Study|Refused further treatment|1|||
37632949|NCT02723864|69099574|FG005|Overall Study|Refused further treatment|2|||
37632950|NCT02723864|69099575|FG006|Overall Study|Refused further treatment|0|||
37632951|NCT02723864|69099569|FG000|Overall Study|Exceed treatment hold time|0|||
37632952|NCT02723864|69099570|FG001|Overall Study|Exceed treatment hold time|1|||
37632953|NCT02723864|69099571|FG002|Overall Study|Exceed treatment hold time|0|||
37632954|NCT02723864|69099572|FG003|Overall Study|Exceed treatment hold time|0|||
37632955|NCT02723864|69099573|FG004|Overall Study|Exceed treatment hold time|0|||
37632956|NCT02723864|69099574|FG005|Overall Study|Exceed treatment hold time|0|||
37632957|NCT02723864|69099575|FG006|Overall Study|Exceed treatment hold time|0|||
37632958|NCT02723864|69099569|FG000|Overall Study|Clinical progression|0|||
37632959|NCT02723864|69099570|FG001|Overall Study|Clinical progression|0|||
37632960|NCT02723864|69099571|FG002|Overall Study|Clinical progression|1|||
37632961|NCT02723864|69099572|FG003|Overall Study|Clinical progression|0|||
37632962|NCT02723864|69099573|FG004|Overall Study|Clinical progression|0|||
37632963|NCT02723864|69099574|FG005|Overall Study|Clinical progression|3|||
37632964|NCT02723864|69099575|FG006|Overall Study|Clinical progression|1|||
37632965|NCT02723864|69099569|FG000|Overall Study|Physician Decision|0|||
37632966|NCT02723864|69099570|FG001|Overall Study|Physician Decision|0|||
37632967|NCT02723864|69099571|FG002|Overall Study|Physician Decision|0|||
37632968|NCT02723864|69099572|FG003|Overall Study|Physician Decision|0|||
37632969|NCT02723864|69099573|FG004|Overall Study|Physician Decision|0|||
37632970|NCT02723864|69099574|FG005|Overall Study|Physician Decision|0|||
37632971|NCT02723864|69099575|FG006|Overall Study|Physician Decision|1|||
37632972|NCT02723864|69099569|FG000|Overall Study|Changes in patient condition|0|||
37632973|NCT02723864|69099570|FG001|Overall Study|Changes in patient condition|0|||
37632974|NCT02723864|69099571|FG002|Overall Study|Changes in patient condition|0|||
37632975|NCT02723864|69099572|FG003|Overall Study|Changes in patient condition|0|||
37632976|NCT02723864|69099573|FG004|Overall Study|Changes in patient condition|0|||
37632977|NCT02723864|69099574|FG005|Overall Study|Changes in patient condition|1|||
37632978|NCT02723864|69099575|FG006|Overall Study|Changes in patient condition|0|||
37632979|NCT02723864|69099569|FG000|Overall Study|Patient choice|0|||
37632980|NCT02723864|69099570|FG001|Overall Study|Patient choice|0|||
37632981|NCT02723864|69099571|FG002|Overall Study|Patient choice|0|||
37632982|NCT02723864|69099572|FG003|Overall Study|Patient choice|0|||
37632983|NCT02723864|69099573|FG004|Overall Study|Patient choice|0|||
37632984|NCT02723864|69099574|FG005|Overall Study|Patient choice|1|||
37632985|NCT02723864|69099575|FG006|Overall Study|Patient choice|0|||
37632986|NCT02723864|69099569|FG000|Overall Study|Adverse Event|0|||
37632987|NCT02723864|69099570|FG001|Overall Study|Adverse Event|0|||
37632988|NCT02723864|69099571|FG002|Overall Study|Adverse Event|0|||
37632989|NCT02723864|69099572|FG003|Overall Study|Adverse Event|0|||
37632990|NCT02723864|69099573|FG004|Overall Study|Adverse Event|0|||
37632991|NCT02723864|69099574|FG005|Overall Study|Adverse Event|1|||
37632992|NCT02723864|69099575|FG006|Overall Study|Adverse Event|0|||
37632993|NCT02723864|69099569|FG000|Overall Study|Started new treatment|0|||
37632994|NCT02723864|69099570|FG001|Overall Study|Started new treatment|0|||
37632995|NCT02723864|69099571|FG002|Overall Study|Started new treatment|0|||
37632996|NCT02723864|69099572|FG003|Overall Study|Started new treatment|0|||
37632997|NCT02723864|69099573|FG004|Overall Study|Started new treatment|0|||
37632998|NCT02723864|69099574|FG005|Overall Study|Started new treatment|1|||
37632999|NCT02723864|69099575|FG006|Overall Study|Started new treatment|0|||
37633000|NCT02723864|69099569|FG000|Overall Study|Switched to alternative treatment|0|||
37633001|NCT02723864|69099570|FG001|Overall Study|Switched to alternative treatment|0|||
37633002|NCT02723864|69099571|FG002|Overall Study|Switched to alternative treatment|0|||
37633003|NCT02723864|69099572|FG003|Overall Study|Switched to alternative treatment|0|||
37633004|NCT02723864|69099573|FG004|Overall Study|Switched to alternative treatment|0|||
37633005|NCT02723864|69099574|FG005|Overall Study|Switched to alternative treatment|1|||
37633006|NCT02723864|69099575|FG006|Overall Study|Switched to alternative treatment|0|||
37633007|NCT02723864|69099569|FG000|Overall Study|Late determination of ineligibility|0|||
37633008|NCT02723864|69099570|FG001|Overall Study|Late determination of ineligibility|0|||
37633009|NCT02723864|69099571|FG002|Overall Study|Late determination of ineligibility|0|||
37921721|NCT00591630|69608520|FG002|Overall Study|Death|1|||
37633010|NCT02723864|69099572|FG003|Overall Study|Late determination of ineligibility|0|||
37633011|NCT02723864|69099573|FG004|Overall Study|Late determination of ineligibility|0|||
37633012|NCT02723864|69099574|FG005|Overall Study|Late determination of ineligibility|1|||
37633013|NCT02723864|69099575|FG006|Overall Study|Late determination of ineligibility|0|||
37633014|NCT00705146|69099614|FG000|Overall Study|Lost to Follow-up|1|||
37633015|NCT00705146|69099615|FG001|Overall Study|Lost to Follow-up|1|||
37633016|NCT03203642|69099623|FG000|Overall Study|Adverse Event|3|||
37633017|NCT03203642|69099624|FG001|Overall Study|Adverse Event|1|||
37633018|NCT03203642|69099623|FG000|Overall Study|Withdrawal by Subject|6|||
37633019|NCT03203642|69099624|FG001|Overall Study|Withdrawal by Subject|6|||
37921722|NCT00591630|69608521|FG003|Overall Study|Death|0|||
37633020|NCT03203642|69099623|FG000|Overall Study|Lost to Follow-up|2|||
37633021|NCT03203642|69099624|FG001|Overall Study|Lost to Follow-up|1|||
37633022|NCT03203642|69099623|FG000|Overall Study|Termination of the study by sponsor|1|||
37633023|NCT03203642|69099624|FG001|Overall Study|Termination of the study by sponsor|1|||
37633024|NCT03203642|69099623|FG000|Overall Study|Participant moved|0|||
37738587|NCT01609556|69221112|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
37738588|NCT01609556|69221113|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
37738589|NCT01609556|69221114|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
37738590|NCT01609556|69221115|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
37738591|NCT01609556|69221116|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
37738592|NCT01609556|69221117|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
37738593|NCT01609556|69221118|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
37738594|NCT01609556|69221119|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
37738595|NCT01609556|69221120|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
37738596|NCT01609556|69221121|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
37738597|NCT01609556|69221106|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
37738598|NCT01609556|69221107|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
37738599|NCT01609556|69221108|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
37738600|NCT01609556|69221109|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
37738601|NCT01609556|69221110|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
37738602|NCT01609556|69221111|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
37738603|NCT01609556|69221112|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
37738604|NCT01609556|69221113|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
37738605|NCT01609556|69221114|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
37738606|NCT01609556|69221115|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
37738607|NCT01609556|69221116|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
37738608|NCT01609556|69221117|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
37738609|NCT01609556|69221118|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
37738610|NCT01609556|69221119|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
37738611|NCT01609556|69221120|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
37738612|NCT01609556|69221121|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
37738613|NCT01609556|69221106|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
37738614|NCT01609556|69221107|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
37738615|NCT01609556|69221108|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
37738616|NCT01609556|69221109|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
37738617|NCT01609556|69221110|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
37738618|NCT01609556|69221111|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
37738619|NCT01609556|69221112|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
37738620|NCT01609556|69221113|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
37738621|NCT01609556|69221114|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
37738622|NCT01609556|69221115|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
37738623|NCT01609556|69221116|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
37738624|NCT01609556|69221117|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
37738625|NCT01609556|69221118|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
37738626|NCT01609556|69221119|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
37738627|NCT01609556|69221120|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
37738628|NCT01609556|69221121|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
37738629|NCT01609556|69221106|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
37738630|NCT01609556|69221107|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
37738631|NCT01609556|69221108|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
37738632|NCT01609556|69221109|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
37738633|NCT01609556|69221110|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
37738634|NCT01609556|69221111|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
37738635|NCT01609556|69221112|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
37738636|NCT01609556|69221113|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
37738637|NCT01609556|69221114|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
37853456|NCT01058668|69537400|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
37853457|NCT01301066|69537410|FG000|Overall Study|Lost to Follow-up|5|||
37853458|NCT01301066|69537411|FG001|Overall Study|Lost to Follow-up|11|||
37853459|NCT01301066|69537410|FG000|Overall Study|Protocol Violation|8|||
37853460|NCT01301066|69537411|FG001|Overall Study|Protocol Violation|7|||
37633025|NCT03203642|69099624|FG001|Overall Study|Participant moved|1|||
37633026|NCT03203642|69099623|FG000|Overall Study|Investigator's decision|3|||
37633027|NCT03203642|69099624|FG001|Overall Study|Investigator's decision|0|||
37633028|NCT03203642|69099623|FG000|Overall Study|Other than above specified|0|||
37633029|NCT03203642|69099624|FG001|Overall Study|Other than above specified|1|||
37633030|NCT02737722|69099634|FG000|Overall Study|Physician Decision|0|||
37633031|NCT02737722|69099635|FG001|Overall Study|Physician Decision|0|||
37633032|NCT02737722|69099636|FG002|Overall Study|Physician Decision|1|||
37633033|NCT02737722|69099637|FG003|Overall Study|Physician Decision|0|||
37633034|NCT03792750|69099647|FG000|Overall Study|Death|3|||
37633035|NCT02750709|69099652|FG000|Treatment Period 1|Adverse Event|0|||
37633036|NCT02750709|69099653|FG001|Treatment Period 1|Adverse Event|0|||
37633037|NCT02750709|69099654|FG002|Treatment Period 1|Adverse Event|0|||
37633038|NCT02750709|69099655|FG003|Treatment Period 1|Adverse Event|0|||
37633039|NCT02750709|69099656|FG004|Treatment Period 1|Adverse Event|0|||
37633040|NCT02750709|69099657|FG005|Treatment Period 1|Adverse Event|1|||
37633041|NCT02723786|69099665|FG000|Overall Study|Lost to Follow-up|1|||
37633042|NCT02723084|69099684|FG000|Overall Study|Withdrawal by Subject|1|||
37633043|NCT02723084|69099685|FG001|Overall Study|Withdrawal by Subject|1|||
37633044|NCT02723084|69099684|FG000|Overall Study|Lost to Follow-up|3|||
37633045|NCT02723084|69099685|FG001|Overall Study|Lost to Follow-up|0|||
37633046|NCT02750943|69099693|FG000|Overall Study|Lost to Follow-up|1|||
37633047|NCT02750943|69099694|FG001|Overall Study|Lost to Follow-up|2|||
37633048|NCT02750943|69099693|FG000|Overall Study|Withdrawal by Subject|5|||
37633049|NCT02750943|69099694|FG001|Overall Study|Withdrawal by Subject|7|||
37633050|NCT05177094|69099719|FG000|Overall Study|Adverse Event|5|||
37633051|NCT05177094|69099720|FG001|Overall Study|Adverse Event|5|||
37633052|NCT05177094|69099719|FG000|Overall Study|Non-compliance With Study Drug and Procedures|0|||
37633053|NCT05177094|69099720|FG001|Overall Study|Non-compliance With Study Drug and Procedures|1|||
37633054|NCT05177094|69099719|FG000|Overall Study|Protocol Deviation|3|||
37633055|NCT05177094|69099720|FG001|Overall Study|Protocol Deviation|0|||
37633056|NCT05177094|69099719|FG000|Overall Study|Withdrawal by Subject|6|||
37633057|NCT05177094|69099720|FG001|Overall Study|Withdrawal by Subject|3|||
37633058|NCT05177094|69099719|FG000|Overall Study|Participant could not tolerate long study visits|1|||
37633059|NCT05177094|69099720|FG001|Overall Study|Participant could not tolerate long study visits|0|||
37633060|NCT05104749|69099730|FG000|Overall Study|Lost to Follow-up|2|||
37633061|NCT05104749|69099731|FG001|Overall Study|Lost to Follow-up|3|||
37633062|NCT05098041|69099737|FG000|Period 1 (1 Day)|Withdrawal by Subject|1|||
37633063|NCT04648241|69099758|FG000|Overall Study|Lost to Follow-up|1|||
37633064|NCT04648241|69099759|FG001|Overall Study|Lost to Follow-up|0|||
37633065|NCT04124952|69099794|FG000|Overall Study|Lost to Follow-up|1|||
37633087|NCT03677596|69099846|FG000|Overall Study|Adverse Event|0|||
37633088|NCT03677596|69099847|FG001|Overall Study|Adverse Event|1|||
37633089|NCT03677596|69099846|FG000|Overall Study|Death|10|||
37633090|NCT03677596|69099847|FG001|Overall Study|Death|6|||
37633091|NCT03677596|69099846|FG000|Overall Study|Lost to Follow-up|0|||
37633092|NCT03677596|69099847|FG001|Overall Study|Lost to Follow-up|1|||
37633093|NCT03677596|69099846|FG000|Overall Study|Progressive Disease|8|||
37633094|NCT03677596|69099847|FG001|Overall Study|Progressive Disease|8|||
37633095|NCT03677596|69099846|FG000|Overall Study|Withdrawal by Subject|3|||
37633096|NCT03677596|69099847|FG001|Overall Study|Withdrawal by Subject|0|||
37921723|NCT00670228|69608533|FG000|Overall Study|Adverse Event|1|||
37633097|NCT03677596|69099846|FG000|Overall Study|Disease Relapse|2|||
37633098|NCT03677596|69099847|FG001|Overall Study|Disease Relapse|2|||
37633099|NCT03677596|69099846|FG000|Overall Study|Other|0|||
37738638|NCT01609556|69221115|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
37633100|NCT03677596|69099847|FG001|Overall Study|Other|1|||
37633101|NCT03422627|69099867|FG000|Overall Study|Protocol-specified Criteria|1|||
37633102|NCT03422627|69099868|FG001|Overall Study|Protocol-specified Criteria|1|||
37633103|NCT03422627|69099869|FG002|Overall Study|Protocol-specified Criteria|0|||
37633104|NCT03422627|69099870|FG003|Overall Study|Protocol-specified Criteria|0|||
37633105|NCT03422627|69099871|FG004|Overall Study|Protocol-specified Criteria|2|||
37633106|NCT03422627|69099867|FG000|Overall Study|Requirement for Alternative Therapy|1|||
37633107|NCT03422627|69099868|FG001|Overall Study|Requirement for Alternative Therapy|1|||
37633108|NCT03422627|69099869|FG002|Overall Study|Requirement for Alternative Therapy|2|||
37633109|NCT03422627|69099870|FG003|Overall Study|Requirement for Alternative Therapy|0|||
37633110|NCT03422627|69099871|FG004|Overall Study|Requirement for Alternative Therapy|0|||
37633111|NCT03422627|69099867|FG000|Overall Study|Disease Progression|1|||
37633112|NCT03422627|69099868|FG001|Overall Study|Disease Progression|0|||
37633113|NCT03422627|69099869|FG002|Overall Study|Disease Progression|1|||
37633114|NCT03422627|69099870|FG003|Overall Study|Disease Progression|2|||
37633115|NCT03422627|69099871|FG004|Overall Study|Disease Progression|0|||
37633116|NCT03422627|69099867|FG000|Overall Study|Adverse Event|2|||
37633117|NCT03422627|69099868|FG001|Overall Study|Adverse Event|1|||
37633118|NCT03422627|69099869|FG002|Overall Study|Adverse Event|0|||
37633119|NCT03422627|69099870|FG003|Overall Study|Adverse Event|0|||
37633120|NCT03422627|69099871|FG004|Overall Study|Adverse Event|2|||
37633121|NCT03422627|69099867|FG000|Overall Study|Ineligibility Determined|0|||
37633122|NCT03422627|69099868|FG001|Overall Study|Ineligibility Determined|1|||
37633123|NCT03422627|69099869|FG002|Overall Study|Ineligibility Determined|0|||
37633124|NCT03422627|69099870|FG003|Overall Study|Ineligibility Determined|0|||
37633125|NCT03422627|69099871|FG004|Overall Study|Ineligibility Determined|0|||
37633126|NCT03422627|69099867|FG000|Overall Study|Death|0|||
37633127|NCT03422627|69099868|FG001|Overall Study|Death|1|||
37633128|NCT03422627|69099869|FG002|Overall Study|Death|1|||
37633129|NCT03422627|69099870|FG003|Overall Study|Death|0|||
37633130|NCT03422627|69099871|FG004|Overall Study|Death|0|||
37633131|NCT03422627|69099867|FG000|Overall Study|Withdrawal by Subject|0|||
37633132|NCT03422627|69099868|FG001|Overall Study|Withdrawal by Subject|0|||
37633133|NCT03422627|69099869|FG002|Overall Study|Withdrawal by Subject|0|||
37633134|NCT03422627|69099870|FG003|Overall Study|Withdrawal by Subject|1|||
37633135|NCT03422627|69099871|FG004|Overall Study|Withdrawal by Subject|0|||
37633136|NCT03403621|69099883|FG000|Overall Study|Withdrawal by Subject|2|||
37633137|NCT03403621|69099884|FG001|Overall Study|Withdrawal by Subject|2|||
37633138|NCT03225105|69099894|FG000|Overall Study|Withdrawal by Subject|1|||
37738639|NCT01609556|69221116|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
37738640|NCT01609556|69221117|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
37738641|NCT01609556|69221118|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
37738642|NCT01609556|69221119|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
37738643|NCT01609556|69221120|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
37738644|NCT01609556|69221121|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
37738645|NCT01609556|69221106|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
37738646|NCT01609556|69221107|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
37738647|NCT01609556|69221108|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
37738648|NCT01609556|69221109|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
37738649|NCT01609556|69221110|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
37738650|NCT01609556|69221111|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
37738651|NCT01609556|69221112|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
37738652|NCT01609556|69221113|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
37738653|NCT01609556|69221114|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
37738654|NCT01609556|69221115|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
37738655|NCT01609556|69221116|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
37738656|NCT01609556|69221117|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
37738657|NCT01609556|69221118|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
37738658|NCT01609556|69221119|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
37738659|NCT01609556|69221120|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
37738660|NCT01609556|69221121|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
37738661|NCT01609556|69221106|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
37738662|NCT01609556|69221107|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
37738663|NCT01609556|69221108|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
37738664|NCT01609556|69221109|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
37738665|NCT01609556|69221110|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
37921724|NCT00670228|69608534|FG001|Overall Study|Adverse Event|0|||
37633139|NCT03225105|69099895|FG001|Overall Study|Withdrawal by Subject|0|||
37633140|NCT03225105|69099896|FG002|Overall Study|Withdrawal by Subject|0|||
37633141|NCT03225105|69099897|FG003|Overall Study|Withdrawal by Subject|0|||
37633142|NCT03225105|69099894|FG000|Overall Study|Death|0|||
37633143|NCT03225105|69099895|FG001|Overall Study|Death|4|||
37633144|NCT03225105|69099896|FG002|Overall Study|Death|2|||
37633145|NCT03225105|69099897|FG003|Overall Study|Death|0|||
37633146|NCT03225105|69099894|FG000|Overall Study|Study termination per Sponsor Decision|2|||
37633147|NCT03225105|69099895|FG001|Overall Study|Study termination per Sponsor Decision|0|||
37633148|NCT03225105|69099896|FG002|Overall Study|Study termination per Sponsor Decision|3|||
37633149|NCT03225105|69099897|FG003|Overall Study|Study termination per Sponsor Decision|3|||
38031868|NCT03351608|69717636|FG004|Overall Study|Withdrawal by parent/guardian|0|||
38031869|NCT03351608|69717632|FG000|Overall Study|Other|0|||
38031870|NCT03351608|69717633|FG001|Overall Study|Other|1|||
38031871|NCT03351608|69717634|FG002|Overall Study|Other|1|||
38031872|NCT03351608|69717635|FG003|Overall Study|Other|3|||
38031873|NCT03351608|69717636|FG004|Overall Study|Other|0|||
37633156|NCT02937818|69099939|FG000|Overall Study|Participants decision|1|||
37633157|NCT02937818|69099940|FG001|Overall Study|Participants decision|0|||
37633158|NCT02937818|69099941|FG002|Overall Study|Participants decision|1|||
37633159|NCT02937818|69099942|FG003|Overall Study|Participants decision|1|||
37633160|NCT02937818|69099939|FG000|Overall Study|Adverse Event|2|||
37633161|NCT02937818|69099940|FG001|Overall Study|Adverse Event|4|||
37633162|NCT02937818|69099941|FG002|Overall Study|Adverse Event|1|||
37633163|NCT02937818|69099942|FG003|Overall Study|Adverse Event|1|||
37633164|NCT02937818|69099939|FG000|Overall Study|Disease progression|17|||
37633165|NCT02937818|69099940|FG001|Overall Study|Disease progression|14|||
37633166|NCT02937818|69099941|FG002|Overall Study|Disease progression|7|||
37633167|NCT02937818|69099942|FG003|Overall Study|Disease progression|18|||
37633168|NCT02937818|69099939|FG000|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|1|||
37633169|NCT02937818|69099940|FG001|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|2|||
37633170|NCT02937818|69099941|FG002|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|0|||
37633171|NCT02937818|69099942|FG003|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|0|||
37633172|NCT02937818|69099939|FG000|Overall Study|Condition under investigation worsened|0|||
37633173|NCT02937818|69099940|FG001|Overall Study|Condition under investigation worsened|0|||
37633174|NCT02937818|69099941|FG002|Overall Study|Condition under investigation worsened|1|||
37633175|NCT02937818|69099942|FG003|Overall Study|Condition under investigation worsened|0|||
37633176|NCT02937818|69099939|FG000|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0|||
37633177|NCT02937818|69099940|FG001|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0|||
37633178|NCT02937818|69099941|FG002|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0|||
37633179|NCT02937818|69099942|FG003|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|1|||
37633180|NCT02900976|69099957|FG000|Overall Study|Adverse Event|0|||
37633181|NCT02900976|69099958|FG001|Overall Study|Adverse Event|1|||
37633182|NCT02900976|69099957|FG000|Overall Study|Physician Decision|0|||
37633183|NCT02900976|69099958|FG001|Overall Study|Physician Decision|2|||
37633184|NCT02900976|69099957|FG000|Overall Study|Progressive disease|0|||
37633185|NCT02900976|69099958|FG001|Overall Study|Progressive disease|6|||
37633186|NCT02654015|69099965|FG000|Overall Study|Death|12|||
37633187|NCT02654015|69099965|FG000|Overall Study|Lost to Follow-up|3|||
37633188|NCT02542696|69099969|FG000|Overall Study|Adverse Event|167|||
37633189|NCT02542696|69099969|FG000|Overall Study|Lack of Efficacy|26|||
37633190|NCT02542696|69099969|FG000|Overall Study|Lost to Follow-up|6|||
37633191|NCT02542696|69099969|FG000|Overall Study|Withdrawal by Subject|104|||
37633192|NCT02542696|69099969|FG000|Overall Study|Protocol Violation|5|||
37633193|NCT02542696|69099969|FG000|Overall Study|Death|8|||
37633194|NCT02542696|69099969|FG000|Overall Study|DECREASED OFF TIME|1|||
37633195|NCT02542696|69099969|FG000|Overall Study|DID NOT MEET CRITERIA FOR CONTINUATION|1|||
37633196|NCT02542696|69099969|FG000|Overall Study|ELIGIBILITY CRITERIA NOT MET|8|||
37633197|NCT02542696|69099969|FG000|Overall Study|MEDICAL HISTORY|1|||
37633198|NCT02542696|69099969|FG000|Overall Study|"PATIENT WITHDRAWN DURING TITRATION AS COULD NOT TITRATE DRUG TO GET RESPONSE OF ON FROM PATIENT"|1|||
37633199|NCT02542696|69099969|FG000|Overall Study|PROGRESSION OF PARKINSON'S DISEASE|5|||
37633200|NCT02542696|69099969|FG000|Overall Study|SITE UNABLE TO COMPLY WITH PROTOCOL|2|||
37633201|NCT02542696|69099969|FG000|Overall Study|SPONSOR DECISION|3|||
37633202|NCT02542696|69099969|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|36|||
37633203|NCT02542696|69099969|FG000|Overall Study|SUBJECT DECISION|2|||
37633204|NCT02421939|69099976|FG000|Overall Study|Progressive disease|70|||
37738666|NCT01609556|69221111|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
37738667|NCT01609556|69221112|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
37738668|NCT01609556|69221113|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
37738669|NCT01609556|69221114|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
37853461|NCT01301066|69537410|FG000|Overall Study|Withdrawal by Subject|4|||
37633205|NCT02421939|69099977|FG001|Overall Study|Progressive disease|16|||
37633206|NCT02421939|69099976|FG000|Overall Study|Lack of Efficacy|21|||
37633207|NCT02421939|69099977|FG001|Overall Study|Lack of Efficacy|31|||
37633208|NCT02421939|69099976|FG000|Overall Study|Death|36|||
37633209|NCT02421939|69099977|FG001|Overall Study|Death|10|||
37633210|NCT02421939|69099976|FG000|Overall Study|Disease relapse|33|||
37853462|NCT01301066|69537411|FG001|Overall Study|Withdrawal by Subject|9|||
37853463|NCT01301066|69537410|FG000|Overall Study|Adverse Event|6|||
37853464|NCT01301066|69537411|FG001|Overall Study|Adverse Event|6|||
37853465|NCT01301066|69537410|FG000|Overall Study|Sponsor Decision|2|||
37853466|NCT01301066|69537411|FG001|Overall Study|Sponsor Decision|1|||
37853467|NCT01301066|69537410|FG000|Overall Study|Physician Decision|0|||
37853468|NCT01301066|69537411|FG001|Overall Study|Physician Decision|1|||
37633211|NCT02421939|69099977|FG001|Overall Study|Disease relapse|2|||
37633212|NCT02421939|69099976|FG000|Overall Study|Adverse Event|28|||
37633213|NCT02421939|69099977|FG001|Overall Study|Adverse Event|5|||
37633214|NCT02421939|69099976|FG000|Overall Study|Withdrawal by Subject|5|||
37633215|NCT02421939|69099977|FG001|Overall Study|Withdrawal by Subject|24|||
37633216|NCT02421939|69099976|FG000|Overall Study|Physician Decision|11|||
37633217|NCT02421939|69099977|FG001|Overall Study|Physician Decision|11|||
37633218|NCT02421939|69099976|FG000|Overall Study|Completed 1 or 2 chemo cycles with CRs|0|||
37633219|NCT02421939|69099977|FG001|Overall Study|Completed 1 or 2 chemo cycles with CRs|19|||
37633220|NCT02421939|69099976|FG000|Overall Study|Miscellaneous|4|||
37633221|NCT02421939|69099977|FG001|Overall Study|Miscellaneous|5|||
37633222|NCT02421939|69099976|FG000|Overall Study|Protocol deviation|1|||
37633223|NCT02421939|69099977|FG001|Overall Study|Protocol deviation|1|||
37633224|NCT02339740|69099985|FG000|Overall Study|Death|1|||
37633225|NCT02339740|69099986|FG001|Overall Study|Death|0|||
37633226|NCT02339740|69099985|FG000|Overall Study|Physician Decision|0|||
37633227|NCT02339740|69099986|FG001|Overall Study|Physician Decision|2|||
37633228|NCT02339740|69099985|FG000|Overall Study|Withdrawal by Subject|5|||
37633229|NCT02339740|69099986|FG001|Overall Study|Withdrawal by Subject|1|||
37633230|NCT02339740|69099985|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
37633231|NCT02339740|69099986|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
37633232|NCT02163395|69099992|FG000|Overall Study|Withdrawal by Subject|1|||
37633233|NCT02163395|69099992|FG000|Overall Study|Lost to Follow-up|3|||
37633234|NCT02163395|69099992|FG000|Overall Study|Adverse Event|1|||
37633235|NCT01397552|69100007|FG000|Overall Study|Adverse Event|1|||
37633236|NCT01397552|69100008|FG001|Overall Study|Adverse Event|0|||
37633237|NCT01397552|69100007|FG000|Overall Study|Withdrawal by Subject|2|||
37633238|NCT01397552|69100008|FG001|Overall Study|Withdrawal by Subject|1|||
37633239|NCT01256710|69100014|FG000|Overall Study|Death|449|||
37633240|NCT01256710|69100014|FG000|Overall Study|System Explant|67|||
37633241|NCT01256710|69100014|FG000|Overall Study|Transcatheter Aortic Valve-in-Valve Intervention|28|||
37633242|NCT01256710|69100014|FG000|Overall Study|Lost to Follow-up|67|||
37633243|NCT01256710|69100014|FG000|Overall Study|Withdrawal by Subject|29|||
37633244|NCT01256710|69100014|FG000|Overall Study|Physician Decision|9|||
37633245|NCT01256710|69100014|FG000|Overall Study|Subject Noncompliance|2|||
37633246|NCT01256710|69100014|FG000|Overall Study|Study Terminated by Sponsor|273|||
37633247|NCT01096368|69100025|FG000|Overall Study|Death|0|||
37633248|NCT01096368|69100026|FG001|Overall Study|Death|1|||
37633249|NCT01096368|69100027|FG002|Overall Study|Death|0|||
37633250|NCT01096368|69100028|FG003|Overall Study|Death|0|||
37633251|NCT01096368|69100029|FG004|Overall Study|Death|0|||
37633252|NCT01096368|69100025|FG000|Overall Study|Physician Decision|0|||
37633253|NCT01096368|69100026|FG001|Overall Study|Physician Decision|13|||
37633254|NCT01096368|69100027|FG002|Overall Study|Physician Decision|2|||
37633255|NCT01096368|69100028|FG003|Overall Study|Physician Decision|4|||
37633256|NCT01096368|69100029|FG004|Overall Study|Physician Decision|6|||
37633257|NCT01096368|69100025|FG000|Overall Study|Withdrawal by Subject|0|||
37633258|NCT01096368|69100026|FG001|Overall Study|Withdrawal by Subject|52|||
37633259|NCT01096368|69100027|FG002|Overall Study|Withdrawal by Subject|0|||
37633260|NCT01096368|69100028|FG003|Overall Study|Withdrawal by Subject|10|||
37633261|NCT01096368|69100029|FG004|Overall Study|Withdrawal by Subject|14|||
37633262|NCT01096368|69100025|FG000|Overall Study|Ineligible|0|||
37633263|NCT01096368|69100026|FG001|Overall Study|Ineligible|3|||
37633264|NCT01096368|69100027|FG002|Overall Study|Ineligible|2|||
37633265|NCT01096368|69100028|FG003|Overall Study|Ineligible|0|||
37633266|NCT01096368|69100029|FG004|Overall Study|Ineligible|25|||
37633267|NCT01096368|69100025|FG000|Overall Study|Did not start treatment|0|||
37633268|NCT01096368|69100026|FG001|Overall Study|Did not start treatment|4|||
37633269|NCT01096368|69100027|FG002|Overall Study|Did not start treatment|4|||
37633270|NCT01096368|69100028|FG003|Overall Study|Did not start treatment|0|||
37633271|NCT01096368|69100029|FG004|Overall Study|Did not start treatment|0|||
37633272|NCT01096368|69100025|FG000|Overall Study|Progressive disease|0|||
37633273|NCT01096368|69100026|FG001|Overall Study|Progressive disease|6|||
37633274|NCT01096368|69100027|FG002|Overall Study|Progressive disease|0|||
37633275|NCT01096368|69100028|FG003|Overall Study|Progressive disease|10|||
37633276|NCT01096368|69100029|FG004|Overall Study|Progressive disease|3|||
37633277|NCT01096368|69100025|FG000|Overall Study|Other|0|||
37633278|NCT01096368|69100026|FG001|Overall Study|Other|0|||
37633279|NCT01096368|69100027|FG002|Overall Study|Other|1|||
37633280|NCT01096368|69100028|FG003|Overall Study|Other|0|||
37738670|NCT01609556|69221115|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
37633281|NCT01096368|69100029|FG004|Overall Study|Other|0|||
37633282|NCT01096368|69100025|FG000|Overall Study|Treated with institutional review|0|||
37633283|NCT01096368|69100026|FG001|Overall Study|Treated with institutional review|0|||
37633284|NCT01096368|69100027|FG002|Overall Study|Treated with institutional review|0|||
37633285|NCT01096368|69100028|FG003|Overall Study|Treated with institutional review|0|||
37633286|NCT01096368|69100029|FG004|Overall Study|Treated with institutional review|1|||
37633287|NCT00977574|69100056|FG000|Overall Study|Never Treated|4|||
37633288|NCT00977574|69100057|FG001|Overall Study|Never Treated|2|||
37633289|NCT00977574|69100058|FG002|Overall Study|Never Treated|4|||
37633290|NCT00938587|69100070|FG000|Overall Study|Adverse Event|2|||
37633291|NCT00938587|69100071|FG001|Overall Study|Adverse Event|0|||
37633292|NCT00938587|69100072|FG002|Overall Study|Adverse Event|0|||
37633293|NCT00938587|69100073|FG003|Overall Study|Adverse Event|2|||
37738671|NCT01609556|69221116|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
37738672|NCT01609556|69221117|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
37738673|NCT01609556|69221118|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
37738674|NCT01609556|69221119|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
37738675|NCT01609556|69221120|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
37738676|NCT01609556|69221121|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
37738677|NCT01609556|69221106|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
37738678|NCT01609556|69221107|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
37738679|NCT01609556|69221108|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
37738680|NCT01609556|69221109|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
37738681|NCT01609556|69221110|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
37738682|NCT01609556|69221111|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
37738683|NCT01609556|69221112|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
37738684|NCT01609556|69221113|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
37738685|NCT01609556|69221114|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
37738686|NCT01609556|69221115|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
37738687|NCT01609556|69221116|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
37738688|NCT01609556|69221117|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
37738689|NCT01609556|69221118|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
37738690|NCT01609556|69221119|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
37738691|NCT01609556|69221120|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
37738692|NCT01609556|69221121|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
37738693|NCT01609556|69221106|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
37738694|NCT01609556|69221107|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
37738695|NCT01609556|69221108|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
37853469|NCT01301066|69537410|FG000|Overall Study|Other|2|||
37853470|NCT01301066|69537411|FG001|Overall Study|Other|0|||
37853471|NCT01022398|69537419|FG000|Overall Study|Study terminated|2|||
37853472|NCT01022398|69537420|FG001|Overall Study|Study terminated|2|||
37853473|NCT01262976|69537431|FG000|Up to Month 2|Serious Adverse Event|0|||
37853474|NCT01262976|69537432|FG001|Up to Month 2|Serious Adverse Event|0|||
37853475|NCT01262976|69537433|FG002|Up to Month 2|Serious Adverse Event|1|||
37853476|NCT01262976|69537434|FG003|Up to Month 2|Serious Adverse Event|0|||
37853477|NCT01262976|69537435|FG004|Up to Month 2|Serious Adverse Event|0|||
37853478|NCT01262976|69537436|FG005|Up to Month 2|Serious Adverse Event|0|||
37853479|NCT01262976|69537431|FG000|Up to Month 2|Withdrawal by Subject|1|||
37853480|NCT01262976|69537432|FG001|Up to Month 2|Withdrawal by Subject|0|||
37853481|NCT01262976|69537433|FG002|Up to Month 2|Withdrawal by Subject|0|||
37853482|NCT01262976|69537434|FG003|Up to Month 2|Withdrawal by Subject|0|||
37853483|NCT01262976|69537435|FG004|Up to Month 2|Withdrawal by Subject|0|||
37853484|NCT01262976|69537436|FG005|Up to Month 2|Withdrawal by Subject|0|||
37853485|NCT01262976|69537431|FG000|Up to Month 2|Migrated/moved from study area|0|||
37853486|NCT01262976|69537432|FG001|Up to Month 2|Migrated/moved from study area|1|||
37853487|NCT01262976|69537433|FG002|Up to Month 2|Migrated/moved from study area|0|||
37853488|NCT01262976|69537434|FG003|Up to Month 2|Migrated/moved from study area|0|||
37853489|NCT01262976|69537435|FG004|Up to Month 2|Migrated/moved from study area|1|||
37853490|NCT01262976|69537436|FG005|Up to Month 2|Migrated/moved from study area|1|||
37853491|NCT01262976|69537431|FG000|Up to Month 2|Lost to Follow-up|1|||
37853492|NCT01262976|69537432|FG001|Up to Month 2|Lost to Follow-up|0|||
37853493|NCT01262976|69537433|FG002|Up to Month 2|Lost to Follow-up|0|||
37853494|NCT01262976|69537434|FG003|Up to Month 2|Lost to Follow-up|1|||
37853495|NCT01262976|69537435|FG004|Up to Month 2|Lost to Follow-up|1|||
37853496|NCT01262976|69537436|FG005|Up to Month 2|Lost to Follow-up|1|||
37853497|NCT01262976|69537431|FG000|Up to Month 2|Other|1|||
37853498|NCT01262976|69537432|FG001|Up to Month 2|Other|0|||
37853499|NCT01262976|69537433|FG002|Up to Month 2|Other|0|||
37853500|NCT01262976|69537434|FG003|Up to Month 2|Other|1|||
37853501|NCT01262976|69537435|FG004|Up to Month 2|Other|0|||
37853502|NCT01262976|69537436|FG005|Up to Month 2|Other|2|||
37853503|NCT01262976|69537431|FG000|Up to Month 7|Serious Adverse Event|0|||
37738696|NCT01609556|69221109|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
37738697|NCT01609556|69221110|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
37738698|NCT01609556|69221111|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
37738699|NCT01609556|69221112|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
37738700|NCT01609556|69221113|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
37853504|NCT01262976|69537432|FG001|Up to Month 7|Serious Adverse Event|0|||
37853505|NCT01262976|69537433|FG002|Up to Month 7|Serious Adverse Event|2|||
37853506|NCT01262976|69537434|FG003|Up to Month 7|Serious Adverse Event|0|||
37853507|NCT01262976|69537435|FG004|Up to Month 7|Serious Adverse Event|0|||
37633294|NCT00938587|69100070|FG000|Overall Study|Did not meet entrance criteria|0|||
37633295|NCT00938587|69100071|FG001|Overall Study|Did not meet entrance criteria|0|||
37633296|NCT00938587|69100072|FG002|Overall Study|Did not meet entrance criteria|1|||
37633297|NCT00938587|69100073|FG003|Overall Study|Did not meet entrance criteria|0|||
37633298|NCT00938587|69100070|FG000|Overall Study|Withdrawal by Subject|1|||
37633299|NCT00938587|69100071|FG001|Overall Study|Withdrawal by Subject|1|||
37633300|NCT00938587|69100072|FG002|Overall Study|Withdrawal by Subject|0|||
37633301|NCT00938587|69100073|FG003|Overall Study|Withdrawal by Subject|0|||
37633302|NCT00937937|69100083|FG000|Overall Study|Adverse Event|6|||
37633303|NCT00937937|69100083|FG000|Overall Study|Withdrawal by Subject|2|||
37633304|NCT00937937|69100083|FG000|Overall Study|Progression/relapse|61|||
37633305|NCT00937937|69100083|FG000|Overall Study|Death|1|||
37633306|NCT00937937|69100083|FG000|Overall Study|Other|2|||
37633307|NCT00861705|69100092|FG000|Overall Study|Never Began Treatment|7|||
37633308|NCT00861705|69100093|FG001|Overall Study|Never Began Treatment|3|||
37633309|NCT00861705|69100094|FG002|Overall Study|Never Began Treatment|0|||
37633310|NCT00861705|69100095|FG003|Overall Study|Never Began Treatment|1|||
37633311|NCT00810693|69100116|FG000|Treatment Period|Adverse Event|8|||
37633312|NCT00810693|69100117|FG001|Treatment Period|Adverse Event|1|||
37633313|NCT00810693|69100118|FG002|Treatment Period|Adverse Event|7|||
37633314|NCT00810693|69100116|FG000|Treatment Period|Death|0|||
37633315|NCT00810693|69100117|FG001|Treatment Period|Death|1|||
37633316|NCT00810693|69100118|FG002|Treatment Period|Death|2|||
37633317|NCT00810693|69100116|FG000|Treatment Period|Lack of Efficacy|0|||
37633318|NCT00810693|69100117|FG001|Treatment Period|Lack of Efficacy|0|||
37633319|NCT00810693|69100118|FG002|Treatment Period|Lack of Efficacy|1|||
37633320|NCT00810693|69100116|FG000|Treatment Period|Lost to Follow-up|1|||
37633321|NCT00810693|69100117|FG001|Treatment Period|Lost to Follow-up|0|||
37633322|NCT00810693|69100118|FG002|Treatment Period|Lost to Follow-up|0|||
37633323|NCT00810693|69100116|FG000|Treatment Period|Non-compliance|1|||
37633324|NCT00810693|69100117|FG001|Treatment Period|Non-compliance|0|||
37633325|NCT00810693|69100118|FG002|Treatment Period|Non-compliance|0|||
37633326|NCT00810693|69100116|FG000|Treatment Period|Protocol Violation|1|||
37633327|NCT00810693|69100117|FG001|Treatment Period|Protocol Violation|2|||
37633328|NCT00810693|69100118|FG002|Treatment Period|Protocol Violation|2|||
37633329|NCT00810693|69100116|FG000|Treatment Period|Withdrawal by Subject|6|||
37633330|NCT00810693|69100117|FG001|Treatment Period|Withdrawal by Subject|2|||
37633331|NCT00810693|69100118|FG002|Treatment Period|Withdrawal by Subject|3|||
37633332|NCT00810693|69100116|FG000|Treatment Period|Not treated|0|||
37633333|NCT00810693|69100117|FG001|Treatment Period|Not treated|1|||
37633334|NCT00810693|69100118|FG002|Treatment Period|Not treated|1|||
37633335|NCT00810693|69100116|FG000|Follow-up Period (FUP)|Adverse Event|3|||
37633336|NCT00810693|69100117|FG001|Follow-up Period (FUP)|Adverse Event|1|||
37633337|NCT00810693|69100118|FG002|Follow-up Period (FUP)|Adverse Event|1|||
37633338|NCT00810693|69100116|FG000|Follow-up Period (FUP)|Death|2|||
37633339|NCT00810693|69100117|FG001|Follow-up Period (FUP)|Death|0|||
37633340|NCT00810693|69100118|FG002|Follow-up Period (FUP)|Death|1|||
37633341|NCT00810693|69100116|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
37633342|NCT00810693|69100117|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
37738701|NCT01609556|69221114|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
37738702|NCT01609556|69221115|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
37738703|NCT01609556|69221116|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
37853508|NCT01262976|69537436|FG005|Up to Month 7|Serious Adverse Event|0|||
37853509|NCT01262976|69537431|FG000|Up to Month 7|Withdrawal by Subject|1|||
37853510|NCT01262976|69537432|FG001|Up to Month 7|Withdrawal by Subject|0|||
37633343|NCT00810693|69100118|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
37633344|NCT00810693|69100116|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
37633345|NCT00810693|69100117|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
37633346|NCT00810693|69100118|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
37633347|NCT00810693|69100116|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
37633348|NCT00810693|69100117|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
37633349|NCT00810693|69100118|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
37633350|NCT00792948|69100126|FG000|Overall Study|Adverse Event|6|||
37633351|NCT00792948|69100126|FG000|Overall Study|Death|4|||
37633352|NCT00792948|69100126|FG000|Overall Study|Withdrawal by Subject|3|||
37633353|NCT00792948|69100126|FG000|Overall Study|Ineligible|2|||
37633354|NCT00792948|69100126|FG000|Overall Study|Insurance denial - not treated|1|||
37633355|NCT00792948|69100126|FG000|Overall Study|Physician Decision|11|||
37633356|NCT00792948|69100126|FG000|Overall Study|Protocol Violation|1|||
37633357|NCT00658814|69100135|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
37633358|NCT00658814|69100136|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
37633359|NCT00658814|69100135|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
37633360|NCT00658814|69100136|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
37633361|NCT00658814|69100135|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
37633362|NCT00658814|69100136|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
37738704|NCT01609556|69221117|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
37633363|NCT00658814|69100135|FG000|Remission Induction Chemotherapy|Death|1|||
37633364|NCT00658814|69100136|FG001|Remission Induction Chemotherapy|Death|4|||
37633365|NCT00658814|69100135|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
37633366|NCT00658814|69100136|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
37633367|NCT00658814|69100135|FG000|Remission Induction Chemotherapy|Not eligible|1|||
37633368|NCT00658814|69100136|FG001|Remission Induction Chemotherapy|Not eligible|2|||
37633369|NCT00658814|69100135|FG000|Consolidation Therapy|Not protocol specified|0|||
37633370|NCT00658814|69100136|FG001|Consolidation Therapy|Not protocol specified|1|||
37633371|NCT00658814|69100135|FG000|Consolidation Therapy|Not eligible|2|||
37633372|NCT00658814|69100136|FG001|Consolidation Therapy|Not eligible|2|||
37633373|NCT00658814|69100135|FG000|Maintenance Therapy|Adverse Event|1|||
37633374|NCT00658814|69100136|FG001|Maintenance Therapy|Adverse Event|1|||
37633375|NCT00658814|69100135|FG000|Maintenance Therapy|Not protocol specified|1|||
37633376|NCT00658814|69100136|FG001|Maintenance Therapy|Not protocol specified|0|||
37633377|NCT00658814|69100135|FG000|Maintenance Therapy|Not eligible|1|||
37633378|NCT00658814|69100136|FG001|Maintenance Therapy|Not eligible|0|||
37633379|NCT00381641|69100148|FG000|Overall Study|Withdrawal by Subject|0|||
37633380|NCT00381641|69100149|FG001|Overall Study|Withdrawal by Subject|2|||
37633381|NCT00334815|69100157|FG000|Overall Study|Adverse Event|3|||
37633382|NCT00334815|69100158|FG001|Overall Study|Adverse Event|2|||
37633383|NCT00334815|69100157|FG000|Overall Study|Death|0|||
37633384|NCT00334815|69100158|FG001|Overall Study|Death|2|||
37633385|NCT00334815|69100157|FG000|Overall Study|Progression|1|||
37633386|NCT00334815|69100158|FG001|Overall Study|Progression|0|||
37633387|NCT00334815|69100157|FG000|Overall Study|ineligible|1|||
37633388|NCT00334815|69100158|FG001|Overall Study|ineligible|1|||
37633389|NCT00334815|69100157|FG000|Overall Study|patient refused treatment|0|||
37633390|NCT00334815|69100158|FG001|Overall Study|patient refused treatment|1|||
37633391|NCT00334815|69100157|FG000|Overall Study|Physician Decision|2|||
37633392|NCT00334815|69100158|FG001|Overall Study|Physician Decision|4|||
37677402|NCT02637895|69152365|FG000|Overall Study|Abnormal baseline lab|0|||
37677403|NCT02637895|69152366|FG001|Overall Study|Abnormal baseline lab|1|||
37677404|NCT02522481|69152373|FG000|Overall Study|discontinued|1|||
37677405|NCT02522481|69152373|FG000|Overall Study|Not dosed|2|||
37677406|NCT02522403|69152386|FG000|Overall Study|Lost to Follow-up|2|||
37677407|NCT02522403|69152387|FG001|Overall Study|Lost to Follow-up|2|||
37677408|NCT02522403|69152386|FG000|Overall Study|Withdrawal by Subject|2|||
37677409|NCT02522403|69152387|FG001|Overall Study|Withdrawal by Subject|4|||
37677410|NCT02522325|69152393|FG000|Overall Study|Adverse Event|0|||
37677411|NCT02522325|69152394|FG001|Overall Study|Adverse Event|1|||
37677412|NCT01672879|69152403|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
37677413|NCT01672879|69152404|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
37677414|NCT01672879|69152405|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
37677415|NCT01672879|69152403|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
37677416|NCT01672879|69152404|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
37677417|NCT01672879|69152405|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
37677418|NCT01672879|69152403|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
37677419|NCT01672879|69152404|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
37677420|NCT01672879|69152405|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
37677421|NCT01672879|69152403|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
37677422|NCT01672879|69152404|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
37677423|NCT01672879|69152405|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
37677424|NCT01672879|69152403|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
37677425|NCT01672879|69152404|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
37677426|NCT01672879|69152405|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
37677427|NCT01672879|69152403|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
37677428|NCT01672879|69152404|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
38031874|NCT02857816|69717659|FG000|Overall Study|Screen Failure|33|||
37677429|NCT01672879|69152405|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
37677430|NCT01672879|69152403|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
37677431|NCT01672879|69152404|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
37677432|NCT01672879|69152405|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
37677433|NCT01672879|69152403|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
37677434|NCT01672879|69152404|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
37677435|NCT01672879|69152405|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
37677436|NCT01672879|69152403|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
37677437|NCT01672879|69152404|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
37921725|NCT00670228|69608533|FG000|Overall Study|Death or MACE|0|||
37677438|NCT01672879|69152405|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
37677439|NCT01672879|69152403|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
37677440|NCT01672879|69152404|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
37677441|NCT01672879|69152405|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
37921726|NCT00670228|69608534|FG001|Overall Study|Death or MACE|1|||
37633393|NCT04730349|69100177|FG000|Overall Study|Participant withdrew consent|1|||
37633394|NCT04730349|69100178|FG001|Overall Study|Participant withdrew consent|0|||
37633395|NCT04730349|69100177|FG000|Overall Study|Disease progression|6|||
37633396|NCT04730349|69100178|FG001|Overall Study|Disease progression|4|||
37633397|NCT04730349|69100177|FG000|Overall Study|Study drug toxicity|0|||
37633398|NCT04730349|69100178|FG001|Overall Study|Study drug toxicity|1|||
37633399|NCT04307394|69100197|FG000|Overall Study|Lost to Follow-up|3|||
37633400|NCT04307394|69100197|FG000|Overall Study|Withdrawal by Subject|2|||
37633401|NCT03940742|69100223|FG000|Overall Study|Lost to Follow-up|0|||
37633402|NCT03940742|69100224|FG001|Overall Study|Lost to Follow-up|0|||
37633403|NCT03940742|69100225|FG002|Overall Study|Lost to Follow-up|0|||
37633404|NCT03940742|69100226|FG003|Overall Study|Lost to Follow-up|1|||
37633405|NCT03917654|69100248|FG000|Year 1|Withdrawal by Subject|1|||
37633406|NCT03917654|69100249|FG001|Year 1|Withdrawal by Subject|0|||
37633407|NCT03917654|69100250|FG002|Year 1|Withdrawal by Subject|0|||
37633408|NCT03917654|69100251|FG003|Year 1|Withdrawal by Subject|0|||
37633409|NCT03917654|69100252|FG004|Year 1|Withdrawal by Subject|0|||
37633410|NCT03917654|69100253|FG005|Year 1|Withdrawal by Subject|1|||
37633411|NCT03917654|69100254|FG006|Year 1|Withdrawal by Subject|6|||
37633412|NCT03917654|69100255|FG007|Year 1|Withdrawal by Subject|2|||
37633413|NCT03917654|69100256|FG008|Year 1|Withdrawal by Subject|5|||
37633414|NCT03917654|69100257|FG009|Year 1|Withdrawal by Subject|3|||
37633415|NCT03917654|69100258|FG010|Year 1|Withdrawal by Subject|1|||
37633416|NCT03917654|69100259|FG011|Year 1|Withdrawal by Subject|0|||
37633417|NCT03917654|69100248|FG000|Year 1|Travel|0|||
37633418|NCT03917654|69100249|FG001|Year 1|Travel|1|||
37633419|NCT03917654|69100250|FG002|Year 1|Travel|1|||
37633420|NCT03917654|69100251|FG003|Year 1|Travel|0|||
37633421|NCT03917654|69100252|FG004|Year 1|Travel|4|||
37633422|NCT03917654|69100253|FG005|Year 1|Travel|4|||
37633423|NCT03917654|69100254|FG006|Year 1|Travel|10|||
37633424|NCT03917654|69100255|FG007|Year 1|Travel|8|||
37633425|NCT03917654|69100256|FG008|Year 1|Travel|2|||
37633426|NCT03917654|69100257|FG009|Year 1|Travel|5|||
37633427|NCT03917654|69100258|FG010|Year 1|Travel|3|||
37633428|NCT03917654|69100259|FG011|Year 1|Travel|3|||
37633429|NCT03917654|69100248|FG000|Year 1|Subject moved away from site|0|||
37633430|NCT03917654|69100249|FG001|Year 1|Subject moved away from site|1|||
37633431|NCT03917654|69100250|FG002|Year 1|Subject moved away from site|0|||
37633432|NCT03917654|69100251|FG003|Year 1|Subject moved away from site|0|||
37633433|NCT03917654|69100252|FG004|Year 1|Subject moved away from site|0|||
37633434|NCT03917654|69100253|FG005|Year 1|Subject moved away from site|0|||
37633435|NCT03917654|69100254|FG006|Year 1|Subject moved away from site|1|||
37633436|NCT03917654|69100255|FG007|Year 1|Subject moved away from site|2|||
37633437|NCT03917654|69100256|FG008|Year 1|Subject moved away from site|1|||
37633438|NCT03917654|69100257|FG009|Year 1|Subject moved away from site|0|||
37633439|NCT03917654|69100258|FG010|Year 1|Subject moved away from site|0|||
37633440|NCT03917654|69100259|FG011|Year 1|Subject moved away from site|3|||
37633441|NCT03917654|69100248|FG000|Year 1|Spouse/Family member request|0|||
37633442|NCT03917654|69100249|FG001|Year 1|Spouse/Family member request|0|||
37633443|NCT03917654|69100250|FG002|Year 1|Spouse/Family member request|1|||
37633444|NCT03917654|69100251|FG003|Year 1|Spouse/Family member request|0|||
37633445|NCT03917654|69100252|FG004|Year 1|Spouse/Family member request|1|||
37633446|NCT03917654|69100253|FG005|Year 1|Spouse/Family member request|0|||
37633447|NCT03917654|69100254|FG006|Year 1|Spouse/Family member request|0|||
37633448|NCT03917654|69100255|FG007|Year 1|Spouse/Family member request|2|||
37633449|NCT03917654|69100256|FG008|Year 1|Spouse/Family member request|0|||
37633450|NCT03917654|69100257|FG009|Year 1|Spouse/Family member request|0|||
37633451|NCT03917654|69100258|FG010|Year 1|Spouse/Family member request|0|||
37738705|NCT01609556|69221118|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
37738706|NCT01609556|69221119|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
37738707|NCT01609556|69221120|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
37633452|NCT03917654|69100259|FG011|Year 1|Spouse/Family member request|1|||
37633453|NCT03917654|69100248|FG000|Year 1|Death|0|||
37633454|NCT03917654|69100249|FG001|Year 1|Death|0|||
37633455|NCT03917654|69100250|FG002|Year 1|Death|0|||
37633456|NCT03917654|69100251|FG003|Year 1|Death|0|||
37633457|NCT03917654|69100252|FG004|Year 1|Death|0|||
37633458|NCT03917654|69100253|FG005|Year 1|Death|0|||
37633459|NCT03917654|69100254|FG006|Year 1|Death|0|||
37633460|NCT03917654|69100255|FG007|Year 1|Death|0|||
37633461|NCT03917654|69100256|FG008|Year 1|Death|1|||
37633462|NCT03917654|69100257|FG009|Year 1|Death|1|||
37633463|NCT03917654|69100258|FG010|Year 1|Death|0|||
37633464|NCT03917654|69100259|FG011|Year 1|Death|0|||
37633465|NCT03917654|69100248|FG000|Year 1|Lost to Follow-up|0|||
37633466|NCT03917654|69100249|FG001|Year 1|Lost to Follow-up|0|||
37921727|NCT00670228|69608533|FG000|Overall Study|Not treated|2|||
37633467|NCT03917654|69100250|FG002|Year 1|Lost to Follow-up|0|||
37633468|NCT03917654|69100251|FG003|Year 1|Lost to Follow-up|0|||
37633469|NCT03917654|69100252|FG004|Year 1|Lost to Follow-up|0|||
37633470|NCT03917654|69100253|FG005|Year 1|Lost to Follow-up|0|||
37633471|NCT03917654|69100254|FG006|Year 1|Lost to Follow-up|2|||
37633472|NCT03917654|69100255|FG007|Year 1|Lost to Follow-up|0|||
37633473|NCT03917654|69100256|FG008|Year 1|Lost to Follow-up|0|||
37633474|NCT03917654|69100257|FG009|Year 1|Lost to Follow-up|0|||
37633475|NCT03917654|69100258|FG010|Year 1|Lost to Follow-up|0|||
37633476|NCT03917654|69100259|FG011|Year 1|Lost to Follow-up|0|||
37633477|NCT03917654|69100248|FG000|Year 1|Missed visits|0|||
37633478|NCT03917654|69100249|FG001|Year 1|Missed visits|0|||
37633479|NCT03917654|69100250|FG002|Year 1|Missed visits|0|||
37633480|NCT03917654|69100251|FG003|Year 1|Missed visits|0|||
37633481|NCT03917654|69100252|FG004|Year 1|Missed visits|0|||
37633482|NCT03917654|69100253|FG005|Year 1|Missed visits|0|||
37633483|NCT03917654|69100254|FG006|Year 1|Missed visits|0|||
37738708|NCT01609556|69221121|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
37738709|NCT01609556|69221106|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
37738710|NCT01609556|69221107|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
37738711|NCT01609556|69221108|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
37738712|NCT01609556|69221109|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
37738713|NCT01609556|69221110|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
37738714|NCT01609556|69221111|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
37738715|NCT01609556|69221112|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
37633484|NCT03917654|69100255|FG007|Year 1|Missed visits|0|||
37633485|NCT03917654|69100256|FG008|Year 1|Missed visits|0|||
37633486|NCT03917654|69100257|FG009|Year 1|Missed visits|0|||
37738716|NCT01609556|69221113|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
37738717|NCT01609556|69221114|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
37738718|NCT01609556|69221115|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
37738719|NCT01609556|69221116|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
37738720|NCT01609556|69221117|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
37738721|NCT01609556|69221118|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
37738722|NCT01609556|69221119|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
37738723|NCT01609556|69221120|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
37738724|NCT01609556|69221121|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
37738725|NCT01609556|69221106|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
37738726|NCT01609556|69221107|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
37738727|NCT01609556|69221108|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
37738728|NCT01609556|69221109|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
37738729|NCT01609556|69221110|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
37738730|NCT01609556|69221111|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
37738731|NCT01609556|69221112|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
37738732|NCT01609556|69221113|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
37738733|NCT01609556|69221114|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
37738734|NCT01609556|69221115|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
37738735|NCT01609556|69221116|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
37738736|NCT01609556|69221117|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
37738737|NCT01609556|69221118|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
37738738|NCT01609556|69221119|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
37738739|NCT01609556|69221120|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
37738740|NCT01609556|69221121|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
37738741|NCT01609556|69221106|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
37738742|NCT01609556|69221107|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
37738743|NCT01609556|69221108|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
37738744|NCT01609556|69221109|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
37738745|NCT01609556|69221110|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
37738746|NCT01609556|69221111|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
37738747|NCT01609556|69221112|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
37738748|NCT01609556|69221113|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
37738749|NCT01609556|69221114|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
37738750|NCT01609556|69221115|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
37738751|NCT01609556|69221116|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
37738752|NCT01609556|69221117|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
37738753|NCT01609556|69221118|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
37738754|NCT01609556|69221119|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
37738755|NCT01609556|69221120|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
37738756|NCT01609556|69221121|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
37853511|NCT01262976|69537433|FG002|Up to Month 7|Withdrawal by Subject|0|||
37853512|NCT01262976|69537434|FG003|Up to Month 7|Withdrawal by Subject|0|||
37633487|NCT03917654|69100258|FG010|Year 1|Missed visits|1|||
37633488|NCT03917654|69100259|FG011|Year 1|Missed visits|1|||
37633489|NCT03917654|69100248|FG000|Year 1|Pregnancy|0|||
37633490|NCT03917654|69100249|FG001|Year 1|Pregnancy|0|||
37633491|NCT03917654|69100250|FG002|Year 1|Pregnancy|0|||
37633492|NCT03917654|69100251|FG003|Year 1|Pregnancy|0|||
37633493|NCT03917654|69100252|FG004|Year 1|Pregnancy|0|||
37633494|NCT03917654|69100253|FG005|Year 1|Pregnancy|0|||
37633495|NCT03917654|69100254|FG006|Year 1|Pregnancy|0|||
37633496|NCT03917654|69100255|FG007|Year 1|Pregnancy|1|||
37633497|NCT03917654|69100256|FG008|Year 1|Pregnancy|0|||
37633498|NCT03917654|69100257|FG009|Year 1|Pregnancy|1|||
37633499|NCT03917654|69100258|FG010|Year 1|Pregnancy|0|||
37633500|NCT03917654|69100259|FG011|Year 1|Pregnancy|0|||
37633501|NCT03917654|69100248|FG000|Year 2|Travel|1|||
37633502|NCT03917654|69100249|FG001|Year 2|Travel|0|||
37633503|NCT03917654|69100250|FG002|Year 2|Travel|0|||
37633504|NCT03917654|69100251|FG003|Year 2|Travel|0|||
37633505|NCT03917654|69100252|FG004|Year 2|Travel|1|||
37633506|NCT03917654|69100253|FG005|Year 2|Travel|1|||
37633507|NCT03917654|69100254|FG006|Year 2|Travel|2|||
37633508|NCT03917654|69100255|FG007|Year 2|Travel|1|||
37633509|NCT03917654|69100256|FG008|Year 2|Travel|0|||
37633510|NCT03917654|69100257|FG009|Year 2|Travel|1|||
37633511|NCT03917654|69100258|FG010|Year 2|Travel|0|||
37633512|NCT03917654|69100259|FG011|Year 2|Travel|1|||
37633513|NCT03917654|69100248|FG000|Year 2|Married|1|||
37633514|NCT03917654|69100249|FG001|Year 2|Married|0|||
37633515|NCT03917654|69100250|FG002|Year 2|Married|0|||
37633516|NCT03917654|69100251|FG003|Year 2|Married|0|||
37633517|NCT03917654|69100252|FG004|Year 2|Married|0|||
37633518|NCT03917654|69100253|FG005|Year 2|Married|0|||
37633519|NCT03917654|69100254|FG006|Year 2|Married|1|||
37633520|NCT03917654|69100255|FG007|Year 2|Married|1|||
37633521|NCT03917654|69100256|FG008|Year 2|Married|0|||
37633522|NCT03917654|69100257|FG009|Year 2|Married|0|||
37633523|NCT03917654|69100258|FG010|Year 2|Married|0|||
37633524|NCT03917654|69100259|FG011|Year 2|Married|0|||
37633525|NCT03917654|69100248|FG000|Year 2|Subject moved away from site|1|||
37633526|NCT03917654|69100249|FG001|Year 2|Subject moved away from site|0|||
37633527|NCT03917654|69100250|FG002|Year 2|Subject moved away from site|0|||
37633528|NCT03917654|69100251|FG003|Year 2|Subject moved away from site|0|||
37633529|NCT03917654|69100252|FG004|Year 2|Subject moved away from site|1|||
37633530|NCT03917654|69100253|FG005|Year 2|Subject moved away from site|0|||
37633531|NCT03917654|69100254|FG006|Year 2|Subject moved away from site|2|||
37633532|NCT03917654|69100255|FG007|Year 2|Subject moved away from site|3|||
37633533|NCT03917654|69100256|FG008|Year 2|Subject moved away from site|0|||
37633534|NCT03917654|69100257|FG009|Year 2|Subject moved away from site|2|||
37633535|NCT03917654|69100258|FG010|Year 2|Subject moved away from site|0|||
37633536|NCT03917654|69100259|FG011|Year 2|Subject moved away from site|1|||
37633537|NCT03917654|69100248|FG000|Year 2|Year 2 Screening failure|0|||
37633538|NCT03917654|69100249|FG001|Year 2|Year 2 Screening failure|1|||
37633539|NCT03917654|69100250|FG002|Year 2|Year 2 Screening failure|0|||
37633540|NCT03917654|69100251|FG003|Year 2|Year 2 Screening failure|0|||
37633541|NCT03917654|69100252|FG004|Year 2|Year 2 Screening failure|2|||
37633542|NCT03917654|69100253|FG005|Year 2|Year 2 Screening failure|0|||
37633543|NCT03917654|69100254|FG006|Year 2|Year 2 Screening failure|4|||
37633544|NCT03917654|69100255|FG007|Year 2|Year 2 Screening failure|3|||
37633545|NCT03917654|69100256|FG008|Year 2|Year 2 Screening failure|10|||
37633546|NCT03917654|69100257|FG009|Year 2|Year 2 Screening failure|2|||
37633547|NCT03917654|69100258|FG010|Year 2|Year 2 Screening failure|1|||
37633548|NCT03917654|69100259|FG011|Year 2|Year 2 Screening failure|1|||
37633549|NCT03917654|69100248|FG000|Year 2|Death|0|||
37633550|NCT03917654|69100249|FG001|Year 2|Death|0|||
37633551|NCT03917654|69100250|FG002|Year 2|Death|0|||
37633552|NCT03917654|69100251|FG003|Year 2|Death|0|||
37633553|NCT03917654|69100252|FG004|Year 2|Death|0|||
37853513|NCT01262976|69537435|FG004|Up to Month 7|Withdrawal by Subject|0|||
37853514|NCT01262976|69537436|FG005|Up to Month 7|Withdrawal by Subject|0|||
37853515|NCT01262976|69537431|FG000|Up to Month 7|Migrated/moved from study area|0|||
37633554|NCT03917654|69100253|FG005|Year 2|Death|1|||
37633555|NCT03917654|69100254|FG006|Year 2|Death|0|||
37633556|NCT03917654|69100255|FG007|Year 2|Death|0|||
37633557|NCT03917654|69100256|FG008|Year 2|Death|1|||
37633558|NCT03917654|69100257|FG009|Year 2|Death|1|||
37633559|NCT03917654|69100258|FG010|Year 2|Death|0|||
37633560|NCT03917654|69100259|FG011|Year 2|Death|0|||
37633561|NCT03917654|69100248|FG000|Year 2|Withdrawal by Subject|0|||
37633562|NCT03917654|69100249|FG001|Year 2|Withdrawal by Subject|0|||
37633563|NCT03917654|69100250|FG002|Year 2|Withdrawal by Subject|0|||
37633564|NCT03917654|69100251|FG003|Year 2|Withdrawal by Subject|0|||
37633565|NCT03917654|69100252|FG004|Year 2|Withdrawal by Subject|0|||
37633566|NCT03917654|69100253|FG005|Year 2|Withdrawal by Subject|0|||
37633567|NCT03917654|69100254|FG006|Year 2|Withdrawal by Subject|3|||
37633568|NCT03917654|69100255|FG007|Year 2|Withdrawal by Subject|0|||
37633569|NCT03917654|69100256|FG008|Year 2|Withdrawal by Subject|2|||
37633570|NCT03917654|69100257|FG009|Year 2|Withdrawal by Subject|5|||
37633571|NCT03917654|69100258|FG010|Year 2|Withdrawal by Subject|0|||
37633572|NCT03917654|69100259|FG011|Year 2|Withdrawal by Subject|0|||
37633573|NCT03917654|69100248|FG000|Year 2|Spouse/family member request|0|||
37633574|NCT03917654|69100249|FG001|Year 2|Spouse/family member request|0|||
37633575|NCT03917654|69100250|FG002|Year 2|Spouse/family member request|0|||
37633576|NCT03917654|69100251|FG003|Year 2|Spouse/family member request|0|||
37633577|NCT03917654|69100252|FG004|Year 2|Spouse/family member request|0|||
37633578|NCT03917654|69100253|FG005|Year 2|Spouse/family member request|0|||
37633579|NCT03917654|69100254|FG006|Year 2|Spouse/family member request|1|||
37633580|NCT03917654|69100255|FG007|Year 2|Spouse/family member request|0|||
37633581|NCT03917654|69100256|FG008|Year 2|Spouse/family member request|0|||
37633582|NCT03917654|69100257|FG009|Year 2|Spouse/family member request|0|||
37633583|NCT03917654|69100258|FG010|Year 2|Spouse/family member request|0|||
37633584|NCT03917654|69100259|FG011|Year 2|Spouse/family member request|0|||
37633585|NCT03917654|69100248|FG000|Year 2|Lost to Follow-up|0|||
37633586|NCT03917654|69100249|FG001|Year 2|Lost to Follow-up|0|||
37738757|NCT01609556|69221106|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
37738758|NCT01609556|69221107|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
37738759|NCT01609556|69221108|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
37738760|NCT01609556|69221109|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
37921728|NCT00670228|69608534|FG001|Overall Study|Not treated|2|||
37633587|NCT03917654|69100250|FG002|Year 2|Lost to Follow-up|0|||
37633588|NCT03917654|69100251|FG003|Year 2|Lost to Follow-up|0|||
37633589|NCT03917654|69100252|FG004|Year 2|Lost to Follow-up|0|||
37633590|NCT03917654|69100253|FG005|Year 2|Lost to Follow-up|0|||
37633591|NCT03917654|69100254|FG006|Year 2|Lost to Follow-up|1|||
37633592|NCT03917654|69100255|FG007|Year 2|Lost to Follow-up|0|||
37633593|NCT03917654|69100256|FG008|Year 2|Lost to Follow-up|1|||
37633594|NCT03917654|69100257|FG009|Year 2|Lost to Follow-up|0|||
37633595|NCT03917654|69100258|FG010|Year 2|Lost to Follow-up|0|||
37633596|NCT03917654|69100259|FG011|Year 2|Lost to Follow-up|1|||
37633597|NCT03917654|69100248|FG000|Year 2|Adverse Event|0|||
37633598|NCT03917654|69100249|FG001|Year 2|Adverse Event|0|||
37633599|NCT03917654|69100250|FG002|Year 2|Adverse Event|0|||
37633600|NCT03917654|69100251|FG003|Year 2|Adverse Event|0|||
37633601|NCT03917654|69100252|FG004|Year 2|Adverse Event|0|||
37633602|NCT03917654|69100253|FG005|Year 2|Adverse Event|0|||
37633603|NCT03917654|69100254|FG006|Year 2|Adverse Event|0|||
37633604|NCT03917654|69100255|FG007|Year 2|Adverse Event|0|||
37633605|NCT03917654|69100256|FG008|Year 2|Adverse Event|0|||
37633606|NCT03917654|69100257|FG009|Year 2|Adverse Event|1|||
37633607|NCT03917654|69100258|FG010|Year 2|Adverse Event|0|||
37633608|NCT03917654|69100259|FG011|Year 2|Adverse Event|0|||
37633609|NCT03060577|69100305|FG000|Overall Study|Withdrawal by Subject|25|||
37633610|NCT03060577|69100306|FG001|Overall Study|Withdrawal by Subject|5|||
37633611|NCT03060577|69100305|FG000|Overall Study|Physician Decision|4|||
37633612|NCT03060577|69100306|FG001|Overall Study|Physician Decision|3|||
37633613|NCT03060577|69100305|FG000|Overall Study|Lost to Follow-up|3|||
37633614|NCT03060577|69100306|FG001|Overall Study|Lost to Follow-up|0|||
37633615|NCT03060577|69100305|FG000|Overall Study|Death|7|||
37633616|NCT03060577|69100306|FG001|Overall Study|Death|1|||
37633617|NCT03060577|69100305|FG000|Overall Study|Adverse Event|9|||
37633618|NCT03060577|69100306|FG001|Overall Study|Adverse Event|1|||
37633619|NCT03060577|69100305|FG000|Overall Study|Inclusion/Exclusion|1|||
37633620|NCT03060577|69100306|FG001|Overall Study|Inclusion/Exclusion|0|||
37633621|NCT03060577|69100305|FG000|Overall Study|Other|8|||
37633622|NCT03060577|69100306|FG001|Overall Study|Other|2|||
37633623|NCT02872714|69100317|FG000|Overall Study|Progressive Disease|1|||
37633624|NCT02872714|69100318|FG001|Overall Study|Progressive Disease|2|||
37633625|NCT02872714|69100319|FG002|Overall Study|Progressive Disease|0|||
37633626|NCT02872714|69100320|FG003|Overall Study|Progressive Disease|0|||
37633627|NCT02872714|69100321|FG004|Overall Study|Progressive Disease|0|||
37921729|NCT00670228|69608533|FG000|Overall Study|Not meeting the selection criteria|2|||
37633628|NCT02872714|69100317|FG000|Overall Study|Death|87|||
37633629|NCT02872714|69100318|FG001|Overall Study|Death|36|||
37633630|NCT02872714|69100319|FG002|Overall Study|Death|8|||
37633631|NCT02872714|69100320|FG003|Overall Study|Death|81|||
37633632|NCT02872714|69100321|FG004|Overall Study|Death|2|||
37633633|NCT02872714|69100317|FG000|Overall Study|Lost to Follow-up|2|||
37633634|NCT02872714|69100318|FG001|Overall Study|Lost to Follow-up|1|||
37633635|NCT02872714|69100319|FG002|Overall Study|Lost to Follow-up|0|||
37633636|NCT02872714|69100320|FG003|Overall Study|Lost to Follow-up|3|||
37633637|NCT02872714|69100321|FG004|Overall Study|Lost to Follow-up|0|||
37633638|NCT02872714|69100317|FG000|Overall Study|Physician Decision|0|||
37633639|NCT02872714|69100318|FG001|Overall Study|Physician Decision|0|||
37921730|NCT00670228|69608534|FG001|Overall Study|Not meeting the selection criteria|0|||
37921731|NCT00570778|69608540|FG000|Overall Study|Protocol deviation|2|||
37633640|NCT02872714|69100319|FG002|Overall Study|Physician Decision|0|||
37633641|NCT02872714|69100320|FG003|Overall Study|Physician Decision|1|||
37633642|NCT02872714|69100321|FG004|Overall Study|Physician Decision|0|||
37633643|NCT02872714|69100317|FG000|Overall Study|Withdrawal by Subject|1|||
37633644|NCT02872714|69100318|FG001|Overall Study|Withdrawal by Subject|3|||
37633645|NCT02872714|69100319|FG002|Overall Study|Withdrawal by Subject|0|||
37633646|NCT02872714|69100320|FG003|Overall Study|Withdrawal by Subject|2|||
37633647|NCT02872714|69100321|FG004|Overall Study|Withdrawal by Subject|0|||
37633648|NCT02872714|69100317|FG000|Overall Study|Captured as Other|2|||
37633649|NCT02872714|69100318|FG001|Overall Study|Captured as Other|0|||
37633650|NCT02872714|69100319|FG002|Overall Study|Captured as Other|0|||
37633651|NCT02872714|69100320|FG003|Overall Study|Captured as Other|1|||
37633652|NCT02872714|69100321|FG004|Overall Study|Captured as Other|0|||
37633653|NCT02787005|69100341|FG000|Overall Study|Adverse Event|24|||
37633654|NCT02787005|69100342|FG001|Overall Study|Adverse Event|9|||
37633655|NCT02787005|69100343|FG002|Overall Study|Adverse Event|9|||
37633656|NCT02787005|69100344|FG003|Overall Study|Adverse Event|7|||
37633657|NCT02787005|69100345|FG004|Overall Study|Adverse Event|2|||
37633658|NCT02787005|69100341|FG000|Overall Study|Death|100|||
37633659|NCT02787005|69100342|FG001|Overall Study|Death|53|||
37633660|NCT02787005|69100343|FG002|Overall Study|Death|48|||
37633661|NCT02787005|69100344|FG003|Overall Study|Death|69|||
37633662|NCT02787005|69100345|FG004|Overall Study|Death|38|||
37633663|NCT02787005|69100341|FG000|Overall Study|Sponsor Decision|7|||
37633664|NCT02787005|69100342|FG001|Overall Study|Sponsor Decision|4|||
37633665|NCT02787005|69100343|FG002|Overall Study|Sponsor Decision|0|||
37633666|NCT02787005|69100344|FG003|Overall Study|Sponsor Decision|4|||
37633667|NCT02787005|69100345|FG004|Overall Study|Sponsor Decision|5|||
37633668|NCT02787005|69100341|FG000|Overall Study|Withdrawal by Subject|2|||
37633669|NCT02787005|69100342|FG001|Overall Study|Withdrawal by Subject|1|||
37633670|NCT02787005|69100343|FG002|Overall Study|Withdrawal by Subject|1|||
37633671|NCT02787005|69100344|FG003|Overall Study|Withdrawal by Subject|0|||
37633672|NCT02787005|69100345|FG004|Overall Study|Withdrawal by Subject|1|||
37633673|NCT02787005|69100341|FG000|Overall Study|Screen Failure|0|||
37633674|NCT02787005|69100342|FG001|Overall Study|Screen Failure|2|||
37633675|NCT02787005|69100343|FG002|Overall Study|Screen Failure|0|||
37633676|NCT02787005|69100344|FG003|Overall Study|Screen Failure|0|||
37633677|NCT02787005|69100345|FG004|Overall Study|Screen Failure|1|||
37633678|NCT02787005|69100341|FG000|Overall Study|Lost to Follow-up|0|||
37633679|NCT02787005|69100342|FG001|Overall Study|Lost to Follow-up|0|||
37633680|NCT02787005|69100343|FG002|Overall Study|Lost to Follow-up|0|||
37633681|NCT02787005|69100344|FG003|Overall Study|Lost to Follow-up|1|||
37633682|NCT02787005|69100345|FG004|Overall Study|Lost to Follow-up|0|||
37633683|NCT02514083|69100376|FG000|Overall Study|Adverse Event|1|||
37633684|NCT02395848|69100380|FG000|Overall Study|Lost to Follow-up|2|||
37633685|NCT02061761|69100397|FG000|Overall Study|Disease progression|2|||
37633686|NCT02061761|69100398|FG001|Overall Study|Disease progression|8|||
37633687|NCT02061761|69100399|FG002|Overall Study|Disease progression|4|||
37633688|NCT02061761|69100400|FG003|Overall Study|Disease progression|5|||
37633689|NCT02061761|69100401|FG004|Overall Study|Disease progression|9|||
37633690|NCT02061761|69100402|FG005|Overall Study|Disease progression|3|||
37633691|NCT02061761|69100403|FG006|Overall Study|Disease progression|1|||
37633692|NCT02061761|69100404|FG007|Overall Study|Disease progression|2|||
37633693|NCT02061761|69100405|FG008|Overall Study|Disease progression|28|||
37633694|NCT02061761|69100397|FG000|Overall Study|Study Drug toxicity|0|||
37633695|NCT02061761|69100398|FG001|Overall Study|Study Drug toxicity|0|||
37633696|NCT02061761|69100399|FG002|Overall Study|Study Drug toxicity|0|||
37633697|NCT02061761|69100400|FG003|Overall Study|Study Drug toxicity|0|||
37633698|NCT02061761|69100401|FG004|Overall Study|Study Drug toxicity|0|||
37633699|NCT02061761|69100402|FG005|Overall Study|Study Drug toxicity|1|||
37633700|NCT02061761|69100403|FG006|Overall Study|Study Drug toxicity|0|||
37633701|NCT02061761|69100404|FG007|Overall Study|Study Drug toxicity|2|||
37633702|NCT02061761|69100405|FG008|Overall Study|Study Drug toxicity|6|||
37633703|NCT02061761|69100397|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
37633704|NCT02061761|69100398|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
37633705|NCT02061761|69100399|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
37633706|NCT02061761|69100400|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
37633707|NCT02061761|69100401|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
37633708|NCT02061761|69100402|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
37633709|NCT02061761|69100403|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
37633710|NCT02061761|69100404|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
37633711|NCT02061761|69100405|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
37633712|NCT02061761|69100397|FG000|Overall Study|Participant request to discontinue study treatment|0|||
37633713|NCT02061761|69100398|FG001|Overall Study|Participant request to discontinue study treatment|0|||
37633714|NCT02061761|69100399|FG002|Overall Study|Participant request to discontinue study treatment|2|||
37738761|NCT01609556|69221110|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
37633715|NCT02061761|69100400|FG003|Overall Study|Participant request to discontinue study treatment|2|||
37633716|NCT02061761|69100401|FG004|Overall Study|Participant request to discontinue study treatment|0|||
37633717|NCT02061761|69100402|FG005|Overall Study|Participant request to discontinue study treatment|1|||
37633718|NCT02061761|69100403|FG006|Overall Study|Participant request to discontinue study treatment|0|||
37633719|NCT02061761|69100404|FG007|Overall Study|Participant request to discontinue study treatment|0|||
37633720|NCT02061761|69100405|FG008|Overall Study|Participant request to discontinue study treatment|2|||
37633721|NCT02061761|69100397|FG000|Overall Study|Withdrawal by Subject|0|||
37633722|NCT02061761|69100398|FG001|Overall Study|Withdrawal by Subject|0|||
37633723|NCT02061761|69100399|FG002|Overall Study|Withdrawal by Subject|0|||
37633724|NCT02061761|69100400|FG003|Overall Study|Withdrawal by Subject|0|||
37633725|NCT02061761|69100401|FG004|Overall Study|Withdrawal by Subject|0|||
37633726|NCT02061761|69100402|FG005|Overall Study|Withdrawal by Subject|0|||
37633727|NCT02061761|69100403|FG006|Overall Study|Withdrawal by Subject|0|||
37633728|NCT02061761|69100404|FG007|Overall Study|Withdrawal by Subject|0|||
37633729|NCT02061761|69100405|FG008|Overall Study|Withdrawal by Subject|2|||
37633730|NCT02061761|69100397|FG000|Overall Study|Maximum clinical benefit|0|||
37633731|NCT02061761|69100398|FG001|Overall Study|Maximum clinical benefit|0|||
37633732|NCT02061761|69100399|FG002|Overall Study|Maximum clinical benefit|0|||
37633733|NCT02061761|69100400|FG003|Overall Study|Maximum clinical benefit|1|||
37633734|NCT02061761|69100401|FG004|Overall Study|Maximum clinical benefit|0|||
37633735|NCT02061761|69100402|FG005|Overall Study|Maximum clinical benefit|0|||
37633736|NCT02061761|69100403|FG006|Overall Study|Maximum clinical benefit|0|||
37633737|NCT02061761|69100404|FG007|Overall Study|Maximum clinical benefit|0|||
37633738|NCT02061761|69100405|FG008|Overall Study|Maximum clinical benefit|6|||
37633739|NCT02061761|69100397|FG000|Overall Study|Participant no longer meets study criteria|0|||
37633740|NCT02061761|69100398|FG001|Overall Study|Participant no longer meets study criteria|0|||
37633741|NCT02061761|69100399|FG002|Overall Study|Participant no longer meets study criteria|0|||
37633742|NCT02061761|69100400|FG003|Overall Study|Participant no longer meets study criteria|0|||
37633743|NCT02061761|69100401|FG004|Overall Study|Participant no longer meets study criteria|0|||
37738762|NCT01609556|69221111|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
37738763|NCT01609556|69221112|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
37738764|NCT01609556|69221113|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
37738765|NCT01609556|69221114|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
37738766|NCT01609556|69221115|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
37738767|NCT01609556|69221116|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
37738768|NCT01609556|69221117|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
37738769|NCT01609556|69221118|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
37738770|NCT01609556|69221119|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
37738771|NCT01609556|69221120|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
37738772|NCT01609556|69221121|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
37738773|NCT01609556|69221106|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
37738774|NCT01609556|69221107|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
37738775|NCT01609556|69221108|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
37738776|NCT01609556|69221109|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
37738777|NCT01609556|69221110|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
37738778|NCT01609556|69221111|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
37738779|NCT01609556|69221112|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
37738780|NCT01609556|69221113|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
37738781|NCT01609556|69221114|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
37738782|NCT01609556|69221115|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
37738783|NCT01609556|69221116|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
37738784|NCT01609556|69221117|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
37738785|NCT01609556|69221118|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
37738786|NCT01609556|69221119|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
37738787|NCT01609556|69221120|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
37738788|NCT01609556|69221121|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
37738789|NCT01609556|69221106|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
37738790|NCT01609556|69221107|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
37738791|NCT01609556|69221108|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
37738792|NCT01609556|69221109|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
37738793|NCT01609556|69221110|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
37738794|NCT01609556|69221111|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
37738795|NCT01609556|69221112|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
37738796|NCT01609556|69221113|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
37738797|NCT01609556|69221114|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
37738798|NCT01609556|69221115|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
37738799|NCT01609556|69221116|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
37738800|NCT01609556|69221117|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
37738801|NCT01609556|69221118|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
37738802|NCT01609556|69221119|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
37738803|NCT01609556|69221120|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
37738804|NCT01609556|69221121|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
37738805|NCT01763996|69221495|FG000|Treatment Period 2|Adverse Event|0|||
37738806|NCT01763996|69221496|FG001|Treatment Period 2|Adverse Event|1|||
37738807|NCT01468701|69221939|FG000|Overall Study|Not eligible|91|||
37738808|NCT01468701|69221940|FG001|Overall Study|Not eligible|140|||
37738809|NCT01468701|69221941|FG002|Overall Study|Not eligible|29|||
37738810|NCT01468701|69221942|FG003|Overall Study|Not eligible|12|||
37633744|NCT02061761|69100402|FG005|Overall Study|Participant no longer meets study criteria|0|||
37633745|NCT02061761|69100403|FG006|Overall Study|Participant no longer meets study criteria|0|||
37633746|NCT02061761|69100404|FG007|Overall Study|Participant no longer meets study criteria|0|||
37633747|NCT02061761|69100405|FG008|Overall Study|Participant no longer meets study criteria|1|||
37633748|NCT02061761|69100397|FG000|Overall Study|Other reasons|0|||
37633749|NCT02061761|69100398|FG001|Overall Study|Other reasons|0|||
37633750|NCT02061761|69100399|FG002|Overall Study|Other reasons|0|||
37633751|NCT02061761|69100400|FG003|Overall Study|Other reasons|0|||
37633752|NCT02061761|69100401|FG004|Overall Study|Other reasons|2|||
37633753|NCT02061761|69100402|FG005|Overall Study|Other reasons|0|||
37633754|NCT02061761|69100403|FG006|Overall Study|Other reasons|0|||
37633755|NCT02061761|69100404|FG007|Overall Study|Other reasons|0|||
37633756|NCT02061761|69100405|FG008|Overall Study|Other reasons|6|||
37633757|NCT01927068|69100433|FG000|Overall Study|Death|37|||
37633758|NCT01927068|69100434|FG001|Overall Study|Death|3|||
37633759|NCT01927068|69100433|FG000|Overall Study|Withdrawal by Subject|50|||
37633760|NCT01927068|69100434|FG001|Overall Study|Withdrawal by Subject|3|||
37633761|NCT01927068|69100433|FG000|Overall Study|Lost to Follow-up|10|||
37633762|NCT01927068|69100434|FG001|Overall Study|Lost to Follow-up|2|||
37633763|NCT01927068|69100433|FG000|Overall Study|Physician Decision|9|||
37633764|NCT01927068|69100434|FG001|Overall Study|Physician Decision|0|||
37633765|NCT01927068|69100433|FG000|Overall Study|Missed last follow-up visit|2|||
37633766|NCT01927068|69100434|FG001|Overall Study|Missed last follow-up visit|0|||
37633767|NCT01309230|69100443|FG000|Overall Study|Withdrawal by Subject|0|||
37633768|NCT01309230|69100444|FG001|Overall Study|Withdrawal by Subject|2|||
37633769|NCT01309230|69100443|FG000|Overall Study|Observation arm closed|0|||
37633770|NCT01309230|69100444|FG001|Overall Study|Observation arm closed|2|||
37633771|NCT00819832|69100456|FG000|Overall Study|Sponsor Termination of Study|3|||
37633772|NCT00819832|69100457|FG001|Overall Study|Sponsor Termination of Study|0|||
37633773|NCT00819832|69100458|FG002|Overall Study|Sponsor Termination of Study|0|||
37633774|NCT00819832|69100459|FG003|Overall Study|Sponsor Termination of Study|0|||
37633775|NCT00819832|69100460|FG004|Overall Study|Sponsor Termination of Study|0|||
37633776|NCT00819832|69100461|FG005|Overall Study|Sponsor Termination of Study|0|||
37633777|NCT00704522|69100477|FG000|Overall Study|Lack of Efficacy|65|||
37633778|NCT00704522|69100478|FG001|Overall Study|Lack of Efficacy|17|||
37633779|NCT00704522|69100477|FG000|Overall Study|Failure to appear again at hospital|56|||
37633780|NCT00704522|69100478|FG001|Overall Study|Failure to appear again at hospital|10|||
37633781|NCT00704522|69100477|FG000|Overall Study|Withdrawal by Subject|17|||
37633782|NCT00704522|69100478|FG001|Overall Study|Withdrawal by Subject|8|||
37633783|NCT00704522|69100477|FG000|Overall Study|Adverse Event|9|||
37633784|NCT00704522|69100478|FG001|Overall Study|Adverse Event|1|||
37633785|NCT00704522|69100477|FG000|Overall Study|Undefined causes|9|||
37738811|NCT01468701|69221943|FG004|Overall Study|Not eligible|22|||
37738812|NCT01468701|69221944|FG005|Overall Study|Not eligible|2|||
37738813|NCT01468701|69221945|FG006|Overall Study|Not eligible|39|||
37738814|NCT01468701|69221946|FG007|Overall Study|Not eligible|1|||
37738815|NCT01468701|69221947|FG008|Overall Study|Not eligible|40|||
37738816|NCT01468701|69221948|FG009|Overall Study|Not eligible|126|||
37738817|NCT01468701|69221949|FG010|Overall Study|Not eligible|39|||
37738818|NCT01468701|69221950|FG011|Overall Study|Not eligible|33|||
37738819|NCT01468701|69221951|FG012|Overall Study|Not eligible|1|||
37738820|NCT01468701|69221952|FG013|Overall Study|Not eligible|19|||
37738821|NCT01468701|69221953|FG014|Overall Study|Not eligible|1|||
37738822|NCT01468701|69221954|FG015|Overall Study|Not eligible|32|||
37738823|NCT01468701|69221955|FG016|Overall Study|Not eligible|0|||
37853516|NCT01262976|69537432|FG001|Up to Month 7|Migrated/moved from study area|0|||
37853517|NCT01262976|69537433|FG002|Up to Month 7|Migrated/moved from study area|1|||
37633786|NCT00704522|69100478|FG001|Overall Study|Undefined causes|7|||
37633787|NCT00704522|69100477|FG000|Overall Study|No information on therapy end|27|||
37633788|NCT00704522|69100478|FG001|Overall Study|No information on therapy end|2|||
37633789|NCT02723630|69100493|FG000|Intervention Period 1|Adverse Event|1|||
37633790|NCT02723630|69100494|FG001|Intervention Period 1|Adverse Event|0|||
37633791|NCT02723630|69100495|FG002|Intervention Period 1|Adverse Event|0|||
37633792|NCT02723630|69100496|FG003|Intervention Period 1|Adverse Event|0|||
37633793|NCT02723630|69100497|FG004|Intervention Period 1|Adverse Event|0|||
37633794|NCT02723630|69100498|FG005|Intervention Period 1|Adverse Event|0|||
37633795|NCT02723630|69100493|FG000|Intervention Period 3|consumption of restricted item|0|||
37633796|NCT02723630|69100494|FG001|Intervention Period 3|consumption of restricted item|1|||
37633797|NCT02723630|69100495|FG002|Intervention Period 3|consumption of restricted item|0|||
37633798|NCT02723630|69100496|FG003|Intervention Period 3|consumption of restricted item|0|||
37633799|NCT02723630|69100497|FG004|Intervention Period 3|consumption of restricted item|0|||
37738824|NCT01468701|69221939|FG000|Overall Study|Lost to Follow-up|306|||
37853518|NCT01262976|69537434|FG003|Up to Month 7|Migrated/moved from study area|3|||
37738825|NCT01468701|69221940|FG001|Overall Study|Lost to Follow-up|0|||
37633800|NCT02723630|69100498|FG005|Intervention Period 3|consumption of restricted item|0|||
37738826|NCT01468701|69221941|FG002|Overall Study|Lost to Follow-up|0|||
37633801|NCT04089735|69100541|FG000|Overall Study|Adverse Event|1|||
37633802|NCT04089735|69100542|FG001|Overall Study|Adverse Event|0|||
37633803|NCT04089735|69100543|FG002|Overall Study|Adverse Event|1|||
37633804|NCT04089735|69100544|FG003|Overall Study|Adverse Event|1|||
37633805|NCT04089735|69100545|FG004|Overall Study|Adverse Event|0|||
37633806|NCT04089735|69100546|FG005|Overall Study|Adverse Event|0|||
37633807|NCT04089735|69100541|FG000|Overall Study|Physician Decision|0|||
37633808|NCT04089735|69100542|FG001|Overall Study|Physician Decision|3|||
37633809|NCT04089735|69100543|FG002|Overall Study|Physician Decision|0|||
37633810|NCT04089735|69100544|FG003|Overall Study|Physician Decision|0|||
37633811|NCT04089735|69100545|FG004|Overall Study|Physician Decision|0|||
37633812|NCT04089735|69100546|FG005|Overall Study|Physician Decision|0|||
37633813|NCT04089735|69100541|FG000|Overall Study|Withdrawal by Subject|0|||
37633814|NCT04089735|69100542|FG001|Overall Study|Withdrawal by Subject|0|||
37633815|NCT04089735|69100543|FG002|Overall Study|Withdrawal by Subject|1|||
37633816|NCT04089735|69100544|FG003|Overall Study|Withdrawal by Subject|0|||
37633817|NCT04089735|69100545|FG004|Overall Study|Withdrawal by Subject|0|||
37633818|NCT04089735|69100546|FG005|Overall Study|Withdrawal by Subject|0|||
37633819|NCT04089735|69100541|FG000|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
37633820|NCT04089735|69100542|FG001|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|3|||
37633821|NCT04089735|69100543|FG002|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
37633822|NCT04089735|69100544|FG003|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|5|||
37633823|NCT04089735|69100545|FG004|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|1|||
37633824|NCT04089735|69100546|FG005|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|6|||
37633825|NCT01876784|69100562|FG000|Overall Study|Withdrawal by Subject|17|||
37633826|NCT01876784|69100563|FG001|Overall Study|Withdrawal by Subject|2|||
37633827|NCT01876784|69100562|FG000|Overall Study|Adverse Event|15|||
37633828|NCT01876784|69100563|FG001|Overall Study|Adverse Event|2|||
37633829|NCT01876784|69100562|FG000|Overall Study|Protocol Violation|1|||
37633830|NCT01876784|69100563|FG001|Overall Study|Protocol Violation|0|||
37633831|NCT01876784|69100562|FG000|Overall Study|Disease progression|37|||
37633832|NCT01876784|69100563|FG001|Overall Study|Disease progression|67|||
37633833|NCT01876784|69100562|FG000|Overall Study|Lost to Follow-up|0|||
37633834|NCT01876784|69100563|FG001|Overall Study|Lost to Follow-up|1|||
37633835|NCT01876784|69100562|FG000|Overall Study|Death|1|||
37633836|NCT01876784|69100563|FG001|Overall Study|Death|0|||
37633837|NCT01876784|69100562|FG000|Overall Study|Randomized but not treated|2|||
37633838|NCT01876784|69100563|FG001|Overall Study|Randomized but not treated|1|||
37633839|NCT01876784|69100562|FG000|Overall Study|Other than specified above|5|||
37633840|NCT01876784|69100563|FG001|Overall Study|Other than specified above|6|||
37633841|NCT01876784|69100562|FG000|Overall Study|Ongoing|41|||
37633842|NCT01876784|69100563|FG001|Overall Study|Ongoing|40|||
37633843|NCT04205162|69100571|FG000|Overall Study|Lost to Follow-up|1|||
37633844|NCT04205162|69100572|FG001|Overall Study|Lost to Follow-up|0|||
37633845|NCT04205162|69100571|FG000|Overall Study|Withdrawal by Subject|2|||
37633846|NCT04205162|69100572|FG001|Overall Study|Withdrawal by Subject|0|||
37633847|NCT04205162|69100571|FG000|Overall Study|University closure due to COVID-19|1|||
37633848|NCT04205162|69100572|FG001|Overall Study|University closure due to COVID-19|0|||
37633849|NCT01329939|69100597|FG000|Overall Study|Lost to Follow-up|3|||
37633850|NCT01329939|69100598|FG001|Overall Study|Lost to Follow-up|0|||
37633851|NCT01329939|69100599|FG002|Overall Study|Lost to Follow-up|1|||
37633852|NCT01329939|69100600|FG003|Overall Study|Lost to Follow-up|2|||
37633853|NCT01329939|69100597|FG000|Overall Study|Withdrawal by Subject|0|||
37633854|NCT01329939|69100598|FG001|Overall Study|Withdrawal by Subject|1|||
37633855|NCT01329939|69100599|FG002|Overall Study|Withdrawal by Subject|0|||
37633856|NCT01329939|69100600|FG003|Overall Study|Withdrawal by Subject|0|||
37633857|NCT01329939|69100597|FG000|Overall Study|Adverse Event|0|||
37633858|NCT01329939|69100598|FG001|Overall Study|Adverse Event|0|||
37633859|NCT01329939|69100599|FG002|Overall Study|Adverse Event|0|||
37633860|NCT01329939|69100600|FG003|Overall Study|Adverse Event|3|||
37633861|NCT02499900|69100612|FG000|Core Study Period|Other|1|||
37633862|NCT02499900|69100613|FG001|Core Study Period|Other|4|||
37633863|NCT02499900|69100612|FG000|Core Study Period|Lost to Follow-up|1|||
37633864|NCT02499900|69100613|FG001|Core Study Period|Lost to Follow-up|2|||
37633865|NCT02499900|69100612|FG000|Core Study Period|Per sponsor request|0|||
37633866|NCT02499900|69100613|FG001|Core Study Period|Per sponsor request|1|||
37633867|NCT02499900|69100612|FG000|Core Study Period|Pregnancy|1|||
37633868|NCT02499900|69100613|FG001|Core Study Period|Pregnancy|0|||
37633869|NCT02499900|69100612|FG000|Core Study Period|Protocol Violation|3|||
37633870|NCT02499900|69100613|FG001|Core Study Period|Protocol Violation|0|||
37633871|NCT02499900|69100612|FG000|Core Study Period|Withdrawal by Subject|11|||
37633872|NCT02499900|69100613|FG001|Core Study Period|Withdrawal by Subject|10|||
37633873|NCT02499900|69100612|FG000|Core Study Period|Adverse Event|18|||
37633874|NCT02499900|69100613|FG001|Core Study Period|Adverse Event|14|||
37633875|NCT02499900|69100612|FG000|Core Study Period|Death|0|||
37633876|NCT02499900|69100613|FG001|Core Study Period|Death|1|||
37633877|NCT02499900|69100612|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
37633878|NCT02499900|69100613|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
37633879|NCT02499900|69100612|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
37633880|NCT02499900|69100613|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
37633881|NCT02499900|69100612|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
37633882|NCT02499900|69100613|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
37633883|NCT02499900|69100612|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
37633884|NCT02499900|69100613|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
37633885|NCT02499900|69100612|FG000|Extension Study Period|Adverse Event|2|||
37633886|NCT02499900|69100613|FG001|Extension Study Period|Adverse Event|4|||
37633887|NCT02499900|69100612|FG000|Extension Study Period|Withdrawal by Subject|5|||
37633888|NCT02499900|69100613|FG001|Extension Study Period|Withdrawal by Subject|2|||
37633889|NCT02499900|69100612|FG000|Extension Study Period|Physician Decision|2|||
37633890|NCT02499900|69100613|FG001|Extension Study Period|Physician Decision|5|||
37633891|NCT02499900|69100612|FG000|Extension Study Period|Pregnancy|1|||
37633892|NCT02499900|69100613|FG001|Extension Study Period|Pregnancy|2|||
37633893|NCT02499900|69100612|FG000|Extension Study Period|Lost to Follow-up|2|||
37633894|NCT02499900|69100613|FG001|Extension Study Period|Lost to Follow-up|5|||
37633895|NCT02499900|69100612|FG000|Extension Study Period|Other|0|||
37633896|NCT02499900|69100613|FG001|Extension Study Period|Other|2|||
37633897|NCT03505749|69100627|FG000|Overall Study|Lost to Follow-up|7|||
37633898|NCT03505749|69100628|FG001|Overall Study|Lost to Follow-up|11|||
37633899|NCT03505749|69100627|FG000|Overall Study|Withdrawal by Subject|6|||
37633900|NCT03505749|69100628|FG001|Overall Study|Withdrawal by Subject|0|||
37633901|NCT03505749|69100627|FG000|Overall Study|Discharged from treatment|3|||
37633902|NCT03505749|69100628|FG001|Overall Study|Discharged from treatment|6|||
37633903|NCT03710642|69100652|FG000|Overall Study|Adverse Event|5|||
37633904|NCT03710642|69100653|FG001|Overall Study|Adverse Event|1|||
37633905|NCT03710642|69100652|FG000|Overall Study|non-site physician recommendation|1|||
37633906|NCT03710642|69100653|FG001|Overall Study|non-site physician recommendation|0|||
37633907|NCT03710642|69100652|FG000|Overall Study|Participant unwilling or unable to participate|1|||
37633908|NCT03710642|69100653|FG001|Overall Study|Participant unwilling or unable to participate|1|||
37633909|NCT03710642|69100652|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
37633910|NCT03710642|69100653|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
37633911|NCT03710642|69100652|FG000|Overall Study|NA-no code provided|1|||
37633912|NCT03710642|69100653|FG001|Overall Study|NA-no code provided|0|||
37633913|NCT03710642|69100652|FG000|Overall Study|Withdrawal by Subject|1|||
37633914|NCT03710642|69100653|FG001|Overall Study|Withdrawal by Subject|0|||
37633915|NCT00705224|69100659|FG000|Overall Study|Adverse Event|1|||
37633916|NCT00705224|69100659|FG000|Overall Study|Lack of Efficacy|2|||
37633917|NCT00705224|69100659|FG000|Overall Study|Withdrawal by Subject|3|||
37633918|NCT00705224|69100659|FG000|Overall Study|Lost to Follow-up|5|||
37633919|NCT02722148|69100666|FG000|Overall Study|Lost to Follow-up|2|||
37633920|NCT02722148|69100666|FG000|Overall Study|Non compliant with treatment regimen|3|||
37633921|NCT00704132|69100672|FG000|Overall Study|Clinical Adverse Experience|1|||
37633922|NCT00704132|69100673|FG001|Overall Study|Clinical Adverse Experience|0|||
37633923|NCT00704132|69100672|FG000|Overall Study|Lack of Efficacy|0|||
37633924|NCT00704132|69100673|FG001|Overall Study|Lack of Efficacy|1|||
37633925|NCT00704132|69100672|FG000|Overall Study|Withdrawal by Subject|0|||
37633926|NCT00704132|69100673|FG001|Overall Study|Withdrawal by Subject|1|||
37633927|NCT01329549|69100688|FG000|Overall Study|Withdrawal by Subject|1|||
37633928|NCT01329549|69100688|FG000|Overall Study|Adverse Event|1|||
37633929|NCT02736474|69100694|FG000|Overall Study|Lost to Follow-up|0|||
37633930|NCT02736474|69100695|FG001|Overall Study|Lost to Follow-up|1|||
37633931|NCT00702650|69100717|FG000|Overall Study|Withdrawal by Subject|9|||
37633932|NCT00702650|69100717|FG000|Overall Study|Non-Compliance of Study Drug|3|||
37633933|NCT00702650|69100717|FG000|Overall Study|Lost to Follow-up|2|||
37633934|NCT00702650|69100717|FG000|Overall Study|Non-Compliance with Site Directives|1|||
37633935|NCT00702650|69100717|FG000|Overall Study|Sponsor Request|1|||
37633936|NCT00702650|69100717|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
37633937|NCT00702650|69100717|FG000|Overall Study|Adverse Event|3|||
37633938|NCT03230916|69100732|FG000|Overall Study|Withdrawal by Subject|0|||
37633939|NCT03230916|69100733|FG001|Overall Study|Withdrawal by Subject|0|||
37633940|NCT03230916|69100734|FG002|Overall Study|Withdrawal by Subject|0|||
37633941|NCT03230916|69100735|FG003|Overall Study|Withdrawal by Subject|0|||
37633942|NCT03230916|69100736|FG004|Overall Study|Withdrawal by Subject|0|||
37633943|NCT03230916|69100737|FG005|Overall Study|Withdrawal by Subject|1|||
37633944|NCT03230916|69100738|FG006|Overall Study|Withdrawal by Subject|0|||
37633945|NCT03230916|69100739|FG007|Overall Study|Withdrawal by Subject|0|||
37633946|NCT03230916|69100740|FG008|Overall Study|Withdrawal by Subject|0|||
37633947|NCT03230916|69100741|FG009|Overall Study|Withdrawal by Subject|0|||
37633948|NCT03230916|69100742|FG010|Overall Study|Withdrawal by Subject|0|||
37633949|NCT01337115|69100785|FG000|Overall Study|Protocol Violation|2|||
37633950|NCT01337115|69100786|FG001|Overall Study|Protocol Violation|0|||
37633951|NCT03761784|69100796|FG000|Overall Study|Adverse Event|4|||
37633952|NCT03761784|69100797|FG001|Overall Study|Adverse Event|0|||
37633953|NCT03761784|69100796|FG000|Overall Study|Lost to Follow-up|10|||
37633954|NCT03761784|69100797|FG001|Overall Study|Lost to Follow-up|7|||
37633955|NCT03761784|69100796|FG000|Overall Study|Pregnancy|1|||
37633956|NCT03761784|69100797|FG001|Overall Study|Pregnancy|0|||
37633957|NCT03761784|69100796|FG000|Overall Study|Protocol Violation|2|||
37633958|NCT03761784|69100797|FG001|Overall Study|Protocol Violation|0|||
37633959|NCT03761784|69100796|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
37633960|NCT03761784|69100797|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
37633961|NCT03761784|69100796|FG000|Overall Study|Withdrawal by Subject|9|||
37633962|NCT03761784|69100797|FG001|Overall Study|Withdrawal by Subject|4|||
37633963|NCT03761784|69100796|FG000|Overall Study|Physician Decision|1|||
37633964|NCT03761784|69100797|FG001|Overall Study|Physician Decision|0|||
37633965|NCT03761784|69100796|FG000|Overall Study|Other Than Specified|1|||
37633966|NCT03761784|69100797|FG001|Overall Study|Other Than Specified|0|||
37633967|NCT03195894|69100805|FG000|Overall Study|"An example is Started other treatment."|4|||
37633968|NCT03195894|69100806|FG001|Overall Study|"An example is Started other treatment."|5|||
37633969|NCT03195894|69100805|FG000|Overall Study|Withdrawal by Subject|15|||
37633970|NCT03195894|69100806|FG001|Overall Study|Withdrawal by Subject|4|||
37633971|NCT03195894|69100805|FG000|Overall Study|Lost to Follow-up|14|||
37633972|NCT03195894|69100806|FG001|Overall Study|Lost to Follow-up|19|||
37633973|NCT01337973|69100818|FG000|Overall Study|Lost to Follow-up|2|||
37633974|NCT01337973|69100819|FG001|Overall Study|Lost to Follow-up|4|||
37633975|NCT01337973|69100820|FG002|Overall Study|Lost to Follow-up|3|||
37633976|NCT01337973|69100818|FG000|Overall Study|Death|1|||
37633977|NCT01337973|69100819|FG001|Overall Study|Death|2|||
37633978|NCT01337973|69100820|FG002|Overall Study|Death|1|||
37633979|NCT01337973|69100818|FG000|Overall Study|Withdrawal by Subject|10|||
37633980|NCT01337973|69100819|FG001|Overall Study|Withdrawal by Subject|8|||
37633981|NCT01337973|69100820|FG002|Overall Study|Withdrawal by Subject|4|||
37633982|NCT01337973|69100818|FG000|Overall Study|missing data on primary outcome|3|||
37633983|NCT01337973|69100819|FG001|Overall Study|missing data on primary outcome|1|||
37633984|NCT01337973|69100820|FG002|Overall Study|missing data on primary outcome|3|||
37633985|NCT02929056|69100830|FG000|Overall Study|Lost to Follow-up|0|||
37633986|NCT02929056|69100831|FG001|Overall Study|Lost to Follow-up|1|||
37633987|NCT00157755|69100850|FG000|Overall Study|Death|2|||
37633988|NCT00157755|69100851|FG001|Overall Study|Death|3|||
37633989|NCT00157755|69100852|FG002|Overall Study|Death|3|||
37633990|NCT00157755|69100853|FG003|Overall Study|Death|2|||
37633991|NCT00157755|69100854|FG004|Overall Study|Death|0|||
37633992|NCT00157755|69100855|FG005|Overall Study|Death|0|||
37633993|NCT00157755|69100850|FG000|Overall Study|Lost to Follow-up|0|||
37633994|NCT00157755|69100851|FG001|Overall Study|Lost to Follow-up|0|||
37633995|NCT00157755|69100852|FG002|Overall Study|Lost to Follow-up|1|||
37633996|NCT00157755|69100853|FG003|Overall Study|Lost to Follow-up|0|||
37633997|NCT00157755|69100854|FG004|Overall Study|Lost to Follow-up|0|||
37633998|NCT00157755|69100855|FG005|Overall Study|Lost to Follow-up|0|||
37633999|NCT00157755|69100850|FG000|Overall Study|Withdrawal by Subject|0|||
37634000|NCT00157755|69100851|FG001|Overall Study|Withdrawal by Subject|0|||
37634001|NCT00157755|69100852|FG002|Overall Study|Withdrawal by Subject|1|||
37634002|NCT00157755|69100853|FG003|Overall Study|Withdrawal by Subject|1|||
37634003|NCT00157755|69100854|FG004|Overall Study|Withdrawal by Subject|1|||
37634004|NCT00157755|69100855|FG005|Overall Study|Withdrawal by Subject|2|||
37634005|NCT00157755|69100850|FG000|Overall Study|Explant due to infection|0|||
37634006|NCT00157755|69100851|FG001|Overall Study|Explant due to infection|0|||
37634007|NCT00157755|69100852|FG002|Overall Study|Explant due to infection|1|||
37634008|NCT00157755|69100853|FG003|Overall Study|Explant due to infection|0|||
37634009|NCT00157755|69100854|FG004|Overall Study|Explant due to infection|0|||
37634010|NCT00157755|69100855|FG005|Overall Study|Explant due to infection|0|||
37634011|NCT00157755|69100850|FG000|Overall Study|Medical reason|0|||
37634012|NCT00157755|69100851|FG001|Overall Study|Medical reason|0|||
37634013|NCT00157755|69100852|FG002|Overall Study|Medical reason|1|||
37634014|NCT00157755|69100853|FG003|Overall Study|Medical reason|1|||
37634015|NCT00157755|69100854|FG004|Overall Study|Medical reason|0|||
37634016|NCT00157755|69100855|FG005|Overall Study|Medical reason|0|||
37634017|NCT00157755|69100850|FG000|Overall Study|Study site closure|0|||
37634018|NCT00157755|69100851|FG001|Overall Study|Study site closure|1|||
37634019|NCT00157755|69100852|FG002|Overall Study|Study site closure|0|||
37634020|NCT00157755|69100853|FG003|Overall Study|Study site closure|0|||
37634021|NCT00157755|69100854|FG004|Overall Study|Study site closure|0|||
37634022|NCT00157755|69100855|FG005|Overall Study|Study site closure|0|||
37634023|NCT00157755|69100850|FG000|Overall Study|Subject non-compliance|0|||
37634024|NCT00157755|69100851|FG001|Overall Study|Subject non-compliance|0|||
37634025|NCT00157755|69100852|FG002|Overall Study|Subject non-compliance|0|||
37634026|NCT00157755|69100853|FG003|Overall Study|Subject non-compliance|0|||
37634027|NCT00157755|69100854|FG004|Overall Study|Subject non-compliance|0|||
37634028|NCT00157755|69100855|FG005|Overall Study|Subject non-compliance|1|||
37634029|NCT00157755|69100850|FG000|Overall Study|Study completion|0|||
37634030|NCT00157755|69100851|FG001|Overall Study|Study completion|0|||
37634031|NCT00157755|69100852|FG002|Overall Study|Study completion|0|||
37634032|NCT00157755|69100853|FG003|Overall Study|Study completion|0|||
37634033|NCT00157755|69100854|FG004|Overall Study|Study completion|1|||
37634034|NCT00157755|69100855|FG005|Overall Study|Study completion|2|||
37634035|NCT02723006|69100864|FG000|Overall Study|Withdrawal by Subject|0|||
37634036|NCT02723006|69100865|FG001|Overall Study|Withdrawal by Subject|1|||
37634037|NCT02723006|69100866|FG002|Overall Study|Withdrawal by Subject|1|||
37634038|NCT02723006|69100864|FG000|Overall Study|Study Terminated by Sponsor|1|||
37634039|NCT02723006|69100865|FG001|Overall Study|Study Terminated by Sponsor|6|||
37634040|NCT02723006|69100866|FG002|Overall Study|Study Terminated by Sponsor|6|||
37634041|NCT00702962|69100876|FG000|Overall Study|Progressive disease|0|||
37634042|NCT00702962|69100877|FG001|Overall Study|Progressive disease|1|||
37634043|NCT00702962|69100876|FG000|Overall Study|Hospitalized for other health disorder|1|||
37634044|NCT00702962|69100877|FG001|Overall Study|Hospitalized for other health disorder|0|||
37634045|NCT01379508|69100889|FG000|Treatment to Week 104|Adverse Event|2|||
37634046|NCT01379508|69100890|FG001|Treatment to Week 104|Adverse Event|0|||
37634047|NCT01379508|69100891|FG002|Treatment to Week 104|Adverse Event|5|||
37634048|NCT01379508|69100892|FG003|Treatment to Week 104|Adverse Event|0|||
37634049|NCT01379508|69100889|FG000|Treatment to Week 104|Abnormal lab value|1|||
37634050|NCT01379508|69100890|FG001|Treatment to Week 104|Abnormal lab value|0|||
37634051|NCT01379508|69100891|FG002|Treatment to Week 104|Abnormal lab value|0|||
37634052|NCT01379508|69100892|FG003|Treatment to Week 104|Abnormal lab value|0|||
37634053|NCT01379508|69100889|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
37634054|NCT01379508|69100890|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
37634055|NCT01379508|69100891|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
37634056|NCT01379508|69100892|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
37634057|NCT01379508|69100889|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
37634058|NCT01379508|69100890|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
37634059|NCT01379508|69100891|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
37634060|NCT01379508|69100892|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
37634061|NCT01379508|69100889|FG000|Treatment to Week 104|Lost to Follow-up|5|||
37634062|NCT01379508|69100890|FG001|Treatment to Week 104|Lost to Follow-up|0|||
37634063|NCT01379508|69100891|FG002|Treatment to Week 104|Lost to Follow-up|3|||
37634064|NCT01379508|69100892|FG003|Treatment to Week 104|Lost to Follow-up|0|||
37634065|NCT01379508|69100889|FG000|Treatment to Week 104|Administrative problems|3|||
37634066|NCT01379508|69100890|FG001|Treatment to Week 104|Administrative problems|1|||
37634067|NCT01379508|69100891|FG002|Treatment to Week 104|Administrative problems|0|||
37634068|NCT01379508|69100892|FG003|Treatment to Week 104|Administrative problems|0|||
37634069|NCT01379508|69100889|FG000|Treatment to Week 104|Protocol Violation|1|||
37634070|NCT01379508|69100890|FG001|Treatment to Week 104|Protocol Violation|1|||
37634071|NCT01379508|69100891|FG002|Treatment to Week 104|Protocol Violation|1|||
37634072|NCT01379508|69100892|FG003|Treatment to Week 104|Protocol Violation|0|||
37634073|NCT01379508|69100889|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
37634074|NCT01379508|69100890|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
37634075|NCT01379508|69100891|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
37634076|NCT01379508|69100892|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
37634077|NCT01379508|69100889|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
37634078|NCT01379508|69100890|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
37634079|NCT01379508|69100891|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
37634080|NCT01379508|69100892|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
37634081|NCT01379508|69100889|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
37634082|NCT01379508|69100890|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
37634083|NCT01379508|69100891|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
37634084|NCT01379508|69100892|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
37634085|NCT01379508|69100889|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
37634086|NCT01379508|69100890|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
37634087|NCT01379508|69100891|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
37634088|NCT01379508|69100892|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
37634089|NCT02722928|69100908|FG000|Overall Study|Standard CT was not as required per prot|5|||
37634090|NCT02722928|69100909|FG001|Overall Study|Standard CT was not as required per prot|13|||
37634091|NCT02722928|69100908|FG000|Overall Study|Required Intraoperative MRI|5|||
37634092|NCT02722928|69100909|FG001|Overall Study|Required Intraoperative MRI|7|||
37634093|NCT02722304|69100940|FG000|Overall Study|Study Terminated by Sponsor|1|||
37634094|NCT02722304|69100941|FG001|Overall Study|Study Terminated by Sponsor|0|||
37634095|NCT02722304|69100942|FG002|Overall Study|Study Terminated by Sponsor|2|||
37634096|NCT02722304|69100943|FG003|Overall Study|Study Terminated by Sponsor|1|||
37634097|NCT02722304|69100944|FG004|Overall Study|Study Terminated by Sponsor|1|||
37634098|NCT02722304|69100940|FG000|Overall Study|Other|0|||
37634099|NCT02722304|69100941|FG001|Overall Study|Other|0|||
37634100|NCT02722304|69100942|FG002|Overall Study|Other|0|||
37634101|NCT02722304|69100943|FG003|Overall Study|Other|1|||
37634102|NCT02722304|69100944|FG004|Overall Study|Other|1|||
37634103|NCT00709956|69100960|FG000|Overall Study|Withdrawal by Subject|1|||
37634104|NCT00709956|69100961|FG001|Overall Study|Withdrawal by Subject|1|||
37634105|NCT00709956|69100960|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
37634106|NCT00709956|69100961|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
37634107|NCT02719028|69100991|FG000|Overall Study|Adverse Event|2|||
37634108|NCT02719028|69100992|FG001|Overall Study|Adverse Event|1|||
37634109|NCT02719028|69100993|FG002|Overall Study|Adverse Event|4|||
37634110|NCT02719028|69100994|FG003|Overall Study|Adverse Event|8|||
37634111|NCT02719028|69100991|FG000|Overall Study|Physician Decision|0|||
37634112|NCT02719028|69100992|FG001|Overall Study|Physician Decision|1|||
37634113|NCT02719028|69100993|FG002|Overall Study|Physician Decision|1|||
37634114|NCT02719028|69100994|FG003|Overall Study|Physician Decision|1|||
37634115|NCT02719028|69100991|FG000|Overall Study|Use of prohibited medication|0|||
37634116|NCT02719028|69100992|FG001|Overall Study|Use of prohibited medication|0|||
37634117|NCT02719028|69100993|FG002|Overall Study|Use of prohibited medication|1|||
37634118|NCT02719028|69100994|FG003|Overall Study|Use of prohibited medication|0|||
37634119|NCT02719028|69100991|FG000|Overall Study|Protocol Violation|0|||
37634120|NCT02719028|69100992|FG001|Overall Study|Protocol Violation|0|||
37634121|NCT02719028|69100993|FG002|Overall Study|Protocol Violation|0|||
37634122|NCT02719028|69100994|FG003|Overall Study|Protocol Violation|1|||
37634123|NCT02720510|69101006|FG000|Overall Study|Study Terminated by the sponsor|2|||
37634124|NCT02720510|69101007|FG001|Overall Study|Study Terminated by the sponsor|0|||
37634125|NCT02720510|69101006|FG000|Overall Study|Adverse Event|0|||
37634126|NCT02720510|69101007|FG001|Overall Study|Adverse Event|1|||
37634127|NCT02720510|69101006|FG000|Overall Study|Physician Decision|1|||
37634128|NCT02720510|69101007|FG001|Overall Study|Physician Decision|2|||
37634129|NCT02720198|69101015|FG000|Overall Study|Withdrawal by Subject|0|||
37634130|NCT02720198|69101016|FG001|Overall Study|Withdrawal by Subject|1|||
37634131|NCT00703118|69101038|FG000|Overall Study|Adverse Event|1|||
37634132|NCT00703118|69101039|FG001|Overall Study|Adverse Event|2|||
37634133|NCT00703118|69101040|FG002|Overall Study|Adverse Event|2|||
37634134|NCT00703118|69101038|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
37634135|NCT00703118|69101039|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
37634136|NCT00703118|69101040|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
37634137|NCT00703118|69101038|FG000|Overall Study|Lost to Follow-up|6|||
37634138|NCT00703118|69101039|FG001|Overall Study|Lost to Follow-up|4|||
37634139|NCT00703118|69101040|FG002|Overall Study|Lost to Follow-up|4|||
37634140|NCT00703118|69101038|FG000|Overall Study|Withdrawal by Subject|8|||
37634141|NCT00703118|69101039|FG001|Overall Study|Withdrawal by Subject|7|||
37634142|NCT00703118|69101040|FG002|Overall Study|Withdrawal by Subject|13|||
37634143|NCT00703118|69101038|FG000|Overall Study|Other|0|||
37634144|NCT00703118|69101039|FG001|Overall Study|Other|0|||
37634145|NCT00703118|69101040|FG002|Overall Study|Other|1|||
37634146|NCT00909753|69101062|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
37634147|NCT00909753|69101063|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
37634148|NCT00909753|69101062|FG000|Period: Second Intervention|Protocol Violation|1|||
37634149|NCT00909753|69101063|FG001|Period: Second Intervention|Protocol Violation|0|||
37634150|NCT03715764|69101069|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
37853519|NCT01262976|69537435|FG004|Up to Month 7|Migrated/moved from study area|1|||
37853520|NCT01262976|69537436|FG005|Up to Month 7|Migrated/moved from study area|1|||
37853521|NCT01262976|69537431|FG000|Up to Month 7|Lost to Follow-up|1|||
37853522|NCT01262976|69537432|FG001|Up to Month 7|Lost to Follow-up|0|||
37853523|NCT01262976|69537433|FG002|Up to Month 7|Lost to Follow-up|1|||
37853524|NCT01262976|69537434|FG003|Up to Month 7|Lost to Follow-up|3|||
37853525|NCT01262976|69537435|FG004|Up to Month 7|Lost to Follow-up|1|||
37853526|NCT01262976|69537436|FG005|Up to Month 7|Lost to Follow-up|3|||
37853527|NCT01262976|69537431|FG000|Up to Month 7|Other|3|||
37853528|NCT01262976|69537432|FG001|Up to Month 7|Other|0|||
37853529|NCT01262976|69537433|FG002|Up to Month 7|Other|2|||
37853530|NCT01262976|69537434|FG003|Up to Month 7|Other|0|||
37853531|NCT01262976|69537435|FG004|Up to Month 7|Other|0|||
37853532|NCT01262976|69537436|FG005|Up to Month 7|Other|0|||
37853533|NCT01262976|69537431|FG000|Up to Year 1|Serious Adverse Event|0|||
37634151|NCT03715764|69101070|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
37634152|NCT03715764|69101069|FG000|3 Month Follow-up|Lost to Follow-up|2|||
37634153|NCT03715764|69101070|FG001|3 Month Follow-up|Lost to Follow-up|2|||
37634154|NCT03715764|69101069|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
37634155|NCT03715764|69101070|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
37634156|NCT03715764|69101069|FG000|6 Month Follow-up|Lost to Follow-up|3|||
37634157|NCT03715764|69101070|FG001|6 Month Follow-up|Lost to Follow-up|0|||
37634158|NCT03715764|69101069|FG000|12 Month Follow-up|Lost to Follow-up|2|||
37853534|NCT01262976|69537432|FG001|Up to Year 1|Serious Adverse Event|0|||
37853535|NCT01262976|69537433|FG002|Up to Year 1|Serious Adverse Event|2|||
37853536|NCT01262976|69537434|FG003|Up to Year 1|Serious Adverse Event|0|||
37634159|NCT03715764|69101070|FG001|12 Month Follow-up|Lost to Follow-up|3|||
37853537|NCT01262976|69537435|FG004|Up to Year 1|Serious Adverse Event|0|||
37853538|NCT01262976|69537436|FG005|Up to Year 1|Serious Adverse Event|0|||
37853539|NCT01262976|69537431|FG000|Up to Year 1|Withdrawal by Subject|1|||
37853540|NCT01262976|69537432|FG001|Up to Year 1|Withdrawal by Subject|0|||
37853541|NCT01262976|69537433|FG002|Up to Year 1|Withdrawal by Subject|0|||
37853542|NCT01262976|69537434|FG003|Up to Year 1|Withdrawal by Subject|0|||
37853543|NCT01262976|69537435|FG004|Up to Year 1|Withdrawal by Subject|0|||
37853544|NCT01262976|69537436|FG005|Up to Year 1|Withdrawal by Subject|0|||
37853545|NCT01262976|69537431|FG000|Up to Year 1|Migrated/moved from study area|1|||
37853546|NCT01262976|69537432|FG001|Up to Year 1|Migrated/moved from study area|0|||
37853547|NCT01262976|69537433|FG002|Up to Year 1|Migrated/moved from study area|0|||
37853548|NCT01262976|69537434|FG003|Up to Year 1|Migrated/moved from study area|3|||
37853549|NCT01262976|69537435|FG004|Up to Year 1|Migrated/moved from study area|3|||
37853550|NCT01262976|69537436|FG005|Up to Year 1|Migrated/moved from study area|2|||
37853551|NCT01262976|69537431|FG000|Up to Year 1|Lost to Follow-up|4|||
37853552|NCT01262976|69537432|FG001|Up to Year 1|Lost to Follow-up|0|||
37853553|NCT01262976|69537433|FG002|Up to Year 1|Lost to Follow-up|0|||
37853554|NCT01262976|69537434|FG003|Up to Year 1|Lost to Follow-up|1|||
37634160|NCT03715764|69101069|FG000|12 Month Follow-up|Pregnancy|0|||
37634161|NCT03715764|69101070|FG001|12 Month Follow-up|Pregnancy|1|||
37634162|NCT03715764|69101069|FG000|12 Month Follow-up|Surgery|2|||
37634163|NCT03715764|69101070|FG001|12 Month Follow-up|Surgery|0|||
37634164|NCT03715764|69101069|FG000|12 Month Follow-up|Wrong address|1|||
37634165|NCT03715764|69101070|FG001|12 Month Follow-up|Wrong address|0|||
37634166|NCT03715764|69101069|FG000|12 Month Follow-up|No symptoms|1|||
37634167|NCT03715764|69101070|FG001|12 Month Follow-up|No symptoms|0|||
37634168|NCT03715764|69101069|FG000|12 Month Follow-up|Changed primary care centre|0|||
37634169|NCT03715764|69101070|FG001|12 Month Follow-up|Changed primary care centre|1|||
37634170|NCT02718326|69101079|FG000|Overall Study|Adverse Event|4|||
37634171|NCT02718326|69101080|FG001|Overall Study|Adverse Event|9|||
37634172|NCT02718326|69101081|FG002|Overall Study|Adverse Event|0|||
37634173|NCT02718326|69101079|FG000|Overall Study|Death|8|||
37634174|NCT02718326|69101080|FG001|Overall Study|Death|1|||
37634175|NCT02718326|69101081|FG002|Overall Study|Death|2|||
37634176|NCT02718326|69101079|FG000|Overall Study|Withdrawal by Subject|4|||
37634177|NCT02718326|69101080|FG001|Overall Study|Withdrawal by Subject|9|||
37634178|NCT02718326|69101081|FG002|Overall Study|Withdrawal by Subject|6|||
37634179|NCT02718326|69101079|FG000|Overall Study|Lost to Follow-up|18|||
37634180|NCT02718326|69101080|FG001|Overall Study|Lost to Follow-up|5|||
37634181|NCT02718326|69101081|FG002|Overall Study|Lost to Follow-up|14|||
37634182|NCT02718326|69101079|FG000|Overall Study|Protocol Deviation|1|||
37634183|NCT02718326|69101080|FG001|Overall Study|Protocol Deviation|0|||
37634184|NCT02718326|69101081|FG002|Overall Study|Protocol Deviation|0|||
37634185|NCT02718326|69101079|FG000|Overall Study|Pregnancy|1|||
37634186|NCT02718326|69101080|FG001|Overall Study|Pregnancy|0|||
37634187|NCT02718326|69101081|FG002|Overall Study|Pregnancy|0|||
37634188|NCT03600714|69101091|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
37634189|NCT02720042|69101130|FG000|Overall Study|Death|3|||
37634190|NCT02720042|69101130|FG000|Overall Study|Lost to Follow-up|4|||
37634191|NCT02720042|69101130|FG000|Overall Study|Withdrawal by Subject|1|||
37634192|NCT02720042|69101130|FG000|Overall Study|Physician Decision|3|||
37634193|NCT02720042|69101130|FG000|Overall Study|Phasix Mesh explanted|1|||
37634194|NCT02720042|69101130|FG000|Overall Study|unable due to non-study-related illness|3|||
37634195|NCT01352793|69101136|FG000|Overall Study|Lost to Follow-up|289|||
37634196|NCT01352793|69101137|FG001|Overall Study|Lost to Follow-up|125|||
37634197|NCT01352793|69101136|FG000|Overall Study|Withdrawal by Subject|120|||
37634198|NCT01352793|69101137|FG001|Overall Study|Withdrawal by Subject|55|||
37634199|NCT01352793|69101136|FG000|Overall Study|Protocol Violation|44|||
37634200|NCT01352793|69101137|FG001|Overall Study|Protocol Violation|23|||
37634201|NCT01352793|69101136|FG000|Overall Study|Adverse Event|44|||
37634202|NCT01352793|69101137|FG001|Overall Study|Adverse Event|10|||
37634203|NCT01352793|69101136|FG000|Overall Study|Physician Decision|1|||
37853555|NCT01262976|69537435|FG004|Up to Year 1|Lost to Follow-up|6|||
37634204|NCT01352793|69101137|FG001|Overall Study|Physician Decision|0|||
37634205|NCT01352793|69101136|FG000|Overall Study|Pregnancy|26|||
37634206|NCT01352793|69101137|FG001|Overall Study|Pregnancy|8|||
37634207|NCT01352793|69101136|FG000|Overall Study|Other|25|||
37634208|NCT01352793|69101137|FG001|Overall Study|Other|7|||
37634209|NCT01352793|69101136|FG000|Overall Study|Medication error|2|||
37634210|NCT01352793|69101137|FG001|Overall Study|Medication error|2|||
37634211|NCT01352793|69101136|FG000|Overall Study|Death|1|||
37634212|NCT01352793|69101137|FG001|Overall Study|Death|0|||
37634213|NCT01352793|69101136|FG000|Overall Study|Randomized but not vaccinated|8|||
37634214|NCT01352793|69101137|FG001|Overall Study|Randomized but not vaccinated|0|||
37853556|NCT01262976|69537436|FG005|Up to Year 1|Lost to Follow-up|5|||
37853557|NCT01262976|69537431|FG000|Up to Year 1|Other|3|||
37634215|NCT01352793|69101136|FG000|Overall Study|No longer meets eligibility criteria|25|||
37634216|NCT01352793|69101137|FG001|Overall Study|No longer meets eligibility criteria|15|||
37634217|NCT02717546|69101143|FG000|Overall Study|Lost to Follow-up|12|||
37634218|NCT01378962|69101147|FG000|Overall Study|Death|14|||
37738827|NCT01468701|69221942|FG003|Overall Study|Lost to Follow-up|0|||
37738828|NCT01468701|69221943|FG004|Overall Study|Lost to Follow-up|0|||
37738829|NCT01468701|69221944|FG005|Overall Study|Lost to Follow-up|0|||
37738830|NCT01468701|69221945|FG006|Overall Study|Lost to Follow-up|0|||
37738831|NCT01468701|69221946|FG007|Overall Study|Lost to Follow-up|0|||
37738832|NCT01468701|69221947|FG008|Overall Study|Lost to Follow-up|215|||
37738833|NCT01468701|69221948|FG009|Overall Study|Lost to Follow-up|309|||
37738834|NCT01468701|69221949|FG010|Overall Study|Lost to Follow-up|224|||
37738835|NCT01468701|69221950|FG011|Overall Study|Lost to Follow-up|212|||
37738836|NCT01468701|69221951|FG012|Overall Study|Lost to Follow-up|11|||
37738837|NCT01468701|69221952|FG013|Overall Study|Lost to Follow-up|164|||
37738838|NCT01468701|69221953|FG014|Overall Study|Lost to Follow-up|17|||
37738839|NCT01468701|69221954|FG015|Overall Study|Lost to Follow-up|127|||
37738840|NCT01468701|69221955|FG016|Overall Study|Lost to Follow-up|1|||
37738841|NCT01468701|69221939|FG000|Overall Study|Withdrawal by Subject|165|||
37738842|NCT01468701|69221940|FG001|Overall Study|Withdrawal by Subject|0|||
37738843|NCT01468701|69221941|FG002|Overall Study|Withdrawal by Subject|0|||
37738844|NCT01468701|69221942|FG003|Overall Study|Withdrawal by Subject|0|||
37738845|NCT01468701|69221943|FG004|Overall Study|Withdrawal by Subject|0|||
37738846|NCT01468701|69221944|FG005|Overall Study|Withdrawal by Subject|0|||
37738847|NCT01468701|69221945|FG006|Overall Study|Withdrawal by Subject|0|||
37738848|NCT01468701|69221946|FG007|Overall Study|Withdrawal by Subject|0|||
37738849|NCT01468701|69221947|FG008|Overall Study|Withdrawal by Subject|83|||
37738850|NCT01468701|69221948|FG009|Overall Study|Withdrawal by Subject|88|||
37738851|NCT01468701|69221949|FG010|Overall Study|Withdrawal by Subject|100|||
37738852|NCT01468701|69221950|FG011|Overall Study|Withdrawal by Subject|114|||
37738853|NCT01468701|69221951|FG012|Overall Study|Withdrawal by Subject|9|||
37738854|NCT01468701|69221952|FG013|Overall Study|Withdrawal by Subject|47|||
37738855|NCT01468701|69221953|FG014|Overall Study|Withdrawal by Subject|6|||
37738856|NCT01468701|69221954|FG015|Overall Study|Withdrawal by Subject|31|||
37738857|NCT01468701|69221955|FG016|Overall Study|Withdrawal by Subject|0|||
37738858|NCT01468701|69221939|FG000|Overall Study|Other reasons than listed|437|||
37738859|NCT01468701|69221940|FG001|Overall Study|Other reasons than listed|0|||
37738860|NCT01468701|69221941|FG002|Overall Study|Other reasons than listed|0|||
37738861|NCT01468701|69221942|FG003|Overall Study|Other reasons than listed|0|||
37738862|NCT01468701|69221943|FG004|Overall Study|Other reasons than listed|0|||
37738863|NCT01468701|69221944|FG005|Overall Study|Other reasons than listed|0|||
37738864|NCT01468701|69221945|FG006|Overall Study|Other reasons than listed|0|||
37738865|NCT01468701|69221946|FG007|Overall Study|Other reasons than listed|0|||
37738866|NCT01468701|69221947|FG008|Overall Study|Other reasons than listed|318|||
37738867|NCT01468701|69221948|FG009|Overall Study|Other reasons than listed|658|||
37738868|NCT01468701|69221949|FG010|Overall Study|Other reasons than listed|433|||
37738869|NCT01468701|69221950|FG011|Overall Study|Other reasons than listed|504|||
37738870|NCT01468701|69221951|FG012|Overall Study|Other reasons than listed|28|||
37738871|NCT01468701|69221952|FG013|Overall Study|Other reasons than listed|239|||
37738872|NCT01468701|69221953|FG014|Overall Study|Other reasons than listed|39|||
37738873|NCT01468701|69221954|FG015|Overall Study|Other reasons than listed|172|||
37738874|NCT01468701|69221955|FG016|Overall Study|Other reasons than listed|0|||
37738875|NCT01468701|69221939|FG000|Overall Study|No end of study case report form|0|||
37738876|NCT01468701|69221940|FG001|Overall Study|No end of study case report form|0|||
37738877|NCT01468701|69221941|FG002|Overall Study|No end of study case report form|0|||
37738878|NCT01468701|69221942|FG003|Overall Study|No end of study case report form|0|||
37738879|NCT01468701|69221943|FG004|Overall Study|No end of study case report form|0|||
37738880|NCT01468701|69221944|FG005|Overall Study|No end of study case report form|0|||
37738881|NCT01468701|69221945|FG006|Overall Study|No end of study case report form|0|||
37738882|NCT01468701|69221946|FG007|Overall Study|No end of study case report form|0|||
37738883|NCT01468701|69221947|FG008|Overall Study|No end of study case report form|4|||
37738884|NCT01468701|69221948|FG009|Overall Study|No end of study case report form|1|||
37738885|NCT01468701|69221949|FG010|Overall Study|No end of study case report form|2|||
37738886|NCT01468701|69221950|FG011|Overall Study|No end of study case report form|3|||
37738887|NCT01468701|69221951|FG012|Overall Study|No end of study case report form|0|||
37634219|NCT01378962|69101147|FG000|Overall Study|Lost to Follow-up|1|||
37738888|NCT01468701|69221952|FG013|Overall Study|No end of study case report form|1|||
37738889|NCT01468701|69221953|FG014|Overall Study|No end of study case report form|0|||
37634220|NCT01378962|69101147|FG000|Overall Study|Other|2|||
37738890|NCT01468701|69221954|FG015|Overall Study|No end of study case report form|0|||
37738891|NCT01468701|69221955|FG016|Overall Study|No end of study case report form|0|||
37738892|NCT01468701|69221939|FG000|Overall Study|Not being followed up|0|||
37738893|NCT01468701|69221940|FG001|Overall Study|Not being followed up|4963|||
37738894|NCT01468701|69221941|FG002|Overall Study|Not being followed up|1755|||
37738895|NCT01468701|69221942|FG003|Overall Study|Not being followed up|703|||
37738896|NCT01468701|69221943|FG004|Overall Study|Not being followed up|1714|||
37853558|NCT01262976|69537432|FG001|Up to Year 1|Other|1|||
37853559|NCT01262976|69537433|FG002|Up to Year 1|Other|0|||
37634221|NCT00890409|69101153|FG000|Overall Study|Lost to Follow-up|20|||
37634222|NCT00890409|69101154|FG001|Overall Study|Lost to Follow-up|21|||
37634223|NCT04495478|69101165|FG000|Overall Study|Withdrawal by Subject|0|||
37634224|NCT04495478|69101166|FG001|Overall Study|Withdrawal by Subject|0|||
37634225|NCT04495478|69101167|FG002|Overall Study|Withdrawal by Subject|0|||
37634226|NCT04495478|69101168|FG003|Overall Study|Withdrawal by Subject|1|||
37634227|NCT04495478|69101169|FG004|Overall Study|Withdrawal by Subject|0|||
37634228|NCT04495478|69101170|FG005|Overall Study|Withdrawal by Subject|0|||
37634229|NCT04495478|69101171|FG006|Overall Study|Withdrawal by Subject|0|||
37634230|NCT04495478|69101165|FG000|Overall Study|Physician Decision|0|||
37634231|NCT04495478|69101166|FG001|Overall Study|Physician Decision|1|||
37634232|NCT04495478|69101167|FG002|Overall Study|Physician Decision|0|||
37634233|NCT04495478|69101168|FG003|Overall Study|Physician Decision|0|||
37634234|NCT04495478|69101169|FG004|Overall Study|Physician Decision|1|||
37634235|NCT04495478|69101170|FG005|Overall Study|Physician Decision|0|||
37634236|NCT04495478|69101171|FG006|Overall Study|Physician Decision|0|||
37634237|NCT00152763|69101197|FG000|Overall Study|Death|4|||
37634238|NCT00152763|69101198|FG001|Overall Study|Death|1|||
37634239|NCT00152763|69101199|FG002|Overall Study|Death|2|||
37634240|NCT00152763|69101200|FG003|Overall Study|Death|1|||
37634241|NCT00152763|69101197|FG000|Overall Study|Lost to Follow-up|6|||
37634242|NCT00152763|69101198|FG001|Overall Study|Lost to Follow-up|4|||
37634243|NCT00152763|69101199|FG002|Overall Study|Lost to Follow-up|2|||
37634244|NCT00152763|69101200|FG003|Overall Study|Lost to Follow-up|13|||
37634245|NCT03181542|69101214|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
37634246|NCT03181542|69101215|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
37634247|NCT00806403|69101223|FG000|Overall Study|Death|4|||
37634248|NCT00806403|69101224|FG001|Overall Study|Death|3|||
37634249|NCT00701558|69101241|FG000|Overall Study|Death|7|||
37634250|NCT00701558|69101241|FG000|Overall Study|Lost to Follow-up|8|||
37634251|NCT01663402|69101264|FG000|Overall Study|Randomized but not treated|19|||
37634252|NCT01663402|69101265|FG001|Overall Study|Randomized but not treated|11|||
37634253|NCT01663402|69101264|FG000|Overall Study|Adverse Event|347|||
37634254|NCT01663402|69101265|FG001|Overall Study|Adverse Event|362|||
37634255|NCT01663402|69101264|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
37634256|NCT01663402|69101265|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
37634257|NCT01663402|69101264|FG000|Overall Study|Poor compliance to protocol|529|||
37634258|NCT01663402|69101265|FG001|Overall Study|Poor compliance to protocol|454|||
37634259|NCT01663402|69101264|FG000|Overall Study|Physician Decision|77|||
37634260|NCT01663402|69101265|FG001|Overall Study|Physician Decision|62|||
37634261|NCT01663402|69101264|FG000|Overall Study|Site terminated by sponsor|1|||
37634262|NCT01663402|69101265|FG001|Overall Study|Site terminated by sponsor|3|||
37634263|NCT01663402|69101264|FG000|Overall Study|Participant moved|139|||
37634264|NCT01663402|69101265|FG001|Overall Study|Participant moved|104|||
37738897|NCT01468701|69221944|FG005|Overall Study|Not being followed up|126|||
37738898|NCT01468701|69221945|FG006|Overall Study|Not being followed up|1170|||
37738899|NCT01468701|69221946|FG007|Overall Study|Not being followed up|4|||
37738900|NCT01468701|69221947|FG008|Overall Study|Not being followed up|0|||
37738901|NCT01468701|69221948|FG009|Overall Study|Not being followed up|0|||
37738902|NCT01468701|69221949|FG010|Overall Study|Not being followed up|0|||
37738903|NCT01468701|69221950|FG011|Overall Study|Not being followed up|0|||
37738904|NCT01468701|69221951|FG012|Overall Study|Not being followed up|0|||
37738905|NCT01468701|69221952|FG013|Overall Study|Not being followed up|0|||
37738906|NCT01468701|69221953|FG014|Overall Study|Not being followed up|0|||
37738907|NCT01468701|69221954|FG015|Overall Study|Not being followed up|0|||
37738908|NCT01468701|69221955|FG016|Overall Study|Not being followed up|0|||
37738909|NCT01492101|69221970|FG000|Overall Study|Death|323|||
37738910|NCT01492101|69221971|FG001|Overall Study|Death|322|||
37853560|NCT01262976|69537434|FG003|Up to Year 1|Other|0|||
37634265|NCT01663402|69101264|FG000|Overall Study|Withdrawal by Subject|118|||
37634266|NCT01663402|69101265|FG001|Overall Study|Withdrawal by Subject|91|||
37634267|NCT01663402|69101264|FG000|Overall Study|Related to study drug administration|96|||
37634268|NCT01663402|69101265|FG001|Overall Study|Related to study drug administration|105|||
37634269|NCT01663402|69101264|FG000|Overall Study|Lost to Follow-up|17|||
37634270|NCT01663402|69101265|FG001|Overall Study|Lost to Follow-up|15|||
37634271|NCT01663402|69101264|FG000|Overall Study|Other than specified above|172|||
37738911|NCT01492101|69221970|FG000|Overall Study|Withdrawal by Subject|14|||
37738912|NCT01492101|69221971|FG001|Overall Study|Withdrawal by Subject|18|||
37853561|NCT01262976|69537435|FG004|Up to Year 1|Other|2|||
37853562|NCT01262976|69537436|FG005|Up to Year 1|Other|1|||
37853563|NCT01262976|69537431|FG000|Up to Year 1|Subjects with unknown completion status|0|||
37634272|NCT01663402|69101265|FG001|Overall Study|Other than specified above|147|||
37634273|NCT00859521|69101282|FG000|Washout|Withdrawal by Subject|0|||
37634274|NCT00859521|69101283|FG001|Washout|Withdrawal by Subject|1|||
37634275|NCT00841815|69101298|FG000|Washout|Withdrawal by Subject|0|||
37634276|NCT00841815|69101299|FG001|Washout|Withdrawal by Subject|1|||
37738913|NCT01492101|69221970|FG000|Overall Study|Lost to Follow-up|0|||
37634277|NCT00841659|69101306|FG000|Washout: 2 Weeks|Protocol Violation|1|||
37634278|NCT00841659|69101307|FG001|Washout: 2 Weeks|Protocol Violation|0|||
37634279|NCT02716298|69101311|FG000|First Intervention (1 Month)|Lens discomfort|1|||
37634280|NCT02716298|69101312|FG001|First Intervention (1 Month)|Lens discomfort|1|||
37634281|NCT00840879|69101325|FG000|Second Intervention|Withdrawal by Subject|1|||
37634282|NCT00840879|69101326|FG001|Second Intervention|Withdrawal by Subject|0|||
37634283|NCT00840411|69101341|FG000|First Intervention|Adverse Event|1|||
37634284|NCT00840411|69101342|FG001|First Intervention|Adverse Event|0|||
37634285|NCT00840411|69101341|FG000|Washout|Withdrawal by Subject|1|||
37634286|NCT00840411|69101342|FG001|Washout|Withdrawal by Subject|0|||
37634287|NCT00836901|69101355|FG000|First Intervention|Withdrawal by Subject|1|||
37634288|NCT00836901|69101356|FG001|First Intervention|Withdrawal by Subject|0|||
37634289|NCT04466384|69101360|FG000|First Phase|Protocol Violation|1|||
37634290|NCT04466384|69101361|FG001|First Phase|Protocol Violation|0|||
37634291|NCT04466384|69101360|FG000|First Phase|Missing data|1|||
37634292|NCT04466384|69101361|FG001|First Phase|Missing data|0|||
37634293|NCT04466384|69101360|FG000|Cross Over Phase|Physician Decision|1|||
37634294|NCT04466384|69101361|FG001|Cross Over Phase|Physician Decision|0|||
37634295|NCT04466384|69101360|FG000|Cross Over Phase|Withdrawal by Subject|0|||
37634296|NCT04466384|69101361|FG001|Cross Over Phase|Withdrawal by Subject|1|||
37634297|NCT03050814|69101372|FG000|Overall Study|Screen failures|0|||
37634298|NCT03050814|69101373|FG001|Overall Study|Screen failures|0|||
37634299|NCT03050814|69101374|FG002|Overall Study|Screen failures|4|||
37634300|NCT00835575|69101382|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
37634301|NCT00835575|69101383|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
37634302|NCT04601194|69101387|FG000|Overall Study|Lost to Follow-up|7|||
37634303|NCT00835263|69101400|FG000|Second Intervention|Adverse Event|1|||
37738914|NCT01492101|69221971|FG001|Overall Study|Lost to Follow-up|2|||
37738915|NCT01468311|69221977|FG000|Overall Study|mobilization failure|1|||
37738916|NCT01468311|69221977|FG000|Overall Study|Withdrawal by Subject|1|||
37738917|NCT01730534|69222088|FG000|Overall Study|Withdrawal by Subject|97|||
37738918|NCT01730534|69222089|FG001|Overall Study|Withdrawal by Subject|127|||
37738919|NCT01730534|69222088|FG000|Overall Study|Lost to Follow-up|12|||
37738920|NCT01730534|69222089|FG001|Overall Study|Lost to Follow-up|18|||
37738921|NCT01783730|69222109|FG000|Overall Study|Failed to meet inclusion criteria|6|||
37738922|NCT01730378|69222115|FG000|Overall Study|Lost to Follow-up|1|||
37738923|NCT01730378|69222116|FG001|Overall Study|Lost to Follow-up|0|||
37738924|NCT01783496|69222129|FG000|Overall Study|Lost to Follow-up|0|||
37738925|NCT01783496|69222130|FG001|Overall Study|Lost to Follow-up|0|||
37738926|NCT01783496|69222131|FG002|Overall Study|Lost to Follow-up|0|||
37738927|NCT01783496|69222132|FG003|Overall Study|Lost to Follow-up|2|||
37738928|NCT01783496|69222133|FG004|Overall Study|Lost to Follow-up|0|||
37738929|NCT01783496|69222134|FG005|Overall Study|Lost to Follow-up|1|||
37738930|NCT01783496|69222129|FG000|Overall Study|Withdrawal by Subject|1|||
37738931|NCT01783496|69222130|FG001|Overall Study|Withdrawal by Subject|0|||
37738932|NCT01783496|69222131|FG002|Overall Study|Withdrawal by Subject|0|||
37738933|NCT01783496|69222132|FG003|Overall Study|Withdrawal by Subject|0|||
37738934|NCT01783496|69222133|FG004|Overall Study|Withdrawal by Subject|0|||
37738935|NCT01783496|69222134|FG005|Overall Study|Withdrawal by Subject|0|||
37738936|NCT01729208|69222159|FG000|Baseline|Physician Decision|5|||
37738937|NCT01729208|69222160|FG001|Baseline|Physician Decision|4|||
37738938|NCT01729208|69222159|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
37738939|NCT01729208|69222160|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
37738940|NCT01729208|69222159|FG000|12 Months Follow-up|Lost to Follow-up|3|||
37738941|NCT01729208|69222160|FG001|12 Months Follow-up|Lost to Follow-up|3|||
37738942|NCT01729208|69222159|FG000|24 Months Follow-up|Lost to Follow-up|3|||
37738943|NCT01729208|69222160|FG001|24 Months Follow-up|Lost to Follow-up|0|||
37738944|NCT01729208|69222159|FG000|36 Months Follow-up|Physician Decision|1|||
37738945|NCT01729208|69222160|FG001|36 Months Follow-up|Physician Decision|0|||
37738946|NCT01729208|69222159|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
37738947|NCT01729208|69222160|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
37738948|NCT01609010|69222177|FG000|Overall Study|Stable disease (SD)|22|||
37634304|NCT00835263|69101401|FG001|Second Intervention|Adverse Event|0|||
37738949|NCT01609010|69222178|FG001|Overall Study|Stable disease (SD)|16|||
37738950|NCT01609010|69222177|FG000|Overall Study|Progressive disease (PD)|8|||
37738951|NCT01609010|69222178|FG001|Overall Study|Progressive disease (PD)|10|||
37738952|NCT01609010|69222177|FG000|Overall Study|Adverse Event|3|||
37634305|NCT01963208|69101439|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
37634306|NCT01963208|69101440|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
37634307|NCT01963208|69101441|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
37738953|NCT01609010|69222178|FG001|Overall Study|Adverse Event|6|||
37738954|NCT01609010|69222177|FG000|Overall Study|Withdrawal by Subject|2|||
37634308|NCT01963208|69101442|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
37738955|NCT01609010|69222178|FG001|Overall Study|Withdrawal by Subject|2|||
37738956|NCT01609010|69222177|FG000|Overall Study|Other|2|||
37738957|NCT01609010|69222178|FG001|Overall Study|Other|0|||
37738958|NCT01609010|69222177|FG000|Overall Study|Other malignancy|1|||
37738959|NCT01609010|69222178|FG001|Overall Study|Other malignancy|0|||
37738960|NCT01609010|69222177|FG000|Overall Study|Pathology review|2|||
37738961|NCT01609010|69222178|FG001|Overall Study|Pathology review|1|||
37738962|NCT01609010|69222177|FG000|Overall Study|Protocol Violation|1|||
37738963|NCT01609010|69222178|FG001|Overall Study|Protocol Violation|1|||
37738964|NCT01609010|69222177|FG000|Overall Study|New cancer|1|||
37738965|NCT01609010|69222178|FG001|Overall Study|New cancer|0|||
37738966|NCT01609010|69222177|FG000|Overall Study|Lost to Follow-up|1|||
37738967|NCT01609010|69222178|FG001|Overall Study|Lost to Follow-up|1|||
37738968|NCT01608308|69222186|FG000|Overall Study|pretreatment medical and billing reasons|0|||
37738969|NCT01608308|69222187|FG001|Overall Study|pretreatment medical and billing reasons|2|||
37738970|NCT01755416|69222218|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
37738971|NCT01755416|69222219|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
37738972|NCT01755026|69222227|FG000|Overall Study|Adverse Event|1|||
37738973|NCT01755026|69222228|FG001|Overall Study|Adverse Event|0|||
37738974|NCT01755026|69222227|FG000|Overall Study|Withdrawal by Subject|1|||
37738975|NCT01755026|69222228|FG001|Overall Study|Withdrawal by Subject|1|||
37738976|NCT01491945|69222243|FG000|Overall Study|Death|30|||
37738977|NCT01491945|69222243|FG000|Overall Study|Withdrwan/LTF|16|||
37738978|NCT01491945|69222243|FG000|Overall Study|Conversion|4|||
37853564|NCT01262976|69537432|FG001|Up to Year 1|Subjects with unknown completion status|0|||
37853565|NCT01262976|69537433|FG002|Up to Year 1|Subjects with unknown completion status|1|||
37853566|NCT01262976|69537434|FG003|Up to Year 1|Subjects with unknown completion status|0|||
37853567|NCT01262976|69537435|FG004|Up to Year 1|Subjects with unknown completion status|0|||
37853568|NCT01262976|69537436|FG005|Up to Year 1|Subjects with unknown completion status|1|||
37738979|NCT01491945|69222243|FG000|Overall Study|Missed Visit|1|||
37738980|NCT01728584|69222265|FG000|Overall Study|Adverse Event|1|||
37738981|NCT01728584|69222266|FG001|Overall Study|Adverse Event|0|||
37738982|NCT01728584|69222267|FG002|Overall Study|Adverse Event|0|||
37738983|NCT01728584|69222268|FG003|Overall Study|Adverse Event|0|||
37738984|NCT01728584|69222265|FG000|Overall Study|Physician Decision|4|||
37738985|NCT01728584|69222266|FG001|Overall Study|Physician Decision|0|||
37738986|NCT01728584|69222267|FG002|Overall Study|Physician Decision|1|||
37738987|NCT01728584|69222268|FG003|Overall Study|Physician Decision|0|||
37738988|NCT01728584|69222265|FG000|Overall Study|Withdrawal by Subject|1|||
37738989|NCT01728584|69222266|FG001|Overall Study|Withdrawal by Subject|0|||
37738990|NCT01728584|69222267|FG002|Overall Study|Withdrawal by Subject|0|||
37738991|NCT01728584|69222268|FG003|Overall Study|Withdrawal by Subject|0|||
37738992|NCT01728584|69222265|FG000|Overall Study|Screen failure|1|||
37738993|NCT01728584|69222266|FG001|Overall Study|Screen failure|0|||
37738994|NCT01728584|69222267|FG002|Overall Study|Screen failure|0|||
37738995|NCT01728584|69222268|FG003|Overall Study|Screen failure|0|||
37738996|NCT01728584|69222265|FG000|Overall Study|Other reason (not specified)|1|||
37738997|NCT01728584|69222266|FG001|Overall Study|Other reason (not specified)|0|||
37738998|NCT01728584|69222267|FG002|Overall Study|Other reason (not specified)|0|||
37738999|NCT01728584|69222268|FG003|Overall Study|Other reason (not specified)|1|||
37739000|NCT01522443|69222301|FG000|Overall Study|No longer receiving clinical benefit|36|||
37739001|NCT01522443|69222302|FG001|Overall Study|No longer receiving clinical benefit|28|||
37739002|NCT01522443|69222301|FG000|Overall Study|Adverse Event|10|||
37739003|NCT01522443|69222302|FG001|Overall Study|Adverse Event|15|||
37739004|NCT01522443|69222301|FG000|Overall Study|Withdrawal by Subject|5|||
37739005|NCT01522443|69222302|FG001|Overall Study|Withdrawal by Subject|8|||
37739006|NCT01522443|69222301|FG000|Overall Study|No study treatment given|1|||
37739007|NCT01522443|69222302|FG001|Overall Study|No study treatment given|1|||
37739008|NCT01522443|69222301|FG000|Overall Study|Other|1|||
37739009|NCT01522443|69222302|FG001|Overall Study|Other|3|||
37739010|NCT01468233|69222323|FG000|Treatment Period 1|Adverse Event|5|||
37739011|NCT01468233|69222324|FG001|Treatment Period 1|Adverse Event|3|||
37853569|NCT01262976|69537431|FG000|Up to Year 2|Serious Adverse Event|0|||
37853570|NCT01262976|69537432|FG001|Up to Year 2|Serious Adverse Event|0|||
37853571|NCT01262976|69537433|FG002|Up to Year 2|Serious Adverse Event|2|||
37853572|NCT01262976|69537434|FG003|Up to Year 2|Serious Adverse Event|0|||
37853573|NCT01262976|69537435|FG004|Up to Year 2|Serious Adverse Event|0|||
37853574|NCT01262976|69537436|FG005|Up to Year 2|Serious Adverse Event|0|||
37853575|NCT01262976|69537431|FG000|Up to Year 2|Withdrawal by Subject|1|||
37853576|NCT01262976|69537432|FG001|Up to Year 2|Withdrawal by Subject|0|||
37634309|NCT01963208|69101443|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
37853577|NCT01262976|69537433|FG002|Up to Year 2|Withdrawal by Subject|0|||
37853578|NCT01262976|69537434|FG003|Up to Year 2|Withdrawal by Subject|0|||
37853579|NCT01262976|69537435|FG004|Up to Year 2|Withdrawal by Subject|0|||
37739012|NCT01468233|69222325|FG002|Treatment Period 1|Adverse Event|0|||
37739013|NCT01468233|69222326|FG003|Treatment Period 1|Adverse Event|0|||
37739014|NCT01468233|69222327|FG004|Treatment Period 1|Adverse Event|0|||
37739015|NCT01468233|69222328|FG005|Treatment Period 1|Adverse Event|0|||
37739016|NCT01468233|69222323|FG000|Treatment Period 1|Withdrawal by Subject|3|||
37739017|NCT01468233|69222324|FG001|Treatment Period 1|Withdrawal by Subject|4|||
37739018|NCT01468233|69222325|FG002|Treatment Period 1|Withdrawal by Subject|0|||
37853580|NCT01262976|69537436|FG005|Up to Year 2|Withdrawal by Subject|0|||
37853581|NCT01262976|69537431|FG000|Up to Year 2|Migrated/moved from study area|0|||
37739019|NCT01468233|69222326|FG003|Treatment Period 1|Withdrawal by Subject|0|||
37739020|NCT01468233|69222327|FG004|Treatment Period 1|Withdrawal by Subject|0|||
37739021|NCT01468233|69222328|FG005|Treatment Period 1|Withdrawal by Subject|0|||
37739022|NCT01468233|69222323|FG000|Treatment Period 1|Lost to Follow-up|3|||
37739023|NCT01468233|69222324|FG001|Treatment Period 1|Lost to Follow-up|0|||
37739024|NCT01468233|69222325|FG002|Treatment Period 1|Lost to Follow-up|0|||
37739025|NCT01468233|69222326|FG003|Treatment Period 1|Lost to Follow-up|0|||
37739026|NCT01468233|69222327|FG004|Treatment Period 1|Lost to Follow-up|0|||
37739027|NCT01468233|69222328|FG005|Treatment Period 1|Lost to Follow-up|0|||
37739028|NCT01468233|69222323|FG000|Treatment Period 1|Other|1|||
37739029|NCT01468233|69222324|FG001|Treatment Period 1|Other|1|||
37739030|NCT01468233|69222325|FG002|Treatment Period 1|Other|0|||
37739031|NCT01468233|69222326|FG003|Treatment Period 1|Other|0|||
37739032|NCT01468233|69222327|FG004|Treatment Period 1|Other|0|||
37739033|NCT01468233|69222328|FG005|Treatment Period 1|Other|0|||
37739034|NCT01468233|69222323|FG000|Treatment Period 2|Adverse Event|0|||
37853582|NCT01262976|69537432|FG001|Up to Year 2|Migrated/moved from study area|0|||
37853583|NCT01262976|69537433|FG002|Up to Year 2|Migrated/moved from study area|0|||
37853584|NCT01262976|69537434|FG003|Up to Year 2|Migrated/moved from study area|2|||
37853585|NCT01262976|69537435|FG004|Up to Year 2|Migrated/moved from study area|1|||
37853586|NCT01262976|69537436|FG005|Up to Year 2|Migrated/moved from study area|2|||
37853587|NCT01262976|69537431|FG000|Up to Year 2|Lost to Follow-up|1|||
37853588|NCT01262976|69537432|FG001|Up to Year 2|Lost to Follow-up|1|||
37853589|NCT01262976|69537433|FG002|Up to Year 2|Lost to Follow-up|2|||
37853590|NCT01262976|69537434|FG003|Up to Year 2|Lost to Follow-up|2|||
37853591|NCT01262976|69537435|FG004|Up to Year 2|Lost to Follow-up|3|||
37853592|NCT01262976|69537436|FG005|Up to Year 2|Lost to Follow-up|3|||
37853593|NCT01262976|69537431|FG000|Up to Year 2|Subjects with unknown completion status|0|||
37853594|NCT01262976|69537432|FG001|Up to Year 2|Subjects with unknown completion status|0|||
37921732|NCT00570778|69608541|FG001|Overall Study|Protocol deviation|1|||
37921733|NCT00570778|69608542|FG002|Overall Study|Protocol deviation|2|||
37921734|NCT00570778|69608543|FG003|Overall Study|Protocol deviation|2|||
37921735|NCT00570778|69608540|FG000|Overall Study|Adverse Event|0|||
37921736|NCT00570778|69608541|FG001|Overall Study|Adverse Event|1|||
37921737|NCT00570778|69608542|FG002|Overall Study|Adverse Event|4|||
37921738|NCT00570778|69608543|FG003|Overall Study|Adverse Event|1|||
37921739|NCT00570778|69608540|FG000|Overall Study|Subject withdrew consent|0|||
37921740|NCT00570778|69608541|FG001|Overall Study|Subject withdrew consent|1|||
37921741|NCT00570778|69608542|FG002|Overall Study|Subject withdrew consent|0|||
37921742|NCT00570778|69608543|FG003|Overall Study|Subject withdrew consent|1|||
37921743|NCT00570778|69608540|FG000|Overall Study|Abnormal test procedure|1|||
37921744|NCT00570778|69608541|FG001|Overall Study|Abnormal test procedure|0|||
37634310|NCT01963208|69101444|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
37634311|NCT01963208|69101439|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
37634312|NCT01963208|69101440|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
37634313|NCT01963208|69101441|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
37634314|NCT01963208|69101442|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
37634315|NCT01963208|69101443|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
37634316|NCT01963208|69101444|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
37634317|NCT01963208|69101439|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
37634318|NCT01963208|69101440|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
37634319|NCT01963208|69101441|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
37634320|NCT01963208|69101442|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
37634321|NCT01963208|69101443|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
37634322|NCT01963208|69101444|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
37634323|NCT01963208|69101439|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
37634324|NCT01963208|69101440|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
37634325|NCT01963208|69101441|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
37634326|NCT01963208|69101442|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
37634327|NCT01963208|69101443|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
37634328|NCT01963208|69101444|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
37634329|NCT01963208|69101439|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
37634330|NCT01963208|69101440|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
37634331|NCT01963208|69101441|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
37634332|NCT01963208|69101442|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
37853595|NCT01262976|69537433|FG002|Up to Year 2|Subjects with unknown completion status|1|||
37739035|NCT01468233|69222324|FG001|Treatment Period 2|Adverse Event|0|||
37739036|NCT01468233|69222325|FG002|Treatment Period 2|Adverse Event|3|||
37739037|NCT01468233|69222326|FG003|Treatment Period 2|Adverse Event|0|||
37921745|NCT00570778|69608542|FG002|Overall Study|Abnormal test procedure|0|||
37739038|NCT01468233|69222327|FG004|Treatment Period 2|Adverse Event|2|||
37921746|NCT00570778|69608543|FG003|Overall Study|Abnormal test procedure|0|||
37739039|NCT01468233|69222328|FG005|Treatment Period 2|Adverse Event|1|||
37739040|NCT01468233|69222323|FG000|Treatment Period 2|Lack of Efficacy|0|||
37739041|NCT01468233|69222324|FG001|Treatment Period 2|Lack of Efficacy|0|||
37739042|NCT01468233|69222325|FG002|Treatment Period 2|Lack of Efficacy|9|||
37739043|NCT01468233|69222326|FG003|Treatment Period 2|Lack of Efficacy|2|||
37739044|NCT01468233|69222327|FG004|Treatment Period 2|Lack of Efficacy|0|||
37739045|NCT01468233|69222328|FG005|Treatment Period 2|Lack of Efficacy|1|||
37739046|NCT01468233|69222323|FG000|Treatment Period 2|Withdrawal by Subject|0|||
37739047|NCT01468233|69222324|FG001|Treatment Period 2|Withdrawal by Subject|0|||
37739048|NCT01468233|69222325|FG002|Treatment Period 2|Withdrawal by Subject|9|||
37739049|NCT01468233|69222326|FG003|Treatment Period 2|Withdrawal by Subject|1|||
37739050|NCT01468233|69222327|FG004|Treatment Period 2|Withdrawal by Subject|1|||
37739051|NCT01468233|69222328|FG005|Treatment Period 2|Withdrawal by Subject|1|||
37739052|NCT01468233|69222323|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
37739053|NCT01468233|69222324|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
37739054|NCT01468233|69222325|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
37739055|NCT01468233|69222326|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
37739056|NCT01468233|69222327|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
37739057|NCT01468233|69222328|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
37739058|NCT01468233|69222323|FG000|Treatment Period 2|Lost to Follow-up|0|||
37739059|NCT01468233|69222324|FG001|Treatment Period 2|Lost to Follow-up|0|||
37739060|NCT01468233|69222325|FG002|Treatment Period 2|Lost to Follow-up|3|||
37739061|NCT01468233|69222326|FG003|Treatment Period 2|Lost to Follow-up|0|||
37739062|NCT01468233|69222327|FG004|Treatment Period 2|Lost to Follow-up|2|||
37739063|NCT01468233|69222328|FG005|Treatment Period 2|Lost to Follow-up|0|||
37739064|NCT01468233|69222323|FG000|Treatment Period 2|Other|0|||
37739065|NCT01468233|69222324|FG001|Treatment Period 2|Other|0|||
37853596|NCT01262976|69537434|FG003|Up to Year 2|Subjects with unknown completion status|0|||
38031875|NCT02857816|69717659|FG000|Overall Study|Withdrawal by Subject|4|||
38031876|NCT02857816|69717659|FG000|Overall Study|Lost to Follow-up|1|||
38031877|NCT02858440|69717664|FG000|Overall Study|Lost to Follow-up|3|||
38031878|NCT02858440|69717664|FG000|Overall Study|Protocol Violation|2|||
38031879|NCT02858440|69717664|FG000|Overall Study|Consent withdrawal|3|||
38031880|NCT02858440|69717664|FG000|Overall Study|Migrated/moved from study area|4|||
38031881|NCT03382418|69717671|FG000|Overall Study|Withdrawal by Subject|1|||
38031882|NCT03382418|69717672|FG001|Overall Study|Withdrawal by Subject|0|||
38031883|NCT03382418|69717673|FG002|Overall Study|Withdrawal by Subject|0|||
38031884|NCT03382418|69717671|FG000|Overall Study|Lost to Follow-up|2|||
38031885|NCT03382418|69717672|FG001|Overall Study|Lost to Follow-up|3|||
38031886|NCT03382418|69717673|FG002|Overall Study|Lost to Follow-up|0|||
38031887|NCT02858362|69717685|FG000|Overall Study|Protocol Violation|0|||
38031888|NCT02858362|69717686|FG001|Overall Study|Protocol Violation|1|||
38031889|NCT02858362|69717687|FG002|Overall Study|Protocol Violation|0|||
38031890|NCT02858362|69717685|FG000|Overall Study|Withdrawal by Subject|1|||
38031891|NCT02858362|69717686|FG001|Overall Study|Withdrawal by Subject|0|||
38031892|NCT02858362|69717687|FG002|Overall Study|Withdrawal by Subject|0|||
38031893|NCT02858362|69717685|FG000|Overall Study|Early Study Termination|0|||
38031894|NCT02858362|69717686|FG001|Overall Study|Early Study Termination|0|||
38031895|NCT02858362|69717687|FG002|Overall Study|Early Study Termination|3|||
38031896|NCT02858362|69717685|FG000|Overall Study|Lost to Follow-up|1|||
38031897|NCT02858362|69717686|FG001|Overall Study|Lost to Follow-up|0|||
38031898|NCT02858362|69717687|FG002|Overall Study|Lost to Follow-up|0|||
38031899|NCT03382262|69717704|FG000|Overall Study|Physician Decision|0|||
38031900|NCT03382262|69717705|FG001|Overall Study|Physician Decision|0|||
38031901|NCT03382262|69717706|FG002|Overall Study|Physician Decision|1|||
38031902|NCT03382262|69717707|FG003|Overall Study|Physician Decision|0|||
38031903|NCT03382262|69717704|FG000|Overall Study|Withdrawal by Subject|0|||
38031904|NCT03382262|69717705|FG001|Overall Study|Withdrawal by Subject|0|||
38031905|NCT03382262|69717706|FG002|Overall Study|Withdrawal by Subject|0|||
38031906|NCT03382262|69717707|FG003|Overall Study|Withdrawal by Subject|1|||
38031907|NCT03350750|69717719|FG000|Overall Study|Death|1|||
38031908|NCT03350750|69717720|FG001|Overall Study|Death|1|||
38031909|NCT03394508|69717730|FG000|Overall Study|Protocol Violation|0|||
37853597|NCT01262976|69537435|FG004|Up to Year 2|Subjects with unknown completion status|0|||
37853598|NCT01262976|69537436|FG005|Up to Year 2|Subjects with unknown completion status|0|||
38031910|NCT03394508|69717731|FG001|Overall Study|Protocol Violation|3|||
38031911|NCT03394508|69717730|FG000|Overall Study|Lost to Follow-up|1|||
38031912|NCT03394508|69717731|FG001|Overall Study|Lost to Follow-up|0|||
38031913|NCT02856880|69717741|FG000|Overall Study|Withdrawal of consent|1|||
37739066|NCT01468233|69222325|FG002|Treatment Period 2|Other|3|||
37853599|NCT01262976|69537431|FG000|Up to Year 2|Other|3|||
38031914|NCT03393806|69717762|FG000|Overall Study|Physician Decision|1|||
38031915|NCT03393806|69717763|FG001|Overall Study|Physician Decision|0|||
38031916|NCT02856802|69717772|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
38031917|NCT02856802|69717773|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
38031918|NCT02856802|69717772|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
37739067|NCT01468233|69222326|FG003|Treatment Period 2|Other|0|||
37739068|NCT01468233|69222327|FG004|Treatment Period 2|Other|1|||
37739069|NCT01468233|69222328|FG005|Treatment Period 2|Other|0|||
37739070|NCT01468077|69222348|FG000|Overall Study|Adverse Event|2|||
37853600|NCT01262976|69537432|FG001|Up to Year 2|Other|0|||
37853601|NCT01262976|69537433|FG002|Up to Year 2|Other|0|||
37853602|NCT01262976|69537434|FG003|Up to Year 2|Other|0|||
37853603|NCT01262976|69537435|FG004|Up to Year 2|Other|0|||
37853604|NCT01262976|69537436|FG005|Up to Year 2|Other|0|||
38031919|NCT02856802|69717773|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
38031920|NCT02856802|69717772|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
38031921|NCT02856802|69717773|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
38031922|NCT02856802|69717772|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
38031923|NCT02856802|69717773|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
38031924|NCT02856802|69717772|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
38031925|NCT02856802|69717773|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
38031926|NCT02856802|69717772|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
38031927|NCT02856802|69717773|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
38031928|NCT03380390|69717783|FG000|Overall Study|Adverse Event|3|||
38031929|NCT03350672|69717790|FG000|Overall Study|Withdrawal by Subject|7|||
38031930|NCT03350672|69717791|FG001|Overall Study|Withdrawal by Subject|0|||
38031931|NCT03350672|69717792|FG002|Overall Study|Withdrawal by Subject|0|||
38031932|NCT03392168|69717804|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
38031933|NCT03392168|69717805|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
38031934|NCT03392168|69717806|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
38031935|NCT03392168|69717807|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
38031936|NCT03392168|69717804|FG000|Period 2: Cohort 2|Other|0|||
38031937|NCT03392168|69717805|FG001|Period 2: Cohort 2|Other|1|||
38031938|NCT03392168|69717806|FG002|Period 2: Cohort 2|Other|0|||
38031939|NCT03392168|69717807|FG003|Period 2: Cohort 2|Other|0|||
38031940|NCT03391232|69717818|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
38031941|NCT03391232|69717819|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
38031942|NCT03391232|69717818|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
38031943|NCT03391232|69717819|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
37739071|NCT01468077|69222349|FG001|Overall Study|Adverse Event|2|||
37739072|NCT01468077|69222348|FG000|Overall Study|Lack of Efficacy|1|||
37739073|NCT01468077|69222349|FG001|Overall Study|Lack of Efficacy|1|||
37739074|NCT01468077|69222348|FG000|Overall Study|Physician Decision|1|||
37739075|NCT01468077|69222349|FG001|Overall Study|Physician Decision|0|||
38031944|NCT03379376|69717827|FG000|Overall Study|Lost to Follow-up|2|||
38031945|NCT03379376|69717827|FG000|Overall Study|Did not wish to complete follow up|1|||
38031946|NCT03379376|69717827|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
38031947|NCT03379376|69717827|FG000|Overall Study|Death|1|||
38031948|NCT03349034|69717833|FG000|Overall Study|catheters dislodged during transport|2|||
38031949|NCT03349034|69717834|FG001|Overall Study|catheters dislodged during transport|0|||
38031950|NCT03349034|69717833|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
37634333|NCT01963208|69101443|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
37634334|NCT01963208|69101444|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
37634335|NCT01963208|69101439|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
37634336|NCT01963208|69101440|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
37634337|NCT01963208|69101441|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
37634338|NCT01963208|69101442|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
37634339|NCT01963208|69101443|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
37634340|NCT01963208|69101444|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
37634341|NCT01963208|69101439|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
37634342|NCT01963208|69101440|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
37634343|NCT01963208|69101441|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
37634344|NCT01963208|69101442|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
37634345|NCT01963208|69101443|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
37634346|NCT01963208|69101444|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
37739076|NCT01522365|69222357|FG000|Overall Study|Withdrawal by Subject|1|||
37739077|NCT01522365|69222358|FG001|Overall Study|Withdrawal by Subject|1|||
37853605|NCT01262976|69537431|FG000|Up to Year 3|Serious Adverse Event|0|||
37853606|NCT01262976|69537432|FG001|Up to Year 3|Serious Adverse Event|0|||
37853607|NCT01262976|69537433|FG002|Up to Year 3|Serious Adverse Event|2|||
37634347|NCT01963208|69101439|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
37739078|NCT01522365|69222357|FG000|Overall Study|Lost to Follow-up|1|||
37739079|NCT01522365|69222358|FG001|Overall Study|Lost to Follow-up|1|||
37739080|NCT01754402|69222368|FG000|Overall Study|Death|0|||
37739081|NCT01754402|69222369|FG001|Overall Study|Death|0|||
37853608|NCT01262976|69537434|FG003|Up to Year 3|Serious Adverse Event|0|||
37739082|NCT01754402|69222370|FG002|Overall Study|Death|1|||
37853609|NCT01262976|69537435|FG004|Up to Year 3|Serious Adverse Event|0|||
37853610|NCT01262976|69537436|FG005|Up to Year 3|Serious Adverse Event|0|||
37853611|NCT01262976|69537431|FG000|Up to Year 3|Withdrawal by Subject|1|||
37853612|NCT01262976|69537432|FG001|Up to Year 3|Withdrawal by Subject|0|||
37853613|NCT01262976|69537433|FG002|Up to Year 3|Withdrawal by Subject|0|||
37739083|NCT01754402|69222368|FG000|Overall Study|Adverse Event|2|||
37739084|NCT01754402|69222369|FG001|Overall Study|Adverse Event|2|||
37739085|NCT01754402|69222370|FG002|Overall Study|Adverse Event|1|||
37739086|NCT01754402|69222368|FG000|Overall Study|Withdrawal by Subject|0|||
37739087|NCT01754402|69222369|FG001|Overall Study|Withdrawal by Subject|0|||
37739088|NCT01754402|69222370|FG002|Overall Study|Withdrawal by Subject|1|||
37739089|NCT01754402|69222368|FG000|Overall Study|Lack of Efficacy|0|||
37739090|NCT01754402|69222369|FG001|Overall Study|Lack of Efficacy|0|||
37739091|NCT01754402|69222370|FG002|Overall Study|Lack of Efficacy|1|||
37739092|NCT01783418|69222381|FG000|Overall Study|Withdrawal by Subject|1|||
37739093|NCT01783418|69222382|FG001|Overall Study|Withdrawal by Subject|0|||
37739094|NCT01521897|69222388|FG000|Overall Study|Protocol Violation|18|||
37739095|NCT01521897|69222388|FG000|Overall Study|Lost to Follow-up|5|||
37739096|NCT01782872|69222396|FG000|Overall Study|Protocol Violation|0|||
37739097|NCT01782872|69222397|FG001|Overall Study|Protocol Violation|0|||
37739098|NCT01782872|69222398|FG002|Overall Study|Protocol Violation|0|||
37739099|NCT01782872|69222399|FG003|Overall Study|Protocol Violation|1|||
37739100|NCT01782872|69222396|FG000|Overall Study|Withdrawal by Subject|0|||
37739101|NCT01782872|69222397|FG001|Overall Study|Withdrawal by Subject|1|||
37739102|NCT01782872|69222398|FG002|Overall Study|Withdrawal by Subject|0|||
37739103|NCT01782872|69222399|FG003|Overall Study|Withdrawal by Subject|0|||
37739104|NCT01490697|69222411|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
37739105|NCT01490697|69222412|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
37739106|NCT01728194|69222420|FG000|Overall Study|Lost to Follow-up|4|||
37739107|NCT01728194|69222421|FG001|Overall Study|Lost to Follow-up|3|||
37739108|NCT01728194|69222420|FG000|Overall Study|Physician Decision|4|||
37739109|NCT01728194|69222421|FG001|Overall Study|Physician Decision|0|||
37739110|NCT01728194|69222420|FG000|Overall Study|Withdrawal by Subject|7|||
37739111|NCT01728194|69222421|FG001|Overall Study|Withdrawal by Subject|3|||
37739112|NCT01728194|69222420|FG000|Overall Study|Perceived Medication Side Effects|4|||
37739113|NCT01728194|69222421|FG001|Overall Study|Perceived Medication Side Effects|0|||
37739114|NCT01728194|69222420|FG000|Overall Study|Family Member Request|1|||
37739115|NCT01728194|69222421|FG001|Overall Study|Family Member Request|0|||
37739116|NCT01782482|69222429|FG000|Overall Study|Adverse Event|2|||
37739117|NCT01782482|69222430|FG001|Overall Study|Adverse Event|1|||
37739118|NCT01782482|69222429|FG000|Overall Study|Lost to Follow-up|2|||
37853614|NCT01262976|69537434|FG003|Up to Year 3|Withdrawal by Subject|0|||
37739119|NCT01782482|69222430|FG001|Overall Study|Lost to Follow-up|3|||
37739120|NCT01782482|69222429|FG000|Overall Study|Physician Decision|1|||
37739121|NCT01782482|69222430|FG001|Overall Study|Physician Decision|0|||
37739122|NCT01782482|69222429|FG000|Overall Study|Protocol Violation|1|||
37739123|NCT01782482|69222430|FG001|Overall Study|Protocol Violation|0|||
37739124|NCT01782482|69222429|FG000|Overall Study|Withdrawal by Subject|2|||
37739125|NCT01782482|69222430|FG001|Overall Study|Withdrawal by Subject|3|||
37739126|NCT01782482|69222429|FG000|Overall Study|Randomized in Error|2|||
37739127|NCT01782482|69222430|FG001|Overall Study|Randomized in Error|2|||
37739128|NCT01782482|69222429|FG000|Overall Study|Habitually wearing toric lens OS|0|||
37739129|NCT01782482|69222430|FG001|Overall Study|Habitually wearing toric lens OS|1|||
37739130|NCT01466673|69222438|FG000|Overall Study|Non-compliance with study treatment|2|||
37739131|NCT01466673|69222439|FG001|Overall Study|Non-compliance with study treatment|0|||
37739132|NCT01466673|69222438|FG000|Overall Study|Lost to Follow-up|3|||
37739133|NCT01466673|69222439|FG001|Overall Study|Lost to Follow-up|5|||
37739134|NCT01466673|69222438|FG000|Overall Study|Adverse Event|2|||
37739135|NCT01466673|69222439|FG001|Overall Study|Adverse Event|1|||
37739136|NCT01753856|69222447|FG000|Overall Study|Adverse Event|1|||
37739137|NCT01753856|69222448|FG001|Overall Study|Adverse Event|0|||
37739138|NCT01753856|69222447|FG000|Overall Study|Withdrawal by Subject|0|||
37853615|NCT01262976|69537435|FG004|Up to Year 3|Withdrawal by Subject|0|||
37853616|NCT01262976|69537436|FG005|Up to Year 3|Withdrawal by Subject|0|||
37853617|NCT01262976|69537431|FG000|Up to Year 3|Migrated/moved from study area|0|||
37853618|NCT01262976|69537432|FG001|Up to Year 3|Migrated/moved from study area|0|||
37853619|NCT01262976|69537433|FG002|Up to Year 3|Migrated/moved from study area|0|||
37853620|NCT01262976|69537434|FG003|Up to Year 3|Migrated/moved from study area|2|||
37739139|NCT01753856|69222448|FG001|Overall Study|Withdrawal by Subject|2|||
37739140|NCT01753856|69222447|FG000|Overall Study|Sponsor Decision|2|||
37739141|NCT01753856|69222448|FG001|Overall Study|Sponsor Decision|0|||
37739142|NCT01464333|69222457|FG000|Overall Study|Adverse Event|34|||
37739143|NCT01464333|69222457|FG000|Overall Study|Lack of Efficacy|72|||
37739144|NCT01464333|69222457|FG000|Overall Study|Withdrawal by Subject|11|||
37739145|NCT01464333|69222457|FG000|Overall Study|Other|4|||
37739146|NCT01464333|69222457|FG000|Overall Study|No Hospital Visit|42|||
37739147|NCT01464255|69222463|FG000|Overall Study|unresolve corneal staining|0|||
37739148|NCT01464255|69222464|FG001|Overall Study|unresolve corneal staining|1|||
37739149|NCT01464021|69222471|FG000|Overall Study|Withdrawal by Subject|13|||
37739150|NCT01464021|69222471|FG000|Overall Study|Lost to Follow-up|1|||
37739151|NCT01464021|69222471|FG000|Overall Study|Lack of Efficacy|1|||
37739152|NCT01464021|69222471|FG000|Overall Study|various|11|||
37739153|NCT01753310|69222477|FG000|Overall Study|Entered into open label extension study|25|||
37739154|NCT01753310|69222478|FG001|Overall Study|Entered into open label extension study|22|||
37739155|NCT01753310|69222477|FG000|Overall Study|Adverse Event|1|||
37634348|NCT01963208|69101440|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
37634349|NCT01963208|69101441|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
37634350|NCT01963208|69101442|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
37739156|NCT01753310|69222478|FG001|Overall Study|Adverse Event|0|||
37739157|NCT01753310|69222477|FG000|Overall Study|Lost to Follow-up|2|||
37739158|NCT01753310|69222478|FG001|Overall Study|Lost to Follow-up|0|||
37739159|NCT01753310|69222477|FG000|Overall Study|Subject decision|2|||
37739160|NCT01753310|69222478|FG001|Overall Study|Subject decision|2|||
37739161|NCT01753310|69222477|FG000|Overall Study|Sponsor decision|1|||
37739162|NCT01753310|69222478|FG001|Overall Study|Sponsor decision|0|||
37739163|NCT01753310|69222477|FG000|Overall Study|Withdrawal by Subject|1|||
37739164|NCT01753310|69222478|FG001|Overall Study|Withdrawal by Subject|0|||
37739165|NCT01463631|69222488|FG000|Overall Study|Withdrawal by Subject|0|||
37739166|NCT01463631|69222489|FG001|Overall Study|Withdrawal by Subject|0|||
37739167|NCT01463631|69222490|FG002|Overall Study|Withdrawal by Subject|0|||
37739168|NCT01463631|69222491|FG003|Overall Study|Withdrawal by Subject|1|||
37739169|NCT01463631|69222488|FG000|Overall Study|Death|0|||
37739170|NCT01463631|69222489|FG001|Overall Study|Death|0|||
37739171|NCT01463631|69222490|FG002|Overall Study|Death|1|||
37739172|NCT01463631|69222491|FG003|Overall Study|Death|0|||
37739173|NCT01463631|69222488|FG000|Overall Study|Progressive Disease|0|||
37739174|NCT01463631|69222489|FG001|Overall Study|Progressive Disease|0|||
37739175|NCT01463631|69222490|FG002|Overall Study|Progressive Disease|0|||
37739176|NCT01463631|69222491|FG003|Overall Study|Progressive Disease|5|||
37739177|NCT01521507|69222505|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
37739178|NCT01521507|69222506|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
37739179|NCT01521507|69222505|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
37739180|NCT01521507|69222506|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
37739181|NCT01521507|69222505|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
37739182|NCT01521507|69222506|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
37739183|NCT01521507|69222505|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
37739184|NCT01521507|69222506|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
37739185|NCT01521507|69222505|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
37739186|NCT01521507|69222506|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
37739187|NCT01521507|69222505|FG000|Stage 2: Observational Design|Physician Decision|1|||
37739188|NCT01521507|69222506|FG001|Stage 2: Observational Design|Physician Decision|0|||
37739189|NCT01521117|69222519|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
37739190|NCT01521117|69222520|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
37739191|NCT01521117|69222519|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
37739192|NCT01521117|69222520|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
37739193|NCT01521117|69222519|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
37739194|NCT01521117|69222520|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
37739195|NCT01466595|69222528|FG000|Overall Study|Withdrawal by Subject|0|||
37739196|NCT01466595|69222529|FG001|Overall Study|Withdrawal by Subject|1|||
37739197|NCT01728116|69222546|FG000|Overall Study|Sponsor Terminated Study|106|||
37739198|NCT01728116|69222547|FG001|Overall Study|Sponsor Terminated Study|35|||
37739199|NCT01728116|69222546|FG000|Overall Study|Withdrawal by Subject|16|||
37739200|NCT01728116|69222547|FG001|Overall Study|Withdrawal by Subject|9|||
37739201|NCT01728116|69222546|FG000|Overall Study|Adverse Event|13|||
37739202|NCT01728116|69222547|FG001|Overall Study|Adverse Event|0|||
37739203|NCT01728116|69222546|FG000|Overall Study|Procedure/device failure|7|||
37739204|NCT01728116|69222547|FG001|Overall Study|Procedure/device failure|0|||
37739205|NCT01728116|69222546|FG000|Overall Study|Lost to Follow-up|9|||
37739206|NCT01728116|69222547|FG001|Overall Study|Lost to Follow-up|2|||
37739207|NCT01728116|69222546|FG000|Overall Study|Physician Decision|2|||
37739208|NCT01728116|69222547|FG001|Overall Study|Physician Decision|0|||
37739209|NCT01728116|69222546|FG000|Overall Study|Subject Non-Compliance|2|||
37853621|NCT01262976|69537435|FG004|Up to Year 3|Migrated/moved from study area|1|||
37739210|NCT01728116|69222547|FG001|Overall Study|Subject Non-Compliance|0|||
37739211|NCT01728116|69222546|FG000|Overall Study|Inter-current finding at procedure|1|||
37739212|NCT01728116|69222547|FG001|Overall Study|Inter-current finding at procedure|0|||
37739213|NCT01728116|69222546|FG000|Overall Study|Incorrectly enrolled in Study|0|||
37739214|NCT01728116|69222547|FG001|Overall Study|Incorrectly enrolled in Study|1|||
37739215|NCT01728116|69222546|FG000|Overall Study|various not noted previously|5|||
37739216|NCT01728116|69222547|FG001|Overall Study|various not noted previously|0|||
37739217|NCT01465659|69222558|FG000|Completed 1 Cycle of Treatment|Death|0|||
37739218|NCT01465659|69222559|FG001|Completed 1 Cycle of Treatment|Death|1|||
37739219|NCT01465659|69222560|FG002|Completed 1 Cycle of Treatment|Death|0|||
37739220|NCT01465659|69222561|FG003|Completed 1 Cycle of Treatment|Death|0|||
37739221|NCT01465659|69222558|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
37739222|NCT01465659|69222559|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
37739223|NCT01465659|69222560|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
37739224|NCT01465659|69222561|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
37739225|NCT01465659|69222558|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
37739226|NCT01465659|69222559|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
37739227|NCT01465659|69222560|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
37739228|NCT01465659|69222561|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
37739229|NCT01465659|69222558|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
37739230|NCT01465659|69222559|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
37739231|NCT01465659|69222560|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
37739232|NCT01465659|69222561|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
37739233|NCT01465659|69222558|FG000|Completed Follow for 1 Year|Death|6|||
37739234|NCT01465659|69222559|FG001|Completed Follow for 1 Year|Death|3|||
37739235|NCT01465659|69222560|FG002|Completed Follow for 1 Year|Death|2|||
37739236|NCT01465659|69222561|FG003|Completed Follow for 1 Year|Death|4|||
37739237|NCT01753076|69222576|FG000|Overall Study|Adverse Event|17|||
37739238|NCT01753076|69222577|FG001|Overall Study|Adverse Event|18|||
37739239|NCT01753076|69222576|FG000|Overall Study|Lack of Efficacy|3|||
37739240|NCT01753076|69222577|FG001|Overall Study|Lack of Efficacy|1|||
37739241|NCT01753076|69222576|FG000|Overall Study|Lost to Follow-up|2|||
37739242|NCT01753076|69222577|FG001|Overall Study|Lost to Follow-up|1|||
37739243|NCT01753076|69222576|FG000|Overall Study|Physician Decision|4|||
37739244|NCT01753076|69222577|FG001|Overall Study|Physician Decision|2|||
37739245|NCT01753076|69222576|FG000|Overall Study|Withdrawal by Subject|14|||
37739246|NCT01753076|69222577|FG001|Overall Study|Withdrawal by Subject|24|||
37739247|NCT01753076|69222576|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
37739248|NCT01753076|69222577|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
37739249|NCT01463007|69222585|FG000|Overall Study|Physician Decision|1|||
37739250|NCT01462929|69222593|FG000|Overall Study|Adverse Event|3|||
37739251|NCT01462929|69222594|FG001|Overall Study|Adverse Event|3|||
37739252|NCT01462929|69222595|FG002|Overall Study|Adverse Event|4|||
37739253|NCT01462929|69222593|FG000|Overall Study|Withdrawal by Subject|2|||
37739254|NCT01462929|69222594|FG001|Overall Study|Withdrawal by Subject|1|||
37739255|NCT01462929|69222595|FG002|Overall Study|Withdrawal by Subject|0|||
37739256|NCT01462929|69222593|FG000|Overall Study|Lack of Efficacy|0|||
37739257|NCT01462929|69222594|FG001|Overall Study|Lack of Efficacy|0|||
37739258|NCT01462929|69222595|FG002|Overall Study|Lack of Efficacy|1|||
37739259|NCT01462695|69222605|FG000|Overall Study|Adverse Event|1|||
37739260|NCT01462695|69222606|FG001|Overall Study|Adverse Event|1|||
37739261|NCT01462695|69222605|FG000|Overall Study|Death|2|||
37739262|NCT01462695|69222606|FG001|Overall Study|Death|0|||
37739263|NCT01462695|69222605|FG000|Overall Study|Lack of Efficacy|6|||
37739264|NCT01462695|69222606|FG001|Overall Study|Lack of Efficacy|12|||
37739265|NCT01462695|69222605|FG000|Overall Study|Physician Decision|5|||
37739266|NCT01462695|69222606|FG001|Overall Study|Physician Decision|0|||
37739267|NCT01462695|69222605|FG000|Overall Study|Withdrawal by Subject|2|||
37739268|NCT01462695|69222606|FG001|Overall Study|Withdrawal by Subject|0|||
37739269|NCT01462695|69222605|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
37739270|NCT01462695|69222606|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
37739271|NCT01465347|69222612|FG000|Overall Study|Withdrawal by Subject|1|||
37739272|NCT01465347|69222613|FG001|Overall Study|Withdrawal by Subject|1|||
37739273|NCT01465347|69222612|FG000|Overall Study|Physician Decision|0|||
37739274|NCT01465347|69222613|FG001|Overall Study|Physician Decision|1|||
37739275|NCT01465347|69222612|FG000|Overall Study|Admitted to hospice|0|||
37739276|NCT01465347|69222613|FG001|Overall Study|Admitted to hospice|1|||
37739277|NCT01465191|69222625|FG000|Overall Study|Protocol Violation|6|||
37739278|NCT01465191|69222626|FG001|Overall Study|Protocol Violation|3|||
37739279|NCT01465191|69222627|FG002|Overall Study|Protocol Violation|3|||
37739280|NCT01465191|69222625|FG000|Overall Study|Lost to Follow-up|3|||
37739281|NCT01465191|69222626|FG001|Overall Study|Lost to Follow-up|6|||
37739282|NCT01465191|69222627|FG002|Overall Study|Lost to Follow-up|4|||
37739283|NCT01519947|69222642|FG000|Overall Study|Death|0|||
37739284|NCT01519947|69222643|FG001|Overall Study|Death|0|||
37739285|NCT01519947|69222644|FG002|Overall Study|Death|0|||
37739286|NCT01519947|69222645|FG003|Overall Study|Death|1|||
37739287|NCT01519947|69222642|FG000|Overall Study|Protocol Violation|0|||
37739288|NCT01519947|69222643|FG001|Overall Study|Protocol Violation|0|||
37739289|NCT01519947|69222644|FG002|Overall Study|Protocol Violation|2|||
37739290|NCT01519947|69222645|FG003|Overall Study|Protocol Violation|1|||
37739291|NCT01519947|69222642|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
37739292|NCT01519947|69222643|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
37739293|NCT01519947|69222644|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
37739294|NCT01519947|69222645|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
37739295|NCT01519947|69222642|FG000|Overall Study|Development of Anemia|0|||
37739296|NCT01519947|69222643|FG001|Overall Study|Development of Anemia|1|||
37739297|NCT01519947|69222644|FG002|Overall Study|Development of Anemia|0|||
37739298|NCT01519947|69222645|FG003|Overall Study|Development of Anemia|1|||
37739299|NCT01519947|69222642|FG000|Overall Study|Blood Transfusion|0|||
37739300|NCT01519947|69222643|FG001|Overall Study|Blood Transfusion|1|||
37739301|NCT01519947|69222644|FG002|Overall Study|Blood Transfusion|1|||
37739302|NCT01519947|69222645|FG003|Overall Study|Blood Transfusion|0|||
37739303|NCT01519947|69222642|FG000|Overall Study|Withdrawal by Subject|0|||
37739304|NCT01519947|69222643|FG001|Overall Study|Withdrawal by Subject|1|||
37739305|NCT01519947|69222644|FG002|Overall Study|Withdrawal by Subject|0|||
37739306|NCT01519947|69222645|FG003|Overall Study|Withdrawal by Subject|1|||
37739307|NCT01519947|69222642|FG000|Overall Study|Lost to Follow-up|0|||
37739308|NCT01519947|69222643|FG001|Overall Study|Lost to Follow-up|0|||
37739309|NCT01519947|69222644|FG002|Overall Study|Lost to Follow-up|3|||
37739310|NCT01519947|69222645|FG003|Overall Study|Lost to Follow-up|2|||
37739311|NCT01519947|69222642|FG000|Overall Study|Poor Response|1|||
37739312|NCT01519947|69222643|FG001|Overall Study|Poor Response|0|||
37739313|NCT01519947|69222644|FG002|Overall Study|Poor Response|0|||
37739314|NCT01519947|69222645|FG003|Overall Study|Poor Response|1|||
37739315|NCT01519947|69222642|FG000|Overall Study|Adverse Event|1|||
37739316|NCT01519947|69222643|FG001|Overall Study|Adverse Event|0|||
37739317|NCT01519947|69222644|FG002|Overall Study|Adverse Event|1|||
37739318|NCT01519947|69222645|FG003|Overall Study|Adverse Event|1|||
37739319|NCT01462227|69222657|FG000|Second Assignment|Lost to Follow-up|1|||
37739320|NCT01462227|69222658|FG001|Second Assignment|Lost to Follow-up|0|||
37739321|NCT01462227|69222659|FG002|Second Assignment|Lost to Follow-up|0|||
37739322|NCT01462227|69222660|FG003|Second Assignment|Lost to Follow-up|0|||
37739323|NCT01462227|69222657|FG000|Second Assignment|Protocol Violation|0|||
37739324|NCT01462227|69222658|FG001|Second Assignment|Protocol Violation|1|||
37739325|NCT01462227|69222659|FG002|Second Assignment|Protocol Violation|1|||
37739326|NCT01462227|69222660|FG003|Second Assignment|Protocol Violation|0|||
37739327|NCT01464879|69222668|FG000|Overall Study|Physician Decision|1|||
37739328|NCT01464879|69222668|FG000|Overall Study|Non-compliance|1|||
37739329|NCT01519869|69222678|FG000|Overall Study|Lost to Follow-up|1|||
37739330|NCT01519791|69222684|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
37739331|NCT01519791|69222685|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
37739332|NCT01519791|69222684|FG000|Overall Study|Protocol Violation|6|||
37739333|NCT01519791|69222685|FG001|Overall Study|Protocol Violation|19|||
37739334|NCT01519791|69222684|FG000|Overall Study|Other Reason|87|||
37739335|NCT01519791|69222685|FG001|Overall Study|Other Reason|222|||
37739336|NCT01519791|69222684|FG000|Overall Study|subjects randomized in error|2|||
37739337|NCT01519791|69222685|FG001|Overall Study|subjects randomized in error|0|||
37739338|NCT01519791|69222684|FG000|Overall Study|Lack of Efficacy|16|||
37739339|NCT01519791|69222685|FG001|Overall Study|Lack of Efficacy|20|||
37739340|NCT01519791|69222684|FG000|Overall Study|SAE, non-fatal|6|||
37739341|NCT01519791|69222685|FG001|Overall Study|SAE, non-fatal|22|||
37739342|NCT01519791|69222684|FG000|Overall Study|AE, serious fatal|0|||
37739343|NCT01519791|69222685|FG001|Overall Study|AE, serious fatal|1|||
37739344|NCT01519791|69222684|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
37739345|NCT01519791|69222685|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
37739346|NCT01519791|69222684|FG000|Overall Study|AE, non-serious non-fatal|12|||
37739347|NCT01519791|69222685|FG001|Overall Study|AE, non-serious non-fatal|31|||
37739348|NCT01519791|69222684|FG000|Overall Study|Withdrawal by Subject|15|||
37739349|NCT01519791|69222685|FG001|Overall Study|Withdrawal by Subject|37|||
37634351|NCT01963208|69101443|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
37739350|NCT01519791|69222684|FG000|Overall Study|Lost to Follow-up|6|||
37853622|NCT01262976|69537436|FG005|Up to Year 3|Migrated/moved from study area|1|||
37634352|NCT01963208|69101444|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
37634353|NCT01963208|69101439|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
37634354|NCT01963208|69101440|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
37634355|NCT01963208|69101441|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
37634356|NCT01963208|69101442|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
37634357|NCT01963208|69101443|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
37634358|NCT01963208|69101444|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
37634359|NCT01963208|69101439|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
37634360|NCT01963208|69101440|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
37739351|NCT01519791|69222685|FG001|Overall Study|Lost to Follow-up|14|||
37739352|NCT01461993|69222696|FG000|Overall Study|Withdrawal by Subject|60|||
37739353|NCT01461993|69222697|FG001|Overall Study|Withdrawal by Subject|53|||
37739354|NCT01461993|69222698|FG002|Overall Study|Withdrawal by Subject|16|||
37739355|NCT01461993|69222696|FG000|Overall Study|Lost to Follow-up|44|||
37853623|NCT01262976|69537431|FG000|Up to Year 3|Lost to Follow-up|2|||
37739356|NCT01461993|69222697|FG001|Overall Study|Lost to Follow-up|48|||
37739357|NCT01461993|69222698|FG002|Overall Study|Lost to Follow-up|22|||
37739358|NCT01461993|69222696|FG000|Overall Study|Protocol Violation|10|||
37739359|NCT01461993|69222697|FG001|Overall Study|Protocol Violation|9|||
37634361|NCT01963208|69101441|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
37634362|NCT01963208|69101442|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
37634363|NCT01963208|69101443|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
37634364|NCT01963208|69101444|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
37634365|NCT01963208|69101439|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
37634366|NCT01963208|69101440|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
37634367|NCT01963208|69101441|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
37634368|NCT01963208|69101442|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
37634369|NCT01963208|69101443|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
37634370|NCT01963208|69101444|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
37634371|NCT01963208|69101439|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
37634372|NCT01963208|69101440|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
37634373|NCT01963208|69101441|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
37634374|NCT01963208|69101442|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
37634375|NCT01963208|69101443|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
37634376|NCT01963208|69101444|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
37634377|NCT01963208|69101439|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
37634378|NCT01963208|69101440|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
37634379|NCT01963208|69101441|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
37634380|NCT01963208|69101442|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
37634381|NCT01963208|69101443|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
37634382|NCT01963208|69101444|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
37634383|NCT01963208|69101439|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
37634384|NCT01963208|69101440|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
37634385|NCT01963208|69101441|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
37634386|NCT01963208|69101442|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
37634387|NCT01963208|69101443|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
37634388|NCT01963208|69101444|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
37634389|NCT00834873|69101456|FG000|First Intervention|Adverse Event|0|||
37634390|NCT00834873|69101457|FG001|First Intervention|Adverse Event|1|||
37634391|NCT01377480|69101465|FG000|Overall Study|Protocol Violation|0|||
37634392|NCT01377480|69101466|FG001|Overall Study|Protocol Violation|0|||
37634393|NCT01377480|69101467|FG002|Overall Study|Protocol Violation|0|||
37634394|NCT01377480|69101468|FG003|Overall Study|Protocol Violation|4|||
37634395|NCT01377480|69101465|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
37634396|NCT01377480|69101466|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
37634397|NCT01377480|69101467|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
37634398|NCT01377480|69101468|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
37634399|NCT01377480|69101465|FG000|Overall Study|Withdrawal by Subject|0|||
37634400|NCT01377480|69101466|FG001|Overall Study|Withdrawal by Subject|0|||
37634401|NCT01377480|69101467|FG002|Overall Study|Withdrawal by Subject|1|||
37634402|NCT01377480|69101468|FG003|Overall Study|Withdrawal by Subject|0|||
37634403|NCT01377480|69101465|FG000|Overall Study|Serious adverse event|0|||
37634404|NCT01377480|69101466|FG001|Overall Study|Serious adverse event|0|||
37634405|NCT01377480|69101467|FG002|Overall Study|Serious adverse event|1|||
37634406|NCT01377480|69101468|FG003|Overall Study|Serious adverse event|1|||
37634407|NCT01377480|69101465|FG000|Overall Study|Other|0|||
37634408|NCT01377480|69101466|FG001|Overall Study|Other|0|||
37634409|NCT01377480|69101467|FG002|Overall Study|Other|7|||
37634410|NCT01377480|69101468|FG003|Overall Study|Other|6|||
37634411|NCT00834795|69101480|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
37634412|NCT00834795|69101481|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
37634413|NCT00834795|69101480|FG000|Second Intervention|Adverse Event|1|||
37634414|NCT00834795|69101481|FG001|Second Intervention|Adverse Event|0|||
37634415|NCT00834717|69101487|FG000|First Intervention|Adverse Event|1|||
37634416|NCT00834717|69101488|FG001|First Intervention|Adverse Event|0|||
37634417|NCT00834717|69101487|FG000|First Intervention|Withdrawal by Subject|0|||
37634418|NCT00834717|69101488|FG001|First Intervention|Withdrawal by Subject|1|||
37634419|NCT00834639|69101494|FG000|Second Intervention|Physician Decision|0|||
37853624|NCT01262976|69537432|FG001|Up to Year 3|Lost to Follow-up|2|||
37853625|NCT01262976|69537433|FG002|Up to Year 3|Lost to Follow-up|4|||
37853626|NCT01262976|69537434|FG003|Up to Year 3|Lost to Follow-up|3|||
37853627|NCT01262976|69537435|FG004|Up to Year 3|Lost to Follow-up|1|||
37634420|NCT00834639|69101495|FG001|Second Intervention|Physician Decision|2|||
37634421|NCT00834249|69101515|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
37634422|NCT00834249|69101516|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
37634423|NCT00834249|69101515|FG000|Second Intervention|Adverse Event|1|||
37634424|NCT00834249|69101516|FG001|Second Intervention|Adverse Event|0|||
37634425|NCT00833937|69101522|FG000|Washout|Withdrawal by Subject|1|||
37634426|NCT00833937|69101523|FG001|Washout|Withdrawal by Subject|0|||
37634427|NCT00924170|69101529|FG000|Overall Study|Refused further treatment|0|||
37634428|NCT00924170|69101530|FG001|Overall Study|Refused further treatment|1|||
37853628|NCT01262976|69537436|FG005|Up to Year 3|Lost to Follow-up|3|||
37853629|NCT01262976|69537431|FG000|Up to Year 3|Subjects with unknown completion status|0|||
37634429|NCT00924170|69101529|FG000|Overall Study|Physician Decision|0|||
37634430|NCT00924170|69101530|FG001|Overall Study|Physician Decision|1|||
37634431|NCT00924170|69101529|FG000|Overall Study|Progressive disease|3|||
37634432|NCT00924170|69101530|FG001|Overall Study|Progressive disease|6|||
37634433|NCT00924170|69101529|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
37634434|NCT00924170|69101530|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
37634435|NCT00924170|69101529|FG000|Overall Study|Death|1|||
37634436|NCT00924170|69101530|FG001|Overall Study|Death|0|||
37634437|NCT00828321|69101544|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
37634438|NCT00828321|69101545|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
37634439|NCT00828321|69101544|FG000|Second Intervention|Protocol Violation|0|||
37634440|NCT00828321|69101545|FG001|Second Intervention|Protocol Violation|1|||
37634441|NCT01352715|69101551|FG000|Overall Study|Death|3|||
37634442|NCT01352715|69101552|FG001|Overall Study|Death|3|||
37634443|NCT01352715|69101551|FG000|Overall Study|Lost to Follow-up|5|||
37634444|NCT01352715|69101552|FG001|Overall Study|Lost to Follow-up|7|||
37634445|NCT01352715|69101551|FG000|Overall Study|Withdrawal by Subject|4|||
37634446|NCT01352715|69101552|FG001|Overall Study|Withdrawal by Subject|8|||
37634447|NCT01352715|69101551|FG000|Overall Study|site closure|16|||
37634448|NCT01352715|69101552|FG001|Overall Study|site closure|15|||
37634449|NCT01352715|69101551|FG000|Overall Study|no final visit in closeout period|15|||
37634450|NCT01352715|69101552|FG001|Overall Study|no final visit in closeout period|12|||
37634451|NCT01352715|69101551|FG000|Overall Study|major ineligibility|2|||
37634452|NCT01352715|69101552|FG001|Overall Study|major ineligibility|1|||
37634453|NCT00919893|69101563|FG000|Overall Study|Protocol Violation|19|||
37634454|NCT00919893|69101564|FG001|Overall Study|Protocol Violation|9|||
37634455|NCT02559622|69101572|FG000|Overall Study|Progressive disease|0|||
37634456|NCT02559622|69101573|FG001|Overall Study|Progressive disease|1|||
37634457|NCT02559622|69101574|FG002|Overall Study|Progressive disease|0|||
37634458|NCT02559622|69101575|FG003|Overall Study|Progressive disease|0|||
37634459|NCT02559622|69101572|FG000|Overall Study|Adverse Event|0|||
37634460|NCT02559622|69101573|FG001|Overall Study|Adverse Event|2|||
37634461|NCT02559622|69101574|FG002|Overall Study|Adverse Event|2|||
37634462|NCT02559622|69101575|FG003|Overall Study|Adverse Event|2|||
37634463|NCT02559622|69101572|FG000|Overall Study|Patient/guardian decision|1|||
37634464|NCT02559622|69101573|FG001|Overall Study|Patient/guardian decision|2|||
37634465|NCT02559622|69101574|FG002|Overall Study|Patient/guardian decision|0|||
37634466|NCT02559622|69101575|FG003|Overall Study|Patient/guardian decision|1|||
37634467|NCT02559310|69101591|FG000|Overall Study|Death|4|||
37634468|NCT02559310|69101592|FG001|Overall Study|Death|3|||
37634469|NCT02559310|69101591|FG000|Overall Study|Lost to Follow-up|5|||
37634470|NCT02559310|69101592|FG001|Overall Study|Lost to Follow-up|3|||
37634471|NCT02559310|69101591|FG000|Overall Study|Physician Decision|2|||
37634472|NCT02559310|69101592|FG001|Overall Study|Physician Decision|1|||
37634473|NCT02559310|69101591|FG000|Overall Study|Withdrawal by Subject|13|||
37634474|NCT02559310|69101592|FG001|Overall Study|Withdrawal by Subject|9|||
37634475|NCT02559310|69101591|FG000|Overall Study|Sponsor Decision|0|||
37634476|NCT02559310|69101592|FG001|Overall Study|Sponsor Decision|1|||
37634477|NCT02559310|69101591|FG000|Overall Study|Randomized but not treated|3|||
37634478|NCT02559310|69101592|FG001|Overall Study|Randomized but not treated|2|||
37634479|NCT02555878|69101600|FG000|Overall Study|Lost to Follow-up|2|||
37634480|NCT02555878|69101601|FG001|Overall Study|Lost to Follow-up|3|||
37634481|NCT02555878|69101600|FG000|Overall Study|Withdrawal by Subject|48|||
37634482|NCT02555878|69101601|FG001|Overall Study|Withdrawal by Subject|48|||
37634483|NCT02555878|69101600|FG000|Overall Study|Adverse Event|12|||
37634484|NCT02555878|69101601|FG001|Overall Study|Adverse Event|8|||
37634485|NCT02555878|69101600|FG000|Overall Study|Death|74|||
37634486|NCT02555878|69101601|FG001|Overall Study|Death|59|||
37634487|NCT02555878|69101600|FG000|Overall Study|Protocol Violation|1|||
37634488|NCT02555878|69101601|FG001|Overall Study|Protocol Violation|2|||
37634489|NCT02555878|69101600|FG000|Overall Study|Physician Decision|12|||
37634490|NCT02555878|69101601|FG001|Overall Study|Physician Decision|13|||
37634491|NCT02555878|69101600|FG000|Overall Study|Other|17|||
37634492|NCT02555878|69101601|FG001|Overall Study|Other|17|||
37634493|NCT02555722|69101609|FG000|Week 2|Adverse Event|0|||
37634494|NCT02555722|69101610|FG001|Week 2|Adverse Event|1|||
37634495|NCT02555722|69101609|FG000|Week 2|Withdrawal by Subject|1|||
37634496|NCT02555722|69101610|FG001|Week 2|Withdrawal by Subject|0|||
37634497|NCT02555722|69101609|FG000|Month 1|Lens Discomfort|1|||
37634498|NCT02555722|69101610|FG001|Month 1|Lens Discomfort|0|||
37634499|NCT02555722|69101609|FG000|Month 2|Withdrawal by Subject|3|||
37634500|NCT02555722|69101610|FG001|Month 2|Withdrawal by Subject|0|||
37634501|NCT02555722|69101609|FG000|Month 2|Lost to Follow-up|1|||
37634502|NCT02555722|69101610|FG001|Month 2|Lost to Follow-up|0|||
37634503|NCT03287960|69101662|FG000|Open-Label Period (10 Weeks)|Adverse Event|1|||
37634504|NCT03287960|69101662|FG000|Open-Label Period (32 Weeks)|Serious Adverse Event|1|||
37634505|NCT02558296|69101669|FG000|Completed the Study Through Week 24|Adverse Event|9|||
37634506|NCT02558296|69101670|FG001|Completed the Study Through Week 24|Adverse Event|3|||
37634507|NCT02558296|69101669|FG000|Completed the Study Through Week 24|Death|7|||
37634508|NCT02558296|69101670|FG001|Completed the Study Through Week 24|Death|7|||
37634509|NCT02558296|69101669|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
37634510|NCT02558296|69101670|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
37634511|NCT02558296|69101669|FG000|Completed the Study Through Week 24|Physician Decision|1|||
37634512|NCT02558296|69101670|FG001|Completed the Study Through Week 24|Physician Decision|0|||
37634513|NCT02558296|69101669|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
37634514|NCT02558296|69101670|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
37634515|NCT02558296|69101669|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
37634516|NCT02558296|69101670|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
37634517|NCT02558296|69101669|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
37634518|NCT02558296|69101670|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
37634519|NCT02558296|69101669|FG000|Completed the Study|Adverse Event|14|||
37634520|NCT02558296|69101670|FG001|Completed the Study|Adverse Event|5|||
37634521|NCT02558296|69101669|FG000|Completed the Study|Death|39|||
37634522|NCT02558296|69101670|FG001|Completed the Study|Death|25|||
37634523|NCT02558296|69101669|FG000|Completed the Study|Lost to Follow-up|31|||
37634524|NCT02558296|69101670|FG001|Completed the Study|Lost to Follow-up|23|||
37634525|NCT02558296|69101669|FG000|Completed the Study|Physician Decision|6|||
37634526|NCT02558296|69101670|FG001|Completed the Study|Physician Decision|0|||
37634527|NCT02558296|69101669|FG000|Completed the Study|Protocol Violation|2|||
37634528|NCT02558296|69101670|FG001|Completed the Study|Protocol Violation|1|||
37634529|NCT02558296|69101669|FG000|Completed the Study|Withdrawal by Subject|53|||
37634530|NCT02558296|69101670|FG001|Completed the Study|Withdrawal by Subject|31|||
37634531|NCT02558296|69101669|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
37634532|NCT02558296|69101670|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
37634533|NCT02737475|69101707|FG000|Overall Study|Other reasons|0|||
37634534|NCT02737475|69101708|FG001|Overall Study|Other reasons|0|||
37634535|NCT02737475|69101709|FG002|Overall Study|Other reasons|0|||
37634536|NCT02737475|69101710|FG003|Overall Study|Other reasons|0|||
37634537|NCT02737475|69101711|FG004|Overall Study|Other reasons|1|||
37634538|NCT02737475|69101712|FG005|Overall Study|Other reasons|1|||
37634539|NCT02737475|69101713|FG006|Overall Study|Other reasons|0|||
37634540|NCT02737475|69101714|FG007|Overall Study|Other reasons|0|||
37634541|NCT02737475|69101715|FG008|Overall Study|Other reasons|1|||
37634542|NCT02737475|69101716|FG009|Overall Study|Other reasons|0|||
37634543|NCT02737475|69101717|FG010|Overall Study|Other reasons|1|||
37634544|NCT02737475|69101718|FG011|Overall Study|Other reasons|0|||
37634545|NCT02737475|69101719|FG012|Overall Study|Other reasons|0|||
37634546|NCT02737475|69101720|FG013|Overall Study|Other reasons|0|||
37634547|NCT02737475|69101721|FG014|Overall Study|Other reasons|0|||
37634548|NCT02737475|69101722|FG015|Overall Study|Other reasons|0|||
37634549|NCT02737475|69101723|FG016|Overall Study|Other reasons|0|||
37634550|NCT02737475|69101724|FG017|Overall Study|Other reasons|0|||
37634551|NCT02737475|69101725|FG018|Overall Study|Other reasons|0|||
37634552|NCT02737475|69101726|FG019|Overall Study|Other reasons|0|||
37634553|NCT02737475|69101727|FG020|Overall Study|Other reasons|0|||
37634554|NCT02737475|69101728|FG021|Overall Study|Other reasons|1|||
37634555|NCT02737475|69101729|FG022|Overall Study|Other reasons|0|||
37634556|NCT02737475|69101730|FG023|Overall Study|Other reasons|1|||
37634557|NCT02737475|69101731|FG024|Overall Study|Other reasons|1|||
37634558|NCT02737475|69101732|FG025|Overall Study|Other reasons|1|||
37634559|NCT02737475|69101733|FG026|Overall Study|Other reasons|0|||
37921747|NCT00570778|69608540|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
37921748|NCT00570778|69608541|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
37921749|NCT00570778|69608542|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
37921750|NCT00570778|69608543|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
37634560|NCT02737475|69101707|FG000|Overall Study|Death|1|||
37634561|NCT02737475|69101708|FG001|Overall Study|Death|0|||
37634562|NCT02737475|69101709|FG002|Overall Study|Death|0|||
37634563|NCT02737475|69101710|FG003|Overall Study|Death|1|||
37634564|NCT02737475|69101711|FG004|Overall Study|Death|0|||
37634565|NCT02737475|69101712|FG005|Overall Study|Death|0|||
37634566|NCT02737475|69101713|FG006|Overall Study|Death|0|||
37634567|NCT02737475|69101714|FG007|Overall Study|Death|2|||
37634568|NCT02737475|69101715|FG008|Overall Study|Death|0|||
37634569|NCT02737475|69101716|FG009|Overall Study|Death|0|||
37634570|NCT02737475|69101717|FG010|Overall Study|Death|0|||
37634571|NCT02737475|69101718|FG011|Overall Study|Death|4|||
37634572|NCT02737475|69101719|FG012|Overall Study|Death|2|||
37634573|NCT02737475|69101720|FG013|Overall Study|Death|2|||
37634574|NCT02737475|69101721|FG014|Overall Study|Death|0|||
37634575|NCT02737475|69101722|FG015|Overall Study|Death|2|||
37634576|NCT02737475|69101723|FG016|Overall Study|Death|2|||
37634577|NCT02737475|69101724|FG017|Overall Study|Death|2|||
37634578|NCT02737475|69101725|FG018|Overall Study|Death|1|||
37634579|NCT02737475|69101726|FG019|Overall Study|Death|0|||
37634580|NCT02737475|69101727|FG020|Overall Study|Death|0|||
37634581|NCT02737475|69101728|FG021|Overall Study|Death|0|||
37853630|NCT01262976|69537432|FG001|Up to Year 3|Subjects with unknown completion status|0|||
37853631|NCT01262976|69537433|FG002|Up to Year 3|Subjects with unknown completion status|1|||
37853632|NCT01262976|69537434|FG003|Up to Year 3|Subjects with unknown completion status|0|||
37853633|NCT01262976|69537435|FG004|Up to Year 3|Subjects with unknown completion status|0|||
37853634|NCT01262976|69537436|FG005|Up to Year 3|Subjects with unknown completion status|0|||
37853635|NCT01262976|69537431|FG000|Up to Year 3|Other|3|||
37853636|NCT01262976|69537432|FG001|Up to Year 3|Other|0|||
37853637|NCT01262976|69537433|FG002|Up to Year 3|Other|0|||
37853638|NCT01262976|69537434|FG003|Up to Year 3|Other|0|||
37853639|NCT01262976|69537435|FG004|Up to Year 3|Other|0|||
37853640|NCT01262976|69537436|FG005|Up to Year 3|Other|0|||
37853641|NCT01300286|69537451|FG000|Overall Study|did not get dosed|1|||
37853642|NCT01300052|69537458|FG000|Overall Study|Adverse Event|3|||
37853643|NCT01300052|69537459|FG001|Overall Study|Adverse Event|0|||
37853644|NCT01300052|69537458|FG000|Overall Study|Withdrawal by Subject|2|||
37853645|NCT01300052|69537459|FG001|Overall Study|Withdrawal by Subject|2|||
37853646|NCT01300052|69537458|FG000|Overall Study|Protocol Violation|1|||
37853647|NCT01300052|69537459|FG001|Overall Study|Protocol Violation|1|||
37853648|NCT01299896|69537467|FG000|Overall Study|Withdrawal by Subject|1|||
37853649|NCT01299896|69537468|FG001|Overall Study|Withdrawal by Subject|7|||
37853650|NCT01299896|69537467|FG000|Overall Study|Lost to Follow-up|0|||
37853651|NCT01299896|69537468|FG001|Overall Study|Lost to Follow-up|11|||
37853652|NCT01299584|69537474|FG000|Overall Study|Protocol Violation|9|||
37921751|NCT00570778|69608540|FG000|Overall Study|Lost to Follow-up|0|||
37921752|NCT00570778|69608541|FG001|Overall Study|Lost to Follow-up|0|||
37921753|NCT00570778|69608542|FG002|Overall Study|Lost to Follow-up|1|||
37921754|NCT00570778|69608543|FG003|Overall Study|Lost to Follow-up|0|||
37921755|NCT00570778|69608540|FG000|Overall Study|Subject no longer requires study drug|0|||
37921756|NCT00570778|69608541|FG001|Overall Study|Subject no longer requires study drug|1|||
37921757|NCT00570778|69608542|FG002|Overall Study|Subject no longer requires study drug|0|||
37921758|NCT00570778|69608543|FG003|Overall Study|Subject no longer requires study drug|0|||
37921759|NCT00668746|69608555|FG000|Overall Study|Lost to Follow-up|2|||
37921760|NCT00668746|69608556|FG001|Overall Study|Lost to Follow-up|1|||
37921761|NCT00878189|69608574|FG000|Overall Study|Death|0|||
37921762|NCT00878189|69608575|FG001|Overall Study|Death|1|||
37921763|NCT00878189|69608576|FG002|Overall Study|Death|0|||
37921764|NCT00878189|69608577|FG003|Overall Study|Death|1|||
37921765|NCT00878189|69608578|FG004|Overall Study|Death|0|||
37921766|NCT00878189|69608579|FG005|Overall Study|Death|0|||
37921767|NCT00878189|69608580|FG006|Overall Study|Death|0|||
37921768|NCT00878189|69608581|FG007|Overall Study|Death|0|||
37921769|NCT00878189|69608582|FG008|Overall Study|Death|1|||
37921770|NCT00878189|69608574|FG000|Overall Study|Participant Refused to Follow-up|0|||
37921771|NCT00878189|69608575|FG001|Overall Study|Participant Refused to Follow-up|0|||
37921772|NCT00878189|69608576|FG002|Overall Study|Participant Refused to Follow-up|0|||
37921773|NCT00878189|69608577|FG003|Overall Study|Participant Refused to Follow-up|0|||
37921774|NCT00878189|69608578|FG004|Overall Study|Participant Refused to Follow-up|0|||
37921775|NCT00878189|69608579|FG005|Overall Study|Participant Refused to Follow-up|4|||
37921776|NCT00878189|69608580|FG006|Overall Study|Participant Refused to Follow-up|0|||
37921777|NCT00878189|69608581|FG007|Overall Study|Participant Refused to Follow-up|0|||
37921778|NCT00878189|69608582|FG008|Overall Study|Participant Refused to Follow-up|0|||
37921779|NCT00878189|69608574|FG000|Overall Study|Other|3|||
37921780|NCT00878189|69608575|FG001|Overall Study|Other|2|||
37921781|NCT00878189|69608576|FG002|Overall Study|Other|4|||
37921782|NCT00878189|69608577|FG003|Overall Study|Other|7|||
37921783|NCT00878189|69608578|FG004|Overall Study|Other|4|||
37921784|NCT00878189|69608579|FG005|Overall Study|Other|18|||
37921785|NCT00878189|69608580|FG006|Overall Study|Other|15|||
37921786|NCT00878189|69608581|FG007|Overall Study|Other|3|||
37921787|NCT00878189|69608582|FG008|Overall Study|Other|4|||
37921788|NCT00878189|69608574|FG000|Overall Study|Lost to Follow-up|0|||
37921789|NCT00878189|69608575|FG001|Overall Study|Lost to Follow-up|0|||
37921790|NCT00878189|69608576|FG002|Overall Study|Lost to Follow-up|0|||
37921791|NCT00878189|69608577|FG003|Overall Study|Lost to Follow-up|0|||
37921792|NCT00878189|69608578|FG004|Overall Study|Lost to Follow-up|0|||
37921793|NCT00878189|69608579|FG005|Overall Study|Lost to Follow-up|1|||
37921794|NCT00878189|69608580|FG006|Overall Study|Lost to Follow-up|1|||
37921795|NCT00878189|69608581|FG007|Overall Study|Lost to Follow-up|0|||
37921796|NCT00878189|69608582|FG008|Overall Study|Lost to Follow-up|0|||
37921797|NCT00878189|69608574|FG000|Overall Study|Objection Progression or Relapse|0|||
37921798|NCT00878189|69608575|FG001|Overall Study|Objection Progression or Relapse|0|||
37921799|NCT00878189|69608576|FG002|Overall Study|Objection Progression or Relapse|0|||
37921800|NCT00878189|69608577|FG003|Overall Study|Objection Progression or Relapse|0|||
37921801|NCT00878189|69608578|FG004|Overall Study|Objection Progression or Relapse|0|||
37921802|NCT00878189|69608579|FG005|Overall Study|Objection Progression or Relapse|0|||
37921803|NCT00878189|69608580|FG006|Overall Study|Objection Progression or Relapse|0|||
37921804|NCT00878189|69608581|FG007|Overall Study|Objection Progression or Relapse|0|||
37921805|NCT00878189|69608582|FG008|Overall Study|Objection Progression or Relapse|3|||
38031951|NCT03349034|69717834|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
38031952|NCT03349034|69717833|FG000|Overall Study|soft tissue flap used|1|||
38031953|NCT03349034|69717834|FG001|Overall Study|soft tissue flap used|0|||
38031954|NCT03349034|69717833|FG000|Overall Study|Other|0|||
38031955|NCT03349034|69717834|FG001|Overall Study|Other|1|||
38031956|NCT00358215|69717844|FG000|Overall Study|Ineligibility determined|4|||
38031957|NCT00358215|69717845|FG001|Overall Study|Ineligibility determined|3|||
38031958|NCT00358215|69717844|FG000|Overall Study|Adverse Event|83|||
38031959|NCT00358215|69717845|FG001|Overall Study|Adverse Event|65|||
38031960|NCT00358215|69717844|FG000|Overall Study|Withdrawal by Subject|111|||
38031961|NCT00358215|69717845|FG001|Overall Study|Withdrawal by Subject|102|||
38031962|NCT00358215|69717844|FG000|Overall Study|Participant request|65|||
38031963|NCT00358215|69717845|FG001|Overall Study|Participant request|64|||
38031964|NCT00358215|69717844|FG000|Overall Study|Physician Decision|47|||
38031965|NCT00358215|69717845|FG001|Overall Study|Physician Decision|39|||
38031966|NCT00358215|69717844|FG000|Overall Study|Lost to Follow-up|16|||
38031967|NCT00358215|69717845|FG001|Overall Study|Lost to Follow-up|22|||
38031968|NCT00358215|69717844|FG000|Overall Study|Death|265|||
38031969|NCT00358215|69717845|FG001|Overall Study|Death|281|||
38031970|NCT00358215|69717844|FG000|Overall Study|Protocol Violation|64|||
38031971|NCT00358215|69717845|FG001|Overall Study|Protocol Violation|59|||
38031972|NCT00358215|69717844|FG000|Overall Study|Pregnancy|1|||
38031973|NCT00358215|69717845|FG001|Overall Study|Pregnancy|0|||
38031974|NCT00358215|69717844|FG000|Overall Study|Other|21|||
38031975|NCT00358215|69717845|FG001|Overall Study|Other|14|||
38031976|NCT00358215|69717844|FG000|Overall Study|Did not receive investigational product|2|||
38031977|NCT00358215|69717845|FG001|Overall Study|Did not receive investigational product|3|||
38031978|NCT02855164|69717859|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
38031979|NCT02855164|69717860|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
38031980|NCT02855164|69717861|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
38031981|NCT02855164|69717862|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
38031982|NCT02855164|69717863|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
38031983|NCT02855164|69717864|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
38031984|NCT02855164|69717865|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
38031985|NCT02855164|69717866|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
38031986|NCT02855164|69717859|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
38031987|NCT02855164|69717860|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
38031988|NCT02855164|69717861|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
38031989|NCT02855164|69717862|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
38031990|NCT02855164|69717863|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
38031991|NCT02855164|69717864|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
38031992|NCT02855164|69717865|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
38031993|NCT02855164|69717866|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
38031994|NCT02855164|69717859|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
38031995|NCT02855164|69717860|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
38031996|NCT02855164|69717861|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
38031997|NCT02855164|69717862|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
38031998|NCT02855164|69717863|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
38031999|NCT02855164|69717864|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
38032000|NCT02855164|69717865|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
38032001|NCT02855164|69717866|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
38032002|NCT02855164|69717859|FG000|Part C (Randomized Set)|Adverse Event|0|||
37634582|NCT02737475|69101729|FG022|Overall Study|Death|0|||
37634583|NCT02737475|69101730|FG023|Overall Study|Death|0|||
37634584|NCT02737475|69101731|FG024|Overall Study|Death|0|||
37634585|NCT02737475|69101732|FG025|Overall Study|Death|0|||
37634586|NCT02737475|69101733|FG026|Overall Study|Death|0|||
37634587|NCT02737475|69101707|FG000|Overall Study|Participant withdrew consent|0|||
37921806|NCT00668200|69608616|FG000|Overall Study|Withdrawal by Subject|2|||
37921807|NCT00668200|69608616|FG000|Overall Study|Lost to Follow-up|1|||
37921808|NCT00838578|69608620|FG000|Overall Study|Protocol Violation|2|||
37921809|NCT00829296|69608630|FG000|Overall Study|Adverse Event|5|||
37921810|NCT00829296|69608631|FG001|Overall Study|Adverse Event|4|||
37921811|NCT00881621|69608637|FG000|Overall Study|Physician Decision|34|||
37921812|NCT00818766|69608643|FG000|Overall Study|Could not be Contacted on Day 28|11|||
37921813|NCT00818766|69608644|FG001|Overall Study|Could not be Contacted on Day 28|10|||
37921814|NCT00818766|69608643|FG000|Overall Study|Death|1|||
37921815|NCT00818766|69608644|FG001|Overall Study|Death|0|||
37921816|NCT00818766|69608643|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
37921817|NCT00818766|69608644|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
38032003|NCT02855164|69717860|FG001|Part C (Randomized Set)|Adverse Event|0|||
38032004|NCT02855164|69717861|FG002|Part C (Randomized Set)|Adverse Event|0|||
37921818|NCT00667888|69608652|FG000|Overall Study|Death|1|||
37921819|NCT00667888|69608653|FG001|Overall Study|Death|1|||
38032005|NCT02855164|69717862|FG003|Part C (Randomized Set)|Adverse Event|0|||
37634588|NCT02737475|69101708|FG001|Overall Study|Participant withdrew consent|0|||
37634589|NCT02737475|69101709|FG002|Overall Study|Participant withdrew consent|0|||
37634590|NCT02737475|69101710|FG003|Overall Study|Participant withdrew consent|0|||
37634591|NCT02737475|69101711|FG004|Overall Study|Participant withdrew consent|0|||
37634592|NCT02737475|69101712|FG005|Overall Study|Participant withdrew consent|2|||
37634593|NCT02737475|69101713|FG006|Overall Study|Participant withdrew consent|0|||
37634594|NCT02737475|69101714|FG007|Overall Study|Participant withdrew consent|0|||
37634595|NCT02737475|69101715|FG008|Overall Study|Participant withdrew consent|0|||
37634596|NCT02737475|69101716|FG009|Overall Study|Participant withdrew consent|0|||
37634597|NCT02737475|69101717|FG010|Overall Study|Participant withdrew consent|0|||
37634598|NCT02737475|69101718|FG011|Overall Study|Participant withdrew consent|0|||
37634599|NCT02737475|69101719|FG012|Overall Study|Participant withdrew consent|0|||
37634600|NCT02737475|69101720|FG013|Overall Study|Participant withdrew consent|0|||
37634601|NCT02737475|69101721|FG014|Overall Study|Participant withdrew consent|1|||
37634602|NCT02737475|69101722|FG015|Overall Study|Participant withdrew consent|0|||
37634603|NCT02737475|69101723|FG016|Overall Study|Participant withdrew consent|0|||
37634604|NCT02737475|69101724|FG017|Overall Study|Participant withdrew consent|2|||
37739360|NCT01461993|69222698|FG002|Overall Study|Protocol Violation|7|||
37739361|NCT01461993|69222696|FG000|Overall Study|Adverse Event|9|||
37739362|NCT01461993|69222697|FG001|Overall Study|Adverse Event|11|||
37739363|NCT01461993|69222698|FG002|Overall Study|Adverse Event|3|||
37739364|NCT01461993|69222696|FG000|Overall Study|No longer met eligibility criteria|13|||
37739365|NCT01461993|69222697|FG001|Overall Study|No longer met eligibility criteria|18|||
37739366|NCT01461993|69222698|FG002|Overall Study|No longer met eligibility criteria|10|||
37739367|NCT01461993|69222696|FG000|Overall Study|Did not meet entrance criteria|2|||
37739368|NCT01461993|69222697|FG001|Overall Study|Did not meet entrance criteria|3|||
37739369|NCT01461993|69222698|FG002|Overall Study|Did not meet entrance criteria|0|||
37739370|NCT01461993|69222696|FG000|Overall Study|Other|13|||
37739371|NCT01461993|69222697|FG001|Overall Study|Other|15|||
37739372|NCT01461993|69222698|FG002|Overall Study|Other|6|||
37739373|NCT01782326|69222709|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
37739374|NCT01782326|69222710|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
37739375|NCT01782326|69222709|FG000|Planned Treatment Epoch|Death|29|||
37739376|NCT01782326|69222710|FG001|Planned Treatment Epoch|Death|30|||
37739377|NCT01782326|69222709|FG000|Planned Treatment Epoch|Physician Decision|18|||
37739378|NCT01782326|69222710|FG001|Planned Treatment Epoch|Physician Decision|16|||
37739379|NCT01782326|69222709|FG000|Planned Treatment Epoch|Protocol deviation|2|||
37739380|NCT01782326|69222710|FG001|Planned Treatment Epoch|Protocol deviation|3|||
37739381|NCT01782326|69222709|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
37739382|NCT01782326|69222710|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
37739383|NCT01782326|69222709|FG000|Planned Treatment Epoch|Technical problems|0|||
37739384|NCT01782326|69222710|FG001|Planned Treatment Epoch|Technical problems|4|||
37739385|NCT01782326|69222709|FG000|Double-blind Treatment|Adverse Event|129|||
37739386|NCT01782326|69222710|FG001|Double-blind Treatment|Adverse Event|145|||
37739387|NCT01782326|69222709|FG000|Double-blind Treatment|Subject/guardian decision|111|||
37739388|NCT01782326|69222710|FG001|Double-blind Treatment|Subject/guardian decision|125|||
37739389|NCT01782326|69222709|FG000|Double-blind Treatment|Lack of Efficacy|17|||
37739390|NCT01782326|69222710|FG001|Double-blind Treatment|Lack of Efficacy|22|||
37739391|NCT01782326|69222709|FG000|Double-blind Treatment|Physician Decision|13|||
37739392|NCT01782326|69222710|FG001|Double-blind Treatment|Physician Decision|16|||
37739393|NCT01782326|69222709|FG000|Double-blind Treatment|Protocol deviation|8|||
37739394|NCT01782326|69222710|FG001|Double-blind Treatment|Protocol deviation|7|||
37739395|NCT01782326|69222709|FG000|Double-blind Treatment|Technical problems|0|||
37739396|NCT01782326|69222710|FG001|Double-blind Treatment|Technical problems|5|||
37739397|NCT01439373|69222718|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
37739398|NCT01439373|69222719|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
37739399|NCT01439373|69222718|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
37739400|NCT01439373|69222719|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
37739401|NCT01461369|69222732|FG000|Overall Study|Lack of Efficacy|2|||
37739402|NCT01461369|69222733|FG001|Overall Study|Lack of Efficacy|0|||
37739403|NCT01461369|69222734|FG002|Overall Study|Lack of Efficacy|6|||
37739404|NCT01461369|69222732|FG000|Overall Study|Lost to Follow-up|0|||
37739405|NCT01461369|69222733|FG001|Overall Study|Lost to Follow-up|0|||
37739406|NCT01461369|69222734|FG002|Overall Study|Lost to Follow-up|3|||
37634605|NCT02737475|69101725|FG018|Overall Study|Participant withdrew consent|1|||
37634606|NCT02737475|69101726|FG019|Overall Study|Participant withdrew consent|0|||
37739407|NCT01461369|69222732|FG000|Overall Study|Adverse Event|9|||
37739408|NCT01461369|69222733|FG001|Overall Study|Adverse Event|12|||
37739409|NCT01461369|69222734|FG002|Overall Study|Adverse Event|4|||
37739410|NCT01461369|69222732|FG000|Overall Study|Protocol Violation|1|||
37634607|NCT02737475|69101727|FG020|Overall Study|Participant withdrew consent|2|||
37739411|NCT01461369|69222733|FG001|Overall Study|Protocol Violation|2|||
37739412|NCT01461369|69222734|FG002|Overall Study|Protocol Violation|2|||
37739413|NCT01461369|69222732|FG000|Overall Study|Withdrawal by Subject|1|||
37634608|NCT02737475|69101728|FG021|Overall Study|Participant withdrew consent|0|||
37634609|NCT02737475|69101729|FG022|Overall Study|Participant withdrew consent|0|||
37634610|NCT02737475|69101730|FG023|Overall Study|Participant withdrew consent|0|||
37634611|NCT02737475|69101731|FG024|Overall Study|Participant withdrew consent|0|||
37634612|NCT02737475|69101732|FG025|Overall Study|Participant withdrew consent|0|||
37634613|NCT02737475|69101733|FG026|Overall Study|Participant withdrew consent|0|||
37634614|NCT02737475|69101707|FG000|Overall Study|Lost to Follow-up|0|||
37634615|NCT02737475|69101708|FG001|Overall Study|Lost to Follow-up|0|||
37634616|NCT02737475|69101709|FG002|Overall Study|Lost to Follow-up|0|||
37634617|NCT02737475|69101710|FG003|Overall Study|Lost to Follow-up|0|||
37634618|NCT02737475|69101711|FG004|Overall Study|Lost to Follow-up|0|||
37634619|NCT02737475|69101712|FG005|Overall Study|Lost to Follow-up|0|||
37634620|NCT02737475|69101713|FG006|Overall Study|Lost to Follow-up|0|||
37634621|NCT02737475|69101714|FG007|Overall Study|Lost to Follow-up|0|||
37634622|NCT02737475|69101715|FG008|Overall Study|Lost to Follow-up|0|||
37634623|NCT02737475|69101716|FG009|Overall Study|Lost to Follow-up|0|||
37634624|NCT02737475|69101717|FG010|Overall Study|Lost to Follow-up|0|||
37634625|NCT02737475|69101718|FG011|Overall Study|Lost to Follow-up|0|||
37634626|NCT02737475|69101719|FG012|Overall Study|Lost to Follow-up|0|||
37634627|NCT02737475|69101720|FG013|Overall Study|Lost to Follow-up|0|||
37634628|NCT02737475|69101721|FG014|Overall Study|Lost to Follow-up|0|||
37634629|NCT02737475|69101722|FG015|Overall Study|Lost to Follow-up|1|||
37634630|NCT02737475|69101723|FG016|Overall Study|Lost to Follow-up|0|||
37634631|NCT02737475|69101724|FG017|Overall Study|Lost to Follow-up|0|||
37634632|NCT02737475|69101725|FG018|Overall Study|Lost to Follow-up|0|||
37634633|NCT02737475|69101726|FG019|Overall Study|Lost to Follow-up|0|||
37634634|NCT02737475|69101727|FG020|Overall Study|Lost to Follow-up|0|||
37634635|NCT02737475|69101728|FG021|Overall Study|Lost to Follow-up|0|||
37634636|NCT02737475|69101729|FG022|Overall Study|Lost to Follow-up|0|||
37634637|NCT02737475|69101730|FG023|Overall Study|Lost to Follow-up|0|||
37634638|NCT02737475|69101731|FG024|Overall Study|Lost to Follow-up|0|||
37634639|NCT02737475|69101732|FG025|Overall Study|Lost to Follow-up|0|||
37634640|NCT02737475|69101733|FG026|Overall Study|Lost to Follow-up|0|||
37634641|NCT02737475|69101707|FG000|Overall Study|Disease Progression|0|||
37634642|NCT02737475|69101708|FG001|Overall Study|Disease Progression|0|||
37634643|NCT02737475|69101709|FG002|Overall Study|Disease Progression|0|||
37634644|NCT02737475|69101710|FG003|Overall Study|Disease Progression|0|||
37634645|NCT02737475|69101711|FG004|Overall Study|Disease Progression|0|||
37634646|NCT02737475|69101712|FG005|Overall Study|Disease Progression|0|||
37739414|NCT01461369|69222733|FG001|Overall Study|Withdrawal by Subject|3|||
37739415|NCT01461369|69222734|FG002|Overall Study|Withdrawal by Subject|2|||
37739416|NCT01727258|69222745|FG000|Overall Study|Adverse Event|0|||
37739417|NCT01727258|69222746|FG001|Overall Study|Adverse Event|2|||
37739418|NCT01727258|69222747|FG002|Overall Study|Adverse Event|0|||
37739419|NCT01727258|69222745|FG000|Overall Study|Noncompliance with Study Drug|0|||
37739420|NCT01727258|69222746|FG001|Overall Study|Noncompliance with Study Drug|0|||
37739421|NCT01727258|69222747|FG002|Overall Study|Noncompliance with Study Drug|1|||
37739422|NCT01727258|69222745|FG000|Overall Study|Withdrawal by Subject|1|||
37739423|NCT01727258|69222746|FG001|Overall Study|Withdrawal by Subject|1|||
37739424|NCT01727258|69222747|FG002|Overall Study|Withdrawal by Subject|0|||
37739425|NCT01727258|69222745|FG000|Overall Study|Lost to Follow-up|1|||
37739426|NCT01727258|69222746|FG001|Overall Study|Lost to Follow-up|0|||
37739427|NCT01727258|69222747|FG002|Overall Study|Lost to Follow-up|0|||
37739428|NCT01781390|69222758|FG000|Overall Study|Withdrawal of Consent|0|||
37739429|NCT01781390|69222759|FG001|Overall Study|Withdrawal of Consent|3|||
37739430|NCT01781390|69222760|FG002|Overall Study|Withdrawal of Consent|1|||
37739431|NCT01781390|69222758|FG000|Overall Study|Lost to Follow-up|1|||
37739432|NCT01781390|69222759|FG001|Overall Study|Lost to Follow-up|1|||
37739433|NCT01781390|69222760|FG002|Overall Study|Lost to Follow-up|1|||
37739434|NCT01781390|69222758|FG000|Overall Study|Adverse Event|1|||
37739435|NCT01781390|69222759|FG001|Overall Study|Adverse Event|2|||
37634647|NCT02737475|69101713|FG006|Overall Study|Disease Progression|0|||
37634648|NCT02737475|69101714|FG007|Overall Study|Disease Progression|0|||
37634649|NCT02737475|69101715|FG008|Overall Study|Disease Progression|0|||
37634650|NCT02737475|69101716|FG009|Overall Study|Disease Progression|0|||
37634651|NCT02737475|69101717|FG010|Overall Study|Disease Progression|0|||
37634652|NCT02737475|69101718|FG011|Overall Study|Disease Progression|0|||
37634653|NCT02737475|69101719|FG012|Overall Study|Disease Progression|0|||
37739436|NCT01781390|69222760|FG002|Overall Study|Adverse Event|1|||
37739437|NCT01781390|69222758|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
37739438|NCT01781390|69222759|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
37739439|NCT01781390|69222760|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
37634654|NCT02737475|69101720|FG013|Overall Study|Disease Progression|0|||
37634655|NCT02737475|69101721|FG014|Overall Study|Disease Progression|0|||
37634656|NCT02737475|69101722|FG015|Overall Study|Disease Progression|0|||
37634657|NCT02737475|69101723|FG016|Overall Study|Disease Progression|0|||
37634658|NCT02737475|69101724|FG017|Overall Study|Disease Progression|0|||
37634659|NCT02737475|69101725|FG018|Overall Study|Disease Progression|0|||
37634660|NCT02737475|69101726|FG019|Overall Study|Disease Progression|0|||
37634661|NCT02737475|69101727|FG020|Overall Study|Disease Progression|0|||
37634662|NCT02737475|69101728|FG021|Overall Study|Disease Progression|0|||
37634663|NCT02737475|69101729|FG022|Overall Study|Disease Progression|0|||
37634664|NCT02737475|69101730|FG023|Overall Study|Disease Progression|0|||
37634665|NCT02737475|69101731|FG024|Overall Study|Disease Progression|0|||
37634666|NCT02737475|69101732|FG025|Overall Study|Disease Progression|0|||
37634667|NCT02737475|69101733|FG026|Overall Study|Disease Progression|1|||
37634668|NCT02557672|69101823|FG000|Overall Study|Withdrawal by Subject|4|||
37634669|NCT02557672|69101824|FG001|Overall Study|Withdrawal by Subject|2|||
37677442|NCT01672879|69152403|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
37677443|NCT01672879|69152404|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
37677444|NCT01672879|69152405|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
37677445|NCT01672879|69152403|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
37677446|NCT01672879|69152404|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
37677447|NCT01672879|69152405|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
37677448|NCT01672879|69152403|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
37677449|NCT01672879|69152404|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
37677450|NCT01672879|69152405|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
37677451|NCT02601209|69152421|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
37677452|NCT02601209|69152422|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
37677453|NCT02601209|69152423|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
37677454|NCT02601209|69152424|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
37677455|NCT02601209|69152425|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
37677456|NCT02601209|69152426|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
37677457|NCT02601209|69152427|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
37677458|NCT02601209|69152428|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
37677459|NCT02601209|69152429|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
37677460|NCT02601209|69152421|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
37677461|NCT02601209|69152422|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
37677462|NCT02601209|69152423|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
37677463|NCT02601209|69152424|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
37677464|NCT02601209|69152425|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
37677465|NCT02601209|69152426|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
37677466|NCT02601209|69152427|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
37677467|NCT02601209|69152428|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
37677468|NCT02601209|69152429|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
37677469|NCT01659021|69152445|FG000|Main Study|Adverse Event|2|||
37677470|NCT01659021|69152446|FG001|Main Study|Adverse Event|3|||
37677471|NCT01659021|69152445|FG000|Main Study|Lost to Follow-up|1|||
37677472|NCT01659021|69152446|FG001|Main Study|Lost to Follow-up|0|||
37677473|NCT01659021|69152445|FG000|Main Study|Unknown Reasons|2|||
37677474|NCT01659021|69152446|FG001|Main Study|Unknown Reasons|1|||
37677475|NCT01659021|69152445|FG000|Main Study|Physician Decision|34|||
37677476|NCT01659021|69152446|FG001|Main Study|Physician Decision|16|||
37677477|NCT01659021|69152445|FG000|Main Study|Withdrawal by Subject|19|||
37677478|NCT01659021|69152446|FG001|Main Study|Withdrawal by Subject|16|||
37677479|NCT01659021|69152445|FG000|Main Study|Study Terminated by Sponsor|16|||
37677480|NCT01659021|69152446|FG001|Main Study|Study Terminated by Sponsor|1|||
37677481|NCT01659021|69152445|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
37677482|NCT01659021|69152446|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
37677483|NCT01659021|69152445|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
37677484|NCT01659021|69152446|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
37677485|NCT02524665|69152456|FG000|Overall Study|Lost to Follow-up|1|||
37677486|NCT02638129|69152463|FG000|Overall Study|Study terminated|28|||
37677487|NCT02638129|69152464|FG001|Overall Study|Study terminated|30|||
37677488|NCT01658943|69152472|FG000|Overall Study|Adverse Event|6|||
37677489|NCT01658943|69152473|FG001|Overall Study|Adverse Event|13|||
37677490|NCT01658943|69152472|FG000|Overall Study|Withdrawal by Subject|9|||
37677491|NCT01658943|69152473|FG001|Overall Study|Withdrawal by Subject|2|||
37677492|NCT01658943|69152472|FG000|Overall Study|Progression/Relapse|39|||
37677493|NCT01658943|69152473|FG001|Overall Study|Progression/Relapse|40|||
37677494|NCT01658943|69152472|FG000|Overall Study|Death|4|||
37677495|NCT01658943|69152473|FG001|Overall Study|Death|2|||
37677496|NCT01658943|69152472|FG000|Overall Study|not protocol specified|4|||
37677497|NCT01658943|69152473|FG001|Overall Study|not protocol specified|1|||
37677498|NCT01658943|69152472|FG000|Overall Study|Not eligible|7|||
37677499|NCT01658943|69152473|FG001|Overall Study|Not eligible|9|||
37677500|NCT01658943|69152472|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
37677501|NCT01658943|69152473|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
37634670|NCT02714426|69101836|FG000|Overall Study|Withdrawal by Subject|2|||
37634671|NCT02714426|69101837|FG001|Overall Study|Withdrawal by Subject|2|||
37634672|NCT02925923|69101850|FG000|Overall Study|blood samples hemolyzed|0|||
37634673|NCT02925923|69101851|FG001|Overall Study|blood samples hemolyzed|2|||
37634674|NCT02410343|69101859|FG000|Core Period (24 Weeks)|Adverse Event|1|||
37634675|NCT02410343|69101860|FG001|Core Period (24 Weeks)|Adverse Event|0|||
37634676|NCT02410343|69101859|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
37634677|NCT02410343|69101860|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
37634678|NCT02410343|69101859|FG000|Extension Period (12 Months)|Adverse Event|1|||
37634679|NCT02410343|69101860|FG001|Extension Period (12 Months)|Adverse Event|0|||
37634680|NCT02410343|69101859|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
37634681|NCT02410343|69101860|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
37634682|NCT03064841|69101867|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
37634683|NCT03064841|69101867|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
37634684|NCT03064841|69101867|FG000|Overall Study|Screen failure|2|||
37634685|NCT02045303|69101873|FG000|Overall Study|Protocol Violation|2|||
37634686|NCT02045303|69101874|FG001|Overall Study|Protocol Violation|1|||
37634687|NCT02045303|69101875|FG002|Overall Study|Protocol Violation|0|||
37634688|NCT02045303|69101873|FG000|Overall Study|Withdrawal by Subject|0|||
37634689|NCT02045303|69101874|FG001|Overall Study|Withdrawal by Subject|2|||
37634690|NCT02045303|69101875|FG002|Overall Study|Withdrawal by Subject|0|||
37634691|NCT03064451|69101888|FG000|Overall Study|Lost to Follow-up|1|||
37634692|NCT03064451|69101888|FG000|Overall Study|Mapping Failure|4|||
37634693|NCT03064451|69101888|FG000|Overall Study|Exited prior to procedure|8|||
37634694|NCT03064451|69101888|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
37634695|NCT03058679|69101894|FG000|Baseline to Week 6|Lost to Follow-up|3|||
37634696|NCT03058679|69101895|FG001|Baseline to Week 6|Lost to Follow-up|2|||
37634697|NCT03058679|69101894|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
37634698|NCT03058679|69101895|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
37634699|NCT03058679|69101894|FG000|Baseline to Week 6|Adverse Event|6|||
37634700|NCT03058679|69101895|FG001|Baseline to Week 6|Adverse Event|6|||
37634701|NCT03058679|69101894|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
37634702|NCT03058679|69101895|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
37634703|NCT03058679|69101894|FG000|Baseline to Week 6|Difficulty following the diet|0|||
37634704|NCT03058679|69101895|FG001|Baseline to Week 6|Difficulty following the diet|2|||
37634705|NCT03058679|69101894|FG000|Baseline to Week 6|Physician Decision|1|||
37634706|NCT03058679|69101895|FG001|Baseline to Week 6|Physician Decision|0|||
37634707|NCT03058679|69101894|FG000|Week 6 to Week 12|Change in medication|5|||
37634708|NCT03058679|69101895|FG001|Week 6 to Week 12|Change in medication|7|||
37634709|NCT03058679|69101894|FG000|Week 6 to Week 12|Adverse Event|4|||
37634710|NCT03058679|69101895|FG001|Week 6 to Week 12|Adverse Event|3|||
37634711|NCT03058679|69101894|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
37634712|NCT03058679|69101895|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
37634713|NCT03058679|69101894|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
37634714|NCT03058679|69101895|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
37634715|NCT03382821|69101903|FG000|Overall Study|Did not receive allocated intervention.|0|||
37634716|NCT03382821|69101904|FG001|Overall Study|Did not receive allocated intervention.|3|||
37634717|NCT02557516|69101915|FG000|Overall Study|Adverse Event|1|||
37634718|NCT02557516|69101916|FG001|Overall Study|Adverse Event|0|||
37634719|NCT02557516|69101917|FG002|Overall Study|Adverse Event|2|||
37634720|NCT02557516|69101918|FG003|Overall Study|Adverse Event|1|||
37634721|NCT02557516|69101915|FG000|Overall Study|Disease progression|0|||
37634722|NCT02557516|69101916|FG001|Overall Study|Disease progression|2|||
37634723|NCT02557516|69101917|FG002|Overall Study|Disease progression|0|||
37634724|NCT02557516|69101918|FG003|Overall Study|Disease progression|0|||
37634725|NCT02557516|69101915|FG000|Overall Study|Physician Decision|0|||
37634726|NCT02557516|69101916|FG001|Overall Study|Physician Decision|2|||
37634727|NCT02557516|69101917|FG002|Overall Study|Physician Decision|0|||
37634728|NCT02557516|69101918|FG003|Overall Study|Physician Decision|0|||
37634729|NCT02557516|69101915|FG000|Overall Study|Sponsor decision|0|||
37634730|NCT02557516|69101916|FG001|Overall Study|Sponsor decision|1|||
37634731|NCT02557516|69101917|FG002|Overall Study|Sponsor decision|2|||
37634732|NCT02557516|69101918|FG003|Overall Study|Sponsor decision|8|||
37634733|NCT00711555|69101937|FG000|Overall Study|Adverse Event|3|||
37634734|NCT02713490|69101942|FG000|Overall Study|Withdrawal by Subject|2|||
37634735|NCT02713490|69101943|FG001|Overall Study|Withdrawal by Subject|1|||
37634736|NCT02713490|69101942|FG000|Overall Study|Did not receive study drug|1|||
37634737|NCT02713490|69101943|FG001|Overall Study|Did not receive study drug|0|||
37634738|NCT02713490|69101942|FG000|Overall Study|Met exclusion criteria|0|||
37634739|NCT02713490|69101943|FG001|Overall Study|Met exclusion criteria|1|||
37634740|NCT03772574|69101952|FG000|Overall Study|Protocol Violation|2|||
37634741|NCT03772574|69101953|FG001|Overall Study|Protocol Violation|0|||
37634742|NCT03772574|69101954|FG002|Overall Study|Protocol Violation|0|||
37634743|NCT03772574|69101952|FG000|Overall Study|Discomfort|0|||
37634744|NCT03772574|69101953|FG001|Overall Study|Discomfort|5|||
37634745|NCT03772574|69101954|FG002|Overall Study|Discomfort|4|||
37634746|NCT02743221|69101964|FG000|Overall Study|Progressive disease|29|||
37634747|NCT02743221|69101965|FG001|Overall Study|Progressive disease|38|||
37634748|NCT02743221|69101964|FG000|Overall Study|Adverse Event|17|||
37634749|NCT02743221|69101965|FG001|Overall Study|Adverse Event|14|||
37634750|NCT02743221|69101964|FG000|Overall Study|non medical reason|8|||
37634751|NCT02743221|69101965|FG001|Overall Study|non medical reason|2|||
37634752|NCT02743221|69101964|FG000|Overall Study|Physician Decision|2|||
37634753|NCT02743221|69101965|FG001|Overall Study|Physician Decision|5|||
37634754|NCT02743221|69101964|FG000|Overall Study|Patient not eligible, not treated|0|||
37634755|NCT02743221|69101965|FG001|Overall Study|Patient not eligible, not treated|1|||
37634756|NCT03836625|69101973|FG000|Overall Study|Lost to Follow-up|9|||
37634757|NCT03836625|69101974|FG001|Overall Study|Lost to Follow-up|9|||
37634758|NCT03836625|69101973|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
37634759|NCT03836625|69101974|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
37634760|NCT03836625|69101973|FG000|Overall Study|Death|0|||
37634761|NCT03836625|69101974|FG001|Overall Study|Death|1|||
37634762|NCT03836625|69101973|FG000|Overall Study|Refused follow-up|0|||
37634763|NCT03836625|69101974|FG001|Overall Study|Refused follow-up|1|||
37634764|NCT01358968|69101980|FG000|Period 2|Adverse Event|0|||
37634765|NCT01358968|69101981|FG001|Period 2|Adverse Event|1|||
37634766|NCT01358968|69101982|FG002|Period 2|Adverse Event|0|||
37634767|NCT01358968|69101983|FG003|Period 2|Adverse Event|0|||
37634768|NCT01358968|69101980|FG000|Continued Access Phase|Progression of Disease|0|||
37634769|NCT01358968|69101981|FG001|Continued Access Phase|Progression of Disease|0|||
37634770|NCT01358968|69101982|FG002|Continued Access Phase|Progression of Disease|8|||
37634771|NCT01358968|69101983|FG003|Continued Access Phase|Progression of Disease|4|||
37634772|NCT01358968|69101980|FG000|Continued Access Phase|Protocol Violation|0|||
37634773|NCT01358968|69101981|FG001|Continued Access Phase|Protocol Violation|0|||
37634774|NCT01358968|69101982|FG002|Continued Access Phase|Protocol Violation|0|||
37634775|NCT01358968|69101983|FG003|Continued Access Phase|Protocol Violation|2|||
37634776|NCT01358968|69101980|FG000|Continued Access Phase|Withdrawal by Subject|0|||
37634777|NCT01358968|69101981|FG001|Continued Access Phase|Withdrawal by Subject|0|||
37634778|NCT01358968|69101982|FG002|Continued Access Phase|Withdrawal by Subject|3|||
37634779|NCT01358968|69101983|FG003|Continued Access Phase|Withdrawal by Subject|0|||
37634780|NCT01358968|69101980|FG000|Continued Access Phase|Death|0|||
37634781|NCT01358968|69101981|FG001|Continued Access Phase|Death|0|||
37634782|NCT01358968|69101982|FG002|Continued Access Phase|Death|1|||
37634783|NCT01358968|69101983|FG003|Continued Access Phase|Death|1|||
37634784|NCT00701090|69101995|FG000|Overall Study|Adverse Event|11|||
37634785|NCT00701090|69101996|FG001|Overall Study|Adverse Event|2|||
37634786|NCT00701090|69101995|FG000|Overall Study|Death|0|||
37634787|NCT00701090|69101996|FG001|Overall Study|Death|1|||
37634788|NCT00701090|69101995|FG000|Overall Study|Lack of Efficacy|5|||
37634789|NCT00701090|69101996|FG001|Overall Study|Lack of Efficacy|4|||
37634790|NCT00701090|69101995|FG000|Overall Study|Lost to Follow-up|9|||
37634791|NCT00701090|69101996|FG001|Overall Study|Lost to Follow-up|9|||
37634792|NCT00701090|69101995|FG000|Overall Study|Physician Decision|3|||
37634793|NCT00701090|69101996|FG001|Overall Study|Physician Decision|4|||
37634794|NCT00701090|69101995|FG000|Overall Study|Protocol Violation|2|||
37634795|NCT00701090|69101996|FG001|Overall Study|Protocol Violation|3|||
37634796|NCT00701090|69101995|FG000|Overall Study|Withdrawal by Subject|11|||
37634797|NCT00701090|69101996|FG001|Overall Study|Withdrawal by Subject|16|||
37634798|NCT00701090|69101995|FG000|Overall Study|Other|7|||
37634799|NCT00701090|69101996|FG001|Overall Study|Other|12|||
37634800|NCT03057977|69102004|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
37634801|NCT03057977|69102005|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
37634802|NCT03057977|69102004|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
37634803|NCT03057977|69102005|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
37634804|NCT03057977|69102004|FG000|Discontinuation From Treatment|Protocol Violation|6|||
37634805|NCT03057977|69102005|FG001|Discontinuation From Treatment|Protocol Violation|5|||
37634806|NCT03057977|69102004|FG000|Discontinuation From Treatment|Not treated|4|||
37634807|NCT03057977|69102005|FG001|Discontinuation From Treatment|Not treated|0|||
37739440|NCT01781234|69222770|FG000|Overall Study|Adverse Event|2|||
37634808|NCT03057977|69102004|FG000|Discontinuation From Treatment|Adverse Event|343|||
37634809|NCT03057977|69102005|FG001|Discontinuation From Treatment|Adverse Event|337|||
37739441|NCT01781234|69222771|FG001|Overall Study|Adverse Event|0|||
37634810|NCT03057977|69102004|FG000|Discontinuation From Treatment|Reason Unknown|0|||
37634811|NCT03057977|69102005|FG001|Discontinuation From Treatment|Reason Unknown|1|||
37634812|NCT03057977|69102004|FG000|Discontinuation From Treatment|Personal Reasons|1|||
37634813|NCT03057977|69102005|FG001|Discontinuation From Treatment|Personal Reasons|1|||
37739442|NCT01781234|69222770|FG000|Overall Study|Protocol Violation|3|||
37739443|NCT01781234|69222771|FG001|Overall Study|Protocol Violation|0|||
37634814|NCT03057977|69102004|FG000|Discontinuation From Treatment|Unblinded medication|1|||
37634815|NCT03057977|69102005|FG001|Discontinuation From Treatment|Unblinded medication|0|||
37634816|NCT03057977|69102004|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
37634817|NCT03057977|69102005|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
37634818|NCT03057977|69102004|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
37634819|NCT03057977|69102005|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
37634820|NCT03057977|69102004|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
37634821|NCT03057977|69102005|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
37634822|NCT03057977|69102004|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
37634823|NCT03057977|69102005|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
37634824|NCT03057977|69102004|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
37634825|NCT03057977|69102005|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
37634826|NCT03057977|69102004|FG000|Discontinuation From Treatment|Not attending study visit|3|||
37634827|NCT03057977|69102005|FG001|Discontinuation From Treatment|Not attending study visit|10|||
37634828|NCT03057977|69102004|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
37634829|NCT03057977|69102005|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
37634830|NCT03057977|69102004|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
37634831|NCT03057977|69102005|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
37634832|NCT03057977|69102004|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
37634833|NCT03057977|69102005|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
37634834|NCT03057977|69102004|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
37634835|NCT03057977|69102005|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
37634836|NCT03057977|69102004|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
37634837|NCT03057977|69102005|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
37634838|NCT03062891|69102017|FG000|Overall Study|Withdrawal by Subject|2|||
37634839|NCT03062891|69102018|FG001|Overall Study|Withdrawal by Subject|0|||
37634840|NCT03062891|69102017|FG000|Overall Study|Lost to Follow-up|50|||
37634841|NCT03062891|69102018|FG001|Overall Study|Lost to Follow-up|38|||
37634842|NCT02552212|69102027|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
37634843|NCT02552212|69102028|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
37634844|NCT02552212|69102029|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
37634845|NCT02552212|69102027|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
37634846|NCT02552212|69102028|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
37634847|NCT02552212|69102029|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
37634848|NCT02552212|69102027|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
38032006|NCT02855164|69717863|FG004|Part C (Randomized Set)|Adverse Event|0|||
38032007|NCT02855164|69717864|FG005|Part C (Randomized Set)|Adverse Event|5|||
38032008|NCT02855164|69717865|FG006|Part C (Randomized Set)|Adverse Event|9|||
38032009|NCT02855164|69717866|FG007|Part C (Randomized Set)|Adverse Event|2|||
38032010|NCT02855164|69717859|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
38032011|NCT02855164|69717860|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
38032012|NCT02855164|69717861|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
38032013|NCT02855164|69717862|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
38032014|NCT02855164|69717863|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
38032015|NCT02855164|69717864|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
38032016|NCT02855164|69717865|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
38032017|NCT02855164|69717866|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
38032018|NCT02855164|69717859|FG000|Part C (Randomized Set)|Physician Decision|0|||
38032019|NCT02855164|69717860|FG001|Part C (Randomized Set)|Physician Decision|0|||
38032020|NCT02855164|69717861|FG002|Part C (Randomized Set)|Physician Decision|0|||
38032021|NCT02855164|69717862|FG003|Part C (Randomized Set)|Physician Decision|0|||
38032022|NCT02855164|69717863|FG004|Part C (Randomized Set)|Physician Decision|0|||
38032023|NCT02855164|69717864|FG005|Part C (Randomized Set)|Physician Decision|1|||
38032024|NCT02855164|69717865|FG006|Part C (Randomized Set)|Physician Decision|0|||
38032025|NCT02855164|69717866|FG007|Part C (Randomized Set)|Physician Decision|1|||
38032026|NCT02855164|69717859|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
38032027|NCT02855164|69717860|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
38032028|NCT02855164|69717861|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
38032029|NCT02855164|69717862|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
38032030|NCT02855164|69717863|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
38032031|NCT02855164|69717864|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
38032032|NCT02855164|69717865|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
38032033|NCT02855164|69717866|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
38032034|NCT01002742|69717906|FG000|Overall Study|Determined to be ineligible|0|||
38032035|NCT01002742|69717907|FG001|Overall Study|Determined to be ineligible|1|||
37634849|NCT02552212|69102028|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
37634850|NCT02552212|69102029|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
37677502|NCT02600819|69152479|FG000|GEN Phase|Adverse Event|2|||
38032036|NCT02853760|69717913|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
38032037|NCT02853760|69717914|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
38032038|NCT02853760|69717915|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
37634851|NCT02552212|69102027|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
37634852|NCT02552212|69102028|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
37634853|NCT02552212|69102029|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
37634854|NCT02552212|69102027|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
37634855|NCT02552212|69102028|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
37634856|NCT02552212|69102029|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
37634857|NCT02552212|69102027|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
37634858|NCT02552212|69102028|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
37634859|NCT02552212|69102029|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
37634860|NCT02552212|69102027|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
37634861|NCT02552212|69102028|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
37634862|NCT02552212|69102029|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
37634863|NCT02552212|69102027|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
37634864|NCT02552212|69102028|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
37634865|NCT02552212|69102029|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
37634866|NCT02552212|69102027|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
37634867|NCT02552212|69102028|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
37634868|NCT02552212|69102029|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
37634869|NCT02552212|69102027|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
37634870|NCT02552212|69102028|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
37634871|NCT02552212|69102029|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
37634872|NCT02552212|69102027|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
37634873|NCT02552212|69102028|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
37634874|NCT02552212|69102029|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
37634875|NCT02552212|69102027|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
37634876|NCT02552212|69102028|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
37634877|NCT02552212|69102029|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
37634878|NCT02552212|69102027|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
37634879|NCT02552212|69102028|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
37634880|NCT02552212|69102029|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
37634881|NCT02552212|69102027|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
37634882|NCT02552212|69102028|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
37634883|NCT02552212|69102029|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
37634884|NCT02552212|69102027|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
37634885|NCT02552212|69102028|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
37634886|NCT02552212|69102029|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
37634887|NCT02552212|69102027|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
37634888|NCT02552212|69102028|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
37634889|NCT02552212|69102029|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
37634890|NCT02552212|69102027|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
37634891|NCT02552212|69102028|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
37634892|NCT02552212|69102029|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
37634893|NCT02552212|69102027|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
37634894|NCT02552212|69102028|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
37634895|NCT02552212|69102029|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
37634896|NCT02552212|69102027|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
37634897|NCT02552212|69102028|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
37634898|NCT02552212|69102029|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
37634899|NCT02552212|69102027|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
37634900|NCT02552212|69102028|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
37634901|NCT02552212|69102029|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
37634902|NCT02552212|69102027|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
37634903|NCT02552212|69102028|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
37634904|NCT02552212|69102029|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
37634905|NCT00685919|69102049|FG000|Overall Study|Withdrawal by Subject|0|||
37634906|NCT00685919|69102050|FG001|Overall Study|Withdrawal by Subject|0|||
37634907|NCT00685919|69102051|FG002|Overall Study|Withdrawal by Subject|1|||
37634908|NCT00685919|69102052|FG003|Overall Study|Withdrawal by Subject|0|||
37634909|NCT00685919|69102049|FG000|Overall Study|Physician Decision|1|||
37634910|NCT00685919|69102050|FG001|Overall Study|Physician Decision|0|||
37634911|NCT00685919|69102051|FG002|Overall Study|Physician Decision|0|||
37634912|NCT00685919|69102052|FG003|Overall Study|Physician Decision|0|||
37634913|NCT03061331|69102064|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
37634914|NCT03061331|69102065|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
37634915|NCT00700778|69102071|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
37739444|NCT01781234|69222770|FG000|Overall Study|Withdrawal by Subject|4|||
37739445|NCT01781234|69222771|FG001|Overall Study|Withdrawal by Subject|3|||
37634916|NCT02551666|69102077|FG000|Overall Study|Withdrawal by Subject|1|||
37634917|NCT02551666|69102078|FG001|Overall Study|Withdrawal by Subject|3|||
37634918|NCT03061175|69102090|FG000|Baseline|Participant was deemed ineligible|1|||
37634919|NCT03061175|69102091|FG001|Baseline|Participant was deemed ineligible|0|||
37634920|NCT03061175|69102090|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
37634921|NCT03061175|69102091|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
37634922|NCT03061175|69102090|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
37634923|NCT03061175|69102091|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
37634924|NCT03061175|69102090|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
37634925|NCT03061175|69102091|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
37634926|NCT02554474|69102108|FG000|Overall Study|Protocol Violation|1|||
37634927|NCT02554474|69102109|FG001|Overall Study|Protocol Violation|1|||
37634928|NCT02554474|69102108|FG000|Overall Study|Health issue not related to the study|1|||
37634929|NCT02554474|69102109|FG001|Overall Study|Health issue not related to the study|0|||
37634930|NCT02554474|69102108|FG000|Overall Study|Withdrawal by Subject|1|||
37634931|NCT02554474|69102109|FG001|Overall Study|Withdrawal by Subject|1|||
37634932|NCT03061097|69102117|FG000|Overall Study|Withdrawal by Subject|0|||
37634933|NCT03061097|69102118|FG001|Overall Study|Withdrawal by Subject|3|||
37634934|NCT02554318|69102126|FG000|Overall Study|Withdrawal by Subject|10|||
37634935|NCT02554318|69102127|FG001|Overall Study|Withdrawal by Subject|8|||
37634936|NCT02550106|69102133|FG000|Overall Study|Adverse Event|1|||
37634937|NCT02550106|69102133|FG000|Overall Study|Lack of Efficacy|3|||
37634938|NCT02550106|69102133|FG000|Overall Study|Protocol Violation|6|||
37634939|NCT02550106|69102133|FG000|Overall Study|Withdrawal by Subject|2|||
37634940|NCT03060551|69102139|FG000|Overall Study|Withdrawal by Subject|1|||
37634941|NCT03060551|69102139|FG000|Overall Study|Adverse Event|1|||
37634942|NCT01662310|69102143|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
37634943|NCT01662310|69102144|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
37634944|NCT01662310|69102145|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
37634945|NCT01662310|69102146|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
37634946|NCT01662310|69102147|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
37634947|NCT01662310|69102143|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
37634948|NCT01662310|69102144|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
37634949|NCT01662310|69102145|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
37634950|NCT01662310|69102146|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
37634951|NCT01662310|69102147|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
37634952|NCT01662310|69102143|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
37634953|NCT01662310|69102144|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
37634954|NCT01662310|69102145|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
37634955|NCT01662310|69102146|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
37634956|NCT01662310|69102147|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
37634957|NCT01662310|69102143|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
37634958|NCT01662310|69102144|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
37634959|NCT01662310|69102145|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
37634960|NCT01662310|69102146|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
37739446|NCT01752842|69222781|FG000|Overall Study|Adverse Event|3|||
37739447|NCT01752842|69222782|FG001|Overall Study|Adverse Event|0|||
37739448|NCT01752842|69222781|FG000|Overall Study|Withdrawal by Subject|0|||
37739449|NCT01752842|69222782|FG001|Overall Study|Withdrawal by Subject|2|||
37739450|NCT01461057|69222790|FG000|Overall Study|Death|10|||
37739451|NCT01461057|69222791|FG001|Overall Study|Death|9|||
37739452|NCT01461057|69222790|FG000|Overall Study|Withdrawal by Subject|2|||
37739453|NCT01461057|69222791|FG001|Overall Study|Withdrawal by Subject|3|||
37739454|NCT01461057|69222790|FG000|Overall Study|Physician Decision|0|||
37739455|NCT01461057|69222791|FG001|Overall Study|Physician Decision|2|||
37739456|NCT01461057|69222790|FG000|Overall Study|Adverse Event|0|||
37739457|NCT01461057|69222791|FG001|Overall Study|Adverse Event|1|||
37739458|NCT01461057|69222790|FG000|Overall Study|Progression of Disease|1|||
37739459|NCT01461057|69222791|FG001|Overall Study|Progression of Disease|0|||
37739460|NCT01461057|69222790|FG000|Overall Study|Study Terminated by Sponsor|2|||
37739461|NCT01461057|69222791|FG001|Overall Study|Study Terminated by Sponsor|0|||
37739462|NCT01460901|69222797|FG000|Overall Study|Withdrawal by Subject|2|||
37739463|NCT01519635|69222806|FG000|Overall Study|Withdrawal by Subject|0|||
37739464|NCT01519635|69222807|FG001|Overall Study|Withdrawal by Subject|1|||
37853653|NCT01236573|69537489|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
37853654|NCT01236573|69537490|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
37739465|NCT01519635|69222806|FG000|Overall Study|No possibility to put a catheter|1|||
37739466|NCT01519635|69222807|FG001|Overall Study|No possibility to put a catheter|2|||
37739467|NCT01519323|69222813|FG000|Overall Study|Death|3|||
37634961|NCT01662310|69102147|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
37634962|NCT01662310|69102143|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
37739468|NCT01519323|69222814|FG001|Overall Study|Death|2|||
37739469|NCT01519323|69222813|FG000|Overall Study|Study terminated by sponsor|0|||
37634963|NCT01662310|69102144|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
37634964|NCT01662310|69102145|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
37634965|NCT01662310|69102146|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
37634966|NCT01662310|69102147|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
37634967|NCT01662310|69102143|FG000|Run-In or Stabilization Phase|Other|1|||
37634968|NCT01662310|69102144|FG001|Run-In or Stabilization Phase|Other|0|||
37634969|NCT01662310|69102145|FG002|Run-In or Stabilization Phase|Other|0|||
37634970|NCT01662310|69102146|FG003|Run-In or Stabilization Phase|Other|0|||
37634971|NCT01662310|69102147|FG004|Run-In or Stabilization Phase|Other|0|||
37634972|NCT01662310|69102143|FG000|Double-Blind Phase|Adverse Event|0|||
37634973|NCT01662310|69102144|FG001|Double-Blind Phase|Adverse Event|0|||
37634974|NCT01662310|69102145|FG002|Double-Blind Phase|Adverse Event|1|||
37634975|NCT01662310|69102146|FG003|Double-Blind Phase|Adverse Event|0|||
37634976|NCT01662310|69102147|FG004|Double-Blind Phase|Adverse Event|0|||
37634977|NCT01662310|69102143|FG000|Double-Blind Phase|Lost to Follow-up|0|||
37634978|NCT01662310|69102144|FG001|Double-Blind Phase|Lost to Follow-up|3|||
37634979|NCT01662310|69102145|FG002|Double-Blind Phase|Lost to Follow-up|0|||
37634980|NCT01662310|69102146|FG003|Double-Blind Phase|Lost to Follow-up|0|||
37634981|NCT01662310|69102147|FG004|Double-Blind Phase|Lost to Follow-up|0|||
37634982|NCT01662310|69102143|FG000|Double-Blind Phase|Pregnancy|0|||
37634983|NCT01662310|69102144|FG001|Double-Blind Phase|Pregnancy|2|||
37634984|NCT01662310|69102145|FG002|Double-Blind Phase|Pregnancy|0|||
37634985|NCT01662310|69102146|FG003|Double-Blind Phase|Pregnancy|0|||
37634986|NCT01662310|69102147|FG004|Double-Blind Phase|Pregnancy|0|||
37634987|NCT01662310|69102143|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
37634988|NCT01662310|69102144|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
37634989|NCT01662310|69102145|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
37634990|NCT01662310|69102146|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
37634991|NCT01662310|69102147|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
37634992|NCT01662310|69102143|FG000|Double-Blind Phase|Other|0|||
37634993|NCT01662310|69102144|FG001|Double-Blind Phase|Other|0|||
37634994|NCT01662310|69102145|FG002|Double-Blind Phase|Other|1|||
37634995|NCT01662310|69102146|FG003|Double-Blind Phase|Other|0|||
37634996|NCT01662310|69102147|FG004|Double-Blind Phase|Other|0|||
37634997|NCT01662310|69102143|FG000|Double-Blind Phase|Randomized but not treated|0|||
37634998|NCT01662310|69102144|FG001|Double-Blind Phase|Randomized but not treated|1|||
37634999|NCT01662310|69102145|FG002|Double-Blind Phase|Randomized but not treated|0|||
37635000|NCT01662310|69102146|FG003|Double-Blind Phase|Randomized but not treated|0|||
37635001|NCT01662310|69102147|FG004|Double-Blind Phase|Randomized but not treated|0|||
37635002|NCT01662310|69102143|FG000|Open-Label Extension Phase|Adverse Event|0|||
37635003|NCT01662310|69102144|FG001|Open-Label Extension Phase|Adverse Event|0|||
37635004|NCT01662310|69102145|FG002|Open-Label Extension Phase|Adverse Event|0|||
37635005|NCT01662310|69102146|FG003|Open-Label Extension Phase|Adverse Event|3|||
37635006|NCT01662310|69102147|FG004|Open-Label Extension Phase|Adverse Event|0|||
37635007|NCT01662310|69102143|FG000|Open-Label Extension Phase|Death|0|||
37635008|NCT01662310|69102144|FG001|Open-Label Extension Phase|Death|0|||
37635009|NCT01662310|69102145|FG002|Open-Label Extension Phase|Death|0|||
37635010|NCT01662310|69102146|FG003|Open-Label Extension Phase|Death|1|||
37635011|NCT01662310|69102147|FG004|Open-Label Extension Phase|Death|0|||
37635012|NCT01662310|69102143|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
37635013|NCT01662310|69102144|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
37635014|NCT01662310|69102145|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
37635015|NCT01662310|69102146|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
37635016|NCT01662310|69102147|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
37635017|NCT01662310|69102143|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
37635018|NCT01662310|69102144|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
37635019|NCT01662310|69102145|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
37635020|NCT01662310|69102146|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
37635021|NCT01662310|69102147|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
37635022|NCT01662310|69102143|FG000|Open-Label Extension Phase|Pregnancy|0|||
37635023|NCT01662310|69102144|FG001|Open-Label Extension Phase|Pregnancy|0|||
37635024|NCT01662310|69102145|FG002|Open-Label Extension Phase|Pregnancy|0|||
37739470|NCT01519323|69222814|FG001|Overall Study|Study terminated by sponsor|1|||
37739471|NCT01519245|69222822|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
37739472|NCT01519245|69222823|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
37739473|NCT01519167|69222833|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
37635025|NCT01662310|69102146|FG003|Open-Label Extension Phase|Pregnancy|1|||
37635026|NCT01662310|69102147|FG004|Open-Label Extension Phase|Pregnancy|0|||
37635027|NCT01662310|69102143|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
37635028|NCT01662310|69102144|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
37635029|NCT01662310|69102145|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
37635030|NCT01662310|69102146|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
37635031|NCT01662310|69102147|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
37635032|NCT00700622|69102161|FG000|Overall Study|Adverse Event|4|||
37635033|NCT00700622|69102162|FG001|Overall Study|Adverse Event|0|||
37635034|NCT00700622|69102161|FG000|Overall Study|Lost to Follow-up|0|||
37635035|NCT00700622|69102162|FG001|Overall Study|Lost to Follow-up|1|||
37635036|NCT00700622|69102161|FG000|Overall Study|Physician Decision|2|||
37635037|NCT00700622|69102162|FG001|Overall Study|Physician Decision|1|||
37635038|NCT00700622|69102161|FG000|Overall Study|Protocol Violation|0|||
37635039|NCT00700622|69102162|FG001|Overall Study|Protocol Violation|1|||
37635040|NCT00700622|69102161|FG000|Overall Study|Withdrawal by Subject|4|||
37635041|NCT00700622|69102162|FG001|Overall Study|Withdrawal by Subject|1|||
37635042|NCT00700622|69102161|FG000|Overall Study|Other|3|||
37635043|NCT00700622|69102162|FG001|Overall Study|Other|1|||
37635044|NCT02553928|69102170|FG000|Overall Study|Adverse Event|2|||
37635045|NCT02553928|69102171|FG001|Overall Study|Adverse Event|1|||
37635046|NCT02553928|69102170|FG000|Overall Study|Lost to Follow-up|0|||
37635047|NCT02553928|69102171|FG001|Overall Study|Lost to Follow-up|1|||
37635048|NCT02553928|69102170|FG000|Overall Study|Administrative reason(s)|0|||
37635049|NCT02553928|69102171|FG001|Overall Study|Administrative reason(s)|1|||
37635050|NCT03076775|69102180|FG000|Overall Study|Lost to Follow-up|1|||
37635051|NCT03076775|69102181|FG001|Overall Study|Lost to Follow-up|0|||
37635052|NCT03058991|69102198|FG000|Overall Study|Lost to Follow-up|17|||
37635053|NCT03058991|69102199|FG001|Overall Study|Lost to Follow-up|12|||
37635054|NCT03058991|69102200|FG002|Overall Study|Lost to Follow-up|12|||
37635055|NCT03058991|69102198|FG000|Overall Study|Withdrawal by Subject|1|||
37635056|NCT03058991|69102199|FG001|Overall Study|Withdrawal by Subject|0|||
37635057|NCT03058991|69102200|FG002|Overall Study|Withdrawal by Subject|0|||
37635058|NCT00700310|69102212|FG000|Overall Study|Adverse Event|6|||
37635059|NCT00700310|69102213|FG001|Overall Study|Adverse Event|10|||
37635060|NCT00700310|69102214|FG002|Overall Study|Adverse Event|5|||
37635061|NCT00700310|69102215|FG003|Overall Study|Adverse Event|11|||
37635062|NCT00700310|69102212|FG000|Overall Study|Lost to Follow-up|4|||
37853655|NCT01236573|69537491|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
37635063|NCT00700310|69102213|FG001|Overall Study|Lost to Follow-up|1|||
37635064|NCT00700310|69102214|FG002|Overall Study|Lost to Follow-up|0|||
37635065|NCT00700310|69102215|FG003|Overall Study|Lost to Follow-up|1|||
37635066|NCT00700310|69102212|FG000|Overall Study|Withdrawal by Subject|8|||
37635067|NCT00700310|69102213|FG001|Overall Study|Withdrawal by Subject|9|||
37635068|NCT00700310|69102214|FG002|Overall Study|Withdrawal by Subject|8|||
37635069|NCT00700310|69102215|FG003|Overall Study|Withdrawal by Subject|8|||
37635070|NCT00700310|69102212|FG000|Overall Study|Lack of Efficacy|0|||
37635071|NCT00700310|69102213|FG001|Overall Study|Lack of Efficacy|3|||
37635072|NCT00700310|69102214|FG002|Overall Study|Lack of Efficacy|0|||
37635073|NCT00700310|69102215|FG003|Overall Study|Lack of Efficacy|1|||
37635074|NCT00700310|69102212|FG000|Overall Study|Administrative/Other|1|||
37635075|NCT00700310|69102213|FG001|Overall Study|Administrative/Other|3|||
37635076|NCT00700310|69102214|FG002|Overall Study|Administrative/Other|1|||
37635077|NCT00700310|69102215|FG003|Overall Study|Administrative/Other|3|||
37635078|NCT00700310|69102212|FG000|Overall Study|Randomized, Not Treated|2|||
37635079|NCT00700310|69102213|FG001|Overall Study|Randomized, Not Treated|0|||
37635080|NCT00700310|69102214|FG002|Overall Study|Randomized, Not Treated|2|||
37635081|NCT00700310|69102215|FG003|Overall Study|Randomized, Not Treated|2|||
37635082|NCT01575548|69102236|FG000|Overall Study|Adverse Event|15|||
37635083|NCT01575548|69102237|FG001|Overall Study|Adverse Event|2|||
37635084|NCT01575548|69102236|FG000|Overall Study|Disease progression|12|||
37635085|NCT01575548|69102237|FG001|Overall Study|Disease progression|25|||
37635086|NCT01575548|69102236|FG000|Overall Study|Death|1|||
37635087|NCT01575548|69102237|FG001|Overall Study|Death|0|||
37635088|NCT01575548|69102236|FG000|Overall Study|Other complicating disease|1|||
37635089|NCT01575548|69102237|FG001|Overall Study|Other complicating disease|0|||
37635090|NCT01575548|69102236|FG000|Overall Study|Withdrawal by Subject|7|||
37635091|NCT01575548|69102237|FG001|Overall Study|Withdrawal by Subject|3|||
37635092|NCT01575548|69102236|FG000|Overall Study|Noncompliance|1|||
37635093|NCT01575548|69102237|FG001|Overall Study|Noncompliance|0|||
37635094|NCT01575548|69102236|FG000|Overall Study|Anticipated surgery|0|||
37739474|NCT01519167|69222834|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
37739475|NCT01519167|69222833|FG000|Overall Study|Adverse Event|0|||
37739476|NCT01519167|69222834|FG001|Overall Study|Adverse Event|1|||
37739477|NCT01519167|69222833|FG000|Overall Study|Lack of Efficacy|0|||
37635095|NCT01575548|69102237|FG001|Overall Study|Anticipated surgery|1|||
37635096|NCT01575548|69102236|FG000|Overall Study|Never started protocol therapy|3|||
37635097|NCT01575548|69102237|FG001|Overall Study|Never started protocol therapy|2|||
37635100|NCT02554786|69102282|FG000|Overall Study|Subject/guardian decision|29|||
37635101|NCT02554786|69102283|FG001|Overall Study|Subject/guardian decision|17|||
37635102|NCT02554786|69102284|FG002|Overall Study|Subject/guardian decision|18|||
37635103|NCT02554786|69102285|FG003|Overall Study|Subject/guardian decision|30|||
37635104|NCT02554786|69102286|FG004|Overall Study|Subject/guardian decision|20|||
37739478|NCT01519167|69222834|FG001|Overall Study|Lack of Efficacy|1|||
37635105|NCT02554786|69102282|FG000|Overall Study|Lost to Follow-up|4|||
37635106|NCT02554786|69102283|FG001|Overall Study|Lost to Follow-up|3|||
37635107|NCT02554786|69102284|FG002|Overall Study|Lost to Follow-up|4|||
37635108|NCT02554786|69102285|FG003|Overall Study|Lost to Follow-up|2|||
37635109|NCT02554786|69102286|FG004|Overall Study|Lost to Follow-up|2|||
37635110|NCT02554786|69102282|FG000|Overall Study|Protocol deviation|1|||
37635111|NCT02554786|69102283|FG001|Overall Study|Protocol deviation|3|||
37635112|NCT02554786|69102284|FG002|Overall Study|Protocol deviation|3|||
37635113|NCT02554786|69102285|FG003|Overall Study|Protocol deviation|4|||
37635114|NCT02554786|69102286|FG004|Overall Study|Protocol deviation|2|||
37635115|NCT02554786|69102282|FG000|Overall Study|Technical problems|1|||
37635116|NCT02554786|69102283|FG001|Overall Study|Technical problems|1|||
37635117|NCT02554786|69102284|FG002|Overall Study|Technical problems|0|||
37635118|NCT02554786|69102285|FG003|Overall Study|Technical problems|2|||
37635119|NCT02554786|69102286|FG004|Overall Study|Technical problems|1|||
37635120|NCT02554786|69102282|FG000|Overall Study|Adverse Event|0|||
37921820|NCT00667888|69608652|FG000|Overall Study|Withdrawal by Subject|6|||
37921821|NCT00667888|69608653|FG001|Overall Study|Withdrawal by Subject|3|||
37921822|NCT00667888|69608652|FG000|Overall Study|Proceed with other treatment|3|||
37921823|NCT00667888|69608653|FG001|Overall Study|Proceed with other treatment|3|||
37635121|NCT02554786|69102283|FG001|Overall Study|Adverse Event|0|||
37635122|NCT02554786|69102284|FG002|Overall Study|Adverse Event|0|||
37635123|NCT02554786|69102285|FG003|Overall Study|Adverse Event|0|||
37635124|NCT02554786|69102286|FG004|Overall Study|Adverse Event|2|||
37635125|NCT02554786|69102282|FG000|Overall Study|Death|0|||
37635126|NCT02554786|69102283|FG001|Overall Study|Death|0|||
37635127|NCT02554786|69102284|FG002|Overall Study|Death|0|||
37635128|NCT02554786|69102285|FG003|Overall Study|Death|1|||
37635129|NCT02554786|69102286|FG004|Overall Study|Death|0|||
37635130|NCT02554786|69102282|FG000|Overall Study|Non-compliance with study treatment|0|||
37635131|NCT02554786|69102283|FG001|Overall Study|Non-compliance with study treatment|1|||
37635132|NCT02554786|69102284|FG002|Overall Study|Non-compliance with study treatment|1|||
37635133|NCT02554786|69102285|FG003|Overall Study|Non-compliance with study treatment|0|||
37635134|NCT02554786|69102286|FG004|Overall Study|Non-compliance with study treatment|1|||
37635135|NCT02554786|69102282|FG000|Overall Study|Physician Decision|0|||
37635136|NCT02554786|69102283|FG001|Overall Study|Physician Decision|1|||
37635137|NCT02554786|69102284|FG002|Overall Study|Physician Decision|4|||
37635138|NCT02554786|69102285|FG003|Overall Study|Physician Decision|1|||
37635139|NCT02554786|69102286|FG004|Overall Study|Physician Decision|1|||
37635140|NCT02554786|69102282|FG000|Overall Study|Pregnancy|0|||
37635141|NCT02554786|69102283|FG001|Overall Study|Pregnancy|0|||
37635142|NCT02554786|69102284|FG002|Overall Study|Pregnancy|0|||
37635143|NCT02554786|69102285|FG003|Overall Study|Pregnancy|1|||
37635144|NCT02554786|69102286|FG004|Overall Study|Pregnancy|1|||
37635145|NCT01347645|69102307|FG000|Overall Study|Death|1|||
37635146|NCT01347645|69102308|FG001|Overall Study|Death|5|||
37635147|NCT01347645|69102309|FG002|Overall Study|Death|2|||
37635148|NCT01347645|69102310|FG003|Overall Study|Death|7|||
37635149|NCT01347645|69102311|FG004|Overall Study|Death|7|||
37635150|NCT01347645|69102307|FG000|Overall Study|Lost to Follow-up|1|||
37635151|NCT01347645|69102308|FG001|Overall Study|Lost to Follow-up|1|||
37635152|NCT01347645|69102309|FG002|Overall Study|Lost to Follow-up|0|||
37635153|NCT01347645|69102310|FG003|Overall Study|Lost to Follow-up|1|||
37635154|NCT01347645|69102311|FG004|Overall Study|Lost to Follow-up|1|||
37635155|NCT01347645|69102307|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
37635156|NCT01347645|69102308|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
37635157|NCT01347645|69102309|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
37635158|NCT01347645|69102310|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
37635159|NCT01347645|69102311|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
37635160|NCT01347645|69102307|FG000|Overall Study|Other|1|||
37635161|NCT01347645|69102308|FG001|Overall Study|Other|0|||
37635162|NCT01347645|69102309|FG002|Overall Study|Other|0|||
37635163|NCT01347645|69102310|FG003|Overall Study|Other|0|||
37635164|NCT01347645|69102311|FG004|Overall Study|Other|1|||
37635165|NCT01347645|69102307|FG000|Overall Study|Withdrawal by Subject|0|||
37635166|NCT01347645|69102308|FG001|Overall Study|Withdrawal by Subject|0|||
37635167|NCT01347645|69102309|FG002|Overall Study|Withdrawal by Subject|0|||
37635168|NCT01347645|69102310|FG003|Overall Study|Withdrawal by Subject|3|||
37635169|NCT01347645|69102311|FG004|Overall Study|Withdrawal by Subject|3|||
37635170|NCT01347645|69102307|FG000|Overall Study|Physician Decision|0|||
37635171|NCT01347645|69102308|FG001|Overall Study|Physician Decision|0|||
37635172|NCT01347645|69102309|FG002|Overall Study|Physician Decision|0|||
37635173|NCT01347645|69102310|FG003|Overall Study|Physician Decision|0|||
37635174|NCT01347645|69102311|FG004|Overall Study|Physician Decision|1|||
37635175|NCT01347645|69102307|FG000|Overall Study|Adverse Event|0|||
37635176|NCT01347645|69102308|FG001|Overall Study|Adverse Event|0|||
37635177|NCT01347645|69102309|FG002|Overall Study|Adverse Event|0|||
37635178|NCT01347645|69102310|FG003|Overall Study|Adverse Event|1|||
37635179|NCT01347645|69102311|FG004|Overall Study|Adverse Event|1|||
37635180|NCT00484419|69102349|FG000|Overall Study|Adverse Event|3|||
37635181|NCT00484419|69102350|FG001|Overall Study|Adverse Event|0|||
37635182|NCT00484419|69102351|FG002|Overall Study|Adverse Event|0|||
37635183|NCT00484419|69102349|FG000|Overall Study|Lost to Follow-up|1|||
37635184|NCT00484419|69102350|FG001|Overall Study|Lost to Follow-up|0|||
37635185|NCT00484419|69102351|FG002|Overall Study|Lost to Follow-up|2|||
37635186|NCT00484419|69102349|FG000|Overall Study|Withdrawal by Subject|3|||
37635187|NCT00484419|69102350|FG001|Overall Study|Withdrawal by Subject|1|||
37635188|NCT00484419|69102351|FG002|Overall Study|Withdrawal by Subject|1|||
37635189|NCT00484419|69102349|FG000|Overall Study|subject met discontinuation criteria|2|||
37635190|NCT00484419|69102350|FG001|Overall Study|subject met discontinuation criteria|2|||
37635191|NCT00484419|69102351|FG002|Overall Study|subject met discontinuation criteria|4|||
37635192|NCT00484419|69102349|FG000|Overall Study|required restricted medication|1|||
37635193|NCT00484419|69102350|FG001|Overall Study|required restricted medication|0|||
37635194|NCT00484419|69102351|FG002|Overall Study|required restricted medication|1|||
37635195|NCT00484419|69102349|FG000|Overall Study|Physician Decision|1|||
37635196|NCT00484419|69102350|FG001|Overall Study|Physician Decision|1|||
37635197|NCT00484419|69102351|FG002|Overall Study|Physician Decision|1|||
37635198|NCT00484419|69102349|FG000|Overall Study|subject unable to receive medication|1|||
37635199|NCT00484419|69102350|FG001|Overall Study|subject unable to receive medication|0|||
37635200|NCT00484419|69102351|FG002|Overall Study|subject unable to receive medication|0|||
37635201|NCT00484419|69102349|FG000|Overall Study|subject relocated|0|||
37635202|NCT00484419|69102350|FG001|Overall Study|subject relocated|1|||
37635203|NCT00484419|69102351|FG002|Overall Study|subject relocated|0|||
37635204|NCT00484419|69102349|FG000|Overall Study|sponsor decision, randomized in error|0|||
37635205|NCT00484419|69102350|FG001|Overall Study|sponsor decision, randomized in error|0|||
37635206|NCT00484419|69102351|FG002|Overall Study|sponsor decision, randomized in error|2|||
37635207|NCT03220724|69102360|FG000|Overall Study|Lost to Follow-up|2|||
37635208|NCT03220724|69102361|FG001|Overall Study|Lost to Follow-up|1|||
37635209|NCT03220724|69102362|FG002|Overall Study|Lost to Follow-up|0|||
37635210|NCT03220724|69102363|FG003|Overall Study|Lost to Follow-up|3|||
37635211|NCT03220724|69102360|FG000|Overall Study|Withdrawal by Subject|1|||
37635212|NCT03220724|69102361|FG001|Overall Study|Withdrawal by Subject|1|||
37635213|NCT03220724|69102362|FG002|Overall Study|Withdrawal by Subject|1|||
37635214|NCT03220724|69102363|FG003|Overall Study|Withdrawal by Subject|0|||
37635225|NCT03056573|69102387|FG000|Overall Study|Death|2|||
37635226|NCT03056573|69102388|FG001|Overall Study|Death|4|||
37635227|NCT03056573|69102387|FG000|Overall Study|Withdrawal by Subject|2|||
37635228|NCT03056573|69102388|FG001|Overall Study|Withdrawal by Subject|0|||
37635229|NCT03056573|69102387|FG000|Overall Study|Lost to Follow-up|1|||
37635230|NCT03056573|69102388|FG001|Overall Study|Lost to Follow-up|1|||
37635231|NCT02553772|69102396|FG000|Overall Study|Adverse Event|2|||
37635232|NCT02553772|69102397|FG001|Overall Study|Adverse Event|3|||
37635233|NCT02553772|69102396|FG000|Overall Study|Lost to Follow-up|2|||
37635234|NCT02553772|69102397|FG001|Overall Study|Lost to Follow-up|1|||
37635235|NCT02553772|69102396|FG000|Overall Study|Withdrawal of Consent|1|||
37635236|NCT02553772|69102397|FG001|Overall Study|Withdrawal of Consent|1|||
37635237|NCT02553772|69102396|FG000|Overall Study|Lack of Efficacy|1|||
37635238|NCT02553772|69102397|FG001|Overall Study|Lack of Efficacy|0|||
37635239|NCT02553772|69102396|FG000|Overall Study|Other Miscellaneous Reasons|0|||
37635240|NCT02553772|69102397|FG001|Overall Study|Other Miscellaneous Reasons|1|||
37635241|NCT02553538|69102405|FG000|Overall Study|Could Not Reach by Telephone|133|||
37635242|NCT02553538|69102406|FG001|Overall Study|Could Not Reach by Telephone|0|||
37635243|NCT02553538|69102405|FG000|Overall Study|Died or Left Network|54|||
37635244|NCT02553538|69102406|FG001|Overall Study|Died or Left Network|56|||
37635245|NCT02548156|69102412|FG000|Washout Period 1|Lost to Follow-up|0|||
37635246|NCT02548156|69102413|FG001|Washout Period 1|Lost to Follow-up|0|||
37635247|NCT02548156|69102414|FG002|Washout Period 1|Lost to Follow-up|0|||
37635248|NCT02548156|69102415|FG003|Washout Period 1|Lost to Follow-up|0|||
37635249|NCT02548156|69102416|FG004|Washout Period 1|Lost to Follow-up|1|||
37677503|NCT02600819|69152480|FG001|GEN Phase|Adverse Event|0|||
37677504|NCT02600819|69152479|FG000|GEN Phase|Death|2|||
37677505|NCT02600819|69152480|FG001|GEN Phase|Death|0|||
37635250|NCT02548156|69102417|FG005|Washout Period 1|Lost to Follow-up|0|||
37635251|NCT01503515|69102427|FG000|Overall Study|Adverse Event|4|||
37635252|NCT01503515|69102428|FG001|Overall Study|Adverse Event|5|||
37635253|NCT01503515|69102427|FG000|Overall Study|Death|0|||
37635254|NCT01503515|69102428|FG001|Overall Study|Death|1|||
37635255|NCT01503515|69102427|FG000|Overall Study|Physician Decision|14|||
37635256|NCT01503515|69102428|FG001|Overall Study|Physician Decision|23|||
37635257|NCT01503515|69102427|FG000|Overall Study|Withdrawal by Subject|0|||
37635258|NCT01503515|69102428|FG001|Overall Study|Withdrawal by Subject|1|||
37635259|NCT01503515|69102427|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
37635260|NCT01503515|69102428|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
37635261|NCT01503515|69102427|FG000|Overall Study|Ineligible|1|||
37635262|NCT01503515|69102428|FG001|Overall Study|Ineligible|1|||
37635263|NCT02742519|69102436|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
37635264|NCT02742519|69102437|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
37635265|NCT02742519|69102438|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
37635266|NCT02742519|69102436|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
37635267|NCT02742519|69102437|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
37635268|NCT02742519|69102438|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
37635269|NCT02742519|69102436|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
37635270|NCT02742519|69102437|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
37635271|NCT02742519|69102438|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
37635272|NCT01375010|69102448|FG000|Overall Study|Lost to Follow-up|8|||
37635273|NCT01375010|69102449|FG001|Overall Study|Lost to Follow-up|2|||
37635274|NCT01375010|69102448|FG000|Overall Study|Withdrawal by Subject|4|||
37635275|NCT01375010|69102449|FG001|Overall Study|Withdrawal by Subject|2|||
37635276|NCT00659061|69102473|FG000|Overall Study|Migration due to political unrest|21|||
37635277|NCT00659061|69102474|FG001|Overall Study|Migration due to political unrest|15|||
37635278|NCT02548078|69102491|FG000|Overall Study|Serious adverse event/Adverse event|1|||
37635279|NCT02548078|69102492|FG001|Overall Study|Serious adverse event/Adverse event|0|||
37635280|NCT02548078|69102491|FG000|Overall Study|Moved from study area|3|||
37635281|NCT02548078|69102492|FG001|Overall Study|Moved from study area|3|||
37635282|NCT02548078|69102491|FG000|Overall Study|Lost to Follow-up|1|||
37635283|NCT02548078|69102492|FG001|Overall Study|Lost to Follow-up|3|||
37635284|NCT02916433|69102507|FG000|Overall Study|Withdrawal by Subject|1|||
37635285|NCT02916433|69102508|FG001|Overall Study|Withdrawal by Subject|0|||
37635286|NCT02916433|69102507|FG000|Overall Study|Physician Decision|1|||
37635287|NCT02916433|69102508|FG001|Overall Study|Physician Decision|0|||
37635288|NCT00526227|69102517|FG000|Overall Study|Device not implanted|1|||
37635289|NCT00526227|69102517|FG000|Overall Study|Death|1|||
37635290|NCT02547922|69102525|FG000|Overall Study|Withdrawal by Subject|9|||
37635291|NCT02547922|69102526|FG001|Overall Study|Withdrawal by Subject|6|||
37635292|NCT02547922|69102527|FG002|Overall Study|Withdrawal by Subject|10|||
37635293|NCT02547922|69102525|FG000|Overall Study|Adverse Event|3|||
37635294|NCT02547922|69102526|FG001|Overall Study|Adverse Event|1|||
37635295|NCT02547922|69102527|FG002|Overall Study|Adverse Event|2|||
37635296|NCT02547922|69102525|FG000|Overall Study|Lost to Follow-up|1|||
37635297|NCT02547922|69102526|FG001|Overall Study|Lost to Follow-up|0|||
37635298|NCT02547922|69102527|FG002|Overall Study|Lost to Follow-up|0|||
37635299|NCT02547922|69102525|FG000|Overall Study|Lack of Efficacy|5|||
37635300|NCT02547922|69102526|FG001|Overall Study|Lack of Efficacy|7|||
37635301|NCT02547922|69102527|FG002|Overall Study|Lack of Efficacy|4|||
37635302|NCT02547922|69102525|FG000|Overall Study|Death|1|||
37635303|NCT02547922|69102526|FG001|Overall Study|Death|0|||
37635304|NCT02547922|69102527|FG002|Overall Study|Death|0|||
37635305|NCT02547922|69102525|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
37635306|NCT02547922|69102526|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
37635307|NCT02547922|69102527|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
37635308|NCT02547922|69102525|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
37635309|NCT02547922|69102526|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
37635310|NCT02547922|69102527|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
37635311|NCT02547922|69102525|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
37635312|NCT02547922|69102526|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
37635313|NCT02547922|69102527|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
37635314|NCT02547922|69102525|FG000|Overall Study|Physician Decision|2|||
37635315|NCT02547922|69102526|FG001|Overall Study|Physician Decision|1|||
37635316|NCT02547922|69102527|FG002|Overall Study|Physician Decision|2|||
37635317|NCT02547922|69102525|FG000|Overall Study|Patients did not receive IP|1|||
37635318|NCT02547922|69102526|FG001|Overall Study|Patients did not receive IP|1|||
37635319|NCT02547922|69102527|FG002|Overall Study|Patients did not receive IP|0|||
37635320|NCT02547766|69102541|FG000|Overall Study|Withdrawal by Subject|1|||
37635321|NCT02742441|69102554|FG000|Overall Study|Lost to Follow-up|4|||
37635322|NCT02742441|69102555|FG001|Overall Study|Lost to Follow-up|4|||
37635323|NCT02742441|69102554|FG000|Overall Study|Withdrawal by Subject|2|||
37635324|NCT02742441|69102555|FG001|Overall Study|Withdrawal by Subject|2|||
37635325|NCT02742441|69102554|FG000|Overall Study|Adverse Event|0|||
37635326|NCT02742441|69102555|FG001|Overall Study|Adverse Event|2|||
37635327|NCT02547220|69102563|FG000|Overall Study|Withdrawal by Subject|1|||
37635328|NCT02547220|69102564|FG001|Overall Study|Withdrawal by Subject|0|||
37635329|NCT02547220|69102563|FG000|Overall Study|Study terminated by sponsor|18|||
37635330|NCT02547220|69102564|FG001|Overall Study|Study terminated by sponsor|20|||
37635331|NCT02542072|69102572|FG000|First Intervention (1 Month)|Adverse Event|1|||
37635332|NCT02542072|69102573|FG001|First Intervention (1 Month)|Adverse Event|1|||
37635333|NCT02542072|69102572|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
37635334|NCT02542072|69102573|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
37635335|NCT02542072|69102572|FG000|First Intervention (1 Month)|Lens discomfort|1|||
37635336|NCT02542072|69102573|FG001|First Intervention (1 Month)|Lens discomfort|2|||
37635337|NCT02542072|69102572|FG000|First Intervention (1 Month)|Protocol Violation|1|||
37635338|NCT02542072|69102573|FG001|First Intervention (1 Month)|Protocol Violation|0|||
37635339|NCT02542072|69102572|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
37635340|NCT02542072|69102573|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
37635341|NCT02542072|69102572|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
37635342|NCT02542072|69102573|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
37635343|NCT02547454|69102599|FG000|Overall Study|Due to hemodialysis|53|||
37635344|NCT02547454|69102599|FG000|Overall Study|Due to transplantation|1|||
37635345|NCT02547454|69102599|FG000|Overall Study|Due to no further need to treat|4|||
37635346|NCT02547454|69102599|FG000|Overall Study|Death|38|||
37635347|NCT02547454|69102599|FG000|Overall Study|Lost to Follow-up|26|||
37635348|NCT02547454|69102599|FG000|Overall Study|Other|39|||
37635349|NCT02547454|69102599|FG000|Overall Study|No data|11|||
37635350|NCT00415623|69102605|FG000|Overall Study|Adverse Event|3|||
37635351|NCT00415623|69102606|FG001|Overall Study|Adverse Event|4|||
37635352|NCT00415623|69102605|FG000|Overall Study|Death|1|||
37635353|NCT00415623|69102606|FG001|Overall Study|Death|0|||
37635354|NCT00415623|69102605|FG000|Overall Study|Withdrawal by Subject|1|||
37635355|NCT00415623|69102606|FG001|Overall Study|Withdrawal by Subject|1|||
37635356|NCT01969409|69102615|FG000|Overall Study|Death|2|||
37635357|NCT01969409|69102616|FG001|Overall Study|Death|2|||
37635358|NCT01969409|69102615|FG000|Overall Study|Transplant|1|||
37635359|NCT01969409|69102616|FG001|Overall Study|Transplant|1|||
37635360|NCT01969409|69102615|FG000|Overall Study|Withdrawal by Subject|0|||
37635361|NCT01969409|69102616|FG001|Overall Study|Withdrawal by Subject|1|||
37635362|NCT00150813|69102622|FG000|Overall Study|Adverse Event|1|||
37635363|NCT00150813|69102622|FG000|Overall Study|Lack of Efficacy|1|||
37635364|NCT00150813|69102622|FG000|Overall Study|Lost to Follow-up|5|||
37635365|NCT00150813|69102622|FG000|Overall Study|Withdrawal by Subject|5|||
37635366|NCT00150813|69102622|FG000|Overall Study|Remission|3|||
37635367|NCT00150813|69102622|FG000|Overall Study|Planned pregancy|1|||
37635368|NCT00150813|69102622|FG000|Overall Study|Switch to commercially available LEV|2|||
37635369|NCT02712788|69102628|FG000|Overall Study|Physician Decision|1|||
37635370|NCT02712788|69102629|FG001|Overall Study|Physician Decision|0|||
37635371|NCT02712788|69102628|FG000|Overall Study|Protocol Violation|1|||
37635372|NCT02712788|69102629|FG001|Overall Study|Protocol Violation|0|||
37635373|NCT02308111|69102637|FG000|Overall Study|Adverse Event|31|||
37635374|NCT02308111|69102638|FG001|Overall Study|Adverse Event|19|||
37635375|NCT02308111|69102637|FG000|Overall Study|Death|9|||
37635376|NCT02308111|69102638|FG001|Overall Study|Death|6|||
37635377|NCT02308111|69102637|FG000|Overall Study|Lost to Follow-up|2|||
37635378|NCT02308111|69102638|FG001|Overall Study|Lost to Follow-up|7|||
37635379|NCT02308111|69102637|FG000|Overall Study|Physician Decision|6|||
37635380|NCT02308111|69102638|FG001|Overall Study|Physician Decision|17|||
37635381|NCT02308111|69102637|FG000|Overall Study|Protocol Violation|0|||
37635382|NCT02308111|69102638|FG001|Overall Study|Protocol Violation|1|||
37635383|NCT02308111|69102637|FG000|Overall Study|Withdrawal by Subject|28|||
37635384|NCT02308111|69102638|FG001|Overall Study|Withdrawal by Subject|38|||
37635385|NCT02308111|69102637|FG000|Overall Study|Study Terminated by Sponsor|72|||
37635386|NCT02308111|69102638|FG001|Overall Study|Study Terminated by Sponsor|61|||
37635387|NCT02308111|69102637|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
37635388|NCT02308111|69102638|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
37635389|NCT02308111|69102637|FG000|Overall Study|Site Closure|3|||
37635390|NCT02308111|69102638|FG001|Overall Study|Site Closure|3|||
37635391|NCT02308111|69102637|FG000|Overall Study|Non-compliance with Study Drug|3|||
37635392|NCT02308111|69102638|FG001|Overall Study|Non-compliance with Study Drug|1|||
37635393|NCT02308111|69102637|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
37635394|NCT02308111|69102638|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
37635395|NCT02308111|69102637|FG000|Overall Study|Liver Transplant|3|||
37635396|NCT02308111|69102638|FG001|Overall Study|Liver Transplant|3|||
37635397|NCT02308111|69102637|FG000|Overall Study|Liver Transplant Waitlist|2|||
37635398|NCT02308111|69102638|FG001|Overall Study|Liver Transplant Waitlist|2|||
37635399|NCT02308111|69102637|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
37635400|NCT02308111|69102638|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
37635401|NCT01346189|69102649|FG000|Overall Study|Withdrawal by Subject|7|||
37635402|NCT01346189|69102650|FG001|Overall Study|Withdrawal by Subject|5|||
37635403|NCT01346189|69102651|FG002|Overall Study|Withdrawal by Subject|3|||
37635404|NCT01346189|69102652|FG003|Overall Study|Withdrawal by Subject|5|||
37635405|NCT01346189|69102649|FG000|Overall Study|Physician Decision|4|||
37635406|NCT01346189|69102650|FG001|Overall Study|Physician Decision|0|||
37635407|NCT01346189|69102651|FG002|Overall Study|Physician Decision|0|||
37853656|NCT01236573|69537492|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
37853657|NCT01236573|69537493|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
37635408|NCT01346189|69102652|FG003|Overall Study|Physician Decision|0|||
37635409|NCT01346189|69102649|FG000|Overall Study|Moved|3|||
37635410|NCT01346189|69102650|FG001|Overall Study|Moved|0|||
37635411|NCT01346189|69102651|FG002|Overall Study|Moved|4|||
37635412|NCT01346189|69102652|FG003|Overall Study|Moved|0|||
37635413|NCT01346189|69102649|FG000|Overall Study|Other|2|||
37635414|NCT01346189|69102650|FG001|Overall Study|Other|4|||
37635415|NCT01346189|69102651|FG002|Overall Study|Other|7|||
37635416|NCT01346189|69102652|FG003|Overall Study|Other|3|||
37635417|NCT01346189|69102649|FG000|Overall Study|Death|0|||
37635418|NCT01346189|69102650|FG001|Overall Study|Death|3|||
37635419|NCT01346189|69102651|FG002|Overall Study|Death|0|||
37635420|NCT01346189|69102652|FG003|Overall Study|Death|0|||
37635421|NCT01346189|69102649|FG000|Overall Study|Non-health system primary care physician|0|||
37635422|NCT01346189|69102650|FG001|Overall Study|Non-health system primary care physician|5|||
37635423|NCT01346189|69102651|FG002|Overall Study|Non-health system primary care physician|0|||
37635424|NCT01346189|69102652|FG003|Overall Study|Non-health system primary care physician|0|||
37635425|NCT01346189|69102649|FG000|Overall Study|Travel|0|||
37635426|NCT01346189|69102650|FG001|Overall Study|Travel|0|||
37635427|NCT01346189|69102651|FG002|Overall Study|Travel|0|||
37635428|NCT01346189|69102652|FG003|Overall Study|Travel|3|||
37635429|NCT00369317|69102662|FG000|Overall Study|Adverse Event|3|||
37635430|NCT00369317|69102662|FG000|Overall Study|Death|1|||
37635431|NCT00369317|69102662|FG000|Overall Study|Lack of Efficacy|5|||
37635432|NCT00369317|69102662|FG000|Overall Study|Physician Decision|2|||
37635433|NCT00369317|69102662|FG000|Overall Study|Withdrawal by Subject|8|||
37635434|NCT00369317|69102662|FG000|Overall Study|Ineligible|1|||
37635435|NCT03193021|69102669|FG000|Overall Study|Lost to Follow-up|1|||
37635436|NCT03193021|69102670|FG001|Overall Study|Lost to Follow-up|1|||
37635437|NCT03913091|69102678|FG000|Overall Study|Lost to Follow-up|18|||
37635438|NCT03913091|69102679|FG001|Overall Study|Lost to Follow-up|11|||
37635439|NCT03913091|69102678|FG000|Overall Study|Required additional meds/surgery|1|||
37635440|NCT03913091|69102679|FG001|Overall Study|Required additional meds/surgery|2|||
37635441|NCT03913091|69102678|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
37635442|NCT03913091|69102679|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
37635443|NCT01318499|69102703|FG000|Overall Study|Adverse Event|16|||
37635444|NCT01318499|69102704|FG001|Overall Study|Adverse Event|11|||
37635445|NCT01318499|69102705|FG002|Overall Study|Adverse Event|6|||
37635446|NCT01318499|69102703|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
37635447|NCT01318499|69102704|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
37635448|NCT01318499|69102705|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
37635449|NCT01318499|69102703|FG000|Overall Study|Noncompliance|2|||
37635450|NCT01318499|69102704|FG001|Overall Study|Noncompliance|3|||
37635451|NCT01318499|69102705|FG002|Overall Study|Noncompliance|0|||
37635452|NCT01318499|69102703|FG000|Overall Study|Treatment Failure|19|||
37635453|NCT01318499|69102704|FG001|Overall Study|Treatment Failure|19|||
37635454|NCT01318499|69102705|FG002|Overall Study|Treatment Failure|101|||
37635455|NCT01318499|69102703|FG000|Overall Study|Protocol Violation|2|||
37635456|NCT01318499|69102704|FG001|Overall Study|Protocol Violation|4|||
37635457|NCT01318499|69102705|FG002|Overall Study|Protocol Violation|2|||
37635458|NCT01318499|69102703|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
37635459|NCT01318499|69102704|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
37635460|NCT01318499|69102705|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
37635461|NCT01318499|69102703|FG000|Overall Study|Other|7|||
37635462|NCT01318499|69102704|FG001|Overall Study|Other|10|||
37635463|NCT01318499|69102705|FG002|Overall Study|Other|22|||
37635464|NCT02285595|69102739|FG000|Overall Study|Lost to Follow-up|14|||
37635465|NCT02285595|69102739|FG000|Overall Study|Withdrawal by Subject|1|||
37635466|NCT02712398|69102762|FG000|Overall Study|Withdrawal by Subject|6|||
37635467|NCT02712398|69102762|FG000|Overall Study|Lost to Follow-up|6|||
37635468|NCT02712398|69102762|FG000|Overall Study|Sponsor Decision|1|||
37635469|NCT02712398|69102762|FG000|Overall Study|Physician Decision|1|||
37635470|NCT02712398|69102762|FG000|Overall Study|Death|2|||
37635471|NCT02712398|69102762|FG000|Overall Study|Re-operation|21|||
37635472|NCT00282867|69102769|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
37635473|NCT00282867|69102770|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
37635474|NCT00282867|69102771|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
37853658|NCT01236573|69537494|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
37853659|NCT01236573|69537495|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
37635475|NCT00151281|69102781|FG000|Overall Study|Not evaluable|3|||
37635476|NCT01318109|69102796|FG000|Overall Study|Adverse Event|0|||
37635477|NCT01318109|69102797|FG001|Overall Study|Adverse Event|2|||
37635478|NCT01318109|69102798|FG002|Overall Study|Adverse Event|0|||
37635479|NCT01318109|69102796|FG000|Overall Study|Withdrawal by Subject|1|||
37635480|NCT01318109|69102797|FG001|Overall Study|Withdrawal by Subject|0|||
37635481|NCT01318109|69102798|FG002|Overall Study|Withdrawal by Subject|0|||
37635482|NCT01318109|69102796|FG000|Overall Study|Schedule Conflict|0|||
37635483|NCT01318109|69102797|FG001|Overall Study|Schedule Conflict|1|||
37635484|NCT01318109|69102798|FG002|Overall Study|Schedule Conflict|0|||
37635485|NCT02712554|69102808|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
37635486|NCT02712554|69102809|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
37635487|NCT02712554|69102808|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
37635488|NCT02712554|69102809|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
37635489|NCT02712554|69102808|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
37635490|NCT02712554|69102809|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
37635491|NCT02712554|69102808|FG000|Part B: Qualification Phase|Adverse Event|0|||
37635492|NCT02712554|69102809|FG001|Part B: Qualification Phase|Adverse Event|1|||
37635493|NCT02712554|69102808|FG000|Part B: Treatment Phase|Adverse Event|0|||
37635494|NCT02712554|69102809|FG001|Part B: Treatment Phase|Adverse Event|1|||
37635495|NCT02712554|69102808|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
37635496|NCT02712554|69102809|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
37635497|NCT02712554|69102808|FG000|Part B: Treatment Phase|Other|0|||
37635498|NCT02712554|69102809|FG001|Part B: Treatment Phase|Other|1|||
37635499|NCT02712320|69102832|FG000|Overall Study|Lost to Follow-up|1|||
37635500|NCT02712320|69102832|FG000|Overall Study|Withdrawal by Subject|1|||
37635501|NCT02712320|69102832|FG000|Overall Study|Transferred to another facility|1|||
37635502|NCT02712320|69102832|FG000|Overall Study|Treating with the prohibited medications|2|||
37635503|NCT03052751|69102838|FG000|Dosing Period 1|Adverse Event|0|||
37635504|NCT03052751|69102839|FG001|Dosing Period 1|Adverse Event|1|||
37635505|NCT03052751|69102840|FG002|Dosing Period 1|Adverse Event|0|||
37635506|NCT03052751|69102841|FG003|Dosing Period 1|Adverse Event|0|||
37635507|NCT03052751|69102842|FG004|Dosing Period 1|Adverse Event|0|||
37635508|NCT03052751|69102843|FG005|Dosing Period 1|Adverse Event|0|||
37635509|NCT03052751|69102838|FG000|Dosing Period 2|Adverse Event|0|||
37635510|NCT03052751|69102839|FG001|Dosing Period 2|Adverse Event|0|||
37635511|NCT03052751|69102840|FG002|Dosing Period 2|Adverse Event|3|||
37635512|NCT03052751|69102841|FG003|Dosing Period 2|Adverse Event|0|||
37635513|NCT03052751|69102842|FG004|Dosing Period 2|Adverse Event|0|||
37635514|NCT03052751|69102843|FG005|Dosing Period 2|Adverse Event|0|||
37635515|NCT03052751|69102838|FG000|Observation Period|Adverse Event|0|||
37635516|NCT03052751|69102839|FG001|Observation Period|Adverse Event|0|||
37635517|NCT03052751|69102840|FG002|Observation Period|Adverse Event|0|||
37739479|NCT01519167|69222833|FG000|Overall Study|Medical condition changes&deep sedation|0|||
37739480|NCT01519167|69222834|FG001|Overall Study|Medical condition changes&deep sedation|2|||
37739481|NCT01519167|69222833|FG000|Overall Study|Physician Decision|0|||
37739482|NCT01519167|69222834|FG001|Overall Study|Physician Decision|1|||
37739483|NCT01519089|69223075|FG000|Overall Study|Adverse Event|4|||
37739484|NCT01519089|69223076|FG001|Overall Study|Adverse Event|4|||
37739485|NCT01519089|69223075|FG000|Overall Study|Lack of Efficacy|0|||
37739486|NCT01519089|69223076|FG001|Overall Study|Lack of Efficacy|2|||
37739487|NCT01519089|69223075|FG000|Overall Study|Lost to Follow-up|1|||
37739488|NCT01519089|69223076|FG001|Overall Study|Lost to Follow-up|0|||
37739489|NCT01519089|69223075|FG000|Overall Study|Withdrawal by Subject|0|||
37739490|NCT01519089|69223076|FG001|Overall Study|Withdrawal by Subject|2|||
37853660|NCT01236573|69537496|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
37853661|NCT01236573|69537497|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
37853662|NCT01236573|69537498|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
37853663|NCT01236573|69537499|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
37853664|NCT01236573|69537489|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
37853665|NCT01236573|69537490|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
37853666|NCT01236573|69537491|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
37635518|NCT03052751|69102841|FG003|Observation Period|Adverse Event|0|||
37635519|NCT03052751|69102842|FG004|Observation Period|Adverse Event|1|||
37635520|NCT03052751|69102843|FG005|Observation Period|Adverse Event|0|||
37635521|NCT01317797|69102856|FG000|Overall Study|Other|0|||
37635522|NCT01317797|69102857|FG001|Overall Study|Other|1|||
37635523|NCT01317797|69102858|FG002|Overall Study|Other|0|||
37635524|NCT01317797|69102856|FG000|Overall Study|Withdrawal of Patient|0|||
37635525|NCT01317797|69102857|FG001|Overall Study|Withdrawal of Patient|0|||
37739491|NCT01519089|69223075|FG000|Overall Study|Other|2|||
37739492|NCT01519089|69223076|FG001|Overall Study|Other|6|||
37739493|NCT01519089|69223075|FG000|Overall Study|Not received study drug|0|||
37635526|NCT01317797|69102858|FG002|Overall Study|Withdrawal of Patient|1|||
37635527|NCT01343693|69102866|FG000|Overall Study|Lost to Follow-up|9|||
37635528|NCT02712008|69102873|FG000|Baseline (Day 1) up to Week 12|Death|3|||
37635529|NCT02712008|69102874|FG001|Baseline (Day 1) up to Week 12|Death|0|||
37635530|NCT02712008|69102875|FG002|Baseline (Day 1) up to Week 12|Death|0|||
37635531|NCT02712008|69102876|FG003|Baseline (Day 1) up to Week 12|Death|0|||
37635532|NCT02712008|69102877|FG004|Baseline (Day 1) up to Week 12|Death|0|||
37635533|NCT02712008|69102878|FG005|Baseline (Day 1) up to Week 12|Death|0|||
37635534|NCT02712008|69102879|FG006|Baseline (Day 1) up to Week 12|Death|0|||
37635535|NCT02712008|69102880|FG007|Baseline (Day 1) up to Week 12|Death|0|||
37635536|NCT02712008|69102873|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
37635537|NCT02712008|69102874|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
37635538|NCT02712008|69102875|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
37635539|NCT02712008|69102876|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
37635540|NCT02712008|69102877|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
37635541|NCT02712008|69102878|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
37635542|NCT02712008|69102879|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
37635543|NCT02712008|69102880|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
37635544|NCT02712008|69102873|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
37635545|NCT02712008|69102874|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
37635546|NCT02712008|69102875|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
37635547|NCT02712008|69102876|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
37635548|NCT02712008|69102877|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
37635549|NCT02712008|69102878|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
37635550|NCT02712008|69102879|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
37635551|NCT02712008|69102880|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
37635552|NCT02712008|69102873|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
37635553|NCT02712008|69102874|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
37635554|NCT02712008|69102875|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
37635555|NCT02712008|69102876|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
37635556|NCT02712008|69102877|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
37635557|NCT02712008|69102878|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
37635558|NCT02712008|69102879|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
37635559|NCT02712008|69102880|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
37635560|NCT02712008|69102873|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
37635561|NCT02712008|69102874|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
37635562|NCT02712008|69102875|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
37635563|NCT02712008|69102876|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
37635564|NCT02712008|69102877|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
37635565|NCT02712008|69102878|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
37635566|NCT02712008|69102879|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
37635567|NCT02712008|69102880|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
37635568|NCT02712008|69102873|FG000|From Week 12 up to Week 36|Adverse Event|0|||
37635569|NCT02712008|69102874|FG001|From Week 12 up to Week 36|Adverse Event|0|||
37635570|NCT02712008|69102875|FG002|From Week 12 up to Week 36|Adverse Event|0|||
37635571|NCT02712008|69102876|FG003|From Week 12 up to Week 36|Adverse Event|0|||
37635572|NCT02712008|69102877|FG004|From Week 12 up to Week 36|Adverse Event|1|||
37635573|NCT02712008|69102878|FG005|From Week 12 up to Week 36|Adverse Event|0|||
37635574|NCT02712008|69102879|FG006|From Week 12 up to Week 36|Adverse Event|0|||
37635575|NCT02712008|69102880|FG007|From Week 12 up to Week 36|Adverse Event|2|||
37635576|NCT02712008|69102873|FG000|From Week 12 up to Week 36|Death|1|||
37635577|NCT02712008|69102874|FG001|From Week 12 up to Week 36|Death|0|||
37635578|NCT02712008|69102875|FG002|From Week 12 up to Week 36|Death|0|||
37635579|NCT02712008|69102876|FG003|From Week 12 up to Week 36|Death|0|||
37635580|NCT02712008|69102877|FG004|From Week 12 up to Week 36|Death|0|||
37635581|NCT02712008|69102878|FG005|From Week 12 up to Week 36|Death|0|||
37635582|NCT02712008|69102879|FG006|From Week 12 up to Week 36|Death|1|||
37635583|NCT02712008|69102880|FG007|From Week 12 up to Week 36|Death|0|||
37635584|NCT02712008|69102873|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
37635585|NCT02712008|69102874|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
37635586|NCT02712008|69102875|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
37635587|NCT02712008|69102876|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
37635588|NCT02712008|69102877|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
37635589|NCT02712008|69102878|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
37635590|NCT02712008|69102879|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
37635591|NCT02712008|69102880|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
37635592|NCT02712008|69102873|FG000|From Week 12 up to Week 36|Physician Decision|0|||
37635593|NCT02712008|69102874|FG001|From Week 12 up to Week 36|Physician Decision|0|||
37635594|NCT02712008|69102875|FG002|From Week 12 up to Week 36|Physician Decision|0|||
37635595|NCT02712008|69102876|FG003|From Week 12 up to Week 36|Physician Decision|1|||
37635596|NCT02712008|69102877|FG004|From Week 12 up to Week 36|Physician Decision|1|||
37635597|NCT02712008|69102878|FG005|From Week 12 up to Week 36|Physician Decision|0|||
37635598|NCT02712008|69102879|FG006|From Week 12 up to Week 36|Physician Decision|0|||
37635599|NCT02712008|69102880|FG007|From Week 12 up to Week 36|Physician Decision|0|||
37635600|NCT02712008|69102873|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
37635601|NCT02712008|69102874|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
37635602|NCT02712008|69102875|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
37635603|NCT02712008|69102876|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
37635604|NCT02712008|69102877|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
37635605|NCT02712008|69102878|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
37635606|NCT02712008|69102879|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
37635607|NCT02712008|69102880|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
37635608|NCT02711306|69102900|FG000|Overall Study|Withdrawal by Subject|2|||
37635609|NCT02711306|69102901|FG001|Overall Study|Withdrawal by Subject|2|||
37635610|NCT02710292|69102907|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
37635611|NCT02710292|69102908|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
37739494|NCT01519089|69223076|FG001|Overall Study|Not received study drug|1|||
37739495|NCT01518699|69223098|FG000|Period 2|Protocol Violation|1|||
37739496|NCT01518699|69223099|FG001|Period 2|Protocol Violation|1|||
37739497|NCT01518699|69223100|FG002|Period 2|Protocol Violation|0|||
37739498|NCT01518699|69223101|FG003|Period 2|Protocol Violation|0|||
37739499|NCT01518699|69223102|FG004|Period 2|Protocol Violation|0|||
37739500|NCT01518699|69223103|FG005|Period 2|Protocol Violation|0|||
37739501|NCT01518699|69223098|FG000|Period 2|Lost to Follow-up|0|||
37739502|NCT01518699|69223099|FG001|Period 2|Lost to Follow-up|1|||
37739503|NCT01518699|69223100|FG002|Period 2|Lost to Follow-up|0|||
37739504|NCT01518699|69223101|FG003|Period 2|Lost to Follow-up|0|||
37739505|NCT01518699|69223102|FG004|Period 2|Lost to Follow-up|0|||
37739506|NCT01518699|69223103|FG005|Period 2|Lost to Follow-up|0|||
37635612|NCT02710292|69102907|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
37635613|NCT02710292|69102908|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
37739507|NCT01518699|69223098|FG000|Period 2|Adverse Event|1|||
37739508|NCT01518699|69223099|FG001|Period 2|Adverse Event|0|||
37739509|NCT01518699|69223100|FG002|Period 2|Adverse Event|0|||
37739510|NCT01518699|69223101|FG003|Period 2|Adverse Event|0|||
37739511|NCT01518699|69223102|FG004|Period 2|Adverse Event|0|||
37739512|NCT01518699|69223103|FG005|Period 2|Adverse Event|0|||
37739513|NCT01518309|69223111|FG000|Overall Study|Adverse Event|6|||
37635614|NCT02710214|69102917|FG000|Overall Study|Lost to Follow-up|1|||
37739514|NCT01518309|69223111|FG000|Overall Study|Death|6|||
37739515|NCT01518309|69223111|FG000|Overall Study|Lack of Efficacy|7|||
37739516|NCT01518309|69223111|FG000|Overall Study|Withdrawal by Subject|6|||
37739517|NCT01518309|69223111|FG000|Overall Study|Physician Decision|3|||
37739518|NCT01518309|69223111|FG000|Overall Study|Sponsor Decision|2|||
37739519|NCT01518309|69223111|FG000|Overall Study|Not in Predefined Categories|9|||
37739520|NCT01419717|69223115|FG000|Overall Study|Protocol-specified Criteria|62|||
37739521|NCT01419717|69223115|FG000|Overall Study|Adverse Event|19|||
37739522|NCT01419717|69223115|FG000|Overall Study|Death|17|||
37739523|NCT01419717|69223115|FG000|Overall Study|Withdrawal by Subject|10|||
37739524|NCT01419717|69223115|FG000|Overall Study|Disease Progression|9|||
37739525|NCT01419717|69223115|FG000|Overall Study|Other|4|||
37739526|NCT01419717|69223115|FG000|Overall Study|Lost to Follow-up|2|||
37739527|NCT01419717|69223115|FG000|Overall Study|Administrative Decision|1|||
37739528|NCT01419717|69223115|FG000|Overall Study|Noncompliance|1|||
37739529|NCT01458951|69223122|FG000|Overall Study|Other|1|||
37739530|NCT01458951|69223123|FG001|Overall Study|Other|0|||
37739531|NCT01458951|69223124|FG002|Overall Study|Other|0|||
37739532|NCT01458951|69223122|FG000|Overall Study|Protocol Violation|5|||
37739533|NCT01458951|69223123|FG001|Overall Study|Protocol Violation|1|||
37739534|NCT01458951|69223124|FG002|Overall Study|Protocol Violation|0|||
37739535|NCT01458951|69223122|FG000|Overall Study|Withdrawal by Subject|2|||
37739536|NCT01458951|69223123|FG001|Overall Study|Withdrawal by Subject|0|||
37739537|NCT01458951|69223124|FG002|Overall Study|Withdrawal by Subject|2|||
37635615|NCT02710214|69102918|FG001|Overall Study|Lost to Follow-up|0|||
37635616|NCT02710214|69102917|FG000|Overall Study|Lack of Efficacy|0|||
37635617|NCT02710214|69102918|FG001|Overall Study|Lack of Efficacy|1|||
37635618|NCT02710214|69102917|FG000|Overall Study|Death|0|||
37739538|NCT01458951|69223122|FG000|Overall Study|Adverse Event|7|||
37739539|NCT01458951|69223123|FG001|Overall Study|Adverse Event|0|||
37739540|NCT01458951|69223124|FG002|Overall Study|Adverse Event|2|||
37739541|NCT01458951|69223122|FG000|Overall Study|Insufficient Clinical Response|17|||
37739542|NCT01458951|69223123|FG001|Overall Study|Insufficient Clinical Response|0|||
37739543|NCT01458951|69223124|FG002|Overall Study|Insufficient Clinical Response|11|||
37739544|NCT01458639|69223131|FG000|Overall Study|Physician Decision|4|||
37739545|NCT01458639|69223131|FG000|Overall Study|Equipment issue|1|||
37739546|NCT01458639|69223131|FG000|Overall Study|Inability to obtain subject blood sample|1|||
37739547|NCT01437423|69223135|FG000|Overall Study|Lost to Follow-up|12|||
37739548|NCT01437423|69223135|FG000|Overall Study|Off label usage|3|||
37739549|NCT01458249|69223166|FG000|Overall Study|Not treated|1|||
37739550|NCT01458249|69223166|FG000|Overall Study|Adverse Event|4|||
37635619|NCT02710214|69102918|FG001|Overall Study|Death|1|||
37635620|NCT03052517|69102927|FG000|Overall Study|Study Terminated By Sponsor|928|||
37635621|NCT03052517|69102928|FG001|Overall Study|Study Terminated By Sponsor|938|||
37635622|NCT03052517|69102929|FG002|Overall Study|Study Terminated By Sponsor|296|||
37635623|NCT03052517|69102927|FG000|Overall Study|Subject/Guardian Decision|50|||
37635624|NCT03052517|69102928|FG001|Overall Study|Subject/Guardian Decision|45|||
37635625|NCT03052517|69102929|FG002|Overall Study|Subject/Guardian Decision|22|||
37635626|NCT03052517|69102927|FG000|Overall Study|Lack of Efficacy|23|||
37635627|NCT03052517|69102928|FG001|Overall Study|Lack of Efficacy|14|||
37635628|NCT03052517|69102929|FG002|Overall Study|Lack of Efficacy|7|||
37635629|NCT03052517|69102927|FG000|Overall Study|Adverse Event|6|||
37635630|NCT03052517|69102928|FG001|Overall Study|Adverse Event|5|||
37635631|NCT03052517|69102929|FG002|Overall Study|Adverse Event|0|||
37635632|NCT03052517|69102927|FG000|Overall Study|Physician Decision|4|||
37635633|NCT03052517|69102928|FG001|Overall Study|Physician Decision|5|||
37635634|NCT03052517|69102929|FG002|Overall Study|Physician Decision|1|||
37635635|NCT03052517|69102927|FG000|Overall Study|Death|3|||
37635636|NCT03052517|69102928|FG001|Overall Study|Death|0|||
37635637|NCT03052517|69102929|FG002|Overall Study|Death|1|||
37635638|NCT03052517|69102927|FG000|Overall Study|Lost to Follow-up|2|||
37635639|NCT03052517|69102928|FG001|Overall Study|Lost to Follow-up|4|||
37635640|NCT03052517|69102929|FG002|Overall Study|Lost to Follow-up|0|||
37635641|NCT03052517|69102927|FG000|Overall Study|Pregnancy|1|||
37635642|NCT03052517|69102928|FG001|Overall Study|Pregnancy|0|||
37635643|NCT03052517|69102929|FG002|Overall Study|Pregnancy|1|||
37635644|NCT03052517|69102927|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
37635645|NCT03052517|69102928|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
37635646|NCT03052517|69102929|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
37635647|NCT03052517|69102927|FG000|Overall Study|Technical Problems|0|||
37635648|NCT03052517|69102928|FG001|Overall Study|Technical Problems|1|||
37635649|NCT03052517|69102929|FG002|Overall Study|Technical Problems|0|||
37635650|NCT02708498|69102945|FG000|Overall Study|Death|20|||
37635651|NCT02708498|69102946|FG001|Overall Study|Death|19|||
37635652|NCT02708498|69102947|FG002|Overall Study|Death|0|||
37635653|NCT02708498|69102948|FG003|Overall Study|Death|0|||
37635654|NCT02708498|69102949|FG004|Overall Study|Death|1|||
37635655|NCT02708498|69102950|FG005|Overall Study|Death|0|||
37635656|NCT02708498|69102951|FG006|Overall Study|Death|0|||
37635657|NCT02708498|69102952|FG007|Overall Study|Death|0|||
37635658|NCT02708498|69102945|FG000|Overall Study|Unknown reason, missing data|0|||
37635659|NCT02708498|69102946|FG001|Overall Study|Unknown reason, missing data|0|||
37635660|NCT02708498|69102947|FG002|Overall Study|Unknown reason, missing data|62|||
37635661|NCT02708498|69102948|FG003|Overall Study|Unknown reason, missing data|51|||
37635662|NCT02708498|69102949|FG004|Overall Study|Unknown reason, missing data|195|||
37635663|NCT02708498|69102950|FG005|Overall Study|Unknown reason, missing data|132|||
37635664|NCT02708498|69102951|FG006|Overall Study|Unknown reason, missing data|0|||
37635665|NCT02708498|69102952|FG007|Overall Study|Unknown reason, missing data|0|||
37635666|NCT02710136|69102970|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
37635667|NCT02710136|69102971|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
37635668|NCT03702231|69102981|FG000|Overall Study|Withdrawal by Subject|1|||
37635669|NCT03702231|69102982|FG001|Overall Study|Withdrawal by Subject|0|||
37635670|NCT03702231|69102983|FG002|Overall Study|Withdrawal by Subject|0|||
37635671|NCT03702231|69102981|FG000|Overall Study|Protocol Violation|0|||
37635672|NCT03702231|69102982|FG001|Overall Study|Protocol Violation|0|||
37635673|NCT03702231|69102983|FG002|Overall Study|Protocol Violation|1|||
37635674|NCT03702231|69102981|FG000|Overall Study|Change in CLL Treatment|0|||
37635675|NCT03702231|69102982|FG001|Overall Study|Change in CLL Treatment|0|||
37635676|NCT03702231|69102983|FG002|Overall Study|Change in CLL Treatment|1|||
37635677|NCT03702231|69102981|FG000|Overall Study|COVID Pandemic|1|||
37635678|NCT03702231|69102982|FG001|Overall Study|COVID Pandemic|4|||
37635679|NCT03702231|69102983|FG002|Overall Study|COVID Pandemic|1|||
37635680|NCT03702231|69102981|FG000|Overall Study|Non-compliance|0|||
37635681|NCT03702231|69102982|FG001|Overall Study|Non-compliance|0|||
37635682|NCT03702231|69102983|FG002|Overall Study|Non-compliance|1|||
37635683|NCT02741271|69102993|FG000|Overall Study|Lost to Follow-up|2|||
37635684|NCT02741271|69102994|FG001|Overall Study|Lost to Follow-up|0|||
37635685|NCT02741271|69102993|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
37635686|NCT02741271|69102994|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
37635687|NCT02709746|69103007|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
37635688|NCT02709746|69103008|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
37635689|NCT02709746|69103009|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
37635690|NCT02709746|69103010|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
37635691|NCT02709746|69103011|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
37635692|NCT02709746|69103007|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
37635693|NCT02709746|69103008|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
37635694|NCT02709746|69103009|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
37635695|NCT02709746|69103010|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
37635696|NCT02709746|69103011|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
37635697|NCT02709746|69103007|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
37635698|NCT02709746|69103008|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
37635699|NCT02709746|69103009|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
37635700|NCT02709746|69103010|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
37635701|NCT02709746|69103011|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
37635702|NCT02709746|69103007|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
37635703|NCT02709746|69103008|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
37635704|NCT02709746|69103009|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
37635705|NCT02709746|69103010|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
37635706|NCT02709746|69103011|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
37635707|NCT02709746|69103007|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
37635708|NCT02709746|69103008|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
37635709|NCT02709746|69103009|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
37635710|NCT02709746|69103010|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
37635711|NCT02709746|69103011|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
37635712|NCT02709746|69103007|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
37635713|NCT02709746|69103008|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
37635714|NCT02709746|69103009|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
37635715|NCT02709746|69103010|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
37635716|NCT02709746|69103011|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
37635717|NCT02709746|69103007|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
37635718|NCT02709746|69103008|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
37635719|NCT02709746|69103009|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
37635720|NCT02709746|69103010|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
37635721|NCT02709746|69103011|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
37635722|NCT02709746|69103007|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
37635723|NCT02709746|69103008|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
37635724|NCT02709746|69103009|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
37635725|NCT02709746|69103010|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
37635726|NCT02709746|69103011|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
37635727|NCT02709746|69103007|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
37635728|NCT02709746|69103008|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
37635729|NCT02709746|69103009|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
37635730|NCT02709746|69103010|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
37635731|NCT02709746|69103011|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
37635732|NCT02709746|69103007|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
37635733|NCT02709746|69103008|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
37635734|NCT02709746|69103009|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
37635735|NCT02709746|69103010|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
37635736|NCT02709746|69103011|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
37635737|NCT02709746|69103007|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
37635738|NCT02709746|69103008|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
37635739|NCT02709746|69103009|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
37635740|NCT02709746|69103010|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
37635741|NCT02709746|69103011|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
37635742|NCT02709746|69103007|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
37635743|NCT02709746|69103008|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
37635744|NCT02709746|69103009|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
37635745|NCT02709746|69103010|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
37635746|NCT02709746|69103011|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
37635747|NCT02709746|69103007|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
37635748|NCT02709746|69103008|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
37739551|NCT01458249|69223166|FG000|Overall Study|Other|2|||
37739552|NCT01458249|69223166|FG000|Overall Study|Ongoing|1|||
37739553|NCT01458171|69223182|FG000|Overall Study|Adverse Event|1|||
37739554|NCT01457703|69223199|FG000|Overall Study|Screen Failure|5|||
37739555|NCT01457703|69223200|FG001|Overall Study|Screen Failure|7|||
37739556|NCT01457703|69223199|FG000|Overall Study|Withdrawal by Subject|1|||
37739557|NCT01457703|69223200|FG001|Overall Study|Withdrawal by Subject|4|||
37739558|NCT01419015|69223218|FG000|Overall Study|Death|2|||
37853667|NCT01236573|69537492|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
37853668|NCT01236573|69537493|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
37635749|NCT02709746|69103009|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
37635750|NCT02709746|69103010|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
37635751|NCT02709746|69103011|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
37635752|NCT02709746|69103007|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
37635753|NCT02709746|69103008|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
37635754|NCT02709746|69103009|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
37635755|NCT02709746|69103010|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
37635756|NCT02709746|69103011|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
37635757|NCT02709746|69103007|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
37635758|NCT02709746|69103008|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
37635759|NCT02709746|69103009|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
37635760|NCT02709746|69103010|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
37635761|NCT02709746|69103011|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
37739559|NCT01418937|69223239|FG000|Overall Study|Lost to Follow-up|5|||
37739560|NCT01418937|69223239|FG000|Overall Study|Protocol Violation|1|||
37739561|NCT01418937|69223239|FG000|Overall Study|Pregnancy|1|||
37739562|NCT01418937|69223239|FG000|Overall Study|Withdrawal by Subject|1|||
37739563|NCT01417377|69223252|FG000|Overall Study|Lost to Follow-up|12|||
37635762|NCT02709746|69103007|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
37635763|NCT02709746|69103008|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
37635764|NCT02709746|69103009|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
37635765|NCT02709746|69103010|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
37635766|NCT02709746|69103011|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
37635767|NCT02709746|69103007|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
37635768|NCT02709746|69103008|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
37635769|NCT02709746|69103009|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
37635770|NCT02709746|69103010|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
37635771|NCT02709746|69103011|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
37635772|NCT01317641|69103032|FG000|Overall Study|Not treated|0|||
37635773|NCT01317641|69103033|FG001|Overall Study|Not treated|0|||
37635774|NCT01317641|69103034|FG002|Overall Study|Not treated|0|||
37635775|NCT01317641|69103035|FG003|Overall Study|Not treated|0|||
37635776|NCT01317641|69103036|FG004|Overall Study|Not treated|0|||
37635777|NCT01317641|69103037|FG005|Overall Study|Not treated|0|||
37635778|NCT01317641|69103038|FG006|Overall Study|Not treated|0|||
37635779|NCT01317641|69103039|FG007|Overall Study|Not treated|1|||
37635780|NCT01317641|69103040|FG008|Overall Study|Not treated|1|||
37635781|NCT01317641|69103032|FG000|Overall Study|Adverse Event|0|||
37635782|NCT01317641|69103033|FG001|Overall Study|Adverse Event|1|||
37635783|NCT01317641|69103034|FG002|Overall Study|Adverse Event|0|||
37635784|NCT01317641|69103035|FG003|Overall Study|Adverse Event|1|||
37635785|NCT01317641|69103036|FG004|Overall Study|Adverse Event|0|||
37635786|NCT01317641|69103037|FG005|Overall Study|Adverse Event|0|||
37635787|NCT01317641|69103038|FG006|Overall Study|Adverse Event|2|||
37635788|NCT01317641|69103039|FG007|Overall Study|Adverse Event|1|||
37739564|NCT01417377|69223252|FG000|Overall Study|Enrolled, but not treated|1|||
37739565|NCT01437267|69223299|FG000|Overall Study|Withdrawal by Subject|0|||
37739566|NCT01437267|69223300|FG001|Overall Study|Withdrawal by Subject|0|||
37739567|NCT01437267|69223301|FG002|Overall Study|Withdrawal by Subject|0|||
37739568|NCT01437267|69223302|FG003|Overall Study|Withdrawal by Subject|1|||
37739569|NCT01437267|69223303|FG004|Overall Study|Withdrawal by Subject|0|||
37739570|NCT01437267|69223304|FG005|Overall Study|Withdrawal by Subject|0|||
37853669|NCT01236573|69537494|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
37635789|NCT01317641|69103040|FG008|Overall Study|Adverse Event|0|||
37635790|NCT01317641|69103032|FG000|Overall Study|Protocol Violation|1|||
37635791|NCT01317641|69103033|FG001|Overall Study|Protocol Violation|0|||
37635792|NCT01317641|69103034|FG002|Overall Study|Protocol Violation|0|||
37635793|NCT01317641|69103035|FG003|Overall Study|Protocol Violation|0|||
37635794|NCT01317641|69103036|FG004|Overall Study|Protocol Violation|0|||
37635795|NCT01317641|69103037|FG005|Overall Study|Protocol Violation|0|||
37635796|NCT01317641|69103038|FG006|Overall Study|Protocol Violation|0|||
37635797|NCT01317641|69103039|FG007|Overall Study|Protocol Violation|0|||
37635798|NCT01317641|69103040|FG008|Overall Study|Protocol Violation|0|||
37635799|NCT01317641|69103032|FG000|Overall Study|Disease progression|0|||
37635800|NCT01317641|69103033|FG001|Overall Study|Disease progression|0|||
37635801|NCT01317641|69103034|FG002|Overall Study|Disease progression|0|||
37635802|NCT01317641|69103035|FG003|Overall Study|Disease progression|0|||
37635803|NCT01317641|69103036|FG004|Overall Study|Disease progression|0|||
37635804|NCT01317641|69103037|FG005|Overall Study|Disease progression|0|||
37635805|NCT01317641|69103038|FG006|Overall Study|Disease progression|0|||
37853670|NCT01236573|69537495|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
37853671|NCT01236573|69537496|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
37853672|NCT01236573|69537497|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
37853673|NCT01236573|69537498|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
37635806|NCT01317641|69103039|FG007|Overall Study|Disease progression|3|||
37635807|NCT01317641|69103040|FG008|Overall Study|Disease progression|4|||
37635808|NCT01317641|69103032|FG000|Overall Study|Withdrawal by Subject|0|||
37635809|NCT01317641|69103033|FG001|Overall Study|Withdrawal by Subject|0|||
37635810|NCT01317641|69103034|FG002|Overall Study|Withdrawal by Subject|0|||
37635811|NCT01317641|69103035|FG003|Overall Study|Withdrawal by Subject|0|||
37635812|NCT01317641|69103036|FG004|Overall Study|Withdrawal by Subject|0|||
37635813|NCT01317641|69103037|FG005|Overall Study|Withdrawal by Subject|0|||
37635814|NCT01317641|69103038|FG006|Overall Study|Withdrawal by Subject|1|||
37635815|NCT01317641|69103039|FG007|Overall Study|Withdrawal by Subject|0|||
37635816|NCT01317641|69103040|FG008|Overall Study|Withdrawal by Subject|0|||
37635817|NCT03186794|69103076|FG000|Overall Study|Physician Decision|2|||
37635818|NCT03186794|69103076|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
37635819|NCT02290431|69103081|FG000|Overall Study|Adverse Event|20|||
37635820|NCT02290431|69103081|FG000|Overall Study|Progressive disease|4|||
37635821|NCT02290431|69103081|FG000|Overall Study|Study terminated by Sponsor|1|||
37635822|NCT02290431|69103081|FG000|Overall Study|Physician Decision|2|||
37635823|NCT02707952|69103089|FG000|Overall Study|Adverse Event|1|||
37635824|NCT02707952|69103090|FG001|Overall Study|Adverse Event|0|||
37635825|NCT02707952|69103091|FG002|Overall Study|Adverse Event|0|||
37635826|NCT02707952|69103092|FG003|Overall Study|Adverse Event|0|||
37635827|NCT02707952|69103089|FG000|Overall Study|Lost to Follow-up|1|||
37635828|NCT02707952|69103090|FG001|Overall Study|Lost to Follow-up|0|||
37635829|NCT02707952|69103091|FG002|Overall Study|Lost to Follow-up|0|||
37635830|NCT02707952|69103092|FG003|Overall Study|Lost to Follow-up|0|||
37635831|NCT02707952|69103089|FG000|Overall Study|Withdrawal by Subject|0|||
37635832|NCT02707952|69103090|FG001|Overall Study|Withdrawal by Subject|1|||
37635833|NCT02707952|69103091|FG002|Overall Study|Withdrawal by Subject|2|||
37635834|NCT02707952|69103092|FG003|Overall Study|Withdrawal by Subject|0|||
37635835|NCT03050801|69103110|FG000|Experiment 1|Lost to Follow-up|0|||
37635836|NCT03050801|69103111|FG001|Experiment 1|Lost to Follow-up|1|||
37921824|NCT00667888|69608652|FG000|Overall Study|Ineligible after SIM|0|||
37921825|NCT00667888|69608653|FG001|Overall Study|Ineligible after SIM|2|||
37921826|NCT00594815|69608659|FG000|Overall Study|Never Treated|3|||
37921827|NCT00594815|69608659|FG000|Overall Study|Withdrawal by Subject|2|||
37921828|NCT00594815|69608659|FG000|Overall Study|Toxicity|4|||
37921829|NCT00820170|69608668|FG000|Overall Study|Adverse Event|0|||
37921830|NCT00820170|69608669|FG001|Overall Study|Adverse Event|0|||
38032039|NCT02853760|69717916|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
38032040|NCT02853760|69717917|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
38032041|NCT02853760|69717918|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
38032042|NCT02852434|69717928|FG000|Overall Study|Withdrawal by Subject|0|||
38032043|NCT02852434|69717929|FG001|Overall Study|Withdrawal by Subject|1|||
38032044|NCT02852434|69717928|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
38032045|NCT02852434|69717929|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
38032046|NCT02850016|69717937|FG000|Overall Study|Withdrawal by Subject|1|||
38032047|NCT02850016|69717938|FG001|Overall Study|Withdrawal by Subject|2|||
38032048|NCT02849704|69717946|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
38032049|NCT02849704|69717947|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
38032050|NCT02849704|69717946|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
38032051|NCT02849704|69717947|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
38032052|NCT02849704|69717946|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
37635837|NCT03050801|69103112|FG002|Experiment 1|Lost to Follow-up|0|||
37635838|NCT03050801|69103113|FG003|Experiment 1|Lost to Follow-up|0|||
37635839|NCT03050801|69103114|FG004|Experiment 1|Lost to Follow-up|0|||
37635840|NCT03050801|69103115|FG005|Experiment 1|Lost to Follow-up|0|||
37635841|NCT03050801|69103110|FG000|Experiment 1|Physician Decision|0|||
37635842|NCT03050801|69103111|FG001|Experiment 1|Physician Decision|3|||
37635843|NCT03050801|69103112|FG002|Experiment 1|Physician Decision|0|||
37635844|NCT03050801|69103113|FG003|Experiment 1|Physician Decision|0|||
37635845|NCT03050801|69103114|FG004|Experiment 1|Physician Decision|0|||
37635846|NCT03050801|69103115|FG005|Experiment 1|Physician Decision|0|||
37635847|NCT03050801|69103110|FG000|Experiment 1|Change of experimental design|0|||
37635848|NCT03050801|69103111|FG001|Experiment 1|Change of experimental design|3|||
37635849|NCT03050801|69103112|FG002|Experiment 1|Change of experimental design|0|||
37635850|NCT03050801|69103113|FG003|Experiment 1|Change of experimental design|0|||
37635851|NCT03050801|69103114|FG004|Experiment 1|Change of experimental design|0|||
37635852|NCT03050801|69103115|FG005|Experiment 1|Change of experimental design|0|||
37635853|NCT03050801|69103110|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
37635854|NCT03050801|69103111|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
37635855|NCT03050801|69103112|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
37635856|NCT03050801|69103113|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
37921831|NCT00820170|69608670|FG002|Overall Study|Adverse Event|0|||
37921832|NCT00820170|69608671|FG003|Overall Study|Adverse Event|0|||
37635857|NCT03050801|69103114|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
37635858|NCT03050801|69103115|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
37635859|NCT03050801|69103110|FG000|Experiment 2|Lost to Follow-up|0|||
37635860|NCT03050801|69103111|FG001|Experiment 2|Lost to Follow-up|0|||
37635861|NCT03050801|69103112|FG002|Experiment 2|Lost to Follow-up|0|||
37635862|NCT03050801|69103113|FG003|Experiment 2|Lost to Follow-up|1|||
37635863|NCT03050801|69103114|FG004|Experiment 2|Lost to Follow-up|1|||
37635864|NCT03050801|69103115|FG005|Experiment 2|Lost to Follow-up|0|||
37635865|NCT03050801|69103110|FG000|Experiment 2|Physician Decision|0|||
37635866|NCT03050801|69103111|FG001|Experiment 2|Physician Decision|0|||
37635867|NCT03050801|69103112|FG002|Experiment 2|Physician Decision|0|||
37635868|NCT03050801|69103113|FG003|Experiment 2|Physician Decision|0|||
37635869|NCT03050801|69103114|FG004|Experiment 2|Physician Decision|1|||
37635870|NCT03050801|69103115|FG005|Experiment 2|Physician Decision|0|||
37635871|NCT03050801|69103110|FG000|Experiment 2|Pregnancy|0|||
37635872|NCT03050801|69103111|FG001|Experiment 2|Pregnancy|0|||
37635873|NCT03050801|69103112|FG002|Experiment 2|Pregnancy|0|||
37635874|NCT03050801|69103113|FG003|Experiment 2|Pregnancy|0|||
37635875|NCT03050801|69103114|FG004|Experiment 2|Pregnancy|1|||
37635876|NCT03050801|69103115|FG005|Experiment 2|Pregnancy|0|||
37635877|NCT03050801|69103110|FG000|Experiment 2|Withdrawal by Subject|0|||
37635878|NCT03050801|69103111|FG001|Experiment 2|Withdrawal by Subject|0|||
38032053|NCT02849704|69717947|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
38032054|NCT03347396|69717968|FG000|Part A (26 Weeks)|Adverse Event|1|||
38032055|NCT03347396|69717969|FG001|Part A (26 Weeks)|Adverse Event|0|||
38032056|NCT03347396|69717968|FG000|Part A (26 Weeks)|Death|0|||
38032057|NCT03347396|69717969|FG001|Part A (26 Weeks)|Death|1|||
38032058|NCT03347396|69717968|FG000|Part B (149 Weeks)|Adverse Event|1|||
38032059|NCT03347396|69717969|FG001|Part B (149 Weeks)|Adverse Event|1|||
38032060|NCT03347396|69717968|FG000|Part B (149 Weeks)|Death|1|||
38032061|NCT03347396|69717969|FG001|Part B (149 Weeks)|Death|0|||
37921833|NCT00820170|69608672|FG004|Overall Study|Adverse Event|2|||
37921834|NCT00820170|69608668|FG000|Overall Study|Progressive Disease|0|||
37921835|NCT00820170|69608669|FG001|Overall Study|Progressive Disease|0|||
37921836|NCT00820170|69608670|FG002|Overall Study|Progressive Disease|0|||
37921837|NCT00820170|69608671|FG003|Overall Study|Progressive Disease|0|||
37921838|NCT00820170|69608672|FG004|Overall Study|Progressive Disease|2|||
37921839|NCT00818454|69608689|FG000|Treatment Period 1|Adverse Event|0|||
38032062|NCT03335150|69717980|FG000|Overall Study|Withdrawal by Subject|10|||
38032063|NCT03335150|69717981|FG001|Overall Study|Withdrawal by Subject|4|||
37635879|NCT03050801|69103112|FG002|Experiment 2|Withdrawal by Subject|0|||
37635880|NCT03050801|69103113|FG003|Experiment 2|Withdrawal by Subject|1|||
37635881|NCT03050801|69103114|FG004|Experiment 2|Withdrawal by Subject|0|||
37635882|NCT03050801|69103115|FG005|Experiment 2|Withdrawal by Subject|0|||
37635883|NCT03050801|69103110|FG000|Experiment 2|Poor data quality|0|||
37635884|NCT03050801|69103111|FG001|Experiment 2|Poor data quality|0|||
37635885|NCT03050801|69103112|FG002|Experiment 2|Poor data quality|0|||
37635886|NCT03050801|69103113|FG003|Experiment 2|Poor data quality|4|||
37635887|NCT03050801|69103114|FG004|Experiment 2|Poor data quality|1|||
37635888|NCT03050801|69103115|FG005|Experiment 2|Poor data quality|0|||
37635889|NCT03050801|69103110|FG000|Experiment 2|Discomfort during stimulation|0|||
37921840|NCT00818454|69608690|FG001|Treatment Period 1|Adverse Event|1|||
37635890|NCT03050801|69103111|FG001|Experiment 2|Discomfort during stimulation|0|||
37635891|NCT03050801|69103112|FG002|Experiment 2|Discomfort during stimulation|0|||
37635892|NCT03050801|69103113|FG003|Experiment 2|Discomfort during stimulation|0|||
37635893|NCT03050801|69103114|FG004|Experiment 2|Discomfort during stimulation|0|||
37635894|NCT03050801|69103115|FG005|Experiment 2|Discomfort during stimulation|2|||
37635895|NCT02707640|69103134|FG000|Overall Study|Adverse Event|4|||
37635896|NCT02707640|69103135|FG001|Overall Study|Adverse Event|2|||
37635897|NCT02707640|69103134|FG000|Overall Study|Death|1|||
37635898|NCT02707640|69103135|FG001|Overall Study|Death|2|||
37635899|NCT02707640|69103134|FG000|Overall Study|Physician Decision|2|||
37635900|NCT02707640|69103135|FG001|Overall Study|Physician Decision|0|||
37635901|NCT02707640|69103134|FG000|Overall Study|Withdrawal by Subject|0|||
37635902|NCT02707640|69103135|FG001|Overall Study|Withdrawal by Subject|1|||
37635903|NCT02707640|69103134|FG000|Overall Study|Participant's Personal Decision|1|||
37635904|NCT02707640|69103135|FG001|Overall Study|Participant's Personal Decision|2|||
37635905|NCT02707640|69103134|FG000|Overall Study|Sponsor Discretion|1|||
37635906|NCT02707640|69103135|FG001|Overall Study|Sponsor Discretion|0|||
37635907|NCT02708966|69103143|FG000|Overall Study|Lost to Follow-up|2|||
37635908|NCT02708966|69103144|FG001|Overall Study|Lost to Follow-up|2|||
37635909|NCT02706938|69103152|FG000|First Period, 6 Weeks|Adverse Event|8|||
37635910|NCT02706938|69103153|FG001|First Period, 6 Weeks|Adverse Event|0|||
37921841|NCT00818454|69608691|FG002|Treatment Period 1|Adverse Event|0|||
37921842|NCT00818454|69608692|FG003|Treatment Period 1|Adverse Event|0|||
38032064|NCT03335150|69717980|FG000|Overall Study|Adverse Event|0|||
37635911|NCT02706938|69103152|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
38032065|NCT03335150|69717981|FG001|Overall Study|Adverse Event|1|||
37635912|NCT02706938|69103153|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
37635913|NCT02706938|69103152|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
37635914|NCT02706938|69103153|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
37635915|NCT02706938|69103152|FG000|Second Period, 6 Weeks|Adverse Event|0|||
37635916|NCT02706938|69103153|FG001|Second Period, 6 Weeks|Adverse Event|7|||
37635917|NCT02706938|69103152|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
37635918|NCT02706938|69103153|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
37635919|NCT03053063|69103163|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
37635920|NCT03053063|69103164|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
37635921|NCT03053063|69103165|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
37635922|NCT03053063|69103166|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
37635923|NCT03053063|69103163|FG000|Randomized Phase|Withdrew consent|8|||
37635924|NCT03053063|69103164|FG001|Randomized Phase|Withdrew consent|11|||
37635925|NCT03053063|69103165|FG002|Randomized Phase|Withdrew consent|5|||
37635926|NCT03053063|69103166|FG003|Randomized Phase|Withdrew consent|0|||
37635927|NCT03053063|69103163|FG000|Randomized Phase|Investigator's Discretion|8|||
37635928|NCT03053063|69103164|FG001|Randomized Phase|Investigator's Discretion|6|||
37635929|NCT03053063|69103165|FG002|Randomized Phase|Investigator's Discretion|2|||
37635930|NCT03053063|69103166|FG003|Randomized Phase|Investigator's Discretion|0|||
37635931|NCT03053063|69103163|FG000|Randomized Phase|Lost to Follow-up|3|||
37635932|NCT03053063|69103164|FG001|Randomized Phase|Lost to Follow-up|5|||
37635933|NCT03053063|69103165|FG002|Randomized Phase|Lost to Follow-up|1|||
37635934|NCT03053063|69103166|FG003|Randomized Phase|Lost to Follow-up|0|||
37635935|NCT03053063|69103163|FG000|Randomized Phase|Adverse Event|0|||
37635936|NCT03053063|69103164|FG001|Randomized Phase|Adverse Event|1|||
37635937|NCT03053063|69103165|FG002|Randomized Phase|Adverse Event|0|||
37635938|NCT03053063|69103166|FG003|Randomized Phase|Adverse Event|0|||
37635939|NCT03053063|69103163|FG000|Randomized Phase|Randomized but Never Treated|1|||
37635940|NCT03053063|69103164|FG001|Randomized Phase|Randomized but Never Treated|3|||
37635941|NCT03053063|69103165|FG002|Randomized Phase|Randomized but Never Treated|2|||
37635942|NCT03053063|69103166|FG003|Randomized Phase|Randomized but Never Treated|0|||
37635943|NCT03053063|69103163|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
37635944|NCT03053063|69103164|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
37635945|NCT03053063|69103165|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
37635946|NCT03053063|69103166|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
37635947|NCT03053063|69103163|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
37635948|NCT03053063|69103164|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
37635949|NCT03053063|69103165|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
37635950|NCT03053063|69103166|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
37635951|NCT03053063|69103163|FG000|Open-Label Phase|Death|0|||
37635952|NCT03053063|69103164|FG001|Open-Label Phase|Death|0|||
37635953|NCT03053063|69103165|FG002|Open-Label Phase|Death|0|||
37635954|NCT03053063|69103166|FG003|Open-Label Phase|Death|2|||
37635955|NCT03053063|69103163|FG000|Open-Label Phase|Investigator's discretion|0|||
37635956|NCT03053063|69103164|FG001|Open-Label Phase|Investigator's discretion|0|||
37635957|NCT03053063|69103165|FG002|Open-Label Phase|Investigator's discretion|0|||
37635958|NCT03053063|69103166|FG003|Open-Label Phase|Investigator's discretion|2|||
37635959|NCT01316939|69103188|FG000|Overall Study|Study closed/terminated|26|||
37635960|NCT01316939|69103189|FG001|Overall Study|Study closed/terminated|25|||
37635961|NCT01316939|69103190|FG002|Overall Study|Study closed/terminated|23|||
37635962|NCT01316939|69103188|FG000|Overall Study|Lack of Efficacy|24|||
37635963|NCT01316939|69103189|FG001|Overall Study|Lack of Efficacy|25|||
37635964|NCT01316939|69103190|FG002|Overall Study|Lack of Efficacy|25|||
37635965|NCT01316939|69103188|FG000|Overall Study|Adverse Event|9|||
37635966|NCT01316939|69103189|FG001|Overall Study|Adverse Event|12|||
37635967|NCT01316939|69103190|FG002|Overall Study|Adverse Event|11|||
37635968|NCT01316939|69103188|FG000|Overall Study|Withdrawal by Subject|1|||
37635969|NCT01316939|69103189|FG001|Overall Study|Withdrawal by Subject|3|||
37635970|NCT01316939|69103190|FG002|Overall Study|Withdrawal by Subject|6|||
37635971|NCT01316939|69103188|FG000|Overall Study|Physician Decision|2|||
37635972|NCT01316939|69103189|FG001|Overall Study|Physician Decision|2|||
37635973|NCT01316939|69103190|FG002|Overall Study|Physician Decision|1|||
37635974|NCT01316939|69103188|FG000|Overall Study|Lost to Follow-up|0|||
37635975|NCT01316939|69103189|FG001|Overall Study|Lost to Follow-up|0|||
37635976|NCT01316939|69103190|FG002|Overall Study|Lost to Follow-up|2|||
37635977|NCT01316939|69103188|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
37635978|NCT01316939|69103189|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
37635979|NCT01316939|69103190|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
37635980|NCT01316939|69103188|FG000|Overall Study|Protocol Violation|0|||
37635981|NCT01316939|69103189|FG001|Overall Study|Protocol Violation|1|||
37635982|NCT01316939|69103190|FG002|Overall Study|Protocol Violation|0|||
37635983|NCT03044249|69103200|FG000|Overall Study|Adverse Event|4|||
37635984|NCT03044249|69103201|FG001|Overall Study|Adverse Event|9|||
37635985|NCT03044249|69103200|FG000|Overall Study|Lost to Follow-up|1|||
37635986|NCT03044249|69103201|FG001|Overall Study|Lost to Follow-up|0|||
37635987|NCT03044249|69103200|FG000|Overall Study|Non-compliance with Study Drug|1|||
37635988|NCT03044249|69103201|FG001|Overall Study|Non-compliance with Study Drug|0|||
37635989|NCT03044249|69103200|FG000|Overall Study|Study Terminated by Sponsor|2|||
37635990|NCT03044249|69103201|FG001|Overall Study|Study Terminated by Sponsor|0|||
37635991|NCT03044249|69103200|FG000|Overall Study|Withdrawal by Subject|2|||
37635992|NCT03044249|69103201|FG001|Overall Study|Withdrawal by Subject|5|||
37635993|NCT02704130|69103214|FG000|Overall Study|Physician Decision|5|||
37635994|NCT02704130|69103215|FG001|Overall Study|Physician Decision|3|||
37635995|NCT03740009|69103221|FG000|Overall Study|Physician Decision|9|||
37635996|NCT03740009|69103221|FG000|Overall Study|Lost to Follow-up|1|||
37635997|NCT03649217|69103225|FG000|Overall Study|subject had severe ataxia not initially found|1|||
37635998|NCT03649217|69103225|FG000|Overall Study|subject had cognitive issues not initially found|1|||
37635999|NCT03138889|69103254|FG000|Overall Study|Withdrawal by Subject|5|||
37636000|NCT03138889|69103255|FG001|Overall Study|Withdrawal by Subject|5|||
37636001|NCT03138889|69103256|FG002|Overall Study|Withdrawal by Subject|0|||
37636002|NCT03138889|69103257|FG003|Overall Study|Withdrawal by Subject|2|||
37636003|NCT03138889|69103258|FG004|Overall Study|Withdrawal by Subject|1|||
37636004|NCT03138889|69103259|FG005|Overall Study|Withdrawal by Subject|3|||
37636005|NCT03138889|69103260|FG006|Overall Study|Withdrawal by Subject|0|||
37636006|NCT03138889|69103261|FG007|Overall Study|Withdrawal by Subject|1|||
37636007|NCT02706392|69103313|FG000|Overall Study|Death|1|||
37636008|NCT02706392|69103314|FG001|Overall Study|Death|0|||
37636009|NCT02706392|69103315|FG002|Overall Study|Death|2|||
37636010|NCT02706392|69103316|FG003|Overall Study|Death|2|||
37636011|NCT02706392|69103317|FG004|Overall Study|Death|5|||
37636012|NCT02706392|69103318|FG005|Overall Study|Death|2|||
37636013|NCT03042767|69103334|FG000|Overall Study|Lost to Follow-up|1|||
37636014|NCT03042767|69103335|FG001|Overall Study|Lost to Follow-up|2|||
37636015|NCT00703820|69103343|FG000|Overall Study|Adverse Event|12|||
37636016|NCT00703820|69103344|FG001|Overall Study|Adverse Event|17|||
37636017|NCT00703820|69103343|FG000|Overall Study|Death|5|||
37636018|NCT00703820|69103344|FG001|Overall Study|Death|0|||
37636019|NCT00703820|69103343|FG000|Overall Study|Lack of Efficacy|11|||
37636020|NCT00703820|69103344|FG001|Overall Study|Lack of Efficacy|11|||
37636021|NCT00703820|69103343|FG000|Overall Study|Received non-protocol therapy|1|||
37636022|NCT00703820|69103344|FG001|Overall Study|Received non-protocol therapy|0|||
37636023|NCT00703820|69103343|FG000|Overall Study|Physician Decision|4|||
37636024|NCT00703820|69103344|FG001|Overall Study|Physician Decision|5|||
37636025|NCT00703820|69103343|FG000|Overall Study|Withdrawal by Subject|2|||
37636026|NCT00703820|69103344|FG001|Overall Study|Withdrawal by Subject|1|||
37636027|NCT03045887|69103362|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
37636028|NCT03045887|69103363|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
37636029|NCT03045887|69103364|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
37636030|NCT03045887|69103365|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
37636031|NCT03045887|69103366|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
37636032|NCT03045887|69103367|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
37636033|NCT03045887|69103368|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
37636034|NCT03045887|69103369|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
37636035|NCT03045887|69103370|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
37636036|NCT03045887|69103371|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
37636037|NCT03045887|69103362|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
37636038|NCT03045887|69103363|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
37636039|NCT03045887|69103364|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
37636040|NCT03045887|69103365|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
37636041|NCT03045887|69103366|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
37636042|NCT03045887|69103367|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
37636043|NCT03045887|69103368|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
37636044|NCT03045887|69103369|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
37636045|NCT03045887|69103370|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
37636046|NCT03045887|69103371|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
37636047|NCT03045887|69103362|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
37636048|NCT03045887|69103363|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
37636049|NCT03045887|69103364|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
37636050|NCT03045887|69103365|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
37636051|NCT03045887|69103366|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
37636052|NCT03045887|69103367|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
37636053|NCT03045887|69103368|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
37636054|NCT03045887|69103369|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
37636055|NCT03045887|69103370|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
37636056|NCT03045887|69103371|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
37636057|NCT03045887|69103362|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
37636058|NCT03045887|69103363|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
37636059|NCT03045887|69103364|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
37921843|NCT00818454|69608689|FG000|Treatment Period 1|Other|3|||
37636060|NCT03045887|69103365|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
37636061|NCT03045887|69103366|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
37636062|NCT03045887|69103367|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
37636063|NCT03045887|69103368|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
37636064|NCT03045887|69103369|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
37636065|NCT03045887|69103370|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
37636066|NCT03045887|69103371|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
37636067|NCT03045887|69103362|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
37636068|NCT03045887|69103363|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
37636069|NCT03045887|69103364|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
37636070|NCT03045887|69103365|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
37636071|NCT03045887|69103366|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
37636072|NCT03045887|69103367|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
37636073|NCT03045887|69103368|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
37636074|NCT03045887|69103369|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
37636075|NCT03045887|69103370|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
37636076|NCT03045887|69103371|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
37636077|NCT01564537|69103400|FG000|Overall Study|Site Terminated by Sponsor|1|||
37636078|NCT01564537|69103401|FG001|Overall Study|Site Terminated by Sponsor|0|||
37636079|NCT01564537|69103400|FG000|Overall Study|Withdrawal by Subject|12|||
37636080|NCT01564537|69103401|FG001|Overall Study|Withdrawal by Subject|14|||
37636081|NCT01564537|69103400|FG000|Overall Study|Lost to Follow-up|7|||
37636082|NCT01564537|69103401|FG001|Overall Study|Lost to Follow-up|3|||
37636083|NCT01564537|69103400|FG000|Overall Study|Reason not specified|81|||
37636084|NCT01564537|69103401|FG001|Overall Study|Reason not specified|82|||
37636085|NCT03042611|69103412|FG000|Core Phase|Withdrawal by Subject|13|||
37636086|NCT03042611|69103413|FG001|Core Phase|Withdrawal by Subject|4|||
37636087|NCT03042611|69103414|FG002|Core Phase|Withdrawal by Subject|0|||
37636088|NCT03042611|69103415|FG003|Core Phase|Withdrawal by Subject|0|||
37636089|NCT03042611|69103412|FG000|Core Phase|Death|232|||
37636090|NCT03042611|69103413|FG001|Core Phase|Death|110|||
37636091|NCT03042611|69103414|FG002|Core Phase|Death|0|||
37636092|NCT03042611|69103415|FG003|Core Phase|Death|0|||
37636093|NCT03042611|69103412|FG000|Core Phase|Lost to Follow-up|4|||
37636094|NCT03042611|69103413|FG001|Core Phase|Lost to Follow-up|7|||
37636095|NCT03042611|69103414|FG002|Core Phase|Lost to Follow-up|0|||
37636096|NCT03042611|69103415|FG003|Core Phase|Lost to Follow-up|0|||
37636097|NCT03042611|69103412|FG000|Core Phase|Physician Decision|7|||
37636098|NCT03042611|69103413|FG001|Core Phase|Physician Decision|2|||
37636099|NCT03042611|69103414|FG002|Core Phase|Physician Decision|0|||
37636100|NCT03042611|69103415|FG003|Core Phase|Physician Decision|0|||
37636101|NCT03042611|69103412|FG000|Core Phase|Study Closed|0|||
37636102|NCT03042611|69103413|FG001|Core Phase|Study Closed|1|||
37636103|NCT03042611|69103414|FG002|Core Phase|Study Closed|0|||
37636104|NCT03042611|69103415|FG003|Core Phase|Study Closed|0|||
37636105|NCT03042611|69103412|FG000|Extension Phase|Death|0|||
37636106|NCT03042611|69103413|FG001|Extension Phase|Death|0|||
37636107|NCT03042611|69103414|FG002|Extension Phase|Death|34|||
37636108|NCT03042611|69103415|FG003|Extension Phase|Death|16|||
37636109|NCT03042611|69103412|FG000|Extension Phase|Lost to Follow-up|0|||
37636110|NCT03042611|69103413|FG001|Extension Phase|Lost to Follow-up|0|||
37636111|NCT03042611|69103414|FG002|Extension Phase|Lost to Follow-up|1|||
37636112|NCT03042611|69103415|FG003|Extension Phase|Lost to Follow-up|1|||
37636113|NCT03042611|69103412|FG000|Extension Phase|Study Closed|0|||
37636114|NCT03042611|69103413|FG001|Extension Phase|Study Closed|0|||
37636115|NCT03042611|69103414|FG002|Extension Phase|Study Closed|17|||
37636116|NCT03042611|69103415|FG003|Extension Phase|Study Closed|11|||
37636117|NCT02701634|69103423|FG000|Overall Study|Adverse Event|2|||
37636118|NCT02701634|69103424|FG001|Overall Study|Adverse Event|3|||
37636119|NCT02701634|69103423|FG000|Overall Study|Death|1|||
37636120|NCT02701634|69103424|FG001|Overall Study|Death|0|||
37636121|NCT02701634|69103423|FG000|Overall Study|Investigator's Discretion|7|||
37636122|NCT02701634|69103424|FG001|Overall Study|Investigator's Discretion|4|||
37636123|NCT02701634|69103423|FG000|Overall Study|Study terminated by Sponsor|15|||
37636124|NCT02701634|69103424|FG001|Overall Study|Study terminated by Sponsor|17|||
37636125|NCT02701634|69103423|FG000|Overall Study|Withdrew Consent|6|||
37636126|NCT02701634|69103424|FG001|Overall Study|Withdrew Consent|7|||
37636127|NCT02701634|69103423|FG000|Overall Study|Randomized but not treated|1|||
37636128|NCT02701634|69103424|FG001|Overall Study|Randomized but not treated|0|||
37636129|NCT02442765|69103434|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
37636130|NCT02442765|69103435|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
37636131|NCT02442765|69103436|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
37636132|NCT02442765|69103437|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
37636133|NCT02442765|69103438|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
37636134|NCT02442765|69103439|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
37636135|NCT02442765|69103440|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
37636136|NCT02442765|69103441|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
37636137|NCT02442765|69103434|FG000|Stage 2- (Days 43 to 85)|Death|0|||
37636138|NCT02442765|69103435|FG001|Stage 2- (Days 43 to 85)|Death|0|||
37636139|NCT02442765|69103436|FG002|Stage 2- (Days 43 to 85)|Death|0|||
37636140|NCT02442765|69103437|FG003|Stage 2- (Days 43 to 85)|Death|1|||
37636141|NCT02442765|69103438|FG004|Stage 2- (Days 43 to 85)|Death|1|||
37636142|NCT02442765|69103439|FG005|Stage 2- (Days 43 to 85)|Death|0|||
37636143|NCT02442765|69103440|FG006|Stage 2- (Days 43 to 85)|Death|2|||
37636144|NCT02442765|69103441|FG007|Stage 2- (Days 43 to 85)|Death|0|||
37636145|NCT02442765|69103434|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
37636146|NCT02442765|69103435|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
37636147|NCT02442765|69103436|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
37636148|NCT02442765|69103437|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
37636149|NCT02442765|69103438|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
37636150|NCT02442765|69103439|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
37636151|NCT02442765|69103440|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
37636152|NCT02442765|69103441|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
37636153|NCT02442765|69103434|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
37636154|NCT02442765|69103435|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
37636155|NCT02442765|69103436|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
37636156|NCT02442765|69103437|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
37636157|NCT02442765|69103438|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
37636158|NCT02442765|69103439|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
37636159|NCT02442765|69103440|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
37636160|NCT02442765|69103441|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
37636161|NCT02442765|69103434|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
37636162|NCT02442765|69103435|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
37636163|NCT02442765|69103436|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
37636164|NCT02442765|69103437|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
37636165|NCT02442765|69103438|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
37636166|NCT02442765|69103439|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
37636167|NCT02442765|69103440|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
37636168|NCT02442765|69103441|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
37636169|NCT02442765|69103434|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
37636170|NCT02442765|69103435|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
37636171|NCT02442765|69103436|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
37636172|NCT02442765|69103437|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
37636173|NCT02442765|69103438|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
37636174|NCT02442765|69103439|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
37636175|NCT02442765|69103440|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
37636176|NCT02442765|69103441|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
37636177|NCT02442765|69103434|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
37636178|NCT02442765|69103435|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
37636179|NCT02442765|69103436|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
37636180|NCT02442765|69103437|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
37636181|NCT02442765|69103438|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
37636182|NCT02442765|69103439|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
37636183|NCT02442765|69103440|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
37636184|NCT02442765|69103441|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
37636185|NCT02442765|69103434|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
37636186|NCT02442765|69103435|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
37636187|NCT02442765|69103436|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
37636188|NCT02442765|69103437|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
37636189|NCT02442765|69103438|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
37636190|NCT02442765|69103439|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
37636191|NCT02442765|69103440|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
37636192|NCT02442765|69103441|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
37636193|NCT02699684|69103472|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
37636194|NCT02699684|69103473|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
37921844|NCT00818454|69608690|FG001|Treatment Period 1|Other|0|||
37921845|NCT00818454|69608691|FG002|Treatment Period 1|Other|0|||
37921846|NCT00818454|69608692|FG003|Treatment Period 1|Other|0|||
37636195|NCT02700698|69103482|FG000|Overall Study|Withdrawal by Subject|1|||
37636196|NCT02700698|69103483|FG001|Overall Study|Withdrawal by Subject|0|||
37636197|NCT01774721|69103491|FG000|Overall Study|Death|133|||
37636198|NCT01774721|69103492|FG001|Overall Study|Death|152|||
37636199|NCT01774721|69103491|FG000|Overall Study|Withdrawal by Subject|20|||
37636200|NCT01774721|69103492|FG001|Overall Study|Withdrawal by Subject|14|||
37636201|NCT01774721|69103491|FG000|Overall Study|Lost to Follow-up|6|||
37636202|NCT01774721|69103492|FG001|Overall Study|Lost to Follow-up|7|||
37921847|NCT00818454|69608689|FG000|Washout Period of 1 Week|Adverse Event|1|||
37636203|NCT01774721|69103491|FG000|Overall Study|Did not meet eligibility criteria|0|||
37636204|NCT01774721|69103492|FG001|Overall Study|Did not meet eligibility criteria|3|||
37636205|NCT01774721|69103491|FG000|Overall Study|Other reasons and patients who completed the 48-month follow-up period|58|||
37636206|NCT01774721|69103492|FG001|Overall Study|Other reasons and patients who completed the 48-month follow-up period|49|||
37636207|NCT01774721|69103491|FG000|Overall Study|Study terminated by sponsor|5|||
37636208|NCT01774721|69103492|FG001|Overall Study|Study terminated by sponsor|0|||
37636209|NCT01774721|69103491|FG000|Overall Study|Disease progression|5|||
37636210|NCT01774721|69103492|FG001|Overall Study|Disease progression|0|||
37636211|NCT02699450|69103504|FG000|Overall Study|Death|2|||
37636212|NCT02699450|69103505|FG001|Overall Study|Death|1|||
37636213|NCT02699450|69103506|FG002|Overall Study|Death|2|||
37636214|NCT02699450|69103504|FG000|Overall Study|Met Criteria for Study Exit|0|||
37636215|NCT02699450|69103505|FG001|Overall Study|Met Criteria for Study Exit|0|||
37636216|NCT02699450|69103506|FG002|Overall Study|Met Criteria for Study Exit|1|||
37636217|NCT02699450|69103504|FG000|Overall Study|Protocol Violation|4|||
37636218|NCT02699450|69103505|FG001|Overall Study|Protocol Violation|3|||
37636219|NCT02699450|69103506|FG002|Overall Study|Protocol Violation|5|||
37636220|NCT02699450|69103504|FG000|Overall Study|Lost to Follow-up|3|||
37636221|NCT02699450|69103505|FG001|Overall Study|Lost to Follow-up|0|||
37636222|NCT02699450|69103506|FG002|Overall Study|Lost to Follow-up|5|||
37636223|NCT02699450|69103504|FG000|Overall Study|Physician Decision|2|||
37636224|NCT02699450|69103505|FG001|Overall Study|Physician Decision|0|||
37636225|NCT02699450|69103506|FG002|Overall Study|Physician Decision|0|||
37636226|NCT02699450|69103504|FG000|Overall Study|Withdrawal by Subject|3|||
37636227|NCT02699450|69103505|FG001|Overall Study|Withdrawal by Subject|1|||
37636228|NCT02699450|69103506|FG002|Overall Study|Withdrawal by Subject|2|||
37636229|NCT02699450|69103504|FG000|Overall Study|Adverse Event|1|||
37636230|NCT02699450|69103505|FG001|Overall Study|Adverse Event|0|||
37636231|NCT02699450|69103506|FG002|Overall Study|Adverse Event|0|||
37636232|NCT02699996|69103517|FG000|Overall Study|Withdrawal by Subject|5|||
37636233|NCT02699996|69103518|FG001|Overall Study|Withdrawal by Subject|2|||
37636234|NCT02739321|69103527|FG000|Overall Study|Lack of Efficacy|1|||
37636235|NCT02739321|69103528|FG001|Overall Study|Lack of Efficacy|1|||
37636236|NCT02739321|69103527|FG000|Overall Study|Lost to Follow-up|1|||
37636237|NCT02739321|69103528|FG001|Overall Study|Lost to Follow-up|1|||
37636238|NCT02739321|69103527|FG000|Overall Study|Withdrawal by Subject|1|||
37636239|NCT02739321|69103528|FG001|Overall Study|Withdrawal by Subject|2|||
37636240|NCT02696798|69103546|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
37636241|NCT02696798|69103547|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
37636242|NCT02696798|69103548|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
37636243|NCT02696798|69103546|FG000|Blinded Treatment Dosing Period|Death|0|||
37636244|NCT02696798|69103547|FG001|Blinded Treatment Dosing Period|Death|0|||
37636245|NCT02696798|69103548|FG002|Blinded Treatment Dosing Period|Death|1|||
37636246|NCT02696798|69103546|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
37636247|NCT02696798|69103547|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
37636248|NCT02696798|69103548|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
37636249|NCT02696798|69103546|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
37636250|NCT02696798|69103547|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
37636251|NCT02696798|69103548|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
37636252|NCT02696798|69103546|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
37636253|NCT02696798|69103547|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
37636254|NCT02696798|69103548|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
37636255|NCT02696798|69103546|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
37636256|NCT02696798|69103547|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
37636257|NCT02696798|69103548|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
37636258|NCT02696798|69103546|FG000|Extended Treatment Period|Adverse Event|1|||
37636259|NCT02696798|69103547|FG001|Extended Treatment Period|Adverse Event|4|||
37636260|NCT02696798|69103548|FG002|Extended Treatment Period|Adverse Event|5|||
37636261|NCT02696798|69103546|FG000|Extended Treatment Period|Lack of Efficacy|7|||
37636262|NCT02696798|69103547|FG001|Extended Treatment Period|Lack of Efficacy|2|||
37636263|NCT02696798|69103548|FG002|Extended Treatment Period|Lack of Efficacy|2|||
37921848|NCT00818454|69608690|FG001|Washout Period of 1 Week|Adverse Event|1|||
37636264|NCT02696798|69103546|FG000|Extended Treatment Period|Lost to Follow-up|1|||
38032066|NCT03334448|69717987|FG000|Washout|Personal Reason|0|||
38032067|NCT03334448|69717988|FG001|Washout|Personal Reason|1|||
38032068|NCT03334448|69717989|FG002|Washout|Personal Reason|0|||
37636265|NCT02696798|69103547|FG001|Extended Treatment Period|Lost to Follow-up|0|||
37636266|NCT02696798|69103548|FG002|Extended Treatment Period|Lost to Follow-up|0|||
37636267|NCT02696798|69103546|FG000|Extended Treatment Period|Physician Decision|0|||
37636268|NCT02696798|69103547|FG001|Extended Treatment Period|Physician Decision|1|||
37636269|NCT02696798|69103548|FG002|Extended Treatment Period|Physician Decision|0|||
37636270|NCT02696798|69103546|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
37636271|NCT02696798|69103547|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
37636272|NCT02696798|69103548|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
37636273|NCT02696798|69103546|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
37636274|NCT02696798|69103547|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
37636275|NCT02696798|69103548|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
37636276|NCT02696798|69103546|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
37636277|NCT02696798|69103547|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
37636278|NCT02696798|69103548|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
37636279|NCT02696798|69103546|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
37636280|NCT02696798|69103547|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
37636281|NCT02696798|69103548|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
37853674|NCT01236573|69537499|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
37853675|NCT01236573|69537489|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
37853676|NCT01236573|69537490|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
37853677|NCT01236573|69537491|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
37853678|NCT01236573|69537492|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
37853679|NCT01236573|69537493|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
37853680|NCT01236573|69537494|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
37853681|NCT01236573|69537495|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
37853682|NCT01236573|69537496|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
38032069|NCT03334448|69717990|FG003|Washout|Personal Reason|0|||
38032070|NCT03334448|69717987|FG000|Washout|Protocol Violation|0|||
37636282|NCT02696798|69103546|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
37636283|NCT02696798|69103547|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
37636284|NCT02696798|69103548|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
37636285|NCT02696798|69103546|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
37636286|NCT02696798|69103547|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
37636287|NCT02696798|69103548|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
37636288|NCT02696798|69103546|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
37636289|NCT02696798|69103547|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
37636290|NCT02696798|69103548|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
37636291|NCT02698826|69103570|FG000|Overall Study|Death|13|||
37636292|NCT02698826|69103570|FG000|Overall Study|Adverse Event|1|||
37636293|NCT02541604|69103588|FG000|Overall Study|Death|6|||
37636294|NCT02541604|69103589|FG001|Overall Study|Death|5|||
37636295|NCT02541604|69103590|FG002|Overall Study|Death|7|||
37636296|NCT02541604|69103591|FG003|Overall Study|Death|2|||
37636297|NCT02541604|69103592|FG004|Overall Study|Death|9|||
37636298|NCT02541604|69103593|FG005|Overall Study|Death|8|||
37636299|NCT02541604|69103594|FG006|Overall Study|Death|9|||
37636300|NCT02541604|69103595|FG007|Overall Study|Death|9|||
37636301|NCT02541604|69103596|FG008|Overall Study|Death|3|||
37636302|NCT02541604|69103597|FG009|Overall Study|Death|4|||
37636303|NCT02541604|69103598|FG010|Overall Study|Death|2|||
37636304|NCT02541604|69103599|FG011|Overall Study|Death|3|||
37636305|NCT02541604|69103588|FG000|Overall Study|Lost to Follow-up|2|||
37636306|NCT02541604|69103589|FG001|Overall Study|Lost to Follow-up|0|||
37636307|NCT02541604|69103590|FG002|Overall Study|Lost to Follow-up|1|||
37636308|NCT02541604|69103591|FG003|Overall Study|Lost to Follow-up|0|||
37636309|NCT02541604|69103592|FG004|Overall Study|Lost to Follow-up|0|||
37636310|NCT02541604|69103593|FG005|Overall Study|Lost to Follow-up|1|||
37636311|NCT02541604|69103594|FG006|Overall Study|Lost to Follow-up|1|||
37636312|NCT02541604|69103595|FG007|Overall Study|Lost to Follow-up|0|||
37636313|NCT02541604|69103596|FG008|Overall Study|Lost to Follow-up|0|||
37636314|NCT02541604|69103597|FG009|Overall Study|Lost to Follow-up|0|||
37636315|NCT02541604|69103598|FG010|Overall Study|Lost to Follow-up|0|||
37636316|NCT02541604|69103599|FG011|Overall Study|Lost to Follow-up|0|||
37636317|NCT02541604|69103588|FG000|Overall Study|Withdrawal by Subject|2|||
37636318|NCT02541604|69103589|FG001|Overall Study|Withdrawal by Subject|0|||
37636319|NCT02541604|69103590|FG002|Overall Study|Withdrawal by Subject|1|||
37636320|NCT02541604|69103591|FG003|Overall Study|Withdrawal by Subject|0|||
37739571|NCT01437267|69223299|FG000|Overall Study|Protocol Violation|0|||
37739572|NCT01437267|69223300|FG001|Overall Study|Protocol Violation|1|||
37739573|NCT01437267|69223301|FG002|Overall Study|Protocol Violation|0|||
37739574|NCT01437267|69223302|FG003|Overall Study|Protocol Violation|0|||
37739575|NCT01437267|69223303|FG004|Overall Study|Protocol Violation|0|||
38032071|NCT03334448|69717988|FG001|Washout|Protocol Violation|0|||
37636321|NCT02541604|69103592|FG004|Overall Study|Withdrawal by Subject|1|||
37636322|NCT02541604|69103593|FG005|Overall Study|Withdrawal by Subject|1|||
37636323|NCT02541604|69103594|FG006|Overall Study|Withdrawal by Subject|0|||
37636324|NCT02541604|69103595|FG007|Overall Study|Withdrawal by Subject|0|||
37636325|NCT02541604|69103596|FG008|Overall Study|Withdrawal by Subject|1|||
37636326|NCT02541604|69103597|FG009|Overall Study|Withdrawal by Subject|0|||
37636327|NCT02541604|69103598|FG010|Overall Study|Withdrawal by Subject|0|||
37636328|NCT02541604|69103599|FG011|Overall Study|Withdrawal by Subject|0|||
37636329|NCT02541604|69103588|FG000|Overall Study|Study Terminated by Sponsor|1|||
37636330|NCT02541604|69103589|FG001|Overall Study|Study Terminated by Sponsor|4|||
37636331|NCT02541604|69103590|FG002|Overall Study|Study Terminated by Sponsor|2|||
37636332|NCT02541604|69103591|FG003|Overall Study|Study Terminated by Sponsor|1|||
37636333|NCT02541604|69103592|FG004|Overall Study|Study Terminated by Sponsor|0|||
37636334|NCT02541604|69103593|FG005|Overall Study|Study Terminated by Sponsor|0|||
37636335|NCT02541604|69103594|FG006|Overall Study|Study Terminated by Sponsor|0|||
37636336|NCT02541604|69103595|FG007|Overall Study|Study Terminated by Sponsor|0|||
37636337|NCT02541604|69103596|FG008|Overall Study|Study Terminated by Sponsor|0|||
37636338|NCT02541604|69103597|FG009|Overall Study|Study Terminated by Sponsor|0|||
37636339|NCT02541604|69103598|FG010|Overall Study|Study Terminated by Sponsor|0|||
37739576|NCT01437267|69223304|FG005|Overall Study|Protocol Violation|0|||
37739577|NCT01456221|69223333|FG000|Overall Study|Withdrawal by Subject|56|||
37739578|NCT01456221|69223334|FG001|Overall Study|Withdrawal by Subject|49|||
37739579|NCT01456221|69223333|FG000|Overall Study|Lost to Follow-up|1|||
37739580|NCT01456221|69223334|FG001|Overall Study|Lost to Follow-up|4|||
37739581|NCT01456221|69223333|FG000|Overall Study|Received medication|3|||
37739582|NCT01456221|69223334|FG001|Overall Study|Received medication|2|||
37739583|NCT01456221|69223333|FG000|Overall Study|Incomplete data|4|||
37739584|NCT01456221|69223334|FG001|Overall Study|Incomplete data|2|||
37739585|NCT01437111|69223340|FG000|Overall Study|Adverse Event|2|||
37739586|NCT01437111|69223340|FG000|Overall Study|Withdrawal by Subject|4|||
37739587|NCT01437111|69223340|FG000|Overall Study|Not reported|5|||
37739588|NCT01437111|69223340|FG000|Overall Study|Physician Decision|1|||
37739589|NCT01437111|69223340|FG000|Overall Study|Lost to Follow-up|5|||
37739590|NCT01437111|69223340|FG000|Overall Study|Protocol Violation|1|||
37739591|NCT01436643|69223388|FG000|2-week Pre-treatment|Abnormal test result|0|||
37739592|NCT01436643|69223389|FG001|2-week Pre-treatment|Abnormal test result|0|||
37739593|NCT01436643|69223390|FG002|2-week Pre-treatment|Abnormal test result|0|||
37739594|NCT01436643|69223391|FG003|2-week Pre-treatment|Abnormal test result|1|||
37739595|NCT01436643|69223388|FG000|2-week Pre-treatment|Adverse Event|0|||
37739596|NCT01436643|69223389|FG001|2-week Pre-treatment|Adverse Event|0|||
37739597|NCT01436643|69223390|FG002|2-week Pre-treatment|Adverse Event|0|||
37739598|NCT01436643|69223391|FG003|2-week Pre-treatment|Adverse Event|5|||
37739599|NCT01436643|69223388|FG000|2-week Pre-treatment|Protocol Violation|0|||
37739600|NCT01436643|69223389|FG001|2-week Pre-treatment|Protocol Violation|0|||
37739601|NCT01436643|69223390|FG002|2-week Pre-treatment|Protocol Violation|0|||
37739602|NCT01436643|69223391|FG003|2-week Pre-treatment|Protocol Violation|4|||
37739603|NCT01436643|69223388|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
37739604|NCT01436643|69223389|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
37739605|NCT01436643|69223390|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
37739606|NCT01436643|69223391|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
37739607|NCT01436643|69223388|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
37739608|NCT01436643|69223389|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
37739609|NCT01436643|69223390|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
37739610|NCT01436643|69223391|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
37739611|NCT01436643|69223388|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
37739612|NCT01436643|69223389|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
37739613|NCT01436643|69223390|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
37739614|NCT01436643|69223391|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
37739615|NCT01454739|69223489|FG000|Overall Study|Protocol Violation|2|||
37739616|NCT01454739|69223490|FG001|Overall Study|Protocol Violation|3|||
37739617|NCT01454739|69223489|FG000|Overall Study|Withdrawal by Subject|2|||
37739618|NCT01454739|69223490|FG001|Overall Study|Withdrawal by Subject|6|||
37739619|NCT01454739|69223489|FG000|Overall Study|Other|3|||
37739620|NCT01454739|69223490|FG001|Overall Study|Other|5|||
37739621|NCT01454739|69223489|FG000|Overall Study|Physician Decision|0|||
37739622|NCT01454739|69223490|FG001|Overall Study|Physician Decision|5|||
37739623|NCT01454739|69223489|FG000|Overall Study|Lost to Follow-up|0|||
37739624|NCT01454739|69223490|FG001|Overall Study|Lost to Follow-up|1|||
37739625|NCT01454739|69223489|FG000|Overall Study|Adverse Event|0|||
37739626|NCT01454739|69223490|FG001|Overall Study|Adverse Event|1|||
37739627|NCT01416441|69223528|FG000|Overall Study|Lost to Follow-up|5|||
37739628|NCT01416441|69223528|FG000|Overall Study|Adverse Event|6|||
37636340|NCT02541604|69103599|FG011|Overall Study|Study Terminated by Sponsor|0|||
37636341|NCT02541604|69103588|FG000|Overall Study|Medical condition may jeopardize safety|0|||
37636342|NCT02541604|69103589|FG001|Overall Study|Medical condition may jeopardize safety|0|||
37636343|NCT02541604|69103590|FG002|Overall Study|Medical condition may jeopardize safety|0|||
37636344|NCT02541604|69103591|FG003|Overall Study|Medical condition may jeopardize safety|0|||
37636345|NCT02541604|69103592|FG004|Overall Study|Medical condition may jeopardize safety|0|||
37636346|NCT02541604|69103593|FG005|Overall Study|Medical condition may jeopardize safety|0|||
37636347|NCT02541604|69103594|FG006|Overall Study|Medical condition may jeopardize safety|0|||
37636348|NCT02541604|69103595|FG007|Overall Study|Medical condition may jeopardize safety|1|||
37739629|NCT01416441|69223528|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
37739630|NCT01416441|69223528|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
37739631|NCT01416441|69223528|FG000|Overall Study|Investigator Withdrew Subject|2|||
37739632|NCT01416441|69223528|FG000|Overall Study|Subject Withdrew Consent|12|||
37636349|NCT02541604|69103596|FG008|Overall Study|Medical condition may jeopardize safety|0|||
37636350|NCT02541604|69103597|FG009|Overall Study|Medical condition may jeopardize safety|0|||
37636351|NCT02541604|69103598|FG010|Overall Study|Medical condition may jeopardize safety|0|||
37636352|NCT02541604|69103599|FG011|Overall Study|Medical condition may jeopardize safety|0|||
37636353|NCT02546674|69103648|FG000|Overall Study|Adverse Event|19|||
37636354|NCT02546674|69103648|FG000|Overall Study|Death|1|||
37636355|NCT02546674|69103648|FG000|Overall Study|Lost to Follow-up|1|||
37853683|NCT01236573|69537497|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
38032072|NCT03334448|69717989|FG002|Washout|Protocol Violation|0|||
37636356|NCT02546674|69103648|FG000|Overall Study|Physician Decision|13|||
37636357|NCT02546674|69103648|FG000|Overall Study|Pregnancy|1|||
37636358|NCT02546674|69103648|FG000|Overall Study|Progressive Disease|2|||
37636359|NCT02546674|69103648|FG000|Overall Study|Protocol Deviation|2|||
37636360|NCT02546674|69103648|FG000|Overall Study|Subject/Guardian Decision|6|||
37636361|NCT02546674|69103648|FG000|Overall Study|Withdrawal of Informed Consent|3|||
37636362|NCT02546362|69103653|FG000|4-week Treatment Period|Lost to Follow-up|1|||
37636363|NCT02546362|69103653|FG000|4-week Treatment Period|Change in medication|2|||
37636364|NCT02546362|69103653|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
37636365|NCT02546362|69103653|FG000|12-week Treatment Period|Lost to Follow-up|2|||
37636366|NCT02546362|69103653|FG000|12-week Treatment Period|Change in medication|1|||
37636367|NCT02698436|69103659|FG000|Overall Study|Adverse Event|1|||
37636368|NCT02698436|69103660|FG001|Overall Study|Adverse Event|0|||
37636369|NCT02698436|69103659|FG000|Overall Study|Withdrawal by Subject|3|||
37739633|NCT01416441|69223528|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
37739634|NCT01436253|69223537|FG000|Overall Study|Lost to Follow-up|182|||
37739635|NCT01436253|69223537|FG000|Overall Study|Not meeting all eligibility criteria|117|||
37739636|NCT01454583|69224450|FG000|1st Year|Lost to Follow-up|1057|||
37739637|NCT01454583|69224451|FG001|1st Year|Lost to Follow-up|318|||
37739638|NCT01454583|69224452|FG002|1st Year|Lost to Follow-up|180|||
37739639|NCT01454583|69224450|FG000|2nd Year|Lost to Follow-up|3965|||
37739640|NCT01454583|69224451|FG001|2nd Year|Lost to Follow-up|1049|||
37739641|NCT01454583|69224452|FG002|2nd Year|Lost to Follow-up|737|||
37739642|NCT01454583|69224450|FG000|3rd Year|Lost to Follow-up|1959|||
37739643|NCT01454583|69224451|FG001|3rd Year|Lost to Follow-up|512|||
37739644|NCT01454583|69224452|FG002|3rd Year|Lost to Follow-up|297|||
37739645|NCT01436175|69224475|FG000|Overall Study|Adverse Event|111|||
37739646|NCT01436175|69224475|FG000|Overall Study|Protocol Violation|49|||
37739647|NCT01436175|69224475|FG000|Overall Study|Withdrawal by Subject|108|||
37739648|NCT01436175|69224475|FG000|Overall Study|Lost to Follow-up|89|||
37739649|NCT01436175|69224475|FG000|Overall Study|Lack of Efficacy|24|||
37739650|NCT01436175|69224475|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
37739651|NCT01436175|69224475|FG000|Overall Study|Other|826|||
37739652|NCT01453725|69224503|FG000|Overall Study|Adverse Event|3|||
37739653|NCT01453725|69224504|FG001|Overall Study|Adverse Event|3|||
37739654|NCT01453725|69224503|FG000|Overall Study|Lost to Follow-up|4|||
37739655|NCT01453725|69224504|FG001|Overall Study|Lost to Follow-up|0|||
37739656|NCT01453725|69224503|FG000|Overall Study|Non-compliance With Protocol|1|||
37739657|NCT01453725|69224504|FG001|Overall Study|Non-compliance With Protocol|2|||
37739658|NCT01453725|69224503|FG000|Overall Study|Protocol Violation|1|||
37739659|NCT01453725|69224504|FG001|Overall Study|Protocol Violation|0|||
37739660|NCT01453725|69224503|FG000|Overall Study|Withdrawal by Subject|2|||
37739661|NCT01453725|69224504|FG001|Overall Study|Withdrawal by Subject|3|||
37739662|NCT01453725|69224503|FG000|Overall Study|Pregnancy Wish|0|||
37739663|NCT01453725|69224504|FG001|Overall Study|Pregnancy Wish|2|||
37739664|NCT01453725|69224503|FG000|Overall Study|Pregnancy|1|||
37739665|NCT01453725|69224504|FG001|Overall Study|Pregnancy|0|||
37739666|NCT01453725|69224503|FG000|Overall Study|Physician Decision|1|||
37739667|NCT01453725|69224504|FG001|Overall Study|Physician Decision|1|||
37739668|NCT01415349|69224543|FG000|Treatment Period 1|Adverse Event|0|||
37739669|NCT01415349|69224544|FG001|Treatment Period 1|Adverse Event|1|||
37739670|NCT01415349|69224543|FG000|Treatment Period 1|Withdrawal by Subject|0|||
37739671|NCT01415349|69224544|FG001|Treatment Period 1|Withdrawal by Subject|1|||
37739672|NCT01453023|69224598|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
37739673|NCT01453023|69224599|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
37739674|NCT01453023|69224598|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
37739675|NCT01453023|69224599|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
37739676|NCT01453023|69224598|FG000|Treatment Period 2|Protocol Violation|0|||
37739677|NCT01453023|69224599|FG001|Treatment Period 2|Protocol Violation|1|||
37739678|NCT01452789|69224607|FG000|Overall Study|Withdrawal by Subject|3|||
37739679|NCT01452789|69224608|FG001|Overall Study|Withdrawal by Subject|2|||
37739680|NCT01451931|69224617|FG000|Overall Study|Lost to Follow-up|17|||
37739681|NCT01451931|69224618|FG001|Overall Study|Lost to Follow-up|36|||
37739682|NCT01451931|69224619|FG002|Overall Study|Lost to Follow-up|21|||
37739683|NCT01451931|69224617|FG000|Overall Study|Withdrawal by Subject|16|||
37739684|NCT01451931|69224618|FG001|Overall Study|Withdrawal by Subject|22|||
37636370|NCT02698436|69103660|FG001|Overall Study|Withdrawal by Subject|3|||
37636371|NCT02698436|69103659|FG000|Overall Study|Lost to Follow-up|2|||
37636372|NCT02698436|69103660|FG001|Overall Study|Lost to Follow-up|4|||
37636373|NCT02698436|69103659|FG000|Overall Study|Non-compliance with study regimen|1|||
37636374|NCT02698436|69103660|FG001|Overall Study|Non-compliance with study regimen|0|||
37636375|NCT02694536|69103666|FG000|Overall Study|Progressive Disease|40|||
37636376|NCT02694536|69103666|FG000|Overall Study|Lost to Follow-up|1|||
37636377|NCT02694536|69103666|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
37636378|NCT02694536|69103666|FG000|Overall Study|Withdrawal by Subject|8|||
37636379|NCT02694536|69103666|FG000|Overall Study|Death|8|||
37636380|NCT02694536|69103666|FG000|Overall Study|Other|22|||
37636381|NCT01661686|69103672|FG000|Overall Study|Lost to Follow-up|2|||
37636382|NCT01661686|69103673|FG001|Overall Study|Lost to Follow-up|1|||
37636383|NCT01661686|69103672|FG000|Overall Study|did not receive allocated intervention|0|||
37636384|NCT01661686|69103673|FG001|Overall Study|did not receive allocated intervention|1|||
37636385|NCT02696096|69103679|FG000|Overall Study|ruled out at screening|1|||
37636386|NCT02696096|69103679|FG000|Overall Study|did not attend second fMRI|1|||
37636387|NCT02695628|69103687|FG000|Overall Study|Withdrawal by Subject|1|||
37636388|NCT02693834|69103691|FG000|Baseline Measurement|Withdrawal by Subject|1|||
37636389|NCT02693834|69103692|FG001|Baseline Measurement|Withdrawal by Subject|0|||
37636390|NCT02693834|69103691|FG000|Baseline Measurement|Adverse Event|1|||
37636391|NCT02693834|69103692|FG001|Baseline Measurement|Adverse Event|0|||
37636392|NCT02693834|69103691|FG000|Week 2 Practice|Adverse Event|0|||
37636393|NCT02693834|69103692|FG001|Week 2 Practice|Adverse Event|1|||
37636394|NCT02545504|69103700|FG000|Overall Study|Death|174|||
37636395|NCT02545504|69103701|FG001|Overall Study|Death|168|||
37636396|NCT02545504|69103700|FG000|Overall Study|Unknown reason|30|||
37636397|NCT02545504|69103701|FG001|Overall Study|Unknown reason|32|||
37636398|NCT02545504|69103700|FG000|Overall Study|Withdrew consent|9|||
37636399|NCT02545504|69103701|FG001|Overall Study|Withdrew consent|11|||
37636400|NCT02545504|69103700|FG000|Overall Study|Investigator's discretion|3|||
37636401|NCT02545504|69103701|FG001|Overall Study|Investigator's discretion|1|||
37636402|NCT02545504|69103700|FG000|Overall Study|Lost to Follow-up|2|||
37636403|NCT02545504|69103701|FG001|Overall Study|Lost to Follow-up|2|||
37636404|NCT02545270|69103714|FG000|Overall Study|technical difficulties|0|||
37636405|NCT02545270|69103715|FG001|Overall Study|technical difficulties|1|||
37636406|NCT02545270|69103716|FG002|Overall Study|technical difficulties|0|||
37636407|NCT02545270|69103714|FG000|Overall Study|Videos being too similar to other|0|||
37636408|NCT02545270|69103715|FG001|Overall Study|Videos being too similar to other|0|||
37636409|NCT02545270|69103716|FG002|Overall Study|Videos being too similar to other|2|||
37853684|NCT01236573|69537498|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
37853685|NCT01236573|69537499|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
37853686|NCT01236339|69537526|FG000|Overall Study|Termination of study by sponsor|11|||
37853687|NCT01236339|69537527|FG001|Overall Study|Termination of study by sponsor|13|||
37853688|NCT01262898|69537538|FG000|Overall Study|Protocol Violation|1|||
37853689|NCT01262898|69537539|FG001|Overall Study|Protocol Violation|1|||
37853690|NCT01262898|69537540|FG002|Overall Study|Protocol Violation|0|||
37853691|NCT01262898|69537541|FG003|Overall Study|Protocol Violation|0|||
37853692|NCT01262898|69537538|FG000|Overall Study|Lost to Follow-up|1|||
37853693|NCT01262898|69537539|FG001|Overall Study|Lost to Follow-up|0|||
37853694|NCT01262898|69537540|FG002|Overall Study|Lost to Follow-up|0|||
37853695|NCT01262898|69537541|FG003|Overall Study|Lost to Follow-up|0|||
37853696|NCT01262898|69537538|FG000|Overall Study|Withdrawal by Subject|1|||
37853697|NCT01262898|69537539|FG001|Overall Study|Withdrawal by Subject|1|||
37853698|NCT01262898|69537540|FG002|Overall Study|Withdrawal by Subject|0|||
37853699|NCT01262898|69537541|FG003|Overall Study|Withdrawal by Subject|0|||
37853700|NCT01262820|69537554|FG000|Overall Study|Adverse Event|5|||
37853701|NCT01262820|69537554|FG000|Overall Study|Lack of Efficacy|9|||
37853702|NCT01262820|69537554|FG000|Overall Study|Drug held for 21+ days|1|||
37853703|NCT01057810|69537560|FG000|Overall Study|Disease progression|156|||
37636410|NCT02540668|69103725|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
37636411|NCT02540668|69103726|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
37636412|NCT02535364|69103750|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
37636413|NCT02535364|69103750|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
37636414|NCT02535364|69103750|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
37636415|NCT02535364|69103750|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
37636416|NCT02535364|69103750|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
37636417|NCT02535364|69103750|FG000|Part B Screening|Death|2|||
37636418|NCT02535364|69103750|FG000|Part B Screening|Physician Decision|1|||
37636419|NCT02535364|69103750|FG000|Part B Screening|Withdrawal by Subject|1|||
37636420|NCT02535364|69103750|FG000|Part B Screening|Adverse Event|1|||
37636421|NCT02535364|69103750|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
37853704|NCT01057810|69537561|FG001|Overall Study|Disease progression|197|||
37853705|NCT01057810|69537560|FG000|Overall Study|Study drug toxicity|5|||
37853706|NCT01057810|69537561|FG001|Overall Study|Study drug toxicity|114|||
37853707|NCT01057810|69537560|FG000|Overall Study|Adverse event unrelated to study drug|13|||
37636422|NCT02535364|69103750|FG000|Study Treatment|Death|1|||
37636423|NCT02535364|69103750|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
37636424|NCT02535364|69103750|FG000|12-Month Follow-up Period|Disease progression|22|||
37853708|NCT01057810|69537561|FG001|Overall Study|Adverse event unrelated to study drug|29|||
37853709|NCT01057810|69537560|FG000|Overall Study|Withdrawal by Subject|10|||
37853710|NCT01057810|69537561|FG001|Overall Study|Withdrawal by Subject|25|||
37853711|NCT01057810|69537560|FG000|Overall Study|Death|2|||
37853712|NCT01057810|69537561|FG001|Overall Study|Death|12|||
37853713|NCT01057810|69537560|FG000|Overall Study|Maximum clinical benefit|5|||
37853714|NCT01057810|69537561|FG001|Overall Study|Maximum clinical benefit|5|||
37853715|NCT01057810|69537560|FG000|Overall Study|Poor/non-compliance|0|||
37853716|NCT01057810|69537561|FG001|Overall Study|Poor/non-compliance|1|||
37853717|NCT01057810|69537560|FG000|Overall Study|No longer met study criteria|0|||
37853718|NCT01057810|69537561|FG001|Overall Study|No longer met study criteria|1|||
37853719|NCT01057810|69537560|FG000|Overall Study|Other|7|||
37853720|NCT01057810|69537561|FG001|Overall Study|Other|14|||
37853721|NCT01262352|69537569|FG000|Period 1|Illness after randomization|1|||
37853722|NCT01262352|69537570|FG001|Period 1|Illness after randomization|0|||
37853723|NCT01262352|69537569|FG000|Washout|Adverse Event|1|||
37853724|NCT01262352|69537570|FG001|Washout|Adverse Event|1|||
37853725|NCT01262352|69537569|FG000|Washout|Extended Washout|0|||
37636425|NCT02535364|69103750|FG000|12-Month Follow-up Period|Death|5|||
37636426|NCT02535364|69103750|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
37636427|NCT02535364|69103750|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
37636428|NCT02535364|69103750|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
37636429|NCT02540356|69103756|FG000|Overall Study|Terminated due to disease progression|1|||
37636430|NCT02540356|69103757|FG001|Overall Study|Terminated due to disease progression|0|||
37636431|NCT02534896|69103765|FG000|Overall Study|Adverse Event|2|||
37636432|NCT02534896|69103766|FG001|Overall Study|Adverse Event|1|||
37636433|NCT02534896|69103767|FG002|Overall Study|Adverse Event|1|||
37636434|NCT02534896|69103765|FG000|Overall Study|Insufficient therapeutic response|2|||
37636435|NCT02534896|69103766|FG001|Overall Study|Insufficient therapeutic response|0|||
37636436|NCT02534896|69103767|FG002|Overall Study|Insufficient therapeutic response|0|||
37636437|NCT02697734|69103777|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
37636438|NCT02697734|69103778|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
37636439|NCT02697734|69103777|FG000|Core Phase - up to Week 48|Adverse Event|1|||
37636440|NCT02697734|69103778|FG001|Core Phase - up to Week 48|Adverse Event|2|||
37636441|NCT02697734|69103777|FG000|Core Phase - up to Week 48|Physician Decision|1|||
37636442|NCT02697734|69103778|FG001|Core Phase - up to Week 48|Physician Decision|0|||
37636443|NCT02697734|69103777|FG000|Optional Extension Phase|Adverse Event|5|||
37636444|NCT02697734|69103778|FG001|Optional Extension Phase|Adverse Event|1|||
37636445|NCT02697734|69103777|FG000|Optional Extension Phase|Physician Decision|0|||
37636446|NCT02697734|69103778|FG001|Optional Extension Phase|Physician Decision|1|||
37636447|NCT02692586|69103792|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
37636448|NCT02692586|69103792|FG000|Overall Study|Received adjunctive thrombolytics|2|||
37636449|NCT02534350|69103798|FG000|Overall Study|Randomized But Not Treated|1|||
37636450|NCT02534350|69103799|FG001|Overall Study|Randomized But Not Treated|0|||
37636451|NCT02534350|69103798|FG000|Overall Study|Protocol Violation|1|||
37636452|NCT02534350|69103799|FG001|Overall Study|Protocol Violation|0|||
37636453|NCT02534350|69103798|FG000|Overall Study|Withdrew Consent|2|||
37636454|NCT02534350|69103799|FG001|Overall Study|Withdrew Consent|0|||
37636455|NCT02688764|69103807|FG000|Overall Study|Adverse Event|3|||
37636456|NCT02688764|69103808|FG001|Overall Study|Adverse Event|3|||
37636457|NCT02688764|69103807|FG000|Overall Study|AE/Kidney transplant|1|||
37636458|NCT02688764|69103808|FG001|Overall Study|AE/Kidney transplant|0|||
37739685|NCT01451931|69224619|FG002|Overall Study|Withdrawal by Subject|22|||
37739686|NCT01414257|69224642|FG000|Overall Study|No Visit After First Day of Treatment|12|||
37739687|NCT01414257|69224642|FG000|Overall Study|Protocol Violation|10|||
37739688|NCT01434693|69224685|FG000|Overall Study|Adverse Event|1|||
37853726|NCT01262352|69537570|FG001|Washout|Extended Washout|1|||
37853727|NCT01299272|69537576|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
37853728|NCT01299272|69537577|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
37853729|NCT01299272|69537578|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
37853730|NCT01299272|69537579|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
38032073|NCT03334448|69717990|FG003|Washout|Protocol Violation|1|||
38032074|NCT02849080|69717998|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
37636459|NCT02688764|69103807|FG000|Overall Study|AE/Lack of efficacy|1|||
37636460|NCT02688764|69103808|FG001|Overall Study|AE/Lack of efficacy|0|||
37636461|NCT02688764|69103807|FG000|Overall Study|AE/Non-compl.|1|||
37636462|NCT02688764|69103808|FG001|Overall Study|AE/Non-compl.|0|||
37636463|NCT02688764|69103807|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
37636464|NCT02688764|69103808|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
37636465|NCT02688764|69103807|FG000|Overall Study|AE/Other|0|||
37636466|NCT02688764|69103808|FG001|Overall Study|AE/Other|1|||
37853731|NCT01299272|69537576|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
37853732|NCT01299272|69537577|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
37636467|NCT02688764|69103807|FG000|Overall Study|AE/Physician decision|1|||
37636468|NCT02688764|69103808|FG001|Overall Study|AE/Physician decision|0|||
37636469|NCT02688764|69103807|FG000|Overall Study|AE/Withd. parent|3|||
37636470|NCT02688764|69103808|FG001|Overall Study|AE/Withd. parent|0|||
37636471|NCT02688764|69103807|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
37636472|NCT02688764|69103808|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
37636473|NCT02688764|69103807|FG000|Overall Study|AE/Withd. subject|1|||
37636474|NCT02688764|69103808|FG001|Overall Study|AE/Withd. subject|0|||
37636475|NCT02688764|69103807|FG000|Overall Study|Kidney transplant|10|||
37636476|NCT02688764|69103808|FG001|Overall Study|Kidney transplant|4|||
37636477|NCT02688764|69103807|FG000|Overall Study|Lack of Efficacy|3|||
37636478|NCT02688764|69103808|FG001|Overall Study|Lack of Efficacy|2|||
37636479|NCT02688764|69103807|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
37636480|NCT02688764|69103808|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
37636481|NCT02688764|69103807|FG000|Overall Study|Non-compliance with study drug|4|||
37636482|NCT02688764|69103808|FG001|Overall Study|Non-compliance with study drug|0|||
37636483|NCT02688764|69103807|FG000|Overall Study|Non-compl./Physician decision|2|||
37636484|NCT02688764|69103808|FG001|Overall Study|Non-compl./Physician decision|0|||
37636485|NCT02688764|69103807|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
37636486|NCT02688764|69103808|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
37636487|NCT02688764|69103807|FG000|Overall Study|Non-compl./Withd. subject|0|||
37636488|NCT02688764|69103808|FG001|Overall Study|Non-compl./Withd. subject|2|||
37636489|NCT02688764|69103807|FG000|Overall Study|Phosphorus level outside safe range|0|||
37636490|NCT02688764|69103808|FG001|Overall Study|Phosphorus level outside safe range|1|||
37636491|NCT02688764|69103807|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
37636492|NCT02688764|69103808|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
37636493|NCT02688764|69103807|FG000|Overall Study|Study drug taste/Withd. parent|1|||
37636494|NCT02688764|69103808|FG001|Overall Study|Study drug taste/Withd. parent|0|||
37636495|NCT02688764|69103807|FG000|Overall Study|Subject moving out|2|||
37636496|NCT02688764|69103808|FG001|Overall Study|Subject moving out|0|||
37636497|NCT02688764|69103807|FG000|Overall Study|Subject taken off dialysis|1|||
37636498|NCT02688764|69103808|FG001|Overall Study|Subject taken off dialysis|0|||
37636499|NCT02688764|69103807|FG000|Overall Study|Withdrawal by parent|3|||
37636500|NCT02688764|69103808|FG001|Overall Study|Withdrawal by parent|0|||
37636501|NCT02688608|69103817|FG000|Overall Study|Lost to Follow-up|1|||
37853733|NCT01299272|69537578|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
37853734|NCT01299272|69537579|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
37853735|NCT01299272|69537576|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
37853736|NCT01299272|69537577|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
38032075|NCT02849080|69717999|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
37636502|NCT02688530|69103825|FG000|Overall Study|Withdrawal by Subject|0|||
37636503|NCT02688530|69103826|FG001|Overall Study|Withdrawal by Subject|1|||
37636504|NCT02688530|69103827|FG002|Overall Study|Withdrawal by Subject|0|||
37636505|NCT02688530|69103828|FG003|Overall Study|Withdrawal by Subject|0|||
37636506|NCT02688530|69103825|FG000|Overall Study|Lost to Follow-up|0|||
37636507|NCT02688530|69103826|FG001|Overall Study|Lost to Follow-up|0|||
37636508|NCT02688530|69103827|FG002|Overall Study|Lost to Follow-up|2|||
37636509|NCT02688530|69103828|FG003|Overall Study|Lost to Follow-up|0|||
37636510|NCT02467270|69103845|FG000|Overall Study|Participants Never Treated|0|||
37636511|NCT02467270|69103846|FG001|Overall Study|Participants Never Treated|1|||
37636512|NCT02467270|69103847|FG002|Overall Study|Participants Never Treated|0|||
37636513|NCT02467270|69103845|FG000|Overall Study|Ongoing|50|||
37636514|NCT02467270|69103846|FG001|Overall Study|Ongoing|41|||
37636515|NCT02467270|69103847|FG002|Overall Study|Ongoing|43|||
37636516|NCT02467270|69103845|FG000|Overall Study|Adverse Event|16|||
37636517|NCT02467270|69103846|FG001|Overall Study|Adverse Event|15|||
37636518|NCT02467270|69103847|FG002|Overall Study|Adverse Event|14|||
37636519|NCT02467270|69103845|FG000|Overall Study|Progressive Disease|7|||
37636520|NCT02467270|69103846|FG001|Overall Study|Progressive Disease|7|||
37636521|NCT02467270|69103847|FG002|Overall Study|Progressive Disease|4|||
37636522|NCT02467270|69103845|FG000|Overall Study|Death|2|||
37636523|NCT02467270|69103846|FG001|Overall Study|Death|0|||
37636524|NCT02467270|69103847|FG002|Overall Study|Death|2|||
37636525|NCT02467270|69103845|FG000|Overall Study|Lack of Efficacy|12|||
37636526|NCT02467270|69103846|FG001|Overall Study|Lack of Efficacy|18|||
37636527|NCT02467270|69103847|FG002|Overall Study|Lack of Efficacy|23|||
37636528|NCT02467270|69103845|FG000|Overall Study|Non-compliance With Study Drug|0|||
37636529|NCT02467270|69103846|FG001|Overall Study|Non-compliance With Study Drug|2|||
37739689|NCT01434693|69224686|FG001|Overall Study|Adverse Event|0|||
38032076|NCT02849080|69718000|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
38032077|NCT02849080|69718001|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
37636530|NCT02467270|69103847|FG002|Overall Study|Non-compliance With Study Drug|1|||
37636531|NCT02467270|69103845|FG000|Overall Study|Lost to Follow-up|2|||
37636532|NCT02467270|69103846|FG001|Overall Study|Lost to Follow-up|1|||
37636533|NCT02467270|69103847|FG002|Overall Study|Lost to Follow-up|0|||
37636534|NCT02467270|69103845|FG000|Overall Study|Pregnancy|0|||
37636535|NCT02467270|69103846|FG001|Overall Study|Pregnancy|1|||
37636536|NCT02467270|69103847|FG002|Overall Study|Pregnancy|0|||
37636537|NCT02467270|69103845|FG000|Overall Study|Physician Decision|0|||
37636538|NCT02467270|69103846|FG001|Overall Study|Physician Decision|4|||
37636539|NCT02467270|69103847|FG002|Overall Study|Physician Decision|1|||
37636540|NCT02467270|69103845|FG000|Overall Study|Withdrawal by Subject|4|||
37636541|NCT02467270|69103846|FG001|Overall Study|Withdrawal by Subject|3|||
37636542|NCT02467270|69103847|FG002|Overall Study|Withdrawal by Subject|5|||
37636543|NCT02467270|69103845|FG000|Overall Study|Reason not Specified|1|||
37636544|NCT02467270|69103846|FG001|Overall Study|Reason not Specified|2|||
37636545|NCT02467270|69103847|FG002|Overall Study|Reason not Specified|1|||
37636546|NCT05083559|69103857|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
37636547|NCT05083559|69103858|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
37636548|NCT05083559|69103857|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
37636549|NCT05083559|69103858|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
37636550|NCT05083559|69103857|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
37636551|NCT05083559|69103858|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
37853737|NCT01299272|69537578|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
37853738|NCT01299272|69537579|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
37853739|NCT01299272|69537576|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
37853740|NCT01299272|69537577|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
37853741|NCT01299272|69537578|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
37853742|NCT01299272|69537579|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
37853743|NCT01299272|69537576|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
37853744|NCT01299272|69537577|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
37636552|NCT03037307|69103864|FG000|Period 1|Did Not Meet Study Criteria|0|||
37636553|NCT03037307|69103865|FG001|Period 1|Did Not Meet Study Criteria|0|||
37636554|NCT03037307|69103866|FG002|Period 1|Did Not Meet Study Criteria|0|||
37636555|NCT03037307|69103867|FG003|Period 1|Did Not Meet Study Criteria|1|||
37636556|NCT03037307|69103868|FG004|Period 1|Did Not Meet Study Criteria|0|||
37636557|NCT03037307|69103869|FG005|Period 1|Did Not Meet Study Criteria|0|||
37636558|NCT02538094|69103878|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
37636559|NCT02538094|69103879|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
37636560|NCT02538094|69103878|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
37636561|NCT02538094|69103879|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
37636562|NCT02686034|69103887|FG000|Run-In Period 1|Eligibility|12|||
37636563|NCT02686034|69103888|FG001|Run-In Period 1|Eligibility|10|||
37636564|NCT02686034|69103887|FG000|Run-In Period 1|Withdrawal by Subject|4|||
37636565|NCT02686034|69103888|FG001|Run-In Period 1|Withdrawal by Subject|3|||
37636566|NCT02686034|69103887|FG000|Run-In Period 1|Lost to Follow-up|4|||
37636567|NCT02686034|69103888|FG001|Run-In Period 1|Lost to Follow-up|4|||
37636568|NCT02686034|69103887|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
37636569|NCT02686034|69103888|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
37636570|NCT02686034|69103887|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
37739690|NCT01434693|69224687|FG002|Overall Study|Adverse Event|0|||
37739691|NCT01434693|69224688|FG003|Overall Study|Adverse Event|0|||
37739692|NCT01434693|69224685|FG000|Overall Study|Withdrawal by Subject|1|||
37739693|NCT01434693|69224686|FG001|Overall Study|Withdrawal by Subject|0|||
37739694|NCT01434693|69224687|FG002|Overall Study|Withdrawal by Subject|1|||
37739695|NCT01434693|69224688|FG003|Overall Study|Withdrawal by Subject|1|||
37739696|NCT01434693|69224685|FG000|Overall Study|Lost to Follow-up|1|||
37739697|NCT01434693|69224686|FG001|Overall Study|Lost to Follow-up|0|||
37739698|NCT01434693|69224687|FG002|Overall Study|Lost to Follow-up|0|||
37739699|NCT01434693|69224688|FG003|Overall Study|Lost to Follow-up|0|||
37739700|NCT01451541|69224705|FG000|Overall Study|Adverse Event|4|||
37739701|NCT01451541|69224706|FG001|Overall Study|Adverse Event|3|||
37739702|NCT01451541|69224707|FG002|Overall Study|Adverse Event|6|||
37739703|NCT01451541|69224705|FG000|Overall Study|Lack of Efficacy|2|||
37739704|NCT01451541|69224706|FG001|Overall Study|Lack of Efficacy|0|||
37739705|NCT01451541|69224707|FG002|Overall Study|Lack of Efficacy|0|||
37739706|NCT01451541|69224705|FG000|Overall Study|Lost to Follow-up|4|||
37739707|NCT01451541|69224706|FG001|Overall Study|Lost to Follow-up|4|||
37739708|NCT01451541|69224707|FG002|Overall Study|Lost to Follow-up|7|||
37739709|NCT01451541|69224705|FG000|Overall Study|Withdrawal by Subject|15|||
37739710|NCT01451541|69224706|FG001|Overall Study|Withdrawal by Subject|8|||
37739711|NCT01451541|69224707|FG002|Overall Study|Withdrawal by Subject|6|||
37739712|NCT01451541|69224705|FG000|Overall Study|randomization error, noncompliance|11|||
37636571|NCT02686034|69103888|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
37739713|NCT01451541|69224706|FG001|Overall Study|randomization error, noncompliance|10|||
37739714|NCT01451541|69224707|FG002|Overall Study|randomization error, noncompliance|8|||
37739715|NCT01450761|69224835|FG000|Randomization|Subject no longer meets study criteria|1|||
37739716|NCT01450761|69224836|FG001|Randomization|Subject no longer meets study criteria|2|||
37739717|NCT01450761|69224835|FG000|Randomization|Withdrawal by Subject|2|||
37636572|NCT02686034|69103887|FG000|Randomized Controlled Period 2|Adverse Event|0|||
37636573|NCT02686034|69103888|FG001|Randomized Controlled Period 2|Adverse Event|2|||
37636574|NCT02686034|69103887|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
37636575|NCT02686034|69103888|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
37636576|NCT02686034|69103887|FG000|Open Label Period 3|Lost to Follow-up|0|||
37636577|NCT02686034|69103888|FG001|Open Label Period 3|Lost to Follow-up|1|||
37636578|NCT02685488|69103896|FG000|Overall Study|Withdrawal by Subject|0|||
37636579|NCT02685488|69103897|FG001|Overall Study|Withdrawal by Subject|1|||
37636580|NCT02533570|69103906|FG000|Overall Study|Adverse Event|0|||
37636581|NCT02533570|69103907|FG001|Overall Study|Adverse Event|1|||
37636582|NCT02533570|69103908|FG002|Overall Study|Adverse Event|1|||
37636583|NCT03036839|69103919|FG000|Overall Study|Adverse Event|0|||
37636584|NCT03036839|69103920|FG001|Overall Study|Adverse Event|0|||
37636585|NCT03036839|69103921|FG002|Overall Study|Adverse Event|1|||
37636586|NCT03036839|69103919|FG000|Overall Study|Death|3|||
37636587|NCT03036839|69103920|FG001|Overall Study|Death|0|||
37636588|NCT03036839|69103921|FG002|Overall Study|Death|3|||
37636589|NCT03036839|69103919|FG000|Overall Study|Withdrew Consent|0|||
37636590|NCT03036839|69103920|FG001|Overall Study|Withdrew Consent|0|||
37636591|NCT03036839|69103921|FG002|Overall Study|Withdrew Consent|1|||
37636592|NCT01286207|69103932|FG000|Overall Study|Adverse Event|27|||
37636593|NCT01286207|69103933|FG001|Overall Study|Adverse Event|41|||
37636594|NCT01286207|69103934|FG002|Overall Study|Adverse Event|8|||
37636595|NCT01286207|69103932|FG000|Overall Study|Lost to Follow-up|49|||
37636596|NCT01286207|69103933|FG001|Overall Study|Lost to Follow-up|43|||
37636597|NCT01286207|69103934|FG002|Overall Study|Lost to Follow-up|20|||
37636598|NCT01286207|69103932|FG000|Overall Study|Withdrawal by Subject|93|||
37636599|NCT01286207|69103933|FG001|Overall Study|Withdrawal by Subject|79|||
37636600|NCT01286207|69103934|FG002|Overall Study|Withdrawal by Subject|41|||
37636601|NCT01286207|69103932|FG000|Overall Study|Lack of Response|92|||
37636602|NCT01286207|69103933|FG001|Overall Study|Lack of Response|38|||
37636603|NCT01286207|69103934|FG002|Overall Study|Lack of Response|8|||
37636604|NCT01286207|69103932|FG000|Overall Study|Other|37|||
37636605|NCT01286207|69103933|FG001|Overall Study|Other|47|||
37636606|NCT01286207|69103934|FG002|Overall Study|Other|13|||
37636607|NCT00968201|69103971|FG000|Base Study - (Period II)|Adverse Event|8|||
37636608|NCT00968201|69103972|FG001|Base Study - (Period II)|Adverse Event|0|||
37636609|NCT00968201|69103973|FG002|Base Study - (Period II)|Adverse Event|16|||
37636610|NCT00968201|69103971|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
37636611|NCT00968201|69103972|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
37636612|NCT00968201|69103973|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
37636613|NCT00968201|69103971|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
37636614|NCT00968201|69103972|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
37636615|NCT00968201|69103973|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
37636616|NCT00968201|69103971|FG000|Base Study - (Period II)|Protocol Violation|12|||
37636617|NCT00968201|69103972|FG001|Base Study - (Period II)|Protocol Violation|0|||
37636618|NCT00968201|69103973|FG002|Base Study - (Period II)|Protocol Violation|12|||
37636619|NCT00968201|69103971|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
37636620|NCT00968201|69103972|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
37636621|NCT00968201|69103973|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
37636622|NCT00968201|69103971|FG000|Base Study - (Period II)|Site Error|0|||
37636623|NCT00968201|69103972|FG001|Base Study - (Period II)|Site Error|0|||
37636624|NCT00968201|69103973|FG002|Base Study - (Period II)|Site Error|1|||
37636625|NCT00968201|69103971|FG000|Extension Study - (Period III)|Adverse Event|0|||
37636626|NCT00968201|69103972|FG001|Extension Study - (Period III)|Adverse Event|5|||
37636627|NCT00968201|69103973|FG002|Extension Study - (Period III)|Adverse Event|22|||
37636628|NCT00968201|69103971|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
37636629|NCT00968201|69103972|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
37636630|NCT00968201|69103973|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
37636631|NCT00968201|69103971|FG000|Extension Study - (Period III)|Protocol Violation|0|||
37636632|NCT00968201|69103972|FG001|Extension Study - (Period III)|Protocol Violation|17|||
37636633|NCT00968201|69103973|FG002|Extension Study - (Period III)|Protocol Violation|14|||
37739718|NCT01450761|69224836|FG001|Randomization|Withdrawal by Subject|0|||
37739719|NCT01450761|69224835|FG000|Randomization|Disease progression|0|||
37636634|NCT00968201|69103971|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
37636635|NCT00968201|69103972|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
37739720|NCT01450761|69224836|FG001|Randomization|Disease progression|2|||
37636636|NCT00968201|69103973|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
37636637|NCT00968201|69103971|FG000|Extension Study - (Period III)|Patient Relocated|0|||
37636638|NCT00968201|69103972|FG001|Extension Study - (Period III)|Patient Relocated|1|||
37636639|NCT00968201|69103973|FG002|Extension Study - (Period III)|Patient Relocated|1|||
37636640|NCT00968201|69103971|FG000|Extension Study - (Period III)|Noncompliance|0|||
37636641|NCT00968201|69103972|FG001|Extension Study - (Period III)|Noncompliance|0|||
37739721|NCT01450761|69224835|FG000|Randomization|Adverse Event unrelated to study drug|1|||
37636642|NCT00968201|69103973|FG002|Extension Study - (Period III)|Noncompliance|3|||
37636643|NCT00968201|69103971|FG000|Extension Study - (Period III)|Other|0|||
37636644|NCT00968201|69103972|FG001|Extension Study - (Period III)|Other|0|||
37636645|NCT00968201|69103973|FG002|Extension Study - (Period III)|Other|2|||
37636646|NCT00968201|69103971|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
37636647|NCT00968201|69103972|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
37636648|NCT00968201|69103973|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
37636649|NCT00943397|69103984|FG000|Overall Study|Adverse Event|0|||
37636650|NCT00943397|69103985|FG001|Overall Study|Adverse Event|6|||
37636651|NCT00943397|69103984|FG000|Overall Study|Lost to Follow-up|0|||
37636652|NCT00943397|69103985|FG001|Overall Study|Lost to Follow-up|4|||
37636653|NCT00943397|69103984|FG000|Overall Study|Protocol Violation|2|||
37636654|NCT00943397|69103985|FG001|Overall Study|Protocol Violation|5|||
37636655|NCT00943397|69103984|FG000|Overall Study|Withdrawal by Subject|1|||
37636656|NCT00943397|69103985|FG001|Overall Study|Withdrawal by Subject|1|||
37636657|NCT00943397|69103984|FG000|Overall Study|Site terminated and other|12|||
37636658|NCT00943397|69103985|FG001|Overall Study|Site terminated and other|56|||
37636659|NCT00702845|69103993|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
37636660|NCT00702845|69103994|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
37636661|NCT00702845|69103993|FG000|Overall Study|Too high ovarian response|5|||
37636662|NCT00702845|69103994|FG001|Overall Study|Too high ovarian response|1|||
37636663|NCT00702845|69103993|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
37636664|NCT00702845|69103994|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
37636665|NCT00702845|69103993|FG000|Overall Study|Insufficient ovarian response|1|||
37739722|NCT01450761|69224836|FG001|Randomization|Adverse Event unrelated to study drug|0|||
37739723|NCT01450761|69224835|FG000|Randomization|Other|0|||
37739724|NCT01450761|69224836|FG001|Randomization|Other|1|||
37739725|NCT01450761|69224835|FG000|Lead-in Chemotherapy|Disease progression|33|||
37739726|NCT01450761|69224836|FG001|Lead-in Chemotherapy|Disease progression|32|||
37739727|NCT01450761|69224835|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
37739728|NCT01450761|69224836|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
37739729|NCT01450761|69224835|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
37739730|NCT01450761|69224836|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
37739731|NCT01450761|69224835|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
37739732|NCT01450761|69224836|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
37739733|NCT01450761|69224835|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
37739734|NCT01450761|69224836|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
37739735|NCT01450761|69224835|FG000|Lead-in Chemotherapy|Death|3|||
37739736|NCT01450761|69224836|FG001|Lead-in Chemotherapy|Death|3|||
37739737|NCT01450761|69224835|FG000|Lead-in Chemotherapy|Other|2|||
37739738|NCT01450761|69224836|FG001|Lead-in Chemotherapy|Other|2|||
37739739|NCT01450761|69224835|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
37739740|NCT01450761|69224836|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
37739741|NCT01450761|69224835|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
37739742|NCT01450761|69224836|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
37739743|NCT01450761|69224835|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
37739744|NCT01450761|69224836|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
37739745|NCT01450761|69224835|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
37739746|NCT01450761|69224836|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
37739747|NCT01450761|69224835|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
37739748|NCT01450761|69224836|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
37739749|NCT01450761|69224835|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
37739750|NCT01450761|69224836|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
37739751|NCT01450761|69224835|FG000|Treatment With Blinded Study Therapy|Death|5|||
37739752|NCT01450761|69224836|FG001|Treatment With Blinded Study Therapy|Death|6|||
37739753|NCT01450761|69224835|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
37739754|NCT01450761|69224836|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
37739755|NCT01450761|69224835|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
37636666|NCT00702845|69103994|FG001|Overall Study|Insufficient ovarian response|0|||
37636667|NCT00702845|69103993|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
37636668|NCT00702845|69103994|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
37636669|NCT00702845|69103993|FG000|Overall Study|No or abnormal fertilization|4|||
37636670|NCT00702845|69103994|FG001|Overall Study|No or abnormal fertilization|2|||
37636671|NCT00702845|69103993|FG000|Overall Study|Patient's decision|2|||
37636672|NCT00702845|69103994|FG001|Overall Study|Patient's decision|1|||
37739756|NCT01450761|69224836|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
37739757|NCT01450761|69224835|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
37636673|NCT00702845|69103993|FG000|Overall Study|Not randomized|0|||
37636674|NCT00702845|69103994|FG001|Overall Study|Not randomized|1|||
37636675|NCT01302847|69104008|FG000|Overall Study|Ongoing|0|||
37636676|NCT01302847|69104009|FG001|Overall Study|Ongoing|0|||
37636677|NCT01302847|69104010|FG002|Overall Study|Ongoing|0|||
37636678|NCT01302847|69104011|FG003|Overall Study|Ongoing|0|||
37636679|NCT01302847|69104012|FG004|Overall Study|Ongoing|0|||
37636680|NCT01302847|69104013|FG005|Overall Study|Ongoing|27|||
37636681|NCT01302847|69104014|FG006|Overall Study|Ongoing|22|||
37636682|NCT01302847|69104015|FG007|Overall Study|Ongoing|17|||
37636683|NCT01302847|69104008|FG000|Overall Study|Death|0|||
37636684|NCT01302847|69104009|FG001|Overall Study|Death|1|||
37636685|NCT01302847|69104010|FG002|Overall Study|Death|0|||
37636686|NCT01302847|69104011|FG003|Overall Study|Death|0|||
37636687|NCT01302847|69104012|FG004|Overall Study|Death|0|||
37636688|NCT01302847|69104013|FG005|Overall Study|Death|1|||
37636689|NCT01302847|69104014|FG006|Overall Study|Death|1|||
37636690|NCT01302847|69104015|FG007|Overall Study|Death|0|||
37636691|NCT01302847|69104008|FG000|Overall Study|Pregnancy|2|||
37636692|NCT01302847|69104009|FG001|Overall Study|Pregnancy|0|||
37636693|NCT01302847|69104010|FG002|Overall Study|Pregnancy|0|||
37636694|NCT01302847|69104011|FG003|Overall Study|Pregnancy|0|||
37636695|NCT01302847|69104012|FG004|Overall Study|Pregnancy|0|||
37636696|NCT01302847|69104013|FG005|Overall Study|Pregnancy|0|||
37739758|NCT01450761|69224836|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
37739759|NCT01450761|69224835|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
37739760|NCT01450761|69224836|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
37739761|NCT01450761|69224835|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
37739762|NCT01450761|69224836|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
37739763|NCT01450761|69224835|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
37739764|NCT01450761|69224836|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
37739765|NCT01450761|69224835|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
37739766|NCT01450761|69224836|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
37739767|NCT01433991|69224886|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
37739768|NCT01433991|69224887|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
37739769|NCT01433991|69224888|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
37739770|NCT01433991|69224889|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
37739771|NCT01433991|69224886|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
37636697|NCT01302847|69104014|FG006|Overall Study|Pregnancy|0|||
37636698|NCT01302847|69104015|FG007|Overall Study|Pregnancy|0|||
37636699|NCT01302847|69104008|FG000|Overall Study|Virologic failure|0|||
37636700|NCT01302847|69104009|FG001|Overall Study|Virologic failure|2|||
37636701|NCT01302847|69104010|FG002|Overall Study|Virologic failure|2|||
37636702|NCT01302847|69104011|FG003|Overall Study|Virologic failure|0|||
37636703|NCT01302847|69104012|FG004|Overall Study|Virologic failure|1|||
37636704|NCT01302847|69104013|FG005|Overall Study|Virologic failure|1|||
37739772|NCT01433991|69224887|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
37853745|NCT01299272|69537578|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
37853746|NCT01299272|69537579|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
37853747|NCT01299272|69537576|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
37853748|NCT01299272|69537577|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
37853749|NCT01299272|69537578|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
37853750|NCT01299272|69537579|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
37853751|NCT01299272|69537576|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
37853752|NCT01299272|69537577|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
37853753|NCT01299272|69537578|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
37921849|NCT00818454|69608691|FG002|Washout Period of 1 Week|Adverse Event|0|||
37921850|NCT00818454|69608692|FG003|Washout Period of 1 Week|Adverse Event|0|||
37921851|NCT00818454|69608689|FG000|Washout Period of 1 Week|Protocol Violation|2|||
37921852|NCT00818454|69608690|FG001|Washout Period of 1 Week|Protocol Violation|0|||
37921853|NCT00818454|69608691|FG002|Washout Period of 1 Week|Protocol Violation|0|||
37921854|NCT00818454|69608692|FG003|Washout Period of 1 Week|Protocol Violation|0|||
37921855|NCT00818454|69608689|FG000|Washout Period of 1 Week|Other|1|||
37921856|NCT00818454|69608690|FG001|Washout Period of 1 Week|Other|2|||
37921857|NCT00818454|69608691|FG002|Washout Period of 1 Week|Other|0|||
37921858|NCT00818454|69608692|FG003|Washout Period of 1 Week|Other|0|||
37921859|NCT00818454|69608689|FG000|Treatment Period 2|Other|2|||
37636705|NCT01302847|69104014|FG006|Overall Study|Virologic failure|0|||
37636706|NCT01302847|69104015|FG007|Overall Study|Virologic failure|2|||
37636707|NCT01302847|69104008|FG000|Overall Study|Severe debilitation, unable to continue|0|||
37636708|NCT01302847|69104009|FG001|Overall Study|Severe debilitation, unable to continue|0|||
37636709|NCT01302847|69104010|FG002|Overall Study|Severe debilitation, unable to continue|0|||
37636710|NCT01302847|69104011|FG003|Overall Study|Severe debilitation, unable to continue|0|||
37636711|NCT01302847|69104012|FG004|Overall Study|Severe debilitation, unable to continue|0|||
37636712|NCT01302847|69104013|FG005|Overall Study|Severe debilitation, unable to continue|1|||
37636713|NCT01302847|69104014|FG006|Overall Study|Severe debilitation, unable to continue|1|||
37636714|NCT01302847|69104015|FG007|Overall Study|Severe debilitation, unable to continue|0|||
37636715|NCT01302847|69104008|FG000|Overall Study|Not able to get to clinic|1|||
37636716|NCT01302847|69104009|FG001|Overall Study|Not able to get to clinic|1|||
37636717|NCT01302847|69104010|FG002|Overall Study|Not able to get to clinic|0|||
37636718|NCT01302847|69104011|FG003|Overall Study|Not able to get to clinic|0|||
37636719|NCT01302847|69104012|FG004|Overall Study|Not able to get to clinic|0|||
37636720|NCT01302847|69104013|FG005|Overall Study|Not able to get to clinic|0|||
37636721|NCT01302847|69104014|FG006|Overall Study|Not able to get to clinic|0|||
37636722|NCT01302847|69104015|FG007|Overall Study|Not able to get to clinic|0|||
37636723|NCT01302847|69104008|FG000|Overall Study|Site closing|2|||
37636724|NCT01302847|69104009|FG001|Overall Study|Site closing|2|||
37636725|NCT01302847|69104010|FG002|Overall Study|Site closing|0|||
37636726|NCT01302847|69104011|FG003|Overall Study|Site closing|0|||
37636727|NCT01302847|69104012|FG004|Overall Study|Site closing|0|||
37853754|NCT01299272|69537579|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
37853755|NCT01299272|69537576|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
37853756|NCT01299272|69537577|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
37853757|NCT01299272|69537578|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
37853758|NCT01299272|69537579|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
37853759|NCT01299272|69537576|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
37853760|NCT01299272|69537577|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
37853761|NCT01299272|69537578|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
37853762|NCT01299272|69537579|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
37853763|NCT01299272|69537576|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
37853764|NCT01299272|69537577|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
37853765|NCT01299272|69537578|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
37853766|NCT01299272|69537579|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
37853767|NCT01299272|69537576|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
37853768|NCT01299272|69537577|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
37853769|NCT01299272|69537578|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
37853770|NCT01299272|69537579|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
37853771|NCT01299272|69537576|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
37853772|NCT01299272|69537577|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
37853773|NCT01299272|69537578|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
37853774|NCT01299272|69537579|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
37853775|NCT01299272|69537576|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
37853776|NCT01299272|69537577|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
37853777|NCT01299272|69537578|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
37636728|NCT01302847|69104013|FG005|Overall Study|Site closing|0|||
37636729|NCT01302847|69104014|FG006|Overall Study|Site closing|0|||
37636730|NCT01302847|69104015|FG007|Overall Study|Site closing|0|||
37636731|NCT01302847|69104008|FG000|Overall Study|Withdrawal by Subject|1|||
37636732|NCT01302847|69104009|FG001|Overall Study|Withdrawal by Subject|0|||
37636733|NCT01302847|69104010|FG002|Overall Study|Withdrawal by Subject|0|||
37636734|NCT01302847|69104011|FG003|Overall Study|Withdrawal by Subject|0|||
37636735|NCT01302847|69104012|FG004|Overall Study|Withdrawal by Subject|1|||
37636736|NCT01302847|69104013|FG005|Overall Study|Withdrawal by Subject|0|||
37636737|NCT01302847|69104014|FG006|Overall Study|Withdrawal by Subject|0|||
37636738|NCT01302847|69104015|FG007|Overall Study|Withdrawal by Subject|1|||
37636739|NCT01302847|69104008|FG000|Overall Study|Not willing to adhere to requirements|5|||
37636740|NCT01302847|69104009|FG001|Overall Study|Not willing to adhere to requirements|0|||
37739773|NCT01433991|69224888|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
37739774|NCT01433991|69224889|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
37739775|NCT01433991|69224886|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
37739776|NCT01433991|69224887|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
37921860|NCT00818454|69608690|FG001|Treatment Period 2|Other|1|||
37739777|NCT01433991|69224888|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
37853778|NCT01299272|69537579|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
37853779|NCT01299272|69537576|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
37853780|NCT01299272|69537577|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
37853781|NCT01299272|69537578|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
37853782|NCT01299272|69537579|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
37853783|NCT01299272|69537576|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
37921861|NCT00818454|69608691|FG002|Treatment Period 2|Other|0|||
37921862|NCT00818454|69608692|FG003|Treatment Period 2|Other|0|||
37921863|NCT00818454|69608689|FG000|Treatment Period 3|Adverse Event|0|||
37921864|NCT00818454|69608690|FG001|Treatment Period 3|Adverse Event|0|||
37636741|NCT01302847|69104010|FG002|Overall Study|Not willing to adhere to requirements|0|||
37636742|NCT01302847|69104011|FG003|Overall Study|Not willing to adhere to requirements|1|||
37636743|NCT01302847|69104012|FG004|Overall Study|Not willing to adhere to requirements|0|||
37636744|NCT01302847|69104013|FG005|Overall Study|Not willing to adhere to requirements|0|||
37853784|NCT01299272|69537577|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
37853785|NCT01299272|69537578|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
37853786|NCT01299272|69537579|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
37853787|NCT01299272|69537576|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
37853788|NCT01299272|69537577|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
37853789|NCT01299272|69537578|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
37853790|NCT01299272|69537579|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
37853791|NCT01299272|69537576|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
37853792|NCT01299272|69537577|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
37853793|NCT01299272|69537578|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
37853794|NCT01299272|69537579|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
37853795|NCT01299272|69537576|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
37853796|NCT01299272|69537577|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
37853797|NCT01299272|69537578|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
37853798|NCT01299272|69537579|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
37853799|NCT01299272|69537576|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
37853800|NCT01299272|69537577|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
37853801|NCT01299272|69537578|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
37853802|NCT01299272|69537579|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
37853803|NCT01299272|69537576|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
37636745|NCT01302847|69104014|FG006|Overall Study|Not willing to adhere to requirements|0|||
37636746|NCT01302847|69104015|FG007|Overall Study|Not willing to adhere to requirements|2|||
37636747|NCT01302847|69104008|FG000|Overall Study|Site unable to contact participant|2|||
37636748|NCT01302847|69104009|FG001|Overall Study|Site unable to contact participant|1|||
37636749|NCT01302847|69104010|FG002|Overall Study|Site unable to contact participant|0|||
37636750|NCT01302847|69104011|FG003|Overall Study|Site unable to contact participant|0|||
37636751|NCT01302847|69104012|FG004|Overall Study|Site unable to contact participant|0|||
37636752|NCT01302847|69104013|FG005|Overall Study|Site unable to contact participant|0|||
37636753|NCT01302847|69104014|FG006|Overall Study|Site unable to contact participant|2|||
37739778|NCT01433991|69224889|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
37739779|NCT01433991|69224886|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
37739780|NCT01433991|69224887|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
37739781|NCT01433991|69224888|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
37739782|NCT01433991|69224889|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
37739783|NCT01433991|69224886|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
37739784|NCT01433991|69224887|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
37739785|NCT01433991|69224888|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
37739786|NCT01433991|69224889|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
37739787|NCT01433991|69224886|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
37739788|NCT01433991|69224887|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
37739789|NCT01433991|69224888|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
37739790|NCT01433991|69224889|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
37739791|NCT01433991|69224886|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
37739792|NCT01433991|69224887|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
37739793|NCT01433991|69224888|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
37739794|NCT01433991|69224889|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
37739795|NCT01450683|69224905|FG000|Overall Study|Adverse Event|2|||
37739796|NCT01433055|69224911|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
37739797|NCT01433055|69224912|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
37739798|NCT01433055|69224911|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
37739799|NCT01433055|69224912|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
37739800|NCT01450137|69224920|FG000|Up to Week 12|Adverse Event|2|||
37739801|NCT01450137|69224921|FG001|Up to Week 12|Adverse Event|1|||
37739802|NCT01450137|69224920|FG000|Up to Week 12|Withdrawal by Subject|0|||
37739803|NCT01450137|69224921|FG001|Up to Week 12|Withdrawal by Subject|2|||
37739804|NCT01450137|69224920|FG000|Week 12 to Study End|Death|0|||
37739805|NCT01450137|69224921|FG001|Week 12 to Study End|Death|1|||
37739806|NCT01450137|69224920|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
37739807|NCT01450137|69224921|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
37739808|NCT01412229|69224927|FG000|Overall Study|Physician Decision|1|||
37739809|NCT01412151|69224932|FG000|Week 0 - 306 - Treatment Period|Death|1|||
37739810|NCT01412151|69224932|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
37739811|NCT01412151|69224932|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
37636754|NCT01302847|69104015|FG007|Overall Study|Site unable to contact participant|0|||
37739812|NCT01412151|69224932|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
37739813|NCT01432275|69224938|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
37739814|NCT01432275|69224939|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
37853804|NCT01299272|69537577|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
37853805|NCT01299272|69537578|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
37853806|NCT01299272|69537579|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
37853807|NCT01299272|69537576|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
37853808|NCT01299272|69537577|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
37853809|NCT01299272|69537578|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
37853810|NCT01299272|69537579|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
37853811|NCT01299272|69537576|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
37853812|NCT01299272|69537577|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
37853813|NCT01299272|69537578|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
37853814|NCT01299272|69537579|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
37853815|NCT01299272|69537576|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
37853816|NCT01299272|69537577|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
37853817|NCT01299272|69537578|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
37853818|NCT01299272|69537579|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
37853819|NCT01299272|69537576|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
37853820|NCT01299272|69537577|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
37853821|NCT01299272|69537578|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
37853822|NCT01299272|69537579|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
37853823|NCT01299272|69537576|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
37853824|NCT01299272|69537577|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
37853825|NCT01299272|69537578|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
37853826|NCT01299272|69537579|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
37853827|NCT01299116|69537596|FG000|Overall Study|Lost to Follow-up|65|||
37853828|NCT01299116|69537597|FG001|Overall Study|Lost to Follow-up|9|||
37853829|NCT01299116|69537598|FG002|Overall Study|Lost to Follow-up|11|||
37853830|NCT01299038|69537611|FG000|Overall Study|Withdrawal by Subject|1|||
37853831|NCT01299038|69537612|FG001|Overall Study|Withdrawal by Subject|0|||
37853832|NCT01298648|69537618|FG000|Overall Study|Withdrawal by Subject|2|||
37636755|NCT03039569|69104044|FG000|Overall Study|Lost to Follow-up|5|||
37636756|NCT03039569|69104045|FG001|Overall Study|Lost to Follow-up|4|||
37636757|NCT02738775|69104058|FG000|Overall Study|Withdrawal by Subject|0|||
37636758|NCT02738775|69104059|FG001|Overall Study|Withdrawal by Subject|1|||
37636759|NCT02738775|69104060|FG002|Overall Study|Withdrawal by Subject|0|||
37636760|NCT02738775|69104061|FG003|Overall Study|Withdrawal by Subject|0|||
37636761|NCT02738775|69104062|FG004|Overall Study|Withdrawal by Subject|0|||
37636762|NCT02738775|69104063|FG005|Overall Study|Withdrawal by Subject|0|||
37636763|NCT02738775|69104058|FG000|Overall Study|Adverse Event|0|||
37636764|NCT02738775|69104059|FG001|Overall Study|Adverse Event|0|||
37636765|NCT02738775|69104060|FG002|Overall Study|Adverse Event|0|||
37921865|NCT00818454|69608691|FG002|Treatment Period 3|Adverse Event|0|||
37921866|NCT00818454|69608692|FG003|Treatment Period 3|Adverse Event|1|||
37921867|NCT00828984|69608705|FG000|Overall Study|Adverse Event|2|||
37921868|NCT00828984|69608706|FG001|Overall Study|Adverse Event|3|||
37921869|NCT00828984|69608707|FG002|Overall Study|Adverse Event|0|||
37636766|NCT02738775|69104061|FG003|Overall Study|Adverse Event|1|||
37636767|NCT02738775|69104062|FG004|Overall Study|Adverse Event|0|||
37636768|NCT02738775|69104063|FG005|Overall Study|Adverse Event|0|||
37636769|NCT02738775|69104058|FG000|Overall Study|Pregnancy|0|||
37636770|NCT02738775|69104059|FG001|Overall Study|Pregnancy|1|||
37636771|NCT02738775|69104060|FG002|Overall Study|Pregnancy|0|||
37636772|NCT02738775|69104061|FG003|Overall Study|Pregnancy|0|||
37636773|NCT02738775|69104062|FG004|Overall Study|Pregnancy|0|||
37636774|NCT02738775|69104063|FG005|Overall Study|Pregnancy|0|||
37636775|NCT02738775|69104058|FG000|Overall Study|Missing|0|||
37636776|NCT02738775|69104059|FG001|Overall Study|Missing|0|||
37636777|NCT02738775|69104060|FG002|Overall Study|Missing|0|||
37636778|NCT02738775|69104061|FG003|Overall Study|Missing|0|||
37636779|NCT02738775|69104062|FG004|Overall Study|Missing|0|||
37636780|NCT02738775|69104063|FG005|Overall Study|Missing|1|||
37636781|NCT02314923|69104100|FG000|Overall Study|Death|0|||
37636782|NCT02314923|69104101|FG001|Overall Study|Death|0|||
37853833|NCT01298648|69537618|FG000|Overall Study|Lost to Follow-up|21|||
37853834|NCT01261338|69537624|FG000|Overall Study|Withdrawal by Subject|3|||
37853835|NCT01261338|69537625|FG001|Overall Study|Withdrawal by Subject|2|||
37853836|NCT01260948|69537633|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
37853837|NCT01260948|69537634|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
37921870|NCT00828984|69608705|FG000|Overall Study|Lost to Follow-up|5|||
37921871|NCT00828984|69608706|FG001|Overall Study|Lost to Follow-up|3|||
37636783|NCT02314923|69104102|FG002|Overall Study|Death|0|||
37636784|NCT02314923|69104103|FG003|Overall Study|Death|1|||
37636785|NCT02314923|69104104|FG004|Overall Study|Death|0|||
37739815|NCT01432275|69224938|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
37636786|NCT02314923|69104105|FG005|Overall Study|Death|0|||
37636787|NCT02314923|69104106|FG006|Overall Study|Death|0|||
37853838|NCT01260948|69537633|FG000|Second Intervention|Emesis|0|||
37853839|NCT01260948|69537634|FG001|Second Intervention|Emesis|1|||
37853840|NCT01025284|69537643|FG000|Overall Study|Investigator Decision|0|||
37853841|NCT01025284|69537644|FG001|Overall Study|Investigator Decision|1|||
37853842|NCT01025284|69537645|FG002|Overall Study|Investigator Decision|0|||
37853843|NCT01025284|69537643|FG000|Overall Study|Withdrawal by Subject|0|||
37853844|NCT01025284|69537644|FG001|Overall Study|Withdrawal by Subject|1|||
37853845|NCT01025284|69537645|FG002|Overall Study|Withdrawal by Subject|0|||
37853846|NCT01021852|69537663|FG000|Treatment Period 1|Adverse Event|3|||
37853847|NCT01021852|69537664|FG001|Treatment Period 1|Adverse Event|1|||
37853848|NCT01021852|69537665|FG002|Treatment Period 1|Adverse Event|1|||
37853849|NCT01021852|69537666|FG003|Treatment Period 1|Adverse Event|0|||
37853850|NCT01021852|69537667|FG004|Treatment Period 1|Adverse Event|2|||
37853851|NCT01021852|69537668|FG005|Treatment Period 1|Adverse Event|2|||
37853852|NCT01021852|69537669|FG006|Treatment Period 1|Adverse Event|0|||
37853853|NCT01021852|69537670|FG007|Treatment Period 1|Adverse Event|0|||
37636788|NCT02314923|69104107|FG007|Overall Study|Death|0|||
37636789|NCT02314923|69104108|FG008|Overall Study|Death|0|||
37636790|NCT02314923|69104109|FG009|Overall Study|Death|0|||
37636791|NCT02314923|69104100|FG000|Overall Study|Lost to Follow-up|2|||
37636792|NCT02314923|69104101|FG001|Overall Study|Lost to Follow-up|3|||
37636793|NCT02314923|69104102|FG002|Overall Study|Lost to Follow-up|1|||
37636794|NCT02314923|69104103|FG003|Overall Study|Lost to Follow-up|0|||
37636795|NCT02314923|69104104|FG004|Overall Study|Lost to Follow-up|0|||
37636796|NCT02314923|69104105|FG005|Overall Study|Lost to Follow-up|0|||
37853854|NCT01021852|69537663|FG000|Treatment Period 1|Pregnancy|0|||
37853855|NCT01021852|69537664|FG001|Treatment Period 1|Pregnancy|0|||
37853856|NCT01021852|69537665|FG002|Treatment Period 1|Pregnancy|1|||
37853857|NCT01021852|69537666|FG003|Treatment Period 1|Pregnancy|0|||
37853858|NCT01021852|69537667|FG004|Treatment Period 1|Pregnancy|0|||
37853859|NCT01021852|69537668|FG005|Treatment Period 1|Pregnancy|0|||
37853860|NCT01021852|69537669|FG006|Treatment Period 1|Pregnancy|0|||
37853861|NCT01021852|69537670|FG007|Treatment Period 1|Pregnancy|0|||
37853862|NCT01021852|69537663|FG000|Treatment Period 1|Withdrawal by Subject|0|||
37853863|NCT01021852|69537664|FG001|Treatment Period 1|Withdrawal by Subject|0|||
37853864|NCT01021852|69537665|FG002|Treatment Period 1|Withdrawal by Subject|0|||
37853865|NCT01021852|69537666|FG003|Treatment Period 1|Withdrawal by Subject|0|||
37853866|NCT01021852|69537667|FG004|Treatment Period 1|Withdrawal by Subject|1|||
37853867|NCT01021852|69537668|FG005|Treatment Period 1|Withdrawal by Subject|0|||
37853868|NCT01021852|69537669|FG006|Treatment Period 1|Withdrawal by Subject|0|||
37853869|NCT01021852|69537670|FG007|Treatment Period 1|Withdrawal by Subject|1|||
37853870|NCT01021852|69537663|FG000|Treatment Period 1|Not Treated|0|||
37853871|NCT01021852|69537664|FG001|Treatment Period 1|Not Treated|0|||
37853872|NCT01021852|69537665|FG002|Treatment Period 1|Not Treated|0|||
37853873|NCT01021852|69537666|FG003|Treatment Period 1|Not Treated|2|||
37853874|NCT01021852|69537667|FG004|Treatment Period 1|Not Treated|0|||
37853875|NCT01021852|69537668|FG005|Treatment Period 1|Not Treated|0|||
37853876|NCT01021852|69537669|FG006|Treatment Period 1|Not Treated|0|||
37853877|NCT01021852|69537670|FG007|Treatment Period 1|Not Treated|0|||
37853878|NCT01021852|69537663|FG000|Washout Period-Placebo|Adverse Event|0|||
37853879|NCT01021852|69537664|FG001|Washout Period-Placebo|Adverse Event|0|||
37853880|NCT01021852|69537665|FG002|Washout Period-Placebo|Adverse Event|0|||
37853881|NCT01021852|69537666|FG003|Washout Period-Placebo|Adverse Event|1|||
37853882|NCT01021852|69537667|FG004|Washout Period-Placebo|Adverse Event|0|||
37853883|NCT01021852|69537668|FG005|Washout Period-Placebo|Adverse Event|1|||
37853884|NCT01021852|69537669|FG006|Washout Period-Placebo|Adverse Event|0|||
37853885|NCT01021852|69537670|FG007|Washout Period-Placebo|Adverse Event|0|||
37853886|NCT01021852|69537663|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
37853887|NCT01021852|69537664|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
37853888|NCT01021852|69537665|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
37853889|NCT01021852|69537666|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
37853890|NCT01021852|69537667|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
37853891|NCT01021852|69537668|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
37853892|NCT01021852|69537669|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
37853893|NCT01021852|69537670|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
37636797|NCT02314923|69104106|FG006|Overall Study|Lost to Follow-up|3|||
37853894|NCT01021852|69537663|FG000|Washout Period-Placebo|Protocol Violation|0|||
37853895|NCT01021852|69537664|FG001|Washout Period-Placebo|Protocol Violation|0|||
37853896|NCT01021852|69537665|FG002|Washout Period-Placebo|Protocol Violation|0|||
37853897|NCT01021852|69537666|FG003|Washout Period-Placebo|Protocol Violation|0|||
37853898|NCT01021852|69537667|FG004|Washout Period-Placebo|Protocol Violation|0|||
37853899|NCT01021852|69537668|FG005|Washout Period-Placebo|Protocol Violation|0|||
37853900|NCT01021852|69537669|FG006|Washout Period-Placebo|Protocol Violation|1|||
37853901|NCT01021852|69537670|FG007|Washout Period-Placebo|Protocol Violation|0|||
37636798|NCT02314923|69104107|FG007|Overall Study|Lost to Follow-up|4|||
37636799|NCT02314923|69104108|FG008|Overall Study|Lost to Follow-up|2|||
37853902|NCT01021852|69537663|FG000|Washout Period-No Drug|Adverse Event|1|||
37636800|NCT02314923|69104109|FG009|Overall Study|Lost to Follow-up|0|||
37853903|NCT01021852|69537664|FG001|Washout Period-No Drug|Adverse Event|0|||
37853904|NCT01021852|69537665|FG002|Washout Period-No Drug|Adverse Event|0|||
37853905|NCT01021852|69537666|FG003|Washout Period-No Drug|Adverse Event|0|||
37853906|NCT01021852|69537667|FG004|Washout Period-No Drug|Adverse Event|0|||
37853907|NCT01021852|69537668|FG005|Washout Period-No Drug|Adverse Event|1|||
37853908|NCT01021852|69537669|FG006|Washout Period-No Drug|Adverse Event|0|||
37853909|NCT01021852|69537670|FG007|Washout Period-No Drug|Adverse Event|0|||
37853910|NCT01021852|69537663|FG000|Treatment Period 2|Adverse Event|0|||
37853911|NCT01021852|69537664|FG001|Treatment Period 2|Adverse Event|1|||
37853912|NCT01021852|69537665|FG002|Treatment Period 2|Adverse Event|0|||
37853913|NCT01021852|69537666|FG003|Treatment Period 2|Adverse Event|0|||
37853914|NCT01021852|69537667|FG004|Treatment Period 2|Adverse Event|1|||
37853915|NCT01021852|69537668|FG005|Treatment Period 2|Adverse Event|0|||
37853916|NCT01021852|69537669|FG006|Treatment Period 2|Adverse Event|1|||
37853917|NCT01021852|69537670|FG007|Treatment Period 2|Adverse Event|0|||
37853918|NCT01021852|69537663|FG000|Treatment Period 2|Lack of Efficacy|0|||
37853919|NCT01021852|69537664|FG001|Treatment Period 2|Lack of Efficacy|0|||
37853920|NCT01021852|69537665|FG002|Treatment Period 2|Lack of Efficacy|0|||
37853921|NCT01021852|69537666|FG003|Treatment Period 2|Lack of Efficacy|0|||
37853922|NCT01021852|69537667|FG004|Treatment Period 2|Lack of Efficacy|0|||
37853923|NCT01021852|69537668|FG005|Treatment Period 2|Lack of Efficacy|1|||
37853924|NCT01021852|69537669|FG006|Treatment Period 2|Lack of Efficacy|0|||
37853925|NCT01021852|69537670|FG007|Treatment Period 2|Lack of Efficacy|0|||
37853926|NCT01021852|69537663|FG000|Treatment Period 2|Physician Decision|0|||
37853927|NCT01021852|69537664|FG001|Treatment Period 2|Physician Decision|0|||
37853928|NCT01021852|69537665|FG002|Treatment Period 2|Physician Decision|1|||
37853929|NCT01021852|69537666|FG003|Treatment Period 2|Physician Decision|0|||
37853930|NCT01021852|69537667|FG004|Treatment Period 2|Physician Decision|0|||
37853931|NCT01021852|69537668|FG005|Treatment Period 2|Physician Decision|0|||
37853932|NCT01021852|69537669|FG006|Treatment Period 2|Physician Decision|0|||
37853933|NCT01021852|69537670|FG007|Treatment Period 2|Physician Decision|0|||
37853934|NCT01021852|69537663|FG000|Treatment Period 2|Protocol Violation|0|||
37853935|NCT01021852|69537664|FG001|Treatment Period 2|Protocol Violation|0|||
37853936|NCT01021852|69537665|FG002|Treatment Period 2|Protocol Violation|0|||
37853937|NCT01021852|69537666|FG003|Treatment Period 2|Protocol Violation|0|||
37853938|NCT01021852|69537667|FG004|Treatment Period 2|Protocol Violation|1|||
37853939|NCT01021852|69537668|FG005|Treatment Period 2|Protocol Violation|0|||
37853940|NCT01021852|69537669|FG006|Treatment Period 2|Protocol Violation|1|||
37853941|NCT01021852|69537670|FG007|Treatment Period 2|Protocol Violation|0|||
37853942|NCT01021852|69537663|FG000|Treatment Period 2|Withdrawal by Subject|0|||
37853943|NCT01021852|69537664|FG001|Treatment Period 2|Withdrawal by Subject|0|||
37853944|NCT01021852|69537665|FG002|Treatment Period 2|Withdrawal by Subject|0|||
37853945|NCT01021852|69537666|FG003|Treatment Period 2|Withdrawal by Subject|0|||
37853946|NCT01021852|69537667|FG004|Treatment Period 2|Withdrawal by Subject|0|||
37853947|NCT01021852|69537668|FG005|Treatment Period 2|Withdrawal by Subject|0|||
37853948|NCT01021852|69537669|FG006|Treatment Period 2|Withdrawal by Subject|1|||
37853949|NCT01021852|69537670|FG007|Treatment Period 2|Withdrawal by Subject|2|||
37853950|NCT01056718|69537684|FG000|Overall Study|Withdrawal by Subject|2|||
37853951|NCT01056718|69537684|FG000|Overall Study|Ischemia on baseline stress test|1|||
37853952|NCT01298570|69537691|FG000|Overall Study|Disease progression, relapse during acti|64|||
37853953|NCT01298570|69537692|FG001|Overall Study|Disease progression, relapse during acti|40|||
37853954|NCT01298570|69537691|FG000|Overall Study|Adverse Event|20|||
37853955|NCT01298570|69537692|FG001|Overall Study|Adverse Event|2|||
37853956|NCT01298570|69537691|FG000|Overall Study|Withdrawal by Subject|21|||
37853957|NCT01298570|69537692|FG001|Overall Study|Withdrawal by Subject|6|||
37853958|NCT01298570|69537691|FG000|Overall Study|Treatment delay > 4 weeks|4|||
37853959|NCT01298570|69537692|FG001|Overall Study|Treatment delay > 4 weeks|5|||
37853960|NCT01298570|69537691|FG000|Overall Study|Physician Decision|4|||
37853961|NCT01298570|69537692|FG001|Overall Study|Physician Decision|2|||
37853962|NCT01298570|69537691|FG000|Overall Study|Other complicating disease|2|||
37853963|NCT01298570|69537692|FG001|Overall Study|Other complicating disease|1|||
37853964|NCT01298570|69537691|FG000|Overall Study|Surgery|2|||
37853965|NCT01298570|69537692|FG001|Overall Study|Surgery|1|||
37853966|NCT01298570|69537691|FG000|Overall Study|Symptomatic progression/deterioration|3|||
37853967|NCT01298570|69537692|FG001|Overall Study|Symptomatic progression/deterioration|2|||
37853968|NCT01298570|69537691|FG000|Overall Study|Death|0|||
37853969|NCT01298570|69537692|FG001|Overall Study|Death|1|||
37853970|NCT01298570|69537691|FG000|Overall Study|Ineligibility|0|||
37853971|NCT01298570|69537692|FG001|Overall Study|Ineligibility|1|||
37853972|NCT01259856|69537700|FG000|Overall Study|Adverse Event|12|||
37853973|NCT01259856|69537701|FG001|Overall Study|Adverse Event|9|||
37853974|NCT01259856|69537700|FG000|Overall Study|Death|0|||
37853975|NCT01259856|69537701|FG001|Overall Study|Death|1|||
37853976|NCT01259856|69537700|FG000|Overall Study|Lack of Efficacy|3|||
37853977|NCT01259856|69537701|FG001|Overall Study|Lack of Efficacy|1|||
37853978|NCT01259856|69537700|FG000|Overall Study|Lost to Follow-up|1|||
37853979|NCT01259856|69537701|FG001|Overall Study|Lost to Follow-up|1|||
37853980|NCT01259856|69537700|FG000|Overall Study|Physician Decision|2|||
37853981|NCT01259856|69537701|FG001|Overall Study|Physician Decision|1|||
37853982|NCT01259856|69537700|FG000|Overall Study|Withdrawal by Subject|9|||
37853983|NCT01259856|69537701|FG001|Overall Study|Withdrawal by Subject|10|||
37853984|NCT01259856|69537700|FG000|Overall Study|Treatment never started|0|||
37853985|NCT01259856|69537701|FG001|Overall Study|Treatment never started|6|||
37853986|NCT01259856|69537700|FG000|Overall Study|Study closure by sponsor|40|||
37853987|NCT01259856|69537701|FG001|Overall Study|Study closure by sponsor|41|||
37853988|NCT01259856|69537700|FG000|Overall Study|Patient developed other disease|0|||
37853989|NCT01259856|69537701|FG001|Overall Study|Patient developed other disease|1|||
37853990|NCT01259856|69537700|FG000|Overall Study|Transfer to another study|0|||
37853991|NCT01259856|69537701|FG001|Overall Study|Transfer to another study|1|||
37853992|NCT01259856|69537700|FG000|Overall Study|Unknown/missing|2|||
37853993|NCT01259856|69537701|FG001|Overall Study|Unknown/missing|2|||
37853994|NCT01020838|69537707|FG000|Overall Study|Death|90|||
37853995|NCT01020838|69537707|FG000|Overall Study|Adverse Event|1|||
37853996|NCT01020838|69537707|FG000|Overall Study|Withdrawal by Subject|9|||
37853997|NCT01020838|69537707|FG000|Overall Study|Lost to Follow-up|6|||
37853998|NCT01020838|69537707|FG000|Overall Study|Most common: Study ended by sponsor|77|||
37853999|NCT01259466|69537722|FG000|Overall Study|Withdrawal by Subject|1|||
37854000|NCT01259466|69537723|FG001|Overall Study|Withdrawal by Subject|9|||
37854001|NCT01259388|69537731|FG000|Overall Study|Adverse Event|3|||
37854002|NCT01259388|69537732|FG001|Overall Study|Adverse Event|0|||
37854003|NCT01259388|69537731|FG000|Overall Study|Withdrawal by Subject|1|||
37854004|NCT01259388|69537732|FG001|Overall Study|Withdrawal by Subject|1|||
37854005|NCT01259388|69537731|FG000|Overall Study|Physician Decision|1|||
37854006|NCT01259388|69537732|FG001|Overall Study|Physician Decision|0|||
37854007|NCT01298492|69537738|FG000|Overall Study|Death|2|||
37739816|NCT01432275|69224939|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
37739817|NCT01432275|69224938|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
37739818|NCT01432275|69224939|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
37739819|NCT01432275|69224938|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
37739820|NCT01432275|69224939|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
37739821|NCT01432275|69224938|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
37739822|NCT01432275|69224939|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
37739823|NCT01432275|69224938|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
37739824|NCT01432275|69224939|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
37739825|NCT01432275|69224938|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
37739826|NCT01432275|69224939|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
37739827|NCT01432275|69224938|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
37739828|NCT01432275|69224939|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
37739829|NCT01432275|69224938|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
37739830|NCT01432275|69224939|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
37739831|NCT01411995|69224947|FG000|Overall Study|Failed IUD insertion|0|||
37739832|NCT01411995|69224948|FG001|Overall Study|Failed IUD insertion|1|||
37739833|NCT01411917|69224956|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
37739834|NCT01411917|69224957|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
37739835|NCT01411839|69224965|FG000|Overall Study|Lost to Follow-up|4|||
37739836|NCT01411839|69224966|FG001|Overall Study|Lost to Follow-up|3|||
37739837|NCT01411215|69224974|FG000|Overall Study|Adverse Event|1|||
37739838|NCT01411215|69224975|FG001|Overall Study|Adverse Event|2|||
37739839|NCT01411215|69224974|FG000|Overall Study|Lack of Efficacy|2|||
37739840|NCT01411215|69224975|FG001|Overall Study|Lack of Efficacy|4|||
37739841|NCT01411215|69224974|FG000|Overall Study|Lost to Follow-up|12|||
37739842|NCT01411215|69224975|FG001|Overall Study|Lost to Follow-up|18|||
37854008|NCT01298492|69537738|FG000|Overall Study|Insufficient Clinical Response|22|||
37854009|NCT01298492|69537738|FG000|Overall Study|Lost to Follow-up|12|||
37854010|NCT01298492|69537738|FG000|Overall Study|Withdrawal by Subject|47|||
37854011|NCT01298492|69537738|FG000|Overall Study|Other (Unspecified)|7|||
37854012|NCT01298492|69537738|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
37854013|NCT01298492|69537738|FG000|Overall Study|Protocol Violation|2|||
37854014|NCT01298492|69537738|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
37739843|NCT01411215|69224974|FG000|Overall Study|Did not meet entrance criteria|0|||
37739844|NCT01411215|69224975|FG001|Overall Study|Did not meet entrance criteria|1|||
37739845|NCT01411215|69224974|FG000|Overall Study|Study terminated by sponsor|2|||
37739846|NCT01411215|69224975|FG001|Overall Study|Study terminated by sponsor|15|||
37854015|NCT01298492|69537738|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
37854016|NCT01297322|69537744|FG000|Overall Study|Lost to Follow-up|1|||
37854017|NCT01297322|69537745|FG001|Overall Study|Lost to Follow-up|0|||
37854018|NCT01297322|69537744|FG000|Overall Study|Withdrawal by Subject|0|||
37854019|NCT01297322|69537745|FG001|Overall Study|Withdrawal by Subject|1|||
37854020|NCT01297322|69537744|FG000|Overall Study|Protocol Violation|0|||
37854021|NCT01297322|69537745|FG001|Overall Study|Protocol Violation|3|||
37854022|NCT01297244|69537754|FG000|Overall Study|Progressive disease|22|||
37739847|NCT01411215|69224974|FG000|Overall Study|Protocol Violation|3|||
37739848|NCT01411215|69224975|FG001|Overall Study|Protocol Violation|5|||
37739849|NCT01411215|69224974|FG000|Overall Study|Withdrawal by Subject|34|||
37739850|NCT01411215|69224975|FG001|Overall Study|Withdrawal by Subject|21|||
37739851|NCT01411215|69224974|FG000|Overall Study|Other|12|||
37739852|NCT01411215|69224975|FG001|Overall Study|Other|17|||
37854023|NCT01297244|69537755|FG001|Overall Study|Progressive disease|3|||
37854024|NCT01297244|69537754|FG000|Overall Study|Adverse Event|9|||
37854025|NCT01297244|69537755|FG001|Overall Study|Adverse Event|1|||
37636801|NCT02314923|69104100|FG000|Overall Study|Withdrawal by Subject|0|||
37636802|NCT02314923|69104101|FG001|Overall Study|Withdrawal by Subject|0|||
37636803|NCT02314923|69104102|FG002|Overall Study|Withdrawal by Subject|1|||
37636804|NCT02314923|69104103|FG003|Overall Study|Withdrawal by Subject|0|||
37636805|NCT02314923|69104104|FG004|Overall Study|Withdrawal by Subject|1|||
37636806|NCT02314923|69104105|FG005|Overall Study|Withdrawal by Subject|0|||
37921872|NCT00828984|69608707|FG002|Overall Study|Lost to Follow-up|1|||
37921873|NCT00828984|69608705|FG000|Overall Study|Withdrawal by Subject|4|||
37921874|NCT00828984|69608706|FG001|Overall Study|Withdrawal by Subject|4|||
37921875|NCT00828984|69608707|FG002|Overall Study|Withdrawal by Subject|4|||
37921876|NCT00828984|69608705|FG000|Overall Study|Ineligable|1|||
37921877|NCT00828984|69608706|FG001|Overall Study|Ineligable|2|||
37636807|NCT02314923|69104106|FG006|Overall Study|Withdrawal by Subject|1|||
37636808|NCT02314923|69104107|FG007|Overall Study|Withdrawal by Subject|0|||
37636809|NCT02314923|69104108|FG008|Overall Study|Withdrawal by Subject|0|||
37636810|NCT02314923|69104109|FG009|Overall Study|Withdrawal by Subject|0|||
37636811|NCT02314923|69104100|FG000|Overall Study|Physician Decision|0|||
37636812|NCT02314923|69104101|FG001|Overall Study|Physician Decision|1|||
37636813|NCT02314923|69104102|FG002|Overall Study|Physician Decision|0|||
37636814|NCT02314923|69104103|FG003|Overall Study|Physician Decision|0|||
37636815|NCT02314923|69104104|FG004|Overall Study|Physician Decision|0|||
37636816|NCT02314923|69104105|FG005|Overall Study|Physician Decision|0|||
37636817|NCT02314923|69104106|FG006|Overall Study|Physician Decision|0|||
37636818|NCT02314923|69104107|FG007|Overall Study|Physician Decision|0|||
37636819|NCT02314923|69104108|FG008|Overall Study|Physician Decision|0|||
37636820|NCT02314923|69104109|FG009|Overall Study|Physician Decision|0|||
37636821|NCT02314923|69104100|FG000|Overall Study|Participant unavailable|0|||
37636822|NCT02314923|69104101|FG001|Overall Study|Participant unavailable|0|||
37636823|NCT02314923|69104102|FG002|Overall Study|Participant unavailable|0|||
37636824|NCT02314923|69104103|FG003|Overall Study|Participant unavailable|0|||
37636825|NCT02314923|69104104|FG004|Overall Study|Participant unavailable|0|||
37636826|NCT02314923|69104105|FG005|Overall Study|Participant unavailable|1|||
37636827|NCT02314923|69104106|FG006|Overall Study|Participant unavailable|0|||
37636828|NCT02314923|69104107|FG007|Overall Study|Participant unavailable|0|||
37636829|NCT02314923|69104108|FG008|Overall Study|Participant unavailable|0|||
37636830|NCT02314923|69104109|FG009|Overall Study|Participant unavailable|0|||
37636831|NCT02314923|69104100|FG000|Overall Study|Screen failure|0|||
37636832|NCT02314923|69104101|FG001|Overall Study|Screen failure|0|||
37636833|NCT02314923|69104102|FG002|Overall Study|Screen failure|0|||
37636834|NCT02314923|69104103|FG003|Overall Study|Screen failure|0|||
37636835|NCT02314923|69104104|FG004|Overall Study|Screen failure|0|||
37636836|NCT02314923|69104105|FG005|Overall Study|Screen failure|0|||
37636837|NCT02314923|69104106|FG006|Overall Study|Screen failure|1|||
37636838|NCT02314923|69104107|FG007|Overall Study|Screen failure|0|||
37636839|NCT02314923|69104108|FG008|Overall Study|Screen failure|0|||
37636840|NCT02314923|69104109|FG009|Overall Study|Screen failure|0|||
37739853|NCT01411215|69224974|FG000|Overall Study|Screen failure|0|||
37854026|NCT01297244|69537754|FG000|Overall Study|Death|1|||
37854027|NCT01297244|69537755|FG001|Overall Study|Death|1|||
37854028|NCT01297244|69537754|FG000|Overall Study|Clinical progression|1|||
37854029|NCT01297244|69537755|FG001|Overall Study|Clinical progression|1|||
37854030|NCT01297244|69537754|FG000|Overall Study|Withdrawal by Subject|2|||
37854031|NCT01297244|69537755|FG001|Overall Study|Withdrawal by Subject|0|||
37921878|NCT00828984|69608707|FG002|Overall Study|Ineligable|0|||
37636841|NCT02314923|69104100|FG000|Overall Study|Participant relocation|1|||
37636842|NCT02314923|69104101|FG001|Overall Study|Participant relocation|0|||
37636843|NCT02314923|69104102|FG002|Overall Study|Participant relocation|0|||
37636844|NCT02314923|69104103|FG003|Overall Study|Participant relocation|0|||
37636845|NCT02314923|69104104|FG004|Overall Study|Participant relocation|0|||
37739854|NCT01411215|69224975|FG001|Overall Study|Screen failure|1|||
37636846|NCT02314923|69104105|FG005|Overall Study|Participant relocation|0|||
37636847|NCT02314923|69104106|FG006|Overall Study|Participant relocation|0|||
37739855|NCT01449279|69224981|FG000|Overall Study|Lack of Efficacy|5|||
37739856|NCT01449279|69224981|FG000|Overall Study|Toxicity|2|||
37739857|NCT01447719|69224985|FG000|Overall Study|Image acquisition failure|2|||
37739858|NCT01447719|69224985|FG000|Overall Study|Invalid image or not imaged|3|||
37636848|NCT02314923|69104107|FG007|Overall Study|Participant relocation|1|||
37854032|NCT03456726|69537768|FG000|Overall Study|Disease Progression|6|||
37854033|NCT03456726|69537769|FG001|Overall Study|Disease Progression|1|||
37921879|NCT00828984|69608705|FG000|Overall Study|Medical Contraindication|0|||
37854034|NCT03456726|69537768|FG000|Overall Study|Adverse Event|4|||
37854035|NCT03456726|69537769|FG001|Overall Study|Adverse Event|2|||
37854036|NCT03456726|69537768|FG000|Overall Study|Withdrawal by Subject|1|||
37854037|NCT03456726|69537769|FG001|Overall Study|Withdrawal by Subject|0|||
37854038|NCT03456726|69537768|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
37854039|NCT03456726|69537769|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
37854040|NCT03181932|69537777|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
37854041|NCT03181932|69537778|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
37854042|NCT03181932|69537777|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
37854043|NCT03181932|69537778|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
37854044|NCT03181932|69537777|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
37854045|NCT03181932|69537778|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
37854046|NCT03181932|69537777|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
37854047|NCT03181932|69537778|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
37854048|NCT03181932|69537777|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
37854049|NCT03181932|69537778|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
37854050|NCT03181932|69537777|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
37854051|NCT03181932|69537778|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
37854052|NCT03181932|69537777|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
37854053|NCT03181932|69537778|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
37854054|NCT03181932|69537777|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
37854055|NCT03181932|69537778|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
37854056|NCT03181932|69537777|FG000|Period 2 (Open-label Period)|Reason missing|2|||
37854057|NCT03181932|69537778|FG001|Period 2 (Open-label Period)|Reason missing|0|||
37854058|NCT02864862|69537788|FG000|Overall Study|Lost to Follow-up|1|||
37854059|NCT02864862|69537789|FG001|Overall Study|Lost to Follow-up|0|||
37854060|NCT02864862|69537790|FG002|Overall Study|Lost to Follow-up|1|||
37854061|NCT02864862|69537788|FG000|Overall Study|Protocol Violation|0|||
37854062|NCT02864862|69537789|FG001|Overall Study|Protocol Violation|0|||
37854063|NCT02864862|69537790|FG002|Overall Study|Protocol Violation|1|||
37854064|NCT01598298|69537802|FG000|Overall Study|Not eligible|5|||
37854065|NCT01598298|69537803|FG001|Overall Study|Not eligible|5|||
37854066|NCT01598298|69537802|FG000|Overall Study|Adverse Event|21|||
37854067|NCT01598298|69537803|FG001|Overall Study|Adverse Event|19|||
37854068|NCT01598298|69537802|FG000|Overall Study|Progression/relapse|0|||
37854069|NCT01598298|69537803|FG001|Overall Study|Progression/relapse|2|||
37854070|NCT01598298|69537802|FG000|Overall Study|Withdrawal by Subject|10|||
37854071|NCT01598298|69537803|FG001|Overall Study|Withdrawal by Subject|15|||
37854072|NCT01598298|69537802|FG000|Overall Study|Other reason (not protocol specified)|4|||
37854073|NCT01598298|69537803|FG001|Overall Study|Other reason (not protocol specified)|0|||
37854074|NCT01235949|69537827|FG000|Primary Phase|Migrated/moved from study area|1|||
37854075|NCT01235949|69537828|FG001|Primary Phase|Migrated/moved from study area|1|||
37854076|NCT01235949|69537829|FG002|Primary Phase|Migrated/moved from study area|0|||
37854077|NCT01235949|69537830|FG003|Primary Phase|Migrated/moved from study area|0|||
37854078|NCT01235949|69537831|FG004|Primary Phase|Migrated/moved from study area|1|||
37854079|NCT01235949|69537832|FG005|Primary Phase|Migrated/moved from study area|2|||
37854080|NCT01235949|69537833|FG006|Primary Phase|Migrated/moved from study area|0|||
37854081|NCT01235949|69537834|FG007|Primary Phase|Migrated/moved from study area|0|||
37854082|NCT01235949|69537835|FG008|Primary Phase|Migrated/moved from study area|0|||
37854083|NCT01235949|69537836|FG009|Primary Phase|Migrated/moved from study area|0|||
37854084|NCT01235949|69537837|FG010|Primary Phase|Migrated/moved from study area|0|||
37854085|NCT01235949|69537838|FG011|Primary Phase|Migrated/moved from study area|0|||
37854086|NCT01235949|69537839|FG012|Primary Phase|Migrated/moved from study area|0|||
37854087|NCT01235949|69537840|FG013|Primary Phase|Migrated/moved from study area|0|||
37854088|NCT01235949|69537841|FG014|Primary Phase|Migrated/moved from study area|0|||
37854089|NCT01235949|69537842|FG015|Primary Phase|Migrated/moved from study area|0|||
37854090|NCT01235949|69537843|FG016|Primary Phase|Migrated/moved from study area|0|||
37854091|NCT01235949|69537844|FG017|Primary Phase|Migrated/moved from study area|0|||
37854092|NCT01235949|69537827|FG000|Primary Phase|Adverse Event|0|||
37854093|NCT01235949|69537828|FG001|Primary Phase|Adverse Event|0|||
37854094|NCT01235949|69537829|FG002|Primary Phase|Adverse Event|0|||
37854095|NCT01235949|69537830|FG003|Primary Phase|Adverse Event|1|||
37854096|NCT01235949|69537831|FG004|Primary Phase|Adverse Event|0|||
37854097|NCT01235949|69537832|FG005|Primary Phase|Adverse Event|0|||
37854098|NCT01235949|69537833|FG006|Primary Phase|Adverse Event|0|||
37854099|NCT01235949|69537834|FG007|Primary Phase|Adverse Event|0|||
37739859|NCT01447719|69224985|FG000|Overall Study|Subject still living at end of study|79|||
37854100|NCT01235949|69537835|FG008|Primary Phase|Adverse Event|0|||
37854101|NCT01235949|69537836|FG009|Primary Phase|Adverse Event|0|||
37854102|NCT01235949|69537837|FG010|Primary Phase|Adverse Event|0|||
37854103|NCT01235949|69537838|FG011|Primary Phase|Adverse Event|0|||
37854104|NCT01235949|69537839|FG012|Primary Phase|Adverse Event|0|||
37854105|NCT01235949|69537840|FG013|Primary Phase|Adverse Event|0|||
37854106|NCT01235949|69537841|FG014|Primary Phase|Adverse Event|0|||
37854107|NCT01235949|69537842|FG015|Primary Phase|Adverse Event|0|||
37854108|NCT01235949|69537843|FG016|Primary Phase|Adverse Event|0|||
37854109|NCT01235949|69537844|FG017|Primary Phase|Adverse Event|0|||
37854110|NCT01235949|69537827|FG000|Primary Phase|Withdrawal by Subject|3|||
37854111|NCT01235949|69537828|FG001|Primary Phase|Withdrawal by Subject|2|||
37854112|NCT01235949|69537829|FG002|Primary Phase|Withdrawal by Subject|2|||
37854113|NCT01235949|69537830|FG003|Primary Phase|Withdrawal by Subject|0|||
37854114|NCT01235949|69537831|FG004|Primary Phase|Withdrawal by Subject|0|||
37854115|NCT01235949|69537832|FG005|Primary Phase|Withdrawal by Subject|3|||
37854116|NCT01235949|69537833|FG006|Primary Phase|Withdrawal by Subject|0|||
37854117|NCT01235949|69537834|FG007|Primary Phase|Withdrawal by Subject|0|||
37854118|NCT01235949|69537835|FG008|Primary Phase|Withdrawal by Subject|0|||
37854119|NCT01235949|69537836|FG009|Primary Phase|Withdrawal by Subject|0|||
37854120|NCT01235949|69537837|FG010|Primary Phase|Withdrawal by Subject|0|||
37854121|NCT01235949|69537838|FG011|Primary Phase|Withdrawal by Subject|0|||
37854122|NCT01235949|69537839|FG012|Primary Phase|Withdrawal by Subject|0|||
37854123|NCT01235949|69537840|FG013|Primary Phase|Withdrawal by Subject|0|||
37854124|NCT01235949|69537841|FG014|Primary Phase|Withdrawal by Subject|0|||
37854125|NCT01235949|69537842|FG015|Primary Phase|Withdrawal by Subject|0|||
37854126|NCT01235949|69537843|FG016|Primary Phase|Withdrawal by Subject|0|||
37854127|NCT01235949|69537844|FG017|Primary Phase|Withdrawal by Subject|0|||
37854128|NCT01235949|69537827|FG000|Primary Phase|Lost to Follow-up|0|||
37854129|NCT01235949|69537828|FG001|Primary Phase|Lost to Follow-up|0|||
37854130|NCT01235949|69537829|FG002|Primary Phase|Lost to Follow-up|1|||
37854131|NCT01235949|69537830|FG003|Primary Phase|Lost to Follow-up|1|||
37854132|NCT01235949|69537831|FG004|Primary Phase|Lost to Follow-up|0|||
37854133|NCT01235949|69537832|FG005|Primary Phase|Lost to Follow-up|2|||
37854134|NCT01235949|69537833|FG006|Primary Phase|Lost to Follow-up|0|||
37854135|NCT01235949|69537834|FG007|Primary Phase|Lost to Follow-up|0|||
37854136|NCT01235949|69537835|FG008|Primary Phase|Lost to Follow-up|0|||
37854137|NCT01235949|69537836|FG009|Primary Phase|Lost to Follow-up|0|||
37854138|NCT01235949|69537837|FG010|Primary Phase|Lost to Follow-up|0|||
37854139|NCT01235949|69537838|FG011|Primary Phase|Lost to Follow-up|0|||
37854140|NCT01235949|69537839|FG012|Primary Phase|Lost to Follow-up|0|||
37854141|NCT01235949|69537840|FG013|Primary Phase|Lost to Follow-up|0|||
37854142|NCT01235949|69537841|FG014|Primary Phase|Lost to Follow-up|0|||
37854143|NCT01235949|69537842|FG015|Primary Phase|Lost to Follow-up|0|||
37854144|NCT01235949|69537843|FG016|Primary Phase|Lost to Follow-up|0|||
37854145|NCT01235949|69537844|FG017|Primary Phase|Lost to Follow-up|0|||
37854146|NCT01235949|69537827|FG000|Booster Phase|Migrated/moved from study area|0|||
37854147|NCT01235949|69537828|FG001|Booster Phase|Migrated/moved from study area|0|||
37854148|NCT01235949|69537829|FG002|Booster Phase|Migrated/moved from study area|0|||
37854149|NCT01235949|69537830|FG003|Booster Phase|Migrated/moved from study area|0|||
37854150|NCT01235949|69537831|FG004|Booster Phase|Migrated/moved from study area|0|||
37854151|NCT01235949|69537832|FG005|Booster Phase|Migrated/moved from study area|0|||
37854152|NCT01235949|69537833|FG006|Booster Phase|Migrated/moved from study area|0|||
37854153|NCT01235949|69537834|FG007|Booster Phase|Migrated/moved from study area|0|||
37854154|NCT01235949|69537835|FG008|Booster Phase|Migrated/moved from study area|0|||
37854155|NCT01235949|69537836|FG009|Booster Phase|Migrated/moved from study area|0|||
37854156|NCT01235949|69537837|FG010|Booster Phase|Migrated/moved from study area|0|||
37854157|NCT01235949|69537838|FG011|Booster Phase|Migrated/moved from study area|1|||
37854158|NCT01235949|69537839|FG012|Booster Phase|Migrated/moved from study area|1|||
37854159|NCT01235949|69537840|FG013|Booster Phase|Migrated/moved from study area|0|||
37854160|NCT01235949|69537841|FG014|Booster Phase|Migrated/moved from study area|0|||
37854161|NCT01235949|69537842|FG015|Booster Phase|Migrated/moved from study area|0|||
37854162|NCT01235949|69537843|FG016|Booster Phase|Migrated/moved from study area|0|||
37854163|NCT01235949|69537844|FG017|Booster Phase|Migrated/moved from study area|1|||
37854164|NCT01235949|69537827|FG000|Booster Phase|Adverse Event|0|||
37854165|NCT01235949|69537828|FG001|Booster Phase|Adverse Event|0|||
37854166|NCT01235949|69537829|FG002|Booster Phase|Adverse Event|0|||
37921880|NCT00828984|69608706|FG001|Overall Study|Medical Contraindication|1|||
37854167|NCT01235949|69537830|FG003|Booster Phase|Adverse Event|0|||
37854168|NCT01235949|69537831|FG004|Booster Phase|Adverse Event|0|||
37854169|NCT01235949|69537832|FG005|Booster Phase|Adverse Event|0|||
37854170|NCT01235949|69537833|FG006|Booster Phase|Adverse Event|0|||
37854171|NCT01235949|69537834|FG007|Booster Phase|Adverse Event|0|||
37854172|NCT01235949|69537835|FG008|Booster Phase|Adverse Event|0|||
37854173|NCT01235949|69537836|FG009|Booster Phase|Adverse Event|0|||
37854174|NCT01235949|69537837|FG010|Booster Phase|Adverse Event|0|||
37854175|NCT01235949|69537838|FG011|Booster Phase|Adverse Event|0|||
37854176|NCT01235949|69537839|FG012|Booster Phase|Adverse Event|0|||
37854177|NCT01235949|69537840|FG013|Booster Phase|Adverse Event|0|||
37854178|NCT01235949|69537841|FG014|Booster Phase|Adverse Event|0|||
37854179|NCT01235949|69537842|FG015|Booster Phase|Adverse Event|1|||
37854180|NCT01235949|69537843|FG016|Booster Phase|Adverse Event|0|||
37854181|NCT01235949|69537844|FG017|Booster Phase|Adverse Event|0|||
37854182|NCT01235949|69537827|FG000|Booster Phase|Withdrawal by Subject|0|||
37854183|NCT01235949|69537828|FG001|Booster Phase|Withdrawal by Subject|0|||
37854184|NCT01235949|69537829|FG002|Booster Phase|Withdrawal by Subject|0|||
37854185|NCT01235949|69537830|FG003|Booster Phase|Withdrawal by Subject|0|||
37854186|NCT01235949|69537831|FG004|Booster Phase|Withdrawal by Subject|0|||
37854187|NCT01235949|69537832|FG005|Booster Phase|Withdrawal by Subject|0|||
37854188|NCT01235949|69537833|FG006|Booster Phase|Withdrawal by Subject|0|||
37854189|NCT01235949|69537834|FG007|Booster Phase|Withdrawal by Subject|1|||
37854190|NCT01235949|69537835|FG008|Booster Phase|Withdrawal by Subject|1|||
37854191|NCT01235949|69537836|FG009|Booster Phase|Withdrawal by Subject|0|||
37854192|NCT01235949|69537837|FG010|Booster Phase|Withdrawal by Subject|1|||
37854193|NCT01235949|69537838|FG011|Booster Phase|Withdrawal by Subject|1|||
37854194|NCT01235949|69537839|FG012|Booster Phase|Withdrawal by Subject|2|||
37854195|NCT01235949|69537840|FG013|Booster Phase|Withdrawal by Subject|0|||
37854196|NCT01235949|69537841|FG014|Booster Phase|Withdrawal by Subject|2|||
37854197|NCT01235949|69537842|FG015|Booster Phase|Withdrawal by Subject|0|||
37854198|NCT01235949|69537843|FG016|Booster Phase|Withdrawal by Subject|0|||
37854199|NCT01235949|69537844|FG017|Booster Phase|Withdrawal by Subject|0|||
37854200|NCT01235949|69537827|FG000|Booster Phase|Lost to Follow-up|0|||
37854201|NCT01235949|69537828|FG001|Booster Phase|Lost to Follow-up|0|||
37854202|NCT01235949|69537829|FG002|Booster Phase|Lost to Follow-up|0|||
37854203|NCT01235949|69537830|FG003|Booster Phase|Lost to Follow-up|0|||
37854204|NCT01235949|69537831|FG004|Booster Phase|Lost to Follow-up|0|||
37854205|NCT01235949|69537832|FG005|Booster Phase|Lost to Follow-up|0|||
37854206|NCT01235949|69537833|FG006|Booster Phase|Lost to Follow-up|0|||
37854207|NCT01235949|69537834|FG007|Booster Phase|Lost to Follow-up|0|||
37854208|NCT01235949|69537835|FG008|Booster Phase|Lost to Follow-up|1|||
37854209|NCT01235949|69537836|FG009|Booster Phase|Lost to Follow-up|1|||
37854210|NCT01235949|69537837|FG010|Booster Phase|Lost to Follow-up|1|||
37854211|NCT01235949|69537838|FG011|Booster Phase|Lost to Follow-up|1|||
37854212|NCT01235949|69537839|FG012|Booster Phase|Lost to Follow-up|0|||
37854213|NCT01235949|69537840|FG013|Booster Phase|Lost to Follow-up|0|||
37854214|NCT01235949|69537841|FG014|Booster Phase|Lost to Follow-up|0|||
37854215|NCT01235949|69537842|FG015|Booster Phase|Lost to Follow-up|0|||
37854216|NCT01235949|69537843|FG016|Booster Phase|Lost to Follow-up|0|||
37854217|NCT01235949|69537844|FG017|Booster Phase|Lost to Follow-up|1|||
37854218|NCT01235793|69537882|FG000|Overall Study|Death|6|||
37854219|NCT01258998|69537887|FG000|Overall Study|Ineligible|1|||
37854220|NCT01235715|69537893|FG000|Overall Study|Physician Decision|0|||
37854221|NCT01235715|69537894|FG001|Overall Study|Physician Decision|2|||
37854222|NCT01235403|69537901|FG000|Overall Study|Adverse Event|14|||
37854223|NCT01235403|69537901|FG000|Overall Study|Lost to Follow-up|2|||
37854224|NCT01235403|69537901|FG000|Overall Study|Withdrawal by Subject|4|||
37854225|NCT01235403|69537901|FG000|Overall Study|Lack of Efficacy|2|||
37854226|NCT01235403|69537901|FG000|Overall Study|Other reasons for premature termination|4|||
37854227|NCT01024036|69537907|FG000|Blinded Treatment|Adverse Event|1|||
37854228|NCT01024036|69537908|FG001|Blinded Treatment|Adverse Event|1|||
37854229|NCT01024036|69537907|FG000|Blinded Treatment|Lack of Efficacy|16|||
37854230|NCT01024036|69537908|FG001|Blinded Treatment|Lack of Efficacy|14|||
37854231|NCT01024036|69537907|FG000|Blinded Treatment|Physician Decision|1|||
37854232|NCT01024036|69537908|FG001|Blinded Treatment|Physician Decision|0|||
37854233|NCT01024036|69537907|FG000|Blinded Treatment|Death|0|||
37854234|NCT01024036|69537908|FG001|Blinded Treatment|Death|2|||
37854235|NCT01024036|69537907|FG000|Blinded Treatment|Withdrawal by Subject|4|||
37854236|NCT01024036|69537908|FG001|Blinded Treatment|Withdrawal by Subject|3|||
37854237|NCT01024036|69537907|FG000|Unblinded Treatment|Adverse Event|0|||
37854238|NCT01024036|69537908|FG001|Unblinded Treatment|Adverse Event|1|||
37854239|NCT01024036|69537907|FG000|Unblinded Treatment|Lack of Efficacy|0|||
37854240|NCT01024036|69537908|FG001|Unblinded Treatment|Lack of Efficacy|2|||
37854241|NCT01024036|69537907|FG000|Follow-Up Period|Lost to Follow-up|1|||
37854242|NCT01024036|69537908|FG001|Follow-Up Period|Lost to Follow-up|1|||
37854243|NCT01024036|69537907|FG000|Follow-Up Period|Withdrawal by Subject|0|||
37854244|NCT01024036|69537908|FG001|Follow-Up Period|Withdrawal by Subject|1|||
37854245|NCT01024036|69537907|FG000|Follow-Up Period|Adverse Event|4|||
37854246|NCT01024036|69537908|FG001|Follow-Up Period|Adverse Event|1|||
37854247|NCT01234467|69537917|FG000|Overall Study|Adverse Event|3|||
37921881|NCT00828984|69608707|FG002|Overall Study|Medical Contraindication|0|||
37921882|NCT00828984|69608705|FG000|Overall Study|Noncompliant|1|||
37921883|NCT00828984|69608706|FG001|Overall Study|Noncompliant|2|||
37636849|NCT02314923|69104108|FG008|Overall Study|Participant relocation|0|||
37636850|NCT02314923|69104109|FG009|Overall Study|Participant relocation|0|||
37636851|NCT03023137|69104134|FG000|Overall Study|Multiple pregnancy|2|||
37636852|NCT03023137|69104135|FG001|Overall Study|Multiple pregnancy|4|||
37854248|NCT01234467|69537917|FG000|Overall Study|Death|2|||
37854249|NCT01234467|69537917|FG000|Overall Study|Withdrawal by Subject|2|||
37854250|NCT01234467|69537917|FG000|Overall Study|Disease Progression|2|||
37854251|NCT01234467|69537917|FG000|Overall Study|Clinical deterioration|1|||
37854252|NCT01234467|69537917|FG000|Overall Study|Physician Decision|1|||
37636853|NCT03023137|69104134|FG000|Overall Study|Lost to Follow-up|1|||
37636854|NCT03023137|69104135|FG001|Overall Study|Lost to Follow-up|1|||
37636855|NCT03023137|69104134|FG000|Overall Study|Protocol Violation|0|||
37636856|NCT03023137|69104135|FG001|Overall Study|Protocol Violation|4|||
37636857|NCT03023137|69104134|FG000|Overall Study|Lost the baby in a car accident|1|||
37636858|NCT03023137|69104135|FG001|Overall Study|Lost the baby in a car accident|0|||
37636859|NCT03049813|69104146|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
37636860|NCT03049813|69104147|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
37636861|NCT03049813|69104148|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
37636862|NCT03049813|69104149|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
37636863|NCT03049813|69104146|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
37636864|NCT03049813|69104147|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
37636865|NCT03049813|69104148|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
37636866|NCT03049813|69104149|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
37636867|NCT03049813|69104146|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
37636868|NCT03049813|69104147|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
37636869|NCT03049813|69104148|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
37636870|NCT03049813|69104149|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
37636871|NCT03049813|69104146|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
37636872|NCT03049813|69104147|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
37636873|NCT03049813|69104148|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
37636874|NCT03049813|69104149|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
37636875|NCT03022981|69104160|FG000|Overall Study|Adverse Event|0|||
37636876|NCT03022981|69104161|FG001|Overall Study|Adverse Event|1|||
37636877|NCT03022981|69104162|FG002|Overall Study|Adverse Event|0|||
37636878|NCT03022981|69104160|FG000|Overall Study|Investigator's Discretion|0|||
37636879|NCT03022981|69104161|FG001|Overall Study|Investigator's Discretion|1|||
37636880|NCT03022981|69104162|FG002|Overall Study|Investigator's Discretion|2|||
37854253|NCT01234467|69537917|FG000|Overall Study|Other complicating disease (stroke)|1|||
37854254|NCT01233999|69537921|FG000|Overall Study|Withdrawal by Subject|1|||
37854255|NCT01233999|69537921|FG000|Overall Study|Lost to Follow-up|1|||
37854256|NCT01233687|69537925|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
37854257|NCT01233687|69537925|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
37854258|NCT01233687|69537925|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
37854259|NCT01023958|69537929|FG000|Overall Study|Progressive disease|48|||
37854260|NCT01023958|69537929|FG000|Overall Study|Other adverse event|1|||
37854261|NCT01023958|69537929|FG000|Overall Study|Refused to continue medication|1|||
37854262|NCT01233609|69537935|FG000|Overall Study|Death|1|||
37854263|NCT01233609|69537936|FG001|Overall Study|Death|0|||
37854264|NCT01233609|69537935|FG000|Overall Study|Lost to Follow-up|3|||
37854265|NCT01233609|69537936|FG001|Overall Study|Lost to Follow-up|1|||
37854266|NCT01233609|69537935|FG000|Overall Study|Adverse Event|2|||
37854267|NCT01233609|69537936|FG001|Overall Study|Adverse Event|1|||
37854268|NCT01233609|69537935|FG000|Overall Study|Withdrawal by Subject|3|||
37854269|NCT01233609|69537936|FG001|Overall Study|Withdrawal by Subject|0|||
37854270|NCT01232283|69537952|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
37854271|NCT01232283|69537953|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
37854272|NCT01232283|69537954|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
37854273|NCT01232283|69537955|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
37854274|NCT01232283|69537956|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
37854275|NCT01232283|69537957|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
37854276|NCT01232283|69537958|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
37854277|NCT01232283|69537959|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
37854278|NCT01232283|69537960|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
37854279|NCT01232283|69537961|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
37854280|NCT01232283|69537952|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
37854281|NCT01232283|69537953|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
37854282|NCT01232283|69537954|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
37854283|NCT01232283|69537955|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
37854284|NCT01232283|69537956|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
37854285|NCT01232283|69537957|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
37854286|NCT01232283|69537958|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
37854287|NCT01232283|69537959|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
37854288|NCT01232283|69537960|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
37854289|NCT01232283|69537961|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
37854290|NCT01232283|69537952|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
37854291|NCT01232283|69537953|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
37921884|NCT00828984|69608707|FG002|Overall Study|Noncompliant|3|||
37636881|NCT03022981|69104160|FG000|Overall Study|Lost to Follow-up|6|||
37636882|NCT03022981|69104161|FG001|Overall Study|Lost to Follow-up|2|||
37854292|NCT01232283|69537954|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
37854293|NCT01232283|69537955|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
37854294|NCT01232283|69537956|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
37854295|NCT01232283|69537957|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
37854296|NCT01232283|69537958|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
37854297|NCT01232283|69537959|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
37854298|NCT01232283|69537960|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
37854299|NCT01232283|69537961|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
37854300|NCT01232283|69537952|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
37854301|NCT01232283|69537953|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
37854302|NCT01232283|69537954|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
37854303|NCT01232283|69537955|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
37636883|NCT03022981|69104162|FG002|Overall Study|Lost to Follow-up|1|||
37636884|NCT03022981|69104160|FG000|Overall Study|Non-Compliance With Study Drug|0|||
37636885|NCT03022981|69104161|FG001|Overall Study|Non-Compliance With Study Drug|0|||
37636886|NCT03022981|69104162|FG002|Overall Study|Non-Compliance With Study Drug|2|||
37636887|NCT03022981|69104160|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
37636888|NCT03022981|69104161|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
37636889|NCT03022981|69104162|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
37636890|NCT03377699|69104182|FG000|Overall Study|Withdrawal by Subject|2|||
37636891|NCT03377699|69104183|FG001|Overall Study|Withdrawal by Subject|9|||
37636892|NCT03377699|69104182|FG000|Overall Study|Lost to Follow-up|1|||
37636893|NCT03377699|69104183|FG001|Overall Study|Lost to Follow-up|1|||
37636894|NCT03377699|69104182|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
37636895|NCT03377699|69104183|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
37636896|NCT03377699|69104182|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
37636897|NCT03377699|69104183|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
37636898|NCT03377699|69104182|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
37636899|NCT03377699|69104183|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
37636900|NCT03377699|69104182|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
37636901|NCT03377699|69104183|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
37636902|NCT01314443|69104195|FG000|Overall Study|Withdrawal by Subject|2|||
37636903|NCT01314443|69104196|FG001|Overall Study|Withdrawal by Subject|1|||
37636904|NCT01314443|69104197|FG002|Overall Study|Withdrawal by Subject|1|||
37636905|NCT01314443|69104198|FG003|Overall Study|Withdrawal by Subject|1|||
37636906|NCT01314443|69104195|FG000|Overall Study|Protocol Violation|2|||
37636907|NCT01314443|69104196|FG001|Overall Study|Protocol Violation|2|||
37636908|NCT01314443|69104197|FG002|Overall Study|Protocol Violation|1|||
37636909|NCT01314443|69104198|FG003|Overall Study|Protocol Violation|1|||
37636910|NCT02923921|69104210|FG000|Overall Study|Sponsor Decision|39|||
37636911|NCT02923921|69104211|FG001|Overall Study|Sponsor Decision|38|||
37636912|NCT02923921|69104210|FG000|Overall Study|Lost to Follow-up|1|||
37636913|NCT02923921|69104211|FG001|Overall Study|Lost to Follow-up|0|||
37636914|NCT02923921|69104210|FG000|Overall Study|Withdrawal by Subject|6|||
37636915|NCT02923921|69104211|FG001|Overall Study|Withdrawal by Subject|13|||
37636916|NCT02923921|69104210|FG000|Overall Study|Unknown, Not Collected|7|||
37636917|NCT02923921|69104211|FG001|Overall Study|Unknown, Not Collected|6|||
37636918|NCT03039023|69104222|FG000|Overall Study|Withdrawal by Subject|1|||
37636919|NCT03039023|69104223|FG001|Overall Study|Withdrawal by Subject|0|||
37636920|NCT03039023|69104224|FG002|Overall Study|Withdrawal by Subject|1|||
37636921|NCT03039023|69104225|FG003|Overall Study|Withdrawal by Subject|1|||
37636922|NCT03039023|69104226|FG004|Overall Study|Withdrawal by Subject|0|||
37636923|NCT03039023|69104222|FG000|Overall Study|Physician Decision|0|||
37636924|NCT03039023|69104223|FG001|Overall Study|Physician Decision|0|||
37636925|NCT03039023|69104224|FG002|Overall Study|Physician Decision|0|||
37636926|NCT03039023|69104225|FG003|Overall Study|Physician Decision|1|||
37636927|NCT03039023|69104226|FG004|Overall Study|Physician Decision|0|||
37636928|NCT03022045|69104240|FG000|Overall Study|Adverse Event|0|||
37636929|NCT03022045|69104241|FG001|Overall Study|Adverse Event|1|||
37636930|NCT03022045|69104240|FG000|Overall Study|Withdrawal by Subject|1|||
37636931|NCT03022045|69104241|FG001|Overall Study|Withdrawal by Subject|1|||
37636932|NCT03037619|69104253|FG000|Overall Study|Lost to Follow-up|0|||
37636933|NCT03037619|69104254|FG001|Overall Study|Lost to Follow-up|1|||
37636934|NCT04771013|69104262|FG000|Overall Study|Withdrawal by Subject|2|||
37636935|NCT04771013|69104263|FG001|Overall Study|Withdrawal by Subject|0|||
37636936|NCT04771013|69104262|FG000|Overall Study|Death|0|||
37636937|NCT04771013|69104263|FG001|Overall Study|Death|5|||
37636938|NCT04771013|69104262|FG000|Overall Study|Referred to another hospital before day 20|0|||
37636939|NCT04771013|69104263|FG001|Overall Study|Referred to another hospital before day 20|1|||
37636940|NCT03021265|69104269|FG000|Overall Study|Adverse Event|29|||
37636941|NCT03021265|69104269|FG000|Overall Study|Lack of Efficacy|3|||
37636942|NCT03021265|69104269|FG000|Overall Study|Improved|17|||
37636943|NCT03021265|69104269|FG000|Overall Study|Lost to Follow-up|67|||
37636944|NCT03021265|69104269|FG000|Overall Study|No reason given|2|||
37636945|NCT03021265|69104269|FG000|Overall Study|No visit since the first visit|4|||
37636946|NCT04611789|69104276|FG000|Overall Study|Lost to Follow-up|1|||
37636947|NCT04611789|69104277|FG001|Overall Study|Lost to Follow-up|0|||
37636948|NCT04611789|69104278|FG002|Overall Study|Lost to Follow-up|0|||
37636949|NCT03561597|69104294|FG000|Overall Study|Lost to Follow-up|20|||
37636950|NCT03034967|69104317|FG000|Overall Study|Withdrawal by Subject|9|||
37636951|NCT03034967|69104318|FG001|Overall Study|Withdrawal by Subject|2|||
37636952|NCT03034967|69104319|FG002|Overall Study|Withdrawal by Subject|6|||
37636953|NCT03034967|69104320|FG003|Overall Study|Withdrawal by Subject|6|||
37636954|NCT03034967|69104321|FG004|Overall Study|Withdrawal by Subject|9|||
37636955|NCT03034967|69104322|FG005|Overall Study|Withdrawal by Subject|2|||
37636956|NCT03034967|69104317|FG000|Overall Study|Physician Decision|1|||
37636957|NCT03034967|69104318|FG001|Overall Study|Physician Decision|0|||
37636958|NCT03034967|69104319|FG002|Overall Study|Physician Decision|1|||
37636959|NCT03034967|69104320|FG003|Overall Study|Physician Decision|1|||
37636960|NCT03034967|69104321|FG004|Overall Study|Physician Decision|1|||
37636961|NCT03034967|69104322|FG005|Overall Study|Physician Decision|0|||
37636962|NCT03034967|69104317|FG000|Overall Study|Lost to Follow-up|0|||
37636963|NCT03034967|69104318|FG001|Overall Study|Lost to Follow-up|0|||
37636964|NCT03034967|69104319|FG002|Overall Study|Lost to Follow-up|0|||
37636965|NCT03034967|69104320|FG003|Overall Study|Lost to Follow-up|1|||
37636966|NCT03034967|69104321|FG004|Overall Study|Lost to Follow-up|0|||
37636967|NCT03034967|69104322|FG005|Overall Study|Lost to Follow-up|2|||
37636968|NCT03034967|69104317|FG000|Overall Study|Liver function test abnormality|0|||
37636969|NCT03034967|69104318|FG001|Overall Study|Liver function test abnormality|0|||
37636970|NCT03034967|69104319|FG002|Overall Study|Liver function test abnormality|1|||
37636971|NCT03034967|69104320|FG003|Overall Study|Liver function test abnormality|0|||
37636972|NCT03034967|69104321|FG004|Overall Study|Liver function test abnormality|0|||
37636973|NCT03034967|69104322|FG005|Overall Study|Liver function test abnormality|0|||
37636974|NCT03034967|69104317|FG000|Overall Study|Protocol Violation|1|||
37636975|NCT03034967|69104318|FG001|Overall Study|Protocol Violation|0|||
37636976|NCT03034967|69104319|FG002|Overall Study|Protocol Violation|0|||
37636977|NCT03034967|69104320|FG003|Overall Study|Protocol Violation|0|||
37636978|NCT03034967|69104321|FG004|Overall Study|Protocol Violation|0|||
37636979|NCT03034967|69104322|FG005|Overall Study|Protocol Violation|2|||
37636980|NCT03034967|69104317|FG000|Overall Study|Lack of Efficacy|0|||
37636981|NCT03034967|69104318|FG001|Overall Study|Lack of Efficacy|1|||
37636982|NCT03034967|69104319|FG002|Overall Study|Lack of Efficacy|2|||
37636983|NCT03034967|69104320|FG003|Overall Study|Lack of Efficacy|1|||
37636984|NCT03034967|69104321|FG004|Overall Study|Lack of Efficacy|1|||
37636985|NCT03034967|69104322|FG005|Overall Study|Lack of Efficacy|0|||
37636986|NCT03034967|69104317|FG000|Overall Study|Adverse Event, non-fatal|3|||
37636987|NCT03034967|69104318|FG001|Overall Study|Adverse Event, non-fatal|1|||
37636988|NCT03034967|69104319|FG002|Overall Study|Adverse Event, non-fatal|2|||
37636989|NCT03034967|69104320|FG003|Overall Study|Adverse Event, non-fatal|0|||
37636990|NCT03034967|69104321|FG004|Overall Study|Adverse Event, non-fatal|2|||
37636991|NCT03034967|69104322|FG005|Overall Study|Adverse Event, non-fatal|8|||
37636992|NCT03034967|69104317|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
37636993|NCT03034967|69104318|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
37636994|NCT03034967|69104319|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
37636995|NCT03034967|69104320|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
37636996|NCT03034967|69104321|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
37636997|NCT03034967|69104322|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
37636998|NCT03021187|69104345|FG000|Overall Study|Death|0|||
37636999|NCT03021187|69104346|FG001|Overall Study|Death|0|||
37637000|NCT03021187|69104347|FG002|Overall Study|Death|3|||
37637001|NCT03021187|69104348|FG003|Overall Study|Death|0|||
37637002|NCT03021187|69104345|FG000|Overall Study|Withdrawal by Subject|0|||
37637003|NCT03021187|69104346|FG001|Overall Study|Withdrawal by Subject|6|||
37637004|NCT03021187|69104347|FG002|Overall Study|Withdrawal by Subject|2|||
37637005|NCT03021187|69104348|FG003|Overall Study|Withdrawal by Subject|5|||
37637006|NCT03021187|69104345|FG000|Overall Study|Lost to Follow-up|10|||
37637007|NCT03021187|69104346|FG001|Overall Study|Lost to Follow-up|3|||
37637008|NCT03021187|69104347|FG002|Overall Study|Lost to Follow-up|1|||
37637009|NCT03021187|69104348|FG003|Overall Study|Lost to Follow-up|4|||
37637010|NCT03014479|69104360|FG000|Overall Study|Adverse Event|0|||
37637011|NCT03014479|69104361|FG001|Overall Study|Adverse Event|1|||
37637012|NCT03014479|69104360|FG000|Overall Study|Voluntary Withdrawal|0|||
37637013|NCT03014479|69104361|FG001|Overall Study|Voluntary Withdrawal|2|||
37637014|NCT03014479|69104360|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
37637015|NCT03014479|69104361|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
37637016|NCT04766333|69104369|FG000|Overall Study|Lost to Follow-up|40|||
37637017|NCT04766333|69104370|FG001|Overall Study|Lost to Follow-up|826|||
37637018|NCT03020641|69104378|FG000|Overall Study|Lost to Follow-up|0|||
37637019|NCT03020641|69104379|FG001|Overall Study|Lost to Follow-up|1|||
37637020|NCT03020641|69104378|FG000|Overall Study|Converted to open surgery|2|||
37637021|NCT03020641|69104379|FG001|Overall Study|Converted to open surgery|1|||
37637022|NCT03020641|69104378|FG000|Overall Study|for surgery not performed|0|||
37637023|NCT03020641|69104379|FG001|Overall Study|for surgery not performed|1|||
37637024|NCT03020407|69104390|FG000|Overall Study|Withdrawal by Subject|2|||
37637025|NCT03020407|69104391|FG001|Overall Study|Withdrawal by Subject|1|||
37637026|NCT03020407|69104390|FG000|Overall Study|Lost to Follow-up|2|||
37637027|NCT03020407|69104391|FG001|Overall Study|Lost to Follow-up|3|||
37637028|NCT03020407|69104390|FG000|Overall Study|Protocol Violation|0|||
37637029|NCT03020407|69104391|FG001|Overall Study|Protocol Violation|1|||
37637030|NCT02536846|69104397|FG000|Overall Study|Withdrawal by Subject|1|||
37637031|NCT03014011|69104402|FG000|First Intervention|Withdrawal by Subject|1|||
37637032|NCT03014011|69104403|FG001|First Intervention|Withdrawal by Subject|0|||
37637033|NCT03014011|69104402|FG000|Washout|Withdrawal by Subject|1|||
37637034|NCT03014011|69104403|FG001|Washout|Withdrawal by Subject|0|||
37637035|NCT03012841|69104418|FG000|Overall Study|Protocol Violation|0|||
37637036|NCT03012841|69104419|FG001|Overall Study|Protocol Violation|10|||
37637037|NCT03012841|69104418|FG000|Overall Study|Lost to Follow-up|6|||
37637038|NCT03012841|69104419|FG001|Overall Study|Lost to Follow-up|1|||
37637039|NCT03012841|69104418|FG000|Overall Study|Withdrawal by Subject|6|||
37637040|NCT03012841|69104419|FG001|Overall Study|Withdrawal by Subject|0|||
37637041|NCT03012841|69104418|FG000|Overall Study|Unable to complete 12 month visit|6|||
37637042|NCT03012841|69104419|FG001|Overall Study|Unable to complete 12 month visit|0|||
37637043|NCT03012841|69104418|FG000|Overall Study|Subject relocation|1|||
37637044|NCT03012841|69104419|FG001|Overall Study|Subject relocation|0|||
37637045|NCT03012841|69104418|FG000|Overall Study|Seasonal winter travel|1|||
37637046|NCT03012841|69104419|FG001|Overall Study|Seasonal winter travel|0|||
37637047|NCT03012841|69104418|FG000|Overall Study|Physician Decision|0|||
37637048|NCT03012841|69104419|FG001|Overall Study|Physician Decision|2|||
37637049|NCT03012841|69104418|FG000|Overall Study|No ablation performed|0|||
37637050|NCT03012841|69104419|FG001|Overall Study|No ablation performed|2|||
37637051|NCT03012841|69104418|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
37637052|NCT03012841|69104419|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
37637053|NCT03012841|69104418|FG000|Overall Study|Insurance change|0|||
37637054|NCT03012841|69104419|FG001|Overall Study|Insurance change|1|||
37637055|NCT02359864|69104426|FG000|Overall Study|Withdrawal by Subject|1|||
37637056|NCT02359864|69104427|FG001|Overall Study|Withdrawal by Subject|0|||
37637057|NCT02533258|69104433|FG000|Overall Study|Adverse Event|1|||
37637058|NCT02533258|69104433|FG000|Overall Study|Death|2|||
37637059|NCT02533258|69104433|FG000|Overall Study|Other|1|||
37637060|NCT02533258|69104433|FG000|Overall Study|Economic factor|1|||
37637061|NCT02533258|69104433|FG000|Overall Study|Progression of pleural effusion|1|||
37637062|NCT02533258|69104433|FG000|Overall Study|Lack of Efficacy|2|||
37637063|NCT03019627|69104452|FG000|Overall Study|Adverse Event|8|||
37637064|NCT03019627|69104453|FG001|Overall Study|Adverse Event|0|||
37637065|NCT03019627|69104452|FG000|Overall Study|Unrelated to adverse event|1|||
37637066|NCT03019627|69104453|FG001|Overall Study|Unrelated to adverse event|3|||
37637067|NCT03019627|69104452|FG000|Overall Study|Lost to Follow-up|2|||
37637068|NCT03019627|69104453|FG001|Overall Study|Lost to Follow-up|1|||
37637069|NCT03019627|69104452|FG000|Overall Study|not compliance|2|||
37637070|NCT03019627|69104453|FG001|Overall Study|not compliance|2|||
37637071|NCT03019627|69104452|FG000|Overall Study|Other|2|||
37637072|NCT03019627|69104453|FG001|Overall Study|Other|2|||
37637073|NCT01661140|69104459|FG000|Open-Label Period|Adverse Event|44|||
37637074|NCT01661140|69104460|FG001|Open-Label Period|Adverse Event|0|||
37637075|NCT01661140|69104461|FG002|Open-Label Period|Adverse Event|0|||
37637076|NCT01661140|69104459|FG000|Open-Label Period|Protocol Violation|3|||
37637077|NCT01661140|69104460|FG001|Open-Label Period|Protocol Violation|0|||
37637078|NCT01661140|69104461|FG002|Open-Label Period|Protocol Violation|0|||
37637079|NCT01661140|69104459|FG000|Open-Label Period|Withdrawal by Subject|5|||
37637080|NCT01661140|69104460|FG001|Open-Label Period|Withdrawal by Subject|0|||
37637081|NCT01661140|69104461|FG002|Open-Label Period|Withdrawal by Subject|0|||
37637082|NCT01661140|69104459|FG000|Open-Label Period|Investigator Decision|3|||
37637083|NCT01661140|69104460|FG001|Open-Label Period|Investigator Decision|0|||
37637084|NCT01661140|69104461|FG002|Open-Label Period|Investigator Decision|0|||
37637085|NCT01661140|69104459|FG000|Open-Label Period|Death|1|||
37637086|NCT01661140|69104460|FG001|Open-Label Period|Death|0|||
37637087|NCT01661140|69104461|FG002|Open-Label Period|Death|0|||
37637088|NCT01661140|69104459|FG000|Open-Label Period|Administrative/Other|1|||
37637089|NCT01661140|69104460|FG001|Open-Label Period|Administrative/Other|0|||
37637090|NCT01661140|69104461|FG002|Open-Label Period|Administrative/Other|0|||
37637091|NCT01661140|69104459|FG000|Open-Label Period|Sponsor termination|16|||
37637092|NCT01661140|69104460|FG001|Open-Label Period|Sponsor termination|0|||
37637093|NCT01661140|69104461|FG002|Open-Label Period|Sponsor termination|0|||
37637094|NCT01661140|69104459|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
37637095|NCT01661140|69104460|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
37637096|NCT01661140|69104461|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
37637097|NCT01661140|69104459|FG000|Open-Label Period|Lost to Follow-up|2|||
37637098|NCT01661140|69104460|FG001|Open-Label Period|Lost to Follow-up|0|||
37637099|NCT01661140|69104461|FG002|Open-Label Period|Lost to Follow-up|0|||
37637100|NCT01661140|69104459|FG000|Double-Blind Period|Refused Treatment|0|||
37637101|NCT01661140|69104460|FG001|Double-Blind Period|Refused Treatment|0|||
37637102|NCT01661140|69104461|FG002|Double-Blind Period|Refused Treatment|1|||
37637103|NCT01661140|69104459|FG000|Double-Blind Period|Adverse Event|0|||
37637104|NCT01661140|69104460|FG001|Double-Blind Period|Adverse Event|16|||
37637105|NCT01661140|69104461|FG002|Double-Blind Period|Adverse Event|18|||
37637106|NCT01661140|69104459|FG000|Double-Blind Period|Protocol Violation|0|||
37637107|NCT01661140|69104460|FG001|Double-Blind Period|Protocol Violation|2|||
37637108|NCT01661140|69104461|FG002|Double-Blind Period|Protocol Violation|3|||
37637109|NCT01661140|69104459|FG000|Double-Blind Period|Withdrawal by Subject|0|||
37637110|NCT01661140|69104460|FG001|Double-Blind Period|Withdrawal by Subject|1|||
37637111|NCT01661140|69104461|FG002|Double-Blind Period|Withdrawal by Subject|3|||
37637112|NCT01661140|69104459|FG000|Double-Blind Period|Investigator's Decision|0|||
37637113|NCT01661140|69104460|FG001|Double-Blind Period|Investigator's Decision|1|||
37637114|NCT01661140|69104461|FG002|Double-Blind Period|Investigator's Decision|2|||
37637115|NCT01661140|69104459|FG000|Double-Blind Period|Sponsor Termination|0|||
37637116|NCT01661140|69104460|FG001|Double-Blind Period|Sponsor Termination|14|||
37637117|NCT01661140|69104461|FG002|Double-Blind Period|Sponsor Termination|17|||
37637118|NCT01661140|69104459|FG000|Double-Blind Period|Administrative/Other|0|||
37637119|NCT01661140|69104460|FG001|Double-Blind Period|Administrative/Other|7|||
37637120|NCT01661140|69104461|FG002|Double-Blind Period|Administrative/Other|6|||
37637121|NCT03019549|69104469|FG000|Washout|DId not meet genotype criteria|11|||
37637122|NCT03019549|69104469|FG000|Period 2|Adverse Event|2|||
37637123|NCT03019549|69104469|FG000|Period 2|Physician Decision|2|||
37637124|NCT03019549|69104469|FG000|Period 2|Withdrawal by Subject|1|||
37637125|NCT01661062|69104478|FG000|Overall Study|Completed Treatment Off Study|3|||
37637126|NCT01661062|69104478|FG000|Overall Study|Withdrawal by Subject|2|||
37637127|NCT02536378|69104484|FG000|Overall Study|Physician Decision|0|||
37637128|NCT02536378|69104485|FG001|Overall Study|Physician Decision|2|||
37637129|NCT02536378|69104484|FG000|Overall Study|Withdrawal by Subject|0|||
37637130|NCT02536378|69104485|FG001|Overall Study|Withdrawal by Subject|1|||
37637131|NCT02536378|69104484|FG000|Overall Study|Death|1|||
37637132|NCT02536378|69104485|FG001|Overall Study|Death|2|||
37637133|NCT02536378|69104484|FG000|Overall Study|Patient refused further follow up|6|||
37637134|NCT02536378|69104485|FG001|Overall Study|Patient refused further follow up|2|||
37637135|NCT01373151|69104500|FG000|Period 1|Lack of Efficacy|3|||
37637136|NCT01373151|69104501|FG001|Period 1|Lack of Efficacy|0|||
37637137|NCT01373151|69104502|FG002|Period 1|Lack of Efficacy|0|||
37637138|NCT01373151|69104503|FG003|Period 1|Lack of Efficacy|0|||
37637139|NCT01373151|69104504|FG004|Period 1|Lack of Efficacy|1|||
37637140|NCT01373151|69104505|FG005|Period 1|Lack of Efficacy|0|||
37637141|NCT01373151|69104506|FG006|Period 1|Lack of Efficacy|0|||
37637142|NCT01373151|69104500|FG000|Period 1|Adverse Event|0|||
37637143|NCT01373151|69104501|FG001|Period 1|Adverse Event|0|||
37637144|NCT01373151|69104502|FG002|Period 1|Adverse Event|1|||
37637145|NCT01373151|69104503|FG003|Period 1|Adverse Event|0|||
37637146|NCT01373151|69104504|FG004|Period 1|Adverse Event|4|||
37637147|NCT01373151|69104505|FG005|Period 1|Adverse Event|3|||
37637148|NCT01373151|69104506|FG006|Period 1|Adverse Event|0|||
37637149|NCT01373151|69104500|FG000|Period 1|Withdrawal by Subject|2|||
37637150|NCT01373151|69104501|FG001|Period 1|Withdrawal by Subject|0|||
37637151|NCT01373151|69104502|FG002|Period 1|Withdrawal by Subject|3|||
37637152|NCT01373151|69104503|FG003|Period 1|Withdrawal by Subject|1|||
37637153|NCT01373151|69104504|FG004|Period 1|Withdrawal by Subject|0|||
37637154|NCT01373151|69104505|FG005|Period 1|Withdrawal by Subject|1|||
37637155|NCT01373151|69104506|FG006|Period 1|Withdrawal by Subject|0|||
37637156|NCT01373151|69104500|FG000|Period 2|Lack of Efficacy|9|||
37637157|NCT01373151|69104501|FG001|Period 2|Lack of Efficacy|0|||
37637158|NCT01373151|69104502|FG002|Period 2|Lack of Efficacy|0|||
37637159|NCT01373151|69104503|FG003|Period 2|Lack of Efficacy|1|||
37637160|NCT01373151|69104504|FG004|Period 2|Lack of Efficacy|2|||
37637161|NCT01373151|69104505|FG005|Period 2|Lack of Efficacy|0|||
37637162|NCT01373151|69104506|FG006|Period 2|Lack of Efficacy|3|||
37637163|NCT01373151|69104500|FG000|Period 2|Adverse Event|0|||
37637164|NCT01373151|69104501|FG001|Period 2|Adverse Event|0|||
37637165|NCT01373151|69104502|FG002|Period 2|Adverse Event|3|||
37637166|NCT01373151|69104503|FG003|Period 2|Adverse Event|3|||
37637167|NCT01373151|69104504|FG004|Period 2|Adverse Event|0|||
37637168|NCT01373151|69104505|FG005|Period 2|Adverse Event|0|||
37637169|NCT01373151|69104506|FG006|Period 2|Adverse Event|1|||
37637170|NCT01373151|69104500|FG000|Period 2|subject request to discontinue|0|||
37637171|NCT01373151|69104501|FG001|Period 2|subject request to discontinue|1|||
37637172|NCT01373151|69104502|FG002|Period 2|subject request to discontinue|0|||
37637173|NCT01373151|69104503|FG003|Period 2|subject request to discontinue|0|||
37637174|NCT01373151|69104504|FG004|Period 2|subject request to discontinue|0|||
37637175|NCT01373151|69104505|FG005|Period 2|subject request to discontinue|0|||
37637176|NCT01373151|69104506|FG006|Period 2|subject request to discontinue|0|||
37637177|NCT01373151|69104500|FG000|Period 2|Withdrawal by Subject|0|||
37637178|NCT01373151|69104501|FG001|Period 2|Withdrawal by Subject|0|||
37637179|NCT01373151|69104502|FG002|Period 2|Withdrawal by Subject|0|||
37637180|NCT01373151|69104503|FG003|Period 2|Withdrawal by Subject|1|||
37637181|NCT01373151|69104504|FG004|Period 2|Withdrawal by Subject|0|||
37637182|NCT01373151|69104505|FG005|Period 2|Withdrawal by Subject|0|||
37637183|NCT01373151|69104506|FG006|Period 2|Withdrawal by Subject|0|||
37637184|NCT01373151|69104500|FG000|Period 2|Other|0|||
37637185|NCT01373151|69104501|FG001|Period 2|Other|0|||
37637186|NCT01373151|69104502|FG002|Period 2|Other|1|||
37637187|NCT01373151|69104503|FG003|Period 2|Other|0|||
37637188|NCT01373151|69104504|FG004|Period 2|Other|0|||
37637189|NCT01373151|69104505|FG005|Period 2|Other|0|||
37637190|NCT01373151|69104506|FG006|Period 2|Other|1|||
37637191|NCT01660906|69104522|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
37637192|NCT03015181|69104542|FG000|Overall Study|Enrolled, but product never administered|1|||
37637193|NCT03015181|69104543|FG001|Overall Study|Enrolled, but product never administered|0|||
37637194|NCT03015181|69104544|FG002|Overall Study|Enrolled, but product never administered|0|||
37637195|NCT03015181|69104545|FG003|Overall Study|Enrolled, but product never administered|0|||
37637196|NCT03015181|69104546|FG004|Overall Study|Enrolled, but product never administered|0|||
37637197|NCT03015181|69104547|FG005|Overall Study|Enrolled, but product never administered|0|||
37637198|NCT03015181|69104548|FG006|Overall Study|Enrolled, but product never administered|0|||
37637199|NCT03015181|69104542|FG000|Overall Study|Withdrawal by Subject|0|||
37637200|NCT03015181|69104543|FG001|Overall Study|Withdrawal by Subject|0|||
37637201|NCT03015181|69104544|FG002|Overall Study|Withdrawal by Subject|0|||
37637202|NCT03015181|69104545|FG003|Overall Study|Withdrawal by Subject|0|||
37637203|NCT03015181|69104546|FG004|Overall Study|Withdrawal by Subject|0|||
37637204|NCT03015181|69104547|FG005|Overall Study|Withdrawal by Subject|1|||
37637205|NCT03015181|69104548|FG006|Overall Study|Withdrawal by Subject|0|||
37637206|NCT03015181|69104542|FG000|Overall Study|Physician Decision|0|||
37637207|NCT03015181|69104543|FG001|Overall Study|Physician Decision|0|||
37637208|NCT03015181|69104544|FG002|Overall Study|Physician Decision|0|||
37637209|NCT03015181|69104545|FG003|Overall Study|Physician Decision|0|||
37637210|NCT03015181|69104546|FG004|Overall Study|Physician Decision|0|||
37637211|NCT03015181|69104547|FG005|Overall Study|Physician Decision|0|||
37637212|NCT03015181|69104548|FG006|Overall Study|Physician Decision|1|||
37637213|NCT00960297|69104597|FG000|Overall Study|Physician Decision|1|||
37637214|NCT00960297|69104597|FG000|Overall Study|Venous port infection|1|||
37637215|NCT00960297|69104597|FG000|Overall Study|Disease progression|1|||
37637216|NCT03018691|69104604|FG000|Overall Study|Adverse Event|1|||
37637217|NCT03018691|69104605|FG001|Overall Study|Adverse Event|1|||
37637218|NCT03018691|69104606|FG002|Overall Study|Adverse Event|4|||
37637219|NCT03018691|69104604|FG000|Overall Study|Lack of Efficacy|0|||
37637220|NCT03018691|69104605|FG001|Overall Study|Lack of Efficacy|0|||
37637221|NCT03018691|69104606|FG002|Overall Study|Lack of Efficacy|1|||
37637222|NCT03018691|69104604|FG000|Overall Study|Withdrawal by Subject|0|||
37637223|NCT03018691|69104605|FG001|Overall Study|Withdrawal by Subject|0|||
37637224|NCT03018691|69104606|FG002|Overall Study|Withdrawal by Subject|1|||
37637225|NCT03018691|69104604|FG000|Overall Study|Withdrawal by parent/guardian|1|||
37637226|NCT03018691|69104605|FG001|Overall Study|Withdrawal by parent/guardian|0|||
37637227|NCT03018691|69104606|FG002|Overall Study|Withdrawal by parent/guardian|1|||
37637228|NCT03012061|69104619|FG000|Overall Study|Withdrawal by Subject|1|||
37637229|NCT03012061|69104620|FG001|Overall Study|Withdrawal by Subject|5|||
37637230|NCT03012061|69104621|FG002|Overall Study|Withdrawal by Subject|4|||
37637231|NCT03012061|69104619|FG000|Overall Study|Investigator Site Closed|1|||
37637232|NCT03012061|69104620|FG001|Overall Study|Investigator Site Closed|2|||
37637233|NCT03012061|69104621|FG002|Overall Study|Investigator Site Closed|0|||
37637234|NCT03012061|69104619|FG000|Overall Study|Lost to Follow-up|2|||
37637235|NCT03012061|69104620|FG001|Overall Study|Lost to Follow-up|1|||
37637236|NCT03012061|69104621|FG002|Overall Study|Lost to Follow-up|0|||
37921885|NCT00828984|69608705|FG000|Overall Study|ConMed|1|||
37637237|NCT03012061|69104619|FG000|Overall Study|Study closed/ Terminated|0|||
37637238|NCT03012061|69104620|FG001|Overall Study|Study closed/ Terminated|0|||
37637239|NCT03012061|69104621|FG002|Overall Study|Study closed/ Terminated|1|||
37637240|NCT03012061|69104619|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
37637241|NCT03012061|69104620|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
37637242|NCT03012061|69104621|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
37637243|NCT03012061|69104619|FG000|Overall Study|Protocol Violation|0|||
37637244|NCT03012061|69104620|FG001|Overall Study|Protocol Violation|0|||
37637245|NCT03012061|69104621|FG002|Overall Study|Protocol Violation|2|||
37637246|NCT03012061|69104619|FG000|Overall Study|Lack of Efficacy|0|||
37637247|NCT03012061|69104620|FG001|Overall Study|Lack of Efficacy|1|||
37637248|NCT03012061|69104621|FG002|Overall Study|Lack of Efficacy|0|||
37637249|NCT03012061|69104619|FG000|Overall Study|Adverse Event|2|||
37637250|NCT03012061|69104620|FG001|Overall Study|Adverse Event|0|||
37637251|NCT03012061|69104621|FG002|Overall Study|Adverse Event|0|||
37637252|NCT03010501|69104629|FG000|Study Week 1|Withdrawal by Subject|2|||
37637253|NCT03010501|69104630|FG001|Study Week 1|Withdrawal by Subject|1|||
37637254|NCT03010501|69104631|FG002|Study Week 1|Withdrawal by Subject|0|||
37637255|NCT03010501|69104632|FG003|Study Week 1|Withdrawal by Subject|2|||
37637256|NCT03010501|69104633|FG004|Study Week 1|Withdrawal by Subject|0|||
37637257|NCT03010501|69104634|FG005|Study Week 1|Withdrawal by Subject|0|||
37637258|NCT03010501|69104629|FG000|Study Week 3|Withdrawal by Subject|0|||
37637259|NCT03010501|69104630|FG001|Study Week 3|Withdrawal by Subject|0|||
37637260|NCT03010501|69104631|FG002|Study Week 3|Withdrawal by Subject|0|||
37739860|NCT01447719|69224985|FG000|Overall Study|Withdrawal by Subject|2|||
37739861|NCT01447719|69224985|FG000|Overall Study|Family withdrew autopsy consent|7|||
37739862|NCT01431963|69224994|FG000|Overall Study|Adverse Event|18|||
37739863|NCT01431963|69224994|FG000|Overall Study|Lack of Efficacy|7|||
37739864|NCT01431963|69224994|FG000|Overall Study|Protocol Violation|1|||
37739865|NCT01431963|69224994|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
37739866|NCT01431963|69224994|FG000|Overall Study|Physician Decision|4|||
37739867|NCT01431963|69224994|FG000|Overall Study|Withdrawal by Subject|3|||
37739868|NCT01447407|69225002|FG000|Overall Study|Withdrawal by Subject|2|||
37739869|NCT01447407|69225003|FG001|Overall Study|Withdrawal by Subject|0|||
37739870|NCT01447407|69225004|FG002|Overall Study|Withdrawal by Subject|0|||
37739871|NCT01447407|69225005|FG003|Overall Study|Withdrawal by Subject|1|||
37739872|NCT01447407|69225002|FG000|Overall Study|Physician Decision|0|||
37739873|NCT01447407|69225003|FG001|Overall Study|Physician Decision|0|||
37739874|NCT01447407|69225004|FG002|Overall Study|Physician Decision|1|||
37739875|NCT01447407|69225005|FG003|Overall Study|Physician Decision|1|||
37739876|NCT01446237|69225015|FG000|Overall Study|Adverse Event|1|||
37739877|NCT01446237|69225015|FG000|Overall Study|Lost to Follow-up|2|||
37739878|NCT01446237|69225015|FG000|Overall Study|Withdrawal by Subject|7|||
37739879|NCT01446159|69225159|FG000|Overall Study|Withdrawal by Subject|1|||
37739880|NCT01446159|69225160|FG001|Overall Study|Withdrawal by Subject|0|||
37739881|NCT01446159|69225161|FG002|Overall Study|Withdrawal by Subject|14|||
37739882|NCT01446159|69225162|FG003|Overall Study|Withdrawal by Subject|11|||
37739883|NCT01446159|69225159|FG000|Overall Study|Lost to Follow-up|0|||
37739884|NCT01446159|69225160|FG001|Overall Study|Lost to Follow-up|0|||
37739885|NCT01446159|69225161|FG002|Overall Study|Lost to Follow-up|1|||
37739886|NCT01446159|69225162|FG003|Overall Study|Lost to Follow-up|2|||
37739887|NCT01446159|69225159|FG000|Overall Study|Death|2|||
37739888|NCT01446159|69225160|FG001|Overall Study|Death|3|||
37739889|NCT01446159|69225161|FG002|Overall Study|Death|43|||
37739890|NCT01446159|69225162|FG003|Overall Study|Death|36|||
37739891|NCT01446159|69225159|FG000|Overall Study|Other|0|||
37739892|NCT01446159|69225160|FG001|Overall Study|Other|0|||
37739893|NCT01446159|69225161|FG002|Overall Study|Other|13|||
37739894|NCT01446159|69225162|FG003|Overall Study|Other|13|||
37739895|NCT01446003|69225198|FG000|Period 1|Protocol Violation|2|||
37739896|NCT01446003|69225199|FG001|Period 1|Protocol Violation|0|||
37739897|NCT01446003|69225198|FG000|Period 2|Adverse Event|1|||
37739898|NCT01446003|69225199|FG001|Period 2|Adverse Event|0|||
37739899|NCT01430559|69225216|FG000|Overall Study|Adverse Event|7|||
37739900|NCT01430559|69225217|FG001|Overall Study|Adverse Event|3|||
37739901|NCT01430559|69225216|FG000|Overall Study|Entry criteria not met|1|||
37739902|NCT01430559|69225217|FG001|Overall Study|Entry criteria not met|1|||
37739903|NCT01430559|69225216|FG000|Overall Study|Lost to Follow-up|1|||
37637261|NCT03010501|69104632|FG003|Study Week 3|Withdrawal by Subject|1|||
37637262|NCT03010501|69104633|FG004|Study Week 3|Withdrawal by Subject|0|||
37637263|NCT03010501|69104634|FG005|Study Week 3|Withdrawal by Subject|0|||
37637264|NCT03002623|69104644|FG000|Overall Study|Lost to Follow-up|1|||
37637265|NCT03002623|69104645|FG001|Overall Study|Lost to Follow-up|0|||
37637266|NCT03002623|69104644|FG000|Overall Study|Physician Decision|1|||
37637267|NCT03002623|69104645|FG001|Overall Study|Physician Decision|1|||
37637268|NCT03010423|69104653|FG000|Overall Study|Study termination|8|||
37637269|NCT03002311|69104659|FG000|Overall Study|Lost to Follow-up|13|||
37739904|NCT01430559|69225217|FG001|Overall Study|Lost to Follow-up|0|||
37637270|NCT03002311|69104660|FG001|Overall Study|Lost to Follow-up|26|||
37739905|NCT01430559|69225216|FG000|Overall Study|Medication error|1|||
37739906|NCT01430559|69225217|FG001|Overall Study|Medication error|0|||
37739907|NCT01430559|69225216|FG000|Overall Study|Withdrawal by Subject|3|||
37739908|NCT01430559|69225217|FG001|Overall Study|Withdrawal by Subject|2|||
37739909|NCT01430559|69225216|FG000|Overall Study|Protocol Violation|1|||
37739910|NCT01430559|69225217|FG001|Overall Study|Protocol Violation|0|||
37921886|NCT00828984|69608706|FG001|Overall Study|ConMed|1|||
37637271|NCT03002311|69104659|FG000|Overall Study|Referral provider called to schedule app|3|||
37637272|NCT03002311|69104660|FG001|Overall Study|Referral provider called to schedule app|3|||
37921887|NCT00828984|69608707|FG002|Overall Study|ConMed|1|||
37739911|NCT01430559|69225216|FG000|Overall Study|Other|3|||
37739912|NCT01430559|69225217|FG001|Overall Study|Other|3|||
37739913|NCT01430559|69225216|FG000|Overall Study|Randomized, Not Treated|3|||
37739914|NCT01430559|69225217|FG001|Overall Study|Randomized, Not Treated|3|||
37739915|NCT01410357|69225230|FG000|Overall Study|Death|2|||
37739916|NCT01410357|69225231|FG001|Overall Study|Death|1|||
37739917|NCT01410357|69225230|FG000|Overall Study|Withdrawal by Subject|1|||
37739918|NCT01410357|69225231|FG001|Overall Study|Withdrawal by Subject|2|||
37739919|NCT01410357|69225230|FG000|Overall Study|Lost to Follow-up|23|||
37739920|NCT01410357|69225231|FG001|Overall Study|Lost to Follow-up|21|||
37637273|NCT03002311|69104659|FG000|Overall Study|Physician Decision|3|||
37637274|NCT03002311|69104660|FG001|Overall Study|Physician Decision|1|||
37637275|NCT03002077|69104666|FG000|Overall Study|Non-compliance with Study Drug|4|||
37637276|NCT03002077|69104666|FG000|Overall Study|Non-compliance w/Background ADT|1|||
37637277|NCT03002077|69104666|FG000|Overall Study|Study Terminated by Sponsor|257|||
37637278|NCT03002077|69104666|FG000|Overall Study|Site Terminated by Sponsor|5|||
37637279|NCT03002077|69104666|FG000|Overall Study|Miscellaneous Reasons|10|||
37637280|NCT03002077|69104666|FG000|Overall Study|Adverse Event|23|||
37637281|NCT03002077|69104666|FG000|Overall Study|Lack of Efficacy|20|||
37637282|NCT03002077|69104666|FG000|Overall Study|Withdrawal by Subject|72|||
37637283|NCT03002077|69104666|FG000|Overall Study|Lost to Follow-up|21|||
37637284|NCT03002077|69104666|FG000|Overall Study|Pregnancy|4|||
37637285|NCT03002077|69104666|FG000|Overall Study|Protocol Violation|21|||
37739921|NCT01409811|69225256|FG000|Overall Study|Insurance denial|1|||
37739922|NCT01445847|69225262|FG000|Overall Study|Protocol Violation|13|||
37739923|NCT01445847|69225263|FG001|Overall Study|Protocol Violation|14|||
37739924|NCT01445847|69225262|FG000|Overall Study|Missed Data|1|||
37739925|NCT01445847|69225263|FG001|Overall Study|Missed Data|0|||
37739926|NCT01445769|69225282|FG000|Overall Study|Consent Withdrawn|2|||
37739927|NCT01445769|69225282|FG000|Overall Study|Disease Progression|1|||
37739928|NCT01445769|69225282|FG000|Overall Study|Lost to Follow-up|5|||
37739929|NCT01445613|69225364|FG000|30-day Follow-up|Withdrawal by Subject|6|||
37739930|NCT01445613|69225364|FG000|30-day Follow-up|Physician Decision|3|||
37739931|NCT01445613|69225364|FG000|30-day Follow-up|Missed visit|23|||
37739932|NCT01445613|69225364|FG000|30-day Follow-up|Death|3|||
37739933|NCT01445613|69225364|FG000|1-year Follow-up|Withdrawal by Subject|12|||
37739934|NCT01445613|69225364|FG000|1-year Follow-up|Missed visit|29|||
37637286|NCT03008005|69104673|FG000|Overall Study|Physician Decision|1|||
37637287|NCT03008005|69104674|FG001|Overall Study|Physician Decision|0|||
37637288|NCT03008005|69104675|FG002|Overall Study|Physician Decision|0|||
37637289|NCT03008005|69104673|FG000|Overall Study|Withdrawal by Subject|1|||
37637290|NCT03008005|69104674|FG001|Overall Study|Withdrawal by Subject|0|||
37637291|NCT03008005|69104675|FG002|Overall Study|Withdrawal by Subject|0|||
37739935|NCT01445613|69225364|FG000|1-year Follow-up|Lost to Follow-up|2|||
37739936|NCT01445613|69225364|FG000|1-year Follow-up|Death|30|||
37739937|NCT01445613|69225364|FG000|1-year Follow-up|Physician Decision|2|||
37739938|NCT01445613|69225364|FG000|1-year Follow-up|Received a non-study stent|2|||
37739939|NCT01445535|69225468|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
37739940|NCT01445535|69225469|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
37739941|NCT01445535|69225470|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
37739942|NCT01445535|69225471|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
37739943|NCT01445535|69225468|FG000|Overall Study|Disease progression|1|||
37739944|NCT01445535|69225469|FG001|Overall Study|Disease progression|0|||
37739945|NCT01445535|69225470|FG002|Overall Study|Disease progression|1|||
37637292|NCT03008005|69104673|FG000|Overall Study|Ineligible|0|||
37637293|NCT03008005|69104674|FG001|Overall Study|Ineligible|1|||
37637294|NCT03008005|69104675|FG002|Overall Study|Ineligible|0|||
37637295|NCT02440425|69104692|FG000|Overall Study|Death likely due to disease progression|1|||
37637296|NCT02440425|69104692|FG000|Overall Study|Withdrawal by Subject|2|||
37637297|NCT02440425|69104692|FG000|Overall Study|Adverse Event|1|||
37637298|NCT02440425|69104692|FG000|Overall Study|Adverse Event/Ineligible|1|||
37637299|NCT03001219|69104707|FG000|Proof of Concept|Study Termination by Sponsor|0|||
37637300|NCT03001219|69104708|FG001|Proof of Concept|Study Termination by Sponsor|1|||
37637301|NCT03001219|69104707|FG000|Proof of Concept|Withdrawal by Subject|0|||
37637302|NCT03001219|69104708|FG001|Proof of Concept|Withdrawal by Subject|4|||
37637303|NCT03001219|69104707|FG000|Proof of Concept|Protocol Deviation|0|||
37637304|NCT03001219|69104708|FG001|Proof of Concept|Protocol Deviation|1|||
37637305|NCT03001219|69104707|FG000|Proof of Concept|Adverse Event|1|||
37637306|NCT03001219|69104708|FG001|Proof of Concept|Adverse Event|1|||
37637307|NCT03001219|69104707|FG000|Proof of Concept|Physician Decision|1|||
37637308|NCT03001219|69104708|FG001|Proof of Concept|Physician Decision|0|||
37637309|NCT03001219|69104707|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
37637310|NCT03001219|69104708|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
37739946|NCT01445535|69225471|FG003|Overall Study|Disease progression|0|||
37739947|NCT01445535|69225468|FG000|Overall Study|PI discretion|0|||
37637311|NCT03001219|69104707|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
37739948|NCT01445535|69225469|FG001|Overall Study|PI discretion|0|||
37739949|NCT01445535|69225470|FG002|Overall Study|PI discretion|0|||
37739950|NCT01445535|69225471|FG003|Overall Study|PI discretion|1|||
37739951|NCT01445301|69225485|FG000|Overall Study|Adverse Event|15|||
37739952|NCT01445301|69225486|FG001|Overall Study|Adverse Event|25|||
37637312|NCT03001219|69104708|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
37739953|NCT01445301|69225487|FG002|Overall Study|Adverse Event|4|||
37637313|NCT03001219|69104707|FG000|Extension Period Analysis|Physician Decision|0|||
37637314|NCT03001219|69104708|FG001|Extension Period Analysis|Physician Decision|1|||
37637315|NCT03001219|69104707|FG000|Extension Period Analysis|Adverse Event|1|||
37637316|NCT03001219|69104708|FG001|Extension Period Analysis|Adverse Event|1|||
37637317|NCT03001219|69104707|FG000|Extension Period Analysis|Protocol Deviation|0|||
37637318|NCT03001219|69104708|FG001|Extension Period Analysis|Protocol Deviation|1|||
37637319|NCT03001219|69104707|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
37637320|NCT03001219|69104708|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
37637321|NCT03000673|69104723|FG000|Overall Study|Withdrawal by Subject|1|||
37637322|NCT03000673|69104724|FG001|Overall Study|Withdrawal by Subject|0|||
37637323|NCT03000673|69104725|FG002|Overall Study|Withdrawal by Subject|0|||
37637324|NCT03000673|69104726|FG003|Overall Study|Withdrawal by Subject|0|||
37637325|NCT02912455|69104739|FG000|Overall Study|Withdrawal by Subject|0|||
37637326|NCT02912455|69104740|FG001|Overall Study|Withdrawal by Subject|1|||
37637327|NCT02912455|69104739|FG000|Overall Study|Lack of Efficacy|0|||
37637328|NCT02912455|69104740|FG001|Overall Study|Lack of Efficacy|1|||
37637329|NCT02912455|69104739|FG000|Overall Study|Lost to Follow-up|2|||
37637330|NCT02912455|69104740|FG001|Overall Study|Lost to Follow-up|1|||
37637331|NCT04524507|69104748|FG000|Overall Study|Lost to Follow-up|2|||
37637332|NCT04524507|69104749|FG001|Overall Study|Lost to Follow-up|4|||
37637333|NCT04524507|69104748|FG000|Overall Study|Withdrawal by Subject|2|||
37637334|NCT04524507|69104749|FG001|Overall Study|Withdrawal by Subject|9|||
37637335|NCT04524507|69104748|FG000|Overall Study|Death|2|||
37739954|NCT01445301|69225485|FG000|Overall Study|Lack of Efficacy|0|||
37739955|NCT01445301|69225486|FG001|Overall Study|Lack of Efficacy|1|||
37739956|NCT01445301|69225487|FG002|Overall Study|Lack of Efficacy|0|||
37739957|NCT01445301|69225485|FG000|Overall Study|Protocol Violation|1|||
37637336|NCT04524507|69104749|FG001|Overall Study|Death|10|||
37637337|NCT02999191|69104758|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
37637338|NCT02999191|69104759|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
37637339|NCT02999191|69104760|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
37637340|NCT02531698|69104770|FG000|Overall Study|Adverse Event|2|||
37637341|NCT02531698|69104771|FG001|Overall Study|Adverse Event|1|||
37739958|NCT01445301|69225486|FG001|Overall Study|Protocol Violation|0|||
37739959|NCT01445301|69225487|FG002|Overall Study|Protocol Violation|0|||
37739960|NCT01445301|69225485|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
37739961|NCT01445301|69225486|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
37739962|NCT01445301|69225487|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
37739963|NCT01445301|69225485|FG000|Overall Study|Physician Decision|0|||
37921888|NCT00828750|69608715|FG000|Overall Study|Lack of Efficacy|3|||
37637342|NCT02531698|69104770|FG000|Overall Study|Withdrawal by Subject|6|||
37637343|NCT02531698|69104771|FG001|Overall Study|Withdrawal by Subject|1|||
37637344|NCT02531698|69104770|FG000|Overall Study|Protocol Violation|2|||
37637345|NCT02531698|69104771|FG001|Overall Study|Protocol Violation|0|||
37637346|NCT02531698|69104770|FG000|Overall Study|Lost to Follow-up|1|||
37637347|NCT02531698|69104771|FG001|Overall Study|Lost to Follow-up|0|||
37637348|NCT02998021|69104788|FG000|Overall Study|Withdrawal by Subject|3|||
37637349|NCT02998021|69104789|FG001|Overall Study|Withdrawal by Subject|1|||
37637350|NCT02998021|69104788|FG000|Overall Study|unsafe home|0|||
37637351|NCT02998021|69104789|FG001|Overall Study|unsafe home|1|||
37637352|NCT03034577|69104803|FG000|Overall Study|Withdrawal by Subject|6|||
37637353|NCT03034577|69104804|FG001|Overall Study|Withdrawal by Subject|9|||
37637354|NCT03034577|69104803|FG000|Overall Study|Lost to Follow-up|25|||
37637355|NCT03034577|69104804|FG001|Overall Study|Lost to Follow-up|26|||
37637356|NCT01659736|69104814|FG000|Treatment Period|Adverse Event|1|||
37637357|NCT01659736|69104815|FG001|Treatment Period|Adverse Event|1|||
37637358|NCT01659736|69104814|FG000|Treatment Period|Protocol Violation|3|||
37637359|NCT01659736|69104815|FG001|Treatment Period|Protocol Violation|1|||
37637360|NCT01659736|69104814|FG000|Treatment Period|Withdrawal by Subject|1|||
37637361|NCT01659736|69104815|FG001|Treatment Period|Withdrawal by Subject|0|||
37637362|NCT01659736|69104814|FG000|3-month Follow-up|Lost to Follow-up|0|||
37637363|NCT01659736|69104815|FG001|3-month Follow-up|Lost to Follow-up|1|||
37637364|NCT02997163|69104827|FG000|Overall Study|Adverse Event|1|||
37637365|NCT02997163|69104828|FG001|Overall Study|Adverse Event|0|||
37637366|NCT02997163|69104829|FG002|Overall Study|Adverse Event|0|||
37637367|NCT02997163|69104830|FG003|Overall Study|Adverse Event|1|||
37637368|NCT00458536|69104840|FG000|Overall Study|Disease progression prior to treatment|7|||
37739964|NCT01445301|69225486|FG001|Overall Study|Physician Decision|2|||
37739965|NCT01445301|69225487|FG002|Overall Study|Physician Decision|0|||
37739966|NCT01445301|69225485|FG000|Overall Study|Withdrawal by Subject|5|||
37739967|NCT01445301|69225486|FG001|Overall Study|Withdrawal by Subject|6|||
37921889|NCT00828750|69608715|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
37637369|NCT00458536|69104840|FG000|Overall Study|Unable to make vaccine|3|||
37637370|NCT00458536|69104840|FG000|Overall Study|No measurable disease after surgery|2|||
37637371|NCT00458536|69104840|FG000|Overall Study|Did not have renal cell carcinoma|2|||
37637372|NCT00458536|69104840|FG000|Overall Study|Patient did not have surgery|1|||
37637373|NCT00458536|69104840|FG000|Overall Study|Ineligible due to toxicity|1|||
37637374|NCT00458536|69104840|FG000|Overall Study|Withdrawal by Subject|1|||
37921890|NCT00667810|69608724|FG000|Overall Study|Adverse Event|13|||
37637375|NCT00458536|69104840|FG000|Overall Study|Progressive disease during treatment|2|||
37637376|NCT02526550|69104844|FG000|Overall Study|Lost to Follow-up|1|||
37637377|NCT03030989|69104859|FG000|Overall Study|Fever|2|||
37637378|NCT03030989|69104860|FG001|Overall Study|Fever|2|||
37637379|NCT03030989|69104859|FG000|Overall Study|Rash|2|||
37637380|NCT03030989|69104860|FG001|Overall Study|Rash|1|||
37637381|NCT03030989|69104859|FG000|Overall Study|Fatigue/Overwhelmed|1|||
37637382|NCT03030989|69104860|FG001|Overall Study|Fatigue/Overwhelmed|5|||
37637383|NCT03030989|69104859|FG000|Overall Study|Positive Blood Cultures|2|||
37637384|NCT03030989|69104860|FG001|Overall Study|Positive Blood Cultures|1|||
37637385|NCT03030989|69104859|FG000|Overall Study|Line Removed|0|||
37637386|NCT03030989|69104860|FG001|Overall Study|Line Removed|2|||
37637387|NCT03030989|69104859|FG000|Overall Study|No longer interested|5|||
37637388|NCT03030989|69104860|FG001|Overall Study|No longer interested|3|||
37637389|NCT03030599|69104866|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
37637390|NCT03030599|69104867|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
37637391|NCT03030599|69104868|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
37637392|NCT03030599|69104866|FG000|Open Label Treatment and Titration|Other|1|||
37637393|NCT03030599|69104867|FG001|Open Label Treatment and Titration|Other|0|||
37637394|NCT03030599|69104868|FG002|Open Label Treatment and Titration|Other|0|||
37637395|NCT03030599|69104866|FG000|Open Label Treatment and Titration|Physician Decision|3|||
37637396|NCT03030599|69104867|FG001|Open Label Treatment and Titration|Physician Decision|0|||
37637397|NCT03030599|69104868|FG002|Open Label Treatment and Titration|Physician Decision|0|||
37637398|NCT03030599|69104866|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
37637399|NCT03030599|69104867|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
37637400|NCT03030599|69104868|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
37637401|NCT03030599|69104866|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
37637402|NCT03030599|69104867|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
37637403|NCT03030599|69104868|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
37637404|NCT03030599|69104866|FG000|Open Label Treatment and Titration|Adverse Event|18|||
37637405|NCT03030599|69104867|FG001|Open Label Treatment and Titration|Adverse Event|0|||
37637406|NCT03030599|69104868|FG002|Open Label Treatment and Titration|Adverse Event|0|||
37637407|NCT03030599|69104866|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
37637408|NCT03030599|69104867|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
37637409|NCT03030599|69104868|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
37637410|NCT03030599|69104866|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
37637411|NCT03030599|69104867|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
37637412|NCT03030599|69104868|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
37637413|NCT03030599|69104866|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
37637414|NCT03030599|69104867|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
37637415|NCT03030599|69104868|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
37637416|NCT03030599|69104866|FG000|Stable Dose|Protocol deviation|3|||
37637417|NCT03030599|69104867|FG001|Stable Dose|Protocol deviation|0|||
37637418|NCT03030599|69104868|FG002|Stable Dose|Protocol deviation|0|||
37637419|NCT03030599|69104866|FG000|Stable Dose|Adverse Event|1|||
37637420|NCT03030599|69104867|FG001|Stable Dose|Adverse Event|0|||
37637421|NCT03030599|69104868|FG002|Stable Dose|Adverse Event|0|||
37637422|NCT03030599|69104866|FG000|Stable Dose|Lost to Follow-up|1|||
37637423|NCT03030599|69104867|FG001|Stable Dose|Lost to Follow-up|0|||
37637424|NCT03030599|69104868|FG002|Stable Dose|Lost to Follow-up|0|||
37637425|NCT03030599|69104866|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
37637426|NCT03030599|69104867|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
37637427|NCT03030599|69104868|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
37637428|NCT03030599|69104866|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
37637429|NCT03030599|69104867|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
37921891|NCT00667810|69608725|FG001|Overall Study|Adverse Event|14|||
37921892|NCT00667810|69608726|FG002|Overall Study|Adverse Event|19|||
37921893|NCT00667810|69608727|FG003|Overall Study|Adverse Event|1|||
37921894|NCT00667810|69608724|FG000|Overall Study|Death|1|||
37921895|NCT00667810|69608725|FG001|Overall Study|Death|1|||
37637430|NCT03030599|69104868|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
37637431|NCT03030599|69104866|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
37637432|NCT03030599|69104867|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
37637433|NCT03030599|69104868|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
37637434|NCT03030599|69104866|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
37637435|NCT03030599|69104867|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
37637436|NCT03030599|69104868|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
37637437|NCT03030599|69104866|FG000|Open-label Extension|Adverse Event|3|||
37637438|NCT03030599|69104867|FG001|Open-label Extension|Adverse Event|0|||
37921896|NCT00667810|69608726|FG002|Overall Study|Death|3|||
37921897|NCT00667810|69608727|FG003|Overall Study|Death|0|||
37637439|NCT03030599|69104868|FG002|Open-label Extension|Adverse Event|0|||
37637440|NCT03030599|69104866|FG000|Open-label Extension|Lost to Follow-up|2|||
37637441|NCT03030599|69104867|FG001|Open-label Extension|Lost to Follow-up|0|||
37637442|NCT03030599|69104868|FG002|Open-label Extension|Lost to Follow-up|0|||
37637443|NCT03030599|69104866|FG000|Open-label Extension|Lack of Efficacy|1|||
37637444|NCT03030599|69104867|FG001|Open-label Extension|Lack of Efficacy|0|||
37637445|NCT03030599|69104868|FG002|Open-label Extension|Lack of Efficacy|0|||
37637446|NCT03030599|69104866|FG000|Open-label Extension|Other Reason|1|||
37637447|NCT03030599|69104867|FG001|Open-label Extension|Other Reason|0|||
37637448|NCT03030599|69104868|FG002|Open-label Extension|Other Reason|0|||
37637449|NCT03031847|69104878|FG000|Overall Study|Death|1|||
37637450|NCT03031847|69104879|FG001|Overall Study|Death|1|||
37637451|NCT03031847|69104880|FG002|Overall Study|Death|2|||
37637452|NCT03031847|69104881|FG003|Overall Study|Death|3|||
37637453|NCT03031847|69104878|FG000|Overall Study|Lost to Follow-up|1|||
37637454|NCT03031847|69104879|FG001|Overall Study|Lost to Follow-up|1|||
37637455|NCT03031847|69104880|FG002|Overall Study|Lost to Follow-up|2|||
37637456|NCT03031847|69104881|FG003|Overall Study|Lost to Follow-up|3|||
37637457|NCT03028415|69104893|FG000|Overall Study|Lost to Follow-up|6|||
37637458|NCT03028415|69104894|FG001|Overall Study|Lost to Follow-up|3|||
37637459|NCT03028415|69104893|FG000|Overall Study|Withdrawal by Subject|1|||
37637460|NCT03028415|69104894|FG001|Overall Study|Withdrawal by Subject|0|||
37637461|NCT03028415|69104893|FG000|Overall Study|Discontinued due to COVID-19|1|||
37637462|NCT03028415|69104894|FG001|Overall Study|Discontinued due to COVID-19|0|||
37637463|NCT02692040|69104918|FG000|Overall Study|Protocol Violation|0|||
37637464|NCT02692040|69104919|FG001|Overall Study|Protocol Violation|0|||
37637465|NCT02692040|69104920|FG002|Overall Study|Protocol Violation|0|||
37637466|NCT02692040|69104921|FG003|Overall Study|Protocol Violation|0|||
37637467|NCT02692040|69104922|FG004|Overall Study|Protocol Violation|0|||
37637468|NCT02692040|69104923|FG005|Overall Study|Protocol Violation|0|||
37637469|NCT02692040|69104924|FG006|Overall Study|Protocol Violation|0|||
37637470|NCT02692040|69104925|FG007|Overall Study|Protocol Violation|0|||
37637471|NCT02692040|69104926|FG008|Overall Study|Protocol Violation|0|||
37637472|NCT02692040|69104927|FG009|Overall Study|Protocol Violation|0|||
37637473|NCT02692040|69104928|FG010|Overall Study|Protocol Violation|0|||
37637474|NCT02692040|69104929|FG011|Overall Study|Protocol Violation|0|||
37637475|NCT02692040|69104930|FG012|Overall Study|Protocol Violation|1|||
37637476|NCT02692040|69104931|FG013|Overall Study|Protocol Violation|0|||
37637477|NCT02692040|69104932|FG014|Overall Study|Protocol Violation|0|||
37637478|NCT02692040|69104933|FG015|Overall Study|Protocol Violation|0|||
37921898|NCT00667810|69608724|FG000|Overall Study|Lack of Efficacy|1|||
37739968|NCT01445301|69225487|FG002|Overall Study|Withdrawal by Subject|4|||
37739969|NCT01409031|69225497|FG000|Overall Study|transferred to other hosp|1|||
37739970|NCT01409031|69225498|FG001|Overall Study|transferred to other hosp|0|||
37739971|NCT01430403|69225507|FG000|Overall Study|Lost to Follow-up|5|||
37739972|NCT01430403|69225508|FG001|Overall Study|Lost to Follow-up|5|||
37739973|NCT01430403|69225509|FG002|Overall Study|Lost to Follow-up|3|||
37739974|NCT01430403|69225507|FG000|Overall Study|Physician Decision|1|||
37739975|NCT01430403|69225508|FG001|Overall Study|Physician Decision|0|||
37739976|NCT01430403|69225509|FG002|Overall Study|Physician Decision|0|||
37739977|NCT01430403|69225507|FG000|Overall Study|Protocol Violation|2|||
37739978|NCT01430403|69225508|FG001|Overall Study|Protocol Violation|3|||
37739979|NCT01430403|69225509|FG002|Overall Study|Protocol Violation|2|||
37921899|NCT00667810|69608725|FG001|Overall Study|Lack of Efficacy|0|||
37921900|NCT00667810|69608726|FG002|Overall Study|Lack of Efficacy|2|||
37921901|NCT00667810|69608727|FG003|Overall Study|Lack of Efficacy|0|||
37921902|NCT00667810|69608724|FG000|Overall Study|Lost to Follow-up|1|||
37637479|NCT02692040|69104934|FG016|Overall Study|Protocol Violation|0|||
37739980|NCT01430403|69225507|FG000|Overall Study|Withdrawal by Subject|9|||
37739981|NCT01430403|69225508|FG001|Overall Study|Withdrawal by Subject|1|||
37739982|NCT01430403|69225509|FG002|Overall Study|Withdrawal by Subject|3|||
37739983|NCT01429623|69225524|FG000|Overall Study|Death|1|||
37921903|NCT00667810|69608725|FG001|Overall Study|Lost to Follow-up|4|||
37921904|NCT00667810|69608726|FG002|Overall Study|Lost to Follow-up|2|||
37637480|NCT02692040|69104918|FG000|Overall Study|Adverse Event|0|||
37637481|NCT02692040|69104919|FG001|Overall Study|Adverse Event|0|||
37637482|NCT02692040|69104920|FG002|Overall Study|Adverse Event|0|||
37637483|NCT02692040|69104921|FG003|Overall Study|Adverse Event|0|||
37637484|NCT02692040|69104922|FG004|Overall Study|Adverse Event|0|||
37637485|NCT02692040|69104923|FG005|Overall Study|Adverse Event|0|||
37637486|NCT02692040|69104924|FG006|Overall Study|Adverse Event|0|||
37637487|NCT02692040|69104925|FG007|Overall Study|Adverse Event|0|||
37637488|NCT02692040|69104926|FG008|Overall Study|Adverse Event|0|||
37637489|NCT02692040|69104927|FG009|Overall Study|Adverse Event|0|||
37637490|NCT02692040|69104928|FG010|Overall Study|Adverse Event|0|||
37637491|NCT02692040|69104929|FG011|Overall Study|Adverse Event|0|||
37637492|NCT02692040|69104930|FG012|Overall Study|Adverse Event|0|||
37637493|NCT02692040|69104931|FG013|Overall Study|Adverse Event|3|||
37637494|NCT02692040|69104932|FG014|Overall Study|Adverse Event|1|||
37637495|NCT02692040|69104933|FG015|Overall Study|Adverse Event|1|||
37739984|NCT01429623|69225525|FG001|Overall Study|Death|0|||
37739985|NCT01429623|69225524|FG000|Overall Study|Adverse Event|7|||
37739986|NCT01429623|69225525|FG001|Overall Study|Adverse Event|14|||
37739987|NCT01429623|69225524|FG000|Overall Study|Withdrawal by Subject|19|||
37739988|NCT01429623|69225525|FG001|Overall Study|Withdrawal by Subject|13|||
37739989|NCT01429623|69225524|FG000|Overall Study|Physician Decision|2|||
37739990|NCT01429623|69225525|FG001|Overall Study|Physician Decision|3|||
37739991|NCT01429623|69225524|FG000|Overall Study|Protocol Violation|3|||
37739992|NCT01429623|69225525|FG001|Overall Study|Protocol Violation|2|||
37739993|NCT01429623|69225524|FG000|Overall Study|Assorted|1|||
37739994|NCT01429623|69225525|FG001|Overall Study|Assorted|2|||
37739995|NCT01429623|69225524|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
37739996|NCT01429623|69225525|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
37739997|NCT01429623|69225524|FG000|Overall Study|No post baseline data|4|||
37739998|NCT01429623|69225525|FG001|Overall Study|No post baseline data|4|||
37739999|NCT01408641|69225533|FG000|Overall Study|Physician Decision|1|||
37740000|NCT01408641|69225534|FG001|Overall Study|Physician Decision|0|||
37740001|NCT01429077|69225542|FG000|Overall Study|Lost to Follow-up|0|||
37740002|NCT01429077|69225543|FG001|Overall Study|Lost to Follow-up|3|||
37740003|NCT01428453|69225551|FG000|Overall Study|Adverse Event|2|||
37740004|NCT01428453|69225552|FG001|Overall Study|Adverse Event|7|||
37740005|NCT01428453|69225551|FG000|Overall Study|Protocol Violation|1|||
37740006|NCT01428453|69225552|FG001|Overall Study|Protocol Violation|0|||
37740007|NCT01428453|69225551|FG000|Overall Study|Lost to Follow-up|0|||
37740008|NCT01428453|69225552|FG001|Overall Study|Lost to Follow-up|1|||
37740009|NCT01428453|69225551|FG000|Overall Study|Withdrawal by Subject|3|||
37740010|NCT01428453|69225552|FG001|Overall Study|Withdrawal by Subject|1|||
37740011|NCT01408563|69225560|FG000|Overall Study|Ineligible after consent/ registration|2|||
37740012|NCT01442493|69225566|FG000|Overall Study|withdrawn from study|3|||
37740013|NCT01442493|69225567|FG001|Overall Study|withdrawn from study|2|||
37740014|NCT01442181|69225575|FG000|Overall Study|patient refused surgery|1|||
37740015|NCT01442181|69225576|FG001|Overall Study|patient refused surgery|0|||
37740016|NCT01442181|69225575|FG000|Overall Study|no insurance for surgery|1|||
37740017|NCT01442181|69225576|FG001|Overall Study|no insurance for surgery|0|||
37740018|NCT01442181|69225575|FG000|Overall Study|low ejection factor|0|||
37740019|NCT01442181|69225576|FG001|Overall Study|low ejection factor|1|||
37740020|NCT01442181|69225575|FG000|Overall Study|Lost to Follow-up|1|||
37740021|NCT01442181|69225576|FG001|Overall Study|Lost to Follow-up|1|||
37740022|NCT01442181|69225575|FG000|Overall Study|patient in an additional study|1|||
37740023|NCT01442181|69225576|FG001|Overall Study|patient in an additional study|0|||
37740024|NCT01442181|69225575|FG000|Overall Study|atrial fibrillation not noted|0|||
37740025|NCT01442181|69225576|FG001|Overall Study|atrial fibrillation not noted|1|||
37740026|NCT01442103|69225583|FG000|Overall Study|Lost to Follow-up|2|||
37740027|NCT01428219|69225587|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
37740028|NCT01428063|69225594|FG000|Overall Study|Lack of Efficacy|8|||
37740029|NCT01428063|69225595|FG001|Overall Study|Lack of Efficacy|4|||
37740030|NCT01428063|69225596|FG002|Overall Study|Lack of Efficacy|1|||
37740031|NCT01428063|69225594|FG000|Overall Study|Adverse Event|2|||
37740032|NCT01428063|69225595|FG001|Overall Study|Adverse Event|3|||
37740033|NCT01428063|69225596|FG002|Overall Study|Adverse Event|0|||
37740034|NCT01428063|69225594|FG000|Overall Study|Lost to Follow-up|0|||
37740035|NCT01428063|69225595|FG001|Overall Study|Lost to Follow-up|2|||
37854304|NCT01232283|69537956|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
37854305|NCT01232283|69537957|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
37854306|NCT01232283|69537958|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
37854307|NCT01232283|69537959|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
37854308|NCT01232283|69537960|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
37854309|NCT01232283|69537961|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
37854310|NCT01232283|69537952|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
37740036|NCT01428063|69225596|FG002|Overall Study|Lost to Follow-up|0|||
37740037|NCT01428063|69225594|FG000|Overall Study|No longer meets study criteria|0|||
37854311|NCT01232283|69537953|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
37740038|NCT01428063|69225595|FG001|Overall Study|No longer meets study criteria|1|||
37740039|NCT01428063|69225596|FG002|Overall Study|No longer meets study criteria|0|||
37740040|NCT01441635|69225754|FG000|Overall Study|Adverse Event|4|||
37740041|NCT01441635|69225755|FG001|Overall Study|Adverse Event|3|||
37740042|NCT01441635|69225756|FG002|Overall Study|Adverse Event|1|||
37740043|NCT01441635|69225757|FG003|Overall Study|Adverse Event|5|||
37740044|NCT01441635|69225758|FG004|Overall Study|Adverse Event|1|||
37740045|NCT01441635|69225759|FG005|Overall Study|Adverse Event|2|||
37740046|NCT01441635|69225760|FG006|Overall Study|Adverse Event|2|||
37740047|NCT01441635|69225761|FG007|Overall Study|Adverse Event|2|||
37740048|NCT01441635|69225762|FG008|Overall Study|Adverse Event|1|||
37740049|NCT01441635|69225763|FG009|Overall Study|Adverse Event|0|||
37740050|NCT01441635|69225754|FG000|Overall Study|Withdrawal by Subject|1|||
37740051|NCT01441635|69225755|FG001|Overall Study|Withdrawal by Subject|1|||
37740052|NCT01441635|69225756|FG002|Overall Study|Withdrawal by Subject|0|||
37740053|NCT01441635|69225757|FG003|Overall Study|Withdrawal by Subject|1|||
37740054|NCT01441635|69225758|FG004|Overall Study|Withdrawal by Subject|0|||
37740055|NCT01441635|69225759|FG005|Overall Study|Withdrawal by Subject|0|||
37740056|NCT01441635|69225760|FG006|Overall Study|Withdrawal by Subject|2|||
37740057|NCT01441635|69225761|FG007|Overall Study|Withdrawal by Subject|0|||
37740058|NCT01441635|69225762|FG008|Overall Study|Withdrawal by Subject|1|||
37740059|NCT01441635|69225763|FG009|Overall Study|Withdrawal by Subject|1|||
37740060|NCT01441635|69225754|FG000|Overall Study|Lost to Follow-up|0|||
37740061|NCT01441635|69225755|FG001|Overall Study|Lost to Follow-up|1|||
37740062|NCT01441635|69225756|FG002|Overall Study|Lost to Follow-up|1|||
37740063|NCT01441635|69225757|FG003|Overall Study|Lost to Follow-up|1|||
37740064|NCT01441635|69225758|FG004|Overall Study|Lost to Follow-up|1|||
37740065|NCT01441635|69225759|FG005|Overall Study|Lost to Follow-up|3|||
37740066|NCT01441635|69225760|FG006|Overall Study|Lost to Follow-up|1|||
37740067|NCT01441635|69225761|FG007|Overall Study|Lost to Follow-up|1|||
37740068|NCT01441635|69225762|FG008|Overall Study|Lost to Follow-up|0|||
37740069|NCT01441635|69225763|FG009|Overall Study|Lost to Follow-up|1|||
37740070|NCT01441635|69225754|FG000|Overall Study|Noncompliance|0|||
37740071|NCT01441635|69225755|FG001|Overall Study|Noncompliance|1|||
37740072|NCT01441635|69225756|FG002|Overall Study|Noncompliance|0|||
37740073|NCT01441635|69225757|FG003|Overall Study|Noncompliance|0|||
37740074|NCT01441635|69225758|FG004|Overall Study|Noncompliance|0|||
37740075|NCT01441635|69225759|FG005|Overall Study|Noncompliance|0|||
37637496|NCT02692040|69104934|FG016|Overall Study|Adverse Event|0|||
37637497|NCT03029819|69105013|FG000|Overall Study|Lost to Follow-up|3|||
37637498|NCT03029819|69105014|FG001|Overall Study|Lost to Follow-up|5|||
37637499|NCT03029819|69105013|FG000|Overall Study|Removed due to disruptive behavior|0|||
37637500|NCT03029819|69105014|FG001|Overall Study|Removed due to disruptive behavior|1|||
37637501|NCT02678390|69105025|FG000|AE (1 Day)|Withdrawal by Subject|0|||
37637502|NCT02678390|69105026|FG001|AE (1 Day)|Withdrawal by Subject|1|||
37637503|NCT03027557|69105035|FG000|Overall Study|Adverse Event|1|||
37637504|NCT03027557|69105036|FG001|Overall Study|Adverse Event|0|||
37637505|NCT03027557|69105037|FG002|Overall Study|Adverse Event|0|||
37637506|NCT03029585|69105047|FG000|Overall Study|Death|1|||
37637507|NCT03029585|69105048|FG001|Overall Study|Death|1|||
37637508|NCT03029585|69105047|FG000|Overall Study|Withdrawal by Subject|1|||
37637509|NCT03029585|69105048|FG001|Overall Study|Withdrawal by Subject|0|||
37637510|NCT02678000|69105059|FG000|PART 2|Adverse Event|0|||
37637511|NCT02678000|69105060|FG001|PART 2|Adverse Event|0|||
37637512|NCT02678000|69105061|FG002|PART 2|Adverse Event|2|||
37637513|NCT02678000|69105062|FG003|PART 2|Adverse Event|1|||
37637514|NCT02678000|69105063|FG004|PART 2|Adverse Event|0|||
37637515|NCT02678000|69105059|FG000|PART 2|Withdrawal by Subject|0|||
37637516|NCT02678000|69105060|FG001|PART 2|Withdrawal by Subject|0|||
37637517|NCT02678000|69105061|FG002|PART 2|Withdrawal by Subject|1|||
37637518|NCT02678000|69105062|FG003|PART 2|Withdrawal by Subject|0|||
37637519|NCT02678000|69105063|FG004|PART 2|Withdrawal by Subject|0|||
37637520|NCT02691572|69105090|FG000|Overall Study|Withdrawal by Subject|1|||
37637521|NCT02691572|69105091|FG001|Overall Study|Withdrawal by Subject|0|||
37637522|NCT02691572|69105090|FG000|Overall Study|Protocol Violation|0|||
37637523|NCT02691572|69105091|FG001|Overall Study|Protocol Violation|1|||
37637524|NCT02677844|69105099|FG000|Period 3|Withdrawal by Subject|0|||
37637525|NCT02677844|69105100|FG001|Period 3|Withdrawal by Subject|0|||
37637526|NCT02677844|69105101|FG002|Period 3|Withdrawal by Subject|0|||
37637527|NCT02677844|69105102|FG003|Period 3|Withdrawal by Subject|1|||
37637528|NCT02677844|69105103|FG004|Period 3|Withdrawal by Subject|0|||
37740076|NCT01441635|69225760|FG006|Overall Study|Noncompliance|1|||
37740077|NCT01441635|69225761|FG007|Overall Study|Noncompliance|0|||
37854312|NCT01232283|69537954|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
37854313|NCT01232283|69537955|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
37854314|NCT01232283|69537956|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
37854315|NCT01232283|69537957|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
37854316|NCT01232283|69537958|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
37740078|NCT01441635|69225762|FG008|Overall Study|Noncompliance|0|||
37637529|NCT02677844|69105104|FG005|Period 3|Withdrawal by Subject|0|||
37921905|NCT00667810|69608727|FG003|Overall Study|Lost to Follow-up|0|||
37637530|NCT02677844|69105105|FG006|Period 3|Withdrawal by Subject|0|||
37637531|NCT02691494|69105127|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
37740079|NCT01441635|69225763|FG009|Overall Study|Noncompliance|0|||
37740080|NCT01441635|69225754|FG000|Overall Study|Surgery or Invasive Intervention|0|||
37740081|NCT01441635|69225755|FG001|Overall Study|Surgery or Invasive Intervention|0|||
37637532|NCT02691494|69105128|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
37637533|NCT02691494|69105129|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
37637534|NCT02691494|69105127|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
37637535|NCT02691494|69105128|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
37637536|NCT02691494|69105129|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
37740082|NCT01441635|69225756|FG002|Overall Study|Surgery or Invasive Intervention|1|||
37740083|NCT01441635|69225757|FG003|Overall Study|Surgery or Invasive Intervention|0|||
37740084|NCT01441635|69225758|FG004|Overall Study|Surgery or Invasive Intervention|0|||
37740085|NCT01441635|69225759|FG005|Overall Study|Surgery or Invasive Intervention|0|||
37740086|NCT01441635|69225760|FG006|Overall Study|Surgery or Invasive Intervention|0|||
37740087|NCT01441635|69225761|FG007|Overall Study|Surgery or Invasive Intervention|0|||
37740088|NCT01441635|69225762|FG008|Overall Study|Surgery or Invasive Intervention|0|||
37740089|NCT01441635|69225763|FG009|Overall Study|Surgery or Invasive Intervention|0|||
37740090|NCT01441635|69225754|FG000|Overall Study|Received Exclusionary Medication|1|||
37740091|NCT01441635|69225755|FG001|Overall Study|Received Exclusionary Medication|0|||
37740092|NCT01441635|69225756|FG002|Overall Study|Received Exclusionary Medication|0|||
37740093|NCT01441635|69225757|FG003|Overall Study|Received Exclusionary Medication|0|||
37740094|NCT01441635|69225758|FG004|Overall Study|Received Exclusionary Medication|0|||
37740095|NCT01441635|69225759|FG005|Overall Study|Received Exclusionary Medication|0|||
37740096|NCT01441635|69225760|FG006|Overall Study|Received Exclusionary Medication|0|||
37740097|NCT01441635|69225761|FG007|Overall Study|Received Exclusionary Medication|0|||
37740098|NCT01441635|69225762|FG008|Overall Study|Received Exclusionary Medication|0|||
37740099|NCT01441635|69225763|FG009|Overall Study|Received Exclusionary Medication|0|||
37740100|NCT01441635|69225754|FG000|Overall Study|Other|0|||
37740101|NCT01441635|69225755|FG001|Overall Study|Other|0|||
37740102|NCT01441635|69225756|FG002|Overall Study|Other|0|||
37740103|NCT01441635|69225757|FG003|Overall Study|Other|0|||
37740104|NCT01441635|69225758|FG004|Overall Study|Other|0|||
37740105|NCT01441635|69225759|FG005|Overall Study|Other|0|||
37740106|NCT01441635|69225760|FG006|Overall Study|Other|0|||
37740107|NCT01441635|69225761|FG007|Overall Study|Other|1|||
37740108|NCT01441635|69225762|FG008|Overall Study|Other|0|||
37740109|NCT01441635|69225763|FG009|Overall Study|Other|0|||
37740110|NCT01408485|69225785|FG000|Overall Study|Withdrawal by Subject|21|||
37740111|NCT01427907|69225791|FG000|Overall Study|Withdrawal by Subject|3|||
37740112|NCT01427907|69225792|FG001|Overall Study|Withdrawal by Subject|4|||
37740113|NCT01427751|69225800|FG000|Overall Study|Adverse Event|18|||
37740114|NCT01427751|69225801|FG001|Overall Study|Adverse Event|2|||
37740115|NCT01427751|69225800|FG000|Overall Study|No further treatment benefit expected|5|||
37740116|NCT01427751|69225801|FG001|Overall Study|No further treatment benefit expected|1|||
37740117|NCT01427751|69225800|FG000|Overall Study|Lost to Follow-up|3|||
37637537|NCT02691494|69105127|FG000|Post-Treatment Follow-Up Period|Other|2|||
37637538|NCT02691494|69105128|FG001|Post-Treatment Follow-Up Period|Other|1|||
37637539|NCT02691494|69105129|FG002|Post-Treatment Follow-Up Period|Other|1|||
37637540|NCT02691494|69105127|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
37637541|NCT02691494|69105128|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
37637542|NCT02691494|69105129|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
37637543|NCT02691494|69105127|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
37637544|NCT02691494|69105128|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
37637545|NCT02691494|69105129|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
37637546|NCT02677220|69105137|FG000|Overall Study|Adverse Event|1|||
37637547|NCT02682602|69105144|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
37637548|NCT02682602|69105145|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
37637549|NCT02682602|69105144|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
37637550|NCT02682602|69105145|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
37637551|NCT02681510|69105155|FG000|Overall Study|Withdrawal by Subject|1|||
37637552|NCT02681510|69105155|FG000|Overall Study|Lost to Follow-up|9|||
37637553|NCT02690714|69105159|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
37637554|NCT02690714|69105159|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
37637555|NCT01898793|69105174|FG000|Overall Study|Death|2|||
37637556|NCT01898793|69105175|FG001|Overall Study|Death|1|||
37637557|NCT01898793|69105176|FG002|Overall Study|Death|4|||
37637558|NCT01898793|69105177|FG003|Overall Study|Death|0|||
37637559|NCT01898793|69105178|FG004|Overall Study|Death|0|||
37637560|NCT01898793|69105179|FG005|Overall Study|Death|0|||
37637561|NCT01898793|69105180|FG006|Overall Study|Death|0|||
37637562|NCT01791543|69105199|FG000|Overall Study|Lost to Follow-up|1|||
37637563|NCT01791543|69105199|FG000|Overall Study|Adverse Event|1|||
37637564|NCT02925455|69105206|FG000|Overall Study|Withdrawal by Subject|2|||
37637565|NCT02925455|69105207|FG001|Overall Study|Withdrawal by Subject|0|||
37740118|NCT01427751|69225801|FG001|Overall Study|Lost to Follow-up|1|||
37740119|NCT01427751|69225800|FG000|Overall Study|Withdrawal of consent|2|||
37740120|NCT01427751|69225801|FG001|Overall Study|Withdrawal of consent|2|||
37854317|NCT01232283|69537959|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
37854318|NCT01232283|69537960|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
37740121|NCT01427751|69225800|FG000|Overall Study|Protocol Violation|6|||
37740122|NCT01427751|69225801|FG001|Overall Study|Protocol Violation|4|||
37740123|NCT01427751|69225800|FG000|Overall Study|Death|2|||
37740124|NCT01427751|69225801|FG001|Overall Study|Death|0|||
37854319|NCT01232283|69537961|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
37637566|NCT03033069|69105217|FG000|Overall Study|Adverse Event|6|||
37637567|NCT03033069|69105218|FG001|Overall Study|Adverse Event|7|||
37637568|NCT03033069|69105219|FG002|Overall Study|Adverse Event|4|||
37637569|NCT03033069|69105220|FG003|Overall Study|Adverse Event|6|||
37637570|NCT03033069|69105217|FG000|Overall Study|Lack of Efficacy|0|||
37637571|NCT03033069|69105218|FG001|Overall Study|Lack of Efficacy|0|||
37637572|NCT03033069|69105219|FG002|Overall Study|Lack of Efficacy|1|||
37637573|NCT03033069|69105220|FG003|Overall Study|Lack of Efficacy|0|||
37637574|NCT03033069|69105217|FG000|Overall Study|Lost to Follow-up|6|||
37637575|NCT03033069|69105218|FG001|Overall Study|Lost to Follow-up|5|||
37637576|NCT03033069|69105219|FG002|Overall Study|Lost to Follow-up|5|||
37637577|NCT03033069|69105220|FG003|Overall Study|Lost to Follow-up|6|||
37637578|NCT03033069|69105217|FG000|Overall Study|Non-Compliance With Study Drug|1|||
37637579|NCT03033069|69105218|FG001|Overall Study|Non-Compliance With Study Drug|1|||
37637580|NCT03033069|69105219|FG002|Overall Study|Non-Compliance With Study Drug|1|||
37637581|NCT03033069|69105220|FG003|Overall Study|Non-Compliance With Study Drug|0|||
37637582|NCT03033069|69105217|FG000|Overall Study|Protocol Deviation|0|||
37637583|NCT03033069|69105218|FG001|Overall Study|Protocol Deviation|1|||
37637584|NCT03033069|69105219|FG002|Overall Study|Protocol Deviation|0|||
37637585|NCT03033069|69105220|FG003|Overall Study|Protocol Deviation|0|||
37637586|NCT03033069|69105217|FG000|Overall Study|Withdrawal by Subject|10|||
37637587|NCT03033069|69105218|FG001|Overall Study|Withdrawal by Subject|10|||
37637588|NCT03033069|69105219|FG002|Overall Study|Withdrawal by Subject|11|||
37637589|NCT03033069|69105220|FG003|Overall Study|Withdrawal by Subject|6|||
37637590|NCT03033069|69105217|FG000|Overall Study|Withdrawal By Caregiver|1|||
37637591|NCT03033069|69105218|FG001|Overall Study|Withdrawal By Caregiver|0|||
37637592|NCT03033069|69105219|FG002|Overall Study|Withdrawal By Caregiver|0|||
37637593|NCT03033069|69105220|FG003|Overall Study|Withdrawal By Caregiver|0|||
37637594|NCT03033069|69105217|FG000|Overall Study|Reason not Specified|0|||
37637595|NCT03033069|69105218|FG001|Overall Study|Reason not Specified|1|||
37637596|NCT03033069|69105219|FG002|Overall Study|Reason not Specified|0|||
37637597|NCT03033069|69105220|FG003|Overall Study|Reason not Specified|1|||
37637598|NCT02917265|69105232|FG000|Overall Study|Physician Decision|1|||
37637599|NCT02917265|69105233|FG001|Overall Study|Physician Decision|0|||
37637600|NCT02917265|69105232|FG000|Overall Study|Withdrawal by Subject|1|||
37637601|NCT02917265|69105233|FG001|Overall Study|Withdrawal by Subject|0|||
37637602|NCT02136069|69105243|FG000|Overall Study|UC flare-up|1|||
37637603|NCT02136069|69105244|FG001|Overall Study|UC flare-up|0|||
37637604|NCT02136069|69105243|FG000|Overall Study|Adverse Event|6|||
37637605|NCT02136069|69105244|FG001|Overall Study|Adverse Event|8|||
37637606|NCT02136069|69105243|FG000|Overall Study|Death|0|||
37637607|NCT02136069|69105244|FG001|Overall Study|Death|1|||
37637608|NCT02136069|69105243|FG000|Overall Study|Lack of Efficacy|10|||
37637609|NCT02136069|69105244|FG001|Overall Study|Lack of Efficacy|4|||
37637610|NCT02136069|69105243|FG000|Overall Study|Lost to Follow-up|1|||
37637611|NCT02136069|69105244|FG001|Overall Study|Lost to Follow-up|0|||
37637612|NCT02136069|69105243|FG000|Overall Study|Non-Compliance|1|||
37637613|NCT02136069|69105244|FG001|Overall Study|Non-Compliance|0|||
37637614|NCT02136069|69105243|FG000|Overall Study|Physician Decision|5|||
37637615|NCT02136069|69105244|FG001|Overall Study|Physician Decision|4|||
37637616|NCT02136069|69105243|FG000|Overall Study|Withdrawal by Subject|10|||
37637617|NCT02136069|69105244|FG001|Overall Study|Withdrawal by Subject|11|||
37637618|NCT02917031|69105253|FG000|Overall Study|Reason not specified|7|||
37637619|NCT02917031|69105254|FG001|Overall Study|Reason not specified|5|||
37637620|NCT02917031|69105255|FG002|Overall Study|Reason not specified|6|||
37637621|NCT02917031|69105253|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
37637622|NCT02917031|69105254|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
37637623|NCT02917031|69105255|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
37637624|NCT02917031|69105253|FG000|Overall Study|Withdrawal by Subject|3|||
37637625|NCT02917031|69105254|FG001|Overall Study|Withdrawal by Subject|3|||
37637626|NCT02917031|69105255|FG002|Overall Study|Withdrawal by Subject|0|||
37637627|NCT02917031|69105253|FG000|Overall Study|Physician Decision|1|||
37637628|NCT02917031|69105254|FG001|Overall Study|Physician Decision|0|||
37637629|NCT02917031|69105255|FG002|Overall Study|Physician Decision|0|||
37637630|NCT02917031|69105253|FG000|Overall Study|Adverse Event|4|||
37637631|NCT02917031|69105254|FG001|Overall Study|Adverse Event|1|||
37637632|NCT02917031|69105255|FG002|Overall Study|Adverse Event|5|||
37637633|NCT02917031|69105253|FG000|Overall Study|Death|2|||
37637634|NCT02917031|69105254|FG001|Overall Study|Death|3|||
37637635|NCT02917031|69105255|FG002|Overall Study|Death|4|||
37637636|NCT01018563|69105264|FG000|Overall Study|Termination of the study by Sponsor|2|||
37637637|NCT01018563|69105265|FG001|Overall Study|Termination of the study by Sponsor|1|||
37921906|NCT00667810|69608724|FG000|Overall Study|Physician Decision|1|||
37921907|NCT00667810|69608725|FG001|Overall Study|Physician Decision|1|||
37637638|NCT02528188|69105278|FG000|Overall Study|Adverse Event|23|||
37637639|NCT02528188|69105279|FG001|Overall Study|Adverse Event|22|||
37637640|NCT02528188|69105280|FG002|Overall Study|Adverse Event|8|||
37921908|NCT00667810|69608726|FG002|Overall Study|Physician Decision|2|||
37637641|NCT02528188|69105278|FG000|Overall Study|Protocol Violation|4|||
37637642|NCT02528188|69105279|FG001|Overall Study|Protocol Violation|6|||
37637643|NCT02528188|69105280|FG002|Overall Study|Protocol Violation|4|||
37740125|NCT01427751|69225800|FG000|Overall Study|Other miscellaneous reasons|6|||
37740126|NCT01427751|69225801|FG001|Overall Study|Other miscellaneous reasons|4|||
37740127|NCT01920061|69225827|FG000|Overall Study|Death|1|||
37740128|NCT01920061|69225828|FG001|Overall Study|Death|1|||
37740129|NCT01920061|69225829|FG002|Overall Study|Death|0|||
37740130|NCT01920061|69225830|FG003|Overall Study|Death|1|||
37637644|NCT02528188|69105278|FG000|Overall Study|Lack of Efficacy|19|||
37637645|NCT02528188|69105279|FG001|Overall Study|Lack of Efficacy|21|||
37637646|NCT02528188|69105280|FG002|Overall Study|Lack of Efficacy|22|||
37637647|NCT02528188|69105278|FG000|Overall Study|Withdrawal by Subject|97|||
37637648|NCT02528188|69105279|FG001|Overall Study|Withdrawal by Subject|104|||
37637649|NCT02528188|69105280|FG002|Overall Study|Withdrawal by Subject|100|||
37637650|NCT02528188|69105278|FG000|Overall Study|Lost to Follow-up|25|||
37637651|NCT02528188|69105279|FG001|Overall Study|Lost to Follow-up|21|||
37637652|NCT02528188|69105280|FG002|Overall Study|Lost to Follow-up|31|||
37637653|NCT02528188|69105278|FG000|Overall Study|Death|4|||
37637654|NCT02528188|69105279|FG001|Overall Study|Death|4|||
37637655|NCT02528188|69105280|FG002|Overall Study|Death|0|||
37740131|NCT01920061|69225831|FG004|Overall Study|Death|1|||
37740132|NCT01920061|69225832|FG005|Overall Study|Death|0|||
37740133|NCT01920061|69225833|FG006|Overall Study|Death|0|||
37740134|NCT01920061|69225834|FG007|Overall Study|Death|1|||
37740135|NCT01920061|69225835|FG008|Overall Study|Death|0|||
37740136|NCT01920061|69225836|FG009|Overall Study|Death|1|||
37637656|NCT02528188|69105278|FG000|Overall Study|Other|89|||
37637657|NCT02528188|69105279|FG001|Overall Study|Other|91|||
37637658|NCT02528188|69105280|FG002|Overall Study|Other|74|||
37637659|NCT02528188|69105278|FG000|Overall Study|Randomized but not treated|6|||
37637660|NCT02528188|69105279|FG001|Overall Study|Randomized but not treated|7|||
37637661|NCT02528188|69105280|FG002|Overall Study|Randomized but not treated|12|||
37637662|NCT03896165|69105288|FG000|Overall Study|Withdrawal by Subject|2|||
37637663|NCT05361304|69105301|FG000|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|1|||
37637664|NCT05361304|69105302|FG001|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|0|||
37637665|NCT05361304|69105301|FG000|Overall Study|COVID-19 Related|1|||
37637666|NCT05361304|69105302|FG001|Overall Study|COVID-19 Related|2|||
37637667|NCT05361304|69105301|FG000|Overall Study|Withdrawal by Subject|1|||
37637668|NCT05361304|69105302|FG001|Overall Study|Withdrawal by Subject|0|||
37637669|NCT02269917|69105325|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
37637670|NCT02269917|69105326|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
37637671|NCT02269917|69105327|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
37637672|NCT02269917|69105325|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
37637673|NCT02269917|69105326|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
37637674|NCT02269917|69105327|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
37637675|NCT02269917|69105325|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
37637676|NCT02269917|69105326|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
37637677|NCT02269917|69105327|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
37637678|NCT02269917|69105325|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
37637679|NCT02269917|69105326|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
37637680|NCT02269917|69105327|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
37637681|NCT02269917|69105325|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
37637682|NCT02269917|69105326|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
37637683|NCT02269917|69105327|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
37637684|NCT02269917|69105325|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
37637685|NCT02269917|69105326|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
37637686|NCT02269917|69105327|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
37637687|NCT02269917|69105325|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
37637688|NCT02269917|69105326|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
37740137|NCT01920061|69225837|FG010|Overall Study|Death|0|||
37740138|NCT01920061|69225838|FG011|Overall Study|Death|1|||
37740139|NCT01920061|69225839|FG012|Overall Study|Death|0|||
37740140|NCT01920061|69225840|FG013|Overall Study|Death|2|||
37854320|NCT01232283|69537952|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
37854321|NCT01232283|69537953|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
37637689|NCT02269917|69105327|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
37637690|NCT02269917|69105325|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
37637691|NCT02269917|69105326|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
37637692|NCT02269917|69105327|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
37740141|NCT01920061|69225841|FG014|Overall Study|Death|0|||
37740142|NCT01920061|69225842|FG015|Overall Study|Death|0|||
37740143|NCT01920061|69225843|FG016|Overall Study|Death|0|||
37740144|NCT01920061|69225844|FG017|Overall Study|Death|0|||
37637693|NCT02269917|69105325|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
37637694|NCT02269917|69105326|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
37637695|NCT02269917|69105327|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
37637696|NCT02269917|69105325|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
37637697|NCT02269917|69105326|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
37637698|NCT02269917|69105327|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
37637699|NCT02269917|69105325|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
37637700|NCT02269917|69105326|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
37637701|NCT02269917|69105327|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
37637702|NCT02269917|69105325|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
37637703|NCT02269917|69105326|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
37637704|NCT02269917|69105327|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
37637705|NCT02269917|69105325|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
37637706|NCT02269917|69105326|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
37637707|NCT02269917|69105327|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
37637708|NCT02269917|69105325|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
37637709|NCT02269917|69105326|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
37637710|NCT02269917|69105327|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
37637711|NCT02269917|69105325|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
37637712|NCT02269917|69105326|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
37740145|NCT01920061|69225845|FG018|Overall Study|Death|1|||
37740146|NCT01920061|69225846|FG019|Overall Study|Death|0|||
37740147|NCT01920061|69225827|FG000|Overall Study|Lost to Follow-up|0|||
37740148|NCT01920061|69225828|FG001|Overall Study|Lost to Follow-up|2|||
37740149|NCT01920061|69225829|FG002|Overall Study|Lost to Follow-up|0|||
37740150|NCT01920061|69225830|FG003|Overall Study|Lost to Follow-up|0|||
37740151|NCT01920061|69225831|FG004|Overall Study|Lost to Follow-up|0|||
37740152|NCT01920061|69225832|FG005|Overall Study|Lost to Follow-up|0|||
37740153|NCT01920061|69225833|FG006|Overall Study|Lost to Follow-up|1|||
37740154|NCT01920061|69225834|FG007|Overall Study|Lost to Follow-up|0|||
37740155|NCT01920061|69225835|FG008|Overall Study|Lost to Follow-up|0|||
37740156|NCT01920061|69225836|FG009|Overall Study|Lost to Follow-up|0|||
37740157|NCT01920061|69225837|FG010|Overall Study|Lost to Follow-up|3|||
37740158|NCT01920061|69225838|FG011|Overall Study|Lost to Follow-up|0|||
37740159|NCT01920061|69225839|FG012|Overall Study|Lost to Follow-up|0|||
37740160|NCT01920061|69225840|FG013|Overall Study|Lost to Follow-up|0|||
37740161|NCT01920061|69225841|FG014|Overall Study|Lost to Follow-up|0|||
37740162|NCT01920061|69225842|FG015|Overall Study|Lost to Follow-up|0|||
37740163|NCT01920061|69225843|FG016|Overall Study|Lost to Follow-up|0|||
37740164|NCT01920061|69225844|FG017|Overall Study|Lost to Follow-up|1|||
37740165|NCT01920061|69225845|FG018|Overall Study|Lost to Follow-up|4|||
37740166|NCT01920061|69225846|FG019|Overall Study|Lost to Follow-up|3|||
37740167|NCT01920061|69225827|FG000|Overall Study|Other|1|||
37740168|NCT01920061|69225828|FG001|Overall Study|Other|1|||
37740169|NCT01920061|69225829|FG002|Overall Study|Other|2|||
37740170|NCT01920061|69225830|FG003|Overall Study|Other|1|||
37740171|NCT01920061|69225831|FG004|Overall Study|Other|0|||
37740172|NCT01920061|69225832|FG005|Overall Study|Other|1|||
37740173|NCT01920061|69225833|FG006|Overall Study|Other|0|||
37740174|NCT01920061|69225834|FG007|Overall Study|Other|0|||
37740175|NCT01920061|69225835|FG008|Overall Study|Other|0|||
37740176|NCT01920061|69225836|FG009|Overall Study|Other|1|||
37740177|NCT01920061|69225837|FG010|Overall Study|Other|1|||
37740178|NCT01920061|69225838|FG011|Overall Study|Other|2|||
37740179|NCT01920061|69225839|FG012|Overall Study|Other|1|||
37740180|NCT01920061|69225840|FG013|Overall Study|Other|4|||
37740181|NCT01920061|69225841|FG014|Overall Study|Other|0|||
37740182|NCT01920061|69225842|FG015|Overall Study|Other|1|||
37740183|NCT01920061|69225843|FG016|Overall Study|Other|1|||
37740184|NCT01920061|69225844|FG017|Overall Study|Other|0|||
37740185|NCT01920061|69225845|FG018|Overall Study|Other|1|||
37740186|NCT01920061|69225846|FG019|Overall Study|Other|1|||
37740187|NCT01920061|69225827|FG000|Overall Study|Participant refused further follow-up|0|||
37740188|NCT01920061|69225828|FG001|Overall Study|Participant refused further follow-up|0|||
37740189|NCT01920061|69225829|FG002|Overall Study|Participant refused further follow-up|0|||
37740190|NCT01920061|69225830|FG003|Overall Study|Participant refused further follow-up|0|||
37740191|NCT01920061|69225831|FG004|Overall Study|Participant refused further follow-up|1|||
37740192|NCT01920061|69225832|FG005|Overall Study|Participant refused further follow-up|1|||
37740193|NCT01920061|69225833|FG006|Overall Study|Participant refused further follow-up|0|||
37740194|NCT01920061|69225834|FG007|Overall Study|Participant refused further follow-up|0|||
37740195|NCT01920061|69225835|FG008|Overall Study|Participant refused further follow-up|1|||
37740196|NCT01920061|69225836|FG009|Overall Study|Participant refused further follow-up|0|||
37740197|NCT01920061|69225837|FG010|Overall Study|Participant refused further follow-up|1|||
37740198|NCT01920061|69225838|FG011|Overall Study|Participant refused further follow-up|0|||
37740199|NCT01920061|69225839|FG012|Overall Study|Participant refused further follow-up|1|||
37740200|NCT01920061|69225840|FG013|Overall Study|Participant refused further follow-up|0|||
37740201|NCT01920061|69225841|FG014|Overall Study|Participant refused further follow-up|1|||
37740202|NCT01920061|69225842|FG015|Overall Study|Participant refused further follow-up|2|||
37740203|NCT01920061|69225843|FG016|Overall Study|Participant refused further follow-up|1|||
37740204|NCT01920061|69225844|FG017|Overall Study|Participant refused further follow-up|1|||
37740205|NCT01920061|69225845|FG018|Overall Study|Participant refused further follow-up|0|||
37740206|NCT01920061|69225846|FG019|Overall Study|Participant refused further follow-up|0|||
37740207|NCT01426425|69225909|FG000|Overall Study|Exited prior to EP study|22|||
37740208|NCT01426425|69225909|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
37740209|NCT01426425|69225909|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
37740210|NCT01426347|69225922|FG000|Overall Study|Lost to Follow-up|0|||
37740211|NCT01426347|69225923|FG001|Overall Study|Lost to Follow-up|3|||
37740212|NCT01426347|69225922|FG000|Overall Study|Protocol Violation|2|||
37740213|NCT01426347|69225923|FG001|Overall Study|Protocol Violation|0|||
37740214|NCT01426347|69225922|FG000|Overall Study|Withdrawal by Subject|5|||
37740215|NCT01426347|69225923|FG001|Overall Study|Withdrawal by Subject|0|||
37740216|NCT01882465|69225929|FG000|Period 1|Lens Discomfort|0|||
37740217|NCT01882465|69225930|FG001|Period 1|Lens Discomfort|0|||
37740218|NCT01882465|69225931|FG002|Period 1|Lens Discomfort|0|||
37740219|NCT01882465|69225932|FG003|Period 1|Lens Discomfort|1|||
37740220|NCT01882465|69225933|FG004|Period 1|Lens Discomfort|0|||
37740221|NCT01882465|69225934|FG005|Period 1|Lens Discomfort|0|||
37637713|NCT02269917|69105327|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
37637714|NCT02269917|69105325|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
37637715|NCT02269917|69105326|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
37637716|NCT02269917|69105327|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
37637717|NCT02522494|69105338|FG000|Overall Study|Lost to Follow-up|6|||
37637718|NCT02522494|69105339|FG001|Overall Study|Lost to Follow-up|2|||
37637719|NCT02522494|69105338|FG000|Overall Study|Withdrawal by Subject|1|||
37637720|NCT02522494|69105339|FG001|Overall Study|Withdrawal by Subject|0|||
37637721|NCT02522494|69105338|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
37637722|NCT02522494|69105339|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
37637723|NCT02522494|69105338|FG000|Overall Study|Participant did not watch the video|1|||
37637724|NCT02522494|69105339|FG001|Overall Study|Participant did not watch the video|0|||
37637725|NCT02522494|69105338|FG000|Overall Study|Death|0|||
37637726|NCT02522494|69105339|FG001|Overall Study|Death|1|||
37637727|NCT01658020|69105347|FG000|Overall Study|Adverse Event|3|||
37637728|NCT01658020|69105348|FG001|Overall Study|Adverse Event|3|||
37637729|NCT01658020|69105347|FG000|Overall Study|Lost to Follow-up|1|||
37637730|NCT01658020|69105348|FG001|Overall Study|Lost to Follow-up|0|||
37637731|NCT01658020|69105347|FG000|Overall Study|Withdrawal by Subject|4|||
37637732|NCT01658020|69105348|FG001|Overall Study|Withdrawal by Subject|5|||
37637733|NCT01658020|69105347|FG000|Overall Study|Protocol Violation|0|||
37637734|NCT01658020|69105348|FG001|Overall Study|Protocol Violation|1|||
37637735|NCT03389477|69105366|FG000|Step 1|Withdrawal by Subject|1|||
37637736|NCT03389477|69105367|FG001|Step 1|Withdrawal by Subject|0|||
37637737|NCT03389477|69105366|FG000|Step 2|Withdrawal by Subject|1|||
37637738|NCT03389477|69105367|FG001|Step 2|Withdrawal by Subject|2|||
37637739|NCT03389477|69105366|FG000|Step 2|Disease progression|1|||
37637740|NCT03389477|69105367|FG001|Step 2|Disease progression|0|||
37637741|NCT03389477|69105366|FG000|Step 2|Death|0|||
37637742|NCT03389477|69105367|FG001|Step 2|Death|1|||
37637743|NCT03389477|69105366|FG000|Step 2|Poor performance status and nutrition|0|||
37637744|NCT03389477|69105367|FG001|Step 2|Poor performance status and nutrition|1|||
37637745|NCT03389477|69105366|FG000|Step 3|Withdrawal after 3 cycles|0|||
37637746|NCT03389477|69105367|FG001|Step 3|Withdrawal after 3 cycles|1|||
37637747|NCT03389477|69105366|FG000|Step 3|Still receiving active treatment|4|||
37637748|NCT03389477|69105367|FG001|Step 3|Still receiving active treatment|0|||
37637749|NCT03389477|69105366|FG000|Step 3|Progressive disease after 2 cycles|1|||
37637750|NCT03389477|69105367|FG001|Step 3|Progressive disease after 2 cycles|0|||
37637751|NCT02680574|69105377|FG000|Overall Study|Death|137|||
37637752|NCT02680574|69105378|FG001|Overall Study|Death|137|||
37637753|NCT02680574|69105377|FG000|Overall Study|Withdrawal by Subject|17|||
37637754|NCT02680574|69105378|FG001|Overall Study|Withdrawal by Subject|9|||
37637755|NCT02680574|69105377|FG000|Overall Study|Lost to Follow-up|4|||
37637756|NCT02680574|69105378|FG001|Overall Study|Lost to Follow-up|6|||
37637757|NCT02522884|69105384|FG000|Overall Study|Withdrawal by Subject|6|||
37637758|NCT02522884|69105384|FG000|Overall Study|Death|3|||
37740222|NCT01882465|69225935|FG006|Period 1|Lens Discomfort|0|||
37740223|NCT01882465|69225929|FG000|Period 1|Withdrawal by Subject|0|||
37740224|NCT01882465|69225930|FG001|Period 1|Withdrawal by Subject|0|||
37740225|NCT01882465|69225931|FG002|Period 1|Withdrawal by Subject|0|||
37740226|NCT01882465|69225932|FG003|Period 1|Withdrawal by Subject|0|||
37740227|NCT01882465|69225933|FG004|Period 1|Withdrawal by Subject|0|||
37740228|NCT01882465|69225934|FG005|Period 1|Withdrawal by Subject|0|||
37637759|NCT02522884|69105384|FG000|Overall Study|Missed 12-month Follow-up|9|||
37637760|NCT02674568|69105401|FG000|Overall Study|Withdrawal by Subject|5|||
37637761|NCT02674568|69105401|FG000|Overall Study|Death|303|||
37637762|NCT02674568|69105401|FG000|Overall Study|Physician Decision|2|||
37637763|NCT02674568|69105401|FG000|Overall Study|Lost to Follow-up|9|||
37637764|NCT02674568|69105401|FG000|Overall Study|Other, Not Specified|20|||
37637765|NCT03022799|69105430|FG000|Overall Study|Adverse Event|0|||
37637766|NCT03022799|69105431|FG001|Overall Study|Adverse Event|0|||
37637767|NCT03022799|69105432|FG002|Overall Study|Adverse Event|0|||
37637768|NCT03022799|69105433|FG003|Overall Study|Adverse Event|0|||
37637769|NCT03022799|69105434|FG004|Overall Study|Adverse Event|0|||
37637770|NCT03022799|69105435|FG005|Overall Study|Adverse Event|0|||
37637771|NCT03022799|69105436|FG006|Overall Study|Adverse Event|0|||
37637772|NCT03022799|69105437|FG007|Overall Study|Adverse Event|0|||
37637773|NCT03022799|69105438|FG008|Overall Study|Adverse Event|0|||
37637774|NCT03022799|69105439|FG009|Overall Study|Adverse Event|1|||
37637775|NCT03022799|69105440|FG010|Overall Study|Adverse Event|1|||
37637776|NCT03022799|69105441|FG011|Overall Study|Adverse Event|0|||
37637777|NCT03022799|69105442|FG012|Overall Study|Adverse Event|0|||
37637778|NCT02674334|69105489|FG000|Overall Study|Lost to Follow-up|5|||
37637779|NCT02674334|69105490|FG001|Overall Study|Lost to Follow-up|3|||
37740229|NCT01882465|69225935|FG006|Period 1|Withdrawal by Subject|1|||
37740230|NCT01882465|69225929|FG000|Period 2|Protocol Violation|0|||
37740231|NCT01882465|69225930|FG001|Period 2|Protocol Violation|0|||
37740232|NCT01882465|69225931|FG002|Period 2|Protocol Violation|0|||
37740233|NCT01882465|69225932|FG003|Period 2|Protocol Violation|0|||
37740234|NCT01882465|69225933|FG004|Period 2|Protocol Violation|1|||
37740235|NCT01882465|69225934|FG005|Period 2|Protocol Violation|0|||
37740236|NCT01882465|69225935|FG006|Period 2|Protocol Violation|0|||
37740237|NCT01426269|69225943|FG000|Period 1: 12 Weeks|Adverse Event|5|||
37740238|NCT01426269|69225944|FG001|Period 1: 12 Weeks|Adverse Event|0|||
37740239|NCT01426269|69225945|FG002|Period 1: 12 Weeks|Adverse Event|0|||
37740240|NCT01426269|69225943|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
37740241|NCT01426269|69225944|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
37740242|NCT01426269|69225945|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
37740243|NCT01426269|69225943|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
37740244|NCT01426269|69225944|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
37740245|NCT01426269|69225945|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
37740246|NCT01426269|69225943|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
37740247|NCT01426269|69225944|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
37740248|NCT01426269|69225945|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
37740249|NCT01426269|69225943|FG000|Period 1: 12 Weeks|Pregnancy|1|||
37740250|NCT01426269|69225944|FG001|Period 1: 12 Weeks|Pregnancy|0|||
37740251|NCT01426269|69225945|FG002|Period 1: 12 Weeks|Pregnancy|0|||
37740252|NCT01426269|69225943|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
37740253|NCT01426269|69225944|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
37740254|NCT01426269|69225945|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
37740255|NCT01426269|69225943|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
37740256|NCT01426269|69225944|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
37740257|NCT01426269|69225945|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
37740258|NCT01426269|69225943|FG000|Period 2: 40 Weeks|Adverse Event|0|||
37637780|NCT02674334|69105489|FG000|Overall Study|participant difficulty breathing|1|||
37637781|NCT02674334|69105490|FG001|Overall Study|participant difficulty breathing|0|||
37637782|NCT02674334|69105489|FG000|Overall Study|NIRS not recording|1|||
37637783|NCT02674334|69105490|FG001|Overall Study|NIRS not recording|0|||
37637784|NCT03026075|69105496|FG000|Overall Study|Physician Decision|1|||
37637785|NCT01373918|69105502|FG000|Overall Study|Physician Decision|0|||
37637786|NCT01373918|69105503|FG001|Overall Study|Physician Decision|1|||
37740259|NCT01426269|69225944|FG001|Period 2: 40 Weeks|Adverse Event|1|||
37740260|NCT01426269|69225945|FG002|Period 2: 40 Weeks|Adverse Event|2|||
37740261|NCT01426269|69225943|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
37740262|NCT01426269|69225944|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
37740263|NCT01426269|69225945|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
37740264|NCT01426269|69225943|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
37740265|NCT01426269|69225944|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
37740266|NCT01426269|69225945|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
37637787|NCT02667626|69105511|FG000|Overall Study|Withdrawal by Subject|0|||
37740267|NCT01426269|69225943|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
37740268|NCT01426269|69225944|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
37740269|NCT01426269|69225945|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
37740270|NCT01426269|69225943|FG000|Period 2: 40 Weeks|Site closed|0|||
37637788|NCT02667626|69105512|FG001|Overall Study|Withdrawal by Subject|1|||
37637789|NCT02522728|69105523|FG000|Overall Study|Withdrawal by Subject|6|||
37637790|NCT02522728|69105524|FG001|Overall Study|Withdrawal by Subject|6|||
37740271|NCT01426269|69225944|FG001|Period 2: 40 Weeks|Site closed|6|||
37740272|NCT01426269|69225945|FG002|Period 2: 40 Weeks|Site closed|5|||
37740273|NCT01426269|69225943|FG000|Period 2: 40 Weeks|Relapsed|0|||
37740274|NCT01426269|69225944|FG001|Period 2: 40 Weeks|Relapsed|9|||
37637791|NCT02522728|69105523|FG000|Overall Study|Death|4|||
37637792|NCT02522728|69105524|FG001|Overall Study|Death|3|||
37637793|NCT02522728|69105523|FG000|Overall Study|Adverse Event|2|||
37740275|NCT01426269|69225945|FG002|Period 2: 40 Weeks|Relapsed|18|||
37740276|NCT01426113|69225958|FG000|Overall Study|Study Discontinued|1|||
37740277|NCT01426113|69225959|FG001|Overall Study|Study Discontinued|1|||
37740278|NCT01426113|69225958|FG000|Overall Study|Adverse Event|0|||
37740279|NCT01426113|69225959|FG001|Overall Study|Adverse Event|1|||
37740280|NCT01864603|69225967|FG000|Stage 2|DSMB design modification|86056|||
37740281|NCT01864603|69225968|FG001|Stage 2|DSMB design modification|92558|||
37637794|NCT02522728|69105524|FG001|Overall Study|Adverse Event|1|||
37637795|NCT02522728|69105523|FG000|Overall Study|Did not receive randomized study device|0|||
37637796|NCT02522728|69105524|FG001|Overall Study|Did not receive randomized study device|1|||
37637797|NCT03025217|69105539|FG000|Overall Study|Pregnancy|1|||
37637798|NCT03025217|69105539|FG000|Overall Study|Lost to Follow-up|1|||
37637799|NCT03025217|69105539|FG000|Overall Study|Not eligible, poor English|2|||
37637800|NCT03023813|69105546|FG000|Overall Study|Lost to Follow-up|1|||
37637801|NCT03023813|69105547|FG001|Overall Study|Lost to Follow-up|2|||
37637802|NCT03023813|69105548|FG002|Overall Study|Lost to Follow-up|0|||
37637803|NCT01365130|69105557|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
37637804|NCT01657162|69105563|FG000|Overall Study|Adverse Event|26|||
37637805|NCT01657162|69105564|FG001|Overall Study|Adverse Event|36|||
37637806|NCT01657162|69105563|FG000|Overall Study|Withdrawal by Subject|13|||
37637807|NCT01657162|69105564|FG001|Overall Study|Withdrawal by Subject|13|||
37637808|NCT01657162|69105563|FG000|Overall Study|Continuing Significant Deterioration|9|||
37637809|NCT01657162|69105564|FG001|Overall Study|Continuing Significant Deterioration|3|||
37637810|NCT01657162|69105563|FG000|Overall Study|Refusal of Treatment|4|||
37637811|NCT01657162|69105564|FG001|Overall Study|Refusal of Treatment|6|||
37637812|NCT01657162|69105563|FG000|Overall Study|Lost to Follow-up|3|||
37637813|NCT01657162|69105564|FG001|Overall Study|Lost to Follow-up|4|||
37637814|NCT01657162|69105563|FG000|Overall Study|Death|2|||
37637815|NCT01657162|69105564|FG001|Overall Study|Death|3|||
37637816|NCT01657162|69105563|FG000|Overall Study|Inability to Complete Study Procedures|1|||
37637817|NCT01657162|69105564|FG001|Overall Study|Inability to Complete Study Procedures|7|||
37637818|NCT01657162|69105563|FG000|Overall Study|Protocol Violation|1|||
37637819|NCT01657162|69105564|FG001|Overall Study|Protocol Violation|0|||
37637820|NCT01657162|69105563|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
37637821|NCT01657162|69105564|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
37637822|NCT01657162|69105563|FG000|Overall Study|Other than Specified|0|||
37637823|NCT01657162|69105564|FG001|Overall Study|Other than Specified|2|||
37637824|NCT01373294|69105598|FG000|Overall Study|Adverse Event|1|||
37637825|NCT01373294|69105599|FG001|Overall Study|Adverse Event|0|||
37637826|NCT01656304|69105605|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
37637827|NCT03023423|69105612|FG000|Overall Study|Death|5|||
37637828|NCT03023423|69105613|FG001|Overall Study|Death|12|||
37637829|NCT03023423|69105614|FG002|Overall Study|Death|20|||
37637830|NCT03023423|69105612|FG000|Overall Study|Other|0|||
37637831|NCT03023423|69105613|FG001|Overall Study|Other|2|||
37637832|NCT03023423|69105614|FG002|Overall Study|Other|2|||
37637833|NCT03023423|69105612|FG000|Overall Study|Ongoing|2|||
37637834|NCT03023423|69105613|FG001|Overall Study|Ongoing|32|||
37637835|NCT03023423|69105614|FG002|Overall Study|Ongoing|24|||
37637836|NCT03185741|69105629|FG000|Baseline|Withdrawal by Subject|1|||
37637837|NCT03185741|69105630|FG001|Baseline|Withdrawal by Subject|3|||
37637838|NCT03185741|69105631|FG002|Baseline|Withdrawal by Subject|2|||
37637839|NCT03185741|69105629|FG000|Baseline|Lost to Follow-up|1|||
37637840|NCT03185741|69105630|FG001|Baseline|Lost to Follow-up|2|||
37637841|NCT03185741|69105631|FG002|Baseline|Lost to Follow-up|3|||
37637842|NCT03185741|69105629|FG000|3Month|Death|1|||
37637843|NCT03185741|69105630|FG001|3Month|Death|1|||
37637844|NCT03185741|69105631|FG002|3Month|Death|2|||
37637845|NCT03185741|69105629|FG000|3Month|Withdrawal by Subject|1|||
37637846|NCT03185741|69105630|FG001|3Month|Withdrawal by Subject|5|||
37637847|NCT03185741|69105631|FG002|3Month|Withdrawal by Subject|1|||
37637848|NCT03185741|69105629|FG000|3Month|Lost to Follow-up|7|||
37637849|NCT03185741|69105630|FG001|3Month|Lost to Follow-up|9|||
37637850|NCT03185741|69105631|FG002|3Month|Lost to Follow-up|8|||
37637851|NCT03185741|69105629|FG000|3Month|Unavailable for 3Month|11|||
37637852|NCT03185741|69105630|FG001|3Month|Unavailable for 3Month|10|||
37637853|NCT03185741|69105631|FG002|3Month|Unavailable for 3Month|11|||
37637854|NCT03185741|69105629|FG000|3Month|Protocol Violation|0|||
37637855|NCT03185741|69105630|FG001|3Month|Protocol Violation|0|||
37637856|NCT03185741|69105631|FG002|3Month|Protocol Violation|3|||
37637857|NCT03185741|69105629|FG000|6Month|Death|1|||
37637858|NCT03185741|69105630|FG001|6Month|Death|1|||
37637859|NCT03185741|69105631|FG002|6Month|Death|2|||
37637860|NCT03185741|69105629|FG000|6Month|Withdrawal by Subject|2|||
37637861|NCT03185741|69105630|FG001|6Month|Withdrawal by Subject|3|||
37637862|NCT03185741|69105631|FG002|6Month|Withdrawal by Subject|1|||
37637863|NCT03185741|69105629|FG000|6Month|Lost to Follow-up|16|||
37637864|NCT03185741|69105630|FG001|6Month|Lost to Follow-up|15|||
37637865|NCT03185741|69105631|FG002|6Month|Lost to Follow-up|16|||
37637866|NCT02672852|69105641|FG000|Part A1|Disease Worsening|1|||
37637867|NCT02672852|69105642|FG001|Part A1|Disease Worsening|0|||
37740282|NCT01892293|69225979|FG000|Overall Study|Apheresed but not treated|4|||
37637868|NCT02672852|69105643|FG002|Part A1|Disease Worsening|0|||
37637869|NCT02672852|69105644|FG003|Part A1|Disease Worsening|0|||
37637870|NCT02672852|69105645|FG004|Part A1|Disease Worsening|0|||
37637871|NCT02672852|69105646|FG005|Part A1|Disease Worsening|0|||
37637872|NCT02672852|69105647|FG006|Part A1|Disease Worsening|0|||
37637873|NCT02672852|69105641|FG000|Part A1|Adverse Event|0|||
37637874|NCT02672852|69105642|FG001|Part A1|Adverse Event|1|||
37637875|NCT02672852|69105643|FG002|Part A1|Adverse Event|0|||
37637876|NCT02672852|69105644|FG003|Part A1|Adverse Event|0|||
37637877|NCT02672852|69105645|FG004|Part A1|Adverse Event|0|||
37637878|NCT02672852|69105646|FG005|Part A1|Adverse Event|0|||
37637879|NCT02672852|69105647|FG006|Part A1|Adverse Event|0|||
37637880|NCT02672852|69105641|FG000|Part A1|Lost to Follow-up|1|||
37637881|NCT02672852|69105642|FG001|Part A1|Lost to Follow-up|2|||
37637882|NCT02672852|69105643|FG002|Part A1|Lost to Follow-up|0|||
37637883|NCT02672852|69105644|FG003|Part A1|Lost to Follow-up|0|||
37637884|NCT02672852|69105645|FG004|Part A1|Lost to Follow-up|0|||
37637885|NCT02672852|69105646|FG005|Part A1|Lost to Follow-up|0|||
37637886|NCT02672852|69105647|FG006|Part A1|Lost to Follow-up|0|||
37637887|NCT02672852|69105641|FG000|Part A1|Withdrawal by Subject|1|||
37637888|NCT02672852|69105642|FG001|Part A1|Withdrawal by Subject|1|||
37637889|NCT02672852|69105643|FG002|Part A1|Withdrawal by Subject|0|||
37637890|NCT02672852|69105644|FG003|Part A1|Withdrawal by Subject|0|||
37637891|NCT02672852|69105645|FG004|Part A1|Withdrawal by Subject|0|||
37637892|NCT02672852|69105646|FG005|Part A1|Withdrawal by Subject|0|||
37637893|NCT02672852|69105647|FG006|Part A1|Withdrawal by Subject|0|||
37637894|NCT02672852|69105641|FG000|Part A2|Disease worsening|0|||
37637895|NCT02672852|69105642|FG001|Part A2|Disease worsening|0|||
37637896|NCT02672852|69105643|FG002|Part A2|Disease worsening|1|||
37637897|NCT02672852|69105644|FG003|Part A2|Disease worsening|0|||
37637898|NCT02672852|69105645|FG004|Part A2|Disease worsening|0|||
37637899|NCT02672852|69105646|FG005|Part A2|Disease worsening|0|||
37637900|NCT02672852|69105647|FG006|Part A2|Disease worsening|0|||
37637901|NCT02672852|69105641|FG000|Part A2|Adverse Event|0|||
37637902|NCT02672852|69105642|FG001|Part A2|Adverse Event|0|||
37637903|NCT02672852|69105643|FG002|Part A2|Adverse Event|3|||
37637904|NCT02672852|69105644|FG003|Part A2|Adverse Event|0|||
37637905|NCT02672852|69105645|FG004|Part A2|Adverse Event|0|||
37637906|NCT02672852|69105646|FG005|Part A2|Adverse Event|0|||
37637907|NCT02672852|69105647|FG006|Part A2|Adverse Event|0|||
37637908|NCT02672852|69105641|FG000|Part A2|Lost to Follow-up|0|||
37637909|NCT02672852|69105642|FG001|Part A2|Lost to Follow-up|0|||
37637910|NCT02672852|69105643|FG002|Part A2|Lost to Follow-up|2|||
37637911|NCT02672852|69105644|FG003|Part A2|Lost to Follow-up|0|||
37637912|NCT02672852|69105645|FG004|Part A2|Lost to Follow-up|0|||
37637913|NCT02672852|69105646|FG005|Part A2|Lost to Follow-up|0|||
37637914|NCT02672852|69105647|FG006|Part A2|Lost to Follow-up|0|||
37637915|NCT02672852|69105641|FG000|Part A2|Withdrawal by Subject|0|||
37637916|NCT02672852|69105642|FG001|Part A2|Withdrawal by Subject|0|||
37637917|NCT02672852|69105643|FG002|Part A2|Withdrawal by Subject|1|||
37637918|NCT02672852|69105644|FG003|Part A2|Withdrawal by Subject|0|||
37637919|NCT02672852|69105645|FG004|Part A2|Withdrawal by Subject|0|||
37637920|NCT02672852|69105646|FG005|Part A2|Withdrawal by Subject|0|||
37637921|NCT02672852|69105647|FG006|Part A2|Withdrawal by Subject|0|||
37637922|NCT02672852|69105641|FG000|Part A2|Other|0|||
37740283|NCT01393899|69225986|FG000|Overall Study|Study terminated by sponsor|1|||
37740284|NCT01393899|69225987|FG001|Overall Study|Study terminated by sponsor|0|||
37740285|NCT01393899|69225988|FG002|Overall Study|Study terminated by sponsor|1|||
37921909|NCT00667810|69608727|FG003|Overall Study|Physician Decision|0|||
37921910|NCT00667810|69608724|FG000|Overall Study|Protocol Violation|0|||
37921911|NCT00667810|69608725|FG001|Overall Study|Protocol Violation|2|||
37921912|NCT00667810|69608726|FG002|Overall Study|Protocol Violation|0|||
37921913|NCT00667810|69608727|FG003|Overall Study|Protocol Violation|0|||
37637923|NCT02672852|69105642|FG001|Part A2|Other|0|||
37637924|NCT02672852|69105643|FG002|Part A2|Other|3|||
37637925|NCT02672852|69105644|FG003|Part A2|Other|0|||
37637926|NCT02672852|69105645|FG004|Part A2|Other|0|||
37637927|NCT02672852|69105646|FG005|Part A2|Other|0|||
37637928|NCT02672852|69105647|FG006|Part A2|Other|0|||
37637929|NCT02672852|69105641|FG000|Part A2|Not entered in Part B|0|||
37637930|NCT02672852|69105642|FG001|Part A2|Not entered in Part B|0|||
37637931|NCT02672852|69105643|FG002|Part A2|Not entered in Part B|0|||
37637932|NCT02672852|69105644|FG003|Part A2|Not entered in Part B|4|||
37637933|NCT02672852|69105645|FG004|Part A2|Not entered in Part B|0|||
37637934|NCT02672852|69105646|FG005|Part A2|Not entered in Part B|0|||
37637935|NCT02672852|69105647|FG006|Part A2|Not entered in Part B|0|||
37637936|NCT02672852|69105641|FG000|Part B|Disease worsening|0|||
37637937|NCT02672852|69105642|FG001|Part B|Disease worsening|0|||
37637938|NCT02672852|69105643|FG002|Part B|Disease worsening|0|||
37637939|NCT02672852|69105644|FG003|Part B|Disease worsening|0|||
37637940|NCT02672852|69105645|FG004|Part B|Disease worsening|1|||
37637941|NCT02672852|69105646|FG005|Part B|Disease worsening|0|||
37637942|NCT02672852|69105647|FG006|Part B|Disease worsening|1|||
37637943|NCT02672852|69105641|FG000|Part B|Worsening pre-existing condition|0|||
37921914|NCT00667810|69608724|FG000|Overall Study|Withdrawal by Subject|14|||
37921915|NCT00667810|69608725|FG001|Overall Study|Withdrawal by Subject|20|||
37921916|NCT00667810|69608726|FG002|Overall Study|Withdrawal by Subject|29|||
37921917|NCT00667810|69608727|FG003|Overall Study|Withdrawal by Subject|1|||
37921918|NCT00667810|69608724|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
37921919|NCT00667810|69608725|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
37921920|NCT00667810|69608726|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
37921921|NCT00667810|69608727|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
37921922|NCT00667810|69608724|FG000|Overall Study|Failed to Return|0|||
37921923|NCT00667810|69608725|FG001|Overall Study|Failed to Return|0|||
37921924|NCT00667810|69608726|FG002|Overall Study|Failed to Return|2|||
37637944|NCT02672852|69105642|FG001|Part B|Worsening pre-existing condition|0|||
37637945|NCT02672852|69105643|FG002|Part B|Worsening pre-existing condition|0|||
37637946|NCT02672852|69105644|FG003|Part B|Worsening pre-existing condition|0|||
37637947|NCT02672852|69105645|FG004|Part B|Worsening pre-existing condition|0|||
37637948|NCT02672852|69105646|FG005|Part B|Worsening pre-existing condition|1|||
37637949|NCT02672852|69105647|FG006|Part B|Worsening pre-existing condition|0|||
37637950|NCT02672852|69105641|FG000|Part B|Other adverse event|0|||
37637951|NCT02672852|69105642|FG001|Part B|Other adverse event|0|||
37637952|NCT02672852|69105643|FG002|Part B|Other adverse event|0|||
37637953|NCT02672852|69105644|FG003|Part B|Other adverse event|0|||
37637954|NCT02672852|69105645|FG004|Part B|Other adverse event|3|||
37637955|NCT02672852|69105646|FG005|Part B|Other adverse event|5|||
37637956|NCT02672852|69105647|FG006|Part B|Other adverse event|1|||
37637957|NCT02672852|69105641|FG000|Part B|Lost to Follow-up|0|||
37637958|NCT02672852|69105642|FG001|Part B|Lost to Follow-up|0|||
37637959|NCT02672852|69105643|FG002|Part B|Lost to Follow-up|0|||
37637960|NCT02672852|69105644|FG003|Part B|Lost to Follow-up|0|||
37637961|NCT02672852|69105645|FG004|Part B|Lost to Follow-up|3|||
37637962|NCT02672852|69105646|FG005|Part B|Lost to Follow-up|4|||
37637963|NCT02672852|69105647|FG006|Part B|Lost to Follow-up|1|||
37637964|NCT02672852|69105641|FG000|Part B|Withdrawal by Subject|0|||
37637965|NCT02672852|69105642|FG001|Part B|Withdrawal by Subject|0|||
37921925|NCT00667810|69608727|FG003|Overall Study|Failed to Return|0|||
37921926|NCT00667810|69608724|FG000|Overall Study|Loss of Caregiver|0|||
37921927|NCT00667810|69608725|FG001|Overall Study|Loss of Caregiver|1|||
38032078|NCT02849080|69717998|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
37637966|NCT02672852|69105643|FG002|Part B|Withdrawal by Subject|0|||
37637967|NCT02672852|69105644|FG003|Part B|Withdrawal by Subject|0|||
37637968|NCT02672852|69105645|FG004|Part B|Withdrawal by Subject|5|||
37637969|NCT02672852|69105646|FG005|Part B|Withdrawal by Subject|0|||
37637970|NCT02672852|69105647|FG006|Part B|Withdrawal by Subject|7|||
37637971|NCT02672852|69105641|FG000|Part B|Other|0|||
37637972|NCT02672852|69105642|FG001|Part B|Other|0|||
37637973|NCT02672852|69105643|FG002|Part B|Other|0|||
37637974|NCT02672852|69105644|FG003|Part B|Other|0|||
37637975|NCT02672852|69105645|FG004|Part B|Other|4|||
37637976|NCT02672852|69105646|FG005|Part B|Other|1|||
37637977|NCT02672852|69105647|FG006|Part B|Other|2|||
37637978|NCT02671760|69105658|FG000|Overall Study|Lost to Follow-up|0|||
37637979|NCT02671760|69105659|FG001|Overall Study|Lost to Follow-up|1|||
37637980|NCT02671760|69105660|FG002|Overall Study|Lost to Follow-up|0|||
37637981|NCT02667236|69105670|FG000|Overall Study|Adverse Event|1|||
37637982|NCT02667236|69105671|FG001|Overall Study|Adverse Event|1|||
37637983|NCT02667236|69105670|FG000|Overall Study|Withdrawal by Subject|2|||
37637984|NCT02667236|69105671|FG001|Overall Study|Withdrawal by Subject|0|||
37637985|NCT01126749|69105681|FG000|Phase 1b|Other|0|||
37637986|NCT01126749|69105682|FG001|Phase 1b|Other|1|||
37637987|NCT01126749|69105683|FG002|Phase 1b|Other|0|||
37637988|NCT01126749|69105684|FG003|Phase 1b|Other|0|||
37740286|NCT01393899|69225986|FG000|Overall Study|Other|1|||
37740287|NCT01393899|69225987|FG001|Overall Study|Other|0|||
38032079|NCT02849080|69717999|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
37740288|NCT01393899|69225988|FG002|Overall Study|Other|0|||
37637989|NCT01126749|69105681|FG000|Phase 1b|Withdrawal by Subject|0|||
37637990|NCT01126749|69105682|FG001|Phase 1b|Withdrawal by Subject|1|||
37740289|NCT01393899|69225986|FG000|Overall Study|Withdrawal by Subject|2|||
37740290|NCT01393899|69225987|FG001|Overall Study|Withdrawal by Subject|2|||
37740291|NCT01393899|69225988|FG002|Overall Study|Withdrawal by Subject|1|||
37921928|NCT00667810|69608726|FG002|Overall Study|Loss of Caregiver|3|||
37921929|NCT00667810|69608727|FG003|Overall Study|Loss of Caregiver|0|||
37637991|NCT01126749|69105683|FG002|Phase 1b|Withdrawal by Subject|0|||
37637992|NCT01126749|69105684|FG003|Phase 1b|Withdrawal by Subject|0|||
37637993|NCT01126749|69105681|FG000|Phase 1b|Death|3|||
37637994|NCT01126749|69105682|FG001|Phase 1b|Death|4|||
37637995|NCT01126749|69105683|FG002|Phase 1b|Death|0|||
37637996|NCT01126749|69105684|FG003|Phase 1b|Death|0|||
37637997|NCT01126749|69105681|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
37637998|NCT01126749|69105682|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
37637999|NCT01126749|69105683|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
37638000|NCT01126749|69105684|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
37740292|NCT01393899|69225986|FG000|Overall Study|Lost to Follow-up|0|||
37740293|NCT01393899|69225987|FG001|Overall Study|Lost to Follow-up|0|||
37740294|NCT01393899|69225988|FG002|Overall Study|Lost to Follow-up|1|||
37740295|NCT01393899|69225986|FG000|Overall Study|Does not meet entrance criteria|1|||
37740296|NCT01393899|69225987|FG001|Overall Study|Does not meet entrance criteria|0|||
37740297|NCT01393899|69225988|FG002|Overall Study|Does not meet entrance criteria|1|||
37740298|NCT01393899|69225986|FG000|Overall Study|Lack of Efficacy|26|||
37740299|NCT01393899|69225987|FG001|Overall Study|Lack of Efficacy|21|||
37638001|NCT01126749|69105681|FG000|Phase 2|Study Termination by Sponsor|0|||
37638002|NCT01126749|69105682|FG001|Phase 2|Study Termination by Sponsor|0|||
37740300|NCT01393899|69225988|FG002|Overall Study|Lack of Efficacy|16|||
37740301|NCT01393899|69225986|FG000|Overall Study|Adverse Event|1|||
37740302|NCT01393899|69225987|FG001|Overall Study|Adverse Event|5|||
37740303|NCT01393899|69225988|FG002|Overall Study|Adverse Event|3|||
37638003|NCT01126749|69105683|FG002|Phase 2|Study Termination by Sponsor|12|||
37638004|NCT01126749|69105684|FG003|Phase 2|Study Termination by Sponsor|6|||
37638005|NCT01126749|69105681|FG000|Phase 2|Other|0|||
37638006|NCT01126749|69105682|FG001|Phase 2|Other|0|||
37638007|NCT01126749|69105683|FG002|Phase 2|Other|4|||
37638008|NCT01126749|69105684|FG003|Phase 2|Other|2|||
37638009|NCT01126749|69105681|FG000|Phase 2|Withdrawal by Subject|0|||
37638010|NCT01126749|69105682|FG001|Phase 2|Withdrawal by Subject|0|||
37638011|NCT01126749|69105683|FG002|Phase 2|Withdrawal by Subject|0|||
37638012|NCT01126749|69105684|FG003|Phase 2|Withdrawal by Subject|2|||
37740304|NCT01393743|69226000|FG000|Core Study|Adverse Event|5|||
37740305|NCT01393743|69226001|FG001|Core Study|Adverse Event|9|||
37740306|NCT01393743|69226002|FG002|Core Study|Adverse Event|0|||
37740307|NCT01393743|69226000|FG000|Core Study|Lost to Follow-up|1|||
37740308|NCT01393743|69226001|FG001|Core Study|Lost to Follow-up|1|||
37740309|NCT01393743|69226002|FG002|Core Study|Lost to Follow-up|0|||
37740310|NCT01393743|69226000|FG000|Core Study|Participant's Choice|2|||
37740311|NCT01393743|69226001|FG001|Core Study|Participant's Choice|3|||
37740312|NCT01393743|69226002|FG002|Core Study|Participant's Choice|0|||
37740313|NCT01393743|69226000|FG000|Core Study|Inadequate therapeutic effect|2|||
37740314|NCT01393743|69226001|FG001|Core Study|Inadequate therapeutic effect|0|||
37740315|NCT01393743|69226002|FG002|Core Study|Inadequate therapeutic effect|0|||
37740316|NCT01393743|69226000|FG000|Extension Phase|Adverse Event|0|||
37740317|NCT01393743|69226001|FG001|Extension Phase|Adverse Event|0|||
37740318|NCT01393743|69226002|FG002|Extension Phase|Adverse Event|12|||
37740319|NCT01393743|69226000|FG000|Extension Phase|Lost to Follow-up|0|||
37740320|NCT01393743|69226001|FG001|Extension Phase|Lost to Follow-up|0|||
37740321|NCT01393743|69226002|FG002|Extension Phase|Lost to Follow-up|2|||
37740322|NCT01393743|69226000|FG000|Extension Phase|Participant choice|0|||
37740323|NCT01393743|69226001|FG001|Extension Phase|Participant choice|0|||
37740324|NCT01393743|69226002|FG002|Extension Phase|Participant choice|16|||
37740325|NCT01393743|69226000|FG000|Extension Phase|Inadequate therapeutic effect|0|||
37740326|NCT01393743|69226001|FG001|Extension Phase|Inadequate therapeutic effect|0|||
37740327|NCT01393743|69226002|FG002|Extension Phase|Inadequate therapeutic effect|7|||
37740328|NCT01393743|69226000|FG000|Extension Phase|Withdrawal by Subject|0|||
37740329|NCT01393743|69226001|FG001|Extension Phase|Withdrawal by Subject|0|||
37740330|NCT01393743|69226002|FG002|Extension Phase|Withdrawal by Subject|8|||
37740331|NCT01393743|69226000|FG000|Extension Phase|Pregnancy|0|||
37854322|NCT01232283|69537954|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
37854323|NCT01232283|69537955|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
37854324|NCT01232283|69537956|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
37854325|NCT01232283|69537957|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
37854326|NCT01232283|69537958|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
37854327|NCT01232283|69537959|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
37854328|NCT01232283|69537960|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
37638013|NCT01126749|69105681|FG000|Phase 2|Lost to Follow-up|0|||
37638014|NCT01126749|69105682|FG001|Phase 2|Lost to Follow-up|0|||
37638015|NCT01126749|69105683|FG002|Phase 2|Lost to Follow-up|0|||
37638016|NCT01126749|69105684|FG003|Phase 2|Lost to Follow-up|1|||
37740332|NCT01393743|69226001|FG001|Extension Phase|Pregnancy|0|||
37740333|NCT01393743|69226002|FG002|Extension Phase|Pregnancy|1|||
37740334|NCT01393743|69226000|FG000|Extension Phase|Other|0|||
37740335|NCT01393743|69226001|FG001|Extension Phase|Other|0|||
37740336|NCT01393743|69226002|FG002|Extension Phase|Other|14|||
37740337|NCT01405911|69226021|FG000|Overall Study|Pre-treatment lab AE|0|||
37740338|NCT01405911|69226022|FG001|Overall Study|Pre-treatment lab AE|1|||
37638017|NCT01126749|69105681|FG000|Phase 2|Death|0|||
37638018|NCT01126749|69105682|FG001|Phase 2|Death|0|||
37638019|NCT01126749|69105683|FG002|Phase 2|Death|22|||
37638020|NCT01126749|69105684|FG003|Phase 2|Death|22|||
37638021|NCT01126749|69105681|FG000|Phase 2|Adverse Event|0|||
37638022|NCT01126749|69105682|FG001|Phase 2|Adverse Event|0|||
37740339|NCT01405911|69226023|FG002|Overall Study|Pre-treatment lab AE|0|||
37740340|NCT01405911|69226021|FG000|Overall Study|Lost to Follow-up|0|||
37740341|NCT01405911|69226022|FG001|Overall Study|Lost to Follow-up|1|||
37740342|NCT01405911|69226023|FG002|Overall Study|Lost to Follow-up|0|||
37740343|NCT01405911|69226021|FG000|Overall Study|Protocol Violation|1|||
37740344|NCT01405911|69226022|FG001|Overall Study|Protocol Violation|0|||
37740345|NCT01405911|69226023|FG002|Overall Study|Protocol Violation|0|||
37740346|NCT01405911|69226021|FG000|Overall Study|Withdrawal by Subject|3|||
37740347|NCT01405911|69226022|FG001|Overall Study|Withdrawal by Subject|1|||
37740348|NCT01405911|69226023|FG002|Overall Study|Withdrawal by Subject|1|||
37740349|NCT01425801|69226031|FG000|Period 1|Withdrawal by Subject|0|||
37740350|NCT01425801|69226032|FG001|Period 1|Withdrawal by Subject|0|||
37740351|NCT01425801|69226033|FG002|Period 1|Withdrawal by Subject|0|||
37740352|NCT01425801|69226034|FG003|Period 1|Withdrawal by Subject|0|||
37740353|NCT01425801|69226035|FG004|Period 1|Withdrawal by Subject|1|||
37740354|NCT01425801|69226036|FG005|Period 1|Withdrawal by Subject|0|||
37740355|NCT01425801|69226031|FG000|Period 2|Withdrawal by Subject|0|||
37740356|NCT01425801|69226032|FG001|Period 2|Withdrawal by Subject|0|||
37740357|NCT01425801|69226033|FG002|Period 2|Withdrawal by Subject|0|||
37740358|NCT01425801|69226034|FG003|Period 2|Withdrawal by Subject|0|||
37740359|NCT01425801|69226035|FG004|Period 2|Withdrawal by Subject|1|||
37740360|NCT01425801|69226036|FG005|Period 2|Withdrawal by Subject|0|||
37740361|NCT01425801|69226031|FG000|Period 3|Stability criteria not fullfilled|0|||
37740362|NCT01425801|69226032|FG001|Period 3|Stability criteria not fullfilled|0|||
37740363|NCT01425801|69226033|FG002|Period 3|Stability criteria not fullfilled|1|||
37740364|NCT01425801|69226034|FG003|Period 3|Stability criteria not fullfilled|0|||
37740365|NCT01425801|69226035|FG004|Period 3|Stability criteria not fullfilled|0|||
37740366|NCT01425801|69226036|FG005|Period 3|Stability criteria not fullfilled|0|||
37740367|NCT01425801|69226031|FG000|Period 4|Not able to maintain visit schedule|0|||
37740368|NCT01425801|69226032|FG001|Period 4|Not able to maintain visit schedule|0|||
37740369|NCT01425801|69226033|FG002|Period 4|Not able to maintain visit schedule|1|||
37740370|NCT01425801|69226034|FG003|Period 4|Not able to maintain visit schedule|0|||
37740371|NCT01425801|69226035|FG004|Period 4|Not able to maintain visit schedule|0|||
37740372|NCT01425801|69226036|FG005|Period 4|Not able to maintain visit schedule|0|||
37740373|NCT01425723|69226061|FG000|Overall Study|Lack of Efficacy|0|||
37740374|NCT01425723|69226062|FG001|Overall Study|Lack of Efficacy|1|||
37740375|NCT01425723|69226061|FG000|Overall Study|Withdrawal by Subject|1|||
37638023|NCT01126749|69105683|FG002|Phase 2|Adverse Event|0|||
37638024|NCT01126749|69105684|FG003|Phase 2|Adverse Event|1|||
37638025|NCT02521948|69105694|FG000|Overall Study|Adverse Event|2|||
37638026|NCT02521948|69105694|FG000|Overall Study|Death|4|||
37638027|NCT02521948|69105694|FG000|Overall Study|Lost to Follow-up|1|||
37638028|NCT02521948|69105694|FG000|Overall Study|Did not attend one or both follow-ups|6|||
37740376|NCT01425723|69226062|FG001|Overall Study|Withdrawal by Subject|4|||
37740377|NCT01425723|69226061|FG000|Overall Study|Lost to Follow-up|0|||
37740378|NCT01425723|69226062|FG001|Overall Study|Lost to Follow-up|3|||
37740379|NCT01425723|69226061|FG000|Overall Study|Physician Decision|2|||
37638029|NCT04446429|69105703|FG000|Overall Study|Lost to Follow-up|6|||
37638030|NCT04446429|69105704|FG001|Overall Study|Lost to Follow-up|0|||
37638031|NCT02832687|69105712|FG000|Overall Study|Adverse Event|0|||
37638032|NCT02832687|69105713|FG001|Overall Study|Adverse Event|2|||
37638033|NCT01656850|69105738|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
37638034|NCT01656850|69105739|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
37638035|NCT03116685|69105751|FG000|Overall Study|Physician Decision|0|||
37638036|NCT03116685|69105752|FG001|Overall Study|Physician Decision|1|||
37638037|NCT02666222|69105772|FG000|Overall Study|Death|2|||
37638038|NCT00739401|69105776|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
37638039|NCT00739401|69105776|FG000|Overall Study|Death|3|||
37638040|NCT00739401|69105776|FG000|Overall Study|Withdrawal by Subject|4|||
37638041|NCT01365052|69105782|FG000|Overall Study|Adverse Event|4|||
37638042|NCT01365052|69105783|FG001|Overall Study|Adverse Event|4|||
37638043|NCT01372748|69105791|FG000|Overall Study|Lost to Follow-up|16|||
37638044|NCT01372748|69105792|FG001|Overall Study|Lost to Follow-up|34|||
37638045|NCT01372748|69105791|FG000|Overall Study|Withdrawal by Subject|7|||
37740380|NCT01425723|69226062|FG001|Overall Study|Physician Decision|0|||
37740381|NCT01425723|69226061|FG000|Overall Study|Other|1|||
37740382|NCT01425723|69226062|FG001|Overall Study|Other|10|||
37638046|NCT01372748|69105792|FG001|Overall Study|Withdrawal by Subject|5|||
37740383|NCT01424397|69226093|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
37740384|NCT01424397|69226094|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
37740385|NCT01424397|69226095|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
37740386|NCT01424397|69226096|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
37740387|NCT01424397|69226097|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
37740388|NCT01424397|69226098|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
37740389|NCT01424397|69226099|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
37740390|NCT01424397|69226100|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
37638047|NCT02736825|69105800|FG000|Overall Study|Lost to Follow-up|10|||
37638048|NCT02736825|69105801|FG001|Overall Study|Lost to Follow-up|11|||
37638049|NCT02736825|69105800|FG000|Overall Study|Early Termination|0|||
37638050|NCT02736825|69105801|FG001|Overall Study|Early Termination|1|||
37638051|NCT02670122|69105808|FG000|Overall Study|Lost to Follow-up|4|||
37740391|NCT01424397|69226101|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
37740392|NCT01424397|69226102|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
37740393|NCT01424397|69226103|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
37740394|NCT01424397|69226104|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
37740395|NCT01392963|69226120|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
37740396|NCT01392963|69226121|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
37740397|NCT01392963|69226120|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
37740398|NCT01392963|69226121|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
37740399|NCT01392963|69226120|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
37740400|NCT01392963|69226121|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
37740401|NCT01392573|69226131|FG000|Overall Study|Adverse Event|1|||
37740402|NCT01392573|69226132|FG001|Overall Study|Adverse Event|3|||
37740403|NCT01392573|69226131|FG000|Overall Study|Lack of Efficacy|1|||
37740404|NCT01392573|69226132|FG001|Overall Study|Lack of Efficacy|2|||
37740405|NCT01392573|69226131|FG000|Overall Study|Protocol Violation|0|||
37740406|NCT01392573|69226132|FG001|Overall Study|Protocol Violation|2|||
37740407|NCT01392573|69226131|FG000|Overall Study|Withdrawal Criteria|13|||
37740408|NCT01392573|69226132|FG001|Overall Study|Withdrawal Criteria|15|||
37740409|NCT01392573|69226131|FG000|Overall Study|Site closure|8|||
37740410|NCT01392573|69226132|FG001|Overall Study|Site closure|7|||
37740411|NCT01392573|69226131|FG000|Overall Study|Unclassified|9|||
37740412|NCT01392573|69226132|FG001|Overall Study|Unclassified|6|||
37740413|NCT01392495|69226138|FG000|Overall Study|Death|3|||
37740414|NCT01392495|69226138|FG000|Overall Study|Administrative problems|8|||
37740415|NCT01392495|69226138|FG000|Overall Study|Withdrawal by Subject|2|||
37740416|NCT01392495|69226138|FG000|Overall Study|Adverse Event|3|||
37740417|NCT01405053|69226146|FG000|Overall Study|Adverse Event|3|||
37740418|NCT01405053|69226147|FG001|Overall Study|Adverse Event|0|||
37740419|NCT01405053|69226146|FG000|Overall Study|Lost to Follow-up|0|||
37740420|NCT01405053|69226147|FG001|Overall Study|Lost to Follow-up|1|||
37740421|NCT01405053|69226146|FG000|Overall Study|Participant choice|2|||
37740422|NCT01405053|69226147|FG001|Overall Study|Participant choice|1|||
37740423|NCT01405053|69226146|FG000|Overall Study|Inadequate therapeutic effect|2|||
37740424|NCT01405053|69226147|FG001|Overall Study|Inadequate therapeutic effect|1|||
37740425|NCT01405053|69226146|FG000|Overall Study|Withdrawal by Subject|3|||
37740426|NCT01405053|69226147|FG001|Overall Study|Withdrawal by Subject|4|||
37740427|NCT01405053|69226146|FG000|Overall Study|Other|0|||
37740428|NCT01405053|69226147|FG001|Overall Study|Other|1|||
37740429|NCT01403805|69226155|FG000|Overall Study|Withdrawal by Subject|0|||
37740430|NCT01403805|69226156|FG001|Overall Study|Withdrawal by Subject|4|||
37740431|NCT01403805|69226155|FG000|Overall Study|Lost to Follow-up|0|||
37740432|NCT01403805|69226156|FG001|Overall Study|Lost to Follow-up|2|||
37740433|NCT01403805|69226155|FG000|Overall Study|Death|0|||
37740434|NCT01403805|69226156|FG001|Overall Study|Death|1|||
37740435|NCT01423617|69226168|FG000|Overall Study|Lost to Follow-up|0|||
37740436|NCT01423617|69226169|FG001|Overall Study|Lost to Follow-up|1|||
37740437|NCT01392183|69226177|FG000|First Drug Administration|Adverse Event|3|||
37740438|NCT01392183|69226178|FG001|First Drug Administration|Adverse Event|2|||
37740439|NCT01392183|69226177|FG000|First Drug Administration|Death|1|||
37740440|NCT01392183|69226178|FG001|First Drug Administration|Death|0|||
37740441|NCT01392183|69226177|FG000|First Drug Administration|Withdrawal by Subject|10|||
37740442|NCT01392183|69226178|FG001|First Drug Administration|Withdrawal by Subject|17|||
37740443|NCT01402947|69226188|FG000|First Intervention|Adverse Event|0|||
37740444|NCT01402947|69226189|FG001|First Intervention|Adverse Event|1|||
37740445|NCT01402869|69226198|FG000|Overall Study|Required Tooth Extraction|0|||
37740446|NCT01402869|69226199|FG001|Overall Study|Required Tooth Extraction|0|||
37740447|NCT01402869|69226200|FG002|Overall Study|Required Tooth Extraction|1|||
37740448|NCT01391793|69226210|FG000|Overall Study|Ineligible|3|||
37740449|NCT01391793|69226211|FG001|Overall Study|Ineligible|0|||
37740450|NCT01391793|69226210|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
37740451|NCT01391793|69226211|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
37638052|NCT03283371|69105821|FG000|Placebo-controlled|Adverse Event|1|||
37740452|NCT01391793|69226210|FG000|Overall Study|No DMSA|73|||
37740453|NCT01391793|69226211|FG001|Overall Study|No DMSA|57|||
37740454|NCT01422915|69226217|FG000|Overall Study|Adverse Event|1|||
37740455|NCT01727024|69226222|FG000|Period 1|Lost to Follow-up|1|||
37740456|NCT01727024|69226223|FG001|Period 1|Lost to Follow-up|1|||
37740457|NCT01727024|69226222|FG000|Period 1|Withdrawal by Subject|2|||
37740458|NCT01727024|69226223|FG001|Period 1|Withdrawal by Subject|3|||
37854329|NCT01232283|69537961|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
37638053|NCT03283371|69105822|FG001|Placebo-controlled|Adverse Event|1|||
37740459|NCT01422213|69226232|FG000|Overall Study|Adverse Event|8|||
37740460|NCT01422213|69226233|FG001|Overall Study|Adverse Event|7|||
37740461|NCT01422213|69226234|FG002|Overall Study|Adverse Event|11|||
37638054|NCT03283371|69105823|FG002|Placebo-controlled|Adverse Event|0|||
37740462|NCT01422213|69226232|FG000|Overall Study|Lack of Efficacy|10|||
37740463|NCT01422213|69226233|FG001|Overall Study|Lack of Efficacy|2|||
37740464|NCT01422213|69226234|FG002|Overall Study|Lack of Efficacy|2|||
37740465|NCT01422213|69226232|FG000|Overall Study|Non-compliance with study drug|0|||
37740466|NCT01422213|69226233|FG001|Overall Study|Non-compliance with study drug|1|||
37740467|NCT01422213|69226234|FG002|Overall Study|Non-compliance with study drug|0|||
37740468|NCT01422213|69226232|FG000|Overall Study|Protocol Violation|0|||
37740469|NCT01422213|69226233|FG001|Overall Study|Protocol Violation|2|||
37740470|NCT01422213|69226234|FG002|Overall Study|Protocol Violation|4|||
37740471|NCT01422213|69226232|FG000|Overall Study|Withdrawal of Consent|7|||
37740472|NCT01422213|69226233|FG001|Overall Study|Withdrawal of Consent|3|||
37740473|NCT01422213|69226234|FG002|Overall Study|Withdrawal of Consent|5|||
37740474|NCT01422213|69226232|FG000|Overall Study|Lost to Follow-up|3|||
37740475|NCT01422213|69226233|FG001|Overall Study|Lost to Follow-up|3|||
37740476|NCT01422213|69226234|FG002|Overall Study|Lost to Follow-up|5|||
37740477|NCT01422213|69226232|FG000|Overall Study|Administrative or Other Reason(s)|5|||
37638055|NCT03283371|69105824|FG003|Placebo-controlled|Adverse Event|0|||
37638056|NCT03283371|69105821|FG000|Placebo-controlled|Lack of Efficacy|1|||
37638057|NCT03283371|69105822|FG001|Placebo-controlled|Lack of Efficacy|0|||
37740478|NCT01422213|69226233|FG001|Overall Study|Administrative or Other Reason(s)|4|||
37740479|NCT01422213|69226234|FG002|Overall Study|Administrative or Other Reason(s)|2|||
37740480|NCT01390857|69226242|FG000|Overall Study|Protocol Violation|2|||
37740481|NCT01390857|69226242|FG000|Overall Study|Lost to Follow-up|1|||
37740482|NCT01390857|69226242|FG000|Overall Study|No Visit after the First Visit|7|||
37740483|NCT01725386|69226248|FG000|Overall Study|Death|84|||
37740484|NCT01725386|69226249|FG001|Overall Study|Death|40|||
37740485|NCT01725386|69226248|FG000|Overall Study|Lost to Follow-up|81|||
37740486|NCT01725386|69226249|FG001|Overall Study|Lost to Follow-up|6|||
37740487|NCT01725386|69226248|FG000|Overall Study|Withdrawal by Subject|10|||
37740488|NCT01725386|69226249|FG001|Overall Study|Withdrawal by Subject|0|||
37740489|NCT01402011|69226258|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
37740490|NCT01402011|69226259|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
37740491|NCT01402011|69226260|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
37740492|NCT01402011|69226258|FG000|Active Treatment Period|Withdrawal by Subject|1|||
37740493|NCT01402011|69226259|FG001|Active Treatment Period|Withdrawal by Subject|3|||
37740494|NCT01402011|69226260|FG002|Active Treatment Period|Withdrawal by Subject|0|||
37740495|NCT01402011|69226258|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
37740496|NCT01402011|69226259|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
37854330|NCT01232283|69537952|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
37854331|NCT01232283|69537953|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
37854332|NCT01232283|69537954|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
37854333|NCT01232283|69537955|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
37854334|NCT01232283|69537956|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
37854335|NCT01232283|69537957|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
37854336|NCT01232283|69537958|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
37854337|NCT01232283|69537959|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
37921930|NCT00667810|69608724|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
37740497|NCT01402011|69226260|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
37740498|NCT01421667|69226275|FG000|Overall Study|Withdrawal by Subject|0|||
37740499|NCT01421667|69226276|FG001|Overall Study|Withdrawal by Subject|1|||
37740500|NCT01421667|69226277|FG002|Overall Study|Withdrawal by Subject|2|||
37740501|NCT01421667|69226278|FG003|Overall Study|Withdrawal by Subject|1|||
37740502|NCT01421667|69226275|FG000|Overall Study|Lost to Follow-up|0|||
37740503|NCT01421667|69226276|FG001|Overall Study|Lost to Follow-up|1|||
37740504|NCT01421667|69226277|FG002|Overall Study|Lost to Follow-up|0|||
37740505|NCT01421667|69226278|FG003|Overall Study|Lost to Follow-up|0|||
37740506|NCT01390779|69226296|FG000|Overall Study|Physician Decision|1|||
37740507|NCT01891669|69226310|FG000|Overall Study|Death|0|||
37740508|NCT01891669|69226311|FG001|Overall Study|Death|0|||
37740509|NCT01891669|69226312|FG002|Overall Study|Death|0|||
37921931|NCT00667810|69608725|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
37638058|NCT03283371|69105823|FG002|Placebo-controlled|Lack of Efficacy|0|||
37638059|NCT03283371|69105824|FG003|Placebo-controlled|Lack of Efficacy|0|||
37740510|NCT01891669|69226313|FG003|Overall Study|Death|0|||
37854338|NCT01232283|69537960|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
37854339|NCT01232283|69537961|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
37854340|NCT01232283|69537952|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
37854341|NCT01232283|69537953|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
37854342|NCT01232283|69537954|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
37854343|NCT01232283|69537955|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
37740511|NCT01891669|69226314|FG004|Overall Study|Death|0|||
37854344|NCT01232283|69537956|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
37638060|NCT03283371|69105821|FG000|Placebo-controlled|Withdrawal by Subject|1|||
37740512|NCT01891669|69226315|FG005|Overall Study|Death|0|||
37740513|NCT01891669|69226316|FG006|Overall Study|Death|0|||
37740514|NCT01891669|69226317|FG007|Overall Study|Death|1|||
37740515|NCT01891669|69226318|FG008|Overall Study|Death|0|||
37740516|NCT01891669|69226319|FG009|Overall Study|Death|1|||
37740517|NCT01891669|69226310|FG000|Overall Study|Withdrawal by Subject|1|||
37638061|NCT03283371|69105822|FG001|Placebo-controlled|Withdrawal by Subject|1|||
37638062|NCT03283371|69105823|FG002|Placebo-controlled|Withdrawal by Subject|0|||
37638063|NCT03283371|69105824|FG003|Placebo-controlled|Withdrawal by Subject|0|||
37638064|NCT03283371|69105821|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
37638065|NCT03283371|69105822|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
37638066|NCT03283371|69105823|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
37638067|NCT03283371|69105824|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
37638068|NCT03283371|69105821|FG000|Open-label Phase|Adverse Event|0|||
37638069|NCT03283371|69105822|FG001|Open-label Phase|Adverse Event|0|||
37638070|NCT03283371|69105823|FG002|Open-label Phase|Adverse Event|2|||
37638071|NCT03283371|69105824|FG003|Open-label Phase|Adverse Event|0|||
37638072|NCT03283371|69105821|FG000|Open-label Phase|Withdrawal by Subject|0|||
37638073|NCT03283371|69105822|FG001|Open-label Phase|Withdrawal by Subject|0|||
37638074|NCT03283371|69105823|FG002|Open-label Phase|Withdrawal by Subject|1|||
37638075|NCT03283371|69105824|FG003|Open-label Phase|Withdrawal by Subject|0|||
37638076|NCT03283371|69105821|FG000|Open-label Phase|Other|0|||
37638077|NCT03283371|69105822|FG001|Open-label Phase|Other|0|||
37638078|NCT03283371|69105823|FG002|Open-label Phase|Other|1|||
37638079|NCT03283371|69105824|FG003|Open-label Phase|Other|1|||
37638080|NCT03069417|69105836|FG000|Overall Study|Lost to Follow-up|2|||
37638081|NCT03069417|69105837|FG001|Overall Study|Lost to Follow-up|0|||
37638082|NCT03069417|69105836|FG000|Overall Study|Reason Unknown|4|||
37638083|NCT03069417|69105837|FG001|Overall Study|Reason Unknown|7|||
37638084|NCT04930263|69105846|FG000|Overall Study|Withdrawal by Subject|3|||
37638085|NCT04930263|69105847|FG001|Overall Study|Withdrawal by Subject|5|||
37638086|NCT02665286|69105856|FG000|Overall Study|Lost to Follow-up|3|||
37638087|NCT02665286|69105857|FG001|Overall Study|Lost to Follow-up|2|||
37638088|NCT02665286|69105858|FG002|Overall Study|Lost to Follow-up|1|||
37638089|NCT02911519|69105868|FG000|Overall Study|Lost to Follow-up|2|||
37638090|NCT02911519|69105869|FG001|Overall Study|Lost to Follow-up|2|||
37638091|NCT02911519|69105868|FG000|Overall Study|Death|0|||
37638092|NCT02911519|69105869|FG001|Overall Study|Death|2|||
37638093|NCT02911285|69105877|FG000|Overall Study|Lost to Follow-up|8|||
37638094|NCT02911285|69105878|FG001|Overall Study|Lost to Follow-up|5|||
37638095|NCT02911285|69105877|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
37638096|NCT02911285|69105878|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
37638097|NCT02910739|69105890|FG000|Overall Study|Adverse Event|1|||
37638098|NCT02910739|69105891|FG001|Overall Study|Adverse Event|0|||
37638099|NCT02910739|69105892|FG002|Overall Study|Adverse Event|0|||
37638100|NCT02910739|69105893|FG003|Overall Study|Adverse Event|0|||
37638101|NCT01069939|69105901|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
37638102|NCT01069939|69105902|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
37638103|NCT01069939|69105901|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
37638104|NCT01069939|69105902|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
37638105|NCT01069939|69105901|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
37638106|NCT01069939|69105902|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
37638107|NCT01069939|69105901|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
37638108|NCT01069939|69105902|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
37638109|NCT01069939|69105901|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
37638110|NCT01069939|69105902|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
37638111|NCT01069939|69105901|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
37638112|NCT01069939|69105902|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
37638113|NCT01069939|69105901|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
37638114|NCT01069939|69105902|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
37638115|NCT01069939|69105901|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
37638116|NCT01069939|69105902|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
37638117|NCT01069939|69105901|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
37638118|NCT01069939|69105902|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
37638119|NCT01069939|69105901|FG000|Randomised and Included in the Analyses|Removal|1|||
37740518|NCT01891669|69226311|FG001|Overall Study|Withdrawal by Subject|1|||
37921932|NCT00667810|69608726|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
37921933|NCT00667810|69608727|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
37921934|NCT00667810|69608724|FG000|Overall Study|Other|6|||
37638120|NCT01069939|69105902|FG001|Randomised and Included in the Analyses|Removal|0|||
37638121|NCT01069705|69105908|FG000|Overall Study|Adverse Event|1|||
37638122|NCT01069705|69105908|FG000|Overall Study|Withdrawal by Subject|2|||
37638123|NCT01069627|69105912|FG000|Overall Study|Disease progression|7|||
37638124|NCT01069627|69105912|FG000|Overall Study|Adverse Event|12|||
37638125|NCT01069627|69105912|FG000|Overall Study|Protocol Violation|1|||
37921935|NCT00667810|69608725|FG001|Overall Study|Other|6|||
37638154|NCT03021551|69105935|FG000|Overall Study|Equipment Issues|2|||
37638155|NCT03021551|69105935|FG000|Overall Study|Protocol Violation|1|||
37638156|NCT01585025|69105942|FG000|Overall Study|Withdrawal by Subject|0|||
37638157|NCT01585025|69105943|FG001|Overall Study|Withdrawal by Subject|3|||
37638158|NCT01585025|69105944|FG002|Overall Study|Withdrawal by Subject|4|||
37638159|NCT01068769|69105952|FG000|Overall Study|Ineligible|1|||
37638160|NCT05114564|69105971|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
37638161|NCT05114564|69105972|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
37638162|NCT05114564|69105971|FG000|First Intervention|Adverse Event|0|||
37638163|NCT05114564|69105972|FG001|First Intervention|Adverse Event|1|||
37638164|NCT04706416|69105980|FG000|Overall Study|Lost to Follow-up|2|||
37638165|NCT04706416|69105981|FG001|Overall Study|Lost to Follow-up|0|||
37638166|NCT04683926|69105994|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
37638167|NCT04683926|69105995|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
37638168|NCT04683926|69105996|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
37638169|NCT04683926|69105997|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
37638170|NCT04343755|69106009|FG000|Overall Study|Death|11|||
37638171|NCT04343755|69106009|FG000|Overall Study|Screen Failure|1|||
37638172|NCT04285346|69106013|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
37638173|NCT04285346|69106014|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
37638174|NCT04285346|69106013|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
37638175|NCT04285346|69106014|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
37638176|NCT04285346|69106013|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
37638177|NCT04285346|69106014|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
37638178|NCT04148287|69106029|FG000|Overall Study|Death|2|||
37638179|NCT03772613|69106057|FG000|Overall Study|Lost to Follow-up|0|||
37638180|NCT03772613|69106058|FG001|Overall Study|Lost to Follow-up|1|||
37638181|NCT03772613|69106059|FG002|Overall Study|Lost to Follow-up|1|||
37638182|NCT03739437|69106069|FG000|Overall Study|Lost to Follow-up|2|||
37638183|NCT03739437|69106070|FG001|Overall Study|Lost to Follow-up|5|||
37638184|NCT03730194|69106078|FG000|First Stage Treatment|Withdrawal by Subject|1|||
37638185|NCT03730194|69106079|FG001|First Stage Treatment|Withdrawal by Subject|1|||
37638186|NCT03730194|69106080|FG002|First Stage Treatment|Withdrawal by Subject|0|||
37638187|NCT03730194|69106081|FG003|First Stage Treatment|Withdrawal by Subject|0|||
37638188|NCT03730194|69106082|FG004|First Stage Treatment|Withdrawal by Subject|0|||
37638189|NCT03730194|69106083|FG005|First Stage Treatment|Withdrawal by Subject|0|||
37638190|NCT03730194|69106078|FG000|First Stage Treatment|Protocol Violation|3|||
37638191|NCT03730194|69106079|FG001|First Stage Treatment|Protocol Violation|3|||
37638192|NCT03730194|69106080|FG002|First Stage Treatment|Protocol Violation|0|||
37638193|NCT03730194|69106081|FG003|First Stage Treatment|Protocol Violation|0|||
37638194|NCT03730194|69106082|FG004|First Stage Treatment|Protocol Violation|0|||
37638195|NCT03730194|69106083|FG005|First Stage Treatment|Protocol Violation|0|||
37638196|NCT03701555|69106126|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
37638197|NCT03701555|69106127|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
37638198|NCT03701555|69106128|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
37638199|NCT03701555|69106129|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
37638200|NCT03701555|69106130|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
37638201|NCT03701555|69106131|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
37638202|NCT03701555|69106132|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
37638203|NCT03701555|69106133|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
37638204|NCT03701555|69106134|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
37638205|NCT03701555|69106135|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
37638206|NCT03701555|69106136|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
37638207|NCT03701555|69106137|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
37638208|NCT03701555|69106138|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
37638209|NCT03701555|69106139|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
37638210|NCT03701555|69106140|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
37638211|NCT03701555|69106141|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
37638212|NCT03701555|69106142|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
37638213|NCT03701555|69106143|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
37638214|NCT03701555|69106144|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
37638215|NCT03701555|69106145|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
37638216|NCT03701555|69106146|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
37638217|NCT03701555|69106147|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
37638218|NCT03701555|69106148|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
37638219|NCT03701555|69106149|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
37638220|NCT03701555|69106150|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
37638221|NCT03701555|69106151|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
37638222|NCT03701555|69106152|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
37638223|NCT03701555|69106153|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
37638224|NCT03701555|69106154|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
37638225|NCT03701555|69106155|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
37638226|NCT03701555|69106156|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
37638227|NCT03701555|69106157|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
37638228|NCT03701555|69106158|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
37638229|NCT03701555|69106159|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
37638230|NCT03701555|69106160|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
37638231|NCT03701555|69106161|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
37638232|NCT03701555|69106126|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
37638233|NCT03701555|69106127|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
37638234|NCT03701555|69106128|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
37638235|NCT03701555|69106129|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
37638236|NCT03701555|69106130|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
37638237|NCT03701555|69106131|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
37638238|NCT03701555|69106132|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
37638239|NCT03701555|69106133|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
37638240|NCT03701555|69106134|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
37638241|NCT03701555|69106135|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
37638242|NCT03701555|69106136|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
37638243|NCT03701555|69106137|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
37638244|NCT03701555|69106138|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
37638245|NCT03701555|69106139|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
37638246|NCT03701555|69106140|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
37638247|NCT03701555|69106141|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
37638248|NCT03701555|69106142|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
37638249|NCT03701555|69106143|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
37638250|NCT03701555|69106144|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
37638251|NCT03701555|69106145|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
37638252|NCT03701555|69106146|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
37638253|NCT03701555|69106147|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
37638254|NCT03701555|69106148|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
37638255|NCT03701555|69106149|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
37638256|NCT03701555|69106150|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
37638257|NCT03701555|69106151|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
37638258|NCT03701555|69106152|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
37638259|NCT03701555|69106153|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
37638260|NCT03701555|69106154|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
37638261|NCT03701555|69106155|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
37638262|NCT03701555|69106156|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
37638263|NCT03701555|69106157|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
37638264|NCT03701555|69106158|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
37638265|NCT03701555|69106159|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
37638266|NCT03701555|69106160|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
37638267|NCT03701555|69106161|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
37638268|NCT03701555|69106126|FG000|Part 2 (Day 1)|Other|0|||
37638269|NCT03701555|69106127|FG001|Part 2 (Day 1)|Other|0|||
37638270|NCT03701555|69106128|FG002|Part 2 (Day 1)|Other|0|||
37638271|NCT03701555|69106129|FG003|Part 2 (Day 1)|Other|0|||
37638272|NCT03701555|69106130|FG004|Part 2 (Day 1)|Other|0|||
37638273|NCT03701555|69106131|FG005|Part 2 (Day 1)|Other|0|||
37638274|NCT03701555|69106132|FG006|Part 2 (Day 1)|Other|0|||
37638275|NCT03701555|69106133|FG007|Part 2 (Day 1)|Other|0|||
37638276|NCT03701555|69106134|FG008|Part 2 (Day 1)|Other|0|||
37638277|NCT03701555|69106135|FG009|Part 2 (Day 1)|Other|0|||
37638278|NCT03701555|69106136|FG010|Part 2 (Day 1)|Other|3|||
37638279|NCT03701555|69106137|FG011|Part 2 (Day 1)|Other|1|||
37638280|NCT03701555|69106138|FG012|Part 2 (Day 1)|Other|0|||
37638281|NCT03701555|69106139|FG013|Part 2 (Day 1)|Other|1|||
37638282|NCT03701555|69106140|FG014|Part 2 (Day 1)|Other|0|||
37638283|NCT03701555|69106141|FG015|Part 2 (Day 1)|Other|2|||
37638284|NCT03701555|69106142|FG016|Part 2 (Day 1)|Other|2|||
37638285|NCT03701555|69106143|FG017|Part 2 (Day 1)|Other|0|||
37638286|NCT03701555|69106144|FG018|Part 2 (Day 1)|Other|0|||
37638287|NCT03701555|69106145|FG019|Part 2 (Day 1)|Other|0|||
37638288|NCT03701555|69106146|FG020|Part 2 (Day 1)|Other|0|||
37638289|NCT03701555|69106147|FG021|Part 2 (Day 1)|Other|0|||
37638290|NCT03701555|69106148|FG022|Part 2 (Day 1)|Other|0|||
37638291|NCT03701555|69106149|FG023|Part 2 (Day 1)|Other|0|||
37638292|NCT03701555|69106150|FG024|Part 2 (Day 1)|Other|0|||
37638293|NCT03701555|69106151|FG025|Part 2 (Day 1)|Other|0|||
37638294|NCT03701555|69106152|FG026|Part 2 (Day 1)|Other|0|||
37638295|NCT03701555|69106153|FG027|Part 2 (Day 1)|Other|0|||
37638296|NCT03701555|69106154|FG028|Part 2 (Day 1)|Other|0|||
37638297|NCT03701555|69106155|FG029|Part 2 (Day 1)|Other|0|||
37638298|NCT03701555|69106156|FG030|Part 2 (Day 1)|Other|0|||
37638299|NCT03701555|69106157|FG031|Part 2 (Day 1)|Other|0|||
37638300|NCT03701555|69106158|FG032|Part 2 (Day 1)|Other|0|||
37638301|NCT03701555|69106159|FG033|Part 2 (Day 1)|Other|0|||
37638302|NCT03701555|69106160|FG034|Part 2 (Day 1)|Other|0|||
37638303|NCT03701555|69106161|FG035|Part 2 (Day 1)|Other|0|||
37638304|NCT03701555|69106126|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
37638305|NCT03701555|69106127|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
37638306|NCT03701555|69106128|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
37638307|NCT03701555|69106129|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
37638308|NCT03701555|69106130|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
37638309|NCT03701555|69106131|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
37638310|NCT03701555|69106132|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
37638311|NCT03701555|69106133|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
37638312|NCT03701555|69106134|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
37638313|NCT03701555|69106135|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
37638314|NCT03701555|69106136|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
37638315|NCT03701555|69106137|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
37638316|NCT03701555|69106138|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
37638317|NCT03701555|69106139|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
37638318|NCT03701555|69106140|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
37638319|NCT03701555|69106141|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
37638320|NCT03701555|69106142|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
37638321|NCT03701555|69106143|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
37638322|NCT03701555|69106144|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
37638323|NCT03701555|69106145|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
37638324|NCT03701555|69106146|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
37638325|NCT03701555|69106147|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
37638326|NCT03701555|69106148|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
37638327|NCT03701555|69106149|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
37638328|NCT03701555|69106150|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
37638329|NCT03701555|69106151|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
37638330|NCT03701555|69106152|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
37638331|NCT03701555|69106153|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
37638332|NCT03701555|69106154|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
37638333|NCT03701555|69106155|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
37638334|NCT03701555|69106156|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
37638335|NCT03701555|69106157|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
37638336|NCT03701555|69106158|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
37638337|NCT03701555|69106159|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
37638338|NCT03701555|69106160|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
37638339|NCT03701555|69106161|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
37638340|NCT03701555|69106126|FG000|Part 3 (Day 1)|Subject Decision|0|||
37638341|NCT03701555|69106127|FG001|Part 3 (Day 1)|Subject Decision|0|||
37638342|NCT03701555|69106128|FG002|Part 3 (Day 1)|Subject Decision|0|||
37638343|NCT03701555|69106129|FG003|Part 3 (Day 1)|Subject Decision|0|||
37638344|NCT03701555|69106130|FG004|Part 3 (Day 1)|Subject Decision|0|||
37638345|NCT03701555|69106131|FG005|Part 3 (Day 1)|Subject Decision|0|||
37638346|NCT03701555|69106132|FG006|Part 3 (Day 1)|Subject Decision|0|||
37740519|NCT01891669|69226312|FG002|Overall Study|Withdrawal by Subject|0|||
37638347|NCT03701555|69106133|FG007|Part 3 (Day 1)|Subject Decision|0|||
37740520|NCT01891669|69226313|FG003|Overall Study|Withdrawal by Subject|0|||
37638348|NCT03701555|69106134|FG008|Part 3 (Day 1)|Subject Decision|0|||
37638349|NCT03701555|69106135|FG009|Part 3 (Day 1)|Subject Decision|0|||
37638350|NCT03701555|69106136|FG010|Part 3 (Day 1)|Subject Decision|0|||
37638351|NCT03701555|69106137|FG011|Part 3 (Day 1)|Subject Decision|0|||
37638352|NCT03701555|69106138|FG012|Part 3 (Day 1)|Subject Decision|0|||
37740521|NCT01891669|69226314|FG004|Overall Study|Withdrawal by Subject|0|||
37638353|NCT03701555|69106139|FG013|Part 3 (Day 1)|Subject Decision|0|||
37638354|NCT03701555|69106140|FG014|Part 3 (Day 1)|Subject Decision|0|||
37638355|NCT03701555|69106141|FG015|Part 3 (Day 1)|Subject Decision|0|||
37638356|NCT03701555|69106142|FG016|Part 3 (Day 1)|Subject Decision|0|||
37638357|NCT03701555|69106143|FG017|Part 3 (Day 1)|Subject Decision|0|||
37638358|NCT03701555|69106144|FG018|Part 3 (Day 1)|Subject Decision|0|||
37638359|NCT03701555|69106145|FG019|Part 3 (Day 1)|Subject Decision|0|||
37638360|NCT03701555|69106146|FG020|Part 3 (Day 1)|Subject Decision|0|||
37638361|NCT03701555|69106147|FG021|Part 3 (Day 1)|Subject Decision|0|||
37638362|NCT03701555|69106148|FG022|Part 3 (Day 1)|Subject Decision|0|||
37638363|NCT03701555|69106149|FG023|Part 3 (Day 1)|Subject Decision|0|||
37638364|NCT03701555|69106150|FG024|Part 3 (Day 1)|Subject Decision|0|||
37638365|NCT03701555|69106151|FG025|Part 3 (Day 1)|Subject Decision|0|||
37638366|NCT03701555|69106152|FG026|Part 3 (Day 1)|Subject Decision|1|||
37638367|NCT03701555|69106153|FG027|Part 3 (Day 1)|Subject Decision|0|||
37638368|NCT03701555|69106154|FG028|Part 3 (Day 1)|Subject Decision|0|||
37638369|NCT03701555|69106155|FG029|Part 3 (Day 1)|Subject Decision|0|||
37638370|NCT03701555|69106156|FG030|Part 3 (Day 1)|Subject Decision|0|||
37638371|NCT03701555|69106157|FG031|Part 3 (Day 1)|Subject Decision|2|||
37638372|NCT03701555|69106158|FG032|Part 3 (Day 1)|Subject Decision|1|||
37638373|NCT03701555|69106159|FG033|Part 3 (Day 1)|Subject Decision|1|||
37638374|NCT03701555|69106160|FG034|Part 3 (Day 1)|Subject Decision|0|||
37638375|NCT03701555|69106161|FG035|Part 3 (Day 1)|Subject Decision|0|||
37638376|NCT03701555|69106126|FG000|Part 3 (Day 1)|Other|0|||
37638377|NCT03701555|69106127|FG001|Part 3 (Day 1)|Other|0|||
37638378|NCT03701555|69106128|FG002|Part 3 (Day 1)|Other|0|||
37638379|NCT03701555|69106129|FG003|Part 3 (Day 1)|Other|0|||
37638380|NCT03701555|69106130|FG004|Part 3 (Day 1)|Other|0|||
37638381|NCT03701555|69106131|FG005|Part 3 (Day 1)|Other|0|||
37638382|NCT03701555|69106132|FG006|Part 3 (Day 1)|Other|0|||
37638383|NCT03701555|69106133|FG007|Part 3 (Day 1)|Other|0|||
37638384|NCT03701555|69106134|FG008|Part 3 (Day 1)|Other|0|||
37638385|NCT03701555|69106135|FG009|Part 3 (Day 1)|Other|0|||
37638386|NCT03701555|69106136|FG010|Part 3 (Day 1)|Other|0|||
37638387|NCT03701555|69106137|FG011|Part 3 (Day 1)|Other|0|||
37638388|NCT03701555|69106138|FG012|Part 3 (Day 1)|Other|0|||
37638389|NCT03701555|69106139|FG013|Part 3 (Day 1)|Other|0|||
37638390|NCT03701555|69106140|FG014|Part 3 (Day 1)|Other|0|||
37638391|NCT03701555|69106141|FG015|Part 3 (Day 1)|Other|0|||
37638392|NCT03701555|69106142|FG016|Part 3 (Day 1)|Other|0|||
37638393|NCT03701555|69106143|FG017|Part 3 (Day 1)|Other|0|||
37638394|NCT03701555|69106144|FG018|Part 3 (Day 1)|Other|0|||
37638395|NCT03701555|69106145|FG019|Part 3 (Day 1)|Other|0|||
37638396|NCT03701555|69106146|FG020|Part 3 (Day 1)|Other|0|||
37638397|NCT03701555|69106147|FG021|Part 3 (Day 1)|Other|0|||
37638398|NCT03701555|69106148|FG022|Part 3 (Day 1)|Other|0|||
37638399|NCT03701555|69106149|FG023|Part 3 (Day 1)|Other|0|||
37638400|NCT03701555|69106150|FG024|Part 3 (Day 1)|Other|1|||
37638401|NCT03701555|69106151|FG025|Part 3 (Day 1)|Other|1|||
37638402|NCT03701555|69106152|FG026|Part 3 (Day 1)|Other|0|||
37638403|NCT03701555|69106153|FG027|Part 3 (Day 1)|Other|0|||
37638404|NCT03701555|69106154|FG028|Part 3 (Day 1)|Other|0|||
37638405|NCT03701555|69106155|FG029|Part 3 (Day 1)|Other|1|||
37638406|NCT03701555|69106156|FG030|Part 3 (Day 1)|Other|1|||
37638407|NCT03701555|69106157|FG031|Part 3 (Day 1)|Other|0|||
37638408|NCT03701555|69106158|FG032|Part 3 (Day 1)|Other|1|||
37638409|NCT03701555|69106159|FG033|Part 3 (Day 1)|Other|1|||
37638410|NCT03701555|69106160|FG034|Part 3 (Day 1)|Other|0|||
37638411|NCT03701555|69106161|FG035|Part 3 (Day 1)|Other|0|||
37638412|NCT02178098|69106297|FG000|Overall Study|Withdrawal by Subject|0|||
37638413|NCT02178098|69106298|FG001|Overall Study|Withdrawal by Subject|6|||
37638414|NCT02178098|69106297|FG000|Overall Study|Adverse Event|1|||
37638415|NCT02178098|69106298|FG001|Overall Study|Adverse Event|2|||
37854345|NCT01232283|69537957|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
37638416|NCT02178098|69106297|FG000|Overall Study|Protocol Violation|1|||
37638417|NCT02178098|69106298|FG001|Overall Study|Protocol Violation|1|||
37638418|NCT02178098|69106297|FG000|Overall Study|Lost to Follow-up|0|||
37638419|NCT02178098|69106298|FG001|Overall Study|Lost to Follow-up|1|||
37854346|NCT01232283|69537958|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
37638420|NCT02178098|69106297|FG000|Overall Study|Sponsor Request|1|||
37638421|NCT02178098|69106298|FG001|Overall Study|Sponsor Request|0|||
37740522|NCT01891669|69226315|FG005|Overall Study|Withdrawal by Subject|0|||
37638422|NCT02178098|69106297|FG000|Overall Study|Other|2|||
37638423|NCT02178098|69106298|FG001|Overall Study|Other|2|||
37638424|NCT01915498|69106324|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
37638425|NCT01915498|69106325|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
37638426|NCT01915498|69106326|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
37638427|NCT01915498|69106327|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
37638428|NCT01915498|69106328|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
37638429|NCT01915498|69106329|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
37638430|NCT01915498|69106330|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
37638431|NCT01915498|69106331|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
37638432|NCT01915498|69106332|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
37638433|NCT01915498|69106333|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
37638434|NCT01915498|69106334|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
37638435|NCT01915498|69106335|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
37638436|NCT01915498|69106336|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
37638437|NCT01915498|69106337|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
37638438|NCT01915498|69106338|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
37638439|NCT01915498|69106339|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
37638440|NCT01915498|69106340|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
37638441|NCT01915498|69106341|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
37638442|NCT01915498|69106342|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
37638443|NCT01915498|69106324|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
37638444|NCT01915498|69106325|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
37638445|NCT01915498|69106326|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
37638446|NCT01915498|69106327|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
37638447|NCT01915498|69106328|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
37638448|NCT01915498|69106329|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
37638449|NCT01915498|69106330|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
37638450|NCT01915498|69106331|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
37638451|NCT01915498|69106332|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
37638452|NCT01915498|69106333|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
37638453|NCT01915498|69106334|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
37638454|NCT01915498|69106335|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
37638455|NCT01915498|69106336|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
37638456|NCT01915498|69106337|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
37638457|NCT01915498|69106338|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
37638458|NCT01915498|69106339|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
37740523|NCT01891669|69226316|FG006|Overall Study|Withdrawal by Subject|1|||
37740524|NCT01891669|69226317|FG007|Overall Study|Withdrawal by Subject|2|||
37740525|NCT01891669|69226318|FG008|Overall Study|Withdrawal by Subject|1|||
37740526|NCT01891669|69226319|FG009|Overall Study|Withdrawal by Subject|1|||
37740527|NCT01891669|69226310|FG000|Overall Study|Other|1|||
37740528|NCT01891669|69226311|FG001|Overall Study|Other|0|||
37740529|NCT01891669|69226312|FG002|Overall Study|Other|0|||
37740530|NCT01891669|69226313|FG003|Overall Study|Other|0|||
37740531|NCT01891669|69226314|FG004|Overall Study|Other|0|||
37740532|NCT01891669|69226315|FG005|Overall Study|Other|0|||
37740533|NCT01891669|69226316|FG006|Overall Study|Other|0|||
37740534|NCT01891669|69226317|FG007|Overall Study|Other|1|||
37740535|NCT01891669|69226318|FG008|Overall Study|Other|0|||
37740536|NCT01891669|69226319|FG009|Overall Study|Other|0|||
37740537|NCT01421511|69226352|FG000|Overall Study|Lost to Follow-up|11|||
37740538|NCT01421511|69226353|FG001|Overall Study|Lost to Follow-up|14|||
37740539|NCT01421511|69226352|FG000|Overall Study|Randomized but didn't receive study drug|1|||
37740540|NCT01421511|69226353|FG001|Overall Study|Randomized but didn't receive study drug|7|||
37740541|NCT01421511|69226352|FG000|Overall Study|Physician Decision|0|||
37740542|NCT01421511|69226353|FG001|Overall Study|Physician Decision|1|||
37740543|NCT01421511|69226352|FG000|Overall Study|Withdrawal by Subject|6|||
37740544|NCT01421511|69226353|FG001|Overall Study|Withdrawal by Subject|5|||
37740545|NCT01421511|69226352|FG000|Overall Study|Death|1|||
37740546|NCT01421511|69226353|FG001|Overall Study|Death|1|||
37740547|NCT01864525|69226362|FG000|Overall Study|Adverse Event|1|||
37740548|NCT01864525|69226363|FG001|Overall Study|Adverse Event|0|||
37740549|NCT01421277|69226371|FG000|Overall Study|Lack of qualifying event|0|||
37740550|NCT01421277|69226372|FG001|Overall Study|Lack of qualifying event|61|||
37740551|NCT01421277|69226371|FG000|Overall Study|Incomplete baseline data|0|||
37740552|NCT01421277|69226372|FG001|Overall Study|Incomplete baseline data|31|||
37740553|NCT01891357|69226378|FG000|Overall Study|Protocol Violation|3|||
37740554|NCT01420965|69226385|FG000|Overall Study|Withdrawal by Subject|1|||
37740555|NCT01420965|69226386|FG001|Overall Study|Withdrawal by Subject|0|||
37740556|NCT01420965|69226387|FG002|Overall Study|Withdrawal by Subject|0|||
37740557|NCT01420965|69226385|FG000|Overall Study|Adverse Event|0|||
37740558|NCT01420965|69226386|FG001|Overall Study|Adverse Event|1|||
37740559|NCT01420965|69226387|FG002|Overall Study|Adverse Event|0|||
37740560|NCT01390389|69226397|FG000|Overall Study|Withdrawal by Subject|2|||
37740561|NCT01390389|69226398|FG001|Overall Study|Withdrawal by Subject|0|||
37740562|NCT01390389|69226397|FG000|Overall Study|Screen Fail|2|||
38032080|NCT02849080|69718000|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
37740563|NCT01390389|69226398|FG001|Overall Study|Screen Fail|1|||
38032081|NCT02849080|69718001|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
37740564|NCT01401465|69226410|FG000|Treatment Period 1|Adverse Event|4|||
37740565|NCT01401465|69226411|FG001|Treatment Period 1|Adverse Event|1|||
37740566|NCT01401465|69226410|FG000|Treatment Period 1|Pregnancy|0|||
37638459|NCT01915498|69106340|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
37638460|NCT01915498|69106341|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
37638461|NCT01915498|69106342|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
37638462|NCT01915498|69106324|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
37638463|NCT01915498|69106325|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
37638464|NCT01915498|69106326|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
37638465|NCT01915498|69106327|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
37638466|NCT01915498|69106328|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
37638467|NCT01915498|69106329|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
37638468|NCT01915498|69106330|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
37638469|NCT01915498|69106331|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
37638470|NCT01915498|69106332|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
37638471|NCT01915498|69106333|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
37638472|NCT01915498|69106334|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
37638473|NCT01915498|69106335|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
37638474|NCT01915498|69106336|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
37638475|NCT01915498|69106337|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
37638476|NCT01915498|69106338|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
37638477|NCT01915498|69106339|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
37638478|NCT01915498|69106340|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
37638479|NCT01915498|69106341|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
37638480|NCT01915498|69106342|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
37638481|NCT01915498|69106324|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
37638482|NCT01915498|69106325|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
37638483|NCT01915498|69106326|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
37638484|NCT01915498|69106327|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
37638485|NCT01915498|69106328|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
37638486|NCT01915498|69106329|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
37638487|NCT01915498|69106330|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
37638488|NCT01915498|69106331|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
37638489|NCT01915498|69106332|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
37638490|NCT01915498|69106333|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
37638491|NCT01915498|69106334|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
37638492|NCT01915498|69106335|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
37638493|NCT01915498|69106336|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
37638494|NCT01915498|69106337|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
37638495|NCT01915498|69106338|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
37638496|NCT01915498|69106339|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
37638497|NCT01915498|69106340|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
37638498|NCT01915498|69106341|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
37638499|NCT01915498|69106342|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
37638500|NCT01915498|69106324|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
37638501|NCT01915498|69106325|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
37638502|NCT01915498|69106326|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
37638503|NCT01915498|69106327|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
37638504|NCT01915498|69106328|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
37638505|NCT01915498|69106329|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
37638506|NCT01915498|69106330|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
37638507|NCT01915498|69106331|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
37638508|NCT01915498|69106332|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
37638509|NCT01915498|69106333|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
37638510|NCT01915498|69106334|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
37740567|NCT01401465|69226411|FG001|Treatment Period 1|Pregnancy|1|||
37740568|NCT01401465|69226410|FG000|Treatment Period 1|Protocol Violation|5|||
37740569|NCT01401465|69226411|FG001|Treatment Period 1|Protocol Violation|0|||
38032082|NCT02849080|69717998|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
38032083|NCT02849080|69717999|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
38032084|NCT02849080|69718000|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
38032085|NCT02849080|69718001|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
38032086|NCT02849080|69717998|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
37638511|NCT01915498|69106335|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
37638512|NCT01915498|69106336|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
37638513|NCT01915498|69106337|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
37638514|NCT01915498|69106338|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
37638515|NCT01915498|69106339|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
37638516|NCT01915498|69106340|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
37638517|NCT01915498|69106341|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
37740570|NCT01401465|69226410|FG000|Treatment Period 1|Withdrawal by Subject|1|||
37638518|NCT01915498|69106342|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
37638519|NCT01915498|69106324|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
37638520|NCT01915498|69106325|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
37638521|NCT01915498|69106326|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
37638522|NCT01915498|69106327|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
37638523|NCT01915498|69106328|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
37638524|NCT01915498|69106329|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
37638525|NCT01915498|69106330|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
37638526|NCT01915498|69106331|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
37638527|NCT01915498|69106332|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
37638528|NCT01915498|69106333|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
37638529|NCT01915498|69106334|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
37638530|NCT01915498|69106335|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
37638531|NCT01915498|69106336|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
37638532|NCT01915498|69106337|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
37638533|NCT01915498|69106338|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
37638534|NCT01915498|69106339|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
37638535|NCT01915498|69106340|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
37638536|NCT01915498|69106341|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
37638537|NCT01915498|69106342|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
37638538|NCT01915498|69106324|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
37638539|NCT01915498|69106325|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
37638540|NCT01915498|69106326|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
37638541|NCT01915498|69106327|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
37638542|NCT01915498|69106328|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
37638543|NCT01915498|69106329|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
37638544|NCT01915498|69106330|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
37638545|NCT01915498|69106331|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
37638546|NCT01915498|69106332|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
37638547|NCT01915498|69106333|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
37638548|NCT01915498|69106334|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
37638549|NCT01915498|69106335|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
37638550|NCT01915498|69106336|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
37638551|NCT01915498|69106337|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
37638552|NCT01915498|69106338|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
37638553|NCT01915498|69106339|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
37638554|NCT01915498|69106340|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
37638555|NCT01915498|69106341|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
37638556|NCT01915498|69106342|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
37638557|NCT01915498|69106324|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
37638558|NCT01915498|69106325|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
37638559|NCT01915498|69106326|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
37638560|NCT01915498|69106327|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
37638561|NCT01915498|69106328|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
37638562|NCT01915498|69106329|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
37638563|NCT01915498|69106330|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
37638564|NCT01915498|69106331|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
37638565|NCT01915498|69106332|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
37638566|NCT01915498|69106333|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
37638567|NCT01915498|69106334|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
37638568|NCT01915498|69106335|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
37638569|NCT01915498|69106336|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
37638570|NCT01915498|69106337|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
37638571|NCT01915498|69106338|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
37638572|NCT01915498|69106339|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
37740571|NCT01401465|69226411|FG001|Treatment Period 1|Withdrawal by Subject|4|||
37740572|NCT01401465|69226410|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
37740573|NCT01401465|69226411|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
37740574|NCT01401465|69226410|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
37740575|NCT01401465|69226411|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
37638573|NCT01915498|69106340|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
37638574|NCT01915498|69106341|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
37638575|NCT01915498|69106342|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
37638576|NCT01915498|69106324|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
37638577|NCT01915498|69106325|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
37638578|NCT01915498|69106326|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
37638579|NCT01915498|69106327|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
37638580|NCT01915498|69106328|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
37638581|NCT01915498|69106329|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
37638582|NCT01915498|69106330|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
37638583|NCT01915498|69106331|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
37638584|NCT01915498|69106332|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
37638585|NCT01915498|69106333|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
37638586|NCT01915498|69106334|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
37638587|NCT01915498|69106335|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
37638588|NCT01915498|69106336|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
37638589|NCT01915498|69106337|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
37638590|NCT01915498|69106338|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
37638591|NCT01915498|69106339|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
37638592|NCT01915498|69106340|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
37638593|NCT01915498|69106341|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
37638594|NCT01915498|69106342|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
37638595|NCT01915498|69106324|FG000|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1|||
37638596|NCT01915498|69106325|FG001|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
37638597|NCT01915498|69106326|FG002|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
37638598|NCT01915498|69106327|FG003|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
37638599|NCT01915498|69106328|FG004|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
37638600|NCT01915498|69106329|FG005|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1|||
37638601|NCT01915498|69106330|FG006|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
37638602|NCT01915498|69106331|FG007|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
37638603|NCT01915498|69106332|FG008|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
37638604|NCT01915498|69106333|FG009|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
37638605|NCT01915498|69106334|FG010|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
37638606|NCT01915498|69106335|FG011|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
37638607|NCT01915498|69106336|FG012|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
37638608|NCT01915498|69106337|FG013|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
37638609|NCT01915498|69106338|FG014|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1|||
37638610|NCT01915498|69106339|FG015|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
37638611|NCT01915498|69106340|FG016|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
37638612|NCT01915498|69106341|FG017|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|2|||
37638613|NCT01915498|69106342|FG018|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
37638614|NCT01915498|69106324|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
37638615|NCT01915498|69106325|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
37638616|NCT01915498|69106326|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
37638617|NCT01915498|69106327|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
37638618|NCT01915498|69106328|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
37638619|NCT01915498|69106329|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
37638620|NCT01915498|69106330|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
37638621|NCT01915498|69106331|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
37638622|NCT01915498|69106332|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
37638623|NCT01915498|69106333|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
37638624|NCT01915498|69106334|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
37638625|NCT01915498|69106335|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
37638626|NCT01915498|69106336|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
37638627|NCT01915498|69106337|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
37638628|NCT01915498|69106338|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
37638629|NCT01915498|69106339|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
37638630|NCT01915498|69106340|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
37638631|NCT01915498|69106341|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
37638632|NCT01915498|69106342|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
37638633|NCT01915498|69106324|FG000|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
37638634|NCT01915498|69106325|FG001|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
37638635|NCT01915498|69106326|FG002|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
37638636|NCT01915498|69106327|FG003|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
37638637|NCT01915498|69106328|FG004|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
37638638|NCT01915498|69106329|FG005|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
37638639|NCT01915498|69106330|FG006|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
37638640|NCT01915498|69106331|FG007|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
37638641|NCT01915498|69106332|FG008|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
37638642|NCT01915498|69106333|FG009|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
37638643|NCT01915498|69106334|FG010|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
37638644|NCT01915498|69106335|FG011|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
37638645|NCT01915498|69106336|FG012|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
37638646|NCT01915498|69106337|FG013|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
37638647|NCT01915498|69106338|FG014|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
37638648|NCT01915498|69106339|FG015|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
37638649|NCT01915498|69106340|FG016|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
37638650|NCT01915498|69106341|FG017|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
37638651|NCT01915498|69106342|FG018|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|2|||
37638652|NCT01798004|69106434|FG000|Overall Study|Death|2|||
37638653|NCT01798004|69106434|FG000|Overall Study|Lack of Efficacy|8|||
37638654|NCT01798004|69106434|FG000|Overall Study|Physician Decision|25|||
37638655|NCT01798004|69106434|FG000|Overall Study|Withdrawal by Subject|4|||
37638656|NCT01798004|69106434|FG000|Overall Study|Ineligible|4|||
37638657|NCT01798004|69106434|FG000|Overall Study|Patient/parent refusal|7|||
37638658|NCT01798004|69106434|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
37638659|NCT01798004|69106434|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
37638660|NCT01630434|69106440|FG000|Overall Study|Donor lungs turned down|1|||
37638661|NCT01630434|69106441|FG001|Overall Study|Donor lungs turned down|0|||
37638662|NCT01630434|69106440|FG000|Overall Study|Protocol Violation|9|||
37638663|NCT01630434|69106441|FG001|Overall Study|Protocol Violation|4|||
37638664|NCT01630434|69106440|FG000|Overall Study|Death|20|||
37638665|NCT01630434|69106441|FG001|Overall Study|Death|26|||
37638666|NCT01256398|69106451|FG000|Overall Study|Withdrawal by Subject|1|||
37638667|NCT01175356|69106457|FG000|Overall Study|Death|1|||
37638668|NCT01175356|69106457|FG000|Overall Study|Lack of Efficacy|12|||
37638669|NCT01175356|69106457|FG000|Overall Study|Lost to Follow-up|1|||
37638670|NCT01175356|69106457|FG000|Overall Study|Physician Decision|23|||
37638671|NCT01175356|69106457|FG000|Overall Study|Ineligible|1|||
37638672|NCT01175356|69106457|FG000|Overall Study|Treatment Slot Not Available|18|||
37638673|NCT01175356|69106457|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
37638674|NCT01175356|69106457|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
37638675|NCT01175356|69106457|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
37638676|NCT01175356|69106457|FG000|Overall Study|Inadequate stem cell for transplant|1|||
37638677|NCT01175356|69106457|FG000|Overall Study|Initiation other tx prior to completion|9|||
37638678|NCT01151423|69106463|FG000|Overall Study|Study terminated by Sponsor|9|||
37638679|NCT01151423|69106464|FG001|Overall Study|Study terminated by Sponsor|10|||
37638680|NCT01151423|69106463|FG000|Overall Study|Protocol Violation|0|||
37638681|NCT01151423|69106464|FG001|Overall Study|Protocol Violation|1|||
37638682|NCT01151423|69106463|FG000|Overall Study|Physician Decision|1|||
37638683|NCT01151423|69106464|FG001|Overall Study|Physician Decision|1|||
37638684|NCT01151423|69106463|FG000|Overall Study|Pregnancy|0|||
37638685|NCT01151423|69106464|FG001|Overall Study|Pregnancy|1|||
37638686|NCT01151423|69106463|FG000|Overall Study|Death|0|||
37638687|NCT01151423|69106464|FG001|Overall Study|Death|1|||
37638688|NCT01151423|69106463|FG000|Overall Study|Adverse Event|3|||
37638689|NCT01151423|69106464|FG001|Overall Study|Adverse Event|0|||
37638690|NCT01151423|69106463|FG000|Overall Study|Withdrawal by Subject|1|||
37638691|NCT01151423|69106464|FG001|Overall Study|Withdrawal by Subject|3|||
37638692|NCT01151423|69106463|FG000|Overall Study|Lost to Follow-up|1|||
37638693|NCT01151423|69106464|FG001|Overall Study|Lost to Follow-up|0|||
37638694|NCT01151423|69106463|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
37638695|NCT01151423|69106464|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
37638696|NCT01151423|69106463|FG000|Overall Study|Participated in other clinical trial|1|||
37638697|NCT01151423|69106464|FG001|Overall Study|Participated in other clinical trial|0|||
37638698|NCT00565617|69106475|FG000|Overall Study|Withdrawal by Subject|1|||
37638699|NCT00453154|69106482|FG000|Double BIind Maintenance|Adverse Event|0|||
37638700|NCT00453154|69106483|FG001|Double BIind Maintenance|Adverse Event|0|||
37638701|NCT00453154|69106484|FG002|Double BIind Maintenance|Adverse Event|3|||
37638702|NCT00453154|69106485|FG003|Double BIind Maintenance|Adverse Event|12|||
37638703|NCT00453154|69106482|FG000|Double BIind Maintenance|Death|0|||
37638704|NCT00453154|69106483|FG001|Double BIind Maintenance|Death|0|||
37638705|NCT00453154|69106484|FG002|Double BIind Maintenance|Death|2|||
37638706|NCT00453154|69106485|FG003|Double BIind Maintenance|Death|1|||
37638707|NCT00453154|69106482|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
37638708|NCT00453154|69106483|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
37638709|NCT00453154|69106484|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
37638710|NCT00453154|69106485|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
37638711|NCT00453154|69106482|FG000|Double BIind Maintenance|Progression|0|||
37638712|NCT00453154|69106483|FG001|Double BIind Maintenance|Progression|0|||
37638713|NCT00453154|69106484|FG002|Double BIind Maintenance|Progression|29|||
37638714|NCT00453154|69106485|FG003|Double BIind Maintenance|Progression|26|||
37638715|NCT00453154|69106482|FG000|Double BIind Maintenance|Medical Issues|0|||
37638716|NCT00453154|69106483|FG001|Double BIind Maintenance|Medical Issues|0|||
37638717|NCT00453154|69106484|FG002|Double BIind Maintenance|Medical Issues|3|||
37638718|NCT00453154|69106485|FG003|Double BIind Maintenance|Medical Issues|1|||
37638719|NCT00453154|69106482|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
37638720|NCT00453154|69106483|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
37638721|NCT00453154|69106484|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
37638722|NCT00453154|69106485|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
37638723|NCT00258960|69106494|FG000|Overall Study|Death|2|||
37638724|NCT00258960|69106494|FG000|Overall Study|Disease Progression|7|||
37638725|NCT00258960|69106494|FG000|Overall Study|Adverse Event|4|||
37638726|NCT00258960|69106494|FG000|Overall Study|Physician Decision|1|||
37638727|NCT00258960|69106494|FG000|Overall Study|Withdrawal by Subject|1|||
37638728|NCT00258960|69106494|FG000|Overall Study|Mistake|2|||
37638729|NCT00121992|69106500|FG000|Overall Study|Treatment not received|2|||
37638730|NCT00121992|69106501|FG001|Overall Study|Treatment not received|11|||
37638731|NCT00070564|69106513|FG000|Overall Study|Progression|2|||
37638732|NCT00070564|69106514|FG001|Overall Study|Progression|4|||
37638733|NCT00070564|69106515|FG002|Overall Study|Progression|7|||
37638734|NCT00070564|69106516|FG003|Overall Study|Progression|7|||
37638735|NCT00070564|69106517|FG004|Overall Study|Progression|1|||
37638736|NCT00070564|69106518|FG005|Overall Study|Progression|0|||
37638737|NCT00070564|69106513|FG000|Overall Study|Delinquent|1|||
37638738|NCT00070564|69106514|FG001|Overall Study|Delinquent|4|||
37638739|NCT00070564|69106515|FG002|Overall Study|Delinquent|2|||
37638740|NCT00070564|69106516|FG003|Overall Study|Delinquent|0|||
37638741|NCT00070564|69106517|FG004|Overall Study|Delinquent|0|||
37638742|NCT00070564|69106518|FG005|Overall Study|Delinquent|0|||
37638743|NCT00070564|69106513|FG000|Overall Study|Adverse Event|150|||
37638744|NCT00070564|69106514|FG001|Overall Study|Adverse Event|142|||
37638745|NCT00070564|69106515|FG002|Overall Study|Adverse Event|120|||
37638746|NCT00070564|69106516|FG003|Overall Study|Adverse Event|108|||
37638747|NCT00070564|69106517|FG004|Overall Study|Adverse Event|63|||
37638748|NCT00070564|69106518|FG005|Overall Study|Adverse Event|36|||
37638749|NCT00070564|69106513|FG000|Overall Study|Death|4|||
37638750|NCT00070564|69106514|FG001|Overall Study|Death|1|||
37638751|NCT00070564|69106515|FG002|Overall Study|Death|5|||
37638752|NCT00070564|69106516|FG003|Overall Study|Death|3|||
37638753|NCT00070564|69106517|FG004|Overall Study|Death|0|||
37638754|NCT00070564|69106518|FG005|Overall Study|Death|1|||
37638755|NCT00070564|69106513|FG000|Overall Study|Other, not protocol specified|17|||
37638756|NCT00070564|69106514|FG001|Overall Study|Other, not protocol specified|15|||
37638757|NCT00070564|69106515|FG002|Overall Study|Other, not protocol specified|14|||
37638758|NCT00070564|69106516|FG003|Overall Study|Other, not protocol specified|19|||
37638759|NCT00070564|69106517|FG004|Overall Study|Other, not protocol specified|6|||
37638760|NCT00070564|69106518|FG005|Overall Study|Other, not protocol specified|7|||
37638761|NCT00070564|69106513|FG000|Overall Study|Withdrawal by Subject|26|||
37638762|NCT00070564|69106514|FG001|Overall Study|Withdrawal by Subject|37|||
37638763|NCT00070564|69106515|FG002|Overall Study|Withdrawal by Subject|23|||
37638764|NCT00070564|69106516|FG003|Overall Study|Withdrawal by Subject|30|||
37638765|NCT00070564|69106517|FG004|Overall Study|Withdrawal by Subject|8|||
37638766|NCT00070564|69106518|FG005|Overall Study|Withdrawal by Subject|8|||
37638767|NCT00070564|69106513|FG000|Overall Study|Not reported|0|||
37638768|NCT00070564|69106514|FG001|Overall Study|Not reported|0|||
37638769|NCT00070564|69106515|FG002|Overall Study|Not reported|0|||
37638770|NCT00070564|69106516|FG003|Overall Study|Not reported|0|||
37638771|NCT00070564|69106517|FG004|Overall Study|Not reported|1|||
37638772|NCT00070564|69106518|FG005|Overall Study|Not reported|0|||
37638773|NCT02738151|69106544|FG000|Overall Study|Randomized but not treated|4|||
37638774|NCT02738151|69106545|FG001|Overall Study|Randomized but not treated|1|||
37638775|NCT02738151|69106544|FG000|Overall Study|Adverse Event|4|||
37638776|NCT02738151|69106545|FG001|Overall Study|Adverse Event|5|||
37638777|NCT02738151|69106544|FG000|Overall Study|Hypoglycemia|0|||
37638778|NCT02738151|69106545|FG001|Overall Study|Hypoglycemia|1|||
37638779|NCT02738151|69106544|FG000|Overall Study|Poor Compliance to Protocol|4|||
37638780|NCT02738151|69106545|FG001|Overall Study|Poor Compliance to Protocol|3|||
37638781|NCT02738151|69106544|FG000|Overall Study|Other than specified above|11|||
37638782|NCT02738151|69106545|FG001|Overall Study|Other than specified above|21|||
37638783|NCT02915159|69106553|FG000|Overall Study|Participant no longer meets criteria|2|||
37638784|NCT02915159|69106554|FG001|Overall Study|Participant no longer meets criteria|0|||
37638785|NCT02915159|69106553|FG000|Overall Study|poor/non-compliance|1|||
37638786|NCT02915159|69106554|FG001|Overall Study|poor/non-compliance|0|||
37638787|NCT02915159|69106553|FG000|Overall Study|Participant withdrew consent|5|||
37638788|NCT02915159|69106554|FG001|Overall Study|Participant withdrew consent|1|||
37638789|NCT02915159|69106553|FG000|Overall Study|Request to discontinue treatment|1|||
37638790|NCT02915159|69106554|FG001|Overall Study|Request to discontinue treatment|2|||
37638791|NCT02915159|69106553|FG000|Overall Study|Adverse Event|2|||
37638792|NCT02915159|69106554|FG001|Overall Study|Adverse Event|2|||
37638793|NCT02915159|69106553|FG000|Overall Study|Lack of Efficacy|0|||
37638794|NCT02915159|69106554|FG001|Overall Study|Lack of Efficacy|3|||
37638795|NCT02924051|69106566|FG000|Overall Study|Withdrawal by Subject|1|||
37638796|NCT02924051|69106567|FG001|Overall Study|Withdrawal by Subject|9|||
37638797|NCT02923427|69106581|FG000|Overall Study|convert to laparatomy|2|||
37638798|NCT02923427|69106582|FG001|Overall Study|convert to laparatomy|2|||
37638799|NCT02923427|69106581|FG000|Overall Study|destaturation|1|||
37638800|NCT02923427|69106582|FG001|Overall Study|destaturation|0|||
37638801|NCT02923427|69106581|FG000|Overall Study|can not replace LMA|1|||
37638802|NCT02923427|69106582|FG001|Overall Study|can not replace LMA|0|||
37638803|NCT02669264|69106595|FG000|Overall Study|Death|5|||
37638804|NCT02669264|69106596|FG001|Overall Study|Death|5|||
37638805|NCT02669264|69106597|FG002|Overall Study|Death|3|||
37638806|NCT02669264|69106598|FG003|Overall Study|Death|3|||
37638807|NCT02669264|69106599|FG004|Overall Study|Death|3|||
37638808|NCT02669264|69106600|FG005|Overall Study|Death|6|||
37638809|NCT02669264|69106601|FG006|Overall Study|Death|3|||
37638810|NCT02669264|69106595|FG000|Overall Study|Withdrawal by Subject|0|||
37638811|NCT02669264|69106596|FG001|Overall Study|Withdrawal by Subject|1|||
37638812|NCT02669264|69106597|FG002|Overall Study|Withdrawal by Subject|0|||
37638813|NCT02669264|69106598|FG003|Overall Study|Withdrawal by Subject|0|||
37638814|NCT02669264|69106599|FG004|Overall Study|Withdrawal by Subject|1|||
37638815|NCT02669264|69106600|FG005|Overall Study|Withdrawal by Subject|0|||
37638816|NCT02669264|69106601|FG006|Overall Study|Withdrawal by Subject|0|||
37638817|NCT02669264|69106595|FG000|Overall Study|Lost to Follow-up|0|||
37638818|NCT02669264|69106596|FG001|Overall Study|Lost to Follow-up|0|||
37638819|NCT02669264|69106597|FG002|Overall Study|Lost to Follow-up|0|||
37638820|NCT02669264|69106598|FG003|Overall Study|Lost to Follow-up|0|||
37638821|NCT02669264|69106599|FG004|Overall Study|Lost to Follow-up|1|||
37638822|NCT02669264|69106600|FG005|Overall Study|Lost to Follow-up|0|||
37638823|NCT02669264|69106601|FG006|Overall Study|Lost to Follow-up|0|||
37638824|NCT02669264|69106595|FG000|Overall Study|Miscellaneous|0|||
37638825|NCT02669264|69106596|FG001|Overall Study|Miscellaneous|0|||
37638826|NCT02669264|69106597|FG002|Overall Study|Miscellaneous|0|||
37638827|NCT02669264|69106598|FG003|Overall Study|Miscellaneous|0|||
37638828|NCT02669264|69106599|FG004|Overall Study|Miscellaneous|0|||
37638829|NCT02669264|69106600|FG005|Overall Study|Miscellaneous|0|||
37638830|NCT02669264|69106601|FG006|Overall Study|Miscellaneous|2|||
37638831|NCT02521870|69106627|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
37638832|NCT02521870|69106628|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
37638833|NCT02521870|69106629|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
37638834|NCT02521870|69106630|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
37638835|NCT02521870|69106631|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
37638836|NCT02521870|69106632|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
37638837|NCT02521870|69106633|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
37638838|NCT02521870|69106634|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
37638839|NCT02521870|69106635|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
37638840|NCT02521870|69106636|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
37638841|NCT02521870|69106637|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
37638842|NCT02521870|69106638|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
37638843|NCT02521870|69106627|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
37638844|NCT02521870|69106628|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
37638845|NCT02521870|69106629|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
37638846|NCT02521870|69106630|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
37638847|NCT02521870|69106631|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
37638848|NCT02521870|69106632|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
37638849|NCT02521870|69106633|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
37638850|NCT02521870|69106634|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
37638851|NCT02521870|69106635|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
37638852|NCT02521870|69106636|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
37638853|NCT02521870|69106637|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
37740576|NCT01401465|69226410|FG000|Treatment Period 1|Scheduling Difficulties|1|||
37638854|NCT02521870|69106638|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
37638855|NCT02521870|69106627|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
37638856|NCT02521870|69106628|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
37638857|NCT02521870|69106629|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
37638858|NCT02521870|69106630|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
37638859|NCT02521870|69106631|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
37638860|NCT02521870|69106632|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
37638861|NCT02521870|69106633|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
37638862|NCT02521870|69106634|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
37638863|NCT02521870|69106635|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
37638864|NCT02521870|69106636|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
37638865|NCT02521870|69106637|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
37638866|NCT02521870|69106638|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
37638867|NCT02521870|69106627|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
37638868|NCT02521870|69106628|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
37638869|NCT02521870|69106629|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
37638870|NCT02521870|69106630|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
37638871|NCT02521870|69106631|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
37638872|NCT02521870|69106632|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
37638873|NCT02521870|69106633|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
37638874|NCT02521870|69106634|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
37638875|NCT02521870|69106635|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
37638876|NCT02521870|69106636|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
37638877|NCT02521870|69106637|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
37638878|NCT02521870|69106638|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
37638879|NCT02521870|69106627|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
37638880|NCT02521870|69106628|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
37638881|NCT02521870|69106629|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
37638882|NCT02521870|69106630|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
37638883|NCT02521870|69106631|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
37638884|NCT02521870|69106632|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
37638885|NCT02521870|69106633|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
37638886|NCT02521870|69106634|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
37638887|NCT02521870|69106635|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
37638888|NCT02521870|69106636|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
37638889|NCT02521870|69106637|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
37638890|NCT02521870|69106638|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
37638891|NCT02521870|69106627|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
37638892|NCT02521870|69106628|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
37638893|NCT02521870|69106629|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
37638894|NCT02521870|69106630|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
37638895|NCT02521870|69106631|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
37638896|NCT02521870|69106632|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
37638897|NCT02521870|69106633|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
37638898|NCT02521870|69106634|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
37638899|NCT02521870|69106635|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
37638900|NCT02521870|69106636|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
37638901|NCT02521870|69106637|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
37638902|NCT02521870|69106638|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
37638903|NCT02521870|69106627|FG000|Phase 2: Dose Expansion|Death|0|||
37638904|NCT02521870|69106628|FG001|Phase 2: Dose Expansion|Death|0|||
37638905|NCT02521870|69106629|FG002|Phase 2: Dose Expansion|Death|0|||
37638906|NCT02521870|69106630|FG003|Phase 2: Dose Expansion|Death|0|||
37638907|NCT02521870|69106631|FG004|Phase 2: Dose Expansion|Death|1|||
37638908|NCT02521870|69106632|FG005|Phase 2: Dose Expansion|Death|1|||
37638909|NCT02521870|69106633|FG006|Phase 2: Dose Expansion|Death|3|||
37638910|NCT02521870|69106634|FG007|Phase 2: Dose Expansion|Death|1|||
37638911|NCT02521870|69106635|FG008|Phase 2: Dose Expansion|Death|1|||
37638912|NCT02521870|69106636|FG009|Phase 2: Dose Expansion|Death|5|||
37638913|NCT02521870|69106637|FG010|Phase 2: Dose Expansion|Death|2|||
37638914|NCT02521870|69106638|FG011|Phase 2: Dose Expansion|Death|2|||
37638915|NCT02521870|69106627|FG000|Phase 2: Dose Expansion|Other|0|||
37638916|NCT02521870|69106628|FG001|Phase 2: Dose Expansion|Other|0|||
37638917|NCT02521870|69106629|FG002|Phase 2: Dose Expansion|Other|0|||
37638918|NCT02521870|69106630|FG003|Phase 2: Dose Expansion|Other|0|||
37638919|NCT02521870|69106631|FG004|Phase 2: Dose Expansion|Other|10|||
37638920|NCT02521870|69106632|FG005|Phase 2: Dose Expansion|Other|3|||
37638921|NCT02521870|69106633|FG006|Phase 2: Dose Expansion|Other|2|||
37638922|NCT02521870|69106634|FG007|Phase 2: Dose Expansion|Other|0|||
37638923|NCT02521870|69106635|FG008|Phase 2: Dose Expansion|Other|10|||
37638924|NCT02521870|69106636|FG009|Phase 2: Dose Expansion|Other|5|||
37638925|NCT02521870|69106637|FG010|Phase 2: Dose Expansion|Other|1|||
37638926|NCT02521870|69106638|FG011|Phase 2: Dose Expansion|Other|7|||
37638927|NCT02521870|69106627|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
37638928|NCT02521870|69106628|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
37638929|NCT02521870|69106629|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
37638930|NCT02521870|69106630|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
37638931|NCT02521870|69106631|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
37854347|NCT01232283|69537959|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
37854348|NCT01232283|69537960|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
37854349|NCT01232283|69537961|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
37854350|NCT01232283|69537952|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
37638932|NCT02521870|69106632|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
37638933|NCT02521870|69106633|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
37638934|NCT02521870|69106634|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
37638935|NCT02521870|69106635|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
37638936|NCT02521870|69106636|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
37638937|NCT02521870|69106637|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
37638938|NCT02521870|69106638|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
37638939|NCT02521870|69106627|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
37638940|NCT02521870|69106628|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
37638941|NCT02521870|69106629|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
37638942|NCT02521870|69106630|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
37638943|NCT02521870|69106631|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
37638944|NCT02521870|69106632|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
37638945|NCT02521870|69106633|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
37638946|NCT02521870|69106634|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
37638947|NCT02521870|69106635|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
37638948|NCT02521870|69106636|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
37638949|NCT02521870|69106637|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
37638950|NCT02521870|69106638|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
37638951|NCT02923349|69106675|FG000|Overall Study|Other|1|||
37638952|NCT02923349|69106676|FG001|Overall Study|Other|2|||
37638953|NCT02923349|69106677|FG002|Overall Study|Other|4|||
37638954|NCT02923349|69106678|FG003|Overall Study|Other|1|||
37638955|NCT02923349|69106679|FG004|Overall Study|Other|3|||
37638956|NCT02923349|69106680|FG005|Overall Study|Other|0|||
37638957|NCT02923349|69106681|FG006|Overall Study|Other|1|||
37638958|NCT02923349|69106675|FG000|Overall Study|Withdrawal by Subject|2|||
37638959|NCT02923349|69106676|FG001|Overall Study|Withdrawal by Subject|2|||
37638960|NCT02923349|69106677|FG002|Overall Study|Withdrawal by Subject|8|||
37638961|NCT02923349|69106678|FG003|Overall Study|Withdrawal by Subject|10|||
37638962|NCT02923349|69106679|FG004|Overall Study|Withdrawal by Subject|12|||
37638963|NCT02923349|69106680|FG005|Overall Study|Withdrawal by Subject|3|||
37638964|NCT02923349|69106681|FG006|Overall Study|Withdrawal by Subject|0|||
37638965|NCT02923349|69106675|FG000|Overall Study|Physician Decision|0|||
37638966|NCT02923349|69106676|FG001|Overall Study|Physician Decision|0|||
37638967|NCT02923349|69106677|FG002|Overall Study|Physician Decision|0|||
37638968|NCT02923349|69106678|FG003|Overall Study|Physician Decision|1|||
37638969|NCT02923349|69106679|FG004|Overall Study|Physician Decision|1|||
37638970|NCT02923349|69106680|FG005|Overall Study|Physician Decision|0|||
37638971|NCT02923349|69106681|FG006|Overall Study|Physician Decision|2|||
37638972|NCT02923349|69106675|FG000|Overall Study|Lost to Follow-up|0|||
37638973|NCT02923349|69106676|FG001|Overall Study|Lost to Follow-up|0|||
37638974|NCT02923349|69106677|FG002|Overall Study|Lost to Follow-up|3|||
37638975|NCT02923349|69106678|FG003|Overall Study|Lost to Follow-up|0|||
37638976|NCT02923349|69106679|FG004|Overall Study|Lost to Follow-up|1|||
37638977|NCT02923349|69106680|FG005|Overall Study|Lost to Follow-up|1|||
37638978|NCT02923349|69106681|FG006|Overall Study|Lost to Follow-up|0|||
37638979|NCT02923349|69106675|FG000|Overall Study|Death|1|||
37638980|NCT02923349|69106676|FG001|Overall Study|Death|0|||
37638981|NCT02923349|69106677|FG002|Overall Study|Death|2|||
37638982|NCT02923349|69106678|FG003|Overall Study|Death|4|||
37638983|NCT02923349|69106679|FG004|Overall Study|Death|2|||
37638984|NCT02923349|69106680|FG005|Overall Study|Death|3|||
37638985|NCT02923349|69106681|FG006|Overall Study|Death|0|||
37638986|NCT02521792|69106697|FG000|Overall Study|Study Terminated|6|||
38032087|NCT02849080|69717999|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
38032088|NCT02849080|69718000|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
38032089|NCT02849080|69718001|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
38032090|NCT02849080|69717998|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
37638987|NCT03020615|69106704|FG000|Overall Study|Physician Decision|3|||
37638988|NCT03020615|69106705|FG001|Overall Study|Physician Decision|1|||
37638989|NCT03020615|69106706|FG002|Overall Study|Physician Decision|2|||
37638990|NCT03020615|69106704|FG000|Overall Study|Parent/guardian/patient choice|3|||
37638991|NCT03020615|69106705|FG001|Overall Study|Parent/guardian/patient choice|0|||
37638992|NCT03020615|69106706|FG002|Overall Study|Parent/guardian/patient choice|4|||
38032091|NCT02849080|69717999|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
38032092|NCT02849080|69718000|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
38032093|NCT02849080|69718001|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
37638993|NCT03020615|69106704|FG000|Overall Study|Screen failure|0|||
37638994|NCT03020615|69106705|FG001|Overall Study|Screen failure|0|||
37638995|NCT03020615|69106706|FG002|Overall Study|Screen failure|1|||
37638996|NCT03020615|69106704|FG000|Overall Study|Death|1|||
37638997|NCT03020615|69106705|FG001|Overall Study|Death|0|||
37638998|NCT03020615|69106706|FG002|Overall Study|Death|0|||
37638999|NCT03020615|69106704|FG000|Overall Study|Lost to Follow-up|0|||
37639000|NCT03020615|69106705|FG001|Overall Study|Lost to Follow-up|1|||
37639001|NCT03020615|69106706|FG002|Overall Study|Lost to Follow-up|0|||
37639002|NCT03020069|69106719|FG000|Overall Study|Lost to Follow-up|0|||
37639003|NCT03020069|69106720|FG001|Overall Study|Lost to Follow-up|1|||
37639004|NCT03693170|69106726|FG000|Overall Study|Disease Progression|48|||
37639005|NCT03693170|69106726|FG000|Overall Study|Adverse Event|16|||
37639006|NCT03693170|69106726|FG000|Overall Study|Physician Decision|6|||
37639007|NCT03693170|69106726|FG000|Overall Study|Protocol Violation|2|||
37639008|NCT03693170|69106726|FG000|Overall Study|Death|1|||
37639009|NCT03693170|69106726|FG000|Overall Study|Non compliance with study drug|1|||
37639010|NCT03693170|69106726|FG000|Overall Study|Withdrawal by Subject|1|||
37639011|NCT03021005|69106733|FG000|Overall Study|Lost to Follow-up|39|||
37639012|NCT03021005|69106734|FG001|Overall Study|Lost to Follow-up|26|||
37639013|NCT02914457|69106740|FG000|Overall Study|Withdrawal by Subject|1|||
37639014|NCT02914457|69106740|FG000|Overall Study|Physician Decision|1|||
37639015|NCT02914457|69106740|FG000|Overall Study|No veins available for lead placement|1|||
37639016|NCT02914457|69106740|FG000|Overall Study|Electrical instability of patient|1|||
37639017|NCT02914457|69106740|FG000|Overall Study|ECG acquisition error due to sweating|1|||
37639018|NCT02914457|69106740|FG000|Overall Study|Protocol Violation|1|||
37639019|NCT02665052|69106748|FG000|Overall Study|Lost to Follow-up|1|||
37639020|NCT02665052|69106749|FG001|Overall Study|Lost to Follow-up|0|||
37639021|NCT02665052|69106750|FG002|Overall Study|Lost to Follow-up|0|||
37639022|NCT02665052|69106751|FG003|Overall Study|Lost to Follow-up|0|||
37639023|NCT02665052|69106748|FG000|Overall Study|Withdrawal by Subject|1|||
37639024|NCT02665052|69106749|FG001|Overall Study|Withdrawal by Subject|1|||
37639025|NCT02665052|69106750|FG002|Overall Study|Withdrawal by Subject|0|||
37639026|NCT02665052|69106751|FG003|Overall Study|Withdrawal by Subject|5|||
37639027|NCT02665052|69106748|FG000|Overall Study|Adverse Event|1|||
37639028|NCT02665052|69106749|FG001|Overall Study|Adverse Event|1|||
37639029|NCT02665052|69106750|FG002|Overall Study|Adverse Event|0|||
37639030|NCT02665052|69106751|FG003|Overall Study|Adverse Event|0|||
37639031|NCT03019289|69106771|FG000|Overall Study|Adverse Event|1|||
37639032|NCT03019289|69106772|FG001|Overall Study|Adverse Event|0|||
37639033|NCT03019289|69106773|FG002|Overall Study|Adverse Event|0|||
37639034|NCT03019289|69106774|FG003|Overall Study|Adverse Event|0|||
37639035|NCT03019289|69106775|FG004|Overall Study|Adverse Event|0|||
37639036|NCT03019289|69106776|FG005|Overall Study|Adverse Event|0|||
37639037|NCT03019289|69106777|FG006|Overall Study|Adverse Event|0|||
37639038|NCT03019289|69106778|FG007|Overall Study|Adverse Event|0|||
37639039|NCT03019289|69106779|FG008|Overall Study|Adverse Event|1|||
37639040|NCT03019289|69106771|FG000|Overall Study|Other|1|||
37639041|NCT03019289|69106772|FG001|Overall Study|Other|0|||
37639042|NCT03019289|69106773|FG002|Overall Study|Other|0|||
37639043|NCT03019289|69106774|FG003|Overall Study|Other|0|||
37639044|NCT03019289|69106775|FG004|Overall Study|Other|0|||
37639045|NCT03019289|69106776|FG005|Overall Study|Other|0|||
37639046|NCT03019289|69106777|FG006|Overall Study|Other|0|||
37639047|NCT03019289|69106778|FG007|Overall Study|Other|0|||
37639048|NCT03019289|69106779|FG008|Overall Study|Other|0|||
37639049|NCT02520388|69106802|FG000|Overall Study|Physician Decision|1|||
37639050|NCT02520388|69106803|FG001|Overall Study|Physician Decision|0|||
37639051|NCT02520388|69106802|FG000|Overall Study|Subject or parent/guardian request|0|||
37639052|NCT02520388|69106803|FG001|Overall Study|Subject or parent/guardian request|6|||
37639053|NCT02520388|69106802|FG000|Overall Study|Adverse Event|1|||
37639054|NCT02520388|69106803|FG001|Overall Study|Adverse Event|4|||
37639055|NCT02520388|69106802|FG000|Overall Study|Lost to Follow-up|3|||
37639056|NCT02520388|69106803|FG001|Overall Study|Lost to Follow-up|2|||
37639057|NCT02520388|69106802|FG000|Overall Study|Other (reason not defined)|4|||
37639058|NCT02520388|69106803|FG001|Overall Study|Other (reason not defined)|4|||
37639059|NCT02924129|69106811|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
37639060|NCT02924129|69106812|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
37639061|NCT02924129|69106811|FG000|Overall Study|Withdrawal by Subject|2|||
37639062|NCT02924129|69106812|FG001|Overall Study|Withdrawal by Subject|2|||
38032094|NCT02849080|69717998|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
37639063|NCT02924129|69106811|FG000|Overall Study|Physician Decision|1|||
37639064|NCT02924129|69106812|FG001|Overall Study|Physician Decision|0|||
37854351|NCT01232283|69537953|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
37854352|NCT01232283|69537954|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
37854353|NCT01232283|69537955|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
37639065|NCT02924129|69106811|FG000|Overall Study|Missed Visit|0|||
37639066|NCT02924129|69106812|FG001|Overall Study|Missed Visit|1|||
37639067|NCT02668640|69106818|FG000|Overall Study|Lost to Follow-up|13|||
37854354|NCT01232283|69537956|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
37854355|NCT01232283|69537957|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
37854356|NCT01232283|69537958|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
37854357|NCT01232283|69537959|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
37639068|NCT02668640|69106818|FG000|Overall Study|Other, not specified|1|||
37639069|NCT03014453|69106822|FG000|Overall Study|Lost to Follow-up|12|||
37639070|NCT03014453|69106822|FG000|Overall Study|Discontinued GER|3|||
37639071|NCT03014453|69106822|FG000|Overall Study|Excluded|19|||
37639072|NCT03014453|69106822|FG000|Overall Study|Refused to take part in|37|||
37639073|NCT02664272|69106826|FG000|Overall Study|Fluoroscopic images not made available|2|||
37639074|NCT02663882|69106832|FG000|Overall Study|Lost to Follow-up|4|||
37639075|NCT02663882|69106833|FG001|Overall Study|Lost to Follow-up|2|||
37639076|NCT03011333|69106846|FG000|Overall Study|Lost to Follow-up|0|||
37639077|NCT03011333|69106847|FG001|Overall Study|Lost to Follow-up|1|||
37639078|NCT03011333|69106848|FG002|Overall Study|Lost to Follow-up|0|||
37639079|NCT03011333|69106849|FG003|Overall Study|Lost to Follow-up|1|||
37639080|NCT03011333|69106850|FG004|Overall Study|Lost to Follow-up|4|||
37639081|NCT03011333|69106851|FG005|Overall Study|Lost to Follow-up|4|||
37639082|NCT03011333|69106852|FG006|Overall Study|Lost to Follow-up|5|||
37639083|NCT03011099|69106870|FG000|Overall Study|Withdrawal by Subject|0|||
37639084|NCT03011099|69106871|FG001|Overall Study|Withdrawal by Subject|2|||
37639085|NCT03013985|69106881|FG000|Overall Study|Protocol Violation|2|||
37639086|NCT03013985|69106882|FG001|Overall Study|Protocol Violation|2|||
37639087|NCT03013985|69106881|FG000|Overall Study|Withdrawal by Subject|14|||
37639088|NCT03013985|69106882|FG001|Overall Study|Withdrawal by Subject|17|||
37639089|NCT03016403|69106892|FG000|Baseline|Death|5|||
37639090|NCT03016403|69106893|FG001|Baseline|Death|8|||
37639091|NCT03016403|69106894|FG002|Baseline|Death|1|||
37639092|NCT03016403|69106895|FG003|Baseline|Death|0|||
37639093|NCT03016403|69106892|FG000|Baseline|Withdrawal by Subject|2|||
37639094|NCT03016403|69106893|FG001|Baseline|Withdrawal by Subject|8|||
37639095|NCT03016403|69106894|FG002|Baseline|Withdrawal by Subject|4|||
37639096|NCT03016403|69106895|FG003|Baseline|Withdrawal by Subject|10|||
37639097|NCT03016403|69106892|FG000|Baseline|Lost to Follow-up|9|||
37639098|NCT03016403|69106893|FG001|Baseline|Lost to Follow-up|11|||
37639099|NCT03016403|69106894|FG002|Baseline|Lost to Follow-up|6|||
37639100|NCT03016403|69106895|FG003|Baseline|Lost to Follow-up|24|||
37639101|NCT03016403|69106892|FG000|6-week Follow-up|Death|1|||
37639102|NCT03016403|69106893|FG001|6-week Follow-up|Death|4|||
37639103|NCT03016403|69106894|FG002|6-week Follow-up|Death|0|||
37639104|NCT03016403|69106895|FG003|6-week Follow-up|Death|0|||
37639105|NCT03016403|69106892|FG000|6-week Follow-up|Lost to Follow-up|2|||
37639106|NCT03016403|69106893|FG001|6-week Follow-up|Lost to Follow-up|7|||
37639107|NCT03016403|69106894|FG002|6-week Follow-up|Lost to Follow-up|4|||
37639108|NCT03016403|69106895|FG003|6-week Follow-up|Lost to Follow-up|8|||
37639109|NCT03016403|69106892|FG000|6-week Follow-up|Withdrawal by Subject|0|||
37639110|NCT03016403|69106893|FG001|6-week Follow-up|Withdrawal by Subject|2|||
37639111|NCT03016403|69106894|FG002|6-week Follow-up|Withdrawal by Subject|0|||
37639112|NCT03016403|69106895|FG003|6-week Follow-up|Withdrawal by Subject|1|||
37639113|NCT03016403|69106892|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
37639114|NCT03016403|69106893|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
37639115|NCT03016403|69106894|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
37639116|NCT03016403|69106895|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
37639117|NCT03016403|69106892|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
37639118|NCT03016403|69106893|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
37639119|NCT03016403|69106894|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
37639120|NCT03016403|69106895|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
37639121|NCT03016403|69106892|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
37639122|NCT03016403|69106893|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
37639123|NCT03016403|69106894|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
37639124|NCT03016403|69106895|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
37639125|NCT02520310|69106907|FG000|At 6 Months Clinical Follow-up|Death|1|||
37639126|NCT02520310|69106907|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
37639127|NCT02520310|69106907|FG000|AT 3 Year Clinical Follow-up|Death|2|||
37639128|NCT02520310|69106907|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
37639129|NCT02520310|69106907|FG000|AT 4 Year Clinical Follow-up|Death|1|||
37639130|NCT02520310|69106907|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
37639131|NCT02662556|69106913|FG000|Overall Study|Adverse Event|4|||
37639132|NCT02662556|69106913|FG000|Overall Study|Lack of Efficacy|4|||
37639133|NCT02516098|69106920|FG000|Period 1|Protocol Violation|1|||
37639134|NCT02516098|69106921|FG001|Period 1|Protocol Violation|0|||
37639135|NCT02516098|69106920|FG000|Washout After Period 1|Adverse Event|0|||
37639136|NCT02516098|69106921|FG001|Washout After Period 1|Adverse Event|1|||
38032095|NCT02849080|69717999|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
38032096|NCT02849080|69718000|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
38032097|NCT02849080|69718001|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
38032098|NCT03346070|69718018|FG000|Overall Study|Death|0|||
38032099|NCT03346070|69718019|FG001|Overall Study|Death|0|||
38032100|NCT03346070|69718020|FG002|Overall Study|Death|0|||
38032101|NCT03346070|69718021|FG003|Overall Study|Death|0|||
38032102|NCT03346070|69718022|FG004|Overall Study|Death|1|||
38032103|NCT03346070|69718018|FG000|Overall Study|Lost to Follow-up|0|||
38032104|NCT03346070|69718019|FG001|Overall Study|Lost to Follow-up|1|||
38032105|NCT03346070|69718020|FG002|Overall Study|Lost to Follow-up|2|||
37639137|NCT02516098|69106920|FG000|Period 2|Withdrawal by Subject|0|||
37639138|NCT02516098|69106921|FG001|Period 2|Withdrawal by Subject|1|||
37639139|NCT01364428|69106929|FG000|Overall Study|Adverse Event|1|||
37639140|NCT01364428|69106930|FG001|Overall Study|Adverse Event|2|||
37639141|NCT01364428|69106929|FG000|Overall Study|Protocol Violation|2|||
37639142|NCT01364428|69106930|FG001|Overall Study|Protocol Violation|0|||
37639143|NCT01364428|69106929|FG000|Overall Study|Withdrawal Criteria|14|||
37639144|NCT01364428|69106930|FG001|Overall Study|Withdrawal Criteria|10|||
37639145|NCT01364428|69106929|FG000|Overall Study|Other|3|||
37639146|NCT01364428|69106930|FG001|Overall Study|Other|3|||
37639147|NCT02515942|69106939|FG000|Overall Study|Adverse Event|5|||
37639148|NCT02515942|69106940|FG001|Overall Study|Adverse Event|0|||
37639149|NCT02515942|69106941|FG002|Overall Study|Adverse Event|0|||
37639150|NCT02515942|69106939|FG000|Overall Study|Death|0|||
37639151|NCT02515942|69106940|FG001|Overall Study|Death|0|||
37639152|NCT02515942|69106941|FG002|Overall Study|Death|1|||
37639153|NCT02515942|69106939|FG000|Overall Study|Lack of Efficacy|0|||
37639154|NCT02515942|69106940|FG001|Overall Study|Lack of Efficacy|0|||
37639155|NCT02515942|69106941|FG002|Overall Study|Lack of Efficacy|1|||
37639156|NCT02515942|69106939|FG000|Overall Study|Lost to Follow-up|2|||
37639157|NCT02515942|69106940|FG001|Overall Study|Lost to Follow-up|0|||
37639158|NCT02515942|69106941|FG002|Overall Study|Lost to Follow-up|0|||
37639159|NCT02515942|69106939|FG000|Overall Study|Withdrawal by Subject|0|||
37639160|NCT02515942|69106940|FG001|Overall Study|Withdrawal by Subject|3|||
37639161|NCT02515942|69106941|FG002|Overall Study|Withdrawal by Subject|2|||
37639162|NCT02991859|69106968|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
37639163|NCT02991859|69106969|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
37639164|NCT02991859|69106970|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
37639165|NCT02991859|69106971|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
37639166|NCT02991859|69106972|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
37639167|NCT02991859|69106973|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
37639168|NCT02991859|69106974|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
37639169|NCT02991859|69106975|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
37639170|NCT02991859|69106976|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
37639171|NCT02991859|69106977|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
37639172|NCT02991859|69106978|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
37639173|NCT02991859|69106979|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
37639174|NCT02991859|69106980|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
37639175|NCT02991859|69106981|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
37639176|NCT02991859|69106982|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
37639177|NCT02991859|69106983|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
37639178|NCT02991859|69106984|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
37639179|NCT02991859|69106968|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
37639180|NCT02991859|69106969|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
37639181|NCT02991859|69106970|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
37639182|NCT02991859|69106971|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
37639183|NCT02991859|69106972|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
37639184|NCT02991859|69106973|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
37639185|NCT02991859|69106974|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
37639186|NCT02991859|69106975|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
37639187|NCT02991859|69106976|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
37639188|NCT02991859|69106977|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
37639189|NCT02991859|69106978|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
37639190|NCT02991859|69106979|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
37639191|NCT02991859|69106980|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
37639192|NCT02991859|69106981|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
37639193|NCT02991859|69106982|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
37639194|NCT02991859|69106983|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
37639195|NCT02991859|69106984|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
37740577|NCT01401465|69226411|FG001|Treatment Period 1|Scheduling Difficulties|1|||
37740578|NCT01401465|69226410|FG000|Treatment Period 2|Lost to Follow-up|0|||
37740579|NCT01401465|69226411|FG001|Treatment Period 2|Lost to Follow-up|1|||
37639196|NCT02991859|69106968|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
37639197|NCT02991859|69106969|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
37639198|NCT02991859|69106970|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
37639199|NCT02991859|69106971|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
37639200|NCT02991859|69106972|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
37639201|NCT02991859|69106973|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
37639202|NCT02991859|69106974|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
37639203|NCT02991859|69106975|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
37639204|NCT02991859|69106976|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
37639205|NCT02991859|69106977|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
37639206|NCT02991859|69106978|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
37639207|NCT02991859|69106979|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
37639208|NCT02991859|69106980|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
37639209|NCT02991859|69106981|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
37639210|NCT02991859|69106982|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
37639211|NCT02991859|69106983|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
37639212|NCT02991859|69106984|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
37639213|NCT02991859|69106968|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
37639214|NCT02991859|69106969|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
37639215|NCT02991859|69106970|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
37639216|NCT02991859|69106971|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
37639217|NCT02991859|69106972|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
37639218|NCT02991859|69106973|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
37639219|NCT02991859|69106974|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
37639220|NCT02991859|69106975|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
37639221|NCT02991859|69106976|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
37639222|NCT02991859|69106977|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
37639223|NCT02991859|69106978|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
37639224|NCT02991859|69106979|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
37639225|NCT02991859|69106980|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
37639226|NCT02991859|69106981|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
37639227|NCT02991859|69106982|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
37639228|NCT02991859|69106983|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
37639229|NCT02991859|69106984|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
37639230|NCT02991859|69106968|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
37639231|NCT02991859|69106969|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
37639232|NCT02991859|69106970|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
37639233|NCT02991859|69106971|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
37639234|NCT02991859|69106972|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
37639235|NCT02991859|69106973|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
37639236|NCT02991859|69106974|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
37639237|NCT02991859|69106975|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
37639238|NCT02991859|69106976|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
37639239|NCT02991859|69106977|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
37639240|NCT02991859|69106978|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
37639241|NCT02991859|69106979|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
37639242|NCT02991859|69106980|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
37639243|NCT02991859|69106981|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
37639244|NCT02991859|69106982|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
37639245|NCT02991859|69106983|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
37639246|NCT02991859|69106984|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
37639247|NCT03016325|69107067|FG000|Treatment Period|Participant withdrew consent|0|||
37639248|NCT03016325|69107068|FG001|Treatment Period|Participant withdrew consent|1|||
37639249|NCT03016325|69107069|FG002|Treatment Period|Participant withdrew consent|0|||
37639250|NCT03016325|69107070|FG003|Treatment Period|Participant withdrew consent|0|||
37639251|NCT03016325|69107071|FG004|Treatment Period|Participant withdrew consent|0|||
37639252|NCT03016325|69107072|FG005|Treatment Period|Participant withdrew consent|0|||
37639253|NCT03016325|69107073|FG006|Treatment Period|Participant withdrew consent|0|||
37639254|NCT03016325|69107074|FG007|Treatment Period|Participant withdrew consent|0|||
37639255|NCT03016325|69107067|FG000|Treatment Period|Death|0|||
37639256|NCT03016325|69107068|FG001|Treatment Period|Death|0|||
37639257|NCT03016325|69107069|FG002|Treatment Period|Death|0|||
37639258|NCT03016325|69107070|FG003|Treatment Period|Death|0|||
37639259|NCT03016325|69107071|FG004|Treatment Period|Death|2|||
37639260|NCT03016325|69107072|FG005|Treatment Period|Death|0|||
37639261|NCT03016325|69107073|FG006|Treatment Period|Death|0|||
37639262|NCT03016325|69107074|FG007|Treatment Period|Death|0|||
37639263|NCT03016325|69107067|FG000|Treatment Period|Participant refuses assessments|0|||
37639264|NCT03016325|69107068|FG001|Treatment Period|Participant refuses assessments|0|||
38032106|NCT03346070|69718021|FG003|Overall Study|Lost to Follow-up|0|||
38032107|NCT03346070|69718022|FG004|Overall Study|Lost to Follow-up|0|||
37639265|NCT03016325|69107069|FG002|Treatment Period|Participant refuses assessments|1|||
37639266|NCT03016325|69107070|FG003|Treatment Period|Participant refuses assessments|0|||
37639267|NCT03016325|69107071|FG004|Treatment Period|Participant refuses assessments|0|||
37639268|NCT03016325|69107072|FG005|Treatment Period|Participant refuses assessments|0|||
37639269|NCT03016325|69107073|FG006|Treatment Period|Participant refuses assessments|0|||
37639270|NCT03016325|69107074|FG007|Treatment Period|Participant refuses assessments|0|||
37639271|NCT03016325|69107067|FG000|32-Day Follow-Up Period|Death|2|||
37639272|NCT03016325|69107068|FG001|32-Day Follow-Up Period|Death|0|||
37639273|NCT03016325|69107069|FG002|32-Day Follow-Up Period|Death|5|||
37639274|NCT03016325|69107070|FG003|32-Day Follow-Up Period|Death|6|||
37639275|NCT03016325|69107071|FG004|32-Day Follow-Up Period|Death|3|||
37639276|NCT03016325|69107072|FG005|32-Day Follow-Up Period|Death|0|||
37639277|NCT03016325|69107073|FG006|32-Day Follow-Up Period|Death|0|||
37639278|NCT03016325|69107074|FG007|32-Day Follow-Up Period|Death|0|||
37639279|NCT03016325|69107067|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
37639280|NCT03016325|69107068|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
37639281|NCT03016325|69107069|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
37639282|NCT03016325|69107070|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
37639283|NCT03016325|69107071|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
37639284|NCT03016325|69107072|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
37639285|NCT03016325|69107073|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
37639286|NCT03016325|69107074|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
37639287|NCT03016325|69107067|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
37639288|NCT03016325|69107068|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
37639289|NCT03016325|69107069|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
37639290|NCT03016325|69107070|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
37639291|NCT03016325|69107071|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
37639292|NCT03016325|69107072|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
37639293|NCT03016325|69107073|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
37639294|NCT03016325|69107074|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
37639295|NCT03016325|69107067|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
37639296|NCT03016325|69107068|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
37639297|NCT03016325|69107069|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
37639298|NCT03016325|69107070|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
37639299|NCT03016325|69107071|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
37639300|NCT03016325|69107072|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
37639301|NCT03016325|69107073|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
37639302|NCT03016325|69107074|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
37639303|NCT03016325|69107067|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
37639304|NCT03016325|69107068|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
37639305|NCT03016325|69107069|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
37639306|NCT03016325|69107070|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
37639307|NCT03016325|69107071|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
37639308|NCT03016325|69107072|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
37639309|NCT03016325|69107073|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
37639310|NCT03016325|69107074|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
37639311|NCT03016325|69107067|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
37639312|NCT03016325|69107068|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
37639313|NCT03016325|69107069|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
37639314|NCT03016325|69107070|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
37639315|NCT03016325|69107071|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
37639316|NCT03016325|69107072|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
37639317|NCT03016325|69107073|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
37639318|NCT03016325|69107074|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
37639319|NCT03016325|69107067|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
37639320|NCT03016325|69107068|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
37639321|NCT03016325|69107069|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
37639322|NCT03016325|69107070|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
37639323|NCT03016325|69107071|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
37639324|NCT03016325|69107072|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
37639325|NCT03016325|69107073|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
37639326|NCT03016325|69107074|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
37639327|NCT03016325|69107067|FG000|182-Day Follow-Up Period|Death|3|||
37639328|NCT03016325|69107068|FG001|182-Day Follow-Up Period|Death|3|||
37639329|NCT03016325|69107069|FG002|182-Day Follow-Up Period|Death|11|||
37639330|NCT03016325|69107070|FG003|182-Day Follow-Up Period|Death|12|||
37921936|NCT00667810|69608726|FG002|Overall Study|Other|5|||
37639331|NCT03016325|69107071|FG004|182-Day Follow-Up Period|Death|9|||
37639332|NCT03016325|69107072|FG005|182-Day Follow-Up Period|Death|0|||
37639333|NCT03016325|69107073|FG006|182-Day Follow-Up Period|Death|0|||
37639334|NCT03016325|69107074|FG007|182-Day Follow-Up Period|Death|1|||
37639335|NCT03016325|69107067|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
37639336|NCT03016325|69107068|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
37639337|NCT03016325|69107069|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
37921937|NCT00667810|69608727|FG003|Overall Study|Other|0|||
37921938|NCT00819390|69608746|FG000|Overall Study|Lost to Follow-up|1|||
37921939|NCT00819390|69608747|FG001|Overall Study|Lost to Follow-up|1|||
37921940|NCT00819390|69608748|FG002|Overall Study|Lost to Follow-up|0|||
37639338|NCT03016325|69107070|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
37639339|NCT03016325|69107071|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
37639340|NCT03016325|69107072|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
37639341|NCT03016325|69107073|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
37639342|NCT03016325|69107074|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
37639343|NCT03016325|69107067|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
37639344|NCT03016325|69107068|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
37639345|NCT03016325|69107069|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
37639346|NCT03016325|69107070|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
37639347|NCT03016325|69107071|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
37639348|NCT03016325|69107072|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
37639349|NCT03016325|69107073|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
37639350|NCT03016325|69107074|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
37639351|NCT03016325|69107067|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
37639352|NCT03016325|69107068|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
37639353|NCT03016325|69107069|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
37639354|NCT03016325|69107070|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
37639355|NCT03016325|69107071|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
37639356|NCT03016325|69107072|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
37639357|NCT03016325|69107073|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
37639358|NCT03016325|69107074|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
37639359|NCT03016325|69107067|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
37639360|NCT03016325|69107068|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
37639361|NCT03016325|69107069|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
37639362|NCT03016325|69107070|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
37639363|NCT03016325|69107071|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
37639364|NCT03016325|69107072|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
37639365|NCT03016325|69107073|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
37639366|NCT03016325|69107074|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
37639367|NCT03016325|69107067|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
37639368|NCT03016325|69107068|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
37639369|NCT03016325|69107069|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
37639370|NCT03016325|69107070|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
37639371|NCT03016325|69107071|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
37639372|NCT03016325|69107072|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
37639373|NCT03016325|69107073|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
37639374|NCT03016325|69107074|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
37639375|NCT03016325|69107067|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
37639376|NCT03016325|69107068|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
37639377|NCT03016325|69107069|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
37639378|NCT03016325|69107070|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
37639379|NCT03016325|69107071|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
37639380|NCT03016325|69107072|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
37639381|NCT03016325|69107073|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
37639382|NCT03016325|69107074|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
37639383|NCT03016325|69107067|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
37639384|NCT03016325|69107068|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
37639385|NCT03016325|69107069|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
37639386|NCT03016325|69107070|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
37639387|NCT03016325|69107071|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
37639388|NCT03016325|69107072|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
37639389|NCT03016325|69107073|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
37639390|NCT03016325|69107074|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
37639391|NCT02988115|69107097|FG000|Overall Study|Adverse Event|6|||
37639392|NCT02988115|69107098|FG001|Overall Study|Adverse Event|1|||
37639393|NCT02988115|69107097|FG000|Overall Study|Sponsor Decision|5|||
37639394|NCT02988115|69107098|FG001|Overall Study|Sponsor Decision|2|||
37639395|NCT02988115|69107097|FG000|Overall Study|Withdrawal by Subject|1|||
37639396|NCT02988115|69107098|FG001|Overall Study|Withdrawal by Subject|1|||
37639397|NCT02988115|69107097|FG000|Overall Study|Withdrawn by Mistake|1|||
37639398|NCT02988115|69107098|FG001|Overall Study|Withdrawn by Mistake|0|||
37639399|NCT02988115|69107097|FG000|Overall Study|Lost to Follow-up|1|||
37639400|NCT02988115|69107098|FG001|Overall Study|Lost to Follow-up|0|||
37639401|NCT02921425|69107104|FG000|Overall Study|Protocol Violation|9|||
37639402|NCT03008915|69107108|FG000|Treatment 1|Withdrawal by Subject|0|||
37639403|NCT03008915|69107109|FG001|Treatment 1|Withdrawal by Subject|1|||
37639404|NCT02920957|69107120|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
37921941|NCT00819390|69608749|FG003|Overall Study|Lost to Follow-up|0|||
37639405|NCT02920957|69107121|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
37639406|NCT02920957|69107120|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
37639407|NCT02920957|69107121|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
37639408|NCT02920957|69107120|FG000|First Intervention : 1 Month|Adverse Event|1|||
37639409|NCT02920957|69107121|FG001|First Intervention : 1 Month|Adverse Event|0|||
37639410|NCT02920957|69107120|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
37639411|NCT02920957|69107121|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
37639412|NCT03006887|69107138|FG000|Overall Study|Adverse Event|1|||
37639413|NCT02514772|69107144|FG000|Overall Study|Adverse Event|1|||
37639414|NCT02514772|69107145|FG001|Overall Study|Adverse Event|0|||
37639415|NCT02514772|69107144|FG000|Overall Study|Death|0|||
37639416|NCT02514772|69107145|FG001|Overall Study|Death|1|||
37639417|NCT02514772|69107144|FG000|Overall Study|Withdrawal by Subject|2|||
37639418|NCT02514772|69107145|FG001|Overall Study|Withdrawal by Subject|1|||
37639419|NCT03000179|69107153|FG000|Overall Study|Lost to Follow-up|2|||
37639420|NCT02920177|69107159|FG000|Overall Study|Withdrawal by Subject|1|||
37639421|NCT02920177|69107160|FG001|Overall Study|Withdrawal by Subject|1|||
37639422|NCT02920177|69107159|FG000|Overall Study|Physician Decision|1|||
37639423|NCT02920177|69107160|FG001|Overall Study|Physician Decision|0|||
37639424|NCT02920177|69107159|FG000|Overall Study|Lost to Follow-up|0|||
37639425|NCT02920177|69107160|FG001|Overall Study|Lost to Follow-up|1|||
37639426|NCT03006341|69107170|FG000|Overall Study|Not linked in the EMR|25069|||
37639427|NCT03006341|69107171|FG001|Overall Study|Not linked in the EMR|67505|||
37639428|NCT03006341|69107172|FG002|Overall Study|Not linked in the EMR|30993|||
37639429|NCT03006341|69107173|FG003|Overall Study|Not linked in the EMR|10685|||
37639430|NCT03935594|69107181|FG000|Overall Study|Physician Decision|3|||
37639431|NCT02512042|69107189|FG000|Overall Study|Adverse Event|0|||
37639432|NCT02512042|69107190|FG001|Overall Study|Adverse Event|4|||
37639433|NCT02512042|69107189|FG000|Overall Study|Withdrawal by Subject|6|||
37639434|NCT02512042|69107190|FG001|Overall Study|Withdrawal by Subject|6|||
37639435|NCT02512042|69107189|FG000|Overall Study|Non-compliance with study drug|1|||
37639436|NCT02512042|69107190|FG001|Overall Study|Non-compliance with study drug|2|||
37639437|NCT02512042|69107189|FG000|Overall Study|Lost to Follow-up|5|||
37639438|NCT02512042|69107190|FG001|Overall Study|Lost to Follow-up|2|||
37639439|NCT02512042|69107189|FG000|Overall Study|Other|11|||
37639440|NCT02512042|69107190|FG001|Overall Study|Other|11|||
37639441|NCT02911025|69107196|FG000|Overall Study|Lost to Follow-up|3|||
37639442|NCT02919475|69107205|FG000|Overall Study|Adverse Event|3|||
37639443|NCT02919475|69107206|FG001|Overall Study|Adverse Event|3|||
37639444|NCT02919475|69107207|FG002|Overall Study|Adverse Event|3|||
37639445|NCT02919475|69107208|FG003|Overall Study|Adverse Event|9|||
37639446|NCT02919475|69107209|FG004|Overall Study|Adverse Event|2|||
37639447|NCT02919475|69107205|FG000|Overall Study|Death|0|||
37639448|NCT02919475|69107206|FG001|Overall Study|Death|1|||
37639449|NCT02919475|69107207|FG002|Overall Study|Death|0|||
37639450|NCT02919475|69107208|FG003|Overall Study|Death|0|||
37639451|NCT02919475|69107209|FG004|Overall Study|Death|0|||
37639452|NCT02919475|69107205|FG000|Overall Study|Lost to Follow-up|0|||
37639453|NCT02919475|69107206|FG001|Overall Study|Lost to Follow-up|0|||
37639454|NCT02919475|69107207|FG002|Overall Study|Lost to Follow-up|0|||
37639455|NCT02919475|69107208|FG003|Overall Study|Lost to Follow-up|1|||
37639456|NCT02919475|69107209|FG004|Overall Study|Lost to Follow-up|0|||
37639457|NCT02919475|69107205|FG000|Overall Study|Withdrawal by Subject|2|||
37639458|NCT02919475|69107206|FG001|Overall Study|Withdrawal by Subject|3|||
37639459|NCT02919475|69107207|FG002|Overall Study|Withdrawal by Subject|1|||
37740580|NCT01401465|69226410|FG000|Treatment Period 2|Withdrawal by Subject|0|||
37854358|NCT01232283|69537960|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
37854359|NCT01232283|69537961|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
37854360|NCT01232283|69537952|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
37854361|NCT01232283|69537953|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
37854362|NCT01232283|69537954|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
37854363|NCT01232283|69537955|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
38032108|NCT03346070|69718018|FG000|Overall Study|Physician Decision|0|||
37639460|NCT02919475|69107208|FG003|Overall Study|Withdrawal by Subject|2|||
37639461|NCT02919475|69107209|FG004|Overall Study|Withdrawal by Subject|2|||
37639462|NCT02919475|69107205|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
37639463|NCT02919475|69107206|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
37639464|NCT02919475|69107207|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
37639465|NCT02919475|69107208|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
37639466|NCT02919475|69107209|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
37639467|NCT01066897|69107223|FG000|Overall Study|Withdrawal by Subject|1|||
37639468|NCT01066897|69107224|FG001|Overall Study|Withdrawal by Subject|0|||
37639469|NCT01066897|69107223|FG000|Overall Study|stopped study after developing the flu.|1|||
37639470|NCT01066897|69107224|FG001|Overall Study|stopped study after developing the flu.|0|||
37639471|NCT02985541|69107231|FG000|Overall Study|Withdrawal by Subject|33|||
37639472|NCT02985541|69107231|FG000|Overall Study|Lost to Follow-up|26|||
37639473|NCT02985541|69107231|FG000|Overall Study|Adverse Event|27|||
37639474|NCT02985541|69107231|FG000|Overall Study|Physician Decision|2|||
37639475|NCT02985541|69107231|FG000|Overall Study|Pregnancy|2|||
37639476|NCT02985541|69107231|FG000|Overall Study|Wish for pregnancy|44|||
37639477|NCT02985541|69107231|FG000|Overall Study|Other reason|5|||
37639478|NCT02985541|69107231|FG000|Overall Study|Not valid for analysis|2|||
37639479|NCT02910037|69107244|FG000|Overall Study|Withdrawal by Subject|4|||
37639480|NCT02910037|69107244|FG000|Overall Study|Lost to Follow-up|6|||
37639481|NCT02511184|69107279|FG000|Overall Study|Death|1|||
37639482|NCT02511184|69107280|FG001|Overall Study|Death|0|||
37639483|NCT02511184|69107279|FG000|Overall Study|Lost to Follow-up|0|||
37639484|NCT02511184|69107280|FG001|Overall Study|Lost to Follow-up|1|||
37639485|NCT02511184|69107279|FG000|Overall Study|Study terminated by sponsor|1|||
37639486|NCT02511184|69107280|FG001|Overall Study|Study terminated by sponsor|5|||
37639487|NCT02511184|69107279|FG000|Overall Study|Withdrawal by Subject|0|||
37639488|NCT02511184|69107280|FG001|Overall Study|Withdrawal by Subject|1|||
37639489|NCT02984995|69107289|FG000|Overall Study|Required stem cell transplant|13|||
37639490|NCT02984995|69107290|FG001|Overall Study|Required stem cell transplant|2|||
37639491|NCT02984995|69107289|FG000|Overall Study|Progressive disease|11|||
37639492|NCT02984995|69107290|FG001|Overall Study|Progressive disease|1|||
37639493|NCT02984995|69107289|FG000|Overall Study|Adverse Event|1|||
37639494|NCT02984995|69107290|FG001|Overall Study|Adverse Event|0|||
37639495|NCT02984683|69107314|FG000|Overall Study|Adverse Event|3|||
37639496|NCT02984683|69107315|FG001|Overall Study|Adverse Event|3|||
37639497|NCT02984683|69107314|FG000|Overall Study|Withdrawal by Subject|1|||
37639498|NCT02984683|69107315|FG001|Overall Study|Withdrawal by Subject|0|||
37639499|NCT02984683|69107314|FG000|Overall Study|Disease progression|7|||
37639500|NCT02984683|69107315|FG001|Overall Study|Disease progression|9|||
37639501|NCT02909101|69107323|FG000|Overall Study|Lost to Follow-up|1|||
37639502|NCT02909101|69107324|FG001|Overall Study|Lost to Follow-up|1|||
37639503|NCT03004469|69107333|FG000|Overall Study|Adverse Event|6|||
37639504|NCT03004469|69107334|FG001|Overall Study|Adverse Event|4|||
37639505|NCT03004469|69107335|FG002|Overall Study|Adverse Event|6|||
37639506|NCT03004469|69107333|FG000|Overall Study|Lack of Efficacy|1|||
37639507|NCT03004469|69107334|FG001|Overall Study|Lack of Efficacy|0|||
37639508|NCT03004469|69107335|FG002|Overall Study|Lack of Efficacy|1|||
37639509|NCT03004469|69107333|FG000|Overall Study|Lost to Follow-up|23|||
37639510|NCT03004469|69107334|FG001|Overall Study|Lost to Follow-up|14|||
37639511|NCT03004469|69107335|FG002|Overall Study|Lost to Follow-up|6|||
37639512|NCT03004469|69107333|FG000|Overall Study|Non-Compliance with Study Drug|2|||
37639513|NCT03004469|69107334|FG001|Overall Study|Non-Compliance with Study Drug|0|||
37639514|NCT03004469|69107335|FG002|Overall Study|Non-Compliance with Study Drug|0|||
37639515|NCT03004469|69107333|FG000|Overall Study|Protocol Violation|0|||
37639516|NCT03004469|69107334|FG001|Overall Study|Protocol Violation|0|||
37639517|NCT03004469|69107335|FG002|Overall Study|Protocol Violation|1|||
37639518|NCT03004469|69107333|FG000|Overall Study|Withdrawal by Subject|29|||
37639519|NCT03004469|69107334|FG001|Overall Study|Withdrawal by Subject|27|||
37639520|NCT03004469|69107335|FG002|Overall Study|Withdrawal by Subject|10|||
37639521|NCT03004469|69107333|FG000|Overall Study|Other unspecified reason|0|||
37639522|NCT03004469|69107334|FG001|Overall Study|Other unspecified reason|4|||
37639523|NCT03004469|69107335|FG002|Overall Study|Other unspecified reason|1|||
37639524|NCT02910713|69107344|FG000|Overall Study|Protocol Violation|2|||
37639525|NCT02910713|69107344|FG000|Overall Study|Subject Choice|4|||
37639526|NCT02910713|69107344|FG000|Overall Study|Received One Application|10|||
37639527|NCT02910713|69107344|FG000|Overall Study|Received Neither Application|18|||
37639528|NCT02910713|69107344|FG000|Overall Study|Enrollment cap|7|||
37639529|NCT02910713|69107344|FG000|Overall Study|Investigator Discretion|1|||
37639530|NCT02998541|69107352|FG000|Overall Study|Adverse Event|4|||
37639531|NCT02998541|69107353|FG001|Overall Study|Adverse Event|5|||
37639532|NCT02998541|69107354|FG002|Overall Study|Adverse Event|1|||
37639533|NCT02998541|69107352|FG000|Overall Study|Protocol Violation|1|||
37639534|NCT02998541|69107353|FG001|Overall Study|Protocol Violation|0|||
37639535|NCT02998541|69107354|FG002|Overall Study|Protocol Violation|0|||
37639536|NCT02998541|69107352|FG000|Overall Study|Withdrawal by Subject|3|||
37639537|NCT02998541|69107353|FG001|Overall Study|Withdrawal by Subject|1|||
37639538|NCT02998541|69107354|FG002|Overall Study|Withdrawal by Subject|0|||
38032109|NCT03346070|69718019|FG001|Overall Study|Physician Decision|0|||
37639539|NCT02998541|69107352|FG000|Overall Study|Lost to Follow-up|0|||
37639540|NCT02998541|69107353|FG001|Overall Study|Lost to Follow-up|3|||
37639541|NCT02998541|69107354|FG002|Overall Study|Lost to Follow-up|1|||
37639542|NCT02998541|69107352|FG000|Overall Study|Physician Decision|0|||
37639543|NCT02998541|69107353|FG001|Overall Study|Physician Decision|0|||
38032110|NCT03346070|69718020|FG002|Overall Study|Physician Decision|0|||
37639544|NCT02998541|69107354|FG002|Overall Study|Physician Decision|3|||
37639545|NCT02998541|69107352|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
37639546|NCT02998541|69107353|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
37639547|NCT02998541|69107354|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
37639548|NCT02998151|69107362|FG000|Overall Study|Withdrawal by Subject|3|||
37639549|NCT02998151|69107362|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
37639550|NCT02998151|69107362|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
37639551|NCT01066819|69107393|FG000|Overall Study|Adverse Event|18|||
37639552|NCT01066819|69107394|FG001|Overall Study|Adverse Event|1|||
37639553|NCT01066819|69107395|FG002|Overall Study|Adverse Event|6|||
37639554|NCT01066819|69107396|FG003|Overall Study|Adverse Event|0|||
37639555|NCT01066819|69107397|FG004|Overall Study|Adverse Event|0|||
37639556|NCT01066819|69107398|FG005|Overall Study|Adverse Event|0|||
37639557|NCT01066819|69107393|FG000|Overall Study|Death|5|||
37639558|NCT01066819|69107394|FG001|Overall Study|Death|0|||
37639559|NCT01066819|69107395|FG002|Overall Study|Death|1|||
37639560|NCT01066819|69107396|FG003|Overall Study|Death|0|||
37639561|NCT01066819|69107397|FG004|Overall Study|Death|0|||
37639562|NCT01066819|69107398|FG005|Overall Study|Death|0|||
37639563|NCT01066819|69107393|FG000|Overall Study|Lack of Efficacy|22|||
37639564|NCT01066819|69107394|FG001|Overall Study|Lack of Efficacy|1|||
37639565|NCT01066819|69107395|FG002|Overall Study|Lack of Efficacy|2|||
37639566|NCT01066819|69107396|FG003|Overall Study|Lack of Efficacy|1|||
37639567|NCT01066819|69107397|FG004|Overall Study|Lack of Efficacy|0|||
37639568|NCT01066819|69107398|FG005|Overall Study|Lack of Efficacy|0|||
37639569|NCT01066819|69107393|FG000|Overall Study|Physician Decision|6|||
37639570|NCT01066819|69107394|FG001|Overall Study|Physician Decision|2|||
37639571|NCT01066819|69107395|FG002|Overall Study|Physician Decision|3|||
37639572|NCT01066819|69107396|FG003|Overall Study|Physician Decision|0|||
37639573|NCT01066819|69107397|FG004|Overall Study|Physician Decision|0|||
37639574|NCT01066819|69107398|FG005|Overall Study|Physician Decision|0|||
37639575|NCT01066819|69107393|FG000|Overall Study|Protocol Violation|12|||
37639576|NCT01066819|69107394|FG001|Overall Study|Protocol Violation|6|||
37639577|NCT01066819|69107395|FG002|Overall Study|Protocol Violation|0|||
37639578|NCT01066819|69107396|FG003|Overall Study|Protocol Violation|0|||
37639579|NCT01066819|69107397|FG004|Overall Study|Protocol Violation|0|||
37639580|NCT01066819|69107398|FG005|Overall Study|Protocol Violation|0|||
37639581|NCT01066819|69107393|FG000|Overall Study|Withdrawal by Subject|29|||
37639582|NCT01066819|69107394|FG001|Overall Study|Withdrawal by Subject|11|||
37639583|NCT01066819|69107395|FG002|Overall Study|Withdrawal by Subject|6|||
37639584|NCT01066819|69107396|FG003|Overall Study|Withdrawal by Subject|0|||
37639585|NCT01066819|69107397|FG004|Overall Study|Withdrawal by Subject|0|||
37639586|NCT01066819|69107398|FG005|Overall Study|Withdrawal by Subject|0|||
37639587|NCT01066819|69107393|FG000|Overall Study|Administrative|6|||
37639588|NCT01066819|69107394|FG001|Overall Study|Administrative|4|||
37639589|NCT01066819|69107395|FG002|Overall Study|Administrative|2|||
37639590|NCT01066819|69107396|FG003|Overall Study|Administrative|0|||
37639591|NCT01066819|69107397|FG004|Overall Study|Administrative|0|||
37639592|NCT01066819|69107398|FG005|Overall Study|Administrative|0|||
37639593|NCT01066819|69107393|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
37639594|NCT01066819|69107394|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
37639595|NCT01066819|69107395|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
37639596|NCT01066819|69107396|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
37639597|NCT01066819|69107397|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
37639598|NCT01066819|69107398|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
37639599|NCT01066819|69107393|FG000|Overall Study|Early termination|2|||
37639600|NCT01066819|69107394|FG001|Overall Study|Early termination|0|||
37639601|NCT01066819|69107395|FG002|Overall Study|Early termination|0|||
37639602|NCT01066819|69107396|FG003|Overall Study|Early termination|0|||
37639603|NCT01066819|69107397|FG004|Overall Study|Early termination|0|||
37639604|NCT01066819|69107398|FG005|Overall Study|Early termination|0|||
37639605|NCT01066819|69107393|FG000|Overall Study|Failed to return|298|||
37639606|NCT01066819|69107394|FG001|Overall Study|Failed to return|107|||
37639607|NCT01066819|69107395|FG002|Overall Study|Failed to return|68|||
37639608|NCT01066819|69107396|FG003|Overall Study|Failed to return|7|||
37639609|NCT01066819|69107397|FG004|Overall Study|Failed to return|2|||
37639610|NCT01066819|69107398|FG005|Overall Study|Failed to return|3|||
37639611|NCT01066819|69107393|FG000|Overall Study|Lab test not done|9|||
37639612|NCT01066819|69107394|FG001|Overall Study|Lab test not done|0|||
37639613|NCT01066819|69107395|FG002|Overall Study|Lab test not done|2|||
37639614|NCT01066819|69107396|FG003|Overall Study|Lab test not done|1|||
37740581|NCT01401465|69226411|FG001|Treatment Period 2|Withdrawal by Subject|1|||
37740582|NCT01401153|69226422|FG000|First Test Day|Learning disabilities; illness|1|||
37639615|NCT01066819|69107397|FG004|Overall Study|Lab test not done|0|||
37639616|NCT01066819|69107398|FG005|Overall Study|Lab test not done|0|||
37639617|NCT01066819|69107393|FG000|Overall Study|Miscellaneous|28|||
37639618|NCT01066819|69107394|FG001|Overall Study|Miscellaneous|10|||
37639619|NCT01066819|69107395|FG002|Overall Study|Miscellaneous|18|||
37639620|NCT01066819|69107396|FG003|Overall Study|Miscellaneous|1|||
37639621|NCT01066819|69107397|FG004|Overall Study|Miscellaneous|0|||
37639622|NCT01066819|69107398|FG005|Overall Study|Miscellaneous|0|||
37639623|NCT01066819|69107393|FG000|Overall Study|Non responders|123|||
37639624|NCT01066819|69107394|FG001|Overall Study|Non responders|2|||
37639625|NCT01066819|69107395|FG002|Overall Study|Non responders|7|||
37639626|NCT01066819|69107396|FG003|Overall Study|Non responders|2|||
37639627|NCT01066819|69107397|FG004|Overall Study|Non responders|0|||
37639628|NCT01066819|69107398|FG005|Overall Study|Non responders|1|||
37639629|NCT01066819|69107393|FG000|Overall Study|Not categorised|9|||
37639630|NCT01066819|69107394|FG001|Overall Study|Not categorised|2|||
37639631|NCT01066819|69107395|FG002|Overall Study|Not categorised|6|||
37639632|NCT01066819|69107396|FG003|Overall Study|Not categorised|1|||
37639633|NCT01066819|69107397|FG004|Overall Study|Not categorised|0|||
37639634|NCT01066819|69107398|FG005|Overall Study|Not categorised|0|||
37639635|NCT01066819|69107393|FG000|Overall Study|Relapse|16|||
37740583|NCT01401153|69226423|FG001|First Test Day|Learning disabilities; illness|10|||
37740584|NCT01401153|69226422|FG000|Second Test Day|illness|0|||
37740585|NCT01401153|69226423|FG001|Second Test Day|illness|5|||
37740586|NCT01890967|69226436|FG000|Overall Study|Adverse Event|3|||
37740587|NCT01890967|69226437|FG001|Overall Study|Adverse Event|3|||
37740588|NCT01890967|69226438|FG002|Overall Study|Adverse Event|3|||
37740589|NCT01890967|69226439|FG003|Overall Study|Adverse Event|2|||
37740590|NCT01890967|69226440|FG004|Overall Study|Adverse Event|1|||
37854364|NCT01232283|69537956|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
37854365|NCT01232283|69537957|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
37854366|NCT01232283|69537958|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
37854367|NCT01232283|69537959|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
37854368|NCT01232283|69537960|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
37854369|NCT01232283|69537961|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
37854370|NCT01232283|69537952|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
37854371|NCT01232283|69537953|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
37854372|NCT01232283|69537954|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
37639636|NCT01066819|69107394|FG001|Overall Study|Relapse|4|||
37639637|NCT01066819|69107395|FG002|Overall Study|Relapse|3|||
37639638|NCT01066819|69107396|FG003|Overall Study|Relapse|0|||
37639639|NCT01066819|69107397|FG004|Overall Study|Relapse|0|||
37639640|NCT01066819|69107398|FG005|Overall Study|Relapse|0|||
37639641|NCT01066819|69107393|FG000|Overall Study|Results not available|1|||
37639642|NCT01066819|69107394|FG001|Overall Study|Results not available|0|||
37639643|NCT01066819|69107395|FG002|Overall Study|Results not available|0|||
37639644|NCT01066819|69107396|FG003|Overall Study|Results not available|0|||
37639645|NCT01066819|69107397|FG004|Overall Study|Results not available|0|||
37639646|NCT01066819|69107398|FG005|Overall Study|Results not available|0|||
37639647|NCT01066819|69107393|FG000|Overall Study|Screen failure|1|||
37639648|NCT01066819|69107394|FG001|Overall Study|Screen failure|0|||
37639649|NCT01066819|69107395|FG002|Overall Study|Screen failure|0|||
37639650|NCT01066819|69107396|FG003|Overall Study|Screen failure|0|||
37639651|NCT01066819|69107397|FG004|Overall Study|Screen failure|0|||
37639652|NCT01066819|69107398|FG005|Overall Study|Screen failure|0|||
37639653|NCT01066819|69107393|FG000|Overall Study|Spontaneous cure|1|||
37639654|NCT01066819|69107394|FG001|Overall Study|Spontaneous cure|0|||
37639655|NCT01066819|69107395|FG002|Overall Study|Spontaneous cure|0|||
37639656|NCT01066819|69107396|FG003|Overall Study|Spontaneous cure|0|||
37639657|NCT01066819|69107397|FG004|Overall Study|Spontaneous cure|0|||
37639658|NCT01066819|69107398|FG005|Overall Study|Spontaneous cure|0|||
37639659|NCT01066819|69107393|FG000|Overall Study|Treatment never started|85|||
37639660|NCT01066819|69107394|FG001|Overall Study|Treatment never started|19|||
37639661|NCT01066819|69107395|FG002|Overall Study|Treatment never started|19|||
37639662|NCT01066819|69107396|FG003|Overall Study|Treatment never started|3|||
37639663|NCT01066819|69107397|FG004|Overall Study|Treatment never started|2|||
37740591|NCT01890967|69226441|FG005|Overall Study|Adverse Event|7|||
37740592|NCT01890967|69226436|FG000|Overall Study|Death|1|||
37740593|NCT01890967|69226437|FG001|Overall Study|Death|0|||
37740594|NCT01890967|69226438|FG002|Overall Study|Death|0|||
37740595|NCT01890967|69226439|FG003|Overall Study|Death|0|||
37854373|NCT01232283|69537955|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
37854374|NCT01232283|69537956|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
38032111|NCT03346070|69718021|FG003|Overall Study|Physician Decision|1|||
37639664|NCT01066819|69107398|FG005|Overall Study|Treatment never started|2|||
37639665|NCT01066819|69107393|FG000|Overall Study|Treatment stopped|12|||
37639666|NCT01066819|69107394|FG001|Overall Study|Treatment stopped|1|||
37639667|NCT01066819|69107395|FG002|Overall Study|Treatment stopped|2|||
37639668|NCT01066819|69107396|FG003|Overall Study|Treatment stopped|1|||
37639669|NCT01066819|69107397|FG004|Overall Study|Treatment stopped|0|||
37639670|NCT01066819|69107398|FG005|Overall Study|Treatment stopped|0|||
37639671|NCT01066819|69107393|FG000|Overall Study|Other|5|||
37639672|NCT01066819|69107394|FG001|Overall Study|Other|1|||
37639673|NCT01066819|69107395|FG002|Overall Study|Other|1|||
37639674|NCT01066819|69107396|FG003|Overall Study|Other|0|||
37639675|NCT01066819|69107397|FG004|Overall Study|Other|0|||
37639676|NCT01066819|69107398|FG005|Overall Study|Other|0|||
37740596|NCT01890967|69226440|FG004|Overall Study|Death|0|||
37639677|NCT04056299|69107412|FG000|Overall Study|Sponsor discontinued study|3|||
37639678|NCT04056299|69107413|FG001|Overall Study|Sponsor discontinued study|3|||
37639679|NCT04057937|69107421|FG000|Placebo-controlled Phase|Adverse Event|3|||
37639680|NCT04057937|69107422|FG001|Placebo-controlled Phase|Adverse Event|0|||
37639681|NCT04057937|69107421|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
37639682|NCT04057937|69107422|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
37639683|NCT04057937|69107421|FG000|Active-treatment Phase|Pregnancy|0|||
37639684|NCT04057937|69107422|FG001|Active-treatment Phase|Pregnancy|1|||
37639685|NCT04057937|69107421|FG000|Active-treatment Phase|Physician Decision|0|||
37639686|NCT04057937|69107422|FG001|Active-treatment Phase|Physician Decision|1|||
37639687|NCT01069523|69107431|FG000|Overall Study|Withdrawal by Subject|4|||
37639688|NCT01069523|69107432|FG001|Overall Study|Withdrawal by Subject|7|||
37639689|NCT01069289|69107442|FG000|Overall Study|Withdrawal by Subject|15|||
37639690|NCT01069289|69107443|FG001|Overall Study|Withdrawal by Subject|26|||
37639691|NCT01069289|69107442|FG000|Overall Study|Adverse Event|21|||
37639692|NCT01069289|69107443|FG001|Overall Study|Adverse Event|28|||
37639693|NCT01069289|69107442|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
37639694|NCT01069289|69107443|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
37639695|NCT01069289|69107442|FG000|Overall Study|Severe non-compliance to protocol|3|||
37639696|NCT01069289|69107443|FG001|Overall Study|Severe non-compliance to protocol|2|||
37639697|NCT01069289|69107442|FG000|Overall Study|Due to deteriorating health condition|1|||
37639698|NCT01069289|69107443|FG001|Overall Study|Due to deteriorating health condition|0|||
37639699|NCT02510794|69107462|FG000|Overall Study|Adverse Event|0|||
37639700|NCT02510794|69107463|FG001|Overall Study|Adverse Event|1|||
37639701|NCT02510794|69107464|FG002|Overall Study|Adverse Event|0|||
37639702|NCT02510794|69107465|FG003|Overall Study|Adverse Event|0|||
37639703|NCT02510794|69107462|FG000|Overall Study|Death|1|||
37639704|NCT02510794|69107463|FG001|Overall Study|Death|2|||
37639705|NCT02510794|69107464|FG002|Overall Study|Death|1|||
37639706|NCT02510794|69107465|FG003|Overall Study|Death|1|||
37639707|NCT02510794|69107462|FG000|Overall Study|Lack of Efficacy|3|||
37639708|NCT02510794|69107463|FG001|Overall Study|Lack of Efficacy|1|||
37639709|NCT02510794|69107464|FG002|Overall Study|Lack of Efficacy|1|||
37639710|NCT02510794|69107465|FG003|Overall Study|Lack of Efficacy|0|||
37639711|NCT02510794|69107462|FG000|Overall Study|Participant moved out of the area|0|||
37639712|NCT02510794|69107463|FG001|Overall Study|Participant moved out of the area|0|||
37639713|NCT02510794|69107464|FG002|Overall Study|Participant moved out of the area|0|||
37639714|NCT02510794|69107465|FG003|Overall Study|Participant moved out of the area|1|||
37639715|NCT02510794|69107462|FG000|Overall Study|Physician Decision|3|||
37639716|NCT02510794|69107463|FG001|Overall Study|Physician Decision|0|||
37639717|NCT02510794|69107464|FG002|Overall Study|Physician Decision|0|||
37639718|NCT02510794|69107465|FG003|Overall Study|Physician Decision|0|||
37639719|NCT02510794|69107462|FG000|Overall Study|Protocol Violation|0|||
37639720|NCT02510794|69107463|FG001|Overall Study|Protocol Violation|0|||
37639721|NCT02510794|69107464|FG002|Overall Study|Protocol Violation|1|||
37639722|NCT02510794|69107465|FG003|Overall Study|Protocol Violation|0|||
37639723|NCT02510794|69107462|FG000|Overall Study|Withdrawal by Subject|1|||
37639724|NCT02510794|69107463|FG001|Overall Study|Withdrawal by Subject|2|||
37639725|NCT02510794|69107464|FG002|Overall Study|Withdrawal by Subject|4|||
37639726|NCT02510794|69107465|FG003|Overall Study|Withdrawal by Subject|3|||
37639727|NCT02510014|69107490|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
37639728|NCT02510014|69107491|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
37639729|NCT02510014|69107490|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
37639730|NCT02510014|69107491|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
37639731|NCT02510014|69107490|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
37639732|NCT02510014|69107491|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
37639733|NCT02510014|69107490|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
37740597|NCT01890967|69226441|FG005|Overall Study|Death|0|||
37740598|NCT01890967|69226436|FG000|Overall Study|Lost to Follow-up|1|||
37639734|NCT02510014|69107491|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
37639735|NCT02510014|69107490|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
37639736|NCT02510014|69107491|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
37639737|NCT02510014|69107490|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
37639738|NCT02510014|69107491|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
37639739|NCT02510014|69107490|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
37639740|NCT02510014|69107491|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
37639741|NCT02510014|69107490|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
37639742|NCT02510014|69107491|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
37639743|NCT02510014|69107490|FG000|Treatment Period|Adverse Event|11|||
37639744|NCT02510014|69107491|FG001|Treatment Period|Adverse Event|4|||
37639745|NCT02510014|69107490|FG000|Treatment Period|Withdrawal symptoms|3|||
37639746|NCT02510014|69107491|FG001|Treatment Period|Withdrawal symptoms|0|||
37639747|NCT02510014|69107490|FG000|Treatment Period|Lost to Follow-up|80|||
37639748|NCT02510014|69107491|FG001|Treatment Period|Lost to Follow-up|19|||
37740599|NCT01890967|69226437|FG001|Overall Study|Lost to Follow-up|1|||
37639749|NCT02510014|69107490|FG000|Treatment Period|Physician Decision|5|||
37639750|NCT02510014|69107491|FG001|Treatment Period|Physician Decision|0|||
37639751|NCT02510014|69107490|FG000|Treatment Period|Withdrawal by Subject|67|||
37639752|NCT02510014|69107491|FG001|Treatment Period|Withdrawal by Subject|24|||
37639753|NCT02510014|69107490|FG000|Treatment Period|Withdrawn by the investigator|7|||
37639754|NCT02510014|69107491|FG001|Treatment Period|Withdrawn by the investigator|1|||
37639755|NCT02510014|69107490|FG000|Treatment Period|Protocol Violation|4|||
37639756|NCT02510014|69107491|FG001|Treatment Period|Protocol Violation|4|||
37639757|NCT02510014|69107490|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
37639758|NCT02510014|69107491|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
37639759|NCT02509312|69107499|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
37639760|NCT02509312|69107500|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
37639761|NCT02509312|69107499|FG000|Overall Study|Obstetrician refusal|0|||
37639762|NCT02509312|69107500|FG001|Overall Study|Obstetrician refusal|1|||
37639763|NCT02509312|69107499|FG000|Overall Study|Patient elected for TOLAC|1|||
37639764|NCT02509312|69107500|FG001|Overall Study|Patient elected for TOLAC|0|||
37639765|NCT02509312|69107499|FG000|Overall Study|Cesarean deemed stat|1|||
37639766|NCT02509312|69107500|FG001|Overall Study|Cesarean deemed stat|0|||
37639767|NCT02509312|69107499|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
37639768|NCT02509312|69107500|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
37639769|NCT02509156|69107510|FG000|Randomized Phase|Death|1|||
37639770|NCT02509156|69107511|FG001|Randomized Phase|Death|0|||
37639771|NCT02509156|69107510|FG000|Randomized Phase|Withdrawal by Subject|1|||
37639772|NCT02509156|69107511|FG001|Randomized Phase|Withdrawal by Subject|1|||
37639773|NCT01654666|69107520|FG000|Overall Study|Protocol Violation|7|||
37639774|NCT01654666|69107521|FG001|Overall Study|Protocol Violation|4|||
37639775|NCT01654666|69107522|FG002|Overall Study|Protocol Violation|8|||
37639776|NCT01654666|69107520|FG000|Overall Study|Lost to Follow-up|4|||
37639777|NCT01654666|69107521|FG001|Overall Study|Lost to Follow-up|5|||
37639778|NCT01654666|69107522|FG002|Overall Study|Lost to Follow-up|5|||
37639779|NCT01654666|69107520|FG000|Overall Study|Withdrawal by Subject|4|||
37639780|NCT01654666|69107521|FG001|Overall Study|Withdrawal by Subject|4|||
37639781|NCT01654666|69107522|FG002|Overall Study|Withdrawal by Subject|1|||
37639782|NCT02519842|69107532|FG000|Base Study: Cycle 1|Screening Failure|1|||
37639783|NCT02519842|69107533|FG001|Base Study: Cycle 1|Screening Failure|1|||
37639784|NCT02519842|69107534|FG002|Base Study: Cycle 1|Screening Failure|0|||
37639785|NCT02519842|69107532|FG000|Base Study: Cycle 1|Adverse Event|1|||
37639786|NCT02519842|69107533|FG001|Base Study: Cycle 1|Adverse Event|0|||
37639787|NCT02519842|69107534|FG002|Base Study: Cycle 1|Adverse Event|0|||
37639788|NCT02519842|69107532|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
37639789|NCT02519842|69107533|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
37639790|NCT02519842|69107534|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
37639791|NCT02519842|69107532|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
37639792|NCT02519842|69107533|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
37639793|NCT02519842|69107534|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
37639794|NCT02519842|69107532|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
37639795|NCT02519842|69107533|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
37639796|NCT02519842|69107534|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
37639797|NCT02519842|69107532|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
37639798|NCT02519842|69107533|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
37639799|NCT02519842|69107534|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
37639800|NCT02519842|69107532|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
37639801|NCT02519842|69107533|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
37639802|NCT02519842|69107534|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
37639803|NCT02519842|69107532|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
37639804|NCT02519842|69107533|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
37639805|NCT02519842|69107534|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
37639806|NCT02519842|69107532|FG000|Optional Extension: Cycles 2-6|Death|0|||
37639807|NCT02519842|69107533|FG001|Optional Extension: Cycles 2-6|Death|0|||
37639808|NCT02519842|69107534|FG002|Optional Extension: Cycles 2-6|Death|1|||
38032112|NCT03346070|69718022|FG004|Overall Study|Physician Decision|1|||
38032113|NCT03346070|69718018|FG000|Overall Study|Withdrawal by Subject|1|||
38032114|NCT03346070|69718019|FG001|Overall Study|Withdrawal by Subject|0|||
37639809|NCT02519842|69107532|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
37639810|NCT02519842|69107533|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
37639811|NCT02519842|69107534|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
37639812|NCT02519842|69107532|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
37854375|NCT01232283|69537957|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
38032115|NCT03346070|69718020|FG002|Overall Study|Withdrawal by Subject|0|||
37639813|NCT02519842|69107533|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
37639814|NCT02519842|69107534|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
37639815|NCT02519842|69107532|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
37639816|NCT02519842|69107533|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
37639817|NCT02519842|69107534|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
37639818|NCT02519842|69107532|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
37639819|NCT02519842|69107533|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
37639820|NCT02519842|69107534|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
37639821|NCT02509078|69107544|FG000|Overall Study|Protocol Violation|1|||
37639822|NCT02509078|69107545|FG001|Overall Study|Protocol Violation|1|||
37639823|NCT02993783|69107555|FG000|Overall Study|Reason not Specified|6|||
37639824|NCT02993783|69107556|FG001|Overall Study|Reason not Specified|9|||
37639825|NCT02993471|69107562|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
37639826|NCT02993471|69107562|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
37639827|NCT02988713|69107584|FG000|Overall Study|Withdrawal by Subject|1|||
37639828|NCT02988713|69107584|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
37639829|NCT01068743|69107588|FG000|Period 3|Adverse Event|0|||
37639830|NCT01068743|69107589|FG001|Period 3|Adverse Event|1|||
37639831|NCT01068743|69107590|FG002|Period 3|Adverse Event|0|||
37639832|NCT01068743|69107591|FG003|Period 3|Adverse Event|0|||
37639833|NCT02992691|69107604|FG000|Overall Study|Adverse Event|2|||
37639834|NCT02992691|69107604|FG000|Overall Study|Withdrawal by Subject|1|||
37639835|NCT02921087|69107621|FG000|Overall Study|Withdrawal by Subject|0|||
37639836|NCT02921087|69107622|FG001|Overall Study|Withdrawal by Subject|1|||
37639837|NCT02907619|69107641|FG000|Overall Study|Study terminated by sponsor|18|||
37639838|NCT02907619|69107642|FG001|Overall Study|Study terminated by sponsor|18|||
37639839|NCT02907619|69107643|FG002|Overall Study|Study terminated by sponsor|19|||
37639840|NCT02907619|69107641|FG000|Overall Study|Death|0|||
37639841|NCT02907619|69107642|FG001|Overall Study|Death|0|||
37639842|NCT02907619|69107643|FG002|Overall Study|Death|1|||
37639843|NCT02907619|69107641|FG000|Overall Study|Withdrawal by Subject|1|||
37639844|NCT02907619|69107642|FG001|Overall Study|Withdrawal by Subject|1|||
37639845|NCT02907619|69107643|FG002|Overall Study|Withdrawal by Subject|0|||
37639846|NCT02907619|69107641|FG000|Overall Study|Other|0|||
37639847|NCT02907619|69107642|FG001|Overall Study|Other|1|||
37639848|NCT02907619|69107643|FG002|Overall Study|Other|0|||
37639849|NCT02986373|69107653|FG000|Overall Study|Adverse Event|4|||
37639850|NCT02986373|69107653|FG000|Overall Study|Lost to Follow-up|1|||
37639851|NCT02986373|69107653|FG000|Overall Study|Withdrawal by Subject|10|||
37639852|NCT02986373|69107653|FG000|Overall Study|Other|24|||
37639853|NCT02986139|69107659|FG000|Overall Study|Sponsor Decision|1|||
37639854|NCT02986139|69107660|FG001|Overall Study|Sponsor Decision|2|||
37740600|NCT01890967|69226438|FG002|Overall Study|Lost to Follow-up|1|||
37740601|NCT01890967|69226439|FG003|Overall Study|Lost to Follow-up|1|||
37740602|NCT01890967|69226440|FG004|Overall Study|Lost to Follow-up|0|||
37740603|NCT01890967|69226441|FG005|Overall Study|Lost to Follow-up|1|||
37740604|NCT01890967|69226436|FG000|Overall Study|Protocol Violation|0|||
37740605|NCT01890967|69226437|FG001|Overall Study|Protocol Violation|3|||
37740606|NCT01890967|69226438|FG002|Overall Study|Protocol Violation|3|||
37740607|NCT01890967|69226439|FG003|Overall Study|Protocol Violation|2|||
37740608|NCT01890967|69226440|FG004|Overall Study|Protocol Violation|4|||
37740609|NCT01890967|69226441|FG005|Overall Study|Protocol Violation|1|||
37740610|NCT01890967|69226436|FG000|Overall Study|Sponsor Decision|2|||
37740611|NCT01890967|69226437|FG001|Overall Study|Sponsor Decision|0|||
37740612|NCT01890967|69226438|FG002|Overall Study|Sponsor Decision|1|||
37740613|NCT01890967|69226439|FG003|Overall Study|Sponsor Decision|3|||
37740614|NCT01890967|69226440|FG004|Overall Study|Sponsor Decision|2|||
37740615|NCT01890967|69226441|FG005|Overall Study|Sponsor Decision|3|||
37740616|NCT01890967|69226436|FG000|Overall Study|Withdrawal by Subject|3|||
37740617|NCT01890967|69226437|FG001|Overall Study|Withdrawal by Subject|4|||
37740618|NCT01890967|69226438|FG002|Overall Study|Withdrawal by Subject|2|||
37740619|NCT01890967|69226439|FG003|Overall Study|Withdrawal by Subject|3|||
37740620|NCT01890967|69226440|FG004|Overall Study|Withdrawal by Subject|3|||
37740621|NCT01890967|69226441|FG005|Overall Study|Withdrawal by Subject|1|||
37740622|NCT01400919|69226460|FG000|Overall Study|Withdrawal by Subject|4|||
37740623|NCT01400919|69226460|FG000|Overall Study|Lost to Follow-up|2|||
37740624|NCT01400919|69226460|FG000|Overall Study|Missed visit|2|||
37740625|NCT01864291|69226464|FG000|Overall Study|need for revision surgery|2|||
37639855|NCT02986139|69107659|FG000|Overall Study|Withdrawal by Subject|0|||
37639856|NCT02986139|69107660|FG001|Overall Study|Withdrawal by Subject|1|||
37740626|NCT01400841|69226468|FG000|Initial Study Phase (6 Months)|Death|1|||
37740627|NCT01400841|69226468|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
37639857|NCT02986139|69107659|FG000|Overall Study|Lost to Follow-up|0|||
37639858|NCT02986139|69107660|FG001|Overall Study|Lost to Follow-up|1|||
37639859|NCT02989805|69107672|FG000|Overall Study|invalid consent|6|||
37639860|NCT02989805|69107673|FG001|Overall Study|invalid consent|4|||
37639861|NCT02907463|69107679|FG000|Overall Study|Lost to Follow-up|17|||
37639862|NCT02907463|69107679|FG000|Overall Study|Death|10|||
37740628|NCT01863667|69226474|FG000|Overall Study|Adverse Event|1|||
37639863|NCT02907463|69107679|FG000|Overall Study|Withdrawal by Subject|4|||
37639864|NCT02907463|69107679|FG000|Overall Study|MIS Approach was not used|2|||
37639865|NCT02907463|69107679|FG000|Overall Study|Not Implanted with Study Device|2|||
37639866|NCT02907463|69107679|FG000|Overall Study|Device Explanted|1|||
37639867|NCT02907463|69107679|FG000|Overall Study|Missing Exit Form|1|||
37639868|NCT02906917|69107693|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
37639869|NCT02906917|69107694|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
37639870|NCT02906917|69107693|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
37639871|NCT02906917|69107694|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
37639872|NCT02906917|69107693|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
37639873|NCT02906917|69107694|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
37639874|NCT02906917|69107693|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
37639875|NCT02906917|69107694|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
37639876|NCT02906917|69107693|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
37639877|NCT02906917|69107694|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
37639878|NCT02906917|69107693|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
37639879|NCT02906917|69107694|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
37639880|NCT02906917|69107693|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
37639881|NCT02906917|69107694|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
37639882|NCT02906917|69107693|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
37639883|NCT02906917|69107694|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
37639884|NCT02982187|69107702|FG000|Overall Study|Withdrawal by Subject|0|||
37639885|NCT02982187|69107703|FG001|Overall Study|Withdrawal by Subject|0|||
37639886|NCT02982187|69107704|FG002|Overall Study|Withdrawal by Subject|0|||
37639887|NCT02982187|69107705|FG003|Overall Study|Withdrawal by Subject|0|||
37639888|NCT02982187|69107706|FG004|Overall Study|Withdrawal by Subject|0|||
37639889|NCT02982187|69107707|FG005|Overall Study|Withdrawal by Subject|0|||
37639890|NCT02982187|69107708|FG006|Overall Study|Withdrawal by Subject|1|||
37639891|NCT02982187|69107709|FG007|Overall Study|Withdrawal by Subject|0|||
37639892|NCT02981953|69107719|FG000|Overall Study|Death|9|||
37639893|NCT02981953|69107719|FG000|Overall Study|Withdrawal by Subject|1|||
37639894|NCT02981953|69107719|FG000|Overall Study|Withdrawal to non-compliance|1|||
37639895|NCT01066585|69107735|FG000|Overall Study|Protocol Violation|1|||
37639896|NCT01066585|69107736|FG001|Overall Study|Protocol Violation|0|||
37639897|NCT01066585|69107735|FG000|Overall Study|Withdrawal by Subject|0|||
37639898|NCT01066585|69107736|FG001|Overall Study|Withdrawal by Subject|3|||
37639899|NCT02980783|69107742|FG000|Overall Study|Lost to Follow-up|1|||
37639900|NCT02980705|69107748|FG000|Overall Study|Adverse Event|0|||
37639901|NCT02980705|69107749|FG001|Overall Study|Adverse Event|1|||
37639902|NCT02980705|69107748|FG000|Overall Study|Withdrawal by Subject|6|||
37639903|NCT02980705|69107749|FG001|Overall Study|Withdrawal by Subject|9|||
37639904|NCT02980705|69107748|FG000|Overall Study|withdrew participation|0|||
37639905|NCT02980705|69107749|FG001|Overall Study|withdrew participation|1|||
37639906|NCT02980705|69107748|FG000|Overall Study|Lost to Follow-up|2|||
37639907|NCT02980705|69107749|FG001|Overall Study|Lost to Follow-up|0|||
37639908|NCT02989649|69107756|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
37639909|NCT02989649|69107756|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
37639910|NCT02989649|69107756|FG000|Overall Study|Lost For Observation During Study|3|||
37639911|NCT02989649|69107756|FG000|Overall Study|Reason Not Specified|13|||
37639912|NCT02905435|69107760|FG000|Overall Study|Death|2|||
37639913|NCT02905435|69107760|FG000|Overall Study|Physician Decision|1|||
37639914|NCT02905435|69107760|FG000|Overall Study|Lost to Follow-up|4|||
37639915|NCT02978833|69107767|FG000|Overall Study|Study terminated|1|||
37639916|NCT02978833|69107768|FG001|Overall Study|Study terminated|1|||
37639917|NCT01067339|69107777|FG000|Overall Study|Withdrawal by Subject|6|||
37639918|NCT01067339|69107778|FG001|Overall Study|Withdrawal by Subject|5|||
37639919|NCT02573259|69107791|FG000|Overall Study|Death|1|||
37639920|NCT02573259|69107792|FG001|Overall Study|Death|6|||
37639921|NCT02573259|69107793|FG002|Overall Study|Death|5|||
37639922|NCT02573259|69107794|FG003|Overall Study|Death|6|||
37639923|NCT02573259|69107795|FG004|Overall Study|Death|9|||
37639924|NCT02573259|69107796|FG005|Overall Study|Death|32|||
37639925|NCT02573259|69107797|FG006|Overall Study|Death|21|||
37639926|NCT02573259|69107791|FG000|Overall Study|Lost to Follow-up|0|||
37639927|NCT02573259|69107792|FG001|Overall Study|Lost to Follow-up|0|||
37639928|NCT02573259|69107793|FG002|Overall Study|Lost to Follow-up|0|||
37639929|NCT02573259|69107794|FG003|Overall Study|Lost to Follow-up|0|||
37639930|NCT02573259|69107795|FG004|Overall Study|Lost to Follow-up|0|||
37740629|NCT01863667|69226475|FG001|Overall Study|Adverse Event|0|||
37639931|NCT02573259|69107796|FG005|Overall Study|Lost to Follow-up|2|||
37639932|NCT02573259|69107797|FG006|Overall Study|Lost to Follow-up|1|||
37639933|NCT02573259|69107791|FG000|Overall Study|Participant refused further follow-up|0|||
37639934|NCT02573259|69107792|FG001|Overall Study|Participant refused further follow-up|2|||
37639935|NCT02573259|69107793|FG002|Overall Study|Participant refused further follow-up|1|||
37639936|NCT02573259|69107794|FG003|Overall Study|Participant refused further follow-up|0|||
37639937|NCT02573259|69107795|FG004|Overall Study|Participant refused further follow-up|3|||
37639938|NCT02573259|69107796|FG005|Overall Study|Participant refused further follow-up|20|||
37639939|NCT02573259|69107797|FG006|Overall Study|Participant refused further follow-up|7|||
37639940|NCT02573259|69107791|FG000|Overall Study|Other|0|||
37639941|NCT02573259|69107792|FG001|Overall Study|Other|0|||
37639942|NCT02573259|69107793|FG002|Overall Study|Other|0|||
37639943|NCT02573259|69107794|FG003|Overall Study|Other|0|||
37639944|NCT02573259|69107795|FG004|Overall Study|Other|1|||
37639945|NCT02573259|69107796|FG005|Overall Study|Other|4|||
37639946|NCT02573259|69107797|FG006|Overall Study|Other|5|||
37639947|NCT02977507|69107834|FG000|Overall Study|Protocol Deviation|1|||
37639948|NCT02977507|69107835|FG001|Overall Study|Protocol Deviation|0|||
37639949|NCT02977507|69107834|FG000|Overall Study|Lost to Follow-up|1|||
37639950|NCT02977507|69107835|FG001|Overall Study|Lost to Follow-up|0|||
37639951|NCT02976103|69107844|FG000|Overall Study|Withdrawal by Subject|1|||
37639952|NCT02976103|69107845|FG001|Overall Study|Withdrawal by Subject|0|||
37639953|NCT02976103|69107844|FG000|Overall Study|Lost to Follow-up|12|||
37639954|NCT02976103|69107845|FG001|Overall Study|Lost to Follow-up|8|||
37639955|NCT01066039|69107852|FG000|Overall Study|Adverse Event|6|||
37639956|NCT01066039|69107852|FG000|Overall Study|Withdrawal by Subject|17|||
37639957|NCT01066039|69107852|FG000|Overall Study|Protocol Violation|2|||
37639958|NCT01066039|69107852|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
37639959|NCT01066039|69107852|FG000|Overall Study|Investigator's Request|1|||
37639960|NCT01066039|69107852|FG000|Overall Study|Dropout due to Insulin Administration|1|||
37639961|NCT01066039|69107852|FG000|Overall Study|Additional Antihypertensive Required|4|||
37639962|NCT01066039|69107852|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
37639963|NCT01066039|69107852|FG000|Overall Study|Failure to Control Blood Pressure|1|||
37639964|NCT01066039|69107852|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
37639965|NCT02919995|69107862|FG000|Overall Study|Adverse Event|0|||
37639966|NCT02919995|69107863|FG001|Overall Study|Adverse Event|0|||
37639967|NCT02919995|69107864|FG002|Overall Study|Adverse Event|0|||
37639968|NCT02919995|69107865|FG003|Overall Study|Adverse Event|0|||
37639969|NCT02919995|69107866|FG004|Overall Study|Adverse Event|0|||
37639970|NCT02919995|69107867|FG005|Overall Study|Adverse Event|1|||
37639971|NCT02919761|69107875|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
37639972|NCT02919761|69107876|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
37639973|NCT02919761|69107877|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
37639974|NCT02919761|69107875|FG000|Part 1: Open Label|Adverse Event|1|||
37639975|NCT02919761|69107876|FG001|Part 1: Open Label|Adverse Event|0|||
37639976|NCT02919761|69107877|FG002|Part 1: Open Label|Adverse Event|0|||
37639977|NCT02919761|69107875|FG000|Part 1: Open Label|Lost to Follow-up|1|||
37639978|NCT02919761|69107876|FG001|Part 1: Open Label|Lost to Follow-up|0|||
37639979|NCT02919761|69107877|FG002|Part 1: Open Label|Lost to Follow-up|0|||
37639980|NCT02919761|69107875|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
37639981|NCT02919761|69107876|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
37639982|NCT02919761|69107877|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
37639983|NCT02919761|69107875|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
37639984|NCT02919761|69107876|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
37639985|NCT02919761|69107877|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
37639986|NCT02919761|69107875|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
37639987|NCT02919761|69107876|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
37639988|NCT02919761|69107877|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
37639989|NCT02919761|69107875|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
37639990|NCT02919761|69107876|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
37639991|NCT02919761|69107877|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
37639992|NCT02919761|69107875|FG000|Part 1: Open Label|Termination by Sponsor|1|||
37639993|NCT02919761|69107876|FG001|Part 1: Open Label|Termination by Sponsor|0|||
37639994|NCT02919761|69107877|FG002|Part 1: Open Label|Termination by Sponsor|0|||
37639995|NCT02919761|69107875|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
37639996|NCT02919761|69107876|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
37639997|NCT02919761|69107877|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
38032116|NCT03346070|69718021|FG003|Overall Study|Withdrawal by Subject|1|||
37639998|NCT02919761|69107875|FG000|Part 2: Double-blind|Adverse Event|0|||
37639999|NCT02919761|69107876|FG001|Part 2: Double-blind|Adverse Event|1|||
37640000|NCT02919761|69107877|FG002|Part 2: Double-blind|Adverse Event|0|||
37640001|NCT02919761|69107875|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
37640002|NCT02919761|69107876|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
37640003|NCT02919761|69107877|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
37640004|NCT02919761|69107875|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
37640005|NCT02919761|69107876|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
37640006|NCT02919761|69107877|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
37640007|NCT02919761|69107875|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
37640008|NCT02919761|69107876|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
37640009|NCT02919761|69107877|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
37640010|NCT02919761|69107875|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
37640011|NCT02919761|69107876|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
37640012|NCT02919761|69107877|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
37640013|NCT02919761|69107875|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
37640014|NCT02919761|69107876|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
37640015|NCT02919761|69107877|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
37640016|NCT02919761|69107875|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
37640017|NCT02919761|69107876|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
37640018|NCT02919761|69107877|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
37640019|NCT02910167|69107888|FG000|Overall Study|Adverse Event|1|||
37640020|NCT02910167|69107888|FG000|Overall Study|Lost to Follow-up|18|||
37640021|NCT01067105|69107892|FG000|Overall Study|Adverse Event|14|||
37640022|NCT01067105|69107892|FG000|Overall Study|Protocol Violation|48|||
37640023|NCT01067105|69107892|FG000|Overall Study|Withdrawal by Subject|36|||
37640024|NCT01067105|69107892|FG000|Overall Study|Lost to Follow-up|6|||
37640025|NCT01067105|69107892|FG000|Overall Study|Physician Decision|6|||
37640026|NCT01067105|69107892|FG000|Overall Study|Other|31|||
37640027|NCT02910089|69107902|FG000|Overall Study|Lost insurance eligibility|22|||
37640028|NCT02910089|69107903|FG001|Overall Study|Lost insurance eligibility|16|||
37640029|NCT02985515|69107911|FG000|Olfaction Testing|Lost to Follow-up|0|||
37640030|NCT02985515|69107912|FG001|Olfaction Testing|Lost to Follow-up|5|||
37640031|NCT02985515|69107911|FG000|Olfaction Testing|Protocol Violation|0|||
37640032|NCT02985515|69107912|FG001|Olfaction Testing|Protocol Violation|3|||
37640033|NCT02910011|69107925|FG000|Overall Study|Physician Decision|2|||
37640034|NCT02908841|69107933|FG000|Overall Study|Physician Decision|4|||
37640035|NCT02908841|69107934|FG001|Overall Study|Physician Decision|0|||
37640036|NCT02909153|69107945|FG000|Overall Study|Withdrawal by Subject|0|||
37640037|NCT02909153|69107946|FG001|Overall Study|Withdrawal by Subject|1|||
37640038|NCT02909153|69107947|FG002|Overall Study|Withdrawal by Subject|0|||
37640039|NCT02909153|69107948|FG003|Overall Study|Withdrawal by Subject|0|||
37640040|NCT02909153|69107949|FG004|Overall Study|Withdrawal by Subject|0|||
37640041|NCT02908529|69107961|FG000|Overall Study|Lost to Follow-up|0|||
37640042|NCT02908529|69107962|FG001|Overall Study|Lost to Follow-up|2|||
37640043|NCT02984267|69107972|FG000|Overall Study|Protocol Violation|1|||
37640044|NCT02984267|69107973|FG001|Overall Study|Protocol Violation|0|||
37640045|NCT02984267|69107972|FG000|Overall Study|Withdrawal by Subject|0|||
37640046|NCT02984267|69107973|FG001|Overall Study|Withdrawal by Subject|1|||
37640047|NCT02675751|69107979|FG000|Overall Study|Lost to Follow-up|16|||
37640048|NCT02974855|69107996|FG000|Overall Study|Adverse Event|0|||
37640049|NCT02974855|69107997|FG001|Overall Study|Adverse Event|1|||
37640050|NCT02974855|69107998|FG002|Overall Study|Adverse Event|0|||
37640051|NCT02974855|69107999|FG003|Overall Study|Adverse Event|1|||
37640052|NCT00455403|69108024|FG000|Overall Study|Lost to Follow-up|2|||
37640053|NCT00455403|69108025|FG001|Overall Study|Lost to Follow-up|1|||
37640054|NCT00455403|69108024|FG000|Overall Study|Withdrawal by Subject|1|||
37640055|NCT00455403|69108025|FG001|Overall Study|Withdrawal by Subject|3|||
37640056|NCT00455403|69108024|FG000|Overall Study|Protocol Violation|0|||
37640057|NCT00455403|69108025|FG001|Overall Study|Protocol Violation|2|||
37640058|NCT02979613|69108033|FG000|Double-Blind Phase|Withdrew Consent|2|||
37640059|NCT02979613|69108034|FG001|Double-Blind Phase|Withdrew Consent|4|||
37640060|NCT02979613|69108033|FG000|Double-Blind Phase|Pregnancy|2|||
37640061|NCT02979613|69108034|FG001|Double-Blind Phase|Pregnancy|2|||
37640062|NCT02979613|69108033|FG000|Double-Blind Phase|Adverse Event|2|||
37640063|NCT02979613|69108034|FG001|Double-Blind Phase|Adverse Event|0|||
37640064|NCT02979613|69108033|FG000|Double-Blind Phase|Lost to Follow-up|1|||
37640065|NCT02979613|69108034|FG001|Double-Blind Phase|Lost to Follow-up|1|||
37640066|NCT02979613|69108033|FG000|Double-Blind Phase|Protocol Violation|1|||
37640067|NCT02979613|69108034|FG001|Double-Blind Phase|Protocol Violation|1|||
37640068|NCT02979613|69108033|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
37640069|NCT02979613|69108034|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
37640070|NCT02979613|69108033|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
37640071|NCT02979613|69108034|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
37640072|NCT02979613|69108033|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
37854376|NCT01232283|69537958|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
37640073|NCT02979613|69108034|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
37640074|NCT02979613|69108033|FG000|Open-Label Extension (OLE) Phase|Death|0|||
37640075|NCT02979613|69108034|FG001|Open-Label Extension (OLE) Phase|Death|1|||
37640076|NCT02979613|69108033|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
37640077|NCT02979613|69108034|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
37640078|NCT01064167|69108044|FG000|Overall Study|Protocol Violation|14|||
37640079|NCT01064167|69108045|FG001|Overall Study|Protocol Violation|15|||
37640080|NCT02974543|69108053|FG000|Overall Study|Withdrawal by Subject|1|||
37640081|NCT02974543|69108054|FG001|Overall Study|Withdrawal by Subject|0|||
37640082|NCT01064947|69108068|FG000|Overall Study|negative culture|41|||
37640083|NCT02974153|69108079|FG000|Overall Study|Adverse Event|6|||
37640084|NCT02974153|69108080|FG001|Overall Study|Adverse Event|0|||
37640085|NCT02974153|69108081|FG002|Overall Study|Adverse Event|1|||
37640086|NCT02974153|69108079|FG000|Overall Study|Lack of Efficacy|6|||
37640087|NCT02974153|69108080|FG001|Overall Study|Lack of Efficacy|5|||
37640088|NCT02974153|69108081|FG002|Overall Study|Lack of Efficacy|10|||
37640089|NCT02974153|69108079|FG000|Overall Study|Lost to Follow-up|9|||
37640090|NCT02974153|69108080|FG001|Overall Study|Lost to Follow-up|10|||
37640091|NCT02974153|69108081|FG002|Overall Study|Lost to Follow-up|17|||
37640092|NCT02974153|69108079|FG000|Overall Study|Physician Decision|0|||
37640093|NCT02974153|69108080|FG001|Overall Study|Physician Decision|2|||
37640094|NCT02974153|69108081|FG002|Overall Study|Physician Decision|1|||
37640095|NCT02974153|69108079|FG000|Overall Study|Withdrawal by Subject|9|||
37640096|NCT02974153|69108080|FG001|Overall Study|Withdrawal by Subject|16|||
37640097|NCT02974153|69108081|FG002|Overall Study|Withdrawal by Subject|11|||
37640098|NCT02974153|69108079|FG000|Overall Study|Study Burden|8|||
37640099|NCT02974153|69108080|FG001|Overall Study|Study Burden|7|||
37640100|NCT02974153|69108081|FG002|Overall Study|Study Burden|3|||
37640101|NCT02974153|69108079|FG000|Overall Study|Other|14|||
37640102|NCT02974153|69108080|FG001|Overall Study|Other|8|||
37640103|NCT02974153|69108081|FG002|Overall Study|Other|7|||
37640104|NCT02508532|69108096|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
37640105|NCT02508532|69108097|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
37640106|NCT02508532|69108098|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
37640107|NCT02508532|69108099|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
37640108|NCT02508532|69108100|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
37640109|NCT02508532|69108101|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
37640110|NCT02508532|69108102|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
37640111|NCT02508532|69108103|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
37640112|NCT02508532|69108104|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
37640113|NCT02508532|69108096|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
37640114|NCT02508532|69108097|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
37640115|NCT02508532|69108098|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
37640116|NCT02508532|69108099|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
37640117|NCT02508532|69108100|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
37640118|NCT02508532|69108101|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
37640119|NCT02508532|69108102|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
37640120|NCT02508532|69108103|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
37640121|NCT02508532|69108104|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
37640122|NCT02508532|69108096|FG000|Part 2 - Treatment|Disease Progression|0|||
37640123|NCT02508532|69108097|FG001|Part 2 - Treatment|Disease Progression|0|||
37640124|NCT02508532|69108098|FG002|Part 2 - Treatment|Disease Progression|0|||
37640125|NCT02508532|69108099|FG003|Part 2 - Treatment|Disease Progression|0|||
37640126|NCT02508532|69108100|FG004|Part 2 - Treatment|Disease Progression|0|||
37640127|NCT02508532|69108101|FG005|Part 2 - Treatment|Disease Progression|0|||
37640128|NCT02508532|69108102|FG006|Part 2 - Treatment|Disease Progression|0|||
37640129|NCT02508532|69108103|FG007|Part 2 - Treatment|Disease Progression|0|||
37640130|NCT02508532|69108104|FG008|Part 2 - Treatment|Disease Progression|118|||
37640131|NCT02508532|69108096|FG000|Part 2 - Treatment|Adverse Event|0|||
37640132|NCT02508532|69108097|FG001|Part 2 - Treatment|Adverse Event|0|||
37640133|NCT02508532|69108098|FG002|Part 2 - Treatment|Adverse Event|0|||
37640134|NCT02508532|69108099|FG003|Part 2 - Treatment|Adverse Event|0|||
37640135|NCT02508532|69108100|FG004|Part 2 - Treatment|Adverse Event|0|||
37640136|NCT02508532|69108101|FG005|Part 2 - Treatment|Adverse Event|0|||
37640137|NCT02508532|69108102|FG006|Part 2 - Treatment|Adverse Event|0|||
37640138|NCT02508532|69108103|FG007|Part 2 - Treatment|Adverse Event|0|||
37640139|NCT02508532|69108104|FG008|Part 2 - Treatment|Adverse Event|49|||
37640140|NCT02508532|69108096|FG000|Part 2 - Treatment|Physician Decision|0|||
37640141|NCT02508532|69108097|FG001|Part 2 - Treatment|Physician Decision|0|||
37640142|NCT02508532|69108098|FG002|Part 2 - Treatment|Physician Decision|0|||
37640143|NCT02508532|69108099|FG003|Part 2 - Treatment|Physician Decision|0|||
37640144|NCT02508532|69108100|FG004|Part 2 - Treatment|Physician Decision|0|||
37640145|NCT02508532|69108101|FG005|Part 2 - Treatment|Physician Decision|0|||
37640146|NCT02508532|69108102|FG006|Part 2 - Treatment|Physician Decision|0|||
37640147|NCT02508532|69108103|FG007|Part 2 - Treatment|Physician Decision|0|||
37640148|NCT02508532|69108104|FG008|Part 2 - Treatment|Physician Decision|12|||
37640149|NCT02508532|69108096|FG000|Part 2 - Treatment|Administrative|0|||
37640150|NCT02508532|69108097|FG001|Part 2 - Treatment|Administrative|0|||
37640151|NCT02508532|69108098|FG002|Part 2 - Treatment|Administrative|0|||
37640152|NCT02508532|69108099|FG003|Part 2 - Treatment|Administrative|0|||
37640153|NCT02508532|69108100|FG004|Part 2 - Treatment|Administrative|0|||
37640154|NCT02508532|69108101|FG005|Part 2 - Treatment|Administrative|0|||
37640155|NCT02508532|69108102|FG006|Part 2 - Treatment|Administrative|0|||
37640156|NCT02508532|69108103|FG007|Part 2 - Treatment|Administrative|0|||
37640157|NCT02508532|69108104|FG008|Part 2 - Treatment|Administrative|3|||
37640158|NCT02508532|69108096|FG000|Part 2 - Treatment|Sponsor Decision|0|||
37640159|NCT02508532|69108097|FG001|Part 2 - Treatment|Sponsor Decision|0|||
37640160|NCT02508532|69108098|FG002|Part 2 - Treatment|Sponsor Decision|0|||
37640161|NCT02508532|69108099|FG003|Part 2 - Treatment|Sponsor Decision|0|||
37640162|NCT02508532|69108100|FG004|Part 2 - Treatment|Sponsor Decision|0|||
37640163|NCT02508532|69108101|FG005|Part 2 - Treatment|Sponsor Decision|0|||
37640164|NCT02508532|69108102|FG006|Part 2 - Treatment|Sponsor Decision|0|||
37640165|NCT02508532|69108103|FG007|Part 2 - Treatment|Sponsor Decision|0|||
37640166|NCT02508532|69108104|FG008|Part 2 - Treatment|Sponsor Decision|28|||
37640167|NCT02508532|69108096|FG000|Part 2 - Treatment|Death|0|||
37640168|NCT02508532|69108097|FG001|Part 2 - Treatment|Death|0|||
37640169|NCT02508532|69108098|FG002|Part 2 - Treatment|Death|0|||
37640170|NCT02508532|69108099|FG003|Part 2 - Treatment|Death|0|||
37640171|NCT02508532|69108100|FG004|Part 2 - Treatment|Death|0|||
37640172|NCT02508532|69108101|FG005|Part 2 - Treatment|Death|0|||
37640173|NCT02508532|69108102|FG006|Part 2 - Treatment|Death|0|||
37640174|NCT02508532|69108103|FG007|Part 2 - Treatment|Death|0|||
37640175|NCT02508532|69108104|FG008|Part 2 - Treatment|Death|1|||
37640176|NCT02508532|69108096|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
37640177|NCT02508532|69108097|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
37640178|NCT02508532|69108098|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
37640179|NCT02508532|69108099|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
37640180|NCT02508532|69108100|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
37640181|NCT02508532|69108101|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
37640182|NCT02508532|69108102|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
37640183|NCT02508532|69108103|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
37640184|NCT02508532|69108104|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
37640185|NCT02508532|69108096|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
37640186|NCT02508532|69108097|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
37640187|NCT02508532|69108098|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
37640188|NCT02508532|69108099|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
37640189|NCT02508532|69108100|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
37640190|NCT02508532|69108101|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
37640191|NCT02508532|69108102|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
37640192|NCT02508532|69108103|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
37640193|NCT02508532|69108104|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
37640194|NCT02508532|69108096|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
37640195|NCT02508532|69108097|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
37640196|NCT02508532|69108098|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
37640197|NCT02508532|69108099|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
37640198|NCT02508532|69108100|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
37640199|NCT02508532|69108101|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
37640200|NCT02508532|69108102|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
37640201|NCT02508532|69108103|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
37640202|NCT02508532|69108104|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
37640203|NCT02508532|69108096|FG000|Part 1 and Part 2 End of Study|Death|0|||
37640204|NCT02508532|69108097|FG001|Part 1 and Part 2 End of Study|Death|4|||
37640205|NCT02508532|69108098|FG002|Part 1 and Part 2 End of Study|Death|2|||
37640206|NCT02508532|69108099|FG003|Part 1 and Part 2 End of Study|Death|4|||
37640207|NCT02508532|69108100|FG004|Part 1 and Part 2 End of Study|Death|3|||
37640208|NCT02508532|69108101|FG005|Part 1 and Part 2 End of Study|Death|0|||
37640209|NCT02508532|69108102|FG006|Part 1 and Part 2 End of Study|Death|0|||
37640210|NCT02508532|69108103|FG007|Part 1 and Part 2 End of Study|Death|1|||
37640211|NCT02508532|69108104|FG008|Part 1 and Part 2 End of Study|Death|111|||
37640212|NCT02508532|69108096|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
37640213|NCT02508532|69108097|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
37640214|NCT02508532|69108098|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
37640215|NCT02508532|69108099|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
37640216|NCT02508532|69108100|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
37640217|NCT02508532|69108101|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
37640218|NCT02508532|69108102|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
37640219|NCT02508532|69108103|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
37640220|NCT02508532|69108104|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
37640221|NCT02508532|69108096|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
37640222|NCT02508532|69108097|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
37640223|NCT02508532|69108098|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
37640224|NCT02508532|69108099|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
37640225|NCT02508532|69108100|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
37640226|NCT02508532|69108101|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
37640227|NCT02508532|69108102|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
37640228|NCT02508532|69108103|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
37640229|NCT02508532|69108104|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
37640230|NCT02508532|69108096|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
37640231|NCT02508532|69108097|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
37640232|NCT02508532|69108098|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
37640233|NCT02508532|69108099|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
37640234|NCT02508532|69108100|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
37640235|NCT02508532|69108101|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
37640236|NCT02508532|69108102|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
37640237|NCT02508532|69108103|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
37640238|NCT02508532|69108104|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
37640239|NCT02508532|69108096|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
37640240|NCT02508532|69108097|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
38032117|NCT03346070|69718022|FG004|Overall Study|Withdrawal by Subject|0|||
38032118|NCT03346070|69718018|FG000|Overall Study|Study medication not received as planned|2|||
38032119|NCT03346070|69718019|FG001|Overall Study|Study medication not received as planned|3|||
38032120|NCT03346070|69718020|FG002|Overall Study|Study medication not received as planned|2|||
38032121|NCT03346070|69718021|FG003|Overall Study|Study medication not received as planned|3|||
38032122|NCT03346070|69718022|FG004|Overall Study|Study medication not received as planned|2|||
38032123|NCT03346070|69718018|FG000|Overall Study|Screen Failure|0|||
37640241|NCT02508532|69108098|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
37640242|NCT02508532|69108099|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
37640243|NCT02508532|69108100|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
37640244|NCT02508532|69108101|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
37640245|NCT02508532|69108102|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
37640246|NCT02508532|69108103|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
37640247|NCT02508532|69108104|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
37640248|NCT02508532|69108096|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
37640249|NCT02508532|69108097|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
37640250|NCT02508532|69108098|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
37640251|NCT02508532|69108099|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
37640252|NCT02508532|69108100|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
37640253|NCT02508532|69108101|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
37640254|NCT02508532|69108102|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
37640255|NCT02508532|69108103|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
37640256|NCT02508532|69108104|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
37640257|NCT02918071|69108133|FG000|Overall Study|Withdrawal by Subject|2|||
37640258|NCT02918071|69108133|FG000|Overall Study|Lost to Follow-up|1|||
37640259|NCT02507752|69108137|FG000|Overall Study|Adverse Event|1|||
37640260|NCT02507752|69108137|FG000|Overall Study|Protocol Violation|6|||
37640261|NCT02507752|69108137|FG000|Overall Study|Lost to Follow-up|7|||
37640262|NCT02507752|69108137|FG000|Overall Study|Infusion reaction at first infusion|1|||
37640263|NCT02507752|69108137|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
37640264|NCT02507752|69108137|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
37640265|NCT02506816|69108141|FG000|Overall Study|Adverse Event|3|||
37640266|NCT02506036|69108147|FG000|First Intervention (4-6 Weeks)|Death|1|||
37640267|NCT02506036|69108148|FG001|First Intervention (4-6 Weeks)|Death|0|||
37640268|NCT02506036|69108147|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
37640269|NCT02506036|69108148|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
37640270|NCT02506036|69108147|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
37640271|NCT02506036|69108148|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
37640272|NCT01063855|69108156|FG000|Overall Study|Adverse Event|4|||
37640273|NCT01063855|69108157|FG001|Overall Study|Adverse Event|4|||
37640274|NCT01063855|69108156|FG000|Overall Study|Death|0|||
37640275|NCT01063855|69108157|FG001|Overall Study|Death|1|||
37640276|NCT01063855|69108156|FG000|Overall Study|Lost to Follow-up|8|||
37640277|NCT01063855|69108157|FG001|Overall Study|Lost to Follow-up|4|||
37640278|NCT01063855|69108156|FG000|Overall Study|Pregnancy|1|||
37640279|NCT01063855|69108157|FG001|Overall Study|Pregnancy|0|||
37640280|NCT01063855|69108156|FG000|Overall Study|Lack of Efficacy|0|||
37640281|NCT01063855|69108157|FG001|Overall Study|Lack of Efficacy|1|||
37640282|NCT01063855|69108156|FG000|Overall Study|Withdrawal by Subject|11|||
37640283|NCT01063855|69108157|FG001|Overall Study|Withdrawal by Subject|8|||
37640284|NCT01063855|69108156|FG000|Overall Study|Reason not specified|13|||
37640285|NCT01063855|69108157|FG001|Overall Study|Reason not specified|11|||
37640286|NCT01063153|69108169|FG000|Overall Study|Found Ineligible During Screening|2|||
37640287|NCT01063153|69108170|FG001|Overall Study|Found Ineligible During Screening|0|||
37640288|NCT01063153|69108169|FG000|Overall Study|Lost to Follow-up|0|||
37640289|NCT01063153|69108170|FG001|Overall Study|Lost to Follow-up|7|||
37640290|NCT01063153|69108169|FG000|Overall Study|Withdrawal by Subject|0|||
37640291|NCT01063153|69108170|FG001|Overall Study|Withdrawal by Subject|1|||
38032124|NCT03346070|69718019|FG001|Overall Study|Screen Failure|0|||
37640292|NCT01063153|69108169|FG000|Overall Study|Physician Decision|0|||
37640293|NCT01063153|69108170|FG001|Overall Study|Physician Decision|4|||
37640294|NCT01062841|69108182|FG000|Overall Study|Indwelling Device Removed|41|||
38032125|NCT03346070|69718020|FG002|Overall Study|Screen Failure|0|||
37640295|NCT01062841|69108183|FG001|Overall Study|Indwelling Device Removed|48|||
37640296|NCT01062841|69108182|FG000|Overall Study|Death|3|||
37640297|NCT01062841|69108183|FG001|Overall Study|Death|5|||
37640298|NCT01062841|69108182|FG000|Overall Study|Withdrawal by Subject|2|||
37640299|NCT01062841|69108183|FG001|Overall Study|Withdrawal by Subject|0|||
37640300|NCT01062841|69108182|FG000|Overall Study|Withdrawal by Study|3|||
37640301|NCT01062841|69108183|FG001|Overall Study|Withdrawal by Study|0|||
37640302|NCT02505334|69108191|FG000|Main Treatment Period|Adverse Event|3|||
37640303|NCT02505334|69108192|FG001|Main Treatment Period|Adverse Event|3|||
37640304|NCT02505334|69108191|FG000|Main Treatment Period|Lack of Efficacy|7|||
37640305|NCT02505334|69108192|FG001|Main Treatment Period|Lack of Efficacy|17|||
37640306|NCT02505334|69108191|FG000|Main Treatment Period|Protocol Violation|0|||
37640307|NCT02505334|69108192|FG001|Main Treatment Period|Protocol Violation|1|||
37640308|NCT02505334|69108191|FG000|Main Treatment Period|Withdrawal by Subject|1|||
37640309|NCT02505334|69108192|FG001|Main Treatment Period|Withdrawal by Subject|8|||
37640310|NCT02505334|69108191|FG000|Main Treatment Period|Unclassified|4|||
37640311|NCT02505334|69108192|FG001|Main Treatment Period|Unclassified|10|||
37640312|NCT02505334|69108191|FG000|Extension Treatment Period|Adverse Event|5|||
37640313|NCT02505334|69108192|FG001|Extension Treatment Period|Adverse Event|0|||
37640314|NCT02505334|69108191|FG000|Extension Treatment Period|Lack of Efficacy|4|||
37640315|NCT02505334|69108192|FG001|Extension Treatment Period|Lack of Efficacy|0|||
37640316|NCT02505334|69108191|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
37640317|NCT02505334|69108192|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
37640318|NCT02505334|69108191|FG000|Extension Treatment Period|Unclassified|3|||
37640319|NCT02505334|69108192|FG001|Extension Treatment Period|Unclassified|0|||
37640320|NCT01062061|69108198|FG000|Overall Study|Enrolled more than once|2|||
37640321|NCT01062061|69108198|FG000|Overall Study|Investigated before study start|13|||
37640322|NCT01062061|69108198|FG000|Overall Study|Outside chief indications|10|||
37640323|NCT01062061|69108198|FG000|Overall Study|Failed to meet inclusion criteria|2|||
37640324|NCT02504320|69108210|FG000|Treatment Period 1|Positive Drug Screen|0|||
37640325|NCT02504320|69108211|FG001|Treatment Period 1|Positive Drug Screen|0|||
37640326|NCT02504320|69108212|FG002|Treatment Period 1|Positive Drug Screen|1|||
37640327|NCT02504320|69108213|FG003|Treatment Period 1|Positive Drug Screen|0|||
37640328|NCT02504320|69108210|FG000|Treatment Period 2|Positive Drug Screen|0|||
37640329|NCT02504320|69108211|FG001|Treatment Period 2|Positive Drug Screen|1|||
37640330|NCT02504320|69108212|FG002|Treatment Period 2|Positive Drug Screen|0|||
37640331|NCT02504320|69108213|FG003|Treatment Period 2|Positive Drug Screen|0|||
37640332|NCT02504320|69108210|FG000|Treatment Period 3|Positive Drug Screen|0|||
37640333|NCT02504320|69108211|FG001|Treatment Period 3|Positive Drug Screen|0|||
37640334|NCT02504320|69108212|FG002|Treatment Period 3|Positive Drug Screen|0|||
37640335|NCT02504320|69108213|FG003|Treatment Period 3|Positive Drug Screen|1|||
37640336|NCT02504320|69108210|FG000|Treatment Period 3|Adverse Event|0|||
37640337|NCT02504320|69108211|FG001|Treatment Period 3|Adverse Event|0|||
37640338|NCT02504320|69108212|FG002|Treatment Period 3|Adverse Event|1|||
37640339|NCT02504320|69108213|FG003|Treatment Period 3|Adverse Event|0|||
37640340|NCT01061671|69108225|FG000|Overall Study|Withdrawal by Subject|16|||
37640341|NCT01061671|69108226|FG001|Overall Study|Withdrawal by Subject|20|||
37640342|NCT01061671|69108225|FG000|Overall Study|Lost to Follow-up|3|||
37640343|NCT01061671|69108226|FG001|Overall Study|Lost to Follow-up|5|||
37640344|NCT01061671|69108225|FG000|Overall Study|Death|28|||
37640345|NCT01061671|69108226|FG001|Overall Study|Death|30|||
37640346|NCT00709995|69108234|FG000|Overall Study|Adverse Event|4|||
37640347|NCT00709995|69108235|FG001|Overall Study|Adverse Event|2|||
37640348|NCT00709995|69108234|FG000|Overall Study|Withdrawal by Subject|1|||
37640349|NCT00709995|69108235|FG001|Overall Study|Withdrawal by Subject|3|||
37640350|NCT02503540|69108244|FG000|Overall Study|Death|2|||
37640351|NCT02503540|69108244|FG000|Overall Study|Withdrawal by Subject|1|||
38032126|NCT03346070|69718021|FG003|Overall Study|Screen Failure|1|||
38032127|NCT03346070|69718022|FG004|Overall Study|Screen Failure|1|||
38032128|NCT02951780|69718045|FG000|Period 1|Adverse Event|0|||
37640352|NCT02502526|69108251|FG000|Overall Study|Lost to Follow-up|2|||
37640353|NCT02502526|69108252|FG001|Overall Study|Lost to Follow-up|2|||
37640354|NCT02502526|69108253|FG002|Overall Study|Lost to Follow-up|3|||
37640355|NCT02502526|69108251|FG000|Overall Study|Withdrawal by Subject|0|||
37640356|NCT02502526|69108252|FG001|Overall Study|Withdrawal by Subject|1|||
37640357|NCT02502526|69108253|FG002|Overall Study|Withdrawal by Subject|1|||
37640358|NCT02502526|69108251|FG000|Overall Study|Disqualified due to cataract grading|0|||
37640359|NCT02502526|69108252|FG001|Overall Study|Disqualified due to cataract grading|0|||
37640360|NCT02502526|69108253|FG002|Overall Study|Disqualified due to cataract grading|1|||
37640361|NCT02502526|69108251|FG000|Overall Study|Enrollment suspension|4|||
37640362|NCT02502526|69108252|FG001|Overall Study|Enrollment suspension|1|||
37640363|NCT02502526|69108253|FG002|Overall Study|Enrollment suspension|1|||
37640364|NCT02972515|69108262|FG000|Overall Study|Lost to Follow-up|78|||
37640365|NCT02972359|69108266|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
37640366|NCT02972359|69108266|FG000|Overall Study|Lack of Efficacy|1|||
37640367|NCT02972359|69108266|FG000|Overall Study|Adverse Event|4|||
37640368|NCT02972359|69108266|FG000|Overall Study|Death|1|||
37640369|NCT02972359|69108266|FG000|Overall Study|Withdrawal by Subject|30|||
37640370|NCT02972359|69108266|FG000|Overall Study|Protocol Violation|1|||
37640371|NCT02972359|69108266|FG000|Overall Study|Lost to Follow-up|26|||
37640372|NCT02972359|69108266|FG000|Overall Study|Other reasons|5|||
37640373|NCT02972359|69108266|FG000|Overall Study|Missing|1|||
37640374|NCT01060111|69108273|FG000|Overall Study|Adverse Event|9|||
37640375|NCT01060111|69108274|FG001|Overall Study|Adverse Event|5|||
37640376|NCT01060111|69108275|FG002|Overall Study|Adverse Event|18|||
37640377|NCT01060111|69108273|FG000|Overall Study|Lack of Efficacy|2|||
37640378|NCT01060111|69108274|FG001|Overall Study|Lack of Efficacy|1|||
37640379|NCT01060111|69108275|FG002|Overall Study|Lack of Efficacy|0|||
37640380|NCT01060111|69108273|FG000|Overall Study|Inappropriate participant|5|||
37640381|NCT01060111|69108274|FG001|Overall Study|Inappropriate participant|4|||
37640382|NCT01060111|69108275|FG002|Overall Study|Inappropriate participant|5|||
37640383|NCT01060111|69108273|FG000|Overall Study|Participants' evasion for hospital visit|0|||
37640384|NCT01060111|69108274|FG001|Overall Study|Participants' evasion for hospital visit|3|||
37640385|NCT01060111|69108275|FG002|Overall Study|Participants' evasion for hospital visit|2|||
37640386|NCT01060111|69108273|FG000|Overall Study|Participants' non-cooperation|8|||
37640387|NCT01060111|69108274|FG001|Overall Study|Participants' non-cooperation|6|||
37640388|NCT01060111|69108275|FG002|Overall Study|Participants' non-cooperation|6|||
37640389|NCT01060111|69108273|FG000|Overall Study|Adverse event and insufficient effect|0|||
37640390|NCT01060111|69108274|FG001|Overall Study|Adverse event and insufficient effect|1|||
37640391|NCT01060111|69108275|FG002|Overall Study|Adverse event and insufficient effect|0|||
37640392|NCT01060111|69108273|FG000|Overall Study|Participants' non-cooperation|1|||
37640393|NCT01060111|69108274|FG001|Overall Study|Participants' non-cooperation|0|||
37640394|NCT01060111|69108275|FG002|Overall Study|Participants' non-cooperation|0|||
37640395|NCT01060111|69108273|FG000|Overall Study|Other|2|||
37640396|NCT01060111|69108274|FG001|Overall Study|Other|3|||
37640397|NCT01060111|69108275|FG002|Overall Study|Other|4|||
37640398|NCT02969863|69108286|FG000|Overall Study|Physician Decision|1|||
37640399|NCT02969863|69108287|FG001|Overall Study|Physician Decision|0|||
37640400|NCT02969863|69108288|FG002|Overall Study|Physician Decision|0|||
37640401|NCT02969863|69108289|FG003|Overall Study|Physician Decision|0|||
37640402|NCT02969863|69108290|FG004|Overall Study|Physician Decision|0|||
37640403|NCT02969863|69108291|FG005|Overall Study|Physician Decision|0|||
37640404|NCT02969707|69108307|FG000|Overall Study|Adverse Event|1|||
37640405|NCT02969707|69108308|FG001|Overall Study|Adverse Event|2|||
37640406|NCT02969707|69108307|FG000|Overall Study|Lost to Follow-up|3|||
37640407|NCT02969707|69108308|FG001|Overall Study|Lost to Follow-up|0|||
37640408|NCT02969707|69108307|FG000|Overall Study|Physician Decision|0|||
37640409|NCT02969707|69108308|FG001|Overall Study|Physician Decision|1|||
37640410|NCT02969707|69108307|FG000|Overall Study|Protocol Violation|1|||
37640411|NCT02969707|69108308|FG001|Overall Study|Protocol Violation|1|||
37640412|NCT02969707|69108307|FG000|Overall Study|Withdrawal by Subject|3|||
37640413|NCT02969707|69108308|FG001|Overall Study|Withdrawal by Subject|4|||
37640414|NCT02967055|69108319|FG000|Overall Study|Excluded|40|||
37640415|NCT02967055|69108319|FG000|Overall Study|Screen fail|3|||
37640416|NCT02967055|69108319|FG000|Overall Study|Lost to Follow-up|2|||
37640417|NCT02967055|69108319|FG000|Overall Study|Stopped due to side effects|3|||
37640418|NCT02967055|69108319|FG000|Overall Study|Stopped due to drug cost|1|||
37640419|NCT02904265|69108325|FG000|Overall Study|Physician Decision|1|||
37640420|NCT02904265|69108326|FG001|Overall Study|Physician Decision|2|||
37640421|NCT03461211|69108334|FG000|Overall Study|Adverse Event|1|||
37640422|NCT03461211|69108335|FG001|Overall Study|Adverse Event|1|||
37640423|NCT03461211|69108334|FG000|Overall Study|Lack of Efficacy|0|||
37640424|NCT03461211|69108335|FG001|Overall Study|Lack of Efficacy|1|||
37640425|NCT02967679|69108343|FG000|Overall Study|Adverse Event|1|||
37640426|NCT02966509|69108353|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
37640427|NCT02966509|69108354|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
37640428|NCT02966509|69108353|FG000|Baseline Satisfaction Survey|Death|0|||
37740630|NCT01863667|69226474|FG000|Overall Study|Study terminated by Sponsor|30|||
37740631|NCT01863667|69226475|FG001|Overall Study|Study terminated by Sponsor|30|||
37640429|NCT02966509|69108354|FG001|Baseline Satisfaction Survey|Death|1|||
37640430|NCT02966509|69108353|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
37640431|NCT02966509|69108354|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
37640432|NCT02966509|69108353|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
37640433|NCT02966509|69108354|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
37640434|NCT02966509|69108353|FG000|6 Month Satisfaction Decision Survey|Death|22|||
37640435|NCT02966509|69108354|FG001|6 Month Satisfaction Decision Survey|Death|25|||
37640436|NCT02966509|69108353|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
37640437|NCT02966509|69108354|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
37640438|NCT02966509|69108353|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
38032129|NCT02951780|69718046|FG001|Period 1|Adverse Event|0|||
37640439|NCT02966509|69108354|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
37640440|NCT02966509|69108353|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
37640441|NCT02966509|69108354|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
37640442|NCT02966509|69108353|FG000|6 Month Satisfaction Survey|Death|36|||
37640443|NCT02966509|69108354|FG001|6 Month Satisfaction Survey|Death|33|||
37640444|NCT02966509|69108353|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
37640445|NCT02966509|69108354|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
37640446|NCT02966509|69108353|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
37640447|NCT02966509|69108354|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
37640448|NCT02966509|69108353|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
37640449|NCT02966509|69108354|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
37640450|NCT02966509|69108353|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
37640451|NCT02966509|69108354|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
37640452|NCT02966509|69108353|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
37640453|NCT02966509|69108354|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
37640454|NCT02966353|69108360|FG000|Overall Study|Withdrawal by Subject|7|||
37640455|NCT02966353|69108360|FG000|Overall Study|Adverse Event|4|||
37640456|NCT02966353|69108360|FG000|Overall Study|Death|4|||
37640457|NCT02966353|69108360|FG000|Overall Study|Physician Decision|3|||
37640458|NCT02966353|69108360|FG000|Overall Study|Progressive disease|2|||
37640459|NCT02966353|69108360|FG000|Overall Study|Protocol deviation|2|||
37640460|NCT02965573|69108393|FG000|Overall Study|Lack of Efficacy|1|||
37640461|NCT02965573|69108394|FG001|Overall Study|Lack of Efficacy|0|||
37640462|NCT02964325|69108402|FG000|Overall Study|Lost to Follow-up|3|||
37640463|NCT02964325|69108403|FG001|Overall Study|Lost to Follow-up|3|||
37640464|NCT02964325|69108402|FG000|Overall Study|Physician Decision|5|||
37640465|NCT02964325|69108403|FG001|Overall Study|Physician Decision|4|||
37640466|NCT02964325|69108402|FG000|Overall Study|Death|1|||
37640467|NCT02964325|69108403|FG001|Overall Study|Death|3|||
37640468|NCT02964325|69108402|FG000|Overall Study|Withdrawal by Subject|2|||
37640469|NCT02964325|69108403|FG001|Overall Study|Withdrawal by Subject|1|||
37640470|NCT02964325|69108402|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
37640471|NCT02964325|69108403|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
37640472|NCT02964247|69108411|FG000|Overall Study|Lost to Follow-up|2|||
37640473|NCT02964247|69108412|FG001|Overall Study|Lost to Follow-up|0|||
37640474|NCT02964247|69108411|FG000|Overall Study|Withdrawal by Subject|1|||
37640475|NCT02964247|69108412|FG001|Overall Study|Withdrawal by Subject|2|||
37640476|NCT03654729|69108421|FG000|Overall Study|Death|9|||
37640477|NCT03654729|69108422|FG001|Overall Study|Death|9|||
37640478|NCT03654729|69108423|FG002|Overall Study|Death|16|||
37640479|NCT03654729|69108421|FG000|Overall Study|Withdrawal by Subject|8|||
37640480|NCT03654729|69108422|FG001|Overall Study|Withdrawal by Subject|6|||
37640481|NCT03654729|69108423|FG002|Overall Study|Withdrawal by Subject|4|||
37640482|NCT03654729|69108421|FG000|Overall Study|Study terminated by Sponsor|3|||
37640483|NCT03654729|69108422|FG001|Overall Study|Study terminated by Sponsor|5|||
37640484|NCT03654729|69108423|FG002|Overall Study|Study terminated by Sponsor|4|||
37640485|NCT03654729|69108421|FG000|Overall Study|Not reported|2|||
37640486|NCT03654729|69108422|FG001|Overall Study|Not reported|4|||
37640487|NCT03654729|69108423|FG002|Overall Study|Not reported|5|||
37640488|NCT03654729|69108421|FG000|Overall Study|Progressive disease|3|||
37640489|NCT03654729|69108422|FG001|Overall Study|Progressive disease|0|||
37640490|NCT03654729|69108423|FG002|Overall Study|Progressive disease|0|||
37640491|NCT03654729|69108421|FG000|Overall Study|Lost to Follow-up|2|||
37640492|NCT03654729|69108422|FG001|Overall Study|Lost to Follow-up|0|||
37640493|NCT03654729|69108423|FG002|Overall Study|Lost to Follow-up|0|||
37640494|NCT03654729|69108421|FG000|Overall Study|Physician Decision|2|||
37640495|NCT03654729|69108422|FG001|Overall Study|Physician Decision|0|||
37640496|NCT03654729|69108423|FG002|Overall Study|Physician Decision|0|||
37640497|NCT03654729|69108421|FG000|Overall Study|Protocol Violation|1|||
37640498|NCT03654729|69108422|FG001|Overall Study|Protocol Violation|1|||
37640499|NCT03654729|69108423|FG002|Overall Study|Protocol Violation|0|||
37640500|NCT03654729|69108421|FG000|Overall Study|Non-compliance with study drug|0|||
37640501|NCT03654729|69108422|FG001|Overall Study|Non-compliance with study drug|1|||
37740632|NCT01863667|69226474|FG000|Overall Study|Withdrawal by Subject|2|||
37740633|NCT01863667|69226475|FG001|Overall Study|Withdrawal by Subject|2|||
37640502|NCT03654729|69108423|FG002|Overall Study|Non-compliance with study drug|0|||
37640503|NCT03654729|69108421|FG000|Overall Study|Site terminated by Sponsor|1|||
37640504|NCT03654729|69108422|FG001|Overall Study|Site terminated by Sponsor|0|||
37740634|NCT01614769|69226481|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
37740635|NCT01614769|69226482|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
37740636|NCT01614769|69226483|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
37640505|NCT03654729|69108423|FG002|Overall Study|Site terminated by Sponsor|0|||
37640506|NCT01377987|69108431|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
37640507|NCT01377987|69108432|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
37640508|NCT02898259|69108443|FG000|Overall Study|Adverse Event|0|||
37640509|NCT02898259|69108444|FG001|Overall Study|Adverse Event|0|||
37640510|NCT02898259|69108445|FG002|Overall Study|Adverse Event|1|||
37640511|NCT02898259|69108446|FG003|Overall Study|Adverse Event|0|||
37640512|NCT02898259|69108447|FG004|Overall Study|Adverse Event|0|||
37640513|NCT02898259|69108443|FG000|Overall Study|Lack of Efficacy|1|||
37640514|NCT02898259|69108444|FG001|Overall Study|Lack of Efficacy|1|||
37640515|NCT02898259|69108445|FG002|Overall Study|Lack of Efficacy|3|||
37640516|NCT02898259|69108446|FG003|Overall Study|Lack of Efficacy|0|||
37640517|NCT02898259|69108447|FG004|Overall Study|Lack of Efficacy|0|||
37640518|NCT02898259|69108443|FG000|Overall Study|Lost to Follow-up|0|||
37640519|NCT02898259|69108444|FG001|Overall Study|Lost to Follow-up|0|||
37640520|NCT02898259|69108445|FG002|Overall Study|Lost to Follow-up|1|||
37640521|NCT02898259|69108446|FG003|Overall Study|Lost to Follow-up|0|||
37640522|NCT02898259|69108447|FG004|Overall Study|Lost to Follow-up|0|||
37640523|NCT02898259|69108443|FG000|Overall Study|Transformation before study began|0|||
37640524|NCT02898259|69108444|FG001|Overall Study|Transformation before study began|0|||
37640525|NCT02898259|69108445|FG002|Overall Study|Transformation before study began|0|||
37640526|NCT02898259|69108446|FG003|Overall Study|Transformation before study began|1|||
37640527|NCT02898259|69108447|FG004|Overall Study|Transformation before study began|0|||
37640528|NCT02963935|69108462|FG000|Overall Study|Adverse Event|12|||
37640529|NCT02963935|69108463|FG001|Overall Study|Adverse Event|6|||
37640530|NCT02963935|69108462|FG000|Overall Study|Protocol Violation|2|||
37640531|NCT02963935|69108463|FG001|Overall Study|Protocol Violation|1|||
37640532|NCT02963935|69108462|FG000|Overall Study|Lack of Efficacy|0|||
37640533|NCT02963935|69108463|FG001|Overall Study|Lack of Efficacy|2|||
37640534|NCT02963935|69108462|FG000|Overall Study|Lost to Follow-up|1|||
37640535|NCT02963935|69108463|FG001|Overall Study|Lost to Follow-up|6|||
37640536|NCT02963935|69108462|FG000|Overall Study|Unclassified|13|||
37640537|NCT02963935|69108463|FG001|Overall Study|Unclassified|22|||
37640538|NCT02963701|69108471|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
37640539|NCT02963701|69108472|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
37640540|NCT01345591|69108478|FG000|Overall Study|Lost to Follow-up|1|||
37640541|NCT02961751|69108487|FG000|Overall Study|Lost to Follow-up|11|||
37640542|NCT02961751|69108487|FG000|Overall Study|Physician Decision|2|||
37640543|NCT02961751|69108487|FG000|Overall Study|Not Eligible at Enrollment|1|||
37640544|NCT02961751|69108487|FG000|Overall Study|Protocol Violation|1|||
37640545|NCT02963311|69108491|FG000|Overall Study|Withdrawal by Subject|1|||
37640546|NCT02963311|69108491|FG000|Overall Study|Screen Failure|4|||
37640547|NCT02962765|69108495|FG000|Overall Study|Protocol Violation|9|||
37640548|NCT02962765|69108495|FG000|Overall Study|Withdrawal by Subject|3|||
37640549|NCT02962765|69108495|FG000|Overall Study|Lost to Follow-up|1|||
37640550|NCT02962765|69108495|FG000|Overall Study|Death|1|||
37640551|NCT02962765|69108495|FG000|Overall Study|Limited access to study medication|3|||
37640552|NCT00965757|69108508|FG000|Double-blind Phase|Progression of concomitant disease|1|||
37640553|NCT00965757|69108509|FG001|Double-blind Phase|Progression of concomitant disease|2|||
37640554|NCT00965757|69108510|FG002|Double-blind Phase|Progression of concomitant disease|0|||
37640555|NCT00965757|69108511|FG003|Double-blind Phase|Progression of concomitant disease|0|||
37640556|NCT00965757|69108508|FG000|Double-blind Phase|Adverse drug reaction|2|||
37640557|NCT00965757|69108509|FG001|Double-blind Phase|Adverse drug reaction|1|||
37640558|NCT00965757|69108510|FG002|Double-blind Phase|Adverse drug reaction|0|||
37640559|NCT00965757|69108511|FG003|Double-blind Phase|Adverse drug reaction|0|||
37640560|NCT00965757|69108508|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
37640561|NCT00965757|69108509|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
37640562|NCT00965757|69108510|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
37640563|NCT00965757|69108511|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
37640564|NCT00965757|69108508|FG000|Double-blind Phase|Lack of Efficacy|7|||
37640565|NCT00965757|69108509|FG001|Double-blind Phase|Lack of Efficacy|11|||
37640566|NCT00965757|69108510|FG002|Double-blind Phase|Lack of Efficacy|0|||
37640567|NCT00965757|69108511|FG003|Double-blind Phase|Lack of Efficacy|0|||
37640568|NCT00965757|69108508|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
37640569|NCT00965757|69108509|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
37640570|NCT00965757|69108510|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
37640571|NCT00965757|69108511|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
37640572|NCT00965757|69108508|FG000|Double-blind Phase|Lost to Follow-up|0|||
37640573|NCT00965757|69108509|FG001|Double-blind Phase|Lost to Follow-up|1|||
37640574|NCT00965757|69108510|FG002|Double-blind Phase|Lost to Follow-up|0|||
37640575|NCT00965757|69108511|FG003|Double-blind Phase|Lost to Follow-up|0|||
37640576|NCT00965757|69108508|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
37640577|NCT00965757|69108509|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
37854377|NCT01232283|69537959|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
37640578|NCT00965757|69108510|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
37640579|NCT00965757|69108511|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
37640580|NCT00965757|69108508|FG000|Double-blind Phase|Other|1|||
37740637|NCT01614769|69226484|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
37740638|NCT01614769|69226485|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
37640581|NCT00965757|69108509|FG001|Double-blind Phase|Other|0|||
37640582|NCT00965757|69108510|FG002|Double-blind Phase|Other|0|||
37640583|NCT00965757|69108511|FG003|Double-blind Phase|Other|0|||
37640584|NCT00965757|69108508|FG000|Extension Phase|Progression of concomitant disease|0|||
37640585|NCT00965757|69108509|FG001|Extension Phase|Progression of concomitant disease|0|||
37640586|NCT00965757|69108510|FG002|Extension Phase|Progression of concomitant disease|4|||
37640587|NCT00965757|69108511|FG003|Extension Phase|Progression of concomitant disease|2|||
37640588|NCT00965757|69108508|FG000|Extension Phase|Adverse drug reaction|0|||
37640589|NCT00965757|69108509|FG001|Extension Phase|Adverse drug reaction|0|||
37640590|NCT00965757|69108510|FG002|Extension Phase|Adverse drug reaction|6|||
37640591|NCT00965757|69108511|FG003|Extension Phase|Adverse drug reaction|3|||
37640592|NCT00965757|69108508|FG000|Extension Phase|Abnormal Laboratory Value|0|||
37640593|NCT00965757|69108509|FG001|Extension Phase|Abnormal Laboratory Value|0|||
37640594|NCT00965757|69108510|FG002|Extension Phase|Abnormal Laboratory Value|6|||
37640595|NCT00965757|69108511|FG003|Extension Phase|Abnormal Laboratory Value|1|||
37640596|NCT00965757|69108508|FG000|Extension Phase|Lack of Efficacy|0|||
37640597|NCT00965757|69108509|FG001|Extension Phase|Lack of Efficacy|0|||
37640598|NCT00965757|69108510|FG002|Extension Phase|Lack of Efficacy|8|||
37640599|NCT00965757|69108511|FG003|Extension Phase|Lack of Efficacy|12|||
37640600|NCT00965757|69108508|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
37640601|NCT00965757|69108509|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
37640602|NCT00965757|69108510|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
37640603|NCT00965757|69108511|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
37640604|NCT00965757|69108508|FG000|Extension Phase|Lost to Follow-up|0|||
37640605|NCT00965757|69108509|FG001|Extension Phase|Lost to Follow-up|0|||
37640606|NCT00965757|69108510|FG002|Extension Phase|Lost to Follow-up|0|||
37640607|NCT00965757|69108511|FG003|Extension Phase|Lost to Follow-up|1|||
37640608|NCT00965757|69108508|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
37640609|NCT00965757|69108509|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
37640610|NCT00965757|69108510|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
37640611|NCT00965757|69108511|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
37640612|NCT00965757|69108508|FG000|Extension Phase|Protocol Violation|0|||
37640613|NCT00965757|69108509|FG001|Extension Phase|Protocol Violation|0|||
37640614|NCT00965757|69108510|FG002|Extension Phase|Protocol Violation|0|||
37640615|NCT00965757|69108511|FG003|Extension Phase|Protocol Violation|1|||
37640616|NCT00965757|69108508|FG000|Extension Phase|Other|0|||
37640617|NCT00965757|69108509|FG001|Extension Phase|Other|0|||
37640618|NCT00965757|69108510|FG002|Extension Phase|Other|2|||
37640619|NCT00965757|69108511|FG003|Extension Phase|Other|1|||
37640620|NCT03072459|69108519|FG000|Overall Study|Device revised/removed|1|||
37640621|NCT03072459|69108519|FG000|Overall Study|Subject not able to return|1|||
37640622|NCT01067521|69108525|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
37640623|NCT01067521|69108526|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
37640624|NCT01067521|69108525|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
37640625|NCT01067521|69108526|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
37640626|NCT01067521|69108525|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
37640627|NCT01067521|69108526|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
37640628|NCT01067521|69108525|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
37640629|NCT01067521|69108526|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
37640630|NCT01067521|69108525|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
37640631|NCT01067521|69108526|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
37640632|NCT01067521|69108525|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
37640633|NCT01067521|69108526|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
37640634|NCT01067521|69108525|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
37640635|NCT01067521|69108526|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
37640636|NCT01067521|69108525|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
37640637|NCT01067521|69108526|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
37640638|NCT01067521|69108525|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
37640639|NCT01067521|69108526|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
37640640|NCT01067521|69108525|FG000|Open-Label Period|Death|3|||
37640641|NCT01067521|69108526|FG001|Open-Label Period|Death|1|||
37640642|NCT01067521|69108525|FG000|Open-Label Period|Adverse Event|30|||
37640643|NCT01067521|69108526|FG001|Open-Label Period|Adverse Event|28|||
37640644|NCT01067521|69108525|FG000|Open-Label Period|Withdrawal by Subject|160|||
37640645|NCT01067521|69108526|FG001|Open-Label Period|Withdrawal by Subject|88|||
37640646|NCT01067521|69108525|FG000|Open-Label Period|Physician Decision|13|||
37640647|NCT01067521|69108526|FG001|Open-Label Period|Physician Decision|11|||
37640648|NCT01067521|69108525|FG000|Open-Label Period|Non-compliance with study drug|5|||
37640649|NCT01067521|69108526|FG001|Open-Label Period|Non-compliance with study drug|0|||
37640650|NCT01067521|69108525|FG000|Open-Label Period|Protocol Violation|3|||
37640651|NCT01067521|69108526|FG001|Open-Label Period|Protocol Violation|0|||
37640652|NCT01067521|69108525|FG000|Open-Label Period|Pregnancy|14|||
37740639|NCT01614769|69226486|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
37740640|NCT01614769|69226481|FG000|Period 1|Protocol Violation|0|||
37740641|NCT01614769|69226482|FG001|Period 1|Protocol Violation|0|||
37640653|NCT01067521|69108526|FG001|Open-Label Period|Pregnancy|8|||
37640654|NCT01067521|69108525|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
37640655|NCT01067521|69108526|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
37640656|NCT01067521|69108525|FG000|Open-Label Period|Lost to Follow-up|21|||
37640657|NCT01067521|69108526|FG001|Open-Label Period|Lost to Follow-up|20|||
37640658|NCT02735577|69108537|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
37640659|NCT02735577|69108537|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
37640660|NCT01345123|69108544|FG000|Overall Study|participants no longer with health plan|79|||
37640661|NCT01345123|69108545|FG001|Overall Study|participants no longer with health plan|85|||
37640662|NCT01345123|69108546|FG002|Overall Study|participants no longer with health plan|88|||
37640663|NCT02735421|69108555|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
37640664|NCT02735421|69108555|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
37640665|NCT02735421|69108555|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
37640666|NCT02735421|69108555|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
37640667|NCT02735421|69108555|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
37640668|NCT02735421|69108555|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
37640669|NCT02735421|69108555|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
37640670|NCT02983799|69108572|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
37640671|NCT02983799|69108573|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
37640672|NCT02983799|69108574|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
37640673|NCT02983799|69108575|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
37640674|NCT02983799|69108576|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
37640675|NCT02983799|69108572|FG000|Overall Study|Death|20|||
37640676|NCT02983799|69108573|FG001|Overall Study|Death|5|||
37640677|NCT02983799|69108574|FG002|Overall Study|Death|23|||
37640678|NCT02983799|69108575|FG003|Overall Study|Death|47|||
37640679|NCT02983799|69108576|FG004|Overall Study|Death|7|||
37640680|NCT02983799|69108572|FG000|Overall Study|Withdrawal by Subject|1|||
37640681|NCT02983799|69108573|FG001|Overall Study|Withdrawal by Subject|0|||
37640682|NCT02983799|69108574|FG002|Overall Study|Withdrawal by Subject|3|||
37640683|NCT02983799|69108575|FG003|Overall Study|Withdrawal by Subject|4|||
37640684|NCT02983799|69108576|FG004|Overall Study|Withdrawal by Subject|1|||
37640685|NCT02983799|69108572|FG000|Overall Study|Protocol Violation|0|||
37640686|NCT02983799|69108573|FG001|Overall Study|Protocol Violation|1|||
37640687|NCT02983799|69108574|FG002|Overall Study|Protocol Violation|0|||
37640688|NCT02983799|69108575|FG003|Overall Study|Protocol Violation|0|||
37640689|NCT02983799|69108576|FG004|Overall Study|Protocol Violation|1|||
37640690|NCT02983799|69108572|FG000|Overall Study|Lost to Follow-up|1|||
37640691|NCT02983799|69108573|FG001|Overall Study|Lost to Follow-up|0|||
37640692|NCT02983799|69108574|FG002|Overall Study|Lost to Follow-up|1|||
37640693|NCT02983799|69108575|FG003|Overall Study|Lost to Follow-up|0|||
37640694|NCT02983799|69108576|FG004|Overall Study|Lost to Follow-up|0|||
37640695|NCT02186847|69108594|FG000|Overall Study|Protocol Violation|3|||
37640696|NCT02186847|69108595|FG001|Overall Study|Protocol Violation|0|||
37640697|NCT01066871|69108605|FG000|Overall Study|Lost to Follow-up|0|||
37640698|NCT01066871|69108606|FG001|Overall Study|Lost to Follow-up|2|||
37640699|NCT01066871|69108607|FG002|Overall Study|Lost to Follow-up|2|||
37640700|NCT01066871|69108608|FG003|Overall Study|Lost to Follow-up|0|||
37640701|NCT01066871|69108605|FG000|Overall Study|Protocol Violation|1|||
37640702|NCT01066871|69108606|FG001|Overall Study|Protocol Violation|0|||
37640703|NCT01066871|69108607|FG002|Overall Study|Protocol Violation|3|||
37640704|NCT01066871|69108608|FG003|Overall Study|Protocol Violation|2|||
37640705|NCT01066871|69108605|FG000|Overall Study|Lack of Efficacy|0|||
37640706|NCT01066871|69108606|FG001|Overall Study|Lack of Efficacy|0|||
37640707|NCT01066871|69108607|FG002|Overall Study|Lack of Efficacy|0|||
37640708|NCT01066871|69108608|FG003|Overall Study|Lack of Efficacy|1|||
37640709|NCT01066871|69108605|FG000|Overall Study|Withdrawal by Subject|3|||
37640710|NCT01066871|69108606|FG001|Overall Study|Withdrawal by Subject|1|||
37640711|NCT01066871|69108607|FG002|Overall Study|Withdrawal by Subject|0|||
37640712|NCT01066871|69108608|FG003|Overall Study|Withdrawal by Subject|0|||
37640713|NCT01066871|69108605|FG000|Overall Study|Other|0|||
37640714|NCT01066871|69108606|FG001|Overall Study|Other|2|||
37640715|NCT01066871|69108607|FG002|Overall Study|Other|1|||
37640716|NCT01066871|69108608|FG003|Overall Study|Other|2|||
37740642|NCT01614769|69226483|FG002|Period 1|Protocol Violation|0|||
37740643|NCT01614769|69226484|FG003|Period 1|Protocol Violation|1|||
37640717|NCT02982863|69108628|FG000|Overall Study|Not eligible patients|809|||
37640718|NCT02982863|69108629|FG001|Overall Study|Not eligible patients|4261|||
37640719|NCT02982863|69108630|FG002|Overall Study|Not eligible patients|1852|||
37640720|NCT02982863|69108631|FG003|Overall Study|Not eligible patients|1400|||
37640721|NCT02982863|69108632|FG004|Overall Study|Not eligible patients|492|||
37640722|NCT04343651|69108675|FG000|Overall Study|Physician Decision|2|||
37640723|NCT04343651|69108676|FG001|Overall Study|Physician Decision|1|||
37640724|NCT04343651|69108675|FG000|Overall Study|Lost to Follow-up|2|||
37640725|NCT04343651|69108676|FG001|Overall Study|Lost to Follow-up|1|||
37640726|NCT04343651|69108675|FG000|Overall Study|Protocol Violation|4|||
37640727|NCT04343651|69108676|FG001|Overall Study|Protocol Violation|6|||
37640728|NCT04343651|69108675|FG000|Overall Study|Missing|3|||
37640729|NCT04343651|69108676|FG001|Overall Study|Missing|9|||
37640730|NCT04343651|69108675|FG000|Overall Study|Withdrawal by Subject|0|||
37640731|NCT04343651|69108676|FG001|Overall Study|Withdrawal by Subject|4|||
37640732|NCT04343651|69108675|FG000|Overall Study|Death|0|||
37640733|NCT04343651|69108676|FG001|Overall Study|Death|1|||
37640734|NCT04343651|69108675|FG000|Overall Study|Did not start treatment|1|||
37640735|NCT04343651|69108676|FG001|Overall Study|Did not start treatment|1|||
37640736|NCT04343651|69108675|FG000|Overall Study|Patient did not complete visits 3-6|0|||
37640737|NCT04343651|69108676|FG001|Overall Study|Patient did not complete visits 3-6|1|||
37921942|NCT00819390|69608746|FG000|Overall Study|Withdrawal by Subject|2|||
37921943|NCT00819390|69608747|FG001|Overall Study|Withdrawal by Subject|0|||
37640738|NCT02906579|69108684|FG000|Overall Study|Adverse Event|1|||
37640739|NCT02906579|69108684|FG000|Overall Study|Physician Decision|1|||
37640740|NCT01328535|69108704|FG000|Overall Study|Ineligible|1|||
37640741|NCT02905331|69108712|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
37640742|NCT02905331|69108713|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
37640743|NCT02905331|69108714|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
37640744|NCT02905331|69108712|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
37640745|NCT02905331|69108713|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
37640746|NCT02905331|69108714|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
37640747|NCT02905331|69108712|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
37640748|NCT02905331|69108713|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
37640749|NCT02905331|69108714|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
37640750|NCT02905331|69108712|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
37640751|NCT02905331|69108713|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
37640752|NCT02905331|69108714|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
37640753|NCT02905331|69108712|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
37640754|NCT02905331|69108713|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
37640755|NCT02905331|69108714|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
37640756|NCT02979197|69108725|FG000|Overall Study|Adverse Event|4|||
37640757|NCT02979197|69108726|FG001|Overall Study|Adverse Event|2|||
37640758|NCT02979197|69108727|FG002|Overall Study|Adverse Event|0|||
37640759|NCT02979197|69108725|FG000|Overall Study|Protocol Violation|0|||
37640760|NCT02979197|69108726|FG001|Overall Study|Protocol Violation|1|||
37640761|NCT02979197|69108727|FG002|Overall Study|Protocol Violation|0|||
37640762|NCT02979197|69108725|FG000|Overall Study|Subject unable to commit to study dates|0|||
37640763|NCT02979197|69108726|FG001|Overall Study|Subject unable to commit to study dates|1|||
37640764|NCT02979197|69108727|FG002|Overall Study|Subject unable to commit to study dates|0|||
37640765|NCT02982239|69108737|FG000|Overall Study|Lost to Follow-up|3|||
37640766|NCT02982239|69108738|FG001|Overall Study|Lost to Follow-up|2|||
37640767|NCT01066793|69108751|FG000|Overall Study|Death|4|||
37640768|NCT01066793|69108752|FG001|Overall Study|Death|1|||
37640769|NCT01066793|69108753|FG002|Overall Study|Death|1|||
37640770|NCT01066793|69108754|FG003|Overall Study|Death|0|||
37640771|NCT01066793|69108755|FG004|Overall Study|Death|0|||
37640772|NCT01066793|69108756|FG005|Overall Study|Death|0|||
37640773|NCT01066793|69108751|FG000|Overall Study|Lack of Efficacy|2|||
37640774|NCT01066793|69108752|FG001|Overall Study|Lack of Efficacy|1|||
37640775|NCT01066793|69108753|FG002|Overall Study|Lack of Efficacy|0|||
37640776|NCT01066793|69108754|FG003|Overall Study|Lack of Efficacy|0|||
37640777|NCT01066793|69108755|FG004|Overall Study|Lack of Efficacy|0|||
37854378|NCT01232283|69537960|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
37854379|NCT01232283|69537961|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
37854380|NCT01232283|69537952|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
37854381|NCT01232283|69537953|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
37854382|NCT01232283|69537954|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
37854383|NCT01232283|69537955|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
37854384|NCT01232283|69537956|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
37854385|NCT01232283|69537957|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
37854386|NCT01232283|69537958|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
37921944|NCT00819390|69608748|FG002|Overall Study|Withdrawal by Subject|0|||
37640778|NCT01066793|69108756|FG005|Overall Study|Lack of Efficacy|0|||
37640779|NCT01066793|69108751|FG000|Overall Study|Lost to Follow-up|180|||
37921945|NCT00819390|69608749|FG003|Overall Study|Withdrawal by Subject|0|||
37640780|NCT01066793|69108752|FG001|Overall Study|Lost to Follow-up|39|||
37640781|NCT01066793|69108753|FG002|Overall Study|Lost to Follow-up|82|||
37640782|NCT01066793|69108754|FG003|Overall Study|Lost to Follow-up|16|||
37640783|NCT01066793|69108755|FG004|Overall Study|Lost to Follow-up|0|||
37640784|NCT01066793|69108756|FG005|Overall Study|Lost to Follow-up|1|||
37640785|NCT01066793|69108751|FG000|Overall Study|Physician Decision|3|||
37854387|NCT01232283|69537959|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
37854388|NCT01232283|69537960|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
37921946|NCT00819390|69608746|FG000|Overall Study|Adverse Event|0|||
37640786|NCT01066793|69108752|FG001|Overall Study|Physician Decision|0|||
37640787|NCT01066793|69108753|FG002|Overall Study|Physician Decision|0|||
37740644|NCT01614769|69226485|FG004|Period 1|Protocol Violation|0|||
37740645|NCT01614769|69226486|FG005|Period 1|Protocol Violation|0|||
37740646|NCT01614769|69226481|FG000|Period 1|Withdrawal by Subject|1|||
37740647|NCT01614769|69226482|FG001|Period 1|Withdrawal by Subject|0|||
37740648|NCT01614769|69226483|FG002|Period 1|Withdrawal by Subject|0|||
37740649|NCT01614769|69226484|FG003|Period 1|Withdrawal by Subject|0|||
37740650|NCT01614769|69226485|FG004|Period 1|Withdrawal by Subject|0|||
37740651|NCT01614769|69226486|FG005|Period 1|Withdrawal by Subject|0|||
37740652|NCT01614769|69226481|FG000|Period 3|Withdrawal by Subject|0|||
37740653|NCT01614769|69226482|FG001|Period 3|Withdrawal by Subject|0|||
37740654|NCT01614769|69226483|FG002|Period 3|Withdrawal by Subject|1|||
37740655|NCT01614769|69226484|FG003|Period 3|Withdrawal by Subject|0|||
37740656|NCT01614769|69226485|FG004|Period 3|Withdrawal by Subject|0|||
37740657|NCT01614769|69226486|FG005|Period 3|Withdrawal by Subject|0|||
37740658|NCT01614457|69226496|FG000|Overall Study|Non-Compliance|1|||
37740659|NCT01614457|69226497|FG001|Overall Study|Non-Compliance|0|||
37740660|NCT01614457|69226496|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
37740661|NCT01614457|69226497|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
37740662|NCT01863433|69226503|FG000|Overall Study|Protocol Violation|1|||
37740663|NCT01862029|69226507|FG000|Overall Study|Physician Decision|1|||
37740664|NCT01835431|69226514|FG000|Overall Study|Adverse Event|1|||
37740665|NCT01835431|69226515|FG001|Overall Study|Adverse Event|0|||
37740666|NCT01835431|69226514|FG000|Overall Study|other|0|||
37740667|NCT01835431|69226515|FG001|Overall Study|other|2|||
37740668|NCT01835431|69226514|FG000|Overall Study|Withdrawal by Subject|6|||
37740669|NCT01835431|69226515|FG001|Overall Study|Withdrawal by Subject|10|||
37740670|NCT01835431|69226514|FG000|Overall Study|Protocol Violation|1|||
37740671|NCT01835431|69226515|FG001|Overall Study|Protocol Violation|0|||
37740672|NCT01880593|69226523|FG000|Overall Study|Adverse Event|1|||
37740673|NCT01880593|69226524|FG001|Overall Study|Adverse Event|0|||
37740674|NCT01880593|69226523|FG000|Overall Study|Lack of Efficacy|1|||
37740675|NCT01880593|69226524|FG001|Overall Study|Lack of Efficacy|5|||
37740676|NCT01880593|69226523|FG000|Overall Study|Withdrawal by Subject|6|||
37740677|NCT01880593|69226524|FG001|Overall Study|Withdrawal by Subject|1|||
37740678|NCT01400451|69226533|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
37740679|NCT01400451|69226534|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
37740680|NCT01400451|69226535|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
37740681|NCT01400451|69226533|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
37740682|NCT01400451|69226534|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
37740683|NCT01400451|69226535|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
37740684|NCT01400451|69226533|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
37740685|NCT01400451|69226534|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
37740686|NCT01400451|69226535|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
37740687|NCT01400451|69226533|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
37740688|NCT01400451|69226534|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
37740689|NCT01400451|69226535|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
37740690|NCT01400451|69226533|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
37740691|NCT01400451|69226534|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
37740692|NCT01400451|69226535|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
37740693|NCT01400139|69226548|FG000|HYD Core Study|Adverse Event|210|||
37740694|NCT01400139|69226548|FG000|HYD Core Study|Lack of Efficacy|59|||
37740695|NCT01400139|69226548|FG000|HYD Core Study|Withdrawal by Subject|114|||
37740696|NCT01400139|69226548|FG000|HYD Core Study|Lost to Follow-up|39|||
37740697|NCT01400139|69226548|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
37740698|NCT01400139|69226548|FG000|HYD Core Study|Administrative|56|||
37740699|NCT01400139|69226548|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
37740700|NCT01400139|69226548|FG000|HYD Extension Period|Adverse Event|8|||
37740701|NCT01400139|69226548|FG000|HYD Extension Period|Withdrawal by Subject|5|||
37740702|NCT01400139|69226548|FG000|HYD Extension Period|Administrative|10|||
37740703|NCT01399905|69226556|FG000|Overall Study|Withdrawal by Subject|1|||
38032130|NCT02951780|69718047|FG002|Period 1|Adverse Event|0|||
37640788|NCT01066793|69108754|FG003|Overall Study|Physician Decision|0|||
37740704|NCT01399905|69226557|FG001|Overall Study|Withdrawal by Subject|1|||
37740705|NCT01725308|69226571|FG000|Treatment Period I|Did Not Receive Drug|1|||
37921947|NCT00819390|69608747|FG001|Overall Study|Adverse Event|0|||
37921948|NCT00819390|69608748|FG002|Overall Study|Adverse Event|1|||
37640789|NCT01066793|69108755|FG004|Overall Study|Physician Decision|0|||
37740706|NCT01725308|69226572|FG001|Treatment Period I|Did Not Receive Drug|0|||
37740707|NCT01725308|69226573|FG002|Treatment Period I|Did Not Receive Drug|0|||
37740708|NCT01725308|69226571|FG000|Treatment Period I|Adverse Event|5|||
37740709|NCT01725308|69226572|FG001|Treatment Period I|Adverse Event|4|||
37740710|NCT01725308|69226573|FG002|Treatment Period I|Adverse Event|21|||
37740711|NCT01725308|69226571|FG000|Treatment Period I|Insufficient Response|7|||
37740712|NCT01725308|69226572|FG001|Treatment Period I|Insufficient Response|0|||
37640790|NCT01066793|69108756|FG005|Overall Study|Physician Decision|0|||
37640791|NCT01066793|69108751|FG000|Overall Study|Protocol Violation|3|||
37640792|NCT01066793|69108752|FG001|Overall Study|Protocol Violation|2|||
37640793|NCT01066793|69108753|FG002|Overall Study|Protocol Violation|2|||
37640794|NCT01066793|69108754|FG003|Overall Study|Protocol Violation|0|||
37640795|NCT01066793|69108755|FG004|Overall Study|Protocol Violation|0|||
37640796|NCT01066793|69108756|FG005|Overall Study|Protocol Violation|0|||
37640797|NCT01066793|69108751|FG000|Overall Study|Withdrawal by Subject|7|||
37640798|NCT01066793|69108752|FG001|Overall Study|Withdrawal by Subject|4|||
37640799|NCT01066793|69108753|FG002|Overall Study|Withdrawal by Subject|1|||
37640800|NCT01066793|69108754|FG003|Overall Study|Withdrawal by Subject|0|||
37640801|NCT01066793|69108755|FG004|Overall Study|Withdrawal by Subject|0|||
37640802|NCT01066793|69108756|FG005|Overall Study|Withdrawal by Subject|0|||
37640803|NCT01066793|69108751|FG000|Overall Study|Early Termination|3|||
37640804|NCT01066793|69108752|FG001|Overall Study|Early Termination|0|||
37640805|NCT01066793|69108753|FG002|Overall Study|Early Termination|0|||
37640806|NCT01066793|69108754|FG003|Overall Study|Early Termination|0|||
37640807|NCT01066793|69108755|FG004|Overall Study|Early Termination|0|||
37640808|NCT01066793|69108756|FG005|Overall Study|Early Termination|0|||
37640809|NCT01066793|69108751|FG000|Overall Study|Lab test not done|7|||
37640810|NCT01066793|69108752|FG001|Overall Study|Lab test not done|0|||
37640811|NCT01066793|69108753|FG002|Overall Study|Lab test not done|0|||
37640812|NCT01066793|69108754|FG003|Overall Study|Lab test not done|1|||
37640813|NCT01066793|69108755|FG004|Overall Study|Lab test not done|0|||
37640814|NCT01066793|69108756|FG005|Overall Study|Lab test not done|0|||
37640815|NCT01066793|69108751|FG000|Overall Study|Miscellaneous|4|||
37640816|NCT01066793|69108752|FG001|Overall Study|Miscellaneous|5|||
37640817|NCT01066793|69108753|FG002|Overall Study|Miscellaneous|6|||
37640818|NCT01066793|69108754|FG003|Overall Study|Miscellaneous|0|||
37640819|NCT01066793|69108755|FG004|Overall Study|Miscellaneous|0|||
37640820|NCT01066793|69108756|FG005|Overall Study|Miscellaneous|0|||
37640821|NCT01066793|69108751|FG000|Overall Study|Non-responders|104|||
37640822|NCT01066793|69108752|FG001|Overall Study|Non-responders|5|||
37640823|NCT01066793|69108753|FG002|Overall Study|Non-responders|11|||
37640824|NCT01066793|69108754|FG003|Overall Study|Non-responders|25|||
37640825|NCT01066793|69108755|FG004|Overall Study|Non-responders|0|||
37640826|NCT01066793|69108756|FG005|Overall Study|Non-responders|0|||
37640827|NCT01066793|69108751|FG000|Overall Study|Other|15|||
37640828|NCT01066793|69108752|FG001|Overall Study|Other|5|||
37640829|NCT01066793|69108753|FG002|Overall Study|Other|6|||
37640830|NCT01066793|69108754|FG003|Overall Study|Other|2|||
37640831|NCT01066793|69108755|FG004|Overall Study|Other|0|||
37640832|NCT01066793|69108756|FG005|Overall Study|Other|0|||
37640833|NCT01066793|69108751|FG000|Overall Study|Relapse|20|||
37640834|NCT01066793|69108752|FG001|Overall Study|Relapse|8|||
37640835|NCT01066793|69108753|FG002|Overall Study|Relapse|2|||
37640836|NCT01066793|69108754|FG003|Overall Study|Relapse|3|||
37640837|NCT01066793|69108755|FG004|Overall Study|Relapse|0|||
37640838|NCT01066793|69108756|FG005|Overall Study|Relapse|0|||
37640839|NCT01066793|69108751|FG000|Overall Study|Result Not Available|1|||
37640840|NCT01066793|69108752|FG001|Overall Study|Result Not Available|0|||
37640841|NCT01066793|69108753|FG002|Overall Study|Result Not Available|0|||
37640842|NCT01066793|69108754|FG003|Overall Study|Result Not Available|0|||
37640843|NCT01066793|69108755|FG004|Overall Study|Result Not Available|0|||
37640844|NCT01066793|69108756|FG005|Overall Study|Result Not Available|0|||
37640845|NCT01066793|69108751|FG000|Overall Study|Treatment Interrupted|1|||
37640846|NCT01066793|69108752|FG001|Overall Study|Treatment Interrupted|1|||
37640847|NCT01066793|69108753|FG002|Overall Study|Treatment Interrupted|0|||
37640848|NCT01066793|69108754|FG003|Overall Study|Treatment Interrupted|0|||
37640849|NCT01066793|69108755|FG004|Overall Study|Treatment Interrupted|0|||
37640850|NCT01066793|69108756|FG005|Overall Study|Treatment Interrupted|0|||
37854389|NCT01232283|69537961|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
37854390|NCT01232283|69537952|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
37640851|NCT01066793|69108751|FG000|Overall Study|Treatment Never Started|18|||
37640852|NCT01066793|69108752|FG001|Overall Study|Treatment Never Started|5|||
37640853|NCT01066793|69108753|FG002|Overall Study|Treatment Never Started|4|||
37640854|NCT01066793|69108754|FG003|Overall Study|Treatment Never Started|1|||
37640855|NCT01066793|69108755|FG004|Overall Study|Treatment Never Started|0|||
37640856|NCT01066793|69108756|FG005|Overall Study|Treatment Never Started|0|||
37640857|NCT01066793|69108751|FG000|Overall Study|Treatment Stopped|2|||
37640858|NCT01066793|69108752|FG001|Overall Study|Treatment Stopped|1|||
37640859|NCT01066793|69108753|FG002|Overall Study|Treatment Stopped|0|||
37640860|NCT01066793|69108754|FG003|Overall Study|Treatment Stopped|1|||
37640861|NCT01066793|69108755|FG004|Overall Study|Treatment Stopped|0|||
37640862|NCT01066793|69108756|FG005|Overall Study|Treatment Stopped|0|||
37640863|NCT03985293|69108777|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
37640864|NCT03985293|69108778|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
37640865|NCT03985293|69108779|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
37640866|NCT03985293|69108780|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
37640867|NCT03985293|69108781|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
37640868|NCT03985293|69108782|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
37640869|NCT03985293|69108777|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
37640870|NCT03985293|69108778|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
37640871|NCT03985293|69108779|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
37640872|NCT03985293|69108780|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
37640873|NCT03985293|69108781|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
37640874|NCT03985293|69108782|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
37640875|NCT03985293|69108777|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
37640876|NCT03985293|69108778|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
37640877|NCT03985293|69108779|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
37640878|NCT03985293|69108780|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
37640879|NCT03985293|69108781|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
37640880|NCT03985293|69108782|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
37640881|NCT03985293|69108777|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
37640882|NCT03985293|69108778|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
37640883|NCT03985293|69108779|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
37640884|NCT03985293|69108780|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
37640885|NCT03985293|69108781|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
37640886|NCT03985293|69108782|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
37640887|NCT03985293|69108777|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
37640888|NCT03985293|69108778|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
37640889|NCT03985293|69108779|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
37640890|NCT03985293|69108780|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
37640891|NCT03985293|69108781|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
37640892|NCT03985293|69108782|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
37640893|NCT03985293|69108777|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
37640894|NCT03985293|69108778|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
37640895|NCT03985293|69108779|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
37640896|NCT03985293|69108780|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
37640897|NCT03985293|69108781|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
37640898|NCT03985293|69108782|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
37640899|NCT03985293|69108777|FG000|FOLLOW-UP|Lost to Follow-up|0|||
37640900|NCT03985293|69108778|FG001|FOLLOW-UP|Lost to Follow-up|0|||
37640901|NCT03985293|69108779|FG002|FOLLOW-UP|Lost to Follow-up|1|||
37640902|NCT03985293|69108780|FG003|FOLLOW-UP|Lost to Follow-up|0|||
37640903|NCT03985293|69108781|FG004|FOLLOW-UP|Lost to Follow-up|0|||
37640904|NCT03985293|69108782|FG005|FOLLOW-UP|Lost to Follow-up|0|||
37640905|NCT03654755|69108799|FG000|Overall Study|Early Termination of study due to COVID-19|42|||
37640906|NCT03654755|69108800|FG001|Overall Study|Early Termination of study due to COVID-19|33|||
37640907|NCT03654755|69108801|FG002|Overall Study|Early Termination of study due to COVID-19|56|||
37640908|NCT03654755|69108799|FG000|Overall Study|Withdrawal by Subject|2|||
37640909|NCT03654755|69108800|FG001|Overall Study|Withdrawal by Subject|4|||
37640910|NCT03654755|69108801|FG002|Overall Study|Withdrawal by Subject|8|||
37640911|NCT03654755|69108799|FG000|Overall Study|Lost to Follow-up|1|||
37640912|NCT03654755|69108800|FG001|Overall Study|Lost to Follow-up|3|||
37640913|NCT03654755|69108801|FG002|Overall Study|Lost to Follow-up|7|||
37640914|NCT03654755|69108799|FG000|Overall Study|Physician Decision|0|||
37640915|NCT03654755|69108800|FG001|Overall Study|Physician Decision|1|||
37640916|NCT03654755|69108801|FG002|Overall Study|Physician Decision|0|||
37640917|NCT03654755|69108799|FG000|Overall Study|Adverse Event|0|||
37640918|NCT03654755|69108800|FG001|Overall Study|Adverse Event|0|||
37640919|NCT03654755|69108801|FG002|Overall Study|Adverse Event|4|||
37640920|NCT03654755|69108799|FG000|Overall Study|Lack of Efficacy|0|||
37640921|NCT03654755|69108800|FG001|Overall Study|Lack of Efficacy|0|||
37640922|NCT03654755|69108801|FG002|Overall Study|Lack of Efficacy|1|||
37640923|NCT02980601|69108811|FG000|Overall Study|Lost to Follow-up|2|||
37640924|NCT02980601|69108812|FG001|Overall Study|Lost to Follow-up|2|||
37640925|NCT02980601|69108811|FG000|Overall Study|Death|0|||
37640926|NCT02980601|69108812|FG001|Overall Study|Death|1|||
37640927|NCT02980601|69108811|FG000|Overall Study|Graft loss|1|||
37640928|NCT02980601|69108812|FG001|Overall Study|Graft loss|0|||
37640929|NCT02980601|69108811|FG000|Overall Study|Failed to sign consent|2|||
37640930|NCT02980601|69108812|FG001|Overall Study|Failed to sign consent|0|||
37640931|NCT02980523|69108823|FG000|Overall Study|Lost to Follow-up|1|||
37640932|NCT02980523|69108824|FG001|Overall Study|Lost to Follow-up|4|||
37640933|NCT02980523|69108825|FG002|Overall Study|Lost to Follow-up|1|||
37640934|NCT02980523|69108826|FG003|Overall Study|Lost to Follow-up|2|||
37640935|NCT02980523|69108827|FG004|Overall Study|Lost to Follow-up|1|||
37640936|NCT02980523|69108823|FG000|Overall Study|Excluded from analysis|1|||
37640937|NCT02980523|69108824|FG001|Overall Study|Excluded from analysis|3|||
37640938|NCT02980523|69108825|FG002|Overall Study|Excluded from analysis|1|||
37640939|NCT02980523|69108826|FG003|Overall Study|Excluded from analysis|1|||
37640940|NCT02980523|69108827|FG004|Overall Study|Excluded from analysis|1|||
37640941|NCT02980523|69108823|FG000|Overall Study|Lack of Efficacy|1|||
37640942|NCT02980523|69108824|FG001|Overall Study|Lack of Efficacy|4|||
37640943|NCT02980523|69108825|FG002|Overall Study|Lack of Efficacy|4|||
37640944|NCT02980523|69108826|FG003|Overall Study|Lack of Efficacy|5|||
37640945|NCT02980523|69108827|FG004|Overall Study|Lack of Efficacy|8|||
37640946|NCT02980523|69108823|FG000|Overall Study|Did not receive intervention|0|||
37640947|NCT02980523|69108824|FG001|Overall Study|Did not receive intervention|0|||
37640948|NCT02980523|69108825|FG002|Overall Study|Did not receive intervention|0|||
37640949|NCT02980523|69108826|FG003|Overall Study|Did not receive intervention|1|||
37640950|NCT02980523|69108827|FG004|Overall Study|Did not receive intervention|0|||
37640951|NCT02980133|69108846|FG000|Overall Study|Other than specified|1|||
37640952|NCT02980133|69108847|FG001|Overall Study|Other than specified|1|||
37640953|NCT02980133|69108848|FG002|Overall Study|Other than specified|2|||
37640954|NCT02980133|69108849|FG003|Overall Study|Other than specified|2|||
37640955|NCT02980133|69108846|FG000|Overall Study|Lost to Follow-up|0|||
37640956|NCT02980133|69108847|FG001|Overall Study|Lost to Follow-up|0|||
37640957|NCT02980133|69108848|FG002|Overall Study|Lost to Follow-up|1|||
37640958|NCT02980133|69108849|FG003|Overall Study|Lost to Follow-up|3|||
37640959|NCT02980133|69108846|FG000|Overall Study|Protocol Violation|0|||
37640960|NCT02980133|69108847|FG001|Overall Study|Protocol Violation|1|||
37640961|NCT02980133|69108848|FG002|Overall Study|Protocol Violation|0|||
37640962|NCT02980133|69108849|FG003|Overall Study|Protocol Violation|0|||
37640963|NCT02980133|69108846|FG000|Overall Study|Withdrawal by parent/guardian|6|||
37640964|NCT02980133|69108847|FG001|Overall Study|Withdrawal by parent/guardian|3|||
37640965|NCT02980133|69108848|FG002|Overall Study|Withdrawal by parent/guardian|3|||
37640966|NCT02980133|69108849|FG003|Overall Study|Withdrawal by parent/guardian|1|||
37640967|NCT02980133|69108846|FG000|Overall Study|Withdrawal by Subject|0|||
37640968|NCT02980133|69108847|FG001|Overall Study|Withdrawal by Subject|0|||
37640969|NCT02980133|69108848|FG002|Overall Study|Withdrawal by Subject|1|||
37640970|NCT02980133|69108849|FG003|Overall Study|Withdrawal by Subject|0|||
37640971|NCT02979431|69108866|FG000|Overall Study|Parent/guardian withdrew consent|2|||
37640972|NCT02979431|69108867|FG001|Overall Study|Parent/guardian withdrew consent|1|||
37640973|NCT02979431|69108868|FG002|Overall Study|Parent/guardian withdrew consent|1|||
37640974|NCT02979431|69108869|FG003|Overall Study|Parent/guardian withdrew consent|1|||
37640975|NCT02979431|69108866|FG000|Overall Study|Randomized but received no study drug|1|||
37640976|NCT02979431|69108867|FG001|Overall Study|Randomized but received no study drug|1|||
37640977|NCT02979431|69108868|FG002|Overall Study|Randomized but received no study drug|0|||
37640978|NCT02979431|69108869|FG003|Overall Study|Randomized but received no study drug|0|||
37640979|NCT02979431|69108866|FG000|Overall Study|Adverse Event|0|||
37640980|NCT02979431|69108867|FG001|Overall Study|Adverse Event|0|||
37640981|NCT02979431|69108868|FG002|Overall Study|Adverse Event|1|||
37640982|NCT02979431|69108869|FG003|Overall Study|Adverse Event|0|||
37640983|NCT02979431|69108866|FG000|Overall Study|Subject left country after Day14|1|||
37640984|NCT02979431|69108867|FG001|Overall Study|Subject left country after Day14|0|||
37640985|NCT02979431|69108868|FG002|Overall Study|Subject left country after Day14|0|||
37640986|NCT02979431|69108869|FG003|Overall Study|Subject left country after Day14|0|||
37640987|NCT02978417|69108881|FG000|Overall Study|Lost to Follow-up|2|||
37640988|NCT02978417|69108882|FG001|Overall Study|Lost to Follow-up|2|||
37740713|NCT01725308|69226573|FG002|Treatment Period I|Insufficient Response|5|||
37740714|NCT01725308|69226571|FG000|Treatment Period I|Worsening of the Target Disease|8|||
37740715|NCT01725308|69226572|FG001|Treatment Period I|Worsening of the Target Disease|0|||
37740716|NCT01725308|69226573|FG002|Treatment Period I|Worsening of the Target Disease|2|||
37740717|NCT01725308|69226571|FG000|Treatment Period I|Changes in the Episodes|3|||
37740718|NCT01725308|69226572|FG001|Treatment Period I|Changes in the Episodes|0|||
37740719|NCT01725308|69226573|FG002|Treatment Period I|Changes in the Episodes|2|||
37740720|NCT01725308|69226571|FG000|Treatment Period I|Withdrawal of Consent|12|||
37740721|NCT01725308|69226572|FG001|Treatment Period I|Withdrawal of Consent|7|||
37854391|NCT01232283|69537953|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
37854392|NCT01232283|69537954|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
37640989|NCT02733627|69108905|FG000|Overall Study|Adverse Event|0|||
37640990|NCT02733627|69108906|FG001|Overall Study|Adverse Event|1|||
37640991|NCT02733627|69108907|FG002|Overall Study|Adverse Event|1|||
37640992|NCT02733627|69108908|FG003|Overall Study|Adverse Event|0|||
37740722|NCT01725308|69226573|FG002|Treatment Period I|Withdrawal of Consent|5|||
37740723|NCT01725308|69226571|FG000|Treatment Period I|Lost to Follow-up|3|||
37854393|NCT01232283|69537955|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
37854394|NCT01232283|69537956|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
37854395|NCT01232283|69537957|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
37640993|NCT02733627|69108905|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
37640994|NCT02733627|69108906|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
37854396|NCT01232283|69537958|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
37640995|NCT02733627|69108907|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
37640996|NCT02733627|69108908|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
37640997|NCT02958865|69108925|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
37640998|NCT02958865|69108926|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
37640999|NCT02958865|69108927|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
37641000|NCT02958865|69108928|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
37641001|NCT02958865|69108929|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
37641002|NCT02958865|69108930|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
37641003|NCT02958865|69108931|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
37641004|NCT02958865|69108932|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
37641005|NCT02958865|69108933|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
37641006|NCT02958865|69108934|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
37641007|NCT02958865|69108935|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
37641008|NCT02958865|69108936|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
37641009|NCT02958865|69108937|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
37641010|NCT02958865|69108938|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
37641011|NCT02958865|69108939|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
37641012|NCT02958865|69108940|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
37641013|NCT02958865|69108925|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
37641014|NCT02958865|69108926|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
37641015|NCT02958865|69108927|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
37641016|NCT02958865|69108928|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
37641017|NCT02958865|69108929|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
37641018|NCT02958865|69108930|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
37641019|NCT02958865|69108931|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
37641020|NCT02958865|69108932|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
37641021|NCT02958865|69108933|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
37641022|NCT02958865|69108934|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
37641023|NCT02958865|69108935|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
37641024|NCT02958865|69108936|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
37641025|NCT02958865|69108937|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
37641026|NCT02958865|69108938|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
37641027|NCT02958865|69108939|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
37641028|NCT02958865|69108940|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
37641029|NCT02958865|69108925|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
37641030|NCT02958865|69108926|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
37641031|NCT02958865|69108927|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
37641032|NCT02958865|69108928|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
37641033|NCT02958865|69108929|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
37641034|NCT02958865|69108930|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
37641035|NCT02958865|69108931|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
37641036|NCT02958865|69108932|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
37641037|NCT02958865|69108933|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
37641038|NCT02958865|69108934|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
37641039|NCT02958865|69108935|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
37641040|NCT02958865|69108936|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
37641041|NCT02958865|69108937|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
37641042|NCT02958865|69108938|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
37641043|NCT02958865|69108939|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
37641044|NCT02958865|69108940|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
37641045|NCT02958865|69108925|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
37641046|NCT02958865|69108926|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
37641047|NCT02958865|69108927|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
37641048|NCT02958865|69108928|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
37641049|NCT02958865|69108929|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
37641050|NCT02958865|69108930|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
37641051|NCT02958865|69108931|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
37641052|NCT02958865|69108932|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
37641053|NCT02958865|69108933|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
37641054|NCT02958865|69108934|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
37641055|NCT02958865|69108935|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
37641056|NCT02958865|69108936|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
37641057|NCT02958865|69108937|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
37641058|NCT02958865|69108938|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
37641059|NCT02958865|69108939|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
37641060|NCT02958865|69108940|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
37641061|NCT02958865|69108925|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
37641062|NCT02958865|69108926|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
37641063|NCT02958865|69108927|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
37641064|NCT02958865|69108928|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
37641065|NCT02958865|69108929|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
37641066|NCT02958865|69108930|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
37641067|NCT02958865|69108931|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
37641068|NCT02958865|69108932|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
37641069|NCT02958865|69108933|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
37641070|NCT02958865|69108934|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
37641071|NCT02958865|69108935|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
37641072|NCT02958865|69108936|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
37641073|NCT02958865|69108937|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
37641074|NCT02958865|69108938|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
37641075|NCT02958865|69108939|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
37641076|NCT02958865|69108940|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
37641077|NCT02958865|69108925|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
37641078|NCT02958865|69108926|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
37641079|NCT02958865|69108927|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
37641080|NCT02958865|69108928|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
37641081|NCT02958865|69108929|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
37641082|NCT02958865|69108930|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
37641083|NCT02958865|69108931|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
37641084|NCT02958865|69108932|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
37641085|NCT02958865|69108933|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
37641086|NCT02958865|69108934|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
37641087|NCT02958865|69108935|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
37641088|NCT02958865|69108936|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
37641089|NCT02958865|69108937|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
37641090|NCT02958865|69108938|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
37641091|NCT02958865|69108939|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
37641092|NCT02958865|69108940|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
37641093|NCT02958865|69108925|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
37641094|NCT02958865|69108926|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
37641095|NCT02958865|69108927|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
37641096|NCT02958865|69108928|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
37641097|NCT02958865|69108929|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
37641098|NCT02958865|69108930|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
37641099|NCT02958865|69108931|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
37641100|NCT02958865|69108932|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
37641101|NCT02958865|69108933|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
37641102|NCT02958865|69108934|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
37641103|NCT02958865|69108935|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
37641104|NCT02958865|69108936|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
37641105|NCT02958865|69108937|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
37641106|NCT02958865|69108938|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
37641107|NCT02958865|69108939|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
37641108|NCT02958865|69108940|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
37641109|NCT02958865|69108925|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
37641110|NCT02958865|69108926|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
37641111|NCT02958865|69108927|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
37641112|NCT02958865|69108928|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
37641113|NCT02958865|69108929|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
37641114|NCT02958865|69108930|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
37641115|NCT02958865|69108931|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
37641116|NCT02958865|69108932|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
37641117|NCT02958865|69108933|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
37641118|NCT02958865|69108934|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
37641119|NCT02958865|69108935|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
37641120|NCT02958865|69108936|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
37641121|NCT02958865|69108937|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
37641122|NCT02958865|69108938|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
37641123|NCT02958865|69108939|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
37641124|NCT02958865|69108940|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
37641125|NCT02958865|69108925|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
37641126|NCT02958865|69108926|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
37854397|NCT01232283|69537959|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
37854398|NCT01232283|69537960|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
37641127|NCT02958865|69108927|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
37641128|NCT02958865|69108928|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
37641129|NCT02958865|69108929|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
37854399|NCT01232283|69537961|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
37854400|NCT01232283|69537952|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
37641130|NCT02958865|69108930|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
37641131|NCT02958865|69108931|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
37641132|NCT02958865|69108932|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
37641133|NCT02958865|69108933|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
37641134|NCT02958865|69108934|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
37641135|NCT02958865|69108935|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
37641136|NCT02958865|69108936|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
37641137|NCT02958865|69108937|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
37641138|NCT02958865|69108938|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
37641139|NCT02958865|69108939|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
37641140|NCT02958865|69108940|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
37641141|NCT02958865|69108925|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
37641142|NCT02958865|69108926|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
37641143|NCT02958865|69108927|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
37641144|NCT02958865|69108928|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
37641145|NCT02958865|69108929|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
37641146|NCT02958865|69108930|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
37641147|NCT02958865|69108931|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
37641148|NCT02958865|69108932|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
37641149|NCT02958865|69108933|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
37641150|NCT02958865|69108934|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
37641151|NCT02958865|69108935|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
37641152|NCT02958865|69108936|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
37641153|NCT02958865|69108937|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
37641154|NCT02958865|69108938|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
37641155|NCT02958865|69108939|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
37641156|NCT02958865|69108940|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
37641157|NCT02958865|69108925|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
37641158|NCT02958865|69108926|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
37641159|NCT02958865|69108927|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
37641160|NCT02958865|69108928|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
37641161|NCT02958865|69108929|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
37641162|NCT02958865|69108930|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
37641163|NCT02958865|69108931|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
37641164|NCT02958865|69108932|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
37641165|NCT02958865|69108933|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
37641166|NCT02958865|69108934|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
37641167|NCT02958865|69108935|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
37641168|NCT02958865|69108936|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
37641169|NCT02958865|69108937|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
37641170|NCT02958865|69108938|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
37641171|NCT02958865|69108939|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
37641172|NCT02958865|69108940|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
37641173|NCT02958865|69108925|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
37641174|NCT02958865|69108926|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
37641175|NCT02958865|69108927|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
37641176|NCT02958865|69108928|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
37641177|NCT02958865|69108929|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
37641178|NCT02958865|69108930|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
37641179|NCT02958865|69108931|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
37641180|NCT02958865|69108932|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
37641181|NCT02958865|69108933|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
37641182|NCT02958865|69108934|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
37641183|NCT02958865|69108935|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
37641184|NCT02958865|69108936|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
37641185|NCT02958865|69108937|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
37641186|NCT02958865|69108938|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
37641187|NCT02958865|69108939|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
37641188|NCT02958865|69108940|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
37641189|NCT02958865|69108925|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
37641190|NCT02958865|69108926|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
37641191|NCT02958865|69108927|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
37641192|NCT02958865|69108928|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
37641193|NCT02958865|69108929|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
37641194|NCT02958865|69108930|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
37740724|NCT01725308|69226572|FG001|Treatment Period I|Lost to Follow-up|2|||
37740725|NCT01725308|69226573|FG002|Treatment Period I|Lost to Follow-up|2|||
37854401|NCT01232283|69537953|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
37641195|NCT02958865|69108931|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
37641196|NCT02958865|69108932|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
37641197|NCT02958865|69108933|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
37641198|NCT02958865|69108934|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
37641199|NCT02958865|69108935|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
37641200|NCT02958865|69108936|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
37641201|NCT02958865|69108937|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
37641202|NCT02958865|69108938|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
37641203|NCT02958865|69108939|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
37641204|NCT02958865|69108940|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
37641205|NCT02958865|69108925|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
37641206|NCT02958865|69108926|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
37641207|NCT02958865|69108927|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
37641208|NCT02958865|69108928|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
37641209|NCT02958865|69108929|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
37641210|NCT02958865|69108930|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
37641211|NCT02958865|69108931|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
37641212|NCT02958865|69108932|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
37641213|NCT02958865|69108933|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
37641214|NCT02958865|69108934|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
37641215|NCT02958865|69108935|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
37641216|NCT02958865|69108936|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
37641217|NCT02958865|69108937|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
37641218|NCT02958865|69108938|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
37641219|NCT02958865|69108939|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
37641220|NCT02958865|69108940|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
37641221|NCT02958865|69108925|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
37641222|NCT02958865|69108926|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
37641223|NCT02958865|69108927|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
37641224|NCT02958865|69108928|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
37641225|NCT02958865|69108929|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
37641226|NCT02958865|69108930|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
37641227|NCT02958865|69108931|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
37641228|NCT02958865|69108932|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
37641229|NCT02958865|69108933|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
37641230|NCT02958865|69108934|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
37641231|NCT02958865|69108935|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
37641232|NCT02958865|69108936|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
37641233|NCT02958865|69108937|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
37641234|NCT02958865|69108938|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
37641235|NCT02958865|69108939|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
37641236|NCT02958865|69108940|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
37641237|NCT02958865|69108925|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
37641238|NCT02958865|69108926|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
37641239|NCT02958865|69108927|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
37641240|NCT02958865|69108928|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
37641241|NCT02958865|69108929|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
37641242|NCT02958865|69108930|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
37641243|NCT02958865|69108931|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
37641244|NCT02958865|69108932|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
37641245|NCT02958865|69108933|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
37641246|NCT02958865|69108934|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
37641247|NCT02958865|69108935|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
37641248|NCT02958865|69108936|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
37641249|NCT02958865|69108937|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
37641250|NCT02958865|69108938|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
37641251|NCT02958865|69108939|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
37641252|NCT02958865|69108940|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
37641253|NCT02958865|69108925|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
37641254|NCT02958865|69108926|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
37641255|NCT02958865|69108927|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
37641256|NCT02958865|69108928|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
37641257|NCT02958865|69108929|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
37641258|NCT02958865|69108930|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
37641259|NCT02958865|69108931|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
37921949|NCT00819390|69608749|FG003|Overall Study|Adverse Event|0|||
37641260|NCT02958865|69108932|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
37641261|NCT02958865|69108933|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
37641262|NCT02958865|69108934|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
37641263|NCT02958865|69108935|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
37641264|NCT02958865|69108936|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
37641265|NCT02958865|69108937|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
37641266|NCT02958865|69108938|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
37641267|NCT02958865|69108939|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
37641268|NCT02958865|69108940|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
37641269|NCT02958553|69108992|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
37641270|NCT02958553|69108992|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
37641271|NCT02501902|69109005|FG000|Overall Study|Subject Refused Further Follow-up|0|||
37641272|NCT02501902|69109006|FG001|Overall Study|Subject Refused Further Follow-up|0|||
37641273|NCT02501902|69109007|FG002|Overall Study|Subject Refused Further Follow-up|0|||
37641274|NCT02501902|69109008|FG003|Overall Study|Subject Refused Further Follow-up|0|||
37641275|NCT02501902|69109009|FG004|Overall Study|Subject Refused Further Follow-up|0|||
37641276|NCT02501902|69109010|FG005|Overall Study|Subject Refused Further Follow-up|0|||
37641277|NCT02501902|69109011|FG006|Overall Study|Subject Refused Further Follow-up|0|||
37641278|NCT02501902|69109012|FG007|Overall Study|Subject Refused Further Follow-up|1|||
37641279|NCT02501902|69109005|FG000|Overall Study|Study Terminated by Sponsor|0|||
37641280|NCT02501902|69109006|FG001|Overall Study|Study Terminated by Sponsor|3|||
37641281|NCT02501902|69109007|FG002|Overall Study|Study Terminated by Sponsor|0|||
37641282|NCT02501902|69109008|FG003|Overall Study|Study Terminated by Sponsor|1|||
37641283|NCT02501902|69109009|FG004|Overall Study|Study Terminated by Sponsor|1|||
37641284|NCT02501902|69109010|FG005|Overall Study|Study Terminated by Sponsor|0|||
37641285|NCT02501902|69109011|FG006|Overall Study|Study Terminated by Sponsor|2|||
37641286|NCT02501902|69109012|FG007|Overall Study|Study Terminated by Sponsor|4|||
37641287|NCT02501902|69109005|FG000|Overall Study|Death|3|||
37641288|NCT02501902|69109006|FG001|Overall Study|Death|4|||
37641289|NCT02501902|69109007|FG002|Overall Study|Death|4|||
37641290|NCT02501902|69109008|FG003|Overall Study|Death|10|||
37641291|NCT02501902|69109009|FG004|Overall Study|Death|10|||
37641292|NCT02501902|69109010|FG005|Overall Study|Death|11|||
37641293|NCT02501902|69109011|FG006|Overall Study|Death|7|||
37641294|NCT02501902|69109012|FG007|Overall Study|Death|15|||
37641295|NCT01955109|69109037|FG000|Overall Study|Adverse Event|2|||
37641296|NCT01955109|69109038|FG001|Overall Study|Adverse Event|0|||
37641297|NCT01955109|69109037|FG000|Overall Study|Participant unwilling to continue|35|||
37641298|NCT01955109|69109038|FG001|Overall Study|Participant unwilling to continue|7|||
37641299|NCT01955109|69109037|FG000|Overall Study|Physician Decision|2|||
37641300|NCT01955109|69109038|FG001|Overall Study|Physician Decision|0|||
37641301|NCT01955109|69109037|FG000|Overall Study|Lost to Follow-up|3|||
37641302|NCT01955109|69109038|FG001|Overall Study|Lost to Follow-up|1|||
37641303|NCT01955109|69109037|FG000|Overall Study|Non-compliance|3|||
37641304|NCT01955109|69109038|FG001|Overall Study|Non-compliance|1|||
37641305|NCT02500732|69109046|FG000|Overall Study|Physician Decision|0|||
37641306|NCT02500732|69109047|FG001|Overall Study|Physician Decision|1|||
37641307|NCT02518048|69109053|FG000|Overall Study|Withdrawal by Subject|1|||
37641308|NCT02499952|69109058|FG000|Overall Study|Lost to Follow-up|1|||
37641309|NCT02499952|69109058|FG000|Overall Study|Death|9|||
37641310|NCT02499406|69109062|FG000|Overall Study|missed 3 treatment sessions|4|||
37641311|NCT02499172|69109070|FG000|Overall Study|Financial reason|0|||
37641312|NCT02499172|69109071|FG001|Overall Study|Financial reason|0|||
37641313|NCT02499172|69109072|FG002|Overall Study|Financial reason|523|||
37641314|NCT02499172|69109073|FG003|Overall Study|Financial reason|436|||
37641315|NCT02499172|69109070|FG000|Overall Study|Lost to Follow-up|65|||
37641316|NCT02499172|69109071|FG001|Overall Study|Lost to Follow-up|64|||
37641317|NCT02499172|69109072|FG002|Overall Study|Lost to Follow-up|0|||
37641318|NCT02499172|69109073|FG003|Overall Study|Lost to Follow-up|0|||
37641319|NCT02498392|69109085|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
37641320|NCT02498392|69109086|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
37641321|NCT02498392|69109085|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
37641322|NCT02498392|69109086|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
37641323|NCT02498392|69109085|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
37854402|NCT01232283|69537954|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
37854403|NCT01232283|69537955|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
37854404|NCT01232283|69537956|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
37854405|NCT01232283|69537957|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
37641324|NCT02498392|69109086|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
37641325|NCT02498392|69109085|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
37641326|NCT02498392|69109086|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
37641327|NCT02498392|69109085|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
37641328|NCT02498392|69109086|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
37641329|NCT02498392|69109085|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
37641330|NCT02498392|69109086|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
37641331|NCT03205605|69109094|FG000|Overall Study|Withdrawal by Subject|1|||
37641332|NCT02498236|69109112|FG000|Overall Study|Did not show for testing|1|||
37641333|NCT02498236|69109113|FG001|Overall Study|Did not show for testing|0|||
37641334|NCT02498236|69109114|FG002|Overall Study|Did not show for testing|0|||
37641335|NCT02498236|69109115|FG003|Overall Study|Did not show for testing|0|||
37641336|NCT02498236|69109116|FG004|Overall Study|Did not show for testing|0|||
37641337|NCT02498236|69109117|FG005|Overall Study|Did not show for testing|0|||
37641338|NCT02498236|69109118|FG006|Overall Study|Did not show for testing|0|||
37641339|NCT02498236|69109119|FG007|Overall Study|Did not show for testing|1|||
37641340|NCT02498236|69109112|FG000|Overall Study|Equipment failure|0|||
37641341|NCT02498236|69109113|FG001|Overall Study|Equipment failure|0|||
37641342|NCT02498236|69109114|FG002|Overall Study|Equipment failure|0|||
37641343|NCT02498236|69109115|FG003|Overall Study|Equipment failure|0|||
37641344|NCT02498236|69109116|FG004|Overall Study|Equipment failure|0|||
37641345|NCT02498236|69109117|FG005|Overall Study|Equipment failure|0|||
37641346|NCT02498236|69109118|FG006|Overall Study|Equipment failure|1|||
37641347|NCT02498236|69109119|FG007|Overall Study|Equipment failure|0|||
37641348|NCT02498236|69109112|FG000|Overall Study|Withdrawal by Subject|0|||
37641349|NCT02498236|69109113|FG001|Overall Study|Withdrawal by Subject|0|||
37641350|NCT02498236|69109114|FG002|Overall Study|Withdrawal by Subject|0|||
37641351|NCT02498236|69109115|FG003|Overall Study|Withdrawal by Subject|0|||
37641352|NCT02498236|69109116|FG004|Overall Study|Withdrawal by Subject|1|||
37641353|NCT02498236|69109117|FG005|Overall Study|Withdrawal by Subject|0|||
37641354|NCT02498236|69109118|FG006|Overall Study|Withdrawal by Subject|0|||
37641355|NCT02498236|69109119|FG007|Overall Study|Withdrawal by Subject|0|||
37641356|NCT02496676|69109142|FG000|Phase 1 - Period 1|Adverse Event|0|||
37641357|NCT02496676|69109143|FG001|Phase 1 - Period 1|Adverse Event|1|||
37641358|NCT02496676|69109142|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
37641359|NCT02496676|69109143|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
37641360|NCT02517268|69109159|FG000|Overall Study|Withdrawal by Subject|1|||
37641361|NCT02517268|69109160|FG001|Overall Study|Withdrawal by Subject|0|||
37641362|NCT01160211|69109169|FG000|Overall Study|ongoing|90|||
37641363|NCT01160211|69109170|FG001|Overall Study|ongoing|75|||
37641364|NCT01160211|69109171|FG002|Overall Study|ongoing|79|||
37641365|NCT01160211|69109169|FG000|Overall Study|Withdrawal by Subject|3|||
37641366|NCT01160211|69109170|FG001|Overall Study|Withdrawal by Subject|5|||
37641367|NCT01160211|69109171|FG002|Overall Study|Withdrawal by Subject|3|||
37641368|NCT01160211|69109169|FG000|Overall Study|Physician Decision|2|||
37641369|NCT01160211|69109170|FG001|Overall Study|Physician Decision|0|||
37641370|NCT01160211|69109171|FG002|Overall Study|Physician Decision|0|||
37641371|NCT01160211|69109169|FG000|Overall Study|Lost to Follow-up|4|||
37641372|NCT01160211|69109170|FG001|Overall Study|Lost to Follow-up|7|||
37641373|NCT01160211|69109171|FG002|Overall Study|Lost to Follow-up|5|||
37740726|NCT01725308|69226571|FG000|Treatment Period I|Protocol Deviations|3|||
37740727|NCT01725308|69226572|FG001|Treatment Period I|Protocol Deviations|1|||
37740728|NCT01725308|69226573|FG002|Treatment Period I|Protocol Deviations|1|||
37740729|NCT01725308|69226571|FG000|Treatment Period I|Miscellaneous|2|||
37854406|NCT01232283|69537958|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
37921950|NCT00876395|69608764|FG000|Overall Study|Untreated|8|||
37921951|NCT00876395|69608765|FG001|Overall Study|Untreated|1|||
37921952|NCT00876395|69608764|FG000|Overall Study|Adverse Event|63|||
37921953|NCT00876395|69608765|FG001|Overall Study|Adverse Event|11|||
37641374|NCT01064687|69109184|FG000|Overall Study|Adverse Event|9|||
37854407|NCT01232283|69537959|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
37854408|NCT01232283|69537960|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
37854409|NCT01232283|69537961|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
37854410|NCT01232283|69537952|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
37854411|NCT01232283|69537953|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
37854412|NCT01232283|69537954|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
37921954|NCT00876395|69608764|FG000|Overall Study|Abnormal test procedure result(s)|1|||
37641375|NCT01064687|69109185|FG001|Overall Study|Adverse Event|4|||
37641376|NCT01064687|69109186|FG002|Overall Study|Adverse Event|10|||
37641377|NCT01064687|69109187|FG003|Overall Study|Adverse Event|3|||
37641378|NCT01064687|69109184|FG000|Overall Study|Death|1|||
37740730|NCT01725308|69226572|FG001|Treatment Period I|Miscellaneous|0|||
37641379|NCT01064687|69109185|FG001|Overall Study|Death|1|||
37641380|NCT01064687|69109186|FG002|Overall Study|Death|0|||
37641381|NCT01064687|69109187|FG003|Overall Study|Death|0|||
37641382|NCT01064687|69109184|FG000|Overall Study|Entry Criteria Not Met|3|||
37641383|NCT01064687|69109185|FG001|Overall Study|Entry Criteria Not Met|0|||
37641384|NCT01064687|69109186|FG002|Overall Study|Entry Criteria Not Met|0|||
37641385|NCT01064687|69109187|FG003|Overall Study|Entry Criteria Not Met|0|||
37641386|NCT01064687|69109184|FG000|Overall Study|Lack of Efficacy|1|||
37641387|NCT01064687|69109185|FG001|Overall Study|Lack of Efficacy|0|||
37641388|NCT01064687|69109186|FG002|Overall Study|Lack of Efficacy|2|||
37641389|NCT01064687|69109187|FG003|Overall Study|Lack of Efficacy|3|||
37641390|NCT01064687|69109184|FG000|Overall Study|Lost to Follow-up|7|||
37641391|NCT01064687|69109185|FG001|Overall Study|Lost to Follow-up|10|||
37641392|NCT01064687|69109186|FG002|Overall Study|Lost to Follow-up|13|||
37641393|NCT01064687|69109187|FG003|Overall Study|Lost to Follow-up|5|||
37641394|NCT01064687|69109184|FG000|Overall Study|Physician Decision|2|||
37641395|NCT01064687|69109185|FG001|Overall Study|Physician Decision|2|||
37641396|NCT01064687|69109186|FG002|Overall Study|Physician Decision|0|||
37641397|NCT01064687|69109187|FG003|Overall Study|Physician Decision|0|||
37641398|NCT01064687|69109184|FG000|Overall Study|Protocol Violation|1|||
37641399|NCT01064687|69109185|FG001|Overall Study|Protocol Violation|1|||
37641400|NCT01064687|69109186|FG002|Overall Study|Protocol Violation|0|||
37641401|NCT01064687|69109187|FG003|Overall Study|Protocol Violation|1|||
37641402|NCT01064687|69109184|FG000|Overall Study|Sponsor Decision|0|||
37641403|NCT01064687|69109185|FG001|Overall Study|Sponsor Decision|0|||
37641404|NCT01064687|69109186|FG002|Overall Study|Sponsor Decision|3|||
37641405|NCT01064687|69109187|FG003|Overall Study|Sponsor Decision|0|||
37641406|NCT01064687|69109184|FG000|Overall Study|Withdrawal by Subject|9|||
37641407|NCT01064687|69109185|FG001|Overall Study|Withdrawal by Subject|7|||
37641408|NCT01064687|69109186|FG002|Overall Study|Withdrawal by Subject|12|||
37641409|NCT01064687|69109187|FG003|Overall Study|Withdrawal by Subject|5|||
37641410|NCT01064687|69109184|FG000|Overall Study|Treatment Noncompliance|1|||
37641411|NCT01064687|69109185|FG001|Overall Study|Treatment Noncompliance|1|||
37641412|NCT01064687|69109186|FG002|Overall Study|Treatment Noncompliance|1|||
37641413|NCT01064687|69109187|FG003|Overall Study|Treatment Noncompliance|0|||
37641414|NCT02493946|69109211|FG000|DB Period|Withdrawal by Subject|8|||
37641415|NCT02493946|69109212|FG001|DB Period|Withdrawal by Subject|5|||
37641416|NCT02493946|69109213|FG002|DB Period|Withdrawal by Subject|0|||
37641417|NCT02493946|69109211|FG000|Open Label Period|Withdrawal by Subject|0|||
37641418|NCT02493946|69109212|FG001|Open Label Period|Withdrawal by Subject|0|||
37641419|NCT02493946|69109213|FG002|Open Label Period|Withdrawal by Subject|74|||
37641420|NCT02493946|69109211|FG000|Open Label Period|Adverse Event|0|||
37641421|NCT02493946|69109212|FG001|Open Label Period|Adverse Event|0|||
37641422|NCT02493946|69109213|FG002|Open Label Period|Adverse Event|4|||
37641423|NCT02493946|69109211|FG000|Open Label Period|Lost to Follow-up|0|||
37641424|NCT02493946|69109212|FG001|Open Label Period|Lost to Follow-up|0|||
37641425|NCT02493946|69109213|FG002|Open Label Period|Lost to Follow-up|1|||
37641426|NCT02493946|69109211|FG000|Open Label Period|Investigator decision, non-compliance|0|||
37641427|NCT02493946|69109212|FG001|Open Label Period|Investigator decision, non-compliance|0|||
37641428|NCT02493946|69109213|FG002|Open Label Period|Investigator decision, non-compliance|2|||
37641429|NCT02493946|69109211|FG000|Open Label Period|Investigator decision, non-availability|0|||
37641430|NCT02493946|69109212|FG001|Open Label Period|Investigator decision, non-availability|0|||
37641431|NCT02493946|69109213|FG002|Open Label Period|Investigator decision, non-availability|1|||
37641432|NCT02493946|69109211|FG000|Open Label Period|Pregnancy|0|||
37641433|NCT02493946|69109212|FG001|Open Label Period|Pregnancy|0|||
37641434|NCT02493946|69109213|FG002|Open Label Period|Pregnancy|3|||
37641435|NCT02493946|69109211|FG000|Open Label Period|Site error|0|||
37641436|NCT02493946|69109212|FG001|Open Label Period|Site error|0|||
37641437|NCT02493946|69109213|FG002|Open Label Period|Site error|1|||
37641438|NCT01064531|69109223|FG000|Overall Study|Lost to Follow-up|0|||
37641439|NCT01064531|69109224|FG001|Overall Study|Lost to Follow-up|2|||
37641440|NCT01064531|69109223|FG000|Overall Study|Physician Decision|0|||
37641441|NCT01064531|69109224|FG001|Overall Study|Physician Decision|1|||
37641442|NCT01064531|69109223|FG000|Overall Study|Withdrawal by Subject|2|||
37641443|NCT01064531|69109224|FG001|Overall Study|Withdrawal by Subject|2|||
37641444|NCT01064531|69109223|FG000|Overall Study|Revision due to femoral stem loosening|1|||
37641445|NCT01064531|69109224|FG001|Overall Study|Revision due to femoral stem loosening|0|||
37641446|NCT01064531|69109223|FG000|Overall Study|Revision due to dislocation|0|||
37641447|NCT01064531|69109224|FG001|Overall Study|Revision due to dislocation|1|||
37641448|NCT01064531|69109223|FG000|Overall Study|Death|0|||
37641449|NCT01064531|69109224|FG001|Overall Study|Death|1|||
37641450|NCT02220855|69109230|FG000|Overall Study|Adverse Event|8|||
37641451|NCT02220855|69109230|FG000|Overall Study|Disease Progression|5|||
37641452|NCT02220855|69109230|FG000|Overall Study|Withdrawal by Subject|1|||
37641453|NCT02918279|69109236|FG000|Overall Study|Lost to Follow-up|3|||
37641454|NCT02918279|69109237|FG001|Overall Study|Lost to Follow-up|6|||
37740731|NCT01725308|69226573|FG002|Treatment Period I|Miscellaneous|3|||
37740732|NCT01725308|69226571|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
37641455|NCT02918279|69109236|FG000|Overall Study|Withdrawal by Subject|5|||
37641456|NCT02918279|69109237|FG001|Overall Study|Withdrawal by Subject|15|||
37641457|NCT02918279|69109236|FG000|Overall Study|Withdrawal by parent/guardian|2|||
37641458|NCT02918279|69109237|FG001|Overall Study|Withdrawal by parent/guardian|1|||
37641459|NCT02918279|69109236|FG000|Overall Study|Other|3|||
37641460|NCT02918279|69109237|FG001|Overall Study|Other|1|||
37641461|NCT02956837|69109247|FG000|Overall Study|Serious Adverse Events|0|||
37641462|NCT02956837|69109248|FG001|Overall Study|Serious Adverse Events|1|||
37641463|NCT02956837|69109249|FG002|Overall Study|Serious Adverse Events|0|||
37641464|NCT02956837|69109250|FG003|Overall Study|Serious Adverse Events|0|||
37641465|NCT02956837|69109247|FG000|Overall Study|Withdrawal by Subject|0|||
37641466|NCT02956837|69109248|FG001|Overall Study|Withdrawal by Subject|1|||
37641467|NCT02956837|69109249|FG002|Overall Study|Withdrawal by Subject|0|||
37641468|NCT02956837|69109250|FG003|Overall Study|Withdrawal by Subject|3|||
37641469|NCT02956837|69109247|FG000|Overall Study|Lost to Follow-up|0|||
37641470|NCT02956837|69109248|FG001|Overall Study|Lost to Follow-up|1|||
37641471|NCT02956837|69109249|FG002|Overall Study|Lost to Follow-up|2|||
37641472|NCT02956837|69109250|FG003|Overall Study|Lost to Follow-up|0|||
37641473|NCT01063595|69109263|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
37641474|NCT01063595|69109264|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
37641475|NCT01063595|69109263|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
37641476|NCT01063595|69109264|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
37641477|NCT01063595|69109263|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
37641478|NCT01063595|69109264|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
37641479|NCT01063595|69109263|FG000|First Intervention|Adverse Event|1|||
37641480|NCT01063595|69109264|FG001|First Intervention|Adverse Event|4|||
37641481|NCT01063595|69109263|FG000|First Intervention|Withdrawal by Subject|1|||
37641482|NCT01063595|69109264|FG001|First Intervention|Withdrawal by Subject|0|||
37641483|NCT01063595|69109263|FG000|First Intervention|Reason not Specified|0|||
37641484|NCT01063595|69109264|FG001|First Intervention|Reason not Specified|1|||
37641485|NCT01063283|69109272|FG000|Cycle 1|Adverse Event|2|||
37641486|NCT01063283|69109273|FG001|Cycle 1|Adverse Event|0|||
37641487|NCT01063283|69109274|FG002|Cycle 1|Adverse Event|0|||
37641488|NCT01063283|69109272|FG000|Cycle 1|Technical failure in data collection|1|||
37641489|NCT01063283|69109273|FG001|Cycle 1|Technical failure in data collection|0|||
37641490|NCT01063283|69109274|FG002|Cycle 1|Technical failure in data collection|0|||
37641491|NCT01062971|69109282|FG000|Overall Study|Protocol Violation|1|||
37641492|NCT01062971|69109283|FG001|Overall Study|Protocol Violation|3|||
37641493|NCT01062971|69109282|FG000|Overall Study|Lost to Follow-up|3|||
38032131|NCT02951780|69718048|FG003|Period 1|Adverse Event|1|||
38032132|NCT02951780|69718049|FG004|Period 1|Adverse Event|0|||
38032133|NCT02951780|69718050|FG005|Period 1|Adverse Event|0|||
38032134|NCT02951780|69718051|FG006|Period 1|Adverse Event|0|||
38032135|NCT02951780|69718052|FG007|Period 1|Adverse Event|0|||
38032136|NCT02951780|69718053|FG008|Period 1|Adverse Event|0|||
38032137|NCT02951780|69718045|FG000|Period 1|Scheduling Conflicts|0|||
38032138|NCT02951780|69718046|FG001|Period 1|Scheduling Conflicts|0|||
38032139|NCT02951780|69718047|FG002|Period 1|Scheduling Conflicts|0|||
38032140|NCT02951780|69718048|FG003|Period 1|Scheduling Conflicts|0|||
37641494|NCT01062971|69109283|FG001|Overall Study|Lost to Follow-up|4|||
37641495|NCT01348165|69109296|FG000|Overall Study|Adverse Event|0|||
37641496|NCT01348165|69109297|FG001|Overall Study|Adverse Event|0|||
37641497|NCT01348165|69109298|FG002|Overall Study|Adverse Event|0|||
37641498|NCT01348165|69109299|FG003|Overall Study|Adverse Event|0|||
37641499|NCT01348165|69109300|FG004|Overall Study|Adverse Event|0|||
37641500|NCT01348165|69109301|FG005|Overall Study|Adverse Event|0|||
37641501|NCT01348165|69109302|FG006|Overall Study|Adverse Event|1|||
37641502|NCT02493868|69109322|FG000|Induction Phase: DE Participants|Adverse Event|22|||
37641503|NCT02493868|69109323|FG001|Induction Phase: DE Participants|Adverse Event|0|||
37641504|NCT02493868|69109322|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
37641505|NCT02493868|69109323|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
37641506|NCT02493868|69109322|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
37641507|NCT02493868|69109323|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
37641508|NCT02493868|69109322|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
37641509|NCT02493868|69109323|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
37740733|NCT01725308|69226572|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
37740734|NCT01725308|69226573|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
38032141|NCT02951780|69718049|FG004|Period 1|Scheduling Conflicts|0|||
38032142|NCT02951780|69718050|FG005|Period 1|Scheduling Conflicts|0|||
38032143|NCT02951780|69718051|FG006|Period 1|Scheduling Conflicts|0|||
38032144|NCT02951780|69718052|FG007|Period 1|Scheduling Conflicts|1|||
37641510|NCT02493868|69109322|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
37641511|NCT02493868|69109323|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
37641512|NCT02493868|69109322|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
37641513|NCT02493868|69109323|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
37641514|NCT02493868|69109322|FG000|Induction Phase: DE Participants|Other|8|||
37641515|NCT02493868|69109323|FG001|Induction Phase: DE Participants|Other|0|||
37641516|NCT02493868|69109322|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
37641517|NCT02493868|69109323|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
37641518|NCT02493868|69109322|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
37641519|NCT02493868|69109323|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
38032145|NCT02951780|69718053|FG008|Period 1|Scheduling Conflicts|0|||
38032146|NCT02951780|69718045|FG000|Period 2|Scheduling Conflicts|0|||
37641520|NCT02493868|69109322|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
37641521|NCT02493868|69109323|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
37641522|NCT02493868|69109322|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
37641523|NCT02493868|69109323|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
37641524|NCT02493868|69109322|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
37641525|NCT02493868|69109323|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
37641526|NCT02493868|69109322|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
37641527|NCT02493868|69109323|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
37641528|NCT02493868|69109322|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
37641529|NCT02493868|69109323|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
37641530|NCT02493868|69109322|FG000|Optimization Phase: DE+TE Participants|Other|10|||
37641531|NCT02493868|69109323|FG001|Optimization Phase: DE+TE Participants|Other|2|||
37641532|NCT02493868|69109322|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
37641533|NCT02493868|69109323|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
37641534|NCT02493868|69109322|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
37641535|NCT02493868|69109323|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
37641536|NCT02493868|69109322|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
37641537|NCT02493868|69109323|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
37641538|NCT02493868|69109322|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
37641539|NCT02493868|69109323|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
37641540|NCT02493868|69109322|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
37641541|NCT02493868|69109323|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
37641542|NCT02493868|69109322|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
37641543|NCT02493868|69109323|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
37641544|NCT02493868|69109322|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
37641545|NCT02493868|69109323|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
37641546|NCT02493868|69109322|FG000|Follow-up Phase|Lost to Follow-up|1|||
37641547|NCT02493868|69109323|FG001|Follow-up Phase|Lost to Follow-up|0|||
37641548|NCT02493868|69109322|FG000|Follow-up Phase|Withdrawal by Subject|3|||
37641549|NCT02493868|69109323|FG001|Follow-up Phase|Withdrawal by Subject|0|||
37641550|NCT02493868|69109322|FG000|Follow-up Phase|Investigator Decision|5|||
37641551|NCT02493868|69109323|FG001|Follow-up Phase|Investigator Decision|1|||
37740735|NCT01725308|69226571|FG000|Treatment Period II|Did Not Receive Drug|4|||
37921955|NCT00876395|69608765|FG001|Overall Study|Abnormal test procedure result(s)|0|||
37921956|NCT00876395|69608764|FG000|Overall Study|Disease progression|259|||
37921957|NCT00876395|69608765|FG001|Overall Study|Disease progression|162|||
37921958|NCT00876395|69608764|FG000|Overall Study|New cancer therapy|25|||
37921959|NCT00876395|69608765|FG001|Overall Study|New cancer therapy|7|||
37921960|NCT00876395|69608764|FG000|Overall Study|Protocol Violation|5|||
37921961|NCT00876395|69608765|FG001|Overall Study|Protocol Violation|2|||
37921962|NCT00876395|69608764|FG000|Overall Study|Withdrawal by Subject|66|||
37921963|NCT00876395|69608765|FG001|Overall Study|Withdrawal by Subject|33|||
37921964|NCT00876395|69608764|FG000|Overall Study|Lost to Follow-up|2|||
37921965|NCT00876395|69608765|FG001|Overall Study|Lost to Follow-up|0|||
37921966|NCT00876395|69608764|FG000|Overall Study|Administrative problems|39|||
37921967|NCT00876395|69608765|FG001|Overall Study|Administrative problems|23|||
37921968|NCT00876395|69608764|FG000|Overall Study|Death|12|||
37921969|NCT00876395|69608765|FG001|Overall Study|Death|0|||
37921970|NCT00594659|69608779|FG000|Overall Study|Lost to Follow-up|13|||
37921971|NCT00594659|69608780|FG001|Overall Study|Lost to Follow-up|9|||
37921972|NCT00594659|69608781|FG002|Overall Study|Lost to Follow-up|7|||
37921973|NCT00667732|69608791|FG000|Run -In (8 Weeks)|Adverse Event|4|||
37921974|NCT00667732|69608792|FG001|Run -In (8 Weeks)|Adverse Event|0|||
37921975|NCT00667732|69608793|FG002|Run -In (8 Weeks)|Adverse Event|0|||
37921976|NCT00667732|69608791|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
37921977|NCT00667732|69608792|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
37921978|NCT00667732|69608793|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
37921979|NCT00667732|69608791|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
37921980|NCT00667732|69608792|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
37921981|NCT00667732|69608793|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
37921982|NCT00671788|69608803|FG000|Overall Study|Adverse Event|8|||
37921983|NCT00671788|69608803|FG000|Overall Study|Refused further treatment|3|||
37921984|NCT00671788|69608803|FG000|Overall Study|Ineligible|1|||
37921985|NCT00671788|69608803|FG000|Overall Study|MD Decision|1|||
37921986|NCT00671788|69608803|FG000|Overall Study|Other|1|||
37921987|NCT00875615|69608807|FG000|Overall Study|Withdrawal by Subject|1|||
37921988|NCT00597701|69608813|FG000|Overall Study|Withdrawal by Subject|5|||
37921989|NCT00597701|69608814|FG001|Overall Study|Withdrawal by Subject|5|||
37921990|NCT00597701|69608813|FG000|Overall Study|Death|0|||
37921991|NCT00597701|69608814|FG001|Overall Study|Death|1|||
37921992|NCT00597701|69608813|FG000|Overall Study|Physician Decision|2|||
38032147|NCT02951780|69718046|FG001|Period 2|Scheduling Conflicts|0|||
37641552|NCT02493868|69109322|FG000|Follow-up Phase|Other|2|||
37641553|NCT02493868|69109323|FG001|Follow-up Phase|Other|1|||
37641554|NCT02516410|69109337|FG000|Overall Study|Adverse Event|0|||
37641555|NCT02516410|69109338|FG001|Overall Study|Adverse Event|1|||
37641556|NCT02516410|69109337|FG000|Overall Study|Withdrawal by Subject|0|||
37641557|NCT02516410|69109338|FG001|Overall Study|Withdrawal by Subject|1|||
37641558|NCT02493712|69109348|FG000|Overall Study|Withdrawal by Subject|1|||
37641559|NCT02493712|69109349|FG001|Overall Study|Withdrawal by Subject|0|||
37641560|NCT02493712|69109350|FG002|Overall Study|Withdrawal by Subject|2|||
37641561|NCT02493712|69109348|FG000|Overall Study|Protocol Violation|0|||
37641562|NCT02493712|69109349|FG001|Overall Study|Protocol Violation|0|||
37641563|NCT02493712|69109350|FG002|Overall Study|Protocol Violation|1|||
37641564|NCT02493712|69109348|FG000|Overall Study|Lost to Follow-up|1|||
37641565|NCT02493712|69109349|FG001|Overall Study|Lost to Follow-up|0|||
37641566|NCT02493712|69109350|FG002|Overall Study|Lost to Follow-up|0|||
37641567|NCT02493712|69109348|FG000|Overall Study|Physician Decision|0|||
37641568|NCT02493712|69109349|FG001|Overall Study|Physician Decision|1|||
37641569|NCT02493712|69109350|FG002|Overall Study|Physician Decision|0|||
37641570|NCT02493712|69109348|FG000|Overall Study|Lack of Efficacy|0|||
37641571|NCT02493712|69109349|FG001|Overall Study|Lack of Efficacy|5|||
37641572|NCT02493712|69109350|FG002|Overall Study|Lack of Efficacy|3|||
37641573|NCT02516332|69109361|FG000|Overall Study|Withdrawal by Subject|2|||
37641574|NCT02516332|69109362|FG001|Overall Study|Withdrawal by Subject|1|||
37641575|NCT02516332|69109363|FG002|Overall Study|Withdrawal by Subject|2|||
37641576|NCT02483572|69109373|FG000|Overall Study|Withdrawal by Subject|1|||
37641577|NCT02483572|69109374|FG001|Overall Study|Withdrawal by Subject|0|||
37641578|NCT02483572|69109373|FG000|Overall Study|Lost to Follow-up|1|||
37641579|NCT02483572|69109374|FG001|Overall Study|Lost to Follow-up|0|||
37641580|NCT02483572|69109373|FG000|Overall Study|Physician Decision|0|||
37641581|NCT02483572|69109374|FG001|Overall Study|Physician Decision|1|||
37641582|NCT01062425|69109382|FG000|Overall Study|Protocol Violation|3|||
37641583|NCT01062425|69109383|FG001|Overall Study|Protocol Violation|6|||
37641584|NCT01060553|69109389|FG000|Overall Study|Lost to Follow-up|3|||
37641585|NCT01060553|69109390|FG001|Overall Study|Lost to Follow-up|5|||
37641586|NCT01060553|69109389|FG000|Overall Study|Withdrawal by Subject|5|||
37641587|NCT01060553|69109390|FG001|Overall Study|Withdrawal by Subject|5|||
37641588|NCT01060553|69109389|FG000|Overall Study|Lack of Efficacy|1|||
37641589|NCT01060553|69109390|FG001|Overall Study|Lack of Efficacy|0|||
37641590|NCT02491684|69109397|FG000|Treatment Phase|Adverse Event|2|||
37641591|NCT02491684|69109398|FG001|Treatment Phase|Adverse Event|2|||
37641592|NCT02491684|69109397|FG000|Treatment Phase|Incorrect randomisation|1|||
37641593|NCT02491684|69109398|FG001|Treatment Phase|Incorrect randomisation|0|||
37641594|NCT02491684|69109397|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
37641595|NCT02491684|69109398|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
37641596|NCT01061723|69109410|FG000|Overall Study|Adverse Event|0|||
37641597|NCT01061723|69109411|FG001|Overall Study|Adverse Event|2|||
37641598|NCT01061723|69109412|FG002|Overall Study|Adverse Event|5|||
37641599|NCT01061723|69109413|FG003|Overall Study|Adverse Event|5|||
37641600|NCT01061723|69109414|FG004|Overall Study|Adverse Event|2|||
37641601|NCT01061723|69109415|FG005|Overall Study|Adverse Event|6|||
37641602|NCT01061723|69109410|FG000|Overall Study|Lack of Efficacy|2|||
37641603|NCT01061723|69109411|FG001|Overall Study|Lack of Efficacy|3|||
37641604|NCT01061723|69109412|FG002|Overall Study|Lack of Efficacy|4|||
37641605|NCT01061723|69109413|FG003|Overall Study|Lack of Efficacy|2|||
37641606|NCT01061723|69109414|FG004|Overall Study|Lack of Efficacy|1|||
37641607|NCT01061723|69109415|FG005|Overall Study|Lack of Efficacy|1|||
37641608|NCT01061723|69109410|FG000|Overall Study|Randomized but not treated|0|||
37641609|NCT01061723|69109411|FG001|Overall Study|Randomized but not treated|0|||
37641610|NCT01061723|69109412|FG002|Overall Study|Randomized but not treated|0|||
37740736|NCT01725308|69226572|FG001|Treatment Period II|Did Not Receive Drug|0|||
37740737|NCT01725308|69226573|FG002|Treatment Period II|Did Not Receive Drug|0|||
37740738|NCT01725308|69226571|FG000|Treatment Period II|Adverse Event|13|||
37641611|NCT01061723|69109413|FG003|Overall Study|Randomized but not treated|0|||
37641612|NCT01061723|69109414|FG004|Overall Study|Randomized but not treated|0|||
37641613|NCT01061723|69109415|FG005|Overall Study|Randomized but not treated|1|||
37641614|NCT01061723|69109410|FG000|Overall Study|Other than specified above|2|||
37740739|NCT01725308|69226572|FG001|Treatment Period II|Adverse Event|8|||
37740740|NCT01725308|69226573|FG002|Treatment Period II|Adverse Event|20|||
37740741|NCT01725308|69226571|FG000|Treatment Period II|Insufficient Response|2|||
37921993|NCT00597701|69608814|FG001|Overall Study|Physician Decision|0|||
37740742|NCT01725308|69226572|FG001|Treatment Period II|Insufficient Response|4|||
37641615|NCT01061723|69109411|FG001|Overall Study|Other than specified above|1|||
37641616|NCT01061723|69109412|FG002|Overall Study|Other than specified above|1|||
37641617|NCT01061723|69109413|FG003|Overall Study|Other than specified above|1|||
37641618|NCT01061723|69109414|FG004|Overall Study|Other than specified above|0|||
37641619|NCT01061723|69109415|FG005|Overall Study|Other than specified above|1|||
37641620|NCT01061567|69109434|FG000|Overall Study|Adverse Event|32|||
37641621|NCT01061567|69109434|FG000|Overall Study|Death|2|||
37641622|NCT01061567|69109434|FG000|Overall Study|Lack of Efficacy|3|||
37641623|NCT01061567|69109434|FG000|Overall Study|Lost to Follow-up|24|||
37641624|NCT01061567|69109434|FG000|Overall Study|Protocol Violation|1|||
37641625|NCT01061567|69109434|FG000|Overall Study|Withdrawal by Subject|11|||
37641626|NCT01061567|69109434|FG000|Overall Study|Other reason than stated above|3|||
37641627|NCT01061333|69109438|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
37641628|NCT01061333|69109439|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
37641629|NCT02489968|69109452|FG000|Open-label Treatment Period|Adverse Event|14|||
37641630|NCT02489968|69109453|FG001|Open-label Treatment Period|Adverse Event|7|||
37641631|NCT02489968|69109454|FG002|Open-label Treatment Period|Adverse Event|0|||
37641632|NCT02489968|69109455|FG003|Open-label Treatment Period|Adverse Event|0|||
37641633|NCT02489968|69109456|FG004|Open-label Treatment Period|Adverse Event|0|||
37641634|NCT02489968|69109457|FG005|Open-label Treatment Period|Adverse Event|0|||
37641635|NCT02489968|69109452|FG000|Open-label Treatment Period|Protocol Violation|2|||
37641636|NCT02489968|69109453|FG001|Open-label Treatment Period|Protocol Violation|2|||
37641637|NCT02489968|69109454|FG002|Open-label Treatment Period|Protocol Violation|0|||
37641638|NCT02489968|69109455|FG003|Open-label Treatment Period|Protocol Violation|0|||
37641639|NCT02489968|69109456|FG004|Open-label Treatment Period|Protocol Violation|0|||
37641640|NCT02489968|69109457|FG005|Open-label Treatment Period|Protocol Violation|0|||
37641641|NCT02489968|69109452|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
37641642|NCT02489968|69109453|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
37641643|NCT02489968|69109454|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
37641644|NCT02489968|69109455|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
37641645|NCT02489968|69109456|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
37641646|NCT02489968|69109457|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
37641647|NCT02489968|69109452|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
37641648|NCT02489968|69109453|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
37641649|NCT02489968|69109454|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
37641650|NCT02489968|69109455|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
37641651|NCT02489968|69109456|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
37641652|NCT02489968|69109457|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
37641653|NCT02489968|69109452|FG000|Open-label Treatment Period|Other than specified above|204|||
37641654|NCT02489968|69109453|FG001|Open-label Treatment Period|Other than specified above|189|||
37641655|NCT02489968|69109454|FG002|Open-label Treatment Period|Other than specified above|0|||
37641656|NCT02489968|69109455|FG003|Open-label Treatment Period|Other than specified above|0|||
37641657|NCT02489968|69109456|FG004|Open-label Treatment Period|Other than specified above|0|||
37641658|NCT02489968|69109457|FG005|Open-label Treatment Period|Other than specified above|0|||
37641659|NCT02489968|69109452|FG000|Double-blind Treatment Period|Adverse Event|0|||
37641660|NCT02489968|69109453|FG001|Double-blind Treatment Period|Adverse Event|0|||
37641661|NCT02489968|69109454|FG002|Double-blind Treatment Period|Adverse Event|2|||
37641662|NCT02489968|69109455|FG003|Double-blind Treatment Period|Adverse Event|6|||
37641663|NCT02489968|69109456|FG004|Double-blind Treatment Period|Adverse Event|4|||
37641664|NCT02489968|69109457|FG005|Double-blind Treatment Period|Adverse Event|5|||
37641665|NCT02489968|69109452|FG000|Double-blind Treatment Period|Protocol Violation|0|||
37641666|NCT02489968|69109453|FG001|Double-blind Treatment Period|Protocol Violation|0|||
37641667|NCT02489968|69109454|FG002|Double-blind Treatment Period|Protocol Violation|0|||
37641668|NCT02489968|69109455|FG003|Double-blind Treatment Period|Protocol Violation|0|||
37641669|NCT02489968|69109456|FG004|Double-blind Treatment Period|Protocol Violation|1|||
37641670|NCT02489968|69109457|FG005|Double-blind Treatment Period|Protocol Violation|1|||
37641671|NCT02489968|69109452|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
37641672|NCT02489968|69109453|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
37641673|NCT02489968|69109454|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
37641674|NCT02489968|69109455|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
37641675|NCT02489968|69109456|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
37641676|NCT02489968|69109457|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
37641677|NCT02489968|69109452|FG000|Double-blind Treatment Period|Other than specified above|0|||
37854413|NCT01232283|69537955|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
37854414|NCT01232283|69537956|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
37854415|NCT01232283|69537957|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
37854416|NCT01232283|69537958|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
37854417|NCT01232283|69537959|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
37641678|NCT02489968|69109453|FG001|Double-blind Treatment Period|Other than specified above|0|||
37641679|NCT02489968|69109454|FG002|Double-blind Treatment Period|Other than specified above|0|||
37641680|NCT02489968|69109455|FG003|Double-blind Treatment Period|Other than specified above|0|||
37641681|NCT02489968|69109456|FG004|Double-blind Treatment Period|Other than specified above|1|||
37641682|NCT02489968|69109457|FG005|Double-blind Treatment Period|Other than specified above|0|||
37641683|NCT02483416|69109471|FG000|Overall Study|Other reason|0|||
37641684|NCT02483416|69109472|FG001|Overall Study|Other reason|1|||
37641685|NCT02483416|69109471|FG000|Overall Study|Treatment stop|3|||
37641686|NCT02483416|69109472|FG001|Overall Study|Treatment stop|0|||
37641687|NCT01061177|69109479|FG000|Overall Study|Adverse Event|117|||
37641688|NCT01061177|69109479|FG000|Overall Study|Withdrawal by Subject|27|||
37641689|NCT01061177|69109479|FG000|Overall Study|Disease progression|17|||
37641690|NCT01061177|69109479|FG000|Overall Study|Protocol Violation|11|||
37641691|NCT01061177|69109479|FG000|Overall Study|Lost to Follow-up|9|||
37641692|NCT01061177|69109479|FG000|Overall Study|New cancer therapy|9|||
37641693|NCT01061177|69109479|FG000|Overall Study|Abnormal laboratory values|6|||
37641694|NCT01061177|69109479|FG000|Overall Study|Abnormal test procedure results|4|||
37641695|NCT01061177|69109479|FG000|Overall Study|Administratie problems|4|||
37641696|NCT01061177|69109479|FG000|Overall Study|Death|4|||
37641697|NCT02481934|69109483|FG000|Overall Study|Death|2|||
37641698|NCT02973425|69109489|FG000|Overall Study|Lost to Follow-up|49|||
37641699|NCT02973425|69109490|FG001|Overall Study|Lost to Follow-up|53|||
37641700|NCT02489500|69109499|FG000|Overall Study|Death|1|||
37641701|NCT02489500|69109500|FG001|Overall Study|Death|1|||
37641702|NCT02732847|69109508|FG000|Overall Study|some filled early|42|||
37641703|NCT02732847|69109509|FG001|Overall Study|some filled early|42|||
37641704|NCT02489344|69109515|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
37641705|NCT02489344|69109515|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
37641706|NCT02489344|69109515|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
37641707|NCT02489344|69109515|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
37641708|NCT02488330|69109519|FG000|Overall Study|Adverse Event|1|||
37641709|NCT02488330|69109519|FG000|Overall Study|Physician Decision|2|||
37641710|NCT02488330|69109519|FG000|Overall Study|Death|2|||
37641711|NCT02488330|69109519|FG000|Overall Study|Disease Progression|3|||
37641712|NCT02488330|69109519|FG000|Overall Study|Study Termination by Sponsor|4|||
37641713|NCT02481310|69109526|FG000|Follow up|Still in follow up|0|||
37641714|NCT02481310|69109527|FG001|Follow up|Still in follow up|3|||
37641715|NCT02481310|69109528|FG002|Follow up|Still in follow up|0|||
37641716|NCT02480764|69109535|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
37641717|NCT02480764|69109536|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
37641718|NCT02480764|69109537|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
37641719|NCT02480764|69109535|FG000|Overall Study|Major Protocol Deviation|1|||
37641720|NCT02480764|69109536|FG001|Overall Study|Major Protocol Deviation|4|||
37641721|NCT02480764|69109537|FG002|Overall Study|Major Protocol Deviation|3|||
37641722|NCT02480764|69109535|FG000|Overall Study|Lost to Follow-up|0|||
37641723|NCT02480764|69109536|FG001|Overall Study|Lost to Follow-up|1|||
37641724|NCT02480764|69109537|FG002|Overall Study|Lost to Follow-up|2|||
37641725|NCT02480764|69109535|FG000|Overall Study|Voluntary Withdrawal|6|||
37641726|NCT02480764|69109536|FG001|Overall Study|Voluntary Withdrawal|5|||
37641727|NCT02480764|69109537|FG002|Overall Study|Voluntary Withdrawal|10|||
37641728|NCT02480764|69109535|FG000|Overall Study|Lack of Efficacy|0|||
37641729|NCT02480764|69109536|FG001|Overall Study|Lack of Efficacy|3|||
37641730|NCT02480764|69109537|FG002|Overall Study|Lack of Efficacy|3|||
37641731|NCT02480764|69109535|FG000|Overall Study|Reason not Specified|0|||
37641732|NCT02480764|69109536|FG001|Overall Study|Reason not Specified|1|||
37641733|NCT02480764|69109537|FG002|Overall Study|Reason not Specified|0|||
37641734|NCT02487472|69109545|FG000|Overall Study|Did not complete telephonic interviews|9|||
37641735|NCT02487472|69109545|FG000|Overall Study|Other|2|||
37641736|NCT02451670|69109553|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
37641737|NCT02451670|69109554|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
37641738|NCT02486692|69109562|FG000|Overall Study|did not login for randomization|4|||
37641739|NCT02486692|69109563|FG001|Overall Study|did not login for randomization|7|||
37641740|NCT01060007|69109580|FG000|Overall Study|Withdrawal by Subject|1|||
37641741|NCT01060007|69109580|FG000|Overall Study|Inevaluable for response at surgery|3|||
37641742|NCT02971163|69109589|FG000|Overall Study|Lost to Follow-up|4|||
37641743|NCT02971163|69109590|FG001|Overall Study|Lost to Follow-up|2|||
37641744|NCT02971007|69109599|FG000|Overall Study|Adverse Event|1|||
37641745|NCT02971007|69109600|FG001|Overall Study|Adverse Event|0|||
37641746|NCT02971007|69109601|FG002|Overall Study|Adverse Event|0|||
37740743|NCT01725308|69226573|FG002|Treatment Period II|Insufficient Response|6|||
37641747|NCT02971007|69109599|FG000|Overall Study|Lost to Follow-up|0|||
37641748|NCT02971007|69109600|FG001|Overall Study|Lost to Follow-up|1|||
37641749|NCT02971007|69109601|FG002|Overall Study|Lost to Follow-up|1|||
37641750|NCT02971007|69109599|FG000|Overall Study|Withdrawal by Subject|0|||
37641751|NCT02971007|69109600|FG001|Overall Study|Withdrawal by Subject|1|||
37641752|NCT02971007|69109601|FG002|Overall Study|Withdrawal by Subject|0|||
37641753|NCT02971007|69109599|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
37641754|NCT02971007|69109600|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
37641755|NCT02971007|69109601|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
37641756|NCT02971007|69109599|FG000|Overall Study|Patient discontinued study drug|0|||
37641757|NCT02971007|69109600|FG001|Overall Study|Patient discontinued study drug|1|||
37641758|NCT02971007|69109601|FG002|Overall Study|Patient discontinued study drug|0|||
37641759|NCT03881553|69109612|FG000|Overall Study|Discharged prior to participation|1|||
38032148|NCT02951780|69718047|FG002|Period 2|Scheduling Conflicts|0|||
37641760|NCT03881553|69109613|FG001|Overall Study|Discharged prior to participation|1|||
37641761|NCT03881553|69109614|FG002|Overall Study|Discharged prior to participation|0|||
37641762|NCT03881553|69109612|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
37641763|NCT03881553|69109613|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
37641764|NCT03881553|69109614|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
37641765|NCT02970929|69109622|FG000|Overall Study|Adverse Event|18|||
37641766|NCT02970929|69109622|FG000|Overall Study|Lack of Efficacy|8|||
37641767|NCT02970929|69109622|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
37641768|NCT02970929|69109622|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
37641769|NCT02970929|69109622|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
37641770|NCT02970929|69109622|FG000|Overall Study|LOST TO FOLLOWUP|6|||
37641771|NCT02970929|69109622|FG000|Overall Study|MOVED OUT OF STATE|1|||
37641772|NCT02970929|69109622|FG000|Overall Study|Withdrawal by Subject|16|||
37641773|NCT02970305|69109639|FG000|Overall Study|Adverse Event|10|||
37641774|NCT02970305|69109640|FG001|Overall Study|Adverse Event|6|||
37641775|NCT02970305|69109639|FG000|Overall Study|Lack of Efficacy|1|||
37641776|NCT02970305|69109640|FG001|Overall Study|Lack of Efficacy|1|||
37641777|NCT02970305|69109639|FG000|Overall Study|Noncompliance with study drug|2|||
37641778|NCT02970305|69109640|FG001|Overall Study|Noncompliance with study drug|4|||
37641779|NCT02970305|69109639|FG000|Overall Study|Protocol Violation|2|||
37641780|NCT02970305|69109640|FG001|Overall Study|Protocol Violation|2|||
37641781|NCT02970305|69109639|FG000|Overall Study|Withdrawal by Subject|12|||
37641782|NCT02970305|69109640|FG001|Overall Study|Withdrawal by Subject|11|||
37641783|NCT02970305|69109639|FG000|Overall Study|Not further specified|1|||
37641784|NCT02970305|69109640|FG001|Overall Study|Not further specified|2|||
37641785|NCT02970305|69109639|FG000|Overall Study|Lost to Follow-up|1|||
37641786|NCT02970305|69109640|FG001|Overall Study|Lost to Follow-up|2|||
37641787|NCT02022033|69109659|FG000|Overall Study|Physician Decision|1|||
37641788|NCT03505671|69109665|FG000|Overall Study|Withdrawal by Subject|2|||
37641789|NCT03505671|69109666|FG001|Overall Study|Withdrawal by Subject|1|||
37641790|NCT03505671|69109665|FG000|Overall Study|Lost to Follow-up|1|||
37641791|NCT03505671|69109666|FG001|Overall Study|Lost to Follow-up|0|||
37641792|NCT01103349|69109687|FG000|Overall Study|Adverse Event|8|||
37641793|NCT01103349|69109688|FG001|Overall Study|Adverse Event|5|||
37641794|NCT01103349|69109689|FG002|Overall Study|Adverse Event|3|||
37641795|NCT01103349|69109687|FG000|Overall Study|Consent withdrawn|1|||
37641796|NCT01103349|69109688|FG001|Overall Study|Consent withdrawn|0|||
37641797|NCT01103349|69109689|FG002|Overall Study|Consent withdrawn|0|||
37641798|NCT01103349|69109687|FG000|Overall Study|Incorrectly included in the trial|1|||
37641799|NCT01103349|69109688|FG001|Overall Study|Incorrectly included in the trial|0|||
37641800|NCT01103349|69109689|FG002|Overall Study|Incorrectly included in the trial|0|||
37641801|NCT01103349|69109687|FG000|Overall Study|Withdrawal by Subject|1|||
37641802|NCT01103349|69109688|FG001|Overall Study|Withdrawal by Subject|1|||
37641803|NCT01103349|69109689|FG002|Overall Study|Withdrawal by Subject|0|||
37641804|NCT01103349|69109687|FG000|Overall Study|did not want to take trial medication|0|||
37641805|NCT01103349|69109688|FG001|Overall Study|did not want to take trial medication|1|||
37641806|NCT01103349|69109689|FG002|Overall Study|did not want to take trial medication|0|||
37641807|NCT01103349|69109687|FG000|Overall Study|forgot to take medication|0|||
37641808|NCT01103349|69109688|FG001|Overall Study|forgot to take medication|0|||
37641809|NCT01103349|69109689|FG002|Overall Study|forgot to take medication|1|||
37641810|NCT02959177|69109700|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
37641811|NCT02959177|69109701|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
37641812|NCT02959177|69109702|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
37641813|NCT02959177|69109700|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
37641814|NCT02959177|69109701|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
37641815|NCT02959177|69109702|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
37641816|NCT02959177|69109700|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
37641817|NCT02959177|69109701|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
37641818|NCT02959177|69109702|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
37641819|NCT02959177|69109700|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
37641820|NCT02959177|69109701|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
37641821|NCT02959177|69109702|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
37641822|NCT02959177|69109700|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
37641823|NCT02959177|69109701|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
37641824|NCT02959177|69109702|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
37641825|NCT02959177|69109700|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
37641826|NCT02959177|69109701|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
37641827|NCT02959177|69109702|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
37641828|NCT02959177|69109700|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
37740744|NCT01725308|69226571|FG000|Treatment Period II|Worsening of the Target Disease|1|||
37740745|NCT01725308|69226572|FG001|Treatment Period II|Worsening of the Target Disease|4|||
37641829|NCT02959177|69109701|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
37740746|NCT01725308|69226573|FG002|Treatment Period II|Worsening of the Target Disease|2|||
37641830|NCT02959177|69109702|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
37641831|NCT04706403|69109719|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
37641832|NCT04706403|69109720|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
37641833|NCT04706403|69109721|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
37641834|NCT04706403|69109722|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
37641835|NCT04706403|69109723|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
37641836|NCT02983617|69109737|FG000|Overall Study|Adverse Event|0|||
37641837|NCT02983617|69109738|FG001|Overall Study|Adverse Event|7|||
37641838|NCT02983617|69109737|FG000|Overall Study|Death|0|||
37641839|NCT02983617|69109738|FG001|Overall Study|Death|1|||
37641840|NCT02983617|69109737|FG000|Overall Study|Investigator's Discretion|0|||
37641841|NCT02983617|69109738|FG001|Overall Study|Investigator's Discretion|1|||
37641842|NCT02873689|69109746|FG000|Overall Study|Lack of Efficacy|1|||
37641843|NCT02873689|69109747|FG001|Overall Study|Lack of Efficacy|0|||
37641844|NCT02873689|69109746|FG000|Overall Study|Withdrawal by Subject|2|||
37641845|NCT02873689|69109747|FG001|Overall Study|Withdrawal by Subject|2|||
37641846|NCT02873689|69109746|FG000|Overall Study|Protocol Violation|1|||
37641847|NCT02873689|69109747|FG001|Overall Study|Protocol Violation|0|||
37641848|NCT02873689|69109746|FG000|Overall Study|Adverse Event|2|||
37641849|NCT02873689|69109747|FG001|Overall Study|Adverse Event|2|||
37641850|NCT02873689|69109746|FG000|Overall Study|Randomized but not Treated|1|||
37641851|NCT02873689|69109747|FG001|Overall Study|Randomized but not Treated|1|||
37641852|NCT02901431|69109761|FG000|PK Part|Adverse Event|0|||
37641853|NCT02901431|69109762|FG001|PK Part|Adverse Event|1|||
37641854|NCT02901431|69109763|FG002|PK Part|Adverse Event|0|||
37641855|NCT02901431|69109764|FG003|PK Part|Adverse Event|0|||
37641856|NCT02901431|69109765|FG004|PK Part|Adverse Event|0|||
37641857|NCT02901431|69109766|FG005|PK Part|Adverse Event|0|||
37641858|NCT02901431|69109767|FG006|PK Part|Adverse Event|0|||
37641859|NCT02901431|69109768|FG007|PK Part|Adverse Event|0|||
37641860|NCT02901431|69109769|FG008|PK Part|Adverse Event|0|||
37641861|NCT02901431|69109770|FG009|PK Part|Adverse Event|0|||
37641862|NCT02901431|69109771|FG010|PK Part|Adverse Event|0|||
37641863|NCT02901431|69109772|FG011|PK Part|Adverse Event|0|||
37641864|NCT02901431|69109773|FG012|PK Part|Adverse Event|0|||
37641865|NCT02901431|69109761|FG000|PK Part|Lost to Follow-up|0|||
37641866|NCT02901431|69109762|FG001|PK Part|Lost to Follow-up|0|||
37641867|NCT02901431|69109763|FG002|PK Part|Lost to Follow-up|1|||
37641868|NCT02901431|69109764|FG003|PK Part|Lost to Follow-up|0|||
37641869|NCT02901431|69109765|FG004|PK Part|Lost to Follow-up|0|||
37641870|NCT02901431|69109766|FG005|PK Part|Lost to Follow-up|0|||
37641871|NCT02901431|69109767|FG006|PK Part|Lost to Follow-up|0|||
37641872|NCT02901431|69109768|FG007|PK Part|Lost to Follow-up|0|||
37641873|NCT02901431|69109769|FG008|PK Part|Lost to Follow-up|0|||
37641874|NCT02901431|69109770|FG009|PK Part|Lost to Follow-up|0|||
37641875|NCT02901431|69109771|FG010|PK Part|Lost to Follow-up|0|||
37641876|NCT02901431|69109772|FG011|PK Part|Lost to Follow-up|0|||
37641877|NCT02901431|69109773|FG012|PK Part|Lost to Follow-up|0|||
37641878|NCT02901431|69109761|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
37641879|NCT02901431|69109762|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
37641880|NCT02901431|69109763|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
37641881|NCT02901431|69109764|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
37641882|NCT02901431|69109765|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
37641883|NCT02901431|69109766|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
37641884|NCT02901431|69109767|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
37641885|NCT02901431|69109768|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
37641886|NCT02901431|69109769|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
37740747|NCT01725308|69226571|FG000|Treatment Period II|Changes in the Episodes|1|||
37740748|NCT01725308|69226572|FG001|Treatment Period II|Changes in the Episodes|0|||
37740749|NCT01725308|69226573|FG002|Treatment Period II|Changes in the Episodes|5|||
37854418|NCT01232283|69537960|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
37641887|NCT02901431|69109770|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
37641888|NCT02901431|69109771|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
37641889|NCT02901431|69109772|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
37641890|NCT02901431|69109773|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
37641891|NCT02901431|69109761|FG000|PK Part|Pending dose confirmation|0|||
37641892|NCT02901431|69109762|FG001|PK Part|Pending dose confirmation|1|||
37641893|NCT02901431|69109763|FG002|PK Part|Pending dose confirmation|0|||
37641894|NCT02901431|69109764|FG003|PK Part|Pending dose confirmation|0|||
37641895|NCT02901431|69109765|FG004|PK Part|Pending dose confirmation|0|||
37641896|NCT02901431|69109766|FG005|PK Part|Pending dose confirmation|0|||
37641897|NCT02901431|69109767|FG006|PK Part|Pending dose confirmation|0|||
37641898|NCT02901431|69109768|FG007|PK Part|Pending dose confirmation|0|||
37641899|NCT02901431|69109769|FG008|PK Part|Pending dose confirmation|0|||
37641900|NCT02901431|69109770|FG009|PK Part|Pending dose confirmation|0|||
37641901|NCT02901431|69109771|FG010|PK Part|Pending dose confirmation|0|||
37641902|NCT02901431|69109772|FG011|PK Part|Pending dose confirmation|0|||
37641903|NCT02901431|69109773|FG012|PK Part|Pending dose confirmation|0|||
37641904|NCT02901431|69109761|FG000|PK Part|8 weeks of treatment ran out|2|||
37641905|NCT02901431|69109762|FG001|PK Part|8 weeks of treatment ran out|0|||
37641906|NCT02901431|69109763|FG002|PK Part|8 weeks of treatment ran out|0|||
37641907|NCT02901431|69109764|FG003|PK Part|8 weeks of treatment ran out|0|||
37641908|NCT02901431|69109765|FG004|PK Part|8 weeks of treatment ran out|0|||
37641909|NCT02901431|69109766|FG005|PK Part|8 weeks of treatment ran out|0|||
37641910|NCT02901431|69109767|FG006|PK Part|8 weeks of treatment ran out|0|||
37641911|NCT02901431|69109768|FG007|PK Part|8 weeks of treatment ran out|0|||
37641912|NCT02901431|69109769|FG008|PK Part|8 weeks of treatment ran out|0|||
37641913|NCT02901431|69109770|FG009|PK Part|8 weeks of treatment ran out|0|||
37641914|NCT02901431|69109771|FG010|PK Part|8 weeks of treatment ran out|0|||
37641915|NCT02901431|69109772|FG011|PK Part|8 weeks of treatment ran out|0|||
37641916|NCT02901431|69109773|FG012|PK Part|8 weeks of treatment ran out|0|||
37641917|NCT02901431|69109761|FG000|PK Part|Stopped treatment after 8 weeks|1|||
37641918|NCT02901431|69109762|FG001|PK Part|Stopped treatment after 8 weeks|0|||
37641919|NCT02901431|69109763|FG002|PK Part|Stopped treatment after 8 weeks|1|||
37641920|NCT02901431|69109764|FG003|PK Part|Stopped treatment after 8 weeks|0|||
37641921|NCT02901431|69109765|FG004|PK Part|Stopped treatment after 8 weeks|0|||
37641922|NCT02901431|69109766|FG005|PK Part|Stopped treatment after 8 weeks|0|||
37641923|NCT02901431|69109767|FG006|PK Part|Stopped treatment after 8 weeks|0|||
37641924|NCT02901431|69109768|FG007|PK Part|Stopped treatment after 8 weeks|0|||
37641925|NCT02901431|69109769|FG008|PK Part|Stopped treatment after 8 weeks|0|||
37641926|NCT02901431|69109770|FG009|PK Part|Stopped treatment after 8 weeks|0|||
37641927|NCT02901431|69109771|FG010|PK Part|Stopped treatment after 8 weeks|0|||
37641928|NCT02901431|69109772|FG011|PK Part|Stopped treatment after 8 weeks|0|||
37641929|NCT02901431|69109773|FG012|PK Part|Stopped treatment after 8 weeks|0|||
37641930|NCT02901431|69109761|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
37641931|NCT02901431|69109762|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
37641932|NCT02901431|69109763|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
37641933|NCT02901431|69109764|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
37641934|NCT02901431|69109765|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
37641935|NCT02901431|69109766|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
37641936|NCT02901431|69109767|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
37641937|NCT02901431|69109768|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
37641938|NCT02901431|69109769|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
37641939|NCT02901431|69109770|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
37641940|NCT02901431|69109771|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
37641941|NCT02901431|69109772|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
37641942|NCT02901431|69109773|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
37641943|NCT02901431|69109761|FG000|PK Part|Discontinued per Sponsor|0|||
37641944|NCT02901431|69109762|FG001|PK Part|Discontinued per Sponsor|3|||
37641945|NCT02901431|69109763|FG002|PK Part|Discontinued per Sponsor|0|||
37641946|NCT02901431|69109764|FG003|PK Part|Discontinued per Sponsor|0|||
37641947|NCT02901431|69109765|FG004|PK Part|Discontinued per Sponsor|0|||
37641948|NCT02901431|69109766|FG005|PK Part|Discontinued per Sponsor|0|||
37641949|NCT02901431|69109767|FG006|PK Part|Discontinued per Sponsor|0|||
37641950|NCT02901431|69109768|FG007|PK Part|Discontinued per Sponsor|0|||
37641951|NCT02901431|69109769|FG008|PK Part|Discontinued per Sponsor|0|||
37641952|NCT02901431|69109770|FG009|PK Part|Discontinued per Sponsor|0|||
37641953|NCT02901431|69109771|FG010|PK Part|Discontinued per Sponsor|0|||
37641954|NCT02901431|69109772|FG011|PK Part|Discontinued per Sponsor|0|||
37641955|NCT02901431|69109773|FG012|PK Part|Discontinued per Sponsor|0|||
37641956|NCT02901431|69109761|FG000|PK Part|Withdrawal by Subject|1|||
37641957|NCT02901431|69109762|FG001|PK Part|Withdrawal by Subject|1|||
37641958|NCT02901431|69109763|FG002|PK Part|Withdrawal by Subject|3|||
37641959|NCT02901431|69109764|FG003|PK Part|Withdrawal by Subject|0|||
37641960|NCT02901431|69109765|FG004|PK Part|Withdrawal by Subject|0|||
37641961|NCT02901431|69109766|FG005|PK Part|Withdrawal by Subject|0|||
37641962|NCT02901431|69109767|FG006|PK Part|Withdrawal by Subject|0|||
37921994|NCT00597701|69608813|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
37641963|NCT02901431|69109768|FG007|PK Part|Withdrawal by Subject|0|||
37641964|NCT02901431|69109769|FG008|PK Part|Withdrawal by Subject|0|||
37641965|NCT02901431|69109770|FG009|PK Part|Withdrawal by Subject|0|||
37641966|NCT02901431|69109771|FG010|PK Part|Withdrawal by Subject|0|||
37641967|NCT02901431|69109772|FG011|PK Part|Withdrawal by Subject|0|||
37641968|NCT02901431|69109773|FG012|PK Part|Withdrawal by Subject|0|||
37641969|NCT02901431|69109761|FG000|Main Treatment Part|Adverse Event|0|||
37641970|NCT02901431|69109762|FG001|Main Treatment Part|Adverse Event|0|||
37641971|NCT02901431|69109763|FG002|Main Treatment Part|Adverse Event|0|||
37641972|NCT02901431|69109764|FG003|Main Treatment Part|Adverse Event|3|||
37641973|NCT02901431|69109765|FG004|Main Treatment Part|Adverse Event|3|||
37641974|NCT02901431|69109766|FG005|Main Treatment Part|Adverse Event|4|||
37641975|NCT02901431|69109767|FG006|Main Treatment Part|Adverse Event|1|||
37641976|NCT02901431|69109768|FG007|Main Treatment Part|Adverse Event|0|||
37641977|NCT02901431|69109769|FG008|Main Treatment Part|Adverse Event|0|||
37641978|NCT02901431|69109770|FG009|Main Treatment Part|Adverse Event|0|||
37641979|NCT02901431|69109771|FG010|Main Treatment Part|Adverse Event|0|||
37641980|NCT02901431|69109772|FG011|Main Treatment Part|Adverse Event|0|||
37641981|NCT02901431|69109773|FG012|Main Treatment Part|Adverse Event|0|||
37641982|NCT02901431|69109761|FG000|Main Treatment Part|Lack of Efficacy|0|||
37641983|NCT02901431|69109762|FG001|Main Treatment Part|Lack of Efficacy|0|||
37641984|NCT02901431|69109763|FG002|Main Treatment Part|Lack of Efficacy|0|||
37641985|NCT02901431|69109764|FG003|Main Treatment Part|Lack of Efficacy|1|||
37641986|NCT02901431|69109765|FG004|Main Treatment Part|Lack of Efficacy|0|||
37641987|NCT02901431|69109766|FG005|Main Treatment Part|Lack of Efficacy|0|||
37641988|NCT02901431|69109767|FG006|Main Treatment Part|Lack of Efficacy|0|||
37641989|NCT02901431|69109768|FG007|Main Treatment Part|Lack of Efficacy|0|||
37641990|NCT02901431|69109769|FG008|Main Treatment Part|Lack of Efficacy|0|||
37641991|NCT02901431|69109770|FG009|Main Treatment Part|Lack of Efficacy|0|||
37641992|NCT02901431|69109771|FG010|Main Treatment Part|Lack of Efficacy|0|||
37641993|NCT02901431|69109772|FG011|Main Treatment Part|Lack of Efficacy|0|||
37641994|NCT02901431|69109773|FG012|Main Treatment Part|Lack of Efficacy|0|||
37641995|NCT02901431|69109761|FG000|Main Treatment Part|Lost to Follow-up|0|||
37641996|NCT02901431|69109762|FG001|Main Treatment Part|Lost to Follow-up|0|||
37641997|NCT02901431|69109763|FG002|Main Treatment Part|Lost to Follow-up|0|||
37641998|NCT02901431|69109764|FG003|Main Treatment Part|Lost to Follow-up|3|||
37641999|NCT02901431|69109765|FG004|Main Treatment Part|Lost to Follow-up|1|||
37642000|NCT02901431|69109766|FG005|Main Treatment Part|Lost to Follow-up|2|||
37642001|NCT02901431|69109767|FG006|Main Treatment Part|Lost to Follow-up|3|||
37642002|NCT02901431|69109768|FG007|Main Treatment Part|Lost to Follow-up|0|||
37642003|NCT02901431|69109769|FG008|Main Treatment Part|Lost to Follow-up|0|||
37642004|NCT02901431|69109770|FG009|Main Treatment Part|Lost to Follow-up|0|||
37642005|NCT02901431|69109771|FG010|Main Treatment Part|Lost to Follow-up|0|||
37642006|NCT02901431|69109772|FG011|Main Treatment Part|Lost to Follow-up|0|||
37642007|NCT02901431|69109773|FG012|Main Treatment Part|Lost to Follow-up|0|||
37642008|NCT02901431|69109761|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
37642009|NCT02901431|69109762|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
37642010|NCT02901431|69109763|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
37642011|NCT02901431|69109764|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
37642012|NCT02901431|69109765|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
37642013|NCT02901431|69109766|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
37642014|NCT02901431|69109767|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
37642015|NCT02901431|69109768|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
37642016|NCT02901431|69109769|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
37642017|NCT02901431|69109770|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
37642018|NCT02901431|69109771|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
37740750|NCT01725308|69226571|FG000|Treatment Period II|Withdrawal of Consent|28|||
37740751|NCT01725308|69226572|FG001|Treatment Period II|Withdrawal of Consent|2|||
37740752|NCT01725308|69226573|FG002|Treatment Period II|Withdrawal of Consent|16|||
37740753|NCT01725308|69226571|FG000|Treatment Period II|Lost to Follow-up|1|||
37740754|NCT01725308|69226572|FG001|Treatment Period II|Lost to Follow-up|5|||
37740755|NCT01725308|69226573|FG002|Treatment Period II|Lost to Follow-up|3|||
37740756|NCT01725308|69226571|FG000|Treatment Period II|Protocol Deviations|0|||
37740757|NCT01725308|69226572|FG001|Treatment Period II|Protocol Deviations|0|||
37740758|NCT01725308|69226573|FG002|Treatment Period II|Protocol Deviations|1|||
37740759|NCT01725308|69226571|FG000|Treatment Period II|Miscellaneous|5|||
37740760|NCT01725308|69226572|FG001|Treatment Period II|Miscellaneous|3|||
37740761|NCT01725308|69226573|FG002|Treatment Period II|Miscellaneous|7|||
37740762|NCT01724528|69226590|FG000|Overall Study|Death|3|||
37740763|NCT01724528|69226591|FG001|Overall Study|Death|0|||
37740764|NCT01724528|69226590|FG000|Overall Study|Withdrawal by Subject|0|||
37740765|NCT01724528|69226591|FG001|Overall Study|Withdrawal by Subject|2|||
37740766|NCT01724528|69226590|FG000|Overall Study|Protocol Violation|0|||
37854419|NCT01232283|69537961|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
37854420|NCT01232283|69537952|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
37854421|NCT01232283|69537953|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
37854422|NCT01232283|69537954|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
37854423|NCT01232283|69537955|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
37642019|NCT02901431|69109772|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
37642020|NCT02901431|69109773|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
37642021|NCT02901431|69109761|FG000|Main Treatment Part|Physician Decision|0|||
37740767|NCT01724528|69226591|FG001|Overall Study|Protocol Violation|1|||
37740768|NCT01724528|69226590|FG000|Overall Study|Patient refused to attend last visit|1|||
37740769|NCT01724528|69226591|FG001|Overall Study|Patient refused to attend last visit|0|||
37642022|NCT02901431|69109762|FG001|Main Treatment Part|Physician Decision|0|||
37642023|NCT02901431|69109763|FG002|Main Treatment Part|Physician Decision|0|||
37642024|NCT02901431|69109764|FG003|Main Treatment Part|Physician Decision|1|||
37740770|NCT01779440|69226599|FG000|Overall Study|Withdrawal by Subject|3|||
37642025|NCT02901431|69109765|FG004|Main Treatment Part|Physician Decision|0|||
37642026|NCT02901431|69109766|FG005|Main Treatment Part|Physician Decision|0|||
37642027|NCT02901431|69109767|FG006|Main Treatment Part|Physician Decision|1|||
37642028|NCT02901431|69109768|FG007|Main Treatment Part|Physician Decision|0|||
37642029|NCT02901431|69109769|FG008|Main Treatment Part|Physician Decision|0|||
37642030|NCT02901431|69109770|FG009|Main Treatment Part|Physician Decision|0|||
37642031|NCT02901431|69109771|FG010|Main Treatment Part|Physician Decision|0|||
37642032|NCT02901431|69109772|FG011|Main Treatment Part|Physician Decision|0|||
37642033|NCT02901431|69109773|FG012|Main Treatment Part|Physician Decision|0|||
37642034|NCT02901431|69109761|FG000|Main Treatment Part|Withdrawal by Subject|0|||
37642035|NCT02901431|69109762|FG001|Main Treatment Part|Withdrawal by Subject|0|||
37642036|NCT02901431|69109763|FG002|Main Treatment Part|Withdrawal by Subject|0|||
37642037|NCT02901431|69109764|FG003|Main Treatment Part|Withdrawal by Subject|18|||
37642038|NCT02901431|69109765|FG004|Main Treatment Part|Withdrawal by Subject|3|||
37642039|NCT02901431|69109766|FG005|Main Treatment Part|Withdrawal by Subject|5|||
37642040|NCT02901431|69109767|FG006|Main Treatment Part|Withdrawal by Subject|6|||
37642041|NCT02901431|69109768|FG007|Main Treatment Part|Withdrawal by Subject|0|||
37642042|NCT02901431|69109769|FG008|Main Treatment Part|Withdrawal by Subject|0|||
37642043|NCT02901431|69109770|FG009|Main Treatment Part|Withdrawal by Subject|0|||
37642044|NCT02901431|69109771|FG010|Main Treatment Part|Withdrawal by Subject|0|||
37642045|NCT02901431|69109772|FG011|Main Treatment Part|Withdrawal by Subject|0|||
37642046|NCT02901431|69109773|FG012|Main Treatment Part|Withdrawal by Subject|0|||
37642047|NCT02901431|69109761|FG000|Open Label Part|Adverse Event|0|||
37642048|NCT02901431|69109762|FG001|Open Label Part|Adverse Event|0|||
37642049|NCT02901431|69109763|FG002|Open Label Part|Adverse Event|0|||
37642050|NCT02901431|69109764|FG003|Open Label Part|Adverse Event|0|||
37642051|NCT02901431|69109765|FG004|Open Label Part|Adverse Event|0|||
37642052|NCT02901431|69109766|FG005|Open Label Part|Adverse Event|0|||
37642053|NCT02901431|69109767|FG006|Open Label Part|Adverse Event|0|||
37642054|NCT02901431|69109768|FG007|Open Label Part|Adverse Event|0|||
37642055|NCT02901431|69109769|FG008|Open Label Part|Adverse Event|4|||
37642056|NCT02901431|69109770|FG009|Open Label Part|Adverse Event|4|||
37642057|NCT02901431|69109771|FG010|Open Label Part|Adverse Event|0|||
37642058|NCT02901431|69109772|FG011|Open Label Part|Adverse Event|4|||
37642059|NCT02901431|69109773|FG012|Open Label Part|Adverse Event|1|||
37642060|NCT02901431|69109761|FG000|Open Label Part|Lost to Follow-up|0|||
37642061|NCT02901431|69109762|FG001|Open Label Part|Lost to Follow-up|0|||
37642062|NCT02901431|69109763|FG002|Open Label Part|Lost to Follow-up|0|||
37642063|NCT02901431|69109764|FG003|Open Label Part|Lost to Follow-up|0|||
37642064|NCT02901431|69109765|FG004|Open Label Part|Lost to Follow-up|0|||
37642065|NCT02901431|69109766|FG005|Open Label Part|Lost to Follow-up|0|||
37642066|NCT02901431|69109767|FG006|Open Label Part|Lost to Follow-up|0|||
37642067|NCT02901431|69109768|FG007|Open Label Part|Lost to Follow-up|0|||
37642068|NCT02901431|69109769|FG008|Open Label Part|Lost to Follow-up|2|||
37642069|NCT02901431|69109770|FG009|Open Label Part|Lost to Follow-up|2|||
37642070|NCT02901431|69109771|FG010|Open Label Part|Lost to Follow-up|1|||
37642071|NCT02901431|69109772|FG011|Open Label Part|Lost to Follow-up|1|||
37642072|NCT02901431|69109773|FG012|Open Label Part|Lost to Follow-up|1|||
37642073|NCT02901431|69109761|FG000|Open Label Part|Physician Decision|0|||
37642074|NCT02901431|69109762|FG001|Open Label Part|Physician Decision|0|||
37642075|NCT02901431|69109763|FG002|Open Label Part|Physician Decision|0|||
37642076|NCT02901431|69109764|FG003|Open Label Part|Physician Decision|0|||
37642077|NCT02901431|69109765|FG004|Open Label Part|Physician Decision|0|||
37642078|NCT02901431|69109766|FG005|Open Label Part|Physician Decision|0|||
37642079|NCT02901431|69109767|FG006|Open Label Part|Physician Decision|0|||
37642080|NCT02901431|69109768|FG007|Open Label Part|Physician Decision|0|||
37642081|NCT02901431|69109769|FG008|Open Label Part|Physician Decision|1|||
37642082|NCT02901431|69109770|FG009|Open Label Part|Physician Decision|1|||
37642083|NCT02901431|69109771|FG010|Open Label Part|Physician Decision|0|||
37642084|NCT02901431|69109772|FG011|Open Label Part|Physician Decision|0|||
37642085|NCT02901431|69109773|FG012|Open Label Part|Physician Decision|0|||
37642086|NCT02901431|69109761|FG000|Open Label Part|Study Terminated By Sponsor|0|||
37642087|NCT02901431|69109762|FG001|Open Label Part|Study Terminated By Sponsor|0|||
37642088|NCT02901431|69109763|FG002|Open Label Part|Study Terminated By Sponsor|0|||
37642089|NCT02901431|69109764|FG003|Open Label Part|Study Terminated By Sponsor|0|||
37642090|NCT02901431|69109765|FG004|Open Label Part|Study Terminated By Sponsor|0|||
37642091|NCT02901431|69109766|FG005|Open Label Part|Study Terminated By Sponsor|0|||
37740771|NCT01779440|69226600|FG001|Overall Study|Withdrawal by Subject|5|||
37740772|NCT01750346|69226609|FG000|Overall Study|Adverse Event|1|||
37642092|NCT02901431|69109767|FG006|Open Label Part|Study Terminated By Sponsor|0|||
37642093|NCT02901431|69109768|FG007|Open Label Part|Study Terminated By Sponsor|0|||
37642094|NCT02901431|69109769|FG008|Open Label Part|Study Terminated By Sponsor|35|||
37642095|NCT02901431|69109770|FG009|Open Label Part|Study Terminated By Sponsor|12|||
37642096|NCT02901431|69109771|FG010|Open Label Part|Study Terminated By Sponsor|21|||
37642097|NCT02901431|69109772|FG011|Open Label Part|Study Terminated By Sponsor|31|||
37642098|NCT02901431|69109773|FG012|Open Label Part|Study Terminated By Sponsor|0|||
37642099|NCT02901431|69109761|FG000|Open Label Part|Withdrawal by Subject|0|||
37642100|NCT02901431|69109762|FG001|Open Label Part|Withdrawal by Subject|0|||
37642101|NCT02901431|69109763|FG002|Open Label Part|Withdrawal by Subject|0|||
37642102|NCT02901431|69109764|FG003|Open Label Part|Withdrawal by Subject|0|||
37642103|NCT02901431|69109765|FG004|Open Label Part|Withdrawal by Subject|0|||
37642104|NCT02901431|69109766|FG005|Open Label Part|Withdrawal by Subject|0|||
37642105|NCT02901431|69109767|FG006|Open Label Part|Withdrawal by Subject|0|||
37642106|NCT02901431|69109768|FG007|Open Label Part|Withdrawal by Subject|0|||
37642107|NCT02901431|69109769|FG008|Open Label Part|Withdrawal by Subject|6|||
37642108|NCT02901431|69109770|FG009|Open Label Part|Withdrawal by Subject|5|||
37642109|NCT02901431|69109771|FG010|Open Label Part|Withdrawal by Subject|7|||
37642110|NCT02901431|69109772|FG011|Open Label Part|Withdrawal by Subject|3|||
37642111|NCT02901431|69109773|FG012|Open Label Part|Withdrawal by Subject|1|||
37642112|NCT02873377|69109800|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
37642113|NCT02873377|69109801|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
37642114|NCT02873377|69109800|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
37642115|NCT02873377|69109801|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
37642116|NCT02966795|69109810|FG000|Overall Study|Patient Left the Country|0|||
37642117|NCT02966795|69109811|FG001|Overall Study|Patient Left the Country|1|||
37642118|NCT02873221|69109819|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
37642119|NCT02873221|69109820|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
37642120|NCT02873221|69109821|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
37642121|NCT02873221|69109819|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
37642122|NCT02873221|69109820|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
37642123|NCT02873221|69109821|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
37642124|NCT02873221|69109819|FG000|Treatment Period|Protocol Violation|2|||
37642125|NCT02873221|69109820|FG001|Treatment Period|Protocol Violation|5|||
37642126|NCT02873221|69109821|FG002|Treatment Period|Protocol Violation|8|||
37642127|NCT02873221|69109819|FG000|Treatment Period|Pregnancy|4|||
37642128|NCT02873221|69109820|FG001|Treatment Period|Pregnancy|6|||
37642129|NCT02873221|69109821|FG002|Treatment Period|Pregnancy|3|||
37642130|NCT02873221|69109819|FG000|Treatment Period|Lack of Qualifying Event|0|||
37642131|NCT02873221|69109820|FG001|Treatment Period|Lack of Qualifying Event|3|||
37642132|NCT02873221|69109821|FG002|Treatment Period|Lack of Qualifying Event|1|||
37642133|NCT02873221|69109819|FG000|Treatment Period|Withdrawal of Consent|52|||
37642134|NCT02873221|69109820|FG001|Treatment Period|Withdrawal of Consent|51|||
37642135|NCT02873221|69109821|FG002|Treatment Period|Withdrawal of Consent|41|||
37642136|NCT02873221|69109819|FG000|Treatment Period|Lack of Efficacy|0|||
37642137|NCT02873221|69109820|FG001|Treatment Period|Lack of Efficacy|17|||
37642138|NCT02873221|69109821|FG002|Treatment Period|Lack of Efficacy|12|||
37642139|NCT02873221|69109819|FG000|Treatment Period|Adverse Event|4|||
37642140|NCT02873221|69109820|FG001|Treatment Period|Adverse Event|9|||
37642141|NCT02873221|69109821|FG002|Treatment Period|Adverse Event|11|||
37642142|NCT02873221|69109819|FG000|Treatment Period|Lost to Follow-up|26|||
37642143|NCT02873221|69109820|FG001|Treatment Period|Lost to Follow-up|30|||
37642144|NCT02873221|69109821|FG002|Treatment Period|Lost to Follow-up|26|||
37642145|NCT02873221|69109819|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
37642146|NCT02873221|69109820|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
37642147|NCT02873221|69109821|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
37642148|NCT02873221|69109819|FG000|Safety Follow-up Period|Protocol Violation|0|||
37642149|NCT02873221|69109820|FG001|Safety Follow-up Period|Protocol Violation|0|||
37642150|NCT02873221|69109821|FG002|Safety Follow-up Period|Protocol Violation|1|||
37642151|NCT02873221|69109819|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
37642152|NCT02873221|69109820|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
37642153|NCT02873221|69109821|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
37642154|NCT02873221|69109819|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
37642155|NCT02873221|69109820|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
37642156|NCT02873221|69109821|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
37642157|NCT02968979|69109829|FG000|Overall Study|Protocol Violation|7|||
37642158|NCT02968979|69109829|FG000|Overall Study|Withdrawal by Subject|1|||
37642159|NCT02966015|69109881|FG000|Inclusion Visit|did not answer questionnaire|8|||
37642160|NCT02966015|69109882|FG001|Inclusion Visit|did not answer questionnaire|3|||
37642161|NCT02968433|69109888|FG000|Overall Study|Withdrawal by Subject|1|||
37642162|NCT02872285|69109900|FG000|Overall Study|Withdrawal by Subject|2|||
37921995|NCT00597701|69608814|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
37642163|NCT02872285|69109901|FG001|Overall Study|Withdrawal by Subject|0|||
37642164|NCT02872285|69109900|FG000|Overall Study|Lost to Follow-up|2|||
37921996|NCT00671554|69608820|FG000|Overall Study|Disease progression|3|||
37921997|NCT00667576|69608830|FG000|Overall Study|Withdrawal by Subject|1|||
37921998|NCT00667576|69608831|FG001|Overall Study|Withdrawal by Subject|0|||
37921999|NCT00667576|69608832|FG002|Overall Study|Withdrawal by Subject|1|||
37642165|NCT02872285|69109901|FG001|Overall Study|Lost to Follow-up|2|||
38032149|NCT02951780|69718048|FG003|Period 2|Scheduling Conflicts|0|||
37642166|NCT02872285|69109900|FG000|Overall Study|Discontinued due to back surgery|1|||
37642167|NCT02872285|69109901|FG001|Overall Study|Discontinued due to back surgery|0|||
37642168|NCT02871739|69109911|FG000|Overall Study|Lost to Follow-up|3|||
37642169|NCT02871739|69109912|FG001|Overall Study|Lost to Follow-up|2|||
37642170|NCT02871739|69109913|FG002|Overall Study|Lost to Follow-up|0|||
37642171|NCT02871739|69109914|FG003|Overall Study|Lost to Follow-up|2|||
37642172|NCT02896361|69109924|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
37642173|NCT02896361|69109925|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
37642174|NCT02896361|69109926|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
37642175|NCT02896361|69109924|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
37642176|NCT02896361|69109925|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
37642177|NCT02896361|69109926|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
37642178|NCT02962739|69109949|FG000|Overall Study|Withdrawal by Subject|0|||
37642179|NCT02962739|69109950|FG001|Overall Study|Withdrawal by Subject|1|||
37642180|NCT02962739|69109951|FG002|Overall Study|Withdrawal by Subject|0|||
37642181|NCT02962739|69109952|FG003|Overall Study|Withdrawal by Subject|0|||
37642182|NCT02962739|69109953|FG004|Overall Study|Withdrawal by Subject|0|||
37642183|NCT02962739|69109954|FG005|Overall Study|Withdrawal by Subject|0|||
37642184|NCT02962739|69109949|FG000|Overall Study|Protocol Violation|0|||
37642185|NCT02962739|69109950|FG001|Overall Study|Protocol Violation|0|||
37642186|NCT02962739|69109951|FG002|Overall Study|Protocol Violation|1|||
37642187|NCT02962739|69109952|FG003|Overall Study|Protocol Violation|0|||
37642188|NCT02962739|69109953|FG004|Overall Study|Protocol Violation|1|||
37642189|NCT02962739|69109954|FG005|Overall Study|Protocol Violation|0|||
37642190|NCT01344629|69109962|FG000|Crossover Period 2|Withdrawal by Subject|0|||
37642191|NCT01344629|69109963|FG001|Crossover Period 2|Withdrawal by Subject|1|||
37642192|NCT01092117|69109969|FG000|Index Procedure to 1 Month|Death|1|||
37642193|NCT01092117|69109969|FG000|1 Month|Death|1|||
37642194|NCT01092117|69109969|FG000|1 Month|Withdrawal by Subject|1|||
37642195|NCT01092117|69109969|FG000|1 Month|Lost to Follow-up|1|||
37642196|NCT01092117|69109969|FG000|6 Months|Death|2|||
37642197|NCT01092117|69109969|FG000|6 Months|Withdrawal by Subject|3|||
37642198|NCT01092117|69109969|FG000|12 Month|Death|11|||
37642199|NCT01092117|69109969|FG000|12 Month|Withdrawal by Subject|2|||
37642200|NCT01092117|69109969|FG000|12 Month|Lost to Follow-up|1|||
37642201|NCT01092117|69109969|FG000|Year 2|Death|5|||
37642202|NCT01092117|69109969|FG000|Year 2|Withdrawal by Subject|4|||
37642203|NCT01092117|69109969|FG000|Year 2|Lost to Follow-up|1|||
37642204|NCT01092117|69109969|FG000|Year 3|Death|7|||
37642205|NCT01092117|69109969|FG000|Year 3|Withdrawal by Subject|9|||
37642206|NCT01092117|69109969|FG000|Year 3|Lost to Follow-up|3|||
37642207|NCT01092117|69109969|FG000|Year 4|Death|8|||
37642208|NCT01092117|69109969|FG000|Year 4|Withdrawal by Subject|4|||
37642209|NCT01092117|69109969|FG000|Year 4|Lost to Follow-up|4|||
37642210|NCT01065779|69109982|FG000|Overall Study|Duplicate Investigation|1|||
37642211|NCT01065779|69109982|FG000|Overall Study|Investigation Before Contract Date|37|||
37642212|NCT01065779|69109982|FG000|Overall Study|Non-enrollment Period Administration|10|||
37642213|NCT01065779|69109982|FG000|Overall Study|Not Administered With Study Drug|17|||
37642214|NCT01065779|69109982|FG000|Overall Study|Failed to Follow-up|10|||
37642215|NCT01065779|69109982|FG000|Overall Study|Inclusion Criteria Violation|7|||
37642216|NCT02963441|69109986|FG000|Overall Study|Protocol violation or withdrawn|8|||
37642217|NCT02963441|69109986|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
37642218|NCT02963441|69109986|FG000|Overall Study|IDx-DR insufficient quality|33|||
37642219|NCT01345253|69109993|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
37642220|NCT01345253|69109994|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
37642221|NCT01345253|69109993|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
37642222|NCT01345253|69109994|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
37642223|NCT01345253|69109993|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
37642224|NCT01345253|69109994|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
37642225|NCT01345253|69109993|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
37642226|NCT01345253|69109994|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
37642227|NCT01345253|69109993|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
37642228|NCT01345253|69109994|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
37642229|NCT01345253|69109993|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
37642230|NCT01345253|69109994|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
37854424|NCT01232283|69537956|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
37642231|NCT01345253|69109993|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
37642232|NCT01345253|69109994|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
37740773|NCT01750346|69226610|FG001|Overall Study|Adverse Event|0|||
37854425|NCT01232283|69537957|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
37642233|NCT01345253|69109993|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
37642234|NCT01345253|69109994|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
37642235|NCT01345253|69109993|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
37642236|NCT01345253|69109994|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
37642237|NCT01345253|69109993|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
37642238|NCT01345253|69109994|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
37642239|NCT01345253|69109993|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
37642240|NCT01345253|69109994|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
37642241|NCT01345253|69109993|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
37642242|NCT01345253|69109994|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
37642243|NCT01345253|69109993|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
37642244|NCT01345253|69109994|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
37642245|NCT01345253|69109993|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
37642246|NCT01345253|69109994|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
37642247|NCT01345253|69109993|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
37642248|NCT01345253|69109994|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
37642249|NCT02477800|69110005|FG000|Placebo-Controlled Period|Adverse Event|16|||
37642250|NCT02477800|69110006|FG001|Placebo-Controlled Period|Adverse Event|25|||
37642251|NCT02477800|69110007|FG002|Placebo-Controlled Period|Adverse Event|28|||
37642252|NCT02477800|69110008|FG003|Placebo-Controlled Period|Adverse Event|0|||
37642253|NCT02477800|69110009|FG004|Placebo-Controlled Period|Adverse Event|0|||
37642254|NCT02477800|69110010|FG005|Placebo-Controlled Period|Adverse Event|0|||
37642255|NCT02477800|69110011|FG006|Placebo-Controlled Period|Adverse Event|0|||
37642256|NCT02477800|69110005|FG000|Placebo-Controlled Period|Change of Treatment|1|||
37642257|NCT02477800|69110006|FG001|Placebo-Controlled Period|Change of Treatment|2|||
37642258|NCT02477800|69110007|FG002|Placebo-Controlled Period|Change of Treatment|1|||
37642259|NCT02477800|69110008|FG003|Placebo-Controlled Period|Change of Treatment|0|||
37642260|NCT02477800|69110009|FG004|Placebo-Controlled Period|Change of Treatment|0|||
37642261|NCT02477800|69110010|FG005|Placebo-Controlled Period|Change of Treatment|0|||
37642262|NCT02477800|69110011|FG006|Placebo-Controlled Period|Change of Treatment|0|||
37642263|NCT02477800|69110005|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
37642264|NCT02477800|69110006|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
37642265|NCT02477800|69110007|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
37642266|NCT02477800|69110008|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
37642267|NCT02477800|69110009|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
37642268|NCT02477800|69110010|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
37642269|NCT02477800|69110011|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
37642270|NCT02477800|69110005|FG000|Placebo-Controlled Period|Death|0|||
37642271|NCT02477800|69110006|FG001|Placebo-Controlled Period|Death|3|||
37642272|NCT02477800|69110007|FG002|Placebo-Controlled Period|Death|2|||
37642273|NCT02477800|69110008|FG003|Placebo-Controlled Period|Death|0|||
37642274|NCT02477800|69110009|FG004|Placebo-Controlled Period|Death|0|||
37642275|NCT02477800|69110010|FG005|Placebo-Controlled Period|Death|0|||
37642276|NCT02477800|69110011|FG006|Placebo-Controlled Period|Death|0|||
37642277|NCT02477800|69110005|FG000|Placebo-Controlled Period|Disease Progression|1|||
37642278|NCT02477800|69110006|FG001|Placebo-Controlled Period|Disease Progression|0|||
37642279|NCT02477800|69110007|FG002|Placebo-Controlled Period|Disease Progression|1|||
37642280|NCT02477800|69110008|FG003|Placebo-Controlled Period|Disease Progression|0|||
37642281|NCT02477800|69110009|FG004|Placebo-Controlled Period|Disease Progression|0|||
37642282|NCT02477800|69110010|FG005|Placebo-Controlled Period|Disease Progression|0|||
37740774|NCT01750346|69226611|FG002|Overall Study|Adverse Event|0|||
37740775|NCT01750268|69226621|FG000|Overall Study|Lost to Follow-up|0|||
37740776|NCT01750268|69226622|FG001|Overall Study|Lost to Follow-up|2|||
37740777|NCT01750268|69226621|FG000|Overall Study|Physician Decision|0|||
37740778|NCT01750268|69226622|FG001|Overall Study|Physician Decision|3|||
37740779|NCT01750268|69226621|FG000|Overall Study|Withdrawal by Subject|2|||
37740780|NCT01750268|69226622|FG001|Overall Study|Withdrawal by Subject|0|||
37740781|NCT01880437|69226631|FG000|Overall Study|Death|12|||
37740782|NCT01880437|69226632|FG001|Overall Study|Death|4|||
37740783|NCT01880437|69226633|FG002|Overall Study|Death|17|||
37740784|NCT01880437|69226631|FG000|Overall Study|Study terminated by Sponsor|3|||
37740785|NCT01880437|69226632|FG001|Overall Study|Study terminated by Sponsor|0|||
37740786|NCT01880437|69226633|FG002|Overall Study|Study terminated by Sponsor|2|||
37740787|NCT01861717|69226643|FG000|Overall Study|Lost to Follow-up|1|||
37740788|NCT01861717|69226643|FG000|Overall Study|Withdrawal by Subject|1|||
37740789|NCT01834729|69226652|FG000|Overall Study|Did not return bowel diaries|0|||
37740790|NCT01834729|69226653|FG001|Overall Study|Did not return bowel diaries|0|||
37740791|NCT01834729|69226654|FG002|Overall Study|Did not return bowel diaries|3|||
37740792|NCT01834729|69226655|FG003|Overall Study|Did not return bowel diaries|0|||
37740793|NCT01834729|69226652|FG000|Overall Study|Withdrawal by Subject|1|||
37740794|NCT01834729|69226653|FG001|Overall Study|Withdrawal by Subject|1|||
37740795|NCT01834729|69226654|FG002|Overall Study|Withdrawal by Subject|0|||
37740796|NCT01834729|69226655|FG003|Overall Study|Withdrawal by Subject|0|||
37740797|NCT01834729|69226652|FG000|Overall Study|Adverse Event|0|||
37922000|NCT00667576|69608833|FG003|Overall Study|Withdrawal by Subject|1|||
38032150|NCT02951780|69718049|FG004|Period 2|Scheduling Conflicts|0|||
37740798|NCT01834729|69226653|FG001|Overall Study|Adverse Event|0|||
37740799|NCT01834729|69226654|FG002|Overall Study|Adverse Event|0|||
37642283|NCT02477800|69110011|FG006|Placebo-Controlled Period|Disease Progression|0|||
37642284|NCT02477800|69110005|FG000|Placebo-Controlled Period|Investigator Decision|3|||
37642285|NCT02477800|69110006|FG001|Placebo-Controlled Period|Investigator Decision|2|||
37642286|NCT02477800|69110007|FG002|Placebo-Controlled Period|Investigator Decision|1|||
37642287|NCT02477800|69110008|FG003|Placebo-Controlled Period|Investigator Decision|0|||
37642288|NCT02477800|69110009|FG004|Placebo-Controlled Period|Investigator Decision|0|||
37642289|NCT02477800|69110010|FG005|Placebo-Controlled Period|Investigator Decision|0|||
37642290|NCT02477800|69110011|FG006|Placebo-Controlled Period|Investigator Decision|0|||
37642291|NCT02477800|69110005|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
37642292|NCT02477800|69110006|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
37642293|NCT02477800|69110007|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
37642294|NCT02477800|69110008|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
37642295|NCT02477800|69110009|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
37642296|NCT02477800|69110010|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
37642297|NCT02477800|69110011|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
37642298|NCT02477800|69110005|FG000|Placebo-Controlled Period|Relocation|2|||
37642299|NCT02477800|69110006|FG001|Placebo-Controlled Period|Relocation|0|||
37642300|NCT02477800|69110007|FG002|Placebo-Controlled Period|Relocation|0|||
37642301|NCT02477800|69110008|FG003|Placebo-Controlled Period|Relocation|0|||
37642302|NCT02477800|69110009|FG004|Placebo-Controlled Period|Relocation|0|||
37642303|NCT02477800|69110010|FG005|Placebo-Controlled Period|Relocation|0|||
37642304|NCT02477800|69110011|FG006|Placebo-Controlled Period|Relocation|0|||
37642305|NCT02477800|69110005|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
37642306|NCT02477800|69110006|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
37642307|NCT02477800|69110007|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
37642308|NCT02477800|69110008|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
37642309|NCT02477800|69110009|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
37642310|NCT02477800|69110010|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
37642311|NCT02477800|69110011|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
37642312|NCT02477800|69110005|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
37642313|NCT02477800|69110006|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
37642314|NCT02477800|69110007|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
37642315|NCT02477800|69110008|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
37642316|NCT02477800|69110009|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
37642317|NCT02477800|69110010|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
37642318|NCT02477800|69110011|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
37642319|NCT02477800|69110005|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
37642320|NCT02477800|69110006|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
37642321|NCT02477800|69110007|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
37642322|NCT02477800|69110008|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
37642323|NCT02477800|69110009|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
37642324|NCT02477800|69110010|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
37642325|NCT02477800|69110011|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
37642326|NCT02477800|69110005|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
37642327|NCT02477800|69110006|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
37642328|NCT02477800|69110007|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
37642329|NCT02477800|69110008|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
37642330|NCT02477800|69110009|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
37642331|NCT02477800|69110010|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
37642332|NCT02477800|69110011|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
37642333|NCT02477800|69110005|FG000|Placebo-Controlled Period|Reason not Specified|161|||
37642334|NCT02477800|69110006|FG001|Placebo-Controlled Period|Reason not Specified|161|||
37642335|NCT02477800|69110007|FG002|Placebo-Controlled Period|Reason not Specified|189|||
37642336|NCT02477800|69110008|FG003|Placebo-Controlled Period|Reason not Specified|0|||
37642337|NCT02477800|69110009|FG004|Placebo-Controlled Period|Reason not Specified|0|||
37642338|NCT02477800|69110010|FG005|Placebo-Controlled Period|Reason not Specified|0|||
37642339|NCT02477800|69110011|FG006|Placebo-Controlled Period|Reason not Specified|0|||
37642340|NCT02477800|69110005|FG000|Long Term Extension Period|Adverse Event|0|||
37642341|NCT02477800|69110006|FG001|Long Term Extension Period|Adverse Event|0|||
37642342|NCT02477800|69110007|FG002|Long Term Extension Period|Adverse Event|0|||
37642343|NCT02477800|69110008|FG003|Long Term Extension Period|Adverse Event|6|||
37642344|NCT02477800|69110009|FG004|Long Term Extension Period|Adverse Event|2|||
37642345|NCT02477800|69110010|FG005|Long Term Extension Period|Adverse Event|4|||
37642346|NCT02477800|69110011|FG006|Long Term Extension Period|Adverse Event|3|||
37642347|NCT02477800|69110005|FG000|Long Term Extension Period|Death|0|||
37642348|NCT02477800|69110006|FG001|Long Term Extension Period|Death|0|||
37642349|NCT02477800|69110007|FG002|Long Term Extension Period|Death|0|||
37642350|NCT02477800|69110008|FG003|Long Term Extension Period|Death|1|||
37922001|NCT00667576|69608834|FG004|Overall Study|Withdrawal by Subject|1|||
37922002|NCT00667576|69608830|FG000|Overall Study|Adverse Event|1|||
37642351|NCT02477800|69110009|FG004|Long Term Extension Period|Death|1|||
37642352|NCT02477800|69110010|FG005|Long Term Extension Period|Death|1|||
37642353|NCT02477800|69110011|FG006|Long Term Extension Period|Death|2|||
37642354|NCT02477800|69110005|FG000|Long Term Extension Period|Consent Withdrawn|0|||
37642355|NCT02477800|69110006|FG001|Long Term Extension Period|Consent Withdrawn|0|||
37642356|NCT02477800|69110007|FG002|Long Term Extension Period|Consent Withdrawn|0|||
37642357|NCT02477800|69110008|FG003|Long Term Extension Period|Consent Withdrawn|10|||
37642358|NCT02477800|69110009|FG004|Long Term Extension Period|Consent Withdrawn|4|||
37922003|NCT00667576|69608831|FG001|Overall Study|Adverse Event|1|||
37922004|NCT00667576|69608832|FG002|Overall Study|Adverse Event|0|||
37922005|NCT00667576|69608833|FG003|Overall Study|Adverse Event|0|||
37922006|NCT00667576|69608834|FG004|Overall Study|Adverse Event|0|||
37922007|NCT00667576|69608830|FG000|Overall Study|Lost to Follow-up|0|||
37922008|NCT00667576|69608831|FG001|Overall Study|Lost to Follow-up|0|||
37922009|NCT00667576|69608832|FG002|Overall Study|Lost to Follow-up|1|||
37922010|NCT00667576|69608833|FG003|Overall Study|Lost to Follow-up|0|||
37642359|NCT02477800|69110010|FG005|Long Term Extension Period|Consent Withdrawn|13|||
37642360|NCT02477800|69110011|FG006|Long Term Extension Period|Consent Withdrawn|16|||
37642361|NCT02477800|69110005|FG000|Long Term Extension Period|Disease Progression|0|||
37642362|NCT02477800|69110006|FG001|Long Term Extension Period|Disease Progression|0|||
37642363|NCT02477800|69110007|FG002|Long Term Extension Period|Disease Progression|0|||
37642364|NCT02477800|69110008|FG003|Long Term Extension Period|Disease Progression|3|||
37642365|NCT02477800|69110009|FG004|Long Term Extension Period|Disease Progression|1|||
37642366|NCT02477800|69110010|FG005|Long Term Extension Period|Disease Progression|1|||
37642367|NCT02477800|69110011|FG006|Long Term Extension Period|Disease Progression|0|||
37642368|NCT02477800|69110005|FG000|Long Term Extension Period|Investigator Decision|0|||
37642369|NCT02477800|69110006|FG001|Long Term Extension Period|Investigator Decision|0|||
37642370|NCT02477800|69110007|FG002|Long Term Extension Period|Investigator Decision|0|||
37642371|NCT02477800|69110008|FG003|Long Term Extension Period|Investigator Decision|0|||
37642372|NCT02477800|69110009|FG004|Long Term Extension Period|Investigator Decision|0|||
37642373|NCT02477800|69110010|FG005|Long Term Extension Period|Investigator Decision|0|||
37642374|NCT02477800|69110011|FG006|Long Term Extension Period|Investigator Decision|2|||
37642375|NCT02477800|69110005|FG000|Long Term Extension Period|Lost to Follow-up|0|||
37642376|NCT02477800|69110006|FG001|Long Term Extension Period|Lost to Follow-up|0|||
37642377|NCT02477800|69110007|FG002|Long Term Extension Period|Lost to Follow-up|0|||
37642378|NCT02477800|69110008|FG003|Long Term Extension Period|Lost to Follow-up|0|||
37642379|NCT02477800|69110009|FG004|Long Term Extension Period|Lost to Follow-up|1|||
37642380|NCT02477800|69110010|FG005|Long Term Extension Period|Lost to Follow-up|3|||
37642381|NCT02477800|69110011|FG006|Long Term Extension Period|Lost to Follow-up|0|||
37642382|NCT02477800|69110005|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
37642383|NCT02477800|69110006|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
37642384|NCT02477800|69110007|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
37642385|NCT02477800|69110008|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
37642386|NCT02477800|69110009|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
37642387|NCT02477800|69110010|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
37642388|NCT02477800|69110011|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
37642389|NCT02477800|69110005|FG000|Long Term Extension Period|Study Visit Burden|0|||
37642390|NCT02477800|69110006|FG001|Long Term Extension Period|Study Visit Burden|0|||
37642391|NCT02477800|69110007|FG002|Long Term Extension Period|Study Visit Burden|0|||
37642392|NCT02477800|69110008|FG003|Long Term Extension Period|Study Visit Burden|3|||
37642393|NCT02477800|69110009|FG004|Long Term Extension Period|Study Visit Burden|0|||
37642394|NCT02477800|69110010|FG005|Long Term Extension Period|Study Visit Burden|2|||
37642395|NCT02477800|69110011|FG006|Long Term Extension Period|Study Visit Burden|2|||
37642396|NCT02477800|69110005|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
37642397|NCT02477800|69110006|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
37642398|NCT02477800|69110007|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
37642399|NCT02477800|69110008|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
37642400|NCT02477800|69110009|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
37642401|NCT02477800|69110010|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
37642402|NCT02477800|69110011|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
37922011|NCT00667576|69608834|FG004|Overall Study|Lost to Follow-up|0|||
37922012|NCT00667576|69608830|FG000|Overall Study|Protocol Violation|0|||
37922013|NCT00667576|69608831|FG001|Overall Study|Protocol Violation|0|||
37922014|NCT00667576|69608832|FG002|Overall Study|Protocol Violation|0|||
37642403|NCT02477800|69110005|FG000|Long Term Extension Period|Reason not Specified|0|||
37642404|NCT02477800|69110006|FG001|Long Term Extension Period|Reason not Specified|0|||
37922015|NCT00667576|69608833|FG003|Overall Study|Protocol Violation|1|||
37922016|NCT00667576|69608834|FG004|Overall Study|Protocol Violation|0|||
37642405|NCT02477800|69110007|FG002|Long Term Extension Period|Reason not Specified|0|||
37642406|NCT02477800|69110008|FG003|Long Term Extension Period|Reason not Specified|126|||
38032151|NCT02951780|69718050|FG005|Period 2|Scheduling Conflicts|0|||
38032152|NCT02951780|69718051|FG006|Period 2|Scheduling Conflicts|0|||
37642407|NCT02477800|69110009|FG004|Long Term Extension Period|Reason not Specified|140|||
37642408|NCT02477800|69110010|FG005|Long Term Extension Period|Reason not Specified|270|||
37642409|NCT02477800|69110011|FG006|Long Term Extension Period|Reason not Specified|224|||
37642410|NCT02957747|69110025|FG000|Overall Study|Withdrawal by Subject|0|||
37642411|NCT02957747|69110026|FG001|Overall Study|Withdrawal by Subject|3|||
37642412|NCT02957747|69110025|FG000|Overall Study|Lost to Follow-up|10|||
37642413|NCT02957747|69110026|FG001|Overall Study|Lost to Follow-up|5|||
37642414|NCT01344161|69110035|FG000|Overall Study|Lost to Follow-up|4|||
37642415|NCT01344161|69110036|FG001|Overall Study|Lost to Follow-up|1|||
37642416|NCT01344161|69110035|FG000|Overall Study|Pregnancy|0|||
37642417|NCT01344161|69110036|FG001|Overall Study|Pregnancy|1|||
37642418|NCT01344161|69110035|FG000|Overall Study|Protocol Violation|1|||
37642419|NCT01344161|69110036|FG001|Overall Study|Protocol Violation|1|||
37642420|NCT02451358|69110046|FG000|Overall Study|Withdrawal by Subject|1|||
37642421|NCT02451358|69110047|FG001|Overall Study|Withdrawal by Subject|1|||
37642422|NCT02451358|69110048|FG002|Overall Study|Withdrawal by Subject|0|||
37642423|NCT02451358|69110049|FG003|Overall Study|Withdrawal by Subject|0|||
37642424|NCT02451358|69110046|FG000|Overall Study|Protocol Violation|0|||
37642425|NCT02451358|69110047|FG001|Overall Study|Protocol Violation|1|||
37642426|NCT02451358|69110048|FG002|Overall Study|Protocol Violation|1|||
37642427|NCT02451358|69110049|FG003|Overall Study|Protocol Violation|0|||
37642428|NCT02749721|69110059|FG000|Screening|Withdrawal by Subject|1|||
37642429|NCT02749721|69110059|FG000|Screening|Lost to Follow-up|2|||
37642430|NCT02749721|69110059|FG000|Screening|Protocol Violation|3|||
37642431|NCT02749721|69110059|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
37642432|NCT02749721|69110059|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
37642433|NCT01348139|69110065|FG000|Period 1|Adverse Event|1|||
37642434|NCT01348139|69110066|FG001|Period 1|Adverse Event|0|||
37642435|NCT01348139|69110067|FG002|Period 1|Adverse Event|0|||
37642436|NCT01348139|69110068|FG003|Period 1|Adverse Event|0|||
37642437|NCT01348139|69110069|FG004|Period 1|Adverse Event|0|||
37642438|NCT01348139|69110070|FG005|Period 1|Adverse Event|0|||
37642439|NCT02868229|69110088|FG000|Overall Study|Adverse Event|1|||
37642440|NCT02868229|69110089|FG001|Overall Study|Adverse Event|0|||
37642441|NCT02868229|69110090|FG002|Overall Study|Adverse Event|0|||
37642442|NCT02868229|69110091|FG003|Overall Study|Adverse Event|1|||
37642443|NCT02868229|69110088|FG000|Overall Study|Death|0|||
37642444|NCT02868229|69110089|FG001|Overall Study|Death|0|||
37642445|NCT02868229|69110090|FG002|Overall Study|Death|1|||
37642446|NCT02868229|69110091|FG003|Overall Study|Death|1|||
37642447|NCT02868229|69110088|FG000|Overall Study|Missed dose|0|||
37642448|NCT02868229|69110089|FG001|Overall Study|Missed dose|0|||
37642449|NCT02868229|69110090|FG002|Overall Study|Missed dose|0|||
37642450|NCT02868229|69110091|FG003|Overall Study|Missed dose|3|||
37642451|NCT02956967|69110106|FG000|Overall Study|Adverse Event|3|||
37642452|NCT02956967|69110106|FG000|Overall Study|Reason non-related to neutropenia|10|||
37642453|NCT02956967|69110106|FG000|Overall Study|Lost to Follow-up|5|||
37642454|NCT02956967|69110106|FG000|Overall Study|Missing|1|||
37642455|NCT02956967|69110106|FG000|Overall Study|Termination of Nivestim administration|29|||
37642456|NCT02867995|69110130|FG000|Overall Study|Withdrawal by Subject|0|||
37642457|NCT02867995|69110131|FG001|Overall Study|Withdrawal by Subject|1|||
37642458|NCT02867995|69110130|FG000|Overall Study|Lost to Follow-up|0|||
37642459|NCT02867995|69110131|FG001|Overall Study|Lost to Follow-up|2|||
37642460|NCT03392883|69110144|FG000|Overall Study|Lost to Follow-up|122|||
37642461|NCT03392883|69110145|FG001|Overall Study|Lost to Follow-up|13|||
37642462|NCT03392883|69110146|FG002|Overall Study|Lost to Follow-up|9|||
37642463|NCT03392883|69110144|FG000|Overall Study|Death|4|||
37642464|NCT03392883|69110145|FG001|Overall Study|Death|0|||
37642465|NCT03392883|69110146|FG002|Overall Study|Death|0|||
37642466|NCT03392883|69110144|FG000|Overall Study|Lack of Efficacy|29|||
37642467|NCT03392883|69110145|FG001|Overall Study|Lack of Efficacy|0|||
37642468|NCT03392883|69110146|FG002|Overall Study|Lack of Efficacy|0|||
37642469|NCT03392883|69110144|FG000|Overall Study|Withdrawal by Subject|180|||
37642470|NCT03392883|69110145|FG001|Overall Study|Withdrawal by Subject|0|||
37642471|NCT03392883|69110146|FG002|Overall Study|Withdrawal by Subject|0|||
37642472|NCT03392883|69110144|FG000|Overall Study|Adverse Event|1|||
37922017|NCT00667576|69608830|FG000|Overall Study|Physician Decision|0|||
37922018|NCT00667576|69608831|FG001|Overall Study|Physician Decision|0|||
37922019|NCT00667576|69608832|FG002|Overall Study|Physician Decision|0|||
37642473|NCT03392883|69110145|FG001|Overall Study|Adverse Event|0|||
37642474|NCT03392883|69110146|FG002|Overall Study|Adverse Event|0|||
37642475|NCT02748863|69110157|FG000|Treatment Period 1|Adverse Event|0|||
37642476|NCT02748863|69110158|FG001|Treatment Period 1|Adverse Event|1|||
37642477|NCT02748863|69110159|FG002|Treatment Period 1|Adverse Event|0|||
37642478|NCT02748863|69110160|FG003|Treatment Period 1|Adverse Event|0|||
37642479|NCT02748863|69110161|FG004|Treatment Period 1|Adverse Event|0|||
37642480|NCT02748863|69110157|FG000|Treatment Period 1|Lack of Efficacy|0|||
37642481|NCT02748863|69110158|FG001|Treatment Period 1|Lack of Efficacy|0|||
37642482|NCT02748863|69110159|FG002|Treatment Period 1|Lack of Efficacy|1|||
37642483|NCT02748863|69110160|FG003|Treatment Period 1|Lack of Efficacy|0|||
37642484|NCT02748863|69110161|FG004|Treatment Period 1|Lack of Efficacy|0|||
37642485|NCT02748863|69110157|FG000|Treatment Period 1|Withdrawal by Subject|0|||
37642486|NCT02748863|69110158|FG001|Treatment Period 1|Withdrawal by Subject|1|||
37642487|NCT02748863|69110159|FG002|Treatment Period 1|Withdrawal by Subject|1|||
37642488|NCT02748863|69110160|FG003|Treatment Period 1|Withdrawal by Subject|0|||
37642489|NCT02748863|69110161|FG004|Treatment Period 1|Withdrawal by Subject|0|||
37642490|NCT02748863|69110157|FG000|Treatment Period 2|Lost to Follow-up|2|||
37642491|NCT02748863|69110158|FG001|Treatment Period 2|Lost to Follow-up|0|||
37642492|NCT02748863|69110159|FG002|Treatment Period 2|Lost to Follow-up|0|||
37642493|NCT02748863|69110160|FG003|Treatment Period 2|Lost to Follow-up|0|||
37642494|NCT02748863|69110161|FG004|Treatment Period 2|Lost to Follow-up|0|||
37642495|NCT02748863|69110157|FG000|Treatment Period 2|Adverse Event|3|||
37642496|NCT02748863|69110158|FG001|Treatment Period 2|Adverse Event|2|||
37642497|NCT02748863|69110159|FG002|Treatment Period 2|Adverse Event|0|||
37642498|NCT02748863|69110160|FG003|Treatment Period 2|Adverse Event|2|||
37642499|NCT02748863|69110161|FG004|Treatment Period 2|Adverse Event|0|||
37642500|NCT02748863|69110157|FG000|Treatment Period 2|Lack of Efficacy|0|||
37642501|NCT02748863|69110158|FG001|Treatment Period 2|Lack of Efficacy|1|||
37642502|NCT02748863|69110159|FG002|Treatment Period 2|Lack of Efficacy|0|||
37642503|NCT02748863|69110160|FG003|Treatment Period 2|Lack of Efficacy|0|||
37642504|NCT02748863|69110161|FG004|Treatment Period 2|Lack of Efficacy|0|||
37642505|NCT02748863|69110157|FG000|Treatment Period 2|Pregnancy|0|||
37642506|NCT02748863|69110158|FG001|Treatment Period 2|Pregnancy|0|||
37642507|NCT02748863|69110159|FG002|Treatment Period 2|Pregnancy|0|||
37642508|NCT02748863|69110160|FG003|Treatment Period 2|Pregnancy|0|||
37642509|NCT02748863|69110161|FG004|Treatment Period 2|Pregnancy|1|||
37642510|NCT02865499|69110182|FG000|Baseline|Adverse Event|1|||
37642511|NCT02865499|69110182|FG000|Baseline|Withdrawal by Subject|1|||
37642512|NCT02870933|69110188|FG000|Overall Study|Death|2|||
37642513|NCT02870933|69110189|FG001|Overall Study|Death|1|||
37642514|NCT02870933|69110188|FG000|Overall Study|Withdrawal by Subject|0|||
37642515|NCT02870933|69110189|FG001|Overall Study|Withdrawal by Subject|1|||
37642516|NCT02864407|69110196|FG000|Overall Study|Protocol Violation|3|||
37642517|NCT02864407|69110196|FG000|Overall Study|Lost to Follow-up|115|||
37642518|NCT02864407|69110196|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
37642519|NCT02864407|69110196|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
37642520|NCT02864407|69110196|FG000|Overall Study|Consent prior to the contract date|1|||
37642521|NCT02873429|69110202|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
37642522|NCT02873429|69110203|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
37642523|NCT02873429|69110202|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
37642524|NCT02873429|69110203|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
37642525|NCT02873429|69110202|FG000|16 Weeks|Lost to Follow-up|3|||
37642526|NCT02873429|69110203|FG001|16 Weeks|Lost to Follow-up|0|||
37642527|NCT02486302|69110209|FG000|Overall Study|Discontinued prematurely|410|||
37642528|NCT02486302|69110209|FG000|Overall Study|Documentation not completed|255|||
37642529|NCT02486302|69110209|FG000|Overall Study|Excluded due to legal reasons|8|||
37642530|NCT02486302|69110209|FG000|Overall Study|Not treated|3|||
37642531|NCT02747875|69110224|FG000|Overall Study|Physician Decision|1|||
37642532|NCT02747875|69110225|FG001|Overall Study|Physician Decision|0|||
37642533|NCT02747875|69110224|FG000|Overall Study|Adverse Event|0|||
37642534|NCT02747875|69110225|FG001|Overall Study|Adverse Event|1|||
37642535|NCT02451124|69110251|FG000|Overall Study|Withdrawal by Subject|1|||
37642536|NCT02450578|69110263|FG000|Overall Study|ECG abnormality so not treated|1|||
37642537|NCT02450578|69110264|FG001|Overall Study|ECG abnormality so not treated|0|||
37642538|NCT02450578|69110265|FG002|Overall Study|ECG abnormality so not treated|0|||
37642539|NCT02450578|69110266|FG003|Overall Study|ECG abnormality so not treated|0|||
37642540|NCT02449018|69110293|FG000|Overall Study|Abnormal laboratory value|0|||
37642541|NCT02449018|69110294|FG001|Overall Study|Abnormal laboratory value|1|||
37642542|NCT02449018|69110293|FG000|Overall Study|Administrative problems|1|||
37642543|NCT02449018|69110294|FG001|Overall Study|Administrative problems|0|||
37642544|NCT02449018|69110293|FG000|Overall Study|Adverse Event|5|||
37642545|NCT02449018|69110294|FG001|Overall Study|Adverse Event|1|||
37642546|NCT02449018|69110293|FG000|Overall Study|Protocol deviation|4|||
37740800|NCT01834729|69226655|FG003|Overall Study|Adverse Event|2|||
37740801|NCT01860703|69226666|FG000|Overall Study|Adverse Event|1|||
37642547|NCT02449018|69110294|FG001|Overall Study|Protocol deviation|0|||
37642548|NCT02449018|69110293|FG000|Overall Study|Patient decision|2|||
37642549|NCT02449018|69110294|FG001|Overall Study|Patient decision|0|||
37740802|NCT01860703|69226667|FG001|Overall Study|Adverse Event|4|||
37642550|NCT02859415|69110302|FG000|Overall Study|Physician Decision|1|||
37642551|NCT02859415|69110303|FG001|Overall Study|Physician Decision|0|||
37642552|NCT02859415|69110302|FG000|Overall Study|Off treatment due to cardiac event|0|||
37642553|NCT02859415|69110303|FG001|Overall Study|Off treatment due to cardiac event|1|||
37642554|NCT02871791|69110313|FG000|Phase 1b|Death|0|||
37642555|NCT02871791|69110314|FG001|Phase 1b|Death|1|||
37642556|NCT02871791|69110313|FG000|Phase 1b|progressive disease|6|||
37740803|NCT01860703|69226668|FG002|Overall Study|Adverse Event|0|||
37642557|NCT02871791|69110314|FG001|Phase 1b|progressive disease|2|||
37642558|NCT02871791|69110313|FG000|Phase 2|Death|1|||
37642559|NCT02871791|69110314|FG001|Phase 2|Death|0|||
37642560|NCT02871791|69110313|FG000|Phase 2|Lost to Follow-up|2|||
37642561|NCT02871791|69110314|FG001|Phase 2|Lost to Follow-up|0|||
37642562|NCT02871635|69110322|FG000|Overall Study|Primary lack of efficacy|4|||
37642563|NCT02871635|69110323|FG001|Overall Study|Primary lack of efficacy|4|||
37642564|NCT02871635|69110322|FG000|Overall Study|Protocol Violation|3|||
37642565|NCT02871635|69110323|FG001|Overall Study|Protocol Violation|1|||
37642566|NCT02871635|69110322|FG000|Overall Study|Lost to Follow-up|1|||
37642567|NCT02871635|69110323|FG001|Overall Study|Lost to Follow-up|2|||
37642568|NCT02871635|69110322|FG000|Overall Study|Pregnancy|0|||
37642569|NCT02871635|69110323|FG001|Overall Study|Pregnancy|2|||
37642570|NCT02871635|69110322|FG000|Overall Study|Physician Decision|1|||
37642571|NCT02871635|69110323|FG001|Overall Study|Physician Decision|1|||
37642572|NCT02871635|69110322|FG000|Overall Study|Withdrawal by Subject|3|||
37642573|NCT02871635|69110323|FG001|Overall Study|Withdrawal by Subject|4|||
37642574|NCT02871635|69110322|FG000|Overall Study|Adverse Event|4|||
37642575|NCT02871635|69110323|FG001|Overall Study|Adverse Event|4|||
37642576|NCT02871635|69110322|FG000|Overall Study|Secondary lack of efficacy|2|||
37642577|NCT02871635|69110323|FG001|Overall Study|Secondary lack of efficacy|1|||
37642578|NCT02477332|69110337|FG000|Overall Study|Adverse Event|0|||
37642579|NCT02477332|69110338|FG001|Overall Study|Adverse Event|1|||
37642580|NCT02477332|69110339|FG002|Overall Study|Adverse Event|1|||
37642581|NCT02477332|69110340|FG003|Overall Study|Adverse Event|2|||
37642582|NCT02477332|69110341|FG004|Overall Study|Adverse Event|1|||
37642583|NCT02477332|69110342|FG005|Overall Study|Adverse Event|2|||
37642584|NCT02477332|69110337|FG000|Overall Study|Lack of Efficacy|1|||
37642585|NCT02477332|69110338|FG001|Overall Study|Lack of Efficacy|2|||
37642586|NCT02477332|69110339|FG002|Overall Study|Lack of Efficacy|1|||
37642587|NCT02477332|69110340|FG003|Overall Study|Lack of Efficacy|2|||
37642588|NCT02477332|69110341|FG004|Overall Study|Lack of Efficacy|1|||
37642589|NCT02477332|69110342|FG005|Overall Study|Lack of Efficacy|1|||
37642590|NCT02477332|69110337|FG000|Overall Study|Non-compliance with study treatment|0|||
37642591|NCT02477332|69110338|FG001|Overall Study|Non-compliance with study treatment|1|||
37642592|NCT02477332|69110339|FG002|Overall Study|Non-compliance with study treatment|2|||
37642593|NCT02477332|69110340|FG003|Overall Study|Non-compliance with study treatment|0|||
37642594|NCT02477332|69110341|FG004|Overall Study|Non-compliance with study treatment|0|||
37642595|NCT02477332|69110342|FG005|Overall Study|Non-compliance with study treatment|0|||
37642596|NCT02477332|69110337|FG000|Overall Study|Pregnancy|0|||
37854426|NCT01232283|69537958|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
37642597|NCT02477332|69110338|FG001|Overall Study|Pregnancy|0|||
37642598|NCT02477332|69110339|FG002|Overall Study|Pregnancy|0|||
37642599|NCT02477332|69110340|FG003|Overall Study|Pregnancy|1|||
37642600|NCT02477332|69110341|FG004|Overall Study|Pregnancy|0|||
37642601|NCT02477332|69110342|FG005|Overall Study|Pregnancy|0|||
37642602|NCT02477332|69110337|FG000|Overall Study|Protocol Violation|2|||
37642603|NCT02477332|69110338|FG001|Overall Study|Protocol Violation|0|||
37642604|NCT02477332|69110339|FG002|Overall Study|Protocol Violation|3|||
37642605|NCT02477332|69110340|FG003|Overall Study|Protocol Violation|3|||
37642606|NCT02477332|69110341|FG004|Overall Study|Protocol Violation|1|||
37642607|NCT02477332|69110342|FG005|Overall Study|Protocol Violation|1|||
37642608|NCT02477332|69110337|FG000|Overall Study|Technical problems|0|||
37642609|NCT02477332|69110338|FG001|Overall Study|Technical problems|0|||
37642610|NCT02477332|69110339|FG002|Overall Study|Technical problems|1|||
37642611|NCT02477332|69110340|FG003|Overall Study|Technical problems|0|||
37642612|NCT02477332|69110341|FG004|Overall Study|Technical problems|0|||
37642613|NCT02477332|69110342|FG005|Overall Study|Technical problems|0|||
37854427|NCT01232283|69537959|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
37854428|NCT01232283|69537960|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
37642614|NCT02477332|69110337|FG000|Overall Study|Lost to Follow-up|0|||
37642615|NCT02477332|69110338|FG001|Overall Study|Lost to Follow-up|0|||
37642616|NCT02477332|69110339|FG002|Overall Study|Lost to Follow-up|2|||
37642617|NCT02477332|69110340|FG003|Overall Study|Lost to Follow-up|0|||
37740804|NCT01860703|69226669|FG003|Overall Study|Adverse Event|2|||
37740805|NCT01860703|69226666|FG000|Overall Study|Withdrawal by Subject|0|||
37854429|NCT01232283|69537961|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
37642618|NCT02477332|69110341|FG004|Overall Study|Lost to Follow-up|0|||
37854430|NCT01232283|69537952|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
37642619|NCT02477332|69110342|FG005|Overall Study|Lost to Follow-up|0|||
37642620|NCT02477332|69110337|FG000|Overall Study|Physician Decision|0|||
37642621|NCT02477332|69110338|FG001|Overall Study|Physician Decision|0|||
37740806|NCT01860703|69226667|FG001|Overall Study|Withdrawal by Subject|1|||
37642622|NCT02477332|69110339|FG002|Overall Study|Physician Decision|1|||
37642623|NCT02477332|69110340|FG003|Overall Study|Physician Decision|3|||
37642624|NCT02477332|69110341|FG004|Overall Study|Physician Decision|0|||
37642625|NCT02477332|69110342|FG005|Overall Study|Physician Decision|1|||
37642626|NCT02477332|69110337|FG000|Overall Study|Withdrawal by Subject|0|||
37642627|NCT02477332|69110338|FG001|Overall Study|Withdrawal by Subject|3|||
37642628|NCT02477332|69110339|FG002|Overall Study|Withdrawal by Subject|1|||
37642629|NCT02477332|69110340|FG003|Overall Study|Withdrawal by Subject|2|||
37642630|NCT02477332|69110341|FG004|Overall Study|Withdrawal by Subject|1|||
37642631|NCT02477332|69110342|FG005|Overall Study|Withdrawal by Subject|0|||
37642632|NCT02477020|69110360|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
37642633|NCT02477020|69110361|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
37642634|NCT02477020|69110360|FG000|Overall Study|Voluntary Withdrawal|7|||
37642635|NCT02477020|69110361|FG001|Overall Study|Voluntary Withdrawal|16|||
37642636|NCT02477020|69110360|FG000|Overall Study|Reason not Specified|3|||
37642637|NCT02477020|69110361|FG001|Overall Study|Reason not Specified|1|||
37642638|NCT02477020|69110360|FG000|Overall Study|Lack of Efficacy|14|||
37642639|NCT02477020|69110361|FG001|Overall Study|Lack of Efficacy|5|||
37642640|NCT02862535|69110371|FG000|Overall Study|Death|7|||
37642641|NCT02862535|69110372|FG001|Overall Study|Death|3|||
37642642|NCT02862535|69110373|FG002|Overall Study|Death|2|||
37642643|NCT02862535|69110374|FG003|Overall Study|Death|5|||
37642644|NCT02862535|69110371|FG000|Overall Study|Study Terminated by Sponsor|1|||
37642645|NCT02862535|69110372|FG001|Overall Study|Study Terminated by Sponsor|3|||
37642646|NCT02862535|69110373|FG002|Overall Study|Study Terminated by Sponsor|8|||
37642647|NCT02862535|69110374|FG003|Overall Study|Study Terminated by Sponsor|5|||
37642648|NCT02862535|69110371|FG000|Overall Study|Enrolled, not Treated|1|||
37642649|NCT02862535|69110372|FG001|Overall Study|Enrolled, not Treated|0|||
37642650|NCT02862535|69110373|FG002|Overall Study|Enrolled, not Treated|0|||
37642651|NCT02862535|69110374|FG003|Overall Study|Enrolled, not Treated|1|||
37642652|NCT02448706|69110384|FG000|Overall Study|Withdrawal by Subject|4|||
37642653|NCT02448706|69110385|FG001|Overall Study|Withdrawal by Subject|3|||
37642654|NCT02448706|69110384|FG000|Overall Study|Protocol Violation|1|||
37642655|NCT02448706|69110385|FG001|Overall Study|Protocol Violation|1|||
37642656|NCT02868281|69110395|FG000|Overall Study|Adverse Event|2|||
37642657|NCT02868281|69110396|FG001|Overall Study|Adverse Event|2|||
37642658|NCT02868281|69110395|FG000|Overall Study|Protocol Violation|13|||
37642659|NCT02868281|69110396|FG001|Overall Study|Protocol Violation|10|||
37642660|NCT02868281|69110395|FG000|Overall Study|Lost to Follow-up|3|||
37642661|NCT02868281|69110396|FG001|Overall Study|Lost to Follow-up|6|||
37642662|NCT02868281|69110395|FG000|Overall Study|Withdrawal by Subject|11|||
37642663|NCT02868281|69110396|FG001|Overall Study|Withdrawal by Subject|15|||
37642664|NCT02868281|69110395|FG000|Overall Study|Physician Decision|2|||
37642665|NCT02868281|69110396|FG001|Overall Study|Physician Decision|0|||
37642666|NCT02868281|69110395|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
37642667|NCT02868281|69110396|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
37642668|NCT02868281|69110395|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
37642669|NCT02868281|69110396|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
37642670|NCT02868281|69110395|FG000|Overall Study|Long journey/moving away|1|||
37642671|NCT02868281|69110396|FG001|Overall Study|Long journey/moving away|1|||
37642672|NCT02476006|69110402|FG000|Overall Study|Death|4|||
37642673|NCT02476006|69110402|FG000|Overall Study|Lack of treatment efficacy|2|||
37642674|NCT02476006|69110402|FG000|Overall Study|Pregnancy|1|||
37642675|NCT02476006|69110402|FG000|Overall Study|Participant did not wish to continue|39|||
37642676|NCT02476006|69110402|FG000|Overall Study|Adverse Event|41|||
37642677|NCT02476006|69110402|FG000|Overall Study|Poor compliance to study protocol|3|||
37642678|NCT02476006|69110402|FG000|Overall Study|Sponsor decision|6|||
37642679|NCT02476006|69110402|FG000|Overall Study|Lost to Follow-up|5|||
37642680|NCT02476006|69110402|FG000|Overall Study|Physician Decision|5|||
37642681|NCT02476006|69110402|FG000|Overall Study|Study ended treatment not available|4|||
37642682|NCT02476006|69110402|FG000|Overall Study|Switched to commercial drug|4|||
37642683|NCT02476006|69110402|FG000|Overall Study|Excluded from study|1|||
37642684|NCT02476006|69110402|FG000|Overall Study|Protocol Violation|1|||
37642685|NCT02476006|69110402|FG000|Overall Study|Enrolled but not treated|4|||
37642686|NCT02475850|69110408|FG000|Overall Study|Death|155|||
37642687|NCT02475850|69110409|FG001|Overall Study|Death|141|||
37642688|NCT02475850|69110408|FG000|Overall Study|Lost to Follow-up|217|||
37642689|NCT02475850|69110409|FG001|Overall Study|Lost to Follow-up|188|||
37642690|NCT02475850|69110408|FG000|Overall Study|Withdrawal by Subject|221|||
37642691|NCT02475850|69110409|FG001|Overall Study|Withdrawal by Subject|155|||
37642692|NCT02419612|69110418|FG000|Short-term Treatment Period|Adverse Event|1|||
37642693|NCT02419612|69110419|FG001|Short-term Treatment Period|Adverse Event|1|||
37642694|NCT02419612|69110418|FG000|Short-term Treatment Period|Death|0|||
37642695|NCT02419612|69110419|FG001|Short-term Treatment Period|Death|2|||
37642696|NCT02419612|69110418|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
37642697|NCT02419612|69110419|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
37642698|NCT02419612|69110418|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
37642699|NCT02419612|69110419|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
37642700|NCT02419612|69110418|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
37642701|NCT02419612|69110419|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
37642702|NCT02419612|69110418|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
37642703|NCT02419612|69110419|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
37642704|NCT02419612|69110418|FG000|Short-term Treatment Period|Worsening of liver function|0|||
37642705|NCT02419612|69110419|FG001|Short-term Treatment Period|Worsening of liver function|1|||
37642706|NCT02419612|69110418|FG000|Short-term Treatment Period|Subject moved out of state|0|||
37642707|NCT02419612|69110419|FG001|Short-term Treatment Period|Subject moved out of state|1|||
37642708|NCT02419612|69110418|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
37642709|NCT02419612|69110419|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
37642710|NCT02419612|69110418|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
37642711|NCT02419612|69110419|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
37642712|NCT02419612|69110418|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
37642713|NCT02419612|69110419|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
37642714|NCT02419612|69110418|FG000|Long-term Treatment Period|Death|0|||
37642715|NCT02419612|69110419|FG001|Long-term Treatment Period|Death|1|||
37642716|NCT02419612|69110418|FG000|Long-term Treatment Period|Adverse Event|0|||
37642717|NCT02419612|69110419|FG001|Long-term Treatment Period|Adverse Event|5|||
37642718|NCT02419612|69110418|FG000|Long-term Treatment Period|Other|4|||
37642719|NCT02419612|69110419|FG001|Long-term Treatment Period|Other|4|||
37642720|NCT02419612|69110418|FG000|Long-term Treatment Period|Subject Decision|2|||
37642721|NCT02419612|69110419|FG001|Long-term Treatment Period|Subject Decision|4|||
37642722|NCT02419612|69110418|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
37642723|NCT02419612|69110419|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
37642724|NCT02447848|69110425|FG000|Overall Study|Patient discharged|3|||
37642725|NCT02447848|69110425|FG000|Overall Study|Lack of Efficacy|4|||
37642726|NCT02447848|69110425|FG000|Overall Study|Withdrawal by Subject|4|||
37642727|NCT02418910|69110429|FG000|Overall Study|Lost to Follow-up|3|||
37642728|NCT02418910|69110429|FG000|Overall Study|Withdrawal by Subject|4|||
37642729|NCT02418754|69110445|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
37642730|NCT02418754|69110446|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
37642731|NCT02418754|69110447|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
37642732|NCT02418754|69110448|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
37642733|NCT02418754|69110449|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
37642734|NCT02418754|69110445|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
37642735|NCT02418754|69110446|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
37642736|NCT02418754|69110447|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
37642737|NCT02418754|69110448|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
37642738|NCT02418754|69110449|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
37642739|NCT02418754|69110445|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
37642740|NCT02418754|69110446|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
37642741|NCT02418754|69110447|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
37642742|NCT02418754|69110448|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
37642743|NCT02418754|69110449|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
37642744|NCT02418754|69110445|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
37642745|NCT02418754|69110446|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
37642746|NCT02418754|69110447|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
37642747|NCT02418754|69110448|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
37642748|NCT02418754|69110449|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
37642749|NCT02418754|69110445|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
37642750|NCT02418754|69110446|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
37642751|NCT02418754|69110447|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
37642752|NCT02418754|69110448|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
37642753|NCT02418754|69110449|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
37642754|NCT02418754|69110445|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
37642755|NCT02418754|69110446|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
37642756|NCT02418754|69110447|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
37642757|NCT02418754|69110448|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
37642758|NCT02418754|69110449|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
37642759|NCT02418754|69110445|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
37642760|NCT02418754|69110446|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
37642761|NCT02418754|69110447|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
37854431|NCT01232283|69537953|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
37854432|NCT01232283|69537954|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
37854433|NCT01232283|69537955|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
37854434|NCT01232283|69537956|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
37854435|NCT01232283|69537957|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
37854436|NCT01232283|69537958|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
37642762|NCT02418754|69110448|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
37642763|NCT02418754|69110449|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
37642764|NCT02418754|69110445|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
37642765|NCT02418754|69110446|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
37642766|NCT02418754|69110447|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
37642767|NCT02418754|69110448|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
37642768|NCT02418754|69110449|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
37642769|NCT02418754|69110445|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
37642770|NCT02418754|69110446|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
37642771|NCT02418754|69110447|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
37642772|NCT02418754|69110448|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
37642773|NCT02418754|69110449|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
37642774|NCT02418754|69110445|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
37642775|NCT02418754|69110446|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
37642776|NCT02418754|69110447|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
37642777|NCT02418754|69110448|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
37642778|NCT02418754|69110449|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
37642779|NCT02418754|69110445|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
37642780|NCT02418754|69110446|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
37642781|NCT02418754|69110447|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
37642782|NCT02418754|69110448|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
37642783|NCT02418754|69110449|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
37642784|NCT02447458|69110465|FG000|Overall Study|Other|0|||
37642785|NCT02447458|69110466|FG001|Overall Study|Other|0|||
37642786|NCT02447458|69110467|FG002|Overall Study|Other|1|||
37642787|NCT02447458|69110468|FG003|Overall Study|Other|0|||
37642788|NCT02447458|69110469|FG004|Overall Study|Other|0|||
37642789|NCT02447458|69110470|FG005|Overall Study|Other|0|||
37642790|NCT02862457|69110496|FG000|Overall Study|Death|1|||
37642791|NCT02862457|69110497|FG001|Overall Study|Death|3|||
37642792|NCT02862457|69110498|FG002|Overall Study|Death|2|||
37642793|NCT02862457|69110499|FG003|Overall Study|Death|3|||
37642794|NCT02862457|69110500|FG004|Overall Study|Death|0|||
37642795|NCT02862457|69110501|FG005|Overall Study|Death|2|||
37642796|NCT02862457|69110502|FG006|Overall Study|Death|1|||
37642797|NCT02862457|69110496|FG000|Overall Study|Lost to Follow-up|1|||
37642798|NCT02862457|69110497|FG001|Overall Study|Lost to Follow-up|0|||
37642799|NCT02862457|69110498|FG002|Overall Study|Lost to Follow-up|0|||
37642800|NCT02862457|69110499|FG003|Overall Study|Lost to Follow-up|1|||
37642801|NCT02862457|69110500|FG004|Overall Study|Lost to Follow-up|0|||
37642802|NCT02862457|69110501|FG005|Overall Study|Lost to Follow-up|0|||
37642803|NCT02862457|69110502|FG006|Overall Study|Lost to Follow-up|0|||
37642804|NCT02862457|69110496|FG000|Overall Study|Withdrawal by Subject|0|||
37642805|NCT02862457|69110497|FG001|Overall Study|Withdrawal by Subject|0|||
37642806|NCT02862457|69110498|FG002|Overall Study|Withdrawal by Subject|1|||
37642807|NCT02862457|69110499|FG003|Overall Study|Withdrawal by Subject|0|||
37642808|NCT02862457|69110500|FG004|Overall Study|Withdrawal by Subject|0|||
37642809|NCT02862457|69110501|FG005|Overall Study|Withdrawal by Subject|1|||
37642810|NCT02862457|69110502|FG006|Overall Study|Withdrawal by Subject|0|||
37642811|NCT02447302|69110529|FG000|Overall Study|Physician Decision|1|||
37642812|NCT02447302|69110530|FG001|Overall Study|Physician Decision|0|||
37642813|NCT02447302|69110531|FG002|Overall Study|Physician Decision|0|||
37642814|NCT02447302|69110529|FG000|Overall Study|Adverse Event|4|||
37642815|NCT02447302|69110530|FG001|Overall Study|Adverse Event|3|||
37642816|NCT02447302|69110531|FG002|Overall Study|Adverse Event|0|||
37642817|NCT02447302|69110529|FG000|Overall Study|Withdrawal by Subject|0|||
37642818|NCT02447302|69110530|FG001|Overall Study|Withdrawal by Subject|1|||
37642819|NCT02447302|69110531|FG002|Overall Study|Withdrawal by Subject|5|||
37642820|NCT02447302|69110529|FG000|Overall Study|Sponsor Decision|0|||
37642821|NCT02447302|69110530|FG001|Overall Study|Sponsor Decision|0|||
37642822|NCT02447302|69110531|FG002|Overall Study|Sponsor Decision|1|||
37642823|NCT02454517|69110541|FG000|Overall Study|Withdrawal by Subject|3|||
37642824|NCT02454517|69110542|FG001|Overall Study|Withdrawal by Subject|0|||
37642825|NCT02454517|69110541|FG000|Overall Study|Lost to Follow-up|4|||
37642826|NCT02454517|69110542|FG001|Overall Study|Lost to Follow-up|7|||
37642827|NCT02454517|69110541|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
37642828|NCT02454517|69110542|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
37642829|NCT03861039|69110553|FG000|Overall Study|Adverse Event|2|||
37642830|NCT03861039|69110554|FG001|Overall Study|Adverse Event|5|||
37642831|NCT03861039|69110555|FG002|Overall Study|Adverse Event|11|||
37642832|NCT03861039|69110553|FG000|Overall Study|Withdrawal by Subject|1|||
37642833|NCT03861039|69110554|FG001|Overall Study|Withdrawal by Subject|3|||
37642834|NCT03861039|69110555|FG002|Overall Study|Withdrawal by Subject|4|||
37642835|NCT02731755|69110565|FG000|First Intervention|Withdrawal by Subject|0|||
37642836|NCT02731755|69110566|FG001|First Intervention|Withdrawal by Subject|2|||
37642837|NCT02866175|69110595|FG000|Overall Study|Adverse Event|56|||
37642838|NCT02866175|69110596|FG001|Overall Study|Adverse Event|54|||
37642839|NCT02866175|69110595|FG000|Overall Study|Withdrawal by Subject|31|||
37642840|NCT02866175|69110596|FG001|Overall Study|Withdrawal by Subject|52|||
37642841|NCT02866175|69110595|FG000|Overall Study|Death|30|||
37642842|NCT02866175|69110596|FG001|Overall Study|Death|23|||
37642843|NCT02866175|69110595|FG000|Overall Study|Other|7|||
37642844|NCT02866175|69110596|FG001|Overall Study|Other|14|||
37642845|NCT02866175|69110595|FG000|Overall Study|Progressive disease|1|||
37642846|NCT02866175|69110596|FG001|Overall Study|Progressive disease|1|||
37642847|NCT02866175|69110595|FG000|Overall Study|Lost to Follow-up|2|||
37642848|NCT02866175|69110596|FG001|Overall Study|Lost to Follow-up|0|||
37642849|NCT02866175|69110595|FG000|Overall Study|Lack of Efficacy|0|||
37642850|NCT02866175|69110596|FG001|Overall Study|Lack of Efficacy|1|||
37642851|NCT02866175|69110595|FG000|Overall Study|Physician Decision|3|||
37642852|NCT02866175|69110596|FG001|Overall Study|Physician Decision|15|||
37642853|NCT02866175|69110595|FG000|Overall Study|Did not receive treatment|5|||
37642854|NCT02866175|69110596|FG001|Overall Study|Did not receive treatment|15|||
37642855|NCT01336205|69110609|FG000|Overall Study|Other|22|||
37642856|NCT01336205|69110610|FG001|Overall Study|Other|9|||
37642857|NCT01336205|69110609|FG000|Overall Study|Lost to Follow-up|40|||
37642858|NCT01336205|69110610|FG001|Overall Study|Lost to Follow-up|20|||
37642859|NCT01336205|69110609|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
37642860|NCT01336205|69110610|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
37642861|NCT01336205|69110609|FG000|Overall Study|Lack of Efficacy|4|||
37642862|NCT01336205|69110610|FG001|Overall Study|Lack of Efficacy|0|||
37642863|NCT01336205|69110609|FG000|Overall Study|Severe noncompliance with protocol|9|||
37642864|NCT01336205|69110610|FG001|Overall Study|Severe noncompliance with protocol|2|||
37642865|NCT01336205|69110609|FG000|Overall Study|Adverse Event|56|||
37642866|NCT01336205|69110610|FG001|Overall Study|Adverse Event|6|||
37642867|NCT01336205|69110609|FG000|Overall Study|Death|1|||
37642868|NCT01336205|69110610|FG001|Overall Study|Death|1|||
37642869|NCT01336205|69110609|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
37642870|NCT01336205|69110610|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
37642871|NCT01336205|69110609|FG000|Overall Study|Withdrawal by Subject|72|||
37642872|NCT01336205|69110610|FG001|Overall Study|Withdrawal by Subject|38|||
37642873|NCT01336205|69110609|FG000|Overall Study|Did not receive treatment|4|||
37642874|NCT01336205|69110610|FG001|Overall Study|Did not receive treatment|0|||
37642875|NCT02865395|69110619|FG000|Overall Study|Physician Decision|6|||
37642876|NCT02865395|69110620|FG001|Overall Study|Physician Decision|10|||
37642877|NCT02865395|69110621|FG002|Overall Study|Physician Decision|7|||
37642878|NCT01123707|69110633|FG000|Overall Study|Lost to Follow-up|3|||
37642879|NCT01123707|69110634|FG001|Overall Study|Lost to Follow-up|1|||
37642880|NCT01123707|69110635|FG002|Overall Study|Lost to Follow-up|3|||
37642881|NCT01123707|69110636|FG003|Overall Study|Lost to Follow-up|2|||
37642882|NCT01123707|69110633|FG000|Overall Study|Adverse Event|5|||
37642883|NCT01123707|69110634|FG001|Overall Study|Adverse Event|7|||
37642884|NCT01123707|69110635|FG002|Overall Study|Adverse Event|5|||
37642885|NCT01123707|69110636|FG003|Overall Study|Adverse Event|3|||
37642886|NCT01123707|69110633|FG000|Overall Study|Sponsor Discontinued Study|30|||
37642887|NCT01123707|69110634|FG001|Overall Study|Sponsor Discontinued Study|24|||
37642888|NCT01123707|69110635|FG002|Overall Study|Sponsor Discontinued Study|25|||
37642889|NCT01123707|69110636|FG003|Overall Study|Sponsor Discontinued Study|40|||
37642890|NCT01123707|69110633|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
37642891|NCT01123707|69110634|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
37642892|NCT01123707|69110635|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
37642893|NCT01123707|69110636|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
37642894|NCT01123707|69110633|FG000|Overall Study|Investigator Withdrew Participant|0|||
37642895|NCT01123707|69110634|FG001|Overall Study|Investigator Withdrew Participant|1|||
37642896|NCT01123707|69110635|FG002|Overall Study|Investigator Withdrew Participant|1|||
37642897|NCT01123707|69110636|FG003|Overall Study|Investigator Withdrew Participant|1|||
37642898|NCT01123707|69110633|FG000|Overall Study|Subject Withdrew Consent|4|||
37642899|NCT01123707|69110634|FG001|Overall Study|Subject Withdrew Consent|5|||
37642900|NCT01123707|69110635|FG002|Overall Study|Subject Withdrew Consent|1|||
37642901|NCT01123707|69110636|FG003|Overall Study|Subject Withdrew Consent|2|||
37642902|NCT01123707|69110633|FG000|Overall Study|Lack of Efficacy|1|||
37642903|NCT01123707|69110634|FG001|Overall Study|Lack of Efficacy|2|||
37642904|NCT01123707|69110635|FG002|Overall Study|Lack of Efficacy|1|||
37642905|NCT01123707|69110636|FG003|Overall Study|Lack of Efficacy|0|||
37642906|NCT01123707|69110633|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
37642907|NCT01123707|69110634|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
37642908|NCT01123707|69110635|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
37642909|NCT01123707|69110636|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
37642910|NCT02755103|69110648|FG000|Overall Study|Lost to Follow-up|17|||
37642911|NCT02755103|69110649|FG001|Overall Study|Lost to Follow-up|15|||
37854437|NCT01232283|69537959|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
37922020|NCT00667576|69608833|FG003|Overall Study|Physician Decision|1|||
37642912|NCT02755103|69110648|FG000|Overall Study|Death|0|||
37642913|NCT02755103|69110649|FG001|Overall Study|Death|1|||
37642914|NCT02755103|69110648|FG000|Overall Study|Physician Decision|0|||
37642915|NCT02755103|69110649|FG001|Overall Study|Physician Decision|1|||
37642916|NCT02755103|69110648|FG000|Overall Study|Pregnancy|0|||
37642917|NCT02755103|69110649|FG001|Overall Study|Pregnancy|1|||
37642918|NCT02755103|69110648|FG000|Overall Study|Withdrawal by Subject|3|||
37642919|NCT02755103|69110649|FG001|Overall Study|Withdrawal by Subject|0|||
37642920|NCT01258803|69110659|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
37642921|NCT01258803|69110660|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
37642922|NCT01258803|69110661|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
37642923|NCT01258803|69110662|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
37642924|NCT01258803|69110663|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
37642925|NCT01258803|69110664|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
37642926|NCT01258803|69110659|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
37642927|NCT01258803|69110660|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
37642928|NCT01258803|69110661|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
37642929|NCT01258803|69110662|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
37642930|NCT01258803|69110663|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
37642931|NCT01258803|69110664|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
37642932|NCT01258803|69110659|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
37642933|NCT01258803|69110660|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
37642934|NCT01258803|69110661|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
37642935|NCT01258803|69110662|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
37642936|NCT01258803|69110663|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
37642937|NCT01258803|69110664|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
37642938|NCT02865083|69110680|FG000|Overall Study|Early Termination|3|||
37642939|NCT02865083|69110681|FG001|Overall Study|Early Termination|1|||
37642940|NCT00862251|69110690|FG000|Overall Study|Adverse Event|8|||
37642941|NCT00862251|69110691|FG001|Overall Study|Adverse Event|3|||
37642942|NCT00862251|69110692|FG002|Overall Study|Adverse Event|1|||
37642943|NCT00862251|69110690|FG000|Overall Study|Lost to Follow-up|0|||
37642944|NCT00862251|69110691|FG001|Overall Study|Lost to Follow-up|0|||
37642945|NCT00862251|69110692|FG002|Overall Study|Lost to Follow-up|1|||
37642946|NCT00862251|69110690|FG000|Overall Study|Protocol Violation|2|||
37642947|NCT00862251|69110691|FG001|Overall Study|Protocol Violation|0|||
37642948|NCT00862251|69110692|FG002|Overall Study|Protocol Violation|1|||
37642949|NCT00862251|69110690|FG000|Overall Study|Withdrawal by Subject|9|||
37642950|NCT00862251|69110691|FG001|Overall Study|Withdrawal by Subject|2|||
37642951|NCT00862251|69110692|FG002|Overall Study|Withdrawal by Subject|6|||
37642952|NCT02864381|69110721|FG000|Overall Study|Death|58|||
37642953|NCT02864381|69110722|FG001|Overall Study|Death|61|||
37642954|NCT02864381|69110721|FG000|Overall Study|Withdrew Consent|5|||
37642955|NCT02864381|69110722|FG001|Overall Study|Withdrew Consent|6|||
37642956|NCT02864381|69110721|FG000|Overall Study|Reason Unknown|7|||
37642957|NCT02864381|69110722|FG001|Overall Study|Reason Unknown|3|||
37642958|NCT02864381|69110721|FG000|Overall Study|Lost to Follow-up|1|||
37642959|NCT02864381|69110722|FG001|Overall Study|Lost to Follow-up|1|||
37642960|NCT02864381|69110721|FG000|Overall Study|Investigator's Discretion|1|||
37642961|NCT02864381|69110722|FG001|Overall Study|Investigator's Discretion|0|||
37642962|NCT02864381|69110721|FG000|Overall Study|Protocol Violation|0|||
37642963|NCT02864381|69110722|FG001|Overall Study|Protocol Violation|1|||
37642964|NCT02860169|69110730|FG000|Part A|Withdrawal by Subject|1|||
37642965|NCT02860169|69110730|FG000|Part A|Other (Screening failure)|6|||
37642966|NCT02860169|69110730|FG000|Part A|Other (Survey not completed)|3|||
37642967|NCT02860169|69110730|FG000|Part A|Other (did not completed consent)|1|||
37642968|NCT02860169|69110730|FG000|Part B|Other (Screening failure)|10|||
37642969|NCT02860169|69110730|FG000|Part B|Withdrawal by Subject|1|||
37642970|NCT02860169|69110730|FG000|Part C|Other (Screening failure)|1|||
37642971|NCT00409773|69110741|FG000|Overall Study|Adverse Event|3|||
37642972|NCT00409773|69110742|FG001|Overall Study|Adverse Event|4|||
37642973|NCT00409773|69110743|FG002|Overall Study|Adverse Event|4|||
37642974|NCT00409773|69110744|FG003|Overall Study|Adverse Event|2|||
37642975|NCT00409773|69110745|FG004|Overall Study|Adverse Event|6|||
37642976|NCT00409773|69110741|FG000|Overall Study|Lost to Follow-up|6|||
37642977|NCT00409773|69110742|FG001|Overall Study|Lost to Follow-up|1|||
37642978|NCT00409773|69110743|FG002|Overall Study|Lost to Follow-up|2|||
37642979|NCT00409773|69110744|FG003|Overall Study|Lost to Follow-up|3|||
37642980|NCT00409773|69110745|FG004|Overall Study|Lost to Follow-up|1|||
37642981|NCT00409773|69110741|FG000|Overall Study|Physician Decision|0|||
37642982|NCT00409773|69110742|FG001|Overall Study|Physician Decision|0|||
37642983|NCT00409773|69110743|FG002|Overall Study|Physician Decision|0|||
37642984|NCT00409773|69110744|FG003|Overall Study|Physician Decision|2|||
37642985|NCT00409773|69110745|FG004|Overall Study|Physician Decision|0|||
37642986|NCT00409773|69110741|FG000|Overall Study|Protocol Violation|0|||
37642987|NCT00409773|69110742|FG001|Overall Study|Protocol Violation|2|||
37642988|NCT00409773|69110743|FG002|Overall Study|Protocol Violation|3|||
37642989|NCT00409773|69110744|FG003|Overall Study|Protocol Violation|3|||
37642990|NCT00409773|69110745|FG004|Overall Study|Protocol Violation|1|||
37642991|NCT00409773|69110741|FG000|Overall Study|Withdrawal by Subject|0|||
37642992|NCT00409773|69110742|FG001|Overall Study|Withdrawal by Subject|0|||
37642993|NCT00409773|69110743|FG002|Overall Study|Withdrawal by Subject|0|||
37642994|NCT00409773|69110744|FG003|Overall Study|Withdrawal by Subject|2|||
37642995|NCT00409773|69110745|FG004|Overall Study|Withdrawal by Subject|1|||
37642996|NCT00409773|69110741|FG000|Overall Study|Lack of Eligibility|0|||
37642997|NCT00409773|69110742|FG001|Overall Study|Lack of Eligibility|0|||
37642998|NCT00409773|69110743|FG002|Overall Study|Lack of Eligibility|0|||
37642999|NCT00409773|69110744|FG003|Overall Study|Lack of Eligibility|0|||
37643000|NCT00409773|69110745|FG004|Overall Study|Lack of Eligibility|1|||
37643001|NCT02861807|69110759|FG000|Overall Study|Lost to Follow-up|7|||
37643002|NCT02861807|69110760|FG001|Overall Study|Lost to Follow-up|6|||
37740807|NCT01860703|69226668|FG002|Overall Study|Withdrawal by Subject|0|||
37740808|NCT01860703|69226669|FG003|Overall Study|Withdrawal by Subject|0|||
37740809|NCT01860703|69226666|FG000|Overall Study|Personal reason|1|||
37740810|NCT01860703|69226667|FG001|Overall Study|Personal reason|0|||
37740811|NCT01860703|69226668|FG002|Overall Study|Personal reason|1|||
37740812|NCT01860703|69226669|FG003|Overall Study|Personal reason|0|||
37740813|NCT01399593|69226687|FG000|Overall Study|Physician Decision|1|||
37740814|NCT01399593|69226688|FG001|Overall Study|Physician Decision|0|||
37740815|NCT01399593|69226687|FG000|Overall Study|Adverse Event|1|||
37740816|NCT01399593|69226688|FG001|Overall Study|Adverse Event|0|||
37740817|NCT01399593|69226687|FG000|Overall Study|Death|1|||
37740818|NCT01399593|69226688|FG001|Overall Study|Death|1|||
37854438|NCT01232283|69537960|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
37854439|NCT01232283|69537961|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
37854440|NCT01232283|69537952|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
37854441|NCT01232283|69537953|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
37854442|NCT01232283|69537954|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
37643003|NCT02861807|69110759|FG000|Overall Study|Withdrawal by Subject|5|||
37643004|NCT02861807|69110760|FG001|Overall Study|Withdrawal by Subject|8|||
37643005|NCT02858401|69110773|FG000|Overall Study|Withdrew Consent|0|||
37643006|NCT02858401|69110774|FG001|Overall Study|Withdrew Consent|0|||
37643007|NCT02858401|69110775|FG002|Overall Study|Withdrew Consent|0|||
37643008|NCT02858401|69110776|FG003|Overall Study|Withdrew Consent|0|||
37643009|NCT02858401|69110777|FG004|Overall Study|Withdrew Consent|0|||
37643010|NCT02858401|69110778|FG005|Overall Study|Withdrew Consent|1|||
37643011|NCT02858401|69110779|FG006|Overall Study|Withdrew Consent|0|||
37643012|NCT02858401|69110773|FG000|Overall Study|Lost to Follow-up|0|||
37643013|NCT02858401|69110774|FG001|Overall Study|Lost to Follow-up|1|||
37643014|NCT02858401|69110775|FG002|Overall Study|Lost to Follow-up|0|||
37643015|NCT02858401|69110776|FG003|Overall Study|Lost to Follow-up|0|||
37643016|NCT02858401|69110777|FG004|Overall Study|Lost to Follow-up|0|||
37643017|NCT02858401|69110778|FG005|Overall Study|Lost to Follow-up|0|||
37643018|NCT02858401|69110779|FG006|Overall Study|Lost to Follow-up|0|||
37643019|NCT02857283|69110806|FG000|First Exposure|Withdrawal by Subject|1|||
37643020|NCT02857283|69110807|FG001|First Exposure|Withdrawal by Subject|0|||
37643021|NCT02746679|69110825|FG000|Overall Study|Lost to Follow-up|4|||
37643022|NCT02746679|69110826|FG001|Overall Study|Lost to Follow-up|6|||
37643023|NCT02731131|69110834|FG000|Overall Study|Psychiatric Disorder|0|||
37643024|NCT02731131|69110835|FG001|Overall Study|Psychiatric Disorder|1|||
37643025|NCT02731131|69110834|FG000|Overall Study|Refused Therapy|0|||
37643026|NCT02731131|69110835|FG001|Overall Study|Refused Therapy|1|||
37643027|NCT02746705|69110843|FG000|Overall Study|Physician Decision|1|||
37643028|NCT02746705|69110844|FG001|Overall Study|Physician Decision|1|||
37643029|NCT02746705|69110843|FG000|Overall Study|Lost to Follow-up|1|||
37643030|NCT02746705|69110844|FG001|Overall Study|Lost to Follow-up|0|||
37643031|NCT02746705|69110843|FG000|Overall Study|outlier scores deemed not valid|0|||
37643032|NCT02746705|69110844|FG001|Overall Study|outlier scores deemed not valid|1|||
37643033|NCT02746627|69110853|FG000|Overall Study|Withdrawal by Subject|1|||
37643034|NCT02746627|69110854|FG001|Overall Study|Withdrawal by Subject|1|||
37643035|NCT02746627|69110855|FG002|Overall Study|Withdrawal by Subject|1|||
37643036|NCT02856113|69110865|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
37643037|NCT02856113|69110866|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
37643038|NCT02856113|69110865|FG000|Overall Study|Significant Protocol Deviation|1|||
37740819|NCT01399593|69226687|FG000|Overall Study|Transplantectomy|0|||
37740820|NCT01399593|69226688|FG001|Overall Study|Transplantectomy|1|||
37740821|NCT01833169|69226694|FG000|Overall Study|Disease Progression|99|||
37740822|NCT01833169|69226694|FG000|Overall Study|Adverse Event|33|||
37854443|NCT01232283|69537955|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
37922021|NCT00667576|69608834|FG004|Overall Study|Physician Decision|0|||
37922022|NCT00667576|69608830|FG000|Overall Study|Missed Visit|0|||
37643039|NCT02856113|69110866|FG001|Overall Study|Significant Protocol Deviation|0|||
37643040|NCT02856113|69110865|FG000|Overall Study|Lost to Follow-up|3|||
37643041|NCT02856113|69110866|FG001|Overall Study|Lost to Follow-up|5|||
37643042|NCT02856113|69110865|FG000|Overall Study|Voluntary Withdrawal|3|||
37740823|NCT01833169|69226694|FG000|Overall Study|Withdrawal by Subject|9|||
37643043|NCT02856113|69110866|FG001|Overall Study|Voluntary Withdrawal|5|||
37643044|NCT02856113|69110865|FG000|Overall Study|Pregnancy|0|||
37643045|NCT02856113|69110866|FG001|Overall Study|Pregnancy|1|||
37643046|NCT02856113|69110865|FG000|Overall Study|Principal Investigator Discretion|2|||
37643047|NCT02856113|69110866|FG001|Overall Study|Principal Investigator Discretion|1|||
37643048|NCT02856113|69110865|FG000|Overall Study|Randomized but not Treated|1|||
37740824|NCT01833169|69226694|FG000|Overall Study|Death|3|||
37643049|NCT02856113|69110866|FG001|Overall Study|Randomized but not Treated|0|||
37643050|NCT02856113|69110865|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
37643051|NCT02856113|69110866|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
37643052|NCT02855411|69110873|FG000|Overall Study|Study terminated by sponsor|21|||
37643053|NCT02855411|69110873|FG000|Overall Study|Does not meet entrance criteria|14|||
37643054|NCT02745145|69110880|FG000|Overall Study|Adverse Event|1|||
37643055|NCT02745145|69110881|FG001|Overall Study|Adverse Event|0|||
37643056|NCT02745145|69110882|FG002|Overall Study|Adverse Event|0|||
37643057|NCT02745145|69110880|FG000|Overall Study|Death|0|||
37643058|NCT02745145|69110881|FG001|Overall Study|Death|1|||
37643059|NCT02745145|69110882|FG002|Overall Study|Death|0|||
37643060|NCT02745145|69110880|FG000|Overall Study|Progressive disease|0|||
37643061|NCT02745145|69110881|FG001|Overall Study|Progressive disease|0|||
37643062|NCT02745145|69110882|FG002|Overall Study|Progressive disease|1|||
37643063|NCT02745145|69110880|FG000|Overall Study|Withdrew consent|1|||
37643064|NCT02745145|69110881|FG001|Overall Study|Withdrew consent|1|||
37643065|NCT02745145|69110882|FG002|Overall Study|Withdrew consent|1|||
37643066|NCT02745145|69110880|FG000|Overall Study|Study Termination|8|||
37643067|NCT02745145|69110881|FG001|Overall Study|Study Termination|3|||
37643068|NCT02745145|69110882|FG002|Overall Study|Study Termination|7|||
37643069|NCT02854631|69110901|FG000|Overall Study|Adverse Event|1|||
37643070|NCT02854631|69110902|FG001|Overall Study|Adverse Event|2|||
37643071|NCT02854631|69110901|FG000|Overall Study|Withdrew Consent|3|||
37643072|NCT02854631|69110902|FG001|Overall Study|Withdrew Consent|2|||
37643073|NCT02854631|69110901|FG000|Overall Study|Investigator's Discretion|2|||
37643074|NCT02854631|69110902|FG001|Overall Study|Investigator's Discretion|0|||
37643075|NCT02854631|69110901|FG000|Overall Study|Death|12|||
37643076|NCT02854631|69110902|FG001|Overall Study|Death|8|||
37643077|NCT02854631|69110901|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
37643078|NCT02854631|69110902|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
37643079|NCT02854631|69110901|FG000|Overall Study|Protocol Violation|0|||
37643080|NCT02854631|69110902|FG001|Overall Study|Protocol Violation|1|||
37643081|NCT02854631|69110901|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
37643082|NCT02854631|69110902|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
37643083|NCT02854631|69110901|FG000|Overall Study|Lost to Follow-up|4|||
37643084|NCT02854631|69110902|FG001|Overall Study|Lost to Follow-up|2|||
37643085|NCT02855359|69110910|FG000|Overall Study|Death|2|||
37643086|NCT02855359|69110911|FG001|Overall Study|Death|2|||
37643087|NCT02855359|69110912|FG002|Overall Study|Death|0|||
37643088|NCT02855359|69110913|FG003|Overall Study|Death|0|||
37643089|NCT02855359|69110910|FG000|Overall Study|Study Termination by Sponsor|9|||
37643090|NCT02855359|69110911|FG001|Overall Study|Study Termination by Sponsor|11|||
37643091|NCT02855359|69110912|FG002|Overall Study|Study Termination by Sponsor|0|||
37643092|NCT02855359|69110913|FG003|Overall Study|Study Termination by Sponsor|0|||
37643093|NCT02853929|69110927|FG000|Overall Study|Lost to Follow-up|3|||
37643094|NCT02853929|69110928|FG001|Overall Study|Lost to Follow-up|0|||
37643095|NCT02853929|69110927|FG000|Overall Study|Withdrawal by Subject|1|||
37643096|NCT02853929|69110928|FG001|Overall Study|Withdrawal by Subject|0|||
37643097|NCT02853929|69110927|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
37643098|NCT02853929|69110928|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
37643099|NCT02730819|69110964|FG000|Overall Study|Lost to Follow-up|9|||
37643100|NCT02038946|69110968|FG000|Overall Study|Death|5|||
37643101|NCT02038946|69110968|FG000|Overall Study|Withdrawal by Subject|3|||
37643102|NCT02038946|69110968|FG000|Overall Study|Lost to Follow-up|2|||
37643103|NCT02038946|69110968|FG000|Overall Study|Other reasons|2|||
37643104|NCT03143829|69110974|FG000|Overall Study|Withdrawal by Subject|2|||
37643105|NCT03143829|69110975|FG001|Overall Study|Withdrawal by Subject|5|||
37643106|NCT03143829|69110974|FG000|Overall Study|Lost to Follow-up|0|||
37643107|NCT03143829|69110975|FG001|Overall Study|Lost to Follow-up|2|||
37643108|NCT03143829|69110974|FG000|Overall Study|Death|1|||
37643109|NCT03143829|69110975|FG001|Overall Study|Death|1|||
37643110|NCT03143829|69110974|FG000|Overall Study|changed treatment, no longer eligible|2|||
37643111|NCT03143829|69110975|FG001|Overall Study|changed treatment, no longer eligible|2|||
37643112|NCT02853331|69110983|FG000|Overall Study|Death|59|||
37643113|NCT02853331|69110984|FG001|Overall Study|Death|95|||
37643114|NCT02853331|69110983|FG000|Overall Study|Withdrawal by Subject|5|||
37643115|NCT02853331|69110984|FG001|Overall Study|Withdrawal by Subject|9|||
37643116|NCT02853331|69110983|FG000|Overall Study|Ongoing in study|368|||
37740825|NCT01833169|69226694|FG000|Overall Study|Physician Decision|2|||
37643117|NCT02853331|69110984|FG001|Overall Study|Ongoing in study|325|||
37740826|NCT01860079|69226700|FG000|Overall Study|Physician Decision|14|||
37740827|NCT01860079|69226701|FG001|Overall Study|Physician Decision|22|||
37643118|NCT05896761|69110992|FG000|Thigh Injection Phase (Up to Week 16)|Adverse Event|1|||
37643119|NCT05896761|69110993|FG001|Thigh Injection Phase (Up to Week 16)|Adverse Event|0|||
37643120|NCT05896761|69110992|FG000|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|2|||
37643121|NCT05896761|69110993|FG001|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|3|||
37740828|NCT01388985|69226709|FG000|Overall Study|Death|0|||
37643122|NCT05048784|69111018|FG000|Period 1|Adverse Event|3|||
37643123|NCT05048784|69111019|FG001|Period 1|Adverse Event|1|||
37643124|NCT05048784|69111020|FG002|Period 1|Adverse Event|0|||
37643125|NCT05048784|69111021|FG003|Period 1|Adverse Event|0|||
37643126|NCT05048784|69111018|FG000|Period 2|Lost to Follow-up|0|||
37643127|NCT05048784|69111019|FG001|Period 2|Lost to Follow-up|1|||
37643128|NCT05048784|69111020|FG002|Period 2|Lost to Follow-up|0|||
37740829|NCT01388985|69226710|FG001|Overall Study|Death|1|||
37740830|NCT01388985|69226709|FG000|Overall Study|Lost to Follow-up|30|||
37740831|NCT01388985|69226710|FG001|Overall Study|Lost to Follow-up|30|||
37740832|NCT01388985|69226709|FG000|Overall Study|Withdrawal by Subject|13|||
37740833|NCT01388985|69226710|FG001|Overall Study|Withdrawal by Subject|4|||
37740834|NCT01388985|69226709|FG000|Overall Study|Subject unavailable|1|||
37740835|NCT01388985|69226710|FG001|Overall Study|Subject unavailable|1|||
37740836|NCT01388985|69226709|FG000|Overall Study|Other (no reason)|0|||
37740837|NCT01388985|69226710|FG001|Overall Study|Other (no reason)|1|||
37740838|NCT01388985|69226709|FG000|Overall Study|Error of nurse|5|||
37740839|NCT01388985|69226710|FG001|Overall Study|Error of nurse|1|||
37740840|NCT01388907|69226718|FG000|Overall Study|Adverse Event|2|||
37740841|NCT01388907|69226719|FG001|Overall Study|Adverse Event|0|||
37740842|NCT01388361|69226730|FG000|Overall Study|Adverse Event|0|||
37740843|NCT01388361|69226731|FG001|Overall Study|Adverse Event|5|||
37740844|NCT01388361|69226732|FG002|Overall Study|Adverse Event|1|||
37740845|NCT01388361|69226730|FG000|Overall Study|Protocol Violation|0|||
37740846|NCT01388361|69226731|FG001|Overall Study|Protocol Violation|0|||
37740847|NCT01388361|69226732|FG002|Overall Study|Protocol Violation|2|||
37740848|NCT01388361|69226730|FG000|Overall Study|Withdrawal criteria|12|||
37740849|NCT01388361|69226731|FG001|Overall Study|Withdrawal criteria|7|||
37740850|NCT01388361|69226732|FG002|Overall Study|Withdrawal criteria|10|||
37740851|NCT01388361|69226730|FG000|Overall Study|Unclassified|0|||
37740852|NCT01388361|69226731|FG001|Overall Study|Unclassified|0|||
37740853|NCT01388361|69226732|FG002|Overall Study|Unclassified|1|||
37740854|NCT01399125|69226742|FG000|Overall Study|Adverse Event|32|||
37740855|NCT01399125|69226743|FG001|Overall Study|Adverse Event|30|||
37740856|NCT01399125|69226742|FG000|Overall Study|Abnormal Lab values|0|||
37740857|NCT01399125|69226743|FG001|Overall Study|Abnormal Lab values|1|||
37740858|NCT01399125|69226742|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
37740859|NCT01399125|69226743|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
37740860|NCT01399125|69226742|FG000|Overall Study|Withdrawal by Subject|5|||
37740861|NCT01399125|69226743|FG001|Overall Study|Withdrawal by Subject|8|||
37740862|NCT01399125|69226742|FG000|Overall Study|Lost to Follow-up|2|||
37740863|NCT01399125|69226743|FG001|Overall Study|Lost to Follow-up|3|||
37740864|NCT01399125|69226742|FG000|Overall Study|Administrative Problems|7|||
37740865|NCT01399125|69226743|FG001|Overall Study|Administrative Problems|11|||
37740866|NCT01399125|69226742|FG000|Overall Study|Death|0|||
37740867|NCT01399125|69226743|FG001|Overall Study|Death|1|||
37740868|NCT01399125|69226742|FG000|Overall Study|Protocol Deviation|5|||
37740869|NCT01399125|69226743|FG001|Overall Study|Protocol Deviation|2|||
37740870|NCT01399047|69226751|FG000|Overall Study|Withdrawal by Subject|0|||
37740871|NCT01399047|69226752|FG001|Overall Study|Withdrawal by Subject|1|||
37740872|NCT01387737|69226762|FG000|Overall Study|Adverse Event|20|||
37740873|NCT01387737|69226763|FG001|Overall Study|Adverse Event|30|||
37740874|NCT01387737|69226762|FG000|Overall Study|Lack of Efficacy|1|||
37740875|NCT01387737|69226763|FG001|Overall Study|Lack of Efficacy|0|||
37854444|NCT01232283|69537956|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
37854445|NCT01232283|69537957|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
37854446|NCT01232283|69537958|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
37854447|NCT01232283|69537959|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
37740876|NCT01387737|69226762|FG000|Overall Study|Physician Decision|3|||
37740877|NCT01387737|69226763|FG001|Overall Study|Physician Decision|10|||
37740878|NCT01387737|69226762|FG000|Overall Study|Withdrawal by Subject|27|||
37740879|NCT01387737|69226763|FG001|Overall Study|Withdrawal by Subject|31|||
37740880|NCT01387737|69226762|FG000|Overall Study|Clearly not eligible for the study|1|||
37740881|NCT01387737|69226763|FG001|Overall Study|Clearly not eligible for the study|3|||
37740882|NCT01387347|69226771|FG000|Overall Study|Lost to Follow-up|2|||
37740883|NCT01387347|69226772|FG001|Overall Study|Lost to Follow-up|1|||
37740884|NCT01859923|69226786|FG000|Overall Study|Adverse Event|0|||
37740885|NCT01859923|69226787|FG001|Overall Study|Adverse Event|0|||
37740886|NCT01859923|69226788|FG002|Overall Study|Adverse Event|1|||
37740887|NCT01859923|69226789|FG003|Overall Study|Adverse Event|1|||
37922023|NCT00667576|69608831|FG001|Overall Study|Missed Visit|0|||
37740888|NCT01832155|69226804|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
37643129|NCT05048784|69111021|FG003|Period 2|Lost to Follow-up|0|||
37740889|NCT01832155|69226805|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
37740890|NCT01832155|69226804|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
37643130|NCT04700280|69111050|FG000|Overall Study|Adverse Event|4|||
37740891|NCT01832155|69226805|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
37740892|NCT01879579|69226819|FG000|Overall Study|Phone incompatible with texting platform|3|||
37643131|NCT04700280|69111051|FG001|Overall Study|Adverse Event|0|||
37643132|NCT04700280|69111050|FG000|Overall Study|Lack of Efficacy|1|||
37643133|NCT04700280|69111051|FG001|Overall Study|Lack of Efficacy|0|||
37643134|NCT04700280|69111050|FG000|Overall Study|Study terminated by sponsor|5|||
37643135|NCT04700280|69111051|FG001|Overall Study|Study terminated by sponsor|3|||
37643136|NCT04700280|69111050|FG000|Overall Study|Other than specified|1|||
37643137|NCT04700280|69111051|FG001|Overall Study|Other than specified|0|||
37643138|NCT04679675|69111061|FG000|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|356|||
37643139|NCT04679675|69111062|FG001|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|261|||
37643140|NCT04679675|69111063|FG002|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|50|||
37643141|NCT04679675|69111064|FG003|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|210|||
37643142|NCT04679675|69111061|FG000|Overall Study|Excluded from analysis, recent disenrollment from KPWA|211|||
37643143|NCT04679675|69111062|FG001|Overall Study|Excluded from analysis, recent disenrollment from KPWA|164|||
37643144|NCT04679675|69111063|FG002|Overall Study|Excluded from analysis, recent disenrollment from KPWA|27|||
37643145|NCT04679675|69111064|FG003|Overall Study|Excluded from analysis, recent disenrollment from KPWA|137|||
37643146|NCT04626128|69111078|FG000|Overall Study|Withdrawal by Subject|0|||
37643147|NCT04626128|69111079|FG001|Overall Study|Withdrawal by Subject|1|||
37643148|NCT04626128|69111080|FG002|Overall Study|Withdrawal by Subject|0|||
37643149|NCT04626128|69111081|FG003|Overall Study|Withdrawal by Subject|0|||
37643150|NCT04581824|69111093|FG000|Overall Study|Ongoing|75|||
37643151|NCT04581824|69111094|FG001|Overall Study|Ongoing|69|||
37643152|NCT04581824|69111093|FG000|Overall Study|Withdrawal by Subject|3|||
37643153|NCT04581824|69111094|FG001|Overall Study|Withdrawal by Subject|5|||
37643154|NCT04581824|69111093|FG000|Overall Study|Lost to Follow-up|1|||
37643155|NCT04581824|69111094|FG001|Overall Study|Lost to Follow-up|0|||
37643156|NCT04523571|69111106|FG000|Received 2 Doses|Withdrawal by Subject|0|||
37643157|NCT04523571|69111107|FG001|Received 2 Doses|Withdrawal by Subject|0|||
37643158|NCT04523571|69111108|FG002|Received 2 Doses|Withdrawal by Subject|0|||
37643159|NCT04523571|69111109|FG003|Received 2 Doses|Withdrawal by Subject|1|||
37643160|NCT04523571|69111110|FG004|Received 2 Doses|Withdrawal by Subject|1|||
37643161|NCT04523571|69111111|FG005|Received 2 Doses|Withdrawal by Subject|0|||
37643162|NCT04523571|69111106|FG000|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
37643163|NCT04523571|69111107|FG001|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
37643164|NCT04523571|69111108|FG002|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
37643165|NCT04523571|69111109|FG003|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
37643166|NCT04523571|69111110|FG004|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
37643167|NCT04523571|69111111|FG005|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
37643168|NCT04523571|69111106|FG000|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
37643169|NCT04523571|69111107|FG001|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
37643170|NCT04523571|69111108|FG002|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
37643171|NCT04523571|69111109|FG003|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
37643172|NCT04523571|69111110|FG004|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
37643173|NCT04523571|69111111|FG005|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|1|||
37643174|NCT04523571|69111106|FG000|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
37643175|NCT04523571|69111107|FG001|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
37643176|NCT04523571|69111108|FG002|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
37643177|NCT04523571|69111109|FG003|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
37643178|NCT04523571|69111110|FG004|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
37643179|NCT04523571|69111111|FG005|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
37740893|NCT01879579|69226820|FG001|Overall Study|Phone incompatible with texting platform|0|||
37740894|NCT01879579|69226819|FG000|Overall Study|Did not enroll in texting platform|1|||
37740895|NCT01879579|69226820|FG001|Overall Study|Did not enroll in texting platform|0|||
37740896|NCT01879579|69226819|FG000|Overall Study|Did not initiate insulin treatment|1|||
37740897|NCT01879579|69226820|FG001|Overall Study|Did not initiate insulin treatment|0|||
37740898|NCT01879579|69226819|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
37740899|NCT01879579|69226820|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
37740900|NCT01879579|69226819|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
37740901|NCT01879579|69226820|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
37740902|NCT01386645|69226832|FG000|Overall Study|Physician Decision|0|||
37740903|NCT01386645|69226833|FG001|Overall Study|Physician Decision|0|||
37740904|NCT01386645|69226834|FG002|Overall Study|Physician Decision|1|||
37740905|NCT01386645|69226832|FG000|Overall Study|Withdrawal by Subject|0|||
37740906|NCT01386645|69226833|FG001|Overall Study|Withdrawal by Subject|1|||
37740907|NCT01386645|69226834|FG002|Overall Study|Withdrawal by Subject|1|||
38032153|NCT02951780|69718052|FG007|Period 2|Scheduling Conflicts|1|||
37740908|NCT01387269|69226844|FG000|Overall Study|Death|38|||
37740909|NCT01387269|69226845|FG001|Overall Study|Death|20|||
37740910|NCT01387269|69226844|FG000|Overall Study|Other|8|||
37643180|NCT04361617|69111127|FG000|Overall Study|Withdrawal by Subject|0|||
37643181|NCT04361617|69111128|FG001|Overall Study|Withdrawal by Subject|1|||
37643182|NCT04021914|69111134|FG000|Overall Study|Did not meet inclusion criteria on confirmatory testing|1|||
37643183|NCT03850444|69111160|FG000|Overall Study|Adverse Event|16|||
37643184|NCT03850444|69111161|FG001|Overall Study|Adverse Event|10|||
37643185|NCT03850444|69111160|FG000|Overall Study|Death|87|||
37643186|NCT03850444|69111161|FG001|Overall Study|Death|107|||
37643187|NCT03850444|69111160|FG000|Overall Study|Lost to Follow-up|1|||
37643188|NCT03850444|69111161|FG001|Overall Study|Lost to Follow-up|1|||
37643189|NCT03850444|69111160|FG000|Overall Study|Withdrawal by Subject|1|||
37643190|NCT03850444|69111161|FG001|Overall Study|Withdrawal by Subject|5|||
37643191|NCT03850444|69111160|FG000|Overall Study|Participation in study terminated by Sponsor|23|||
37643192|NCT03850444|69111161|FG001|Overall Study|Participation in study terminated by Sponsor|11|||
37643193|NCT03781804|69111171|FG000|Overall Study|Adverse Event|2|||
37643194|NCT03781804|69111172|FG001|Overall Study|Adverse Event|2|||
37643195|NCT03781804|69111173|FG002|Overall Study|Adverse Event|3|||
37643196|NCT03781804|69111171|FG000|Overall Study|Lost to Follow-up|1|||
37643197|NCT03781804|69111172|FG001|Overall Study|Lost to Follow-up|1|||
37643198|NCT03781804|69111173|FG002|Overall Study|Lost to Follow-up|2|||
37643199|NCT03781804|69111171|FG000|Overall Study|Lack of Efficacy|4|||
37643200|NCT03781804|69111172|FG001|Overall Study|Lack of Efficacy|2|||
37643201|NCT03781804|69111173|FG002|Overall Study|Lack of Efficacy|9|||
37643202|NCT03781804|69111171|FG000|Overall Study|Protocol Violation|0|||
37643203|NCT03781804|69111172|FG001|Overall Study|Protocol Violation|0|||
37643204|NCT03781804|69111173|FG002|Overall Study|Protocol Violation|1|||
37643205|NCT03781804|69111171|FG000|Overall Study|Withdrawal by Subject|0|||
37643206|NCT03781804|69111172|FG001|Overall Study|Withdrawal by Subject|1|||
37643207|NCT03781804|69111173|FG002|Overall Study|Withdrawal by Subject|1|||
37643208|NCT03781804|69111171|FG000|Overall Study|Reason not provided|2|||
37643209|NCT03781804|69111172|FG001|Overall Study|Reason not provided|2|||
37643210|NCT03781804|69111173|FG002|Overall Study|Reason not provided|0|||
37643211|NCT03623386|69111184|FG000|Overall Study|Protocol Violation|3|||
37643212|NCT03623386|69111185|FG001|Overall Study|Protocol Violation|2|||
37643213|NCT03623386|69111186|FG002|Overall Study|Protocol Violation|0|||
37643214|NCT03623386|69111184|FG000|Overall Study|Physician Decision|1|||
37643215|NCT03623386|69111185|FG001|Overall Study|Physician Decision|1|||
37643216|NCT03623386|69111186|FG002|Overall Study|Physician Decision|0|||
37643217|NCT03623386|69111184|FG000|Overall Study|Lost to Follow-up|0|||
37643218|NCT03623386|69111185|FG001|Overall Study|Lost to Follow-up|2|||
37643219|NCT03623386|69111186|FG002|Overall Study|Lost to Follow-up|0|||
37643220|NCT03623386|69111184|FG000|Overall Study|COVID-19|0|||
37643221|NCT03623386|69111185|FG001|Overall Study|COVID-19|1|||
37643222|NCT03623386|69111186|FG002|Overall Study|COVID-19|0|||
37643223|NCT03507686|69111197|FG000|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|4|||
37643224|NCT03507686|69111198|FG001|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|0|||
37643225|NCT03507686|69111197|FG000|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|2|||
37643226|NCT03507686|69111198|FG001|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|0|||
37643227|NCT03507686|69111197|FG000|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|2|||
37643228|NCT03507686|69111198|FG001|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|0|||
37643229|NCT03507686|69111197|FG000|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|2|||
37643230|NCT03507686|69111198|FG001|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|0|||
37643231|NCT03507686|69111197|FG000|Treatment Period 2 (Month13 to Month24)|Death|0|||
37643232|NCT03507686|69111198|FG001|Treatment Period 2 (Month13 to Month24)|Death|1|||
37643233|NCT03507686|69111197|FG000|Treatment Period 2 (Month13 to Month24)|Reason not Specified|0|||
37643234|NCT03507686|69111198|FG001|Treatment Period 2 (Month13 to Month24)|Reason not Specified|2|||
37643235|NCT03471507|69111206|FG000|Overall Study|Lost to Follow-up|1|||
37643236|NCT03471507|69111207|FG001|Overall Study|Lost to Follow-up|3|||
37643237|NCT03471507|69111206|FG000|Overall Study|Physician Decision|0|||
37643238|NCT03471507|69111207|FG001|Overall Study|Physician Decision|1|||
37643239|NCT03471507|69111206|FG000|Overall Study|Withdrawal by Subject|2|||
37643240|NCT03471507|69111207|FG001|Overall Study|Withdrawal by Subject|1|||
37643241|NCT03338894|69111213|FG000|Overall Study|Withdrew, or not able to attend 9 or more classes, or did not complete final survey.|22|||
37643242|NCT03138564|69111221|FG000|Overall Study|Death of patient prior to the Week 2 assessment|14|||
37643243|NCT03138564|69111222|FG001|Overall Study|Death of patient prior to the Week 2 assessment|2|||
37643244|NCT03138564|69111221|FG000|Overall Study|Lost to Follow-up|16|||
37643245|NCT03138564|69111222|FG001|Overall Study|Lost to Follow-up|2|||
37643246|NCT03138564|69111221|FG000|Overall Study|Withdrawal by Subject|48|||
37643247|NCT03138564|69111222|FG001|Overall Study|Withdrawal by Subject|4|||
37643248|NCT03138564|69111221|FG000|Overall Study|No longer met eligibility criteria|2|||
37643249|NCT03138564|69111222|FG001|Overall Study|No longer met eligibility criteria|0|||
37643250|NCT03138564|69111221|FG000|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|4|||
37643251|NCT03138564|69111222|FG001|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|0|||
37740911|NCT01387269|69226845|FG001|Overall Study|Other|7|||
37643252|NCT03138564|69111221|FG000|Overall Study|Patient died before surrogate completed Week 2 assessment|12|||
37643253|NCT03138564|69111222|FG001|Overall Study|Patient died before surrogate completed Week 2 assessment|0|||
37643254|NCT03138564|69111221|FG000|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|0|||
37643255|NCT03138564|69111222|FG001|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|1|||
37643256|NCT03138564|69111221|FG000|Overall Study|Death of surrogate prior to Week 2 assessment|1|||
37643257|NCT03138564|69111222|FG001|Overall Study|Death of surrogate prior to Week 2 assessment|0|||
37643258|NCT02923180|69111245|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
37643259|NCT02923180|69111245|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
37643260|NCT02836717|69111252|FG000|Test Phase|Lack of Efficacy|14|||
37643261|NCT02836717|69111253|FG001|Test Phase|Lack of Efficacy|8|||
37643262|NCT02836717|69111254|FG002|Test Phase|Lack of Efficacy|0|||
37643263|NCT02836717|69111252|FG000|Study Phase|Adverse Event|2|||
37643264|NCT02836717|69111253|FG001|Study Phase|Adverse Event|0|||
37643265|NCT02836717|69111254|FG002|Study Phase|Adverse Event|0|||
37643266|NCT02836717|69111252|FG000|Study Phase|Lack of Efficacy|8|||
37643267|NCT02836717|69111253|FG001|Study Phase|Lack of Efficacy|6|||
37643268|NCT02836717|69111254|FG002|Study Phase|Lack of Efficacy|1|||
37643269|NCT02836717|69111252|FG000|Study Phase|Withdrawal by Subject|1|||
37643270|NCT02836717|69111253|FG001|Study Phase|Withdrawal by Subject|0|||
37643271|NCT02836717|69111254|FG002|Study Phase|Withdrawal by Subject|0|||
37643272|NCT02836717|69111252|FG000|Study Phase|Death|1|||
37643273|NCT02836717|69111253|FG001|Study Phase|Death|0|||
37643274|NCT02836717|69111254|FG002|Study Phase|Death|0|||
37643275|NCT02836717|69111252|FG000|Study Phase|abdominal surgeries|2|||
37643276|NCT02836717|69111253|FG001|Study Phase|abdominal surgeries|1|||
37643277|NCT02836717|69111254|FG002|Study Phase|abdominal surgeries|0|||
37643278|NCT02743494|69111265|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
37643279|NCT02743494|69111266|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
37643280|NCT02743494|69111265|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
37643281|NCT02743494|69111266|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
37643282|NCT02743494|69111265|FG000|Treatment Period|Completed treatment|229|||
37643283|NCT02743494|69111266|FG001|Treatment Period|Completed treatment|99|||
37643284|NCT02743494|69111265|FG000|Treatment Period|Disease recurrence|149|||
37643285|NCT02743494|69111266|FG001|Treatment Period|Disease recurrence|113|||
37643286|NCT02743494|69111265|FG000|Treatment Period|Study drug toxicity|57|||
37643287|NCT02743494|69111266|FG001|Treatment Period|Study drug toxicity|8|||
37643288|NCT02743494|69111265|FG000|Treatment Period|Death|1|||
37643289|NCT02743494|69111266|FG001|Treatment Period|Death|0|||
37643290|NCT02743494|69111265|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
37643291|NCT02743494|69111266|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
37643292|NCT02743494|69111265|FG000|Treatment Period|Participant request to discontinue treatment|30|||
37643293|NCT02743494|69111266|FG001|Treatment Period|Participant request to discontinue treatment|5|||
37643294|NCT02743494|69111265|FG000|Treatment Period|Participant withdrew consent|12|||
37643295|NCT02743494|69111266|FG001|Treatment Period|Participant withdrew consent|4|||
37643296|NCT02743494|69111265|FG000|Treatment Period|Lost to Follow-up|0|||
37643297|NCT02743494|69111266|FG001|Treatment Period|Lost to Follow-up|1|||
37643298|NCT02743494|69111265|FG000|Treatment Period|Poor/Non-compliance|1|||
37643299|NCT02743494|69111266|FG001|Treatment Period|Poor/Non-compliance|0|||
37643300|NCT02743494|69111265|FG000|Treatment Period|Other reasons|7|||
37643301|NCT02743494|69111266|FG001|Treatment Period|Other reasons|2|||
37643302|NCT02336282|69111272|FG000|Overall Study|Unrelated illness|1|||
37643303|NCT02336282|69111272|FG000|Overall Study|Uncomfortable with technology|1|||
37643304|NCT02336282|69111272|FG000|Overall Study|Lost to Follow-up|1|||
37643305|NCT02336282|69111272|FG000|Overall Study|Not enough time to complete sessions|2|||
37740912|NCT01387269|69226844|FG000|Overall Study|Unrelated AE|12|||
37740913|NCT01387269|69226845|FG001|Overall Study|Unrelated AE|3|||
37740914|NCT01387269|69226844|FG000|Overall Study|Withdrawal by patient|32|||
37740915|NCT01387269|69226845|FG001|Overall Study|Withdrawal by patient|10|||
37740916|NCT01387269|69226844|FG000|Overall Study|Study drug-related AE|1|||
37740917|NCT01387269|69226845|FG001|Overall Study|Study drug-related AE|0|||
37740918|NCT01387269|69226844|FG000|Overall Study|Lost to Follow-up|1|||
37740919|NCT01387269|69226845|FG001|Overall Study|Lost to Follow-up|0|||
37740920|NCT01859143|69226853|FG000|Overall Study|Lost to Follow-up|2|||
37740921|NCT01859143|69226854|FG001|Overall Study|Lost to Follow-up|0|||
37740922|NCT01878253|69226861|FG000|Overall Study|Death|1|||
37740923|NCT01878253|69226861|FG000|Overall Study|SIdus System Removal|3|||
37643306|NCT02272842|69111286|FG000|Overall Study|Lost to Follow-up|8|||
37643307|NCT02272842|69111287|FG001|Overall Study|Lost to Follow-up|8|||
37643308|NCT02272842|69111286|FG000|Overall Study|Withdrawal by Subject|8|||
37643309|NCT02272842|69111287|FG001|Overall Study|Withdrawal by Subject|2|||
37643310|NCT02258659|69111294|FG000|Overall Study|Withdrawal by Subject|1|||
37643311|NCT01990300|69111307|FG000|Overall Study|Case Report Forms Uncollected|89|||
37643312|NCT01990300|69111307|FG000|Overall Study|Protocol Deviation|53|||
37740924|NCT01878253|69226861|FG000|Overall Study|Withdrawal by Subject|1|||
37643313|NCT01909934|69111311|FG000|Overall Study|Ongoing|23|||
37643314|NCT01909934|69111311|FG000|Overall Study|Withdrawal by Subject|3|||
37643315|NCT01909934|69111311|FG000|Overall Study|Lost to Follow-up|1|||
37643316|NCT01909934|69111311|FG000|Overall Study|Withdrawal of Informed Consent|1|||
37643317|NCT01909934|69111311|FG000|Overall Study|Death|22|||
37643318|NCT01076400|69111340|FG000|Overall Study|Adverse Event|2|||
37643319|NCT01076400|69111341|FG001|Overall Study|Adverse Event|0|||
37643320|NCT01076400|69111342|FG002|Overall Study|Adverse Event|0|||
37643321|NCT01076400|69111340|FG000|Overall Study|Progressive Disease|5|||
37643322|NCT01076400|69111341|FG001|Overall Study|Progressive Disease|0|||
37643323|NCT01076400|69111342|FG002|Overall Study|Progressive Disease|0|||
37643324|NCT01000051|69111348|FG000|Overall Study|Withdrawal by Subject|1|||
37643325|NCT01000051|69111349|FG001|Overall Study|Withdrawal by Subject|1|||
37643326|NCT01000051|69111348|FG000|Overall Study|Disease Progression|1|||
37643327|NCT01000051|69111349|FG001|Overall Study|Disease Progression|0|||
37643328|NCT01000051|69111348|FG000|Overall Study|Serious noncompliance|1|||
37643329|NCT01000051|69111349|FG001|Overall Study|Serious noncompliance|0|||
37643330|NCT00953160|69111355|FG000|Overall Study|Lost to Follow-up|23|||
37643331|NCT00953160|69111355|FG000|Overall Study|Withdrawal by Subject|4|||
37643332|NCT00913497|69111382|FG000|Overall Study|Adverse Event|1|||
37643333|NCT00913497|69111382|FG000|Overall Study|Withdrawal by Subject|2|||
37643334|NCT00874822|69111388|FG000|Overall Study|excluded by criteria|8|||
37643335|NCT00556933|69111405|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
37643336|NCT00556933|69111406|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
37643337|NCT00556933|69111407|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
37643338|NCT00556933|69111408|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
37643339|NCT00556933|69111405|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
37643340|NCT00556933|69111406|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
37643341|NCT00556933|69111407|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
37643342|NCT00556933|69111408|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
37643343|NCT00556933|69111405|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
37643344|NCT00556933|69111406|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
37643345|NCT00556933|69111407|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
37643346|NCT00556933|69111408|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
37643347|NCT00556933|69111405|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
37643348|NCT00556933|69111406|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
37643349|NCT00556933|69111407|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
37643350|NCT00556933|69111408|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
37643351|NCT00556933|69111405|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
37643352|NCT00556933|69111406|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
37643353|NCT00556933|69111407|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
37643354|NCT00556933|69111408|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
37643355|NCT00556933|69111405|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
37643356|NCT00556933|69111406|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
37643357|NCT00556933|69111407|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
37643358|NCT00556933|69111408|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
37643359|NCT00556933|69111405|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
37643360|NCT00556933|69111406|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
37643361|NCT00556933|69111407|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
37643362|NCT00556933|69111408|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
37643363|NCT00556933|69111405|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
37643364|NCT00556933|69111406|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
37643365|NCT00556933|69111407|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
37643366|NCT00556933|69111408|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
37643367|NCT00556933|69111405|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
37643368|NCT00556933|69111406|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
37643369|NCT00556933|69111407|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
37643370|NCT00556933|69111408|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
37643371|NCT00556933|69111405|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
37643372|NCT00556933|69111406|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
37643373|NCT00556933|69111407|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
37643374|NCT00556933|69111408|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
37643375|NCT00556933|69111405|FG000|CNI Withdrawal vs. Minimization|Death|0|||
37643376|NCT00556933|69111406|FG001|CNI Withdrawal vs. Minimization|Death|0|||
37643377|NCT00556933|69111407|FG002|CNI Withdrawal vs. Minimization|Death|0|||
37854448|NCT01232283|69537960|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
37643378|NCT00556933|69111408|FG003|CNI Withdrawal vs. Minimization|Death|1|||
37643379|NCT00280917|69111447|FG000|Overall Study|Adverse Event|1|||
37643380|NCT00280917|69111448|FG001|Overall Study|Adverse Event|1|||
37643381|NCT00280917|69111449|FG002|Overall Study|Adverse Event|4|||
37643382|NCT00280917|69111450|FG003|Overall Study|Adverse Event|1|||
37643383|NCT00280917|69111447|FG000|Overall Study|Change Therapy|1|||
37643384|NCT00280917|69111448|FG001|Overall Study|Change Therapy|2|||
37643385|NCT00280917|69111449|FG002|Overall Study|Change Therapy|0|||
37643386|NCT00280917|69111450|FG003|Overall Study|Change Therapy|0|||
37643387|NCT00280917|69111447|FG000|Overall Study|Withdrawal by Subject|0|||
37643388|NCT00280917|69111448|FG001|Overall Study|Withdrawal by Subject|2|||
37643389|NCT00280917|69111449|FG002|Overall Study|Withdrawal by Subject|0|||
37643390|NCT00280917|69111450|FG003|Overall Study|Withdrawal by Subject|1|||
37643391|NCT00280917|69111447|FG000|Overall Study|Noncompliance|0|||
37643392|NCT00280917|69111448|FG001|Overall Study|Noncompliance|1|||
37643393|NCT00280917|69111449|FG002|Overall Study|Noncompliance|2|||
37643394|NCT00280917|69111450|FG003|Overall Study|Noncompliance|0|||
37643395|NCT00006478|69111469|FG000|Overall Study|Vaccine could not be produced|1|||
37643396|NCT00006478|69111469|FG000|Overall Study|Physician Decision|6|||
37643397|NCT05718466|69111475|FG000|Overall Study|Withdrawal by Subject|1|||
37643398|NCT05718466|69111476|FG001|Overall Study|Withdrawal by Subject|2|||
37643399|NCT05718466|69111475|FG000|Overall Study|Death|0|||
37643400|NCT05718466|69111476|FG001|Overall Study|Death|1|||
37643401|NCT04938453|69111484|FG000|Washout Period 1|Adverse Event|1|||
37643402|NCT04938453|69111485|FG001|Washout Period 1|Adverse Event|0|||
37643403|NCT04938453|69111484|FG000|Washout Period 1|Physician Decision|0|||
37643404|NCT04938453|69111485|FG001|Washout Period 1|Physician Decision|1|||
37643405|NCT04147260|69111530|FG000|Overall Study|Adverse Event|1|||
37643406|NCT04147260|69111531|FG001|Overall Study|Adverse Event|0|||
37643407|NCT04147260|69111532|FG002|Overall Study|Adverse Event|1|||
37643408|NCT04147260|69111533|FG003|Overall Study|Adverse Event|2|||
37643409|NCT04147260|69111534|FG004|Overall Study|Adverse Event|0|||
37643410|NCT04147260|69111530|FG000|Overall Study|Withdrawal by Subject|0|||
37643411|NCT04147260|69111531|FG001|Overall Study|Withdrawal by Subject|0|||
37643412|NCT04147260|69111532|FG002|Overall Study|Withdrawal by Subject|1|||
37643413|NCT04147260|69111533|FG003|Overall Study|Withdrawal by Subject|1|||
37643414|NCT04147260|69111534|FG004|Overall Study|Withdrawal by Subject|0|||
37643415|NCT04134728|69111551|FG000|Overall Study|Adverse Event|3|||
37643416|NCT04134728|69111552|FG001|Overall Study|Adverse Event|2|||
37643417|NCT04134728|69111553|FG002|Overall Study|Adverse Event|9|||
37643418|NCT04134728|69111554|FG003|Overall Study|Adverse Event|0|||
37643419|NCT04134728|69111555|FG004|Overall Study|Adverse Event|0|||
37643420|NCT04134728|69111556|FG005|Overall Study|Adverse Event|0|||
37643421|NCT04134728|69111551|FG000|Overall Study|Lack of Efficacy|3|||
37643422|NCT04134728|69111552|FG001|Overall Study|Lack of Efficacy|3|||
37643423|NCT04134728|69111553|FG002|Overall Study|Lack of Efficacy|1|||
37643424|NCT04134728|69111554|FG003|Overall Study|Lack of Efficacy|2|||
37643425|NCT04134728|69111555|FG004|Overall Study|Lack of Efficacy|0|||
37643426|NCT04134728|69111556|FG005|Overall Study|Lack of Efficacy|0|||
37643427|NCT04134728|69111551|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
37643428|NCT04134728|69111552|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
37643429|NCT04134728|69111553|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
37643430|NCT04134728|69111554|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
37643431|NCT04134728|69111555|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
37643432|NCT04134728|69111556|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
37643433|NCT04134728|69111551|FG000|Overall Study|Protocol Deviation|0|||
37643434|NCT04134728|69111552|FG001|Overall Study|Protocol Deviation|0|||
37643435|NCT04134728|69111553|FG002|Overall Study|Protocol Deviation|1|||
37643436|NCT04134728|69111554|FG003|Overall Study|Protocol Deviation|0|||
37643437|NCT04134728|69111555|FG004|Overall Study|Protocol Deviation|0|||
37643438|NCT04134728|69111556|FG005|Overall Study|Protocol Deviation|0|||
37643439|NCT04134728|69111551|FG000|Overall Study|Informed Consent Withdrawn|3|||
37643440|NCT04134728|69111552|FG001|Overall Study|Informed Consent Withdrawn|6|||
37643441|NCT04134728|69111553|FG002|Overall Study|Informed Consent Withdrawn|8|||
37643442|NCT04134728|69111554|FG003|Overall Study|Informed Consent Withdrawn|1|||
37643443|NCT04134728|69111555|FG004|Overall Study|Informed Consent Withdrawn|1|||
37643444|NCT04134728|69111556|FG005|Overall Study|Informed Consent Withdrawn|0|||
37643445|NCT04134728|69111551|FG000|Overall Study|Physician Decision|2|||
37643446|NCT04134728|69111552|FG001|Overall Study|Physician Decision|0|||
37643447|NCT04134728|69111553|FG002|Overall Study|Physician Decision|0|||
37854449|NCT01232283|69537961|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
37643448|NCT04134728|69111554|FG003|Overall Study|Physician Decision|0|||
37643449|NCT04134728|69111555|FG004|Overall Study|Physician Decision|0|||
37643450|NCT04134728|69111556|FG005|Overall Study|Physician Decision|0|||
37643451|NCT04134728|69111551|FG000|Overall Study|Lost to Follow-up|1|||
37643452|NCT04134728|69111552|FG001|Overall Study|Lost to Follow-up|2|||
37643453|NCT04134728|69111553|FG002|Overall Study|Lost to Follow-up|1|||
37643454|NCT04134728|69111554|FG003|Overall Study|Lost to Follow-up|0|||
37643455|NCT04134728|69111555|FG004|Overall Study|Lost to Follow-up|0|||
37643456|NCT04134728|69111556|FG005|Overall Study|Lost to Follow-up|1|||
37922024|NCT00667576|69608832|FG002|Overall Study|Missed Visit|0|||
37643457|NCT04134728|69111551|FG000|Overall Study|Investigator Site Closed|0|||
37643458|NCT04134728|69111552|FG001|Overall Study|Investigator Site Closed|1|||
37643459|NCT04134728|69111553|FG002|Overall Study|Investigator Site Closed|1|||
37643460|NCT04134728|69111554|FG003|Overall Study|Investigator Site Closed|0|||
37643461|NCT04134728|69111555|FG004|Overall Study|Investigator Site Closed|0|||
37643462|NCT04134728|69111556|FG005|Overall Study|Investigator Site Closed|0|||
37643463|NCT03886272|69111590|FG000|Period 1|Withdrawal by Subject|0|||
37643464|NCT03886272|69111591|FG001|Period 1|Withdrawal by Subject|0|||
37643465|NCT03886272|69111592|FG002|Period 1|Withdrawal by Subject|0|||
37643466|NCT03886272|69111593|FG003|Period 1|Withdrawal by Subject|0|||
37643467|NCT03886272|69111594|FG004|Period 1|Withdrawal by Subject|0|||
37643468|NCT03886272|69111595|FG005|Period 1|Withdrawal by Subject|1|||
37643469|NCT03886272|69111596|FG006|Period 1|Withdrawal by Subject|0|||
37643470|NCT03732833|69111615|FG000|Overall Study|Adverse Event|0|||
37643471|NCT03732833|69111616|FG001|Overall Study|Adverse Event|3|||
37643472|NCT03732833|69111617|FG002|Overall Study|Adverse Event|1|||
37643473|NCT03732833|69111615|FG000|Overall Study|Withdrawal by Subject|11|||
37643474|NCT03732833|69111616|FG001|Overall Study|Withdrawal by Subject|13|||
37643475|NCT03732833|69111617|FG002|Overall Study|Withdrawal by Subject|8|||
37643476|NCT03732833|69111615|FG000|Overall Study|Lost to Follow-up|3|||
37643477|NCT03732833|69111616|FG001|Overall Study|Lost to Follow-up|5|||
37643478|NCT03732833|69111617|FG002|Overall Study|Lost to Follow-up|4|||
37643479|NCT03732833|69111615|FG000|Overall Study|Pregnancy|0|||
37643480|NCT03732833|69111616|FG001|Overall Study|Pregnancy|2|||
37643481|NCT03732833|69111617|FG002|Overall Study|Pregnancy|0|||
37643482|NCT03732833|69111615|FG000|Overall Study|Physician Decision|2|||
37643483|NCT03732833|69111616|FG001|Overall Study|Physician Decision|3|||
37643484|NCT03732833|69111617|FG002|Overall Study|Physician Decision|1|||
37643485|NCT03732833|69111615|FG000|Overall Study|Covid-19 related and other reasons|2|||
37643486|NCT03732833|69111616|FG001|Overall Study|Covid-19 related and other reasons|7|||
37643487|NCT03732833|69111617|FG002|Overall Study|Covid-19 related and other reasons|3|||
37643488|NCT03493919|69111634|FG000|Overall Study|Other|2|||
37643489|NCT03493919|69111635|FG001|Overall Study|Other|0|||
37643490|NCT03493919|69111636|FG002|Overall Study|Other|1|||
37643491|NCT03493919|69111637|FG003|Overall Study|Other|0|||
37643492|NCT03493919|69111634|FG000|Overall Study|Withdrawal by Subject|9|||
37643493|NCT03493919|69111635|FG001|Overall Study|Withdrawal by Subject|3|||
37643494|NCT03493919|69111636|FG002|Overall Study|Withdrawal by Subject|1|||
37643495|NCT03493919|69111637|FG003|Overall Study|Withdrawal by Subject|1|||
37643496|NCT03493919|69111634|FG000|Overall Study|Lost to Follow-up|5|||
37643497|NCT03493919|69111635|FG001|Overall Study|Lost to Follow-up|0|||
37643498|NCT03493919|69111636|FG002|Overall Study|Lost to Follow-up|0|||
37643499|NCT03493919|69111637|FG003|Overall Study|Lost to Follow-up|3|||
37643500|NCT03493919|69111634|FG000|Overall Study|Adverse Event|0|||
37643501|NCT03493919|69111635|FG001|Overall Study|Adverse Event|1|||
37643502|NCT03493919|69111636|FG002|Overall Study|Adverse Event|0|||
37643503|NCT03493919|69111637|FG003|Overall Study|Adverse Event|0|||
37643504|NCT03280628|69111655|FG000|Overall Study|Lost to Follow-up|8|||
37643505|NCT03280628|69111656|FG001|Overall Study|Lost to Follow-up|6|||
37643506|NCT03280628|69111657|FG002|Overall Study|Lost to Follow-up|11|||
37643507|NCT03058146|69111684|FG000|Overall Study|Withdrawal by Subject|4|||
37643508|NCT03058146|69111685|FG001|Overall Study|Withdrawal by Subject|1|||
37643509|NCT03058146|69111684|FG000|Overall Study|Coronavirus (COVID)-19 shutdown|0|||
37643510|NCT03058146|69111685|FG001|Overall Study|Coronavirus (COVID)-19 shutdown|1|||
37643511|NCT02851511|69111697|FG000|Overall (Phase I + Phase II)|Physician Decision|18|||
37643512|NCT02851511|69111698|FG001|Overall (Phase I + Phase II)|Physician Decision|16|||
37643513|NCT02851511|69111699|FG002|Overall (Phase I + Phase II)|Physician Decision|0|||
37643514|NCT02851511|69111700|FG003|Overall (Phase I + Phase II)|Physician Decision|1|||
37643515|NCT02851511|69111697|FG000|Overall (Phase I + Phase II)|Withdrawal by Subject|20|||
37643516|NCT02851511|69111698|FG001|Overall (Phase I + Phase II)|Withdrawal by Subject|17|||
37643517|NCT02851511|69111699|FG002|Overall (Phase I + Phase II)|Withdrawal by Subject|0|||
37643518|NCT02851511|69111700|FG003|Overall (Phase I + Phase II)|Withdrawal by Subject|3|||
37643519|NCT02851511|69111697|FG000|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|4|||
37643520|NCT02851511|69111698|FG001|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|5|||
37643521|NCT02851511|69111699|FG002|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
37643522|NCT02851511|69111700|FG003|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
37643523|NCT02851511|69111697|FG000|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
37643524|NCT02851511|69111698|FG001|Overall (Phase I + Phase II)|Lost to Follow-up|1|||
37643525|NCT02851511|69111699|FG002|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
37643526|NCT02851511|69111700|FG003|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
37643527|NCT02851511|69111697|FG000|Phase I|Physician Decision|0|||
37643528|NCT02851511|69111698|FG001|Phase I|Physician Decision|0|||
37643529|NCT02851511|69111699|FG002|Phase I|Physician Decision|0|||
37643530|NCT02851511|69111700|FG003|Phase I|Physician Decision|1|||
37643531|NCT02851511|69111697|FG000|Phase I|Withdrawal by Subject|2|||
37643532|NCT02851511|69111698|FG001|Phase I|Withdrawal by Subject|1|||
37643533|NCT02851511|69111699|FG002|Phase I|Withdrawal by Subject|0|||
37643534|NCT02851511|69111700|FG003|Phase I|Withdrawal by Subject|3|||
37643535|NCT02851511|69111697|FG000|Phase II|Physician Decision|18|||
37643536|NCT02851511|69111698|FG001|Phase II|Physician Decision|16|||
37643537|NCT02851511|69111699|FG002|Phase II|Physician Decision|0|||
37643538|NCT02851511|69111700|FG003|Phase II|Physician Decision|0|||
37643539|NCT02851511|69111697|FG000|Phase II|Withdrawal by Subject|18|||
37643540|NCT02851511|69111698|FG001|Phase II|Withdrawal by Subject|16|||
37643541|NCT02851511|69111699|FG002|Phase II|Withdrawal by Subject|0|||
37643542|NCT02851511|69111700|FG003|Phase II|Withdrawal by Subject|0|||
37643543|NCT02851511|69111697|FG000|Phase II|COVID-19 lockdown, no reason specified|4|||
37643544|NCT02851511|69111698|FG001|Phase II|COVID-19 lockdown, no reason specified|5|||
37643545|NCT02851511|69111699|FG002|Phase II|COVID-19 lockdown, no reason specified|0|||
37643546|NCT02851511|69111700|FG003|Phase II|COVID-19 lockdown, no reason specified|0|||
37643547|NCT02851511|69111697|FG000|Phase II|Lost to Follow-up|0|||
37643548|NCT02851511|69111698|FG001|Phase II|Lost to Follow-up|1|||
37643549|NCT02851511|69111699|FG002|Phase II|Lost to Follow-up|0|||
37643550|NCT02851511|69111700|FG003|Phase II|Lost to Follow-up|0|||
37643551|NCT02478320|69111721|FG000|Overall Study|Adverse Event|2|||
37643552|NCT02478320|69111722|FG001|Overall Study|Adverse Event|0|||
37643553|NCT02478320|69111721|FG000|Overall Study|Death|1|||
37643554|NCT02478320|69111722|FG001|Overall Study|Death|0|||
37643555|NCT02478320|69111721|FG000|Overall Study|Lack of Efficacy|4|||
37643556|NCT02478320|69111722|FG001|Overall Study|Lack of Efficacy|0|||
37643557|NCT02478320|69111721|FG000|Overall Study|Withdrawal by Subject|2|||
37643558|NCT02478320|69111722|FG001|Overall Study|Withdrawal by Subject|0|||
37643559|NCT02478320|69111721|FG000|Overall Study|Screen Failure|3|||
37643560|NCT02478320|69111722|FG001|Overall Study|Screen Failure|0|||
37643561|NCT02252042|69111747|FG000|Overall Study|Adverse Event|9|||
37643562|NCT02252042|69111748|FG001|Overall Study|Adverse Event|6|||
37643563|NCT02252042|69111747|FG000|Overall Study|Death|209|||
37643564|NCT02252042|69111748|FG001|Overall Study|Death|217|||
37643565|NCT02252042|69111747|FG000|Overall Study|Physician Decision|0|||
37643566|NCT02252042|69111748|FG001|Overall Study|Physician Decision|2|||
37643567|NCT02252042|69111747|FG000|Overall Study|Transferred to Extension Study|7|||
37643568|NCT02252042|69111748|FG001|Overall Study|Transferred to Extension Study|1|||
37643569|NCT02252042|69111747|FG000|Overall Study|Did Not Continue on Extension Study|7|||
37643570|NCT02252042|69111748|FG001|Overall Study|Did Not Continue on Extension Study|2|||
37643571|NCT02252042|69111747|FG000|Overall Study|Withdrawal by Subject|15|||
37643572|NCT02252042|69111748|FG001|Overall Study|Withdrawal by Subject|20|||
37643573|NCT00378482|69111775|FG000|Overall Study|Lost to Follow-up|1|||
37643574|NCT00378482|69111775|FG000|Overall Study|Lack of Efficacy|8|||
37643575|NCT00378482|69111775|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
37643576|NCT00378482|69111775|FG000|Overall Study|Withdrawal by Subject|4|||
37643577|NCT00378482|69111775|FG000|Overall Study|Adverse Event|9|||
37643578|NCT05288673|69111782|FG000|Overall Study|Consent withdrawn by subject|0|||
37643579|NCT05288673|69111783|FG001|Overall Study|Consent withdrawn by subject|0|||
37643580|NCT05288673|69111784|FG002|Overall Study|Consent withdrawn by subject|1|||
37643581|NCT04604795|69111830|FG000|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
37643582|NCT04604795|69111831|FG001|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
37643583|NCT04604795|69111832|FG002|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
37643584|NCT04604795|69111833|FG003|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
37643585|NCT04604795|69111834|FG004|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
37643586|NCT04604795|69111835|FG005|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
37643587|NCT04604795|69111836|FG006|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
37643588|NCT04604795|69111837|FG007|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
37643589|NCT04604795|69111838|FG008|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
37643590|NCT04604795|69111839|FG009|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
37643591|NCT04604795|69111830|FG000|Part B: Up to Day 14|Adverse Event|0|||
37643592|NCT04604795|69111831|FG001|Part B: Up to Day 14|Adverse Event|0|||
37643593|NCT04604795|69111832|FG002|Part B: Up to Day 14|Adverse Event|0|||
37643594|NCT04604795|69111833|FG003|Part B: Up to Day 14|Adverse Event|0|||
37643595|NCT04604795|69111834|FG004|Part B: Up to Day 14|Adverse Event|2|||
37643596|NCT04604795|69111835|FG005|Part B: Up to Day 14|Adverse Event|1|||
37643597|NCT04604795|69111836|FG006|Part B: Up to Day 14|Adverse Event|0|||
37643598|NCT04604795|69111837|FG007|Part B: Up to Day 14|Adverse Event|0|||
37643599|NCT04604795|69111838|FG008|Part B: Up to Day 14|Adverse Event|0|||
37643600|NCT04604795|69111839|FG009|Part B: Up to Day 14|Adverse Event|0|||
37643601|NCT04604795|69111830|FG000|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
37643602|NCT04604795|69111831|FG001|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
37643603|NCT04604795|69111832|FG002|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
37643604|NCT04604795|69111833|FG003|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
37643605|NCT04604795|69111834|FG004|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
37643606|NCT04604795|69111835|FG005|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
37643607|NCT04604795|69111836|FG006|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
37643608|NCT04604795|69111837|FG007|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
37643609|NCT04604795|69111838|FG008|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
37643610|NCT04604795|69111839|FG009|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|1|||
37643611|NCT04604795|69111830|FG000|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
37643612|NCT04604795|69111831|FG001|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
37643613|NCT04604795|69111832|FG002|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
37643614|NCT04604795|69111833|FG003|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
37643615|NCT04604795|69111834|FG004|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
37643616|NCT04604795|69111835|FG005|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
37643617|NCT04604795|69111836|FG006|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
37643618|NCT04604795|69111837|FG007|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
37643619|NCT04604795|69111838|FG008|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|1|||
37643620|NCT04604795|69111839|FG009|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
37643621|NCT04604795|69111830|FG000|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
37643622|NCT04604795|69111831|FG001|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
37643623|NCT04604795|69111832|FG002|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
37643624|NCT04604795|69111833|FG003|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
37643625|NCT04604795|69111834|FG004|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
37643626|NCT04604795|69111835|FG005|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
37643627|NCT04604795|69111836|FG006|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
37643628|NCT04604795|69111837|FG007|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
37643629|NCT04604795|69111838|FG008|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|1|||
37643630|NCT04604795|69111839|FG009|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
37643631|NCT04604795|69111830|FG000|Part C: Period 5 (Day 1)|Adverse Event|0|||
37643632|NCT04604795|69111831|FG001|Part C: Period 5 (Day 1)|Adverse Event|0|||
37643633|NCT04604795|69111832|FG002|Part C: Period 5 (Day 1)|Adverse Event|0|||
37643634|NCT04604795|69111833|FG003|Part C: Period 5 (Day 1)|Adverse Event|0|||
37643635|NCT04604795|69111834|FG004|Part C: Period 5 (Day 1)|Adverse Event|0|||
37643636|NCT04604795|69111835|FG005|Part C: Period 5 (Day 1)|Adverse Event|0|||
37643637|NCT04604795|69111836|FG006|Part C: Period 5 (Day 1)|Adverse Event|0|||
37643638|NCT04604795|69111837|FG007|Part C: Period 5 (Day 1)|Adverse Event|0|||
37643639|NCT04604795|69111838|FG008|Part C: Period 5 (Day 1)|Adverse Event|1|||
37643640|NCT04604795|69111839|FG009|Part C: Period 5 (Day 1)|Adverse Event|0|||
37643641|NCT04314284|69111935|FG000|Overall Study|Withdrawal by Subject|4|||
37643642|NCT04314284|69111936|FG001|Overall Study|Withdrawal by Subject|7|||
37643643|NCT04314284|69111935|FG000|Overall Study|Consented but did not complete survey|0|||
37643644|NCT04314284|69111936|FG001|Overall Study|Consented but did not complete survey|6|||
37643645|NCT04203823|69111944|FG000|Overall Study|Withdrawal by Subject|2|||
37643646|NCT04203823|69111945|FG001|Overall Study|Withdrawal by Subject|2|||
37643647|NCT04203823|69111944|FG000|Overall Study|Adverse Event|1|||
37643648|NCT04203823|69111945|FG001|Overall Study|Adverse Event|1|||
37643649|NCT04203823|69111944|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
37643650|NCT04203823|69111945|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
37643651|NCT03703466|69111998|FG000|Overall Study|Death|2|||
37643652|NCT03703466|69111999|FG001|Overall Study|Death|1|||
37643653|NCT03703466|69112000|FG002|Overall Study|Death|0|||
37643654|NCT03703466|69111998|FG000|Overall Study|Protocol Violation|1|||
37643655|NCT03703466|69111999|FG001|Overall Study|Protocol Violation|0|||
37643656|NCT03703466|69112000|FG002|Overall Study|Protocol Violation|0|||
37643657|NCT03703466|69111998|FG000|Overall Study|Withdrawal by Subject|0|||
37643658|NCT03703466|69111999|FG001|Overall Study|Withdrawal by Subject|3|||
37643659|NCT03703466|69112000|FG002|Overall Study|Withdrawal by Subject|0|||
37643660|NCT03703466|69111998|FG000|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|1|||
37643661|NCT03703466|69111999|FG001|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|2|||
37643662|NCT03703466|69112000|FG002|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|2|||
37643663|NCT03248128|69112059|FG000|Overall Study|Lost to Follow-up|1|||
37643664|NCT03248128|69112060|FG001|Overall Study|Lost to Follow-up|0|||
37643665|NCT03248128|69112059|FG000|Overall Study|Withdrawal by Subject|16|||
37643666|NCT03248128|69112060|FG001|Overall Study|Withdrawal by Subject|14|||
37643667|NCT03248128|69112059|FG000|Overall Study|Site Closed|4|||
37643668|NCT03248128|69112060|FG001|Overall Study|Site Closed|3|||
37643669|NCT03248128|69112059|FG000|Overall Study|Randomized, but did not receive treatment|1|||
37643670|NCT03248128|69112060|FG001|Overall Study|Randomized, but did not receive treatment|3|||
37643671|NCT02802631|69112103|FG000|Overall Study|Withdrawal by Subject|1|||
37643672|NCT02802631|69112104|FG001|Overall Study|Withdrawal by Subject|0|||
37643673|NCT02802631|69112105|FG002|Overall Study|Withdrawal by Subject|0|||
37643674|NCT02802631|69112106|FG003|Overall Study|Withdrawal by Subject|0|||
37643675|NCT02802631|69112107|FG004|Overall Study|Withdrawal by Subject|0|||
37643676|NCT02802631|69112108|FG005|Overall Study|Withdrawal by Subject|0|||
37643677|NCT02802631|69112109|FG006|Overall Study|Withdrawal by Subject|0|||
37643678|NCT02802631|69112110|FG007|Overall Study|Withdrawal by Subject|0|||
37643679|NCT02802631|69112103|FG000|Overall Study|Physician Decision|1|||
37643680|NCT02802631|69112104|FG001|Overall Study|Physician Decision|0|||
37643681|NCT02802631|69112105|FG002|Overall Study|Physician Decision|0|||
37643682|NCT02802631|69112106|FG003|Overall Study|Physician Decision|0|||
37643683|NCT02802631|69112107|FG004|Overall Study|Physician Decision|0|||
37643684|NCT02802631|69112108|FG005|Overall Study|Physician Decision|0|||
37643685|NCT02802631|69112109|FG006|Overall Study|Physician Decision|1|||
37643686|NCT02802631|69112110|FG007|Overall Study|Physician Decision|0|||
37643687|NCT02802631|69112103|FG000|Overall Study|Adverse Event|0|||
37643688|NCT02802631|69112104|FG001|Overall Study|Adverse Event|2|||
37643689|NCT02802631|69112105|FG002|Overall Study|Adverse Event|0|||
37643690|NCT02802631|69112106|FG003|Overall Study|Adverse Event|1|||
37643691|NCT02802631|69112107|FG004|Overall Study|Adverse Event|6|||
37643692|NCT02802631|69112108|FG005|Overall Study|Adverse Event|1|||
37643693|NCT02802631|69112109|FG006|Overall Study|Adverse Event|4|||
37643694|NCT02802631|69112110|FG007|Overall Study|Adverse Event|0|||
37643695|NCT02802631|69112103|FG000|Overall Study|Sponsor Decision|0|||
37643696|NCT02802631|69112104|FG001|Overall Study|Sponsor Decision|0|||
37643697|NCT02802631|69112105|FG002|Overall Study|Sponsor Decision|6|||
37643698|NCT02802631|69112106|FG003|Overall Study|Sponsor Decision|0|||
37643699|NCT02802631|69112107|FG004|Overall Study|Sponsor Decision|2|||
37643700|NCT02802631|69112108|FG005|Overall Study|Sponsor Decision|0|||
37643701|NCT02802631|69112109|FG006|Overall Study|Sponsor Decision|0|||
37643702|NCT02802631|69112110|FG007|Overall Study|Sponsor Decision|4|||
37643703|NCT02754479|69112142|FG000|Overall Study|Lost to Follow-up|1|||
37643704|NCT02036476|69112155|FG000|Overall Study|Withdrawal by Subject|2|||
37643705|NCT02036476|69112155|FG000|Overall Study|Progressive Disease|4|||
37643706|NCT02036476|69112155|FG000|Overall Study|Unacceptable Toxicity|2|||
37643707|NCT00643994|69112195|FG000|Overall Study|Death|24|||
37643708|NCT00643994|69112195|FG000|Overall Study|Lost to Follow-up|72|||
37643709|NCT00643617|69112201|FG000|Overall Study|Death|6|||
37643710|NCT00643617|69112202|FG001|Overall Study|Death|9|||
37643711|NCT00643617|69112201|FG000|Overall Study|Lost to Follow-up|42|||
37643712|NCT00643617|69112202|FG001|Overall Study|Lost to Follow-up|51|||
37643713|NCT00504582|69112229|FG000|Overall Study|Lost to Follow-up|1|||
37643714|NCT00504582|69112230|FG001|Overall Study|Lost to Follow-up|0|||
37643715|NCT00504582|69112231|FG002|Overall Study|Lost to Follow-up|0|||
37643716|NCT00314366|69112254|FG000|Overall Study|not treated due to patient medical condi|1|||
37643717|NCT00314366|69112255|FG001|Overall Study|not treated due to patient medical condi|0|||
37643718|NCT01595061|69112264|FG000|Overall Study|Never Treated|3|||
37643719|NCT01595061|69112264|FG000|Overall Study|Inadequate Pathology|1|||
37643720|NCT02852005|69112285|FG000|Overall Study|Lost to Follow-up|0|||
37643721|NCT02852005|69112286|FG001|Overall Study|Lost to Follow-up|0|||
37643722|NCT02852005|69112287|FG002|Overall Study|Lost to Follow-up|0|||
37643723|NCT02852005|69112288|FG003|Overall Study|Lost to Follow-up|0|||
37643724|NCT02852005|69112289|FG004|Overall Study|Lost to Follow-up|1|||
37643725|NCT02852005|69112285|FG000|Overall Study|Withdrawal by Subject|1|||
37643726|NCT02852005|69112286|FG001|Overall Study|Withdrawal by Subject|0|||
37643727|NCT02852005|69112287|FG002|Overall Study|Withdrawal by Subject|0|||
37643728|NCT02852005|69112288|FG003|Overall Study|Withdrawal by Subject|0|||
37643729|NCT02852005|69112289|FG004|Overall Study|Withdrawal by Subject|0|||
37643730|NCT02851615|69112305|FG000|Overall Study|Cognitive Issue|1|||
37643731|NCT02851615|69112306|FG001|Overall Study|Cognitive Issue|0|||
37643732|NCT02851615|69112305|FG000|Overall Study|Lost to Follow-up|0|||
37643733|NCT02851615|69112306|FG001|Overall Study|Lost to Follow-up|4|||
37643734|NCT02849743|69112315|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
37643735|NCT02849743|69112316|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
37643736|NCT02849743|69112315|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
37643737|NCT02849743|69112316|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
37643738|NCT02851069|69112351|FG000|Overall Study|Failure to Return|3|||
37643739|NCT02851069|69112351|FG000|Overall Study|Other|3|||
37643740|NCT02849509|69112359|FG000|Overall Study|Worsening of disease under study|1|||
37643741|NCT02849509|69112360|FG001|Overall Study|Worsening of disease under study|1|||
37643742|NCT02849509|69112361|FG002|Overall Study|Worsening of disease under study|1|||
37643743|NCT02849509|69112359|FG000|Overall Study|Worsening of other pre-existing disease|0|||
37643744|NCT02849509|69112360|FG001|Overall Study|Worsening of other pre-existing disease|1|||
37922025|NCT00667576|69608833|FG003|Overall Study|Missed Visit|1|||
37643745|NCT02849509|69112361|FG002|Overall Study|Worsening of other pre-existing disease|2|||
37922026|NCT00667576|69608834|FG004|Overall Study|Missed Visit|0|||
37643746|NCT02849509|69112359|FG000|Overall Study|Other adverse event|36|||
37643747|NCT02849509|69112360|FG001|Overall Study|Other adverse event|41|||
37643748|NCT02849509|69112361|FG002|Overall Study|Other adverse event|8|||
37643749|NCT02849509|69112359|FG000|Overall Study|Withdrawal by Subject|6|||
37643750|NCT02849509|69112360|FG001|Overall Study|Withdrawal by Subject|17|||
37643751|NCT02849509|69112361|FG002|Overall Study|Withdrawal by Subject|12|||
37643752|NCT02849509|69112359|FG000|Overall Study|Lost to Follow-up|27|||
37643753|NCT02849509|69112360|FG001|Overall Study|Lost to Follow-up|67|||
37922027|NCT00666718|69608848|FG000|Overall Study|Adverse Event|0|||
37643754|NCT02849509|69112361|FG002|Overall Study|Lost to Follow-up|36|||
37643755|NCT02849509|69112359|FG000|Overall Study|Other, reason not specified|14|||
37643756|NCT02849509|69112360|FG001|Overall Study|Other, reason not specified|29|||
37643757|NCT02849509|69112361|FG002|Overall Study|Other, reason not specified|25|||
37643758|NCT02849509|69112359|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
37643759|NCT02849509|69112360|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
37643760|NCT02849509|69112361|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
37643761|NCT02848729|69112373|FG000|Overall Study|Withdrawal by Subject|1|||
37643762|NCT02848729|69112374|FG001|Overall Study|Withdrawal by Subject|0|||
37643763|NCT02848729|69112373|FG000|Overall Study|Emesis|15|||
37643764|NCT02848729|69112374|FG001|Overall Study|Emesis|11|||
37643765|NCT00158756|69112392|FG000|Overall Study|Withdrawal by Subject|5|||
37643766|NCT00158756|69112393|FG001|Overall Study|Withdrawal by Subject|0|||
37643767|NCT00158756|69112394|FG002|Overall Study|Withdrawal by Subject|6|||
37643768|NCT00158756|69112395|FG003|Overall Study|Withdrawal by Subject|1|||
37643769|NCT00158756|69112396|FG004|Overall Study|Withdrawal by Subject|3|||
37643770|NCT00158756|69112392|FG000|Overall Study|Adverse Event|0|||
37643771|NCT00158756|69112393|FG001|Overall Study|Adverse Event|0|||
37643772|NCT00158756|69112394|FG002|Overall Study|Adverse Event|1|||
37643773|NCT00158756|69112395|FG003|Overall Study|Adverse Event|0|||
37643774|NCT00158756|69112396|FG004|Overall Study|Adverse Event|0|||
37643775|NCT00158756|69112392|FG000|Overall Study|Serious adverse event|0|||
37643776|NCT00158756|69112393|FG001|Overall Study|Serious adverse event|0|||
37643777|NCT00158756|69112394|FG002|Overall Study|Serious adverse event|1|||
37643778|NCT00158756|69112395|FG003|Overall Study|Serious adverse event|0|||
37643779|NCT00158756|69112396|FG004|Overall Study|Serious adverse event|0|||
37643780|NCT02730195|69112408|FG000|Overall Study|Withdrawal by Subject|1|||
37643781|NCT02730351|69112416|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
37643782|NCT02730351|69112417|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
37643783|NCT02730351|69112416|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
37740925|NCT01878253|69226861|FG000|Overall Study|Lost to Follow-up|2|||
37740926|NCT01878253|69226861|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
37740927|NCT01878175|69226870|FG000|Overall Study|Developed contraindicated health problem|2|||
37740928|NCT01878097|69226877|FG000|Baseline|Surveys not fully completed|2497|||
37740929|NCT01878097|69226878|FG001|Baseline|Surveys not fully completed|1800|||
37740930|NCT01878097|69226877|FG000|Implementation Year 1|Surveys not fully completed|3202|||
37740931|NCT01878097|69226878|FG001|Implementation Year 1|Surveys not fully completed|2549|||
37740932|NCT01878097|69226877|FG000|Implementation Year 2|Surveys not fully completed|3281|||
37740933|NCT01878097|69226878|FG001|Implementation Year 2|Surveys not fully completed|2841|||
37740934|NCT01878097|69226877|FG000|Implementation Year 3|Surveys not fully completed|3494|||
37740935|NCT01878097|69226878|FG001|Implementation Year 3|Surveys not fully completed|2980|||
37740936|NCT01878097|69226877|FG000|Implementation Year 4|Surveys not fully completed|3604|||
37740937|NCT01878097|69226878|FG001|Implementation Year 4|Surveys not fully completed|3007|||
37740938|NCT01750190|69226886|FG000|Overall Study|Adverse Event|47|||
37740939|NCT01750190|69226887|FG001|Overall Study|Adverse Event|19|||
37740940|NCT01750190|69226886|FG000|Overall Study|Death|38|||
37740941|NCT01750190|69226887|FG001|Overall Study|Death|11|||
37740942|NCT01750190|69226886|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
37740943|NCT01750190|69226887|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
37740944|NCT01750190|69226886|FG000|Overall Study|Lost to Follow-up|28|||
37740945|NCT01750190|69226887|FG001|Overall Study|Lost to Follow-up|7|||
37740946|NCT01750190|69226886|FG000|Overall Study|Physician Decision|16|||
37740947|NCT01750190|69226887|FG001|Overall Study|Physician Decision|17|||
37740948|NCT01750190|69226886|FG000|Overall Study|Protocol Violation|6|||
37740949|NCT01750190|69226887|FG001|Overall Study|Protocol Violation|5|||
37740950|NCT01750190|69226886|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
37740951|NCT01750190|69226887|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
37740952|NCT01750190|69226886|FG000|Overall Study|Withdrawal by Subject|83|||
37740953|NCT01750190|69226887|FG001|Overall Study|Withdrawal by Subject|89|||
37740954|NCT01750190|69226886|FG000|Overall Study|Kidney Transplant|8|||
37643784|NCT02730351|69112417|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
37643785|NCT02730351|69112416|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
37643786|NCT02730351|69112417|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
37740955|NCT01750190|69226887|FG001|Overall Study|Kidney Transplant|4|||
37740956|NCT01750190|69226886|FG000|Overall Study|Dialysis|22|||
37740957|NCT01750190|69226887|FG001|Overall Study|Dialysis|8|||
37740958|NCT01750190|69226886|FG000|Overall Study|Other than Specified|13|||
37740959|NCT01750190|69226887|FG001|Overall Study|Other than Specified|4|||
37740960|NCT01831765|69226896|FG000|Overall Study|Lack of Efficacy|1|||
37922028|NCT00666718|69608849|FG001|Overall Study|Adverse Event|1|||
37740961|NCT01831765|69226897|FG001|Overall Study|Lack of Efficacy|0|||
37740962|NCT01831765|69226898|FG002|Overall Study|Lack of Efficacy|0|||
37740963|NCT01831765|69226896|FG000|Overall Study|Other, sponsor withdrew subject|0|||
37740964|NCT01831765|69226897|FG001|Overall Study|Other, sponsor withdrew subject|1|||
37643787|NCT02730351|69112416|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
37643788|NCT02730351|69112417|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
37643789|NCT02730351|69112416|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
37643790|NCT02730351|69112417|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
37643791|NCT01376349|69112426|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
37643792|NCT01376349|69112427|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
37643793|NCT01376349|69112428|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
37643794|NCT01376349|69112426|FG000|Raondomized Treatment|Adverse Event|13|||
37643795|NCT01376349|69112427|FG001|Raondomized Treatment|Adverse Event|17|||
37643796|NCT01376349|69112428|FG002|Raondomized Treatment|Adverse Event|14|||
37643797|NCT01376349|69112426|FG000|Raondomized Treatment|Unkown|1|||
37643798|NCT01376349|69112427|FG001|Raondomized Treatment|Unkown|2|||
37643799|NCT01376349|69112428|FG002|Raondomized Treatment|Unkown|1|||
37643800|NCT01376349|69112426|FG000|Raondomized Treatment|Alternative Treatment|0|||
37643801|NCT01376349|69112427|FG001|Raondomized Treatment|Alternative Treatment|0|||
37643802|NCT01376349|69112428|FG002|Raondomized Treatment|Alternative Treatment|1|||
37643803|NCT00158600|69112466|FG000|Overall Study|unable to commit time to study|0|||
37643804|NCT00158600|69112467|FG001|Overall Study|unable to commit time to study|1|||
37643805|NCT00158600|69112466|FG000|Overall Study|Adverse Event|2|||
37643806|NCT00158600|69112467|FG001|Overall Study|Adverse Event|1|||
37643807|NCT00158600|69112466|FG000|Overall Study|Death|1|||
37643808|NCT00158600|69112467|FG001|Overall Study|Death|0|||
37643809|NCT00158600|69112466|FG000|Overall Study|Withdrawal by Subject|2|||
37643810|NCT00158600|69112467|FG001|Overall Study|Withdrawal by Subject|2|||
37643811|NCT01680458|69112474|FG000|Overall Study|Protocol Violation|3|||
37643812|NCT04543136|69112478|FG000|Overall Study|Withdrawal by Subject|0|||
37643813|NCT04543136|69112479|FG001|Overall Study|Withdrawal by Subject|1|||
37643814|NCT04543136|69112480|FG002|Overall Study|Withdrawal by Subject|0|||
37643815|NCT04543136|69112481|FG003|Overall Study|Withdrawal by Subject|1|||
37643816|NCT04543136|69112482|FG004|Overall Study|Withdrawal by Subject|0|||
37643817|NCT04543136|69112483|FG005|Overall Study|Withdrawal by Subject|0|||
37643818|NCT00709761|69112491|FG000|Overall Study|Withdrawal by Subject|8|||
37643819|NCT00709761|69112491|FG000|Overall Study|study closed/terminated|17|||
37643820|NCT00709761|69112491|FG000|Overall Study|Lost to Follow-up|2|||
37643821|NCT02848651|69112501|FG000|Overall Study|Death|85|||
37643822|NCT02848651|69112501|FG000|Overall Study|Lost to Follow-up|1|||
37643823|NCT02848651|69112501|FG000|Overall Study|Non-Compliance|1|||
37643824|NCT02848651|69112501|FG000|Overall Study|Symptomatic Deterioration|1|||
37643825|NCT02848651|69112501|FG000|Overall Study|Physician Decision|4|||
37643826|NCT02848651|69112501|FG000|Overall Study|Withdrawal by Subject|14|||
37643827|NCT00709059|69112521|FG000|Overall Study|Lost to Follow-up|34|||
37643828|NCT00709059|69112521|FG000|Overall Study|Withdrawal by Subject|19|||
37643829|NCT00709059|69112521|FG000|Overall Study|Physician Decision|7|||
37643830|NCT00709059|69112521|FG000|Overall Study|Disease complication|3|||
37643831|NCT00709059|69112521|FG000|Overall Study|Side effects|20|||
37643832|NCT00709059|69112521|FG000|Overall Study|Serious side effects|11|||
37643833|NCT01678820|69112528|FG000|Overall Study|Study Terminated by Sponsor|45|||
37643834|NCT01678820|69112529|FG001|Overall Study|Study Terminated by Sponsor|43|||
37643835|NCT01678820|69112530|FG002|Overall Study|Study Terminated by Sponsor|43|||
37643836|NCT01678820|69112528|FG000|Overall Study|Withdrawal by Subject|2|||
37643837|NCT01678820|69112529|FG001|Overall Study|Withdrawal by Subject|5|||
37643838|NCT01678820|69112530|FG002|Overall Study|Withdrawal by Subject|2|||
37643839|NCT01678820|69112528|FG000|Overall Study|Protocol Specified Criteria|2|||
37643840|NCT01678820|69112529|FG001|Overall Study|Protocol Specified Criteria|3|||
37643841|NCT01678820|69112530|FG002|Overall Study|Protocol Specified Criteria|1|||
37643842|NCT01678820|69112528|FG000|Overall Study|Adverse Event|2|||
37643843|NCT01678820|69112529|FG001|Overall Study|Adverse Event|2|||
37643844|NCT01678820|69112530|FG002|Overall Study|Adverse Event|2|||
37643845|NCT01678820|69112528|FG000|Overall Study|Lost to Follow-up|7|||
37643846|NCT01678820|69112529|FG001|Overall Study|Lost to Follow-up|2|||
37643847|NCT01678820|69112530|FG002|Overall Study|Lost to Follow-up|2|||
37643848|NCT01678820|69112528|FG000|Overall Study|Non-compliance with study drug|0|||
37643849|NCT01678820|69112529|FG001|Overall Study|Non-compliance with study drug|1|||
37643850|NCT01678820|69112530|FG002|Overall Study|Non-compliance with study drug|0|||
37643851|NCT01678820|69112528|FG000|Overall Study|Physician Decision|0|||
37854450|NCT01232283|69537952|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
37854451|NCT01232283|69537953|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
37854452|NCT01232283|69537954|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
37854453|NCT01232283|69537955|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
37854454|NCT01232283|69537956|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
37643852|NCT01678820|69112529|FG001|Overall Study|Physician Decision|0|||
37643853|NCT01678820|69112530|FG002|Overall Study|Physician Decision|1|||
37643854|NCT01678820|69112528|FG000|Overall Study|Protocol Violation|4|||
37643855|NCT01678820|69112529|FG001|Overall Study|Protocol Violation|5|||
37643856|NCT01678820|69112530|FG002|Overall Study|Protocol Violation|4|||
37643857|NCT01678820|69112528|FG000|Overall Study|Not treated with double-blind study drug|0|||
37643858|NCT01678820|69112529|FG001|Overall Study|Not treated with double-blind study drug|2|||
37643859|NCT01678820|69112530|FG002|Overall Study|Not treated with double-blind study drug|2|||
37643860|NCT02660138|69112542|FG000|Overall Study|Adverse Event|0|||
37643861|NCT02660138|69112543|FG001|Overall Study|Adverse Event|3|||
37643862|NCT02660138|69112544|FG002|Overall Study|Adverse Event|2|||
37643863|NCT02660138|69112542|FG000|Overall Study|Lack of Efficacy|1|||
37643864|NCT02660138|69112543|FG001|Overall Study|Lack of Efficacy|2|||
37643865|NCT02660138|69112544|FG002|Overall Study|Lack of Efficacy|1|||
37643866|NCT02660138|69112542|FG000|Overall Study|Withdrawal by Subject|7|||
37643867|NCT02660138|69112543|FG001|Overall Study|Withdrawal by Subject|6|||
37643868|NCT02660138|69112544|FG002|Overall Study|Withdrawal by Subject|6|||
37643869|NCT02660138|69112542|FG000|Overall Study|Lost to Follow-up|4|||
37643870|NCT02660138|69112543|FG001|Overall Study|Lost to Follow-up|4|||
37643871|NCT02660138|69112544|FG002|Overall Study|Lost to Follow-up|1|||
37643872|NCT02660138|69112542|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
37643873|NCT02660138|69112543|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
37643874|NCT02660138|69112544|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
37643875|NCT02660138|69112542|FG000|Overall Study|Other|1|||
37643876|NCT02660138|69112543|FG001|Overall Study|Other|1|||
37643877|NCT02660138|69112544|FG002|Overall Study|Other|0|||
37643878|NCT02660138|69112542|FG000|Overall Study|Not treated|0|||
37643879|NCT02660138|69112543|FG001|Overall Study|Not treated|1|||
37643880|NCT02660138|69112544|FG002|Overall Study|Not treated|0|||
37643881|NCT01603394|69112555|FG000|Overall Study|Adverse Event|1|||
37643882|NCT02729025|69112561|FG000|Overall Study|Sponsor Decision|0|||
37643883|NCT02729025|69112562|FG001|Overall Study|Sponsor Decision|1|||
37643884|NCT01603082|69112570|FG000|Overall Study|Adverse Event|0|||
37643885|NCT01603082|69112571|FG001|Overall Study|Adverse Event|1|||
37643886|NCT01603082|69112570|FG000|Overall Study|Withdrawal by Subject|1|||
37643887|NCT01603082|69112571|FG001|Overall Study|Withdrawal by Subject|0|||
37643888|NCT01603082|69112570|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
37643889|NCT01603082|69112571|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
37643890|NCT02846779|69112584|FG000|Overall Study|Lost Enrollment|83|||
37643891|NCT02846779|69112585|FG001|Overall Study|Lost Enrollment|82|||
37643892|NCT02846779|69112586|FG002|Overall Study|Lost Enrollment|86|||
37643893|NCT02846779|69112584|FG000|Overall Study|Less than 31 days of follow-up|56|||
37643894|NCT02846779|69112585|FG001|Overall Study|Less than 31 days of follow-up|45|||
37643895|NCT02846779|69112586|FG002|Overall Study|Less than 31 days of follow-up|52|||
37643896|NCT00406393|69112596|FG000|Overall Study|Did not undergo transplantation|2|||
37643897|NCT00406393|69112597|FG001|Overall Study|Did not undergo transplantation|1|||
37643898|NCT02845375|69112606|FG000|Overall Study|upper airway obstruction|1|||
37643899|NCT02845375|69112607|FG001|Overall Study|upper airway obstruction|2|||
37643900|NCT02845375|69112608|FG002|Overall Study|upper airway obstruction|1|||
37643901|NCT02658734|69112616|FG000|Overall Study|Adverse Event|2|||
37643902|NCT02658734|69112616|FG000|Overall Study|Death|4|||
37643903|NCT02658734|69112616|FG000|Overall Study|Lost to Follow-up|7|||
37643904|NCT02658734|69112616|FG000|Overall Study|Withdrawal of Consent|16|||
37643905|NCT02658734|69112616|FG000|Overall Study|Disease Progression|28|||
37643906|NCT02844439|69112620|FG000|Overall Study|Withdrawal by Subject|1|||
37643907|NCT02844439|69112620|FG000|Overall Study|Lost to Follow-up|2|||
37643908|NCT02844439|69112620|FG000|Overall Study|Termination by Sponsor|4|||
37643909|NCT02844439|69112620|FG000|Overall Study|Death|28|||
37643910|NCT02844439|69112620|FG000|Overall Study|Other|5|||
37643911|NCT01677182|69112634|FG000|Overall Study|Adverse Event|2|||
37643912|NCT01677182|69112635|FG001|Overall Study|Adverse Event|1|||
37643913|NCT01677182|69112636|FG002|Overall Study|Adverse Event|8|||
37643914|NCT01677182|69112634|FG000|Overall Study|Protocol Violation|5|||
37643915|NCT01677182|69112635|FG001|Overall Study|Protocol Violation|1|||
37643916|NCT01677182|69112636|FG002|Overall Study|Protocol Violation|4|||
37643917|NCT01677182|69112634|FG000|Overall Study|Lost to Follow-up|4|||
37643918|NCT01677182|69112635|FG001|Overall Study|Lost to Follow-up|0|||
37854455|NCT01232283|69537957|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
37643919|NCT01677182|69112636|FG002|Overall Study|Lost to Follow-up|3|||
37854456|NCT01232283|69537958|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
37643920|NCT01677182|69112634|FG000|Overall Study|Withdrawal by Subject|7|||
37643921|NCT01677182|69112635|FG001|Overall Study|Withdrawal by Subject|12|||
37643922|NCT01677182|69112636|FG002|Overall Study|Withdrawal by Subject|10|||
37643923|NCT01677182|69112634|FG000|Overall Study|Study termination|12|||
37643924|NCT01677182|69112635|FG001|Overall Study|Study termination|9|||
37643925|NCT01677182|69112636|FG002|Overall Study|Study termination|11|||
37643926|NCT01677182|69112634|FG000|Overall Study|Lack of Efficacy|3|||
37643927|NCT01677182|69112635|FG001|Overall Study|Lack of Efficacy|0|||
37643928|NCT01677182|69112636|FG002|Overall Study|Lack of Efficacy|1|||
37643929|NCT01677182|69112634|FG000|Overall Study|Other reasons|1|||
37643930|NCT01677182|69112635|FG001|Overall Study|Other reasons|5|||
37643931|NCT01677182|69112636|FG002|Overall Study|Other reasons|2|||
37643932|NCT02843659|69112647|FG000|Overall Study|Subject Withdrew Consent|0|||
37643933|NCT02843659|69112648|FG001|Overall Study|Subject Withdrew Consent|0|||
37643934|NCT02843659|69112649|FG002|Overall Study|Subject Withdrew Consent|1|||
37643935|NCT02843659|69112647|FG000|Overall Study|Administrative Reason by Sponsor|4|||
37643936|NCT02843659|69112648|FG001|Overall Study|Administrative Reason by Sponsor|5|||
37643937|NCT02843659|69112649|FG002|Overall Study|Administrative Reason by Sponsor|4|||
37643938|NCT02843659|69112647|FG000|Overall Study|Adverse Event|0|||
37643939|NCT02843659|69112648|FG001|Overall Study|Adverse Event|1|||
37643940|NCT02843659|69112649|FG002|Overall Study|Adverse Event|0|||
37643941|NCT00708435|69112659|FG000|Overall Study|Death / Serious Adverse Event|10|||
37643942|NCT00708435|69112660|FG001|Overall Study|Death / Serious Adverse Event|5|||
37643943|NCT00708435|69112659|FG000|Overall Study|Lost to Follow-up|9|||
37643944|NCT00708435|69112660|FG001|Overall Study|Lost to Follow-up|4|||
37643945|NCT00708435|69112659|FG000|Overall Study|Withdrawal by Subject|3|||
37643946|NCT00708435|69112660|FG001|Overall Study|Withdrawal by Subject|7|||
37643947|NCT00708435|69112659|FG000|Overall Study|Adverse Event|1|||
37643948|NCT00708435|69112660|FG001|Overall Study|Adverse Event|0|||
37643949|NCT00708435|69112659|FG000|Overall Study|Protocol Violation|0|||
37643950|NCT00708435|69112660|FG001|Overall Study|Protocol Violation|1|||
37643951|NCT00708435|69112659|FG000|Overall Study|Intervention by primary care physician|1|||
37643952|NCT00708435|69112660|FG001|Overall Study|Intervention by primary care physician|0|||
37643953|NCT00708435|69112659|FG000|Overall Study|Refused hospitalization|1|||
37643954|NCT00708435|69112660|FG001|Overall Study|Refused hospitalization|0|||
37643955|NCT02841787|69112671|FG000|Overall Study|Lost to Follow-up|1|||
37643956|NCT02841787|69112672|FG001|Overall Study|Lost to Follow-up|0|||
37643957|NCT02841787|69112673|FG002|Overall Study|Lost to Follow-up|0|||
37643958|NCT02841787|69112671|FG000|Overall Study|Symptoms dropped below threshold|1|||
37643959|NCT02841787|69112672|FG001|Overall Study|Symptoms dropped below threshold|0|||
37643960|NCT02841787|69112673|FG002|Overall Study|Symptoms dropped below threshold|0|||
37643961|NCT02841787|69112671|FG000|Overall Study|Withdrawal by Subject|1|||
37643962|NCT02841787|69112672|FG001|Overall Study|Withdrawal by Subject|4|||
37643963|NCT02841787|69112673|FG002|Overall Study|Withdrawal by Subject|0|||
37643964|NCT01376037|69112683|FG000|Overall Study|Lost to Follow-up|0|||
37643965|NCT01376037|69112684|FG001|Overall Study|Lost to Follow-up|2|||
37643966|NCT02657408|69112692|FG000|Overall Study|Adverse Event|3|||
37643967|NCT02657408|69112693|FG001|Overall Study|Adverse Event|7|||
37643968|NCT02841709|69112699|FG000|5th Intervention|Adverse Event|2|||
37643969|NCT02841709|69112700|FG001|5th Intervention|Adverse Event|0|||
37643970|NCT02841709|69112701|FG002|5th Intervention|Adverse Event|0|||
37643971|NCT02841709|69112702|FG003|5th Intervention|Adverse Event|0|||
37643972|NCT02841709|69112703|FG004|5th Intervention|Adverse Event|2|||
37643973|NCT01353859|69112716|FG000|Overall Study|Adverse Event|3|||
37643974|NCT01353859|69112716|FG000|Overall Study|Lack of Efficacy|1|||
37643975|NCT02850965|69112722|FG000|Overall Study|Other than listed|3|||
37643976|NCT02850965|69112723|FG001|Overall Study|Other than listed|4|||
37643977|NCT02850965|69112722|FG000|Overall Study|Protocol Violation|0|||
37643978|NCT02850965|69112723|FG001|Overall Study|Protocol Violation|2|||
37643979|NCT02850965|69112722|FG000|Overall Study|Lost to Follow-up|5|||
37643980|NCT02850965|69112723|FG001|Overall Study|Lost to Follow-up|3|||
37643981|NCT02850965|69112722|FG000|Overall Study|Lack of Efficacy|4|||
37643982|NCT02850965|69112723|FG001|Overall Study|Lack of Efficacy|8|||
37643983|NCT02850965|69112722|FG000|Overall Study|Adverse Event|3|||
37643984|NCT02850965|69112723|FG001|Overall Study|Adverse Event|2|||
37643985|NCT02850965|69112722|FG000|Overall Study|Withdrawal by Subject|3|||
37643986|NCT02850965|69112723|FG001|Overall Study|Withdrawal by Subject|4|||
37643987|NCT02850965|69112722|FG000|Overall Study|Physician Decision|0|||
37643988|NCT02850965|69112723|FG001|Overall Study|Physician Decision|1|||
37643989|NCT02850965|69112722|FG000|Overall Study|Randomized but not treated|0|||
37643990|NCT02850965|69112723|FG001|Overall Study|Randomized but not treated|1|||
37643991|NCT01375959|69112731|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
37643992|NCT01375959|69112732|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
37643993|NCT01375959|69112731|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
37643994|NCT01375959|69112732|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
37643995|NCT01375959|69112731|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
37643996|NCT01375959|69112732|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
37643997|NCT00708201|69112742|FG000|Overall Study|Adverse Event|4|||
37643998|NCT00708201|69112743|FG001|Overall Study|Adverse Event|4|||
37643999|NCT00708201|69112742|FG000|Overall Study|Withdrawal by Subject|1|||
37644000|NCT00708201|69112743|FG001|Overall Study|Withdrawal by Subject|1|||
37644001|NCT00708201|69112742|FG000|Overall Study|Lost to Follow-up|2|||
37644002|NCT00708201|69112743|FG001|Overall Study|Lost to Follow-up|0|||
37854457|NCT01232283|69537959|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
37644003|NCT00708201|69112742|FG000|Overall Study|Protocol Violation|0|||
37644004|NCT00708201|69112743|FG001|Overall Study|Protocol Violation|1|||
37644005|NCT02848313|69112751|FG000|Overall Study|Adverse Event|1|||
37644006|NCT02848313|69112752|FG001|Overall Study|Adverse Event|2|||
37644007|NCT02848313|69112751|FG000|Overall Study|Lack of Efficacy|0|||
37644008|NCT02848313|69112752|FG001|Overall Study|Lack of Efficacy|1|||
37644009|NCT02848313|69112751|FG000|Overall Study|Withdrawal by Subject|1|||
37644010|NCT02848313|69112752|FG001|Overall Study|Withdrawal by Subject|1|||
37644011|NCT02848313|69112751|FG000|Overall Study|Lost to follow up|1|||
37644012|NCT02848313|69112752|FG001|Overall Study|Lost to follow up|0|||
37644013|NCT02728089|69112758|FG000|Overall Study|Physician Decision|2|||
37644014|NCT02728089|69112758|FG000|Overall Study|Withdrawal by Subject|1|||
37644015|NCT02840461|69112765|FG000|Overall Study|Adverse Event|1|||
37644016|NCT02840461|69112766|FG001|Overall Study|Adverse Event|5|||
37644017|NCT02840461|69112767|FG002|Overall Study|Adverse Event|3|||
37644018|NCT02840461|69112765|FG000|Overall Study|Lost to Follow-up|10|||
37644019|NCT02840461|69112766|FG001|Overall Study|Lost to Follow-up|7|||
37644020|NCT02840461|69112767|FG002|Overall Study|Lost to Follow-up|6|||
37644021|NCT02840461|69112765|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
37644022|NCT02840461|69112766|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
37644023|NCT02840461|69112767|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
37644024|NCT02840461|69112765|FG000|Overall Study|Protocol Violation|2|||
37644025|NCT02840461|69112766|FG001|Overall Study|Protocol Violation|3|||
37644026|NCT02840461|69112767|FG002|Overall Study|Protocol Violation|1|||
37644027|NCT02840461|69112765|FG000|Overall Study|Withdrawal by Subject|10|||
37644028|NCT02840461|69112766|FG001|Overall Study|Withdrawal by Subject|6|||
37644029|NCT02840461|69112767|FG002|Overall Study|Withdrawal by Subject|2|||
37644030|NCT02840461|69112765|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
37644031|NCT02840461|69112766|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
37644032|NCT02840461|69112767|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
37644033|NCT02839681|69112776|FG000|Overall Study|Death|2|||
37644034|NCT01676012|69112780|FG000|Overall Study|Adverse Event|2|||
37644035|NCT01676012|69112780|FG000|Overall Study|incomplete set of videos|1|||
37644036|NCT02727777|69112796|FG000|Overall Study|Screen Failure|2|||
37644037|NCT02727777|69112797|FG001|Overall Study|Screen Failure|0|||
37644038|NCT02727777|69112798|FG002|Overall Study|Screen Failure|0|||
37644039|NCT02727777|69112796|FG000|Overall Study|Progressive disease|2|||
37644040|NCT02727777|69112797|FG001|Overall Study|Progressive disease|0|||
37644041|NCT02727777|69112798|FG002|Overall Study|Progressive disease|0|||
37644042|NCT00707577|69112808|FG000|Overall Study|Withdrawal by Subject|3|||
37644043|NCT00707577|69112809|FG001|Overall Study|Withdrawal by Subject|2|||
37644044|NCT00707577|69112808|FG000|Overall Study|Lost to Follow-up|34|||
37644045|NCT00707577|69112809|FG001|Overall Study|Lost to Follow-up|25|||
37644046|NCT00707577|69112808|FG000|Overall Study|Left employment|13|||
37644047|NCT00707577|69112809|FG001|Overall Study|Left employment|10|||
37644048|NCT00707577|69112808|FG000|Overall Study|Pregnancy|4|||
37644049|NCT00707577|69112809|FG001|Overall Study|Pregnancy|1|||
37644050|NCT01675622|69112817|FG000|Overall Study|Withdrawal by Subject|2|||
37644051|NCT01675622|69112818|FG001|Overall Study|Withdrawal by Subject|2|||
37644052|NCT01675622|69112817|FG000|Overall Study|Adverse Event|12|||
37644053|NCT01675622|69112818|FG001|Overall Study|Adverse Event|10|||
37644054|NCT01675622|69112817|FG000|Overall Study|Protocol Violation|4|||
37644055|NCT01675622|69112818|FG001|Overall Study|Protocol Violation|1|||
37644056|NCT01675622|69112817|FG000|Overall Study|Lack of Efficacy|2|||
37644057|NCT01675622|69112818|FG001|Overall Study|Lack of Efficacy|4|||
37644058|NCT01675622|69112817|FG000|Overall Study|Lost to Follow-up|1|||
37644059|NCT01675622|69112818|FG001|Overall Study|Lost to Follow-up|3|||
37644060|NCT01675622|69112817|FG000|Overall Study|Other|5|||
37644061|NCT01675622|69112818|FG001|Overall Study|Other|4|||
37644062|NCT02655224|69112826|FG000|Overall Study|Adverse Event|1|||
37740965|NCT01831765|69226898|FG002|Overall Study|Other, sponsor withdrew subject|0|||
37740966|NCT01831765|69226896|FG000|Overall Study|Pregnancy|1|||
37644063|NCT02655224|69112827|FG001|Overall Study|Adverse Event|1|||
37644064|NCT01675544|69112833|FG000|Overall Study|Withdrawal by Subject|2|||
37644065|NCT02838901|69112876|FG000|Overall Study|Withdrawal by Subject|1|||
37644066|NCT02838901|69112877|FG001|Overall Study|Withdrawal by Subject|1|||
37644067|NCT02838901|69112876|FG000|Overall Study|Lost to Follow-up|1|||
37644068|NCT02838901|69112877|FG001|Overall Study|Lost to Follow-up|1|||
37644069|NCT00706797|69112905|FG000|Overall Study|Lack of Efficacy|3|||
37740967|NCT01831765|69226897|FG001|Overall Study|Pregnancy|1|||
37740968|NCT01831765|69226898|FG002|Overall Study|Pregnancy|2|||
37740969|NCT01831765|69226896|FG000|Overall Study|Death|0|||
37644070|NCT00706797|69112906|FG001|Overall Study|Lack of Efficacy|0|||
37644071|NCT00706797|69112905|FG000|Overall Study|Adverse Event|0|||
37740970|NCT01831765|69226897|FG001|Overall Study|Death|1|||
37644072|NCT00706797|69112906|FG001|Overall Study|Adverse Event|3|||
37644073|NCT00706797|69112905|FG000|Overall Study|Withdrawal by Subject|8|||
37644074|NCT00706797|69112906|FG001|Overall Study|Withdrawal by Subject|1|||
37644075|NCT00706797|69112905|FG000|Overall Study|Death|1|||
37644076|NCT00706797|69112906|FG001|Overall Study|Death|0|||
37644077|NCT00706797|69112905|FG000|Overall Study|Discontinuation of study by sponsor|52|||
37644078|NCT00706797|69112906|FG001|Overall Study|Discontinuation of study by sponsor|63|||
37740971|NCT01831765|69226898|FG002|Overall Study|Death|1|||
37644079|NCT00706797|69112905|FG000|Overall Study|Protocol Violation|3|||
37644080|NCT00706797|69112906|FG001|Overall Study|Protocol Violation|2|||
37644081|NCT00706797|69112905|FG000|Overall Study|Lost to Follow-up|1|||
37644082|NCT00706797|69112906|FG001|Overall Study|Lost to Follow-up|2|||
37644083|NCT00706797|69112905|FG000|Overall Study|Other|1|||
37644084|NCT00706797|69112906|FG001|Overall Study|Other|0|||
37644085|NCT00706641|69112912|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
37644086|NCT00706641|69112912|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
37644087|NCT00706641|69112912|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
37740972|NCT01831765|69226896|FG000|Overall Study|Other, site closed|1|||
37740973|NCT01831765|69226897|FG001|Overall Study|Other, site closed|1|||
37740974|NCT01831765|69226898|FG002|Overall Study|Other, site closed|0|||
37740975|NCT01831765|69226896|FG000|Overall Study|Adverse Event|5|||
37740976|NCT01831765|69226897|FG001|Overall Study|Adverse Event|3|||
37740977|NCT01831765|69226898|FG002|Overall Study|Adverse Event|3|||
37740978|NCT01831765|69226896|FG000|Overall Study|Withdrawal by Subject|22|||
37740979|NCT01831765|69226897|FG001|Overall Study|Withdrawal by Subject|7|||
37740980|NCT01831765|69226898|FG002|Overall Study|Withdrawal by Subject|17|||
37740981|NCT01831765|69226896|FG000|Overall Study|Withdrawal criteria|12|||
37740982|NCT01831765|69226897|FG001|Overall Study|Withdrawal criteria|10|||
37740983|NCT01831765|69226898|FG002|Overall Study|Withdrawal criteria|16|||
37740984|NCT01831765|69226896|FG000|Overall Study|Lost to Follow-up|2|||
37740985|NCT01831765|69226897|FG001|Overall Study|Lost to Follow-up|3|||
37740986|NCT01831765|69226898|FG002|Overall Study|Lost to Follow-up|3|||
37740987|NCT01749800|69226911|FG000|Overall Study|not meeting inclusion criteria|3|||
37740988|NCT01749800|69226912|FG001|Overall Study|not meeting inclusion criteria|0|||
37740989|NCT01749800|69226913|FG002|Overall Study|not meeting inclusion criteria|0|||
37740990|NCT01749800|69226911|FG000|Overall Study|Withdrawal by Subject|0|||
37740991|NCT01749800|69226912|FG001|Overall Study|Withdrawal by Subject|1|||
37740992|NCT01749800|69226913|FG002|Overall Study|Withdrawal by Subject|0|||
37740993|NCT01830595|69226921|FG000|First Period|Withdrawal by Subject|1|||
37740994|NCT01830595|69226922|FG001|First Period|Withdrawal by Subject|3|||
37740995|NCT01830595|69226921|FG000|Washout|Withdrawal by Subject|2|||
37740996|NCT01830595|69226922|FG001|Washout|Withdrawal by Subject|2|||
37740997|NCT01748552|69226940|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
37740998|NCT01748552|69226941|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
37740999|NCT01748552|69226942|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
37741000|NCT01748552|69226943|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
37741001|NCT01748552|69226944|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
37741002|NCT01748552|69226945|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
37741003|NCT01748552|69226946|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
37741004|NCT01748552|69226947|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
37741005|NCT01748552|69226948|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
37741006|NCT01748552|69226949|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
37741007|NCT01748552|69226950|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
37741008|NCT01748552|69226951|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
37741009|NCT01748552|69226940|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
37741010|NCT01748552|69226941|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
37741011|NCT01748552|69226942|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
37741012|NCT01748552|69226943|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
37741013|NCT01748552|69226944|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
37741014|NCT01748552|69226945|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
37741015|NCT01748552|69226946|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
37741016|NCT01748552|69226947|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
37741017|NCT01748552|69226948|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
37741018|NCT01748552|69226949|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
37741019|NCT01748552|69226950|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
37741020|NCT01748552|69226951|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
37741021|NCT01748162|69226993|FG000|Overall Study|no additional croup episodes to evaluate|2|||
37854458|NCT01232283|69537960|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
37854459|NCT01232283|69537961|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
37854460|NCT01232283|69537952|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
37854461|NCT01232283|69537953|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
37854462|NCT01232283|69537954|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
37741022|NCT01748162|69226994|FG001|Overall Study|no additional croup episodes to evaluate|2|||
37854463|NCT01232283|69537955|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
37854464|NCT01232283|69537956|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
37854465|NCT01232283|69537957|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
37922029|NCT00666718|69608848|FG000|Overall Study|Death|1|||
37644088|NCT01362530|69112918|FG000|Base Study (Cycle 1)|Adverse Event|2|||
37741023|NCT01748162|69226993|FG000|Overall Study|participant consented but did not begin|0|||
37644089|NCT01362530|69112919|FG001|Base Study (Cycle 1)|Adverse Event|0|||
37644090|NCT01362530|69112918|FG000|Base Study (Cycle 1)|Physician Decision|0|||
37644091|NCT01362530|69112919|FG001|Base Study (Cycle 1)|Physician Decision|1|||
37644092|NCT01362530|69112918|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
37644093|NCT01362530|69112919|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
37644094|NCT01362530|69112918|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
37644095|NCT01362530|69112919|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
37644096|NCT01362530|69112918|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
37644097|NCT01362530|69112919|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
37644098|NCT01362530|69112918|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
37644099|NCT01362530|69112919|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
37644100|NCT01362530|69112918|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
37644101|NCT01362530|69112919|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
37644102|NCT01362530|69112918|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
37644103|NCT01362530|69112919|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
37644104|NCT01362530|69112918|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
37644105|NCT01362530|69112919|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
37644106|NCT01362530|69112918|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
37644107|NCT01362530|69112919|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
37644108|NCT01362530|69112918|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
37644109|NCT01362530|69112919|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
37644110|NCT01362530|69112918|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
37644111|NCT01362530|69112919|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
37644112|NCT01362530|69112918|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
37644113|NCT01362530|69112919|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
37644114|NCT02654054|69112929|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
37644115|NCT02654054|69112930|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
37644116|NCT02654054|69112931|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
37644117|NCT02654054|69112929|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
37644118|NCT02654054|69112930|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
37644119|NCT02654054|69112931|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
37644120|NCT02654054|69112929|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
37644121|NCT02654054|69112930|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
37644122|NCT02654054|69112931|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
37644123|NCT02654054|69112929|FG000|Post-Treatment Follow-Up Period|Other|1|||
37644124|NCT02654054|69112930|FG001|Post-Treatment Follow-Up Period|Other|0|||
37644125|NCT02654054|69112931|FG002|Post-Treatment Follow-Up Period|Other|4|||
37644126|NCT02654054|69112929|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
37644127|NCT02654054|69112930|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
37644128|NCT02654054|69112931|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
37644129|NCT02653664|69112952|FG000|Post-Treatment|Withdrawal by Subject|6|||
37644130|NCT02653664|69112953|FG001|Post-Treatment|Withdrawal by Subject|5|||
37644131|NCT02653664|69112954|FG002|Post-Treatment|Withdrawal by Subject|7|||
37644132|NCT02653664|69112952|FG000|Post-Treatment|Lost to Follow-up|8|||
37644133|NCT02653664|69112953|FG001|Post-Treatment|Lost to Follow-up|1|||
37644134|NCT02653664|69112954|FG002|Post-Treatment|Lost to Follow-up|7|||
37644135|NCT02653664|69112952|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
37644136|NCT02653664|69112953|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
37644137|NCT02653664|69112954|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
37644138|NCT02653664|69112952|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
37644139|NCT02653664|69112953|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
37644140|NCT02653664|69112954|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
37644141|NCT02653664|69112952|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
37644142|NCT02653664|69112953|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
37644143|NCT02653664|69112954|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
37644144|NCT02653664|69112952|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
37644145|NCT02653664|69112953|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
37644146|NCT02653664|69112954|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
37644147|NCT02653664|69112952|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
37644148|NCT02653664|69112953|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
37644149|NCT02653664|69112954|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
37644150|NCT02653664|69112952|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
37644151|NCT02653664|69112953|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
37644152|NCT02653664|69112954|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
37644153|NCT02653664|69112952|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
37644154|NCT02653664|69112953|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
37644155|NCT02653664|69112954|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
37644156|NCT02653664|69112952|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
37644157|NCT02653664|69112953|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
37644158|NCT02653664|69112954|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
37644159|NCT02488629|69112972|FG000|Overall Study|Lack of Efficacy|3|||
37644160|NCT02488629|69112973|FG001|Overall Study|Lack of Efficacy|1|||
37644161|NCT02488629|69112974|FG002|Overall Study|Lack of Efficacy|0|||
37644162|NCT02488629|69112975|FG003|Overall Study|Lack of Efficacy|0|||
37644163|NCT02488629|69112972|FG000|Overall Study|Withdrawal by Subject|0|||
37644164|NCT02488629|69112973|FG001|Overall Study|Withdrawal by Subject|1|||
37644165|NCT02488629|69112974|FG002|Overall Study|Withdrawal by Subject|0|||
37644166|NCT02488629|69112975|FG003|Overall Study|Withdrawal by Subject|0|||
37644167|NCT02727699|69112986|FG000|Overall Study|Adverse Event|2|||
37644168|NCT02727699|69112987|FG001|Overall Study|Adverse Event|0|||
37644169|NCT02727699|69112986|FG000|Overall Study|Withdrawal by Subject|5|||
37644170|NCT02727699|69112987|FG001|Overall Study|Withdrawal by Subject|3|||
37644171|NCT02727699|69112986|FG000|Overall Study|Protocol Violation|0|||
37644172|NCT02727699|69112987|FG001|Overall Study|Protocol Violation|1|||
37644173|NCT02727699|69112986|FG000|Overall Study|Physician Decision|0|||
38032154|NCT02951780|69718053|FG008|Period 2|Scheduling Conflicts|0|||
38032155|NCT03334214|69718075|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
38032156|NCT03334214|69718076|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
38032157|NCT03334214|69718075|FG000|Overall Study|Withdrawal by Subject|0|||
37644174|NCT02727699|69112987|FG001|Overall Study|Physician Decision|1|||
37644175|NCT02727699|69112986|FG000|Overall Study|Lost to Follow-up|1|||
37644176|NCT02727699|69112987|FG001|Overall Study|Lost to Follow-up|0|||
37644177|NCT02727699|69112986|FG000|Overall Study|Sponsor Decision|1|||
37644178|NCT02727699|69112987|FG001|Overall Study|Sponsor Decision|0|||
37644179|NCT03576716|69112995|FG000|Overall Study|Withdrawal by Subject|0|||
37644180|NCT03576716|69112996|FG001|Overall Study|Withdrawal by Subject|1|||
37644181|NCT02847637|69113015|FG000|Overall Study|Withdrawal by Subject|0|||
37644182|NCT02847637|69113016|FG001|Overall Study|Withdrawal by Subject|1|||
37644183|NCT02847637|69113017|FG002|Overall Study|Withdrawal by Subject|1|||
37644184|NCT02847637|69113018|FG003|Overall Study|Withdrawal by Subject|0|||
37644185|NCT02847637|69113015|FG000|Overall Study|Lost to Follow-up|1|||
37644186|NCT02847637|69113016|FG001|Overall Study|Lost to Follow-up|1|||
37644187|NCT02847637|69113017|FG002|Overall Study|Lost to Follow-up|0|||
37644188|NCT02847637|69113018|FG003|Overall Study|Lost to Follow-up|0|||
37644189|NCT02652260|69113044|FG000|Overall Study|Pregnancy|0|||
37644190|NCT02652260|69113045|FG001|Overall Study|Pregnancy|1|||
37644191|NCT02652260|69113044|FG000|Overall Study|Withdrawal by Subject|0|||
37644192|NCT02652260|69113045|FG001|Overall Study|Withdrawal by Subject|1|||
37644193|NCT00706095|69113057|FG000|Overall Study|Progressive Disease|4|||
37644194|NCT00706095|69113058|FG001|Overall Study|Progressive Disease|5|||
37644195|NCT00706095|69113059|FG002|Overall Study|Progressive Disease|3|||
37644196|NCT00706095|69113057|FG000|Overall Study|Clinical Progression|1|||
37644197|NCT00706095|69113058|FG001|Overall Study|Clinical Progression|2|||
37644198|NCT00706095|69113059|FG002|Overall Study|Clinical Progression|2|||
37644199|NCT00706095|69113057|FG000|Overall Study|Withdrawal by Subject|1|||
37644200|NCT00706095|69113058|FG001|Overall Study|Withdrawal by Subject|0|||
37644201|NCT00706095|69113059|FG002|Overall Study|Withdrawal by Subject|0|||
37644202|NCT02837731|69113069|FG000|Allocation|Admitted to General Floor|3|||
37644203|NCT02837731|69113070|FG001|Allocation|Admitted to General Floor|4|||
37644204|NCT02837731|69113069|FG000|Allocation|Immediate surgery/withdrew|2|||
37644205|NCT02837731|69113070|FG001|Allocation|Immediate surgery/withdrew|0|||
37644206|NCT02837731|69113069|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
37644207|NCT02837731|69113070|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
37644208|NCT02837731|69113069|FG000|Allocation|Withdrawal by Subject|2|||
37644209|NCT02837731|69113070|FG001|Allocation|Withdrawal by Subject|0|||
37644210|NCT02837731|69113069|FG000|Allocation|Device not available|1|||
37644211|NCT02837731|69113070|FG001|Allocation|Device not available|0|||
37644212|NCT02837731|69113069|FG000|Allocation|Protocol not implemented|7|||
37644213|NCT02837731|69113070|FG001|Allocation|Protocol not implemented|0|||
37644214|NCT02837731|69113069|FG000|Allocation|Moribund/Do not resuscitate|2|||
37644215|NCT02837731|69113070|FG001|Allocation|Moribund/Do not resuscitate|0|||
37644216|NCT02837731|69113069|FG000|Allocation|Did not meet sepsis criteria|1|||
37644217|NCT02837731|69113070|FG001|Allocation|Did not meet sepsis criteria|2|||
37644218|NCT02837731|69113069|FG000|Allocation|Known aortic abnormalities|0|||
37644219|NCT02837731|69113070|FG001|Allocation|Known aortic abnormalities|1|||
37644220|NCT02836873|69113078|FG000|Overall Study|Protocol Violation|0|||
37644221|NCT02836873|69113079|FG001|Overall Study|Protocol Violation|1|||
37644222|NCT02836873|69113078|FG000|Overall Study|Adverse Event|1|||
37644223|NCT02836873|69113079|FG001|Overall Study|Adverse Event|4|||
37644224|NCT02836873|69113078|FG000|Overall Study|Withdrawal by Subject|2|||
37644225|NCT02836873|69113079|FG001|Overall Study|Withdrawal by Subject|2|||
37644226|NCT02836873|69113078|FG000|Overall Study|Lost to Follow-up|1|||
37644227|NCT02836873|69113079|FG001|Overall Study|Lost to Follow-up|3|||
37644228|NCT02836873|69113078|FG000|Overall Study|Physician Decision|0|||
37644229|NCT02836873|69113079|FG001|Overall Study|Physician Decision|1|||
38032158|NCT03334214|69718076|FG001|Overall Study|Withdrawal by Subject|1|||
37644230|NCT02836873|69113078|FG000|Overall Study|Other|1|||
37644231|NCT02836873|69113079|FG001|Overall Study|Other|0|||
37644232|NCT01342081|69113097|FG000|Overall Study|Did not receive allocated intervention|0|||
37644233|NCT01342081|69113098|FG001|Overall Study|Did not receive allocated intervention|0|||
37644234|NCT01342081|69113099|FG002|Overall Study|Did not receive allocated intervention|1|||
37644235|NCT01342081|69113097|FG000|Overall Study|Adverse Event|1|||
37644236|NCT01342081|69113098|FG001|Overall Study|Adverse Event|0|||
37644237|NCT01342081|69113099|FG002|Overall Study|Adverse Event|0|||
37644238|NCT01342081|69113097|FG000|Overall Study|Physician Decision|0|||
37644239|NCT01342081|69113098|FG001|Overall Study|Physician Decision|1|||
37644240|NCT01342081|69113099|FG002|Overall Study|Physician Decision|0|||
37644241|NCT01342081|69113097|FG000|Overall Study|Withdrawal by Subject|1|||
37644242|NCT01342081|69113098|FG001|Overall Study|Withdrawal by Subject|1|||
37644243|NCT01342081|69113099|FG002|Overall Study|Withdrawal by Subject|0|||
37644244|NCT01341457|69113109|FG000|Overall Study|Adverse Event|2|||
37644245|NCT01341457|69113110|FG001|Overall Study|Adverse Event|0|||
37644246|NCT02832037|69113122|FG000|Overall Study|Administrative reasons|0|||
37644247|NCT02832037|69113123|FG001|Overall Study|Administrative reasons|0|||
37644248|NCT02832037|69113124|FG002|Overall Study|Administrative reasons|1|||
37644249|NCT02832037|69113125|FG003|Overall Study|Administrative reasons|0|||
37644250|NCT02832037|69113126|FG004|Overall Study|Administrative reasons|0|||
37644251|NCT02832037|69113122|FG000|Overall Study|Protocol Violation|3|||
37644252|NCT02832037|69113123|FG001|Overall Study|Protocol Violation|0|||
37644253|NCT02832037|69113124|FG002|Overall Study|Protocol Violation|4|||
37644254|NCT02832037|69113125|FG003|Overall Study|Protocol Violation|1|||
37644255|NCT02832037|69113126|FG004|Overall Study|Protocol Violation|2|||
37644256|NCT02832037|69113122|FG000|Overall Study|Lost to Follow-up|2|||
37644257|NCT02832037|69113123|FG001|Overall Study|Lost to Follow-up|0|||
37644258|NCT02832037|69113124|FG002|Overall Study|Lost to Follow-up|3|||
37644259|NCT02832037|69113125|FG003|Overall Study|Lost to Follow-up|0|||
37644260|NCT02832037|69113126|FG004|Overall Study|Lost to Follow-up|5|||
37644261|NCT02832037|69113122|FG000|Overall Study|Withdrawal by Subject|9|||
37644262|NCT02832037|69113123|FG001|Overall Study|Withdrawal by Subject|8|||
37644263|NCT02832037|69113124|FG002|Overall Study|Withdrawal by Subject|0|||
37644264|NCT02832037|69113125|FG003|Overall Study|Withdrawal by Subject|4|||
37644265|NCT02832037|69113126|FG004|Overall Study|Withdrawal by Subject|8|||
37644266|NCT02832037|69113122|FG000|Overall Study|Adverse Event|5|||
37644267|NCT02832037|69113123|FG001|Overall Study|Adverse Event|4|||
37644268|NCT02832037|69113124|FG002|Overall Study|Adverse Event|0|||
37644269|NCT02832037|69113125|FG003|Overall Study|Adverse Event|2|||
37644270|NCT02832037|69113126|FG004|Overall Study|Adverse Event|4|||
37644271|NCT01675154|69113142|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
37644272|NCT01675154|69113143|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
37644273|NCT01675154|69113144|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
37644274|NCT01675154|69113145|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
37644275|NCT02744755|69113169|FG000|Study Period 1|Protocol Violation|2|||
37644276|NCT02744755|69113170|FG001|Study Period 1|Protocol Violation|1|||
37644277|NCT02744755|69113169|FG000|Study Period 1|not defined|0|||
37644278|NCT02744755|69113170|FG001|Study Period 1|not defined|1|||
37644279|NCT02744755|69113169|FG000|Study Period 1|Pregnancy|1|||
37644280|NCT02744755|69113170|FG001|Study Period 1|Pregnancy|0|||
37644281|NCT02744755|69113169|FG000|Study Period 1|Adverse Event|1|||
37644282|NCT02744755|69113170|FG001|Study Period 1|Adverse Event|1|||
37644283|NCT02744755|69113169|FG000|Study Period 1|Lost to Follow-up|1|||
37644284|NCT02744755|69113170|FG001|Study Period 1|Lost to Follow-up|1|||
37644285|NCT02744755|69113169|FG000|Study Period 1|Lack of Efficacy|1|||
37644286|NCT02744755|69113170|FG001|Study Period 1|Lack of Efficacy|0|||
37644287|NCT02744755|69113169|FG000|Study Period 1|Withdrawal by Subject|8|||
37644288|NCT02744755|69113170|FG001|Study Period 1|Withdrawal by Subject|4|||
37644289|NCT02744755|69113169|FG000|Study Period 2|Adverse Event|5|||
37644290|NCT02744755|69113170|FG001|Study Period 2|Adverse Event|0|||
37644291|NCT02744755|69113169|FG000|Study Period 2|Protocol Violation|1|||
37644292|NCT02744755|69113170|FG001|Study Period 2|Protocol Violation|0|||
37644293|NCT02744755|69113169|FG000|Study Period 2|not defined|3|||
37644294|NCT02744755|69113170|FG001|Study Period 2|not defined|2|||
37644295|NCT02744755|69113169|FG000|Study Period 2|Lost to Follow-up|0|||
37644296|NCT02744755|69113170|FG001|Study Period 2|Lost to Follow-up|2|||
37922030|NCT00666718|69608849|FG001|Overall Study|Death|0|||
37644297|NCT02744755|69113169|FG000|Study Period 2|Withdrawal by Subject|2|||
37644298|NCT02744755|69113170|FG001|Study Period 2|Withdrawal by Subject|2|||
37644299|NCT02744755|69113169|FG000|Study Period 2|Lack of Efficacy|3|||
37644300|NCT02744755|69113170|FG001|Study Period 2|Lack of Efficacy|2|||
37644301|NCT01356589|69113184|FG000|Overall Study|Enrolled, but not treated|3|||
37644302|NCT01356589|69113184|FG000|Overall Study|Dose data not recorded|2|||
37644303|NCT02830087|69113194|FG000|Overall Study|No study staff to follow-up patients|4|||
37644304|NCT02830087|69113195|FG001|Overall Study|No study staff to follow-up patients|4|||
37644305|NCT02830087|69113196|FG002|Overall Study|No study staff to follow-up patients|4|||
37644306|NCT02830087|69113197|FG003|Overall Study|No study staff to follow-up patients|3|||
37644307|NCT02830087|69113198|FG004|Overall Study|No study staff to follow-up patients|3|||
37644308|NCT02830087|69113199|FG005|Overall Study|No study staff to follow-up patients|3|||
37644309|NCT02829775|69113213|FG000|Overall Study|Death|1|||
37644310|NCT02829775|69113213|FG000|Overall Study|Withdrawal by Subject|3|||
37644311|NCT02829775|69113213|FG000|Overall Study|Disease remission|1|||
37644312|NCT01355497|69113234|FG000|Overall Study|Death|19|||
37644313|NCT01355497|69113235|FG001|Overall Study|Death|18|||
37644314|NCT01355497|69113234|FG000|Overall Study|Lost to Follow-up|3|||
37644315|NCT01355497|69113235|FG001|Overall Study|Lost to Follow-up|0|||
37644316|NCT01355497|69113234|FG000|Overall Study|Protocol Violation|0|||
37644317|NCT01355497|69113235|FG001|Overall Study|Protocol Violation|1|||
37644318|NCT01355497|69113234|FG000|Overall Study|other-not provided|9|||
37644319|NCT01355497|69113235|FG001|Overall Study|other-not provided|4|||
37644320|NCT01355497|69113234|FG000|Overall Study|Withdrawal by Subject|12|||
37644321|NCT01355497|69113235|FG001|Overall Study|Withdrawal by Subject|20|||
37644322|NCT01355497|69113234|FG000|Overall Study|noncompliance|1|||
37644323|NCT01355497|69113235|FG001|Overall Study|noncompliance|2|||
37644324|NCT01355497|69113234|FG000|Overall Study|progressive disease|11|||
37644325|NCT01355497|69113235|FG001|Overall Study|progressive disease|8|||
37644326|NCT01355497|69113234|FG000|Overall Study|Adverse Event|11|||
37644327|NCT01355497|69113235|FG001|Overall Study|Adverse Event|10|||
37644328|NCT01355575|69113241|FG000|Overall Study|Withdrawal by Subject|2|||
37644329|NCT02826421|69113253|FG000|Overall Study|Adverse Event|1|||
37644330|NCT02826421|69113254|FG001|Overall Study|Adverse Event|0|||
37644331|NCT02826421|69113255|FG002|Overall Study|Adverse Event|0|||
37644332|NCT02826421|69113256|FG003|Overall Study|Adverse Event|1|||
37644333|NCT02826421|69113253|FG000|Overall Study|Withdrawal by Subject|1|||
37644334|NCT02826421|69113254|FG001|Overall Study|Withdrawal by Subject|3|||
37644335|NCT02826421|69113255|FG002|Overall Study|Withdrawal by Subject|1|||
37644336|NCT02826421|69113256|FG003|Overall Study|Withdrawal by Subject|1|||
37644337|NCT02826421|69113253|FG000|Overall Study|Reason not given|1|||
37644338|NCT02826421|69113254|FG001|Overall Study|Reason not given|0|||
37644339|NCT02826421|69113255|FG002|Overall Study|Reason not given|1|||
37644340|NCT02826421|69113256|FG003|Overall Study|Reason not given|0|||
37644341|NCT02825251|69113269|FG000|Overall Study|Adverse Event|0|||
37644342|NCT02825251|69113270|FG001|Overall Study|Adverse Event|1|||
37644343|NCT02825251|69113269|FG000|Overall Study|Lost to Follow-up|0|||
37644344|NCT02825251|69113270|FG001|Overall Study|Lost to Follow-up|1|||
37644345|NCT02825251|69113269|FG000|Overall Study|Withdrawal by Subject|1|||
37644346|NCT02825251|69113270|FG001|Overall Study|Withdrawal by Subject|4|||
37644347|NCT02825251|69113269|FG000|Overall Study|Unclassified|2|||
37644348|NCT02825251|69113270|FG001|Overall Study|Unclassified|0|||
37644349|NCT04860505|69113276|FG000|Overall Study|Lost to Follow-up|2|||
37644350|NCT04063865|69113282|FG000|Overall Study|Physician Decision|1|||
37644351|NCT04063865|69113283|FG001|Overall Study|Physician Decision|3|||
37644352|NCT04063865|69113282|FG000|Overall Study|Study Closed Prior to Completion|4|||
37644353|NCT04063865|69113283|FG001|Overall Study|Study Closed Prior to Completion|4|||
37644354|NCT04063865|69113282|FG000|Overall Study|Withdrawal by Subject|1|||
37644355|NCT04063865|69113283|FG001|Overall Study|Withdrawal by Subject|1|||
37644356|NCT03994211|69113291|FG000|Core Phase|Adverse Event|0|||
37644357|NCT03994211|69113292|FG001|Core Phase|Adverse Event|1|||
37644358|NCT03994211|69113293|FG002|Core Phase|Adverse Event|0|||
37644359|NCT03994211|69113291|FG000|Extension Phase|Adverse Event|0|||
37644360|NCT03994211|69113292|FG001|Extension Phase|Adverse Event|0|||
37644361|NCT03994211|69113293|FG002|Extension Phase|Adverse Event|1|||
37644362|NCT03994211|69113291|FG000|Extension Phase|Physician Decision|0|||
37922031|NCT00666718|69608848|FG000|Overall Study|Lost to Follow-up|1|||
38032159|NCT03334214|69718075|FG000|Overall Study|Other|1|||
37644363|NCT03994211|69113292|FG001|Extension Phase|Physician Decision|0|||
37644364|NCT03994211|69113293|FG002|Extension Phase|Physician Decision|1|||
37644365|NCT03994211|69113291|FG000|Extension Phase|Progressive Disease|0|||
37644366|NCT03994211|69113292|FG001|Extension Phase|Progressive Disease|0|||
37644367|NCT03994211|69113293|FG002|Extension Phase|Progressive Disease|20|||
37644368|NCT03994211|69113291|FG000|Extension Phase|Withdrawal by Subject|0|||
37644369|NCT03994211|69113292|FG001|Extension Phase|Withdrawal by Subject|0|||
37644370|NCT03994211|69113293|FG002|Extension Phase|Withdrawal by Subject|2|||
37644371|NCT03818607|69113308|FG000|Period 1 (Week 1 to Week 52)|Adverse Event|0|||
37644372|NCT03818607|69113309|FG001|Period 1 (Week 1 to Week 52)|Adverse Event|1|||
37644373|NCT03818607|69113308|FG000|Period 2 (Week 53 to Week 79)|Participant's personal needs|0|||
37644374|NCT03818607|69113309|FG001|Period 2 (Week 53 to Week 79)|Participant's personal needs|1|||
37644375|NCT03818607|69113308|FG000|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|1|||
37644376|NCT03818607|69113309|FG001|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|0|||
37644377|NCT02422615|69113349|FG000|Overall Study|Progressive disease|193|||
37644378|NCT02422615|69113350|FG001|Overall Study|Progressive disease|142|||
37644379|NCT02422615|69113349|FG000|Overall Study|Adverse Event|41|||
37644380|NCT02422615|69113350|FG001|Overall Study|Adverse Event|10|||
37644381|NCT02422615|69113349|FG000|Overall Study|Physician Decision|22|||
37644382|NCT02422615|69113350|FG001|Overall Study|Physician Decision|7|||
37644383|NCT02422615|69113349|FG000|Overall Study|Subject/guardian decision|21|||
37644384|NCT02422615|69113350|FG001|Overall Study|Subject/guardian decision|5|||
37644385|NCT02422615|69113349|FG000|Overall Study|Death|2|||
37644386|NCT02422615|69113350|FG001|Overall Study|Death|0|||
37644387|NCT02422615|69113349|FG000|Overall Study|Protocol Violation|1|||
37644388|NCT02422615|69113350|FG001|Overall Study|Protocol Violation|1|||
37854466|NCT01232283|69537958|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
37644389|NCT02422615|69113349|FG000|Overall Study|Technical problems|0|||
37644390|NCT02422615|69113350|FG001|Overall Study|Technical problems|1|||
37644391|NCT02382406|69113359|FG000|Study Treatment|Disease Progression|8|||
37644392|NCT02382406|69113360|FG001|Study Treatment|Disease Progression|0|||
37644393|NCT02382406|69113361|FG002|Study Treatment|Disease Progression|20|||
37644394|NCT02382406|69113359|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
37644395|NCT02382406|69113360|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
37644396|NCT02382406|69113361|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
37644397|NCT02382406|69113359|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
37644398|NCT02382406|69113360|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
37644399|NCT02382406|69113361|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
37644400|NCT02382406|69113359|FG000|Study Treatment|symptomatic deterioration|1|||
37644401|NCT02382406|69113360|FG001|Study Treatment|symptomatic deterioration|0|||
37644402|NCT02382406|69113361|FG002|Study Treatment|symptomatic deterioration|1|||
37644403|NCT02382406|69113359|FG000|Study Treatment|Death|0|||
37644404|NCT02382406|69113360|FG001|Study Treatment|Death|0|||
37644405|NCT02382406|69113361|FG002|Study Treatment|Death|2|||
37644406|NCT02382406|69113359|FG000|Follow up|Death|11|||
37644407|NCT02382406|69113360|FG001|Follow up|Death|0|||
37644408|NCT02382406|69113361|FG002|Follow up|Death|19|||
37644409|NCT02382406|69113359|FG000|Follow up|Symptomatic deterioration|1|||
37644410|NCT02382406|69113360|FG001|Follow up|Symptomatic deterioration|0|||
37644411|NCT02382406|69113361|FG002|Follow up|Symptomatic deterioration|1|||
37644412|NCT02382406|69113359|FG000|Follow up|Patient Refused Follow-up|1|||
37644413|NCT02382406|69113360|FG001|Follow up|Patient Refused Follow-up|0|||
37644414|NCT02382406|69113361|FG002|Follow up|Patient Refused Follow-up|0|||
37644415|NCT02382406|69113359|FG000|Follow up|Study Terminated|1|||
37644416|NCT02382406|69113360|FG001|Follow up|Study Terminated|0|||
37644417|NCT02382406|69113361|FG002|Follow up|Study Terminated|8|||
37644418|NCT02382406|69113359|FG000|Follow up|Withdrawal by Subject|0|||
37644419|NCT02382406|69113360|FG001|Follow up|Withdrawal by Subject|0|||
37644420|NCT02382406|69113361|FG002|Follow up|Withdrawal by Subject|2|||
37644421|NCT02101268|69113381|FG000|Randomized Treatment Phase|Subject Decision|8|||
37644422|NCT02101268|69113382|FG001|Randomized Treatment Phase|Subject Decision|4|||
37644423|NCT02101268|69113383|FG002|Randomized Treatment Phase|Subject Decision|0|||
37644424|NCT02101268|69113384|FG003|Randomized Treatment Phase|Subject Decision|0|||
37644425|NCT02101268|69113381|FG000|Randomized Treatment Phase|Physician Decision|4|||
37644426|NCT02101268|69113382|FG001|Randomized Treatment Phase|Physician Decision|1|||
37644427|NCT02101268|69113383|FG002|Randomized Treatment Phase|Physician Decision|0|||
37644428|NCT02101268|69113384|FG003|Randomized Treatment Phase|Physician Decision|0|||
37644429|NCT02101268|69113381|FG000|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
37644430|NCT02101268|69113382|FG001|Randomized Treatment Phase|Symptomatic Spleen Growth|1|||
37644431|NCT02101268|69113383|FG002|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
37644432|NCT02101268|69113384|FG003|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
37644433|NCT02101268|69113381|FG000|Randomized Treatment Phase|Adverse Event|6|||
37644434|NCT02101268|69113382|FG001|Randomized Treatment Phase|Adverse Event|0|||
37644435|NCT02101268|69113383|FG002|Randomized Treatment Phase|Adverse Event|0|||
37644436|NCT02101268|69113384|FG003|Randomized Treatment Phase|Adverse Event|0|||
37644437|NCT02101268|69113381|FG000|Randomized Treatment Phase|Death|5|||
37644438|NCT02101268|69113382|FG001|Randomized Treatment Phase|Death|4|||
37644439|NCT02101268|69113383|FG002|Randomized Treatment Phase|Death|0|||
37644440|NCT02101268|69113384|FG003|Randomized Treatment Phase|Death|0|||
37644441|NCT02101268|69113381|FG000|Randomized Treatment Phase|Disease Progression|4|||
37644442|NCT02101268|69113382|FG001|Randomized Treatment Phase|Disease Progression|1|||
37644443|NCT02101268|69113383|FG002|Randomized Treatment Phase|Disease Progression|0|||
37644444|NCT02101268|69113384|FG003|Randomized Treatment Phase|Disease Progression|0|||
37644445|NCT02101268|69113381|FG000|Extended Treatment Phase|Subject Decision|0|||
37644446|NCT02101268|69113382|FG001|Extended Treatment Phase|Subject Decision|0|||
37644447|NCT02101268|69113383|FG002|Extended Treatment Phase|Subject Decision|3|||
37644448|NCT02101268|69113384|FG003|Extended Treatment Phase|Subject Decision|2|||
37644449|NCT02101268|69113381|FG000|Extended Treatment Phase|Physician Decision|0|||
37644450|NCT02101268|69113382|FG001|Extended Treatment Phase|Physician Decision|0|||
37644451|NCT02101268|69113383|FG002|Extended Treatment Phase|Physician Decision|5|||
37644452|NCT02101268|69113384|FG003|Extended Treatment Phase|Physician Decision|2|||
37644453|NCT02101268|69113381|FG000|Extended Treatment Phase|Adverse Event|0|||
37644454|NCT02101268|69113382|FG001|Extended Treatment Phase|Adverse Event|0|||
37644455|NCT02101268|69113383|FG002|Extended Treatment Phase|Adverse Event|14|||
37644456|NCT02101268|69113384|FG003|Extended Treatment Phase|Adverse Event|18|||
37644457|NCT02101268|69113381|FG000|Extended Treatment Phase|Death|0|||
37644458|NCT02101268|69113382|FG001|Extended Treatment Phase|Death|0|||
37644459|NCT02101268|69113383|FG002|Extended Treatment Phase|Death|5|||
37644460|NCT02101268|69113384|FG003|Extended Treatment Phase|Death|1|||
37644461|NCT02101268|69113381|FG000|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
37644462|NCT02101268|69113382|FG001|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
37644463|NCT02101268|69113383|FG002|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|15|||
37644464|NCT02101268|69113384|FG003|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|7|||
37644465|NCT02101268|69113381|FG000|Extended Treatment Phase|Disease Progression|0|||
37644466|NCT02101268|69113382|FG001|Extended Treatment Phase|Disease Progression|0|||
37644467|NCT02101268|69113383|FG002|Extended Treatment Phase|Disease Progression|13|||
37644468|NCT02101268|69113384|FG003|Extended Treatment Phase|Disease Progression|6|||
37644469|NCT02101268|69113381|FG000|Extended Treatment Phase|Lack of Efficacy|0|||
37644470|NCT02101268|69113382|FG001|Extended Treatment Phase|Lack of Efficacy|0|||
37644471|NCT02101268|69113383|FG002|Extended Treatment Phase|Lack of Efficacy|9|||
37644472|NCT02101268|69113384|FG003|Extended Treatment Phase|Lack of Efficacy|4|||
37644473|NCT01898650|69113401|FG000|Overall Study|the subject would not lie still for imaging|1|||
37644474|NCT01880515|69113407|FG000|Overall Study|Lost to Follow-up|3|||
37644475|NCT01880515|69113408|FG001|Overall Study|Lost to Follow-up|2|||
37644476|NCT01880515|69113407|FG000|Overall Study|Disease Progression|5|||
37644477|NCT01880515|69113408|FG001|Overall Study|Disease Progression|7|||
37644478|NCT01668719|69113418|FG000|Phase I|On treatment|1|||
37644479|NCT01668719|69113419|FG001|Phase I|On treatment|0|||
37644480|NCT01668719|69113420|FG002|Phase I|On treatment|0|||
37644481|NCT01668719|69113418|FG000|Phase I|Adverse Event|2|||
37644482|NCT01668719|69113419|FG001|Phase I|Adverse Event|0|||
37644483|NCT01668719|69113420|FG002|Phase I|Adverse Event|0|||
37644484|NCT01668719|69113418|FG000|Phase I|Progression/relapse|1|||
37644485|NCT01668719|69113419|FG001|Phase I|Progression/relapse|0|||
37644486|NCT01668719|69113420|FG002|Phase I|Progression/relapse|0|||
37644487|NCT01668719|69113418|FG000|Phase I|not protocol specified|2|||
37644488|NCT01668719|69113419|FG001|Phase I|not protocol specified|0|||
37644489|NCT01668719|69113420|FG002|Phase I|not protocol specified|0|||
37644490|NCT01668719|69113418|FG000|Phase II|On treatment|0|||
37644491|NCT01668719|69113419|FG001|Phase II|On treatment|4|||
37644492|NCT01668719|69113420|FG002|Phase II|On treatment|3|||
37644493|NCT01668719|69113418|FG000|Phase II|Adverse Event|0|||
37644494|NCT01668719|69113419|FG001|Phase II|Adverse Event|18|||
37644495|NCT01668719|69113420|FG002|Phase II|Adverse Event|18|||
37644496|NCT01668719|69113418|FG000|Phase II|Refusal unrelated to adverse event|0|||
37644497|NCT01668719|69113419|FG001|Phase II|Refusal unrelated to adverse event|4|||
37644498|NCT01668719|69113420|FG002|Phase II|Refusal unrelated to adverse event|1|||
37644499|NCT01668719|69113418|FG000|Phase II|Progression/relapse|0|||
37644500|NCT01668719|69113419|FG001|Phase II|Progression/relapse|13|||
37644501|NCT01668719|69113420|FG002|Phase II|Progression/relapse|17|||
37644502|NCT01668719|69113418|FG000|Phase II|Death|0|||
37644503|NCT01668719|69113419|FG001|Phase II|Death|0|||
37644504|NCT01668719|69113420|FG002|Phase II|Death|2|||
37644505|NCT01668719|69113418|FG000|Phase II|not protocol specified|0|||
37644506|NCT01668719|69113419|FG001|Phase II|not protocol specified|13|||
37644507|NCT01668719|69113420|FG002|Phase II|not protocol specified|7|||
37644508|NCT01642901|69113432|FG000|12-month Follow-up|Withdrawal by Subject|1|||
37644509|NCT01642901|69113433|FG001|12-month Follow-up|Withdrawal by Subject|0|||
37644510|NCT01488045|69113441|FG000|Overall Study|Withdrawal by Subject|6|||
37644511|NCT01488045|69113442|FG001|Overall Study|Withdrawal by Subject|11|||
37644512|NCT01488045|69113441|FG000|Overall Study|Failure to present for colonoscopy|3|||
37644513|NCT01488045|69113442|FG001|Overall Study|Failure to present for colonoscopy|6|||
37644514|NCT01488045|69113441|FG000|Overall Study|Failure to report exclusion criteria|0|||
37644515|NCT01488045|69113442|FG001|Overall Study|Failure to report exclusion criteria|1|||
37644516|NCT00946712|69113461|FG000|Overall Study|Adverse Event|118|||
37644517|NCT00946712|69113462|FG001|Overall Study|Adverse Event|124|||
37644518|NCT00946712|69113461|FG000|Overall Study|Disease progression|308|||
37644519|NCT00946712|69113462|FG001|Overall Study|Disease progression|404|||
37644520|NCT00946712|69113461|FG000|Overall Study|Death|21|||
37644521|NCT00946712|69113462|FG001|Overall Study|Death|22|||
37644522|NCT00946712|69113461|FG000|Overall Study|No treatment given|25|||
37644523|NCT00946712|69113462|FG001|Overall Study|No treatment given|29|||
37854467|NCT01232283|69537959|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
37644524|NCT00946712|69113461|FG000|Overall Study|Other reasons|61|||
37644525|NCT00946712|69113462|FG001|Overall Study|Other reasons|73|||
37644526|NCT00946712|69113461|FG000|Overall Study|On Treatment|0|||
37644527|NCT00946712|69113462|FG001|Overall Study|On Treatment|4|||
37644528|NCT00946712|69113461|FG000|Overall Study|Ineligible|14|||
37644529|NCT00946712|69113462|FG001|Overall Study|Ineligible|6|||
37644530|NCT00656669|69113469|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
37644531|NCT00656669|69113469|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
37644532|NCT00656669|69113469|FG000|AC (Cycles 6-9)|Adverse Event|1|||
37644533|NCT00656669|69113469|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
37644534|NCT00470704|69113480|FG000|Overall Study|Withdrawal by Subject|4|||
37644535|NCT00470704|69113481|FG001|Overall Study|Withdrawal by Subject|3|||
37644536|NCT00470704|69113480|FG000|Overall Study|Relapse/Progression|37|||
37644537|NCT00470704|69113481|FG001|Overall Study|Relapse/Progression|42|||
37644538|NCT00470704|69113480|FG000|Overall Study|toxicity|0|||
37644539|NCT00470704|69113481|FG001|Overall Study|toxicity|1|||
37644540|NCT01338493|69113487|FG000|Enrolled|Withdrawal by Subject|1|||
37644541|NCT01338493|69113487|FG000|Enrolled|Patient not implanted|4|||
37644542|NCT01338493|69113487|FG000|Discharge|Death|1|||
37644543|NCT01338493|69113487|FG000|Discharge|Missed visit|1|||
37644544|NCT01338493|69113487|FG000|6 Months Follow up|Lost to Follow-up|11|||
37644545|NCT01338493|69113487|FG000|6 Months Follow up|Missed visit|8|||
37644546|NCT01338493|69113487|FG000|12 Months Follow up|Lost to Follow-up|9|||
37644547|NCT01362296|69113493|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
37644548|NCT01362296|69113494|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
37644549|NCT01362296|69113495|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
37644550|NCT01362296|69113496|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
37644551|NCT01362296|69113493|FG000|Randomized Phase (RP)|Physician Decision|1|||
37644552|NCT01362296|69113494|FG001|Randomized Phase (RP)|Physician Decision|9|||
37644553|NCT01362296|69113495|FG002|Randomized Phase (RP)|Physician Decision|0|||
37644554|NCT01362296|69113496|FG003|Randomized Phase (RP)|Physician Decision|0|||
37644555|NCT01362296|69113493|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
37644556|NCT01362296|69113494|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
37644557|NCT01362296|69113495|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
37644558|NCT01362296|69113496|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
37644559|NCT01362296|69113493|FG000|Randomized Phase (RP)|Adverse Event|20|||
37644560|NCT01362296|69113494|FG001|Randomized Phase (RP)|Adverse Event|4|||
37644561|NCT01362296|69113495|FG002|Randomized Phase (RP)|Adverse Event|0|||
37644562|NCT01362296|69113496|FG003|Randomized Phase (RP)|Adverse Event|0|||
37644563|NCT01362296|69113493|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
37644564|NCT01362296|69113494|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
37644565|NCT01362296|69113495|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
37644566|NCT01362296|69113496|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
37644567|NCT01362296|69113493|FG000|Crossover Phase|PD including Death due to PD|0|||
37644568|NCT01362296|69113494|FG001|Crossover Phase|PD including Death due to PD|0|||
37644569|NCT01362296|69113495|FG002|Crossover Phase|PD including Death due to PD|16|||
37644570|NCT01362296|69113496|FG003|Crossover Phase|PD including Death due to PD|1|||
37644571|NCT01362296|69113493|FG000|Crossover Phase|Withdrawal by Subject|0|||
37644572|NCT01362296|69113494|FG001|Crossover Phase|Withdrawal by Subject|0|||
37644573|NCT01362296|69113495|FG002|Crossover Phase|Withdrawal by Subject|2|||
37644574|NCT01362296|69113496|FG003|Crossover Phase|Withdrawal by Subject|1|||
37644575|NCT01362296|69113493|FG000|Crossover Phase|Adverse Event|0|||
37644576|NCT01362296|69113494|FG001|Crossover Phase|Adverse Event|0|||
37644577|NCT01362296|69113495|FG002|Crossover Phase|Adverse Event|4|||
37644578|NCT01362296|69113496|FG003|Crossover Phase|Adverse Event|0|||
37644579|NCT01362296|69113493|FG000|Crossover Phase|Study Closed/Terminated|0|||
37644580|NCT01362296|69113494|FG001|Crossover Phase|Study Closed/Terminated|0|||
37644581|NCT01362296|69113495|FG002|Crossover Phase|Study Closed/Terminated|1|||
37644582|NCT01362296|69113496|FG003|Crossover Phase|Study Closed/Terminated|0|||
37644583|NCT01338415|69113508|FG000|Core + Extension|Adverse Event|8|||
37644584|NCT01338415|69113509|FG001|Core + Extension|Adverse Event|6|||
37644585|NCT01338415|69113510|FG002|Core + Extension|Adverse Event|0|||
37644586|NCT01338415|69113508|FG000|Core + Extension|Withdrawal by Subject|1|||
37644587|NCT01338415|69113509|FG001|Core + Extension|Withdrawal by Subject|1|||
37644588|NCT01338415|69113510|FG002|Core + Extension|Withdrawal by Subject|0|||
37644589|NCT01338415|69113508|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
37644590|NCT01338415|69113509|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
37644591|NCT01338415|69113510|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
37644592|NCT01338415|69113508|FG000|Core + Extension|Other (administrative reason)|1|||
37644593|NCT01338415|69113509|FG001|Core + Extension|Other (administrative reason)|0|||
37644594|NCT01338415|69113510|FG002|Core + Extension|Other (administrative reason)|0|||
37922032|NCT00666718|69608849|FG001|Overall Study|Lost to Follow-up|0|||
37644595|NCT01338415|69113508|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
37644596|NCT01338415|69113509|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
37644597|NCT01338415|69113510|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
37644598|NCT01338415|69113508|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
37644599|NCT01338415|69113509|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
37922033|NCT00666718|69608848|FG000|Overall Study|Entry Criteria Not Met|2|||
37922034|NCT00666718|69608849|FG001|Overall Study|Entry Criteria Not Met|0|||
37922035|NCT00666718|69608848|FG000|Overall Study|Protocol Violation|1|||
37644600|NCT01338415|69113510|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
37644601|NCT01338415|69113508|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
37644602|NCT01338415|69113509|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
37644603|NCT01338415|69113510|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
37644604|NCT01338415|69113508|FG000|Exceptional Use Treatment Period|Death|0|||
37644605|NCT01338415|69113509|FG001|Exceptional Use Treatment Period|Death|0|||
37644606|NCT01338415|69113510|FG002|Exceptional Use Treatment Period|Death|1|||
37644607|NCT05258149|69113520|FG000|Period 1|Protocol Deviation|1|||
37644608|NCT05258149|69113521|FG001|Period 1|Protocol Deviation|0|||
37644609|NCT05258149|69113520|FG000|Period 1|Adverse Event|0|||
37644610|NCT05258149|69113521|FG001|Period 1|Adverse Event|1|||
37644611|NCT05258149|69113520|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
37644612|NCT05258149|69113521|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
37644613|NCT05258149|69113520|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
37644614|NCT05258149|69113521|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
37644615|NCT05258149|69113520|FG000|Period 3|Subject Was Not Returning for More Than A Week|0|||
37644616|NCT05258149|69113521|FG001|Period 3|Subject Was Not Returning for More Than A Week|1|||
37644617|NCT01371643|69113529|FG000|Overall Study|Withdrawal by Subject|3|||
37644618|NCT01371643|69113530|FG001|Overall Study|Withdrawal by Subject|0|||
37644619|NCT01371565|69113536|FG000|Overall Study|Withdrawal by Subject|1|||
37644620|NCT01371565|69113536|FG000|Overall Study|Death|1|||
37644621|NCT01371565|69113536|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
37644622|NCT02821819|69113544|FG000|Overall Study|Protocol Violation|1|||
37644623|NCT03926611|69113555|FG000|Overall Study|Adverse Event|0|||
37644624|NCT03926611|69113556|FG001|Overall Study|Adverse Event|0|||
37644625|NCT03926611|69113557|FG002|Overall Study|Adverse Event|0|||
37644626|NCT03926611|69113558|FG003|Overall Study|Adverse Event|3|||
37644627|NCT03926611|69113559|FG004|Overall Study|Adverse Event|1|||
37644628|NCT03926611|69113560|FG005|Overall Study|Adverse Event|3|||
37644629|NCT03926611|69113561|FG006|Overall Study|Adverse Event|0|||
37644630|NCT03926611|69113555|FG000|Overall Study|Lack of Efficacy|1|||
37644631|NCT03926611|69113556|FG001|Overall Study|Lack of Efficacy|2|||
37644632|NCT03926611|69113557|FG002|Overall Study|Lack of Efficacy|0|||
37644633|NCT03926611|69113558|FG003|Overall Study|Lack of Efficacy|0|||
37644634|NCT03926611|69113559|FG004|Overall Study|Lack of Efficacy|1|||
37644635|NCT03926611|69113560|FG005|Overall Study|Lack of Efficacy|0|||
37644636|NCT03926611|69113561|FG006|Overall Study|Lack of Efficacy|1|||
37644637|NCT03926611|69113555|FG000|Overall Study|Physician Decision|0|||
37644638|NCT03926611|69113556|FG001|Overall Study|Physician Decision|0|||
37644639|NCT03926611|69113557|FG002|Overall Study|Physician Decision|0|||
37644640|NCT03926611|69113558|FG003|Overall Study|Physician Decision|0|||
37644641|NCT03926611|69113559|FG004|Overall Study|Physician Decision|0|||
37644642|NCT03926611|69113560|FG005|Overall Study|Physician Decision|1|||
37644643|NCT03926611|69113561|FG006|Overall Study|Physician Decision|0|||
37644644|NCT03926611|69113555|FG000|Overall Study|Protocol Violation|1|||
37644645|NCT03926611|69113556|FG001|Overall Study|Protocol Violation|0|||
37644646|NCT03926611|69113557|FG002|Overall Study|Protocol Violation|0|||
37644647|NCT03926611|69113558|FG003|Overall Study|Protocol Violation|1|||
37644648|NCT03926611|69113559|FG004|Overall Study|Protocol Violation|1|||
37644649|NCT03926611|69113560|FG005|Overall Study|Protocol Violation|1|||
37644650|NCT03926611|69113561|FG006|Overall Study|Protocol Violation|1|||
37644651|NCT03926611|69113555|FG000|Overall Study|Technical problems|0|||
37644652|NCT03926611|69113556|FG001|Overall Study|Technical problems|0|||
37644653|NCT03926611|69113557|FG002|Overall Study|Technical problems|0|||
37644654|NCT03926611|69113558|FG003|Overall Study|Technical problems|0|||
37644655|NCT03926611|69113559|FG004|Overall Study|Technical problems|0|||
37644656|NCT03926611|69113560|FG005|Overall Study|Technical problems|1|||
37644657|NCT03926611|69113561|FG006|Overall Study|Technical problems|0|||
37644658|NCT03926611|69113555|FG000|Overall Study|Withdrawal by Subject|1|||
37644659|NCT03926611|69113556|FG001|Overall Study|Withdrawal by Subject|1|||
37644660|NCT03926611|69113557|FG002|Overall Study|Withdrawal by Subject|1|||
37644661|NCT03926611|69113558|FG003|Overall Study|Withdrawal by Subject|0|||
37644662|NCT03926611|69113559|FG004|Overall Study|Withdrawal by Subject|0|||
37644663|NCT03926611|69113560|FG005|Overall Study|Withdrawal by Subject|1|||
37644664|NCT03926611|69113561|FG006|Overall Study|Withdrawal by Subject|3|||
37644665|NCT03926611|69113555|FG000|Overall Study|Covid-19 pandemic|0|||
37644666|NCT03926611|69113556|FG001|Overall Study|Covid-19 pandemic|0|||
37644667|NCT03926611|69113557|FG002|Overall Study|Covid-19 pandemic|1|||
37644668|NCT03926611|69113558|FG003|Overall Study|Covid-19 pandemic|0|||
37644669|NCT03926611|69113559|FG004|Overall Study|Covid-19 pandemic|1|||
37644670|NCT03926611|69113560|FG005|Overall Study|Covid-19 pandemic|2|||
37644671|NCT03926611|69113561|FG006|Overall Study|Covid-19 pandemic|0|||
37644672|NCT02818777|69113590|FG000|Overall Study|Adverse Event|3|||
37644673|NCT02817841|69113604|FG000|Overall Study|Lost to Follow-up|287|||
37644674|NCT02817841|69113604|FG000|Overall Study|Withdrawal by Subject|183|||
37644675|NCT02817841|69113604|FG000|Overall Study|Adverse event not related to bleeding|131|||
37644676|NCT02817841|69113604|FG000|Overall Study|Adverse event related to bleeding|51|||
37644677|NCT02817841|69113604|FG000|Overall Study|Pregnancy|32|||
37644678|NCT02817841|69113604|FG000|Overall Study|Pregnancy wish|17|||
37644679|NCT02817841|69113604|FG000|Overall Study|Other reasons|53|||
38032160|NCT03334214|69718076|FG001|Overall Study|Other|0|||
37644680|NCT02817841|69113604|FG000|Overall Study|Protocol Violation|94|||
37644681|NCT02814565|69113614|FG000|Overall Study|Lack of Efficacy|0|||
37644682|NCT02814565|69113615|FG001|Overall Study|Lack of Efficacy|1|||
37644683|NCT02814565|69113614|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
37644684|NCT02814565|69113615|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
37644685|NCT02650466|69113621|FG000|Overall Study|Physician Decision|1|||
37644686|NCT02650466|69113621|FG000|Overall Study|Withdrawal by Subject|5|||
37644687|NCT02650466|69113621|FG000|Overall Study|Lost to Follow-up|1|||
37644688|NCT02815735|69113627|FG000|First Intervention (4 Weeks)|Discomfort|1|||
37644689|NCT02815735|69113628|FG001|First Intervention (4 Weeks)|Discomfort|0|||
37644690|NCT02815735|69113627|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
37644691|NCT02815735|69113628|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
37644692|NCT02815735|69113627|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
37644693|NCT02815735|69113628|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
37644694|NCT02815735|69113627|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
37644695|NCT02815735|69113628|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
37644696|NCT02814643|69113645|FG000|Overall Study|Lost to Follow-up|0|||
37644697|NCT02814643|69113646|FG001|Overall Study|Lost to Follow-up|1|||
37644698|NCT02814643|69113645|FG000|Overall Study|Withdrawal by Subject|1|||
37644699|NCT02814643|69113646|FG001|Overall Study|Withdrawal by Subject|2|||
37644700|NCT02724111|69113654|FG000|Overall Study|Protocol Violation|2|||
37644701|NCT02724111|69113655|FG001|Overall Study|Protocol Violation|5|||
37644702|NCT02649218|69113661|FG000|Overall Study|Adverse Event|8|||
37644703|NCT02649218|69113661|FG000|Overall Study|Lack of Efficacy|8|||
37644704|NCT02649218|69113661|FG000|Overall Study|Pregnancy|3|||
37644705|NCT02649218|69113661|FG000|Overall Study|Protocol Violation|3|||
37644706|NCT02649218|69113661|FG000|Overall Study|Physician Decision|1|||
37644707|NCT02649218|69113661|FG000|Overall Study|Withdrawal by Subject|2|||
37644708|NCT02814175|69113668|FG000|Part 1|Adverse Event|2|||
37644709|NCT02814175|69113669|FG001|Part 1|Adverse Event|3|||
37644710|NCT02814175|69113670|FG002|Part 1|Adverse Event|0|||
37644711|NCT02814175|69113671|FG003|Part 1|Adverse Event|0|||
37644712|NCT02814175|69113672|FG004|Part 1|Adverse Event|0|||
37644713|NCT02814175|69113673|FG005|Part 1|Adverse Event|0|||
37644714|NCT02814175|69113668|FG000|Part 1|Withdrawal Consent|8|||
37644715|NCT02814175|69113669|FG001|Part 1|Withdrawal Consent|1|||
37644716|NCT02814175|69113670|FG002|Part 1|Withdrawal Consent|0|||
37644717|NCT02814175|69113671|FG003|Part 1|Withdrawal Consent|0|||
37644718|NCT02814175|69113672|FG004|Part 1|Withdrawal Consent|0|||
37644719|NCT02814175|69113673|FG005|Part 1|Withdrawal Consent|0|||
37644720|NCT02814175|69113668|FG000|Part 1|Lost to Follow-up|1|||
37644721|NCT02814175|69113669|FG001|Part 1|Lost to Follow-up|0|||
37644722|NCT02814175|69113670|FG002|Part 1|Lost to Follow-up|0|||
37644723|NCT02814175|69113671|FG003|Part 1|Lost to Follow-up|0|||
37644724|NCT02814175|69113672|FG004|Part 1|Lost to Follow-up|0|||
37644725|NCT02814175|69113673|FG005|Part 1|Lost to Follow-up|0|||
37644726|NCT02814175|69113668|FG000|Part 1|Lack of Efficacy|1|||
37644727|NCT02814175|69113669|FG001|Part 1|Lack of Efficacy|2|||
37644728|NCT02814175|69113670|FG002|Part 1|Lack of Efficacy|0|||
37644729|NCT02814175|69113671|FG003|Part 1|Lack of Efficacy|0|||
37644730|NCT02814175|69113672|FG004|Part 1|Lack of Efficacy|0|||
37644731|NCT02814175|69113673|FG005|Part 1|Lack of Efficacy|0|||
37644732|NCT02814175|69113668|FG000|Part 2|Adverse Event|0|||
37644733|NCT02814175|69113669|FG001|Part 2|Adverse Event|0|||
37644734|NCT02814175|69113670|FG002|Part 2|Adverse Event|0|||
37644735|NCT02814175|69113671|FG003|Part 2|Adverse Event|1|||
37644736|NCT02814175|69113672|FG004|Part 2|Adverse Event|1|||
37644737|NCT02814175|69113673|FG005|Part 2|Adverse Event|2|||
37644738|NCT02814175|69113668|FG000|Part 2|Withdrawal Consent|0|||
37644739|NCT02814175|69113669|FG001|Part 2|Withdrawal Consent|0|||
37644740|NCT02814175|69113670|FG002|Part 2|Withdrawal Consent|0|||
37644741|NCT02814175|69113671|FG003|Part 2|Withdrawal Consent|2|||
37644742|NCT02814175|69113672|FG004|Part 2|Withdrawal Consent|1|||
37644743|NCT02814175|69113673|FG005|Part 2|Withdrawal Consent|1|||
37644744|NCT02814175|69113668|FG000|Part 2|Lost to Follow-up|0|||
37644745|NCT02814175|69113669|FG001|Part 2|Lost to Follow-up|0|||
37644746|NCT02814175|69113670|FG002|Part 2|Lost to Follow-up|0|||
37644747|NCT02814175|69113671|FG003|Part 2|Lost to Follow-up|1|||
37644748|NCT02814175|69113672|FG004|Part 2|Lost to Follow-up|0|||
37644749|NCT02814175|69113673|FG005|Part 2|Lost to Follow-up|0|||
37644750|NCT02814175|69113668|FG000|Part 2|Lack of Efficacy|0|||
37644751|NCT02814175|69113669|FG001|Part 2|Lack of Efficacy|0|||
37644752|NCT02814175|69113670|FG002|Part 2|Lack of Efficacy|0|||
37644753|NCT02814175|69113671|FG003|Part 2|Lack of Efficacy|0|||
37644754|NCT02814175|69113672|FG004|Part 2|Lack of Efficacy|0|||
37644755|NCT02814175|69113673|FG005|Part 2|Lack of Efficacy|3|||
37644756|NCT01335997|69113689|FG000|Period I and II|Adverse Event|63|||
37644757|NCT01335997|69113690|FG001|Period I and II|Adverse Event|43|||
37644758|NCT01335997|69113689|FG000|Period I and II|Noncompliance with Study Drug|1|||
37644759|NCT01335997|69113690|FG001|Period I and II|Noncompliance with Study Drug|1|||
37644760|NCT01335997|69113689|FG000|Period I and II|Lost to Follow-up|3|||
37644761|NCT01335997|69113690|FG001|Period I and II|Lost to Follow-up|5|||
37644762|NCT01335997|69113689|FG000|Period I and II|Withdrawal by Subject|9|||
37644763|NCT01335997|69113690|FG001|Period I and II|Withdrawal by Subject|4|||
37644764|NCT01335997|69113689|FG000|Period I and II|Study Terminated by Sponsor|406|||
37644765|NCT01335997|69113690|FG001|Period I and II|Study Terminated by Sponsor|415|||
37644766|NCT01335997|69113689|FG000|Period I and II|Protocol Violation|9|||
37644767|NCT01335997|69113690|FG001|Period I and II|Protocol Violation|10|||
37644768|NCT01335997|69113689|FG000|Period I and II|Physician Decision|2|||
37644769|NCT01335997|69113690|FG001|Period I and II|Physician Decision|1|||
37644770|NCT01335997|69113689|FG000|Period III|Adverse Event|0|||
37644771|NCT01335997|69113690|FG001|Period III|Adverse Event|2|||
37644772|NCT01335997|69113689|FG000|Period III|Study Terminated by Sponsor|77|||
37644773|NCT01335997|69113690|FG001|Period III|Study Terminated by Sponsor|76|||
37644774|NCT01335997|69113689|FG000|Period III|Protocol Violation|0|||
37644775|NCT01335997|69113690|FG001|Period III|Protocol Violation|1|||
37644776|NCT01335997|69113689|FG000|Period III|Lost to Follow-up|1|||
37644777|NCT01335997|69113690|FG001|Period III|Lost to Follow-up|0|||
37644778|NCT02725671|69113698|FG000|Overall Study|Lost to Follow-up|1|||
37644779|NCT02446990|69113706|FG000|Overall Study|Death|485|||
37644780|NCT02446990|69113707|FG001|Overall Study|Death|458|||
37644781|NCT02446990|69113706|FG000|Overall Study|Lost to Follow-up|3|||
37644782|NCT02446990|69113707|FG001|Overall Study|Lost to Follow-up|1|||
37644783|NCT02446990|69113706|FG000|Overall Study|Physician Decision|1|||
37644784|NCT02446990|69113707|FG001|Overall Study|Physician Decision|0|||
37644785|NCT02446990|69113706|FG000|Overall Study|Withdrawal by Subject|231|||
37644786|NCT02446990|69113707|FG001|Overall Study|Withdrawal by Subject|199|||
37644787|NCT02725515|69113715|FG000|Overall Study|Refused infusion (no study treatment)|1|||
37644788|NCT02725515|69113716|FG001|Overall Study|Refused infusion (no study treatment)|0|||
37644789|NCT02725515|69113715|FG000|Overall Study|Loss of Improvement per Protocol|14|||
37644790|NCT02725515|69113716|FG001|Overall Study|Loss of Improvement per Protocol|25|||
37644791|NCT02725515|69113715|FG000|Overall Study|Withdrawal by Subject|2|||
37644792|NCT02725515|69113716|FG001|Overall Study|Withdrawal by Subject|1|||
37644793|NCT02725515|69113715|FG000|Overall Study|Non-Compliance With Study Drug|0|||
37644794|NCT02725515|69113716|FG001|Overall Study|Non-Compliance With Study Drug|3|||
37644795|NCT02725515|69113715|FG000|Overall Study|Lost to Follow-up|1|||
37644796|NCT02725515|69113716|FG001|Overall Study|Lost to Follow-up|1|||
37644797|NCT02725515|69113715|FG000|Overall Study|Adverse Event|7|||
37644798|NCT02725515|69113716|FG001|Overall Study|Adverse Event|2|||
37644799|NCT02725515|69113715|FG000|Overall Study|No Documented Disease Improvement|0|||
37644800|NCT02725515|69113716|FG001|Overall Study|No Documented Disease Improvement|1|||
37644801|NCT02725515|69113715|FG000|Overall Study|Completed Study Under Original Protocol|0|||
37644802|NCT02725515|69113716|FG001|Overall Study|Completed Study Under Original Protocol|1|||
37644803|NCT02725515|69113715|FG000|Overall Study|Lack of Response|0|||
37644804|NCT02725515|69113716|FG001|Overall Study|Lack of Response|1|||
37644805|NCT02416180|69113722|FG000|Overall Study|Withdrawal by Subject|1|||
37644806|NCT02473510|69113728|FG000|Overall Study|Lost to Follow-up|1|||
37644807|NCT02473510|69113729|FG001|Overall Study|Lost to Follow-up|2|||
37644808|NCT02445586|69113735|FG000|Overall Study|Death|14|||
37644809|NCT02445586|69113735|FG000|Overall Study|Withdrawal by Subject|13|||
37644810|NCT02445586|69113735|FG000|Overall Study|Disease Progression|10|||
37644811|NCT02445586|69113735|FG000|Overall Study|Protocol Violation|1|||
37644812|NCT02445586|69113735|FG000|Overall Study|Medical Condition|1|||
37644813|NCT01674062|69113741|FG000|Overall Study|Insufficient Therapeutic Response|56|||
37644814|NCT01674062|69113742|FG001|Overall Study|Insufficient Therapeutic Response|26|||
37644815|NCT01674062|69113741|FG000|Overall Study|Other|8|||
37644816|NCT01674062|69113742|FG001|Overall Study|Other|1|||
37644817|NCT01674062|69113741|FG000|Overall Study|Adverse Event|1|||
37644818|NCT01674062|69113742|FG001|Overall Study|Adverse Event|1|||
37644819|NCT01674062|69113741|FG000|Overall Study|Death|0|||
37644820|NCT01674062|69113742|FG001|Overall Study|Death|1|||
37644821|NCT01674062|69113741|FG000|Overall Study|Programming Error|1|||
37644822|NCT01674062|69113742|FG001|Overall Study|Programming Error|0|||
37644823|NCT02472886|69113751|FG000|Overall Study|Lack of Efficacy|0|||
37644824|NCT02472886|69113752|FG001|Overall Study|Lack of Efficacy|2|||
37644825|NCT02472886|69113753|FG002|Overall Study|Lack of Efficacy|1|||
37644826|NCT02472652|69113766|FG000|Overall Study|Lost to Follow-up|1|||
37644827|NCT02807857|69113770|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
37644828|NCT02807857|69113770|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
37644829|NCT02807857|69113770|FG000|Follow-Up Set|Withdrawal by Subject|8|||
37644830|NCT02807857|69113770|FG000|Follow-Up Set|Lost to Follow-up|7|||
37644831|NCT02807857|69113770|FG000|Follow-Up Set|Physician Decision|6|||
37644832|NCT02807857|69113770|FG000|Follow-Up Set|Adverse Event|3|||
37644833|NCT02807857|69113770|FG000|Follow-Up Set|Death|27|||
37644834|NCT02807857|69113770|FG000|Follow-Up Set|Relocation|2|||
37644835|NCT02648438|69113783|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
37644836|NCT02648438|69113784|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
37644837|NCT02648438|69113785|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
37644838|NCT02648438|69113783|FG000|Overall Study|Protocol Violation|2|||
37644839|NCT02648438|69113784|FG001|Overall Study|Protocol Violation|0|||
37644840|NCT02648438|69113785|FG002|Overall Study|Protocol Violation|0|||
37644841|NCT02648438|69113783|FG000|Overall Study|Withdrawal by Subject|1|||
37644842|NCT02648438|69113784|FG001|Overall Study|Withdrawal by Subject|1|||
37644843|NCT02648438|69113785|FG002|Overall Study|Withdrawal by Subject|0|||
37644844|NCT02415556|69113805|FG000|Overall Study|Adverse Event|3|||
37644845|NCT02415556|69113806|FG001|Overall Study|Adverse Event|4|||
37644846|NCT02415556|69113807|FG002|Overall Study|Adverse Event|2|||
37644847|NCT02415556|69113808|FG003|Overall Study|Adverse Event|4|||
37644848|NCT02415556|69113805|FG000|Overall Study|Lost to Follow-up|4|||
37644849|NCT02415556|69113806|FG001|Overall Study|Lost to Follow-up|5|||
37644850|NCT02415556|69113807|FG002|Overall Study|Lost to Follow-up|4|||
37644851|NCT02415556|69113808|FG003|Overall Study|Lost to Follow-up|1|||
37644852|NCT02415556|69113805|FG000|Overall Study|Withdrawal by Subject|13|||
37644853|NCT02415556|69113806|FG001|Overall Study|Withdrawal by Subject|4|||
37644854|NCT02415556|69113807|FG002|Overall Study|Withdrawal by Subject|14|||
37644855|NCT02415556|69113808|FG003|Overall Study|Withdrawal by Subject|12|||
37644856|NCT02415556|69113805|FG000|Overall Study|Physician Decision|1|||
37644857|NCT02415556|69113806|FG001|Overall Study|Physician Decision|3|||
37644858|NCT02415556|69113807|FG002|Overall Study|Physician Decision|1|||
37644859|NCT02415556|69113808|FG003|Overall Study|Physician Decision|2|||
37644860|NCT02415556|69113805|FG000|Overall Study|Censored - study completion|4|||
37644861|NCT02415556|69113806|FG001|Overall Study|Censored - study completion|5|||
37644862|NCT02415556|69113807|FG002|Overall Study|Censored - study completion|1|||
37644863|NCT02415556|69113808|FG003|Overall Study|Censored - study completion|0|||
37644864|NCT02415556|69113805|FG000|Overall Study|Family-related issues|0|||
37644865|NCT02415556|69113806|FG001|Overall Study|Family-related issues|0|||
37644866|NCT02415556|69113807|FG002|Overall Study|Family-related issues|0|||
37644867|NCT02415556|69113808|FG003|Overall Study|Family-related issues|1|||
37644868|NCT02807623|69113821|FG000|Overall Study|Lost to Follow-up|23|||
37644869|NCT02807623|69113822|FG001|Overall Study|Lost to Follow-up|18|||
37644870|NCT02807623|69113823|FG002|Overall Study|Lost to Follow-up|22|||
37644871|NCT02807623|69113821|FG000|Overall Study|Drug intolerance|0|||
37644872|NCT02807623|69113822|FG001|Overall Study|Drug intolerance|1|||
37644873|NCT02807623|69113823|FG002|Overall Study|Drug intolerance|0|||
37644874|NCT02807623|69113821|FG000|Overall Study|incomplete blood draw|0|||
37644875|NCT02807623|69113822|FG001|Overall Study|incomplete blood draw|2|||
37644876|NCT02807623|69113823|FG002|Overall Study|incomplete blood draw|1|||
37644877|NCT02805907|69113842|FG000|Overall Study|Lost to Follow-up|3|||
37644878|NCT02805907|69113843|FG001|Overall Study|Lost to Follow-up|3|||
37644879|NCT02723175|69113851|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
37644880|NCT02723175|69113852|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
37644881|NCT02723175|69113851|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
37644882|NCT02723175|69113852|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
37644883|NCT02801617|69113860|FG000|Overall Study|Protocol Violation|2|||
37644884|NCT02801617|69113861|FG001|Overall Study|Protocol Violation|6|||
37644885|NCT01334515|69113873|FG000|Overall Study|Adverse Event|1|||
37644886|NCT01334515|69113874|FG001|Overall Study|Adverse Event|6|||
37644887|NCT01334515|69113873|FG000|Overall Study|Death|1|||
37644888|NCT01334515|69113874|FG001|Overall Study|Death|0|||
37644889|NCT01334515|69113873|FG000|Overall Study|Lack of Efficacy|8|||
37644890|NCT01334515|69113874|FG001|Overall Study|Lack of Efficacy|21|||
37644891|NCT01334515|69113873|FG000|Overall Study|Physician Decision|1|||
37644892|NCT01334515|69113874|FG001|Overall Study|Physician Decision|1|||
37644893|NCT01334515|69113873|FG000|Overall Study|Withdrawal by Subject|1|||
37644894|NCT01334515|69113874|FG001|Overall Study|Withdrawal by Subject|1|||
37644895|NCT02802319|69113882|FG000|Overall Study|Physician Decision|2|||
37644896|NCT02802319|69113883|FG001|Overall Study|Physician Decision|1|||
37644897|NCT02802319|69113882|FG000|Overall Study|Lost to Follow-up|0|||
37644898|NCT02802319|69113883|FG001|Overall Study|Lost to Follow-up|4|||
37644899|NCT02415400|69113893|FG000|Overall Study|Adverse Event|0|||
37644900|NCT02415400|69113894|FG001|Overall Study|Adverse Event|1|||
37644901|NCT02415400|69113895|FG002|Overall Study|Adverse Event|1|||
37644902|NCT02415400|69113896|FG003|Overall Study|Adverse Event|2|||
37644903|NCT02415400|69113893|FG000|Overall Study|Participant request to stop therapy|4|||
37644904|NCT02415400|69113894|FG001|Overall Study|Participant request to stop therapy|3|||
37644905|NCT02415400|69113895|FG002|Overall Study|Participant request to stop therapy|8|||
37644906|NCT02415400|69113896|FG003|Overall Study|Participant request to stop therapy|6|||
37644907|NCT02415400|69113893|FG000|Overall Study|Participant withdrew consent|14|||
37644908|NCT02415400|69113894|FG001|Overall Study|Participant withdrew consent|12|||
37644909|NCT02415400|69113895|FG002|Overall Study|Participant withdrew consent|30|||
37644910|NCT02415400|69113896|FG003|Overall Study|Participant withdrew consent|21|||
37644911|NCT02415400|69113893|FG000|Overall Study|Death|39|||
37644912|NCT02415400|69113894|FG001|Overall Study|Death|41|||
37644913|NCT02415400|69113895|FG002|Overall Study|Death|35|||
37644914|NCT02415400|69113896|FG003|Overall Study|Death|42|||
37644915|NCT02415400|69113893|FG000|Overall Study|Lost to Follow-up|3|||
37644916|NCT02415400|69113894|FG001|Overall Study|Lost to Follow-up|3|||
37644917|NCT02415400|69113895|FG002|Overall Study|Lost to Follow-up|2|||
37644918|NCT02415400|69113896|FG003|Overall Study|Lost to Follow-up|5|||
37644919|NCT02415400|69113893|FG000|Overall Study|Poor/Non-Compliance|0|||
37644920|NCT02415400|69113894|FG001|Overall Study|Poor/Non-Compliance|1|||
37644921|NCT02415400|69113895|FG002|Overall Study|Poor/Non-Compliance|3|||
37644922|NCT02415400|69113896|FG003|Overall Study|Poor/Non-Compliance|4|||
37644923|NCT02415400|69113893|FG000|Overall Study|Participant no longer meets criteria|2|||
37644924|NCT02415400|69113894|FG001|Overall Study|Participant no longer meets criteria|0|||
37644925|NCT02415400|69113895|FG002|Overall Study|Participant no longer meets criteria|0|||
37644926|NCT02415400|69113896|FG003|Overall Study|Participant no longer meets criteria|1|||
37644927|NCT02415400|69113893|FG000|Overall Study|Participant doesn't answer phone|1|||
37644928|NCT02415400|69113894|FG001|Overall Study|Participant doesn't answer phone|0|||
37644929|NCT02415400|69113895|FG002|Overall Study|Participant doesn't answer phone|0|||
37644930|NCT02415400|69113896|FG003|Overall Study|Participant doesn't answer phone|0|||
37644931|NCT02415400|69113893|FG000|Overall Study|Participant wanted home visits|1|||
37644932|NCT02415400|69113894|FG001|Overall Study|Participant wanted home visits|0|||
37644933|NCT02415400|69113895|FG002|Overall Study|Participant wanted home visits|0|||
37644934|NCT02415400|69113896|FG003|Overall Study|Participant wanted home visits|0|||
37644935|NCT02415400|69113893|FG000|Overall Study|Randomized in error|2|||
37922036|NCT00666718|69608849|FG001|Overall Study|Protocol Violation|3|||
37922037|NCT00666718|69608848|FG000|Overall Study|Withdrawal by Subject|7|||
37922038|NCT00666718|69608849|FG001|Overall Study|Withdrawal by Subject|12|||
37922039|NCT00666718|69608848|FG000|Overall Study|Physician Decision|0|||
37922040|NCT00666718|69608849|FG001|Overall Study|Physician Decision|2|||
37922041|NCT00667420|69608855|FG000|Overall Study|Adverse Event|2|||
37922042|NCT00667420|69608855|FG000|Overall Study|Lack of Efficacy|5|||
37922043|NCT00667420|69608855|FG000|Overall Study|Physician Decision|1|||
37922044|NCT00667420|69608855|FG000|Overall Study|Withdrawal by Subject|2|||
37644936|NCT02415400|69113894|FG001|Overall Study|Randomized in error|0|||
37644937|NCT02415400|69113895|FG002|Overall Study|Randomized in error|0|||
37644938|NCT02415400|69113896|FG003|Overall Study|Randomized in error|0|||
37644939|NCT02415400|69113893|FG000|Overall Study|No study drug on site|0|||
37644940|NCT02415400|69113894|FG001|Overall Study|No study drug on site|1|||
37644941|NCT02415400|69113895|FG002|Overall Study|No study drug on site|0|||
37644942|NCT02415400|69113896|FG003|Overall Study|No study drug on site|0|||
37644943|NCT02415400|69113893|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
37644944|NCT02415400|69113894|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
37644945|NCT02415400|69113895|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
37644946|NCT02415400|69113896|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
37644947|NCT02415400|69113893|FG000|Overall Study|Coagulation values cannot be set|0|||
37644948|NCT02415400|69113894|FG001|Overall Study|Coagulation values cannot be set|0|||
37644949|NCT02415400|69113895|FG002|Overall Study|Coagulation values cannot be set|1|||
37644950|NCT02415400|69113896|FG003|Overall Study|Coagulation values cannot be set|0|||
37644951|NCT02415400|69113893|FG000|Overall Study|State regulations prevent participation|0|||
37644952|NCT02415400|69113894|FG001|Overall Study|State regulations prevent participation|0|||
37644953|NCT02415400|69113895|FG002|Overall Study|State regulations prevent participation|1|||
37644954|NCT02415400|69113896|FG003|Overall Study|State regulations prevent participation|0|||
37644955|NCT02415400|69113893|FG000|Overall Study|Poor treatment monitoring|0|||
37644956|NCT02415400|69113894|FG001|Overall Study|Poor treatment monitoring|0|||
37644957|NCT02415400|69113895|FG002|Overall Study|Poor treatment monitoring|1|||
37644958|NCT02415400|69113896|FG003|Overall Study|Poor treatment monitoring|0|||
37644959|NCT02415400|69113893|FG000|Overall Study|Participant in jail|0|||
37644960|NCT02415400|69113894|FG001|Overall Study|Participant in jail|0|||
37644961|NCT02415400|69113895|FG002|Overall Study|Participant in jail|1|||
37644962|NCT02415400|69113896|FG003|Overall Study|Participant in jail|0|||
37644963|NCT02415400|69113893|FG000|Overall Study|Investigator decision|0|||
37644964|NCT02415400|69113894|FG001|Overall Study|Investigator decision|0|||
37644965|NCT02415400|69113895|FG002|Overall Study|Investigator decision|1|||
37644966|NCT02415400|69113896|FG003|Overall Study|Investigator decision|1|||
37644967|NCT02415400|69113893|FG000|Overall Study|Site closure; participant won't transfer|0|||
37644968|NCT02415400|69113894|FG001|Overall Study|Site closure; participant won't transfer|0|||
37644969|NCT02415400|69113895|FG002|Overall Study|Site closure; participant won't transfer|0|||
37854468|NCT01232283|69537960|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
37854469|NCT01232283|69537961|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
37854470|NCT01232283|69537952|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
37854471|NCT01232283|69537953|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
37854472|NCT01232283|69537954|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
37854473|NCT01232283|69537955|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
37854474|NCT01232283|69537956|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
37854475|NCT01232283|69537957|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
37854476|NCT01232283|69537958|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
37854477|NCT01232283|69537959|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
37854478|NCT01232283|69537960|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
37854479|NCT01232283|69537961|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
37644970|NCT02415400|69113896|FG003|Overall Study|Site closure; participant won't transfer|1|||
37644971|NCT04194801|69113913|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
37644972|NCT04194801|69113914|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
37644973|NCT04194801|69113915|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
37644974|NCT04194801|69113913|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
37644975|NCT04194801|69113914|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
37644976|NCT04194801|69113915|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
37644977|NCT04194801|69113913|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
37644978|NCT04194801|69113914|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
37644979|NCT04194801|69113915|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
37644980|NCT04194801|69113913|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
37644981|NCT04194801|69113914|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
37644982|NCT04194801|69113915|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
37644983|NCT04194801|69113913|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
37644984|NCT04194801|69113914|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
37644985|NCT04194801|69113915|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
37644986|NCT04194801|69113913|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
37644987|NCT04194801|69113914|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
37644988|NCT04194801|69113915|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
37644989|NCT04194801|69113913|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
37644990|NCT04194801|69113914|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
37644991|NCT04194801|69113915|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
37644992|NCT04194801|69113913|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
37644993|NCT04194801|69113914|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
37644994|NCT04194801|69113915|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
37644995|NCT04194801|69113913|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
37644996|NCT04194801|69113914|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
37644997|NCT04194801|69113915|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
37644998|NCT04194801|69113913|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
37644999|NCT04194801|69113914|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
37645000|NCT04194801|69113915|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
37645001|NCT04194801|69113913|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
37645002|NCT04194801|69113914|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
37645003|NCT04194801|69113915|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
37645004|NCT04194801|69113913|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
37645005|NCT04194801|69113914|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
37645006|NCT04194801|69113915|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
37645007|NCT04194801|69113913|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
37645008|NCT04194801|69113914|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
37645009|NCT04194801|69113915|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
37645010|NCT04194801|69113913|FG000|Part Ib/II End of Study|Death|2|||
37645011|NCT04194801|69113914|FG001|Part Ib/II End of Study|Death|3|||
37645012|NCT04194801|69113915|FG002|Part Ib/II End of Study|Death|3|||
37645013|NCT04194801|69113913|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
37645014|NCT04194801|69113914|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
37645015|NCT04194801|69113915|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
37645016|NCT04194801|69113913|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
37645017|NCT04194801|69113914|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
37645018|NCT04194801|69113915|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
37645019|NCT04194801|69113913|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
37645020|NCT04194801|69113914|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
37645021|NCT04194801|69113915|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
37645022|NCT04194801|69113913|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
37645023|NCT04194801|69113914|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
37645024|NCT04194801|69113915|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
37645025|NCT02802865|69113939|FG000|Overall Study|Pregnancy|1|||
37645026|NCT02802865|69113940|FG001|Overall Study|Pregnancy|1|||
37645027|NCT02802865|69113939|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
37645028|NCT02802865|69113940|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
37645029|NCT02414932|69113948|FG000|Overall Study|Withdrawal by Subject|2|||
37645030|NCT02414932|69113949|FG001|Overall Study|Withdrawal by Subject|3|||
37645031|NCT02414932|69113948|FG000|Overall Study|Adverse Event|1|||
37645032|NCT02414932|69113949|FG001|Overall Study|Adverse Event|0|||
37645033|NCT00704535|69113955|FG000|Overall Study|Adverse Event|2|||
37645034|NCT00704535|69113955|FG000|Overall Study|Death|2|||
37645035|NCT00704535|69113955|FG000|Overall Study|Lost to Follow-up|8|||
37645036|NCT00704535|69113955|FG000|Overall Study|Protocol Violation|10|||
37645037|NCT00704535|69113955|FG000|Overall Study|Completed status not on Case Report Form|124|||
37645038|NCT01740687|69113959|FG000|Overall Study|Lost to Follow-up|11|||
37645039|NCT01740687|69113959|FG000|Overall Study|Withdrawal by Subject|2|||
37645040|NCT01740687|69113959|FG000|Overall Study|other reason|22|||
37645041|NCT01740687|69113959|FG000|Overall Study|treatment not received|2|||
37645042|NCT02648204|69113967|FG000|Overall Study|Withdrawal by Subject|12|||
37645043|NCT02648204|69113968|FG001|Overall Study|Withdrawal by Subject|8|||
37645044|NCT02648204|69113969|FG002|Overall Study|Withdrawal by Subject|2|||
37645045|NCT02648204|69113970|FG003|Overall Study|Withdrawal by Subject|6|||
37645046|NCT02648204|69113967|FG000|Overall Study|Lost to Follow-up|5|||
37645047|NCT02648204|69113968|FG001|Overall Study|Lost to Follow-up|8|||
37645048|NCT02648204|69113969|FG002|Overall Study|Lost to Follow-up|4|||
37645049|NCT02648204|69113970|FG003|Overall Study|Lost to Follow-up|6|||
37645050|NCT02648204|69113967|FG000|Overall Study|Missing follow-up information|4|||
37645051|NCT02648204|69113968|FG001|Overall Study|Missing follow-up information|4|||
37645052|NCT02648204|69113969|FG002|Overall Study|Missing follow-up information|4|||
37645053|NCT02648204|69113970|FG003|Overall Study|Missing follow-up information|2|||
37645054|NCT02648204|69113967|FG000|Overall Study|Death|1|||
37645055|NCT02648204|69113968|FG001|Overall Study|Death|1|||
37645056|NCT02648204|69113969|FG002|Overall Study|Death|2|||
37645057|NCT02648204|69113970|FG003|Overall Study|Death|2|||
37645058|NCT02648204|69113967|FG000|Overall Study|Adverse Event|0|||
37645059|NCT02648204|69113968|FG001|Overall Study|Adverse Event|0|||
37645060|NCT02648204|69113969|FG002|Overall Study|Adverse Event|1|||
37645061|NCT02648204|69113970|FG003|Overall Study|Adverse Event|0|||
37645062|NCT02799745|69113982|FG000|Overall Study|Participant moved out of state|1|||
37645063|NCT02799745|69113983|FG001|Overall Study|Participant moved out of state|0|||
37645064|NCT02799745|69113982|FG000|Overall Study|Discontinued due to planned surgery|1|||
37645065|NCT02799745|69113983|FG001|Overall Study|Discontinued due to planned surgery|0|||
37645066|NCT02799745|69113982|FG000|Overall Study|Withdrawal by Subject|16|||
37645067|NCT02799745|69113983|FG001|Overall Study|Withdrawal by Subject|25|||
37645068|NCT02799745|69113982|FG000|Overall Study|Protocol Deviation|4|||
37645069|NCT02799745|69113983|FG001|Overall Study|Protocol Deviation|5|||
37645070|NCT02799745|69113982|FG000|Overall Study|Progressive Disease|28|||
37645071|NCT02799745|69113983|FG001|Overall Study|Progressive Disease|38|||
37645072|NCT02799745|69113982|FG000|Overall Study|Lost to Follow-up|3|||
37645073|NCT02799745|69113983|FG001|Overall Study|Lost to Follow-up|2|||
37645074|NCT02799745|69113982|FG000|Overall Study|Death|3|||
37645075|NCT02799745|69113983|FG001|Overall Study|Death|0|||
37645076|NCT02799745|69113982|FG000|Overall Study|Adverse Event|0|||
37645077|NCT02799745|69113983|FG001|Overall Study|Adverse Event|1|||
37645078|NCT00705159|69113993|FG000|Overall Study|Withdrawal by Subject|0|||
37645079|NCT00705159|69113994|FG001|Overall Study|Withdrawal by Subject|1|||
37645080|NCT00705159|69113995|FG002|Overall Study|Withdrawal by Subject|1|||
37645081|NCT00705159|69113996|FG003|Overall Study|Withdrawal by Subject|1|||
37645082|NCT00705159|69113993|FG000|Overall Study|Protocol Violation|0|||
37645083|NCT00705159|69113994|FG001|Overall Study|Protocol Violation|1|||
37645084|NCT00705159|69113995|FG002|Overall Study|Protocol Violation|0|||
37645085|NCT00705159|69113996|FG003|Overall Study|Protocol Violation|0|||
37645086|NCT00705159|69113993|FG000|Overall Study|Adverse Event|0|||
37645087|NCT00705159|69113994|FG001|Overall Study|Adverse Event|0|||
37645088|NCT00705159|69113995|FG002|Overall Study|Adverse Event|1|||
37645089|NCT00705159|69113996|FG003|Overall Study|Adverse Event|0|||
37645090|NCT00705159|69113993|FG000|Overall Study|Lost to Follow-up|0|||
37645091|NCT00705159|69113994|FG001|Overall Study|Lost to Follow-up|0|||
37645092|NCT00705159|69113995|FG002|Overall Study|Lost to Follow-up|3|||
37645093|NCT00705159|69113996|FG003|Overall Study|Lost to Follow-up|2|||
37645094|NCT00705159|69113993|FG000|Overall Study|Screen Failure|0|||
37645095|NCT00705159|69113994|FG001|Overall Study|Screen Failure|0|||
37645096|NCT00705159|69113995|FG002|Overall Study|Screen Failure|0|||
37645097|NCT00705159|69113996|FG003|Overall Study|Screen Failure|1|||
37645098|NCT01673984|69114008|FG000|Overall Study|Adverse Event|1|||
37645099|NCT01673984|69114009|FG001|Overall Study|Adverse Event|0|||
37645100|NCT01673984|69114008|FG000|Overall Study|Study termination|9|||
37645101|NCT01673984|69114009|FG001|Overall Study|Study termination|6|||
37645102|NCT02332928|69114028|FG000|Overall Study|Withdrawal by Subject|0|||
37645103|NCT02332928|69114029|FG001|Overall Study|Withdrawal by Subject|2|||
37645104|NCT02332928|69114028|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
37741024|NCT01748162|69226994|FG001|Overall Study|participant consented but did not begin|1|||
37645105|NCT02332928|69114029|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
37645106|NCT02647658|69114037|FG000|Overall Study|Consent refusal|15|||
37645107|NCT02647658|69114038|FG001|Overall Study|Consent refusal|24|||
37645108|NCT00703677|69114044|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
37645109|NCT00703911|69114052|FG000|Overall Study|Death|1|||
37645110|NCT00703911|69114052|FG000|Overall Study|Physician Decision|6|||
37645111|NCT00703911|69114052|FG000|Overall Study|Lost to Follow-up|1|||
37645112|NCT00703911|69114052|FG000|Overall Study|Withdrawal by Subject|2|||
37645113|NCT02055547|69114056|FG000|Overall Study|Protocol Violation|0|||
37645114|NCT02055547|69114057|FG001|Overall Study|Protocol Violation|0|||
37854480|NCT01232283|69537952|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
37645115|NCT02055547|69114058|FG002|Overall Study|Protocol Violation|1|||
37645116|NCT02055547|69114059|FG003|Overall Study|Protocol Violation|0|||
37645117|NCT02055547|69114060|FG004|Overall Study|Protocol Violation|0|||
37645118|NCT02055547|69114061|FG005|Overall Study|Protocol Violation|0|||
37645119|NCT02055547|69114062|FG006|Overall Study|Protocol Violation|1|||
37645120|NCT02055547|69114063|FG007|Overall Study|Protocol Violation|0|||
37645121|NCT02055547|69114064|FG008|Overall Study|Protocol Violation|0|||
37645122|NCT02055547|69114065|FG009|Overall Study|Protocol Violation|0|||
37645123|NCT02055547|69114066|FG010|Overall Study|Protocol Violation|0|||
37645124|NCT02055547|69114067|FG011|Overall Study|Protocol Violation|0|||
37645125|NCT02055547|69114068|FG012|Overall Study|Protocol Violation|0|||
37645126|NCT02055547|69114069|FG013|Overall Study|Protocol Violation|0|||
37645127|NCT02055547|69114070|FG014|Overall Study|Protocol Violation|0|||
37645128|NCT02055547|69114071|FG015|Overall Study|Protocol Violation|0|||
37645129|NCT02055547|69114072|FG016|Overall Study|Protocol Violation|0|||
37645130|NCT02055547|69114073|FG017|Overall Study|Protocol Violation|0|||
37645131|NCT02055547|69114074|FG018|Overall Study|Protocol Violation|0|||
37645132|NCT02055547|69114056|FG000|Overall Study|Physician Decision|0|||
37645133|NCT02055547|69114057|FG001|Overall Study|Physician Decision|1|||
37645134|NCT02055547|69114058|FG002|Overall Study|Physician Decision|1|||
37645135|NCT02055547|69114059|FG003|Overall Study|Physician Decision|0|||
37645136|NCT02055547|69114060|FG004|Overall Study|Physician Decision|1|||
37645137|NCT02055547|69114061|FG005|Overall Study|Physician Decision|0|||
37645138|NCT02055547|69114062|FG006|Overall Study|Physician Decision|0|||
37645139|NCT02055547|69114063|FG007|Overall Study|Physician Decision|0|||
37645140|NCT02055547|69114064|FG008|Overall Study|Physician Decision|0|||
37645141|NCT02055547|69114065|FG009|Overall Study|Physician Decision|1|||
37645142|NCT02055547|69114066|FG010|Overall Study|Physician Decision|1|||
37645143|NCT02055547|69114067|FG011|Overall Study|Physician Decision|0|||
37645144|NCT02055547|69114068|FG012|Overall Study|Physician Decision|0|||
37645145|NCT02055547|69114069|FG013|Overall Study|Physician Decision|0|||
37645146|NCT02055547|69114070|FG014|Overall Study|Physician Decision|0|||
37645147|NCT02055547|69114071|FG015|Overall Study|Physician Decision|0|||
37645148|NCT02055547|69114072|FG016|Overall Study|Physician Decision|0|||
37741025|NCT01748162|69226993|FG000|Overall Study|reasons not available|3|||
37741026|NCT01748162|69226994|FG001|Overall Study|reasons not available|2|||
37741027|NCT01724216|69227000|FG000|Overall Study|Scan was not completed|1|||
37741028|NCT01723904|69227004|FG000|Overall Study|Noncompliant|3|||
37741029|NCT01723904|69227004|FG000|Overall Study|Adverse Event|5|||
37741030|NCT01723904|69227004|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
37741031|NCT01747772|69227008|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
37741032|NCT01830127|69227018|FG000|Overall Study|Adverse Event|1|||
37741033|NCT01830127|69227019|FG001|Overall Study|Adverse Event|6|||
37741034|NCT01830127|69227018|FG000|Overall Study|Lack of Efficacy|3|||
37741035|NCT01830127|69227019|FG001|Overall Study|Lack of Efficacy|0|||
37741036|NCT01830127|69227018|FG000|Overall Study|Withdrawal by Subject|1|||
37741037|NCT01830127|69227019|FG001|Overall Study|Withdrawal by Subject|1|||
37741038|NCT01830127|69227018|FG000|Overall Study|Other reason not defined above|0|||
37741039|NCT01830127|69227019|FG001|Overall Study|Other reason not defined above|2|||
37645149|NCT02055547|69114073|FG017|Overall Study|Physician Decision|0|||
37645150|NCT02055547|69114074|FG018|Overall Study|Physician Decision|0|||
37645151|NCT02055547|69114056|FG000|Overall Study|Adverse Event|0|||
37645152|NCT02055547|69114057|FG001|Overall Study|Adverse Event|0|||
37645153|NCT02055547|69114058|FG002|Overall Study|Adverse Event|0|||
37645154|NCT02055547|69114059|FG003|Overall Study|Adverse Event|0|||
37645155|NCT02055547|69114060|FG004|Overall Study|Adverse Event|0|||
37645156|NCT02055547|69114061|FG005|Overall Study|Adverse Event|0|||
37741040|NCT01614067|69227027|FG000|Overall Study|Pregnancy|1|||
37741041|NCT01614067|69227028|FG001|Overall Study|Pregnancy|0|||
37741042|NCT01614067|69227027|FG000|Overall Study|Physician Decision|6|||
37854481|NCT01232283|69537953|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
37854482|NCT01232283|69537954|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
37645157|NCT02055547|69114062|FG006|Overall Study|Adverse Event|1|||
37645158|NCT02055547|69114063|FG007|Overall Study|Adverse Event|0|||
37645159|NCT02055547|69114064|FG008|Overall Study|Adverse Event|1|||
37645160|NCT02055547|69114065|FG009|Overall Study|Adverse Event|0|||
37645161|NCT02055547|69114066|FG010|Overall Study|Adverse Event|0|||
37645162|NCT02055547|69114067|FG011|Overall Study|Adverse Event|0|||
37645163|NCT02055547|69114068|FG012|Overall Study|Adverse Event|0|||
37645164|NCT02055547|69114069|FG013|Overall Study|Adverse Event|0|||
37645165|NCT02055547|69114070|FG014|Overall Study|Adverse Event|0|||
37645166|NCT02055547|69114071|FG015|Overall Study|Adverse Event|0|||
37645167|NCT02055547|69114072|FG016|Overall Study|Adverse Event|0|||
37645168|NCT02055547|69114073|FG017|Overall Study|Adverse Event|0|||
37645169|NCT02055547|69114074|FG018|Overall Study|Adverse Event|0|||
37645170|NCT02055547|69114056|FG000|Overall Study|Withdrawal by Subject|0|||
37741043|NCT01614067|69227028|FG001|Overall Study|Physician Decision|5|||
37741044|NCT01614067|69227027|FG000|Overall Study|Withdrawal by Subject|0|||
37741045|NCT01614067|69227028|FG001|Overall Study|Withdrawal by Subject|1|||
37645171|NCT02055547|69114057|FG001|Overall Study|Withdrawal by Subject|0|||
37645172|NCT02055547|69114058|FG002|Overall Study|Withdrawal by Subject|0|||
37645173|NCT02055547|69114059|FG003|Overall Study|Withdrawal by Subject|0|||
37645174|NCT02055547|69114060|FG004|Overall Study|Withdrawal by Subject|0|||
37645175|NCT02055547|69114061|FG005|Overall Study|Withdrawal by Subject|1|||
37645176|NCT02055547|69114062|FG006|Overall Study|Withdrawal by Subject|0|||
37645177|NCT02055547|69114063|FG007|Overall Study|Withdrawal by Subject|0|||
37645178|NCT02055547|69114064|FG008|Overall Study|Withdrawal by Subject|1|||
37645179|NCT02055547|69114065|FG009|Overall Study|Withdrawal by Subject|0|||
37645180|NCT02055547|69114066|FG010|Overall Study|Withdrawal by Subject|0|||
37645181|NCT02055547|69114067|FG011|Overall Study|Withdrawal by Subject|0|||
37645182|NCT02055547|69114068|FG012|Overall Study|Withdrawal by Subject|0|||
37645183|NCT02055547|69114069|FG013|Overall Study|Withdrawal by Subject|1|||
37645184|NCT02055547|69114070|FG014|Overall Study|Withdrawal by Subject|0|||
37645185|NCT02055547|69114071|FG015|Overall Study|Withdrawal by Subject|1|||
37645186|NCT02055547|69114072|FG016|Overall Study|Withdrawal by Subject|0|||
37645187|NCT02055547|69114073|FG017|Overall Study|Withdrawal by Subject|0|||
37645188|NCT02055547|69114074|FG018|Overall Study|Withdrawal by Subject|0|||
37645189|NCT02055547|69114056|FG000|Overall Study|Lost to Follow-up|0|||
37645190|NCT02055547|69114057|FG001|Overall Study|Lost to Follow-up|0|||
37645191|NCT02055547|69114058|FG002|Overall Study|Lost to Follow-up|1|||
37645192|NCT02055547|69114059|FG003|Overall Study|Lost to Follow-up|0|||
37645193|NCT02055547|69114060|FG004|Overall Study|Lost to Follow-up|0|||
37645194|NCT02055547|69114061|FG005|Overall Study|Lost to Follow-up|0|||
37645195|NCT02055547|69114062|FG006|Overall Study|Lost to Follow-up|0|||
37645196|NCT02055547|69114063|FG007|Overall Study|Lost to Follow-up|0|||
37645197|NCT02055547|69114064|FG008|Overall Study|Lost to Follow-up|0|||
37645198|NCT02055547|69114065|FG009|Overall Study|Lost to Follow-up|0|||
37645199|NCT02055547|69114066|FG010|Overall Study|Lost to Follow-up|0|||
37645200|NCT02055547|69114067|FG011|Overall Study|Lost to Follow-up|0|||
37645201|NCT02055547|69114068|FG012|Overall Study|Lost to Follow-up|0|||
37645202|NCT02055547|69114069|FG013|Overall Study|Lost to Follow-up|0|||
37645203|NCT02055547|69114070|FG014|Overall Study|Lost to Follow-up|0|||
37645204|NCT02055547|69114071|FG015|Overall Study|Lost to Follow-up|0|||
37645205|NCT02055547|69114072|FG016|Overall Study|Lost to Follow-up|0|||
37645206|NCT02055547|69114073|FG017|Overall Study|Lost to Follow-up|0|||
37645207|NCT02055547|69114074|FG018|Overall Study|Lost to Follow-up|0|||
37645208|NCT02414854|69114112|FG000|Overall Study|Adverse Event|9|||
37645209|NCT02414854|69114113|FG001|Overall Study|Adverse Event|7|||
37645210|NCT02414854|69114114|FG002|Overall Study|Adverse Event|1|||
37645211|NCT02414854|69114115|FG003|Overall Study|Adverse Event|12|||
37645212|NCT02414854|69114112|FG000|Overall Study|Poor compliance to protocol|1|||
37645213|NCT02414854|69114113|FG001|Overall Study|Poor compliance to protocol|1|||
37645214|NCT02414854|69114114|FG002|Overall Study|Poor compliance to protocol|2|||
37645215|NCT02414854|69114115|FG003|Overall Study|Poor compliance to protocol|2|||
37645216|NCT02414854|69114112|FG000|Overall Study|Other than specified above|12|||
37645217|NCT02414854|69114113|FG001|Overall Study|Other than specified above|37|||
37645218|NCT02414854|69114114|FG002|Overall Study|Other than specified above|17|||
37645219|NCT02414854|69114115|FG003|Overall Study|Other than specified above|37|||
37645220|NCT03332498|69114128|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
37645221|NCT03332498|69114129|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
37645222|NCT03332498|69114130|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
37645223|NCT01334125|69114139|FG000|Overall Study|Lost to Follow-up|3|||
37645224|NCT01334125|69114140|FG001|Overall Study|Lost to Follow-up|3|||
37645225|NCT02414152|69114147|FG000|Overall Study|Withdrawal by Subject|1|||
37645226|NCT02414152|69114147|FG000|Overall Study|Lack of Efficacy|1|||
37854483|NCT01232283|69537955|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
37645227|NCT02413996|69114153|FG000|Overall Study|not comfortable with the intervention|9|||
37645228|NCT02413996|69114154|FG001|Overall Study|not comfortable with the intervention|2|||
37645229|NCT01333501|69114162|FG000|Overall Study|Adverse Event|3|||
37645230|NCT01333501|69114163|FG001|Overall Study|Adverse Event|1|||
37645231|NCT01333501|69114162|FG000|Overall Study|Abnormal laboratory value|2|||
37645232|NCT01333501|69114163|FG001|Overall Study|Abnormal laboratory value|1|||
37645233|NCT01333501|69114162|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
37645234|NCT01333501|69114163|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
37645235|NCT01333501|69114162|FG000|Overall Study|Withdrawn consent|3|||
37645236|NCT01333501|69114163|FG001|Overall Study|Withdrawn consent|12|||
37645237|NCT01362140|69114171|FG000|Overall Study|Noncompliance|1|||
37645238|NCT01362140|69114172|FG001|Overall Study|Noncompliance|0|||
37645239|NCT01362140|69114171|FG000|Overall Study|Adverse Event|2|||
37645240|NCT01362140|69114172|FG001|Overall Study|Adverse Event|2|||
37854484|NCT01232283|69537956|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
37645241|NCT01362140|69114171|FG000|Overall Study|Withdrawal by Subject|3|||
37645242|NCT01362140|69114172|FG001|Overall Study|Withdrawal by Subject|3|||
37645243|NCT01362140|69114171|FG000|Overall Study|Administrative Decision|0|||
37645244|NCT01362140|69114172|FG001|Overall Study|Administrative Decision|1|||
37645245|NCT01362140|69114171|FG000|Overall Study|Death|2|||
37645246|NCT01362140|69114172|FG001|Overall Study|Death|1|||
37645247|NCT01362140|69114171|FG000|Overall Study|Other|1|||
37645248|NCT01362140|69114172|FG001|Overall Study|Other|1|||
37645249|NCT01362140|69114171|FG000|Overall Study|Protocol-specified Criteria|1|||
37645250|NCT01362140|69114172|FG001|Overall Study|Protocol-specified Criteria|2|||
37645251|NCT01362140|69114171|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
37645252|NCT01362140|69114172|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
37645253|NCT01333189|69114180|FG000|Overall Study|Time constraints|1|||
37645254|NCT01333189|69114181|FG001|Overall Study|Time constraints|0|||
37645255|NCT01333189|69114180|FG000|Overall Study|Adverse Event|1|||
37645256|NCT01333189|69114181|FG001|Overall Study|Adverse Event|0|||
37645257|NCT01333189|69114180|FG000|Overall Study|Transportation difficulties|0|||
37645258|NCT01333189|69114181|FG001|Overall Study|Transportation difficulties|1|||
37645259|NCT01333189|69114180|FG000|Overall Study|Moved from region|0|||
37645260|NCT01333189|69114181|FG001|Overall Study|Moved from region|1|||
37645261|NCT01333111|69114190|FG000|Overall Study|patient undergoing major surgery|0|||
37645262|NCT01333111|69114191|FG001|Overall Study|patient undergoing major surgery|2|||
37645263|NCT01333111|69114192|FG002|Overall Study|patient undergoing major surgery|0|||
37645264|NCT01333111|69114190|FG000|Overall Study|personal reasons|0|||
37645265|NCT01333111|69114191|FG001|Overall Study|personal reasons|0|||
37645266|NCT01333111|69114192|FG002|Overall Study|personal reasons|1|||
37645267|NCT01333111|69114190|FG000|Overall Study|unclassified|1|||
37645268|NCT01333111|69114191|FG001|Overall Study|unclassified|0|||
37645269|NCT01333111|69114192|FG002|Overall Study|unclassified|0|||
37645270|NCT01333111|69114190|FG000|Overall Study|withdrawal criteria|0|||
37645271|NCT01333111|69114191|FG001|Overall Study|withdrawal criteria|1|||
37645272|NCT01333111|69114192|FG002|Overall Study|withdrawal criteria|0|||
37645273|NCT01333111|69114190|FG000|Overall Study|Non-compliance|1|||
37645274|NCT01333111|69114191|FG001|Overall Study|Non-compliance|0|||
37645275|NCT01333111|69114192|FG002|Overall Study|Non-compliance|0|||
37645276|NCT01333111|69114190|FG000|Overall Study|Ineffective therapy|0|||
37645277|NCT01333111|69114191|FG001|Overall Study|Ineffective therapy|0|||
37645278|NCT01333111|69114192|FG002|Overall Study|Ineffective therapy|1|||
37645279|NCT00702507|69114200|FG000|Initial Treatment Phase|Adverse Event|2|||
37645280|NCT00702507|69114200|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
37645281|NCT00702507|69114200|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
37645282|NCT00702507|69114200|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
37645283|NCT00702507|69114200|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
37645284|NCT00702507|69114200|FG000|Follow-up Phase|Protocol Violation|2|||
37645285|NCT00702507|69114200|FG000|Follow-up Phase|Lost to Follow-up|23|||
37645286|NCT00702507|69114200|FG000|Follow-up Phase|Late Enrollment|1|||
37645287|NCT01673594|69114216|FG000|Overall Study|Adverse Event|3|||
37645288|NCT01673594|69114217|FG001|Overall Study|Adverse Event|1|||
37645289|NCT01673594|69114216|FG000|Overall Study|Lost to Follow-up|1|||
37645290|NCT01673594|69114217|FG001|Overall Study|Lost to Follow-up|0|||
37645291|NCT01673594|69114216|FG000|Overall Study|Physician Decision|2|||
37645292|NCT01673594|69114217|FG001|Overall Study|Physician Decision|4|||
37645293|NCT01673594|69114216|FG000|Overall Study|Withdrawal by Subject|0|||
37645294|NCT01673594|69114217|FG001|Overall Study|Withdrawal by Subject|1|||
37645295|NCT02721147|69114226|FG000|Overall Study|Lost to Follow-up|2|||
37645296|NCT02721147|69114227|FG001|Overall Study|Lost to Follow-up|0|||
37645297|NCT02721147|69114228|FG002|Overall Study|Lost to Follow-up|0|||
37645298|NCT02720757|69114236|FG000|Overall Study|Other reason|5|||
37645299|NCT02720757|69114236|FG000|Overall Study|Loss of contact|4|||
37645300|NCT02720757|69114236|FG000|Overall Study|Informed consent withdrawal|1|||
37645301|NCT02720757|69114236|FG000|Overall Study|Patients wish to withdraw|2|||
37645302|NCT02720757|69114236|FG000|Overall Study|Missing|3|||
37854485|NCT01232283|69537957|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
38032161|NCT02250664|69718086|FG000|Overall Study|Lost to Follow-up|18|||
38032162|NCT02250664|69718087|FG001|Overall Study|Lost to Follow-up|28|||
38032163|NCT02250664|69718088|FG002|Overall Study|Lost to Follow-up|33|||
37645303|NCT02720757|69114236|FG000|Overall Study|General exclusion|3|||
37645304|NCT02646566|69114266|FG000|Overall Study|Lost to Follow-up|5|||
37645305|NCT02646566|69114267|FG001|Overall Study|Lost to Follow-up|4|||
37645306|NCT02646566|69114268|FG002|Overall Study|Lost to Follow-up|5|||
37645307|NCT02646566|69114266|FG000|Overall Study|Treatment failure|1|||
37645308|NCT02646566|69114267|FG001|Overall Study|Treatment failure|0|||
37854486|NCT01232283|69537958|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
38032164|NCT02250664|69718086|FG000|Overall Study|Personal Reasons|7|||
37645309|NCT02646566|69114268|FG002|Overall Study|Treatment failure|0|||
37645310|NCT02720523|69114284|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
37645311|NCT02720523|69114285|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
37645312|NCT02720523|69114286|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
37645313|NCT02720523|69114287|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
37645314|NCT02720523|69114288|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
37645315|NCT02720523|69114289|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
37645316|NCT02720523|69114290|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
37645317|NCT02720523|69114284|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
37645318|NCT02720523|69114285|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
37645319|NCT02720523|69114286|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
37645320|NCT02720523|69114287|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
37645321|NCT02720523|69114288|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
37645322|NCT02720523|69114289|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
37645323|NCT02720523|69114290|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
37645324|NCT02720523|69114284|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
37645325|NCT02720523|69114285|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
37645326|NCT02720523|69114286|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
37645327|NCT02720523|69114287|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
37645328|NCT02720523|69114288|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
37645329|NCT02720523|69114289|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
37645330|NCT02720523|69114290|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
37645331|NCT02720523|69114284|FG000|Period 1: Placebo-controlled Period|Other|0|||
37645332|NCT02720523|69114285|FG001|Period 1: Placebo-controlled Period|Other|0|||
37645333|NCT02720523|69114286|FG002|Period 1: Placebo-controlled Period|Other|1|||
37645334|NCT02720523|69114287|FG003|Period 1: Placebo-controlled Period|Other|1|||
37645335|NCT02720523|69114288|FG004|Period 1: Placebo-controlled Period|Other|0|||
37645336|NCT02720523|69114289|FG005|Period 1: Placebo-controlled Period|Other|0|||
37645337|NCT02720523|69114290|FG006|Period 1: Placebo-controlled Period|Other|0|||
37645338|NCT02720523|69114284|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
37645339|NCT02720523|69114285|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
37645340|NCT02720523|69114286|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
37645341|NCT02720523|69114287|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
37645342|NCT02720523|69114288|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
37645343|NCT02720523|69114289|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
37645344|NCT02720523|69114290|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
37645345|NCT02720523|69114284|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
37645346|NCT02720523|69114285|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
37645347|NCT02720523|69114286|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
37645348|NCT02720523|69114287|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
37645349|NCT02720523|69114288|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
37645350|NCT02720523|69114289|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
37645351|NCT02720523|69114290|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
37645352|NCT02720523|69114284|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
37645353|NCT02720523|69114285|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
37645354|NCT02720523|69114286|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
37854487|NCT01232283|69537959|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
37854488|NCT01232283|69537960|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
37854489|NCT01232283|69537961|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
37854490|NCT01232283|69537952|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
37854491|NCT01232283|69537953|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
37854492|NCT01232283|69537954|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
37854493|NCT01232283|69537955|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
37854494|NCT01232283|69537956|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
37854495|NCT01232283|69537957|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
37854496|NCT01232283|69537958|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
37854497|NCT01232283|69537959|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
37854498|NCT01232283|69537960|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
37854499|NCT01232283|69537961|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
37854500|NCT01232283|69537952|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
37854501|NCT01232283|69537953|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
37854502|NCT01232283|69537954|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
37854503|NCT01232283|69537955|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
37854504|NCT01232283|69537956|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
37854505|NCT01232283|69537957|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
37854506|NCT01232283|69537958|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
37854507|NCT01232283|69537959|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
37854508|NCT01232283|69537960|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
38032165|NCT02250664|69718087|FG001|Overall Study|Personal Reasons|8|||
37645355|NCT02720523|69114287|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
38032166|NCT02250664|69718088|FG002|Overall Study|Personal Reasons|14|||
37741046|NCT01614067|69227027|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
37645356|NCT02720523|69114288|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
37645357|NCT02720523|69114289|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
37645358|NCT02720523|69114290|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
37645359|NCT02720523|69114284|FG000|Period 2: Long-term Extension Period|Other|0|||
37645360|NCT02720523|69114285|FG001|Period 2: Long-term Extension Period|Other|0|||
37645361|NCT02720523|69114286|FG002|Period 2: Long-term Extension Period|Other|0|||
37645362|NCT02720523|69114287|FG003|Period 2: Long-term Extension Period|Other|0|||
37645363|NCT02720523|69114288|FG004|Period 2: Long-term Extension Period|Other|2|||
37645364|NCT02720523|69114289|FG005|Period 2: Long-term Extension Period|Other|0|||
37645365|NCT02720523|69114290|FG006|Period 2: Long-term Extension Period|Other|3|||
37645366|NCT02646332|69114305|FG000|Overall Study|Lost to Follow-up|0|||
37645367|NCT02646332|69114306|FG001|Overall Study|Lost to Follow-up|3|||
37645368|NCT02471716|69114317|FG000|Overall Study|Withdrawal by Subject|0|||
37645369|NCT02471716|69114318|FG001|Overall Study|Withdrawal by Subject|1|||
37645370|NCT02471716|69114319|FG002|Overall Study|Withdrawal by Subject|0|||
37645371|NCT02471716|69114320|FG003|Overall Study|Withdrawal by Subject|2|||
37645372|NCT02471716|69114321|FG004|Overall Study|Withdrawal by Subject|5|||
37645373|NCT02471716|69114317|FG000|Overall Study|Study Terminiated by sponsor|0|||
37645374|NCT02471716|69114318|FG001|Overall Study|Study Terminiated by sponsor|0|||
37645375|NCT02471716|69114319|FG002|Overall Study|Study Terminiated by sponsor|0|||
37645376|NCT02471716|69114320|FG003|Overall Study|Study Terminiated by sponsor|1|||
37645377|NCT02471716|69114321|FG004|Overall Study|Study Terminiated by sponsor|0|||
37645378|NCT02471716|69114317|FG000|Overall Study|Lost to Follow-up|0|||
37645379|NCT02471716|69114318|FG001|Overall Study|Lost to Follow-up|0|||
37645380|NCT02471716|69114319|FG002|Overall Study|Lost to Follow-up|0|||
37645381|NCT02471716|69114320|FG003|Overall Study|Lost to Follow-up|3|||
37645382|NCT02471716|69114321|FG004|Overall Study|Lost to Follow-up|2|||
37645383|NCT02471716|69114317|FG000|Overall Study|Death|0|||
37645384|NCT02471716|69114318|FG001|Overall Study|Death|0|||
37645385|NCT02471716|69114319|FG002|Overall Study|Death|0|||
37645386|NCT02471716|69114320|FG003|Overall Study|Death|1|||
37645387|NCT02471716|69114321|FG004|Overall Study|Death|0|||
37645388|NCT02471716|69114317|FG000|Overall Study|Other|0|||
37645389|NCT02471716|69114318|FG001|Overall Study|Other|0|||
37645390|NCT02471716|69114319|FG002|Overall Study|Other|0|||
37645391|NCT02471716|69114320|FG003|Overall Study|Other|8|||
37645392|NCT02471716|69114321|FG004|Overall Study|Other|9|||
37645393|NCT01370863|69114337|FG000|Overall Study|Adverse Event|1|||
37645394|NCT01370863|69114338|FG001|Overall Study|Adverse Event|1|||
37645395|NCT01370863|69114337|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
37645396|NCT01370863|69114338|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
37645397|NCT01370863|69114337|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
37645398|NCT01370863|69114338|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
37645399|NCT02444182|69114346|FG000|Overall Study|non-compliance|2|||
37645400|NCT02444182|69114347|FG001|Overall Study|non-compliance|1|||
37645401|NCT02444182|69114346|FG000|Overall Study|Lost to Follow-up|0|||
37645402|NCT02444182|69114347|FG001|Overall Study|Lost to Follow-up|4|||
37645403|NCT02471404|69114356|FG000|Overall Study|Adverse Event|7|||
37645404|NCT02471404|69114357|FG001|Overall Study|Adverse Event|1|||
37645405|NCT02471404|69114358|FG002|Overall Study|Adverse Event|2|||
37645406|NCT02471404|69114356|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
37645407|NCT02471404|69114357|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
37645408|NCT02471404|69114358|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
38032167|NCT02250664|69718086|FG000|Overall Study|Adverse Event|6|||
38032168|NCT02250664|69718087|FG001|Overall Study|Adverse Event|3|||
38032169|NCT02250664|69718088|FG002|Overall Study|Adverse Event|8|||
38032170|NCT02250664|69718086|FG000|Overall Study|Incarcerated|2|||
38032171|NCT02250664|69718087|FG001|Overall Study|Incarcerated|1|||
37645409|NCT02471404|69114356|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
37645410|NCT02471404|69114357|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
37645411|NCT02471404|69114358|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
37645412|NCT02471404|69114356|FG000|Overall Study|Lost to Follow-up|1|||
37645413|NCT02471404|69114357|FG001|Overall Study|Lost to Follow-up|1|||
37645414|NCT02471404|69114358|FG002|Overall Study|Lost to Follow-up|3|||
37645415|NCT02471404|69114356|FG000|Overall Study|Protocol Violation|1|||
37645416|NCT02471404|69114357|FG001|Overall Study|Protocol Violation|0|||
37645417|NCT02471404|69114358|FG002|Overall Study|Protocol Violation|0|||
38032172|NCT02250664|69718088|FG002|Overall Study|Incarcerated|2|||
38032173|NCT02250664|69718086|FG000|Overall Study|Withdrawal by Subject|0|||
37645418|NCT02471404|69114356|FG000|Overall Study|Withdrawal by Subject|8|||
37645419|NCT02471404|69114357|FG001|Overall Study|Withdrawal by Subject|4|||
37645420|NCT02471404|69114358|FG002|Overall Study|Withdrawal by Subject|5|||
37645421|NCT02471404|69114356|FG000|Overall Study|Other reasons not specified|10|||
37645422|NCT02471404|69114357|FG001|Overall Study|Other reasons not specified|7|||
37645423|NCT02471404|69114358|FG002|Overall Study|Other reasons not specified|12|||
37645424|NCT02471014|69114368|FG000|Overall Study|Lost to Follow-up|2|||
37645425|NCT02471014|69114369|FG001|Overall Study|Lost to Follow-up|2|||
37645426|NCT02413372|69114378|FG000|Treatment|Lost to Follow-up|0|||
37645427|NCT02413372|69114379|FG001|Treatment|Lost to Follow-up|2|||
37645428|NCT02413372|69114380|FG002|Treatment|Lost to Follow-up|1|||
37645429|NCT02413372|69114378|FG000|Treatment|Withdrawal by Subject|1|||
37645430|NCT02413372|69114379|FG001|Treatment|Withdrawal by Subject|0|||
37645431|NCT02413372|69114380|FG002|Treatment|Withdrawal by Subject|0|||
37645432|NCT02413372|69114378|FG000|Follow-up|Lost to Follow-up|1|||
37645433|NCT02413372|69114379|FG001|Follow-up|Lost to Follow-up|1|||
37645434|NCT02413372|69114380|FG002|Follow-up|Lost to Follow-up|0|||
37645435|NCT02413372|69114378|FG000|Follow-up|Subject Withdrew Consent|1|||
37645436|NCT02413372|69114379|FG001|Follow-up|Subject Withdrew Consent|0|||
37645437|NCT02413372|69114380|FG002|Follow-up|Subject Withdrew Consent|1|||
37645438|NCT02413372|69114378|FG000|Follow-up|Subject unable to return for visit|0|||
37645439|NCT02413372|69114379|FG001|Follow-up|Subject unable to return for visit|0|||
37645440|NCT02413372|69114380|FG002|Follow-up|Subject unable to return for visit|1|||
37645441|NCT02413294|69114388|FG000|Overall Study|Withdrawal by Subject|1|||
37645442|NCT02719353|69114401|FG000|First Intervention|Physician Decision|0|||
37645443|NCT02719353|69114402|FG001|First Intervention|Physician Decision|1|||
37645444|NCT01362062|69114411|FG000|Overall Study|Adverse Event|1|||
37645445|NCT01362062|69114412|FG001|Overall Study|Adverse Event|0|||
37645446|NCT01362062|69114411|FG000|Overall Study|Lost to Follow-up|11|||
37645447|NCT01362062|69114412|FG001|Overall Study|Lost to Follow-up|0|||
37645448|NCT01362062|69114411|FG000|Overall Study|Withdrawal by Subject|2|||
37645449|NCT01362062|69114412|FG001|Overall Study|Withdrawal by Subject|0|||
37645450|NCT01362062|69114411|FG000|Overall Study|Non-compliant participant|2|||
37645451|NCT01362062|69114412|FG001|Overall Study|Non-compliant participant|0|||
37645452|NCT01362062|69114411|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
37645453|NCT01362062|69114412|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
37645454|NCT01362062|69114411|FG000|Overall Study|Had significant improvement|9|||
37645455|NCT01362062|69114412|FG001|Overall Study|Had significant improvement|0|||
37645456|NCT01361594|69114419|FG000|Overall Study|Withdrawal by Subject|1|||
37645457|NCT01361594|69114420|FG001|Overall Study|Withdrawal by Subject|2|||
37645458|NCT02642432|69114426|FG000|Overall Study|Adverse Event|2|||
37645459|NCT02642432|69114426|FG000|Overall Study|Withdrew Consent|1|||
37645460|NCT02642432|69114426|FG000|Overall Study|Lost to Follow-up|2|||
37645461|NCT02642432|69114426|FG000|Overall Study|Other|3|||
37645462|NCT02640482|69114432|FG000|Overall Study|Lost to Follow-up|3|||
37645463|NCT02640482|69114433|FG001|Overall Study|Lost to Follow-up|0|||
37645464|NCT02719743|69114444|FG000|Overall Study|Consent withdrawal|0|||
37645465|NCT02719743|69114445|FG001|Overall Study|Consent withdrawal|2|||
37645466|NCT02719743|69114446|FG002|Overall Study|Consent withdrawal|0|||
37645467|NCT02719743|69114447|FG003|Overall Study|Consent withdrawal|1|||
37645468|NCT02719743|69114448|FG004|Overall Study|Consent withdrawal|0|||
37645469|NCT02719743|69114444|FG000|Overall Study|Migrated/moved from study area|0|||
37645470|NCT02719743|69114445|FG001|Overall Study|Migrated/moved from study area|0|||
37645471|NCT02719743|69114446|FG002|Overall Study|Migrated/moved from study area|0|||
37645472|NCT02719743|69114447|FG003|Overall Study|Migrated/moved from study area|0|||
37645473|NCT02719743|69114448|FG004|Overall Study|Migrated/moved from study area|2|||
37645474|NCT02719743|69114444|FG000|Overall Study|Lost to Follow-up|1|||
37645475|NCT02719743|69114445|FG001|Overall Study|Lost to Follow-up|1|||
37645476|NCT02719743|69114446|FG002|Overall Study|Lost to Follow-up|0|||
37645477|NCT02719743|69114447|FG003|Overall Study|Lost to Follow-up|0|||
37645478|NCT02719743|69114448|FG004|Overall Study|Lost to Follow-up|0|||
37645479|NCT02641730|69114463|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
37645480|NCT02641730|69114464|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
37645481|NCT02641730|69114465|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
37645482|NCT02641730|69114466|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
37645483|NCT02641730|69114467|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
37645484|NCT02641730|69114463|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
37645485|NCT02641730|69114464|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
37645486|NCT02641730|69114465|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
37645487|NCT02641730|69114466|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
37645488|NCT02641730|69114467|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
37645489|NCT02641730|69114463|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
37645490|NCT02641730|69114464|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
37645491|NCT02641730|69114465|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
37645492|NCT02641730|69114466|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
37645493|NCT02641730|69114467|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
37645494|NCT02641730|69114463|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
37741047|NCT01614067|69227028|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
37741048|NCT01777490|69227038|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
37741049|NCT01777490|69227039|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
37741050|NCT01777490|69227040|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
37645495|NCT02641730|69114464|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
37645496|NCT02641730|69114465|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
37645497|NCT02641730|69114466|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
37645498|NCT02641730|69114467|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
37645499|NCT02641730|69114463|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
37645500|NCT02641730|69114464|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
37645501|NCT02641730|69114465|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
37645502|NCT02641730|69114466|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
37645503|NCT02641730|69114467|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
37645504|NCT02641730|69114463|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
37645505|NCT02641730|69114464|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
37645506|NCT02641730|69114465|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
37922045|NCT00853658|69608863|FG000|Overall Study|Death|713|||
37645507|NCT02641730|69114466|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
37645508|NCT02641730|69114467|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
37645509|NCT02797171|69114487|FG000|Overall Study|Lost to Follow-up|2|||
37645510|NCT02797171|69114488|FG001|Overall Study|Lost to Follow-up|0|||
37645511|NCT02797171|69114489|FG002|Overall Study|Lost to Follow-up|2|||
37645512|NCT02797171|69114490|FG003|Overall Study|Lost to Follow-up|1|||
37645513|NCT02797171|69114491|FG004|Overall Study|Lost to Follow-up|2|||
37645514|NCT02797171|69114492|FG005|Overall Study|Lost to Follow-up|0|||
37645515|NCT02797171|69114487|FG000|Overall Study|Withdrawal by Subject|1|||
37645516|NCT02797171|69114488|FG001|Overall Study|Withdrawal by Subject|1|||
37645517|NCT02797171|69114489|FG002|Overall Study|Withdrawal by Subject|0|||
37645518|NCT02797171|69114490|FG003|Overall Study|Withdrawal by Subject|0|||
37645519|NCT02797171|69114491|FG004|Overall Study|Withdrawal by Subject|0|||
37645520|NCT02797171|69114492|FG005|Overall Study|Withdrawal by Subject|0|||
37645521|NCT02797171|69114487|FG000|Overall Study|Protocol Violation|1|||
37645522|NCT02797171|69114488|FG001|Overall Study|Protocol Violation|0|||
37645523|NCT02797171|69114489|FG002|Overall Study|Protocol Violation|0|||
37645524|NCT02797171|69114490|FG003|Overall Study|Protocol Violation|0|||
37645525|NCT02797171|69114491|FG004|Overall Study|Protocol Violation|0|||
37645526|NCT02797171|69114492|FG005|Overall Study|Protocol Violation|0|||
37645527|NCT02797171|69114487|FG000|Overall Study|Participant unable to adhere|0|||
37645528|NCT02797171|69114488|FG001|Overall Study|Participant unable to adhere|1|||
37645529|NCT02797171|69114489|FG002|Overall Study|Participant unable to adhere|0|||
37645530|NCT02797171|69114490|FG003|Overall Study|Participant unable to adhere|0|||
37645531|NCT02797171|69114491|FG004|Overall Study|Participant unable to adhere|0|||
37645532|NCT02797171|69114492|FG005|Overall Study|Participant unable to adhere|0|||
37645533|NCT02797171|69114487|FG000|Overall Study|Not Randomized|0|||
37645534|NCT02797171|69114488|FG001|Overall Study|Not Randomized|0|||
37645535|NCT02797171|69114489|FG002|Overall Study|Not Randomized|0|||
37645536|NCT02797171|69114490|FG003|Overall Study|Not Randomized|0|||
37645537|NCT02797171|69114491|FG004|Overall Study|Not Randomized|0|||
37645538|NCT02797171|69114492|FG005|Overall Study|Not Randomized|1|||
37645539|NCT02797951|69114506|FG000|Overall Study|Adverse Event|4|||
37645540|NCT02797951|69114506|FG000|Overall Study|Death|1|||
37645541|NCT02797951|69114506|FG000|Overall Study|Lack of Efficacy|19|||
37645542|NCT02797951|69114506|FG000|Overall Study|Lost to Follow-up|4|||
37645543|NCT02797951|69114506|FG000|Overall Study|Physician Decision|6|||
37645544|NCT02797951|69114506|FG000|Overall Study|Withdrawal by Subject|15|||
37645545|NCT00701805|69114514|FG000|Overall Study|Withdrawal by Subject|3|||
37645546|NCT00701805|69114515|FG001|Overall Study|Withdrawal by Subject|1|||
37645547|NCT00701805|69114516|FG002|Overall Study|Withdrawal by Subject|4|||
37645548|NCT00701805|69114517|FG003|Overall Study|Withdrawal by Subject|3|||
37645549|NCT00701805|69114514|FG000|Overall Study|Adverse Event|0|||
37645550|NCT00701805|69114515|FG001|Overall Study|Adverse Event|1|||
37645551|NCT00701805|69114516|FG002|Overall Study|Adverse Event|1|||
37645552|NCT00701805|69114517|FG003|Overall Study|Adverse Event|0|||
37645553|NCT00701805|69114514|FG000|Overall Study|Missed 7 consecutive doses|0|||
37645554|NCT00701805|69114515|FG001|Overall Study|Missed 7 consecutive doses|1|||
37645555|NCT00701805|69114516|FG002|Overall Study|Missed 7 consecutive doses|0|||
37645556|NCT00701805|69114517|FG003|Overall Study|Missed 7 consecutive doses|0|||
37645557|NCT00701805|69114514|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
37645558|NCT00701805|69114515|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
37645559|NCT00701805|69114516|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
37645560|NCT00701805|69114517|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
37645561|NCT00701805|69114514|FG000|Overall Study|Physician decision, change of therapy|0|||
37645562|NCT00701805|69114515|FG001|Overall Study|Physician decision, change of therapy|0|||
37645563|NCT00701805|69114516|FG002|Overall Study|Physician decision, change of therapy|0|||
37645564|NCT00701805|69114517|FG003|Overall Study|Physician decision, change of therapy|1|||
37645565|NCT00701805|69114514|FG000|Overall Study|Difficult to travel to dialysis site|0|||
37645566|NCT00701805|69114515|FG001|Overall Study|Difficult to travel to dialysis site|0|||
37645567|NCT00701805|69114516|FG002|Overall Study|Difficult to travel to dialysis site|1|||
37645568|NCT00701805|69114517|FG003|Overall Study|Difficult to travel to dialysis site|0|||
37922046|NCT00853658|69608864|FG001|Overall Study|Death|768|||
37922047|NCT00853658|69608865|FG002|Overall Study|Death|753|||
37645569|NCT00701805|69114514|FG000|Overall Study|Resumption criteria were not met|0|||
37645570|NCT00701805|69114515|FG001|Overall Study|Resumption criteria were not met|1|||
37645571|NCT00701805|69114516|FG002|Overall Study|Resumption criteria were not met|0|||
37645572|NCT00701805|69114517|FG003|Overall Study|Resumption criteria were not met|0|||
37645573|NCT02715765|69114530|FG000|Overall Study|Study Termination|3|||
37645574|NCT02715765|69114531|FG001|Overall Study|Study Termination|0|||
37645575|NCT02715765|69114532|FG002|Overall Study|Study Termination|0|||
37645576|NCT04542291|69114540|FG000|Overall Study|Adverse Event|1|||
37645577|NCT04542291|69114540|FG000|Overall Study|Physician Decision|2|||
37645578|NCT02795767|69114547|FG000|Overall Study|Received Commercial Emicizumab|1|||
37645579|NCT02795767|69114548|FG001|Overall Study|Received Commercial Emicizumab|0|||
37645580|NCT02795767|69114549|FG002|Overall Study|Received Commercial Emicizumab|0|||
37645581|NCT02796391|69114576|FG000|Overall Study|Lost to Follow-up|2|||
37645582|NCT02796391|69114577|FG001|Overall Study|Lost to Follow-up|2|||
37645583|NCT02796391|69114578|FG002|Overall Study|Lost to Follow-up|13|||
37645584|NCT02796391|69114579|FG003|Overall Study|Lost to Follow-up|8|||
37645585|NCT02796391|69114580|FG004|Overall Study|Lost to Follow-up|14|||
37645586|NCT02796391|69114581|FG005|Overall Study|Lost to Follow-up|13|||
37645587|NCT02796391|69114576|FG000|Overall Study|COVID|0|||
37645588|NCT02796391|69114577|FG001|Overall Study|COVID|0|||
37645589|NCT02796391|69114578|FG002|Overall Study|COVID|5|||
37645590|NCT02796391|69114579|FG003|Overall Study|COVID|5|||
37645591|NCT02796391|69114580|FG004|Overall Study|COVID|2|||
37645592|NCT02796391|69114581|FG005|Overall Study|COVID|4|||
37645593|NCT02796391|69114576|FG000|Overall Study|Participant did not like study cigarettes|0|||
37645594|NCT02796391|69114577|FG001|Overall Study|Participant did not like study cigarettes|0|||
37645595|NCT02796391|69114578|FG002|Overall Study|Participant did not like study cigarettes|3|||
37645596|NCT02796391|69114579|FG003|Overall Study|Participant did not like study cigarettes|0|||
37645597|NCT02796391|69114580|FG004|Overall Study|Participant did not like study cigarettes|0|||
37645598|NCT02796391|69114581|FG005|Overall Study|Participant did not like study cigarettes|0|||
37645599|NCT02796391|69114576|FG000|Overall Study|Withdrawal by Subject|1|||
37645600|NCT02796391|69114577|FG001|Overall Study|Withdrawal by Subject|1|||
37645601|NCT02796391|69114578|FG002|Overall Study|Withdrawal by Subject|4|||
37645602|NCT02796391|69114579|FG003|Overall Study|Withdrawal by Subject|3|||
37645603|NCT02796391|69114580|FG004|Overall Study|Withdrawal by Subject|4|||
37645604|NCT02796391|69114581|FG005|Overall Study|Withdrawal by Subject|3|||
37645605|NCT02796391|69114576|FG000|Overall Study|Adverse Event|0|||
37645606|NCT02796391|69114577|FG001|Overall Study|Adverse Event|0|||
37645607|NCT02796391|69114578|FG002|Overall Study|Adverse Event|0|||
37645608|NCT02796391|69114579|FG003|Overall Study|Adverse Event|1|||
37645609|NCT02796391|69114580|FG004|Overall Study|Adverse Event|0|||
37645610|NCT02796391|69114581|FG005|Overall Study|Adverse Event|0|||
37645611|NCT02796391|69114576|FG000|Overall Study|Protocol Violation|0|||
37645612|NCT02796391|69114577|FG001|Overall Study|Protocol Violation|0|||
37645613|NCT02796391|69114578|FG002|Overall Study|Protocol Violation|0|||
37645614|NCT02796391|69114579|FG003|Overall Study|Protocol Violation|1|||
37645615|NCT02796391|69114580|FG004|Overall Study|Protocol Violation|0|||
37645616|NCT02796391|69114581|FG005|Overall Study|Protocol Violation|0|||
37645617|NCT01370317|69114597|FG000|Overall Study|Participant withdrew consent|1|||
37645618|NCT01370317|69114598|FG001|Overall Study|Participant withdrew consent|0|||
37645619|NCT01370317|69114597|FG000|Overall Study|Protocol deviation|0|||
37645620|NCT01370317|69114598|FG001|Overall Study|Protocol deviation|1|||
37645621|NCT01370083|69114606|FG000|Overall Study|Lost to Follow-up|2|||
37645622|NCT01370083|69114607|FG001|Overall Study|Lost to Follow-up|0|||
37645623|NCT01370083|69114606|FG000|Overall Study|Adverse Event|0|||
37645624|NCT01370083|69114607|FG001|Overall Study|Adverse Event|1|||
37645625|NCT03350815|69114613|FG000|Period 1|Adverse Event|10|||
37645626|NCT03350815|69114614|FG001|Period 1|Adverse Event|0|||
37645627|NCT03350815|69114615|FG002|Period 1|Adverse Event|0|||
37645628|NCT03350815|69114616|FG003|Period 1|Adverse Event|0|||
37645629|NCT03350815|69114613|FG000|Period 1|Technical problems|1|||
37645630|NCT03350815|69114614|FG001|Period 1|Technical problems|0|||
37645631|NCT03350815|69114615|FG002|Period 1|Technical problems|0|||
37645632|NCT03350815|69114616|FG003|Period 1|Technical problems|0|||
37645633|NCT03350815|69114613|FG000|Period 1|Lost to Follow-up|3|||
37645634|NCT03350815|69114614|FG001|Period 1|Lost to Follow-up|0|||
37645635|NCT03350815|69114615|FG002|Period 1|Lost to Follow-up|0|||
37645636|NCT03350815|69114616|FG003|Period 1|Lost to Follow-up|0|||
37645637|NCT03350815|69114613|FG000|Period 1|Physician Decision|1|||
37645638|NCT03350815|69114614|FG001|Period 1|Physician Decision|0|||
37645639|NCT03350815|69114615|FG002|Period 1|Physician Decision|0|||
37645640|NCT03350815|69114616|FG003|Period 1|Physician Decision|0|||
37645641|NCT03350815|69114613|FG000|Period 1|Withdrawal by Subject|8|||
37645642|NCT03350815|69114614|FG001|Period 1|Withdrawal by Subject|0|||
37645643|NCT03350815|69114615|FG002|Period 1|Withdrawal by Subject|0|||
37922048|NCT00853658|69608863|FG000|Overall Study|Lost to Follow-up|11|||
37922049|NCT00853658|69608864|FG001|Overall Study|Lost to Follow-up|6|||
37645644|NCT03350815|69114616|FG003|Period 1|Withdrawal by Subject|0|||
37645645|NCT03350815|69114613|FG000|Period 1|Lack of Efficacy|15|||
37645646|NCT03350815|69114614|FG001|Period 1|Lack of Efficacy|0|||
37645647|NCT03350815|69114615|FG002|Period 1|Lack of Efficacy|0|||
37645648|NCT03350815|69114616|FG003|Period 1|Lack of Efficacy|0|||
37645649|NCT03350815|69114613|FG000|Period 1|Non-compliance with study treatment|2|||
37645650|NCT03350815|69114614|FG001|Period 1|Non-compliance with study treatment|0|||
37645651|NCT03350815|69114615|FG002|Period 1|Non-compliance with study treatment|0|||
37645652|NCT03350815|69114616|FG003|Period 1|Non-compliance with study treatment|0|||
37645653|NCT03350815|69114613|FG000|Period 1|Protocol Violation|3|||
37645654|NCT03350815|69114614|FG001|Period 1|Protocol Violation|0|||
37645655|NCT03350815|69114615|FG002|Period 1|Protocol Violation|0|||
37645656|NCT03350815|69114616|FG003|Period 1|Protocol Violation|0|||
37645657|NCT03350815|69114613|FG000|Period 2|Adverse Event|0|||
37645658|NCT03350815|69114614|FG001|Period 2|Adverse Event|3|||
37645659|NCT03350815|69114615|FG002|Period 2|Adverse Event|5|||
37645660|NCT03350815|69114616|FG003|Period 2|Adverse Event|0|||
37645661|NCT03350815|69114613|FG000|Period 2|Technical problem|0|||
37645662|NCT03350815|69114614|FG001|Period 2|Technical problem|1|||
37645663|NCT03350815|69114615|FG002|Period 2|Technical problem|0|||
37645664|NCT03350815|69114616|FG003|Period 2|Technical problem|0|||
37645665|NCT03350815|69114613|FG000|Period 2|Lost to Follow-up|0|||
37645666|NCT03350815|69114614|FG001|Period 2|Lost to Follow-up|3|||
37645667|NCT03350815|69114615|FG002|Period 2|Lost to Follow-up|3|||
37645668|NCT03350815|69114616|FG003|Period 2|Lost to Follow-up|0|||
37645669|NCT03350815|69114613|FG000|Period 2|Physician Decision|0|||
37645670|NCT03350815|69114614|FG001|Period 2|Physician Decision|0|||
37645671|NCT03350815|69114615|FG002|Period 2|Physician Decision|1|||
37645672|NCT03350815|69114616|FG003|Period 2|Physician Decision|0|||
37645673|NCT03350815|69114613|FG000|Period 2|Withdrawal by Subject|0|||
37645674|NCT03350815|69114614|FG001|Period 2|Withdrawal by Subject|3|||
37645675|NCT03350815|69114615|FG002|Period 2|Withdrawal by Subject|4|||
37645676|NCT03350815|69114616|FG003|Period 2|Withdrawal by Subject|0|||
37645677|NCT03350815|69114613|FG000|Period 2|Lack of Efficacy|0|||
37645678|NCT03350815|69114614|FG001|Period 2|Lack of Efficacy|6|||
37645679|NCT03350815|69114615|FG002|Period 2|Lack of Efficacy|2|||
37645680|NCT03350815|69114616|FG003|Period 2|Lack of Efficacy|0|||
37645681|NCT03350815|69114613|FG000|Period 2|Protocol Violation|0|||
37645682|NCT03350815|69114614|FG001|Period 2|Protocol Violation|0|||
37645683|NCT03350815|69114615|FG002|Period 2|Protocol Violation|1|||
37645684|NCT03350815|69114616|FG003|Period 2|Protocol Violation|0|||
37645685|NCT03350815|69114613|FG000|Period 2|New therapy for study indication|0|||
37645686|NCT03350815|69114614|FG001|Period 2|New therapy for study indication|0|||
37645687|NCT03350815|69114615|FG002|Period 2|New therapy for study indication|1|||
37645688|NCT03350815|69114616|FG003|Period 2|New therapy for study indication|0|||
37645689|NCT00854295|69114631|FG000|Overall Study|Death|7|||
37645690|NCT00854295|69114632|FG001|Overall Study|Death|0|||
37645691|NCT00854295|69114633|FG002|Overall Study|Death|1|||
37645692|NCT00854295|69114634|FG003|Overall Study|Death|1|||
37645693|NCT00854295|69114631|FG000|Overall Study|Adverse Event|6|||
37645694|NCT00854295|69114632|FG001|Overall Study|Adverse Event|1|||
37645695|NCT00854295|69114633|FG002|Overall Study|Adverse Event|1|||
37645696|NCT00854295|69114634|FG003|Overall Study|Adverse Event|3|||
37645697|NCT00854295|69114631|FG000|Overall Study|Lost to Follow-up|18|||
37645698|NCT00854295|69114632|FG001|Overall Study|Lost to Follow-up|5|||
37645699|NCT00854295|69114633|FG002|Overall Study|Lost to Follow-up|21|||
37645700|NCT00854295|69114634|FG003|Overall Study|Lost to Follow-up|21|||
37645701|NCT00854295|69114631|FG000|Overall Study|Physician Decision|10|||
37645702|NCT00854295|69114632|FG001|Overall Study|Physician Decision|0|||
37645703|NCT00854295|69114633|FG002|Overall Study|Physician Decision|0|||
37645704|NCT00854295|69114634|FG003|Overall Study|Physician Decision|0|||
37645705|NCT02792959|69114645|FG000|Overall Study|Protocol Violation|1|||
37645706|NCT01652872|69114651|FG000|Overall Study|Death|36|||
37645707|NCT01652872|69114652|FG001|Overall Study|Death|39|||
37645708|NCT01652872|69114651|FG000|Overall Study|Lost to Follow-up|28|||
37645709|NCT01652872|69114652|FG001|Overall Study|Lost to Follow-up|23|||
37645710|NCT01652872|69114651|FG000|Overall Study|Decision by sponsor|5|||
37645711|NCT01652872|69114652|FG001|Overall Study|Decision by sponsor|7|||
37645712|NCT01652872|69114651|FG000|Overall Study|Withdrawal by Subject|76|||
37645713|NCT01652872|69114652|FG001|Overall Study|Withdrawal by Subject|84|||
37645714|NCT04251273|69114660|FG000|Overall Study|Lost to Follow-up|331|||
37645715|NCT04251273|69114661|FG001|Overall Study|Lost to Follow-up|290|||
37645716|NCT02443402|69114669|FG000|Overall Study|Withdrawal by Subject|3|||
37645717|NCT02443402|69114670|FG001|Overall Study|Withdrawal by Subject|1|||
37645718|NCT02443402|69114669|FG000|Overall Study|Screen Failure|1|||
37645719|NCT02443402|69114670|FG001|Overall Study|Screen Failure|2|||
37645720|NCT01370005|69114679|FG000|Overall Study|Not treated|1|||
37645721|NCT01370005|69114680|FG001|Overall Study|Not treated|0|||
37645722|NCT01370005|69114681|FG002|Overall Study|Not treated|0|||
37645723|NCT01370005|69114679|FG000|Overall Study|Adverse Event|5|||
37645724|NCT01370005|69114680|FG001|Overall Study|Adverse Event|5|||
37645725|NCT01370005|69114681|FG002|Overall Study|Adverse Event|6|||
37645726|NCT01370005|69114679|FG000|Overall Study|Lack of Efficacy|1|||
37645727|NCT01370005|69114680|FG001|Overall Study|Lack of Efficacy|0|||
37645728|NCT01370005|69114681|FG002|Overall Study|Lack of Efficacy|0|||
37645729|NCT01370005|69114679|FG000|Overall Study|Non compliant with protocol|0|||
37645730|NCT01370005|69114680|FG001|Overall Study|Non compliant with protocol|1|||
37645731|NCT01370005|69114681|FG002|Overall Study|Non compliant with protocol|2|||
37645732|NCT01370005|69114679|FG000|Overall Study|Lost to Follow-up|1|||
37645733|NCT01370005|69114680|FG001|Overall Study|Lost to Follow-up|1|||
37645734|NCT01370005|69114681|FG002|Overall Study|Lost to Follow-up|1|||
37645735|NCT01370005|69114679|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
37645736|NCT01370005|69114680|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
37645737|NCT01370005|69114681|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
37645738|NCT01370005|69114679|FG000|Overall Study|Other reason not defined above|3|||
37645739|NCT01370005|69114680|FG001|Overall Study|Other reason not defined above|0|||
37645740|NCT01370005|69114681|FG002|Overall Study|Other reason not defined above|2|||
37645741|NCT02442778|69114692|FG000|Overall Study|Adverse Event|2|||
37645742|NCT02442778|69114693|FG001|Overall Study|Adverse Event|6|||
37645743|NCT02442778|69114694|FG002|Overall Study|Adverse Event|6|||
37645744|NCT02442778|69114692|FG000|Overall Study|Death|0|||
37645745|NCT02442778|69114693|FG001|Overall Study|Death|2|||
37645746|NCT02442778|69114694|FG002|Overall Study|Death|0|||
37645747|NCT02442778|69114692|FG000|Overall Study|Lack of Efficacy|1|||
37645748|NCT02442778|69114693|FG001|Overall Study|Lack of Efficacy|0|||
37645749|NCT02442778|69114694|FG002|Overall Study|Lack of Efficacy|0|||
37645750|NCT02442778|69114692|FG000|Overall Study|Lost to Follow-up|1|||
37645751|NCT02442778|69114693|FG001|Overall Study|Lost to Follow-up|1|||
37645752|NCT02442778|69114694|FG002|Overall Study|Lost to Follow-up|1|||
37645753|NCT02442778|69114692|FG000|Overall Study|Non-compliance with study drug|2|||
37645754|NCT02442778|69114693|FG001|Overall Study|Non-compliance with study drug|0|||
37645755|NCT02442778|69114694|FG002|Overall Study|Non-compliance with study drug|1|||
37645756|NCT02442778|69114692|FG000|Overall Study|Physician Decision|1|||
37645757|NCT02442778|69114693|FG001|Overall Study|Physician Decision|1|||
37645758|NCT02442778|69114694|FG002|Overall Study|Physician Decision|1|||
37645759|NCT02442778|69114692|FG000|Overall Study|Protocol Deviation|3|||
37645760|NCT02442778|69114693|FG001|Overall Study|Protocol Deviation|0|||
37645761|NCT02442778|69114694|FG002|Overall Study|Protocol Deviation|1|||
37645762|NCT02442778|69114692|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
37645763|NCT02442778|69114693|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
37645764|NCT02442778|69114694|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
37645765|NCT02442778|69114692|FG000|Overall Study|Withdrawal by Subject|4|||
37645766|NCT02442778|69114693|FG001|Overall Study|Withdrawal by Subject|4|||
37645767|NCT02442778|69114694|FG002|Overall Study|Withdrawal by Subject|3|||
37645768|NCT02442778|69114692|FG000|Overall Study|Reason not specified|1|||
37645769|NCT02442778|69114693|FG001|Overall Study|Reason not specified|4|||
37645770|NCT02442778|69114694|FG002|Overall Study|Reason not specified|0|||
37645771|NCT02412436|69114702|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
37645772|NCT02412436|69114702|FG000|Overall Study|Lost to Follow-up|6|||
37645773|NCT02412436|69114702|FG000|Overall Study|Unable to get to clinic|3|||
37645774|NCT02412436|69114702|FG000|Overall Study|Death|1|||
37645775|NCT02412436|69114702|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
37645776|NCT01651000|69114708|FG000|Overall Study|Adverse Event|2|||
37645777|NCT01651000|69114709|FG001|Overall Study|Adverse Event|8|||
37645778|NCT01651000|69114708|FG000|Overall Study|Lost to Follow-up|3|||
37645779|NCT01651000|69114709|FG001|Overall Study|Lost to Follow-up|2|||
37645780|NCT01651000|69114708|FG000|Overall Study|Protocol Violation|0|||
37645781|NCT01651000|69114709|FG001|Overall Study|Protocol Violation|3|||
37645782|NCT01651000|69114708|FG000|Overall Study|Withdrawal by Subject|2|||
37645783|NCT01651000|69114709|FG001|Overall Study|Withdrawal by Subject|10|||
37645784|NCT01651000|69114708|FG000|Overall Study|Subject noncompliance|0|||
37645785|NCT01651000|69114709|FG001|Overall Study|Subject noncompliance|3|||
37645786|NCT01651000|69114708|FG000|Overall Study|Lack of Efficacy|1|||
37645787|NCT01651000|69114709|FG001|Overall Study|Lack of Efficacy|1|||
37645788|NCT01651000|69114708|FG000|Overall Study|Physician Decision|1|||
37645789|NCT01651000|69114709|FG001|Overall Study|Physician Decision|0|||
37645790|NCT01651000|69114708|FG000|Overall Study|Administrative reason|1|||
37645791|NCT01651000|69114709|FG001|Overall Study|Administrative reason|0|||
37645792|NCT01651000|69114708|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
37645793|NCT01651000|69114709|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
37645794|NCT02469610|69114717|FG000|Overall Study|Death|1|||
37645795|NCT02469610|69114718|FG001|Overall Study|Death|0|||
37645796|NCT02469610|69114717|FG000|Overall Study|Lost to Follow-up|1|||
37645797|NCT02469610|69114718|FG001|Overall Study|Lost to Follow-up|0|||
37645798|NCT02469610|69114717|FG000|Overall Study|exclusion criteria|2|||
37645799|NCT02469610|69114718|FG001|Overall Study|exclusion criteria|1|||
37645800|NCT02469298|69114728|FG000|Overall Study|Protocol Violation|0|||
37645801|NCT02469298|69114729|FG001|Overall Study|Protocol Violation|1|||
37645802|NCT02469298|69114730|FG002|Overall Study|Protocol Violation|1|||
37645803|NCT02469298|69114731|FG003|Overall Study|Protocol Violation|0|||
37645804|NCT02469298|69114728|FG000|Overall Study|Lost to Follow-up|1|||
37645805|NCT02469298|69114729|FG001|Overall Study|Lost to Follow-up|0|||
37645806|NCT02469298|69114730|FG002|Overall Study|Lost to Follow-up|1|||
37645807|NCT02469298|69114731|FG003|Overall Study|Lost to Follow-up|0|||
37645808|NCT02469298|69114728|FG000|Overall Study|Physician Decision|0|||
37645809|NCT02469298|69114729|FG001|Overall Study|Physician Decision|0|||
37645810|NCT02469298|69114730|FG002|Overall Study|Physician Decision|0|||
37645811|NCT02469298|69114731|FG003|Overall Study|Physician Decision|1|||
37645812|NCT02469298|69114728|FG000|Overall Study|Withdrawal by Subject|0|||
37645813|NCT02469298|69114729|FG001|Overall Study|Withdrawal by Subject|0|||
37645814|NCT02469298|69114730|FG002|Overall Study|Withdrawal by Subject|0|||
37645815|NCT02469298|69114731|FG003|Overall Study|Withdrawal by Subject|1|||
37645816|NCT04163991|69114753|FG000|Overall Study|Adverse Event|0|||
37645817|NCT04163991|69114754|FG001|Overall Study|Adverse Event|0|||
37645818|NCT04163991|69114755|FG002|Overall Study|Adverse Event|0|||
37645819|NCT04163991|69114756|FG003|Overall Study|Adverse Event|1|||
37645820|NCT04163991|69114757|FG004|Overall Study|Adverse Event|0|||
37645821|NCT04163991|69114753|FG000|Overall Study|Death|0|||
37645822|NCT04163991|69114754|FG001|Overall Study|Death|0|||
37645823|NCT04163991|69114755|FG002|Overall Study|Death|1|||
37645824|NCT04163991|69114756|FG003|Overall Study|Death|0|||
37645825|NCT04163991|69114757|FG004|Overall Study|Death|0|||
37645826|NCT04163991|69114753|FG000|Overall Study|Lost to Follow-up|0|||
37645827|NCT04163991|69114754|FG001|Overall Study|Lost to Follow-up|1|||
37645828|NCT04163991|69114755|FG002|Overall Study|Lost to Follow-up|0|||
37645829|NCT04163991|69114756|FG003|Overall Study|Lost to Follow-up|0|||
37645830|NCT04163991|69114757|FG004|Overall Study|Lost to Follow-up|0|||
37645831|NCT04163991|69114753|FG000|Overall Study|Withdrawal by Subject|1|||
37645832|NCT04163991|69114754|FG001|Overall Study|Withdrawal by Subject|1|||
37645833|NCT04163991|69114755|FG002|Overall Study|Withdrawal by Subject|3|||
37645834|NCT04163991|69114756|FG003|Overall Study|Withdrawal by Subject|1|||
37645835|NCT04163991|69114757|FG004|Overall Study|Withdrawal by Subject|1|||
37645836|NCT04163991|69114753|FG000|Overall Study|Other, Not Specified|0|||
37645837|NCT04163991|69114754|FG001|Overall Study|Other, Not Specified|1|||
37645838|NCT04163991|69114755|FG002|Overall Study|Other, Not Specified|1|||
37645839|NCT04163991|69114756|FG003|Overall Study|Other, Not Specified|1|||
37645840|NCT04163991|69114757|FG004|Overall Study|Other, Not Specified|0|||
37645841|NCT02442622|69114775|FG000|Overall Study|Withdrawal by Subject|3|||
37645842|NCT02442622|69114776|FG001|Overall Study|Withdrawal by Subject|1|||
37645843|NCT02411578|69114784|FG000|Crossover Trial Phase|Pregnancy|0|||
37645844|NCT02411578|69114785|FG001|Crossover Trial Phase|Pregnancy|1|||
37645845|NCT02442310|69114793|FG000|Overall Study|Adverse Event|2|||
37645846|NCT02442310|69114793|FG000|Overall Study|Withdrawal by Subject|1|||
37645847|NCT02411110|69114805|FG000|Treatment Period 1|Adverse Event|4|||
37645848|NCT02411110|69114806|FG001|Treatment Period 1|Adverse Event|2|||
37645849|NCT02411110|69114805|FG000|Treatment Period 1|Lost to Follow-up|1|||
37645850|NCT02411110|69114806|FG001|Treatment Period 1|Lost to Follow-up|0|||
37645851|NCT02411110|69114805|FG000|Treatment Period 1|Personal Reasons|2|||
37645852|NCT02411110|69114806|FG001|Treatment Period 1|Personal Reasons|5|||
37645853|NCT02411110|69114805|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
37645854|NCT02411110|69114806|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
37645855|NCT02411110|69114805|FG000|Treatment Period 2|Adverse Event|1|||
37645856|NCT02411110|69114806|FG001|Treatment Period 2|Adverse Event|0|||
37645857|NCT02411110|69114805|FG000|Treatment Period 2|Lost to Follow-up|0|||
37645858|NCT02411110|69114806|FG001|Treatment Period 2|Lost to Follow-up|2|||
37645859|NCT02411110|69114805|FG000|Treatment Period 2|Personal Reasons|0|||
37645860|NCT02411110|69114806|FG001|Treatment Period 2|Personal Reasons|2|||
37645861|NCT01369849|69114817|FG000|Overall Study|Ineligible prior to treatment|0|||
37645862|NCT01369849|69114818|FG001|Overall Study|Ineligible prior to treatment|0|||
37645863|NCT01369849|69114819|FG002|Overall Study|Ineligible prior to treatment|1|||
37645864|NCT01369849|69114817|FG000|Overall Study|Ineligible after receiving treatment|0|||
37645865|NCT01369849|69114818|FG001|Overall Study|Ineligible after receiving treatment|1|||
37645866|NCT01369849|69114819|FG002|Overall Study|Ineligible after receiving treatment|0|||
37645867|NCT02716779|69114832|FG000|Monotherapy|Adverse Event|0|||
37645868|NCT02716779|69114833|FG001|Monotherapy|Adverse Event|1|||
37645869|NCT02716779|69114834|FG002|Monotherapy|Adverse Event|1|||
37854509|NCT01232283|69537961|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
37854510|NCT01232283|69537952|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
37854511|NCT01232283|69537953|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
37645870|NCT02716779|69114832|FG000|Combination Therapy|Adverse Event|0|||
37645871|NCT02716779|69114833|FG001|Combination Therapy|Adverse Event|2|||
37645872|NCT02716779|69114834|FG002|Combination Therapy|Adverse Event|1|||
37645873|NCT01369615|69114850|FG000|Overall Study|Withdrawal by Subject|0|||
37645874|NCT01369615|69114851|FG001|Overall Study|Withdrawal by Subject|1|||
37645875|NCT01369615|69114850|FG000|Overall Study|Lost to Follow-up|0|||
37645876|NCT01369615|69114851|FG001|Overall Study|Lost to Follow-up|1|||
37645877|NCT02468674|69114875|FG000|Overall Study|Adverse Event|0|||
37645878|NCT02468674|69114876|FG001|Overall Study|Adverse Event|0|||
37645879|NCT02468674|69114877|FG002|Overall Study|Adverse Event|0|||
37645880|NCT02468674|69114878|FG003|Overall Study|Adverse Event|1|||
37645881|NCT02468674|69114879|FG004|Overall Study|Adverse Event|0|||
37645882|NCT02468674|69114880|FG005|Overall Study|Adverse Event|1|||
37645883|NCT02468674|69114881|FG006|Overall Study|Adverse Event|0|||
37645884|NCT02468674|69114882|FG007|Overall Study|Adverse Event|0|||
37645885|NCT02468674|69114883|FG008|Overall Study|Adverse Event|0|||
37645886|NCT02468674|69114875|FG000|Overall Study|Lost to Follow-up|1|||
37645887|NCT02468674|69114876|FG001|Overall Study|Lost to Follow-up|0|||
37645888|NCT02468674|69114877|FG002|Overall Study|Lost to Follow-up|0|||
37645889|NCT02468674|69114878|FG003|Overall Study|Lost to Follow-up|0|||
37645890|NCT02468674|69114879|FG004|Overall Study|Lost to Follow-up|0|||
37645891|NCT02468674|69114880|FG005|Overall Study|Lost to Follow-up|0|||
37645892|NCT02468674|69114881|FG006|Overall Study|Lost to Follow-up|0|||
37645893|NCT02468674|69114882|FG007|Overall Study|Lost to Follow-up|1|||
37645894|NCT02468674|69114883|FG008|Overall Study|Lost to Follow-up|1|||
37645895|NCT02468674|69114875|FG000|Overall Study|Physician Decision|0|||
37645896|NCT02468674|69114876|FG001|Overall Study|Physician Decision|0|||
37645897|NCT02468674|69114877|FG002|Overall Study|Physician Decision|0|||
37645898|NCT02468674|69114878|FG003|Overall Study|Physician Decision|0|||
37645899|NCT02468674|69114879|FG004|Overall Study|Physician Decision|0|||
37645900|NCT02468674|69114880|FG005|Overall Study|Physician Decision|0|||
37645901|NCT02468674|69114881|FG006|Overall Study|Physician Decision|1|||
37645902|NCT02468674|69114882|FG007|Overall Study|Physician Decision|0|||
37645903|NCT02468674|69114883|FG008|Overall Study|Physician Decision|0|||
37645904|NCT02468674|69114875|FG000|Overall Study|Patient/Guardian Decision|0|||
37645905|NCT02468674|69114876|FG001|Overall Study|Patient/Guardian Decision|0|||
37645906|NCT02468674|69114877|FG002|Overall Study|Patient/Guardian Decision|0|||
37645907|NCT02468674|69114878|FG003|Overall Study|Patient/Guardian Decision|0|||
37645908|NCT02468674|69114879|FG004|Overall Study|Patient/Guardian Decision|1|||
37645909|NCT02468674|69114880|FG005|Overall Study|Patient/Guardian Decision|0|||
37645910|NCT02468674|69114881|FG006|Overall Study|Patient/Guardian Decision|0|||
37645911|NCT02468674|69114882|FG007|Overall Study|Patient/Guardian Decision|2|||
37645912|NCT02468674|69114883|FG008|Overall Study|Patient/Guardian Decision|1|||
37645913|NCT02468674|69114875|FG000|Overall Study|Protocol Deviation|0|||
37645914|NCT02468674|69114876|FG001|Overall Study|Protocol Deviation|0|||
37645915|NCT02468674|69114877|FG002|Overall Study|Protocol Deviation|0|||
37645916|NCT02468674|69114878|FG003|Overall Study|Protocol Deviation|0|||
37645917|NCT02468674|69114879|FG004|Overall Study|Protocol Deviation|0|||
37645918|NCT02468674|69114880|FG005|Overall Study|Protocol Deviation|0|||
37645919|NCT02468674|69114881|FG006|Overall Study|Protocol Deviation|0|||
37645920|NCT02468674|69114882|FG007|Overall Study|Protocol Deviation|1|||
37645921|NCT02468674|69114883|FG008|Overall Study|Protocol Deviation|1|||
37645922|NCT02467192|69114903|FG000|Overall Study|Death|1|||
37645923|NCT02467192|69114903|FG000|Overall Study|revealed to have pneumonia before|2|||
37645924|NCT02410954|69114913|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
37645925|NCT02410954|69114914|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
37645926|NCT02410954|69114913|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
37645927|NCT02410954|69114914|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
37645928|NCT05153499|69114935|FG000|Overall Study|Withdrawal by Subject|1|||
37645929|NCT05153499|69114936|FG001|Overall Study|Withdrawal by Subject|0|||
37645930|NCT05153499|69114935|FG000|Overall Study|Clinical Hold|1|||
37645931|NCT05153499|69114936|FG001|Overall Study|Clinical Hold|0|||
37645932|NCT05153499|69114935|FG000|Overall Study|Study Termination|6|||
37645933|NCT05153499|69114936|FG001|Overall Study|Study Termination|5|||
37645934|NCT05047770|69114946|FG000|Overall Study|Withdrawal by Subject|15|||
37645935|NCT05047770|69114947|FG001|Overall Study|Withdrawal by Subject|10|||
37645936|NCT05047770|69114948|FG002|Overall Study|Withdrawal by Subject|6|||
37645937|NCT05047770|69114949|FG003|Overall Study|Withdrawal by Subject|12|||
37645938|NCT05047770|69114946|FG000|Overall Study|Lost to Follow-up|7|||
37645939|NCT05047770|69114947|FG001|Overall Study|Lost to Follow-up|5|||
37645940|NCT05047770|69114948|FG002|Overall Study|Lost to Follow-up|12|||
37741051|NCT01777490|69227041|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
37741052|NCT01397409|69227063|FG000|Stage 2|Adverse Event|0|||
37645941|NCT05047770|69114949|FG003|Overall Study|Lost to Follow-up|13|||
37645942|NCT05047770|69114946|FG000|Overall Study|Other|1|||
37645943|NCT05047770|69114947|FG001|Overall Study|Other|0|||
37741053|NCT01397409|69227064|FG001|Stage 2|Adverse Event|0|||
37645944|NCT05047770|69114948|FG002|Overall Study|Other|1|||
37645945|NCT05047770|69114949|FG003|Overall Study|Other|0|||
37645946|NCT04740814|69114989|FG000|Overall Study|Adverse Event|3|||
37645947|NCT04740814|69114989|FG000|Overall Study|Protocol Violation|2|||
37645948|NCT04740814|69114989|FG000|Overall Study|Lost to Follow-up|2|||
37645949|NCT04740814|69114989|FG000|Overall Study|Withdrawal by Subject|3|||
37645950|NCT04652453|69115000|FG000|Overall Study|Death|8|||
37645951|NCT04652453|69115001|FG001|Overall Study|Death|2|||
37645952|NCT04652453|69115002|FG002|Overall Study|Death|0|||
37645953|NCT04652453|69115000|FG000|Overall Study|Hospice|5|||
37645954|NCT04652453|69115001|FG001|Overall Study|Hospice|5|||
37645955|NCT04652453|69115002|FG002|Overall Study|Hospice|0|||
37645956|NCT04652453|69115000|FG000|Overall Study|Withdrawal by Subject|2|||
37645957|NCT04652453|69115001|FG001|Overall Study|Withdrawal by Subject|0|||
37645958|NCT04652453|69115002|FG002|Overall Study|Withdrawal by Subject|0|||
37645959|NCT04624672|69115010|FG000|Overall Study|Early Study Closure|2|||
37645960|NCT04624672|69115011|FG001|Overall Study|Early Study Closure|1|||
37645961|NCT04476108|69115048|FG000|Overall Study|Adverse Event|4|||
37645962|NCT04476108|69115049|FG001|Overall Study|Adverse Event|1|||
37645963|NCT04476108|69115048|FG000|Overall Study|Lost to Follow-up|1|||
37645964|NCT04476108|69115049|FG001|Overall Study|Lost to Follow-up|0|||
37645965|NCT04476108|69115048|FG000|Overall Study|Inadvertent Enrollment|1|||
37645966|NCT04476108|69115049|FG001|Overall Study|Inadvertent Enrollment|0|||
37645967|NCT04476108|69115048|FG000|Overall Study|Protocol Violation|1|||
37645968|NCT04476108|69115049|FG001|Overall Study|Protocol Violation|1|||
37645969|NCT04476108|69115048|FG000|Overall Study|Withdrawal by Subject|1|||
37645970|NCT04476108|69115049|FG001|Overall Study|Withdrawal by Subject|1|||
37645971|NCT04456686|69115057|FG000|Overall Study|Adverse Event|2|||
37645972|NCT04456686|69115058|FG001|Overall Study|Adverse Event|1|||
37645973|NCT04456686|69115057|FG000|Overall Study|Lack of Efficacy|3|||
37645974|NCT04456686|69115058|FG001|Overall Study|Lack of Efficacy|1|||
37645975|NCT04456686|69115057|FG000|Overall Study|Withdrew consent|3|||
37645976|NCT04456686|69115058|FG001|Overall Study|Withdrew consent|1|||
37645977|NCT04456686|69115057|FG000|Overall Study|Physician Decision|2|||
37645978|NCT04456686|69115058|FG001|Overall Study|Physician Decision|2|||
37645979|NCT04456686|69115057|FG000|Overall Study|Withdrawal by Subject|5|||
37645980|NCT04456686|69115058|FG001|Overall Study|Withdrawal by Subject|1|||
37645981|NCT04456686|69115057|FG000|Overall Study|Protocol Violation|0|||
37645982|NCT04456686|69115058|FG001|Overall Study|Protocol Violation|1|||
37645983|NCT04325828|69115097|FG000|Overall Study|Ongoing|26|||
37645984|NCT04269889|69115105|FG000|Initial Phase (Day 0 to Month 6)|Lack of Efficacy|1|||
37645985|NCT04269889|69115105|FG000|Extended Phase (6 Months to Year 3)|Lack of Efficacy|13|||
37645986|NCT04219189|69115123|FG000|Overall Study|Withdrawal by Subject|1|||
37645987|NCT04219189|69115124|FG001|Overall Study|Withdrawal by Subject|2|||
37645988|NCT04219189|69115123|FG000|Overall Study|Protocol Violation|0|||
37645989|NCT04219189|69115124|FG001|Overall Study|Protocol Violation|1|||
37645990|NCT04219189|69115123|FG000|Overall Study|Lost to Follow-up|0|||
37645991|NCT04219189|69115124|FG001|Overall Study|Lost to Follow-up|1|||
37645992|NCT04219189|69115123|FG000|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|0|||
37645993|NCT04219189|69115124|FG001|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|1|||
37645994|NCT04099251|69115138|FG000|Pre-Treatment|Other reasons|1|||
37645995|NCT04099251|69115139|FG001|Pre-Treatment|Other reasons|0|||
37645996|NCT04099251|69115138|FG000|Pre-Treatment|Participant no longer meets study criteria|1|||
37645997|NCT04099251|69115139|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
37645998|NCT04099251|69115138|FG000|Blinded Treatment Phase|Other reasons|16|||
37645999|NCT04099251|69115139|FG001|Blinded Treatment Phase|Other reasons|7|||
37646000|NCT04099251|69115138|FG000|Blinded Treatment Phase|Disease recurrence|26|||
37646001|NCT04099251|69115139|FG001|Blinded Treatment Phase|Disease recurrence|41|||
37646002|NCT04099251|69115138|FG000|Blinded Treatment Phase|Adverse event unrelated to study drug|11|||
37646003|NCT04099251|69115139|FG001|Blinded Treatment Phase|Adverse event unrelated to study drug|1|||
37646004|NCT04099251|69115138|FG000|Blinded Treatment Phase|Study drug toxicity|94|||
37646005|NCT04099251|69115139|FG001|Blinded Treatment Phase|Study drug toxicity|7|||
37646006|NCT04099251|69115138|FG000|Blinded Treatment Phase|Participant no longer meets study criteria|1|||
37646007|NCT04099251|69115139|FG001|Blinded Treatment Phase|Participant no longer meets study criteria|0|||
37646008|NCT04099251|69115138|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
37646009|NCT04099251|69115139|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
37646010|NCT04099251|69115138|FG000|Blinded Treatment Phase|Death|6|||
37646011|NCT04099251|69115139|FG001|Blinded Treatment Phase|Death|2|||
37646012|NCT04099251|69115138|FG000|Blinded Treatment Phase|Withdrawal by Subject|18|||
37646013|NCT04099251|69115139|FG001|Blinded Treatment Phase|Withdrawal by Subject|7|||
37646014|NCT04099251|69115138|FG000|Blinded Treatment Phase|Participant request to discontinue study treatment|29|||
37646015|NCT04099251|69115139|FG001|Blinded Treatment Phase|Participant request to discontinue study treatment|0|||
37646016|NCT04099251|69115138|FG000|Blinded Treatment Phase|Ongoing treatment|64|||
37646017|NCT04099251|69115139|FG001|Blinded Treatment Phase|Ongoing treatment|39|||
37646018|NCT04099251|69115138|FG000|Blinded Treatment Phase|Maximum clinical benefit|1|||
37646019|NCT04099251|69115139|FG001|Blinded Treatment Phase|Maximum clinical benefit|2|||
37854512|NCT01232283|69537954|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
37854513|NCT01232283|69537955|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
37646020|NCT04099251|69115138|FG000|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|0|||
37646021|NCT04099251|69115139|FG001|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|2|||
37646022|NCT04099251|69115138|FG000|Optional Open-Label Phase Treatment|Disease progression/recurrence|0|||
37646023|NCT04099251|69115139|FG001|Optional Open-Label Phase Treatment|Disease progression/recurrence|5|||
37741054|NCT01397409|69227065|FG002|Stage 2|Adverse Event|0|||
37646024|NCT04099251|69115138|FG000|Optional Open-Label Phase Treatment|Decision by Principal Investigator|0|||
37646025|NCT04099251|69115139|FG001|Optional Open-Label Phase Treatment|Decision by Principal Investigator|1|||
37646026|NCT04099251|69115138|FG000|Optional Open-Label Phase Treatment|Study drug toxicity|0|||
37646027|NCT04099251|69115139|FG001|Optional Open-Label Phase Treatment|Study drug toxicity|2|||
37646028|NCT04099251|69115138|FG000|Optional Open-Label Phase Treatment|Ongoing treatment|2|||
37646029|NCT04099251|69115139|FG001|Optional Open-Label Phase Treatment|Ongoing treatment|17|||
37646030|NCT04066491|69115149|FG000|Overall Study|Randomized, not treated|0|||
37646031|NCT04066491|69115150|FG001|Overall Study|Randomized, not treated|0|||
37646032|NCT04066491|69115151|FG002|Overall Study|Randomized, not treated|2|||
37646033|NCT03904693|69115163|FG000|Overall Study|Death|0|||
37646034|NCT03904693|69115164|FG001|Overall Study|Death|0|||
37646035|NCT03904693|69115165|FG002|Overall Study|Death|3|||
37646036|NCT03904693|69115163|FG000|Overall Study|Physician Decision|0|||
37646037|NCT03904693|69115164|FG001|Overall Study|Physician Decision|0|||
37646038|NCT03904693|69115165|FG002|Overall Study|Physician Decision|2|||
37646039|NCT03904693|69115163|FG000|Overall Study|Withdrawal by Subject|0|||
37646040|NCT03904693|69115164|FG001|Overall Study|Withdrawal by Subject|1|||
37646041|NCT03904693|69115165|FG002|Overall Study|Withdrawal by Subject|4|||
37646042|NCT03883828|69115181|FG000|Overall Study|Did not start radiotherapy|1|||
37646043|NCT03883828|69115182|FG001|Overall Study|Did not start radiotherapy|2|||
37646044|NCT03844269|69115188|FG000|Overall Study|Withdrawal pre-intervention|1|||
37646045|NCT03844269|69115188|FG000|Overall Study|Did not complete the intervention|2|||
37646046|NCT03778294|69115203|FG000|Overall Study|Death|1|||
37646047|NCT03778294|69115203|FG000|Overall Study|Issues with insurance|1|||
37646048|NCT03778294|69115203|FG000|Overall Study|disease progression before treatment|2|||
37646049|NCT03777917|69115209|FG000|Overall Study|Withdrawal by Subject|1|||
37646050|NCT03777917|69115210|FG001|Overall Study|Withdrawal by Subject|0|||
37646051|NCT03777917|69115209|FG000|Overall Study|Physician Decision|1|||
37646052|NCT03777917|69115210|FG001|Overall Study|Physician Decision|0|||
37646053|NCT03777917|69115209|FG000|Overall Study|Lost to Follow-up|6|||
37646054|NCT03777917|69115210|FG001|Overall Study|Lost to Follow-up|2|||
37646055|NCT03777917|69115209|FG000|Overall Study|Other|1|||
37646056|NCT03777917|69115210|FG001|Overall Study|Other|0|||
37646057|NCT03748641|69115222|FG000|Overall Study|Ongoing|155|||
37646058|NCT03748641|69115223|FG001|Overall Study|Ongoing|148|||
37646059|NCT03748641|69115224|FG002|Overall Study|Ongoing|66|||
37646060|NCT03748641|69115225|FG003|Overall Study|Ongoing|79|||
37646061|NCT03748641|69115226|FG004|Overall Study|Ongoing|84|||
37646062|NCT03748641|69115222|FG000|Overall Study|Death|54|||
37646063|NCT03748641|69115223|FG001|Overall Study|Death|59|||
37646064|NCT03748641|69115224|FG002|Overall Study|Death|51|||
37646065|NCT03748641|69115225|FG003|Overall Study|Death|42|||
37646066|NCT03748641|69115226|FG004|Overall Study|Death|9|||
37646067|NCT03748641|69115222|FG000|Overall Study|Lost to Follow-up|0|||
37646068|NCT03748641|69115223|FG001|Overall Study|Lost to Follow-up|2|||
37646069|NCT03748641|69115224|FG002|Overall Study|Lost to Follow-up|1|||
37646070|NCT03748641|69115225|FG003|Overall Study|Lost to Follow-up|0|||
37646071|NCT03748641|69115226|FG004|Overall Study|Lost to Follow-up|0|||
37646072|NCT03748641|69115222|FG000|Overall Study|Withdrawal by Subject|3|||
37646073|NCT03748641|69115223|FG001|Overall Study|Withdrawal by Subject|2|||
37646074|NCT03748641|69115224|FG002|Overall Study|Withdrawal by Subject|5|||
37646075|NCT03748641|69115225|FG003|Overall Study|Withdrawal by Subject|3|||
37646076|NCT03748641|69115226|FG004|Overall Study|Withdrawal by Subject|2|||
37646077|NCT03635567|69115237|FG000|Overall Study|Lost to Follow-up|0|||
37646078|NCT03635567|69115238|FG001|Overall Study|Lost to Follow-up|2|||
37646079|NCT03635567|69115237|FG000|Overall Study|Withdrawal by Subject|9|||
37646080|NCT03635567|69115238|FG001|Overall Study|Withdrawal by Subject|10|||
37646081|NCT03635567|69115237|FG000|Overall Study|Ongoing in Study|125|||
37646082|NCT03635567|69115238|FG001|Overall Study|Ongoing in Study|76|||
37646083|NCT03635567|69115237|FG000|Overall Study|Death|174|||
37646084|NCT03635567|69115238|FG001|Overall Study|Death|221|||
37646085|NCT03594123|69115247|FG000|Overall Study|Lost to Follow-up|0|||
37646086|NCT03594123|69115248|FG001|Overall Study|Lost to Follow-up|1|||
37646087|NCT03594123|69115247|FG000|Overall Study|Adverse Event|8|||
37646088|NCT03594123|69115248|FG001|Overall Study|Adverse Event|5|||
37646089|NCT03594123|69115247|FG000|Overall Study|Site Terminated by Sponsor|4|||
37646090|NCT03594123|69115248|FG001|Overall Study|Site Terminated by Sponsor|1|||
37646091|NCT03594123|69115247|FG000|Overall Study|Subject Withdrew Consent to Participate|7|||
37646092|NCT03594123|69115248|FG001|Overall Study|Subject Withdrew Consent to Participate|1|||
37646093|NCT03594123|69115247|FG000|Overall Study|Lack of Efficacy|1|||
37646094|NCT03594123|69115248|FG001|Overall Study|Lack of Efficacy|0|||
37646095|NCT03594123|69115247|FG000|Overall Study|Other (Not Related to COVID-19)|1|||
37646096|NCT03594123|69115248|FG001|Overall Study|Other (Not Related to COVID-19)|1|||
37646097|NCT03583359|69115256|FG000|Overall Study|Withdrawal by Subject|15|||
37646098|NCT03583359|69115257|FG001|Overall Study|Withdrawal by Subject|6|||
37646099|NCT03583359|69115256|FG000|Overall Study|Lost to Follow-up|12|||
37646100|NCT03583359|69115257|FG001|Overall Study|Lost to Follow-up|3|||
37646101|NCT03583359|69115256|FG000|Overall Study|Adverse Event|0|||
37646102|NCT03583359|69115257|FG001|Overall Study|Adverse Event|1|||
37646103|NCT03583359|69115256|FG000|Overall Study|Protocol Violation|0|||
37646104|NCT03583359|69115257|FG001|Overall Study|Protocol Violation|1|||
37646105|NCT03583359|69115256|FG000|Overall Study|Other|2|||
37646106|NCT03583359|69115257|FG001|Overall Study|Other|1|||
37646107|NCT03537651|69115263|FG000|Overall Study|Adverse Event|2|||
37646108|NCT03537651|69115263|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
37646109|NCT03537651|69115263|FG000|Overall Study|Commercial Drug is Available for Participant|56|||
37646110|NCT03537651|69115263|FG000|Overall Study|Other|1|||
37646111|NCT03506438|69115276|FG000|Overall Study|Lost to Follow-up|8|||
37646112|NCT03506438|69115277|FG001|Overall Study|Lost to Follow-up|7|||
37646113|NCT03506438|69115278|FG002|Overall Study|Lost to Follow-up|8|||
37646114|NCT03506438|69115279|FG003|Overall Study|Lost to Follow-up|7|||
37646115|NCT03506438|69115280|FG004|Overall Study|Lost to Follow-up|0|||
37646116|NCT03506438|69115281|FG005|Overall Study|Lost to Follow-up|0|||
37646117|NCT03493542|69115294|FG000|Overall Study|Ongoing|2|||
37646118|NCT03493542|69115295|FG001|Overall Study|Ongoing|3|||
37646119|NCT03493542|69115294|FG000|Overall Study|Withdrawal by parent or guardian|3|||
37646120|NCT03493542|69115295|FG001|Overall Study|Withdrawal by parent or guardian|0|||
37646121|NCT03493542|69115294|FG000|Overall Study|Withdrawal by Subject|2|||
37646122|NCT03493542|69115295|FG001|Overall Study|Withdrawal by Subject|6|||
37646123|NCT03476798|69115301|FG000|Overall Study|Death|1|||
37646124|NCT03476798|69115301|FG000|Overall Study|Withdrawal by Subject|2|||
37646125|NCT03476798|69115301|FG000|Overall Study|Protocol Violation|2|||
37646126|NCT03366337|69115332|FG000|Overall Study|Lost to Follow-up|1|||
37646127|NCT03366337|69115333|FG001|Overall Study|Lost to Follow-up|0|||
37646128|NCT03366337|69115334|FG002|Overall Study|Lost to Follow-up|1|||
37646129|NCT03366337|69115335|FG003|Overall Study|Lost to Follow-up|0|||
37646130|NCT03366337|69115332|FG000|Overall Study|Withdrawal by Subject|2|||
37646131|NCT03366337|69115333|FG001|Overall Study|Withdrawal by Subject|0|||
37646132|NCT03366337|69115334|FG002|Overall Study|Withdrawal by Subject|1|||
37646133|NCT03366337|69115335|FG003|Overall Study|Withdrawal by Subject|1|||
37646134|NCT03253744|69115358|FG000|Completion of Follow-Up|Continuing follow-up.|2|||
37646135|NCT03253744|69115359|FG001|Completion of Follow-Up|Continuing follow-up.|0|||
37646136|NCT03253744|69115360|FG002|Completion of Follow-Up|Continuing follow-up.|0|||
37646137|NCT03253744|69115361|FG003|Completion of Follow-Up|Continuing follow-up.|4|||
37646138|NCT03104400|69115390|FG000|Overall Study|Adverse Event|5|||
37646139|NCT03104400|69115391|FG001|Overall Study|Adverse Event|7|||
37646140|NCT03104400|69115392|FG002|Overall Study|Adverse Event|11|||
37646141|NCT03104400|69115393|FG003|Overall Study|Adverse Event|9|||
37646142|NCT03104400|69115394|FG004|Overall Study|Adverse Event|21|||
37646143|NCT03104400|69115390|FG000|Overall Study|Withdrawal by Subject|17|||
37646144|NCT03104400|69115391|FG001|Overall Study|Withdrawal by Subject|19|||
37646145|NCT03104400|69115392|FG002|Overall Study|Withdrawal by Subject|29|||
37646146|NCT03104400|69115393|FG003|Overall Study|Withdrawal by Subject|25|||
37646147|NCT03104400|69115394|FG004|Overall Study|Withdrawal by Subject|24|||
37646148|NCT03104400|69115390|FG000|Overall Study|Lost to Follow-up|4|||
37646149|NCT03104400|69115391|FG001|Overall Study|Lost to Follow-up|1|||
37646150|NCT03104400|69115392|FG002|Overall Study|Lost to Follow-up|4|||
37646151|NCT03104400|69115393|FG003|Overall Study|Lost to Follow-up|8|||
37646152|NCT03104400|69115394|FG004|Overall Study|Lost to Follow-up|7|||
37646153|NCT03104400|69115390|FG000|Overall Study|Lack of Efficacy|6|||
37646154|NCT03104400|69115391|FG001|Overall Study|Lack of Efficacy|3|||
37646155|NCT03104400|69115392|FG002|Overall Study|Lack of Efficacy|8|||
37646156|NCT03104400|69115393|FG003|Overall Study|Lack of Efficacy|2|||
37646157|NCT03104400|69115394|FG004|Overall Study|Lack of Efficacy|1|||
37646158|NCT03104400|69115390|FG000|Overall Study|COVID Logistical Restrictions|0|||
37646159|NCT03104400|69115391|FG001|Overall Study|COVID Logistical Restrictions|0|||
37646160|NCT03104400|69115392|FG002|Overall Study|COVID Logistical Restrictions|0|||
37646161|NCT03104400|69115393|FG003|Overall Study|COVID Logistical Restrictions|1|||
37646162|NCT03104400|69115394|FG004|Overall Study|COVID Logistical Restrictions|0|||
37646163|NCT03104400|69115390|FG000|Overall Study|Other|2|||
37646164|NCT03104400|69115391|FG001|Overall Study|Other|3|||
37646165|NCT03104400|69115392|FG002|Overall Study|Other|7|||
37646166|NCT03104400|69115393|FG003|Overall Study|Other|6|||
37646167|NCT03104400|69115394|FG004|Overall Study|Other|4|||
37741055|NCT01397409|69227066|FG003|Stage 2|Adverse Event|0|||
37646168|NCT03104400|69115390|FG000|Overall Study|Other|0|||
37646169|NCT03104400|69115391|FG001|Overall Study|Other|1|||
37646170|NCT03104400|69115392|FG002|Overall Study|Other|0|||
37646171|NCT03104400|69115393|FG003|Overall Study|Other|0|||
37646172|NCT03104400|69115394|FG004|Overall Study|Other|0|||
37646173|NCT03034044|69115417|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
37646174|NCT02878798|69115423|FG000|Overall Study|Withdrawal by Subject|5|||
37646175|NCT02878798|69115424|FG001|Overall Study|Withdrawal by Subject|4|||
37646176|NCT02878798|69115423|FG000|Overall Study|Lost to Follow-up|2|||
37646177|NCT02878798|69115424|FG001|Overall Study|Lost to Follow-up|2|||
37646178|NCT02878798|69115423|FG000|Overall Study|Protocol Violation|0|||
37646179|NCT02878798|69115424|FG001|Overall Study|Protocol Violation|1|||
37646180|NCT02854436|69115430|FG000|Overall Study|Adverse Event|1|||
37646181|NCT02854436|69115430|FG000|Overall Study|Death|208|||
37646182|NCT02854436|69115430|FG000|Overall Study|Lost to Follow-up|5|||
37646183|NCT02854436|69115430|FG000|Overall Study|Withdrawal by Subject|12|||
37646184|NCT02854436|69115430|FG000|Overall Study|Other|45|||
37646185|NCT02854436|69115430|FG000|Overall Study|Ongoing|18|||
37646186|NCT02741193|69115434|FG000|Overall Study|Participant deemed not to be a surgical resection candidate|1|||
37646187|NCT02741193|69115434|FG000|Overall Study|Participant found to be seizure-free due to new epilepsy medication, did not participate|1|||
37646188|NCT02725177|69115438|FG000|Overall Study|Physician Decision|4|||
37646189|NCT02725177|69115438|FG000|Overall Study|Adverse Event|1|||
37646190|NCT02489318|69115444|FG000|Randomized|Withdrawal by Subject|0|||
37646191|NCT02489318|69115445|FG001|Randomized|Withdrawal by Subject|1|||
37646192|NCT02489318|69115444|FG000|Treated|Adverse Event|19|||
37646193|NCT02489318|69115445|FG001|Treated|Adverse Event|62|||
37646194|NCT02489318|69115444|FG000|Treated|Death|13|||
37646195|NCT02489318|69115445|FG001|Treated|Death|11|||
37646196|NCT02489318|69115444|FG000|Treated|Physician Decision|4|||
37646197|NCT02489318|69115445|FG001|Treated|Physician Decision|6|||
37646198|NCT02489318|69115444|FG000|Treated|Protocol Violation|1|||
37646199|NCT02489318|69115445|FG001|Treated|Protocol Violation|2|||
37646200|NCT02489318|69115444|FG000|Treated|Withdrawal by Subject|37|||
37646201|NCT02489318|69115445|FG001|Treated|Withdrawal by Subject|36|||
37646202|NCT02489318|69115444|FG000|Treated|Other: Progressive Disease|245|||
37646203|NCT02489318|69115445|FG001|Treated|Other: Progressive Disease|138|||
37646204|NCT02489318|69115444|FG000|Treated|Other|0|||
37646205|NCT02489318|69115445|FG001|Treated|Other|2|||
37646206|NCT02489318|69115444|FG000|Treated|Ongoing|0|||
37646207|NCT02489318|69115445|FG001|Treated|Ongoing|267|||
37646208|NCT02488759|69115458|FG000|Overall Study|Disease progression|73|||
37646209|NCT02488759|69115459|FG001|Overall Study|Disease progression|111|||
37646210|NCT02488759|69115460|FG002|Overall Study|Disease progression|62|||
37646211|NCT02488759|69115461|FG003|Overall Study|Disease progression|7|||
37646212|NCT02488759|69115462|FG004|Overall Study|Disease progression|4|||
37646213|NCT02488759|69115463|FG005|Overall Study|Disease progression|2|||
37646214|NCT02488759|69115458|FG000|Overall Study|Study drug toxicity|11|||
37646215|NCT02488759|69115459|FG001|Overall Study|Study drug toxicity|33|||
37646216|NCT02488759|69115460|FG002|Overall Study|Study drug toxicity|31|||
37646217|NCT02488759|69115461|FG003|Overall Study|Study drug toxicity|0|||
37646218|NCT02488759|69115462|FG004|Overall Study|Study drug toxicity|0|||
37646219|NCT02488759|69115463|FG005|Overall Study|Study drug toxicity|2|||
37646220|NCT02488759|69115458|FG000|Overall Study|Adverse event unrelated to study drug|9|||
37646221|NCT02488759|69115459|FG001|Overall Study|Adverse event unrelated to study drug|11|||
37646222|NCT02488759|69115460|FG002|Overall Study|Adverse event unrelated to study drug|7|||
37646223|NCT02488759|69115461|FG003|Overall Study|Adverse event unrelated to study drug|0|||
37646224|NCT02488759|69115462|FG004|Overall Study|Adverse event unrelated to study drug|1|||
37646225|NCT02488759|69115463|FG005|Overall Study|Adverse event unrelated to study drug|0|||
37646226|NCT02488759|69115458|FG000|Overall Study|Participant request to discontinue study treatment|6|||
37646227|NCT02488759|69115459|FG001|Overall Study|Participant request to discontinue study treatment|8|||
37646228|NCT02488759|69115460|FG002|Overall Study|Participant request to discontinue study treatment|4|||
37646229|NCT02488759|69115461|FG003|Overall Study|Participant request to discontinue study treatment|0|||
37646230|NCT02488759|69115462|FG004|Overall Study|Participant request to discontinue study treatment|0|||
37646231|NCT02488759|69115463|FG005|Overall Study|Participant request to discontinue study treatment|0|||
37646232|NCT02488759|69115458|FG000|Overall Study|Withdrawal by Subject|4|||
37646233|NCT02488759|69115459|FG001|Overall Study|Withdrawal by Subject|0|||
37646234|NCT02488759|69115460|FG002|Overall Study|Withdrawal by Subject|3|||
37646235|NCT02488759|69115461|FG003|Overall Study|Withdrawal by Subject|0|||
37646236|NCT02488759|69115462|FG004|Overall Study|Withdrawal by Subject|0|||
37854514|NCT01232283|69537956|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
37646237|NCT02488759|69115463|FG005|Overall Study|Withdrawal by Subject|2|||
37646238|NCT02488759|69115458|FG000|Overall Study|Lost to Follow-up|0|||
37646239|NCT02488759|69115459|FG001|Overall Study|Lost to Follow-up|0|||
37741056|NCT01397409|69227067|FG004|Stage 2|Adverse Event|6|||
37741057|NCT01397409|69227068|FG005|Stage 2|Adverse Event|3|||
37854515|NCT01232283|69537957|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
37646240|NCT02488759|69115460|FG002|Overall Study|Lost to Follow-up|2|||
37646241|NCT02488759|69115461|FG003|Overall Study|Lost to Follow-up|0|||
37646242|NCT02488759|69115462|FG004|Overall Study|Lost to Follow-up|0|||
37646243|NCT02488759|69115463|FG005|Overall Study|Lost to Follow-up|0|||
37646244|NCT02488759|69115458|FG000|Overall Study|Maximum clinical benefit|3|||
37646245|NCT02488759|69115459|FG001|Overall Study|Maximum clinical benefit|0|||
37646246|NCT02488759|69115460|FG002|Overall Study|Maximum clinical benefit|1|||
37646247|NCT02488759|69115461|FG003|Overall Study|Maximum clinical benefit|0|||
37646248|NCT02488759|69115462|FG004|Overall Study|Maximum clinical benefit|0|||
37646249|NCT02488759|69115463|FG005|Overall Study|Maximum clinical benefit|0|||
37646250|NCT02488759|69115458|FG000|Overall Study|Other reasons|7|||
37646251|NCT02488759|69115459|FG001|Overall Study|Other reasons|32|||
37646252|NCT02488759|69115460|FG002|Overall Study|Other reasons|23|||
37646253|NCT02488759|69115461|FG003|Overall Study|Other reasons|1|||
37646254|NCT02488759|69115462|FG004|Overall Study|Other reasons|1|||
37646255|NCT02488759|69115463|FG005|Overall Study|Other reasons|1|||
37646256|NCT02466685|69115479|FG000|Overall Study|Adverse Event|5|||
37646257|NCT02466685|69115480|FG001|Overall Study|Adverse Event|2|||
37646258|NCT02466685|69115479|FG000|Overall Study|Lost to Follow-up|1|||
37646259|NCT02466685|69115480|FG001|Overall Study|Lost to Follow-up|1|||
37646260|NCT02466685|69115479|FG000|Overall Study|Withdrawal by Subject|1|||
37646261|NCT02466685|69115480|FG001|Overall Study|Withdrawal by Subject|0|||
37646262|NCT02466685|69115479|FG000|Overall Study|Physician Decision|1|||
37646263|NCT02466685|69115480|FG001|Overall Study|Physician Decision|1|||
37646264|NCT02367040|69115491|FG000|Overall Study|Lost to Follow-up|1|||
37646265|NCT02367040|69115492|FG001|Overall Study|Lost to Follow-up|1|||
37646266|NCT02367040|69115491|FG000|Overall Study|Lack of Efficacy|1|||
37646267|NCT02367040|69115492|FG001|Overall Study|Lack of Efficacy|0|||
37646268|NCT02367040|69115491|FG000|Overall Study|Additional primary malignancy|0|||
37646269|NCT02367040|69115492|FG001|Overall Study|Additional primary malignancy|1|||
37646270|NCT02367040|69115491|FG000|Overall Study|AE not associated with clinical disease progression|114|||
37646271|NCT02367040|69115492|FG001|Overall Study|AE not associated with clinical disease progression|11|||
37646272|NCT02367040|69115491|FG000|Overall Study|AE associated with clinical disease progression|1|||
37646273|NCT02367040|69115492|FG001|Overall Study|AE associated with clinical disease progression|3|||
37646274|NCT02367040|69115491|FG000|Overall Study|Physician Decision|2|||
37646275|NCT02367040|69115492|FG001|Overall Study|Physician Decision|8|||
37646276|NCT02367040|69115491|FG000|Overall Study|Non-compliance with study drug|1|||
37646277|NCT02367040|69115492|FG001|Overall Study|Non-compliance with study drug|0|||
37646278|NCT02367040|69115491|FG000|Overall Study|Failure to meet continuation criteria|1|||
37646279|NCT02367040|69115492|FG001|Overall Study|Failure to meet continuation criteria|0|||
37646280|NCT02367040|69115491|FG000|Overall Study|Switching to other therapy|2|||
37646281|NCT02367040|69115492|FG001|Overall Study|Switching to other therapy|0|||
37646282|NCT02367040|69115491|FG000|Overall Study|Withdrawal by Subject|46|||
37646283|NCT02367040|69115492|FG001|Overall Study|Withdrawal by Subject|16|||
37646284|NCT02367040|69115491|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
37646285|NCT02367040|69115492|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
37646286|NCT02367040|69115491|FG000|Overall Study|Patient decision|39|||
37646287|NCT02367040|69115492|FG001|Overall Study|Patient decision|14|||
37646288|NCT02367040|69115491|FG000|Overall Study|Required procedure failed|1|||
37646289|NCT02367040|69115492|FG001|Overall Study|Required procedure failed|0|||
37646290|NCT02367040|69115491|FG000|Overall Study|Randomized by mistake with study treatment|1|||
37646291|NCT02367040|69115492|FG001|Overall Study|Randomized by mistake with study treatment|0|||
37646292|NCT02367040|69115491|FG000|Overall Study|Protocol Violation|1|||
37646293|NCT02367040|69115492|FG001|Overall Study|Protocol Violation|0|||
37646294|NCT02367040|69115491|FG000|Overall Study|Progressive disease - radiological progression|51|||
37646295|NCT02367040|69115492|FG001|Overall Study|Progressive disease - radiological progression|78|||
37646296|NCT02367040|69115491|FG000|Overall Study|Progressive disease - clinical progression|6|||
37646297|NCT02367040|69115492|FG001|Overall Study|Progressive disease - clinical progression|6|||
37646298|NCT02367040|69115491|FG000|Overall Study|Drug not administered|3|||
37646299|NCT02367040|69115492|FG001|Overall Study|Drug not administered|2|||
37646300|NCT02367040|69115491|FG000|Overall Study|Progressive disease|0|||
37646301|NCT02367040|69115492|FG001|Overall Study|Progressive disease|1|||
37646302|NCT02367040|69115491|FG000|Overall Study|Other reason: Covid-19 pandemic related|1|||
38032174|NCT02250664|69718087|FG001|Overall Study|Withdrawal by Subject|1|||
38032175|NCT02250664|69718088|FG002|Overall Study|Withdrawal by Subject|2|||
38032176|NCT02250664|69718086|FG000|Overall Study|Death|0|||
38032177|NCT02250664|69718087|FG001|Overall Study|Death|1|||
38032178|NCT02250664|69718088|FG002|Overall Study|Death|1|||
38032179|NCT02250664|69718086|FG000|Overall Study|Physician Decision|1|||
38032180|NCT02250664|69718087|FG001|Overall Study|Physician Decision|3|||
38032181|NCT02250664|69718088|FG002|Overall Study|Physician Decision|1|||
38032182|NCT02250664|69718086|FG000|Overall Study|Protocol Violation|1|||
37646303|NCT02367040|69115492|FG001|Overall Study|Other reason: Covid-19 pandemic related|0|||
37646304|NCT02367040|69115491|FG000|Overall Study|Death|2|||
37646305|NCT02367040|69115492|FG001|Overall Study|Death|0|||
37646306|NCT02312206|69115500|FG000|Overall Study|Adverse Event|3|||
37646307|NCT02312206|69115501|FG001|Overall Study|Adverse Event|6|||
37646308|NCT02312206|69115500|FG000|Overall Study|Withdrawal by Subject|6|||
37646309|NCT02312206|69115501|FG001|Overall Study|Withdrawal by Subject|6|||
37646310|NCT02312206|69115500|FG000|Overall Study|Physician Decision|7|||
37646311|NCT02312206|69115501|FG001|Overall Study|Physician Decision|6|||
38032183|NCT02250664|69718087|FG001|Overall Study|Protocol Violation|0|||
37646312|NCT02312206|69115500|FG000|Overall Study|Death|31|||
37646313|NCT02312206|69115501|FG001|Overall Study|Death|36|||
37646314|NCT02312206|69115500|FG000|Overall Study|Study Terminated by Sponsor|81|||
37646315|NCT02312206|69115501|FG001|Overall Study|Study Terminated by Sponsor|74|||
38032184|NCT02250664|69718088|FG002|Overall Study|Protocol Violation|1|||
37646316|NCT02312206|69115500|FG000|Overall Study|Patient transferred to hospice|0|||
37646317|NCT02312206|69115501|FG001|Overall Study|Patient transferred to hospice|1|||
37646318|NCT02312206|69115500|FG000|Overall Study|Subject missed three consecutive treatment visits|0|||
37646319|NCT02312206|69115501|FG001|Overall Study|Subject missed three consecutive treatment visits|1|||
37646320|NCT02312206|69115500|FG000|Overall Study|Patient progression and institution of a new therapy|1|||
37646321|NCT02312206|69115501|FG001|Overall Study|Patient progression and institution of a new therapy|0|||
37646322|NCT02312206|69115500|FG000|Overall Study|Disease Progression|1|||
37646323|NCT02312206|69115501|FG001|Overall Study|Disease Progression|0|||
37646324|NCT02264665|69115512|FG000|Overall Study|Other|0|||
37646325|NCT02264665|69115513|FG001|Overall Study|Other|0|||
37646326|NCT02264665|69115514|FG002|Overall Study|Other|3|||
37646327|NCT02264665|69115515|FG003|Overall Study|Other|0|||
37646328|NCT02264665|69115516|FG004|Overall Study|Other|0|||
37646329|NCT02264665|69115517|FG005|Overall Study|Other|0|||
37646330|NCT02264665|69115518|FG006|Overall Study|Other|0|||
37646331|NCT02264665|69115512|FG000|Overall Study|Death|9|||
37646332|NCT02264665|69115513|FG001|Overall Study|Death|8|||
37646333|NCT02264665|69115514|FG002|Overall Study|Death|13|||
37646334|NCT02264665|69115515|FG003|Overall Study|Death|5|||
37646335|NCT02264665|69115516|FG004|Overall Study|Death|0|||
37646336|NCT02264665|69115517|FG005|Overall Study|Death|0|||
37646337|NCT02264665|69115518|FG006|Overall Study|Death|1|||
37646338|NCT02264665|69115512|FG000|Overall Study|Lost to Follow-up|1|||
37646339|NCT02264665|69115513|FG001|Overall Study|Lost to Follow-up|0|||
37646340|NCT02264665|69115514|FG002|Overall Study|Lost to Follow-up|2|||
37646341|NCT02264665|69115515|FG003|Overall Study|Lost to Follow-up|1|||
37646342|NCT02264665|69115516|FG004|Overall Study|Lost to Follow-up|0|||
37646343|NCT02264665|69115517|FG005|Overall Study|Lost to Follow-up|0|||
37646344|NCT02264665|69115518|FG006|Overall Study|Lost to Follow-up|0|||
37646345|NCT02264665|69115512|FG000|Overall Study|Participant decision|0|||
37646346|NCT02264665|69115513|FG001|Overall Study|Participant decision|0|||
37646347|NCT02264665|69115514|FG002|Overall Study|Participant decision|0|||
37646348|NCT02264665|69115515|FG003|Overall Study|Participant decision|1|||
37646349|NCT02264665|69115516|FG004|Overall Study|Participant decision|0|||
37646350|NCT02264665|69115517|FG005|Overall Study|Participant decision|0|||
37646351|NCT02264665|69115518|FG006|Overall Study|Participant decision|0|||
37646352|NCT02264665|69115512|FG000|Overall Study|Inclusion/non-inclusion criteria not respected|3|||
37646353|NCT02264665|69115513|FG001|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
37646354|NCT02264665|69115514|FG002|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
37646355|NCT02264665|69115515|FG003|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
37646356|NCT02264665|69115516|FG004|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
37646357|NCT02264665|69115517|FG005|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
37646358|NCT02264665|69115518|FG006|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
37741058|NCT01397409|69227069|FG006|Stage 2|Adverse Event|0|||
37741059|NCT01397409|69227070|FG007|Stage 2|Adverse Event|0|||
37741060|NCT01397409|69227071|FG008|Stage 2|Adverse Event|0|||
37741061|NCT01397409|69227072|FG009|Stage 2|Adverse Event|0|||
37741062|NCT01397409|69227063|FG000|Stage 2|Personal Reasons|0|||
37741063|NCT01397409|69227064|FG001|Stage 2|Personal Reasons|0|||
37741064|NCT01397409|69227065|FG002|Stage 2|Personal Reasons|0|||
37741065|NCT01397409|69227066|FG003|Stage 2|Personal Reasons|0|||
37741066|NCT01397409|69227067|FG004|Stage 2|Personal Reasons|1|||
37741067|NCT01397409|69227068|FG005|Stage 2|Personal Reasons|0|||
37741068|NCT01397409|69227069|FG006|Stage 2|Personal Reasons|0|||
37741069|NCT01397409|69227070|FG007|Stage 2|Personal Reasons|0|||
37741070|NCT01397409|69227071|FG008|Stage 2|Personal Reasons|0|||
37741071|NCT01397409|69227072|FG009|Stage 2|Personal Reasons|0|||
37741072|NCT01397409|69227063|FG000|Stage 2|Other Miscellaneous Reasons|0|||
37741073|NCT01397409|69227064|FG001|Stage 2|Other Miscellaneous Reasons|0|||
37741074|NCT01397409|69227065|FG002|Stage 2|Other Miscellaneous Reasons|0|||
37741075|NCT01397409|69227066|FG003|Stage 2|Other Miscellaneous Reasons|0|||
37741076|NCT01397409|69227067|FG004|Stage 2|Other Miscellaneous Reasons|1|||
37646359|NCT02264665|69115512|FG000|Overall Study|Data Missing|0|||
37741077|NCT01397409|69227068|FG005|Stage 2|Other Miscellaneous Reasons|1|||
37741078|NCT01397409|69227069|FG006|Stage 2|Other Miscellaneous Reasons|0|||
37741079|NCT01397409|69227070|FG007|Stage 2|Other Miscellaneous Reasons|0|||
37741080|NCT01397409|69227071|FG008|Stage 2|Other Miscellaneous Reasons|0|||
37741081|NCT01397409|69227072|FG009|Stage 2|Other Miscellaneous Reasons|0|||
37741082|NCT01397409|69227063|FG000|Stage 3|Adverse Event|0|||
37854516|NCT01232283|69537958|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
37854517|NCT01232283|69537959|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
37922050|NCT00853658|69608865|FG002|Overall Study|Lost to Follow-up|11|||
37646360|NCT02264665|69115513|FG001|Overall Study|Data Missing|0|||
37646361|NCT02264665|69115514|FG002|Overall Study|Data Missing|1|||
37646362|NCT02264665|69115515|FG003|Overall Study|Data Missing|0|||
37646363|NCT02264665|69115516|FG004|Overall Study|Data Missing|0|||
37741083|NCT01397409|69227064|FG001|Stage 3|Adverse Event|0|||
37741084|NCT01397409|69227065|FG002|Stage 3|Adverse Event|0|||
37646364|NCT02264665|69115517|FG005|Overall Study|Data Missing|0|||
37646365|NCT02264665|69115518|FG006|Overall Study|Data Missing|0|||
37646366|NCT02257736|69115545|FG000|Overall Study|Progressive disease|365|||
37646367|NCT02257736|69115546|FG001|Overall Study|Progressive disease|327|||
37646368|NCT02257736|69115545|FG000|Overall Study|Adverse Event|45|||
37646369|NCT02257736|69115546|FG001|Overall Study|Adverse Event|56|||
37646370|NCT02257736|69115545|FG000|Overall Study|Withdrawal by Subject|21|||
37646371|NCT02257736|69115546|FG001|Overall Study|Withdrawal by Subject|38|||
37646372|NCT02257736|69115545|FG000|Overall Study|Death|11|||
37646373|NCT02257736|69115546|FG001|Overall Study|Death|6|||
37646374|NCT02257736|69115545|FG000|Overall Study|Physician Decision|5|||
37646375|NCT02257736|69115546|FG001|Overall Study|Physician Decision|9|||
37646376|NCT02257736|69115545|FG000|Overall Study|Non-Compliance with study drug|1|||
37646377|NCT02257736|69115546|FG001|Overall Study|Non-Compliance with study drug|2|||
37646378|NCT02257736|69115545|FG000|Overall Study|Protocol Violation|1|||
37646379|NCT02257736|69115546|FG001|Overall Study|Protocol Violation|0|||
37646380|NCT02257736|69115545|FG000|Overall Study|Other|1|||
37646381|NCT02257736|69115546|FG001|Overall Study|Other|7|||
37646382|NCT02257736|69115545|FG000|Overall Study|Randomized, not treated|1|||
37646383|NCT02257736|69115546|FG001|Overall Study|Randomized, not treated|2|||
37646384|NCT02155712|69115554|FG000|Overall Study|Death|12|||
37646385|NCT02155712|69115555|FG001|Overall Study|Death|0|||
37646386|NCT02155712|69115554|FG000|Overall Study|Lost to Follow-up|37|||
37646387|NCT02155712|69115555|FG001|Overall Study|Lost to Follow-up|22|||
37646388|NCT02155712|69115554|FG000|Overall Study|Revision of device|4|||
37646389|NCT02155712|69115555|FG001|Overall Study|Revision of device|3|||
37646390|NCT02155712|69115554|FG000|Overall Study|Withdrawal by Subject|39|||
37646391|NCT02155712|69115555|FG001|Overall Study|Withdrawal by Subject|21|||
37646392|NCT02155712|69115554|FG000|Overall Study|Site termination|77|||
37646393|NCT02155712|69115555|FG001|Overall Study|Site termination|19|||
37646394|NCT02155712|69115554|FG000|Overall Study|Sponsor terminated study early|150|||
37646395|NCT02155712|69115555|FG001|Overall Study|Sponsor terminated study early|0|||
37646396|NCT02155712|69115554|FG000|Overall Study|Missed final 5-year protocol visit|0|||
37922051|NCT00853658|69608863|FG000|Overall Study|H.A. Request|26|||
37646397|NCT02155712|69115555|FG001|Overall Study|Missed final 5-year protocol visit|32|||
37646398|NCT02155712|69115554|FG000|Overall Study|Censored because surgery cancelled|6|||
37646399|NCT02155712|69115555|FG001|Overall Study|Censored because surgery cancelled|10|||
37646400|NCT02155712|69115554|FG000|Overall Study|Censored because study device was not implanted|61|||
37646401|NCT02155712|69115555|FG001|Overall Study|Censored because study device was not implanted|66|||
37646402|NCT02155712|69115554|FG000|Overall Study|Censored because of inclusion/exclusion violation|11|||
37646403|NCT02155712|69115555|FG001|Overall Study|Censored because of inclusion/exclusion violation|6|||
37646404|NCT01972217|69115569|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
37646405|NCT01972217|69115570|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
37646406|NCT01972217|69115571|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
37646407|NCT01972217|69115572|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
37646408|NCT01972217|69115569|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
37646409|NCT01972217|69115570|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
37646410|NCT01972217|69115571|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
37646411|NCT01972217|69115572|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
37646412|NCT01972217|69115569|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
37646413|NCT01972217|69115570|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
37646414|NCT01972217|69115571|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
37646415|NCT01972217|69115572|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
37646416|NCT01972217|69115569|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
37646417|NCT01972217|69115570|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
37646418|NCT01972217|69115571|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
37646419|NCT01972217|69115572|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
37646420|NCT01972217|69115569|FG000|Part B Double-blind, Randomised Period|Death|0|||
37646421|NCT01972217|69115570|FG001|Part B Double-blind, Randomised Period|Death|0|||
37646422|NCT01972217|69115571|FG002|Part B Double-blind, Randomised Period|Death|43|||
37646423|NCT01972217|69115572|FG003|Part B Double-blind, Randomised Period|Death|44|||
37854518|NCT01232283|69537960|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
37854519|NCT01232283|69537961|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
37854520|NCT01232283|69537952|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
37854521|NCT01232283|69537953|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
37646424|NCT01972217|69115569|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
37646425|NCT01972217|69115570|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
37646426|NCT01972217|69115571|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
37854522|NCT01232283|69537954|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
37854523|NCT01232283|69537955|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
37646427|NCT01972217|69115572|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
37646428|NCT01972217|69115569|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
37646429|NCT01972217|69115570|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
37646430|NCT01972217|69115571|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
37646431|NCT01972217|69115572|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
37646432|NCT01972217|69115569|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
37646433|NCT01972217|69115570|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
37646434|NCT01972217|69115571|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
37646435|NCT01972217|69115572|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
37646436|NCT01972217|69115569|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
37646437|NCT01972217|69115570|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
37646438|NCT01972217|69115571|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
37646439|NCT01972217|69115572|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
37646440|NCT01946204|69115586|FG000|Overall Study|Death|38|||
37646441|NCT01946204|69115587|FG001|Overall Study|Death|59|||
37646442|NCT01946204|69115586|FG000|Overall Study|Withdrawal by Subject|37|||
37646443|NCT01946204|69115587|FG001|Overall Study|Withdrawal by Subject|50|||
37646444|NCT01946204|69115586|FG000|Overall Study|Lost to Follow-up|3|||
37646445|NCT01946204|69115587|FG001|Overall Study|Lost to Follow-up|7|||
37646446|NCT01946204|69115586|FG000|Overall Study|Ongoing|316|||
37646447|NCT01946204|69115587|FG001|Overall Study|Ongoing|687|||
37646448|NCT01946204|69115586|FG000|Overall Study|Other|7|||
37646449|NCT01946204|69115587|FG001|Overall Study|Other|3|||
37646450|NCT01918007|69115604|FG000|Overall Study|Baseline oximetry not acceptable|11|||
37646451|NCT01918007|69115605|FG001|Overall Study|Baseline oximetry not acceptable|7|||
37646452|NCT01918007|69115604|FG000|Overall Study|Follow-up oximetry not acceptable|10|||
37646453|NCT01918007|69115605|FG001|Overall Study|Follow-up oximetry not acceptable|7|||
37646454|NCT01918007|69115604|FG000|Overall Study|Lost to Follow-up|4|||
37646455|NCT01918007|69115605|FG001|Overall Study|Lost to Follow-up|7|||
37646456|NCT01902173|69115617|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
37646457|NCT01902173|69115618|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
37646458|NCT01902173|69115619|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
37646459|NCT01902173|69115620|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
37646460|NCT01902173|69115621|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
37646461|NCT01902173|69115622|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
37646462|NCT01902173|69115617|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
37646463|NCT01902173|69115618|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
37646464|NCT01902173|69115619|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
37646465|NCT01902173|69115620|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
37646466|NCT01902173|69115621|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
37646467|NCT01902173|69115622|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
37646468|NCT01902173|69115617|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
37646469|NCT01902173|69115618|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
37646470|NCT01902173|69115619|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
37646471|NCT01902173|69115620|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
37646472|NCT01902173|69115621|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
37646473|NCT01902173|69115622|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
37646474|NCT01902173|69115617|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
37646475|NCT01902173|69115618|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
37646476|NCT01902173|69115619|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
37646477|NCT01902173|69115620|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
37646478|NCT01902173|69115621|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
37646479|NCT01902173|69115622|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
37646480|NCT01902173|69115617|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
37646481|NCT01902173|69115618|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
37646482|NCT01902173|69115619|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
37646483|NCT01902173|69115620|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
37646484|NCT01902173|69115621|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
37646485|NCT01902173|69115622|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
37646486|NCT01902173|69115617|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
37646487|NCT01902173|69115618|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
37646488|NCT01902173|69115619|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
37646489|NCT01902173|69115620|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
37646490|NCT01902173|69115621|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
37646491|NCT01902173|69115622|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
37646492|NCT01902173|69115617|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
37741085|NCT01397409|69227066|FG003|Stage 3|Adverse Event|0|||
37741086|NCT01397409|69227067|FG004|Stage 3|Adverse Event|0|||
37741087|NCT01397409|69227068|FG005|Stage 3|Adverse Event|0|||
37741088|NCT01397409|69227069|FG006|Stage 3|Adverse Event|0|||
37741089|NCT01397409|69227070|FG007|Stage 3|Adverse Event|1|||
37741090|NCT01397409|69227071|FG008|Stage 3|Adverse Event|0|||
37646493|NCT01902173|69115618|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
37646494|NCT01902173|69115619|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
37646495|NCT01902173|69115620|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
37646496|NCT01902173|69115621|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
37646497|NCT01902173|69115622|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
37646498|NCT01902173|69115617|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
37646499|NCT01902173|69115618|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
37646500|NCT01902173|69115619|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
37646501|NCT01902173|69115620|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
37646502|NCT01902173|69115621|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
37646503|NCT01902173|69115622|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
37646504|NCT01902173|69115617|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
37646505|NCT01902173|69115618|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
37646506|NCT01902173|69115619|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
37646507|NCT01902173|69115620|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
37646508|NCT01902173|69115621|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
37646509|NCT01902173|69115622|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
37646510|NCT01902173|69115617|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
37646511|NCT01902173|69115618|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
37646512|NCT01902173|69115619|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
37646513|NCT01902173|69115620|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
37646514|NCT01902173|69115621|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
37646515|NCT01902173|69115622|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
37646516|NCT01902173|69115617|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
37646517|NCT01902173|69115618|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
37646518|NCT01902173|69115619|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
37646519|NCT01902173|69115620|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
37646520|NCT01902173|69115621|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
37646521|NCT01902173|69115622|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
37646522|NCT01902173|69115617|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
37646523|NCT01902173|69115618|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
37646524|NCT01902173|69115619|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
37646525|NCT01902173|69115620|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
37646526|NCT01902173|69115621|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
37646527|NCT01902173|69115622|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
37646528|NCT01902173|69115617|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
37646529|NCT01902173|69115618|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
37646530|NCT01902173|69115619|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
37646531|NCT01902173|69115620|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
37646532|NCT01902173|69115621|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
37646533|NCT01902173|69115622|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
37646534|NCT01902173|69115617|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
37646535|NCT01902173|69115618|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
37646536|NCT01902173|69115619|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
37646537|NCT01902173|69115620|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
37646538|NCT01902173|69115621|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
37646539|NCT01902173|69115622|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
37646540|NCT01863446|69115643|FG000|Overall Study|Withdrawal by Subject|1|||
37646541|NCT01863446|69115644|FG001|Overall Study|Withdrawal by Subject|0|||
37646542|NCT01863446|69115645|FG002|Overall Study|Withdrawal by Subject|1|||
37646543|NCT01863446|69115646|FG003|Overall Study|Withdrawal by Subject|2|||
37646544|NCT01863446|69115643|FG000|Overall Study|Physician Decision|0|||
37646545|NCT01863446|69115644|FG001|Overall Study|Physician Decision|0|||
37646546|NCT01863446|69115645|FG002|Overall Study|Physician Decision|1|||
37646547|NCT01863446|69115646|FG003|Overall Study|Physician Decision|0|||
37646548|NCT01809691|69115658|FG000|Overall Study|Currently on Treatment|192|||
37646549|NCT01809691|69115659|FG001|Overall Study|Currently on Treatment|100|||
37646550|NCT01809691|69115658|FG000|Overall Study|No Protocol Treatment|10|||
37646551|NCT01809691|69115659|FG001|Overall Study|No Protocol Treatment|11|||
37646552|NCT01809691|69115658|FG000|Overall Study|Adverse Event|80|||
37854524|NCT01232283|69537956|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
37854525|NCT01232283|69537957|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
37854526|NCT01232283|69537958|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
37646553|NCT01809691|69115659|FG001|Overall Study|Adverse Event|21|||
37646554|NCT01809691|69115658|FG000|Overall Study|Disease Progression|226|||
37646555|NCT01809691|69115659|FG001|Overall Study|Disease Progression|372|||
37646556|NCT01809691|69115658|FG000|Overall Study|Death|26|||
37646557|NCT01809691|69115659|FG001|Overall Study|Death|13|||
37646558|NCT01809691|69115658|FG000|Overall Study|Participant Refusal|70|||
37646559|NCT01809691|69115659|FG001|Overall Study|Participant Refusal|72|||
37646560|NCT01809691|69115658|FG000|Overall Study|Other, Not Specified|34|||
37646561|NCT01809691|69115659|FG001|Overall Study|Other, Not Specified|52|||
37646562|NCT01772472|69115667|FG000|Overall Study|Death|56|||
37646563|NCT01772472|69115668|FG001|Overall Study|Death|42|||
37646564|NCT01772472|69115667|FG000|Overall Study|Physician Decision|1|||
37646565|NCT01772472|69115668|FG001|Overall Study|Physician Decision|3|||
37646566|NCT01772472|69115667|FG000|Overall Study|Other|5|||
37646567|NCT01772472|69115668|FG001|Overall Study|Other|5|||
37646568|NCT01772472|69115667|FG000|Overall Study|Lost to Follow-up|12|||
37646569|NCT01772472|69115668|FG001|Overall Study|Lost to Follow-up|8|||
37646570|NCT01772472|69115667|FG000|Overall Study|Withdrawal by Subject|72|||
37646571|NCT01772472|69115668|FG001|Overall Study|Withdrawal by Subject|50|||
37646572|NCT01772472|69115667|FG000|Overall Study|Ongoing|597|||
37646573|NCT01772472|69115668|FG001|Overall Study|Ongoing|635|||
37646574|NCT01532388|69115685|FG000|3-month Follow-up|Lost to Follow-up|68|||
37646575|NCT01532388|69115686|FG001|3-month Follow-up|Lost to Follow-up|68|||
37646576|NCT01532388|69115685|FG000|6-month Follow-up|Lost to Follow-up|74|||
37646577|NCT01532388|69115686|FG001|6-month Follow-up|Lost to Follow-up|66|||
37646578|NCT01532388|69115685|FG000|12-month Follow-up|Lost to Follow-up|69|||
37646579|NCT01532388|69115686|FG001|12-month Follow-up|Lost to Follow-up|67|||
37646580|NCT01314118|69115701|FG000|Overall Study|Adverse Event|9|||
37646581|NCT01314118|69115701|FG000|Overall Study|Progressive disease|27|||
37646582|NCT01314118|69115701|FG000|Overall Study|Physician Decision|11|||
37646583|NCT01314118|69115701|FG000|Overall Study|Death|4|||
37646584|NCT01314118|69115701|FG000|Overall Study|Protocol Violation|5|||
37646585|NCT01314118|69115701|FG000|Overall Study|Withdrawal by Subject|11|||
37646586|NCT01314118|69115701|FG000|Overall Study|Other|2|||
37646587|NCT01314118|69115701|FG000|Overall Study|Ongoing|62|||
37646588|NCT01272037|69115707|FG000|Overall Study|Death|25|||
37646589|NCT01272037|69115708|FG001|Overall Study|Death|28|||
37646590|NCT01272037|69115707|FG000|Overall Study|Adverse Event|12|||
37646591|NCT01272037|69115708|FG001|Overall Study|Adverse Event|7|||
37646592|NCT01272037|69115707|FG000|Overall Study|Withdrawal by Subject|175|||
37646593|NCT01272037|69115708|FG001|Overall Study|Withdrawal by Subject|93|||
37646594|NCT01272037|69115707|FG000|Overall Study|Disease progression|70|||
37646595|NCT01272037|69115708|FG001|Overall Study|Disease progression|111|||
37646596|NCT01272037|69115707|FG000|Overall Study|Other reason|42|||
37646597|NCT01272037|69115708|FG001|Overall Study|Other reason|41|||
37646598|NCT01272037|69115707|FG000|Overall Study|Delinquent data|24|||
37646599|NCT01272037|69115708|FG001|Overall Study|Delinquent data|19|||
37646600|NCT01272037|69115707|FG000|Overall Study|Reason under review|33|||
37646601|NCT01272037|69115708|FG001|Overall Study|Reason under review|29|||
37646602|NCT01272037|69115707|FG000|Overall Study|On treatment|626|||
37646603|NCT01272037|69115708|FG001|Overall Study|On treatment|632|||
37646604|NCT01171898|69115718|FG000|Overall Study|Death|0|||
37646605|NCT01171898|69115719|FG001|Overall Study|Death|0|||
37646606|NCT01171898|69115720|FG002|Overall Study|Death|2|||
37646607|NCT01171898|69115721|FG003|Overall Study|Death|0|||
37646608|NCT01171898|69115718|FG000|Overall Study|Lost to Follow-up|0|||
37646609|NCT01171898|69115719|FG001|Overall Study|Lost to Follow-up|1|||
37646610|NCT01171898|69115720|FG002|Overall Study|Lost to Follow-up|1|||
37646611|NCT01171898|69115721|FG003|Overall Study|Lost to Follow-up|1|||
37646612|NCT01171898|69115718|FG000|Overall Study|Withdrawal by Subject|1|||
37646613|NCT01171898|69115719|FG001|Overall Study|Withdrawal by Subject|4|||
37646614|NCT01171898|69115720|FG002|Overall Study|Withdrawal by Subject|6|||
37646615|NCT01171898|69115721|FG003|Overall Study|Withdrawal by Subject|3|||
37646616|NCT01171898|69115718|FG000|Overall Study|Terminated by Sponsor|1|||
37646617|NCT01171898|69115719|FG001|Overall Study|Terminated by Sponsor|0|||
37646618|NCT01171898|69115720|FG002|Overall Study|Terminated by Sponsor|0|||
37646619|NCT01171898|69115721|FG003|Overall Study|Terminated by Sponsor|0|||
37646620|NCT01171898|69115718|FG000|Overall Study|Ongoing|1|||
37646621|NCT01171898|69115719|FG001|Overall Study|Ongoing|9|||
37646622|NCT01171898|69115720|FG002|Overall Study|Ongoing|3|||
37646623|NCT01171898|69115721|FG003|Overall Study|Ongoing|0|||
37646624|NCT01171898|69115718|FG000|Overall Study|Other|1|||
37646625|NCT01171898|69115719|FG001|Overall Study|Other|5|||
37646626|NCT01171898|69115720|FG002|Overall Study|Other|0|||
37646627|NCT01171898|69115721|FG003|Overall Study|Other|2|||
37646628|NCT01106534|69115734|FG000|Overall Study|Withdrawal by Subject|18|||
37646629|NCT01106534|69115734|FG000|Overall Study|Lost to Follow-up|2|||
37646630|NCT01106534|69115734|FG000|Overall Study|Death|16|||
37646631|NCT01106534|69115734|FG000|Overall Study|Physician Decision|1|||
37646632|NCT00961064|69115739|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
37646633|NCT00961064|69115739|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
37646634|NCT00961064|69115739|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
37646635|NCT00961064|69115739|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
37646636|NCT00961064|69115739|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
37646637|NCT00961064|69115739|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
37646638|NCT00961064|69115739|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
37646639|NCT00961064|69115739|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
37646640|NCT00321555|69115751|FG000|Overall Study|Developed antibodies|1|||
37741091|NCT01397409|69227072|FG009|Stage 3|Adverse Event|0|||
37646641|NCT00321555|69115751|FG000|Overall Study|Switched to alternative treatment|3|||
37646642|NCT00321555|69115751|FG000|Overall Study|Physician Decision|1|||
37646643|NCT00321555|69115751|FG000|Overall Study|Disease progression on study|1|||
37646644|NCT00099437|69115774|FG000|Overall Study|Lost to Follow-up|30|||
37646645|NCT00099437|69115775|FG001|Overall Study|Lost to Follow-up|33|||
37646646|NCT00099437|69115774|FG000|Overall Study|Death|293|||
37646647|NCT00099437|69115775|FG001|Overall Study|Death|261|||
37646648|NCT00099437|69115774|FG000|Overall Study|Withdrawal by Subject|6|||
37646649|NCT00099437|69115775|FG001|Overall Study|Withdrawal by Subject|10|||
37646650|NCT00099437|69115774|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
37646651|NCT00099437|69115775|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
37646652|NCT02689453|69115790|FG000|Overall Study|Progressive disease|0|||
37646653|NCT02689453|69115791|FG001|Overall Study|Progressive disease|1|||
37646654|NCT02689453|69115792|FG002|Overall Study|Progressive disease|1|||
37646655|NCT00701103|69115827|FG000|Overall Study|Adverse Event|0|||
37646656|NCT00701103|69115828|FG001|Overall Study|Adverse Event|0|||
37646657|NCT00701103|69115829|FG002|Overall Study|Adverse Event|1|||
37646658|NCT00701103|69115830|FG003|Overall Study|Adverse Event|1|||
37646659|NCT00701103|69115831|FG004|Overall Study|Adverse Event|0|||
37646660|NCT00701103|69115832|FG005|Overall Study|Adverse Event|1|||
37646661|NCT00701103|69115833|FG006|Overall Study|Adverse Event|1|||
37646662|NCT00701103|69115834|FG007|Overall Study|Adverse Event|0|||
37646663|NCT00701103|69115835|FG008|Overall Study|Adverse Event|0|||
37646664|NCT00701103|69115836|FG009|Overall Study|Adverse Event|2|||
37646665|NCT00701103|69115837|FG010|Overall Study|Adverse Event|0|||
37646666|NCT00701103|69115827|FG000|Overall Study|Progressive Disease|5|||
37646667|NCT00701103|69115828|FG001|Overall Study|Progressive Disease|2|||
37646668|NCT00701103|69115829|FG002|Overall Study|Progressive Disease|6|||
37646669|NCT00701103|69115830|FG003|Overall Study|Progressive Disease|5|||
37646670|NCT00701103|69115831|FG004|Overall Study|Progressive Disease|6|||
37646671|NCT00701103|69115832|FG005|Overall Study|Progressive Disease|5|||
37646672|NCT00701103|69115833|FG006|Overall Study|Progressive Disease|7|||
37646673|NCT00701103|69115834|FG007|Overall Study|Progressive Disease|7|||
37646674|NCT00701103|69115835|FG008|Overall Study|Progressive Disease|8|||
37646675|NCT00701103|69115836|FG009|Overall Study|Progressive Disease|8|||
37646676|NCT00701103|69115837|FG010|Overall Study|Progressive Disease|11|||
37646677|NCT00701103|69115827|FG000|Overall Study|Withdrawal by Subject|0|||
37646678|NCT00701103|69115828|FG001|Overall Study|Withdrawal by Subject|1|||
37646679|NCT00701103|69115829|FG002|Overall Study|Withdrawal by Subject|1|||
37646680|NCT00701103|69115830|FG003|Overall Study|Withdrawal by Subject|0|||
37646681|NCT00701103|69115831|FG004|Overall Study|Withdrawal by Subject|0|||
37646682|NCT00701103|69115832|FG005|Overall Study|Withdrawal by Subject|0|||
37646683|NCT00701103|69115833|FG006|Overall Study|Withdrawal by Subject|0|||
37646684|NCT00701103|69115834|FG007|Overall Study|Withdrawal by Subject|0|||
37646685|NCT00701103|69115835|FG008|Overall Study|Withdrawal by Subject|0|||
37646686|NCT00701103|69115836|FG009|Overall Study|Withdrawal by Subject|0|||
38032185|NCT02250664|69718086|FG000|Overall Study|Reason unknown|1|||
38032186|NCT02250664|69718087|FG001|Overall Study|Reason unknown|0|||
38032187|NCT02250664|69718088|FG002|Overall Study|Reason unknown|0|||
37646687|NCT00701103|69115837|FG010|Overall Study|Withdrawal by Subject|0|||
37646688|NCT00701103|69115827|FG000|Overall Study|Other|0|||
37646689|NCT00701103|69115828|FG001|Overall Study|Other|0|||
37646690|NCT00701103|69115829|FG002|Overall Study|Other|0|||
37646691|NCT00701103|69115830|FG003|Overall Study|Other|0|||
37646692|NCT00701103|69115831|FG004|Overall Study|Other|0|||
37646693|NCT00701103|69115832|FG005|Overall Study|Other|0|||
37646694|NCT00701103|69115833|FG006|Overall Study|Other|0|||
37646695|NCT00701103|69115834|FG007|Overall Study|Other|0|||
37646696|NCT00701103|69115835|FG008|Overall Study|Other|1|||
37646697|NCT00701103|69115836|FG009|Overall Study|Other|1|||
37646698|NCT00701103|69115837|FG010|Overall Study|Other|0|||
37646699|NCT01369225|69115871|FG000|Overall Study|Withdrawal by Subject|1|||
37646700|NCT01369225|69115872|FG001|Overall Study|Withdrawal by Subject|0|||
37646701|NCT01369225|69115873|FG002|Overall Study|Withdrawal by Subject|2|||
37646702|NCT01369225|69115874|FG003|Overall Study|Withdrawal by Subject|1|||
37646703|NCT01369225|69115875|FG004|Overall Study|Withdrawal by Subject|0|||
37646704|NCT01369225|69115876|FG005|Overall Study|Withdrawal by Subject|0|||
37646705|NCT01369225|69115871|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
37646706|NCT01369225|69115872|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
37646707|NCT01369225|69115873|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
37646708|NCT01369225|69115874|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
37646709|NCT01369225|69115875|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
37646710|NCT01369225|69115876|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
37646711|NCT01369225|69115871|FG000|Overall Study|Other|1|||
37646712|NCT01369225|69115872|FG001|Overall Study|Other|0|||
37646713|NCT01369225|69115873|FG002|Overall Study|Other|0|||
37646714|NCT01369225|69115874|FG003|Overall Study|Other|0|||
37646715|NCT01369225|69115875|FG004|Overall Study|Other|1|||
37646716|NCT01369225|69115876|FG005|Overall Study|Other|0|||
37646717|NCT01369225|69115871|FG000|Overall Study|Adverse Event|0|||
38032188|NCT02646982|69718098|FG000|Overall Study|Adverse Event|1|||
38032189|NCT02646982|69718099|FG001|Overall Study|Adverse Event|1|||
38032190|NCT02646982|69718098|FG000|Overall Study|Withdrawal by Subject|2|||
38032191|NCT02646982|69718099|FG001|Overall Study|Withdrawal by Subject|1|||
38032192|NCT02845336|69718107|FG000|Overall Study|Lost to Follow-up|3|||
38032193|NCT02845336|69718108|FG001|Overall Study|Lost to Follow-up|1|||
38032194|NCT02845336|69718107|FG000|Overall Study|Inability to get medication|2|||
38032195|NCT02845336|69718108|FG001|Overall Study|Inability to get medication|0|||
38032196|NCT02844946|69718116|FG000|Overall Study|Lost to Follow-up|7|||
37646718|NCT01369225|69115872|FG001|Overall Study|Adverse Event|0|||
37646719|NCT01369225|69115873|FG002|Overall Study|Adverse Event|0|||
37646720|NCT01369225|69115874|FG003|Overall Study|Adverse Event|1|||
37646721|NCT01369225|69115875|FG004|Overall Study|Adverse Event|1|||
37646722|NCT01369225|69115876|FG005|Overall Study|Adverse Event|0|||
37646723|NCT02639546|69115898|FG000|Overall Study|Death|2|||
37646724|NCT02639546|69115899|FG001|Overall Study|Death|2|||
37646725|NCT02639546|69115900|FG002|Overall Study|Death|1|||
37646726|NCT02639546|69115901|FG003|Overall Study|Death|2|||
37646727|NCT02639546|69115902|FG004|Overall Study|Death|2|||
37646728|NCT02639546|69115903|FG005|Overall Study|Death|2|||
37646729|NCT02639546|69115904|FG006|Overall Study|Death|0|||
37646730|NCT02639546|69115905|FG007|Overall Study|Death|0|||
37646731|NCT02639546|69115898|FG000|Overall Study|Lost to Follow-up|0|||
37646732|NCT02639546|69115899|FG001|Overall Study|Lost to Follow-up|0|||
37646733|NCT02639546|69115900|FG002|Overall Study|Lost to Follow-up|1|||
37646734|NCT02639546|69115901|FG003|Overall Study|Lost to Follow-up|0|||
37646735|NCT02639546|69115902|FG004|Overall Study|Lost to Follow-up|1|||
37646736|NCT02639546|69115903|FG005|Overall Study|Lost to Follow-up|1|||
37741092|NCT01397409|69227063|FG000|Stage 3|Other Miscellaneous Reasons|0|||
37741093|NCT01397409|69227064|FG001|Stage 3|Other Miscellaneous Reasons|0|||
37741094|NCT01397409|69227065|FG002|Stage 3|Other Miscellaneous Reasons|0|||
37741095|NCT01397409|69227066|FG003|Stage 3|Other Miscellaneous Reasons|0|||
37741096|NCT01397409|69227067|FG004|Stage 3|Other Miscellaneous Reasons|0|||
37741097|NCT01397409|69227068|FG005|Stage 3|Other Miscellaneous Reasons|0|||
37741098|NCT01397409|69227069|FG006|Stage 3|Other Miscellaneous Reasons|0|||
37741099|NCT01397409|69227070|FG007|Stage 3|Other Miscellaneous Reasons|1|||
37741100|NCT01397409|69227071|FG008|Stage 3|Other Miscellaneous Reasons|0|||
37741101|NCT01397409|69227072|FG009|Stage 3|Other Miscellaneous Reasons|0|||
37741102|NCT01397253|69227097|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
37741103|NCT01397253|69227098|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
37741104|NCT01777334|69227106|FG000|Overall Study|Adverse Event|18|||
37741105|NCT01777334|69227107|FG001|Overall Study|Adverse Event|14|||
37741106|NCT01777334|69227106|FG000|Overall Study|Lack of Efficacy|15|||
37741107|NCT01777334|69227107|FG001|Overall Study|Lack of Efficacy|29|||
37741108|NCT01777334|69227106|FG000|Overall Study|Protocol Violation|3|||
37741109|NCT01777334|69227107|FG001|Overall Study|Protocol Violation|7|||
37741110|NCT01777334|69227106|FG000|Overall Study|Lost to Follow-up|3|||
37741111|NCT01777334|69227107|FG001|Overall Study|Lost to Follow-up|2|||
37741112|NCT01777334|69227106|FG000|Overall Study|Withdrawal by Subject|14|||
37741113|NCT01777334|69227107|FG001|Overall Study|Withdrawal by Subject|11|||
37741114|NCT01383993|69227116|FG000|Overall Study|Adverse Event|1|||
37741115|NCT01383993|69227117|FG001|Overall Study|Adverse Event|1|||
37741116|NCT01383993|69227118|FG002|Overall Study|Adverse Event|0|||
37741117|NCT01383993|69227116|FG000|Overall Study|Withdrawal by Subject|0|||
37741118|NCT01383993|69227117|FG001|Overall Study|Withdrawal by Subject|0|||
37741119|NCT01383993|69227118|FG002|Overall Study|Withdrawal by Subject|1|||
37741120|NCT01383993|69227116|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
37741121|NCT01383993|69227117|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
37741122|NCT01383993|69227118|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
37741123|NCT01396395|69227129|FG000|Overall Study|Withdrawal by Subject|10|||
37741124|NCT01396395|69227130|FG001|Overall Study|Withdrawal by Subject|12|||
38032197|NCT02844946|69718117|FG001|Overall Study|Lost to Follow-up|0|||
37646737|NCT02639546|69115904|FG006|Overall Study|Lost to Follow-up|0|||
37646738|NCT02639546|69115905|FG007|Overall Study|Lost to Follow-up|1|||
37646739|NCT02639546|69115898|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
37646740|NCT02639546|69115899|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
37741125|NCT01396395|69227129|FG000|Overall Study|Protocol Violation|3|||
37741126|NCT01396395|69227130|FG001|Overall Study|Protocol Violation|1|||
37741127|NCT01396395|69227129|FG000|Overall Study|Adverse Event|10|||
38032198|NCT02951156|69718126|FG000|Overall Study|Death|3|||
38032199|NCT02951156|69718127|FG001|Overall Study|Death|8|||
38032200|NCT02951156|69718128|FG002|Overall Study|Death|5|||
37646741|NCT02639546|69115900|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
37646742|NCT02639546|69115901|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
37646743|NCT02639546|69115902|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
37646744|NCT02639546|69115903|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
37646745|NCT02639546|69115904|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
37741128|NCT01396395|69227130|FG001|Overall Study|Adverse Event|2|||
37646746|NCT02639546|69115905|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
37646747|NCT02639546|69115898|FG000|Overall Study|Study Terminated By Sponsor|0|||
37646748|NCT02639546|69115899|FG001|Overall Study|Study Terminated By Sponsor|2|||
37646749|NCT02639546|69115900|FG002|Overall Study|Study Terminated By Sponsor|3|||
37646750|NCT02639546|69115901|FG003|Overall Study|Study Terminated By Sponsor|4|||
37646751|NCT02639546|69115902|FG004|Overall Study|Study Terminated By Sponsor|4|||
37646752|NCT02639546|69115903|FG005|Overall Study|Study Terminated By Sponsor|3|||
37646753|NCT02639546|69115904|FG006|Overall Study|Study Terminated By Sponsor|3|||
37646754|NCT02639546|69115905|FG007|Overall Study|Study Terminated By Sponsor|9|||
37646755|NCT02639546|69115898|FG000|Overall Study|Withdrawal by Subject|2|||
37646756|NCT02639546|69115899|FG001|Overall Study|Withdrawal by Subject|2|||
37646757|NCT02639546|69115900|FG002|Overall Study|Withdrawal by Subject|1|||
37646758|NCT02639546|69115901|FG003|Overall Study|Withdrawal by Subject|0|||
37646759|NCT02639546|69115902|FG004|Overall Study|Withdrawal by Subject|0|||
37646760|NCT02639546|69115903|FG005|Overall Study|Withdrawal by Subject|1|||
37646761|NCT02639546|69115904|FG006|Overall Study|Withdrawal by Subject|2|||
37646762|NCT02639546|69115905|FG007|Overall Study|Withdrawal by Subject|1|||
37646763|NCT02639390|69115939|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
37646764|NCT02639390|69115940|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
37646765|NCT02718417|69115949|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
37646766|NCT02718417|69115950|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
37646767|NCT02718417|69115951|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
37646768|NCT02718417|69115949|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
37646769|NCT02718417|69115950|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
37646770|NCT02718417|69115951|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
37646771|NCT02718417|69115949|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
37646772|NCT02718417|69115950|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
37646773|NCT02718417|69115951|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
37646774|NCT02718417|69115949|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
37646775|NCT02718417|69115950|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
37646776|NCT02718417|69115951|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
37646777|NCT02718417|69115949|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
37646778|NCT02718417|69115950|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
37646779|NCT02718417|69115951|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
37646780|NCT02718417|69115949|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
37646781|NCT02718417|69115950|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
37646782|NCT02718417|69115951|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
37646783|NCT02718417|69115949|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
37646784|NCT02718417|69115950|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
37646785|NCT02718417|69115951|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
37646786|NCT02718417|69115949|FG000|Chemotherapy Phase (CP)|Other|2|||
37646787|NCT02718417|69115950|FG001|Chemotherapy Phase (CP)|Other|0|||
37646788|NCT02718417|69115951|FG002|Chemotherapy Phase (CP)|Other|1|||
37646789|NCT02718417|69115949|FG000|Maintenance Phase (MP)|Adverse Event|21|||
37646790|NCT02718417|69115950|FG001|Maintenance Phase (MP)|Adverse Event|26|||
37646791|NCT02718417|69115951|FG002|Maintenance Phase (MP)|Adverse Event|0|||
37646792|NCT02718417|69115949|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
37646793|NCT02718417|69115950|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
37646794|NCT02718417|69115951|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
37646795|NCT02718417|69115949|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
37646796|NCT02718417|69115950|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
37646797|NCT02718417|69115951|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
37646798|NCT02718417|69115949|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
37646799|NCT02718417|69115950|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
37646800|NCT02718417|69115951|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
37646801|NCT02718417|69115949|FG000|Maintenance Phase (MP)|Physician's decision|6|||
37646802|NCT02718417|69115950|FG001|Maintenance Phase (MP)|Physician's decision|7|||
37646803|NCT02718417|69115951|FG002|Maintenance Phase (MP)|Physician's decision|0|||
37646804|NCT02718417|69115949|FG000|Maintenance Phase (MP)|Progressive disease|100|||
37646805|NCT02718417|69115950|FG001|Maintenance Phase (MP)|Progressive disease|88|||
37854527|NCT01232283|69537959|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
37854528|NCT01232283|69537960|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
37646806|NCT02718417|69115951|FG002|Maintenance Phase (MP)|Progressive disease|0|||
37854529|NCT01232283|69537961|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
37854530|NCT01232283|69537952|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
37854531|NCT01232283|69537953|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
37854532|NCT01232283|69537954|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
37854533|NCT01232283|69537955|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
37854534|NCT01232283|69537956|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
37646807|NCT02718417|69115949|FG000|Maintenance Phase (MP)|Other|2|||
37646808|NCT02718417|69115950|FG001|Maintenance Phase (MP)|Other|1|||
37646809|NCT02718417|69115951|FG002|Maintenance Phase (MP)|Other|0|||
37646810|NCT02718417|69115949|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
37646811|NCT02718417|69115950|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
37646812|NCT02718417|69115951|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
37646813|NCT02718417|69115949|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
37646814|NCT02718417|69115950|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
37646815|NCT02718417|69115951|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
37646816|NCT02718417|69115949|FG000|Observation Phase (OP)|Adverse Event|0|||
37646817|NCT02718417|69115950|FG001|Observation Phase (OP)|Adverse Event|0|||
37646818|NCT02718417|69115951|FG002|Observation Phase (OP)|Adverse Event|1|||
37646819|NCT02718417|69115949|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
37646820|NCT02718417|69115950|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
37646821|NCT02718417|69115951|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
37646822|NCT02718417|69115949|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
37646823|NCT02718417|69115950|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
37646824|NCT02718417|69115951|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
37646825|NCT02718417|69115949|FG000|Observation Phase (OP)|Physician Decision|0|||
37646826|NCT02718417|69115950|FG001|Observation Phase (OP)|Physician Decision|0|||
37646827|NCT02718417|69115951|FG002|Observation Phase (OP)|Physician Decision|9|||
37646828|NCT02718417|69115949|FG000|Observation Phase (OP)|Progressive disease|0|||
37646829|NCT02718417|69115950|FG001|Observation Phase (OP)|Progressive disease|0|||
37646830|NCT02718417|69115951|FG002|Observation Phase (OP)|Progressive disease|92|||
37646831|NCT02718417|69115949|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
37646832|NCT02718417|69115950|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
37646833|NCT02718417|69115951|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
37646834|NCT02718417|69115949|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
37646835|NCT02718417|69115950|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
37646836|NCT02718417|69115951|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
37646837|NCT02718417|69115949|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
37646838|NCT02718417|69115950|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
37646839|NCT02718417|69115951|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
37646840|NCT02718417|69115949|FG000|Observation Phase (OP)|Other|0|||
37646841|NCT02718417|69115950|FG001|Observation Phase (OP)|Other|0|||
37646842|NCT02718417|69115951|FG002|Observation Phase (OP)|Other|7|||
37646843|NCT02718417|69115949|FG000|Follow-up Phase|Adverse Event|3|||
37646844|NCT02718417|69115950|FG001|Follow-up Phase|Adverse Event|1|||
37646845|NCT02718417|69115951|FG002|Follow-up Phase|Adverse Event|1|||
37646846|NCT02718417|69115949|FG000|Follow-up Phase|Other|4|||
37646847|NCT02718417|69115950|FG001|Follow-up Phase|Other|6|||
37646848|NCT02718417|69115951|FG002|Follow-up Phase|Other|4|||
37646849|NCT02718417|69115949|FG000|Follow-up Phase|Withdrawal by Subject|19|||
37646850|NCT02718417|69115950|FG001|Follow-up Phase|Withdrawal by Subject|17|||
37646851|NCT02718417|69115951|FG002|Follow-up Phase|Withdrawal by Subject|5|||
37646852|NCT02718417|69115949|FG000|Follow-up Phase|Study terminated by sponsor|100|||
37646853|NCT02718417|69115950|FG001|Follow-up Phase|Study terminated by sponsor|138|||
37646854|NCT02718417|69115951|FG002|Follow-up Phase|Study terminated by sponsor|6|||
37646855|NCT02718417|69115949|FG000|Follow-up Phase|Lost to Follow-up|2|||
37646856|NCT02718417|69115950|FG001|Follow-up Phase|Lost to Follow-up|3|||
37646857|NCT02718417|69115951|FG002|Follow-up Phase|Lost to Follow-up|0|||
37646858|NCT02718417|69115949|FG000|Follow-up Phase|Death leading to discontinuation|7|||
37646859|NCT02718417|69115950|FG001|Follow-up Phase|Death leading to discontinuation|7|||
37646860|NCT02718417|69115951|FG002|Follow-up Phase|Death leading to discontinuation|3|||
37646861|NCT02718417|69115949|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
37646862|NCT02718417|69115950|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
37646863|NCT02718417|69115951|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
37646864|NCT02718417|69115949|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
37646865|NCT02718417|69115950|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
37646866|NCT02718417|69115951|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
37646867|NCT02718417|69115949|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
37646868|NCT02718417|69115950|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
37646869|NCT02718417|69115951|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
37646870|NCT02718417|69115949|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
37646871|NCT02718417|69115950|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
37646872|NCT02718417|69115951|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
37646873|NCT02718417|69115949|FG000|Long-term Follow-up Phase|Other|0|||
37646874|NCT02718417|69115950|FG001|Long-term Follow-up Phase|Other|2|||
37646875|NCT02718417|69115951|FG002|Long-term Follow-up Phase|Other|0|||
37646876|NCT02640404|69115968|FG000|Overall Study|Protocol Violation|1|||
37646877|NCT02640404|69115969|FG001|Overall Study|Protocol Violation|0|||
37646878|NCT02640404|69115968|FG000|Overall Study|Withdrawal by Subject|1|||
37646879|NCT02640404|69115969|FG001|Overall Study|Withdrawal by Subject|0|||
37646880|NCT00701727|69115975|FG000|First Treatment Period|Adverse Event|0|||
37646881|NCT00701727|69115976|FG001|First Treatment Period|Adverse Event|0|||
37646882|NCT00701727|69115975|FG000|First Treatment Period|Withdrawal by Subject|1|||
37646883|NCT00701727|69115976|FG001|First Treatment Period|Withdrawal by Subject|0|||
37646884|NCT00701727|69115975|FG000|First Treatment Period|sponsor decision|0|||
37646885|NCT00701727|69115976|FG001|First Treatment Period|sponsor decision|1|||
37646886|NCT00701727|69115975|FG000|First Treatment Period|Lost to Follow-up|0|||
37646887|NCT00701727|69115976|FG001|First Treatment Period|Lost to Follow-up|1|||
37646888|NCT00701727|69115975|FG000|Second Treatment Period|Withdrawal by Subject|2|||
37646889|NCT00701727|69115976|FG001|Second Treatment Period|Withdrawal by Subject|0|||
37646890|NCT01369069|69115993|FG000|Overall Study|Lost to Follow-up|8|||
37646891|NCT01369069|69115994|FG001|Overall Study|Lost to Follow-up|9|||
38032201|NCT02951156|69718126|FG000|Overall Study|Progressive disease|1|||
38032202|NCT02951156|69718127|FG001|Overall Study|Progressive disease|0|||
38032203|NCT02951156|69718128|FG002|Overall Study|Progressive disease|1|||
38032204|NCT02951156|69718126|FG000|Overall Study|Withdrawal by Subject|0|||
38032205|NCT02951156|69718127|FG001|Overall Study|Withdrawal by Subject|0|||
38032206|NCT02951156|69718128|FG002|Overall Study|Withdrawal by Subject|1|||
38032207|NCT02951156|69718126|FG000|Overall Study|Study terminated by sponsor|0|||
38032208|NCT02951156|69718127|FG001|Overall Study|Study terminated by sponsor|0|||
38032209|NCT02951156|69718128|FG002|Overall Study|Study terminated by sponsor|1|||
38032210|NCT02951156|69718126|FG000|Overall Study|Other|5|||
37646892|NCT01369069|69115993|FG000|Overall Study|Withdrawal by Subject|9|||
37646893|NCT01369069|69115994|FG001|Overall Study|Withdrawal by Subject|7|||
37646894|NCT02441218|69116002|FG000|Overall Study|Death|503|||
37646895|NCT02441218|69116003|FG001|Overall Study|Death|553|||
37646896|NCT02441218|69116002|FG000|Overall Study|Withdrawal by Subject|73|||
37646897|NCT02441218|69116003|FG001|Overall Study|Withdrawal by Subject|58|||
37646898|NCT02441218|69116002|FG000|Overall Study|Lost to Follow-up|2|||
37646899|NCT02441218|69116003|FG001|Overall Study|Lost to Follow-up|1|||
37646900|NCT02410252|69116009|FG000|Overall Study|Withdrawal by Subject|4|||
37854535|NCT01232283|69537957|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
37854536|NCT01232283|69537958|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
37854537|NCT01232283|69537959|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
37854538|NCT01232283|69537960|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
37854539|NCT01232283|69537961|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
37854540|NCT01232283|69537952|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
37854541|NCT01232283|69537953|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
37854542|NCT01232283|69537954|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
37646901|NCT02410252|69116009|FG000|Overall Study|Physician Decision|2|||
37646902|NCT02440594|69116023|FG000|Overall Study|Lost to Follow-up|34|||
37854543|NCT01232283|69537955|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
37854544|NCT01232283|69537956|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
37646903|NCT02440594|69116024|FG001|Overall Study|Lost to Follow-up|33|||
37646904|NCT02440594|69116025|FG002|Overall Study|Lost to Follow-up|54|||
37646905|NCT02440594|69116026|FG003|Overall Study|Lost to Follow-up|47|||
37646906|NCT02440594|69116027|FG004|Overall Study|Lost to Follow-up|5|||
37854545|NCT01232283|69537957|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
37854546|NCT01232283|69537958|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
37854547|NCT01232283|69537959|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
37854548|NCT01232283|69537960|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
37854549|NCT01232283|69537961|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
37854550|NCT01232127|69537983|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
37854551|NCT01232127|69537984|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
37854552|NCT01232127|69537985|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
37854553|NCT01258608|69537999|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
37854554|NCT01258608|69538000|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
37854555|NCT01258608|69537999|FG000|Overall Study|Clinical progression|1|||
37854556|NCT01258608|69538000|FG001|Overall Study|Clinical progression|0|||
37854557|NCT01258608|69537999|FG000|Overall Study|Sponsor decision|0|||
37854558|NCT01258608|69538000|FG001|Overall Study|Sponsor decision|1|||
38032211|NCT02951156|69718127|FG001|Overall Study|Other|1|||
38032212|NCT02951156|69718128|FG002|Overall Study|Other|2|||
37646907|NCT02440594|69116028|FG005|Overall Study|Lost to Follow-up|4|||
37646908|NCT02440594|69116029|FG006|Overall Study|Lost to Follow-up|28|||
37646909|NCT02440594|69116030|FG007|Overall Study|Lost to Follow-up|48|||
37646910|NCT02440594|69116023|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
37646911|NCT02440594|69116024|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
37646912|NCT02440594|69116025|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
37646913|NCT02440594|69116026|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
38032213|NCT03345914|69718140|FG000|Overall Study|Transition to another study at week 16|80|||
37646914|NCT02440594|69116027|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
37854559|NCT01258608|69537999|FG000|Overall Study|Physician Decision|6|||
37646915|NCT02440594|69116028|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
37646916|NCT02440594|69116029|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
37646917|NCT02440594|69116030|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
37646918|NCT02440594|69116023|FG000|Overall Study|Withdrawal by Subject|81|||
37646919|NCT02440594|69116024|FG001|Overall Study|Withdrawal by Subject|67|||
37646920|NCT02440594|69116025|FG002|Overall Study|Withdrawal by Subject|59|||
37646921|NCT02440594|69116026|FG003|Overall Study|Withdrawal by Subject|38|||
37646922|NCT02440594|69116027|FG004|Overall Study|Withdrawal by Subject|2|||
37646923|NCT02440594|69116028|FG005|Overall Study|Withdrawal by Subject|2|||
37646924|NCT02440594|69116029|FG006|Overall Study|Withdrawal by Subject|7|||
37646925|NCT02440594|69116030|FG007|Overall Study|Withdrawal by Subject|7|||
37646926|NCT02440594|69116023|FG000|Overall Study|Administratively w/drawn|3|||
37646927|NCT02440594|69116024|FG001|Overall Study|Administratively w/drawn|2|||
37646928|NCT02440594|69116025|FG002|Overall Study|Administratively w/drawn|0|||
37646929|NCT02440594|69116026|FG003|Overall Study|Administratively w/drawn|0|||
37646930|NCT02440594|69116027|FG004|Overall Study|Administratively w/drawn|0|||
37646931|NCT02440594|69116028|FG005|Overall Study|Administratively w/drawn|0|||
37646932|NCT02440594|69116029|FG006|Overall Study|Administratively w/drawn|2|||
37854560|NCT01258608|69538000|FG001|Overall Study|Physician Decision|1|||
37854561|NCT01258608|69537999|FG000|Overall Study|Lost to Follow-up|0|||
37854562|NCT01258608|69538000|FG001|Overall Study|Lost to Follow-up|1|||
37646933|NCT02440594|69116030|FG007|Overall Study|Administratively w/drawn|1|||
37646934|NCT03836001|69116057|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
37646935|NCT03836001|69116058|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
37646936|NCT03836001|69116059|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
37646937|NCT03836001|69116057|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
37646938|NCT03836001|69116058|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
37646939|NCT03836001|69116059|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
37646940|NCT03836001|69116057|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
37646941|NCT03836001|69116058|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
37646942|NCT03836001|69116059|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
37646943|NCT03836001|69116057|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
37646944|NCT03836001|69116058|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
37854563|NCT01258608|69537999|FG000|Overall Study|Lack of compliance|1|||
37854564|NCT01258608|69538000|FG001|Overall Study|Lack of compliance|0|||
37854565|NCT01258608|69537999|FG000|Overall Study|Lack of Efficacy|0|||
37854566|NCT01258608|69538000|FG001|Overall Study|Lack of Efficacy|1|||
37854567|NCT01258608|69537999|FG000|Overall Study|Adverse Event|6|||
37854568|NCT01258608|69538000|FG001|Overall Study|Adverse Event|10|||
37854569|NCT01258608|69537999|FG000|Overall Study|Withdrawal by Subject|6|||
37854570|NCT01258608|69538000|FG001|Overall Study|Withdrawal by Subject|5|||
37854571|NCT01015612|69538007|FG000|Overall Study|Death|113|||
37854572|NCT01015612|69538007|FG000|Overall Study|Withdrawal by Subject|40|||
37854573|NCT01231659|69538011|FG000|Overall Study|Adverse Event|9|||
37854574|NCT01231659|69538011|FG000|Overall Study|Disease Progression|48|||
37854575|NCT01231659|69538011|FG000|Overall Study|Death|2|||
37854576|NCT01231659|69538011|FG000|Overall Study|Patient refused to complete study visit|1|||
37854577|NCT01231659|69538011|FG000|Overall Study|Other protocol defined criteria|12|||
37854578|NCT01054222|69538015|FG000|Overall Study|Lack of Efficacy|1|||
37854579|NCT01054222|69538015|FG000|Overall Study|Lost to Follow-up|4|||
37854580|NCT01054222|69538015|FG000|Overall Study|Withdrawal by Subject|6|||
37854581|NCT01052428|69538021|FG000|Overall Study|Death|1|||
37854582|NCT01052428|69538022|FG001|Overall Study|Death|0|||
37854583|NCT01052428|69538021|FG000|Overall Study|Withdrawal by Subject|0|||
37854584|NCT01052428|69538022|FG001|Overall Study|Withdrawal by Subject|1|||
37854585|NCT01052272|69538032|FG000|Overall Study|Death|0|||
37854586|NCT01052272|69538033|FG001|Overall Study|Death|0|||
37854587|NCT01052272|69538034|FG002|Overall Study|Death|1|||
37854588|NCT01052272|69538035|FG003|Overall Study|Death|1|||
37854589|NCT01052272|69538032|FG000|Overall Study|Physician Decision|0|||
37854590|NCT01052272|69538033|FG001|Overall Study|Physician Decision|1|||
37854591|NCT01052272|69538034|FG002|Overall Study|Physician Decision|0|||
37854592|NCT01052272|69538035|FG003|Overall Study|Physician Decision|0|||
37854593|NCT01052272|69538032|FG000|Overall Study|patient refuses follow-up|5|||
37854594|NCT01052272|69538033|FG001|Overall Study|patient refuses follow-up|4|||
37646945|NCT03836001|69116059|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
37646946|NCT02465866|69116066|FG000|Period 3|Withdrawal by Subject|0|||
37646947|NCT02465866|69116067|FG001|Period 3|Withdrawal by Subject|1|||
37646948|NCT02465866|69116068|FG002|Period 3|Withdrawal by Subject|0|||
37646949|NCT02465866|69116069|FG003|Period 3|Withdrawal by Subject|0|||
37854595|NCT01052272|69538034|FG002|Overall Study|patient refuses follow-up|2|||
37854596|NCT01052272|69538035|FG003|Overall Study|patient refuses follow-up|4|||
37854597|NCT01052272|69538032|FG000|Overall Study|Withdrawal by Subject|0|||
37854598|NCT01052272|69538033|FG001|Overall Study|Withdrawal by Subject|2|||
37854599|NCT01052272|69538034|FG002|Overall Study|Withdrawal by Subject|3|||
37646950|NCT02439970|69116081|FG000|Overall Study|Study Terminated|2|||
37646951|NCT02439970|69116082|FG001|Overall Study|Study Terminated|3|||
37646952|NCT02437864|69116090|FG000|Overall Study|Protocol Violation|4|||
37646953|NCT02437864|69116091|FG001|Overall Study|Protocol Violation|0|||
37646954|NCT02408068|69116097|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
37646955|NCT02408068|69116098|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
37646956|NCT02408068|69116099|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
37646957|NCT02408068|69116100|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
37646958|NCT02408068|69116101|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
37646959|NCT02408068|69116102|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
37646960|NCT01361126|69116115|FG000|Overall Study|Sponsor decision|0|||
37646961|NCT01361126|69116116|FG001|Overall Study|Sponsor decision|2|||
37646962|NCT04428645|69116123|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
37646963|NCT01368835|69116127|FG000|Overall Study|Inclusion criteria/photography quality|22|||
37646964|NCT01368835|69116127|FG000|Overall Study|Lost to Follow-up|11|||
37646965|NCT02407990|69116146|FG000|Overall Study|Death|2|||
37646966|NCT02407990|69116147|FG001|Overall Study|Death|22|||
37646967|NCT02407990|69116148|FG002|Overall Study|Death|23|||
37646968|NCT02407990|69116149|FG003|Overall Study|Death|7|||
37646969|NCT02407990|69116150|FG004|Overall Study|Death|17|||
37646970|NCT02407990|69116151|FG005|Overall Study|Death|16|||
37854600|NCT01052272|69538035|FG003|Overall Study|Withdrawal by Subject|2|||
37854601|NCT01052272|69538032|FG000|Overall Study|placed in long-term care|0|||
37854602|NCT01052272|69538033|FG001|Overall Study|placed in long-term care|0|||
37854603|NCT01052272|69538034|FG002|Overall Study|placed in long-term care|1|||
37854604|NCT01052272|69538035|FG003|Overall Study|placed in long-term care|0|||
37854605|NCT01052272|69538032|FG000|Overall Study|decline in health|0|||
37854606|NCT01052272|69538033|FG001|Overall Study|decline in health|0|||
37854607|NCT01052272|69538034|FG002|Overall Study|decline in health|1|||
37854608|NCT01052272|69538035|FG003|Overall Study|decline in health|0|||
37854609|NCT01257204|69538048|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
37854610|NCT01257204|69538049|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
37854611|NCT01257204|69538050|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
37854612|NCT01257204|69538048|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
37854613|NCT01257204|69538049|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
37854614|NCT01257204|69538050|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
37854615|NCT01257204|69538048|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
37854616|NCT01257204|69538049|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
37854617|NCT01257204|69538050|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
37854618|NCT01257204|69538048|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
37854619|NCT01257204|69538049|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
37854620|NCT01257204|69538050|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
37854621|NCT01257204|69538048|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
37854622|NCT01257204|69538049|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
37854623|NCT01257204|69538050|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
37854624|NCT01257204|69538048|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
37854625|NCT01257204|69538049|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
37854626|NCT01257204|69538050|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
37854627|NCT01257204|69538048|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
38032214|NCT03345914|69718141|FG001|Overall Study|Transition to another study at week 16|86|||
38032215|NCT03345914|69718142|FG002|Overall Study|Transition to another study at week 16|78|||
38032216|NCT03345914|69718140|FG000|Overall Study|Transition to OLE during follow-up|37|||
38032217|NCT03345914|69718141|FG001|Overall Study|Transition to OLE during follow-up|33|||
38032218|NCT03345914|69718142|FG002|Overall Study|Transition to OLE during follow-up|39|||
38032219|NCT03345914|69718140|FG000|Overall Study|Physician Decision|0|||
38032220|NCT03345914|69718141|FG001|Overall Study|Physician Decision|1|||
38032221|NCT03345914|69718142|FG002|Overall Study|Physician Decision|1|||
38032222|NCT03345914|69718140|FG000|Overall Study|Withdrawal by Subject|5|||
38032223|NCT03345914|69718141|FG001|Overall Study|Withdrawal by Subject|1|||
38032224|NCT03345914|69718142|FG002|Overall Study|Withdrawal by Subject|2|||
38032225|NCT03345914|69718140|FG000|Overall Study|Other|1|||
38032226|NCT03345914|69718141|FG001|Overall Study|Other|1|||
38032227|NCT03345914|69718142|FG002|Overall Study|Other|1|||
38032228|NCT03345914|69718140|FG000|Overall Study|Ongoing|0|||
38032229|NCT03345914|69718141|FG001|Overall Study|Ongoing|0|||
38032230|NCT03345914|69718142|FG002|Overall Study|Ongoing|1|||
38032231|NCT03369704|69718152|FG000|Treatment Epoch|technical problems|1|||
38032232|NCT03369704|69718153|FG001|Treatment Epoch|technical problems|0|||
37646971|NCT02407990|69116152|FG006|Overall Study|Death|10|||
37646972|NCT02407990|69116153|FG007|Overall Study|Death|248|||
37646973|NCT02407990|69116146|FG000|Overall Study|Lost to Follow-up|0|||
37646974|NCT02407990|69116147|FG001|Overall Study|Lost to Follow-up|1|||
37646975|NCT02407990|69116148|FG002|Overall Study|Lost to Follow-up|0|||
37646976|NCT02407990|69116149|FG003|Overall Study|Lost to Follow-up|0|||
37646977|NCT02407990|69116150|FG004|Overall Study|Lost to Follow-up|0|||
37854628|NCT01257204|69538049|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
37854629|NCT01257204|69538050|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
37854630|NCT01257204|69538048|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
37854631|NCT01257204|69538049|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
37854632|NCT01257204|69538050|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
37854633|NCT01257204|69538048|FG000|Follow-up Period (up to Week 48)|Other|0|||
37854634|NCT01257204|69538049|FG001|Follow-up Period (up to Week 48)|Other|0|||
37854635|NCT01257204|69538050|FG002|Follow-up Period (up to Week 48)|Other|5|||
37854636|NCT01231581|69538072|FG000|Overall Study|Lost to Follow-up|2|||
37854637|NCT01231581|69538073|FG001|Overall Study|Lost to Follow-up|2|||
37854638|NCT01231581|69538072|FG000|Overall Study|Withdrawal by Subject|6|||
37854639|NCT01231581|69538073|FG001|Overall Study|Withdrawal by Subject|9|||
37854640|NCT01231581|69538072|FG000|Overall Study|Study Closed/Terminated|6|||
37854641|NCT01231581|69538073|FG001|Overall Study|Study Closed/Terminated|5|||
37854642|NCT01231581|69538072|FG000|Overall Study|Death|65|||
37854643|NCT01231581|69538073|FG001|Overall Study|Death|64|||
37854644|NCT01231581|69538072|FG000|Overall Study|Ongoing|1|||
37854645|NCT01231581|69538073|FG001|Overall Study|Ongoing|0|||
37854646|NCT01050634|69538079|FG000|Overall Study|Enrolled, but Not Treated|56|||
37854647|NCT01050634|69538079|FG000|Overall Study|Death|2|||
37854648|NCT01050634|69538079|FG000|Overall Study|Adverse Event|42|||
37854649|NCT01050634|69538079|FG000|Overall Study|Lost to Follow-up|2|||
37854650|NCT01050634|69538079|FG000|Overall Study|Other|21|||
37854651|NCT01050634|69538079|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
37854652|NCT01020526|69538083|FG000|Overall Study|Withdrawal by Subject|5|||
37854653|NCT01020526|69538083|FG000|Overall Study|Other reasons|3|||
37854654|NCT01020526|69538083|FG000|Overall Study|Insufficient clinical response|3|||
37854655|NCT01020526|69538083|FG000|Overall Study|Lost to Follow-up|1|||
37854656|NCT01020526|69538083|FG000|Overall Study|Adverse Event|2|||
37854657|NCT01020448|69538087|FG000|Pre-assignment|Adverse Event|6|||
37854658|NCT01020448|69538087|FG000|Pre-assignment|Withdrawal by Subject|5|||
37854659|NCT01020448|69538087|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
37854660|NCT01020448|69538087|FG000|Treatment|Adverse Event|11|||
37854661|NCT01020448|69538087|FG000|Treatment|Consent Withdrawn|3|||
37854662|NCT01020448|69538087|FG000|Treatment|Disease Progression|2|||
37854663|NCT01020448|69538087|FG000|Treatment|Lack of Efficacy|8|||
37854664|NCT01020448|69538087|FG000|Treatment|Lost to Follow-up|2|||
37854665|NCT01256658|69538094|FG000|Period 1|Lost to Follow-up|837|||
37854666|NCT01256658|69538095|FG001|Period 1|Lost to Follow-up|661|||
37854667|NCT01256658|69538094|FG000|Period 1|Withdrawal by Subject|35|||
37854668|NCT01256658|69538095|FG001|Period 1|Withdrawal by Subject|43|||
37854669|NCT01256658|69538094|FG000|Period 1|Death|48|||
37854670|NCT01256658|69538095|FG001|Period 1|Death|44|||
37854671|NCT01256502|69538104|FG000|Overall Study|Had scaffold removed|4|||
37854672|NCT01256502|69538104|FG000|Overall Study|Personal reasons|5|||
37854673|NCT01256502|69538104|FG000|Overall Study|Protocol deviation|1|||
37854674|NCT01256190|69538115|FG000|Overall Study|Lost to Follow-up|2|||
37646978|NCT02407990|69116151|FG005|Overall Study|Lost to Follow-up|0|||
37646979|NCT02407990|69116152|FG006|Overall Study|Lost to Follow-up|0|||
37646980|NCT02407990|69116153|FG007|Overall Study|Lost to Follow-up|17|||
37646981|NCT02407990|69116146|FG000|Overall Study|Progressive Disease|0|||
37646982|NCT02407990|69116147|FG001|Overall Study|Progressive Disease|0|||
37646983|NCT02407990|69116148|FG002|Overall Study|Progressive Disease|0|||
37646984|NCT02407990|69116149|FG003|Overall Study|Progressive Disease|0|||
37646985|NCT02407990|69116150|FG004|Overall Study|Progressive Disease|0|||
37646986|NCT02407990|69116151|FG005|Overall Study|Progressive Disease|0|||
37646987|NCT02407990|69116152|FG006|Overall Study|Progressive Disease|0|||
37646988|NCT02407990|69116153|FG007|Overall Study|Progressive Disease|1|||
37646989|NCT02407990|69116146|FG000|Overall Study|Withdrawal by Subject|0|||
37646990|NCT02407990|69116147|FG001|Overall Study|Withdrawal by Subject|0|||
37646991|NCT02407990|69116148|FG002|Overall Study|Withdrawal by Subject|0|||
37646992|NCT02407990|69116149|FG003|Overall Study|Withdrawal by Subject|0|||
37854675|NCT01256190|69538116|FG001|Overall Study|Lost to Follow-up|0|||
37646993|NCT02407990|69116150|FG004|Overall Study|Withdrawal by Subject|1|||
37646994|NCT02407990|69116151|FG005|Overall Study|Withdrawal by Subject|0|||
37646995|NCT02407990|69116152|FG006|Overall Study|Withdrawal by Subject|0|||
37854676|NCT01255722|69538125|FG000|Overall Study|Adverse Event|0|||
37646996|NCT02407990|69116153|FG007|Overall Study|Withdrawal by Subject|30|||
37646997|NCT02407990|69116146|FG000|Overall Study|Study Terminated by Sponsor|1|||
37854677|NCT01255722|69538126|FG001|Overall Study|Adverse Event|1|||
37854678|NCT01255722|69538127|FG002|Overall Study|Adverse Event|1|||
37854679|NCT01255722|69538125|FG000|Overall Study|asymptomatic patient|1|||
37854680|NCT01255722|69538126|FG001|Overall Study|asymptomatic patient|0|||
37646998|NCT02407990|69116147|FG001|Overall Study|Study Terminated by Sponsor|3|||
37646999|NCT02407990|69116148|FG002|Overall Study|Study Terminated by Sponsor|3|||
37647000|NCT02407990|69116149|FG003|Overall Study|Study Terminated by Sponsor|0|||
37854681|NCT01255722|69538127|FG002|Overall Study|asymptomatic patient|0|||
37854682|NCT01255722|69538125|FG000|Overall Study|beta-blocker contraindicated|2|||
37647001|NCT02407990|69116150|FG004|Overall Study|Study Terminated by Sponsor|3|||
37647002|NCT02407990|69116151|FG005|Overall Study|Study Terminated by Sponsor|4|||
37647003|NCT02407990|69116152|FG006|Overall Study|Study Terminated by Sponsor|3|||
37647004|NCT02407990|69116153|FG007|Overall Study|Study Terminated by Sponsor|37|||
37647005|NCT02407990|69116146|FG000|Overall Study|Logistics|0|||
37647006|NCT02407990|69116147|FG001|Overall Study|Logistics|0|||
37647007|NCT02407990|69116148|FG002|Overall Study|Logistics|0|||
37647008|NCT02407990|69116149|FG003|Overall Study|Logistics|0|||
37647009|NCT02407990|69116150|FG004|Overall Study|Logistics|0|||
37647010|NCT02407990|69116151|FG005|Overall Study|Logistics|0|||
37647011|NCT02407990|69116152|FG006|Overall Study|Logistics|0|||
37854683|NCT01255722|69538126|FG001|Overall Study|beta-blocker contraindicated|0|||
37854684|NCT01255722|69538127|FG002|Overall Study|beta-blocker contraindicated|0|||
37854685|NCT01231503|69538144|FG000|Overall Study|Adverse Event|0|||
37854686|NCT01231503|69538145|FG001|Overall Study|Adverse Event|0|||
37854687|NCT01231503|69538146|FG002|Overall Study|Adverse Event|0|||
37854688|NCT01231503|69538147|FG003|Overall Study|Adverse Event|0|||
37647012|NCT02407990|69116153|FG007|Overall Study|Logistics|1|||
37647013|NCT02407990|69116146|FG000|Overall Study|Rolled into long-term extension study|0|||
37647014|NCT02407990|69116147|FG001|Overall Study|Rolled into long-term extension study|0|||
37647015|NCT02407990|69116148|FG002|Overall Study|Rolled into long-term extension study|0|||
37647016|NCT02407990|69116149|FG003|Overall Study|Rolled into long-term extension study|0|||
37647017|NCT02407990|69116150|FG004|Overall Study|Rolled into long-term extension study|0|||
37647018|NCT02407990|69116151|FG005|Overall Study|Rolled into long-term extension study|0|||
37647019|NCT02407990|69116152|FG006|Overall Study|Rolled into long-term extension study|0|||
37647020|NCT02407990|69116153|FG007|Overall Study|Rolled into long-term extension study|1|||
37647021|NCT03288129|69116177|FG000|Overall Study|Adverse Event|10|||
37647022|NCT03288129|69116177|FG000|Overall Study|Lost to Follow-up|3|||
37854689|NCT01231503|69538148|FG004|Overall Study|Adverse Event|0|||
37854690|NCT01231503|69538149|FG005|Overall Study|Adverse Event|1|||
37922052|NCT00853658|69608864|FG001|Overall Study|H.A. Request|23|||
37922053|NCT00853658|69608865|FG002|Overall Study|H.A. Request|19|||
37922054|NCT00853658|69608863|FG000|Overall Study|IRB request|0|||
37922055|NCT00853658|69608864|FG001|Overall Study|IRB request|0|||
37922056|NCT00853658|69608865|FG002|Overall Study|IRB request|2|||
37922057|NCT00853658|69608863|FG000|Overall Study|Vital Status known (alive) at study end|2|||
37922058|NCT00853658|69608864|FG001|Overall Study|Vital Status known (alive) at study end|3|||
37922059|NCT00853658|69608865|FG002|Overall Study|Vital Status known (alive) at study end|3|||
37922060|NCT00853658|69608863|FG000|Overall Study|Vital Status unknown at study end|1|||
37922061|NCT00853658|69608864|FG001|Overall Study|Vital Status unknown at study end|1|||
37922062|NCT00853658|69608865|FG002|Overall Study|Vital Status unknown at study end|0|||
37922063|NCT00853658|69608863|FG000|Overall Study|Vital Status at study end N/A|8|||
37922064|NCT00853658|69608864|FG001|Overall Study|Vital Status at study end N/A|10|||
37922065|NCT00853658|69608865|FG002|Overall Study|Vital Status at study end N/A|10|||
37922066|NCT00853658|69608863|FG000|Overall Study|Patient's request|21|||
37922067|NCT00853658|69608864|FG001|Overall Study|Patient's request|17|||
37922068|NCT00853658|69608865|FG002|Overall Study|Patient's request|11|||
38032233|NCT03369704|69718152|FG000|Treatment Epoch|Protocol Violation|1|||
37922069|NCT00853658|69608863|FG000|Overall Study|Missing study completion information|5|||
37922070|NCT00853658|69608864|FG001|Overall Study|Missing study completion information|4|||
37922071|NCT00853658|69608865|FG002|Overall Study|Missing study completion information|6|||
37922072|NCT00666562|69608876|FG000|Overall Study|Withdrawal by Subject|0|||
37922073|NCT00666562|69608877|FG001|Overall Study|Withdrawal by Subject|1|||
37922074|NCT00666562|69608878|FG002|Overall Study|Withdrawal by Subject|0|||
37922075|NCT00666562|69608876|FG000|Overall Study|Concomitant Medication|0|||
38032234|NCT03369704|69718153|FG001|Treatment Epoch|Protocol Violation|0|||
37854691|NCT01231503|69538150|FG006|Overall Study|Adverse Event|0|||
37854692|NCT01231503|69538151|FG007|Overall Study|Adverse Event|0|||
37854693|NCT01231503|69538144|FG000|Overall Study|Adverse event, serious fatal|0|||
37854694|NCT01231503|69538145|FG001|Overall Study|Adverse event, serious fatal|0|||
37922076|NCT00666562|69608877|FG001|Overall Study|Concomitant Medication|1|||
37922077|NCT00666562|69608878|FG002|Overall Study|Concomitant Medication|0|||
37922078|NCT00666328|69608893|FG000|Overall Study|Death|2|||
38032235|NCT03369704|69718152|FG000|Treatment Epoch|Lost to Follow-up|0|||
37647023|NCT03288129|69116177|FG000|Overall Study|Withdrawal by Subject|3|||
37647024|NCT03288129|69116177|FG000|Overall Study|Withdrawal of consent/assent|1|||
37647025|NCT03288129|69116177|FG000|Overall Study|Other|5|||
37922079|NCT00666328|69608893|FG000|Overall Study|Lost to Follow-up|2|||
37922080|NCT00666328|69608893|FG000|Overall Study|No longer met eligibility criteria|1|||
37922081|NCT00853580|69608901|FG000|Overall Study|Lost to Follow-up|3|||
37647026|NCT01673282|69116183|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
37647027|NCT01673282|69116184|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
37647028|NCT01673282|69116183|FG000|Overall Study|Lack of Efficacy|9|||
37854695|NCT01231503|69538146|FG002|Overall Study|Adverse event, serious fatal|1|||
37854696|NCT01231503|69538147|FG003|Overall Study|Adverse event, serious fatal|1|||
37922082|NCT00853580|69608902|FG001|Overall Study|Lost to Follow-up|5|||
37922083|NCT00853580|69608901|FG000|Overall Study|Protocol Violation|2|||
37922084|NCT00853580|69608902|FG001|Overall Study|Protocol Violation|1|||
37922085|NCT00853580|69608901|FG000|Overall Study|Withdrawal by Subject|2|||
37922086|NCT00853580|69608902|FG001|Overall Study|Withdrawal by Subject|8|||
37922087|NCT00853580|69608901|FG000|Overall Study|Commenced contraindicated therapy|0|||
37922088|NCT00853580|69608902|FG001|Overall Study|Commenced contraindicated therapy|2|||
37922089|NCT00865514|69608908|FG000|Overall Study|Infusion cost exceeded funding|2|||
37922090|NCT00865280|69608915|FG000|Overall Study|Withdrawal by Subject|4|||
37922091|NCT00865280|69608916|FG001|Overall Study|Withdrawal by Subject|1|||
37922092|NCT00865280|69608915|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
37922093|NCT00865280|69608916|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
37854697|NCT01231503|69538148|FG004|Overall Study|Adverse event, serious fatal|0|||
37854698|NCT01231503|69538149|FG005|Overall Study|Adverse event, serious fatal|1|||
37854699|NCT01231503|69538150|FG006|Overall Study|Adverse event, serious fatal|0|||
37854700|NCT01231503|69538151|FG007|Overall Study|Adverse event, serious fatal|0|||
37922094|NCT00865280|69608915|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
37922095|NCT00865280|69608916|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
37922096|NCT00865280|69608915|FG000|Overall Study|Exclusion Condition|1|||
37922097|NCT00865280|69608916|FG001|Overall Study|Exclusion Condition|0|||
37922098|NCT00865280|69608915|FG000|Overall Study|Adverse Event|0|||
37922099|NCT00865280|69608916|FG001|Overall Study|Adverse Event|1|||
37922100|NCT00865124|69608925|FG000|Overall Study|Physician Decision|2|||
38032236|NCT03369704|69718153|FG001|Treatment Epoch|Lost to Follow-up|1|||
38032237|NCT03369704|69718152|FG000|Treatment Epoch|Lack of Efficacy|0|||
38032238|NCT03369704|69718153|FG001|Treatment Epoch|Lack of Efficacy|2|||
38032239|NCT03369704|69718152|FG000|Treatment Epoch|Adverse Event|2|||
38032240|NCT03369704|69718153|FG001|Treatment Epoch|Adverse Event|0|||
37854701|NCT01231503|69538144|FG000|Overall Study|Withdrawal by Subject|6|||
37854702|NCT01231503|69538145|FG001|Overall Study|Withdrawal by Subject|3|||
38032241|NCT03369704|69718152|FG000|Follow-up Epoch|Lost to Follow-up|1|||
38032242|NCT03369704|69718153|FG001|Follow-up Epoch|Lost to Follow-up|0|||
38032243|NCT03366428|69718159|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
38032244|NCT03366428|69718159|FG000|Overall Study|Adverse Event|12|||
37647029|NCT01673282|69116184|FG001|Overall Study|Lack of Efficacy|2|||
37647030|NCT01673282|69116183|FG000|Overall Study|Lost to Follow-up|11|||
37647031|NCT01673282|69116184|FG001|Overall Study|Lost to Follow-up|10|||
37647032|NCT01673282|69116183|FG000|Overall Study|Withdrawal by Subject|3|||
37647033|NCT01673282|69116184|FG001|Overall Study|Withdrawal by Subject|3|||
37647034|NCT01673282|69116183|FG000|Overall Study|Other|1|||
37647035|NCT01673282|69116184|FG001|Overall Study|Other|6|||
37647036|NCT04157751|69116192|FG000|Overall Study|Withdrawal by Subject|12|||
37647037|NCT04157751|69116193|FG001|Overall Study|Withdrawal by Subject|17|||
37647038|NCT04157751|69116192|FG000|Overall Study|Lost to Follow-up|6|||
37647039|NCT04157751|69116193|FG001|Overall Study|Lost to Follow-up|2|||
37647040|NCT04157751|69116192|FG000|Overall Study|Adverse Event|34|||
37647041|NCT04157751|69116193|FG001|Overall Study|Adverse Event|23|||
37647042|NCT04157751|69116192|FG000|Overall Study|Not treated|1|||
37647043|NCT04157751|69116193|FG001|Overall Study|Not treated|5|||
37647044|NCT04157751|69116192|FG000|Overall Study|Other reason not stated above|10|||
37647045|NCT04157751|69116193|FG001|Overall Study|Other reason not stated above|10|||
37647046|NCT01673126|69116201|FG000|Overall Study|change of diagnosis|4|||
37647047|NCT01673126|69116202|FG001|Overall Study|change of diagnosis|3|||
37647048|NCT02407054|69116211|FG000|Overall Study|Adverse Event|1|||
37741129|NCT01396395|69227129|FG000|Overall Study|Lost to Follow-up|17|||
37741130|NCT01396395|69227130|FG001|Overall Study|Lost to Follow-up|11|||
37741131|NCT01396395|69227129|FG000|Overall Study|Other|0|||
37741132|NCT01396395|69227130|FG001|Overall Study|Other|1|||
37741133|NCT01396317|69227140|FG000|Overall Study|Adverse Event|1|||
37741134|NCT01396317|69227141|FG001|Overall Study|Adverse Event|0|||
37741135|NCT01396161|69227156|FG000|Overall Study|Withdrawal by Subject|0|||
37741136|NCT01396161|69227157|FG001|Overall Study|Withdrawal by Subject|0|||
37854703|NCT01231503|69538146|FG002|Overall Study|Withdrawal by Subject|3|||
37854704|NCT01231503|69538147|FG003|Overall Study|Withdrawal by Subject|1|||
37854705|NCT01231503|69538148|FG004|Overall Study|Withdrawal by Subject|3|||
38032245|NCT03366428|69718159|FG000|Overall Study|Clinical progression|2|||
37647049|NCT02407054|69116212|FG001|Overall Study|Adverse Event|4|||
37741137|NCT01396161|69227158|FG002|Overall Study|Withdrawal by Subject|0|||
37854706|NCT01231503|69538149|FG005|Overall Study|Withdrawal by Subject|5|||
38032246|NCT03366428|69718159|FG000|Overall Study|Withdrawal by Subject|4|||
38032247|NCT02839876|69718167|FG000|Overall Study|Protocol Violation|10|||
38032248|NCT02839876|69718168|FG001|Overall Study|Protocol Violation|11|||
38032249|NCT03366194|69718174|FG000|Overall Study|Lost to Follow-up|2|||
37647050|NCT02407054|69116213|FG002|Overall Study|Adverse Event|1|||
37647051|NCT02407054|69116211|FG000|Overall Study|Non-compliance with Study|0|||
37647052|NCT02407054|69116212|FG001|Overall Study|Non-compliance with Study|2|||
37647053|NCT02407054|69116213|FG002|Overall Study|Non-compliance with Study|1|||
37741138|NCT01396161|69227159|FG003|Overall Study|Withdrawal by Subject|0|||
37647054|NCT02407054|69116211|FG000|Overall Study|Physician Decision|1|||
37647055|NCT02407054|69116212|FG001|Overall Study|Physician Decision|3|||
37647056|NCT02407054|69116213|FG002|Overall Study|Physician Decision|3|||
37647057|NCT02407054|69116211|FG000|Overall Study|Withdrawal by Subject|5|||
37647058|NCT02407054|69116212|FG001|Overall Study|Withdrawal by Subject|9|||
37647059|NCT02407054|69116213|FG002|Overall Study|Withdrawal by Subject|2|||
37647060|NCT01652716|69116224|FG000|Overall Study|Loss of glucose control|1|||
37647061|NCT01652716|69116225|FG001|Overall Study|Loss of glucose control|0|||
37647062|NCT01652716|69116224|FG000|Overall Study|Administrative|0|||
37647063|NCT01652716|69116225|FG001|Overall Study|Administrative|2|||
37647064|NCT01652716|69116224|FG000|Overall Study|Investigator decision|1|||
37647065|NCT01652716|69116225|FG001|Overall Study|Investigator decision|4|||
37647066|NCT01652716|69116224|FG000|Overall Study|Lost to Follow-up|12|||
37647067|NCT01652716|69116225|FG001|Overall Study|Lost to Follow-up|11|||
37647068|NCT01652716|69116224|FG000|Overall Study|Protocol Violation|2|||
37647069|NCT01652716|69116225|FG001|Overall Study|Protocol Violation|1|||
37647070|NCT01652716|69116224|FG000|Overall Study|Adverse Event|7|||
37647071|NCT01652716|69116225|FG001|Overall Study|Adverse Event|10|||
37647072|NCT01652716|69116224|FG000|Overall Study|Withdrawal by Subject|33|||
37647073|NCT01652716|69116225|FG001|Overall Study|Withdrawal by Subject|18|||
37647074|NCT02790073|69116231|FG000|Overall Study|Death|1|||
37647075|NCT02790073|69116231|FG000|Overall Study|Withdrawal from HD|1|||
37647076|NCT02790073|69116231|FG000|Overall Study|Withdrawal by Subject|1|||
37647077|NCT02789137|69116235|FG000|Overall Study|Dropped out/Died|58|||
37647078|NCT01672970|69116240|FG000|Overall Study|Lack of Efficacy|12|||
37647079|NCT01672970|69116240|FG000|Overall Study|Adverse Event|18|||
37647080|NCT01672970|69116240|FG000|Overall Study|Withdrawal by Subject|2|||
37647081|NCT01672970|69116240|FG000|Overall Study|Lost to Follow-up|5|||
37647082|NCT01672970|69116240|FG000|Overall Study|Other|9|||
37647083|NCT01672970|69116240|FG000|Overall Study|Enrolled but not treated|1|||
37647084|NCT02788747|69116247|FG000|Overall Study|Adverse Event|1|||
37647085|NCT02788747|69116248|FG001|Overall Study|Adverse Event|0|||
37647086|NCT02788747|69116249|FG002|Overall Study|Adverse Event|0|||
37647087|NCT02406742|69116263|FG000|Overall Study|Progression of Disease|5|||
37647088|NCT02406742|69116264|FG001|Overall Study|Progression of Disease|1|||
37647089|NCT02406742|69116265|FG002|Overall Study|Progression of Disease|6|||
37922101|NCT00865124|69608926|FG001|Overall Study|Physician Decision|1|||
37922102|NCT00865124|69608927|FG002|Overall Study|Physician Decision|0|||
37922103|NCT00865124|69608925|FG000|Overall Study|Withdrawn consent|2|||
37922104|NCT00865124|69608926|FG001|Overall Study|Withdrawn consent|0|||
37922105|NCT00865124|69608927|FG002|Overall Study|Withdrawn consent|0|||
37922106|NCT00871715|69608938|FG000|Overall Study|Withdrawal by Subject|6|||
37922107|NCT00871715|69608939|FG001|Overall Study|Withdrawal by Subject|10|||
37922108|NCT00871715|69608940|FG002|Overall Study|Withdrawal by Subject|15|||
37922109|NCT00871715|69608938|FG000|Overall Study|Physician Decision|6|||
37922110|NCT00871715|69608939|FG001|Overall Study|Physician Decision|0|||
37922111|NCT00871715|69608940|FG002|Overall Study|Physician Decision|2|||
37922112|NCT00871715|69608938|FG000|Overall Study|Lost to Follow-up|3|||
37922113|NCT00871715|69608939|FG001|Overall Study|Lost to Follow-up|6|||
37922114|NCT00871715|69608940|FG002|Overall Study|Lost to Follow-up|9|||
37922115|NCT00819234|69608949|FG000|Overall Study|Withdrawal by Subject|8|||
37922116|NCT00819234|69608950|FG001|Overall Study|Withdrawal by Subject|13|||
37922117|NCT00819234|69608951|FG002|Overall Study|Withdrawal by Subject|6|||
37922118|NCT00819234|69608952|FG003|Overall Study|Withdrawal by Subject|3|||
37922119|NCT00819234|69608953|FG004|Overall Study|Withdrawal by Subject|0|||
37922120|NCT00819234|69608954|FG005|Overall Study|Withdrawal by Subject|4|||
37922121|NCT00819234|69608955|FG006|Overall Study|Withdrawal by Subject|4|||
37922122|NCT00819234|69608956|FG007|Overall Study|Withdrawal by Subject|8|||
37922123|NCT00819234|69608957|FG008|Overall Study|Withdrawal by Subject|5|||
37922124|NCT00819234|69608958|FG009|Overall Study|Withdrawal by Subject|3|||
37922125|NCT00819234|69608949|FG000|Overall Study|Adverse Event|0|||
37922126|NCT00819234|69608950|FG001|Overall Study|Adverse Event|0|||
37922127|NCT00819234|69608951|FG002|Overall Study|Adverse Event|1|||
37922128|NCT00819234|69608952|FG003|Overall Study|Adverse Event|0|||
37647090|NCT02406742|69116263|FG000|Overall Study|Adverse Event|3|||
37647091|NCT02406742|69116264|FG001|Overall Study|Adverse Event|0|||
37647092|NCT02406742|69116265|FG002|Overall Study|Adverse Event|2|||
37647093|NCT02406742|69116263|FG000|Overall Study|Death|1|||
37922129|NCT00819234|69608953|FG004|Overall Study|Adverse Event|0|||
38032250|NCT02839798|69718179|FG000|Overall Study|Withdrawal by Subject|2|||
37922130|NCT00819234|69608954|FG005|Overall Study|Adverse Event|2|||
37922131|NCT00819234|69608955|FG006|Overall Study|Adverse Event|0|||
37647094|NCT02406742|69116264|FG001|Overall Study|Death|0|||
37647095|NCT02406742|69116265|FG002|Overall Study|Death|0|||
37647096|NCT02406742|69116263|FG000|Overall Study|Lack of Efficacy|0|||
37647097|NCT02406742|69116264|FG001|Overall Study|Lack of Efficacy|0|||
37647098|NCT02406742|69116265|FG002|Overall Study|Lack of Efficacy|1|||
37647099|NCT02406742|69116263|FG000|Overall Study|Withdrawal by Participant|1|||
37922132|NCT00819234|69608956|FG007|Overall Study|Adverse Event|0|||
37647100|NCT02406742|69116264|FG001|Overall Study|Withdrawal by Participant|2|||
37647101|NCT02406742|69116265|FG002|Overall Study|Withdrawal by Participant|0|||
37647102|NCT02406742|69116263|FG000|Overall Study|Physician Decision|1|||
37647103|NCT02406742|69116264|FG001|Overall Study|Physician Decision|2|||
37647104|NCT02406742|69116265|FG002|Overall Study|Physician Decision|1|||
37647105|NCT02406742|69116263|FG000|Overall Study|Transition to other treatment|2|||
37647106|NCT02406742|69116264|FG001|Overall Study|Transition to other treatment|0|||
37647107|NCT02406742|69116265|FG002|Overall Study|Transition to other treatment|1|||
37647108|NCT02406742|69116263|FG000|Overall Study|Other Reasons|1|||
37647109|NCT02406742|69116264|FG001|Overall Study|Other Reasons|11|||
37647110|NCT02406742|69116265|FG002|Overall Study|Other Reasons|5|||
37647111|NCT02714595|69116275|FG000|Overall Study|Lost to Follow-up|1|||
37741139|NCT01396161|69227160|FG004|Overall Study|Withdrawal by Subject|1|||
37854707|NCT01231503|69538150|FG006|Overall Study|Withdrawal by Subject|1|||
37854708|NCT01231503|69538151|FG007|Overall Study|Withdrawal by Subject|2|||
37854709|NCT01231503|69538144|FG000|Overall Study|Lost to Follow-up|8|||
37854710|NCT01231503|69538145|FG001|Overall Study|Lost to Follow-up|10|||
37854711|NCT01231503|69538146|FG002|Overall Study|Lost to Follow-up|8|||
37854712|NCT01231503|69538147|FG003|Overall Study|Lost to Follow-up|5|||
37854713|NCT01231503|69538148|FG004|Overall Study|Lost to Follow-up|7|||
37854714|NCT01231503|69538149|FG005|Overall Study|Lost to Follow-up|9|||
37647112|NCT02714595|69116276|FG001|Overall Study|Lost to Follow-up|0|||
37647113|NCT02714595|69116275|FG000|Overall Study|Withdrawal by Subject|1|||
37647114|NCT02714595|69116276|FG001|Overall Study|Withdrawal by Subject|2|||
37647115|NCT02714595|69116275|FG000|Overall Study|Lack of Efficacy|0|||
37647116|NCT02714595|69116276|FG001|Overall Study|Lack of Efficacy|1|||
37647117|NCT02714595|69116275|FG000|Overall Study|Death|30|||
37647118|NCT02714595|69116276|FG001|Overall Study|Death|9|||
37647119|NCT02714595|69116275|FG000|Overall Study|Other-Miscellaneous|0|||
37647120|NCT02714595|69116276|FG001|Overall Study|Other-Miscellaneous|1|||
37647121|NCT02437162|69116303|FG000|Overall Study|Protocol Violation|0|||
37647122|NCT02437162|69116304|FG001|Overall Study|Protocol Violation|1|||
37647123|NCT02437162|69116305|FG002|Overall Study|Protocol Violation|0|||
37647124|NCT02437162|69116303|FG000|Overall Study|Randomized but not treated|0|||
37647125|NCT02437162|69116304|FG001|Overall Study|Randomized but not treated|0|||
37647126|NCT02437162|69116305|FG002|Overall Study|Randomized but not treated|1|||
37647127|NCT02437162|69116303|FG000|Overall Study|Study discontinued by Sponsor|93|||
37647128|NCT02437162|69116304|FG001|Overall Study|Study discontinued by Sponsor|98|||
37647129|NCT02437162|69116305|FG002|Overall Study|Study discontinued by Sponsor|97|||
37647130|NCT02437162|69116303|FG000|Overall Study|Withdrawal by Subject|13|||
37647131|NCT02437162|69116304|FG001|Overall Study|Withdrawal by Subject|7|||
37647132|NCT02437162|69116305|FG002|Overall Study|Withdrawal by Subject|9|||
37647133|NCT02437162|69116303|FG000|Overall Study|Adverse Event|0|||
37647134|NCT02437162|69116304|FG001|Overall Study|Adverse Event|1|||
37854715|NCT01231503|69538150|FG006|Overall Study|Lost to Follow-up|6|||
37854716|NCT01231503|69538151|FG007|Overall Study|Lost to Follow-up|6|||
37854717|NCT01231503|69538144|FG000|Overall Study|Protocol Violation|0|||
37854718|NCT01231503|69538145|FG001|Overall Study|Protocol Violation|0|||
37854719|NCT01231503|69538146|FG002|Overall Study|Protocol Violation|0|||
37854720|NCT01231503|69538147|FG003|Overall Study|Protocol Violation|1|||
37854721|NCT01231503|69538148|FG004|Overall Study|Protocol Violation|0|||
37854722|NCT01231503|69538149|FG005|Overall Study|Protocol Violation|0|||
37854723|NCT01231503|69538150|FG006|Overall Study|Protocol Violation|0|||
37854724|NCT01231503|69538151|FG007|Overall Study|Protocol Violation|0|||
37854725|NCT01230489|69538179|FG000|Overall Study|Death|2|||
37854726|NCT01230489|69538179|FG000|Overall Study|Adverse Event|2|||
37854727|NCT01230489|69538179|FG000|Overall Study|Treatment modality changed|1|||
37854728|NCT01229397|69538185|FG000|Overall Study|Withdrawal by Subject|3|||
37854729|NCT01229397|69538186|FG001|Overall Study|Withdrawal by Subject|3|||
37854730|NCT01229397|69538185|FG000|Overall Study|Lost to Follow-up|7|||
37854731|NCT01229397|69538186|FG001|Overall Study|Lost to Follow-up|6|||
37854732|NCT01229397|69538185|FG000|Overall Study|Migrated/moved from study area|1|||
37854733|NCT01229397|69538186|FG001|Overall Study|Migrated/moved from study area|0|||
37922133|NCT00819234|69608957|FG008|Overall Study|Adverse Event|0|||
37647135|NCT02437162|69116305|FG002|Overall Study|Adverse Event|0|||
37647136|NCT02437162|69116303|FG000|Overall Study|Lost to Follow-up|1|||
37854734|NCT01228071|69538196|FG000|Overall Study|Protocol Violation|1|||
37854735|NCT01228071|69538196|FG000|Overall Study|Withdrawal by Subject|1|||
37854736|NCT01008475|69538207|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
37854737|NCT01008475|69538208|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
37741140|NCT01396161|69227161|FG005|Overall Study|Withdrawal by Subject|0|||
37647137|NCT02437162|69116304|FG001|Overall Study|Lost to Follow-up|0|||
37647138|NCT02437162|69116305|FG002|Overall Study|Lost to Follow-up|1|||
37647139|NCT02437162|69116303|FG000|Overall Study|Death|0|||
37647140|NCT02437162|69116304|FG001|Overall Study|Death|1|||
37647141|NCT02437162|69116305|FG002|Overall Study|Death|0|||
37647142|NCT02437162|69116303|FG000|Overall Study|Other|0|||
37647143|NCT02437162|69116304|FG001|Overall Study|Other|0|||
37647144|NCT02437162|69116305|FG002|Overall Study|Other|1|||
37647145|NCT01368211|69116320|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
37647146|NCT01368211|69116321|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
37647147|NCT02437084|69116327|FG000|Overall Study|Withdrawal by Subject|2|||
37647148|NCT02437084|69116327|FG000|Overall Study|Physician Decision|1|||
37647149|NCT02406586|69116334|FG000|Overall Study|Lost to Follow-up|0|||
37647150|NCT02406586|69116335|FG001|Overall Study|Lost to Follow-up|4|||
37647151|NCT02406586|69116336|FG002|Overall Study|Lost to Follow-up|2|||
37647152|NCT02406586|69116334|FG000|Overall Study|Withdrawal by Subject|1|||
37647153|NCT02406586|69116335|FG001|Overall Study|Withdrawal by Subject|0|||
37647154|NCT02406586|69116336|FG002|Overall Study|Withdrawal by Subject|0|||
37647155|NCT02460562|69116349|FG000|Overall Study|Lost to Follow-up|15|||
37647156|NCT02460562|69116350|FG001|Overall Study|Lost to Follow-up|16|||
37647157|NCT02788357|69116358|FG000|Overall Study|Lost to Follow-up|3|||
37647158|NCT02788357|69116359|FG001|Overall Study|Lost to Follow-up|0|||
37647159|NCT02457910|69116371|FG000|Overall Study|Withdrawal by Subject|0|||
37647160|NCT02457910|69116372|FG001|Overall Study|Withdrawal by Subject|0|||
37647161|NCT02457910|69116373|FG002|Overall Study|Withdrawal by Subject|0|||
37647162|NCT02457910|69116374|FG003|Overall Study|Withdrawal by Subject|0|||
37647163|NCT02457910|69116375|FG004|Overall Study|Withdrawal by Subject|0|||
37647164|NCT02457910|69116376|FG005|Overall Study|Withdrawal by Subject|1|||
37647165|NCT02457910|69116371|FG000|Overall Study|Adverse Event|0|||
37647166|NCT02457910|69116372|FG001|Overall Study|Adverse Event|2|||
37647167|NCT02457910|69116373|FG002|Overall Study|Adverse Event|1|||
37647168|NCT02457910|69116374|FG003|Overall Study|Adverse Event|1|||
37647169|NCT02457910|69116375|FG004|Overall Study|Adverse Event|1|||
37647170|NCT02457910|69116376|FG005|Overall Study|Adverse Event|3|||
37647171|NCT02457910|69116371|FG000|Overall Study|Disease progression|3|||
37647172|NCT02457910|69116372|FG001|Overall Study|Disease progression|3|||
37647173|NCT02457910|69116373|FG002|Overall Study|Disease progression|1|||
37647174|NCT02457910|69116374|FG003|Overall Study|Disease progression|1|||
37854738|NCT01008475|69538209|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
37854739|NCT01008475|69538210|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
37854740|NCT01008475|69538211|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
37854741|NCT01008475|69538212|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
37854742|NCT01008475|69538213|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
37854743|NCT01226745|69538235|FG000|Overall Study|Did not complete schedule of assessments|8|||
37854744|NCT01226745|69538236|FG001|Overall Study|Did not complete schedule of assessments|3|||
37854745|NCT01226745|69538237|FG002|Overall Study|Did not complete schedule of assessments|6|||
37854746|NCT01226745|69538238|FG003|Overall Study|Did not complete schedule of assessments|0|||
37854747|NCT01226745|69538239|FG004|Overall Study|Did not complete schedule of assessments|0|||
37854748|NCT01226745|69538240|FG005|Overall Study|Did not complete schedule of assessments|1|||
37854749|NCT01226745|69538235|FG000|Overall Study|Lost to Follow-up|2|||
37854750|NCT01226745|69538236|FG001|Overall Study|Lost to Follow-up|6|||
37922134|NCT00819234|69608958|FG009|Overall Study|Adverse Event|0|||
37922135|NCT00819234|69608949|FG000|Overall Study|Physician Decision|0|||
37922136|NCT00819234|69608950|FG001|Overall Study|Physician Decision|0|||
37922137|NCT00819234|69608951|FG002|Overall Study|Physician Decision|0|||
37922138|NCT00819234|69608952|FG003|Overall Study|Physician Decision|1|||
37922139|NCT00819234|69608953|FG004|Overall Study|Physician Decision|0|||
37922140|NCT00819234|69608954|FG005|Overall Study|Physician Decision|0|||
37922141|NCT00819234|69608955|FG006|Overall Study|Physician Decision|0|||
37922142|NCT00819234|69608956|FG007|Overall Study|Physician Decision|0|||
37922143|NCT00819234|69608957|FG008|Overall Study|Physician Decision|0|||
37922144|NCT00819234|69608958|FG009|Overall Study|Physician Decision|2|||
37922145|NCT00819234|69608949|FG000|Overall Study|Protocol Violation|0|||
37922146|NCT00819234|69608950|FG001|Overall Study|Protocol Violation|0|||
37922147|NCT00819234|69608951|FG002|Overall Study|Protocol Violation|1|||
37922148|NCT00819234|69608952|FG003|Overall Study|Protocol Violation|0|||
37922149|NCT00819234|69608953|FG004|Overall Study|Protocol Violation|0|||
37922150|NCT00819234|69608954|FG005|Overall Study|Protocol Violation|0|||
37922151|NCT00819234|69608955|FG006|Overall Study|Protocol Violation|0|||
37922152|NCT00819234|69608956|FG007|Overall Study|Protocol Violation|0|||
37922153|NCT00819234|69608957|FG008|Overall Study|Protocol Violation|0|||
37922154|NCT00819234|69608958|FG009|Overall Study|Protocol Violation|0|||
37922155|NCT00819234|69608949|FG000|Overall Study|Lost to Follow-up|2|||
37922156|NCT00819234|69608950|FG001|Overall Study|Lost to Follow-up|2|||
37922157|NCT00819234|69608951|FG002|Overall Study|Lost to Follow-up|0|||
37922158|NCT00819234|69608952|FG003|Overall Study|Lost to Follow-up|2|||
37922159|NCT00819234|69608953|FG004|Overall Study|Lost to Follow-up|1|||
37922160|NCT00819234|69608954|FG005|Overall Study|Lost to Follow-up|1|||
37647175|NCT02457910|69116375|FG004|Overall Study|Disease progression|4|||
37647176|NCT02457910|69116376|FG005|Overall Study|Disease progression|6|||
37647177|NCT02457910|69116371|FG000|Overall Study|Other complicating illness|0|||
37647178|NCT02457910|69116372|FG001|Overall Study|Other complicating illness|0|||
37647179|NCT02457910|69116373|FG002|Overall Study|Other complicating illness|0|||
37647180|NCT02457910|69116374|FG003|Overall Study|Other complicating illness|0|||
37854751|NCT01226745|69538237|FG002|Overall Study|Lost to Follow-up|6|||
37854752|NCT01226745|69538238|FG003|Overall Study|Lost to Follow-up|1|||
37854753|NCT01226745|69538239|FG004|Overall Study|Lost to Follow-up|1|||
37854754|NCT01226745|69538240|FG005|Overall Study|Lost to Follow-up|2|||
37854755|NCT01226745|69538235|FG000|Overall Study|Death|1|||
37854756|NCT01226745|69538236|FG001|Overall Study|Death|0|||
37854757|NCT01226745|69538237|FG002|Overall Study|Death|0|||
37854758|NCT01226745|69538238|FG003|Overall Study|Death|0|||
37854759|NCT01226745|69538239|FG004|Overall Study|Death|0|||
37854760|NCT01226745|69538240|FG005|Overall Study|Death|1|||
37854761|NCT01226745|69538235|FG000|Overall Study|Other|6|||
37854762|NCT01226745|69538236|FG001|Overall Study|Other|7|||
37854763|NCT01226745|69538237|FG002|Overall Study|Other|8|||
37854764|NCT01226745|69538238|FG003|Overall Study|Other|4|||
37854765|NCT01226745|69538239|FG004|Overall Study|Other|3|||
37854766|NCT01226745|69538240|FG005|Overall Study|Other|1|||
37854767|NCT01226511|69538257|FG000|Acute Treatment Period|Adverse Event|7|||
37854768|NCT01226511|69538258|FG001|Acute Treatment Period|Adverse Event|6|||
37854769|NCT01226511|69538257|FG000|Acute Treatment Period|Lack of Efficacy|2|||
37854770|NCT01226511|69538258|FG001|Acute Treatment Period|Lack of Efficacy|1|||
37854771|NCT01226511|69538257|FG000|Acute Treatment Period|Lost to Follow-up|3|||
37854772|NCT01226511|69538258|FG001|Acute Treatment Period|Lost to Follow-up|6|||
37854773|NCT01226511|69538257|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
37854774|NCT01226511|69538258|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
37854775|NCT01226511|69538257|FG000|Acute Treatment Period|Protocol Violation|5|||
37854776|NCT01226511|69538258|FG001|Acute Treatment Period|Protocol Violation|5|||
37854777|NCT01226511|69538257|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
37854778|NCT01226511|69538258|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
37854779|NCT01226511|69538257|FG000|Extension Treatment Period|Adverse Event|8|||
37854780|NCT01226511|69538258|FG001|Extension Treatment Period|Adverse Event|8|||
37854781|NCT01226511|69538257|FG000|Extension Treatment Period|Lack of Efficacy|3|||
37854782|NCT01226511|69538258|FG001|Extension Treatment Period|Lack of Efficacy|2|||
37854783|NCT01226511|69538257|FG000|Extension Treatment Period|Lost to Follow-up|4|||
37854784|NCT01226511|69538258|FG001|Extension Treatment Period|Lost to Follow-up|3|||
37854785|NCT01226511|69538257|FG000|Extension Treatment Period|Protocol Violation|2|||
37854786|NCT01226511|69538258|FG001|Extension Treatment Period|Protocol Violation|2|||
37854787|NCT01226511|69538257|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
37854788|NCT01226511|69538258|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
37854789|NCT01226511|69538257|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
37854790|NCT01226511|69538258|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
37854791|NCT01226511|69538257|FG000|Extension Treatment Period|Sponsor Decision|1|||
37854792|NCT01226511|69538258|FG001|Extension Treatment Period|Sponsor Decision|1|||
37854793|NCT01226511|69538257|FG000|Taper Period|Adverse Event|1|||
37854794|NCT01226511|69538258|FG001|Taper Period|Adverse Event|0|||
37854795|NCT01226511|69538257|FG000|Taper Period|Lost to Follow-up|2|||
37854796|NCT01226511|69538258|FG001|Taper Period|Lost to Follow-up|2|||
37854797|NCT01226511|69538257|FG000|Taper Period|Protocol Violation|1|||
37854798|NCT01226511|69538258|FG001|Taper Period|Protocol Violation|0|||
37854799|NCT01226511|69538257|FG000|Taper Period|Parent/Caregiver Decision|1|||
37854800|NCT01226511|69538258|FG001|Taper Period|Parent/Caregiver Decision|1|||
37854801|NCT01226121|69538273|FG000|Overall Study|Lost to Follow-up|2|||
37854802|NCT01226121|69538274|FG001|Overall Study|Lost to Follow-up|0|||
37854803|NCT01226121|69538275|FG002|Overall Study|Lost to Follow-up|1|||
37854804|NCT01226043|69538285|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
37854805|NCT01226043|69538286|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
37854806|NCT01226043|69538287|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
37854807|NCT01226043|69538288|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
37854808|NCT01226043|69538285|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
37854809|NCT01226043|69538286|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
37854810|NCT01226043|69538287|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
37647181|NCT02457910|69116375|FG004|Overall Study|Other complicating illness|0|||
37647182|NCT02457910|69116376|FG005|Overall Study|Other complicating illness|1|||
37647183|NCT02457910|69116371|FG000|Overall Study|Death|0|||
37647184|NCT02457910|69116372|FG001|Overall Study|Death|0|||
37647185|NCT02457910|69116373|FG002|Overall Study|Death|1|||
37647186|NCT02457910|69116374|FG003|Overall Study|Death|0|||
37647187|NCT02457910|69116375|FG004|Overall Study|Death|0|||
37647188|NCT02457910|69116376|FG005|Overall Study|Death|0|||
37647189|NCT02405962|69116395|FG000|Overall Study|Lost to Follow-up|1|||
37741141|NCT01396161|69227162|FG006|Overall Study|Withdrawal by Subject|0|||
37741142|NCT01396161|69227156|FG000|Overall Study|Other|0|||
37647190|NCT02405962|69116396|FG001|Overall Study|Lost to Follow-up|4|||
37647191|NCT02405962|69116395|FG000|Overall Study|A participant has moved to another place|0|||
37647192|NCT02405962|69116396|FG001|Overall Study|A participant has moved to another place|1|||
37741143|NCT01396161|69227157|FG001|Overall Study|Other|0|||
37741144|NCT01396161|69227158|FG002|Overall Study|Other|0|||
37741145|NCT01396161|69227159|FG003|Overall Study|Other|0|||
37854811|NCT01226043|69538288|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
37854812|NCT01226043|69538285|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
37854813|NCT01226043|69538286|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
37854814|NCT01226043|69538287|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
37854815|NCT01226043|69538288|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
37854816|NCT01226043|69538285|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
37854817|NCT01226043|69538286|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
37854818|NCT01226043|69538287|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
37854819|NCT01226043|69538288|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
37854820|NCT01226043|69538285|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
37854821|NCT01226043|69538286|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
37854822|NCT01226043|69538287|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
37854823|NCT01226043|69538288|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
37854824|NCT01226043|69538285|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
37854825|NCT01226043|69538286|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
37854826|NCT01226043|69538287|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
37854827|NCT01226043|69538288|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
37854828|NCT01226043|69538285|FG000|6-week Re-randomization Phase|Adverse Event|0|||
37854829|NCT01226043|69538286|FG001|6-week Re-randomization Phase|Adverse Event|0|||
37854830|NCT01226043|69538287|FG002|6-week Re-randomization Phase|Adverse Event|1|||
37854831|NCT01226043|69538288|FG003|6-week Re-randomization Phase|Adverse Event|1|||
37854832|NCT01226043|69538285|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
37854833|NCT01226043|69538286|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
37854834|NCT01226043|69538287|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
37854835|NCT01226043|69538288|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
37854836|NCT01226043|69538285|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
37854837|NCT01226043|69538286|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
37854838|NCT01226043|69538287|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
37854839|NCT01226043|69538288|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
37854840|NCT01226043|69538285|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
37854841|NCT01226043|69538286|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
37854842|NCT01226043|69538287|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
37854843|NCT01226043|69538288|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
37854844|NCT01226043|69538285|FG000|6-week Re-randomization Phase|Physician Decision|0|||
37854845|NCT01226043|69538286|FG001|6-week Re-randomization Phase|Physician Decision|0|||
37854846|NCT01226043|69538287|FG002|6-week Re-randomization Phase|Physician Decision|3|||
37854847|NCT01226043|69538288|FG003|6-week Re-randomization Phase|Physician Decision|2|||
37854848|NCT01226043|69538285|FG000|6-week Re-randomization Phase|completed in error|0|||
37854849|NCT01226043|69538286|FG001|6-week Re-randomization Phase|completed in error|0|||
37854850|NCT01226043|69538287|FG002|6-week Re-randomization Phase|completed in error|0|||
37854851|NCT01226043|69538288|FG003|6-week Re-randomization Phase|completed in error|1|||
37854852|NCT01226043|69538285|FG000|30-week Observational Phase|Adverse Event|0|||
37854853|NCT01226043|69538286|FG001|30-week Observational Phase|Adverse Event|0|||
37854854|NCT01226043|69538287|FG002|30-week Observational Phase|Adverse Event|1|||
37854855|NCT01226043|69538288|FG003|30-week Observational Phase|Adverse Event|1|||
37854856|NCT01226043|69538285|FG000|30-week Observational Phase|Protocol Violation|0|||
37854857|NCT01226043|69538286|FG001|30-week Observational Phase|Protocol Violation|0|||
37854858|NCT01226043|69538287|FG002|30-week Observational Phase|Protocol Violation|0|||
37854859|NCT01226043|69538288|FG003|30-week Observational Phase|Protocol Violation|1|||
37854860|NCT01226043|69538285|FG000|30-week Observational Phase|Lost to Follow-up|0|||
37854861|NCT01226043|69538286|FG001|30-week Observational Phase|Lost to Follow-up|0|||
37854862|NCT01226043|69538287|FG002|30-week Observational Phase|Lost to Follow-up|2|||
37854863|NCT01226043|69538288|FG003|30-week Observational Phase|Lost to Follow-up|2|||
37854864|NCT01226043|69538285|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
37854865|NCT01226043|69538286|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
37854866|NCT01226043|69538287|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
37854867|NCT01226043|69538288|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
37854868|NCT01226043|69538285|FG000|30-week Observational Phase|Physician Decision|0|||
37854869|NCT01226043|69538286|FG001|30-week Observational Phase|Physician Decision|0|||
37854870|NCT01226043|69538287|FG002|30-week Observational Phase|Physician Decision|2|||
37854871|NCT01226043|69538288|FG003|30-week Observational Phase|Physician Decision|2|||
37854872|NCT01001377|69538320|FG000|Overall Study|Ineligibility determined|2|||
37854873|NCT01001377|69538321|FG001|Overall Study|Ineligibility determined|0|||
37854874|NCT01001377|69538320|FG000|Overall Study|Withdrawal by Subject|19|||
37854875|NCT01001377|69538321|FG001|Overall Study|Withdrawal by Subject|20|||
37741146|NCT01396161|69227160|FG004|Overall Study|Other|0|||
37741147|NCT01396161|69227161|FG005|Overall Study|Other|0|||
37741148|NCT01396161|69227162|FG006|Overall Study|Other|1|||
37741149|NCT01396083|69227185|FG000|Overall Study|Adverse Event|2|||
37741150|NCT01396083|69227186|FG001|Overall Study|Adverse Event|28|||
37854876|NCT01001377|69538320|FG000|Overall Study|Lost to Follow-up|14|||
37854877|NCT01001377|69538321|FG001|Overall Study|Lost to Follow-up|17|||
37854878|NCT01001377|69538320|FG000|Overall Study|Death|391|||
37854879|NCT01001377|69538321|FG001|Overall Study|Death|384|||
37854880|NCT01225887|69538327|FG000|Overall Study|Ineligible:required test not done|2|||
37854881|NCT01225887|69538327|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
37854882|NCT01225887|69538327|FG000|Overall Study|Ineligible:inadequate pathology|2|||
37854883|NCT01001299|69538331|FG000|Overall Study|Insufficient Therapeutic Response|20|||
37854884|NCT01001299|69538331|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
37854885|NCT01001299|69538331|FG000|Overall Study|Death|1|||
37854886|NCT01001299|69538331|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
37854887|NCT01001299|69538331|FG000|Overall Study|Withdrew Consent|1|||
37854888|NCT01296932|69538344|FG000|Overall Study|Dose limiting toxicity|0|||
37854889|NCT01296932|69538345|FG001|Overall Study|Dose limiting toxicity|0|||
37854890|NCT01296932|69538346|FG002|Overall Study|Dose limiting toxicity|0|||
37854891|NCT01296932|69538347|FG003|Overall Study|Dose limiting toxicity|0|||
37854892|NCT01296932|69538348|FG004|Overall Study|Dose limiting toxicity|0|||
37854893|NCT01296932|69538349|FG005|Overall Study|Dose limiting toxicity|0|||
37854894|NCT01296932|69538350|FG006|Overall Study|Dose limiting toxicity|1|||
37854895|NCT01296932|69538351|FG007|Overall Study|Dose limiting toxicity|0|||
37854896|NCT01296932|69538352|FG008|Overall Study|Dose limiting toxicity|1|||
37854897|NCT01296932|69538344|FG000|Overall Study|Progressive disease|2|||
37854898|NCT01296932|69538345|FG001|Overall Study|Progressive disease|0|||
37854899|NCT01296932|69538346|FG002|Overall Study|Progressive disease|1|||
37854900|NCT01296932|69538347|FG003|Overall Study|Progressive disease|1|||
37854901|NCT01296932|69538348|FG004|Overall Study|Progressive disease|2|||
37854902|NCT01296932|69538349|FG005|Overall Study|Progressive disease|3|||
37854903|NCT01296932|69538350|FG006|Overall Study|Progressive disease|1|||
37854904|NCT01296932|69538351|FG007|Overall Study|Progressive disease|0|||
37854905|NCT01296932|69538352|FG008|Overall Study|Progressive disease|0|||
37854906|NCT01296932|69538344|FG000|Overall Study|Withdrawal by Subject|0|||
37854907|NCT01296932|69538345|FG001|Overall Study|Withdrawal by Subject|0|||
37854908|NCT01296932|69538346|FG002|Overall Study|Withdrawal by Subject|1|||
37854909|NCT01296932|69538347|FG003|Overall Study|Withdrawal by Subject|1|||
37854910|NCT01296932|69538348|FG004|Overall Study|Withdrawal by Subject|0|||
37854911|NCT01296932|69538349|FG005|Overall Study|Withdrawal by Subject|0|||
37854912|NCT01296932|69538350|FG006|Overall Study|Withdrawal by Subject|3|||
37854913|NCT01296932|69538351|FG007|Overall Study|Withdrawal by Subject|0|||
37854914|NCT01296932|69538352|FG008|Overall Study|Withdrawal by Subject|0|||
37854915|NCT01296932|69538344|FG000|Overall Study|Adverse Event|1|||
37854916|NCT01296932|69538345|FG001|Overall Study|Adverse Event|1|||
37854917|NCT01296932|69538346|FG002|Overall Study|Adverse Event|1|||
37854918|NCT01296932|69538347|FG003|Overall Study|Adverse Event|2|||
37854919|NCT01296932|69538348|FG004|Overall Study|Adverse Event|1|||
37854920|NCT01296932|69538349|FG005|Overall Study|Adverse Event|0|||
37854921|NCT01296932|69538350|FG006|Overall Study|Adverse Event|0|||
37854922|NCT01296932|69538351|FG007|Overall Study|Adverse Event|0|||
37854923|NCT01296932|69538352|FG008|Overall Study|Adverse Event|1|||
37854924|NCT01296932|69538344|FG000|Overall Study|Investigator decision|0|||
37854925|NCT01296932|69538345|FG001|Overall Study|Investigator decision|1|||
37854926|NCT01296932|69538346|FG002|Overall Study|Investigator decision|0|||
37854927|NCT01296932|69538347|FG003|Overall Study|Investigator decision|1|||
37854928|NCT01296932|69538348|FG004|Overall Study|Investigator decision|0|||
37854929|NCT01296932|69538349|FG005|Overall Study|Investigator decision|0|||
37854930|NCT01296932|69538350|FG006|Overall Study|Investigator decision|1|||
37854931|NCT01296932|69538351|FG007|Overall Study|Investigator decision|0|||
37854932|NCT01296932|69538352|FG008|Overall Study|Investigator decision|1|||
37854933|NCT01296932|69538344|FG000|Overall Study|No clinical benefit anymore|0|||
37854934|NCT01296932|69538345|FG001|Overall Study|No clinical benefit anymore|1|||
37854935|NCT01296932|69538346|FG002|Overall Study|No clinical benefit anymore|0|||
37854936|NCT01296932|69538347|FG003|Overall Study|No clinical benefit anymore|0|||
37854937|NCT01296932|69538348|FG004|Overall Study|No clinical benefit anymore|0|||
37854938|NCT01296932|69538349|FG005|Overall Study|No clinical benefit anymore|0|||
37854939|NCT01296932|69538350|FG006|Overall Study|No clinical benefit anymore|0|||
37854940|NCT01296932|69538351|FG007|Overall Study|No clinical benefit anymore|0|||
38032251|NCT03345836|69718186|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
38032252|NCT03345836|69718187|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
38032253|NCT03345836|69718188|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
37854941|NCT01296932|69538352|FG008|Overall Study|No clinical benefit anymore|0|||
37854942|NCT01296932|69538344|FG000|Overall Study|Physician Decision|0|||
37854943|NCT01296932|69538345|FG001|Overall Study|Physician Decision|0|||
37854944|NCT01296932|69538346|FG002|Overall Study|Physician Decision|1|||
37854945|NCT01296932|69538347|FG003|Overall Study|Physician Decision|0|||
37854946|NCT01296932|69538348|FG004|Overall Study|Physician Decision|0|||
37854947|NCT01296932|69538349|FG005|Overall Study|Physician Decision|0|||
37854948|NCT01296932|69538350|FG006|Overall Study|Physician Decision|0|||
38032254|NCT03345836|69718189|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
38032255|NCT03345836|69718190|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
38032256|NCT03345836|69718191|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
38032257|NCT03345836|69718186|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
38032258|NCT03345836|69718187|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
38032259|NCT03345836|69718188|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
38032260|NCT03345836|69718189|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
38032261|NCT03345836|69718190|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
37647193|NCT02436304|69116405|FG000|Overall Study|Lost to Follow-up|0|||
37647194|NCT02436304|69116406|FG001|Overall Study|Lost to Follow-up|1|||
37647195|NCT02436304|69116407|FG002|Overall Study|Lost to Follow-up|0|||
37647196|NCT02436304|69116405|FG000|Overall Study|Withdrawal by Subject|0|||
37647197|NCT02436304|69116406|FG001|Overall Study|Withdrawal by Subject|1|||
37647198|NCT02436304|69116407|FG002|Overall Study|Withdrawal by Subject|0|||
37647199|NCT02436304|69116405|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
37647200|NCT02436304|69116406|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
37647201|NCT02436304|69116407|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
37647202|NCT02402218|69116419|FG000|Overall Study|Did not pickup study medication|12|||
37647203|NCT02402218|69116420|FG001|Overall Study|Did not pickup study medication|9|||
37647204|NCT02402218|69116421|FG002|Overall Study|Did not pickup study medication|13|||
37647205|NCT02402218|69116419|FG000|Overall Study|Lack of Efficacy|0|||
37647206|NCT02402218|69116420|FG001|Overall Study|Lack of Efficacy|1|||
37647207|NCT02402218|69116421|FG002|Overall Study|Lack of Efficacy|1|||
37647208|NCT02402218|69116419|FG000|Overall Study|Death|1|||
37647209|NCT02402218|69116420|FG001|Overall Study|Death|0|||
37647210|NCT02402218|69116421|FG002|Overall Study|Death|0|||
37647211|NCT02402218|69116419|FG000|Overall Study|Reinfection|0|||
37647212|NCT02402218|69116420|FG001|Overall Study|Reinfection|0|||
37647213|NCT02402218|69116421|FG002|Overall Study|Reinfection|1|||
37647214|NCT02402218|69116419|FG000|Overall Study|Adverse Event|0|||
37647215|NCT02402218|69116420|FG001|Overall Study|Adverse Event|2|||
37647216|NCT02402218|69116421|FG002|Overall Study|Adverse Event|1|||
37647217|NCT02402218|69116419|FG000|Overall Study|Withdrawal by Subject|1|||
37647218|NCT02402218|69116420|FG001|Overall Study|Withdrawal by Subject|1|||
37647219|NCT02402218|69116421|FG002|Overall Study|Withdrawal by Subject|1|||
37647220|NCT02457520|69116429|FG000|Active Treatment Phase|Adverse Event|10|||
37647221|NCT02457520|69116429|FG000|Active Treatment Phase|Lost to Follow-up|8|||
37647222|NCT02457520|69116429|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
37647223|NCT02457520|69116429|FG000|Active Treatment Phase|other|4|||
37647224|NCT02457520|69116429|FG000|Active Treatment Phase|Physician Decision|1|||
37647225|NCT02457520|69116429|FG000|Active Treatment Phase|Protocol Violation|1|||
37647226|NCT02457520|69116429|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
37647227|NCT02457520|69116429|FG000|Post-treatment Period|Other: Retreatment Required|7|||
37647228|NCT02457520|69116429|FG000|Post-treatment Period|Lost to Follow-up|23|||
37647229|NCT02457520|69116429|FG000|Post-treatment Period|Other|3|||
37647230|NCT02457520|69116429|FG000|Post-treatment Period|Physician Decision|1|||
37647231|NCT02457520|69116429|FG000|Post-treatment Period|Withdrawal by Subject|14|||
37647232|NCT02788279|69116462|FG000|Overall Study|Death|62|||
37647233|NCT02788279|69116463|FG001|Overall Study|Death|136|||
37647234|NCT02788279|69116464|FG002|Overall Study|Death|72|||
37647235|NCT02788279|69116462|FG000|Overall Study|Withdrawal by Subject|10|||
37647236|NCT02788279|69116463|FG001|Overall Study|Withdrawal by Subject|15|||
37647237|NCT02788279|69116464|FG002|Overall Study|Withdrawal by Subject|5|||
37647238|NCT02788279|69116462|FG000|Overall Study|Lost to Follow-up|0|||
37647239|NCT02788279|69116463|FG001|Overall Study|Lost to Follow-up|3|||
37647240|NCT02788279|69116464|FG002|Overall Study|Lost to Follow-up|2|||
38032262|NCT03345836|69718191|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
38032263|NCT03345836|69718186|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
38032264|NCT03345836|69718187|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
38032265|NCT03345836|69718188|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
37647241|NCT02788279|69116462|FG000|Overall Study|Sponsor decision|18|||
37647242|NCT02788279|69116463|FG001|Overall Study|Sponsor decision|29|||
37647243|NCT02788279|69116464|FG002|Overall Study|Sponsor decision|11|||
37647244|NCT02435992|69116480|FG000|Overall Study|non compliance with protocol|2|||
37647245|NCT02435992|69116481|FG001|Overall Study|non compliance with protocol|0|||
37647246|NCT02435992|69116482|FG002|Overall Study|non compliance with protocol|1|||
37647247|NCT02435992|69116483|FG003|Overall Study|non compliance with protocol|0|||
37647248|NCT02435992|69116484|FG004|Overall Study|non compliance with protocol|0|||
37647249|NCT02435992|69116480|FG000|Overall Study|Adverse Event|11|||
37647250|NCT02435992|69116481|FG001|Overall Study|Adverse Event|6|||
37647251|NCT02435992|69116482|FG002|Overall Study|Adverse Event|12|||
37647252|NCT02435992|69116483|FG003|Overall Study|Adverse Event|0|||
37647253|NCT02435992|69116484|FG004|Overall Study|Adverse Event|0|||
37647254|NCT02435992|69116480|FG000|Overall Study|Lack of Efficacy|4|||
37647255|NCT02435992|69116481|FG001|Overall Study|Lack of Efficacy|10|||
38032266|NCT03345836|69718189|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
38032267|NCT03345836|69718190|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
38032268|NCT03345836|69718191|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
37647256|NCT02435992|69116482|FG002|Overall Study|Lack of Efficacy|9|||
37854949|NCT01296932|69538351|FG007|Overall Study|Physician Decision|0|||
37854950|NCT01296932|69538352|FG008|Overall Study|Physician Decision|0|||
37854951|NCT01296932|69538344|FG000|Overall Study|IV problems, administration not possible|0|||
37854952|NCT01296932|69538345|FG001|Overall Study|IV problems, administration not possible|0|||
37647257|NCT02435992|69116483|FG003|Overall Study|Lack of Efficacy|0|||
37647258|NCT02435992|69116484|FG004|Overall Study|Lack of Efficacy|0|||
37647259|NCT02435992|69116480|FG000|Overall Study|Withdrawal by Subject|10|||
37647260|NCT02435992|69116481|FG001|Overall Study|Withdrawal by Subject|8|||
37647261|NCT02435992|69116482|FG002|Overall Study|Withdrawal by Subject|20|||
37647262|NCT02435992|69116483|FG003|Overall Study|Withdrawal by Subject|0|||
37647263|NCT02435992|69116484|FG004|Overall Study|Withdrawal by Subject|0|||
37647264|NCT02435992|69116480|FG000|Overall Study|Other Reason|1|||
37647265|NCT02435992|69116481|FG001|Overall Study|Other Reason|0|||
37647266|NCT02435992|69116482|FG002|Overall Study|Other Reason|0|||
37647267|NCT02435992|69116483|FG003|Overall Study|Other Reason|0|||
37647268|NCT02435992|69116484|FG004|Overall Study|Other Reason|0|||
37647269|NCT02435992|69116480|FG000|Overall Study|Physician Decision|0|||
37647270|NCT02435992|69116481|FG001|Overall Study|Physician Decision|0|||
37647271|NCT02435992|69116482|FG002|Overall Study|Physician Decision|1|||
37647272|NCT02435992|69116483|FG003|Overall Study|Physician Decision|0|||
37647273|NCT02435992|69116484|FG004|Overall Study|Physician Decision|0|||
37647274|NCT02788513|69116501|FG000|Overall Study|Withdrawal by Subject|3|||
37647275|NCT02788513|69116502|FG001|Overall Study|Withdrawal by Subject|0|||
37647276|NCT02788513|69116503|FG002|Overall Study|Withdrawal by Subject|2|||
37647277|NCT02788513|69116504|FG003|Overall Study|Withdrawal by Subject|3|||
37647278|NCT02788513|69116505|FG004|Overall Study|Withdrawal by Subject|1|||
37647279|NCT02788513|69116501|FG000|Overall Study|Lost to Follow-up|1|||
37647280|NCT02788513|69116502|FG001|Overall Study|Lost to Follow-up|0|||
37854953|NCT01296932|69538346|FG002|Overall Study|IV problems, administration not possible|1|||
37854954|NCT01296932|69538347|FG003|Overall Study|IV problems, administration not possible|0|||
37647281|NCT02788513|69116503|FG002|Overall Study|Lost to Follow-up|0|||
37647282|NCT02788513|69116504|FG003|Overall Study|Lost to Follow-up|0|||
37647283|NCT02788513|69116505|FG004|Overall Study|Lost to Follow-up|1|||
37647284|NCT02788513|69116501|FG000|Overall Study|Adverse Event|5|||
37647285|NCT02788513|69116502|FG001|Overall Study|Adverse Event|8|||
37922161|NCT00819234|69608955|FG006|Overall Study|Lost to Follow-up|1|||
37922162|NCT00819234|69608956|FG007|Overall Study|Lost to Follow-up|1|||
37922163|NCT00819234|69608957|FG008|Overall Study|Lost to Follow-up|1|||
37922164|NCT00819234|69608958|FG009|Overall Study|Lost to Follow-up|2|||
37922165|NCT00871403|69609016|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
37922166|NCT00871403|69609017|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
37922167|NCT00871403|69609018|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
37922168|NCT00871403|69609016|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
37922169|NCT00871403|69609017|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
37741151|NCT01396083|69227185|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
37741152|NCT01396083|69227186|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
37741153|NCT01396083|69227185|FG000|Overall Study|Consent withdrawn|4|||
37741154|NCT01396083|69227186|FG001|Overall Study|Consent withdrawn|5|||
37741155|NCT01396083|69227185|FG000|Overall Study|Protocol deviation(s)|0|||
37741156|NCT01396083|69227186|FG001|Overall Study|Protocol deviation(s)|1|||
37741157|NCT01396083|69227185|FG000|Overall Study|Abnormal laboratory value(s)|1|||
37854955|NCT01296932|69538348|FG004|Overall Study|IV problems, administration not possible|0|||
37854956|NCT01296932|69538349|FG005|Overall Study|IV problems, administration not possible|0|||
37854957|NCT01296932|69538350|FG006|Overall Study|IV problems, administration not possible|0|||
37922170|NCT00871403|69609018|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
37922171|NCT00871403|69609016|FG000|Combination Treatment Phase|Adverse Event|0|||
37922172|NCT00871403|69609017|FG001|Combination Treatment Phase|Adverse Event|17|||
37922173|NCT00871403|69609018|FG002|Combination Treatment Phase|Adverse Event|2|||
37854958|NCT01296932|69538351|FG007|Overall Study|IV problems, administration not possible|0|||
37922174|NCT00871403|69609016|FG000|Combination Treatment Phase|Disease Progression|0|||
37854959|NCT01296932|69538352|FG008|Overall Study|IV problems, administration not possible|0|||
37854960|NCT01296932|69538344|FG000|Overall Study|per protocol|0|||
37922175|NCT00871403|69609017|FG001|Combination Treatment Phase|Disease Progression|8|||
37922176|NCT00871403|69609018|FG002|Combination Treatment Phase|Disease Progression|5|||
37922177|NCT00871403|69609016|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
37922178|NCT00871403|69609017|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
37647286|NCT02788513|69116503|FG002|Overall Study|Adverse Event|4|||
37647287|NCT02788513|69116504|FG003|Overall Study|Adverse Event|2|||
37741158|NCT01396083|69227186|FG001|Overall Study|Abnormal laboratory value(s)|0|||
37922179|NCT00871403|69609018|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
37922180|NCT00871403|69609016|FG000|Combination Treatment Phase|Physician Decision|0|||
37922181|NCT00871403|69609017|FG001|Combination Treatment Phase|Physician Decision|1|||
37922182|NCT00871403|69609018|FG002|Combination Treatment Phase|Physician Decision|3|||
37647288|NCT02788513|69116505|FG004|Overall Study|Adverse Event|2|||
37647289|NCT02788513|69116501|FG000|Overall Study|Protocol Violation|0|||
37647290|NCT02788513|69116502|FG001|Overall Study|Protocol Violation|0|||
37647291|NCT02788513|69116503|FG002|Overall Study|Protocol Violation|1|||
37647292|NCT02788513|69116504|FG003|Overall Study|Protocol Violation|1|||
37647293|NCT02788513|69116505|FG004|Overall Study|Protocol Violation|0|||
37647294|NCT02788513|69116501|FG000|Overall Study|Subject decided to stop taking treatment|0|||
37647295|NCT02788513|69116502|FG001|Overall Study|Subject decided to stop taking treatment|0|||
37647296|NCT02788513|69116503|FG002|Overall Study|Subject decided to stop taking treatment|1|||
37647297|NCT02788513|69116504|FG003|Overall Study|Subject decided to stop taking treatment|0|||
37647298|NCT02788513|69116505|FG004|Overall Study|Subject decided to stop taking treatment|0|||
37647299|NCT02788513|69116501|FG000|Overall Study|Decision by the study team|0|||
37647300|NCT02788513|69116502|FG001|Overall Study|Decision by the study team|0|||
37647301|NCT02788513|69116503|FG002|Overall Study|Decision by the study team|0|||
37647302|NCT02788513|69116504|FG003|Overall Study|Decision by the study team|0|||
37647303|NCT02788513|69116505|FG004|Overall Study|Decision by the study team|1|||
37647304|NCT03077828|69116517|FG000|Treatment Cycles|Death|1|||
37647305|NCT03077828|69116517|FG000|Treatment Cycles|Withdrawal by Subject|1|||
37647306|NCT03077828|69116517|FG000|Treatment Cycles|Screen Fail|2|||
37647307|NCT03077828|69116517|FG000|Autologous Stem Cell Transplant|Adverse Event|1|||
37647308|NCT03077828|69116517|FG000|Autologous Stem Cell Transplant|Withdrawal by Subject|2|||
37647309|NCT03077828|69116517|FG000|Autologous Stem Cell Transplant|Physician Decision|1|||
37647310|NCT03077828|69116517|FG000|Follow-up|Patients still in follow-up|15|||
37647311|NCT02401672|69116523|FG000|Overall Study|Withdrawal by Subject|1|||
37647312|NCT02401672|69116524|FG001|Overall Study|Withdrawal by Subject|3|||
37647313|NCT02435914|69116534|FG000|Overall Study|Ocular Adverse Event|1|||
37647314|NCT02435914|69116535|FG001|Overall Study|Ocular Adverse Event|0|||
37647315|NCT02435914|69116536|FG002|Overall Study|Ocular Adverse Event|0|||
37647316|NCT02435914|69116537|FG003|Overall Study|Ocular Adverse Event|0|||
37647317|NCT02435914|69116534|FG000|Overall Study|Withdrawal by Subject|0|||
37854961|NCT01296932|69538345|FG001|Overall Study|per protocol|0|||
37854962|NCT01296932|69538346|FG002|Overall Study|per protocol|1|||
37854963|NCT01296932|69538347|FG003|Overall Study|per protocol|1|||
37854964|NCT01296932|69538348|FG004|Overall Study|per protocol|0|||
37854965|NCT01296932|69538349|FG005|Overall Study|per protocol|0|||
37854966|NCT01296932|69538350|FG006|Overall Study|per protocol|0|||
37854967|NCT01296932|69538351|FG007|Overall Study|per protocol|0|||
37854968|NCT01296932|69538352|FG008|Overall Study|per protocol|0|||
37854969|NCT01296932|69538344|FG000|Overall Study|Low benefit and too many side effects|0|||
37854970|NCT01296932|69538345|FG001|Overall Study|Low benefit and too many side effects|0|||
37854971|NCT01296932|69538346|FG002|Overall Study|Low benefit and too many side effects|0|||
37854972|NCT01296932|69538347|FG003|Overall Study|Low benefit and too many side effects|0|||
37854973|NCT01296932|69538348|FG004|Overall Study|Low benefit and too many side effects|0|||
37854974|NCT01296932|69538349|FG005|Overall Study|Low benefit and too many side effects|0|||
37647318|NCT02435914|69116535|FG001|Overall Study|Withdrawal by Subject|1|||
37647319|NCT02435914|69116536|FG002|Overall Study|Withdrawal by Subject|0|||
37647320|NCT02435914|69116537|FG003|Overall Study|Withdrawal by Subject|0|||
37647321|NCT02435914|69116534|FG000|Overall Study|Other Miscellaneous Reason|0|||
37647322|NCT02435914|69116535|FG001|Overall Study|Other Miscellaneous Reason|0|||
37647323|NCT02435914|69116536|FG002|Overall Study|Other Miscellaneous Reason|1|||
37647324|NCT02435914|69116537|FG003|Overall Study|Other Miscellaneous Reason|0|||
37647325|NCT02786953|69116549|FG000|Overall Study|Withdrawal by Subject|3|||
37647326|NCT02786953|69116550|FG001|Overall Study|Withdrawal by Subject|0|||
37647327|NCT02786953|69116549|FG000|Overall Study|Physician Decision|0|||
37647328|NCT02786953|69116550|FG001|Overall Study|Physician Decision|1|||
37647329|NCT02435836|69116556|FG000|Overall Study|Lost to Follow-up|21|||
37854975|NCT01296932|69538350|FG006|Overall Study|Low benefit and too many side effects|0|||
37647330|NCT02435836|69116556|FG000|Overall Study|Lack of Efficacy|1|||
37647331|NCT02435836|69116556|FG000|Overall Study|Withdrawal by Subject|236|||
37647332|NCT02435836|69116556|FG000|Overall Study|Insufficient Clinical Response|26|||
37647333|NCT02435836|69116556|FG000|Overall Study|Adverse Event|44|||
37647334|NCT02435836|69116556|FG000|Overall Study|Sponsor discontinued trial|167|||
37647335|NCT02435836|69116556|FG000|Overall Study|Noncompliance|27|||
37647336|NCT02435836|69116556|FG000|Overall Study|Protocol Violation|6|||
37647337|NCT02435836|69116556|FG000|Overall Study|Met Withdrawal Criteria|7|||
37647338|NCT02435836|69116556|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
37647339|NCT02788201|69116566|FG000|Overall Study|Death|1|||
37647340|NCT02788201|69116567|FG001|Overall Study|Death|1|||
37647341|NCT02788201|69116568|FG002|Overall Study|Death|1|||
37854976|NCT01296932|69538351|FG007|Overall Study|Low benefit and too many side effects|1|||
37922183|NCT00871403|69609016|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
37647342|NCT02788201|69116569|FG003|Overall Study|Death|1|||
37647343|NCT02788201|69116570|FG004|Overall Study|Death|0|||
37647344|NCT02788201|69116571|FG005|Overall Study|Death|1|||
37647345|NCT02788201|69116566|FG000|Overall Study|Ineligible|0|||
37647346|NCT02788201|69116567|FG001|Overall Study|Ineligible|0|||
37647347|NCT02788201|69116568|FG002|Overall Study|Ineligible|0|||
37647348|NCT02788201|69116569|FG003|Overall Study|Ineligible|0|||
37741159|NCT01396083|69227185|FG000|Overall Study|Administrative problems|1|||
37741160|NCT01396083|69227186|FG001|Overall Study|Administrative problems|0|||
37741161|NCT01396083|69227185|FG000|Overall Study|Lost to Follow-up|1|||
37854977|NCT01296932|69538352|FG008|Overall Study|Low benefit and too many side effects|0|||
37854978|NCT01296932|69538344|FG000|Overall Study|No adequate treatment response|0|||
37854979|NCT01296932|69538345|FG001|Overall Study|No adequate treatment response|0|||
37854980|NCT01296932|69538346|FG002|Overall Study|No adequate treatment response|0|||
37854981|NCT01296932|69538347|FG003|Overall Study|No adequate treatment response|0|||
37854982|NCT01296932|69538348|FG004|Overall Study|No adequate treatment response|0|||
37854983|NCT01296932|69538349|FG005|Overall Study|No adequate treatment response|0|||
37854984|NCT01296932|69538350|FG006|Overall Study|No adequate treatment response|0|||
38032269|NCT03345836|69718186|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
38032270|NCT03345836|69718187|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
38032271|NCT03345836|69718188|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
38032272|NCT03345836|69718189|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
38032273|NCT03345836|69718190|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
38032274|NCT03345836|69718191|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
37741162|NCT01396083|69227186|FG001|Overall Study|Lost to Follow-up|0|||
37741163|NCT01723826|69227196|FG000|Overall Study|Adverse Event|4|||
37741164|NCT01723826|69227197|FG001|Overall Study|Adverse Event|1|||
37741165|NCT01723826|69227198|FG002|Overall Study|Adverse Event|4|||
37741166|NCT01723826|69227199|FG003|Overall Study|Adverse Event|5|||
37741167|NCT01723826|69227196|FG000|Overall Study|Death according to AE eCRF|2|||
37741168|NCT01723826|69227197|FG001|Overall Study|Death according to AE eCRF|3|||
37741169|NCT01723826|69227198|FG002|Overall Study|Death according to AE eCRF|3|||
37741170|NCT01723826|69227199|FG003|Overall Study|Death according to AE eCRF|7|||
37741171|NCT01723826|69227196|FG000|Overall Study|Lost to Follow-up|1|||
37741172|NCT01723826|69227197|FG001|Overall Study|Lost to Follow-up|3|||
37741173|NCT01723826|69227198|FG002|Overall Study|Lost to Follow-up|1|||
37741174|NCT01723826|69227199|FG003|Overall Study|Lost to Follow-up|1|||
37741175|NCT01723826|69227196|FG000|Overall Study|Non-compliance|0|||
37741176|NCT01723826|69227197|FG001|Overall Study|Non-compliance|1|||
37741177|NCT01723826|69227198|FG002|Overall Study|Non-compliance|3|||
37741178|NCT01723826|69227199|FG003|Overall Study|Non-compliance|3|||
37741179|NCT01723826|69227196|FG000|Overall Study|Non-compliance With Study Drug|0|||
37741180|NCT01723826|69227197|FG001|Overall Study|Non-compliance With Study Drug|1|||
37741181|NCT01723826|69227198|FG002|Overall Study|Non-compliance With Study Drug|0|||
37741182|NCT01723826|69227199|FG003|Overall Study|Non-compliance With Study Drug|0|||
37741183|NCT01723826|69227196|FG000|Overall Study|Other Reason|8|||
37741184|NCT01723826|69227197|FG001|Overall Study|Other Reason|6|||
37741185|NCT01723826|69227198|FG002|Overall Study|Other Reason|12|||
37741186|NCT01723826|69227199|FG003|Overall Study|Other Reason|14|||
37741187|NCT01723826|69227196|FG000|Overall Study|Physician Decision|1|||
37741188|NCT01723826|69227197|FG001|Overall Study|Physician Decision|3|||
37741189|NCT01723826|69227198|FG002|Overall Study|Physician Decision|4|||
37741190|NCT01723826|69227199|FG003|Overall Study|Physician Decision|11|||
37741191|NCT01723826|69227196|FG000|Overall Study|Protocol Violation|1|||
37741192|NCT01723826|69227197|FG001|Overall Study|Protocol Violation|1|||
37741193|NCT01723826|69227198|FG002|Overall Study|Protocol Violation|3|||
37741194|NCT01723826|69227199|FG003|Overall Study|Protocol Violation|1|||
37741195|NCT01723826|69227196|FG000|Overall Study|Withdrawal by Subject|10|||
37741196|NCT01723826|69227197|FG001|Overall Study|Withdrawal by Subject|17|||
37741197|NCT01723826|69227198|FG002|Overall Study|Withdrawal by Subject|27|||
37741198|NCT01723826|69227199|FG003|Overall Study|Withdrawal by Subject|48|||
38032275|NCT03345836|69718186|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
38032276|NCT03345836|69718187|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
37647349|NCT02788201|69116570|FG004|Overall Study|Ineligible|0|||
37741199|NCT01721954|69227211|FG000|Overall Study|Death|58|||
37741200|NCT01721954|69227212|FG001|Overall Study|Death|64|||
37647350|NCT02788201|69116571|FG005|Overall Study|Ineligible|1|||
37647351|NCT02788201|69116566|FG000|Overall Study|Withdrawal by Subject|0|||
37647352|NCT02788201|69116567|FG001|Overall Study|Withdrawal by Subject|0|||
37647353|NCT02788201|69116568|FG002|Overall Study|Withdrawal by Subject|0|||
37741201|NCT01721954|69227211|FG000|Overall Study|Withdrawal by Subject|8|||
37741202|NCT01721954|69227212|FG001|Overall Study|Withdrawal by Subject|4|||
37741203|NCT01721954|69227211|FG000|Overall Study|Adverse Event|2|||
37741204|NCT01721954|69227212|FG001|Overall Study|Adverse Event|0|||
37854985|NCT01296932|69538351|FG007|Overall Study|No adequate treatment response|1|||
37854986|NCT01296932|69538352|FG008|Overall Study|No adequate treatment response|0|||
37647354|NCT02788201|69116569|FG003|Overall Study|Withdrawal by Subject|0|||
37647355|NCT02788201|69116570|FG004|Overall Study|Withdrawal by Subject|0|||
37647356|NCT02788201|69116571|FG005|Overall Study|Withdrawal by Subject|1|||
37647357|NCT02456740|69116590|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
37647358|NCT02456740|69116591|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
37647359|NCT02456740|69116592|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
37647360|NCT02456740|69116593|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
37647361|NCT02456740|69116594|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
37647362|NCT02456740|69116595|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
37647363|NCT02456740|69116596|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
37647364|NCT02456740|69116597|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
37647365|NCT02456740|69116598|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
37647366|NCT02456740|69116590|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
37647367|NCT02456740|69116591|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
37647368|NCT02456740|69116592|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
37741205|NCT01721954|69227211|FG000|Overall Study|Lost to Follow-up|2|||
37741206|NCT01721954|69227212|FG001|Overall Study|Lost to Follow-up|1|||
37741207|NCT01776554|69227220|FG000|Overall Study|Adverse Event|1|||
37741208|NCT01776554|69227221|FG001|Overall Study|Adverse Event|0|||
37741209|NCT01776554|69227220|FG000|Overall Study|Withdrawal by Subject|3|||
37741210|NCT01776554|69227221|FG001|Overall Study|Withdrawal by Subject|8|||
37741211|NCT01776554|69227220|FG000|Overall Study|Lost to Follow-up|6|||
37741212|NCT01776554|69227221|FG001|Overall Study|Lost to Follow-up|9|||
37741213|NCT01776554|69227220|FG000|Overall Study|Administrative Reason|2|||
37741214|NCT01776554|69227221|FG001|Overall Study|Administrative Reason|5|||
37741215|NCT01776554|69227220|FG000|Overall Study|Protocol Violation|1|||
37741216|NCT01776554|69227221|FG001|Overall Study|Protocol Violation|0|||
37741217|NCT01776554|69227220|FG000|Overall Study|Unclassified|4|||
37741218|NCT01776554|69227221|FG001|Overall Study|Unclassified|1|||
37741219|NCT01776008|69227228|FG000|Overall Study|ineligible|2|||
37741220|NCT01746368|69227234|FG000|Overall Study|Lost to Follow-up|2|||
37741221|NCT01746368|69227235|FG001|Overall Study|Lost to Follow-up|0|||
37741222|NCT01746368|69227234|FG000|Overall Study|Withdrawal by Subject|0|||
37741223|NCT01746368|69227235|FG001|Overall Study|Withdrawal by Subject|1|||
37741224|NCT01381575|69227244|FG000|Overall Study|Serious Adverse Event|1|||
37741225|NCT01381575|69227245|FG001|Overall Study|Serious Adverse Event|0|||
37741226|NCT01381575|69227246|FG002|Overall Study|Serious Adverse Event|0|||
37741227|NCT01381575|69227244|FG000|Overall Study|Non-Serious Adverse Event|0|||
37741228|NCT01381575|69227245|FG001|Overall Study|Non-Serious Adverse Event|0|||
37741229|NCT01381575|69227246|FG002|Overall Study|Non-Serious Adverse Event|1|||
37741230|NCT01381575|69227244|FG000|Overall Study|Protocol Violation|0|||
37741231|NCT01381575|69227245|FG001|Overall Study|Protocol Violation|1|||
37741232|NCT01381575|69227246|FG002|Overall Study|Protocol Violation|1|||
37741233|NCT01381575|69227244|FG000|Overall Study|Withdrawal by Subject|15|||
37741234|NCT01381575|69227245|FG001|Overall Study|Withdrawal by Subject|9|||
37741235|NCT01381575|69227246|FG002|Overall Study|Withdrawal by Subject|7|||
37741236|NCT01381575|69227244|FG000|Overall Study|Migrated/moved from study area|2|||
37741237|NCT01381575|69227245|FG001|Overall Study|Migrated/moved from study area|12|||
37741238|NCT01381575|69227246|FG002|Overall Study|Migrated/moved from study area|2|||
37741239|NCT01381575|69227244|FG000|Overall Study|Lost to Follow-up|8|||
37741240|NCT01381575|69227245|FG001|Overall Study|Lost to Follow-up|17|||
37741241|NCT01381575|69227246|FG002|Overall Study|Lost to Follow-up|9|||
37741242|NCT01858363|69227257|FG000|Overall Study|Death|35|||
37741243|NCT01858363|69227258|FG001|Overall Study|Death|9|||
37741244|NCT01858363|69227257|FG000|Overall Study|Withdrawal by Subject|28|||
37741245|NCT01858363|69227258|FG001|Overall Study|Withdrawal by Subject|14|||
37741246|NCT01858363|69227257|FG000|Overall Study|Lost to Follow-up|13|||
37741247|NCT01858363|69227258|FG001|Overall Study|Lost to Follow-up|3|||
37741248|NCT01877551|69227266|FG000|Overall Study|Physician Decision|0|||
37741249|NCT01877551|69227267|FG001|Overall Study|Physician Decision|1|||
37741250|NCT01396005|69227275|FG000|Overall Study|Withdrawal by Subject|0|||
37741251|NCT01396005|69227276|FG001|Overall Study|Withdrawal by Subject|1|||
37741252|NCT01396005|69227275|FG000|Overall Study|Non-compliance with protocol|0|||
37741253|NCT01396005|69227276|FG001|Overall Study|Non-compliance with protocol|1|||
37741254|NCT01877239|69227284|FG000|Overall Study|Adverse Event|4|||
37741255|NCT01877239|69227284|FG000|Overall Study|Disease Remission|1|||
37741256|NCT01877239|69227284|FG000|Overall Study|Withdrawal by Subject|4|||
37922184|NCT00871403|69609017|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
37922185|NCT00871403|69609018|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
37922186|NCT00871403|69609016|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
37741257|NCT01877239|69227284|FG000|Overall Study|Other|2|||
37741258|NCT01877239|69227284|FG000|Overall Study|Lack of Efficacy|4|||
37741259|NCT01877239|69227284|FG000|Overall Study|Data not available|35|||
37741260|NCT01877083|69227288|FG000|Treatment Phase|Disease Progression|10|||
37647369|NCT02456740|69116593|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
37647370|NCT02456740|69116594|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
37647371|NCT02456740|69116595|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
37647372|NCT02456740|69116596|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
37647373|NCT02456740|69116597|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
37647374|NCT02456740|69116598|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
37647375|NCT02456740|69116590|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
37741261|NCT01877083|69227288|FG000|Treatment Phase|Clinical Progression|1|||
37741262|NCT01877083|69227288|FG000|Treatment Phase|Adverse Event|6|||
37741263|NCT01877083|69227288|FG000|Treatment Phase|Withdrawal by Subject|2|||
37741264|NCT01877083|69227288|FG000|Treatment Phase|Lost to Follow-up|1|||
37741265|NCT01877083|69227288|FG000|Extension Phase|Disease Progression|3|||
37741266|NCT01877083|69227288|FG000|Extension Phase|Adverse Event|2|||
37741267|NCT01380327|69227295|FG000|Overall Study|Lost to Follow-up|0|||
37741268|NCT01380327|69227296|FG001|Overall Study|Lost to Follow-up|1|||
37741269|NCT01380327|69227297|FG002|Overall Study|Lost to Follow-up|1|||
37741270|NCT01380327|69227295|FG000|Overall Study|Protocol Violation|3|||
37741271|NCT01380327|69227296|FG001|Overall Study|Protocol Violation|2|||
37741272|NCT01380327|69227297|FG002|Overall Study|Protocol Violation|3|||
37741273|NCT01380327|69227295|FG000|Overall Study|Withdrawal by Subject|0|||
37741274|NCT01380327|69227296|FG001|Overall Study|Withdrawal by Subject|0|||
37741275|NCT01380327|69227297|FG002|Overall Study|Withdrawal by Subject|1|||
37741276|NCT01380327|69227295|FG000|Overall Study|Housing situation precluded ability to k|0|||
37854987|NCT01296932|69538344|FG000|Overall Study|Dosage already reduced, AE still present|0|||
37854988|NCT01296932|69538345|FG001|Overall Study|Dosage already reduced, AE still present|0|||
37854989|NCT01296932|69538346|FG002|Overall Study|Dosage already reduced, AE still present|0|||
37854990|NCT01296932|69538347|FG003|Overall Study|Dosage already reduced, AE still present|0|||
37854991|NCT01296932|69538348|FG004|Overall Study|Dosage already reduced, AE still present|0|||
37854992|NCT01296932|69538349|FG005|Overall Study|Dosage already reduced, AE still present|0|||
37854993|NCT01296932|69538350|FG006|Overall Study|Dosage already reduced, AE still present|0|||
37854994|NCT01296932|69538351|FG007|Overall Study|Dosage already reduced, AE still present|0|||
37854995|NCT01296932|69538352|FG008|Overall Study|Dosage already reduced, AE still present|1|||
37854996|NCT01296698|69538375|FG000|Overall Study|Adverse Event|1|||
37647376|NCT02456740|69116591|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
37647377|NCT02456740|69116592|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
37647378|NCT02456740|69116593|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
37647379|NCT02456740|69116594|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
37647380|NCT02456740|69116595|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
37647381|NCT02456740|69116596|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
37647382|NCT02456740|69116597|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
37647383|NCT02456740|69116598|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
37647384|NCT02456740|69116590|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
37647385|NCT02456740|69116591|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
37647386|NCT02456740|69116592|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
37647387|NCT02456740|69116593|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
37647388|NCT02456740|69116594|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
37647389|NCT02456740|69116595|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
37647390|NCT02456740|69116596|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
37647391|NCT02456740|69116597|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
37741277|NCT01380327|69227296|FG001|Overall Study|Housing situation precluded ability to k|0|||
37741278|NCT01380327|69227297|FG002|Overall Study|Housing situation precluded ability to k|1|||
37741279|NCT01380327|69227295|FG000|Overall Study|Questionable onset of epilepsy|0|||
37741280|NCT01380327|69227296|FG001|Overall Study|Questionable onset of epilepsy|0|||
37741281|NCT01380327|69227297|FG002|Overall Study|Questionable onset of epilepsy|1|||
37741282|NCT01829425|69227307|FG000|Overall Study|Withdrawal by Subject|4|||
37741283|NCT01829425|69227308|FG001|Overall Study|Withdrawal by Subject|3|||
37741284|NCT01829425|69227307|FG000|Overall Study|Lost to Follow-up|2|||
37741285|NCT01829425|69227308|FG001|Overall Study|Lost to Follow-up|1|||
37741286|NCT01394991|69227325|FG000|Overall Study|Adverse Event|0|||
37741287|NCT01394991|69227326|FG001|Overall Study|Adverse Event|4|||
37854997|NCT01296698|69538376|FG001|Overall Study|Adverse Event|0|||
37922187|NCT00871403|69609017|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
37922188|NCT00871403|69609018|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
37741288|NCT01394991|69227325|FG000|Overall Study|Lack of Efficacy|5|||
37741289|NCT01394991|69227326|FG001|Overall Study|Lack of Efficacy|7|||
37741290|NCT01394991|69227325|FG000|Overall Study|Lost to Follow-up|6|||
37741291|NCT01394991|69227326|FG001|Overall Study|Lost to Follow-up|8|||
37741292|NCT01394991|69227325|FG000|Overall Study|Physician Decision|1|||
37854998|NCT01296698|69538375|FG000|Overall Study|Death|1|||
37647392|NCT02456740|69116598|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
37647393|NCT02456740|69116590|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
37647394|NCT02456740|69116591|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
37647395|NCT02456740|69116592|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
37647396|NCT02456740|69116593|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
37647397|NCT02456740|69116594|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
37647398|NCT02456740|69116595|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
37647399|NCT02456740|69116596|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
37647400|NCT02456740|69116597|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
37647401|NCT02456740|69116598|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
37647402|NCT02456740|69116590|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
37647403|NCT02456740|69116591|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
37647404|NCT02456740|69116592|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
37647405|NCT02456740|69116593|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
37647406|NCT02456740|69116594|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
37647407|NCT02456740|69116595|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
37647408|NCT02456740|69116596|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
37647409|NCT02456740|69116597|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
37647410|NCT02456740|69116598|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
37647411|NCT02456740|69116590|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
37647412|NCT02456740|69116591|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
37647413|NCT02456740|69116592|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
37647414|NCT02456740|69116593|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
37647415|NCT02456740|69116594|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
37647416|NCT02456740|69116595|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
37647417|NCT02456740|69116596|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
37647418|NCT02456740|69116597|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
37647419|NCT02456740|69116598|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
37647420|NCT02400580|69116610|FG000|Overall Study|Withdrawal by Subject|1|||
37647421|NCT02400580|69116611|FG001|Overall Study|Withdrawal by Subject|1|||
37647422|NCT02400580|69116610|FG000|Overall Study|Adverse Event|1|||
37647423|NCT02400580|69116611|FG001|Overall Study|Adverse Event|0|||
37647424|NCT01367119|69116619|FG000|Overall Study|Adverse Event|1|||
37647425|NCT01367119|69116620|FG001|Overall Study|Adverse Event|0|||
37647426|NCT01367119|69116619|FG000|Overall Study|Withdrawal by Subject|1|||
37647427|NCT01367119|69116620|FG001|Overall Study|Withdrawal by Subject|1|||
37647428|NCT02635724|69116629|FG000|Overall Study|Withdrawal by Subject|0|||
37647429|NCT02635724|69116630|FG001|Overall Study|Withdrawal by Subject|1|||
37647430|NCT02635724|69116631|FG002|Overall Study|Withdrawal by Subject|0|||
37647431|NCT02635646|69116641|FG000|Overall Study|Lost to Follow-up|24|||
37647432|NCT02635646|69116642|FG001|Overall Study|Lost to Follow-up|25|||
37647433|NCT02635646|69116641|FG000|Overall Study|Pregnancy|1|||
37647434|NCT02635646|69116642|FG001|Overall Study|Pregnancy|1|||
37647435|NCT02634788|69116658|FG000|Overall Study|Adverse Event|0|||
37647436|NCT02634788|69116659|FG001|Overall Study|Adverse Event|8|||
37647437|NCT02634788|69116660|FG002|Overall Study|Adverse Event|3|||
37647438|NCT02634788|69116661|FG003|Overall Study|Adverse Event|1|||
37647439|NCT02634788|69116658|FG000|Overall Study|Lack of Efficacy|4|||
37647440|NCT02634788|69116659|FG001|Overall Study|Lack of Efficacy|0|||
37647441|NCT02634788|69116660|FG002|Overall Study|Lack of Efficacy|1|||
37647442|NCT02634788|69116661|FG003|Overall Study|Lack of Efficacy|4|||
37647443|NCT02634788|69116658|FG000|Overall Study|Lost to Follow-up|0|||
37647444|NCT02634788|69116659|FG001|Overall Study|Lost to Follow-up|1|||
37647445|NCT02634788|69116660|FG002|Overall Study|Lost to Follow-up|0|||
37647446|NCT02634788|69116661|FG003|Overall Study|Lost to Follow-up|0|||
37647447|NCT02634788|69116658|FG000|Overall Study|Withdrawal by Subject|0|||
37647448|NCT02634788|69116659|FG001|Overall Study|Withdrawal by Subject|1|||
37647449|NCT02634788|69116660|FG002|Overall Study|Withdrawal by Subject|1|||
37647450|NCT02634788|69116661|FG003|Overall Study|Withdrawal by Subject|0|||
37647451|NCT02785939|69116673|FG000|Overall Study|Progression|25|||
37647452|NCT02785939|69116674|FG001|Overall Study|Progression|8|||
37647453|NCT02785939|69116673|FG000|Overall Study|Adverse Event|3|||
37647454|NCT02785939|69116674|FG001|Overall Study|Adverse Event|1|||
37741293|NCT01394991|69227326|FG001|Overall Study|Physician Decision|3|||
37741294|NCT01394991|69227325|FG000|Overall Study|Protocol Violation|1|||
37647455|NCT02785939|69116673|FG000|Overall Study|Death|1|||
37647456|NCT02785939|69116674|FG001|Overall Study|Death|0|||
37741295|NCT01394991|69227326|FG001|Overall Study|Protocol Violation|1|||
37647457|NCT02785939|69116673|FG000|Overall Study|Refusal|1|||
37647458|NCT02785939|69116674|FG001|Overall Study|Refusal|0|||
37647459|NCT02785939|69116673|FG000|Overall Study|Deteriorating health|1|||
37647460|NCT02785939|69116674|FG001|Overall Study|Deteriorating health|0|||
37741296|NCT01394991|69227325|FG000|Overall Study|Withdrawal by Subject|20|||
37647461|NCT02785939|69116673|FG000|Overall Study|Not protocol specified|0|||
37647462|NCT02785939|69116674|FG001|Overall Study|Not protocol specified|1|||
37647463|NCT02634320|69116688|FG000|Overall Study|Adverse Event|2|||
37647464|NCT02634320|69116688|FG000|Overall Study|Lost to Follow-up|3|||
37647465|NCT02634320|69116688|FG000|Overall Study|Moved out of area|2|||
37647466|NCT02634320|69116688|FG000|Overall Study|Out of window for study visits|1|||
37647467|NCT02634320|69116688|FG000|Overall Study|Protocol Violation|1|||
37647468|NCT02634320|69116688|FG000|Overall Study|Withdrawal by Subject|5|||
37647469|NCT02634320|69116688|FG000|Overall Study|Lack of Efficacy|2|||
37647470|NCT02435680|69116695|FG000|Overall Study|Physician Decision|3|||
37647471|NCT02435680|69116696|FG001|Overall Study|Physician Decision|0|||
37647472|NCT02435680|69116697|FG002|Overall Study|Physician Decision|0|||
37647473|NCT02435680|69116695|FG000|Overall Study|subject / guardian decision|0|||
37647474|NCT02435680|69116696|FG001|Overall Study|subject / guardian decision|3|||
37647475|NCT02435680|69116697|FG002|Overall Study|subject / guardian decision|2|||
37647476|NCT02435680|69116695|FG000|Overall Study|Adverse Event|8|||
37647477|NCT02435680|69116696|FG001|Overall Study|Adverse Event|3|||
37647478|NCT02435680|69116697|FG002|Overall Study|Adverse Event|2|||
37647479|NCT02435680|69116695|FG000|Overall Study|progressive disease|10|||
37647480|NCT02435680|69116696|FG001|Overall Study|progressive disease|7|||
37647481|NCT02435680|69116697|FG002|Overall Study|progressive disease|11|||
37647482|NCT02435680|69116695|FG000|Overall Study|not treated|0|||
37647483|NCT02435680|69116696|FG001|Overall Study|not treated|0|||
37647484|NCT02435680|69116697|FG002|Overall Study|not treated|1|||
37647485|NCT03371732|69116711|FG000|Overall Study|Withdrawal by Subject|9|||
37647486|NCT03371732|69116712|FG001|Overall Study|Withdrawal by Subject|3|||
37647487|NCT03371732|69116711|FG000|Overall Study|Refusal to continue|3|||
37647488|NCT03371732|69116712|FG001|Overall Study|Refusal to continue|4|||
37647489|NCT02745119|69116724|FG000|Overall Study|Adverse Event|1|||
37647490|NCT02745119|69116725|FG001|Overall Study|Adverse Event|0|||
37647491|NCT02745119|69116726|FG002|Overall Study|Adverse Event|1|||
37647492|NCT02745119|69116727|FG003|Overall Study|Adverse Event|3|||
37647493|NCT02745119|69116724|FG000|Overall Study|Death|3|||
37647494|NCT02745119|69116725|FG001|Overall Study|Death|3|||
37647495|NCT02745119|69116726|FG002|Overall Study|Death|0|||
37647496|NCT02745119|69116727|FG003|Overall Study|Death|4|||
37647497|NCT02745119|69116724|FG000|Overall Study|Lost to Follow-up|0|||
37647498|NCT02745119|69116725|FG001|Overall Study|Lost to Follow-up|0|||
37647499|NCT02745119|69116726|FG002|Overall Study|Lost to Follow-up|0|||
37647500|NCT02745119|69116727|FG003|Overall Study|Lost to Follow-up|1|||
37647501|NCT02745119|69116724|FG000|Overall Study|Protocol Deviation|0|||
37647502|NCT02745119|69116725|FG001|Overall Study|Protocol Deviation|0|||
37647503|NCT02745119|69116726|FG002|Overall Study|Protocol Deviation|0|||
37647504|NCT02745119|69116727|FG003|Overall Study|Protocol Deviation|1|||
37647505|NCT02745119|69116724|FG000|Overall Study|Withdrawal by Subject|7|||
37647506|NCT02745119|69116725|FG001|Overall Study|Withdrawal by Subject|15|||
37647507|NCT02745119|69116726|FG002|Overall Study|Withdrawal by Subject|8|||
37647508|NCT02745119|69116727|FG003|Overall Study|Withdrawal by Subject|14|||
37647509|NCT02745119|69116724|FG000|Overall Study|Study Terminated by Sponsor|134|||
37647510|NCT02745119|69116725|FG001|Overall Study|Study Terminated by Sponsor|252|||
37647511|NCT02745119|69116726|FG002|Overall Study|Study Terminated by Sponsor|135|||
37647512|NCT02745119|69116727|FG003|Overall Study|Study Terminated by Sponsor|251|||
37647513|NCT02745119|69116724|FG000|Overall Study|Physician Decision|0|||
37647514|NCT02745119|69116725|FG001|Overall Study|Physician Decision|2|||
37647515|NCT02745119|69116726|FG002|Overall Study|Physician Decision|2|||
37647516|NCT02745119|69116727|FG003|Overall Study|Physician Decision|2|||
37647517|NCT02745119|69116724|FG000|Overall Study|Reason Not Specified|0|||
37647518|NCT02745119|69116725|FG001|Overall Study|Reason Not Specified|2|||
37647519|NCT02745119|69116726|FG002|Overall Study|Reason Not Specified|0|||
37647520|NCT02745119|69116727|FG003|Overall Study|Reason Not Specified|1|||
37647521|NCT01367665|69116741|FG000|Overall Study|Death|102|||
37647522|NCT01367665|69116742|FG001|Overall Study|Death|19|||
37647523|NCT01367665|69116741|FG000|Overall Study|Lost to Follow-up|222|||
37647524|NCT01367665|69116742|FG001|Overall Study|Lost to Follow-up|22|||
37647525|NCT01367665|69116741|FG000|Overall Study|Not Done|118|||
37647526|NCT01367665|69116742|FG001|Overall Study|Not Done|14|||
37647527|NCT02576847|69116749|FG000|Overall Study|Adverse Event|27|||
37922189|NCT00853112|69609032|FG000|Overall Study|Randomized but not treated|0|||
37647528|NCT02576847|69116749|FG000|Overall Study|Lost to Follow-up|22|||
37647529|NCT02576847|69116749|FG000|Overall Study|Physician Decision|1|||
37647530|NCT02576847|69116749|FG000|Overall Study|Pregnancy|1|||
37647531|NCT02576847|69116749|FG000|Overall Study|Protocol Violation|3|||
37647532|NCT02576847|69116749|FG000|Overall Study|Withdrawal by Subject|78|||
37647533|NCT02576847|69116749|FG000|Overall Study|Other|5|||
37647534|NCT02135029|69116765|FG000|Overall Study|Adverse Event|2|||
37647535|NCT02135029|69116766|FG001|Overall Study|Adverse Event|2|||
37647536|NCT02135029|69116767|FG002|Overall Study|Adverse Event|2|||
37647537|NCT02135029|69116765|FG000|Overall Study|Lost to Follow-up|0|||
37647538|NCT02135029|69116766|FG001|Overall Study|Lost to Follow-up|1|||
37647539|NCT02135029|69116767|FG002|Overall Study|Lost to Follow-up|0|||
37647540|NCT02135029|69116765|FG000|Overall Study|Withdrawal by Subject|2|||
37647541|NCT02135029|69116766|FG001|Overall Study|Withdrawal by Subject|0|||
37647542|NCT02135029|69116767|FG002|Overall Study|Withdrawal by Subject|1|||
37647543|NCT02135029|69116765|FG000|Overall Study|Other|0|||
37647544|NCT02135029|69116766|FG001|Overall Study|Other|1|||
37647545|NCT02135029|69116767|FG002|Overall Study|Other|0|||
37647546|NCT02135029|69116765|FG000|Overall Study|Death|0|||
37647547|NCT02135029|69116766|FG001|Overall Study|Death|1|||
37647548|NCT02135029|69116767|FG002|Overall Study|Death|0|||
37647549|NCT02842151|69116776|FG000|Overall Study|Adverse Event|1|||
37647550|NCT02842151|69116776|FG000|Overall Study|Subject moved too far away|1|||
37647551|NCT02842073|69116782|FG000|Overall Study|Withdrawal by Subject|1|||
37647552|NCT01367275|69116786|FG000|Overall Study|Ineligible|1|||
37647553|NCT01367275|69116786|FG000|Overall Study|Disease Progression|2|||
37647554|NCT02842853|69116794|FG000|Overall Study|Non-compliance with the protocol|3|||
37647555|NCT02842853|69116795|FG001|Overall Study|Non-compliance with the protocol|7|||
37647556|NCT02842853|69116796|FG002|Overall Study|Non-compliance with the protocol|2|||
37647557|NCT02842853|69116797|FG003|Overall Study|Non-compliance with the protocol|5|||
37647558|NCT02842853|69116794|FG000|Overall Study|Subject met exclusion criteria|0|||
37647559|NCT02842853|69116795|FG001|Overall Study|Subject met exclusion criteria|1|||
37922190|NCT00853112|69609033|FG001|Overall Study|Randomized but not treated|1|||
37922191|NCT00853112|69609034|FG002|Overall Study|Randomized but not treated|0|||
37922192|NCT00853112|69609035|FG003|Overall Study|Randomized but not treated|2|||
37922193|NCT00853112|69609036|FG004|Overall Study|Randomized but not treated|0|||
37922194|NCT00853112|69609037|FG005|Overall Study|Randomized but not treated|0|||
37922195|NCT00853112|69609038|FG006|Overall Study|Randomized but not treated|1|||
37922196|NCT00460603|69609066|FG000|Phase 1|Death|1|||
37922197|NCT00460603|69609067|FG001|Phase 1|Death|0|||
37922198|NCT00460603|69609068|FG002|Phase 1|Death|0|||
38032277|NCT03345836|69718188|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
37647560|NCT02842853|69116796|FG002|Overall Study|Subject met exclusion criteria|0|||
37647561|NCT02842853|69116797|FG003|Overall Study|Subject met exclusion criteria|0|||
37647562|NCT02842853|69116794|FG000|Overall Study|Withdrawal by Subject|11|||
37647563|NCT02842853|69116795|FG001|Overall Study|Withdrawal by Subject|13|||
37647564|NCT02842853|69116796|FG002|Overall Study|Withdrawal by Subject|9|||
37647565|NCT02842853|69116797|FG003|Overall Study|Withdrawal by Subject|8|||
37647566|NCT02842853|69116794|FG000|Overall Study|Lost to Follow-up|9|||
37647567|NCT02842853|69116795|FG001|Overall Study|Lost to Follow-up|13|||
37647568|NCT02842853|69116796|FG002|Overall Study|Lost to Follow-up|10|||
37647569|NCT02842853|69116797|FG003|Overall Study|Lost to Follow-up|11|||
37647570|NCT02433340|69116813|FG000|Overall Study|Adverse Event|0|||
37647571|NCT02433340|69116814|FG001|Overall Study|Adverse Event|0|||
37647572|NCT02433340|69116815|FG002|Overall Study|Adverse Event|1|||
37647573|NCT02433340|69116816|FG003|Overall Study|Adverse Event|0|||
37647574|NCT02433340|69116813|FG000|Overall Study|Withdrawal by Subject|1|||
37647575|NCT02433340|69116814|FG001|Overall Study|Withdrawal by Subject|0|||
37647576|NCT02433340|69116815|FG002|Overall Study|Withdrawal by Subject|1|||
37647577|NCT02433340|69116816|FG003|Overall Study|Withdrawal by Subject|2|||
37647578|NCT02433340|69116813|FG000|Overall Study|Lost to Follow-up|0|||
37647579|NCT02433340|69116814|FG001|Overall Study|Lost to Follow-up|1|||
37647580|NCT02433340|69116815|FG002|Overall Study|Lost to Follow-up|0|||
37647581|NCT02433340|69116816|FG003|Overall Study|Lost to Follow-up|0|||
37647582|NCT02433340|69116813|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
37647583|NCT02433340|69116814|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
37647584|NCT02433340|69116815|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
37647585|NCT02433340|69116816|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
37647586|NCT02433340|69116813|FG000|Overall Study|Other|0|||
37647587|NCT02433340|69116814|FG001|Overall Study|Other|1|||
37647588|NCT02433340|69116815|FG002|Overall Study|Other|0|||
37647589|NCT02433340|69116816|FG003|Overall Study|Other|0|||
37647590|NCT02400346|69116828|FG000|Overall Study|Adverse Event|24|||
37647591|NCT02400346|69116828|FG000|Overall Study|Lack of Efficacy|9|||
37647592|NCT02400346|69116828|FG000|Overall Study|Non-compliance with IMP|1|||
37647593|NCT02400346|69116828|FG000|Overall Study|Withdrawal by Subject|7|||
38032278|NCT03345836|69718189|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
38032279|NCT03345836|69718190|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
37647594|NCT02400346|69116828|FG000|Overall Study|Administrative or other reason(s)|2|||
37647595|NCT02400346|69116828|FG000|Overall Study|Lost to Follow-up|1|||
37647596|NCT02399254|69116832|FG000|Overall Study|Physician Decision|2|||
37647597|NCT02456662|69116839|FG000|Overall Study|Lost to Follow-up|2|||
37647598|NCT02456662|69116840|FG001|Overall Study|Lost to Follow-up|1|||
37741297|NCT01394991|69227326|FG001|Overall Study|Withdrawal by Subject|17|||
37741298|NCT01394991|69227325|FG000|Overall Study|Chemotherapy Termination|10|||
37647599|NCT01653262|69116846|FG000|Overall Study|Lack of Efficacy|1|||
37647600|NCT01653262|69116846|FG000|Overall Study|SAE, non-fatal|1|||
37922199|NCT00460603|69609069|FG003|Phase 1|Death|2|||
37647601|NCT01653262|69116846|FG000|Overall Study|AE, non-serious non-fatal|1|||
37647602|NCT02455336|69116852|FG000|Overall Study|Withdrawal by Subject|0|||
37647603|NCT02455336|69116853|FG001|Overall Study|Withdrawal by Subject|2|||
37647604|NCT02455336|69116852|FG000|Overall Study|Adverse Event|3|||
37647605|NCT02455336|69116853|FG001|Overall Study|Adverse Event|0|||
37647606|NCT02455336|69116852|FG000|Overall Study|Non-responder to treatment|2|||
37647607|NCT02455336|69116853|FG001|Overall Study|Non-responder to treatment|0|||
37647608|NCT04525703|69116880|FG000|Overall Study|Lost to Follow-up|6|||
37647609|NCT04525703|69116881|FG001|Overall Study|Lost to Follow-up|15|||
37647610|NCT04525703|69116882|FG002|Overall Study|Lost to Follow-up|8|||
37647611|NCT04509076|69116895|FG000|Overall Study|Withdrawal by Subject|1|||
37647612|NCT04509076|69116896|FG001|Overall Study|Withdrawal by Subject|2|||
37647613|NCT04509076|69116895|FG000|Overall Study|Lost to Follow-up|1|||
37647614|NCT04509076|69116896|FG001|Overall Study|Lost to Follow-up|2|||
37647615|NCT04267614|69116910|FG000|Overall Study|Participants did not meet inclusion criteria|132|||
37647616|NCT04267614|69116910|FG000|Overall Study|Lost to Follow-up|115|||
37741299|NCT01394991|69227326|FG001|Overall Study|Chemotherapy Termination|15|||
37741300|NCT01394991|69227325|FG000|Overall Study|Disease Progression|7|||
37741301|NCT01394991|69227326|FG001|Overall Study|Disease Progression|7|||
37741302|NCT01394991|69227325|FG000|Overall Study|Prematurely Termination of Trial|9|||
37741303|NCT01394991|69227326|FG001|Overall Study|Prematurely Termination of Trial|10|||
37741304|NCT01829347|69227334|FG000|VTI-210|Death|5|||
37741305|NCT01829347|69227335|FG001|VTI-210|Death|3|||
37741306|NCT01829347|69227334|FG000|VTI-210|Withdrawal by Subject|1|||
37741307|NCT01829347|69227335|FG001|VTI-210|Withdrawal by Subject|0|||
37741308|NCT01829347|69227334|FG000|VTI-210E|Death|2|||
37741309|NCT01829347|69227335|FG001|VTI-210E|Death|1|||
37741310|NCT01829347|69227334|FG000|VTI-210E|Study terminated prematurely|1|||
37741311|NCT01829347|69227335|FG001|VTI-210E|Study terminated prematurely|5|||
37741312|NCT01394523|69227344|FG000|Overall Study|Unable to place block|1|||
37741313|NCT01394523|69227345|FG001|Overall Study|Unable to place block|0|||
37741314|NCT01394523|69227346|FG002|Overall Study|Unable to place block|0|||
37741315|NCT01857973|69227354|FG000|Overall Study|Subject did not meet required BG range|3|||
37741316|NCT01857973|69227354|FG000|Overall Study|drop out after 3 failed attempts|1|||
37741317|NCT01857973|69227354|FG000|Overall Study|Physician Decision|1|||
37741318|NCT01857583|69227362|FG000|Overall Study|Adverse Event|0|||
37741319|NCT01857583|69227363|FG001|Overall Study|Adverse Event|0|||
37741320|NCT01857583|69227364|FG002|Overall Study|Adverse Event|1|||
37741321|NCT01857583|69227365|FG003|Overall Study|Adverse Event|1|||
37741322|NCT01857583|69227362|FG000|Overall Study|Death|0|||
37741323|NCT01857583|69227363|FG001|Overall Study|Death|1|||
37741324|NCT01857583|69227364|FG002|Overall Study|Death|1|||
37741325|NCT01857583|69227365|FG003|Overall Study|Death|0|||
37741326|NCT01857583|69227362|FG000|Overall Study|Physician Decision|0|||
37741327|NCT01857583|69227363|FG001|Overall Study|Physician Decision|0|||
37741328|NCT01857583|69227364|FG002|Overall Study|Physician Decision|0|||
37741329|NCT01857583|69227365|FG003|Overall Study|Physician Decision|1|||
37741330|NCT01857583|69227362|FG000|Overall Study|Withdrawal by Subject|1|||
37741331|NCT01857583|69227363|FG001|Overall Study|Withdrawal by Subject|0|||
37741332|NCT01857583|69227364|FG002|Overall Study|Withdrawal by Subject|1|||
37741333|NCT01857583|69227365|FG003|Overall Study|Withdrawal by Subject|2|||
37741334|NCT01829191|69227377|FG000|Overall Study|Relocation|0|||
37741335|NCT01829191|69227378|FG001|Overall Study|Relocation|1|||
37741336|NCT01829191|69227377|FG000|Overall Study|Lens discomfort|0|||
37741337|NCT01829191|69227378|FG001|Overall Study|Lens discomfort|3|||
37741338|NCT01829191|69227377|FG000|Overall Study|Lens handling difficulty|1|||
37741339|NCT01829191|69227378|FG001|Overall Study|Lens handling difficulty|4|||
37741340|NCT01829191|69227377|FG000|Overall Study|Protocol Violation|4|||
37741341|NCT01829191|69227378|FG001|Overall Study|Protocol Violation|1|||
37741342|NCT01829191|69227377|FG000|Overall Study|Withdrawal by Subject|2|||
37741343|NCT01829191|69227378|FG001|Overall Study|Withdrawal by Subject|3|||
37741344|NCT01829191|69227377|FG000|Overall Study|Lost to Follow-up|0|||
37741345|NCT01829191|69227378|FG001|Overall Study|Lost to Follow-up|1|||
37741346|NCT01829191|69227377|FG000|Overall Study|Subject was fit for ortho - k|0|||
37647617|NCT03735680|69116921|FG000|Overall Study|Withdrawal by Subject|0|||
37741347|NCT01829191|69227378|FG001|Overall Study|Subject was fit for ortho - k|1|||
37741348|NCT00211185|69227383|FG000|Overall Study|Death|2|||
37741349|NCT00211185|69227383|FG000|Overall Study|Disease progression|7|||
37647618|NCT03735680|69116922|FG001|Overall Study|Withdrawal by Subject|1|||
37647619|NCT03735680|69116923|FG002|Overall Study|Withdrawal by Subject|0|||
37741350|NCT00211185|69227383|FG000|Overall Study|Withdrawal by Subject|6|||
37741351|NCT00211185|69227383|FG000|Overall Study|Physician Decision|5|||
37741352|NCT00210639|69227389|FG000|Overall Study|Lost to Follow-up|37|||
37741353|NCT00210639|69227390|FG001|Overall Study|Lost to Follow-up|29|||
37741354|NCT00210639|69227389|FG000|Overall Study|Withdrawal by Subject|8|||
37741355|NCT00210639|69227390|FG001|Overall Study|Withdrawal by Subject|1|||
37741356|NCT00210639|69227389|FG000|Overall Study|Other|18|||
37741357|NCT00210639|69227390|FG001|Overall Study|Other|12|||
37741358|NCT01829113|69227398|FG000|Overall Study|Disease Progression|37|||
37741359|NCT01829113|69227399|FG001|Overall Study|Disease Progression|48|||
37647620|NCT03735680|69116924|FG003|Overall Study|Withdrawal by Subject|0|||
37647621|NCT03735680|69116925|FG004|Overall Study|Withdrawal by Subject|0|||
37647622|NCT03735680|69116926|FG005|Overall Study|Withdrawal by Subject|1|||
37647623|NCT03735680|69116921|FG000|Overall Study|Patient unable or unwilling to continue|0|||
37647624|NCT03735680|69116922|FG001|Overall Study|Patient unable or unwilling to continue|0|||
37647625|NCT03735680|69116923|FG002|Overall Study|Patient unable or unwilling to continue|1|||
37647626|NCT03735680|69116924|FG003|Overall Study|Patient unable or unwilling to continue|0|||
37647627|NCT03735680|69116925|FG004|Overall Study|Patient unable or unwilling to continue|0|||
37647628|NCT03735680|69116926|FG005|Overall Study|Patient unable or unwilling to continue|0|||
37647629|NCT03726658|69116962|FG000|Overall Study|Lost to Follow-up|0|||
37647630|NCT03726658|69116963|FG001|Overall Study|Lost to Follow-up|0|||
37647631|NCT03726658|69116964|FG002|Overall Study|Lost to Follow-up|2|||
37647632|NCT03726658|69116965|FG003|Overall Study|Lost to Follow-up|0|||
37647633|NCT03726658|69116966|FG004|Overall Study|Lost to Follow-up|0|||
37647634|NCT03726658|69116967|FG005|Overall Study|Lost to Follow-up|1|||
37647635|NCT03726658|69116968|FG006|Overall Study|Lost to Follow-up|1|||
37647636|NCT03726658|69116962|FG000|Overall Study|Withdrawal by Subject|1|||
37647637|NCT03726658|69116963|FG001|Overall Study|Withdrawal by Subject|0|||
37647638|NCT03726658|69116964|FG002|Overall Study|Withdrawal by Subject|0|||
37647639|NCT03726658|69116965|FG003|Overall Study|Withdrawal by Subject|0|||
37647640|NCT03726658|69116966|FG004|Overall Study|Withdrawal by Subject|6|||
37922200|NCT00460603|69609070|FG004|Phase 1|Death|0|||
37922201|NCT00460603|69609071|FG005|Phase 1|Death|0|||
37922202|NCT00460603|69609072|FG006|Phase 1|Death|0|||
37922203|NCT00460603|69609073|FG007|Phase 1|Death|0|||
37647641|NCT03726658|69116967|FG005|Overall Study|Withdrawal by Subject|4|||
37647642|NCT03726658|69116968|FG006|Overall Study|Withdrawal by Subject|2|||
37647643|NCT03726658|69116962|FG000|Overall Study|Pregnancy|0|||
37647644|NCT03726658|69116963|FG001|Overall Study|Pregnancy|0|||
37647645|NCT03726658|69116964|FG002|Overall Study|Pregnancy|0|||
37647646|NCT03726658|69116965|FG003|Overall Study|Pregnancy|0|||
37647647|NCT03726658|69116966|FG004|Overall Study|Pregnancy|0|||
37647648|NCT03726658|69116967|FG005|Overall Study|Pregnancy|0|||
37647649|NCT03726658|69116968|FG006|Overall Study|Pregnancy|1|||
37741360|NCT01829113|69227398|FG000|Overall Study|Adverse Event|14|||
37741361|NCT01829113|69227399|FG001|Overall Study|Adverse Event|10|||
37741362|NCT01829113|69227398|FG000|Overall Study|Withdrawal by Subject|17|||
37741363|NCT01829113|69227399|FG001|Overall Study|Withdrawal by Subject|10|||
37741364|NCT01829113|69227398|FG000|Overall Study|Death|4|||
37741365|NCT01829113|69227399|FG001|Overall Study|Death|6|||
37741366|NCT01829113|69227398|FG000|Overall Study|Sponsor Decision|1|||
37741367|NCT01829113|69227399|FG001|Overall Study|Sponsor Decision|1|||
37741368|NCT01829113|69227398|FG000|Overall Study|No Study Treatment Received|3|||
37741369|NCT01829113|69227399|FG001|Overall Study|No Study Treatment Received|2|||
37741370|NCT01829113|69227398|FG000|Overall Study|Physician Decision|1|||
37741371|NCT01829113|69227399|FG001|Overall Study|Physician Decision|1|||
37741372|NCT01857271|69227407|FG000|Overall Study|Lost to Follow-up|1|||
37741373|NCT01745120|69227413|FG000|Overall Study|Investigator decision|1|||
37741374|NCT01745120|69227414|FG001|Overall Study|Investigator decision|0|||
37741375|NCT01828567|69227425|FG000|Overall Study|Lost to Follow-up|27|||
37741376|NCT01828567|69227426|FG001|Overall Study|Lost to Follow-up|9|||
37741377|NCT01828567|69227425|FG000|Overall Study|Excluded - did not meet criteria|4|||
37741378|NCT01828567|69227426|FG001|Overall Study|Excluded - did not meet criteria|1|||
37741379|NCT01721486|69227434|FG000|Overall Study|Protocol Violation|1|||
37741380|NCT01721486|69227435|FG001|Overall Study|Protocol Violation|0|||
37741381|NCT01721486|69227434|FG000|Overall Study|Physician Decision|0|||
37741382|NCT01721486|69227435|FG001|Overall Study|Physician Decision|1|||
37741383|NCT01775930|69227441|FG000|Overall Study|Futility stopping boundary met|1|||
37741384|NCT01856569|69227445|FG000|Overall Study|Other|1|||
37922204|NCT00460603|69609074|FG008|Phase 1|Death|1|||
37647650|NCT03726658|69116962|FG000|Overall Study|Not Reported|0|||
37647651|NCT03726658|69116963|FG001|Overall Study|Not Reported|0|||
37647652|NCT03726658|69116964|FG002|Overall Study|Not Reported|0|||
37647653|NCT03726658|69116965|FG003|Overall Study|Not Reported|0|||
37741385|NCT01856569|69227445|FG000|Overall Study|Changed Site/Structure|1|||
37922205|NCT00460603|69609075|FG009|Phase 1|Death|0|||
37922206|NCT00460603|69609076|FG010|Phase 1|Death|0|||
38032280|NCT03345836|69718191|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
37647654|NCT03726658|69116966|FG004|Overall Study|Not Reported|0|||
37647655|NCT03726658|69116967|FG005|Overall Study|Not Reported|0|||
37647656|NCT03726658|69116968|FG006|Overall Study|Not Reported|1|||
37647657|NCT03106779|69117028|FG000|Overall Study|Lack of Efficacy|33|||
37741386|NCT01856569|69227445|FG000|Overall Study|Lost to Follow-up|3|||
37647658|NCT03106779|69117029|FG001|Overall Study|Lack of Efficacy|24|||
37741387|NCT01856569|69227445|FG000|Overall Study|Did not met inclusion criteria|8|||
37741388|NCT01721408|69227451|FG000|Overall Study|Adverse Event|6|||
37741389|NCT01721408|69227452|FG001|Overall Study|Adverse Event|1|||
37741390|NCT01721408|69227451|FG000|Overall Study|Death|1|||
37922207|NCT00460603|69609077|FG011|Phase 1|Death|0|||
37922208|NCT00460603|69609066|FG000|Phase 1|Adverse Event|3|||
37647659|NCT03106779|69117028|FG000|Overall Study|Adverse Event|8|||
37647660|NCT03106779|69117029|FG001|Overall Study|Adverse Event|16|||
37647661|NCT03106779|69117028|FG000|Overall Study|Physician Decision|10|||
37647662|NCT03106779|69117029|FG001|Overall Study|Physician Decision|6|||
37647663|NCT03106779|69117028|FG000|Overall Study|Patient/guardian decision|4|||
37647664|NCT03106779|69117029|FG001|Overall Study|Patient/guardian decision|3|||
37647665|NCT03106779|69117028|FG000|Overall Study|Progressive disease|1|||
37647666|NCT03106779|69117029|FG001|Overall Study|Progressive disease|3|||
37647667|NCT03106779|69117028|FG000|Overall Study|Lost to Follow-up|1|||
37647668|NCT03106779|69117029|FG001|Overall Study|Lost to Follow-up|2|||
37647669|NCT03106779|69117028|FG000|Overall Study|Death|1|||
37647670|NCT03106779|69117029|FG001|Overall Study|Death|0|||
37647671|NCT03106779|69117028|FG000|Overall Study|Protocol Violation|1|||
37647672|NCT03106779|69117029|FG001|Overall Study|Protocol Violation|0|||
37647673|NCT03106779|69117028|FG000|Overall Study|Not treated|1|||
37647674|NCT03106779|69117029|FG001|Overall Study|Not treated|0|||
37647675|NCT03062358|69117046|FG000|Overall Study|Death|220|||
37647676|NCT03062358|69117047|FG001|Overall Study|Death|127|||
37647677|NCT03062358|69117046|FG000|Overall Study|Withdrawal by Subject|2|||
37647678|NCT03062358|69117047|FG001|Overall Study|Withdrawal by Subject|1|||
37647679|NCT03062358|69117046|FG000|Overall Study|Ongoing in Trial|78|||
37647680|NCT03062358|69117047|FG001|Overall Study|Ongoing in Trial|25|||
37647681|NCT02706873|69117058|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|15|||
37647682|NCT02706873|69117059|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|3|||
37647683|NCT02706873|69117060|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|18|||
37647684|NCT02706873|69117061|FG003|Period 1 (Weeks 1 to 48)|Adverse Event|11|||
37647685|NCT02706873|69117058|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|22|||
37647686|NCT02706873|69117059|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|0|||
37647687|NCT02706873|69117060|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|12|||
37647688|NCT02706873|69117061|FG003|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|20|||
37647689|NCT02706873|69117058|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|4|||
37647690|NCT02706873|69117059|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
37647691|NCT02706873|69117060|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|6|||
37647692|NCT02706873|69117061|FG003|Period 1 (Weeks 1 to 48)|Lost to Follow-up|5|||
37647693|NCT02706873|69117058|FG000|Period 1 (Weeks 1 to 48)|Lack of Efficacy|12|||
37647694|NCT02706873|69117059|FG001|Period 1 (Weeks 1 to 48)|Lack of Efficacy|0|||
37647695|NCT02706873|69117060|FG002|Period 1 (Weeks 1 to 48)|Lack of Efficacy|2|||
37647696|NCT02706873|69117061|FG003|Period 1 (Weeks 1 to 48)|Lack of Efficacy|4|||
37647697|NCT02706873|69117058|FG000|Period 1 (Weeks 1 to 48)|Other|5|||
37647698|NCT02706873|69117059|FG001|Period 1 (Weeks 1 to 48)|Other|1|||
37647699|NCT02706873|69117060|FG002|Period 1 (Weeks 1 to 48)|Other|2|||
37647700|NCT02706873|69117061|FG003|Period 1 (Weeks 1 to 48)|Other|3|||
37647701|NCT02706873|69117058|FG000|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
37647702|NCT02706873|69117059|FG001|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
37647703|NCT02706873|69117060|FG002|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
37647704|NCT02706873|69117061|FG003|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
37647705|NCT02706873|69117058|FG000|Period 2 (Weeks 48 to 260)|Adverse Event|16|||
37647706|NCT02706873|69117059|FG001|Period 2 (Weeks 48 to 260)|Adverse Event|4|||
37922209|NCT00460603|69609067|FG001|Phase 1|Adverse Event|1|||
37922210|NCT00460603|69609068|FG002|Phase 1|Adverse Event|1|||
37922211|NCT00460603|69609069|FG003|Phase 1|Adverse Event|2|||
37922212|NCT00460603|69609070|FG004|Phase 1|Adverse Event|0|||
37922213|NCT00460603|69609071|FG005|Phase 1|Adverse Event|0|||
37922214|NCT00460603|69609072|FG006|Phase 1|Adverse Event|3|||
37647707|NCT02706873|69117060|FG002|Period 2 (Weeks 48 to 260)|Adverse Event|11|||
37647708|NCT02706873|69117061|FG003|Period 2 (Weeks 48 to 260)|Adverse Event|26|||
37647709|NCT02706873|69117058|FG000|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|32|||
37647710|NCT02706873|69117059|FG001|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|5|||
37647711|NCT02706873|69117060|FG002|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|23|||
37647712|NCT02706873|69117061|FG003|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|27|||
37647713|NCT02706873|69117058|FG000|Period 2 (Weeks 48 to 260)|Lost to Follow-up|17|||
37647714|NCT02706873|69117059|FG001|Period 2 (Weeks 48 to 260)|Lost to Follow-up|0|||
37647715|NCT02706873|69117060|FG002|Period 2 (Weeks 48 to 260)|Lost to Follow-up|10|||
37647716|NCT02706873|69117061|FG003|Period 2 (Weeks 48 to 260)|Lost to Follow-up|6|||
37647717|NCT02706873|69117058|FG000|Period 2 (Weeks 48 to 260)|Lack of Efficacy|11|||
37647718|NCT02706873|69117059|FG001|Period 2 (Weeks 48 to 260)|Lack of Efficacy|0|||
37647719|NCT02706873|69117060|FG002|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
37647720|NCT02706873|69117061|FG003|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
37647721|NCT02706873|69117058|FG000|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
37647722|NCT02706873|69117059|FG001|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
37647723|NCT02706873|69117060|FG002|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
37677506|NCT02600819|69152479|FG000|GEN Phase|Investigator's Discretion|4|||
37677507|NCT02600819|69152480|FG001|GEN Phase|Investigator's Discretion|0|||
37922215|NCT00460603|69609073|FG007|Phase 1|Adverse Event|0|||
37922216|NCT00460603|69609074|FG008|Phase 1|Adverse Event|4|||
37922217|NCT00460603|69609075|FG009|Phase 1|Adverse Event|0|||
37647724|NCT02706873|69117061|FG003|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|3|||
37647725|NCT02706873|69117058|FG000|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
37647726|NCT02706873|69117059|FG001|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
37647727|NCT02706873|69117060|FG002|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|2|||
37647728|NCT02706873|69117061|FG003|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|1|||
37647729|NCT02706873|69117058|FG000|Period 2 (Weeks 48 to 260)|Other|14|||
37647730|NCT02706873|69117059|FG001|Period 2 (Weeks 48 to 260)|Other|1|||
37647731|NCT02706873|69117060|FG002|Period 2 (Weeks 48 to 260)|Other|11|||
37647732|NCT02706873|69117061|FG003|Period 2 (Weeks 48 to 260)|Other|17|||
37647733|NCT02584634|69117084|FG000|Overall Study|Adverse Event|3|||
37647734|NCT02584634|69117085|FG001|Overall Study|Adverse Event|5|||
37647735|NCT02584634|69117084|FG000|Overall Study|Death|0|||
37647736|NCT02584634|69117085|FG001|Overall Study|Death|1|||
37647737|NCT02584634|69117084|FG000|Overall Study|Lost to Follow-up|0|||
37647738|NCT02584634|69117085|FG001|Overall Study|Lost to Follow-up|1|||
37647739|NCT02584634|69117084|FG000|Overall Study|Physician Decision|1|||
37647740|NCT02584634|69117085|FG001|Overall Study|Physician Decision|2|||
37647741|NCT02584634|69117084|FG000|Overall Study|Progressive disease|7|||
37647742|NCT02584634|69117085|FG001|Overall Study|Progressive disease|15|||
37647743|NCT02584634|69117084|FG000|Overall Study|Withdrawal by Subject|1|||
37647744|NCT02584634|69117085|FG001|Overall Study|Withdrawal by Subject|1|||
37647745|NCT02584634|69117084|FG000|Overall Study|Other|0|||
37647746|NCT02584634|69117085|FG001|Overall Study|Other|6|||
37647747|NCT01275729|69117099|FG000|Overall Study|Death|3|||
37647748|NCT01275729|69117099|FG000|Overall Study|Withdrawal by Subject|1|||
37647749|NCT01107626|69117107|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
37647750|NCT01107626|69117108|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
37647751|NCT01107626|69117109|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
37647752|NCT01107626|69117110|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
37647753|NCT01107626|69117107|FG000|Step 1: Induction Therapy|Adverse Event|198|||
37647754|NCT01107626|69117108|FG001|Step 1: Induction Therapy|Adverse Event|0|||
37647755|NCT01107626|69117109|FG002|Step 1: Induction Therapy|Adverse Event|0|||
37647756|NCT01107626|69117110|FG003|Step 1: Induction Therapy|Adverse Event|0|||
37647757|NCT01107626|69117107|FG000|Step 1: Induction Therapy|Death|62|||
37647758|NCT01107626|69117108|FG001|Step 1: Induction Therapy|Death|0|||
37647759|NCT01107626|69117109|FG002|Step 1: Induction Therapy|Death|0|||
37647760|NCT01107626|69117110|FG003|Step 1: Induction Therapy|Death|0|||
37647761|NCT01107626|69117107|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
37647762|NCT01107626|69117108|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
37647763|NCT01107626|69117109|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
37647764|NCT01107626|69117110|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
37647765|NCT01107626|69117107|FG000|Step 1: Induction Therapy|Complicating disease|13|||
37647766|NCT01107626|69117108|FG001|Step 1: Induction Therapy|Complicating disease|0|||
37647767|NCT01107626|69117109|FG002|Step 1: Induction Therapy|Complicating disease|0|||
37647768|NCT01107626|69117110|FG003|Step 1: Induction Therapy|Complicating disease|0|||
37647769|NCT01107626|69117107|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
37647770|NCT01107626|69117108|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
37647771|NCT01107626|69117109|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
37647772|NCT01107626|69117110|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
37647773|NCT01107626|69117107|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
37647774|NCT01107626|69117108|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
37647775|NCT01107626|69117109|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
37647776|NCT01107626|69117110|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
37647777|NCT01107626|69117107|FG000|Step 1: Induction Therapy|Non-compliance|4|||
37647778|NCT01107626|69117108|FG001|Step 1: Induction Therapy|Non-compliance|0|||
37647779|NCT01107626|69117109|FG002|Step 1: Induction Therapy|Non-compliance|0|||
37647780|NCT01107626|69117110|FG003|Step 1: Induction Therapy|Non-compliance|0|||
37647781|NCT01107626|69117107|FG000|Step 1: Induction Therapy|Pain|4|||
37647782|NCT01107626|69117108|FG001|Step 1: Induction Therapy|Pain|0|||
37647783|NCT01107626|69117109|FG002|Step 1: Induction Therapy|Pain|0|||
37647784|NCT01107626|69117110|FG003|Step 1: Induction Therapy|Pain|0|||
37647785|NCT01107626|69117107|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
37647786|NCT01107626|69117108|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
38032281|NCT03345836|69718186|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
37647787|NCT01107626|69117109|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
37647788|NCT01107626|69117110|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
37647789|NCT01107626|69117107|FG000|Step 1: Induction Therapy|Hospice care|1|||
37647790|NCT01107626|69117108|FG001|Step 1: Induction Therapy|Hospice care|0|||
37647791|NCT01107626|69117109|FG002|Step 1: Induction Therapy|Hospice care|0|||
37647792|NCT01107626|69117110|FG003|Step 1: Induction Therapy|Hospice care|0|||
37647793|NCT01107626|69117107|FG000|Step 1: Induction Therapy|Physician Decision|1|||
37647794|NCT01107626|69117108|FG001|Step 1: Induction Therapy|Physician Decision|0|||
37647795|NCT01107626|69117109|FG002|Step 1: Induction Therapy|Physician Decision|0|||
37647796|NCT01107626|69117110|FG003|Step 1: Induction Therapy|Physician Decision|0|||
37647797|NCT01107626|69117107|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
37647798|NCT01107626|69117108|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
37647799|NCT01107626|69117109|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
37647800|NCT01107626|69117110|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
37647801|NCT01107626|69117107|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
37647802|NCT01107626|69117108|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
37647803|NCT01107626|69117109|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
37647804|NCT01107626|69117110|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
37647805|NCT01107626|69117107|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
37647806|NCT01107626|69117108|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
37647807|NCT01107626|69117109|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
37647808|NCT01107626|69117110|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
37647809|NCT01107626|69117107|FG000|Step 2: Maintenance Therapy|Death|0|||
37647810|NCT01107626|69117108|FG001|Step 2: Maintenance Therapy|Death|8|||
37647811|NCT01107626|69117109|FG002|Step 2: Maintenance Therapy|Death|2|||
37647812|NCT01107626|69117110|FG003|Step 2: Maintenance Therapy|Death|13|||
37647813|NCT01107626|69117107|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
37647814|NCT01107626|69117108|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
37647815|NCT01107626|69117109|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
37647816|NCT01107626|69117110|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
37647817|NCT01107626|69117107|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
37647818|NCT01107626|69117108|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
37647819|NCT01107626|69117109|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
37647820|NCT01107626|69117110|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
37647821|NCT01107626|69117107|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
37647822|NCT01107626|69117108|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
37647823|NCT01107626|69117109|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
37647824|NCT01107626|69117110|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
37647825|NCT01107626|69117107|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
37647826|NCT01107626|69117108|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
37647827|NCT01107626|69117109|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
37647828|NCT01107626|69117110|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
37647829|NCT01107626|69117107|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
37647830|NCT01107626|69117108|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
37647831|NCT01107626|69117109|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
37647832|NCT01107626|69117110|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
37647833|NCT01107626|69117107|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
37647834|NCT01107626|69117108|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
37647835|NCT01107626|69117109|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
37647836|NCT01107626|69117110|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
37647837|NCT01107626|69117107|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
37647838|NCT01107626|69117108|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
37647839|NCT01107626|69117109|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
37647840|NCT01107626|69117110|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
37647841|NCT01107626|69117107|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
37647842|NCT01107626|69117108|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
37647843|NCT01107626|69117109|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
37647844|NCT01107626|69117110|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
37647845|NCT01107626|69117107|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
37647846|NCT01107626|69117108|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
37647847|NCT01107626|69117109|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
37647848|NCT01107626|69117110|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
37647849|NCT01107626|69117107|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
37647850|NCT01107626|69117108|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
37647851|NCT01107626|69117109|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
37647852|NCT01107626|69117110|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
37647853|NCT01107626|69117107|FG000|Step 2: Maintenance Therapy|Pain|0|||
37647854|NCT01107626|69117108|FG001|Step 2: Maintenance Therapy|Pain|0|||
37647855|NCT01107626|69117109|FG002|Step 2: Maintenance Therapy|Pain|0|||
37647856|NCT01107626|69117110|FG003|Step 2: Maintenance Therapy|Pain|1|||
37647857|NCT01107626|69117107|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
37647858|NCT01107626|69117108|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
37647859|NCT01107626|69117109|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
37647860|NCT01107626|69117110|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
37647861|NCT00828009|69117119|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
37647862|NCT00828009|69117119|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
37647863|NCT00828009|69117119|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
37647864|NCT00828009|69117119|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
37647865|NCT00828009|69117119|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
37647866|NCT00828009|69117119|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
37647867|NCT00828009|69117119|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
37647868|NCT00828009|69117119|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
37647869|NCT00828009|69117119|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
37647870|NCT00828009|69117119|FG000|Step 2 - Maintenance Therapy|Death|1|||
37647871|NCT00828009|69117119|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
37647872|NCT00828009|69117119|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
37647873|NCT00828009|69117119|FG000|Step 2 - Maintenance Therapy|Other|1|||
37647874|NCT00068393|69117139|FG000|Overall Study|Adverse Event|2|||
37647875|NCT00068393|69117139|FG000|Overall Study|Death|3|||
37647876|NCT00068393|69117139|FG000|Overall Study|Withdrawal by Subject|3|||
37647877|NCT00068393|69117139|FG000|Overall Study|Alternative treatment|1|||
37647878|NCT00068393|69117139|FG000|Overall Study|Quality of life worsening|1|||
37647879|NCT00062010|69117143|FG000|Overall Study|Ineligible|3|||
37647880|NCT00047008|69117149|FG000|Overall Study|Withdrawn consent|2|||
37647881|NCT00047008|69117150|FG001|Overall Study|Withdrawn consent|3|||
37647882|NCT00047008|69117149|FG000|Overall Study|Ineligible|9|||
37647883|NCT00047008|69117150|FG001|Overall Study|Ineligible|8|||
37647884|NCT02397694|69117158|FG000|Double-Blinded Phase|Adverse Event|1|||
37647885|NCT02397694|69117159|FG001|Double-Blinded Phase|Adverse Event|0|||
37647886|NCT02397694|69117158|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
37647887|NCT02397694|69117159|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
37647888|NCT02397694|69117158|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
37647889|NCT02397694|69117159|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
37647890|NCT02397694|69117158|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
37647891|NCT02397694|69117159|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
37647892|NCT02397694|69117158|FG000|Open Label Extension Phase|Protocol Violation|1|||
37647893|NCT02397694|69117159|FG001|Open Label Extension Phase|Protocol Violation|0|||
37647894|NCT02397694|69117158|FG000|Open Label Extension Phase|Withdrew Consent|3|||
37647895|NCT02397694|69117159|FG001|Open Label Extension Phase|Withdrew Consent|1|||
37647896|NCT02397694|69117158|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
37647897|NCT02397694|69117159|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
37647898|NCT02783599|69117169|FG000|Overall Study|Progressive disease|23|||
37647899|NCT02783599|69117169|FG000|Overall Study|Surgical Resection|10|||
37647900|NCT02783599|69117169|FG000|Overall Study|Adverse Event|4|||
37647901|NCT02783599|69117169|FG000|Overall Study|Physician Decision|2|||
37647902|NCT02783599|69117169|FG000|Overall Study|Death|1|||
37647903|NCT02838017|69117182|FG000|Overall Study|Lost to Follow-up|14|||
37647904|NCT02838017|69117183|FG001|Overall Study|Lost to Follow-up|11|||
37647905|NCT03188666|69117191|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
37647906|NCT03188666|69117192|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
37647907|NCT03188666|69117193|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
37647908|NCT03188666|69117194|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
37647909|NCT03188666|69117191|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
37647910|NCT03188666|69117192|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
37647911|NCT03188666|69117193|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
37647912|NCT03188666|69117194|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
37647913|NCT03188666|69117191|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
37647914|NCT03188666|69117192|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
37647915|NCT03188666|69117193|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
37647916|NCT03188666|69117194|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
37647917|NCT03188666|69117191|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
37647918|NCT03188666|69117192|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
37647919|NCT03188666|69117193|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
37647920|NCT03188666|69117194|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
37647921|NCT02836769|69117208|FG000|Overall Study|Lost to Follow-up|10|||
37647922|NCT02836769|69117208|FG000|Overall Study|Medical withdrawal|2|||
37647923|NCT02836769|69117208|FG000|Overall Study|Withdrawal by Subject|3|||
37854999|NCT01296698|69538376|FG001|Overall Study|Death|0|||
37647924|NCT02836613|69117214|FG000|Overall Study|Accidental drowning|1|||
37647925|NCT02836613|69117215|FG001|Overall Study|Accidental drowning|0|||
37647926|NCT02836613|69117214|FG000|Overall Study|Lost to Follow-up|0|||
37647927|NCT02836613|69117215|FG001|Overall Study|Lost to Follow-up|1|||
37647928|NCT02836613|69117214|FG000|Overall Study|Withdrawal by Subject|0|||
37647929|NCT02836613|69117215|FG001|Overall Study|Withdrawal by Subject|2|||
37647930|NCT02397460|69117229|FG000|Treatment Period 2|Adverse Event|0|||
37855000|NCT01296698|69538375|FG000|Overall Study|Lost to Follow-up|19|||
37647931|NCT02397460|69117230|FG001|Treatment Period 2|Adverse Event|0|||
37647932|NCT02397460|69117231|FG002|Treatment Period 2|Adverse Event|0|||
37647933|NCT02397460|69117232|FG003|Treatment Period 2|Adverse Event|0|||
37647934|NCT02397460|69117233|FG004|Treatment Period 2|Adverse Event|0|||
37647935|NCT02397460|69117234|FG005|Treatment Period 2|Adverse Event|0|||
37647936|NCT02397460|69117235|FG006|Treatment Period 2|Adverse Event|0|||
37855001|NCT01296698|69538376|FG001|Overall Study|Lost to Follow-up|1|||
37647937|NCT02397460|69117236|FG007|Treatment Period 2|Adverse Event|1|||
37647938|NCT02397460|69117229|FG000|Treatment Period 4|Adverse Event|0|||
37647939|NCT02397460|69117230|FG001|Treatment Period 4|Adverse Event|1|||
37647940|NCT02397460|69117231|FG002|Treatment Period 4|Adverse Event|0|||
37647941|NCT02397460|69117232|FG003|Treatment Period 4|Adverse Event|0|||
37647942|NCT02397460|69117233|FG004|Treatment Period 4|Adverse Event|0|||
37647943|NCT02397460|69117234|FG005|Treatment Period 4|Adverse Event|0|||
37647944|NCT02397460|69117235|FG006|Treatment Period 4|Adverse Event|0|||
37647945|NCT02397460|69117236|FG007|Treatment Period 4|Adverse Event|0|||
37647946|NCT02397460|69117229|FG000|Treatment Period 4|Physician Decision|0|||
37647947|NCT02397460|69117230|FG001|Treatment Period 4|Physician Decision|0|||
37647948|NCT02397460|69117231|FG002|Treatment Period 4|Physician Decision|0|||
37647949|NCT02397460|69117232|FG003|Treatment Period 4|Physician Decision|0|||
37647950|NCT02397460|69117233|FG004|Treatment Period 4|Physician Decision|1|||
37647951|NCT02397460|69117234|FG005|Treatment Period 4|Physician Decision|0|||
37647952|NCT02397460|69117235|FG006|Treatment Period 4|Physician Decision|0|||
37647953|NCT02397460|69117236|FG007|Treatment Period 4|Physician Decision|0|||
37647954|NCT02834819|69117312|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
37647955|NCT02834819|69117313|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
37647956|NCT02454478|69117319|FG000|Overall Study|Incomplete DLT Evaluation|1|||
37647957|NCT01341587|69117325|FG000|Overall Study|Lost to Follow-up|2|||
37647958|NCT01341587|69117326|FG001|Overall Study|Lost to Follow-up|0|||
37647959|NCT01341587|69117325|FG000|Overall Study|stopped using the meters|2|||
37647960|NCT01341587|69117326|FG001|Overall Study|stopped using the meters|10|||
37647961|NCT01358825|69117334|FG000|Overall Study|Blood sample not drawn|0|||
37647962|NCT01358825|69117335|FG001|Overall Study|Blood sample not drawn|1|||
37647963|NCT02453386|69117344|FG000|Overall Study|Adverse Event|22|||
37647964|NCT02453386|69117345|FG001|Overall Study|Adverse Event|30|||
37647965|NCT02453386|69117346|FG002|Overall Study|Adverse Event|15|||
37647966|NCT02453386|69117344|FG000|Overall Study|Protocol Violation|1|||
37647967|NCT02453386|69117345|FG001|Overall Study|Protocol Violation|0|||
37647968|NCT02453386|69117346|FG002|Overall Study|Protocol Violation|1|||
37647969|NCT02453386|69117344|FG000|Overall Study|Withdrawal by Subject|10|||
37647970|NCT02453386|69117345|FG001|Overall Study|Withdrawal by Subject|9|||
37647971|NCT02453386|69117346|FG002|Overall Study|Withdrawal by Subject|9|||
37647972|NCT02453386|69117344|FG000|Overall Study|Sponsor Terminated Study|14|||
37647973|NCT02453386|69117345|FG001|Overall Study|Sponsor Terminated Study|8|||
37647974|NCT02453386|69117346|FG002|Overall Study|Sponsor Terminated Study|11|||
37647975|NCT02453386|69117344|FG000|Overall Study|Subject Terminated by Sponsor|1|||
37647976|NCT02453386|69117345|FG001|Overall Study|Subject Terminated by Sponsor|1|||
37647977|NCT02453386|69117346|FG002|Overall Study|Subject Terminated by Sponsor|1|||
37647978|NCT02453386|69117344|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
37647979|NCT02453386|69117345|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
37647980|NCT02453386|69117346|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
37647981|NCT02453386|69117344|FG000|Overall Study|Lost to Follow-up|0|||
37647982|NCT02453386|69117345|FG001|Overall Study|Lost to Follow-up|0|||
37647983|NCT02453386|69117346|FG002|Overall Study|Lost to Follow-up|1|||
37647984|NCT02453386|69117344|FG000|Overall Study|Other|1|||
37647985|NCT02453386|69117345|FG001|Overall Study|Other|0|||
37647986|NCT02453386|69117346|FG002|Overall Study|Other|1|||
37647987|NCT02431468|69117364|FG000|Overall Study|Adverse Event|2|||
37647988|NCT02431468|69117365|FG001|Overall Study|Adverse Event|4|||
37647989|NCT02431468|69117366|FG002|Overall Study|Adverse Event|5|||
37647990|NCT02431468|69117364|FG000|Overall Study|Withdrawal by Subject|4|||
37647991|NCT02431468|69117365|FG001|Overall Study|Withdrawal by Subject|12|||
37647992|NCT02431468|69117366|FG002|Overall Study|Withdrawal by Subject|2|||
37647993|NCT02431468|69117364|FG000|Overall Study|noncompliance, investigator termination,|2|||
37647994|NCT02431468|69117365|FG001|Overall Study|noncompliance, investigator termination,|2|||
37647995|NCT02431468|69117366|FG002|Overall Study|noncompliance, investigator termination,|2|||
37647996|NCT02452762|69117382|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
37647997|NCT02452762|69117383|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
37647998|NCT02452762|69117382|FG000|Overall Study|Withdrawal by Subject|1|||
37647999|NCT02452762|69117383|FG001|Overall Study|Withdrawal by Subject|0|||
37648000|NCT02631746|69117390|FG000|Overall Study|Lack of Efficacy|3|||
37648001|NCT02633306|69117394|FG000|Overall Study|Withdrawal by Subject|3|||
37648002|NCT02396758|69117403|FG000|Overall Study|Withdrawal by Subject|2|||
37648003|NCT02396758|69117404|FG001|Overall Study|Withdrawal by Subject|0|||
37648004|NCT02396758|69117405|FG002|Overall Study|Withdrawal by Subject|0|||
37648005|NCT02396758|69117406|FG003|Overall Study|Withdrawal by Subject|1|||
37648006|NCT02396758|69117403|FG000|Overall Study|Lost to Follow-up|8|||
37648007|NCT02396758|69117404|FG001|Overall Study|Lost to Follow-up|5|||
37648008|NCT02396758|69117405|FG002|Overall Study|Lost to Follow-up|3|||
37648009|NCT02396758|69117406|FG003|Overall Study|Lost to Follow-up|3|||
37648010|NCT02396758|69117403|FG000|Overall Study|Death|1|||
37648011|NCT02396758|69117404|FG001|Overall Study|Death|1|||
37648012|NCT02396758|69117405|FG002|Overall Study|Death|0|||
37648013|NCT02396758|69117406|FG003|Overall Study|Death|1|||
37648014|NCT02396758|69117403|FG000|Overall Study|Randomized but not treated|1|||
37648015|NCT02396758|69117404|FG001|Overall Study|Randomized but not treated|0|||
37648016|NCT02396758|69117405|FG002|Overall Study|Randomized but not treated|1|||
37648017|NCT02396758|69117406|FG003|Overall Study|Randomized but not treated|0|||
37648018|NCT02632838|69117418|FG000|Overall Study|Withdrawal by Subject|3|||
37648019|NCT02632838|69117419|FG001|Overall Study|Withdrawal by Subject|0|||
37648020|NCT02632838|69117418|FG000|Overall Study|Lost to Follow-up|0|||
37648021|NCT02632838|69117419|FG001|Overall Study|Lost to Follow-up|2|||
37648022|NCT02396212|69117429|FG000|Overall Study|Adverse Event|1|||
37648023|NCT02396212|69117429|FG000|Overall Study|Lack of Efficacy|2|||
37648024|NCT02395822|69117433|FG000|Overall Study|Withdrawal by Subject|1|||
37648025|NCT02395822|69117433|FG000|Overall Study|Death|1|||
37648026|NCT01651936|69117439|FG000|Base Study|Adverse Event|3|||
37648027|NCT01651936|69117440|FG001|Base Study|Adverse Event|0|||
37648028|NCT01651936|69117441|FG002|Base Study|Adverse Event|0|||
37648029|NCT01651936|69117439|FG000|Base Study|Withdrawal by Subject|1|||
37648030|NCT01651936|69117440|FG001|Base Study|Withdrawal by Subject|1|||
37648031|NCT01651936|69117441|FG002|Base Study|Withdrawal by Subject|0|||
37648032|NCT01651936|69117439|FG000|Base Study|Early Escape|2|||
37648033|NCT01651936|69117440|FG001|Base Study|Early Escape|8|||
37648034|NCT01651936|69117441|FG002|Base Study|Early Escape|0|||
37648035|NCT01651936|69117439|FG000|Base Study|Study terminated by sponsor|21|||
37648036|NCT01651936|69117440|FG001|Base Study|Study terminated by sponsor|16|||
37648037|NCT01651936|69117441|FG002|Base Study|Study terminated by sponsor|0|||
37741391|NCT01721408|69227452|FG001|Overall Study|Death|0|||
37741392|NCT01721408|69227451|FG000|Overall Study|Insufficient clinical response|15|||
37741393|NCT01721408|69227452|FG001|Overall Study|Insufficient clinical response|6|||
37741394|NCT01721408|69227451|FG000|Overall Study|No longer willing to participate study|9|||
37741395|NCT01721408|69227452|FG001|Overall Study|No longer willing to participate study|10|||
37741396|NCT01721408|69227451|FG000|Overall Study|Protocol Violation|0|||
37741397|NCT01721408|69227452|FG001|Overall Study|Protocol Violation|2|||
37741398|NCT01721408|69227451|FG000|Overall Study|Other|3|||
37741399|NCT01721408|69227452|FG001|Overall Study|Other|3|||
37741400|NCT01721408|69227451|FG000|Overall Study|Lost to Follow-up|1|||
37741401|NCT01721408|69227452|FG001|Overall Study|Lost to Follow-up|2|||
37741402|NCT01721408|69227451|FG000|Overall Study|Does not meet entrance criteria|1|||
37741403|NCT01721408|69227452|FG001|Overall Study|Does not meet entrance criteria|0|||
37741404|NCT01744496|69227460|FG000|Titration Period|Adverse Event|2|||
37741405|NCT01744496|69227461|FG001|Titration Period|Adverse Event|1|||
37741406|NCT01744496|69227460|FG000|Titration Period|Personal reasons|0|||
37741407|NCT01744496|69227461|FG001|Titration Period|Personal reasons|1|||
37741408|NCT01744496|69227460|FG000|Maintenance Period|Adverse Event|1|||
37741409|NCT01744496|69227461|FG001|Maintenance Period|Adverse Event|3|||
37741410|NCT01744496|69227460|FG000|Maintenance Period|Protocol Violation|1|||
37741411|NCT01744496|69227461|FG001|Maintenance Period|Protocol Violation|0|||
37741412|NCT01744496|69227460|FG000|Maintenance Period|Withdrawal by Subject|1|||
37741413|NCT01744496|69227461|FG001|Maintenance Period|Withdrawal by Subject|1|||
37741414|NCT01744496|69227460|FG000|Maintenance Period|Subject left town|1|||
37741415|NCT01744496|69227461|FG001|Maintenance Period|Subject left town|0|||
37741416|NCT01721330|69227469|FG000|Overall Study|Withdrawal by Subject|0|||
37741417|NCT01721330|69227470|FG001|Overall Study|Withdrawal by Subject|1|||
37741418|NCT01828021|69227486|FG000|Overall Study|Adverse Event|5|||
37741419|NCT01828021|69227486|FG000|Overall Study|Lack of Efficacy|17|||
37741420|NCT01828021|69227486|FG000|Overall Study|Withdrawal by Subject|2|||
37741421|NCT01828021|69227486|FG000|Overall Study|Ileal obstruction, unrelated|1|||
37741422|NCT01827943|69227490|FG000|Overall Study|Protocol Violation|8|||
37741423|NCT01827943|69227490|FG000|Overall Study|Never treated because of an rapid progression|1|||
37741424|NCT00217971|69227496|FG000|Overall Study|Adverse Event|1|||
37741425|NCT00217971|69227497|FG001|Overall Study|Adverse Event|1|||
37741426|NCT00217971|69227496|FG000|Overall Study|Lost to Follow-up|15|||
37741427|NCT00217971|69227497|FG001|Overall Study|Lost to Follow-up|19|||
37741428|NCT00217971|69227496|FG000|Overall Study|Physician Decision|0|||
37741429|NCT00217971|69227497|FG001|Overall Study|Physician Decision|1|||
37741430|NCT00217971|69227496|FG000|Overall Study|Withdrawal by Subject|7|||
37741431|NCT00217971|69227497|FG001|Overall Study|Withdrawal by Subject|12|||
37741432|NCT00217971|69227496|FG000|Overall Study|non compliant|1|||
37741433|NCT00217971|69227497|FG001|Overall Study|non compliant|0|||
37648038|NCT01651936|69117439|FG000|Extension Study|Lack of Efficacy|0|||
37648039|NCT01651936|69117440|FG001|Extension Study|Lack of Efficacy|0|||
37648040|NCT01651936|69117441|FG002|Extension Study|Lack of Efficacy|1|||
37648041|NCT01651936|69117439|FG000|Extension Study|Study terminated by sponsor|0|||
37648042|NCT01651936|69117440|FG001|Extension Study|Study terminated by sponsor|0|||
37741434|NCT00217581|69227503|FG000|Overall Study|Withdrawal by Subject|1|||
37741435|NCT01856257|69227511|FG000|Overall Study|Death|2|||
37741436|NCT01856257|69227512|FG001|Overall Study|Death|0|||
37741437|NCT01856257|69227513|FG002|Overall Study|Death|0|||
37741438|NCT01856257|69227514|FG003|Overall Study|Death|0|||
37741439|NCT01856257|69227511|FG000|Overall Study|Physician Decision|0|||
37648043|NCT01651936|69117441|FG002|Extension Study|Study terminated by sponsor|13|||
37648044|NCT02395042|69117451|FG000|Treatment 1 Period|Adverse Event|1|||
37648045|NCT02395042|69117452|FG001|Treatment 1 Period|Adverse Event|3|||
37648046|NCT02395042|69117453|FG002|Treatment 1 Period|Adverse Event|1|||
37648047|NCT02395042|69117451|FG000|Treatment 1 Period|Lack of Efficacy|1|||
37648048|NCT02395042|69117452|FG001|Treatment 1 Period|Lack of Efficacy|1|||
37648049|NCT02395042|69117453|FG002|Treatment 1 Period|Lack of Efficacy|0|||
37648050|NCT02395042|69117451|FG000|Treatment 1 Period|Lost to Follow-up|1|||
37648051|NCT02395042|69117452|FG001|Treatment 1 Period|Lost to Follow-up|0|||
37648052|NCT02395042|69117453|FG002|Treatment 1 Period|Lost to Follow-up|0|||
37648053|NCT02395042|69117451|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
37648054|NCT02395042|69117452|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
37648055|NCT02395042|69117453|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
37648056|NCT02395042|69117451|FG000|Treatment 2 Period|Lack of Efficacy|1|||
37648057|NCT02395042|69117452|FG001|Treatment 2 Period|Lack of Efficacy|1|||
37648058|NCT02395042|69117453|FG002|Treatment 2 Period|Lack of Efficacy|0|||
37648059|NCT02394808|69117464|FG000|Period 1|Unsatisfactory lens fitting|0|||
37648060|NCT02394808|69117465|FG001|Period 1|Unsatisfactory lens fitting|1|||
37648061|NCT02394808|69117464|FG000|Period 2|Lost to Follow-up|1|||
37648062|NCT02394808|69117465|FG001|Period 2|Lost to Follow-up|0|||
37648063|NCT02630966|69117473|FG000|Overall Study|Adverse Event|1|||
37648064|NCT02630966|69117474|FG001|Overall Study|Adverse Event|3|||
37648065|NCT02630966|69117473|FG000|Overall Study|Significant Protocol Deviation|0|||
37648066|NCT02630966|69117474|FG001|Overall Study|Significant Protocol Deviation|2|||
37648067|NCT02630966|69117473|FG000|Overall Study|Voluntary Withdrawal|1|||
37648068|NCT02630966|69117474|FG001|Overall Study|Voluntary Withdrawal|1|||
37648069|NCT02630966|69117473|FG000|Overall Study|Lack of Efficacy|0|||
37648070|NCT02630966|69117474|FG001|Overall Study|Lack of Efficacy|2|||
37648071|NCT01651780|69117482|FG000|Overall Study|Physician decision: No 30-day visit|2|||
37648072|NCT01651780|69117483|FG001|Overall Study|Physician decision: No 30-day visit|1|||
37648073|NCT01651780|69117482|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
37648074|NCT01651780|69117483|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
37648075|NCT01651780|69117482|FG000|Overall Study|Withdrawal by Subject|2|||
37648076|NCT01651780|69117483|FG001|Overall Study|Withdrawal by Subject|0|||
37648077|NCT01651780|69117482|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
37648078|NCT01651780|69117483|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
37648079|NCT01651780|69117482|FG000|Overall Study|Lost to Follow-up|1|||
37648080|NCT01651780|69117483|FG001|Overall Study|Lost to Follow-up|2|||
37648081|NCT01651780|69117482|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
37648082|NCT01651780|69117483|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
37648083|NCT02394730|69117495|FG000|Overall Study|Lost to Follow-up|1|||
37648084|NCT02394730|69117496|FG001|Overall Study|Lost to Follow-up|0|||
37648085|NCT02394730|69117495|FG000|Overall Study|Withdrawal by Subject|0|||
37648086|NCT02394730|69117496|FG001|Overall Study|Withdrawal by Subject|1|||
37648087|NCT02430532|69117504|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
37648088|NCT02430532|69117505|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
37648089|NCT02430532|69117504|FG000|Overall Study|Consent Withdrawn|0|||
37648090|NCT02430532|69117505|FG001|Overall Study|Consent Withdrawn|2|||
37648091|NCT02430532|69117504|FG000|Overall Study|Adverse Event|0|||
37648092|NCT02430532|69117505|FG001|Overall Study|Adverse Event|1|||
37648093|NCT02394340|69117513|FG000|Overall Study|Failed drug screen test|1|||
37648094|NCT02394340|69117513|FG000|Overall Study|Adverse Event|1|||
37648095|NCT01672736|69117517|FG000|Overall Study|Available drug expired on 31 May 16|3|||
37648096|NCT01560637|69117521|FG000|Overall Study|Adverse Event|63|||
37648097|NCT01560637|69117521|FG000|Overall Study|Death|69|||
37648098|NCT01560637|69117521|FG000|Overall Study|Lost to Follow-up|8|||
37648099|NCT01560637|69117521|FG000|Overall Study|Protocol Violation|8|||
37648100|NCT01560637|69117521|FG000|Overall Study|Withdrawal by Subject|24|||
37648101|NCT01560637|69117521|FG000|Overall Study|Progressive Disease|20|||
37648102|NCT01560637|69117521|FG000|Overall Study|Other Reason Not Specified|6|||
37648103|NCT01353911|69117533|FG000|Overall Study|Lost to Follow-up|2|||
37648104|NCT01353911|69117534|FG001|Overall Study|Lost to Follow-up|6|||
37648105|NCT01353911|69117535|FG002|Overall Study|Lost to Follow-up|4|||
37648106|NCT01353911|69117536|FG003|Overall Study|Lost to Follow-up|0|||
37648107|NCT01353911|69117537|FG004|Overall Study|Lost to Follow-up|4|||
37922218|NCT00460603|69609076|FG010|Phase 1|Adverse Event|0|||
37648108|NCT01353911|69117538|FG005|Overall Study|Lost to Follow-up|4|||
37648109|NCT01353911|69117539|FG006|Overall Study|Lost to Follow-up|3|||
37648110|NCT01353911|69117540|FG007|Overall Study|Lost to Follow-up|6|||
37648111|NCT01353911|69117533|FG000|Overall Study|Withdrawal by Subject|2|||
37648112|NCT01353911|69117534|FG001|Overall Study|Withdrawal by Subject|3|||
37648113|NCT01353911|69117535|FG002|Overall Study|Withdrawal by Subject|4|||
37648114|NCT01353911|69117536|FG003|Overall Study|Withdrawal by Subject|2|||
37648115|NCT01353911|69117537|FG004|Overall Study|Withdrawal by Subject|2|||
37648116|NCT01353911|69117538|FG005|Overall Study|Withdrawal by Subject|3|||
37648117|NCT01353911|69117539|FG006|Overall Study|Withdrawal by Subject|3|||
37648118|NCT01353911|69117540|FG007|Overall Study|Withdrawal by Subject|9|||
37648119|NCT01353911|69117533|FG000|Overall Study|Status Not Recorded|4|||
37648120|NCT01353911|69117534|FG001|Overall Study|Status Not Recorded|0|||
37648121|NCT01353911|69117535|FG002|Overall Study|Status Not Recorded|1|||
37648122|NCT01353911|69117536|FG003|Overall Study|Status Not Recorded|0|||
37648123|NCT01353911|69117537|FG004|Overall Study|Status Not Recorded|0|||
37648124|NCT01353911|69117538|FG005|Overall Study|Status Not Recorded|0|||
37648125|NCT01353911|69117539|FG006|Overall Study|Status Not Recorded|0|||
37648126|NCT01353911|69117540|FG007|Overall Study|Status Not Recorded|0|||
37648127|NCT01671488|69117558|FG000|Overall Study|Withdrawal by Subject|1|||
37648128|NCT02783911|69117564|FG000|Overall Study|Lost to Follow-up|3|||
37648129|NCT02783911|69117565|FG001|Overall Study|Lost to Follow-up|32|||
37648130|NCT01358357|69117573|FG000|Open Label Phase|Adverse Event|0|||
37648131|NCT01358357|69117574|FG001|Open Label Phase|Adverse Event|0|||
37648132|NCT01358357|69117575|FG002|Open Label Phase|Adverse Event|59|||
37648133|NCT01358357|69117573|FG000|Open Label Phase|Lack of Efficacy|0|||
37648134|NCT01358357|69117574|FG001|Open Label Phase|Lack of Efficacy|0|||
37648135|NCT01358357|69117575|FG002|Open Label Phase|Lack of Efficacy|107|||
37648136|NCT01358357|69117573|FG000|Open Label Phase|Lost to Follow-up|0|||
37648137|NCT01358357|69117574|FG001|Open Label Phase|Lost to Follow-up|0|||
37648138|NCT01358357|69117575|FG002|Open Label Phase|Lost to Follow-up|76|||
37648139|NCT01358357|69117573|FG000|Open Label Phase|Protocol Violation|0|||
37648140|NCT01358357|69117574|FG001|Open Label Phase|Protocol Violation|0|||
37648141|NCT01358357|69117575|FG002|Open Label Phase|Protocol Violation|45|||
37648142|NCT01358357|69117573|FG000|Open Label Phase|Withdrawal by Subject|0|||
37648143|NCT01358357|69117574|FG001|Open Label Phase|Withdrawal by Subject|0|||
37648144|NCT01358357|69117575|FG002|Open Label Phase|Withdrawal by Subject|112|||
37648145|NCT01358357|69117573|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
37648146|NCT01358357|69117574|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
37648147|NCT01358357|69117575|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
37648148|NCT01358357|69117573|FG000|Open Label Phase|Terminated at study completion|0|||
37648149|NCT01358357|69117574|FG001|Open Label Phase|Terminated at study completion|0|||
37648150|NCT01358357|69117575|FG002|Open Label Phase|Terminated at study completion|5|||
37648151|NCT01358357|69117573|FG000|Open Label Phase|Mood episode|0|||
37648152|NCT01358357|69117574|FG001|Open Label Phase|Mood episode|0|||
37648153|NCT01358357|69117575|FG002|Open Label Phase|Mood episode|42|||
37648154|NCT01358357|69117573|FG000|Double-Blind Phase|Adverse Event|8|||
37648155|NCT01358357|69117574|FG001|Double-Blind Phase|Adverse Event|5|||
37648156|NCT01358357|69117575|FG002|Double-Blind Phase|Adverse Event|0|||
37648157|NCT01358357|69117573|FG000|Double-Blind Phase|Lost to Follow-up|5|||
37648158|NCT01358357|69117574|FG001|Double-Blind Phase|Lost to Follow-up|7|||
37648159|NCT01358357|69117575|FG002|Double-Blind Phase|Lost to Follow-up|0|||
37648160|NCT01358357|69117573|FG000|Double-Blind Phase|Protocol Violation|1|||
37648161|NCT01358357|69117574|FG001|Double-Blind Phase|Protocol Violation|11|||
37648162|NCT01358357|69117575|FG002|Double-Blind Phase|Protocol Violation|0|||
37648163|NCT01358357|69117573|FG000|Double-Blind Phase|Protocol Violation|16|||
37648164|NCT01358357|69117574|FG001|Double-Blind Phase|Protocol Violation|12|||
37648165|NCT01358357|69117575|FG002|Double-Blind Phase|Protocol Violation|0|||
37648166|NCT01358357|69117573|FG000|Double-Blind Phase|Terminated at study completion|2|||
37648167|NCT01358357|69117574|FG001|Double-Blind Phase|Terminated at study completion|0|||
37648168|NCT01358357|69117575|FG002|Double-Blind Phase|Terminated at study completion|0|||
37648169|NCT01358357|69117573|FG000|Double-Blind Phase|Recurrence of mood event|48|||
37648170|NCT01358357|69117574|FG001|Double-Blind Phase|Recurrence of mood event|64|||
37648171|NCT01358357|69117575|FG002|Double-Blind Phase|Recurrence of mood event|0|||
37648172|NCT01358357|69117573|FG000|Double-Blind Phase|Administrative|0|||
37648173|NCT01358357|69117574|FG001|Double-Blind Phase|Administrative|1|||
37648174|NCT01358357|69117575|FG002|Double-Blind Phase|Administrative|0|||
37648175|NCT02831387|69117584|FG000|Overall Study|Withdrawal by Subject|1|||
37648176|NCT02831387|69117585|FG001|Overall Study|Withdrawal by Subject|1|||
37648177|NCT02831387|69117584|FG000|Overall Study|Discontinued due to stock recovery|0|||
37648178|NCT02831387|69117585|FG001|Overall Study|Discontinued due to stock recovery|1|||
37648179|NCT02831855|69117591|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
37648180|NCT02831855|69117592|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
38032282|NCT03345836|69718187|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
37648181|NCT02831855|69117593|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
37648182|NCT02831855|69117591|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
37648183|NCT02831855|69117592|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
37648184|NCT02831855|69117593|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
38032283|NCT03345836|69718188|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
37648185|NCT02831855|69117591|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
37648186|NCT02831855|69117592|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
37648187|NCT02831855|69117593|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
37648188|NCT02831855|69117591|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
37741440|NCT01856257|69227512|FG001|Overall Study|Physician Decision|0|||
37648189|NCT02831855|69117592|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
37648190|NCT02831855|69117593|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
37648191|NCT02831855|69117591|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
37648192|NCT02831855|69117592|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
37648193|NCT02831855|69117593|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
37648194|NCT02831855|69117591|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
37648195|NCT02831855|69117592|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
37648196|NCT02831855|69117593|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
37648197|NCT02831855|69117591|FG000|Open Label Phase (24 Weeks)|Other|4|||
37648198|NCT02831855|69117592|FG001|Open Label Phase (24 Weeks)|Other|0|||
37648199|NCT02831855|69117593|FG002|Open Label Phase (24 Weeks)|Other|0|||
37648200|NCT02831855|69117591|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
37648201|NCT02831855|69117592|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
37648202|NCT02831855|69117593|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
37648203|NCT02831855|69117591|FG000|Double Blind Phase (24 Weeks)|Death|0|||
37648204|NCT02831855|69117592|FG001|Double Blind Phase (24 Weeks)|Death|0|||
37648205|NCT02831855|69117593|FG002|Double Blind Phase (24 Weeks)|Death|2|||
37648206|NCT02831855|69117591|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
37648207|NCT02831855|69117592|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
37648208|NCT02831855|69117593|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
37648209|NCT02831855|69117591|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
37648210|NCT02831855|69117592|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
37741441|NCT01856257|69227513|FG002|Overall Study|Physician Decision|0|||
37741442|NCT01856257|69227514|FG003|Overall Study|Physician Decision|1|||
37741443|NCT01856257|69227511|FG000|Overall Study|Withdrawal by Subject|1|||
37741444|NCT01856257|69227512|FG001|Overall Study|Withdrawal by Subject|1|||
37741445|NCT01856257|69227513|FG002|Overall Study|Withdrawal by Subject|0|||
37741446|NCT01856257|69227514|FG003|Overall Study|Withdrawal by Subject|0|||
37741447|NCT01856257|69227511|FG000|Overall Study|Donor complication|0|||
37741448|NCT01856257|69227512|FG001|Overall Study|Donor complication|0|||
37741449|NCT01856257|69227513|FG002|Overall Study|Donor complication|0|||
37741450|NCT01856257|69227514|FG003|Overall Study|Donor complication|1|||
37741451|NCT00215943|69227525|FG000|Overall Study|Disease Progression|3|||
37741452|NCT00215943|69227526|FG001|Overall Study|Disease Progression|5|||
37741453|NCT00215943|69227525|FG000|Overall Study|Alternate therapy|0|||
37741454|NCT00215943|69227526|FG001|Overall Study|Alternate therapy|1|||
37741455|NCT00215943|69227525|FG000|Overall Study|Adverse Event|3|||
37741456|NCT00215943|69227526|FG001|Overall Study|Adverse Event|6|||
37741457|NCT00215943|69227525|FG000|Overall Study|Other disease|0|||
37741458|NCT00215943|69227526|FG001|Overall Study|Other disease|1|||
37741459|NCT00215943|69227525|FG000|Overall Study|Other complications|3|||
37741460|NCT00215943|69227526|FG001|Overall Study|Other complications|1|||
37741461|NCT01827319|69227532|FG000|Overall Study|Lost to Follow-up|3|||
37741462|NCT01827163|69227536|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
37741463|NCT01827163|69227536|FG000|Overall Study|Adverse Event|9|||
37741464|NCT00215553|69227547|FG000|Overall Study|Adverse Event|0|||
37741465|NCT00215553|69227548|FG001|Overall Study|Adverse Event|1|||
37741466|NCT00215553|69227549|FG002|Overall Study|Adverse Event|2|||
37741467|NCT00215553|69227550|FG003|Overall Study|Adverse Event|1|||
37741468|NCT00215553|69227551|FG004|Overall Study|Adverse Event|2|||
37741469|NCT00215553|69227552|FG005|Overall Study|Adverse Event|6|||
37741470|NCT00215553|69227553|FG006|Overall Study|Adverse Event|0|||
37741471|NCT00214461|69227573|FG000|Overall Study|Adverse Event|0|||
37741472|NCT00214461|69227574|FG001|Overall Study|Adverse Event|0|||
37741473|NCT00214461|69227575|FG002|Overall Study|Adverse Event|1|||
37741474|NCT00214461|69227576|FG003|Overall Study|Adverse Event|1|||
37741475|NCT00214461|69227573|FG000|Overall Study|Withdrawal by Subject|0|||
37741476|NCT00214461|69227574|FG001|Overall Study|Withdrawal by Subject|0|||
37741477|NCT00214461|69227575|FG002|Overall Study|Withdrawal by Subject|1|||
37741478|NCT00214461|69227576|FG003|Overall Study|Withdrawal by Subject|0|||
37741479|NCT00214383|69227588|FG000|Overall Study|Lost to Follow-up|16|||
37741480|NCT00214383|69227589|FG001|Overall Study|Lost to Follow-up|26|||
37741481|NCT00212355|69227595|FG000|Overall Study|Adverse Event|1|||
37648211|NCT02831855|69117593|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
37648212|NCT02831855|69117591|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
37648213|NCT02831855|69117592|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
37648214|NCT02831855|69117593|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
37741482|NCT00212355|69227595|FG000|Overall Study|Withdrawal by Subject|1|||
37741483|NCT00212355|69227595|FG000|Overall Study|A change of address|1|||
37741484|NCT00211887|69227602|FG000|Overall Study|Adverse Event|8|||
37741485|NCT00211887|69227603|FG001|Overall Study|Adverse Event|4|||
37741486|NCT00211887|69227604|FG002|Overall Study|Adverse Event|6|||
37741487|NCT00211887|69227602|FG000|Overall Study|Death|1|||
37741488|NCT00211887|69227603|FG001|Overall Study|Death|1|||
37741489|NCT00211887|69227604|FG002|Overall Study|Death|1|||
37741490|NCT00211887|69227602|FG000|Overall Study|Lost to Follow-up|28|||
37648215|NCT02831855|69117591|FG000|Double Blind Phase (24 Weeks)|Other|0|||
37648216|NCT02831855|69117592|FG001|Double Blind Phase (24 Weeks)|Other|2|||
37648217|NCT02831855|69117593|FG002|Double Blind Phase (24 Weeks)|Other|5|||
37648218|NCT02831855|69117591|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
37648219|NCT02831855|69117592|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
37648220|NCT02831855|69117593|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
37648221|NCT02831855|69117591|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
37648222|NCT02831855|69117592|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
37648223|NCT02831855|69117593|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
37648224|NCT02831855|69117591|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
37648225|NCT02831855|69117592|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
37648226|NCT02831855|69117593|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
37648227|NCT02628938|69117606|FG000|Overall Study|Did not attend the follow up recall|2|||
37648228|NCT02628938|69117607|FG001|Overall Study|Did not attend the follow up recall|2|||
37648229|NCT02628938|69117608|FG002|Overall Study|Did not attend the follow up recall|1|||
37648230|NCT02628938|69117606|FG000|Overall Study|Failure to comply with the instructions|3|||
37648231|NCT02628938|69117607|FG001|Overall Study|Failure to comply with the instructions|0|||
37648232|NCT02628938|69117608|FG002|Overall Study|Failure to comply with the instructions|3|||
37648233|NCT01356407|69117622|FG000|Overall Study|Lost to Follow-up|2|||
37648234|NCT01356407|69117623|FG001|Overall Study|Lost to Follow-up|0|||
37648235|NCT01356407|69117622|FG000|Overall Study|Patient Withdrew Consent|2|||
37648236|NCT01356407|69117623|FG001|Overall Study|Patient Withdrew Consent|1|||
37648237|NCT01356407|69117622|FG000|Overall Study|Could not afford IMP administration|0|||
37648238|NCT01356407|69117623|FG001|Overall Study|Could not afford IMP administration|1|||
37648239|NCT01356407|69117622|FG000|Overall Study|Not complete Endoscopy|2|||
37648240|NCT01356407|69117623|FG001|Overall Study|Not complete Endoscopy|2|||
37648241|NCT00109837|69117629|FG000|Overall Study|Adverse Event|2|||
37648242|NCT00109837|69117629|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
37648243|NCT00109837|69117629|FG000|Overall Study|Death|1|||
37648244|NCT00109837|69117629|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
37648245|NCT00109837|69117629|FG000|Overall Study|Not treated|1|||
37648246|NCT00109837|69117629|FG000|Overall Study|Ineligible|1|||
37648247|NCT02828111|69117642|FG000|Overall Study|Withdrawal by Subject|0|||
37648248|NCT02828111|69117643|FG001|Overall Study|Withdrawal by Subject|0|||
37648249|NCT02828111|69117644|FG002|Overall Study|Withdrawal by Subject|2|||
37648250|NCT02828111|69117645|FG003|Overall Study|Withdrawal by Subject|0|||
37648251|NCT02828111|69117646|FG004|Overall Study|Withdrawal by Subject|0|||
37648252|NCT02828111|69117642|FG000|Overall Study|Lost to Follow-up|0|||
37648253|NCT02828111|69117643|FG001|Overall Study|Lost to Follow-up|0|||
37648254|NCT02828111|69117644|FG002|Overall Study|Lost to Follow-up|0|||
37648255|NCT02828111|69117645|FG003|Overall Study|Lost to Follow-up|1|||
37648256|NCT02828111|69117646|FG004|Overall Study|Lost to Follow-up|1|||
37648257|NCT01671332|69117669|FG000|Overall Study|Withdrawal by Subject|1|||
37648258|NCT01671332|69117670|FG001|Overall Study|Withdrawal by Subject|1|||
37648259|NCT01355627|69117678|FG000|Overall Study|Request By the Patient to Discontinue|5|||
37648260|NCT01355627|69117679|FG001|Overall Study|Request By the Patient to Discontinue|7|||
37648261|NCT01355627|69117678|FG000|Overall Study|Lost to Follow-up|8|||
37648262|NCT01355627|69117679|FG001|Overall Study|Lost to Follow-up|7|||
37648263|NCT01355627|69117678|FG000|Overall Study|Fatal Adverse Event|19|||
37648264|NCT01355627|69117679|FG001|Overall Study|Fatal Adverse Event|23|||
37648265|NCT01355627|69117678|FG000|Overall Study|Other|1|||
37648266|NCT01355627|69117679|FG001|Overall Study|Other|1|||
37648267|NCT00100802|69117685|FG000|Overall Study|Adverse Event|9|||
37741491|NCT00211887|69227603|FG001|Overall Study|Lost to Follow-up|13|||
37741492|NCT00211887|69227604|FG002|Overall Study|Lost to Follow-up|9|||
37855002|NCT01296698|69538375|FG000|Overall Study|Withdrawal by Subject|12|||
37648268|NCT00100802|69117685|FG000|Overall Study|Death|1|||
37855003|NCT01296698|69538376|FG001|Overall Study|Withdrawal by Subject|0|||
37855004|NCT01296698|69538375|FG000|Overall Study|Difficulty Contacting Subject|2|||
37855005|NCT01296698|69538376|FG001|Overall Study|Difficulty Contacting Subject|0|||
37648269|NCT00100802|69117685|FG000|Overall Study|Lack of Efficacy|47|||
37855006|NCT01296698|69538375|FG000|Overall Study|Study Terminated by Sponsor|209|||
37648270|NCT00100802|69117685|FG000|Overall Study|Physician Decision|5|||
37741493|NCT00211887|69227602|FG000|Overall Study|Non-medical reason|31|||
37741494|NCT00211887|69227603|FG001|Overall Study|Non-medical reason|14|||
37855007|NCT01296698|69538376|FG001|Overall Study|Study Terminated by Sponsor|12|||
37855008|NCT01001221|69538386|FG000|Overall Study|Adverse Event|1|||
37648271|NCT00100802|69117685|FG000|Overall Study|Protocol Violation|1|||
37648272|NCT00100802|69117685|FG000|Overall Study|Withdrawal by Subject|5|||
37648273|NCT00100802|69117685|FG000|Overall Study|Ineligible|12|||
37648274|NCT01355159|69117691|FG000|Overall Study|Withdrew consent|39|||
37648275|NCT01355159|69117692|FG001|Overall Study|Withdrew consent|47|||
37741495|NCT00211887|69227604|FG002|Overall Study|Non-medical reason|8|||
37855009|NCT01001221|69538387|FG001|Overall Study|Adverse Event|2|||
37855010|NCT01001221|69538388|FG002|Overall Study|Adverse Event|0|||
37648276|NCT01355159|69117691|FG000|Overall Study|No primary outcome data|17|||
37648277|NCT01355159|69117692|FG001|Overall Study|No primary outcome data|11|||
37648278|NCT01355159|69117691|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
37648279|NCT01355159|69117692|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
37648280|NCT01355159|69117691|FG000|Overall Study|Early intrauterine fetal death|6|||
37648281|NCT01355159|69117692|FG001|Overall Study|Early intrauterine fetal death|6|||
37648282|NCT02630186|69117698|FG000|Overall Study|Withdrawal by Subject|1|||
37648283|NCT01669928|69117704|FG000|First Intervention|Withdrawal by Subject|3|||
37648284|NCT01669928|69117705|FG001|First Intervention|Withdrawal by Subject|5|||
37648285|NCT01355081|69117716|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
37648286|NCT01355081|69117717|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
37648287|NCT01355081|69117718|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
37648288|NCT01355081|69117716|FG000|Overall Study|Major Protocol Deviation|0|||
37648289|NCT01355081|69117717|FG001|Overall Study|Major Protocol Deviation|1|||
37648290|NCT01355081|69117718|FG002|Overall Study|Major Protocol Deviation|0|||
37648291|NCT01355081|69117716|FG000|Overall Study|Lost to Follow-up|0|||
37648292|NCT01355081|69117717|FG001|Overall Study|Lost to Follow-up|0|||
37648293|NCT01355081|69117718|FG002|Overall Study|Lost to Follow-up|1|||
37648294|NCT01355081|69117716|FG000|Overall Study|Withdrawal of Consent|2|||
37648295|NCT01355081|69117717|FG001|Overall Study|Withdrawal of Consent|3|||
37648296|NCT01355081|69117718|FG002|Overall Study|Withdrawal of Consent|3|||
37648297|NCT01355081|69117716|FG000|Overall Study|Lack of Efficacy|2|||
37648298|NCT01355081|69117717|FG001|Overall Study|Lack of Efficacy|1|||
37648299|NCT01355081|69117718|FG002|Overall Study|Lack of Efficacy|1|||
37648300|NCT01355081|69117716|FG000|Overall Study|Non Compliance with Study Medication|0|||
37648301|NCT01355081|69117717|FG001|Overall Study|Non Compliance with Study Medication|1|||
37648302|NCT01355081|69117718|FG002|Overall Study|Non Compliance with Study Medication|0|||
37648303|NCT01354223|69117728|FG000|Overall Study|Withdrawal by Subject|3|||
37648304|NCT01354223|69117729|FG001|Overall Study|Withdrawal by Subject|1|||
37648305|NCT04043455|69117739|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
37648306|NCT04043455|69117740|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
37648307|NCT04043455|69117741|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
37648308|NCT04043455|69117742|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
37648309|NCT04043455|69117743|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
37648310|NCT04043455|69117744|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
37648311|NCT04043455|69117739|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
37648312|NCT04043455|69117740|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
37648313|NCT04043455|69117741|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
37648314|NCT04043455|69117742|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
37648315|NCT04043455|69117743|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
37648316|NCT04043455|69117744|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
37648317|NCT04043455|69117739|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
37648318|NCT04043455|69117740|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
37648319|NCT04043455|69117741|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
37741496|NCT00211887|69227602|FG000|Overall Study|Other medical reason|15|||
37741497|NCT00211887|69227603|FG001|Overall Study|Other medical reason|11|||
37741498|NCT00211887|69227604|FG002|Overall Study|Other medical reason|7|||
37741499|NCT00211887|69227602|FG000|Overall Study|Side effects|19|||
38032284|NCT03345836|69718189|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
38032285|NCT03345836|69718190|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
38032286|NCT03345836|69718191|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
38032287|NCT03345836|69718186|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
38032288|NCT03345836|69718187|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
38032289|NCT03345836|69718188|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
38032290|NCT03345836|69718189|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
38032291|NCT03345836|69718190|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
38032292|NCT03345836|69718191|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
37855011|NCT01001221|69538389|FG003|Overall Study|Adverse Event|2|||
37855012|NCT01001221|69538390|FG004|Overall Study|Adverse Event|0|||
37648320|NCT04043455|69117742|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
37855013|NCT01001221|69538386|FG000|Overall Study|Disease progression|3|||
37855014|NCT01001221|69538387|FG001|Overall Study|Disease progression|2|||
37648321|NCT04043455|69117743|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
37648322|NCT04043455|69117744|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
37648323|NCT04043455|69117739|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
37648324|NCT04043455|69117740|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
37648325|NCT04043455|69117741|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
37741500|NCT00211887|69227603|FG001|Overall Study|Side effects|13|||
37741501|NCT00211887|69227604|FG002|Overall Study|Side effects|5|||
37855015|NCT01001221|69538388|FG002|Overall Study|Disease progression|2|||
37648326|NCT04043455|69117742|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
37648327|NCT04043455|69117743|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
37648328|NCT04043455|69117744|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
37648329|NCT04043455|69117739|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
37648330|NCT04043455|69117740|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
37648331|NCT04043455|69117741|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
37648332|NCT04043455|69117742|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
37648333|NCT04043455|69117743|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
37648334|NCT04043455|69117744|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
37648335|NCT04043455|69117739|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
37648336|NCT04043455|69117740|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
37648337|NCT04043455|69117741|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
37648338|NCT04043455|69117742|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
37648339|NCT04043455|69117743|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
37648340|NCT04043455|69117744|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
37648341|NCT04043455|69117739|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
37648342|NCT04043455|69117740|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
37648343|NCT04043455|69117741|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
37648344|NCT04043455|69117742|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
37648345|NCT04043455|69117743|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
37648346|NCT04043455|69117744|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
37648347|NCT04043455|69117739|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
37648348|NCT04043455|69117740|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
37648349|NCT04043455|69117741|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
37648350|NCT04043455|69117742|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
37648351|NCT04043455|69117743|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
37648352|NCT04043455|69117744|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
37648353|NCT04043455|69117739|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
37648354|NCT04043455|69117740|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
37648355|NCT04043455|69117741|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
37648356|NCT04043455|69117742|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
37648357|NCT04043455|69117743|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
37648358|NCT04043455|69117744|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
37648359|NCT04043455|69117739|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
37648360|NCT04043455|69117740|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
37648361|NCT04043455|69117741|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
37648362|NCT04043455|69117742|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
37648363|NCT04043455|69117743|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
37648364|NCT04043455|69117744|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
37648365|NCT04043455|69117739|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
37648366|NCT04043455|69117740|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
37648367|NCT04043455|69117741|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
37648368|NCT04043455|69117742|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
37648369|NCT04043455|69117743|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
37648370|NCT04043455|69117744|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
37648371|NCT02627144|69117762|FG000|Overall Study|Serious adverse event|32|||
37648372|NCT02627144|69117762|FG000|Overall Study|Cancer progression|171|||
37648373|NCT02627144|69117762|FG000|Overall Study|Death from cancer|20|||
37648374|NCT02627144|69117762|FG000|Overall Study|Death from other cause|8|||
37648375|NCT02627144|69117762|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
37648376|NCT02627144|69117762|FG000|Overall Study|Administrative reasons|65|||
37648377|NCT02627144|69117762|FG000|Overall Study|Lost to Follow-up|8|||
37648378|NCT02627144|69117762|FG000|Overall Study|Enrolled, not treated|6|||
37648379|NCT02627144|69117762|FG000|Overall Study|Other|17|||
37648380|NCT02626520|69117768|FG000|Overall Study|Physician Decision|1|||
37648381|NCT02626520|69117769|FG001|Overall Study|Physician Decision|1|||
37648382|NCT02626520|69117768|FG000|Overall Study|Adverse Event|0|||
37648383|NCT02626520|69117769|FG001|Overall Study|Adverse Event|4|||
37648384|NCT02626520|69117768|FG000|Overall Study|Lack of Efficacy|0|||
37648385|NCT02626520|69117769|FG001|Overall Study|Lack of Efficacy|2|||
37648386|NCT02626520|69117768|FG000|Overall Study|Did not start protocol therapy|0|||
37648387|NCT02626520|69117769|FG001|Overall Study|Did not start protocol therapy|2|||
37648388|NCT02626520|69117768|FG000|Overall Study|Study terminated|0|||
37648389|NCT02626520|69117769|FG001|Overall Study|Study terminated|1|||
37648390|NCT04522141|69117777|FG000|Overall Study|Withdrawal by Subject|1|||
37741502|NCT01855945|69227624|FG000|Overall Study|Adverse Event|0|||
37648391|NCT04522141|69117778|FG001|Overall Study|Withdrawal by Subject|0|||
37648392|NCT01329029|69117801|FG000|Overall Study|Withdrawal by Subject|117|||
37648393|NCT01329029|69117802|FG001|Overall Study|Withdrawal by Subject|87|||
37648394|NCT01329029|69117801|FG000|Overall Study|Adverse Event|82|||
37648395|NCT01329029|69117802|FG001|Overall Study|Adverse Event|29|||
37648396|NCT01329029|69117801|FG000|Overall Study|Death|16|||
37648397|NCT01329029|69117802|FG001|Overall Study|Death|19|||
37648398|NCT01329029|69117801|FG000|Overall Study|Other|14|||
37648399|NCT01329029|69117802|FG001|Overall Study|Other|20|||
37648400|NCT01329029|69117801|FG000|Overall Study|COPD Exacerbation|11|||
37648401|NCT01329029|69117802|FG001|Overall Study|COPD Exacerbation|18|||
37648402|NCT01329029|69117801|FG000|Overall Study|Physician Decision|16|||
37648403|NCT01329029|69117802|FG001|Overall Study|Physician Decision|13|||
37648404|NCT01329029|69117801|FG000|Overall Study|Lost to Follow-up|8|||
37648405|NCT01329029|69117802|FG001|Overall Study|Lost to Follow-up|5|||
37648406|NCT01329029|69117801|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
37648407|NCT01329029|69117802|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
37648408|NCT01372085|69117818|FG000|Washout Period 2|Physician Decision|0|||
37648409|NCT01372085|69117819|FG001|Washout Period 2|Physician Decision|0|||
37648410|NCT01372085|69117820|FG002|Washout Period 2|Physician Decision|0|||
37648411|NCT01372085|69117821|FG003|Washout Period 2|Physician Decision|0|||
37648412|NCT01372085|69117822|FG004|Washout Period 2|Physician Decision|1|||
37648413|NCT01372085|69117823|FG005|Washout Period 2|Physician Decision|0|||
37648414|NCT01372085|69117824|FG006|Washout Period 2|Physician Decision|0|||
37648415|NCT01372085|69117825|FG007|Washout Period 2|Physician Decision|0|||
37648416|NCT01372085|69117826|FG008|Washout Period 2|Physician Decision|0|||
37648417|NCT01372085|69117827|FG009|Washout Period 2|Physician Decision|0|||
37648418|NCT01372085|69117818|FG000|Washout Period 3|Withdrawal by Subject|0|||
37648419|NCT01372085|69117819|FG001|Washout Period 3|Withdrawal by Subject|0|||
37648420|NCT01372085|69117820|FG002|Washout Period 3|Withdrawal by Subject|0|||
37648421|NCT01372085|69117821|FG003|Washout Period 3|Withdrawal by Subject|0|||
37648422|NCT01372085|69117822|FG004|Washout Period 3|Withdrawal by Subject|0|||
37648423|NCT01372085|69117823|FG005|Washout Period 3|Withdrawal by Subject|2|||
37648424|NCT01372085|69117824|FG006|Washout Period 3|Withdrawal by Subject|0|||
37648425|NCT01372085|69117825|FG007|Washout Period 3|Withdrawal by Subject|0|||
37648426|NCT01372085|69117826|FG008|Washout Period 3|Withdrawal by Subject|0|||
37648427|NCT01372085|69117827|FG009|Washout Period 3|Withdrawal by Subject|0|||
37648428|NCT04012853|69117853|FG000|Overall Study|Withdrawal by Subject|1|||
37648429|NCT04012853|69117854|FG001|Overall Study|Withdrawal by Subject|1|||
37648430|NCT04012853|69117853|FG000|Overall Study|Protocol Violation|1|||
37648431|NCT04012853|69117854|FG001|Overall Study|Protocol Violation|0|||
37648432|NCT04012853|69117853|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
37648433|NCT04012853|69117854|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
37648434|NCT02941549|69117863|FG000|Overall Study|Adverse Event|1|||
37648435|NCT02941549|69117864|FG001|Overall Study|Adverse Event|0|||
37648436|NCT02941549|69117865|FG002|Overall Study|Adverse Event|0|||
37648437|NCT02941549|69117863|FG000|Overall Study|Withdrawal by Subject|2|||
37648438|NCT02941549|69117864|FG001|Overall Study|Withdrawal by Subject|1|||
37648439|NCT02941549|69117865|FG002|Overall Study|Withdrawal by Subject|2|||
37648440|NCT02394028|69117887|FG000|Induction Phase|Adverse Event|2|||
37648441|NCT02394028|69117888|FG001|Induction Phase|Adverse Event|4|||
37648442|NCT02394028|69117889|FG002|Induction Phase|Adverse Event|1|||
37648443|NCT02394028|69117890|FG003|Induction Phase|Adverse Event|2|||
37648444|NCT02394028|69117891|FG004|Induction Phase|Adverse Event|5|||
37648445|NCT02394028|69117892|FG005|Induction Phase|Adverse Event|2|||
37648446|NCT02394028|69117893|FG006|Induction Phase|Adverse Event|0|||
37648447|NCT02394028|69117894|FG007|Induction Phase|Adverse Event|0|||
37648448|NCT02394028|69117895|FG008|Induction Phase|Adverse Event|0|||
37648449|NCT02394028|69117896|FG009|Induction Phase|Adverse Event|0|||
37648450|NCT02394028|69117897|FG010|Induction Phase|Adverse Event|0|||
37648451|NCT02394028|69117887|FG000|Induction Phase|Lack of Efficacy|3|||
37648452|NCT02394028|69117888|FG001|Induction Phase|Lack of Efficacy|6|||
37648453|NCT02394028|69117889|FG002|Induction Phase|Lack of Efficacy|2|||
37648454|NCT02394028|69117890|FG003|Induction Phase|Lack of Efficacy|17|||
37648455|NCT02394028|69117891|FG004|Induction Phase|Lack of Efficacy|14|||
37648456|NCT02394028|69117892|FG005|Induction Phase|Lack of Efficacy|8|||
37648457|NCT02394028|69117893|FG006|Induction Phase|Lack of Efficacy|17|||
37648458|NCT02394028|69117894|FG007|Induction Phase|Lack of Efficacy|23|||
37648459|NCT02394028|69117895|FG008|Induction Phase|Lack of Efficacy|0|||
37648460|NCT02394028|69117896|FG009|Induction Phase|Lack of Efficacy|0|||
37648461|NCT02394028|69117897|FG010|Induction Phase|Lack of Efficacy|0|||
37922219|NCT00460603|69609077|FG011|Phase 1|Adverse Event|0|||
37648462|NCT02394028|69117887|FG000|Induction Phase|Lost to Follow-up|1|||
37648463|NCT02394028|69117888|FG001|Induction Phase|Lost to Follow-up|0|||
37648464|NCT02394028|69117889|FG002|Induction Phase|Lost to Follow-up|0|||
37648465|NCT02394028|69117890|FG003|Induction Phase|Lost to Follow-up|1|||
37648466|NCT02394028|69117891|FG004|Induction Phase|Lost to Follow-up|0|||
37648467|NCT02394028|69117892|FG005|Induction Phase|Lost to Follow-up|0|||
37648468|NCT02394028|69117893|FG006|Induction Phase|Lost to Follow-up|1|||
37648469|NCT02394028|69117894|FG007|Induction Phase|Lost to Follow-up|0|||
37648470|NCT02394028|69117895|FG008|Induction Phase|Lost to Follow-up|0|||
37648471|NCT02394028|69117896|FG009|Induction Phase|Lost to Follow-up|0|||
37648472|NCT02394028|69117897|FG010|Induction Phase|Lost to Follow-up|0|||
37648473|NCT02394028|69117887|FG000|Induction Phase|Non-compliance|0|||
37648474|NCT02394028|69117888|FG001|Induction Phase|Non-compliance|1|||
37648475|NCT02394028|69117889|FG002|Induction Phase|Non-compliance|3|||
37648476|NCT02394028|69117890|FG003|Induction Phase|Non-compliance|1|||
37648477|NCT02394028|69117891|FG004|Induction Phase|Non-compliance|3|||
37648478|NCT02394028|69117892|FG005|Induction Phase|Non-compliance|0|||
37648479|NCT02394028|69117893|FG006|Induction Phase|Non-compliance|1|||
37648480|NCT02394028|69117894|FG007|Induction Phase|Non-compliance|1|||
37648481|NCT02394028|69117895|FG008|Induction Phase|Non-compliance|0|||
37648482|NCT02394028|69117896|FG009|Induction Phase|Non-compliance|0|||
37648483|NCT02394028|69117897|FG010|Induction Phase|Non-compliance|0|||
37648484|NCT02394028|69117887|FG000|Induction Phase|Physician Decision|0|||
37648485|NCT02394028|69117888|FG001|Induction Phase|Physician Decision|0|||
37648486|NCT02394028|69117889|FG002|Induction Phase|Physician Decision|1|||
37648487|NCT02394028|69117890|FG003|Induction Phase|Physician Decision|4|||
37648488|NCT02394028|69117891|FG004|Induction Phase|Physician Decision|0|||
37648489|NCT02394028|69117892|FG005|Induction Phase|Physician Decision|2|||
37648490|NCT02394028|69117893|FG006|Induction Phase|Physician Decision|1|||
37648491|NCT02394028|69117894|FG007|Induction Phase|Physician Decision|0|||
37648492|NCT02394028|69117895|FG008|Induction Phase|Physician Decision|0|||
37648493|NCT02394028|69117896|FG009|Induction Phase|Physician Decision|0|||
37648494|NCT02394028|69117897|FG010|Induction Phase|Physician Decision|0|||
37648495|NCT02394028|69117887|FG000|Induction Phase|Protocol Violation|0|||
37648496|NCT02394028|69117888|FG001|Induction Phase|Protocol Violation|2|||
37648497|NCT02394028|69117889|FG002|Induction Phase|Protocol Violation|0|||
37648498|NCT02394028|69117890|FG003|Induction Phase|Protocol Violation|3|||
37648499|NCT02394028|69117891|FG004|Induction Phase|Protocol Violation|0|||
37648500|NCT02394028|69117892|FG005|Induction Phase|Protocol Violation|1|||
37648501|NCT02394028|69117893|FG006|Induction Phase|Protocol Violation|1|||
37648502|NCT02394028|69117894|FG007|Induction Phase|Protocol Violation|0|||
37648503|NCT02394028|69117895|FG008|Induction Phase|Protocol Violation|0|||
37648504|NCT02394028|69117896|FG009|Induction Phase|Protocol Violation|0|||
37648505|NCT02394028|69117897|FG010|Induction Phase|Protocol Violation|0|||
37648506|NCT02394028|69117887|FG000|Induction Phase|Withdrawal by Subject|1|||
37648507|NCT02394028|69117888|FG001|Induction Phase|Withdrawal by Subject|2|||
37648508|NCT02394028|69117889|FG002|Induction Phase|Withdrawal by Subject|4|||
37648509|NCT02394028|69117890|FG003|Induction Phase|Withdrawal by Subject|6|||
37648510|NCT02394028|69117891|FG004|Induction Phase|Withdrawal by Subject|7|||
37648511|NCT02394028|69117892|FG005|Induction Phase|Withdrawal by Subject|4|||
37648512|NCT02394028|69117893|FG006|Induction Phase|Withdrawal by Subject|3|||
37648513|NCT02394028|69117894|FG007|Induction Phase|Withdrawal by Subject|6|||
37648514|NCT02394028|69117895|FG008|Induction Phase|Withdrawal by Subject|0|||
37648515|NCT02394028|69117896|FG009|Induction Phase|Withdrawal by Subject|0|||
37648516|NCT02394028|69117897|FG010|Induction Phase|Withdrawal by Subject|0|||
37648517|NCT02394028|69117887|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
37648518|NCT02394028|69117888|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
37648519|NCT02394028|69117889|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
37648520|NCT02394028|69117890|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
37648521|NCT02394028|69117891|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
37648522|NCT02394028|69117892|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
37648523|NCT02394028|69117893|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
37648524|NCT02394028|69117894|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
37648525|NCT02394028|69117895|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
37648526|NCT02394028|69117896|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
37648527|NCT02394028|69117897|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
37648528|NCT02394028|69117887|FG000|Induction Phase|Sponsor decision|0|||
37648529|NCT02394028|69117888|FG001|Induction Phase|Sponsor decision|1|||
37648530|NCT02394028|69117889|FG002|Induction Phase|Sponsor decision|2|||
37648531|NCT02394028|69117890|FG003|Induction Phase|Sponsor decision|0|||
37741503|NCT01855945|69227625|FG001|Overall Study|Adverse Event|0|||
37741504|NCT01855945|69227626|FG002|Overall Study|Adverse Event|0|||
37855016|NCT01001221|69538389|FG003|Overall Study|Disease progression|4|||
37855017|NCT01001221|69538390|FG004|Overall Study|Disease progression|0|||
38032293|NCT03345836|69718186|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
38032294|NCT03345836|69718187|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
38032295|NCT03345836|69718188|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
38032296|NCT03345836|69718189|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
38032297|NCT03345836|69718190|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
38032298|NCT03345836|69718191|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
38032299|NCT03345836|69718186|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
38032300|NCT03345836|69718187|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
37648532|NCT02394028|69117891|FG004|Induction Phase|Sponsor decision|0|||
37648533|NCT02394028|69117892|FG005|Induction Phase|Sponsor decision|0|||
37648534|NCT02394028|69117893|FG006|Induction Phase|Sponsor decision|0|||
37648535|NCT02394028|69117894|FG007|Induction Phase|Sponsor decision|0|||
37648536|NCT02394028|69117895|FG008|Induction Phase|Sponsor decision|0|||
37648537|NCT02394028|69117896|FG009|Induction Phase|Sponsor decision|0|||
37648538|NCT02394028|69117897|FG010|Induction Phase|Sponsor decision|0|||
37648539|NCT02394028|69117887|FG000|Induction Phase|Technical reason|0|||
37648540|NCT02394028|69117888|FG001|Induction Phase|Technical reason|0|||
37648541|NCT02394028|69117889|FG002|Induction Phase|Technical reason|0|||
37648542|NCT02394028|69117890|FG003|Induction Phase|Technical reason|1|||
37648543|NCT02394028|69117891|FG004|Induction Phase|Technical reason|0|||
37648544|NCT02394028|69117892|FG005|Induction Phase|Technical reason|0|||
37648545|NCT02394028|69117893|FG006|Induction Phase|Technical reason|0|||
37648546|NCT02394028|69117894|FG007|Induction Phase|Technical reason|0|||
37648547|NCT02394028|69117895|FG008|Induction Phase|Technical reason|0|||
37648548|NCT02394028|69117896|FG009|Induction Phase|Technical reason|0|||
37648549|NCT02394028|69117897|FG010|Induction Phase|Technical reason|0|||
37648550|NCT02394028|69117887|FG000|Induction Phase|:ack of calculation|0|||
37648551|NCT02394028|69117888|FG001|Induction Phase|:ack of calculation|0|||
37648552|NCT02394028|69117889|FG002|Induction Phase|:ack of calculation|0|||
37648553|NCT02394028|69117890|FG003|Induction Phase|:ack of calculation|0|||
37648554|NCT02394028|69117891|FG004|Induction Phase|:ack of calculation|0|||
37648555|NCT02394028|69117892|FG005|Induction Phase|:ack of calculation|0|||
37648556|NCT02394028|69117893|FG006|Induction Phase|:ack of calculation|0|||
37648557|NCT02394028|69117894|FG007|Induction Phase|:ack of calculation|1|||
37648558|NCT02394028|69117895|FG008|Induction Phase|:ack of calculation|0|||
37648559|NCT02394028|69117896|FG009|Induction Phase|:ack of calculation|0|||
37648560|NCT02394028|69117897|FG010|Induction Phase|:ack of calculation|0|||
37648561|NCT02394028|69117887|FG000|Maintenance Phase|Protocol Violation|0|||
37648562|NCT02394028|69117888|FG001|Maintenance Phase|Protocol Violation|0|||
37648563|NCT02394028|69117889|FG002|Maintenance Phase|Protocol Violation|0|||
37648564|NCT02394028|69117890|FG003|Maintenance Phase|Protocol Violation|0|||
37648565|NCT02394028|69117891|FG004|Maintenance Phase|Protocol Violation|0|||
37648566|NCT02394028|69117892|FG005|Maintenance Phase|Protocol Violation|0|||
37648567|NCT02394028|69117893|FG006|Maintenance Phase|Protocol Violation|0|||
37648568|NCT02394028|69117894|FG007|Maintenance Phase|Protocol Violation|0|||
37648569|NCT02394028|69117895|FG008|Maintenance Phase|Protocol Violation|0|||
37648570|NCT02394028|69117896|FG009|Maintenance Phase|Protocol Violation|0|||
37648571|NCT02394028|69117897|FG010|Maintenance Phase|Protocol Violation|1|||
37648572|NCT02394028|69117887|FG000|Maintenance Phase|Physician Decision|0|||
37648573|NCT02394028|69117888|FG001|Maintenance Phase|Physician Decision|0|||
37648574|NCT02394028|69117889|FG002|Maintenance Phase|Physician Decision|0|||
37648575|NCT02394028|69117890|FG003|Maintenance Phase|Physician Decision|0|||
37648576|NCT02394028|69117891|FG004|Maintenance Phase|Physician Decision|0|||
37648577|NCT02394028|69117892|FG005|Maintenance Phase|Physician Decision|0|||
37648578|NCT02394028|69117893|FG006|Maintenance Phase|Physician Decision|0|||
37648579|NCT02394028|69117894|FG007|Maintenance Phase|Physician Decision|0|||
37648580|NCT02394028|69117895|FG008|Maintenance Phase|Physician Decision|1|||
37648581|NCT02394028|69117896|FG009|Maintenance Phase|Physician Decision|3|||
37648582|NCT02394028|69117897|FG010|Maintenance Phase|Physician Decision|2|||
37648583|NCT02394028|69117887|FG000|Maintenance Phase|Lack of Efficacy|0|||
37648584|NCT02394028|69117888|FG001|Maintenance Phase|Lack of Efficacy|0|||
37648585|NCT02394028|69117889|FG002|Maintenance Phase|Lack of Efficacy|0|||
37648586|NCT02394028|69117890|FG003|Maintenance Phase|Lack of Efficacy|0|||
37648587|NCT02394028|69117891|FG004|Maintenance Phase|Lack of Efficacy|0|||
37741505|NCT01855945|69227627|FG003|Overall Study|Adverse Event|0|||
37855018|NCT01001221|69538386|FG000|Overall Study|Other|1|||
37855019|NCT01001221|69538387|FG001|Overall Study|Other|1|||
37648588|NCT02394028|69117892|FG005|Maintenance Phase|Lack of Efficacy|0|||
37648589|NCT02394028|69117893|FG006|Maintenance Phase|Lack of Efficacy|0|||
37648590|NCT02394028|69117894|FG007|Maintenance Phase|Lack of Efficacy|0|||
37648591|NCT02394028|69117895|FG008|Maintenance Phase|Lack of Efficacy|7|||
37741506|NCT01855945|69227628|FG004|Overall Study|Adverse Event|0|||
37855020|NCT01001221|69538388|FG002|Overall Study|Other|0|||
37648592|NCT02394028|69117896|FG009|Maintenance Phase|Lack of Efficacy|25|||
37648593|NCT02394028|69117897|FG010|Maintenance Phase|Lack of Efficacy|33|||
37648594|NCT02394028|69117887|FG000|Maintenance Phase|Death|0|||
37648595|NCT02394028|69117888|FG001|Maintenance Phase|Death|0|||
37648596|NCT02394028|69117889|FG002|Maintenance Phase|Death|0|||
37648597|NCT02394028|69117890|FG003|Maintenance Phase|Death|0|||
37648598|NCT02394028|69117891|FG004|Maintenance Phase|Death|0|||
37741507|NCT01855945|69227629|FG005|Overall Study|Adverse Event|0|||
37855021|NCT01001221|69538389|FG003|Overall Study|Other|0|||
37648599|NCT02394028|69117892|FG005|Maintenance Phase|Death|0|||
37648600|NCT02394028|69117893|FG006|Maintenance Phase|Death|0|||
37648601|NCT02394028|69117894|FG007|Maintenance Phase|Death|0|||
37648602|NCT02394028|69117895|FG008|Maintenance Phase|Death|0|||
37648603|NCT02394028|69117896|FG009|Maintenance Phase|Death|0|||
37648604|NCT02394028|69117897|FG010|Maintenance Phase|Death|1|||
37648605|NCT02394028|69117887|FG000|Maintenance Phase|Adverse Event|0|||
37648606|NCT02394028|69117888|FG001|Maintenance Phase|Adverse Event|0|||
37648607|NCT02394028|69117889|FG002|Maintenance Phase|Adverse Event|0|||
37648608|NCT02394028|69117890|FG003|Maintenance Phase|Adverse Event|0|||
37648609|NCT02394028|69117891|FG004|Maintenance Phase|Adverse Event|0|||
37648610|NCT02394028|69117892|FG005|Maintenance Phase|Adverse Event|0|||
37648611|NCT02394028|69117893|FG006|Maintenance Phase|Adverse Event|0|||
37648612|NCT02394028|69117894|FG007|Maintenance Phase|Adverse Event|0|||
37648613|NCT02394028|69117895|FG008|Maintenance Phase|Adverse Event|1|||
37648614|NCT02394028|69117896|FG009|Maintenance Phase|Adverse Event|1|||
37648615|NCT02394028|69117897|FG010|Maintenance Phase|Adverse Event|3|||
37648616|NCT02394028|69117887|FG000|Maintenance Phase|Site closure|0|||
37648617|NCT02394028|69117888|FG001|Maintenance Phase|Site closure|0|||
37648618|NCT02394028|69117889|FG002|Maintenance Phase|Site closure|0|||
37648619|NCT02394028|69117890|FG003|Maintenance Phase|Site closure|0|||
37648620|NCT02394028|69117891|FG004|Maintenance Phase|Site closure|0|||
37648621|NCT02394028|69117892|FG005|Maintenance Phase|Site closure|0|||
37648622|NCT02394028|69117893|FG006|Maintenance Phase|Site closure|0|||
37648623|NCT02394028|69117894|FG007|Maintenance Phase|Site closure|0|||
37648624|NCT02394028|69117895|FG008|Maintenance Phase|Site closure|0|||
37648625|NCT02394028|69117896|FG009|Maintenance Phase|Site closure|1|||
37648626|NCT02394028|69117897|FG010|Maintenance Phase|Site closure|0|||
37648627|NCT02394028|69117887|FG000|Maintenance Phase|Withdrawal by Subject|0|||
37648628|NCT02394028|69117888|FG001|Maintenance Phase|Withdrawal by Subject|0|||
37648629|NCT02394028|69117889|FG002|Maintenance Phase|Withdrawal by Subject|0|||
37648630|NCT02394028|69117890|FG003|Maintenance Phase|Withdrawal by Subject|0|||
37648631|NCT02394028|69117891|FG004|Maintenance Phase|Withdrawal by Subject|0|||
37648632|NCT02394028|69117892|FG005|Maintenance Phase|Withdrawal by Subject|0|||
37648633|NCT02394028|69117893|FG006|Maintenance Phase|Withdrawal by Subject|0|||
37648634|NCT02394028|69117894|FG007|Maintenance Phase|Withdrawal by Subject|0|||
37648635|NCT02394028|69117895|FG008|Maintenance Phase|Withdrawal by Subject|3|||
37648636|NCT02394028|69117896|FG009|Maintenance Phase|Withdrawal by Subject|12|||
37648637|NCT02394028|69117897|FG010|Maintenance Phase|Withdrawal by Subject|12|||
37648638|NCT01371539|69117951|FG000|Period One: One Week|Lost to Follow-up|0|||
37648639|NCT01371539|69117952|FG001|Period One: One Week|Lost to Follow-up|1|||
37648640|NCT01371539|69117951|FG000|Period Two: One Week|Lost to Follow-up|0|||
37648641|NCT01371539|69117952|FG001|Period Two: One Week|Lost to Follow-up|1|||
37648642|NCT01371539|69117951|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
37648643|NCT01371539|69117952|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
37648644|NCT01371539|69117951|FG000|Period Two: One Week|Time/job conflict|0|||
37648645|NCT01371539|69117952|FG001|Period Two: One Week|Time/job conflict|1|||
37648646|NCT02819297|69117960|FG000|Overall Study|Withdrawal by Subject|25|||
37648647|NCT02819297|69117961|FG001|Overall Study|Withdrawal by Subject|13|||
37648648|NCT02819297|69117960|FG000|Overall Study|Lost to Follow-up|12|||
37648649|NCT02819297|69117961|FG001|Overall Study|Lost to Follow-up|14|||
37648650|NCT02819297|69117960|FG000|Overall Study|Adverse Event|12|||
37741508|NCT01855945|69227630|FG006|Overall Study|Adverse Event|1|||
37741509|NCT01855945|69227631|FG007|Overall Study|Adverse Event|0|||
37741510|NCT01855945|69227632|FG008|Overall Study|Adverse Event|0|||
37741511|NCT01855945|69227633|FG009|Overall Study|Adverse Event|0|||
37741512|NCT01855945|69227634|FG010|Overall Study|Adverse Event|0|||
37741513|NCT01855945|69227635|FG011|Overall Study|Adverse Event|0|||
37855022|NCT01001221|69538390|FG004|Overall Study|Other|0|||
37648651|NCT02819297|69117961|FG001|Overall Study|Adverse Event|10|||
37648652|NCT02819297|69117960|FG000|Overall Study|Physician Decision|5|||
37855023|NCT01001221|69538386|FG000|Overall Study|Not treated; protocol exclusion|0|||
37648653|NCT02819297|69117961|FG001|Overall Study|Physician Decision|5|||
37648654|NCT02819297|69117960|FG000|Overall Study|Lack of Efficacy|5|||
37648655|NCT02819297|69117961|FG001|Overall Study|Lack of Efficacy|8|||
37648656|NCT02819297|69117960|FG000|Overall Study|Protocol Violation|1|||
37648657|NCT02819297|69117961|FG001|Overall Study|Protocol Violation|2|||
37648658|NCT02429830|69117967|FG000|Overall Study|Lost to Follow-up|1|||
37648659|NCT02429830|69117967|FG000|Overall Study|Device Explant|2|||
37648660|NCT02821715|69117971|FG000|Overall Study|Protocol Violation|1|||
37648661|NCT02821715|69117972|FG001|Overall Study|Protocol Violation|0|||
37648662|NCT02821715|69117973|FG002|Overall Study|Protocol Violation|0|||
37648663|NCT02821715|69117974|FG003|Overall Study|Protocol Violation|0|||
37648664|NCT02821715|69117975|FG004|Overall Study|Protocol Violation|0|||
37648665|NCT02821715|69117976|FG005|Overall Study|Protocol Violation|0|||
37648666|NCT02813681|69117987|FG000|Overall Study|Physician Decision|5|||
37648667|NCT02813681|69117988|FG001|Overall Study|Physician Decision|5|||
37648668|NCT02813681|69117989|FG002|Overall Study|Physician Decision|0|||
37741514|NCT01855945|69227624|FG000|Overall Study|Death|0|||
37855024|NCT01001221|69538387|FG001|Overall Study|Not treated; protocol exclusion|0|||
37648669|NCT02813681|69117987|FG000|Overall Study|Lost to Follow-up|0|||
37648670|NCT02813681|69117988|FG001|Overall Study|Lost to Follow-up|1|||
37648671|NCT02813681|69117989|FG002|Overall Study|Lost to Follow-up|0|||
37648672|NCT02393950|69118001|FG000|Overall Study|Adverse Event|1|||
37648673|NCT02393950|69118002|FG001|Overall Study|Adverse Event|0|||
37648674|NCT02393950|69118001|FG000|Overall Study|Withdrawal by Subject|0|||
37648675|NCT02393950|69118002|FG001|Overall Study|Withdrawal by Subject|1|||
37648676|NCT02815397|69118037|FG000|Overall Study|Physician Decision|2|||
37648677|NCT02427958|69118041|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
37648678|NCT02427958|69118041|FG000|Overall Study|Lost to Follow-up|6|||
37648679|NCT02427958|69118041|FG000|Overall Study|Withdrawal by Subject|14|||
37648680|NCT02427958|69118041|FG000|Overall Study|Lack of Efficacy|1|||
37648681|NCT02392624|69118048|FG000|Overall Study|Withdrawal by Subject|15|||
37741515|NCT01855945|69227625|FG001|Overall Study|Death|0|||
37741516|NCT01855945|69227626|FG002|Overall Study|Death|0|||
37741517|NCT01855945|69227627|FG003|Overall Study|Death|0|||
37741518|NCT01855945|69227628|FG004|Overall Study|Death|0|||
37741519|NCT01855945|69227629|FG005|Overall Study|Death|0|||
37741520|NCT01855945|69227630|FG006|Overall Study|Death|2|||
37741521|NCT01855945|69227631|FG007|Overall Study|Death|0|||
37741522|NCT01855945|69227632|FG008|Overall Study|Death|0|||
37741523|NCT01855945|69227633|FG009|Overall Study|Death|0|||
37741524|NCT01855945|69227634|FG010|Overall Study|Death|0|||
37741525|NCT01855945|69227635|FG011|Overall Study|Death|0|||
37741526|NCT01855945|69227624|FG000|Overall Study|Lost to Follow-up|11|||
37741527|NCT01855945|69227625|FG001|Overall Study|Lost to Follow-up|10|||
37741528|NCT01855945|69227626|FG002|Overall Study|Lost to Follow-up|7|||
37741529|NCT01855945|69227627|FG003|Overall Study|Lost to Follow-up|3|||
37741530|NCT01855945|69227628|FG004|Overall Study|Lost to Follow-up|0|||
37741531|NCT01855945|69227629|FG005|Overall Study|Lost to Follow-up|3|||
37741532|NCT01855945|69227630|FG006|Overall Study|Lost to Follow-up|4|||
37855025|NCT01001221|69538388|FG002|Overall Study|Not treated; protocol exclusion|1|||
37855026|NCT01001221|69538389|FG003|Overall Study|Not treated; protocol exclusion|0|||
37855027|NCT01001221|69538390|FG004|Overall Study|Not treated; protocol exclusion|0|||
37855028|NCT01296152|69538401|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
37855029|NCT01002547|69538408|FG000|Overall Study|Withdrawal by Subject|4|||
37855030|NCT01002547|69538409|FG001|Overall Study|Withdrawal by Subject|0|||
38032301|NCT03345836|69718188|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
38032302|NCT03345836|69718189|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
37648682|NCT02392624|69118049|FG001|Overall Study|Withdrawal by Subject|12|||
37741533|NCT01855945|69227631|FG007|Overall Study|Lost to Follow-up|7|||
37741534|NCT01855945|69227632|FG008|Overall Study|Lost to Follow-up|2|||
37741535|NCT01855945|69227633|FG009|Overall Study|Lost to Follow-up|0|||
37741536|NCT01855945|69227634|FG010|Overall Study|Lost to Follow-up|0|||
37741537|NCT01855945|69227635|FG011|Overall Study|Lost to Follow-up|2|||
37741538|NCT01855945|69227624|FG000|Overall Study|Other - Unclassified|1|||
37741539|NCT01855945|69227625|FG001|Overall Study|Other - Unclassified|1|||
37741540|NCT01855945|69227626|FG002|Overall Study|Other - Unclassified|1|||
38032303|NCT03345836|69718190|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
38032304|NCT03345836|69718191|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
37648683|NCT02392624|69118050|FG002|Overall Study|Withdrawal by Subject|9|||
37648684|NCT02392624|69118048|FG000|Overall Study|Adverse Event|4|||
37648685|NCT02392624|69118049|FG001|Overall Study|Adverse Event|1|||
37648686|NCT02392624|69118050|FG002|Overall Study|Adverse Event|2|||
37648687|NCT02392624|69118048|FG000|Overall Study|Pregnancy|1|||
37648688|NCT02392624|69118049|FG001|Overall Study|Pregnancy|0|||
37648689|NCT02392624|69118050|FG002|Overall Study|Pregnancy|0|||
37741541|NCT01855945|69227627|FG003|Overall Study|Other - Unclassified|0|||
37648690|NCT02392624|69118048|FG000|Overall Study|Protocol Violation|0|||
37648691|NCT02392624|69118049|FG001|Overall Study|Protocol Violation|0|||
37648692|NCT02392624|69118050|FG002|Overall Study|Protocol Violation|1|||
37648693|NCT02392624|69118048|FG000|Overall Study|Sponsor/Investigator Decision|2|||
37741542|NCT01855945|69227628|FG004|Overall Study|Other - Unclassified|0|||
37741543|NCT01855945|69227629|FG005|Overall Study|Other - Unclassified|0|||
37741544|NCT01855945|69227630|FG006|Overall Study|Other - Unclassified|2|||
37855031|NCT01002547|69538410|FG002|Overall Study|Withdrawal by Subject|5|||
37855032|NCT01002547|69538408|FG000|Overall Study|Lost to Follow-up|2|||
37855033|NCT01002547|69538409|FG001|Overall Study|Lost to Follow-up|1|||
37855034|NCT01002547|69538410|FG002|Overall Study|Lost to Follow-up|1|||
37855035|NCT01002547|69538408|FG000|Overall Study|Physician Decision|1|||
37855036|NCT01002547|69538409|FG001|Overall Study|Physician Decision|0|||
37855037|NCT01002547|69538410|FG002|Overall Study|Physician Decision|0|||
37855038|NCT01002547|69538408|FG000|Overall Study|Death|0|||
37855039|NCT01002547|69538409|FG001|Overall Study|Death|2|||
37855040|NCT01002547|69538410|FG002|Overall Study|Death|2|||
37855041|NCT01002547|69538408|FG000|Overall Study|Adverse Event|1|||
37855042|NCT01002547|69538409|FG001|Overall Study|Adverse Event|0|||
37855043|NCT01002547|69538410|FG002|Overall Study|Adverse Event|0|||
37648694|NCT02392624|69118049|FG001|Overall Study|Sponsor/Investigator Decision|1|||
37648695|NCT02392624|69118050|FG002|Overall Study|Sponsor/Investigator Decision|0|||
37648696|NCT02392624|69118048|FG000|Overall Study|Other|49|||
37648697|NCT02392624|69118049|FG001|Overall Study|Other|1|||
37648698|NCT02392624|69118050|FG002|Overall Study|Other|1|||
37648699|NCT02387164|69118060|FG000|Overall Study|Lost to Follow-up|2|||
37648700|NCT02387164|69118061|FG001|Overall Study|Lost to Follow-up|0|||
37648701|NCT02387164|69118060|FG000|Overall Study|Diagnosed|1|||
37648702|NCT02387164|69118061|FG001|Overall Study|Diagnosed|2|||
37648703|NCT02392234|69118079|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
37648704|NCT02392234|69118080|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
37648705|NCT02392234|69118081|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
37648706|NCT02392234|69118082|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
37648707|NCT02392234|69118083|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
37648708|NCT02392234|69118084|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
37648709|NCT02392234|69118079|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
37648710|NCT02392234|69118080|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
37648711|NCT02392234|69118081|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
37648712|NCT02392234|69118082|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
37648713|NCT02392234|69118083|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
37648714|NCT02392234|69118084|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
37648715|NCT02392234|69118079|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
37648716|NCT02392234|69118080|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
37648717|NCT02392234|69118081|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
37648718|NCT02392234|69118082|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
37648719|NCT02392234|69118083|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
37648720|NCT02392234|69118084|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
37648721|NCT02392234|69118079|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
37648722|NCT02392234|69118080|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
37648723|NCT02392234|69118081|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
37648724|NCT02392234|69118082|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
37648725|NCT02392234|69118083|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
37648726|NCT02392234|69118084|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
37648727|NCT02392234|69118079|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
37648728|NCT02392234|69118080|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
37648729|NCT02392234|69118081|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
37648730|NCT02392234|69118082|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
37648731|NCT02392234|69118083|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
37648732|NCT02392234|69118084|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
37648733|NCT02392234|69118079|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
37648734|NCT02392234|69118080|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
37648735|NCT02392234|69118081|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
37648736|NCT02392234|69118082|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
37648737|NCT02392234|69118083|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
37648738|NCT02392234|69118084|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
37648739|NCT02392234|69118079|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
37648740|NCT02392234|69118080|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
37648741|NCT02392234|69118081|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
37648742|NCT02392234|69118082|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
37648743|NCT02392234|69118083|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
37648744|NCT02392234|69118084|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
37648745|NCT02392234|69118079|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
37648746|NCT02392234|69118080|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
37648747|NCT02392234|69118081|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
37648748|NCT02392234|69118082|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
37648749|NCT02392234|69118083|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
37648750|NCT02392234|69118084|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
37648751|NCT02963090|69118098|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
37648752|NCT02963090|69118099|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
37648753|NCT02427802|69118111|FG000|Overall Study|Adverse Event|11|||
37922220|NCT00460603|69609066|FG000|Phase 1|Lack of Efficacy|1|||
37922221|NCT00460603|69609067|FG001|Phase 1|Lack of Efficacy|0|||
37922222|NCT00460603|69609068|FG002|Phase 1|Lack of Efficacy|1|||
37922223|NCT00460603|69609069|FG003|Phase 1|Lack of Efficacy|2|||
37648754|NCT02427802|69118112|FG001|Overall Study|Adverse Event|3|||
37648755|NCT02427802|69118113|FG002|Overall Study|Adverse Event|7|||
37648756|NCT02427802|69118111|FG000|Overall Study|Death|0|||
37648757|NCT02427802|69118112|FG001|Overall Study|Death|4|||
37648758|NCT02427802|69118113|FG002|Overall Study|Death|1|||
37648759|NCT02427802|69118111|FG000|Overall Study|Lost to Follow-up|13|||
37648760|NCT02427802|69118112|FG001|Overall Study|Lost to Follow-up|8|||
37922224|NCT00460603|69609070|FG004|Phase 1|Lack of Efficacy|2|||
37922225|NCT00460603|69609071|FG005|Phase 1|Lack of Efficacy|2|||
37648761|NCT02427802|69118113|FG002|Overall Study|Lost to Follow-up|8|||
37648762|NCT02427802|69118111|FG000|Overall Study|Physician Decision|4|||
37648763|NCT02427802|69118112|FG001|Overall Study|Physician Decision|2|||
37648764|NCT02427802|69118113|FG002|Overall Study|Physician Decision|4|||
37648765|NCT02427802|69118111|FG000|Overall Study|Withdrawal by Subject|10|||
37648766|NCT02427802|69118112|FG001|Overall Study|Withdrawal by Subject|5|||
37648767|NCT02427802|69118113|FG002|Overall Study|Withdrawal by Subject|11|||
37648768|NCT02427802|69118111|FG000|Overall Study|Protocol Violation|3|||
37648769|NCT02427802|69118112|FG001|Overall Study|Protocol Violation|1|||
37648770|NCT02427802|69118113|FG002|Overall Study|Protocol Violation|1|||
37648771|NCT02427802|69118111|FG000|Overall Study|protocol specific treatment unrelated|18|||
37648772|NCT02427802|69118112|FG001|Overall Study|protocol specific treatment unrelated|11|||
37648773|NCT02427802|69118113|FG002|Overall Study|protocol specific treatment unrelated|11|||
37648774|NCT02427646|69118123|FG000|Overall Study|Lack of Efficacy|2|||
37648775|NCT02427646|69118124|FG001|Overall Study|Lack of Efficacy|3|||
37648776|NCT02427646|69118123|FG000|Overall Study|Physician Decision|1|||
37648777|NCT02427646|69118124|FG001|Overall Study|Physician Decision|4|||
37648778|NCT02427646|69118123|FG000|Overall Study|Protocol Violation|3|||
37648779|NCT02427646|69118124|FG001|Overall Study|Protocol Violation|3|||
37648780|NCT02427646|69118123|FG000|Overall Study|Bothersome hand weakness|2|||
37648781|NCT02427646|69118124|FG001|Overall Study|Bothersome hand weakness|4|||
37648782|NCT02392000|69118132|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
37648783|NCT02392000|69118132|FG000|Overall Study|Withdrawal by Subject|1|||
37648784|NCT02392000|69118132|FG000|Overall Study|Lost to Follow-up|8|||
37648785|NCT02385526|69118140|FG000|Overall Study|Withdrawal by Subject|0|||
37648786|NCT02385526|69118141|FG001|Overall Study|Withdrawal by Subject|2|||
37648787|NCT02385526|69118142|FG002|Overall Study|Withdrawal by Subject|0|||
37648788|NCT02385526|69118140|FG000|Overall Study|Lost to Follow-up|0|||
37648789|NCT02385526|69118141|FG001|Overall Study|Lost to Follow-up|1|||
37648790|NCT02385526|69118142|FG002|Overall Study|Lost to Follow-up|0|||
37648791|NCT02385526|69118140|FG000|Overall Study|Physician Decision|1|||
37648792|NCT02385526|69118141|FG001|Overall Study|Physician Decision|0|||
37741545|NCT01855945|69227631|FG007|Overall Study|Other - Unclassified|1|||
37741546|NCT01855945|69227632|FG008|Overall Study|Other - Unclassified|0|||
37741547|NCT01855945|69227633|FG009|Overall Study|Other - Unclassified|0|||
37741548|NCT01855945|69227634|FG010|Overall Study|Other - Unclassified|1|||
37741549|NCT01855945|69227635|FG011|Overall Study|Other - Unclassified|0|||
37741550|NCT01855945|69227624|FG000|Overall Study|Withdrawal by Subject|4|||
37741551|NCT01855945|69227625|FG001|Overall Study|Withdrawal by Subject|0|||
37741552|NCT01855945|69227626|FG002|Overall Study|Withdrawal by Subject|4|||
37741553|NCT01855945|69227627|FG003|Overall Study|Withdrawal by Subject|1|||
37648793|NCT02385526|69118142|FG002|Overall Study|Physician Decision|0|||
37741554|NCT01855945|69227628|FG004|Overall Study|Withdrawal by Subject|1|||
37741555|NCT01855945|69227629|FG005|Overall Study|Withdrawal by Subject|0|||
37741556|NCT01855945|69227630|FG006|Overall Study|Withdrawal by Subject|1|||
37741557|NCT01855945|69227631|FG007|Overall Study|Withdrawal by Subject|0|||
37741558|NCT01855945|69227632|FG008|Overall Study|Withdrawal by Subject|0|||
37741559|NCT01855945|69227633|FG009|Overall Study|Withdrawal by Subject|2|||
37741560|NCT01855945|69227634|FG010|Overall Study|Withdrawal by Subject|4|||
37741561|NCT01855945|69227635|FG011|Overall Study|Withdrawal by Subject|1|||
37741562|NCT01855789|69227698|FG000|1) Baseline up to Week 24|Adverse Event|37|||
37741563|NCT01855789|69227699|FG001|1) Baseline up to Week 24|Adverse Event|0|||
37741564|NCT01855789|69227700|FG002|1) Baseline up to Week 24|Adverse Event|0|||
37741565|NCT01855789|69227701|FG003|1) Baseline up to Week 24|Adverse Event|0|||
37741566|NCT01855789|69227698|FG000|1) Baseline up to Week 24|Death|2|||
37741567|NCT01855789|69227699|FG001|1) Baseline up to Week 24|Death|0|||
37741568|NCT01855789|69227700|FG002|1) Baseline up to Week 24|Death|0|||
37741569|NCT01855789|69227701|FG003|1) Baseline up to Week 24|Death|0|||
37741570|NCT01855789|69227698|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
37741571|NCT01855789|69227699|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
37741572|NCT01855789|69227700|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
37648794|NCT02385526|69118140|FG000|Overall Study|Protocol Violation|1|||
37648795|NCT02385526|69118141|FG001|Overall Study|Protocol Violation|0|||
37648796|NCT02385526|69118142|FG002|Overall Study|Protocol Violation|0|||
37648797|NCT02808143|69118152|FG000|Maintenance Phase|Disease recurrence|1|||
37648798|NCT02808143|69118153|FG001|Maintenance Phase|Disease recurrence|3|||
37648799|NCT02808143|69118152|FG000|Maintenance Phase|Disease progression|1|||
37648800|NCT02808143|69118153|FG001|Maintenance Phase|Disease progression|2|||
37648801|NCT02808143|69118152|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
37648802|NCT02808143|69118153|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
37648803|NCT02808143|69118152|FG000|Survival Follow-Up|Disease recurrence|0|||
37648804|NCT02808143|69118153|FG001|Survival Follow-Up|Disease recurrence|2|||
37648805|NCT02808143|69118152|FG000|Survival Follow-Up|Adverse Event|0|||
37741573|NCT01855789|69227701|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
37648806|NCT02808143|69118153|FG001|Survival Follow-Up|Adverse Event|1|||
37648807|NCT02808143|69118152|FG000|Survival Follow-Up|Death|1|||
37648808|NCT02808143|69118153|FG001|Survival Follow-Up|Death|0|||
37648809|NCT02427100|69118163|FG000|Overall Study|Lost to Follow-up|0|||
37648810|NCT02427100|69118164|FG001|Overall Study|Lost to Follow-up|2|||
37648811|NCT02806973|69118170|FG000|Period 1|Withdrawal by Subject|0|||
37648812|NCT02806973|69118171|FG001|Period 1|Withdrawal by Subject|2|||
37648813|NCT02806973|69118172|FG002|Period 1|Withdrawal by Subject|1|||
37648814|NCT02806973|69118173|FG003|Period 1|Withdrawal by Subject|1|||
37648815|NCT02806973|69118170|FG000|Period 1|Adverse Event|0|||
37648816|NCT02806973|69118171|FG001|Period 1|Adverse Event|0|||
37741574|NCT01855789|69227698|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
37741575|NCT01855789|69227699|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
37741576|NCT01855789|69227700|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
37741577|NCT01855789|69227701|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
37741578|NCT01855789|69227698|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
37741579|NCT01855789|69227699|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
37741580|NCT01855789|69227700|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
37741581|NCT01855789|69227701|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
37741582|NCT01855789|69227698|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
37741583|NCT01855789|69227699|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
37741584|NCT01855789|69227700|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
37741585|NCT01855789|69227701|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
37741586|NCT01855789|69227698|FG000|1) Baseline up to Week 24|Physician Decision|4|||
37741587|NCT01855789|69227699|FG001|1) Baseline up to Week 24|Physician Decision|0|||
37741588|NCT01855789|69227700|FG002|1) Baseline up to Week 24|Physician Decision|0|||
37741589|NCT01855789|69227701|FG003|1) Baseline up to Week 24|Physician Decision|0|||
37741590|NCT01855789|69227698|FG000|1) Baseline up to Week 24|Pregnancy|1|||
37741591|NCT01855789|69227699|FG001|1) Baseline up to Week 24|Pregnancy|0|||
37741592|NCT01855789|69227700|FG002|1) Baseline up to Week 24|Pregnancy|0|||
37741593|NCT01855789|69227701|FG003|1) Baseline up to Week 24|Pregnancy|0|||
37741594|NCT01855789|69227698|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
37741595|NCT01855789|69227699|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
37741596|NCT01855789|69227700|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
37741597|NCT01855789|69227701|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
37741598|NCT01855789|69227698|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
37741599|NCT01855789|69227699|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
37741600|NCT01855789|69227700|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
37741601|NCT01855789|69227701|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
37741602|NCT01855789|69227698|FG000|1) Baseline up to Week 24|Other|4|||
37741603|NCT01855789|69227699|FG001|1) Baseline up to Week 24|Other|0|||
37741604|NCT01855789|69227700|FG002|1) Baseline up to Week 24|Other|0|||
37741605|NCT01855789|69227701|FG003|1) Baseline up to Week 24|Other|0|||
37741606|NCT01855789|69227698|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
37741607|NCT01855789|69227699|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
37741608|NCT01855789|69227700|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
37741609|NCT01855789|69227701|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
37741610|NCT01855789|69227698|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
37741611|NCT01855789|69227699|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
37741612|NCT01855789|69227700|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
37741613|NCT01855789|69227701|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
37741614|NCT01855789|69227698|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
37741615|NCT01855789|69227699|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
37741616|NCT01855789|69227700|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
37741617|NCT01855789|69227701|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
37741618|NCT01855789|69227698|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
37741619|NCT01855789|69227699|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
37741620|NCT01855789|69227700|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
37741621|NCT01855789|69227701|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
37741622|NCT01855789|69227698|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
37741623|NCT01855789|69227699|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
37741624|NCT01855789|69227700|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
37741625|NCT01855789|69227701|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
37741626|NCT01855789|69227698|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
37741627|NCT01855789|69227699|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
37741628|NCT01855789|69227700|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
37741629|NCT01855789|69227701|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
37741630|NCT01855789|69227698|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
37741631|NCT01855789|69227699|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
37741632|NCT01855789|69227700|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
37741633|NCT01855789|69227701|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
37922226|NCT00460603|69609072|FG006|Phase 1|Lack of Efficacy|2|||
37648817|NCT02806973|69118172|FG002|Period 1|Adverse Event|0|||
37648818|NCT02806973|69118173|FG003|Period 1|Adverse Event|1|||
37648819|NCT02806973|69118170|FG000|Period 3|Withdrawal by Subject|0|||
37648820|NCT02806973|69118171|FG001|Period 3|Withdrawal by Subject|0|||
37648821|NCT02806973|69118172|FG002|Period 3|Withdrawal by Subject|0|||
37648822|NCT02806973|69118173|FG003|Period 3|Withdrawal by Subject|3|||
37648823|NCT02806973|69118170|FG000|Period 3|Adverse Event|0|||
37648824|NCT02806973|69118171|FG001|Period 3|Adverse Event|0|||
37648825|NCT02806973|69118172|FG002|Period 3|Adverse Event|1|||
37648826|NCT02806973|69118173|FG003|Period 3|Adverse Event|0|||
37648827|NCT02806505|69118185|FG000|Overall Study|Adverse event/intercurrent illness|1|||
37648828|NCT02806505|69118186|FG001|Overall Study|Adverse event/intercurrent illness|3|||
37648829|NCT02806505|69118185|FG000|Overall Study|Death|4|||
37648830|NCT02806505|69118186|FG001|Overall Study|Death|0|||
37648831|NCT02806505|69118185|FG000|Overall Study|Did not cooperate/refused treatment|3|||
37648832|NCT02806505|69118186|FG001|Overall Study|Did not cooperate/refused treatment|3|||
37648833|NCT02806505|69118185|FG000|Overall Study|Failure to return|0|||
37648834|NCT02806505|69118186|FG001|Overall Study|Failure to return|1|||
37648835|NCT02806505|69118185|FG000|Overall Study|Insufficient therapeutic response|2|||
37648836|NCT02806505|69118186|FG001|Overall Study|Insufficient therapeutic response|4|||
37648837|NCT02807363|69118196|FG000|Dosing Period|Adverse Event|0|||
37648838|NCT02807363|69118197|FG001|Dosing Period|Adverse Event|1|||
37648839|NCT02807363|69118198|FG002|Dosing Period|Adverse Event|0|||
37648840|NCT02807363|69118199|FG003|Dosing Period|Adverse Event|0|||
37648841|NCT02383966|69118213|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
37648842|NCT02383966|69118214|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
37648843|NCT02383966|69118213|FG000|Overall Study|Randomized, but not treated|1|||
37648844|NCT02383966|69118214|FG001|Overall Study|Randomized, but not treated|3|||
37648845|NCT02383576|69118222|FG000|Overall Study|Death|53|||
37648846|NCT02383576|69118223|FG001|Overall Study|Death|33|||
37648847|NCT02383576|69118222|FG000|Overall Study|Lost to Follow-up|7|||
37648848|NCT02383576|69118223|FG001|Overall Study|Lost to Follow-up|1|||
37648849|NCT02383576|69118222|FG000|Overall Study|Withdrew Consent|1|||
37648850|NCT02383576|69118223|FG001|Overall Study|Withdrew Consent|6|||
37648851|NCT02383576|69118222|FG000|Overall Study|Investigator's Decision|0|||
37648852|NCT02383576|69118223|FG001|Overall Study|Investigator's Decision|1|||
37648853|NCT02383576|69118222|FG000|Overall Study|Administrative/Other|2|||
37648854|NCT02383576|69118223|FG001|Overall Study|Administrative/Other|4|||
37648855|NCT02748317|69118229|FG000|Overall Study|Withdrawal by Subject|14|||
37648856|NCT02748317|69118229|FG000|Overall Study|Lost to Follow-up|8|||
37648857|NCT02748317|69118229|FG000|Overall Study|Death|1|||
37648858|NCT02426086|69118235|FG000|Overall Study|Death|33|||
37648859|NCT02426086|69118236|FG001|Overall Study|Death|36|||
37648860|NCT02426086|69118235|FG000|Overall Study|Lost to Follow-up|2|||
37648861|NCT02426086|69118236|FG001|Overall Study|Lost to Follow-up|0|||
37648862|NCT02426086|69118235|FG000|Overall Study|Study Terminated by Sponsor|5|||
37648863|NCT02426086|69118236|FG001|Overall Study|Study Terminated by Sponsor|14|||
37648864|NCT02426086|69118235|FG000|Overall Study|Withdrawal by Subject|8|||
37648865|NCT02426086|69118236|FG001|Overall Study|Withdrawal by Subject|9|||
37648866|NCT02422264|69118249|FG000|Overall Study|Serious Adverse Event|1|||
37648867|NCT02422264|69118250|FG001|Overall Study|Serious Adverse Event|0|||
37648868|NCT02422264|69118249|FG000|Overall Study|Withdrawal by Subject|1|||
37648869|NCT02422264|69118250|FG001|Overall Study|Withdrawal by Subject|2|||
37648870|NCT02422264|69118249|FG000|Overall Study|Migrated/moved from study area|3|||
37648871|NCT02422264|69118250|FG001|Overall Study|Migrated/moved from study area|1|||
37648872|NCT02422264|69118249|FG000|Overall Study|Subject vaccinated outside of the study|0|||
37648873|NCT02422264|69118250|FG001|Overall Study|Subject vaccinated outside of the study|1|||
37648874|NCT02390362|69118258|FG000|Overall Study|Withdrawal by Subject|0|||
37648875|NCT02390362|69118259|FG001|Overall Study|Withdrawal by Subject|1|||
37648876|NCT02389894|69118268|FG000|Overall Study|Death|4|||
37648877|NCT02389894|69118269|FG001|Overall Study|Death|5|||
37648878|NCT02389894|69118270|FG002|Overall Study|Death|3|||
37648879|NCT02389894|69118268|FG000|Overall Study|Withdrawal by Subject|2|||
37648880|NCT02389894|69118269|FG001|Overall Study|Withdrawal by Subject|4|||
37648881|NCT02389894|69118270|FG002|Overall Study|Withdrawal by Subject|5|||
37648882|NCT02389894|69118268|FG000|Overall Study|Lost to Follow-up|2|||
37648883|NCT02389894|69118269|FG001|Overall Study|Lost to Follow-up|1|||
37648884|NCT02389894|69118270|FG002|Overall Study|Lost to Follow-up|1|||
37648885|NCT02389816|69118281|FG000|Overall Study|Randomized but Not Treated|1|||
37648886|NCT02389816|69118282|FG001|Overall Study|Randomized but Not Treated|0|||
37648887|NCT02389816|69118283|FG002|Overall Study|Randomized but Not Treated|0|||
37648888|NCT02389816|69118281|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
37648889|NCT02389816|69118282|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
37648890|NCT02389816|69118283|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
37648891|NCT02389816|69118281|FG000|Overall Study|Major Protocol Deviation|1|||
37648892|NCT02389816|69118282|FG001|Overall Study|Major Protocol Deviation|0|||
37648893|NCT02389816|69118283|FG002|Overall Study|Major Protocol Deviation|0|||
37648894|NCT02389816|69118281|FG000|Overall Study|Lost to Follow-up|1|||
37648895|NCT02389816|69118282|FG001|Overall Study|Lost to Follow-up|0|||
37648896|NCT02389816|69118283|FG002|Overall Study|Lost to Follow-up|0|||
37648897|NCT02389816|69118281|FG000|Overall Study|Withdrawal of Consent|6|||
37648898|NCT02389816|69118282|FG001|Overall Study|Withdrawal of Consent|4|||
37648899|NCT02389816|69118283|FG002|Overall Study|Withdrawal of Consent|4|||
37648900|NCT02389816|69118281|FG000|Overall Study|Lack of Efficacy|1|||
37648901|NCT02389816|69118282|FG001|Overall Study|Lack of Efficacy|0|||
37648902|NCT02389816|69118283|FG002|Overall Study|Lack of Efficacy|0|||
37648903|NCT02389816|69118281|FG000|Overall Study|Non Compliance with Study Drug|1|||
37648904|NCT02389816|69118282|FG001|Overall Study|Non Compliance with Study Drug|1|||
37648905|NCT02389816|69118283|FG002|Overall Study|Non Compliance with Study Drug|1|||
37648906|NCT02389816|69118281|FG000|Overall Study|Reason not Specified|0|||
37648907|NCT02389816|69118282|FG001|Overall Study|Reason not Specified|2|||
37648908|NCT02389816|69118283|FG002|Overall Study|Reason not Specified|0|||
37648909|NCT02388724|69118293|FG000|Overall Study|Reason not Specified|0|||
37648910|NCT02388724|69118294|FG001|Overall Study|Reason not Specified|1|||
37648911|NCT02388724|69118293|FG000|Overall Study|Major Protocol Deviation|3|||
37648912|NCT02388724|69118294|FG001|Overall Study|Major Protocol Deviation|3|||
37648913|NCT02388724|69118293|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
37741634|NCT01855789|69227698|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
37741635|NCT01855789|69227699|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
37741636|NCT01855789|69227700|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
37741637|NCT01855789|69227701|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
37741638|NCT01855789|69227698|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
37741639|NCT01855789|69227699|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
37741640|NCT01855789|69227700|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
37741641|NCT01855789|69227701|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
37741642|NCT01855789|69227698|FG000|2) Week 24 up to End of Study|Other|0|||
37741643|NCT01855789|69227699|FG001|2) Week 24 up to End of Study|Other|0|||
37741644|NCT01855789|69227700|FG002|2) Week 24 up to End of Study|Other|0|||
37741645|NCT01855789|69227701|FG003|2) Week 24 up to End of Study|Other|1|||
37741646|NCT01610791|69227707|FG000|Overall Study|Lost to Follow-up|7|||
37741647|NCT01610791|69227707|FG000|Overall Study|Adverse Event|6|||
37741648|NCT01610791|69227707|FG000|Overall Study|Physician Decision|1|||
37741649|NCT01610791|69227707|FG000|Overall Study|Adverse event and Investigator decision|1|||
37741650|NCT01610791|69227707|FG000|Overall Study|Death|1|||
37741651|NCT01610791|69227707|FG000|Overall Study|Not determined|5|||
37741652|NCT01876381|69227711|FG000|Overall Study|Lack of Efficacy|5|||
37741653|NCT01876381|69227711|FG000|Overall Study|Physician Decision|1|||
37741654|NCT01876381|69227711|FG000|Overall Study|Withdrawal by Subject|1|||
37741655|NCT01855399|69227726|FG000|6 Month|Lost to Follow-up|12|||
37741656|NCT01855399|69227727|FG001|6 Month|Lost to Follow-up|9|||
37741657|NCT01855399|69227726|FG000|6 Month|Withdrawal by Subject|8|||
37741658|NCT01855399|69227727|FG001|6 Month|Withdrawal by Subject|6|||
37741659|NCT01855399|69227726|FG000|12 Month|Lost to Follow-up|7|||
37741660|NCT01855399|69227727|FG001|12 Month|Lost to Follow-up|11|||
37741661|NCT01875991|69227735|FG000|Overall Study|Withdrawal by Subject|6|||
37741662|NCT01875991|69227736|FG001|Overall Study|Withdrawal by Subject|6|||
37741663|NCT01875991|69227735|FG000|Overall Study|Sponsor Decision|1|||
37741664|NCT01875991|69227736|FG001|Overall Study|Sponsor Decision|0|||
37741665|NCT01855243|69227748|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
37741666|NCT01855243|69227749|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
37741667|NCT01855243|69227750|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
37741668|NCT01825837|69227762|FG000|PART I|Withdrawal by Subject|0|||
37741669|NCT01825837|69227763|FG001|PART I|Withdrawal by Subject|0|||
37741670|NCT01825837|69227764|FG002|PART I|Withdrawal by Subject|0|||
37741671|NCT01825837|69227765|FG003|PART I|Withdrawal by Subject|6|||
37741672|NCT01825837|69227762|FG000|PART I|Patient non-compliance|0|||
37741673|NCT01825837|69227763|FG001|PART I|Patient non-compliance|0|||
38032305|NCT03345836|69718186|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
38032306|NCT03345836|69718187|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
38032307|NCT03345836|69718188|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
38032308|NCT03345836|69718189|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
37648914|NCT02388724|69118294|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
37741674|NCT01825837|69227764|FG002|PART I|Patient non-compliance|0|||
37741675|NCT01825837|69227765|FG003|PART I|Patient non-compliance|1|||
37741676|NCT01825837|69227762|FG000|PART I|Treatment failure|0|||
37741677|NCT01825837|69227763|FG001|PART I|Treatment failure|0|||
37648915|NCT02388724|69118293|FG000|Overall Study|Voluntary Withdrawal|6|||
37648916|NCT02388724|69118294|FG001|Overall Study|Voluntary Withdrawal|5|||
37741678|NCT01825837|69227764|FG002|PART I|Treatment failure|0|||
37741679|NCT01825837|69227765|FG003|PART I|Treatment failure|7|||
37741680|NCT01825837|69227762|FG000|PART I|reason unspecified|0|||
37741681|NCT01825837|69227763|FG001|PART I|reason unspecified|0|||
37741682|NCT01825837|69227764|FG002|PART I|reason unspecified|0|||
37741683|NCT01825837|69227765|FG003|PART I|reason unspecified|3|||
37648917|NCT02388724|69118293|FG000|Overall Study|Randomized but not Treated|0|||
37648918|NCT02388724|69118294|FG001|Overall Study|Randomized but not Treated|2|||
37648919|NCT02382796|69118300|FG000|Overall Study|Global deterioration of health status|1|||
37648920|NCT02382796|69118300|FG000|Overall Study|Objective progression or relapse|3|||
37648921|NCT02382796|69118300|FG000|Overall Study|Commercial dacomitinib became available|3|||
37648922|NCT02382640|69118308|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
37648923|NCT02382640|69118309|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
37648924|NCT02382640|69118310|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
37648925|NCT02382640|69118311|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
37648926|NCT02801669|69118323|FG000|Overall Study|Death|66|||
37648927|NCT02801669|69118324|FG001|Overall Study|Death|69|||
37648928|NCT02801669|69118323|FG000|Overall Study|Withdrawal by Subject|81|||
37648929|NCT02801669|69118324|FG001|Overall Study|Withdrawal by Subject|77|||
37648930|NCT02801669|69118323|FG000|Overall Study|Other|4|||
37648931|NCT02801669|69118324|FG001|Overall Study|Other|6|||
37648932|NCT02804399|69118330|FG000|Period 2|Adverse Event|0|||
37648933|NCT02804399|69118331|FG001|Period 2|Adverse Event|1|||
38032309|NCT03345836|69718190|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
37648934|NCT01333943|69118342|FG000|Overall Study|Known neuropathy|1|||
37855044|NCT01225731|69538423|FG000|Part 1|Did not meet eligibility criteria|1|||
37855045|NCT01225731|69538424|FG001|Part 1|Did not meet eligibility criteria|0|||
37855046|NCT01225731|69538425|FG002|Part 1|Did not meet eligibility criteria|0|||
37855047|NCT01225731|69538426|FG003|Part 1|Did not meet eligibility criteria|0|||
37855048|NCT01225731|69538427|FG004|Part 1|Did not meet eligibility criteria|1|||
37855049|NCT01225731|69538428|FG005|Part 1|Did not meet eligibility criteria|0|||
37855050|NCT01225731|69538429|FG006|Part 1|Did not meet eligibility criteria|0|||
37855051|NCT01225731|69538430|FG007|Part 1|Did not meet eligibility criteria|0|||
37855052|NCT01225731|69538431|FG008|Part 1|Did not meet eligibility criteria|0|||
37855053|NCT01225731|69538432|FG009|Part 1|Did not meet eligibility criteria|0|||
37855054|NCT01225731|69538433|FG010|Part 1|Did not meet eligibility criteria|0|||
37855055|NCT01225731|69538434|FG011|Part 1|Did not meet eligibility criteria|0|||
37855056|NCT01225731|69538435|FG012|Part 1|Did not meet eligibility criteria|0|||
37855057|NCT01225731|69538423|FG000|Part 1|Adverse Event|1|||
37855058|NCT01225731|69538424|FG001|Part 1|Adverse Event|2|||
37855059|NCT01225731|69538425|FG002|Part 1|Adverse Event|1|||
37648935|NCT01333943|69118343|FG001|Overall Study|Known neuropathy|0|||
37648936|NCT01333865|69118349|FG000|Overall Study|Adverse Event|2|||
37648937|NCT01333475|69118355|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
37648938|NCT01333475|69118356|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
37648939|NCT01333475|69118355|FG000|Overall Study|Toxicity|1|||
37648940|NCT01333475|69118356|FG001|Overall Study|Toxicity|3|||
37648941|NCT01333397|69118368|FG000|Overall Study|Lost to Follow-up|1|||
37648942|NCT01333397|69118369|FG001|Overall Study|Lost to Follow-up|0|||
37648943|NCT01333397|69118370|FG002|Overall Study|Lost to Follow-up|0|||
37648944|NCT01333397|69118371|FG003|Overall Study|Lost to Follow-up|1|||
37648945|NCT01333397|69118372|FG004|Overall Study|Lost to Follow-up|0|||
37648946|NCT02798861|69118393|FG000|Overall Study|Lost to Follow-up|22|||
37648947|NCT02798861|69118393|FG000|Overall Study|Withdrawal by Subject|1|||
37648948|NCT02798315|69118397|FG000|Overall Study|Failure to return|1|||
37648949|NCT02796755|69118403|FG000|Overall Study|Adverse Event|2|||
37648950|NCT02796755|69118404|FG001|Overall Study|Adverse Event|0|||
37648951|NCT02382016|69118412|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
37648952|NCT02382016|69118413|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
37648953|NCT02382016|69118412|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
37648954|NCT02382016|69118413|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
37648955|NCT02382016|69118412|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
37648956|NCT02382016|69118413|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
37648957|NCT02382016|69118412|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
37648958|NCT02382016|69118413|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
37648959|NCT02382016|69118412|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
37648960|NCT02382016|69118413|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
37648961|NCT02382016|69118412|FG000|Open-label (OL) Treatment Period|Death|4|||
37648962|NCT02382016|69118413|FG001|Open-label (OL) Treatment Period|Death|0|||
37648963|NCT02382016|69118412|FG000|OL Extension Period|Physician Decision|3|||
37648964|NCT02382016|69118413|FG001|OL Extension Period|Physician Decision|0|||
37648965|NCT02382016|69118412|FG000|OL Extension Period|Death|2|||
37648966|NCT02382016|69118413|FG001|OL Extension Period|Death|0|||
37648967|NCT02382016|69118412|FG000|OL Extension Period|Withdrawal by Subject|1|||
37648968|NCT02382016|69118413|FG001|OL Extension Period|Withdrawal by Subject|0|||
37648969|NCT02422186|69118423|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
37648970|NCT02422186|69118424|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
37648971|NCT02422186|69118423|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
37741684|NCT01825837|69227762|FG000|PART II|Withdrawal by Subject|3|||
37855060|NCT01225731|69538426|FG003|Part 1|Adverse Event|1|||
37855061|NCT01225731|69538427|FG004|Part 1|Adverse Event|1|||
37648972|NCT02422186|69118424|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
37648973|NCT02422186|69118423|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
37648974|NCT02422186|69118424|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
37648975|NCT02422186|69118423|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
37648976|NCT02422186|69118424|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
37648977|NCT02422186|69118423|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
37648978|NCT02422186|69118424|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
37741685|NCT01825837|69227763|FG001|PART II|Withdrawal by Subject|3|||
37741686|NCT01825837|69227764|FG002|PART II|Withdrawal by Subject|7|||
37922227|NCT00460603|69609073|FG007|Phase 1|Lack of Efficacy|2|||
37922228|NCT00460603|69609074|FG008|Phase 1|Lack of Efficacy|11|||
37922229|NCT00460603|69609075|FG009|Phase 1|Lack of Efficacy|0|||
37922230|NCT00460603|69609076|FG010|Phase 1|Lack of Efficacy|0|||
37922231|NCT00460603|69609077|FG011|Phase 1|Lack of Efficacy|0|||
37922232|NCT00460603|69609066|FG000|Phase 1|Withdrawal by Subject|1|||
37922233|NCT00460603|69609067|FG001|Phase 1|Withdrawal by Subject|2|||
37922234|NCT00460603|69609068|FG002|Phase 1|Withdrawal by Subject|1|||
37922235|NCT00460603|69609069|FG003|Phase 1|Withdrawal by Subject|1|||
37922236|NCT00460603|69609070|FG004|Phase 1|Withdrawal by Subject|3|||
37922237|NCT00460603|69609071|FG005|Phase 1|Withdrawal by Subject|0|||
37922238|NCT00460603|69609072|FG006|Phase 1|Withdrawal by Subject|1|||
37922239|NCT00460603|69609073|FG007|Phase 1|Withdrawal by Subject|0|||
37922240|NCT00460603|69609074|FG008|Phase 1|Withdrawal by Subject|2|||
37922241|NCT00460603|69609075|FG009|Phase 1|Withdrawal by Subject|0|||
37922242|NCT00460603|69609076|FG010|Phase 1|Withdrawal by Subject|0|||
37741687|NCT01825837|69227765|FG003|PART II|Withdrawal by Subject|0|||
37741688|NCT01825837|69227762|FG000|PART II|Patient non-compliance|5|||
37741689|NCT01825837|69227763|FG001|PART II|Patient non-compliance|2|||
37741690|NCT01825837|69227764|FG002|PART II|Patient non-compliance|4|||
37741691|NCT01825837|69227765|FG003|PART II|Patient non-compliance|0|||
37741692|NCT01825837|69227762|FG000|PART II|Adverse Event|3|||
37741693|NCT01825837|69227763|FG001|PART II|Adverse Event|3|||
37741694|NCT01825837|69227764|FG002|PART II|Adverse Event|1|||
37741695|NCT01825837|69227765|FG003|PART II|Adverse Event|0|||
37741696|NCT01825837|69227762|FG000|PART II|Treatment failure|6|||
37741697|NCT01825837|69227763|FG001|PART II|Treatment failure|4|||
37741698|NCT01825837|69227764|FG002|PART II|Treatment failure|5|||
37741699|NCT01825837|69227765|FG003|PART II|Treatment failure|0|||
37741700|NCT01825837|69227762|FG000|PART II|reason unspecified|2|||
37741701|NCT01825837|69227763|FG001|PART II|reason unspecified|2|||
37741702|NCT01825837|69227764|FG002|PART II|reason unspecified|2|||
37741703|NCT01825837|69227765|FG003|PART II|reason unspecified|0|||
37741704|NCT01854697|69227778|FG000|Overall Study|Adverse Event|1|||
37741705|NCT01854697|69227779|FG001|Overall Study|Adverse Event|0|||
37922243|NCT00460603|69609077|FG011|Phase 1|Withdrawal by Subject|0|||
37922244|NCT00460603|69609066|FG000|Phase 1|Other|0|||
37922245|NCT00460603|69609067|FG001|Phase 1|Other|3|||
37922246|NCT00460603|69609068|FG002|Phase 1|Other|1|||
37922247|NCT00460603|69609069|FG003|Phase 1|Other|1|||
37922248|NCT00460603|69609070|FG004|Phase 1|Other|1|||
37648979|NCT02422186|69118423|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
37648980|NCT02422186|69118424|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
37648981|NCT02422186|69118423|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
37648982|NCT02422186|69118424|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
37648983|NCT02422186|69118423|FG000|Follow-up Phase (2 Weeks)|Other|3|||
37648984|NCT02422186|69118424|FG001|Follow-up Phase (2 Weeks)|Other|0|||
37648985|NCT02421952|69118432|FG000|Overall Study|Diary Not Returned|93|||
37648986|NCT02421952|69118432|FG000|Overall Study|Failed seriation task|13|||
37648987|NCT02421952|69118432|FG000|Overall Study|Subject uncooperative for baseline test|2|||
37648988|NCT02421952|69118432|FG000|Overall Study|Surgery cancelled|1|||
37648989|NCT02796677|69118443|FG000|Overall Study|Adverse Event|11|||
37648990|NCT02796677|69118444|FG001|Overall Study|Adverse Event|22|||
37648991|NCT02796677|69118445|FG002|Overall Study|Adverse Event|14|||
37648992|NCT02796677|69118446|FG003|Overall Study|Adverse Event|14|||
37648993|NCT02796677|69118443|FG000|Overall Study|Protocol Violation|7|||
37648994|NCT02796677|69118444|FG001|Overall Study|Protocol Violation|5|||
37648995|NCT02796677|69118445|FG002|Overall Study|Protocol Violation|4|||
37648996|NCT02796677|69118446|FG003|Overall Study|Protocol Violation|8|||
37648997|NCT02796677|69118443|FG000|Overall Study|Lost to Follow-up|1|||
37648998|NCT02796677|69118444|FG001|Overall Study|Lost to Follow-up|5|||
37648999|NCT02796677|69118445|FG002|Overall Study|Lost to Follow-up|2|||
37649000|NCT02796677|69118446|FG003|Overall Study|Lost to Follow-up|2|||
37741706|NCT01854697|69227780|FG002|Overall Study|Adverse Event|0|||
37741707|NCT01854697|69227781|FG003|Overall Study|Adverse Event|0|||
37741708|NCT01854697|69227782|FG004|Overall Study|Adverse Event|1|||
37741709|NCT01854697|69227778|FG000|Overall Study|Lost to Follow-up|4|||
37922249|NCT00460603|69609071|FG005|Phase 1|Other|2|||
37922250|NCT00460603|69609072|FG006|Phase 1|Other|0|||
37922251|NCT00460603|69609073|FG007|Phase 1|Other|1|||
37922252|NCT00460603|69609074|FG008|Phase 1|Other|0|||
37922253|NCT00460603|69609075|FG009|Phase 1|Other|0|||
37922254|NCT00460603|69609076|FG010|Phase 1|Other|0|||
37922255|NCT00460603|69609077|FG011|Phase 1|Other|0|||
37922256|NCT00460603|69609066|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
37922257|NCT00460603|69609067|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
37922258|NCT00460603|69609068|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
37922259|NCT00460603|69609069|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
37922260|NCT00460603|69609070|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
37922261|NCT00460603|69609071|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
37922262|NCT00460603|69609072|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
37922263|NCT00460603|69609073|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
37922264|NCT00460603|69609074|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
37922265|NCT00460603|69609075|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
37922266|NCT00460603|69609076|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
37922267|NCT00460603|69609077|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
37922268|NCT00460603|69609066|FG000|Phase 2|Adverse Event|0|||
37649001|NCT02796677|69118443|FG000|Overall Study|Lack of Efficacy|7|||
37649002|NCT02796677|69118444|FG001|Overall Study|Lack of Efficacy|9|||
37649003|NCT02796677|69118445|FG002|Overall Study|Lack of Efficacy|14|||
37649004|NCT02796677|69118446|FG003|Overall Study|Lack of Efficacy|20|||
37649005|NCT02796677|69118443|FG000|Overall Study|Withdrawal by Subject|4|||
37649006|NCT02796677|69118444|FG001|Overall Study|Withdrawal by Subject|14|||
37649007|NCT02796677|69118445|FG002|Overall Study|Withdrawal by Subject|6|||
37649008|NCT02796677|69118446|FG003|Overall Study|Withdrawal by Subject|7|||
37649009|NCT02796677|69118443|FG000|Overall Study|Progressive disease|6|||
37649010|NCT02796677|69118444|FG001|Overall Study|Progressive disease|15|||
37649011|NCT02796677|69118445|FG002|Overall Study|Progressive disease|13|||
37649012|NCT02796677|69118446|FG003|Overall Study|Progressive disease|18|||
37649013|NCT02796677|69118443|FG000|Overall Study|Reason not mentioned|2|||
37649014|NCT02796677|69118444|FG001|Overall Study|Reason not mentioned|3|||
37649015|NCT02796677|69118445|FG002|Overall Study|Reason not mentioned|0|||
37649016|NCT02796677|69118446|FG003|Overall Study|Reason not mentioned|5|||
37649017|NCT02421172|69118460|FG000|Period 1|Adverse Event|1|||
37649018|NCT02421172|69118461|FG001|Period 1|Adverse Event|0|||
37649019|NCT02421172|69118462|FG002|Period 1|Adverse Event|0|||
37649020|NCT02421172|69118463|FG003|Period 1|Adverse Event|0|||
37649021|NCT02421172|69118464|FG004|Period 1|Adverse Event|0|||
37649022|NCT02421172|69118460|FG000|Period 1|Lost to Follow-up|3|||
37649023|NCT02421172|69118461|FG001|Period 1|Lost to Follow-up|1|||
37649024|NCT02421172|69118462|FG002|Period 1|Lost to Follow-up|0|||
37649025|NCT02421172|69118463|FG003|Period 1|Lost to Follow-up|0|||
37649026|NCT02421172|69118464|FG004|Period 1|Lost to Follow-up|0|||
37649027|NCT02421172|69118460|FG000|Period 1|Patient/guardian decision|0|||
37649028|NCT02421172|69118461|FG001|Period 1|Patient/guardian decision|1|||
37649029|NCT02421172|69118462|FG002|Period 1|Patient/guardian decision|0|||
37649030|NCT02421172|69118463|FG003|Period 1|Patient/guardian decision|0|||
37649031|NCT02421172|69118464|FG004|Period 1|Patient/guardian decision|0|||
37649032|NCT02421172|69118460|FG000|Period 2|Adverse Event|0|||
37649033|NCT02421172|69118461|FG001|Period 2|Adverse Event|0|||
37649034|NCT02421172|69118462|FG002|Period 2|Adverse Event|4|||
37649035|NCT02421172|69118463|FG003|Period 2|Adverse Event|0|||
37649036|NCT02421172|69118464|FG004|Period 2|Adverse Event|0|||
37649037|NCT02421172|69118460|FG000|Period 2|Lost to Follow-up|0|||
37649038|NCT02421172|69118461|FG001|Period 2|Lost to Follow-up|0|||
37649039|NCT02421172|69118462|FG002|Period 2|Lost to Follow-up|0|||
37649040|NCT02421172|69118463|FG003|Period 2|Lost to Follow-up|1|||
37649041|NCT02421172|69118464|FG004|Period 2|Lost to Follow-up|0|||
37649042|NCT02421172|69118460|FG000|Period 2|Patient/guardian decision|0|||
37741710|NCT01854697|69227779|FG001|Overall Study|Lost to Follow-up|1|||
37741711|NCT01854697|69227780|FG002|Overall Study|Lost to Follow-up|1|||
37741712|NCT01854697|69227781|FG003|Overall Study|Lost to Follow-up|2|||
37741713|NCT01854697|69227782|FG004|Overall Study|Lost to Follow-up|0|||
37741714|NCT01854697|69227778|FG000|Overall Study|To enter another AbbVie study|1|||
37649043|NCT02421172|69118461|FG001|Period 2|Patient/guardian decision|0|||
37741715|NCT01854697|69227779|FG001|Overall Study|To enter another AbbVie study|0|||
37741716|NCT01854697|69227780|FG002|Overall Study|To enter another AbbVie study|0|||
37922269|NCT00460603|69609067|FG001|Phase 2|Adverse Event|0|||
37922270|NCT00460603|69609068|FG002|Phase 2|Adverse Event|0|||
37649044|NCT02421172|69118462|FG002|Period 2|Patient/guardian decision|3|||
37649045|NCT02421172|69118463|FG003|Period 2|Patient/guardian decision|2|||
37649046|NCT02421172|69118464|FG004|Period 2|Patient/guardian decision|1|||
37649047|NCT02379052|69118477|FG000|Overall Study|Protocol Violation|0|||
37649048|NCT02379052|69118478|FG001|Overall Study|Protocol Violation|1|||
37649049|NCT02379052|69118477|FG000|Overall Study|Adverse Event|0|||
37649050|NCT02379052|69118478|FG001|Overall Study|Adverse Event|1|||
37649051|NCT02379052|69118477|FG000|Overall Study|Physician Decision|1|||
37922271|NCT00460603|69609069|FG003|Phase 2|Adverse Event|0|||
37922272|NCT00460603|69609070|FG004|Phase 2|Adverse Event|0|||
37649052|NCT02379052|69118478|FG001|Overall Study|Physician Decision|1|||
37649053|NCT02379052|69118477|FG000|Overall Study|Withdrawal by Subject|2|||
37649054|NCT02379052|69118478|FG001|Overall Study|Withdrawal by Subject|0|||
37649055|NCT02379052|69118477|FG000|Overall Study|Lost to Follow-up|2|||
37649056|NCT02379052|69118478|FG001|Overall Study|Lost to Follow-up|1|||
37649057|NCT02379052|69118477|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
37649058|NCT02379052|69118478|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
37649059|NCT02379052|69118477|FG000|Overall Study|Subject was Incarcerated|0|||
37649060|NCT02379052|69118478|FG001|Overall Study|Subject was Incarcerated|1|||
37649061|NCT02378662|69118486|FG000|Overall Study|Early Discontinuation|2|||
37649062|NCT02378662|69118487|FG001|Overall Study|Early Discontinuation|0|||
37649063|NCT02378506|69118493|FG000|Overall Study|Lack of Efficacy|3|||
37649064|NCT02378506|69118493|FG000|Overall Study|Withdrawal by Subject|4|||
37649065|NCT02378506|69118493|FG000|Overall Study|Protocol Violation|2|||
37649066|NCT02378506|69118493|FG000|Overall Study|Death|1|||
37649067|NCT02378506|69118493|FG000|Overall Study|Adverse Event|14|||
37649068|NCT02378506|69118493|FG000|Overall Study|Randomized But Not Treated|1|||
37649069|NCT02347774|69118500|FG000|Study Participation|Lost to Follow-up|3|||
37649070|NCT02347774|69118501|FG001|Study Participation|Lost to Follow-up|6|||
37649071|NCT02347774|69118502|FG002|Study Participation|Lost to Follow-up|2|||
37649072|NCT02347774|69118500|FG000|Study Participation|Withdrawal by Subject|8|||
37649073|NCT02347774|69118501|FG001|Study Participation|Withdrawal by Subject|9|||
37649074|NCT02347774|69118502|FG002|Study Participation|Withdrawal by Subject|15|||
37649075|NCT02347774|69118500|FG000|Study Participation|Adverse Event|1|||
37649076|NCT02347774|69118501|FG001|Study Participation|Adverse Event|4|||
37649077|NCT02347774|69118502|FG002|Study Participation|Adverse Event|6|||
37649078|NCT02347774|69118500|FG000|Study Participation|withdrew consent|1|||
37649079|NCT02347774|69118501|FG001|Study Participation|withdrew consent|1|||
37741717|NCT01854697|69227781|FG003|Overall Study|To enter another AbbVie study|0|||
37741718|NCT01854697|69227782|FG004|Overall Study|To enter another AbbVie study|1|||
37741719|NCT01854697|69227778|FG000|Overall Study|Withdrew Consent|0|||
37741720|NCT01854697|69227779|FG001|Overall Study|Withdrew Consent|1|||
37741721|NCT01854697|69227780|FG002|Overall Study|Withdrew Consent|0|||
37741722|NCT01854697|69227781|FG003|Overall Study|Withdrew Consent|1|||
37741723|NCT01854697|69227782|FG004|Overall Study|Withdrew Consent|0|||
37741724|NCT01854697|69227778|FG000|Overall Study|Other|0|||
37855062|NCT01225731|69538428|FG005|Part 1|Adverse Event|0|||
37922273|NCT00460603|69609071|FG005|Phase 2|Adverse Event|0|||
37922274|NCT00460603|69609072|FG006|Phase 2|Adverse Event|0|||
37922275|NCT00460603|69609073|FG007|Phase 2|Adverse Event|0|||
37922276|NCT00460603|69609074|FG008|Phase 2|Adverse Event|0|||
37922277|NCT00460603|69609075|FG009|Phase 2|Adverse Event|12|||
37922278|NCT00460603|69609076|FG010|Phase 2|Adverse Event|9|||
37922279|NCT00460603|69609077|FG011|Phase 2|Adverse Event|10|||
37922280|NCT00460603|69609066|FG000|Phase 2|Death|0|||
37922281|NCT00460603|69609067|FG001|Phase 2|Death|0|||
37922282|NCT00460603|69609068|FG002|Phase 2|Death|0|||
37922283|NCT00460603|69609069|FG003|Phase 2|Death|0|||
37922284|NCT00460603|69609070|FG004|Phase 2|Death|0|||
37922285|NCT00460603|69609071|FG005|Phase 2|Death|0|||
37922286|NCT00460603|69609072|FG006|Phase 2|Death|0|||
37922287|NCT00460603|69609073|FG007|Phase 2|Death|0|||
37922288|NCT00460603|69609074|FG008|Phase 2|Death|0|||
37922289|NCT00460603|69609075|FG009|Phase 2|Death|4|||
37922290|NCT00460603|69609076|FG010|Phase 2|Death|2|||
37855063|NCT01225731|69538429|FG006|Part 1|Adverse Event|0|||
37855064|NCT01225731|69538430|FG007|Part 1|Adverse Event|0|||
37855065|NCT01225731|69538431|FG008|Part 1|Adverse Event|0|||
37855066|NCT01225731|69538432|FG009|Part 1|Adverse Event|0|||
37855067|NCT01225731|69538433|FG010|Part 1|Adverse Event|0|||
37855068|NCT01225731|69538434|FG011|Part 1|Adverse Event|0|||
37855069|NCT01225731|69538435|FG012|Part 1|Adverse Event|0|||
37855070|NCT01225731|69538423|FG000|Part 1|Withdrawal by Subject|0|||
37855071|NCT01225731|69538424|FG001|Part 1|Withdrawal by Subject|3|||
37922291|NCT00460603|69609077|FG011|Phase 2|Death|2|||
37649080|NCT02347774|69118502|FG002|Study Participation|withdrew consent|1|||
37649081|NCT02347774|69118500|FG000|Study Participation|Met Prolonged QT criteria|1|||
37649082|NCT02347774|69118501|FG001|Study Participation|Met Prolonged QT criteria|0|||
37649083|NCT02347774|69118502|FG002|Study Participation|Met Prolonged QT criteria|0|||
37649084|NCT02347774|69118500|FG000|Study Participation|non-compliance with study drug|0|||
37649085|NCT02347774|69118501|FG001|Study Participation|non-compliance with study drug|1|||
37741725|NCT01854697|69227779|FG001|Overall Study|Other|1|||
37741726|NCT01854697|69227780|FG002|Overall Study|Other|1|||
37855072|NCT01225731|69538425|FG002|Part 1|Withdrawal by Subject|0|||
37649086|NCT02347774|69118502|FG002|Study Participation|non-compliance with study drug|0|||
37649087|NCT02347774|69118500|FG000|Study Participation|incarceration|1|||
37649088|NCT02347774|69118501|FG001|Study Participation|incarceration|0|||
37741727|NCT01854697|69227781|FG003|Overall Study|Other|0|||
37855073|NCT01225731|69538426|FG003|Part 1|Withdrawal by Subject|0|||
37922292|NCT00460603|69609066|FG000|Phase 2|Protocol Violation|0|||
37922293|NCT00460603|69609067|FG001|Phase 2|Protocol Violation|0|||
37922294|NCT00460603|69609068|FG002|Phase 2|Protocol Violation|0|||
37922295|NCT00460603|69609069|FG003|Phase 2|Protocol Violation|0|||
37649089|NCT02347774|69118502|FG002|Study Participation|incarceration|0|||
37649090|NCT02347774|69118500|FG000|Study Participation|randomized in error|0|||
37649091|NCT02347774|69118501|FG001|Study Participation|randomized in error|0|||
37649092|NCT02347774|69118502|FG002|Study Participation|randomized in error|1|||
37649093|NCT02347774|69118500|FG000|On Study Treatment|Adverse Event|9|||
37649094|NCT02347774|69118501|FG001|On Study Treatment|Adverse Event|15|||
37649095|NCT02347774|69118502|FG002|On Study Treatment|Adverse Event|19|||
37649096|NCT02347774|69118500|FG000|On Study Treatment|Lack of Efficacy|3|||
37649097|NCT02347774|69118501|FG001|On Study Treatment|Lack of Efficacy|0|||
37649098|NCT02347774|69118502|FG002|On Study Treatment|Lack of Efficacy|2|||
37649099|NCT02347774|69118500|FG000|On Study Treatment|non-complicance with study medication|0|||
37649100|NCT02347774|69118501|FG001|On Study Treatment|non-complicance with study medication|2|||
37649101|NCT02347774|69118502|FG002|On Study Treatment|non-complicance with study medication|0|||
37649102|NCT02347774|69118500|FG000|On Study Treatment|Protocol Violation|0|||
37649103|NCT02347774|69118501|FG001|On Study Treatment|Protocol Violation|0|||
37649104|NCT02347774|69118502|FG002|On Study Treatment|Protocol Violation|1|||
37649105|NCT02347774|69118500|FG000|On Study Treatment|withdrew consent|9|||
37649106|NCT02347774|69118501|FG001|On Study Treatment|withdrew consent|8|||
37649107|NCT02347774|69118502|FG002|On Study Treatment|withdrew consent|12|||
37649108|NCT02347774|69118500|FG000|On Study Treatment|Lost to Follow-up|2|||
37649109|NCT02347774|69118501|FG001|On Study Treatment|Lost to Follow-up|6|||
37649110|NCT02347774|69118502|FG002|On Study Treatment|Lost to Follow-up|1|||
37649111|NCT02347774|69118500|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
37649112|NCT02347774|69118501|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
37649113|NCT02347774|69118502|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
37649114|NCT02347774|69118500|FG000|On Study Treatment|ranomized in error|0|||
37649115|NCT02347774|69118501|FG001|On Study Treatment|ranomized in error|0|||
37649116|NCT02347774|69118502|FG002|On Study Treatment|ranomized in error|1|||
37649117|NCT02794883|69118513|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
37649118|NCT02794883|69118514|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
37649119|NCT02794883|69118515|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
37649120|NCT02794883|69118513|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
37649121|NCT02794883|69118514|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
37649122|NCT02794883|69118515|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
37649123|NCT02794883|69118513|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
37649124|NCT02794883|69118514|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
37649125|NCT02794883|69118515|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
37649126|NCT02794883|69118513|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
37649127|NCT02794883|69118514|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
37649128|NCT02794883|69118515|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
37649129|NCT02794883|69118513|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
37649130|NCT02794883|69118514|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
37649131|NCT02794883|69118515|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
37649132|NCT02794883|69118513|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
37649133|NCT02794883|69118514|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
37649134|NCT02794883|69118515|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
37649135|NCT02794883|69118513|FG000|Follow-up Period (up to 2 Years)|Death|12|||
37649136|NCT02794883|69118514|FG001|Follow-up Period (up to 2 Years)|Death|10|||
37649137|NCT02794883|69118515|FG002|Follow-up Period (up to 2 Years)|Death|10|||
37649138|NCT01370603|69118525|FG000|Period 1|Adverse Event|5|||
37649139|NCT01370603|69118526|FG001|Period 1|Adverse Event|3|||
37649140|NCT01370603|69118525|FG000|Period 1|Lost to Follow-up|2|||
37649141|NCT01370603|69118526|FG001|Period 1|Lost to Follow-up|0|||
37649142|NCT01370603|69118525|FG000|Period 1|Protocol Violation|2|||
37649143|NCT01370603|69118526|FG001|Period 1|Protocol Violation|2|||
37649144|NCT01370603|69118525|FG000|Period 1|Withdrawal by Subject|5|||
37649145|NCT01370603|69118526|FG001|Period 1|Withdrawal by Subject|5|||
37649146|NCT01370603|69118525|FG000|Crossover Washout|Adverse Event|2|||
37649147|NCT01370603|69118526|FG001|Crossover Washout|Adverse Event|1|||
37649148|NCT01370603|69118525|FG000|Crossover Washout|Lost to Follow-up|2|||
37649149|NCT01370603|69118526|FG001|Crossover Washout|Lost to Follow-up|0|||
37649150|NCT01370603|69118525|FG000|Crossover Washout|Protocol Violation|1|||
37649151|NCT01370603|69118526|FG001|Crossover Washout|Protocol Violation|0|||
37855074|NCT01225731|69538427|FG004|Part 1|Withdrawal by Subject|4|||
37855075|NCT01225731|69538428|FG005|Part 1|Withdrawal by Subject|0|||
37855076|NCT01225731|69538429|FG006|Part 1|Withdrawal by Subject|0|||
37649152|NCT01370603|69118525|FG000|Crossover Washout|Withdrawal by Subject|4|||
37649153|NCT01370603|69118526|FG001|Crossover Washout|Withdrawal by Subject|1|||
37855077|NCT01225731|69538430|FG007|Part 1|Withdrawal by Subject|0|||
37855078|NCT01225731|69538431|FG008|Part 1|Withdrawal by Subject|0|||
37855079|NCT01225731|69538432|FG009|Part 1|Withdrawal by Subject|0|||
37649154|NCT01370603|69118525|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
37649155|NCT01370603|69118526|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
37649156|NCT01370603|69118525|FG000|Period 2|Adverse Event|1|||
37649157|NCT01370603|69118526|FG001|Period 2|Adverse Event|4|||
37649158|NCT01370603|69118525|FG000|Period 2|Lost to Follow-up|1|||
37649159|NCT01370603|69118526|FG001|Period 2|Lost to Follow-up|0|||
37649160|NCT01370603|69118525|FG000|Period 2|Withdrawal by Subject|1|||
37649161|NCT01370603|69118526|FG001|Period 2|Withdrawal by Subject|0|||
37649162|NCT02347072|69118532|FG000|Overall Study|Adverse Event|2|||
37649163|NCT02347072|69118532|FG000|Overall Study|Withdrawal by Subject|6|||
37649164|NCT02347072|69118532|FG000|Overall Study|Physician Decision|1|||
37649165|NCT02347072|69118532|FG000|Overall Study|Lost to Follow-up|2|||
37649166|NCT02347072|69118532|FG000|Overall Study|Protocol Violation|1|||
37649167|NCT02347072|69118532|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
37649168|NCT02794103|69118540|FG000|Overall Study|Loss to follow up due to high sedation|3|||
37649169|NCT02346370|69118547|FG000|Overall Study|Not treated|1|||
37649170|NCT02346370|69118548|FG001|Overall Study|Not treated|0|||
37649171|NCT02346370|69118549|FG002|Overall Study|Not treated|0|||
37649172|NCT02346370|69118547|FG000|Overall Study|Withdrawal of consent|1|||
37649173|NCT02346370|69118548|FG001|Overall Study|Withdrawal of consent|0|||
37649174|NCT02346370|69118549|FG002|Overall Study|Withdrawal of consent|0|||
37649175|NCT02346370|69118547|FG000|Overall Study|Death|1|||
37649176|NCT02346370|69118548|FG001|Overall Study|Death|3|||
37649177|NCT02346370|69118549|FG002|Overall Study|Death|1|||
37649178|NCT02346370|69118547|FG000|Overall Study|Sponsor discontinued study|5|||
37649179|NCT02346370|69118548|FG001|Overall Study|Sponsor discontinued study|0|||
37649180|NCT02346370|69118549|FG002|Overall Study|Sponsor discontinued study|2|||
37649181|NCT02346370|69118547|FG000|Overall Study|Radiologic progression|0|||
37649182|NCT02346370|69118548|FG001|Overall Study|Radiologic progression|0|||
37649183|NCT02346370|69118549|FG002|Overall Study|Radiologic progression|1|||
37649184|NCT02346370|69118547|FG000|Overall Study|Physician Decision|0|||
37649185|NCT02346370|69118548|FG001|Overall Study|Physician Decision|1|||
37649186|NCT02346370|69118549|FG002|Overall Study|Physician Decision|0|||
37649187|NCT02346136|69118561|FG000|Overall Study|Withdrawal by Subject|7|||
37649188|NCT02346136|69118562|FG001|Overall Study|Withdrawal by Subject|5|||
37922296|NCT00460603|69609070|FG004|Phase 2|Protocol Violation|0|||
37922297|NCT00460603|69609071|FG005|Phase 2|Protocol Violation|0|||
37922298|NCT00460603|69609072|FG006|Phase 2|Protocol Violation|0|||
37649189|NCT02346136|69118561|FG000|Overall Study|Death|1|||
37741728|NCT01854697|69227782|FG004|Overall Study|Other|0|||
37741729|NCT01824979|69227794|FG000|Overall Study|Withdrawal by Subject|5|||
37741730|NCT01824979|69227795|FG001|Overall Study|Withdrawal by Subject|0|||
37741731|NCT01824979|69227794|FG000|Overall Study|Physician Decision|2|||
37741732|NCT01824979|69227795|FG001|Overall Study|Physician Decision|0|||
37741733|NCT01824979|69227794|FG000|Overall Study|Protocol Violation|6|||
37741734|NCT01824979|69227795|FG001|Overall Study|Protocol Violation|13|||
37741735|NCT01824823|69227803|FG000|Overall Study|Lack of Efficacy|1|||
37741736|NCT01824823|69227804|FG001|Overall Study|Lack of Efficacy|1|||
37741737|NCT01824823|69227803|FG000|Overall Study|Off-treatment reason not submitted|1|||
37741738|NCT01824823|69227804|FG001|Overall Study|Off-treatment reason not submitted|0|||
37741739|NCT01875367|69227812|FG000|Overall Study|Not complete at least 2 questionaries|4|||
37741740|NCT01875367|69227813|FG001|Overall Study|Not complete at least 2 questionaries|2|||
37741741|NCT01875367|69227812|FG000|Overall Study|Not receive study treatment|1|||
37741742|NCT01875367|69227813|FG001|Overall Study|Not receive study treatment|0|||
37741743|NCT01853839|69227823|FG000|Overall Study|Violated inclusion criteria|2|||
37741744|NCT01853839|69227823|FG000|Overall Study|Not meet ITT population definition|58|||
37741745|NCT01853839|69227823|FG000|Overall Study|End of treatment visit too early|33|||
37741746|NCT01853839|69227823|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
37741747|NCT01874665|69227833|FG000|Overall Study|Adverse Event|6|||
37741748|NCT01874665|69227834|FG001|Overall Study|Adverse Event|2|||
37741749|NCT01874665|69227833|FG000|Overall Study|Withdrawal by Subject|4|||
37741750|NCT01874665|69227834|FG001|Overall Study|Withdrawal by Subject|1|||
37741751|NCT01874665|69227833|FG000|Overall Study|Physician Decision|3|||
37649190|NCT02346136|69118562|FG001|Overall Study|Death|0|||
37649191|NCT02346136|69118561|FG000|Overall Study|Study termination|14|||
37649192|NCT02346136|69118562|FG001|Overall Study|Study termination|18|||
37649193|NCT02793947|69118570|FG000|Overall Study|Death|1|||
37649194|NCT02793947|69118571|FG001|Overall Study|Death|0|||
37649195|NCT02793947|69118570|FG000|Overall Study|Physician Decision|1|||
37649196|NCT02793947|69118571|FG001|Overall Study|Physician Decision|5|||
37741752|NCT01874665|69227834|FG001|Overall Study|Physician Decision|0|||
37649197|NCT02345512|69118577|FG000|Overall Study|Adverse Event|1|||
37741753|NCT01874665|69227833|FG000|Overall Study|Clinical Progressive Disease|4|||
37741754|NCT01874665|69227834|FG001|Overall Study|Clinical Progressive Disease|3|||
37741755|NCT01874665|69227833|FG000|Overall Study|Study Terminated by Sponsor|0|||
37741756|NCT01874665|69227834|FG001|Overall Study|Study Terminated by Sponsor|2|||
37741757|NCT01874665|69227833|FG000|Overall Study|Documented Progressive Disease|11|||
37649198|NCT02345512|69118577|FG000|Overall Study|Withdrawal by Subject|1|||
37649199|NCT02345434|69118588|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
37649200|NCT02345434|69118589|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
37649201|NCT01370213|69118598|FG000|Overall Study|Early Death|1|||
37649202|NCT01370213|69118599|FG001|Overall Study|Early Death|0|||
37649203|NCT01370213|69118600|FG002|Overall Study|Early Death|0|||
37649204|NCT01370213|69118598|FG000|Overall Study|Not evaluable|0|||
37649205|NCT01370213|69118599|FG001|Overall Study|Not evaluable|2|||
37649206|NCT01370213|69118600|FG002|Overall Study|Not evaluable|0|||
37649207|NCT01370525|69118609|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
37649208|NCT01370525|69118610|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
37649209|NCT01370525|69118609|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
37649210|NCT01370525|69118610|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
37649211|NCT01370525|69118609|FG000|Overall Study|Adverse Event|0|||
37649212|NCT01370525|69118610|FG001|Overall Study|Adverse Event|1|||
37649213|NCT01370525|69118609|FG000|Overall Study|Protocol Violation|2|||
37649214|NCT01370525|69118610|FG001|Overall Study|Protocol Violation|1|||
37649215|NCT01370525|69118609|FG000|Overall Study|Lost to follow up|2|||
37649216|NCT01370525|69118610|FG001|Overall Study|Lost to follow up|6|||
37649217|NCT02792777|69118618|FG000|Overall Study|Withdrawal by Subject|2|||
37649218|NCT02792777|69118619|FG001|Overall Study|Withdrawal by Subject|0|||
37649219|NCT02792777|69118618|FG000|Overall Study|Recording malfunction|2|||
37649220|NCT02792777|69118619|FG001|Overall Study|Recording malfunction|0|||
37649221|NCT02792777|69118618|FG000|Overall Study|Later determined to be ineligible|2|||
37649222|NCT02792777|69118619|FG001|Overall Study|Later determined to be ineligible|0|||
37649223|NCT02792777|69118618|FG000|Overall Study|Participant interviewed twice|1|||
37649224|NCT02792777|69118619|FG001|Overall Study|Participant interviewed twice|0|||
37649225|NCT02625974|69118628|FG000|Overall Study|Adverse Event|12|||
37649226|NCT02625974|69118629|FG001|Overall Study|Adverse Event|2|||
37649227|NCT02625974|69118628|FG000|Overall Study|Withdrawal by Subject|3|||
37649228|NCT02625974|69118629|FG001|Overall Study|Withdrawal by Subject|1|||
37649229|NCT02625974|69118628|FG000|Overall Study|positive parasitemia|1|||
37649230|NCT02625974|69118629|FG001|Overall Study|positive parasitemia|0|||
37649231|NCT02625974|69118628|FG000|Overall Study|non-compliance with study drug|0|||
37649232|NCT02625974|69118629|FG001|Overall Study|non-compliance with study drug|2|||
37649233|NCT02625974|69118628|FG000|Overall Study|Protocol Violation|0|||
37649234|NCT02625974|69118629|FG001|Overall Study|Protocol Violation|1|||
37649235|NCT02792699|69118674|FG000|Overall Study|Adverse Event|1|||
37649236|NCT02792699|69118675|FG001|Overall Study|Adverse Event|2|||
37649237|NCT02792699|69118676|FG002|Overall Study|Adverse Event|4|||
37649238|NCT02792699|69118674|FG000|Overall Study|Withdrawal by Subject|4|||
37649239|NCT02792699|69118675|FG001|Overall Study|Withdrawal by Subject|4|||
37649240|NCT02792699|69118676|FG002|Overall Study|Withdrawal by Subject|3|||
37649241|NCT02792699|69118674|FG000|Overall Study|Lost to Follow-up|0|||
37649242|NCT02792699|69118675|FG001|Overall Study|Lost to Follow-up|1|||
37649243|NCT02792699|69118676|FG002|Overall Study|Lost to Follow-up|2|||
37649244|NCT02792699|69118674|FG000|Overall Study|Physician Decision|2|||
37649245|NCT02792699|69118675|FG001|Overall Study|Physician Decision|0|||
37649246|NCT02792699|69118676|FG002|Overall Study|Physician Decision|0|||
37649247|NCT02792699|69118674|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
37649248|NCT02792699|69118675|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
37741758|NCT01874665|69227834|FG001|Overall Study|Documented Progressive Disease|7|||
37741759|NCT01874665|69227833|FG000|Overall Study|Other|2|||
37741760|NCT01874665|69227834|FG001|Overall Study|Other|0|||
37741761|NCT01874431|69227849|FG000|Overall Study|Physician Decision|0|||
37741762|NCT01874431|69227850|FG001|Overall Study|Physician Decision|0|||
37855080|NCT01225731|69538433|FG010|Part 1|Withdrawal by Subject|0|||
37855081|NCT01225731|69538434|FG011|Part 1|Withdrawal by Subject|0|||
37855082|NCT01225731|69538435|FG012|Part 1|Withdrawal by Subject|0|||
37855083|NCT01225731|69538423|FG000|Part 1|Protocol Violation|0|||
37855084|NCT01225731|69538424|FG001|Part 1|Protocol Violation|0|||
37855085|NCT01225731|69538425|FG002|Part 1|Protocol Violation|0|||
37649249|NCT02792699|69118676|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
37649250|NCT02792699|69118674|FG000|Overall Study|Other|1|||
37649251|NCT02792699|69118675|FG001|Overall Study|Other|0|||
37649252|NCT02792699|69118676|FG002|Overall Study|Other|0|||
37649253|NCT03010319|69118693|FG000|Overall Study|Adverse Event|15|||
37855086|NCT01225731|69538426|FG003|Part 1|Protocol Violation|1|||
38032310|NCT03345836|69718191|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
38032311|NCT03345836|69718186|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
37649254|NCT03010319|69118694|FG001|Overall Study|Adverse Event|9|||
37649255|NCT03010319|69118693|FG000|Overall Study|Withdrawal by Subject|1|||
37741763|NCT01874431|69227851|FG002|Overall Study|Physician Decision|1|||
37855087|NCT01225731|69538427|FG004|Part 1|Protocol Violation|0|||
37649256|NCT03010319|69118694|FG001|Overall Study|Withdrawal by Subject|6|||
37649257|NCT03010319|69118693|FG000|Overall Study|Physician Decision|2|||
37649258|NCT03010319|69118694|FG001|Overall Study|Physician Decision|4|||
37649259|NCT03010319|69118693|FG000|Overall Study|Sponsor requested withdrawal|2|||
37649260|NCT03010319|69118694|FG001|Overall Study|Sponsor requested withdrawal|2|||
37855088|NCT01225731|69538428|FG005|Part 1|Protocol Violation|0|||
37649261|NCT03010319|69118693|FG000|Overall Study|Death|1|||
37649262|NCT03010319|69118694|FG001|Overall Study|Death|0|||
37649263|NCT03010319|69118693|FG000|Overall Study|Lost to Follow-up|0|||
37649264|NCT03010319|69118694|FG001|Overall Study|Lost to Follow-up|1|||
37649265|NCT03010319|69118693|FG000|Overall Study|Other Reason|5|||
37649266|NCT03010319|69118694|FG001|Overall Study|Other Reason|7|||
37649267|NCT01369511|69118704|FG000|Overall Study|Adverse Event|1|||
37649268|NCT01369511|69118705|FG001|Overall Study|Adverse Event|1|||
37649269|NCT01369511|69118706|FG002|Overall Study|Adverse Event|5|||
37649270|NCT01369511|69118707|FG003|Overall Study|Adverse Event|0|||
37649271|NCT01369511|69118704|FG000|Overall Study|Entry criteria not met|2|||
37649272|NCT01369511|69118705|FG001|Overall Study|Entry criteria not met|0|||
37649273|NCT01369511|69118706|FG002|Overall Study|Entry criteria not met|0|||
37649274|NCT01369511|69118707|FG003|Overall Study|Entry criteria not met|1|||
37649275|NCT01369511|69118704|FG000|Overall Study|Lost to Follow-up|0|||
37649276|NCT01369511|69118705|FG001|Overall Study|Lost to Follow-up|1|||
37649277|NCT01369511|69118706|FG002|Overall Study|Lost to Follow-up|1|||
37649278|NCT01369511|69118707|FG003|Overall Study|Lost to Follow-up|2|||
37649279|NCT01369511|69118704|FG000|Overall Study|Protocol Violation|0|||
37649280|NCT01369511|69118705|FG001|Overall Study|Protocol Violation|1|||
37649281|NCT01369511|69118706|FG002|Overall Study|Protocol Violation|0|||
37649282|NCT01369511|69118707|FG003|Overall Study|Protocol Violation|2|||
37649283|NCT01369511|69118704|FG000|Overall Study|Physician Decision|3|||
37649284|NCT01369511|69118705|FG001|Overall Study|Physician Decision|4|||
37649285|NCT01369511|69118706|FG002|Overall Study|Physician Decision|0|||
37649286|NCT01369511|69118707|FG003|Overall Study|Physician Decision|0|||
37649287|NCT01369511|69118704|FG000|Overall Study|Sponsor decision|2|||
37649288|NCT01369511|69118705|FG001|Overall Study|Sponsor decision|0|||
37649289|NCT01369511|69118706|FG002|Overall Study|Sponsor decision|1|||
37649290|NCT01369511|69118707|FG003|Overall Study|Sponsor decision|0|||
37741764|NCT01874431|69227852|FG003|Overall Study|Physician Decision|0|||
37741765|NCT01874431|69227853|FG004|Overall Study|Physician Decision|0|||
37741766|NCT01874431|69227854|FG005|Overall Study|Physician Decision|0|||
37741767|NCT01874431|69227855|FG006|Overall Study|Physician Decision|0|||
37741768|NCT01874431|69227856|FG007|Overall Study|Physician Decision|0|||
37741769|NCT01874431|69227849|FG000|Overall Study|Adverse Event|5|||
37741770|NCT01874431|69227850|FG001|Overall Study|Adverse Event|4|||
37741771|NCT01874431|69227851|FG002|Overall Study|Adverse Event|6|||
37741772|NCT01874431|69227852|FG003|Overall Study|Adverse Event|5|||
37741773|NCT01874431|69227853|FG004|Overall Study|Adverse Event|2|||
37741774|NCT01874431|69227854|FG005|Overall Study|Adverse Event|8|||
37741775|NCT01874431|69227855|FG006|Overall Study|Adverse Event|2|||
37741776|NCT01874431|69227856|FG007|Overall Study|Adverse Event|3|||
37741777|NCT01874431|69227849|FG000|Overall Study|Protocol Violation|1|||
37741778|NCT01874431|69227850|FG001|Overall Study|Protocol Violation|1|||
37741779|NCT01874431|69227851|FG002|Overall Study|Protocol Violation|1|||
37855089|NCT01225731|69538429|FG006|Part 1|Protocol Violation|0|||
37855090|NCT01225731|69538430|FG007|Part 1|Protocol Violation|0|||
37855091|NCT01225731|69538431|FG008|Part 1|Protocol Violation|0|||
37855092|NCT01225731|69538432|FG009|Part 1|Protocol Violation|0|||
37855093|NCT01225731|69538433|FG010|Part 1|Protocol Violation|0|||
37855094|NCT01225731|69538434|FG011|Part 1|Protocol Violation|0|||
37649291|NCT01369511|69118704|FG000|Overall Study|Withdrawal by Subject|5|||
37649292|NCT01369511|69118705|FG001|Overall Study|Withdrawal by Subject|6|||
37649293|NCT01369511|69118706|FG002|Overall Study|Withdrawal by Subject|4|||
37649294|NCT01369511|69118707|FG003|Overall Study|Withdrawal by Subject|6|||
37649295|NCT01369433|69118719|FG000|Overall Study|Adverse Event|31|||
37649296|NCT01369433|69118720|FG001|Overall Study|Adverse Event|1|||
37649297|NCT01369433|69118719|FG000|Overall Study|Required significant surgical procedure|1|||
37649298|NCT01369433|69118720|FG001|Overall Study|Required significant surgical procedure|0|||
37649299|NCT01369433|69118719|FG000|Overall Study|Non-compliance|1|||
37649300|NCT01369433|69118720|FG001|Overall Study|Non-compliance|0|||
37649301|NCT01369433|69118719|FG000|Overall Study|Withdrawal by Subject|5|||
37741780|NCT01874431|69227852|FG003|Overall Study|Protocol Violation|0|||
37741781|NCT01874431|69227853|FG004|Overall Study|Protocol Violation|3|||
37855095|NCT01225731|69538435|FG012|Part 1|Protocol Violation|0|||
37855096|NCT01225731|69538423|FG000|Part 2|Protocol Violation|0|||
37855097|NCT01225731|69538424|FG001|Part 2|Protocol Violation|0|||
37649302|NCT01369433|69118720|FG001|Overall Study|Withdrawal by Subject|2|||
37649303|NCT01369433|69118719|FG000|Overall Study|Study terminated by Sponsor|67|||
37649304|NCT01369433|69118720|FG001|Overall Study|Study terminated by Sponsor|0|||
37649305|NCT01369433|69118719|FG000|Overall Study|Lost to Follow-up|1|||
37649306|NCT01369433|69118720|FG001|Overall Study|Lost to Follow-up|0|||
37649307|NCT01369433|69118719|FG000|Overall Study|Death|5|||
37649308|NCT01369433|69118720|FG001|Overall Study|Death|0|||
37741782|NCT01874431|69227854|FG005|Overall Study|Protocol Violation|2|||
37741783|NCT01874431|69227855|FG006|Overall Study|Protocol Violation|1|||
37741784|NCT01874431|69227856|FG007|Overall Study|Protocol Violation|1|||
37855098|NCT01225731|69538425|FG002|Part 2|Protocol Violation|0|||
37855099|NCT01225731|69538426|FG003|Part 2|Protocol Violation|0|||
37855100|NCT01225731|69538427|FG004|Part 2|Protocol Violation|0|||
37649309|NCT01369433|69118719|FG000|Overall Study|Investigator discretion|6|||
37649310|NCT01369433|69118720|FG001|Overall Study|Investigator discretion|1|||
37649311|NCT01369433|69118719|FG000|Overall Study|Progressive Disease|92|||
37649312|NCT01369433|69118720|FG001|Overall Study|Progressive Disease|12|||
37649313|NCT02624492|69118729|FG000|Overall Study|Adverse Event|2|||
37649314|NCT02624492|69118730|FG001|Overall Study|Adverse Event|2|||
37649315|NCT02624492|69118731|FG002|Overall Study|Adverse Event|2|||
37649316|NCT02624492|69118729|FG000|Overall Study|Progressive disease|0|||
37649317|NCT02624492|69118730|FG001|Overall Study|Progressive disease|2|||
37649318|NCT02624492|69118731|FG002|Overall Study|Progressive disease|3|||
37649319|NCT01975831|69118748|FG000|Overall Study|Adverse Event|1|||
37649320|NCT01975831|69118749|FG001|Overall Study|Adverse Event|2|||
37649321|NCT01975831|69118750|FG002|Overall Study|Adverse Event|2|||
37649322|NCT01975831|69118751|FG003|Overall Study|Adverse Event|0|||
37649323|NCT01975831|69118752|FG004|Overall Study|Adverse Event|1|||
37649324|NCT01975831|69118753|FG005|Overall Study|Adverse Event|1|||
37649325|NCT01975831|69118754|FG006|Overall Study|Adverse Event|3|||
37649326|NCT01975831|69118755|FG007|Overall Study|Adverse Event|4|||
37649327|NCT01975831|69118756|FG008|Overall Study|Adverse Event|1|||
37649328|NCT01975831|69118748|FG000|Overall Study|Death|1|||
37649329|NCT01975831|69118749|FG001|Overall Study|Death|1|||
37649330|NCT01975831|69118750|FG002|Overall Study|Death|0|||
37649331|NCT01975831|69118751|FG003|Overall Study|Death|0|||
37649332|NCT01975831|69118752|FG004|Overall Study|Death|1|||
37649333|NCT01975831|69118753|FG005|Overall Study|Death|0|||
37649334|NCT01975831|69118754|FG006|Overall Study|Death|1|||
37649335|NCT01975831|69118755|FG007|Overall Study|Death|0|||
37649336|NCT01975831|69118756|FG008|Overall Study|Death|0|||
37649337|NCT01975831|69118748|FG000|Overall Study|Progressive Disease|1|||
37649338|NCT01975831|69118749|FG001|Overall Study|Progressive Disease|3|||
37649339|NCT01975831|69118750|FG002|Overall Study|Progressive Disease|2|||
37649340|NCT01975831|69118751|FG003|Overall Study|Progressive Disease|4|||
37649341|NCT01975831|69118752|FG004|Overall Study|Progressive Disease|13|||
37649342|NCT01975831|69118753|FG005|Overall Study|Progressive Disease|9|||
37649343|NCT01975831|69118754|FG006|Overall Study|Progressive Disease|10|||
37649344|NCT01975831|69118755|FG007|Overall Study|Progressive Disease|8|||
37649345|NCT01975831|69118756|FG008|Overall Study|Progressive Disease|10|||
37649346|NCT01975831|69118748|FG000|Overall Study|Withdrawal by Subject|0|||
37649347|NCT01975831|69118749|FG001|Overall Study|Withdrawal by Subject|3|||
37649348|NCT01975831|69118750|FG002|Overall Study|Withdrawal by Subject|0|||
37649349|NCT01975831|69118751|FG003|Overall Study|Withdrawal by Subject|0|||
37649350|NCT01975831|69118752|FG004|Overall Study|Withdrawal by Subject|3|||
37649351|NCT01975831|69118753|FG005|Overall Study|Withdrawal by Subject|1|||
37649352|NCT01975831|69118754|FG006|Overall Study|Withdrawal by Subject|1|||
37649353|NCT01975831|69118755|FG007|Overall Study|Withdrawal by Subject|0|||
37649354|NCT01975831|69118756|FG008|Overall Study|Withdrawal by Subject|0|||
37649355|NCT01975831|69118748|FG000|Overall Study|Physician Decision|0|||
37649356|NCT01975831|69118749|FG001|Overall Study|Physician Decision|0|||
37649357|NCT01975831|69118750|FG002|Overall Study|Physician Decision|0|||
37649358|NCT01975831|69118751|FG003|Overall Study|Physician Decision|0|||
37649359|NCT01975831|69118752|FG004|Overall Study|Physician Decision|0|||
37649360|NCT01975831|69118753|FG005|Overall Study|Physician Decision|1|||
37649361|NCT01975831|69118754|FG006|Overall Study|Physician Decision|0|||
37649362|NCT01975831|69118755|FG007|Overall Study|Physician Decision|1|||
37649363|NCT01975831|69118756|FG008|Overall Study|Physician Decision|0|||
37649364|NCT01975831|69118748|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
37649365|NCT01975831|69118749|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
37649366|NCT01975831|69118750|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
37649367|NCT01975831|69118751|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
37649368|NCT01975831|69118752|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
37649369|NCT01975831|69118753|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
37649370|NCT01975831|69118754|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
37649371|NCT01975831|69118755|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
37649372|NCT01975831|69118756|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
37649373|NCT01975831|69118748|FG000|Overall Study|Entered Hospice|0|||
37649374|NCT01975831|69118749|FG001|Overall Study|Entered Hospice|0|||
37649375|NCT01975831|69118750|FG002|Overall Study|Entered Hospice|0|||
37649376|NCT01975831|69118751|FG003|Overall Study|Entered Hospice|0|||
37649377|NCT01975831|69118752|FG004|Overall Study|Entered Hospice|0|||
37649378|NCT01975831|69118753|FG005|Overall Study|Entered Hospice|1|||
37649379|NCT01975831|69118754|FG006|Overall Study|Entered Hospice|0|||
37649380|NCT01975831|69118755|FG007|Overall Study|Entered Hospice|0|||
37649381|NCT01975831|69118756|FG008|Overall Study|Entered Hospice|0|||
37649382|NCT01975831|69118748|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
37649383|NCT01975831|69118749|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
37649384|NCT01975831|69118750|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
37649385|NCT01975831|69118751|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
37649386|NCT01975831|69118752|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
37649387|NCT01975831|69118753|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
37649388|NCT01975831|69118754|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
37649389|NCT01975831|69118755|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
37649390|NCT01975831|69118756|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
37649391|NCT00700713|69118779|FG000|Overall Study|Protocol Violation|1|||
37649392|NCT00700713|69118780|FG001|Overall Study|Protocol Violation|0|||
37649393|NCT00700713|69118781|FG002|Overall Study|Protocol Violation|1|||
37649394|NCT00700713|69118779|FG000|Overall Study|Withdrawal by Subject|0|||
37649395|NCT00700713|69118780|FG001|Overall Study|Withdrawal by Subject|0|||
37649396|NCT00700713|69118781|FG002|Overall Study|Withdrawal by Subject|1|||
37649397|NCT02622386|69118789|FG000|First Assignment|Withdrawal by Subject|3|||
37649398|NCT02622386|69118790|FG001|First Assignment|Withdrawal by Subject|2|||
37649399|NCT02622386|69118789|FG000|Washout|Withdrawal by Subject|4|||
37649400|NCT02622386|69118790|FG001|Washout|Withdrawal by Subject|4|||
37649401|NCT02622386|69118789|FG000|Second Assignment|Withdrawal by Subject|0|||
37649402|NCT02622386|69118790|FG001|Second Assignment|Withdrawal by Subject|2|||
37649403|NCT02792231|69118798|FG000|Overall Study|Patient/guardian decision|32|||
37649404|NCT02792231|69118799|FG001|Overall Study|Patient/guardian decision|42|||
37649405|NCT02792231|69118798|FG000|Overall Study|Adverse Event|15|||
37649406|NCT02792231|69118799|FG001|Overall Study|Adverse Event|11|||
37649407|NCT02792231|69118798|FG000|Overall Study|Physician Decision|14|||
37649408|NCT02792231|69118799|FG001|Overall Study|Physician Decision|12|||
37649409|NCT02792231|69118798|FG000|Overall Study|Lack of Efficacy|7|||
37649410|NCT02792231|69118799|FG001|Overall Study|Lack of Efficacy|9|||
37649411|NCT02792231|69118798|FG000|Overall Study|Lost to Follow-up|9|||
37649412|NCT02792231|69118799|FG001|Overall Study|Lost to Follow-up|5|||
37649413|NCT02792231|69118798|FG000|Overall Study|Pregnancy|1|||
37649414|NCT02792231|69118799|FG001|Overall Study|Pregnancy|3|||
37922299|NCT00460603|69609073|FG007|Phase 2|Protocol Violation|0|||
37922300|NCT00460603|69609074|FG008|Phase 2|Protocol Violation|0|||
37922301|NCT00460603|69609075|FG009|Phase 2|Protocol Violation|1|||
37922302|NCT00460603|69609076|FG010|Phase 2|Protocol Violation|1|||
37922303|NCT00460603|69609077|FG011|Phase 2|Protocol Violation|0|||
37922304|NCT00460603|69609066|FG000|Phase 2|Lost to Follow-up|0|||
37922305|NCT00460603|69609067|FG001|Phase 2|Lost to Follow-up|0|||
37922306|NCT00460603|69609068|FG002|Phase 2|Lost to Follow-up|0|||
37922307|NCT00460603|69609069|FG003|Phase 2|Lost to Follow-up|0|||
37922308|NCT00460603|69609070|FG004|Phase 2|Lost to Follow-up|0|||
37922309|NCT00460603|69609071|FG005|Phase 2|Lost to Follow-up|0|||
37922310|NCT00460603|69609072|FG006|Phase 2|Lost to Follow-up|0|||
37922311|NCT00460603|69609073|FG007|Phase 2|Lost to Follow-up|0|||
37922312|NCT00460603|69609074|FG008|Phase 2|Lost to Follow-up|0|||
37922313|NCT00460603|69609075|FG009|Phase 2|Lost to Follow-up|1|||
37922314|NCT00460603|69609076|FG010|Phase 2|Lost to Follow-up|0|||
37922315|NCT00460603|69609077|FG011|Phase 2|Lost to Follow-up|0|||
37741785|NCT01874431|69227849|FG000|Overall Study|Non-compliance|0|||
37855101|NCT01225731|69538428|FG005|Part 2|Protocol Violation|1|||
37649415|NCT02792231|69118798|FG000|Overall Study|Non-compliance with study treatment|2|||
37649416|NCT02792231|69118799|FG001|Overall Study|Non-compliance with study treatment|1|||
37649417|NCT02792231|69118798|FG000|Overall Study|Protocol deviation|2|||
37649418|NCT02792231|69118799|FG001|Overall Study|Protocol deviation|0|||
37649419|NCT02792231|69118798|FG000|Overall Study|Technical problems|0|||
37649420|NCT02792231|69118799|FG001|Overall Study|Technical problems|1|||
37649421|NCT00700401|69118805|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
37649422|NCT00700401|69118805|FG000|Overall Study|Adverse Event|5|||
37649423|NCT00700401|69118805|FG000|Overall Study|Refused Treatment|2|||
37649424|NCT00700401|69118805|FG000|Overall Study|Lost to Follow-up|1|||
37649425|NCT00700401|69118805|FG000|Overall Study|Treatment never started|1|||
37649426|NCT00700401|69118805|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
37649427|NCT00700401|69118805|FG000|Overall Study|Withdrawal by Subject|2|||
37649428|NCT02621606|69118812|FG000|Overall Study|Withdrawal by Subject|0|||
37649429|NCT02621606|69118813|FG001|Overall Study|Withdrawal by Subject|1|||
37649430|NCT02621606|69118814|FG002|Overall Study|Withdrawal by Subject|0|||
37855102|NCT01225731|69538429|FG006|Part 2|Protocol Violation|0|||
37855103|NCT01225731|69538430|FG007|Part 2|Protocol Violation|0|||
37855104|NCT01225731|69538431|FG008|Part 2|Protocol Violation|1|||
37855105|NCT01225731|69538432|FG009|Part 2|Protocol Violation|0|||
37855106|NCT01225731|69538433|FG010|Part 2|Protocol Violation|0|||
37855107|NCT01225731|69538434|FG011|Part 2|Protocol Violation|0|||
37855108|NCT01225731|69538435|FG012|Part 2|Protocol Violation|0|||
37649431|NCT02871401|69118824|FG000|Overall Study|Adverse Event|1|||
37649432|NCT02871401|69118825|FG001|Overall Study|Adverse Event|0|||
37649433|NCT02619812|69118835|FG000|Overall Study|Withdrawal by Subject|0|||
37649434|NCT02619812|69118836|FG001|Overall Study|Withdrawal by Subject|0|||
37649435|NCT02619812|69118837|FG002|Overall Study|Withdrawal by Subject|1|||
37855109|NCT01225731|69538423|FG000|Part 2|Adverse Event|0|||
37855110|NCT01225731|69538424|FG001|Part 2|Adverse Event|0|||
37855111|NCT01225731|69538425|FG002|Part 2|Adverse Event|0|||
37922316|NCT00460603|69609066|FG000|Phase 2|Other|0|||
37922317|NCT00460603|69609067|FG001|Phase 2|Other|0|||
37922318|NCT00460603|69609068|FG002|Phase 2|Other|0|||
37649436|NCT02619812|69118838|FG003|Overall Study|Withdrawal by Subject|2|||
37649437|NCT02623322|69118851|FG000|Overall Study|Lost to Follow-up|2|||
37649438|NCT02623322|69118852|FG001|Overall Study|Lost to Follow-up|1|||
37649439|NCT02623322|69118853|FG002|Overall Study|Lost to Follow-up|0|||
37649440|NCT00105157|69118867|FG000|Double-Blind (DB)|Never Treated|1|||
37649441|NCT00105157|69118868|FG001|Double-Blind (DB)|Never Treated|0|||
37649442|NCT00105157|69118869|FG002|Double-Blind (DB)|Never Treated|0|||
37649443|NCT00105157|69118870|FG003|Double-Blind (DB)|Never Treated|0|||
37649444|NCT00105157|69118867|FG000|Double-Blind (DB)|Adverse Event|2|||
37649445|NCT00105157|69118868|FG001|Double-Blind (DB)|Adverse Event|0|||
37649446|NCT00105157|69118869|FG002|Double-Blind (DB)|Adverse Event|1|||
37649447|NCT00105157|69118870|FG003|Double-Blind (DB)|Adverse Event|1|||
37649448|NCT00105157|69118867|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
37649449|NCT00105157|69118868|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
37649450|NCT00105157|69118869|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
37649451|NCT00105157|69118870|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
37649452|NCT00105157|69118867|FG000|Open-Label Continuation of DB|Adverse Event|3|||
37649453|NCT00105157|69118868|FG001|Open-Label Continuation of DB|Adverse Event|1|||
37649454|NCT00105157|69118869|FG002|Open-Label Continuation of DB|Adverse Event|0|||
37649455|NCT00105157|69118870|FG003|Open-Label Continuation of DB|Adverse Event|0|||
37649456|NCT00105157|69118867|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
37649457|NCT00105157|69118868|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
37649458|NCT00105157|69118869|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
37649459|NCT00105157|69118870|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
37649460|NCT00105157|69118867|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
37649461|NCT00105157|69118868|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
37649462|NCT00105157|69118869|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
37649463|NCT00105157|69118870|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
37649464|NCT00105157|69118867|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
37649465|NCT00105157|69118868|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
37649466|NCT00105157|69118869|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
37649467|NCT00105157|69118870|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
37649468|NCT00105157|69118867|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
37649469|NCT00105157|69118868|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
37855112|NCT01225731|69538426|FG003|Part 2|Adverse Event|0|||
37855113|NCT01225731|69538427|FG004|Part 2|Adverse Event|0|||
37922319|NCT00460603|69609069|FG003|Phase 2|Other|0|||
37922320|NCT00460603|69609070|FG004|Phase 2|Other|0|||
37855114|NCT01225731|69538428|FG005|Part 2|Adverse Event|0|||
37855115|NCT01225731|69538429|FG006|Part 2|Adverse Event|4|||
37855116|NCT01225731|69538430|FG007|Part 2|Adverse Event|4|||
37855117|NCT01225731|69538431|FG008|Part 2|Adverse Event|2|||
37855118|NCT01225731|69538432|FG009|Part 2|Adverse Event|0|||
37855119|NCT01225731|69538433|FG010|Part 2|Adverse Event|0|||
37855120|NCT01225731|69538434|FG011|Part 2|Adverse Event|0|||
37922321|NCT00460603|69609071|FG005|Phase 2|Other|0|||
38032312|NCT03345836|69718187|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
38032313|NCT03345836|69718188|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
38032314|NCT03345836|69718189|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
37922322|NCT00460603|69609072|FG006|Phase 2|Other|0|||
37922323|NCT00460603|69609073|FG007|Phase 2|Other|0|||
37922324|NCT00460603|69609074|FG008|Phase 2|Other|0|||
37922325|NCT00460603|69609075|FG009|Phase 2|Other|6|||
37922326|NCT00460603|69609076|FG010|Phase 2|Other|16|||
37922327|NCT00460603|69609077|FG011|Phase 2|Other|7|||
37922328|NCT00460603|69609066|FG000|Phase 2|Objective Progression or Relapse|0|||
37922329|NCT00460603|69609067|FG001|Phase 2|Objective Progression or Relapse|0|||
37922330|NCT00460603|69609068|FG002|Phase 2|Objective Progression or Relapse|0|||
37922331|NCT00460603|69609069|FG003|Phase 2|Objective Progression or Relapse|0|||
37922332|NCT00460603|69609070|FG004|Phase 2|Objective Progression or Relapse|0|||
37922333|NCT00460603|69609071|FG005|Phase 2|Objective Progression or Relapse|0|||
37922334|NCT00460603|69609072|FG006|Phase 2|Objective Progression or Relapse|0|||
37922335|NCT00460603|69609073|FG007|Phase 2|Objective Progression or Relapse|0|||
37922336|NCT00460603|69609074|FG008|Phase 2|Objective Progression or Relapse|0|||
37922337|NCT00460603|69609075|FG009|Phase 2|Objective Progression or Relapse|9|||
37922338|NCT00460603|69609076|FG010|Phase 2|Objective Progression or Relapse|10|||
37922339|NCT00460603|69609077|FG011|Phase 2|Objective Progression or Relapse|17|||
37922340|NCT00460603|69609066|FG000|Phase 2|Global Deterioration of Health Status|0|||
37649470|NCT00105157|69118869|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
37649471|NCT00105157|69118870|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
37855121|NCT01225731|69538435|FG012|Part 2|Adverse Event|0|||
37855122|NCT01225731|69538423|FG000|Part 2|Lack of Efficacy|0|||
37855123|NCT01225731|69538424|FG001|Part 2|Lack of Efficacy|0|||
38032315|NCT03345836|69718190|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
37922341|NCT00460603|69609067|FG001|Phase 2|Global Deterioration of Health Status|0|||
37922342|NCT00460603|69609068|FG002|Phase 2|Global Deterioration of Health Status|0|||
37649472|NCT00105157|69118867|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
37649473|NCT00105157|69118868|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
37649474|NCT00105157|69118869|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
37649475|NCT00105157|69118870|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
37649476|NCT00105157|69118867|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
37649477|NCT00105157|69118868|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
37649478|NCT00105157|69118869|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
37649479|NCT00105157|69118870|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
37649480|NCT00105157|69118867|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
37649481|NCT00105157|69118868|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
37649482|NCT00105157|69118869|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
37649483|NCT00105157|69118870|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
37649484|NCT00105157|69118867|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
37649485|NCT00105157|69118868|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
37649486|NCT00105157|69118869|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
37741786|NCT01874431|69227850|FG001|Overall Study|Non-compliance|0|||
37922343|NCT00460603|69609069|FG003|Phase 2|Global Deterioration of Health Status|0|||
37922344|NCT00460603|69609070|FG004|Phase 2|Global Deterioration of Health Status|0|||
37922345|NCT00460603|69609071|FG005|Phase 2|Global Deterioration of Health Status|0|||
37922346|NCT00460603|69609072|FG006|Phase 2|Global Deterioration of Health Status|0|||
37922347|NCT00460603|69609073|FG007|Phase 2|Global Deterioration of Health Status|0|||
37922348|NCT00460603|69609074|FG008|Phase 2|Global Deterioration of Health Status|0|||
37922349|NCT00460603|69609075|FG009|Phase 2|Global Deterioration of Health Status|0|||
37922350|NCT00460603|69609076|FG010|Phase 2|Global Deterioration of Health Status|1|||
37922351|NCT00460603|69609077|FG011|Phase 2|Global Deterioration of Health Status|0|||
37922352|NCT00460603|69609066|FG000|Phase 2|Withdrawal by Subject|0|||
37922353|NCT00460603|69609067|FG001|Phase 2|Withdrawal by Subject|0|||
37922354|NCT00460603|69609068|FG002|Phase 2|Withdrawal by Subject|0|||
37922355|NCT00460603|69609069|FG003|Phase 2|Withdrawal by Subject|0|||
37922356|NCT00460603|69609070|FG004|Phase 2|Withdrawal by Subject|0|||
37922357|NCT00460603|69609071|FG005|Phase 2|Withdrawal by Subject|0|||
37922358|NCT00460603|69609072|FG006|Phase 2|Withdrawal by Subject|0|||
37922359|NCT00460603|69609073|FG007|Phase 2|Withdrawal by Subject|0|||
37922360|NCT00460603|69609074|FG008|Phase 2|Withdrawal by Subject|0|||
37922361|NCT00460603|69609075|FG009|Phase 2|Withdrawal by Subject|5|||
37922362|NCT00460603|69609076|FG010|Phase 2|Withdrawal by Subject|4|||
37922363|NCT00460603|69609077|FG011|Phase 2|Withdrawal by Subject|5|||
37922364|NCT00460603|69609066|FG000|Phase 2|Randomized, but not treated|0|||
37922365|NCT00460603|69609067|FG001|Phase 2|Randomized, but not treated|0|||
37922366|NCT00460603|69609068|FG002|Phase 2|Randomized, but not treated|0|||
37922367|NCT00460603|69609069|FG003|Phase 2|Randomized, but not treated|0|||
37922368|NCT00460603|69609070|FG004|Phase 2|Randomized, but not treated|0|||
37922369|NCT00460603|69609071|FG005|Phase 2|Randomized, but not treated|0|||
37922370|NCT00460603|69609072|FG006|Phase 2|Randomized, but not treated|0|||
37922371|NCT00460603|69609073|FG007|Phase 2|Randomized, but not treated|0|||
37922372|NCT00460603|69609074|FG008|Phase 2|Randomized, but not treated|0|||
37922373|NCT00460603|69609075|FG009|Phase 2|Randomized, but not treated|3|||
37922374|NCT00460603|69609076|FG010|Phase 2|Randomized, but not treated|0|||
37922375|NCT00460603|69609077|FG011|Phase 2|Randomized, but not treated|0|||
37922376|NCT00662038|69609103|FG000|Overall Study|Reason not specified|3|||
37922377|NCT00662038|69609103|FG000|Overall Study|Withdrawn consent|22|||
37922378|NCT00662038|69609103|FG000|Overall Study|Withdrawal by Subject|83|||
37922379|NCT00662038|69609103|FG000|Overall Study|Sponsor decision|1|||
37922380|NCT00662038|69609103|FG000|Overall Study|Physician Decision|19|||
37922381|NCT00662038|69609103|FG000|Overall Study|Lung transplantation|44|||
37922382|NCT00662038|69609103|FG000|Overall Study|Lost to Follow-up|1|||
37922383|NCT00662038|69609103|FG000|Overall Study|Death|95|||
37922384|NCT00662038|69609103|FG000|Overall Study|Adverse Event|358|||
37922385|NCT00662038|69609103|FG000|Overall Study|Continued treatment|5|||
37922386|NCT00819156|69609113|FG000|Overall Study|Adverse Event|1|||
37922387|NCT00819156|69609114|FG001|Overall Study|Adverse Event|4|||
37922388|NCT00819156|69609115|FG002|Overall Study|Adverse Event|2|||
37922389|NCT00819156|69609116|FG003|Overall Study|Adverse Event|1|||
37922390|NCT00819156|69609117|FG004|Overall Study|Adverse Event|2|||
37922391|NCT00819156|69609118|FG005|Overall Study|Adverse Event|3|||
37922392|NCT00819156|69609113|FG000|Overall Study|Withdrawal by Subject|0|||
37922393|NCT00819156|69609114|FG001|Overall Study|Withdrawal by Subject|3|||
37922394|NCT00819156|69609115|FG002|Overall Study|Withdrawal by Subject|2|||
37922395|NCT00819156|69609116|FG003|Overall Study|Withdrawal by Subject|0|||
37922396|NCT00819156|69609117|FG004|Overall Study|Withdrawal by Subject|1|||
37922397|NCT00819156|69609118|FG005|Overall Study|Withdrawal by Subject|0|||
37922398|NCT00819156|69609113|FG000|Overall Study|Protocol Violation|1|||
37922399|NCT00819156|69609114|FG001|Overall Study|Protocol Violation|0|||
37922400|NCT00819156|69609115|FG002|Overall Study|Protocol Violation|1|||
37649487|NCT00105157|69118870|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
37649488|NCT00105157|69118867|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
37649489|NCT00105157|69118868|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
37649490|NCT00105157|69118869|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
37649491|NCT00105157|69118870|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
37649492|NCT00105157|69118867|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
37649493|NCT00105157|69118868|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
37649494|NCT00105157|69118869|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
37649495|NCT00105157|69118870|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
37649496|NCT02148133|69118891|FG000|Overall Study|Investigator discretion|1|||
37649497|NCT02148133|69118891|FG000|Overall Study|Lack of Efficacy|1|||
37649498|NCT02148133|69118891|FG000|Overall Study|Protocol deviation|1|||
37649499|NCT02148133|69118891|FG000|Overall Study|Protocol-defined stopping criteria|2|||
37649500|NCT00803569|69118895|FG000|Overall Study|Progressive Disease|3|||
37649501|NCT00803569|69118895|FG000|Overall Study|Noncompliance|1|||
37649502|NCT00112957|69118899|FG000|Overall Study|Progressive disease|18|||
37649503|NCT00112957|69118899|FG000|Overall Study|Physician Decision|1|||
37649504|NCT02376790|69118906|FG000|Overall Study|Withdrawal by Subject|43|||
37649505|NCT02376790|69118907|FG001|Overall Study|Withdrawal by Subject|36|||
37649506|NCT02376790|69118908|FG002|Overall Study|Withdrawal by Subject|37|||
37649507|NCT02376790|69118906|FG000|Overall Study|Decision by Sponsor|2|||
37649508|NCT02376790|69118907|FG001|Overall Study|Decision by Sponsor|1|||
37649509|NCT02376790|69118908|FG002|Overall Study|Decision by Sponsor|4|||
37649510|NCT02376790|69118906|FG000|Overall Study|Lost to Follow-up|15|||
37649511|NCT02376790|69118907|FG001|Overall Study|Lost to Follow-up|10|||
37649512|NCT02376790|69118908|FG002|Overall Study|Lost to Follow-up|12|||
37649513|NCT02376166|69118916|FG000|Overall Study|Adverse Event|1|||
37649514|NCT02376166|69118916|FG000|Overall Study|Discontinued metformin early|2|||
37649515|NCT02311894|69118920|FG000|Overall Study|Discontinued in error|1|||
37649516|NCT02311894|69118920|FG000|Overall Study|Lost to Follow-up|1|||
37649517|NCT02311894|69118920|FG000|Overall Study|Adverse Event|1|||
37649518|NCT02311894|69118920|FG000|Overall Study|Withdrawal by Subject|1|||
37649519|NCT02310646|69118926|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
37649520|NCT02310646|69118927|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
37649521|NCT02310646|69118926|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
37649522|NCT02310646|69118927|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
37649523|NCT02375698|69118951|FG000|Overall Study|Withdrawal by Subject|0|||
37649524|NCT02375698|69118952|FG001|Overall Study|Withdrawal by Subject|2|||
37649525|NCT02375698|69118951|FG000|Overall Study|Physician Decision|2|||
37649526|NCT02375698|69118952|FG001|Overall Study|Physician Decision|0|||
37649527|NCT02374918|69118962|FG000|Overall Study|Protocol Violation|2|||
37741787|NCT01874431|69227851|FG002|Overall Study|Non-compliance|0|||
37741788|NCT01874431|69227852|FG003|Overall Study|Non-compliance|0|||
37741789|NCT01874431|69227853|FG004|Overall Study|Non-compliance|1|||
37741790|NCT01874431|69227854|FG005|Overall Study|Non-compliance|0|||
37741791|NCT01874431|69227855|FG006|Overall Study|Non-compliance|1|||
37741792|NCT01874431|69227856|FG007|Overall Study|Non-compliance|0|||
37741793|NCT01874431|69227849|FG000|Overall Study|Logistical difficulties|0|||
37741794|NCT01874431|69227850|FG001|Overall Study|Logistical difficulties|0|||
37741795|NCT01874431|69227851|FG002|Overall Study|Logistical difficulties|0|||
37741796|NCT01874431|69227852|FG003|Overall Study|Logistical difficulties|0|||
37741797|NCT01874431|69227853|FG004|Overall Study|Logistical difficulties|0|||
37741798|NCT01874431|69227854|FG005|Overall Study|Logistical difficulties|0|||
37741799|NCT01874431|69227855|FG006|Overall Study|Logistical difficulties|1|||
37741800|NCT01874431|69227856|FG007|Overall Study|Logistical difficulties|0|||
37741801|NCT01874431|69227849|FG000|Overall Study|Withdrawal by Subject|0|||
37741802|NCT01874431|69227850|FG001|Overall Study|Withdrawal by Subject|0|||
37741803|NCT01874431|69227851|FG002|Overall Study|Withdrawal by Subject|1|||
37741804|NCT01874431|69227852|FG003|Overall Study|Withdrawal by Subject|2|||
37741805|NCT01874431|69227853|FG004|Overall Study|Withdrawal by Subject|1|||
38032316|NCT03345836|69718191|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
38032317|NCT02839330|69718211|FG000|Overall Study|Adverse Event|0|||
38032318|NCT02839330|69718212|FG001|Overall Study|Adverse Event|1|||
38032319|NCT02839330|69718213|FG002|Overall Study|Adverse Event|2|||
37649528|NCT02374918|69118963|FG001|Overall Study|Protocol Violation|0|||
37741806|NCT01874431|69227854|FG005|Overall Study|Withdrawal by Subject|1|||
37649529|NCT02374918|69118964|FG002|Overall Study|Protocol Violation|2|||
37649530|NCT02374918|69118965|FG003|Overall Study|Protocol Violation|1|||
37649531|NCT02374918|69118962|FG000|Overall Study|Withdrawal by Subject|1|||
37649532|NCT02374918|69118963|FG001|Overall Study|Withdrawal by Subject|1|||
37649533|NCT02374918|69118964|FG002|Overall Study|Withdrawal by Subject|1|||
38032320|NCT02839330|69718214|FG003|Overall Study|Adverse Event|2|||
37741807|NCT01874431|69227855|FG006|Overall Study|Withdrawal by Subject|3|||
37855124|NCT01225731|69538425|FG002|Part 2|Lack of Efficacy|0|||
38032321|NCT02839330|69718211|FG000|Overall Study|Death|4|||
37649534|NCT02374918|69118965|FG003|Overall Study|Withdrawal by Subject|0|||
37649535|NCT02374918|69118962|FG000|Overall Study|Lack of Efficacy|0|||
37649536|NCT02374918|69118963|FG001|Overall Study|Lack of Efficacy|0|||
37649537|NCT02374918|69118964|FG002|Overall Study|Lack of Efficacy|1|||
37649538|NCT02374918|69118965|FG003|Overall Study|Lack of Efficacy|1|||
37649539|NCT02344576|69118977|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
37649540|NCT02344576|69118978|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
37649541|NCT02344576|69118979|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
37649542|NCT02344576|69118980|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
37649543|NCT02344576|69118977|FG000|1-Month Follow-Up|Death|13|||
37649544|NCT02344576|69118978|FG001|1-Month Follow-Up|Death|8|||
37649545|NCT02344576|69118979|FG002|1-Month Follow-Up|Death|0|||
37649546|NCT02344576|69118980|FG003|1-Month Follow-Up|Death|0|||
37649547|NCT02344576|69118977|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
37649548|NCT02344576|69118978|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
37649549|NCT02344576|69118979|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
37649550|NCT02344576|69118980|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
37649551|NCT02344576|69118977|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
37649552|NCT02344576|69118978|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
37649553|NCT02344576|69118979|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
37649554|NCT02344576|69118980|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
37649555|NCT02344576|69118977|FG000|6-Month Follow-Up|Death|14|||
37649556|NCT02344576|69118978|FG001|6-Month Follow-Up|Death|14|||
37649557|NCT02344576|69118979|FG002|6-Month Follow-Up|Death|0|||
37649558|NCT02344576|69118980|FG003|6-Month Follow-Up|Death|0|||
37649559|NCT02344576|69118977|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
37649560|NCT02344576|69118978|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
37649561|NCT02344576|69118979|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
37649562|NCT02344576|69118980|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
37649563|NCT02344576|69118977|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
37649564|NCT02344576|69118978|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
37649565|NCT02344576|69118979|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
37649566|NCT02344576|69118980|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
37649567|NCT02344342|69118996|FG000|Overall Study|Industry partner dropped out|11|||
37649568|NCT02344342|69118997|FG001|Overall Study|Industry partner dropped out|9|||
37649569|NCT02344342|69118998|FG002|Overall Study|Industry partner dropped out|14|||
37649570|NCT02344342|69118999|FG003|Overall Study|Industry partner dropped out|10|||
37649571|NCT02310568|69119018|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
37649572|NCT02310568|69119019|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
37649573|NCT02310568|69119020|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
37649574|NCT02310568|69119021|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
37649575|NCT02310568|69119022|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
37649576|NCT02310568|69119018|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
37649577|NCT02310568|69119019|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
37649578|NCT02310568|69119020|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
37649579|NCT02310568|69119021|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
37649580|NCT02310568|69119022|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
37649581|NCT02310568|69119018|FG000|Stage 1 ( 4 Weeks)|Other|1|||
37649582|NCT02310568|69119019|FG001|Stage 1 ( 4 Weeks)|Other|1|||
37649583|NCT02310568|69119020|FG002|Stage 1 ( 4 Weeks)|Other|0|||
37649584|NCT02310568|69119021|FG003|Stage 1 ( 4 Weeks)|Other|0|||
37649585|NCT02310568|69119022|FG004|Stage 1 ( 4 Weeks)|Other|0|||
37649586|NCT02310568|69119018|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
37649587|NCT02310568|69119019|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
37649588|NCT02310568|69119020|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
37649589|NCT02310568|69119021|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
37649590|NCT02310568|69119022|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
37649591|NCT02310568|69119018|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
37649592|NCT02310568|69119019|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
37649593|NCT02310568|69119020|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
37649594|NCT02310568|69119021|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
37649595|NCT02310568|69119022|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
37649596|NCT02310568|69119018|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
37741808|NCT01874431|69227856|FG007|Overall Study|Withdrawal by Subject|0|||
37741809|NCT01874431|69227849|FG000|Overall Study|Sponsor decision|0|||
37741810|NCT01874431|69227850|FG001|Overall Study|Sponsor decision|0|||
37741811|NCT01874431|69227851|FG002|Overall Study|Sponsor decision|0|||
37649597|NCT02310568|69119019|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
37855125|NCT01225731|69538426|FG003|Part 2|Lack of Efficacy|0|||
37649598|NCT02310568|69119020|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
37649599|NCT02310568|69119021|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
37649600|NCT02310568|69119022|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
37649601|NCT02310568|69119018|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
37649602|NCT02310568|69119019|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
37649603|NCT02310568|69119020|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
37649604|NCT02310568|69119021|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
37649605|NCT02310568|69119022|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
37649606|NCT02310568|69119018|FG000|Stage 2 (4 Weeks)|Other|0|||
37649607|NCT02310568|69119019|FG001|Stage 2 (4 Weeks)|Other|1|||
37649608|NCT02310568|69119020|FG002|Stage 2 (4 Weeks)|Other|1|||
37649609|NCT02310568|69119021|FG003|Stage 2 (4 Weeks)|Other|0|||
37649610|NCT02310568|69119022|FG004|Stage 2 (4 Weeks)|Other|0|||
37649611|NCT02310568|69119018|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
37649612|NCT02310568|69119019|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
37649613|NCT02310568|69119020|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
37649614|NCT02310568|69119021|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
37649615|NCT02310568|69119022|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
37649616|NCT02310568|69119018|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
37649617|NCT02310568|69119019|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
37649618|NCT02310568|69119020|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
37649619|NCT02310568|69119021|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
37649620|NCT02310568|69119022|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
37649621|NCT02310568|69119018|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
37649622|NCT02310568|69119019|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
37649623|NCT02310568|69119020|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
37649624|NCT02310568|69119021|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
37649625|NCT02310568|69119022|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
37649626|NCT02310100|69119040|FG000|Overall Study|Physician Decision|3|||
37649627|NCT02310100|69119040|FG000|Overall Study|Withdrawal by Subject|10|||
37649628|NCT02310100|69119040|FG000|Overall Study|Enrollment closure|1|||
37649629|NCT02310100|69119040|FG000|Overall Study|Unapproved ablation operator|1|||
37649630|NCT02310100|69119040|FG000|Overall Study|Visit compliance|1|||
37649631|NCT02310100|69119040|FG000|Overall Study|Lost to Follow-up|2|||
37649632|NCT02780167|69119050|FG000|Overall Study|Adverse Event|9|||
37649633|NCT02780167|69119051|FG001|Overall Study|Adverse Event|8|||
37649634|NCT02780167|69119052|FG002|Overall Study|Adverse Event|8|||
37649635|NCT02780167|69119053|FG003|Overall Study|Adverse Event|12|||
37649636|NCT02780167|69119054|FG004|Overall Study|Adverse Event|8|||
37649637|NCT02780167|69119050|FG000|Overall Study|Lack of Efficacy|6|||
37649638|NCT02780167|69119051|FG001|Overall Study|Lack of Efficacy|5|||
37649639|NCT02780167|69119052|FG002|Overall Study|Lack of Efficacy|6|||
37649640|NCT02780167|69119053|FG003|Overall Study|Lack of Efficacy|1|||
37649641|NCT02780167|69119054|FG004|Overall Study|Lack of Efficacy|0|||
37649642|NCT02780167|69119050|FG000|Overall Study|Lost to Follow-up|2|||
37649643|NCT02780167|69119051|FG001|Overall Study|Lost to Follow-up|0|||
37649644|NCT02780167|69119052|FG002|Overall Study|Lost to Follow-up|1|||
37649645|NCT02780167|69119053|FG003|Overall Study|Lost to Follow-up|0|||
37649646|NCT02780167|69119054|FG004|Overall Study|Lost to Follow-up|0|||
37649647|NCT02780167|69119050|FG000|Overall Study|Does not meet entrance criteria|0|||
37649648|NCT02780167|69119051|FG001|Overall Study|Does not meet entrance criteria|0|||
37649649|NCT02780167|69119052|FG002|Overall Study|Does not meet entrance criteria|1|||
37649650|NCT02780167|69119053|FG003|Overall Study|Does not meet entrance criteria|0|||
37649651|NCT02780167|69119054|FG004|Overall Study|Does not meet entrance criteria|0|||
37649652|NCT02780167|69119050|FG000|Overall Study|No longer meets eligibility criteria|0|||
37649653|NCT02780167|69119051|FG001|Overall Study|No longer meets eligibility criteria|0|||
37649654|NCT02780167|69119052|FG002|Overall Study|No longer meets eligibility criteria|0|||
37922401|NCT00819156|69609116|FG003|Overall Study|Protocol Violation|0|||
37922402|NCT00819156|69609117|FG004|Overall Study|Protocol Violation|0|||
37922403|NCT00819156|69609118|FG005|Overall Study|Protocol Violation|1|||
37922404|NCT00819156|69609113|FG000|Overall Study|Lost to Follow-up|0|||
37922405|NCT00819156|69609114|FG001|Overall Study|Lost to Follow-up|1|||
37922406|NCT00819156|69609115|FG002|Overall Study|Lost to Follow-up|0|||
37922407|NCT00819156|69609116|FG003|Overall Study|Lost to Follow-up|0|||
37922408|NCT00819156|69609117|FG004|Overall Study|Lost to Follow-up|0|||
37922409|NCT00819156|69609118|FG005|Overall Study|Lost to Follow-up|2|||
37922410|NCT00819156|69609113|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
37741812|NCT01874431|69227852|FG003|Overall Study|Sponsor decision|0|||
37741813|NCT01874431|69227853|FG004|Overall Study|Sponsor decision|1|||
37741814|NCT01874431|69227854|FG005|Overall Study|Sponsor decision|0|||
37741815|NCT01874431|69227855|FG006|Overall Study|Sponsor decision|0|||
37922411|NCT00819156|69609114|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
37922412|NCT00819156|69609115|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
37922413|NCT00819156|69609116|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
37922414|NCT00819156|69609117|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
37922415|NCT00819156|69609118|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
37922416|NCT00819156|69609113|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
37922417|NCT00819156|69609114|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
37922418|NCT00819156|69609115|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
37922419|NCT00819156|69609116|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
37649655|NCT02780167|69119053|FG003|Overall Study|No longer meets eligibility criteria|1|||
37649656|NCT02780167|69119054|FG004|Overall Study|No longer meets eligibility criteria|1|||
37741816|NCT01874431|69227856|FG007|Overall Study|Sponsor decision|0|||
37922420|NCT00819156|69609117|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
37649657|NCT02780167|69119050|FG000|Overall Study|Protocol Violation|5|||
37649658|NCT02780167|69119051|FG001|Overall Study|Protocol Violation|5|||
37649659|NCT02780167|69119052|FG002|Overall Study|Protocol Violation|1|||
37649660|NCT02780167|69119053|FG003|Overall Study|Protocol Violation|1|||
37649661|NCT02780167|69119054|FG004|Overall Study|Protocol Violation|2|||
37649662|NCT02780167|69119050|FG000|Overall Study|Withdrawal by Subject|6|||
37649663|NCT02780167|69119051|FG001|Overall Study|Withdrawal by Subject|4|||
37649664|NCT02780167|69119052|FG002|Overall Study|Withdrawal by Subject|4|||
37649665|NCT02780167|69119053|FG003|Overall Study|Withdrawal by Subject|3|||
37649666|NCT02780167|69119054|FG004|Overall Study|Withdrawal by Subject|4|||
37649667|NCT02780167|69119050|FG000|Overall Study|Other|0|||
37649668|NCT02780167|69119051|FG001|Overall Study|Other|0|||
37649669|NCT02780167|69119052|FG002|Overall Study|Other|3|||
37649670|NCT02780167|69119053|FG003|Overall Study|Other|1|||
37649671|NCT02780167|69119054|FG004|Overall Study|Other|2|||
37649672|NCT02779075|69119066|FG000|Overall Study|Withdrawal by Subject|1|||
37649673|NCT02779075|69119067|FG001|Overall Study|Withdrawal by Subject|3|||
37649674|NCT02779075|69119066|FG000|Overall Study|IV lost during 2nd study|1|||
37649675|NCT02779075|69119067|FG001|Overall Study|IV lost during 2nd study|0|||
37649676|NCT00105079|69119079|FG000|Overall Study|Adverse Event|5|||
37649677|NCT00105079|69119080|FG001|Overall Study|Adverse Event|12|||
37649678|NCT00105079|69119079|FG000|Overall Study|Death|3|||
37649679|NCT00105079|69119080|FG001|Overall Study|Death|1|||
37649680|NCT00105079|69119079|FG000|Overall Study|Lost to Follow-up|12|||
37649681|NCT00105079|69119080|FG001|Overall Study|Lost to Follow-up|12|||
37649682|NCT00105079|69119079|FG000|Overall Study|Lack of Efficacy|9|||
37649683|NCT00105079|69119080|FG001|Overall Study|Lack of Efficacy|3|||
37649684|NCT00105079|69119079|FG000|Overall Study|Refused treatment|6|||
37649685|NCT00105079|69119080|FG001|Overall Study|Refused treatment|4|||
37649686|NCT00105079|69119079|FG000|Overall Study|Violation of selection criteria at entry|0|||
37649687|NCT00105079|69119080|FG001|Overall Study|Violation of selection criteria at entry|2|||
37649688|NCT00105079|69119079|FG000|Overall Study|Protocol Violation|1|||
37649689|NCT00105079|69119080|FG001|Overall Study|Protocol Violation|0|||
37649690|NCT00105079|69119079|FG000|Overall Study|Other|3|||
37649691|NCT00105079|69119080|FG001|Overall Study|Other|1|||
37649692|NCT02777827|69119086|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
37649693|NCT02777827|69119087|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
37649694|NCT02777827|69119088|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
37649695|NCT02777827|69119089|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
37649696|NCT02777827|69119090|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
37649697|NCT02777827|69119091|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
37649698|NCT02712333|69119107|FG000|First Period|Withdrawal by Subject|3|||
37649699|NCT02712333|69119108|FG001|First Period|Withdrawal by Subject|2|||
37649700|NCT02343406|69119124|FG000|Overall Study|Progressive disease|72|||
37649701|NCT02343406|69119125|FG001|Overall Study|Progressive disease|70|||
37649702|NCT02343406|69119126|FG002|Overall Study|Progressive disease|43|||
37649703|NCT02343406|69119127|FG003|Overall Study|Progressive disease|15|||
37649704|NCT02343406|69119128|FG004|Overall Study|Progressive disease|5|||
37649705|NCT02343406|69119124|FG000|Overall Study|Adverse Event|6|||
37649706|NCT02343406|69119125|FG001|Overall Study|Adverse Event|8|||
37649707|NCT02343406|69119126|FG002|Overall Study|Adverse Event|6|||
37649708|NCT02343406|69119127|FG003|Overall Study|Adverse Event|3|||
37649709|NCT02343406|69119128|FG004|Overall Study|Adverse Event|0|||
37649710|NCT02343406|69119124|FG000|Overall Study|Withdrawal by Subject|6|||
37649711|NCT02343406|69119125|FG001|Overall Study|Withdrawal by Subject|4|||
37649712|NCT02343406|69119126|FG002|Overall Study|Withdrawal by Subject|8|||
37649713|NCT02343406|69119127|FG003|Overall Study|Withdrawal by Subject|3|||
37649714|NCT02343406|69119128|FG004|Overall Study|Withdrawal by Subject|0|||
37649715|NCT02343406|69119124|FG000|Overall Study|Death|2|||
37649716|NCT02343406|69119125|FG001|Overall Study|Death|1|||
37649717|NCT02343406|69119126|FG002|Overall Study|Death|0|||
37649718|NCT02343406|69119127|FG003|Overall Study|Death|0|||
37649719|NCT02343406|69119128|FG004|Overall Study|Death|0|||
37649720|NCT02343406|69119124|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
37649721|NCT02343406|69119125|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
37741817|NCT01874431|69227849|FG000|Overall Study|Lost to Follow-up|0|||
37649722|NCT02343406|69119126|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
37649723|NCT02343406|69119127|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
37649724|NCT02343406|69119128|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
37649725|NCT02343406|69119124|FG000|Overall Study|Other primary malignancy|0|||
37649726|NCT02343406|69119125|FG001|Overall Study|Other primary malignancy|1|||
37649727|NCT02343406|69119126|FG002|Overall Study|Other primary malignancy|0|||
37649728|NCT02343406|69119127|FG003|Overall Study|Other primary malignancy|0|||
37649729|NCT02343406|69119128|FG004|Overall Study|Other primary malignancy|0|||
37649730|NCT02343406|69119124|FG000|Overall Study|Other, not specified|2|||
37649731|NCT02343406|69119125|FG001|Overall Study|Other, not specified|1|||
37649732|NCT02343406|69119126|FG002|Overall Study|Other, not specified|1|||
37649733|NCT02343406|69119127|FG003|Overall Study|Other, not specified|4|||
37649734|NCT02343406|69119128|FG004|Overall Study|Other, not specified|0|||
37649735|NCT02710071|69119141|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
37649736|NCT02710071|69119142|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
37649737|NCT02710071|69119141|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
37649738|NCT02710071|69119142|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
37741818|NCT01874431|69227850|FG001|Overall Study|Lost to Follow-up|0|||
37741819|NCT01874431|69227851|FG002|Overall Study|Lost to Follow-up|1|||
37741820|NCT01874431|69227852|FG003|Overall Study|Lost to Follow-up|0|||
37741821|NCT01874431|69227853|FG004|Overall Study|Lost to Follow-up|0|||
37741822|NCT01874431|69227854|FG005|Overall Study|Lost to Follow-up|0|||
37741823|NCT01874431|69227855|FG006|Overall Study|Lost to Follow-up|0|||
37741824|NCT01874431|69227856|FG007|Overall Study|Lost to Follow-up|0|||
37741825|NCT01824355|69227874|FG000|Overall Study|Adverse Event|2|||
37741826|NCT01824355|69227874|FG000|Overall Study|unevaluable reference method results per|1|||
37741827|NCT01823341|69227882|FG000|Overall Study|Failed run-in|7|||
37741828|NCT01823341|69227882|FG000|Overall Study|Withdrawal by Subject|7|||
37741829|NCT01823341|69227882|FG000|Overall Study|Adverse Event|1|||
37741830|NCT01853137|69227891|FG000|Overall Study|Lost to Follow-up|4|||
37741831|NCT01853137|69227892|FG001|Overall Study|Lost to Follow-up|1|||
37741832|NCT01823107|69227899|FG000|Overall Study|Withdrawal by Subject|1|||
37741833|NCT01874275|69227905|FG000|Overall Study|Lost to Follow-up|1|||
37741834|NCT01874275|69227906|FG001|Overall Study|Lost to Follow-up|0|||
37741835|NCT01873729|69227918|FG000|Overall Study|Withdrawal by Subject|1|||
37741836|NCT01873495|69227922|FG000|Overall Study|Withdrawal by Subject|1|||
37741837|NCT01873495|69227922|FG000|Overall Study|Physician Decision|3|||
37741838|NCT01873495|69227922|FG000|Overall Study|Adverse Event|1|||
37741839|NCT01873495|69227922|FG000|Overall Study|Removed for Transplantation|1|||
37741840|NCT01873495|69227922|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
37741841|NCT01852825|69227929|FG000|Overall Study|Withdrawal by Subject|2|||
37741842|NCT01852825|69227930|FG001|Overall Study|Withdrawal by Subject|0|||
37741843|NCT01852825|69227931|FG002|Overall Study|Withdrawal by Subject|0|||
37741844|NCT01822561|69227939|FG000|Overall Study|Withdrawal by Subject|2|||
37741845|NCT01852591|69227964|FG000|Overall Study|Withdrawal by Subject|2|||
37741846|NCT01852591|69227964|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
37649739|NCT02373202|69119153|FG000|Overall Study|Adverse Event|2|||
37649740|NCT02373202|69119154|FG001|Overall Study|Adverse Event|5|||
37649741|NCT02373202|69119155|FG002|Overall Study|Adverse Event|2|||
37649742|NCT02373202|69119156|FG003|Overall Study|Adverse Event|1|||
37649743|NCT02373202|69119153|FG000|Overall Study|Lack of Efficacy|0|||
37649744|NCT02373202|69119154|FG001|Overall Study|Lack of Efficacy|0|||
37649745|NCT02373202|69119155|FG002|Overall Study|Lack of Efficacy|1|||
37649746|NCT02373202|69119156|FG003|Overall Study|Lack of Efficacy|0|||
37649747|NCT02373202|69119153|FG000|Overall Study|Other|0|||
37649748|NCT02373202|69119154|FG001|Overall Study|Other|1|||
37649749|NCT02373202|69119155|FG002|Overall Study|Other|0|||
37649750|NCT02373202|69119156|FG003|Overall Study|Other|0|||
37649751|NCT02622074|69119172|FG000|Overall Study|Death|4|||
37649752|NCT02622074|69119173|FG001|Overall Study|Death|0|||
37649753|NCT02622074|69119174|FG002|Overall Study|Death|0|||
37649754|NCT02622074|69119175|FG003|Overall Study|Death|1|||
37649755|NCT02622074|69119176|FG004|Overall Study|Death|1|||
37649756|NCT02622074|69119177|FG005|Overall Study|Death|0|||
37649757|NCT02622074|69119172|FG000|Overall Study|Withdrawal by Subject|0|||
37649758|NCT02622074|69119173|FG001|Overall Study|Withdrawal by Subject|1|||
37649759|NCT02622074|69119174|FG002|Overall Study|Withdrawal by Subject|0|||
37649760|NCT02622074|69119175|FG003|Overall Study|Withdrawal by Subject|0|||
37649761|NCT02622074|69119176|FG004|Overall Study|Withdrawal by Subject|0|||
37649762|NCT02622074|69119177|FG005|Overall Study|Withdrawal by Subject|0|||
37649763|NCT02308696|69119193|FG000|Overall Study|Lost to Follow-up|28|||
37649764|NCT02308696|69119194|FG001|Overall Study|Lost to Follow-up|21|||
37649765|NCT02308696|69119193|FG000|Overall Study|Death|8|||
37649766|NCT02308696|69119194|FG001|Overall Study|Death|4|||
37649767|NCT02308696|69119193|FG000|Overall Study|Moved to a Higher Level of Care|17|||
37649768|NCT02308696|69119194|FG001|Overall Study|Moved to a Higher Level of Care|6|||
37649769|NCT02342704|69119202|FG000|Overall Study|Physician Decision|0|||
37649770|NCT02342704|69119203|FG001|Overall Study|Physician Decision|3|||
37649771|NCT02342704|69119202|FG000|Overall Study|Sponsor Termination|49|||
37649772|NCT02342704|69119203|FG001|Overall Study|Sponsor Termination|43|||
37649773|NCT02342704|69119202|FG000|Overall Study|Other|0|||
37649774|NCT02342704|69119203|FG001|Overall Study|Other|1|||
37649775|NCT02342704|69119202|FG000|Overall Study|Withdrawal by Subject|1|||
37649776|NCT02342704|69119203|FG001|Overall Study|Withdrawal by Subject|0|||
37649777|NCT02342704|69119202|FG000|Overall Study|Lost to Follow-up|2|||
37649778|NCT02342704|69119203|FG001|Overall Study|Lost to Follow-up|1|||
37649779|NCT02342704|69119202|FG000|Overall Study|Adverse Event|1|||
37649780|NCT02342704|69119203|FG001|Overall Study|Adverse Event|3|||
37649781|NCT02342548|69119212|FG000|Overall Study|Adverse Event|12|||
37649782|NCT02342548|69119213|FG001|Overall Study|Adverse Event|17|||
37649783|NCT02342548|69119214|FG002|Overall Study|Adverse Event|13|||
37649784|NCT02342548|69119212|FG000|Overall Study|Lost to Follow-up|0|||
37649785|NCT02342548|69119213|FG001|Overall Study|Lost to Follow-up|1|||
37649786|NCT02342548|69119214|FG002|Overall Study|Lost to Follow-up|0|||
37649787|NCT02342548|69119212|FG000|Overall Study|Study terminated by sponsor|20|||
37649788|NCT02342548|69119213|FG001|Overall Study|Study terminated by sponsor|39|||
37649789|NCT02342548|69119214|FG002|Overall Study|Study terminated by sponsor|25|||
37649790|NCT02342548|69119212|FG000|Overall Study|Protocol Violation|0|||
37649791|NCT02342548|69119213|FG001|Overall Study|Protocol Violation|1|||
37649792|NCT02342548|69119214|FG002|Overall Study|Protocol Violation|0|||
37649793|NCT02342548|69119212|FG000|Overall Study|Withdrawal by Subject|1|||
37649794|NCT02342548|69119213|FG001|Overall Study|Withdrawal by Subject|3|||
37649795|NCT02342548|69119214|FG002|Overall Study|Withdrawal by Subject|4|||
37649796|NCT02342548|69119212|FG000|Overall Study|Other|1|||
37649797|NCT02342548|69119213|FG001|Overall Study|Other|1|||
37649798|NCT02342548|69119214|FG002|Overall Study|Other|1|||
37649799|NCT03142191|69119227|FG000|Placebo Controlled Period|Death|0|||
37649800|NCT03142191|69119228|FG001|Placebo Controlled Period|Death|1|||
37649801|NCT03142191|69119229|FG002|Placebo Controlled Period|Death|1|||
37649802|NCT03142191|69119230|FG003|Placebo Controlled Period|Death|0|||
37649803|NCT03142191|69119231|FG004|Placebo Controlled Period|Death|0|||
37649804|NCT03142191|69119227|FG000|Placebo Controlled Period|Adverse Event|4|||
37649805|NCT03142191|69119228|FG001|Placebo Controlled Period|Adverse Event|5|||
37649806|NCT03142191|69119229|FG002|Placebo Controlled Period|Adverse Event|1|||
37649807|NCT03142191|69119230|FG003|Placebo Controlled Period|Adverse Event|0|||
37649808|NCT03142191|69119231|FG004|Placebo Controlled Period|Adverse Event|0|||
37649809|NCT03142191|69119227|FG000|Placebo Controlled Period|Progressive Disease|1|||
37649810|NCT03142191|69119228|FG001|Placebo Controlled Period|Progressive Disease|0|||
37649811|NCT03142191|69119229|FG002|Placebo Controlled Period|Progressive Disease|1|||
37649812|NCT03142191|69119230|FG003|Placebo Controlled Period|Progressive Disease|0|||
37649813|NCT03142191|69119231|FG004|Placebo Controlled Period|Progressive Disease|0|||
37649814|NCT03142191|69119227|FG000|Placebo Controlled Period|Withdrawal by participant|1|||
37649815|NCT03142191|69119228|FG001|Placebo Controlled Period|Withdrawal by participant|3|||
37649816|NCT03142191|69119229|FG002|Placebo Controlled Period|Withdrawal by participant|2|||
37649817|NCT03142191|69119230|FG003|Placebo Controlled Period|Withdrawal by participant|0|||
37649818|NCT03142191|69119231|FG004|Placebo Controlled Period|Withdrawal by participant|1|||
37649819|NCT03142191|69119227|FG000|Placebo Controlled Period|Other Reasons|1|||
37649820|NCT03142191|69119228|FG001|Placebo Controlled Period|Other Reasons|0|||
37649821|NCT03142191|69119229|FG002|Placebo Controlled Period|Other Reasons|0|||
37649822|NCT03142191|69119230|FG003|Placebo Controlled Period|Other Reasons|0|||
37649823|NCT03142191|69119231|FG004|Placebo Controlled Period|Other Reasons|0|||
37649824|NCT03142191|69119227|FG000|Active Treatment Extension Period|Death|2|||
37649825|NCT03142191|69119228|FG001|Active Treatment Extension Period|Death|1|||
37649826|NCT03142191|69119229|FG002|Active Treatment Extension Period|Death|1|||
37649827|NCT03142191|69119230|FG003|Active Treatment Extension Period|Death|1|||
37649828|NCT03142191|69119231|FG004|Active Treatment Extension Period|Death|0|||
37649829|NCT03142191|69119227|FG000|Active Treatment Extension Period|Adverse Event|6|||
37649830|NCT03142191|69119228|FG001|Active Treatment Extension Period|Adverse Event|5|||
37649831|NCT03142191|69119229|FG002|Active Treatment Extension Period|Adverse Event|4|||
37649832|NCT03142191|69119230|FG003|Active Treatment Extension Period|Adverse Event|1|||
37649833|NCT03142191|69119231|FG004|Active Treatment Extension Period|Adverse Event|0|||
37649834|NCT03142191|69119227|FG000|Active Treatment Extension Period|Progressive Disease|10|||
37649835|NCT03142191|69119228|FG001|Active Treatment Extension Period|Progressive Disease|5|||
37649836|NCT03142191|69119229|FG002|Active Treatment Extension Period|Progressive Disease|4|||
37649837|NCT03142191|69119230|FG003|Active Treatment Extension Period|Progressive Disease|1|||
37649838|NCT03142191|69119231|FG004|Active Treatment Extension Period|Progressive Disease|2|||
37649839|NCT03142191|69119227|FG000|Active Treatment Extension Period|Withdrawal by participant|2|||
37649840|NCT03142191|69119228|FG001|Active Treatment Extension Period|Withdrawal by participant|0|||
37649841|NCT03142191|69119229|FG002|Active Treatment Extension Period|Withdrawal by participant|3|||
37649842|NCT03142191|69119230|FG003|Active Treatment Extension Period|Withdrawal by participant|1|||
37649843|NCT03142191|69119231|FG004|Active Treatment Extension Period|Withdrawal by participant|1|||
37649844|NCT03142191|69119227|FG000|Active Treatment Extension Period|Physician Decision|2|||
37649845|NCT03142191|69119228|FG001|Active Treatment Extension Period|Physician Decision|0|||
37649846|NCT03142191|69119229|FG002|Active Treatment Extension Period|Physician Decision|0|||
37649847|NCT03142191|69119230|FG003|Active Treatment Extension Period|Physician Decision|0|||
37922421|NCT00819156|69609118|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
37649848|NCT03142191|69119231|FG004|Active Treatment Extension Period|Physician Decision|0|||
37649849|NCT03142191|69119227|FG000|Active Treatment Extension Period|Other Reasons|3|||
37649850|NCT03142191|69119228|FG001|Active Treatment Extension Period|Other Reasons|3|||
37649851|NCT03142191|69119229|FG002|Active Treatment Extension Period|Other Reasons|3|||
37649852|NCT03142191|69119230|FG003|Active Treatment Extension Period|Other Reasons|8|||
37649853|NCT03142191|69119231|FG004|Active Treatment Extension Period|Other Reasons|3|||
37649854|NCT03142191|69119227|FG000|Active Treatment Extension Period|Unknown, participant missing|1|||
37649855|NCT03142191|69119228|FG001|Active Treatment Extension Period|Unknown, participant missing|0|||
37649856|NCT03142191|69119229|FG002|Active Treatment Extension Period|Unknown, participant missing|0|||
37649857|NCT03142191|69119230|FG003|Active Treatment Extension Period|Unknown, participant missing|0|||
37649858|NCT03142191|69119231|FG004|Active Treatment Extension Period|Unknown, participant missing|0|||
37649859|NCT02617628|69119260|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
37649860|NCT02617628|69119261|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
37649861|NCT02308540|69119277|FG000|Overall Study|Lost to Follow-up|0|||
37649862|NCT02308540|69119278|FG001|Overall Study|Lost to Follow-up|0|||
37649863|NCT02308540|69119279|FG002|Overall Study|Lost to Follow-up|0|||
37649864|NCT02308540|69119280|FG003|Overall Study|Lost to Follow-up|0|||
37649865|NCT02308540|69119281|FG004|Overall Study|Lost to Follow-up|0|||
37649866|NCT02308540|69119282|FG005|Overall Study|Lost to Follow-up|1|||
37649867|NCT02308228|69119333|FG000|Overall Study|Adverse Event|3|||
37649868|NCT02308228|69119334|FG001|Overall Study|Adverse Event|4|||
37649869|NCT02308228|69119333|FG000|Overall Study|Withdrawal by Subject|5|||
37649870|NCT02308228|69119334|FG001|Overall Study|Withdrawal by Subject|3|||
37649871|NCT02616614|69119352|FG000|Overall Study|Withdrawal by Subject|10|||
37649872|NCT02616614|69119353|FG001|Overall Study|Withdrawal by Subject|5|||
37649873|NCT02616614|69119354|FG002|Overall Study|Withdrawal by Subject|6|||
37649874|NCT02616614|69119352|FG000|Overall Study|Physician Decision|2|||
37649875|NCT02616614|69119353|FG001|Overall Study|Physician Decision|1|||
37649876|NCT02616614|69119354|FG002|Overall Study|Physician Decision|0|||
37649877|NCT02616614|69119352|FG000|Overall Study|Adverse Event|1|||
37649878|NCT02616614|69119353|FG001|Overall Study|Adverse Event|4|||
37649879|NCT02616614|69119354|FG002|Overall Study|Adverse Event|1|||
37649880|NCT02616614|69119352|FG000|Overall Study|Protocol Violation|0|||
37649881|NCT02616614|69119353|FG001|Overall Study|Protocol Violation|3|||
37649882|NCT02616614|69119354|FG002|Overall Study|Protocol Violation|1|||
37649883|NCT02616614|69119352|FG000|Overall Study|Prohibited Medication|12|||
37649884|NCT02616614|69119353|FG001|Overall Study|Prohibited Medication|9|||
37649885|NCT02616614|69119354|FG002|Overall Study|Prohibited Medication|5|||
37649886|NCT02616614|69119352|FG000|Overall Study|More than 3 applications missed|6|||
37649887|NCT02616614|69119353|FG001|Overall Study|More than 3 applications missed|8|||
37649888|NCT02616614|69119354|FG002|Overall Study|More than 3 applications missed|1|||
37649889|NCT02616614|69119352|FG000|Overall Study|Lost to Follow-up|31|||
37649890|NCT02616614|69119353|FG001|Overall Study|Lost to Follow-up|28|||
37649891|NCT02616614|69119354|FG002|Overall Study|Lost to Follow-up|13|||
37649892|NCT02616614|69119352|FG000|Overall Study|Pregnancy|2|||
37649893|NCT02616614|69119353|FG001|Overall Study|Pregnancy|0|||
38032322|NCT02839330|69718212|FG001|Overall Study|Death|6|||
38032323|NCT02839330|69718213|FG002|Overall Study|Death|1|||
38032324|NCT02839330|69718214|FG003|Overall Study|Death|1|||
38032325|NCT02839330|69718211|FG000|Overall Study|Withdrawal by Subject|27|||
37649894|NCT02616614|69119354|FG002|Overall Study|Pregnancy|1|||
37649895|NCT02616614|69119352|FG000|Overall Study|Other|1|||
37649896|NCT02616614|69119353|FG001|Overall Study|Other|2|||
37649897|NCT02616614|69119354|FG002|Overall Study|Other|1|||
37649898|NCT02616380|69119380|FG000|Overall Study|Lost to Follow-up|1|||
37649899|NCT02616380|69119380|FG000|Overall Study|Other|2|||
37649900|NCT04436822|69119390|FG000|Overall Study|Physician Decision|2|||
37649901|NCT04436822|69119391|FG001|Overall Study|Physician Decision|0|||
37649902|NCT04436822|69119390|FG000|Overall Study|Sponsor request|1|||
37649903|NCT04436822|69119391|FG001|Overall Study|Sponsor request|0|||
37649904|NCT04436822|69119390|FG000|Overall Study|Withdrawal by parent/guardian|0|||
37649905|NCT04436822|69119391|FG001|Overall Study|Withdrawal by parent/guardian|3|||
37649906|NCT04436822|69119390|FG000|Overall Study|Unsuccessful procedure|0|||
37649907|NCT04436822|69119391|FG001|Overall Study|Unsuccessful procedure|1|||
37649908|NCT04436822|69119390|FG000|Overall Study|Withdrawal due to Covid-19|8|||
37649909|NCT04436822|69119391|FG001|Overall Study|Withdrawal due to Covid-19|1|||
37649910|NCT04436822|69119390|FG000|Overall Study|Withdrawal by Subject|1|||
37649911|NCT04436822|69119391|FG001|Overall Study|Withdrawal by Subject|0|||
37649912|NCT04436822|69119390|FG000|Overall Study|The sponsor was not able to provide the investigational product|0|||
37649913|NCT04436822|69119391|FG001|Overall Study|The sponsor was not able to provide the investigational product|1|||
37649914|NCT01596062|69119401|FG000|Overall Study|Adverse Event|1|||
37649915|NCT01596062|69119402|FG001|Overall Study|Adverse Event|0|||
37649916|NCT01596062|69119403|FG002|Overall Study|Adverse Event|2|||
37649917|NCT01596062|69119401|FG000|Overall Study|Lack of Efficacy|0|||
37649918|NCT01596062|69119402|FG001|Overall Study|Lack of Efficacy|0|||
37649919|NCT01596062|69119403|FG002|Overall Study|Lack of Efficacy|1|||
37649920|NCT02614898|69119422|FG000|Overall Study|Participated until study termination|10|||
37649921|NCT02614898|69119423|FG001|Overall Study|Participated until study termination|26|||
37649922|NCT02614898|69119422|FG000|Overall Study|Lost to Follow-up|0|||
38032326|NCT02839330|69718212|FG001|Overall Study|Withdrawal by Subject|19|||
38032327|NCT02839330|69718213|FG002|Overall Study|Withdrawal by Subject|11|||
38032328|NCT02839330|69718214|FG003|Overall Study|Withdrawal by Subject|13|||
37649923|NCT02614898|69119423|FG001|Overall Study|Lost to Follow-up|2|||
37649924|NCT02614898|69119422|FG000|Overall Study|Physician Decision|1|||
37649925|NCT02614898|69119423|FG001|Overall Study|Physician Decision|8|||
37649926|NCT02614898|69119422|FG000|Overall Study|Study Terminated by Sponsor|3|||
37649927|NCT02614898|69119423|FG001|Overall Study|Study Terminated by Sponsor|0|||
37649928|NCT02614898|69119422|FG000|Overall Study|Withdrawal by Subject|0|||
37649929|NCT02614898|69119423|FG001|Overall Study|Withdrawal by Subject|2|||
37649930|NCT02614898|69119422|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
37649931|NCT02614898|69119423|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
37649932|NCT02614898|69119422|FG000|Overall Study|Other-Additional Information Unavailable|0|||
37649933|NCT02614898|69119423|FG001|Overall Study|Other-Additional Information Unavailable|11|||
37649934|NCT02614898|69119422|FG000|Overall Study|Missing|0|||
37649935|NCT02614898|69119423|FG001|Overall Study|Missing|1|||
37649936|NCT02776033|69119443|FG000|Overall Study|Withdrawal by Subject|0|||
37649937|NCT02776033|69119444|FG001|Overall Study|Withdrawal by Subject|0|||
37649938|NCT02776033|69119445|FG002|Overall Study|Withdrawal by Subject|2|||
37649939|NCT02776033|69119443|FG000|Overall Study|Physician Decision|2|||
37649940|NCT02776033|69119444|FG001|Overall Study|Physician Decision|0|||
37649941|NCT02776033|69119445|FG002|Overall Study|Physician Decision|0|||
37649942|NCT02776033|69119443|FG000|Overall Study|Lost to Follow-up|1|||
37649943|NCT02776033|69119444|FG001|Overall Study|Lost to Follow-up|0|||
37649944|NCT02776033|69119445|FG002|Overall Study|Lost to Follow-up|0|||
37649945|NCT02776033|69119443|FG000|Overall Study|Adverse Event|1|||
37649946|NCT02776033|69119444|FG001|Overall Study|Adverse Event|2|||
37649947|NCT02776033|69119445|FG002|Overall Study|Adverse Event|0|||
37649948|NCT02777125|69119461|FG000|Overall Study|Consent form violation|14|||
37649949|NCT02777125|69119462|FG001|Overall Study|Consent form violation|12|||
37649950|NCT02777125|69119461|FG000|Overall Study|Assent form violation|21|||
37649951|NCT02777125|69119462|FG001|Overall Study|Assent form violation|23|||
37649952|NCT02777125|69119461|FG000|Overall Study|Protocol Violation|8|||
37649953|NCT02777125|69119462|FG001|Overall Study|Protocol Violation|12|||
37649954|NCT02769481|69119487|FG000|Overall Study|Protocol Violation|1|||
37649955|NCT02769481|69119488|FG001|Overall Study|Protocol Violation|0|||
37649956|NCT02769481|69119487|FG000|Overall Study|Adverse Event|3|||
37649957|NCT02769481|69119488|FG001|Overall Study|Adverse Event|6|||
37649958|NCT02769481|69119487|FG000|Overall Study|Entry Criteria Not Met|1|||
37649959|NCT02769481|69119488|FG001|Overall Study|Entry Criteria Not Met|2|||
37649960|NCT02769481|69119487|FG000|Overall Study|Withdrawal by Subject|14|||
37649961|NCT02769481|69119488|FG001|Overall Study|Withdrawal by Subject|16|||
37649962|NCT02769481|69119487|FG000|Overall Study|Lost to Follow-up|9|||
37649963|NCT02769481|69119488|FG001|Overall Study|Lost to Follow-up|9|||
37649964|NCT02769481|69119487|FG000|Overall Study|Physician Decision|0|||
37649965|NCT02769481|69119488|FG001|Overall Study|Physician Decision|1|||
37649966|NCT02769481|69119487|FG000|Overall Study|Terminated by Sponsor|1|||
37649967|NCT02769481|69119488|FG001|Overall Study|Terminated by Sponsor|0|||
37649968|NCT02769481|69119487|FG000|Overall Study|Death|0|||
37649969|NCT02769481|69119488|FG001|Overall Study|Death|1|||
37649970|NCT02769481|69119487|FG000|Overall Study|Undefined|4|||
37649971|NCT02769481|69119488|FG001|Overall Study|Undefined|1|||
37649972|NCT02769247|69119498|FG000|Overall Study|Withdrawal by Subject|1|||
37649973|NCT02769247|69119499|FG001|Overall Study|Withdrawal by Subject|0|||
37649974|NCT02769247|69119500|FG002|Overall Study|Withdrawal by Subject|0|||
37649975|NCT02769247|69119501|FG003|Overall Study|Withdrawal by Subject|1|||
37649976|NCT02769247|69119498|FG000|Overall Study|Protocol Violation|0|||
37649977|NCT02769247|69119499|FG001|Overall Study|Protocol Violation|0|||
37649978|NCT02769247|69119500|FG002|Overall Study|Protocol Violation|1|||
37649979|NCT02769247|69119501|FG003|Overall Study|Protocol Violation|0|||
37649980|NCT02769247|69119498|FG000|Overall Study|Physician Decision|1|||
37649981|NCT02769247|69119499|FG001|Overall Study|Physician Decision|0|||
37649982|NCT02769247|69119500|FG002|Overall Study|Physician Decision|0|||
37649983|NCT02769247|69119501|FG003|Overall Study|Physician Decision|0|||
37649984|NCT02773537|69119518|FG000|Overall Study|Lost to Follow-up|0|||
38032329|NCT02839330|69718211|FG000|Overall Study|Lost to Follow-up|22|||
38032330|NCT02839330|69718212|FG001|Overall Study|Lost to Follow-up|27|||
38032331|NCT02839330|69718213|FG002|Overall Study|Lost to Follow-up|29|||
37649985|NCT02773537|69119519|FG001|Overall Study|Lost to Follow-up|1|||
37649986|NCT02773537|69119520|FG002|Overall Study|Lost to Follow-up|4|||
37649987|NCT02780713|69119528|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
37649988|NCT02780713|69119529|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
38032332|NCT02839330|69718214|FG003|Overall Study|Lost to Follow-up|25|||
38032333|NCT02839330|69718211|FG000|Overall Study|Administrative Reason|0|||
38032334|NCT02839330|69718212|FG001|Overall Study|Administrative Reason|0|||
38032335|NCT02839330|69718213|FG002|Overall Study|Administrative Reason|0|||
38032336|NCT02839330|69718214|FG003|Overall Study|Administrative Reason|1|||
38032337|NCT02839330|69718211|FG000|Overall Study|Protocol Violation|1|||
38032338|NCT02839330|69718212|FG001|Overall Study|Protocol Violation|2|||
38032339|NCT02839330|69718213|FG002|Overall Study|Protocol Violation|2|||
38032340|NCT02839330|69718214|FG003|Overall Study|Protocol Violation|3|||
38032341|NCT02839330|69718211|FG000|Overall Study|Other reason, not specified|4|||
38032342|NCT02839330|69718212|FG001|Overall Study|Other reason, not specified|3|||
38032343|NCT02839330|69718213|FG002|Overall Study|Other reason, not specified|3|||
38032344|NCT02839330|69718214|FG003|Overall Study|Other reason, not specified|6|||
38032345|NCT03363776|69718228|FG000|Overall Study|Progressive disease|2|||
38032346|NCT03363776|69718229|FG001|Overall Study|Progressive disease|3|||
38032347|NCT03363776|69718230|FG002|Overall Study|Progressive disease|1|||
38032348|NCT03363776|69718228|FG000|Overall Study|Study drug toxicity|0|||
37741847|NCT01852045|69227971|FG000|Overall Study|Adverse Event|1|||
37649989|NCT02780713|69119530|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
37649990|NCT02780713|69119531|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
37649991|NCT02780713|69119532|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
37649992|NCT02767765|69119551|FG000|Overall Study|Adverse Event|4|||
37649993|NCT02767765|69119551|FG000|Overall Study|Death|1|||
37649994|NCT02767765|69119551|FG000|Overall Study|Insufficient response|1|||
37649995|NCT02767765|69119551|FG000|Overall Study|Lost to Follow-up|2|||
37649996|NCT02767765|69119551|FG000|Overall Study|Investigator decision|1|||
37649997|NCT02767765|69119551|FG000|Overall Study|Non-Compliance|1|||
37649998|NCT02767765|69119551|FG000|Overall Study|Withdrawal by Subject|1|||
37649999|NCT02772757|69119558|FG000|Overall Study|Withdrawal by Subject|1|||
37741848|NCT01852045|69227972|FG001|Overall Study|Adverse Event|0|||
37741849|NCT01852045|69227973|FG002|Overall Study|Adverse Event|0|||
37741850|NCT01852045|69227971|FG000|Overall Study|Lack of Efficacy|3|||
37741851|NCT01852045|69227972|FG001|Overall Study|Lack of Efficacy|0|||
37741852|NCT01852045|69227973|FG002|Overall Study|Lack of Efficacy|0|||
37741853|NCT01852045|69227971|FG000|Overall Study|Lost to Follow-up|0|||
37741854|NCT01852045|69227972|FG001|Overall Study|Lost to Follow-up|1|||
37741855|NCT01852045|69227973|FG002|Overall Study|Lost to Follow-up|1|||
37741856|NCT01852045|69227971|FG000|Overall Study|Withdrawal by Subject|1|||
37741857|NCT01852045|69227972|FG001|Overall Study|Withdrawal by Subject|0|||
37741858|NCT01852045|69227973|FG002|Overall Study|Withdrawal by Subject|1|||
37741859|NCT01852045|69227971|FG000|Overall Study|Other Miscellaneous Reasons|1|||
37741860|NCT01852045|69227972|FG001|Overall Study|Other Miscellaneous Reasons|3|||
37741861|NCT01852045|69227973|FG002|Overall Study|Other Miscellaneous Reasons|2|||
37741862|NCT01821937|69227992|FG000|Overall Study|Adverse Event|0|||
37741863|NCT01821937|69227993|FG001|Overall Study|Adverse Event|3|||
37650000|NCT02772757|69119559|FG001|Overall Study|Withdrawal by Subject|0|||
37650001|NCT02772757|69119560|FG002|Overall Study|Withdrawal by Subject|1|||
37650002|NCT02772757|69119558|FG000|Overall Study|Protocol Violation|0|||
37650003|NCT02772757|69119559|FG001|Overall Study|Protocol Violation|0|||
37650004|NCT02772757|69119560|FG002|Overall Study|Protocol Violation|1|||
37650005|NCT02772757|69119558|FG000|Overall Study|Physician Decision|0|||
37650006|NCT02772757|69119559|FG001|Overall Study|Physician Decision|3|||
37650007|NCT02772757|69119560|FG002|Overall Study|Physician Decision|3|||
37741864|NCT01821625|69228001|FG000|Overall Study|Withdrawal by Subject|2|||
37855126|NCT01225731|69538427|FG004|Part 2|Lack of Efficacy|0|||
37855127|NCT01225731|69538428|FG005|Part 2|Lack of Efficacy|1|||
37855128|NCT01225731|69538429|FG006|Part 2|Lack of Efficacy|0|||
37855129|NCT01225731|69538430|FG007|Part 2|Lack of Efficacy|12|||
37855130|NCT01225731|69538431|FG008|Part 2|Lack of Efficacy|3|||
37855131|NCT01225731|69538432|FG009|Part 2|Lack of Efficacy|0|||
37855132|NCT01225731|69538433|FG010|Part 2|Lack of Efficacy|0|||
37855133|NCT01225731|69538434|FG011|Part 2|Lack of Efficacy|0|||
37855134|NCT01225731|69538435|FG012|Part 2|Lack of Efficacy|0|||
37855135|NCT01225731|69538423|FG000|Part 2|Pregnancy|0|||
37855136|NCT01225731|69538424|FG001|Part 2|Pregnancy|0|||
37855137|NCT01225731|69538425|FG002|Part 2|Pregnancy|0|||
37855138|NCT01225731|69538426|FG003|Part 2|Pregnancy|0|||
37855139|NCT01225731|69538427|FG004|Part 2|Pregnancy|0|||
37855140|NCT01225731|69538428|FG005|Part 2|Pregnancy|0|||
37855141|NCT01225731|69538429|FG006|Part 2|Pregnancy|1|||
37855142|NCT01225731|69538430|FG007|Part 2|Pregnancy|0|||
37855143|NCT01225731|69538431|FG008|Part 2|Pregnancy|1|||
37855144|NCT01225731|69538432|FG009|Part 2|Pregnancy|0|||
37855145|NCT01225731|69538433|FG010|Part 2|Pregnancy|0|||
37855146|NCT01225731|69538434|FG011|Part 2|Pregnancy|0|||
37855147|NCT01225731|69538435|FG012|Part 2|Pregnancy|0|||
37855148|NCT01225731|69538423|FG000|Part 2|Lost to Follow-up|0|||
37855149|NCT01225731|69538424|FG001|Part 2|Lost to Follow-up|0|||
37855150|NCT01225731|69538425|FG002|Part 2|Lost to Follow-up|0|||
37855151|NCT01225731|69538426|FG003|Part 2|Lost to Follow-up|0|||
37855152|NCT01225731|69538427|FG004|Part 2|Lost to Follow-up|0|||
37855153|NCT01225731|69538428|FG005|Part 2|Lost to Follow-up|0|||
37855154|NCT01225731|69538429|FG006|Part 2|Lost to Follow-up|0|||
37855155|NCT01225731|69538430|FG007|Part 2|Lost to Follow-up|3|||
37855156|NCT01225731|69538431|FG008|Part 2|Lost to Follow-up|1|||
37855157|NCT01225731|69538432|FG009|Part 2|Lost to Follow-up|0|||
37855158|NCT01225731|69538433|FG010|Part 2|Lost to Follow-up|0|||
37855159|NCT01225731|69538434|FG011|Part 2|Lost to Follow-up|0|||
37855160|NCT01225731|69538435|FG012|Part 2|Lost to Follow-up|0|||
37855161|NCT01225731|69538423|FG000|Part 2|Physician Decision|0|||
37855162|NCT01225731|69538424|FG001|Part 2|Physician Decision|0|||
37650008|NCT00103207|69119569|FG000|Overall Study|Adverse Event|3|||
37650009|NCT00103207|69119569|FG000|Overall Study|Death|1|||
37650010|NCT00103207|69119569|FG000|Overall Study|Withdrawal by Subject|2|||
37650011|NCT00103207|69119569|FG000|Overall Study|Other complicating disease|1|||
37650012|NCT00103207|69119569|FG000|Overall Study|Ineligible|4|||
37650013|NCT00103207|69119569|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
37650014|NCT01369355|69119581|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
37650015|NCT01369355|69119582|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
37650016|NCT01369355|69119583|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
37650017|NCT01369355|69119584|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
37650018|NCT01369355|69119585|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
37650019|NCT01369355|69119586|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
37650020|NCT01369355|69119587|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
37650021|NCT01369355|69119588|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
37650022|NCT01369355|69119589|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
37650023|NCT01369355|69119581|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
37650024|NCT01369355|69119582|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
37650025|NCT01369355|69119583|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
37650026|NCT01369355|69119584|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
37650027|NCT01369355|69119585|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
37650028|NCT01369355|69119586|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
37650029|NCT01369355|69119587|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
37650030|NCT01369355|69119588|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
37650031|NCT01369355|69119589|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
37650032|NCT01369355|69119581|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
37650033|NCT01369355|69119582|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
37650034|NCT01369355|69119583|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
37650035|NCT01369355|69119584|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
37650036|NCT01369355|69119585|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
37741865|NCT01821625|69228001|FG000|Overall Study|Lack of Efficacy|2|||
37741866|NCT01821625|69228001|FG000|Overall Study|Adverse Event|1|||
37741867|NCT01821625|69228001|FG000|Overall Study|Medical contraindication|1|||
37741868|NCT01821391|69228007|FG000|Overall Study|Adverse Event|1|||
37741869|NCT01821391|69228008|FG001|Overall Study|Adverse Event|0|||
37741870|NCT01873417|69228016|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
37741871|NCT01873417|69228016|FG000|Overall Study|Adverse Event|24|||
37741872|NCT01873417|69228016|FG000|Overall Study|Lost to Follow-up|2|||
37741873|NCT01873417|69228016|FG000|Overall Study|Withdrawal by Subject|2|||
37741874|NCT01873417|69228016|FG000|Overall Study|Physician Decision|3|||
37741875|NCT01872715|69228020|FG000|Overall Study|Adverse Event|1|||
37741876|NCT01872715|69228020|FG000|Overall Study|Protocol Violation|1|||
37741877|NCT01872715|69228020|FG000|Overall Study|Withdrawal by Subject|2|||
37741878|NCT01871545|69228036|FG000|Overall Study|Death|2|||
37741879|NCT01871545|69228037|FG001|Overall Study|Death|0|||
37650037|NCT01369355|69119586|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
37650038|NCT01369355|69119587|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
37650039|NCT01369355|69119588|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
37650040|NCT01369355|69119589|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
37650041|NCT01369355|69119581|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
37650042|NCT01369355|69119582|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
37650043|NCT01369355|69119583|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
37650044|NCT01369355|69119584|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
37741880|NCT01871545|69228036|FG000|Overall Study|Lack of Efficacy|11|||
37741881|NCT01871545|69228037|FG001|Overall Study|Lack of Efficacy|2|||
37741882|NCT01871545|69228036|FG000|Overall Study|Physician Decision|4|||
37741883|NCT01871545|69228037|FG001|Overall Study|Physician Decision|0|||
37741884|NCT01871545|69228036|FG000|Overall Study|Withdrawal by Subject|0|||
37741885|NCT01871545|69228037|FG001|Overall Study|Withdrawal by Subject|1|||
37741886|NCT01613599|69228046|FG000|Overall Study|Death|9|||
37855163|NCT01225731|69538425|FG002|Part 2|Physician Decision|0|||
37650045|NCT01369355|69119585|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
37650046|NCT01369355|69119586|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
37855164|NCT01225731|69538426|FG003|Part 2|Physician Decision|0|||
37650047|NCT01369355|69119587|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
37741887|NCT01613599|69228046|FG000|Overall Study|Lost to Follow-up|5|||
37741888|NCT01613599|69228046|FG000|Overall Study|Withdrawal by Subject|8|||
38032349|NCT03363776|69718229|FG001|Overall Study|Study drug toxicity|0|||
37650048|NCT01369355|69119588|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
37650049|NCT01369355|69119589|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
37650050|NCT01369355|69119581|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
37650051|NCT01369355|69119582|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
37650052|NCT01369355|69119583|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
37741889|NCT01613599|69228046|FG000|Overall Study|Reason not specified|3|||
37741890|NCT01850641|69228050|FG000|Overall Study|Physician Decision|1|||
37741891|NCT01850641|69228050|FG000|Overall Study|Decrease in serum phosphorus|1|||
37741892|NCT01850641|69228050|FG000|Overall Study|Decrease in serum calcium|2|||
37741893|NCT01850641|69228050|FG000|Overall Study|Increase in serum ferritin|1|||
37741894|NCT01850563|69228056|FG000|Overall Study|Not eligible|3|||
37741895|NCT01850563|69228057|FG001|Overall Study|Not eligible|0|||
37741896|NCT04999839|69228109|FG000|Overall Study|Adverse Event|1|||
37741897|NCT04999839|69228110|FG001|Overall Study|Adverse Event|1|||
37650053|NCT01369355|69119584|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
37650054|NCT01369355|69119585|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
37650055|NCT01369355|69119586|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
37650056|NCT01369355|69119587|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
37650057|NCT01369355|69119588|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
37650058|NCT01369355|69119589|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
37650059|NCT01369355|69119581|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
37650060|NCT01369355|69119582|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
37650061|NCT01369355|69119583|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
37650062|NCT01369355|69119584|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
37650063|NCT01369355|69119585|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
37650064|NCT01369355|69119586|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
37650065|NCT01369355|69119587|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
37650066|NCT01369355|69119588|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
37650067|NCT01369355|69119589|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
37650068|NCT01369355|69119581|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
37650069|NCT01369355|69119582|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
37650070|NCT01369355|69119583|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
37650071|NCT01369355|69119584|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
37650072|NCT01369355|69119585|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
37650073|NCT01369355|69119586|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
37741898|NCT04999839|69228111|FG002|Overall Study|Adverse Event|1|||
37741899|NCT04999839|69228112|FG003|Overall Study|Adverse Event|1|||
37741900|NCT04999839|69228113|FG004|Overall Study|Adverse Event|1|||
37741901|NCT04999839|69228109|FG000|Overall Study|Lost to Follow-up|2|||
37650074|NCT01369355|69119587|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
37650075|NCT01369355|69119588|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
37650076|NCT01369355|69119589|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
37650077|NCT01369355|69119581|FG000|Long-term Extension (Week 44-272)|Death|0|||
37650078|NCT01369355|69119582|FG001|Long-term Extension (Week 44-272)|Death|0|||
37650079|NCT01369355|69119583|FG002|Long-term Extension (Week 44-272)|Death|0|||
37650080|NCT01369355|69119584|FG003|Long-term Extension (Week 44-272)|Death|0|||
37650081|NCT01369355|69119585|FG004|Long-term Extension (Week 44-272)|Death|0|||
37650082|NCT01369355|69119586|FG005|Long-term Extension (Week 44-272)|Death|0|||
37650083|NCT01369355|69119587|FG006|Long-term Extension (Week 44-272)|Death|0|||
37650084|NCT01369355|69119588|FG007|Long-term Extension (Week 44-272)|Death|1|||
37650085|NCT01369355|69119589|FG008|Long-term Extension (Week 44-272)|Death|3|||
37650086|NCT01369355|69119581|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
37650087|NCT01369355|69119582|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
37650088|NCT01369355|69119583|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
37650089|NCT01369355|69119584|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
37650090|NCT01369355|69119585|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
37650091|NCT01369355|69119586|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
37650092|NCT01369355|69119587|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
37650093|NCT01369355|69119588|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
37650094|NCT01369355|69119589|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
37650095|NCT01369355|69119581|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
37650096|NCT01369355|69119582|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
37650097|NCT01369355|69119583|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
37650098|NCT01369355|69119584|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
37650099|NCT01369355|69119585|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
37650100|NCT01369355|69119586|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
37650101|NCT01369355|69119587|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
37741902|NCT04999839|69228110|FG001|Overall Study|Lost to Follow-up|0|||
37741903|NCT04999839|69228111|FG002|Overall Study|Lost to Follow-up|2|||
37741904|NCT04999839|69228112|FG003|Overall Study|Lost to Follow-up|4|||
37741905|NCT04999839|69228113|FG004|Overall Study|Lost to Follow-up|1|||
37741906|NCT04999839|69228109|FG000|Overall Study|Withdrawal by Subject|6|||
37650102|NCT01369355|69119588|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
37650103|NCT01369355|69119589|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
37650104|NCT01369355|69119581|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
37650105|NCT01369355|69119582|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
37741907|NCT04999839|69228110|FG001|Overall Study|Withdrawal by Subject|5|||
37741908|NCT04999839|69228111|FG002|Overall Study|Withdrawal by Subject|3|||
37855165|NCT01225731|69538427|FG004|Part 2|Physician Decision|0|||
37650106|NCT01369355|69119583|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
37650107|NCT01369355|69119584|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
37650108|NCT01369355|69119585|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
37650109|NCT01369355|69119586|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
37650110|NCT01369355|69119587|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
37650111|NCT01369355|69119588|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
37650112|NCT01369355|69119589|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
37650113|NCT01369355|69119581|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
37650114|NCT01369355|69119582|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
37650115|NCT01369355|69119583|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
37650116|NCT01369355|69119584|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
37741909|NCT04999839|69228112|FG003|Overall Study|Withdrawal by Subject|2|||
37741910|NCT04999839|69228113|FG004|Overall Study|Withdrawal by Subject|2|||
37741911|NCT04999839|69228109|FG000|Overall Study|Lack of Efficacy|0|||
37741912|NCT04999839|69228110|FG001|Overall Study|Lack of Efficacy|1|||
37741913|NCT04999839|69228111|FG002|Overall Study|Lack of Efficacy|0|||
37741914|NCT04999839|69228112|FG003|Overall Study|Lack of Efficacy|0|||
37741915|NCT04999839|69228113|FG004|Overall Study|Lack of Efficacy|0|||
37741916|NCT04999839|69228109|FG000|Overall Study|Physician Decision|0|||
37741917|NCT04999839|69228110|FG001|Overall Study|Physician Decision|0|||
37741918|NCT04999839|69228111|FG002|Overall Study|Physician Decision|0|||
37741919|NCT04999839|69228112|FG003|Overall Study|Physician Decision|0|||
37741920|NCT04999839|69228113|FG004|Overall Study|Physician Decision|1|||
37741921|NCT04999839|69228109|FG000|Overall Study|Sponsor request|0|||
37741922|NCT04999839|69228110|FG001|Overall Study|Sponsor request|1|||
37741923|NCT04999839|69228111|FG002|Overall Study|Sponsor request|0|||
37741924|NCT04999839|69228112|FG003|Overall Study|Sponsor request|0|||
37741925|NCT04999839|69228113|FG004|Overall Study|Sponsor request|0|||
37741926|NCT04999839|69228109|FG000|Overall Study|Other|0|||
37741927|NCT04999839|69228110|FG001|Overall Study|Other|0|||
37741928|NCT04999839|69228111|FG002|Overall Study|Other|1|||
37741929|NCT04999839|69228112|FG003|Overall Study|Other|0|||
37741930|NCT04999839|69228113|FG004|Overall Study|Other|0|||
37741931|NCT04696146|69228157|FG000|Overall Study|Transplant Cancelled and did not proceed with study|0|||
37741932|NCT04696146|69228158|FG001|Overall Study|Transplant Cancelled and did not proceed with study|4|||
37741933|NCT04696146|69228157|FG000|Overall Study|Off hours issue with product|1|||
37741934|NCT04696146|69228158|FG001|Overall Study|Off hours issue with product|0|||
37741935|NCT04658940|69228164|FG000|Overall Study|Withdrawal by Subject|1|||
37741936|NCT04629066|69228170|FG000|Overall Study|Lost to Follow-up|3|||
37741937|NCT04629066|69228171|FG001|Overall Study|Lost to Follow-up|2|||
37741938|NCT04598269|69228179|FG000|Overall Study|Adverse Event|0|||
37741939|NCT04598269|69228180|FG001|Overall Study|Adverse Event|3|||
37741940|NCT04598269|69228179|FG000|Overall Study|Withdrawal by Subject|1|||
37741941|NCT04598269|69228180|FG001|Overall Study|Withdrawal by Subject|4|||
37741942|NCT04598269|69228179|FG000|Overall Study|Lost to Follow-up|1|||
37741943|NCT04598269|69228180|FG001|Overall Study|Lost to Follow-up|0|||
37650117|NCT01369355|69119585|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
37650118|NCT01369355|69119586|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
37650119|NCT01369355|69119587|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
37650120|NCT01369355|69119588|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
37650121|NCT01369355|69119589|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
37650122|NCT01369355|69119581|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
37650123|NCT01369355|69119582|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
37650124|NCT01369355|69119583|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
37650125|NCT01369355|69119584|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
37650126|NCT01369355|69119585|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
37650127|NCT01369355|69119586|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
37650128|NCT01369355|69119587|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
37650129|NCT01369355|69119588|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
37650130|NCT01369355|69119589|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
37650131|NCT01369355|69119581|FG000|Long-term Extension (Week 44-272)|Other|0|||
37650132|NCT01369355|69119582|FG001|Long-term Extension (Week 44-272)|Other|0|||
37650133|NCT01369355|69119583|FG002|Long-term Extension (Week 44-272)|Other|0|||
37650134|NCT01369355|69119584|FG003|Long-term Extension (Week 44-272)|Other|0|||
37650135|NCT01369355|69119585|FG004|Long-term Extension (Week 44-272)|Other|0|||
37855166|NCT01225731|69538428|FG005|Part 2|Physician Decision|0|||
37650136|NCT01369355|69119586|FG005|Long-term Extension (Week 44-272)|Other|0|||
37650137|NCT01369355|69119587|FG006|Long-term Extension (Week 44-272)|Other|110|||
37650138|NCT01369355|69119588|FG007|Long-term Extension (Week 44-272)|Other|9|||
37650139|NCT01369355|69119589|FG008|Long-term Extension (Week 44-272)|Other|17|||
37650140|NCT02614196|69119612|FG000|Double Blind Treatment Phase|Adverse Event|8|||
37741944|NCT04598269|69228179|FG000|Overall Study|Not Treated|2|||
37741945|NCT04598269|69228180|FG001|Overall Study|Not Treated|0|||
37855167|NCT01225731|69538429|FG006|Part 2|Physician Decision|0|||
37650141|NCT02614196|69119613|FG001|Double Blind Treatment Phase|Adverse Event|5|||
37650142|NCT02614196|69119614|FG002|Double Blind Treatment Phase|Adverse Event|9|||
37650143|NCT02614196|69119615|FG003|Double Blind Treatment Phase|Adverse Event|0|||
37650144|NCT02614196|69119616|FG004|Double Blind Treatment Phase|Adverse Event|0|||
37650145|NCT02614196|69119617|FG005|Double Blind Treatment Phase|Adverse Event|0|||
37650146|NCT02614196|69119612|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
37650147|NCT02614196|69119613|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
37650148|NCT02614196|69119614|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
37650149|NCT02614196|69119615|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
37650150|NCT02614196|69119616|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
37650151|NCT02614196|69119617|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
37650152|NCT02614196|69119612|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
37650153|NCT02614196|69119613|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
37650154|NCT02614196|69119614|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
37650155|NCT02614196|69119615|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
37650156|NCT02614196|69119616|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
37650157|NCT02614196|69119617|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
37650158|NCT02614196|69119612|FG000|Double Blind Treatment Phase|Physician Decision|4|||
37650159|NCT02614196|69119613|FG001|Double Blind Treatment Phase|Physician Decision|0|||
37650160|NCT02614196|69119614|FG002|Double Blind Treatment Phase|Physician Decision|2|||
37650161|NCT02614196|69119615|FG003|Double Blind Treatment Phase|Physician Decision|0|||
37650162|NCT02614196|69119616|FG004|Double Blind Treatment Phase|Physician Decision|0|||
37650163|NCT02614196|69119617|FG005|Double Blind Treatment Phase|Physician Decision|0|||
37650164|NCT02614196|69119612|FG000|Double Blind Treatment Phase|Pregnancy|1|||
37650165|NCT02614196|69119613|FG001|Double Blind Treatment Phase|Pregnancy|2|||
37650166|NCT02614196|69119614|FG002|Double Blind Treatment Phase|Pregnancy|0|||
37650167|NCT02614196|69119615|FG003|Double Blind Treatment Phase|Pregnancy|0|||
37650168|NCT02614196|69119616|FG004|Double Blind Treatment Phase|Pregnancy|0|||
37650169|NCT02614196|69119617|FG005|Double Blind Treatment Phase|Pregnancy|0|||
37650170|NCT02614196|69119612|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
37650171|NCT02614196|69119613|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
37650172|NCT02614196|69119614|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
37650173|NCT02614196|69119615|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
37650174|NCT02614196|69119616|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
37922422|NCT00819156|69609113|FG000|Overall Study|Prostate-specific antigen progression|0|||
37922423|NCT00819156|69609114|FG001|Overall Study|Prostate-specific antigen progression|0|||
37922424|NCT00819156|69609115|FG002|Overall Study|Prostate-specific antigen progression|0|||
37650175|NCT02614196|69119617|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
37650176|NCT02614196|69119612|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
37650177|NCT02614196|69119613|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
37741946|NCT04591015|69228188|FG000|Overall Study|Death|6|||
37741947|NCT04591015|69228189|FG001|Overall Study|Death|4|||
37741948|NCT04591015|69228188|FG000|Overall Study|Withdrawal by Subject|6|||
37741949|NCT04591015|69228189|FG001|Overall Study|Withdrawal by Subject|3|||
37741950|NCT04591015|69228188|FG000|Overall Study|Lost to Follow-up|16|||
37741951|NCT04591015|69228189|FG001|Overall Study|Lost to Follow-up|11|||
37741952|NCT04566692|69228197|FG000|Overall Study|Adverse Event|2|||
37741953|NCT04566692|69228198|FG001|Overall Study|Adverse Event|0|||
37741954|NCT04566692|69228197|FG000|Overall Study|Withdrawal by Subject|1|||
37741955|NCT04566692|69228198|FG001|Overall Study|Withdrawal by Subject|1|||
37741956|NCT04533412|69228213|FG000|Overall Study|Withdrawal by Subject|1|||
37741957|NCT04533412|69228214|FG001|Overall Study|Withdrawal by Subject|1|||
37741958|NCT04533412|69228213|FG000|Overall Study|Lost to Follow-up|1|||
37741959|NCT04533412|69228214|FG001|Overall Study|Lost to Follow-up|4|||
37741960|NCT04515147|69228226|FG000|Overall Study|Withdrawal by Subject|1|||
37741961|NCT04515147|69228227|FG001|Overall Study|Withdrawal by Subject|0|||
37741962|NCT04515147|69228228|FG002|Overall Study|Withdrawal by Subject|10|||
37741963|NCT04515147|69228229|FG003|Overall Study|Withdrawal by Subject|18|||
37741964|NCT04515147|69228230|FG004|Overall Study|Withdrawal by Subject|1|||
37741965|NCT04515147|69228231|FG005|Overall Study|Withdrawal by Subject|8|||
37741966|NCT04515147|69228226|FG000|Overall Study|Lost to Follow-up|0|||
37741967|NCT04515147|69228227|FG001|Overall Study|Lost to Follow-up|1|||
37741968|NCT04515147|69228228|FG002|Overall Study|Lost to Follow-up|5|||
37741969|NCT04515147|69228229|FG003|Overall Study|Lost to Follow-up|6|||
37741970|NCT04515147|69228230|FG004|Overall Study|Lost to Follow-up|2|||
37741971|NCT04515147|69228231|FG005|Overall Study|Lost to Follow-up|1|||
37741972|NCT04515147|69228226|FG000|Overall Study|Adverse Event|0|||
37741973|NCT04515147|69228227|FG001|Overall Study|Adverse Event|0|||
37741974|NCT04515147|69228228|FG002|Overall Study|Adverse Event|0|||
37741975|NCT04515147|69228229|FG003|Overall Study|Adverse Event|2|||
37741976|NCT04515147|69228230|FG004|Overall Study|Adverse Event|0|||
37741977|NCT04515147|69228231|FG005|Overall Study|Adverse Event|0|||
37741978|NCT04515147|69228226|FG000|Overall Study|Miscellaneous|0|||
37741979|NCT04515147|69228227|FG001|Overall Study|Miscellaneous|0|||
37650178|NCT02614196|69119614|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
37650179|NCT02614196|69119615|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
37650180|NCT02614196|69119616|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
37650181|NCT02614196|69119617|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
37650182|NCT02614196|69119612|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
37650183|NCT02614196|69119613|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
37650184|NCT02614196|69119614|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
37650185|NCT02614196|69119615|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
37650186|NCT02614196|69119616|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
37650187|NCT02614196|69119617|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
37650188|NCT02614196|69119612|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
37650189|NCT02614196|69119613|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
37650190|NCT02614196|69119614|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
37650191|NCT02614196|69119615|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
37650192|NCT02614196|69119616|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
37922425|NCT00819156|69609116|FG003|Overall Study|Prostate-specific antigen progression|0|||
37650193|NCT02614196|69119617|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
37650194|NCT02614196|69119612|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
37650195|NCT02614196|69119613|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
37650196|NCT02614196|69119614|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
37650197|NCT02614196|69119615|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
37650198|NCT02614196|69119616|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
37922426|NCT00819156|69609117|FG004|Overall Study|Prostate-specific antigen progression|1|||
37922427|NCT00819156|69609118|FG005|Overall Study|Prostate-specific antigen progression|0|||
37922428|NCT00459979|69609140|FG000|Overall Study|Withdrawal by Subject|1|||
37922429|NCT00459979|69609140|FG000|Overall Study|Protocol Violation|1|||
37922430|NCT00851786|69609146|FG000|Overall Study|Withdrawal by Subject|0|||
37922431|NCT00851786|69609147|FG001|Overall Study|Withdrawal by Subject|1|||
37922432|NCT00851786|69609146|FG000|Overall Study|Protocol Violation|0|||
37922433|NCT00851786|69609147|FG001|Overall Study|Protocol Violation|1|||
37650199|NCT02614196|69119617|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
37650200|NCT02614196|69119612|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
37650201|NCT02614196|69119613|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
37650202|NCT02614196|69119614|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
37922434|NCT00851786|69609146|FG000|Overall Study|Lost to Follow-up|1|||
37922435|NCT00851786|69609147|FG001|Overall Study|Lost to Follow-up|0|||
37922436|NCT00851786|69609146|FG000|Overall Study|Incarceration|1|||
37922437|NCT00851786|69609147|FG001|Overall Study|Incarceration|0|||
37922438|NCT00851786|69609146|FG000|Overall Study|Site Closure|1|||
37922439|NCT00851786|69609147|FG001|Overall Study|Site Closure|0|||
37922440|NCT00851786|69609146|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
37922441|NCT00851786|69609147|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
37922442|NCT00665626|69609155|FG000|Overall Study|Lack of Efficacy|8|||
37922443|NCT00665626|69609156|FG001|Overall Study|Lack of Efficacy|5|||
37922444|NCT00665626|69609155|FG000|Overall Study|Lost to Follow-up|0|||
37922445|NCT00665626|69609156|FG001|Overall Study|Lost to Follow-up|2|||
37922446|NCT00665626|69609155|FG000|Overall Study|Withdrawal by Subject|0|||
37922447|NCT00665626|69609156|FG001|Overall Study|Withdrawal by Subject|1|||
37922448|NCT00665626|69609155|FG000|Overall Study|Protocol Violation|0|||
38032350|NCT03363776|69718230|FG002|Overall Study|Study drug toxicity|1|||
37650203|NCT02614196|69119615|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
37650204|NCT02614196|69119616|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
37650205|NCT02614196|69119617|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
37650206|NCT02614196|69119612|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
37650207|NCT02614196|69119613|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
37650208|NCT02614196|69119614|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
37650209|NCT02614196|69119615|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
37650210|NCT02614196|69119616|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
37650211|NCT02614196|69119617|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
37650212|NCT02614196|69119612|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
37650213|NCT02614196|69119613|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
37650214|NCT02614196|69119614|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
37650215|NCT02614196|69119615|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
37650216|NCT02614196|69119616|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
37650217|NCT02614196|69119617|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
37650218|NCT02765035|69119647|FG000|First Intervention (90 Days)|Adverse Event|1|||
37922449|NCT00665626|69609156|FG001|Overall Study|Protocol Violation|2|||
37922450|NCT00665626|69609155|FG000|Overall Study|Adverse Event|1|||
37922451|NCT00665626|69609156|FG001|Overall Study|Adverse Event|9|||
37922452|NCT00665626|69609155|FG000|Overall Study|Due to exclusion criteria|0|||
37922453|NCT00665626|69609156|FG001|Overall Study|Due to exclusion criteria|1|||
38032351|NCT03363776|69718228|FG000|Overall Study|Death|1|||
37650219|NCT02765035|69119648|FG001|First Intervention (90 Days)|Adverse Event|1|||
37650220|NCT02765035|69119647|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
37650221|NCT02765035|69119648|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
37650222|NCT02307682|69119658|FG000|Overall Study|Adverse Event|9|||
37650223|NCT02307682|69119659|FG001|Overall Study|Adverse Event|8|||
37650224|NCT02307682|69119660|FG002|Overall Study|Adverse Event|12|||
37650225|NCT02307682|69119658|FG000|Overall Study|Lack of Efficacy|1|||
37650226|NCT02307682|69119659|FG001|Overall Study|Lack of Efficacy|0|||
37650227|NCT02307682|69119660|FG002|Overall Study|Lack of Efficacy|1|||
37650228|NCT02307682|69119658|FG000|Overall Study|Physician Decision|2|||
37922454|NCT00665626|69609155|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
37922455|NCT00665626|69609156|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
37922456|NCT00665626|69609155|FG000|Overall Study|Unably to comply with dosing regimen|0|||
37922457|NCT00665626|69609156|FG001|Overall Study|Unably to comply with dosing regimen|1|||
37922458|NCT00665626|69609155|FG000|Overall Study|Death|1|||
37922459|NCT00665626|69609156|FG001|Overall Study|Death|0|||
37922460|NCT00828672|69609164|FG000|Study Treatment|Lost to Follow-up|1|||
37650229|NCT02307682|69119659|FG001|Overall Study|Physician Decision|2|||
37650230|NCT02307682|69119660|FG002|Overall Study|Physician Decision|8|||
37650231|NCT02307682|69119658|FG000|Overall Study|Progressive Disease|1|||
37650232|NCT02307682|69119659|FG001|Overall Study|Progressive Disease|0|||
37650233|NCT02307682|69119660|FG002|Overall Study|Progressive Disease|0|||
37922461|NCT00828672|69609165|FG001|Study Treatment|Lost to Follow-up|0|||
37922462|NCT00828672|69609164|FG000|Study Treatment|Adverse Event|0|||
37922463|NCT00828672|69609165|FG001|Study Treatment|Adverse Event|1|||
37922464|NCT00828672|69609164|FG000|Study Treatment|Complete response, no surgery|1|||
37922465|NCT00828672|69609165|FG001|Study Treatment|Complete response, no surgery|1|||
37922466|NCT00828672|69609164|FG000|Post-surgery (<30 Days)|No central review materials|0|||
37922467|NCT00828672|69609165|FG001|Post-surgery (<30 Days)|No central review materials|1|||
37922468|NCT00873119|69609173|FG000|Overall Study|Patient request|4|||
37922469|NCT00873119|69609174|FG001|Overall Study|Patient request|2|||
37922470|NCT00873119|69609173|FG000|Overall Study|Adverse Event|8|||
37922471|NCT00873119|69609174|FG001|Overall Study|Adverse Event|0|||
37922472|NCT00873119|69609173|FG000|Overall Study|Progressive disease|26|||
37922473|NCT00873119|69609174|FG001|Overall Study|Progressive disease|18|||
37922474|NCT00873119|69609173|FG000|Overall Study|Death|2|||
37922475|NCT00873119|69609174|FG001|Overall Study|Death|1|||
37922476|NCT00873119|69609173|FG000|Overall Study|Other|2|||
37922477|NCT00873119|69609174|FG001|Overall Study|Other|5|||
37922478|NCT00873119|69609173|FG000|Overall Study|Not treated|2|||
37922479|NCT00873119|69609174|FG001|Overall Study|Not treated|0|||
37922480|NCT00661726|69609180|FG000|Overall Study|Adverse Event|1|||
37922481|NCT00865046|69609187|FG000|Overall Study|Lost to Follow-up|1|||
37650234|NCT02307682|69119658|FG000|Overall Study|Withdrawal by Subject|26|||
37650235|NCT02307682|69119659|FG001|Overall Study|Withdrawal by Subject|34|||
37650236|NCT02307682|69119660|FG002|Overall Study|Withdrawal by Subject|23|||
37650237|NCT02307682|69119658|FG000|Overall Study|Death|9|||
37650238|NCT02307682|69119659|FG001|Overall Study|Death|7|||
37650239|NCT02307682|69119660|FG002|Overall Study|Death|12|||
37650240|NCT02307682|69119658|FG000|Overall Study|Lost to Follow-up|1|||
37650241|NCT02307682|69119659|FG001|Overall Study|Lost to Follow-up|5|||
37650242|NCT02307682|69119660|FG002|Overall Study|Lost to Follow-up|6|||
37650243|NCT02307682|69119658|FG000|Overall Study|Protocol Deviation|0|||
37650244|NCT02307682|69119659|FG001|Overall Study|Protocol Deviation|0|||
37650245|NCT02307682|69119660|FG002|Overall Study|Protocol Deviation|2|||
37650246|NCT02307682|69119658|FG000|Overall Study|Other|1|||
37650247|NCT02307682|69119659|FG001|Overall Study|Other|1|||
37650248|NCT02307682|69119660|FG002|Overall Study|Other|0|||
37650249|NCT02615990|69119670|FG000|Overall Study|study terminated|1|||
37650250|NCT02615990|69119671|FG001|Overall Study|study terminated|1|||
37922482|NCT00865046|69609188|FG001|Overall Study|Lost to Follow-up|4|||
37922483|NCT00865046|69609189|FG002|Overall Study|Lost to Follow-up|0|||
37650251|NCT02613884|69119677|FG000|Overall Study|Death|1|||
37650252|NCT02613884|69119677|FG000|Overall Study|Lost to Follow-up|1|||
37650253|NCT02791763|69119685|FG000|Overall Study|Protocol Violation|0|||
37650254|NCT02791763|69119686|FG001|Overall Study|Protocol Violation|0|||
37922484|NCT00865046|69609187|FG000|Overall Study|Death|0|||
37922485|NCT00865046|69609188|FG001|Overall Study|Death|1|||
37922486|NCT00865046|69609189|FG002|Overall Study|Death|1|||
37922487|NCT00865046|69609187|FG000|Overall Study|Withdrawal by Subject|5|||
37922488|NCT00865046|69609188|FG001|Overall Study|Withdrawal by Subject|0|||
37922489|NCT00865046|69609189|FG002|Overall Study|Withdrawal by Subject|0|||
37650255|NCT02791763|69119687|FG002|Overall Study|Protocol Violation|1|||
37922490|NCT00828516|69609197|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
37922491|NCT00665392|69609201|FG000|Overall Study|not treated|1|||
37922492|NCT00851630|69609208|FG000|Overall Study|Death|2|||
37922493|NCT00851630|69609209|FG001|Overall Study|Death|1|||
37650256|NCT02791763|69119685|FG000|Overall Study|Withdrawal by Subject|5|||
37922494|NCT00851630|69609208|FG000|Overall Study|Clinical failure|0|||
37922495|NCT00851630|69609209|FG001|Overall Study|Clinical failure|1|||
37650257|NCT02791763|69119686|FG001|Overall Study|Withdrawal by Subject|1|||
37650258|NCT02791763|69119687|FG002|Overall Study|Withdrawal by Subject|0|||
37650259|NCT02791763|69119685|FG000|Overall Study|Physician Decision|0|||
37650260|NCT02791763|69119686|FG001|Overall Study|Physician Decision|1|||
37650261|NCT02791763|69119687|FG002|Overall Study|Physician Decision|0|||
37650262|NCT02791763|69119685|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
37650263|NCT02791763|69119686|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
37650264|NCT02791763|69119687|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
37650265|NCT02791763|69119685|FG000|Overall Study|Cancer event|1|||
37650266|NCT02791763|69119686|FG001|Overall Study|Cancer event|3|||
37922496|NCT00459667|69609218|FG000|Overall Study|Adverse Event|9|||
37922497|NCT00459667|69609219|FG001|Overall Study|Adverse Event|12|||
37922498|NCT00459667|69609220|FG002|Overall Study|Adverse Event|8|||
37922499|NCT00459667|69609218|FG000|Overall Study|Lost to Follow-up|5|||
37922500|NCT00459667|69609219|FG001|Overall Study|Lost to Follow-up|9|||
37922501|NCT00459667|69609220|FG002|Overall Study|Lost to Follow-up|3|||
37922502|NCT00459667|69609218|FG000|Overall Study|Pregnancy|1|||
37922503|NCT00459667|69609219|FG001|Overall Study|Pregnancy|1|||
37922504|NCT00459667|69609220|FG002|Overall Study|Pregnancy|1|||
37922505|NCT00459667|69609218|FG000|Overall Study|Protocol Violation|1|||
37922506|NCT00459667|69609219|FG001|Overall Study|Protocol Violation|0|||
37922507|NCT00459667|69609220|FG002|Overall Study|Protocol Violation|0|||
37922508|NCT00459667|69609218|FG000|Overall Study|Withdrawal by Subject|3|||
37922509|NCT00459667|69609219|FG001|Overall Study|Withdrawal by Subject|5|||
37922510|NCT00459667|69609220|FG002|Overall Study|Withdrawal by Subject|5|||
37922511|NCT00459667|69609218|FG000|Overall Study|Other disease modifying treatment|1|||
37922512|NCT00459667|69609219|FG001|Overall Study|Other disease modifying treatment|2|||
37922513|NCT00459667|69609220|FG002|Overall Study|Other disease modifying treatment|1|||
37922514|NCT00459667|69609218|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
37922515|NCT00459667|69609219|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
37922516|NCT00459667|69609220|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
37922517|NCT00459667|69609218|FG000|Overall Study|No treatment administered|6|||
37922518|NCT00459667|69609219|FG001|Overall Study|No treatment administered|3|||
37922519|NCT00459667|69609220|FG002|Overall Study|No treatment administered|1|||
37922520|NCT00828204|69609230|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
37922521|NCT00828204|69609231|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
37922522|NCT00828204|69609230|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
38032352|NCT03363776|69718229|FG001|Overall Study|Death|0|||
38032353|NCT03363776|69718230|FG002|Overall Study|Death|0|||
38032354|NCT03360344|69718241|FG000|Overall Study|Withdrawal by Subject|0|||
37922523|NCT00828204|69609231|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
37922524|NCT00828204|69609230|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
37922525|NCT00828204|69609231|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
37922526|NCT00828204|69609230|FG000|Main Study: After Study Restart|Adverse Event|0|||
37922527|NCT00828204|69609231|FG001|Main Study: After Study Restart|Adverse Event|2|||
37922528|NCT00828204|69609230|FG000|Main Study: After Study Restart|Noncompliance|0|||
37922529|NCT00828204|69609231|FG001|Main Study: After Study Restart|Noncompliance|1|||
37922530|NCT00828204|69609230|FG000|Extension Study|Lost to Follow-up|0|||
37922531|NCT00828204|69609231|FG001|Extension Study|Lost to Follow-up|1|||
37650267|NCT02791763|69119687|FG002|Overall Study|Cancer event|0|||
37650268|NCT02791763|69119685|FG000|Overall Study|Participant had renal transplant|3|||
37650269|NCT02791763|69119686|FG001|Overall Study|Participant had renal transplant|0|||
37650270|NCT02791763|69119687|FG002|Overall Study|Participant had renal transplant|0|||
37650271|NCT02791763|69119685|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
37650272|NCT02791763|69119686|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
37650273|NCT02791763|69119687|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
37650274|NCT02791763|69119685|FG000|Overall Study|Adverse Event|12|||
37650275|NCT02791763|69119686|FG001|Overall Study|Adverse Event|13|||
37650276|NCT02791763|69119687|FG002|Overall Study|Adverse Event|7|||
37650277|NCT02613572|69119707|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
37650278|NCT02613572|69119708|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
37650279|NCT02613572|69119709|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
37650280|NCT02613572|69119707|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
37650281|NCT02613572|69119708|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
37650282|NCT02613572|69119709|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
37650283|NCT02087189|69119721|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
37650284|NCT02341456|69119728|FG000|Overall Study|Disease progression|2|||
37650285|NCT02341456|69119729|FG001|Overall Study|Disease progression|3|||
37650286|NCT02341456|69119730|FG002|Overall Study|Disease progression|1|||
37922532|NCT00828204|69609230|FG000|Extension Study|Physician Decision|0|||
37922533|NCT00828204|69609231|FG001|Extension Study|Physician Decision|2|||
37922534|NCT00851552|69609238|FG000|Overall Study|Death|2|||
37922535|NCT00851552|69609238|FG000|Overall Study|Adverse Event|1|||
38032355|NCT03360344|69718242|FG001|Overall Study|Withdrawal by Subject|1|||
37922536|NCT00851552|69609238|FG000|Overall Study|Disease Progression|4|||
37922537|NCT00459355|69609244|FG000|Overall Study|Subject no longer met inc criteria|20|||
37922538|NCT00459355|69609245|FG001|Overall Study|Subject no longer met inc criteria|18|||
37922539|NCT00459043|69609257|FG000|Overall Study|Withdrawal by Subject|1|||
37922540|NCT00459043|69609258|FG001|Overall Study|Withdrawal by Subject|0|||
37922541|NCT00817206|69609266|FG000|Overall Study|Adverse Event|10|||
37922542|NCT00817206|69609267|FG001|Overall Study|Adverse Event|3|||
37922543|NCT00817206|69609266|FG000|Overall Study|Protocol Violation|0|||
37922544|NCT00817206|69609267|FG001|Overall Study|Protocol Violation|2|||
37922545|NCT00817206|69609266|FG000|Overall Study|Lost to Follow-up|0|||
37922546|NCT00817206|69609267|FG001|Overall Study|Lost to Follow-up|1|||
37922547|NCT00817206|69609266|FG000|Overall Study|Death|2|||
37922548|NCT00817206|69609267|FG001|Overall Study|Death|0|||
37922549|NCT00817206|69609266|FG000|Overall Study|Withdrawal by Subject|7|||
37922550|NCT00817206|69609267|FG001|Overall Study|Withdrawal by Subject|3|||
37922551|NCT00817206|69609266|FG000|Overall Study|Physician Decision|2|||
37922552|NCT00817206|69609267|FG001|Overall Study|Physician Decision|0|||
37922553|NCT00665002|69609273|FG000|Overall Study|Progression/relapse during treatment|11|||
37922554|NCT00665002|69609273|FG000|Overall Study|Cytogenetic resistance|1|||
37922555|NCT03847987|69609279|FG000|Overall Study|Lost to Follow-up|1|||
37922556|NCT03847987|69609280|FG001|Overall Study|Lost to Follow-up|0|||
37922557|NCT03847987|69609279|FG000|Overall Study|Adverse Event|2|||
37922558|NCT03847987|69609280|FG001|Overall Study|Adverse Event|0|||
37922559|NCT00660010|69609297|FG000|Overall Study|Withdrawal by Subject|2|||
37650287|NCT02341456|69119728|FG000|Overall Study|Death|1|||
37650288|NCT02341456|69119729|FG001|Overall Study|Death|1|||
37650289|NCT02341456|69119730|FG002|Overall Study|Death|1|||
37650290|NCT02341456|69119728|FG000|Overall Study|Withdrawal by Subject|0|||
37650291|NCT02341456|69119729|FG001|Overall Study|Withdrawal by Subject|1|||
37650292|NCT02341456|69119730|FG002|Overall Study|Withdrawal by Subject|1|||
37650293|NCT02341456|69119728|FG000|Overall Study|Moved to local access programme.|0|||
37650294|NCT02341456|69119729|FG001|Overall Study|Moved to local access programme.|1|||
37650295|NCT02341456|69119730|FG002|Overall Study|Moved to local access programme.|1|||
37650296|NCT02341456|69119728|FG000|Overall Study|Physician Decision|1|||
37650297|NCT02341456|69119729|FG001|Overall Study|Physician Decision|0|||
37650298|NCT02341456|69119730|FG002|Overall Study|Physician Decision|0|||
37650299|NCT02370784|69119740|FG000|Overall Study|Patient started prohibited medication|0|||
37650300|NCT02370784|69119741|FG001|Overall Study|Patient started prohibited medication|1|||
37650301|NCT02307370|69119749|FG000|Overall Study|Death|5|||
37650302|NCT02307370|69119749|FG000|Overall Study|Lost to Follow-up|1|||
37650303|NCT02307370|69119749|FG000|Overall Study|Withdrawal by Subject|1|||
37650304|NCT02307370|69119749|FG000|Overall Study|Declined Addendum ICF|6|||
37650305|NCT02307370|69119749|FG000|Overall Study|No response during telephone contact|5|||
37650306|NCT02307370|69119749|FG000|Overall Study|Protocol Violation|1|||
37650307|NCT02370394|69119757|FG000|Overall Study|Lost to Follow-up|2|||
37650308|NCT02370394|69119758|FG001|Overall Study|Lost to Follow-up|1|||
37650309|NCT02370394|69119757|FG000|Overall Study|Withdrawal by Subject|0|||
37650310|NCT02370394|69119758|FG001|Overall Study|Withdrawal by Subject|1|||
37650311|NCT01595438|69119767|FG000|Overall Study|Lost to Follow-up|20|||
37650312|NCT01595438|69119768|FG001|Overall Study|Lost to Follow-up|20|||
37650313|NCT01595438|69119767|FG000|Overall Study|Withdrawal by Subject|12|||
37650314|NCT01595438|69119768|FG001|Overall Study|Withdrawal by Subject|12|||
37650315|NCT01595438|69119767|FG000|Overall Study|Other Eligibility criteria|11|||
37650316|NCT01595438|69119768|FG001|Overall Study|Other Eligibility criteria|9|||
37650317|NCT02340520|69119774|FG000|Overall Study|Lost to Follow-up|1|||
37650318|NCT02340520|69119774|FG000|Overall Study|Patient did not take drug as specified|1|||
37650319|NCT02340520|69119774|FG000|Overall Study|Withdrawal by Subject|1|||
37650320|NCT02339584|69119780|FG000|Overall Study|Adverse Event|11|||
37650321|NCT02339584|69119781|FG001|Overall Study|Adverse Event|7|||
37650322|NCT02339584|69119780|FG000|Overall Study|Lack of Efficacy|0|||
37650323|NCT02339584|69119781|FG001|Overall Study|Lack of Efficacy|1|||
37650324|NCT02339584|69119780|FG000|Overall Study|Physician Decision|1|||
37650325|NCT02339584|69119781|FG001|Overall Study|Physician Decision|2|||
37650326|NCT02339584|69119780|FG000|Overall Study|Protocol Violation|1|||
37650327|NCT02339584|69119781|FG001|Overall Study|Protocol Violation|1|||
37650328|NCT02339584|69119780|FG000|Overall Study|Withdrawal by Subject|2|||
37650329|NCT02339584|69119781|FG001|Overall Study|Withdrawal by Subject|4|||
37650330|NCT02339506|69119787|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
37650331|NCT02339506|69119788|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
37650332|NCT02339506|69119787|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
37650333|NCT02339506|69119788|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
37650334|NCT02305888|69119797|FG000|Overall Study|Lost to Follow-up|0|||
37922560|NCT00660010|69609297|FG000|Overall Study|Lost to Follow-up|3|||
37922561|NCT00660010|69609297|FG000|Overall Study|Adverse Event|1|||
37922562|NCT00660010|69609297|FG000|Overall Study|Noncompliance with visit schedule|3|||
37922563|NCT00873041|69609304|FG000|Core Study|Adverse Event|2|||
37922564|NCT00873041|69609305|FG001|Core Study|Adverse Event|3|||
37922565|NCT00873041|69609306|FG002|Core Study|Adverse Event|1|||
37650335|NCT02305888|69119798|FG001|Overall Study|Lost to Follow-up|0|||
37650336|NCT02305888|69119799|FG002|Overall Study|Lost to Follow-up|1|||
37650337|NCT02305888|69119797|FG000|Overall Study|Adverse Event|0|||
37650338|NCT02305888|69119798|FG001|Overall Study|Adverse Event|1|||
37650339|NCT02305888|69119799|FG002|Overall Study|Adverse Event|0|||
37650340|NCT02338882|69119809|FG000|Overall Study|Death|1|||
37650341|NCT02338882|69119810|FG001|Overall Study|Death|0|||
37855168|NCT01225731|69538430|FG007|Part 2|Physician Decision|2|||
37855169|NCT01225731|69538431|FG008|Part 2|Physician Decision|2|||
37855170|NCT01225731|69538432|FG009|Part 2|Physician Decision|0|||
37855171|NCT01225731|69538433|FG010|Part 2|Physician Decision|0|||
37855172|NCT01225731|69538434|FG011|Part 2|Physician Decision|0|||
38032356|NCT03360344|69718243|FG002|Overall Study|Withdrawal by Subject|1|||
38032357|NCT02838628|69718253|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
38032358|NCT02838628|69718254|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
37650342|NCT02338882|69119809|FG000|Overall Study|Lost to Follow-up|6|||
37650343|NCT02338882|69119810|FG001|Overall Study|Lost to Follow-up|3|||
37650344|NCT01594970|69119822|FG000|Overall Study|Non-Adverse Event Related|4|||
37650345|NCT01594970|69119823|FG001|Overall Study|Non-Adverse Event Related|5|||
38032359|NCT02838628|69718253|FG000|Recurrence Follow-up Period|Adverse Event|1|||
38032360|NCT02838628|69718254|FG001|Recurrence Follow-up Period|Adverse Event|0|||
38032361|NCT02838628|69718253|FG000|Recurrence Follow-up Period|Non-compliance|0|||
38032362|NCT02838628|69718254|FG001|Recurrence Follow-up Period|Non-compliance|1|||
37650346|NCT01594970|69119824|FG002|Overall Study|Non-Adverse Event Related|6|||
37650347|NCT01594970|69119822|FG000|Overall Study|Adverse Event|17|||
37650348|NCT01594970|69119823|FG001|Overall Study|Adverse Event|23|||
37650349|NCT01594970|69119824|FG002|Overall Study|Adverse Event|23|||
37650350|NCT01594970|69119822|FG000|Overall Study|Lost to Follow-up|54|||
37650351|NCT01594970|69119823|FG001|Overall Study|Lost to Follow-up|54|||
37650352|NCT01594970|69119824|FG002|Overall Study|Lost to Follow-up|37|||
37650353|NCT02338492|69119832|FG000|Overall Study|Death|32|||
37650354|NCT02338492|69119832|FG000|Overall Study|Adverse Event|3|||
38032363|NCT02838628|69718253|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
37650355|NCT02338492|69119832|FG000|Overall Study|Lost to Follow-up|4|||
37650356|NCT02338492|69119832|FG000|Overall Study|Reason not captured above|6|||
37650357|NCT02337946|69119836|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
37650358|NCT02337946|69119837|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
37650359|NCT02337946|69119838|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
37650360|NCT02337946|69119836|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
37650361|NCT02337946|69119837|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
37650362|NCT02337946|69119838|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
37650363|NCT02337946|69119836|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
37650364|NCT02337946|69119837|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
37650365|NCT02337946|69119838|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
37650366|NCT02337946|69119836|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
37650367|NCT02337946|69119837|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
37650368|NCT02337946|69119838|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
37650369|NCT02337946|69119836|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
37650370|NCT02337946|69119837|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
37650371|NCT02337946|69119838|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
37650372|NCT02337946|69119836|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
37650373|NCT02337946|69119837|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
37650374|NCT02337946|69119838|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
37855173|NCT01225731|69538435|FG012|Part 2|Physician Decision|0|||
37855174|NCT01225731|69538423|FG000|Part 2|Withdrawal by Subject|0|||
37855175|NCT01225731|69538424|FG001|Part 2|Withdrawal by Subject|0|||
37855176|NCT01225731|69538425|FG002|Part 2|Withdrawal by Subject|0|||
38032364|NCT02838628|69718254|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
38032365|NCT02838628|69718253|FG000|Recurrence Follow-up Period|Other un-specified|1|||
38032366|NCT02838628|69718254|FG001|Recurrence Follow-up Period|Other un-specified|1|||
37650375|NCT02337946|69119836|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
37650376|NCT02337946|69119837|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
37650377|NCT02337946|69119838|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
37650378|NCT02337946|69119836|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
37650379|NCT02337946|69119837|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
37650380|NCT02337946|69119838|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
37650381|NCT02337946|69119836|FG000|In-between Period|Without Informed Consent|1|||
37650382|NCT02337946|69119837|FG001|In-between Period|Without Informed Consent|0|||
37650383|NCT02337946|69119838|FG002|In-between Period|Without Informed Consent|0|||
37650384|NCT02337946|69119836|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
37855177|NCT01225731|69538426|FG003|Part 2|Withdrawal by Subject|0|||
37855178|NCT01225731|69538427|FG004|Part 2|Withdrawal by Subject|0|||
37855179|NCT01225731|69538428|FG005|Part 2|Withdrawal by Subject|1|||
37855180|NCT01225731|69538429|FG006|Part 2|Withdrawal by Subject|3|||
37650385|NCT02337946|69119837|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
37650386|NCT02337946|69119838|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
37650387|NCT02337946|69119836|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
37650388|NCT02337946|69119837|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
37650389|NCT02337946|69119838|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
37650390|NCT02337946|69119836|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
37650391|NCT02337946|69119837|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
37650392|NCT02337946|69119838|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
37650393|NCT02337946|69119836|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
37650394|NCT02337946|69119837|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
37650395|NCT02337946|69119838|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
37650396|NCT02337946|69119836|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
37650397|NCT02337946|69119837|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
37650398|NCT02337946|69119838|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
37650399|NCT02337946|69119836|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
37650400|NCT02337946|69119837|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
37650401|NCT02337946|69119838|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
37650402|NCT01369199|69119844|FG000|Overall Study|Withdrawal by Subject|1|||
37650403|NCT01369199|69119844|FG000|Overall Study|Lost to Follow-up|2|||
37650404|NCT01368965|69119848|FG000|Overall Study|Lost to Follow-up|12|||
37650405|NCT02610140|69119856|FG000|Randomization and Treatment Period|Radiological progression|23|||
37650406|NCT02610140|69119857|FG001|Randomization and Treatment Period|Radiological progression|15|||
37650407|NCT02610140|69119856|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
37650408|NCT02610140|69119857|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
37650409|NCT02610140|69119856|FG000|Randomization and Treatment Period|Protocol Violation|1|||
37650410|NCT02610140|69119857|FG001|Randomization and Treatment Period|Protocol Violation|0|||
37650411|NCT02610140|69119856|FG000|Randomization and Treatment Period|Physician Decision|0|||
37650412|NCT02610140|69119857|FG001|Randomization and Treatment Period|Physician Decision|1|||
37650413|NCT02610140|69119856|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
37650414|NCT02610140|69119857|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
37650415|NCT02610140|69119856|FG000|Randomization and Treatment Period|Death|7|||
37650416|NCT02610140|69119857|FG001|Randomization and Treatment Period|Death|1|||
37650417|NCT02610140|69119856|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
37650418|NCT02610140|69119857|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
37650419|NCT02610140|69119856|FG000|Randomization and Treatment Period|Adverse Event|44|||
37650420|NCT02610140|69119857|FG001|Randomization and Treatment Period|Adverse Event|13|||
37650421|NCT02610140|69119856|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
37650422|NCT02610140|69119857|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
37650423|NCT02610140|69119856|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
37650424|NCT02610140|69119857|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
37650425|NCT02610140|69119856|FG000|Randomization and Treatment Period|Not treated|3|||
37650426|NCT02610140|69119857|FG001|Randomization and Treatment Period|Not treated|10|||
37650427|NCT02610140|69119856|FG000|Safety Follow-up|Other|0|||
37650428|NCT02610140|69119857|FG001|Safety Follow-up|Other|2|||
37650429|NCT02610140|69119856|FG000|Safety Follow-up|Lost to Follow-up|1|||
37650430|NCT02610140|69119857|FG001|Safety Follow-up|Lost to Follow-up|0|||
37650431|NCT02610140|69119856|FG000|Safety Follow-up|No follow-up|5|||
37650432|NCT02610140|69119857|FG001|Safety Follow-up|No follow-up|3|||
37650433|NCT02610140|69119856|FG000|Safety Follow-up|Death|12|||
37650434|NCT02610140|69119857|FG001|Safety Follow-up|Death|2|||
37650435|NCT02610140|69119856|FG000|Safety Follow-up|Deterioration of general conditions|15|||
37650436|NCT02610140|69119857|FG001|Safety Follow-up|Deterioration of general conditions|5|||
37650437|NCT02610140|69119856|FG000|Safety Follow-up|Withdrawal by Subject|12|||
37650438|NCT02610140|69119857|FG001|Safety Follow-up|Withdrawal by Subject|12|||
37650439|NCT02610140|69119856|FG000|Active Follow-up|Progressive disease - radiological|30|||
37650440|NCT02610140|69119857|FG001|Active Follow-up|Progressive disease - radiological|22|||
37650441|NCT02610140|69119856|FG000|Active Follow-up|Death|8|||
37650442|NCT02610140|69119857|FG001|Active Follow-up|Death|1|||
37650443|NCT02610140|69119856|FG000|Active Follow-up|Withdrawal by Subject|4|||
37650444|NCT02610140|69119857|FG001|Active Follow-up|Withdrawal by Subject|0|||
37650445|NCT02610140|69119856|FG000|Active Follow-up|Progressive disease - clinical|1|||
37650446|NCT02610140|69119857|FG001|Active Follow-up|Progressive disease - clinical|2|||
37650447|NCT02610140|69119856|FG000|Active Follow-up|Deterioration of general conditions|1|||
37650448|NCT02610140|69119857|FG001|Active Follow-up|Deterioration of general conditions|0|||
37650449|NCT02610140|69119856|FG000|Active Follow-up|Ongoing but not completed|4|||
37650450|NCT02610140|69119857|FG001|Active Follow-up|Ongoing but not completed|1|||
37650451|NCT02610140|69119856|FG000|Long-term Follow-up|Death|86|||
37650452|NCT02610140|69119857|FG001|Long-term Follow-up|Death|44|||
37650453|NCT02610140|69119856|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
37650454|NCT02610140|69119857|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
37650455|NCT02610140|69119856|FG000|Long-term Follow-up|Lost to Follow-up|1|||
37650456|NCT02610140|69119857|FG001|Long-term Follow-up|Lost to Follow-up|2|||
37650457|NCT02610140|69119856|FG000|Long-term Follow-up|Ongoing but not completed|30|||
37650458|NCT02610140|69119857|FG001|Long-term Follow-up|Ongoing but not completed|17|||
37650459|NCT02789657|69119867|FG000|Overall Study|Withdrawal by Subject|2|||
37650460|NCT02789657|69119868|FG001|Overall Study|Withdrawal by Subject|0|||
37650461|NCT02789657|69119869|FG002|Overall Study|Withdrawal by Subject|0|||
37650462|NCT02789657|69119870|FG003|Overall Study|Withdrawal by Subject|0|||
37650463|NCT02609984|69119881|FG000|Overall Study|Death|29|||
37650464|NCT02609984|69119882|FG001|Overall Study|Death|26|||
37650465|NCT02609984|69119881|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
37650466|NCT02609984|69119882|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
37650467|NCT02609984|69119881|FG000|Overall Study|Lost to Follow-up|1|||
37650468|NCT02609984|69119882|FG001|Overall Study|Lost to Follow-up|2|||
37650469|NCT02609984|69119881|FG000|Overall Study|Withdrawal by Subject|0|||
37650470|NCT02609984|69119882|FG001|Overall Study|Withdrawal by Subject|1|||
37650471|NCT02609984|69119881|FG000|Overall Study|Disease Progression|2|||
37650472|NCT02609984|69119882|FG001|Overall Study|Disease Progression|0|||
37650473|NCT02609672|69119890|FG000|Overall Study|Lost to Follow-up|3|||
37650474|NCT02609672|69119891|FG001|Overall Study|Lost to Follow-up|1|||
37650475|NCT02611778|69119899|FG000|Overall Study|Withdrawal by Subject|2|||
37650476|NCT02611778|69119900|FG001|Overall Study|Withdrawal by Subject|8|||
37650477|NCT02611778|69119899|FG000|Overall Study|Adverse Event|1|||
37650478|NCT02611778|69119900|FG001|Overall Study|Adverse Event|2|||
37650479|NCT02611778|69119899|FG000|Overall Study|Death|2|||
37650480|NCT02611778|69119900|FG001|Overall Study|Death|1|||
37650481|NCT02611778|69119899|FG000|Overall Study|Protocol Violation|1|||
37650482|NCT02611778|69119900|FG001|Overall Study|Protocol Violation|0|||
37650483|NCT02611778|69119899|FG000|Overall Study|Lost to Follow-up|3|||
37650484|NCT02611778|69119900|FG001|Overall Study|Lost to Follow-up|1|||
37650485|NCT02611778|69119899|FG000|Overall Study|Need for alternative treatment|1|||
37650486|NCT02611778|69119900|FG001|Overall Study|Need for alternative treatment|0|||
37650487|NCT02611778|69119899|FG000|Overall Study|Other Reason|2|||
37650488|NCT02611778|69119900|FG001|Overall Study|Other Reason|1|||
37650489|NCT02711553|69119911|FG000|Overall Study|Withdrawal by Subject|2|||
37650490|NCT02711553|69119912|FG001|Overall Study|Withdrawal by Subject|1|||
37650491|NCT02711553|69119913|FG002|Overall Study|Withdrawal by Subject|1|||
37650492|NCT02711553|69119914|FG003|Overall Study|Withdrawal by Subject|0|||
37650493|NCT02711553|69119911|FG000|Overall Study|Lost to Follow-up|3|||
37650494|NCT02711553|69119912|FG001|Overall Study|Lost to Follow-up|3|||
37650495|NCT02711553|69119913|FG002|Overall Study|Lost to Follow-up|6|||
37650496|NCT02711553|69119914|FG003|Overall Study|Lost to Follow-up|3|||
37650497|NCT02711553|69119911|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
37650498|NCT02711553|69119912|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
37650499|NCT02711553|69119913|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
37650500|NCT02711553|69119914|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
37650501|NCT02709369|69119926|FG000|Overall Study|Lost to Follow-up|15|||
37650502|NCT02709369|69119926|FG000|Overall Study|Withdrawal by Subject|10|||
37650503|NCT02709369|69119926|FG000|Overall Study|Did not received intervention|2|||
37650504|NCT02613182|69119930|FG000|Overall Study|Death|6|||
37650505|NCT02613182|69119930|FG000|Overall Study|Physician Decision|1|||
37650506|NCT02613182|69119930|FG000|Overall Study|Study Terminated by Sponsor|21|||
37650507|NCT02613182|69119930|FG000|Overall Study|Withdrawal by Subject|6|||
37650508|NCT04843579|69119956|FG000|Overall Study|Adverse Event|1|||
37650509|NCT04843579|69119956|FG000|Overall Study|Disease Progression|1|||
37650510|NCT04649359|69119962|FG000|Overall Study|Withdrawal by Subject|7|||
37650511|NCT04649359|69119963|FG001|Overall Study|Withdrawal by Subject|7|||
37650512|NCT04649359|69119962|FG000|Overall Study|Death|41|||
37650513|NCT04649359|69119963|FG001|Overall Study|Death|26|||
37650514|NCT04649359|69119962|FG000|Overall Study|Ongoing in the study|75|||
37650515|NCT04649359|69119963|FG001|Overall Study|Ongoing in the study|31|||
37650516|NCT04567693|69119985|FG000|Overall Study|Death|0|||
37650517|NCT04567693|69119986|FG001|Overall Study|Death|0|||
38032367|NCT02835820|69718263|FG000|Overall Study|Baseline Screen Failure|0|||
38032368|NCT02835820|69718264|FG001|Overall Study|Baseline Screen Failure|3|||
37650518|NCT04567693|69119987|FG002|Overall Study|Death|2|||
37650519|NCT04567693|69119985|FG000|Overall Study|Lost to Follow-up|1|||
37650520|NCT04567693|69119986|FG001|Overall Study|Lost to Follow-up|0|||
37650521|NCT04567693|69119987|FG002|Overall Study|Lost to Follow-up|2|||
37650522|NCT04567693|69119985|FG000|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|1|||
37650523|NCT04567693|69119986|FG001|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|0|||
37650524|NCT04567693|69119987|FG002|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|2|||
37650525|NCT04238663|69119998|FG000|Overall Study|Lost to Follow-up|0|||
37650526|NCT04238663|69119999|FG001|Overall Study|Lost to Follow-up|1|||
37650527|NCT04238663|69120000|FG002|Overall Study|Lost to Follow-up|0|||
37677508|NCT02600819|69152479|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
37650528|NCT04139642|69120020|FG000|First Intervention (9 Months)|Permission denied to use the device by clinic manager|0|||
37650529|NCT04139642|69120021|FG001|First Intervention (9 Months)|Permission denied to use the device by clinic manager|1|||
37650530|NCT03980483|69120064|FG000|Overall Study|Adverse Event|13|||
37650531|NCT03980483|69120065|FG001|Overall Study|Adverse Event|29|||
37650532|NCT03980483|69120066|FG002|Overall Study|Adverse Event|11|||
37650533|NCT03980483|69120067|FG003|Overall Study|Adverse Event|2|||
37650534|NCT03980483|69120068|FG004|Overall Study|Adverse Event|2|||
37650535|NCT03980483|69120069|FG005|Overall Study|Adverse Event|2|||
37650536|NCT03980483|69120064|FG000|Overall Study|Lack of Efficacy|7|||
37650537|NCT03980483|69120065|FG001|Overall Study|Lack of Efficacy|6|||
37650538|NCT03980483|69120066|FG002|Overall Study|Lack of Efficacy|0|||
37650539|NCT03980483|69120067|FG003|Overall Study|Lack of Efficacy|3|||
37650540|NCT03980483|69120068|FG004|Overall Study|Lack of Efficacy|1|||
37650541|NCT03980483|69120069|FG005|Overall Study|Lack of Efficacy|1|||
37650542|NCT03980483|69120064|FG000|Overall Study|Lost to Follow-up|2|||
37650543|NCT03980483|69120065|FG001|Overall Study|Lost to Follow-up|4|||
37650544|NCT03980483|69120066|FG002|Overall Study|Lost to Follow-up|2|||
37650545|NCT03980483|69120067|FG003|Overall Study|Lost to Follow-up|1|||
37650546|NCT03980483|69120068|FG004|Overall Study|Lost to Follow-up|2|||
37650547|NCT03980483|69120069|FG005|Overall Study|Lost to Follow-up|0|||
37650548|NCT03980483|69120064|FG000|Overall Study|Protocol Violation|4|||
37650549|NCT03980483|69120065|FG001|Overall Study|Protocol Violation|2|||
37650550|NCT03980483|69120066|FG002|Overall Study|Protocol Violation|1|||
37650551|NCT03980483|69120067|FG003|Overall Study|Protocol Violation|1|||
37650552|NCT03980483|69120068|FG004|Overall Study|Protocol Violation|0|||
37650553|NCT03980483|69120069|FG005|Overall Study|Protocol Violation|0|||
37650554|NCT03980483|69120064|FG000|Overall Study|Physician Decision|14|||
37650555|NCT03980483|69120065|FG001|Overall Study|Physician Decision|10|||
37650556|NCT03980483|69120066|FG002|Overall Study|Physician Decision|7|||
37650557|NCT03980483|69120067|FG003|Overall Study|Physician Decision|4|||
37650558|NCT03980483|69120068|FG004|Overall Study|Physician Decision|4|||
37650559|NCT03980483|69120069|FG005|Overall Study|Physician Decision|2|||
37650560|NCT03980483|69120064|FG000|Overall Study|Withdrawal by Subject|38|||
37650561|NCT03980483|69120065|FG001|Overall Study|Withdrawal by Subject|21|||
37650562|NCT03980483|69120066|FG002|Overall Study|Withdrawal by Subject|15|||
37650563|NCT03980483|69120067|FG003|Overall Study|Withdrawal by Subject|5|||
37650564|NCT03980483|69120068|FG004|Overall Study|Withdrawal by Subject|3|||
37650565|NCT03980483|69120069|FG005|Overall Study|Withdrawal by Subject|4|||
37650566|NCT03980483|69120064|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|4|||
37650567|NCT03980483|69120065|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
37650568|NCT03980483|69120066|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
37650569|NCT03980483|69120067|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
37650570|NCT03980483|69120068|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
37650571|NCT03980483|69120069|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
37650572|NCT03980483|69120064|FG000|Overall Study|INVESTIGATOR SITE CLOSED|0|||
37650573|NCT03980483|69120065|FG001|Overall Study|INVESTIGATOR SITE CLOSED|1|||
37650574|NCT03980483|69120066|FG002|Overall Study|INVESTIGATOR SITE CLOSED|0|||
37650575|NCT03980483|69120067|FG003|Overall Study|INVESTIGATOR SITE CLOSED|0|||
37650576|NCT03980483|69120068|FG004|Overall Study|INVESTIGATOR SITE CLOSED|0|||
37650577|NCT03980483|69120069|FG005|Overall Study|INVESTIGATOR SITE CLOSED|0|||
37650578|NCT03980483|69120064|FG000|Overall Study|Other|0|||
37650579|NCT03980483|69120065|FG001|Overall Study|Other|1|||
37650580|NCT03980483|69120066|FG002|Overall Study|Other|0|||
37650581|NCT03980483|69120067|FG003|Overall Study|Other|0|||
37650582|NCT03980483|69120068|FG004|Overall Study|Other|0|||
37650583|NCT03980483|69120069|FG005|Overall Study|Other|0|||
37650586|NCT03510468|69120116|FG000|Overall Study|Lost to Follow-up|1|||
37650587|NCT03510468|69120116|FG000|Overall Study|Adverse Event|5|||
37650588|NCT03510468|69120116|FG000|Overall Study|Physician Decision|1|||
37650589|NCT03510468|69120116|FG000|Overall Study|non-compliant with treatment|2|||
37650590|NCT03510468|69120116|FG000|Overall Study|Missed visit|1|||
37650591|NCT03473743|69120128|FG000|Overall Study|Withdrawal by Subject|0|||
37650592|NCT03473743|69120129|FG001|Overall Study|Withdrawal by Subject|0|||
37650593|NCT03473743|69120130|FG002|Overall Study|Withdrawal by Subject|0|||
37650594|NCT03473743|69120131|FG003|Overall Study|Withdrawal by Subject|0|||
37650595|NCT03473743|69120132|FG004|Overall Study|Withdrawal by Subject|0|||
37650596|NCT03473743|69120133|FG005|Overall Study|Withdrawal by Subject|0|||
37650597|NCT03473743|69120134|FG006|Overall Study|Withdrawal by Subject|0|||
37650598|NCT03473743|69120135|FG007|Overall Study|Withdrawal by Subject|3|||
37650599|NCT03473743|69120128|FG000|Overall Study|Other|0|||
37650600|NCT03473743|69120129|FG001|Overall Study|Other|0|||
37650601|NCT03473743|69120130|FG002|Overall Study|Other|0|||
37650602|NCT03473743|69120131|FG003|Overall Study|Other|1|||
37650603|NCT03473743|69120132|FG004|Overall Study|Other|0|||
37650604|NCT03473743|69120133|FG005|Overall Study|Other|0|||
37650605|NCT03473743|69120134|FG006|Overall Study|Other|0|||
37650606|NCT03473743|69120135|FG007|Overall Study|Other|0|||
37650607|NCT03473743|69120128|FG000|Overall Study|Ongoing|0|||
37650608|NCT03473743|69120129|FG001|Overall Study|Ongoing|0|||
37650609|NCT03473743|69120130|FG002|Overall Study|Ongoing|6|||
37650610|NCT03473743|69120131|FG003|Overall Study|Ongoing|8|||
37650611|NCT03473743|69120132|FG004|Overall Study|Ongoing|1|||
37650612|NCT03473743|69120133|FG005|Overall Study|Ongoing|1|||
37650613|NCT03473743|69120134|FG006|Overall Study|Ongoing|22|||
37650614|NCT03473743|69120135|FG007|Overall Study|Ongoing|24|||
37650615|NCT03473743|69120128|FG000|Overall Study|Randomized but not treated|0|||
37650616|NCT03473743|69120129|FG001|Overall Study|Randomized but not treated|0|||
37650617|NCT03473743|69120130|FG002|Overall Study|Randomized but not treated|0|||
37650618|NCT03473743|69120131|FG003|Overall Study|Randomized but not treated|0|||
37650619|NCT03473743|69120132|FG004|Overall Study|Randomized but not treated|0|||
37650620|NCT03473743|69120133|FG005|Overall Study|Randomized but not treated|0|||
37650621|NCT03473743|69120134|FG006|Overall Study|Randomized but not treated|1|||
37650622|NCT03473743|69120135|FG007|Overall Study|Randomized but not treated|1|||
37650623|NCT03374202|69120156|FG000|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|1|||
37650624|NCT03374202|69120157|FG001|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|2|||
37650625|NCT03374202|69120158|FG002|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|4|||
37650626|NCT03374202|69120156|FG000|Five Year Long Term Follow Up|Death|0|||
37650627|NCT03374202|69120157|FG001|Five Year Long Term Follow Up|Death|1|||
37650628|NCT03374202|69120158|FG002|Five Year Long Term Follow Up|Death|0|||
37650629|NCT03218826|69120180|FG000|Overall Study|Non-compliance with protocol|1|||
37650630|NCT03218826|69120181|FG001|Overall Study|Non-compliance with protocol|0|||
37650631|NCT03218826|69120182|FG002|Overall Study|Non-compliance with protocol|2|||
37650632|NCT03218826|69120183|FG003|Overall Study|Non-compliance with protocol|1|||
37650633|NCT03218826|69120184|FG004|Overall Study|Non-compliance with protocol|1|||
37650634|NCT03075215|69120196|FG000|12-Month Primary Endpoint|Death|152|||
37650635|NCT03075215|69120196|FG000|12-Month Primary Endpoint|Withdrawal by Subject|267|||
37650636|NCT03075215|69120196|FG000|Post Market Clinical Follow-Up ONLY|Death|15|||
37650637|NCT03075215|69120196|FG000|Post Market Clinical Follow-Up ONLY|Withdrawal by Subject|25|||
37650638|NCT03063632|69120202|FG000|Overall Study|Death|4|||
37650639|NCT03063632|69120203|FG001|Overall Study|Death|6|||
37650640|NCT03063632|69120202|FG000|Overall Study|Lost to Follow-up|0|||
37650641|NCT03063632|69120203|FG001|Overall Study|Lost to Follow-up|1|||
37650642|NCT03063632|69120202|FG000|Overall Study|Withdrawal by Subject|0|||
37650643|NCT03063632|69120203|FG001|Overall Study|Withdrawal by Subject|2|||
37650644|NCT03063632|69120202|FG000|Overall Study|Physician Decision|2|||
37650645|NCT03063632|69120203|FG001|Overall Study|Physician Decision|0|||
37650646|NCT03063632|69120202|FG000|Overall Study|Other: Disease progression; starting another treatment|1|||
37650647|NCT03063632|69120203|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
37650648|NCT02759731|69120223|FG000|Overall Study|Did not complete treatment.|8|||
37650649|NCT02665117|69120231|FG000|Overall Study|Physician Decision|1|||
37650650|NCT02665117|69120232|FG001|Overall Study|Physician Decision|0|||
37650651|NCT02617485|69120240|FG000|Treatment and Observation Period|Adverse Event|9|||
37650652|NCT02617485|69120241|FG001|Treatment and Observation Period|Adverse Event|1|||
37650653|NCT02617485|69120240|FG000|Treatment and Observation Period|Withdrawal by Subject|4|||
37650654|NCT02617485|69120241|FG001|Treatment and Observation Period|Withdrawal by Subject|1|||
37650655|NCT02617485|69120240|FG000|Treatment and Observation Period|Patient needed radiotherapy|1|||
37650656|NCT02617485|69120241|FG001|Treatment and Observation Period|Patient needed radiotherapy|0|||
37650657|NCT02617485|69120240|FG000|Treatment and Observation Period|Lack of Efficacy|1|||
37650658|NCT02617485|69120241|FG001|Treatment and Observation Period|Lack of Efficacy|2|||
37650659|NCT02617485|69120240|FG000|Treatment and Observation Period|Physician Decision|0|||
37650660|NCT02617485|69120241|FG001|Treatment and Observation Period|Physician Decision|1|||
37650661|NCT02617485|69120240|FG000|Follow-up Period|Adverse Event|1|||
37650662|NCT02617485|69120241|FG001|Follow-up Period|Adverse Event|0|||
37650663|NCT02617485|69120240|FG000|Follow-up Period|Withdrawal by Subject|1|||
37650664|NCT02617485|69120241|FG001|Follow-up Period|Withdrawal by Subject|0|||
37650665|NCT02617485|69120240|FG000|Follow-up Period|Disease progression|2|||
37650666|NCT02617485|69120241|FG001|Follow-up Period|Disease progression|1|||
37650667|NCT02617485|69120240|FG000|Follow-up Period|Need for CNS prophylaxis|1|||
37650668|NCT02617485|69120241|FG001|Follow-up Period|Need for CNS prophylaxis|0|||
37650669|NCT02617485|69120240|FG000|Follow-up Period|Patient needed radiotherapy|9|||
37650670|NCT02617485|69120241|FG001|Follow-up Period|Patient needed radiotherapy|5|||
37650671|NCT02617485|69120240|FG000|Follow-up Period|Patient needed bone marrow transplantation|1|||
37650672|NCT02617485|69120241|FG001|Follow-up Period|Patient needed bone marrow transplantation|0|||
37650673|NCT02589522|69120250|FG000|Overall Study|Physician Decision|1|||
37650674|NCT02589522|69120251|FG001|Overall Study|Physician Decision|2|||
37650675|NCT02589522|69120252|FG002|Overall Study|Physician Decision|0|||
37650676|NCT02589522|69120250|FG000|Overall Study|Did not start treatment|1|||
37650677|NCT02589522|69120251|FG001|Overall Study|Did not start treatment|0|||
37650678|NCT02589522|69120252|FG002|Overall Study|Did not start treatment|0|||
37650679|NCT02485860|69120262|FG000|Overall Study|Lost to Follow-up|4|||
37650680|NCT02485860|69120263|FG001|Overall Study|Lost to Follow-up|1|||
37650681|NCT02485860|69120262|FG000|Overall Study|Physician Decision|1|||
37650682|NCT02485860|69120263|FG001|Overall Study|Physician Decision|2|||
37650683|NCT02485860|69120262|FG000|Overall Study|Health context (COVID-19)|1|||
37650684|NCT02485860|69120263|FG001|Overall Study|Health context (COVID-19)|0|||
37650685|NCT02385123|69120278|FG000|Overall Study|15 participants were unable to complete study. Research was halted due to Coronavirus Disease 2019.|15|||
37650686|NCT02337686|69120282|FG000|Overall Study|Adverse Event|1|||
38032369|NCT03359174|69718270|FG000|Overall Study|Adverse Event|1|||
38032370|NCT02832622|69718274|FG000|Overall Study|MPP not programmed|1259|||
37650697|NCT02097420|69120295|FG000|Overall Study|Death|6|||
37650698|NCT02097420|69120295|FG000|Overall Study|Valve explanted|13|||
37650699|NCT02097420|69120295|FG000|Overall Study|Other Reason|1|||
37650700|NCT02000115|69120302|FG000|Overall Study|Death|56|||
37650701|NCT02000115|69120303|FG001|Overall Study|Death|45|||
37650702|NCT02000115|69120304|FG002|Overall Study|Death|0|||
37650703|NCT02000115|69120305|FG003|Overall Study|Death|0|||
37650704|NCT02000115|69120302|FG000|Overall Study|Missed Visit|6|||
37650705|NCT02000115|69120303|FG001|Overall Study|Missed Visit|8|||
37650706|NCT02000115|69120304|FG002|Overall Study|Missed Visit|1|||
37650707|NCT02000115|69120305|FG003|Overall Study|Missed Visit|0|||
37650708|NCT02000115|69120302|FG000|Overall Study|Protocol Violation|2|||
37650709|NCT02000115|69120303|FG001|Overall Study|Protocol Violation|1|||
37650710|NCT02000115|69120304|FG002|Overall Study|Protocol Violation|0|||
37650711|NCT02000115|69120305|FG003|Overall Study|Protocol Violation|0|||
37650712|NCT02000115|69120302|FG000|Overall Study|Physician Decision|2|||
37650713|NCT02000115|69120303|FG001|Overall Study|Physician Decision|0|||
37650714|NCT02000115|69120304|FG002|Overall Study|Physician Decision|0|||
37650715|NCT02000115|69120305|FG003|Overall Study|Physician Decision|0|||
37650716|NCT02000115|69120302|FG000|Overall Study|Withdrawal by Subject|11|||
37650717|NCT02000115|69120303|FG001|Overall Study|Withdrawal by Subject|11|||
37650718|NCT02000115|69120304|FG002|Overall Study|Withdrawal by Subject|0|||
37650719|NCT02000115|69120305|FG003|Overall Study|Withdrawal by Subject|0|||
37650720|NCT02000115|69120302|FG000|Overall Study|Lost to Follow-up|0|||
37650721|NCT02000115|69120303|FG001|Overall Study|Lost to Follow-up|1|||
37650722|NCT02000115|69120304|FG002|Overall Study|Lost to Follow-up|0|||
37650723|NCT02000115|69120305|FG003|Overall Study|Lost to Follow-up|0|||
37650724|NCT02000115|69120302|FG000|Overall Study|Non-compliance|2|||
37650725|NCT02000115|69120303|FG001|Overall Study|Non-compliance|1|||
37650726|NCT02000115|69120304|FG002|Overall Study|Non-compliance|0|||
37650727|NCT02000115|69120305|FG003|Overall Study|Non-compliance|0|||
37650728|NCT02000115|69120302|FG000|Overall Study|Withdrawn on day of randomization|0|||
37650729|NCT02000115|69120303|FG001|Overall Study|Withdrawn on day of randomization|1|||
37650730|NCT02000115|69120304|FG002|Overall Study|Withdrawn on day of randomization|0|||
37650731|NCT02000115|69120305|FG003|Overall Study|Withdrawn on day of randomization|0|||
37650732|NCT02000115|69120302|FG000|Overall Study|Still on Study|0|||
37650733|NCT02000115|69120303|FG001|Overall Study|Still on Study|0|||
37650734|NCT02000115|69120304|FG002|Overall Study|Still on Study|0|||
37650735|NCT02000115|69120305|FG003|Overall Study|Still on Study|53|||
37650736|NCT01844505|69120322|FG000|Overall Study|Disease progression|170|||
37855181|NCT01225731|69538430|FG007|Part 2|Withdrawal by Subject|4|||
37855182|NCT01225731|69538431|FG008|Part 2|Withdrawal by Subject|1|||
37650737|NCT01844505|69120323|FG001|Overall Study|Disease progression|88|||
37650738|NCT01844505|69120324|FG002|Overall Study|Disease progression|224|||
37650739|NCT01844505|69120322|FG000|Overall Study|Study drug toxicity|40|||
37650740|NCT01844505|69120323|FG001|Overall Study|Study drug toxicity|131|||
37650741|NCT01844505|69120324|FG002|Overall Study|Study drug toxicity|50|||
37650742|NCT01844505|69120322|FG000|Overall Study|Death|1|||
37650743|NCT01844505|69120323|FG001|Overall Study|Death|3|||
37650744|NCT01844505|69120324|FG002|Overall Study|Death|1|||
37650745|NCT01844505|69120322|FG000|Overall Study|Adverse event unrelated to study drug|7|||
37650746|NCT01844505|69120323|FG001|Overall Study|Adverse event unrelated to study drug|15|||
37650747|NCT01844505|69120324|FG002|Overall Study|Adverse event unrelated to study drug|6|||
37650748|NCT01844505|69120322|FG000|Overall Study|Subject request discontinue treatment|17|||
37650749|NCT01844505|69120323|FG001|Overall Study|Subject request discontinue treatment|14|||
37650750|NCT01844505|69120324|FG002|Overall Study|Subject request discontinue treatment|8|||
37650751|NCT01844505|69120322|FG000|Overall Study|Withdrawal by Subject|0|||
37650752|NCT01844505|69120323|FG001|Overall Study|Withdrawal by Subject|3|||
37855183|NCT01225731|69538432|FG009|Part 2|Withdrawal by Subject|0|||
37855184|NCT01225731|69538433|FG010|Part 2|Withdrawal by Subject|0|||
37855185|NCT01225731|69538434|FG011|Part 2|Withdrawal by Subject|0|||
37855186|NCT01225731|69538435|FG012|Part 2|Withdrawal by Subject|0|||
37855187|NCT01225731|69538423|FG000|Part 3|Adverse Event|0|||
37855188|NCT01225731|69538424|FG001|Part 3|Adverse Event|0|||
37855189|NCT01225731|69538425|FG002|Part 3|Adverse Event|0|||
37855190|NCT01225731|69538426|FG003|Part 3|Adverse Event|0|||
37855191|NCT01225731|69538427|FG004|Part 3|Adverse Event|0|||
37855192|NCT01225731|69538428|FG005|Part 3|Adverse Event|0|||
37650753|NCT01844505|69120324|FG002|Overall Study|Withdrawal by Subject|0|||
37650754|NCT01844505|69120322|FG000|Overall Study|Lost to Follow-up|1|||
37650755|NCT01844505|69120323|FG001|Overall Study|Lost to Follow-up|0|||
37650756|NCT01844505|69120324|FG002|Overall Study|Lost to Follow-up|0|||
37650757|NCT01844505|69120322|FG000|Overall Study|Maximum clinical benefit|8|||
37650758|NCT01844505|69120323|FG001|Overall Study|Maximum clinical benefit|11|||
37650759|NCT01844505|69120324|FG002|Overall Study|Maximum clinical benefit|2|||
37650760|NCT01844505|69120322|FG000|Overall Study|Poor/non-compliance|1|||
37650761|NCT01844505|69120323|FG001|Overall Study|Poor/non-compliance|1|||
37650762|NCT01844505|69120324|FG002|Overall Study|Poor/non-compliance|1|||
37650763|NCT01844505|69120322|FG000|Overall Study|Subject no longer meets criteria|0|||
37650764|NCT01844505|69120323|FG001|Overall Study|Subject no longer meets criteria|1|||
37650765|NCT01844505|69120324|FG002|Overall Study|Subject no longer meets criteria|0|||
37650766|NCT01844505|69120322|FG000|Overall Study|Other Reasons|4|||
37650767|NCT01844505|69120323|FG001|Overall Study|Other Reasons|2|||
37650768|NCT01844505|69120324|FG002|Overall Study|Other Reasons|2|||
37650769|NCT01844505|69120322|FG000|Overall Study|Not Reported|0|||
37650770|NCT01844505|69120323|FG001|Overall Study|Not Reported|0|||
37650771|NCT01844505|69120324|FG002|Overall Study|Not Reported|1|||
37650793|NCT01371981|69120367|FG000|Overall Study|Adverse Event|12|||
37650794|NCT01371981|69120368|FG001|Overall Study|Adverse Event|17|||
37650795|NCT01371981|69120369|FG002|Overall Study|Adverse Event|0|||
37650796|NCT01371981|69120370|FG003|Overall Study|Adverse Event|4|||
37650797|NCT01371981|69120371|FG004|Overall Study|Adverse Event|1|||
37650798|NCT01371981|69120372|FG005|Overall Study|Adverse Event|0|||
37650799|NCT01371981|69120367|FG000|Overall Study|Death|22|||
37650800|NCT01371981|69120368|FG001|Overall Study|Death|16|||
37650801|NCT01371981|69120369|FG002|Overall Study|Death|0|||
37650802|NCT01371981|69120370|FG003|Overall Study|Death|0|||
37650803|NCT01371981|69120371|FG004|Overall Study|Death|2|||
37650804|NCT01371981|69120372|FG005|Overall Study|Death|2|||
37650805|NCT01371981|69120367|FG000|Overall Study|Lack of Efficacy|69|||
37650806|NCT01371981|69120368|FG001|Overall Study|Lack of Efficacy|61|||
37650807|NCT01371981|69120369|FG002|Overall Study|Lack of Efficacy|4|||
37650808|NCT01371981|69120370|FG003|Overall Study|Lack of Efficacy|8|||
37650809|NCT01371981|69120371|FG004|Overall Study|Lack of Efficacy|5|||
37650810|NCT01371981|69120372|FG005|Overall Study|Lack of Efficacy|0|||
37650811|NCT01371981|69120367|FG000|Overall Study|Physician Decision|48|||
37650812|NCT01371981|69120368|FG001|Overall Study|Physician Decision|63|||
37650813|NCT01371981|69120369|FG002|Overall Study|Physician Decision|1|||
37650814|NCT01371981|69120370|FG003|Overall Study|Physician Decision|7|||
37650815|NCT01371981|69120371|FG004|Overall Study|Physician Decision|14|||
37650816|NCT01371981|69120372|FG005|Overall Study|Physician Decision|3|||
37650817|NCT01371981|69120367|FG000|Overall Study|Withdrawal by Subject|12|||
37650818|NCT01371981|69120368|FG001|Overall Study|Withdrawal by Subject|19|||
37650819|NCT01371981|69120369|FG002|Overall Study|Withdrawal by Subject|1|||
37650820|NCT01371981|69120370|FG003|Overall Study|Withdrawal by Subject|2|||
37650821|NCT01371981|69120371|FG004|Overall Study|Withdrawal by Subject|10|||
37650822|NCT01371981|69120372|FG005|Overall Study|Withdrawal by Subject|3|||
37650823|NCT01371981|69120367|FG000|Overall Study|Ineligible|19|||
37650824|NCT01371981|69120368|FG001|Overall Study|Ineligible|13|||
37650825|NCT01371981|69120369|FG002|Overall Study|Ineligible|0|||
37650826|NCT01371981|69120370|FG003|Overall Study|Ineligible|0|||
37650827|NCT01371981|69120371|FG004|Overall Study|Ineligible|0|||
37650828|NCT01371981|69120372|FG005|Overall Study|Ineligible|4|||
37650829|NCT01371981|69120367|FG000|Overall Study|Did not start treatment|2|||
37650830|NCT01371981|69120368|FG001|Overall Study|Did not start treatment|3|||
37650831|NCT01371981|69120369|FG002|Overall Study|Did not start treatment|0|||
37650832|NCT01371981|69120370|FG003|Overall Study|Did not start treatment|0|||
37650833|NCT01371981|69120371|FG004|Overall Study|Did not start treatment|0|||
37650834|NCT01371981|69120372|FG005|Overall Study|Did not start treatment|2|||
37922566|NCT00873041|69609304|FG000|Core Study|Withdrawal by Subject|1|||
37922567|NCT00873041|69609305|FG001|Core Study|Withdrawal by Subject|2|||
37922568|NCT00873041|69609306|FG002|Core Study|Withdrawal by Subject|2|||
37650838|NCT00113360|69120413|FG000|Overall Study|Adverse Event|3|||
37650839|NCT00113360|69120413|FG000|Overall Study|Subject required surgery|1|||
37650840|NCT00113360|69120413|FG000|Overall Study|Did not meet eligibility criteria|3|||
37650841|NCT00087685|69120417|FG000|Overall Study|Adverse Event|5|||
37650842|NCT00087685|69120417|FG000|Overall Study|Non-Compliance|1|||
37650843|NCT00087685|69120417|FG000|Overall Study|Progressive Disease|5|||
37650844|NCT00087685|69120417|FG000|Overall Study|Withdrawal by Subject|3|||
37650845|NCT02610842|69120421|FG000|Overall Study|Lost to Follow-up|5|||
37650846|NCT01648582|69120430|FG000|Overall Study|Adverse Event|6|||
37650847|NCT01648582|69120431|FG001|Overall Study|Adverse Event|11|||
37650848|NCT01648582|69120432|FG002|Overall Study|Adverse Event|2|||
37650849|NCT01648582|69120430|FG000|Overall Study|Lost to Follow-up|9|||
37650850|NCT01648582|69120431|FG001|Overall Study|Lost to Follow-up|6|||
37650851|NCT01648582|69120432|FG002|Overall Study|Lost to Follow-up|8|||
37650852|NCT01648582|69120430|FG000|Overall Study|Protocol Violation|1|||
37650853|NCT01648582|69120431|FG001|Overall Study|Protocol Violation|2|||
37650854|NCT01648582|69120432|FG002|Overall Study|Protocol Violation|1|||
37650855|NCT01648582|69120430|FG000|Overall Study|Withdrawal by Subject|15|||
37650856|NCT01648582|69120431|FG001|Overall Study|Withdrawal by Subject|17|||
37650857|NCT01648582|69120432|FG002|Overall Study|Withdrawal by Subject|17|||
37650858|NCT01648582|69120430|FG000|Overall Study|Physician Decision|0|||
37650859|NCT01648582|69120431|FG001|Overall Study|Physician Decision|1|||
37922569|NCT00873041|69609304|FG000|Core Study|Lost to Follow-up|3|||
37922570|NCT00873041|69609305|FG001|Core Study|Lost to Follow-up|1|||
37922571|NCT00873041|69609306|FG002|Core Study|Lost to Follow-up|0|||
37922572|NCT00873041|69609304|FG000|Core Study|Abnormal laboratory value|0|||
37922573|NCT00873041|69609305|FG001|Core Study|Abnormal laboratory value|0|||
37922574|NCT00873041|69609306|FG002|Core Study|Abnormal laboratory value|1|||
37650860|NCT01648582|69120432|FG002|Overall Study|Physician Decision|3|||
37650861|NCT01648582|69120430|FG000|Overall Study|Death|1|||
37855193|NCT01225731|69538429|FG006|Part 3|Adverse Event|0|||
37855194|NCT01225731|69538430|FG007|Part 3|Adverse Event|0|||
37650862|NCT01648582|69120431|FG001|Overall Study|Death|0|||
37650863|NCT01648582|69120432|FG002|Overall Study|Death|0|||
37650864|NCT01648582|69120430|FG000|Overall Study|Sponsor Decision|0|||
37650865|NCT01648582|69120431|FG001|Overall Study|Sponsor Decision|1|||
37650866|NCT01648582|69120432|FG002|Overall Study|Sponsor Decision|1|||
37650867|NCT02607800|69120445|FG000|Overall Study|Lost to Follow-up|7|||
37650868|NCT02607800|69120446|FG001|Overall Study|Lost to Follow-up|10|||
37650869|NCT02607800|69120445|FG000|Overall Study|Withdrew Consent|2|||
37650870|NCT02607800|69120446|FG001|Overall Study|Withdrew Consent|0|||
37650871|NCT02607800|69120445|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
37650872|NCT02607800|69120446|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
37650873|NCT02304484|69120453|FG000|Overall Study|Death|9|||
37650874|NCT02304484|69120453|FG000|Overall Study|Withdrawal by Subject|14|||
37855195|NCT01225731|69538431|FG008|Part 3|Adverse Event|0|||
37855196|NCT01225731|69538432|FG009|Part 3|Adverse Event|0|||
37855197|NCT01225731|69538433|FG010|Part 3|Adverse Event|1|||
37855198|NCT01225731|69538434|FG011|Part 3|Adverse Event|1|||
37855199|NCT01225731|69538435|FG012|Part 3|Adverse Event|0|||
37855200|NCT01225731|69538423|FG000|Part 3|Lost to Follow-up|0|||
37855201|NCT01225731|69538424|FG001|Part 3|Lost to Follow-up|0|||
37855202|NCT01225731|69538425|FG002|Part 3|Lost to Follow-up|0|||
37855203|NCT01225731|69538426|FG003|Part 3|Lost to Follow-up|0|||
37855204|NCT01225731|69538427|FG004|Part 3|Lost to Follow-up|0|||
37855205|NCT01225731|69538428|FG005|Part 3|Lost to Follow-up|0|||
37855206|NCT01225731|69538429|FG006|Part 3|Lost to Follow-up|0|||
38032371|NCT02832622|69718274|FG000|Overall Study|Withdrawal by Subject|123|||
37650875|NCT02304484|69120453|FG000|Overall Study|Lost to Follow-up|2|||
37650876|NCT02708355|69120460|FG000|Overall Study|Adverse Event|1|||
37650877|NCT02708355|69120461|FG001|Overall Study|Adverse Event|0|||
37650878|NCT02708355|69120462|FG002|Overall Study|Adverse Event|0|||
37650879|NCT02708277|69120472|FG000|Overall Study|Lost to Follow-up|7|||
37650880|NCT02708277|69120473|FG001|Overall Study|Lost to Follow-up|4|||
37650881|NCT02337478|69120479|FG000|Overall Study|Lack of Efficacy|5|||
37650882|NCT02303704|69120485|FG000|Overall Study|Protocol Violation|5|||
37650883|NCT02303704|69120486|FG001|Overall Study|Protocol Violation|9|||
37650884|NCT02608892|69120494|FG000|Overall Study|Lost to Follow-up|1|||
37650885|NCT02608892|69120495|FG001|Overall Study|Lost to Follow-up|0|||
37650886|NCT02706951|69120505|FG000|Overall Study|Adverse Event|1|||
37650887|NCT02706951|69120506|FG001|Overall Study|Adverse Event|5|||
37650888|NCT02706951|69120507|FG002|Overall Study|Adverse Event|3|||
37855207|NCT01225731|69538430|FG007|Part 3|Lost to Follow-up|0|||
37855208|NCT01225731|69538431|FG008|Part 3|Lost to Follow-up|0|||
37855209|NCT01225731|69538432|FG009|Part 3|Lost to Follow-up|0|||
37922575|NCT00873041|69609304|FG000|Core Study|Protocol deviation|1|||
38032372|NCT02832622|69718274|FG000|Overall Study|Death|119|||
37650889|NCT02706951|69120505|FG000|Overall Study|Withdrawal by Subject|11|||
37650890|NCT02706951|69120506|FG001|Overall Study|Withdrawal by Subject|6|||
37650891|NCT02706951|69120507|FG002|Overall Study|Withdrawal by Subject|6|||
37650892|NCT02706951|69120505|FG000|Overall Study|Lost to Follow-up|0|||
37650893|NCT02706951|69120506|FG001|Overall Study|Lost to Follow-up|4|||
37650894|NCT02706951|69120507|FG002|Overall Study|Lost to Follow-up|1|||
37650895|NCT02706951|69120505|FG000|Overall Study|Other|2|||
37650896|NCT02706951|69120506|FG001|Overall Study|Other|1|||
37650897|NCT02706951|69120507|FG002|Overall Study|Other|0|||
37650898|NCT02708121|69120517|FG000|Overall Study|Withdrawn by Study Team|1|||
37650899|NCT02708121|69120518|FG001|Overall Study|Withdrawn by Study Team|1|||
37650900|NCT02708121|69120517|FG000|Overall Study|Withdrawal by Subject|0|||
37650901|NCT02708121|69120518|FG001|Overall Study|Withdrawal by Subject|4|||
37650902|NCT02707965|69120533|FG000|Overall Study|Withdrawal by Subject|0|||
37650903|NCT02707965|69120534|FG001|Overall Study|Withdrawal by Subject|0|||
37650904|NCT02707965|69120535|FG002|Overall Study|Withdrawal by Subject|1|||
37650905|NCT02707965|69120536|FG003|Overall Study|Withdrawal by Subject|0|||
37650906|NCT02707965|69120537|FG004|Overall Study|Withdrawal by Subject|0|||
37650907|NCT02707965|69120538|FG005|Overall Study|Withdrawal by Subject|0|||
37650908|NCT02707965|69120539|FG006|Overall Study|Withdrawal by Subject|0|||
37650909|NCT02707965|69120540|FG007|Overall Study|Withdrawal by Subject|2|||
37650910|NCT02707965|69120541|FG008|Overall Study|Withdrawal by Subject|0|||
37650911|NCT02707965|69120542|FG009|Overall Study|Withdrawal by Subject|0|||
37650912|NCT02707965|69120543|FG010|Overall Study|Withdrawal by Subject|0|||
37855210|NCT01225731|69538433|FG010|Part 3|Lost to Follow-up|1|||
37650913|NCT02707965|69120544|FG011|Overall Study|Withdrawal by Subject|0|||
37650914|NCT02707965|69120545|FG012|Overall Study|Withdrawal by Subject|0|||
37650915|NCT02707965|69120546|FG013|Overall Study|Withdrawal by Subject|0|||
37650916|NCT02707965|69120547|FG014|Overall Study|Withdrawal by Subject|0|||
37650917|NCT02707965|69120548|FG015|Overall Study|Withdrawal by Subject|0|||
37650918|NCT02707965|69120533|FG000|Overall Study|PI decisions|0|||
37650919|NCT02707965|69120534|FG001|Overall Study|PI decisions|0|||
37650920|NCT02707965|69120535|FG002|Overall Study|PI decisions|0|||
37650921|NCT02707965|69120536|FG003|Overall Study|PI decisions|0|||
37650922|NCT02707965|69120537|FG004|Overall Study|PI decisions|0|||
37650923|NCT02707965|69120538|FG005|Overall Study|PI decisions|0|||
37650924|NCT02707965|69120539|FG006|Overall Study|PI decisions|0|||
37650925|NCT02707965|69120540|FG007|Overall Study|PI decisions|0|||
37650926|NCT02707965|69120541|FG008|Overall Study|PI decisions|0|||
37650927|NCT02707965|69120542|FG009|Overall Study|PI decisions|0|||
37650928|NCT02707965|69120543|FG010|Overall Study|PI decisions|0|||
37650929|NCT02707965|69120544|FG011|Overall Study|PI decisions|0|||
37650930|NCT02707965|69120545|FG012|Overall Study|PI decisions|0|||
37650931|NCT02707965|69120546|FG013|Overall Study|PI decisions|0|||
37650932|NCT02707965|69120547|FG014|Overall Study|PI decisions|2|||
37650933|NCT02707965|69120548|FG015|Overall Study|PI decisions|0|||
37650934|NCT02707965|69120533|FG000|Overall Study|Protocol deviation|1|||
37650935|NCT02707965|69120534|FG001|Overall Study|Protocol deviation|1|||
37650936|NCT02707965|69120535|FG002|Overall Study|Protocol deviation|0|||
37650937|NCT02707965|69120536|FG003|Overall Study|Protocol deviation|0|||
37650938|NCT02707965|69120537|FG004|Overall Study|Protocol deviation|0|||
37650939|NCT02707965|69120538|FG005|Overall Study|Protocol deviation|0|||
37650940|NCT02707965|69120539|FG006|Overall Study|Protocol deviation|0|||
37650941|NCT02707965|69120540|FG007|Overall Study|Protocol deviation|1|||
37650942|NCT02707965|69120541|FG008|Overall Study|Protocol deviation|0|||
37650943|NCT02707965|69120542|FG009|Overall Study|Protocol deviation|0|||
37650944|NCT02707965|69120543|FG010|Overall Study|Protocol deviation|0|||
37650945|NCT02707965|69120544|FG011|Overall Study|Protocol deviation|0|||
37650946|NCT02707965|69120545|FG012|Overall Study|Protocol deviation|0|||
37650947|NCT02707965|69120546|FG013|Overall Study|Protocol deviation|0|||
37650948|NCT02707965|69120547|FG014|Overall Study|Protocol deviation|0|||
37650949|NCT02707965|69120548|FG015|Overall Study|Protocol deviation|0|||
37855211|NCT01225731|69538434|FG011|Part 3|Lost to Follow-up|2|||
37855212|NCT01225731|69538435|FG012|Part 3|Lost to Follow-up|1|||
37650950|NCT01667900|69120586|FG000|Part B|Death|0|||
37650951|NCT01667900|69120587|FG001|Part B|Death|0|||
37650952|NCT01667900|69120588|FG002|Part B|Death|0|||
37650953|NCT01667900|69120589|FG003|Part B|Death|0|||
37855213|NCT01225731|69538423|FG000|Part 3|Physician Decision|0|||
37650954|NCT01667900|69120590|FG004|Part B|Death|0|||
37650955|NCT01667900|69120591|FG005|Part B|Death|0|||
37855214|NCT01225731|69538424|FG001|Part 3|Physician Decision|0|||
37650956|NCT01667900|69120592|FG006|Part B|Death|0|||
37650957|NCT01667900|69120593|FG007|Part B|Death|0|||
37650958|NCT01667900|69120594|FG008|Part B|Death|0|||
37650959|NCT01667900|69120595|FG009|Part B|Death|0|||
37650960|NCT01667900|69120596|FG010|Part B|Death|0|||
37650961|NCT01667900|69120597|FG011|Part B|Death|0|||
37650962|NCT01667900|69120598|FG012|Part B|Death|0|||
37650963|NCT01667900|69120599|FG013|Part B|Death|0|||
37650964|NCT01667900|69120600|FG014|Part B|Death|0|||
37650965|NCT01667900|69120601|FG015|Part B|Death|0|||
37855215|NCT01225731|69538425|FG002|Part 3|Physician Decision|0|||
37650966|NCT01667900|69120602|FG016|Part B|Death|1|||
37650967|NCT01667900|69120603|FG017|Part B|Death|0|||
37650968|NCT01667900|69120604|FG018|Part B|Death|0|||
37650969|NCT01667900|69120605|FG019|Part B|Death|0|||
37650970|NCT02605928|69120634|FG000|Overall Study|Model tuning phase|28|||
37650971|NCT02605928|69120634|FG000|Overall Study|Lack of Efficacy|5|||
37650972|NCT02706717|69120640|FG000|Overall Study|Withdrawal by Subject|1|||
37650973|NCT02706717|69120641|FG001|Overall Study|Withdrawal by Subject|8|||
37650974|NCT02706717|69120640|FG000|Overall Study|Lost to Follow-up|0|||
37650975|NCT02706717|69120641|FG001|Overall Study|Lost to Follow-up|1|||
37650976|NCT02706717|69120640|FG000|Overall Study|Physician Decision|0|||
37650977|NCT02706717|69120641|FG001|Overall Study|Physician Decision|1|||
37650978|NCT02706717|69120640|FG000|Overall Study|Death|0|||
37650979|NCT02706717|69120641|FG001|Overall Study|Death|1|||
37650980|NCT01331837|69120649|FG000|Overall Study|Death|30|||
37650981|NCT01331837|69120650|FG001|Overall Study|Death|34|||
37650982|NCT01331837|69120649|FG000|Overall Study|Lost to Follow-up|3|||
37650983|NCT01331837|69120650|FG001|Overall Study|Lost to Follow-up|1|||
37650984|NCT01331837|69120649|FG000|Overall Study|Info not recorded|10|||
37650985|NCT01331837|69120650|FG001|Overall Study|Info not recorded|16|||
37650986|NCT01331837|69120649|FG000|Overall Study|Withdrawal by Subject|13|||
37650987|NCT01331837|69120650|FG001|Overall Study|Withdrawal by Subject|16|||
37650988|NCT02706483|69120656|FG000|Overall Study|Adverse Event|97|||
37650989|NCT02706483|69120656|FG000|Overall Study|Death|1|||
37650990|NCT02706483|69120656|FG000|Overall Study|Lack of Efficacy|39|||
37650991|NCT02706483|69120656|FG000|Overall Study|Lost to Follow-up|101|||
37650992|NCT02706483|69120656|FG000|Overall Study|Non-compliance with study drug|15|||
37650993|NCT02706483|69120656|FG000|Overall Study|Physician Decision|6|||
37650994|NCT02706483|69120656|FG000|Overall Study|Pregnancy|6|||
37650995|NCT02706483|69120656|FG000|Overall Study|Protocol Violation|18|||
37650996|NCT02706483|69120656|FG000|Overall Study|Withdrawal by Subject|136|||
37650997|NCT02706483|69120656|FG000|Overall Study|Non-compliance with visits|6|||
37650998|NCT02706483|69120656|FG000|Overall Study|Site closure|4|||
37650999|NCT02706483|69120656|FG000|Overall Study|Subject moved|1|||
37651000|NCT01648348|69120663|FG000|Overall Study|Cancel|1|||
37651001|NCT01648348|69120664|FG001|Overall Study|Cancel|0|||
37651002|NCT01648348|69120665|FG002|Overall Study|Cancel|0|||
37651003|NCT01648348|69120666|FG003|Overall Study|Cancel|0|||
37651004|NCT01648348|69120667|FG004|Overall Study|Cancel|3|||
37651005|NCT01648348|69120668|FG005|Overall Study|Cancel|6|||
37651006|NCT01648348|69120663|FG000|Overall Study|Replaced for MTD analysis|1|||
37651007|NCT01648348|69120664|FG001|Overall Study|Replaced for MTD analysis|0|||
37651008|NCT01648348|69120665|FG002|Overall Study|Replaced for MTD analysis|1|||
37651009|NCT01648348|69120666|FG003|Overall Study|Replaced for MTD analysis|0|||
37651010|NCT01648348|69120667|FG004|Overall Study|Replaced for MTD analysis|0|||
37651011|NCT01648348|69120668|FG005|Overall Study|Replaced for MTD analysis|0|||
37651012|NCT01648270|69120681|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
37651013|NCT02302846|69120691|FG000|Overall Study|Withdrawal by Subject|1|||
37651014|NCT02336230|69120695|FG000|Overall Study|Adverse Event|1|||
37651015|NCT02336230|69120695|FG000|Overall Study|Withdrawal of consent|1|||
37651016|NCT02336230|69120695|FG000|Overall Study|Death|9|||
37651017|NCT02336230|69120695|FG000|Overall Study|Dose not received due to shipping delay|1|||
37651018|NCT02336230|69120695|FG000|Overall Study|Discontinuation of MSC infusion|1|||
37651019|NCT02302222|69120701|FG000|Overall Study|Physician Decision|0|||
37651020|NCT02302222|69120702|FG001|Overall Study|Physician Decision|4|||
37651021|NCT02302222|69120701|FG000|Overall Study|Lost to Follow-up|1|||
37651022|NCT02302222|69120702|FG001|Overall Study|Lost to Follow-up|0|||
37651023|NCT02302222|69120701|FG000|Overall Study|Treatment discontinued before day 5|0|||
37651024|NCT02302222|69120702|FG001|Overall Study|Treatment discontinued before day 5|1|||
37922576|NCT00873041|69609305|FG001|Core Study|Protocol deviation|0|||
37651025|NCT02302222|69120701|FG000|Overall Study|Withdrawn prior to any treatment|0|||
37651026|NCT02302222|69120702|FG001|Overall Study|Withdrawn prior to any treatment|1|||
37651027|NCT02335450|69120708|FG000|Overall Study|Pregnancy|1|||
37651028|NCT02302066|69120722|FG000|Overall Study|Adverse Event|1|||
37651029|NCT02302066|69120723|FG001|Overall Study|Adverse Event|1|||
37651030|NCT02302066|69120724|FG002|Overall Study|Adverse Event|3|||
37651031|NCT02302066|69120725|FG003|Overall Study|Adverse Event|0|||
37651032|NCT02302066|69120722|FG000|Overall Study|Lost to Follow-up|4|||
37651033|NCT02302066|69120723|FG001|Overall Study|Lost to Follow-up|5|||
37651034|NCT02302066|69120724|FG002|Overall Study|Lost to Follow-up|24|||
37651035|NCT02302066|69120725|FG003|Overall Study|Lost to Follow-up|7|||
37651036|NCT02302066|69120722|FG000|Overall Study|Withdrawal by Subject|25|||
37651037|NCT02302066|69120723|FG001|Overall Study|Withdrawal by Subject|58|||
37651038|NCT02302066|69120724|FG002|Overall Study|Withdrawal by Subject|124|||
37651039|NCT02302066|69120725|FG003|Overall Study|Withdrawal by Subject|33|||
37651040|NCT02302066|69120722|FG000|Overall Study|Pregnancy|2|||
37651041|NCT02302066|69120723|FG001|Overall Study|Pregnancy|10|||
37651042|NCT02302066|69120724|FG002|Overall Study|Pregnancy|12|||
37651043|NCT02302066|69120725|FG003|Overall Study|Pregnancy|0|||
37651044|NCT02302066|69120722|FG000|Overall Study|Reason Not Specified|1|||
37651045|NCT02302066|69120723|FG001|Overall Study|Reason Not Specified|1|||
37651046|NCT02302066|69120724|FG002|Overall Study|Reason Not Specified|9|||
37651047|NCT02302066|69120725|FG003|Overall Study|Reason Not Specified|1|||
37651048|NCT02301988|69120747|FG000|Overall Study|Withdrawal by Subject|2|||
37651049|NCT02301988|69120748|FG001|Overall Study|Withdrawal by Subject|1|||
37651050|NCT02301988|69120747|FG000|Overall Study|Physician Decision|2|||
37651051|NCT02301988|69120748|FG001|Overall Study|Physician Decision|2|||
37651052|NCT02301988|69120747|FG000|Overall Study|Unknown Reason|1|||
37651053|NCT02301988|69120748|FG001|Overall Study|Unknown Reason|3|||
37651054|NCT02301988|69120747|FG000|Overall Study|Lack of Efficacy|3|||
37651055|NCT02301988|69120748|FG001|Overall Study|Lack of Efficacy|2|||
37651056|NCT02301988|69120747|FG000|Overall Study|Death|1|||
37651057|NCT02301988|69120748|FG001|Overall Study|Death|0|||
37651058|NCT02301988|69120747|FG000|Overall Study|Adverse Event|1|||
37651059|NCT02301988|69120748|FG001|Overall Study|Adverse Event|1|||
37651060|NCT02334748|69120763|FG000|Overall Study|Adverse Event|1|||
37651061|NCT02334748|69120763|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
37651062|NCT02334748|69120763|FG000|Overall Study|Patient no longer required study drug|2|||
37651063|NCT02334748|69120763|FG000|Overall Study|Lack of Efficacy|4|||
37651064|NCT02332876|69120769|FG000|Overall Study|Lost to Follow-up|1|||
37651065|NCT02332876|69120770|FG001|Overall Study|Lost to Follow-up|1|||
37651066|NCT02332798|69120779|FG000|Overall Study|Unwilling to Participate in Study|0|||
37651067|NCT02332798|69120780|FG001|Overall Study|Unwilling to Participate in Study|1|||
37651068|NCT02332798|69120781|FG002|Overall Study|Unwilling to Participate in Study|1|||
37651069|NCT02332798|69120779|FG000|Overall Study|Positive Urine Drug Test|0|||
37651070|NCT02332798|69120780|FG001|Overall Study|Positive Urine Drug Test|1|||
37651071|NCT02332798|69120781|FG002|Overall Study|Positive Urine Drug Test|0|||
37651072|NCT02332798|69120779|FG000|Overall Study|Abnormal Laboratory Findings|1|||
37651073|NCT02332798|69120780|FG001|Overall Study|Abnormal Laboratory Findings|0|||
37651074|NCT02332798|69120781|FG002|Overall Study|Abnormal Laboratory Findings|0|||
37651075|NCT02790437|69120791|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
37651076|NCT02790437|69120792|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
37651077|NCT02790437|69120791|FG000|Overall Study|Adverse Event|1|||
37651078|NCT02790437|69120792|FG001|Overall Study|Adverse Event|0|||
37651079|NCT02790437|69120791|FG000|Overall Study|Withdrawal by Subject|1|||
37651080|NCT02790437|69120792|FG001|Overall Study|Withdrawal by Subject|0|||
37651081|NCT02604212|69120809|FG000|Overall Study|Study Terminated by Sponsor|2|||
37651082|NCT02604212|69120810|FG001|Overall Study|Study Terminated by Sponsor|1|||
37741980|NCT04515147|69228228|FG002|Overall Study|Miscellaneous|0|||
37651083|NCT02604212|69120811|FG002|Overall Study|Study Terminated by Sponsor|3|||
37651084|NCT02604212|69120812|FG003|Overall Study|Study Terminated by Sponsor|3|||
37651085|NCT02604212|69120809|FG000|Overall Study|Withdrawal by Subject|0|||
37651086|NCT02604212|69120810|FG001|Overall Study|Withdrawal by Subject|0|||
37651087|NCT02604212|69120811|FG002|Overall Study|Withdrawal by Subject|1|||
37651088|NCT02604212|69120812|FG003|Overall Study|Withdrawal by Subject|0|||
37651089|NCT02789111|69120829|FG000|Overall Study|Withdrawal by Subject|1|||
37651090|NCT02789111|69120830|FG001|Overall Study|Withdrawal by Subject|4|||
37651091|NCT01359644|69120848|FG000|Treatment Period|Lack of Efficacy|0|||
37651092|NCT01359644|69120849|FG001|Treatment Period|Lack of Efficacy|1|||
37651093|NCT01359644|69120850|FG002|Treatment Period|Lack of Efficacy|0|||
37651094|NCT01359644|69120851|FG003|Treatment Period|Lack of Efficacy|0|||
37651095|NCT01359644|69120852|FG004|Treatment Period|Lack of Efficacy|0|||
37651096|NCT01359644|69120853|FG005|Treatment Period|Lack of Efficacy|0|||
37741981|NCT04515147|69228229|FG003|Overall Study|Miscellaneous|1|||
37741982|NCT04515147|69228230|FG004|Overall Study|Miscellaneous|0|||
37741983|NCT04515147|69228231|FG005|Overall Study|Miscellaneous|1|||
37741984|NCT04479618|69228253|FG000|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
37855216|NCT01225731|69538426|FG003|Part 3|Physician Decision|0|||
37855217|NCT01225731|69538427|FG004|Part 3|Physician Decision|0|||
37651097|NCT01359644|69120854|FG006|Treatment Period|Lack of Efficacy|0|||
37651098|NCT01359644|69120855|FG007|Treatment Period|Lack of Efficacy|0|||
37651099|NCT01359644|69120856|FG008|Treatment Period|Lack of Efficacy|0|||
37651100|NCT01359644|69120857|FG009|Treatment Period|Lack of Efficacy|0|||
37651101|NCT01359644|69120848|FG000|Treatment Period|Adverse Event|0|||
37651102|NCT01359644|69120849|FG001|Treatment Period|Adverse Event|0|||
37651103|NCT01359644|69120850|FG002|Treatment Period|Adverse Event|1|||
37651104|NCT01359644|69120851|FG003|Treatment Period|Adverse Event|0|||
37651105|NCT01359644|69120852|FG004|Treatment Period|Adverse Event|0|||
37651106|NCT01359644|69120853|FG005|Treatment Period|Adverse Event|1|||
37651107|NCT01359644|69120854|FG006|Treatment Period|Adverse Event|0|||
37855218|NCT01225731|69538428|FG005|Part 3|Physician Decision|0|||
37651108|NCT01359644|69120855|FG007|Treatment Period|Adverse Event|0|||
37651109|NCT01359644|69120856|FG008|Treatment Period|Adverse Event|0|||
37651110|NCT01359644|69120857|FG009|Treatment Period|Adverse Event|0|||
37651111|NCT01359644|69120848|FG000|Treatment Period|Lost to Follow-up|0|||
37651112|NCT01359644|69120849|FG001|Treatment Period|Lost to Follow-up|0|||
37651113|NCT01359644|69120850|FG002|Treatment Period|Lost to Follow-up|0|||
37651114|NCT01359644|69120851|FG003|Treatment Period|Lost to Follow-up|0|||
37651115|NCT01359644|69120852|FG004|Treatment Period|Lost to Follow-up|0|||
37651116|NCT01359644|69120853|FG005|Treatment Period|Lost to Follow-up|1|||
37651117|NCT01359644|69120854|FG006|Treatment Period|Lost to Follow-up|0|||
37651118|NCT01359644|69120855|FG007|Treatment Period|Lost to Follow-up|0|||
37651119|NCT01359644|69120856|FG008|Treatment Period|Lost to Follow-up|0|||
37651120|NCT01359644|69120857|FG009|Treatment Period|Lost to Follow-up|0|||
37651121|NCT01359644|69120848|FG000|Follow-up Period|Withdrawal by Subject|0|||
37651122|NCT01359644|69120849|FG001|Follow-up Period|Withdrawal by Subject|0|||
37651123|NCT01359644|69120850|FG002|Follow-up Period|Withdrawal by Subject|0|||
37651124|NCT01359644|69120851|FG003|Follow-up Period|Withdrawal by Subject|0|||
37651125|NCT01359644|69120852|FG004|Follow-up Period|Withdrawal by Subject|0|||
37651126|NCT01359644|69120853|FG005|Follow-up Period|Withdrawal by Subject|1|||
37651127|NCT01359644|69120854|FG006|Follow-up Period|Withdrawal by Subject|0|||
37651128|NCT01359644|69120855|FG007|Follow-up Period|Withdrawal by Subject|0|||
37651129|NCT01359644|69120856|FG008|Follow-up Period|Withdrawal by Subject|0|||
37651130|NCT01359644|69120857|FG009|Follow-up Period|Withdrawal by Subject|0|||
37651131|NCT01359644|69120848|FG000|Follow-up Period|Lost to Follow-up|0|||
37651132|NCT01359644|69120849|FG001|Follow-up Period|Lost to Follow-up|0|||
37651133|NCT01359644|69120850|FG002|Follow-up Period|Lost to Follow-up|0|||
37651134|NCT01359644|69120851|FG003|Follow-up Period|Lost to Follow-up|0|||
37651135|NCT01359644|69120852|FG004|Follow-up Period|Lost to Follow-up|0|||
37651136|NCT01359644|69120853|FG005|Follow-up Period|Lost to Follow-up|0|||
37651137|NCT01359644|69120854|FG006|Follow-up Period|Lost to Follow-up|1|||
37651138|NCT01359644|69120855|FG007|Follow-up Period|Lost to Follow-up|2|||
37651139|NCT01359644|69120856|FG008|Follow-up Period|Lost to Follow-up|0|||
37651140|NCT01359644|69120857|FG009|Follow-up Period|Lost to Follow-up|0|||
37651141|NCT02603120|69120892|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
37651142|NCT02603120|69120893|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
37651143|NCT02603120|69120892|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
37651144|NCT02603120|69120893|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
37651145|NCT02603120|69120892|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
37651146|NCT02603120|69120893|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
37651147|NCT02603120|69120892|FG000|Double-Blind Treatment Phase|Death|2|||
37651148|NCT02603120|69120893|FG001|Double-Blind Treatment Phase|Death|0|||
37651149|NCT02603120|69120892|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
37651150|NCT02603120|69120893|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
37651151|NCT02603120|69120892|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
37651152|NCT02603120|69120893|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
37651153|NCT02603120|69120892|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
37651154|NCT02603120|69120893|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
37651155|NCT02603120|69120892|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
37651156|NCT02603120|69120893|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
37651157|NCT02603120|69120892|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
37651158|NCT02603120|69120893|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
37651159|NCT02603120|69120892|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
37651160|NCT02603120|69120893|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
37651161|NCT02603120|69120892|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
37651162|NCT02603120|69120893|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
37651163|NCT02603120|69120892|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
37651164|NCT02603120|69120893|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
37651165|NCT02603120|69120892|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
37651166|NCT02603120|69120893|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
37651167|NCT02603120|69120892|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
37651168|NCT02603120|69120893|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
37651169|NCT02599688|69120901|FG000|Overall Study|Lack of Efficacy|1|||
37651170|NCT02599688|69120901|FG000|Overall Study|Withdrawal by Subject|1|||
37651171|NCT02599688|69120901|FG000|Overall Study|Termination by Sponsor|2|||
38032373|NCT02832622|69718274|FG000|Overall Study|Unsuccessful CRT implant|93|||
38032374|NCT02832622|69718274|FG000|Overall Study|Lost to Follow-up|45|||
38032375|NCT02832622|69718274|FG000|Overall Study|Patient non-compliance|42|||
38032376|NCT02832622|69718274|FG000|Overall Study|Withdrawal by other reasons|25|||
38032377|NCT02832622|69718274|FG000|Overall Study|System explant|24|||
38032378|NCT02832622|69718274|FG000|Overall Study|Physician Decision|6|||
38032379|NCT00093015|69718281|FG000|Overall Study|Withdrawal by Subject|194|||
38032380|NCT00093015|69718282|FG001|Overall Study|Withdrawal by Subject|171|||
38032381|NCT00093015|69718281|FG000|Overall Study|Lost to Follow-up|96|||
38032382|NCT00093015|69718282|FG001|Overall Study|Lost to Follow-up|108|||
38032383|NCT00093015|69718281|FG000|Overall Study|Death|375|||
37741985|NCT04479618|69228254|FG001|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|0|||
37741986|NCT04479618|69228255|FG002|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
38032384|NCT00093015|69718282|FG001|Overall Study|Death|385|||
38032385|NCT03358238|69718290|FG000|Overall Study|Withdrawal by Subject|0|||
38032386|NCT03358238|69718291|FG001|Overall Study|Withdrawal by Subject|1|||
38032387|NCT03342638|69718303|FG000|Overall Study|Withdrawal by Subject|1|||
38032388|NCT03342638|69718304|FG001|Overall Study|Withdrawal by Subject|0|||
38032389|NCT03342638|69718303|FG000|Overall Study|Physician Decision|0|||
38032390|NCT03342638|69718304|FG001|Overall Study|Physician Decision|1|||
38032391|NCT03342560|69718310|FG000|Overall Study|Lost to Follow-up|2|||
38032392|NCT03355742|69718327|FG000|Overall Study|Lost to Follow-up|4|||
38032393|NCT03355742|69718327|FG000|Overall Study|Withdrawal by Subject|29|||
38032394|NCT03355742|69718327|FG000|Overall Study|Physician Decision|6|||
38032395|NCT03355742|69718327|FG000|Overall Study|Death|55|||
38032396|NCT03355742|69718327|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
38032397|NCT03341312|69718331|FG000|Period 1|Withdrawal by Subject|0|||
38032398|NCT03341312|69718332|FG001|Period 1|Withdrawal by Subject|1|||
38032399|NCT03341312|69718333|FG002|Period 1|Withdrawal by Subject|0|||
38032400|NCT03341312|69718334|FG003|Period 1|Withdrawal by Subject|0|||
38032401|NCT02949908|69718346|FG000|Overall Study|Study termination|2|||
38032402|NCT01358734|69718353|FG000|Overall Study|Adverse Event|4|||
38032403|NCT01358734|69718354|FG001|Overall Study|Adverse Event|7|||
38032404|NCT01358734|69718355|FG002|Overall Study|Adverse Event|3|||
38032405|NCT01358734|69718353|FG000|Overall Study|Lack of Efficacy|0|||
37651205|NCT01331291|69120920|FG000|Overall Study|Lack of Efficacy|2|||
37651206|NCT01331291|69120921|FG001|Overall Study|Lack of Efficacy|8|||
37651207|NCT01331291|69120920|FG000|Overall Study|Death|0|||
37651208|NCT01331291|69120921|FG001|Overall Study|Death|1|||
37651209|NCT02601560|69120934|FG000|Overall Study|Other|0|||
37651210|NCT02601560|69120935|FG001|Overall Study|Other|0|||
37651211|NCT02601560|69120936|FG002|Overall Study|Other|0|||
37741987|NCT04479618|69228253|FG000|Overall Study|Lack of Efficacy|1|||
37741988|NCT04479618|69228254|FG001|Overall Study|Lack of Efficacy|0|||
37741989|NCT04479618|69228255|FG002|Overall Study|Lack of Efficacy|0|||
37741990|NCT04479618|69228253|FG000|Overall Study|No reliable phone and unable to come in weekly|0|||
37741991|NCT04479618|69228254|FG001|Overall Study|No reliable phone and unable to come in weekly|1|||
37741992|NCT04479618|69228255|FG002|Overall Study|No reliable phone and unable to come in weekly|1|||
37741993|NCT04479618|69228253|FG000|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
37741994|NCT04479618|69228254|FG001|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
37741995|NCT04479618|69228255|FG002|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|1|||
37741996|NCT04479618|69228253|FG000|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
37741997|NCT04479618|69228254|FG001|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
37741998|NCT04479618|69228255|FG002|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|1|||
37741999|NCT04479618|69228253|FG000|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
37742000|NCT04479618|69228254|FG001|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
37742001|NCT04479618|69228255|FG002|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|1|||
37742002|NCT04476043|69228270|FG000|Overall Study|Withdrawal by Subject|1|||
37742003|NCT04476043|69228271|FG001|Overall Study|Withdrawal by Subject|3|||
37742004|NCT04476043|69228272|FG002|Overall Study|Withdrawal by Subject|4|||
37742005|NCT04476043|69228273|FG003|Overall Study|Withdrawal by Subject|1|||
37742006|NCT04476043|69228270|FG000|Overall Study|Lost to Follow-up|1|||
37742007|NCT04476043|69228271|FG001|Overall Study|Lost to Follow-up|1|||
37742008|NCT04476043|69228272|FG002|Overall Study|Lost to Follow-up|2|||
37742009|NCT04476043|69228273|FG003|Overall Study|Lost to Follow-up|1|||
37742010|NCT04476043|69228270|FG000|Overall Study|Adverse Event|2|||
37742011|NCT04476043|69228271|FG001|Overall Study|Adverse Event|0|||
37742012|NCT04476043|69228272|FG002|Overall Study|Adverse Event|1|||
37742013|NCT04476043|69228273|FG003|Overall Study|Adverse Event|0|||
37742014|NCT04476043|69228270|FG000|Overall Study|Protocol Violation|0|||
37742015|NCT04476043|69228271|FG001|Overall Study|Protocol Violation|1|||
37742016|NCT04476043|69228272|FG002|Overall Study|Protocol Violation|0|||
37742017|NCT04476043|69228273|FG003|Overall Study|Protocol Violation|0|||
37742018|NCT04418765|69228286|FG000|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
37742019|NCT04418765|69228287|FG001|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
37742020|NCT04418765|69228288|FG002|Placebo-controlled Period (24 Weeks)|Adverse Event|6|||
37742021|NCT04418765|69228286|FG000|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|1|||
37855219|NCT01225731|69538429|FG006|Part 3|Physician Decision|0|||
37855220|NCT01225731|69538430|FG007|Part 3|Physician Decision|0|||
37651212|NCT02601560|69120937|FG003|Overall Study|Other|0|||
37651213|NCT02601560|69120938|FG004|Overall Study|Other|0|||
37651214|NCT02601560|69120939|FG005|Overall Study|Other|0|||
37651215|NCT02601560|69120940|FG006|Overall Study|Other|1|||
37651216|NCT02601560|69120941|FG007|Overall Study|Other|0|||
37651217|NCT02595398|69120972|FG000|Overall Study|Non-compliance|1|||
37651218|NCT02595398|69120973|FG001|Overall Study|Non-compliance|0|||
37651219|NCT02595398|69120972|FG000|Overall Study|Withdrawal by Subject|2|||
37651220|NCT02595398|69120973|FG001|Overall Study|Withdrawal by Subject|1|||
37651221|NCT02595398|69120972|FG000|Overall Study|Lost to Follow-up|1|||
37651222|NCT02595398|69120973|FG001|Overall Study|Lost to Follow-up|0|||
37651223|NCT01368497|69120979|FG000|Overall Study|Lost to Follow-up|2|||
37651224|NCT02595008|69120985|FG000|Overall Study|Enrolled In Error|1|||
37651225|NCT02595008|69120986|FG001|Overall Study|Enrolled In Error|0|||
37651226|NCT02598128|69120992|FG000|Period A: Days -7 to -1|Adverse Event|1|||
37651227|NCT02598128|69120993|FG001|Period A: Days -7 to -1|Adverse Event|0|||
37651228|NCT02598128|69120994|FG002|Period A: Days -7 to -1|Adverse Event|0|||
37651229|NCT02598128|69120995|FG003|Period A: Days -7 to -1|Adverse Event|0|||
37651230|NCT02788175|69121007|FG000|Overall Study|Protocol Violation|3|||
37651231|NCT02788175|69121007|FG000|Overall Study|Withdrawal by Subject|4|||
37651232|NCT02788175|69121007|FG000|Overall Study|Ineligible prior to study agent|6|||
37651233|NCT02787083|69121013|FG000|Overall Study|Adverse Event|1|||
37651234|NCT02787083|69121014|FG001|Overall Study|Adverse Event|0|||
37651235|NCT02787083|69121013|FG000|Overall Study|Withdrawal by Subject|2|||
37651236|NCT02787083|69121014|FG001|Overall Study|Withdrawal by Subject|2|||
37651237|NCT02787863|69121028|FG000|Overall Study|Death|1|||
37651238|NCT02787863|69121029|FG001|Overall Study|Death|0|||
37651239|NCT02787863|69121030|FG002|Overall Study|Death|1|||
37651240|NCT02787863|69121031|FG003|Overall Study|Death|0|||
37651241|NCT02787863|69121032|FG004|Overall Study|Death|0|||
37651242|NCT02787863|69121033|FG005|Overall Study|Death|0|||
37651243|NCT02787863|69121034|FG006|Overall Study|Death|0|||
37651244|NCT02787863|69121035|FG007|Overall Study|Death|0|||
37651245|NCT02787863|69121028|FG000|Overall Study|Withdrawal by Subject|0|||
37651246|NCT02787863|69121029|FG001|Overall Study|Withdrawal by Subject|1|||
37651247|NCT02787863|69121030|FG002|Overall Study|Withdrawal by Subject|1|||
37651248|NCT02787863|69121031|FG003|Overall Study|Withdrawal by Subject|0|||
37651249|NCT02787863|69121032|FG004|Overall Study|Withdrawal by Subject|0|||
37651250|NCT02787863|69121033|FG005|Overall Study|Withdrawal by Subject|0|||
37651251|NCT02787863|69121034|FG006|Overall Study|Withdrawal by Subject|0|||
37651252|NCT02787863|69121035|FG007|Overall Study|Withdrawal by Subject|0|||
37651253|NCT02596958|69121076|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
37651254|NCT02596958|69121076|FG000|Overall Study|Cancer Progression|441|||
37651255|NCT02596958|69121076|FG000|Overall Study|Death From Cancer|112|||
37651256|NCT02596958|69121076|FG000|Overall Study|Death From Other Cause|33|||
37651257|NCT02596958|69121076|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
37651258|NCT02596958|69121076|FG000|Overall Study|Administrative Reasons/Other|231|||
37651259|NCT02596958|69121076|FG000|Overall Study|Lost to Follow-up|33|||
37651260|NCT02596958|69121076|FG000|Overall Study|Missing|32|||
37651261|NCT02596958|69121076|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
37651262|NCT01367249|69121082|FG000|Overall Study|Withdrawal by Subject|6|||
37651263|NCT01367249|69121083|FG001|Overall Study|Withdrawal by Subject|6|||
37742022|NCT04418765|69228287|FG001|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|3|||
37742023|NCT04418765|69228288|FG002|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|0|||
37742024|NCT04418765|69228286|FG000|Placebo-controlled Period (24 Weeks)|Protocol Violation|0|||
37742025|NCT04418765|69228287|FG001|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
37742026|NCT04418765|69228288|FG002|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
37742027|NCT04418765|69228286|FG000|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|1|||
37742028|NCT04418765|69228287|FG001|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|5|||
37742029|NCT04418765|69228288|FG002|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|2|||
37742030|NCT04418765|69228286|FG000|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
37742031|NCT04418765|69228287|FG001|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|1|||
37742032|NCT04418765|69228288|FG002|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
37742033|NCT04418765|69228286|FG000|Placebo-controlled Period (24 Weeks)|Other than specified|2|||
37742034|NCT04418765|69228287|FG001|Placebo-controlled Period (24 Weeks)|Other than specified|0|||
37742035|NCT04418765|69228288|FG002|Placebo-controlled Period (24 Weeks)|Other than specified|1|||
37742036|NCT04418765|69228286|FG000|Placebo-controlled Period (24 Weeks)|Randomized but not treated|1|||
37742037|NCT04418765|69228287|FG001|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
37651264|NCT01367249|69121082|FG000|Overall Study|Other|3|||
37651265|NCT01367249|69121083|FG001|Overall Study|Other|10|||
37651266|NCT02786927|69121089|FG000|Overall Study|Adverse Event|1|||
37651267|NCT02786927|69121089|FG000|Overall Study|Protocol Violation|4|||
37651268|NCT02592434|69121094|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
37651269|NCT02592434|69121095|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
37651270|NCT02592434|69121096|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
37651271|NCT02592434|69121094|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
37742038|NCT04418765|69228288|FG002|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
37651272|NCT02592434|69121095|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
37651273|NCT02592434|69121096|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
37651274|NCT02592434|69121094|FG000|Open-Label Phase (18 Weeks)|Other|3|||
37651275|NCT02592434|69121095|FG001|Open-Label Phase (18 Weeks)|Other|0|||
37651276|NCT02592434|69121096|FG002|Open-Label Phase (18 Weeks)|Other|0|||
37651277|NCT02592434|69121094|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
37651278|NCT02592434|69121095|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
37651279|NCT02592434|69121096|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
37651280|NCT02592434|69121094|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
37742039|NCT04418765|69228286|FG000|Extension Period (48 Weeks)|Adverse Event|0|||
37742040|NCT04418765|69228287|FG001|Extension Period (48 Weeks)|Adverse Event|2|||
37742041|NCT04418765|69228288|FG002|Extension Period (48 Weeks)|Adverse Event|9|||
37742042|NCT04418765|69228286|FG000|Extension Period (48 Weeks)|Lack of Efficacy|0|||
37742043|NCT04418765|69228287|FG001|Extension Period (48 Weeks)|Lack of Efficacy|13|||
37742044|NCT04418765|69228288|FG002|Extension Period (48 Weeks)|Lack of Efficacy|13|||
37742045|NCT04418765|69228286|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|0|||
37742046|NCT04418765|69228287|FG001|Extension Period (48 Weeks)|Withdrawal by Subject|21|||
37742047|NCT04418765|69228288|FG002|Extension Period (48 Weeks)|Withdrawal by Subject|14|||
37742048|NCT04418765|69228286|FG000|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
37742049|NCT04418765|69228287|FG001|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
37742050|NCT04418765|69228288|FG002|Extension Period (48 Weeks)|Non-compliance with study drug|2|||
37742051|NCT04418765|69228286|FG000|Extension Period (48 Weeks)|Protocol Violation|0|||
37742052|NCT04418765|69228287|FG001|Extension Period (48 Weeks)|Protocol Violation|0|||
37742053|NCT04418765|69228288|FG002|Extension Period (48 Weeks)|Protocol Violation|2|||
37742054|NCT04418765|69228286|FG000|Extension Period (48 Weeks)|Other than specified|0|||
37742055|NCT04418765|69228287|FG001|Extension Period (48 Weeks)|Other than specified|5|||
37742056|NCT04418765|69228288|FG002|Extension Period (48 Weeks)|Other than specified|2|||
37742057|NCT04359758|69228306|FG000|Overall Study|Protocol Violation|3|||
37742058|NCT04359758|69228307|FG001|Overall Study|Protocol Violation|2|||
37742059|NCT04266795|69228315|FG000|Overall Study|Adverse Event|10|||
37742060|NCT04266795|69228316|FG001|Overall Study|Adverse Event|19|||
37742061|NCT04266795|69228315|FG000|Overall Study|Death|7|||
37742062|NCT04266795|69228316|FG001|Overall Study|Death|8|||
37742063|NCT04266795|69228315|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|6|||
37742064|NCT04266795|69228316|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|2|||
37742065|NCT04266795|69228315|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
37742066|NCT04266795|69228316|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
37742067|NCT04266795|69228315|FG000|Overall Study|Progressive Disease|12|||
37742068|NCT04266795|69228316|FG001|Overall Study|Progressive Disease|9|||
37742069|NCT04266795|69228315|FG000|Overall Study|Withdrawal by Patient|5|||
37742070|NCT04266795|69228316|FG001|Overall Study|Withdrawal by Patient|6|||
37742071|NCT04266795|69228315|FG000|Overall Study|Disease Relapse|3|||
37742072|NCT04266795|69228316|FG001|Overall Study|Disease Relapse|6|||
37742073|NCT04266795|69228315|FG000|Overall Study|Reason not Specified|12|||
37742074|NCT04266795|69228316|FG001|Overall Study|Reason not Specified|10|||
37742075|NCT04266795|69228315|FG000|Overall Study|Participants Ongoing on Treatment|25|||
37742076|NCT04266795|69228316|FG001|Overall Study|Participants Ongoing on Treatment|23|||
37742077|NCT04212169|69228326|FG000|Overall Study|Adverse Event|0|||
37742078|NCT04212169|69228327|FG001|Overall Study|Adverse Event|0|||
37742079|NCT04212169|69228328|FG002|Overall Study|Adverse Event|0|||
37742080|NCT04212169|69228329|FG003|Overall Study|Adverse Event|2|||
37742081|NCT04212169|69228326|FG000|Overall Study|Lost to Follow-up|1|||
37742082|NCT04212169|69228327|FG001|Overall Study|Lost to Follow-up|0|||
37742083|NCT04212169|69228328|FG002|Overall Study|Lost to Follow-up|0|||
37742084|NCT04212169|69228329|FG003|Overall Study|Lost to Follow-up|2|||
37742085|NCT04212169|69228326|FG000|Overall Study|Withdrawal by Subject|10|||
37742086|NCT04212169|69228327|FG001|Overall Study|Withdrawal by Subject|2|||
37742087|NCT04212169|69228328|FG002|Overall Study|Withdrawal by Subject|5|||
37742088|NCT04212169|69228329|FG003|Overall Study|Withdrawal by Subject|7|||
37742089|NCT04212169|69228326|FG000|Overall Study|Other reason, unspecified|3|||
37742090|NCT04212169|69228327|FG001|Overall Study|Other reason, unspecified|1|||
37742091|NCT04212169|69228328|FG002|Overall Study|Other reason, unspecified|0|||
37742092|NCT04212169|69228329|FG003|Overall Study|Other reason, unspecified|2|||
37742093|NCT04109313|69228358|FG000|Overall Study|Pregnancy|1|||
37855221|NCT01225731|69538431|FG008|Part 3|Physician Decision|0|||
37651281|NCT02592434|69121095|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
37651282|NCT02592434|69121096|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
37651283|NCT02592434|69121094|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
37651284|NCT02592434|69121095|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
37651285|NCT02592434|69121096|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
37651286|NCT02592434|69121094|FG000|Double Blind Phase (26 Weeks)|Other|0|||
37651287|NCT02592434|69121095|FG001|Double Blind Phase (26 Weeks)|Other|1|||
37651288|NCT02592434|69121096|FG002|Double Blind Phase (26 Weeks)|Other|0|||
37651289|NCT02592434|69121094|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
37651290|NCT02592434|69121095|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
37651291|NCT02592434|69121096|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
37742094|NCT04109313|69228358|FG000|Overall Study|Adverse Event|11|||
37651292|NCT02592434|69121094|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
37651293|NCT02592434|69121095|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
37651294|NCT02592434|69121096|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
37651295|NCT02592434|69121094|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
37651296|NCT02592434|69121095|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
37651297|NCT02592434|69121096|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
37651298|NCT02785913|69121104|FG000|Overall Study|Adverse Event|5|||
37651299|NCT02785913|69121104|FG000|Overall Study|Death|2|||
37651300|NCT02785913|69121104|FG000|Overall Study|Progression|18|||
37651301|NCT02785913|69121104|FG000|Overall Study|Not protocol specified|1|||
37651302|NCT02590562|69121113|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
37651303|NCT02783729|69121140|FG000|Overall Study|Lack of Efficacy|1|||
37651304|NCT02783729|69121141|FG001|Overall Study|Lack of Efficacy|0|||
37651305|NCT02783729|69121142|FG002|Overall Study|Lack of Efficacy|0|||
37651306|NCT02783729|69121143|FG003|Overall Study|Lack of Efficacy|0|||
37651307|NCT02783729|69121140|FG000|Overall Study|Adverse Event|2|||
37742095|NCT04109313|69228358|FG000|Overall Study|Lack of Efficacy|11|||
37742096|NCT04109313|69228358|FG000|Overall Study|Lost to Follow-up|1|||
37742097|NCT04109313|69228358|FG000|Overall Study|Physician Decision|2|||
37742098|NCT04109313|69228358|FG000|Overall Study|Subject Decision|13|||
37742099|NCT04109313|69228358|FG000|Overall Study|Covid-19 situation|2|||
37742100|NCT04089865|69228367|FG000|Overall Study|Withdrawal by Subject|2|||
37742101|NCT04089865|69228368|FG001|Overall Study|Withdrawal by Subject|2|||
37742102|NCT04089865|69228369|FG002|Overall Study|Withdrawal by Subject|7|||
37742103|NCT04089865|69228370|FG003|Overall Study|Withdrawal by Subject|2|||
37742104|NCT04059484|69228382|FG000|Overall Study|Adverse Event|2|||
37742105|NCT04059484|69228383|FG001|Overall Study|Adverse Event|5|||
37742106|NCT04059484|69228382|FG000|Overall Study|Withdrawal by Subject|5|||
37855222|NCT01225731|69538432|FG009|Part 3|Physician Decision|0|||
37651308|NCT02783729|69121141|FG001|Overall Study|Adverse Event|6|||
37651309|NCT02783729|69121142|FG002|Overall Study|Adverse Event|2|||
37651310|NCT02783729|69121143|FG003|Overall Study|Adverse Event|3|||
37651311|NCT02783729|69121140|FG000|Overall Study|Other|1|||
37651312|NCT02783729|69121141|FG001|Overall Study|Other|6|||
37651313|NCT02783729|69121142|FG002|Overall Study|Other|2|||
37651314|NCT02783729|69121143|FG003|Overall Study|Other|3|||
37651315|NCT02783729|69121140|FG000|Overall Study|Withdrawal by Subject|2|||
37651316|NCT02783729|69121141|FG001|Overall Study|Withdrawal by Subject|3|||
37651317|NCT02783729|69121142|FG002|Overall Study|Withdrawal by Subject|1|||
37651318|NCT02783729|69121143|FG003|Overall Study|Withdrawal by Subject|2|||
37651319|NCT02783729|69121140|FG000|Overall Study|Participant's choice|2|||
37651320|NCT02783729|69121141|FG001|Overall Study|Participant's choice|1|||
37651321|NCT02783729|69121142|FG002|Overall Study|Participant's choice|2|||
37651322|NCT02783729|69121143|FG003|Overall Study|Participant's choice|1|||
37651323|NCT02783729|69121140|FG000|Overall Study|Lost to Follow-up|2|||
37651324|NCT02783729|69121141|FG001|Overall Study|Lost to Follow-up|1|||
37651325|NCT02783729|69121142|FG002|Overall Study|Lost to Follow-up|1|||
37651326|NCT02783729|69121143|FG003|Overall Study|Lost to Follow-up|0|||
37651327|NCT02784431|69121165|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
37651328|NCT02784431|69121165|FG000|Overall Study|Early Study Termination|19|||
37651329|NCT02590406|69121171|FG000|Overall Study|Adverse Event|1|||
37651330|NCT02590406|69121172|FG001|Overall Study|Adverse Event|0|||
37651331|NCT02590406|69121171|FG000|Overall Study|Saturometer malfunction|0|||
37651332|NCT02590406|69121172|FG001|Overall Study|Saturometer malfunction|1|||
37651333|NCT01359254|69121180|FG000|Overall Study|Death|1|||
37651334|NCT01359254|69121181|FG001|Overall Study|Death|0|||
37651335|NCT01667432|69121187|FG000|Overall Study|Premature Study Termination|26|||
37651336|NCT01667432|69121187|FG000|Overall Study|Failure to Return|10|||
37651337|NCT01667432|69121187|FG000|Overall Study|Moved to Another Center|3|||
37651338|NCT01667432|69121187|FG000|Overall Study|Lost to Follow-up|3|||
37651339|NCT01667432|69121187|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
37651340|NCT01667432|69121187|FG000|Overall Study|Insufficient Therapeutic Response|4|||
37651341|NCT01667432|69121187|FG000|Overall Study|Adverse Event|1|||
37651342|NCT01667432|69121187|FG000|Overall Study|Protocol Deviation|2|||
37651343|NCT01667432|69121187|FG000|Overall Study|Principal Investigator Decision|1|||
37651344|NCT01667432|69121187|FG000|Overall Study|Reason Not Specified|2|||
37651345|NCT01667432|69121187|FG000|Overall Study|Missing Information|4|||
37651346|NCT01563107|69121195|FG000|Overall Study|Physician Decision|0|||
37651347|NCT01563107|69121196|FG001|Overall Study|Physician Decision|1|||
37651348|NCT01563107|69121197|FG002|Overall Study|Physician Decision|1|||
37651349|NCT01563107|69121198|FG003|Overall Study|Physician Decision|3|||
37651350|NCT01563107|69121195|FG000|Overall Study|Withdrawal by Subject|1|||
37651351|NCT01563107|69121196|FG001|Overall Study|Withdrawal by Subject|2|||
37651352|NCT01563107|69121197|FG002|Overall Study|Withdrawal by Subject|1|||
37742107|NCT04059484|69228383|FG001|Overall Study|Withdrawal by Subject|3|||
37742108|NCT04059484|69228382|FG000|Overall Study|Progressive disease|112|||
37742109|NCT04059484|69228383|FG001|Overall Study|Progressive disease|112|||
37651353|NCT01563107|69121198|FG003|Overall Study|Withdrawal by Subject|2|||
37651354|NCT02589626|69121260|FG000|Overall Study|Other than the reason specified|1|||
37651355|NCT02589626|69121261|FG001|Overall Study|Other than the reason specified|0|||
37651356|NCT02589626|69121260|FG000|Overall Study|Withdrawal by Subject|1|||
37651357|NCT02589626|69121261|FG001|Overall Study|Withdrawal by Subject|1|||
37651358|NCT02589626|69121260|FG000|Overall Study|Adverse Event|1|||
37651359|NCT02589626|69121261|FG001|Overall Study|Adverse Event|1|||
37651360|NCT01666730|69121276|FG000|Overall Study|Adverse Event|16|||
37651361|NCT01666730|69121276|FG000|Overall Study|Death|2|||
37651362|NCT01666730|69121276|FG000|Overall Study|Physician Decision|5|||
37651363|NCT01666730|69121276|FG000|Overall Study|Withdrawal by Subject|9|||
37651364|NCT01666730|69121276|FG000|Overall Study|Disease progression/relapse|18|||
37651365|NCT00103285|69121289|FG000|Induction|Adverse Event|14|||
37651366|NCT00103285|69121290|FG001|Induction|Adverse Event|0|||
37651367|NCT00103285|69121291|FG002|Induction|Adverse Event|0|||
37651368|NCT00103285|69121292|FG003|Induction|Adverse Event|0|||
37651369|NCT00103285|69121293|FG004|Induction|Adverse Event|0|||
37651370|NCT00103285|69121294|FG005|Induction|Adverse Event|0|||
37651371|NCT00103285|69121295|FG006|Induction|Adverse Event|0|||
37651372|NCT00103285|69121296|FG007|Induction|Adverse Event|0|||
37651373|NCT00103285|69121289|FG000|Induction|Death|24|||
37651374|NCT00103285|69121290|FG001|Induction|Death|0|||
37651375|NCT00103285|69121291|FG002|Induction|Death|0|||
37651376|NCT00103285|69121292|FG003|Induction|Death|0|||
37651377|NCT00103285|69121293|FG004|Induction|Death|0|||
37651378|NCT00103285|69121294|FG005|Induction|Death|0|||
37651379|NCT00103285|69121295|FG006|Induction|Death|0|||
37651380|NCT00103285|69121296|FG007|Induction|Death|0|||
37651381|NCT00103285|69121289|FG000|Induction|Physician Decision|103|||
37651382|NCT00103285|69121290|FG001|Induction|Physician Decision|0|||
37651383|NCT00103285|69121291|FG002|Induction|Physician Decision|0|||
37651384|NCT00103285|69121292|FG003|Induction|Physician Decision|0|||
37651385|NCT00103285|69121293|FG004|Induction|Physician Decision|0|||
37651386|NCT00103285|69121294|FG005|Induction|Physician Decision|0|||
37651387|NCT00103285|69121295|FG006|Induction|Physician Decision|0|||
37651388|NCT00103285|69121296|FG007|Induction|Physician Decision|0|||
37651389|NCT00103285|69121289|FG000|Induction|Withdrawal by Subject|1|||
37651390|NCT00103285|69121290|FG001|Induction|Withdrawal by Subject|0|||
37651391|NCT00103285|69121291|FG002|Induction|Withdrawal by Subject|0|||
37651392|NCT00103285|69121292|FG003|Induction|Withdrawal by Subject|0|||
37651393|NCT00103285|69121293|FG004|Induction|Withdrawal by Subject|0|||
37651394|NCT00103285|69121294|FG005|Induction|Withdrawal by Subject|0|||
37651395|NCT00103285|69121295|FG006|Induction|Withdrawal by Subject|0|||
37651396|NCT00103285|69121296|FG007|Induction|Withdrawal by Subject|0|||
37651397|NCT00103285|69121289|FG000|Induction|Ineligible|43|||
37651398|NCT00103285|69121290|FG001|Induction|Ineligible|0|||
37651399|NCT00103285|69121291|FG002|Induction|Ineligible|0|||
37651400|NCT00103285|69121292|FG003|Induction|Ineligible|0|||
37651401|NCT00103285|69121293|FG004|Induction|Ineligible|0|||
37651402|NCT00103285|69121294|FG005|Induction|Ineligible|0|||
37651403|NCT00103285|69121295|FG006|Induction|Ineligible|0|||
37651404|NCT00103285|69121296|FG007|Induction|Ineligible|0|||
37651405|NCT00103285|69121289|FG000|Induction|Refusal|906|||
37651406|NCT00103285|69121290|FG001|Induction|Refusal|0|||
37651407|NCT00103285|69121291|FG002|Induction|Refusal|0|||
37651408|NCT00103285|69121292|FG003|Induction|Refusal|0|||
37651409|NCT00103285|69121293|FG004|Induction|Refusal|0|||
37651410|NCT00103285|69121294|FG005|Induction|Refusal|0|||
37651411|NCT00103285|69121295|FG006|Induction|Refusal|0|||
37651412|NCT00103285|69121296|FG007|Induction|Refusal|0|||
37651413|NCT00103285|69121289|FG000|Induction|Other|258|||
37651414|NCT00103285|69121290|FG001|Induction|Other|0|||
37651415|NCT00103285|69121291|FG002|Induction|Other|0|||
37651416|NCT00103285|69121292|FG003|Induction|Other|0|||
37651417|NCT00103285|69121293|FG004|Induction|Other|0|||
37651418|NCT00103285|69121294|FG005|Induction|Other|0|||
37651419|NCT00103285|69121295|FG006|Induction|Other|0|||
37651420|NCT00103285|69121296|FG007|Induction|Other|0|||
37651421|NCT00103285|69121289|FG000|Response Assignment|Adverse Event|0|||
37651422|NCT00103285|69121290|FG001|Response Assignment|Adverse Event|8|||
37651423|NCT00103285|69121291|FG002|Response Assignment|Adverse Event|3|||
37651424|NCT00103285|69121292|FG003|Response Assignment|Adverse Event|2|||
37651425|NCT00103285|69121293|FG004|Response Assignment|Adverse Event|3|||
37651426|NCT00103285|69121294|FG005|Response Assignment|Adverse Event|1|||
37651427|NCT00103285|69121295|FG006|Response Assignment|Adverse Event|1|||
37651428|NCT00103285|69121296|FG007|Response Assignment|Adverse Event|2|||
37651429|NCT00103285|69121289|FG000|Response Assignment|Death|0|||
37651430|NCT00103285|69121290|FG001|Response Assignment|Death|5|||
37651431|NCT00103285|69121291|FG002|Response Assignment|Death|2|||
37651432|NCT00103285|69121292|FG003|Response Assignment|Death|2|||
37651433|NCT00103285|69121293|FG004|Response Assignment|Death|3|||
37651434|NCT00103285|69121294|FG005|Response Assignment|Death|1|||
37651435|NCT00103285|69121295|FG006|Response Assignment|Death|0|||
37651436|NCT00103285|69121296|FG007|Response Assignment|Death|8|||
37651437|NCT00103285|69121289|FG000|Response Assignment|Lost to Follow-up|0|||
37651438|NCT00103285|69121290|FG001|Response Assignment|Lost to Follow-up|9|||
37651439|NCT00103285|69121291|FG002|Response Assignment|Lost to Follow-up|5|||
37651440|NCT00103285|69121292|FG003|Response Assignment|Lost to Follow-up|5|||
37651441|NCT00103285|69121293|FG004|Response Assignment|Lost to Follow-up|1|||
37651442|NCT00103285|69121294|FG005|Response Assignment|Lost to Follow-up|2|||
37651443|NCT00103285|69121295|FG006|Response Assignment|Lost to Follow-up|2|||
37651444|NCT00103285|69121296|FG007|Response Assignment|Lost to Follow-up|5|||
37651445|NCT00103285|69121289|FG000|Response Assignment|Physician Decision|0|||
37651446|NCT00103285|69121290|FG001|Response Assignment|Physician Decision|13|||
37651447|NCT00103285|69121291|FG002|Response Assignment|Physician Decision|14|||
37651448|NCT00103285|69121292|FG003|Response Assignment|Physician Decision|9|||
37651449|NCT00103285|69121293|FG004|Response Assignment|Physician Decision|13|||
37651450|NCT00103285|69121294|FG005|Response Assignment|Physician Decision|7|||
37651451|NCT00103285|69121295|FG006|Response Assignment|Physician Decision|4|||
37651452|NCT00103285|69121296|FG007|Response Assignment|Physician Decision|35|||
37651453|NCT00103285|69121289|FG000|Response Assignment|Protocol Violation|0|||
37651454|NCT00103285|69121290|FG001|Response Assignment|Protocol Violation|2|||
37651455|NCT00103285|69121291|FG002|Response Assignment|Protocol Violation|0|||
37651456|NCT00103285|69121292|FG003|Response Assignment|Protocol Violation|0|||
37651457|NCT00103285|69121293|FG004|Response Assignment|Protocol Violation|0|||
37651458|NCT00103285|69121294|FG005|Response Assignment|Protocol Violation|0|||
37651459|NCT00103285|69121295|FG006|Response Assignment|Protocol Violation|0|||
37651460|NCT00103285|69121296|FG007|Response Assignment|Protocol Violation|0|||
37651461|NCT00103285|69121289|FG000|Response Assignment|Withdrawal by Subject|0|||
37651462|NCT00103285|69121290|FG001|Response Assignment|Withdrawal by Subject|4|||
37651463|NCT00103285|69121291|FG002|Response Assignment|Withdrawal by Subject|1|||
37651464|NCT00103285|69121292|FG003|Response Assignment|Withdrawal by Subject|1|||
37651465|NCT00103285|69121293|FG004|Response Assignment|Withdrawal by Subject|2|||
37651466|NCT00103285|69121294|FG005|Response Assignment|Withdrawal by Subject|2|||
37651467|NCT00103285|69121295|FG006|Response Assignment|Withdrawal by Subject|0|||
37651468|NCT00103285|69121296|FG007|Response Assignment|Withdrawal by Subject|2|||
37651469|NCT00103285|69121289|FG000|Response Assignment|Ineligible|0|||
37651470|NCT00103285|69121290|FG001|Response Assignment|Ineligible|8|||
37651471|NCT00103285|69121291|FG002|Response Assignment|Ineligible|6|||
37651472|NCT00103285|69121292|FG003|Response Assignment|Ineligible|2|||
37651473|NCT00103285|69121293|FG004|Response Assignment|Ineligible|0|||
37651474|NCT00103285|69121294|FG005|Response Assignment|Ineligible|3|||
37651475|NCT00103285|69121295|FG006|Response Assignment|Ineligible|1|||
37651476|NCT00103285|69121296|FG007|Response Assignment|Ineligible|5|||
37651477|NCT00103285|69121289|FG000|Response Assignment|Refusal|0|||
37651478|NCT00103285|69121290|FG001|Response Assignment|Refusal|53|||
37651479|NCT00103285|69121291|FG002|Response Assignment|Refusal|5|||
37651480|NCT00103285|69121292|FG003|Response Assignment|Refusal|3|||
37651481|NCT00103285|69121293|FG004|Response Assignment|Refusal|25|||
37651482|NCT00103285|69121294|FG005|Response Assignment|Refusal|15|||
37742110|NCT04059484|69228382|FG000|Overall Study|Other|8|||
37742111|NCT04059484|69228383|FG001|Overall Study|Other|3|||
37742112|NCT04059484|69228382|FG000|Overall Study|Ongoing|20|||
37742113|NCT04059484|69228383|FG001|Overall Study|Ongoing|20|||
37742114|NCT04033003|69228394|FG000|T1 3rd Trimester|Lost to Follow-up|113|||
37742115|NCT04033003|69228395|FG001|T1 3rd Trimester|Lost to Follow-up|190|||
37742116|NCT04033003|69228394|FG000|T1 3rd Trimester|Protocol Violation|115|||
37742117|NCT04033003|69228395|FG001|T1 3rd Trimester|Protocol Violation|0|||
37742118|NCT04033003|69228394|FG000|T1 3rd Trimester|Withdrawal by Subject|2|||
37742119|NCT04033003|69228395|FG001|T1 3rd Trimester|Withdrawal by Subject|6|||
37742120|NCT04033003|69228394|FG000|T1 3rd Trimester|No longer meets criteria|30|||
37742121|NCT04033003|69228395|FG001|T1 3rd Trimester|No longer meets criteria|19|||
37742122|NCT04033003|69228394|FG000|T1 3rd Trimester|Death|0|||
37742123|NCT04033003|69228395|FG001|T1 3rd Trimester|Death|1|||
37742124|NCT04033003|69228394|FG000|T2 Post Delivery|Lost to Follow-up|133|||
37742125|NCT04033003|69228395|FG001|T2 Post Delivery|Lost to Follow-up|247|||
37651483|NCT00103285|69121295|FG006|Response Assignment|Refusal|30|||
37651484|NCT00103285|69121296|FG007|Response Assignment|Refusal|10|||
37651485|NCT00103285|69121289|FG000|Response Assignment|Other|0|||
37651486|NCT00103285|69121290|FG001|Response Assignment|Other|30|||
37651487|NCT00103285|69121291|FG002|Response Assignment|Other|48|||
37651488|NCT00103285|69121292|FG003|Response Assignment|Other|38|||
37742126|NCT04033003|69228394|FG000|T2 Post Delivery|Protocol Violation|4|||
37742127|NCT04033003|69228395|FG001|T2 Post Delivery|Protocol Violation|0|||
37651489|NCT00103285|69121293|FG004|Response Assignment|Other|37|||
37651490|NCT00103285|69121294|FG005|Response Assignment|Other|17|||
37651491|NCT00103285|69121295|FG006|Response Assignment|Other|11|||
37651492|NCT00103285|69121296|FG007|Response Assignment|Other|53|||
37651493|NCT02783573|69121324|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
37651494|NCT02783573|69121325|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
37651495|NCT02783573|69121326|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
37742128|NCT04033003|69228394|FG000|T2 Post Delivery|Withdrawal by Subject|5|||
37742129|NCT04033003|69228395|FG001|T2 Post Delivery|Withdrawal by Subject|3|||
37742130|NCT04033003|69228394|FG000|T2 Post Delivery|No longer meets criteria|1|||
37651496|NCT02783573|69121324|FG000|Placebo-Controlled Treatment Period|Death|4|||
37651497|NCT02783573|69121325|FG001|Placebo-Controlled Treatment Period|Death|2|||
37651498|NCT02783573|69121326|FG002|Placebo-Controlled Treatment Period|Death|3|||
37651499|NCT02783573|69121324|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
37651500|NCT02783573|69121325|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
37651501|NCT02783573|69121326|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
37651502|NCT02783573|69121324|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
37651503|NCT02783573|69121325|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
37651504|NCT02783573|69121326|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
37651505|NCT02783573|69121324|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
37651506|NCT02783573|69121325|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
37651507|NCT02783573|69121326|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
37651508|NCT02783573|69121324|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
37651509|NCT02783573|69121325|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
37651510|NCT02783573|69121326|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
37651511|NCT02783573|69121324|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
37651512|NCT02783573|69121325|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
37651513|NCT02783573|69121326|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
37651514|NCT02783573|69121324|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
37651515|NCT02783573|69121325|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
37651516|NCT02783573|69121326|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
37651517|NCT02783573|69121324|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
37651518|NCT02783573|69121325|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
37651519|NCT02783573|69121326|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
37651520|NCT02783573|69121324|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
37651521|NCT02783573|69121325|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
37651522|NCT02783573|69121326|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
37651523|NCT02783573|69121324|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
37651524|NCT02783573|69121325|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
37651525|NCT02783573|69121326|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
37651526|NCT02783573|69121324|FG000|Delayed-Start Period|Sponsor Decision|0|||
37651527|NCT02783573|69121325|FG001|Delayed-Start Period|Sponsor Decision|17|||
37651528|NCT02783573|69121326|FG002|Delayed-Start Period|Sponsor Decision|12|||
37651529|NCT01666652|69121342|FG000|Overall Study|Serious Adverse Event|0|||
37651530|NCT01666652|69121343|FG001|Overall Study|Serious Adverse Event|0|||
37651531|NCT01666652|69121344|FG002|Overall Study|Serious Adverse Event|0|||
37651532|NCT01666652|69121345|FG003|Overall Study|Serious Adverse Event|1|||
37651533|NCT01666652|69121346|FG004|Overall Study|Serious Adverse Event|0|||
37651534|NCT01666652|69121342|FG000|Overall Study|Withdrawal by Subject|0|||
37651535|NCT01666652|69121343|FG001|Overall Study|Withdrawal by Subject|0|||
37651536|NCT01666652|69121344|FG002|Overall Study|Withdrawal by Subject|0|||
37651537|NCT01666652|69121345|FG003|Overall Study|Withdrawal by Subject|0|||
37651538|NCT01666652|69121346|FG004|Overall Study|Withdrawal by Subject|1|||
37651539|NCT01666652|69121342|FG000|Overall Study|Moved from study area|1|||
37651540|NCT01666652|69121343|FG001|Overall Study|Moved from study area|0|||
37651541|NCT01666652|69121344|FG002|Overall Study|Moved from study area|0|||
37651542|NCT01666652|69121345|FG003|Overall Study|Moved from study area|2|||
37651543|NCT01666652|69121346|FG004|Overall Study|Moved from study area|0|||
37651544|NCT01666652|69121342|FG000|Overall Study|Lost to Follow-up|1|||
37651545|NCT01666652|69121343|FG001|Overall Study|Lost to Follow-up|1|||
37651546|NCT01666652|69121344|FG002|Overall Study|Lost to Follow-up|1|||
37651547|NCT01666652|69121345|FG003|Overall Study|Lost to Follow-up|1|||
37651548|NCT01666652|69121346|FG004|Overall Study|Lost to Follow-up|0|||
37651549|NCT00109733|69121360|FG000|Overall Study|Protocol Violation|0|||
37651550|NCT00109733|69121361|FG001|Overall Study|Protocol Violation|1|||
37651551|NCT00109733|69121360|FG000|Overall Study|Stopped taking study drug|1|||
37651552|NCT00109733|69121361|FG001|Overall Study|Stopped taking study drug|1|||
37651553|NCT00109733|69121360|FG000|Overall Study|Non-compliant|0|||
37651554|NCT00109733|69121361|FG001|Overall Study|Non-compliant|1|||
37651555|NCT00109733|69121360|FG000|Overall Study|Could not commit time for study|1|||
37651556|NCT00109733|69121361|FG001|Overall Study|Could not commit time for study|1|||
37651557|NCT02706405|69121375|FG000|Overall Study|Death|3|||
37651558|NCT02706405|69121376|FG001|Overall Study|Death|2|||
37651559|NCT02706405|69121377|FG002|Overall Study|Death|0|||
37651560|NCT02706405|69121378|FG003|Overall Study|Death|1|||
37651561|NCT02706405|69121379|FG004|Overall Study|Death|0|||
37651562|NCT02706405|69121380|FG005|Overall Study|Death|0|||
37651563|NCT02706405|69121381|FG006|Overall Study|Death|3|||
37651564|NCT02706405|69121382|FG007|Overall Study|Death|4|||
37651565|NCT02706405|69121375|FG000|Overall Study|Disease progression|0|||
37651566|NCT02706405|69121376|FG001|Overall Study|Disease progression|0|||
37651567|NCT02706405|69121377|FG002|Overall Study|Disease progression|0|||
37651568|NCT02706405|69121378|FG003|Overall Study|Disease progression|0|||
37651569|NCT02706405|69121379|FG004|Overall Study|Disease progression|0|||
37651570|NCT02706405|69121380|FG005|Overall Study|Disease progression|0|||
37651571|NCT02706405|69121381|FG006|Overall Study|Disease progression|0|||
37651572|NCT02706405|69121382|FG007|Overall Study|Disease progression|1|||
37651573|NCT02706405|69121375|FG000|Overall Study|Pt moved to new therapy|0|||
37651574|NCT02706405|69121376|FG001|Overall Study|Pt moved to new therapy|0|||
37651575|NCT02706405|69121377|FG002|Overall Study|Pt moved to new therapy|0|||
37651576|NCT02706405|69121378|FG003|Overall Study|Pt moved to new therapy|0|||
37651577|NCT02706405|69121379|FG004|Overall Study|Pt moved to new therapy|0|||
37651578|NCT02706405|69121380|FG005|Overall Study|Pt moved to new therapy|1|||
37651579|NCT02706405|69121381|FG006|Overall Study|Pt moved to new therapy|0|||
37651580|NCT02706405|69121382|FG007|Overall Study|Pt moved to new therapy|1|||
37651581|NCT02706405|69121375|FG000|Overall Study|Physician Decision|1|||
37651582|NCT02706405|69121376|FG001|Overall Study|Physician Decision|0|||
37651583|NCT02706405|69121377|FG002|Overall Study|Physician Decision|0|||
37651584|NCT02706405|69121378|FG003|Overall Study|Physician Decision|0|||
37651585|NCT02706405|69121379|FG004|Overall Study|Physician Decision|0|||
37651586|NCT02706405|69121380|FG005|Overall Study|Physician Decision|0|||
37651587|NCT02706405|69121381|FG006|Overall Study|Physician Decision|0|||
37651588|NCT02706405|69121382|FG007|Overall Study|Physician Decision|0|||
37651589|NCT02761993|69121411|FG000|Overall Study|Adverse Event|0|||
38032406|NCT01358734|69718354|FG001|Overall Study|Lack of Efficacy|1|||
38032407|NCT01358734|69718355|FG002|Overall Study|Lack of Efficacy|3|||
38032408|NCT01358734|69718353|FG000|Overall Study|Withdrawal by Subject|1|||
38032409|NCT01358734|69718354|FG001|Overall Study|Withdrawal by Subject|6|||
38032410|NCT01358734|69718355|FG002|Overall Study|Withdrawal by Subject|3|||
38032411|NCT01358734|69718353|FG000|Overall Study|Death|3|||
38032412|NCT01358734|69718354|FG001|Overall Study|Death|7|||
38032413|NCT01358734|69718355|FG002|Overall Study|Death|2|||
37651590|NCT02761993|69121412|FG001|Overall Study|Adverse Event|2|||
37651591|NCT02761993|69121413|FG002|Overall Study|Adverse Event|0|||
37651592|NCT02761993|69121411|FG000|Overall Study|Lost to Follow-up|1|||
37651593|NCT02761993|69121412|FG001|Overall Study|Lost to Follow-up|3|||
37651594|NCT02761993|69121413|FG002|Overall Study|Lost to Follow-up|2|||
37651595|NCT02761993|69121411|FG000|Overall Study|Withdrawal by Subject|1|||
37651596|NCT02761993|69121412|FG001|Overall Study|Withdrawal by Subject|1|||
37651597|NCT02761993|69121413|FG002|Overall Study|Withdrawal by Subject|2|||
37651598|NCT02766283|69121421|FG000|Overall Study|Lost to Follow-up|27|||
37651599|NCT02761915|69121455|FG000|Overall Study|Death|3|||
37651600|NCT02761915|69121456|FG001|Overall Study|Death|1|||
37651601|NCT02761915|69121457|FG002|Overall Study|Death|1|||
37651602|NCT02761915|69121458|FG003|Overall Study|Death|1|||
37651603|NCT02761915|69121459|FG004|Overall Study|Death|0|||
37651604|NCT02761915|69121460|FG005|Overall Study|Death|1|||
37651605|NCT02761915|69121455|FG000|Overall Study|Withdrawal by Subject|1|||
37651606|NCT02761915|69121456|FG001|Overall Study|Withdrawal by Subject|0|||
37651607|NCT02761915|69121457|FG002|Overall Study|Withdrawal by Subject|0|||
37651608|NCT02761915|69121458|FG003|Overall Study|Withdrawal by Subject|0|||
37651609|NCT02761915|69121459|FG004|Overall Study|Withdrawal by Subject|1|||
37651610|NCT02761915|69121460|FG005|Overall Study|Withdrawal by Subject|2|||
37651611|NCT02761915|69121455|FG000|Overall Study|Disease Progression|0|||
37651612|NCT02761915|69121456|FG001|Overall Study|Disease Progression|0|||
37651613|NCT02761915|69121457|FG002|Overall Study|Disease Progression|0|||
37651614|NCT02761915|69121458|FG003|Overall Study|Disease Progression|2|||
37651615|NCT02761915|69121459|FG004|Overall Study|Disease Progression|2|||
37651616|NCT02761915|69121460|FG005|Overall Study|Disease Progression|2|||
37651617|NCT02706327|69121481|FG000|Overall Study|Lost to Follow-up|1|||
37651618|NCT02706327|69121482|FG001|Overall Study|Lost to Follow-up|1|||
37651619|NCT02706327|69121483|FG002|Overall Study|Lost to Follow-up|2|||
37651620|NCT02764333|69121491|FG000|Overall Study|Ineligible|1|||
37651621|NCT02705625|69121498|FG000|Overall Study|Protocol Violation|1|||
37651622|NCT02705625|69121499|FG001|Overall Study|Protocol Violation|0|||
37651623|NCT02705625|69121500|FG002|Overall Study|Protocol Violation|0|||
37651624|NCT02705625|69121498|FG000|Overall Study|Adverse Event|6|||
37742131|NCT04033003|69228395|FG001|T2 Post Delivery|No longer meets criteria|10|||
37651625|NCT02705625|69121499|FG001|Overall Study|Adverse Event|5|||
37651626|NCT02705625|69121500|FG002|Overall Study|Adverse Event|2|||
37651627|NCT02705625|69121498|FG000|Overall Study|Death|0|||
37651628|NCT02705625|69121499|FG001|Overall Study|Death|0|||
37651629|NCT02705625|69121500|FG002|Overall Study|Death|1|||
37651630|NCT02705625|69121498|FG000|Overall Study|Withdrawal by Subject|1|||
37742132|NCT04033003|69228394|FG000|T2 Post Delivery|Death|2|||
38032414|NCT01358734|69718353|FG000|Overall Study|Progressive Disease|5|||
37651631|NCT02705625|69121499|FG001|Overall Study|Withdrawal by Subject|4|||
37651632|NCT02705625|69121500|FG002|Overall Study|Withdrawal by Subject|5|||
38032415|NCT01358734|69718354|FG001|Overall Study|Progressive Disease|13|||
37651633|NCT02705625|69121498|FG000|Overall Study|Lost to Follow-up|0|||
37651634|NCT02705625|69121499|FG001|Overall Study|Lost to Follow-up|0|||
37742133|NCT04033003|69228395|FG001|T2 Post Delivery|Death|2|||
37651635|NCT02705625|69121500|FG002|Overall Study|Lost to Follow-up|1|||
37651636|NCT02705625|69121498|FG000|Overall Study|Non-compliance|0|||
37651637|NCT02705625|69121499|FG001|Overall Study|Non-compliance|1|||
37651638|NCT02705625|69121500|FG002|Overall Study|Non-compliance|1|||
37651639|NCT02705625|69121498|FG000|Overall Study|Overdosing|0|||
37651640|NCT02705625|69121499|FG001|Overall Study|Overdosing|0|||
37651641|NCT02705625|69121500|FG002|Overall Study|Overdosing|1|||
37651642|NCT02588612|69121508|FG000|Overall Study|Physician Decision|1|||
37651643|NCT02588612|69121508|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
37651644|NCT02588612|69121508|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
37651645|NCT02588612|69121508|FG000|Overall Study|Death prior to T-cell infusion|1|||
37651646|NCT02704689|69121521|FG000|Overall Study|Physician Decision|1|||
37651647|NCT02704689|69121521|FG000|Overall Study|Study device not implanted|2|||
37922577|NCT00873041|69609306|FG002|Core Study|Protocol deviation|1|||
37651648|NCT02704143|69121525|FG000|Overall Study|disease progression|10|||
37651649|NCT02586506|69121529|FG000|Overall Study|Protocol Violation|6|||
37651650|NCT02586506|69121529|FG000|Overall Study|Lost to Follow-up|1|||
37651651|NCT02586506|69121529|FG000|Overall Study|Other Reason|2|||
37651652|NCT00109031|69121537|FG000|Overall Study|Adverse Event|0|||
37651653|NCT00109031|69121538|FG001|Overall Study|Adverse Event|0|||
37651654|NCT00109031|69121539|FG002|Overall Study|Adverse Event|1|||
37651655|NCT00109031|69121540|FG003|Overall Study|Adverse Event|0|||
37651656|NCT00109031|69121537|FG000|Overall Study|Withdrawal by Subject|0|||
37651657|NCT00109031|69121538|FG001|Overall Study|Withdrawal by Subject|1|||
37651658|NCT00109031|69121539|FG002|Overall Study|Withdrawal by Subject|0|||
37651659|NCT00109031|69121540|FG003|Overall Study|Withdrawal by Subject|0|||
37651660|NCT00109031|69121537|FG000|Overall Study|Physician Decision|0|||
37651661|NCT00109031|69121538|FG001|Overall Study|Physician Decision|1|||
37651662|NCT00109031|69121539|FG002|Overall Study|Physician Decision|0|||
37651663|NCT00109031|69121540|FG003|Overall Study|Physician Decision|0|||
37651664|NCT00109031|69121537|FG000|Overall Study|Protocol Violation|0|||
37651665|NCT00109031|69121538|FG001|Overall Study|Protocol Violation|0|||
37651666|NCT00109031|69121539|FG002|Overall Study|Protocol Violation|1|||
37651667|NCT00109031|69121540|FG003|Overall Study|Protocol Violation|0|||
37651668|NCT01664624|69121554|FG000|Overall Study|Adverse Event|0|||
37651669|NCT01664624|69121555|FG001|Overall Study|Adverse Event|1|||
37651670|NCT01664624|69121556|FG002|Overall Study|Adverse Event|0|||
37651671|NCT01664624|69121557|FG003|Overall Study|Adverse Event|0|||
37651672|NCT02702193|69121569|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
37651673|NCT02702193|69121570|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
37651674|NCT02702193|69121569|FG000|4 Month Follow up|Withdrawal by Subject|1|||
37651675|NCT02702193|69121570|FG001|4 Month Follow up|Withdrawal by Subject|0|||
37651676|NCT02702193|69121569|FG000|4 Month Follow up|Lost to Follow-up|17|||
37651677|NCT02702193|69121570|FG001|4 Month Follow up|Lost to Follow-up|18|||
37651678|NCT02702193|69121569|FG000|8 Month Follow up|Withdrawal by Subject|1|||
37651679|NCT02702193|69121570|FG001|8 Month Follow up|Withdrawal by Subject|0|||
37651680|NCT02702193|69121569|FG000|8 Month Follow up|Lost to Follow-up|14|||
37651681|NCT02702193|69121570|FG001|8 Month Follow up|Lost to Follow-up|18|||
37651682|NCT02702193|69121569|FG000|12 Month Follow up|Withdrawal by Subject|1|||
37651683|NCT02702193|69121570|FG001|12 Month Follow up|Withdrawal by Subject|0|||
37651684|NCT02702193|69121569|FG000|12 Month Follow up|Lost to Follow-up|16|||
37651685|NCT02702193|69121570|FG001|12 Month Follow up|Lost to Follow-up|18|||
37651686|NCT02761057|69121580|FG000|Overall Study|Currently On Study Treatment|0|||
37651687|NCT02761057|69121581|FG001|Overall Study|Currently On Study Treatment|3|||
37651688|NCT02761057|69121582|FG002|Overall Study|Currently On Study Treatment|0|||
37742134|NCT04017832|69228419|FG000|Overall Study|Withdrawal by Subject|13|||
37742135|NCT04017832|69228420|FG001|Overall Study|Withdrawal by Subject|12|||
37742136|NCT04017832|69228421|FG002|Overall Study|Withdrawal by Subject|21|||
37742137|NCT04017832|69228422|FG003|Overall Study|Withdrawal by Subject|7|||
37742138|NCT04017832|69228419|FG000|Overall Study|Lost to Follow-up|0|||
37742139|NCT04017832|69228420|FG001|Overall Study|Lost to Follow-up|3|||
37742140|NCT04017832|69228421|FG002|Overall Study|Lost to Follow-up|3|||
37742141|NCT04017832|69228422|FG003|Overall Study|Lost to Follow-up|1|||
37651689|NCT02761057|69121583|FG003|Overall Study|Currently On Study Treatment|0|||
37742142|NCT04017832|69228419|FG000|Overall Study|Physician Decision|1|||
37742143|NCT04017832|69228420|FG001|Overall Study|Physician Decision|1|||
37742144|NCT04017832|69228421|FG002|Overall Study|Physician Decision|1|||
37922578|NCT00873041|69609304|FG000|Extension Study|Adverse Event|1|||
37651690|NCT02761057|69121580|FG000|Overall Study|Adverse Event|11|||
37651691|NCT02761057|69121581|FG001|Overall Study|Adverse Event|9|||
37651692|NCT02761057|69121582|FG002|Overall Study|Adverse Event|5|||
37651693|NCT02761057|69121583|FG003|Overall Study|Adverse Event|3|||
37742145|NCT04017832|69228422|FG003|Overall Study|Physician Decision|1|||
37651694|NCT02761057|69121580|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
37651695|NCT02761057|69121581|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
37651696|NCT02761057|69121582|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
37742146|NCT04017832|69228419|FG000|Overall Study|Death|2|||
37922579|NCT00873041|69609305|FG001|Extension Study|Adverse Event|0|||
37651697|NCT02761057|69121583|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
37651698|NCT02761057|69121580|FG000|Overall Study|Progression/Relapse|29|||
37651699|NCT02761057|69121581|FG001|Overall Study|Progression/Relapse|27|||
37742147|NCT04017832|69228420|FG001|Overall Study|Death|2|||
37742148|NCT04017832|69228421|FG002|Overall Study|Death|1|||
37742149|NCT04017832|69228422|FG003|Overall Study|Death|0|||
37742150|NCT03952806|69228438|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|26|||
37742151|NCT03952806|69228439|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|15|||
37742152|NCT03952806|69228438|FG000|Randomization Phase (Weeks 1 Through 48)|Disease progression|5|||
37742153|NCT03952806|69228439|FG001|Randomization Phase (Weeks 1 Through 48)|Disease progression|0|||
37742154|NCT03952806|69228438|FG000|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
37742155|NCT03952806|69228439|FG001|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
37742156|NCT03952806|69228438|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|4|||
37742157|NCT03952806|69228439|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|2|||
37742158|NCT03952806|69228438|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
37742159|NCT03952806|69228439|FG001|Randomization Phase (Weeks 1 Through 48)|Other|0|||
37742160|NCT03952806|69228438|FG000|OLE Phase (48 Weeks)|Adverse Event|18|||
37651700|NCT02761057|69121582|FG002|Overall Study|Progression/Relapse|20|||
37651701|NCT02761057|69121583|FG003|Overall Study|Progression/Relapse|23|||
37651702|NCT02761057|69121580|FG000|Overall Study|Death|2|||
37651703|NCT02761057|69121581|FG001|Overall Study|Death|2|||
37651704|NCT02761057|69121582|FG002|Overall Study|Death|1|||
37651705|NCT02761057|69121583|FG003|Overall Study|Death|1|||
37651706|NCT02761057|69121580|FG000|Overall Study|Other - Not Protocol Specified|2|||
37651707|NCT02761057|69121581|FG001|Overall Study|Other - Not Protocol Specified|1|||
37651708|NCT02761057|69121582|FG002|Overall Study|Other - Not Protocol Specified|2|||
37651709|NCT02761057|69121583|FG003|Overall Study|Other - Not Protocol Specified|0|||
37651710|NCT05085730|69121593|FG000|Overall Study|Withdrawal by Subject|4|||
37651711|NCT05085730|69121593|FG000|Overall Study|Physician Decision|1|||
37651712|NCT04886596|69121605|FG000|Overall Study|Adverse Event|73|||
37651713|NCT04886596|69121606|FG001|Overall Study|Adverse Event|78|||
37651714|NCT04886596|69121605|FG000|Overall Study|Lost to Follow-up|104|||
37651715|NCT04886596|69121606|FG001|Overall Study|Lost to Follow-up|104|||
37651716|NCT04886596|69121605|FG000|Overall Study|Ongoing|12095|||
37651717|NCT04886596|69121606|FG001|Overall Study|Ongoing|12107|||
37651718|NCT04886596|69121605|FG000|Overall Study|Consent withdrawal, not due to an (S)AE|162|||
37651719|NCT04886596|69121606|FG001|Overall Study|Consent withdrawal, not due to an (S)AE|173|||
37651720|NCT04886596|69121605|FG000|Overall Study|Migrated / Moved from the study area|17|||
37651721|NCT04886596|69121606|FG001|Overall Study|Migrated / Moved from the study area|14|||
37651722|NCT04886596|69121605|FG000|Overall Study|Unknown reason|16|||
37651723|NCT04886596|69121606|FG001|Overall Study|Unknown reason|23|||
37651724|NCT04839380|69121612|FG000|Overall Study|Withdrawal by Subject|2|||
37651725|NCT04839380|69121612|FG000|Overall Study|Dosed, but Did Not Complete Run-in Period|3|||
37651726|NCT04788147|69121618|FG000|Overall Study|Screen Failure|3|||
37651727|NCT04788147|69121619|FG001|Overall Study|Screen Failure|10|||
37651728|NCT04788147|69121618|FG000|Overall Study|Incomplete RMRS image session|2|||
37651729|NCT04788147|69121619|FG001|Overall Study|Incomplete RMRS image session|0|||
37651730|NCT04770155|69121640|FG000|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
37651731|NCT04770155|69121641|FG001|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
37651732|NCT04770155|69121642|FG002|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
37651733|NCT04770155|69121643|FG003|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
37651734|NCT04770155|69121644|FG004|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
37651735|NCT04770155|69121645|FG005|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
37651736|NCT04770155|69121646|FG006|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
37651737|NCT04770155|69121647|FG007|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
37651738|NCT04576988|69121667|FG000|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
37651739|NCT04576988|69121668|FG001|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
37651740|NCT04576988|69121667|FG000|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|2|||
37651741|NCT04576988|69121668|FG001|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|3|||
37651742|NCT04576988|69121667|FG000|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
37651743|NCT04576988|69121668|FG001|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
37651744|NCT04576988|69121667|FG000|Double Blind Placebo Controlled (DBPC)|Death|0|||
37651745|NCT04576988|69121668|FG001|Double Blind Placebo Controlled (DBPC)|Death|5|||
37651746|NCT04576988|69121667|FG000|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|0|||
37742161|NCT03952806|69228439|FG001|OLE Phase (48 Weeks)|Adverse Event|29|||
37742162|NCT03952806|69228438|FG000|OLE Phase (48 Weeks)|Disease Progression|6|||
37742163|NCT03952806|69228439|FG001|OLE Phase (48 Weeks)|Disease Progression|9|||
37742164|NCT03952806|69228438|FG000|OLE Phase (48 Weeks)|Participant Request to Discontinue|35|||
37651747|NCT04576988|69121668|FG001|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|2|||
37651748|NCT04576988|69121667|FG000|Long Term Double Blind (LTDB)|Adverse Event|2|||
37651749|NCT04576988|69121668|FG001|Long Term Double Blind (LTDB)|Adverse Event|0|||
37651750|NCT04576988|69121667|FG000|Long Term Double Blind (LTDB)|Withdrawal by Subject|0|||
37651751|NCT04576988|69121668|FG001|Long Term Double Blind (LTDB)|Withdrawal by Subject|3|||
37651752|NCT04576988|69121667|FG000|Long Term Double Blind (LTDB)|Protocol Violation|0|||
37651753|NCT04576988|69121668|FG001|Long Term Double Blind (LTDB)|Protocol Violation|1|||
37651754|NCT04576988|69121667|FG000|Long Term Double Blind (LTDB)|Death|2|||
37651755|NCT04576988|69121668|FG001|Long Term Double Blind (LTDB)|Death|1|||
37651756|NCT04576988|69121667|FG000|Long Term Double Blind (LTDB)|Sponsor decision|0|||
37651757|NCT04576988|69121668|FG001|Long Term Double Blind (LTDB)|Sponsor decision|1|||
37651758|NCT04471207|69121682|FG000|Overall Study|Lost to Follow-up|4|||
37651759|NCT04471207|69121683|FG001|Overall Study|Lost to Follow-up|1|||
37651760|NCT04471207|69121682|FG000|Overall Study|Medication Contraindication|0|||
37651761|NCT04471207|69121683|FG001|Overall Study|Medication Contraindication|1|||
37651762|NCT04471207|69121682|FG000|Overall Study|Loss of Interest|2|||
37651763|NCT04471207|69121683|FG001|Overall Study|Loss of Interest|1|||
37651764|NCT04471207|69121682|FG000|Overall Study|Unwilling to Discuss Trauma|1|||
37651765|NCT04471207|69121683|FG001|Overall Study|Unwilling to Discuss Trauma|1|||
37651766|NCT04471207|69121682|FG000|Overall Study|Scheduling Conflicts|3|||
37651767|NCT04471207|69121683|FG001|Overall Study|Scheduling Conflicts|1|||
37651768|NCT04471207|69121682|FG000|Overall Study|Physician Decision|1|||
37651769|NCT04471207|69121683|FG001|Overall Study|Physician Decision|0|||
37651770|NCT04471207|69121682|FG000|Overall Study|Unwilling to Use System|0|||
37651771|NCT04471207|69121683|FG001|Overall Study|Unwilling to Use System|1|||
37651772|NCT04356040|69121695|FG000|Overall Study|Death|2|||
37651773|NCT04356040|69121696|FG001|Overall Study|Death|0|||
37651774|NCT04356040|69121695|FG000|Overall Study|Lost to Follow-up|1|||
37651775|NCT04356040|69121696|FG001|Overall Study|Lost to Follow-up|0|||
37651776|NCT04356040|69121695|FG000|Overall Study|Physician Decision|0|||
37651777|NCT04356040|69121696|FG001|Overall Study|Physician Decision|1|||
37651778|NCT04356040|69121695|FG000|Overall Study|Withdrawal by Subject|13|||
37651779|NCT04356040|69121696|FG001|Overall Study|Withdrawal by Subject|1|||
37651780|NCT04356040|69121695|FG000|Overall Study|Enrollment Pause|10|||
37651781|NCT04356040|69121696|FG001|Overall Study|Enrollment Pause|0|||
37651782|NCT04356040|69121695|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|7|||
37651783|NCT04356040|69121696|FG001|Overall Study|Did not meet Inclusion/Exclusion criteria|0|||
37651784|NCT04356040|69121695|FG000|Overall Study|Procedure aborted prior to device insertion into the vasculature|1|||
37651785|NCT04356040|69121696|FG001|Overall Study|Procedure aborted prior to device insertion into the vasculature|0|||
37742165|NCT03952806|69228439|FG001|OLE Phase (48 Weeks)|Participant Request to Discontinue|38|||
37742166|NCT03952806|69228438|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|4|||
37742167|NCT03952806|69228439|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|5|||
37742168|NCT03952806|69228438|FG000|OLE Phase (48 Weeks)|Other|16|||
37742169|NCT03952806|69228439|FG001|OLE Phase (48 Weeks)|Other|13|||
37742170|NCT03924947|69228464|FG000|Part 1: Double Blind Period 1|Other, Not Specified|0|||
37742171|NCT03924947|69228465|FG001|Part 1: Double Blind Period 1|Other, Not Specified|0|||
37742172|NCT03924947|69228466|FG002|Part 1: Double Blind Period 1|Other, Not Specified|1|||
37742173|NCT03924947|69228467|FG003|Part 1: Double Blind Period 1|Other, Not Specified|0|||
38032416|NCT01358734|69718355|FG002|Overall Study|Progressive Disease|16|||
38032417|NCT01358734|69718353|FG000|Overall Study|Non-compliance with study drug|0|||
38032418|NCT01358734|69718354|FG001|Overall Study|Non-compliance with study drug|0|||
38032419|NCT01358734|69718355|FG002|Overall Study|Non-compliance with study drug|1|||
37742174|NCT03924947|69228468|FG004|Part 1: Double Blind Period 1|Other, Not Specified|0|||
37742175|NCT03924947|69228469|FG005|Part 1: Double Blind Period 1|Other, Not Specified|0|||
37742176|NCT03845985|69228494|FG000|Overall Study|Lost to Follow-up|2|||
37742177|NCT03845985|69228495|FG001|Overall Study|Lost to Follow-up|1|||
37742178|NCT03845985|69228494|FG000|Overall Study|Physician Decision|1|||
37742179|NCT03845985|69228495|FG001|Overall Study|Physician Decision|0|||
37742180|NCT03845985|69228494|FG000|Overall Study|Withdrawal by Subject|4|||
37742181|NCT03845985|69228495|FG001|Overall Study|Withdrawal by Subject|1|||
37742182|NCT03745651|69228504|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
37742183|NCT03745651|69228505|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
37742184|NCT03745651|69228506|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
37922580|NCT00873041|69609306|FG002|Extension Study|Adverse Event|1|||
38032420|NCT01358734|69718353|FG000|Overall Study|Other|2|||
37651786|NCT04356040|69121695|FG000|Overall Study|PI left institution|3|||
37651787|NCT04356040|69121696|FG001|Overall Study|PI left institution|0|||
37742185|NCT03745651|69228507|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
37742186|NCT03745651|69228508|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
37742187|NCT03745651|69228509|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
38032421|NCT01358734|69718354|FG001|Overall Study|Other|5|||
37651788|NCT04349631|69121702|FG000|Overall Study|Lost to Follow-up|3|||
37651789|NCT04349631|69121702|FG000|Overall Study|Withdrawal by Subject|7|||
37651790|NCT03961204|69121706|FG000|Overall Study|Withdrawal by Subject|2|||
37651791|NCT03961204|69121706|FG000|Overall Study|Lost to Follow-up|3|||
37651792|NCT03961204|69121706|FG000|Overall Study|Other|1|||
37651793|NCT03961204|69121706|FG000|Overall Study|Missing|1|||
37651794|NCT03898180|69121712|FG000|Overall Study|Ongoing in Study|133|||
37651795|NCT03898180|69121713|FG001|Overall Study|Ongoing in Study|134|||
37651796|NCT03898180|69121712|FG000|Overall Study|Withdrawal by Subject|3|||
37651797|NCT03898180|69121713|FG001|Overall Study|Withdrawal by Subject|2|||
37651798|NCT03898180|69121712|FG000|Overall Study|Death|109|||
37651799|NCT03898180|69121713|FG001|Overall Study|Death|106|||
37651800|NCT03816007|69121721|FG000|End of 12-week Intervention|Withdrawal by Subject|0|||
37651801|NCT03816007|69121722|FG001|End of 12-week Intervention|Withdrawal by Subject|2|||
37742188|NCT03745651|69228510|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
37742189|NCT03745651|69228504|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
37742190|NCT03745651|69228505|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
37742191|NCT03745651|69228506|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
37742192|NCT03745651|69228507|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
37742193|NCT03745651|69228508|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
37742194|NCT03745651|69228509|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
37742195|NCT03745651|69228510|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
37742196|NCT03745651|69228504|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
37651802|NCT03816007|69121721|FG000|End of 12-week Intervention|Lost to Follow-up|3|||
37651803|NCT03816007|69121722|FG001|End of 12-week Intervention|Lost to Follow-up|4|||
37651804|NCT03816007|69121721|FG000|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
37651805|NCT03816007|69121722|FG001|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
37651806|NCT03712449|69121730|FG000|Overall Study|Withdraw Consent|0|||
37651807|NCT03712449|69121731|FG001|Overall Study|Withdraw Consent|1|||
37651808|NCT03530124|69121739|FG000|Overall Study|Withdrawal by Subject|0|||
37651809|NCT03530124|69121740|FG001|Overall Study|Withdrawal by Subject|1|||
37651810|NCT03530124|69121739|FG000|Overall Study|Protocol Violation|1|||
37651811|NCT03530124|69121740|FG001|Overall Study|Protocol Violation|0|||
37651812|NCT03530124|69121739|FG000|Overall Study|Discharged prior to study completion|1|||
37651813|NCT03530124|69121740|FG001|Overall Study|Discharged prior to study completion|0|||
37651814|NCT03343483|69121748|FG000|Overall Study|Death|0|||
37651815|NCT03343483|69121749|FG001|Overall Study|Death|3|||
37651816|NCT03343483|69121748|FG000|Overall Study|Lost to Follow-up|9|||
37651817|NCT03343483|69121749|FG001|Overall Study|Lost to Follow-up|13|||
37651818|NCT03343483|69121748|FG000|Overall Study|Withdrawal by Subject|8|||
37651819|NCT03343483|69121749|FG001|Overall Study|Withdrawal by Subject|17|||
37651820|NCT03035409|69121755|FG000|Overall Study|Adverse Event|5|||
37651821|NCT03035409|69121755|FG000|Overall Study|Death|2|||
37651822|NCT03035409|69121755|FG000|Overall Study|Withdrawal by Subject|2|||
37742197|NCT03745651|69228505|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
37742198|NCT03745651|69228506|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
37742199|NCT03745651|69228507|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
37742200|NCT03745651|69228508|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
37742201|NCT03745651|69228509|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
37742202|NCT03745651|69228510|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
37742203|NCT03745651|69228504|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
37742204|NCT03745651|69228505|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
37742205|NCT03745651|69228506|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
37742206|NCT03745651|69228507|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
37742207|NCT03745651|69228508|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
37742208|NCT03745651|69228509|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
37742209|NCT03745651|69228510|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
37742210|NCT03745651|69228504|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
37742211|NCT03745651|69228505|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
37742212|NCT03745651|69228506|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
37742213|NCT03745651|69228507|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
37742214|NCT03745651|69228508|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
37742215|NCT03745651|69228509|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
37742216|NCT03745651|69228510|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
37742217|NCT03745651|69228504|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
37922581|NCT00873041|69609304|FG000|Extension Study|Administrative reasons|0|||
37651823|NCT03035409|69121755|FG000|Overall Study|Non compliance|4|||
37651824|NCT03035409|69121755|FG000|Overall Study|Patient was jittery|1|||
37651825|NCT03035409|69121755|FG000|Overall Study|Did not like Questionnaire|1|||
37651826|NCT03035409|69121755|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
37651827|NCT03035409|69121755|FG000|Overall Study|Did not like taking drugs|1|||
37651828|NCT02948088|69121759|FG000|Overall Study|Lost to Follow-up|8|||
37651829|NCT02948088|69121759|FG000|Overall Study|Death|1|||
37651830|NCT02948088|69121759|FG000|Overall Study|Withdrawal by Subject|4|||
37651831|NCT02948088|69121759|FG000|Overall Study|Other|2|||
37651832|NCT02943915|69121798|FG000|Overall Study|Withdrawal by Subject|2|||
37651833|NCT02943915|69121799|FG001|Overall Study|Withdrawal by Subject|1|||
37651834|NCT02943915|69121800|FG002|Overall Study|Withdrawal by Subject|0|||
37651835|NCT02943915|69121801|FG003|Overall Study|Withdrawal by Subject|0|||
37651836|NCT02943915|69121798|FG000|Overall Study|Lost to Follow-up|3|||
37651837|NCT02943915|69121799|FG001|Overall Study|Lost to Follow-up|1|||
37651838|NCT02943915|69121800|FG002|Overall Study|Lost to Follow-up|0|||
37651839|NCT02943915|69121801|FG003|Overall Study|Lost to Follow-up|0|||
37651840|NCT02943915|69121798|FG000|Overall Study|excluded|0|||
37651841|NCT02943915|69121799|FG001|Overall Study|excluded|1|||
37651842|NCT02943915|69121800|FG002|Overall Study|excluded|0|||
37651843|NCT02943915|69121801|FG003|Overall Study|excluded|0|||
37651844|NCT02890355|69121812|FG000|Overall Study|Adverse Event|5|||
37651845|NCT02890355|69121813|FG001|Overall Study|Adverse Event|5|||
37651846|NCT02890355|69121812|FG000|Overall Study|Refusal unrelated to adverse event|5|||
37651847|NCT02890355|69121813|FG001|Overall Study|Refusal unrelated to adverse event|10|||
37651848|NCT02890355|69121812|FG000|Overall Study|Progression/relapse|46|||
37651849|NCT02890355|69121813|FG001|Overall Study|Progression/relapse|39|||
37651850|NCT02890355|69121812|FG000|Overall Study|Not protocol specified|3|||
37651851|NCT02890355|69121813|FG001|Overall Study|Not protocol specified|4|||
37651852|NCT02763384|69121821|FG000|Overall Study|Physician Decision|1|||
37651853|NCT02763384|69121821|FG000|Overall Study|Rapid decline - went on hospice|1|||
37651854|NCT02649855|69121828|FG000|Overall Study|Refused further treatment|2|||
37651855|NCT02649855|69121829|FG001|Overall Study|Refused further treatment|1|||
37651856|NCT02649855|69121830|FG002|Overall Study|Refused further treatment|1|||
37651857|NCT02649855|69121828|FG000|Overall Study|Withdrew consent|0|||
37651858|NCT02649855|69121829|FG001|Overall Study|Withdrew consent|1|||
37651859|NCT02649855|69121830|FG002|Overall Study|Withdrew consent|0|||
37651860|NCT02649855|69121828|FG000|Overall Study|Switched to alternative treatment|0|||
37651861|NCT02649855|69121829|FG001|Overall Study|Switched to alternative treatment|1|||
37651862|NCT02649855|69121830|FG002|Overall Study|Switched to alternative treatment|1|||
37651863|NCT02649855|69121828|FG000|Overall Study|Principal investigator discretion|0|||
37742218|NCT03745651|69228505|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
37651864|NCT02649855|69121829|FG001|Overall Study|Principal investigator discretion|1|||
37651865|NCT02649855|69121830|FG002|Overall Study|Principal investigator discretion|1|||
37651866|NCT02649855|69121828|FG000|Overall Study|No treatment, per protocol|1|||
37651867|NCT02649855|69121829|FG001|Overall Study|No treatment, per protocol|0|||
37651868|NCT02649855|69121830|FG002|Overall Study|No treatment, per protocol|0|||
37651869|NCT02649855|69121828|FG000|Overall Study|Initiate new treatment|1|||
37651870|NCT02649855|69121829|FG001|Overall Study|Initiate new treatment|0|||
37651871|NCT02649855|69121830|FG002|Overall Study|Initiate new treatment|0|||
37651872|NCT02642042|69121838|FG000|Overall Study|Adverse Event|22|||
37651873|NCT02642042|69121838|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
37651874|NCT02642042|69121838|FG000|Overall Study|Progression/Relapse|28|||
37651875|NCT02642042|69121838|FG000|Overall Study|Death|1|||
37651876|NCT02642042|69121838|FG000|Overall Study|Not Protocol Specified|2|||
37651877|NCT02619682|69121842|FG000|Overall Study|Withdrawal by Subject|3|||
37651878|NCT02619682|69121842|FG000|Overall Study|Lack of Efficacy|8|||
37651879|NCT02619682|69121842|FG000|Overall Study|new secondary cancer|1|||
37651880|NCT02619682|69121842|FG000|Overall Study|post surgery complications|2|||
37651881|NCT02613507|69121849|FG000|Overall Study|Disease Progression|237|||
37651882|NCT02613507|69121850|FG001|Overall Study|Disease Progression|109|||
37651883|NCT02613507|69121849|FG000|Overall Study|Study Drug Toxicity|15|||
37651884|NCT02613507|69121850|FG001|Overall Study|Study Drug Toxicity|14|||
37651885|NCT02613507|69121849|FG000|Overall Study|Death|3|||
37651886|NCT02613507|69121850|FG001|Overall Study|Death|0|||
37742219|NCT03745651|69228506|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
37651887|NCT02613507|69121849|FG000|Overall Study|Adverse Event Unrelated to Study Drug|17|||
37651888|NCT02613507|69121850|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
37651889|NCT02613507|69121849|FG000|Overall Study|Request to Discontinue Study Treatment|8|||
37651890|NCT02613507|69121850|FG001|Overall Study|Request to Discontinue Study Treatment|17|||
37855223|NCT01225731|69538433|FG010|Part 3|Physician Decision|0|||
37651891|NCT02613507|69121849|FG000|Overall Study|Participant Withdrew Consent|0|||
37651892|NCT02613507|69121850|FG001|Overall Study|Participant Withdrew Consent|2|||
37651893|NCT02613507|69121849|FG000|Overall Study|Lost to Follow-up|1|||
37651894|NCT02613507|69121850|FG001|Overall Study|Lost to Follow-up|0|||
37651895|NCT02613507|69121849|FG000|Overall Study|Maximum Clinical Benefit|4|||
37651896|NCT02613507|69121850|FG001|Overall Study|Maximum Clinical Benefit|10|||
37651897|NCT02613507|69121849|FG000|Overall Study|Brain Radiotherapy Activity Limited|1|||
37651898|NCT02613507|69121850|FG001|Overall Study|Brain Radiotherapy Activity Limited|0|||
37651899|NCT02613507|69121849|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
37651900|NCT02613507|69121850|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
37651901|NCT02613507|69121849|FG000|Overall Study|Randomized but not Treated|1|||
37651902|NCT02613507|69121850|FG001|Overall Study|Randomized but not Treated|10|||
37651903|NCT02581930|69121856|FG000|Overall Study|Withdrawal by Subject|1|||
37651904|NCT02581930|69121856|FG000|Overall Study|patient declined further treatment|1|||
37651905|NCT02521285|69121879|FG000|Overall Study|Lost to Follow-up|1|||
37651906|NCT02521285|69121880|FG001|Overall Study|Lost to Follow-up|1|||
37651907|NCT02521285|69121879|FG000|Overall Study|Withdrawal by Subject|1|||
37651908|NCT02521285|69121880|FG001|Overall Study|Withdrawal by Subject|1|||
37651909|NCT02521285|69121879|FG000|Overall Study|Adverse Event|0|||
37651910|NCT02521285|69121880|FG001|Overall Study|Adverse Event|1|||
37651911|NCT02331134|69121932|FG000|Overall Study|Withdrawal by Subject|1|||
37651912|NCT02257528|69121945|FG000|Overall Study|Never received study treatment|1|||
37651913|NCT02243605|69121951|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
37651914|NCT02243605|69121952|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
37651915|NCT02243605|69121951|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
37651916|NCT02243605|69121952|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
37651917|NCT02243605|69121951|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
37651918|NCT02243605|69121952|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
37651919|NCT02243605|69121951|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
37651920|NCT02243605|69121952|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
37651921|NCT02243605|69121951|FG000|Stage 2 - Final Analysis Population|Progression|0|||
37651922|NCT02243605|69121952|FG001|Stage 2 - Final Analysis Population|Progression|1|||
37651923|NCT01284348|69121995|FG000|Overall Study|Death|1|||
37651924|NCT01284348|69121996|FG001|Overall Study|Death|1|||
37651925|NCT01284348|69121995|FG000|Overall Study|Withdrew consent|0|||
37651926|NCT01284348|69121996|FG001|Overall Study|Withdrew consent|1|||
37742220|NCT03745651|69228507|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
37742221|NCT03745651|69228508|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
37742222|NCT03745651|69228509|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
37742223|NCT03745651|69228510|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
37651927|NCT01284348|69121995|FG000|Overall Study|Status not recorded|9|||
37651928|NCT01284348|69121996|FG001|Overall Study|Status not recorded|10|||
37651929|NCT01263769|69122002|FG000|Overall Study|Non-Compliant with treatment|1|||
37651930|NCT00727025|69122026|FG000|Overall Study|Physician Decision|23|||
37651931|NCT02701413|69122036|FG000|Overall Study|Withdrawal by Subject|7|||
37651932|NCT02701413|69122037|FG001|Overall Study|Withdrawal by Subject|11|||
37651933|NCT02582684|69122043|FG000|Overall Study|Unable to contact subject/parent|4|||
37651934|NCT02582684|69122043|FG000|Overall Study|Subject not able to get to clinic|10|||
37651935|NCT02582684|69122043|FG000|Overall Study|Subject withdrew consent|1|||
37651936|NCT02582684|69122043|FG000|Overall Study|Found to be ineligible after enrollment|2|||
37651937|NCT02585960|69122050|FG000|PK/Safety Assessment Period|Physician Decision|0|||
37651938|NCT02585960|69122051|FG001|PK/Safety Assessment Period|Physician Decision|1|||
37651939|NCT02585960|69122052|FG002|PK/Safety Assessment Period|Physician Decision|0|||
37651940|NCT02585960|69122050|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
37651941|NCT02585960|69122051|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
37651942|NCT02585960|69122052|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
37651943|NCT02585960|69122050|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
37651944|NCT02585960|69122051|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
37651945|NCT02585960|69122052|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
37651946|NCT02585960|69122050|FG000|PK/Safety Assessment Period|Other|4|||
37651947|NCT02585960|69122051|FG001|PK/Safety Assessment Period|Other|4|||
37651948|NCT02585960|69122052|FG002|PK/Safety Assessment Period|Other|0|||
37651949|NCT02585960|69122050|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
37651950|NCT02585960|69122051|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
37651951|NCT02585960|69122052|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
37651952|NCT02585960|69122050|FG000|PK/Safety Assessment Period|Screen Failure|0|||
37651953|NCT02585960|69122051|FG001|PK/Safety Assessment Period|Screen Failure|0|||
37651954|NCT02585960|69122052|FG002|PK/Safety Assessment Period|Screen Failure|1|||
37651955|NCT02585960|69122050|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
37651956|NCT02585960|69122051|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
37651957|NCT02585960|69122052|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
37651958|NCT02585960|69122050|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
37651959|NCT02585960|69122051|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
37651960|NCT02585960|69122052|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
37742224|NCT03745651|69228504|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
37855224|NCT01225731|69538434|FG011|Part 3|Physician Decision|1|||
37855225|NCT01225731|69538435|FG012|Part 3|Physician Decision|2|||
37651961|NCT02699463|69122065|FG000|Overall Study|Lost to Follow-up|11|||
37651962|NCT02699463|69122066|FG001|Overall Study|Lost to Follow-up|8|||
37651963|NCT02699463|69122065|FG000|Overall Study|Withdrawal by Subject|4|||
37651964|NCT02699463|69122066|FG001|Overall Study|Withdrawal by Subject|1|||
37651965|NCT00100789|69122072|FG000|Overall Study|Adverse Event|10|||
37651966|NCT00100789|69122072|FG000|Overall Study|Withdrawal by Subject|1|||
37651967|NCT00100789|69122072|FG000|Overall Study|Progression/relapse|42|||
37651968|NCT00100789|69122072|FG000|Overall Study|Death|2|||
37651969|NCT00100789|69122072|FG000|Overall Study|Not protocol specified|5|||
37651970|NCT00100789|69122072|FG000|Overall Study|Ineligible|3|||
37651971|NCT00100789|69122072|FG000|Overall Study|Never received treatment|1|||
37651972|NCT00708123|69122077|FG000|Period 1|Protocol Violation|0|||
37651973|NCT00708123|69122078|FG001|Period 1|Protocol Violation|1|||
37651974|NCT00708123|69122079|FG002|Period 1|Protocol Violation|0|||
37651975|NCT00708123|69122080|FG003|Period 1|Protocol Violation|1|||
37651976|NCT00708123|69122081|FG004|Period 1|Protocol Violation|0|||
37651977|NCT00708123|69122077|FG000|Period 1|Adverse Event|0|||
37651978|NCT00708123|69122078|FG001|Period 1|Adverse Event|0|||
37651979|NCT00708123|69122079|FG002|Period 1|Adverse Event|1|||
37651980|NCT00708123|69122080|FG003|Period 1|Adverse Event|0|||
37651981|NCT00708123|69122081|FG004|Period 1|Adverse Event|0|||
37651982|NCT00708123|69122077|FG000|Period 2|Protocol Violation|0|||
37651983|NCT00708123|69122078|FG001|Period 2|Protocol Violation|0|||
37651984|NCT00708123|69122079|FG002|Period 2|Protocol Violation|0|||
37651985|NCT00708123|69122080|FG003|Period 2|Protocol Violation|1|||
37651986|NCT00708123|69122081|FG004|Period 2|Protocol Violation|0|||
37651987|NCT00708123|69122077|FG000|Period 2|Other Reason|1|||
37651988|NCT00708123|69122078|FG001|Period 2|Other Reason|0|||
37651989|NCT00708123|69122079|FG002|Period 2|Other Reason|0|||
37651990|NCT00708123|69122080|FG003|Period 2|Other Reason|0|||
37651991|NCT00708123|69122081|FG004|Period 2|Other Reason|0|||
37651992|NCT00708123|69122077|FG000|Period 3|Lost to Follow-up|0|||
37651993|NCT00708123|69122078|FG001|Period 3|Lost to Follow-up|0|||
37651994|NCT00708123|69122079|FG002|Period 3|Lost to Follow-up|1|||
37651995|NCT00708123|69122080|FG003|Period 3|Lost to Follow-up|1|||
37651996|NCT00708123|69122081|FG004|Period 3|Lost to Follow-up|0|||
37651997|NCT00708123|69122077|FG000|Period 4|Protocol Violation|0|||
37651998|NCT00708123|69122078|FG001|Period 4|Protocol Violation|1|||
37651999|NCT00708123|69122079|FG002|Period 4|Protocol Violation|0|||
37652000|NCT00708123|69122080|FG003|Period 4|Protocol Violation|0|||
37652001|NCT00708123|69122081|FG004|Period 4|Protocol Violation|0|||
37652002|NCT02165215|69122100|FG000|Induction Phase|Adverse Event|1|||
37652003|NCT02165215|69122101|FG001|Induction Phase|Adverse Event|0|||
37652004|NCT02165215|69122102|FG002|Induction Phase|Adverse Event|0|||
37652005|NCT02165215|69122100|FG000|Induction Phase|Withdrawal by Subject|10|||
37652006|NCT02165215|69122101|FG001|Induction Phase|Withdrawal by Subject|0|||
37652007|NCT02165215|69122102|FG002|Induction Phase|Withdrawal by Subject|0|||
37652008|NCT02165215|69122100|FG000|Induction Phase|Protocol Violation|1|||
37652009|NCT02165215|69122101|FG001|Induction Phase|Protocol Violation|0|||
37652010|NCT02165215|69122102|FG002|Induction Phase|Protocol Violation|0|||
37652011|NCT02165215|69122100|FG000|Induction Phase|Physician Decision|1|||
37652012|NCT02165215|69122101|FG001|Induction Phase|Physician Decision|0|||
37652013|NCT02165215|69122102|FG002|Induction Phase|Physician Decision|0|||
37652014|NCT02165215|69122100|FG000|Induction Phase|Lack of Efficacy|2|||
37652015|NCT02165215|69122101|FG001|Induction Phase|Lack of Efficacy|0|||
37652016|NCT02165215|69122102|FG002|Induction Phase|Lack of Efficacy|0|||
37652017|NCT02165215|69122100|FG000|Induction Phase|Non-Compliance|2|||
37652018|NCT02165215|69122101|FG001|Induction Phase|Non-Compliance|0|||
37652019|NCT02165215|69122102|FG002|Induction Phase|Non-Compliance|0|||
37652020|NCT02165215|69122100|FG000|Induction Phase|Lost to Follow-up|6|||
37652021|NCT02165215|69122101|FG001|Induction Phase|Lost to Follow-up|0|||
37652022|NCT02165215|69122102|FG002|Induction Phase|Lost to Follow-up|0|||
37652023|NCT02165215|69122100|FG000|Maintenance Phase|Withdrawal by Subject|0|||
37652024|NCT02165215|69122101|FG001|Maintenance Phase|Withdrawal by Subject|7|||
37652025|NCT02165215|69122102|FG002|Maintenance Phase|Withdrawal by Subject|3|||
37652026|NCT02165215|69122100|FG000|Maintenance Phase|Multiple reasons|0|||
37652027|NCT02165215|69122101|FG001|Maintenance Phase|Multiple reasons|2|||
37652028|NCT02165215|69122102|FG002|Maintenance Phase|Multiple reasons|1|||
37652029|NCT02165215|69122100|FG000|Maintenance Phase|Lost to Follow-up|0|||
37652030|NCT02165215|69122101|FG001|Maintenance Phase|Lost to Follow-up|2|||
37652031|NCT02165215|69122102|FG002|Maintenance Phase|Lost to Follow-up|0|||
37652032|NCT02165215|69122100|FG000|Maintenance Phase|Adverse Event|0|||
37652033|NCT02165215|69122101|FG001|Maintenance Phase|Adverse Event|1|||
37652034|NCT02165215|69122102|FG002|Maintenance Phase|Adverse Event|1|||
37652035|NCT02757625|69122117|FG000|Overall Study|Investigator's discretion|0|||
37652036|NCT02757625|69122118|FG001|Overall Study|Investigator's discretion|0|||
37652037|NCT02757625|69122119|FG002|Overall Study|Investigator's discretion|1|||
37652038|NCT02757625|69122120|FG003|Overall Study|Investigator's discretion|0|||
37652039|NCT02757625|69122117|FG000|Overall Study|Adverse Event|0|||
37652040|NCT02757625|69122118|FG001|Overall Study|Adverse Event|0|||
37652041|NCT02757625|69122119|FG002|Overall Study|Adverse Event|1|||
37652042|NCT02757625|69122120|FG003|Overall Study|Adverse Event|0|||
37652043|NCT02581202|69122132|FG000|Overall Study|Lack of Efficacy|2|||
37652044|NCT02581202|69122132|FG000|Overall Study|Withdrawal by Subject|4|||
37652045|NCT02581202|69122132|FG000|Overall Study|Lost to Follow-up|5|||
37652046|NCT02581202|69122132|FG000|Overall Study|Pregnancy|3|||
37652047|NCT02758171|69122139|FG000|Wash-out|Withdrawal by Subject|1|||
37652048|NCT02758171|69122140|FG001|Wash-out|Withdrawal by Subject|0|||
37652049|NCT02758171|69122139|FG000|Wash-out|Other reason|1|||
37652050|NCT02758171|69122140|FG001|Wash-out|Other reason|0|||
37652051|NCT01664078|69122155|FG000|Overall Study|Death|9|||
37652052|NCT01664078|69122155|FG000|Overall Study|Withdrawal by Subject|4|||
37652053|NCT01664078|69122155|FG000|Overall Study|Lost to Follow-up|2|||
37652054|NCT01664078|69122155|FG000|Overall Study|missed 5 year visit|1|||
37652055|NCT01664078|69122155|FG000|Overall Study|Other|53|||
37652056|NCT03367403|69122208|FG000|Overall Study|Adverse Event|20|||
37652057|NCT03367403|69122209|FG001|Overall Study|Adverse Event|6|||
37652058|NCT03367403|69122210|FG002|Overall Study|Adverse Event|2|||
37652059|NCT03367403|69122208|FG000|Overall Study|Withdrawal by Subject|12|||
37652060|NCT03367403|69122209|FG001|Overall Study|Withdrawal by Subject|13|||
37652061|NCT03367403|69122210|FG002|Overall Study|Withdrawal by Subject|1|||
37652062|NCT03367403|69122208|FG000|Overall Study|Death|1|||
37652063|NCT03367403|69122209|FG001|Overall Study|Death|2|||
37652064|NCT03367403|69122210|FG002|Overall Study|Death|0|||
37652065|NCT03367403|69122208|FG000|Overall Study|Physician Decision|0|||
37652066|NCT03367403|69122209|FG001|Overall Study|Physician Decision|1|||
37652067|NCT03367403|69122210|FG002|Overall Study|Physician Decision|0|||
37652068|NCT03367403|69122208|FG000|Overall Study|Protocol Violation|1|||
37652069|NCT03367403|69122209|FG001|Overall Study|Protocol Violation|1|||
37652070|NCT03367403|69122210|FG002|Overall Study|Protocol Violation|0|||
37652071|NCT03367403|69122208|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
37652072|NCT03367403|69122209|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
37652073|NCT03367403|69122210|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
37652074|NCT03367403|69122208|FG000|Overall Study|COVID-19|3|||
37652075|NCT03367403|69122209|FG001|Overall Study|COVID-19|6|||
37652076|NCT03367403|69122210|FG002|Overall Study|COVID-19|0|||
37652077|NCT03367403|69122208|FG000|Overall Study|Abuse of Alcohol Intake|0|||
37652078|NCT03367403|69122209|FG001|Overall Study|Abuse of Alcohol Intake|1|||
37652079|NCT03367403|69122210|FG002|Overall Study|Abuse of Alcohol Intake|0|||
37652080|NCT03367403|69122208|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
37652081|NCT03367403|69122209|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
37652082|NCT03367403|69122210|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
37652083|NCT02577146|69122218|FG000|Overall Study|Lost to Follow-up|8|||
37652084|NCT02577146|69122218|FG000|Overall Study|Physician Decision|3|||
37652085|NCT02577146|69122218|FG000|Overall Study|Screen Failure|17|||
37652086|NCT00109967|69122224|FG000|Overall Study|Cancel Prior to Treatment|2|||
37652087|NCT00109967|69122225|FG001|Overall Study|Cancel Prior to Treatment|0|||
37652088|NCT00109967|69122224|FG000|Overall Study|Adverse Event|12|||
37652089|NCT00109967|69122225|FG001|Overall Study|Adverse Event|1|||
37652090|NCT00109967|69122224|FG000|Overall Study|Withdrawal by Subject|5|||
37652091|NCT00109967|69122225|FG001|Overall Study|Withdrawal by Subject|0|||
37652092|NCT00109967|69122224|FG000|Overall Study|Physician Decision|1|||
37652093|NCT00109967|69122225|FG001|Overall Study|Physician Decision|3|||
37652094|NCT00109967|69122224|FG000|Overall Study|Death|0|||
37652095|NCT00109967|69122225|FG001|Overall Study|Death|2|||
37652096|NCT02579096|69122233|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
37652097|NCT02579096|69122234|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
37652098|NCT02579096|69122233|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
37652099|NCT02579096|69122234|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
37652100|NCT02579096|69122233|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
37652101|NCT02579096|69122234|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
37652102|NCT02579096|69122233|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
37652103|NCT02579096|69122234|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
37652104|NCT02579096|69122233|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
37855226|NCT01225731|69538423|FG000|Part 3|Withdrawal by Subject|0|||
37855227|NCT01225731|69538424|FG001|Part 3|Withdrawal by Subject|0|||
37855228|NCT01225731|69538425|FG002|Part 3|Withdrawal by Subject|0|||
37855229|NCT01225731|69538426|FG003|Part 3|Withdrawal by Subject|0|||
37855230|NCT01225731|69538427|FG004|Part 3|Withdrawal by Subject|0|||
37855231|NCT01225731|69538428|FG005|Part 3|Withdrawal by Subject|0|||
37855232|NCT01225731|69538429|FG006|Part 3|Withdrawal by Subject|0|||
37652105|NCT02579096|69122234|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
37652106|NCT02579096|69122233|FG000|Phase 2, Weeks 25 - 48|Death|2|||
37652107|NCT02579096|69122234|FG001|Phase 2, Weeks 25 - 48|Death|4|||
37652108|NCT02579096|69122233|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
37855233|NCT01225731|69538430|FG007|Part 3|Withdrawal by Subject|0|||
37855234|NCT01225731|69538431|FG008|Part 3|Withdrawal by Subject|0|||
37922582|NCT00873041|69609305|FG001|Extension Study|Administrative reasons|0|||
37652109|NCT02579096|69122234|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
37652110|NCT02579096|69122233|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
38032422|NCT01358734|69718355|FG002|Overall Study|Other|4|||
38032423|NCT01358734|69718353|FG000|Overall Study|Protocol Violation|0|||
38032424|NCT01358734|69718354|FG001|Overall Study|Protocol Violation|0|||
38032425|NCT01358734|69718355|FG002|Overall Study|Protocol Violation|2|||
38032426|NCT01341652|69718365|FG000|Overall Study|Incorrect Random Assignment|0|||
38032427|NCT01341652|69718366|FG001|Overall Study|Incorrect Random Assignment|1|||
38032428|NCT01341652|69718365|FG000|Overall Study|ineligible; presence metastatic disease|0|||
38032429|NCT01341652|69718366|FG001|Overall Study|ineligible; presence metastatic disease|1|||
38032430|NCT02828644|69718374|FG000|Overall Study|Lost to Follow-up|23|||
38032431|NCT02828644|69718375|FG001|Overall Study|Lost to Follow-up|22|||
38032432|NCT02949362|69718384|FG000|Retrospective Period|Inform consent not signed by participant|4|||
38032433|NCT02949362|69718385|FG001|Retrospective Period|Inform consent not signed by participant|1|||
38032434|NCT02949362|69718386|FG002|Retrospective Period|Inform consent not signed by participant|0|||
38032435|NCT02949362|69718387|FG003|Retrospective Period|Inform consent not signed by participant|0|||
38032436|NCT02949362|69718384|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
38032437|NCT02949362|69718385|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
38032438|NCT02949362|69718386|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
38032439|NCT02949362|69718387|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
38032440|NCT02949362|69718384|FG000|Prospective Period|Other|0|||
38032441|NCT02949362|69718385|FG001|Prospective Period|Other|0|||
38032442|NCT02949362|69718386|FG002|Prospective Period|Other|0|||
38032443|NCT02949362|69718387|FG003|Prospective Period|Other|4|||
38032444|NCT02947022|69718399|FG000|Overall Study|Study Stopped|1|||
38032445|NCT03338972|69718410|FG000|Overall Study|Death|1|||
38032446|NCT03338972|69718411|FG001|Overall Study|Death|1|||
38032447|NCT03338972|69718412|FG002|Overall Study|Death|0|||
38032448|NCT03338972|69718413|FG003|Overall Study|Death|0|||
38032449|NCT03338972|69718410|FG000|Overall Study|Withdrawal by Subject|1|||
38032450|NCT03338972|69718411|FG001|Overall Study|Withdrawal by Subject|0|||
38032451|NCT03338972|69718412|FG002|Overall Study|Withdrawal by Subject|0|||
38032452|NCT03338972|69718413|FG003|Overall Study|Withdrawal by Subject|0|||
38032453|NCT03338816|69718429|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
38032454|NCT03338816|69718430|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
38032455|NCT03338816|69718431|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
38032456|NCT03338816|69718432|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
38032457|NCT03338816|69718429|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
37652111|NCT02579096|69122234|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
37652112|NCT02579096|69122233|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
37652113|NCT02579096|69122234|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
37652114|NCT02579096|69122233|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
37652115|NCT02579096|69122234|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
37652116|NCT02579096|69122233|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
37652117|NCT02579096|69122234|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
37652118|NCT02579096|69122233|FG000|Phase 3, Weeks 49 - 72|Death|3|||
37652119|NCT02579096|69122234|FG001|Phase 3, Weeks 49 - 72|Death|2|||
37652120|NCT02579096|69122233|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
37652121|NCT02579096|69122234|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
37652122|NCT02579096|69122233|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
37652123|NCT02579096|69122234|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
37652124|NCT02579096|69122233|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
37652125|NCT02579096|69122234|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
37652126|NCT02579096|69122233|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
37652127|NCT02579096|69122234|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
37652128|NCT02579096|69122233|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
37652129|NCT02579096|69122234|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
37652130|NCT02579096|69122233|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
37652131|NCT02579096|69122234|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
37652132|NCT02578940|69122240|FG000|Overall Study|Screening failure|5|||
37652133|NCT02578940|69122240|FG000|Overall Study|Lost to Follow-up|1|||
37652134|NCT02578862|69122248|FG000|Overall Study|Withdrawal by Subject|0|||
37652135|NCT02578862|69122249|FG001|Overall Study|Withdrawal by Subject|1|||
37742225|NCT03745651|69228505|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
37742226|NCT03745651|69228506|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
37742227|NCT03745651|69228507|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
37742228|NCT03745651|69228508|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
37742229|NCT03745651|69228509|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
37742230|NCT03745651|69228510|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
37652136|NCT02578862|69122248|FG000|Overall Study|Unplanned unilateral procedure|0|||
38032458|NCT03338816|69718430|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
38032459|NCT03338816|69718431|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
38032460|NCT03338816|69718432|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
37652137|NCT02578862|69122249|FG001|Overall Study|Unplanned unilateral procedure|1|||
37652138|NCT02578706|69122258|FG000|Overall Study|Withdrawal by Subject|1|||
37652139|NCT02578706|69122259|FG001|Overall Study|Withdrawal by Subject|0|||
37652140|NCT02578706|69122260|FG002|Overall Study|Withdrawal by Subject|0|||
37652141|NCT02578706|69122258|FG000|Overall Study|Lost to Follow-up|0|||
37652142|NCT02578706|69122259|FG001|Overall Study|Lost to Follow-up|4|||
37652143|NCT02578706|69122260|FG002|Overall Study|Lost to Follow-up|0|||
37652144|NCT02578706|69122258|FG000|Overall Study|Physician Decision|0|||
37922583|NCT00873041|69609306|FG002|Extension Study|Administrative reasons|1|||
37922584|NCT00458341|69609323|FG000|Cycle 1|Adverse Event|1|||
37922585|NCT00458341|69609324|FG001|Cycle 1|Adverse Event|0|||
37922586|NCT00816036|69609332|FG000|Overall Study|Death|47|||
37922587|NCT00816036|69609333|FG001|Overall Study|Death|28|||
37922588|NCT00816036|69609332|FG000|Overall Study|Lost to Follow-up|75|||
37922589|NCT00816036|69609333|FG001|Overall Study|Lost to Follow-up|57|||
37922590|NCT00816036|69609332|FG000|Overall Study|Withdrawal by Subject|54|||
37922591|NCT00816036|69609333|FG001|Overall Study|Withdrawal by Subject|23|||
38032461|NCT03338816|69718429|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
38032462|NCT03338816|69718430|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
38032463|NCT03338816|69718431|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
37652145|NCT02578706|69122259|FG001|Overall Study|Physician Decision|1|||
37652146|NCT02578706|69122260|FG002|Overall Study|Physician Decision|0|||
37652147|NCT00108953|69122270|FG000|Follow-up|Death|18|||
37652148|NCT00108953|69122271|FG001|Follow-up|Death|26|||
37652149|NCT00108953|69122270|FG000|Follow-up|Lost to Follow-up|1|||
37652150|NCT00108953|69122271|FG001|Follow-up|Lost to Follow-up|1|||
37652151|NCT00108953|69122270|FG000|Follow-up|Study terminated by sponsor|10|||
37652152|NCT00108953|69122271|FG001|Follow-up|Study terminated by sponsor|6|||
37652153|NCT02578316|69122279|FG000|Extension Phase|Progression of disease|6|||
37742231|NCT03745651|69228504|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
37742232|NCT03745651|69228505|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
37742233|NCT03745651|69228506|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
37742234|NCT03745651|69228507|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
37742235|NCT03745651|69228508|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
37742236|NCT03745651|69228509|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
38032464|NCT03338816|69718432|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
38032465|NCT03338816|69718429|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
38032466|NCT03338816|69718430|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
38032467|NCT03338816|69718431|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
38032468|NCT03338816|69718432|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
38032469|NCT03338816|69718429|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
37742237|NCT03745651|69228510|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
37742238|NCT03745651|69228504|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
37742239|NCT03745651|69228505|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
37742240|NCT03745651|69228506|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
37742241|NCT03745651|69228507|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
37742242|NCT03745651|69228508|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
37742243|NCT03745651|69228509|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
37742244|NCT03745651|69228510|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
37742245|NCT03745651|69228504|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
37742246|NCT03745651|69228505|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
37742247|NCT03745651|69228506|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
37742248|NCT03745651|69228507|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
37742249|NCT03745651|69228508|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
37742250|NCT03745651|69228509|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
37742251|NCT03745651|69228510|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
37742252|NCT03745651|69228504|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
37742253|NCT03745651|69228505|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
37742254|NCT03745651|69228506|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
37742255|NCT03745651|69228507|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
37742256|NCT03745651|69228508|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
37742257|NCT03745651|69228509|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
38032470|NCT03338816|69718430|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
37652154|NCT02576678|69122290|FG000|Overall Study|Adverse Event|0|||
37742258|NCT03745651|69228510|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
37922592|NCT00664534|69609341|FG000|Overall Study|Adverse Event|2|||
37922593|NCT00664534|69609342|FG001|Overall Study|Adverse Event|3|||
37652155|NCT02576678|69122291|FG001|Overall Study|Adverse Event|0|||
37652156|NCT02576678|69122292|FG002|Overall Study|Adverse Event|2|||
37652157|NCT02576678|69122290|FG000|Overall Study|Withdrawal by Subject|3|||
37652158|NCT02576678|69122291|FG001|Overall Study|Withdrawal by Subject|1|||
38032471|NCT03338816|69718431|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
38032472|NCT03338816|69718432|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
38032473|NCT03338816|69718429|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
38032474|NCT03338816|69718430|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
38032475|NCT03338816|69718431|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
38032476|NCT03338816|69718432|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
38032477|NCT03338816|69718429|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
38032478|NCT03338816|69718430|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
38032479|NCT03338816|69718431|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
38032480|NCT03338816|69718432|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
38032481|NCT03337490|69718444|FG000|Overall Study|Withdrawal by Subject|1|||
38032482|NCT03337490|69718445|FG001|Overall Study|Withdrawal by Subject|0|||
38032483|NCT03337490|69718446|FG002|Overall Study|Withdrawal by Subject|0|||
38032484|NCT03337490|69718444|FG000|Overall Study|Lack of Efficacy|10|||
38032485|NCT03337490|69718445|FG001|Overall Study|Lack of Efficacy|12|||
38032486|NCT03337490|69718446|FG002|Overall Study|Lack of Efficacy|35|||
38032487|NCT03337490|69718444|FG000|Overall Study|Physician Decision|0|||
38032488|NCT03337490|69718445|FG001|Overall Study|Physician Decision|1|||
38032489|NCT03337490|69718446|FG002|Overall Study|Physician Decision|0|||
37652159|NCT02576678|69122292|FG002|Overall Study|Withdrawal by Subject|2|||
37652160|NCT02576678|69122290|FG000|Overall Study|Lost to Follow-up|0|||
37652161|NCT02576678|69122291|FG001|Overall Study|Lost to Follow-up|0|||
37652162|NCT02576678|69122292|FG002|Overall Study|Lost to Follow-up|1|||
37652163|NCT02576678|69122290|FG000|Overall Study|Miscellaneous|2|||
37652164|NCT02576678|69122291|FG001|Overall Study|Miscellaneous|0|||
37652165|NCT02576678|69122292|FG002|Overall Study|Miscellaneous|0|||
37652166|NCT00108745|69122303|FG000|Overall Study|Withdrawal by Subject|19|||
37652167|NCT00108745|69122304|FG001|Overall Study|Withdrawal by Subject|12|||
37652168|NCT00108745|69122305|FG002|Overall Study|Withdrawal by Subject|12|||
37652169|NCT00108745|69122303|FG000|Overall Study|Never Treated|8|||
37652170|NCT00108745|69122304|FG001|Overall Study|Never Treated|10|||
37652171|NCT00108745|69122305|FG002|Overall Study|Never Treated|12|||
37652172|NCT00108745|69122303|FG000|Overall Study|Ineligible|7|||
37652173|NCT00108745|69122304|FG001|Overall Study|Ineligible|13|||
37652174|NCT00108745|69122305|FG002|Overall Study|Ineligible|13|||
37652175|NCT02716805|69122335|FG000|Overall Study|Progressive disease|2|||
37652176|NCT02716805|69122336|FG001|Overall Study|Progressive disease|0|||
37652177|NCT02716805|69122337|FG002|Overall Study|Progressive disease|0|||
37652178|NCT02716805|69122338|FG003|Overall Study|Progressive disease|0|||
37652179|NCT02581982|69122342|FG000|Overall Study|Lack of Efficacy|12|||
37652180|NCT02581982|69122342|FG000|Overall Study|Adverse Event|3|||
37652181|NCT02581982|69122342|FG000|Overall Study|Physician Decision|1|||
37652182|NCT04318132|69122396|FG000|Overall Study|Protocol Violation|0|||
37652183|NCT04318132|69122397|FG001|Overall Study|Protocol Violation|0|||
37652184|NCT04318132|69122398|FG002|Overall Study|Protocol Violation|3|||
37652185|NCT04318132|69122399|FG003|Overall Study|Protocol Violation|0|||
37652186|NCT04271254|69122415|FG000|Overall Study|Withdrawal by Subject|3|||
37652187|NCT03938636|69122435|FG000|Overall Study|Protocol Violation|0|||
37652188|NCT03938636|69122436|FG001|Overall Study|Protocol Violation|1|||
37652189|NCT03938636|69122437|FG002|Overall Study|Protocol Violation|1|||
37652190|NCT03938636|69122435|FG000|Overall Study|Subject withdrew due to death in family|0|||
37652191|NCT03938636|69122436|FG001|Overall Study|Subject withdrew due to death in family|1|||
37652192|NCT03938636|69122437|FG002|Overall Study|Subject withdrew due to death in family|0|||
37652193|NCT03938636|69122435|FG000|Overall Study|Missed visit|0|||
37652194|NCT03938636|69122436|FG001|Overall Study|Missed visit|1|||
37652195|NCT03938636|69122437|FG002|Overall Study|Missed visit|0|||
37652196|NCT03938636|69122435|FG000|Overall Study|Adverse Event|0|||
37652197|NCT03938636|69122436|FG001|Overall Study|Adverse Event|0|||
37652198|NCT03938636|69122437|FG002|Overall Study|Adverse Event|1|||
37652199|NCT03938636|69122435|FG000|Overall Study|Lost to Follow-up|0|||
37652200|NCT03938636|69122436|FG001|Overall Study|Lost to Follow-up|0|||
37652201|NCT03938636|69122437|FG002|Overall Study|Lost to Follow-up|1|||
37652202|NCT03836716|69122462|FG000|Overall Study|Adverse Event|3|||
37652203|NCT03836716|69122462|FG000|Overall Study|Death|22|||
38032490|NCT03337490|69718444|FG000|Overall Study|Lost to Follow-up|0|||
38032491|NCT03337490|69718445|FG001|Overall Study|Lost to Follow-up|1|||
37652204|NCT03836716|69122462|FG000|Overall Study|Withdrawal by Subject|8|||
37652205|NCT03836716|69122462|FG000|Overall Study|Study terminated by sponsor|87|||
37652206|NCT03686215|69122469|FG000|Overall Study|Adverse Event|0|||
37652207|NCT03686215|69122470|FG001|Overall Study|Adverse Event|0|||
37652208|NCT03686215|69122471|FG002|Overall Study|Adverse Event|7|||
37652209|NCT03686215|69122469|FG000|Overall Study|Physician Decision|0|||
37652210|NCT03686215|69122470|FG001|Overall Study|Physician Decision|0|||
37652211|NCT03686215|69122471|FG002|Overall Study|Physician Decision|1|||
37652212|NCT03686215|69122469|FG000|Overall Study|Protocol Violation|0|||
37652213|NCT03686215|69122470|FG001|Overall Study|Protocol Violation|0|||
37652214|NCT03686215|69122471|FG002|Overall Study|Protocol Violation|4|||
37652215|NCT03686215|69122469|FG000|Overall Study|Device issue|1|||
37652216|NCT03686215|69122470|FG001|Overall Study|Device issue|0|||
37652217|NCT03686215|69122471|FG002|Overall Study|Device issue|2|||
37652218|NCT03665077|69122479|FG000|Overall Study|Lost to Follow-up|2|||
37652219|NCT03665077|69122479|FG000|Overall Study|Physician Decision|2|||
37652220|NCT03606174|69122494|FG000|Overall Study|Death|37|||
37652221|NCT03606174|69122495|FG001|Overall Study|Death|15|||
37652222|NCT03606174|69122496|FG002|Overall Study|Death|15|||
37652223|NCT03606174|69122497|FG003|Overall Study|Death|7|||
37652224|NCT03606174|69122498|FG004|Overall Study|Death|35|||
37652225|NCT03606174|69122499|FG005|Overall Study|Death|12|||
37652226|NCT03606174|69122500|FG006|Overall Study|Death|35|||
37652227|NCT03606174|69122501|FG007|Overall Study|Death|8|||
37652228|NCT03606174|69122502|FG008|Overall Study|Death|5|||
37652229|NCT03606174|69122503|FG009|Overall Study|Death|3|||
37652230|NCT03606174|69122504|FG010|Overall Study|Death|0|||
37652231|NCT03606174|69122494|FG000|Overall Study|Lost to Follow-up|0|||
37652232|NCT03606174|69122495|FG001|Overall Study|Lost to Follow-up|0|||
37652233|NCT03606174|69122496|FG002|Overall Study|Lost to Follow-up|0|||
37652234|NCT03606174|69122497|FG003|Overall Study|Lost to Follow-up|0|||
37652235|NCT03606174|69122498|FG004|Overall Study|Lost to Follow-up|1|||
37652236|NCT03606174|69122499|FG005|Overall Study|Lost to Follow-up|1|||
37652237|NCT03606174|69122500|FG006|Overall Study|Lost to Follow-up|0|||
37652238|NCT03606174|69122501|FG007|Overall Study|Lost to Follow-up|0|||
37652239|NCT03606174|69122502|FG008|Overall Study|Lost to Follow-up|0|||
37922594|NCT00664534|69609341|FG000|Overall Study|Lost to Follow-up|6|||
38032492|NCT03337490|69718446|FG002|Overall Study|Lost to Follow-up|0|||
38032493|NCT02944448|69718456|FG000|Overall Study|Adverse Event|37|||
37652240|NCT03606174|69122503|FG009|Overall Study|Lost to Follow-up|0|||
37652241|NCT03606174|69122504|FG010|Overall Study|Lost to Follow-up|0|||
37652242|NCT03606174|69122494|FG000|Overall Study|Withdrawal by Subject|6|||
37652243|NCT03606174|69122495|FG001|Overall Study|Withdrawal by Subject|0|||
37652244|NCT03606174|69122496|FG002|Overall Study|Withdrawal by Subject|0|||
37652245|NCT03606174|69122497|FG003|Overall Study|Withdrawal by Subject|1|||
37652246|NCT03606174|69122498|FG004|Overall Study|Withdrawal by Subject|2|||
37652247|NCT03606174|69122499|FG005|Overall Study|Withdrawal by Subject|1|||
37652248|NCT03606174|69122500|FG006|Overall Study|Withdrawal by Subject|4|||
37652249|NCT03606174|69122501|FG007|Overall Study|Withdrawal by Subject|0|||
37652250|NCT03606174|69122502|FG008|Overall Study|Withdrawal by Subject|0|||
37652251|NCT03606174|69122503|FG009|Overall Study|Withdrawal by Subject|0|||
37652252|NCT03606174|69122504|FG010|Overall Study|Withdrawal by Subject|1|||
37652253|NCT03606174|69122494|FG000|Overall Study|Study Terminated by Sponsor|5|||
37652254|NCT03606174|69122495|FG001|Overall Study|Study Terminated by Sponsor|7|||
37652255|NCT03606174|69122496|FG002|Overall Study|Study Terminated by Sponsor|3|||
37652256|NCT03606174|69122497|FG003|Overall Study|Study Terminated by Sponsor|0|||
37652257|NCT03606174|69122498|FG004|Overall Study|Study Terminated by Sponsor|11|||
37652258|NCT03606174|69122499|FG005|Overall Study|Study Terminated by Sponsor|6|||
37652259|NCT03606174|69122500|FG006|Overall Study|Study Terminated by Sponsor|12|||
37652260|NCT03606174|69122501|FG007|Overall Study|Study Terminated by Sponsor|1|||
37652261|NCT03606174|69122502|FG008|Overall Study|Study Terminated by Sponsor|3|||
37652262|NCT03606174|69122503|FG009|Overall Study|Study Terminated by Sponsor|1|||
37652263|NCT03606174|69122504|FG010|Overall Study|Study Terminated by Sponsor|2|||
37652264|NCT03606174|69122494|FG000|Overall Study|Miscellaneous|1|||
37652265|NCT03606174|69122495|FG001|Overall Study|Miscellaneous|1|||
37652266|NCT03606174|69122496|FG002|Overall Study|Miscellaneous|0|||
37652267|NCT03606174|69122497|FG003|Overall Study|Miscellaneous|1|||
37652268|NCT03606174|69122498|FG004|Overall Study|Miscellaneous|4|||
37652269|NCT03606174|69122499|FG005|Overall Study|Miscellaneous|7|||
37652270|NCT03606174|69122500|FG006|Overall Study|Miscellaneous|5|||
37742259|NCT03745651|69228504|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
37742260|NCT03745651|69228505|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
37742261|NCT03745651|69228506|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
37742262|NCT03745651|69228507|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
37742263|NCT03745651|69228508|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
37742264|NCT03745651|69228509|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
37742265|NCT03745651|69228510|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
37742266|NCT03745651|69228504|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
37742267|NCT03745651|69228505|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
37742268|NCT03745651|69228506|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
37742269|NCT03745651|69228507|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
37742270|NCT03745651|69228508|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
37742271|NCT03745651|69228509|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
37742272|NCT03745651|69228510|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
37742273|NCT03745651|69228504|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
38032494|NCT02944448|69718457|FG001|Overall Study|Adverse Event|6|||
37652271|NCT03606174|69122501|FG007|Overall Study|Miscellaneous|0|||
38032495|NCT02944448|69718456|FG000|Overall Study|Lack of Efficacy|8|||
37652272|NCT03606174|69122502|FG008|Overall Study|Miscellaneous|0|||
37652273|NCT03606174|69122503|FG009|Overall Study|Miscellaneous|0|||
37652274|NCT03606174|69122504|FG010|Overall Study|Miscellaneous|1|||
38032496|NCT02944448|69718457|FG001|Overall Study|Lack of Efficacy|5|||
37652275|NCT03450707|69122534|FG000|Overall Study|Outside enrollment window|4|||
37652276|NCT03450707|69122535|FG001|Overall Study|Outside enrollment window|1|||
37652277|NCT03450707|69122534|FG000|Overall Study|Death|1|||
37652278|NCT03450707|69122535|FG001|Overall Study|Death|0|||
37652279|NCT03450707|69122534|FG000|Overall Study|Indication for thiamine|1|||
37652280|NCT03450707|69122535|FG001|Overall Study|Indication for thiamine|1|||
37652281|NCT03450707|69122534|FG000|Overall Study|Evidence of traumatic brain injury|1|||
37652282|NCT03450707|69122535|FG001|Overall Study|Evidence of traumatic brain injury|0|||
37652283|NCT03450707|69122534|FG000|Overall Study|Following commands|0|||
37652284|NCT03450707|69122535|FG001|Overall Study|Following commands|3|||
37652285|NCT03450707|69122534|FG000|Overall Study|Lactate < 3.5|0|||
37652286|NCT03450707|69122535|FG001|Overall Study|Lactate < 3.5|2|||
37652287|NCT03450707|69122534|FG000|Overall Study|Rearrest with ECMO|0|||
37652288|NCT03450707|69122535|FG001|Overall Study|Rearrest with ECMO|1|||
37652289|NCT03450707|69122534|FG000|Overall Study|Indication for thiamine + head CT results|0|||
37652290|NCT03450707|69122535|FG001|Overall Study|Indication for thiamine + head CT results|1|||
37652291|NCT03450707|69122534|FG000|Overall Study|Family/patient goals of care|0|||
37652292|NCT03450707|69122535|FG001|Overall Study|Family/patient goals of care|1|||
38032497|NCT02944448|69718456|FG000|Overall Study|Lost to Follow-up|3|||
38032498|NCT02944448|69718457|FG001|Overall Study|Lost to Follow-up|1|||
38032499|NCT02944448|69718456|FG000|Overall Study|Protocol Violation|25|||
38032500|NCT02944448|69718457|FG001|Overall Study|Protocol Violation|7|||
38032501|NCT02944448|69718456|FG000|Overall Study|Withdrawal by Subject|14|||
38032502|NCT02944448|69718457|FG001|Overall Study|Withdrawal by Subject|4|||
38032503|NCT02944448|69718456|FG000|Overall Study|Sponsor did not supply drug in time|0|||
38032504|NCT02944448|69718457|FG001|Overall Study|Sponsor did not supply drug in time|1|||
38032505|NCT02944448|69718456|FG000|Overall Study|Noncompliant with dosing|1|||
38032506|NCT02944448|69718457|FG001|Overall Study|Noncompliant with dosing|0|||
38032507|NCT02944448|69718456|FG000|Overall Study|Abnormal laboratory values|1|||
38032508|NCT02944448|69718457|FG001|Overall Study|Abnormal laboratory values|0|||
38032509|NCT02943668|69718464|FG000|Overall Study|Disease Progression|1|||
37652293|NCT03296527|69122543|FG000|Overall Study|Adverse Event|15|||
37652294|NCT03296527|69122544|FG001|Overall Study|Adverse Event|33|||
37652295|NCT03296527|69122543|FG000|Overall Study|Protocol Deviation|4|||
37652296|NCT03296527|69122544|FG001|Overall Study|Protocol Deviation|0|||
37652297|NCT03296527|69122543|FG000|Overall Study|Participant withdrew consent|3|||
37652298|NCT03296527|69122544|FG001|Overall Study|Participant withdrew consent|1|||
37652299|NCT03296527|69122543|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
37652300|NCT03296527|69122544|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
37652301|NCT03296527|69122543|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
37652302|NCT03296527|69122544|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
37652303|NCT03296527|69122543|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
37652304|NCT03296527|69122544|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
37652305|NCT03296527|69122543|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
37652306|NCT03296527|69122544|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
37677509|NCT02600819|69152480|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
37677510|NCT02600819|69152479|FG000|GEN Phase|Withdrew Consent|5|||
37677511|NCT02600819|69152480|FG001|GEN Phase|Withdrew Consent|0|||
37677512|NCT02600819|69152479|FG000|GEN Phase|Lost to Follow-up|2|||
37677513|NCT02600819|69152480|FG001|GEN Phase|Lost to Follow-up|0|||
37677514|NCT02597933|69152488|FG000|Overall Study|Withdrawal by Subject|7|||
37677515|NCT02597933|69152489|FG001|Overall Study|Withdrawal by Subject|5|||
37677516|NCT02597933|69152488|FG000|Overall Study|Protocol Violation|2|||
37677517|NCT02597933|69152489|FG001|Overall Study|Protocol Violation|2|||
37677518|NCT02597933|69152488|FG000|Overall Study|Adverse Event|20|||
37677519|NCT02597933|69152489|FG001|Overall Study|Adverse Event|28|||
37677520|NCT02597933|69152488|FG000|Overall Study|Not treated|2|||
37677521|NCT02597933|69152489|FG001|Overall Study|Not treated|2|||
37677522|NCT02597933|69152488|FG000|Overall Study|Other than stated above|7|||
37677523|NCT02597933|69152489|FG001|Overall Study|Other than stated above|14|||
37677524|NCT02597855|69152497|FG000|Overall Study|Lost to Follow-up|2|||
37677525|NCT02597855|69152498|FG001|Overall Study|Lost to Follow-up|1|||
37677526|NCT02604407|69152507|FG000|Overall Study|Adverse Event|0|||
37677527|NCT02604407|69152508|FG001|Overall Study|Adverse Event|7|||
37677528|NCT02604407|69152509|FG002|Overall Study|Adverse Event|5|||
37677529|NCT02604407|69152507|FG000|Overall Study|Protocol Violation|2|||
37677530|NCT02604407|69152508|FG001|Overall Study|Protocol Violation|0|||
37677531|NCT02604407|69152509|FG002|Overall Study|Protocol Violation|0|||
37652307|NCT03296527|69122543|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
37652308|NCT03296527|69122544|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
37652309|NCT03228680|69122553|FG000|Overall Study|Adverse Event|13|||
37652310|NCT03228680|69122554|FG001|Overall Study|Adverse Event|18|||
37742274|NCT03745651|69228505|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
37742275|NCT03745651|69228506|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
37742276|NCT03745651|69228507|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
37742277|NCT03745651|69228508|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
37742278|NCT03745651|69228509|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
37742279|NCT03745651|69228510|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
37742280|NCT03745638|69228529|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
37742281|NCT03745638|69228530|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
37742282|NCT03745638|69228531|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
37742283|NCT03745638|69228532|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
37742284|NCT03745638|69228533|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
37652311|NCT03228680|69122553|FG000|Overall Study|Randomization failure|0|||
37652312|NCT03228680|69122554|FG001|Overall Study|Randomization failure|1|||
37652313|NCT03228680|69122553|FG000|Overall Study|Withdrawal by Subject|1|||
37742285|NCT03745638|69228534|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
37652314|NCT03228680|69122554|FG001|Overall Study|Withdrawal by Subject|0|||
37652315|NCT03228680|69122553|FG000|Overall Study|Other|9|||
37652316|NCT03228680|69122554|FG001|Overall Study|Other|16|||
37652317|NCT03194542|69122565|FG000|Overall Study|Participant to Receive Bone Marrow Transplant|1|||
37652318|NCT03194542|69122566|FG001|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
37652319|NCT03194542|69122567|FG002|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
37652320|NCT03194542|69122568|FG003|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
37652321|NCT03194542|69122565|FG000|Overall Study|Rollover to Long-term follow-up Protocol|1|||
37652322|NCT03194542|69122566|FG001|Overall Study|Rollover to Long-term follow-up Protocol|1|||
37652323|NCT03194542|69122567|FG002|Overall Study|Rollover to Long-term follow-up Protocol|0|||
37652324|NCT03194542|69122568|FG003|Overall Study|Rollover to Long-term follow-up Protocol|5|||
37652325|NCT03194542|69122565|FG000|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
37652326|NCT03194542|69122566|FG001|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
37652327|NCT03194542|69122567|FG002|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
37652328|NCT03194542|69122568|FG003|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
37652329|NCT03194542|69122565|FG000|Overall Study|Loss of Response|4|||
37652330|NCT03194542|69122566|FG001|Overall Study|Loss of Response|2|||
37652331|NCT03194542|69122567|FG002|Overall Study|Loss of Response|3|||
37652332|NCT03194542|69122568|FG003|Overall Study|Loss of Response|4|||
37652333|NCT03194542|69122565|FG000|Overall Study|Physician Decision|0|||
37652334|NCT03194542|69122566|FG001|Overall Study|Physician Decision|1|||
37652335|NCT03194542|69122567|FG002|Overall Study|Physician Decision|0|||
37652336|NCT03194542|69122568|FG003|Overall Study|Physician Decision|0|||
37652337|NCT03194542|69122565|FG000|Overall Study|Lack of Efficacy|2|||
37652338|NCT03194542|69122566|FG001|Overall Study|Lack of Efficacy|2|||
37652339|NCT03194542|69122567|FG002|Overall Study|Lack of Efficacy|2|||
37652340|NCT03194542|69122568|FG003|Overall Study|Lack of Efficacy|6|||
37652341|NCT03194542|69122565|FG000|Overall Study|Withdrawal by Subject|2|||
37652342|NCT03194542|69122566|FG001|Overall Study|Withdrawal by Subject|1|||
37652343|NCT03194542|69122567|FG002|Overall Study|Withdrawal by Subject|5|||
37652344|NCT03194542|69122568|FG003|Overall Study|Withdrawal by Subject|4|||
37652345|NCT03194542|69122565|FG000|Overall Study|Progressive Disease|1|||
37652346|NCT03194542|69122566|FG001|Overall Study|Progressive Disease|0|||
37652347|NCT03194542|69122567|FG002|Overall Study|Progressive Disease|1|||
37652348|NCT03194542|69122568|FG003|Overall Study|Progressive Disease|1|||
37652349|NCT03194542|69122565|FG000|Overall Study|Adverse Event|1|||
37652350|NCT03194542|69122566|FG001|Overall Study|Adverse Event|2|||
37652351|NCT03194542|69122567|FG002|Overall Study|Adverse Event|0|||
37652352|NCT03194542|69122568|FG003|Overall Study|Adverse Event|5|||
37652353|NCT03194542|69122565|FG000|Overall Study|Death|1|||
37652354|NCT03194542|69122566|FG001|Overall Study|Death|2|||
37742286|NCT03745638|69228535|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
37652355|NCT03194542|69122567|FG002|Overall Study|Death|0|||
37742287|NCT03745638|69228529|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
37652356|NCT03194542|69122568|FG003|Overall Study|Death|5|||
37652357|NCT03194542|69122565|FG000|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
37652358|NCT03194542|69122566|FG001|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|10|||
37652359|NCT03194542|69122567|FG002|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|2|||
37652360|NCT03194542|69122568|FG003|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
37652361|NCT02717611|69122585|FG000|Overall Study|Death|13|||
37652362|NCT02717611|69122585|FG000|Overall Study|Withdrawal by Subject|6|||
37652363|NCT02717611|69122585|FG000|Overall Study|Active, not recruiting|40|||
37652364|NCT02717611|69122585|FG000|Overall Study|Complicating disease|1|||
37652365|NCT02362035|69122589|FG000|Overall Study|Death|67|||
37652366|NCT02362035|69122589|FG000|Overall Study|Lost to Follow-up|3|||
37652367|NCT02362035|69122589|FG000|Overall Study|Adverse Event|1|||
37652368|NCT02362035|69122589|FG000|Overall Study|Physician Decision|1|||
37652369|NCT02362035|69122589|FG000|Overall Study|Subject started another cancer therapy|10|||
37652370|NCT02362035|69122589|FG000|Overall Study|Study terminated by sponsor|45|||
37652371|NCT02362035|69122589|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
37652372|NCT02362035|69122589|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
37652373|NCT02362035|69122589|FG000|Overall Study|Disease progression|11|||
37652374|NCT02362035|69122589|FG000|Overall Study|Withdrawal by Subject|20|||
37652375|NCT02328014|69122597|FG000|Overall Study|Adverse Event|1|||
37742288|NCT03745638|69228530|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
37742289|NCT03745638|69228531|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
37652376|NCT02328014|69122598|FG001|Overall Study|Adverse Event|0|||
37652377|NCT02328014|69122599|FG002|Overall Study|Adverse Event|0|||
37652378|NCT02328014|69122600|FG003|Overall Study|Adverse Event|1|||
37652379|NCT02328014|69122597|FG000|Overall Study|Death|0|||
37652380|NCT02328014|69122598|FG001|Overall Study|Death|0|||
37652381|NCT02328014|69122599|FG002|Overall Study|Death|0|||
37652382|NCT02328014|69122600|FG003|Overall Study|Death|4|||
37652383|NCT02328014|69122597|FG000|Overall Study|Physician Decision|0|||
37652384|NCT02328014|69122598|FG001|Overall Study|Physician Decision|0|||
37652385|NCT02328014|69122599|FG002|Overall Study|Physician Decision|0|||
37652386|NCT02328014|69122600|FG003|Overall Study|Physician Decision|1|||
37652387|NCT02328014|69122597|FG000|Overall Study|Disease Progression|1|||
37652388|NCT02328014|69122598|FG001|Overall Study|Disease Progression|0|||
37652389|NCT02328014|69122599|FG002|Overall Study|Disease Progression|1|||
37652390|NCT02328014|69122600|FG003|Overall Study|Disease Progression|3|||
37652391|NCT02328014|69122597|FG000|Overall Study|Study Terminated by Sponsor|4|||
37652392|NCT02328014|69122598|FG001|Overall Study|Study Terminated by Sponsor|1|||
37652393|NCT02328014|69122599|FG002|Overall Study|Study Terminated by Sponsor|1|||
37652394|NCT02328014|69122600|FG003|Overall Study|Study Terminated by Sponsor|0|||
37652395|NCT02328014|69122597|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
37652396|NCT02328014|69122598|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
37652397|NCT02328014|69122599|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
37652398|NCT02328014|69122600|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
37652399|NCT02328014|69122597|FG000|Overall Study|Withdrawal by Subject|0|||
37652400|NCT02328014|69122598|FG001|Overall Study|Withdrawal by Subject|0|||
37652401|NCT02328014|69122599|FG002|Overall Study|Withdrawal by Subject|0|||
37652402|NCT02328014|69122600|FG003|Overall Study|Withdrawal by Subject|1|||
37652403|NCT02213926|69122610|FG000|Overall Study|Death|59|||
37652404|NCT02213926|69122610|FG000|Overall Study|Withdrawal by Subject|10|||
37652405|NCT02213926|69122610|FG000|Overall Study|study terminated by sponsor|51|||
37652406|NCT02213926|69122610|FG000|Overall Study|Lost to Follow-up|3|||
37652407|NCT02213926|69122610|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
37652408|NCT02180724|69122616|FG000|Overall Study|Death|26|||
37652409|NCT02180724|69122617|FG001|Overall Study|Death|1|||
37855235|NCT01225731|69538432|FG009|Part 3|Withdrawal by Subject|0|||
37652410|NCT02180724|69122616|FG000|Overall Study|Lost to Follow-up|3|||
37652411|NCT02180724|69122617|FG001|Overall Study|Lost to Follow-up|1|||
37652412|NCT02180724|69122616|FG000|Overall Study|Withdrawal by Subject|4|||
37652413|NCT02180724|69122617|FG001|Overall Study|Withdrawal by Subject|2|||
37652414|NCT02180724|69122616|FG000|Overall Study|PI Decision|5|||
37652415|NCT02180724|69122617|FG001|Overall Study|PI Decision|2|||
37652416|NCT02180724|69122616|FG000|Overall Study|Study terminated by sponsor|54|||
37652417|NCT02180724|69122617|FG001|Overall Study|Study terminated by sponsor|8|||
37652418|NCT01892085|69122632|FG000|Overall Study|Death|4|||
37652419|NCT01892085|69122633|FG001|Overall Study|Death|1|||
37652420|NCT01892085|69122634|FG002|Overall Study|Death|3|||
38032510|NCT02891408|69718499|FG000|Overall Study|Lost to Follow-up|0|||
37652421|NCT01892085|69122632|FG000|Overall Study|Withdrawal by Subject|2|||
37652422|NCT01892085|69122633|FG001|Overall Study|Withdrawal by Subject|0|||
37652423|NCT01892085|69122634|FG002|Overall Study|Withdrawal by Subject|2|||
38032511|NCT02891408|69718500|FG001|Overall Study|Lost to Follow-up|0|||
38032512|NCT02891408|69718501|FG002|Overall Study|Lost to Follow-up|1|||
38032513|NCT02891408|69718502|FG003|Overall Study|Lost to Follow-up|0|||
37652427|NCT04510285|69122668|FG000|Overall Study|Death|1|||
37652428|NCT02576054|69122672|FG000|Overall Study|Withdrawal by Subject|1|||
37652429|NCT01606202|69122680|FG000|Overall Study|Adverse Event|5|||
37652430|NCT01606202|69122681|FG001|Overall Study|Adverse Event|0|||
37652431|NCT01606202|69122680|FG000|Overall Study|Withdrawal by Subject|2|||
37652432|NCT01606202|69122681|FG001|Overall Study|Withdrawal by Subject|1|||
37652433|NCT01606202|69122680|FG000|Overall Study|Personal problems|0|||
37652434|NCT01606202|69122681|FG001|Overall Study|Personal problems|1|||
37652435|NCT01606202|69122680|FG000|Overall Study|Problems with administration|0|||
37855236|NCT01225731|69538433|FG010|Part 3|Withdrawal by Subject|4|||
37855237|NCT01225731|69538434|FG011|Part 3|Withdrawal by Subject|6|||
37742290|NCT03745638|69228532|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
37742291|NCT03745638|69228533|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
37742292|NCT03745638|69228534|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
37742293|NCT03745638|69228535|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
37742294|NCT03745638|69228529|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
37742295|NCT03745638|69228530|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
37742296|NCT03745638|69228531|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
37742297|NCT03745638|69228532|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
37652436|NCT01606202|69122681|FG001|Overall Study|Problems with administration|1|||
37652437|NCT01493960|69122689|FG000|Overall Study|Adverse Event|0|||
37652438|NCT01493960|69122690|FG001|Overall Study|Adverse Event|1|||
37652439|NCT01493960|69122689|FG000|Overall Study|Lack of Efficacy|15|||
37652440|NCT01493960|69122690|FG001|Overall Study|Lack of Efficacy|9|||
37652441|NCT01493960|69122689|FG000|Overall Study|Protocol Violation|3|||
37652442|NCT01493960|69122690|FG001|Overall Study|Protocol Violation|0|||
37652443|NCT01493960|69122689|FG000|Overall Study|Withdrawal by Subject|10|||
37652444|NCT01493960|69122690|FG001|Overall Study|Withdrawal by Subject|4|||
37652445|NCT01493960|69122689|FG000|Overall Study|Non-specified|4|||
37652446|NCT01493960|69122690|FG001|Overall Study|Non-specified|4|||
37652447|NCT02630459|69122700|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
37652448|NCT02630459|69122701|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
37652449|NCT02630459|69122702|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
37652450|NCT02630459|69122703|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
37652451|NCT02630459|69122704|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
37652452|NCT02630459|69122705|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
37652453|NCT02630459|69122706|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
37652454|NCT02630459|69122707|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
37652455|NCT02630459|69122700|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
37652456|NCT02630459|69122701|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
37652457|NCT02630459|69122702|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
37652458|NCT02630459|69122703|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
37652459|NCT02630459|69122704|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
37652460|NCT02630459|69122705|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
37652461|NCT02630459|69122706|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
37652462|NCT02630459|69122707|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
37652463|NCT02630459|69122700|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
37652464|NCT02630459|69122701|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
37652465|NCT02630459|69122702|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
37652466|NCT02630459|69122703|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
37652467|NCT02630459|69122704|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
37652468|NCT02630459|69122705|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
37652469|NCT02630459|69122706|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
37652470|NCT02630459|69122707|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
37652471|NCT02630459|69122700|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
37652472|NCT02630459|69122701|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
37652473|NCT02630459|69122702|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
37652474|NCT02630459|69122703|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
37652475|NCT02630459|69122704|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
37652476|NCT02630459|69122705|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
37652477|NCT02630459|69122706|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
37652478|NCT02630459|69122707|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
37652479|NCT02630459|69122700|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
37652480|NCT02630459|69122701|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
37652481|NCT02630459|69122702|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
37652482|NCT02630459|69122703|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
37652483|NCT02630459|69122704|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
37652484|NCT02630459|69122705|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
37742298|NCT03745638|69228533|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
37742299|NCT03745638|69228534|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
37742300|NCT03745638|69228535|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
37742301|NCT03745638|69228529|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
37742302|NCT03745638|69228530|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
37742303|NCT03745638|69228531|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
38032514|NCT02891408|69718503|FG004|Overall Study|Lost to Follow-up|0|||
38032515|NCT02891408|69718504|FG005|Overall Study|Lost to Follow-up|0|||
37742304|NCT03745638|69228532|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
37742305|NCT03745638|69228533|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
37742306|NCT03745638|69228534|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
37742307|NCT03745638|69228535|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
37742308|NCT03745638|69228529|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
37652485|NCT02630459|69122706|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
37652486|NCT02630459|69122707|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
37652487|NCT02630459|69122700|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
37652488|NCT02630459|69122701|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
37652489|NCT02630459|69122702|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
37652490|NCT02630459|69122703|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
37652491|NCT02630459|69122704|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
37652492|NCT02630459|69122705|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
37742309|NCT03745638|69228530|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
37742310|NCT03745638|69228531|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
37652493|NCT02630459|69122706|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
37652494|NCT02630459|69122707|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
37652495|NCT02630459|69122700|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
37652496|NCT02630459|69122701|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
37652497|NCT02630459|69122702|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
37742311|NCT03745638|69228532|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
37742312|NCT03745638|69228533|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
37742313|NCT03745638|69228534|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
37742314|NCT03745638|69228535|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
37742315|NCT03745638|69228529|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
37742316|NCT03745638|69228530|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
37742317|NCT03745638|69228531|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
37742318|NCT03745638|69228532|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
37742319|NCT03745638|69228533|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
37742320|NCT03745638|69228534|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
37742321|NCT03745638|69228535|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
37742322|NCT03745638|69228529|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
37742323|NCT03745638|69228530|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
37652498|NCT02630459|69122703|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
37652499|NCT02630459|69122704|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
37652500|NCT02630459|69122705|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
37652501|NCT02630459|69122706|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
37652502|NCT02630459|69122707|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
37652503|NCT02573948|69122732|FG000|Longitudinal Cohort|Death|9|||
37652504|NCT02573948|69122732|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
37652505|NCT02573948|69122732|FG000|Longitudinal Cohort|Incarcerated|25|||
37652506|NCT01464593|69122739|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
37652507|NCT01361711|69122743|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
37652508|NCT01361711|69122743|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
37652509|NCT01361711|69122743|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
37652510|NCT01361711|69122743|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
37652511|NCT01361711|69122743|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
37652512|NCT01361711|69122743|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
37652513|NCT01361711|69122743|FG000|Completed Week 18 of Treatment|Other|9|||
38032516|NCT02891408|69718505|FG006|Overall Study|Lost to Follow-up|0|||
37652514|NCT01361711|69122743|FG000|10 Year Follow-up|Still in follow-up|22|||
37652515|NCT01361711|69122743|FG000|10 Year Follow-up|Death|7|||
37652516|NCT01361711|69122743|FG000|10 Year Follow-up|Developed new cancer|1|||
37652517|NCT01361711|69122743|FG000|10 Year Follow-up|Lost to Follow-up|2|||
37652518|NCT01361711|69122743|FG000|10 Year Follow-up|New treatment started|6|||
37652519|NCT01361711|69122743|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
37652520|NCT01361711|69122743|FG000|10 Year Follow-up|Progressive Disease|1|||
38032517|NCT03283670|69718531|FG000|Placebo Gas|Withdrawal by Subject|2|||
37652521|NCT02572388|69122751|FG000|Overall Study|Withdrawal by Subject|1|||
37652522|NCT02572388|69122752|FG001|Overall Study|Withdrawal by Subject|1|||
37652523|NCT02572388|69122753|FG002|Overall Study|Withdrawal by Subject|2|||
37742324|NCT03745638|69228531|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
37742325|NCT03745638|69228532|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
37742326|NCT03745638|69228533|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
38032518|NCT03283670|69718531|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
38032519|NCT03283670|69718531|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
37652524|NCT02572388|69122754|FG003|Overall Study|Withdrawal by Subject|2|||
37652525|NCT02573870|69122766|FG000|Overall Study|Adverse Event|0|||
37742327|NCT03745638|69228534|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
37742328|NCT03745638|69228535|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
37742329|NCT03745638|69228529|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
37742330|NCT03745638|69228530|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
37742331|NCT03745638|69228531|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
37742332|NCT03745638|69228532|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
37652526|NCT02573870|69122767|FG001|Overall Study|Adverse Event|2|||
37742333|NCT03745638|69228533|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
37742334|NCT03745638|69228534|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
38032520|NCT01358578|69718552|FG000|Induction Period|Adverse Event|2|||
38032521|NCT01358578|69718553|FG001|Induction Period|Adverse Event|4|||
38032522|NCT01358578|69718554|FG002|Induction Period|Adverse Event|2|||
38032523|NCT01358578|69718555|FG003|Induction Period|Adverse Event|6|||
38032524|NCT01358578|69718556|FG004|Induction Period|Adverse Event|0|||
38032525|NCT01358578|69718557|FG005|Induction Period|Adverse Event|0|||
38032526|NCT01358578|69718552|FG000|Induction Period|Lack of Efficacy|0|||
37652527|NCT02573870|69122766|FG000|Overall Study|Lack of Efficacy|0|||
37652528|NCT02573870|69122767|FG001|Overall Study|Lack of Efficacy|1|||
37652529|NCT02573870|69122766|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
37652530|NCT02573870|69122767|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
37652531|NCT02573870|69122766|FG000|Overall Study|Lost to Follow-up|0|||
37652532|NCT02573870|69122767|FG001|Overall Study|Lost to Follow-up|1|||
37652533|NCT02573870|69122766|FG000|Overall Study|Other: Fail to Meet Visit|0|||
37652534|NCT02573870|69122767|FG001|Overall Study|Other: Fail to Meet Visit|2|||
37652535|NCT02572076|69122773|FG000|Overall Study|Protocol Violation|1|||
37652536|NCT02571452|69122779|FG000|Overall Study Treatment|Protocol Violation|0|||
37652537|NCT02571452|69122780|FG001|Overall Study Treatment|Protocol Violation|1|||
37652538|NCT02571452|69122779|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
37652539|NCT02571452|69122780|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
37652540|NCT02571452|69122779|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
37652541|NCT02571452|69122780|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
37652542|NCT02574260|69122786|FG000|Overall Study|Disease Progression|1|||
37652543|NCT02570126|69122792|FG000|Overall Study|Lost to Follow-up|2|||
37652544|NCT02570126|69122793|FG001|Overall Study|Lost to Follow-up|0|||
37652545|NCT02570126|69122792|FG000|Overall Study|Unable To Arrange Visit 3|1|||
37652546|NCT02570126|69122793|FG001|Overall Study|Unable To Arrange Visit 3|0|||
37652547|NCT02570126|69122792|FG000|Overall Study|Violation Of Procedures GSK|0|||
37652548|NCT02570126|69122793|FG001|Overall Study|Violation Of Procedures GSK|1|||
37652549|NCT02570126|69122792|FG000|Overall Study|Protocol Violation|0|||
37652550|NCT02570126|69122793|FG001|Overall Study|Protocol Violation|1|||
37652551|NCT02570126|69122792|FG000|Overall Study|Withdrawal by Subject|3|||
37652552|NCT02570126|69122793|FG001|Overall Study|Withdrawal by Subject|7|||
37652553|NCT02755831|69122801|FG000|Overall Study|Lost to Follow-up|3|||
37652554|NCT02755831|69122802|FG001|Overall Study|Lost to Follow-up|3|||
37652555|NCT02573246|69122813|FG000|Overall Study|Lost to Follow-up|2|||
37652556|NCT02573246|69122814|FG001|Overall Study|Lost to Follow-up|0|||
38032527|NCT01358578|69718553|FG001|Induction Period|Lack of Efficacy|0|||
38032528|NCT01358578|69718554|FG002|Induction Period|Lack of Efficacy|9|||
38032529|NCT01358578|69718555|FG003|Induction Period|Lack of Efficacy|1|||
38032530|NCT01358578|69718556|FG004|Induction Period|Lack of Efficacy|0|||
38032531|NCT01358578|69718557|FG005|Induction Period|Lack of Efficacy|0|||
38032532|NCT01358578|69718552|FG000|Induction Period|Lost to Follow-up|0|||
37652557|NCT02573246|69122815|FG002|Overall Study|Lost to Follow-up|0|||
37652558|NCT02573246|69122816|FG003|Overall Study|Lost to Follow-up|0|||
37652559|NCT02573246|69122817|FG004|Overall Study|Lost to Follow-up|1|||
37652560|NCT02573246|69122813|FG000|Overall Study|Withdrawal by Subject|0|||
37652561|NCT02573246|69122814|FG001|Overall Study|Withdrawal by Subject|0|||
37652562|NCT02573246|69122815|FG002|Overall Study|Withdrawal by Subject|0|||
37652563|NCT02573246|69122816|FG003|Overall Study|Withdrawal by Subject|0|||
37652564|NCT02573246|69122817|FG004|Overall Study|Withdrawal by Subject|1|||
38032533|NCT01358578|69718553|FG001|Induction Period|Lost to Follow-up|0|||
38032534|NCT01358578|69718554|FG002|Induction Period|Lost to Follow-up|1|||
38032535|NCT01358578|69718555|FG003|Induction Period|Lost to Follow-up|4|||
37855238|NCT01225731|69538435|FG012|Part 3|Withdrawal by Subject|4|||
37855239|NCT01007149|69538466|FG000|Overall Study|Administrative problems|0|||
38032536|NCT01358578|69718556|FG004|Induction Period|Lost to Follow-up|0|||
38032537|NCT01358578|69718557|FG005|Induction Period|Lost to Follow-up|0|||
38032538|NCT01358578|69718552|FG000|Induction Period|Physician Decision|2|||
37652565|NCT02573246|69122813|FG000|Overall Study|Physician Decision|1|||
37652566|NCT02573246|69122814|FG001|Overall Study|Physician Decision|1|||
37652567|NCT02573246|69122815|FG002|Overall Study|Physician Decision|3|||
38032539|NCT01358578|69718553|FG001|Induction Period|Physician Decision|1|||
37652568|NCT02573246|69122816|FG003|Overall Study|Physician Decision|2|||
37652569|NCT02573246|69122817|FG004|Overall Study|Physician Decision|2|||
37652570|NCT02570750|69122836|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
37652571|NCT02570750|69122837|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
37652572|NCT02570750|69122836|FG000|Overall Study|Protocol deviation|4|||
37652573|NCT02570750|69122837|FG001|Overall Study|Protocol deviation|2|||
37652574|NCT02570750|69122836|FG000|Overall Study|Withdrawal by Subject|5|||
37652575|NCT02570750|69122837|FG001|Overall Study|Withdrawal by Subject|0|||
37652576|NCT02570750|69122836|FG000|Overall Study|Lost to Follow-up|2|||
37652577|NCT02570750|69122837|FG001|Overall Study|Lost to Follow-up|2|||
37652578|NCT02570750|69122836|FG000|Overall Study|Adverse Event|2|||
37652579|NCT02570750|69122837|FG001|Overall Study|Adverse Event|1|||
37652580|NCT02573012|69122845|FG000|Overall Study|Adverse Event|5|||
37652581|NCT02573012|69122846|FG001|Overall Study|Adverse Event|5|||
37652582|NCT02573012|69122845|FG000|Overall Study|Lack of Efficacy|5|||
37652583|NCT02573012|69122846|FG001|Overall Study|Lack of Efficacy|4|||
37652584|NCT02573012|69122845|FG000|Overall Study|Non-compliance|1|||
37652585|NCT02573012|69122846|FG001|Overall Study|Non-compliance|2|||
37652586|NCT02573012|69122845|FG000|Overall Study|Withdrawal by Subject|2|||
37742335|NCT03745638|69228535|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
37742336|NCT03745638|69228529|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
37742337|NCT03745638|69228530|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
37742338|NCT03745638|69228531|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
37742339|NCT03745638|69228532|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
37742340|NCT03745638|69228533|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
37742341|NCT03745638|69228534|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
37742342|NCT03745638|69228535|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
37742343|NCT03745638|69228529|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
37742344|NCT03745638|69228530|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
37742345|NCT03745638|69228531|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
37742346|NCT03745638|69228532|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
37742347|NCT03745638|69228533|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
37742348|NCT03745638|69228534|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
37742349|NCT03745638|69228535|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
37742350|NCT03745638|69228529|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
37742351|NCT03745638|69228530|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
37742352|NCT03745638|69228531|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
37742353|NCT03745638|69228532|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
37742354|NCT03745638|69228533|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
37742355|NCT03745638|69228534|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
37742356|NCT03745638|69228535|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
37742357|NCT03745638|69228529|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
37742358|NCT03745638|69228530|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
37742359|NCT03745638|69228531|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
37742360|NCT03745638|69228532|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
37742361|NCT03745638|69228533|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
37742362|NCT03745638|69228534|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
37742363|NCT03745638|69228535|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
37742364|NCT03745638|69228529|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
37742365|NCT03745638|69228530|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
37742366|NCT03745638|69228531|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
37742367|NCT03745638|69228532|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
37742368|NCT03745638|69228533|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
37742369|NCT03745638|69228534|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
37742370|NCT03745638|69228535|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
37742371|NCT03745638|69228529|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
37742372|NCT03745638|69228530|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
37742373|NCT03745638|69228531|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
37742374|NCT03745638|69228532|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
37742375|NCT03745638|69228533|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
37742376|NCT03745638|69228534|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
37742377|NCT03745638|69228535|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
38032540|NCT01358578|69718554|FG002|Induction Period|Physician Decision|2|||
37742378|NCT03745638|69228529|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
37742379|NCT03745638|69228530|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
37742380|NCT03745638|69228531|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
38032541|NCT01358578|69718555|FG003|Induction Period|Physician Decision|0|||
37652587|NCT02573012|69122846|FG001|Overall Study|Withdrawal by Subject|2|||
37652588|NCT02573012|69122845|FG000|Overall Study|Study Ended per Protocol|1|||
37652589|NCT02573012|69122846|FG001|Overall Study|Study Ended per Protocol|0|||
37652590|NCT02573012|69122845|FG000|Overall Study|Physician Decision|1|||
37652591|NCT02573012|69122846|FG001|Overall Study|Physician Decision|2|||
37652592|NCT02752633|69122852|FG000|Overall Study|Withdrawal by Subject|1|||
37652593|NCT02752087|69122856|FG000|Washout|Physician Decision|1|||
37652594|NCT02752087|69122857|FG001|Washout|Physician Decision|0|||
37652595|NCT04766996|69122866|FG000|Overall Study|Withdrawal by Subject|1|||
37652596|NCT04766996|69122867|FG001|Overall Study|Withdrawal by Subject|0|||
37652597|NCT04766996|69122868|FG002|Overall Study|Withdrawal by Subject|13|||
37652598|NCT02563028|69122874|FG000|Overall Study|Lack of equipment|1|||
37652599|NCT02563028|69122874|FG000|Overall Study|Unable to elicit VEP post induction|1|||
37652600|NCT02192827|69122880|FG000|Overall Study|Lost to Follow-up|25|||
37652601|NCT02192827|69122881|FG001|Overall Study|Lost to Follow-up|27|||
37652602|NCT02192827|69122880|FG000|Overall Study|Given additional steroids with admission|13|||
37652603|NCT02192827|69122881|FG001|Overall Study|Given additional steroids with admission|11|||
37652604|NCT02562482|69122889|FG000|Overall Study|Enrolled, but did not receive product|4|||
37652605|NCT02562482|69122890|FG001|Overall Study|Enrolled, but did not receive product|0|||
37652606|NCT02562482|69122889|FG000|Overall Study|Lost to Follow-up|9|||
37652607|NCT02562482|69122890|FG001|Overall Study|Lost to Follow-up|6|||
37652608|NCT02562482|69122889|FG000|Overall Study|Moved from area|2|||
37652609|NCT02562482|69122890|FG001|Overall Study|Moved from area|3|||
37652610|NCT02562482|69122889|FG000|Overall Study|Withdrawal by Subject|5|||
37652611|NCT02562482|69122890|FG001|Overall Study|Withdrawal by Subject|3|||
37652612|NCT02562482|69122889|FG000|Overall Study|Physician Decision|1|||
37652613|NCT02562482|69122890|FG001|Overall Study|Physician Decision|3|||
37652614|NCT02562482|69122889|FG000|Overall Study|Illness/Injury unrelated to product|0|||
37652615|NCT02562482|69122890|FG001|Overall Study|Illness/Injury unrelated to product|1|||
37652616|NCT02568254|69122905|FG000|Period 2|Adverse Event|0|||
37652617|NCT02568254|69122906|FG001|Period 2|Adverse Event|0|||
37652618|NCT02568254|69122907|FG002|Period 2|Adverse Event|1|||
37652619|NCT02568254|69122908|FG003|Period 2|Adverse Event|0|||
37652620|NCT02568254|69122909|FG004|Period 2|Adverse Event|0|||
37652621|NCT02568254|69122910|FG005|Period 2|Adverse Event|0|||
37652622|NCT02568254|69122905|FG000|Period 3|Unstatisfactory Lens fitting|0|||
37652623|NCT02568254|69122906|FG001|Period 3|Unstatisfactory Lens fitting|0|||
37652624|NCT02568254|69122907|FG002|Period 3|Unstatisfactory Lens fitting|0|||
37652625|NCT02568254|69122908|FG003|Period 3|Unstatisfactory Lens fitting|0|||
37652626|NCT02568254|69122909|FG004|Period 3|Unstatisfactory Lens fitting|1|||
37652627|NCT02568254|69122910|FG005|Period 3|Unstatisfactory Lens fitting|0|||
37652628|NCT02567708|69122918|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
37652629|NCT02567708|69122919|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
37652630|NCT02567708|69122918|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
37652631|NCT02567708|69122919|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
37652632|NCT02567708|69122918|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
37652633|NCT02567708|69122919|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
37652634|NCT02567708|69122918|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
37742381|NCT03745638|69228532|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
37742382|NCT03745638|69228533|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
37742383|NCT03745638|69228534|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
37742384|NCT03745638|69228535|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
37742385|NCT03699475|69228565|FG000|Overall Study|Death|1|||
37742386|NCT03668613|69228571|FG000|Overall Study|Adverse Event|0|||
37742387|NCT03668613|69228572|FG001|Overall Study|Adverse Event|2|||
37742388|NCT03668613|69228571|FG000|Overall Study|Lack of Efficacy|0|||
37742389|NCT03668613|69228572|FG001|Overall Study|Lack of Efficacy|1|||
37742390|NCT03650413|69228579|FG000|Overall Study|Adverse Event|1|||
37742391|NCT03650413|69228579|FG000|Overall Study|Lack of Efficacy|17|||
37742392|NCT03650413|69228579|FG000|Overall Study|Other|9|||
37742393|NCT03650413|69228579|FG000|Overall Study|Physician Decision|2|||
37742394|NCT03650413|69228579|FG000|Overall Study|Study Terminated By Sponsor|16|||
37652635|NCT02567708|69122919|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
37652636|NCT02562716|69122928|FG000|Overall Study|Adverse Event|7|||
37652637|NCT02562716|69122929|FG001|Overall Study|Adverse Event|14|||
37652638|NCT02562716|69122928|FG000|Overall Study|Withdrawal unrelated to AE|7|||
37652639|NCT02562716|69122929|FG001|Overall Study|Withdrawal unrelated to AE|1|||
37742395|NCT03650413|69228579|FG000|Overall Study|Withdrawal by Subject|16|||
37742396|NCT03596242|69228589|FG000|Overall Study|Lost to Follow-up|2|||
37742397|NCT03596242|69228590|FG001|Overall Study|Lost to Follow-up|2|||
37742398|NCT03514017|69228596|FG000|Overall Study|Death|1|||
37742399|NCT03514017|69228596|FG000|Overall Study|Adverse Event|1|||
37652640|NCT02562716|69122928|FG000|Overall Study|Progression|8|||
37652641|NCT02562716|69122929|FG001|Overall Study|Progression|10|||
37652642|NCT02562716|69122928|FG000|Overall Study|Death|2|||
37652643|NCT02562716|69122929|FG001|Overall Study|Death|1|||
37652644|NCT02562716|69122928|FG000|Overall Study|Not protocol specified|4|||
37742400|NCT03471078|69228602|FG000|Overall Study|Withdrawal by Subject|9|||
37742401|NCT03471078|69228603|FG001|Overall Study|Withdrawal by Subject|1|||
37742402|NCT03471078|69228602|FG000|Overall Study|Adverse Event|4|||
37742403|NCT03471078|69228603|FG001|Overall Study|Adverse Event|1|||
37742404|NCT03471078|69228602|FG000|Overall Study|Physician Decision|3|||
37742405|NCT03471078|69228603|FG001|Overall Study|Physician Decision|2|||
37742406|NCT03471078|69228602|FG000|Overall Study|Death|2|||
37742407|NCT03471078|69228603|FG001|Overall Study|Death|0|||
37742408|NCT03471078|69228602|FG000|Overall Study|Other|3|||
37742409|NCT03471078|69228603|FG001|Overall Study|Other|2|||
37742410|NCT03308188|69228641|FG000|Overall Study|Withdrawal by Subject|0|||
37742411|NCT03308188|69228642|FG001|Overall Study|Withdrawal by Subject|3|||
37652645|NCT02562716|69122929|FG001|Overall Study|Not protocol specified|2|||
37652646|NCT02751931|69122939|FG000|Overall Study|Adverse Event|3|||
37652647|NCT02751931|69122940|FG001|Overall Study|Adverse Event|0|||
37652648|NCT02751931|69122939|FG000|Overall Study|Other: Miscelleneous|10|||
37652649|NCT02751931|69122940|FG001|Overall Study|Other: Miscelleneous|8|||
37652650|NCT02561156|69122965|FG000|Part 2|Adverse Event|0|||
37652651|NCT02561156|69122966|FG001|Part 2|Adverse Event|0|||
37652652|NCT02561156|69122967|FG002|Part 2|Adverse Event|0|||
37652653|NCT02561156|69122968|FG003|Part 2|Adverse Event|0|||
37652654|NCT02561156|69122969|FG004|Part 2|Adverse Event|0|||
37652655|NCT02561156|69122970|FG005|Part 2|Adverse Event|0|||
37652656|NCT02561156|69122971|FG006|Part 2|Adverse Event|0|||
37652657|NCT02561156|69122972|FG007|Part 2|Adverse Event|0|||
37652658|NCT02561156|69122973|FG008|Part 2|Adverse Event|0|||
37652659|NCT02561156|69122974|FG009|Part 2|Adverse Event|0|||
37652660|NCT02561156|69122975|FG010|Part 2|Adverse Event|0|||
37652661|NCT02561156|69122976|FG011|Part 2|Adverse Event|1|||
37652662|NCT02561156|69122977|FG012|Part 2|Adverse Event|0|||
37652663|NCT02561078|69123023|FG000|Overall Study|Adverse Event|5|||
37652664|NCT02561078|69123024|FG001|Overall Study|Adverse Event|2|||
37652665|NCT02561078|69123023|FG000|Overall Study|Death|2|||
37652666|NCT02561078|69123024|FG001|Overall Study|Death|1|||
37652667|NCT02561078|69123023|FG000|Overall Study|Lost to Follow-up|2|||
37652668|NCT02561078|69123024|FG001|Overall Study|Lost to Follow-up|6|||
37652669|NCT02561078|69123023|FG000|Overall Study|Non-Compliance with Study Drug|6|||
37652670|NCT02561078|69123024|FG001|Overall Study|Non-Compliance with Study Drug|3|||
37652671|NCT02561078|69123023|FG000|Overall Study|Physician Decision|2|||
37652672|NCT02561078|69123024|FG001|Overall Study|Physician Decision|3|||
37652673|NCT02561078|69123023|FG000|Overall Study|Withdrawal by Subject|13|||
37652674|NCT02561078|69123024|FG001|Overall Study|Withdrawal by Subject|10|||
37652675|NCT04907227|69123032|FG000|Overall Study|Death|10|||
37652676|NCT04907227|69123033|FG001|Overall Study|Death|7|||
37652677|NCT04907227|69123032|FG000|Overall Study|Withdrawal by Subject|1|||
37652678|NCT04907227|69123033|FG001|Overall Study|Withdrawal by Subject|0|||
37652679|NCT04907227|69123032|FG000|Overall Study|Participants ongoing in the study|30|||
37652680|NCT04907227|69123033|FG001|Overall Study|Participants ongoing in the study|33|||
37652681|NCT04881448|69123039|FG000|Overall Study|Study cancelled by sponsor|220|||
37652682|NCT04881448|69123039|FG000|Overall Study|Withdrawal by Subject|2|||
37652683|NCT04881448|69123039|FG000|Overall Study|Exhausted all attempts to contact subject|1|||
37652684|NCT04275310|69123070|FG000|Overall Study|Non-randomized due to running out of funding|4|||
37652685|NCT04275310|69123071|FG001|Overall Study|Non-randomized due to running out of funding|0|||
37742412|NCT03308188|69228641|FG000|Overall Study|Death|0|||
37742413|NCT03308188|69228642|FG001|Overall Study|Death|1|||
37742414|NCT03113968|69228663|FG000|Overall Study|Withdrawal by Subject|31|||
37742415|NCT03113968|69228664|FG001|Overall Study|Withdrawal by Subject|4|||
37742416|NCT02864251|69228673|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
37742417|NCT02864251|69228674|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
37742418|NCT02864251|69228675|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
38032542|NCT01358578|69718556|FG004|Induction Period|Physician Decision|0|||
38032543|NCT01358578|69718557|FG005|Induction Period|Physician Decision|0|||
37652686|NCT04157088|69123077|FG000|Overall Study|Study terminated by sponsor|23|||
37652687|NCT04157088|69123077|FG000|Overall Study|Withdrawal by Subject|4|||
37652688|NCT04157088|69123077|FG000|Overall Study|Lost to Follow-up|2|||
37652689|NCT04157088|69123077|FG000|Overall Study|Death|1|||
37742419|NCT02864251|69228673|FG000|Pre-Treatment|Withdrawal by Participant|0|||
37742420|NCT02864251|69228674|FG001|Pre-Treatment|Withdrawal by Participant|0|||
37742421|NCT02864251|69228675|FG002|Pre-Treatment|Withdrawal by Participant|4|||
37652690|NCT04140266|69123085|FG000|Overall Study|Physician Decision|2|||
37652691|NCT04140266|69123086|FG001|Overall Study|Physician Decision|0|||
37652692|NCT04140266|69123085|FG000|Overall Study|Withdrawal by Subject|4|||
37652693|NCT04140266|69123086|FG001|Overall Study|Withdrawal by Subject|2|||
37742422|NCT02864251|69228673|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
37922595|NCT00664534|69609342|FG001|Overall Study|Lost to Follow-up|10|||
37652694|NCT03926143|69123109|FG000|Overall Study|Physician Decision|3|||
37652695|NCT03926143|69123109|FG000|Overall Study|Subject decision: Covid-19 Pandemic related|1|||
37652696|NCT03926143|69123109|FG000|Overall Study|Adverse Event|2|||
37652697|NCT03926143|69123109|FG000|Overall Study|Progressive disease|3|||
37742423|NCT02864251|69228674|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
37742424|NCT02864251|69228675|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
37742425|NCT02864251|69228673|FG000|Pre-Treatment|Other Reasons|0|||
37742426|NCT02864251|69228674|FG001|Pre-Treatment|Other Reasons|1|||
37742427|NCT02864251|69228675|FG002|Pre-Treatment|Other Reasons|1|||
37742428|NCT02864251|69228673|FG000|Treatment|Disease Progression|109|||
37742429|NCT02864251|69228674|FG001|Treatment|Disease Progression|52|||
37652698|NCT03018080|69123126|FG000|Overall Study|Death|12|||
37652699|NCT03018080|69123127|FG001|Overall Study|Death|19|||
37652700|NCT02781090|69123135|FG000|3-Month Follow-Up|Missed Visit|20|||
37652701|NCT02781090|69123136|FG001|3-Month Follow-Up|Missed Visit|20|||
37652702|NCT02781090|69123135|FG000|3-Month Follow-Up|Lost to Follow-up|40|||
37652703|NCT02781090|69123136|FG001|3-Month Follow-Up|Lost to Follow-up|34|||
37652704|NCT02781090|69123135|FG000|3-Month Follow-Up|Withdrawal by Subject|4|||
37652705|NCT02781090|69123136|FG001|3-Month Follow-Up|Withdrawal by Subject|3|||
37652706|NCT02781090|69123135|FG000|3-Month Follow-Up|Death|1|||
37742430|NCT02864251|69228675|FG002|Treatment|Disease Progression|101|||
37742431|NCT02864251|69228673|FG000|Treatment|Study Drug Toxicity|9|||
37742432|NCT02864251|69228674|FG001|Treatment|Study Drug Toxicity|4|||
37742433|NCT02864251|69228675|FG002|Treatment|Study Drug Toxicity|10|||
37742434|NCT02864251|69228673|FG000|Treatment|Death|0|||
37742435|NCT02864251|69228674|FG001|Treatment|Death|2|||
37742436|NCT02864251|69228675|FG002|Treatment|Death|3|||
37742437|NCT02864251|69228673|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
37742438|NCT02864251|69228674|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
37652707|NCT02781090|69123136|FG001|3-Month Follow-Up|Death|0|||
37652708|NCT02781090|69123135|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
37652709|NCT02781090|69123136|FG001|6-Month Follow-Up|Withdrawal by Subject|2|||
37652710|NCT02781090|69123135|FG000|6-Month Follow-Up|Lost to Follow-up|20|||
37652711|NCT02781090|69123136|FG001|6-Month Follow-Up|Lost to Follow-up|22|||
37652712|NCT02781090|69123135|FG000|6-Month Follow-Up|Death|0|||
37652713|NCT02781090|69123136|FG001|6-Month Follow-Up|Death|1|||
37652714|NCT02774291|69123144|FG000|Overall Study|Lost to Follow-up|1|||
37652715|NCT01897571|69123160|FG000|Overall Study|Lost to Follow-up|3|||
37652716|NCT01897571|69123161|FG001|Overall Study|Lost to Follow-up|0|||
37652717|NCT01897571|69123162|FG002|Overall Study|Lost to Follow-up|0|||
37652718|NCT01897571|69123163|FG003|Overall Study|Lost to Follow-up|0|||
37652719|NCT01897571|69123164|FG004|Overall Study|Lost to Follow-up|2|||
37652720|NCT01897571|69123165|FG005|Overall Study|Lost to Follow-up|0|||
37652721|NCT01897571|69123166|FG006|Overall Study|Lost to Follow-up|0|||
37652722|NCT01897571|69123167|FG007|Overall Study|Lost to Follow-up|0|||
37652723|NCT01897571|69123168|FG008|Overall Study|Lost to Follow-up|1|||
37652724|NCT01897571|69123169|FG009|Overall Study|Lost to Follow-up|2|||
37652725|NCT01897571|69123170|FG010|Overall Study|Lost to Follow-up|4|||
37652726|NCT01897571|69123160|FG000|Overall Study|Withdrawal by Subject|0|||
37652727|NCT01897571|69123161|FG001|Overall Study|Withdrawal by Subject|0|||
37652728|NCT01897571|69123162|FG002|Overall Study|Withdrawal by Subject|0|||
37652729|NCT01897571|69123163|FG003|Overall Study|Withdrawal by Subject|0|||
37652730|NCT01897571|69123164|FG004|Overall Study|Withdrawal by Subject|0|||
37652731|NCT01897571|69123165|FG005|Overall Study|Withdrawal by Subject|0|||
37652732|NCT01897571|69123166|FG006|Overall Study|Withdrawal by Subject|0|||
37652733|NCT01897571|69123167|FG007|Overall Study|Withdrawal by Subject|1|||
37652734|NCT01897571|69123168|FG008|Overall Study|Withdrawal by Subject|4|||
37652735|NCT01897571|69123169|FG009|Overall Study|Withdrawal by Subject|3|||
37652736|NCT01897571|69123170|FG010|Overall Study|Withdrawal by Subject|1|||
37652737|NCT01897571|69123160|FG000|Overall Study|Other|1|||
37652738|NCT01897571|69123161|FG001|Overall Study|Other|0|||
37652739|NCT01897571|69123162|FG002|Overall Study|Other|0|||
37652740|NCT01897571|69123163|FG003|Overall Study|Other|3|||
37742439|NCT02864251|69228675|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
37742440|NCT02864251|69228673|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
38032544|NCT01358578|69718552|FG000|Induction Period|Protocol Deviation|3|||
38032545|NCT01358578|69718553|FG001|Induction Period|Protocol Deviation|5|||
37652741|NCT01897571|69123164|FG004|Overall Study|Other|3|||
37652742|NCT01897571|69123165|FG005|Overall Study|Other|4|||
37652743|NCT01897571|69123166|FG006|Overall Study|Other|7|||
37652744|NCT01897571|69123167|FG007|Overall Study|Other|0|||
37652745|NCT01897571|69123168|FG008|Overall Study|Other|0|||
37742441|NCT02864251|69228674|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
37742442|NCT02864251|69228675|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
37742443|NCT02864251|69228673|FG000|Treatment|Withdrawal by Participant|8|||
37652746|NCT01897571|69123169|FG009|Overall Study|Other|0|||
37652747|NCT01897571|69123170|FG010|Overall Study|Other|0|||
37652748|NCT01897571|69123160|FG000|Overall Study|Enrolled in rollover study|0|||
37652749|NCT01897571|69123161|FG001|Overall Study|Enrolled in rollover study|0|||
37652750|NCT01897571|69123162|FG002|Overall Study|Enrolled in rollover study|0|||
37652751|NCT01897571|69123163|FG003|Overall Study|Enrolled in rollover study|0|||
37652752|NCT01897571|69123164|FG004|Overall Study|Enrolled in rollover study|0|||
37652753|NCT01897571|69123165|FG005|Overall Study|Enrolled in rollover study|0|||
37652754|NCT01897571|69123166|FG006|Overall Study|Enrolled in rollover study|0|||
37652755|NCT01897571|69123167|FG007|Overall Study|Enrolled in rollover study|9|||
37652756|NCT01897571|69123168|FG008|Overall Study|Enrolled in rollover study|7|||
37652757|NCT01897571|69123169|FG009|Overall Study|Enrolled in rollover study|9|||
37742444|NCT02864251|69228674|FG001|Treatment|Withdrawal by Participant|5|||
38032546|NCT01358578|69718554|FG002|Induction Period|Protocol Deviation|0|||
37922596|NCT00664534|69609341|FG000|Overall Study|Protocol Violation|10|||
37922597|NCT00664534|69609342|FG001|Overall Study|Protocol Violation|8|||
37922598|NCT00664534|69609341|FG000|Overall Study|Withdrawal by Subject|7|||
37922599|NCT00664534|69609342|FG001|Overall Study|Withdrawal by Subject|6|||
37922600|NCT00664534|69609341|FG000|Overall Study|Physician Decision|8|||
37922601|NCT00664534|69609342|FG001|Overall Study|Physician Decision|0|||
37922602|NCT00664534|69609341|FG000|Overall Study|Sponsor decision|8|||
37922603|NCT00664534|69609342|FG001|Overall Study|Sponsor decision|6|||
37922604|NCT00594035|69609350|FG000|Overall Study|Lost to Follow-up|1|||
37922605|NCT00594035|69609351|FG001|Overall Study|Lost to Follow-up|1|||
37922606|NCT00594035|69609350|FG000|Overall Study|Withdrawal by Subject|1|||
37922607|NCT00594035|69609351|FG001|Overall Study|Withdrawal by Subject|0|||
37922608|NCT00594035|69609350|FG000|Overall Study|Subject transferred to nursing home|0|||
37922609|NCT00594035|69609351|FG001|Overall Study|Subject transferred to nursing home|1|||
37922610|NCT00594035|69609350|FG000|Overall Study|Subject couldn't return due to job|0|||
37922611|NCT00594035|69609351|FG001|Overall Study|Subject couldn't return due to job|1|||
37922612|NCT00570310|69609359|FG000|Overall Study|Adverse Event|1|||
37922613|NCT00570310|69609360|FG001|Overall Study|Adverse Event|2|||
37922614|NCT00570310|69609359|FG000|Overall Study|Lack of Efficacy|1|||
37922615|NCT00570310|69609360|FG001|Overall Study|Lack of Efficacy|4|||
37922616|NCT00664066|69609366|FG000|Overall Study|Study terminated|3|||
37922617|NCT00814710|69609372|FG000|Overall Study|Adverse Event|1|||
37922618|NCT00814710|69609373|FG001|Overall Study|Adverse Event|0|||
37922619|NCT00814710|69609372|FG000|Overall Study|Lost to Follow-up|7|||
37922620|NCT00814710|69609373|FG001|Overall Study|Lost to Follow-up|3|||
37922621|NCT00871169|69609379|FG000|Overall Study|Protocol Violation|1|||
37922622|NCT00871169|69609379|FG000|Overall Study|Patient did not receive study treatment|2|||
37922623|NCT00814632|69609383|FG000|Overall Study|Lack of Efficacy|2|||
37922624|NCT00851318|69609391|FG000|Overall Study|Withdrawal by Subject|7|||
37922625|NCT00851318|69609392|FG001|Overall Study|Withdrawal by Subject|1|||
37922626|NCT00851318|69609393|FG002|Overall Study|Withdrawal by Subject|5|||
38032547|NCT01358578|69718555|FG003|Induction Period|Protocol Deviation|3|||
38032548|NCT01358578|69718556|FG004|Induction Period|Protocol Deviation|0|||
37652758|NCT01897571|69123170|FG010|Overall Study|Enrolled in rollover study|1|||
37652759|NCT01897571|69123160|FG000|Overall Study|Death|2|||
37742445|NCT02864251|69228675|FG002|Treatment|Withdrawal by Participant|13|||
38032549|NCT01358578|69718557|FG005|Induction Period|Protocol Deviation|0|||
38032550|NCT01358578|69718552|FG000|Induction Period|technical problems|0|||
38032551|NCT01358578|69718553|FG001|Induction Period|technical problems|0|||
38032552|NCT01358578|69718554|FG002|Induction Period|technical problems|1|||
38032553|NCT01358578|69718555|FG003|Induction Period|technical problems|1|||
38032554|NCT01358578|69718556|FG004|Induction Period|technical problems|0|||
38032555|NCT01358578|69718557|FG005|Induction Period|technical problems|0|||
38032556|NCT01358578|69718552|FG000|Induction Period|Withdrawal by Subject|5|||
38032557|NCT01358578|69718553|FG001|Induction Period|Withdrawal by Subject|5|||
38032558|NCT01358578|69718554|FG002|Induction Period|Withdrawal by Subject|10|||
38032559|NCT01358578|69718555|FG003|Induction Period|Withdrawal by Subject|6|||
38032560|NCT01358578|69718556|FG004|Induction Period|Withdrawal by Subject|0|||
37855240|NCT01007149|69538467|FG001|Overall Study|Administrative problems|1|||
37855241|NCT00998335|69538475|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
37855242|NCT00998335|69538476|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
37855243|NCT01294670|69538493|FG000|Overall Study|Not treated|1|||
37855244|NCT01294670|69538494|FG001|Overall Study|Not treated|0|||
37855245|NCT01294670|69538495|FG002|Overall Study|Not treated|0|||
37855246|NCT01294670|69538496|FG003|Overall Study|Not treated|0|||
37855247|NCT01294670|69538497|FG004|Overall Study|Not treated|0|||
37855248|NCT01006603|69538511|FG000|Overall Study|Withdrawal by Subject|17|||
37855249|NCT01006603|69538512|FG001|Overall Study|Withdrawal by Subject|19|||
37855250|NCT01006603|69538511|FG000|Overall Study|Lost to Follow-up|0|||
38032561|NCT01358578|69718557|FG005|Induction Period|Withdrawal by Subject|0|||
37652760|NCT01897571|69123161|FG001|Overall Study|Death|2|||
37652761|NCT01897571|69123162|FG002|Overall Study|Death|3|||
37855251|NCT01006603|69538512|FG001|Overall Study|Lost to Follow-up|1|||
37855252|NCT01006603|69538511|FG000|Overall Study|Safety reason|1|||
37855253|NCT01006603|69538512|FG001|Overall Study|Safety reason|1|||
37922627|NCT00851318|69609394|FG003|Overall Study|Withdrawal by Subject|3|||
37922628|NCT00851318|69609391|FG000|Overall Study|Adverse Event|13|||
37922629|NCT00851318|69609392|FG001|Overall Study|Adverse Event|2|||
37922630|NCT00851318|69609393|FG002|Overall Study|Adverse Event|9|||
37922631|NCT00851318|69609394|FG003|Overall Study|Adverse Event|12|||
37922632|NCT00851318|69609391|FG000|Overall Study|Pregnancy|0|||
37922633|NCT00851318|69609392|FG001|Overall Study|Pregnancy|0|||
38032562|NCT01358578|69718552|FG000|Maintenance Period|Adverse Event|2|||
38032563|NCT01358578|69718553|FG001|Maintenance Period|Adverse Event|7|||
38032564|NCT01358578|69718554|FG002|Maintenance Period|Adverse Event|0|||
38032565|NCT01358578|69718555|FG003|Maintenance Period|Adverse Event|6|||
38032566|NCT01358578|69718556|FG004|Maintenance Period|Adverse Event|4|||
38032567|NCT01358578|69718557|FG005|Maintenance Period|Adverse Event|3|||
38032568|NCT01358578|69718552|FG000|Maintenance Period|Lack of Efficacy|10|||
38032569|NCT01358578|69718553|FG001|Maintenance Period|Lack of Efficacy|2|||
38032570|NCT01358578|69718554|FG002|Maintenance Period|Lack of Efficacy|0|||
38032571|NCT01358578|69718555|FG003|Maintenance Period|Lack of Efficacy|11|||
38032572|NCT01358578|69718556|FG004|Maintenance Period|Lack of Efficacy|3|||
38032573|NCT01358578|69718557|FG005|Maintenance Period|Lack of Efficacy|0|||
37742446|NCT02864251|69228673|FG000|Treatment|Maximum Clinical Benefit|1|||
37742447|NCT02864251|69228674|FG001|Treatment|Maximum Clinical Benefit|0|||
37742448|NCT02864251|69228675|FG002|Treatment|Maximum Clinical Benefit|1|||
37742449|NCT02864251|69228673|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
37742450|NCT02864251|69228674|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
37742451|NCT02864251|69228675|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
37742452|NCT02864251|69228673|FG000|Treatment|Other Reasons|1|||
37742453|NCT02864251|69228674|FG001|Treatment|Other Reasons|1|||
38032574|NCT01358578|69718552|FG000|Maintenance Period|Lost to Follow-up|4|||
38032575|NCT01358578|69718553|FG001|Maintenance Period|Lost to Follow-up|0|||
38032576|NCT01358578|69718554|FG002|Maintenance Period|Lost to Follow-up|0|||
38032577|NCT01358578|69718555|FG003|Maintenance Period|Lost to Follow-up|5|||
38032578|NCT01358578|69718556|FG004|Maintenance Period|Lost to Follow-up|1|||
37652762|NCT01897571|69123163|FG003|Overall Study|Death|6|||
37652763|NCT01897571|69123164|FG004|Overall Study|Death|7|||
37652764|NCT01897571|69123165|FG005|Overall Study|Death|9|||
37652765|NCT01897571|69123166|FG006|Overall Study|Death|5|||
37652766|NCT01897571|69123167|FG007|Overall Study|Death|22|||
37652767|NCT01897571|69123168|FG008|Overall Study|Death|23|||
37652768|NCT01897571|69123169|FG009|Overall Study|Death|129|||
37652769|NCT01897571|69123170|FG010|Overall Study|Death|59|||
37652770|NCT01651403|69123191|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
37652771|NCT01651403|69123192|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
37652772|NCT01651403|69123191|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
37652773|NCT01651403|69123192|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
37652774|NCT01651403|69123191|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
37652775|NCT01651403|69123192|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
37652776|NCT01651403|69123191|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
37652777|NCT01651403|69123192|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
37652778|NCT01651403|69123191|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
37652779|NCT01651403|69123192|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
37652780|NCT01651403|69123191|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
37652781|NCT01651403|69123192|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
37652782|NCT01207778|69123206|FG000|Overall Study|Lost to Follow-up|0|||
37652783|NCT01207778|69123207|FG001|Overall Study|Lost to Follow-up|3|||
37652784|NCT01207778|69123208|FG002|Overall Study|Lost to Follow-up|3|||
37652785|NCT00953771|69123218|FG000|Overall Study|Death|1|||
37652786|NCT00953771|69123219|FG001|Overall Study|Death|0|||
37652787|NCT02567552|69123227|FG000|Overall Study|Adverse Event|0|||
37742454|NCT02864251|69228675|FG002|Treatment|Other Reasons|4|||
37855254|NCT01006603|69538511|FG000|Overall Study|Protocol Violation|1|||
37855255|NCT01006603|69538512|FG001|Overall Study|Protocol Violation|3|||
37855256|NCT01006603|69538511|FG000|Overall Study|Incorrect enrolment|0|||
37855257|NCT01006603|69538512|FG001|Overall Study|Incorrect enrolment|2|||
37855258|NCT01006603|69538511|FG000|Overall Study|Adverse Event|15|||
37855259|NCT01006603|69538512|FG001|Overall Study|Adverse Event|7|||
37855260|NCT01006603|69538511|FG000|Overall Study|Death|1|||
37855261|NCT01006603|69538512|FG001|Overall Study|Death|1|||
37855262|NCT01006603|69538511|FG000|Overall Study|Study specific discontinuation criteria|33|||
37855263|NCT01006603|69538512|FG001|Overall Study|Study specific discontinuation criteria|34|||
38032579|NCT01358578|69718557|FG005|Maintenance Period|Lost to Follow-up|1|||
38032580|NCT01358578|69718552|FG000|Maintenance Period|Non-compliance with study treatment|3|||
38032581|NCT01358578|69718553|FG001|Maintenance Period|Non-compliance with study treatment|1|||
37652788|NCT02567552|69123228|FG001|Overall Study|Adverse Event|1|||
37652789|NCT02561000|69123242|FG000|Overall Study|Withdrawal by Subject|2|||
37742455|NCT02864251|69228673|FG000|Treatment|Administrative Reason by Sponsor|1|||
37652790|NCT02561000|69123243|FG001|Overall Study|Withdrawal by Subject|3|||
37652791|NCT02561000|69123244|FG002|Overall Study|Withdrawal by Subject|0|||
37652792|NCT02561000|69123242|FG000|Overall Study|Adverse Event|0|||
37742456|NCT02864251|69228674|FG001|Treatment|Administrative Reason by Sponsor|0|||
37855264|NCT01006603|69538511|FG000|Overall Study|Other|3|||
37855265|NCT01006603|69538512|FG001|Overall Study|Other|7|||
37855266|NCT00997321|69538520|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
37652793|NCT02561000|69123243|FG001|Overall Study|Adverse Event|1|||
37652794|NCT02561000|69123244|FG002|Overall Study|Adverse Event|0|||
37652795|NCT01663532|69123254|FG000|Overall Study|Lost to Follow-up|9|||
37652796|NCT01663532|69123255|FG001|Overall Study|Lost to Follow-up|10|||
37652797|NCT01663532|69123254|FG000|Overall Study|Adverse Event|7|||
37652798|NCT01663532|69123255|FG001|Overall Study|Adverse Event|13|||
37652799|NCT01663532|69123254|FG000|Overall Study|Met Withdrawal Criteria|7|||
37652800|NCT01663532|69123255|FG001|Overall Study|Met Withdrawal Criteria|6|||
37652801|NCT01663532|69123254|FG000|Overall Study|Physician Decision|1|||
37652802|NCT01663532|69123255|FG001|Overall Study|Physician Decision|1|||
37652803|NCT01663532|69123254|FG000|Overall Study|Withdrawal by Subject|35|||
37652804|NCT01663532|69123255|FG001|Overall Study|Withdrawal by Subject|17|||
37652805|NCT01663532|69123254|FG000|Overall Study|Lack of Efficacy|15|||
37652806|NCT01663532|69123255|FG001|Overall Study|Lack of Efficacy|60|||
37652807|NCT02525939|69123263|FG000|Overall Study|Lost to Follow-up|27|||
37652808|NCT02525939|69123264|FG001|Overall Study|Lost to Follow-up|24|||
37652809|NCT02525939|69123263|FG000|Overall Study|Physician Decision|0|||
37652810|NCT02525939|69123264|FG001|Overall Study|Physician Decision|1|||
37652811|NCT02525939|69123263|FG000|Overall Study|Withdrawal by Subject|24|||
37652812|NCT02525939|69123264|FG001|Overall Study|Withdrawal by Subject|39|||
37652813|NCT02525939|69123263|FG000|Overall Study|Death|180|||
37652814|NCT02525939|69123264|FG001|Overall Study|Death|179|||
37652815|NCT02697591|69123301|FG000|Overall Study|Lost to Follow-up|0|||
37652816|NCT02697591|69123302|FG001|Overall Study|Lost to Follow-up|0|||
37652817|NCT02697591|69123303|FG002|Overall Study|Lost to Follow-up|0|||
37652818|NCT02697591|69123304|FG003|Overall Study|Lost to Follow-up|0|||
37652819|NCT02697591|69123305|FG004|Overall Study|Lost to Follow-up|0|||
37652820|NCT02697591|69123306|FG005|Overall Study|Lost to Follow-up|1|||
37652821|NCT02697591|69123307|FG006|Overall Study|Lost to Follow-up|1|||
37652822|NCT02697591|69123308|FG007|Overall Study|Lost to Follow-up|0|||
37652823|NCT02697591|69123309|FG008|Overall Study|Lost to Follow-up|0|||
37652824|NCT02697591|69123310|FG009|Overall Study|Lost to Follow-up|1|||
37652825|NCT02697591|69123301|FG000|Overall Study|Withdrawal by Subject|1|||
37652826|NCT02697591|69123302|FG001|Overall Study|Withdrawal by Subject|1|||
37652827|NCT02697591|69123303|FG002|Overall Study|Withdrawal by Subject|2|||
37652828|NCT02697591|69123304|FG003|Overall Study|Withdrawal by Subject|1|||
37652829|NCT02697591|69123305|FG004|Overall Study|Withdrawal by Subject|7|||
37652830|NCT02697591|69123306|FG005|Overall Study|Withdrawal by Subject|6|||
37652831|NCT02697591|69123307|FG006|Overall Study|Withdrawal by Subject|9|||
37652832|NCT02697591|69123308|FG007|Overall Study|Withdrawal by Subject|1|||
37652833|NCT02697591|69123309|FG008|Overall Study|Withdrawal by Subject|6|||
37742457|NCT02864251|69228675|FG002|Treatment|Administrative Reason by Sponsor|0|||
37855267|NCT00997321|69538521|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
37855268|NCT01294592|69538535|FG000|Overall Study|Adverse Event|28|||
37652834|NCT02697591|69123310|FG009|Overall Study|Withdrawal by Subject|10|||
37652835|NCT02697591|69123301|FG000|Overall Study|Physician Decision|1|||
37652836|NCT02697591|69123302|FG001|Overall Study|Physician Decision|0|||
37652837|NCT02697591|69123303|FG002|Overall Study|Physician Decision|0|||
37652838|NCT02697591|69123304|FG003|Overall Study|Physician Decision|0|||
37652839|NCT02697591|69123305|FG004|Overall Study|Physician Decision|1|||
37652840|NCT02697591|69123306|FG005|Overall Study|Physician Decision|2|||
37652841|NCT02697591|69123307|FG006|Overall Study|Physician Decision|0|||
37652842|NCT02697591|69123308|FG007|Overall Study|Physician Decision|0|||
37652843|NCT02697591|69123309|FG008|Overall Study|Physician Decision|1|||
37652844|NCT02697591|69123310|FG009|Overall Study|Physician Decision|1|||
37652845|NCT02697591|69123301|FG000|Overall Study|Death|2|||
37652846|NCT02697591|69123302|FG001|Overall Study|Death|3|||
37652847|NCT02697591|69123303|FG002|Overall Study|Death|1|||
37652848|NCT02697591|69123304|FG003|Overall Study|Death|1|||
37652849|NCT02697591|69123305|FG004|Overall Study|Death|4|||
37652850|NCT02697591|69123306|FG005|Overall Study|Death|5|||
37652851|NCT02697591|69123307|FG006|Overall Study|Death|3|||
37652852|NCT02697591|69123308|FG007|Overall Study|Death|1|||
37652853|NCT02697591|69123309|FG008|Overall Study|Death|1|||
37742458|NCT02658487|69228709|FG000|Overall Study|Death|2|||
37742459|NCT02658487|69228709|FG000|Overall Study|Disease progression|10|||
37742460|NCT02658487|69228709|FG000|Overall Study|Alternative therapy|1|||
37742461|NCT02658487|69228709|FG000|Overall Study|Adverse Event|1|||
37742462|NCT02658487|69228709|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
37742463|NCT02658487|69228709|FG000|Overall Study|Refractory AML|1|||
37742464|NCT02632409|69228716|FG000|Randomized|AE unrelated to study Drug|0|||
37742465|NCT02632409|69228717|FG001|Randomized|AE unrelated to study Drug|1|||
37742466|NCT02632409|69228716|FG000|Randomized|Participant withdrew consent|2|||
37742467|NCT02632409|69228717|FG001|Randomized|Participant withdrew consent|1|||
37742468|NCT02632409|69228716|FG000|Randomized|No Longer meets study criteria|5|||
37742469|NCT02632409|69228717|FG001|Randomized|No Longer meets study criteria|0|||
37742470|NCT02632409|69228716|FG000|Randomized|other reasons|1|||
37742471|NCT02632409|69228717|FG001|Randomized|other reasons|0|||
37742472|NCT02632409|69228716|FG000|Treatment Period|Ongoing Treatment|20|||
37742473|NCT02632409|69228717|FG001|Treatment Period|Ongoing Treatment|21|||
37652854|NCT02697591|69123310|FG009|Overall Study|Death|5|||
37652855|NCT02697591|69123301|FG000|Overall Study|Reason not Specified|0|||
37652856|NCT02697591|69123302|FG001|Overall Study|Reason not Specified|0|||
37742474|NCT02632409|69228716|FG000|Treatment Period|Disease Recurrence|147|||
37742475|NCT02632409|69228717|FG001|Treatment Period|Disease Recurrence|90|||
37742476|NCT02632409|69228716|FG000|Treatment Period|Study Drug Toxicity|8|||
37652857|NCT02697591|69123303|FG002|Overall Study|Reason not Specified|0|||
37652858|NCT02697591|69123304|FG003|Overall Study|Reason not Specified|1|||
37652859|NCT02697591|69123305|FG004|Overall Study|Reason not Specified|1|||
37652860|NCT02697591|69123306|FG005|Overall Study|Reason not Specified|2|||
37652861|NCT02697591|69123307|FG006|Overall Study|Reason not Specified|3|||
37652862|NCT02697591|69123308|FG007|Overall Study|Reason not Specified|1|||
37652863|NCT02697591|69123309|FG008|Overall Study|Reason not Specified|1|||
37652864|NCT02697591|69123310|FG009|Overall Study|Reason not Specified|3|||
37652865|NCT02697435|69123335|FG000|Overall Study|Withdrawal by Subject|1|||
37652866|NCT02697435|69123336|FG001|Overall Study|Withdrawal by Subject|0|||
37652867|NCT02697435|69123335|FG000|Overall Study|Physician Decision|0|||
37652868|NCT02697435|69123336|FG001|Overall Study|Physician Decision|4|||
37742477|NCT02632409|69228717|FG001|Treatment Period|Study Drug Toxicity|49|||
37742478|NCT02632409|69228716|FG000|Treatment Period|Death|1|||
37742479|NCT02632409|69228717|FG001|Treatment Period|Death|0|||
37742480|NCT02632409|69228716|FG000|Treatment Period|AE unrelated to study drug|15|||
37742481|NCT02632409|69228717|FG001|Treatment Period|AE unrelated to study drug|16|||
37742482|NCT02632409|69228716|FG000|Treatment Period|Request to discontinue treatment|4|||
37742483|NCT02632409|69228717|FG001|Treatment Period|Request to discontinue treatment|19|||
37742484|NCT02632409|69228716|FG000|Treatment Period|Participant withdrew consent|7|||
37742485|NCT02632409|69228717|FG001|Treatment Period|Participant withdrew consent|5|||
37742486|NCT02632409|69228716|FG000|Treatment Period|Lost to Follow-up|0|||
37742487|NCT02632409|69228717|FG001|Treatment Period|Lost to Follow-up|1|||
37742488|NCT02632409|69228716|FG000|Treatment Period|Maximum clinical benefit|1|||
37742489|NCT02632409|69228717|FG001|Treatment Period|Maximum clinical benefit|0|||
37742490|NCT02632409|69228716|FG000|Treatment Period|No longer meets study criteria|3|||
37742491|NCT02632409|69228717|FG001|Treatment Period|No longer meets study criteria|0|||
37742492|NCT02632409|69228716|FG000|Treatment Period|Administrative Reason by sponsor|0|||
37742493|NCT02632409|69228717|FG001|Treatment Period|Administrative Reason by sponsor|1|||
37742494|NCT02632409|69228716|FG000|Treatment Period|Other Reasons|10|||
37742495|NCT02632409|69228717|FG001|Treatment Period|Other Reasons|6|||
37742496|NCT02570113|69228723|FG000|Overall Study|Withdrawal by Subject|3|||
37742497|NCT02565914|69228727|FG000|Part A (Up to 96 Weeks)|Adverse Event|17|||
37742498|NCT02565914|69228727|FG000|Part A (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|25|||
37742499|NCT02565914|69228727|FG000|Part A (Up to 96 Weeks)|Lost to Follow-up|12|||
37742500|NCT02565914|69228727|FG000|Part A (Up to 96 Weeks)|Death (not treatment emergent)|1|||
37742501|NCT02565914|69228727|FG000|Part A (Up to 96 Weeks)|Other noncompliance|6|||
37742502|NCT02565914|69228727|FG000|Part A (Up to 96 Weeks)|Physician Decision|6|||
37652869|NCT02174861|69123343|FG000|Overall Study|Decision by sponsor|8|||
37652870|NCT02174861|69123343|FG000|Overall Study|Withdrawal by Subject|124|||
37652871|NCT02174861|69123343|FG000|Overall Study|Lost to Follow-up|26|||
37652872|NCT00140855|69123349|FG000|Overall Study|Progressive disease|2|||
37652873|NCT00700635|69123356|FG000|Overall Study|Adverse Event|1|||
37652874|NCT00700635|69123357|FG001|Overall Study|Adverse Event|0|||
37742503|NCT02565914|69228727|FG000|Part A (Up to 96 Weeks)|Parent study termination by sponsor|1|||
37652875|NCT00700635|69123358|FG002|Overall Study|Adverse Event|0|||
37652876|NCT00700635|69123356|FG000|Overall Study|Lost to Follow-up|1|||
37652877|NCT00700635|69123357|FG001|Overall Study|Lost to Follow-up|3|||
37652878|NCT00700635|69123358|FG002|Overall Study|Lost to Follow-up|0|||
37652879|NCT00700635|69123356|FG000|Overall Study|Protocol Violation|2|||
37652880|NCT00700635|69123357|FG001|Overall Study|Protocol Violation|2|||
37652881|NCT00700635|69123358|FG002|Overall Study|Protocol Violation|0|||
37652882|NCT00700635|69123356|FG000|Overall Study|Withdrawal by Subject|7|||
37652883|NCT00700635|69123357|FG001|Overall Study|Withdrawal by Subject|3|||
37652884|NCT00700635|69123358|FG002|Overall Study|Withdrawal by Subject|1|||
37652885|NCT02780687|69123368|FG000|Overall Study|Adverse Event|1|||
37742504|NCT02565914|69228727|FG000|Part A (Up to 96 Weeks)|Commercial drug available|5|||
37742505|NCT02565914|69228727|FG000|Part A (Up to 96 Weeks)|Other|18|||
37742506|NCT02565914|69228727|FG000|Part A (Up to 96 Weeks)|Enrolled, but did not receive study drug|2|||
37742507|NCT02565914|69228727|FG000|Part B (Up to 96 Weeks)|Physician Decision|1|||
37742508|NCT02565914|69228727|FG000|Part B (Up to 96 Weeks)|Other|1|||
37742509|NCT02565914|69228727|FG000|Part B (Up to 96 Weeks)|Enrolled, but did not receive study drug|1|||
37742510|NCT02565914|69228727|FG000|Part B (Up to 96 Weeks)|Adverse Event|4|||
37652886|NCT02780687|69123369|FG001|Overall Study|Adverse Event|1|||
37652887|NCT02780687|69123368|FG000|Overall Study|Withdrawal by Subject|2|||
37922634|NCT00851318|69609393|FG002|Overall Study|Pregnancy|1|||
37652888|NCT02780687|69123369|FG001|Overall Study|Withdrawal by Subject|1|||
37742511|NCT02565914|69228727|FG000|Part B (Up to 96 Weeks)|Sponsor Decision|2|||
37742512|NCT02565914|69228727|FG000|Part B (Up to 96 Weeks)|Rolled over into another study|25|||
37652889|NCT02780687|69123368|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
37742513|NCT02565914|69228727|FG000|Part B (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|6|||
37742514|NCT02565914|69228727|FG000|Part B (Up to 96 Weeks)|Commercial drug is available for participant|196|||
37652890|NCT02780687|69123369|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
37652891|NCT02780687|69123368|FG000|Overall Study|progressive disease|29|||
37652892|NCT02780687|69123369|FG001|Overall Study|progressive disease|6|||
37652893|NCT02698371|69123374|FG000|All Participants Flow|Lost to Follow-up|3|||
37652894|NCT02698371|69123374|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
37652895|NCT02698371|69123374|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
37652896|NCT02698371|69123374|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
37652897|NCT02698371|69123374|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
37652898|NCT02698371|69123374|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
37652899|NCT02698371|69123374|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
37652900|NCT02781311|69123393|FG000|Overall Study|Adverse Event|2|||
37652901|NCT02781311|69123394|FG001|Overall Study|Adverse Event|6|||
37652902|NCT02781311|69123395|FG002|Overall Study|Adverse Event|1|||
37652903|NCT02781311|69123393|FG000|Overall Study|Withdrawal of Consent|11|||
37652904|NCT02781311|69123394|FG001|Overall Study|Withdrawal of Consent|12|||
37652905|NCT02781311|69123395|FG002|Overall Study|Withdrawal of Consent|2|||
37652906|NCT02781311|69123393|FG000|Overall Study|Lost to Follow-up|11|||
37652907|NCT02781311|69123394|FG001|Overall Study|Lost to Follow-up|8|||
37652908|NCT02781311|69123395|FG002|Overall Study|Lost to Follow-up|1|||
37652909|NCT02781311|69123393|FG000|Overall Study|Non-Compliance with Study Drug|2|||
37652910|NCT02781311|69123394|FG001|Overall Study|Non-Compliance with Study Drug|0|||
37652911|NCT02781311|69123395|FG002|Overall Study|Non-Compliance with Study Drug|0|||
37652912|NCT02564198|69123405|FG000|Overall Study|Withdrawal by Subject|2|||
37652913|NCT02564198|69123406|FG001|Overall Study|Withdrawal by Subject|4|||
37652914|NCT02564198|69123407|FG002|Overall Study|Withdrawal by Subject|0|||
37652915|NCT02564198|69123405|FG000|Overall Study|Adverse Event|0|||
37652916|NCT02564198|69123406|FG001|Overall Study|Adverse Event|1|||
37652917|NCT02564198|69123407|FG002|Overall Study|Adverse Event|0|||
37652918|NCT02564120|69123422|FG000|Overall Study|Did not return release forms|160|||
37742515|NCT02565914|69228727|FG000|Part C (Up to 192 Weeks)|Physician Decision|5|||
37742516|NCT02565914|69228727|FG000|Part C (Up to 192 Weeks)|Adverse Event|1|||
37742517|NCT02565914|69228727|FG000|Part C (Up to 192 Weeks)|Other non-compliance|2|||
37742518|NCT02565914|69228727|FG000|Part C (Up to 192 Weeks)|Rolled over into another study|11|||
37742519|NCT02565914|69228727|FG000|Part C (Up to 192 Weeks)|Withdrawal of consent (not due to AE)|4|||
37855269|NCT01294592|69538536|FG001|Overall Study|Adverse Event|13|||
37742520|NCT02565914|69228727|FG000|Part C (Up to 192 Weeks)|Commercial drug is available for participant|174|||
37742521|NCT02435849|69228737|FG000|Overall Study|Death|23|||
37742522|NCT02435849|69228738|FG001|Overall Study|Death|0|||
37742523|NCT02435849|69228737|FG000|Overall Study|Lack of Efficacy|10|||
37742524|NCT02435849|69228738|FG001|Overall Study|Lack of Efficacy|0|||
37742525|NCT02435849|69228737|FG000|Overall Study|New therapy for study indication|8|||
37742526|NCT02435849|69228738|FG001|Overall Study|New therapy for study indication|0|||
37742527|NCT02435849|69228737|FG000|Overall Study|Subject/guardian decision|5|||
37742528|NCT02435849|69228738|FG001|Overall Study|Subject/guardian decision|1|||
37742529|NCT02435849|69228737|FG000|Overall Study|Lost to Follow-up|1|||
37742530|NCT02435849|69228738|FG001|Overall Study|Lost to Follow-up|0|||
37742531|NCT02435849|69228737|FG000|Overall Study|Physician Decision|1|||
37742532|NCT02435849|69228738|FG001|Overall Study|Physician Decision|0|||
37742533|NCT02248701|69228746|FG000|Overall Study|Withdrawal by Subject|2|||
37742534|NCT02248701|69228747|FG001|Overall Study|Withdrawal by Subject|1|||
37742535|NCT02248701|69228746|FG000|Overall Study|Physician Decision|0|||
37742536|NCT02248701|69228747|FG001|Overall Study|Physician Decision|1|||
37742537|NCT02248701|69228746|FG000|Overall Study|Adverse Event|1|||
37742538|NCT02248701|69228747|FG001|Overall Study|Adverse Event|0|||
37742539|NCT02248701|69228746|FG000|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|1|||
37742540|NCT02248701|69228747|FG001|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|0|||
37742541|NCT02204982|69228755|FG000|Overall Study|Patient ineligible-medical monitor|1|||
37742542|NCT02204982|69228756|FG001|Overall Study|Patient ineligible-medical monitor|0|||
37855270|NCT01294592|69538535|FG000|Overall Study|Lack of Efficacy|7|||
37855271|NCT01294592|69538536|FG001|Overall Study|Lack of Efficacy|5|||
37855272|NCT01294592|69538535|FG000|Overall Study|Protocol Violation|1|||
38032582|NCT01358578|69718554|FG002|Maintenance Period|Non-compliance with study treatment|0|||
38032583|NCT01358578|69718555|FG003|Maintenance Period|Non-compliance with study treatment|2|||
38032584|NCT01358578|69718556|FG004|Maintenance Period|Non-compliance with study treatment|1|||
38032585|NCT01358578|69718557|FG005|Maintenance Period|Non-compliance with study treatment|2|||
38032586|NCT01358578|69718552|FG000|Maintenance Period|Physician Decision|0|||
38032587|NCT01358578|69718553|FG001|Maintenance Period|Physician Decision|1|||
37855273|NCT01294592|69538536|FG001|Overall Study|Protocol Violation|7|||
38032588|NCT01358578|69718554|FG002|Maintenance Period|Physician Decision|0|||
38032589|NCT01358578|69718555|FG003|Maintenance Period|Physician Decision|1|||
37652919|NCT02564120|69123422|FG000|Overall Study|Death|58|||
37652920|NCT02564120|69123422|FG000|Overall Study|Withdrawal by Subject|204|||
37652921|NCT02564120|69123422|FG000|Overall Study|Other medical condition|24|||
37652922|NCT00705783|69123438|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
37652923|NCT00705783|69123439|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
37652924|NCT00705783|69123440|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
37652925|NCT00705783|69123438|FG000|Conversion Phase|Lost to Follow-up|13|||
37652926|NCT00705783|69123439|FG001|Conversion Phase|Lost to Follow-up|0|||
37652927|NCT00705783|69123440|FG002|Conversion Phase|Lost to Follow-up|0|||
37652928|NCT00705783|69123438|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
37652929|NCT00705783|69123439|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
37652930|NCT00705783|69123440|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
37652931|NCT00705783|69123438|FG000|Conversion Phase|Withdrawn by Investigator|4|||
37652932|NCT00705783|69123439|FG001|Conversion Phase|Withdrawn by Investigator|0|||
37652933|NCT00705783|69123440|FG002|Conversion Phase|Withdrawn by Investigator|0|||
37652934|NCT00705783|69123438|FG000|Conversion Phase|Withdrew Consent|24|||
37652935|NCT00705783|69123439|FG001|Conversion Phase|Withdrew Consent|0|||
37652936|NCT00705783|69123440|FG002|Conversion Phase|Withdrew Consent|0|||
37652937|NCT00705783|69123438|FG000|Conversion Phase|Protocol Deviation|2|||
37652938|NCT00705783|69123439|FG001|Conversion Phase|Protocol Deviation|0|||
37652939|NCT00705783|69123440|FG002|Conversion Phase|Protocol Deviation|0|||
37652940|NCT00705783|69123438|FG000|Conversion Phase|Adverse Event|11|||
37652941|NCT00705783|69123439|FG001|Conversion Phase|Adverse Event|0|||
37652942|NCT00705783|69123440|FG002|Conversion Phase|Adverse Event|0|||
37652943|NCT00705783|69123438|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
37652944|NCT00705783|69123439|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
37652945|NCT00705783|69123440|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
37652946|NCT00705783|69123438|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
37652947|NCT00705783|69123439|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
37652948|NCT00705783|69123440|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
37652949|NCT00705783|69123438|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
37652950|NCT00705783|69123439|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
37652951|NCT00705783|69123440|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
37652952|NCT00705783|69123438|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
37652953|NCT00705783|69123439|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
37652954|NCT00705783|69123440|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
37652955|NCT00705783|69123438|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
37652956|NCT00705783|69123439|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
37742543|NCT02204982|69228755|FG000|Overall Study|Withdrawal by Subject|1|||
37742544|NCT02204982|69228756|FG001|Overall Study|Withdrawal by Subject|0|||
37742545|NCT02204982|69228755|FG000|Overall Study|Adverse Event|1|||
37742546|NCT02204982|69228756|FG001|Overall Study|Adverse Event|0|||
37742547|NCT02204982|69228755|FG000|Overall Study|Adverse Event and Investigator decision|1|||
37742548|NCT02204982|69228756|FG001|Overall Study|Adverse Event and Investigator decision|0|||
37742549|NCT02204982|69228755|FG000|Overall Study|Physician Decision|0|||
37742550|NCT02204982|69228756|FG001|Overall Study|Physician Decision|2|||
37742551|NCT02204982|69228755|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
37742552|NCT02204982|69228756|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
37742553|NCT02204982|69228755|FG000|Overall Study|Termination of Study bySponsor|0|||
37742554|NCT02204982|69228756|FG001|Overall Study|Termination of Study bySponsor|1|||
37742555|NCT02101385|69228764|FG000|Study Treatment|Disease Progression|9|||
37742556|NCT02101385|69228765|FG001|Study Treatment|Disease Progression|3|||
37742557|NCT02101385|69228764|FG000|Study Treatment|Alternative therapy|0|||
37742558|NCT02101385|69228765|FG001|Study Treatment|Alternative therapy|1|||
38032590|NCT01358578|69718556|FG004|Maintenance Period|Physician Decision|0|||
38032591|NCT01358578|69718557|FG005|Maintenance Period|Physician Decision|0|||
38032592|NCT01358578|69718552|FG000|Maintenance Period|Pregnancy|1|||
37652957|NCT00705783|69123440|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
37652958|NCT00705783|69123438|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
37652959|NCT00705783|69123439|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
37652960|NCT00705783|69123440|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
37652961|NCT00705783|69123438|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
37652962|NCT00705783|69123439|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
37652963|NCT00705783|69123440|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
37652964|NCT00705783|69123438|FG000|Oral Stabilization Phase|Adverse Event|14|||
37652965|NCT00705783|69123439|FG001|Oral Stabilization Phase|Adverse Event|0|||
37652966|NCT00705783|69123440|FG002|Oral Stabilization Phase|Adverse Event|0|||
37742559|NCT02101385|69228764|FG000|Study Treatment|No treatment, per protocol criteria|0|||
37742560|NCT02101385|69228765|FG001|Study Treatment|No treatment, per protocol criteria|4|||
37742561|NCT02101385|69228764|FG000|Study Treatment|Patient Non compliance|0|||
37742562|NCT02101385|69228765|FG001|Study Treatment|Patient Non compliance|2|||
38032593|NCT01358578|69718553|FG001|Maintenance Period|Pregnancy|0|||
38032594|NCT01358578|69718554|FG002|Maintenance Period|Pregnancy|0|||
37652967|NCT00705783|69123438|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
37652968|NCT00705783|69123439|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
37652969|NCT00705783|69123440|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
37652970|NCT00705783|69123438|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
37652971|NCT00705783|69123439|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
37652972|NCT00705783|69123440|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
37652973|NCT00705783|69123438|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
37652974|NCT00705783|69123439|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
37652975|NCT00705783|69123440|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
37652976|NCT00705783|69123438|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
37652977|NCT00705783|69123439|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
37742563|NCT02101385|69228764|FG000|Study Treatment|Withdrawal by Subject|5|||
37742564|NCT02101385|69228765|FG001|Study Treatment|Withdrawal by Subject|2|||
37742565|NCT02101385|69228764|FG000|Study Treatment|screen failure|1|||
37742566|NCT02101385|69228765|FG001|Study Treatment|screen failure|0|||
37652978|NCT00705783|69123440|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
37652979|NCT00705783|69123438|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
37652980|NCT00705783|69123439|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
37742567|NCT02101385|69228764|FG000|Study Treatment|AE/Side Effects/Complications|8|||
37742568|NCT02101385|69228765|FG001|Study Treatment|AE/Side Effects/Complications|0|||
37742569|NCT02101385|69228764|FG000|Study Treatment|Lost to Follow-up|1|||
37742570|NCT02101385|69228765|FG001|Study Treatment|Lost to Follow-up|0|||
37742571|NCT02101385|69228764|FG000|Study Treatment|Disease Progression before treatment|1|||
38032595|NCT01358578|69718555|FG003|Maintenance Period|Pregnancy|0|||
38032596|NCT01358578|69718556|FG004|Maintenance Period|Pregnancy|0|||
37652981|NCT00705783|69123440|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
37652982|NCT00705783|69123438|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
37652983|NCT00705783|69123439|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
37652984|NCT00705783|69123440|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
37652985|NCT00705783|69123438|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
37652986|NCT00705783|69123439|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
37652987|NCT00705783|69123440|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
37652988|NCT00705783|69123438|FG000|Depot Stabilization Phase|Adverse Event|17|||
37652989|NCT00705783|69123439|FG001|Depot Stabilization Phase|Adverse Event|0|||
37652990|NCT00705783|69123440|FG002|Depot Stabilization Phase|Adverse Event|0|||
37652991|NCT00705783|69123438|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
37652992|NCT00705783|69123439|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
37652993|NCT00705783|69123440|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
37652994|NCT00705783|69123438|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
37652995|NCT00705783|69123439|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
37652996|NCT00705783|69123440|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
37652997|NCT00705783|69123438|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
37652998|NCT00705783|69123439|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
37652999|NCT00705783|69123440|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
37653000|NCT00705783|69123438|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
37653001|NCT00705783|69123439|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
37653002|NCT00705783|69123440|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
37653003|NCT00705783|69123438|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
37653004|NCT00705783|69123439|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
37653005|NCT00705783|69123440|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
37653006|NCT00705783|69123438|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
37653007|NCT00705783|69123439|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
37653008|NCT00705783|69123440|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
37653009|NCT00705783|69123438|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
37653010|NCT00705783|69123439|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
37653011|NCT00705783|69123440|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
37653012|NCT00705783|69123438|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
37653013|NCT00705783|69123439|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
37653014|NCT00705783|69123440|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
37653015|NCT00705783|69123438|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
37653016|NCT00705783|69123439|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
37653017|NCT00705783|69123440|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
37653018|NCT00705783|69123438|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
37653019|NCT00705783|69123439|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
37742572|NCT02101385|69228765|FG001|Study Treatment|Disease Progression before treatment|0|||
37742573|NCT02101385|69228764|FG000|Study Treatment|Death|1|||
37742574|NCT02101385|69228765|FG001|Study Treatment|Death|0|||
37742575|NCT02101385|69228764|FG000|Follow up|Lost to Follow-up|4|||
37742576|NCT02101385|69228765|FG001|Follow up|Lost to Follow-up|9|||
37653020|NCT00705783|69123440|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
37653021|NCT00705783|69123438|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
37653022|NCT00705783|69123439|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
37653023|NCT00705783|69123440|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
37653024|NCT02694549|69123449|FG000|Overall Study|screen failures|2|||
37653025|NCT02782325|69123455|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
37653026|NCT02782325|69123456|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
37653027|NCT02782325|69123457|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
37653028|NCT02782325|69123455|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
37653029|NCT02782325|69123456|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
37653030|NCT02782325|69123457|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
37653031|NCT02693691|69123465|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
37653032|NCT02693691|69123465|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
37653033|NCT02693691|69123465|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
37653034|NCT02693691|69123465|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
37653035|NCT02693691|69123465|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
37653036|NCT02693691|69123465|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
37653037|NCT02693691|69123465|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
37653038|NCT04203667|69123469|FG000|Overall Study|Withdrawal by Subject|1|||
37653039|NCT04203667|69123469|FG000|Overall Study|Lost to Follow-up|1|||
37653040|NCT04203667|69123469|FG000|Overall Study|Death|1|||
37653041|NCT04203667|69123469|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
37653042|NCT02782169|69123476|FG000|Overall Study|Lost to Follow-up|1|||
37653043|NCT02782169|69123477|FG001|Overall Study|Lost to Follow-up|2|||
37742577|NCT02101385|69228764|FG000|Follow up|Refused to follow up|5|||
37742578|NCT02101385|69228765|FG001|Follow up|Refused to follow up|4|||
37742579|NCT02101385|69228764|FG000|Follow up|Death|21|||
37742580|NCT02101385|69228765|FG001|Follow up|Death|39|||
37742581|NCT02101385|69228764|FG000|Follow up|study completed|33|||
37742582|NCT02101385|69228765|FG001|Follow up|study completed|52|||
37653044|NCT02564042|69123489|FG000|Overall Study|Adverse Event|4|||
37653045|NCT02564042|69123490|FG001|Overall Study|Adverse Event|4|||
37653046|NCT02564042|69123491|FG002|Overall Study|Adverse Event|3|||
37653047|NCT02564042|69123492|FG003|Overall Study|Adverse Event|0|||
37653048|NCT02564042|69123493|FG004|Overall Study|Adverse Event|0|||
37653049|NCT02564042|69123494|FG005|Overall Study|Adverse Event|1|||
37653050|NCT02564042|69123489|FG000|Overall Study|Lost to Follow-up|1|||
37653051|NCT02564042|69123490|FG001|Overall Study|Lost to Follow-up|1|||
37653052|NCT02564042|69123491|FG002|Overall Study|Lost to Follow-up|1|||
37653053|NCT02564042|69123492|FG003|Overall Study|Lost to Follow-up|0|||
37653054|NCT02564042|69123493|FG004|Overall Study|Lost to Follow-up|1|||
37653055|NCT02564042|69123494|FG005|Overall Study|Lost to Follow-up|1|||
37653056|NCT02564042|69123489|FG000|Overall Study|Physician Decision|1|||
37653057|NCT02564042|69123490|FG001|Overall Study|Physician Decision|0|||
37653058|NCT02564042|69123491|FG002|Overall Study|Physician Decision|0|||
37653059|NCT02564042|69123492|FG003|Overall Study|Physician Decision|1|||
37653060|NCT02564042|69123493|FG004|Overall Study|Physician Decision|0|||
37742583|NCT02101385|69228764|FG000|Follow up|screen failure|2|||
37742584|NCT02101385|69228765|FG001|Follow up|screen failure|0|||
37742585|NCT02101385|69228764|FG000|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|0|||
37742586|NCT02101385|69228765|FG001|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|1|||
37742587|NCT02101385|69228764|FG000|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|0|||
38032597|NCT01358578|69718557|FG005|Maintenance Period|Pregnancy|0|||
37653061|NCT02564042|69123494|FG005|Overall Study|Physician Decision|0|||
37653062|NCT02564042|69123489|FG000|Overall Study|Withdrawal by Subject|5|||
37653063|NCT02564042|69123490|FG001|Overall Study|Withdrawal by Subject|3|||
37653064|NCT02564042|69123491|FG002|Overall Study|Withdrawal by Subject|2|||
37653065|NCT02564042|69123492|FG003|Overall Study|Withdrawal by Subject|2|||
37742588|NCT02101385|69228765|FG001|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|1|||
37742589|NCT02101385|69228764|FG000|Follow up|Withdrawal by Subject|2|||
38032598|NCT01358578|69718552|FG000|Maintenance Period|Protocol deviation|7|||
37653066|NCT02564042|69123493|FG004|Overall Study|Withdrawal by Subject|10|||
37653067|NCT02564042|69123494|FG005|Overall Study|Withdrawal by Subject|12|||
37653068|NCT02695719|69123527|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
37653069|NCT02695719|69123528|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
37653070|NCT02695719|69123527|FG000|Overall Study|Significant Protocol Deviation|0|||
37653071|NCT02695719|69123528|FG001|Overall Study|Significant Protocol Deviation|1|||
37653072|NCT02695719|69123527|FG000|Overall Study|Voluntary Withdrawal|1|||
37653073|NCT02695719|69123528|FG001|Overall Study|Voluntary Withdrawal|0|||
37653074|NCT02563106|69123545|FG000|Overall Study|Withdrawal by Subject|7|||
37653075|NCT02563106|69123546|FG001|Overall Study|Withdrawal by Subject|8|||
37653076|NCT02563106|69123545|FG000|Overall Study|Adverse Event|17|||
37653077|NCT02563106|69123546|FG001|Overall Study|Adverse Event|15|||
37653078|NCT02563106|69123545|FG000|Overall Study|Protocol Violation|1|||
37653079|NCT02563106|69123546|FG001|Overall Study|Protocol Violation|0|||
37653080|NCT02563106|69123545|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
37653081|NCT02563106|69123546|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
37653082|NCT02563106|69123545|FG000|Overall Study|Lost to Follow-up|3|||
37653083|NCT02563106|69123546|FG001|Overall Study|Lost to Follow-up|2|||
37653084|NCT02563106|69123545|FG000|Overall Study|Physician Decision|3|||
37653085|NCT02563106|69123546|FG001|Overall Study|Physician Decision|1|||
37653086|NCT02563106|69123545|FG000|Overall Study|Other reason - not specified|2|||
37653087|NCT02563106|69123546|FG001|Overall Study|Other reason - not specified|1|||
37653088|NCT02691741|69123554|FG000|Overall Study|Adverse Event|0|||
37653089|NCT02691741|69123555|FG001|Overall Study|Adverse Event|2|||
37653090|NCT02691741|69123554|FG000|Overall Study|Lost to Follow-up|1|||
37653091|NCT02691741|69123555|FG001|Overall Study|Lost to Follow-up|0|||
37653092|NCT02691741|69123554|FG000|Overall Study|Physician Decision|0|||
37653093|NCT02691741|69123555|FG001|Overall Study|Physician Decision|1|||
37653094|NCT02691741|69123554|FG000|Overall Study|Withdrawal by Subject|0|||
37653095|NCT02691741|69123555|FG001|Overall Study|Withdrawal by Subject|4|||
37653096|NCT02691507|69123568|FG000|Overall Study|Missed Visit 3|0|||
37653097|NCT02691507|69123569|FG001|Overall Study|Missed Visit 3|1|||
37653098|NCT04579393|69123577|FG000|Overall Study|Withdrawal by Subject|2|||
37653099|NCT04579393|69123578|FG001|Overall Study|Withdrawal by Subject|2|||
37653100|NCT04579393|69123577|FG000|Overall Study|Death|1|||
37653101|NCT04579393|69123578|FG001|Overall Study|Death|3|||
37653102|NCT02776553|69123587|FG000|Overall Study|Lost to Follow-up|1|||
37653103|NCT02776553|69123588|FG001|Overall Study|Lost to Follow-up|0|||
37653104|NCT02776553|69123587|FG000|Overall Study|got liver transplant|1|||
37653105|NCT02776553|69123588|FG001|Overall Study|got liver transplant|2|||
37653106|NCT02776553|69123587|FG000|Overall Study|had other surgery|1|||
37653107|NCT02776553|69123588|FG001|Overall Study|had other surgery|0|||
37653108|NCT02776553|69123587|FG000|Overall Study|Protocol Violation|0|||
37653109|NCT02776553|69123588|FG001|Overall Study|Protocol Violation|1|||
37653110|NCT02690727|69123594|FG000|Overall Study|Adverse Event|2|||
37653111|NCT02690727|69123595|FG001|Overall Study|Adverse Event|2|||
37653112|NCT02777333|69123605|FG000|Overall Study|Withdrawal by Subject|0|||
37653113|NCT02777333|69123606|FG001|Overall Study|Withdrawal by Subject|1|||
37653114|NCT02777333|69123605|FG000|Overall Study|Lost to Follow-up|0|||
37653115|NCT02777333|69123606|FG001|Overall Study|Lost to Follow-up|1|||
37653116|NCT02695329|69123614|FG000|Overall Study|Adverse Event|1|||
37653117|NCT02695329|69123615|FG001|Overall Study|Adverse Event|0|||
37653118|NCT02695329|69123614|FG000|Overall Study|Poor X-ray quality for measurement|4|||
37653119|NCT02695329|69123615|FG001|Overall Study|Poor X-ray quality for measurement|5|||
37653120|NCT02690649|69123623|FG000|Overall Study|Withdrawal by Subject|1|||
37653121|NCT02690649|69123624|FG001|Overall Study|Withdrawal by Subject|1|||
37653122|NCT02690649|69123623|FG000|Overall Study|Protocol Violation|0|||
37653123|NCT02690649|69123624|FG001|Overall Study|Protocol Violation|3|||
37653124|NCT01358864|69123640|FG000|Overall Study|Adverse Event|0|||
37653125|NCT01358864|69123641|FG001|Overall Study|Adverse Event|6|||
37653126|NCT01358864|69123642|FG002|Overall Study|Adverse Event|9|||
37653127|NCT01358864|69123643|FG003|Overall Study|Adverse Event|0|||
37653128|NCT01358864|69123644|FG004|Overall Study|Adverse Event|4|||
37653129|NCT01358864|69123645|FG005|Overall Study|Adverse Event|8|||
37653130|NCT01358864|69123646|FG006|Overall Study|Adverse Event|12|||
37653131|NCT01358864|69123647|FG007|Overall Study|Adverse Event|7|||
37742590|NCT02101385|69228765|FG001|Follow up|Withdrawal by Subject|2|||
37742591|NCT02101385|69228764|FG000|Follow up|PI requested closure of site|0|||
37742592|NCT02101385|69228765|FG001|Follow up|PI requested closure of site|5|||
37742593|NCT02068443|69228780|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
37742594|NCT02068443|69228781|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
38032599|NCT01358578|69718553|FG001|Maintenance Period|Protocol deviation|4|||
38032600|NCT01358578|69718554|FG002|Maintenance Period|Protocol deviation|0|||
38032601|NCT01358578|69718555|FG003|Maintenance Period|Protocol deviation|2|||
38032602|NCT01358578|69718556|FG004|Maintenance Period|Protocol deviation|2|||
38032603|NCT01358578|69718557|FG005|Maintenance Period|Protocol deviation|2|||
37653132|NCT01358864|69123640|FG000|Overall Study|Lack of Efficacy|26|||
37653133|NCT01358864|69123641|FG001|Overall Study|Lack of Efficacy|3|||
37653134|NCT01358864|69123642|FG002|Overall Study|Lack of Efficacy|4|||
37653135|NCT01358864|69123643|FG003|Overall Study|Lack of Efficacy|19|||
37653136|NCT01358864|69123644|FG004|Overall Study|Lack of Efficacy|7|||
37653137|NCT01358864|69123645|FG005|Overall Study|Lack of Efficacy|4|||
37653138|NCT01358864|69123646|FG006|Overall Study|Lack of Efficacy|49|||
37653139|NCT01358864|69123647|FG007|Overall Study|Lack of Efficacy|44|||
37653140|NCT01358864|69123640|FG000|Overall Study|Lost to Follow-up|0|||
37653141|NCT01358864|69123641|FG001|Overall Study|Lost to Follow-up|0|||
37653142|NCT01358864|69123642|FG002|Overall Study|Lost to Follow-up|1|||
37653143|NCT01358864|69123643|FG003|Overall Study|Lost to Follow-up|0|||
37653144|NCT01358864|69123644|FG004|Overall Study|Lost to Follow-up|0|||
37742595|NCT02068443|69228782|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
37742596|NCT02068443|69228780|FG000|Overall Study|Voluntary Withdrawal|4|||
37742597|NCT02068443|69228781|FG001|Overall Study|Voluntary Withdrawal|0|||
37742598|NCT02068443|69228782|FG002|Overall Study|Voluntary Withdrawal|1|||
37742599|NCT02068443|69228780|FG000|Overall Study|Lack of Efficacy|2|||
37742600|NCT02068443|69228781|FG001|Overall Study|Lack of Efficacy|1|||
37742601|NCT02068443|69228782|FG002|Overall Study|Lack of Efficacy|0|||
37742602|NCT02068443|69228780|FG000|Overall Study|Other Reason Not Specified|1|||
37742603|NCT02068443|69228781|FG001|Overall Study|Other Reason Not Specified|0|||
37742604|NCT02068443|69228782|FG002|Overall Study|Other Reason Not Specified|0|||
37742605|NCT02065869|69228790|FG000|Overall Study|Death|7|||
37742606|NCT02065869|69228790|FG000|Overall Study|Disease relapse|16|||
37742607|NCT02065869|69228790|FG000|Overall Study|Lost to Follow-up|4|||
37742608|NCT02065869|69228790|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
37742609|NCT02065869|69228790|FG000|Overall Study|Withdrawal by Subject|1|||
37742610|NCT02018861|69228805|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
37653145|NCT01358864|69123645|FG005|Overall Study|Lost to Follow-up|0|||
37653146|NCT01358864|69123646|FG006|Overall Study|Lost to Follow-up|0|||
37742611|NCT02018861|69228806|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
37742612|NCT02018861|69228807|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
37653147|NCT01358864|69123647|FG007|Overall Study|Lost to Follow-up|1|||
37653148|NCT01358864|69123640|FG000|Overall Study|Withdrawal by Subject|3|||
37653149|NCT01358864|69123641|FG001|Overall Study|Withdrawal by Subject|4|||
37653150|NCT01358864|69123642|FG002|Overall Study|Withdrawal by Subject|2|||
37653151|NCT01358864|69123643|FG003|Overall Study|Withdrawal by Subject|0|||
37653152|NCT01358864|69123644|FG004|Overall Study|Withdrawal by Subject|0|||
37653153|NCT01358864|69123645|FG005|Overall Study|Withdrawal by Subject|1|||
37653154|NCT01358864|69123646|FG006|Overall Study|Withdrawal by Subject|1|||
37653155|NCT01358864|69123647|FG007|Overall Study|Withdrawal by Subject|3|||
37653156|NCT01358864|69123640|FG000|Overall Study|Other reason not defined above|2|||
37653157|NCT01358864|69123641|FG001|Overall Study|Other reason not defined above|0|||
37653158|NCT01358864|69123642|FG002|Overall Study|Other reason not defined above|0|||
37742613|NCT02018861|69228808|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
37742614|NCT02018861|69228809|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
37742615|NCT02018861|69228810|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
37742616|NCT02018861|69228811|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
37742617|NCT02018861|69228812|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
37742618|NCT02018861|69228813|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
37742619|NCT02018861|69228814|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
37742620|NCT02018861|69228805|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
37742621|NCT02018861|69228806|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
37742622|NCT02018861|69228807|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
37742623|NCT02018861|69228808|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
38032604|NCT01358578|69718552|FG000|Maintenance Period|Withdrawal by Subject|12|||
38032605|NCT01358578|69718553|FG001|Maintenance Period|Withdrawal by Subject|7|||
37653159|NCT01358864|69123643|FG003|Overall Study|Other reason not defined above|0|||
37653160|NCT01358864|69123644|FG004|Overall Study|Other reason not defined above|0|||
37653161|NCT01358864|69123645|FG005|Overall Study|Other reason not defined above|0|||
37653162|NCT01358864|69123646|FG006|Overall Study|Other reason not defined above|2|||
37653163|NCT01358864|69123647|FG007|Overall Study|Other reason not defined above|0|||
37653164|NCT01358864|69123640|FG000|Overall Study|Not treated|0|||
37653165|NCT01358864|69123641|FG001|Overall Study|Not treated|0|||
37653166|NCT01358864|69123642|FG002|Overall Study|Not treated|0|||
37653167|NCT01358864|69123643|FG003|Overall Study|Not treated|0|||
37653168|NCT01358864|69123644|FG004|Overall Study|Not treated|0|||
38032606|NCT01358578|69718554|FG002|Maintenance Period|Withdrawal by Subject|2|||
37653169|NCT01358864|69123645|FG005|Overall Study|Not treated|0|||
37653170|NCT01358864|69123646|FG006|Overall Study|Not treated|1|||
37653171|NCT01358864|69123647|FG007|Overall Study|Not treated|0|||
37653172|NCT02750761|69123673|FG000|Overall Study|Lost to Follow-up|0|||
37653173|NCT02750761|69123674|FG001|Overall Study|Lost to Follow-up|0|||
37653174|NCT02750761|69123675|FG002|Overall Study|Lost to Follow-up|1|||
37742624|NCT02018861|69228809|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
37855274|NCT01294592|69538535|FG000|Overall Study|Lost to Follow-up|7|||
38032607|NCT01358578|69718555|FG003|Maintenance Period|Withdrawal by Subject|15|||
38032608|NCT01358578|69718556|FG004|Maintenance Period|Withdrawal by Subject|6|||
38032609|NCT01358578|69718557|FG005|Maintenance Period|Withdrawal by Subject|3|||
37653175|NCT02750761|69123676|FG003|Overall Study|Lost to Follow-up|0|||
37653176|NCT02750761|69123677|FG004|Overall Study|Lost to Follow-up|0|||
38032610|NCT01358578|69718552|FG000|Follow-up Period|Adverse Event|1|||
37653177|NCT02750761|69123678|FG005|Overall Study|Lost to Follow-up|0|||
37653178|NCT02688933|69123721|FG000|Overall Study|Adverse Event|3|||
37653179|NCT02688933|69123722|FG001|Overall Study|Adverse Event|1|||
37653180|NCT02688933|69123721|FG000|Overall Study|Lack of Efficacy|2|||
37653181|NCT02688933|69123722|FG001|Overall Study|Lack of Efficacy|2|||
37653182|NCT02688933|69123721|FG000|Overall Study|Poor compliance to protocol|7|||
37653183|NCT02688933|69123722|FG001|Overall Study|Poor compliance to protocol|4|||
37653184|NCT02688933|69123721|FG000|Overall Study|Hypoglycemia|2|||
37653185|NCT02688933|69123722|FG001|Overall Study|Hypoglycemia|0|||
37922635|NCT00851318|69609394|FG003|Overall Study|Pregnancy|1|||
37922636|NCT00851318|69609391|FG000|Overall Study|Lack of Efficacy|8|||
37922637|NCT00851318|69609392|FG001|Overall Study|Lack of Efficacy|2|||
37742625|NCT02018861|69228810|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
37742626|NCT02018861|69228811|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
37653186|NCT02688933|69123721|FG000|Overall Study|Other than Specified|14|||
37922638|NCT00851318|69609393|FG002|Overall Study|Lack of Efficacy|4|||
37742627|NCT02018861|69228812|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
37742628|NCT02018861|69228813|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
37742629|NCT02018861|69228814|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
37742630|NCT02018861|69228805|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
37742631|NCT02018861|69228806|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
37742632|NCT02018861|69228807|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
37742633|NCT02018861|69228808|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
37742634|NCT02018861|69228809|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
37742635|NCT02018861|69228810|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
37742636|NCT02018861|69228811|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
37742637|NCT02018861|69228812|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
37742638|NCT02018861|69228813|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
37742639|NCT02018861|69228814|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
37742640|NCT02018861|69228805|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
37742641|NCT02018861|69228806|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
37742642|NCT02018861|69228807|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
37742643|NCT02018861|69228808|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
37742644|NCT02018861|69228809|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
37742645|NCT02018861|69228810|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
37742646|NCT02018861|69228811|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
37742647|NCT02018861|69228812|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
37742648|NCT02018861|69228813|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
38032611|NCT01358578|69718553|FG001|Follow-up Period|Adverse Event|1|||
38032612|NCT01358578|69718554|FG002|Follow-up Period|Adverse Event|0|||
37922639|NCT00851318|69609394|FG003|Overall Study|Lack of Efficacy|2|||
37922640|NCT00851318|69609391|FG000|Overall Study|Non-compliance with Study Procedures|2|||
37922641|NCT00851318|69609392|FG001|Overall Study|Non-compliance with Study Procedures|0|||
37922642|NCT00851318|69609393|FG002|Overall Study|Non-compliance with Study Procedures|1|||
37922643|NCT00851318|69609394|FG003|Overall Study|Non-compliance with Study Procedures|0|||
37922644|NCT00851318|69609391|FG000|Overall Study|Physician Decision|0|||
37922645|NCT00851318|69609392|FG001|Overall Study|Physician Decision|0|||
37922646|NCT00851318|69609393|FG002|Overall Study|Physician Decision|1|||
37653187|NCT02688933|69123722|FG001|Overall Study|Other than Specified|25|||
37653188|NCT02688933|69123721|FG000|Overall Study|Lost to Follow-up|1|||
37653189|NCT02688933|69123722|FG001|Overall Study|Lost to Follow-up|5|||
37653190|NCT02688621|69123742|FG000|Overall Study|Pregnancy|1|||
37653191|NCT02688621|69123743|FG001|Overall Study|Pregnancy|3|||
37653192|NCT02688621|69123742|FG000|Overall Study|Lost to Follow-up|38|||
37653193|NCT02688621|69123743|FG001|Overall Study|Lost to Follow-up|15|||
37653194|NCT02688621|69123742|FG000|Overall Study|Withdrawal by Subject|1|||
37653195|NCT02688621|69123743|FG001|Overall Study|Withdrawal by Subject|0|||
37742649|NCT02018861|69228814|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
37922647|NCT00851318|69609394|FG003|Overall Study|Physician Decision|1|||
38032613|NCT01358578|69718555|FG003|Follow-up Period|Adverse Event|0|||
38032614|NCT01358578|69718556|FG004|Follow-up Period|Adverse Event|0|||
38032615|NCT01358578|69718557|FG005|Follow-up Period|Adverse Event|0|||
38032616|NCT01358578|69718552|FG000|Follow-up Period|Lack of Efficacy|3|||
38032617|NCT01358578|69718553|FG001|Follow-up Period|Lack of Efficacy|0|||
38032618|NCT01358578|69718554|FG002|Follow-up Period|Lack of Efficacy|4|||
38032619|NCT01358578|69718555|FG003|Follow-up Period|Lack of Efficacy|1|||
38032620|NCT01358578|69718556|FG004|Follow-up Period|Lack of Efficacy|0|||
38032621|NCT01358578|69718557|FG005|Follow-up Period|Lack of Efficacy|0|||
38032622|NCT01358578|69718552|FG000|Follow-up Period|Lost to Follow-up|0|||
38032623|NCT01358578|69718553|FG001|Follow-up Period|Lost to Follow-up|1|||
37922648|NCT00593957|69609407|FG000|Overall Study|Physician Decision|0|||
37922649|NCT00593957|69609408|FG001|Overall Study|Physician Decision|1|||
37922650|NCT00593957|69609409|FG002|Overall Study|Physician Decision|2|||
37922651|NCT00870233|69609431|FG000|Overall Study|Withdrawal by Subject|18|||
37922652|NCT00870233|69609431|FG000|Overall Study|Did not undergo laparotomy|3|||
38032624|NCT01358578|69718554|FG002|Follow-up Period|Lost to Follow-up|0|||
38032625|NCT01358578|69718555|FG003|Follow-up Period|Lost to Follow-up|4|||
37653196|NCT04227704|69123755|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
37653197|NCT04227704|69123756|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
37653198|NCT04227704|69123757|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
37653199|NCT04227704|69123755|FG000|Overall Study|due to C/S being cancelled|1|||
37653200|NCT04227704|69123756|FG001|Overall Study|due to C/S being cancelled|0|||
37653201|NCT04227704|69123757|FG002|Overall Study|due to C/S being cancelled|0|||
37653202|NCT03530293|69123778|FG000|Pre-randomization|Adverse Event|12|||
37653203|NCT03530293|69123779|FG001|Pre-randomization|Adverse Event|0|||
37653204|NCT03530293|69123780|FG002|Pre-randomization|Adverse Event|0|||
37653205|NCT03530293|69123778|FG000|Pre-randomization|Protocol Violation|2|||
37653206|NCT03530293|69123779|FG001|Pre-randomization|Protocol Violation|0|||
37653207|NCT03530293|69123780|FG002|Pre-randomization|Protocol Violation|0|||
37653208|NCT03530293|69123778|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
37653209|NCT03530293|69123779|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
37653210|NCT03530293|69123780|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
37653211|NCT03530293|69123778|FG000|Pre-randomization|Withdrawal by Subject|5|||
37653212|NCT03530293|69123779|FG001|Pre-randomization|Withdrawal by Subject|0|||
37653213|NCT03530293|69123780|FG002|Pre-randomization|Withdrawal by Subject|0|||
37653214|NCT03530293|69123778|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
37653215|NCT03530293|69123779|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
37653216|NCT03530293|69123780|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
37653217|NCT03530293|69123778|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
37653218|NCT03530293|69123779|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
37653219|NCT03530293|69123780|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
37653220|NCT03530293|69123778|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
37653221|NCT03530293|69123779|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
37653222|NCT03530293|69123780|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
37653223|NCT03530293|69123778|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
37653224|NCT03530293|69123779|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
37653225|NCT03530293|69123780|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
37653226|NCT03530293|69123778|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
37653227|NCT03530293|69123779|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
37653228|NCT03530293|69123780|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
37653229|NCT03335371|69123809|FG000|Overall Study|Lost to Follow-up|0|||
37653230|NCT03335371|69123810|FG001|Overall Study|Lost to Follow-up|0|||
37742650|NCT02018861|69228805|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
37742651|NCT02018861|69228806|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
37742652|NCT02018861|69228807|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
37742653|NCT02018861|69228808|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
37742654|NCT02018861|69228809|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
37742655|NCT02018861|69228810|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
37742656|NCT02018861|69228811|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
37742657|NCT02018861|69228812|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
37742658|NCT02018861|69228813|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
37742659|NCT02018861|69228814|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
37742660|NCT02018861|69228805|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
37742661|NCT02018861|69228806|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
37742662|NCT02018861|69228807|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
37742663|NCT02018861|69228808|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
37742664|NCT02018861|69228809|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
37742665|NCT02018861|69228810|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
37742666|NCT02018861|69228811|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
37742667|NCT02018861|69228812|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
37742668|NCT02018861|69228813|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
37742669|NCT02018861|69228814|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
37742670|NCT02018861|69228805|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
37742671|NCT02018861|69228806|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
37742672|NCT02018861|69228807|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
37742673|NCT02018861|69228808|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
37742674|NCT02018861|69228809|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
37742675|NCT02018861|69228810|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
37742676|NCT02018861|69228811|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
37742677|NCT02018861|69228812|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
37742678|NCT02018861|69228813|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
37742679|NCT02018861|69228814|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
37653231|NCT03335371|69123811|FG002|Overall Study|Lost to Follow-up|0|||
37653232|NCT03335371|69123812|FG003|Overall Study|Lost to Follow-up|0|||
37653233|NCT03335371|69123813|FG004|Overall Study|Lost to Follow-up|1|||
37653234|NCT03335371|69123809|FG000|Overall Study|Withdrawal by Subject|0|||
37742680|NCT02018861|69228805|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
37742681|NCT02018861|69228806|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
37742682|NCT02018861|69228807|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
37742683|NCT02018861|69228808|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
37742684|NCT02018861|69228809|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
37742685|NCT02018861|69228810|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
37653235|NCT03335371|69123810|FG001|Overall Study|Withdrawal by Subject|0|||
37653236|NCT03335371|69123811|FG002|Overall Study|Withdrawal by Subject|0|||
37653237|NCT03335371|69123812|FG003|Overall Study|Withdrawal by Subject|0|||
37653238|NCT03335371|69123813|FG004|Overall Study|Withdrawal by Subject|1|||
37653239|NCT03335371|69123809|FG000|Overall Study|Randomization Error|0|||
37653240|NCT03335371|69123810|FG001|Overall Study|Randomization Error|0|||
37653241|NCT03335371|69123811|FG002|Overall Study|Randomization Error|1|||
37653242|NCT03335371|69123812|FG003|Overall Study|Randomization Error|0|||
37653243|NCT03335371|69123813|FG004|Overall Study|Randomization Error|0|||
37653244|NCT02762929|69123845|FG000|Overall Study|Adverse Event|0|||
37653245|NCT02762929|69123846|FG001|Overall Study|Adverse Event|0|||
37653246|NCT02762929|69123847|FG002|Overall Study|Adverse Event|0|||
37653247|NCT02762929|69123848|FG003|Overall Study|Adverse Event|1|||
37653248|NCT02762929|69123849|FG004|Overall Study|Adverse Event|0|||
37653249|NCT02762929|69123850|FG005|Overall Study|Adverse Event|0|||
37653250|NCT02762929|69123845|FG000|Overall Study|Lost to Follow-up|1|||
37653251|NCT02762929|69123846|FG001|Overall Study|Lost to Follow-up|2|||
37653252|NCT02762929|69123847|FG002|Overall Study|Lost to Follow-up|0|||
37653253|NCT02762929|69123848|FG003|Overall Study|Lost to Follow-up|1|||
37653254|NCT02762929|69123849|FG004|Overall Study|Lost to Follow-up|0|||
37653255|NCT02762929|69123850|FG005|Overall Study|Lost to Follow-up|0|||
37653256|NCT02762929|69123845|FG000|Overall Study|Withdrawal by Subject|0|||
37653257|NCT02762929|69123846|FG001|Overall Study|Withdrawal by Subject|1|||
37653258|NCT02762929|69123847|FG002|Overall Study|Withdrawal by Subject|0|||
37653259|NCT02762929|69123848|FG003|Overall Study|Withdrawal by Subject|0|||
37653260|NCT02762929|69123849|FG004|Overall Study|Withdrawal by Subject|0|||
37653261|NCT02762929|69123850|FG005|Overall Study|Withdrawal by Subject|0|||
37653262|NCT02762929|69123845|FG000|Overall Study|exclusionary medication disclosed late|0|||
37653263|NCT02762929|69123846|FG001|Overall Study|exclusionary medication disclosed late|0|||
37653264|NCT02762929|69123847|FG002|Overall Study|exclusionary medication disclosed late|0|||
37653265|NCT02762929|69123848|FG003|Overall Study|exclusionary medication disclosed late|1|||
37653266|NCT02762929|69123849|FG004|Overall Study|exclusionary medication disclosed late|0|||
37653267|NCT02762929|69123850|FG005|Overall Study|exclusionary medication disclosed late|0|||
37653268|NCT03301051|69123871|FG000|Overall Study|Adverse Event|0|||
37653269|NCT03301051|69123872|FG001|Overall Study|Adverse Event|4|||
37653270|NCT03301051|69123871|FG000|Overall Study|Withdrawal by Subject|59|||
37653271|NCT03301051|69123872|FG001|Overall Study|Withdrawal by Subject|65|||
37653272|NCT03301051|69123871|FG000|Overall Study|Lost to Follow-up|263|||
37653273|NCT03301051|69123872|FG001|Overall Study|Lost to Follow-up|282|||
37653274|NCT03301051|69123871|FG000|Overall Study|Protocol Violation|1|||
37653275|NCT03301051|69123872|FG001|Overall Study|Protocol Violation|3|||
37653276|NCT03301051|69123871|FG000|Overall Study|Physician Decision|1|||
37653277|NCT03301051|69123872|FG001|Overall Study|Physician Decision|3|||
37653278|NCT03301051|69123871|FG000|Overall Study|Death|1|||
37653279|NCT03301051|69123872|FG001|Overall Study|Death|1|||
37653280|NCT03301051|69123871|FG000|Overall Study|Miscellaneous|8|||
37653281|NCT03301051|69123872|FG001|Overall Study|Miscellaneous|4|||
37653282|NCT03301051|69123871|FG000|Overall Study|Randomized, not vaccinated|13|||
38032626|NCT01358578|69718556|FG004|Follow-up Period|Lost to Follow-up|0|||
38032627|NCT01358578|69718557|FG005|Follow-up Period|Lost to Follow-up|0|||
38032628|NCT01358578|69718552|FG000|Follow-up Period|non- compliance with study treatment|1|||
38032629|NCT01358578|69718553|FG001|Follow-up Period|non- compliance with study treatment|0|||
38032630|NCT01358578|69718554|FG002|Follow-up Period|non- compliance with study treatment|0|||
37653283|NCT03301051|69123872|FG001|Overall Study|Randomized, not vaccinated|10|||
37653284|NCT01662986|69123880|FG000|Overall Study|Adverse Event|5|||
37653285|NCT01662986|69123881|FG001|Overall Study|Adverse Event|4|||
37653286|NCT01662986|69123880|FG000|Overall Study|Protocol Violation|2|||
37653287|NCT01662986|69123881|FG001|Overall Study|Protocol Violation|3|||
37653288|NCT01662986|69123880|FG000|Overall Study|Lost to Follow-up|5|||
37653289|NCT01662986|69123881|FG001|Overall Study|Lost to Follow-up|4|||
37653290|NCT01662986|69123880|FG000|Overall Study|Withdrawal by Subject|2|||
37653291|NCT01662986|69123881|FG001|Overall Study|Withdrawal by Subject|2|||
37653292|NCT01662986|69123880|FG000|Overall Study|Not Treated|1|||
37653293|NCT01662986|69123881|FG001|Overall Study|Not Treated|0|||
37653294|NCT01662986|69123880|FG000|Overall Study|Other than stated above|3|||
37742686|NCT02018861|69228811|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
37742687|NCT02018861|69228812|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
37742688|NCT02018861|69228813|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
37742689|NCT02018861|69228814|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
37742690|NCT02018861|69228805|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
37742691|NCT02018861|69228806|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
37742692|NCT02018861|69228807|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
37742693|NCT02018861|69228808|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
37742694|NCT02018861|69228809|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
37742695|NCT02018861|69228810|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
37742696|NCT02018861|69228811|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
37742697|NCT02018861|69228812|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
37742698|NCT02018861|69228813|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
37742699|NCT02018861|69228814|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
37742700|NCT02018861|69228805|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
37742701|NCT02018861|69228806|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
37742702|NCT02018861|69228807|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
37742703|NCT02018861|69228808|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
37742704|NCT02018861|69228809|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
37742705|NCT02018861|69228810|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
37742706|NCT02018861|69228811|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
37653295|NCT01662986|69123881|FG001|Overall Study|Other than stated above|0|||
37653296|NCT01337167|69123889|FG000|Infant Series|Adverse Event|1|||
37742707|NCT02018861|69228812|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
38032631|NCT01358578|69718555|FG003|Follow-up Period|non- compliance with study treatment|0|||
38032632|NCT01358578|69718556|FG004|Follow-up Period|non- compliance with study treatment|0|||
37742708|NCT02018861|69228813|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
37742709|NCT02018861|69228814|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
37742710|NCT02018861|69228805|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
37742711|NCT02018861|69228806|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
37742712|NCT02018861|69228807|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
37742713|NCT02018861|69228808|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
37742714|NCT02018861|69228809|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
37742715|NCT02018861|69228810|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
37742716|NCT02018861|69228811|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
37742717|NCT02018861|69228812|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
37742718|NCT02018861|69228813|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
37742719|NCT02018861|69228814|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
37742720|NCT02018861|69228805|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
37742721|NCT02018861|69228806|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
37742722|NCT02018861|69228807|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
37742723|NCT02018861|69228808|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
37742724|NCT02018861|69228809|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
37922653|NCT00870233|69609431|FG000|Overall Study|Incompatible internet browser|2|||
37922654|NCT00870233|69609431|FG000|Overall Study|Death|1|||
37922655|NCT00851084|69609438|FG000|Overall Study|Randomized but not treated|1|||
37922656|NCT00851084|69609439|FG001|Overall Study|Randomized but not treated|0|||
37653297|NCT01337167|69123890|FG001|Infant Series|Adverse Event|1|||
37653298|NCT01337167|69123889|FG000|Infant Series|Death|1|||
37653299|NCT01337167|69123890|FG001|Infant Series|Death|1|||
37653300|NCT01337167|69123889|FG000|Infant Series|Lost to Follow-up|13|||
37653301|NCT01337167|69123890|FG001|Infant Series|Lost to Follow-up|7|||
37653302|NCT01337167|69123889|FG000|Infant Series|Non-compliance with study drug|2|||
37653303|NCT01337167|69123890|FG001|Infant Series|Non-compliance with study drug|1|||
37653304|NCT01337167|69123889|FG000|Infant Series|Physician Decision|3|||
37653305|NCT01337167|69123890|FG001|Infant Series|Physician Decision|1|||
37653306|NCT01337167|69123889|FG000|Infant Series|Protocol Violation|22|||
37653307|NCT01337167|69123890|FG001|Infant Series|Protocol Violation|9|||
37653308|NCT01337167|69123889|FG000|Infant Series|Withdrawal by Subject|15|||
37653309|NCT01337167|69123890|FG001|Infant Series|Withdrawal by Subject|4|||
37653310|NCT01337167|69123889|FG000|Infant Series|Randomized but not vaccinated|5|||
37653311|NCT01337167|69123890|FG001|Infant Series|Randomized but not vaccinated|3|||
37653312|NCT01337167|69123889|FG000|Interim Period|Lost to Follow-up|51|||
37653313|NCT01337167|69123890|FG001|Interim Period|Lost to Follow-up|23|||
37653314|NCT01337167|69123889|FG000|Interim Period|Non-compliance with study drug|1|||
37653315|NCT01337167|69123890|FG001|Interim Period|Non-compliance with study drug|0|||
37653316|NCT01337167|69123889|FG000|Interim Period|Physician Decision|6|||
37653317|NCT01337167|69123890|FG001|Interim Period|Physician Decision|3|||
37922657|NCT00851084|69609438|FG000|Overall Study|Adverse Event|26|||
37922658|NCT00851084|69609439|FG001|Overall Study|Adverse Event|36|||
37922659|NCT00851084|69609438|FG000|Overall Study|Disease progression|52|||
37922660|NCT00851084|69609439|FG001|Overall Study|Disease progression|47|||
37922661|NCT00851084|69609438|FG000|Overall Study|Poor compliance to protocol|1|||
37922662|NCT00851084|69609439|FG001|Overall Study|Poor compliance to protocol|1|||
37922663|NCT00851084|69609438|FG000|Overall Study|Physician Decision|13|||
37922664|NCT00851084|69609439|FG001|Overall Study|Physician Decision|14|||
37922665|NCT00851084|69609438|FG000|Overall Study|Consent withdrawn|0|||
37922666|NCT00851084|69609439|FG001|Overall Study|Consent withdrawn|2|||
37922667|NCT00851084|69609438|FG000|Overall Study|Withdrawal by Subject|11|||
37653318|NCT01337167|69123889|FG000|Interim Period|Protocol Violation|5|||
37653319|NCT01337167|69123890|FG001|Interim Period|Protocol Violation|3|||
37653320|NCT01337167|69123889|FG000|Interim Period|Withdrawal by Subject|18|||
37653321|NCT01337167|69123890|FG001|Interim Period|Withdrawal by Subject|10|||
37653322|NCT01337167|69123889|FG000|Interim Period|Other protocol criterion not met|0|||
37653323|NCT01337167|69123890|FG001|Interim Period|Other protocol criterion not met|1|||
37653324|NCT01337167|69123889|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
37653325|NCT01337167|69123890|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
37653326|NCT01337167|69123889|FG000|Toddler Vaccinations|Protocol Violation|0|||
37653327|NCT01337167|69123890|FG001|Toddler Vaccinations|Protocol Violation|1|||
37653328|NCT01337167|69123889|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
37653329|NCT01337167|69123890|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
37653330|NCT01338025|69123898|FG000|Overall Study|Unexpected closure of study|10|||
37653331|NCT01338025|69123899|FG001|Overall Study|Unexpected closure of study|9|||
37653332|NCT01338025|69123898|FG000|Overall Study|Withdrawal by Subject|0|||
37653333|NCT01338025|69123899|FG001|Overall Study|Withdrawal by Subject|2|||
37653334|NCT01338025|69123898|FG000|Overall Study|Found ineligible after starting|1|||
37653335|NCT01338025|69123899|FG001|Overall Study|Found ineligible after starting|0|||
37653336|NCT02559206|69123943|FG000|Overall Study|Adverse Event|0|||
37653337|NCT02559206|69123944|FG001|Overall Study|Adverse Event|4|||
37922668|NCT00851084|69609439|FG001|Overall Study|Withdrawal by Subject|12|||
37922669|NCT00851084|69609438|FG000|Overall Study|Metastatic surgery|6|||
37922670|NCT00851084|69609439|FG001|Overall Study|Metastatic surgery|6|||
37922671|NCT00851084|69609438|FG000|Overall Study|Other|7|||
37922672|NCT00851084|69609439|FG001|Overall Study|Other|1|||
37922673|NCT00845858|69609450|FG000|Overall Study|Withdrawal by Subject|5|||
37922674|NCT00845858|69609451|FG001|Overall Study|Withdrawal by Subject|1|||
37922675|NCT00845858|69609452|FG002|Overall Study|Withdrawal by Subject|1|||
37922676|NCT00845858|69609450|FG000|Overall Study|Adverse Event|3|||
37922677|NCT00845858|69609451|FG001|Overall Study|Adverse Event|8|||
37922678|NCT00845858|69609452|FG002|Overall Study|Adverse Event|4|||
37922679|NCT00845858|69609450|FG000|Overall Study|Protocol Violation|0|||
37922680|NCT00845858|69609451|FG001|Overall Study|Protocol Violation|0|||
37653338|NCT02559206|69123945|FG002|Overall Study|Adverse Event|1|||
37653339|NCT02559206|69123946|FG003|Overall Study|Adverse Event|5|||
37653340|NCT02559206|69123947|FG004|Overall Study|Adverse Event|3|||
37653341|NCT02559206|69123948|FG005|Overall Study|Adverse Event|0|||
37653342|NCT02559206|69123949|FG006|Overall Study|Adverse Event|1|||
37653343|NCT02559206|69123950|FG007|Overall Study|Adverse Event|0|||
37653344|NCT02559206|69123943|FG000|Overall Study|Protocol Violation|1|||
37653345|NCT02559206|69123944|FG001|Overall Study|Protocol Violation|0|||
37653346|NCT02559206|69123945|FG002|Overall Study|Protocol Violation|1|||
37653347|NCT02559206|69123946|FG003|Overall Study|Protocol Violation|0|||
37653348|NCT02559206|69123947|FG004|Overall Study|Protocol Violation|0|||
37653349|NCT02559206|69123948|FG005|Overall Study|Protocol Violation|2|||
37653350|NCT02559206|69123949|FG006|Overall Study|Protocol Violation|0|||
37653351|NCT02559206|69123950|FG007|Overall Study|Protocol Violation|0|||
37653352|NCT02559206|69123943|FG000|Overall Study|Withdrawal by Subject|3|||
37653353|NCT02559206|69123944|FG001|Overall Study|Withdrawal by Subject|3|||
37653354|NCT02559206|69123945|FG002|Overall Study|Withdrawal by Subject|1|||
37653355|NCT02559206|69123946|FG003|Overall Study|Withdrawal by Subject|3|||
37653356|NCT02559206|69123947|FG004|Overall Study|Withdrawal by Subject|5|||
37922681|NCT00845858|69609452|FG002|Overall Study|Protocol Violation|1|||
37922682|NCT00845858|69609450|FG000|Overall Study|not eligible|0|||
37653357|NCT02559206|69123948|FG005|Overall Study|Withdrawal by Subject|4|||
37653358|NCT02559206|69123949|FG006|Overall Study|Withdrawal by Subject|1|||
37653359|NCT02559206|69123950|FG007|Overall Study|Withdrawal by Subject|2|||
37653360|NCT02559206|69123943|FG000|Overall Study|Lost to Follow-up|3|||
37653361|NCT02559206|69123944|FG001|Overall Study|Lost to Follow-up|5|||
37653362|NCT02559206|69123945|FG002|Overall Study|Lost to Follow-up|3|||
37653363|NCT02559206|69123946|FG003|Overall Study|Lost to Follow-up|3|||
37742725|NCT02018861|69228810|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
37922683|NCT00845858|69609451|FG001|Overall Study|not eligible|3|||
37922684|NCT00845858|69609452|FG002|Overall Study|not eligible|2|||
37922685|NCT00850538|69609463|FG000|Overall Study|unable/unwilling to complete MRI|13|||
37922686|NCT00850538|69609463|FG000|Overall Study|specimen missed due to scheduling error|14|||
37922687|NCT00850538|69609463|FG000|Overall Study|specimen unusable|7|||
37653364|NCT02559206|69123947|FG004|Overall Study|Lost to Follow-up|2|||
37653365|NCT02559206|69123948|FG005|Overall Study|Lost to Follow-up|5|||
37653366|NCT02559206|69123949|FG006|Overall Study|Lost to Follow-up|1|||
37653367|NCT02559206|69123950|FG007|Overall Study|Lost to Follow-up|4|||
37653368|NCT02559206|69123943|FG000|Overall Study|Lack of Efficacy|1|||
37653369|NCT02559206|69123944|FG001|Overall Study|Lack of Efficacy|0|||
37653370|NCT02559206|69123945|FG002|Overall Study|Lack of Efficacy|3|||
37653371|NCT02559206|69123946|FG003|Overall Study|Lack of Efficacy|2|||
37653372|NCT02559206|69123947|FG004|Overall Study|Lack of Efficacy|2|||
37653373|NCT02559206|69123948|FG005|Overall Study|Lack of Efficacy|3|||
37653374|NCT02559206|69123949|FG006|Overall Study|Lack of Efficacy|3|||
37653375|NCT02559206|69123950|FG007|Overall Study|Lack of Efficacy|3|||
37653376|NCT02559206|69123943|FG000|Overall Study|Other Not Specified|0|||
37653377|NCT02559206|69123944|FG001|Overall Study|Other Not Specified|0|||
37653378|NCT02559206|69123945|FG002|Overall Study|Other Not Specified|0|||
37653379|NCT02559206|69123946|FG003|Overall Study|Other Not Specified|1|||
37653380|NCT02559206|69123947|FG004|Overall Study|Other Not Specified|0|||
37653381|NCT02559206|69123948|FG005|Overall Study|Other Not Specified|0|||
37653382|NCT02559206|69123949|FG006|Overall Study|Other Not Specified|0|||
37653383|NCT02559206|69123950|FG007|Overall Study|Other Not Specified|0|||
37653384|NCT02558894|69123970|FG000|Overall Study|Death; any cause, entire study duration|28|||
37922688|NCT00850538|69609463|FG000|Overall Study|Withdrawal by Subject|3|||
37922689|NCT00850538|69609463|FG000|Overall Study|radiology error|2|||
37653385|NCT02558894|69123971|FG001|Overall Study|Death; any cause, entire study duration|31|||
37653386|NCT02558894|69123970|FG000|Overall Study|Withdrawal by Subject|2|||
37653387|NCT02558894|69123971|FG001|Overall Study|Withdrawal by Subject|1|||
37653388|NCT02558894|69123970|FG000|Overall Study|Closure of Part A|2|||
37653389|NCT02558894|69123971|FG001|Overall Study|Closure of Part A|1|||
37653390|NCT02688387|69123981|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
37653391|NCT02688387|69123982|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
37653392|NCT02688387|69123983|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
37653393|NCT02688387|69123984|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
37653394|NCT02688387|69123985|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
37653395|NCT02688387|69123986|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
37653396|NCT02688387|69123987|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
37653397|NCT02688387|69123988|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
37653398|NCT02688387|69123989|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
37653399|NCT02688387|69123990|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
37653400|NCT02688387|69123991|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
37653401|NCT02688387|69123992|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
37653402|NCT02688387|69123993|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
37653403|NCT02688387|69123994|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
37653404|NCT02688387|69123995|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
37653405|NCT02688387|69123996|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
37653406|NCT02688387|69123997|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
37653407|NCT02688387|69123998|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
37653408|NCT02688387|69123999|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
37653409|NCT02688387|69124000|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
37653410|NCT02688387|69124001|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
37653411|NCT02688387|69124002|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
37653412|NCT02688387|69123981|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
37653413|NCT02688387|69123982|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
37653414|NCT02688387|69123983|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
37653415|NCT02688387|69123984|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
37653416|NCT02688387|69123985|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
37653417|NCT02688387|69123986|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
37653418|NCT02688387|69123987|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
37653419|NCT02688387|69123988|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
37653420|NCT02688387|69123989|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
37653421|NCT02688387|69123990|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
37653422|NCT02688387|69123991|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
37653423|NCT02688387|69123992|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
37922690|NCT00850538|69609463|FG000|Overall Study|Protocol Violation|2|||
38032633|NCT01358578|69718557|FG005|Follow-up Period|non- compliance with study treatment|0|||
37922691|NCT00850460|69609469|FG000|Overall Study|Lost to Follow-up|4|||
37653424|NCT02688387|69123993|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
37653425|NCT02688387|69123994|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
37653426|NCT02688387|69123995|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
37653427|NCT02688387|69123996|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
37653428|NCT02688387|69123997|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
37653429|NCT02688387|69123998|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
37922692|NCT00850460|69609470|FG001|Overall Study|Lost to Follow-up|4|||
37653430|NCT02688387|69123999|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
37653431|NCT02688387|69124000|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
37653432|NCT02688387|69124001|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
37653433|NCT02688387|69124002|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
37653434|NCT02688387|69123981|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
37653435|NCT02688387|69123982|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
37653436|NCT02688387|69123983|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
37653437|NCT02688387|69123984|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
37653438|NCT02688387|69123985|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
37653439|NCT02688387|69123986|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
37653440|NCT02688387|69123987|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
37653441|NCT02688387|69123988|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
37653442|NCT02688387|69123989|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
37653443|NCT02688387|69123990|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
37653444|NCT02688387|69123991|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
37653445|NCT02688387|69123992|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
37653446|NCT02688387|69123993|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
37653447|NCT02688387|69123994|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
37653448|NCT02688387|69123995|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
37653449|NCT02688387|69123996|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
37653450|NCT02688387|69123997|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
37653451|NCT02688387|69123998|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
37653452|NCT02688387|69123999|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
37653453|NCT02688387|69124000|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
37653454|NCT02688387|69124001|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
37653455|NCT02688387|69124002|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
37653456|NCT02688387|69123981|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
37653457|NCT02688387|69123982|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
37653458|NCT02688387|69123983|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
37653459|NCT02688387|69123984|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
37653460|NCT02688387|69123985|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
37653461|NCT02688387|69123986|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
37922693|NCT00661492|69609478|FG000|Overall Study|Adverse Event|16|||
37922694|NCT00661492|69609479|FG001|Overall Study|Adverse Event|13|||
37922695|NCT00661492|69609478|FG000|Overall Study|Disease Progression|44|||
37922696|NCT00661492|69609479|FG001|Overall Study|Disease Progression|14|||
37922697|NCT00661492|69609478|FG000|Overall Study|Patient Request|6|||
37922698|NCT00661492|69609479|FG001|Overall Study|Patient Request|1|||
37742726|NCT02018861|69228811|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
37742727|NCT02018861|69228812|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
37742728|NCT02018861|69228813|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
37653462|NCT02688387|69123987|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
37653463|NCT02688387|69123988|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
37653464|NCT02688387|69123989|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
37653465|NCT02688387|69123990|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
37653466|NCT02688387|69123991|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
37742729|NCT02018861|69228814|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
37742730|NCT02018861|69228805|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
37742731|NCT02018861|69228806|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
37742732|NCT02018861|69228807|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
37742733|NCT02018861|69228808|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
37742734|NCT02018861|69228809|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
37742735|NCT02018861|69228810|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
37742736|NCT02018861|69228811|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
37742737|NCT02018861|69228812|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
38032634|NCT01358578|69718552|FG000|Follow-up Period|Pregnancy|1|||
38032635|NCT01358578|69718553|FG001|Follow-up Period|Pregnancy|0|||
38032636|NCT01358578|69718554|FG002|Follow-up Period|Pregnancy|0|||
37653467|NCT02688387|69123992|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
37742738|NCT02018861|69228813|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
37922699|NCT00661492|69609478|FG000|Overall Study|Investigator Request|1|||
37922700|NCT00661492|69609479|FG001|Overall Study|Investigator Request|0|||
38032637|NCT01358578|69718555|FG003|Follow-up Period|Pregnancy|0|||
38032638|NCT01358578|69718556|FG004|Follow-up Period|Pregnancy|0|||
37653468|NCT02688387|69123993|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
37653469|NCT02688387|69123994|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
37653470|NCT02688387|69123995|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
37742739|NCT02018861|69228814|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
37742740|NCT01827384|69228866|FG000|Overall Study|Switched to alternative treatment|0|||
37742741|NCT01827384|69228867|FG001|Overall Study|Switched to alternative treatment|0|||
37742742|NCT01827384|69228868|FG002|Overall Study|Switched to alternative treatment|0|||
37742743|NCT01827384|69228869|FG003|Overall Study|Switched to alternative treatment|0|||
37742744|NCT01827384|69228870|FG004|Overall Study|Switched to alternative treatment|0|||
37742745|NCT01827384|69228871|FG005|Overall Study|Switched to alternative treatment|0|||
37742746|NCT01827384|69228872|FG006|Overall Study|Switched to alternative treatment|0|||
37653471|NCT02688387|69123996|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
37653472|NCT02688387|69123997|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
37653473|NCT02688387|69123998|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
37742747|NCT01827384|69228873|FG007|Overall Study|Switched to alternative treatment|0|||
37742748|NCT01827384|69228874|FG008|Overall Study|Switched to alternative treatment|0|||
37742749|NCT01827384|69228875|FG009|Overall Study|Switched to alternative treatment|0|||
37742750|NCT01827384|69228876|FG010|Overall Study|Switched to alternative treatment|0|||
37742751|NCT01827384|69228877|FG011|Overall Study|Switched to alternative treatment|0|||
37742752|NCT01827384|69228878|FG012|Overall Study|Switched to alternative treatment|0|||
37742753|NCT01827384|69228879|FG013|Overall Study|Switched to alternative treatment|2|||
37742754|NCT01827384|69228866|FG000|Overall Study|Disease progression before treatment|0|||
37742755|NCT01827384|69228867|FG001|Overall Study|Disease progression before treatment|0|||
37742756|NCT01827384|69228868|FG002|Overall Study|Disease progression before treatment|0|||
37742757|NCT01827384|69228869|FG003|Overall Study|Disease progression before treatment|0|||
37742758|NCT01827384|69228870|FG004|Overall Study|Disease progression before treatment|0|||
37742759|NCT01827384|69228871|FG005|Overall Study|Disease progression before treatment|0|||
37742760|NCT01827384|69228872|FG006|Overall Study|Disease progression before treatment|0|||
37742761|NCT01827384|69228873|FG007|Overall Study|Disease progression before treatment|0|||
37742762|NCT01827384|69228874|FG008|Overall Study|Disease progression before treatment|0|||
37742763|NCT01827384|69228875|FG009|Overall Study|Disease progression before treatment|0|||
37742764|NCT01827384|69228876|FG010|Overall Study|Disease progression before treatment|0|||
37742765|NCT01827384|69228877|FG011|Overall Study|Disease progression before treatment|0|||
37742766|NCT01827384|69228878|FG012|Overall Study|Disease progression before treatment|0|||
37742767|NCT01827384|69228879|FG013|Overall Study|Disease progression before treatment|4|||
37742768|NCT01827384|69228866|FG000|Overall Study|Ineligible|0|||
37742769|NCT01827384|69228867|FG001|Overall Study|Ineligible|0|||
38032639|NCT01358578|69718557|FG005|Follow-up Period|Pregnancy|0|||
37653474|NCT02688387|69123999|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
37653475|NCT02688387|69124000|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
37653476|NCT02688387|69124001|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
37653477|NCT02688387|69124002|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
37653478|NCT02688387|69123981|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
37653479|NCT02688387|69123982|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
37653480|NCT02688387|69123983|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
37653481|NCT02688387|69123984|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
37653482|NCT02688387|69123985|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
37653483|NCT02688387|69123986|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
37653484|NCT02688387|69123987|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
37653485|NCT02688387|69123988|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
37653486|NCT02688387|69123989|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
37653487|NCT02688387|69123990|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
37653488|NCT02688387|69123991|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
37653489|NCT02688387|69123992|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
37653490|NCT02688387|69123993|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
37653491|NCT02688387|69123994|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
37653492|NCT02688387|69123995|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
37653493|NCT02688387|69123996|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
37653494|NCT02688387|69123997|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
37653495|NCT02688387|69123998|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
37653496|NCT02688387|69123999|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
37653497|NCT02688387|69124000|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
37653498|NCT02688387|69124001|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
37742770|NCT01827384|69228868|FG002|Overall Study|Ineligible|0|||
37742771|NCT01827384|69228869|FG003|Overall Study|Ineligible|0|||
37742772|NCT01827384|69228870|FG004|Overall Study|Ineligible|0|||
37742773|NCT01827384|69228871|FG005|Overall Study|Ineligible|0|||
37653499|NCT02688387|69124002|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
37653500|NCT02688387|69123981|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
37653501|NCT02688387|69123982|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
37653502|NCT02688387|69123983|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
37742774|NCT01827384|69228872|FG006|Overall Study|Ineligible|0|||
37742775|NCT01827384|69228873|FG007|Overall Study|Ineligible|0|||
37742776|NCT01827384|69228874|FG008|Overall Study|Ineligible|0|||
37742777|NCT01827384|69228875|FG009|Overall Study|Ineligible|0|||
37742778|NCT01827384|69228876|FG010|Overall Study|Ineligible|0|||
37742779|NCT01827384|69228877|FG011|Overall Study|Ineligible|0|||
37742780|NCT01827384|69228878|FG012|Overall Study|Ineligible|0|||
37742781|NCT01827384|69228879|FG013|Overall Study|Ineligible|19|||
37742782|NCT01827384|69228866|FG000|Overall Study|Participant died before treatment|0|||
37742783|NCT01827384|69228867|FG001|Overall Study|Participant died before treatment|0|||
37742784|NCT01827384|69228868|FG002|Overall Study|Participant died before treatment|0|||
37742785|NCT01827384|69228869|FG003|Overall Study|Participant died before treatment|0|||
37742786|NCT01827384|69228870|FG004|Overall Study|Participant died before treatment|0|||
37742787|NCT01827384|69228871|FG005|Overall Study|Participant died before treatment|0|||
37742788|NCT01827384|69228872|FG006|Overall Study|Participant died before treatment|0|||
37742789|NCT01827384|69228873|FG007|Overall Study|Participant died before treatment|0|||
37742790|NCT01827384|69228874|FG008|Overall Study|Participant died before treatment|0|||
37742791|NCT01827384|69228875|FG009|Overall Study|Participant died before treatment|0|||
37742792|NCT01827384|69228876|FG010|Overall Study|Participant died before treatment|0|||
37742793|NCT01827384|69228877|FG011|Overall Study|Participant died before treatment|0|||
37742794|NCT01827384|69228878|FG012|Overall Study|Participant died before treatment|0|||
37742795|NCT01827384|69228879|FG013|Overall Study|Participant died before treatment|5|||
37742796|NCT01827384|69228866|FG000|Overall Study|Insufficient tumor cells|0|||
37742797|NCT01827384|69228867|FG001|Overall Study|Insufficient tumor cells|0|||
37742798|NCT01827384|69228868|FG002|Overall Study|Insufficient tumor cells|0|||
37742799|NCT01827384|69228869|FG003|Overall Study|Insufficient tumor cells|0|||
37742800|NCT01827384|69228870|FG004|Overall Study|Insufficient tumor cells|0|||
37742801|NCT01827384|69228871|FG005|Overall Study|Insufficient tumor cells|0|||
37742802|NCT01827384|69228872|FG006|Overall Study|Insufficient tumor cells|0|||
37742803|NCT01827384|69228873|FG007|Overall Study|Insufficient tumor cells|0|||
37742804|NCT01827384|69228874|FG008|Overall Study|Insufficient tumor cells|0|||
37742805|NCT01827384|69228875|FG009|Overall Study|Insufficient tumor cells|0|||
37653503|NCT02688387|69123984|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
37653504|NCT02688387|69123985|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
37653505|NCT02688387|69123986|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
37653506|NCT02688387|69123987|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
37653507|NCT02688387|69123988|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
37653508|NCT02688387|69123989|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
37653509|NCT02688387|69123990|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
37653510|NCT02688387|69123991|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
37653511|NCT02688387|69123992|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
37653512|NCT02688387|69123993|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
37653513|NCT02688387|69123994|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
37653514|NCT02688387|69123995|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
37653515|NCT02688387|69123996|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
37653516|NCT02688387|69123997|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
37653517|NCT02688387|69123998|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
37653518|NCT02688387|69123999|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
37653519|NCT02688387|69124000|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
37653520|NCT02688387|69124001|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
37653521|NCT02688387|69124002|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
37653522|NCT02688387|69123981|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
37653523|NCT02688387|69123982|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
37653524|NCT02688387|69123983|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
37653525|NCT02688387|69123984|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
37653526|NCT02688387|69123985|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
37653527|NCT02688387|69123986|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
37653528|NCT02688387|69123987|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
37653529|NCT02688387|69123988|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
37653530|NCT02688387|69123989|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
37742806|NCT01827384|69228876|FG010|Overall Study|Insufficient tumor cells|0|||
37742807|NCT01827384|69228877|FG011|Overall Study|Insufficient tumor cells|0|||
37742808|NCT01827384|69228878|FG012|Overall Study|Insufficient tumor cells|0|||
37742809|NCT01827384|69228879|FG013|Overall Study|Insufficient tumor cells|13|||
37742810|NCT01827384|69228866|FG000|Overall Study|No actionable mutation|0|||
37742811|NCT01827384|69228867|FG001|Overall Study|No actionable mutation|0|||
37742812|NCT01827384|69228868|FG002|Overall Study|No actionable mutation|0|||
37742813|NCT01827384|69228869|FG003|Overall Study|No actionable mutation|0|||
37653531|NCT02688387|69123990|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
37653532|NCT02688387|69123991|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
37653533|NCT02688387|69123992|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
37653534|NCT02688387|69123993|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
37653535|NCT02688387|69123994|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
37653536|NCT02688387|69123995|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
37742814|NCT01827384|69228870|FG004|Overall Study|No actionable mutation|0|||
37742815|NCT01827384|69228871|FG005|Overall Study|No actionable mutation|0|||
37742816|NCT01827384|69228872|FG006|Overall Study|No actionable mutation|0|||
37742817|NCT01827384|69228873|FG007|Overall Study|No actionable mutation|0|||
37742818|NCT01827384|69228874|FG008|Overall Study|No actionable mutation|0|||
37742819|NCT01827384|69228875|FG009|Overall Study|No actionable mutation|0|||
37742820|NCT01827384|69228876|FG010|Overall Study|No actionable mutation|0|||
37742821|NCT01827384|69228877|FG011|Overall Study|No actionable mutation|0|||
37742822|NCT01827384|69228878|FG012|Overall Study|No actionable mutation|0|||
37742823|NCT01827384|69228879|FG013|Overall Study|No actionable mutation|73|||
37742824|NCT01827384|69228866|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
37742825|NCT01827384|69228867|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
37742826|NCT01827384|69228868|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
37742827|NCT01827384|69228869|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
37742828|NCT01827384|69228870|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
37742829|NCT01827384|69228871|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
37742830|NCT01827384|69228872|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
37742831|NCT01827384|69228873|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
37742832|NCT01827384|69228874|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
37742833|NCT01827384|69228875|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
37742834|NCT01827384|69228876|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
37742835|NCT01827384|69228877|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
37742836|NCT01827384|69228878|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
37742837|NCT01827384|69228879|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
37742838|NCT01585194|69228914|FG000|Overall Study|Withdrawal by Subject|1|||
37742839|NCT01585194|69228914|FG000|Overall Study|Physician Decision|2|||
37742840|NCT01585194|69228914|FG000|Overall Study|Lack of insurance|1|||
37742841|NCT01377389|69228918|FG000|Overall Study|Withdrawal by Subject|1|||
37742842|NCT01377389|69228918|FG000|Overall Study|Screen failure|2|||
37742843|NCT01287611|69228924|FG000|Overall Study|Lost to Follow-up|29|||
37742844|NCT01287611|69228925|FG001|Overall Study|Lost to Follow-up|16|||
37742845|NCT01287611|69228924|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
37742846|NCT01287611|69228925|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
37742847|NCT01194271|69228933|FG000|Overall Study|Withdrawal by Subject|1|||
37742848|NCT01194271|69228933|FG000|Overall Study|Ineligible, Screen Failure|1|||
37742849|NCT01194271|69228933|FG000|Overall Study|Death|1|||
37742850|NCT01119508|69228948|FG000|Overall Study|Adverse Event|56|||
37742851|NCT01119508|69228948|FG000|Overall Study|Withdrawal by Subject|2|||
37742852|NCT01119508|69228948|FG000|Overall Study|Died before tumor response evaluation|1|||
37742853|NCT00754338|69228960|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
37742854|NCT00754338|69228961|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
37742855|NCT00754338|69228962|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
37742856|NCT00754338|69228963|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
38032640|NCT01358578|69718552|FG000|Follow-up Period|Withdrawal by Subject|3|||
38032641|NCT01358578|69718553|FG001|Follow-up Period|Withdrawal by Subject|3|||
38032642|NCT01358578|69718554|FG002|Follow-up Period|Withdrawal by Subject|1|||
38032643|NCT01358578|69718555|FG003|Follow-up Period|Withdrawal by Subject|12|||
38032644|NCT01358578|69718556|FG004|Follow-up Period|Withdrawal by Subject|0|||
38032645|NCT01358578|69718557|FG005|Follow-up Period|Withdrawal by Subject|0|||
37653537|NCT02688387|69123996|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
37653538|NCT02688387|69123997|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
37742857|NCT00754338|69228960|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
37742858|NCT00754338|69228961|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
37742859|NCT00754338|69228962|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
37742860|NCT00754338|69228963|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
37742861|NCT00574496|69228989|FG000|Overall Study|Withdrawal by Subject|1|||
38032646|NCT01358578|69718552|FG000|Follow-up Period|Physician Decision|1|||
38032647|NCT01358578|69718553|FG001|Follow-up Period|Physician Decision|1|||
38032648|NCT01358578|69718554|FG002|Follow-up Period|Physician Decision|0|||
37653539|NCT02688387|69123998|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
37653540|NCT02688387|69123999|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
37653541|NCT02688387|69124000|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
37653542|NCT02688387|69124001|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
37653543|NCT02688387|69124002|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
37653544|NCT02688387|69123981|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
37653545|NCT02688387|69123982|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
37653546|NCT02688387|69123983|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
37653547|NCT02688387|69123984|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
37653548|NCT02688387|69123985|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
37653549|NCT02688387|69123986|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
37653550|NCT02688387|69123987|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
37653551|NCT02688387|69123988|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
37653552|NCT02688387|69123989|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
37653553|NCT02688387|69123990|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
37653554|NCT02688387|69123991|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
37653555|NCT02688387|69123992|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
37653556|NCT02688387|69123993|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
37653557|NCT02688387|69123994|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
37653558|NCT02688387|69123995|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
37653559|NCT02688387|69123996|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
37653560|NCT02688387|69123997|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
37653561|NCT02688387|69123998|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
37653562|NCT02688387|69123999|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
37653563|NCT02688387|69124000|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
37653564|NCT02688387|69124001|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
37653565|NCT02688387|69124002|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
37653566|NCT02688387|69123981|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
37653567|NCT02688387|69123982|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
37653568|NCT02688387|69123983|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
37653569|NCT02688387|69123984|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
37742869|NCT00499083|69229000|FG000|Overall Study|Not evaluable|3|||
37742870|NCT00418886|69229006|FG000|Overall Study|discontinue treatment survival follow up|90|||
37742871|NCT00418886|69229007|FG001|Overall Study|discontinue treatment survival follow up|91|||
37742872|NCT00418886|69229006|FG000|Overall Study|Death|122|||
37742873|NCT00418886|69229007|FG001|Overall Study|Death|147|||
37742874|NCT00418886|69229006|FG000|Overall Study|Withdrawal by Subject|9|||
37742875|NCT00418886|69229007|FG001|Overall Study|Withdrawal by Subject|10|||
37742876|NCT00418886|69229006|FG000|Overall Study|Lost to Follow-up|4|||
37742877|NCT00418886|69229007|FG001|Overall Study|Lost to Follow-up|6|||
37742878|NCT00418886|69229006|FG000|Overall Study|withdrawn due to other reason|1|||
37742879|NCT00418886|69229007|FG001|Overall Study|withdrawn due to other reason|0|||
37742880|NCT00418886|69229006|FG000|Overall Study|randomised but no treatment received|0|||
37742881|NCT00418886|69229007|FG001|Overall Study|randomised but no treatment received|1|||
37742882|NCT01819129|69229019|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
37742883|NCT01819129|69229020|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
37742884|NCT01819129|69229019|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
37742885|NCT01819129|69229020|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
37742886|NCT01819129|69229019|FG000|Overall Study|Other, Subject moved out of the country|0|||
37742887|NCT01819129|69229020|FG001|Overall Study|Other, Subject moved out of the country|1|||
37742888|NCT01819129|69229019|FG000|Overall Study|Withdrawal by Subject|15|||
37742889|NCT01819129|69229020|FG001|Overall Study|Withdrawal by Subject|15|||
37742890|NCT01819129|69229019|FG000|Overall Study|Lost to Follow-up|5|||
37742891|NCT01819129|69229020|FG001|Overall Study|Lost to Follow-up|2|||
37742892|NCT01819129|69229019|FG000|Overall Study|Lack of Efficacy|0|||
37742893|NCT01819129|69229020|FG001|Overall Study|Lack of Efficacy|1|||
37742894|NCT01819129|69229019|FG000|Overall Study|Adverse Event|1|||
37742895|NCT01819129|69229020|FG001|Overall Study|Adverse Event|4|||
37742896|NCT01819129|69229019|FG000|Overall Study|Death|1|||
37653570|NCT02688387|69123985|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
37653571|NCT02688387|69123986|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
37742897|NCT01819129|69229020|FG001|Overall Study|Death|1|||
37742898|NCT01819129|69229019|FG000|Overall Study|Withdrawal Criteria|20|||
37742899|NCT01819129|69229020|FG001|Overall Study|Withdrawal Criteria|15|||
37742900|NCT04022889|69229028|FG000|Stage 1: Period 1|Adverse Event|1|||
37742901|NCT04022889|69229029|FG001|Stage 1: Period 1|Adverse Event|0|||
37742902|NCT04022889|69229030|FG002|Stage 1: Period 1|Adverse Event|0|||
37742903|NCT04022889|69229028|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
37742904|NCT04022889|69229029|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
37742905|NCT04022889|69229030|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
37653572|NCT02688387|69123987|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
37653573|NCT02688387|69123988|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
37653574|NCT02688387|69123989|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
37653575|NCT02688387|69123990|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
37653576|NCT02688387|69123991|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
37653577|NCT02688387|69123992|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
37653578|NCT02688387|69123993|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
37653579|NCT02688387|69123994|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
37653580|NCT02688387|69123995|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
37653581|NCT02688387|69123996|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
37742906|NCT04022889|69229028|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
37742907|NCT04022889|69229029|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
37653582|NCT02688387|69123997|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
37653583|NCT02688387|69123998|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
37653584|NCT02688387|69123999|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
37742908|NCT04022889|69229030|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
37742909|NCT04022889|69229028|FG000|Stage 2|Screen Failure|0|||
37742910|NCT04022889|69229029|FG001|Stage 2|Screen Failure|0|||
37742911|NCT04022889|69229030|FG002|Stage 2|Screen Failure|3|||
37742912|NCT04022889|69229028|FG000|Stage 2|Ineligible for apheresis donation|0|||
37742913|NCT04022889|69229029|FG001|Stage 2|Ineligible for apheresis donation|0|||
37742914|NCT04022889|69229030|FG002|Stage 2|Ineligible for apheresis donation|2|||
37742915|NCT04022889|69229028|FG000|Stage 2|Adverse Event|0|||
37742916|NCT04022889|69229029|FG001|Stage 2|Adverse Event|0|||
38032649|NCT01358578|69718555|FG003|Follow-up Period|Physician Decision|2|||
38032650|NCT01358578|69718556|FG004|Follow-up Period|Physician Decision|0|||
37653585|NCT02688387|69124000|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
37653586|NCT02688387|69124001|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
37653587|NCT02688387|69124002|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
37653588|NCT02688387|69123981|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
37653589|NCT02688387|69123982|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
37653590|NCT02688387|69123983|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
37653591|NCT02688387|69123984|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
37653592|NCT02688387|69123985|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
37653593|NCT02688387|69123986|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
37653594|NCT02688387|69123987|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
37653595|NCT02688387|69123988|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
37653596|NCT02688387|69123989|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
37653597|NCT02688387|69123990|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
37653598|NCT02688387|69123991|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
37653599|NCT02688387|69123992|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
37653600|NCT02688387|69123993|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
37653601|NCT02688387|69123994|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
37653602|NCT02688387|69123995|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
37653603|NCT02688387|69123996|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
37653604|NCT02688387|69123997|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
37653605|NCT02688387|69123998|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
37653606|NCT02688387|69123999|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
37653607|NCT02688387|69124000|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
37653608|NCT02688387|69124001|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
37653609|NCT02688387|69124002|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
37653610|NCT02476201|69124048|FG000|Overall Study|Unable to program MPP|9|||
37653611|NCT02476201|69124048|FG000|Overall Study|Study echo not performed|5|||
37653612|NCT02476201|69124048|FG000|Overall Study|Adverse Event|4|||
37653613|NCT02476201|69124048|FG000|Overall Study|Death|2|||
37653614|NCT02476201|69124048|FG000|Overall Study|Lost to Follow-up|2|||
37653615|NCT02476201|69124048|FG000|Overall Study|MPP programmed to OFF|2|||
37653616|NCT02476201|69124048|FG000|Overall Study|Withdrawal by Subject|1|||
37653617|NCT02476201|69124048|FG000|Overall Study|Unsuccessful implant|1|||
37653618|NCT02688153|69124055|FG000|Overall Study|Death|7|||
37653619|NCT02688153|69124056|FG001|Overall Study|Death|5|||
37653620|NCT02688153|69124055|FG000|Overall Study|Withdrawal by Subject|4|||
37653621|NCT02688153|69124056|FG001|Overall Study|Withdrawal by Subject|2|||
37653622|NCT02688153|69124055|FG000|Overall Study|Valve Explant|1|||
37653623|NCT02688153|69124056|FG001|Overall Study|Valve Explant|0|||
37742917|NCT04022889|69229030|FG002|Stage 2|Adverse Event|2|||
37742918|NCT04022889|69229028|FG000|Stage 2|Protocol Violation|0|||
37653624|NCT02688153|69124055|FG000|Overall Study|Conversion to Commercial Valve|3|||
37653625|NCT02688153|69124056|FG001|Overall Study|Conversion to Commercial Valve|0|||
37653626|NCT02687919|69124065|FG000|Overall Study|Withdrawal by Subject|6|||
37653627|NCT02687919|69124066|FG001|Overall Study|Withdrawal by Subject|6|||
37653628|NCT02687919|69124065|FG000|Overall Study|Protocol Violation|2|||
37653629|NCT02687919|69124066|FG001|Overall Study|Protocol Violation|0|||
37653630|NCT02687451|69124078|FG000|Overall Study|Withdrawal by Subject|1|||
37742919|NCT04022889|69229029|FG001|Stage 2|Protocol Violation|0|||
37653631|NCT02687451|69124079|FG001|Overall Study|Withdrawal by Subject|0|||
37653632|NCT02687451|69124080|FG002|Overall Study|Withdrawal by Subject|0|||
37653633|NCT02687451|69124081|FG003|Overall Study|Withdrawal by Subject|0|||
37653634|NCT02687451|69124082|FG004|Overall Study|Withdrawal by Subject|0|||
37653635|NCT02687451|69124083|FG005|Overall Study|Withdrawal by Subject|1|||
37653636|NCT02557646|69124099|FG000|Overall Study|Adverse Event|40|||
37653637|NCT02557646|69124099|FG000|Overall Study|Death|1|||
37653638|NCT02557646|69124099|FG000|Overall Study|Lack of Efficacy|186|||
37653639|NCT02557646|69124099|FG000|Overall Study|Withdrawal by Subject|18|||
37653640|NCT02557646|69124099|FG000|Overall Study|Lost to Follow-up|17|||
37653641|NCT02557646|69124099|FG000|Overall Study|Other|14|||
37653642|NCT02679573|69124105|FG000|Overall Study|Adverse Event|13|||
37653643|NCT02679573|69124106|FG001|Overall Study|Adverse Event|6|||
37653644|NCT02679573|69124105|FG000|Overall Study|Lack of Efficacy|12|||
37653645|NCT02679573|69124106|FG001|Overall Study|Lack of Efficacy|15|||
37653646|NCT02679573|69124105|FG000|Overall Study|Could not complete required study visits|6|||
37653647|NCT02679573|69124106|FG001|Overall Study|Could not complete required study visits|2|||
37653648|NCT02679573|69124105|FG000|Overall Study|Withdrawal by Subject|2|||
37653649|NCT02679573|69124106|FG001|Overall Study|Withdrawal by Subject|9|||
37653650|NCT02679573|69124105|FG000|Overall Study|Death|2|||
37653651|NCT02679573|69124106|FG001|Overall Study|Death|0|||
37653652|NCT02679573|69124105|FG000|Overall Study|Physician Decision|2|||
37653653|NCT02679573|69124106|FG001|Overall Study|Physician Decision|4|||
37653654|NCT02679573|69124105|FG000|Overall Study|Lost to Follow-up|0|||
37653655|NCT02679573|69124106|FG001|Overall Study|Lost to Follow-up|3|||
37653656|NCT02685033|69124114|FG000|Overall Study|Withdrawal of Consent|0|||
37653657|NCT02685033|69124115|FG001|Overall Study|Withdrawal of Consent|1|||
37653658|NCT02685033|69124114|FG000|Overall Study|Lost to Follow-up|2|||
37653659|NCT02685033|69124115|FG001|Overall Study|Lost to Follow-up|1|||
37653660|NCT02685033|69124114|FG000|Overall Study|Adverse Event|1|||
37653661|NCT02685033|69124115|FG001|Overall Study|Adverse Event|0|||
37742920|NCT04022889|69229030|FG002|Stage 2|Protocol Violation|1|||
37742921|NCT04022889|69229028|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
37742922|NCT04022889|69229029|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
37742923|NCT04022889|69229030|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
37742924|NCT01849783|69229048|FG000|Overall Study|Adverse Event|5|||
37742925|NCT01849783|69229048|FG000|Overall Study|Death|2|||
37742926|NCT01849783|69229048|FG000|Overall Study|Physician Decision|1|||
37742927|NCT01849783|69229048|FG000|Overall Study|Withdrawal by Subject|1|||
37742928|NCT01849783|69229048|FG000|Overall Study|Unable to comply|2|||
37742929|NCT01849783|69229048|FG000|Overall Study|Disease progression|11|||
37742930|NCT01611883|69229060|FG000|Overall Study|Adverse Event|1|||
37742931|NCT01611883|69229061|FG001|Overall Study|Adverse Event|1|||
37742932|NCT01848457|69229071|FG000|Overall Study|Death|1|||
37742933|NCT01848457|69229072|FG001|Overall Study|Death|0|||
37653662|NCT02684097|69124123|FG000|Overall Study|Lack of Efficacy|13|||
37653663|NCT02684097|69124124|FG001|Overall Study|Lack of Efficacy|6|||
37653664|NCT02555618|69124132|FG000|Overall Study|Sponsor's Circumstances|1|||
37653665|NCT02555618|69124133|FG001|Overall Study|Sponsor's Circumstances|0|||
37653666|NCT02557100|69124159|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
37653667|NCT02557100|69124160|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
37653668|NCT02557100|69124161|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
37653669|NCT02557100|69124159|FG000|Single Blind Treatment Period|Death|0|||
37742934|NCT01848457|69229073|FG002|Overall Study|Death|0|||
37742935|NCT01848457|69229074|FG003|Overall Study|Death|0|||
37742936|NCT01817959|69229094|FG000|Overall Study|Graft loss|1|||
37742937|NCT01817959|69229095|FG001|Overall Study|Graft loss|1|||
37742938|NCT01817959|69229094|FG000|Overall Study|forbidden medication|1|||
37653670|NCT02557100|69124160|FG001|Single Blind Treatment Period|Death|1|||
37653671|NCT02557100|69124161|FG002|Single Blind Treatment Period|Death|0|||
37742939|NCT01817959|69229095|FG001|Overall Study|forbidden medication|1|||
37653672|NCT02557100|69124159|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
37653673|NCT02557100|69124160|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
37653674|NCT02557100|69124161|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
37653675|NCT02557100|69124159|FG000|Single Blind Treatment Period|Adverse Event|0|||
37653676|NCT02557100|69124160|FG001|Single Blind Treatment Period|Adverse Event|1|||
37742940|NCT01817959|69229094|FG000|Overall Study|Adverse Event|1|||
37742941|NCT01817959|69229095|FG001|Overall Study|Adverse Event|0|||
37742942|NCT01817959|69229094|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
37653677|NCT02557100|69124161|FG002|Single Blind Treatment Period|Adverse Event|0|||
37653678|NCT02557100|69124159|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
37653679|NCT02557100|69124160|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
37653680|NCT02557100|69124161|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
37653681|NCT02557100|69124159|FG000|Cumulative Abatacept Period|Other Reasons|0|||
37653682|NCT02557100|69124160|FG001|Cumulative Abatacept Period|Other Reasons|0|||
37653683|NCT02557100|69124161|FG002|Cumulative Abatacept Period|Other Reasons|1|||
37653684|NCT02557100|69124159|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
37653685|NCT02557100|69124160|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
37653686|NCT02557100|69124161|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
37653687|NCT02557100|69124159|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
37742943|NCT01817959|69229095|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
37742944|NCT01817725|69229101|FG000|Overall Study|Withdrawal by Subject|1|||
37742945|NCT01870999|69229108|FG000|Overall Study|Adverse Event|0|||
37742946|NCT01870999|69229109|FG001|Overall Study|Adverse Event|4|||
37742947|NCT01870999|69229110|FG002|Overall Study|Adverse Event|1|||
37742948|NCT01870999|69229108|FG000|Overall Study|Subject met withdrawal criteria|3|||
37742949|NCT01870999|69229109|FG001|Overall Study|Subject met withdrawal criteria|2|||
37742950|NCT01870999|69229110|FG002|Overall Study|Subject met withdrawal criteria|0|||
37742951|NCT01870999|69229108|FG000|Overall Study|Subject withdrawn by Investigator|1|||
37742952|NCT01870999|69229109|FG001|Overall Study|Subject withdrawn by Investigator|0|||
37742953|NCT01870999|69229110|FG002|Overall Study|Subject withdrawn by Investigator|0|||
37742954|NCT01870999|69229108|FG000|Overall Study|Withdrawal by Subject|0|||
37742955|NCT01870999|69229109|FG001|Overall Study|Withdrawal by Subject|2|||
37742956|NCT01870999|69229110|FG002|Overall Study|Withdrawal by Subject|5|||
37742957|NCT01870999|69229108|FG000|Overall Study|Protocol Violation|0|||
37742958|NCT01870999|69229109|FG001|Overall Study|Protocol Violation|0|||
37742959|NCT01870999|69229110|FG002|Overall Study|Protocol Violation|1|||
37742960|NCT01870921|69229118|FG000|Overall Study|Subject decision|80|||
37742961|NCT01870921|69229118|FG000|Overall Study|Severe non-compliance to protocol|7|||
37742962|NCT01870921|69229118|FG000|Overall Study|Subject Lost to Follow up|2|||
37742963|NCT01870921|69229118|FG000|Overall Study|Other|1|||
37742964|NCT01848145|69229131|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
37742965|NCT01848145|69229131|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
37742966|NCT01848145|69229131|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
37742967|NCT01848145|69229131|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
37742968|NCT01848145|69229131|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
37742969|NCT01848145|69229131|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
37742970|NCT01848145|69229131|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
37742971|NCT01847755|69229135|FG000|Overall Study|Adverse Event|2|||
37742972|NCT01847755|69229135|FG000|Overall Study|Withdrawal by Subject|2|||
37742973|NCT01847755|69229135|FG000|Overall Study|Physician Decision|1|||
37742974|NCT01847443|69229166|FG000|Study Period 1|Withdrawal by Subject|0|||
37742975|NCT01847443|69229167|FG001|Study Period 1|Withdrawal by Subject|1|||
37653688|NCT02557100|69124160|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
37653689|NCT02557100|69124161|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
37742976|NCT01847443|69229168|FG002|Study Period 1|Withdrawal by Subject|0|||
37742977|NCT01847443|69229169|FG003|Study Period 1|Withdrawal by Subject|0|||
37742978|NCT01847443|69229166|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
37742979|NCT01847443|69229167|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
37742980|NCT01847443|69229168|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
37742981|NCT01847443|69229169|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
37742982|NCT01847443|69229166|FG000|Washout Period Before Study Period 2|Other reason|1|||
37742983|NCT01847443|69229167|FG001|Washout Period Before Study Period 2|Other reason|0|||
37742984|NCT01847443|69229168|FG002|Washout Period Before Study Period 2|Other reason|0|||
38032651|NCT01358578|69718557|FG005|Follow-up Period|Physician Decision|0|||
37653690|NCT01337635|69124171|FG000|Overall Study|Lost to Follow-up|0|||
37653691|NCT01337635|69124172|FG001|Overall Study|Lost to Follow-up|1|||
37653692|NCT02556710|69124180|FG000|Overall Study|Surgical treatment|3|||
37653693|NCT02556710|69124181|FG001|Overall Study|Surgical treatment|0|||
37742985|NCT01847443|69229169|FG003|Washout Period Before Study Period 2|Other reason|0|||
37742986|NCT01847443|69229166|FG000|Washout Period Before Study Period 3|Other reason|1|||
37742987|NCT01847443|69229167|FG001|Washout Period Before Study Period 3|Other reason|0|||
37742988|NCT01847443|69229168|FG002|Washout Period Before Study Period 3|Other reason|0|||
37742989|NCT01847443|69229169|FG003|Washout Period Before Study Period 3|Other reason|0|||
37742990|NCT01847443|69229166|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
37742991|NCT01847443|69229167|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
37742992|NCT01847443|69229168|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
38032652|NCT02833948|69718587|FG000|Overall Study|Death|2|||
37742993|NCT01847443|69229169|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
37742994|NCT01847443|69229166|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
37742995|NCT01847443|69229167|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
37742996|NCT01847443|69229168|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
37742997|NCT01847443|69229169|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
37742998|NCT01847209|69229188|FG000|Overall Study|Withdrawal by Subject|1|||
37742999|NCT01847209|69229188|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
37743000|NCT01846741|69229192|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
37743001|NCT01870843|69229231|FG000|Overall Study|Adverse Event|10|||
37743002|NCT01870843|69229231|FG000|Overall Study|Lost to Follow-up|24|||
37653694|NCT02556710|69124180|FG000|Overall Study|Required proscribed pain medication|2|||
37653695|NCT02556710|69124181|FG001|Overall Study|Required proscribed pain medication|1|||
37653696|NCT02556710|69124180|FG000|Overall Study|Lack of Efficacy|1|||
37653697|NCT02556710|69124181|FG001|Overall Study|Lack of Efficacy|0|||
37743003|NCT01870843|69229231|FG000|Overall Study|Death|1|||
37743004|NCT01870843|69229231|FG000|Overall Study|Withdrawal by Subject|18|||
37743005|NCT01816477|69229237|FG000|Overall Study|Withdrawal by Subject|13|||
37743006|NCT01816477|69229238|FG001|Overall Study|Withdrawal by Subject|1|||
37743007|NCT01816477|69229237|FG000|Overall Study|Unable to tolerate catheter placement|3|||
37743008|NCT01816477|69229238|FG001|Overall Study|Unable to tolerate catheter placement|0|||
37743009|NCT01846507|69229244|FG000|Overall Study|Lost to Follow-up|4|||
37743010|NCT01846507|69229244|FG000|Overall Study|Protocol Violation|1|||
37743011|NCT01846507|69229244|FG000|Overall Study|Missing data|2|||
37743012|NCT01846039|69229250|FG000|Overall Study|Protocol Violation|1|||
37743013|NCT01846039|69229250|FG000|Overall Study|Subject Withdrew Consent|1|||
37743014|NCT01610167|69229257|FG000|Overall Study|Scheduling conflict.|0|||
37743015|NCT01610167|69229258|FG001|Overall Study|Scheduling conflict.|0|||
37743016|NCT01610167|69229259|FG002|Overall Study|Scheduling conflict.|2|||
37743017|NCT01816243|69229267|FG000|Overall Study|Adverse Event|6|||
37743018|NCT01816243|69229267|FG000|Overall Study|Lost to Follow-up|1|||
37743019|NCT01816243|69229267|FG000|Overall Study|Lack of Efficacy|1|||
37653698|NCT02556710|69124180|FG000|Overall Study|Worsening osteoarthritis|1|||
37653699|NCT02556710|69124181|FG001|Overall Study|Worsening osteoarthritis|0|||
37653700|NCT02556710|69124180|FG000|Overall Study|Moved out of state|1|||
37653701|NCT02556710|69124181|FG001|Overall Study|Moved out of state|0|||
37653702|NCT02556710|69124180|FG000|Overall Study|Missing reason|3|||
37653703|NCT02556710|69124181|FG001|Overall Study|Missing reason|1|||
37653704|NCT02556710|69124180|FG000|Overall Study|Pain as lack of efficacy|0|||
37653705|NCT02556710|69124181|FG001|Overall Study|Pain as lack of efficacy|4|||
37653706|NCT02556632|69124192|FG000|Overall Study|Lost to Follow-up|1|||
37653707|NCT02556632|69124193|FG001|Overall Study|Lost to Follow-up|0|||
37653708|NCT02556632|69124194|FG002|Overall Study|Lost to Follow-up|0|||
37653709|NCT02556632|69124192|FG000|Overall Study|Disliked Intervention|1|||
37653710|NCT02556632|69124193|FG001|Overall Study|Disliked Intervention|1|||
37653711|NCT02556632|69124194|FG002|Overall Study|Disliked Intervention|1|||
37653712|NCT02556632|69124192|FG000|Overall Study|No Reason|1|||
37653713|NCT02556632|69124193|FG001|Overall Study|No Reason|0|||
37653714|NCT02556632|69124194|FG002|Overall Study|No Reason|1|||
37653715|NCT02556632|69124192|FG000|Overall Study|Personal Issues|0|||
37653716|NCT02556632|69124193|FG001|Overall Study|Personal Issues|1|||
37653717|NCT02556632|69124194|FG002|Overall Study|Personal Issues|1|||
37653718|NCT02556632|69124192|FG000|Overall Study|Changed Mind|0|||
37653719|NCT02556632|69124193|FG001|Overall Study|Changed Mind|1|||
37653720|NCT02556632|69124194|FG002|Overall Study|Changed Mind|0|||
37653721|NCT02556632|69124192|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
37653722|NCT02556632|69124193|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
37653723|NCT02556632|69124194|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
37653724|NCT02556632|69124192|FG000|Overall Study|Unrelated Adverse Event|1|||
37653725|NCT02556632|69124193|FG001|Overall Study|Unrelated Adverse Event|0|||
37653726|NCT02556632|69124194|FG002|Overall Study|Unrelated Adverse Event|3|||
37653727|NCT02556632|69124192|FG000|Overall Study|Related Adverse Event|0|||
37653728|NCT02556632|69124193|FG001|Overall Study|Related Adverse Event|1|||
37653729|NCT02556632|69124194|FG002|Overall Study|Related Adverse Event|0|||
37653730|NCT02556632|69124192|FG000|Overall Study|Possibly Related Adverse Event|0|||
37743020|NCT01816243|69229267|FG000|Overall Study|Not eligible for the study|1|||
37743021|NCT01816243|69229267|FG000|Overall Study|Amputation|3|||
37743022|NCT01845805|69229273|FG000|Overall Study|Withdrawal by Subject|1|||
37743023|NCT01845805|69229274|FG001|Overall Study|Withdrawal by Subject|2|||
37743024|NCT01845805|69229273|FG000|Overall Study|Disease Progression|13|||
37743025|NCT01845805|69229274|FG001|Overall Study|Disease Progression|14|||
37743026|NCT01845805|69229273|FG000|Overall Study|Drug-related Toxicity|4|||
37653731|NCT02556632|69124193|FG001|Overall Study|Possibly Related Adverse Event|0|||
37653732|NCT02556632|69124194|FG002|Overall Study|Possibly Related Adverse Event|1|||
37653733|NCT02556632|69124192|FG000|Overall Study|Did Not Start RT|0|||
37653734|NCT02556632|69124193|FG001|Overall Study|Did Not Start RT|1|||
37743027|NCT01845805|69229274|FG001|Overall Study|Drug-related Toxicity|0|||
37653735|NCT02556632|69124194|FG002|Overall Study|Did Not Start RT|0|||
37653736|NCT02556632|69124192|FG000|Overall Study|Ineligible|0|||
37653737|NCT02556632|69124193|FG001|Overall Study|Ineligible|1|||
37653738|NCT02556632|69124194|FG002|Overall Study|Ineligible|0|||
37653739|NCT02556632|69124192|FG000|Overall Study|Disliked Study Procedures|0|||
37653740|NCT02556632|69124193|FG001|Overall Study|Disliked Study Procedures|0|||
37653741|NCT02556632|69124194|FG002|Overall Study|Disliked Study Procedures|1|||
37653742|NCT02556632|69124192|FG000|Overall Study|Treatment or Change Delay|0|||
37653743|NCT02556632|69124193|FG001|Overall Study|Treatment or Change Delay|0|||
37653744|NCT02556632|69124194|FG002|Overall Study|Treatment or Change Delay|1|||
37653745|NCT01662440|69124206|FG000|Overall Study|Adverse Event|1|||
37653746|NCT01662440|69124207|FG001|Overall Study|Adverse Event|0|||
37653747|NCT01662440|69124208|FG002|Overall Study|Adverse Event|0|||
37653748|NCT01662440|69124209|FG003|Overall Study|Adverse Event|1|||
37653749|NCT01662440|69124206|FG000|Overall Study|Death|0|||
37743028|NCT01845025|69229282|FG000|Overall Study|Adverse Event|6|||
37743029|NCT01845025|69229283|FG001|Overall Study|Adverse Event|3|||
37743030|NCT01845025|69229282|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
37653750|NCT01662440|69124207|FG001|Overall Study|Death|1|||
37653751|NCT01662440|69124208|FG002|Overall Study|Death|0|||
37653752|NCT01662440|69124209|FG003|Overall Study|Death|0|||
37653753|NCT01662440|69124206|FG000|Overall Study|Lost to Follow-up|2|||
37653754|NCT01662440|69124207|FG001|Overall Study|Lost to Follow-up|2|||
37653755|NCT01662440|69124208|FG002|Overall Study|Lost to Follow-up|4|||
37653756|NCT01662440|69124209|FG003|Overall Study|Lost to Follow-up|1|||
37653757|NCT01662440|69124206|FG000|Overall Study|Subject moved to another country.|0|||
37653758|NCT01662440|69124207|FG001|Overall Study|Subject moved to another country.|1|||
37653759|NCT01662440|69124208|FG002|Overall Study|Subject moved to another country.|0|||
37653760|NCT01662440|69124209|FG003|Overall Study|Subject moved to another country.|0|||
37653761|NCT01662440|69124206|FG000|Overall Study|Protocol Violation|1|||
37653762|NCT01662440|69124207|FG001|Overall Study|Protocol Violation|0|||
37653763|NCT01662440|69124208|FG002|Overall Study|Protocol Violation|0|||
37653764|NCT01662440|69124209|FG003|Overall Study|Protocol Violation|0|||
37653765|NCT01662440|69124206|FG000|Overall Study|Withdrawal by Subject|5|||
37653766|NCT01662440|69124207|FG001|Overall Study|Withdrawal by Subject|2|||
37653767|NCT01662440|69124208|FG002|Overall Study|Withdrawal by Subject|2|||
37653768|NCT01662440|69124209|FG003|Overall Study|Withdrawal by Subject|2|||
37653769|NCT01662362|69124229|FG000|Overall Study|Lost to Follow-up|38|||
37653770|NCT02554682|69124244|FG000|Overall Study|Lost to Follow-up|11|||
37653771|NCT02554682|69124245|FG001|Overall Study|Lost to Follow-up|9|||
37653772|NCT02554682|69124246|FG002|Overall Study|Lost to Follow-up|4|||
37653773|NCT02554682|69124247|FG003|Overall Study|Lost to Follow-up|3|||
37653774|NCT02554682|69124248|FG004|Overall Study|Lost to Follow-up|2|||
37653775|NCT02554682|69124249|FG005|Overall Study|Lost to Follow-up|1|||
37653776|NCT02554682|69124250|FG006|Overall Study|Lost to Follow-up|6|||
37653777|NCT02554682|69124251|FG007|Overall Study|Lost to Follow-up|6|||
37653778|NCT02554682|69124252|FG008|Overall Study|Lost to Follow-up|2|||
37653779|NCT02554682|69124253|FG009|Overall Study|Lost to Follow-up|2|||
37653780|NCT02554682|69124244|FG000|Overall Study|Withdrawal by Subject|2|||
37653781|NCT02554682|69124245|FG001|Overall Study|Withdrawal by Subject|1|||
37653782|NCT02554682|69124246|FG002|Overall Study|Withdrawal by Subject|0|||
37653783|NCT02554682|69124247|FG003|Overall Study|Withdrawal by Subject|0|||
37653784|NCT02554682|69124248|FG004|Overall Study|Withdrawal by Subject|0|||
37653785|NCT02554682|69124249|FG005|Overall Study|Withdrawal by Subject|0|||
37653786|NCT02554682|69124250|FG006|Overall Study|Withdrawal by Subject|0|||
37653787|NCT02554682|69124251|FG007|Overall Study|Withdrawal by Subject|0|||
37653788|NCT02554682|69124252|FG008|Overall Study|Withdrawal by Subject|0|||
37653789|NCT02554682|69124253|FG009|Overall Study|Withdrawal by Subject|0|||
37653790|NCT02554682|69124244|FG000|Overall Study|Physician Decision|2|||
37653791|NCT02554682|69124245|FG001|Overall Study|Physician Decision|2|||
37922701|NCT00661492|69609478|FG000|Overall Study|Lost to Follow-up|0|||
37653792|NCT02554682|69124246|FG002|Overall Study|Physician Decision|0|||
37653793|NCT02554682|69124247|FG003|Overall Study|Physician Decision|0|||
37653794|NCT02554682|69124248|FG004|Overall Study|Physician Decision|0|||
37743031|NCT01845025|69229283|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
37653795|NCT02554682|69124249|FG005|Overall Study|Physician Decision|0|||
37653796|NCT02554682|69124250|FG006|Overall Study|Physician Decision|0|||
37653797|NCT02554682|69124251|FG007|Overall Study|Physician Decision|0|||
37653798|NCT02554682|69124252|FG008|Overall Study|Physician Decision|0|||
37653799|NCT02554682|69124253|FG009|Overall Study|Physician Decision|0|||
37743032|NCT01845025|69229282|FG000|Overall Study|Withdrawal by Subject|48|||
37743033|NCT01845025|69229283|FG001|Overall Study|Withdrawal by Subject|44|||
37653800|NCT00154063|69124289|FG000|Overall Study|Adverse Event|4|||
37653801|NCT00154063|69124290|FG001|Overall Study|Adverse Event|8|||
37653802|NCT00154063|69124289|FG000|Overall Study|Protocol Violation|1|||
37653803|NCT00154063|69124290|FG001|Overall Study|Protocol Violation|1|||
37653804|NCT00154063|69124289|FG000|Overall Study|Investigator or Sponsor Request|0|||
37653805|NCT00154063|69124290|FG001|Overall Study|Investigator or Sponsor Request|1|||
37653806|NCT00154063|69124289|FG000|Overall Study|Withdrawal by Subject|4|||
37653807|NCT00154063|69124290|FG001|Overall Study|Withdrawal by Subject|9|||
37743034|NCT01845025|69229282|FG000|Overall Study|Lost to Follow-up|13|||
37743035|NCT01845025|69229283|FG001|Overall Study|Lost to Follow-up|13|||
37743036|NCT01845025|69229282|FG000|Overall Study|Administrative problems|8|||
37743037|NCT01845025|69229283|FG001|Overall Study|Administrative problems|8|||
37743038|NCT01845025|69229282|FG000|Overall Study|Death|2|||
37743039|NCT01845025|69229283|FG001|Overall Study|Death|0|||
37743040|NCT01845025|69229282|FG000|Overall Study|Protocol deviation|3|||
37743041|NCT01845025|69229283|FG001|Overall Study|Protocol deviation|6|||
37743042|NCT01845025|69229282|FG000|Overall Study|Missing|1|||
37743043|NCT01845025|69229283|FG001|Overall Study|Missing|1|||
37743044|NCT01870297|69229324|FG000|Overall Study|Adverse Event|0|||
37743045|NCT01870297|69229325|FG001|Overall Study|Adverse Event|0|||
37743046|NCT01870297|69229326|FG002|Overall Study|Adverse Event|0|||
37743047|NCT01870297|69229327|FG003|Overall Study|Adverse Event|0|||
37743048|NCT01870297|69229328|FG004|Overall Study|Adverse Event|2|||
37743049|NCT01870297|69229329|FG005|Overall Study|Adverse Event|0|||
37743050|NCT01870297|69229330|FG006|Overall Study|Adverse Event|0|||
37743051|NCT01870297|69229324|FG000|Overall Study|Lost to Follow-up|0|||
37743052|NCT01870297|69229325|FG001|Overall Study|Lost to Follow-up|1|||
37743053|NCT01870297|69229326|FG002|Overall Study|Lost to Follow-up|1|||
37743054|NCT01870297|69229327|FG003|Overall Study|Lost to Follow-up|0|||
37743055|NCT01870297|69229328|FG004|Overall Study|Lost to Follow-up|0|||
37743056|NCT01870297|69229329|FG005|Overall Study|Lost to Follow-up|0|||
37743057|NCT01870297|69229330|FG006|Overall Study|Lost to Follow-up|0|||
37743058|NCT01870297|69229324|FG000|Overall Study|Withdrawal by Subject|0|||
37743059|NCT01870297|69229325|FG001|Overall Study|Withdrawal by Subject|0|||
37743060|NCT01870297|69229326|FG002|Overall Study|Withdrawal by Subject|0|||
37743061|NCT01870297|69229327|FG003|Overall Study|Withdrawal by Subject|0|||
37743062|NCT01870297|69229328|FG004|Overall Study|Withdrawal by Subject|1|||
37743063|NCT01870297|69229329|FG005|Overall Study|Withdrawal by Subject|1|||
37743064|NCT01870297|69229330|FG006|Overall Study|Withdrawal by Subject|1|||
37743065|NCT01870297|69229324|FG000|Overall Study|Sponsor Decision|0|||
37743066|NCT01870297|69229325|FG001|Overall Study|Sponsor Decision|6|||
37743067|NCT01870297|69229326|FG002|Overall Study|Sponsor Decision|0|||
37743068|NCT01870297|69229327|FG003|Overall Study|Sponsor Decision|0|||
37743069|NCT01870297|69229328|FG004|Overall Study|Sponsor Decision|0|||
37743070|NCT01870297|69229329|FG005|Overall Study|Sponsor Decision|0|||
37743071|NCT01870297|69229330|FG006|Overall Study|Sponsor Decision|1|||
37743072|NCT01814761|69229357|FG000|Overall Study|Other Reasons|1|||
37743073|NCT01814761|69229358|FG001|Overall Study|Other Reasons|10|||
37743074|NCT01814761|69229357|FG000|Overall Study|Ocular Adverse Event|6|||
37743075|NCT01814761|69229358|FG001|Overall Study|Ocular Adverse Event|15|||
37653808|NCT00154063|69124289|FG000|Overall Study|Other|3|||
37653809|NCT00154063|69124290|FG001|Overall Study|Other|3|||
37653810|NCT02683941|69124302|FG000|Double-blind Phase|Adverse Event|0|||
37653811|NCT02683941|69124303|FG001|Double-blind Phase|Adverse Event|1|||
37653812|NCT02683941|69124302|FG000|Double-blind Phase|Withdrawal by Subject|4|||
37653813|NCT02683941|69124303|FG001|Double-blind Phase|Withdrawal by Subject|2|||
37653814|NCT02683941|69124302|FG000|Double-blind Phase|Lost to Follow-up|1|||
37653815|NCT02683941|69124303|FG001|Double-blind Phase|Lost to Follow-up|0|||
37653816|NCT02683941|69124302|FG000|Double-blind Phase|Disease Progression|5|||
37653817|NCT02683941|69124303|FG001|Double-blind Phase|Disease Progression|2|||
37653818|NCT02683941|69124302|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
37653819|NCT02683941|69124303|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
37653820|NCT02683941|69124302|FG000|Open-label Treatment Phase|Disease Progression|1|||
37653821|NCT02683941|69124303|FG001|Open-label Treatment Phase|Disease Progression|2|||
37653822|NCT02683941|69124302|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
37653823|NCT02683941|69124303|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
37653824|NCT02683941|69124302|FG000|Open-label Treatment Phase|Other|1|||
37653825|NCT02683941|69124303|FG001|Open-label Treatment Phase|Other|0|||
37653826|NCT02683941|69124302|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
37653827|NCT02683941|69124303|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
37653828|NCT02683941|69124302|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
37653829|NCT02683941|69124303|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
37653830|NCT02683941|69124302|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
37743076|NCT01814761|69229357|FG000|Overall Study|Lost to Follow-up|1|||
37743077|NCT01814761|69229358|FG001|Overall Study|Lost to Follow-up|5|||
37743078|NCT01843933|69229366|FG000|Overall Study|Data lost|6|||
37743079|NCT01843933|69229367|FG001|Overall Study|Data lost|4|||
37743080|NCT01814371|69229375|FG000|Overall Study|Lost to Follow-up|30|||
37653831|NCT02683941|69124303|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
37743081|NCT01814371|69229376|FG001|Overall Study|Lost to Follow-up|27|||
37743082|NCT01814137|69229450|FG000|Overall Study|Adverse Event|0|||
37743083|NCT01814137|69229451|FG001|Overall Study|Adverse Event|1|||
37653832|NCT02683941|69124302|FG000|Open-label Follow-up Phase|Other|8|||
37653833|NCT02683941|69124303|FG001|Open-label Follow-up Phase|Other|1|||
37743084|NCT01814137|69229450|FG000|Overall Study|Withdrawal by Subject|2|||
37743085|NCT01814137|69229451|FG001|Overall Study|Withdrawal by Subject|2|||
37743086|NCT01814137|69229450|FG000|Overall Study|Physician Decision|1|||
37743087|NCT01814137|69229451|FG001|Overall Study|Physician Decision|1|||
37743088|NCT01814137|69229450|FG000|Overall Study|Unclassified|2|||
37743089|NCT01814137|69229451|FG001|Overall Study|Unclassified|1|||
37743090|NCT01813435|69229468|FG000|Overall Study|did not finish experimental regimen|1902|||
37743091|NCT01813435|69229469|FG001|Overall Study|did not finish experimental regimen|770|||
37743092|NCT01813435|69229468|FG000|Overall Study|Lost to Follow-up|268|||
37653834|NCT02678247|69124315|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
37653835|NCT02678247|69124316|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
37653836|NCT02678247|69124315|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
37653837|NCT02678247|69124316|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
37653838|NCT02678247|69124315|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
37653839|NCT02678247|69124316|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
37653840|NCT02678247|69124315|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
37653841|NCT02678247|69124316|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
37743093|NCT01813435|69229469|FG001|Overall Study|Lost to Follow-up|237|||
37743094|NCT01813357|69229477|FG000|Overall Study|Lost to Follow-up|5|||
37743095|NCT01813357|69229478|FG001|Overall Study|Lost to Follow-up|6|||
37743096|NCT01812655|69229487|FG000|Overall Study|Protocol Violation|1|||
37743097|NCT01812655|69229488|FG001|Overall Study|Protocol Violation|1|||
37743098|NCT01812655|69229489|FG002|Overall Study|Protocol Violation|0|||
37743099|NCT01812109|69229510|FG000|Overall Study|research personnel delay|16|||
37743100|NCT01812109|69229510|FG000|Overall Study|NIRS Unattainable|17|||
37743101|NCT01811953|69229520|FG000|Overall Study|Adverse Event|0|||
37743102|NCT01811953|69229521|FG001|Overall Study|Adverse Event|0|||
37743103|NCT01811953|69229522|FG002|Overall Study|Adverse Event|0|||
37743104|NCT01811953|69229523|FG003|Overall Study|Adverse Event|1|||
37743105|NCT01811953|69229524|FG004|Overall Study|Adverse Event|0|||
37743106|NCT01811953|69229525|FG005|Overall Study|Adverse Event|1|||
37743107|NCT01811953|69229520|FG000|Overall Study|Protocol Violation|0|||
37743108|NCT01811953|69229521|FG001|Overall Study|Protocol Violation|0|||
37743109|NCT01811953|69229522|FG002|Overall Study|Protocol Violation|0|||
37743110|NCT01811953|69229523|FG003|Overall Study|Protocol Violation|0|||
37743111|NCT01811953|69229524|FG004|Overall Study|Protocol Violation|1|||
37743112|NCT01811953|69229525|FG005|Overall Study|Protocol Violation|0|||
37743113|NCT01811563|69229541|FG000|Overall Study|Lost to Follow-up|5|||
37743114|NCT01811563|69229542|FG001|Overall Study|Lost to Follow-up|2|||
37743115|NCT01811563|69229541|FG000|Overall Study|Incorrect Randomization procedure|0|||
37743116|NCT01811563|69229542|FG001|Overall Study|Incorrect Randomization procedure|1|||
37743117|NCT01811485|69229551|FG000|Overall Study|Adverse Event|1|||
37743118|NCT01811485|69229552|FG001|Overall Study|Adverse Event|3|||
37743119|NCT01811485|69229553|FG002|Overall Study|Adverse Event|2|||
37743120|NCT01811485|69229551|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
37743121|NCT01811485|69229552|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
37743122|NCT01811485|69229553|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
37743123|NCT01811485|69229551|FG000|Overall Study|Administrative problems|1|||
37743124|NCT01811485|69229552|FG001|Overall Study|Administrative problems|0|||
37743125|NCT01811485|69229553|FG002|Overall Study|Administrative problems|0|||
37743126|NCT01811485|69229551|FG000|Overall Study|Protocol Deviation|0|||
37743127|NCT01811485|69229552|FG001|Overall Study|Protocol Deviation|1|||
37743128|NCT01811485|69229553|FG002|Overall Study|Protocol Deviation|0|||
37743129|NCT01810939|69229564|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
37743130|NCT01810939|69229565|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
37743131|NCT01810939|69229566|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
37743132|NCT01810939|69229564|FG000|Part A Treatment Period|Protocol Violation|2|||
37743133|NCT01810939|69229565|FG001|Part A Treatment Period|Protocol Violation|0|||
37743134|NCT01810939|69229566|FG002|Part A Treatment Period|Protocol Violation|0|||
38032653|NCT02833948|69718588|FG001|Overall Study|Death|3|||
38032654|NCT02833948|69718587|FG000|Overall Study|were not scanned|8|||
38032655|NCT02833948|69718588|FG001|Overall Study|were not scanned|13|||
38032656|NCT02833948|69718587|FG000|Overall Study|scans could not be evaluated|5|||
38032657|NCT02833948|69718588|FG001|Overall Study|scans could not be evaluated|2|||
38032658|NCT02828020|69718601|FG000|Treatment Period|Adverse Event|3|||
38032659|NCT02828020|69718602|FG001|Treatment Period|Adverse Event|1|||
38032660|NCT02828020|69718603|FG002|Treatment Period|Adverse Event|1|||
37743135|NCT01810939|69229564|FG000|Part A Treatment Period|Adverse Event|10|||
37743136|NCT01810939|69229565|FG001|Part A Treatment Period|Adverse Event|0|||
37743137|NCT01810939|69229566|FG002|Part A Treatment Period|Adverse Event|0|||
38032661|NCT02828020|69718601|FG000|Treatment Period|Withdrawal of Consent|10|||
38032662|NCT02828020|69718602|FG001|Treatment Period|Withdrawal of Consent|14|||
37743138|NCT01810939|69229564|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
37743139|NCT01810939|69229565|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
37743140|NCT01810939|69229566|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
37743141|NCT01810939|69229564|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
37743142|NCT01810939|69229565|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
37743143|NCT01810939|69229566|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
37743144|NCT01810939|69229564|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
37743145|NCT01810939|69229565|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
37743146|NCT01810939|69229566|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
37743147|NCT01810939|69229564|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
37743148|NCT01810939|69229565|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
37743149|NCT01810939|69229566|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
37743150|NCT01810939|69229564|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
37743151|NCT01810939|69229565|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
37743152|NCT01810939|69229566|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
37743153|NCT01810939|69229564|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
37743154|NCT01810939|69229565|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
37743155|NCT01810939|69229566|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
37743156|NCT01810939|69229564|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
37743157|NCT01810939|69229565|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
37743158|NCT01810939|69229566|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
37743159|NCT01810939|69229564|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
37743160|NCT01810939|69229565|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
37743161|NCT01810939|69229566|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
37743162|NCT01810939|69229564|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
37743163|NCT01810939|69229565|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
37743164|NCT01810939|69229566|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
37743165|NCT01810939|69229564|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
37743166|NCT01810939|69229565|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
37743167|NCT01810939|69229566|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
37743168|NCT01810939|69229564|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
37653842|NCT02678247|69124315|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
37653843|NCT02678247|69124316|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
37653844|NCT02678247|69124315|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
37653845|NCT02678247|69124316|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
37653846|NCT02683785|69124329|FG000|Overall Study|Withdrawal by Subject|1|||
37653847|NCT02683785|69124330|FG001|Overall Study|Withdrawal by Subject|1|||
37653848|NCT02683785|69124329|FG000|Overall Study|Lost to Follow-up|0|||
37653849|NCT02683785|69124330|FG001|Overall Study|Lost to Follow-up|1|||
37653850|NCT02683785|69124329|FG000|Overall Study|Adverse Event|0|||
37653851|NCT02683785|69124330|FG001|Overall Study|Adverse Event|2|||
37653852|NCT02543294|69124338|FG000|Overall Study|Lost to Follow-up|3|||
37653853|NCT02543294|69124338|FG000|Overall Study|Physician Decision|2|||
37653854|NCT02543294|69124338|FG000|Overall Study|Withdrawal by Subject|7|||
37653855|NCT02728076|69124343|FG000|Overall Study|Physician Decision|4|||
37653856|NCT02551874|69124349|FG000|Overall Study|Lost to Follow-up|0|||
37653857|NCT02551874|69124350|FG001|Overall Study|Lost to Follow-up|2|||
37653858|NCT02551874|69124349|FG000|Overall Study|Pregnancy|0|||
37653859|NCT02551874|69124350|FG001|Overall Study|Pregnancy|1|||
37653860|NCT02551874|69124349|FG000|Overall Study|Reason not reported|10|||
37653861|NCT02551874|69124350|FG001|Overall Study|Reason not reported|4|||
37653862|NCT02551874|69124349|FG000|Overall Study|Did not receive randomized treatment|0|||
37653863|NCT02551874|69124350|FG001|Overall Study|Did not receive randomized treatment|7|||
37653864|NCT02551874|69124349|FG000|Overall Study|Did not enter long-term study|18|||
37653865|NCT02551874|69124350|FG001|Overall Study|Did not enter long-term study|25|||
37653866|NCT02550938|69124373|FG000|Overall Study|Lost to Follow-up|8|||
37653867|NCT02550938|69124374|FG001|Overall Study|Lost to Follow-up|7|||
37653868|NCT02550938|69124375|FG002|Overall Study|Lost to Follow-up|12|||
37653869|NCT02550938|69124376|FG003|Overall Study|Lost to Follow-up|11|||
37653870|NCT02769065|69124416|FG000|Overall Study|Voluntary Withdrawal|1|||
37653871|NCT02769065|69124417|FG001|Overall Study|Voluntary Withdrawal|0|||
37653872|NCT02769065|69124418|FG002|Overall Study|Voluntary Withdrawal|0|||
37743169|NCT01810939|69229565|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
37743170|NCT01810939|69229566|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
37743171|NCT01810939|69229564|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
37743172|NCT01810939|69229565|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
37743173|NCT01810939|69229566|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
37743174|NCT01810939|69229564|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
37653873|NCT02769065|69124419|FG003|Overall Study|Voluntary Withdrawal|0|||
37653874|NCT02769065|69124420|FG004|Overall Study|Voluntary Withdrawal|0|||
37653875|NCT02769065|69124421|FG005|Overall Study|Voluntary Withdrawal|0|||
37653876|NCT02769065|69124422|FG006|Overall Study|Voluntary Withdrawal|0|||
37653877|NCT02769065|69124423|FG007|Overall Study|Voluntary Withdrawal|0|||
37855275|NCT01294592|69538536|FG001|Overall Study|Lost to Follow-up|9|||
37653878|NCT02769065|69124424|FG008|Overall Study|Voluntary Withdrawal|0|||
37653879|NCT02769065|69124425|FG009|Overall Study|Voluntary Withdrawal|0|||
37653880|NCT02769065|69124426|FG010|Overall Study|Voluntary Withdrawal|0|||
37653881|NCT02769065|69124427|FG011|Overall Study|Voluntary Withdrawal|0|||
37653882|NCT02769065|69124428|FG012|Overall Study|Voluntary Withdrawal|0|||
37653883|NCT02769065|69124429|FG013|Overall Study|Voluntary Withdrawal|0|||
37653884|NCT02769065|69124430|FG014|Overall Study|Voluntary Withdrawal|0|||
37653885|NCT02769065|69124431|FG015|Overall Study|Voluntary Withdrawal|0|||
37653886|NCT02769065|69124432|FG016|Overall Study|Voluntary Withdrawal|0|||
37653887|NCT02769065|69124433|FG017|Overall Study|Voluntary Withdrawal|0|||
37653888|NCT02769065|69124434|FG018|Overall Study|Voluntary Withdrawal|0|||
37653889|NCT02769065|69124435|FG019|Overall Study|Voluntary Withdrawal|0|||
37653890|NCT02769065|69124436|FG020|Overall Study|Voluntary Withdrawal|0|||
37653891|NCT02769065|69124437|FG021|Overall Study|Voluntary Withdrawal|0|||
37653892|NCT02769065|69124438|FG022|Overall Study|Voluntary Withdrawal|0|||
37653893|NCT02769065|69124439|FG023|Overall Study|Voluntary Withdrawal|0|||
37653894|NCT02769065|69124440|FG024|Overall Study|Voluntary Withdrawal|0|||
37653895|NCT02769065|69124441|FG025|Overall Study|Voluntary Withdrawal|0|||
37653896|NCT02769065|69124442|FG026|Overall Study|Voluntary Withdrawal|0|||
37653897|NCT02769065|69124443|FG027|Overall Study|Voluntary Withdrawal|0|||
37653898|NCT02769065|69124444|FG028|Overall Study|Voluntary Withdrawal|0|||
37653899|NCT02769065|69124445|FG029|Overall Study|Voluntary Withdrawal|0|||
37653900|NCT02769065|69124416|FG000|Overall Study|Reason Not Specified|0|||
37653901|NCT02769065|69124417|FG001|Overall Study|Reason Not Specified|0|||
37653902|NCT02769065|69124418|FG002|Overall Study|Reason Not Specified|0|||
37653903|NCT02769065|69124419|FG003|Overall Study|Reason Not Specified|0|||
37653904|NCT02769065|69124420|FG004|Overall Study|Reason Not Specified|0|||
37653905|NCT02769065|69124421|FG005|Overall Study|Reason Not Specified|0|||
37653906|NCT02769065|69124422|FG006|Overall Study|Reason Not Specified|1|||
37653907|NCT02769065|69124423|FG007|Overall Study|Reason Not Specified|0|||
37653908|NCT02769065|69124424|FG008|Overall Study|Reason Not Specified|0|||
37653909|NCT02769065|69124425|FG009|Overall Study|Reason Not Specified|0|||
37653910|NCT02769065|69124426|FG010|Overall Study|Reason Not Specified|0|||
37653911|NCT02769065|69124427|FG011|Overall Study|Reason Not Specified|0|||
37653912|NCT02769065|69124428|FG012|Overall Study|Reason Not Specified|0|||
37653913|NCT02769065|69124429|FG013|Overall Study|Reason Not Specified|0|||
37653914|NCT02769065|69124430|FG014|Overall Study|Reason Not Specified|0|||
37653915|NCT02769065|69124431|FG015|Overall Study|Reason Not Specified|0|||
37653916|NCT02769065|69124432|FG016|Overall Study|Reason Not Specified|0|||
37653917|NCT02769065|69124433|FG017|Overall Study|Reason Not Specified|0|||
37653918|NCT02769065|69124434|FG018|Overall Study|Reason Not Specified|0|||
37653919|NCT02769065|69124435|FG019|Overall Study|Reason Not Specified|0|||
37653920|NCT02769065|69124436|FG020|Overall Study|Reason Not Specified|0|||
37653921|NCT02769065|69124437|FG021|Overall Study|Reason Not Specified|0|||
37653922|NCT02769065|69124438|FG022|Overall Study|Reason Not Specified|0|||
37653923|NCT02769065|69124439|FG023|Overall Study|Reason Not Specified|0|||
37653924|NCT02769065|69124440|FG024|Overall Study|Reason Not Specified|0|||
37653925|NCT02769065|69124441|FG025|Overall Study|Reason Not Specified|0|||
37653926|NCT02769065|69124442|FG026|Overall Study|Reason Not Specified|0|||
37653927|NCT02769065|69124443|FG027|Overall Study|Reason Not Specified|0|||
37653928|NCT02769065|69124444|FG028|Overall Study|Reason Not Specified|0|||
37653929|NCT02769065|69124445|FG029|Overall Study|Reason Not Specified|0|||
37653930|NCT02769065|69124416|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
37653931|NCT02769065|69124417|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
37743175|NCT01810939|69229565|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
37743176|NCT01810939|69229566|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
37743177|NCT01810939|69229564|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
37743178|NCT01810939|69229565|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
37743179|NCT01810939|69229566|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
37743180|NCT01810783|69229585|FG000|Overall Study|Adverse Event|32|||
37743181|NCT01810783|69229585|FG000|Overall Study|Withdrawal by Subject|22|||
37653932|NCT02769065|69124418|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
37653933|NCT02769065|69124419|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
37743182|NCT01810783|69229585|FG000|Overall Study|Lack of Efficacy|12|||
37653934|NCT02769065|69124420|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
37653935|NCT02769065|69124421|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
37653936|NCT02769065|69124422|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
37653937|NCT02769065|69124423|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
37653938|NCT02769065|69124424|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
37653939|NCT02769065|69124425|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
37653940|NCT02769065|69124426|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
37653941|NCT02769065|69124427|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
37653942|NCT02769065|69124428|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
37653943|NCT02769065|69124429|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
37743183|NCT01810783|69229585|FG000|Overall Study|Lost to Follow-up|10|||
37743184|NCT01810783|69229585|FG000|Overall Study|Protocol Violation|5|||
37743185|NCT01810783|69229585|FG000|Overall Study|Non-compliance with IMP|4|||
37743186|NCT01810783|69229585|FG000|Overall Study|Adminstrative or other reason(s)|23|||
37743187|NCT01810783|69229585|FG000|Overall Study|Enrolled, not treated|1|||
37743188|NCT01808209|69229606|FG000|Overall Study|Lost to Follow-up|0|||
37743189|NCT01808209|69229607|FG001|Overall Study|Lost to Follow-up|1|||
37743190|NCT01807117|69229617|FG000|Overall Study|Physician Decision|2|||
37743191|NCT01807117|69229617|FG000|Overall Study|Disease diagnosis not a study disease|1|||
37743192|NCT01806961|69229623|FG000|Overall Study|sponsor decision|16|||
37743193|NCT01613131|69229629|FG000|Overall Study|Withdrawal by Subject|3|||
37743194|NCT01613131|69229630|FG001|Overall Study|Withdrawal by Subject|5|||
37743195|NCT01868893|69229636|FG000|Overall Study|Adverse Event|2|||
37743196|NCT01868893|69229636|FG000|Overall Study|Commercial availability of study drug|17|||
37743197|NCT01868893|69229636|FG000|Overall Study|Neutropenia|1|||
37743198|NCT01868503|69229642|FG000|Overall Study|Withdrawal by Subject|1|||
37743199|NCT01868503|69229642|FG000|Overall Study|Protocol Violation|1|||
37743200|NCT01868035|69229652|FG000|Overall Study|Lost to Follow-up|3|||
37743201|NCT01868035|69229652|FG000|Overall Study|Withdrawal by Subject|1|||
37743202|NCT01868035|69229652|FG000|Overall Study|Progressive Disease|2|||
37653944|NCT02769065|69124430|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
37653945|NCT02769065|69124431|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
37922702|NCT00661492|69609479|FG001|Overall Study|Lost to Follow-up|1|||
37922703|NCT00661492|69609478|FG000|Overall Study|Other|1|||
37922704|NCT00661492|69609479|FG001|Overall Study|Other|0|||
37922705|NCT00850070|69609487|FG000|Overall Study|Lack of Efficacy|1|||
37922706|NCT00850070|69609488|FG001|Overall Study|Lack of Efficacy|1|||
37922707|NCT00850070|69609487|FG000|Overall Study|Adverse Event|2|||
37922708|NCT00850070|69609488|FG001|Overall Study|Adverse Event|0|||
37922709|NCT00592358|69609499|FG000|Overall Study|Withdrawal by Subject|2|||
37922710|NCT00592358|69609499|FG000|Overall Study|Adverse Event|1|||
37922711|NCT00592358|69609499|FG000|Overall Study|Lack of Efficacy|2|||
37922712|NCT00592358|69609499|FG000|Overall Study|Inability to swallow pills|1|||
37922713|NCT00814320|69609505|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
37922714|NCT00814320|69609506|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
37922715|NCT00814320|69609505|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
37922716|NCT00814320|69609506|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
37922717|NCT00814320|69609505|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
37653946|NCT02769065|69124432|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
37653947|NCT02769065|69124433|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
37653948|NCT02769065|69124434|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
37653949|NCT02769065|69124435|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
37653950|NCT02769065|69124436|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
37653951|NCT02769065|69124437|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
37653952|NCT02769065|69124438|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
37653953|NCT02769065|69124439|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
37653954|NCT02769065|69124440|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
37743203|NCT01868035|69229652|FG000|Overall Study|Non-compliance|1|||
37743204|NCT01609933|69229656|FG000|Overall Study|Adverse Event|1|||
37743205|NCT01609933|69229656|FG000|Overall Study|Withdrawal by Subject|3|||
37743206|NCT01843777|69229664|FG000|Overall Study|Withdrawal by Subject|1|||
37743207|NCT01843777|69229665|FG001|Overall Study|Withdrawal by Subject|0|||
37743208|NCT01842607|69229671|FG000|Overall Study|Adverse Event|11|||
37743209|NCT01842607|69229671|FG000|Overall Study|Lack of Efficacy|19|||
37743210|NCT01842607|69229671|FG000|Overall Study|Protocol Violation|8|||
37743211|NCT01842607|69229671|FG000|Overall Study|Protocol defined stopping criteria|2|||
38032663|NCT02828020|69718603|FG002|Treatment Period|Withdrawal of Consent|9|||
37653955|NCT02769065|69124441|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
37653956|NCT02769065|69124442|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
37653957|NCT02769065|69124443|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
37653958|NCT02769065|69124444|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
37653959|NCT02769065|69124445|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
37653960|NCT02681523|69124538|FG000|Overall Study|Adverse Event|1|||
37653961|NCT02681523|69124538|FG000|Overall Study|Patient Non-compliance|1|||
37653962|NCT02540954|69124544|FG000|Overall Study|Physician Decision|3|||
37653963|NCT02540954|69124545|FG001|Overall Study|Physician Decision|1|||
37653964|NCT02540954|69124544|FG000|Overall Study|Withdrawal by Subject|6|||
37743212|NCT01842607|69229671|FG000|Overall Study|Lost to Follow-up|3|||
37743213|NCT01842607|69229671|FG000|Overall Study|Physician Decision|9|||
37743214|NCT01842607|69229671|FG000|Overall Study|Withdrawal by Subject|14|||
37743215|NCT01803607|69229677|FG000|Overall Study|Adverse Event|5|||
37743216|NCT01803607|69229678|FG001|Overall Study|Adverse Event|3|||
37743217|NCT01803607|69229677|FG000|Overall Study|Lack of Efficacy|0|||
37922718|NCT00814320|69609506|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
37922719|NCT00814320|69609505|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
37743218|NCT01803607|69229678|FG001|Overall Study|Lack of Efficacy|1|||
37743219|NCT01803607|69229677|FG000|Overall Study|Protocol Violation|3|||
37743220|NCT01803607|69229678|FG001|Overall Study|Protocol Violation|2|||
38032664|NCT02828020|69718601|FG000|Treatment Period|Lost to Follow-up|21|||
38032665|NCT02828020|69718602|FG001|Treatment Period|Lost to Follow-up|24|||
38032666|NCT02828020|69718603|FG002|Treatment Period|Lost to Follow-up|18|||
38032667|NCT02828020|69718601|FG000|Treatment Period|Lack of Qualifying Event|44|||
37743221|NCT01803607|69229677|FG000|Overall Study|Study terminated by sponsor|54|||
37743222|NCT01803607|69229678|FG001|Overall Study|Study terminated by sponsor|56|||
37743223|NCT01803607|69229677|FG000|Overall Study|Withdrawal by Subject|6|||
37743224|NCT01803607|69229678|FG001|Overall Study|Withdrawal by Subject|5|||
37743225|NCT01867021|69229686|FG000|Overall Study|Adverse Event|0|||
37743226|NCT01867021|69229687|FG001|Overall Study|Adverse Event|1|||
37743227|NCT01867021|69229686|FG000|Overall Study|Not Eligible|0|||
37743228|NCT01867021|69229687|FG001|Overall Study|Not Eligible|1|||
37743229|NCT01867021|69229686|FG000|Overall Study|Death|1|||
37743230|NCT01867021|69229687|FG001|Overall Study|Death|0|||
37743231|NCT01867021|69229686|FG000|Overall Study|Lost to Follow-up|0|||
37743232|NCT01867021|69229687|FG001|Overall Study|Lost to Follow-up|2|||
37743233|NCT01867021|69229686|FG000|Overall Study|Withdrawal by Subject|1|||
37743234|NCT01867021|69229687|FG001|Overall Study|Withdrawal by Subject|6|||
37743235|NCT01866709|69229700|FG000|Overall Study|Adverse Event|1|||
37743236|NCT01866709|69229701|FG001|Overall Study|Adverse Event|0|||
37743237|NCT01841593|69229709|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
37743238|NCT01841593|69229710|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
37743239|NCT01841593|69229709|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
37743240|NCT01841593|69229710|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
37743241|NCT01866319|69229978|FG000|Overall Study|Adverse Event|12|||
37743242|NCT01866319|69229979|FG001|Overall Study|Adverse Event|5|||
37743243|NCT01866319|69229980|FG002|Overall Study|Adverse Event|9|||
37743244|NCT01866319|69229978|FG000|Overall Study|Clinical progression|3|||
37743245|NCT01866319|69229979|FG001|Overall Study|Clinical progression|2|||
37743246|NCT01866319|69229980|FG002|Overall Study|Clinical progression|2|||
37743247|NCT01866319|69229978|FG000|Overall Study|Death|153|||
37743248|NCT01866319|69229979|FG001|Overall Study|Death|154|||
37743249|NCT01866319|69229980|FG002|Overall Study|Death|147|||
37743250|NCT01866319|69229978|FG000|Overall Study|Lost to Follow-up|6|||
37743251|NCT01866319|69229979|FG001|Overall Study|Lost to Follow-up|3|||
37653965|NCT02540954|69124545|FG001|Overall Study|Withdrawal by Subject|5|||
37653966|NCT02540954|69124544|FG000|Overall Study|Lost to Follow-up|1|||
37653967|NCT02540954|69124545|FG001|Overall Study|Lost to Follow-up|1|||
37653968|NCT02540954|69124544|FG000|Overall Study|Adverse Event|4|||
37653969|NCT02540954|69124545|FG001|Overall Study|Adverse Event|2|||
37653970|NCT02540954|69124544|FG000|Overall Study|Death|0|||
37653971|NCT02540954|69124545|FG001|Overall Study|Death|3|||
37653972|NCT02540954|69124544|FG000|Overall Study|Treatment failure|1|||
37653973|NCT02540954|69124545|FG001|Overall Study|Treatment failure|0|||
37653974|NCT02540954|69124544|FG000|Overall Study|Other reason|4|||
37743252|NCT01866319|69229980|FG002|Overall Study|Lost to Follow-up|8|||
37743253|NCT01866319|69229978|FG000|Overall Study|Physician Decision|1|||
37653975|NCT02540954|69124545|FG001|Overall Study|Other reason|2|||
37653976|NCT02658812|69124551|FG000|Overall Study|Disease Progression|7|||
37653977|NCT02658812|69124551|FG000|Overall Study|Unrelated to study treatment|1|||
37743254|NCT01866319|69229979|FG001|Overall Study|Physician Decision|0|||
37743255|NCT01866319|69229980|FG002|Overall Study|Physician Decision|1|||
37743256|NCT01866319|69229978|FG000|Overall Study|Protocol Violation|0|||
37743257|NCT01866319|69229979|FG001|Overall Study|Protocol Violation|0|||
37743258|NCT01866319|69229980|FG002|Overall Study|Protocol Violation|1|||
37743259|NCT01866319|69229978|FG000|Overall Study|Withdrawal by Subject|32|||
37743260|NCT01866319|69229979|FG001|Overall Study|Withdrawal by Subject|14|||
37743261|NCT01866319|69229980|FG002|Overall Study|Withdrawal by Subject|12|||
38032668|NCT02828020|69718602|FG001|Treatment Period|Lack of Qualifying Event|53|||
37653978|NCT02658812|69124551|FG000|Overall Study|Adverse Event|1|||
37653979|NCT02680665|69124555|FG000|Overall Study|No visit after the first prescription|5|||
37653980|NCT00154375|69124561|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
37743262|NCT01802515|69230007|FG000|Overall Study|Withdrawal by Subject|3|||
37743263|NCT01802515|69230008|FG001|Overall Study|Withdrawal by Subject|0|||
37743264|NCT01802515|69230009|FG002|Overall Study|Withdrawal by Subject|0|||
37743265|NCT01802437|69230019|FG000|Overall Study|Lost to Follow-up|1|||
37743266|NCT01802437|69230020|FG001|Overall Study|Lost to Follow-up|0|||
37743267|NCT01802437|69230019|FG000|Overall Study|Withdrawal by Subject|3|||
37743268|NCT01802437|69230020|FG001|Overall Study|Withdrawal by Subject|4|||
37743269|NCT01801735|69230127|FG000|Overall Study|Adverse Event|79|||
37743270|NCT01801735|69230127|FG000|Overall Study|Lack of Efficacy|28|||
37743271|NCT01801735|69230127|FG000|Overall Study|Withdrawal by Subject|27|||
37743272|NCT01801735|69230127|FG000|Overall Study|Protocol Violation|25|||
37743273|NCT01801735|69230127|FG000|Overall Study|Lost to Follow-up|15|||
37743274|NCT01801735|69230127|FG000|Overall Study|Non-compliance with Trial Drug|13|||
37743275|NCT01801735|69230127|FG000|Overall Study|Physician Decision|3|||
37743276|NCT01801735|69230127|FG000|Overall Study|Death|1|||
37743277|NCT01801735|69230127|FG000|Overall Study|Other, including site closure|19|||
37653981|NCT00154375|69124562|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
37653982|NCT00154375|69124561|FG000|Overall Study|Adverse Event|18|||
37653983|NCT00154375|69124562|FG001|Overall Study|Adverse Event|20|||
37653984|NCT00154375|69124561|FG000|Overall Study|Withdrawal by Subject|14|||
37653985|NCT00154375|69124562|FG001|Overall Study|Withdrawal by Subject|10|||
37653986|NCT00154375|69124561|FG000|Overall Study|Death|5|||
37653987|NCT00154375|69124562|FG001|Overall Study|Death|13|||
37653988|NCT00154375|69124561|FG000|Overall Study|Study drug no longer required|5|||
37653989|NCT00154375|69124562|FG001|Overall Study|Study drug no longer required|3|||
37653990|NCT00154375|69124561|FG000|Overall Study|Lost to Follow-up|2|||
37653991|NCT00154375|69124562|FG001|Overall Study|Lost to Follow-up|1|||
37653992|NCT00154375|69124561|FG000|Overall Study|Abnormal laboratory value(s)|0|||
37653993|NCT00154375|69124562|FG001|Overall Study|Abnormal laboratory value(s)|2|||
37653994|NCT00154375|69124561|FG000|Overall Study|Protocol Violation|0|||
37653995|NCT00154375|69124562|FG001|Overall Study|Protocol Violation|1|||
37653996|NCT00154375|69124561|FG000|Overall Study|Suspected progression of disease|44|||
37653997|NCT00154375|69124562|FG001|Overall Study|Suspected progression of disease|30|||
37653998|NCT02765399|69124571|FG000|Overall Study|Nausea|1|||
37653999|NCT02765399|69124572|FG001|Overall Study|Nausea|0|||
37654000|NCT02676765|69124580|FG000|Overall Study|Lost to Follow-up|0|||
37654001|NCT02676765|69124581|FG001|Overall Study|Lost to Follow-up|1|||
37654002|NCT02680041|69124587|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
37654003|NCT02680041|69124587|FG000|Overall Study|Lost to Follow-up|2|||
37654004|NCT02547974|69124596|FG000|Overall Study|Withdrawal by Subject|1|||
37654005|NCT02547974|69124597|FG001|Overall Study|Withdrawal by Subject|0|||
37654006|NCT02547974|69124598|FG002|Overall Study|Withdrawal by Subject|0|||
37654007|NCT02547974|69124599|FG003|Overall Study|Withdrawal by Subject|0|||
37654008|NCT00154297|69124614|FG000|Overall Study|Death|5|||
37654009|NCT00154297|69124615|FG001|Overall Study|Death|2|||
37654010|NCT00154297|69124614|FG000|Overall Study|Withdrawal by Subject|0|||
37654011|NCT00154297|69124615|FG001|Overall Study|Withdrawal by Subject|5|||
37654012|NCT00154297|69124614|FG000|Overall Study|Lost to Follow-up|3|||
37654013|NCT00154297|69124615|FG001|Overall Study|Lost to Follow-up|0|||
37654014|NCT02679729|69124630|FG000|Overall Study|Lost to Follow-up|0|||
37654015|NCT02679729|69124631|FG001|Overall Study|Lost to Follow-up|1|||
37654016|NCT02679729|69124632|FG002|Overall Study|Lost to Follow-up|0|||
37654017|NCT02679729|69124633|FG003|Overall Study|Lost to Follow-up|0|||
37654018|NCT02679729|69124634|FG004|Overall Study|Lost to Follow-up|1|||
37654019|NCT02679729|69124635|FG005|Overall Study|Lost to Follow-up|0|||
37654020|NCT02679729|69124636|FG006|Overall Study|Lost to Follow-up|0|||
37654021|NCT02679729|69124637|FG007|Overall Study|Lost to Follow-up|0|||
37654022|NCT02679729|69124638|FG008|Overall Study|Lost to Follow-up|0|||
37654023|NCT02679729|69124630|FG000|Overall Study|Participant decision|0|||
37654024|NCT02679729|69124631|FG001|Overall Study|Participant decision|1|||
37654025|NCT02679729|69124632|FG002|Overall Study|Participant decision|0|||
37654026|NCT02679729|69124633|FG003|Overall Study|Participant decision|0|||
37654027|NCT02679729|69124634|FG004|Overall Study|Participant decision|0|||
37654028|NCT02679729|69124635|FG005|Overall Study|Participant decision|0|||
37654029|NCT02679729|69124636|FG006|Overall Study|Participant decision|1|||
37654030|NCT02679729|69124637|FG007|Overall Study|Participant decision|0|||
37654031|NCT02679729|69124638|FG008|Overall Study|Participant decision|0|||
37654032|NCT02765165|69124677|FG000|Treatment Period|Progressive disease|3|||
37654033|NCT02765165|69124678|FG001|Treatment Period|Progressive disease|2|||
37654034|NCT02765165|69124679|FG002|Treatment Period|Progressive disease|3|||
37654035|NCT02765165|69124680|FG003|Treatment Period|Progressive disease|3|||
37654036|NCT02765165|69124681|FG004|Treatment Period|Progressive disease|4|||
37743278|NCT01840579|69230885|FG000|Overall Study|Status not recorded|0|||
37743279|NCT01840579|69230886|FG001|Overall Study|Status not recorded|0|||
37743280|NCT01840579|69230887|FG002|Overall Study|Status not recorded|2|||
37654037|NCT02765165|69124682|FG005|Treatment Period|Progressive disease|2|||
37654038|NCT02765165|69124683|FG006|Treatment Period|Progressive disease|2|||
37743281|NCT01840579|69230888|FG003|Overall Study|Status not recorded|3|||
37654039|NCT02765165|69124677|FG000|Treatment Period|Physician Decision|0|||
37654040|NCT02765165|69124678|FG001|Treatment Period|Physician Decision|1|||
37654041|NCT02765165|69124679|FG002|Treatment Period|Physician Decision|0|||
37654042|NCT02765165|69124680|FG003|Treatment Period|Physician Decision|0|||
37654043|NCT02765165|69124681|FG004|Treatment Period|Physician Decision|0|||
37654044|NCT02765165|69124682|FG005|Treatment Period|Physician Decision|0|||
37654045|NCT02765165|69124683|FG006|Treatment Period|Physician Decision|0|||
37654046|NCT02765165|69124677|FG000|Treatment Period|Adverse Event|0|||
37654047|NCT02765165|69124678|FG001|Treatment Period|Adverse Event|1|||
37743282|NCT01840579|69230889|FG004|Overall Study|Status not recorded|4|||
37743283|NCT01840579|69230890|FG005|Overall Study|Status not recorded|3|||
37654048|NCT02765165|69124679|FG002|Treatment Period|Adverse Event|0|||
37743284|NCT01840579|69230891|FG006|Overall Study|Status not recorded|0|||
37743285|NCT01840579|69230892|FG007|Overall Study|Status not recorded|3|||
37743286|NCT01840579|69230893|FG008|Overall Study|Status not recorded|3|||
37743287|NCT01840579|69230894|FG009|Overall Study|Status not recorded|3|||
37743288|NCT01840579|69230885|FG000|Overall Study|Progressive disease|3|||
37743289|NCT01840579|69230886|FG001|Overall Study|Progressive disease|5|||
37743290|NCT01840579|69230887|FG002|Overall Study|Progressive disease|0|||
37743291|NCT01840579|69230888|FG003|Overall Study|Progressive disease|0|||
37743292|NCT01840579|69230889|FG004|Overall Study|Progressive disease|0|||
37743293|NCT01840579|69230890|FG005|Overall Study|Progressive disease|0|||
37743294|NCT01840579|69230891|FG006|Overall Study|Progressive disease|0|||
37743295|NCT01840579|69230892|FG007|Overall Study|Progressive disease|0|||
37743296|NCT01840579|69230893|FG008|Overall Study|Progressive disease|0|||
37743297|NCT01840579|69230894|FG009|Overall Study|Progressive disease|0|||
37743298|NCT01840579|69230885|FG000|Overall Study|Ongoing in study|0|||
37743299|NCT01840579|69230886|FG001|Overall Study|Ongoing in study|1|||
37743300|NCT01840579|69230887|FG002|Overall Study|Ongoing in study|0|||
37743301|NCT01840579|69230888|FG003|Overall Study|Ongoing in study|0|||
37743302|NCT01840579|69230889|FG004|Overall Study|Ongoing in study|0|||
37743303|NCT01840579|69230890|FG005|Overall Study|Ongoing in study|0|||
37743304|NCT01840579|69230891|FG006|Overall Study|Ongoing in study|0|||
37743305|NCT01840579|69230892|FG007|Overall Study|Ongoing in study|0|||
37743306|NCT01840579|69230893|FG008|Overall Study|Ongoing in study|0|||
37743307|NCT01840579|69230894|FG009|Overall Study|Ongoing in study|0|||
38032669|NCT02828020|69718603|FG002|Treatment Period|Lack of Qualifying Event|43|||
38032670|NCT02828020|69718601|FG000|Treatment Period|Pregnancy|0|||
38032671|NCT02828020|69718602|FG001|Treatment Period|Pregnancy|2|||
38032672|NCT02828020|69718603|FG002|Treatment Period|Pregnancy|0|||
38032673|NCT02828020|69718601|FG000|Treatment Period|Protocol Violation|2|||
38032674|NCT02828020|69718602|FG001|Treatment Period|Protocol Violation|4|||
38032675|NCT02828020|69718603|FG002|Treatment Period|Protocol Violation|7|||
38032676|NCT02828020|69718601|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
38032677|NCT02828020|69718602|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
38032678|NCT02828020|69718603|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
38032679|NCT02828020|69718601|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
38032680|NCT02828020|69718602|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
38032681|NCT02828020|69718603|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
38032682|NCT02828020|69718601|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
38032683|NCT02828020|69718602|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
38032684|NCT02828020|69718603|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
38032685|NCT02828020|69718601|FG000|Safety Follow-up Period|Protocol Violation|0|||
38032686|NCT02828020|69718602|FG001|Safety Follow-up Period|Protocol Violation|2|||
38032687|NCT02828020|69718603|FG002|Safety Follow-up Period|Protocol Violation|1|||
38032688|NCT02828020|69718601|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
38032689|NCT02828020|69718602|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
38032690|NCT02828020|69718603|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
38032691|NCT02827708|69718622|FG000|Overall Study|Lost to Follow-up|3|||
38032692|NCT02827708|69718623|FG001|Overall Study|Lost to Follow-up|1|||
37654049|NCT02765165|69124680|FG003|Treatment Period|Adverse Event|0|||
37654050|NCT02765165|69124681|FG004|Treatment Period|Adverse Event|0|||
37654051|NCT02765165|69124682|FG005|Treatment Period|Adverse Event|0|||
37654052|NCT02765165|69124683|FG006|Treatment Period|Adverse Event|0|||
38032693|NCT02827708|69718622|FG000|Overall Study|Withdrawal by Subject|1|||
38032694|NCT02827708|69718623|FG001|Overall Study|Withdrawal by Subject|2|||
38032695|NCT02827708|69718622|FG000|Overall Study|Death|1|||
38032696|NCT02827708|69718623|FG001|Overall Study|Death|2|||
37654053|NCT02765165|69124677|FG000|Treatment Period|Withdrawal by Subject|0|||
37654054|NCT02765165|69124678|FG001|Treatment Period|Withdrawal by Subject|0|||
37654055|NCT02765165|69124679|FG002|Treatment Period|Withdrawal by Subject|0|||
37654056|NCT02765165|69124680|FG003|Treatment Period|Withdrawal by Subject|0|||
37654057|NCT02765165|69124681|FG004|Treatment Period|Withdrawal by Subject|2|||
37654058|NCT02765165|69124682|FG005|Treatment Period|Withdrawal by Subject|0|||
37654059|NCT02765165|69124683|FG006|Treatment Period|Withdrawal by Subject|0|||
37654060|NCT02765165|69124677|FG000|Treatment Period|Study terminated|0|||
38032697|NCT03760185|69718629|FG000|Overall Study|Lost to Follow-up|1|||
38032698|NCT03760185|69718630|FG001|Overall Study|Lost to Follow-up|1|||
38032699|NCT02891174|69718640|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
37654061|NCT02765165|69124678|FG001|Treatment Period|Study terminated|0|||
37743308|NCT01840579|69230885|FG000|Overall Study|Death|0|||
37743309|NCT01840579|69230886|FG001|Overall Study|Death|0|||
37743310|NCT01840579|69230887|FG002|Overall Study|Death|0|||
37743311|NCT01840579|69230888|FG003|Overall Study|Death|0|||
37743312|NCT01840579|69230889|FG004|Overall Study|Death|0|||
37743313|NCT01840579|69230890|FG005|Overall Study|Death|1|||
37743314|NCT01840579|69230891|FG006|Overall Study|Death|0|||
37743315|NCT01840579|69230892|FG007|Overall Study|Death|0|||
37743316|NCT01840579|69230893|FG008|Overall Study|Death|0|||
37743317|NCT01840579|69230894|FG009|Overall Study|Death|0|||
37743318|NCT01840579|69230885|FG000|Overall Study|Adverse Event|0|||
37743319|NCT01840579|69230886|FG001|Overall Study|Adverse Event|1|||
37743320|NCT01840579|69230887|FG002|Overall Study|Adverse Event|0|||
37743321|NCT01840579|69230888|FG003|Overall Study|Adverse Event|0|||
37743322|NCT01840579|69230889|FG004|Overall Study|Adverse Event|0|||
37743323|NCT01840579|69230890|FG005|Overall Study|Adverse Event|0|||
37743324|NCT01840579|69230891|FG006|Overall Study|Adverse Event|0|||
37743325|NCT01840579|69230892|FG007|Overall Study|Adverse Event|0|||
37743326|NCT01840579|69230893|FG008|Overall Study|Adverse Event|0|||
37743327|NCT01840579|69230894|FG009|Overall Study|Adverse Event|0|||
37743328|NCT01840579|69230885|FG000|Overall Study|Follow-up ended by Sponsor|0|||
37743329|NCT01840579|69230886|FG001|Overall Study|Follow-up ended by Sponsor|0|||
37743330|NCT01840579|69230887|FG002|Overall Study|Follow-up ended by Sponsor|0|||
37743331|NCT01840579|69230888|FG003|Overall Study|Follow-up ended by Sponsor|0|||
37743332|NCT01840579|69230889|FG004|Overall Study|Follow-up ended by Sponsor|0|||
37743333|NCT01840579|69230890|FG005|Overall Study|Follow-up ended by Sponsor|0|||
37743334|NCT01840579|69230891|FG006|Overall Study|Follow-up ended by Sponsor|2|||
37743335|NCT01840579|69230892|FG007|Overall Study|Follow-up ended by Sponsor|0|||
37743336|NCT01840579|69230893|FG008|Overall Study|Follow-up ended by Sponsor|0|||
37743337|NCT01840579|69230894|FG009|Overall Study|Follow-up ended by Sponsor|0|||
37743338|NCT01801111|69230973|FG000|Overall Study|Adverse Event|12|||
37743339|NCT01801111|69230973|FG000|Overall Study|Death|8|||
37743340|NCT01801111|69230973|FG000|Overall Study|Physician Decision|5|||
37743341|NCT01801111|69230973|FG000|Overall Study|Other|1|||
37743342|NCT01801111|69230973|FG000|Overall Study|Withdrawal by Subject|4|||
37743343|NCT01801111|69230973|FG000|Overall Study|Study Terminated by Sponsor|27|||
37743344|NCT01801111|69230973|FG000|Overall Study|Progressive Disease|81|||
37743345|NCT01773967|69231005|FG000|Overall Study|Lost to Follow-up|15|||
37743346|NCT01773967|69231006|FG001|Overall Study|Lost to Follow-up|13|||
37743347|NCT01773889|69231016|FG000|Overall Study|lack of funding|2|||
37743348|NCT01839487|69231194|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
37654062|NCT02765165|69124679|FG002|Treatment Period|Study terminated|0|||
37654063|NCT02765165|69124680|FG003|Treatment Period|Study terminated|0|||
37654064|NCT02765165|69124681|FG004|Treatment Period|Study terminated|0|||
37654065|NCT02765165|69124682|FG005|Treatment Period|Study terminated|1|||
37654066|NCT02765165|69124683|FG006|Treatment Period|Study terminated|2|||
37654067|NCT02765165|69124677|FG000|Post-treatment Follow-up|Death|1|||
37654068|NCT02765165|69124678|FG001|Post-treatment Follow-up|Death|2|||
37654069|NCT02765165|69124679|FG002|Post-treatment Follow-up|Death|1|||
37654070|NCT02765165|69124680|FG003|Post-treatment Follow-up|Death|1|||
37654071|NCT02765165|69124681|FG004|Post-treatment Follow-up|Death|1|||
37654072|NCT02765165|69124682|FG005|Post-treatment Follow-up|Death|1|||
37654073|NCT02765165|69124683|FG006|Post-treatment Follow-up|Death|0|||
37654074|NCT02765165|69124677|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
37654075|NCT02765165|69124678|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
37654076|NCT02765165|69124679|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
37654077|NCT02765165|69124680|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
37654078|NCT02765165|69124681|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
37654079|NCT02765165|69124682|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
37654080|NCT02765165|69124683|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
37654081|NCT02765165|69124677|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
37654082|NCT02765165|69124678|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
37654083|NCT02765165|69124679|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
37654084|NCT02765165|69124680|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
37654085|NCT02765165|69124681|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
37654086|NCT02765165|69124682|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
37654087|NCT02765165|69124683|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
37654088|NCT02765165|69124677|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
37654089|NCT02765165|69124678|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
37654090|NCT02765165|69124679|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
37743349|NCT01839487|69231195|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
37654091|NCT02765165|69124680|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
37743350|NCT01839487|69231196|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
37654092|NCT02765165|69124681|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
37654093|NCT02765165|69124682|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
37743351|NCT01839487|69231197|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
37743352|NCT01839487|69231198|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
38032700|NCT02891174|69718641|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
37654094|NCT02765165|69124683|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
37743353|NCT01839487|69231199|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
37743354|NCT01839487|69231194|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
37743355|NCT01839487|69231195|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
37743356|NCT01839487|69231196|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
37654095|NCT02765165|69124677|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
37654096|NCT02765165|69124678|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
37654097|NCT02765165|69124679|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
37654098|NCT02765165|69124680|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
37654099|NCT02765165|69124681|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
37654100|NCT02765165|69124682|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
37654101|NCT02765165|69124683|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
37654102|NCT02765165|69124677|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
37654103|NCT02765165|69124678|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
37654104|NCT02765165|69124679|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
37743357|NCT01839487|69231197|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
37743358|NCT01839487|69231198|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
37743359|NCT01839487|69231199|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
37743360|NCT01839487|69231194|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
37743361|NCT01839487|69231195|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
37743362|NCT01839487|69231196|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
37743363|NCT01839487|69231197|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
37743364|NCT01839487|69231198|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
37743365|NCT01839487|69231199|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
37743366|NCT01839487|69231194|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
37743367|NCT01839487|69231195|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
37743368|NCT01839487|69231196|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
37743369|NCT01839487|69231197|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
37743370|NCT01839487|69231198|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
37743371|NCT01839487|69231199|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
37743372|NCT01839487|69231194|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
37743373|NCT01839487|69231195|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
37743374|NCT01839487|69231196|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
37743375|NCT01839487|69231197|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
37743376|NCT01839487|69231198|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
37743377|NCT01839487|69231199|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
37743378|NCT01839487|69231194|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
37743379|NCT01839487|69231195|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
37654105|NCT02765165|69124680|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
37654106|NCT02765165|69124681|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
37654107|NCT02765165|69124682|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
37654108|NCT02765165|69124683|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
37654109|NCT02675907|69124705|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
37654110|NCT02675907|69124706|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
37654111|NCT02675907|69124705|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
37654112|NCT02675907|69124706|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
37654113|NCT02675907|69124705|FG000|Study Overall|Lack of Efficacy|1|||
37654114|NCT02675907|69124706|FG001|Study Overall|Lack of Efficacy|0|||
37654115|NCT02675907|69124705|FG000|Study Overall|Withdrawal by Subject|2|||
37654116|NCT02675907|69124706|FG001|Study Overall|Withdrawal by Subject|2|||
37654117|NCT02675907|69124705|FG000|Study Overall|Lost to Follow-up|0|||
37743380|NCT01839487|69231196|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
37743381|NCT01839487|69231197|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
37743382|NCT01839487|69231198|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
37743383|NCT01839487|69231199|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
37743384|NCT01839487|69231194|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
37743385|NCT01839487|69231195|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
37743386|NCT01839487|69231196|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
37743387|NCT01839487|69231197|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
37743388|NCT01839487|69231198|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
37743389|NCT01839487|69231199|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
37743390|NCT01839487|69231194|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
37855276|NCT01294592|69538535|FG000|Overall Study|Physician Decision|6|||
37654118|NCT02675907|69124706|FG001|Study Overall|Lost to Follow-up|2|||
37654119|NCT02675517|69124712|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
38032701|NCT02891174|69718640|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
37654120|NCT02675517|69124712|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
38032702|NCT02891174|69718641|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
38032703|NCT02891174|69718640|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
37654121|NCT02764775|69124716|FG000|Overall Study|Death|1|||
37654122|NCT02764775|69124716|FG000|Overall Study|Lost to Follow-up|2|||
37654123|NCT02764775|69124716|FG000|Overall Study|Withdrawal by Subject|3|||
37743391|NCT01839487|69231195|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
37743392|NCT01839487|69231196|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
37743393|NCT01839487|69231197|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
37743394|NCT01839487|69231198|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
37743395|NCT01839487|69231199|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
37743396|NCT01839487|69231194|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
37743397|NCT01839487|69231195|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
37743398|NCT01839487|69231196|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
37743399|NCT01839487|69231197|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
37743400|NCT01839487|69231198|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
37743401|NCT01839487|69231199|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
37743402|NCT01799941|69231226|FG000|Overall Study|Adverse Event|34|||
37654124|NCT02774681|69124720|FG000|Treatment on Study|Progressive Disease|7|||
37654125|NCT02774681|69124720|FG000|Follow-Up for 3 Years|Death|11|||
37654126|NCT02774681|69124720|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
37654127|NCT02547428|69124726|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
37743403|NCT01799941|69231226|FG000|Overall Study|Withdrawal by Subject|21|||
37743404|NCT01799941|69231226|FG000|Overall Study|Death|2|||
37743405|NCT01799941|69231226|FG000|Overall Study|Investigator Decision|4|||
37743406|NCT01799941|69231226|FG000|Overall Study|Lack of Efficacy|3|||
37743407|NCT01799941|69231226|FG000|Overall Study|Lost to Follow-up|17|||
37743408|NCT01799941|69231226|FG000|Overall Study|Other|15|||
37743409|NCT01799239|69231254|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
37743410|NCT01799239|69231255|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
37743411|NCT01799239|69231254|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
37743412|NCT01799239|69231255|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
37743413|NCT01799239|69231254|FG000|Period 1 (7 Days)|Protocol Violation|0|||
37743414|NCT01799239|69231255|FG001|Period 1 (7 Days)|Protocol Violation|1|||
37743415|NCT01799239|69231254|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
37743416|NCT01799239|69231255|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
37654128|NCT02547428|69124727|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
37654129|NCT02547428|69124726|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
37654130|NCT02547428|69124727|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
37654131|NCT02547428|69124726|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
37654132|NCT02547428|69124727|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
37654133|NCT02547428|69124726|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
37654134|NCT02547428|69124727|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
37654135|NCT02547428|69124726|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
37654136|NCT02547428|69124727|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
37654137|NCT02547428|69124726|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
37654138|NCT02547428|69124727|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
37654139|NCT02547428|69124726|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
37654140|NCT02547428|69124727|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
37654141|NCT02547428|69124726|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
37654142|NCT02547428|69124727|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
37654143|NCT01374087|69124742|FG000|Overall Study|Adverse Event|1|||
37654144|NCT01374087|69124743|FG001|Overall Study|Adverse Event|0|||
37654145|NCT01374087|69124742|FG000|Overall Study|Disease progression|2|||
37654146|NCT01374087|69124743|FG001|Overall Study|Disease progression|2|||
37654147|NCT01374087|69124742|FG000|Overall Study|Study discontinued|13|||
37654148|NCT01374087|69124743|FG001|Overall Study|Study discontinued|13|||
37654149|NCT00152971|69124752|FG000|Overall Study|Adverse Event|12|||
37654150|NCT00152971|69124753|FG001|Overall Study|Adverse Event|10|||
37654151|NCT00152971|69124754|FG002|Overall Study|Adverse Event|9|||
37654152|NCT00152971|69124752|FG000|Overall Study|Protocol Violation|10|||
37654153|NCT00152971|69124753|FG001|Overall Study|Protocol Violation|11|||
37654154|NCT00152971|69124754|FG002|Overall Study|Protocol Violation|8|||
37654155|NCT00152971|69124752|FG000|Overall Study|Lost to Follow-up|17|||
37654156|NCT00152971|69124753|FG001|Overall Study|Lost to Follow-up|14|||
37654157|NCT00152971|69124754|FG002|Overall Study|Lost to Follow-up|13|||
37654158|NCT00152971|69124752|FG000|Overall Study|Withdrawal by Subject|9|||
37654159|NCT00152971|69124753|FG001|Overall Study|Withdrawal by Subject|8|||
37654160|NCT00152971|69124754|FG002|Overall Study|Withdrawal by Subject|14|||
37654161|NCT00152971|69124752|FG000|Overall Study|Other|3|||
37743417|NCT01799239|69231254|FG000|Period 2 (7 Days)|Protocol Violation|1|||
37743418|NCT01799239|69231255|FG001|Period 2 (7 Days)|Protocol Violation|0|||
37654162|NCT00152971|69124753|FG001|Overall Study|Other|5|||
37654163|NCT00152971|69124754|FG002|Overall Study|Other|5|||
37654164|NCT00152971|69124752|FG000|Treatment|Adverse Event|49|||
37654165|NCT00152971|69124753|FG001|Treatment|Adverse Event|40|||
37654166|NCT00152971|69124754|FG002|Treatment|Adverse Event|54|||
37654167|NCT00152971|69124752|FG000|Treatment|Protocol Violation|8|||
37855277|NCT01294592|69538536|FG001|Overall Study|Physician Decision|11|||
37743419|NCT02999854|69231271|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
37743420|NCT02999854|69231272|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
37654168|NCT00152971|69124753|FG001|Treatment|Protocol Violation|6|||
37654169|NCT00152971|69124754|FG002|Treatment|Protocol Violation|10|||
37654170|NCT00152971|69124752|FG000|Treatment|Lost to Follow-up|1|||
37654171|NCT00152971|69124753|FG001|Treatment|Lost to Follow-up|2|||
37654172|NCT00152971|69124754|FG002|Treatment|Lost to Follow-up|1|||
37654173|NCT00152971|69124752|FG000|Treatment|Withdrawal by Subject|4|||
37654174|NCT00152971|69124753|FG001|Treatment|Withdrawal by Subject|4|||
37654175|NCT00152971|69124754|FG002|Treatment|Withdrawal by Subject|5|||
37654176|NCT00152971|69124752|FG000|Treatment|Other|9|||
37654177|NCT00152971|69124753|FG001|Treatment|Other|11|||
37654178|NCT00152971|69124754|FG002|Treatment|Other|10|||
37654179|NCT02538614|69124762|FG000|Overall Study|Progressive Disease|2|||
37654180|NCT04620135|69124770|FG000|Study Completion|Adverse Event|2|||
37654181|NCT04620135|69124771|FG001|Study Completion|Adverse Event|3|||
37654182|NCT04620135|69124770|FG000|Study Completion|Withdrawal by Subject|2|||
37743421|NCT02999854|69231271|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
37743422|NCT02999854|69231272|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
37743423|NCT02999854|69231271|FG000|Active Study Phase (up to 18 Months)|Death|7|||
37743424|NCT02999854|69231272|FG001|Active Study Phase (up to 18 Months)|Death|5|||
37743425|NCT02999854|69231271|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
37743426|NCT02999854|69231272|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
37654183|NCT04620135|69124771|FG001|Study Completion|Withdrawal by Subject|0|||
37654184|NCT02552966|69124777|FG000|Overall Study|Lost to Follow-up|2|||
37654185|NCT02552966|69124777|FG000|Overall Study|Withdrawal by Subject|3|||
37654186|NCT02552888|69124783|FG000|Overall Study|Lost to Follow-up|1|||
37654187|NCT02552888|69124784|FG001|Overall Study|Lost to Follow-up|1|||
37654188|NCT01373931|69124803|FG000|Lead-in Period|Adverse Event|2|||
37654189|NCT01373931|69124804|FG001|Lead-in Period|Adverse Event|0|||
37654190|NCT01373931|69124803|FG000|Period 1|Adverse Event|2|||
37654191|NCT01373931|69124804|FG001|Period 1|Adverse Event|0|||
37654192|NCT01373931|69124803|FG000|Period 1|Withdrawal by Subject|0|||
37654193|NCT01373931|69124804|FG001|Period 1|Withdrawal by Subject|2|||
37654194|NCT02552732|69124811|FG000|Overall Study|Lost to Follow-up|2|||
37654195|NCT02552732|69124811|FG000|Overall Study|Physician Decision|1|||
37743427|NCT02999854|69231271|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
37743428|NCT02999854|69231272|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
37743429|NCT02999854|69231271|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
37743430|NCT02999854|69231272|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
37743431|NCT02999854|69231271|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
37743432|NCT02999854|69231272|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
37743433|NCT02999854|69231271|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
37743434|NCT02999854|69231272|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
37743435|NCT04146363|69231405|FG000|Induction Period|Adverse Event|1|||
37743436|NCT04146363|69231406|FG001|Induction Period|Adverse Event|2|||
37743437|NCT04146363|69231407|FG002|Induction Period|Adverse Event|0|||
37743438|NCT04146363|69231408|FG003|Induction Period|Adverse Event|0|||
37743439|NCT04146363|69231409|FG004|Induction Period|Adverse Event|0|||
37743440|NCT04146363|69231410|FG005|Induction Period|Adverse Event|0|||
37743441|NCT04146363|69231411|FG006|Induction Period|Adverse Event|0|||
37743442|NCT04146363|69231412|FG007|Induction Period|Adverse Event|0|||
37743443|NCT04146363|69231413|FG008|Induction Period|Adverse Event|0|||
37743444|NCT04146363|69231414|FG009|Induction Period|Adverse Event|0|||
37743445|NCT04146363|69231415|FG010|Induction Period|Adverse Event|0|||
37743446|NCT04146363|69231405|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
37743447|NCT04146363|69231406|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
37743448|NCT04146363|69231407|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
37743449|NCT04146363|69231408|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
37654196|NCT02552732|69124811|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
37654197|NCT02552732|69124811|FG000|Overall Study|Withdrawal by Subject|6|||
37743450|NCT04146363|69231409|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
37743451|NCT04146363|69231410|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
37743452|NCT04146363|69231411|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
37743453|NCT04146363|69231412|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
37743454|NCT04146363|69231413|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
37743455|NCT04146363|69231414|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
37743456|NCT04146363|69231415|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
37743457|NCT04146363|69231405|FG000|Induction Period|Lack of Efficacy|7|||
37654198|NCT02547038|69124818|FG000|Overall Study|Lost to Follow-up|3|||
37654199|NCT02547038|69124819|FG001|Overall Study|Lost to Follow-up|2|||
37654200|NCT02764697|69124825|FG000|Overall Study|Lack of Efficacy|3|||
37743458|NCT04146363|69231406|FG001|Induction Period|Lack of Efficacy|2|||
37743459|NCT04146363|69231407|FG002|Induction Period|Lack of Efficacy|0|||
37654201|NCT02673489|69124831|FG000|Treatment Period|Lost to Follow-up|3|||
37654202|NCT02673489|69124832|FG001|Treatment Period|Lost to Follow-up|0|||
37743460|NCT04146363|69231408|FG003|Induction Period|Lack of Efficacy|0|||
37743461|NCT04146363|69231409|FG004|Induction Period|Lack of Efficacy|0|||
37743462|NCT04146363|69231410|FG005|Induction Period|Lack of Efficacy|0|||
37743463|NCT04146363|69231411|FG006|Induction Period|Lack of Efficacy|0|||
37743464|NCT04146363|69231412|FG007|Induction Period|Lack of Efficacy|0|||
37743465|NCT04146363|69231413|FG008|Induction Period|Lack of Efficacy|0|||
37743466|NCT04146363|69231414|FG009|Induction Period|Lack of Efficacy|0|||
37743467|NCT04146363|69231415|FG010|Induction Period|Lack of Efficacy|0|||
37743468|NCT04146363|69231405|FG000|Induction Period|Lost to Follow-up|1|||
37743469|NCT04146363|69231406|FG001|Induction Period|Lost to Follow-up|4|||
37743470|NCT04146363|69231407|FG002|Induction Period|Lost to Follow-up|0|||
37743471|NCT04146363|69231408|FG003|Induction Period|Lost to Follow-up|0|||
37743472|NCT04146363|69231409|FG004|Induction Period|Lost to Follow-up|0|||
37743473|NCT04146363|69231410|FG005|Induction Period|Lost to Follow-up|0|||
37654203|NCT02673489|69124831|FG000|Treatment Period|Participant request to discontinue|1|||
37654204|NCT02673489|69124832|FG001|Treatment Period|Participant request to discontinue|1|||
37654205|NCT02673489|69124831|FG000|Treatment Period|Participant moved to another province|1|||
37654206|NCT02673489|69124832|FG001|Treatment Period|Participant moved to another province|0|||
37654207|NCT02673489|69124831|FG000|Treatment Period|Participant was incarcerated|0|||
37654208|NCT02673489|69124832|FG001|Treatment Period|Participant was incarcerated|1|||
37654209|NCT02673489|69124831|FG000|Treatment Period|Adverse Event|0|||
37654210|NCT02673489|69124832|FG001|Treatment Period|Adverse Event|1|||
37654211|NCT02673489|69124831|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
37654212|NCT02673489|69124832|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
37654213|NCT02673489|69124831|FG000|Follow Up Period|Unable to return for follow-up|0|||
37654214|NCT02673489|69124832|FG001|Follow Up Period|Unable to return for follow-up|1|||
37654215|NCT02772809|69124839|FG000|Overall Study|not completed some tasks|6|||
37654216|NCT02537678|69124850|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
37654217|NCT02537678|69124851|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
37654218|NCT02537678|69124850|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
37654219|NCT02537678|69124851|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
37654220|NCT02537678|69124850|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
37654221|NCT02537678|69124851|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
37654222|NCT02537678|69124850|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
37743474|NCT04146363|69231411|FG006|Induction Period|Lost to Follow-up|0|||
37743475|NCT04146363|69231412|FG007|Induction Period|Lost to Follow-up|0|||
37743476|NCT04146363|69231413|FG008|Induction Period|Lost to Follow-up|0|||
37743477|NCT04146363|69231414|FG009|Induction Period|Lost to Follow-up|0|||
37743478|NCT04146363|69231415|FG010|Induction Period|Lost to Follow-up|0|||
37743479|NCT04146363|69231405|FG000|Induction Period|Positive quantiferon test|0|||
37743480|NCT04146363|69231406|FG001|Induction Period|Positive quantiferon test|1|||
37743481|NCT04146363|69231407|FG002|Induction Period|Positive quantiferon test|0|||
37743482|NCT04146363|69231408|FG003|Induction Period|Positive quantiferon test|0|||
37743483|NCT04146363|69231409|FG004|Induction Period|Positive quantiferon test|0|||
37743484|NCT04146363|69231410|FG005|Induction Period|Positive quantiferon test|0|||
38032704|NCT02891174|69718641|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
37654223|NCT02537678|69124851|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
37654224|NCT02537678|69124850|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
37654225|NCT02537678|69124851|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
37654226|NCT02537678|69124850|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
37654227|NCT02537678|69124851|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
37654228|NCT02537678|69124850|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
37654229|NCT02537678|69124851|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
37654230|NCT02766023|69124863|FG000|Overall Study|Lost to Follow-up|23|||
37654231|NCT02766023|69124864|FG001|Overall Study|Lost to Follow-up|11|||
37654232|NCT02766023|69124863|FG000|Overall Study|Pregnancy|1|||
37654233|NCT02766023|69124864|FG001|Overall Study|Pregnancy|0|||
37654234|NCT02766023|69124863|FG000|Overall Study|Adverse Event|1|||
37654235|NCT02766023|69124864|FG001|Overall Study|Adverse Event|0|||
37654236|NCT02766023|69124863|FG000|Overall Study|Withdrawal by Subject|4|||
37743485|NCT04146363|69231411|FG006|Induction Period|Positive quantiferon test|0|||
37743486|NCT04146363|69231412|FG007|Induction Period|Positive quantiferon test|0|||
37743487|NCT04146363|69231413|FG008|Induction Period|Positive quantiferon test|0|||
37743488|NCT04146363|69231414|FG009|Induction Period|Positive quantiferon test|0|||
37743489|NCT04146363|69231415|FG010|Induction Period|Positive quantiferon test|0|||
37743490|NCT04146363|69231405|FG000|Induction Period|Protocol Deviation|5|||
38032705|NCT02891174|69718640|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
38032706|NCT02891174|69718641|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
38032707|NCT02891174|69718640|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
37743491|NCT04146363|69231406|FG001|Induction Period|Protocol Deviation|6|||
38032708|NCT02891174|69718641|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
38032709|NCT02891174|69718640|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
38032710|NCT02891174|69718641|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
38032711|NCT02891174|69718640|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
38032712|NCT02891174|69718641|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
38032713|NCT01751984|69718662|FG000|Overall Study|Adverse Event|5|||
38032714|NCT01751984|69718663|FG001|Overall Study|Adverse Event|3|||
38032715|NCT01751984|69718662|FG000|Overall Study|Withdrawal by Subject|0|||
38032716|NCT01751984|69718663|FG001|Overall Study|Withdrawal by Subject|1|||
38032717|NCT01751984|69718662|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
37855278|NCT01294592|69538535|FG000|Overall Study|Withdrawal by Subject|28|||
37855279|NCT01294592|69538536|FG001|Overall Study|Withdrawal by Subject|28|||
37855280|NCT00997243|69538545|FG000|Overall Study|Early termination of study by sponsor|7|||
37855281|NCT01294514|69538549|FG000|Overall Study|Excluded due to Arrhythmia|1|||
37855282|NCT00999661|69538557|FG000|Overall Study|Lost to Follow-up|59|||
37855283|NCT00999661|69538557|FG000|Overall Study|Adverse Event|1|||
38032718|NCT01751984|69718663|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
38032719|NCT03330236|69718671|FG000|Overall Study|Death|2|||
38032720|NCT03330236|69718672|FG001|Overall Study|Death|1|||
38032721|NCT03330236|69718671|FG000|Overall Study|Withdrawal by Subject|2|||
38032722|NCT03330236|69718672|FG001|Overall Study|Withdrawal by Subject|4|||
38032723|NCT03330236|69718671|FG000|Overall Study|Lost to Follow-up|0|||
38032724|NCT03330236|69718672|FG001|Overall Study|Lost to Follow-up|2|||
38032725|NCT03330236|69718671|FG000|Overall Study|Physician Decision|2|||
38032726|NCT03330236|69718672|FG001|Overall Study|Physician Decision|0|||
38032727|NCT03330236|69718671|FG000|Overall Study|Protocol Violation|4|||
38032728|NCT03330236|69718672|FG001|Overall Study|Protocol Violation|3|||
38032729|NCT03330236|69718671|FG000|Overall Study|SedLine malfunction/blinding|19|||
38032730|NCT03330236|69718672|FG001|Overall Study|SedLine malfunction/blinding|14|||
38032731|NCT03330236|69718671|FG000|Overall Study|Volatile anesthetics used|11|||
37654237|NCT02766023|69124864|FG001|Overall Study|Withdrawal by Subject|5|||
37654238|NCT02766023|69124863|FG000|Overall Study|Physician Decision|1|||
37654239|NCT02766023|69124864|FG001|Overall Study|Physician Decision|0|||
37654240|NCT02766023|69124863|FG000|Overall Study|Not Eligible at Enrollment|0|||
37654241|NCT02766023|69124864|FG001|Overall Study|Not Eligible at Enrollment|1|||
37654242|NCT02764229|69124870|FG000|Overall Study|Withdrawal by Subject|15|||
37654243|NCT02764229|69124870|FG000|Overall Study|Adverse Event|9|||
37654244|NCT02764229|69124870|FG000|Overall Study|Physician Decision|5|||
37654245|NCT02764229|69124870|FG000|Overall Study|Lost to Follow-up|3|||
37654246|NCT02764229|69124870|FG000|Overall Study|Lack of Efficacy|1|||
37654247|NCT02764229|69124870|FG000|Overall Study|Study Stopped by Sponsor|69|||
37654248|NCT02537522|69124874|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
37654249|NCT02537522|69124875|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
37654250|NCT02537522|69124876|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
37654251|NCT02537522|69124877|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
37654252|NCT02537522|69124874|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
37654253|NCT02537522|69124875|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
37654254|NCT02537522|69124876|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
37654255|NCT02537522|69124877|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
37654256|NCT02537522|69124874|FG000|Phase I - Contralateral|incorrect randomization|0|||
37654257|NCT02537522|69124875|FG001|Phase I - Contralateral|incorrect randomization|1|||
37654258|NCT02537522|69124876|FG002|Phase I - Contralateral|incorrect randomization|0|||
37654259|NCT02537522|69124877|FG003|Phase I - Contralateral|incorrect randomization|0|||
37654260|NCT02537522|69124874|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
37654261|NCT02537522|69124875|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
37654262|NCT02537522|69124876|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
37654263|NCT02537522|69124877|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
37654264|NCT02537522|69124874|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
37654265|NCT02537522|69124875|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
37654266|NCT02537522|69124876|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
37654267|NCT02537522|69124877|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
37654268|NCT02536976|69124885|FG000|Overall Study|Physician Decision|0|||
37654269|NCT02536976|69124886|FG001|Overall Study|Physician Decision|1|||
37654270|NCT02672553|69124896|FG000|Overall Study|Death|3|||
37654271|NCT02672553|69124897|FG001|Overall Study|Death|5|||
38032732|NCT03330236|69718672|FG001|Overall Study|Volatile anesthetics used|8|||
38032733|NCT03330236|69718671|FG000|Overall Study|Surgery aborted/converted to open|60|||
38032734|NCT03330236|69718672|FG001|Overall Study|Surgery aborted/converted to open|52|||
38032735|NCT03330002|69718678|FG000|Overall Study|Lost to Follow-up|15|||
37654272|NCT02672553|69124896|FG000|Overall Study|Valve Explant|1|||
37654273|NCT02672553|69124897|FG001|Overall Study|Valve Explant|0|||
37855284|NCT00999661|69538557|FG000|Overall Study|Withdrawal by Subject|1|||
37855285|NCT00999661|69538557|FG000|Overall Study|Not meeting eligibility criteria|9|||
38032736|NCT03330002|69718678|FG000|Overall Study|Death|7|||
37743492|NCT04146363|69231407|FG002|Induction Period|Protocol Deviation|0|||
37743493|NCT04146363|69231408|FG003|Induction Period|Protocol Deviation|0|||
37743494|NCT04146363|69231409|FG004|Induction Period|Protocol Deviation|0|||
37743495|NCT04146363|69231410|FG005|Induction Period|Protocol Deviation|0|||
37743496|NCT04146363|69231411|FG006|Induction Period|Protocol Deviation|0|||
37743497|NCT04146363|69231412|FG007|Induction Period|Protocol Deviation|0|||
37743498|NCT04146363|69231413|FG008|Induction Period|Protocol Deviation|0|||
37743499|NCT04146363|69231414|FG009|Induction Period|Protocol Deviation|0|||
37743500|NCT04146363|69231415|FG010|Induction Period|Protocol Deviation|0|||
37743501|NCT04146363|69231405|FG000|Induction Period|Withdrawal by Subject|6|||
37743502|NCT04146363|69231406|FG001|Induction Period|Withdrawal by Subject|3|||
37743503|NCT04146363|69231407|FG002|Induction Period|Withdrawal by Subject|0|||
37743504|NCT04146363|69231408|FG003|Induction Period|Withdrawal by Subject|0|||
37743505|NCT04146363|69231409|FG004|Induction Period|Withdrawal by Subject|0|||
37743506|NCT04146363|69231410|FG005|Induction Period|Withdrawal by Subject|0|||
37743507|NCT04146363|69231411|FG006|Induction Period|Withdrawal by Subject|0|||
37743508|NCT04146363|69231412|FG007|Induction Period|Withdrawal by Subject|0|||
37654274|NCT02672553|69124896|FG000|Overall Study|Conversion to Commercial Valve|3|||
37654275|NCT02672553|69124897|FG001|Overall Study|Conversion to Commercial Valve|0|||
37654276|NCT02672553|69124896|FG000|Overall Study|Withdrawal by Subject|3|||
37654277|NCT02672553|69124897|FG001|Overall Study|Withdrawal by Subject|3|||
37654278|NCT02672553|69124896|FG000|Overall Study|Intraoperative screen failure|2|||
37654279|NCT02672553|69124897|FG001|Overall Study|Intraoperative screen failure|0|||
37654280|NCT01373229|69124904|FG000|Overall Study|Death|3|||
37654281|NCT01373229|69124904|FG000|Overall Study|Physician Decision|3|||
37654282|NCT02671461|69124911|FG000|Treatment|Adverse Event|0|||
37654283|NCT02671461|69124912|FG001|Treatment|Adverse Event|0|||
37743509|NCT04146363|69231413|FG008|Induction Period|Withdrawal by Subject|0|||
37743510|NCT04146363|69231414|FG009|Induction Period|Withdrawal by Subject|0|||
37743511|NCT04146363|69231415|FG010|Induction Period|Withdrawal by Subject|0|||
37743512|NCT04146363|69231405|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
37743513|NCT04146363|69231406|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
37743514|NCT04146363|69231407|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
37743515|NCT04146363|69231408|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
37743516|NCT04146363|69231409|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
37743517|NCT04146363|69231410|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
37743518|NCT04146363|69231411|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
37743519|NCT04146363|69231412|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
37743520|NCT04146363|69231413|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
37743521|NCT04146363|69231414|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
37743522|NCT04146363|69231415|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
37743523|NCT04146363|69231405|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
37743524|NCT04146363|69231406|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
37743525|NCT04146363|69231407|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
37743526|NCT04146363|69231408|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
37743527|NCT04146363|69231409|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
37743528|NCT04146363|69231410|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
37743529|NCT04146363|69231411|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
37743530|NCT04146363|69231412|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
37743531|NCT04146363|69231413|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
37743532|NCT04146363|69231414|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
37743533|NCT04146363|69231415|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
37743534|NCT04146363|69231405|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
37743535|NCT04146363|69231406|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
37743536|NCT04146363|69231407|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
37743537|NCT04146363|69231408|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
37743538|NCT04146363|69231409|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
37743539|NCT04146363|69231410|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
37743540|NCT04146363|69231411|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
37743541|NCT04146363|69231412|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
37654284|NCT02671461|69124913|FG002|Treatment|Adverse Event|1|||
37654285|NCT02671461|69124911|FG000|Treatment|Administrative Reason by Sponsor|1|||
37743542|NCT04146363|69231413|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
37743543|NCT04146363|69231414|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
37855286|NCT01294436|69538563|FG000|Overall Study|Adverse Event|10|||
37654286|NCT02671461|69124912|FG001|Treatment|Administrative Reason by Sponsor|3|||
37654287|NCT02671461|69124913|FG002|Treatment|Administrative Reason by Sponsor|4|||
37654288|NCT02671461|69124911|FG000|Treatment|Randomized, not treated|1|||
37654289|NCT02671461|69124912|FG001|Treatment|Randomized, not treated|0|||
37654290|NCT02671461|69124913|FG002|Treatment|Randomized, not treated|0|||
37654291|NCT02671461|69124911|FG000|Follow-up|Withdrawal by Subject|1|||
37654292|NCT02671461|69124912|FG001|Follow-up|Withdrawal by Subject|0|||
37654293|NCT02671461|69124913|FG002|Follow-up|Withdrawal by Subject|0|||
37654294|NCT02671461|69124911|FG000|Follow-up|Lost to Follow-up|0|||
37654295|NCT02671461|69124912|FG001|Follow-up|Lost to Follow-up|0|||
37654296|NCT02671461|69124913|FG002|Follow-up|Lost to Follow-up|1|||
37654297|NCT02671461|69124911|FG000|Follow-up|Administrative Reason by Sponsor|0|||
37743544|NCT04146363|69231415|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
37743545|NCT04146363|69231405|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
37743546|NCT04146363|69231406|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
37743547|NCT04146363|69231407|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
37654298|NCT02671461|69124912|FG001|Follow-up|Administrative Reason by Sponsor|1|||
37654299|NCT02671461|69124913|FG002|Follow-up|Administrative Reason by Sponsor|0|||
37654300|NCT02535416|69124930|FG000|Overall Study|Family bereavement overseas|1|||
37654301|NCT02535416|69124931|FG001|Overall Study|Family bereavement overseas|0|||
37654302|NCT02535416|69124932|FG002|Overall Study|Family bereavement overseas|0|||
37654303|NCT02535416|69124933|FG003|Overall Study|Family bereavement overseas|0|||
37654304|NCT02535416|69124934|FG004|Overall Study|Family bereavement overseas|0|||
37654305|NCT02535416|69124935|FG005|Overall Study|Family bereavement overseas|0|||
37654306|NCT02535416|69124936|FG006|Overall Study|Family bereavement overseas|0|||
37654307|NCT02535416|69124937|FG007|Overall Study|Family bereavement overseas|0|||
37743548|NCT04146363|69231408|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
37743549|NCT04146363|69231409|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
37743550|NCT04146363|69231410|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
37743551|NCT04146363|69231411|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
37743552|NCT04146363|69231412|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
37743553|NCT04146363|69231413|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
37743554|NCT04146363|69231414|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
37743555|NCT04146363|69231415|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
37743556|NCT04146363|69231405|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
37743557|NCT04146363|69231406|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
37743558|NCT04146363|69231407|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
37743559|NCT04146363|69231408|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
37743560|NCT04146363|69231409|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
37743561|NCT04146363|69231410|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
37743562|NCT04146363|69231411|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
37743563|NCT04146363|69231412|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
37743564|NCT04146363|69231413|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
37743565|NCT04146363|69231414|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
37743566|NCT04146363|69231415|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
37743567|NCT04146363|69231405|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
37743568|NCT04146363|69231406|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
37743569|NCT04146363|69231407|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
37743570|NCT04146363|69231408|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
37743571|NCT04146363|69231409|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
37743572|NCT04146363|69231410|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
37743573|NCT04146363|69231411|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
37743574|NCT04146363|69231412|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
37743575|NCT04146363|69231413|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
37743576|NCT04146363|69231414|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
37743577|NCT04146363|69231415|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
37743578|NCT04146363|69231405|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
37743579|NCT04146363|69231406|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
37743580|NCT04146363|69231407|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
37743581|NCT04146363|69231408|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
37743582|NCT04146363|69231409|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
37743583|NCT04146363|69231410|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
37743584|NCT04146363|69231411|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
37743585|NCT04146363|69231412|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
37743586|NCT04146363|69231413|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
37743587|NCT04146363|69231414|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
37922720|NCT00814320|69609506|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
37654308|NCT02535416|69124938|FG008|Overall Study|Family bereavement overseas|0|||
37654309|NCT02670915|69124988|FG000|Overall Study|Withdrawal by Subject|0|||
37654310|NCT02670915|69124989|FG001|Overall Study|Withdrawal by Subject|1|||
37922721|NCT00814320|69609505|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
37654311|NCT02670915|69124990|FG002|Overall Study|Withdrawal by Subject|4|||
37654312|NCT02670915|69124988|FG000|Overall Study|Withdrawal by parent/guardian|4|||
37654313|NCT02670915|69124989|FG001|Overall Study|Withdrawal by parent/guardian|4|||
37743588|NCT04146363|69231415|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
37743589|NCT04146363|69231405|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
37743590|NCT04146363|69231406|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
37743591|NCT04146363|69231407|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
37743592|NCT04146363|69231408|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
37743593|NCT04146363|69231409|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
37743594|NCT04146363|69231410|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
37743595|NCT04146363|69231411|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
37743596|NCT04146363|69231412|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
37743597|NCT04146363|69231413|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
37743598|NCT04146363|69231414|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
37743599|NCT04146363|69231415|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
37743600|NCT04146363|69231405|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
37743601|NCT04146363|69231406|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
37743602|NCT04146363|69231407|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
37743603|NCT04146363|69231408|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
37743604|NCT04146363|69231409|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
37743605|NCT04146363|69231410|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
37743606|NCT04146363|69231411|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
37743607|NCT04146363|69231412|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
37743608|NCT04146363|69231413|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
37743609|NCT04146363|69231414|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
37743610|NCT04146363|69231415|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
37743611|NCT04146363|69231405|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
37743612|NCT04146363|69231406|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
37743613|NCT04146363|69231407|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
37743614|NCT04146363|69231408|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
37743615|NCT04146363|69231409|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
37743616|NCT04146363|69231410|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
37743617|NCT04146363|69231411|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
37743618|NCT04146363|69231412|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
37743619|NCT04146363|69231413|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
37743620|NCT04146363|69231414|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
37743621|NCT04146363|69231415|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
37743622|NCT04146363|69231405|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
37743623|NCT04146363|69231406|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
37743624|NCT04146363|69231407|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
37855287|NCT01294436|69538564|FG001|Overall Study|Adverse Event|17|||
37855288|NCT01294436|69538563|FG000|Overall Study|Withdrawal by Subject|11|||
37855289|NCT01294436|69538564|FG001|Overall Study|Withdrawal by Subject|28|||
37654314|NCT02670915|69124990|FG002|Overall Study|Withdrawal by parent/guardian|1|||
37654315|NCT02670915|69124988|FG000|Overall Study|Unclassified|0|||
37654316|NCT02670915|69124989|FG001|Overall Study|Unclassified|3|||
37654317|NCT02670915|69124990|FG002|Overall Study|Unclassified|0|||
37654318|NCT02545868|69125001|FG000|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|33|||
37654319|NCT02545868|69125002|FG001|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|35|||
37654320|NCT02545868|69125003|FG002|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|34|||
37654321|NCT02764151|69125020|FG000|Overall Study|Subject refused further follow-up|0|||
37654322|NCT02764151|69125021|FG001|Overall Study|Subject refused further follow-up|0|||
37654323|NCT02764151|69125022|FG002|Overall Study|Subject refused further follow-up|0|||
37654324|NCT02764151|69125023|FG003|Overall Study|Subject refused further follow-up|1|||
37654325|NCT02764151|69125020|FG000|Overall Study|Other|0|||
37654326|NCT02764151|69125021|FG001|Overall Study|Other|0|||
37654327|NCT02764151|69125022|FG002|Overall Study|Other|0|||
37654328|NCT02764151|69125023|FG003|Overall Study|Other|2|||
37654329|NCT02545322|69125033|FG000|Overall Study|Withdrawal by Subject|3|||
37654330|NCT02763215|69125037|FG000|Overall Study|Participants withdrew from study|3|||
37654331|NCT02763215|69125037|FG000|Overall Study|Missed visit|1|||
37654332|NCT02763215|69125037|FG000|Overall Study|Visit outside visit-window|1|||
37654333|NCT02763215|69125037|FG000|Overall Study|Death|1|||
37654334|NCT02763215|69125037|FG000|Overall Study|Lost to Follow-up|1|||
37654335|NCT02770547|69125056|FG000|Overall Study|Patient non-compliant|1|||
37654336|NCT02770547|69125057|FG001|Overall Study|Patient non-compliant|0|||
37654337|NCT02770547|69125056|FG000|Overall Study|Adverse Event|0|||
37654338|NCT02770547|69125057|FG001|Overall Study|Adverse Event|1|||
37654339|NCT01661972|69125065|FG000|Overall Study|Adverse Event|1|||
37654340|NCT01661972|69125066|FG001|Overall Study|Adverse Event|2|||
37654341|NCT01661972|69125065|FG000|Overall Study|Death during Treatment period|1|||
37654342|NCT01661972|69125066|FG001|Overall Study|Death during Treatment period|1|||
37654343|NCT01661972|69125065|FG000|Overall Study|Withdrawal by Subject|0|||
37654344|NCT01661972|69125066|FG001|Overall Study|Withdrawal by Subject|1|||
37654345|NCT00888355|69125078|FG000|Overall Study|Adverse Event|10|||
37654346|NCT00888355|69125079|FG001|Overall Study|Adverse Event|0|||
37654347|NCT00888355|69125080|FG002|Overall Study|Adverse Event|3|||
37654348|NCT00888355|69125081|FG003|Overall Study|Adverse Event|3|||
37654349|NCT00888355|69125078|FG000|Overall Study|Lack of Efficacy|9|||
37654350|NCT00888355|69125079|FG001|Overall Study|Lack of Efficacy|2|||
37654351|NCT00888355|69125080|FG002|Overall Study|Lack of Efficacy|5|||
37654352|NCT00888355|69125081|FG003|Overall Study|Lack of Efficacy|2|||
37654353|NCT00888355|69125078|FG000|Overall Study|Lost to Follow-up|0|||
37654354|NCT00888355|69125079|FG001|Overall Study|Lost to Follow-up|2|||
37654355|NCT00888355|69125080|FG002|Overall Study|Lost to Follow-up|2|||
37654356|NCT00888355|69125081|FG003|Overall Study|Lost to Follow-up|0|||
37654357|NCT00888355|69125078|FG000|Overall Study|Protocol Violation|3|||
37654358|NCT00888355|69125079|FG001|Overall Study|Protocol Violation|2|||
37654359|NCT00888355|69125080|FG002|Overall Study|Protocol Violation|1|||
37654360|NCT00888355|69125081|FG003|Overall Study|Protocol Violation|2|||
37654361|NCT00888355|69125078|FG000|Overall Study|Withdrawal by Subject|0|||
37654362|NCT00888355|69125079|FG001|Overall Study|Withdrawal by Subject|3|||
37654363|NCT00888355|69125080|FG002|Overall Study|Withdrawal by Subject|1|||
37654364|NCT00888355|69125081|FG003|Overall Study|Withdrawal by Subject|3|||
37654365|NCT00794677|69125089|FG000|First Intervention|Withdrawal by Subject|2|||
37654366|NCT00794677|69125090|FG001|First Intervention|Withdrawal by Subject|0|||
37654367|NCT02770391|69125094|FG000|Overall Study|Lost to Follow-up|2|||
37654368|NCT02770391|69125094|FG000|Overall Study|Withdrawal by Subject|1|||
37654369|NCT02770391|69125094|FG000|Overall Study|Surgery delayed unevaluable|2|||
37654370|NCT02770391|69125094|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
37654371|NCT02536508|69125101|FG000|Overall Study|Withdrawal by Subject|18|||
37654372|NCT02536508|69125102|FG001|Overall Study|Withdrawal by Subject|13|||
37654373|NCT02536508|69125103|FG002|Overall Study|Withdrawal by Subject|7|||
37654374|NCT02536508|69125101|FG000|Overall Study|Adverse Event|14|||
37654375|NCT02536508|69125102|FG001|Overall Study|Adverse Event|13|||
37654376|NCT02536508|69125103|FG002|Overall Study|Adverse Event|6|||
37654377|NCT02536508|69125101|FG000|Overall Study|Lost to Follow-up|12|||
37654378|NCT02536508|69125102|FG001|Overall Study|Lost to Follow-up|4|||
37654379|NCT02536508|69125103|FG002|Overall Study|Lost to Follow-up|0|||
37743625|NCT04146363|69231408|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
37743626|NCT04146363|69231409|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
37743627|NCT04146363|69231410|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
37743628|NCT04146363|69231411|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
37743629|NCT04146363|69231412|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
37743630|NCT04146363|69231413|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
37743631|NCT04146363|69231414|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
37743632|NCT04146363|69231415|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
37743633|NCT04146363|69231405|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
37743634|NCT04146363|69231406|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
37743635|NCT04146363|69231407|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
37743636|NCT04146363|69231408|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
37743637|NCT04146363|69231409|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
37743638|NCT04146363|69231410|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
37743639|NCT04146363|69231411|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
37743640|NCT04146363|69231412|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
37743641|NCT04146363|69231413|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
37743642|NCT04146363|69231414|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
37743643|NCT04146363|69231415|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
37743644|NCT04146363|69231405|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
37743645|NCT04146363|69231406|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
37743646|NCT04146363|69231407|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
37743647|NCT04146363|69231408|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
37743648|NCT04146363|69231409|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
37743649|NCT04146363|69231410|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
37743650|NCT04146363|69231411|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
37743651|NCT04146363|69231412|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
37743652|NCT04146363|69231413|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
37743653|NCT04146363|69231414|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
37743654|NCT04146363|69231415|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
37743655|NCT01838941|69231440|FG000|Overall Study|Adverse Event|1|||
37654380|NCT02536508|69125101|FG000|Overall Study|Lack of Efficacy|3|||
37743656|NCT01838941|69231440|FG000|Overall Study|Withdrawal by Subject|1|||
37654381|NCT02536508|69125102|FG001|Overall Study|Lack of Efficacy|5|||
37654382|NCT02536508|69125103|FG002|Overall Study|Lack of Efficacy|4|||
37654383|NCT02536508|69125101|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
37654384|NCT02536508|69125102|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
37743657|NCT01773109|69231445|FG000|Overall Study|Symptomatic Progression|2|||
37743658|NCT01773109|69231445|FG000|Overall Study|Death|1|||
37654385|NCT02536508|69125103|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
37654386|NCT02536508|69125101|FG000|Overall Study|Physician Decision|0|||
37654387|NCT02536508|69125102|FG001|Overall Study|Physician Decision|4|||
37654388|NCT02536508|69125103|FG002|Overall Study|Physician Decision|2|||
37654389|NCT02536508|69125101|FG000|Overall Study|Major Protocol Deviation|2|||
37654390|NCT02536508|69125102|FG001|Overall Study|Major Protocol Deviation|2|||
37654391|NCT02536508|69125103|FG002|Overall Study|Major Protocol Deviation|2|||
37654392|NCT02536508|69125101|FG000|Overall Study|Administrative Reasons|0|||
37654393|NCT02536508|69125102|FG001|Overall Study|Administrative Reasons|1|||
37654394|NCT02536508|69125103|FG002|Overall Study|Administrative Reasons|0|||
37654395|NCT00103259|69125120|FG000|Overall Study|Death|3|||
37654396|NCT00103259|69125121|FG001|Overall Study|Death|2|||
37654397|NCT00103259|69125120|FG000|Overall Study|Withdrawal by Subject|2|||
37654398|NCT00103259|69125121|FG001|Overall Study|Withdrawal by Subject|3|||
37743659|NCT01772719|69231449|FG000|Overall Study|Withdrawal by Subject|3|||
37743660|NCT01772719|69231449|FG000|Overall Study|Adverse Event|2|||
37654399|NCT00103259|69125120|FG000|Overall Study|alternative therapy|1|||
37743661|NCT01772719|69231449|FG000|Overall Study|Protocol Violation|1|||
37743662|NCT01772719|69231449|FG000|Overall Study|Lost to Follow-up|1|||
37743663|NCT01798927|69231456|FG000|Overall Study|Withdrawal by Subject|1|||
37743664|NCT01276288|69231525|FG000|Overall Study|Adverse Event|1|||
37743665|NCT01276288|69231526|FG001|Overall Study|Adverse Event|1|||
37743666|NCT01276288|69231527|FG002|Overall Study|Adverse Event|0|||
37743667|NCT01276288|69231528|FG003|Overall Study|Adverse Event|0|||
37654400|NCT00103259|69125121|FG001|Overall Study|alternative therapy|0|||
37654401|NCT00103259|69125120|FG000|Overall Study|other (reasons were not specified)|2|||
37743668|NCT01276288|69231525|FG000|Overall Study|not treated|1|||
37743669|NCT01276288|69231526|FG001|Overall Study|not treated|0|||
37743670|NCT01276288|69231527|FG002|Overall Study|not treated|0|||
37743671|NCT01276288|69231528|FG003|Overall Study|not treated|0|||
37743672|NCT02702271|69231552|FG000|Overall Study|Death|36|||
37743673|NCT02702271|69231553|FG001|Overall Study|Death|7|||
37743674|NCT02702271|69231552|FG000|Overall Study|Lost to Follow-up|12|||
37743675|NCT02702271|69231553|FG001|Overall Study|Lost to Follow-up|0|||
37743676|NCT02702271|69231552|FG000|Overall Study|Withdrawal by Subject|8|||
37743677|NCT02702271|69231553|FG001|Overall Study|Withdrawal by Subject|1|||
37743678|NCT02702271|69231552|FG000|Overall Study|Physician Decision|2|||
37743679|NCT02702271|69231553|FG001|Overall Study|Physician Decision|0|||
37743680|NCT02702271|69231552|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
37743681|NCT02702271|69231553|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
37743682|NCT01276054|69231638|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
37743683|NCT01276054|69231639|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
37743684|NCT01798849|69231648|FG000|Overall Study|Physician Decision|0|||
37743685|NCT01798849|69231649|FG001|Overall Study|Physician Decision|0|||
37743686|NCT01798849|69231650|FG002|Overall Study|Physician Decision|1|||
37743687|NCT01797835|69231730|FG000|Overall Study|Lost to Follow-up|31|||
37743688|NCT01797835|69231731|FG001|Overall Study|Lost to Follow-up|27|||
37855290|NCT01294436|69538563|FG000|Overall Study|subject no longer meets study criteria|5|||
37855291|NCT01294436|69538564|FG001|Overall Study|subject no longer meets study criteria|20|||
37855292|NCT01294436|69538563|FG000|Overall Study|poor/non-compliance|2|||
37654402|NCT00103259|69125121|FG001|Overall Study|other (reasons were not specified)|1|||
37654403|NCT00103259|69125120|FG000|Overall Study|ineligible/no protocol therapy|4|||
37654404|NCT00103259|69125121|FG001|Overall Study|ineligible/no protocol therapy|6|||
37654405|NCT02544152|69125131|FG000|Overall Study|Adverse Event|0|||
37654406|NCT02544152|69125132|FG001|Overall Study|Adverse Event|4|||
37654407|NCT02544152|69125131|FG000|Overall Study|Withdrawal by Subject|0|||
37654408|NCT02544152|69125132|FG001|Overall Study|Withdrawal by Subject|3|||
37654409|NCT02544152|69125131|FG000|Overall Study|Other|1|||
37654410|NCT02544152|69125132|FG001|Overall Study|Other|0|||
37654411|NCT02534324|69125140|FG000|Overall Study|Protocol Violation|4|||
37654412|NCT02534324|69125141|FG001|Overall Study|Protocol Violation|1|||
37855293|NCT01294436|69538564|FG001|Overall Study|poor/non-compliance|5|||
37855294|NCT00995371|69538572|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
37855295|NCT00995371|69538573|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
37855296|NCT01294358|69538581|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
37855297|NCT01294358|69538582|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
38032737|NCT02948582|69718682|FG000|Washout Period 1|Adverse Event|0|||
37654413|NCT02534324|69125140|FG000|Overall Study|Lost to Follow-up|20|||
37654414|NCT02534324|69125141|FG001|Overall Study|Lost to Follow-up|7|||
37654415|NCT02534324|69125140|FG000|Overall Study|Adverse Event|1|||
37743689|NCT01275430|69231737|FG000|Overall Study|Adverse Event|1|||
37743690|NCT01275430|69231737|FG000|Overall Study|No Contrast Injection|6|||
37743691|NCT01275430|69231737|FG000|Overall Study|Device Malfunction|1|||
37743692|NCT01275430|69231737|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
37743693|NCT01838551|69231742|FG000|Overall Study|Adverse Event|16|||
37743694|NCT01838551|69231742|FG000|Overall Study|Death|1|||
37654416|NCT02534324|69125141|FG001|Overall Study|Adverse Event|0|||
37743695|NCT01838551|69231742|FG000|Overall Study|Lack of Efficacy|10|||
37743696|NCT01838551|69231742|FG000|Overall Study|Physician Decision|4|||
37654417|NCT02761733|69125151|FG000|Overall Study|Death|3|||
37743697|NCT01838551|69231742|FG000|Overall Study|Withdrawal by Subject|10|||
37743698|NCT01838551|69231742|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
37654418|NCT02761733|69125152|FG001|Overall Study|Death|5|||
37654419|NCT02761733|69125153|FG002|Overall Study|Death|1|||
37654420|NCT02761733|69125154|FG003|Overall Study|Death|1|||
37743699|NCT01797445|69231748|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
37743700|NCT01797445|69231749|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
37743701|NCT01797445|69231748|FG000|Double-Blind Phase|Adverse Event|3|||
37743702|NCT01797445|69231749|FG001|Double-Blind Phase|Adverse Event|0|||
37743703|NCT01797445|69231748|FG000|Double-Blind Phase|Death|5|||
37743704|NCT01797445|69231749|FG001|Double-Blind Phase|Death|4|||
37743705|NCT01797445|69231748|FG000|Double-Blind Phase|Pregnancy|0|||
37743706|NCT01797445|69231749|FG001|Double-Blind Phase|Pregnancy|1|||
37743707|NCT01797445|69231748|FG000|Double-Blind Phase|Lack of Efficacy|1|||
37654421|NCT02761733|69125151|FG000|Overall Study|Lost to Follow-up|6|||
37654422|NCT02761733|69125152|FG001|Overall Study|Lost to Follow-up|7|||
37654423|NCT02761733|69125153|FG002|Overall Study|Lost to Follow-up|0|||
37654424|NCT02761733|69125154|FG003|Overall Study|Lost to Follow-up|3|||
37654425|NCT02761733|69125151|FG000|Overall Study|Physician Decision|4|||
37654426|NCT02761733|69125152|FG001|Overall Study|Physician Decision|0|||
37654427|NCT02761733|69125153|FG002|Overall Study|Physician Decision|0|||
37654428|NCT02761733|69125154|FG003|Overall Study|Physician Decision|0|||
37654429|NCT02761733|69125151|FG000|Overall Study|Withdrawal by Subject|2|||
37654430|NCT02761733|69125152|FG001|Overall Study|Withdrawal by Subject|0|||
37743708|NCT01797445|69231749|FG001|Double-Blind Phase|Lack of Efficacy|2|||
37743709|NCT01797445|69231748|FG000|Double-Blind Phase|Investigator's Discretion|15|||
37743710|NCT01797445|69231749|FG001|Double-Blind Phase|Investigator's Discretion|17|||
37743711|NCT01797445|69231748|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
37743712|NCT01797445|69231749|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
37743713|NCT01797445|69231748|FG000|Double-Blind Phase|Protocol Violation|0|||
37743714|NCT01797445|69231749|FG001|Double-Blind Phase|Protocol Violation|1|||
37743715|NCT01797445|69231748|FG000|Double-Blind Phase|Withdrew Consent|20|||
37743716|NCT01797445|69231749|FG001|Double-Blind Phase|Withdrew Consent|35|||
37743717|NCT01797445|69231748|FG000|Double-Blind Phase|Lost to Follow-up|34|||
37743718|NCT01797445|69231749|FG001|Double-Blind Phase|Lost to Follow-up|26|||
37743719|NCT01797445|69231748|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
37743720|NCT01797445|69231749|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
37654431|NCT02761733|69125153|FG002|Overall Study|Withdrawal by Subject|0|||
37654432|NCT02761733|69125154|FG003|Overall Study|Withdrawal by Subject|0|||
37654433|NCT02761733|69125151|FG000|Overall Study|Discharged from Study Site|10|||
37654434|NCT02761733|69125152|FG001|Overall Study|Discharged from Study Site|9|||
37654435|NCT02761733|69125153|FG002|Overall Study|Discharged from Study Site|25|||
37654436|NCT02761733|69125154|FG003|Overall Study|Discharged from Study Site|11|||
37654437|NCT02761733|69125151|FG000|Overall Study|Cognitive Impairment|5|||
37654438|NCT02761733|69125152|FG001|Overall Study|Cognitive Impairment|0|||
37654439|NCT02761733|69125153|FG002|Overall Study|Cognitive Impairment|1|||
37654440|NCT02761733|69125154|FG003|Overall Study|Cognitive Impairment|0|||
37654441|NCT03715465|69125166|FG000|Overall Study|Withdrawal by Subject|1|||
37654442|NCT03715465|69125167|FG001|Overall Study|Withdrawal by Subject|2|||
37654443|NCT00840073|69125175|FG000|Second Intervention|Missed 72 hour blood draw|1|||
37654444|NCT00840073|69125176|FG001|Second Intervention|Missed 72 hour blood draw|1|||
37654445|NCT00838279|69125182|FG000|Washout|Protocol Violation|1|||
37654446|NCT00838279|69125183|FG001|Washout|Protocol Violation|0|||
37654447|NCT00838279|69125182|FG000|Washout|Withdrawal by Subject|0|||
37654448|NCT00838279|69125183|FG001|Washout|Withdrawal by Subject|1|||
37654449|NCT02759939|69125191|FG000|Overall Study|Missing data on first outcome assessed|11|||
37654450|NCT02759939|69125192|FG001|Overall Study|Missing data on first outcome assessed|2|||
37654451|NCT02759939|69125193|FG002|Overall Study|Missing data on first outcome assessed|5|||
37654452|NCT02759939|69125194|FG003|Overall Study|Missing data on first outcome assessed|2|||
37654453|NCT02759939|69125191|FG000|Overall Study|Ineligible for T2 and T3|310|||
37654454|NCT02759939|69125192|FG001|Overall Study|Ineligible for T2 and T3|179|||
37743721|NCT01611259|69231757|FG000|Overall Study|Physician Decision|1|||
37743722|NCT01611259|69231757|FG000|Overall Study|Lack of Efficacy|2|||
37743723|NCT01611259|69231757|FG000|Overall Study|Adverse Event|4|||
37743724|NCT01611259|69231757|FG000|Overall Study|Withdrawal by Subject|7|||
37743725|NCT01795495|69231764|FG000|Overall Study|Protocol Violation|1|||
37743726|NCT01795495|69231765|FG001|Overall Study|Protocol Violation|0|||
37743727|NCT01795495|69231766|FG002|Overall Study|Protocol Violation|1|||
37654455|NCT02759939|69125193|FG002|Overall Study|Ineligible for T2 and T3|366|||
37654456|NCT02759939|69125194|FG003|Overall Study|Ineligible for T2 and T3|391|||
37654457|NCT02759939|69125191|FG000|Overall Study|Lost to Follow-up|735|||
37654458|NCT02759939|69125192|FG001|Overall Study|Lost to Follow-up|791|||
37654459|NCT02759939|69125193|FG002|Overall Study|Lost to Follow-up|783|||
37654460|NCT02759939|69125194|FG003|Overall Study|Lost to Follow-up|650|||
37654461|NCT00835705|69125213|FG000|First Intervention|Difficulty with vein|1|||
37654462|NCT00835705|69125214|FG001|First Intervention|Difficulty with vein|0|||
37654463|NCT00835705|69125213|FG000|Second Intervention|Difficulty with vein|1|||
37654464|NCT00835705|69125214|FG001|Second Intervention|Difficulty with vein|0|||
37654465|NCT02759471|69125218|FG000|Overall Study|discomfort|2|||
37654466|NCT00835549|69125226|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
37654467|NCT00835549|69125227|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
37654468|NCT03945825|69125237|FG000|Overall Study|Enrolled but treatment not administered|0|||
37654469|NCT03945825|69125238|FG001|Overall Study|Enrolled but treatment not administered|0|||
37654470|NCT03945825|69125239|FG002|Overall Study|Enrolled but treatment not administered|0|||
37654471|NCT03945825|69125240|FG003|Overall Study|Enrolled but treatment not administered|0|||
37654472|NCT03945825|69125241|FG004|Overall Study|Enrolled but treatment not administered|1|||
37654473|NCT03945825|69125242|FG005|Overall Study|Enrolled but treatment not administered|0|||
37654474|NCT03945825|69125237|FG000|Overall Study|Lost to Follow-up|1|||
37654475|NCT03945825|69125238|FG001|Overall Study|Lost to Follow-up|5|||
37654476|NCT03945825|69125239|FG002|Overall Study|Lost to Follow-up|0|||
37654477|NCT03945825|69125240|FG003|Overall Study|Lost to Follow-up|1|||
37654478|NCT03945825|69125241|FG004|Overall Study|Lost to Follow-up|2|||
37654479|NCT03945825|69125242|FG005|Overall Study|Lost to Follow-up|2|||
37654480|NCT03945825|69125237|FG000|Overall Study|Withdrawal by Subject|1|||
37654481|NCT03945825|69125238|FG001|Overall Study|Withdrawal by Subject|0|||
37654482|NCT03945825|69125239|FG002|Overall Study|Withdrawal by Subject|1|||
37654483|NCT03945825|69125240|FG003|Overall Study|Withdrawal by Subject|1|||
37654484|NCT03945825|69125241|FG004|Overall Study|Withdrawal by Subject|0|||
37654485|NCT03945825|69125242|FG005|Overall Study|Withdrawal by Subject|1|||
37654486|NCT02759315|69125270|FG000|Overall Study|Adverse Event|0|||
37654487|NCT02759315|69125271|FG001|Overall Study|Adverse Event|0|||
37654488|NCT02759315|69125272|FG002|Overall Study|Adverse Event|0|||
37654489|NCT02759315|69125273|FG003|Overall Study|Adverse Event|1|||
37654490|NCT02759315|69125274|FG004|Overall Study|Adverse Event|0|||
37654491|NCT02759315|69125270|FG000|Overall Study|Death|0|||
37654492|NCT02759315|69125271|FG001|Overall Study|Death|0|||
37654493|NCT02759315|69125272|FG002|Overall Study|Death|1|||
37654494|NCT02759315|69125273|FG003|Overall Study|Death|0|||
37654495|NCT02759315|69125274|FG004|Overall Study|Death|0|||
37654496|NCT02759315|69125270|FG000|Overall Study|Lost to Follow-up|2|||
37654497|NCT02759315|69125271|FG001|Overall Study|Lost to Follow-up|0|||
37654498|NCT02759315|69125272|FG002|Overall Study|Lost to Follow-up|4|||
37654499|NCT02759315|69125273|FG003|Overall Study|Lost to Follow-up|0|||
37654500|NCT02759315|69125274|FG004|Overall Study|Lost to Follow-up|0|||
37654501|NCT02759315|69125270|FG000|Overall Study|Protocol Violation|0|||
37654502|NCT02759315|69125271|FG001|Overall Study|Protocol Violation|1|||
37654503|NCT02759315|69125272|FG002|Overall Study|Protocol Violation|0|||
37654504|NCT02759315|69125273|FG003|Overall Study|Protocol Violation|0|||
37654505|NCT02759315|69125274|FG004|Overall Study|Protocol Violation|0|||
37654506|NCT02759315|69125270|FG000|Overall Study|Study terminated prior to completion|2|||
37654507|NCT02759315|69125271|FG001|Overall Study|Study terminated prior to completion|0|||
37654508|NCT02759315|69125272|FG002|Overall Study|Study terminated prior to completion|5|||
37654509|NCT02759315|69125273|FG003|Overall Study|Study terminated prior to completion|0|||
37654510|NCT02759315|69125274|FG004|Overall Study|Study terminated prior to completion|1|||
37654511|NCT00835081|69125290|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
37654512|NCT00835081|69125291|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
37654513|NCT02543918|69125297|FG000|Overall Study|Never treated|0|||
37654514|NCT02543918|69125298|FG001|Overall Study|Never treated|1|||
37654515|NCT02543918|69125297|FG000|Overall Study|Lost to Follow-up|1|||
37654516|NCT02543918|69125298|FG001|Overall Study|Lost to Follow-up|1|||
37654517|NCT02543918|69125297|FG000|Overall Study|Withdrawal by Subject|1|||
37654518|NCT02543918|69125298|FG001|Overall Study|Withdrawal by Subject|1|||
37654519|NCT02543918|69125297|FG000|Overall Study|Adverse Event|1|||
37654520|NCT02543918|69125298|FG001|Overall Study|Adverse Event|1|||
37654521|NCT01372995|69125307|FG000|Overall Study|Spouse withdrew participant from study|0|||
37654522|NCT01372995|69125308|FG001|Overall Study|Spouse withdrew participant from study|1|||
37654523|NCT01372995|69125309|FG002|Overall Study|Spouse withdrew participant from study|0|||
37654524|NCT01372995|69125307|FG000|Overall Study|Physician Decision|0|||
37654525|NCT01372995|69125308|FG001|Overall Study|Physician Decision|0|||
37654526|NCT01372995|69125309|FG002|Overall Study|Physician Decision|1|||
37654527|NCT02757521|69125319|FG000|Overall Study|Adverse Event|1|||
37654528|NCT02757521|69125320|FG001|Overall Study|Adverse Event|0|||
37654529|NCT00834613|69125328|FG000|First Intervention|Protocol Violation|1|||
37654530|NCT00834613|69125329|FG001|First Intervention|Protocol Violation|0|||
37654531|NCT00834067|69125346|FG000|Washout of 21 Days|Protocol Violation|0|||
37654532|NCT00834067|69125347|FG001|Washout of 21 Days|Protocol Violation|1|||
37654533|NCT02758613|69125355|FG000|Treatment|Physician and Sponsor Decision|1|||
37654534|NCT02758613|69125356|FG001|Treatment|Physician and Sponsor Decision|0|||
37743728|NCT01795495|69231764|FG000|Overall Study|Physician Decision|0|||
37654535|NCT02758613|69125357|FG002|Treatment|Physician and Sponsor Decision|0|||
37654536|NCT02758613|69125358|FG003|Treatment|Physician and Sponsor Decision|0|||
37654537|NCT02758613|69125355|FG000|Treatment|Withdrawal by Subject|1|||
37654538|NCT02758613|69125356|FG001|Treatment|Withdrawal by Subject|0|||
37654539|NCT02758613|69125357|FG002|Treatment|Withdrawal by Subject|1|||
37654540|NCT02758613|69125358|FG003|Treatment|Withdrawal by Subject|0|||
37654541|NCT02758301|69125373|FG000|Overall Study|Death|12|||
37654542|NCT02758301|69125374|FG001|Overall Study|Death|0|||
37654543|NCT02758301|69125373|FG000|Overall Study|Physician Decision|10|||
37654544|NCT02758301|69125374|FG001|Overall Study|Physician Decision|1|||
37654545|NCT02758301|69125373|FG000|Overall Study|Withdrawal by Subject|5|||
37654546|NCT02758301|69125374|FG001|Overall Study|Withdrawal by Subject|6|||
37654547|NCT02758301|69125373|FG000|Overall Study|Lost to Follow-up|7|||
37654548|NCT02758301|69125374|FG001|Overall Study|Lost to Follow-up|0|||
37654549|NCT02758301|69125373|FG000|Overall Study|Protocol Violation|0|||
37654550|NCT02758301|69125374|FG001|Overall Study|Protocol Violation|1|||
37654551|NCT02669667|69125394|FG000|Overall Study|Lost to Follow-up|0|||
37743729|NCT01795495|69231765|FG001|Overall Study|Physician Decision|0|||
37743730|NCT01795495|69231766|FG002|Overall Study|Physician Decision|1|||
37743731|NCT01794949|69231776|FG000|Overall Study|Lost to Follow-up|1|||
37743732|NCT01794949|69231777|FG001|Overall Study|Lost to Follow-up|0|||
37743733|NCT01770379|69231786|FG000|Overall Study|Technical issues|1|||
37743734|NCT01770379|69231787|FG001|Overall Study|Technical issues|0|||
37743735|NCT01770379|69231788|FG002|Overall Study|Technical issues|0|||
37743736|NCT01770379|69231786|FG000|Overall Study|Withdrawal by Subject|7|||
37743737|NCT01770379|69231787|FG001|Overall Study|Withdrawal by Subject|10|||
37743738|NCT01770379|69231788|FG002|Overall Study|Withdrawal by Subject|7|||
37743739|NCT01770379|69231786|FG000|Overall Study|study terminated by sponsor|22|||
37743740|NCT01770379|69231787|FG001|Overall Study|study terminated by sponsor|23|||
37743741|NCT01770379|69231788|FG002|Overall Study|study terminated by sponsor|22|||
37743742|NCT01770379|69231786|FG000|Overall Study|Protocol Violation|0|||
37743743|NCT01770379|69231787|FG001|Overall Study|Protocol Violation|1|||
37743744|NCT01770379|69231788|FG002|Overall Study|Protocol Violation|1|||
37743745|NCT01770379|69231786|FG000|Overall Study|Physician Decision|0|||
37743746|NCT01770379|69231787|FG001|Overall Study|Physician Decision|1|||
37743747|NCT01770379|69231788|FG002|Overall Study|Physician Decision|2|||
37743748|NCT01770379|69231786|FG000|Overall Study|Lost to Follow-up|0|||
37743749|NCT01770379|69231787|FG001|Overall Study|Lost to Follow-up|0|||
37743750|NCT01770379|69231788|FG002|Overall Study|Lost to Follow-up|2|||
37743751|NCT01770379|69231786|FG000|Overall Study|Lack of Efficacy|8|||
37743752|NCT01770379|69231787|FG001|Overall Study|Lack of Efficacy|6|||
37743753|NCT01770379|69231788|FG002|Overall Study|Lack of Efficacy|6|||
37743754|NCT01770379|69231786|FG000|Overall Study|Adverse Event|1|||
37743755|NCT01770379|69231787|FG001|Overall Study|Adverse Event|3|||
37743756|NCT01770379|69231788|FG002|Overall Study|Adverse Event|2|||
37743757|NCT01986881|69231801|FG000|Overall Study|Death|228|||
37743758|NCT01986881|69231802|FG001|Overall Study|Death|233|||
37743759|NCT01986881|69231803|FG002|Overall Study|Death|247|||
37654552|NCT02669667|69125395|FG001|Overall Study|Lost to Follow-up|0|||
37654553|NCT02669667|69125396|FG002|Overall Study|Lost to Follow-up|0|||
37654554|NCT02669667|69125397|FG003|Overall Study|Lost to Follow-up|0|||
37654555|NCT02669667|69125398|FG004|Overall Study|Lost to Follow-up|0|||
37654556|NCT02669667|69125399|FG005|Overall Study|Lost to Follow-up|1|||
37654557|NCT02669667|69125400|FG006|Overall Study|Lost to Follow-up|0|||
37654558|NCT02669433|69125425|FG000|Overall Study|Protocol Violation|0|||
37654559|NCT02669433|69125426|FG001|Overall Study|Protocol Violation|4|||
37654560|NCT02669433|69125427|FG002|Overall Study|Protocol Violation|1|||
37654561|NCT02669433|69125425|FG000|Overall Study|Disease Progression|1|||
37654562|NCT02669433|69125426|FG001|Overall Study|Disease Progression|0|||
37654563|NCT02669433|69125427|FG002|Overall Study|Disease Progression|0|||
37654564|NCT02669433|69125425|FG000|Overall Study|Physician Decision|1|||
37654565|NCT02669433|69125426|FG001|Overall Study|Physician Decision|1|||
37654566|NCT02669433|69125427|FG002|Overall Study|Physician Decision|0|||
37654567|NCT02669433|69125425|FG000|Overall Study|Adverse Event|6|||
37743760|NCT01986881|69231801|FG000|Overall Study|Lost to Follow-up|51|||
37743761|NCT01986881|69231802|FG001|Overall Study|Lost to Follow-up|44|||
37743762|NCT01986881|69231803|FG002|Overall Study|Lost to Follow-up|55|||
37743763|NCT01986881|69231801|FG000|Overall Study|Physician Decision|7|||
38032738|NCT02948582|69718683|FG001|Washout Period 1|Adverse Event|2|||
38032739|NCT02948582|69718684|FG002|Washout Period 1|Adverse Event|0|||
37743764|NCT01986881|69231802|FG001|Overall Study|Physician Decision|4|||
37654568|NCT02669433|69125426|FG001|Overall Study|Adverse Event|7|||
37654569|NCT02669433|69125427|FG002|Overall Study|Adverse Event|10|||
37654570|NCT02669433|69125425|FG000|Overall Study|Sponsor Termination|1|||
37654571|NCT02669433|69125426|FG001|Overall Study|Sponsor Termination|0|||
37654572|NCT02669433|69125427|FG002|Overall Study|Sponsor Termination|1|||
37654573|NCT02669433|69125425|FG000|Overall Study|Withdrawal by Subject|5|||
37654574|NCT02669433|69125426|FG001|Overall Study|Withdrawal by Subject|1|||
37743765|NCT01986881|69231803|FG002|Overall Study|Physician Decision|6|||
37743766|NCT01986881|69231801|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
37654575|NCT02669433|69125427|FG002|Overall Study|Withdrawal by Subject|0|||
37654576|NCT02669433|69125425|FG000|Overall Study|Withdrawal by Caregiver|1|||
37654577|NCT02669433|69125426|FG001|Overall Study|Withdrawal by Caregiver|0|||
37654578|NCT02669433|69125427|FG002|Overall Study|Withdrawal by Caregiver|2|||
37654579|NCT02669433|69125425|FG000|Overall Study|Death|0|||
37654580|NCT02669433|69125426|FG001|Overall Study|Death|1|||
37654581|NCT02669433|69125427|FG002|Overall Study|Death|1|||
37654582|NCT02756819|69125435|FG000|Overall Study|Lost for observation|23|||
37654583|NCT02756819|69125435|FG000|Overall Study|Patient's unwillingness|16|||
37654584|NCT02756819|69125435|FG000|Overall Study|Insufficient efficacy|2|||
37654585|NCT02756819|69125435|FG000|Overall Study|Adverse Event|2|||
37654586|NCT02756819|69125435|FG000|Overall Study|Reason not Specified|9|||
37654587|NCT00829309|69125441|FG000|Washout: 7 Days|Protocol Violation|1|||
37743767|NCT01986881|69231802|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
37743768|NCT01986881|69231803|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
37743769|NCT01986881|69231801|FG000|Overall Study|Withdrawal by Subject|41|||
37743770|NCT01986881|69231802|FG001|Overall Study|Withdrawal by Subject|60|||
37743771|NCT01986881|69231803|FG002|Overall Study|Withdrawal by Subject|45|||
37922722|NCT00814320|69609506|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
37654588|NCT00829309|69125442|FG001|Washout: 7 Days|Protocol Violation|0|||
37654589|NCT02669121|69125448|FG000|Overall Study|Adverse Event|4|||
37654590|NCT02669121|69125449|FG001|Overall Study|Adverse Event|5|||
37654591|NCT02669121|69125448|FG000|Overall Study|Lost to Follow-up|15|||
37654592|NCT02669121|69125449|FG001|Overall Study|Lost to Follow-up|27|||
37654593|NCT02669121|69125448|FG000|Overall Study|Withdrawal by Subject|132|||
37654594|NCT02669121|69125449|FG001|Overall Study|Withdrawal by Subject|140|||
37654595|NCT02669121|69125448|FG000|Overall Study|Pregnancy|0|||
37654596|NCT02669121|69125449|FG001|Overall Study|Pregnancy|1|||
37654597|NCT02669121|69125448|FG000|Overall Study|Discharged from US Military Active Service|117|||
37654598|NCT02669121|69125449|FG001|Overall Study|Discharged from US Military Active Service|91|||
37654599|NCT02669121|69125448|FG000|Overall Study|Reason not Specified|22|||
37654600|NCT02669121|69125449|FG001|Overall Study|Reason not Specified|18|||
37654601|NCT02743117|69125457|FG000|Overall Study|Lost to Follow-up|0|||
37654602|NCT02743117|69125458|FG001|Overall Study|Lost to Follow-up|1|||
37654603|NCT02743117|69125457|FG000|Overall Study|Other|1|||
37654604|NCT02743117|69125458|FG001|Overall Study|Other|0|||
37654605|NCT02669043|69125473|FG000|Overall Study|Didn't meet I/E criteria|4|||
37654606|NCT00805129|69125477|FG000|Overall Study|Not treated|1|||
37654607|NCT02668185|69125481|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
37654608|NCT02668185|69125482|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
37654609|NCT02668185|69125481|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
37654610|NCT02668185|69125482|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
37654611|NCT02668185|69125481|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
37654612|NCT02668185|69125482|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
37654613|NCT02668185|69125481|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
37654614|NCT02668185|69125482|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
37654615|NCT02742181|69125493|FG000|Overall Study|Physician Decision|1|||
37654616|NCT02742181|69125494|FG001|Overall Study|Physician Decision|0|||
37654617|NCT02742103|69125502|FG000|Overall Study|Protocol Violation|1|||
37654618|NCT02742103|69125503|FG001|Overall Study|Protocol Violation|0|||
37654619|NCT02742103|69125502|FG000|Overall Study|Death|2|||
37654620|NCT02742103|69125503|FG001|Overall Study|Death|2|||
37654621|NCT02742103|69125502|FG000|Overall Study|Adverse Event|1|||
37654622|NCT02742103|69125503|FG001|Overall Study|Adverse Event|0|||
37654623|NCT02742103|69125502|FG000|Overall Study|Moved to another town|0|||
37654624|NCT02742103|69125503|FG001|Overall Study|Moved to another town|1|||
37654625|NCT02742103|69125502|FG000|Overall Study|Withdrawal by Subject|5|||
37654626|NCT02742103|69125503|FG001|Overall Study|Withdrawal by Subject|2|||
37654627|NCT02741713|69125511|FG000|Overall Study|Surgery type changed intra-operatively|2|||
37654628|NCT02741713|69125512|FG001|Overall Study|Surgery type changed intra-operatively|1|||
37654629|NCT02663271|69125519|FG000|Overall Study|Withdrawal by Subject|5|||
37654630|NCT02663271|69125519|FG000|Overall Study|Lack of Efficacy|1|||
37654631|NCT02742649|69125526|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
37654632|NCT02742649|69125527|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
37654633|NCT02742649|69125528|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
37922723|NCT00814320|69609505|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
37654634|NCT02742649|69125529|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
37654635|NCT02742649|69125530|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
37654636|NCT02742649|69125526|FG000|Double-Blind Treatment Period|Adverse Event|0|||
37654637|NCT02742649|69125527|FG001|Double-Blind Treatment Period|Adverse Event|1|||
37654638|NCT02742649|69125528|FG002|Double-Blind Treatment Period|Adverse Event|0|||
37654639|NCT02742649|69125529|FG003|Double-Blind Treatment Period|Adverse Event|0|||
37654640|NCT02742649|69125530|FG004|Double-Blind Treatment Period|Adverse Event|0|||
37654641|NCT02742649|69125526|FG000|Open-Label Period|Lost to Follow-up|0|||
37654642|NCT02742649|69125527|FG001|Open-Label Period|Lost to Follow-up|0|||
37654643|NCT02742649|69125528|FG002|Open-Label Period|Lost to Follow-up|0|||
37654644|NCT02742649|69125529|FG003|Open-Label Period|Lost to Follow-up|0|||
37654645|NCT02742649|69125530|FG004|Open-Label Period|Lost to Follow-up|1|||
37654646|NCT02665689|69125543|FG000|Overall Study|Adverse Event|1|||
37654647|NCT02665689|69125544|FG001|Overall Study|Adverse Event|0|||
37654648|NCT02665689|69125543|FG000|Overall Study|Trial termination|1|||
37654649|NCT02665689|69125544|FG001|Overall Study|Trial termination|1|||
37654650|NCT02665689|69125543|FG000|Overall Study|Lost to Follow-up|0|||
37654651|NCT02665689|69125544|FG001|Overall Study|Lost to Follow-up|1|||
37654652|NCT02665455|69125550|FG000|Overall Study|Withdrawal by Subject|6|||
37654653|NCT02665455|69125550|FG000|Overall Study|Lost to Follow-up|1|||
37654654|NCT02665455|69125550|FG000|Overall Study|Adverse Event|1|||
37654655|NCT02665455|69125550|FG000|Overall Study|Protocol Violation|1|||
37654656|NCT02755805|69125556|FG000|Overall Study|Lost to Follow-up|1|||
37654657|NCT02755805|69125557|FG001|Overall Study|Lost to Follow-up|2|||
37654658|NCT02755805|69125556|FG000|Overall Study|Refused assessments|1|||
37654659|NCT02755805|69125557|FG001|Overall Study|Refused assessments|0|||
37654660|NCT02755805|69125556|FG000|Overall Study|Withdrawal by Subject|0|||
37654661|NCT02755805|69125557|FG001|Overall Study|Withdrawal by Subject|2|||
37654662|NCT02755649|69125566|FG000|Overall Study|Transitioned into OLE study|99|||
37654663|NCT02755649|69125567|FG001|Overall Study|Transitioned into OLE study|98|||
37654664|NCT02755649|69125568|FG002|Overall Study|Transitioned into OLE study|100|||
37654665|NCT02755649|69125566|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
37654666|NCT02755649|69125567|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
37654667|NCT02755649|69125568|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
37654668|NCT02755649|69125566|FG000|Overall Study|Physician Decision|0|||
37654669|NCT02755649|69125567|FG001|Overall Study|Physician Decision|0|||
37654670|NCT02755649|69125568|FG002|Overall Study|Physician Decision|2|||
37654671|NCT02755649|69125566|FG000|Overall Study|Withdrawal by Subject|0|||
37654672|NCT02755649|69125567|FG001|Overall Study|Withdrawal by Subject|1|||
37654673|NCT02755649|69125568|FG002|Overall Study|Withdrawal by Subject|0|||
37654674|NCT02755649|69125566|FG000|Overall Study|Undecided|1|||
37654675|NCT02755649|69125567|FG001|Overall Study|Undecided|0|||
37654676|NCT02755649|69125568|FG002|Overall Study|Undecided|0|||
37654677|NCT00151411|69125578|FG000|Overall Study|Lost to Follow-up|15|||
37654678|NCT00151411|69125579|FG001|Overall Study|Lost to Follow-up|19|||
37654679|NCT00151411|69125578|FG000|Overall Study|Withdrawal by Subject|12|||
37654680|NCT00151411|69125579|FG001|Overall Study|Withdrawal by Subject|20|||
37654681|NCT00151411|69125578|FG000|Overall Study|Adverse Event|6|||
37743772|NCT01986881|69231801|FG000|Overall Study|Subject Moved|0|||
37743773|NCT01986881|69231802|FG001|Overall Study|Subject Moved|1|||
37743774|NCT01986881|69231803|FG002|Overall Study|Subject Moved|0|||
37743775|NCT01986881|69231801|FG000|Overall Study|Other|1|||
37743776|NCT01986881|69231802|FG001|Overall Study|Other|2|||
37743777|NCT01986881|69231803|FG002|Overall Study|Other|2|||
37743778|NCT01609543|69231834|FG000|Overall Study|Disease Progression|28|||
37743779|NCT01609543|69231834|FG000|Overall Study|Adverse Event|5|||
37743780|NCT01609543|69231834|FG000|Overall Study|Withdrawal by Subject|1|||
37743781|NCT01609543|69231834|FG000|Overall Study|Protocol Violation|1|||
37743782|NCT01609543|69231834|FG000|Overall Study|Death|7|||
37743783|NCT02003183|69231841|FG000|Overall Study|Lost to Follow-up|0|||
37743784|NCT02003183|69231842|FG001|Overall Study|Lost to Follow-up|2|||
37743785|NCT01986647|69231852|FG000|Overall Study|Lost to Follow-up|4|||
37743786|NCT01986647|69231853|FG001|Overall Study|Lost to Follow-up|1|||
37743787|NCT01986647|69231854|FG002|Overall Study|Lost to Follow-up|4|||
37743788|NCT01986647|69231855|FG003|Overall Study|Lost to Follow-up|4|||
37743789|NCT01986647|69231852|FG000|Overall Study|Withdrawal by Subject|1|||
37743790|NCT01986647|69231853|FG001|Overall Study|Withdrawal by Subject|3|||
37743791|NCT01986647|69231854|FG002|Overall Study|Withdrawal by Subject|2|||
37743792|NCT01986647|69231855|FG003|Overall Study|Withdrawal by Subject|3|||
37743793|NCT01986647|69231852|FG000|Overall Study|Health|5|||
37743794|NCT01986647|69231853|FG001|Overall Study|Health|3|||
37654682|NCT00151411|69125579|FG001|Overall Study|Adverse Event|0|||
37654683|NCT00151411|69125578|FG000|Overall Study|Pregnancy|0|||
37654684|NCT00151411|69125579|FG001|Overall Study|Pregnancy|4|||
37654685|NCT02662569|69125589|FG000|Overall Study|Withdrawal by Subject|6|||
37654686|NCT02662569|69125590|FG001|Overall Study|Withdrawal by Subject|1|||
37654687|NCT02662569|69125591|FG002|Overall Study|Withdrawal by Subject|6|||
37743795|NCT01986647|69231854|FG002|Overall Study|Health|6|||
37743796|NCT01986647|69231855|FG003|Overall Study|Health|4|||
37743797|NCT02002091|69231871|FG000|Screening|Lost to Follow-up|10|||
37743798|NCT02002091|69231872|FG001|Screening|Lost to Follow-up|12|||
37743799|NCT02002091|69231871|FG000|Screening|Death|3|||
37654688|NCT02662569|69125592|FG003|Overall Study|Withdrawal by Subject|4|||
37654689|NCT02662569|69125589|FG000|Overall Study|Lost to Follow-up|1|||
37654690|NCT02662569|69125590|FG001|Overall Study|Lost to Follow-up|0|||
37654691|NCT02662569|69125591|FG002|Overall Study|Lost to Follow-up|0|||
37654692|NCT02662569|69125592|FG003|Overall Study|Lost to Follow-up|0|||
37654693|NCT02741635|69125602|FG000|Overall Study|Withdrawal by Subject|1|||
37743800|NCT02002091|69231872|FG001|Screening|Death|2|||
37654694|NCT02753075|69125610|FG000|Overall Study|Adverse Event|2|||
37654695|NCT02753075|69125611|FG001|Overall Study|Adverse Event|1|||
37654696|NCT02753075|69125612|FG002|Overall Study|Adverse Event|0|||
37654697|NCT02753075|69125610|FG000|Overall Study|Lost to Follow-up|2|||
37654698|NCT02753075|69125611|FG001|Overall Study|Lost to Follow-up|0|||
37743801|NCT01985321|69231909|FG000|Overall Study|Protocol Violation|4|||
37743802|NCT01985321|69231910|FG001|Overall Study|Protocol Violation|3|||
37743803|NCT01985321|69231909|FG000|Overall Study|Withdrawal by Subject|1|||
37743804|NCT01985321|69231910|FG001|Overall Study|Withdrawal by Subject|0|||
37743805|NCT01985321|69231909|FG000|Overall Study|Lost to Follow-up|5|||
37743806|NCT01985321|69231910|FG001|Overall Study|Lost to Follow-up|2|||
37654699|NCT02753075|69125612|FG002|Overall Study|Lost to Follow-up|0|||
37654700|NCT02753075|69125610|FG000|Overall Study|Withdrawal of Consent|1|||
37654701|NCT02753075|69125611|FG001|Overall Study|Withdrawal of Consent|1|||
37654702|NCT02753075|69125612|FG002|Overall Study|Withdrawal of Consent|3|||
37654703|NCT02753075|69125610|FG000|Overall Study|Physician Decision|3|||
37654704|NCT02753075|69125611|FG001|Overall Study|Physician Decision|1|||
37743807|NCT01985321|69231909|FG000|Overall Study|Subject treated wrong type of sore|1|||
37743808|NCT01985321|69231910|FG001|Overall Study|Subject treated wrong type of sore|0|||
37743809|NCT02000921|69231919|FG000|Overall Study|Withdrawal by Subject|3|||
37743810|NCT02000921|69231920|FG001|Overall Study|Withdrawal by Subject|10|||
37743811|NCT02000921|69231921|FG002|Overall Study|Withdrawal by Subject|5|||
37743812|NCT02000921|69231919|FG000|Overall Study|Lost to Follow-up|2|||
37743813|NCT02000921|69231920|FG001|Overall Study|Lost to Follow-up|4|||
37743814|NCT02000921|69231921|FG002|Overall Study|Lost to Follow-up|5|||
37743815|NCT02000921|69231919|FG000|Overall Study|Physician Decision|0|||
37743816|NCT02000921|69231920|FG001|Overall Study|Physician Decision|2|||
37743817|NCT02000921|69231921|FG002|Overall Study|Physician Decision|0|||
37743818|NCT01836523|69231967|FG000|Overall Study|Adverse Event|15|||
37743819|NCT01836523|69231968|FG001|Overall Study|Adverse Event|41|||
37743820|NCT01836523|69231969|FG002|Overall Study|Adverse Event|49|||
37743821|NCT01836523|69231970|FG003|Overall Study|Adverse Event|14|||
37743822|NCT01836523|69231967|FG000|Overall Study|Protocol Violation|6|||
37743823|NCT01836523|69231968|FG001|Overall Study|Protocol Violation|3|||
37743824|NCT01836523|69231969|FG002|Overall Study|Protocol Violation|2|||
37743825|NCT01836523|69231970|FG003|Overall Study|Protocol Violation|4|||
37743826|NCT01836523|69231967|FG000|Overall Study|Met Withdrawal Criteria|13|||
37743827|NCT01836523|69231968|FG001|Overall Study|Met Withdrawal Criteria|13|||
37743828|NCT01836523|69231969|FG002|Overall Study|Met Withdrawal Criteria|21|||
37743829|NCT01836523|69231970|FG003|Overall Study|Met Withdrawal Criteria|27|||
37743830|NCT01836523|69231967|FG000|Overall Study|Unclassified|17|||
37743831|NCT01836523|69231968|FG001|Overall Study|Unclassified|28|||
37743832|NCT01836523|69231969|FG002|Overall Study|Unclassified|19|||
37743833|NCT01836523|69231970|FG003|Overall Study|Unclassified|29|||
37743834|NCT01275196|69231982|FG000|Overall Study|Adverse Event|3|||
37743835|NCT01275196|69231983|FG001|Overall Study|Adverse Event|5|||
37743836|NCT01275196|69231982|FG000|Overall Study|Withdrawal by Subject|4|||
37743837|NCT01275196|69231983|FG001|Overall Study|Withdrawal by Subject|5|||
37743838|NCT01275196|69231982|FG000|Overall Study|Lost to Follow-up|1|||
37743839|NCT01275196|69231983|FG001|Overall Study|Lost to Follow-up|0|||
37743840|NCT01275196|69231982|FG000|Overall Study|Disease Progression|6|||
37654705|NCT02753075|69125612|FG002|Overall Study|Physician Decision|0|||
37654706|NCT02332720|69125644|FG000|Part A and Part B|Lost to Follow-up|1|||
37654707|NCT02332720|69125645|FG001|Part A and Part B|Lost to Follow-up|0|||
37654708|NCT02332720|69125646|FG002|Part A and Part B|Lost to Follow-up|0|||
37654709|NCT02332720|69125647|FG003|Part A and Part B|Lost to Follow-up|0|||
37654710|NCT02332720|69125648|FG004|Part A and Part B|Lost to Follow-up|0|||
37654711|NCT02332720|69125649|FG005|Part A and Part B|Lost to Follow-up|2|||
37654712|NCT02332720|69125650|FG006|Part A and Part B|Lost to Follow-up|1|||
37654713|NCT02332720|69125651|FG007|Part A and Part B|Lost to Follow-up|1|||
37654714|NCT02332720|69125652|FG008|Part A and Part B|Lost to Follow-up|0|||
37654715|NCT02332720|69125653|FG009|Part A and Part B|Lost to Follow-up|0|||
37654716|NCT02332720|69125654|FG010|Part A and Part B|Lost to Follow-up|0|||
37654717|NCT02332720|69125655|FG011|Part A and Part B|Lost to Follow-up|0|||
37654718|NCT02332720|69125656|FG012|Part A and Part B|Lost to Follow-up|0|||
37654719|NCT02332720|69125657|FG013|Part A and Part B|Lost to Follow-up|0|||
37654720|NCT02332720|69125658|FG014|Part A and Part B|Lost to Follow-up|0|||
37654721|NCT02332720|69125659|FG015|Part A and Part B|Lost to Follow-up|1|||
37743841|NCT01275196|69231983|FG001|Overall Study|Disease Progression|5|||
37743842|NCT01275196|69231982|FG000|Overall Study|Protocol Violation|1|||
37743843|NCT01275196|69231983|FG001|Overall Study|Protocol Violation|0|||
37743844|NCT01275196|69231982|FG000|Overall Study|Suboptimal response/treatment failure|5|||
37743845|NCT01275196|69231983|FG001|Overall Study|Suboptimal response/treatment failure|6|||
37743846|NCT01984697|69231996|FG000|Overall Study|Adverse Event|0|||
37743847|NCT01984697|69231997|FG001|Overall Study|Adverse Event|0|||
37743848|NCT01984697|69231998|FG002|Overall Study|Adverse Event|2|||
37743849|NCT01984697|69231999|FG003|Overall Study|Adverse Event|0|||
37743850|NCT01984697|69232000|FG004|Overall Study|Adverse Event|0|||
37654722|NCT02332720|69125660|FG016|Part A and Part B|Lost to Follow-up|0|||
37654723|NCT02332720|69125661|FG017|Part A and Part B|Lost to Follow-up|0|||
37654724|NCT02332720|69125662|FG018|Part A and Part B|Lost to Follow-up|0|||
37654725|NCT02332720|69125663|FG019|Part A and Part B|Lost to Follow-up|0|||
37654726|NCT02332720|69125664|FG020|Part A and Part B|Lost to Follow-up|0|||
37654727|NCT02332720|69125665|FG021|Part A and Part B|Lost to Follow-up|0|||
37654728|NCT02332720|69125666|FG022|Part A and Part B|Lost to Follow-up|0|||
37654729|NCT02332720|69125644|FG000|Part A and Part B|Adverse Event|0|||
37654730|NCT02332720|69125645|FG001|Part A and Part B|Adverse Event|0|||
37654731|NCT02332720|69125646|FG002|Part A and Part B|Adverse Event|0|||
37654732|NCT02332720|69125647|FG003|Part A and Part B|Adverse Event|0|||
37654733|NCT02332720|69125648|FG004|Part A and Part B|Adverse Event|0|||
37654734|NCT02332720|69125649|FG005|Part A and Part B|Adverse Event|0|||
37654735|NCT02332720|69125650|FG006|Part A and Part B|Adverse Event|0|||
37654736|NCT02332720|69125651|FG007|Part A and Part B|Adverse Event|0|||
37654737|NCT02332720|69125652|FG008|Part A and Part B|Adverse Event|0|||
37654738|NCT02332720|69125653|FG009|Part A and Part B|Adverse Event|0|||
37654739|NCT02332720|69125654|FG010|Part A and Part B|Adverse Event|0|||
37654740|NCT02332720|69125655|FG011|Part A and Part B|Adverse Event|0|||
37654741|NCT02332720|69125656|FG012|Part A and Part B|Adverse Event|0|||
37654742|NCT02332720|69125657|FG013|Part A and Part B|Adverse Event|0|||
37654743|NCT02332720|69125658|FG014|Part A and Part B|Adverse Event|0|||
37654744|NCT02332720|69125659|FG015|Part A and Part B|Adverse Event|0|||
37654745|NCT02332720|69125660|FG016|Part A and Part B|Adverse Event|0|||
37654746|NCT02332720|69125661|FG017|Part A and Part B|Adverse Event|1|||
37654747|NCT02332720|69125662|FG018|Part A and Part B|Adverse Event|0|||
37654748|NCT02332720|69125663|FG019|Part A and Part B|Adverse Event|0|||
37654749|NCT02332720|69125664|FG020|Part A and Part B|Adverse Event|0|||
37654750|NCT02332720|69125665|FG021|Part A and Part B|Adverse Event|0|||
37654751|NCT02332720|69125666|FG022|Part A and Part B|Adverse Event|0|||
37654752|NCT02332720|69125644|FG000|Part A and Part B|Physician Decision|0|||
37654753|NCT02332720|69125645|FG001|Part A and Part B|Physician Decision|0|||
37654754|NCT02332720|69125646|FG002|Part A and Part B|Physician Decision|0|||
37654755|NCT02332720|69125647|FG003|Part A and Part B|Physician Decision|0|||
37654756|NCT02332720|69125648|FG004|Part A and Part B|Physician Decision|0|||
37654757|NCT02332720|69125649|FG005|Part A and Part B|Physician Decision|0|||
37654758|NCT02332720|69125650|FG006|Part A and Part B|Physician Decision|0|||
37654759|NCT02332720|69125651|FG007|Part A and Part B|Physician Decision|0|||
37654760|NCT02332720|69125652|FG008|Part A and Part B|Physician Decision|0|||
37654761|NCT02332720|69125653|FG009|Part A and Part B|Physician Decision|0|||
37654762|NCT02332720|69125654|FG010|Part A and Part B|Physician Decision|0|||
37654763|NCT02332720|69125655|FG011|Part A and Part B|Physician Decision|0|||
37654764|NCT02332720|69125656|FG012|Part A and Part B|Physician Decision|0|||
37654765|NCT02332720|69125657|FG013|Part A and Part B|Physician Decision|0|||
37654766|NCT02332720|69125658|FG014|Part A and Part B|Physician Decision|0|||
37654767|NCT02332720|69125659|FG015|Part A and Part B|Physician Decision|0|||
37654768|NCT02332720|69125660|FG016|Part A and Part B|Physician Decision|0|||
37654769|NCT02332720|69125661|FG017|Part A and Part B|Physician Decision|0|||
37654770|NCT02332720|69125662|FG018|Part A and Part B|Physician Decision|1|||
37654771|NCT02332720|69125663|FG019|Part A and Part B|Physician Decision|0|||
37654772|NCT02332720|69125664|FG020|Part A and Part B|Physician Decision|0|||
37654773|NCT02332720|69125665|FG021|Part A and Part B|Physician Decision|0|||
37654774|NCT02332720|69125666|FG022|Part A and Part B|Physician Decision|0|||
37654775|NCT02332720|69125644|FG000|Part A and Part B|Withdrawal by Subject|0|||
37654776|NCT02332720|69125645|FG001|Part A and Part B|Withdrawal by Subject|0|||
37654777|NCT02332720|69125646|FG002|Part A and Part B|Withdrawal by Subject|0|||
37654778|NCT02332720|69125647|FG003|Part A and Part B|Withdrawal by Subject|0|||
37743851|NCT01984697|69231996|FG000|Overall Study|Lost to Follow-up|14|||
37743852|NCT01984697|69231997|FG001|Overall Study|Lost to Follow-up|5|||
37743853|NCT01984697|69231998|FG002|Overall Study|Lost to Follow-up|10|||
37654779|NCT02332720|69125648|FG004|Part A and Part B|Withdrawal by Subject|0|||
37654780|NCT02332720|69125649|FG005|Part A and Part B|Withdrawal by Subject|1|||
37654781|NCT02332720|69125650|FG006|Part A and Part B|Withdrawal by Subject|0|||
37654782|NCT02332720|69125651|FG007|Part A and Part B|Withdrawal by Subject|0|||
37654783|NCT02332720|69125652|FG008|Part A and Part B|Withdrawal by Subject|0|||
37654784|NCT02332720|69125653|FG009|Part A and Part B|Withdrawal by Subject|0|||
37654785|NCT02332720|69125654|FG010|Part A and Part B|Withdrawal by Subject|0|||
37654786|NCT02332720|69125655|FG011|Part A and Part B|Withdrawal by Subject|0|||
37654787|NCT02332720|69125656|FG012|Part A and Part B|Withdrawal by Subject|0|||
37654788|NCT02332720|69125657|FG013|Part A and Part B|Withdrawal by Subject|0|||
38032740|NCT02948582|69718685|FG003|Washout Period 1|Adverse Event|0|||
37654789|NCT02332720|69125658|FG014|Part A and Part B|Withdrawal by Subject|0|||
37654790|NCT02332720|69125659|FG015|Part A and Part B|Withdrawal by Subject|0|||
37654791|NCT02332720|69125660|FG016|Part A and Part B|Withdrawal by Subject|0|||
37654792|NCT02332720|69125661|FG017|Part A and Part B|Withdrawal by Subject|0|||
37654793|NCT02332720|69125662|FG018|Part A and Part B|Withdrawal by Subject|0|||
37743854|NCT01984697|69231999|FG003|Overall Study|Lost to Follow-up|6|||
37654794|NCT02332720|69125663|FG019|Part A and Part B|Withdrawal by Subject|1|||
37654795|NCT02332720|69125664|FG020|Part A and Part B|Withdrawal by Subject|0|||
37654796|NCT02332720|69125665|FG021|Part A and Part B|Withdrawal by Subject|0|||
37654797|NCT02332720|69125666|FG022|Part A and Part B|Withdrawal by Subject|0|||
37654798|NCT02331394|69125738|FG000|Overall Study|Disease progression|1|||
37654799|NCT01645930|69125749|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
37654800|NCT01645930|69125749|FG000|Overall Study|Progressive Disease|12|||
37654801|NCT01645930|69125749|FG000|Overall Study|Adverse Event|4|||
37654802|NCT01645930|69125749|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
37654803|NCT01645930|69125749|FG000|Overall Study|Withdrawal by Participant|2|||
37654804|NCT01645930|69125749|FG000|Overall Study|Reason not Defined|1|||
37654805|NCT02299336|69125753|FG000|Overall Study|Withdrawal by Subject|11|||
37654806|NCT02299336|69125753|FG000|Overall Study|Adverse Event|1|||
37654807|NCT02299336|69125753|FG000|Overall Study|Death|1|||
37654808|NCT02299336|69125753|FG000|Overall Study|Lost to Follow-up|1|||
37654809|NCT02664441|69125759|FG000|Randomization|Withdrawal by Subject|0|||
37654810|NCT02664441|69125760|FG001|Randomization|Withdrawal by Subject|1|||
37654811|NCT02664441|69125759|FG000|36-week Randomized Trial|Adverse Event|2|||
37654812|NCT02664441|69125760|FG001|36-week Randomized Trial|Adverse Event|0|||
37654813|NCT02664441|69125759|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
37654814|NCT02664441|69125760|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
37654815|NCT02664441|69125759|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
37654816|NCT02664441|69125760|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
37654817|NCT02664441|69125759|FG000|18-week Open Label Extension|Adverse Event|1|||
37654818|NCT02664441|69125760|FG001|18-week Open Label Extension|Adverse Event|0|||
37654819|NCT02664441|69125759|FG000|18-week Open Label Extension|Physician Decision|1|||
37654820|NCT02664441|69125760|FG001|18-week Open Label Extension|Physician Decision|0|||
37654821|NCT02664441|69125759|FG000|18-week Open Label Extension|Death|1|||
37654822|NCT02664441|69125760|FG001|18-week Open Label Extension|Death|0|||
37654823|NCT02664441|69125759|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
37654824|NCT02664441|69125760|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
37654825|NCT02298946|69125769|FG000|Overall Study|Did not receive treatment|2|||
37743855|NCT01984697|69232000|FG004|Overall Study|Lost to Follow-up|21|||
37743856|NCT01984697|69231996|FG000|Overall Study|Physician Decision|3|||
37743857|NCT01984697|69231997|FG001|Overall Study|Physician Decision|0|||
37743858|NCT01984697|69231998|FG002|Overall Study|Physician Decision|0|||
37743859|NCT01984697|69231999|FG003|Overall Study|Physician Decision|1|||
37743860|NCT01984697|69232000|FG004|Overall Study|Physician Decision|0|||
37743861|NCT01984697|69231996|FG000|Overall Study|Protocol Violation|8|||
37743862|NCT01984697|69231997|FG001|Overall Study|Protocol Violation|5|||
37743863|NCT01984697|69231998|FG002|Overall Study|Protocol Violation|3|||
37743864|NCT01984697|69231999|FG003|Overall Study|Protocol Violation|2|||
37743865|NCT01984697|69232000|FG004|Overall Study|Protocol Violation|0|||
37743866|NCT01984697|69231996|FG000|Overall Study|Withdrawal by Subject|15|||
37743867|NCT01984697|69231997|FG001|Overall Study|Withdrawal by Subject|21|||
37743868|NCT01984697|69231998|FG002|Overall Study|Withdrawal by Subject|13|||
37743869|NCT01984697|69231999|FG003|Overall Study|Withdrawal by Subject|11|||
37743870|NCT01984697|69232000|FG004|Overall Study|Withdrawal by Subject|13|||
37743871|NCT01984697|69231996|FG000|Overall Study|Missed last follow-up visit|1|||
37743872|NCT01984697|69231997|FG001|Overall Study|Missed last follow-up visit|0|||
38032741|NCT02948582|69718686|FG004|Washout Period 1|Adverse Event|0|||
38032742|NCT02948582|69718687|FG005|Washout Period 1|Adverse Event|0|||
37654826|NCT02298946|69125770|FG001|Overall Study|Did not receive treatment|0|||
37654827|NCT02298946|69125769|FG000|Overall Study|Unevaluable|2|||
37654828|NCT02298946|69125770|FG001|Overall Study|Unevaluable|1|||
37654829|NCT02328040|69125777|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
37654830|NCT02328040|69125778|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
37654831|NCT01647958|69125786|FG000|Initial Study|Lost to Follow-up|2|||
37654832|NCT01647958|69125787|FG001|Initial Study|Lost to Follow-up|3|||
37654833|NCT01647958|69125786|FG000|Continuation Phase|treatment received during Overall Study|39|||
37654834|NCT01647958|69125787|FG001|Continuation Phase|treatment received during Overall Study|0|||
37654835|NCT01647958|69125786|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
37654836|NCT01647958|69125787|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
37654837|NCT02298868|69125802|FG000|Overall Study|Adverse Event|1|||
37654838|NCT02298868|69125802|FG000|Overall Study|Death|1|||
37654839|NCT02298868|69125802|FG000|Overall Study|Patient underwent transplant|1|||
37654840|NCT02327260|69125809|FG000|Overall Study|Lost to Follow-up|2|||
37654841|NCT02327260|69125810|FG001|Overall Study|Lost to Follow-up|3|||
37654842|NCT02327260|69125811|FG002|Overall Study|Lost to Follow-up|2|||
37654843|NCT02327260|69125809|FG000|Overall Study|invalid phone number|1|||
37654844|NCT02327260|69125810|FG001|Overall Study|invalid phone number|1|||
37743873|NCT01984697|69231998|FG002|Overall Study|Missed last follow-up visit|0|||
37743874|NCT01984697|69231999|FG003|Overall Study|Missed last follow-up visit|0|||
37743875|NCT01984697|69232000|FG004|Overall Study|Missed last follow-up visit|0|||
37743876|NCT01984697|69231996|FG000|Overall Study|Death|0|||
37743877|NCT01984697|69231997|FG001|Overall Study|Death|0|||
37654845|NCT02327260|69125811|FG002|Overall Study|invalid phone number|0|||
37654846|NCT02327260|69125809|FG000|Overall Study|non-adherence to protocol|2|||
37654847|NCT02327260|69125810|FG001|Overall Study|non-adherence to protocol|0|||
37654848|NCT02327260|69125811|FG002|Overall Study|non-adherence to protocol|0|||
37654849|NCT02327260|69125809|FG000|Overall Study|cognitive concerns|1|||
37654850|NCT02327260|69125810|FG001|Overall Study|cognitive concerns|0|||
37654851|NCT02327260|69125811|FG002|Overall Study|cognitive concerns|0|||
37654852|NCT02296840|69125822|FG000|Overall Study|Adverse Event|1|||
37654853|NCT02296840|69125823|FG001|Overall Study|Adverse Event|1|||
37654854|NCT02296840|69125822|FG000|Overall Study|Protocol Violation|2|||
37654855|NCT02296840|69125823|FG001|Overall Study|Protocol Violation|1|||
37654856|NCT02296840|69125822|FG000|Overall Study|Lost to Follow-up|6|||
37654857|NCT02296840|69125823|FG001|Overall Study|Lost to Follow-up|17|||
37654858|NCT02663895|69125832|FG000|Overall Study|Adverse Event|3|||
37654859|NCT02663895|69125832|FG000|Overall Study|Physician Decision|2|||
37654860|NCT02663895|69125832|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
37654861|NCT02663895|69125832|FG000|Overall Study|Withdrawal by Subject|1|||
37654862|NCT02663817|69125837|FG000|Overall Study|Screen failure|2|||
37654863|NCT01372605|69125845|FG000|Overall Study|Death|1|||
37654864|NCT01372605|69125846|FG001|Overall Study|Death|2|||
37654865|NCT01372605|69125845|FG000|Overall Study|Lost to Follow-up|2|||
37855298|NCT01294358|69538583|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
37855299|NCT01294358|69538584|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
37855300|NCT01294358|69538585|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
37855301|NCT01294358|69538581|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
37654866|NCT01372605|69125846|FG001|Overall Study|Lost to Follow-up|1|||
37654867|NCT01372605|69125845|FG000|Overall Study|Withdrawal by Subject|4|||
37654868|NCT01372605|69125846|FG001|Overall Study|Withdrawal by Subject|7|||
37654869|NCT01372605|69125845|FG000|Overall Study|Moved|3|||
37654870|NCT01372605|69125846|FG001|Overall Study|Moved|0|||
37654871|NCT01372605|69125845|FG000|Overall Study|Changed medical home|2|||
37654872|NCT01372605|69125846|FG001|Overall Study|Changed medical home|0|||
37654873|NCT02751983|69125854|FG000|Treatment|Stopped ACT, but Remained in study|2|||
37654874|NCT02751983|69125855|FG001|Treatment|Stopped ACT, but Remained in study|0|||
37654875|NCT02751983|69125854|FG000|Treatment|Discharged prior to beginning ACT|2|||
37654876|NCT02751983|69125855|FG001|Treatment|Discharged prior to beginning ACT|0|||
37654877|NCT02751983|69125854|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
37654878|NCT02751983|69125855|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
37654879|NCT02751983|69125854|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
37654880|NCT02751983|69125855|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
37654881|NCT02751983|69125854|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
37654882|NCT02751983|69125855|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
37654883|NCT00232141|69125875|FG000|Overall Study|Adverse Event|9|||
37654884|NCT00232141|69125876|FG001|Overall Study|Adverse Event|4|||
37654885|NCT00232141|69125875|FG000|Overall Study|Lack of Efficacy|0|||
37654886|NCT00232141|69125876|FG001|Overall Study|Lack of Efficacy|3|||
37654887|NCT00232141|69125875|FG000|Overall Study|Lost to Follow-up|9|||
37654888|NCT00232141|69125876|FG001|Overall Study|Lost to Follow-up|6|||
37654889|NCT00232141|69125875|FG000|Overall Study|Other|8|||
37654890|NCT00232141|69125876|FG001|Overall Study|Other|10|||
37654891|NCT00232141|69125875|FG000|Overall Study|Withdrawal by Subject|5|||
37654892|NCT00232141|69125876|FG001|Overall Study|Withdrawal by Subject|3|||
37654893|NCT02741245|69125905|FG000|Overall Study|Adverse Event|0|||
37654894|NCT02741245|69125906|FG001|Overall Study|Adverse Event|0|||
37654895|NCT02741245|69125907|FG002|Overall Study|Adverse Event|0|||
37743878|NCT01984697|69231998|FG002|Overall Study|Death|0|||
37743879|NCT01984697|69231999|FG003|Overall Study|Death|1|||
37743880|NCT01984697|69232000|FG004|Overall Study|Death|0|||
37743881|NCT01984697|69231996|FG000|Overall Study|Pregnancy|2|||
37743882|NCT01984697|69231997|FG001|Overall Study|Pregnancy|0|||
37743883|NCT01984697|69231998|FG002|Overall Study|Pregnancy|1|||
37743884|NCT01984697|69231999|FG003|Overall Study|Pregnancy|0|||
37654896|NCT02741245|69125908|FG003|Overall Study|Adverse Event|2|||
37654897|NCT02741245|69125909|FG004|Overall Study|Adverse Event|2|||
37654898|NCT02741245|69125905|FG000|Overall Study|Protocol Violation|0|||
37654899|NCT02741245|69125906|FG001|Overall Study|Protocol Violation|1|||
37654900|NCT02741245|69125907|FG002|Overall Study|Protocol Violation|0|||
37654901|NCT02741245|69125908|FG003|Overall Study|Protocol Violation|1|||
37654902|NCT02741245|69125909|FG004|Overall Study|Protocol Violation|0|||
37654903|NCT02741245|69125905|FG000|Overall Study|Withdrawal by Subject|0|||
37654904|NCT02741245|69125906|FG001|Overall Study|Withdrawal by Subject|0|||
37654905|NCT02741245|69125907|FG002|Overall Study|Withdrawal by Subject|0|||
37654906|NCT02741245|69125908|FG003|Overall Study|Withdrawal by Subject|1|||
37654907|NCT02741245|69125909|FG004|Overall Study|Withdrawal by Subject|0|||
37654908|NCT03227757|69125921|FG000|Overall Study|Death|7|||
37743885|NCT01984697|69232000|FG004|Overall Study|Pregnancy|1|||
37743886|NCT02000531|69232014|FG000|Overall Study|Lost to Follow-up|1|||
37743887|NCT02000531|69232015|FG001|Overall Study|Lost to Follow-up|0|||
37743888|NCT02000531|69232014|FG000|Overall Study|Discontinued due to data cut-off|3|||
37654909|NCT03227757|69125921|FG000|Overall Study|Withdrawal|5|||
37654910|NCT03227757|69125921|FG000|Overall Study|Missed visits|4|||
37654911|NCT02751827|69125928|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
37654912|NCT02751827|69125929|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
37654913|NCT02751827|69125930|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
37654914|NCT04896593|69125947|FG000|Overall Study|Withdrawal by Subject|2|||
37654915|NCT04896593|69125947|FG000|Overall Study|Lost to Follow-up|1|||
37654916|NCT04896593|69125947|FG000|Overall Study|Did not complete onboarding|2|||
37654917|NCT04601272|69125954|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
37654918|NCT04601272|69125955|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
37743889|NCT02000531|69232015|FG001|Overall Study|Discontinued due to data cut-off|8|||
37654919|NCT04601272|69125956|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
37654920|NCT03965091|69125976|FG000|Overall Study|Adverse Event|0|||
37654921|NCT03965091|69125977|FG001|Overall Study|Adverse Event|2|||
37654922|NCT03965091|69125978|FG002|Overall Study|Adverse Event|3|||
37654923|NCT03965091|69125976|FG000|Overall Study|Withdrawal by Subject|11|||
37654924|NCT03965091|69125977|FG001|Overall Study|Withdrawal by Subject|3|||
37654925|NCT03965091|69125978|FG002|Overall Study|Withdrawal by Subject|5|||
37654926|NCT03965091|69125976|FG000|Overall Study|Non-compliance with study drug|0|||
37654927|NCT03965091|69125977|FG001|Overall Study|Non-compliance with study drug|0|||
37654928|NCT03965091|69125978|FG002|Overall Study|Non-compliance with study drug|1|||
37654929|NCT03965091|69125976|FG000|Overall Study|Lost to Follow-up|1|||
37654930|NCT03965091|69125977|FG001|Overall Study|Lost to Follow-up|1|||
37654931|NCT03965091|69125978|FG002|Overall Study|Lost to Follow-up|1|||
37654932|NCT03965091|69125976|FG000|Overall Study|Lack of Efficacy|2|||
37654933|NCT03965091|69125977|FG001|Overall Study|Lack of Efficacy|0|||
37743890|NCT01609231|69232023|FG000|Overall Study|Adverse Event|1|||
37743891|NCT01609231|69232024|FG001|Overall Study|Adverse Event|3|||
37743892|NCT01609231|69232023|FG000|Overall Study|Physician Decision|1|||
37743893|NCT01609231|69232024|FG001|Overall Study|Physician Decision|0|||
37743894|NCT01609231|69232023|FG000|Overall Study|Withdrawal by Subject|1|||
37743895|NCT01609231|69232024|FG001|Overall Study|Withdrawal by Subject|0|||
37743896|NCT01793935|69232032|FG000|Overall Study|Pregnancy|1|||
37743897|NCT01793935|69232033|FG001|Overall Study|Pregnancy|0|||
37743898|NCT01793935|69232032|FG000|Overall Study|Protocol Violation|2|||
37743899|NCT01793935|69232033|FG001|Overall Study|Protocol Violation|1|||
37743900|NCT01793935|69232032|FG000|Overall Study|Adverse Event|2|||
37743901|NCT01793935|69232033|FG001|Overall Study|Adverse Event|0|||
37743902|NCT01793935|69232032|FG000|Overall Study|Patient did not take study medication|1|||
37743903|NCT01793935|69232033|FG001|Overall Study|Patient did not take study medication|1|||
37743904|NCT01793935|69232032|FG000|Overall Study|Lost to Follow-up|0|||
37743905|NCT01793935|69232033|FG001|Overall Study|Lost to Follow-up|1|||
37743906|NCT02092025|69232039|FG000|Overall Study|Case Report Forms Uncollected|44|||
37743907|NCT02092025|69232039|FG000|Overall Study|Protocol Deviation|24|||
37743908|NCT01769443|69232045|FG000|Overall Study|Study closure|1|||
37743909|NCT01769443|69232046|FG001|Overall Study|Study closure|0|||
37743910|NCT01768117|69232053|FG000|Overall Study|Lost to Follow-up|1|||
37743911|NCT01768117|69232053|FG000|Overall Study|Withdrawal by Subject|2|||
37743912|NCT01768117|69232053|FG000|Overall Study|Protocol Violation|3|||
37743913|NCT01767493|69232057|FG000|Overall Study|screen failures|3|||
37743914|NCT01274182|69232064|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
37743915|NCT01274182|69232065|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
37743916|NCT01274182|69232066|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
37743917|NCT01274182|69232064|FG000|Overall Study|Adverse Event|4|||
37743918|NCT01274182|69232065|FG001|Overall Study|Adverse Event|5|||
37922724|NCT00814320|69609506|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
37922725|NCT00814320|69609505|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
37922726|NCT00814320|69609506|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
37922727|NCT00814320|69609505|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
37654934|NCT03965091|69125978|FG002|Overall Study|Lack of Efficacy|0|||
37654935|NCT03965091|69125976|FG000|Overall Study|Other than specified|9|||
37654936|NCT03965091|69125977|FG001|Overall Study|Other than specified|11|||
37654937|NCT03965091|69125978|FG002|Overall Study|Other than specified|8|||
37743919|NCT01274182|69232066|FG002|Overall Study|Adverse Event|3|||
37743920|NCT01274182|69232064|FG000|Overall Study|Withdrawal by Subject|5|||
37743921|NCT01274182|69232065|FG001|Overall Study|Withdrawal by Subject|5|||
37743922|NCT01274182|69232066|FG002|Overall Study|Withdrawal by Subject|3|||
37743923|NCT01274182|69232064|FG000|Overall Study|Lost to Follow-up|2|||
37743924|NCT01274182|69232065|FG001|Overall Study|Lost to Follow-up|3|||
37743925|NCT01274182|69232066|FG002|Overall Study|Lost to Follow-up|1|||
37743926|NCT01274182|69232064|FG000|Overall Study|Protocol Violation|3|||
37743927|NCT01274182|69232065|FG001|Overall Study|Protocol Violation|2|||
37654938|NCT03359096|69126005|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
37654939|NCT03359096|69126006|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
37654940|NCT03359096|69126005|FG000|First Intervention (4 Weeks)|Death|1|||
37654941|NCT03359096|69126006|FG001|First Intervention (4 Weeks)|Death|0|||
37654942|NCT03359096|69126005|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
37654943|NCT03359096|69126006|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
37654944|NCT03019588|69126023|FG000|Overall Study|Death|44|||
37654945|NCT03019588|69126024|FG001|Overall Study|Death|46|||
37654946|NCT03019588|69126023|FG000|Overall Study|Study terminated by Sponsor|3|||
37654947|NCT03019588|69126024|FG001|Overall Study|Study terminated by Sponsor|1|||
37654948|NCT02455557|69126052|FG000|Overall Study|Withdrawal by Subject|2|||
37654949|NCT02270450|69126060|FG000|Overall Study|Refusal unrelated to adverse event|3|||
37654950|NCT02270450|69126061|FG001|Overall Study|Refusal unrelated to adverse event|1|||
37654951|NCT02270450|69126062|FG002|Overall Study|Refusal unrelated to adverse event|5|||
37654952|NCT02270450|69126063|FG003|Overall Study|Refusal unrelated to adverse event|14|||
37654953|NCT02270450|69126060|FG000|Overall Study|Progression/relapse|1|||
37654954|NCT02270450|69126061|FG001|Overall Study|Progression/relapse|2|||
37654955|NCT02270450|69126062|FG002|Overall Study|Progression/relapse|4|||
37654956|NCT02270450|69126063|FG003|Overall Study|Progression/relapse|9|||
37654957|NCT02270450|69126060|FG000|Overall Study|Death|19|||
37654958|NCT02270450|69126061|FG001|Overall Study|Death|19|||
37654959|NCT02270450|69126062|FG002|Overall Study|Death|31|||
37654960|NCT02270450|69126063|FG003|Overall Study|Death|59|||
37654971|NCT01565499|69126097|FG000|Overall Study|Physician Decision|1|||
37922728|NCT00814320|69609506|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
37922729|NCT00814320|69609505|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
37922730|NCT00814320|69609506|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
37922731|NCT00814320|69609505|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
37922732|NCT00814320|69609506|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
37922733|NCT00869999|69609529|FG000|Overall Study|Withdrawal by Subject|1|||
37922734|NCT00869999|69609529|FG000|Overall Study|removed prior to starting therapy|1|||
37922735|NCT00570232|69609533|FG000|Overall Study|Adverse Event|10|||
37922736|NCT00570232|69609533|FG000|Overall Study|discontinued due to medical condition|3|||
37922737|NCT00570232|69609533|FG000|Overall Study|discontinued due to recurrence|8|||
37922738|NCT00570232|69609533|FG000|Overall Study|discontinued due to noncompliance|2|||
37922739|NCT00809328|69609537|FG000|Overall Study|Lack of Efficacy|18|||
37922740|NCT00809328|69609537|FG000|Overall Study|Adverse Event|6|||
37922741|NCT00809328|69609537|FG000|Overall Study|Protocol Violation|3|||
37922742|NCT00809328|69609537|FG000|Overall Study|Withdrawal by Subject|2|||
37922743|NCT00868517|69609544|FG000|Overall Study|Withdrawal by Subject|3|||
37855302|NCT01294358|69538582|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
37855303|NCT01294358|69538583|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
37855304|NCT01294358|69538584|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
37855305|NCT01294358|69538585|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
37922744|NCT00868517|69609545|FG001|Overall Study|Withdrawal by Subject|3|||
37922745|NCT00868517|69609546|FG002|Overall Study|Withdrawal by Subject|2|||
37922746|NCT00868517|69609544|FG000|Overall Study|Protocol Violation|1|||
37922747|NCT00868517|69609545|FG001|Overall Study|Protocol Violation|1|||
37855306|NCT01294358|69538581|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
37855307|NCT01294358|69538582|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
37855308|NCT01294358|69538583|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
37855309|NCT01294358|69538584|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
37922748|NCT00868517|69609546|FG002|Overall Study|Protocol Violation|0|||
37922749|NCT00868439|69609556|FG000|Overall Study|Adverse Event|4|||
37922750|NCT00868439|69609557|FG001|Overall Study|Adverse Event|3|||
37922751|NCT00868439|69609556|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
37922752|NCT00868439|69609557|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
37922753|NCT00868439|69609556|FG000|Overall Study|Death|0|||
37922754|NCT00868439|69609557|FG001|Overall Study|Death|1|||
37654972|NCT01565499|69126097|FG000|Overall Study|Adverse Event|5|||
37654973|NCT01565499|69126097|FG000|Overall Study|Withdrawal by Subject|2|||
37654974|NCT01036087|69126101|FG000|Overall Study|Adverse Event|2|||
37654975|NCT01036087|69126101|FG000|Overall Study|Lack of Efficacy|1|||
37654976|NCT00572156|69126118|FG000|Overall Study|Adverse Event|3|||
37654977|NCT00572156|69126119|FG001|Overall Study|Adverse Event|1|||
37654978|NCT00572156|69126120|FG002|Overall Study|Adverse Event|5|||
37654979|NCT00572156|69126121|FG003|Overall Study|Adverse Event|1|||
37654980|NCT00572156|69126118|FG000|Overall Study|Lost to Follow-up|1|||
37654981|NCT00572156|69126119|FG001|Overall Study|Lost to Follow-up|1|||
37654982|NCT00572156|69126120|FG002|Overall Study|Lost to Follow-up|1|||
37654983|NCT00572156|69126121|FG003|Overall Study|Lost to Follow-up|0|||
37654984|NCT00572156|69126118|FG000|Overall Study|Protocol Violation|1|||
37654985|NCT00572156|69126119|FG001|Overall Study|Protocol Violation|2|||
37654986|NCT00572156|69126120|FG002|Overall Study|Protocol Violation|0|||
37654987|NCT00572156|69126121|FG003|Overall Study|Protocol Violation|2|||
37654988|NCT00572156|69126118|FG000|Overall Study|Patient/Parent Decision|1|||
37654989|NCT00572156|69126119|FG001|Overall Study|Patient/Parent Decision|6|||
37654990|NCT00572156|69126120|FG002|Overall Study|Patient/Parent Decision|4|||
37654991|NCT00572156|69126121|FG003|Overall Study|Patient/Parent Decision|3|||
37654992|NCT00572156|69126118|FG000|Overall Study|Sponsor Decision|20|||
37654993|NCT00572156|69126119|FG001|Overall Study|Sponsor Decision|16|||
37654994|NCT00572156|69126120|FG002|Overall Study|Sponsor Decision|17|||
37654995|NCT00572156|69126121|FG003|Overall Study|Sponsor Decision|19|||
37855310|NCT01294358|69538585|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
37855311|NCT01294358|69538581|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
37855312|NCT01294358|69538582|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
37855313|NCT01294358|69538583|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
37855314|NCT01294358|69538584|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
38032743|NCT02948582|69718682|FG000|Washout Period 1|Protocol Violation|0|||
38032744|NCT02948582|69718683|FG001|Washout Period 1|Protocol Violation|0|||
38032745|NCT02948582|69718684|FG002|Washout Period 1|Protocol Violation|0|||
38032746|NCT02948582|69718685|FG003|Washout Period 1|Protocol Violation|0|||
38032747|NCT02948582|69718686|FG004|Washout Period 1|Protocol Violation|0|||
38032748|NCT02948582|69718687|FG005|Washout Period 1|Protocol Violation|1|||
38032749|NCT02948582|69718682|FG000|Washout Period 2|Adverse Event|0|||
38032750|NCT02948582|69718683|FG001|Washout Period 2|Adverse Event|1|||
38032751|NCT02948582|69718684|FG002|Washout Period 2|Adverse Event|0|||
38032752|NCT02948582|69718685|FG003|Washout Period 2|Adverse Event|0|||
38032753|NCT02948582|69718686|FG004|Washout Period 2|Adverse Event|0|||
38032754|NCT02948582|69718687|FG005|Washout Period 2|Adverse Event|0|||
38032755|NCT02948582|69718682|FG000|Washout Period 2|personal reasons|0|||
38032756|NCT02948582|69718683|FG001|Washout Period 2|personal reasons|0|||
38032757|NCT02948582|69718684|FG002|Washout Period 2|personal reasons|0|||
38032758|NCT02948582|69718685|FG003|Washout Period 2|personal reasons|1|||
38032759|NCT02948582|69718686|FG004|Washout Period 2|personal reasons|0|||
38032760|NCT02948582|69718687|FG005|Washout Period 2|personal reasons|0|||
38032761|NCT02948582|69718682|FG000|Washout Period 4|Adverse Event|1|||
38032762|NCT02948582|69718683|FG001|Washout Period 4|Adverse Event|0|||
37855315|NCT01294358|69538585|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
37855316|NCT00994279|69538604|FG000|Overall Study|Withdrawal by Subject|2|||
37855317|NCT00994279|69538605|FG001|Overall Study|Withdrawal by Subject|2|||
37855318|NCT00994279|69538604|FG000|Overall Study|Toxicity|1|||
38032763|NCT02948582|69718684|FG002|Washout Period 4|Adverse Event|1|||
38032764|NCT02948582|69718685|FG003|Washout Period 4|Adverse Event|0|||
38032765|NCT02948582|69718686|FG004|Washout Period 4|Adverse Event|0|||
38032766|NCT02948582|69718687|FG005|Washout Period 4|Adverse Event|0|||
37855319|NCT00994279|69538605|FG001|Overall Study|Toxicity|0|||
37855320|NCT00994279|69538604|FG000|Overall Study|Multiple reasons|1|||
37855321|NCT00994279|69538605|FG001|Overall Study|Multiple reasons|3|||
37855322|NCT01294046|69538611|FG000|Overall Study|Infection and surgical explant|1|||
37855323|NCT01294046|69538611|FG000|Overall Study|Eligibility criteria expanded|1|||
37855324|NCT01294046|69538611|FG000|Overall Study|Stimulation response inadqequate|1|||
37855325|NCT01224639|69538626|FG000|Overall Study|Withdrawal by Subject|0|||
37855326|NCT01224639|69538627|FG001|Overall Study|Withdrawal by Subject|0|||
37855327|NCT01224639|69538628|FG002|Overall Study|Withdrawal by Subject|0|||
37855328|NCT01224639|69538629|FG003|Overall Study|Withdrawal by Subject|0|||
37855329|NCT01224639|69538630|FG004|Overall Study|Withdrawal by Subject|2|||
37855330|NCT01224639|69538631|FG005|Overall Study|Withdrawal by Subject|0|||
37855331|NCT01224639|69538632|FG006|Overall Study|Withdrawal by Subject|1|||
37855332|NCT01224639|69538633|FG007|Overall Study|Withdrawal by Subject|1|||
37855333|NCT01224639|69538626|FG000|Overall Study|Adverse Event|0|||
37855334|NCT01224639|69538627|FG001|Overall Study|Adverse Event|0|||
37855335|NCT01224639|69538628|FG002|Overall Study|Adverse Event|0|||
37855336|NCT01224639|69538629|FG003|Overall Study|Adverse Event|0|||
37855337|NCT01224639|69538630|FG004|Overall Study|Adverse Event|0|||
37654996|NCT00447772|69126131|FG000|Overall Study|Lack of Efficacy|3|||
37855338|NCT01224639|69538631|FG005|Overall Study|Adverse Event|0|||
37855339|NCT01224639|69538632|FG006|Overall Study|Adverse Event|0|||
37855340|NCT01224639|69538633|FG007|Overall Study|Adverse Event|1|||
37654997|NCT00447772|69126131|FG000|Overall Study|Insufficient compliance|6|||
37654998|NCT00447772|69126131|FG000|Overall Study|Discontinuation of drug therapy|1|||
37654999|NCT00447772|69126131|FG000|Overall Study|Lost to Follow-up|9|||
37655000|NCT00447772|69126131|FG000|Overall Study|Withdrawal by Subject|1|||
37655001|NCT00447772|69126131|FG000|Overall Study|Unable to attend all study visits|2|||
37655002|NCT00447772|69126131|FG000|Overall Study|Adverse Event|1|||
37655003|NCT00447772|69126131|FG000|Overall Study|Patient relocated|1|||
37655004|NCT00447772|69126131|FG000|Overall Study|Incomplete documentation at visit 1|1|||
37655005|NCT00447772|69126131|FG000|Overall Study|Chemotherapy for lung cancer|1|||
37655006|NCT00447772|69126131|FG000|Overall Study|Premature re-injection required|1|||
37655007|NCT02296138|69126140|FG000|Overall Study|Adverse Event|348|||
37655008|NCT02296138|69126141|FG001|Overall Study|Adverse Event|259|||
37655009|NCT02296138|69126140|FG000|Overall Study|Lack of Efficacy|59|||
37655010|NCT02296138|69126141|FG001|Overall Study|Lack of Efficacy|37|||
37655011|NCT02296138|69126140|FG000|Overall Study|Protocol Violation|35|||
37655012|NCT02296138|69126141|FG001|Overall Study|Protocol Violation|36|||
37655013|NCT02296138|69126140|FG000|Overall Study|Lost to Follow-up|9|||
37655014|NCT02296138|69126141|FG001|Overall Study|Lost to Follow-up|12|||
37655015|NCT02296138|69126140|FG000|Overall Study|Withdrawal by Subject|184|||
37655016|NCT02296138|69126141|FG001|Overall Study|Withdrawal by Subject|131|||
37655017|NCT02296138|69126140|FG000|Overall Study|Not Treated|1|||
37655018|NCT02296138|69126141|FG001|Overall Study|Not Treated|1|||
37655019|NCT02296138|69126140|FG000|Overall Study|Patients with data irregularities|10|||
37655020|NCT02296138|69126141|FG001|Overall Study|Patients with data irregularities|11|||
37655021|NCT02296138|69126140|FG000|Overall Study|Other than specified|15|||
37655022|NCT02296138|69126141|FG001|Overall Study|Other than specified|13|||
37655023|NCT01306942|69126150|FG000|Phase I|Adverse Event|2|||
37655024|NCT01306942|69126151|FG001|Phase I|Adverse Event|2|||
37655025|NCT01306942|69126152|FG002|Phase I|Adverse Event|0|||
37655026|NCT01306942|69126153|FG003|Phase I|Adverse Event|0|||
37655027|NCT01306942|69126150|FG000|Phase I|Physician Decision|3|||
37655028|NCT01306942|69126151|FG001|Phase I|Physician Decision|1|||
37655029|NCT01306942|69126152|FG002|Phase I|Physician Decision|0|||
37655030|NCT01306942|69126153|FG003|Phase I|Physician Decision|0|||
37655031|NCT01306942|69126150|FG000|Phase II|Adverse Event|0|||
37655032|NCT01306942|69126151|FG001|Phase II|Adverse Event|0|||
37855341|NCT01293968|69538653|FG000|Overall Study|non-cooperation|3|||
37855342|NCT01293968|69538654|FG001|Overall Study|non-cooperation|3|||
37855343|NCT01293032|69538664|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
37855344|NCT01293032|69538665|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
37855345|NCT01293032|69538666|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
37855346|NCT01293032|69538667|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
37855347|NCT01293032|69538664|FG000|Treatment|Adverse Event|0|||
37855348|NCT01293032|69538665|FG001|Treatment|Adverse Event|0|||
37855349|NCT01293032|69538666|FG002|Treatment|Adverse Event|1|||
37855350|NCT01293032|69538667|FG003|Treatment|Adverse Event|1|||
37855351|NCT01293032|69538664|FG000|Treatment|Withdrawal by Subject|2|||
37855352|NCT01293032|69538665|FG001|Treatment|Withdrawal by Subject|4|||
37855353|NCT01293032|69538666|FG002|Treatment|Withdrawal by Subject|0|||
37855354|NCT01293032|69538667|FG003|Treatment|Withdrawal by Subject|0|||
37855355|NCT01293032|69538664|FG000|Treatment|Disease Progression, relapse|0|||
37855356|NCT01293032|69538665|FG001|Treatment|Disease Progression, relapse|1|||
37855357|NCT01293032|69538666|FG002|Treatment|Disease Progression, relapse|0|||
37855358|NCT01293032|69538667|FG003|Treatment|Disease Progression, relapse|0|||
37855359|NCT01292876|69538674|FG000|Overall Study|Physician Decision|4|||
37855360|NCT01224171|69538682|FG000|Overall Study|Adverse Event|8|||
37855361|NCT01224171|69538683|FG001|Overall Study|Adverse Event|4|||
38032767|NCT03756285|69718703|FG000|Overall Study|Lost to Follow-up|0|||
38032768|NCT03756285|69718704|FG001|Overall Study|Lost to Follow-up|1|||
38032769|NCT03756285|69718703|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
38032770|NCT03756285|69718704|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
38032771|NCT03756285|69718703|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
38032772|NCT03756285|69718704|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
38032773|NCT02825992|69718730|FG000|Overall Study|Withdrawal by Subject|4|||
38032774|NCT02825992|69718730|FG000|Overall Study|Lost to Follow-up|2|||
38032775|NCT02825992|69718730|FG000|Overall Study|Procedure terminated|2|||
38032776|NCT01339000|69718742|FG000|Overall Study|study closed due to lack of drug supply|1|||
37855362|NCT01224171|69538682|FG000|Overall Study|Protocol Violation|0|||
37855363|NCT01224171|69538683|FG001|Overall Study|Protocol Violation|1|||
37855364|NCT01224171|69538682|FG000|Overall Study|Lack of Efficacy|5|||
37855365|NCT01224171|69538683|FG001|Overall Study|Lack of Efficacy|1|||
37855366|NCT01224171|69538682|FG000|Overall Study|Withdrawal of Consent|2|||
37855367|NCT01224171|69538683|FG001|Overall Study|Withdrawal of Consent|4|||
37855368|NCT01224171|69538682|FG000|Overall Study|Lost to Follow-up|0|||
37655033|NCT01306942|69126152|FG002|Phase II|Adverse Event|0|||
37655034|NCT01306942|69126153|FG003|Phase II|Adverse Event|6|||
37655035|NCT01306942|69126150|FG000|Phase II|Physician Decision|2|||
37655036|NCT01306942|69126151|FG001|Phase II|Physician Decision|0|||
37922755|NCT00868439|69609556|FG000|Overall Study|Protocol Violation|1|||
37922756|NCT00868439|69609557|FG001|Overall Study|Protocol Violation|1|||
37922757|NCT00868439|69609556|FG000|Overall Study|Physician Decision|1|||
37922758|NCT00868439|69609557|FG001|Overall Study|Physician Decision|0|||
37922759|NCT00868439|69609556|FG000|Overall Study|Withdrawal by Subject|0|||
37922760|NCT00868439|69609557|FG001|Overall Study|Withdrawal by Subject|1|||
37922761|NCT00814164|69609563|FG000|Overall Study|Progression|7|||
37655037|NCT01306942|69126152|FG002|Phase II|Physician Decision|0|||
37655038|NCT01306942|69126153|FG003|Phase II|Physician Decision|5|||
37655039|NCT01306942|69126150|FG000|Phase II|Withdrawal by Subject|0|||
37655040|NCT01306942|69126151|FG001|Phase II|Withdrawal by Subject|0|||
37922762|NCT00814164|69609563|FG000|Overall Study|not stated|7|||
37922763|NCT00814164|69609563|FG000|Overall Study|Death|5|||
37922764|NCT00659230|69609569|FG000|Overall Study|Lost to Follow-up|2|||
37922765|NCT00659230|69609570|FG001|Overall Study|Lost to Follow-up|5|||
37922766|NCT00659230|69609569|FG000|Overall Study|Lost source documentation|5|||
37655041|NCT01306942|69126152|FG002|Phase II|Withdrawal by Subject|0|||
37655042|NCT01306942|69126153|FG003|Phase II|Withdrawal by Subject|2|||
37655043|NCT01306942|69126150|FG000|Phase II|Death|0|||
37655044|NCT01306942|69126151|FG001|Phase II|Death|0|||
37655045|NCT01306942|69126152|FG002|Phase II|Death|0|||
37655046|NCT01306942|69126153|FG003|Phase II|Death|1|||
37922767|NCT00659230|69609570|FG001|Overall Study|Lost source documentation|4|||
37922768|NCT00659230|69609569|FG000|Overall Study|Did not return post-randomization|2|||
37922769|NCT00659230|69609570|FG001|Overall Study|Did not return post-randomization|3|||
37922770|NCT00809094|69609578|FG000|Overall Study|Lost to Follow-up|0|||
37922771|NCT00809094|69609579|FG001|Overall Study|Lost to Follow-up|1|||
37922772|NCT00658996|69609585|FG000|First Intervention|Positive slit lamp finding|1|||
37922773|NCT00658996|69609586|FG001|First Intervention|Positive slit lamp finding|0|||
37922774|NCT00658996|69609585|FG000|First Intervention|Lack of lenses|0|||
37922775|NCT00658996|69609586|FG001|First Intervention|Lack of lenses|1|||
37922776|NCT00658996|69609585|FG000|Crossover Period|Physician Decision|1|||
37922777|NCT00658996|69609586|FG001|Crossover Period|Physician Decision|0|||
37922778|NCT00658996|69609585|FG000|Crossover Period|Ineligible|1|||
37922779|NCT00658996|69609586|FG001|Crossover Period|Ineligible|1|||
37922780|NCT00658996|69609585|FG000|Second Intervention|Developed a stye on upper lid|1|||
37655047|NCT01306942|69126150|FG000|Phase II|Not finished treatment|0|||
37655048|NCT01306942|69126151|FG001|Phase II|Not finished treatment|0|||
37655049|NCT01306942|69126152|FG002|Phase II|Not finished treatment|0|||
37655050|NCT01306942|69126153|FG003|Phase II|Not finished treatment|1|||
37743928|NCT01274182|69232066|FG002|Overall Study|Protocol Violation|0|||
37743929|NCT01274182|69232064|FG000|Overall Study|Death|1|||
37743930|NCT01274182|69232065|FG001|Overall Study|Death|0|||
37743931|NCT01274182|69232066|FG002|Overall Study|Death|1|||
37743932|NCT01984229|69232080|FG000|Safety Follow-up Period|Adverse Event|1|||
37743933|NCT01984229|69232081|FG001|Safety Follow-up Period|Adverse Event|1|||
37743934|NCT01984229|69232080|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
37743935|NCT01984229|69232081|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
37743936|NCT01835899|69232096|FG000|Overall Study|Adverse Event|0|||
37743937|NCT01835899|69232097|FG001|Overall Study|Adverse Event|0|||
37743938|NCT01835899|69232098|FG002|Overall Study|Adverse Event|1|||
37743939|NCT01835899|69232096|FG000|Overall Study|Other than stated above|0|||
37743940|NCT01835899|69232097|FG001|Overall Study|Other than stated above|1|||
37743941|NCT01835899|69232098|FG002|Overall Study|Other than stated above|0|||
37743942|NCT01766401|69232110|FG000|Overall Study|Adverse Event|7|||
37655051|NCT01306942|69126150|FG000|Phase II|Protocol Violation|0|||
37743943|NCT01766401|69232111|FG001|Overall Study|Adverse Event|22|||
37743944|NCT01766401|69232110|FG000|Overall Study|Lack of Efficacy|1|||
37743945|NCT01766401|69232111|FG001|Overall Study|Lack of Efficacy|2|||
37743946|NCT01766401|69232110|FG000|Overall Study|Protocol Violation|3|||
37743947|NCT01766401|69232111|FG001|Overall Study|Protocol Violation|8|||
37743948|NCT01766401|69232110|FG000|Overall Study|Withdrawal by Subject|15|||
37743949|NCT01766401|69232111|FG001|Overall Study|Withdrawal by Subject|12|||
37743950|NCT01766401|69232110|FG000|Overall Study|Lost to Follow-up|10|||
37743951|NCT01766401|69232111|FG001|Overall Study|Lost to Follow-up|11|||
37922781|NCT00658996|69609586|FG001|Second Intervention|Developed a stye on upper lid|0|||
37922782|NCT00658996|69609585|FG000|Second Intervention|Positive slit lamp finding|0|||
37655052|NCT01306942|69126151|FG001|Phase II|Protocol Violation|0|||
37655053|NCT01306942|69126152|FG002|Phase II|Protocol Violation|0|||
37655054|NCT01306942|69126153|FG003|Phase II|Protocol Violation|1|||
37743952|NCT01766401|69232110|FG000|Overall Study|Pregnancy|1|||
37743953|NCT01766401|69232111|FG001|Overall Study|Pregnancy|1|||
37743954|NCT01272934|69232119|FG000|Overall Study|Adverse Event|0|||
37743955|NCT01272934|69232120|FG001|Overall Study|Adverse Event|1|||
37743956|NCT01272934|69232119|FG000|Overall Study|Abnormal Laboratory Value|0|||
37743957|NCT01272934|69232120|FG001|Overall Study|Abnormal Laboratory Value|1|||
37922783|NCT00658996|69609586|FG001|Second Intervention|Positive slit lamp finding|1|||
37922784|NCT00867815|69609592|FG000|Overall Study|Lost to Follow-up|1|||
37922785|NCT00452413|69609599|FG000|Overall Study|Progressive Disease|4|||
37922786|NCT00452413|69609600|FG001|Overall Study|Progressive Disease|11|||
37743958|NCT01983683|69232138|FG000|Overall Study|Withdrawal by Subject|14|||
37743959|NCT01983683|69232139|FG001|Overall Study|Withdrawal by Subject|18|||
37743960|NCT01983683|69232138|FG000|Overall Study|Death|11|||
37743961|NCT01983683|69232139|FG001|Overall Study|Death|15|||
37743962|NCT01983683|69232138|FG000|Overall Study|Physician Decision|8|||
37743963|NCT01983683|69232139|FG001|Overall Study|Physician Decision|9|||
37743964|NCT01983683|69232138|FG000|Overall Study|Lost to Follow-up|4|||
37743965|NCT01983683|69232139|FG001|Overall Study|Lost to Follow-up|8|||
37743966|NCT01983683|69232138|FG000|Overall Study|Sponsor Decision|1|||
37743967|NCT01983683|69232139|FG001|Overall Study|Sponsor Decision|1|||
37743968|NCT01998893|69232145|FG000|Overall Study|Adverse Event|2|||
37743969|NCT01998893|69232145|FG000|Overall Study|Death|1|||
37743970|NCT01998893|69232145|FG000|Overall Study|Lost to Follow-up|8|||
37743971|NCT01998893|69232145|FG000|Overall Study|Physician Decision|2|||
37743972|NCT01998893|69232145|FG000|Overall Study|Protocol Violation|2|||
37743973|NCT01998893|69232145|FG000|Overall Study|Withdrawal by Subject|1|||
37743974|NCT01998893|69232145|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
37743975|NCT01791985|69232149|FG000|Overall Study|Adverse Event|7|||
37655055|NCT02324842|69126168|FG000|Overall Study|Lost to Follow-up|1|||
37655056|NCT02324842|69126169|FG001|Overall Study|Lost to Follow-up|1|||
37655057|NCT02324842|69126170|FG002|Overall Study|Lost to Follow-up|2|||
37655058|NCT02295280|69126180|FG000|Overall Study|Adverse Event|0|||
37655059|NCT02295280|69126181|FG001|Overall Study|Adverse Event|1|||
37655060|NCT05263505|69126189|FG000|Overall Study|Adverse Event|0|||
37655061|NCT05263505|69126190|FG001|Overall Study|Adverse Event|1|||
37655062|NCT02294734|69126198|FG000|Overall Study|Adverse Event|5|||
37743976|NCT01791985|69232149|FG000|Overall Study|Withdrawal by Subject|1|||
37743977|NCT01998737|69232156|FG000|Overall Study|Corrupted database|23|||
37743978|NCT01998737|69232157|FG001|Overall Study|Corrupted database|0|||
37743979|NCT01791517|69232166|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
37743980|NCT01791517|69232167|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
37743981|NCT01791517|69232168|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
37743982|NCT01791517|69232169|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
37743983|NCT01791517|69232170|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
37743984|NCT01791517|69232171|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
37655063|NCT02294734|69126199|FG001|Overall Study|Adverse Event|5|||
37655064|NCT02294734|69126198|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
37655065|NCT02294734|69126199|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
37655066|NCT02294734|69126198|FG000|Overall Study|Lost to Follow-up|2|||
37655067|NCT02294734|69126199|FG001|Overall Study|Lost to Follow-up|0|||
37655068|NCT02294734|69126198|FG000|Overall Study|Physician Decision|2|||
37655069|NCT02294734|69126199|FG001|Overall Study|Physician Decision|1|||
37655070|NCT02294734|69126198|FG000|Overall Study|Withdrawal by Subject|4|||
37655071|NCT02294734|69126199|FG001|Overall Study|Withdrawal by Subject|2|||
37655072|NCT02323204|69126220|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
37855369|NCT01224171|69538683|FG001|Overall Study|Lost to Follow-up|3|||
37655073|NCT02323204|69126221|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
37655074|NCT02323204|69126222|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
37655075|NCT02323204|69126223|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
37655076|NCT02323204|69126220|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
37655077|NCT02323204|69126221|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
37655078|NCT02323204|69126222|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
37655079|NCT02323204|69126223|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
37655080|NCT02323204|69126220|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
37655081|NCT02323204|69126221|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
37655082|NCT02323204|69126222|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
37655083|NCT02323204|69126223|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
37655084|NCT02323204|69126220|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
37655085|NCT02323204|69126221|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
37655086|NCT02323204|69126222|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
37655087|NCT02323204|69126223|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
37655088|NCT02323204|69126220|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
38032777|NCT01339000|69718743|FG001|Overall Study|study closed due to lack of drug supply|0|||
37655089|NCT02323204|69126221|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
37655090|NCT02323204|69126222|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
37655091|NCT02323204|69126223|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
37655092|NCT02323204|69126220|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
37743985|NCT01791517|69232172|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
37743986|NCT01791517|69232173|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
37743987|NCT01791517|69232174|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
37743988|NCT01791517|69232175|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
37743989|NCT01791517|69232176|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
37743990|NCT01791517|69232177|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
37743991|NCT01791517|69232166|FG000|Phase I: Period 1|Adverse Event|0|||
37655093|NCT02323204|69126221|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
37655094|NCT02323204|69126222|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
37655095|NCT02323204|69126223|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
37655096|NCT02323204|69126220|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
37655097|NCT02323204|69126221|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
37655098|NCT02323204|69126222|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
37655099|NCT02323204|69126223|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
37655100|NCT02323204|69126220|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
37655101|NCT02323204|69126221|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
37655102|NCT02323204|69126222|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
37655103|NCT02323204|69126223|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
37655104|NCT02323204|69126220|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
37655105|NCT02323204|69126221|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
37655106|NCT02323204|69126222|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
37655107|NCT02323204|69126223|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
37655108|NCT02322892|69126235|FG000|Overall Study|Surgery cancelled|1|||
37655109|NCT02322892|69126236|FG001|Overall Study|Surgery cancelled|2|||
37655110|NCT02322892|69126235|FG000|Overall Study|Met exclusion criteria|0|||
37655111|NCT02322892|69126236|FG001|Overall Study|Met exclusion criteria|1|||
37655112|NCT02322892|69126235|FG000|Overall Study|Protocol Violation|1|||
37655113|NCT02322892|69126236|FG001|Overall Study|Protocol Violation|0|||
37655114|NCT03916081|69126245|FG000|Overall Study|Adverse Event|1|||
37655115|NCT03916081|69126246|FG001|Overall Study|Adverse Event|0|||
37655116|NCT03916081|69126247|FG002|Overall Study|Adverse Event|0|||
37655117|NCT03916081|69126245|FG000|Overall Study|Physician Decision|0|||
37655118|NCT03916081|69126246|FG001|Overall Study|Physician Decision|0|||
37655119|NCT03916081|69126247|FG002|Overall Study|Physician Decision|1|||
37655120|NCT03916081|69126245|FG000|Overall Study|Lost to Follow-up|0|||
37655121|NCT03916081|69126246|FG001|Overall Study|Lost to Follow-up|1|||
37655122|NCT03916081|69126247|FG002|Overall Study|Lost to Follow-up|0|||
37655123|NCT03916081|69126245|FG000|Overall Study|Withdrawal by Subject|3|||
37655124|NCT03916081|69126246|FG001|Overall Study|Withdrawal by Subject|0|||
37655125|NCT03916081|69126247|FG002|Overall Study|Withdrawal by Subject|1|||
37655126|NCT03916081|69126245|FG000|Overall Study|Worsening of AD|0|||
37655127|NCT03916081|69126246|FG001|Overall Study|Worsening of AD|0|||
37655128|NCT03916081|69126247|FG002|Overall Study|Worsening of AD|1|||
37655129|NCT02739997|69126255|FG000|Overall Study|Death|1|||
37655130|NCT02739997|69126255|FG000|Overall Study|Withdrawal by Subject|1|||
37655131|NCT02221037|69126263|FG000|Overall Study|Physician Decision|0|||
37655132|NCT02221037|69126264|FG001|Overall Study|Physician Decision|0|||
37655133|NCT02221037|69126265|FG002|Overall Study|Physician Decision|1|||
37655134|NCT02221037|69126266|FG003|Overall Study|Physician Decision|0|||
37655135|NCT02704429|69126282|FG000|Part A: 24 Weeks|Adverse Event|3|||
37655136|NCT02704429|69126283|FG001|Part A: 24 Weeks|Adverse Event|0|||
37655137|NCT02704429|69126282|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
37655138|NCT02704429|69126283|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
37655139|NCT02751359|69126290|FG000|Overall Study|Lost to Follow-up|1|||
37655140|NCT02750813|69126309|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
37655141|NCT02750813|69126310|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
37655142|NCT02750813|69126309|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
37655143|NCT02750813|69126310|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
37655144|NCT00503035|69126326|FG000|Overall Study|Lost to Follow-up|2|||
37655145|NCT00503035|69126326|FG000|Overall Study|Physician Decision|3|||
37655146|NCT00503035|69126326|FG000|Overall Study|Ineligible|15|||
37655147|NCT03137381|69126335|FG000|Overall Study|Adverse Event|3|||
37655148|NCT03137381|69126336|FG001|Overall Study|Adverse Event|0|||
37655149|NCT03137381|69126337|FG002|Overall Study|Adverse Event|2|||
37655150|NCT03137381|69126338|FG003|Overall Study|Adverse Event|0|||
37655151|NCT03137381|69126335|FG000|Overall Study|Lost to Follow-up|2|||
37655152|NCT03137381|69126336|FG001|Overall Study|Lost to Follow-up|1|||
37655153|NCT03137381|69126337|FG002|Overall Study|Lost to Follow-up|1|||
37655154|NCT03137381|69126338|FG003|Overall Study|Lost to Follow-up|0|||
37922787|NCT00452413|69609601|FG002|Overall Study|Progressive Disease|30|||
37922788|NCT00452413|69609599|FG000|Overall Study|Withdrawal by Subject|0|||
37922789|NCT00452413|69609600|FG001|Overall Study|Withdrawal by Subject|1|||
37655155|NCT03137381|69126335|FG000|Overall Study|Protocol deviation|1|||
37655156|NCT03137381|69126336|FG001|Overall Study|Protocol deviation|1|||
37655157|NCT03137381|69126337|FG002|Overall Study|Protocol deviation|0|||
37655158|NCT03137381|69126338|FG003|Overall Study|Protocol deviation|1|||
37655159|NCT03137381|69126335|FG000|Overall Study|Withdrawal by Investigator|0|||
37655160|NCT03137381|69126336|FG001|Overall Study|Withdrawal by Investigator|1|||
37655161|NCT03137381|69126337|FG002|Overall Study|Withdrawal by Investigator|1|||
37655162|NCT03137381|69126338|FG003|Overall Study|Withdrawal by Investigator|0|||
37655163|NCT03137381|69126335|FG000|Overall Study|Withdrawal by Subject|3|||
37655164|NCT03137381|69126336|FG001|Overall Study|Withdrawal by Subject|4|||
37922790|NCT00452413|69609601|FG002|Overall Study|Withdrawal by Subject|4|||
37655165|NCT03137381|69126337|FG002|Overall Study|Withdrawal by Subject|3|||
37655166|NCT03137381|69126338|FG003|Overall Study|Withdrawal by Subject|0|||
37743992|NCT01791517|69232167|FG001|Phase I: Period 1|Adverse Event|0|||
37743993|NCT01791517|69232168|FG002|Phase I: Period 1|Adverse Event|1|||
37743994|NCT01791517|69232169|FG003|Phase I: Period 1|Adverse Event|1|||
37743995|NCT01791517|69232170|FG004|Phase I: Period 1|Adverse Event|0|||
37855370|NCT01292486|69538689|FG000|Overall Study|Protocol Violation|2|||
37855371|NCT01292486|69538689|FG000|Overall Study|Did not meet screening criteria|2|||
37855372|NCT01292486|69538689|FG000|Overall Study|Adverse Event|1|||
37855373|NCT01292486|69538689|FG000|Overall Study|Physician Decision|1|||
37855374|NCT01223937|69538696|FG000|Overall Study|Withdrawal by Subject|3|||
37855375|NCT01223937|69538697|FG001|Overall Study|Withdrawal by Subject|2|||
37855376|NCT01223937|69538696|FG000|Overall Study|Lost to Follow-up|1|||
37855377|NCT01223937|69538697|FG001|Overall Study|Lost to Follow-up|4|||
37855378|NCT01223937|69538696|FG000|Overall Study|Adverse Event|1|||
37855379|NCT01223937|69538697|FG001|Overall Study|Adverse Event|4|||
37855380|NCT01223937|69538696|FG000|Overall Study|Protocol Violation|8|||
37855381|NCT01223937|69538697|FG001|Overall Study|Protocol Violation|7|||
37855382|NCT01223937|69538696|FG000|Overall Study|Other|4|||
37855383|NCT01223937|69538697|FG001|Overall Study|Other|1|||
37855384|NCT01290224|69538703|FG000|Overall Study|Adverse Event|1|||
37855385|NCT01290224|69538703|FG000|Overall Study|Refused Further Treatment|4|||
37855386|NCT01223235|69538709|FG000|Overall Study|Withdrawal by Subject|1|||
37855387|NCT01290068|69538715|FG000|Overall Study|Adverse Event|1|||
37855388|NCT01290068|69538716|FG001|Overall Study|Adverse Event|3|||
37855389|NCT01290068|69538715|FG000|Overall Study|Lost to Follow-up|3|||
37855390|NCT01290068|69538716|FG001|Overall Study|Lost to Follow-up|0|||
37855391|NCT01290068|69538715|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
37855392|NCT01290068|69538716|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
37855393|NCT01290068|69538715|FG000|Overall Study|Other|3|||
37855394|NCT01290068|69538716|FG001|Overall Study|Other|1|||
37855395|NCT00998881|69538724|FG000|Overall Study|Adverse Event|2|||
37855396|NCT00998881|69538725|FG001|Overall Study|Adverse Event|2|||
37855397|NCT00998881|69538724|FG000|Overall Study|Lack of Efficacy|1|||
37855398|NCT00998881|69538725|FG001|Overall Study|Lack of Efficacy|0|||
37855399|NCT00998881|69538724|FG000|Overall Study|Physician Decision|3|||
37855400|NCT00998881|69538725|FG001|Overall Study|Physician Decision|0|||
37855401|NCT00998881|69538724|FG000|Overall Study|Withdrawal by Subject|1|||
37855402|NCT00998881|69538725|FG001|Overall Study|Withdrawal by Subject|0|||
37855403|NCT00998881|69538724|FG000|Overall Study|Personal matter|1|||
37855404|NCT00998881|69538725|FG001|Overall Study|Personal matter|0|||
37855405|NCT01222767|69538731|FG000|Overall Study|Progressive disease|13|||
37855406|NCT01222767|69538731|FG000|Overall Study|Adverse Event|2|||
37855407|NCT01222767|69538731|FG000|Overall Study|Surgical resection|1|||
37855408|NCT01222767|69538731|FG000|Overall Study|Never treated|1|||
37855409|NCT00993967|69538735|FG000|Overall Study|Adverse Event|8|||
37855410|NCT00993967|69538735|FG000|Overall Study|Death|1|||
37855411|NCT00993967|69538735|FG000|Overall Study|Lost to Follow-up|14|||
37855412|NCT00993967|69538735|FG000|Overall Study|Withdrawal by Subject|36|||
37855413|NCT00993967|69538735|FG000|Overall Study|Protocol Violation|2|||
37855414|NCT01222533|69538739|FG000|Overall Study|Adverse Event|5|||
37855415|NCT01222533|69538739|FG000|Overall Study|Withdrawal by Subject|5|||
37855416|NCT01222533|69538739|FG000|Overall Study|Other|4|||
37855417|NCT01221753|69538751|FG000|Overall Study|Adverse Event|1|||
37855418|NCT01221597|69538757|FG000|Overall Study|Adverse Event|4|||
37855419|NCT01221597|69538758|FG001|Overall Study|Adverse Event|1|||
37855420|NCT01221597|69538757|FG000|Overall Study|Withdrawal by Subject|20|||
37855421|NCT01221597|69538758|FG001|Overall Study|Withdrawal by Subject|6|||
37855422|NCT01221597|69538757|FG000|Overall Study|Lost to Follow-up|6|||
37855423|NCT01221597|69538758|FG001|Overall Study|Lost to Follow-up|5|||
37655167|NCT03137381|69126335|FG000|Overall Study|Pregnancy|0|||
37655168|NCT03137381|69126336|FG001|Overall Study|Pregnancy|0|||
37655169|NCT03137381|69126337|FG002|Overall Study|Pregnancy|1|||
37655170|NCT03137381|69126338|FG003|Overall Study|Pregnancy|0|||
37855424|NCT01221597|69538757|FG000|Overall Study|Protocol Violation|1|||
37922791|NCT00452413|69609599|FG000|Overall Study|Adverse Event|0|||
37922792|NCT00452413|69609600|FG001|Overall Study|Adverse Event|0|||
37655171|NCT03926117|69126352|FG000|Overall Study|Unclassified|1|||
37855425|NCT01221597|69538758|FG001|Overall Study|Protocol Violation|0|||
37855426|NCT01221597|69538757|FG000|Overall Study|Other|3|||
37855427|NCT01221597|69538758|FG001|Overall Study|Other|4|||
37655172|NCT03926117|69126353|FG001|Overall Study|Unclassified|4|||
37655173|NCT03926117|69126354|FG002|Overall Study|Unclassified|1|||
37743996|NCT01791517|69232171|FG005|Phase I: Period 1|Adverse Event|0|||
37743997|NCT01791517|69232172|FG006|Phase I: Period 1|Adverse Event|0|||
37855428|NCT01221597|69538757|FG000|Overall Study|Death|2|||
37855429|NCT01221597|69538758|FG001|Overall Study|Death|0|||
37855430|NCT01221363|69538767|FG000|Overall Study|Pregnancy|1|||
37855431|NCT01221363|69538768|FG001|Overall Study|Pregnancy|0|||
37855432|NCT01221363|69538767|FG000|Overall Study|Withdrawal by Subject|11|||
37922793|NCT00452413|69609601|FG002|Overall Study|Adverse Event|5|||
37655174|NCT03926117|69126355|FG003|Overall Study|Unclassified|4|||
37655175|NCT03926117|69126352|FG000|Overall Study|Withdrawal by Subject|3|||
37655176|NCT03926117|69126353|FG001|Overall Study|Withdrawal by Subject|0|||
37655177|NCT03926117|69126354|FG002|Overall Study|Withdrawal by Subject|1|||
37655178|NCT03926117|69126355|FG003|Overall Study|Withdrawal by Subject|1|||
37655179|NCT03926117|69126352|FG000|Overall Study|Lost to Follow-up|0|||
37655180|NCT03926117|69126353|FG001|Overall Study|Lost to Follow-up|2|||
37655181|NCT03926117|69126354|FG002|Overall Study|Lost to Follow-up|1|||
37655182|NCT03926117|69126355|FG003|Overall Study|Lost to Follow-up|0|||
37655183|NCT03926117|69126352|FG000|Overall Study|Adverse Event|1|||
37655184|NCT03926117|69126353|FG001|Overall Study|Adverse Event|2|||
37655185|NCT03926117|69126354|FG002|Overall Study|Adverse Event|3|||
37655186|NCT03926117|69126355|FG003|Overall Study|Adverse Event|1|||
37655187|NCT03926117|69126352|FG000|Overall Study|Randomized but not treated|1|||
37655188|NCT03926117|69126353|FG001|Overall Study|Randomized but not treated|1|||
37655189|NCT03926117|69126354|FG002|Overall Study|Randomized but not treated|0|||
37655190|NCT03926117|69126355|FG003|Overall Study|Randomized but not treated|1|||
37655191|NCT02750501|69126382|FG000|Overall Study|Adverse Event|4|||
37743998|NCT01791517|69232173|FG007|Phase I: Period 1|Adverse Event|0|||
37743999|NCT01791517|69232174|FG008|Phase I: Period 1|Adverse Event|0|||
37744000|NCT01791517|69232175|FG009|Phase I: Period 1|Adverse Event|0|||
37744001|NCT01791517|69232176|FG010|Phase I: Period 1|Adverse Event|0|||
37744002|NCT01791517|69232177|FG011|Phase I: Period 1|Adverse Event|0|||
37744003|NCT01791517|69232166|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
37655192|NCT02750501|69126382|FG000|Overall Study|Physician Decision|1|||
37655193|NCT02750501|69126382|FG000|Overall Study|Protocol Violation|1|||
37655194|NCT02750501|69126382|FG000|Overall Study|G-tube came out|1|||
37655195|NCT02750501|69126382|FG000|Overall Study|Non-compliant use of PERT|1|||
37655196|NCT01337297|69126405|FG000|Overall Study|They entered to single anodal tDCS|4|||
37655197|NCT01337297|69126406|FG001|Overall Study|They entered to single anodal tDCS|3|||
37655198|NCT01337297|69126405|FG000|Overall Study|Lost to Follow-up|1|||
37655199|NCT01337297|69126406|FG001|Overall Study|Lost to Follow-up|3|||
37655200|NCT02302963|69126414|FG000|Overall Study|Withdrawal by Subject|2|||
37655201|NCT02302963|69126415|FG001|Overall Study|Withdrawal by Subject|1|||
37655202|NCT02302963|69126414|FG000|Overall Study|Steroid injection|0|||
37655203|NCT02302963|69126415|FG001|Overall Study|Steroid injection|1|||
37655204|NCT02302963|69126414|FG000|Overall Study|Physician Decision|1|||
37655205|NCT02302963|69126415|FG001|Overall Study|Physician Decision|0|||
37655206|NCT03507439|69126436|FG000|Overall Study|Other|2|||
37655207|NCT03507439|69126437|FG001|Overall Study|Other|1|||
37655208|NCT03507439|69126436|FG000|Overall Study|Withdrawal by Subject|1|||
37655209|NCT03507439|69126437|FG001|Overall Study|Withdrawal by Subject|0|||
37655210|NCT03507439|69126436|FG000|Overall Study|Death|1|||
37655211|NCT03507439|69126437|FG001|Overall Study|Death|1|||
37655212|NCT03507127|69126445|FG000|Overall Study|Withdrawal by Subject|1|||
37655213|NCT03507127|69126446|FG001|Overall Study|Withdrawal by Subject|0|||
37655214|NCT03507127|69126445|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
37655215|NCT03507127|69126446|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
37655216|NCT02322190|69126469|FG000|Overall Study|Death on study|1|||
37655217|NCT02322190|69126470|FG001|Overall Study|Death on study|0|||
37655218|NCT02321800|69126486|FG000|Overall Study|Withdrawal by Subject|3|||
37655219|NCT02321800|69126487|FG001|Overall Study|Withdrawal by Subject|3|||
37655220|NCT02321800|69126486|FG000|Overall Study|Death|1|||
37655221|NCT02321800|69126487|FG001|Overall Study|Death|0|||
37655222|NCT02321800|69126486|FG000|Overall Study|Protocol Violation|1|||
37655223|NCT02321800|69126487|FG001|Overall Study|Protocol Violation|0|||
37655224|NCT02321800|69126486|FG000|Overall Study|Lost to Follow-up|10|||
37655225|NCT02321800|69126487|FG001|Overall Study|Lost to Follow-up|4|||
37655226|NCT02321800|69126486|FG000|Overall Study|Adverse Event|2|||
37655227|NCT02321800|69126487|FG001|Overall Study|Adverse Event|3|||
37655228|NCT02321800|69126486|FG000|Overall Study|Other, Miscellaneous|3|||
37655229|NCT02321800|69126487|FG001|Overall Study|Other, Miscellaneous|1|||
37655230|NCT02292784|69126533|FG000|Overall Study|Lost to Follow-up|1|||
37655231|NCT02292784|69126534|FG001|Overall Study|Lost to Follow-up|17|||
37655232|NCT02292784|69126535|FG002|Overall Study|Lost to Follow-up|18|||
37655233|NCT02292784|69126533|FG000|Overall Study|Withdrawal by Subject|0|||
37655234|NCT02292784|69126534|FG001|Overall Study|Withdrawal by Subject|3|||
37655235|NCT02292784|69126535|FG002|Overall Study|Withdrawal by Subject|3|||
37922794|NCT00452413|69609599|FG000|Overall Study|Physician Decision|0|||
37922795|NCT00452413|69609600|FG001|Overall Study|Physician Decision|0|||
37655236|NCT02320396|69126545|FG000|Overall Study|Adverse Event|2|||
37655237|NCT02320396|69126546|FG001|Overall Study|Adverse Event|2|||
37655238|NCT02320396|69126545|FG000|Overall Study|Pregnancy|0|||
37655239|NCT02320396|69126546|FG001|Overall Study|Pregnancy|1|||
37655240|NCT02320396|69126545|FG000|Overall Study|Protocol Violation|0|||
37744004|NCT01791517|69232167|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
37655241|NCT02320396|69126546|FG001|Overall Study|Protocol Violation|1|||
37655242|NCT02320396|69126545|FG000|Overall Study|Withdrawal by Subject|2|||
37922796|NCT00452413|69609601|FG002|Overall Study|Physician Decision|4|||
37655243|NCT02320396|69126546|FG001|Overall Study|Withdrawal by Subject|0|||
37655244|NCT02292238|69126554|FG000|Overall Study|Protocol Violation|1|||
37855433|NCT01221363|69538768|FG001|Overall Study|Withdrawal by Subject|5|||
37855434|NCT01221285|69538774|FG000|Overall Study|Withdrawal by Subject|1|||
37855435|NCT01014988|69538784|FG000|Overall Study|Adverse Event|20|||
37744005|NCT01791517|69232168|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
37744006|NCT01791517|69232169|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
37744007|NCT01791517|69232170|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
37744008|NCT01791517|69232171|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
37744009|NCT01791517|69232172|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
37744010|NCT01791517|69232173|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
37744011|NCT01791517|69232174|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
37744012|NCT01791517|69232175|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
37744013|NCT01791517|69232176|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
37744014|NCT01791517|69232177|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
37744015|NCT01791517|69232166|FG000|Phase I: Period 1|Protocol Violation|0|||
37744016|NCT01791517|69232167|FG001|Phase I: Period 1|Protocol Violation|1|||
37744017|NCT01791517|69232168|FG002|Phase I: Period 1|Protocol Violation|0|||
37744018|NCT01791517|69232169|FG003|Phase I: Period 1|Protocol Violation|0|||
37744019|NCT01791517|69232170|FG004|Phase I: Period 1|Protocol Violation|0|||
37744020|NCT01791517|69232171|FG005|Phase I: Period 1|Protocol Violation|0|||
37744021|NCT01791517|69232172|FG006|Phase I: Period 1|Protocol Violation|0|||
37744022|NCT01791517|69232173|FG007|Phase I: Period 1|Protocol Violation|0|||
37744023|NCT01791517|69232174|FG008|Phase I: Period 1|Protocol Violation|0|||
37744024|NCT01791517|69232175|FG009|Phase I: Period 1|Protocol Violation|0|||
37744025|NCT01791517|69232176|FG010|Phase I: Period 1|Protocol Violation|0|||
37744026|NCT01791517|69232177|FG011|Phase I: Period 1|Protocol Violation|0|||
37744027|NCT01791517|69232166|FG000|Phase I: Period 1|Lost to Follow-up|0|||
37744028|NCT01791517|69232167|FG001|Phase I: Period 1|Lost to Follow-up|0|||
37744029|NCT01791517|69232168|FG002|Phase I: Period 1|Lost to Follow-up|0|||
37744030|NCT01791517|69232169|FG003|Phase I: Period 1|Lost to Follow-up|1|||
37744031|NCT01791517|69232170|FG004|Phase I: Period 1|Lost to Follow-up|0|||
37744032|NCT01791517|69232171|FG005|Phase I: Period 1|Lost to Follow-up|0|||
37744033|NCT01791517|69232172|FG006|Phase I: Period 1|Lost to Follow-up|1|||
37744034|NCT01791517|69232173|FG007|Phase I: Period 1|Lost to Follow-up|0|||
37744035|NCT01791517|69232174|FG008|Phase I: Period 1|Lost to Follow-up|1|||
37744036|NCT01791517|69232175|FG009|Phase I: Period 1|Lost to Follow-up|1|||
37744037|NCT01791517|69232176|FG010|Phase I: Period 1|Lost to Follow-up|0|||
37855436|NCT01014988|69538785|FG001|Overall Study|Adverse Event|0|||
37855437|NCT01014988|69538786|FG002|Overall Study|Adverse Event|1|||
37855438|NCT01014988|69538787|FG003|Overall Study|Adverse Event|0|||
37855439|NCT01014988|69538788|FG004|Overall Study|Adverse Event|1|||
37855440|NCT01014988|69538789|FG005|Overall Study|Adverse Event|3|||
37655245|NCT02292238|69126555|FG001|Overall Study|Protocol Violation|2|||
37655246|NCT02292238|69126554|FG000|Overall Study|Withdrawal by Subject|2|||
37655247|NCT02292238|69126555|FG001|Overall Study|Withdrawal by Subject|1|||
37655248|NCT02292238|69126554|FG000|Overall Study|Lost to Follow-up|1|||
37655249|NCT02292238|69126555|FG001|Overall Study|Lost to Follow-up|0|||
37655250|NCT02292238|69126554|FG000|Overall Study|Physician Decision|0|||
37655251|NCT02292238|69126555|FG001|Overall Study|Physician Decision|1|||
37655252|NCT02234843|69126592|FG000|Overall Study|Death|1|||
37655253|NCT02234843|69126593|FG001|Overall Study|Death|0|||
37655254|NCT02234843|69126594|FG002|Overall Study|Death|0|||
37655255|NCT02234843|69126595|FG003|Overall Study|Death|0|||
37655256|NCT02234843|69126596|FG004|Overall Study|Death|0|||
37655257|NCT02234843|69126597|FG005|Overall Study|Death|0|||
37655258|NCT02234843|69126598|FG006|Overall Study|Death|0|||
37655259|NCT02234843|69126599|FG007|Overall Study|Death|0|||
37655260|NCT02234843|69126600|FG008|Overall Study|Death|0|||
37655261|NCT02234843|69126601|FG009|Overall Study|Death|0|||
37655262|NCT02234843|69126592|FG000|Overall Study|Protocol Violation|1|||
37655263|NCT02234843|69126593|FG001|Overall Study|Protocol Violation|0|||
37655264|NCT02234843|69126594|FG002|Overall Study|Protocol Violation|1|||
37655265|NCT02234843|69126595|FG003|Overall Study|Protocol Violation|0|||
37655266|NCT02234843|69126596|FG004|Overall Study|Protocol Violation|0|||
37655267|NCT02234843|69126597|FG005|Overall Study|Protocol Violation|0|||
37655268|NCT02234843|69126598|FG006|Overall Study|Protocol Violation|0|||
37655269|NCT02234843|69126599|FG007|Overall Study|Protocol Violation|0|||
37655270|NCT02234843|69126600|FG008|Overall Study|Protocol Violation|0|||
37744038|NCT01791517|69232177|FG011|Phase I: Period 1|Lost to Follow-up|0|||
37744039|NCT01791517|69232166|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
37744040|NCT01791517|69232167|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
37744041|NCT01791517|69232168|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
37744042|NCT01791517|69232169|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
37855441|NCT01014988|69538784|FG000|Overall Study|Lost to Follow-up|1|||
37655271|NCT02234843|69126601|FG009|Overall Study|Protocol Violation|0|||
37655272|NCT02234843|69126592|FG000|Overall Study|Efficacy outcome reached|2|||
37655273|NCT02234843|69126593|FG001|Overall Study|Efficacy outcome reached|0|||
37655274|NCT02234843|69126594|FG002|Overall Study|Efficacy outcome reached|0|||
37655275|NCT02234843|69126595|FG003|Overall Study|Efficacy outcome reached|0|||
37655276|NCT02234843|69126596|FG004|Overall Study|Efficacy outcome reached|0|||
37655277|NCT02234843|69126597|FG005|Overall Study|Efficacy outcome reached|2|||
37655278|NCT02234843|69126598|FG006|Overall Study|Efficacy outcome reached|0|||
37655279|NCT02234843|69126599|FG007|Overall Study|Efficacy outcome reached|0|||
37655280|NCT02234843|69126600|FG008|Overall Study|Efficacy outcome reached|0|||
37655281|NCT02234843|69126601|FG009|Overall Study|Efficacy outcome reached|0|||
37744043|NCT01791517|69232170|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
37744044|NCT01791517|69232171|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
37744045|NCT01791517|69232172|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
37744046|NCT01791517|69232173|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
37744047|NCT01791517|69232174|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
37744048|NCT01791517|69232175|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
37744049|NCT01791517|69232176|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
37744050|NCT01791517|69232177|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
37744051|NCT01791517|69232166|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
37744052|NCT01791517|69232167|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
37744053|NCT01791517|69232168|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
37744054|NCT01791517|69232169|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
37744055|NCT01791517|69232170|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
37744056|NCT01791517|69232171|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
37744057|NCT01791517|69232172|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
37744058|NCT01791517|69232173|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
37744059|NCT01791517|69232174|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
37655282|NCT02234843|69126592|FG000|Overall Study|Patient convenience|2|||
37655283|NCT02234843|69126593|FG001|Overall Study|Patient convenience|0|||
37655284|NCT02234843|69126594|FG002|Overall Study|Patient convenience|0|||
37655285|NCT02234843|69126595|FG003|Overall Study|Patient convenience|0|||
37655286|NCT02234843|69126596|FG004|Overall Study|Patient convenience|0|||
37655287|NCT02234843|69126597|FG005|Overall Study|Patient convenience|1|||
37744060|NCT01791517|69232175|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
37744061|NCT01791517|69232176|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
37655288|NCT02234843|69126598|FG006|Overall Study|Patient convenience|0|||
37655289|NCT02234843|69126599|FG007|Overall Study|Patient convenience|0|||
37655290|NCT02234843|69126600|FG008|Overall Study|Patient convenience|0|||
37655291|NCT02234843|69126601|FG009|Overall Study|Patient convenience|0|||
37655292|NCT02234843|69126592|FG000|Overall Study|Withdrawal by Subject|5|||
37655293|NCT02234843|69126593|FG001|Overall Study|Withdrawal by Subject|1|||
37655294|NCT02234843|69126594|FG002|Overall Study|Withdrawal by Subject|1|||
37655295|NCT02234843|69126595|FG003|Overall Study|Withdrawal by Subject|0|||
37655296|NCT02234843|69126596|FG004|Overall Study|Withdrawal by Subject|0|||
37655297|NCT02234843|69126597|FG005|Overall Study|Withdrawal by Subject|7|||
37655298|NCT02234843|69126598|FG006|Overall Study|Withdrawal by Subject|0|||
37655299|NCT02234843|69126599|FG007|Overall Study|Withdrawal by Subject|0|||
37655300|NCT02234843|69126600|FG008|Overall Study|Withdrawal by Subject|0|||
37655301|NCT02234843|69126601|FG009|Overall Study|Withdrawal by Subject|0|||
37655302|NCT02234843|69126592|FG000|Overall Study|Recovery|1|||
37655303|NCT02234843|69126593|FG001|Overall Study|Recovery|0|||
37744062|NCT01791517|69232177|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
37744063|NCT01791517|69232166|FG000|Phase I: Period 2|Protocol Violation|0|||
37744064|NCT01791517|69232167|FG001|Phase I: Period 2|Protocol Violation|0|||
37744065|NCT01791517|69232168|FG002|Phase I: Period 2|Protocol Violation|0|||
37655304|NCT02234843|69126594|FG002|Overall Study|Recovery|0|||
37655305|NCT02234843|69126595|FG003|Overall Study|Recovery|0|||
37655306|NCT02234843|69126596|FG004|Overall Study|Recovery|0|||
37744066|NCT01791517|69232169|FG003|Phase I: Period 2|Protocol Violation|1|||
37655307|NCT02234843|69126597|FG005|Overall Study|Recovery|0|||
37744067|NCT01791517|69232170|FG004|Phase I: Period 2|Protocol Violation|0|||
37744068|NCT01791517|69232171|FG005|Phase I: Period 2|Protocol Violation|0|||
37744069|NCT01791517|69232172|FG006|Phase I: Period 2|Protocol Violation|0|||
37744070|NCT01791517|69232173|FG007|Phase I: Period 2|Protocol Violation|0|||
37744071|NCT01791517|69232174|FG008|Phase I: Period 2|Protocol Violation|0|||
37744072|NCT01791517|69232175|FG009|Phase I: Period 2|Protocol Violation|0|||
37744073|NCT01791517|69232176|FG010|Phase I: Period 2|Protocol Violation|0|||
37744074|NCT01791517|69232177|FG011|Phase I: Period 2|Protocol Violation|0|||
37744075|NCT01791517|69232166|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
37744076|NCT01791517|69232167|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
37744077|NCT01791517|69232168|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
37744078|NCT01791517|69232169|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
37744079|NCT01791517|69232170|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
37655308|NCT02234843|69126598|FG006|Overall Study|Recovery|0|||
37655309|NCT02234843|69126599|FG007|Overall Study|Recovery|0|||
37655310|NCT02234843|69126600|FG008|Overall Study|Recovery|0|||
37655311|NCT02234843|69126601|FG009|Overall Study|Recovery|0|||
37655312|NCT02234843|69126592|FG000|Overall Study|Other|0|||
37655313|NCT02234843|69126593|FG001|Overall Study|Other|2|||
37655314|NCT02234843|69126594|FG002|Overall Study|Other|0|||
37655315|NCT02234843|69126595|FG003|Overall Study|Other|1|||
37655316|NCT02234843|69126596|FG004|Overall Study|Other|0|||
37655317|NCT02234843|69126597|FG005|Overall Study|Other|1|||
37655318|NCT02234843|69126598|FG006|Overall Study|Other|0|||
37655319|NCT02234843|69126599|FG007|Overall Study|Other|1|||
37655320|NCT02234843|69126600|FG008|Overall Study|Other|0|||
37655321|NCT02234843|69126601|FG009|Overall Study|Other|0|||
37655322|NCT02234843|69126592|FG000|Overall Study|Physician Decision|4|||
37655323|NCT02234843|69126593|FG001|Overall Study|Physician Decision|1|||
37655324|NCT02234843|69126594|FG002|Overall Study|Physician Decision|0|||
37744080|NCT01791517|69232171|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
37744081|NCT01791517|69232172|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
37744082|NCT01791517|69232173|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
37655325|NCT02234843|69126595|FG003|Overall Study|Physician Decision|1|||
37655326|NCT02234843|69126596|FG004|Overall Study|Physician Decision|0|||
37655327|NCT02234843|69126597|FG005|Overall Study|Physician Decision|0|||
37744083|NCT01791517|69232174|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
37744084|NCT01791517|69232175|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
37744085|NCT01791517|69232176|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
37744086|NCT01791517|69232177|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
37744087|NCT01791517|69232166|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
37744088|NCT01791517|69232167|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
37744089|NCT01791517|69232168|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
37744090|NCT01791517|69232169|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
37744091|NCT01791517|69232170|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
37744092|NCT01791517|69232171|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
37744093|NCT01791517|69232172|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
37744094|NCT01791517|69232173|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
37744095|NCT01791517|69232174|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
37744096|NCT01791517|69232175|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
37744097|NCT01791517|69232176|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
37744098|NCT01791517|69232177|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
37744099|NCT01791517|69232166|FG000|Phase I: Period 2|Lens Discomfort|0|||
37744100|NCT01791517|69232167|FG001|Phase I: Period 2|Lens Discomfort|0|||
37744101|NCT01791517|69232168|FG002|Phase I: Period 2|Lens Discomfort|0|||
37744102|NCT01791517|69232169|FG003|Phase I: Period 2|Lens Discomfort|0|||
37744103|NCT01791517|69232170|FG004|Phase I: Period 2|Lens Discomfort|0|||
37744104|NCT01791517|69232171|FG005|Phase I: Period 2|Lens Discomfort|1|||
37744105|NCT01791517|69232172|FG006|Phase I: Period 2|Lens Discomfort|0|||
37744106|NCT01791517|69232173|FG007|Phase I: Period 2|Lens Discomfort|0|||
37655328|NCT02234843|69126598|FG006|Overall Study|Physician Decision|0|||
37655329|NCT02234843|69126599|FG007|Overall Study|Physician Decision|1|||
37655330|NCT02234843|69126600|FG008|Overall Study|Physician Decision|0|||
37855442|NCT01014988|69538785|FG001|Overall Study|Lost to Follow-up|0|||
37655331|NCT02234843|69126601|FG009|Overall Study|Physician Decision|0|||
37655332|NCT02234843|69126592|FG000|Overall Study|Adverse Event|5|||
37655333|NCT02234843|69126593|FG001|Overall Study|Adverse Event|1|||
37655334|NCT02234843|69126594|FG002|Overall Study|Adverse Event|1|||
37655335|NCT02234843|69126595|FG003|Overall Study|Adverse Event|3|||
37655336|NCT02234843|69126596|FG004|Overall Study|Adverse Event|2|||
37655337|NCT02234843|69126597|FG005|Overall Study|Adverse Event|1|||
37655338|NCT02234843|69126598|FG006|Overall Study|Adverse Event|0|||
37655339|NCT02234843|69126599|FG007|Overall Study|Adverse Event|0|||
37655340|NCT02234843|69126600|FG008|Overall Study|Adverse Event|1|||
37655341|NCT02234843|69126601|FG009|Overall Study|Adverse Event|0|||
37655342|NCT02234843|69126592|FG000|Overall Study|Non-compliance with study drug|1|||
37655343|NCT02234843|69126593|FG001|Overall Study|Non-compliance with study drug|0|||
37655344|NCT02234843|69126594|FG002|Overall Study|Non-compliance with study drug|0|||
37655345|NCT02234843|69126595|FG003|Overall Study|Non-compliance with study drug|0|||
37655346|NCT02234843|69126596|FG004|Overall Study|Non-compliance with study drug|0|||
37655347|NCT02234843|69126597|FG005|Overall Study|Non-compliance with study drug|1|||
37655348|NCT02234843|69126598|FG006|Overall Study|Non-compliance with study drug|1|||
37744107|NCT01791517|69232174|FG008|Phase I: Period 2|Lens Discomfort|0|||
37855443|NCT01014988|69538786|FG002|Overall Study|Lost to Follow-up|1|||
37744108|NCT01791517|69232175|FG009|Phase I: Period 2|Lens Discomfort|0|||
37744109|NCT01791517|69232176|FG010|Phase I: Period 2|Lens Discomfort|0|||
37855444|NCT01014988|69538787|FG003|Overall Study|Lost to Follow-up|0|||
37655349|NCT02234843|69126599|FG007|Overall Study|Non-compliance with study drug|0|||
37744110|NCT01791517|69232177|FG011|Phase I: Period 2|Lens Discomfort|0|||
37655350|NCT02234843|69126600|FG008|Overall Study|Non-compliance with study drug|0|||
37655351|NCT02234843|69126601|FG009|Overall Study|Non-compliance with study drug|0|||
37655352|NCT02234843|69126592|FG000|Overall Study|Lost to Follow-up|0|||
37655353|NCT02234843|69126593|FG001|Overall Study|Lost to Follow-up|1|||
37655354|NCT02234843|69126594|FG002|Overall Study|Lost to Follow-up|0|||
37744111|NCT01791517|69232166|FG000|Phase I: Period 2|Lost to Follow-up|0|||
37855445|NCT01014988|69538788|FG004|Overall Study|Lost to Follow-up|0|||
37655355|NCT02234843|69126595|FG003|Overall Study|Lost to Follow-up|0|||
37655356|NCT02234843|69126596|FG004|Overall Study|Lost to Follow-up|0|||
37655357|NCT02234843|69126597|FG005|Overall Study|Lost to Follow-up|0|||
37655358|NCT02234843|69126598|FG006|Overall Study|Lost to Follow-up|1|||
37655359|NCT02234843|69126599|FG007|Overall Study|Lost to Follow-up|0|||
37655360|NCT02234843|69126600|FG008|Overall Study|Lost to Follow-up|0|||
37855446|NCT01014988|69538789|FG005|Overall Study|Lost to Follow-up|0|||
37855447|NCT01014988|69538784|FG000|Overall Study|Physician Decision|1|||
37855448|NCT01014988|69538785|FG001|Overall Study|Physician Decision|0|||
37855449|NCT01014988|69538786|FG002|Overall Study|Physician Decision|0|||
37855450|NCT01014988|69538787|FG003|Overall Study|Physician Decision|0|||
37855451|NCT01014988|69538788|FG004|Overall Study|Physician Decision|0|||
37855452|NCT01014988|69538789|FG005|Overall Study|Physician Decision|0|||
37855453|NCT01014988|69538784|FG000|Overall Study|Withdrawal by Subject|1|||
37855454|NCT01014988|69538785|FG001|Overall Study|Withdrawal by Subject|0|||
37855455|NCT01014988|69538786|FG002|Overall Study|Withdrawal by Subject|0|||
37855456|NCT01014988|69538787|FG003|Overall Study|Withdrawal by Subject|0|||
37855457|NCT01014988|69538788|FG004|Overall Study|Withdrawal by Subject|0|||
38032778|NCT03755661|69718754|FG000|Overall Study|Lost to Follow-up|1|||
37655361|NCT02234843|69126601|FG009|Overall Study|Lost to Follow-up|0|||
37655362|NCT02740231|69126638|FG000|Overall Study|Withdrawal by Subject|1|||
37655363|NCT02740231|69126639|FG001|Overall Study|Withdrawal by Subject|1|||
37655364|NCT02740231|69126640|FG002|Overall Study|Withdrawal by Subject|1|||
37655365|NCT02740231|69126641|FG003|Overall Study|Withdrawal by Subject|0|||
37655366|NCT02740231|69126638|FG000|Overall Study|Lack of Efficacy|0|||
37655367|NCT02740231|69126639|FG001|Overall Study|Lack of Efficacy|1|||
37655368|NCT02740231|69126640|FG002|Overall Study|Lack of Efficacy|0|||
37655369|NCT02740231|69126641|FG003|Overall Study|Lack of Efficacy|4|||
37655370|NCT02740231|69126638|FG000|Overall Study|Lost to Follow-up|1|||
37655371|NCT02740231|69126639|FG001|Overall Study|Lost to Follow-up|3|||
37655372|NCT02740231|69126640|FG002|Overall Study|Lost to Follow-up|0|||
37655373|NCT02740231|69126641|FG003|Overall Study|Lost to Follow-up|3|||
37655374|NCT02740231|69126638|FG000|Overall Study|Adverse Event|0|||
37655375|NCT02740231|69126639|FG001|Overall Study|Adverse Event|1|||
37655376|NCT02740231|69126640|FG002|Overall Study|Adverse Event|0|||
37655377|NCT02740231|69126641|FG003|Overall Study|Adverse Event|1|||
37655378|NCT02750345|69126651|FG000|Intervention 1|Adverse Event|0|||
37655379|NCT02750345|69126652|FG001|Intervention 1|Adverse Event|0|||
37655380|NCT02750345|69126653|FG002|Intervention 1|Adverse Event|0|||
37655381|NCT02750345|69126654|FG003|Intervention 1|Adverse Event|0|||
37655382|NCT02750345|69126655|FG004|Intervention 1|Adverse Event|1|||
37655383|NCT02750345|69126656|FG005|Intervention 1|Adverse Event|0|||
37655384|NCT02640625|69126666|FG000|Overall Study|Adverse Event|1|||
37655385|NCT01329263|69126673|FG000|Overall Study|Lost to Follow-up|4|||
37655386|NCT01329263|69126674|FG001|Overall Study|Lost to Follow-up|21|||
37655387|NCT01329263|69126673|FG000|Overall Study|Withdrawal by Subject|1|||
37655388|NCT01329263|69126674|FG001|Overall Study|Withdrawal by Subject|2|||
37655389|NCT02474329|69126682|FG000|Overall Study|Withdraw or did not contribute data.|13|||
37655390|NCT01388491|69126689|FG000|Overall Study|Adverse Event|10|||
37655391|NCT01388491|69126690|FG001|Overall Study|Adverse Event|9|||
37655392|NCT01388491|69126689|FG000|Overall Study|Sponsor Request|9|||
37655393|NCT01388491|69126690|FG001|Overall Study|Sponsor Request|7|||
37744112|NCT01791517|69232167|FG001|Phase I: Period 2|Lost to Follow-up|3|||
37744113|NCT01791517|69232168|FG002|Phase I: Period 2|Lost to Follow-up|2|||
37744114|NCT01791517|69232169|FG003|Phase I: Period 2|Lost to Follow-up|0|||
37744115|NCT01791517|69232170|FG004|Phase I: Period 2|Lost to Follow-up|0|||
37744116|NCT01791517|69232171|FG005|Phase I: Period 2|Lost to Follow-up|0|||
37744117|NCT01791517|69232172|FG006|Phase I: Period 2|Lost to Follow-up|0|||
37744118|NCT01791517|69232173|FG007|Phase I: Period 2|Lost to Follow-up|0|||
37744119|NCT01791517|69232174|FG008|Phase I: Period 2|Lost to Follow-up|0|||
37744120|NCT01791517|69232175|FG009|Phase I: Period 2|Lost to Follow-up|0|||
37744121|NCT01791517|69232176|FG010|Phase I: Period 2|Lost to Follow-up|0|||
37744122|NCT01791517|69232177|FG011|Phase I: Period 2|Lost to Follow-up|0|||
37744123|NCT01791517|69232166|FG000|Phase I: Period 3|Lens Discomfort|0|||
37744124|NCT01791517|69232167|FG001|Phase I: Period 3|Lens Discomfort|0|||
38032779|NCT03755661|69718755|FG001|Overall Study|Lost to Follow-up|0|||
37655394|NCT01388491|69126689|FG000|Overall Study|Withdrawal by Subject|6|||
37655395|NCT01388491|69126690|FG001|Overall Study|Withdrawal by Subject|10|||
37655396|NCT01388491|69126689|FG000|Overall Study|Lost to Follow-up|4|||
37855458|NCT01014988|69538789|FG005|Overall Study|Withdrawal by Subject|0|||
37855459|NCT01014910|69538813|FG000|Overall Study|Withdrawal by Subject|0|||
38032780|NCT03752151|69718761|FG000|Overall Study|Withdrawal by Subject|1|||
37655397|NCT01388491|69126690|FG001|Overall Study|Lost to Follow-up|3|||
37655398|NCT01388491|69126689|FG000|Overall Study|Protocol Violation|2|||
37655399|NCT01388491|69126690|FG001|Overall Study|Protocol Violation|0|||
37655400|NCT01388491|69126689|FG000|Overall Study|Noncompliance|2|||
37744125|NCT01791517|69232168|FG002|Phase I: Period 3|Lens Discomfort|0|||
37855460|NCT01014910|69538814|FG001|Overall Study|Withdrawal by Subject|2|||
37855461|NCT01019980|69538822|FG000|Overall Study|Drug not available.|2|||
37655401|NCT01388491|69126690|FG001|Overall Study|Noncompliance|0|||
37655402|NCT01388491|69126689|FG000|Overall Study|Pregnancy|1|||
37655403|NCT01388491|69126690|FG001|Overall Study|Pregnancy|0|||
37655404|NCT02749799|69126696|FG000|Overall Study|Adverse Event|2|||
37655405|NCT02749799|69126696|FG000|Overall Study|Lost to Follow-up|4|||
37655406|NCT02749799|69126696|FG000|Overall Study|Protocol Violation|1|||
37655407|NCT02749799|69126696|FG000|Overall Study|Withdrawal by Subject|1|||
37655408|NCT03253393|69126703|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
37655409|NCT03253393|69126704|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
37655410|NCT03253393|69126705|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
37655411|NCT03128671|69126721|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
37655412|NCT03128671|69126722|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
37655413|NCT03128671|69126721|FG000|Allocation|Death|1|||
37655414|NCT03128671|69126722|FG001|Allocation|Death|0|||
37655415|NCT03128671|69126721|FG000|Allocation|Withdrawal by Subject|4|||
37655416|NCT03128671|69126722|FG001|Allocation|Withdrawal by Subject|0|||
37655417|NCT03128671|69126721|FG000|Intervention|Withdrawal by Subject|11|||
37655418|NCT03128671|69126722|FG001|Intervention|Withdrawal by Subject|10|||
37655419|NCT03128671|69126721|FG000|Intervention|Palliative/hospice care initiated|9|||
37655420|NCT03128671|69126722|FG001|Intervention|Palliative/hospice care initiated|10|||
37655421|NCT03128671|69126721|FG000|Intervention|Death|13|||
37655422|NCT03128671|69126722|FG001|Intervention|Death|11|||
37655423|NCT03128671|69126721|FG000|Intervention|Interrupted by hurricane|1|||
37655424|NCT03128671|69126722|FG001|Intervention|Interrupted by hurricane|0|||
37655425|NCT03128671|69126721|FG000|Intervention|Physician Decision|2|||
37655426|NCT03128671|69126722|FG001|Intervention|Physician Decision|3|||
37655427|NCT02925338|69126733|FG000|Overall Study|Death|0|||
37655428|NCT02925338|69126734|FG001|Overall Study|Death|2|||
37655429|NCT02925338|69126735|FG002|Overall Study|Death|1|||
37655430|NCT02925338|69126736|FG003|Overall Study|Death|0|||
37744126|NCT01791517|69232169|FG003|Phase I: Period 3|Lens Discomfort|0|||
37744127|NCT01791517|69232170|FG004|Phase I: Period 3|Lens Discomfort|0|||
37744128|NCT01791517|69232171|FG005|Phase I: Period 3|Lens Discomfort|0|||
37744129|NCT01791517|69232172|FG006|Phase I: Period 3|Lens Discomfort|0|||
37744130|NCT01791517|69232173|FG007|Phase I: Period 3|Lens Discomfort|0|||
37744131|NCT01791517|69232174|FG008|Phase I: Period 3|Lens Discomfort|0|||
37744132|NCT01791517|69232175|FG009|Phase I: Period 3|Lens Discomfort|0|||
37744133|NCT01791517|69232176|FG010|Phase I: Period 3|Lens Discomfort|0|||
37744134|NCT01791517|69232177|FG011|Phase I: Period 3|Lens Discomfort|1|||
37744135|NCT01791517|69232166|FG000|Phase I: Period 3|Lost to Follow-up|0|||
37744136|NCT01791517|69232167|FG001|Phase I: Period 3|Lost to Follow-up|1|||
37744137|NCT01791517|69232168|FG002|Phase I: Period 3|Lost to Follow-up|0|||
37744138|NCT01791517|69232169|FG003|Phase I: Period 3|Lost to Follow-up|0|||
37744139|NCT01791517|69232170|FG004|Phase I: Period 3|Lost to Follow-up|1|||
37744140|NCT01791517|69232171|FG005|Phase I: Period 3|Lost to Follow-up|0|||
37744141|NCT01791517|69232172|FG006|Phase I: Period 3|Lost to Follow-up|0|||
37744142|NCT01791517|69232173|FG007|Phase I: Period 3|Lost to Follow-up|0|||
37744143|NCT01791517|69232174|FG008|Phase I: Period 3|Lost to Follow-up|0|||
37744144|NCT01791517|69232175|FG009|Phase I: Period 3|Lost to Follow-up|0|||
37744145|NCT01791517|69232176|FG010|Phase I: Period 3|Lost to Follow-up|0|||
37744146|NCT01791517|69232177|FG011|Phase I: Period 3|Lost to Follow-up|0|||
37744147|NCT01791517|69232166|FG000|Phase I: Period 3|Adverse Event|0|||
37744148|NCT01791517|69232167|FG001|Phase I: Period 3|Adverse Event|0|||
37744149|NCT01791517|69232168|FG002|Phase I: Period 3|Adverse Event|0|||
37744150|NCT01791517|69232169|FG003|Phase I: Period 3|Adverse Event|1|||
37744151|NCT01791517|69232170|FG004|Phase I: Period 3|Adverse Event|0|||
37744152|NCT01791517|69232171|FG005|Phase I: Period 3|Adverse Event|0|||
37922797|NCT00452413|69609599|FG000|Overall Study|Death due to study disease|0|||
37655431|NCT02925338|69126737|FG004|Overall Study|Death|0|||
37655432|NCT02925338|69126733|FG000|Overall Study|Lost to Follow-up|30|||
37655433|NCT02925338|69126734|FG001|Overall Study|Lost to Follow-up|10|||
37655434|NCT02925338|69126735|FG002|Overall Study|Lost to Follow-up|1|||
37655435|NCT02925338|69126736|FG003|Overall Study|Lost to Follow-up|16|||
37655436|NCT02925338|69126737|FG004|Overall Study|Lost to Follow-up|3|||
37655437|NCT02925338|69126733|FG000|Overall Study|Withdrawal by Subject|3|||
37744153|NCT01791517|69232172|FG006|Phase I: Period 3|Adverse Event|0|||
37744154|NCT01791517|69232173|FG007|Phase I: Period 3|Adverse Event|0|||
37744155|NCT01791517|69232174|FG008|Phase I: Period 3|Adverse Event|0|||
37744156|NCT01791517|69232175|FG009|Phase I: Period 3|Adverse Event|0|||
37744157|NCT01791517|69232176|FG010|Phase I: Period 3|Adverse Event|0|||
37922798|NCT00452413|69609600|FG001|Overall Study|Death due to study disease|0|||
37655438|NCT02925338|69126734|FG001|Overall Study|Withdrawal by Subject|0|||
37655439|NCT02925338|69126735|FG002|Overall Study|Withdrawal by Subject|3|||
37655440|NCT02925338|69126736|FG003|Overall Study|Withdrawal by Subject|2|||
37655441|NCT02925338|69126737|FG004|Overall Study|Withdrawal by Subject|2|||
37744158|NCT01791517|69232177|FG011|Phase I: Period 3|Adverse Event|0|||
37744159|NCT01791517|69232166|FG000|Phase II|Lost to Follow-up|1|||
37922799|NCT00452413|69609601|FG002|Overall Study|Death due to study disease|2|||
37655442|NCT02925338|69126733|FG000|Overall Study|Missing|38|||
37655443|NCT02925338|69126734|FG001|Overall Study|Missing|27|||
37655444|NCT02925338|69126735|FG002|Overall Study|Missing|0|||
37655445|NCT02925338|69126736|FG003|Overall Study|Missing|3|||
37655446|NCT02925338|69126737|FG004|Overall Study|Missing|2|||
37655447|NCT02925338|69126733|FG000|Overall Study|Participant's Decision|11|||
37655448|NCT02925338|69126734|FG001|Overall Study|Participant's Decision|7|||
37655449|NCT02925338|69126735|FG002|Overall Study|Participant's Decision|3|||
37655450|NCT02925338|69126736|FG003|Overall Study|Participant's Decision|8|||
37655451|NCT02925338|69126737|FG004|Overall Study|Participant's Decision|1|||
37655452|NCT02925338|69126733|FG000|Overall Study|Treatment Discontinuation|144|||
37655453|NCT02925338|69126734|FG001|Overall Study|Treatment Discontinuation|65|||
37655454|NCT02925338|69126735|FG002|Overall Study|Treatment Discontinuation|56|||
37655455|NCT02925338|69126736|FG003|Overall Study|Treatment Discontinuation|131|||
37655456|NCT02925338|69126737|FG004|Overall Study|Treatment Discontinuation|22|||
37655457|NCT02543528|69126755|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
37655458|NCT02543528|69126756|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
37655459|NCT02543528|69126757|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
37655460|NCT02543528|69126758|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
37655461|NCT02543528|69126759|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
37655462|NCT02543528|69126755|FG000|Adaptation Period|Lens Handling Difficultes|0|||
37655463|NCT02543528|69126756|FG001|Adaptation Period|Lens Handling Difficultes|0|||
37655464|NCT02543528|69126757|FG002|Adaptation Period|Lens Handling Difficultes|0|||
37655465|NCT02543528|69126758|FG003|Adaptation Period|Lens Handling Difficultes|0|||
37655466|NCT02543528|69126759|FG004|Adaptation Period|Lens Handling Difficultes|8|||
37655467|NCT02543528|69126755|FG000|Adaptation Period|Lost to Follow-up|0|||
37655468|NCT02543528|69126756|FG001|Adaptation Period|Lost to Follow-up|0|||
37655469|NCT02543528|69126757|FG002|Adaptation Period|Lost to Follow-up|0|||
37655470|NCT02543528|69126758|FG003|Adaptation Period|Lost to Follow-up|0|||
37744160|NCT01791517|69232167|FG001|Phase II|Lost to Follow-up|0|||
37744161|NCT01791517|69232168|FG002|Phase II|Lost to Follow-up|1|||
37744162|NCT01791517|69232169|FG003|Phase II|Lost to Follow-up|0|||
37744163|NCT01791517|69232170|FG004|Phase II|Lost to Follow-up|1|||
37744164|NCT01791517|69232171|FG005|Phase II|Lost to Follow-up|2|||
37744165|NCT01791517|69232172|FG006|Phase II|Lost to Follow-up|0|||
37744166|NCT01791517|69232173|FG007|Phase II|Lost to Follow-up|1|||
37744167|NCT01791517|69232174|FG008|Phase II|Lost to Follow-up|1|||
37744168|NCT01791517|69232175|FG009|Phase II|Lost to Follow-up|1|||
37744169|NCT01791517|69232176|FG010|Phase II|Lost to Follow-up|0|||
37744170|NCT01791517|69232177|FG011|Phase II|Lost to Follow-up|0|||
37744171|NCT01791517|69232166|FG000|Phase II|Withdrawal by Subject|1|||
37744172|NCT01791517|69232167|FG001|Phase II|Withdrawal by Subject|0|||
37744173|NCT01791517|69232168|FG002|Phase II|Withdrawal by Subject|0|||
37744174|NCT01791517|69232169|FG003|Phase II|Withdrawal by Subject|0|||
37744175|NCT01791517|69232170|FG004|Phase II|Withdrawal by Subject|0|||
37744176|NCT01791517|69232171|FG005|Phase II|Withdrawal by Subject|2|||
37744177|NCT01791517|69232172|FG006|Phase II|Withdrawal by Subject|0|||
37744178|NCT01791517|69232173|FG007|Phase II|Withdrawal by Subject|1|||
37744179|NCT01791517|69232174|FG008|Phase II|Withdrawal by Subject|0|||
37744180|NCT01791517|69232175|FG009|Phase II|Withdrawal by Subject|0|||
37744181|NCT01791517|69232176|FG010|Phase II|Withdrawal by Subject|1|||
37744182|NCT01791517|69232177|FG011|Phase II|Withdrawal by Subject|0|||
37744183|NCT01791517|69232166|FG000|Phase II|Lack of Efficacy|0|||
37744184|NCT01791517|69232167|FG001|Phase II|Lack of Efficacy|0|||
37744185|NCT01791517|69232168|FG002|Phase II|Lack of Efficacy|0|||
37744186|NCT01791517|69232169|FG003|Phase II|Lack of Efficacy|0|||
37744187|NCT01791517|69232170|FG004|Phase II|Lack of Efficacy|1|||
37744188|NCT01791517|69232171|FG005|Phase II|Lack of Efficacy|0|||
37744189|NCT01791517|69232172|FG006|Phase II|Lack of Efficacy|0|||
37744190|NCT01791517|69232173|FG007|Phase II|Lack of Efficacy|0|||
37744191|NCT01791517|69232174|FG008|Phase II|Lack of Efficacy|0|||
37744192|NCT01791517|69232175|FG009|Phase II|Lack of Efficacy|0|||
37744193|NCT01791517|69232176|FG010|Phase II|Lack of Efficacy|0|||
37744194|NCT01791517|69232177|FG011|Phase II|Lack of Efficacy|0|||
37744195|NCT01791517|69232166|FG000|Phase II|Adverse Event|0|||
37855462|NCT01019980|69538823|FG001|Overall Study|Drug not available.|0|||
37855463|NCT00993499|69538835|FG000|Run-in Period (8 Days)|Adverse Event|0|||
37655471|NCT02543528|69126759|FG004|Adaptation Period|Lost to Follow-up|14|||
37655472|NCT02543528|69126755|FG000|Adaptation Period|Adverse Event|0|||
37655473|NCT02543528|69126756|FG001|Adaptation Period|Adverse Event|0|||
37655474|NCT02543528|69126757|FG002|Adaptation Period|Adverse Event|0|||
37655475|NCT02543528|69126758|FG003|Adaptation Period|Adverse Event|0|||
37655476|NCT02543528|69126759|FG004|Adaptation Period|Adverse Event|2|||
37655477|NCT02543528|69126755|FG000|Extended Wear Period|Adverse Event|17|||
37744196|NCT01791517|69232167|FG001|Phase II|Adverse Event|0|||
37744197|NCT01791517|69232168|FG002|Phase II|Adverse Event|0|||
37744198|NCT01791517|69232169|FG003|Phase II|Adverse Event|0|||
37744199|NCT01791517|69232170|FG004|Phase II|Adverse Event|0|||
37744200|NCT01791517|69232171|FG005|Phase II|Adverse Event|0|||
37744201|NCT01791517|69232172|FG006|Phase II|Adverse Event|2|||
37744202|NCT01791517|69232173|FG007|Phase II|Adverse Event|1|||
37655478|NCT02543528|69126756|FG001|Extended Wear Period|Adverse Event|11|||
37655479|NCT02543528|69126757|FG002|Extended Wear Period|Adverse Event|16|||
37655480|NCT02543528|69126758|FG003|Extended Wear Period|Adverse Event|3|||
37655481|NCT02543528|69126759|FG004|Extended Wear Period|Adverse Event|0|||
37655482|NCT02543528|69126755|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
37655483|NCT02543528|69126756|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
37655484|NCT02543528|69126757|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
37655485|NCT02543528|69126758|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
37655486|NCT02543528|69126759|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
37655487|NCT02543528|69126755|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
37655488|NCT02543528|69126756|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
37655489|NCT02543528|69126757|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
37655490|NCT02543528|69126758|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
37655491|NCT02543528|69126759|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
37655492|NCT02543528|69126755|FG000|Extended Wear Period|Lost to Follow-up|0|||
37655493|NCT02543528|69126756|FG001|Extended Wear Period|Lost to Follow-up|1|||
37655494|NCT02543528|69126757|FG002|Extended Wear Period|Lost to Follow-up|2|||
37655495|NCT02543528|69126758|FG003|Extended Wear Period|Lost to Follow-up|1|||
37655496|NCT02543528|69126759|FG004|Extended Wear Period|Lost to Follow-up|0|||
37655497|NCT02543528|69126755|FG000|Extended Wear Period|Withdrawal by Subject|10|||
37655498|NCT02543528|69126756|FG001|Extended Wear Period|Withdrawal by Subject|9|||
37655499|NCT02543528|69126757|FG002|Extended Wear Period|Withdrawal by Subject|4|||
37655500|NCT02543528|69126758|FG003|Extended Wear Period|Withdrawal by Subject|5|||
37655501|NCT02543528|69126759|FG004|Extended Wear Period|Withdrawal by Subject|0|||
37655502|NCT00156533|69126777|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
37655503|NCT00156533|69126778|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
37655504|NCT00156533|69126779|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
37655505|NCT00156533|69126780|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
37655506|NCT00156533|69126777|FG000|Overall Study|Withdrawal by Subject|1|||
37655507|NCT00156533|69126778|FG001|Overall Study|Withdrawal by Subject|0|||
37655508|NCT00156533|69126779|FG002|Overall Study|Withdrawal by Subject|0|||
37655509|NCT00156533|69126780|FG003|Overall Study|Withdrawal by Subject|1|||
37655510|NCT00156533|69126777|FG000|Overall Study|Failed Screening|1|||
37655511|NCT00156533|69126778|FG001|Overall Study|Failed Screening|0|||
37655512|NCT00156533|69126779|FG002|Overall Study|Failed Screening|1|||
37655513|NCT00156533|69126780|FG003|Overall Study|Failed Screening|1|||
37655514|NCT01660022|69126798|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
37655515|NCT01660022|69126799|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
37655516|NCT01660022|69126800|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
37655517|NCT01660022|69126801|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
37655518|NCT01660022|69126802|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
37655519|NCT01660022|69126803|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
37655520|NCT01660022|69126798|FG000|First Sequence (7 Days)|Adverse Event|0|||
37744203|NCT01791517|69232174|FG008|Phase II|Adverse Event|0|||
37744204|NCT01791517|69232175|FG009|Phase II|Adverse Event|1|||
37744205|NCT01791517|69232176|FG010|Phase II|Adverse Event|0|||
37744206|NCT01791517|69232177|FG011|Phase II|Adverse Event|0|||
37655521|NCT01660022|69126799|FG001|First Sequence (7 Days)|Adverse Event|0|||
37655522|NCT01660022|69126800|FG002|First Sequence (7 Days)|Adverse Event|0|||
37655523|NCT01660022|69126801|FG003|First Sequence (7 Days)|Adverse Event|0|||
37655524|NCT01660022|69126802|FG004|First Sequence (7 Days)|Adverse Event|1|||
37655525|NCT01660022|69126803|FG005|First Sequence (7 Days)|Adverse Event|3|||
37655526|NCT01660022|69126798|FG000|First Sequence (7 Days)|Protocol Violation|0|||
37655527|NCT01660022|69126799|FG001|First Sequence (7 Days)|Protocol Violation|0|||
37655528|NCT01660022|69126800|FG002|First Sequence (7 Days)|Protocol Violation|0|||
37655529|NCT01660022|69126801|FG003|First Sequence (7 Days)|Protocol Violation|0|||
37655530|NCT01660022|69126802|FG004|First Sequence (7 Days)|Protocol Violation|0|||
37655531|NCT01660022|69126803|FG005|First Sequence (7 Days)|Protocol Violation|1|||
37655532|NCT00156065|69126832|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
37655533|NCT00156065|69126833|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
37655534|NCT00156065|69126834|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
37855464|NCT00993499|69538836|FG001|Run-in Period (8 Days)|Adverse Event|1|||
37655535|NCT00156065|69126832|FG000|Overall Study|Adverse Event|8|||
37655536|NCT00156065|69126833|FG001|Overall Study|Adverse Event|11|||
37655537|NCT00156065|69126834|FG002|Overall Study|Adverse Event|4|||
37744207|NCT01791517|69232166|FG000|Phase II|Lens Handling Difficulties|0|||
38032781|NCT03752151|69718761|FG000|Overall Study|Protocol Violation|1|||
37655538|NCT00156065|69126832|FG000|Overall Study|Lack of Efficacy|2|||
37655539|NCT00156065|69126833|FG001|Overall Study|Lack of Efficacy|9|||
37744208|NCT01791517|69232167|FG001|Phase II|Lens Handling Difficulties|0|||
37655540|NCT00156065|69126834|FG002|Overall Study|Lack of Efficacy|3|||
37655541|NCT00156065|69126832|FG000|Overall Study|Withdrawal by Subject|13|||
37855465|NCT00993499|69538837|FG002|Run-in Period (8 Days)|Adverse Event|0|||
37655542|NCT00156065|69126833|FG001|Overall Study|Withdrawal by Subject|26|||
37655543|NCT00156065|69126834|FG002|Overall Study|Withdrawal by Subject|16|||
37655544|NCT00156065|69126832|FG000|Overall Study|Lost to Follow-up|5|||
37655545|NCT00156065|69126833|FG001|Overall Study|Lost to Follow-up|7|||
37655546|NCT00156065|69126834|FG002|Overall Study|Lost to Follow-up|1|||
37655547|NCT00156065|69126832|FG000|Overall Study|Other|2|||
37655548|NCT00156065|69126833|FG001|Overall Study|Other|9|||
37655549|NCT00156065|69126834|FG002|Overall Study|Other|3|||
37655550|NCT01554956|69126845|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
37655551|NCT01554956|69126846|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
37655552|NCT01554956|69126847|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
37655553|NCT01554956|69126845|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
37655554|NCT01554956|69126846|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
37655555|NCT01554956|69126847|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
37655556|NCT01554956|69126845|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
37655557|NCT01554956|69126846|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
37655558|NCT01554956|69126847|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
37655559|NCT02138786|69126868|FG000|Overall Study|Adverse Event|0|||
37655560|NCT02138786|69126869|FG001|Overall Study|Adverse Event|2|||
37655561|NCT02138786|69126870|FG002|Overall Study|Adverse Event|1|||
37655562|NCT02138786|69126868|FG000|Overall Study|Death|1|||
37655563|NCT02138786|69126869|FG001|Overall Study|Death|7|||
37655564|NCT02138786|69126870|FG002|Overall Study|Death|2|||
37655565|NCT02138786|69126868|FG000|Overall Study|Disease Progression|1|||
37655566|NCT02138786|69126869|FG001|Overall Study|Disease Progression|1|||
37655567|NCT02138786|69126870|FG002|Overall Study|Disease Progression|3|||
37655568|NCT02138786|69126868|FG000|Overall Study|Withdrawal by Subject|1|||
37655569|NCT02138786|69126869|FG001|Overall Study|Withdrawal by Subject|2|||
37655570|NCT02138786|69126870|FG002|Overall Study|Withdrawal by Subject|0|||
37655571|NCT02138786|69126868|FG000|Overall Study|Patient's Wish|0|||
37655572|NCT02138786|69126869|FG001|Overall Study|Patient's Wish|2|||
37655573|NCT02138786|69126870|FG002|Overall Study|Patient's Wish|0|||
37655574|NCT02138786|69126868|FG000|Overall Study|Sponsor Terminated Study|0|||
37655575|NCT02138786|69126869|FG001|Overall Study|Sponsor Terminated Study|1|||
37655576|NCT02138786|69126870|FG002|Overall Study|Sponsor Terminated Study|1|||
37655577|NCT02138786|69126868|FG000|Overall Study|Non-Compliance|0|||
37655578|NCT02138786|69126869|FG001|Overall Study|Non-Compliance|0|||
37655579|NCT02138786|69126870|FG002|Overall Study|Non-Compliance|1|||
37655580|NCT02529488|69126876|FG000|Overall Study|Adverse Event|1|||
37655581|NCT02529488|69126876|FG000|Overall Study|Death|3|||
37655582|NCT01329419|69126884|FG000|Overall Study|Protocol Violation|235|||
37655583|NCT01329341|69126889|FG000|Overall Study|Withdrawal by Subject|44|||
37655584|NCT02532764|69126903|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
37655585|NCT02532764|69126904|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
37655586|NCT02532764|69126905|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
37655587|NCT02532764|69126906|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
37655588|NCT02532764|69126907|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
37655589|NCT02532764|69126908|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
37655590|NCT02532764|69126909|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
37655591|NCT02532764|69126910|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
37655592|NCT02532764|69126911|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
37655593|NCT02532764|69126912|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
37655594|NCT02528942|69126939|FG000|Overall Study|Did not meet imaging criteria|9|||
37655595|NCT02528942|69126939|FG000|Overall Study|Lost to Follow-up|25|||
37744209|NCT01791517|69232168|FG002|Phase II|Lens Handling Difficulties|0|||
37744210|NCT01791517|69232169|FG003|Phase II|Lens Handling Difficulties|0|||
37744211|NCT01791517|69232170|FG004|Phase II|Lens Handling Difficulties|0|||
37744212|NCT01791517|69232171|FG005|Phase II|Lens Handling Difficulties|0|||
37744213|NCT01791517|69232172|FG006|Phase II|Lens Handling Difficulties|0|||
37855466|NCT00993499|69538838|FG003|Run-in Period (8 Days)|Adverse Event|0|||
37855467|NCT00993499|69538839|FG004|Run-in Period (8 Days)|Adverse Event|0|||
37655596|NCT02527148|69126945|FG000|Overall Study|Did not receive study intervention|1|||
37655597|NCT02527148|69126946|FG001|Overall Study|Did not receive study intervention|0|||
37655598|NCT02291614|69126965|FG000|Overall Study|Lost to Follow-up|0|||
37655599|NCT02291614|69126966|FG001|Overall Study|Lost to Follow-up|0|||
37655600|NCT02291614|69126967|FG002|Overall Study|Lost to Follow-up|0|||
37655601|NCT02291614|69126968|FG003|Overall Study|Lost to Follow-up|0|||
37655602|NCT02291614|69126969|FG004|Overall Study|Lost to Follow-up|0|||
37655603|NCT02291614|69126970|FG005|Overall Study|Lost to Follow-up|0|||
37655604|NCT02291614|69126971|FG006|Overall Study|Lost to Follow-up|0|||
37655605|NCT02291614|69126972|FG007|Overall Study|Lost to Follow-up|1|||
37655606|NCT02291614|69126973|FG008|Overall Study|Lost to Follow-up|0|||
37655607|NCT02291614|69126974|FG009|Overall Study|Lost to Follow-up|0|||
37655608|NCT02291614|69126975|FG010|Overall Study|Lost to Follow-up|0|||
37655609|NCT02291614|69126965|FG000|Overall Study|Withdrawal by Subject|0|||
37655610|NCT02291614|69126966|FG001|Overall Study|Withdrawal by Subject|1|||
37655611|NCT02291614|69126967|FG002|Overall Study|Withdrawal by Subject|0|||
37655612|NCT02291614|69126968|FG003|Overall Study|Withdrawal by Subject|0|||
37655613|NCT02291614|69126969|FG004|Overall Study|Withdrawal by Subject|0|||
37655614|NCT02291614|69126970|FG005|Overall Study|Withdrawal by Subject|0|||
37655615|NCT02291614|69126971|FG006|Overall Study|Withdrawal by Subject|0|||
37655616|NCT02291614|69126972|FG007|Overall Study|Withdrawal by Subject|0|||
37655617|NCT02291614|69126973|FG008|Overall Study|Withdrawal by Subject|0|||
37655618|NCT02291614|69126974|FG009|Overall Study|Withdrawal by Subject|2|||
37655619|NCT02291614|69126975|FG010|Overall Study|Withdrawal by Subject|2|||
37655620|NCT02291614|69126965|FG000|Overall Study|Decision by sponsor|0|||
37655621|NCT02291614|69126966|FG001|Overall Study|Decision by sponsor|0|||
37655622|NCT02291614|69126967|FG002|Overall Study|Decision by sponsor|0|||
37655623|NCT02291614|69126968|FG003|Overall Study|Decision by sponsor|1|||
37655624|NCT02291614|69126969|FG004|Overall Study|Decision by sponsor|0|||
37655625|NCT02291614|69126970|FG005|Overall Study|Decision by sponsor|0|||
37655626|NCT02291614|69126971|FG006|Overall Study|Decision by sponsor|0|||
37744214|NCT01791517|69232173|FG007|Phase II|Lens Handling Difficulties|0|||
37744215|NCT01791517|69232174|FG008|Phase II|Lens Handling Difficulties|1|||
37744216|NCT01791517|69232175|FG009|Phase II|Lens Handling Difficulties|0|||
37744217|NCT01791517|69232176|FG010|Phase II|Lens Handling Difficulties|0|||
37744218|NCT01791517|69232177|FG011|Phase II|Lens Handling Difficulties|0|||
37744219|NCT01791517|69232166|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
37744220|NCT01791517|69232167|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
37655627|NCT02291614|69126972|FG007|Overall Study|Decision by sponsor|0|||
37655628|NCT02291614|69126973|FG008|Overall Study|Decision by sponsor|0|||
37655629|NCT02291614|69126974|FG009|Overall Study|Decision by sponsor|0|||
37655630|NCT02291614|69126975|FG010|Overall Study|Decision by sponsor|0|||
37655631|NCT02291614|69126965|FG000|Overall Study|Death|0|||
37655632|NCT02291614|69126966|FG001|Overall Study|Death|0|||
37655633|NCT02291614|69126967|FG002|Overall Study|Death|1|||
37655634|NCT02291614|69126968|FG003|Overall Study|Death|0|||
37655635|NCT02291614|69126969|FG004|Overall Study|Death|1|||
37655636|NCT02291614|69126970|FG005|Overall Study|Death|1|||
37655637|NCT02291614|69126971|FG006|Overall Study|Death|1|||
37655638|NCT02291614|69126972|FG007|Overall Study|Death|0|||
37655639|NCT02291614|69126973|FG008|Overall Study|Death|0|||
37655640|NCT02291614|69126974|FG009|Overall Study|Death|0|||
37655641|NCT02291614|69126975|FG010|Overall Study|Death|0|||
37744221|NCT01791517|69232168|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
37744222|NCT01791517|69232169|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
37744223|NCT01791517|69232170|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
37744224|NCT01791517|69232171|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
37744225|NCT01791517|69232172|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
37744226|NCT01791517|69232173|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
37744227|NCT01791517|69232174|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
37744228|NCT01791517|69232175|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
37744229|NCT01791517|69232176|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
37744230|NCT01791517|69232177|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
37744231|NCT01791517|69232166|FG000|Phase II|Pre-Existing Ocular Issue|0|||
37744232|NCT01791517|69232167|FG001|Phase II|Pre-Existing Ocular Issue|0|||
37744233|NCT01791517|69232168|FG002|Phase II|Pre-Existing Ocular Issue|0|||
37655642|NCT02526524|69127011|FG000|Overall Study|Withdrawal by Subject|3|||
37655643|NCT02526524|69127012|FG001|Overall Study|Withdrawal by Subject|3|||
37655644|NCT02526524|69127013|FG002|Overall Study|Withdrawal by Subject|6|||
37655645|NCT02526524|69127014|FG003|Overall Study|Withdrawal by Subject|1|||
37655646|NCT02526524|69127015|FG004|Overall Study|Withdrawal by Subject|9|||
37655647|NCT02526524|69127016|FG005|Overall Study|Withdrawal by Subject|5|||
37655648|NCT02526524|69127011|FG000|Overall Study|Adverse Event|3|||
37655649|NCT02526524|69127012|FG001|Overall Study|Adverse Event|2|||
37655650|NCT02526524|69127013|FG002|Overall Study|Adverse Event|4|||
37655651|NCT02526524|69127014|FG003|Overall Study|Adverse Event|2|||
37655652|NCT02526524|69127015|FG004|Overall Study|Adverse Event|6|||
37655653|NCT02526524|69127016|FG005|Overall Study|Adverse Event|8|||
37655654|NCT02526524|69127011|FG000|Overall Study|Lost to Follow-up|2|||
37655655|NCT02526524|69127012|FG001|Overall Study|Lost to Follow-up|3|||
37655656|NCT02526524|69127013|FG002|Overall Study|Lost to Follow-up|8|||
37655657|NCT02526524|69127014|FG003|Overall Study|Lost to Follow-up|1|||
37655658|NCT02526524|69127015|FG004|Overall Study|Lost to Follow-up|2|||
37655659|NCT02526524|69127016|FG005|Overall Study|Lost to Follow-up|5|||
37655660|NCT02526524|69127011|FG000|Overall Study|Protocol Violation|3|||
37655661|NCT02526524|69127012|FG001|Overall Study|Protocol Violation|1|||
37655662|NCT02526524|69127013|FG002|Overall Study|Protocol Violation|5|||
37655663|NCT02526524|69127014|FG003|Overall Study|Protocol Violation|3|||
37655664|NCT02526524|69127015|FG004|Overall Study|Protocol Violation|4|||
37655665|NCT02526524|69127016|FG005|Overall Study|Protocol Violation|3|||
37655666|NCT02526524|69127011|FG000|Overall Study|Loss of Glucose Control|0|||
37744234|NCT01791517|69232169|FG003|Phase II|Pre-Existing Ocular Issue|0|||
37744235|NCT01791517|69232170|FG004|Phase II|Pre-Existing Ocular Issue|0|||
37744236|NCT01791517|69232171|FG005|Phase II|Pre-Existing Ocular Issue|0|||
37744237|NCT01791517|69232172|FG006|Phase II|Pre-Existing Ocular Issue|0|||
37744238|NCT01791517|69232173|FG007|Phase II|Pre-Existing Ocular Issue|0|||
37744239|NCT01791517|69232174|FG008|Phase II|Pre-Existing Ocular Issue|0|||
37744240|NCT01791517|69232175|FG009|Phase II|Pre-Existing Ocular Issue|0|||
37744241|NCT01791517|69232176|FG010|Phase II|Pre-Existing Ocular Issue|0|||
37744242|NCT01791517|69232177|FG011|Phase II|Pre-Existing Ocular Issue|1|||
37744243|NCT01998581|69232197|FG000|Overall Study|Refused repeat treatment|20|||
37744244|NCT01998581|69232198|FG001|Overall Study|Refused repeat treatment|4|||
37744245|NCT01998581|69232197|FG000|Overall Study|Protocol Violation|1|||
37744246|NCT01998581|69232198|FG001|Overall Study|Protocol Violation|0|||
37744247|NCT01998581|69232197|FG000|Overall Study|Withdrawal by Subject|8|||
37744248|NCT01998581|69232198|FG001|Overall Study|Withdrawal by Subject|1|||
37744249|NCT01998581|69232197|FG000|Overall Study|Lost to Follow-up|12|||
37744250|NCT01998581|69232198|FG001|Overall Study|Lost to Follow-up|4|||
37744251|NCT01998581|69232197|FG000|Overall Study|Adverse Event|1|||
37744252|NCT01998581|69232198|FG001|Overall Study|Adverse Event|1|||
37744253|NCT01998581|69232197|FG000|Overall Study|Other reasons|3|||
37744254|NCT01998581|69232198|FG001|Overall Study|Other reasons|2|||
37744255|NCT01998581|69232197|FG000|Overall Study|Randomized but withdrew before treatment|1|||
37744256|NCT01998581|69232198|FG001|Overall Study|Randomized but withdrew before treatment|0|||
37744257|NCT01983293|69232207|FG000|Overall Study|Withdrawal by Subject|29|||
37744258|NCT01983293|69232208|FG001|Overall Study|Withdrawal by Subject|15|||
37744259|NCT01983293|69232207|FG000|Overall Study|Missing 12-month visit|3|||
37744260|NCT01983293|69232208|FG001|Overall Study|Missing 12-month visit|3|||
37744261|NCT01983293|69232207|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
37744262|NCT01983293|69232208|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
37744263|NCT01791205|69232216|FG000|Phase II|Lack of Efficacy|6|||
37744264|NCT01791205|69232217|FG001|Phase II|Lack of Efficacy|0|||
37655667|NCT02526524|69127012|FG001|Overall Study|Loss of Glucose Control|0|||
37655668|NCT02526524|69127013|FG002|Overall Study|Loss of Glucose Control|3|||
37655669|NCT02526524|69127014|FG003|Overall Study|Loss of Glucose Control|0|||
37744265|NCT01791205|69232216|FG000|Phase II|Adverse Event|2|||
37744266|NCT01791205|69232217|FG001|Phase II|Adverse Event|0|||
37744267|NCT01791205|69232216|FG000|Phase II|Safety|1|||
37744268|NCT01791205|69232217|FG001|Phase II|Safety|0|||
37744269|NCT01791205|69232216|FG000|Phase II|Lost to Follow-up|1|||
37744270|NCT01791205|69232217|FG001|Phase II|Lost to Follow-up|0|||
37744271|NCT01791205|69232216|FG000|Phase II|Remission of disease|1|||
37744272|NCT01791205|69232217|FG001|Phase II|Remission of disease|0|||
37744273|NCT01791205|69232216|FG000|Phase II|Physician's decision|1|||
37744274|NCT01791205|69232217|FG001|Phase II|Physician's decision|0|||
37744275|NCT01272232|69232226|FG000|Weeks 0-56|Adverse Event|39|||
37744276|NCT01272232|69232227|FG001|Weeks 0-56|Adverse Event|18|||
37855468|NCT00993499|69538840|FG005|Run-in Period (8 Days)|Adverse Event|0|||
38032782|NCT01336634|69718769|FG000|Overall Study|Study closed/terminated|5|||
38032783|NCT01336634|69718770|FG001|Overall Study|Study closed/terminated|6|||
37855469|NCT00993499|69538835|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
37855470|NCT00993499|69538836|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
37855471|NCT00993499|69538837|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
37855472|NCT00993499|69538838|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
37855473|NCT00993499|69538839|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
37855474|NCT00993499|69538840|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
37655670|NCT02526524|69127015|FG004|Overall Study|Loss of Glucose Control|2|||
37655671|NCT02526524|69127016|FG005|Overall Study|Loss of Glucose Control|0|||
37655672|NCT02526524|69127011|FG000|Overall Study|Physician Decision|0|||
37655673|NCT02526524|69127012|FG001|Overall Study|Physician Decision|0|||
37744277|NCT01272232|69232228|FG002|Weeks 0-56|Adverse Event|7|||
37744278|NCT01272232|69232226|FG000|Weeks 0-56|Lack of Efficacy|0|||
37744279|NCT01272232|69232227|FG001|Weeks 0-56|Lack of Efficacy|0|||
37744280|NCT01272232|69232228|FG002|Weeks 0-56|Lack of Efficacy|3|||
37744281|NCT01272232|69232226|FG000|Weeks 0-56|Protocol Violation|12|||
37744282|NCT01272232|69232227|FG001|Weeks 0-56|Protocol Violation|8|||
37744283|NCT01272232|69232228|FG002|Weeks 0-56|Protocol Violation|13|||
37744284|NCT01272232|69232226|FG000|Weeks 0-56|Withdrawal criteria|32|||
37744285|NCT01272232|69232227|FG001|Weeks 0-56|Withdrawal criteria|14|||
37744286|NCT01272232|69232228|FG002|Weeks 0-56|Withdrawal criteria|37|||
37744287|NCT01272232|69232226|FG000|Weeks 0-56|Unclassified|16|||
37744288|NCT01272232|69232227|FG001|Weeks 0-56|Unclassified|7|||
37655674|NCT02526524|69127013|FG002|Overall Study|Physician Decision|0|||
37655675|NCT02526524|69127014|FG003|Overall Study|Physician Decision|0|||
37655676|NCT02526524|69127015|FG004|Overall Study|Physician Decision|1|||
37655677|NCT02526524|69127016|FG005|Overall Study|Physician Decision|0|||
37655678|NCT02526524|69127011|FG000|Overall Study|Sponsor Decision|1|||
37744289|NCT01272232|69232228|FG002|Weeks 0-56|Unclassified|12|||
37655679|NCT02526524|69127012|FG001|Overall Study|Sponsor Decision|0|||
37655680|NCT02526524|69127013|FG002|Overall Study|Sponsor Decision|0|||
37655681|NCT02526524|69127014|FG003|Overall Study|Sponsor Decision|0|||
37655682|NCT02526524|69127015|FG004|Overall Study|Sponsor Decision|0|||
37655683|NCT02526524|69127016|FG005|Overall Study|Sponsor Decision|0|||
37655684|NCT02526290|69127030|FG000|Overall Study|Adverse Event|3|||
37655685|NCT02526290|69127030|FG000|Overall Study|Withdrawal by Subject|4|||
37655686|NCT02526290|69127030|FG000|Overall Study|Physician Decision|1|||
37655687|NCT02319148|69127037|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
37655688|NCT02319148|69127038|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
37655689|NCT02319148|69127039|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
37655690|NCT02319148|69127040|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
37655691|NCT02319148|69127037|FG000|Second Intervention Period|No longer willing to participate|0|||
37655692|NCT02319148|69127038|FG001|Second Intervention Period|No longer willing to participate|1|||
37655693|NCT02319148|69127039|FG002|Second Intervention Period|No longer willing to participate|0|||
37655694|NCT02319148|69127040|FG003|Second Intervention Period|No longer willing to participate|0|||
37655695|NCT02319148|69127037|FG000|Second Intervention Period|Other|0|||
37655696|NCT02319148|69127038|FG001|Second Intervention Period|Other|0|||
37655697|NCT02319148|69127039|FG002|Second Intervention Period|Other|0|||
37655698|NCT02319148|69127040|FG003|Second Intervention Period|Other|1|||
37655699|NCT02526212|69127061|FG000|Overall Study|Incarceration|1|||
37655700|NCT02526212|69127062|FG001|Overall Study|Incarceration|0|||
37655701|NCT02526212|69127061|FG000|Overall Study|Lost to Follow-up|1|||
37655702|NCT02526212|69127062|FG001|Overall Study|Lost to Follow-up|0|||
37744290|NCT01272232|69232226|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
37744291|NCT01272232|69232227|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
37922800|NCT00452413|69609599|FG000|Overall Study|Death due to adverse event (AE)|0|||
37922801|NCT00452413|69609600|FG001|Overall Study|Death due to adverse event (AE)|0|||
37922802|NCT00452413|69609601|FG002|Overall Study|Death due to adverse event (AE)|1|||
37922803|NCT00452413|69609599|FG000|Overall Study|On treatment|0|||
37922804|NCT00452413|69609600|FG001|Overall Study|On treatment|0|||
37744292|NCT01272232|69232228|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
37744293|NCT01272232|69232226|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
37744294|NCT01272232|69232227|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
37744295|NCT01272232|69232228|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
37744296|NCT01272232|69232226|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
37744297|NCT01272232|69232227|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
37744298|NCT01272232|69232228|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
37744299|NCT01272232|69232226|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
37744300|NCT01272232|69232227|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
37744301|NCT01272232|69232228|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
37744302|NCT01272232|69232226|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
37744303|NCT01272232|69232227|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
37744304|NCT01272232|69232228|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
37744305|NCT01791127|69232236|FG000|Overall Study|Death|356|||
37744306|NCT01791127|69232236|FG000|Overall Study|Patient has withdrawn from study|293|||
37744307|NCT01791127|69232236|FG000|Overall Study|Lost to Follow-up|42|||
37744308|NCT01791127|69232236|FG000|Overall Study|All Siello leads are explanted|31|||
37744309|NCT01791127|69232236|FG000|Overall Study|Completion of 30 day safety registry|1|||
37922805|NCT00452413|69609601|FG002|Overall Study|On treatment|3|||
37922806|NCT00867503|69609610|FG000|Overall Study|Withdrawal by Subject|1|||
37922807|NCT00867113|69609616|FG000|Treatment Period|Adverse Event|15|||
37922808|NCT00867113|69609616|FG000|Treatment Period|Death|2|||
37922809|NCT00867113|69609616|FG000|Treatment Period|Withdrawal by Subject|19|||
37922810|NCT00867113|69609616|FG000|Treatment Period|Lost to Follow-up|3|||
37922811|NCT00867113|69609616|FG000|Treatment Period|Administrative problems|1|||
37922812|NCT00867113|69609616|FG000|Treatment Period|Disease progression/relapse|1|||
37922813|NCT00867113|69609616|FG000|Treatment Period|Protocol Violation|4|||
37922814|NCT00867113|69609616|FG000|Post Treatment After Survival Follow-up|Death|1|||
37922815|NCT00867113|69609616|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
37922816|NCT00867113|69609616|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
37922817|NCT00867113|69609616|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
37922818|NCT00451555|69609623|FG000|Overall Study|Protocol Violation|2|||
37922819|NCT00451555|69609624|FG001|Overall Study|Protocol Violation|2|||
37922820|NCT00451555|69609623|FG000|Overall Study|Adverse Event|3|||
37922821|NCT00451555|69609624|FG001|Overall Study|Adverse Event|1|||
37922822|NCT00451555|69609623|FG000|Overall Study|Withdrawal by Subject|6|||
37655703|NCT02526212|69127061|FG000|Overall Study|Death|0|||
37655704|NCT02526212|69127062|FG001|Overall Study|Death|1|||
37655705|NCT02532374|69127068|FG000|Overall Study|Withdrawal by Subject|1|||
37655706|NCT02532374|69127068|FG000|Overall Study|Physician Decision|1|||
37655707|NCT02525744|69127080|FG000|Period 1|Physician Decision|0|||
37655708|NCT02525744|69127081|FG001|Period 1|Physician Decision|0|||
37655709|NCT02525744|69127082|FG002|Period 1|Physician Decision|1|||
37655710|NCT02525744|69127083|FG003|Period 1|Physician Decision|0|||
37655711|NCT02525744|69127080|FG000|Period 3|Adverse Event|0|||
37744310|NCT01791127|69232236|FG000|Overall Study|Study terminated for EP Passion|749|||
37744311|NCT01997333|69232267|FG000|Randomization and Treatment|Disease Progression|70|||
37744312|NCT01997333|69232268|FG001|Randomization and Treatment|Disease Progression|159|||
37744313|NCT01997333|69232267|FG000|Randomization and Treatment|Adverse Event|10|||
37744314|NCT01997333|69232268|FG001|Randomization and Treatment|Adverse Event|32|||
37744315|NCT01997333|69232267|FG000|Randomization and Treatment|Physician Decision|0|||
37744316|NCT01997333|69232268|FG001|Randomization and Treatment|Physician Decision|4|||
37744317|NCT01997333|69232267|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
37744318|NCT01997333|69232268|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
37744319|NCT01997333|69232267|FG000|Randomization and Treatment|Did not receive treatment|17|||
37744320|NCT01997333|69232268|FG001|Randomization and Treatment|Did not receive treatment|5|||
37744321|NCT01997333|69232267|FG000|Survival Follow up|Withdrawal by Subject|15|||
37744322|NCT01997333|69232268|FG001|Survival Follow up|Withdrawal by Subject|6|||
37744323|NCT01997333|69232267|FG000|Survival Follow up|Lost to Follow-up|0|||
37744324|NCT01997333|69232268|FG001|Survival Follow up|Lost to Follow-up|6|||
37744325|NCT01997333|69232267|FG000|Survival Follow up|Various|1|||
37744326|NCT01997333|69232268|FG001|Survival Follow up|Various|2|||
37744327|NCT01982435|69232332|FG000|Overall Study|Adverse Event|1|||
37655712|NCT02525744|69127081|FG001|Period 3|Adverse Event|1|||
37744328|NCT01982435|69232333|FG001|Overall Study|Adverse Event|0|||
37744329|NCT01620983|69232373|FG000|Overall Study|Lost to Follow-up|8|||
37744330|NCT01620983|69232374|FG001|Overall Study|Lost to Follow-up|4|||
37744331|NCT01620983|69232375|FG002|Overall Study|Lost to Follow-up|9|||
37744332|NCT01620983|69232373|FG000|Overall Study|Withdrawal by Subject|6|||
37744333|NCT01620983|69232374|FG001|Overall Study|Withdrawal by Subject|8|||
37744334|NCT01620983|69232375|FG002|Overall Study|Withdrawal by Subject|1|||
37744335|NCT01620983|69232373|FG000|Overall Study|Death|2|||
37744336|NCT01620983|69232374|FG001|Overall Study|Death|0|||
37744337|NCT01620983|69232375|FG002|Overall Study|Death|0|||
37744338|NCT01620983|69232373|FG000|Overall Study|Physician Decision|3|||
37744339|NCT01620983|69232374|FG001|Overall Study|Physician Decision|10|||
37744340|NCT01620983|69232375|FG002|Overall Study|Physician Decision|5|||
37744341|NCT01996709|69232385|FG000|Overall Study|Withdrawal by Subject|1|||
37744342|NCT01996709|69232386|FG001|Overall Study|Withdrawal by Subject|0|||
37744343|NCT01996709|69232385|FG000|Overall Study|Lost to Follow-up|3|||
37744344|NCT01996709|69232386|FG001|Overall Study|Lost to Follow-up|0|||
37744345|NCT01996709|69232385|FG000|Overall Study|Subject Non-Compliant|1|||
37744346|NCT01996709|69232386|FG001|Overall Study|Subject Non-Compliant|0|||
37855475|NCT00993499|69538835|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
37855476|NCT00993499|69538836|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
37655713|NCT02525744|69127082|FG002|Period 3|Adverse Event|0|||
37655714|NCT02525744|69127083|FG003|Period 3|Adverse Event|0|||
37655715|NCT02525744|69127080|FG000|Period 4|Withdrawal by Subject|1|||
37655716|NCT02525744|69127081|FG001|Period 4|Withdrawal by Subject|0|||
37655717|NCT02525744|69127082|FG002|Period 4|Withdrawal by Subject|0|||
37655718|NCT02525744|69127083|FG003|Period 4|Withdrawal by Subject|0|||
37655719|NCT02525744|69127080|FG000|Period 5|Physician Decision|1|||
37655720|NCT02525744|69127081|FG001|Period 5|Physician Decision|0|||
37655721|NCT02525744|69127082|FG002|Period 5|Physician Decision|0|||
37655722|NCT02525744|69127083|FG003|Period 5|Physician Decision|0|||
37655723|NCT00152477|69127096|FG000|Chemotherapy Period|Adverse Event|9|||
37655724|NCT00152477|69127097|FG001|Chemotherapy Period|Adverse Event|4|||
37655725|NCT00152477|69127098|FG002|Chemotherapy Period|Adverse Event|5|||
37655726|NCT00152477|69127096|FG000|Chemotherapy Period|Death|1|||
37655727|NCT00152477|69127097|FG001|Chemotherapy Period|Death|3|||
37744347|NCT01996709|69232385|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
37744348|NCT01996709|69232386|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
37855477|NCT00993499|69538837|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
37744349|NCT01996319|69232411|FG000|Overall Study|Protocol Violation|1|||
37744350|NCT01996319|69232412|FG001|Overall Study|Protocol Violation|0|||
37744351|NCT01996319|69232411|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
37744352|NCT01996319|69232412|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
37744353|NCT01996319|69232411|FG000|Overall Study|Adverse Event|2|||
37744354|NCT01996319|69232412|FG001|Overall Study|Adverse Event|2|||
37855478|NCT00993499|69538838|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
37855479|NCT00993499|69538839|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
37655728|NCT00152477|69127098|FG002|Chemotherapy Period|Death|3|||
37655729|NCT00152477|69127096|FG000|Chemotherapy Period|Lack of Efficacy|4|||
37655730|NCT00152477|69127097|FG001|Chemotherapy Period|Lack of Efficacy|5|||
37655731|NCT00152477|69127098|FG002|Chemotherapy Period|Lack of Efficacy|6|||
37655732|NCT00152477|69127096|FG000|Chemotherapy Period|Lost to Follow-up|1|||
37744355|NCT01279486|69232418|FG000|Overall Study|Lost to Follow-up|1|||
37744356|NCT01279954|69232424|FG000|Overall Study|Lack of Efficacy|3|||
37744357|NCT01279954|69232425|FG001|Overall Study|Lack of Efficacy|4|||
37744358|NCT01278862|69232436|FG000|Overall Study|Lost to Follow-up|1|||
37744359|NCT01278862|69232437|FG001|Overall Study|Lost to Follow-up|1|||
37744360|NCT01278394|69232452|FG000|Overall Study|Lost to Follow-up|1|||
37744361|NCT01981187|69232456|FG000|Overall Study|Participant/guardian decision|2|||
37744362|NCT01981187|69232456|FG000|Overall Study|Physician Decision|1|||
37744363|NCT01981187|69232456|FG000|Overall Study|Disease progression|2|||
37744364|NCT01981187|69232456|FG000|Overall Study|Adverse Event|7|||
37744365|NCT01278160|69232462|FG000|Overall Study|Adverse Event|1|||
37744366|NCT01278160|69232463|FG001|Overall Study|Adverse Event|1|||
37744367|NCT01278160|69232462|FG000|Overall Study|Lost to Follow-up|0|||
37744368|NCT01278160|69232463|FG001|Overall Study|Lost to Follow-up|1|||
37744369|NCT01278160|69232462|FG000|Overall Study|Withdrawal by Subject|3|||
37744370|NCT01278160|69232463|FG001|Overall Study|Withdrawal by Subject|2|||
37744371|NCT01278160|69232462|FG000|Overall Study|Unclassified|1|||
37744372|NCT01278160|69232463|FG001|Overall Study|Unclassified|2|||
37744373|NCT01996241|69232471|FG000|Overall Study|Lost to Follow-up|252|||
37744374|NCT01996241|69232472|FG001|Overall Study|Lost to Follow-up|235|||
37855480|NCT00993499|69538840|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
38032784|NCT01336634|69718771|FG002|Overall Study|Study closed/terminated|6|||
38032785|NCT01336634|69718769|FG000|Overall Study|Lost to Follow-up|2|||
37655733|NCT00152477|69127097|FG001|Chemotherapy Period|Lost to Follow-up|0|||
37655734|NCT00152477|69127098|FG002|Chemotherapy Period|Lost to Follow-up|1|||
37655735|NCT00152477|69127096|FG000|Chemotherapy Period|Protocol Violation|1|||
37655736|NCT00152477|69127097|FG001|Chemotherapy Period|Protocol Violation|1|||
37655737|NCT00152477|69127098|FG002|Chemotherapy Period|Protocol Violation|0|||
37655738|NCT00152477|69127096|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
37655739|NCT00152477|69127097|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
37655740|NCT00152477|69127098|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
37655741|NCT00152477|69127096|FG000|Chemotherapy Period|Progression of Disease|6|||
37655742|NCT00152477|69127097|FG001|Chemotherapy Period|Progression of Disease|8|||
37655743|NCT00152477|69127098|FG002|Chemotherapy Period|Progression of Disease|4|||
37655744|NCT00152477|69127096|FG000|Chemotherapy Period|Investigator decision|0|||
37655745|NCT00152477|69127097|FG001|Chemotherapy Period|Investigator decision|0|||
37655746|NCT00152477|69127098|FG002|Chemotherapy Period|Investigator decision|1|||
37655747|NCT00152477|69127096|FG000|Chemotherapy Period|Patient condition worsened|1|||
37655748|NCT00152477|69127097|FG001|Chemotherapy Period|Patient condition worsened|0|||
37655749|NCT00152477|69127098|FG002|Chemotherapy Period|Patient condition worsened|0|||
37655750|NCT00152477|69127096|FG000|Monotherapy Period|Adverse Event|1|||
37655751|NCT00152477|69127097|FG001|Monotherapy Period|Adverse Event|0|||
37655752|NCT00152477|69127098|FG002|Monotherapy Period|Adverse Event|5|||
37655753|NCT00152477|69127096|FG000|Monotherapy Period|Death|2|||
37655754|NCT00152477|69127097|FG001|Monotherapy Period|Death|0|||
37655755|NCT00152477|69127098|FG002|Monotherapy Period|Death|1|||
37655756|NCT00152477|69127096|FG000|Monotherapy Period|Lack of Efficacy|7|||
37655757|NCT00152477|69127097|FG001|Monotherapy Period|Lack of Efficacy|16|||
37655758|NCT00152477|69127098|FG002|Monotherapy Period|Lack of Efficacy|10|||
37655759|NCT00152477|69127096|FG000|Monotherapy Period|Protocol Violation|0|||
37655760|NCT00152477|69127097|FG001|Monotherapy Period|Protocol Violation|1|||
37655761|NCT00152477|69127098|FG002|Monotherapy Period|Protocol Violation|0|||
37655762|NCT00152477|69127096|FG000|Monotherapy Period|Withdrawal by Subject|0|||
37655763|NCT00152477|69127097|FG001|Monotherapy Period|Withdrawal by Subject|0|||
37655764|NCT00152477|69127098|FG002|Monotherapy Period|Withdrawal by Subject|4|||
37655765|NCT00152477|69127096|FG000|Monotherapy Period|Progression of Disease|5|||
37655766|NCT00152477|69127097|FG001|Monotherapy Period|Progression of Disease|11|||
37655767|NCT00152477|69127098|FG002|Monotherapy Period|Progression of Disease|12|||
37655768|NCT00152477|69127096|FG000|Monotherapy Period|Patient decision|0|||
37655769|NCT00152477|69127097|FG001|Monotherapy Period|Patient decision|1|||
37655770|NCT00152477|69127098|FG002|Monotherapy Period|Patient decision|1|||
37655771|NCT00152477|69127096|FG000|Monotherapy Period|Study personel decision|0|||
37655772|NCT00152477|69127097|FG001|Monotherapy Period|Study personel decision|0|||
37655773|NCT00152477|69127098|FG002|Monotherapy Period|Study personel decision|1|||
37744375|NCT02091869|69232482|FG000|Overall Study|Withdrawal by Subject|0|||
37744376|NCT02091869|69232483|FG001|Overall Study|Withdrawal by Subject|3|||
37744377|NCT01981109|69232498|FG000|Overall Study|Death|36|||
37744378|NCT01981109|69232498|FG000|Overall Study|Withdrawal by Subject|40|||
37744379|NCT01981109|69232498|FG000|Overall Study|Lost to Follow-up|9|||
37744380|NCT01981109|69232498|FG000|Overall Study|No Discontinuation Documentation|37|||
37855481|NCT00993499|69538835|FG000|Run-in Period (8 Days)|Progressive disease|0|||
38032786|NCT01336634|69718770|FG001|Overall Study|Lost to Follow-up|1|||
37655774|NCT02525588|69127111|FG000|Overall Study|Death|3|||
37655775|NCT02525588|69127112|FG001|Overall Study|Death|1|||
37655776|NCT02525588|69127111|FG000|Overall Study|Lost to Follow-up|2|||
37655777|NCT02525588|69127112|FG001|Overall Study|Lost to Follow-up|0|||
37744381|NCT01981109|69232498|FG000|Overall Study|Study Termination|100|||
37744382|NCT01981109|69232498|FG000|Overall Study|No data available|2|||
37744383|NCT00248794|69232506|FG000|Overall Study|Lost to Follow-up|6|||
37744384|NCT00248794|69232507|FG001|Overall Study|Lost to Follow-up|8|||
37655778|NCT02525588|69127111|FG000|Overall Study|Withdrawal by Subject|1|||
37744385|NCT00248794|69232508|FG002|Overall Study|Lost to Follow-up|3|||
37744386|NCT01995539|69232522|FG000|Overall Study|Screening Failure|1|||
37744387|NCT01995539|69232522|FG000|Overall Study|Withdrawal by Investigator|15|||
37744388|NCT01995539|69232522|FG000|Overall Study|Withdrawal by Subject|11|||
37655779|NCT02525588|69127112|FG001|Overall Study|Withdrawal by Subject|1|||
37655780|NCT02525588|69127111|FG000|Overall Study|Adverse Event|0|||
37655781|NCT02525588|69127112|FG001|Overall Study|Adverse Event|1|||
37655782|NCT00153179|69127120|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
37655783|NCT00153179|69127121|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
37655784|NCT00153179|69127122|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
37655785|NCT00153179|69127123|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
37655786|NCT02743949|69127134|FG000|Overall Study|Adverse Event|0|||
37655787|NCT02743949|69127135|FG001|Overall Study|Adverse Event|0|||
37655788|NCT02743949|69127136|FG002|Overall Study|Adverse Event|2|||
37655789|NCT02743949|69127134|FG000|Overall Study|Significant Protocol Deviation|2|||
37655790|NCT02743949|69127135|FG001|Overall Study|Significant Protocol Deviation|0|||
37655791|NCT02743949|69127136|FG002|Overall Study|Significant Protocol Deviation|1|||
37655792|NCT02743949|69127134|FG000|Overall Study|Voluntary Withdrawal|2|||
37655793|NCT02743949|69127135|FG001|Overall Study|Voluntary Withdrawal|1|||
37655794|NCT02743949|69127136|FG002|Overall Study|Voluntary Withdrawal|0|||
37655795|NCT02531438|69127146|FG000|Overall Study|Adverse Event|7|||
37655796|NCT02531438|69127147|FG001|Overall Study|Adverse Event|9|||
37655797|NCT02531438|69127146|FG000|Overall Study|Lost to Follow-up|0|||
37655798|NCT02531438|69127147|FG001|Overall Study|Lost to Follow-up|3|||
37655799|NCT02531438|69127146|FG000|Overall Study|Withdrawal by Subject|7|||
37655800|NCT02531438|69127147|FG001|Overall Study|Withdrawal by Subject|8|||
37655801|NCT02531438|69127146|FG000|Overall Study|Physician Decision|0|||
37744389|NCT01995539|69232522|FG000|Overall Study|Lost to Follow-up|5|||
37744390|NCT01995539|69232522|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
37744391|NCT01835587|69232530|FG000|Overall Study|Disease Recurrence or Relapse|0|||
37744392|NCT01835587|69232531|FG001|Overall Study|Disease Recurrence or Relapse|3|||
37744393|NCT01835587|69232532|FG002|Overall Study|Disease Recurrence or Relapse|0|||
37744394|NCT01835587|69232533|FG003|Overall Study|Disease Recurrence or Relapse|3|||
37744395|NCT01835587|69232530|FG000|Overall Study|Withdrawal by Subject|2|||
37744396|NCT01835587|69232531|FG001|Overall Study|Withdrawal by Subject|0|||
37744397|NCT01835587|69232532|FG002|Overall Study|Withdrawal by Subject|0|||
37744398|NCT01835587|69232533|FG003|Overall Study|Withdrawal by Subject|3|||
37744399|NCT01835587|69232530|FG000|Overall Study|Adverse Event|0|||
37744400|NCT01835587|69232531|FG001|Overall Study|Adverse Event|0|||
37744401|NCT01835587|69232532|FG002|Overall Study|Adverse Event|2|||
37744402|NCT01835587|69232533|FG003|Overall Study|Adverse Event|2|||
37744403|NCT01835587|69232530|FG000|Overall Study|Death|0|||
37744404|NCT01835587|69232531|FG001|Overall Study|Death|0|||
37744405|NCT01835587|69232532|FG002|Overall Study|Death|0|||
37744406|NCT01835587|69232533|FG003|Overall Study|Death|1|||
37744407|NCT01835587|69232530|FG000|Overall Study|Miscellaneous|0|||
37744408|NCT01835587|69232531|FG001|Overall Study|Miscellaneous|1|||
38032787|NCT01336634|69718771|FG002|Overall Study|Lost to Follow-up|1|||
37655802|NCT02531438|69127147|FG001|Overall Study|Physician Decision|1|||
37655803|NCT02531438|69127146|FG000|Overall Study|Death|6|||
37655804|NCT02531438|69127147|FG001|Overall Study|Death|3|||
37655805|NCT02531438|69127146|FG000|Overall Study|Randomized, but Not Treated|4|||
37655806|NCT02531438|69127147|FG001|Overall Study|Randomized, but Not Treated|0|||
37655807|NCT02531438|69127146|FG000|Overall Study|Missed EOT/PTE Visit|5|||
37655808|NCT02531438|69127147|FG001|Overall Study|Missed EOT/PTE Visit|2|||
37655809|NCT02531438|69127146|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
37655810|NCT02531438|69127147|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
37655811|NCT02289898|69127156|FG000|Overall Study|Death|5|||
37744409|NCT01835587|69232532|FG002|Overall Study|Miscellaneous|0|||
37744410|NCT01835587|69232533|FG003|Overall Study|Miscellaneous|0|||
37744411|NCT01736917|69232550|FG000|Overall Study|Adverse Event|1|||
37744412|NCT01736917|69232550|FG000|Overall Study|Protocol Violation|10|||
38032788|NCT01336634|69718769|FG000|Overall Study|Physician Decision|1|||
38032789|NCT01336634|69718770|FG001|Overall Study|Physician Decision|1|||
37655812|NCT02289898|69127157|FG001|Overall Study|Death|4|||
37655813|NCT02289898|69127158|FG002|Overall Study|Death|3|||
37655814|NCT02289898|69127156|FG000|Overall Study|Physician Decision|2|||
37655815|NCT02289898|69127157|FG001|Overall Study|Physician Decision|5|||
37655816|NCT02289898|69127158|FG002|Overall Study|Physician Decision|2|||
37655817|NCT02289898|69127156|FG000|Overall Study|Withdrawal by Subject|0|||
37655818|NCT02289898|69127157|FG001|Overall Study|Withdrawal by Subject|4|||
37655819|NCT02289898|69127158|FG002|Overall Study|Withdrawal by Subject|1|||
37655820|NCT02289898|69127156|FG000|Overall Study|Adverse Event|3|||
37744413|NCT01277302|69232559|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
37744414|NCT01277302|69232560|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
37744415|NCT01277302|69232561|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
37744416|NCT01277302|69232559|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
37744417|NCT01277302|69232560|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
37744418|NCT01277302|69232561|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
37744419|NCT01277302|69232559|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
37744420|NCT01277302|69232560|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
37744421|NCT01277302|69232561|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
37744422|NCT01277302|69232559|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
37655821|NCT02289898|69127157|FG001|Overall Study|Adverse Event|5|||
37655822|NCT02289898|69127158|FG002|Overall Study|Adverse Event|5|||
37655823|NCT02289898|69127156|FG000|Overall Study|Disease progression|34|||
37655824|NCT02289898|69127157|FG001|Overall Study|Disease progression|28|||
37655825|NCT02289898|69127158|FG002|Overall Study|Disease progression|34|||
37655826|NCT02289898|69127156|FG000|Overall Study|Use of another anticancer therapy|0|||
37655827|NCT02289898|69127157|FG001|Overall Study|Use of another anticancer therapy|0|||
37655828|NCT02289898|69127158|FG002|Overall Study|Use of another anticancer therapy|1|||
37744423|NCT01277302|69232560|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
37744424|NCT01277302|69232561|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
37744425|NCT01277302|69232559|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
37744426|NCT01277302|69232560|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
37744427|NCT01277302|69232561|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
37744428|NCT01277302|69232559|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
37655829|NCT02289898|69127156|FG000|Overall Study|Other|8|||
37655830|NCT02289898|69127157|FG001|Overall Study|Other|7|||
37655831|NCT02289898|69127158|FG002|Overall Study|Other|10|||
37655832|NCT01660412|69127165|FG000|Overall Study|Protocol Violation|0|||
37655833|NCT01660412|69127166|FG001|Overall Study|Protocol Violation|3|||
37655834|NCT01659554|69127172|FG000|Overall Study|Study Termination|4|||
37655835|NCT01659320|69127176|FG000|Overall Study|Withdrawal by Subject|2|||
37655836|NCT01659320|69127176|FG000|Overall Study|Physician Decision|1|||
37655837|NCT01660334|69127180|FG000|Overall Study|Lost to Follow-up|1|||
37655838|NCT01660256|69127187|FG000|Overall Study|Adverse Event|4|||
37655839|NCT01660256|69127188|FG001|Overall Study|Adverse Event|0|||
37655840|NCT01660256|69127189|FG002|Overall Study|Adverse Event|2|||
37655841|NCT01660256|69127187|FG000|Overall Study|Withdrawal by Subject|1|||
37655842|NCT01660256|69127188|FG001|Overall Study|Withdrawal by Subject|0|||
37655843|NCT01660256|69127189|FG002|Overall Study|Withdrawal by Subject|2|||
37655844|NCT02034123|69127215|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
37744429|NCT01277302|69232560|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
37744430|NCT01277302|69232561|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
37744431|NCT01277302|69232559|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
37744432|NCT01277302|69232560|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
37744433|NCT01277302|69232561|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
37744434|NCT01277302|69232559|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
37744435|NCT01277302|69232560|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
37744436|NCT01277302|69232561|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
37744437|NCT01277302|69232559|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
37744438|NCT01277302|69232560|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
37744439|NCT01277302|69232561|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
37744440|NCT01980875|69232572|FG000|Overall Study|Withdrew Consent|1|||
37744441|NCT01980875|69232573|FG001|Overall Study|Withdrew Consent|1|||
37744442|NCT01980875|69232574|FG002|Overall Study|Withdrew Consent|1|||
37744443|NCT01980875|69232572|FG000|Overall Study|Study Terminated by Sponsor|7|||
37744444|NCT01980875|69232573|FG001|Overall Study|Study Terminated by Sponsor|24|||
37744445|NCT01980875|69232574|FG002|Overall Study|Study Terminated by Sponsor|22|||
37744446|NCT01980875|69232572|FG000|Overall Study|Lost to Follow-up|0|||
37744447|NCT01980875|69232573|FG001|Overall Study|Lost to Follow-up|0|||
37744448|NCT01980875|69232574|FG002|Overall Study|Lost to Follow-up|1|||
37744449|NCT01995461|69232582|FG000|Overall Study|Death|1|||
37744450|NCT01995461|69232582|FG000|Overall Study|Lost to Follow-up|2|||
37744451|NCT01995461|69232582|FG000|Overall Study|Withdrawal by Subject|2|||
37744452|NCT01980095|69232588|FG000|Overall Study|Lost to Follow-up|6|||
38032790|NCT01336634|69718771|FG002|Overall Study|Physician Decision|0|||
37744453|NCT01980095|69232589|FG001|Overall Study|Lost to Follow-up|7|||
37744454|NCT01980095|69232588|FG000|Overall Study|Withdrawal by Subject|2|||
37744455|NCT01980095|69232589|FG001|Overall Study|Withdrawal by Subject|3|||
37744456|NCT01980095|69232588|FG000|Overall Study|Poor compliance|5|||
37744457|NCT01980095|69232589|FG001|Overall Study|Poor compliance|0|||
37744458|NCT01980095|69232588|FG000|Overall Study|Safety issue|0|||
37744459|NCT01980095|69232589|FG001|Overall Study|Safety issue|1|||
37655845|NCT02034123|69127216|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
37655846|NCT02034123|69127217|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
37655847|NCT02034123|69127218|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
37655848|NCT02034123|69127219|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
37744460|NCT01980095|69232588|FG000|Overall Study|Study drug discontinued|1|||
37744461|NCT01980095|69232589|FG001|Overall Study|Study drug discontinued|0|||
37655849|NCT02034123|69127220|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
37655850|NCT02034123|69127221|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
37744462|NCT01980095|69232588|FG000|Overall Study|Randomized by mistake|1|||
37744463|NCT01980095|69232589|FG001|Overall Study|Randomized by mistake|0|||
37744464|NCT01980017|69232599|FG000|Overall Study|Lost to Follow-up|30|||
37744465|NCT01980017|69232600|FG001|Overall Study|Lost to Follow-up|21|||
37744466|NCT01980017|69232599|FG000|Overall Study|Death|0|||
37744467|NCT01980017|69232600|FG001|Overall Study|Death|1|||
37744468|NCT01978145|69232609|FG000|Treatment Period 1|Adverse Event|1|||
37744469|NCT01978145|69232610|FG001|Treatment Period 1|Adverse Event|9|||
37744470|NCT01978145|69232609|FG000|Treatment Period 1|Physician Decision|1|||
37744471|NCT01978145|69232610|FG001|Treatment Period 1|Physician Decision|0|||
37744472|NCT01978145|69232609|FG000|Treatment Period 1|Withdrawal by Subject|5|||
37744473|NCT01978145|69232610|FG001|Treatment Period 1|Withdrawal by Subject|4|||
37744474|NCT01978145|69232609|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
37744475|NCT01978145|69232610|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
37744476|NCT01978145|69232609|FG000|Washout Period 1|Adverse Event|0|||
37744477|NCT01978145|69232610|FG001|Washout Period 1|Adverse Event|1|||
37744478|NCT01978145|69232609|FG000|Washout Period 1|Withdrawal by Subject|1|||
37744479|NCT01978145|69232610|FG001|Washout Period 1|Withdrawal by Subject|1|||
37744480|NCT01978145|69232609|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
37744481|NCT01978145|69232610|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
37744482|NCT01978145|69232609|FG000|Treatment Period 2|Adverse Event|3|||
37744483|NCT01978145|69232610|FG001|Treatment Period 2|Adverse Event|3|||
37744484|NCT01978145|69232609|FG000|Treatment Period 2|Protocol Violation|0|||
37744485|NCT01978145|69232610|FG001|Treatment Period 2|Protocol Violation|1|||
37655851|NCT02034123|69127222|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
37655852|NCT02034123|69127223|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
37655853|NCT02034123|69127224|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
37744486|NCT01978145|69232609|FG000|Treatment Period 2|Lost to Follow-up|1|||
37744487|NCT01978145|69232610|FG001|Treatment Period 2|Lost to Follow-up|1|||
37744488|NCT01978145|69232609|FG000|Treatment Period 2|Withdrawal by Subject|7|||
37744489|NCT01978145|69232610|FG001|Treatment Period 2|Withdrawal by Subject|4|||
37744490|NCT01978145|69232609|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
37744491|NCT01978145|69232610|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
37744492|NCT01967537|69232616|FG000|Overall Study|Withdrawal by Subject|52|||
37744493|NCT01967537|69232616|FG000|Overall Study|Refuse treatment|2|||
37655854|NCT02034123|69127225|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
37655855|NCT02034123|69127226|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
37655856|NCT02034123|69127227|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
37655857|NCT02034123|69127228|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
37655858|NCT02034123|69127229|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
37655859|NCT02034123|69127230|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
37655860|NCT02034123|69127231|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
37655861|NCT02034123|69127232|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
37655862|NCT02034123|69127215|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
37655863|NCT02034123|69127216|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
37655864|NCT02034123|69127217|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
37655865|NCT02034123|69127218|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
37655866|NCT02034123|69127219|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
37655867|NCT02034123|69127220|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
37655868|NCT02034123|69127221|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
37655869|NCT02034123|69127222|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
37655870|NCT02034123|69127223|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
37655871|NCT02034123|69127224|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
37655872|NCT02034123|69127225|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
37655873|NCT02034123|69127226|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
37655874|NCT02034123|69127227|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
37655875|NCT02034123|69127228|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
37744494|NCT01967537|69232616|FG000|Overall Study|Lost to Follow-up|6|||
37744495|NCT01967225|69232624|FG000|Overall Study|Adverse Event|3|||
37744496|NCT01967225|69232625|FG001|Overall Study|Adverse Event|1|||
37744497|NCT01967225|69232624|FG000|Overall Study|Withdrawal by Subject|2|||
37744498|NCT01967225|69232625|FG001|Overall Study|Withdrawal by Subject|1|||
37744499|NCT01967225|69232624|FG000|Overall Study|Lack of Efficacy|1|||
37744500|NCT01967225|69232625|FG001|Overall Study|Lack of Efficacy|1|||
37744501|NCT01967225|69232624|FG000|Overall Study|Switching to other therapy|2|||
37744502|NCT01967225|69232625|FG001|Overall Study|Switching to other therapy|0|||
37744503|NCT01967225|69232624|FG000|Overall Study|Protocol driven decision point|1|||
37655876|NCT02034123|69127229|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
37655877|NCT02034123|69127230|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
37655878|NCT02034123|69127231|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
37655879|NCT02034123|69127232|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
37655880|NCT02034123|69127215|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
37655881|NCT02034123|69127216|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
37655882|NCT02034123|69127217|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
37655883|NCT02034123|69127218|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
37655884|NCT02034123|69127219|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
37655885|NCT02034123|69127220|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
37655886|NCT02034123|69127221|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
37655887|NCT02034123|69127222|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
37655888|NCT02034123|69127223|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
37655889|NCT02034123|69127224|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
37655890|NCT02034123|69127225|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
37655891|NCT02034123|69127226|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
37655892|NCT02034123|69127227|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
37655893|NCT02034123|69127228|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
37655894|NCT02034123|69127229|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
37655895|NCT02034123|69127230|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
37655896|NCT02034123|69127231|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
37655897|NCT02034123|69127232|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
37655898|NCT02034123|69127215|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
37655899|NCT02034123|69127216|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
37655900|NCT02034123|69127217|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
37655901|NCT02034123|69127218|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
37655902|NCT02034123|69127219|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
37655903|NCT02034123|69127220|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
37655904|NCT02034123|69127221|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
37744504|NCT01967225|69232625|FG001|Overall Study|Protocol driven decision point|0|||
37744505|NCT01967225|69232624|FG000|Overall Study|Logistical difficulties|1|||
38032791|NCT01336634|69718769|FG000|Overall Study|Withdrawal by Subject|6|||
38032792|NCT01336634|69718770|FG001|Overall Study|Withdrawal by Subject|0|||
38032793|NCT01336634|69718771|FG002|Overall Study|Withdrawal by Subject|2|||
38032794|NCT02947100|69718786|FG000|Overall Study|study terminated early|3|||
38032795|NCT02947100|69718786|FG000|Overall Study|did not meet inclusion criteria|1|||
38032796|NCT03329846|69718792|FG000|Overall Study|Disease progression|4|||
38032797|NCT03329846|69718793|FG001|Overall Study|Disease progression|6|||
38032798|NCT03329846|69718792|FG000|Overall Study|Study drug toxicity|1|||
37744506|NCT01967225|69232625|FG001|Overall Study|Logistical difficulties|0|||
38032799|NCT03329846|69718793|FG001|Overall Study|Study drug toxicity|0|||
38032800|NCT03329846|69718792|FG000|Overall Study|Participant request to discontinue treatment|0|||
38032801|NCT03329846|69718793|FG001|Overall Study|Participant request to discontinue treatment|1|||
38032802|NCT03329846|69718792|FG000|Overall Study|Participant withdrew consent|1|||
38032803|NCT03329846|69718793|FG001|Overall Study|Participant withdrew consent|0|||
38032804|NCT03329846|69718792|FG000|Overall Study|Other reasons|2|||
38032805|NCT03329846|69718793|FG001|Overall Study|Other reasons|2|||
38032806|NCT03325010|69718801|FG000|Overall Study|Adverse Event|3|||
38032807|NCT03325010|69718802|FG001|Overall Study|Adverse Event|8|||
38032808|NCT03325010|69718801|FG000|Overall Study|Protocol Violation|1|||
38032809|NCT03325010|69718802|FG001|Overall Study|Protocol Violation|8|||
38032810|NCT03325010|69718801|FG000|Overall Study|Withdrawal by Subject|1|||
38032811|NCT03325010|69718802|FG001|Overall Study|Withdrawal by Subject|3|||
38032812|NCT03325010|69718801|FG000|Overall Study|Lost to Follow-up|1|||
38032813|NCT03325010|69718802|FG001|Overall Study|Lost to Follow-up|0|||
38032814|NCT03325010|69718801|FG000|Overall Study|Physician Decision|1|||
38032815|NCT03325010|69718802|FG001|Overall Study|Physician Decision|1|||
38032816|NCT03325010|69718801|FG000|Overall Study|Lack of Efficacy|2|||
38032817|NCT03325010|69718802|FG001|Overall Study|Lack of Efficacy|0|||
38032818|NCT02824432|69718810|FG000|Overall Study|Major Protocol Deviation|1|||
38032819|NCT02824432|69718811|FG001|Overall Study|Major Protocol Deviation|0|||
38032820|NCT02823964|69718817|FG000|Overall Study|Adverse Event|2|||
38032821|NCT02823964|69718817|FG000|Overall Study|Physician Decision|1|||
38032822|NCT02823964|69718817|FG000|Overall Study|Lack of Efficacy|1|||
38032823|NCT02823964|69718817|FG000|Overall Study|Withdrawal by Subject|1|||
38032824|NCT01338610|69718824|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
38032825|NCT01338610|69718825|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
38032826|NCT01338610|69718826|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
37655905|NCT02034123|69127222|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
37744507|NCT01967225|69232624|FG000|Overall Study|Protocol Violation|2|||
37744508|NCT01967225|69232625|FG001|Overall Study|Protocol Violation|0|||
37744509|NCT01967147|69232635|FG000|Overall Study|Adverse Event|5|||
37744510|NCT01967147|69232636|FG001|Overall Study|Adverse Event|2|||
37744511|NCT01967147|69232635|FG000|Overall Study|Lack of Efficacy|1|||
37744512|NCT01967147|69232636|FG001|Overall Study|Lack of Efficacy|4|||
37744513|NCT01967147|69232635|FG000|Overall Study|Lost to Follow-up|1|||
37744514|NCT01967147|69232636|FG001|Overall Study|Lost to Follow-up|2|||
37744515|NCT01967147|69232635|FG000|Overall Study|Withdrawal by Subject|2|||
37744516|NCT01967147|69232636|FG001|Overall Study|Withdrawal by Subject|4|||
37744517|NCT01967147|69232635|FG000|Overall Study|Non-compliance with Study Drug|0|||
37744518|NCT01967147|69232636|FG001|Overall Study|Non-compliance with Study Drug|3|||
37744519|NCT01967147|69232635|FG000|Overall Study|Other|4|||
37744520|NCT01967147|69232636|FG001|Overall Study|Other|5|||
37744521|NCT01967069|69232645|FG000|Overall Study|Adverse Event|2|||
37744522|NCT01967069|69232646|FG001|Overall Study|Adverse Event|2|||
37744523|NCT01967069|69232645|FG000|Overall Study|Lost to Follow-up|5|||
37744524|NCT01967069|69232646|FG001|Overall Study|Lost to Follow-up|2|||
37655906|NCT02034123|69127223|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
37655907|NCT02034123|69127224|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
37744525|NCT01967069|69232645|FG000|Overall Study|Withdrawal by Subject|1|||
37744526|NCT01967069|69232646|FG001|Overall Study|Withdrawal by Subject|3|||
37744527|NCT01967069|69232645|FG000|Overall Study|Lack of Efficacy|0|||
37744528|NCT01967069|69232646|FG001|Overall Study|Lack of Efficacy|1|||
37744529|NCT01790503|69232663|FG000|Overall Study|Adverse Event|1|||
37744530|NCT01790503|69232664|FG001|Overall Study|Adverse Event|0|||
37655908|NCT02034123|69127225|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
37655909|NCT02034123|69127226|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
37655910|NCT02034123|69127227|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
37655911|NCT02034123|69127228|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
37655912|NCT02034123|69127229|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
37655913|NCT02034123|69127230|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
37655914|NCT02034123|69127231|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
37655915|NCT02034123|69127232|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
37655916|NCT02318602|69127278|FG000|Overall Study|Adverse Event|0|||
37655917|NCT02318602|69127279|FG001|Overall Study|Adverse Event|1|||
37655918|NCT02318602|69127280|FG002|Overall Study|Adverse Event|1|||
37655919|NCT02318602|69127278|FG000|Overall Study|Withdrawal by Subject|0|||
37655920|NCT02318602|69127279|FG001|Overall Study|Withdrawal by Subject|3|||
37655921|NCT02318602|69127280|FG002|Overall Study|Withdrawal by Subject|0|||
37655922|NCT02318602|69127278|FG000|Overall Study|Death|1|||
37655923|NCT02318602|69127279|FG001|Overall Study|Death|0|||
37655924|NCT02318602|69127280|FG002|Overall Study|Death|0|||
37655925|NCT02318602|69127278|FG000|Overall Study|Guardian decision to withdraw|0|||
37655926|NCT02318602|69127279|FG001|Overall Study|Guardian decision to withdraw|0|||
37655927|NCT02318602|69127280|FG002|Overall Study|Guardian decision to withdraw|1|||
37655928|NCT02318368|69127296|FG000|Overall Study|Withdrawal by Subject|2|||
37655929|NCT02318368|69127297|FG001|Overall Study|Withdrawal by Subject|0|||
37655930|NCT02318368|69127296|FG000|Overall Study|Study terminated by the sponsor|5|||
37655931|NCT02318368|69127297|FG001|Overall Study|Study terminated by the sponsor|2|||
37655932|NCT02318368|69127296|FG000|Overall Study|Death|0|||
37655933|NCT02318368|69127297|FG001|Overall Study|Death|1|||
37655934|NCT02318134|69127305|FG000|Overall Study|Withdrawal by Subject|2|||
37655935|NCT02318134|69127306|FG001|Overall Study|Withdrawal by Subject|1|||
37655936|NCT02317510|69127316|FG000|Overall Study|Adverse Event|0|||
37655937|NCT02317510|69127317|FG001|Overall Study|Adverse Event|1|||
37655938|NCT02317432|69127328|FG000|Overall Study|Death|4|||
37655939|NCT02317432|69127329|FG001|Overall Study|Death|1|||
37655940|NCT02317432|69127328|FG000|Overall Study|Lost to Follow-up|0|||
37655941|NCT02317432|69127329|FG001|Overall Study|Lost to Follow-up|5|||
37655942|NCT02317432|69127328|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
37655943|NCT02317432|69127329|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
37655944|NCT00494234|69127337|FG000|Overall Study|Lack of Efficacy|12|||
37655945|NCT00494234|69127338|FG001|Overall Study|Lack of Efficacy|9|||
37655946|NCT00494234|69127337|FG000|Overall Study|Withdrawal by Subject|1|||
37744531|NCT01790503|69232665|FG002|Overall Study|Adverse Event|0|||
37744532|NCT01790503|69232666|FG003|Overall Study|Adverse Event|0|||
37744533|NCT01790503|69232667|FG004|Overall Study|Adverse Event|0|||
37744534|NCT01790503|69232668|FG005|Overall Study|Adverse Event|2|||
37744535|NCT01790503|69232669|FG006|Overall Study|Adverse Event|0|||
37744536|NCT01790503|69232670|FG007|Overall Study|Adverse Event|0|||
37655947|NCT00494234|69127338|FG001|Overall Study|Withdrawal by Subject|0|||
37655948|NCT00494234|69127337|FG000|Overall Study|Death|2|||
37744537|NCT01790503|69232671|FG008|Overall Study|Adverse Event|2|||
37744538|NCT01790503|69232672|FG009|Overall Study|Adverse Event|4|||
37744539|NCT01790503|69232673|FG010|Overall Study|Adverse Event|7|||
37744540|NCT01790503|69232663|FG000|Overall Study|Withdrawal by Subject|0|||
37744541|NCT01790503|69232664|FG001|Overall Study|Withdrawal by Subject|0|||
37744542|NCT01790503|69232665|FG002|Overall Study|Withdrawal by Subject|1|||
37744543|NCT01790503|69232666|FG003|Overall Study|Withdrawal by Subject|1|||
37744544|NCT01790503|69232667|FG004|Overall Study|Withdrawal by Subject|1|||
37744545|NCT01790503|69232668|FG005|Overall Study|Withdrawal by Subject|2|||
37744546|NCT01790503|69232669|FG006|Overall Study|Withdrawal by Subject|1|||
37744547|NCT01790503|69232670|FG007|Overall Study|Withdrawal by Subject|0|||
37744548|NCT01790503|69232671|FG008|Overall Study|Withdrawal by Subject|0|||
37744549|NCT01790503|69232672|FG009|Overall Study|Withdrawal by Subject|0|||
37744550|NCT01790503|69232673|FG010|Overall Study|Withdrawal by Subject|1|||
37744551|NCT01790503|69232663|FG000|Overall Study|Disease progression|2|||
37744552|NCT01790503|69232664|FG001|Overall Study|Disease progression|1|||
37744553|NCT01790503|69232665|FG002|Overall Study|Disease progression|0|||
37744554|NCT01790503|69232666|FG003|Overall Study|Disease progression|1|||
37744555|NCT01790503|69232667|FG004|Overall Study|Disease progression|2|||
37655949|NCT00494234|69127338|FG001|Overall Study|Death|1|||
37655950|NCT02289820|69127355|FG000|Overall Study|Withdrawal by Subject|2|||
37655951|NCT02289820|69127356|FG001|Overall Study|Withdrawal by Subject|1|||
37655952|NCT02289820|69127357|FG002|Overall Study|Withdrawal by Subject|2|||
37655953|NCT02289820|69127358|FG003|Overall Study|Withdrawal by Subject|1|||
37655954|NCT02289820|69127359|FG004|Overall Study|Withdrawal by Subject|0|||
37655955|NCT02289820|69127360|FG005|Overall Study|Withdrawal by Subject|0|||
37655956|NCT02289820|69127361|FG006|Overall Study|Withdrawal by Subject|1|||
37655957|NCT02289820|69127355|FG000|Overall Study|Death|0|||
37655958|NCT02289820|69127356|FG001|Overall Study|Death|0|||
37655959|NCT02289820|69127357|FG002|Overall Study|Death|1|||
37655960|NCT02289820|69127358|FG003|Overall Study|Death|0|||
37655961|NCT02289820|69127359|FG004|Overall Study|Death|0|||
37655962|NCT02289820|69127360|FG005|Overall Study|Death|0|||
37655963|NCT02289820|69127361|FG006|Overall Study|Death|0|||
37655964|NCT02289820|69127355|FG000|Overall Study|Lost to Follow-up|0|||
37655965|NCT02289820|69127356|FG001|Overall Study|Lost to Follow-up|0|||
37655966|NCT02289820|69127357|FG002|Overall Study|Lost to Follow-up|3|||
37655967|NCT02289820|69127358|FG003|Overall Study|Lost to Follow-up|1|||
37655968|NCT02289820|69127359|FG004|Overall Study|Lost to Follow-up|0|||
37655969|NCT02289820|69127360|FG005|Overall Study|Lost to Follow-up|1|||
37655970|NCT02289820|69127361|FG006|Overall Study|Lost to Follow-up|1|||
37655971|NCT02289820|69127355|FG000|Overall Study|withdrawal of consent|0|||
37655972|NCT02289820|69127356|FG001|Overall Study|withdrawal of consent|1|||
37744556|NCT01790503|69232668|FG005|Overall Study|Disease progression|1|||
37744557|NCT01790503|69232669|FG006|Overall Study|Disease progression|0|||
37744558|NCT01790503|69232670|FG007|Overall Study|Disease progression|1|||
37744559|NCT01790503|69232671|FG008|Overall Study|Disease progression|0|||
37744560|NCT01790503|69232672|FG009|Overall Study|Disease progression|17|||
37744561|NCT01790503|69232673|FG010|Overall Study|Disease progression|7|||
37744562|NCT01790503|69232663|FG000|Overall Study|Protocol Violation|0|||
37744563|NCT01790503|69232664|FG001|Overall Study|Protocol Violation|0|||
37744564|NCT01790503|69232665|FG002|Overall Study|Protocol Violation|0|||
37744565|NCT01790503|69232666|FG003|Overall Study|Protocol Violation|0|||
37744566|NCT01790503|69232667|FG004|Overall Study|Protocol Violation|0|||
37744567|NCT01790503|69232668|FG005|Overall Study|Protocol Violation|0|||
37744568|NCT01790503|69232669|FG006|Overall Study|Protocol Violation|0|||
37744569|NCT01790503|69232670|FG007|Overall Study|Protocol Violation|0|||
37744570|NCT01790503|69232671|FG008|Overall Study|Protocol Violation|0|||
37744571|NCT01790503|69232672|FG009|Overall Study|Protocol Violation|1|||
37744572|NCT01790503|69232673|FG010|Overall Study|Protocol Violation|0|||
37744573|NCT01790503|69232663|FG000|Overall Study|Physician Decision|0|||
37744574|NCT01790503|69232664|FG001|Overall Study|Physician Decision|0|||
37744575|NCT01790503|69232665|FG002|Overall Study|Physician Decision|0|||
37655973|NCT02289820|69127357|FG002|Overall Study|withdrawal of consent|0|||
37655974|NCT02289820|69127358|FG003|Overall Study|withdrawal of consent|0|||
37655975|NCT02289820|69127359|FG004|Overall Study|withdrawal of consent|0|||
37655976|NCT02289820|69127360|FG005|Overall Study|withdrawal of consent|0|||
37744576|NCT01790503|69232666|FG003|Overall Study|Physician Decision|0|||
37744577|NCT01790503|69232667|FG004|Overall Study|Physician Decision|0|||
37655977|NCT02289820|69127361|FG006|Overall Study|withdrawal of consent|0|||
37655978|NCT02289742|69127383|FG000|First Wear Period|Adverse event prior to treatment|0|||
37655979|NCT02289742|69127384|FG001|First Wear Period|Adverse event prior to treatment|1|||
37744578|NCT01790503|69232668|FG005|Overall Study|Physician Decision|0|||
37744579|NCT01790503|69232669|FG006|Overall Study|Physician Decision|0|||
37744580|NCT01790503|69232670|FG007|Overall Study|Physician Decision|0|||
37744581|NCT01790503|69232671|FG008|Overall Study|Physician Decision|0|||
37655980|NCT02289742|69127385|FG002|First Wear Period|Adverse event prior to treatment|0|||
37744582|NCT01790503|69232672|FG009|Overall Study|Physician Decision|1|||
37744583|NCT01790503|69232673|FG010|Overall Study|Physician Decision|1|||
37744584|NCT01790503|69232663|FG000|Overall Study|Death|0|||
37744585|NCT01790503|69232664|FG001|Overall Study|Death|0|||
37744586|NCT01790503|69232665|FG002|Overall Study|Death|0|||
37744587|NCT01790503|69232666|FG003|Overall Study|Death|0|||
37744588|NCT01790503|69232667|FG004|Overall Study|Death|0|||
37744589|NCT01790503|69232668|FG005|Overall Study|Death|0|||
37744590|NCT01790503|69232669|FG006|Overall Study|Death|0|||
37744591|NCT01790503|69232670|FG007|Overall Study|Death|0|||
37744592|NCT01790503|69232671|FG008|Overall Study|Death|0|||
37744593|NCT01790503|69232672|FG009|Overall Study|Death|1|||
37744594|NCT01790503|69232673|FG010|Overall Study|Death|0|||
37744595|NCT01790503|69232663|FG000|Overall Study|Non Compliance|0|||
37744596|NCT01790503|69232664|FG001|Overall Study|Non Compliance|0|||
37744597|NCT01790503|69232665|FG002|Overall Study|Non Compliance|0|||
37744598|NCT01790503|69232666|FG003|Overall Study|Non Compliance|0|||
37744599|NCT01790503|69232667|FG004|Overall Study|Non Compliance|1|||
37744600|NCT01790503|69232668|FG005|Overall Study|Non Compliance|0|||
37744601|NCT01790503|69232669|FG006|Overall Study|Non Compliance|0|||
37744602|NCT01790503|69232670|FG007|Overall Study|Non Compliance|0|||
37744603|NCT01790503|69232671|FG008|Overall Study|Non Compliance|0|||
37744604|NCT01790503|69232672|FG009|Overall Study|Non Compliance|0|||
37744605|NCT01790503|69232673|FG010|Overall Study|Non Compliance|0|||
37744606|NCT01790503|69232663|FG000|Overall Study|Other|0|||
37744607|NCT01790503|69232664|FG001|Overall Study|Other|0|||
37744608|NCT01790503|69232665|FG002|Overall Study|Other|0|||
37744609|NCT01790503|69232666|FG003|Overall Study|Other|0|||
37744610|NCT01790503|69232667|FG004|Overall Study|Other|1|||
37744611|NCT01790503|69232668|FG005|Overall Study|Other|0|||
37744612|NCT01790503|69232669|FG006|Overall Study|Other|0|||
37744613|NCT01790503|69232670|FG007|Overall Study|Other|0|||
37744614|NCT01790503|69232671|FG008|Overall Study|Other|1|||
37744615|NCT01790503|69232672|FG009|Overall Study|Other|2|||
37744616|NCT01790503|69232673|FG010|Overall Study|Other|0|||
37744617|NCT01790113|69232712|FG000|Overall Study|Adverse Event|2|||
37744618|NCT01790113|69232713|FG001|Overall Study|Adverse Event|7|||
37744619|NCT01790113|69232712|FG000|Overall Study|Study ended due to FDA clearance|1|||
37744620|NCT01790113|69232713|FG001|Overall Study|Study ended due to FDA clearance|68|||
37744621|NCT01789567|69232719|FG000|Overall Study|Death|6|||
37744622|NCT01765543|69232723|FG000|Overall Study|Death|1|||
37744623|NCT01765543|69232723|FG000|Overall Study|Withdrawal by Subject|2|||
37744624|NCT01765153|69232733|FG000|Training Phase 1|Format of intervention differed|1|||
37744625|NCT01765153|69232734|FG001|Training Phase 1|Format of intervention differed|0|||
37744626|NCT01765153|69232733|FG000|Training Phase 1|Poor participation in intervention|0|||
37744627|NCT01765153|69232734|FG001|Training Phase 1|Poor participation in intervention|1|||
37744628|NCT01765153|69232733|FG000|Rest Phase 1|Withdrawal by Subject|0|||
37744629|NCT01765153|69232734|FG001|Rest Phase 1|Withdrawal by Subject|1|||
37744630|NCT01765153|69232733|FG000|Training Phase 2|Withdrawal by Subject|0|||
38032827|NCT01338610|69718824|FG000|Overall Study|Protocol Violation|1|||
38032828|NCT01338610|69718825|FG001|Overall Study|Protocol Violation|0|||
37655981|NCT02289742|69127386|FG003|First Wear Period|Adverse event prior to treatment|0|||
37655982|NCT02289742|69127383|FG000|First Wear Period|Adverse Event|0|||
37655983|NCT02289742|69127384|FG001|First Wear Period|Adverse Event|0|||
37655984|NCT02289742|69127385|FG002|First Wear Period|Adverse Event|1|||
37655985|NCT02289742|69127386|FG003|First Wear Period|Adverse Event|0|||
37655986|NCT02289742|69127383|FG000|First Wear Period|Other prior to treatment|0|||
37655987|NCT02289742|69127384|FG001|First Wear Period|Other prior to treatment|0|||
37655988|NCT02289742|69127385|FG002|First Wear Period|Other prior to treatment|0|||
37655989|NCT02289742|69127386|FG003|First Wear Period|Other prior to treatment|1|||
37655990|NCT02289742|69127383|FG000|Third Wear Period|Adverse Event|0|||
37655991|NCT02289742|69127384|FG001|Third Wear Period|Adverse Event|1|||
37655992|NCT02289742|69127385|FG002|Third Wear Period|Adverse Event|0|||
37655993|NCT02289742|69127386|FG003|Third Wear Period|Adverse Event|0|||
37655994|NCT02289742|69127383|FG000|Third Wear Period|Reason not given|0|||
37655995|NCT02289742|69127384|FG001|Third Wear Period|Reason not given|0|||
37655996|NCT02289742|69127385|FG002|Third Wear Period|Reason not given|0|||
37744631|NCT01765153|69232734|FG001|Training Phase 2|Withdrawal by Subject|1|||
37744632|NCT01765153|69232733|FG000|Rest Phase 2|Lost to Follow-up|2|||
38032829|NCT01338610|69718826|FG002|Overall Study|Protocol Violation|1|||
37744633|NCT01765153|69232734|FG001|Rest Phase 2|Lost to Follow-up|1|||
37744634|NCT00248170|69232746|FG000|Overall Study|Withdrawal by Subject|71|||
37744635|NCT00248170|69232747|FG001|Overall Study|Withdrawal by Subject|79|||
38032830|NCT01338610|69718824|FG000|Overall Study|Adverse Event|3|||
37655997|NCT02289742|69127386|FG003|Third Wear Period|Reason not given|1|||
37744636|NCT00248170|69232746|FG000|Overall Study|Protocol Violation|35|||
37744637|NCT00248170|69232747|FG001|Overall Study|Protocol Violation|30|||
37744638|NCT00248170|69232746|FG000|Overall Study|Lost to Follow-up|28|||
37744639|NCT00248170|69232747|FG001|Overall Study|Lost to Follow-up|35|||
37744640|NCT00248170|69232746|FG000|Overall Study|Disease progression|196|||
37744641|NCT00248170|69232747|FG001|Overall Study|Disease progression|216|||
37744642|NCT00248170|69232746|FG000|Overall Study|Death|28|||
37744643|NCT00248170|69232747|FG001|Overall Study|Death|47|||
37655998|NCT02289352|69127403|FG000|Overall Study|Withdrawal by Subject|1|||
37655999|NCT02289352|69127404|FG001|Overall Study|Withdrawal by Subject|1|||
37656000|NCT02289352|69127405|FG002|Overall Study|Withdrawal by Subject|0|||
37656001|NCT02315560|69127414|FG000|Overall Study|noncompliance by subjects|3|||
37656002|NCT02522624|69127420|FG000|Overall Study|Technical failure|1|||
37744644|NCT00248170|69232746|FG000|Overall Study|Adverse Event|311|||
37744645|NCT00248170|69232747|FG001|Overall Study|Adverse Event|296|||
37744646|NCT00248170|69232746|FG000|Overall Study|Administrative problems|22|||
37744647|NCT00248170|69232747|FG001|Overall Study|Administrative problems|25|||
37744648|NCT00248170|69232746|FG000|Overall Study|Abnormal test procedure(s) result|49|||
37744649|NCT00248170|69232747|FG001|Overall Study|Abnormal test procedure(s) result|61|||
37744650|NCT00248170|69232746|FG000|Overall Study|Abnormal laboratory values|4|||
37744651|NCT00248170|69232747|FG001|Overall Study|Abnormal laboratory values|0|||
37744652|NCT00248170|69232746|FG000|Overall Study|Protocol deviation|17|||
37744653|NCT00248170|69232747|FG001|Overall Study|Protocol deviation|19|||
37744654|NCT01764997|69232758|FG000|Run-in Period|Adverse Event|15|||
37744655|NCT01764997|69232759|FG001|Run-in Period|Adverse Event|0|||
37744656|NCT01764997|69232760|FG002|Run-in Period|Adverse Event|0|||
37744657|NCT01764997|69232761|FG003|Run-in Period|Adverse Event|0|||
37744658|NCT01764997|69232762|FG004|Run-in Period|Adverse Event|0|||
37744659|NCT01764997|69232758|FG000|Run-in Period|Lack of Efficacy|5|||
37744660|NCT01764997|69232759|FG001|Run-in Period|Lack of Efficacy|0|||
37656003|NCT02522624|69127421|FG001|Overall Study|Technical failure|0|||
37656004|NCT02287402|69127427|FG000|Treatment Period|Adverse Event|17|||
37656005|NCT02287402|69127427|FG000|Treatment Period|Voluntary Withdrawal|10|||
37656006|NCT02287402|69127427|FG000|Follow-up|Lost to Follow-up|1|||
37656007|NCT02287402|69127427|FG000|Follow-up|Voluntary Withdrawal|2|||
37656008|NCT02314780|69127434|FG000|Overall Study|organizational reasons|0|||
37656009|NCT02314780|69127435|FG001|Overall Study|organizational reasons|2|||
37656010|NCT02314780|69127436|FG002|Overall Study|organizational reasons|0|||
37656011|NCT02314780|69127434|FG000|Overall Study|Adverse Event|0|||
37656012|NCT02314780|69127435|FG001|Overall Study|Adverse Event|1|||
37656013|NCT02314780|69127436|FG002|Overall Study|Adverse Event|0|||
37656014|NCT02288182|69127446|FG000|Overall Study|Adverse Event|0|||
37656015|NCT02288182|69127447|FG001|Overall Study|Adverse Event|1|||
37656016|NCT02288182|69127446|FG000|Overall Study|Lost to Follow-up|0|||
37656017|NCT02288182|69127447|FG001|Overall Study|Lost to Follow-up|1|||
37656018|NCT02286466|69127457|FG000|Overall Study|Death|1|||
37656019|NCT02286466|69127458|FG001|Overall Study|Death|3|||
37656020|NCT02286466|69127457|FG000|Overall Study|Withdrawal by Subject|5|||
37656021|NCT02286466|69127458|FG001|Overall Study|Withdrawal by Subject|2|||
37656022|NCT02286466|69127457|FG000|Overall Study|Lost to Follow-up|1|||
37656023|NCT02286466|69127458|FG001|Overall Study|Lost to Follow-up|4|||
37656024|NCT02286466|69127457|FG000|Overall Study|Declined Clinician Assessment|0|||
37656025|NCT02286466|69127458|FG001|Overall Study|Declined Clinician Assessment|1|||
37656026|NCT02313766|69127467|FG000|Overall Study|surgery cancelled|1|||
37656027|NCT02313766|69127468|FG001|Overall Study|surgery cancelled|0|||
37656028|NCT02313766|69127469|FG002|Overall Study|surgery cancelled|0|||
37656029|NCT02313766|69127467|FG000|Overall Study|Lost to Follow-up|0|||
37656030|NCT02313766|69127468|FG001|Overall Study|Lost to Follow-up|2|||
37656031|NCT02313766|69127469|FG002|Overall Study|Lost to Follow-up|0|||
37656032|NCT02313766|69127467|FG000|Overall Study|Adverse Event|0|||
37656033|NCT02313766|69127468|FG001|Overall Study|Adverse Event|1|||
37656034|NCT02313766|69127469|FG002|Overall Study|Adverse Event|0|||
37656035|NCT01646398|69127479|FG000|Overall Study|Withdrawal by Subject|1|||
37656036|NCT01646398|69127480|FG001|Overall Study|Withdrawal by Subject|0|||
37656037|NCT01646320|69127488|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
37656038|NCT01646320|69127489|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
37656039|NCT01646320|69127488|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
37656040|NCT01646320|69127489|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
37656041|NCT01646320|69127488|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
37656042|NCT01646320|69127489|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
37656043|NCT01646320|69127488|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
37656044|NCT01646320|69127489|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
38032831|NCT01338610|69718825|FG001|Overall Study|Adverse Event|0|||
37656045|NCT01646320|69127488|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
37656046|NCT01646320|69127489|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
37656047|NCT01646320|69127488|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
37656048|NCT01646320|69127489|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
37656049|NCT01646320|69127488|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
37656050|NCT01646320|69127489|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
37656051|NCT01646320|69127488|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
37744661|NCT01764997|69232760|FG002|Run-in Period|Lack of Efficacy|0|||
37744662|NCT01764997|69232761|FG003|Run-in Period|Lack of Efficacy|0|||
37744663|NCT01764997|69232762|FG004|Run-in Period|Lack of Efficacy|0|||
37656052|NCT01646320|69127489|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
37656053|NCT01646320|69127488|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
37656054|NCT01646320|69127489|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
37656055|NCT01646320|69127488|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
37656056|NCT01646320|69127489|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
37656057|NCT01646320|69127488|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
37656058|NCT01646320|69127489|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
37656059|NCT02524730|69127495|FG000|Overall Study|Lost to Follow-up|5|||
37656060|NCT02524730|69127495|FG000|Overall Study|Withdrawal by Subject|18|||
37656061|NCT02524730|69127495|FG000|Overall Study|Death|10|||
37744664|NCT01764997|69232758|FG000|Run-in Period|Poor compliance to protocol|1|||
37744665|NCT01764997|69232759|FG001|Run-in Period|Poor compliance to protocol|0|||
37656062|NCT02524730|69127495|FG000|Overall Study|Adverse Event|8|||
37656063|NCT02524730|69127495|FG000|Overall Study|Protocol Violation|1|||
37744666|NCT01764997|69232760|FG002|Run-in Period|Poor compliance to protocol|0|||
37744667|NCT01764997|69232761|FG003|Run-in Period|Poor compliance to protocol|0|||
37744668|NCT01764997|69232762|FG004|Run-in Period|Poor compliance to protocol|0|||
37744669|NCT01764997|69232758|FG000|Run-in Period|Other than specified above|17|||
37744670|NCT01764997|69232759|FG001|Run-in Period|Other than specified above|0|||
37744671|NCT01764997|69232760|FG002|Run-in Period|Other than specified above|0|||
37744672|NCT01764997|69232761|FG003|Run-in Period|Other than specified above|0|||
37744673|NCT01764997|69232762|FG004|Run-in Period|Other than specified above|0|||
37744674|NCT01764997|69232758|FG000|Study Drug Treatment Period|Adverse Event|0|||
37744675|NCT01764997|69232759|FG001|Study Drug Treatment Period|Adverse Event|1|||
37744676|NCT01764997|69232760|FG002|Study Drug Treatment Period|Adverse Event|0|||
37744677|NCT01764997|69232761|FG003|Study Drug Treatment Period|Adverse Event|0|||
37744678|NCT01764997|69232762|FG004|Study Drug Treatment Period|Adverse Event|24|||
37744679|NCT01764997|69232758|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
37744680|NCT01764997|69232759|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
37744681|NCT01764997|69232760|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
37744682|NCT01764997|69232761|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
37744683|NCT01764997|69232762|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
37744684|NCT01764997|69232758|FG000|Study Drug Treatment Period|Other than specified above|0|||
37744685|NCT01764997|69232759|FG001|Study Drug Treatment Period|Other than specified above|0|||
37744686|NCT01764997|69232760|FG002|Study Drug Treatment Period|Other than specified above|0|||
37744687|NCT01764997|69232761|FG003|Study Drug Treatment Period|Other than specified above|0|||
37744688|NCT01764997|69232762|FG004|Study Drug Treatment Period|Other than specified above|10|||
37744689|NCT01276756|69232774|FG000|Overall Study|Lost to Follow-up|2|||
37744690|NCT01276756|69232775|FG001|Overall Study|Lost to Follow-up|0|||
37744691|NCT01276756|69232774|FG000|Overall Study|Adverse Event|3|||
37744692|NCT01276756|69232775|FG001|Overall Study|Adverse Event|2|||
37744693|NCT00246376|69232786|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
37744694|NCT00246376|69232787|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
37744695|NCT00246376|69232788|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
37656064|NCT02524730|69127495|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
37656065|NCT01658150|69127499|FG000|Overall Study|Withdrawal by Subject|1|||
37656066|NCT02285998|69127506|FG000|Overall Study|Adverse Event|9|||
37656067|NCT02285998|69127507|FG001|Overall Study|Adverse Event|8|||
37656068|NCT02285998|69127506|FG000|Overall Study|Physician Decision|1|||
37656069|NCT02285998|69127507|FG001|Overall Study|Physician Decision|2|||
37656070|NCT02285998|69127506|FG000|Overall Study|Lost to Follow-up|176|||
37656071|NCT02285998|69127507|FG001|Overall Study|Lost to Follow-up|172|||
37656072|NCT02285998|69127506|FG000|Overall Study|Withdrawal by Subject|53|||
37656073|NCT02285998|69127507|FG001|Overall Study|Withdrawal by Subject|61|||
37656074|NCT02285998|69127506|FG000|Overall Study|Other Reasons|7|||
37656075|NCT02285998|69127507|FG001|Overall Study|Other Reasons|10|||
37744696|NCT00246376|69232789|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
37744697|NCT00246376|69232790|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
37744698|NCT00246376|69232786|FG000|Overall Study|Adverse Event|2|||
37744699|NCT00246376|69232787|FG001|Overall Study|Adverse Event|3|||
37744700|NCT00246376|69232788|FG002|Overall Study|Adverse Event|1|||
37744701|NCT00246376|69232789|FG003|Overall Study|Adverse Event|3|||
37744702|NCT00246376|69232790|FG004|Overall Study|Adverse Event|1|||
37744703|NCT00246376|69232786|FG000|Overall Study|Lost to Follow-up|2|||
37744704|NCT00246376|69232787|FG001|Overall Study|Lost to Follow-up|11|||
37744705|NCT00246376|69232788|FG002|Overall Study|Lost to Follow-up|11|||
37656076|NCT01658072|69127515|FG000|Overall Study|Protocol Violation|4|||
37656077|NCT01658072|69127516|FG001|Overall Study|Protocol Violation|2|||
37656078|NCT02285920|69127526|FG000|Overall Study|Kidney transplantation|2|||
37656079|NCT02285920|69127527|FG001|Overall Study|Kidney transplantation|2|||
37656080|NCT02285920|69127528|FG002|Overall Study|Kidney transplantation|2|||
37656081|NCT02285920|69127529|FG003|Overall Study|Kidney transplantation|0|||
37744706|NCT00246376|69232789|FG003|Overall Study|Lost to Follow-up|16|||
37744707|NCT00246376|69232790|FG004|Overall Study|Lost to Follow-up|13|||
37744708|NCT01764841|69232848|FG000|Overall Study|Logistical Difficulties|0|||
37744709|NCT01764841|69232849|FG001|Overall Study|Logistical Difficulties|1|||
37744710|NCT01764841|69232850|FG002|Overall Study|Logistical Difficulties|0|||
37744711|NCT01764841|69232851|FG003|Overall Study|Logistical Difficulties|0|||
37744712|NCT01764841|69232848|FG000|Overall Study|Death|3|||
37744713|NCT01764841|69232849|FG001|Overall Study|Death|0|||
37744714|NCT01764841|69232850|FG002|Overall Study|Death|1|||
37744715|NCT01764841|69232851|FG003|Overall Study|Death|4|||
37744716|NCT01764841|69232848|FG000|Overall Study|No Follow Up|1|||
37744717|NCT01764841|69232849|FG001|Overall Study|No Follow Up|0|||
37744718|NCT01764841|69232850|FG002|Overall Study|No Follow Up|1|||
37922823|NCT00451555|69609624|FG001|Overall Study|Withdrawal by Subject|0|||
37922824|NCT00451555|69609623|FG000|Overall Study|Physician Decision|2|||
37922825|NCT00451555|69609624|FG001|Overall Study|Physician Decision|1|||
37656082|NCT02285920|69127526|FG000|Overall Study|Change to peritoneal dialysis|0|||
37744719|NCT01764841|69232851|FG003|Overall Study|No Follow Up|0|||
37744720|NCT01764841|69232848|FG000|Overall Study|Protocol Violation|0|||
37744721|NCT01764841|69232849|FG001|Overall Study|Protocol Violation|1|||
37744722|NCT01764841|69232850|FG002|Overall Study|Protocol Violation|0|||
37744723|NCT01764841|69232851|FG003|Overall Study|Protocol Violation|0|||
37744724|NCT01764841|69232848|FG000|Overall Study|Withdrawal by Subject|16|||
37744725|NCT01764841|69232849|FG001|Overall Study|Withdrawal by Subject|24|||
37744726|NCT01764841|69232850|FG002|Overall Study|Withdrawal by Subject|11|||
37744727|NCT01764841|69232851|FG003|Overall Study|Withdrawal by Subject|15|||
37744728|NCT01764841|69232848|FG000|Overall Study|Lost to Follow-up|3|||
37744729|NCT01764841|69232849|FG001|Overall Study|Lost to Follow-up|0|||
37744730|NCT01764841|69232850|FG002|Overall Study|Lost to Follow-up|1|||
37744731|NCT01764841|69232851|FG003|Overall Study|Lost to Follow-up|0|||
37744732|NCT00245050|69232863|FG000|Overall Study|Adverse Event|3|||
37744733|NCT00245050|69232864|FG001|Overall Study|Adverse Event|2|||
37744734|NCT00243412|69232902|FG000|Overall Study|Death|0|||
37744735|NCT00243412|69232903|FG001|Overall Study|Death|1|||
37744736|NCT00243412|69232902|FG000|Overall Study|Adverse Event|4|||
37744737|NCT00243412|69232903|FG001|Overall Study|Adverse Event|2|||
37744738|NCT00243412|69232902|FG000|Overall Study|Lost to Follow-up|0|||
37744739|NCT00243412|69232903|FG001|Overall Study|Lost to Follow-up|1|||
37744740|NCT00243412|69232902|FG000|Overall Study|Physician Decision|1|||
37744741|NCT00243412|69232903|FG001|Overall Study|Physician Decision|1|||
37744742|NCT00243412|69232902|FG000|Overall Study|Withdrawal by Subject|4|||
37744743|NCT00243412|69232903|FG001|Overall Study|Withdrawal by Subject|5|||
37744744|NCT00243412|69232902|FG000|Overall Study|Other|1|||
37744745|NCT00243412|69232903|FG001|Overall Study|Other|1|||
37744746|NCT03805750|69232918|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
37656083|NCT02285920|69127527|FG001|Overall Study|Change to peritoneal dialysis|0|||
37656084|NCT02285920|69127528|FG002|Overall Study|Change to peritoneal dialysis|1|||
37656085|NCT02285920|69127529|FG003|Overall Study|Change to peritoneal dialysis|0|||
37656086|NCT02285920|69127526|FG000|Overall Study|Transfer to non-participating unit|0|||
37656087|NCT02285920|69127527|FG001|Overall Study|Transfer to non-participating unit|1|||
37656088|NCT02285920|69127528|FG002|Overall Study|Transfer to non-participating unit|0|||
37656089|NCT02285920|69127529|FG003|Overall Study|Transfer to non-participating unit|0|||
37656090|NCT02285920|69127526|FG000|Overall Study|Dialysis discontinuation|0|||
37656091|NCT02285920|69127527|FG001|Overall Study|Dialysis discontinuation|1|||
37656092|NCT02285920|69127528|FG002|Overall Study|Dialysis discontinuation|0|||
37744747|NCT03805750|69232919|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
37744748|NCT03804268|69232927|FG000|Overall Study|Adverse Event|2|||
37744749|NCT03804268|69232928|FG001|Overall Study|Adverse Event|2|||
37744750|NCT03804268|69232927|FG000|Overall Study|Withdrawal by Subject|2|||
37744751|NCT03804268|69232928|FG001|Overall Study|Withdrawal by Subject|0|||
37744752|NCT03804268|69232927|FG000|Overall Study|Lost to Follow-up|1|||
37744753|NCT03804268|69232928|FG001|Overall Study|Lost to Follow-up|0|||
37744754|NCT03804268|69232927|FG000|Overall Study|Physician Decision|2|||
37656093|NCT02285920|69127529|FG003|Overall Study|Dialysis discontinuation|0|||
37656094|NCT02285920|69127526|FG000|Overall Study|Death|2|||
37656095|NCT02285920|69127527|FG001|Overall Study|Death|0|||
37744755|NCT03804268|69232928|FG001|Overall Study|Physician Decision|0|||
37744756|NCT00243022|69232953|FG000|Overall Study|Withdrawal by Subject|1|||
37922826|NCT00808236|69609641|FG000|Overall Study|Was not resuscitated|50|||
37922827|NCT00808236|69609642|FG001|Overall Study|Was not resuscitated|56|||
37922828|NCT00808236|69609641|FG000|Overall Study|Pre-defined exclusion|13|||
37656096|NCT02285920|69127528|FG002|Overall Study|Death|2|||
37656097|NCT02285920|69127529|FG003|Overall Study|Death|1|||
37744757|NCT00243022|69232954|FG001|Overall Study|Withdrawal by Subject|0|||
37744758|NCT00243022|69232953|FG000|Overall Study|Death|1|||
37744759|NCT00243022|69232954|FG001|Overall Study|Death|0|||
37744760|NCT00243022|69232953|FG000|Overall Study|Difficult Travel Distance|0|||
37744761|NCT00243022|69232954|FG001|Overall Study|Difficult Travel Distance|1|||
37744762|NCT01736683|69233039|FG000|Overall Study|Disease Relapse|0|||
37744763|NCT01736683|69233040|FG001|Overall Study|Disease Relapse|0|||
37922829|NCT00808236|69609642|FG001|Overall Study|Pre-defined exclusion|3|||
37744764|NCT01736683|69233041|FG002|Overall Study|Disease Relapse|2|||
37744765|NCT01736683|69233042|FG003|Overall Study|Disease Relapse|1|||
37744766|NCT01736683|69233043|FG004|Overall Study|Disease Relapse|0|||
37744767|NCT01736683|69233039|FG000|Overall Study|Adverse Event|0|||
37744768|NCT01736683|69233040|FG001|Overall Study|Adverse Event|2|||
37744769|NCT01736683|69233041|FG002|Overall Study|Adverse Event|2|||
37744770|NCT01736683|69233042|FG003|Overall Study|Adverse Event|3|||
37744771|NCT01736683|69233043|FG004|Overall Study|Adverse Event|2|||
37744772|NCT01736683|69233039|FG000|Overall Study|Withdrawal by Subject|0|||
37744773|NCT01736683|69233040|FG001|Overall Study|Withdrawal by Subject|0|||
37744774|NCT01736683|69233041|FG002|Overall Study|Withdrawal by Subject|3|||
37744775|NCT01736683|69233042|FG003|Overall Study|Withdrawal by Subject|1|||
38032832|NCT01338610|69718826|FG002|Overall Study|Adverse Event|0|||
38032833|NCT01355302|69718833|FG000|Phase 1b|Death|4|||
38032834|NCT01355302|69718834|FG001|Phase 1b|Death|0|||
38032835|NCT01355302|69718835|FG002|Phase 1b|Death|0|||
38032836|NCT01355302|69718833|FG000|Phase 1b|Study terminated by sponsor|2|||
38032837|NCT01355302|69718834|FG001|Phase 1b|Study terminated by sponsor|0|||
38032838|NCT01355302|69718835|FG002|Phase 1b|Study terminated by sponsor|0|||
38032839|NCT01355068|69718843|FG000|First Intervention Period|Adverse Event|0|||
38032840|NCT01355068|69718844|FG001|First Intervention Period|Adverse Event|1|||
38032841|NCT01355068|69718843|FG000|First Intervention Period|Withdrawal by Subject|0|||
38032842|NCT01355068|69718844|FG001|First Intervention Period|Withdrawal by Subject|1|||
38032843|NCT03756129|69718856|FG000|Overall Study|Adverse Event|1|||
38032844|NCT03756129|69718857|FG001|Overall Study|Adverse Event|1|||
38032845|NCT03756129|69718858|FG002|Overall Study|Adverse Event|0|||
37656098|NCT02035137|69127542|FG000|Overall Study|Physician Decision|0|||
37656099|NCT02035137|69127543|FG001|Overall Study|Physician Decision|0|||
37656100|NCT02035137|69127544|FG002|Overall Study|Physician Decision|1|||
37656101|NCT02035137|69127542|FG000|Overall Study|Withdrawal by Subject|0|||
37656102|NCT02035137|69127543|FG001|Overall Study|Withdrawal by Subject|1|||
37656103|NCT02035137|69127544|FG002|Overall Study|Withdrawal by Subject|2|||
37656104|NCT02035137|69127542|FG000|Overall Study|Ineligible|0|||
37656105|NCT02035137|69127543|FG001|Overall Study|Ineligible|1|||
37656106|NCT02035137|69127544|FG002|Overall Study|Ineligible|2|||
37656107|NCT02035137|69127542|FG000|Overall Study|Disease progression prior to treatment start|2|||
37656108|NCT02035137|69127543|FG001|Overall Study|Disease progression prior to treatment start|0|||
37656109|NCT02035137|69127544|FG002|Overall Study|Disease progression prior to treatment start|0|||
37656110|NCT02522780|69127554|FG000|Overall Study|Consent withdrawn by subject|5|||
37656111|NCT02522780|69127555|FG001|Overall Study|Consent withdrawn by subject|7|||
37656112|NCT02522780|69127554|FG000|Overall Study|Protocol deviation|1|||
37656113|NCT02522780|69127555|FG001|Overall Study|Protocol deviation|3|||
37656114|NCT02522780|69127554|FG000|Overall Study|Subject refused endoscopic procedure|0|||
37656115|NCT02522780|69127555|FG001|Overall Study|Subject refused endoscopic procedure|1|||
37656116|NCT02522780|69127554|FG000|Overall Study|Adverse event, non-fatal|11|||
37656117|NCT02522780|69127555|FG001|Overall Study|Adverse event, non-fatal|16|||
37656118|NCT02285062|69127575|FG000|Pre-Treatment Period|Protocol Violation|0|||
37656119|NCT02285062|69127576|FG001|Pre-Treatment Period|Protocol Violation|2|||
37656120|NCT02285062|69127575|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
37656121|NCT02285062|69127576|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
37656122|NCT01352741|69127582|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
37656123|NCT01352741|69127583|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
37656124|NCT01352741|69127582|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
37656125|NCT01352741|69127583|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
38032846|NCT03756129|69718859|FG003|Overall Study|Adverse Event|2|||
37744776|NCT01736683|69233043|FG004|Overall Study|Withdrawal by Subject|1|||
37744777|NCT01736683|69233039|FG000|Overall Study|Lack of Therapeutic Effect|7|||
37744778|NCT01736683|69233040|FG001|Overall Study|Lack of Therapeutic Effect|4|||
37744779|NCT01736683|69233041|FG002|Overall Study|Lack of Therapeutic Effect|13|||
37744780|NCT01736683|69233042|FG003|Overall Study|Lack of Therapeutic Effect|20|||
37744781|NCT01736683|69233043|FG004|Overall Study|Lack of Therapeutic Effect|1|||
37922830|NCT00808236|69609641|FG000|Overall Study|Lost to Follow-up|1|||
38032847|NCT03756129|69718860|FG004|Overall Study|Adverse Event|0|||
38032848|NCT03756129|69718861|FG005|Overall Study|Adverse Event|0|||
38032849|NCT03756129|69718856|FG000|Overall Study|Withdrawal by Subject|2|||
37656126|NCT01352741|69127582|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
37656127|NCT01352741|69127583|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
37656128|NCT01352741|69127582|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
37744782|NCT01736683|69233039|FG000|Overall Study|Progressive Disease|0|||
37744783|NCT01736683|69233040|FG001|Overall Study|Progressive Disease|0|||
37744784|NCT01736683|69233041|FG002|Overall Study|Progressive Disease|0|||
37744785|NCT01736683|69233042|FG003|Overall Study|Progressive Disease|1|||
37744786|NCT01736683|69233043|FG004|Overall Study|Progressive Disease|0|||
37744787|NCT01736683|69233039|FG000|Overall Study|Other|0|||
38032850|NCT03756129|69718857|FG001|Overall Study|Withdrawal by Subject|1|||
38032851|NCT03756129|69718858|FG002|Overall Study|Withdrawal by Subject|3|||
37656129|NCT01352741|69127583|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
37656130|NCT01352741|69127582|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
37656131|NCT01352741|69127583|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
37656132|NCT01352741|69127582|FG000|Open-label Tapentadol Titration Period|Other|4|||
37656133|NCT01352741|69127583|FG001|Open-label Tapentadol Titration Period|Other|0|||
37656134|NCT01352741|69127582|FG000|Double-blind Comparative Period|Protocol Violation|2|||
37656135|NCT01352741|69127583|FG001|Double-blind Comparative Period|Protocol Violation|0|||
37656136|NCT01352741|69127582|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
37656137|NCT01352741|69127583|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
37656138|NCT01352741|69127582|FG000|Double-blind Comparative Period|Adverse Event|16|||
37744788|NCT01736683|69233040|FG001|Overall Study|Other|0|||
37744789|NCT01736683|69233041|FG002|Overall Study|Other|1|||
37744790|NCT01736683|69233042|FG003|Overall Study|Other|9|||
37744791|NCT01736683|69233043|FG004|Overall Study|Other|1|||
37744792|NCT01788943|69233059|FG000|Overall Study|Withdrawal by Subject|1|||
37744793|NCT01788943|69233060|FG001|Overall Study|Withdrawal by Subject|0|||
37744794|NCT01788163|69233087|FG000|Overall Study|Other|53|||
37744795|NCT01788163|69233088|FG001|Overall Study|Other|0|||
37744796|NCT01788163|69233089|FG002|Overall Study|Other|0|||
37744797|NCT01788163|69233090|FG003|Overall Study|Other|0|||
37744798|NCT01788163|69233091|FG004|Overall Study|Other|0|||
37656139|NCT01352741|69127583|FG001|Double-blind Comparative Period|Adverse Event|17|||
37656140|NCT01352741|69127582|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
37656141|NCT01352741|69127583|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
37656142|NCT01352741|69127582|FG000|Double-blind Comparative Period|Death|0|||
37656143|NCT01352741|69127583|FG001|Double-blind Comparative Period|Death|1|||
37656144|NCT01352741|69127582|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
37656145|NCT01352741|69127583|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
37656146|NCT01352741|69127582|FG000|Double-blind Comparative Period|Other|1|||
37656147|NCT01352741|69127583|FG001|Double-blind Comparative Period|Other|2|||
37656148|NCT01352741|69127582|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
37656149|NCT01352741|69127583|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
37656150|NCT01352741|69127582|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
37656151|NCT01352741|69127583|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
37656152|NCT01352741|69127582|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
37656153|NCT01352741|69127583|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
37656154|NCT01352741|69127582|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
37656155|NCT01352741|69127583|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
37656156|NCT01657292|69127603|FG000|Overall Study|Adverse Event|6|||
37656157|NCT01657292|69127603|FG000|Overall Study|Withdrawal by Subject|2|||
37656158|NCT01657292|69127603|FG000|Overall Study|Violation of eligibility criteria|1|||
37656159|NCT01657292|69127603|FG000|Overall Study|Change of therapy|1|||
37656160|NCT00905567|69127619|FG000|Washout|Withdrawal by Subject|0|||
37656161|NCT00905567|69127620|FG001|Washout|Withdrawal by Subject|1|||
37656162|NCT02282020|69127626|FG000|Overall Study|Objective Disease Progression|128|||
37656163|NCT02282020|69127627|FG001|Overall Study|Objective Disease Progression|30|||
37656164|NCT02282020|69127626|FG000|Overall Study|Adverse Event|18|||
37656165|NCT02282020|69127627|FG001|Overall Study|Adverse Event|15|||
37656166|NCT02282020|69127626|FG000|Overall Study|Withdrawal by Subject|7|||
37656167|NCT02282020|69127627|FG001|Overall Study|Withdrawal by Subject|10|||
37656168|NCT02282020|69127626|FG000|Overall Study|Miscellaneous|5|||
37656169|NCT02282020|69127627|FG001|Overall Study|Miscellaneous|19|||
37656170|NCT02282020|69127626|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
37656171|NCT02282020|69127627|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
37656172|NCT02282020|69127626|FG000|Overall Study|Developed Discontinuation Criteria|0|||
37656173|NCT02282020|69127627|FG001|Overall Study|Developed Discontinuation Criteria|2|||
37656174|NCT02282020|69127626|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
37656175|NCT02282020|69127627|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
37744799|NCT01788163|69233092|FG005|Overall Study|Other|7|||
37744800|NCT01788163|69233093|FG006|Overall Study|Other|1|||
37744801|NCT01788163|69233094|FG007|Overall Study|Other|48|||
38032852|NCT03756129|69718859|FG003|Overall Study|Withdrawal by Subject|1|||
38032853|NCT03756129|69718860|FG004|Overall Study|Withdrawal by Subject|1|||
38032854|NCT03756129|69718861|FG005|Overall Study|Withdrawal by Subject|3|||
38032855|NCT03756129|69718856|FG000|Overall Study|Lost to Follow-up|0|||
37656176|NCT02281552|69127643|FG000|Overall Study|Medication error|1|||
38032856|NCT03756129|69718857|FG001|Overall Study|Lost to Follow-up|0|||
37656177|NCT02281552|69127644|FG001|Overall Study|Medication error|0|||
37656178|NCT02281552|69127643|FG000|Overall Study|Insufficient clinical response|0|||
37744802|NCT01788163|69233095|FG008|Overall Study|Other|15|||
37744803|NCT01788163|69233087|FG000|Overall Study|Withdrawal by Subject|2|||
37744804|NCT01788163|69233088|FG001|Overall Study|Withdrawal by Subject|0|||
37744805|NCT01788163|69233089|FG002|Overall Study|Withdrawal by Subject|0|||
38032857|NCT03756129|69718858|FG002|Overall Study|Lost to Follow-up|0|||
37656179|NCT02281552|69127644|FG001|Overall Study|Insufficient clinical response|1|||
37656180|NCT02281552|69127643|FG000|Overall Study|Adverse Event|3|||
37656181|NCT02281552|69127644|FG001|Overall Study|Adverse Event|9|||
37656182|NCT00890591|69127650|FG000|Overall Study|Lack of Efficacy|20|||
37656183|NCT02284906|69127659|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
37656184|NCT02284906|69127660|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
37656185|NCT02284906|69127661|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
37656186|NCT02284906|69127659|FG000|Overall Study|Major Protocol Deviation|0|||
37744806|NCT01788163|69233090|FG003|Overall Study|Withdrawal by Subject|0|||
37744807|NCT01788163|69233091|FG004|Overall Study|Withdrawal by Subject|0|||
37744808|NCT01788163|69233092|FG005|Overall Study|Withdrawal by Subject|0|||
37744809|NCT01788163|69233093|FG006|Overall Study|Withdrawal by Subject|0|||
37744810|NCT01788163|69233094|FG007|Overall Study|Withdrawal by Subject|0|||
37744811|NCT01788163|69233095|FG008|Overall Study|Withdrawal by Subject|1|||
37744812|NCT01787461|69233231|FG000|Overall Study|Adverse Event|4|||
37744813|NCT01787461|69233232|FG001|Overall Study|Adverse Event|3|||
37744814|NCT01787461|69233231|FG000|Overall Study|Lost to Follow-up|3|||
37744815|NCT01787461|69233232|FG001|Overall Study|Lost to Follow-up|2|||
37744816|NCT01787461|69233231|FG000|Overall Study|No longer met eligibility criteria|1|||
37744817|NCT01787461|69233232|FG001|Overall Study|No longer met eligibility criteria|0|||
37744818|NCT01787461|69233231|FG000|Overall Study|Withdrawal by Subject|3|||
37744819|NCT01787461|69233232|FG001|Overall Study|Withdrawal by Subject|4|||
37744820|NCT01787461|69233231|FG000|Overall Study|Protocol Violation|3|||
37744821|NCT01787461|69233232|FG001|Overall Study|Protocol Violation|0|||
37744822|NCT01786993|69233257|FG000|Overall Study|Death|6|||
37744823|NCT01786993|69233258|FG001|Overall Study|Death|7|||
37744824|NCT01786993|69233257|FG000|Overall Study|Withdrawal by Subject|3|||
37744825|NCT01786993|69233258|FG001|Overall Study|Withdrawal by Subject|2|||
37744826|NCT01786993|69233257|FG000|Overall Study|Lost to Follow-up|0|||
37744827|NCT01786993|69233258|FG001|Overall Study|Lost to Follow-up|1|||
37744828|NCT01786993|69233257|FG000|Overall Study|Subject Non-Compliance|1|||
37744829|NCT01786993|69233258|FG001|Overall Study|Subject Non-Compliance|0|||
37744830|NCT01786993|69233257|FG000|Overall Study|System Explant|1|||
37744831|NCT01786993|69233258|FG001|Overall Study|System Explant|0|||
37744832|NCT01786993|69233257|FG000|Overall Study|Hospice Admission|1|||
37744833|NCT01786993|69233258|FG001|Overall Study|Hospice Admission|0|||
37744834|NCT01966445|69233283|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
37744835|NCT01966445|69233284|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
37744836|NCT01966445|69233285|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
37744837|NCT01966445|69233286|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
37744838|NCT01966445|69233287|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
37744839|NCT01966445|69233288|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
37744840|NCT01966445|69233289|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
37744841|NCT01966445|69233283|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
37744842|NCT01966445|69233284|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
37744843|NCT01966445|69233285|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
37744844|NCT01966445|69233286|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
37744845|NCT01966445|69233287|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
37744846|NCT01966445|69233288|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
37744847|NCT01966445|69233289|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
37744848|NCT01966445|69233283|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
37744849|NCT01966445|69233284|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
37744850|NCT01966445|69233285|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
37744851|NCT01966445|69233286|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
37744852|NCT01966445|69233287|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
37744853|NCT01966445|69233288|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
37744854|NCT01966445|69233289|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
37744855|NCT01966445|69233283|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
37744856|NCT01966445|69233284|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
38032858|NCT03756129|69718859|FG003|Overall Study|Lost to Follow-up|0|||
38032859|NCT03756129|69718860|FG004|Overall Study|Lost to Follow-up|0|||
37656187|NCT02284906|69127660|FG001|Overall Study|Major Protocol Deviation|1|||
37656188|NCT02284906|69127661|FG002|Overall Study|Major Protocol Deviation|0|||
37656189|NCT02284906|69127659|FG000|Overall Study|Voluntary Withdrawal|2|||
37656190|NCT02284906|69127660|FG001|Overall Study|Voluntary Withdrawal|4|||
37656191|NCT02284906|69127661|FG002|Overall Study|Voluntary Withdrawal|5|||
37656192|NCT02284906|69127659|FG000|Overall Study|Study Termination|0|||
37744857|NCT01966445|69233285|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
37744858|NCT01966445|69233286|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
37744859|NCT01966445|69233287|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
37744860|NCT01966445|69233288|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
37744861|NCT01966445|69233289|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
37656193|NCT02284906|69127660|FG001|Overall Study|Study Termination|11|||
37656194|NCT02284906|69127661|FG002|Overall Study|Study Termination|14|||
37656195|NCT02284906|69127659|FG000|Overall Study|Reason not Specified|1|||
37656196|NCT02284906|69127660|FG001|Overall Study|Reason not Specified|1|||
37656197|NCT02284906|69127661|FG002|Overall Study|Reason not Specified|0|||
37656198|NCT02879305|69127671|FG000|Overall Study|Investigator Site Closed|55|||
37656199|NCT02879305|69127672|FG001|Overall Study|Investigator Site Closed|57|||
37656200|NCT02879305|69127671|FG000|Overall Study|Withdrawal by Subject|44|||
37656201|NCT02879305|69127672|FG001|Overall Study|Withdrawal by Subject|42|||
37656202|NCT02879305|69127671|FG000|Overall Study|Lost to Follow-up|17|||
37656203|NCT02879305|69127672|FG001|Overall Study|Lost to Follow-up|12|||
37656204|NCT02879305|69127671|FG000|Overall Study|Other|1|||
37656205|NCT02879305|69127672|FG001|Overall Study|Other|0|||
37656206|NCT02281318|69127680|FG000|Overall Study|Adverse Event|2|||
37656207|NCT02281318|69127681|FG001|Overall Study|Adverse Event|2|||
37656208|NCT02281318|69127680|FG000|Overall Study|Lack of Efficacy|2|||
37656209|NCT02281318|69127681|FG001|Overall Study|Lack of Efficacy|0|||
37656210|NCT02281318|69127680|FG000|Overall Study|Lost to Follow-up|2|||
37656211|NCT02281318|69127681|FG001|Overall Study|Lost to Follow-up|1|||
37656212|NCT02281318|69127680|FG000|Overall Study|Physician Decision|2|||
37656213|NCT02281318|69127681|FG001|Overall Study|Physician Decision|0|||
37656214|NCT02281318|69127680|FG000|Overall Study|Withdrawal by Subject|6|||
37656215|NCT02281318|69127681|FG001|Overall Study|Withdrawal by Subject|2|||
37656216|NCT01657760|69127689|FG000|Overall Study|Withdrawal by Subject|0|||
37656217|NCT01657760|69127690|FG001|Overall Study|Withdrawal by Subject|0|||
37656218|NCT01657760|69127691|FG002|Overall Study|Withdrawal by Subject|0|||
37656219|NCT01657760|69127692|FG003|Overall Study|Withdrawal by Subject|1|||
37656220|NCT01657760|69127689|FG000|Overall Study|Physician Decision|1|||
37656221|NCT01657760|69127690|FG001|Overall Study|Physician Decision|1|||
37656222|NCT01657760|69127691|FG002|Overall Study|Physician Decision|1|||
37656223|NCT01657760|69127692|FG003|Overall Study|Physician Decision|2|||
37656224|NCT02280304|69127719|FG000|Overall Study|Lost to Follow-up|7|||
37656225|NCT02280304|69127720|FG001|Overall Study|Lost to Follow-up|8|||
37656226|NCT02283658|69127740|FG000|Overall Study|Withdrawal by Subject|1|||
37656227|NCT02279524|69127767|FG000|Overall Study|Withdrawal by Subject|3|||
37656228|NCT02279524|69127768|FG001|Overall Study|Withdrawal by Subject|6|||
37656229|NCT02279524|69127769|FG002|Overall Study|Withdrawal by Subject|3|||
37656230|NCT02279524|69127767|FG000|Overall Study|Adverse Event|4|||
37656231|NCT02279524|69127768|FG001|Overall Study|Adverse Event|3|||
37656232|NCT02279524|69127769|FG002|Overall Study|Adverse Event|2|||
37656233|NCT02279524|69127767|FG000|Overall Study|Lost to Follow-up|1|||
37656234|NCT02279524|69127768|FG001|Overall Study|Lost to Follow-up|1|||
37656235|NCT02279524|69127769|FG002|Overall Study|Lost to Follow-up|0|||
37656236|NCT02279524|69127767|FG000|Overall Study|Disallowed medication|1|||
37656237|NCT02279524|69127768|FG001|Overall Study|Disallowed medication|1|||
37656238|NCT02279524|69127769|FG002|Overall Study|Disallowed medication|2|||
37656239|NCT02279524|69127767|FG000|Overall Study|Bariatric surgery|1|||
37656240|NCT02279524|69127768|FG001|Overall Study|Bariatric surgery|0|||
37656241|NCT02279524|69127769|FG002|Overall Study|Bariatric surgery|0|||
37656242|NCT02283268|69127777|FG000|Overall Study|Withdrawal by Subject|1|||
37656243|NCT00857285|69127791|FG000|Overall Study|Adverse Event|4|||
37656244|NCT00857285|69127792|FG001|Overall Study|Adverse Event|2|||
37744862|NCT01966445|69233283|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
37744863|NCT01966445|69233284|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
37744864|NCT01966445|69233285|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
37744865|NCT01966445|69233286|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
37744866|NCT01966445|69233287|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
37744867|NCT01966445|69233288|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
37744868|NCT01966445|69233289|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
37744869|NCT01763905|69233309|FG000|Overall Study|Withdrawal by Subject|1|||
37744870|NCT01763905|69233310|FG001|Overall Study|Withdrawal by Subject|1|||
37744871|NCT01763905|69233311|FG002|Overall Study|Withdrawal by Subject|0|||
37744872|NCT01763905|69233312|FG003|Overall Study|Withdrawal by Subject|1|||
37744873|NCT01763905|69233309|FG000|Overall Study|Decision by sponsor|5|||
37744874|NCT01763905|69233310|FG001|Overall Study|Decision by sponsor|0|||
37744875|NCT01763905|69233311|FG002|Overall Study|Decision by sponsor|8|||
37656245|NCT00857285|69127791|FG000|Overall Study|Lack of Efficacy|0|||
37656246|NCT00857285|69127792|FG001|Overall Study|Lack of Efficacy|2|||
37656247|NCT00857285|69127791|FG000|Overall Study|Protocol Violation|3|||
37656248|NCT00857285|69127792|FG001|Overall Study|Protocol Violation|1|||
37656249|NCT00857285|69127791|FG000|Overall Study|Withdrawal by Subject|4|||
37656250|NCT00857285|69127792|FG001|Overall Study|Withdrawal by Subject|0|||
37656251|NCT00857285|69127791|FG000|Overall Study|Randomization criteria not met|1|||
37656252|NCT00857285|69127792|FG001|Overall Study|Randomization criteria not met|1|||
37744876|NCT01763905|69233312|FG003|Overall Study|Decision by sponsor|0|||
37744877|NCT01763905|69233309|FG000|Overall Study|Lost to Follow-up|0|||
37744878|NCT01763905|69233310|FG001|Overall Study|Lost to Follow-up|0|||
37656253|NCT02278354|69127798|FG000|Overall Study|Lost to Follow-up|2|||
37656254|NCT02278354|69127799|FG001|Overall Study|Lost to Follow-up|2|||
37656255|NCT02278354|69127798|FG000|Overall Study|Withdrawal by Subject|0|||
37656256|NCT02278354|69127799|FG001|Overall Study|Withdrawal by Subject|1|||
37656257|NCT02278354|69127798|FG000|Overall Study|<10 professional fights|2|||
37656258|NCT02278354|69127799|FG001|Overall Study|<10 professional fights|0|||
37656259|NCT01657370|69127818|FG000|Overall Study|Withdrawal by Subject|0|||
37656260|NCT01657370|69127819|FG001|Overall Study|Withdrawal by Subject|0|||
37656261|NCT01657370|69127820|FG002|Overall Study|Withdrawal by Subject|1|||
37656262|NCT01657370|69127821|FG003|Overall Study|Withdrawal by Subject|0|||
37656263|NCT01657370|69127822|FG004|Overall Study|Withdrawal by Subject|0|||
37656264|NCT01657370|69127823|FG005|Overall Study|Withdrawal by Subject|1|||
37656265|NCT01657370|69127818|FG000|Overall Study|Physician Decision|2|||
37656266|NCT01657370|69127819|FG001|Overall Study|Physician Decision|3|||
37656267|NCT01657370|69127820|FG002|Overall Study|Physician Decision|1|||
37656268|NCT01657370|69127821|FG003|Overall Study|Physician Decision|2|||
37656269|NCT01657370|69127822|FG004|Overall Study|Physician Decision|5|||
37744879|NCT01763905|69233311|FG002|Overall Study|Lost to Follow-up|1|||
37744880|NCT01763905|69233312|FG003|Overall Study|Lost to Follow-up|0|||
37744881|NCT02091167|69233324|FG000|Overall Study|Lost to Follow-up|0|||
37744882|NCT02091167|69233325|FG001|Overall Study|Lost to Follow-up|2|||
37744883|NCT02091089|69233331|FG000|Overall Study|Lost to Follow-up|2|||
37744884|NCT01763203|69233346|FG000|Overall Study|Death|4|||
37744885|NCT01763203|69233347|FG001|Overall Study|Death|7|||
37744886|NCT01763203|69233346|FG000|Overall Study|Lost to Follow-up|12|||
37744887|NCT01763203|69233347|FG001|Overall Study|Lost to Follow-up|12|||
37744888|NCT01763203|69233346|FG000|Overall Study|Withdrawal by Subject|8|||
37744889|NCT01763203|69233347|FG001|Overall Study|Withdrawal by Subject|12|||
37744890|NCT01763203|69233346|FG000|Overall Study|Moved out of study region|7|||
37744891|NCT01763203|69233347|FG001|Overall Study|Moved out of study region|10|||
37744892|NCT01763203|69233346|FG000|Overall Study|Physician Decision|2|||
37744893|NCT01763203|69233347|FG001|Overall Study|Physician Decision|1|||
37744894|NCT01763047|69233364|FG000|Period 1|Test Article Not Available|4|||
37744895|NCT01763047|69233365|FG001|Period 1|Test Article Not Available|1|||
37744896|NCT01763047|69233364|FG000|Period 1|Protocol Violation|4|||
37744897|NCT01763047|69233365|FG001|Period 1|Protocol Violation|4|||
37744898|NCT01763047|69233364|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
37744899|NCT01763047|69233365|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
37744900|NCT01763047|69233364|FG000|Period 1|Adverse Event|0|||
37744901|NCT01763047|69233365|FG001|Period 1|Adverse Event|1|||
37744902|NCT01763047|69233364|FG000|Period 1|Unsatisfactory Visual Response|0|||
37744903|NCT01763047|69233365|FG001|Period 1|Unsatisfactory Visual Response|3|||
37744904|NCT01763047|69233364|FG000|Period 1|Lens Power Not Available|0|||
37744905|NCT01763047|69233365|FG001|Period 1|Lens Power Not Available|1|||
37744906|NCT01763047|69233364|FG000|Period 1|Study Site office Closed|0|||
37744907|NCT01763047|69233365|FG001|Period 1|Study Site office Closed|1|||
37744908|NCT01763047|69233364|FG000|Period 2|Lens Discomfort|1|||
37744909|NCT01763047|69233365|FG001|Period 2|Lens Discomfort|0|||
37744910|NCT01763047|69233364|FG000|Period 2|No longer meets Eligibility Criteria|1|||
37744911|NCT01763047|69233365|FG001|Period 2|No longer meets Eligibility Criteria|0|||
37744912|NCT01763047|69233364|FG000|Period 2|Study Site office Closed|1|||
37744913|NCT01763047|69233365|FG001|Period 2|Study Site office Closed|1|||
37744914|NCT01763047|69233364|FG000|Period 2|Unsatisfactory Visual Response|1|||
37744915|NCT01763047|69233365|FG001|Period 2|Unsatisfactory Visual Response|1|||
37744916|NCT01763047|69233364|FG000|Period 2|Protocol Violation|0|||
37744917|NCT01763047|69233365|FG001|Period 2|Protocol Violation|2|||
37744918|NCT01763047|69233364|FG000|Period 2|Unsatisfactory lens Fitting|0|||
37656270|NCT01657370|69127823|FG005|Overall Study|Physician Decision|0|||
37656271|NCT01657370|69127818|FG000|Overall Study|Lack of Qualifying Event|1|||
37656272|NCT01657370|69127819|FG001|Overall Study|Lack of Qualifying Event|0|||
37656273|NCT01657370|69127820|FG002|Overall Study|Lack of Qualifying Event|3|||
37656274|NCT01657370|69127821|FG003|Overall Study|Lack of Qualifying Event|2|||
37656275|NCT01657370|69127822|FG004|Overall Study|Lack of Qualifying Event|1|||
37656276|NCT01657370|69127823|FG005|Overall Study|Lack of Qualifying Event|2|||
37656277|NCT01657370|69127818|FG000|Overall Study|Adverse Event|0|||
37656278|NCT01657370|69127819|FG001|Overall Study|Adverse Event|0|||
37656279|NCT01657370|69127820|FG002|Overall Study|Adverse Event|0|||
37656280|NCT01657370|69127821|FG003|Overall Study|Adverse Event|0|||
37744919|NCT01763047|69233365|FG001|Period 2|Unsatisfactory lens Fitting|1|||
37744920|NCT01977677|69233377|FG000|Overall Study|Unrelated Adverse Event|0|||
37744921|NCT01977677|69233378|FG001|Overall Study|Unrelated Adverse Event|0|||
37744922|NCT01977677|69233379|FG002|Overall Study|Unrelated Adverse Event|1|||
37744923|NCT01762345|69233387|FG000|Overall Study|Adverse Event|5|||
37744924|NCT01762345|69233387|FG000|Overall Study|Protocol Violation|2|||
37744925|NCT02090855|69233392|FG000|Overall Study|no evaluable Standard of Truth results|2|||
37744926|NCT01761565|69233399|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
37744927|NCT01619579|69233409|FG000|Overall Study|Withdrawal by Subject|0|||
37744928|NCT01619579|69233410|FG001|Overall Study|Withdrawal by Subject|3|||
37744929|NCT01736215|69233416|FG000|Overall Study|Early termination of erythropoietin use|1|||
37744930|NCT01736215|69233416|FG000|Overall Study|Adverse Event|4|||
37744931|NCT01736215|69233416|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
37744932|NCT01736215|69233416|FG000|Overall Study|Insufficient data to perform analysis|8|||
38032860|NCT03756129|69718861|FG005|Overall Study|Lost to Follow-up|1|||
38032861|NCT03756129|69718856|FG000|Overall Study|Physician Decision|0|||
38032862|NCT03756129|69718857|FG001|Overall Study|Physician Decision|0|||
37656281|NCT01657370|69127822|FG004|Overall Study|Adverse Event|1|||
37656282|NCT01657370|69127823|FG005|Overall Study|Adverse Event|0|||
37656283|NCT01657370|69127818|FG000|Overall Study|Protocol Violation|1|||
37656284|NCT01657370|69127819|FG001|Overall Study|Protocol Violation|1|||
37656285|NCT01657370|69127820|FG002|Overall Study|Protocol Violation|1|||
37656286|NCT01657370|69127821|FG003|Overall Study|Protocol Violation|1|||
37656287|NCT01657370|69127822|FG004|Overall Study|Protocol Violation|0|||
37656288|NCT01657370|69127823|FG005|Overall Study|Protocol Violation|0|||
37656289|NCT01657370|69127818|FG000|Overall Study|Lost to Follow-up|2|||
37656290|NCT01657370|69127819|FG001|Overall Study|Lost to Follow-up|0|||
37656291|NCT01657370|69127820|FG002|Overall Study|Lost to Follow-up|1|||
37656292|NCT01657370|69127821|FG003|Overall Study|Lost to Follow-up|0|||
37656293|NCT01657370|69127822|FG004|Overall Study|Lost to Follow-up|0|||
37656294|NCT01657370|69127823|FG005|Overall Study|Lost to Follow-up|1|||
37656295|NCT00849797|69127865|FG000|First Intervention|bad veins|1|||
37656296|NCT00849797|69127866|FG001|First Intervention|bad veins|0|||
37656297|NCT00849797|69127865|FG000|First Intervention|Adverse Event|0|||
37656298|NCT00849797|69127866|FG001|First Intervention|Adverse Event|1|||
37656299|NCT00849797|69127865|FG000|Washout: One Week|Withdrawal by Subject|0|||
37656300|NCT00849797|69127866|FG001|Washout: One Week|Withdrawal by Subject|2|||
37656301|NCT00840203|69127887|FG000|First Intervention|Protocol Violation|1|||
37656302|NCT00840203|69127888|FG001|First Intervention|Protocol Violation|1|||
37656303|NCT00840203|69127887|FG000|Washout|Protocol Violation|1|||
37656304|NCT00840203|69127888|FG001|Washout|Protocol Violation|0|||
37656305|NCT00835991|69127894|FG000|First Intervention|Adverse Event|0|||
37656306|NCT00835991|69127895|FG001|First Intervention|Adverse Event|1|||
37656307|NCT00835991|69127894|FG000|Washout|Protocol Violation|0|||
37656308|NCT00835991|69127895|FG001|Washout|Protocol Violation|2|||
37656309|NCT00835991|69127894|FG000|Washout|Withdrawal by Subject|3|||
37656310|NCT00835991|69127895|FG001|Washout|Withdrawal by Subject|1|||
37656311|NCT02276872|69127902|FG000|Overall Study|Adverse Event|1|||
37656312|NCT02276872|69127903|FG001|Overall Study|Adverse Event|0|||
37656313|NCT02276872|69127904|FG002|Overall Study|Adverse Event|0|||
37656314|NCT00835367|69127919|FG000|Washout|Adverse Event|2|||
37656315|NCT00835367|69127920|FG001|Washout|Adverse Event|0|||
37656316|NCT00835367|69127919|FG000|Washout|Withdrawal by Subject|1|||
37656317|NCT00835367|69127920|FG001|Washout|Withdrawal by Subject|0|||
37656318|NCT00835367|69127919|FG000|Second Intervention|Adverse Event|1|||
37656319|NCT00835367|69127920|FG001|Second Intervention|Adverse Event|1|||
37656320|NCT02276560|69127927|FG000|Overall Study|Adverse Event|1|||
37656321|NCT02276560|69127928|FG001|Overall Study|Adverse Event|0|||
37656322|NCT02276560|69127929|FG002|Overall Study|Adverse Event|0|||
37656323|NCT02276482|69127939|FG000|Overall Study|Adverse Event|1|||
37656324|NCT02276482|69127940|FG001|Overall Study|Adverse Event|0|||
37656325|NCT02276482|69127939|FG000|Overall Study|Withdrawal by Subject|1|||
37656326|NCT02276482|69127940|FG001|Overall Study|Withdrawal by Subject|0|||
37656327|NCT02276482|69127939|FG000|Overall Study|Gram-negative infection|1|||
37656328|NCT02276482|69127940|FG001|Overall Study|Gram-negative infection|0|||
37656329|NCT02276482|69127939|FG000|Overall Study|Reason not specified|0|||
37656330|NCT02276482|69127940|FG001|Overall Study|Reason not specified|1|||
37656331|NCT00835211|69127958|FG000|First Intervention|Withdrawal by Subject|0|||
37656332|NCT00835211|69127959|FG001|First Intervention|Withdrawal by Subject|1|||
37656333|NCT00835211|69127958|FG000|Washout: 7 Days|Adverse Event|2|||
37656334|NCT00835211|69127959|FG001|Washout: 7 Days|Adverse Event|1|||
37656335|NCT00835211|69127958|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
37656336|NCT00835211|69127959|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
37656337|NCT00834743|69127972|FG000|Second Intervention|Withdrawal by Subject|1|||
37656338|NCT00834743|69127973|FG001|Second Intervention|Withdrawal by Subject|0|||
37744933|NCT01786603|69233422|FG000|Overall Study|Death|5|||
38032863|NCT03756129|69718858|FG002|Overall Study|Physician Decision|0|||
37656339|NCT00834587|69127979|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
37656340|NCT00834587|69127980|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
37656341|NCT00834431|69127986|FG000|First Intervention|Adverse Event|0|||
37656342|NCT00834431|69127987|FG001|First Intervention|Adverse Event|1|||
37656343|NCT00834431|69127986|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
37656344|NCT00834431|69127987|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
37656345|NCT00830219|69128007|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
37656346|NCT00830219|69128008|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
37744934|NCT01786603|69233423|FG001|Overall Study|Death|1|||
38032864|NCT03756129|69718859|FG003|Overall Study|Physician Decision|0|||
37656347|NCT02274766|69128014|FG000|Overall Study|Withdrawal by Subject|3|||
37744935|NCT01786603|69233422|FG000|Overall Study|Adverse Event|6|||
37744936|NCT01786603|69233423|FG001|Overall Study|Adverse Event|2|||
37744937|NCT01786603|69233422|FG000|Overall Study|Physician decision to withdraw|6|||
37744938|NCT01786603|69233423|FG001|Overall Study|Physician decision to withdraw|7|||
37744939|NCT01786603|69233422|FG000|Overall Study|Lost to Follow-up|1|||
37744940|NCT01786603|69233423|FG001|Overall Study|Lost to Follow-up|2|||
37744941|NCT01619423|69233446|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
37656348|NCT02274766|69128015|FG001|Overall Study|Withdrawal by Subject|6|||
37656349|NCT02274766|69128014|FG000|Overall Study|Did Not Receive Study Drug|1|||
37744942|NCT01619423|69233447|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
37744943|NCT01619423|69233448|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
37656350|NCT02274766|69128015|FG001|Overall Study|Did Not Receive Study Drug|1|||
37656351|NCT02274766|69128014|FG000|Overall Study|Subject Unwilling to Proceed|0|||
37656352|NCT02274766|69128015|FG001|Overall Study|Subject Unwilling to Proceed|1|||
37656353|NCT02274766|69128014|FG000|Overall Study|Adverse Event|0|||
37656354|NCT02274766|69128015|FG001|Overall Study|Adverse Event|1|||
37656355|NCT00829673|69128023|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
37656356|NCT00829673|69128024|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
37656357|NCT02370238|69128030|FG000|Overall Study|Death|42|||
37656358|NCT02370238|69128031|FG001|Overall Study|Death|35|||
37656359|NCT02370238|69128030|FG000|Overall Study|Lost to Follow-up|1|||
37656360|NCT02370238|69128031|FG001|Overall Study|Lost to Follow-up|3|||
37656361|NCT02370238|69128030|FG000|Overall Study|Withdrawal by Subject|2|||
37656362|NCT02370238|69128031|FG001|Overall Study|Withdrawal by Subject|6|||
37656363|NCT02370238|69128030|FG000|Overall Study|Other|2|||
37656364|NCT02370238|69128031|FG001|Overall Study|Other|1|||
37656365|NCT02370160|69128041|FG000|Overall Study|Death|3|||
37656366|NCT02370160|69128042|FG001|Overall Study|Death|4|||
37656367|NCT02370160|69128043|FG002|Overall Study|Death|1|||
37656368|NCT02273908|69128058|FG000|Overall Study|Adverse Event|16|||
37656369|NCT02273908|69128059|FG001|Overall Study|Adverse Event|0|||
37656370|NCT02273908|69128058|FG000|Overall Study|Lost to Follow-up|10|||
37656371|NCT02273908|69128059|FG001|Overall Study|Lost to Follow-up|1|||
37656372|NCT02273908|69128058|FG000|Overall Study|Did not meet entrance criteria|3|||
37656373|NCT02273908|69128059|FG001|Overall Study|Did not meet entrance criteria|2|||
37656374|NCT02273908|69128058|FG000|Overall Study|Withdrawal by Subject|4|||
37656375|NCT02273908|69128059|FG001|Overall Study|Withdrawal by Subject|2|||
37656376|NCT02273752|69128069|FG000|Overall Study|Trial was terminated early|2|||
37656377|NCT05180630|69128073|FG000|First Intervention|Physician Decision|0|||
37656378|NCT05180630|69128074|FG001|First Intervention|Physician Decision|0|||
37656379|NCT05180630|69128075|FG002|First Intervention|Physician Decision|3|||
37656380|NCT02273596|69128084|FG000|24-Week Treatment Period|Adverse Event|3|||
37656381|NCT02273596|69128084|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
37656382|NCT02273596|69128084|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
38032865|NCT03756129|69718860|FG004|Overall Study|Physician Decision|0|||
37656383|NCT02273596|69128084|FG000|24-Week Treatment Period|Physician Decision|1|||
37656384|NCT02273596|69128084|FG000|24-Week Treatment Period|Protocol Deviation|1|||
37656385|NCT02273596|69128084|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
37656386|NCT02273596|69128084|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
37656387|NCT02273596|69128084|FG000|Extension Period|Lost to Follow-up|1|||
37855482|NCT00993499|69538836|FG001|Run-in Period (8 Days)|Progressive disease|1|||
37855483|NCT00993499|69538837|FG002|Run-in Period (8 Days)|Progressive disease|1|||
37855484|NCT00993499|69538838|FG003|Run-in Period (8 Days)|Progressive disease|0|||
37855485|NCT00993499|69538839|FG004|Run-in Period (8 Days)|Progressive disease|0|||
37855486|NCT00993499|69538840|FG005|Run-in Period (8 Days)|Progressive disease|0|||
37656388|NCT02273596|69128084|FG000|Extension Period|Protocol Deviation|1|||
37656389|NCT01656200|69128094|FG000|Overall Study|Withdrawal by Subject|1|||
37656390|NCT02369848|69128098|FG000|Overall Study|Death|1|||
37656391|NCT02369848|69128098|FG000|Overall Study|Withdrawal by Subject|2|||
37656392|NCT02369848|69128098|FG000|Overall Study|Lost to Follow-up|1|||
37656393|NCT02368210|69128104|FG000|Overall Study|Withdrawal by Subject|1|||
37656394|NCT02368210|69128105|FG001|Overall Study|Withdrawal by Subject|0|||
37656395|NCT02368210|69128104|FG000|Overall Study|Adverse Event|0|||
37656396|NCT02368210|69128105|FG001|Overall Study|Adverse Event|1|||
37656397|NCT02273050|69128114|FG000|Overall Study|Adverse Event|4|||
37855487|NCT00993499|69538835|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
38032866|NCT03756129|69718861|FG005|Overall Study|Physician Decision|1|||
37656398|NCT02273050|69128115|FG001|Overall Study|Adverse Event|3|||
37656399|NCT02273050|69128116|FG002|Overall Study|Adverse Event|3|||
37656400|NCT02273050|69128114|FG000|Overall Study|Death|0|||
37656401|NCT02273050|69128115|FG001|Overall Study|Death|0|||
37855488|NCT00993499|69538836|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
37656402|NCT02273050|69128116|FG002|Overall Study|Death|1|||
37656403|NCT02273050|69128114|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
37656404|NCT02273050|69128115|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
37744944|NCT01619423|69233449|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
37922831|NCT00808236|69609642|FG001|Overall Study|Lost to Follow-up|1|||
37656405|NCT02273050|69128116|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
37656406|NCT02273050|69128114|FG000|Overall Study|Lack of Efficacy|0|||
37656407|NCT02273050|69128115|FG001|Overall Study|Lack of Efficacy|1|||
37656408|NCT02273050|69128116|FG002|Overall Study|Lack of Efficacy|1|||
37656409|NCT02273050|69128114|FG000|Overall Study|Withdrawal by Subject|17|||
37922832|NCT00808236|69609641|FG000|Overall Study|Physician Decision|0|||
37922833|NCT00808236|69609642|FG001|Overall Study|Physician Decision|1|||
37922834|NCT00808236|69609641|FG000|Overall Study|Death|18|||
37922835|NCT00808236|69609642|FG001|Overall Study|Death|30|||
37656410|NCT02273050|69128115|FG001|Overall Study|Withdrawal by Subject|14|||
37744945|NCT01735279|69233462|FG000|Overall Study|Lost to Follow-up|11|||
37744946|NCT01735279|69233463|FG001|Overall Study|Lost to Follow-up|8|||
37744947|NCT01759381|69233471|FG000|Overall Study|Death|1|||
37744948|NCT01759381|69233472|FG001|Overall Study|Death|0|||
37744949|NCT01758523|69233491|FG000|Overall Study|Adverse Event|2|||
37656411|NCT02273050|69128116|FG002|Overall Study|Withdrawal by Subject|16|||
37656412|NCT02273050|69128114|FG000|Overall Study|Lost to Follow-up|0|||
37656413|NCT02273050|69128115|FG001|Overall Study|Lost to Follow-up|2|||
37656414|NCT02273050|69128116|FG002|Overall Study|Lost to Follow-up|3|||
37656415|NCT02273050|69128114|FG000|Overall Study|Protocol Violation|3|||
37656416|NCT02273050|69128115|FG001|Overall Study|Protocol Violation|1|||
37656417|NCT02273050|69128116|FG002|Overall Study|Protocol Violation|4|||
37656418|NCT02272816|69128124|FG000|Overall Study|Adverse Event|1|||
37656419|NCT02271880|69128130|FG000|Overall Study|Premature discontinuation of study|3|||
37656420|NCT02271880|69128131|FG001|Overall Study|Premature discontinuation of study|4|||
37656421|NCT02367352|69128139|FG000|Overall Study|Progressive disease|7|||
37656422|NCT02367352|69128140|FG001|Overall Study|Progressive disease|0|||
37656423|NCT02367352|69128141|FG002|Overall Study|Progressive disease|0|||
37656424|NCT02367352|69128139|FG000|Overall Study|Participant Received Alternative Therapy|1|||
37656425|NCT02367352|69128140|FG001|Overall Study|Participant Received Alternative Therapy|0|||
37656426|NCT02367352|69128141|FG002|Overall Study|Participant Received Alternative Therapy|0|||
37656427|NCT02367352|69128139|FG000|Overall Study|Adverse Event|1|||
37656428|NCT02367352|69128140|FG001|Overall Study|Adverse Event|0|||
37656429|NCT02367352|69128141|FG002|Overall Study|Adverse Event|0|||
37656430|NCT02365636|69128150|FG000|Overall Study|Adverse Event|3|||
37656431|NCT02365636|69128151|FG001|Overall Study|Adverse Event|3|||
37656432|NCT02365636|69128152|FG002|Overall Study|Adverse Event|2|||
37656433|NCT02365636|69128150|FG000|Overall Study|Protocol Violation|1|||
37656434|NCT02365636|69128151|FG001|Overall Study|Protocol Violation|4|||
37656435|NCT02365636|69128152|FG002|Overall Study|Protocol Violation|0|||
37656436|NCT02365636|69128150|FG000|Overall Study|Lost to Follow-up|0|||
37656437|NCT02365636|69128151|FG001|Overall Study|Lost to Follow-up|0|||
37656438|NCT02365636|69128152|FG002|Overall Study|Lost to Follow-up|1|||
37656439|NCT02365636|69128150|FG000|Overall Study|Other|2|||
37656440|NCT02365636|69128151|FG001|Overall Study|Other|0|||
37656441|NCT02365636|69128152|FG002|Overall Study|Other|0|||
37656442|NCT01655498|69128160|FG000|Overall Study|Unrelated health issue|2|||
37656443|NCT01655498|69128160|FG000|Overall Study|Protocol Violation|2|||
37656444|NCT01655498|69128160|FG000|Overall Study|Withdrawal by Subject|1|||
37656445|NCT02270944|69128169|FG000|Overall Study|Lost to Follow-up|9|||
37656446|NCT02270944|69128170|FG001|Overall Study|Lost to Follow-up|4|||
37656447|NCT02270944|69128169|FG000|Overall Study|Withdrawal by Subject|2|||
37656448|NCT02270944|69128170|FG001|Overall Study|Withdrawal by Subject|1|||
37656449|NCT02365558|69128177|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
37656450|NCT02365558|69128178|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
37656451|NCT02365558|69128177|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
37744950|NCT01758523|69233492|FG001|Overall Study|Adverse Event|1|||
37744951|NCT01758523|69233491|FG000|Overall Study|Lack of Efficacy|4|||
37744952|NCT01758523|69233492|FG001|Overall Study|Lack of Efficacy|2|||
37744953|NCT01758523|69233491|FG000|Overall Study|Lost to Follow-up|3|||
37656452|NCT02365558|69128178|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
37656453|NCT02365480|69128189|FG000|Overall Study|Withdrawal by Subject|2|||
37656454|NCT02365480|69128190|FG001|Overall Study|Withdrawal by Subject|0|||
37656455|NCT02270242|69128198|FG000|Overall Study|Withdrawal by Subject|18|||
37656456|NCT02270242|69128199|FG001|Overall Study|Withdrawal by Subject|25|||
37656457|NCT02270242|69128198|FG000|Overall Study|Lost to Follow-up|41|||
37656458|NCT02270242|69128199|FG001|Overall Study|Lost to Follow-up|27|||
37656459|NCT02270242|69128198|FG000|Overall Study|Physician Decision|0|||
37656460|NCT02270242|69128199|FG001|Overall Study|Physician Decision|1|||
37656461|NCT02364388|69128205|FG000|Overall Study|Protocol Violation|1|||
37656462|NCT02364388|69128205|FG000|Overall Study|Technical Failure|3|||
37656463|NCT02364388|69128205|FG000|Overall Study|No OA/US data|2|||
37656464|NCT02364388|69128205|FG000|Overall Study|No Biopsy|2|||
37744954|NCT01758523|69233492|FG001|Overall Study|Lost to Follow-up|4|||
37656465|NCT02363686|69128209|FG000|Overall Study|Withdrawal by Subject|22|||
37656466|NCT02363686|69128209|FG000|Overall Study|incomplete FEES examinations|13|||
37744955|NCT01758523|69233491|FG000|Overall Study|Withdrawal by Subject|12|||
37744956|NCT01758523|69233492|FG001|Overall Study|Withdrawal by Subject|7|||
37656467|NCT02268916|69128215|FG000|Overall Study|Lost to Follow-up|1|||
37656468|NCT02268916|69128216|FG001|Overall Study|Lost to Follow-up|1|||
37656469|NCT02268916|69128215|FG000|Overall Study|Withdrawal by Subject|6|||
37656470|NCT02268916|69128216|FG001|Overall Study|Withdrawal by Subject|5|||
37656471|NCT02268916|69128215|FG000|Overall Study|Participant did not have diabetes|1|||
37656472|NCT02268916|69128216|FG001|Overall Study|Participant did not have diabetes|0|||
37656473|NCT02268916|69128215|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
37656474|NCT02268916|69128216|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
37656475|NCT02518490|69128223|FG000|Overall Study|Withdrawal by Subject|1|||
37656476|NCT02518490|69128224|FG001|Overall Study|Withdrawal by Subject|1|||
37656477|NCT01364870|69128234|FG000|Overall Study|Withdrawal by Subject|13|||
37656478|NCT01364870|69128235|FG001|Overall Study|Withdrawal by Subject|24|||
37656479|NCT01364870|69128236|FG002|Overall Study|Withdrawal by Subject|10|||
37656480|NCT01364870|69128234|FG000|Overall Study|Adverse Event|8|||
37656481|NCT01364870|69128235|FG001|Overall Study|Adverse Event|6|||
37656482|NCT01364870|69128236|FG002|Overall Study|Adverse Event|4|||
37656483|NCT01364870|69128234|FG000|Overall Study|Protocol Violation|1|||
37656484|NCT01364870|69128235|FG001|Overall Study|Protocol Violation|0|||
37656485|NCT01364870|69128236|FG002|Overall Study|Protocol Violation|0|||
37656486|NCT02268526|69128247|FG000|Overall Study|Adverse Event|0|||
37656487|NCT02268526|69128248|FG001|Overall Study|Adverse Event|2|||
37656488|NCT02268526|69128249|FG002|Overall Study|Adverse Event|1|||
37656489|NCT02268526|69128247|FG000|Overall Study|Death|1|||
37656490|NCT02268526|69128248|FG001|Overall Study|Death|11|||
37656491|NCT02268526|69128249|FG002|Overall Study|Death|0|||
37656492|NCT02268526|69128247|FG000|Overall Study|protocol deviation|0|||
37656493|NCT02268526|69128248|FG001|Overall Study|protocol deviation|1|||
37656494|NCT02268526|69128249|FG002|Overall Study|protocol deviation|0|||
37656495|NCT02268526|69128247|FG000|Overall Study|Physician Decision|0|||
37656496|NCT02268526|69128248|FG001|Overall Study|Physician Decision|0|||
37656497|NCT02268526|69128249|FG002|Overall Study|Physician Decision|1|||
37656498|NCT02268526|69128247|FG000|Overall Study|Subject/guardian decision|0|||
37656499|NCT02268526|69128248|FG001|Overall Study|Subject/guardian decision|7|||
37656500|NCT02268526|69128249|FG002|Overall Study|Subject/guardian decision|3|||
37744957|NCT01758289|69233515|FG000|Overall Study|Premature Study Termination|44|||
37855489|NCT00993499|69538837|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
37855490|NCT00993499|69538838|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
37855491|NCT00993499|69538839|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
37855492|NCT00993499|69538840|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
37855493|NCT00993499|69538835|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
37855494|NCT00993499|69538836|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
37855495|NCT00993499|69538837|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
37855496|NCT00993499|69538838|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
37855497|NCT00993499|69538839|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
37855498|NCT00993499|69538840|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
37855499|NCT00993499|69538835|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
37855500|NCT00993499|69538836|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
37855501|NCT00993499|69538837|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
37855502|NCT00993499|69538838|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
37855503|NCT00993499|69538839|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
37855504|NCT00993499|69538840|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
37855505|NCT00993499|69538835|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
37855506|NCT00993499|69538836|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
37855507|NCT00993499|69538837|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
37855508|NCT00993499|69538838|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
37855509|NCT00993499|69538839|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
37855510|NCT00993499|69538840|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
38032867|NCT02822794|69718887|FG000|Overall Study|Withdrew Consent|1|||
38032868|NCT02822794|69718888|FG001|Overall Study|Withdrew Consent|0|||
37744958|NCT01758289|69233515|FG000|Overall Study|Adverse Event|9|||
37744959|NCT01757821|69233539|FG000|Overall Study|Adverse Event|1|||
37744960|NCT01735201|69233568|FG000|Overall Study|Adverse Event|1|||
38032869|NCT01338298|69718903|FG000|Overall Study|Withdrawal by Subject|1|||
38032870|NCT01338298|69718904|FG001|Overall Study|Withdrawal by Subject|1|||
38032871|NCT01338298|69718903|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
37744961|NCT01735201|69233569|FG001|Overall Study|Adverse Event|1|||
37656501|NCT02268214|69128262|FG000|Overall Study|Subject no longer meets study criteria|0|||
37656502|NCT02268214|69128263|FG001|Overall Study|Subject no longer meets study criteria|2|||
37656503|NCT02268214|69128264|FG002|Overall Study|Subject no longer meets study criteria|0|||
37744962|NCT01735201|69233570|FG002|Overall Study|Adverse Event|0|||
37744963|NCT01735201|69233571|FG003|Overall Study|Adverse Event|1|||
37744964|NCT01735201|69233572|FG004|Overall Study|Adverse Event|1|||
37744965|NCT01735201|69233573|FG005|Overall Study|Adverse Event|3|||
37744966|NCT01735201|69233574|FG006|Overall Study|Adverse Event|2|||
37744967|NCT01735201|69233575|FG007|Overall Study|Adverse Event|1|||
37744968|NCT01735201|69233568|FG000|Overall Study|Personal Reasons|1|||
37744969|NCT01735201|69233569|FG001|Overall Study|Personal Reasons|0|||
37744970|NCT01735201|69233570|FG002|Overall Study|Personal Reasons|0|||
37744971|NCT01735201|69233571|FG003|Overall Study|Personal Reasons|0|||
37744972|NCT01735201|69233572|FG004|Overall Study|Personal Reasons|0|||
37744973|NCT01735201|69233573|FG005|Overall Study|Personal Reasons|0|||
37744974|NCT01735201|69233574|FG006|Overall Study|Personal Reasons|0|||
37744975|NCT01735201|69233575|FG007|Overall Study|Personal Reasons|0|||
37744976|NCT01735201|69233568|FG000|Overall Study|Protocol Violation|1|||
37744977|NCT01735201|69233569|FG001|Overall Study|Protocol Violation|0|||
37744978|NCT01735201|69233570|FG002|Overall Study|Protocol Violation|0|||
37744979|NCT01735201|69233571|FG003|Overall Study|Protocol Violation|0|||
37744980|NCT01735201|69233572|FG004|Overall Study|Protocol Violation|0|||
37744981|NCT01735201|69233573|FG005|Overall Study|Protocol Violation|0|||
37744982|NCT01735201|69233574|FG006|Overall Study|Protocol Violation|0|||
37744983|NCT01735201|69233575|FG007|Overall Study|Protocol Violation|0|||
37744984|NCT01735201|69233568|FG000|Overall Study|Other Miscellaneous Reasons|0|||
37744985|NCT01735201|69233569|FG001|Overall Study|Other Miscellaneous Reasons|0|||
37744986|NCT01735201|69233570|FG002|Overall Study|Other Miscellaneous Reasons|0|||
37744987|NCT01735201|69233571|FG003|Overall Study|Other Miscellaneous Reasons|1|||
37744988|NCT01735201|69233572|FG004|Overall Study|Other Miscellaneous Reasons|0|||
37744989|NCT01735201|69233573|FG005|Overall Study|Other Miscellaneous Reasons|2|||
37744990|NCT01735201|69233574|FG006|Overall Study|Other Miscellaneous Reasons|1|||
37744991|NCT01735201|69233575|FG007|Overall Study|Other Miscellaneous Reasons|1|||
37744992|NCT01734811|69233595|FG000|Overall Study|Lost to Follow-up|2|||
37744993|NCT01734811|69233596|FG001|Overall Study|Lost to Follow-up|3|||
37744994|NCT01734811|69233595|FG000|Overall Study|Withdrawal by Subject|2|||
37744995|NCT01734811|69233596|FG001|Overall Study|Withdrawal by Subject|0|||
37744996|NCT01757275|69233604|FG000|Overall Study|Lost to Follow-up|1|||
37744997|NCT01757275|69233605|FG001|Overall Study|Lost to Follow-up|2|||
37744998|NCT01757275|69233604|FG000|Overall Study|Adverse Event|3|||
37656504|NCT02268214|69128262|FG000|Overall Study|Pregnancy|2|||
37656505|NCT02268214|69128263|FG001|Overall Study|Pregnancy|2|||
37656506|NCT02268214|69128264|FG002|Overall Study|Pregnancy|1|||
37656507|NCT02268214|69128262|FG000|Overall Study|Lost to Follow-up|3|||
37656508|NCT02268214|69128263|FG001|Overall Study|Lost to Follow-up|3|||
37656509|NCT02268214|69128264|FG002|Overall Study|Lost to Follow-up|4|||
37656510|NCT02268214|69128262|FG000|Overall Study|Lack of Efficacy|1|||
37656511|NCT02268214|69128263|FG001|Overall Study|Lack of Efficacy|0|||
37656512|NCT02268214|69128264|FG002|Overall Study|Lack of Efficacy|2|||
37656513|NCT02268214|69128262|FG000|Overall Study|Adverse Event|11|||
37656514|NCT02268214|69128263|FG001|Overall Study|Adverse Event|14|||
37656515|NCT02268214|69128264|FG002|Overall Study|Adverse Event|9|||
37656516|NCT02268214|69128262|FG000|Overall Study|Withdrawal by Subject|4|||
37656517|NCT02268214|69128263|FG001|Overall Study|Withdrawal by Subject|5|||
37656518|NCT02268214|69128264|FG002|Overall Study|Withdrawal by Subject|10|||
37656519|NCT02268214|69128262|FG000|Overall Study|Subject request to discontinue treatment|10|||
37656520|NCT02268214|69128263|FG001|Overall Study|Subject request to discontinue treatment|8|||
37656521|NCT02268214|69128264|FG002|Overall Study|Subject request to discontinue treatment|6|||
37656522|NCT02268214|69128262|FG000|Overall Study|Poor/non-compliance|2|||
37656523|NCT02268214|69128263|FG001|Overall Study|Poor/non-compliance|1|||
37656524|NCT02268214|69128264|FG002|Overall Study|Poor/non-compliance|2|||
37656525|NCT02268214|69128262|FG000|Overall Study|Other reasons|7|||
37656526|NCT02268214|69128263|FG001|Overall Study|Other reasons|3|||
37656527|NCT02268214|69128264|FG002|Overall Study|Other reasons|3|||
37656528|NCT02268214|69128262|FG000|Overall Study|Not entering long-term period|2|||
37656529|NCT02268214|69128263|FG001|Overall Study|Not entering long-term period|3|||
37656530|NCT02268214|69128264|FG002|Overall Study|Not entering long-term period|5|||
37656531|NCT02521376|69128276|FG000|Overall Study|Enrolled, But Not Treated|1|||
37656532|NCT02521376|69128277|FG001|Overall Study|Enrolled, But Not Treated|0|||
37656533|NCT02521376|69128278|FG002|Overall Study|Enrolled, But Not Treated|0|||
37656534|NCT02521376|69128279|FG003|Overall Study|Enrolled, But Not Treated|0|||
37744999|NCT01757275|69233605|FG001|Overall Study|Adverse Event|3|||
37656535|NCT02268058|69128301|FG000|Overall Study|Protocol Violation|1|||
37656536|NCT02268058|69128302|FG001|Overall Study|Protocol Violation|0|||
37656537|NCT02268058|69128303|FG002|Overall Study|Protocol Violation|0|||
37745000|NCT01757275|69233604|FG000|Overall Study|Withdrawal by Subject|2|||
37745001|NCT01757275|69233605|FG001|Overall Study|Withdrawal by Subject|4|||
37745002|NCT01757275|69233604|FG000|Overall Study|Not treated|3|||
37745003|NCT01757275|69233605|FG001|Overall Study|Not treated|4|||
37745004|NCT01757197|69233620|FG000|Overall Study|Death|2|||
37745005|NCT01784965|69233644|FG000|Overall Study|Withdrawal by Subject|6|||
37745006|NCT01784965|69233645|FG001|Overall Study|Withdrawal by Subject|3|||
37745007|NCT01784965|69233644|FG000|Overall Study|Adverse Event|0|||
37656538|NCT02268058|69128304|FG003|Overall Study|Protocol Violation|0|||
37656539|NCT02267824|69128316|FG000|Overall Study|Pregnancy|1|||
37656540|NCT02267824|69128317|FG001|Overall Study|Pregnancy|1|||
37656541|NCT02267824|69128316|FG000|Overall Study|Lost to Follow-up|4|||
37656542|NCT02267824|69128317|FG001|Overall Study|Lost to Follow-up|0|||
37656543|NCT02267824|69128316|FG000|Overall Study|Protocol Violation|3|||
37656544|NCT02267824|69128317|FG001|Overall Study|Protocol Violation|0|||
37656545|NCT02267824|69128316|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
37656546|NCT02267824|69128317|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
37656547|NCT02267746|69128326|FG000|Overall Study|Adverse Event|0|||
37656548|NCT02267746|69128327|FG001|Overall Study|Adverse Event|2|||
37745008|NCT01784965|69233645|FG001|Overall Study|Adverse Event|8|||
37745009|NCT01784419|69233653|FG000|Overall Study|Adverse Event|3|||
37745010|NCT01784029|69233660|FG000|Overall Study|Lost to Follow-up|19|||
37745011|NCT01784029|69233661|FG001|Overall Study|Lost to Follow-up|20|||
37745012|NCT01784029|69233662|FG002|Overall Study|Lost to Follow-up|22|||
38032872|NCT01338298|69718904|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
38032873|NCT01338298|69718903|FG000|Overall Study|Administrative error|0|||
38032874|NCT01338298|69718904|FG001|Overall Study|Administrative error|1|||
38032875|NCT01338298|69718903|FG000|Overall Study|Positive symptom worsening|1|||
38032876|NCT01338298|69718904|FG001|Overall Study|Positive symptom worsening|0|||
38032877|NCT01338298|69718903|FG000|Overall Study|Depressive symptoms and nausea|1|||
38032878|NCT01338298|69718904|FG001|Overall Study|Depressive symptoms and nausea|0|||
38032879|NCT01338298|69718903|FG000|Overall Study|Non-adherence|1|||
38032880|NCT01338298|69718904|FG001|Overall Study|Non-adherence|0|||
38032881|NCT01354132|69718912|FG000|Randomization|Physician Decision|1|||
38032882|NCT01354132|69718913|FG001|Randomization|Physician Decision|0|||
38032883|NCT01354132|69718912|FG000|Randomization|Withdrawal by Subject|0|||
38032884|NCT01354132|69718913|FG001|Randomization|Withdrawal by Subject|1|||
38032885|NCT01354132|69718912|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
38032886|NCT01354132|69718913|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
38032887|NCT01354132|69718912|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
38032888|NCT01354132|69718913|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
38032889|NCT01354132|69718912|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
37745013|NCT01733329|69233684|FG000|Overall Study|Protocol Violation|1|||
37745014|NCT01733329|69233685|FG001|Overall Study|Protocol Violation|1|||
37745015|NCT01733329|69233684|FG000|Overall Study|Uterine artery injury|1|||
37745016|NCT01733329|69233685|FG001|Overall Study|Uterine artery injury|0|||
37745017|NCT01783483|69233693|FG000|Overall Study|Death|3|||
37745018|NCT01783483|69233694|FG001|Overall Study|Death|3|||
37656549|NCT02267746|69128328|FG002|Overall Study|Adverse Event|1|||
37656550|NCT02267746|69128326|FG000|Overall Study|Protocol Violation|8|||
37656551|NCT02267746|69128327|FG001|Overall Study|Protocol Violation|7|||
37656552|NCT02267746|69128328|FG002|Overall Study|Protocol Violation|3|||
37656553|NCT02267746|69128326|FG000|Overall Study|Lack of Efficacy|11|||
37745019|NCT01783483|69233693|FG000|Overall Study|Lost to Follow-up|14|||
37745020|NCT01783483|69233694|FG001|Overall Study|Lost to Follow-up|10|||
37745021|NCT01783483|69233693|FG000|Overall Study|Withdrawal by Subject|2|||
38032890|NCT01354132|69718913|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
38032891|NCT01353898|69718928|FG000|Overall Study|Study site terminated|0|||
38032892|NCT01353898|69718929|FG001|Overall Study|Study site terminated|0|||
38032893|NCT01353898|69718930|FG002|Overall Study|Study site terminated|0|||
38032894|NCT01353898|69718931|FG003|Overall Study|Study site terminated|0|||
38032895|NCT01353898|69718932|FG004|Overall Study|Study site terminated|0|||
38032896|NCT01353898|69718933|FG005|Overall Study|Study site terminated|1|||
38032897|NCT01372150|69718950|FG000|Overall Study|Lack of Efficacy|3|||
38032898|NCT01372150|69718951|FG001|Overall Study|Lack of Efficacy|0|||
38032899|NCT01372150|69718952|FG002|Overall Study|Lack of Efficacy|1|||
38032900|NCT01372150|69718950|FG000|Overall Study|Lost to Follow-up|4|||
38032901|NCT01372150|69718951|FG001|Overall Study|Lost to Follow-up|5|||
38032902|NCT01372150|69718952|FG002|Overall Study|Lost to Follow-up|6|||
38032903|NCT01372150|69718950|FG000|Overall Study|Protocol Violation|1|||
38032904|NCT01372150|69718951|FG001|Overall Study|Protocol Violation|0|||
38032905|NCT01372150|69718952|FG002|Overall Study|Protocol Violation|3|||
38032906|NCT01372150|69718950|FG000|Overall Study|Withdrawal by Subject|2|||
38032907|NCT01372150|69718951|FG001|Overall Study|Withdrawal by Subject|7|||
38032908|NCT01372150|69718952|FG002|Overall Study|Withdrawal by Subject|2|||
37656554|NCT02267746|69128327|FG001|Overall Study|Lack of Efficacy|11|||
37656555|NCT02267746|69128328|FG002|Overall Study|Lack of Efficacy|15|||
37656556|NCT02267746|69128326|FG000|Overall Study|Protocol Violation|1|||
37745022|NCT01783483|69233694|FG001|Overall Study|Withdrawal by Subject|1|||
37745023|NCT01783483|69233693|FG000|Overall Study|Physician Decision|1|||
37745024|NCT01783483|69233694|FG001|Overall Study|Physician Decision|1|||
37656557|NCT02267746|69128327|FG001|Overall Study|Protocol Violation|2|||
37656558|NCT02267746|69128328|FG002|Overall Study|Protocol Violation|1|||
37745025|NCT01607593|69233713|FG000|Overall Study|Adverse Event|15|||
37745026|NCT01607593|69233713|FG000|Overall Study|Lack of Efficacy|16|||
37745027|NCT01607593|69233713|FG000|Overall Study|Lost to Follow-up|25|||
38032909|NCT01372150|69718950|FG000|Overall Study|Other|1|||
38032910|NCT01372150|69718951|FG001|Overall Study|Other|0|||
38032911|NCT01372150|69718952|FG002|Overall Study|Other|2|||
38032912|NCT01372150|69718950|FG000|Overall Study|Adverse Event|2|||
38032913|NCT01372150|69718951|FG001|Overall Study|Adverse Event|1|||
38032914|NCT01372150|69718952|FG002|Overall Study|Adverse Event|2|||
38032915|NCT01372150|69718950|FG000|Overall Study|Randomized but not treated|0|||
37656559|NCT02267746|69128326|FG000|Overall Study|Miscellaneous|1|||
37656560|NCT02267746|69128327|FG001|Overall Study|Miscellaneous|0|||
37656561|NCT02267746|69128328|FG002|Overall Study|Miscellaneous|1|||
37656562|NCT02362360|69128338|FG000|Period 1|Lack of Efficacy|1|||
37656563|NCT02362360|69128339|FG001|Period 1|Lack of Efficacy|0|||
37656564|NCT02362360|69128338|FG000|Period 1|Withdrawal by Subject|2|||
37656565|NCT02362360|69128339|FG001|Period 1|Withdrawal by Subject|1|||
37656566|NCT02362282|69128347|FG000|Overall Study|Withdrawal by Subject|1|||
37656567|NCT02362282|69128348|FG001|Overall Study|Withdrawal by Subject|0|||
37656568|NCT02361580|69128356|FG000|Overall Study|Lost to Follow-up|6|||
37656569|NCT02361580|69128357|FG001|Overall Study|Lost to Follow-up|3|||
37656570|NCT02520284|69128366|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
37656571|NCT02520284|69128367|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
37656572|NCT02520284|69128368|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
37656573|NCT02520284|69128366|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
37656574|NCT02520284|69128367|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
37656575|NCT02520284|69128368|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
37656576|NCT02520284|69128366|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
37656577|NCT02520284|69128367|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
37656578|NCT02520284|69128368|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
37656579|NCT02520284|69128366|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
37656580|NCT02520284|69128367|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
37656581|NCT02520284|69128368|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
37656582|NCT02520284|69128366|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
37656583|NCT02520284|69128367|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
37656584|NCT02520284|69128368|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
37656585|NCT02520284|69128366|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
37656586|NCT02520284|69128367|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
37656587|NCT02520284|69128368|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
37656588|NCT02520284|69128366|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
37656589|NCT02520284|69128367|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
37656590|NCT02520284|69128368|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
37656591|NCT02520284|69128366|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
37656592|NCT02520284|69128367|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
37656593|NCT02520284|69128368|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
37656594|NCT02520284|69128366|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
37656595|NCT02520284|69128367|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
37656596|NCT02520284|69128368|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
37656597|NCT02520284|69128366|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
37656598|NCT02520284|69128367|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
37656599|NCT02520284|69128368|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
37745028|NCT01607593|69233713|FG000|Overall Study|Continuation|33|||
37745029|NCT01607593|69233713|FG000|Overall Study|Other|4|||
37745030|NCT01755637|69233726|FG000|Period 1|Adverse Event|0|||
37745031|NCT01755637|69233727|FG001|Period 1|Adverse Event|1|||
37745032|NCT01732549|69233745|FG000|Overall Study|Adverse Event|13|||
37745033|NCT01732549|69233746|FG001|Overall Study|Adverse Event|3|||
37745034|NCT01732549|69233745|FG000|Overall Study|Consent withdrawn|13|||
37745035|NCT01732549|69233746|FG001|Overall Study|Consent withdrawn|6|||
37656600|NCT02520284|69128366|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
37656601|NCT02520284|69128367|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
37656602|NCT02520284|69128368|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
37745036|NCT01732549|69233745|FG000|Overall Study|Disease progression|37|||
37745037|NCT01732549|69233746|FG001|Overall Study|Disease progression|50|||
37745038|NCT01732549|69233745|FG000|Overall Study|Other|8|||
37745039|NCT01732549|69233746|FG001|Overall Study|Other|14|||
38032916|NCT01372150|69718951|FG001|Overall Study|Randomized but not treated|1|||
38032917|NCT01372150|69718952|FG002|Overall Study|Randomized but not treated|0|||
38032918|NCT03329690|69718965|FG000|Overall Study|Progressive disease per RECIST|85|||
38032919|NCT03329690|69718966|FG001|Overall Study|Progressive disease per RECIST|44|||
38032920|NCT03329690|69718967|FG002|Overall Study|Progressive disease per RECIST|6|||
38032921|NCT03329690|69718968|FG003|Overall Study|Progressive disease per RECIST|16|||
37745040|NCT01755091|69233765|FG000|Overall Study|Withdrawal by Subject|6|||
37745041|NCT01755091|69233766|FG001|Overall Study|Withdrawal by Subject|1|||
37656603|NCT02517866|69128382|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
37656604|NCT02517866|69128383|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
37656605|NCT02517866|69128384|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
37656606|NCT02517866|69128382|FG000|Overall Study|Significant Protocol Deviation|4|||
37656607|NCT02517866|69128383|FG001|Overall Study|Significant Protocol Deviation|1|||
37656608|NCT02517866|69128384|FG002|Overall Study|Significant Protocol Deviation|0|||
37656609|NCT02517866|69128382|FG000|Overall Study|Lost to Follow-up|1|||
37656610|NCT02517866|69128383|FG001|Overall Study|Lost to Follow-up|0|||
37656611|NCT02517866|69128384|FG002|Overall Study|Lost to Follow-up|0|||
37656612|NCT02517866|69128382|FG000|Overall Study|Voluntary Withdrawal|2|||
37656613|NCT02517866|69128383|FG001|Overall Study|Voluntary Withdrawal|2|||
37656614|NCT02517866|69128384|FG002|Overall Study|Voluntary Withdrawal|0|||
37656615|NCT02517866|69128382|FG000|Overall Study|Investigator Decision|2|||
37656616|NCT02517866|69128383|FG001|Overall Study|Investigator Decision|1|||
37656617|NCT02517866|69128384|FG002|Overall Study|Investigator Decision|0|||
37656618|NCT02517866|69128382|FG000|Overall Study|Reason not specified|2|||
37656619|NCT02517866|69128383|FG001|Overall Study|Reason not specified|0|||
37656620|NCT02517866|69128384|FG002|Overall Study|Reason not specified|0|||
37656621|NCT02515994|69128396|FG000|Overall Study|Protocol Violation|3|||
37656622|NCT02515994|69128397|FG001|Overall Study|Protocol Violation|5|||
37656623|NCT02515994|69128396|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
37656624|NCT02515994|69128397|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
37656625|NCT02515994|69128396|FG000|Overall Study|Adverse Event|3|||
37656626|NCT02515994|69128397|FG001|Overall Study|Adverse Event|1|||
37656627|NCT02515994|69128396|FG000|Overall Study|Withdrawal by Subject|2|||
37656628|NCT02515994|69128397|FG001|Overall Study|Withdrawal by Subject|0|||
37656629|NCT02516306|69128405|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
37656630|NCT02516306|69128406|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
37656631|NCT02516228|69128412|FG000|Overall Study|Lost to Follow-up|1|||
37656632|NCT02516228|69128412|FG000|Overall Study|Withdrawal by Subject|1|||
37656633|NCT02516228|69128412|FG000|Overall Study|Physician Decision|1|||
37656634|NCT02519504|69128418|FG000|Overall Study|Protocol Violation|6|||
37656635|NCT02519504|69128419|FG001|Overall Study|Protocol Violation|5|||
37656636|NCT02519504|69128418|FG000|Overall Study|Ineligible for direct testing|12|||
37656637|NCT02519504|69128419|FG001|Overall Study|Ineligible for direct testing|12|||
37656638|NCT02519504|69128418|FG000|Overall Study|Did not participate in direct testing|95|||
37656639|NCT02519504|69128419|FG001|Overall Study|Did not participate in direct testing|86|||
37656640|NCT02514824|69128427|FG000|Overall Study|Withdrawal by Subject|1|||
37656641|NCT02514824|69128428|FG001|Overall Study|Withdrawal by Subject|0|||
37656642|NCT02514824|69128429|FG002|Overall Study|Withdrawal by Subject|0|||
37656643|NCT02514824|69128430|FG003|Overall Study|Withdrawal by Subject|0|||
37656644|NCT02514824|69128427|FG000|Overall Study|Dose-Limiting Toxicity|0|||
37656645|NCT02514824|69128428|FG001|Overall Study|Dose-Limiting Toxicity|1|||
37656646|NCT02514824|69128429|FG002|Overall Study|Dose-Limiting Toxicity|0|||
37656647|NCT02514824|69128430|FG003|Overall Study|Dose-Limiting Toxicity|0|||
37656648|NCT02514746|69128439|FG000|Overall Study|Chronically Ill|1|||
37656649|NCT02514746|69128440|FG001|Overall Study|Chronically Ill|2|||
37656650|NCT02514746|69128439|FG000|Overall Study|Physician Decision|4|||
37656651|NCT02514746|69128440|FG001|Overall Study|Physician Decision|2|||
37656652|NCT02514746|69128439|FG000|Overall Study|Withdrawal by Subject|12|||
37656653|NCT02514746|69128440|FG001|Overall Study|Withdrawal by Subject|10|||
37656654|NCT02514746|69128439|FG000|Overall Study|Other|5|||
37656655|NCT02514746|69128440|FG001|Overall Study|Other|1|||
37745042|NCT01755091|69233767|FG002|Overall Study|Withdrawal by Subject|3|||
37745043|NCT01755091|69233765|FG000|Overall Study|Adverse Event|1|||
37745044|NCT01755091|69233766|FG001|Overall Study|Adverse Event|1|||
37745045|NCT01755091|69233767|FG002|Overall Study|Adverse Event|1|||
37745046|NCT01755091|69233765|FG000|Overall Study|Lost to Follow-up|1|||
37745047|NCT01755091|69233766|FG001|Overall Study|Lost to Follow-up|0|||
37745048|NCT01755091|69233767|FG002|Overall Study|Lost to Follow-up|1|||
37745049|NCT01755091|69233765|FG000|Overall Study|Physician Decision|1|||
37745050|NCT01755091|69233766|FG001|Overall Study|Physician Decision|1|||
37745051|NCT01755091|69233767|FG002|Overall Study|Physician Decision|2|||
37745052|NCT01754467|69233800|FG000|Overall Study|Lost to Follow-up|1|||
37656656|NCT02483078|69128450|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
37656657|NCT02483078|69128451|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
37656658|NCT02483078|69128450|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
37656659|NCT02483078|69128451|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
37656660|NCT02483078|69128450|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
37656661|NCT02483078|69128451|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
37656662|NCT02483078|69128450|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
37656663|NCT02483078|69128451|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
37656664|NCT02483078|69128450|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
37745053|NCT01753999|69233804|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
37745054|NCT01753999|69233805|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
37745055|NCT01753999|69233804|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
37745056|NCT01753999|69233805|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
37745057|NCT01753999|69233804|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
37745058|NCT01753999|69233805|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
37745059|NCT01753999|69233804|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
37745060|NCT01753999|69233805|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
37745061|NCT01753999|69233804|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
37745062|NCT01753999|69233805|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
37745063|NCT01753999|69233804|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
37745064|NCT01753999|69233805|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
37745065|NCT01783015|69233825|FG000|Blinded Treatment|Adverse Event|0|||
37745066|NCT01783015|69233826|FG001|Blinded Treatment|Adverse Event|1|||
37745067|NCT01783015|69233827|FG002|Blinded Treatment|Adverse Event|0|||
37745068|NCT01783015|69233825|FG000|Blinded Treatment|Protocol Violation|0|||
37745069|NCT01783015|69233826|FG001|Blinded Treatment|Protocol Violation|1|||
37745070|NCT01783015|69233827|FG002|Blinded Treatment|Protocol Violation|0|||
37745071|NCT01783015|69233825|FG000|Blinded Treatment|Withdrawal by Subject|0|||
37745072|NCT01783015|69233826|FG001|Blinded Treatment|Withdrawal by Subject|1|||
37745073|NCT01783015|69233827|FG002|Blinded Treatment|Withdrawal by Subject|0|||
37656665|NCT02483078|69128451|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
37656666|NCT02483078|69128450|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
37656667|NCT02483078|69128451|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
37656668|NCT02452190|69128465|FG000|Overall Study|Withdrawal by Sponsor|1|||
37656669|NCT02452190|69128466|FG001|Overall Study|Withdrawal by Sponsor|3|||
37656670|NCT02452190|69128465|FG000|Overall Study|Pregnancy|1|||
37656671|NCT02452190|69128466|FG001|Overall Study|Pregnancy|0|||
37745074|NCT01783015|69233825|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
37745075|NCT01783015|69233826|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
37745076|NCT01783015|69233827|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
37745077|NCT01783015|69233825|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
37745078|NCT01783015|69233826|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
37656672|NCT02452190|69128465|FG000|Overall Study|Investigator's Decision|2|||
37656673|NCT02452190|69128466|FG001|Overall Study|Investigator's Decision|0|||
37656674|NCT02452190|69128465|FG000|Overall Study|Lack of Efficacy|3|||
37656675|NCT02452190|69128466|FG001|Overall Study|Lack of Efficacy|1|||
37656676|NCT02452190|69128465|FG000|Overall Study|Lost to Follow-up|4|||
37656677|NCT02452190|69128466|FG001|Overall Study|Lost to Follow-up|3|||
37656678|NCT02452190|69128465|FG000|Overall Study|Adverse Event|2|||
37656679|NCT02452190|69128466|FG001|Overall Study|Adverse Event|5|||
37656680|NCT02452190|69128465|FG000|Overall Study|Withdrawal by Subject|20|||
37656681|NCT02452190|69128466|FG001|Overall Study|Withdrawal by Subject|11|||
37745079|NCT01783015|69233827|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
37745080|NCT01782859|69233837|FG000|Overall Study|Protocol Violation|6|||
37745081|NCT01782859|69233838|FG001|Overall Study|Protocol Violation|6|||
37745082|NCT01782859|69233837|FG000|Overall Study|Withdrawal by Subject|0|||
37745083|NCT01782859|69233838|FG001|Overall Study|Withdrawal by Subject|1|||
37745084|NCT01782469|69233845|FG000|Overall Study|Lost to Follow-up|1|||
37745085|NCT01782313|69233849|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
37745086|NCT01782313|69233849|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
37745087|NCT01782313|69233849|FG000|Treated Cycle 3|Progressive Disease|21|||
37745088|NCT01782313|69233849|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
37745089|NCT01782313|69233849|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
37745090|NCT01782313|69233849|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
37745091|NCT01782313|69233849|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
37745092|NCT01782313|69233849|FG000|Survival Follow up|Lost to Follow-up|1|||
37745093|NCT01781611|69233872|FG000|Overall Study|Adverse Event|4|||
37745094|NCT01781611|69233873|FG001|Overall Study|Adverse Event|0|||
37745095|NCT01781299|69233890|FG000|Overall Study|Withdrawal by Subject|0|||
37745096|NCT01781299|69233891|FG001|Overall Study|Withdrawal by Subject|1|||
37656682|NCT02452190|69128465|FG000|Overall Study|Noncompliance with study drug|1|||
37656683|NCT02452190|69128466|FG001|Overall Study|Noncompliance with study drug|0|||
37656684|NCT02452190|69128465|FG000|Overall Study|Participant traveled abroad|1|||
37656685|NCT02452190|69128466|FG001|Overall Study|Participant traveled abroad|0|||
37656686|NCT02452190|69128465|FG000|Overall Study|Death|0|||
37745097|NCT01732471|69233897|FG000|Overall Study|Withdrawal by Subject|1|||
37745098|NCT01780987|69233916|FG000|Overall Study|Adverse Event|0|||
37745099|NCT01780987|69233917|FG001|Overall Study|Adverse Event|4|||
37745100|NCT01780987|69233916|FG000|Overall Study|Withdrawal by Subject|2|||
37656687|NCT02452190|69128466|FG001|Overall Study|Death|1|||
37656688|NCT02514122|69128474|FG000|Overall Study|Withdrawal by Subject|2|||
37656689|NCT02514122|69128475|FG001|Overall Study|Withdrawal by Subject|0|||
37656690|NCT00730639|69128486|FG000|Overall Study|Adverse Event|3|||
37656691|NCT00730639|69128487|FG001|Overall Study|Adverse Event|0|||
37656692|NCT00730639|69128488|FG002|Overall Study|Adverse Event|9|||
37656693|NCT00730639|69128489|FG003|Overall Study|Adverse Event|8|||
38032922|NCT03329690|69718969|FG004|Overall Study|Progressive disease per RECIST|20|||
38032923|NCT03329690|69718965|FG000|Overall Study|Clinical progression|7|||
38032924|NCT03329690|69718966|FG001|Overall Study|Clinical progression|4|||
38032925|NCT03329690|69718967|FG002|Overall Study|Clinical progression|1|||
38032926|NCT03329690|69718968|FG003|Overall Study|Clinical progression|1|||
38032927|NCT03329690|69718969|FG004|Overall Study|Clinical progression|1|||
38032928|NCT03329690|69718965|FG000|Overall Study|Adverse Event|22|||
38032929|NCT03329690|69718966|FG001|Overall Study|Adverse Event|4|||
38032930|NCT03329690|69718967|FG002|Overall Study|Adverse Event|0|||
38032931|NCT03329690|69718968|FG003|Overall Study|Adverse Event|1|||
38032932|NCT03329690|69718969|FG004|Overall Study|Adverse Event|2|||
38032933|NCT03329690|69718965|FG000|Overall Study|Death|2|||
38032934|NCT03329690|69718966|FG001|Overall Study|Death|0|||
38032935|NCT03329690|69718967|FG002|Overall Study|Death|0|||
37656694|NCT00730639|69128490|FG004|Overall Study|Adverse Event|23|||
37656695|NCT00730639|69128486|FG000|Overall Study|Complete Response|0|||
37656696|NCT00730639|69128487|FG001|Overall Study|Complete Response|0|||
37656697|NCT00730639|69128488|FG002|Overall Study|Complete Response|2|||
37745101|NCT01780987|69233917|FG001|Overall Study|Withdrawal by Subject|0|||
37745102|NCT01780987|69233916|FG000|Overall Study|Request of Changing Hospital|0|||
37745103|NCT01780987|69233917|FG001|Overall Study|Request of Changing Hospital|1|||
37745104|NCT01780987|69233916|FG000|Overall Study|Changing Residence|1|||
37745105|NCT01780987|69233917|FG001|Overall Study|Changing Residence|0|||
37745106|NCT01780987|69233916|FG000|Overall Study|Not Receiving any Study Medication|0|||
37745107|NCT01780987|69233917|FG001|Overall Study|Not Receiving any Study Medication|1|||
37745108|NCT01730053|69234006|FG000|Overall Study|Participant moved|0|||
37745109|NCT01730053|69234007|FG001|Overall Study|Participant moved|0|||
37745110|NCT01730053|69234008|FG002|Overall Study|Participant moved|1|||
37745111|NCT01730053|69234009|FG003|Overall Study|Participant moved|0|||
37745112|NCT01730053|69234010|FG004|Overall Study|Participant moved|0|||
37745113|NCT01730053|69234011|FG005|Overall Study|Participant moved|0|||
37745114|NCT01730053|69234006|FG000|Overall Study|Physician Decision|0|||
37745115|NCT01730053|69234007|FG001|Overall Study|Physician Decision|0|||
37745116|NCT01730053|69234008|FG002|Overall Study|Physician Decision|0|||
37745117|NCT01730053|69234009|FG003|Overall Study|Physician Decision|1|||
37745118|NCT01730053|69234010|FG004|Overall Study|Physician Decision|0|||
37745119|NCT01730053|69234011|FG005|Overall Study|Physician Decision|0|||
37745120|NCT01730053|69234006|FG000|Overall Study|Adverse Event|2|||
37745121|NCT01730053|69234007|FG001|Overall Study|Adverse Event|6|||
37745122|NCT01730053|69234008|FG002|Overall Study|Adverse Event|3|||
37745123|NCT01730053|69234009|FG003|Overall Study|Adverse Event|3|||
37745124|NCT01730053|69234010|FG004|Overall Study|Adverse Event|2|||
37745125|NCT01730053|69234011|FG005|Overall Study|Adverse Event|2|||
37745126|NCT01730053|69234006|FG000|Overall Study|Poor compliance to protocol|1|||
37745127|NCT01730053|69234007|FG001|Overall Study|Poor compliance to protocol|2|||
37745128|NCT01730053|69234008|FG002|Overall Study|Poor compliance to protocol|2|||
37745129|NCT01730053|69234009|FG003|Overall Study|Poor compliance to protocol|0|||
37745130|NCT01730053|69234010|FG004|Overall Study|Poor compliance to protocol|0|||
37745131|NCT01730053|69234011|FG005|Overall Study|Poor compliance to protocol|2|||
38032936|NCT03329690|69718968|FG003|Overall Study|Death|1|||
37656698|NCT00730639|69128489|FG003|Overall Study|Complete Response|2|||
37656699|NCT00730639|69128490|FG004|Overall Study|Complete Response|1|||
37656700|NCT00730639|69128486|FG000|Overall Study|Completed Maximum Cycles|0|||
37656701|NCT00730639|69128487|FG001|Overall Study|Completed Maximum Cycles|0|||
37656702|NCT00730639|69128488|FG002|Overall Study|Completed Maximum Cycles|11|||
37656703|NCT00730639|69128489|FG003|Overall Study|Completed Maximum Cycles|3|||
37656704|NCT00730639|69128490|FG004|Overall Study|Completed Maximum Cycles|6|||
37656705|NCT00730639|69128486|FG000|Overall Study|Death|0|||
37656706|NCT00730639|69128487|FG001|Overall Study|Death|0|||
37656707|NCT00730639|69128488|FG002|Overall Study|Death|0|||
37656708|NCT00730639|69128489|FG003|Overall Study|Death|0|||
37656709|NCT00730639|69128490|FG004|Overall Study|Death|2|||
37745132|NCT01730053|69234006|FG000|Overall Study|Other than specified|2|||
37745133|NCT01730053|69234007|FG001|Overall Study|Other than specified|6|||
37745134|NCT01730053|69234008|FG002|Overall Study|Other than specified|5|||
37745135|NCT01730053|69234009|FG003|Overall Study|Other than specified|4|||
37745136|NCT01730053|69234010|FG004|Overall Study|Other than specified|7|||
37745137|NCT01730053|69234011|FG005|Overall Study|Other than specified|9|||
37745138|NCT01752985|69234046|FG000|Treatment Period|Subject request to discontinue treatment|1|||
37745139|NCT01752985|69234047|FG001|Treatment Period|Subject request to discontinue treatment|0|||
37656710|NCT00730639|69128486|FG000|Overall Study|Disease Progression|12|||
37745140|NCT01752985|69234048|FG002|Treatment Period|Subject request to discontinue treatment|1|||
37745141|NCT01752985|69234046|FG000|Treatment Period|Subject no longer meets study criteria|0|||
38032937|NCT03329690|69718969|FG004|Overall Study|Death|0|||
38032938|NCT03329690|69718965|FG000|Overall Study|Withdrawal by Subject|2|||
38032939|NCT03329690|69718966|FG001|Overall Study|Withdrawal by Subject|3|||
37745142|NCT01752985|69234047|FG001|Treatment Period|Subject no longer meets study criteria|1|||
37745143|NCT01752985|69234048|FG002|Treatment Period|Subject no longer meets study criteria|1|||
37745144|NCT01752985|69234046|FG000|Treatment Period|Adverse Event|2|||
37745145|NCT01752985|69234047|FG001|Treatment Period|Adverse Event|1|||
37745146|NCT01752985|69234048|FG002|Treatment Period|Adverse Event|2|||
37745147|NCT01752985|69234046|FG000|Treatment Period|Withdrawal by Subject|1|||
37656711|NCT00730639|69128487|FG001|Overall Study|Disease Progression|13|||
37656712|NCT00730639|69128488|FG002|Overall Study|Disease Progression|48|||
37745148|NCT01752985|69234047|FG001|Treatment Period|Withdrawal by Subject|1|||
37745149|NCT01752985|69234048|FG002|Treatment Period|Withdrawal by Subject|0|||
37745150|NCT01752985|69234046|FG000|Treatment Period|Lost to Follow-up|0|||
37745151|NCT01752985|69234047|FG001|Treatment Period|Lost to Follow-up|0|||
37745152|NCT01752985|69234048|FG002|Treatment Period|Lost to Follow-up|1|||
37745153|NCT01751113|69234056|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
37745154|NCT01751113|69234057|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
37745155|NCT01751113|69234058|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
37745156|NCT01751113|69234059|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
37745157|NCT01751113|69234060|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
37745158|NCT01751113|69234061|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
37745159|NCT01751113|69234056|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
37745160|NCT01751113|69234057|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
37745161|NCT01751113|69234058|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
37745162|NCT01751113|69234059|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
37745163|NCT01751113|69234060|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
37745164|NCT01751113|69234061|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
37745165|NCT01750879|69234072|FG000|Overall Study|Adverse Event|8|||
37745166|NCT01750879|69234073|FG001|Overall Study|Adverse Event|0|||
37745167|NCT01750879|69234072|FG000|Overall Study|Lack of Efficacy|1|||
37745168|NCT01750879|69234073|FG001|Overall Study|Lack of Efficacy|0|||
37745169|NCT01750879|69234072|FG000|Overall Study|Withdrawal by Subject|1|||
37745170|NCT01750879|69234073|FG001|Overall Study|Withdrawal by Subject|0|||
37745171|NCT01750879|69234072|FG000|Overall Study|Did not complete per protocol|0|||
37745172|NCT01750879|69234073|FG001|Overall Study|Did not complete per protocol|3|||
37745173|NCT01719380|69234099|FG000|Overall Study|Adverse Event|0|||
37745174|NCT01719380|69234100|FG001|Overall Study|Adverse Event|0|||
37745175|NCT01719380|69234101|FG002|Overall Study|Adverse Event|1|||
37656713|NCT00730639|69128489|FG003|Overall Study|Disease Progression|32|||
37656714|NCT00730639|69128490|FG004|Overall Study|Disease Progression|88|||
37656715|NCT00730639|69128486|FG000|Overall Study|non-specified|0|||
37656716|NCT00730639|69128487|FG001|Overall Study|non-specified|0|||
37656717|NCT00730639|69128488|FG002|Overall Study|non-specified|4|||
37656718|NCT00730639|69128489|FG003|Overall Study|non-specified|2|||
37656719|NCT00730639|69128490|FG004|Overall Study|non-specified|3|||
37656720|NCT00730639|69128486|FG000|Overall Study|Protocol Violation|0|||
37656721|NCT00730639|69128487|FG001|Overall Study|Protocol Violation|0|||
37656722|NCT00730639|69128488|FG002|Overall Study|Protocol Violation|1|||
37656723|NCT00730639|69128489|FG003|Overall Study|Protocol Violation|0|||
37656724|NCT00730639|69128490|FG004|Overall Study|Protocol Violation|0|||
37656725|NCT00730639|69128486|FG000|Overall Study|Withdrawal by Subject|0|||
37656726|NCT00730639|69128487|FG001|Overall Study|Withdrawal by Subject|0|||
37656727|NCT00730639|69128488|FG002|Overall Study|Withdrawal by Subject|6|||
37656728|NCT00730639|69128489|FG003|Overall Study|Withdrawal by Subject|3|||
37656729|NCT00730639|69128490|FG004|Overall Study|Withdrawal by Subject|4|||
37656730|NCT00730639|69128486|FG000|Overall Study|Treatment on-going|2|||
37656731|NCT00730639|69128487|FG001|Overall Study|Treatment on-going|5|||
37656732|NCT00730639|69128488|FG002|Overall Study|Treatment on-going|5|||
37656733|NCT00730639|69128489|FG003|Overall Study|Treatment on-going|4|||
37656734|NCT00730639|69128490|FG004|Overall Study|Treatment on-going|4|||
37656735|NCT02536339|69128513|FG000|Overall Study|Death|20|||
37745176|NCT01719380|69234102|FG003|Overall Study|Adverse Event|2|||
37745177|NCT01719380|69234103|FG004|Overall Study|Adverse Event|0|||
37745178|NCT01719380|69234104|FG005|Overall Study|Adverse Event|1|||
37745179|NCT01719380|69234105|FG006|Overall Study|Adverse Event|0|||
37745180|NCT01719380|69234106|FG007|Overall Study|Adverse Event|1|||
37745181|NCT01719380|69234107|FG008|Overall Study|Adverse Event|4|||
37745182|NCT01719380|69234108|FG009|Overall Study|Adverse Event|3|||
37745183|NCT01719380|69234099|FG000|Overall Study|Death|0|||
37745184|NCT01719380|69234100|FG001|Overall Study|Death|1|||
37745185|NCT01719380|69234101|FG002|Overall Study|Death|0|||
37745186|NCT01719380|69234102|FG003|Overall Study|Death|0|||
37656736|NCT02536339|69128513|FG000|Overall Study|Withdrawal by Subject|3|||
37656737|NCT02536339|69128513|FG000|Overall Study|Lost to Follow-up|2|||
37656738|NCT02536339|69128513|FG000|Overall Study|Treatment discontinued|2|||
37656739|NCT02536339|69128513|FG000|Overall Study|Physician Decision|1|||
37656740|NCT02743871|69128547|FG000|Overall Study|Lost to Follow-up|0|||
37656741|NCT02743871|69128548|FG001|Overall Study|Lost to Follow-up|0|||
37656742|NCT02743871|69128549|FG002|Overall Study|Lost to Follow-up|0|||
37656743|NCT02743871|69128550|FG003|Overall Study|Lost to Follow-up|1|||
37656744|NCT02743871|69128551|FG004|Overall Study|Lost to Follow-up|0|||
37656745|NCT02743871|69128552|FG005|Overall Study|Lost to Follow-up|0|||
37656746|NCT02743871|69128553|FG006|Overall Study|Lost to Follow-up|1|||
37656747|NCT02743871|69128554|FG007|Overall Study|Lost to Follow-up|0|||
37656748|NCT02743871|69128555|FG008|Overall Study|Lost to Follow-up|0|||
37656749|NCT02743871|69128556|FG009|Overall Study|Lost to Follow-up|0|||
37656750|NCT02743871|69128557|FG010|Overall Study|Lost to Follow-up|0|||
37656751|NCT02743871|69128558|FG011|Overall Study|Lost to Follow-up|2|||
37656752|NCT02743871|69128559|FG012|Overall Study|Lost to Follow-up|0|||
37656753|NCT02743871|69128560|FG013|Overall Study|Lost to Follow-up|0|||
37656754|NCT02743871|69128547|FG000|Overall Study|Withdrawal by Subject|0|||
37656755|NCT02743871|69128548|FG001|Overall Study|Withdrawal by Subject|0|||
37656756|NCT02743871|69128549|FG002|Overall Study|Withdrawal by Subject|0|||
37656757|NCT02743871|69128550|FG003|Overall Study|Withdrawal by Subject|0|||
37656758|NCT02743871|69128551|FG004|Overall Study|Withdrawal by Subject|0|||
37656759|NCT02743871|69128552|FG005|Overall Study|Withdrawal by Subject|0|||
37656760|NCT02743871|69128553|FG006|Overall Study|Withdrawal by Subject|0|||
37745187|NCT01719380|69234103|FG004|Overall Study|Death|0|||
37745188|NCT01719380|69234104|FG005|Overall Study|Death|0|||
37745189|NCT01719380|69234105|FG006|Overall Study|Death|0|||
37745190|NCT01719380|69234106|FG007|Overall Study|Death|0|||
37745191|NCT01719380|69234107|FG008|Overall Study|Death|3|||
37745192|NCT01719380|69234108|FG009|Overall Study|Death|3|||
37745193|NCT01719380|69234099|FG000|Overall Study|Participant/Guardian Decision|0|||
37745194|NCT01719380|69234100|FG001|Overall Study|Participant/Guardian Decision|0|||
37745195|NCT01719380|69234101|FG002|Overall Study|Participant/Guardian Decision|1|||
37745196|NCT01719380|69234102|FG003|Overall Study|Participant/Guardian Decision|0|||
37745197|NCT01719380|69234103|FG004|Overall Study|Participant/Guardian Decision|0|||
37745198|NCT01719380|69234104|FG005|Overall Study|Participant/Guardian Decision|0|||
37745199|NCT01719380|69234105|FG006|Overall Study|Participant/Guardian Decision|0|||
37745200|NCT01719380|69234106|FG007|Overall Study|Participant/Guardian Decision|0|||
37745201|NCT01719380|69234107|FG008|Overall Study|Participant/Guardian Decision|2|||
37745202|NCT01719380|69234108|FG009|Overall Study|Participant/Guardian Decision|2|||
37745203|NCT01719380|69234099|FG000|Overall Study|Physician Decision|0|||
37745204|NCT01719380|69234100|FG001|Overall Study|Physician Decision|0|||
37745205|NCT01719380|69234101|FG002|Overall Study|Physician Decision|2|||
37745206|NCT01719380|69234102|FG003|Overall Study|Physician Decision|0|||
37745207|NCT01719380|69234103|FG004|Overall Study|Physician Decision|0|||
37745208|NCT01719380|69234104|FG005|Overall Study|Physician Decision|0|||
37745209|NCT01719380|69234105|FG006|Overall Study|Physician Decision|0|||
37745210|NCT01719380|69234106|FG007|Overall Study|Physician Decision|0|||
37745211|NCT01719380|69234107|FG008|Overall Study|Physician Decision|1|||
37745212|NCT01719380|69234108|FG009|Overall Study|Physician Decision|1|||
37745213|NCT01719380|69234099|FG000|Overall Study|Lack of Efficacy|2|||
37745214|NCT01719380|69234100|FG001|Overall Study|Lack of Efficacy|6|||
37745215|NCT01719380|69234101|FG002|Overall Study|Lack of Efficacy|5|||
37745216|NCT01719380|69234102|FG003|Overall Study|Lack of Efficacy|6|||
37745217|NCT01719380|69234103|FG004|Overall Study|Lack of Efficacy|3|||
37745218|NCT01719380|69234104|FG005|Overall Study|Lack of Efficacy|7|||
37745219|NCT01719380|69234105|FG006|Overall Study|Lack of Efficacy|10|||
37745220|NCT01719380|69234106|FG007|Overall Study|Lack of Efficacy|6|||
37745221|NCT01719380|69234107|FG008|Overall Study|Lack of Efficacy|39|||
37745222|NCT01719380|69234108|FG009|Overall Study|Lack of Efficacy|42|||
37745223|NCT01719380|69234099|FG000|Overall Study|Progressive Disease|0|||
37745224|NCT01719380|69234100|FG001|Overall Study|Progressive Disease|0|||
37745225|NCT01719380|69234101|FG002|Overall Study|Progressive Disease|0|||
37745226|NCT01719380|69234102|FG003|Overall Study|Progressive Disease|0|||
37745227|NCT01719380|69234103|FG004|Overall Study|Progressive Disease|0|||
37745228|NCT01719380|69234104|FG005|Overall Study|Progressive Disease|0|||
37745229|NCT01719380|69234105|FG006|Overall Study|Progressive Disease|0|||
37745230|NCT01719380|69234106|FG007|Overall Study|Progressive Disease|0|||
38032940|NCT03329690|69718967|FG002|Overall Study|Withdrawal by Subject|0|||
37745231|NCT01719380|69234107|FG008|Overall Study|Progressive Disease|1|||
37745232|NCT01719380|69234108|FG009|Overall Study|Progressive Disease|0|||
37745233|NCT01743560|69234158|FG000|Overall Study|Disease progression|26|||
37745234|NCT01743560|69234158|FG000|Overall Study|Adverse Event|8|||
37745235|NCT01743560|69234158|FG000|Overall Study|Death|3|||
37656761|NCT02743871|69128554|FG007|Overall Study|Withdrawal by Subject|0|||
37745236|NCT01743560|69234158|FG000|Overall Study|Withdrawal by Subject|2|||
37745237|NCT01743560|69234158|FG000|Overall Study|Protocol Violation|1|||
37745238|NCT01743560|69234158|FG000|Overall Study|>1 dose of study drug|3|||
37745239|NCT01743092|69234188|FG000|Overall Study|Lost to Follow-up|14|||
37745240|NCT01743092|69234189|FG001|Overall Study|Lost to Follow-up|15|||
37656762|NCT02743871|69128555|FG008|Overall Study|Withdrawal by Subject|0|||
37656763|NCT02743871|69128556|FG009|Overall Study|Withdrawal by Subject|0|||
37656764|NCT02743871|69128557|FG010|Overall Study|Withdrawal by Subject|1|||
37656765|NCT02743871|69128558|FG011|Overall Study|Withdrawal by Subject|0|||
37745241|NCT01780831|69234222|FG000|Overall Study|Withdrawal by Subject|0|||
37745242|NCT01780831|69234223|FG001|Overall Study|Withdrawal by Subject|0|||
37745243|NCT01780831|69234224|FG002|Overall Study|Withdrawal by Subject|4|||
37745244|NCT01780831|69234225|FG003|Overall Study|Withdrawal by Subject|0|||
37922836|NCT00867035|69609650|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
37922837|NCT00867035|69609651|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
37922838|NCT00867035|69609650|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
37922839|NCT00867035|69609651|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
37922840|NCT00663208|69609664|FG000|Treatment Period|Lost to Follow-up|0|||
37922841|NCT00663208|69609665|FG001|Treatment Period|Lost to Follow-up|1|||
37656766|NCT02743871|69128559|FG012|Overall Study|Withdrawal by Subject|12|||
37656767|NCT02743871|69128560|FG013|Overall Study|Withdrawal by Subject|6|||
37745245|NCT01780831|69234222|FG000|Overall Study|Lost to Follow-up|0|||
37745246|NCT01780831|69234223|FG001|Overall Study|Lost to Follow-up|0|||
37656768|NCT02743871|69128547|FG000|Overall Study|Adverse Event|1|||
37656769|NCT02743871|69128548|FG001|Overall Study|Adverse Event|0|||
37656770|NCT02743871|69128549|FG002|Overall Study|Adverse Event|0|||
37656771|NCT02743871|69128550|FG003|Overall Study|Adverse Event|0|||
37656772|NCT02743871|69128551|FG004|Overall Study|Adverse Event|0|||
37656773|NCT02743871|69128552|FG005|Overall Study|Adverse Event|0|||
37656774|NCT02743871|69128553|FG006|Overall Study|Adverse Event|0|||
37656775|NCT02743871|69128554|FG007|Overall Study|Adverse Event|0|||
37656776|NCT02743871|69128555|FG008|Overall Study|Adverse Event|0|||
37656777|NCT02743871|69128556|FG009|Overall Study|Adverse Event|0|||
37656778|NCT02743871|69128557|FG010|Overall Study|Adverse Event|0|||
37656779|NCT02743871|69128558|FG011|Overall Study|Adverse Event|0|||
37656780|NCT02743871|69128559|FG012|Overall Study|Adverse Event|0|||
37656781|NCT02743871|69128560|FG013|Overall Study|Adverse Event|0|||
37656782|NCT02743871|69128547|FG000|Overall Study|Other|0|||
37656783|NCT02743871|69128548|FG001|Overall Study|Other|0|||
37656784|NCT02743871|69128549|FG002|Overall Study|Other|0|||
37656785|NCT02743871|69128550|FG003|Overall Study|Other|0|||
37656786|NCT02743871|69128551|FG004|Overall Study|Other|0|||
37656787|NCT02743871|69128552|FG005|Overall Study|Other|0|||
37656788|NCT02743871|69128553|FG006|Overall Study|Other|0|||
37656789|NCT02743871|69128554|FG007|Overall Study|Other|0|||
37656790|NCT02743871|69128555|FG008|Overall Study|Other|0|||
37656791|NCT02743871|69128556|FG009|Overall Study|Other|0|||
37656792|NCT02743871|69128557|FG010|Overall Study|Other|0|||
37656793|NCT02743871|69128558|FG011|Overall Study|Other|1|||
37656794|NCT02743871|69128559|FG012|Overall Study|Other|1|||
37656795|NCT02743871|69128560|FG013|Overall Study|Other|1|||
37656796|NCT02743871|69128547|FG000|Overall Study|Protocol Violation|0|||
37656797|NCT02743871|69128548|FG001|Overall Study|Protocol Violation|0|||
37656798|NCT02743871|69128549|FG002|Overall Study|Protocol Violation|0|||
37656799|NCT02743871|69128550|FG003|Overall Study|Protocol Violation|0|||
37656800|NCT02743871|69128551|FG004|Overall Study|Protocol Violation|0|||
37656801|NCT02743871|69128552|FG005|Overall Study|Protocol Violation|0|||
37656802|NCT02743871|69128553|FG006|Overall Study|Protocol Violation|0|||
37656803|NCT02743871|69128554|FG007|Overall Study|Protocol Violation|0|||
37656804|NCT02743871|69128555|FG008|Overall Study|Protocol Violation|0|||
37656805|NCT02743871|69128556|FG009|Overall Study|Protocol Violation|0|||
37656806|NCT02743871|69128557|FG010|Overall Study|Protocol Violation|0|||
37656807|NCT02743871|69128558|FG011|Overall Study|Protocol Violation|0|||
37656808|NCT02743871|69128559|FG012|Overall Study|Protocol Violation|2|||
37656809|NCT02743871|69128560|FG013|Overall Study|Protocol Violation|0|||
37656810|NCT01704547|69128602|FG000|Overall Study|Physician Decision|4|||
37745247|NCT01780831|69234224|FG002|Overall Study|Lost to Follow-up|0|||
37745248|NCT01780831|69234225|FG003|Overall Study|Lost to Follow-up|1|||
37745249|NCT01778023|69234284|FG000|Overall Study|Withdrawal by Subject|0|||
37745250|NCT01778023|69234285|FG001|Overall Study|Withdrawal by Subject|3|||
37745251|NCT01753297|69234293|FG000|Overall Study|Lost to Follow-up|7|||
37745252|NCT01753297|69234294|FG001|Overall Study|Lost to Follow-up|2|||
37922842|NCT00663208|69609666|FG002|Treatment Period|Lost to Follow-up|0|||
38032941|NCT03329690|69718968|FG003|Overall Study|Withdrawal by Subject|1|||
38032942|NCT03329690|69718969|FG004|Overall Study|Withdrawal by Subject|0|||
37656811|NCT01704547|69128602|FG000|Overall Study|Withdrawal by Subject|1|||
37656812|NCT00796523|69128622|FG000|Overall Study|Lost to Follow-up|9|||
37656813|NCT00796523|69128623|FG001|Overall Study|Lost to Follow-up|7|||
37656814|NCT01352585|69128638|FG000|Overall Study|Adverse Event|2|||
37656815|NCT01352585|69128639|FG001|Overall Study|Adverse Event|1|||
37656816|NCT01352585|69128638|FG000|Overall Study|Lost to Follow-up|1|||
37656817|NCT01352585|69128639|FG001|Overall Study|Lost to Follow-up|0|||
37656818|NCT01352585|69128638|FG000|Overall Study|Other|5|||
37656819|NCT01352585|69128639|FG001|Overall Study|Other|2|||
37656820|NCT01352507|69128648|FG000|Treatment Period 1|Adverse Event|3|||
37656821|NCT01352507|69128649|FG001|Treatment Period 1|Adverse Event|0|||
37656822|NCT01352507|69128648|FG000|Treatment Period 1|Lost to Follow-up|3|||
37656823|NCT01352507|69128649|FG001|Treatment Period 1|Lost to Follow-up|4|||
37656824|NCT01352507|69128648|FG000|Treatment Period 1|Withdrawal by Subject|7|||
37656825|NCT01352507|69128649|FG001|Treatment Period 1|Withdrawal by Subject|5|||
38032943|NCT03329690|69718965|FG000|Overall Study|Physician Decision|1|||
37745253|NCT01753297|69234293|FG000|Overall Study|Withdrawal by Subject|26|||
37745254|NCT01753297|69234294|FG001|Overall Study|Withdrawal by Subject|23|||
37745255|NCT01753297|69234293|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
37745256|NCT01753297|69234294|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
37745257|NCT01753297|69234293|FG000|Overall Study|Death|0|||
37745258|NCT01753297|69234294|FG001|Overall Study|Death|2|||
37745259|NCT01753297|69234293|FG000|Overall Study|Did not attend end of study visit|7|||
37745260|NCT01753297|69234294|FG001|Overall Study|Did not attend end of study visit|8|||
37745261|NCT01777321|69234304|FG000|Overall Study|Withdrawal by Subject|0|||
37745262|NCT01777321|69234305|FG001|Overall Study|Withdrawal by Subject|1|||
37745263|NCT01729819|69234313|FG000|Overall Study|Adverse Event|2|||
37745264|NCT01729819|69234314|FG001|Overall Study|Adverse Event|4|||
37745265|NCT01729819|69234313|FG000|Overall Study|Lack of Efficacy|1|||
37745266|NCT01729819|69234314|FG001|Overall Study|Lack of Efficacy|0|||
37745267|NCT01729819|69234313|FG000|Overall Study|Lost to Follow-up|2|||
37745268|NCT01729819|69234314|FG001|Overall Study|Lost to Follow-up|0|||
37745269|NCT01729819|69234313|FG000|Overall Study|Other reason|1|||
37745270|NCT01729819|69234314|FG001|Overall Study|Other reason|0|||
37745271|NCT01729819|69234313|FG000|Overall Study|Protocol Violation|0|||
37745272|NCT01729819|69234314|FG001|Overall Study|Protocol Violation|1|||
37745273|NCT01729819|69234313|FG000|Overall Study|Withdrawal by Subject|0|||
37745274|NCT01729819|69234314|FG001|Overall Study|Withdrawal by Subject|2|||
37745275|NCT01776541|69234325|FG000|Overall Study|Administrative Reason|6|||
37745276|NCT01776541|69234326|FG001|Overall Study|Administrative Reason|2|||
37745277|NCT01776541|69234325|FG000|Overall Study|Death|4|||
37745278|NCT01776541|69234326|FG001|Overall Study|Death|0|||
37745279|NCT01776541|69234325|FG000|Overall Study|Lost to Follow-up|27|||
37745280|NCT01776541|69234326|FG001|Overall Study|Lost to Follow-up|48|||
37745281|NCT01776541|69234325|FG000|Overall Study|Unclassified|5|||
37745282|NCT01776541|69234326|FG001|Overall Study|Unclassified|4|||
37745283|NCT01776541|69234325|FG000|Overall Study|Protocol Violation|2|||
37745284|NCT01776541|69234326|FG001|Overall Study|Protocol Violation|1|||
37745285|NCT01776541|69234325|FG000|Overall Study|Withdrawal by Subject|12|||
37745286|NCT01776541|69234326|FG001|Overall Study|Withdrawal by Subject|20|||
37745287|NCT01742078|69234355|FG000|Overall Study|Withdrawal by Subject|0|||
37745288|NCT01742078|69234356|FG001|Overall Study|Withdrawal by Subject|0|||
37745289|NCT01742078|69234357|FG002|Overall Study|Withdrawal by Subject|0|||
37745290|NCT01742078|69234358|FG003|Overall Study|Withdrawal by Subject|1|||
37745291|NCT01742078|69234359|FG004|Overall Study|Withdrawal by Subject|0|||
37745292|NCT01742078|69234360|FG005|Overall Study|Withdrawal by Subject|0|||
37745293|NCT01742078|69234361|FG006|Overall Study|Withdrawal by Subject|0|||
37745294|NCT01742078|69234362|FG007|Overall Study|Withdrawal by Subject|0|||
37745295|NCT01742078|69234363|FG008|Overall Study|Withdrawal by Subject|0|||
37745296|NCT01741688|69234385|FG000|Overall Study|Lack of insurance coverage|2|||
37745297|NCT01741688|69234385|FG000|Overall Study|Withdrawal by Subject|1|||
37745298|NCT01709084|69234392|FG000|Overall Study|Lost to Follow-up|4|||
37745299|NCT01709084|69234393|FG001|Overall Study|Lost to Follow-up|7|||
37745300|NCT01709084|69234392|FG000|Overall Study|Withdrawal by Subject|2|||
37745301|NCT01709084|69234393|FG001|Overall Study|Withdrawal by Subject|2|||
37745302|NCT01709084|69234392|FG000|Overall Study|Adverse Event|5|||
37745303|NCT01709084|69234393|FG001|Overall Study|Adverse Event|0|||
37745304|NCT01709084|69234392|FG000|Overall Study|Other|5|||
37745305|NCT01709084|69234393|FG001|Overall Study|Other|3|||
37656826|NCT01352507|69128648|FG000|Treatment Period 1|Physician Decision|1|||
37656827|NCT01352507|69128649|FG001|Treatment Period 1|Physician Decision|0|||
37656828|NCT01352507|69128648|FG000|Washout Period|Withdrawal by Subject|0|||
37656829|NCT01352507|69128649|FG001|Washout Period|Withdrawal by Subject|1|||
37656830|NCT01352507|69128648|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
37656831|NCT01352507|69128649|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
37656832|NCT01352507|69128648|FG000|Treatment Period 2|Withdrawal by Subject|4|||
37656833|NCT01352507|69128649|FG001|Treatment Period 2|Withdrawal by Subject|3|||
37656834|NCT01352507|69128648|FG000|Treatment Period 2|Lack of Efficacy|1|||
37656835|NCT01352507|69128649|FG001|Treatment Period 2|Lack of Efficacy|0|||
37745306|NCT01709084|69234392|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
37745307|NCT01709084|69234393|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
38032944|NCT03329690|69718966|FG001|Overall Study|Physician Decision|0|||
38032945|NCT03329690|69718967|FG002|Overall Study|Physician Decision|0|||
37745308|NCT01709084|69234392|FG000|Overall Study|Not Treated|0|||
37656836|NCT02361346|69128670|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
37745309|NCT01709084|69234393|FG001|Overall Study|Not Treated|2|||
37745310|NCT01729039|69234401|FG000|Overall Study|disqualified|2|||
37745311|NCT01729039|69234402|FG001|Overall Study|disqualified|5|||
37656837|NCT02361346|69128671|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
37656838|NCT02361346|69128672|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
37745312|NCT01729039|69234401|FG000|Overall Study|Withdrawal by Subject|8|||
37745313|NCT01729039|69234402|FG001|Overall Study|Withdrawal by Subject|7|||
37745314|NCT01775995|69234413|FG000|Overall Study|Lost to Follow-up|1|||
38032946|NCT03329690|69718968|FG003|Overall Study|Physician Decision|0|||
37745315|NCT01775995|69234414|FG001|Overall Study|Lost to Follow-up|1|||
37745316|NCT01741532|69234422|FG000|Overall Study|Adverse Event|4|||
37745317|NCT01741532|69234423|FG001|Overall Study|Adverse Event|0|||
37745318|NCT01741532|69234422|FG000|Overall Study|Withdrawal by Subject|1|||
37745319|NCT01741532|69234423|FG001|Overall Study|Withdrawal by Subject|1|||
37745320|NCT01741532|69234422|FG000|Overall Study|Protocol Violation|0|||
37745321|NCT01741532|69234423|FG001|Overall Study|Protocol Violation|1|||
37745322|NCT01741532|69234422|FG000|Overall Study|Worsening of the disease|3|||
37745323|NCT01741532|69234423|FG001|Overall Study|Worsening of the disease|1|||
37745324|NCT01741532|69234422|FG000|Overall Study|Sponsor decision|1|||
37745325|NCT01741532|69234423|FG001|Overall Study|Sponsor decision|0|||
37745326|NCT01741532|69234422|FG000|Overall Study|Medical event|1|||
37745327|NCT01741532|69234423|FG001|Overall Study|Medical event|0|||
37745328|NCT01719224|69234433|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
37745329|NCT01719224|69234434|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
37745330|NCT01717976|69234445|FG000|Overall Study|Protocol Violation|0|||
37745331|NCT01717976|69234446|FG001|Overall Study|Protocol Violation|1|||
37656839|NCT02361346|69128673|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
37656840|NCT02361346|69128674|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
37656841|NCT02361346|69128675|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
37745332|NCT01740440|69234452|FG000|Overall Study|Lost to Follow-up|3|||
37745333|NCT01740128|69234459|FG000|Overall Study|Pregnancy|0|||
37745334|NCT01740128|69234460|FG001|Overall Study|Pregnancy|1|||
37745335|NCT01740128|69234459|FG000|Overall Study|Protocol Violation|1|||
37745336|NCT01740128|69234460|FG001|Overall Study|Protocol Violation|2|||
37745337|NCT01740128|69234459|FG000|Overall Study|Lost to Follow-up|2|||
37745338|NCT01740128|69234460|FG001|Overall Study|Lost to Follow-up|2|||
37745339|NCT01740128|69234459|FG000|Overall Study|Withdrawal by Subject|1|||
37745340|NCT01740128|69234460|FG001|Overall Study|Withdrawal by Subject|0|||
37745341|NCT01740128|69234459|FG000|Overall Study|Insufficient protocol compliance|2|||
37745342|NCT01740128|69234460|FG001|Overall Study|Insufficient protocol compliance|2|||
37745343|NCT01976741|69234476|FG000|Overall Study|Withdrawal by Subject|1|||
37745344|NCT01976741|69234477|FG001|Overall Study|Withdrawal by Subject|0|||
37745345|NCT01976741|69234478|FG002|Overall Study|Withdrawal by Subject|1|||
37745346|NCT01976741|69234479|FG003|Overall Study|Withdrawal by Subject|1|||
38032947|NCT03329690|69718969|FG004|Overall Study|Physician Decision|1|||
38032948|NCT03329690|69718965|FG000|Overall Study|Miscellaneous|6|||
38032949|NCT03329690|69718966|FG001|Overall Study|Miscellaneous|0|||
37656842|NCT02361346|69128676|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
37656843|NCT02361346|69128677|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
37656844|NCT02361346|69128678|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
37656845|NCT02361346|69128670|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
37656846|NCT02361346|69128671|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
37656847|NCT02361346|69128672|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
37656848|NCT02361346|69128673|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
37656849|NCT02361346|69128674|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
37656850|NCT02361346|69128675|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
37656851|NCT02361346|69128676|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
37656852|NCT02361346|69128677|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
37656853|NCT02361346|69128678|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
37656854|NCT02361346|69128670|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
37656855|NCT02361346|69128671|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
37656856|NCT02361346|69128672|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
37656857|NCT02361346|69128673|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
37656858|NCT02361346|69128674|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
37656859|NCT02361346|69128675|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
37656860|NCT02361346|69128676|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
37656861|NCT02361346|69128677|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
37656862|NCT02361346|69128678|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
37656863|NCT02361346|69128670|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
37656864|NCT02361346|69128671|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
37656865|NCT02361346|69128672|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
37745347|NCT01976741|69234480|FG004|Overall Study|Withdrawal by Subject|0|||
37745348|NCT01976741|69234481|FG005|Overall Study|Withdrawal by Subject|0|||
37745349|NCT01976741|69234482|FG006|Overall Study|Withdrawal by Subject|1|||
38032950|NCT03329690|69718967|FG002|Overall Study|Miscellaneous|0|||
37745350|NCT01976741|69234483|FG007|Overall Study|Withdrawal by Subject|4|||
37745351|NCT01976741|69234484|FG008|Overall Study|Withdrawal by Subject|0|||
37745352|NCT01976741|69234485|FG009|Overall Study|Withdrawal by Subject|0|||
37745353|NCT01976741|69234476|FG000|Overall Study|Adverse Event|0|||
37656866|NCT02361346|69128673|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
37656867|NCT02361346|69128674|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
37656868|NCT02361346|69128675|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
37656869|NCT02361346|69128676|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
37745354|NCT01976741|69234477|FG001|Overall Study|Adverse Event|0|||
38032951|NCT03329690|69718968|FG003|Overall Study|Miscellaneous|0|||
37656870|NCT02361346|69128677|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
37656871|NCT02361346|69128678|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
37656872|NCT02361346|69128670|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
37656873|NCT02361346|69128671|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
37656874|NCT02361346|69128672|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
37656875|NCT02361346|69128673|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
37656876|NCT02361346|69128674|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
37656877|NCT02361346|69128675|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
37656878|NCT02361346|69128676|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
37656879|NCT02361346|69128677|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
37656880|NCT02361346|69128678|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
37656881|NCT02361346|69128670|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
37656882|NCT02361346|69128671|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
37656883|NCT02361346|69128672|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
37656884|NCT02361346|69128673|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
37656885|NCT02361346|69128674|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
37656886|NCT02361346|69128675|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
37656887|NCT02361346|69128676|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
37656888|NCT02361346|69128677|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
37656889|NCT02361346|69128678|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
37656890|NCT02267278|69128720|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
37656891|NCT02267278|69128720|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
37656892|NCT02267278|69128720|FG000|Overall Study|Developed new cancer diagnoses|2|||
37656893|NCT02267278|69128720|FG000|Overall Study|prescribed prohibited medication|1|||
37656894|NCT02360098|69128726|FG000|Overall Study|Physician Decision|7|||
37656895|NCT02266888|69128737|FG000|Overall Study|Death|2|||
37656896|NCT02266888|69128738|FG001|Overall Study|Death|2|||
37656897|NCT02266888|69128739|FG002|Overall Study|Death|4|||
37656898|NCT02266888|69128740|FG003|Overall Study|Death|2|||
37656899|NCT02266888|69128737|FG000|Overall Study|Physician Decision|0|||
37656900|NCT02266888|69128738|FG001|Overall Study|Physician Decision|1|||
37656901|NCT02266888|69128739|FG002|Overall Study|Physician Decision|2|||
37656902|NCT02266888|69128740|FG003|Overall Study|Physician Decision|2|||
37656903|NCT02266888|69128737|FG000|Overall Study|Study Terminated|5|||
37656904|NCT02266888|69128738|FG001|Overall Study|Study Terminated|1|||
37656905|NCT02266888|69128739|FG002|Overall Study|Study Terminated|0|||
37656906|NCT02266888|69128740|FG003|Overall Study|Study Terminated|0|||
37656907|NCT02266888|69128737|FG000|Overall Study|No Longer Eligible|0|||
37656908|NCT02266888|69128738|FG001|Overall Study|No Longer Eligible|0|||
37656909|NCT02266888|69128739|FG002|Overall Study|No Longer Eligible|0|||
37656910|NCT02266888|69128740|FG003|Overall Study|No Longer Eligible|2|||
37656911|NCT02266888|69128737|FG000|Overall Study|Randomization Closed|0|||
37656912|NCT02266888|69128738|FG001|Overall Study|Randomization Closed|0|||
37656913|NCT02266888|69128739|FG002|Overall Study|Randomization Closed|4|||
37656914|NCT02266888|69128740|FG003|Overall Study|Randomization Closed|0|||
37656915|NCT02266888|69128737|FG000|Overall Study|Personnel unavailable at transplant|0|||
37656916|NCT02266888|69128738|FG001|Overall Study|Personnel unavailable at transplant|0|||
37656917|NCT02266888|69128739|FG002|Overall Study|Personnel unavailable at transplant|0|||
37656918|NCT02266888|69128740|FG003|Overall Study|Personnel unavailable at transplant|1|||
37656919|NCT02266888|69128737|FG000|Overall Study|Transfer of care|0|||
37656920|NCT02266888|69128738|FG001|Overall Study|Transfer of care|0|||
37656921|NCT02266888|69128739|FG002|Overall Study|Transfer of care|1|||
37656922|NCT02266888|69128740|FG003|Overall Study|Transfer of care|0|||
37656923|NCT01641952|69128748|FG000|Overall Study|Lost to Follow-up|28|||
37745355|NCT01976741|69234478|FG002|Overall Study|Adverse Event|2|||
37745356|NCT01976741|69234479|FG003|Overall Study|Adverse Event|0|||
37745357|NCT01976741|69234480|FG004|Overall Study|Adverse Event|0|||
37745358|NCT01976741|69234481|FG005|Overall Study|Adverse Event|0|||
37745359|NCT01976741|69234482|FG006|Overall Study|Adverse Event|3|||
37745360|NCT01976741|69234483|FG007|Overall Study|Adverse Event|8|||
37745361|NCT01976741|69234484|FG008|Overall Study|Adverse Event|1|||
37745362|NCT01976741|69234485|FG009|Overall Study|Adverse Event|4|||
37745363|NCT01727713|69234519|FG000|Overall Study|Lost to Follow-up|5|||
37745364|NCT01727713|69234519|FG000|Overall Study|Adverse Event|10|||
37656924|NCT01641952|69128748|FG000|Overall Study|Adverse Event|6|||
37656925|NCT02359552|69128754|FG000|Overall Study|Lost to Follow-up|3|||
37656926|NCT02359552|69128755|FG001|Overall Study|Lost to Follow-up|4|||
37656927|NCT02743793|69128763|FG000|Overall Study|Death|1|||
37656928|NCT02743793|69128764|FG001|Overall Study|Death|1|||
37656929|NCT02743793|69128763|FG000|Overall Study|Withdrawal by Subject|0|||
37656930|NCT02743793|69128764|FG001|Overall Study|Withdrawal by Subject|1|||
37656931|NCT02743793|69128763|FG000|Overall Study|Screen Failure|4|||
37745365|NCT01727713|69234519|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
37656932|NCT02743793|69128764|FG001|Overall Study|Screen Failure|0|||
37656933|NCT02743793|69128763|FG000|Overall Study|No Primary Care Physician|0|||
37656934|NCT02743793|69128764|FG001|Overall Study|No Primary Care Physician|1|||
37656935|NCT02743793|69128763|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
37656936|NCT02743793|69128764|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
37656937|NCT02743793|69128763|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
37656938|NCT02743793|69128764|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
37656939|NCT00152009|69128773|FG000|Overall Study|Adverse Event|9|||
37656940|NCT00152009|69128774|FG001|Overall Study|Adverse Event|13|||
37656941|NCT00152009|69128775|FG002|Overall Study|Adverse Event|20|||
37656942|NCT00152009|69128776|FG003|Overall Study|Adverse Event|1|||
37656943|NCT00152009|69128773|FG000|Overall Study|Protocol Violation|3|||
37656944|NCT00152009|69128774|FG001|Overall Study|Protocol Violation|0|||
37656945|NCT00152009|69128775|FG002|Overall Study|Protocol Violation|0|||
37656946|NCT00152009|69128776|FG003|Overall Study|Protocol Violation|1|||
37656947|NCT00152009|69128773|FG000|Overall Study|Withdrawal by Subject|2|||
37656948|NCT00152009|69128774|FG001|Overall Study|Withdrawal by Subject|3|||
37656949|NCT00152009|69128775|FG002|Overall Study|Withdrawal by Subject|4|||
37656950|NCT00152009|69128776|FG003|Overall Study|Withdrawal by Subject|9|||
37656951|NCT00152009|69128773|FG000|Overall Study|Lost to Follow-up|2|||
37656952|NCT00152009|69128774|FG001|Overall Study|Lost to Follow-up|4|||
37656953|NCT00152009|69128775|FG002|Overall Study|Lost to Follow-up|3|||
37656954|NCT00152009|69128776|FG003|Overall Study|Lost to Follow-up|3|||
37656955|NCT00152009|69128773|FG000|Overall Study|Lack of Efficacy|8|||
37656956|NCT00152009|69128774|FG001|Overall Study|Lack of Efficacy|6|||
37656957|NCT00152009|69128775|FG002|Overall Study|Lack of Efficacy|7|||
37656958|NCT00152009|69128776|FG003|Overall Study|Lack of Efficacy|15|||
37656959|NCT00152009|69128773|FG000|Overall Study|ECG abnormalities|2|||
37656960|NCT00152009|69128774|FG001|Overall Study|ECG abnormalities|2|||
37656961|NCT00152009|69128775|FG002|Overall Study|ECG abnormalities|2|||
37656962|NCT00152009|69128776|FG003|Overall Study|ECG abnormalities|1|||
37656963|NCT00152009|69128773|FG000|Overall Study|Sponsor's decision|3|||
37656964|NCT00152009|69128774|FG001|Overall Study|Sponsor's decision|3|||
37656965|NCT00152009|69128775|FG002|Overall Study|Sponsor's decision|1|||
37656966|NCT00152009|69128776|FG003|Overall Study|Sponsor's decision|3|||
37656967|NCT02265952|69128786|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
37656968|NCT02265952|69128787|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
37656969|NCT02265952|69128786|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
37656970|NCT02265952|69128787|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
37656971|NCT02265796|69128795|FG000|Overall Study|Death|1|||
37656972|NCT02265796|69128796|FG001|Overall Study|Death|0|||
37656973|NCT02265796|69128795|FG000|Overall Study|started on excluded medication|1|||
37745366|NCT01727713|69234519|FG000|Overall Study|Withdrawal by Subject|13|||
37745367|NCT01727713|69234519|FG000|Overall Study|Protocol Deviation|2|||
37745368|NCT01965431|69234523|FG000|Overall Study|Adverse Event|0|||
37745369|NCT01965431|69234524|FG001|Overall Study|Adverse Event|1|||
37745370|NCT01965431|69234525|FG002|Overall Study|Adverse Event|0|||
37745371|NCT01965431|69234526|FG003|Overall Study|Adverse Event|0|||
38032952|NCT03329690|69718969|FG004|Overall Study|Miscellaneous|0|||
38032953|NCT03329690|69718965|FG000|Overall Study|Did not receive treatment|1|||
38032954|NCT03329690|69718966|FG001|Overall Study|Did not receive treatment|0|||
37656974|NCT02265796|69128796|FG001|Overall Study|started on excluded medication|0|||
37656975|NCT02265796|69128795|FG000|Overall Study|Withdrawal by Subject|1|||
37656976|NCT02265796|69128796|FG001|Overall Study|Withdrawal by Subject|1|||
37656977|NCT02357368|69128806|FG000|Overall Study|Lost to Follow-up|0|||
37656978|NCT02357368|69128807|FG001|Overall Study|Lost to Follow-up|0|||
37656979|NCT02357368|69128808|FG002|Overall Study|Lost to Follow-up|0|||
37656980|NCT02357368|69128809|FG003|Overall Study|Lost to Follow-up|1|||
37656981|NCT02357368|69128806|FG000|Overall Study|Pregnancy|3|||
37656982|NCT02357368|69128807|FG001|Overall Study|Pregnancy|2|||
37656983|NCT02357368|69128808|FG002|Overall Study|Pregnancy|0|||
37656984|NCT02357368|69128809|FG003|Overall Study|Pregnancy|0|||
37656985|NCT02357368|69128806|FG000|Overall Study|Withdrawal by Subject|3|||
37656986|NCT02357368|69128807|FG001|Overall Study|Withdrawal by Subject|1|||
37656987|NCT02357368|69128808|FG002|Overall Study|Withdrawal by Subject|1|||
37656988|NCT02357368|69128809|FG003|Overall Study|Withdrawal by Subject|2|||
37745372|NCT01965431|69234527|FG004|Overall Study|Adverse Event|0|||
38032955|NCT03329690|69718967|FG002|Overall Study|Did not receive treatment|0|||
37656989|NCT03287245|69128823|FG000|Overall Study|Study terminated by sponsor|3|||
37656990|NCT03287245|69128824|FG001|Overall Study|Study terminated by sponsor|0|||
37656991|NCT03287245|69128825|FG002|Overall Study|Study terminated by sponsor|3|||
37656992|NCT03287245|69128826|FG003|Overall Study|Study terminated by sponsor|1|||
37656993|NCT03287245|69128823|FG000|Overall Study|Adverse Event|1|||
37656994|NCT03287245|69128824|FG001|Overall Study|Adverse Event|0|||
37656995|NCT03287245|69128825|FG002|Overall Study|Adverse Event|0|||
37656996|NCT03287245|69128826|FG003|Overall Study|Adverse Event|0|||
37656997|NCT03287245|69128823|FG000|Overall Study|Withdrawal by Subject|8|||
37656998|NCT03287245|69128824|FG001|Overall Study|Withdrawal by Subject|3|||
37656999|NCT03287245|69128825|FG002|Overall Study|Withdrawal by Subject|3|||
37657000|NCT03287245|69128826|FG003|Overall Study|Withdrawal by Subject|0|||
37657001|NCT03287245|69128823|FG000|Overall Study|Physician Decision|3|||
37657002|NCT03287245|69128824|FG001|Overall Study|Physician Decision|2|||
37657003|NCT03287245|69128825|FG002|Overall Study|Physician Decision|0|||
37657004|NCT03287245|69128826|FG003|Overall Study|Physician Decision|0|||
37657005|NCT04495179|69128858|FG000|Overall Study|Lost to Follow-up|0|||
37657006|NCT04495179|69128859|FG001|Overall Study|Lost to Follow-up|1|||
37657007|NCT04495179|69128858|FG000|Overall Study|Withdrawal by Subject|2|||
37657008|NCT04495179|69128859|FG001|Overall Study|Withdrawal by Subject|4|||
37657009|NCT04495179|69128858|FG000|Overall Study|Study terminated by sponsor|0|||
37657010|NCT04495179|69128859|FG001|Overall Study|Study terminated by sponsor|18|||
37657011|NCT04495179|69128858|FG000|Overall Study|Death|0|||
37657012|NCT04495179|69128859|FG001|Overall Study|Death|4|||
37657013|NCT04495179|69128858|FG000|Overall Study|Adverse Event|0|||
37745373|NCT01965431|69234528|FG005|Overall Study|Adverse Event|0|||
37745374|NCT01965431|69234523|FG000|Overall Study|Other than stated above|6|||
37745375|NCT01965431|69234524|FG001|Overall Study|Other than stated above|5|||
37745376|NCT01965431|69234525|FG002|Overall Study|Other than stated above|6|||
37745377|NCT01965431|69234526|FG003|Overall Study|Other than stated above|6|||
37745378|NCT01965431|69234527|FG004|Overall Study|Other than stated above|6|||
37745379|NCT01965431|69234528|FG005|Overall Study|Other than stated above|6|||
37745380|NCT01976663|69234538|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
37745381|NCT01976663|69234538|FG000|Overall Study|Personal Reasons|6|||
37745382|NCT01976663|69234538|FG000|Overall Study|Withdrawal by Subject|4|||
37745383|NCT01976663|69234538|FG000|Overall Study|Screen Failure|3|||
37745384|NCT01976663|69234538|FG000|Overall Study|Adverse Event|2|||
37745385|NCT01976663|69234538|FG000|Overall Study|Lost to Follow-up|3|||
37745386|NCT01775137|69234546|FG000|Overall Study|Death|1|||
37657014|NCT04495179|69128859|FG001|Overall Study|Adverse Event|1|||
37657015|NCT04201262|69128884|FG000|Overall Study|Adverse Event|1|||
37657016|NCT04201262|69128885|FG001|Overall Study|Adverse Event|2|||
37657017|NCT04201262|69128884|FG000|Overall Study|Continuing in the study|57|||
37657018|NCT04201262|69128885|FG001|Overall Study|Continuing in the study|0|||
37657019|NCT04201262|69128884|FG000|Overall Study|Withdrawal by Subject|0|||
37657020|NCT04201262|69128885|FG001|Overall Study|Withdrawal by Subject|1|||
37657021|NCT03831100|69128897|FG000|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|6|||
37657022|NCT03831100|69128898|FG001|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|4|||
37657023|NCT03689244|69128917|FG000|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|7|||
37657024|NCT03689244|69128918|FG001|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|8|||
37657025|NCT03689244|69128919|FG002|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
37657026|NCT03689244|69128920|FG003|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
37657027|NCT03689244|69128917|FG000|Double Blind Period (Up to 27.7 Months)|Other|1|||
37657028|NCT03689244|69128918|FG001|Double Blind Period (Up to 27.7 Months)|Other|1|||
37657029|NCT03689244|69128919|FG002|Double Blind Period (Up to 27.7 Months)|Other|0|||
37657030|NCT03689244|69128920|FG003|Double Blind Period (Up to 27.7 Months)|Other|0|||
37657031|NCT03689244|69128917|FG000|Double Blind Period (Up to 27.7 Months)|Sponsor decision|44|||
37657032|NCT03689244|69128918|FG001|Double Blind Period (Up to 27.7 Months)|Sponsor decision|47|||
37657033|NCT03689244|69128919|FG002|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
37657034|NCT03689244|69128920|FG003|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
37657035|NCT03689244|69128917|FG000|Double Blind Period (Up to 27.7 Months)|Death|1|||
37657036|NCT03689244|69128918|FG001|Double Blind Period (Up to 27.7 Months)|Death|0|||
37657037|NCT03689244|69128919|FG002|Double Blind Period (Up to 27.7 Months)|Death|0|||
37657038|NCT03689244|69128920|FG003|Double Blind Period (Up to 27.7 Months)|Death|0|||
37657039|NCT03689244|69128917|FG000|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
37657040|NCT03689244|69128918|FG001|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
37657041|NCT03689244|69128919|FG002|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
37657042|NCT03689244|69128920|FG003|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
37657043|NCT03689244|69128917|FG000|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
37657044|NCT03689244|69128918|FG001|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
37657045|NCT03689244|69128919|FG002|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|1|||
37657046|NCT03689244|69128920|FG003|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
37657047|NCT03689244|69128917|FG000|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
37657048|NCT03689244|69128918|FG001|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
37657049|NCT03689244|69128919|FG002|Open Label Period (Up to 20.8 Months)|Physician Decision|1|||
37657050|NCT03689244|69128920|FG003|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
37745387|NCT01775137|69234546|FG000|Overall Study|Protocol deviation|2|||
38032956|NCT03329690|69718968|FG003|Overall Study|Did not receive treatment|1|||
37657051|NCT03689244|69128917|FG000|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
37745388|NCT01775137|69234546|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
37657052|NCT03689244|69128918|FG001|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
37657053|NCT03689244|69128919|FG002|Open Label Period (Up to 20.8 Months)|Sponsor Decision|7|||
37657054|NCT03689244|69128920|FG003|Open Label Period (Up to 20.8 Months)|Sponsor Decision|6|||
37657055|NCT03649074|69128930|FG000|Overall Study|Lost to Follow-up|2|||
37657056|NCT03649074|69128931|FG001|Overall Study|Lost to Follow-up|1|||
37657057|NCT03649074|69128930|FG000|Overall Study|Adverse Event|1|||
37657058|NCT03649074|69128931|FG001|Overall Study|Adverse Event|0|||
37657059|NCT03649074|69128930|FG000|Overall Study|Physician Decision|1|||
37657060|NCT03649074|69128931|FG001|Overall Study|Physician Decision|0|||
37657061|NCT03649074|69128930|FG000|Overall Study|Withdrawal by Subject|0|||
37657062|NCT03649074|69128931|FG001|Overall Study|Withdrawal by Subject|2|||
37657063|NCT03649074|69128930|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
37657064|NCT03649074|69128931|FG001|Overall Study|Withdrawn by Parent/Guardian|2|||
37657065|NCT03649074|69128930|FG000|Overall Study|Other|1|||
37657066|NCT03649074|69128931|FG001|Overall Study|Other|0|||
37657067|NCT02133573|69128948|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
37657068|NCT02133573|69128949|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
37657069|NCT02133573|69128948|FG000|Overall Study|Child Deaths|3|||
37657070|NCT02133573|69128949|FG001|Overall Study|Child Deaths|5|||
37745389|NCT01775137|69234546|FG000|Overall Study|Adverse Event|1|||
37745390|NCT01775137|69234546|FG000|Overall Study|Withdrawal by participants|5|||
37745391|NCT01976507|69234553|FG000|Overall Study|Adverse Event|6|||
37745392|NCT01976507|69234553|FG000|Overall Study|ablation not done, drug not given|1|||
37745393|NCT01964963|69234557|FG000|Overall Study|Case Report Forms Uncollected|888|||
37745394|NCT01964963|69234557|FG000|Overall Study|Protocol Deviation|50|||
37657071|NCT02133573|69128948|FG000|Overall Study|Child Declined Follow Ups|2|||
37745395|NCT01964963|69234557|FG000|Overall Study|Data Reliability was not Assured|5|||
37745396|NCT01964105|69234564|FG000|Overall Study|Lost to Follow-up|2|||
37745397|NCT01964105|69234565|FG001|Overall Study|Lost to Follow-up|13|||
37745398|NCT01964105|69234566|FG002|Overall Study|Lost to Follow-up|0|||
37745399|NCT01974323|69234576|FG000|Overall Study|Other Reasons|25|||
37745400|NCT01974323|69234577|FG001|Overall Study|Other Reasons|28|||
37745401|NCT01974323|69234576|FG000|Overall Study|Protocol Violation|2|||
37745402|NCT01974323|69234577|FG001|Overall Study|Protocol Violation|2|||
37745403|NCT01974323|69234576|FG000|Overall Study|Personal Reasons|15|||
37745404|NCT01974323|69234577|FG001|Overall Study|Personal Reasons|19|||
37745405|NCT01974323|69234576|FG000|Overall Study|Lost to Follow-up|45|||
38032957|NCT03329690|69718969|FG004|Overall Study|Did not receive treatment|0|||
38032958|NCT03328832|69718989|FG000|Overall Study|Lost to Follow-up|0|||
37657072|NCT02133573|69128949|FG001|Overall Study|Child Declined Follow Ups|1|||
37657073|NCT02133573|69128948|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
37657074|NCT02133573|69128949|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
37657075|NCT00686595|69128984|FG000|Overall Study|Adverse Event|3|||
37657076|NCT00686595|69128984|FG000|Overall Study|Protocol Violation|1|||
37657077|NCT00686595|69128984|FG000|Overall Study|Lost to Follow-up|1|||
37657078|NCT00686595|69128984|FG000|Overall Study|Lack of Efficacy|1|||
37657079|NCT00686595|69128984|FG000|Overall Study|Poor Compliance|1|||
37657080|NCT00640159|69128988|FG000|Overall Study|Lost to Follow-up|2|||
37657081|NCT02262754|69128998|FG000|Overall Study|Adverse Event|3|||
37657082|NCT02262754|69128999|FG001|Overall Study|Adverse Event|4|||
37657083|NCT02262754|69129000|FG002|Overall Study|Adverse Event|0|||
37657084|NCT02262754|69128998|FG000|Overall Study|Lack of Efficacy|2|||
37657085|NCT02262754|69128999|FG001|Overall Study|Lack of Efficacy|0|||
37657086|NCT02262754|69129000|FG002|Overall Study|Lack of Efficacy|1|||
37657087|NCT02262754|69128998|FG000|Overall Study|Lost to Follow-up|0|||
37657088|NCT02262754|69128999|FG001|Overall Study|Lost to Follow-up|0|||
37657089|NCT02262754|69129000|FG002|Overall Study|Lost to Follow-up|1|||
37657090|NCT02262754|69128998|FG000|Overall Study|No longer meets eligibility criteria|0|||
37657091|NCT02262754|69128999|FG001|Overall Study|No longer meets eligibility criteria|1|||
37657092|NCT02262754|69129000|FG002|Overall Study|No longer meets eligibility criteria|0|||
37657093|NCT02262754|69128998|FG000|Overall Study|Study terminated by sponsor|5|||
37657094|NCT02262754|69128999|FG001|Overall Study|Study terminated by sponsor|4|||
37657095|NCT02262754|69129000|FG002|Overall Study|Study terminated by sponsor|4|||
37657096|NCT02262754|69128998|FG000|Overall Study|Protocol Violation|1|||
37745406|NCT01974323|69234577|FG001|Overall Study|Lost to Follow-up|40|||
37745407|NCT01974323|69234576|FG000|Overall Study|Pregnancy|2|||
37745408|NCT01974323|69234577|FG001|Overall Study|Pregnancy|1|||
38032959|NCT03328832|69718990|FG001|Overall Study|Lost to Follow-up|1|||
38032960|NCT02820844|69718998|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
37657097|NCT02262754|69128999|FG001|Overall Study|Protocol Violation|0|||
37657098|NCT02262754|69129000|FG002|Overall Study|Protocol Violation|0|||
37657099|NCT02262754|69128998|FG000|Overall Study|Withdrawal by Subject|1|||
37657100|NCT02262754|69128999|FG001|Overall Study|Withdrawal by Subject|0|||
37657101|NCT02262754|69129000|FG002|Overall Study|Withdrawal by Subject|1|||
37745409|NCT01974323|69234576|FG000|Overall Study|Lack of Efficacy|1|||
37745410|NCT01974323|69234577|FG001|Overall Study|Lack of Efficacy|1|||
37745411|NCT01974323|69234576|FG000|Overall Study|Adverse Event|2|||
37745412|NCT01974323|69234577|FG001|Overall Study|Adverse Event|2|||
37657102|NCT02262754|69128998|FG000|Overall Study|Other|4|||
37657103|NCT02262754|69128999|FG001|Overall Study|Other|0|||
37657104|NCT02262754|69129000|FG002|Overall Study|Other|2|||
37657105|NCT02262364|69129010|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
37657106|NCT02261974|69129016|FG000|Overall Study|Withdrawal by Subject|3|||
37657107|NCT02261974|69129017|FG001|Overall Study|Withdrawal by Subject|2|||
37657108|NCT02261974|69129016|FG000|Overall Study|Pregnancy|0|||
37657109|NCT02261974|69129017|FG001|Overall Study|Pregnancy|1|||
37657110|NCT02261974|69129016|FG000|Overall Study|Missed treatment cut-off date|6|||
37657111|NCT02261974|69129017|FG001|Overall Study|Missed treatment cut-off date|3|||
37657112|NCT02261974|69129016|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
37657113|NCT02261974|69129017|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
37657114|NCT02261974|69129016|FG000|Overall Study|Lost to Follow-up|2|||
37657115|NCT02261974|69129017|FG001|Overall Study|Lost to Follow-up|0|||
37657116|NCT02261974|69129016|FG000|Overall Study|Adverse Event|1|||
37657117|NCT02261974|69129017|FG001|Overall Study|Adverse Event|0|||
37657118|NCT02356588|69129025|FG000|Overall Study|Lack of Efficacy|4|||
37745413|NCT01963403|69234585|FG000|Overall Study|Lost to Follow-up|2|||
37745414|NCT01963403|69234586|FG001|Overall Study|Lost to Follow-up|3|||
37745415|NCT01963403|69234585|FG000|Overall Study|Implant removal|0|||
37745416|NCT01963403|69234586|FG001|Overall Study|Implant removal|1|||
37745417|NCT01973387|69234596|FG000|Overall Study|Adverse Event|14|||
37745418|NCT01973387|69234597|FG001|Overall Study|Adverse Event|4|||
37745419|NCT01973387|69234596|FG000|Overall Study|Withdrawal by Subject|7|||
37745420|NCT01973387|69234597|FG001|Overall Study|Withdrawal by Subject|4|||
37657119|NCT02356588|69129026|FG001|Overall Study|Lack of Efficacy|10|||
37657120|NCT02356588|69129025|FG000|Overall Study|Adverse Event|0|||
37657121|NCT02356588|69129026|FG001|Overall Study|Adverse Event|2|||
37657122|NCT02356588|69129025|FG000|Overall Study|Withdrawal by Subject|1|||
37657123|NCT02356588|69129026|FG001|Overall Study|Withdrawal by Subject|0|||
37657124|NCT02356588|69129025|FG000|Overall Study|Protocol Violation|0|||
37657125|NCT02356588|69129026|FG001|Overall Study|Protocol Violation|1|||
37657126|NCT02355028|69129034|FG000|Overall Study|Adverse Event|2|||
37657127|NCT02355028|69129035|FG001|Overall Study|Adverse Event|0|||
37657128|NCT02355028|69129034|FG000|Overall Study|Withdrawal by Subject|1|||
37657129|NCT02355028|69129035|FG001|Overall Study|Withdrawal by Subject|1|||
37657130|NCT02355028|69129034|FG000|Overall Study|Deemed ineligible after randomization|8|||
37657131|NCT02355028|69129035|FG001|Overall Study|Deemed ineligible after randomization|4|||
37657132|NCT01643668|69129050|FG000|Overall Study|Death|1|||
37657133|NCT02260882|69129056|FG000|Overall Study|Protocol Violation|0|||
37657134|NCT02260882|69129057|FG001|Overall Study|Protocol Violation|1|||
37657135|NCT02260804|69129066|FG000|Induction Study Period|Protocol Violation|2|||
37657136|NCT02260804|69129067|FG001|Induction Study Period|Protocol Violation|0|||
37657137|NCT02260804|69129066|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
37657138|NCT02260804|69129067|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
37657139|NCT02260804|69129066|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
37657140|NCT02260804|69129067|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
37657141|NCT02260804|69129066|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
37657142|NCT02260804|69129067|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
37657143|NCT02260804|69129066|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
37657144|NCT02260804|69129067|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
37657145|NCT02260804|69129066|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
37657146|NCT02260804|69129067|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
37657147|NCT02260804|69129066|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
37657148|NCT02260804|69129067|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
37657149|NCT02260804|69129066|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
37657150|NCT02260804|69129067|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
37657151|NCT02260804|69129066|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
37657152|NCT02260804|69129067|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
37745421|NCT01973387|69234596|FG000|Overall Study|Study terminated by sponsor|63|||
37745422|NCT01973387|69234597|FG001|Overall Study|Study terminated by sponsor|0|||
37745423|NCT01973387|69234596|FG000|Overall Study|Progressive disease or relapse|16|||
37745424|NCT01973387|69234597|FG001|Overall Study|Progressive disease or relapse|5|||
37745425|NCT01973387|69234596|FG000|Overall Study|Death|4|||
37745426|NCT01973387|69234597|FG001|Overall Study|Death|3|||
37745427|NCT01973387|69234596|FG000|Overall Study|Randomized, not treated|2|||
37745428|NCT01973387|69234597|FG001|Overall Study|Randomized, not treated|2|||
37657153|NCT02260804|69129066|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
37657154|NCT02260804|69129067|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
37657155|NCT02260804|69129066|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
37657156|NCT02260804|69129067|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
37657157|NCT02260648|69129076|FG000|Overall Study|Adverse Event|3|||
37657158|NCT02260648|69129077|FG001|Overall Study|Adverse Event|0|||
37657159|NCT02260648|69129078|FG002|Overall Study|Adverse Event|1|||
37657160|NCT02260648|69129076|FG000|Overall Study|Withdrawal by Subject|1|||
37657161|NCT02260648|69129077|FG001|Overall Study|Withdrawal by Subject|1|||
37657162|NCT02260648|69129078|FG002|Overall Study|Withdrawal by Subject|0|||
37745429|NCT01973231|69234605|FG000|Overall Study|Protocol Violation|1|||
37745430|NCT01973231|69234606|FG001|Overall Study|Protocol Violation|1|||
37657163|NCT02260648|69129076|FG000|Overall Study|Protocol Violation|1|||
37745431|NCT01973231|69234605|FG000|Overall Study|Lost to Follow-up|1|||
37745432|NCT01973231|69234606|FG001|Overall Study|Lost to Follow-up|1|||
37745433|NCT01973231|69234605|FG000|Overall Study|unclassified|2|||
37745434|NCT01973231|69234606|FG001|Overall Study|unclassified|1|||
37657164|NCT02260648|69129077|FG001|Overall Study|Protocol Violation|0|||
37657165|NCT02260648|69129078|FG002|Overall Study|Protocol Violation|0|||
37657166|NCT02260648|69129076|FG000|Overall Study|Discontinue Due to Study Termination|13|||
37657167|NCT02260648|69129077|FG001|Overall Study|Discontinue Due to Study Termination|12|||
37657168|NCT02260648|69129078|FG002|Overall Study|Discontinue Due to Study Termination|7|||
37657169|NCT02260492|69129089|FG000|Overall Study|Adverse Event|6|||
37745435|NCT01973231|69234605|FG000|Overall Study|Withdrawal by Subject|7|||
37745436|NCT01973231|69234606|FG001|Overall Study|Withdrawal by Subject|9|||
37745437|NCT01961687|69234612|FG000|Overall Study|Lost to Follow-up|19|||
37745438|NCT01961687|69234612|FG000|Overall Study|Re-operation|17|||
37745439|NCT01961687|69234612|FG000|Overall Study|Death|7|||
37745440|NCT01961687|69234612|FG000|Overall Study|Withdrawal by Subject|6|||
37745441|NCT01961687|69234612|FG000|Overall Study|Adverse Event|6|||
37745442|NCT01961687|69234612|FG000|Overall Study|Moved to area without study site|2|||
37745443|NCT01961687|69234612|FG000|Overall Study|Sponsor decision|2|||
37745444|NCT01961687|69234612|FG000|Overall Study|Physician Decision|1|||
37745445|NCT01961687|69234612|FG000|Overall Study|Unable to meet follow-up requirements|1|||
37745446|NCT01961609|69234674|FG000|Initiation|Missing|3|||
37657170|NCT02260492|69129090|FG001|Overall Study|Adverse Event|1|||
37657171|NCT02260492|69129091|FG002|Overall Study|Adverse Event|2|||
37657172|NCT02260492|69129089|FG000|Overall Study|Death|0|||
37657173|NCT02260492|69129090|FG001|Overall Study|Death|1|||
37657174|NCT02260492|69129091|FG002|Overall Study|Death|0|||
37657175|NCT02260492|69129089|FG000|Overall Study|Lost to Follow-up|12|||
37657176|NCT02260492|69129090|FG001|Overall Study|Lost to Follow-up|9|||
37657177|NCT02260492|69129091|FG002|Overall Study|Lost to Follow-up|0|||
37657178|NCT02260492|69129089|FG000|Overall Study|Physician Decision|2|||
37657179|NCT02260492|69129090|FG001|Overall Study|Physician Decision|0|||
37657180|NCT02260492|69129091|FG002|Overall Study|Physician Decision|1|||
37657181|NCT02260492|69129089|FG000|Overall Study|Withdrawal by Subject|3|||
37657182|NCT02260492|69129090|FG001|Overall Study|Withdrawal by Subject|2|||
37657183|NCT02260492|69129091|FG002|Overall Study|Withdrawal by Subject|2|||
37657184|NCT02260258|69129101|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
37657185|NCT02260258|69129102|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
37657186|NCT02260180|69129112|FG000|Overall Study|Adverse Event|2|||
37657187|NCT02260180|69129113|FG001|Overall Study|Adverse Event|0|||
37657188|NCT02260180|69129114|FG002|Overall Study|Adverse Event|1|||
37657189|NCT02353468|69129122|FG000|Overall Study|Study terminated|3|||
37657190|NCT02349412|69129128|FG000|Overall Study|Withdrawal by Subject|7|||
37657191|NCT02349412|69129129|FG001|Overall Study|Withdrawal by Subject|7|||
37657192|NCT02259400|69129137|FG000|Overall Study|Death|0|||
37657193|NCT02259400|69129138|FG001|Overall Study|Death|2|||
37657194|NCT01530997|69129144|FG000|Overall Study|Physician Decision|1|||
37657195|NCT01530997|69129144|FG000|Overall Study|Withdrawal by Subject|1|||
37657196|NCT02259088|69129157|FG000|Overall Study|Adverse Event|6|||
37745447|NCT01961609|69234675|FG001|Initiation|Missing|2|||
37745448|NCT01961609|69234676|FG002|Initiation|Missing|0|||
37745449|NCT01961609|69234677|FG003|Initiation|Missing|0|||
37745450|NCT01961609|69234674|FG000|Initiation|Protocol deviation|1|||
38032961|NCT02820844|69718999|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
38032962|NCT02820844|69719000|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
38032963|NCT02820844|69719001|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
38032964|NCT02820844|69719002|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
38032965|NCT02820844|69719003|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
38032966|NCT02820844|69718998|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
38032967|NCT02820844|69718999|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
37657197|NCT02259088|69129158|FG001|Overall Study|Adverse Event|4|||
37657198|NCT02259088|69129157|FG000|Overall Study|Lost to Follow-up|2|||
37657199|NCT02259088|69129158|FG001|Overall Study|Lost to Follow-up|0|||
37657200|NCT02259088|69129157|FG000|Overall Study|Death|2|||
37657201|NCT02259088|69129158|FG001|Overall Study|Death|0|||
37657202|NCT02259088|69129157|FG000|Overall Study|Physician Decision|5|||
37657203|NCT02259088|69129158|FG001|Overall Study|Physician Decision|2|||
37745451|NCT01961609|69234675|FG001|Initiation|Protocol deviation|0|||
37657204|NCT02259088|69129157|FG000|Overall Study|Protocol deviation|5|||
37657205|NCT02259088|69129158|FG001|Overall Study|Protocol deviation|0|||
37657206|NCT02259088|69129157|FG000|Overall Study|Subject/guardian decision|8|||
37657207|NCT02259088|69129158|FG001|Overall Study|Subject/guardian decision|8|||
37657208|NCT02880241|69129170|FG000|Overall Study|Lack of Efficacy|1|||
37657209|NCT02880241|69129171|FG001|Overall Study|Lack of Efficacy|0|||
37745452|NCT01961609|69234676|FG002|Initiation|Protocol deviation|0|||
37745453|NCT01961609|69234677|FG003|Initiation|Protocol deviation|0|||
37745454|NCT01961609|69234674|FG000|Initiation|Death|0|||
37745455|NCT01961609|69234675|FG001|Initiation|Death|1|||
37745456|NCT01961609|69234676|FG002|Initiation|Death|0|||
37745457|NCT01961609|69234677|FG003|Initiation|Death|0|||
37745458|NCT01961609|69234674|FG000|Initiation|Administrative problems|1|||
37745459|NCT01961609|69234675|FG001|Initiation|Administrative problems|0|||
37745460|NCT01961609|69234676|FG002|Initiation|Administrative problems|0|||
37745461|NCT01961609|69234677|FG003|Initiation|Administrative problems|0|||
37745462|NCT01961609|69234674|FG000|Initiation|Withdrawal by Subject|1|||
37745463|NCT01961609|69234675|FG001|Initiation|Withdrawal by Subject|2|||
37745464|NCT01961609|69234676|FG002|Initiation|Withdrawal by Subject|0|||
37745465|NCT01961609|69234677|FG003|Initiation|Withdrawal by Subject|0|||
37745466|NCT01961609|69234674|FG000|Initiation|Lack of Efficacy|2|||
37745467|NCT01961609|69234675|FG001|Initiation|Lack of Efficacy|1|||
37745468|NCT01961609|69234676|FG002|Initiation|Lack of Efficacy|0|||
37745469|NCT01961609|69234677|FG003|Initiation|Lack of Efficacy|0|||
37745470|NCT01961609|69234674|FG000|Initiation|Abnormal lab values|0|||
37745471|NCT01961609|69234675|FG001|Initiation|Abnormal lab values|1|||
37745472|NCT01961609|69234676|FG002|Initiation|Abnormal lab values|0|||
37745473|NCT01961609|69234677|FG003|Initiation|Abnormal lab values|0|||
37745474|NCT01961609|69234674|FG000|Initiation|Adverse Event|3|||
37745475|NCT01961609|69234675|FG001|Initiation|Adverse Event|5|||
37745476|NCT01961609|69234676|FG002|Initiation|Adverse Event|0|||
38032968|NCT02820844|69719000|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
38032969|NCT02820844|69719001|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
37657210|NCT02880241|69129172|FG002|Overall Study|Lack of Efficacy|0|||
37657211|NCT02880241|69129173|FG003|Overall Study|Lack of Efficacy|0|||
37657212|NCT02880241|69129174|FG004|Overall Study|Lack of Efficacy|0|||
37657213|NCT02880241|69129175|FG005|Overall Study|Lack of Efficacy|0|||
37657214|NCT02259010|69129191|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
37657215|NCT02021773|69129200|FG000|Overall Study|Adverse Event|1|||
37657216|NCT02021773|69129201|FG001|Overall Study|Adverse Event|4|||
37657217|NCT02021773|69129202|FG002|Overall Study|Adverse Event|3|||
37657218|NCT02021773|69129200|FG000|Overall Study|Lack of Efficacy|2|||
37657219|NCT02021773|69129201|FG001|Overall Study|Lack of Efficacy|2|||
37657220|NCT02021773|69129202|FG002|Overall Study|Lack of Efficacy|2|||
37657221|NCT02021773|69129200|FG000|Overall Study|Protocol Violation|2|||
37657222|NCT02021773|69129201|FG001|Overall Study|Protocol Violation|3|||
37657223|NCT02021773|69129202|FG002|Overall Study|Protocol Violation|1|||
37657224|NCT02021773|69129200|FG000|Overall Study|Withdrawal by Subject|3|||
37657225|NCT02021773|69129201|FG001|Overall Study|Withdrawal by Subject|4|||
37657226|NCT02021773|69129202|FG002|Overall Study|Withdrawal by Subject|5|||
37657227|NCT02021773|69129200|FG000|Overall Study|Lost to Follow-up|1|||
37657228|NCT02021773|69129201|FG001|Overall Study|Lost to Follow-up|3|||
37657229|NCT02021773|69129202|FG002|Overall Study|Lost to Follow-up|0|||
37657230|NCT02021773|69129200|FG000|Overall Study|Reason not specified|3|||
37745477|NCT01961609|69234677|FG003|Initiation|Adverse Event|0|||
37745478|NCT01961609|69234674|FG000|Initiation|Randomized but not treated|1|||
37745479|NCT01961609|69234675|FG001|Initiation|Randomized but not treated|1|||
37745480|NCT01961609|69234676|FG002|Initiation|Randomized but not treated|0|||
37745481|NCT01961609|69234677|FG003|Initiation|Randomized but not treated|0|||
37745482|NCT01961609|69234674|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
37745483|NCT01961609|69234675|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
37745484|NCT01961609|69234676|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
37745485|NCT01961609|69234677|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
37745486|NCT01961609|69234674|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
37745487|NCT01961609|69234675|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
37745488|NCT01961609|69234676|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
37745489|NCT01961609|69234677|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
37745490|NCT01961609|69234674|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
37745491|NCT01961609|69234675|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
37745492|NCT01961609|69234676|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
37745493|NCT01961609|69234677|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
37745494|NCT01961609|69234674|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
37745495|NCT01961609|69234675|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
37657231|NCT02021773|69129201|FG001|Overall Study|Reason not specified|0|||
37657232|NCT02021773|69129202|FG002|Overall Study|Reason not specified|0|||
37657233|NCT00151775|69129215|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
37745496|NCT01961609|69234676|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
37745497|NCT01961609|69234677|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
37745498|NCT01961609|69234674|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
38032970|NCT02820844|69719002|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
38032971|NCT02820844|69719003|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
38032972|NCT02820844|69718998|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
38032973|NCT02820844|69718999|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
37657234|NCT00151775|69129216|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
37745499|NCT01961609|69234675|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
37745500|NCT01961609|69234676|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
37745501|NCT01961609|69234677|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
37745502|NCT01961609|69234674|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
37745503|NCT01961609|69234675|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
38032974|NCT02820844|69719000|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
38032975|NCT02820844|69719001|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
38032976|NCT02820844|69719002|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
38032977|NCT02820844|69719003|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
38032978|NCT02820844|69718998|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
38032979|NCT02820844|69718999|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
38032980|NCT02820844|69719000|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
38032981|NCT02820844|69719001|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
38032982|NCT02820844|69719002|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
38032983|NCT02820844|69719003|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
38032984|NCT02820844|69718998|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
38032985|NCT02820844|69718999|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
38032986|NCT02820844|69719000|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
38032987|NCT02820844|69719001|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
38032988|NCT02820844|69719002|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
38032989|NCT02820844|69719003|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
38032990|NCT02820844|69718998|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
38032991|NCT02820844|69718999|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
38032992|NCT02820844|69719000|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
38032993|NCT02820844|69719001|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
38032994|NCT02820844|69719002|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
38032995|NCT02820844|69719003|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
37855511|NCT00993499|69538835|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
37855512|NCT00993499|69538836|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
37855513|NCT00993499|69538837|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
37855514|NCT00993499|69538838|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
37855515|NCT00993499|69538839|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
37855516|NCT00993499|69538840|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
37855517|NCT00993499|69538835|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
37855518|NCT00993499|69538836|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
37855519|NCT00993499|69538837|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
37855520|NCT00993499|69538838|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
37855521|NCT00993499|69538839|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
37855522|NCT00993499|69538840|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
37855523|NCT00993499|69538835|FG000|Discontinued After Starting Course 3|DLT|1|||
37855524|NCT00993499|69538836|FG001|Discontinued After Starting Course 3|DLT|0|||
37855525|NCT00993499|69538837|FG002|Discontinued After Starting Course 3|DLT|2|||
37657235|NCT00151775|69129217|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
37657236|NCT00151775|69129218|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
37657237|NCT00151775|69129219|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
37657238|NCT00151775|69129220|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
37657239|NCT00151775|69129221|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
37657240|NCT00151775|69129222|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
37657241|NCT00151775|69129223|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
37657242|NCT00151775|69129224|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
37657243|NCT00151775|69129225|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
37657244|NCT00151775|69129226|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
37657245|NCT00151775|69129215|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
37745504|NCT01961609|69234676|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
37855526|NCT00993499|69538838|FG003|Discontinued After Starting Course 3|DLT|1|||
37855527|NCT00993499|69538839|FG004|Discontinued After Starting Course 3|DLT|0|||
37855528|NCT00993499|69538840|FG005|Discontinued After Starting Course 3|DLT|0|||
37855529|NCT00993499|69538835|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
37657246|NCT00151775|69129216|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
37745505|NCT01961609|69234677|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
37745506|NCT01961609|69234674|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
37745507|NCT01961609|69234675|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
37745508|NCT01961609|69234676|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
37745509|NCT01961609|69234677|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
37745510|NCT01961609|69234674|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
37745511|NCT01961609|69234675|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
37745512|NCT01961609|69234676|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
37745513|NCT01961609|69234677|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
37745514|NCT01961609|69234674|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
37745515|NCT01961609|69234675|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
37745516|NCT01961609|69234676|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
37745517|NCT01961609|69234677|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
37745518|NCT01961609|69234674|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
37745519|NCT01961609|69234675|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
37745520|NCT01961609|69234676|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
37745521|NCT01961609|69234677|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
37745522|NCT01961609|69234674|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
37745523|NCT01961609|69234675|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
37745524|NCT01961609|69234676|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
37745525|NCT01961609|69234677|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
37745526|NCT01961609|69234674|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
37745527|NCT01961609|69234675|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
37745528|NCT01961609|69234676|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
37745529|NCT01961609|69234677|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
37745530|NCT01774981|69234786|FG000|Overall Study|Adverse Event|0|||
37745531|NCT01774981|69234787|FG001|Overall Study|Adverse Event|0|||
37745532|NCT01774981|69234788|FG002|Overall Study|Adverse Event|0|||
37745533|NCT01774981|69234789|FG003|Overall Study|Adverse Event|0|||
37745534|NCT01774981|69234790|FG004|Overall Study|Adverse Event|0|||
37745535|NCT01774981|69234791|FG005|Overall Study|Adverse Event|1|||
37745536|NCT01774981|69234792|FG006|Overall Study|Adverse Event|0|||
37745537|NCT01774981|69234793|FG007|Overall Study|Adverse Event|0|||
37745538|NCT01774981|69234786|FG000|Overall Study|Withdrawal by Subject|0|||
37745539|NCT01774981|69234787|FG001|Overall Study|Withdrawal by Subject|0|||
37745540|NCT01774981|69234788|FG002|Overall Study|Withdrawal by Subject|0|||
37745541|NCT01774981|69234789|FG003|Overall Study|Withdrawal by Subject|0|||
37745542|NCT01774981|69234790|FG004|Overall Study|Withdrawal by Subject|0|||
37745543|NCT01774981|69234791|FG005|Overall Study|Withdrawal by Subject|0|||
37745544|NCT01774981|69234792|FG006|Overall Study|Withdrawal by Subject|0|||
37745545|NCT01774981|69234793|FG007|Overall Study|Withdrawal by Subject|1|||
37745546|NCT01774981|69234786|FG000|Overall Study|Death|0|||
37745547|NCT01774981|69234787|FG001|Overall Study|Death|0|||
37745548|NCT01774981|69234788|FG002|Overall Study|Death|0|||
37745549|NCT01774981|69234789|FG003|Overall Study|Death|0|||
37657247|NCT00151775|69129217|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
37657248|NCT00151775|69129218|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
37657249|NCT00151775|69129219|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
37657250|NCT00151775|69129220|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
37657251|NCT00151775|69129221|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
37657252|NCT00151775|69129222|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
37657253|NCT00151775|69129223|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
37657254|NCT00151775|69129224|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
37657255|NCT00151775|69129225|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
37657256|NCT00151775|69129226|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
37657257|NCT00151775|69129215|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
37745550|NCT01774981|69234790|FG004|Overall Study|Death|1|||
37745551|NCT01774981|69234791|FG005|Overall Study|Death|0|||
37745552|NCT01774981|69234792|FG006|Overall Study|Death|0|||
37745553|NCT01774981|69234793|FG007|Overall Study|Death|0|||
37745554|NCT01972841|69234822|FG000|Overall Study|Randomized but Never Received Treatment|2|||
37745555|NCT01972841|69234823|FG001|Overall Study|Randomized but Never Received Treatment|5|||
37745556|NCT01972841|69234824|FG002|Overall Study|Randomized but Never Received Treatment|4|||
37745557|NCT01972841|69234825|FG003|Overall Study|Randomized but Never Received Treatment|2|||
37745558|NCT01972841|69234826|FG004|Overall Study|Randomized but Never Received Treatment|6|||
37745559|NCT01972841|69234827|FG005|Overall Study|Randomized but Never Received Treatment|13|||
37745560|NCT01972841|69234822|FG000|Overall Study|Adverse Event|13|||
37855530|NCT00993499|69538836|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
37855531|NCT00993499|69538837|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
37855532|NCT00993499|69538838|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
37745561|NCT01972841|69234823|FG001|Overall Study|Adverse Event|8|||
37745562|NCT01972841|69234824|FG002|Overall Study|Adverse Event|12|||
37745563|NCT01972841|69234825|FG003|Overall Study|Adverse Event|9|||
37855533|NCT00993499|69538839|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
37855534|NCT00993499|69538840|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
37855535|NCT01014442|69538856|FG000|Overall Study|Adverse Event|0|||
37855536|NCT01014442|69538857|FG001|Overall Study|Adverse Event|8|||
37855537|NCT01014442|69538856|FG000|Overall Study|Withdrawal by Subject|4|||
37855538|NCT01014442|69538857|FG001|Overall Study|Withdrawal by Subject|4|||
37855539|NCT01014442|69538856|FG000|Overall Study|Protocol Violation|2|||
37855540|NCT01014442|69538857|FG001|Overall Study|Protocol Violation|5|||
37855541|NCT01014442|69538856|FG000|Overall Study|Lack of Compliance|0|||
37855542|NCT01014442|69538857|FG001|Overall Study|Lack of Compliance|1|||
37855543|NCT01014442|69538856|FG000|Overall Study|Unspecified Reason|1|||
37922843|NCT00663208|69609667|FG003|Treatment Period|Lost to Follow-up|0|||
37922844|NCT00663208|69609668|FG004|Treatment Period|Lost to Follow-up|0|||
37922845|NCT00663208|69609669|FG005|Treatment Period|Lost to Follow-up|0|||
37922846|NCT00663208|69609670|FG006|Treatment Period|Lost to Follow-up|0|||
37922847|NCT00663208|69609664|FG000|Follow-up Period|Lost to Follow-up|2|||
37922848|NCT00663208|69609665|FG001|Follow-up Period|Lost to Follow-up|0|||
37922849|NCT00663208|69609666|FG002|Follow-up Period|Lost to Follow-up|3|||
37922850|NCT00663208|69609667|FG003|Follow-up Period|Lost to Follow-up|2|||
37922851|NCT00663208|69609668|FG004|Follow-up Period|Lost to Follow-up|0|||
37922852|NCT00663208|69609669|FG005|Follow-up Period|Lost to Follow-up|0|||
37922853|NCT00663208|69609670|FG006|Follow-up Period|Lost to Follow-up|0|||
37922854|NCT00663208|69609664|FG000|Follow-up Period|Other reason|1|||
37922855|NCT00663208|69609665|FG001|Follow-up Period|Other reason|0|||
37855544|NCT01014442|69538857|FG001|Overall Study|Unspecified Reason|1|||
37855545|NCT00996307|69538871|FG000|Overall Study|Adverse Event|0|||
37855546|NCT00996307|69538872|FG001|Overall Study|Adverse Event|1|||
37855547|NCT00996307|69538873|FG002|Overall Study|Adverse Event|0|||
37855548|NCT00996307|69538874|FG003|Overall Study|Adverse Event|0|||
37855549|NCT00996307|69538871|FG000|Overall Study|Withdrawal by Subject|3|||
37855550|NCT00996307|69538872|FG001|Overall Study|Withdrawal by Subject|2|||
37855551|NCT00996307|69538873|FG002|Overall Study|Withdrawal by Subject|5|||
37855552|NCT00996307|69538874|FG003|Overall Study|Withdrawal by Subject|5|||
37855553|NCT00996307|69538871|FG000|Overall Study|Lost to Follow-up|13|||
37855554|NCT00996307|69538872|FG001|Overall Study|Lost to Follow-up|13|||
37855555|NCT00996307|69538873|FG002|Overall Study|Lost to Follow-up|7|||
37855556|NCT00996307|69538874|FG003|Overall Study|Lost to Follow-up|15|||
37855557|NCT00996307|69538871|FG000|Overall Study|Administrative reason|0|||
37855558|NCT00996307|69538872|FG001|Overall Study|Administrative reason|1|||
37855559|NCT00996307|69538873|FG002|Overall Study|Administrative reason|0|||
37855560|NCT00996307|69538874|FG003|Overall Study|Administrative reason|0|||
37855561|NCT00996307|69538871|FG000|Overall Study|Unable to classify|4|||
37855562|NCT00996307|69538872|FG001|Overall Study|Unable to classify|0|||
37855563|NCT00996307|69538873|FG002|Overall Study|Unable to classify|2|||
37855564|NCT00996307|69538874|FG003|Overall Study|Unable to classify|1|||
37855565|NCT01219959|69538904|FG000|Overall Study|Adverse Event|6|||
37855566|NCT01219959|69538905|FG001|Overall Study|Adverse Event|14|||
37855567|NCT01219959|69538904|FG000|Overall Study|Physician Decision|0|||
37855568|NCT01219959|69538905|FG001|Overall Study|Physician Decision|4|||
37922856|NCT00663208|69609666|FG002|Follow-up Period|Other reason|0|||
37922857|NCT00663208|69609667|FG003|Follow-up Period|Other reason|0|||
37922858|NCT00663208|69609668|FG004|Follow-up Period|Other reason|0|||
37922859|NCT00663208|69609669|FG005|Follow-up Period|Other reason|0|||
37922860|NCT00663208|69609670|FG006|Follow-up Period|Other reason|1|||
37922861|NCT00810810|69609692|FG000|Overall Study|Withdrawal by Subject|0|||
37922862|NCT00810810|69609693|FG001|Overall Study|Withdrawal by Subject|8|||
37922863|NCT00810810|69609694|FG002|Overall Study|Withdrawal by Subject|10|||
37922864|NCT00810810|69609695|FG003|Overall Study|Withdrawal by Subject|8|||
37922865|NCT00810810|69609692|FG000|Overall Study|Physician Decision|0|||
37922866|NCT00810810|69609693|FG001|Overall Study|Physician Decision|3|||
37922867|NCT00810810|69609694|FG002|Overall Study|Physician Decision|1|||
37922868|NCT00810810|69609695|FG003|Overall Study|Physician Decision|5|||
37922869|NCT00661258|69609707|FG000|Overall Study|Death|1|||
37657258|NCT00151775|69129216|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
37657259|NCT00151775|69129217|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
37657260|NCT00151775|69129218|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
37657261|NCT00151775|69129219|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
37657262|NCT00151775|69129220|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
37657263|NCT00151775|69129221|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
37657264|NCT00151775|69129222|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
37657265|NCT00151775|69129223|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
37745564|NCT01972841|69234826|FG004|Overall Study|Adverse Event|21|||
37922870|NCT00661258|69609708|FG001|Overall Study|Death|0|||
37922871|NCT00661258|69609707|FG000|Overall Study|caught by police and in detox center|2|||
37745565|NCT01972841|69234827|FG005|Overall Study|Adverse Event|26|||
37745566|NCT01972841|69234822|FG000|Overall Study|Lack of Efficacy|1|||
37745567|NCT01972841|69234823|FG001|Overall Study|Lack of Efficacy|0|||
37745568|NCT01972841|69234824|FG002|Overall Study|Lack of Efficacy|0|||
37745569|NCT01972841|69234825|FG003|Overall Study|Lack of Efficacy|2|||
37745570|NCT01972841|69234826|FG004|Overall Study|Lack of Efficacy|4|||
37745571|NCT01972841|69234827|FG005|Overall Study|Lack of Efficacy|1|||
37745572|NCT01972841|69234822|FG000|Overall Study|Lost to Follow-up|4|||
37745573|NCT01972841|69234823|FG001|Overall Study|Lost to Follow-up|2|||
37745574|NCT01972841|69234824|FG002|Overall Study|Lost to Follow-up|4|||
37745575|NCT01972841|69234825|FG003|Overall Study|Lost to Follow-up|2|||
37745576|NCT01972841|69234826|FG004|Overall Study|Lost to Follow-up|9|||
37745577|NCT01972841|69234827|FG005|Overall Study|Lost to Follow-up|3|||
37745578|NCT01972841|69234822|FG000|Overall Study|Protocol Violation|2|||
37745579|NCT01972841|69234823|FG001|Overall Study|Protocol Violation|2|||
37745580|NCT01972841|69234824|FG002|Overall Study|Protocol Violation|3|||
37745581|NCT01972841|69234825|FG003|Overall Study|Protocol Violation|5|||
37745582|NCT01972841|69234826|FG004|Overall Study|Protocol Violation|9|||
37745583|NCT01972841|69234827|FG005|Overall Study|Protocol Violation|4|||
37657266|NCT00151775|69129224|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
37657267|NCT00151775|69129225|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
37745584|NCT01972841|69234822|FG000|Overall Study|Withdrawal by participants|21|||
37745585|NCT01972841|69234823|FG001|Overall Study|Withdrawal by participants|27|||
37745586|NCT01972841|69234824|FG002|Overall Study|Withdrawal by participants|23|||
37745587|NCT01972841|69234825|FG003|Overall Study|Withdrawal by participants|16|||
37745588|NCT01972841|69234826|FG004|Overall Study|Withdrawal by participants|33|||
37745589|NCT01972841|69234827|FG005|Overall Study|Withdrawal by participants|34|||
37745590|NCT01972841|69234822|FG000|Overall Study|Miscellaneous|0|||
37745591|NCT01972841|69234823|FG001|Overall Study|Miscellaneous|0|||
37745592|NCT01972841|69234824|FG002|Overall Study|Miscellaneous|4|||
37745593|NCT01972841|69234825|FG003|Overall Study|Miscellaneous|1|||
37745594|NCT01972841|69234826|FG004|Overall Study|Miscellaneous|0|||
37745595|NCT01972841|69234827|FG005|Overall Study|Miscellaneous|4|||
37745596|NCT01972841|69234822|FG000|Overall Study|Did not have end of treatment page|0|||
37657268|NCT00151775|69129226|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
37657269|NCT00151775|69129215|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
37657270|NCT00151775|69129216|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
37657271|NCT00151775|69129217|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
37657272|NCT00151775|69129218|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
37657273|NCT00151775|69129219|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
37657274|NCT00151775|69129220|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
37657275|NCT00151775|69129221|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
37657276|NCT00151775|69129222|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
37657277|NCT00151775|69129223|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
37657278|NCT00151775|69129224|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
37657279|NCT00151775|69129225|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
37657280|NCT00151775|69129226|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
37657281|NCT00151775|69129215|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
37657282|NCT00151775|69129216|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
37657283|NCT00151775|69129217|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
37657284|NCT00151775|69129218|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
37657285|NCT00151775|69129219|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
37745597|NCT01972841|69234823|FG001|Overall Study|Did not have end of treatment page|0|||
37745598|NCT01972841|69234824|FG002|Overall Study|Did not have end of treatment page|0|||
37745599|NCT01972841|69234825|FG003|Overall Study|Did not have end of treatment page|0|||
37745600|NCT01972841|69234826|FG004|Overall Study|Did not have end of treatment page|1|||
37855569|NCT01219959|69538904|FG000|Overall Study|Withdrawal by Subject|0|||
37855570|NCT01219959|69538905|FG001|Overall Study|Withdrawal by Subject|2|||
37855571|NCT01219959|69538904|FG000|Overall Study|Renal Transplantation|0|||
37855572|NCT01219959|69538905|FG001|Overall Study|Renal Transplantation|3|||
37855573|NCT01219959|69538904|FG000|Overall Study|Other|1|||
37855574|NCT01219959|69538905|FG001|Overall Study|Other|0|||
37855575|NCT00993421|69538918|FG000|Overall Study|Adverse Event|2|||
37855576|NCT00993421|69538919|FG001|Overall Study|Adverse Event|7|||
37855577|NCT00993421|69538920|FG002|Overall Study|Adverse Event|6|||
37855578|NCT00993421|69538921|FG003|Overall Study|Adverse Event|9|||
37855579|NCT00993421|69538922|FG004|Overall Study|Adverse Event|5|||
37855580|NCT00993421|69538923|FG005|Overall Study|Adverse Event|7|||
37855581|NCT00993421|69538924|FG006|Overall Study|Adverse Event|1|||
37855582|NCT00993421|69538918|FG000|Overall Study|Sponsor Decision|36|||
37745601|NCT01972841|69234827|FG005|Overall Study|Did not have end of treatment page|0|||
37745602|NCT01774903|69234841|FG000|Overall Study|Adverse Event|7|||
37745603|NCT01774903|69234841|FG000|Overall Study|Withdrawal by Subject|2|||
37745604|NCT01774903|69234841|FG000|Overall Study|Lack of Efficacy|1|||
37745605|NCT01774903|69234841|FG000|Overall Study|Ineligible to continue the trial|1|||
37657286|NCT00151775|69129220|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
37657287|NCT00151775|69129221|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
37657288|NCT00151775|69129222|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
37657289|NCT00151775|69129223|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
37657290|NCT00151775|69129224|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
37657291|NCT00151775|69129225|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
37657292|NCT00151775|69129226|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
37657293|NCT00151775|69129215|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
37745606|NCT01774591|69234848|FG000|Overall Study|Physician Decision|1|||
37745607|NCT01774591|69234849|FG001|Overall Study|Physician Decision|1|||
37745608|NCT01774591|69234848|FG000|Overall Study|Withdrawal by Subject|0|||
37745609|NCT01774591|69234849|FG001|Overall Study|Withdrawal by Subject|1|||
37745610|NCT01774591|69234848|FG000|Overall Study|Adverse Event|0|||
37745611|NCT01774591|69234849|FG001|Overall Study|Adverse Event|2|||
37745612|NCT01708915|69234859|FG000|Overall Study|Adverse Event|1|||
37745613|NCT01708915|69234860|FG001|Overall Study|Adverse Event|0|||
37745614|NCT01708915|69234861|FG002|Overall Study|Adverse Event|9|||
37745615|NCT01708915|69234862|FG003|Overall Study|Adverse Event|13|||
37745616|NCT01708915|69234859|FG000|Overall Study|Lack of Efficacy|84|||
37745617|NCT01708915|69234860|FG001|Overall Study|Lack of Efficacy|60|||
37745618|NCT01708915|69234861|FG002|Overall Study|Lack of Efficacy|35|||
37745619|NCT01708915|69234862|FG003|Overall Study|Lack of Efficacy|15|||
37745620|NCT01708915|69234859|FG000|Overall Study|Protocol Violation|0|||
37745621|NCT01708915|69234860|FG001|Overall Study|Protocol Violation|0|||
37745622|NCT01708915|69234861|FG002|Overall Study|Protocol Violation|0|||
37745623|NCT01708915|69234862|FG003|Overall Study|Protocol Violation|1|||
37745624|NCT01708915|69234859|FG000|Overall Study|Withdrawal by Subject|0|||
37745625|NCT01708915|69234860|FG001|Overall Study|Withdrawal by Subject|1|||
37745626|NCT01708915|69234861|FG002|Overall Study|Withdrawal by Subject|2|||
37745627|NCT01708915|69234862|FG003|Overall Study|Withdrawal by Subject|2|||
37855583|NCT00993421|69538919|FG001|Overall Study|Sponsor Decision|31|||
37855584|NCT00993421|69538920|FG002|Overall Study|Sponsor Decision|28|||
37855585|NCT00993421|69538921|FG003|Overall Study|Sponsor Decision|30|||
37855586|NCT00993421|69538922|FG004|Overall Study|Sponsor Decision|38|||
37657294|NCT00151775|69129216|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
37855587|NCT00993421|69538923|FG005|Overall Study|Sponsor Decision|30|||
37855588|NCT00993421|69538924|FG006|Overall Study|Sponsor Decision|29|||
37855589|NCT00993421|69538918|FG000|Overall Study|Lost to Follow-up|3|||
37855590|NCT00993421|69538919|FG001|Overall Study|Lost to Follow-up|5|||
37855591|NCT00993421|69538920|FG002|Overall Study|Lost to Follow-up|5|||
37855592|NCT00993421|69538921|FG003|Overall Study|Lost to Follow-up|0|||
37855593|NCT00993421|69538922|FG004|Overall Study|Lost to Follow-up|0|||
37855594|NCT00993421|69538923|FG005|Overall Study|Lost to Follow-up|0|||
37855595|NCT00993421|69538924|FG006|Overall Study|Lost to Follow-up|6|||
37855596|NCT00993421|69538918|FG000|Overall Study|Withdrawal by Subject|3|||
37855597|NCT00993421|69538919|FG001|Overall Study|Withdrawal by Subject|2|||
37657295|NCT00151775|69129217|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
37657296|NCT00151775|69129218|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
37745628|NCT01708915|69234859|FG000|Overall Study|Other reasons than stated above|1|||
37745629|NCT01708915|69234860|FG001|Overall Study|Other reasons than stated above|1|||
37745630|NCT01708915|69234861|FG002|Overall Study|Other reasons than stated above|0|||
37745631|NCT01708915|69234862|FG003|Overall Study|Other reasons than stated above|2|||
37745632|NCT01708291|69234874|FG000|Overall Study|fighting|2|||
37745633|NCT01708291|69234875|FG001|Overall Study|fighting|1|||
37745634|NCT01708057|69234881|FG000|Overall Study|Withdrawal due to study termination.|1|||
37745635|NCT01708057|69234882|FG001|Overall Study|Withdrawal due to study termination.|1|||
37745636|NCT01708057|69234883|FG002|Overall Study|Withdrawal due to study termination.|1|||
37745637|NCT01748071|69234900|FG000|Overall Study|Adverse Event|2|||
37745638|NCT01748071|69234901|FG001|Overall Study|Adverse Event|2|||
37745639|NCT01748071|69234902|FG002|Overall Study|Adverse Event|0|||
37745640|NCT01972529|69234914|FG000|Overall Study|Adverse Event|0|||
37745641|NCT01972529|69234915|FG001|Overall Study|Adverse Event|1|||
37855598|NCT00993421|69538920|FG002|Overall Study|Withdrawal by Subject|3|||
37855599|NCT00993421|69538921|FG003|Overall Study|Withdrawal by Subject|3|||
37855600|NCT00993421|69538922|FG004|Overall Study|Withdrawal by Subject|3|||
37745642|NCT01972529|69234916|FG002|Overall Study|Adverse Event|0|||
37745643|NCT01972529|69234917|FG003|Overall Study|Adverse Event|0|||
37745644|NCT01972529|69234914|FG000|Overall Study|Lost to Follow-up|1|||
37745645|NCT01972529|69234915|FG001|Overall Study|Lost to Follow-up|0|||
37745646|NCT01972529|69234916|FG002|Overall Study|Lost to Follow-up|0|||
37745647|NCT01972529|69234917|FG003|Overall Study|Lost to Follow-up|0|||
37745648|NCT01972529|69234914|FG000|Overall Study|Participant Choice|0|||
37745649|NCT01972529|69234915|FG001|Overall Study|Participant Choice|1|||
37855601|NCT00993421|69538923|FG005|Overall Study|Withdrawal by Subject|5|||
37855602|NCT00993421|69538924|FG006|Overall Study|Withdrawal by Subject|3|||
37855603|NCT00993421|69538918|FG000|Overall Study|Death|0|||
37657297|NCT00151775|69129219|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
37657298|NCT00151775|69129220|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
37657299|NCT00151775|69129221|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
37657300|NCT00151775|69129222|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
37657301|NCT00151775|69129223|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
37657302|NCT00151775|69129224|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
37657303|NCT00151775|69129225|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
37657304|NCT00151775|69129226|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
37657305|NCT00151775|69129215|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
37657306|NCT00151775|69129216|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
37657307|NCT00151775|69129217|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
37657308|NCT00151775|69129218|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
37657309|NCT00151775|69129219|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
37657310|NCT00151775|69129220|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
37657311|NCT00151775|69129221|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
37657312|NCT00151775|69129222|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
37657313|NCT00151775|69129223|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
37657314|NCT00151775|69129224|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
37657315|NCT00151775|69129225|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
37657316|NCT00151775|69129226|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
37657317|NCT00151775|69129215|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
37657318|NCT00151775|69129216|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
37657319|NCT00151775|69129217|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
37657320|NCT00151775|69129218|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
37657321|NCT00151775|69129219|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
37657322|NCT00151775|69129220|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
37657323|NCT00151775|69129221|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
37745650|NCT01972529|69234916|FG002|Overall Study|Participant Choice|0|||
37745651|NCT01972529|69234917|FG003|Overall Study|Participant Choice|0|||
37745652|NCT01972529|69234914|FG000|Overall Study|Withdrawl of Consent|1|||
37745653|NCT01972529|69234915|FG001|Overall Study|Withdrawl of Consent|2|||
37745654|NCT01972529|69234916|FG002|Overall Study|Withdrawl of Consent|0|||
37745655|NCT01972529|69234917|FG003|Overall Study|Withdrawl of Consent|1|||
37745656|NCT01972529|69234914|FG000|Overall Study|Other|0|||
37745657|NCT01972529|69234915|FG001|Overall Study|Other|0|||
37745658|NCT01972529|69234916|FG002|Overall Study|Other|0|||
37745659|NCT01972529|69234917|FG003|Overall Study|Other|2|||
37745660|NCT01972529|69234914|FG000|Overall Study|Not treated|0|||
37745661|NCT01972529|69234915|FG001|Overall Study|Not treated|1|||
37745662|NCT01972529|69234916|FG002|Overall Study|Not treated|2|||
37745663|NCT01972529|69234917|FG003|Overall Study|Not treated|1|||
37745664|NCT01747915|69234931|FG000|Overall Study|Other|1|||
37745665|NCT01747915|69234932|FG001|Overall Study|Other|1|||
37745666|NCT01747915|69234933|FG002|Overall Study|Other|1|||
37745667|NCT01747915|69234931|FG000|Overall Study|Adverse Event|8|||
37745668|NCT01747915|69234932|FG001|Overall Study|Adverse Event|5|||
37745669|NCT01747915|69234933|FG002|Overall Study|Adverse Event|2|||
37745670|NCT01747915|69234931|FG000|Overall Study|Death|0|||
37745671|NCT01747915|69234932|FG001|Overall Study|Death|0|||
37745672|NCT01747915|69234933|FG002|Overall Study|Death|1|||
37745673|NCT01747915|69234931|FG000|Overall Study|Lack of Efficacy|0|||
37745674|NCT01747915|69234932|FG001|Overall Study|Lack of Efficacy|1|||
37745675|NCT01747915|69234933|FG002|Overall Study|Lack of Efficacy|0|||
37745676|NCT01747915|69234931|FG000|Overall Study|Lost to Follow-up|1|||
37745677|NCT01747915|69234932|FG001|Overall Study|Lost to Follow-up|0|||
37745678|NCT01747915|69234933|FG002|Overall Study|Lost to Follow-up|0|||
37745679|NCT01747915|69234931|FG000|Overall Study|Withdrawal by Subject|4|||
37745680|NCT01747915|69234932|FG001|Overall Study|Withdrawal by Subject|4|||
37657324|NCT00151775|69129222|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
37657325|NCT00151775|69129223|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
37657326|NCT00151775|69129224|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
37657327|NCT00151775|69129225|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
37657328|NCT00151775|69129226|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
37657329|NCT00151775|69129215|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
37657330|NCT00151775|69129216|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
37657331|NCT00151775|69129217|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
37657332|NCT00151775|69129218|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
37657333|NCT00151775|69129219|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
37745681|NCT01747915|69234933|FG002|Overall Study|Withdrawal by Subject|1|||
37745682|NCT01747915|69234931|FG000|Overall Study|Protocol Violation|1|||
37745683|NCT01747915|69234932|FG001|Overall Study|Protocol Violation|0|||
37745684|NCT01747915|69234933|FG002|Overall Study|Protocol Violation|0|||
37657334|NCT00151775|69129220|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
37657335|NCT00151775|69129221|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
37657336|NCT00151775|69129222|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
37657337|NCT00151775|69129223|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
37657338|NCT00151775|69129224|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
37657339|NCT00151775|69129225|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
37657340|NCT00151775|69129226|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
37657341|NCT00151775|69129215|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
37657342|NCT00151775|69129216|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
37657343|NCT00151775|69129217|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
37657344|NCT00151775|69129218|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
37657345|NCT00151775|69129219|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
37657346|NCT00151775|69129220|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
37657347|NCT00151775|69129221|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
37657348|NCT00151775|69129222|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
37657349|NCT00151775|69129223|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
37657350|NCT00151775|69129224|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
37657351|NCT00151775|69129225|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
37657352|NCT00151775|69129226|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
37657353|NCT00151775|69129215|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
37657354|NCT00151775|69129216|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
37657355|NCT00151775|69129217|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
37657356|NCT00151775|69129218|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
37657357|NCT00151775|69129219|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
37657358|NCT00151775|69129220|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
37657359|NCT00151775|69129221|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
37657360|NCT00151775|69129222|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
37657361|NCT00151775|69129223|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
37657362|NCT00151775|69129224|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
37657363|NCT00151775|69129225|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
37657364|NCT00151775|69129226|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
37657365|NCT00151775|69129215|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
37657366|NCT00151775|69129216|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
37657367|NCT00151775|69129217|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
37657368|NCT00151775|69129218|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
37657369|NCT00151775|69129219|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
37657370|NCT00151775|69129220|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
37657371|NCT00151775|69129221|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
37745685|NCT01747915|69234931|FG000|Overall Study|Pregnancy|0|||
37745686|NCT01747915|69234932|FG001|Overall Study|Pregnancy|0|||
37745687|NCT01747915|69234933|FG002|Overall Study|Pregnancy|1|||
37745688|NCT01961297|69234943|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
37745689|NCT01961297|69234944|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
37745690|NCT01960907|69234952|FG000|Overall Study|Death|4|||
37745691|NCT01960907|69234953|FG001|Overall Study|Death|3|||
38032996|NCT02820844|69718998|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
37657372|NCT00151775|69129222|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
37657373|NCT00151775|69129223|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
37657374|NCT00151775|69129224|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
37657375|NCT00151775|69129225|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
37657376|NCT00151775|69129226|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
37657377|NCT00151775|69129215|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
37657378|NCT00151775|69129216|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
37657379|NCT00151775|69129217|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
37657380|NCT00151775|69129218|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
37657381|NCT00151775|69129219|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
37745692|NCT01960907|69234952|FG000|Overall Study|Withdrawal by Subject|32|||
37745693|NCT01960907|69234953|FG001|Overall Study|Withdrawal by Subject|42|||
37657382|NCT00151775|69129220|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
37657383|NCT00151775|69129221|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
37657384|NCT00151775|69129222|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
37657385|NCT00151775|69129223|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
37745694|NCT01747837|69234964|FG000|Overall Study|Lost to Follow-up|5|||
37657386|NCT00151775|69129224|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
37657387|NCT00151775|69129225|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
37657388|NCT00151775|69129226|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
37745695|NCT01747837|69234965|FG001|Overall Study|Lost to Follow-up|2|||
38032997|NCT02820844|69718999|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
37745696|NCT01747837|69234964|FG000|Overall Study|Death|4|||
37657389|NCT00151775|69129215|FG000|Period 4: Open Label|Increased blood pressure|0|||
37657390|NCT00151775|69129216|FG001|Period 4: Open Label|Increased blood pressure|0|||
37657391|NCT00151775|69129217|FG002|Period 4: Open Label|Increased blood pressure|0|||
37657392|NCT00151775|69129218|FG003|Period 4: Open Label|Increased blood pressure|0|||
37657393|NCT00151775|69129219|FG004|Period 4: Open Label|Increased blood pressure|1|||
37657394|NCT00151775|69129220|FG005|Period 4: Open Label|Increased blood pressure|0|||
37657395|NCT00151775|69129221|FG006|Period 4: Open Label|Increased blood pressure|0|||
37657396|NCT00151775|69129222|FG007|Period 4: Open Label|Increased blood pressure|0|||
37657397|NCT00151775|69129223|FG008|Period 4: Open Label|Increased blood pressure|0|||
37657398|NCT00151775|69129224|FG009|Period 4: Open Label|Increased blood pressure|1|||
37657399|NCT00151775|69129225|FG010|Period 4: Open Label|Increased blood pressure|0|||
37657400|NCT00151775|69129226|FG011|Period 4: Open Label|Increased blood pressure|0|||
37657401|NCT00151775|69129215|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
37657402|NCT00151775|69129216|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
37657403|NCT00151775|69129217|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
37657404|NCT00151775|69129218|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
37657405|NCT00151775|69129219|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
37657406|NCT00151775|69129220|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
37657407|NCT00151775|69129221|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
37657408|NCT00151775|69129222|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
37657409|NCT00151775|69129223|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
37657410|NCT00151775|69129224|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
37657411|NCT00151775|69129225|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
37657412|NCT00151775|69129226|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
37657413|NCT00151775|69129215|FG000|Period 4: Open Label|Adverse Event|0|||
37657414|NCT00151775|69129216|FG001|Period 4: Open Label|Adverse Event|0|||
37745697|NCT01747837|69234965|FG001|Overall Study|Death|4|||
37745698|NCT01971203|69234973|FG000|Overall Study|Protocol Violation|3|||
37745699|NCT01971203|69234974|FG001|Overall Study|Protocol Violation|2|||
37745700|NCT01971203|69234973|FG000|Overall Study|Withdrawal by Subject|5|||
37745701|NCT01971203|69234974|FG001|Overall Study|Withdrawal by Subject|6|||
37745702|NCT01971203|69234973|FG000|Overall Study|Adverse Event|1|||
37745703|NCT01971203|69234974|FG001|Overall Study|Adverse Event|0|||
37745704|NCT01605877|69234980|FG000|Overall Study|Withdrawal by Subject|1|||
37745705|NCT01970501|69235004|FG000|Overall Study|Discontinuation of study by sponsor|16|||
37745706|NCT01970501|69235005|FG001|Overall Study|Discontinuation of study by sponsor|14|||
37745707|NCT01970501|69235004|FG000|Overall Study|Withdrawal by Subject|6|||
37745708|NCT01970501|69235005|FG001|Overall Study|Withdrawal by Subject|7|||
37745709|NCT01970501|69235004|FG000|Overall Study|Adverse Event|2|||
37745710|NCT01970501|69235005|FG001|Overall Study|Adverse Event|4|||
37745711|NCT01970501|69235004|FG000|Overall Study|Death|1|||
37745712|NCT01970501|69235005|FG001|Overall Study|Death|3|||
37745713|NCT01970501|69235004|FG000|Overall Study|Physician Decision|2|||
37745714|NCT01970501|69235005|FG001|Overall Study|Physician Decision|0|||
37745715|NCT01969799|69235013|FG000|Overall Study|Adverse Event|0|||
37745716|NCT01969799|69235014|FG001|Overall Study|Adverse Event|1|||
37745717|NCT01969799|69235013|FG000|Overall Study|Death|16|||
37745718|NCT01969799|69235014|FG001|Overall Study|Death|11|||
37745719|NCT01969799|69235013|FG000|Overall Study|Lost to Follow-up|0|||
37745720|NCT01969799|69235014|FG001|Overall Study|Lost to Follow-up|2|||
37745721|NCT01969799|69235013|FG000|Overall Study|Physician Decision|1|||
37745722|NCT01969799|69235014|FG001|Overall Study|Physician Decision|0|||
37745723|NCT01969721|69235020|FG000|Overall Study|Adverse Event|3|||
37745724|NCT01969721|69235021|FG001|Overall Study|Adverse Event|8|||
37745725|NCT01969721|69235022|FG002|Overall Study|Adverse Event|3|||
37745726|NCT01969721|69235023|FG003|Overall Study|Adverse Event|2|||
37745727|NCT01969721|69235020|FG000|Overall Study|Lack of Efficacy|0|||
37745728|NCT01969721|69235021|FG001|Overall Study|Lack of Efficacy|0|||
37745729|NCT01969721|69235022|FG002|Overall Study|Lack of Efficacy|1|||
37745730|NCT01969721|69235023|FG003|Overall Study|Lack of Efficacy|0|||
37745731|NCT01969721|69235020|FG000|Overall Study|Non compliant with protocol|1|||
37745732|NCT01969721|69235021|FG001|Overall Study|Non compliant with protocol|1|||
37745733|NCT01969721|69235022|FG002|Overall Study|Non compliant with protocol|0|||
37745734|NCT01969721|69235023|FG003|Overall Study|Non compliant with protocol|2|||
37745735|NCT01969721|69235020|FG000|Overall Study|Other not defined above|0|||
37855604|NCT00993421|69538919|FG001|Overall Study|Death|0|||
37745736|NCT01969721|69235021|FG001|Overall Study|Other not defined above|2|||
37745737|NCT01969721|69235022|FG002|Overall Study|Other not defined above|0|||
37855605|NCT00993421|69538920|FG002|Overall Study|Death|0|||
37657415|NCT00151775|69129217|FG002|Period 4: Open Label|Adverse Event|0|||
37745738|NCT01969721|69235023|FG003|Overall Study|Other not defined above|0|||
37745739|NCT01969721|69235020|FG000|Overall Study|Discontinued during washout periods.|0|||
37745740|NCT01969721|69235021|FG001|Overall Study|Discontinued during washout periods.|1|||
37745741|NCT01969721|69235022|FG002|Overall Study|Discontinued during washout periods.|1|||
37745742|NCT01969721|69235023|FG003|Overall Study|Discontinued during washout periods.|2|||
37922872|NCT00661258|69609708|FG001|Overall Study|caught by police and in detox center|1|||
37922873|NCT00871871|69609716|FG000|Part I|Adverse Event|0|||
37922874|NCT00871871|69609717|FG001|Part I|Adverse Event|2|||
37922875|NCT00871871|69609718|FG002|Part I|Adverse Event|0|||
37922876|NCT00871871|69609719|FG003|Part I|Adverse Event|0|||
37922877|NCT00871871|69609716|FG000|Part I|Withdrawal by Subject|3|||
37922878|NCT00871871|69609717|FG001|Part I|Withdrawal by Subject|0|||
37922879|NCT00871871|69609718|FG002|Part I|Withdrawal by Subject|0|||
37922880|NCT00871871|69609719|FG003|Part I|Withdrawal by Subject|0|||
37922881|NCT00871871|69609716|FG000|Part I|Laboratory abnormality|0|||
37922882|NCT00871871|69609717|FG001|Part I|Laboratory abnormality|1|||
37922883|NCT00871871|69609718|FG002|Part I|Laboratory abnormality|0|||
37922884|NCT00871871|69609719|FG003|Part I|Laboratory abnormality|0|||
37922885|NCT00871871|69609716|FG000|Part II|Lack of Efficacy|0|||
37922886|NCT00871871|69609717|FG001|Part II|Lack of Efficacy|0|||
37922887|NCT00871871|69609718|FG002|Part II|Lack of Efficacy|1|||
37922888|NCT00871871|69609719|FG003|Part II|Lack of Efficacy|0|||
37922889|NCT00871871|69609716|FG000|Part II|Withdrawal by Subject|0|||
37922890|NCT00871871|69609717|FG001|Part II|Withdrawal by Subject|0|||
37922891|NCT00871871|69609718|FG002|Part II|Withdrawal by Subject|2|||
37855606|NCT00993421|69538921|FG003|Overall Study|Death|0|||
37855607|NCT00993421|69538922|FG004|Overall Study|Death|0|||
37855608|NCT00993421|69538923|FG005|Overall Study|Death|0|||
37855609|NCT00993421|69538924|FG006|Overall Study|Death|1|||
37855610|NCT00993421|69538918|FG000|Overall Study|Entry Criteria Exclusion|0|||
37855611|NCT00993421|69538919|FG001|Overall Study|Entry Criteria Exclusion|0|||
37855612|NCT00993421|69538920|FG002|Overall Study|Entry Criteria Exclusion|1|||
37855613|NCT00993421|69538921|FG003|Overall Study|Entry Criteria Exclusion|3|||
37855614|NCT00993421|69538922|FG004|Overall Study|Entry Criteria Exclusion|0|||
37855615|NCT00993421|69538923|FG005|Overall Study|Entry Criteria Exclusion|1|||
37855616|NCT00993421|69538924|FG006|Overall Study|Entry Criteria Exclusion|0|||
37855617|NCT00993421|69538918|FG000|Overall Study|Physician Decision|0|||
37855618|NCT00993421|69538919|FG001|Overall Study|Physician Decision|0|||
37855619|NCT00993421|69538920|FG002|Overall Study|Physician Decision|0|||
37855620|NCT00993421|69538921|FG003|Overall Study|Physician Decision|0|||
37855621|NCT00993421|69538922|FG004|Overall Study|Physician Decision|0|||
37855622|NCT00993421|69538923|FG005|Overall Study|Physician Decision|1|||
37855623|NCT00993421|69538924|FG006|Overall Study|Physician Decision|1|||
37855624|NCT00993421|69538918|FG000|Overall Study|Protocol Violation|0|||
37855625|NCT00993421|69538919|FG001|Overall Study|Protocol Violation|0|||
37855626|NCT00993421|69538920|FG002|Overall Study|Protocol Violation|0|||
37855627|NCT00993421|69538921|FG003|Overall Study|Protocol Violation|0|||
37855628|NCT00993421|69538922|FG004|Overall Study|Protocol Violation|0|||
37855629|NCT00993421|69538923|FG005|Overall Study|Protocol Violation|2|||
37855630|NCT00993421|69538924|FG006|Overall Study|Protocol Violation|1|||
37855631|NCT01014208|69538942|FG000|Overall Study|Lost to Follow-up|2|||
37855632|NCT01014208|69538943|FG001|Overall Study|Lost to Follow-up|5|||
37855633|NCT01014208|69538942|FG000|Overall Study|Participant Withdrew Consent|12|||
37657416|NCT00151775|69129218|FG003|Period 4: Open Label|Adverse Event|0|||
37657417|NCT00151775|69129219|FG004|Period 4: Open Label|Adverse Event|1|||
37657418|NCT00151775|69129220|FG005|Period 4: Open Label|Adverse Event|0|||
37657419|NCT00151775|69129221|FG006|Period 4: Open Label|Adverse Event|0|||
37657420|NCT00151775|69129222|FG007|Period 4: Open Label|Adverse Event|0|||
37657421|NCT00151775|69129223|FG008|Period 4: Open Label|Adverse Event|0|||
37657422|NCT00151775|69129224|FG009|Period 4: Open Label|Adverse Event|2|||
37657423|NCT00151775|69129225|FG010|Period 4: Open Label|Adverse Event|0|||
37657424|NCT00151775|69129226|FG011|Period 4: Open Label|Adverse Event|0|||
37657425|NCT00151775|69129215|FG000|Period 4: Open Label|Lost to Follow-up|0|||
37657426|NCT00151775|69129216|FG001|Period 4: Open Label|Lost to Follow-up|0|||
37657427|NCT00151775|69129217|FG002|Period 4: Open Label|Lost to Follow-up|0|||
37657428|NCT00151775|69129218|FG003|Period 4: Open Label|Lost to Follow-up|0|||
37657429|NCT00151775|69129219|FG004|Period 4: Open Label|Lost to Follow-up|17|||
37657430|NCT00151775|69129220|FG005|Period 4: Open Label|Lost to Follow-up|0|||
37855634|NCT01014208|69538943|FG001|Overall Study|Participant Withdrew Consent|12|||
37855635|NCT01014208|69538942|FG000|Overall Study|Did Not Receive Study Drug|2|||
37922892|NCT00871871|69609719|FG003|Part II|Withdrawal by Subject|1|||
37745743|NCT01969565|69235033|FG000|Overall Study|Withdrawal by Subject|1|||
37855636|NCT01014208|69538943|FG001|Overall Study|Did Not Receive Study Drug|0|||
37855637|NCT01014208|69538942|FG000|Overall Study|Study Closed/terminated|78|||
37855638|NCT01014208|69538943|FG001|Overall Study|Study Closed/terminated|83|||
37855639|NCT00991939|69538951|FG000|Overall Study|Lost to Follow-up|0|||
37855640|NCT00991939|69538952|FG001|Overall Study|Lost to Follow-up|1|||
37657431|NCT00151775|69129221|FG006|Period 4: Open Label|Lost to Follow-up|0|||
37855641|NCT00991939|69538951|FG000|Overall Study|Withdrawal by Subject|1|||
37922893|NCT00871871|69609716|FG000|Part II|Adverse Event|0|||
37922894|NCT00871871|69609717|FG001|Part II|Adverse Event|0|||
37922895|NCT00871871|69609718|FG002|Part II|Adverse Event|1|||
37922896|NCT00871871|69609719|FG003|Part II|Adverse Event|2|||
37922897|NCT00871871|69609716|FG000|Part II|Protocol Violation|0|||
37922898|NCT00871871|69609717|FG001|Part II|Protocol Violation|0|||
37657432|NCT00151775|69129222|FG007|Period 4: Open Label|Lost to Follow-up|0|||
37657433|NCT00151775|69129223|FG008|Period 4: Open Label|Lost to Follow-up|0|||
37657434|NCT00151775|69129224|FG009|Period 4: Open Label|Lost to Follow-up|7|||
37657435|NCT00151775|69129225|FG010|Period 4: Open Label|Lost to Follow-up|0|||
37657436|NCT00151775|69129226|FG011|Period 4: Open Label|Lost to Follow-up|0|||
37657437|NCT00151775|69129215|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
37657438|NCT00151775|69129216|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
37657439|NCT00151775|69129217|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
37657440|NCT00151775|69129218|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
37657441|NCT00151775|69129219|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
37657442|NCT00151775|69129220|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
37657443|NCT00151775|69129221|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
37657444|NCT00151775|69129222|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
37657445|NCT00151775|69129223|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
37657446|NCT00151775|69129224|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
37657447|NCT00151775|69129225|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
37657448|NCT00151775|69129226|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
37657449|NCT00151775|69129215|FG000|Period 4: Open Label|Other|0|||
37657450|NCT00151775|69129216|FG001|Period 4: Open Label|Other|0|||
37657451|NCT00151775|69129217|FG002|Period 4: Open Label|Other|0|||
37657452|NCT00151775|69129218|FG003|Period 4: Open Label|Other|0|||
37745744|NCT01968707|69235046|FG000|Overall Study|Did not meet treatment day baseline|49|||
37745745|NCT01968707|69235047|FG001|Overall Study|Did not meet treatment day baseline|12|||
37745746|NCT01968707|69235048|FG002|Overall Study|Did not meet treatment day baseline|41|||
37745747|NCT01968707|69235049|FG003|Overall Study|Did not meet treatment day baseline|44|||
37745748|NCT01968707|69235050|FG004|Overall Study|Did not meet treatment day baseline|36|||
37745749|NCT01968707|69235051|FG005|Overall Study|Did not meet treatment day baseline|11|||
37745750|NCT01968707|69235052|FG006|Overall Study|Did not meet treatment day baseline|34|||
37745751|NCT01968707|69235053|FG007|Overall Study|Did not meet treatment day baseline|35|||
37745752|NCT01959581|69235086|FG000|Overall Study|Lost to Follow-up|5|||
37745753|NCT01746901|69235090|FG000|Naloxone Challenge Phase|Adverse Event|2|||
37745754|NCT01746901|69235091|FG001|Naloxone Challenge Phase|Adverse Event|0|||
37745755|NCT01746901|69235092|FG002|Naloxone Challenge Phase|Adverse Event|0|||
37745756|NCT01746901|69235093|FG003|Naloxone Challenge Phase|Adverse Event|0|||
37745757|NCT01746901|69235094|FG004|Naloxone Challenge Phase|Adverse Event|0|||
37745758|NCT01746901|69235095|FG005|Naloxone Challenge Phase|Adverse Event|0|||
37745759|NCT01746901|69235096|FG006|Naloxone Challenge Phase|Adverse Event|0|||
37745760|NCT01746901|69235097|FG007|Naloxone Challenge Phase|Adverse Event|0|||
37745761|NCT01746901|69235098|FG008|Naloxone Challenge Phase|Adverse Event|0|||
37745762|NCT01746901|69235090|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
37745763|NCT01746901|69235091|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
37745764|NCT01746901|69235092|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
37745765|NCT01746901|69235093|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
37745766|NCT01746901|69235094|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
37745767|NCT01746901|69235095|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
37745768|NCT01746901|69235096|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
37745769|NCT01746901|69235097|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
37745770|NCT01746901|69235098|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
37745771|NCT01746901|69235090|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
37745772|NCT01746901|69235091|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
37745773|NCT01746901|69235092|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
37745774|NCT01746901|69235093|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
37745775|NCT01746901|69235094|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
37745776|NCT01746901|69235095|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
37745777|NCT01746901|69235096|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
37745778|NCT01746901|69235097|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
37745779|NCT01746901|69235098|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
37745780|NCT01746901|69235090|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
37855642|NCT00991939|69538952|FG001|Overall Study|Withdrawal by Subject|0|||
37855643|NCT00991939|69538951|FG000|Overall Study|Entire study terminated|4|||
37855644|NCT00991939|69538952|FG001|Overall Study|Entire study terminated|1|||
37855645|NCT00993265|69538962|FG000|Overall Study|Adverse Event|1|||
37855646|NCT00993265|69538963|FG001|Overall Study|Adverse Event|0|||
37855647|NCT00993265|69538962|FG000|Overall Study|Changed dose of concomitant drug|2|||
37855648|NCT00993265|69538963|FG001|Overall Study|Changed dose of concomitant drug|0|||
37855649|NCT00993265|69538962|FG000|Overall Study|Non-compliant with study medication|1|||
37855650|NCT00993265|69538963|FG001|Overall Study|Non-compliant with study medication|0|||
37855651|NCT04211389|69538971|FG000|Overall Study|Adverse Event|1|||
37657453|NCT00151775|69129219|FG004|Period 4: Open Label|Other|1|||
37657454|NCT00151775|69129220|FG005|Period 4: Open Label|Other|0|||
37657455|NCT00151775|69129221|FG006|Period 4: Open Label|Other|0|||
37657456|NCT00151775|69129222|FG007|Period 4: Open Label|Other|0|||
37745781|NCT01746901|69235091|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
37745782|NCT01746901|69235092|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
37745783|NCT01746901|69235093|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
37745784|NCT01746901|69235094|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
37745785|NCT01746901|69235095|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
37745786|NCT01746901|69235096|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
37745787|NCT01746901|69235097|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
37745788|NCT01746901|69235098|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
37745789|NCT01746901|69235090|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
37745790|NCT01746901|69235091|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
37745791|NCT01746901|69235092|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
37745792|NCT01746901|69235093|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
37745793|NCT01746901|69235094|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
37745794|NCT01746901|69235095|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
37745795|NCT01746901|69235096|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
37745796|NCT01746901|69235097|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
37745797|NCT01746901|69235098|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
37657457|NCT00151775|69129223|FG008|Period 4: Open Label|Other|0|||
37657458|NCT00151775|69129224|FG009|Period 4: Open Label|Other|3|||
37745798|NCT01746901|69235090|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
37745799|NCT01746901|69235091|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
37745800|NCT01746901|69235092|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
37745801|NCT01746901|69235093|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
37745802|NCT01746901|69235094|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
37745803|NCT01746901|69235095|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
37745804|NCT01746901|69235096|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
37745805|NCT01746901|69235097|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
37745806|NCT01746901|69235098|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
37745807|NCT01746901|69235090|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
37657459|NCT00151775|69129225|FG010|Period 4: Open Label|Other|0|||
37657460|NCT00151775|69129226|FG011|Period 4: Open Label|Other|0|||
37657461|NCT00151775|69129215|FG000|Period 4: Open Label|Physician Decision|0|||
37657462|NCT00151775|69129216|FG001|Period 4: Open Label|Physician Decision|0|||
37657463|NCT00151775|69129217|FG002|Period 4: Open Label|Physician Decision|0|||
37657464|NCT00151775|69129218|FG003|Period 4: Open Label|Physician Decision|0|||
37745808|NCT01746901|69235091|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
37745809|NCT01746901|69235092|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
37745810|NCT01746901|69235093|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
37745811|NCT01746901|69235094|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
37745812|NCT01746901|69235095|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
37745813|NCT01746901|69235096|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
37745814|NCT01746901|69235097|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
37745815|NCT01746901|69235098|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
37745816|NCT01746901|69235090|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
37745817|NCT01746901|69235091|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
37657465|NCT00151775|69129219|FG004|Period 4: Open Label|Physician Decision|0|||
37657466|NCT00151775|69129220|FG005|Period 4: Open Label|Physician Decision|0|||
37657467|NCT00151775|69129221|FG006|Period 4: Open Label|Physician Decision|0|||
37657468|NCT00151775|69129222|FG007|Period 4: Open Label|Physician Decision|0|||
37657469|NCT00151775|69129223|FG008|Period 4: Open Label|Physician Decision|0|||
37657470|NCT00151775|69129224|FG009|Period 4: Open Label|Physician Decision|2|||
37657471|NCT00151775|69129225|FG010|Period 4: Open Label|Physician Decision|0|||
37657472|NCT00151775|69129226|FG011|Period 4: Open Label|Physician Decision|0|||
37657473|NCT00151775|69129215|FG000|Period 4: Open Label|Protocol Violation|0|||
37657474|NCT00151775|69129216|FG001|Period 4: Open Label|Protocol Violation|0|||
37657475|NCT00151775|69129217|FG002|Period 4: Open Label|Protocol Violation|0|||
37657476|NCT00151775|69129218|FG003|Period 4: Open Label|Protocol Violation|0|||
37657477|NCT00151775|69129219|FG004|Period 4: Open Label|Protocol Violation|1|||
37657478|NCT00151775|69129220|FG005|Period 4: Open Label|Protocol Violation|0|||
37657479|NCT00151775|69129221|FG006|Period 4: Open Label|Protocol Violation|0|||
37657480|NCT00151775|69129222|FG007|Period 4: Open Label|Protocol Violation|0|||
37657481|NCT00151775|69129223|FG008|Period 4: Open Label|Protocol Violation|0|||
37657482|NCT00151775|69129224|FG009|Period 4: Open Label|Protocol Violation|0|||
38032998|NCT02820844|69719000|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
38032999|NCT02820844|69719001|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
38033000|NCT02820844|69719002|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
37657483|NCT00151775|69129225|FG010|Period 4: Open Label|Protocol Violation|0|||
37657484|NCT00151775|69129226|FG011|Period 4: Open Label|Protocol Violation|0|||
37657485|NCT02258464|69129269|FG000|Overall Study|Progressive disease (PD)|9|||
38033001|NCT02820844|69719003|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
38033002|NCT02820844|69718998|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
38033003|NCT02820844|69718999|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
38033004|NCT02820844|69719000|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
38033005|NCT02820844|69719001|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
38033006|NCT02820844|69719002|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
37657486|NCT02258464|69129270|FG001|Overall Study|Progressive disease (PD)|17|||
37745818|NCT01746901|69235092|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
37745819|NCT01746901|69235093|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
37745820|NCT01746901|69235094|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
37745821|NCT01746901|69235095|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
37745822|NCT01746901|69235096|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
37745823|NCT01746901|69235097|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
37745824|NCT01746901|69235098|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
37745825|NCT01746901|69235090|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
37745826|NCT01746901|69235091|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
37745827|NCT01746901|69235092|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
37745828|NCT01746901|69235093|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
37745829|NCT01746901|69235094|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
37745830|NCT01746901|69235095|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
37745831|NCT01746901|69235096|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
37745832|NCT01746901|69235097|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
37745833|NCT01746901|69235098|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
37745834|NCT01746901|69235090|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
37745835|NCT01746901|69235091|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
37745836|NCT01746901|69235092|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
37745837|NCT01746901|69235093|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
37745838|NCT01746901|69235094|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
37745839|NCT01746901|69235095|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
37745840|NCT01746901|69235096|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
37745841|NCT01746901|69235097|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
37745842|NCT01746901|69235098|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
37745843|NCT01746901|69235090|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
37745844|NCT01746901|69235091|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
37745845|NCT01746901|69235092|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
37745846|NCT01746901|69235093|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
37745847|NCT01746901|69235094|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
37745848|NCT01746901|69235095|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
37745849|NCT01746901|69235096|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
37745850|NCT01746901|69235097|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
37745851|NCT01746901|69235098|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
37745852|NCT01746901|69235090|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
37745853|NCT01746901|69235091|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
37745854|NCT01746901|69235092|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
37745855|NCT01746901|69235093|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
37745856|NCT01746901|69235094|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
37745857|NCT01746901|69235095|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
37745858|NCT01746901|69235096|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
37745859|NCT01746901|69235097|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
37745860|NCT01746901|69235098|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
37657487|NCT02258464|69129269|FG000|Overall Study|Study drug never administered|1|||
37657488|NCT02258464|69129270|FG001|Overall Study|Study drug never administered|1|||
37657489|NCT02258464|69129269|FG000|Overall Study|AE not related to clinical PD|1|||
37657490|NCT02258464|69129270|FG001|Overall Study|AE not related to clinical PD|3|||
37657491|NCT02258464|69129269|FG000|Overall Study|Withdrawal by Subject|5|||
37657492|NCT02258464|69129270|FG001|Overall Study|Withdrawal by Subject|4|||
37657493|NCT02258464|69129269|FG000|Overall Study|AE related to clinical PD|1|||
37657494|NCT02258464|69129270|FG001|Overall Study|AE related to clinical PD|0|||
37657495|NCT02682901|69129278|FG000|Overall Study|Adverse Event|10|||
37657496|NCT02682901|69129279|FG001|Overall Study|Adverse Event|3|||
37657497|NCT02682901|69129278|FG000|Overall Study|Lack of Efficacy|0|||
37657498|NCT02682901|69129279|FG001|Overall Study|Lack of Efficacy|1|||
37657499|NCT02258074|69129289|FG000|Overall Study|Withdrawal by Subject|1|||
37657500|NCT02258074|69129290|FG001|Overall Study|Withdrawal by Subject|0|||
37657501|NCT02258074|69129291|FG002|Overall Study|Withdrawal by Subject|0|||
37657502|NCT02258074|69129292|FG003|Overall Study|Withdrawal by Subject|0|||
37657503|NCT01643044|69129304|FG000|Overall Study|Lost to Follow-up|1|||
37657504|NCT01643044|69129305|FG001|Overall Study|Lost to Follow-up|1|||
37657505|NCT01643044|69129304|FG000|Overall Study|Miscarried baby|2|||
37657506|NCT01643044|69129305|FG001|Overall Study|Miscarried baby|2|||
37745861|NCT01968551|69235137|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
37745862|NCT01968551|69235138|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
37745863|NCT01968551|69235139|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
37745864|NCT01968551|69235137|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
37657507|NCT01643044|69129304|FG000|Overall Study|Delivered outside of hospital|1|||
37657508|NCT01643044|69129305|FG001|Overall Study|Delivered outside of hospital|2|||
37657509|NCT01642732|69129311|FG000|Overall Study|Withdrawal by Subject|1|||
37657510|NCT02257684|69129315|FG000|Overall Study|Adverse Event|2|||
37657511|NCT02257684|69129315|FG000|Overall Study|Lack of Efficacy|1|||
37657512|NCT02257684|69129315|FG000|Overall Study|Sponsor's Decision|1|||
37657513|NCT02190721|69129322|FG000|Overall Study|Patient was out of the city|0|||
37657514|NCT02190721|69129323|FG001|Overall Study|Patient was out of the city|1|||
37657515|NCT02190721|69129324|FG002|Overall Study|Patient was out of the city|0|||
37657516|NCT00581477|69129332|FG000|Overall Study|Physician Decision|2|||
37657517|NCT02348008|69129348|FG000|Overall Study|Adverse Event|2|||
37657518|NCT02348008|69129349|FG001|Overall Study|Adverse Event|3|||
37657519|NCT02348008|69129350|FG002|Overall Study|Adverse Event|3|||
37657520|NCT02348008|69129348|FG000|Overall Study|Disease Progression|1|||
37657521|NCT02348008|69129349|FG001|Overall Study|Disease Progression|5|||
37657522|NCT02348008|69129350|FG002|Overall Study|Disease Progression|16|||
37745865|NCT01968551|69235138|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
37745866|NCT01968551|69235139|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
37745867|NCT01968551|69235137|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
37745868|NCT01968551|69235138|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
37745869|NCT01968551|69235139|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
37745870|NCT01968551|69235137|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
37745871|NCT01968551|69235138|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
37745872|NCT01968551|69235139|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
37745873|NCT01968551|69235137|FG000|Extension Phase|Adverse Event|0|||
37745874|NCT01968551|69235138|FG001|Extension Phase|Adverse Event|0|||
37745875|NCT01968551|69235139|FG002|Extension Phase|Adverse Event|2|||
37745876|NCT01968551|69235137|FG000|Extension Phase|Death|0|||
37745877|NCT01968551|69235138|FG001|Extension Phase|Death|1|||
37745878|NCT01968551|69235139|FG002|Extension Phase|Death|0|||
37657523|NCT02348008|69129348|FG000|Overall Study|Withdrawal by Subject|0|||
37657524|NCT02348008|69129349|FG001|Overall Study|Withdrawal by Subject|1|||
37657525|NCT02348008|69129350|FG002|Overall Study|Withdrawal by Subject|0|||
37657526|NCT02348008|69129348|FG000|Overall Study|Symptomatic Deterioration|0|||
37657527|NCT02348008|69129349|FG001|Overall Study|Symptomatic Deterioration|1|||
37657528|NCT02348008|69129350|FG002|Overall Study|Symptomatic Deterioration|0|||
37657529|NCT04962022|69129356|FG000|Period 1|Withdrawal by Subject|1|||
37657530|NCT04962022|69129357|FG001|Period 1|Withdrawal by Subject|0|||
37657531|NCT04210843|69129409|FG000|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|134|||
37657532|NCT04210843|69129410|FG001|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|322|||
37657533|NCT04210843|69129409|FG000|First Half Treatment Period (52 Weeks)|Subject decision|11|||
37657534|NCT04210843|69129410|FG001|First Half Treatment Period (52 Weeks)|Subject decision|28|||
37657535|NCT04210843|69129409|FG000|First Half Treatment Period (52 Weeks)|Lost to Follow-up|4|||
37745879|NCT01968551|69235137|FG000|Extension Phase|Withdrew Consent|0|||
37745880|NCT01968551|69235138|FG001|Extension Phase|Withdrew Consent|0|||
37745881|NCT01968551|69235139|FG002|Extension Phase|Withdrew Consent|1|||
37745882|NCT01968551|69235137|FG000|Extension Phase|Lost to Follow-up|1|||
37745883|NCT01968551|69235138|FG001|Extension Phase|Lost to Follow-up|0|||
37745884|NCT01968551|69235139|FG002|Extension Phase|Lost to Follow-up|1|||
37745885|NCT01707992|69235154|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
37745886|NCT01707992|69235155|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
37745887|NCT01707992|69235156|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
37745888|NCT01707992|69235157|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
37745889|NCT01707992|69235158|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
37745890|NCT01707992|69235159|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
37745891|NCT01707992|69235154|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
37745892|NCT01707992|69235155|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
37745893|NCT01707992|69235156|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
37745894|NCT01707992|69235157|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
37745895|NCT01707992|69235158|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
37855652|NCT04211389|69538972|FG001|Overall Study|Adverse Event|2|||
37657536|NCT04210843|69129410|FG001|First Half Treatment Period (52 Weeks)|Lost to Follow-up|2|||
37657537|NCT04210843|69129409|FG000|First Half Treatment Period (52 Weeks)|Adverse Event|1|||
37657538|NCT04210843|69129410|FG001|First Half Treatment Period (52 Weeks)|Adverse Event|11|||
37657539|NCT04210843|69129409|FG000|First Half Treatment Period (52 Weeks)|Physician Decision|0|||
37657540|NCT04210843|69129410|FG001|First Half Treatment Period (52 Weeks)|Physician Decision|3|||
37657541|NCT04210843|69129409|FG000|First Half Treatment Period (52 Weeks)|Protocol deviation|0|||
37657542|NCT04210843|69129410|FG001|First Half Treatment Period (52 Weeks)|Protocol deviation|3|||
37657543|NCT04210843|69129409|FG000|First Half Treatment Period (52 Weeks)|Death|0|||
37657544|NCT04210843|69129410|FG001|First Half Treatment Period (52 Weeks)|Death|2|||
37657545|NCT04210843|69129409|FG000|First Half Treatment Period (52 Weeks)|Lack of Efficacy|0|||
37657546|NCT04210843|69129410|FG001|First Half Treatment Period (52 Weeks)|Lack of Efficacy|2|||
37657547|NCT04210843|69129409|FG000|First Half Treatment Period (52 Weeks)|Pregnancy|0|||
37657548|NCT04210843|69129410|FG001|First Half Treatment Period (52 Weeks)|Pregnancy|1|||
37745896|NCT01707992|69235159|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
37745897|NCT01707992|69235154|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
37745898|NCT01707992|69235155|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
37745899|NCT01707992|69235156|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
37745900|NCT01707992|69235157|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
37745901|NCT01707992|69235158|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
37745902|NCT01707992|69235159|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
37745903|NCT01707992|69235154|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
37745904|NCT01707992|69235155|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
37745905|NCT01707992|69235156|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
37745906|NCT01707992|69235157|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
37745907|NCT01707992|69235158|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
37745908|NCT01707992|69235159|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
37745909|NCT01707992|69235154|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
37745910|NCT01707992|69235155|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
37745911|NCT01707992|69235156|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
37745912|NCT01707992|69235157|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
37745913|NCT01707992|69235158|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
37745914|NCT01707992|69235159|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
37745915|NCT01707992|69235154|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
37745916|NCT01707992|69235155|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
37745917|NCT01707992|69235156|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
37745918|NCT01707992|69235157|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
37745919|NCT01707992|69235158|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
37745920|NCT01707992|69235159|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
37745921|NCT01707992|69235154|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
37745922|NCT01707992|69235155|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
37745923|NCT01707992|69235156|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
37745924|NCT01707992|69235157|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
37745925|NCT01707992|69235158|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
37745926|NCT01707992|69235159|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
37657549|NCT04210843|69129409|FG000|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|71|||
37745927|NCT01707992|69235154|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
37745928|NCT01707992|69235155|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
37745929|NCT01707992|69235156|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
37745930|NCT01707992|69235157|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
37745931|NCT01707992|69235158|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
37745932|NCT01707992|69235159|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
37745933|NCT01707992|69235154|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
37745934|NCT01707992|69235155|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
37745935|NCT01707992|69235156|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
37745936|NCT01707992|69235157|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
37745937|NCT01707992|69235158|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
37745938|NCT01707992|69235159|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
37745939|NCT01707992|69235154|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
37745940|NCT01707992|69235155|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
37745941|NCT01707992|69235156|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
37745942|NCT01707992|69235157|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
37745943|NCT01707992|69235158|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
37745944|NCT01707992|69235159|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
37922899|NCT00871871|69609718|FG002|Part II|Protocol Violation|0|||
37922900|NCT00871871|69609719|FG003|Part II|Protocol Violation|1|||
37922901|NCT00849680|69609737|FG000|Overall Study|Adverse Event|0|||
37922902|NCT00849680|69609738|FG001|Overall Study|Adverse Event|0|||
37922903|NCT00849680|69609739|FG002|Overall Study|Adverse Event|0|||
37922904|NCT00849680|69609740|FG003|Overall Study|Adverse Event|0|||
37922905|NCT00849680|69609741|FG004|Overall Study|Adverse Event|0|||
37922906|NCT00849680|69609742|FG005|Overall Study|Adverse Event|0|||
37657550|NCT04210843|69129410|FG001|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|195|||
37657551|NCT04210843|69129409|FG000|Second Half Treatment Period (52 Weeks)|Subject decision|5|||
37657552|NCT04210843|69129410|FG001|Second Half Treatment Period (52 Weeks)|Subject decision|8|||
37657553|NCT04210843|69129409|FG000|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|0|||
37657554|NCT04210843|69129410|FG001|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|1|||
37657555|NCT04210843|69129409|FG000|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|45|||
37657556|NCT04210843|69129410|FG001|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|107|||
37657557|NCT04210843|69129409|FG000|Observation Period 2 (up to 52 Weeks)|Adverse Event|0|||
37657558|NCT04210843|69129410|FG001|Observation Period 2 (up to 52 Weeks)|Adverse Event|1|||
37657559|NCT04210843|69129409|FG000|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|0|||
37657560|NCT04210843|69129410|FG001|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|1|||
37657561|NCT04210843|69129409|FG000|Observation Period 2 (up to 52 Weeks)|Subject decision|0|||
37657562|NCT04210843|69129410|FG001|Observation Period 2 (up to 52 Weeks)|Subject decision|1|||
37657563|NCT04210843|69129409|FG000|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|16|||
37657564|NCT04210843|69129410|FG001|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|32|||
37657565|NCT04210843|69129409|FG000|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|4|||
37657566|NCT04210843|69129410|FG001|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|16|||
37657567|NCT04210843|69129409|FG000|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|1|||
37657568|NCT04210843|69129410|FG001|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|6|||
37657569|NCT04210843|69129409|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|0|||
37657570|NCT04210843|69129410|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|5|||
37657571|NCT04210843|69129409|FG000|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|2|||
37657572|NCT04210843|69129410|FG001|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|1|||
37657573|NCT04210843|69129409|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|0|||
37657574|NCT04210843|69129410|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|2|||
37657575|NCT04210843|69129409|FG000|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|0|||
37657576|NCT04210843|69129410|FG001|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|1|||
37657577|NCT04210843|69129409|FG000|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|0|||
37657578|NCT04210843|69129410|FG001|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|1|||
37855653|NCT04211389|69538971|FG000|Overall Study|Lost to Follow-up|15|||
37855654|NCT04211389|69538972|FG001|Overall Study|Lost to Follow-up|7|||
37855655|NCT04211389|69538971|FG000|Overall Study|Protocol Violation|0|||
37855656|NCT04211389|69538972|FG001|Overall Study|Protocol Violation|1|||
37855657|NCT04211389|69538971|FG000|Overall Study|Withdrawal by Subject|10|||
37855658|NCT04211389|69538972|FG001|Overall Study|Withdrawal by Subject|11|||
37855659|NCT00993031|69538980|FG000|Overall Study|Death|0|||
37922907|NCT00849680|69609743|FG006|Overall Study|Adverse Event|2|||
37922908|NCT00849680|69609744|FG007|Overall Study|Adverse Event|0|||
37922909|NCT00849680|69609737|FG000|Overall Study|Lost to Follow-up|7|||
37922910|NCT00849680|69609738|FG001|Overall Study|Lost to Follow-up|3|||
37922911|NCT00849680|69609739|FG002|Overall Study|Lost to Follow-up|12|||
37922912|NCT00849680|69609740|FG003|Overall Study|Lost to Follow-up|11|||
37922913|NCT00849680|69609741|FG004|Overall Study|Lost to Follow-up|8|||
37922914|NCT00849680|69609742|FG005|Overall Study|Lost to Follow-up|11|||
37922915|NCT00849680|69609743|FG006|Overall Study|Lost to Follow-up|12|||
37922916|NCT00849680|69609744|FG007|Overall Study|Lost to Follow-up|5|||
37922917|NCT00849680|69609737|FG000|Overall Study|Subject moved|1|||
37677532|NCT02604407|69152507|FG000|Overall Study|Withdrawal by Subject|3|||
37677533|NCT02604407|69152508|FG001|Overall Study|Withdrawal by Subject|3|||
37677534|NCT02604407|69152509|FG002|Overall Study|Withdrawal by Subject|5|||
37677535|NCT02604407|69152507|FG000|Overall Study|Lost to Follow-up|2|||
37677536|NCT02604407|69152508|FG001|Overall Study|Lost to Follow-up|1|||
37677537|NCT02604407|69152509|FG002|Overall Study|Lost to Follow-up|2|||
37855660|NCT00993031|69538981|FG001|Overall Study|Death|1|||
37855661|NCT00993031|69538980|FG000|Overall Study|Physician Decision|0|||
37855662|NCT00993031|69538981|FG001|Overall Study|Physician Decision|2|||
37855663|NCT00993031|69538980|FG000|Overall Study|Withdrawal by Subject|3|||
37855664|NCT00993031|69538981|FG001|Overall Study|Withdrawal by Subject|3|||
37855665|NCT00993031|69538980|FG000|Overall Study|Lost to Follow-up|19|||
37855666|NCT00993031|69538981|FG001|Overall Study|Lost to Follow-up|13|||
37855667|NCT01010776|69538991|FG000|Main Phase|Withdrawal by Subject|14|||
37855668|NCT01010776|69538991|FG000|Main Phase|Lack of Efficacy|8|||
37922918|NCT00849680|69609738|FG001|Overall Study|Subject moved|0|||
37922919|NCT00849680|69609739|FG002|Overall Study|Subject moved|3|||
37922920|NCT00849680|69609740|FG003|Overall Study|Subject moved|1|||
37677538|NCT02604407|69152507|FG000|Overall Study|Lack of Efficacy|1|||
37677539|NCT02604407|69152508|FG001|Overall Study|Lack of Efficacy|0|||
37677540|NCT02604407|69152509|FG002|Overall Study|Lack of Efficacy|0|||
37677541|NCT02604407|69152507|FG000|Overall Study|Other|3|||
37677542|NCT02604407|69152508|FG001|Overall Study|Other|1|||
37677543|NCT02604407|69152509|FG002|Overall Study|Other|4|||
37677544|NCT02593097|69152519|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
37677545|NCT02593097|69152520|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
37745945|NCT01707992|69235154|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
37745946|NCT01707992|69235155|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
37745947|NCT01707992|69235156|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
37745948|NCT01707992|69235157|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
37745949|NCT01707992|69235158|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
37745950|NCT01707992|69235159|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
37922921|NCT00849680|69609741|FG004|Overall Study|Subject moved|0|||
37657579|NCT02651675|69129433|FG000|Overall Study|Death|0|||
37657580|NCT02651675|69129434|FG001|Overall Study|Death|0|||
37745951|NCT01707992|69235154|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
37745952|NCT01707992|69235155|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
37745953|NCT01707992|69235156|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
37745954|NCT01707992|69235157|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
37745955|NCT01707992|69235158|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
37745956|NCT01707992|69235159|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
37745957|NCT01707992|69235154|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
37745958|NCT01707992|69235155|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
37745959|NCT01707992|69235156|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
37745960|NCT01707992|69235157|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
37745961|NCT01707992|69235158|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
37745962|NCT01707992|69235159|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
37745963|NCT01707992|69235154|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
37745964|NCT01707992|69235155|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
37745965|NCT01707992|69235156|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
37745966|NCT01707992|69235157|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
37745967|NCT01707992|69235158|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
37745968|NCT01707992|69235159|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
37745969|NCT01707992|69235154|FG000|Active Treatment Phase (24 Months)|Death|0|||
37745970|NCT01707992|69235155|FG001|Active Treatment Phase (24 Months)|Death|0|||
37745971|NCT01707992|69235156|FG002|Active Treatment Phase (24 Months)|Death|0|||
37745972|NCT01707992|69235157|FG003|Active Treatment Phase (24 Months)|Death|2|||
37745973|NCT01707992|69235158|FG004|Active Treatment Phase (24 Months)|Death|0|||
37745974|NCT01707992|69235159|FG005|Active Treatment Phase (24 Months)|Death|0|||
37745975|NCT01707992|69235154|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
37745976|NCT01707992|69235155|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
37745977|NCT01707992|69235156|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
37855669|NCT01010776|69538991|FG000|Main Phase|Adverse Event|7|||
37855670|NCT01010776|69538991|FG000|Main Phase|Lost to Follow-up|6|||
37855671|NCT01010776|69538991|FG000|Main Phase|Non-compliance to study medication|5|||
37855672|NCT01010776|69538991|FG000|Main Phase|Selection failure|2|||
37855673|NCT01010776|69538991|FG000|Main Phase|Inform consent withdrawal|1|||
37855674|NCT01010776|69538991|FG000|Main Phase|Other|1|||
37855675|NCT01010776|69538991|FG000|Main Phase|Did not received study medication|5|||
37855676|NCT01010776|69538991|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
37855677|NCT01010776|69538991|FG000|Extension Phase|Other|3|||
37855678|NCT01018810|69539011|FG000|Overall Study|Withdrawal by Subject|0|||
37855679|NCT01018810|69539012|FG001|Overall Study|Withdrawal by Subject|1|||
37855680|NCT01018810|69539013|FG002|Overall Study|Withdrawal by Subject|0|||
37855681|NCT01018810|69539014|FG003|Overall Study|Withdrawal by Subject|0|||
37922922|NCT00849680|69609742|FG005|Overall Study|Subject moved|2|||
38033007|NCT02820844|69719003|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
37657581|NCT02651675|69129435|FG002|Overall Study|Death|1|||
37657582|NCT02611960|69129445|FG000|Overall Study|Adverse Event|7|||
37657583|NCT02611960|69129446|FG001|Overall Study|Adverse Event|8|||
37657584|NCT02611960|69129445|FG000|Overall Study|Death|98|||
37657585|NCT02611960|69129446|FG001|Overall Study|Death|92|||
37657586|NCT02611960|69129445|FG000|Overall Study|Withdrawal by Subject|1|||
37657587|NCT02611960|69129446|FG001|Overall Study|Withdrawal by Subject|5|||
37657588|NCT02611960|69129445|FG000|Overall Study|Sponsor Decision|11|||
37657589|NCT02611960|69129446|FG001|Overall Study|Sponsor Decision|11|||
37657590|NCT01845597|69129453|FG000|Overall Study|Death|8|||
37657591|NCT01845597|69129453|FG000|Overall Study|Lost to Follow-up|22|||
37657592|NCT00713206|69129477|FG000|Overall Study|Lost to Follow-up|4|||
37657593|NCT00713206|69129478|FG001|Overall Study|Lost to Follow-up|4|||
37657594|NCT00713206|69129477|FG000|Overall Study|Death|1|||
37657595|NCT00713206|69129478|FG001|Overall Study|Death|0|||
37657596|NCT00495131|69129486|FG000|Overall Study|Adverse Event|6|||
37657597|NCT00495131|69129487|FG001|Overall Study|Adverse Event|2|||
37657598|NCT00495131|69129486|FG000|Overall Study|Lack of Efficacy|0|||
37657599|NCT00495131|69129487|FG001|Overall Study|Lack of Efficacy|2|||
37855682|NCT01018810|69539015|FG004|Overall Study|Withdrawal by Subject|0|||
37657600|NCT00495131|69129486|FG000|Overall Study|Lost to Follow-up|0|||
37922923|NCT00849680|69609743|FG006|Overall Study|Subject moved|2|||
37657601|NCT00495131|69129487|FG001|Overall Study|Lost to Follow-up|2|||
37922924|NCT00849680|69609744|FG007|Overall Study|Subject moved|2|||
37922925|NCT00849680|69609737|FG000|Overall Study|Withdrawal by Subject|2|||
37922926|NCT00849680|69609738|FG001|Overall Study|Withdrawal by Subject|0|||
37922927|NCT00849680|69609739|FG002|Overall Study|Withdrawal by Subject|0|||
37922928|NCT00849680|69609740|FG003|Overall Study|Withdrawal by Subject|2|||
37922929|NCT00849680|69609741|FG004|Overall Study|Withdrawal by Subject|2|||
37922930|NCT00849680|69609742|FG005|Overall Study|Withdrawal by Subject|2|||
37922931|NCT00849680|69609743|FG006|Overall Study|Withdrawal by Subject|1|||
37922932|NCT00849680|69609744|FG007|Overall Study|Withdrawal by Subject|1|||
37922933|NCT00849680|69609737|FG000|Overall Study|Subject unable to comply with protocol|1|||
37922934|NCT00849680|69609738|FG001|Overall Study|Subject unable to comply with protocol|0|||
37922935|NCT00849680|69609739|FG002|Overall Study|Subject unable to comply with protocol|0|||
37922936|NCT00849680|69609740|FG003|Overall Study|Subject unable to comply with protocol|0|||
37922937|NCT00849680|69609741|FG004|Overall Study|Subject unable to comply with protocol|0|||
37922938|NCT00849680|69609742|FG005|Overall Study|Subject unable to comply with protocol|0|||
37922939|NCT00849680|69609743|FG006|Overall Study|Subject unable to comply with protocol|0|||
37922940|NCT00849680|69609744|FG007|Overall Study|Subject unable to comply with protocol|0|||
37922941|NCT00810342|69609764|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
37922942|NCT00810342|69609765|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
37922943|NCT00810342|69609764|FG000|Month 1 Follow-up|Pregnancy|1|||
37922944|NCT00810342|69609765|FG001|Month 1 Follow-up|Pregnancy|0|||
37922945|NCT00810342|69609764|FG000|6-month Follow-up|Lost to Follow-up|18|||
37922946|NCT00810342|69609765|FG001|6-month Follow-up|Lost to Follow-up|6|||
37922947|NCT00810342|69609764|FG000|6-month Follow-up|Pregnancy|6|||
37922948|NCT00810342|69609765|FG001|6-month Follow-up|Pregnancy|2|||
37922949|NCT00810342|69609764|FG000|12-month Followup|Pregnancy|9|||
37922950|NCT00810342|69609765|FG001|12-month Followup|Pregnancy|10|||
37922951|NCT00810342|69609764|FG000|12-month Followup|Lost to Follow-up|3|||
37745978|NCT01707992|69235157|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
37745979|NCT01707992|69235158|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
37745980|NCT01707992|69235159|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
37745981|NCT01707992|69235154|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
37745982|NCT01707992|69235155|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
37745983|NCT01707992|69235156|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
37745984|NCT01707992|69235157|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
37745985|NCT01707992|69235158|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
37745986|NCT01707992|69235159|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
37745987|NCT01707992|69235154|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
37745988|NCT01707992|69235155|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
37745989|NCT01707992|69235156|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
37745990|NCT01707992|69235157|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
37745991|NCT01707992|69235158|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
37745992|NCT01707992|69235159|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
37745993|NCT01707992|69235154|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
37745994|NCT01707992|69235155|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
37745995|NCT01707992|69235156|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
37745996|NCT01707992|69235157|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
37745997|NCT01707992|69235158|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
37745998|NCT01707992|69235159|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
37745999|NCT01946165|69235176|FG000|Overall Study|Physician Decision|2|||
37855683|NCT01018810|69539011|FG000|Overall Study|Sponsor Decision|2|||
37855684|NCT01018810|69539012|FG001|Overall Study|Sponsor Decision|0|||
37855685|NCT01018810|69539013|FG002|Overall Study|Sponsor Decision|1|||
37855686|NCT01018810|69539014|FG003|Overall Study|Sponsor Decision|1|||
37855687|NCT01018810|69539015|FG004|Overall Study|Sponsor Decision|1|||
37855688|NCT01018732|69539030|FG000|Overall Study|Lost to Follow-up|0|||
37855689|NCT01018732|69539031|FG001|Overall Study|Lost to Follow-up|0|||
37855690|NCT01018732|69539032|FG002|Overall Study|Lost to Follow-up|3|||
37855691|NCT01018732|69539030|FG000|Overall Study|Protocol Violation|1|||
37855692|NCT01018732|69539031|FG001|Overall Study|Protocol Violation|1|||
37855693|NCT01018732|69539032|FG002|Overall Study|Protocol Violation|0|||
37855694|NCT01018732|69539030|FG000|Overall Study|Inappropriate Enrollment|0|||
38033008|NCT02820844|69718998|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
37746000|NCT01946165|69235177|FG001|Overall Study|Physician Decision|0|||
37855695|NCT01018732|69539031|FG001|Overall Study|Inappropriate Enrollment|1|||
37855696|NCT01018732|69539032|FG002|Overall Study|Inappropriate Enrollment|0|||
37855697|NCT01018732|69539030|FG000|Overall Study|Unable to Classify|0|||
37855698|NCT01018732|69539031|FG001|Overall Study|Unable to Classify|0|||
37922952|NCT00810342|69609765|FG001|12-month Followup|Lost to Follow-up|1|||
37922953|NCT00849524|69609773|FG000|Overall Study|Lack of Efficacy|3|||
37922954|NCT00808080|69609777|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
37922955|NCT00866723|69609782|FG000|Overall Study|Withdrawal by Subject|1|||
37922956|NCT00866723|69609782|FG000|Overall Study|Disease Progression|4|||
37855699|NCT01018732|69539032|FG002|Overall Study|Unable to Classify|1|||
37746001|NCT01946165|69235176|FG000|Overall Study|Withdrawal by Subject|0|||
37746002|NCT01946165|69235177|FG001|Overall Study|Withdrawal by Subject|2|||
37746003|NCT01707667|69235186|FG000|Period 1|expulsion of colonic sensor catheter|1|||
37746004|NCT01707667|69235187|FG001|Period 1|expulsion of colonic sensor catheter|0|||
37855700|NCT01218867|69539051|FG000|Overall Study|Death during treatment|0|||
37855701|NCT01218867|69539052|FG001|Overall Study|Death during treatment|0|||
37855702|NCT01218867|69539053|FG002|Overall Study|Death during treatment|0|||
37855703|NCT01218867|69539054|FG003|Overall Study|Death during treatment|0|||
37855704|NCT01218867|69539055|FG004|Overall Study|Death during treatment|0|||
37855705|NCT01218867|69539056|FG005|Overall Study|Death during treatment|0|||
37855706|NCT01218867|69539057|FG006|Overall Study|Death during treatment|1|||
37855707|NCT01218867|69539058|FG007|Overall Study|Death during treatment|0|||
37922963|NCT00849212|69609790|FG000|Overall Study|Lack of Efficacy|1|||
37922964|NCT00849212|69609790|FG000|Overall Study|Withdrawal by Subject|3|||
37922965|NCT00849212|69609790|FG000|Overall Study|Adverse Event|2|||
37922966|NCT00849212|69609790|FG000|Overall Study|Miscellaneous|1|||
37922967|NCT00810264|69609794|FG000|Overall Study|Lost to Follow-up|191|||
37922968|NCT00810264|69609794|FG000|Overall Study|Withdrawal by subject or physician|721|||
37746005|NCT01959503|69235195|FG000|Overall Study|Death|2|||
37746006|NCT01959503|69235196|FG001|Overall Study|Death|1|||
37746007|NCT01959503|69235195|FG000|Overall Study|Randomized but not treated|1|||
37746008|NCT01959503|69235196|FG001|Overall Study|Randomized but not treated|1|||
37746009|NCT01605799|69235204|FG000|Overall Study|Withdrawal by Subject|2|||
37746010|NCT01605799|69235205|FG001|Overall Study|Withdrawal by Subject|1|||
37746011|NCT01706575|69235211|FG000|Overall Study|Participant Withdrew Consent|4|||
37746012|NCT01706575|69235211|FG000|Overall Study|Lost to Follow-up|2|||
37746013|NCT01706575|69235211|FG000|Overall Study|Started but not Treated|6|||
37922969|NCT00810264|69609794|FG000|Overall Study|Death|641|||
37922970|NCT00849056|69609804|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
37922971|NCT00849056|69609805|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
37657602|NCT00495131|69129486|FG000|Overall Study|Withdrawal by Subject|1|||
37657603|NCT00495131|69129487|FG001|Overall Study|Withdrawal by Subject|0|||
37746014|NCT01959425|69235217|FG000|Overall Study|Withdrawal by Subject|5|||
37746015|NCT01959425|69235218|FG001|Overall Study|Withdrawal by Subject|4|||
37746016|NCT01959425|69235217|FG000|Overall Study|Lost to Follow-up|1|||
37746017|NCT01959425|69235218|FG001|Overall Study|Lost to Follow-up|0|||
37746018|NCT01959425|69235217|FG000|Overall Study|Discontinued Subjects|6|||
37746019|NCT01959425|69235218|FG001|Overall Study|Discontinued Subjects|4|||
37746020|NCT01725529|69235227|FG000|Overall Study|Adverse Event|1|||
37746021|NCT01725529|69235228|FG001|Overall Study|Adverse Event|0|||
37746022|NCT01725529|69235229|FG002|Overall Study|Adverse Event|0|||
37746023|NCT01725529|69235227|FG000|Overall Study|Lost to Follow-up|2|||
37746024|NCT01725529|69235228|FG001|Overall Study|Lost to Follow-up|1|||
37746025|NCT01725529|69235229|FG002|Overall Study|Lost to Follow-up|1|||
37746026|NCT01725529|69235227|FG000|Overall Study|Protocol Violation|0|||
37746027|NCT01725529|69235228|FG001|Overall Study|Protocol Violation|1|||
37746028|NCT01725529|69235229|FG002|Overall Study|Protocol Violation|1|||
37746029|NCT01725529|69235227|FG000|Overall Study|Withdrawal by Subject|12|||
37746030|NCT01725529|69235228|FG001|Overall Study|Withdrawal by Subject|14|||
37746031|NCT01725529|69235229|FG002|Overall Study|Withdrawal by Subject|8|||
37746032|NCT01605097|69235237|FG000|Overall Study|Protocol Violation|1|||
37657604|NCT02257372|69129493|FG000|Overall Study|Adverse Event|3|||
37657605|NCT02257372|69129494|FG001|Overall Study|Adverse Event|7|||
37657606|NCT02257372|69129493|FG000|Overall Study|Lack of Efficacy|2|||
37657607|NCT02257372|69129494|FG001|Overall Study|Lack of Efficacy|1|||
37657608|NCT02257372|69129493|FG000|Overall Study|Protocol Violation|1|||
37657609|NCT02257372|69129494|FG001|Overall Study|Protocol Violation|1|||
37657610|NCT02257372|69129493|FG000|Overall Study|Lost to Follow-up|0|||
37746033|NCT01605019|69235244|FG000|Overall Study|pt did not meet transplant endpoint|3|||
37855708|NCT01218867|69539059|FG008|Overall Study|Death during treatment|0|||
37855709|NCT01218867|69539060|FG009|Overall Study|Death during treatment|0|||
37855710|NCT01218867|69539061|FG010|Overall Study|Death during treatment|0|||
37922972|NCT00849056|69609804|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
37922973|NCT00849056|69609805|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
37922974|NCT00849056|69609804|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
37922975|NCT00849056|69609805|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
37922976|NCT00849056|69609804|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
37922977|NCT00849056|69609805|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
37922978|NCT00849056|69609804|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
37922979|NCT00849056|69609805|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
37922980|NCT00849056|69609804|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
37922981|NCT00849056|69609805|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
37922982|NCT00849056|69609804|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
37922983|NCT00849056|69609805|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
37922984|NCT00849056|69609804|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
37922985|NCT00849056|69609805|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
37922986|NCT00849056|69609804|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
37922987|NCT00849056|69609805|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
37922988|NCT00849056|69609804|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
37922989|NCT00849056|69609805|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
37922990|NCT00849056|69609804|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
37922991|NCT00849056|69609805|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
37922992|NCT00849056|69609804|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
37922993|NCT00849056|69609805|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
37922994|NCT00849056|69609804|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
37922995|NCT00849056|69609805|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
37922996|NCT00849056|69609804|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
37922997|NCT00849056|69609805|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
37746034|NCT01605019|69235245|FG001|Overall Study|pt did not meet transplant endpoint|0|||
37746035|NCT01705717|69235253|FG000|Overall Study|Adverse Event|2|||
37746036|NCT01705717|69235254|FG001|Overall Study|Adverse Event|2|||
37746037|NCT01705717|69235253|FG000|Overall Study|Lack of Efficacy|0|||
37746038|NCT01705717|69235254|FG001|Overall Study|Lack of Efficacy|1|||
37746039|NCT01705717|69235253|FG000|Overall Study|Other|0|||
37746040|NCT01705717|69235254|FG001|Overall Study|Other|2|||
37746041|NCT01744483|69235262|FG000|Overall Study|Death|9|||
37746042|NCT01744483|69235263|FG001|Overall Study|Death|4|||
37746043|NCT01744483|69235264|FG002|Overall Study|Death|11|||
37746044|NCT01744483|69235262|FG000|Overall Study|Lost to Follow-up|8|||
37746045|NCT01744483|69235263|FG001|Overall Study|Lost to Follow-up|9|||
37746046|NCT01744483|69235264|FG002|Overall Study|Lost to Follow-up|11|||
37746047|NCT01744483|69235262|FG000|Overall Study|Protocol Violation|1|||
37746048|NCT01744483|69235263|FG001|Overall Study|Protocol Violation|2|||
37746049|NCT01744483|69235264|FG002|Overall Study|Protocol Violation|1|||
37746050|NCT01744483|69235262|FG000|Overall Study|Withdrawal by Subject|4|||
37746051|NCT01744483|69235263|FG001|Overall Study|Withdrawal by Subject|6|||
37746052|NCT01744483|69235264|FG002|Overall Study|Withdrawal by Subject|2|||
37746053|NCT01744483|69235262|FG000|Overall Study|No ICU Admit|5|||
37746054|NCT01744483|69235263|FG001|Overall Study|No ICU Admit|1|||
37746055|NCT01744483|69235264|FG002|Overall Study|No ICU Admit|2|||
37746056|NCT01744483|69235262|FG000|Overall Study|Routed to OSH|2|||
37746057|NCT01744483|69235263|FG001|Overall Study|Routed to OSH|0|||
37746058|NCT01744483|69235264|FG002|Overall Study|Routed to OSH|1|||
37746059|NCT01744093|69235274|FG000|Overall Study|Withdrawal by Subject|6|||
37746060|NCT01744093|69235275|FG001|Overall Study|Withdrawal by Subject|1|||
37746061|NCT01725451|69235289|FG000|Period 1|Withdrawal by Subject|1|||
37746062|NCT01725451|69235290|FG001|Period 1|Withdrawal by Subject|0|||
37746063|NCT01725451|69235291|FG002|Period 1|Withdrawal by Subject|0|||
37746064|NCT01725451|69235292|FG003|Period 1|Withdrawal by Subject|0|||
37746065|NCT01725451|69235289|FG000|Washout From Period 3|Protocol Violation|0|||
37746066|NCT01725451|69235290|FG001|Washout From Period 3|Protocol Violation|0|||
37746067|NCT01725451|69235291|FG002|Washout From Period 3|Protocol Violation|1|||
37746068|NCT01725451|69235292|FG003|Washout From Period 3|Protocol Violation|0|||
37746069|NCT01725451|69235289|FG000|Washout From Period 3|Adverse Event|0|||
37746070|NCT01725451|69235290|FG001|Washout From Period 3|Adverse Event|1|||
37746071|NCT01725451|69235291|FG002|Washout From Period 3|Adverse Event|0|||
37746072|NCT01725451|69235292|FG003|Washout From Period 3|Adverse Event|0|||
37746073|NCT01725451|69235289|FG000|Period 4|Adverse Event|0|||
37746074|NCT01725451|69235290|FG001|Period 4|Adverse Event|0|||
37746075|NCT01725451|69235291|FG002|Period 4|Adverse Event|1|||
37746076|NCT01725451|69235292|FG003|Period 4|Adverse Event|0|||
37746077|NCT01707290|69235309|FG000|Overall Study|Adverse event (AE)|1|||
37746078|NCT01707290|69235310|FG001|Overall Study|Adverse event (AE)|0|||
37746079|NCT01707290|69235309|FG000|Overall Study|Physician Decision|1|||
37746080|NCT01707290|69235310|FG001|Overall Study|Physician Decision|0|||
37746081|NCT01707290|69235309|FG000|Overall Study|Lost to Follow-up|3|||
37746082|NCT01707290|69235310|FG001|Overall Study|Lost to Follow-up|0|||
37746083|NCT01707290|69235309|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
37746084|NCT01707290|69235310|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
37746085|NCT01707290|69235309|FG000|Overall Study|Commercial drug available|60|||
37746086|NCT01707290|69235310|FG001|Overall Study|Commercial drug available|1|||
37746087|NCT01707290|69235309|FG000|Overall Study|Other unspecified|17|||
37746088|NCT01707290|69235310|FG001|Overall Study|Other unspecified|0|||
37746089|NCT01717040|69235321|FG000|Overall Study|Lost to Follow-up|2|||
37746090|NCT01717040|69235322|FG001|Overall Study|Lost to Follow-up|3|||
37746091|NCT01717040|69235321|FG000|Overall Study|Lack of Efficacy|1|||
37746092|NCT01717040|69235322|FG001|Overall Study|Lack of Efficacy|1|||
37746093|NCT01717040|69235321|FG000|Overall Study|Adverse Event|1|||
37746094|NCT01717040|69235322|FG001|Overall Study|Adverse Event|0|||
37746095|NCT01717040|69235321|FG000|Overall Study|Required Medication Change|0|||
37746096|NCT01717040|69235322|FG001|Overall Study|Required Medication Change|1|||
37746097|NCT01717040|69235321|FG000|Overall Study|New Substance Use Disorder|1|||
37746098|NCT01717040|69235322|FG001|Overall Study|New Substance Use Disorder|0|||
37746099|NCT01743469|69235349|FG000|Active Treatment Phase|Adverse Event|10|||
37746100|NCT01743469|69235350|FG001|Active Treatment Phase|Adverse Event|5|||
37746101|NCT01743469|69235351|FG002|Active Treatment Phase|Adverse Event|8|||
37746102|NCT01743469|69235352|FG003|Active Treatment Phase|Adverse Event|1|||
37746103|NCT01743469|69235349|FG000|Active Treatment Phase|Disease Progression|40|||
37746104|NCT01743469|69235350|FG001|Active Treatment Phase|Disease Progression|47|||
37746105|NCT01743469|69235351|FG002|Active Treatment Phase|Disease Progression|30|||
37746106|NCT01743469|69235352|FG003|Active Treatment Phase|Disease Progression|20|||
37746107|NCT01743469|69235349|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
37746108|NCT01743469|69235350|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
37746109|NCT01743469|69235351|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
37746110|NCT01743469|69235352|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
37746111|NCT01743469|69235349|FG000|Active Treatment Phase|Missing|1|||
37746112|NCT01743469|69235350|FG001|Active Treatment Phase|Missing|0|||
37746113|NCT01743469|69235351|FG002|Active Treatment Phase|Missing|0|||
37855711|NCT01018264|69539098|FG000|Overall Study|Withdrawal by Subject|1|||
37855712|NCT01018264|69539099|FG001|Overall Study|Withdrawal by Subject|0|||
37855713|NCT01018264|69539098|FG000|Overall Study|Lost to Follow-up|0|||
37855714|NCT01018264|69539099|FG001|Overall Study|Lost to Follow-up|1|||
37855715|NCT01018186|69539108|FG000|2-week Run-in Period|Protocol Violation|1|||
37855716|NCT01018186|69539109|FG001|2-week Run-in Period|Protocol Violation|0|||
37855717|NCT01018186|69539110|FG002|2-week Run-in Period|Protocol Violation|0|||
37855718|NCT01018186|69539111|FG003|2-week Run-in Period|Protocol Violation|0|||
37855719|NCT01018186|69539108|FG000|2-week Run-in Period|Lost to Follow-up|2|||
37855720|NCT01018186|69539109|FG001|2-week Run-in Period|Lost to Follow-up|0|||
37855721|NCT01018186|69539110|FG002|2-week Run-in Period|Lost to Follow-up|0|||
37855722|NCT01018186|69539111|FG003|2-week Run-in Period|Lost to Follow-up|0|||
37855723|NCT01018186|69539108|FG000|2-week Run-in Period|Physician Decision|3|||
37657611|NCT02257372|69129494|FG001|Overall Study|Lost to Follow-up|1|||
37657612|NCT02257372|69129493|FG000|Overall Study|Withdrew consent|1|||
37657613|NCT02257372|69129494|FG001|Overall Study|Withdrew consent|0|||
37657614|NCT02256982|69129502|FG000|Overall Study|Disease Progression|0|||
37657615|NCT02256982|69129503|FG001|Overall Study|Disease Progression|1|||
37657616|NCT02736721|69129509|FG000|Overall Study|Adverse Event|8|||
37657617|NCT02736721|69129509|FG000|Overall Study|Lost to Follow-up|3|||
37657618|NCT02736721|69129509|FG000|Overall Study|Other|5|||
37657619|NCT04176445|69129513|FG000|Overall Study|Adverse Event|0|||
37657620|NCT04176445|69129514|FG001|Overall Study|Adverse Event|1|||
37657621|NCT04176445|69129513|FG000|Overall Study|change plans weaning after first intervention|0|||
37657622|NCT04176445|69129514|FG001|Overall Study|change plans weaning after first intervention|1|||
37657623|NCT02738203|69129522|FG000|Overall Study|Failed IUD Insertion|2|||
37657624|NCT02738203|69129523|FG001|Overall Study|Failed IUD Insertion|2|||
37657625|NCT02738203|69129522|FG000|Overall Study|Protocol Violation|0|||
37657626|NCT02738203|69129523|FG001|Overall Study|Protocol Violation|1|||
37657627|NCT02452034|69129535|FG000|Overall Study|Adverse Event|0|||
37657628|NCT02452034|69129536|FG001|Overall Study|Adverse Event|0|||
37657629|NCT02452034|69129537|FG002|Overall Study|Adverse Event|0|||
37657630|NCT02452034|69129538|FG003|Overall Study|Adverse Event|0|||
37657631|NCT02452034|69129539|FG004|Overall Study|Adverse Event|0|||
37657632|NCT02452034|69129540|FG005|Overall Study|Adverse Event|1|||
37657633|NCT02452034|69129535|FG000|Overall Study|Death|0|||
37657634|NCT02452034|69129536|FG001|Overall Study|Death|0|||
37657635|NCT02452034|69129537|FG002|Overall Study|Death|0|||
37657636|NCT02452034|69129538|FG003|Overall Study|Death|0|||
37657637|NCT02452034|69129539|FG004|Overall Study|Death|1|||
37657638|NCT02452034|69129540|FG005|Overall Study|Death|1|||
37657639|NCT02452034|69129535|FG000|Overall Study|Physician Decision|0|||
37657640|NCT02452034|69129536|FG001|Overall Study|Physician Decision|1|||
37657641|NCT02452034|69129537|FG002|Overall Study|Physician Decision|1|||
37855724|NCT01018186|69539109|FG001|2-week Run-in Period|Physician Decision|0|||
37855725|NCT01018186|69539110|FG002|2-week Run-in Period|Physician Decision|0|||
37657642|NCT02452034|69129538|FG003|Overall Study|Physician Decision|0|||
37657643|NCT02452034|69129539|FG004|Overall Study|Physician Decision|0|||
37657644|NCT02452034|69129540|FG005|Overall Study|Physician Decision|0|||
37746114|NCT01743469|69235352|FG003|Active Treatment Phase|Missing|0|||
37746115|NCT01743469|69235349|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
37855726|NCT01018186|69539111|FG003|2-week Run-in Period|Physician Decision|0|||
37657645|NCT02452034|69129535|FG000|Overall Study|Protocol Violation|0|||
37746116|NCT01743469|69235350|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
37746117|NCT01743469|69235351|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
37746118|NCT01743469|69235352|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
37746119|NCT01743469|69235349|FG000|Follow-up Period - Post-Treatment|Death|43|||
37922998|NCT00849056|69609804|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
37922999|NCT00849056|69609805|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
37923000|NCT00849056|69609804|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
37923001|NCT00849056|69609805|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
37923002|NCT00837434|69609813|FG000|Overall Study|Physician Decision|3|||
37923003|NCT00837434|69609814|FG001|Overall Study|Physician Decision|0|||
37923004|NCT00837434|69609813|FG000|Overall Study|Lost to Follow-up|1|||
37923005|NCT00837434|69609814|FG001|Overall Study|Lost to Follow-up|1|||
37657646|NCT02452034|69129536|FG001|Overall Study|Protocol Violation|0|||
37746120|NCT01743469|69235350|FG001|Follow-up Period - Post-Treatment|Death|47|||
37746121|NCT01743469|69235351|FG002|Follow-up Period - Post-Treatment|Death|22|||
37746122|NCT01743469|69235352|FG003|Follow-up Period - Post-Treatment|Death|16|||
37746123|NCT01743469|69235349|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
37746124|NCT01743469|69235350|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
37746125|NCT01743469|69235351|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
37746126|NCT01743469|69235352|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
37746127|NCT01743001|69235364|FG000|Overall Study|Physician Decision|1|||
37746128|NCT01743001|69235365|FG001|Overall Study|Physician Decision|0|||
37746129|NCT01743001|69235364|FG000|Overall Study|Pregnancy|1|||
37746130|NCT01743001|69235365|FG001|Overall Study|Pregnancy|0|||
37746131|NCT01743001|69235364|FG000|Overall Study|Death|1|||
37746132|NCT01743001|69235365|FG001|Overall Study|Death|0|||
37746133|NCT01704079|69235384|FG000|Overall Study|Withdrawal by Subject|5|||
37746134|NCT01704079|69235385|FG001|Overall Study|Withdrawal by Subject|7|||
37746135|NCT01704079|69235384|FG000|Overall Study|Lost to Follow-up|2|||
37746136|NCT01704079|69235385|FG001|Overall Study|Lost to Follow-up|5|||
37746137|NCT01704079|69235384|FG000|Overall Study|Adverse Event|4|||
37746138|NCT01704079|69235385|FG001|Overall Study|Adverse Event|7|||
37746139|NCT01704079|69235384|FG000|Overall Study|Protocol Violation|1|||
37746140|NCT01704079|69235385|FG001|Overall Study|Protocol Violation|0|||
37746141|NCT01704079|69235384|FG000|Overall Study|Subject noncompliance|2|||
37746142|NCT01704079|69235385|FG001|Overall Study|Subject noncompliance|3|||
37746143|NCT01704079|69235384|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
37746144|NCT01704079|69235385|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
37746145|NCT01703845|69235393|FG000|Overall Study|Adverse Event|1|||
37855727|NCT01018186|69539108|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
37855728|NCT01018186|69539109|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
37855729|NCT01018186|69539110|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
37855730|NCT01018186|69539111|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
37855731|NCT01018186|69539108|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
37855732|NCT01018186|69539109|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
37855733|NCT01018186|69539110|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
37855734|NCT01018186|69539111|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
37657647|NCT02452034|69129537|FG002|Overall Study|Protocol Violation|0|||
37657648|NCT02452034|69129538|FG003|Overall Study|Protocol Violation|0|||
37657649|NCT02452034|69129539|FG004|Overall Study|Protocol Violation|0|||
37657650|NCT02452034|69129540|FG005|Overall Study|Protocol Violation|1|||
37657651|NCT02452034|69129535|FG000|Overall Study|Screen Failure|1|||
37657652|NCT02452034|69129536|FG001|Overall Study|Screen Failure|0|||
37657653|NCT02452034|69129537|FG002|Overall Study|Screen Failure|0|||
37657654|NCT02452034|69129538|FG003|Overall Study|Screen Failure|1|||
37657655|NCT02452034|69129539|FG004|Overall Study|Screen Failure|0|||
37657656|NCT02452034|69129540|FG005|Overall Study|Screen Failure|0|||
37657657|NCT02452034|69129535|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
37657658|NCT02452034|69129536|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
37657659|NCT02452034|69129537|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
37657660|NCT02452034|69129538|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
37657661|NCT02452034|69129539|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
37657662|NCT02452034|69129540|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
37657663|NCT02482298|69129567|FG000|Overall Study|Withdrawal by Subject|2|||
37657664|NCT02482298|69129568|FG001|Overall Study|Withdrawal by Subject|1|||
37657665|NCT02482298|69129569|FG002|Overall Study|Withdrawal by Subject|2|||
37657666|NCT02482298|69129567|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
37746146|NCT01703845|69235394|FG001|Overall Study|Adverse Event|0|||
37746147|NCT01703845|69235393|FG000|Overall Study|Protocol Violation|1|||
37746148|NCT01703845|69235394|FG001|Overall Study|Protocol Violation|0|||
37855735|NCT01018186|69539108|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
37923006|NCT00837434|69609813|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
37923007|NCT00837434|69609814|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
37746149|NCT01703845|69235393|FG000|Overall Study|other than stated above|1|||
37657667|NCT02482298|69129568|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
37657668|NCT02482298|69129569|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
37855736|NCT01018186|69539109|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
37855737|NCT01018186|69539110|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
37855738|NCT01018186|69539111|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
37855739|NCT01018186|69539108|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
37657669|NCT02482298|69129567|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
37657670|NCT02482298|69129568|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
37657671|NCT02482298|69129569|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
37657672|NCT02482298|69129567|FG000|Overall Study|Lost to Follow-up|0|||
37657673|NCT02482298|69129568|FG001|Overall Study|Lost to Follow-up|1|||
37657674|NCT02482298|69129569|FG002|Overall Study|Lost to Follow-up|0|||
37657675|NCT00440531|69129580|FG000|Overall Study|Adverse Event|1|||
37657676|NCT00440531|69129581|FG001|Overall Study|Adverse Event|0|||
37657677|NCT00440531|69129582|FG002|Overall Study|Adverse Event|2|||
37657678|NCT00440531|69129580|FG000|Overall Study|Withdrawal by Subject|2|||
37657679|NCT00440531|69129581|FG001|Overall Study|Withdrawal by Subject|0|||
37657680|NCT00440531|69129582|FG002|Overall Study|Withdrawal by Subject|0|||
37657681|NCT00440531|69129580|FG000|Overall Study|Protocol Violation|1|||
37657682|NCT00440531|69129581|FG001|Overall Study|Protocol Violation|2|||
37657683|NCT00440531|69129582|FG002|Overall Study|Protocol Violation|0|||
37657684|NCT00440531|69129580|FG000|Overall Study|Lost to Follow-up|4|||
37657685|NCT00440531|69129581|FG001|Overall Study|Lost to Follow-up|3|||
37657686|NCT00440531|69129582|FG002|Overall Study|Lost to Follow-up|5|||
37657687|NCT00440531|69129580|FG000|Overall Study|see pre-assignment details|2|||
37855740|NCT01018186|69539109|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
37855741|NCT01018186|69539110|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
37855742|NCT01018186|69539111|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
37855743|NCT01018186|69539108|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
37855744|NCT01018186|69539109|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
37855745|NCT01018186|69539110|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
37657688|NCT00440531|69129581|FG001|Overall Study|see pre-assignment details|0|||
37657689|NCT00440531|69129582|FG002|Overall Study|see pre-assignment details|0|||
37657690|NCT02513732|69129588|FG000|Overall Study|Lost to Follow-up|11|||
37657691|NCT02513732|69129588|FG000|Overall Study|Death|9|||
37657692|NCT02513732|69129588|FG000|Overall Study|Changing hospital|2|||
37657693|NCT00429923|69129595|FG000|Overall Study|Adverse Event|0|||
37657694|NCT00429923|69129596|FG001|Overall Study|Adverse Event|2|||
37657695|NCT00429923|69129597|FG002|Overall Study|Adverse Event|3|||
37657696|NCT00429923|69129595|FG000|Overall Study|Lack of Efficacy|4|||
37657697|NCT00429923|69129596|FG001|Overall Study|Lack of Efficacy|1|||
37657698|NCT00429923|69129597|FG002|Overall Study|Lack of Efficacy|33|||
37657699|NCT00429923|69129595|FG000|Overall Study|Lost to Follow-up|0|||
37657700|NCT00429923|69129596|FG001|Overall Study|Lost to Follow-up|0|||
37657701|NCT00429923|69129597|FG002|Overall Study|Lost to Follow-up|2|||
37657702|NCT00429923|69129595|FG000|Overall Study|Withdrew Consent|1|||
37657703|NCT00429923|69129596|FG001|Overall Study|Withdrew Consent|0|||
37657704|NCT00429923|69129597|FG002|Overall Study|Withdrew Consent|1|||
37657705|NCT00429923|69129595|FG000|Overall Study|Early Termination|0|||
37657706|NCT00429923|69129596|FG001|Overall Study|Early Termination|1|||
37657707|NCT00429923|69129597|FG002|Overall Study|Early Termination|0|||
37657708|NCT02256436|69129604|FG000|Overall Study|Adverse Event|9|||
37746150|NCT01703845|69235394|FG001|Overall Study|other than stated above|0|||
37746151|NCT01724359|69235402|FG000|Overall Study|Adverse Event|10|||
37746152|NCT01724359|69235402|FG000|Overall Study|Death|1|||
37746153|NCT01724359|69235402|FG000|Overall Study|Other|20|||
37746154|NCT01703221|69235411|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
37746155|NCT01703221|69235412|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
37746156|NCT01703221|69235413|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
37855746|NCT01018186|69539111|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
37855747|NCT01018186|69539108|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
37855748|NCT01018186|69539109|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
37923008|NCT00837434|69609813|FG000|Overall Study|Noncompliant|2|||
37657709|NCT02256436|69129605|FG001|Overall Study|Adverse Event|14|||
37657710|NCT02256436|69129604|FG000|Overall Study|Death|216|||
37657711|NCT02256436|69129605|FG001|Overall Study|Death|208|||
37657712|NCT02256436|69129604|FG000|Overall Study|Lost to Follow-up|1|||
37657713|NCT02256436|69129605|FG001|Overall Study|Lost to Follow-up|2|||
37746157|NCT01703221|69235411|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
37746158|NCT01703221|69235412|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
37923009|NCT00837434|69609814|FG001|Overall Study|Noncompliant|0|||
37657714|NCT02256436|69129604|FG000|Overall Study|Physician Decision|1|||
37657715|NCT02256436|69129605|FG001|Overall Study|Physician Decision|0|||
37657716|NCT02256436|69129604|FG000|Overall Study|Protocol Violation|0|||
37657717|NCT02256436|69129605|FG001|Overall Study|Protocol Violation|1|||
37657718|NCT02256436|69129604|FG000|Overall Study|Withdrawal by Subject|26|||
37657719|NCT02256436|69129605|FG001|Overall Study|Withdrawal by Subject|10|||
37657720|NCT02256436|69129604|FG000|Overall Study|Transferred to Extension Study|11|||
37657721|NCT02256436|69129605|FG001|Overall Study|Transferred to Extension Study|23|||
37657722|NCT02256436|69129604|FG000|Overall Study|Did Not Continue on Extension Study|8|||
37657723|NCT02256436|69129605|FG001|Overall Study|Did Not Continue on Extension Study|12|||
37657724|NCT00326183|69129614|FG000|Overall Study|Lost to Follow-up|104|||
37657725|NCT00326183|69129615|FG001|Overall Study|Lost to Follow-up|56|||
37657726|NCT00326183|69129614|FG000|Overall Study|Protocol Violation|6|||
37657727|NCT00326183|69129615|FG001|Overall Study|Protocol Violation|3|||
37657728|NCT00326183|69129614|FG000|Overall Study|Withdrawal by Subject|35|||
37657729|NCT00326183|69129615|FG001|Overall Study|Withdrawal by Subject|7|||
37657730|NCT00326183|69129614|FG000|Overall Study|Subject Moved|7|||
37657731|NCT00326183|69129615|FG001|Overall Study|Subject Moved|4|||
37657732|NCT00326183|69129614|FG000|Overall Study|Other|47|||
37657733|NCT00326183|69129615|FG001|Overall Study|Other|13|||
37657734|NCT00326183|69129614|FG000|Overall Study|Adverse Event|1|||
37657735|NCT00326183|69129615|FG001|Overall Study|Adverse Event|0|||
37657736|NCT02481050|69129619|FG000|Overall Study|Adverse Event|1|||
37657737|NCT02481050|69129619|FG000|Overall Study|Disease Progression|47|||
37657738|NCT02481050|69129619|FG000|Overall Study|Withdrawal by Subject|7|||
37657739|NCT02481050|69129619|FG000|Overall Study|Other|3|||
37657740|NCT02511782|69129626|FG000|Overall Study|Withdrawal by Subject|1|||
37657741|NCT02511782|69129627|FG001|Overall Study|Withdrawal by Subject|0|||
37657742|NCT02511782|69129628|FG002|Overall Study|Withdrawal by Subject|0|||
37657743|NCT02480114|69129638|FG000|Overall Study|Not completing surveys|3|||
37657744|NCT02480114|69129639|FG001|Overall Study|Not completing surveys|2|||
37657745|NCT02480114|69129638|FG000|Overall Study|Withdrawal by Subject|2|||
37657746|NCT02480114|69129639|FG001|Overall Study|Withdrawal by Subject|4|||
37657747|NCT02480114|69129638|FG000|Overall Study|Disease progression|3|||
37657748|NCT02480114|69129639|FG001|Overall Study|Disease progression|0|||
37657749|NCT02480114|69129638|FG000|Overall Study|Improper completion of survey|1|||
37657750|NCT02480114|69129639|FG001|Overall Study|Improper completion of survey|1|||
37657751|NCT02480114|69129638|FG000|Overall Study|Not eligible|0|||
37657752|NCT02480114|69129639|FG001|Overall Study|Not eligible|1|||
37657753|NCT02479880|69129647|FG000|Overall Study|Study Terminated by Sponsor|13|||
37657754|NCT02479880|69129648|FG001|Overall Study|Study Terminated by Sponsor|12|||
37657755|NCT02479880|69129647|FG000|Overall Study|Pregnancy|0|||
37657756|NCT02479880|69129648|FG001|Overall Study|Pregnancy|1|||
37657757|NCT02479802|69129654|FG000|Overall Study|Lost to Follow-up|1|||
37657758|NCT02479802|69129654|FG000|Overall Study|Adverse Event|1|||
37657759|NCT02479412|69129667|FG000|Overall Study|Adverse Event|0|||
37657760|NCT02479412|69129668|FG001|Overall Study|Adverse Event|0|||
37657761|NCT02479412|69129669|FG002|Overall Study|Adverse Event|1|||
37657762|NCT02479412|69129670|FG003|Overall Study|Adverse Event|0|||
37657763|NCT02479412|69129671|FG004|Overall Study|Adverse Event|0|||
37657764|NCT02479412|69129672|FG005|Overall Study|Adverse Event|0|||
37657765|NCT02479412|69129673|FG006|Overall Study|Adverse Event|0|||
37657766|NCT02479412|69129674|FG007|Overall Study|Adverse Event|0|||
37657767|NCT02479412|69129675|FG008|Overall Study|Adverse Event|0|||
37746159|NCT01703221|69235413|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
37746160|NCT01703221|69235411|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
37746161|NCT01703221|69235412|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
37746162|NCT01703221|69235413|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
37746163|NCT01703221|69235411|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
37746164|NCT01703221|69235412|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
37746165|NCT01703221|69235413|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
37746166|NCT01703221|69235411|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
37746167|NCT01703221|69235412|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
37746168|NCT01703221|69235413|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
37746169|NCT01703221|69235411|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
37746170|NCT01703221|69235412|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
37746171|NCT01703221|69235413|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
37746172|NCT01703221|69235411|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
37746173|NCT01703221|69235412|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
37746174|NCT01703221|69235413|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
37657768|NCT02479412|69129667|FG000|Overall Study|Study-specific withdrawal criteria|0|||
37657769|NCT02479412|69129668|FG001|Overall Study|Study-specific withdrawal criteria|0|||
37657770|NCT02479412|69129669|FG002|Overall Study|Study-specific withdrawal criteria|1|||
37657771|NCT02479412|69129670|FG003|Overall Study|Study-specific withdrawal criteria|1|||
37657772|NCT02479412|69129671|FG004|Overall Study|Study-specific withdrawal criteria|0|||
37657773|NCT02479412|69129672|FG005|Overall Study|Study-specific withdrawal criteria|0|||
37657774|NCT02479412|69129673|FG006|Overall Study|Study-specific withdrawal criteria|0|||
37657775|NCT02479412|69129674|FG007|Overall Study|Study-specific withdrawal criteria|1|||
37657776|NCT02479412|69129675|FG008|Overall Study|Study-specific withdrawal criteria|1|||
37746175|NCT01703221|69235411|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
37657777|NCT02479412|69129667|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
37657778|NCT02479412|69129668|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
37657779|NCT02479412|69129669|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
37657780|NCT02479412|69129670|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
37657781|NCT02479412|69129671|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
37657782|NCT02479412|69129672|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
37657783|NCT02479412|69129673|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
37657784|NCT02479412|69129674|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
37657785|NCT02479412|69129675|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
37657786|NCT00224003|69129691|FG000|Overall Study|Adverse Event|1|||
37657787|NCT00224003|69129691|FG000|Overall Study|Protocol Violation|2|||
37657788|NCT00224003|69129691|FG000|Overall Study|Withdrawal by Subject|1|||
37657789|NCT00224003|69129691|FG000|Overall Study|unk|3|||
37657790|NCT02450552|69129697|FG000|Overall Study|Withdrawal by Subject|4|||
37657791|NCT02450552|69129698|FG001|Overall Study|Withdrawal by Subject|0|||
37657792|NCT02450552|69129699|FG002|Overall Study|Withdrawal by Subject|4|||
37657793|NCT02450552|69129697|FG000|Overall Study|Physician Decision|1|||
37657794|NCT02450552|69129698|FG001|Overall Study|Physician Decision|0|||
37657795|NCT02450552|69129699|FG002|Overall Study|Physician Decision|1|||
37657796|NCT02508428|69129709|FG000|Overall Study|Death|32|||
37657797|NCT02508428|69129710|FG001|Overall Study|Death|33|||
37657798|NCT02508428|69129709|FG000|Overall Study|Liner revised|3|||
37657799|NCT02508428|69129710|FG001|Overall Study|Liner revised|19|||
37657800|NCT02508428|69129709|FG000|Overall Study|Incomplete follow-up|17|||
37657801|NCT02508428|69129710|FG001|Overall Study|Incomplete follow-up|15|||
37657802|NCT02448680|69129718|FG000|Overall Study|Physician Decision|1|||
37657803|NCT02448680|69129719|FG001|Overall Study|Physician Decision|1|||
37746176|NCT01703221|69235412|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
37746177|NCT01703221|69235413|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
37746178|NCT01722877|69235427|FG000|Overall Study|Death|1|||
37746179|NCT01722877|69235427|FG000|Overall Study|Lost to Follow-up|1|||
37746180|NCT01703065|69235472|FG000|Overall Study|Lack of Efficacy|1|||
37746181|NCT01703065|69235473|FG001|Overall Study|Lack of Efficacy|0|||
37746182|NCT01702987|69235486|FG000|Overall Study|Withdrawal by Subject|1|||
37746183|NCT01702987|69235487|FG001|Overall Study|Withdrawal by Subject|0|||
37746184|NCT01702519|69235508|FG000|Washout Period|Lost to Follow-up|1|||
37746185|NCT01702519|69235509|FG001|Washout Period|Lost to Follow-up|0|||
37746186|NCT01702519|69235508|FG000|Washout Period|Withdrawal by Subject|0|||
37746187|NCT01702519|69235509|FG001|Washout Period|Withdrawal by Subject|2|||
37746188|NCT01739803|69235521|FG000|Overall Study|Lost to Follow-up|9|||
37746189|NCT01739803|69235522|FG001|Overall Study|Lost to Follow-up|6|||
37746190|NCT01739335|69235534|FG000|Overall Study|Lost to Follow-up|7|||
37746191|NCT01739335|69235535|FG001|Overall Study|Lost to Follow-up|4|||
37746192|NCT01739335|69235534|FG000|Overall Study|Ineligible patient randomized|0|||
37746193|NCT01739335|69235535|FG001|Overall Study|Ineligible patient randomized|1|||
37746194|NCT01702363|69235560|FG000|Overall Study|Adverse Event|14|||
37746195|NCT01702363|69235560|FG000|Overall Study|Lack of Efficacy|4|||
37746196|NCT01702363|69235560|FG000|Overall Study|Withdrawal by Subject|2|||
37746197|NCT01722097|69235567|FG000|Overall Study|Patient sheets not returned|6|||
37746198|NCT01722097|69235568|FG001|Overall Study|Patient sheets not returned|5|||
37746199|NCT01701973|69235583|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
37746200|NCT01701973|69235584|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
37746201|NCT01701973|69235585|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
37746202|NCT01701973|69235586|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
37657804|NCT02448680|69129718|FG000|Overall Study|Withdrawal by Subject|0|||
37657805|NCT02448680|69129719|FG001|Overall Study|Withdrawal by Subject|2|||
37657806|NCT02448446|69129729|FG000|Overall Study|Withdrawal by Subject|1|||
37657807|NCT02448446|69129730|FG001|Overall Study|Withdrawal by Subject|0|||
37657808|NCT02447744|69129738|FG000|Overall Study|Withdrawal by Subject|3|||
37657809|NCT02447744|69129739|FG001|Overall Study|Withdrawal by Subject|1|||
37657810|NCT02447744|69129738|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
37657811|NCT02447744|69129739|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
37746203|NCT01701973|69235587|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
37923010|NCT00837434|69609813|FG000|Overall Study|Baseline assessments not done in time|1|||
37657812|NCT02478632|69129747|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
37657813|NCT02478632|69129748|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
37657814|NCT02478632|69129747|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
37657815|NCT02478632|69129748|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
37657816|NCT02478632|69129747|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
37657817|NCT02478632|69129748|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
37746204|NCT01701973|69235588|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
37746205|NCT01701973|69235589|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
37746206|NCT01701973|69235590|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
37657818|NCT02478398|69129759|FG000|Overall Study|Adverse Event|20|||
37657819|NCT02478398|69129760|FG001|Overall Study|Adverse Event|5|||
37657820|NCT02478398|69129759|FG000|Overall Study|Lost to Follow-up|5|||
37657821|NCT02478398|69129760|FG001|Overall Study|Lost to Follow-up|4|||
37657822|NCT02478398|69129759|FG000|Overall Study|Non-Compliance With Study Drug|5|||
37657823|NCT02478398|69129760|FG001|Overall Study|Non-Compliance With Study Drug|1|||
37657824|NCT02478398|69129759|FG000|Overall Study|Protocol Violation|3|||
37657825|NCT02478398|69129760|FG001|Overall Study|Protocol Violation|1|||
37657826|NCT02478398|69129759|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
37657827|NCT02478398|69129760|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
37657828|NCT02478398|69129759|FG000|Overall Study|Withdrawal By Participant|10|||
37657829|NCT02478398|69129760|FG001|Overall Study|Withdrawal By Participant|4|||
37657830|NCT02478164|69129767|FG000|Overall Study|Lack of Efficacy|13|||
37657831|NCT02478164|69129767|FG000|Overall Study|Adverse Event|1|||
37657832|NCT02478164|69129767|FG000|Overall Study|Withdrawal by Subject|1|||
37746207|NCT01721317|69235641|FG000|Overall Study|Study Closed / Terminated|2|||
37746208|NCT01721317|69235642|FG001|Overall Study|Study Closed / Terminated|2|||
37746209|NCT01721317|69235641|FG000|Overall Study|Physician Decision|0|||
37746210|NCT01721317|69235642|FG001|Overall Study|Physician Decision|1|||
37746211|NCT01721317|69235641|FG000|Overall Study|Withdrawal by Subject|0|||
37746212|NCT01721317|69235642|FG001|Overall Study|Withdrawal by Subject|1|||
37746213|NCT01701193|69235652|FG000|Overall Study|Withdrawal by Subject|2|||
37746214|NCT01701193|69235653|FG001|Overall Study|Withdrawal by Subject|2|||
37746215|NCT01701193|69235654|FG002|Overall Study|Withdrawal by Subject|1|||
37746216|NCT01701193|69235655|FG003|Overall Study|Withdrawal by Subject|2|||
37746217|NCT01701193|69235652|FG000|Overall Study|Adverse Event|1|||
37746218|NCT01701193|69235653|FG001|Overall Study|Adverse Event|0|||
37746219|NCT01701193|69235654|FG002|Overall Study|Adverse Event|0|||
37746220|NCT01701193|69235655|FG003|Overall Study|Adverse Event|0|||
37855749|NCT01018186|69539110|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
37855750|NCT01018186|69539111|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
37855751|NCT01018186|69539108|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
37855752|NCT01018186|69539109|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
37746221|NCT01959347|69235703|FG000|Overall Study|Protocol Violation|9|||
37746222|NCT01959347|69235704|FG001|Overall Study|Protocol Violation|7|||
37746223|NCT01959035|69235730|FG000|Overall Study|Adverse Event|5|||
37746224|NCT01959035|69235730|FG000|Overall Study|Withdrawal by Subject|4|||
37746225|NCT01959035|69235730|FG000|Overall Study|Lost to Follow-up|1|||
37746226|NCT01959035|69235730|FG000|Overall Study|Other (no primary reason given)|1|||
37746227|NCT01700959|69235740|FG000|Overall Study|Adverse Event|0|||
37746228|NCT01700959|69235741|FG001|Overall Study|Adverse Event|1|||
37746229|NCT01700959|69235742|FG002|Overall Study|Adverse Event|1|||
37746230|NCT01700959|69235743|FG003|Overall Study|Adverse Event|2|||
37746231|NCT01700959|69235744|FG004|Overall Study|Adverse Event|0|||
37746232|NCT01700959|69235745|FG005|Overall Study|Adverse Event|2|||
37746233|NCT01700959|69235740|FG000|Overall Study|Withdrawal by Subject|15|||
37746234|NCT01700959|69235741|FG001|Overall Study|Withdrawal by Subject|9|||
37746235|NCT01700959|69235742|FG002|Overall Study|Withdrawal by Subject|12|||
37746236|NCT01700959|69235743|FG003|Overall Study|Withdrawal by Subject|11|||
37746237|NCT01700959|69235744|FG004|Overall Study|Withdrawal by Subject|8|||
37746238|NCT01700959|69235745|FG005|Overall Study|Withdrawal by Subject|12|||
37746239|NCT01700959|69235740|FG000|Overall Study|Ineligible|2|||
37746240|NCT01700959|69235741|FG001|Overall Study|Ineligible|1|||
37746241|NCT01700959|69235742|FG002|Overall Study|Ineligible|2|||
37746242|NCT01700959|69235743|FG003|Overall Study|Ineligible|0|||
37746243|NCT01700959|69235744|FG004|Overall Study|Ineligible|0|||
37746244|NCT01700959|69235745|FG005|Overall Study|Ineligible|1|||
37746245|NCT01700959|69235740|FG000|Overall Study|Noncompliant|9|||
37746246|NCT01700959|69235741|FG001|Overall Study|Noncompliant|9|||
37746247|NCT01700959|69235742|FG002|Overall Study|Noncompliant|17|||
37746248|NCT01700959|69235743|FG003|Overall Study|Noncompliant|18|||
37855753|NCT01018186|69539110|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
37746249|NCT01700959|69235744|FG004|Overall Study|Noncompliant|15|||
37746250|NCT01700959|69235745|FG005|Overall Study|Noncompliant|9|||
37657833|NCT02476994|69129773|FG000|Overall Study|Based on feedback from FDA|1|||
37657834|NCT02476994|69129774|FG001|Overall Study|Based on feedback from FDA|0|||
37657835|NCT02508194|69129782|FG000|Overall Study|Death|5|||
37657836|NCT02508194|69129783|FG001|Overall Study|Death|3|||
37657837|NCT02508194|69129782|FG000|Overall Study|Lost to Follow-up|25|||
37657838|NCT02508194|69129783|FG001|Overall Study|Lost to Follow-up|18|||
37746251|NCT01700959|69235740|FG000|Overall Study|Side effects|1|||
37746252|NCT01700959|69235741|FG001|Overall Study|Side effects|4|||
37746253|NCT01700959|69235742|FG002|Overall Study|Side effects|8|||
37746254|NCT01700959|69235743|FG003|Overall Study|Side effects|4|||
37746255|NCT01700959|69235744|FG004|Overall Study|Side effects|4|||
37746256|NCT01700959|69235745|FG005|Overall Study|Side effects|1|||
37746257|NCT01738477|69235767|FG000|Overall Study|Lost to Follow-up|1|||
37746258|NCT01738477|69235768|FG001|Overall Study|Lost to Follow-up|4|||
37746259|NCT01737931|69235784|FG000|Overall Study|Withdrawal by Subject|0|||
37746260|NCT01737931|69235785|FG001|Overall Study|Withdrawal by Subject|1|||
37746261|NCT01737931|69235786|FG002|Overall Study|Withdrawal by Subject|1|||
37746262|NCT01737931|69235784|FG000|Overall Study|Physician Decision|0|||
37746263|NCT01737931|69235785|FG001|Overall Study|Physician Decision|1|||
37746264|NCT01737931|69235786|FG002|Overall Study|Physician Decision|0|||
37746265|NCT01958489|69235792|FG000|Period 2|Adverse Event|0|||
37746266|NCT01958489|69235793|FG001|Period 2|Adverse Event|1|||
37746267|NCT01721161|69235806|FG000|Overall Study|Adverse Event|2|||
37746268|NCT01721161|69235807|FG001|Overall Study|Adverse Event|3|||
37746269|NCT01721161|69235806|FG000|Overall Study|Lost to Follow-up|1|||
37746270|NCT01721161|69235807|FG001|Overall Study|Lost to Follow-up|2|||
37746271|NCT01721161|69235806|FG000|Overall Study|Withdrawal by Subject|1|||
37746272|NCT01721161|69235807|FG001|Overall Study|Withdrawal by Subject|1|||
37657839|NCT02508194|69129782|FG000|Overall Study|Withdrawal by Subject|20|||
37657840|NCT02508194|69129783|FG001|Overall Study|Withdrawal by Subject|18|||
37657841|NCT02508194|69129782|FG000|Overall Study|Error in Randomization|1|||
37657842|NCT02508194|69129783|FG001|Overall Study|Error in Randomization|3|||
37746273|NCT01721161|69235806|FG000|Overall Study|Other|0|||
37746274|NCT01721161|69235807|FG001|Overall Study|Other|1|||
37746275|NCT01699867|69235814|FG000|Overall Study|Screening Failure|3|||
37746276|NCT01699789|69235833|FG000|Overall Study|Withdrawal by Subject|18|||
37746277|NCT01699789|69235834|FG001|Overall Study|Withdrawal by Subject|23|||
37746278|NCT01699789|69235833|FG000|Overall Study|Death|1|||
37746279|NCT01699789|69235834|FG001|Overall Study|Death|2|||
37657843|NCT02508194|69129782|FG000|Overall Study|Principal Investigator Decision|1|||
37657844|NCT02508194|69129783|FG001|Overall Study|Principal Investigator Decision|2|||
37657845|NCT02508116|69129791|FG000|Overall Study|Lost to Follow-up|2|||
37657846|NCT02508116|69129792|FG001|Overall Study|Lost to Follow-up|3|||
37657847|NCT02508116|69129791|FG000|Overall Study|Withdrawal by Subject|3|||
37657848|NCT02508116|69129792|FG001|Overall Study|Withdrawal by Subject|2|||
37657849|NCT02508116|69129791|FG000|Overall Study|Protocol Violation|1|||
37657850|NCT02508116|69129792|FG001|Overall Study|Protocol Violation|2|||
37657851|NCT02508116|69129791|FG000|Overall Study|Physician Decision|2|||
37657852|NCT02508116|69129792|FG001|Overall Study|Physician Decision|0|||
37657853|NCT01653782|69129801|FG000|Overall Study|Withdrawal by Subject|9|||
37657854|NCT01653782|69129802|FG001|Overall Study|Withdrawal by Subject|15|||
37657855|NCT01653782|69129803|FG002|Overall Study|Withdrawal by Subject|4|||
37657856|NCT01653782|69129801|FG000|Overall Study|Lost to Follow-up|7|||
37657857|NCT01653782|69129802|FG001|Overall Study|Lost to Follow-up|3|||
37657858|NCT01653782|69129803|FG002|Overall Study|Lost to Follow-up|2|||
37657859|NCT02318329|69129821|FG000|Overall Study|Progressive Disease|2|||
37746280|NCT01699789|69235833|FG000|Overall Study|Lost to Follow-up|83|||
37746281|NCT01699789|69235834|FG001|Overall Study|Lost to Follow-up|101|||
37746282|NCT01944839|69235857|FG000|Overall Study|Physician Decision|2|||
37746283|NCT01944839|69235858|FG001|Overall Study|Physician Decision|2|||
37746284|NCT01944839|69235857|FG000|Overall Study|Protocol Violation|0|||
37746285|NCT01944839|69235858|FG001|Overall Study|Protocol Violation|1|||
37746286|NCT01944839|69235857|FG000|Overall Study|Adverse Event|10|||
37746287|NCT01944839|69235858|FG001|Overall Study|Adverse Event|5|||
37746288|NCT01944839|69235857|FG000|Overall Study|Withdrawal by Subject|9|||
37746289|NCT01944839|69235858|FG001|Overall Study|Withdrawal by Subject|17|||
37657860|NCT02318329|69129822|FG001|Overall Study|Progressive Disease|3|||
37746290|NCT01944839|69235857|FG000|Overall Study|Lost to Follow-up|1|||
37746291|NCT01944839|69235858|FG001|Overall Study|Lost to Follow-up|0|||
37746292|NCT01944839|69235857|FG000|Overall Study|Subject non-compliance|0|||
37746293|NCT01944839|69235858|FG001|Overall Study|Subject non-compliance|3|||
37746294|NCT01944059|69235873|FG000|Overall Study|Lost to Follow-up|1|||
37746295|NCT01944059|69235873|FG000|Overall Study|Physician Decision|3|||
37746296|NCT01944059|69235873|FG000|Overall Study|Withdrawal by Subject|1|||
37746297|NCT01944059|69235873|FG000|Overall Study|Adverse Event|2|||
37855754|NCT01018186|69539111|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
37855755|NCT01018186|69539108|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
37855756|NCT01018186|69539109|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
37657861|NCT02318329|69129823|FG002|Overall Study|Progressive Disease|2|||
37657862|NCT02318329|69129824|FG003|Overall Study|Progressive Disease|3|||
37657863|NCT02318329|69129825|FG004|Overall Study|Progressive Disease|3|||
37657864|NCT02318329|69129826|FG005|Overall Study|Progressive Disease|3|||
37657865|NCT02318329|69129827|FG006|Overall Study|Progressive Disease|1|||
37746298|NCT01720225|69235880|FG000|Overall Study|Withdrawal by Subject|0|||
37746299|NCT01720225|69235881|FG001|Overall Study|Withdrawal by Subject|1|||
37746300|NCT01720225|69235880|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
37746301|NCT01720225|69235881|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
37746302|NCT01943591|69235889|FG000|Overall Study|Lost to Follow-up|3|||
37746303|NCT01943591|69235890|FG001|Overall Study|Lost to Follow-up|4|||
37746304|NCT01943591|69235889|FG000|Overall Study|Death|2|||
37746305|NCT01943591|69235890|FG001|Overall Study|Death|7|||
37746306|NCT01699087|69235896|FG000|Overall Study|Lost to Follow-up|7|||
37657866|NCT02318329|69129828|FG007|Overall Study|Progressive Disease|1|||
37746307|NCT01699087|69235896|FG000|Overall Study|Screen failure (prior to treatment)|15|||
37746308|NCT01699087|69235896|FG000|Overall Study|Unable to make future visits|2|||
37746309|NCT01943435|69235904|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
37746310|NCT01943435|69235905|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
37746311|NCT01943435|69235906|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
37746312|NCT01943435|69235904|FG000|Intervention Period|Withdrawal by Subject|3|||
37746313|NCT01943435|69235905|FG001|Intervention Period|Withdrawal by Subject|3|||
37746314|NCT01943435|69235906|FG002|Intervention Period|Withdrawal by Subject|4|||
37746315|NCT01943435|69235904|FG000|2 Month Follow up|Lost to Follow-up|2|||
37746316|NCT01943435|69235905|FG001|2 Month Follow up|Lost to Follow-up|3|||
37746317|NCT01943435|69235906|FG002|2 Month Follow up|Lost to Follow-up|0|||
37657867|NCT02318329|69129829|FG008|Overall Study|Progressive Disease|5|||
37657868|NCT02318329|69129830|FG009|Overall Study|Progressive Disease|39|||
37657869|NCT02318329|69129821|FG000|Overall Study|Death|0|||
37657870|NCT02318329|69129822|FG001|Overall Study|Death|0|||
37657871|NCT02318329|69129823|FG002|Overall Study|Death|0|||
37657872|NCT02318329|69129824|FG003|Overall Study|Death|0|||
37657873|NCT02318329|69129825|FG004|Overall Study|Death|0|||
37657874|NCT02318329|69129826|FG005|Overall Study|Death|0|||
37657875|NCT02318329|69129827|FG006|Overall Study|Death|0|||
37657876|NCT02318329|69129828|FG007|Overall Study|Death|0|||
37657877|NCT02318329|69129829|FG008|Overall Study|Death|0|||
37657878|NCT02318329|69129830|FG009|Overall Study|Death|5|||
37657879|NCT02318329|69129821|FG000|Overall Study|Lost to Follow-up|0|||
37657880|NCT02318329|69129822|FG001|Overall Study|Lost to Follow-up|0|||
37657881|NCT02318329|69129823|FG002|Overall Study|Lost to Follow-up|0|||
37657882|NCT02318329|69129824|FG003|Overall Study|Lost to Follow-up|0|||
37657883|NCT02318329|69129825|FG004|Overall Study|Lost to Follow-up|0|||
37657884|NCT02318329|69129826|FG005|Overall Study|Lost to Follow-up|0|||
37657885|NCT02318329|69129827|FG006|Overall Study|Lost to Follow-up|0|||
37657886|NCT02318329|69129828|FG007|Overall Study|Lost to Follow-up|0|||
37657887|NCT02318329|69129829|FG008|Overall Study|Lost to Follow-up|0|||
37657888|NCT02318329|69129830|FG009|Overall Study|Lost to Follow-up|1|||
37657889|NCT02318329|69129821|FG000|Overall Study|Withdrawal by Subject|0|||
37657890|NCT02318329|69129822|FG001|Overall Study|Withdrawal by Subject|0|||
37657891|NCT02318329|69129823|FG002|Overall Study|Withdrawal by Subject|0|||
37657892|NCT02318329|69129824|FG003|Overall Study|Withdrawal by Subject|0|||
37657893|NCT02318329|69129825|FG004|Overall Study|Withdrawal by Subject|0|||
37657894|NCT02318329|69129826|FG005|Overall Study|Withdrawal by Subject|0|||
37657895|NCT02318329|69129827|FG006|Overall Study|Withdrawal by Subject|0|||
37657896|NCT02318329|69129828|FG007|Overall Study|Withdrawal by Subject|0|||
37657897|NCT02318329|69129829|FG008|Overall Study|Withdrawal by Subject|0|||
37657898|NCT02318329|69129830|FG009|Overall Study|Withdrawal by Subject|6|||
37657899|NCT02318329|69129821|FG000|Overall Study|Other|1|||
37657900|NCT02318329|69129822|FG001|Overall Study|Other|1|||
37657901|NCT02318329|69129823|FG002|Overall Study|Other|1|||
37657902|NCT02318329|69129824|FG003|Overall Study|Other|0|||
37657903|NCT02318329|69129825|FG004|Overall Study|Other|0|||
37657904|NCT02318329|69129826|FG005|Overall Study|Other|0|||
37657905|NCT02318329|69129827|FG006|Overall Study|Other|0|||
37657906|NCT02318329|69129828|FG007|Overall Study|Other|0|||
37657907|NCT02318329|69129829|FG008|Overall Study|Other|1|||
37657908|NCT02318329|69129830|FG009|Overall Study|Other|1|||
37657909|NCT02255656|69129871|FG000|Overall Study|Adverse Event|11|||
37657910|NCT02255656|69129871|FG000|Overall Study|Poor compliance to protocol|3|||
37657911|NCT02255656|69129871|FG000|Overall Study|Lost to Follow-up|30|||
37657912|NCT02255656|69129871|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
37657913|NCT02255656|69129871|FG000|Overall Study|Other|126|||
37657914|NCT02255500|69129884|FG000|Overall Study|Withdrawal by Subject|1|||
37657915|NCT02255500|69129885|FG001|Overall Study|Withdrawal by Subject|0|||
37746318|NCT01943435|69235904|FG000|6 Month Follow up|Lost to Follow-up|12|||
37746319|NCT01943435|69235905|FG001|6 Month Follow up|Lost to Follow-up|7|||
37746320|NCT01943435|69235906|FG002|6 Month Follow up|Lost to Follow-up|15|||
37746321|NCT01942733|69235924|FG000|Overall Study|Lost to Follow-up|1|||
37657916|NCT02505542|69129891|FG000|Part A: Open-Label Period|Adverse Event|31|||
37657917|NCT02505542|69129892|FG001|Part A: Open-Label Period|Adverse Event|0|||
37657918|NCT02505542|69129893|FG002|Part A: Open-Label Period|Adverse Event|0|||
37657919|NCT02505542|69129894|FG003|Part A: Open-Label Period|Adverse Event|0|||
37746322|NCT01942733|69235924|FG000|Overall Study|Non-compliance with IMP|1|||
37746323|NCT01942733|69235924|FG000|Overall Study|Administrative|1|||
37657920|NCT02505542|69129891|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
37657921|NCT02505542|69129892|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
37657922|NCT02505542|69129893|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
37657923|NCT02505542|69129894|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
37657924|NCT02505542|69129891|FG000|Part A: Open-Label Period|Protocol Violation|1|||
37657925|NCT02505542|69129892|FG001|Part A: Open-Label Period|Protocol Violation|0|||
37657926|NCT02505542|69129893|FG002|Part A: Open-Label Period|Protocol Violation|0|||
37657927|NCT02505542|69129894|FG003|Part A: Open-Label Period|Protocol Violation|0|||
37746324|NCT01957865|69235940|FG000|Overall Study|Found HIV negative|0|||
37746325|NCT01957865|69235941|FG001|Overall Study|Found HIV negative|0|||
37746326|NCT01957865|69235942|FG002|Overall Study|Found HIV negative|1|||
37746327|NCT01957865|69235940|FG000|Overall Study|Lost to Follow-up|0|||
37746328|NCT01957865|69235941|FG001|Overall Study|Lost to Follow-up|2|||
37746329|NCT01957865|69235942|FG002|Overall Study|Lost to Follow-up|2|||
37746330|NCT01957787|69235951|FG000|Overall Study|Death|18|||
37746331|NCT01957787|69235951|FG000|Overall Study|Lost to Follow-up|3|||
37746332|NCT01957787|69235951|FG000|Overall Study|Withdrawal by Subject|3|||
37746333|NCT01957787|69235951|FG000|Overall Study|Entered Hospice or Similar Program|2|||
37746334|NCT01957787|69235951|FG000|Overall Study|Index Tumor(s) Resected|2|||
37746335|NCT01957787|69235951|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
37746336|NCT01957787|69235951|FG000|Overall Study|Local therapy, not cryoablation|6|||
37746337|NCT01698775|69235957|FG000|Phase A|Adverse Event|2|||
37746338|NCT01698775|69235958|FG001|Phase A|Adverse Event|1|||
37746339|NCT01698775|69235957|FG000|Phase A|Death|1|||
37746340|NCT01698775|69235958|FG001|Phase A|Death|1|||
37746341|NCT01698775|69235957|FG000|Phase A|Lack of Efficacy|1|||
37746342|NCT01698775|69235958|FG001|Phase A|Lack of Efficacy|0|||
37746343|NCT01698775|69235957|FG000|Phase A|Lost to Follow-up|1|||
37746344|NCT01698775|69235958|FG001|Phase A|Lost to Follow-up|2|||
37746345|NCT01698775|69235957|FG000|Phase A|Protocol Violation|1|||
37746346|NCT01698775|69235958|FG001|Phase A|Protocol Violation|0|||
37746347|NCT01698775|69235957|FG000|Phase A|Withdrawal by Subject|3|||
37746348|NCT01698775|69235958|FG001|Phase A|Withdrawal by Subject|4|||
37746349|NCT01698775|69235957|FG000|Phase A|Kidney [transplant]|0|||
37746350|NCT01698775|69235958|FG001|Phase A|Kidney [transplant]|1|||
37746351|NCT01698775|69235957|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
37746352|NCT01698775|69235958|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
37746353|NCT01698775|69235957|FG000|Phase B|Adverse Event|6|||
37746354|NCT01698775|69235958|FG001|Phase B|Adverse Event|3|||
37746355|NCT01698775|69235957|FG000|Phase B|Death|0|||
37746356|NCT01698775|69235958|FG001|Phase B|Death|1|||
37746357|NCT01698775|69235957|FG000|Phase B|Lack of Efficacy|0|||
37746358|NCT01698775|69235958|FG001|Phase B|Lack of Efficacy|1|||
37746359|NCT01698775|69235957|FG000|Phase B|Lost to Follow-up|0|||
37746360|NCT01698775|69235958|FG001|Phase B|Lost to Follow-up|1|||
37746361|NCT01698775|69235957|FG000|Phase B|Physician Decision|1|||
37746362|NCT01698775|69235958|FG001|Phase B|Physician Decision|1|||
37746363|NCT01698775|69235957|FG000|Phase B|Protocol Violation|1|||
37746364|NCT01698775|69235958|FG001|Phase B|Protocol Violation|1|||
37746365|NCT01698775|69235957|FG000|Phase B|Withdrawal by Subject|6|||
37746366|NCT01698775|69235958|FG001|Phase B|Withdrawal by Subject|2|||
37746367|NCT01941095|69235968|FG000|Overall Study|Insufficient therapeutic response|13|||
37746368|NCT01941095|69235968|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
37746369|NCT01941095|69235968|FG000|Overall Study|Adverse Event|11|||
37746370|NCT01941095|69235968|FG000|Overall Study|Physician Decision|3|||
37746371|NCT01941095|69235968|FG000|Overall Study|Withdrawal by Subject|17|||
37657928|NCT02505542|69129891|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
37657929|NCT02505542|69129892|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
37657930|NCT02505542|69129893|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
37657931|NCT02505542|69129894|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
37657932|NCT02505542|69129891|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
37657933|NCT02505542|69129892|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
37657934|NCT02505542|69129893|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
37657935|NCT02505542|69129894|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
37657936|NCT02505542|69129891|FG000|Part A: Open-Label Period|New medical history available|1|||
37657937|NCT02505542|69129892|FG001|Part A: Open-Label Period|New medical history available|0|||
37657938|NCT02505542|69129893|FG002|Part A: Open-Label Period|New medical history available|0|||
37657939|NCT02505542|69129894|FG003|Part A: Open-Label Period|New medical history available|0|||
37657940|NCT02505542|69129891|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
37657941|NCT02505542|69129892|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
37657942|NCT02505542|69129893|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
37657943|NCT02505542|69129894|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
37657944|NCT02505542|69129891|FG000|Part A: Open-Label Period|Pregnancy|2|||
37657945|NCT02505542|69129892|FG001|Part A: Open-Label Period|Pregnancy|0|||
37657946|NCT02505542|69129893|FG002|Part A: Open-Label Period|Pregnancy|0|||
37746372|NCT01941095|69235968|FG000|Overall Study|Lost to Follow-up|10|||
37746373|NCT01957709|69235983|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
37746374|NCT01957553|69236000|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
37746375|NCT01957553|69236001|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
37746376|NCT01957553|69236000|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
37746377|NCT01957553|69236001|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
37746378|NCT01957553|69236000|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
37746379|NCT01957553|69236001|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
37746380|NCT01957553|69236000|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
37746381|NCT01957553|69236001|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
37746382|NCT01957553|69236000|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
37746383|NCT01957553|69236001|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
37746384|NCT01957553|69236000|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
37746385|NCT01957553|69236001|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
37746386|NCT01957553|69236000|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
37746387|NCT01957553|69236001|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
37746388|NCT01957553|69236000|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
37746389|NCT01957553|69236001|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
37746390|NCT01957553|69236000|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
37746391|NCT01957553|69236001|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
37746392|NCT01957475|69236026|FG000|Test Period 1|Withdrawal by Subject|1|||
37746393|NCT01957475|69236027|FG001|Test Period 1|Withdrawal by Subject|0|||
37746394|NCT01957475|69236026|FG000|Test Period 1|Other|1|||
37746395|NCT01957475|69236027|FG001|Test Period 1|Other|0|||
37746396|NCT01957475|69236026|FG000|Test Period 1|Lack of Efficacy|0|||
37746397|NCT01957475|69236027|FG001|Test Period 1|Lack of Efficacy|1|||
37746398|NCT01957475|69236026|FG000|Test Period 2|Adverse Event|1|||
37746399|NCT01957475|69236027|FG001|Test Period 2|Adverse Event|0|||
37746400|NCT01940939|69236035|FG000|Overall Study|Withdrawal by Subject|2|||
37746401|NCT01940939|69236036|FG001|Overall Study|Withdrawal by Subject|8|||
37746402|NCT01957397|69236042|FG000|Test Period 1|sudden leakage/small bag|1|||
37746403|NCT01957397|69236043|FG001|Test Period 1|sudden leakage/small bag|1|||
37746404|NCT01957397|69236042|FG000|Test Period 1|Withdrawal by Subject|1|||
37746405|NCT01957397|69236043|FG001|Test Period 1|Withdrawal by Subject|0|||
37746406|NCT01957397|69236042|FG000|Test Period 2|Adverse Event|0|||
37746407|NCT01957397|69236043|FG001|Test Period 2|Adverse Event|1|||
37746408|NCT01957397|69236042|FG000|Test Period 3|Adverse Event|1|||
37746409|NCT01957397|69236043|FG001|Test Period 3|Adverse Event|2|||
37746410|NCT01957397|69236042|FG000|Test Period 3|the adhesive did not work|1|||
37746411|NCT01957397|69236043|FG001|Test Period 3|the adhesive did not work|0|||
37746412|NCT01940705|69236057|FG000|Overall Study|Lost to Follow-up|1|||
37746413|NCT01940705|69236058|FG001|Overall Study|Lost to Follow-up|3|||
37746414|NCT01940705|69236059|FG002|Overall Study|Lost to Follow-up|2|||
37746415|NCT01940705|69236060|FG003|Overall Study|Lost to Follow-up|2|||
37746416|NCT01940705|69236057|FG000|Overall Study|Withdrawal by Subject|2|||
37746417|NCT01940705|69236058|FG001|Overall Study|Withdrawal by Subject|2|||
37746418|NCT01940705|69236059|FG002|Overall Study|Withdrawal by Subject|3|||
37746419|NCT01940705|69236060|FG003|Overall Study|Withdrawal by Subject|2|||
37746420|NCT01940705|69236057|FG000|Overall Study|Intervention not given|0|||
37746421|NCT01940705|69236058|FG001|Overall Study|Intervention not given|3|||
37746422|NCT01940705|69236059|FG002|Overall Study|Intervention not given|3|||
37746423|NCT01940705|69236060|FG003|Overall Study|Intervention not given|0|||
37746424|NCT01940705|69236057|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
37746425|NCT01940705|69236058|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
37746426|NCT01940705|69236059|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
37746427|NCT01940705|69236060|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
37746428|NCT01957163|69236085|FG000|Overall Study|Adverse Event|5|||
37746429|NCT01957163|69236086|FG001|Overall Study|Adverse Event|2|||
37657947|NCT02505542|69129894|FG003|Part A: Open-Label Period|Pregnancy|0|||
37657948|NCT02505542|69129891|FG000|Part A: Open-Label Period|Sponsor directive|1|||
37657949|NCT02505542|69129892|FG001|Part A: Open-Label Period|Sponsor directive|0|||
37657950|NCT02505542|69129893|FG002|Part A: Open-Label Period|Sponsor directive|0|||
37657951|NCT02505542|69129894|FG003|Part A: Open-Label Period|Sponsor directive|0|||
37657952|NCT02505542|69129891|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
37657953|NCT02505542|69129892|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
37746430|NCT01957163|69236087|FG002|Overall Study|Adverse Event|4|||
37746431|NCT01957163|69236085|FG000|Overall Study|Lack of Efficacy|5|||
37746432|NCT01957163|69236086|FG001|Overall Study|Lack of Efficacy|4|||
37746433|NCT01957163|69236087|FG002|Overall Study|Lack of Efficacy|9|||
37746434|NCT01957163|69236085|FG000|Overall Study|Protocol Violation|1|||
37746435|NCT01957163|69236086|FG001|Overall Study|Protocol Violation|2|||
37746436|NCT01957163|69236087|FG002|Overall Study|Protocol Violation|0|||
37746437|NCT01957163|69236085|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
37657954|NCT02505542|69129893|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
37746438|NCT01957163|69236086|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
37746439|NCT01957163|69236087|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
38033009|NCT02820844|69718999|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
37746440|NCT01957163|69236085|FG000|Overall Study|Lost to Follow-up|0|||
37746441|NCT01957163|69236086|FG001|Overall Study|Lost to Follow-up|1|||
37746442|NCT01957163|69236087|FG002|Overall Study|Lost to Follow-up|0|||
37855757|NCT01018186|69539110|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
38033010|NCT02820844|69719000|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
37746443|NCT01957163|69236085|FG000|Overall Study|Withdrawal by Subject|4|||
37746444|NCT01957163|69236086|FG001|Overall Study|Withdrawal by Subject|2|||
37746445|NCT01957163|69236087|FG002|Overall Study|Withdrawal by Subject|4|||
37746446|NCT01939223|69236141|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
37746447|NCT01939223|69236142|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
37746448|NCT01939223|69236141|FG000|Overall Study|Disease recurrence (radiological)|1|||
37746449|NCT01939223|69236142|FG001|Overall Study|Disease recurrence (radiological)|3|||
37746450|NCT01939223|69236141|FG000|Overall Study|Study stopped by Sponsor|5|||
37746451|NCT01939223|69236142|FG001|Overall Study|Study stopped by Sponsor|7|||
37746452|NCT01939223|69236141|FG000|Overall Study|Withdrawal by Subject|6|||
37746453|NCT01939223|69236142|FG001|Overall Study|Withdrawal by Subject|0|||
37746454|NCT01954745|69236187|FG000|Overall Study|Radiological Progression|11|||
37746455|NCT01954745|69236187|FG000|Overall Study|Clinical Progression|5|||
37746456|NCT01954745|69236187|FG000|Overall Study|Adverse Event|2|||
37746457|NCT01954745|69236187|FG000|Overall Study|Death|1|||
37746458|NCT01954121|69236202|FG000|Overall Study|Lack of Efficacy|94|||
37746459|NCT01954121|69236203|FG001|Overall Study|Lack of Efficacy|41|||
37746460|NCT01954121|69236202|FG000|Overall Study|Protocol Violation|0|||
37746461|NCT01954121|69236203|FG001|Overall Study|Protocol Violation|2|||
37746462|NCT01954121|69236202|FG000|Overall Study|Lost to Follow-up|5|||
37746463|NCT01954121|69236203|FG001|Overall Study|Lost to Follow-up|6|||
37746464|NCT01954121|69236202|FG000|Overall Study|Withdrawal by Subject|18|||
37746465|NCT01954121|69236203|FG001|Overall Study|Withdrawal by Subject|12|||
37746466|NCT01954121|69236202|FG000|Overall Study|Pregnancy|1|||
37657955|NCT02505542|69129894|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
37657956|NCT02505542|69129891|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
37657957|NCT02505542|69129892|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
37657958|NCT02505542|69129893|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
37657959|NCT02505542|69129894|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
37657960|NCT02505542|69129891|FG000|Part A: Open-Label Period|Non-compliance|1|||
37657961|NCT02505542|69129892|FG001|Part A: Open-Label Period|Non-compliance|0|||
37657962|NCT02505542|69129893|FG002|Part A: Open-Label Period|Non-compliance|0|||
37746467|NCT01954121|69236203|FG001|Overall Study|Pregnancy|1|||
37746468|NCT01954121|69236202|FG000|Overall Study|AE, serious fatal|1|||
37746469|NCT01954121|69236203|FG001|Overall Study|AE, serious fatal|0|||
37746470|NCT01954121|69236202|FG000|Overall Study|AE, non-serious non-fatal|5|||
37746471|NCT01954121|69236203|FG001|Overall Study|AE, non-serious non-fatal|22|||
37746472|NCT01954121|69236202|FG000|Overall Study|SAE, non-fatal|1|||
37855758|NCT01018186|69539111|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
37855759|NCT01018186|69539108|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
37855760|NCT01018186|69539109|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
37855761|NCT01018186|69539110|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
37855762|NCT01018186|69539111|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
37855763|NCT00987337|69539126|FG000|Overall Study|Adverse Event|10|||
37855764|NCT00987337|69539127|FG001|Overall Study|Adverse Event|9|||
37855765|NCT00987337|69539128|FG002|Overall Study|Adverse Event|8|||
37855766|NCT00987337|69539126|FG000|Overall Study|Insufficient Virologic Response|10|||
37855767|NCT00987337|69539127|FG001|Overall Study|Insufficient Virologic Response|7|||
37855768|NCT00987337|69539128|FG002|Overall Study|Insufficient Virologic Response|12|||
37855769|NCT00987337|69539126|FG000|Overall Study|Virologic Breakthrough|2|||
37855770|NCT00987337|69539127|FG001|Overall Study|Virologic Breakthrough|2|||
37855771|NCT00987337|69539128|FG002|Overall Study|Virologic Breakthrough|8|||
37746473|NCT01954121|69236203|FG001|Overall Study|SAE, non-fatal|4|||
37746474|NCT01954121|69236202|FG000|Overall Study|Non-compliant with study procedures|1|||
37746475|NCT01954121|69236203|FG001|Overall Study|Non-compliant with study procedures|0|||
37746476|NCT01954121|69236202|FG000|Overall Study|Non-compliant patient|1|||
37746477|NCT01954121|69236203|FG001|Overall Study|Non-compliant patient|1|||
37746478|NCT01954121|69236202|FG000|Overall Study|Subject did not follow instructions|0|||
37746479|NCT01954121|69236203|FG001|Overall Study|Subject did not follow instructions|2|||
37746480|NCT01952015|69236238|FG000|Induction|Protocol Violation|1|||
37746481|NCT01952015|69236238|FG000|Maintenance|Adverse Event|2|||
37746482|NCT01952015|69236238|FG000|Treatment Period 3|Physician Decision|9|||
37923011|NCT00837434|69609814|FG001|Overall Study|Baseline assessments not done in time|0|||
37657963|NCT02505542|69129894|FG003|Part A: Open-Label Period|Non-compliance|0|||
37746483|NCT01951703|69236271|FG000|First Intervention|Withdrawal by Subject|1|||
37746484|NCT01951703|69236272|FG001|First Intervention|Withdrawal by Subject|0|||
37746485|NCT01951703|69236271|FG000|First Intervention|Subject was not compliant|1|||
37746486|NCT01951703|69236272|FG001|First Intervention|Subject was not compliant|1|||
37746487|NCT01951703|69236271|FG000|First Intervention|Physician Decision|1|||
37746488|NCT01951703|69236272|FG001|First Intervention|Physician Decision|0|||
37746489|NCT01951703|69236271|FG000|Second Intervention|Protocol Violation|0|||
37923012|NCT00837434|69609813|FG000|Overall Study|Unable to obtain study drug|1|||
37657964|NCT02505542|69129891|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
37657965|NCT02505542|69129892|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
37657966|NCT02505542|69129893|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
37657967|NCT02505542|69129894|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
37657968|NCT02505542|69129891|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
37657969|NCT02505542|69129892|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
37657970|NCT02505542|69129893|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
37657971|NCT02505542|69129894|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
37657972|NCT02505542|69129891|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
37657973|NCT02505542|69129892|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
37657974|NCT02505542|69129893|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
37657975|NCT02505542|69129894|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
37657976|NCT02505542|69129891|FG000|Part B: Double-Blind Period|Adverse Event|0|||
37657977|NCT02505542|69129892|FG001|Part B: Double-Blind Period|Adverse Event|0|||
37746490|NCT01951703|69236272|FG001|Second Intervention|Protocol Violation|1|||
37746491|NCT01951703|69236271|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
37746492|NCT01951703|69236272|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
37746493|NCT01937351|69236298|FG000|Overall Study|Withdrawal by Subject|4|||
37746494|NCT01937351|69236299|FG001|Overall Study|Withdrawal by Subject|2|||
37746495|NCT01937351|69236298|FG000|Overall Study|Death|1|||
37746496|NCT01937351|69236299|FG001|Overall Study|Death|0|||
37746497|NCT01937351|69236298|FG000|Overall Study|Not treated w device, per protocol fail|4|||
37746498|NCT01937351|69236299|FG001|Overall Study|Not treated w device, per protocol fail|0|||
37746499|NCT01737697|69236332|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
37746500|NCT01737697|69236333|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
37746501|NCT01737697|69236334|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
37746502|NCT01737697|69236335|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
37746503|NCT01737697|69236336|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
37746504|NCT01737697|69236337|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
37746505|NCT01737697|69236338|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
37746506|NCT01737697|69236339|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
37746507|NCT01737697|69236340|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
37746508|NCT01737697|69236341|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
37746509|NCT01737697|69236342|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
37746510|NCT01737697|69236343|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
37746511|NCT01737697|69236344|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
37746512|NCT01737697|69236345|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
37746513|NCT01737697|69236346|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
37746514|NCT01737697|69236332|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
37746515|NCT01737697|69236333|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
37746516|NCT01737697|69236334|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
37657978|NCT02505542|69129893|FG002|Part B: Double-Blind Period|Adverse Event|1|||
37657979|NCT02505542|69129894|FG003|Part B: Double-Blind Period|Adverse Event|3|||
37657980|NCT02505542|69129891|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
37657981|NCT02505542|69129892|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
37746517|NCT01737697|69236335|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
37746518|NCT01737697|69236336|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
37746519|NCT01737697|69236337|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
37746520|NCT01737697|69236338|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
37746521|NCT01737697|69236339|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
37746522|NCT01737697|69236340|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
37746523|NCT01737697|69236341|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
37746524|NCT01737697|69236342|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
37746525|NCT01737697|69236343|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
37746526|NCT01737697|69236344|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
37746527|NCT01737697|69236345|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
37746528|NCT01737697|69236346|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
37746529|NCT01737697|69236332|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
37746530|NCT01737697|69236333|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
37746531|NCT01737697|69236334|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
37746532|NCT01737697|69236335|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
37746533|NCT01737697|69236336|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
37746534|NCT01737697|69236337|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
37855772|NCT00987337|69539126|FG000|Overall Study|Lost to Follow-up|10|||
37855773|NCT00987337|69539127|FG001|Overall Study|Lost to Follow-up|6|||
37855774|NCT00987337|69539128|FG002|Overall Study|Lost to Follow-up|2|||
37855775|NCT00987337|69539126|FG000|Overall Study|Withdrawal by Subject|6|||
37855776|NCT00987337|69539127|FG001|Overall Study|Withdrawal by Subject|9|||
37657982|NCT02505542|69129893|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
37746535|NCT01737697|69236338|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
37746536|NCT01737697|69236339|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
37746537|NCT01737697|69236340|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
37657983|NCT02505542|69129894|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
37657984|NCT02505542|69129891|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
37657985|NCT02505542|69129892|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
37657986|NCT02505542|69129893|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
37657987|NCT02505542|69129894|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
37657988|NCT02505542|69129891|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
37657989|NCT02505542|69129892|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
37657990|NCT02505542|69129893|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
37657991|NCT02505542|69129894|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
37746538|NCT01737697|69236341|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
37746539|NCT01737697|69236342|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
37746540|NCT01737697|69236343|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
37746541|NCT01737697|69236344|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
37746542|NCT01737697|69236345|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
37746543|NCT01737697|69236346|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
37746544|NCT01737697|69236332|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
37746545|NCT01737697|69236333|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
37746546|NCT01737697|69236334|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
37746547|NCT01737697|69236335|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
37746548|NCT01737697|69236336|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
37746549|NCT01737697|69236337|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
37746550|NCT01737697|69236338|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
37746551|NCT01737697|69236339|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
37746552|NCT01737697|69236340|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
37746553|NCT01737697|69236341|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
37746554|NCT01737697|69236342|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
37746555|NCT01737697|69236343|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
37746556|NCT01737697|69236344|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
37746557|NCT01737697|69236345|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
37746558|NCT01737697|69236346|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
37746559|NCT01737697|69236332|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
37746560|NCT01737697|69236333|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
37746561|NCT01737697|69236334|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
37746562|NCT01737697|69236335|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
37746563|NCT01737697|69236336|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
37746564|NCT01737697|69236337|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
37746565|NCT01737697|69236338|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
37746566|NCT01737697|69236339|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
37746567|NCT01737697|69236340|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
37746568|NCT01737697|69236341|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
37746569|NCT01737697|69236342|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
37746570|NCT01737697|69236343|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
37746571|NCT01737697|69236344|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
37746572|NCT01737697|69236345|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
37746573|NCT01737697|69236346|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
37746574|NCT01737697|69236332|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
37746575|NCT01737697|69236333|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
37746576|NCT01737697|69236334|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
37746577|NCT01737697|69236335|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
37746578|NCT01737697|69236336|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
37746579|NCT01737697|69236337|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
37746580|NCT01737697|69236338|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
37746581|NCT01737697|69236339|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
37746582|NCT01737697|69236340|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
37746583|NCT01737697|69236341|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
37746584|NCT01737697|69236342|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
37746585|NCT01737697|69236343|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
37657992|NCT02505542|69129891|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
37657993|NCT02505542|69129892|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
37746586|NCT01737697|69236344|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
37746587|NCT01737697|69236345|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
37746588|NCT01737697|69236346|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
37746589|NCT01737697|69236332|FG000|Subacute Phase|Adverse Event|0|||
37746590|NCT01737697|69236333|FG001|Subacute Phase|Adverse Event|0|||
37746591|NCT01737697|69236334|FG002|Subacute Phase|Adverse Event|0|||
37746592|NCT01737697|69236335|FG003|Subacute Phase|Adverse Event|0|||
37746593|NCT01737697|69236336|FG004|Subacute Phase|Adverse Event|0|||
37746594|NCT01737697|69236337|FG005|Subacute Phase|Adverse Event|1|||
37657994|NCT02505542|69129893|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
37746595|NCT01737697|69236338|FG006|Subacute Phase|Adverse Event|1|||
37746596|NCT01737697|69236339|FG007|Subacute Phase|Adverse Event|1|||
37746597|NCT01737697|69236340|FG008|Subacute Phase|Adverse Event|1|||
37746598|NCT01737697|69236341|FG009|Subacute Phase|Adverse Event|1|||
37746599|NCT01737697|69236342|FG010|Subacute Phase|Adverse Event|4|||
37746600|NCT01737697|69236343|FG011|Subacute Phase|Adverse Event|1|||
37746601|NCT01737697|69236344|FG012|Subacute Phase|Adverse Event|1|||
37746602|NCT01737697|69236345|FG013|Subacute Phase|Adverse Event|0|||
37746603|NCT01737697|69236346|FG014|Subacute Phase|Adverse Event|0|||
37746604|NCT01737697|69236332|FG000|Subacute Phase|Withdrawal by Subject|0|||
37746605|NCT01737697|69236333|FG001|Subacute Phase|Withdrawal by Subject|0|||
37746606|NCT01737697|69236334|FG002|Subacute Phase|Withdrawal by Subject|0|||
37746607|NCT01737697|69236335|FG003|Subacute Phase|Withdrawal by Subject|0|||
37746608|NCT01737697|69236336|FG004|Subacute Phase|Withdrawal by Subject|0|||
37746609|NCT01737697|69236337|FG005|Subacute Phase|Withdrawal by Subject|1|||
37746610|NCT01737697|69236338|FG006|Subacute Phase|Withdrawal by Subject|0|||
37746611|NCT01737697|69236339|FG007|Subacute Phase|Withdrawal by Subject|2|||
37746612|NCT01737697|69236340|FG008|Subacute Phase|Withdrawal by Subject|0|||
37746613|NCT01737697|69236341|FG009|Subacute Phase|Withdrawal by Subject|1|||
37746614|NCT01737697|69236342|FG010|Subacute Phase|Withdrawal by Subject|0|||
37746615|NCT01737697|69236343|FG011|Subacute Phase|Withdrawal by Subject|1|||
37855777|NCT00987337|69539128|FG002|Overall Study|Withdrawal by Subject|9|||
37855778|NCT00987337|69539126|FG000|Overall Study|Other|0|||
37855779|NCT00987337|69539127|FG001|Overall Study|Other|2|||
37855780|NCT00987337|69539128|FG002|Overall Study|Other|5|||
37855781|NCT00987337|69539126|FG000|Overall Study|Protocol Violation|1|||
37855782|NCT00987337|69539127|FG001|Overall Study|Protocol Violation|0|||
37855783|NCT00987337|69539128|FG002|Overall Study|Protocol Violation|2|||
37855784|NCT00987337|69539126|FG000|Overall Study|Participant Relapsed|18|||
37855785|NCT00987337|69539127|FG001|Overall Study|Participant Relapsed|20|||
37657995|NCT02505542|69129894|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
37657996|NCT02505542|69129891|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
37657997|NCT02505542|69129892|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
37657998|NCT02505542|69129893|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
37657999|NCT02505542|69129894|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
37658000|NCT02505542|69129891|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
37658001|NCT02505542|69129892|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
37658002|NCT02505542|69129893|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
37658003|NCT02505542|69129894|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
37658004|NCT02505542|69129891|FG000|Part B: Double-Blind Period|Miscalculation|0|||
37658005|NCT02505542|69129892|FG001|Part B: Double-Blind Period|Miscalculation|1|||
37658006|NCT02505542|69129893|FG002|Part B: Double-Blind Period|Miscalculation|0|||
37658007|NCT02505542|69129894|FG003|Part B: Double-Blind Period|Miscalculation|0|||
37658008|NCT02505542|69129891|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
37658009|NCT02505542|69129892|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
37658010|NCT02505542|69129893|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
37658011|NCT02505542|69129894|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
37658012|NCT02475980|69129943|FG000|Overall Study|Lost to Follow-up|4|||
37658013|NCT02475980|69129943|FG000|Overall Study|Withdrawal by Subject|1|||
37658014|NCT02447432|69129949|FG000|Epoch 001|Adverse Event|1|||
37658015|NCT02447432|69129950|FG001|Epoch 001|Adverse Event|1|||
37658016|NCT02447432|69129949|FG000|Epoch 001|Withdrawal by Subject|0|||
37658017|NCT02447432|69129950|FG001|Epoch 001|Withdrawal by Subject|4|||
37658018|NCT02447432|69129949|FG000|Epoch 001|Migrated/moved from study area|3|||
37658019|NCT02447432|69129950|FG001|Epoch 001|Migrated/moved from study area|5|||
37658020|NCT02447432|69129949|FG000|Epoch 001|Lost to Follow-up|1|||
37658021|NCT02447432|69129950|FG001|Epoch 001|Lost to Follow-up|3|||
37658022|NCT02446886|69129958|FG000|Overall Study|Adverse Event|1|||
37658023|NCT02446886|69129959|FG001|Overall Study|Adverse Event|3|||
37658024|NCT02446886|69129958|FG000|Overall Study|Withdrawal by Subject|1|||
37658025|NCT02446886|69129959|FG001|Overall Study|Withdrawal by Subject|1|||
37658026|NCT03448939|69129977|FG000|Overall Study|Adverse Event|5|||
37658027|NCT03448939|69129978|FG001|Overall Study|Adverse Event|1|||
37658028|NCT03448939|69129977|FG000|Overall Study|Lost to Follow-up|6|||
37658029|NCT03448939|69129978|FG001|Overall Study|Lost to Follow-up|6|||
37746616|NCT01737697|69236344|FG012|Subacute Phase|Withdrawal by Subject|1|||
37746617|NCT01737697|69236345|FG013|Subacute Phase|Withdrawal by Subject|1|||
37746618|NCT01737697|69236346|FG014|Subacute Phase|Withdrawal by Subject|0|||
37746619|NCT01737697|69236332|FG000|Subacute Phase|Lost to Follow-up|0|||
37746620|NCT01737697|69236333|FG001|Subacute Phase|Lost to Follow-up|0|||
37855786|NCT00987337|69539128|FG002|Overall Study|Participant Relapsed|5|||
37855787|NCT00992407|69539140|FG000|Overall Study|Protocol Violation|2|||
37855788|NCT00992407|69539141|FG001|Overall Study|Protocol Violation|1|||
37658030|NCT03448939|69129977|FG000|Overall Study|Pregnancy|1|||
37658031|NCT03448939|69129978|FG001|Overall Study|Pregnancy|1|||
37746621|NCT01737697|69236334|FG002|Subacute Phase|Lost to Follow-up|0|||
37746622|NCT01737697|69236335|FG003|Subacute Phase|Lost to Follow-up|0|||
37746623|NCT01737697|69236336|FG004|Subacute Phase|Lost to Follow-up|0|||
37746624|NCT01737697|69236337|FG005|Subacute Phase|Lost to Follow-up|0|||
37746625|NCT01737697|69236338|FG006|Subacute Phase|Lost to Follow-up|0|||
37746626|NCT01737697|69236339|FG007|Subacute Phase|Lost to Follow-up|0|||
37746627|NCT01737697|69236340|FG008|Subacute Phase|Lost to Follow-up|0|||
37746628|NCT01737697|69236341|FG009|Subacute Phase|Lost to Follow-up|0|||
37746629|NCT01737697|69236342|FG010|Subacute Phase|Lost to Follow-up|0|||
37746630|NCT01737697|69236343|FG011|Subacute Phase|Lost to Follow-up|0|||
37746631|NCT01737697|69236344|FG012|Subacute Phase|Lost to Follow-up|0|||
37746632|NCT01737697|69236345|FG013|Subacute Phase|Lost to Follow-up|0|||
37746633|NCT01737697|69236346|FG014|Subacute Phase|Lost to Follow-up|1|||
37746634|NCT01737697|69236332|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
37746635|NCT01737697|69236333|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
37746636|NCT01737697|69236334|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
37746637|NCT01737697|69236335|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
37746638|NCT01737697|69236336|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
37746639|NCT01737697|69236337|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
37746640|NCT01737697|69236338|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
37746641|NCT01737697|69236339|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
37746642|NCT01737697|69236340|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
37746643|NCT01737697|69236341|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
37746644|NCT01737697|69236342|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
37746645|NCT01737697|69236343|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
37746646|NCT01737697|69236344|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
37746647|NCT01737697|69236345|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
37746648|NCT01737697|69236346|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
37746649|NCT01737697|69236332|FG000|Subacute Phase|Protocol Violation|0|||
37746650|NCT01737697|69236333|FG001|Subacute Phase|Protocol Violation|0|||
37746651|NCT01737697|69236334|FG002|Subacute Phase|Protocol Violation|0|||
37746652|NCT01737697|69236335|FG003|Subacute Phase|Protocol Violation|0|||
37746653|NCT01737697|69236336|FG004|Subacute Phase|Protocol Violation|0|||
37746654|NCT01737697|69236337|FG005|Subacute Phase|Protocol Violation|1|||
37746655|NCT01737697|69236338|FG006|Subacute Phase|Protocol Violation|0|||
37746656|NCT01737697|69236339|FG007|Subacute Phase|Protocol Violation|0|||
37746657|NCT01737697|69236340|FG008|Subacute Phase|Protocol Violation|0|||
37746658|NCT01737697|69236341|FG009|Subacute Phase|Protocol Violation|0|||
37746659|NCT01737697|69236342|FG010|Subacute Phase|Protocol Violation|1|||
37746660|NCT01737697|69236343|FG011|Subacute Phase|Protocol Violation|0|||
37746661|NCT01737697|69236344|FG012|Subacute Phase|Protocol Violation|0|||
37746662|NCT01737697|69236345|FG013|Subacute Phase|Protocol Violation|0|||
37746663|NCT01737697|69236346|FG014|Subacute Phase|Protocol Violation|0|||
37746664|NCT01737697|69236332|FG000|Subacute Phase|Physician Decision|0|||
37746665|NCT01737697|69236333|FG001|Subacute Phase|Physician Decision|0|||
37746666|NCT01737697|69236334|FG002|Subacute Phase|Physician Decision|0|||
37746667|NCT01737697|69236335|FG003|Subacute Phase|Physician Decision|0|||
37746668|NCT01737697|69236336|FG004|Subacute Phase|Physician Decision|0|||
37746669|NCT01737697|69236337|FG005|Subacute Phase|Physician Decision|0|||
37746670|NCT01737697|69236338|FG006|Subacute Phase|Physician Decision|0|||
37746671|NCT01737697|69236339|FG007|Subacute Phase|Physician Decision|0|||
37746672|NCT01737697|69236340|FG008|Subacute Phase|Physician Decision|1|||
37746673|NCT01737697|69236341|FG009|Subacute Phase|Physician Decision|0|||
37746674|NCT01737697|69236342|FG010|Subacute Phase|Physician Decision|0|||
37746675|NCT01737697|69236343|FG011|Subacute Phase|Physician Decision|0|||
37746676|NCT01737697|69236344|FG012|Subacute Phase|Physician Decision|0|||
37746677|NCT01737697|69236345|FG013|Subacute Phase|Physician Decision|0|||
37746678|NCT01737697|69236346|FG014|Subacute Phase|Physician Decision|0|||
37746679|NCT01737697|69236332|FG000|Subacute Phase|Death|0|||
37746680|NCT01737697|69236333|FG001|Subacute Phase|Death|0|||
37746681|NCT01737697|69236334|FG002|Subacute Phase|Death|0|||
37746682|NCT01737697|69236335|FG003|Subacute Phase|Death|0|||
37746683|NCT01737697|69236336|FG004|Subacute Phase|Death|0|||
37746684|NCT01737697|69236337|FG005|Subacute Phase|Death|0|||
37746685|NCT01737697|69236338|FG006|Subacute Phase|Death|0|||
37746686|NCT01737697|69236339|FG007|Subacute Phase|Death|0|||
37746687|NCT01737697|69236340|FG008|Subacute Phase|Death|0|||
37746688|NCT01737697|69236341|FG009|Subacute Phase|Death|0|||
37746689|NCT01737697|69236342|FG010|Subacute Phase|Death|1|||
37746690|NCT01737697|69236343|FG011|Subacute Phase|Death|0|||
37746691|NCT01737697|69236344|FG012|Subacute Phase|Death|0|||
37746692|NCT01737697|69236345|FG013|Subacute Phase|Death|0|||
37746693|NCT01737697|69236346|FG014|Subacute Phase|Death|0|||
37746694|NCT01682863|69236502|FG000|Overall Study|Subject/guardian decision|19|||
37746695|NCT01682863|69236503|FG001|Overall Study|Subject/guardian decision|12|||
37746696|NCT01682863|69236504|FG002|Overall Study|Subject/guardian decision|10|||
37746697|NCT01682863|69236502|FG000|Overall Study|Lost to Follow-up|5|||
37746698|NCT01682863|69236503|FG001|Overall Study|Lost to Follow-up|1|||
37746699|NCT01682863|69236504|FG002|Overall Study|Lost to Follow-up|6|||
37746700|NCT01682863|69236502|FG000|Overall Study|Death|1|||
37746701|NCT01682863|69236503|FG001|Overall Study|Death|3|||
37746702|NCT01682863|69236504|FG002|Overall Study|Death|4|||
37746703|NCT01682863|69236502|FG000|Overall Study|Protocol deviation|1|||
37746704|NCT01682863|69236503|FG001|Overall Study|Protocol deviation|0|||
37746705|NCT01682863|69236504|FG002|Overall Study|Protocol deviation|1|||
37746706|NCT01682863|69236502|FG000|Overall Study|Technical problems|1|||
37746707|NCT01682863|69236503|FG001|Overall Study|Technical problems|0|||
37746708|NCT01682863|69236504|FG002|Overall Study|Technical problems|0|||
37746709|NCT01682863|69236502|FG000|Overall Study|Adverse Event|0|||
37746710|NCT01682863|69236503|FG001|Overall Study|Adverse Event|1|||
37746711|NCT01682863|69236504|FG002|Overall Study|Adverse Event|2|||
37746712|NCT01682863|69236502|FG000|Overall Study|Physician Decision|0|||
37746713|NCT01682863|69236503|FG001|Overall Study|Physician Decision|0|||
37746714|NCT01682863|69236504|FG002|Overall Study|Physician Decision|1|||
37746715|NCT01951625|69236517|FG000|Treatment Period|Protocol Violation|2|||
37658032|NCT03448939|69129977|FG000|Overall Study|Withdrawal by Subject|9|||
37658033|NCT03448939|69129978|FG001|Overall Study|Withdrawal by Subject|3|||
37658034|NCT02504294|69129996|FG000|Overall Study|Adverse Event|15|||
37746716|NCT01951625|69236518|FG001|Treatment Period|Protocol Violation|0|||
37746717|NCT01951625|69236519|FG002|Treatment Period|Protocol Violation|1|||
37746718|NCT01951625|69236520|FG003|Treatment Period|Protocol Violation|3|||
37746719|NCT01951625|69236521|FG004|Treatment Period|Protocol Violation|2|||
37746720|NCT01951625|69236517|FG000|Treatment Period|Physician Decision|0|||
37746721|NCT01951625|69236518|FG001|Treatment Period|Physician Decision|0|||
37746722|NCT01951625|69236519|FG002|Treatment Period|Physician Decision|0|||
37746723|NCT01951625|69236520|FG003|Treatment Period|Physician Decision|0|||
37746724|NCT01951625|69236521|FG004|Treatment Period|Physician Decision|1|||
37746725|NCT01951625|69236517|FG000|Treatment Period|Protocol driven decision point|0|||
37746726|NCT01951625|69236518|FG001|Treatment Period|Protocol driven decision point|5|||
37746727|NCT01951625|69236519|FG002|Treatment Period|Protocol driven decision point|0|||
37746728|NCT01951625|69236520|FG003|Treatment Period|Protocol driven decision point|2|||
37746729|NCT01951625|69236521|FG004|Treatment Period|Protocol driven decision point|1|||
37746730|NCT01951625|69236517|FG000|Treatment Period|Non compliance with study drug|1|||
37746731|NCT01951625|69236518|FG001|Treatment Period|Non compliance with study drug|2|||
37746732|NCT01951625|69236519|FG002|Treatment Period|Non compliance with study drug|2|||
37746733|NCT01951625|69236520|FG003|Treatment Period|Non compliance with study drug|0|||
37658035|NCT02504294|69129997|FG001|Overall Study|Adverse Event|12|||
37658036|NCT02504294|69129996|FG000|Overall Study|Withdrawal by Subject|7|||
37658037|NCT02504294|69129997|FG001|Overall Study|Withdrawal by Subject|1|||
37658038|NCT02504294|69129996|FG000|Overall Study|Protocol Violation|27|||
37658039|NCT02504294|69129997|FG001|Overall Study|Protocol Violation|26|||
37658040|NCT02504294|69129996|FG000|Overall Study|Physician Decision|1|||
37658041|NCT02504294|69129997|FG001|Overall Study|Physician Decision|2|||
37658042|NCT02504294|69129996|FG000|Overall Study|Lost to Follow-up|6|||
37658043|NCT02504294|69129997|FG001|Overall Study|Lost to Follow-up|7|||
37658044|NCT02446418|69130005|FG000|Overall Study|Adverse Event|4|||
37658045|NCT02446418|69130006|FG001|Overall Study|Adverse Event|8|||
37658046|NCT02446418|69130005|FG000|Overall Study|Physician Decision|5|||
37658047|NCT02446418|69130006|FG001|Overall Study|Physician Decision|1|||
37658048|NCT02446418|69130005|FG000|Overall Study|Withdrawal by Subject|3|||
37658049|NCT02446418|69130006|FG001|Overall Study|Withdrawal by Subject|3|||
37658050|NCT02446418|69130005|FG000|Overall Study|Lost to Follow-up|2|||
37658051|NCT02446418|69130006|FG001|Overall Study|Lost to Follow-up|2|||
37658052|NCT02446418|69130005|FG000|Overall Study|Protocol Violation|1|||
37658053|NCT02446418|69130006|FG001|Overall Study|Protocol Violation|2|||
37658054|NCT02446418|69130005|FG000|Overall Study|Lack of Efficacy|2|||
37658055|NCT02446418|69130006|FG001|Overall Study|Lack of Efficacy|0|||
37746734|NCT01951625|69236521|FG004|Treatment Period|Non compliance with study drug|0|||
37746735|NCT01951625|69236517|FG000|Treatment Period|Death|3|||
37746736|NCT01951625|69236518|FG001|Treatment Period|Death|2|||
37746737|NCT01951625|69236519|FG002|Treatment Period|Death|2|||
37746738|NCT01951625|69236520|FG003|Treatment Period|Death|1|||
37746739|NCT01951625|69236521|FG004|Treatment Period|Death|2|||
37746740|NCT01951625|69236517|FG000|Treatment Period|Adverse Event|7|||
37746741|NCT01951625|69236518|FG001|Treatment Period|Adverse Event|10|||
37746742|NCT01951625|69236519|FG002|Treatment Period|Adverse Event|9|||
37746743|NCT01951625|69236520|FG003|Treatment Period|Adverse Event|8|||
37746744|NCT01951625|69236521|FG004|Treatment Period|Adverse Event|8|||
37746745|NCT01951625|69236517|FG000|Treatment Period|Withdrawal by Subject|5|||
37658056|NCT02446418|69130005|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
37658057|NCT02446418|69130006|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
37658058|NCT02445794|69130016|FG000|Overall Study|Adverse Event|0|||
37746746|NCT01951625|69236518|FG001|Treatment Period|Withdrawal by Subject|2|||
37746747|NCT01951625|69236519|FG002|Treatment Period|Withdrawal by Subject|1|||
37746748|NCT01951625|69236520|FG003|Treatment Period|Withdrawal by Subject|7|||
37746749|NCT01951625|69236521|FG004|Treatment Period|Withdrawal by Subject|3|||
37746750|NCT01951625|69236517|FG000|Treatment Period|Lost to Follow-up|1|||
37746751|NCT01951625|69236518|FG001|Treatment Period|Lost to Follow-up|0|||
37746752|NCT01951625|69236519|FG002|Treatment Period|Lost to Follow-up|0|||
37746753|NCT01951625|69236520|FG003|Treatment Period|Lost to Follow-up|1|||
37746754|NCT01951625|69236521|FG004|Treatment Period|Lost to Follow-up|0|||
37746755|NCT01951625|69236517|FG000|Follow Up Period|Non-compliance with study drug|1|||
37746756|NCT01951625|69236518|FG001|Follow Up Period|Non-compliance with study drug|0|||
37746757|NCT01951625|69236519|FG002|Follow Up Period|Non-compliance with study drug|0|||
37746758|NCT01951625|69236520|FG003|Follow Up Period|Non-compliance with study drug|0|||
37746759|NCT01951625|69236521|FG004|Follow Up Period|Non-compliance with study drug|0|||
37746760|NCT01951625|69236517|FG000|Follow Up Period|Death|1|||
37746761|NCT01951625|69236518|FG001|Follow Up Period|Death|3|||
37746762|NCT01951625|69236519|FG002|Follow Up Period|Death|2|||
37746763|NCT01951625|69236520|FG003|Follow Up Period|Death|2|||
37746764|NCT01951625|69236521|FG004|Follow Up Period|Death|1|||
37746765|NCT01951625|69236517|FG000|Follow Up Period|Logistical difficulties|1|||
37746766|NCT01951625|69236518|FG001|Follow Up Period|Logistical difficulties|2|||
37746767|NCT01951625|69236519|FG002|Follow Up Period|Logistical difficulties|0|||
37746768|NCT01951625|69236520|FG003|Follow Up Period|Logistical difficulties|0|||
37746769|NCT01951625|69236521|FG004|Follow Up Period|Logistical difficulties|0|||
37746770|NCT01951625|69236517|FG000|Follow Up Period|Adverse Event|0|||
37746771|NCT01951625|69236518|FG001|Follow Up Period|Adverse Event|3|||
37746772|NCT01951625|69236519|FG002|Follow Up Period|Adverse Event|2|||
37746773|NCT01951625|69236520|FG003|Follow Up Period|Adverse Event|3|||
37746774|NCT01951625|69236521|FG004|Follow Up Period|Adverse Event|5|||
37746775|NCT01951625|69236517|FG000|Follow Up Period|Withdrawal by Subject|4|||
37746776|NCT01951625|69236518|FG001|Follow Up Period|Withdrawal by Subject|1|||
37746777|NCT01951625|69236519|FG002|Follow Up Period|Withdrawal by Subject|0|||
37746778|NCT01951625|69236520|FG003|Follow Up Period|Withdrawal by Subject|5|||
37746779|NCT01951625|69236521|FG004|Follow Up Period|Withdrawal by Subject|3|||
37746780|NCT01951625|69236517|FG000|Follow Up Period|Lost to Follow-up|1|||
37746781|NCT01951625|69236518|FG001|Follow Up Period|Lost to Follow-up|0|||
37746782|NCT01951625|69236519|FG002|Follow Up Period|Lost to Follow-up|0|||
37746783|NCT01951625|69236520|FG003|Follow Up Period|Lost to Follow-up|1|||
37746784|NCT01951625|69236521|FG004|Follow Up Period|Lost to Follow-up|1|||
37746785|NCT04400890|69236536|FG000|Overall Study|Withdrawal by Subject|3|||
37746786|NCT04400890|69236537|FG001|Overall Study|Withdrawal by Subject|2|||
37746787|NCT01936649|69236543|FG000|Overall Study|Withdrawal by Subject|4|||
37746788|NCT01936649|69236543|FG000|Overall Study|Physician Decision|2|||
37746789|NCT01936649|69236543|FG000|Overall Study|Protocol Violation|2|||
37746790|NCT01936649|69236543|FG000|Overall Study|Other than specified above|5|||
37746791|NCT01720069|69236550|FG000|Overall Study|Could not use e-diary correctly|0|||
37746792|NCT01720069|69236551|FG001|Overall Study|Could not use e-diary correctly|1|||
37746793|NCT01720069|69236552|FG002|Overall Study|Could not use e-diary correctly|1|||
37746794|NCT01720069|69236550|FG000|Overall Study|Randomised without baseline values|0|||
37746795|NCT01720069|69236551|FG001|Overall Study|Randomised without baseline values|0|||
37746796|NCT01720069|69236552|FG002|Overall Study|Randomised without baseline values|1|||
37746797|NCT01720069|69236550|FG000|Overall Study|Adverse Event|0|||
37746798|NCT01720069|69236551|FG001|Overall Study|Adverse Event|0|||
37746799|NCT01720069|69236552|FG002|Overall Study|Adverse Event|1|||
37746800|NCT01720069|69236550|FG000|Overall Study|Lack of Efficacy|0|||
37746801|NCT01720069|69236551|FG001|Overall Study|Lack of Efficacy|4|||
37746802|NCT01720069|69236552|FG002|Overall Study|Lack of Efficacy|0|||
37746803|NCT01720069|69236550|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
37746804|NCT01720069|69236551|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
37746805|NCT01720069|69236552|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
37746806|NCT01720069|69236550|FG000|Overall Study|Withdrawal by Subject|0|||
37746807|NCT01720069|69236551|FG001|Overall Study|Withdrawal by Subject|2|||
37746808|NCT01720069|69236552|FG002|Overall Study|Withdrawal by Subject|1|||
37746809|NCT01720069|69236550|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
37746810|NCT01720069|69236551|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
37746811|NCT01720069|69236552|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
37746812|NCT01720069|69236550|FG000|Overall Study|Non-compliance on using e-diary|0|||
37746813|NCT01720069|69236551|FG001|Overall Study|Non-compliance on using e-diary|0|||
37746814|NCT01720069|69236552|FG002|Overall Study|Non-compliance on using e-diary|1|||
37746815|NCT01720069|69236550|FG000|Overall Study|Lost to Follow-up|0|||
37746816|NCT01720069|69236551|FG001|Overall Study|Lost to Follow-up|0|||
37746817|NCT01720069|69236552|FG002|Overall Study|Lost to Follow-up|1|||
37746818|NCT01719757|69236598|FG000|Overall Study|Adverse Event|38|||
37746819|NCT01719757|69236598|FG000|Overall Study|Withdrawal by Subject|15|||
37746820|NCT01719757|69236598|FG000|Overall Study|Lost to Follow-up|20|||
37746821|NCT01719757|69236598|FG000|Overall Study|Protocol Violation|1|||
37746822|NCT01719757|69236598|FG000|Overall Study|well controlled pain|27|||
37746823|NCT01718509|69236606|FG000|Overall Study|Lost to Follow-up|18|||
37746824|NCT01718509|69236607|FG001|Overall Study|Lost to Follow-up|15|||
37746825|NCT01718509|69236606|FG000|Overall Study|Withdrawal by Subject|7|||
37746826|NCT01718509|69236607|FG001|Overall Study|Withdrawal by Subject|13|||
37746827|NCT01718509|69236606|FG000|Overall Study|Adverse Event|5|||
37746828|NCT01718509|69236607|FG001|Overall Study|Adverse Event|7|||
37746829|NCT01718509|69236606|FG000|Overall Study|Other|13|||
37746830|NCT01718509|69236607|FG001|Overall Study|Other|11|||
37746831|NCT01718509|69236606|FG000|Overall Study|Protocol Violation|4|||
37746832|NCT01718509|69236607|FG001|Overall Study|Protocol Violation|2|||
37746833|NCT01718509|69236606|FG000|Overall Study|Lack of Efficacy|1|||
37746834|NCT01718509|69236607|FG001|Overall Study|Lack of Efficacy|0|||
37746835|NCT01857934|69236613|FG000|Overall Study|Relapse or progression|2|||
37746836|NCT01857934|69236613|FG000|Overall Study|Unacceptable toxicity|3|||
37746837|NCT01857934|69236613|FG000|Overall Study|Unwillingness or inability to comply|2|||
37746838|NCT01857934|69236613|FG000|Overall Study|Physician Decision|3|||
37746839|NCT01604941|69236654|FG000|Overall Study|Adverse Event|1|||
37746840|NCT01604941|69236655|FG001|Overall Study|Adverse Event|2|||
37746841|NCT01604941|69236656|FG002|Overall Study|Adverse Event|0|||
37746842|NCT01604941|69236657|FG003|Overall Study|Adverse Event|0|||
37746843|NCT01604941|69236658|FG004|Overall Study|Adverse Event|1|||
37746844|NCT01604941|69236659|FG005|Overall Study|Adverse Event|5|||
37746845|NCT01604941|69236654|FG000|Overall Study|Non-compliance|1|||
37746846|NCT01604941|69236655|FG001|Overall Study|Non-compliance|0|||
37746847|NCT01604941|69236656|FG002|Overall Study|Non-compliance|0|||
37746848|NCT01604941|69236657|FG003|Overall Study|Non-compliance|0|||
37746849|NCT01604941|69236658|FG004|Overall Study|Non-compliance|0|||
37746850|NCT01604941|69236659|FG005|Overall Study|Non-compliance|0|||
37746851|NCT01604941|69236654|FG000|Overall Study|Participant Decision|0|||
37746852|NCT01604941|69236655|FG001|Overall Study|Participant Decision|0|||
37746853|NCT01604941|69236656|FG002|Overall Study|Participant Decision|0|||
37746854|NCT01604941|69236657|FG003|Overall Study|Participant Decision|0|||
37746855|NCT01604941|69236658|FG004|Overall Study|Participant Decision|0|||
37746856|NCT01604941|69236659|FG005|Overall Study|Participant Decision|2|||
37746857|NCT01604941|69236654|FG000|Overall Study|Early Study Termination|9|||
37746858|NCT01604941|69236655|FG001|Overall Study|Early Study Termination|2|||
37746859|NCT01604941|69236656|FG002|Overall Study|Early Study Termination|3|||
37746860|NCT01604941|69236657|FG003|Overall Study|Early Study Termination|3|||
37746861|NCT01604941|69236658|FG004|Overall Study|Early Study Termination|0|||
37746862|NCT01604941|69236659|FG005|Overall Study|Early Study Termination|0|||
37746863|NCT01604785|69236667|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
37746864|NCT01604785|69236668|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
37746865|NCT01681849|69236677|FG000|Overall Study|Protocol Violation|2|||
37746866|NCT01681849|69236678|FG001|Overall Study|Protocol Violation|0|||
37658059|NCT02445794|69130017|FG001|Overall Study|Adverse Event|0|||
37658060|NCT02445794|69130018|FG002|Overall Study|Adverse Event|2|||
37658061|NCT02445794|69130019|FG003|Overall Study|Adverse Event|0|||
37658062|NCT02475278|69130034|FG000|Overall Study|Lost to Follow-up|1|||
37658063|NCT02475278|69130034|FG000|Overall Study|Reason Not Specified|1|||
37658064|NCT02254486|69130040|FG000|Overall Study|Adverse Event|1|||
37658065|NCT02254486|69130041|FG001|Overall Study|Adverse Event|1|||
37658066|NCT02254486|69130040|FG000|Overall Study|Lack of Efficacy|1|||
37658067|NCT02254486|69130041|FG001|Overall Study|Lack of Efficacy|0|||
37658068|NCT02254486|69130040|FG000|Overall Study|Lost to Follow-up|2|||
37658069|NCT02254486|69130041|FG001|Overall Study|Lost to Follow-up|4|||
37658070|NCT02254486|69130040|FG000|Overall Study|Protocol Violation|1|||
37658071|NCT02254486|69130041|FG001|Overall Study|Protocol Violation|2|||
37658072|NCT02254486|69130040|FG000|Overall Study|Withdrawal by Subject|17|||
37658073|NCT02254486|69130041|FG001|Overall Study|Withdrawal by Subject|15|||
37658074|NCT02254486|69130040|FG000|Overall Study|GFR<60mL/min|16|||
37746867|NCT01681849|69236679|FG002|Overall Study|Protocol Violation|0|||
37658075|NCT02254486|69130041|FG001|Overall Study|GFR<60mL/min|21|||
37658076|NCT02254486|69130040|FG000|Overall Study|Various|12|||
37658077|NCT02254486|69130041|FG001|Overall Study|Various|12|||
37658078|NCT01641640|69130047|FG000|Overall Study|Enrolled but not treated|1|||
37658079|NCT01641640|69130047|FG000|Overall Study|Efficacy failure|29|||
37658080|NCT01641640|69130047|FG000|Overall Study|Lost to Follow-up|3|||
37658081|NCT01641640|69130047|FG000|Overall Study|Withdrawal by Subject|2|||
37658082|NCT01641640|69130047|FG000|Overall Study|Adverse Event|1|||
37658083|NCT01639144|69130053|FG000|Overall Study|Withdrawal by Subject|4|||
37658084|NCT01639144|69130054|FG001|Overall Study|Withdrawal by Subject|2|||
37658085|NCT01639144|69130053|FG000|Overall Study|Physician Decision|2|||
37746868|NCT01681849|69236677|FG000|Overall Study|Withdrawal by Subject|3|||
37746869|NCT01681849|69236678|FG001|Overall Study|Withdrawal by Subject|5|||
37746870|NCT01681849|69236679|FG002|Overall Study|Withdrawal by Subject|33|||
37746871|NCT01681849|69236677|FG000|Overall Study|Lost to Follow-up|3|||
37658086|NCT01639144|69130054|FG001|Overall Study|Physician Decision|0|||
37658087|NCT01639144|69130053|FG000|Overall Study|Met postoperative exclusion criteria|4|||
37746872|NCT01681849|69236678|FG001|Overall Study|Lost to Follow-up|2|||
37658088|NCT01639144|69130054|FG001|Overall Study|Met postoperative exclusion criteria|3|||
37658089|NCT01601626|69130063|FG000|Overall Study|Death|1|||
37658090|NCT01601626|69130064|FG001|Overall Study|Death|1|||
37658091|NCT01601626|69130065|FG002|Overall Study|Death|1|||
37658092|NCT01601626|69130063|FG000|Overall Study|Lost to Follow-up|1|||
37746873|NCT01681849|69236679|FG002|Overall Study|Lost to Follow-up|6|||
37746874|NCT01681771|69236688|FG000|Overall Study|Lost to Follow-up|4|||
37746875|NCT01681771|69236689|FG001|Overall Study|Lost to Follow-up|2|||
37746876|NCT04250350|69236695|FG000|Overall Study|Withdrawal by Subject|13|||
37746877|NCT04250350|69236695|FG000|Overall Study|Lost to Follow-up|8|||
37658093|NCT01601626|69130064|FG001|Overall Study|Lost to Follow-up|2|||
37658094|NCT01601626|69130065|FG002|Overall Study|Lost to Follow-up|0|||
37658095|NCT01601626|69130063|FG000|Overall Study|Unable to Get to Clinic|0|||
37658096|NCT01601626|69130064|FG001|Overall Study|Unable to Get to Clinic|1|||
37658097|NCT01601626|69130065|FG002|Overall Study|Unable to Get to Clinic|0|||
37658098|NCT01601626|69130063|FG000|Overall Study|Withdrawal by Subject|0|||
37658099|NCT01601626|69130064|FG001|Overall Study|Withdrawal by Subject|1|||
37658100|NCT01601626|69130065|FG002|Overall Study|Withdrawal by Subject|1|||
37658101|NCT01601626|69130063|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
37746878|NCT04250350|69236695|FG000|Overall Study|Adverse Event|5|||
37746879|NCT04250350|69236695|FG000|Overall Study|Lack of Efficacy|4|||
37746880|NCT04250350|69236695|FG000|Overall Study|Physician Decision|1|||
37746881|NCT04250350|69236695|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
37746882|NCT01718353|69236726|FG000|Overall Study|Lost to Follow-up|0|||
37746883|NCT01718353|69236727|FG001|Overall Study|Lost to Follow-up|1|||
37746884|NCT01718353|69236726|FG000|Overall Study|Principal Investigator's Decision|10|||
37746885|NCT01718353|69236727|FG001|Overall Study|Principal Investigator's Decision|4|||
37746886|NCT01718353|69236726|FG000|Overall Study|Randomized but not treated|2|||
37746887|NCT01718353|69236727|FG001|Overall Study|Randomized but not treated|0|||
37658102|NCT01601626|69130064|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
37658103|NCT01601626|69130065|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
37658104|NCT02737501|69130075|FG000|Randomized Phase|Died|41|||
37658105|NCT02737501|69130076|FG001|Randomized Phase|Died|29|||
37658106|NCT02737501|69130077|FG002|Randomized Phase|Died|0|||
37658107|NCT02737501|69130075|FG000|Randomized Phase|Withdrawal by Subject|16|||
37658108|NCT02737501|69130076|FG001|Randomized Phase|Withdrawal by Subject|6|||
37658109|NCT02737501|69130077|FG002|Randomized Phase|Withdrawal by Subject|0|||
37658110|NCT02737501|69130075|FG000|Randomized Phase|Lost to Follow-up|0|||
37658111|NCT02737501|69130076|FG001|Randomized Phase|Lost to Follow-up|1|||
37658112|NCT02737501|69130077|FG002|Randomized Phase|Lost to Follow-up|0|||
37658113|NCT02737501|69130075|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
37658114|NCT02737501|69130076|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
37658115|NCT02737501|69130077|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
37746888|NCT01716715|69236737|FG000|Overall Study|Never Treated|2|||
37746889|NCT01716715|69236738|FG001|Overall Study|Never Treated|4|||
37746890|NCT01697449|69236746|FG000|Overall Study|Disease progression|47|||
37746891|NCT01697449|69236746|FG000|Overall Study|Adverse Event|7|||
37746892|NCT01697449|69236746|FG000|Overall Study|Lost to Follow-up|5|||
37746893|NCT01697449|69236746|FG000|Overall Study|Withdrawal by Subject|2|||
37746894|NCT01697449|69236746|FG000|Overall Study|Physician Decision|1|||
37746895|NCT01697449|69236746|FG000|Overall Study|Death|2|||
37746896|NCT01697449|69236746|FG000|Overall Study|Other|1|||
37746897|NCT01697449|69236746|FG000|Overall Study|Missing|25|||
37746898|NCT01696981|69236755|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
37746899|NCT01696981|69236756|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
37746900|NCT01696981|69236755|FG000|Overall Study|Died Before Randomization|3|||
37658116|NCT02737501|69130075|FG000|Randomized Phase|Reason not Specified|1|||
37658117|NCT02737501|69130076|FG001|Randomized Phase|Reason not Specified|1|||
37658118|NCT02737501|69130077|FG002|Randomized Phase|Reason not Specified|0|||
37658119|NCT02737501|69130075|FG000|Randomized Phase|Never Treated|1|||
37658120|NCT02737501|69130076|FG001|Randomized Phase|Never Treated|1|||
37658121|NCT02737501|69130077|FG002|Randomized Phase|Never Treated|0|||
37658122|NCT02737501|69130075|FG000|Crossover Phase|Died|0|||
37658123|NCT02737501|69130076|FG001|Crossover Phase|Died|0|||
37658124|NCT02737501|69130077|FG002|Crossover Phase|Died|22|||
37658125|NCT02737501|69130075|FG000|Crossover Phase|Withdrew Consent|0|||
37658126|NCT02737501|69130076|FG001|Crossover Phase|Withdrew Consent|0|||
37658127|NCT02737501|69130077|FG002|Crossover Phase|Withdrew Consent|9|||
37658128|NCT02737501|69130075|FG000|Crossover Phase|Physician Decision|0|||
37658129|NCT02737501|69130076|FG001|Crossover Phase|Physician Decision|0|||
37658130|NCT02737501|69130077|FG002|Crossover Phase|Physician Decision|1|||
37746901|NCT01696981|69236756|FG001|Overall Study|Died Before Randomization|8|||
37746902|NCT01696981|69236755|FG000|Overall Study|Died Before ASU (Control)|278|||
37746903|NCT01696981|69236756|FG001|Overall Study|Died Before ASU (Control)|0|||
37746904|NCT01696981|69236755|FG000|Overall Study|Refused ASU (Control)|920|||
37658131|NCT02737501|69130075|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
37658132|NCT02737501|69130076|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
37658133|NCT02737501|69130077|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
37658134|NCT01640314|69130087|FG000|Overall Study|Protocol Violation|0|||
37658135|NCT01640314|69130088|FG001|Overall Study|Protocol Violation|1|||
37658136|NCT02740049|69130170|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
37746905|NCT01696981|69236756|FG001|Overall Study|Refused ASU (Control)|0|||
37855789|NCT00992407|69539140|FG000|Overall Study|Lost to Follow-up|3|||
37746906|NCT01696981|69236755|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
37746907|NCT01696981|69236756|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
37746908|NCT01696279|69236762|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
37746909|NCT01696279|69236763|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
37746910|NCT01696279|69236764|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
37746911|NCT01696279|69236765|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
37746912|NCT01696279|69236762|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
37746913|NCT01696279|69236763|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
37746914|NCT01696279|69236764|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
37746915|NCT01696279|69236765|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
37746916|NCT01696279|69236762|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
37746917|NCT01696279|69236763|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
37746918|NCT01696279|69236764|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
37746919|NCT01696279|69236765|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
37746920|NCT01696279|69236762|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
37746921|NCT01696279|69236763|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
37746922|NCT01696279|69236764|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
37746923|NCT01696279|69236765|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
37746924|NCT01696279|69236762|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
37746925|NCT01696279|69236763|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
37746926|NCT01696279|69236764|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
37746927|NCT01696279|69236765|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
37746928|NCT01696279|69236762|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
37746929|NCT01696279|69236763|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
37746930|NCT01696279|69236764|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
37746931|NCT01696279|69236765|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
37746932|NCT01696279|69236762|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
37746933|NCT01696279|69236763|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
37746934|NCT01696279|69236764|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
37746935|NCT01696279|69236765|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
37746936|NCT01696279|69236762|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
37746937|NCT01696279|69236763|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
37746938|NCT01696279|69236764|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
37746939|NCT01696279|69236765|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
37746940|NCT01696279|69236762|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
37746941|NCT01696279|69236763|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
37746942|NCT01696279|69236764|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
37746943|NCT01696279|69236765|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
37746944|NCT01696279|69236762|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
37746945|NCT01696279|69236763|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
37746946|NCT01696279|69236764|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
37746947|NCT01696279|69236765|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
37746948|NCT01696279|69236762|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
37746949|NCT01696279|69236763|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
37746950|NCT01696279|69236764|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
37658137|NCT01601704|69130176|FG000|Overall Study|Randomized but not dispensed study med|1|||
37658138|NCT01601704|69130177|FG001|Overall Study|Randomized but not dispensed study med|4|||
37658139|NCT01601470|69130183|FG000|Period 2 - LCZ696|Physician Decision|1|||
37658140|NCT03248375|69130207|FG000|Overall Study|Lost to Follow-up|5|||
37658141|NCT01637272|69130211|FG000|Overall Study|Adverse Event|6|||
37658142|NCT01637272|69130211|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
37658143|NCT01637272|69130211|FG000|Overall Study|Withdrawal by Subject|3|||
37746951|NCT01696279|69236765|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
37746952|NCT01681069|69236776|FG000|Overall Study|Withdrawal by Subject|4|||
37746953|NCT01681069|69236777|FG001|Overall Study|Withdrawal by Subject|5|||
37746954|NCT01681069|69236776|FG000|Overall Study|Protocol Violation|1|||
37658144|NCT01637272|69130211|FG000|Overall Study|Lost to Follow-up|2|||
37658145|NCT01637272|69130211|FG000|Overall Study|completed core, did not enter ext. phase|4|||
37658146|NCT01637272|69130211|FG000|Overall Study|Administrative problems|1|||
37658147|NCT01637272|69130211|FG000|Overall Study|Protocol Violation|2|||
37658148|NCT01636960|69130230|FG000|Induction Phase|Adverse Event|2|||
37658149|NCT01636960|69130230|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
37855790|NCT00992407|69539141|FG001|Overall Study|Lost to Follow-up|3|||
37658150|NCT01636960|69130230|FG000|Maintenance Phase|Adverse Event|3|||
37658151|NCT01636960|69130230|FG000|Maintenance Phase|Progressive disease|1|||
37658152|NCT01636258|69130236|FG000|Overall Study|Lost to Follow-up|1|||
37658153|NCT01636258|69130237|FG001|Overall Study|Lost to Follow-up|0|||
37746955|NCT01681069|69236777|FG001|Overall Study|Protocol Violation|1|||
37746956|NCT01681069|69236776|FG000|Overall Study|Adverse Event|0|||
37746957|NCT01681069|69236777|FG001|Overall Study|Adverse Event|1|||
37746958|NCT01716559|69236783|FG000|Overall Study|Adverse Event|11|||
37746959|NCT01716559|69236783|FG000|Overall Study|Death|21|||
37746960|NCT01716559|69236783|FG000|Overall Study|Withdrawal by Subject|4|||
37746961|NCT01716559|69236783|FG000|Overall Study|Other withdrawal reason|75|||
37746962|NCT01936181|69236789|FG000|Randomised, Double-blind|Adverse Event|27|||
37746963|NCT01936181|69236790|FG001|Randomised, Double-blind|Adverse Event|21|||
37746964|NCT01936181|69236791|FG002|Randomised, Double-blind|Adverse Event|0|||
37746965|NCT01936181|69236792|FG003|Randomised, Double-blind|Adverse Event|0|||
37746966|NCT01936181|69236789|FG000|Randomised, Double-blind|Protocol Violation|1|||
37746967|NCT01936181|69236790|FG001|Randomised, Double-blind|Protocol Violation|5|||
37746968|NCT01936181|69236791|FG002|Randomised, Double-blind|Protocol Violation|0|||
37746969|NCT01936181|69236792|FG003|Randomised, Double-blind|Protocol Violation|0|||
37746970|NCT01936181|69236789|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
37658154|NCT02504216|69130246|FG000|Overall Study|Lost to Follow-up|3|||
37658155|NCT02504216|69130247|FG001|Overall Study|Lost to Follow-up|3|||
37658156|NCT02504216|69130246|FG000|Overall Study|Withdrawal by Subject|8|||
37746971|NCT01936181|69236790|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
37746972|NCT01936181|69236791|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
37746973|NCT01936181|69236792|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
37746974|NCT01936181|69236789|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
37658157|NCT02504216|69130247|FG001|Overall Study|Withdrawal by Subject|12|||
37658158|NCT04354870|69130255|FG000|Overall Study|Lost to Follow-up|32|||
37658159|NCT04354870|69130256|FG001|Overall Study|Lost to Follow-up|12|||
37658160|NCT04354870|69130255|FG000|Overall Study|Withdrawal by Subject|10|||
37658161|NCT04354870|69130256|FG001|Overall Study|Withdrawal by Subject|16|||
37658162|NCT04354870|69130255|FG000|Overall Study|Did not complete all study visits|6|||
37658163|NCT04354870|69130256|FG001|Overall Study|Did not complete all study visits|5|||
37658164|NCT02473952|69130264|FG000|Overall Study|Adverse Event|2|||
37658165|NCT02473952|69130265|FG001|Overall Study|Adverse Event|2|||
37658166|NCT02473952|69130264|FG000|Overall Study|Withdrawal by Subject|0|||
37658167|NCT02473952|69130265|FG001|Overall Study|Withdrawal by Subject|6|||
37658168|NCT02473640|69130271|FG000|Treatment Period 1|Adverse Event|1|||
37658169|NCT01637584|69130280|FG000|Overall Study|Withdrawal by Subject|1|||
37658170|NCT01637584|69130281|FG001|Overall Study|Withdrawal by Subject|3|||
37746975|NCT01936181|69236790|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
37746976|NCT01936181|69236791|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
37658171|NCT03883906|69130288|FG000|Overall Study|Withdrawal by Subject|2|||
37658172|NCT03883906|69130288|FG000|Overall Study|Physician Decision|5|||
37658173|NCT02503202|69130297|FG000|Base Study: Up to Month 6|Death|1|||
37658174|NCT02503202|69130298|FG001|Base Study: Up to Month 6|Death|1|||
37658175|NCT02503202|69130299|FG002|Base Study: Up to Month 6|Death|0|||
37658176|NCT02503202|69130300|FG003|Base Study: Up to Month 6|Death|0|||
37746977|NCT01936181|69236792|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
37746978|NCT01936181|69236789|FG000|Randomised, Double-blind|Pregnancy|0|||
37746979|NCT01936181|69236790|FG001|Randomised, Double-blind|Pregnancy|1|||
37746980|NCT01936181|69236791|FG002|Randomised, Double-blind|Pregnancy|0|||
37746981|NCT01936181|69236792|FG003|Randomised, Double-blind|Pregnancy|0|||
37746982|NCT01936181|69236789|FG000|Randomised, Double-blind|Physician Decision|4|||
37746983|NCT01936181|69236790|FG001|Randomised, Double-blind|Physician Decision|4|||
37746984|NCT01936181|69236791|FG002|Randomised, Double-blind|Physician Decision|0|||
37746985|NCT01936181|69236792|FG003|Randomised, Double-blind|Physician Decision|0|||
37746986|NCT01936181|69236789|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
37746987|NCT01936181|69236790|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
37746988|NCT01936181|69236791|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
37746989|NCT01936181|69236792|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
37658177|NCT02503202|69130301|FG004|Base Study: Up to Month 6|Death|0|||
37658178|NCT02503202|69130297|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
37746990|NCT01936181|69236789|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
37746991|NCT01936181|69236790|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
37746992|NCT01936181|69236791|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
37923013|NCT00837434|69609814|FG001|Overall Study|Unable to obtain study drug|0|||
37923014|NCT00827918|69609823|FG000|Overall Study|Adverse Event|4|||
37658179|NCT02503202|69130298|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
37658180|NCT02503202|69130299|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
37658181|NCT02503202|69130300|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
37658182|NCT02503202|69130301|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
37923015|NCT00827918|69609824|FG001|Overall Study|Adverse Event|0|||
37746993|NCT01936181|69236792|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
37923016|NCT00827918|69609825|FG002|Overall Study|Adverse Event|0|||
37658183|NCT02503202|69130297|FG000|Base Study: Up to Month 6|Physician Decision|0|||
37658184|NCT02503202|69130298|FG001|Base Study: Up to Month 6|Physician Decision|0|||
37746994|NCT01936181|69236789|FG000|Transition-extension|Adverse Event|3|||
37746995|NCT01936181|69236790|FG001|Transition-extension|Adverse Event|0|||
37746996|NCT01936181|69236791|FG002|Transition-extension|Adverse Event|3|||
37746997|NCT01936181|69236792|FG003|Transition-extension|Adverse Event|1|||
37746998|NCT01936181|69236789|FG000|Transition-extension|Lost to Follow-up|3|||
37746999|NCT01936181|69236790|FG001|Transition-extension|Lost to Follow-up|0|||
37747000|NCT01936181|69236791|FG002|Transition-extension|Lost to Follow-up|1|||
37747001|NCT01936181|69236792|FG003|Transition-extension|Lost to Follow-up|2|||
37747002|NCT01936181|69236789|FG000|Transition-extension|Physician Decision|2|||
37747003|NCT01936181|69236790|FG001|Transition-extension|Physician Decision|0|||
37747004|NCT01936181|69236791|FG002|Transition-extension|Physician Decision|0|||
37747005|NCT01936181|69236792|FG003|Transition-extension|Physician Decision|1|||
37747006|NCT01936181|69236789|FG000|Transition-extension|Withdrawal by Subject|7|||
37747007|NCT01936181|69236790|FG001|Transition-extension|Withdrawal by Subject|0|||
37747008|NCT01936181|69236791|FG002|Transition-extension|Withdrawal by Subject|2|||
37747009|NCT01936181|69236792|FG003|Transition-extension|Withdrawal by Subject|1|||
37747010|NCT01696045|69236805|FG000|Overall Study|Study drug toxicity|1|||
37747011|NCT01696045|69236806|FG001|Overall Study|Study drug toxicity|5|||
37747012|NCT01696045|69236805|FG000|Overall Study|Disease progression|2|||
37747013|NCT01696045|69236806|FG001|Overall Study|Disease progression|2|||
37747014|NCT01716169|69236812|FG000|Overall Study|Adverse Event|1|||
37747015|NCT01716169|69236812|FG000|Overall Study|Lost to Follow-up|1|||
37747016|NCT01716169|69236812|FG000|Overall Study|Withdrawal by Subject|1|||
37747017|NCT01716169|69236812|FG000|Overall Study|inconsistent dressing application|1|||
37747018|NCT01935947|69236821|FG000|Overall Study|Adverse Event|0|||
37747019|NCT01935947|69236822|FG001|Overall Study|Adverse Event|2|||
37747020|NCT01935947|69236823|FG002|Overall Study|Adverse Event|0|||
37747021|NCT01935947|69236821|FG000|Overall Study|Diease Progression|2|||
37747022|NCT01935947|69236822|FG001|Overall Study|Diease Progression|2|||
37747023|NCT01935947|69236823|FG002|Overall Study|Diease Progression|2|||
37747024|NCT01935947|69236821|FG000|Overall Study|Death|1|||
37747025|NCT01935947|69236822|FG001|Overall Study|Death|0|||
37747026|NCT01935947|69236823|FG002|Overall Study|Death|0|||
37747027|NCT01618019|69236836|FG000|Overall Study|Withdrawal by Subject|14|||
37747028|NCT01618019|69236837|FG001|Overall Study|Withdrawal by Subject|14|||
37747029|NCT01593787|69236846|FG000|Overall Study|Adverse Event|1|||
37747030|NCT01593787|69236847|FG001|Overall Study|Adverse Event|0|||
37747031|NCT01593787|69236848|FG002|Overall Study|Adverse Event|0|||
37747032|NCT01951157|69236861|FG000|Overall Study|Progressive Disease|12|||
37747033|NCT01951157|69236862|FG001|Overall Study|Progressive Disease|13|||
37747034|NCT01951157|69236863|FG002|Overall Study|Progressive Disease|10|||
37747035|NCT01951157|69236861|FG000|Overall Study|Treatment-unrelated AE|1|||
37747036|NCT01951157|69236862|FG001|Overall Study|Treatment-unrelated AE|0|||
37747037|NCT01951157|69236863|FG002|Overall Study|Treatment-unrelated AE|3|||
37747038|NCT01951157|69236861|FG000|Overall Study|Study Termination|0|||
37747039|NCT01951157|69236862|FG001|Overall Study|Study Termination|0|||
37658185|NCT02503202|69130299|FG002|Base Study: Up to Month 6|Physician Decision|0|||
37658186|NCT02503202|69130300|FG003|Base Study: Up to Month 6|Physician Decision|0|||
37658187|NCT02503202|69130301|FG004|Base Study: Up to Month 6|Physician Decision|1|||
37658188|NCT02503202|69130297|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
37658189|NCT02503202|69130298|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
37658190|NCT02503202|69130299|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
37658191|NCT02503202|69130300|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
37658192|NCT02503202|69130301|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
37658193|NCT02503202|69130297|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
37658194|NCT02503202|69130298|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
37658195|NCT02503202|69130299|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
37658196|NCT02503202|69130300|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
37658197|NCT02503202|69130301|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
37747040|NCT01951157|69236863|FG002|Overall Study|Study Termination|1|||
37747041|NCT01951157|69236861|FG000|Overall Study|Physician Decision|5|||
37747042|NCT01951157|69236862|FG001|Overall Study|Physician Decision|3|||
37658198|NCT02503202|69130297|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
37747043|NCT01951157|69236863|FG002|Overall Study|Physician Decision|2|||
37747044|NCT01951157|69236861|FG000|Overall Study|Non-treatmentrelated death|2|||
37747045|NCT01951157|69236862|FG001|Overall Study|Non-treatmentrelated death|2|||
37747046|NCT01951157|69236863|FG002|Overall Study|Non-treatmentrelated death|2|||
37747047|NCT01951157|69236861|FG000|Overall Study|No treated|0|||
37747048|NCT01951157|69236862|FG001|Overall Study|No treated|1|||
37747049|NCT01951157|69236863|FG002|Overall Study|No treated|0|||
37747050|NCT01951157|69236861|FG000|Overall Study|Treatment-related AE|2|||
37747051|NCT01951157|69236862|FG001|Overall Study|Treatment-related AE|0|||
37855791|NCT00992407|69539140|FG000|Overall Study|Adverse Event|3|||
37855792|NCT00992407|69539141|FG001|Overall Study|Adverse Event|2|||
37855793|NCT00992407|69539140|FG000|Overall Study|protocol Violation & Adverse events|2|||
37855794|NCT00992407|69539141|FG001|Overall Study|protocol Violation & Adverse events|4|||
37747052|NCT01951157|69236863|FG002|Overall Study|Treatment-related AE|4|||
37747053|NCT01951157|69236861|FG000|Overall Study|Consent withdrawn by subject|0|||
37747054|NCT01951157|69236862|FG001|Overall Study|Consent withdrawn by subject|1|||
37747055|NCT01951157|69236863|FG002|Overall Study|Consent withdrawn by subject|3|||
37747056|NCT01951157|69236861|FG000|Overall Study|Treatment-related death|0|||
37747057|NCT01951157|69236862|FG001|Overall Study|Treatment-related death|2|||
37747058|NCT01951157|69236863|FG002|Overall Study|Treatment-related death|0|||
37747059|NCT01363349|69236874|FG000|Overall Study|Adverse Event|6|||
37747060|NCT01363349|69236875|FG001|Overall Study|Adverse Event|7|||
37747061|NCT01363349|69236874|FG000|Overall Study|Lack of Efficacy|3|||
37747062|NCT01363349|69236875|FG001|Overall Study|Lack of Efficacy|10|||
37747063|NCT01363349|69236874|FG000|Overall Study|Non compliance/Protocol deviations|2|||
37747064|NCT01363349|69236875|FG001|Overall Study|Non compliance/Protocol deviations|2|||
37747065|NCT01363349|69236874|FG000|Overall Study|Withdrawal by Subject|14|||
37747066|NCT01363349|69236875|FG001|Overall Study|Withdrawal by Subject|6|||
37747067|NCT01363349|69236874|FG000|Overall Study|Lost to Follow-up|5|||
37747068|NCT01363349|69236875|FG001|Overall Study|Lost to Follow-up|6|||
37747069|NCT01363349|69236874|FG000|Overall Study|Not reported|36|||
37747070|NCT01363349|69236875|FG001|Overall Study|Not reported|37|||
37747071|NCT01363349|69236874|FG000|Overall Study|missing|1|||
37747072|NCT01363349|69236875|FG001|Overall Study|missing|2|||
37747073|NCT01933919|69236966|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
37747074|NCT01933919|69236967|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
37747075|NCT01933919|69236966|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
37747076|NCT01933919|69236967|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
37747077|NCT01933919|69236966|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
37747078|NCT01933919|69236967|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
37747079|NCT01933919|69236966|FG000|Open-label Long-term Phase|Adverse Event|2|||
37747080|NCT01933919|69236967|FG001|Open-label Long-term Phase|Adverse Event|0|||
37747081|NCT01933919|69236966|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
37747082|NCT01933919|69236967|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
37747083|NCT01933919|69236966|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
37747084|NCT01933919|69236967|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
37658199|NCT02503202|69130298|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
37747085|NCT01933919|69236966|FG000|Open-label Long-term Phase|Other|1|||
37747086|NCT01933919|69236967|FG001|Open-label Long-term Phase|Other|2|||
37747087|NCT01933217|69236996|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
37747088|NCT01933217|69236997|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
37747089|NCT01933217|69236996|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
37747090|NCT01933217|69236997|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
37747091|NCT01932437|69237007|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
37747092|NCT01932437|69237008|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
37855795|NCT00992407|69539140|FG000|Overall Study|Other|2|||
37855796|NCT00992407|69539141|FG001|Overall Study|Other|0|||
37855797|NCT00992407|69539140|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
37658200|NCT02503202|69130299|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
37658201|NCT02503202|69130300|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
37658202|NCT02503202|69130301|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
37658203|NCT02503202|69130297|FG000|Extension: Month 6 to 24|Death|1|||
37658204|NCT02503202|69130298|FG001|Extension: Month 6 to 24|Death|0|||
37658205|NCT02503202|69130299|FG002|Extension: Month 6 to 24|Death|0|||
37658206|NCT02503202|69130300|FG003|Extension: Month 6 to 24|Death|0|||
37658207|NCT02503202|69130301|FG004|Extension: Month 6 to 24|Death|0|||
37658208|NCT02503202|69130297|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
37658209|NCT02503202|69130298|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
37658210|NCT02503202|69130299|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
37658211|NCT02503202|69130300|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
37658212|NCT02503202|69130301|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
37658213|NCT02503202|69130297|FG000|Extension: Month 6 to 24|Physician Decision|1|||
37658214|NCT02503202|69130298|FG001|Extension: Month 6 to 24|Physician Decision|0|||
37658215|NCT02503202|69130299|FG002|Extension: Month 6 to 24|Physician Decision|1|||
37658216|NCT02503202|69130300|FG003|Extension: Month 6 to 24|Physician Decision|3|||
37747093|NCT01932437|69237009|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
37747094|NCT01932437|69237010|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
37747095|NCT01932437|69237011|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
37747096|NCT01932437|69237012|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
37747097|NCT01949051|69237033|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
37747098|NCT01949051|69237034|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
37747099|NCT01949051|69237035|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
37855798|NCT00992407|69539141|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
37747100|NCT01949051|69237036|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
37855799|NCT00992407|69539140|FG000|Overall Study|Study medication not administered|17|||
37855800|NCT00992407|69539141|FG001|Overall Study|Study medication not administered|13|||
37658217|NCT02503202|69130301|FG004|Extension: Month 6 to 24|Physician Decision|0|||
37658218|NCT02503202|69130297|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
37658219|NCT02503202|69130298|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
37658220|NCT02503202|69130299|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
37747101|NCT01949051|69237037|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
37747102|NCT01949051|69237038|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
37747103|NCT01949051|69237033|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
37747104|NCT01949051|69237034|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
37747105|NCT01949051|69237035|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
37747106|NCT01949051|69237036|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
37747107|NCT01949051|69237037|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
37747108|NCT01949051|69237038|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
37747109|NCT01949051|69237033|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
37747110|NCT01949051|69237034|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
37747111|NCT01949051|69237035|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
37747112|NCT01949051|69237036|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
37747113|NCT01949051|69237037|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
37747114|NCT01949051|69237038|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
37747115|NCT01949051|69237033|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
37747116|NCT01949051|69237034|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
37747117|NCT01949051|69237035|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
37747118|NCT01949051|69237036|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
37747119|NCT01949051|69237037|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
37747120|NCT01949051|69237038|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
37747121|NCT01949051|69237033|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
37747122|NCT01949051|69237034|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
37747123|NCT01949051|69237035|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
37747124|NCT01949051|69237036|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
37747125|NCT01949051|69237037|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
37747126|NCT01949051|69237038|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
37747127|NCT01948427|69237051|FG000|Overall Study|Serious Adverse Event|3|||
37747128|NCT01948427|69237052|FG001|Overall Study|Serious Adverse Event|0|||
37747129|NCT01948427|69237053|FG002|Overall Study|Serious Adverse Event|0|||
37747130|NCT01948427|69237054|FG003|Overall Study|Serious Adverse Event|0|||
37747131|NCT01948427|69237055|FG004|Overall Study|Serious Adverse Event|1|||
37747132|NCT01948427|69237051|FG000|Overall Study|Investigator Request|0|||
37747133|NCT01948427|69237052|FG001|Overall Study|Investigator Request|8|||
37747134|NCT01948427|69237053|FG002|Overall Study|Investigator Request|0|||
37747135|NCT01948427|69237054|FG003|Overall Study|Investigator Request|0|||
37747136|NCT01948427|69237055|FG004|Overall Study|Investigator Request|6|||
37747137|NCT01948427|69237051|FG000|Overall Study|Lost to Follow-up|1|||
37747138|NCT01948427|69237052|FG001|Overall Study|Lost to Follow-up|0|||
37747139|NCT01948427|69237053|FG002|Overall Study|Lost to Follow-up|0|||
37747140|NCT01948427|69237054|FG003|Overall Study|Lost to Follow-up|0|||
37747141|NCT01948427|69237055|FG004|Overall Study|Lost to Follow-up|4|||
37747142|NCT01948427|69237051|FG000|Overall Study|Withdrawal by Subject|2|||
37658221|NCT02503202|69130300|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
37658222|NCT02503202|69130301|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
37658223|NCT02728102|69130316|FG000|Overall Study|Death|3|||
37658224|NCT02728102|69130317|FG001|Overall Study|Death|0|||
37658225|NCT02728102|69130318|FG002|Overall Study|Death|1|||
37658226|NCT02728102|69130316|FG000|Overall Study|Withdrawal by Subject|0|||
37658227|NCT02728102|69130317|FG001|Overall Study|Withdrawal by Subject|2|||
37658228|NCT02728102|69130318|FG002|Overall Study|Withdrawal by Subject|3|||
37658229|NCT02728102|69130316|FG000|Overall Study|Physician Decision|1|||
37658230|NCT02728102|69130317|FG001|Overall Study|Physician Decision|1|||
37658231|NCT02728102|69130318|FG002|Overall Study|Physician Decision|0|||
37658232|NCT02728102|69130316|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
37658233|NCT02728102|69130317|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
37658234|NCT02728102|69130318|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
37658235|NCT02728102|69130316|FG000|Overall Study|Covid|0|||
37747143|NCT01948427|69237052|FG001|Overall Study|Withdrawal by Subject|0|||
37855801|NCT00986479|69539152|FG000|Period 1|Improved mood|1|||
37855802|NCT00986479|69539153|FG001|Period 1|Improved mood|0|||
37855803|NCT00986479|69539152|FG000|Period 1|Administrative reasons|1|||
37658236|NCT02728102|69130317|FG001|Overall Study|Covid|0|||
37658237|NCT02728102|69130318|FG002|Overall Study|Covid|1|||
37747144|NCT01948427|69237053|FG002|Overall Study|Withdrawal by Subject|0|||
37747145|NCT01948427|69237054|FG003|Overall Study|Withdrawal by Subject|0|||
37747146|NCT01948427|69237055|FG004|Overall Study|Withdrawal by Subject|1|||
37747147|NCT01948427|69237051|FG000|Overall Study|Other, Not Specified|1|||
37747148|NCT01948427|69237052|FG001|Overall Study|Other, Not Specified|9|||
37855804|NCT00986479|69539153|FG001|Period 1|Administrative reasons|0|||
37855805|NCT00986245|69539159|FG000|First Intervention|Poor compliance|8|||
37747149|NCT01948427|69237053|FG002|Overall Study|Other, Not Specified|0|||
37747150|NCT01948427|69237054|FG003|Overall Study|Other, Not Specified|0|||
37747151|NCT01948427|69237055|FG004|Overall Study|Other, Not Specified|2|||
37747152|NCT01948193|69237072|FG000|Overall Study|Serious event|2|||
37747153|NCT01948193|69237072|FG000|Overall Study|Lost to Follow-up|7|||
37747154|NCT01694485|69237082|FG000|Overall Study|Withdrawal by Subject|20|||
37747155|NCT01694485|69237083|FG001|Overall Study|Withdrawal by Subject|6|||
37747156|NCT01694485|69237084|FG002|Overall Study|Withdrawal by Subject|7|||
37747157|NCT01694485|69237085|FG003|Overall Study|Withdrawal by Subject|25|||
37747158|NCT01694485|69237086|FG004|Overall Study|Withdrawal by Subject|18|||
37747159|NCT01694485|69237082|FG000|Overall Study|Sponsor Decision|3|||
37747160|NCT01694485|69237083|FG001|Overall Study|Sponsor Decision|0|||
37747161|NCT01694485|69237084|FG002|Overall Study|Sponsor Decision|0|||
37658238|NCT02502734|69130327|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
37658239|NCT02502734|69130328|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
37658240|NCT02502734|69130327|FG000|Washout Period|Adverse Event|1|||
37658241|NCT02502734|69130328|FG001|Washout Period|Adverse Event|0|||
37658242|NCT02473250|69130336|FG000|Overall Study|Lost to Follow-up|10|||
37658243|NCT02473250|69130336|FG000|Overall Study|Physician Decision|5|||
37658244|NCT02473250|69130336|FG000|Overall Study|Did not tolerate medication washout|3|||
37747162|NCT01694485|69237085|FG003|Overall Study|Sponsor Decision|2|||
37747163|NCT01694485|69237086|FG004|Overall Study|Sponsor Decision|0|||
37747164|NCT01694485|69237082|FG000|Overall Study|Lost to Follow-up|9|||
37747165|NCT01694485|69237083|FG001|Overall Study|Lost to Follow-up|1|||
37747166|NCT01694485|69237084|FG002|Overall Study|Lost to Follow-up|6|||
37747167|NCT01694485|69237085|FG003|Overall Study|Lost to Follow-up|10|||
37747168|NCT01694485|69237086|FG004|Overall Study|Lost to Follow-up|7|||
37747169|NCT01694485|69237082|FG000|Overall Study|Death|1|||
37747170|NCT01694485|69237083|FG001|Overall Study|Death|0|||
37747171|NCT01694485|69237084|FG002|Overall Study|Death|0|||
37747172|NCT01694485|69237085|FG003|Overall Study|Death|1|||
37747173|NCT01694485|69237086|FG004|Overall Study|Death|0|||
37747174|NCT01931735|69237107|FG000|Randomized Phase|Lost to Follow-up|2|||
37747175|NCT01931735|69237108|FG001|Randomized Phase|Lost to Follow-up|2|||
37747176|NCT01931735|69237109|FG002|Randomized Phase|Lost to Follow-up|5|||
37747177|NCT01931735|69237110|FG003|Randomized Phase|Lost to Follow-up|0|||
37747178|NCT01931735|69237107|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
37747179|NCT01931735|69237108|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
37747180|NCT01931735|69237109|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
37747181|NCT01931735|69237110|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
37747182|NCT01931735|69237107|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
37747183|NCT01931735|69237108|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
37747184|NCT01931735|69237109|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
37747185|NCT01931735|69237110|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
37747186|NCT01930799|69237120|FG000|Overall Study|Withdrawal by Subject|3|||
37855806|NCT00986245|69539160|FG001|First Intervention|Poor compliance|4|||
37855807|NCT00986245|69539159|FG000|First Intervention|Lack of Efficacy|1|||
37855808|NCT00986245|69539160|FG001|First Intervention|Lack of Efficacy|2|||
37855809|NCT00986245|69539159|FG000|First Intervention|Withdrawal by Subject|0|||
37855810|NCT00986245|69539160|FG001|First Intervention|Withdrawal by Subject|1|||
37855811|NCT00986245|69539159|FG000|First Intervention|Protocol Violation|0|||
37855812|NCT00986245|69539160|FG001|First Intervention|Protocol Violation|1|||
37658245|NCT02473250|69130336|FG000|Overall Study|Antidepressant effect of divalproex|2|||
37747187|NCT01930799|69237120|FG000|Overall Study|Lost to Follow-up|5|||
37747188|NCT01947491|69237128|FG000|Overall Study|Lost to Follow-up|5|||
37747189|NCT01947491|69237129|FG001|Overall Study|Lost to Follow-up|3|||
37747190|NCT01947491|69237130|FG002|Overall Study|Lost to Follow-up|1|||
37747191|NCT01947491|69237131|FG003|Overall Study|Lost to Follow-up|2|||
37747192|NCT01947491|69237128|FG000|Overall Study|Lack of Efficacy|1|||
37747193|NCT01947491|69237129|FG001|Overall Study|Lack of Efficacy|0|||
37747194|NCT01947491|69237130|FG002|Overall Study|Lack of Efficacy|0|||
37747195|NCT01947491|69237131|FG003|Overall Study|Lack of Efficacy|1|||
37855813|NCT00986245|69539159|FG000|First Intervention|Out of indication|1|||
37747196|NCT01947491|69237128|FG000|Overall Study|Protocol Violation|1|||
37855814|NCT00986245|69539160|FG001|First Intervention|Out of indication|0|||
37855815|NCT00986245|69539159|FG000|Second Intervention|Poor compliance|1|||
37747197|NCT01947491|69237129|FG001|Overall Study|Protocol Violation|0|||
37747198|NCT01947491|69237130|FG002|Overall Study|Protocol Violation|0|||
37747199|NCT01947491|69237131|FG003|Overall Study|Protocol Violation|0|||
37747200|NCT01947491|69237128|FG000|Overall Study|Withdrawal by Subject|1|||
37747201|NCT01947491|69237129|FG001|Overall Study|Withdrawal by Subject|1|||
37747202|NCT01947491|69237130|FG002|Overall Study|Withdrawal by Subject|1|||
37747203|NCT01947491|69237131|FG003|Overall Study|Withdrawal by Subject|0|||
37855816|NCT00986245|69539160|FG001|Second Intervention|Poor compliance|0|||
37855817|NCT00986245|69539159|FG000|Second Intervention|Lost to Follow-up|1|||
37855818|NCT00986245|69539160|FG001|Second Intervention|Lost to Follow-up|0|||
37747204|NCT01947491|69237128|FG000|Overall Study|Worsening of condition|0|||
37747205|NCT01947491|69237129|FG001|Overall Study|Worsening of condition|1|||
37747206|NCT01947491|69237130|FG002|Overall Study|Worsening of condition|0|||
37747207|NCT01947491|69237131|FG003|Overall Study|Worsening of condition|0|||
37747208|NCT01947491|69237128|FG000|Overall Study|Adverse Event|0|||
37747209|NCT01947491|69237129|FG001|Overall Study|Adverse Event|1|||
37747210|NCT01947491|69237130|FG002|Overall Study|Adverse Event|0|||
37747211|NCT01947491|69237131|FG003|Overall Study|Adverse Event|2|||
37747212|NCT01715857|69237141|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
37747213|NCT01692301|69237147|FG000|Overall Study|Adverse Event|15|||
37747214|NCT01692301|69237148|FG001|Overall Study|Adverse Event|12|||
37747215|NCT01692301|69237147|FG000|Overall Study|Death|1|||
37747216|NCT01692301|69237148|FG001|Overall Study|Death|2|||
37747217|NCT01692301|69237147|FG000|Overall Study|Lack of Efficacy|0|||
37747218|NCT01692301|69237148|FG001|Overall Study|Lack of Efficacy|5|||
37747219|NCT01692301|69237147|FG000|Overall Study|Non-compliance with study treatment|1|||
37747220|NCT01692301|69237148|FG001|Overall Study|Non-compliance with study treatment|2|||
37747221|NCT01692301|69237147|FG000|Overall Study|Protocol deviation|9|||
37747222|NCT01692301|69237148|FG001|Overall Study|Protocol deviation|2|||
37747223|NCT01692301|69237147|FG000|Overall Study|Patient/guardian decision|16|||
37747224|NCT01692301|69237148|FG001|Overall Study|Patient/guardian decision|15|||
37747225|NCT01692301|69237147|FG000|Overall Study|Technical problems|0|||
37747226|NCT01692301|69237148|FG001|Overall Study|Technical problems|1|||
37747227|NCT01692301|69237147|FG000|Overall Study|Physician Decision|2|||
37747228|NCT01692301|69237148|FG001|Overall Study|Physician Decision|2|||
37747229|NCT01692301|69237147|FG000|Overall Study|Lost to Follow-up|1|||
37747230|NCT01692301|69237148|FG001|Overall Study|Lost to Follow-up|1|||
37747231|NCT01592773|69237154|FG000|Overall Study|Study Terminated by Sponsor|582|||
37747232|NCT01592773|69237154|FG000|Overall Study|Withdrawal by Subject|35|||
37747233|NCT01592773|69237154|FG000|Overall Study|Lost to Follow-up|19|||
37747234|NCT01592773|69237154|FG000|Overall Study|Adverse Event|17|||
37747235|NCT01592773|69237154|FG000|Overall Study|Lack of Efficacy|9|||
37747236|NCT01592773|69237154|FG000|Overall Study|Protocol Violation|2|||
37747237|NCT01592773|69237154|FG000|Overall Study|Inclusion/exclusion not meet|1|||
37747238|NCT01592773|69237154|FG000|Overall Study|Other Reason|1|||
37747239|NCT01930175|69237161|FG000|Core Study|Lost to Follow-up|0|||
37747240|NCT01930175|69237162|FG001|Core Study|Lost to Follow-up|1|||
37747241|NCT01930175|69237163|FG002|Core Study|Lost to Follow-up|0|||
37747242|NCT01930175|69237161|FG000|Core Study|Adverse Event|0|||
37747243|NCT01930175|69237162|FG001|Core Study|Adverse Event|0|||
37747244|NCT01930175|69237163|FG002|Core Study|Adverse Event|1|||
37747245|NCT01592695|69237174|FG000|Overall Study|Lost to Follow-up|8|||
37747246|NCT01592695|69237175|FG001|Overall Study|Lost to Follow-up|4|||
38033011|NCT02820844|69719001|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
37658246|NCT02706730|69130341|FG000|Overall Study|Adverse Event|3|||
37658247|NCT02706730|69130341|FG000|Overall Study|Lack of Efficacy|5|||
37658248|NCT02706730|69130341|FG000|Overall Study|Withdrawal by Subject|11|||
37658249|NCT02706730|69130341|FG000|Overall Study|Study Terminated by Sponsor|11|||
37658250|NCT02706730|69130341|FG000|Overall Study|Subject chose not to receive injection|3|||
37658251|NCT02443688|69130348|FG000|Overall Study|Adverse Event|2|||
37658252|NCT02443688|69130349|FG001|Overall Study|Adverse Event|3|||
38033012|NCT02820844|69719002|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
38033013|NCT02820844|69719003|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
37658253|NCT02443688|69130350|FG002|Overall Study|Adverse Event|2|||
37658254|NCT02443688|69130348|FG000|Overall Study|Lost to Follow-up|1|||
37658255|NCT02443688|69130349|FG001|Overall Study|Lost to Follow-up|0|||
37658256|NCT02443688|69130350|FG002|Overall Study|Lost to Follow-up|0|||
37658257|NCT02443688|69130348|FG000|Overall Study|Physician Decision|3|||
37658258|NCT02443688|69130349|FG001|Overall Study|Physician Decision|0|||
37658259|NCT02443688|69130350|FG002|Overall Study|Physician Decision|1|||
37658260|NCT02443688|69130348|FG000|Overall Study|Pregnancy|0|||
37658261|NCT02443688|69130349|FG001|Overall Study|Pregnancy|0|||
37658262|NCT02443688|69130350|FG002|Overall Study|Pregnancy|1|||
37658263|NCT02443688|69130348|FG000|Overall Study|Withdrawal by Subject|3|||
37658264|NCT02443688|69130349|FG001|Overall Study|Withdrawal by Subject|3|||
37658265|NCT02443688|69130350|FG002|Overall Study|Withdrawal by Subject|4|||
37658266|NCT02443688|69130348|FG000|Overall Study|Non-compliance with study drug|1|||
37658267|NCT02443688|69130349|FG001|Overall Study|Non-compliance with study drug|2|||
37747247|NCT01929863|69237181|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
37747248|NCT01929863|69237182|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
37747249|NCT01929863|69237181|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
37747250|NCT01929863|69237182|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
37747251|NCT01929863|69237181|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
37747252|NCT01929863|69237182|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
37747253|NCT01918085|69237195|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
37747254|NCT01918085|69237196|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
37747255|NCT01714687|69237206|FG000|Overall Study|Withdrawal by Subject|1|||
37747256|NCT01714687|69237207|FG001|Overall Study|Withdrawal by Subject|0|||
37747257|NCT01714687|69237206|FG000|Overall Study|Lost to Follow-up|2|||
37747258|NCT01714687|69237207|FG001|Overall Study|Lost to Follow-up|4|||
37747259|NCT01714609|69237217|FG000|Overall Study|Protocol Violation|1|||
37747260|NCT01714609|69237218|FG001|Overall Study|Protocol Violation|0|||
37747261|NCT01929707|69237224|FG000|Intervention Period 1|Lost to Follow-up|0|||
37747262|NCT01929707|69237225|FG001|Intervention Period 1|Lost to Follow-up|0|||
37747263|NCT01929707|69237226|FG002|Intervention Period 1|Lost to Follow-up|0|||
37747264|NCT01929707|69237227|FG003|Intervention Period 1|Lost to Follow-up|1|||
37747265|NCT01929707|69237228|FG004|Intervention Period 1|Lost to Follow-up|0|||
37747266|NCT01929707|69237229|FG005|Intervention Period 1|Lost to Follow-up|0|||
37747267|NCT01929707|69237230|FG006|Intervention Period 1|Lost to Follow-up|0|||
37747268|NCT01929707|69237231|FG007|Intervention Period 1|Lost to Follow-up|0|||
37747269|NCT01929707|69237224|FG000|Intervention Period 1|Withdrawal by Subject|0|||
37747270|NCT01929707|69237225|FG001|Intervention Period 1|Withdrawal by Subject|0|||
37747271|NCT01929707|69237226|FG002|Intervention Period 1|Withdrawal by Subject|0|||
37747272|NCT01929707|69237227|FG003|Intervention Period 1|Withdrawal by Subject|2|||
37747273|NCT01929707|69237228|FG004|Intervention Period 1|Withdrawal by Subject|0|||
37747274|NCT01929707|69237229|FG005|Intervention Period 1|Withdrawal by Subject|0|||
37658268|NCT02443688|69130350|FG002|Overall Study|Non-compliance with study drug|4|||
37658269|NCT02443688|69130348|FG000|Overall Study|Sponsor Request|2|||
37658270|NCT02443688|69130349|FG001|Overall Study|Sponsor Request|1|||
37658271|NCT02443688|69130350|FG002|Overall Study|Sponsor Request|0|||
37658272|NCT02443298|69130364|FG000|Overall Study|Adverse Event|3|||
37658273|NCT02443298|69130365|FG001|Overall Study|Adverse Event|3|||
37658274|NCT02443298|69130364|FG000|Overall Study|Withdrawal by Subject|1|||
37658275|NCT02443298|69130365|FG001|Overall Study|Withdrawal by Subject|2|||
37658276|NCT02500706|69130374|FG000|Overall Study|Adverse Event|0|||
37658277|NCT02500706|69130375|FG001|Overall Study|Adverse Event|0|||
37658278|NCT02500706|69130376|FG002|Overall Study|Adverse Event|1|||
37658279|NCT02500706|69130374|FG000|Overall Study|Lost to Follow-up|0|||
37658280|NCT02500706|69130375|FG001|Overall Study|Lost to Follow-up|1|||
37658281|NCT02500706|69130376|FG002|Overall Study|Lost to Follow-up|1|||
37747275|NCT01929707|69237230|FG006|Intervention Period 1|Withdrawal by Subject|0|||
37747276|NCT01929707|69237231|FG007|Intervention Period 1|Withdrawal by Subject|0|||
37747277|NCT01929707|69237224|FG000|Intervention Period 2|Withdrawal by Subject|0|||
37747278|NCT01929707|69237225|FG001|Intervention Period 2|Withdrawal by Subject|0|||
37747279|NCT01929707|69237226|FG002|Intervention Period 2|Withdrawal by Subject|0|||
37747280|NCT01929707|69237227|FG003|Intervention Period 2|Withdrawal by Subject|0|||
37658282|NCT02500706|69130374|FG000|Overall Study|Withdrawal by Subject|4|||
37658283|NCT02500706|69130375|FG001|Overall Study|Withdrawal by Subject|6|||
37658284|NCT02500706|69130376|FG002|Overall Study|Withdrawal by Subject|4|||
37658285|NCT02500706|69130374|FG000|Overall Study|Unclassified|0|||
37658286|NCT02500706|69130375|FG001|Overall Study|Unclassified|0|||
37658287|NCT02500706|69130376|FG002|Overall Study|Unclassified|1|||
37658288|NCT02442830|69130386|FG000|Overall Study|Technical Failure|0|||
37658289|NCT02442830|69130387|FG001|Overall Study|Technical Failure|1|||
37658290|NCT02471612|69130394|FG000|Overall Study|Lost to Follow-up|2|||
37658291|NCT02500550|69130411|FG000|Overall Study|Death|7|||
37658292|NCT02499770|69130417|FG000|Overall Study|Death|17|||
37658293|NCT02499770|69130418|FG001|Overall Study|Death|56|||
37658294|NCT02499770|69130417|FG000|Overall Study|Study completion|1|||
37658295|NCT02499770|69130418|FG001|Overall Study|Study completion|10|||
37658296|NCT02499770|69130417|FG000|Overall Study|Withdrawal by Subject|0|||
37658297|NCT02499770|69130418|FG001|Overall Study|Withdrawal by Subject|7|||
37658298|NCT02499770|69130417|FG000|Overall Study|Lost to Follow-up|0|||
37658299|NCT02499770|69130418|FG001|Overall Study|Lost to Follow-up|2|||
37658300|NCT02499770|69130417|FG000|Overall Study|Subject declined further treatment|1|||
37658301|NCT02499770|69130418|FG001|Overall Study|Subject declined further treatment|0|||
37658302|NCT02499770|69130417|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
37658303|NCT02499770|69130418|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
37658304|NCT02499770|69130417|FG000|Overall Study|Randomized but not enrolled|0|||
37658305|NCT02499770|69130418|FG001|Overall Study|Randomized but not enrolled|1|||
37658306|NCT02442284|69130430|FG000|Overall Study|Adverse Event|1|||
37658307|NCT02442284|69130430|FG000|Overall Study|Withdrew Consent|2|||
37747281|NCT01929707|69237228|FG004|Intervention Period 2|Withdrawal by Subject|0|||
37747282|NCT01929707|69237229|FG005|Intervention Period 2|Withdrawal by Subject|2|||
37747283|NCT01929707|69237230|FG006|Intervention Period 2|Withdrawal by Subject|0|||
37747284|NCT01929707|69237231|FG007|Intervention Period 2|Withdrawal by Subject|0|||
37747285|NCT01714063|69237252|FG000|Overall Study|Equipment malfunction|2|||
37855819|NCT00986245|69539159|FG000|Second Intervention|Protocol Violation|0|||
37658308|NCT02442284|69130430|FG000|Overall Study|Lost to Follow-up|3|||
37658309|NCT02442284|69130430|FG000|Overall Study|Other|1|||
37658310|NCT02442206|69130440|FG000|Period 1|Adverse Event|1|||
37747286|NCT01929395|69237263|FG000|Overall Study|Did not complete - non-related toxicity|1|||
37747287|NCT01929395|69237264|FG001|Overall Study|Did not complete - non-related toxicity|0|||
37747288|NCT01929395|69237265|FG002|Overall Study|Did not complete - non-related toxicity|0|||
37747289|NCT01929395|69237263|FG000|Overall Study|Withdrawal by Subject|0|||
37747290|NCT01929395|69237264|FG001|Overall Study|Withdrawal by Subject|1|||
37747291|NCT01929395|69237265|FG002|Overall Study|Withdrawal by Subject|0|||
37747292|NCT01929395|69237263|FG000|Overall Study|Screen Fail|0|||
37747293|NCT01929395|69237264|FG001|Overall Study|Screen Fail|0|||
37747294|NCT01929395|69237265|FG002|Overall Study|Screen Fail|1|||
37747295|NCT01713283|69237277|FG000|Overall Study|Lack of Efficacy|10|||
37747296|NCT01713283|69237278|FG001|Overall Study|Lack of Efficacy|2|||
37747297|NCT01713283|69237277|FG000|Overall Study|Lost to Follow-up|1|||
37747298|NCT01713283|69237278|FG001|Overall Study|Lost to Follow-up|1|||
37747299|NCT01592383|69237288|FG000|Overall Study|Adverse Event|1|||
37747300|NCT01691521|69237296|FG000|Overall Study|Adverse Event|4|||
37747301|NCT01691521|69237297|FG001|Overall Study|Adverse Event|0|||
37747302|NCT01691521|69237298|FG002|Overall Study|Adverse Event|1|||
37747303|NCT01691521|69237296|FG000|Overall Study|Lack of Efficacy|1|||
37747304|NCT01691521|69237297|FG001|Overall Study|Lack of Efficacy|1|||
37747305|NCT01691521|69237298|FG002|Overall Study|Lack of Efficacy|2|||
37747306|NCT01691521|69237296|FG000|Overall Study|Protocol Violation|0|||
37747307|NCT01691521|69237297|FG001|Overall Study|Protocol Violation|3|||
37747308|NCT01691521|69237298|FG002|Overall Study|Protocol Violation|0|||
37747309|NCT01691521|69237296|FG000|Overall Study|Lost to Follow-up|0|||
37747310|NCT01691521|69237297|FG001|Overall Study|Lost to Follow-up|2|||
37855820|NCT00986245|69539160|FG001|Second Intervention|Protocol Violation|1|||
37658311|NCT02442206|69130441|FG001|Period 1|Adverse Event|1|||
37658312|NCT02442206|69130440|FG000|Period 1|withdrew consent|0|||
37658313|NCT02442206|69130441|FG001|Period 1|withdrew consent|1|||
37658314|NCT02442206|69130440|FG000|Period 1|COPD exacerbation|0|||
37658315|NCT02442206|69130441|FG001|Period 1|COPD exacerbation|1|||
37658316|NCT02442206|69130440|FG000|Period 2|Adverse Event|1|||
37658317|NCT02442206|69130441|FG001|Period 2|Adverse Event|0|||
37658318|NCT02499146|69130448|FG000|Overall Study|Lost to Follow-up|1|||
37658319|NCT02499146|69130448|FG000|Overall Study|Withdrawal by Subject|1|||
37658320|NCT02499146|69130448|FG000|Overall Study|Other|2|||
37658321|NCT02499146|69130448|FG000|Overall Study|Ongoing at date of cut-off|9|||
37658322|NCT02499146|69130448|FG000|Overall Study|Began other treatment/therapy|13|||
37658323|NCT03544138|69130452|FG000|Overall Study|Lost to Follow-up|29|||
37658324|NCT01634854|69130458|FG000|Overall Study|Cesarean delivery|2|||
37658325|NCT01634854|69130459|FG001|Overall Study|Cesarean delivery|7|||
37658326|NCT02469896|69130467|FG000|Overall Study|Withdrawal by Subject|2|||
37658327|NCT02469896|69130468|FG001|Overall Study|Withdrawal by Subject|0|||
37658328|NCT02441114|69130478|FG000|Washout2|Withdrawal by Subject|4|||
37658329|NCT02498678|69130484|FG000|Overall Study|interference from the surgical team|0|||
37658330|NCT02498678|69130485|FG001|Overall Study|interference from the surgical team|2|||
37658331|NCT02441036|69130496|FG000|Overall Study|No tissue resected|0|||
37658332|NCT02441036|69130497|FG001|Overall Study|No tissue resected|1|||
37658333|NCT02441036|69130498|FG002|Overall Study|No tissue resected|0|||
37658334|NCT02441036|69130499|FG003|Overall Study|No tissue resected|1|||
37658335|NCT02441036|69130500|FG004|Overall Study|No tissue resected|0|||
37658336|NCT02498444|69130515|FG000|Overall Study|Withdrawal by Subject|3|||
37658337|NCT02498444|69130516|FG001|Overall Study|Withdrawal by Subject|0|||
37658338|NCT02498444|69130515|FG000|Overall Study|Physician Decision|1|||
37658339|NCT02498444|69130516|FG001|Overall Study|Physician Decision|0|||
37658340|NCT02497976|69130524|FG000|Overall Study|Withdrawal by Subject|2|||
37658341|NCT02497976|69130525|FG001|Overall Study|Withdrawal by Subject|0|||
37658342|NCT02497976|69130524|FG000|Overall Study|Moved out of area|0|||
37747311|NCT01691521|69237298|FG002|Overall Study|Lost to Follow-up|2|||
37747312|NCT01691521|69237296|FG000|Overall Study|Physician Decision|2|||
37747313|NCT01691521|69237297|FG001|Overall Study|Physician Decision|1|||
37747314|NCT01691521|69237298|FG002|Overall Study|Physician Decision|0|||
37747315|NCT01691521|69237296|FG000|Overall Study|Withdrawal by Subject|5|||
37747316|NCT01691521|69237297|FG001|Overall Study|Withdrawal by Subject|9|||
37855821|NCT00989833|69539174|FG000|Overall Study|Lost to Follow-up|0|||
37658343|NCT02497976|69130525|FG001|Overall Study|Moved out of area|1|||
37658344|NCT03347188|69130533|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
37658345|NCT03347188|69130534|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
37658346|NCT03347188|69130533|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
37658347|NCT03347188|69130534|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
37658348|NCT03347188|69130533|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
37747317|NCT01691521|69237298|FG002|Overall Study|Withdrawal by Subject|4|||
37747318|NCT01929317|69237309|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
37747319|NCT01929317|69237310|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
37747320|NCT01929317|69237309|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
37747321|NCT01929317|69237310|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
37747322|NCT01929317|69237309|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
37747323|NCT01929317|69237310|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
37747324|NCT01929317|69237309|FG000|Long-term Phase|Adverse Event|5|||
37855822|NCT00989833|69539175|FG001|Overall Study|Lost to Follow-up|1|||
37658349|NCT03347188|69130534|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
37658350|NCT03347188|69130533|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
37658351|NCT03347188|69130534|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
37658352|NCT03347188|69130533|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
37658353|NCT03347188|69130534|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
37658354|NCT03347188|69130533|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
37658355|NCT03347188|69130534|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
37658356|NCT03347188|69130533|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
37658357|NCT03347188|69130534|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
37658358|NCT03347188|69130533|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
37658359|NCT03347188|69130534|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
37658360|NCT02440568|69130544|FG000|Overall Study|Death|1|||
37658361|NCT02440568|69130545|FG001|Overall Study|Death|3|||
37658362|NCT02440568|69130546|FG002|Overall Study|Death|4|||
37658363|NCT02440568|69130547|FG003|Overall Study|Death|2|||
37658364|NCT02440568|69130544|FG000|Overall Study|Lack of Efficacy|2|||
37658365|NCT02440568|69130545|FG001|Overall Study|Lack of Efficacy|0|||
37658366|NCT02440568|69130546|FG002|Overall Study|Lack of Efficacy|1|||
37658367|NCT02440568|69130547|FG003|Overall Study|Lack of Efficacy|0|||
37658368|NCT02440568|69130544|FG000|Overall Study|Lost to Follow-up|1|||
37658369|NCT02440568|69130545|FG001|Overall Study|Lost to Follow-up|0|||
37658370|NCT02440568|69130546|FG002|Overall Study|Lost to Follow-up|0|||
37658371|NCT02440568|69130547|FG003|Overall Study|Lost to Follow-up|0|||
37658372|NCT03090191|69130560|FG000|Overall Study|Adverse Event|90|||
37658373|NCT03090191|69130561|FG001|Overall Study|Adverse Event|72|||
37658374|NCT03090191|69130560|FG000|Overall Study|Death|365|||
37658375|NCT03090191|69130561|FG001|Overall Study|Death|358|||
37658376|NCT03090191|69130560|FG000|Overall Study|Lost to Follow-up|382|||
37658377|NCT03090191|69130561|FG001|Overall Study|Lost to Follow-up|394|||
37658378|NCT03090191|69130560|FG000|Overall Study|Physician Decision|77|||
37658379|NCT03090191|69130561|FG001|Overall Study|Physician Decision|66|||
37658380|NCT03090191|69130560|FG000|Overall Study|Protocol Violation|43|||
37658381|NCT03090191|69130561|FG001|Overall Study|Protocol Violation|52|||
37658382|NCT03090191|69130560|FG000|Overall Study|Withdrawal by Subject|2160|||
37658383|NCT03090191|69130561|FG001|Overall Study|Withdrawal by Subject|2133|||
37658384|NCT03090191|69130560|FG000|Overall Study|Site terminated|7|||
37658385|NCT03090191|69130561|FG001|Overall Study|Site terminated|8|||
37658386|NCT03090191|69130560|FG000|Overall Study|Other|66|||
37658387|NCT03090191|69130561|FG001|Overall Study|Other|60|||
37658388|NCT03090191|69130560|FG000|Overall Study|Withdrawn before any study vaccination|43|||
37658389|NCT03090191|69130561|FG001|Overall Study|Withdrawn before any study vaccination|52|||
37658390|NCT02439320|69130583|FG000|Overall Study|Adverse Event|0|||
37658391|NCT02439320|69130584|FG001|Overall Study|Adverse Event|2|||
37658392|NCT02439320|69130585|FG002|Overall Study|Adverse Event|0|||
37658393|NCT02439320|69130583|FG000|Overall Study|Lost to Follow-up|37|||
37658394|NCT02439320|69130584|FG001|Overall Study|Lost to Follow-up|34|||
37658395|NCT02439320|69130585|FG002|Overall Study|Lost to Follow-up|42|||
37658396|NCT02439320|69130583|FG000|Overall Study|Death|0|||
37658397|NCT02439320|69130584|FG001|Overall Study|Death|1|||
37658398|NCT02439320|69130585|FG002|Overall Study|Death|0|||
37658399|NCT02439320|69130583|FG000|Overall Study|Noncompliance with Protocol|10|||
37658400|NCT02439320|69130584|FG001|Overall Study|Noncompliance with Protocol|11|||
37658401|NCT02439320|69130585|FG002|Overall Study|Noncompliance with Protocol|7|||
37658402|NCT02439320|69130583|FG000|Overall Study|Pregnancy|0|||
37658403|NCT02439320|69130584|FG001|Overall Study|Pregnancy|1|||
37658404|NCT02439320|69130585|FG002|Overall Study|Pregnancy|1|||
37747325|NCT01929317|69237310|FG001|Long-term Phase|Adverse Event|1|||
37855823|NCT00989833|69539176|FG002|Overall Study|Lost to Follow-up|0|||
37855824|NCT00989833|69539174|FG000|Overall Study|Protocol Violation|1|||
37855825|NCT00989833|69539175|FG001|Overall Study|Protocol Violation|2|||
37855826|NCT00989833|69539176|FG002|Overall Study|Protocol Violation|1|||
37658405|NCT02439320|69130583|FG000|Overall Study|Withdrawal by Subject|12|||
37658406|NCT02439320|69130584|FG001|Overall Study|Withdrawal by Subject|16|||
37658407|NCT02439320|69130585|FG002|Overall Study|Withdrawal by Subject|14|||
37658408|NCT02439320|69130583|FG000|Overall Study|Physician Decision|2|||
37658409|NCT02439320|69130584|FG001|Overall Study|Physician Decision|1|||
37658410|NCT02439320|69130585|FG002|Overall Study|Physician Decision|0|||
37658411|NCT02439320|69130583|FG000|Overall Study|Sponsor Request|0|||
37658412|NCT02439320|69130584|FG001|Overall Study|Sponsor Request|2|||
37658413|NCT02439320|69130585|FG002|Overall Study|Sponsor Request|1|||
37658414|NCT02439320|69130583|FG000|Overall Study|Randomization Failure|35|||
37658415|NCT02439320|69130584|FG001|Overall Study|Randomization Failure|46|||
37658416|NCT02439320|69130585|FG002|Overall Study|Randomization Failure|34|||
37658417|NCT02469038|69130601|FG000|Overall Study|Physician Decision|4|||
37658418|NCT02469038|69130602|FG001|Overall Study|Physician Decision|5|||
37747326|NCT01929317|69237309|FG000|Long-term Phase|Physician Decision|3|||
37747327|NCT01929317|69237310|FG001|Long-term Phase|Physician Decision|0|||
37747328|NCT01929317|69237309|FG000|Long-term Phase|Withdrawal by Subject|4|||
37747329|NCT01929317|69237310|FG001|Long-term Phase|Withdrawal by Subject|0|||
37747330|NCT01929317|69237309|FG000|Long-term Phase|Protocol Violation|1|||
37747331|NCT01929317|69237310|FG001|Long-term Phase|Protocol Violation|0|||
37747332|NCT01929317|69237309|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
37747333|NCT01929317|69237310|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
37747334|NCT01929317|69237309|FG000|Long-term Phase|Study Closed/Terminated|5|||
37747335|NCT01929317|69237310|FG001|Long-term Phase|Study Closed/Terminated|3|||
37747336|NCT01711879|69237324|FG000|Overall Study|Death|1|||
37923017|NCT00827918|69609823|FG000|Overall Study|Lack of Efficacy|16|||
37923018|NCT00827918|69609824|FG001|Overall Study|Lack of Efficacy|4|||
37923019|NCT00827918|69609825|FG002|Overall Study|Lack of Efficacy|15|||
37923020|NCT00827918|69609823|FG000|Overall Study|Physician Decision|1|||
37923021|NCT00827918|69609824|FG001|Overall Study|Physician Decision|0|||
37923022|NCT00827918|69609825|FG002|Overall Study|Physician Decision|0|||
37923023|NCT00827918|69609823|FG000|Overall Study|Pregnancy|0|||
37923024|NCT00827918|69609824|FG001|Overall Study|Pregnancy|1|||
37923025|NCT00827918|69609825|FG002|Overall Study|Pregnancy|0|||
37923026|NCT00827918|69609823|FG000|Overall Study|Progressive Disease|1|||
37923027|NCT00827918|69609824|FG001|Overall Study|Progressive Disease|1|||
37923028|NCT00827918|69609825|FG002|Overall Study|Progressive Disease|0|||
37923029|NCT00827918|69609823|FG000|Overall Study|Protocol Violation|0|||
37923030|NCT00827918|69609824|FG001|Overall Study|Protocol Violation|1|||
37923031|NCT00827918|69609825|FG002|Overall Study|Protocol Violation|0|||
37923032|NCT00827918|69609823|FG000|Overall Study|Withdrawal by Subject|6|||
37658419|NCT02468648|69130608|FG000|Overall Study|Death|1|||
37658420|NCT02468414|69130614|FG000|Overall Study|Early Study Termination by Sponsor|1|||
37658421|NCT02468414|69130615|FG001|Overall Study|Early Study Termination by Sponsor|0|||
37658422|NCT02468414|69130614|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
37658423|NCT02468414|69130615|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
37658424|NCT02468414|69130614|FG000|Overall Study|Screen Failure|1|||
37658425|NCT02468414|69130615|FG001|Overall Study|Screen Failure|0|||
37658426|NCT02466386|69130621|FG000|Overall Study|Adverse Event|5|||
37658427|NCT02466386|69130621|FG000|Overall Study|Protocol Violation|2|||
37658428|NCT02466386|69130621|FG000|Overall Study|Withdrawal by Subject|14|||
37658429|NCT02466386|69130621|FG000|Overall Study|Lost to Follow-up|5|||
37658430|NCT02466386|69130621|FG000|Overall Study|Lack of Efficacy|8|||
37658431|NCT02466386|69130621|FG000|Overall Study|Other|10|||
37658432|NCT01633060|69130627|FG000|Randomization Phase|Protocol deviation|1|||
37658433|NCT01633060|69130628|FG001|Randomization Phase|Protocol deviation|2|||
37658434|NCT01633060|69130627|FG000|Randomization Phase|Technical problem|0|||
37658435|NCT01633060|69130628|FG001|Randomization Phase|Technical problem|1|||
37658436|NCT01633060|69130627|FG000|Treatment Phase|Adverse Event|24|||
37658437|NCT01633060|69130628|FG001|Treatment Phase|Adverse Event|3|||
37658438|NCT01633060|69130627|FG000|Treatment Phase|Lost to Follow-up|1|||
37658439|NCT01633060|69130628|FG001|Treatment Phase|Lost to Follow-up|0|||
37658440|NCT01633060|69130627|FG000|Treatment Phase|Physician Decision|16|||
37658441|NCT01633060|69130628|FG001|Treatment Phase|Physician Decision|7|||
37658442|NCT01633060|69130627|FG000|Treatment Phase|Progressive Disease|210|||
37658443|NCT01633060|69130628|FG001|Treatment Phase|Progressive Disease|120|||
37658444|NCT01633060|69130627|FG000|Treatment Phase|Protocol Deviation|1|||
37658445|NCT01633060|69130628|FG001|Treatment Phase|Protocol Deviation|0|||
37658446|NCT01633060|69130627|FG000|Treatment Phase|Study Terminated by sponsor|7|||
37658447|NCT01633060|69130628|FG001|Treatment Phase|Study Terminated by sponsor|3|||
37658448|NCT01633060|69130627|FG000|Treatment Phase|Subject/guardian decision|25|||
37658449|NCT01633060|69130628|FG001|Treatment Phase|Subject/guardian decision|4|||
37658450|NCT01633060|69130627|FG000|Treatment Phase|Death|4|||
37658451|NCT01633060|69130628|FG001|Treatment Phase|Death|3|||
37658452|NCT01633060|69130627|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
37658453|NCT01633060|69130628|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
37658454|NCT01633060|69130627|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
37658455|NCT01633060|69130628|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
37658456|NCT01633060|69130627|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
37658457|NCT01633060|69130628|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
37658458|NCT01633060|69130627|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
37658459|NCT01633060|69130628|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
37658460|NCT01633060|69130627|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
37747337|NCT01711879|69237325|FG001|Overall Study|Death|0|||
37747338|NCT01689649|69237348|FG000|Overall Study|Lack of Efficacy|3|||
37747339|NCT01689649|69237348|FG000|Overall Study|Non-compliance|11|||
37747340|NCT01689649|69237348|FG000|Overall Study|Protocol Violation|3|||
37747341|NCT01689649|69237348|FG000|Overall Study|Lost to Follow-up|5|||
37747342|NCT01929083|69237352|FG000|Intervention 1|Lost to Follow-up|2|||
37923033|NCT00827918|69609824|FG001|Overall Study|Withdrawal by Subject|2|||
37923034|NCT00827918|69609825|FG002|Overall Study|Withdrawal by Subject|6|||
37923035|NCT00813150|69609835|FG000|Treatment Period|Adverse Event|16|||
37923036|NCT00813150|69609836|FG001|Treatment Period|Adverse Event|15|||
37747343|NCT01929083|69237353|FG001|Intervention 1|Lost to Follow-up|0|||
37747344|NCT01929083|69237352|FG000|Intervention 1|Nonadherent to study medications|1|||
37747345|NCT01929083|69237353|FG001|Intervention 1|Nonadherent to study medications|0|||
37747346|NCT01929083|69237352|FG000|Intervention 2|Adverse Event|0|||
37747347|NCT01929083|69237353|FG001|Intervention 2|Adverse Event|1|||
37747348|NCT01689337|69237359|FG000|Overall Study|Study Discontinuation|1|||
37747349|NCT01688635|69237365|FG000|Washout 1|Withdrawal by Subject|1|||
37747350|NCT01688635|69237366|FG001|Washout 1|Withdrawal by Subject|0|||
37747351|NCT01688635|69237365|FG000|Washout 1|Adverse Event|0|||
37747352|NCT01688635|69237366|FG001|Washout 1|Adverse Event|1|||
37747353|NCT01688635|69237365|FG000|Washout 1|Physician Decision|0|||
37747354|NCT01688635|69237366|FG001|Washout 1|Physician Decision|1|||
37747355|NCT01688635|69237365|FG000|Washout 2|Physician Decision|1|||
37747356|NCT01688635|69237366|FG001|Washout 2|Physician Decision|0|||
37747357|NCT01688635|69237365|FG000|Washout 2|Withdrawal by Subject|1|||
37747358|NCT01688635|69237366|FG001|Washout 2|Withdrawal by Subject|0|||
37747359|NCT01688635|69237365|FG000|Washout 2|Sponsor Decision|1|||
37747360|NCT01688635|69237366|FG001|Washout 2|Sponsor Decision|2|||
37747361|NCT01688635|69237365|FG000|Washout 3|Withdrawal by Subject|1|||
37747362|NCT01688635|69237366|FG001|Washout 3|Withdrawal by Subject|0|||
37747363|NCT01591681|69237373|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
37747364|NCT01591681|69237373|FG000|Overall Study|Failed to use system during run-in|1|||
37747365|NCT01711645|69237388|FG000|Overall Study|Withdrawal by Subject|8|||
37747366|NCT01711645|69237388|FG000|Overall Study|Lost to Follow-up|6|||
37747367|NCT01711645|69237388|FG000|Overall Study|Physician Decision|5|||
37658461|NCT01633060|69130628|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
37658462|NCT01633060|69130627|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
37658463|NCT01633060|69130628|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
37658464|NCT01632904|69130637|FG000|Overall Study|Adverse Event|4|||
37658465|NCT01632904|69130638|FG001|Overall Study|Adverse Event|1|||
37658466|NCT01632904|69130637|FG000|Overall Study|Physician Decision|0|||
37747368|NCT01590433|69237403|FG000|Overall Study|Lost to Follow-up|20|||
37747369|NCT01590433|69237404|FG001|Overall Study|Lost to Follow-up|8|||
37747370|NCT01590433|69237403|FG000|Overall Study|Withdrawal by Subject|21|||
37747371|NCT01590433|69237404|FG001|Overall Study|Withdrawal by Subject|11|||
37747372|NCT01590433|69237403|FG000|Overall Study|Adverse Event|11|||
37747373|NCT01590433|69237404|FG001|Overall Study|Adverse Event|3|||
37855827|NCT00989833|69539174|FG000|Overall Study|Withdrawal by Subject|0|||
37855828|NCT00989833|69539175|FG001|Overall Study|Withdrawal by Subject|0|||
37855829|NCT00989833|69539176|FG002|Overall Study|Withdrawal by Subject|1|||
37855830|NCT00989833|69539174|FG000|Overall Study|Incorrectly randomized|1|||
37658467|NCT01632904|69130638|FG001|Overall Study|Physician Decision|1|||
37658468|NCT01632904|69130637|FG000|Overall Study|Subject decision|3|||
37658469|NCT01632904|69130638|FG001|Overall Study|Subject decision|2|||
37658470|NCT01632904|69130637|FG000|Overall Study|Disease Progression|0|||
37658471|NCT01632904|69130638|FG001|Overall Study|Disease Progression|1|||
37658472|NCT01632904|69130637|FG000|Overall Study|Reason for discontinuation not available|0|||
37658473|NCT01632904|69130638|FG001|Overall Study|Reason for discontinuation not available|1|||
37658474|NCT03834779|69130646|FG000|Overall Study|Death|1|||
37658475|NCT03834779|69130647|FG001|Overall Study|Death|2|||
37658476|NCT03834779|69130646|FG000|Overall Study|Lost to Follow-up|6|||
37658477|NCT03834779|69130647|FG001|Overall Study|Lost to Follow-up|4|||
37658478|NCT03726437|69130656|FG000|Overall Study|Lost to Follow-up|85|||
37658479|NCT03726437|69130657|FG001|Overall Study|Lost to Follow-up|76|||
37658480|NCT02465528|69130667|FG000|Overall Study|Progressive disease|0|||
37658481|NCT02465528|69130668|FG001|Overall Study|Progressive disease|2|||
37658482|NCT02465528|69130669|FG002|Overall Study|Progressive disease|9|||
37658483|NCT02465528|69130670|FG003|Overall Study|Progressive disease|4|||
37658484|NCT02465528|69130667|FG000|Overall Study|Study terminated by sponsor|1|||
37747374|NCT01928927|69237421|FG000|Overall Study|Lost to Follow-up|1|||
37855831|NCT00989833|69539175|FG001|Overall Study|Incorrectly randomized|0|||
37855832|NCT00989833|69539176|FG002|Overall Study|Incorrectly randomized|0|||
37658485|NCT02465528|69130668|FG001|Overall Study|Study terminated by sponsor|2|||
37658486|NCT02465528|69130669|FG002|Overall Study|Study terminated by sponsor|0|||
37658487|NCT02465528|69130670|FG003|Overall Study|Study terminated by sponsor|0|||
37658488|NCT02465528|69130667|FG000|Overall Study|Withdrawal by Subject|0|||
37658489|NCT02465528|69130668|FG001|Overall Study|Withdrawal by Subject|0|||
37658490|NCT02465528|69130669|FG002|Overall Study|Withdrawal by Subject|2|||
37658491|NCT02465528|69130670|FG003|Overall Study|Withdrawal by Subject|0|||
37747375|NCT01928927|69237422|FG001|Overall Study|Lost to Follow-up|0|||
37747376|NCT01928927|69237421|FG000|Overall Study|Withdrawal by Subject|1|||
37747377|NCT01928927|69237422|FG001|Overall Study|Withdrawal by Subject|1|||
37747378|NCT01710709|69237443|FG000|Overall Study|Lost to Follow-up|29|||
37747379|NCT01710709|69237443|FG000|Overall Study|Adverse Event|48|||
37747380|NCT01710709|69237443|FG000|Overall Study|Participant met withdrawal criteria|33|||
37747381|NCT01710709|69237443|FG000|Overall Study|Participant withdrawn by investigator|2|||
37747382|NCT01710709|69237443|FG000|Overall Study|Withdrawal by Subject|53|||
37747383|NCT01710709|69237443|FG000|Overall Study|Protocol Violation|5|||
37658492|NCT02465528|69130667|FG000|Overall Study|Adverse Event|0|||
37658493|NCT02465528|69130668|FG001|Overall Study|Adverse Event|0|||
37658494|NCT02465528|69130669|FG002|Overall Study|Adverse Event|0|||
37658495|NCT02465528|69130670|FG003|Overall Study|Adverse Event|1|||
37658496|NCT02465528|69130667|FG000|Overall Study|Physician Decision|0|||
37658497|NCT02465528|69130668|FG001|Overall Study|Physician Decision|0|||
37658498|NCT02465528|69130669|FG002|Overall Study|Physician Decision|1|||
37658499|NCT02465528|69130670|FG003|Overall Study|Physician Decision|0|||
37658500|NCT02438384|69130685|FG000|Overall Study|Lost to Follow-up|8|||
37658501|NCT02438384|69130686|FG001|Overall Study|Lost to Follow-up|6|||
37658502|NCT02438384|69130687|FG002|Overall Study|Lost to Follow-up|4|||
37658503|NCT02463032|69130697|FG000|Overall Study|Lack of Efficacy|61|||
37658504|NCT02463032|69130698|FG001|Overall Study|Lack of Efficacy|50|||
37658505|NCT02463032|69130697|FG000|Overall Study|Death|8|||
37658506|NCT02463032|69130698|FG001|Overall Study|Death|8|||
37658507|NCT02463032|69130697|FG000|Overall Study|Adverse Event|2|||
37658508|NCT02463032|69130698|FG001|Overall Study|Adverse Event|6|||
37923037|NCT00813150|69609835|FG000|Treatment Period|Death|2|||
37923038|NCT00813150|69609836|FG001|Treatment Period|Death|0|||
37658509|NCT02496884|69130708|FG000|Overall Study|Counted twice as enrolled|2|||
37658510|NCT02496884|69130709|FG001|Overall Study|Counted twice as enrolled|0|||
37658511|NCT02496884|69130710|FG002|Overall Study|Counted twice as enrolled|0|||
37747384|NCT01710709|69237443|FG000|Overall Study|Lack of Efficacy|3|||
37747385|NCT01617629|69237448|FG000|Overall Study|Death|2|||
37747386|NCT01617629|69237448|FG000|Overall Study|Investigator's Clinical Judgement|1|||
37747387|NCT01617629|69237448|FG000|Overall Study|Reason Not Specified|1|||
37747388|NCT01617629|69237448|FG000|Overall Study|Participant Withdrew Consent|2|||
37747389|NCT01686373|69237463|FG000|Overall Study|Lost to Follow-up|3|||
37747390|NCT01686373|69237464|FG001|Overall Study|Lost to Follow-up|0|||
37747391|NCT01686373|69237463|FG000|Overall Study|Withdrawal by Subject|0|||
37747392|NCT01686373|69237464|FG001|Overall Study|Withdrawal by Subject|1|||
37747393|NCT01686373|69237463|FG000|Overall Study|Adverse Event|0|||
37747394|NCT01686373|69237464|FG001|Overall Study|Adverse Event|1|||
37747395|NCT01709695|69237472|FG000|Overall Study|Withdrawal by Subject|1|||
37855833|NCT01218477|69539188|FG000|Overall Study|Disease progression|2|||
37855834|NCT01218477|69539189|FG001|Overall Study|Disease progression|3|||
37855835|NCT01218477|69539190|FG002|Overall Study|Disease progression|6|||
37855836|NCT01218477|69539191|FG003|Overall Study|Disease progression|2|||
37855837|NCT01218477|69539188|FG000|Overall Study|Study drug toxicity|0|||
37855838|NCT01218477|69539189|FG001|Overall Study|Study drug toxicity|2|||
37855839|NCT01218477|69539190|FG002|Overall Study|Study drug toxicity|5|||
37855840|NCT01218477|69539191|FG003|Overall Study|Study drug toxicity|0|||
37855841|NCT01218477|69539188|FG000|Overall Study|No longer meets study criteria|1|||
37855842|NCT01218477|69539189|FG001|Overall Study|No longer meets study criteria|0|||
37855843|NCT01218477|69539190|FG002|Overall Study|No longer meets study criteria|0|||
37855844|NCT01218477|69539191|FG003|Overall Study|No longer meets study criteria|0|||
37855845|NCT01218477|69539188|FG000|Overall Study|Withdrawal by Subject|0|||
37855846|NCT01218477|69539189|FG001|Overall Study|Withdrawal by Subject|0|||
37855847|NCT01218477|69539190|FG002|Overall Study|Withdrawal by Subject|1|||
37855848|NCT01218477|69539191|FG003|Overall Study|Withdrawal by Subject|0|||
37855849|NCT01218477|69539188|FG000|Overall Study|Prepared for cell transplantation|0|||
37855850|NCT01218477|69539189|FG001|Overall Study|Prepared for cell transplantation|1|||
37855851|NCT01218477|69539190|FG002|Overall Study|Prepared for cell transplantation|1|||
37855852|NCT01218477|69539191|FG003|Overall Study|Prepared for cell transplantation|0|||
37855853|NCT01218477|69539188|FG000|Overall Study|Administrative reason by sponsor|0|||
37923039|NCT00813150|69609835|FG000|Treatment Period|Progressive disease|1|||
37923040|NCT00813150|69609836|FG001|Treatment Period|Progressive disease|0|||
37923041|NCT00813150|69609835|FG000|Treatment Period|Complete response|0|||
37923042|NCT00813150|69609836|FG001|Treatment Period|Complete response|1|||
37923043|NCT00813150|69609835|FG000|Treatment Period|Stable disease|1|||
37923044|NCT00813150|69609836|FG001|Treatment Period|Stable disease|2|||
37855854|NCT01218477|69539189|FG001|Overall Study|Administrative reason by sponsor|0|||
37855855|NCT01218477|69539190|FG002|Overall Study|Administrative reason by sponsor|1|||
37855856|NCT01218477|69539191|FG003|Overall Study|Administrative reason by sponsor|0|||
37855857|NCT01218477|69539188|FG000|Overall Study|Maximum clinical benefit|0|||
37658512|NCT02496884|69130711|FG003|Overall Study|Counted twice as enrolled|0|||
37658513|NCT02496884|69130708|FG000|Overall Study|Withdrawal by Subject|0|||
37658514|NCT02496884|69130709|FG001|Overall Study|Withdrawal by Subject|3|||
37658515|NCT02496884|69130710|FG002|Overall Study|Withdrawal by Subject|0|||
37658516|NCT02496884|69130711|FG003|Overall Study|Withdrawal by Subject|0|||
37855858|NCT01218477|69539189|FG001|Overall Study|Maximum clinical benefit|2|||
37923045|NCT00813150|69609835|FG000|Treatment Period|Protocol Violation|3|||
37923046|NCT00813150|69609836|FG001|Treatment Period|Protocol Violation|4|||
37658517|NCT02462876|69130721|FG000|Overall Study|Death|3|||
37747396|NCT01709695|69237473|FG001|Overall Study|Withdrawal by Subject|1|||
37747397|NCT01685983|69237483|FG000|Overall Study|Adverse Event|7|||
37747398|NCT01685983|69237483|FG000|Overall Study|Death|1|||
37747399|NCT01685983|69237483|FG000|Overall Study|Withdrawal by Subject|19|||
37747400|NCT01685983|69237483|FG000|Overall Study|Protocol Violation|2|||
37747401|NCT01685983|69237483|FG000|Overall Study|Physician Decision|13|||
37747402|NCT01685983|69237483|FG000|Overall Study|Other|7|||
37747403|NCT01685983|69237483|FG000|Overall Study|Progressive Disease|32|||
37747404|NCT01685983|69237483|FG000|Overall Study|Noncompliance with Study Drug|1|||
37747405|NCT01685437|69237495|FG000|Overall Study|Withdrawal by Subject|22|||
37747406|NCT01685437|69237495|FG000|Overall Study|Lost to Follow-up|3|||
37747407|NCT01685437|69237495|FG000|Overall Study|Adverse Event|1|||
37747408|NCT01685437|69237495|FG000|Overall Study|Protocol Violation|4|||
37747409|NCT01685437|69237495|FG000|Overall Study|Unable to make visits due to work|1|||
37747410|NCT01685203|69237535|FG000|Overall Study|Lost to Follow-up|3|||
37747411|NCT01685203|69237536|FG001|Overall Study|Lost to Follow-up|3|||
37747412|NCT01685203|69237537|FG002|Overall Study|Lost to Follow-up|0|||
37747413|NCT01685203|69237538|FG003|Overall Study|Lost to Follow-up|1|||
37747414|NCT01685203|69237539|FG004|Overall Study|Lost to Follow-up|0|||
37747415|NCT01685203|69237540|FG005|Overall Study|Lost to Follow-up|0|||
37658518|NCT02462876|69130721|FG000|Overall Study|Lost to Follow-up|7|||
37658519|NCT02462876|69130721|FG000|Overall Study|Surgical Bypass|9|||
37658520|NCT02462876|69130721|FG000|Overall Study|Amputation Above the Metatarsals|1|||
37658521|NCT02462876|69130721|FG000|Overall Study|36 months follow-up visit missed|1|||
37747416|NCT01685203|69237541|FG006|Overall Study|Lost to Follow-up|0|||
37747417|NCT01685203|69237535|FG000|Overall Study|Adverse Event|0|||
37747418|NCT01685203|69237536|FG001|Overall Study|Adverse Event|0|||
37855859|NCT01218477|69539190|FG002|Overall Study|Maximum clinical benefit|0|||
37855860|NCT01218477|69539191|FG003|Overall Study|Maximum clinical benefit|0|||
37855861|NCT01218243|69539207|FG000|Overall Study|Lack of Efficacy|1|||
37855862|NCT01218243|69539208|FG001|Overall Study|Lack of Efficacy|1|||
37855863|NCT01218243|69539207|FG000|Overall Study|Lost to Follow-up|3|||
37855864|NCT01218243|69539208|FG001|Overall Study|Lost to Follow-up|3|||
37855865|NCT01218243|69539207|FG000|Overall Study|Protocol Violation|5|||
37855866|NCT01218243|69539208|FG001|Overall Study|Protocol Violation|10|||
37855867|NCT00989287|69539216|FG000|Overall Study|Adverse Event|1|||
37855868|NCT00989287|69539217|FG001|Overall Study|Adverse Event|0|||
37855869|NCT00989287|69539216|FG000|Overall Study|Lost to Follow-up|0|||
37855870|NCT00989287|69539217|FG001|Overall Study|Lost to Follow-up|1|||
37855871|NCT01218087|69539238|FG000|Overall Study|Death|2|||
37855872|NCT01218087|69539239|FG001|Overall Study|Death|1|||
37855873|NCT01218087|69539238|FG000|Overall Study|Withdrawal by Subject|5|||
37855874|NCT01218087|69539239|FG001|Overall Study|Withdrawal by Subject|0|||
37855875|NCT01218087|69539238|FG000|Overall Study|Transferred|8|||
37855876|NCT01218087|69539239|FG001|Overall Study|Transferred|5|||
37855877|NCT01218009|69539247|FG000|Overall Study|Protocol Violation|2|||
37855878|NCT01218009|69539248|FG001|Overall Study|Protocol Violation|1|||
37855879|NCT01218009|69539247|FG000|Overall Study|Withdrawal by Subject|3|||
37855880|NCT01218009|69539248|FG001|Overall Study|Withdrawal by Subject|1|||
37855881|NCT01218009|69539247|FG000|Overall Study|Sponsor terminated study|161|||
37855882|NCT01218009|69539248|FG001|Overall Study|Sponsor terminated study|163|||
37855883|NCT00992017|69539254|FG000|Overall Study|Lost to Follow-up|2|||
37658522|NCT02462876|69130721|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
37658523|NCT02462876|69130721|FG000|Overall Study|Patient did not come back to the vascular department|1|||
37658524|NCT02462876|69130721|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
37658525|NCT02462876|69130721|FG000|Overall Study|Patient refused to come back|1|||
37658526|NCT02462876|69130721|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
37658527|NCT02462876|69130721|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
37658528|NCT03386721|69130740|FG000|Overall Study|Death|12|||
37855884|NCT00992017|69539254|FG000|Overall Study|Withdrawal by Subject|2|||
37855885|NCT00992017|69539254|FG000|Overall Study|Unable to get to clinic|5|||
37855886|NCT00992017|69539254|FG000|Overall Study|Not adhere to study requirements|1|||
37855887|NCT01217463|69539265|FG000|Overall Study|Adverse Event|8|||
37855888|NCT01217463|69539266|FG001|Overall Study|Adverse Event|5|||
37855889|NCT01217463|69539265|FG000|Overall Study|Physician Decision|0|||
37855890|NCT01217463|69539266|FG001|Overall Study|Physician Decision|1|||
37855891|NCT01217463|69539265|FG000|Overall Study|Withdrawal by Subject|3|||
37855892|NCT01217463|69539266|FG001|Overall Study|Withdrawal by Subject|0|||
37855893|NCT01217463|69539265|FG000|Overall Study|Surgery on the Target Limb|0|||
37855894|NCT01217463|69539266|FG001|Overall Study|Surgery on the Target Limb|1|||
37855895|NCT01217463|69539265|FG000|Overall Study|Patient Non-compliant|1|||
37747419|NCT01685203|69237537|FG002|Overall Study|Adverse Event|0|||
37747420|NCT01685203|69237538|FG003|Overall Study|Adverse Event|0|||
37855896|NCT01217463|69539266|FG001|Overall Study|Patient Non-compliant|0|||
37855897|NCT01217463|69539265|FG000|Overall Study|Other|1|||
37855898|NCT01217463|69539266|FG001|Overall Study|Other|1|||
37855899|NCT01217307|69539276|FG000|Overall Study|Withdrawal by Subject|0|||
37855900|NCT01217307|69539277|FG001|Overall Study|Withdrawal by Subject|1|||
37855901|NCT01217229|69539283|FG000|Overall Study|Adverse Event|1|||
37923047|NCT00813150|69609835|FG000|Treatment Period|Withdrawal by Subject|5|||
37747421|NCT01685203|69237539|FG004|Overall Study|Adverse Event|0|||
37747422|NCT01685203|69237540|FG005|Overall Study|Adverse Event|2|||
37747423|NCT01685203|69237541|FG006|Overall Study|Adverse Event|0|||
37747424|NCT01685203|69237535|FG000|Overall Study|Adverse event and withdrew consent|1|||
37747425|NCT01685203|69237536|FG001|Overall Study|Adverse event and withdrew consent|0|||
37747426|NCT01685203|69237537|FG002|Overall Study|Adverse event and withdrew consent|0|||
37747427|NCT01685203|69237538|FG003|Overall Study|Adverse event and withdrew consent|0|||
37747428|NCT01685203|69237539|FG004|Overall Study|Adverse event and withdrew consent|0|||
37747429|NCT01685203|69237540|FG005|Overall Study|Adverse event and withdrew consent|0|||
37747430|NCT01685203|69237541|FG006|Overall Study|Adverse event and withdrew consent|0|||
37747431|NCT01685203|69237535|FG000|Overall Study|Patient's decision|0|||
37747432|NCT01685203|69237536|FG001|Overall Study|Patient's decision|0|||
37747433|NCT01685203|69237537|FG002|Overall Study|Patient's decision|0|||
37747434|NCT01685203|69237538|FG003|Overall Study|Patient's decision|0|||
37747435|NCT01685203|69237539|FG004|Overall Study|Patient's decision|0|||
37747436|NCT01685203|69237540|FG005|Overall Study|Patient's decision|1|||
37747437|NCT01685203|69237541|FG006|Overall Study|Patient's decision|0|||
37747438|NCT01928771|69237560|FG000|Overall Study|Adverse Event|6|||
37747439|NCT01928771|69237561|FG001|Overall Study|Adverse Event|5|||
37747440|NCT01928771|69237562|FG002|Overall Study|Adverse Event|1|||
37747441|NCT01928771|69237560|FG000|Overall Study|Death|2|||
37747442|NCT01928771|69237561|FG001|Overall Study|Death|2|||
37747443|NCT01928771|69237562|FG002|Overall Study|Death|2|||
37747444|NCT01928771|69237560|FG000|Overall Study|Lost to Follow-up|5|||
37747445|NCT01928771|69237561|FG001|Overall Study|Lost to Follow-up|6|||
37747446|NCT01928771|69237562|FG002|Overall Study|Lost to Follow-up|3|||
37747447|NCT01928771|69237560|FG000|Overall Study|Withdrawal by Subject|20|||
37747448|NCT01928771|69237561|FG001|Overall Study|Withdrawal by Subject|15|||
37747449|NCT01928771|69237562|FG002|Overall Study|Withdrawal by Subject|17|||
37747450|NCT01928771|69237560|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
37747451|NCT01928771|69237561|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
37747452|NCT01928771|69237562|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
37747453|NCT01928771|69237560|FG000|Overall Study|Other Reasons|9|||
37747454|NCT01928771|69237561|FG001|Overall Study|Other Reasons|9|||
37747455|NCT01928771|69237562|FG002|Overall Study|Other Reasons|14|||
37747456|NCT01928771|69237560|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
37747457|NCT01928771|69237561|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
37747458|NCT01928771|69237562|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
37747459|NCT01589653|69237572|FG000|Overall Study|Protocol Violation|3|||
37747460|NCT01589653|69237573|FG001|Overall Study|Protocol Violation|1|||
37747461|NCT01589653|69237572|FG000|Overall Study|Withdrawal criteria|4|||
37747462|NCT01589653|69237573|FG001|Overall Study|Withdrawal criteria|7|||
37747463|NCT01589653|69237572|FG000|Overall Study|Unclassified|0|||
37747464|NCT01589653|69237573|FG001|Overall Study|Unclassified|3|||
37747465|NCT01928615|69237579|FG000|Overall Study|Study Terminated by Sponsor|2|||
37747466|NCT01589497|69237588|FG000|Overall Study|Withdrawal by Subject|0|||
37747467|NCT01589497|69237589|FG001|Overall Study|Withdrawal by Subject|1|||
37747468|NCT01589497|69237590|FG002|Overall Study|Withdrawal by Subject|0|||
37747469|NCT01589497|69237591|FG003|Overall Study|Withdrawal by Subject|1|||
37747470|NCT01589497|69237588|FG000|Overall Study|Death|1|||
37747471|NCT01589497|69237589|FG001|Overall Study|Death|0|||
37747472|NCT01589497|69237590|FG002|Overall Study|Death|0|||
37747473|NCT01589497|69237591|FG003|Overall Study|Death|0|||
37658529|NCT03386721|69130741|FG001|Overall Study|Death|21|||
37658530|NCT03386721|69130742|FG002|Overall Study|Death|2|||
37658531|NCT03386721|69130743|FG003|Overall Study|Death|5|||
37658532|NCT03386721|69130744|FG004|Overall Study|Death|1|||
37658533|NCT03386721|69130745|FG005|Overall Study|Death|12|||
37658534|NCT03386721|69130746|FG006|Overall Study|Death|1|||
37658535|NCT03386721|69130747|FG007|Overall Study|Death|1|||
37658536|NCT03386721|69130748|FG008|Overall Study|Death|12|||
37658537|NCT03386721|69130749|FG009|Overall Study|Death|20|||
37747474|NCT01589497|69237588|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
37747475|NCT01589497|69237589|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
37658538|NCT03386721|69130750|FG010|Overall Study|Death|21|||
37658539|NCT03386721|69130751|FG011|Overall Study|Death|21|||
37658540|NCT03386721|69130752|FG012|Overall Study|Death|14|||
37658541|NCT03386721|69130753|FG013|Overall Study|Death|2|||
37747476|NCT01589497|69237590|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
37747477|NCT01589497|69237591|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
37747478|NCT01928381|69237606|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
37747479|NCT01928381|69237607|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
37747480|NCT01928381|69237608|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
37747481|NCT01928381|69237609|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
37747482|NCT01928381|69237610|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
37658542|NCT03386721|69130754|FG014|Overall Study|Death|1|||
37747483|NCT01928381|69237611|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
37747484|NCT01928381|69237612|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
37747485|NCT01928381|69237606|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
37747486|NCT01928381|69237607|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
37747487|NCT01928381|69237608|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
37747488|NCT01928381|69237609|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
37747489|NCT01928381|69237610|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
37747490|NCT01928381|69237611|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
37747491|NCT01928381|69237612|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
37747492|NCT01928381|69237606|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
37747493|NCT01928381|69237607|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
37747494|NCT01928381|69237608|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
37747495|NCT01928381|69237609|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
37747496|NCT01928381|69237610|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
37747497|NCT01928381|69237611|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
37747498|NCT01928381|69237612|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
37855902|NCT01217229|69539283|FG000|Overall Study|Disease progression, deterioration|2|||
37855903|NCT01217229|69539283|FG000|Overall Study|Disease progression, Cheson criteria|14|||
37747499|NCT01928381|69237606|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
37747500|NCT01928381|69237607|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
37747501|NCT01928381|69237608|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
37747502|NCT01928381|69237609|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
37747503|NCT01928381|69237610|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
37747504|NCT01928381|69237611|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
37747505|NCT01928381|69237612|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
37747506|NCT01928381|69237606|FG000|Part 1 - Pain Training|Protocol Violation|1|||
37747507|NCT01928381|69237607|FG001|Part 1 - Pain Training|Protocol Violation|0|||
37747508|NCT01928381|69237608|FG002|Part 1 - Pain Training|Protocol Violation|0|||
37747509|NCT01928381|69237609|FG003|Part 1 - Pain Training|Protocol Violation|0|||
37747510|NCT01928381|69237610|FG004|Part 1 - Pain Training|Protocol Violation|0|||
37747511|NCT01928381|69237611|FG005|Part 1 - Pain Training|Protocol Violation|0|||
37747512|NCT01928381|69237612|FG006|Part 1 - Pain Training|Protocol Violation|0|||
37747513|NCT01928381|69237606|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
37747514|NCT01928381|69237607|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
37747515|NCT01928381|69237608|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
37747516|NCT01928381|69237609|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
37747517|NCT01928381|69237610|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
37747518|NCT01928381|69237611|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
37747519|NCT01928381|69237612|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
37747520|NCT01928381|69237606|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
37747521|NCT01928381|69237607|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
37747522|NCT01928381|69237608|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
37747523|NCT01928381|69237609|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
37747524|NCT01928381|69237610|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
37747525|NCT01928381|69237611|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
37747526|NCT01928381|69237612|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
37658543|NCT03386721|69130740|FG000|Overall Study|Lost to Follow-up|1|||
37658544|NCT03386721|69130741|FG001|Overall Study|Lost to Follow-up|3|||
37658545|NCT03386721|69130742|FG002|Overall Study|Lost to Follow-up|0|||
37658546|NCT03386721|69130743|FG003|Overall Study|Lost to Follow-up|0|||
37658547|NCT03386721|69130744|FG004|Overall Study|Lost to Follow-up|0|||
37658548|NCT03386721|69130745|FG005|Overall Study|Lost to Follow-up|2|||
37658549|NCT03386721|69130746|FG006|Overall Study|Lost to Follow-up|1|||
37658550|NCT03386721|69130747|FG007|Overall Study|Lost to Follow-up|0|||
37658551|NCT03386721|69130748|FG008|Overall Study|Lost to Follow-up|1|||
37658552|NCT03386721|69130749|FG009|Overall Study|Lost to Follow-up|2|||
37658553|NCT03386721|69130750|FG010|Overall Study|Lost to Follow-up|1|||
37658554|NCT03386721|69130751|FG011|Overall Study|Lost to Follow-up|0|||
37658555|NCT03386721|69130752|FG012|Overall Study|Lost to Follow-up|0|||
37658556|NCT03386721|69130753|FG013|Overall Study|Lost to Follow-up|0|||
37658557|NCT03386721|69130754|FG014|Overall Study|Lost to Follow-up|0|||
37658558|NCT03386721|69130740|FG000|Overall Study|Reason not specified|3|||
37747527|NCT01928381|69237606|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
37658559|NCT03386721|69130741|FG001|Overall Study|Reason not specified|0|||
37747528|NCT01928381|69237607|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
37747529|NCT01928381|69237608|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
37747530|NCT01928381|69237609|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
37658560|NCT03386721|69130742|FG002|Overall Study|Reason not specified|0|||
37658561|NCT03386721|69130743|FG003|Overall Study|Reason not specified|0|||
37658562|NCT03386721|69130744|FG004|Overall Study|Reason not specified|0|||
37658563|NCT03386721|69130745|FG005|Overall Study|Reason not specified|3|||
37855904|NCT01217229|69539283|FG000|Overall Study|Protocol Violation|1|||
37658564|NCT03386721|69130746|FG006|Overall Study|Reason not specified|1|||
37747531|NCT01928381|69237610|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
37747532|NCT01928381|69237611|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
37747533|NCT01928381|69237612|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
37747534|NCT01928381|69237606|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
37747535|NCT01928381|69237607|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
37747536|NCT01928381|69237608|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
37747537|NCT01928381|69237609|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
37747538|NCT01928381|69237610|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
37747539|NCT01928381|69237611|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
37747540|NCT01928381|69237612|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
37747541|NCT01928381|69237606|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
37747542|NCT01928381|69237607|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
37747543|NCT01928381|69237608|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
37747544|NCT01928381|69237609|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
37747545|NCT01928381|69237610|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
37747546|NCT01928381|69237611|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
37747547|NCT01928381|69237612|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
37747548|NCT01928381|69237606|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
37747549|NCT01928381|69237607|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
37747550|NCT01928381|69237608|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
37747551|NCT01928381|69237609|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
37747552|NCT01928381|69237610|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
37747553|NCT01928381|69237611|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
37747554|NCT01928381|69237612|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
37747555|NCT01928381|69237606|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
37747556|NCT01928381|69237607|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
37747557|NCT01928381|69237608|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
37747558|NCT01928381|69237609|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
37747559|NCT01928381|69237610|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
37747560|NCT01928381|69237611|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
37747561|NCT01928381|69237612|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
37923048|NCT00813150|69609836|FG001|Treatment Period|Withdrawal by Subject|3|||
37923049|NCT00813150|69609835|FG000|Treatment Period|Non compliance|0|||
37923050|NCT00813150|69609836|FG001|Treatment Period|Non compliance|1|||
37658565|NCT03386721|69130747|FG007|Overall Study|Reason not specified|0|||
37658566|NCT03386721|69130748|FG008|Overall Study|Reason not specified|0|||
37658567|NCT03386721|69130749|FG009|Overall Study|Reason not specified|1|||
37658568|NCT03386721|69130750|FG010|Overall Study|Reason not specified|2|||
37658569|NCT03386721|69130751|FG011|Overall Study|Reason not specified|6|||
37658570|NCT03386721|69130752|FG012|Overall Study|Reason not specified|1|||
37658571|NCT03386721|69130753|FG013|Overall Study|Reason not specified|0|||
37658572|NCT03386721|69130754|FG014|Overall Study|Reason not specified|0|||
37658573|NCT03386721|69130740|FG000|Overall Study|Progressive Disease|0|||
37658574|NCT03386721|69130741|FG001|Overall Study|Progressive Disease|0|||
37658575|NCT03386721|69130742|FG002|Overall Study|Progressive Disease|1|||
37658576|NCT03386721|69130743|FG003|Overall Study|Progressive Disease|0|||
37658577|NCT03386721|69130744|FG004|Overall Study|Progressive Disease|0|||
37658578|NCT03386721|69130745|FG005|Overall Study|Progressive Disease|1|||
37658579|NCT03386721|69130746|FG006|Overall Study|Progressive Disease|0|||
37658580|NCT03386721|69130747|FG007|Overall Study|Progressive Disease|0|||
37658581|NCT03386721|69130748|FG008|Overall Study|Progressive Disease|2|||
37658582|NCT03386721|69130749|FG009|Overall Study|Progressive Disease|1|||
37658583|NCT03386721|69130750|FG010|Overall Study|Progressive Disease|1|||
37747562|NCT01928381|69237606|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
37747563|NCT01928381|69237607|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
37747564|NCT01928381|69237608|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
37747565|NCT01928381|69237609|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
37747566|NCT01928381|69237610|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
37747567|NCT01928381|69237611|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
37747568|NCT01928381|69237612|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
37747569|NCT01928381|69237606|FG000|Washout First Intervention|Protocol Violation|0|||
37747570|NCT01928381|69237607|FG001|Washout First Intervention|Protocol Violation|0|||
37747571|NCT01928381|69237608|FG002|Washout First Intervention|Protocol Violation|0|||
37747572|NCT01928381|69237609|FG003|Washout First Intervention|Protocol Violation|0|||
37923051|NCT00813150|69609835|FG000|Treatment Period|Reason not specified|3|||
37923052|NCT00813150|69609836|FG001|Treatment Period|Reason not specified|4|||
37658584|NCT03386721|69130751|FG011|Overall Study|Progressive Disease|0|||
37658585|NCT03386721|69130752|FG012|Overall Study|Progressive Disease|1|||
37658586|NCT03386721|69130753|FG013|Overall Study|Progressive Disease|0|||
37658587|NCT03386721|69130754|FG014|Overall Study|Progressive Disease|0|||
37747573|NCT01928381|69237610|FG004|Washout First Intervention|Protocol Violation|1|||
37747574|NCT01928381|69237611|FG005|Washout First Intervention|Protocol Violation|0|||
37747575|NCT01928381|69237612|FG006|Washout First Intervention|Protocol Violation|0|||
37747576|NCT01928381|69237606|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
37747577|NCT01928381|69237607|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
37747578|NCT01928381|69237608|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
37747579|NCT01928381|69237609|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
37747580|NCT01928381|69237610|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
37747581|NCT01928381|69237611|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
37747582|NCT01928381|69237612|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
37747583|NCT01928381|69237606|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
37747584|NCT01928381|69237607|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
37747585|NCT01928381|69237608|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
37747586|NCT01928381|69237609|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
37747587|NCT01928381|69237610|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
37747588|NCT01928381|69237611|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
37747589|NCT01928381|69237612|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
37747590|NCT01928225|69237624|FG000|Overall Study|Pregnancy|1|||
37747591|NCT01928225|69237625|FG001|Overall Study|Pregnancy|0|||
37747592|NCT01928225|69237624|FG000|Overall Study|basaloid cervical cancer|1|||
37747593|NCT01928225|69237625|FG001|Overall Study|basaloid cervical cancer|0|||
37747594|NCT01928225|69237624|FG000|Overall Study|Lost to Follow-up|1|||
37747595|NCT01928225|69237625|FG001|Overall Study|Lost to Follow-up|3|||
37747596|NCT01927757|69237632|FG000|Overall Study|Withdrawal by Subject|14|||
37747597|NCT01927757|69237632|FG000|Overall Study|Lost to Follow-up|2|||
37747598|NCT01927757|69237632|FG000|Overall Study|Decision by Sponsor|2|||
37747599|NCT01927757|69237632|FG000|Overall Study|Other|1|||
37747600|NCT01927757|69237632|FG000|Overall Study|Ethical Reasons|4|||
37747601|NCT01927367|69237642|FG000|Overall Study|Withdrawal by Subject|7|||
37747602|NCT01927367|69237643|FG001|Overall Study|Withdrawal by Subject|4|||
37747603|NCT01927367|69237642|FG000|Overall Study|No baseline data|0|||
37747604|NCT01927367|69237643|FG001|Overall Study|No baseline data|1|||
37747605|NCT01913639|69237649|FG000|Overall Study|Not Eligible|3|||
37747606|NCT01913483|69237655|FG000|Overall Study|Withdrawal by Subject|1|||
37747607|NCT01913483|69237656|FG001|Overall Study|Withdrawal by Subject|2|||
37747608|NCT01913483|69237655|FG000|Overall Study|Lost to Follow-up|6|||
37747609|NCT01913483|69237656|FG001|Overall Study|Lost to Follow-up|3|||
37747610|NCT01913483|69237655|FG000|Overall Study|Death|14|||
37747611|NCT01913483|69237656|FG001|Overall Study|Death|17|||
37747612|NCT01913405|69237662|FG000|Overall Study|Withdrawal by Subject|1|||
37747613|NCT01913405|69237662|FG000|Overall Study|Adverse Event|1|||
37747614|NCT01927055|69237682|FG000|Open-label|Adverse Event|6|||
37747615|NCT01927055|69237683|FG001|Open-label|Adverse Event|0|||
37747616|NCT01927055|69237684|FG002|Open-label|Adverse Event|0|||
37747617|NCT01927055|69237682|FG000|Open-label|Withdrawal by Subject|1|||
37747618|NCT01927055|69237683|FG001|Open-label|Withdrawal by Subject|0|||
37747619|NCT01927055|69237684|FG002|Open-label|Withdrawal by Subject|0|||
37747620|NCT01927055|69237682|FG000|Open-label|Study Stopped|4|||
37747621|NCT01927055|69237683|FG001|Open-label|Study Stopped|0|||
37747622|NCT01927055|69237684|FG002|Open-label|Study Stopped|0|||
37747623|NCT01927055|69237682|FG000|Open-label|Supine Hypertension|4|||
37747624|NCT01927055|69237683|FG001|Open-label|Supine Hypertension|0|||
37747625|NCT01927055|69237684|FG002|Open-label|Supine Hypertension|0|||
37747626|NCT01927055|69237682|FG000|Open-label|Difficulty attending study visits|1|||
37747627|NCT01927055|69237683|FG001|Open-label|Difficulty attending study visits|0|||
37747628|NCT01927055|69237684|FG002|Open-label|Difficulty attending study visits|0|||
37747629|NCT01927055|69237682|FG000|Double-Blind|Adverse Event|0|||
37747630|NCT01927055|69237683|FG001|Double-Blind|Adverse Event|1|||
37747631|NCT01927055|69237684|FG002|Double-Blind|Adverse Event|1|||
37747632|NCT01927055|69237682|FG000|Double-Blind|Protocol Violation|0|||
37747633|NCT01927055|69237683|FG001|Double-Blind|Protocol Violation|0|||
37747634|NCT01927055|69237684|FG002|Double-Blind|Protocol Violation|1|||
37747635|NCT01927055|69237682|FG000|Double-Blind|Withdrawal by Subject|0|||
37747636|NCT01927055|69237683|FG001|Double-Blind|Withdrawal by Subject|2|||
37747637|NCT01927055|69237684|FG002|Double-Blind|Withdrawal by Subject|3|||
37747638|NCT01927055|69237682|FG000|Double-Blind|Study Stopped|0|||
37747639|NCT01927055|69237683|FG001|Double-Blind|Study Stopped|7|||
37747640|NCT01927055|69237684|FG002|Double-Blind|Study Stopped|7|||
37747641|NCT01927055|69237682|FG000|Double-Blind|Supine Hypertension|0|||
37855905|NCT01217229|69539283|FG000|Overall Study|Disease progression not confirmed|2|||
37855906|NCT01013740|69539289|FG000|Overall Study|Lost to Follow-up|3|||
37747642|NCT01927055|69237683|FG001|Double-Blind|Supine Hypertension|0|||
37747643|NCT01927055|69237684|FG002|Double-Blind|Supine Hypertension|1|||
37747644|NCT01927055|69237682|FG000|Double-Blind|Extended Vacation|0|||
37747645|NCT01927055|69237683|FG001|Double-Blind|Extended Vacation|1|||
37747646|NCT01927055|69237684|FG002|Double-Blind|Extended Vacation|0|||
37747647|NCT01913327|69237693|FG000|Overall Study|Withdrawal by Subject|0|||
37747648|NCT01913327|69237694|FG001|Overall Study|Withdrawal by Subject|1|||
37747649|NCT01926509|69237704|FG000|Overall Study|vital sign met discontinuation criteria|1|||
37747650|NCT01926509|69237705|FG001|Overall Study|vital sign met discontinuation criteria|0|||
37747651|NCT01926509|69237706|FG002|Overall Study|vital sign met discontinuation criteria|0|||
37747652|NCT01926509|69237707|FG003|Overall Study|vital sign met discontinuation criteria|0|||
37747653|NCT01926119|69237717|FG000|Overall Study|Withdrawal by Subject|1|||
37747654|NCT01912781|69237723|FG000|Overall Study|Withdrawal by Subject|2|||
37747655|NCT01912781|69237724|FG001|Overall Study|Withdrawal by Subject|0|||
37747656|NCT01925417|69237731|FG000|Overall Study|Withdrawal by Subject|2|||
37747657|NCT01925417|69237731|FG000|Overall Study|Death|1|||
37747658|NCT01911845|69237736|FG000|Overall Study|Adverse Event|2|||
37747659|NCT01911845|69237736|FG000|Overall Study|Lost to Follow-up|1|||
37747660|NCT01911845|69237736|FG000|Overall Study|Other (not specified)|3|||
37747661|NCT01925183|69237744|FG000|Overall Study|Adverse Event|1|||
37747662|NCT01925183|69237745|FG001|Overall Study|Adverse Event|0|||
37747663|NCT01910519|69237753|FG000|Overall Study|Withdrawal by Subject|2|||
37747664|NCT01910519|69237754|FG001|Overall Study|Withdrawal by Subject|0|||
37747665|NCT01910519|69237753|FG000|Overall Study|Adverse Event|2|||
37747666|NCT01910519|69237754|FG001|Overall Study|Adverse Event|0|||
37747667|NCT01910441|69237762|FG000|Overall Study|Sponsor decision|0|||
37747668|NCT01910441|69237763|FG001|Overall Study|Sponsor decision|2|||
37747669|NCT01910441|69237762|FG000|Overall Study|Lost to Follow-up|6|||
37747670|NCT01910441|69237763|FG001|Overall Study|Lost to Follow-up|5|||
37747671|NCT01910441|69237762|FG000|Overall Study|Withdrawal by Subject|0|||
37747672|NCT01910441|69237763|FG001|Overall Study|Withdrawal by Subject|1|||
37747673|NCT01910441|69237762|FG000|Overall Study|Non-compliance|0|||
37747674|NCT01910441|69237763|FG001|Overall Study|Non-compliance|1|||
37747675|NCT01910441|69237762|FG000|Overall Study|Adverse Event|1|||
37747676|NCT01910441|69237763|FG001|Overall Study|Adverse Event|0|||
37855907|NCT01013740|69539290|FG001|Overall Study|Lost to Follow-up|5|||
37855908|NCT01013740|69539289|FG000|Overall Study|Physician Decision|2|||
37855909|NCT01013740|69539290|FG001|Overall Study|Physician Decision|0|||
37855910|NCT01013740|69539289|FG000|Overall Study|Withdrawal by Subject|2|||
38033014|NCT02820844|69718998|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
38033015|NCT02820844|69718999|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
37658588|NCT03386721|69130740|FG000|Overall Study|Site Terminated by Sponsor|5|||
37658589|NCT03386721|69130741|FG001|Overall Study|Site Terminated by Sponsor|5|||
37658590|NCT03386721|69130742|FG002|Overall Study|Site Terminated by Sponsor|0|||
37658591|NCT03386721|69130743|FG003|Overall Study|Site Terminated by Sponsor|0|||
37658592|NCT03386721|69130744|FG004|Overall Study|Site Terminated by Sponsor|1|||
37658593|NCT03386721|69130745|FG005|Overall Study|Site Terminated by Sponsor|3|||
37658594|NCT03386721|69130746|FG006|Overall Study|Site Terminated by Sponsor|0|||
37658595|NCT03386721|69130747|FG007|Overall Study|Site Terminated by Sponsor|1|||
37658596|NCT03386721|69130748|FG008|Overall Study|Site Terminated by Sponsor|4|||
37658597|NCT03386721|69130749|FG009|Overall Study|Site Terminated by Sponsor|5|||
37658598|NCT03386721|69130750|FG010|Overall Study|Site Terminated by Sponsor|3|||
37658599|NCT03386721|69130751|FG011|Overall Study|Site Terminated by Sponsor|11|||
37658600|NCT03386721|69130752|FG012|Overall Study|Site Terminated by Sponsor|6|||
37658601|NCT03386721|69130753|FG013|Overall Study|Site Terminated by Sponsor|0|||
37658602|NCT03386721|69130754|FG014|Overall Study|Site Terminated by Sponsor|0|||
37658603|NCT03386721|69130740|FG000|Overall Study|Symptomatic Deterioration|0|||
37658604|NCT03386721|69130741|FG001|Overall Study|Symptomatic Deterioration|0|||
37658605|NCT03386721|69130742|FG002|Overall Study|Symptomatic Deterioration|0|||
37658606|NCT03386721|69130743|FG003|Overall Study|Symptomatic Deterioration|0|||
37658607|NCT03386721|69130744|FG004|Overall Study|Symptomatic Deterioration|0|||
37658608|NCT03386721|69130745|FG005|Overall Study|Symptomatic Deterioration|0|||
37658609|NCT03386721|69130746|FG006|Overall Study|Symptomatic Deterioration|0|||
37658610|NCT03386721|69130747|FG007|Overall Study|Symptomatic Deterioration|0|||
37658611|NCT03386721|69130748|FG008|Overall Study|Symptomatic Deterioration|1|||
37658612|NCT03386721|69130749|FG009|Overall Study|Symptomatic Deterioration|0|||
37658613|NCT03386721|69130750|FG010|Overall Study|Symptomatic Deterioration|0|||
37658614|NCT03386721|69130751|FG011|Overall Study|Symptomatic Deterioration|1|||
37855911|NCT01013740|69539290|FG001|Overall Study|Withdrawal by Subject|10|||
37658615|NCT03386721|69130752|FG012|Overall Study|Symptomatic Deterioration|0|||
37855912|NCT01013740|69539289|FG000|Overall Study|study close / terminated : done in error|2|||
37658616|NCT03386721|69130753|FG013|Overall Study|Symptomatic Deterioration|0|||
37658617|NCT03386721|69130754|FG014|Overall Study|Symptomatic Deterioration|0|||
37658618|NCT03386721|69130740|FG000|Overall Study|Withdrawal by Subject|1|||
37658619|NCT03386721|69130741|FG001|Overall Study|Withdrawal by Subject|2|||
37658620|NCT03386721|69130742|FG002|Overall Study|Withdrawal by Subject|0|||
37658621|NCT03386721|69130743|FG003|Overall Study|Withdrawal by Subject|0|||
37658622|NCT03386721|69130744|FG004|Overall Study|Withdrawal by Subject|0|||
37747677|NCT01910441|69237762|FG000|Overall Study|Physician Decision|0|||
37747678|NCT01910441|69237763|FG001|Overall Study|Physician Decision|1|||
37855913|NCT01013740|69539290|FG001|Overall Study|study close / terminated : done in error|1|||
37658623|NCT03386721|69130745|FG005|Overall Study|Withdrawal by Subject|0|||
37658624|NCT03386721|69130746|FG006|Overall Study|Withdrawal by Subject|0|||
37658625|NCT03386721|69130747|FG007|Overall Study|Withdrawal by Subject|0|||
37658626|NCT03386721|69130748|FG008|Overall Study|Withdrawal by Subject|2|||
37658627|NCT03386721|69130749|FG009|Overall Study|Withdrawal by Subject|1|||
37658628|NCT03386721|69130750|FG010|Overall Study|Withdrawal by Subject|3|||
37658629|NCT03386721|69130751|FG011|Overall Study|Withdrawal by Subject|2|||
37658630|NCT03386721|69130752|FG012|Overall Study|Withdrawal by Subject|3|||
37658631|NCT03386721|69130753|FG013|Overall Study|Withdrawal by Subject|0|||
37658632|NCT03386721|69130754|FG014|Overall Study|Withdrawal by Subject|0|||
37658633|NCT02462720|69130786|FG000|Part 2|Withdrawal by Subject|1|||
37658634|NCT02462720|69130787|FG001|Part 2|Withdrawal by Subject|0|||
37658635|NCT02462720|69130786|FG000|Part 2|Protocol Violation|0|||
37658636|NCT02462720|69130787|FG001|Part 2|Protocol Violation|1|||
37658637|NCT02246218|69130797|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
37658638|NCT02246218|69130798|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
37658639|NCT02246218|69130797|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
37658640|NCT02246218|69130798|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
37658641|NCT02246218|69130797|FG000|Overall Study|Adverse Event|1|||
37658642|NCT02246218|69130798|FG001|Overall Study|Adverse Event|1|||
37747679|NCT01923467|69237769|FG000|Overall Study|Lost to Follow-up|62|||
37747680|NCT01923467|69237769|FG000|Overall Study|Subject non-interest|479|||
37747681|NCT01910129|69237775|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
37747682|NCT01910129|69237776|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
37747683|NCT01910129|69237777|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
37747684|NCT01910129|69237775|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
37747685|NCT01910129|69237776|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
37747686|NCT01910129|69237777|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
37747687|NCT01909973|69237797|FG000|Overall Study|Lost to Follow-up|1|||
37747688|NCT01909973|69237798|FG001|Overall Study|Lost to Follow-up|0|||
37747689|NCT01617005|69237804|FG000|Overall Study|Pregnancy|1|||
37747690|NCT01617005|69237804|FG000|Overall Study|Lack of motivation for treatment|1|||
37747691|NCT01925339|69237810|FG000|Overall Study|Adverse Event|2|||
37747692|NCT01925339|69237811|FG001|Overall Study|Adverse Event|0|||
37747693|NCT01908803|69237819|FG000|Overall Study|Adverse Event|1|||
37747694|NCT01908803|69237820|FG001|Overall Study|Adverse Event|0|||
37747695|NCT01908803|69237819|FG000|Overall Study|Physician Decision|0|||
37747696|NCT01908803|69237820|FG001|Overall Study|Physician Decision|1|||
37747697|NCT01908803|69237819|FG000|Overall Study|Withdrawal by Subject|1|||
37747698|NCT01908803|69237820|FG001|Overall Study|Withdrawal by Subject|0|||
37747699|NCT01908803|69237819|FG000|Overall Study|Randomization Error|1|||
37747700|NCT01908803|69237820|FG001|Overall Study|Randomization Error|0|||
37747701|NCT01908803|69237819|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
37747702|NCT01908803|69237820|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
37747703|NCT01908101|69237827|FG000|Overall Study|Physician Decision|1|||
37747704|NCT01908101|69237827|FG000|Overall Study|Withdrawal by Subject|1|||
37747705|NCT01908101|69237827|FG000|Overall Study|Incorrect Diagnosis|2|||
37747706|NCT01908101|69237827|FG000|Overall Study|Incorrect Starting Dose|1|||
37747707|NCT01908101|69237827|FG000|Overall Study|Did not complete the first cycle|4|||
37747708|NCT01923389|69237833|FG000|Overall Study|Protocol Violation|1|||
37747709|NCT01923389|69237834|FG001|Overall Study|Protocol Violation|0|||
37747710|NCT01907087|69237841|FG000|Overall Study|Withdrawal by Subject|1|||
37747711|NCT01616771|69237845|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
37747712|NCT01589185|69237859|FG000|Overall Study|Death|1|||
37747713|NCT01589185|69237860|FG001|Overall Study|Death|2|||
37747714|NCT01589185|69237861|FG002|Overall Study|Death|2|||
37747715|NCT01589185|69237862|FG003|Overall Study|Death|0|||
37747716|NCT01589185|69237863|FG004|Overall Study|Death|1|||
37747717|NCT01589185|69237859|FG000|Overall Study|Lost to Follow-up|1|||
37747718|NCT01589185|69237860|FG001|Overall Study|Lost to Follow-up|0|||
37747719|NCT01589185|69237861|FG002|Overall Study|Lost to Follow-up|2|||
37855914|NCT01013740|69539289|FG000|Overall Study|Missing|2|||
37855915|NCT01013740|69539290|FG001|Overall Study|Missing|1|||
37658643|NCT02246218|69130797|FG000|Overall Study|Lost to Follow-up|1|||
37658644|NCT02246218|69130798|FG001|Overall Study|Lost to Follow-up|0|||
37747720|NCT01589185|69237862|FG003|Overall Study|Lost to Follow-up|3|||
37747721|NCT01589185|69237863|FG004|Overall Study|Lost to Follow-up|0|||
37747722|NCT01588951|69237879|FG000|Overall Study|Ineligible in retrospect|0|||
37658645|NCT02244580|69130804|FG000|Overall Study|No cancer tissues available|241|||
37658646|NCT02244424|69130814|FG000|Overall Study|Lost to Follow-up|20|||
37658647|NCT02244424|69130815|FG001|Overall Study|Lost to Follow-up|10|||
37658648|NCT00159783|69130824|FG000|Overall Study|Adverse Event|5|||
37747723|NCT01588951|69237880|FG001|Overall Study|Ineligible in retrospect|0|||
37747724|NCT01588951|69237881|FG002|Overall Study|Ineligible in retrospect|1|||
37747725|NCT01709383|69237891|FG000|Overall Study|Lost to Follow-up|1|||
37747726|NCT01709383|69237892|FG001|Overall Study|Lost to Follow-up|0|||
37747727|NCT01588405|69237900|FG000|Overall Study|Adverse Event|1|||
37855916|NCT01013740|69539289|FG000|Overall Study|Ongoing: Study records not completed|0|||
37747728|NCT01588405|69237900|FG000|Overall Study|Clinical Worsening|1|||
37747729|NCT01923311|69237909|FG000|Overall Study|Pregnancy|1|||
37747730|NCT01923311|69237910|FG001|Overall Study|Pregnancy|0|||
37747731|NCT01923311|69237909|FG000|Overall Study|Investigator's Discretion|1|||
37658649|NCT00159783|69130825|FG001|Overall Study|Adverse Event|7|||
37658650|NCT00159783|69130826|FG002|Overall Study|Adverse Event|9|||
37658651|NCT00159783|69130824|FG000|Overall Study|Lack of Efficacy|1|||
37658652|NCT00159783|69130825|FG001|Overall Study|Lack of Efficacy|2|||
37658653|NCT00159783|69130826|FG002|Overall Study|Lack of Efficacy|3|||
37658654|NCT00159783|69130824|FG000|Overall Study|Withdrawal by Subject|7|||
37658655|NCT00159783|69130825|FG001|Overall Study|Withdrawal by Subject|11|||
37658656|NCT00159783|69130826|FG002|Overall Study|Withdrawal by Subject|12|||
37658657|NCT00159783|69130824|FG000|Overall Study|Lost to Follow-up|6|||
37658658|NCT00159783|69130825|FG001|Overall Study|Lost to Follow-up|5|||
37658659|NCT00159783|69130826|FG002|Overall Study|Lost to Follow-up|11|||
37658660|NCT00159783|69130824|FG000|Overall Study|Other|0|||
37658661|NCT00159783|69130825|FG001|Overall Study|Other|2|||
37658662|NCT00159783|69130826|FG002|Overall Study|Other|4|||
37658663|NCT00646204|69130837|FG000|Overall Study|Adverse Event|3|||
37658664|NCT00646204|69130838|FG001|Overall Study|Adverse Event|0|||
37658665|NCT00646204|69130837|FG000|Overall Study|Withdrawal by Subject|1|||
37658666|NCT00646204|69130838|FG001|Overall Study|Withdrawal by Subject|0|||
37747732|NCT01923311|69237910|FG001|Overall Study|Investigator's Discretion|0|||
37747733|NCT01923311|69237909|FG000|Overall Study|Non-Compliance with Study Drug|2|||
37747734|NCT01923311|69237910|FG001|Overall Study|Non-Compliance with Study Drug|1|||
37747735|NCT01923311|69237909|FG000|Overall Study|Withdrew Consent|1|||
37747736|NCT01923311|69237910|FG001|Overall Study|Withdrew Consent|0|||
37747737|NCT01923311|69237909|FG000|Overall Study|Study Terminated by Sponsor|12|||
37747738|NCT01923311|69237910|FG001|Overall Study|Study Terminated by Sponsor|0|||
37747739|NCT01603615|69237917|FG000|Overall Study|Did not Receive Treatment|7|||
37747740|NCT01603615|69237917|FG000|Overall Study|Lost to Follow-up|9|||
37747741|NCT01603615|69237917|FG000|Overall Study|Personal Reasons|17|||
37747742|NCT01603615|69237917|FG000|Overall Study|Other Miscellaneous|1|||
37747743|NCT01685047|69237921|FG000|Overall Study|Withdrawal by Subject|20|||
37658667|NCT02936323|69130855|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
37658668|NCT02936323|69130856|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
37658669|NCT02936323|69130857|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
37658670|NCT02936323|69130858|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
37658671|NCT02936323|69130859|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
37658672|NCT02936323|69130860|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
37658673|NCT02936323|69130861|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
37658674|NCT02936323|69130862|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
37658675|NCT02936323|69130863|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
37658676|NCT02936323|69130864|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
37658677|NCT02936323|69130855|FG000|Phase 1 Dose Escalation|Death|2|||
37658678|NCT02936323|69130856|FG001|Phase 1 Dose Escalation|Death|1|||
37658679|NCT02936323|69130857|FG002|Phase 1 Dose Escalation|Death|3|||
37658680|NCT02936323|69130858|FG003|Phase 1 Dose Escalation|Death|1|||
37658681|NCT02936323|69130859|FG004|Phase 1 Dose Escalation|Death|2|||
37658682|NCT02936323|69130860|FG005|Phase 1 Dose Escalation|Death|3|||
37658683|NCT02936323|69130861|FG006|Phase 1 Dose Escalation|Death|3|||
37747744|NCT01685047|69237921|FG000|Overall Study|Death|26|||
37747745|NCT01685047|69237921|FG000|Overall Study|Lost to Follow-up|8|||
37747746|NCT01685047|69237921|FG000|Overall Study|Physician Decision|25|||
37747747|NCT01685047|69237921|FG000|Overall Study|Adverse Event|5|||
37747748|NCT01685047|69237921|FG000|Overall Study|patient withdrawn by sponsor|1|||
37747749|NCT01905683|69237925|FG000|Overall Study|Protocol Violation|1|||
37747750|NCT01905683|69237925|FG000|Overall Study|Re-injection criteria not met; others|13|||
37747751|NCT01905683|69237925|FG000|Overall Study|Physician Decision|1|||
37747752|NCT01905683|69237925|FG000|Overall Study|Lack of Efficacy|8|||
37747753|NCT01905683|69237925|FG000|Overall Study|Withdrawal by Subject|20|||
37747754|NCT01905683|69237925|FG000|Overall Study|Adverse Event|4|||
37747755|NCT01905683|69237925|FG000|Overall Study|Lost to Follow-up|4|||
37747756|NCT01921829|69237931|FG000|Overall Study|Withdrawal by Subject|0|||
37747757|NCT01921829|69237932|FG001|Overall Study|Withdrawal by Subject|1|||
37855917|NCT01013740|69539290|FG001|Overall Study|Ongoing: Study records not completed|2|||
37658684|NCT02936323|69130862|FG007|Phase 1 Dose Escalation|Death|0|||
37658685|NCT02936323|69130863|FG008|Phase 1 Dose Escalation|Death|0|||
37658686|NCT02936323|69130864|FG009|Phase 1 Dose Escalation|Death|0|||
37658687|NCT02936323|69130855|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
37658688|NCT02936323|69130856|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
37658689|NCT02936323|69130857|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
37658690|NCT02936323|69130858|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
37747758|NCT01904903|69237938|FG000|Overall Study|Withdrawal by Subject|1|||
37747759|NCT01921517|69237944|FG000|Overall Study|Lost to Follow-up|5|||
37855918|NCT01013350|69539300|FG000|Overall Study|Lost to Follow-up|15|||
37855919|NCT01013350|69539301|FG001|Overall Study|Lost to Follow-up|95|||
37855920|NCT01013350|69539300|FG000|Overall Study|Adverse Event|0|||
37855921|NCT01013350|69539301|FG001|Overall Study|Adverse Event|1|||
37855922|NCT01013350|69539300|FG000|Overall Study|Physician Decision|4|||
37855923|NCT01013350|69539301|FG001|Overall Study|Physician Decision|20|||
37855924|NCT01013350|69539300|FG000|Overall Study|Withdrawal by Subject|15|||
37855925|NCT01013350|69539301|FG001|Overall Study|Withdrawal by Subject|38|||
37855926|NCT01013350|69539300|FG000|Overall Study|Death|3|||
37658691|NCT02936323|69130859|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
37658692|NCT02936323|69130860|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
37658693|NCT02936323|69130861|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
37658694|NCT02936323|69130862|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
37658695|NCT02936323|69130863|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
37658696|NCT02936323|69130864|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
37658697|NCT02936323|69130855|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
37658698|NCT02936323|69130856|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
37658699|NCT02936323|69130857|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
37658700|NCT02936323|69130858|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
37658701|NCT02936323|69130859|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
37658702|NCT02936323|69130860|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
37658703|NCT02936323|69130861|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
37658704|NCT02936323|69130862|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
37747760|NCT01921517|69237945|FG001|Overall Study|Lost to Follow-up|0|||
37747761|NCT01921517|69237944|FG000|Overall Study|Newly diagnosed health concern|2|||
37747762|NCT01921517|69237945|FG001|Overall Study|Newly diagnosed health concern|0|||
37747763|NCT01921517|69237944|FG000|Overall Study|Physician Decision|0|||
37747764|NCT01921517|69237945|FG001|Overall Study|Physician Decision|2|||
37747765|NCT01921517|69237944|FG000|Overall Study|Withdrawal by Subject|7|||
37747766|NCT01921517|69237945|FG001|Overall Study|Withdrawal by Subject|3|||
37747767|NCT01921517|69237944|FG000|Overall Study|Subject missed final imaging|1|||
37747768|NCT01921517|69237945|FG001|Overall Study|Subject missed final imaging|4|||
37747769|NCT01921205|69237953|FG000|Overall Study|Adverse Event|12|||
37747770|NCT01921205|69237954|FG001|Overall Study|Adverse Event|7|||
37747771|NCT01921205|69237953|FG000|Overall Study|Lack of Efficacy|1|||
37747772|NCT01921205|69237954|FG001|Overall Study|Lack of Efficacy|0|||
37747773|NCT01921205|69237953|FG000|Overall Study|Protocol Violation|1|||
37747774|NCT01921205|69237954|FG001|Overall Study|Protocol Violation|3|||
37747775|NCT01921205|69237953|FG000|Overall Study|Lost to Follow-up|1|||
37747776|NCT01921205|69237954|FG001|Overall Study|Lost to Follow-up|1|||
37747777|NCT01921205|69237953|FG000|Overall Study|Withdrawal by Subject|6|||
37747778|NCT01921205|69237954|FG001|Overall Study|Withdrawal by Subject|5|||
37747779|NCT01921205|69237953|FG000|Overall Study|Use Of Prohibited Medication|0|||
37747780|NCT01921205|69237954|FG001|Overall Study|Use Of Prohibited Medication|1|||
37747781|NCT01921205|69237953|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
37747782|NCT01921205|69237954|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
37747783|NCT01921205|69237953|FG000|Overall Study|Non Compliance Of The Parent|0|||
37747784|NCT01921205|69237954|FG001|Overall Study|Non Compliance Of The Parent|1|||
37747785|NCT01921205|69237953|FG000|Overall Study|Non Compliance Of Child|0|||
37747786|NCT01921205|69237954|FG001|Overall Study|Non Compliance Of Child|1|||
37747787|NCT01920893|69237962|FG000|Overall Study|Adverse Event|5|||
37747788|NCT01920893|69237963|FG001|Overall Study|Adverse Event|2|||
37747789|NCT01920893|69237962|FG000|Overall Study|Lack of Efficacy|2|||
37747790|NCT01920893|69237963|FG001|Overall Study|Lack of Efficacy|0|||
37747791|NCT01709305|69237970|FG000|Phase 1|Clinical Adverse Event|80|||
37747792|NCT01709305|69237971|FG001|Phase 1|Clinical Adverse Event|0|||
37747793|NCT01709305|69237972|FG002|Phase 1|Clinical Adverse Event|0|||
37747794|NCT01709305|69237973|FG003|Phase 1|Clinical Adverse Event|0|||
37747795|NCT01709305|69237974|FG004|Phase 1|Clinical Adverse Event|0|||
37747796|NCT01709305|69237970|FG000|Phase 1|Death|2|||
37747797|NCT01709305|69237971|FG001|Phase 1|Death|0|||
37747798|NCT01709305|69237972|FG002|Phase 1|Death|0|||
37747799|NCT01709305|69237973|FG003|Phase 1|Death|0|||
37747800|NCT01709305|69237974|FG004|Phase 1|Death|0|||
37747801|NCT01709305|69237970|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
37747802|NCT01709305|69237971|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
37747803|NCT01709305|69237972|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
37747804|NCT01709305|69237973|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
37747805|NCT01709305|69237974|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
37747806|NCT01709305|69237970|FG000|Phase 1|Laboratory Adverse Event|16|||
37747807|NCT01709305|69237971|FG001|Phase 1|Laboratory Adverse Event|0|||
37747808|NCT01709305|69237972|FG002|Phase 1|Laboratory Adverse Event|0|||
37747809|NCT01709305|69237973|FG003|Phase 1|Laboratory Adverse Event|0|||
37747810|NCT01709305|69237974|FG004|Phase 1|Laboratory Adverse Event|0|||
37747811|NCT01709305|69237970|FG000|Phase 1|Lost to Follow-up|147|||
37855927|NCT01013350|69539301|FG001|Overall Study|Death|5|||
37855928|NCT01013350|69539300|FG000|Overall Study|Participant entered interventional study|0|||
37747812|NCT01709305|69237971|FG001|Phase 1|Lost to Follow-up|0|||
37747813|NCT01709305|69237972|FG002|Phase 1|Lost to Follow-up|0|||
37747814|NCT01709305|69237973|FG003|Phase 1|Lost to Follow-up|0|||
37747815|NCT01709305|69237974|FG004|Phase 1|Lost to Follow-up|0|||
37747816|NCT01709305|69237970|FG000|Phase 1|Travel, moving, etc.|30|||
37747817|NCT01709305|69237971|FG001|Phase 1|Travel, moving, etc.|0|||
37747818|NCT01709305|69237972|FG002|Phase 1|Travel, moving, etc.|0|||
37747819|NCT01709305|69237973|FG003|Phase 1|Travel, moving, etc.|0|||
37747820|NCT01709305|69237974|FG004|Phase 1|Travel, moving, etc.|0|||
37747821|NCT01709305|69237970|FG000|Phase 1|Physician Decision|13|||
37747822|NCT01709305|69237971|FG001|Phase 1|Physician Decision|0|||
37747823|NCT01709305|69237972|FG002|Phase 1|Physician Decision|0|||
37747824|NCT01709305|69237973|FG003|Phase 1|Physician Decision|0|||
37747825|NCT01709305|69237974|FG004|Phase 1|Physician Decision|0|||
37747826|NCT01709305|69237970|FG000|Phase 1|Protocol Violation|118|||
37747827|NCT01709305|69237971|FG001|Phase 1|Protocol Violation|0|||
37747828|NCT01709305|69237972|FG002|Phase 1|Protocol Violation|0|||
37747829|NCT01709305|69237973|FG003|Phase 1|Protocol Violation|0|||
37747830|NCT01709305|69237974|FG004|Phase 1|Protocol Violation|0|||
37747831|NCT01709305|69237970|FG000|Phase 1|Withdrawal by Subject|218|||
37747832|NCT01709305|69237971|FG001|Phase 1|Withdrawal by Subject|0|||
37747833|NCT01709305|69237972|FG002|Phase 1|Withdrawal by Subject|0|||
37747834|NCT01709305|69237973|FG003|Phase 1|Withdrawal by Subject|0|||
37747835|NCT01709305|69237974|FG004|Phase 1|Withdrawal by Subject|0|||
37747836|NCT01709305|69237970|FG000|Phase 2|Clinical Adverse Event|0|||
37747837|NCT01709305|69237971|FG001|Phase 2|Clinical Adverse Event|10|||
37747838|NCT01709305|69237972|FG002|Phase 2|Clinical Adverse Event|10|||
37747839|NCT01709305|69237973|FG003|Phase 2|Clinical Adverse Event|6|||
37747840|NCT01709305|69237974|FG004|Phase 2|Clinical Adverse Event|11|||
37747841|NCT01709305|69237970|FG000|Phase 2|Death|0|||
37747842|NCT01709305|69237971|FG001|Phase 2|Death|0|||
37747843|NCT01709305|69237972|FG002|Phase 2|Death|1|||
37747844|NCT01709305|69237973|FG003|Phase 2|Death|0|||
37747845|NCT01709305|69237974|FG004|Phase 2|Death|0|||
37747846|NCT01709305|69237970|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
37747847|NCT01709305|69237971|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
37855929|NCT01013350|69539301|FG001|Overall Study|Participant entered interventional study|8|||
37855930|NCT01013350|69539300|FG000|Overall Study|Other|1|||
37855931|NCT01013350|69539301|FG001|Overall Study|Other|25|||
37855932|NCT01018030|69539311|FG000|Overall Study|Adverse Event|10|||
37855933|NCT01018030|69539312|FG001|Overall Study|Adverse Event|5|||
37855934|NCT01018030|69539313|FG002|Overall Study|Adverse Event|5|||
37855935|NCT01018030|69539311|FG000|Overall Study|Withdrawal by Subject|2|||
37855936|NCT01018030|69539312|FG001|Overall Study|Withdrawal by Subject|2|||
37855937|NCT01018030|69539313|FG002|Overall Study|Withdrawal by Subject|4|||
37855938|NCT01018030|69539311|FG000|Overall Study|Lost to Follow-up|2|||
37855939|NCT01018030|69539312|FG001|Overall Study|Lost to Follow-up|0|||
37855940|NCT01018030|69539313|FG002|Overall Study|Lost to Follow-up|3|||
37855941|NCT01018030|69539311|FG000|Overall Study|Protocol Violation|2|||
37855942|NCT01018030|69539312|FG001|Overall Study|Protocol Violation|1|||
37855943|NCT01018030|69539313|FG002|Overall Study|Protocol Violation|0|||
37855944|NCT01018030|69539311|FG000|Overall Study|Physician Decision|1|||
37855945|NCT01018030|69539312|FG001|Overall Study|Physician Decision|0|||
37855946|NCT01018030|69539313|FG002|Overall Study|Physician Decision|1|||
37855947|NCT01018030|69539311|FG000|Overall Study|Lack of Efficacy|1|||
37855948|NCT01018030|69539312|FG001|Overall Study|Lack of Efficacy|0|||
37855949|NCT01018030|69539313|FG002|Overall Study|Lack of Efficacy|0|||
37855950|NCT01018030|69539311|FG000|Overall Study|Did Not Receive Study Drug|1|||
37747848|NCT01709305|69237972|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
37747849|NCT01709305|69237973|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
37855951|NCT01018030|69539312|FG001|Overall Study|Did Not Receive Study Drug|3|||
37855952|NCT01018030|69539313|FG002|Overall Study|Did Not Receive Study Drug|0|||
37855953|NCT01217073|69539329|FG000|Base Period|Adverse Event|1|||
37855954|NCT01217073|69539330|FG001|Base Period|Adverse Event|0|||
37855955|NCT01217073|69539331|FG002|Base Period|Adverse Event|1|||
37855956|NCT01217073|69539332|FG003|Base Period|Adverse Event|0|||
37855957|NCT01217073|69539333|FG004|Base Period|Adverse Event|4|||
37855958|NCT01217073|69539334|FG005|Base Period|Adverse Event|1|||
37855959|NCT01217073|69539335|FG006|Base Period|Adverse Event|0|||
37747850|NCT01709305|69237974|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
37855960|NCT01217073|69539336|FG007|Base Period|Adverse Event|0|||
37855961|NCT01217073|69539329|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
37855962|NCT01217073|69539330|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
37855963|NCT01217073|69539331|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
37747851|NCT01709305|69237970|FG000|Phase 2|Laboratory Adverse Event|0|||
37747852|NCT01709305|69237971|FG001|Phase 2|Laboratory Adverse Event|1|||
37747853|NCT01709305|69237972|FG002|Phase 2|Laboratory Adverse Event|0|||
37855964|NCT01217073|69539332|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
37855965|NCT01217073|69539333|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
37855966|NCT01217073|69539334|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
37855967|NCT01217073|69539335|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
37658705|NCT02936323|69130863|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
37658706|NCT02936323|69130864|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
37658707|NCT02936323|69130855|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
37658708|NCT02936323|69130856|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
37658709|NCT02936323|69130857|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
37658710|NCT02936323|69130858|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
37658711|NCT02936323|69130859|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
37658712|NCT02936323|69130860|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
37658713|NCT02936323|69130861|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
37658714|NCT02936323|69130862|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
37658715|NCT02936323|69130863|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
37658716|NCT02936323|69130864|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
37658717|NCT02936323|69130855|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
37658718|NCT02936323|69130856|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
37658719|NCT02936323|69130857|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
37658720|NCT02936323|69130858|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
37658721|NCT02936323|69130859|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
37658722|NCT02936323|69130860|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
37658723|NCT02936323|69130861|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
37658724|NCT02936323|69130862|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
37658725|NCT02936323|69130863|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
37658726|NCT02936323|69130864|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
37747854|NCT01709305|69237973|FG003|Phase 2|Laboratory Adverse Event|1|||
37747855|NCT01709305|69237974|FG004|Phase 2|Laboratory Adverse Event|1|||
37747856|NCT01709305|69237970|FG000|Phase 2|Lost to Follow-up|0|||
37747857|NCT01709305|69237971|FG001|Phase 2|Lost to Follow-up|10|||
37747858|NCT01709305|69237972|FG002|Phase 2|Lost to Follow-up|6|||
37747859|NCT01709305|69237973|FG003|Phase 2|Lost to Follow-up|9|||
37747860|NCT01709305|69237974|FG004|Phase 2|Lost to Follow-up|5|||
37747861|NCT01709305|69237970|FG000|Phase 2|Travel, moving, etc.|0|||
37747862|NCT01709305|69237971|FG001|Phase 2|Travel, moving, etc.|2|||
37747863|NCT01709305|69237972|FG002|Phase 2|Travel, moving, etc.|3|||
37747864|NCT01709305|69237973|FG003|Phase 2|Travel, moving, etc.|3|||
37747865|NCT01709305|69237974|FG004|Phase 2|Travel, moving, etc.|5|||
37747866|NCT01709305|69237970|FG000|Phase 2|Physician Decision|0|||
37747867|NCT01709305|69237971|FG001|Phase 2|Physician Decision|2|||
37747868|NCT01709305|69237972|FG002|Phase 2|Physician Decision|0|||
37747869|NCT01709305|69237973|FG003|Phase 2|Physician Decision|1|||
37747870|NCT01709305|69237974|FG004|Phase 2|Physician Decision|2|||
37747871|NCT01709305|69237970|FG000|Phase 2|Protocol Violation|0|||
37747872|NCT01709305|69237971|FG001|Phase 2|Protocol Violation|19|||
37747873|NCT01709305|69237972|FG002|Phase 2|Protocol Violation|19|||
37747874|NCT01709305|69237973|FG003|Phase 2|Protocol Violation|13|||
37747875|NCT01709305|69237974|FG004|Phase 2|Protocol Violation|9|||
37747876|NCT01709305|69237970|FG000|Phase 2|Withdrawal by Subject|0|||
37747877|NCT01709305|69237971|FG001|Phase 2|Withdrawal by Subject|8|||
37747878|NCT01709305|69237972|FG002|Phase 2|Withdrawal by Subject|6|||
37747879|NCT01709305|69237973|FG003|Phase 2|Withdrawal by Subject|15|||
37747880|NCT01709305|69237974|FG004|Phase 2|Withdrawal by Subject|12|||
37747881|NCT01684423|69237994|FG000|Overall Study|Withdrawal by Subject|0|||
37747882|NCT01684423|69237995|FG001|Overall Study|Withdrawal by Subject|0|||
37747883|NCT01684423|69237996|FG002|Overall Study|Withdrawal by Subject|1|||
37747884|NCT01684423|69237997|FG003|Overall Study|Withdrawal by Subject|0|||
37747885|NCT01684423|69237998|FG004|Overall Study|Withdrawal by Subject|0|||
37747886|NCT01709227|69238014|FG000|Overall Study|Physician Decision|1|||
37747887|NCT01709227|69238015|FG001|Overall Study|Physician Decision|0|||
37747888|NCT01709227|69238014|FG000|Overall Study|Pleural Peritoneal communication|0|||
37747889|NCT01709227|69238015|FG001|Overall Study|Pleural Peritoneal communication|9|||
37747890|NCT01684033|69238022|FG000|Period 1, First 30 Days|Adverse Event|1|||
37747891|NCT01684033|69238023|FG001|Period 1, First 30 Days|Adverse Event|1|||
37747892|NCT01684033|69238022|FG000|Period 1, First 30 Days|Noncompliance|1|||
37747893|NCT01684033|69238023|FG001|Period 1, First 30 Days|Noncompliance|0|||
37747894|NCT01684033|69238022|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
37747895|NCT01684033|69238023|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
37747896|NCT01684033|69238022|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
37747897|NCT01684033|69238023|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
37747898|NCT01684033|69238022|FG000|Period 2, Second 30 Days|Adverse Event|1|||
37747899|NCT01684033|69238023|FG001|Period 2, Second 30 Days|Adverse Event|0|||
37747900|NCT01903811|69238064|FG000|Overall Study|No measurable disease|1|||
37747901|NCT01903811|69238065|FG001|Overall Study|No measurable disease|1|||
37747902|NCT01903811|69238064|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
37747903|NCT01903811|69238065|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
37747904|NCT01903811|69238064|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
37747905|NCT01903811|69238065|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
37747906|NCT01903811|69238064|FG000|Overall Study|Withdrawal by Subject|0|||
37747907|NCT01903811|69238065|FG001|Overall Study|Withdrawal by Subject|1|||
37747908|NCT01709149|69238082|FG000|Open-label Lead-in Phase|Adverse Event|109|||
37658727|NCT02936323|69130855|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
37658728|NCT02936323|69130856|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
37658729|NCT02936323|69130857|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
37658730|NCT02936323|69130858|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
37658731|NCT02936323|69130859|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
37658732|NCT02936323|69130860|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
37658733|NCT02936323|69130861|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
37658734|NCT02936323|69130862|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
37658735|NCT02936323|69130863|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
37658736|NCT02936323|69130864|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
37658737|NCT02936323|69130855|FG000|Phase 2a Dose Expansion|Death|0|||
37658738|NCT02936323|69130856|FG001|Phase 2a Dose Expansion|Death|0|||
37658739|NCT02936323|69130857|FG002|Phase 2a Dose Expansion|Death|0|||
37658740|NCT02936323|69130858|FG003|Phase 2a Dose Expansion|Death|0|||
37855968|NCT01217073|69539336|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
37855969|NCT01217073|69539329|FG000|Base Period|Excluded medication|0|||
37855970|NCT01217073|69539330|FG001|Base Period|Excluded medication|0|||
37855971|NCT01217073|69539331|FG002|Base Period|Excluded medication|0|||
37855972|NCT01217073|69539332|FG003|Base Period|Excluded medication|0|||
37855973|NCT01217073|69539333|FG004|Base Period|Excluded medication|1|||
37855974|NCT01217073|69539334|FG005|Base Period|Excluded medication|0|||
37855975|NCT01217073|69539335|FG006|Base Period|Excluded medication|0|||
37855976|NCT01217073|69539336|FG007|Base Period|Excluded medication|0|||
37747909|NCT01709149|69238083|FG001|Open-label Lead-in Phase|Adverse Event|0|||
37747910|NCT01709149|69238084|FG002|Open-label Lead-in Phase|Adverse Event|0|||
37747911|NCT01709149|69238082|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
37747912|NCT01709149|69238083|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
37747913|NCT01709149|69238084|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
37747914|NCT01709149|69238082|FG000|Open-label Lead-in Phase|Death|1|||
37747915|NCT01709149|69238083|FG001|Open-label Lead-in Phase|Death|0|||
37747916|NCT01709149|69238084|FG002|Open-label Lead-in Phase|Death|0|||
37747917|NCT01709149|69238082|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
37747918|NCT01709149|69238083|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
37747919|NCT01709149|69238084|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
37855977|NCT01217073|69539329|FG000|Base Period|Lack of Efficacy|0|||
37855978|NCT01217073|69539330|FG001|Base Period|Lack of Efficacy|0|||
37855979|NCT01217073|69539331|FG002|Base Period|Lack of Efficacy|0|||
37855980|NCT01217073|69539332|FG003|Base Period|Lack of Efficacy|0|||
37855981|NCT01217073|69539333|FG004|Base Period|Lack of Efficacy|0|||
37855982|NCT01217073|69539334|FG005|Base Period|Lack of Efficacy|1|||
37855983|NCT01217073|69539335|FG006|Base Period|Lack of Efficacy|0|||
37855984|NCT01217073|69539336|FG007|Base Period|Lack of Efficacy|0|||
37855985|NCT01217073|69539329|FG000|Base Period|Lost to Follow-up|0|||
37855986|NCT01217073|69539330|FG001|Base Period|Lost to Follow-up|0|||
37855987|NCT01217073|69539331|FG002|Base Period|Lost to Follow-up|1|||
37855988|NCT01217073|69539332|FG003|Base Period|Lost to Follow-up|1|||
37855989|NCT01217073|69539333|FG004|Base Period|Lost to Follow-up|3|||
37855990|NCT01217073|69539334|FG005|Base Period|Lost to Follow-up|0|||
37855991|NCT01217073|69539335|FG006|Base Period|Lost to Follow-up|0|||
37855992|NCT01217073|69539336|FG007|Base Period|Lost to Follow-up|0|||
37855993|NCT01217073|69539329|FG000|Base Period|Physician Decision|0|||
37855994|NCT01217073|69539330|FG001|Base Period|Physician Decision|0|||
37855995|NCT01217073|69539331|FG002|Base Period|Physician Decision|0|||
37855996|NCT01217073|69539332|FG003|Base Period|Physician Decision|0|||
37855997|NCT01217073|69539333|FG004|Base Period|Physician Decision|1|||
37855998|NCT01217073|69539334|FG005|Base Period|Physician Decision|0|||
37855999|NCT01217073|69539335|FG006|Base Period|Physician Decision|0|||
37856000|NCT01217073|69539336|FG007|Base Period|Physician Decision|0|||
37856001|NCT01217073|69539329|FG000|Base Period|Protocol Violation|1|||
37747920|NCT01709149|69238082|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
37747921|NCT01709149|69238083|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
37747922|NCT01709149|69238084|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
37747923|NCT01709149|69238082|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
37747924|NCT01709149|69238083|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
37856002|NCT01217073|69539330|FG001|Base Period|Protocol Violation|0|||
37856003|NCT01217073|69539331|FG002|Base Period|Protocol Violation|0|||
37747925|NCT01709149|69238084|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
37856004|NCT01217073|69539332|FG003|Base Period|Protocol Violation|0|||
37856005|NCT01217073|69539333|FG004|Base Period|Protocol Violation|1|||
37923053|NCT00813150|69609835|FG000|Treatment Period|Data not available|1|||
37856006|NCT01217073|69539334|FG005|Base Period|Protocol Violation|2|||
37856007|NCT01217073|69539335|FG006|Base Period|Protocol Violation|0|||
37856008|NCT01217073|69539336|FG007|Base Period|Protocol Violation|0|||
37658741|NCT02936323|69130859|FG004|Phase 2a Dose Expansion|Death|0|||
37658742|NCT02936323|69130860|FG005|Phase 2a Dose Expansion|Death|0|||
37658743|NCT02936323|69130861|FG006|Phase 2a Dose Expansion|Death|0|||
37658744|NCT02936323|69130862|FG007|Phase 2a Dose Expansion|Death|4|||
37658745|NCT02936323|69130863|FG008|Phase 2a Dose Expansion|Death|8|||
37658746|NCT02936323|69130864|FG009|Phase 2a Dose Expansion|Death|10|||
37658747|NCT02243176|69130898|FG000|Overall Study|Other reason|1|||
37658748|NCT02243176|69130899|FG001|Overall Study|Other reason|2|||
37658749|NCT02243176|69130898|FG000|Overall Study|protocol specified withdrawal critera|1|||
37658750|NCT02243176|69130899|FG001|Overall Study|protocol specified withdrawal critera|3|||
37658751|NCT02243176|69130898|FG000|Overall Study|Protocol Violation|2|||
37658752|NCT02243176|69130899|FG001|Overall Study|Protocol Violation|1|||
37658753|NCT02243176|69130898|FG000|Overall Study|Withdrawal by Subject|8|||
37658754|NCT02243176|69130899|FG001|Overall Study|Withdrawal by Subject|7|||
37658755|NCT02243176|69130898|FG000|Overall Study|Adverse Event|2|||
37658756|NCT02243176|69130899|FG001|Overall Study|Adverse Event|2|||
37658757|NCT00002663|69130910|FG000|Overall Study|Death|4|||
37658758|NCT00002663|69130911|FG001|Overall Study|Death|1|||
37658759|NCT00002663|69130912|FG002|Overall Study|Death|1|||
37658760|NCT00002663|69130913|FG003|Overall Study|Death|0|||
37658761|NCT00002663|69130914|FG004|Overall Study|Death|0|||
37658762|NCT00002663|69130915|FG005|Overall Study|Death|13|||
37658763|NCT00002663|69130916|FG006|Overall Study|Death|0|||
37658764|NCT00002663|69130917|FG007|Overall Study|Death|1|||
37658765|NCT00002663|69130918|FG008|Overall Study|Death|1|||
37658766|NCT00002663|69130919|FG009|Overall Study|Death|1|||
37658767|NCT00002663|69130910|FG000|Overall Study|Lost to Follow-up|3|||
37658768|NCT00002663|69130911|FG001|Overall Study|Lost to Follow-up|0|||
37658769|NCT00002663|69130912|FG002|Overall Study|Lost to Follow-up|0|||
37658770|NCT00002663|69130913|FG003|Overall Study|Lost to Follow-up|1|||
37658771|NCT00002663|69130914|FG004|Overall Study|Lost to Follow-up|0|||
37658772|NCT00002663|69130915|FG005|Overall Study|Lost to Follow-up|1|||
37658773|NCT00002663|69130916|FG006|Overall Study|Lost to Follow-up|0|||
37658774|NCT00002663|69130917|FG007|Overall Study|Lost to Follow-up|0|||
37658775|NCT00002663|69130918|FG008|Overall Study|Lost to Follow-up|0|||
37747926|NCT01709149|69238082|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
37747927|NCT01709149|69238083|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
37747928|NCT01709149|69238084|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
37747929|NCT01709149|69238082|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
37747930|NCT01709149|69238083|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
37747931|NCT01709149|69238084|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
37747932|NCT01709149|69238082|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
37747933|NCT01709149|69238083|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
37747934|NCT01709149|69238084|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
37747935|NCT01709149|69238082|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
37747936|NCT01709149|69238083|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
37747937|NCT01709149|69238084|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
37747938|NCT01568593|69238093|FG000|Overall Study|Lack of Efficacy|4|||
37747939|NCT01568593|69238094|FG001|Overall Study|Lack of Efficacy|1|||
37747940|NCT01568593|69238093|FG000|Overall Study|Adverse Event|3|||
37747941|NCT01568593|69238094|FG001|Overall Study|Adverse Event|2|||
37856009|NCT01217073|69539329|FG000|Base Period|Withdrawal by Subject|4|||
37856010|NCT01217073|69539330|FG001|Base Period|Withdrawal by Subject|5|||
37856011|NCT01217073|69539331|FG002|Base Period|Withdrawal by Subject|5|||
37856012|NCT01217073|69539332|FG003|Base Period|Withdrawal by Subject|1|||
37856013|NCT01217073|69539333|FG004|Base Period|Withdrawal by Subject|5|||
37856014|NCT01217073|69539334|FG005|Base Period|Withdrawal by Subject|5|||
37856015|NCT01217073|69539335|FG006|Base Period|Withdrawal by Subject|0|||
37856016|NCT01217073|69539336|FG007|Base Period|Withdrawal by Subject|0|||
37856017|NCT01217073|69539329|FG000|Extension Period|Adverse Event|0|||
37856018|NCT01217073|69539330|FG001|Extension Period|Adverse Event|0|||
37856019|NCT01217073|69539331|FG002|Extension Period|Adverse Event|0|||
37923054|NCT00813150|69609836|FG001|Treatment Period|Data not available|2|||
37923055|NCT00813150|69609835|FG000|Long Term Follow-up|Death|0|||
37658776|NCT00002663|69130919|FG009|Overall Study|Lost to Follow-up|0|||
37658777|NCT00002663|69130910|FG000|Overall Study|Other|0|||
37658778|NCT00002663|69130911|FG001|Overall Study|Other|1|||
37747942|NCT01683565|69238102|FG000|Overall Study|Lost to Follow-up|2|||
37923056|NCT00813150|69609836|FG001|Long Term Follow-up|Death|4|||
37658779|NCT00002663|69130912|FG002|Overall Study|Other|0|||
37856020|NCT01217073|69539332|FG003|Extension Period|Adverse Event|0|||
37658780|NCT00002663|69130913|FG003|Overall Study|Other|0|||
37658781|NCT00002663|69130914|FG004|Overall Study|Other|0|||
37923057|NCT00813150|69609835|FG000|Long Term Follow-up|Other|0|||
37923058|NCT00813150|69609836|FG001|Long Term Follow-up|Other|3|||
37658782|NCT00002663|69130915|FG005|Overall Study|Other|1|||
37658783|NCT00002663|69130916|FG006|Overall Study|Other|1|||
37658784|NCT00002663|69130917|FG007|Overall Study|Other|0|||
37923059|NCT00813150|69609835|FG000|Long Term Follow-up|Lost to Follow-up|2|||
37856021|NCT01217073|69539333|FG004|Extension Period|Adverse Event|0|||
37856022|NCT01217073|69539334|FG005|Extension Period|Adverse Event|0|||
37856023|NCT01217073|69539335|FG006|Extension Period|Adverse Event|19|||
37856024|NCT01217073|69539336|FG007|Extension Period|Adverse Event|5|||
37856025|NCT01217073|69539329|FG000|Extension Period|ALT/AST|0|||
37856026|NCT01217073|69539330|FG001|Extension Period|ALT/AST|0|||
37856027|NCT01217073|69539331|FG002|Extension Period|ALT/AST|0|||
37856028|NCT01217073|69539332|FG003|Extension Period|ALT/AST|0|||
37856029|NCT01217073|69539333|FG004|Extension Period|ALT/AST|0|||
37856030|NCT01217073|69539334|FG005|Extension Period|ALT/AST|0|||
37856031|NCT01217073|69539335|FG006|Extension Period|ALT/AST|2|||
37856032|NCT01217073|69539336|FG007|Extension Period|ALT/AST|0|||
37856033|NCT01217073|69539329|FG000|Extension Period|Contraindication to study medication|0|||
37856034|NCT01217073|69539330|FG001|Extension Period|Contraindication to study medication|0|||
37856035|NCT01217073|69539331|FG002|Extension Period|Contraindication to study medication|0|||
37856036|NCT01217073|69539332|FG003|Extension Period|Contraindication to study medication|0|||
37856037|NCT01217073|69539333|FG004|Extension Period|Contraindication to study medication|0|||
37856038|NCT01217073|69539334|FG005|Extension Period|Contraindication to study medication|0|||
37856039|NCT01217073|69539335|FG006|Extension Period|Contraindication to study medication|1|||
37856040|NCT01217073|69539336|FG007|Extension Period|Contraindication to study medication|0|||
37856041|NCT01217073|69539329|FG000|Extension Period|Creatinine/eGFR|0|||
37856042|NCT01217073|69539330|FG001|Extension Period|Creatinine/eGFR|0|||
37856043|NCT01217073|69539331|FG002|Extension Period|Creatinine/eGFR|0|||
37658785|NCT00002663|69130918|FG008|Overall Study|Other|0|||
37658786|NCT00002663|69130919|FG009|Overall Study|Other|0|||
37658787|NCT00002663|69130910|FG000|Overall Study|Physician Decision|0|||
37658788|NCT00002663|69130911|FG001|Overall Study|Physician Decision|0|||
37658789|NCT00002663|69130912|FG002|Overall Study|Physician Decision|0|||
37658790|NCT00002663|69130913|FG003|Overall Study|Physician Decision|0|||
37658791|NCT00002663|69130914|FG004|Overall Study|Physician Decision|1|||
37658792|NCT00002663|69130915|FG005|Overall Study|Physician Decision|0|||
37658793|NCT00002663|69130916|FG006|Overall Study|Physician Decision|0|||
37658794|NCT00002663|69130917|FG007|Overall Study|Physician Decision|0|||
37658795|NCT00002663|69130918|FG008|Overall Study|Physician Decision|1|||
37658796|NCT00002663|69130919|FG009|Overall Study|Physician Decision|1|||
37658797|NCT00002663|69130910|FG000|Overall Study|Adverse Event|0|||
37658798|NCT00002663|69130911|FG001|Overall Study|Adverse Event|0|||
37856044|NCT01217073|69539332|FG003|Extension Period|Creatinine/eGFR|0|||
37856045|NCT01217073|69539333|FG004|Extension Period|Creatinine/eGFR|0|||
37856046|NCT01217073|69539334|FG005|Extension Period|Creatinine/eGFR|0|||
37856047|NCT01217073|69539335|FG006|Extension Period|Creatinine/eGFR|11|||
37856048|NCT01217073|69539336|FG007|Extension Period|Creatinine/eGFR|1|||
37856049|NCT01217073|69539329|FG000|Extension Period|Death|0|||
37856050|NCT01217073|69539330|FG001|Extension Period|Death|0|||
37856051|NCT01217073|69539331|FG002|Extension Period|Death|0|||
37856052|NCT01217073|69539332|FG003|Extension Period|Death|0|||
37856053|NCT01217073|69539333|FG004|Extension Period|Death|0|||
37658799|NCT00002663|69130912|FG002|Overall Study|Adverse Event|0|||
37658800|NCT00002663|69130913|FG003|Overall Study|Adverse Event|1|||
37658801|NCT00002663|69130914|FG004|Overall Study|Adverse Event|0|||
37658802|NCT00002663|69130915|FG005|Overall Study|Adverse Event|0|||
37658803|NCT00002663|69130916|FG006|Overall Study|Adverse Event|0|||
37658804|NCT00002663|69130917|FG007|Overall Study|Adverse Event|1|||
37658805|NCT00002663|69130918|FG008|Overall Study|Adverse Event|0|||
37658806|NCT00002663|69130919|FG009|Overall Study|Adverse Event|0|||
37658807|NCT02240680|69130930|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
37658808|NCT02240680|69130931|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
37658809|NCT02240680|69130932|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
37658810|NCT02240680|69130933|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
37658811|NCT02240680|69130930|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
37658812|NCT02240680|69130931|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
37658813|NCT02240680|69130932|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
37658814|NCT02240680|69130933|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
37658815|NCT02240680|69130930|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
37856054|NCT01217073|69539334|FG005|Extension Period|Death|0|||
37856055|NCT01217073|69539335|FG006|Extension Period|Death|1|||
37856056|NCT01217073|69539336|FG007|Extension Period|Death|0|||
37856057|NCT01217073|69539329|FG000|Extension Period|Excluded medication|0|||
37856058|NCT01217073|69539330|FG001|Extension Period|Excluded medication|0|||
37658816|NCT02240680|69130931|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
37658817|NCT02240680|69130932|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
37658818|NCT02240680|69130933|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
37658819|NCT02240680|69130930|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
37658820|NCT02240680|69130931|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
37658821|NCT02240680|69130932|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
37658822|NCT02240680|69130933|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
37747943|NCT01683565|69238103|FG001|Overall Study|Lost to Follow-up|0|||
37856059|NCT01217073|69539331|FG002|Extension Period|Excluded medication|0|||
37747944|NCT01683565|69238102|FG000|Overall Study|Discontinued Intervention|1|||
37747945|NCT01683565|69238103|FG001|Overall Study|Discontinued Intervention|1|||
37747946|NCT01903031|69238127|FG000|Overall Study|Not Able to Attend Clinic|1|||
37747947|NCT01903031|69238128|FG001|Overall Study|Not Able to Attend Clinic|1|||
37747948|NCT01903031|69238129|FG002|Overall Study|Not Able to Attend Clinic|0|||
37747949|NCT01903031|69238127|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
37747950|NCT01903031|69238128|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
37747951|NCT01903031|69238129|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
37747952|NCT01903031|69238127|FG000|Overall Study|Adverse Event|0|||
37747953|NCT01903031|69238128|FG001|Overall Study|Adverse Event|1|||
37747954|NCT01903031|69238129|FG002|Overall Study|Adverse Event|0|||
37747955|NCT01903031|69238127|FG000|Overall Study|Withdrawal by Subject|0|||
37747956|NCT01903031|69238128|FG001|Overall Study|Withdrawal by Subject|1|||
37747957|NCT01903031|69238129|FG002|Overall Study|Withdrawal by Subject|1|||
37747958|NCT01903031|69238127|FG000|Overall Study|Protocol Violation|0|||
37747959|NCT01903031|69238128|FG001|Overall Study|Protocol Violation|0|||
37747960|NCT01903031|69238129|FG002|Overall Study|Protocol Violation|2|||
37747961|NCT01903031|69238127|FG000|Overall Study|Lost to Follow-up|0|||
37747962|NCT01903031|69238128|FG001|Overall Study|Lost to Follow-up|0|||
37747963|NCT01903031|69238129|FG002|Overall Study|Lost to Follow-up|1|||
37747964|NCT01903031|69238127|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
37747965|NCT01903031|69238128|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
37747966|NCT01903031|69238129|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
37747967|NCT01616693|69238161|FG000|Evaluated for Safety|Physician Decision|1|||
37747968|NCT01616693|69238162|FG001|Evaluated for Safety|Physician Decision|0|||
37747969|NCT01616693|69238163|FG002|Evaluated for Safety|Physician Decision|1|||
37747970|NCT01616693|69238164|FG003|Evaluated for Safety|Physician Decision|0|||
37747971|NCT01616693|69238161|FG000|Received Both Vaccines|Adverse Event|2|||
37747972|NCT01616693|69238162|FG001|Received Both Vaccines|Adverse Event|0|||
37747973|NCT01616693|69238163|FG002|Received Both Vaccines|Adverse Event|0|||
37747974|NCT01616693|69238164|FG003|Received Both Vaccines|Adverse Event|0|||
37747975|NCT01616693|69238161|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
37747976|NCT01616693|69238162|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
37747977|NCT01616693|69238163|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
37747978|NCT01616693|69238164|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
37747979|NCT01616693|69238161|FG000|Received Both Vaccines|Lost to Follow-up|4|||
37747980|NCT01616693|69238162|FG001|Received Both Vaccines|Lost to Follow-up|3|||
37747981|NCT01616693|69238163|FG002|Received Both Vaccines|Lost to Follow-up|4|||
37747982|NCT01616693|69238164|FG003|Received Both Vaccines|Lost to Follow-up|4|||
37747983|NCT01616693|69238161|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
37747984|NCT01616693|69238162|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
37747985|NCT01616693|69238163|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
37747986|NCT01616693|69238164|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
37747987|NCT01616459|69238271|FG000|Overall Study|Adverse Event|1|||
37747988|NCT01616459|69238272|FG001|Overall Study|Adverse Event|1|||
37747989|NCT01616459|69238273|FG002|Overall Study|Adverse Event|2|||
37747990|NCT01616459|69238274|FG003|Overall Study|Adverse Event|0|||
37747991|NCT01616459|69238271|FG000|Overall Study|Lost to Follow-up|1|||
37747992|NCT01616459|69238272|FG001|Overall Study|Lost to Follow-up|11|||
37747993|NCT01616459|69238273|FG002|Overall Study|Lost to Follow-up|3|||
37747994|NCT01616459|69238274|FG003|Overall Study|Lost to Follow-up|2|||
37658823|NCT02240680|69130930|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
37658824|NCT02240680|69130931|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
37658825|NCT02240680|69130932|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
37658826|NCT02240680|69130933|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
37658827|NCT02240680|69130930|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
37658828|NCT02240680|69130931|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
37658829|NCT02240680|69130932|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
37658830|NCT02240680|69130933|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
37658831|NCT02240680|69130930|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
37658832|NCT02240680|69130931|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
37658833|NCT02240680|69130932|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
37658834|NCT02240680|69130933|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
37658835|NCT02240680|69130930|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
37658836|NCT02240680|69130931|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
37747995|NCT01616459|69238271|FG000|Overall Study|Protocol Violation|0|||
37747996|NCT01616459|69238272|FG001|Overall Study|Protocol Violation|0|||
37747997|NCT01616459|69238273|FG002|Overall Study|Protocol Violation|0|||
37747998|NCT01616459|69238274|FG003|Overall Study|Protocol Violation|2|||
37747999|NCT01616459|69238271|FG000|Overall Study|Withdrawal by Subject|2|||
37748000|NCT01616459|69238272|FG001|Overall Study|Withdrawal by Subject|4|||
37748001|NCT01616459|69238273|FG002|Overall Study|Withdrawal by Subject|4|||
37658837|NCT02240680|69130932|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
37748002|NCT01616459|69238274|FG003|Overall Study|Withdrawal by Subject|4|||
37748003|NCT01616459|69238271|FG000|Overall Study|Other reason|0|||
37748004|NCT01616459|69238272|FG001|Overall Study|Other reason|1|||
37748005|NCT01616459|69238273|FG002|Overall Study|Other reason|1|||
37748006|NCT01616459|69238274|FG003|Overall Study|Other reason|0|||
37658838|NCT02240680|69130933|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
37658839|NCT02240368|69130944|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
37658840|NCT02240368|69130945|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
37658841|NCT02240368|69130946|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
37658842|NCT02240368|69130944|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
37658843|NCT02240368|69130945|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
37658844|NCT02240368|69130946|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
37658845|NCT02239978|69130956|FG000|Overall Study|Withdrawal by Subject|2|||
37658846|NCT02239978|69130957|FG001|Overall Study|Withdrawal by Subject|0|||
37658847|NCT02239510|69130967|FG000|Overall Study|Lost to Follow-up|2|||
37658848|NCT02239510|69130968|FG001|Overall Study|Lost to Follow-up|1|||
37658849|NCT02462486|69130977|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
37658850|NCT02462486|69130978|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
37658851|NCT02462486|69130979|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
37658852|NCT02462486|69130977|FG000|Overall Study|Adverse Event|53|||
37658853|NCT02462486|69130978|FG001|Overall Study|Adverse Event|48|||
37658854|NCT02462486|69130979|FG002|Overall Study|Adverse Event|21|||
37658855|NCT02462486|69130977|FG000|Overall Study|Lack of Efficacy|6|||
37748007|NCT01919801|69238291|FG000|Overall Study|Withdrawal by Subject|1|||
37748008|NCT01919801|69238292|FG001|Overall Study|Withdrawal by Subject|0|||
37748009|NCT01919801|69238291|FG000|Overall Study|Physician Decision|0|||
37748010|NCT01919801|69238292|FG001|Overall Study|Physician Decision|1|||
37748011|NCT01919801|69238291|FG000|Overall Study|Lost to Follow-up|0|||
37748012|NCT01919801|69238292|FG001|Overall Study|Lost to Follow-up|1|||
37748013|NCT01919801|69238291|FG000|Overall Study|Other|0|||
37748014|NCT01919801|69238292|FG001|Overall Study|Other|1|||
37748015|NCT01919723|69238300|FG000|Overall Study|Blood Samples Hemolyzed|2|||
37748016|NCT01919723|69238301|FG001|Overall Study|Blood Samples Hemolyzed|2|||
37748017|NCT01919489|69238309|FG000|Overall Study|Rejected the need of injections|4|||
37748018|NCT01919489|69238310|FG001|Overall Study|Rejected the need of injections|7|||
37748019|NCT01919489|69238309|FG000|Overall Study|Adverse Event|10|||
37748020|NCT01919489|69238310|FG001|Overall Study|Adverse Event|0|||
37748021|NCT01919489|69238309|FG000|Overall Study|Hospital readmission|2|||
37748022|NCT01919489|69238310|FG001|Overall Study|Hospital readmission|9|||
37748023|NCT01919489|69238309|FG000|Overall Study|Death|2|||
37748024|NCT01919489|69238310|FG001|Overall Study|Death|1|||
37748025|NCT01919489|69238309|FG000|Overall Study|Lost to Follow-up|38|||
37748026|NCT01919489|69238310|FG001|Overall Study|Lost to Follow-up|27|||
37748027|NCT01919411|69238318|FG000|Overall Study|Lost to Follow-up|2|||
37748028|NCT01919411|69238319|FG001|Overall Study|Lost to Follow-up|4|||
37748029|NCT01919411|69238318|FG000|Overall Study|Physician Decision|1|||
37748030|NCT01919411|69238319|FG001|Overall Study|Physician Decision|0|||
37748031|NCT01919411|69238318|FG000|Overall Study|Protocol Violation|2|||
37748032|NCT01919411|69238319|FG001|Overall Study|Protocol Violation|1|||
37748033|NCT01901393|69238327|FG000|Overall Study|Adverse Event|1|||
37658856|NCT02462486|69130978|FG001|Overall Study|Lack of Efficacy|12|||
37856060|NCT01217073|69539332|FG003|Extension Period|Excluded medication|0|||
37856061|NCT01217073|69539333|FG004|Extension Period|Excluded medication|0|||
37856062|NCT01217073|69539334|FG005|Extension Period|Excluded medication|0|||
37856063|NCT01217073|69539335|FG006|Extension Period|Excluded medication|2|||
37856064|NCT01217073|69539336|FG007|Extension Period|Excluded medication|0|||
37856065|NCT01217073|69539329|FG000|Extension Period|Lack of Efficacy|0|||
37658857|NCT02462486|69130979|FG002|Overall Study|Lack of Efficacy|3|||
37658858|NCT02462486|69130977|FG000|Overall Study|Lost to Follow-up|3|||
37658859|NCT02462486|69130978|FG001|Overall Study|Lost to Follow-up|4|||
37658860|NCT02462486|69130979|FG002|Overall Study|Lost to Follow-up|2|||
37658861|NCT02462486|69130977|FG000|Overall Study|Withdrawal by Subject|25|||
37658862|NCT02462486|69130978|FG001|Overall Study|Withdrawal by Subject|22|||
37658863|NCT02462486|69130979|FG002|Overall Study|Withdrawal by Subject|19|||
37748034|NCT01901393|69238328|FG001|Overall Study|Adverse Event|0|||
37748035|NCT01890707|69238336|FG000|Overall Study|Lost to Follow-up|1|||
37748036|NCT01890707|69238337|FG001|Overall Study|Lost to Follow-up|1|||
37658864|NCT02462486|69130977|FG000|Overall Study|Protocol Violation|3|||
37658865|NCT02462486|69130978|FG001|Overall Study|Protocol Violation|1|||
37658866|NCT02462486|69130979|FG002|Overall Study|Protocol Violation|1|||
37658867|NCT02462486|69130977|FG000|Overall Study|Reason not Specified|3|||
37748037|NCT01900691|69238343|FG000|Overall Study|Death|7|||
37748038|NCT01900691|69238343|FG000|Overall Study|Lost to Follow-up|4|||
37856066|NCT01217073|69539330|FG001|Extension Period|Lack of Efficacy|0|||
37658868|NCT02462486|69130978|FG001|Overall Study|Reason not Specified|4|||
37748039|NCT01900691|69238343|FG000|Overall Study|Study Device Not Placed|3|||
37748040|NCT01900691|69238343|FG000|Overall Study|Non study stent placed|2|||
37748041|NCT01900691|69238343|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
37748042|NCT01900691|69238343|FG000|Overall Study|Complete stent migration through digestive tract|1|||
37748043|NCT01890473|69238350|FG000|Overall Study|Lost to Follow-up|1|||
37748044|NCT01890473|69238351|FG001|Overall Study|Lost to Follow-up|0|||
37748045|NCT01890473|69238350|FG000|Overall Study|Poor/non-compliance|1|||
37748046|NCT01890473|69238351|FG001|Overall Study|Poor/non-compliance|0|||
37748047|NCT01889069|69238361|FG000|Overall Study|Death|18|||
37748048|NCT01889069|69238361|FG000|Overall Study|Progression of Disease|14|||
37748049|NCT01889069|69238361|FG000|Overall Study|Lost to Follow-up|6|||
37748050|NCT01889069|69238361|FG000|Overall Study|Other|4|||
37748051|NCT01889069|69238361|FG000|Overall Study|Consent Withdrawal|3|||
37748052|NCT02533180|69238373|FG000|Overall Study|Death|0|||
37748053|NCT02533180|69238374|FG001|Overall Study|Death|2|||
37748054|NCT02533180|69238373|FG000|Overall Study|Lost to Follow-up|0|||
37748055|NCT02533180|69238374|FG001|Overall Study|Lost to Follow-up|1|||
37748056|NCT02533180|69238373|FG000|Overall Study|Physician Decision|0|||
37748057|NCT02533180|69238374|FG001|Overall Study|Physician Decision|1|||
37748058|NCT02533180|69238373|FG000|Overall Study|Withdrawal by Subject|2|||
37748059|NCT02533180|69238374|FG001|Overall Study|Withdrawal by Subject|5|||
37748060|NCT02533180|69238373|FG000|Overall Study|Screen Failure|37|||
37748061|NCT02533180|69238374|FG001|Overall Study|Screen Failure|0|||
37748062|NCT02533180|69238373|FG000|Overall Study|Protocol Deviation|0|||
37748063|NCT02533180|69238374|FG001|Overall Study|Protocol Deviation|1|||
37748064|NCT02533180|69238373|FG000|Overall Study|Non-compliance|0|||
37748065|NCT02533180|69238374|FG001|Overall Study|Non-compliance|1|||
37748066|NCT01739348|69238412|FG000|Part I (Base Study)|Adverse Event|41|||
37748067|NCT01739348|69238413|FG001|Part I (Base Study)|Adverse Event|52|||
37748068|NCT01739348|69238414|FG002|Part I (Base Study)|Adverse Event|8|||
37748069|NCT01739348|69238415|FG003|Part I (Base Study)|Adverse Event|33|||
37748070|NCT01739348|69238412|FG000|Part I (Base Study)|Death|10|||
37748071|NCT01739348|69238413|FG001|Part I (Base Study)|Death|7|||
37748072|NCT01739348|69238414|FG002|Part I (Base Study)|Death|2|||
37748073|NCT01739348|69238415|FG003|Part I (Base Study)|Death|8|||
37748074|NCT01739348|69238412|FG000|Part I (Base Study)|Lack of Efficacy|3|||
37748075|NCT01739348|69238413|FG001|Part I (Base Study)|Lack of Efficacy|8|||
37748076|NCT01739348|69238414|FG002|Part I (Base Study)|Lack of Efficacy|0|||
37748077|NCT01739348|69238415|FG003|Part I (Base Study)|Lack of Efficacy|7|||
37748078|NCT01739348|69238412|FG000|Part I (Base Study)|Lost to Follow-up|4|||
37748079|NCT01739348|69238413|FG001|Part I (Base Study)|Lost to Follow-up|2|||
37748080|NCT01739348|69238414|FG002|Part I (Base Study)|Lost to Follow-up|4|||
37748081|NCT01739348|69238415|FG003|Part I (Base Study)|Lost to Follow-up|4|||
37748082|NCT01739348|69238412|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
37748083|NCT01739348|69238413|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
37748084|NCT01739348|69238414|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
37748085|NCT01739348|69238415|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
37748086|NCT01739348|69238412|FG000|Part I (Base Study)|Physician Decision|10|||
37748087|NCT01739348|69238413|FG001|Part I (Base Study)|Physician Decision|7|||
37748088|NCT01739348|69238414|FG002|Part I (Base Study)|Physician Decision|1|||
37748089|NCT01739348|69238415|FG003|Part I (Base Study)|Physician Decision|4|||
37748090|NCT01739348|69238412|FG000|Part I (Base Study)|Protocol Violation|2|||
37748091|NCT01739348|69238413|FG001|Part I (Base Study)|Protocol Violation|0|||
37748092|NCT01739348|69238414|FG002|Part I (Base Study)|Protocol Violation|1|||
37748093|NCT01739348|69238415|FG003|Part I (Base Study)|Protocol Violation|2|||
37658869|NCT02462486|69130979|FG002|Overall Study|Reason not Specified|3|||
37658870|NCT02495948|69130987|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
37658871|NCT02495948|69130988|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
37658872|NCT02495948|69130987|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
37658873|NCT02495948|69130988|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
37658874|NCT02461628|69130997|FG000|Overall Study|Refused to complete survey|4|||
37658875|NCT02461628|69130998|FG001|Overall Study|Refused to complete survey|7|||
37748094|NCT01739348|69238412|FG000|Part I (Base Study)|Screen Failure|2|||
37748095|NCT01739348|69238413|FG001|Part I (Base Study)|Screen Failure|0|||
37748096|NCT01739348|69238414|FG002|Part I (Base Study)|Screen Failure|0|||
37748097|NCT01739348|69238415|FG003|Part I (Base Study)|Screen Failure|0|||
37748098|NCT01739348|69238412|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
37748099|NCT01739348|69238413|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
37748100|NCT01739348|69238414|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
37748101|NCT01739348|69238415|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
37748102|NCT01739348|69238412|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
37748103|NCT01739348|69238413|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
37748104|NCT01739348|69238414|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
37748105|NCT01739348|69238415|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
37748106|NCT01739348|69238412|FG000|Part I (Base Study)|Participant Moved|4|||
37748107|NCT01739348|69238413|FG001|Part I (Base Study)|Participant Moved|3|||
37748108|NCT01739348|69238414|FG002|Part I (Base Study)|Participant Moved|1|||
37748109|NCT01739348|69238415|FG003|Part I (Base Study)|Participant Moved|7|||
37748110|NCT01739348|69238412|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
37748111|NCT01739348|69238413|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
37748112|NCT01739348|69238414|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
37748113|NCT01739348|69238415|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
37748114|NCT01739348|69238412|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
37748115|NCT01739348|69238413|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
37748116|NCT01739348|69238414|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
37748117|NCT01739348|69238415|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
37748118|NCT01739348|69238412|FG000|Part II (Extension Study)|Adverse Event|10|||
37748119|NCT01739348|69238413|FG001|Part II (Extension Study)|Adverse Event|11|||
37748120|NCT01739348|69238414|FG002|Part II (Extension Study)|Adverse Event|7|||
37748121|NCT01739348|69238415|FG003|Part II (Extension Study)|Adverse Event|26|||
37748122|NCT01739348|69238412|FG000|Part II (Extension Study)|Death|3|||
37748123|NCT01739348|69238413|FG001|Part II (Extension Study)|Death|3|||
37748124|NCT01739348|69238414|FG002|Part II (Extension Study)|Death|2|||
37748125|NCT01739348|69238415|FG003|Part II (Extension Study)|Death|6|||
37748126|NCT01739348|69238412|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
37748127|NCT01739348|69238413|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
37748128|NCT01739348|69238414|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
37748129|NCT01739348|69238415|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
37748130|NCT01739348|69238412|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
37748131|NCT01739348|69238413|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
37748132|NCT01739348|69238414|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
37748133|NCT01739348|69238415|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
37748134|NCT01739348|69238412|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
37748135|NCT01739348|69238413|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
37748136|NCT01739348|69238414|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
37748137|NCT01739348|69238415|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
37748138|NCT01739348|69238412|FG000|Part II (Extension Study)|Physician Decision|7|||
37748139|NCT01739348|69238413|FG001|Part II (Extension Study)|Physician Decision|11|||
37748140|NCT01739348|69238414|FG002|Part II (Extension Study)|Physician Decision|6|||
37748141|NCT01739348|69238415|FG003|Part II (Extension Study)|Physician Decision|12|||
37748142|NCT01739348|69238412|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
37748143|NCT01739348|69238413|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
37748144|NCT01739348|69238414|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
37748145|NCT01739348|69238415|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
37748146|NCT01739348|69238412|FG000|Part II (Extension Study)|Participant Moved|3|||
37748147|NCT01739348|69238413|FG001|Part II (Extension Study)|Participant Moved|3|||
37748148|NCT01739348|69238414|FG002|Part II (Extension Study)|Participant Moved|0|||
37748149|NCT01739348|69238415|FG003|Part II (Extension Study)|Participant Moved|3|||
37748150|NCT01739348|69238412|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
37748151|NCT01739348|69238413|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
37748152|NCT01739348|69238414|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
37658900|NCT02461160|69131033|FG000|Overall Study|Lost to Follow-up|0|||
37658901|NCT02461160|69131034|FG001|Overall Study|Lost to Follow-up|0|||
37658902|NCT02461160|69131035|FG002|Overall Study|Lost to Follow-up|0|||
37658903|NCT02461160|69131036|FG003|Overall Study|Lost to Follow-up|0|||
37658904|NCT02461160|69131037|FG004|Overall Study|Lost to Follow-up|0|||
37658905|NCT02461160|69131038|FG005|Overall Study|Lost to Follow-up|0|||
37658906|NCT02461160|69131039|FG006|Overall Study|Lost to Follow-up|0|||
37748153|NCT01739348|69238415|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
37748154|NCT01739348|69238412|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
37748155|NCT01739348|69238413|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
37748156|NCT01739348|69238414|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
37748157|NCT01739348|69238415|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
37748158|NCT01738646|69238447|FG000|Overall Study|Still Receiving Treatment|2|||
37748159|NCT01716104|69238454|FG000|Overall Study|Do not meet inclusion criteria|6|||
37658907|NCT02461160|69131040|FG007|Overall Study|Lost to Follow-up|1|||
37658908|NCT02461160|69131041|FG008|Overall Study|Lost to Follow-up|0|||
37658909|NCT02461160|69131042|FG009|Overall Study|Lost to Follow-up|0|||
37658910|NCT02461160|69131043|FG010|Overall Study|Lost to Follow-up|0|||
37658911|NCT02461160|69131044|FG011|Overall Study|Lost to Follow-up|0|||
37658912|NCT02461160|69131045|FG012|Overall Study|Lost to Follow-up|0|||
37658913|NCT01653704|69131096|FG000|Overall Study|Technical failure during recording|1|||
37658914|NCT01653704|69131097|FG001|Overall Study|Technical failure during recording|1|||
37658915|NCT01653704|69131096|FG000|Overall Study|Performance not reflective of training|1|||
37748160|NCT01716104|69238455|FG001|Overall Study|Do not meet inclusion criteria|7|||
37748161|NCT04426695|69238535|FG000|Overall Study|Death|2|||
37748162|NCT04426695|69238536|FG001|Overall Study|Death|0|||
37748163|NCT04426695|69238537|FG002|Overall Study|Death|1|||
37748164|NCT04426695|69238538|FG003|Overall Study|Death|27|||
37748165|NCT04426695|69238539|FG004|Overall Study|Death|25|||
37748166|NCT04426695|69238540|FG005|Overall Study|Death|21|||
37748167|NCT04426695|69238541|FG006|Overall Study|Death|42|||
37748168|NCT04426695|69238542|FG007|Overall Study|Death|23|||
37748169|NCT04426695|69238543|FG008|Overall Study|Death|37|||
37748170|NCT04426695|69238544|FG009|Overall Study|Death|14|||
37748171|NCT04426695|69238545|FG010|Overall Study|Death|8|||
37748172|NCT04426695|69238546|FG011|Overall Study|Death|7|||
37748173|NCT04426695|69238547|FG012|Overall Study|Death|13|||
37748174|NCT04426695|69238548|FG013|Overall Study|Death|25|||
37748175|NCT04426695|69238549|FG014|Overall Study|Death|19|||
37748176|NCT04426695|69238550|FG015|Overall Study|Death|7|||
37748177|NCT04426695|69238551|FG016|Overall Study|Death|8|||
37748178|NCT04426695|69238552|FG017|Overall Study|Death|4|||
37748179|NCT04426695|69238535|FG000|Overall Study|Lost to Follow-up|2|||
37748180|NCT04426695|69238536|FG001|Overall Study|Lost to Follow-up|4|||
37748181|NCT04426695|69238537|FG002|Overall Study|Lost to Follow-up|1|||
37748182|NCT04426695|69238538|FG003|Overall Study|Lost to Follow-up|19|||
37748183|NCT04426695|69238539|FG004|Overall Study|Lost to Follow-up|10|||
37748184|NCT04426695|69238540|FG005|Overall Study|Lost to Follow-up|14|||
37748185|NCT04426695|69238541|FG006|Overall Study|Lost to Follow-up|5|||
37748186|NCT04426695|69238542|FG007|Overall Study|Lost to Follow-up|14|||
37748187|NCT04426695|69238543|FG008|Overall Study|Lost to Follow-up|10|||
37748188|NCT04426695|69238544|FG009|Overall Study|Lost to Follow-up|11|||
37748189|NCT04426695|69238545|FG010|Overall Study|Lost to Follow-up|12|||
37748190|NCT04426695|69238546|FG011|Overall Study|Lost to Follow-up|6|||
37748191|NCT04426695|69238547|FG012|Overall Study|Lost to Follow-up|2|||
37748192|NCT04426695|69238548|FG013|Overall Study|Lost to Follow-up|2|||
37748193|NCT04426695|69238549|FG014|Overall Study|Lost to Follow-up|2|||
37748194|NCT04426695|69238550|FG015|Overall Study|Lost to Follow-up|0|||
37748195|NCT04426695|69238551|FG016|Overall Study|Lost to Follow-up|0|||
37748196|NCT04426695|69238552|FG017|Overall Study|Lost to Follow-up|0|||
37856067|NCT01217073|69539331|FG002|Extension Period|Lack of Efficacy|0|||
37856068|NCT01217073|69539332|FG003|Extension Period|Lack of Efficacy|0|||
37856069|NCT01217073|69539333|FG004|Extension Period|Lack of Efficacy|0|||
37658916|NCT01653704|69131097|FG001|Overall Study|Performance not reflective of training|0|||
37658917|NCT02495168|69131106|FG000|Overall Study|Other than Specified|18|||
37658918|NCT02495168|69131107|FG001|Overall Study|Other than Specified|22|||
37748197|NCT04426695|69238535|FG000|Overall Study|Participant Decision|1|||
37748198|NCT04426695|69238536|FG001|Overall Study|Participant Decision|2|||
37658919|NCT02495168|69131108|FG002|Overall Study|Other than Specified|5|||
37658920|NCT02495168|69131106|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
37658921|NCT02495168|69131107|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
37658922|NCT02495168|69131108|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
37658923|NCT02495168|69131106|FG000|Overall Study|Physician Decision|1|||
37748199|NCT04426695|69238537|FG002|Overall Study|Participant Decision|2|||
37748200|NCT04426695|69238538|FG003|Overall Study|Participant Decision|12|||
37748201|NCT04426695|69238539|FG004|Overall Study|Participant Decision|18|||
37748202|NCT04426695|69238540|FG005|Overall Study|Participant Decision|22|||
37748203|NCT04426695|69238541|FG006|Overall Study|Participant Decision|13|||
37748204|NCT04426695|69238542|FG007|Overall Study|Participant Decision|13|||
37748205|NCT04426695|69238543|FG008|Overall Study|Participant Decision|10|||
37748206|NCT04426695|69238544|FG009|Overall Study|Participant Decision|15|||
37748207|NCT04426695|69238545|FG010|Overall Study|Participant Decision|16|||
37748208|NCT04426695|69238546|FG011|Overall Study|Participant Decision|17|||
37748209|NCT04426695|69238547|FG012|Overall Study|Participant Decision|2|||
37748210|NCT04426695|69238548|FG013|Overall Study|Participant Decision|1|||
37748211|NCT04426695|69238549|FG014|Overall Study|Participant Decision|2|||
37748212|NCT04426695|69238550|FG015|Overall Study|Participant Decision|0|||
37748213|NCT04426695|69238551|FG016|Overall Study|Participant Decision|0|||
37748214|NCT04426695|69238552|FG017|Overall Study|Participant Decision|0|||
37748215|NCT04426695|69238535|FG000|Overall Study|Adverse Event|0|||
37748216|NCT04426695|69238536|FG001|Overall Study|Adverse Event|0|||
37748217|NCT04426695|69238537|FG002|Overall Study|Adverse Event|0|||
37748218|NCT04426695|69238538|FG003|Overall Study|Adverse Event|0|||
37748219|NCT04426695|69238539|FG004|Overall Study|Adverse Event|0|||
37658924|NCT02495168|69131107|FG001|Overall Study|Physician Decision|1|||
37658925|NCT02495168|69131108|FG002|Overall Study|Physician Decision|0|||
37658926|NCT02495168|69131106|FG000|Overall Study|Lost to Follow-up|10|||
37658927|NCT02495168|69131107|FG001|Overall Study|Lost to Follow-up|6|||
37658928|NCT02495168|69131108|FG002|Overall Study|Lost to Follow-up|1|||
37658929|NCT02495168|69131106|FG000|Overall Study|Withdrawal by Subject|1|||
37856070|NCT01217073|69539334|FG005|Extension Period|Lack of Efficacy|0|||
37856071|NCT01217073|69539335|FG006|Extension Period|Lack of Efficacy|3|||
37856072|NCT01217073|69539336|FG007|Extension Period|Lack of Efficacy|0|||
37856073|NCT01217073|69539329|FG000|Extension Period|Lost to Follow-up|0|||
37856074|NCT01217073|69539330|FG001|Extension Period|Lost to Follow-up|0|||
37856075|NCT01217073|69539331|FG002|Extension Period|Lost to Follow-up|0|||
37856076|NCT01217073|69539332|FG003|Extension Period|Lost to Follow-up|0|||
37856077|NCT01217073|69539333|FG004|Extension Period|Lost to Follow-up|0|||
37856078|NCT01217073|69539334|FG005|Extension Period|Lost to Follow-up|0|||
37856079|NCT01217073|69539335|FG006|Extension Period|Lost to Follow-up|9|||
37856080|NCT01217073|69539336|FG007|Extension Period|Lost to Follow-up|1|||
37856081|NCT01217073|69539329|FG000|Extension Period|Non-compliance with study drug|0|||
37658930|NCT02495168|69131107|FG001|Overall Study|Withdrawal by Subject|4|||
37658931|NCT02495168|69131108|FG002|Overall Study|Withdrawal by Subject|2|||
37658932|NCT02495168|69131106|FG000|Overall Study|Protocol Violation|0|||
37658933|NCT02495168|69131107|FG001|Overall Study|Protocol Violation|10|||
37658934|NCT02495168|69131108|FG002|Overall Study|Protocol Violation|1|||
37658935|NCT02495168|69131106|FG000|Overall Study|Adverse Event|4|||
37658936|NCT02495168|69131107|FG001|Overall Study|Adverse Event|8|||
37658937|NCT02495168|69131108|FG002|Overall Study|Adverse Event|3|||
37658938|NCT02495168|69131106|FG000|Overall Study|Lack of Efficacy|0|||
37658939|NCT02495168|69131107|FG001|Overall Study|Lack of Efficacy|0|||
37658940|NCT02495168|69131108|FG002|Overall Study|Lack of Efficacy|3|||
37658941|NCT02494778|69131116|FG000|Overall Study|Death|3|||
37658942|NCT02494778|69131116|FG000|Overall Study|Other|173|||
37658943|NCT02494778|69131116|FG000|Overall Study|Lack of Efficacy|4|||
37658944|NCT02494778|69131116|FG000|Overall Study|Adverse Event|18|||
37658945|NCT02494778|69131116|FG000|Overall Study|Withdrawal by Subject|20|||
37658946|NCT02494778|69131116|FG000|Overall Study|Lost to Follow-up|2|||
37658947|NCT02494778|69131116|FG000|Overall Study|Noncompliant with study drug admin.|1|||
37658948|NCT02493764|69131122|FG000|Overall Study|Adverse Event|2|||
37658949|NCT02493764|69131123|FG001|Overall Study|Adverse Event|2|||
37658950|NCT02493764|69131122|FG000|Overall Study|Death|44|||
37658951|NCT02493764|69131123|FG001|Overall Study|Death|58|||
37658952|NCT02493764|69131122|FG000|Overall Study|Lost to Follow-up|2|||
37658953|NCT02493764|69131123|FG001|Overall Study|Lost to Follow-up|1|||
37748220|NCT04426695|69238540|FG005|Overall Study|Adverse Event|0|||
37748221|NCT04426695|69238541|FG006|Overall Study|Adverse Event|0|||
37748222|NCT04426695|69238542|FG007|Overall Study|Adverse Event|1|||
37658954|NCT02493764|69131122|FG000|Overall Study|Protocol Violation|6|||
37658955|NCT02493764|69131123|FG001|Overall Study|Protocol Violation|7|||
37658956|NCT02493764|69131122|FG000|Overall Study|Physician Decision|1|||
37658957|NCT02493764|69131123|FG001|Overall Study|Physician Decision|1|||
37658958|NCT02493764|69131122|FG000|Overall Study|Participant moved|17|||
37658959|NCT02493764|69131123|FG001|Overall Study|Participant moved|5|||
37658960|NCT02493764|69131122|FG000|Overall Study|Withdrawal parent/guardian|0|||
37658961|NCT02493764|69131123|FG001|Overall Study|Withdrawal parent/guardian|1|||
37658962|NCT02493764|69131122|FG000|Overall Study|Withdrawal by Subject|11|||
37748223|NCT04426695|69238543|FG008|Overall Study|Adverse Event|0|||
37748224|NCT04426695|69238544|FG009|Overall Study|Adverse Event|0|||
37658963|NCT02493764|69131123|FG001|Overall Study|Withdrawal by Subject|7|||
37658964|NCT02460380|69131131|FG000|Overall Study|Withdrawal by Subject|10|||
37658965|NCT02460380|69131132|FG001|Overall Study|Withdrawal by Subject|5|||
37658966|NCT02493062|69131139|FG000|Overall Study|Physician Decision|12|||
37658967|NCT02492984|69131145|FG000|Overall Study|Adverse Event|1|||
37748225|NCT04426695|69238545|FG010|Overall Study|Adverse Event|1|||
37748226|NCT04426695|69238546|FG011|Overall Study|Adverse Event|1|||
37658968|NCT02492984|69131146|FG001|Overall Study|Adverse Event|0|||
37658969|NCT02492984|69131145|FG000|Overall Study|Protocol Violation|1|||
37658970|NCT02492984|69131146|FG001|Overall Study|Protocol Violation|0|||
37748227|NCT04426695|69238547|FG012|Overall Study|Adverse Event|0|||
37748228|NCT04426695|69238548|FG013|Overall Study|Adverse Event|0|||
37748229|NCT04426695|69238549|FG014|Overall Study|Adverse Event|0|||
37748230|NCT04426695|69238550|FG015|Overall Study|Adverse Event|0|||
37748231|NCT04426695|69238551|FG016|Overall Study|Adverse Event|0|||
37748232|NCT04426695|69238552|FG017|Overall Study|Adverse Event|0|||
37748233|NCT04426695|69238535|FG000|Overall Study|Sponsor Request|0|||
37748234|NCT04426695|69238536|FG001|Overall Study|Sponsor Request|0|||
37748235|NCT04426695|69238537|FG002|Overall Study|Sponsor Request|0|||
37748236|NCT04426695|69238538|FG003|Overall Study|Sponsor Request|0|||
37748237|NCT04426695|69238539|FG004|Overall Study|Sponsor Request|0|||
37748238|NCT04426695|69238540|FG005|Overall Study|Sponsor Request|0|||
37748239|NCT04426695|69238541|FG006|Overall Study|Sponsor Request|1|||
37748240|NCT04426695|69238542|FG007|Overall Study|Sponsor Request|0|||
37748241|NCT04426695|69238543|FG008|Overall Study|Sponsor Request|0|||
37748242|NCT04426695|69238544|FG009|Overall Study|Sponsor Request|0|||
37748243|NCT04426695|69238545|FG010|Overall Study|Sponsor Request|0|||
37748244|NCT04426695|69238546|FG011|Overall Study|Sponsor Request|0|||
37748245|NCT04426695|69238547|FG012|Overall Study|Sponsor Request|0|||
37748246|NCT04426695|69238548|FG013|Overall Study|Sponsor Request|0|||
37748247|NCT04426695|69238549|FG014|Overall Study|Sponsor Request|0|||
37748248|NCT04426695|69238550|FG015|Overall Study|Sponsor Request|0|||
38033016|NCT02820844|69719000|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
38033017|NCT02820844|69719001|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
38033018|NCT02820844|69719002|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
38033019|NCT02820844|69719003|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
38033020|NCT02942576|69719022|FG000|Overall Study|Adverse Event|28|||
38033021|NCT02942576|69719023|FG001|Overall Study|Adverse Event|6|||
38033022|NCT02942576|69719022|FG000|Overall Study|Withdrawal by Subject|7|||
37658971|NCT02492984|69131145|FG000|Overall Study|Withdrawal by Subject|1|||
37658972|NCT02492984|69131146|FG001|Overall Study|Withdrawal by Subject|0|||
37658973|NCT01680159|69131159|FG000|Screening Period|Not meet criteria for dose-up period|7|||
37658974|NCT01680159|69131159|FG000|Increased Dose Period|Adverse Event|6|||
37658975|NCT01680159|69131159|FG000|Increased Dose Period|Withdrawal by Subject|2|||
37748249|NCT04426695|69238551|FG016|Overall Study|Sponsor Request|0|||
37748250|NCT04426695|69238552|FG017|Overall Study|Sponsor Request|0|||
37748251|NCT04426695|69238535|FG000|Overall Study|Physician Decision|0|||
37748252|NCT04426695|69238536|FG001|Overall Study|Physician Decision|0|||
37748253|NCT04426695|69238537|FG002|Overall Study|Physician Decision|0|||
37748254|NCT04426695|69238538|FG003|Overall Study|Physician Decision|0|||
37748255|NCT04426695|69238539|FG004|Overall Study|Physician Decision|0|||
37748256|NCT04426695|69238540|FG005|Overall Study|Physician Decision|0|||
37748257|NCT04426695|69238541|FG006|Overall Study|Physician Decision|0|||
37748258|NCT04426695|69238542|FG007|Overall Study|Physician Decision|0|||
37748259|NCT04426695|69238543|FG008|Overall Study|Physician Decision|0|||
37748260|NCT04426695|69238544|FG009|Overall Study|Physician Decision|1|||
37748261|NCT04426695|69238545|FG010|Overall Study|Physician Decision|0|||
37748262|NCT04426695|69238546|FG011|Overall Study|Physician Decision|0|||
37748263|NCT04426695|69238547|FG012|Overall Study|Physician Decision|1|||
37748264|NCT04426695|69238548|FG013|Overall Study|Physician Decision|0|||
37748265|NCT04426695|69238549|FG014|Overall Study|Physician Decision|0|||
37748266|NCT04426695|69238550|FG015|Overall Study|Physician Decision|0|||
37748267|NCT04426695|69238551|FG016|Overall Study|Physician Decision|0|||
37748268|NCT04426695|69238552|FG017|Overall Study|Physician Decision|0|||
37748269|NCT04426695|69238535|FG000|Overall Study|Randomized but Never Treated|3|||
37748270|NCT04426695|69238536|FG001|Overall Study|Randomized but Never Treated|1|||
37748271|NCT04426695|69238537|FG002|Overall Study|Randomized but Never Treated|0|||
37658976|NCT02491892|69131181|FG000|Overall Study|Adverse Event|1|||
37658977|NCT02491892|69131182|FG001|Overall Study|Adverse Event|1|||
37658978|NCT02491892|69131181|FG000|Overall Study|Death|1|||
37658979|NCT02491892|69131182|FG001|Overall Study|Death|1|||
37748272|NCT04426695|69238538|FG003|Overall Study|Randomized but Never Treated|4|||
38033023|NCT02942576|69719023|FG001|Overall Study|Withdrawal by Subject|5|||
37658980|NCT02491892|69131181|FG000|Overall Study|Lack of Efficacy|37|||
37658981|NCT02491892|69131182|FG001|Overall Study|Lack of Efficacy|36|||
37658982|NCT02491892|69131181|FG000|Overall Study|Refused Treatment|1|||
37748273|NCT04426695|69238539|FG004|Overall Study|Randomized but Never Treated|5|||
37748274|NCT04426695|69238540|FG005|Overall Study|Randomized but Never Treated|5|||
37748275|NCT04426695|69238541|FG006|Overall Study|Randomized but Never Treated|4|||
37748276|NCT04426695|69238542|FG007|Overall Study|Randomized but Never Treated|6|||
37748277|NCT04426695|69238543|FG008|Overall Study|Randomized but Never Treated|6|||
37748278|NCT04426695|69238544|FG009|Overall Study|Randomized but Never Treated|3|||
37748279|NCT04426695|69238545|FG010|Overall Study|Randomized but Never Treated|3|||
37748280|NCT04426695|69238546|FG011|Overall Study|Randomized but Never Treated|6|||
37658983|NCT02491892|69131182|FG001|Overall Study|Refused Treatment|0|||
37748281|NCT04426695|69238547|FG012|Overall Study|Randomized but Never Treated|1|||
37748282|NCT04426695|69238548|FG013|Overall Study|Randomized but Never Treated|2|||
37748283|NCT04426695|69238549|FG014|Overall Study|Randomized but Never Treated|0|||
37748284|NCT04426695|69238550|FG015|Overall Study|Randomized but Never Treated|0|||
37748285|NCT04426695|69238551|FG016|Overall Study|Randomized but Never Treated|0|||
37748286|NCT04426695|69238552|FG017|Overall Study|Randomized but Never Treated|0|||
37748287|NCT01838200|69238629|FG000|Overall Study|Adverse Event|0|||
37748288|NCT01838200|69238630|FG001|Overall Study|Adverse Event|2|||
37748289|NCT01838200|69238629|FG000|Overall Study|Progressive disease|3|||
37748290|NCT01838200|69238630|FG001|Overall Study|Progressive disease|0|||
37748291|NCT03219034|69238673|FG000|Overall Study|Lost to Follow-up|9|||
37748292|NCT03219034|69238674|FG001|Overall Study|Lost to Follow-up|13|||
37748293|NCT03219034|69238673|FG000|Overall Study|Additional dental work needed|1|||
37748294|NCT03219034|69238674|FG001|Overall Study|Additional dental work needed|0|||
37748295|NCT03219034|69238673|FG000|Overall Study|UPPP Surgery|1|||
37748296|NCT03219034|69238674|FG001|Overall Study|UPPP Surgery|0|||
37748297|NCT03219034|69238673|FG000|Overall Study|Dental sensitivity|0|||
37748298|NCT03219034|69238674|FG001|Overall Study|Dental sensitivity|1|||
37748299|NCT03219034|69238673|FG000|Overall Study|Death in family|0|||
37748300|NCT03219034|69238674|FG001|Overall Study|Death in family|1|||
37748301|NCT01706198|69238698|FG000|Overall Study|Adverse Event|12|||
37748302|NCT01706198|69238699|FG001|Overall Study|Adverse Event|15|||
37748303|NCT01706198|69238698|FG000|Overall Study|Protocol Violation|7|||
37748304|NCT01706198|69238699|FG001|Overall Study|Protocol Violation|5|||
37748305|NCT01706198|69238698|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
37748306|NCT01706198|69238699|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
37748307|NCT01706198|69238698|FG000|Overall Study|Lost to Follow-up|97|||
37748308|NCT01706198|69238699|FG001|Overall Study|Lost to Follow-up|93|||
37748309|NCT01706198|69238698|FG000|Overall Study|Physician Decision|23|||
37748310|NCT01706198|69238699|FG001|Overall Study|Physician Decision|37|||
37748311|NCT01706198|69238698|FG000|Overall Study|Withdrawal by Subject|23|||
37748312|NCT01706198|69238699|FG001|Overall Study|Withdrawal by Subject|31|||
37748313|NCT01705730|69238705|FG000|Overall Study|Lack of Efficacy|1|||
37748314|NCT01705730|69238705|FG000|Overall Study|Adverse Event|3|||
37748315|NCT01705730|69238705|FG000|Overall Study|Lost to Follow-up|1|||
37748316|NCT01705730|69238705|FG000|Overall Study|Reason not Specified|4|||
37748317|NCT01705652|69238711|FG000|Overall Study|Adverse Event|1|||
37748318|NCT01705652|69238712|FG001|Overall Study|Adverse Event|0|||
37748319|NCT01705652|69238711|FG000|Overall Study|Withdrawal by Subject|1|||
37748320|NCT01705652|69238712|FG001|Overall Study|Withdrawal by Subject|2|||
37748321|NCT01705652|69238711|FG000|Overall Study|non-compliance|1|||
37748322|NCT01705652|69238712|FG001|Overall Study|non-compliance|1|||
37748323|NCT01705574|69238740|FG000|Double-Blind Phase|Lost to Follow-up|12|||
37748324|NCT01705574|69238741|FG001|Double-Blind Phase|Lost to Follow-up|16|||
37748325|NCT01705574|69238742|FG002|Double-Blind Phase|Lost to Follow-up|0|||
37748326|NCT01705574|69238743|FG003|Double-Blind Phase|Lost to Follow-up|0|||
37748327|NCT01705574|69238740|FG000|Double-Blind Phase|Adverse Event|3|||
37748328|NCT01705574|69238741|FG001|Double-Blind Phase|Adverse Event|10|||
37748329|NCT01705574|69238742|FG002|Double-Blind Phase|Adverse Event|0|||
37748330|NCT01705574|69238743|FG003|Double-Blind Phase|Adverse Event|0|||
37748331|NCT01705574|69238740|FG000|Double-Blind Phase|Withdrew Consent|8|||
37748332|NCT01705574|69238741|FG001|Double-Blind Phase|Withdrew Consent|5|||
37658984|NCT02491892|69131181|FG000|Overall Study|Lost to Follow-up|1|||
37658985|NCT02491892|69131182|FG001|Overall Study|Lost to Follow-up|0|||
37658986|NCT02436356|69131198|FG000|Overall Study|Excluded by MRI Screening|0|||
37658987|NCT02436356|69131199|FG001|Overall Study|Excluded by MRI Screening|0|||
37658988|NCT02436356|69131200|FG002|Overall Study|Excluded by MRI Screening|2|||
37658989|NCT02436356|69131198|FG000|Overall Study|Lost to Follow-up|0|||
37658990|NCT02436356|69131199|FG001|Overall Study|Lost to Follow-up|1|||
37658991|NCT02436356|69131200|FG002|Overall Study|Lost to Follow-up|0|||
37658992|NCT02436356|69131198|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
37658993|NCT02436356|69131199|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
37658994|NCT02436356|69131200|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
37658995|NCT02436356|69131198|FG000|Overall Study|Excluded due to other medical conditions|3|||
37658996|NCT02436356|69131199|FG001|Overall Study|Excluded due to other medical conditions|0|||
37658997|NCT02436356|69131200|FG002|Overall Study|Excluded due to other medical conditions|0|||
37658998|NCT02436356|69131198|FG000|Overall Study|Withdrawal by Subject|1|||
37748333|NCT01705574|69238742|FG002|Double-Blind Phase|Withdrew Consent|0|||
37748334|NCT01705574|69238743|FG003|Double-Blind Phase|Withdrew Consent|0|||
37748335|NCT01705574|69238740|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
37748336|NCT01705574|69238741|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
37748337|NCT01705574|69238742|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
37748338|NCT01705574|69238743|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
37748339|NCT01705574|69238740|FG000|Double-Blind Phase|Pregnancy|1|||
37748340|NCT01705574|69238741|FG001|Double-Blind Phase|Pregnancy|1|||
37748341|NCT01705574|69238742|FG002|Double-Blind Phase|Pregnancy|0|||
37748342|NCT01705574|69238743|FG003|Double-Blind Phase|Pregnancy|0|||
37748343|NCT01705574|69238740|FG000|Double-Blind Phase|Protocol Violation|1|||
37748344|NCT01705574|69238741|FG001|Double-Blind Phase|Protocol Violation|0|||
37748345|NCT01705574|69238742|FG002|Double-Blind Phase|Protocol Violation|0|||
37658999|NCT02436356|69131199|FG001|Overall Study|Withdrawal by Subject|0|||
37659000|NCT02436356|69131200|FG002|Overall Study|Withdrawal by Subject|0|||
37659001|NCT02436200|69131213|FG000|Overall Study|Significant outlier|1|||
37659002|NCT01679613|69131217|FG000|Overall Study|other than stated above|0|||
37659003|NCT01679613|69131218|FG001|Overall Study|other than stated above|1|||
37659004|NCT01679613|69131219|FG002|Overall Study|other than stated above|2|||
37748346|NCT01705574|69238743|FG003|Double-Blind Phase|Protocol Violation|0|||
37748347|NCT01705574|69238740|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
37748348|NCT01705574|69238741|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
37748349|NCT01705574|69238742|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
37748350|NCT01705574|69238743|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
37748351|NCT01705574|69238740|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
37748352|NCT01705574|69238741|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
37748353|NCT01705574|69238742|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
37748354|NCT01705574|69238743|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
37748355|NCT01705574|69238740|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
37748356|NCT01705574|69238741|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
37748357|NCT01705574|69238742|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
37748358|NCT01705574|69238743|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
37748359|NCT01705574|69238740|FG000|Open-Label Extension Phase|Adverse Event|3|||
37748360|NCT01705574|69238741|FG001|Open-Label Extension Phase|Adverse Event|0|||
37748361|NCT01705574|69238742|FG002|Open-Label Extension Phase|Adverse Event|0|||
37748362|NCT01705574|69238743|FG003|Open-Label Extension Phase|Adverse Event|1|||
37748363|NCT01705574|69238740|FG000|Open-Label Extension Phase|Death|2|||
37748364|NCT01705574|69238741|FG001|Open-Label Extension Phase|Death|0|||
37748365|NCT01705574|69238742|FG002|Open-Label Extension Phase|Death|1|||
37748366|NCT01705574|69238743|FG003|Open-Label Extension Phase|Death|0|||
37748367|NCT01705574|69238740|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
37748368|NCT01705574|69238741|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
37748369|NCT01705574|69238742|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
37748370|NCT01705574|69238743|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
37748371|NCT01705574|69238740|FG000|Open-Label Extension Phase|Physician Decision|0|||
37748372|NCT01705574|69238741|FG001|Open-Label Extension Phase|Physician Decision|0|||
37748373|NCT01705574|69238742|FG002|Open-Label Extension Phase|Physician Decision|2|||
37748374|NCT01705574|69238743|FG003|Open-Label Extension Phase|Physician Decision|0|||
37748375|NCT01705574|69238740|FG000|Open-Label Extension Phase|Pregnancy|0|||
37748376|NCT01705574|69238741|FG001|Open-Label Extension Phase|Pregnancy|0|||
37748377|NCT01705574|69238742|FG002|Open-Label Extension Phase|Pregnancy|1|||
37748378|NCT01705574|69238743|FG003|Open-Label Extension Phase|Pregnancy|1|||
37748379|NCT01737710|69238764|FG000|Overall Study|Lost to Follow-up|0|||
37748380|NCT01737710|69238765|FG001|Overall Study|Lost to Follow-up|2|||
37748381|NCT01737710|69238766|FG002|Overall Study|Lost to Follow-up|2|||
37748382|NCT01737710|69238767|FG003|Overall Study|Lost to Follow-up|0|||
37748383|NCT01737710|69238768|FG004|Overall Study|Lost to Follow-up|0|||
37748384|NCT01737710|69238764|FG000|Overall Study|Withdrawal by Subject|1|||
37748385|NCT01737710|69238765|FG001|Overall Study|Withdrawal by Subject|1|||
37748386|NCT01737710|69238766|FG002|Overall Study|Withdrawal by Subject|1|||
37748387|NCT01737710|69238767|FG003|Overall Study|Withdrawal by Subject|0|||
37748388|NCT01737710|69238768|FG004|Overall Study|Withdrawal by Subject|0|||
37748389|NCT01737710|69238764|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
37748390|NCT01737710|69238765|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
37748391|NCT01737710|69238766|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
37748392|NCT01737710|69238767|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
37748393|NCT01737710|69238768|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
37659005|NCT01679613|69131220|FG003|Overall Study|other than stated above|2|||
37748394|NCT01682876|69238783|FG000|Overall Study|Administrative reason|4|||
37748395|NCT01682876|69238784|FG001|Overall Study|Administrative reason|4|||
37748396|NCT01682876|69238785|FG002|Overall Study|Administrative reason|0|||
37659006|NCT02489630|69131229|FG000|Overall Study|Oversedation|1|||
37659007|NCT02489630|69131230|FG001|Overall Study|Oversedation|1|||
37659008|NCT02489630|69131229|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
37748397|NCT01682876|69238786|FG003|Overall Study|Administrative reason|3|||
37748398|NCT01682876|69238783|FG000|Overall Study|Adverse Event|0|||
37748399|NCT01682876|69238784|FG001|Overall Study|Adverse Event|0|||
37748400|NCT01682876|69238785|FG002|Overall Study|Adverse Event|0|||
37748401|NCT01682876|69238786|FG003|Overall Study|Adverse Event|1|||
37748402|NCT01682876|69238783|FG000|Overall Study|Lost to Follow-up|11|||
37748403|NCT01682876|69238784|FG001|Overall Study|Lost to Follow-up|15|||
37748404|NCT01682876|69238785|FG002|Overall Study|Lost to Follow-up|9|||
38033024|NCT02942576|69719022|FG000|Overall Study|Physician Decision|1|||
37748405|NCT01682876|69238786|FG003|Overall Study|Lost to Follow-up|11|||
37748406|NCT01682876|69238783|FG000|Overall Study|Protocol Violation|1|||
37659009|NCT02489630|69131230|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
37659010|NCT02739347|69131238|FG000|Overall Study|Adverse Event|3|||
37659011|NCT02739347|69131239|FG001|Overall Study|Adverse Event|0|||
37659012|NCT02739347|69131238|FG000|Overall Study|Protocol Violation|0|||
37659013|NCT02739347|69131239|FG001|Overall Study|Protocol Violation|1|||
37659014|NCT02739347|69131238|FG000|Overall Study|Lost to Follow-up|0|||
37659015|NCT02739347|69131239|FG001|Overall Study|Lost to Follow-up|2|||
37659016|NCT02435966|69131248|FG000|Overall Study|Withdrawal by Subject|0|||
37659017|NCT02435966|69131249|FG001|Overall Study|Withdrawal by Subject|1|||
37659018|NCT02435966|69131250|FG002|Overall Study|Withdrawal by Subject|0|||
37748407|NCT01682876|69238784|FG001|Overall Study|Protocol Violation|1|||
37748408|NCT01682876|69238785|FG002|Overall Study|Protocol Violation|1|||
37748409|NCT01682876|69238786|FG003|Overall Study|Protocol Violation|1|||
37748410|NCT01682876|69238783|FG000|Overall Study|Withdrawal by Subject|4|||
37748411|NCT01682876|69238784|FG001|Overall Study|Withdrawal by Subject|0|||
37748412|NCT01682876|69238785|FG002|Overall Study|Withdrawal by Subject|0|||
37748413|NCT01682876|69238786|FG003|Overall Study|Withdrawal by Subject|2|||
37748414|NCT01682876|69238783|FG000|Overall Study|Other|1|||
37748415|NCT01682876|69238784|FG001|Overall Study|Other|0|||
37748416|NCT01682876|69238785|FG002|Overall Study|Other|1|||
37748417|NCT01682876|69238786|FG003|Overall Study|Other|1|||
37748418|NCT01682720|69238803|FG000|Overall Study|Randomized but Not Treated|0|||
37748419|NCT01682720|69238804|FG001|Overall Study|Randomized but Not Treated|1|||
37748420|NCT01682720|69238805|FG002|Overall Study|Randomized but Not Treated|1|||
37748421|NCT01682720|69238806|FG003|Overall Study|Randomized but Not Treated|0|||
37748422|NCT01682720|69238803|FG000|Overall Study|Terminated by Sponsor|83|||
37748423|NCT01682720|69238804|FG001|Overall Study|Terminated by Sponsor|0|||
37748424|NCT01682720|69238805|FG002|Overall Study|Terminated by Sponsor|0|||
37748425|NCT01682720|69238806|FG003|Overall Study|Terminated by Sponsor|0|||
37748426|NCT01682720|69238803|FG000|Overall Study|Efficacy Failure|0|||
37748427|NCT01682720|69238804|FG001|Overall Study|Efficacy Failure|3|||
37748428|NCT01682720|69238805|FG002|Overall Study|Efficacy Failure|3|||
37748429|NCT01682720|69238806|FG003|Overall Study|Efficacy Failure|30|||
37748430|NCT01682720|69238803|FG000|Overall Study|Lost to Follow-up|1|||
37748431|NCT01682720|69238804|FG001|Overall Study|Lost to Follow-up|1|||
37748432|NCT01682720|69238805|FG002|Overall Study|Lost to Follow-up|0|||
37659019|NCT01679301|69131258|FG000|Screening Period|screen failure|3|||
37659020|NCT01679301|69131259|FG001|Screening Period|screen failure|0|||
37659021|NCT01679301|69131260|FG002|Screening Period|screen failure|0|||
37659022|NCT01678911|69131266|FG000|Second Intervention|Lost to Follow-up|2|||
37659023|NCT01678911|69131267|FG001|Second Intervention|Lost to Follow-up|0|||
37659024|NCT02487446|69131273|FG000|Period 1|Physician Decision|0|||
37659025|NCT02487446|69131274|FG001|Period 1|Physician Decision|1|||
37659026|NCT02487446|69131273|FG000|Period 1|Lack of Efficacy|1|||
37659027|NCT02487446|69131274|FG001|Period 1|Lack of Efficacy|0|||
37659028|NCT02487446|69131273|FG000|Period 1|Protocol deviation|3|||
37659029|NCT02487446|69131274|FG001|Period 1|Protocol deviation|2|||
37659030|NCT02487446|69131273|FG000|Period 1|Lost to Follow-up|2|||
37659031|NCT02487446|69131274|FG001|Period 1|Lost to Follow-up|0|||
37659032|NCT02487446|69131273|FG000|Period 1|Withdrawal by Subject|2|||
37659033|NCT02487446|69131274|FG001|Period 1|Withdrawal by Subject|0|||
37659034|NCT02487446|69131273|FG000|Period 1|Adverse Event|5|||
37659035|NCT02487446|69131274|FG001|Period 1|Adverse Event|5|||
37659036|NCT02487446|69131273|FG000|Washout|Lost to Follow-up|0|||
37659037|NCT02487446|69131274|FG001|Washout|Lost to Follow-up|2|||
37659038|NCT02487446|69131273|FG000|Washout|Withdrawal by Subject|1|||
37659039|NCT02487446|69131274|FG001|Washout|Withdrawal by Subject|4|||
37659040|NCT02487446|69131273|FG000|Washout|Adverse Event|2|||
37659041|NCT02487446|69131274|FG001|Washout|Adverse Event|2|||
37659042|NCT02487446|69131273|FG000|Period 2|Protocol deviation|0|||
37659043|NCT02487446|69131274|FG001|Period 2|Protocol deviation|1|||
37659044|NCT02487446|69131273|FG000|Period 2|Lost to Follow-up|1|||
37659045|NCT02487446|69131274|FG001|Period 2|Lost to Follow-up|1|||
37659046|NCT02487446|69131273|FG000|Period 2|Withdrawal by Subject|1|||
37659047|NCT02487446|69131274|FG001|Period 2|Withdrawal by Subject|1|||
37659048|NCT02487446|69131273|FG000|Period 2|Adverse Event|6|||
37659049|NCT02487446|69131274|FG001|Period 2|Adverse Event|2|||
37659050|NCT02739269|69131283|FG000|Overall Study|Protocol Violation|5|||
37748433|NCT01682720|69238806|FG003|Overall Study|Lost to Follow-up|6|||
37748434|NCT01682720|69238803|FG000|Overall Study|Subject Withdrew Consent|0|||
37748435|NCT01682720|69238804|FG001|Overall Study|Subject Withdrew Consent|0|||
37748436|NCT01682720|69238805|FG002|Overall Study|Subject Withdrew Consent|2|||
37659051|NCT02739269|69131284|FG001|Overall Study|Protocol Violation|0|||
37659052|NCT02739269|69131283|FG000|Overall Study|Cycle cancellation|2|||
37748437|NCT01682720|69238806|FG003|Overall Study|Subject Withdrew Consent|2|||
37748438|NCT01682720|69238803|FG000|Overall Study|Adverse Event|1|||
37748439|NCT01682720|69238804|FG001|Overall Study|Adverse Event|0|||
37748440|NCT01682720|69238805|FG002|Overall Study|Adverse Event|1|||
37659053|NCT02739269|69131284|FG001|Overall Study|Cycle cancellation|2|||
37659054|NCT02739269|69131283|FG000|Overall Study|Withdrawal by Subject|0|||
37659055|NCT02739269|69131284|FG001|Overall Study|Withdrawal by Subject|2|||
37659056|NCT03318523|69131294|FG000|PC Period: Up to Year 1|Adverse Event|1|||
37659057|NCT03318523|69131295|FG001|PC Period: Up to Year 1|Adverse Event|0|||
37659058|NCT03318523|69131296|FG002|PC Period: Up to Year 1|Adverse Event|2|||
37659059|NCT03318523|69131297|FG003|PC Period: Up to Year 1|Adverse Event|0|||
37659060|NCT03318523|69131298|FG004|PC Period: Up to Year 1|Adverse Event|0|||
37659061|NCT03318523|69131299|FG005|PC Period: Up to Year 1|Adverse Event|0|||
37659062|NCT03318523|69131300|FG006|PC Period: Up to Year 1|Adverse Event|0|||
37659063|NCT03318523|69131301|FG007|PC Period: Up to Year 1|Adverse Event|0|||
37659064|NCT03318523|69131302|FG008|PC Period: Up to Year 1|Adverse Event|0|||
37659065|NCT03318523|69131303|FG009|PC Period: Up to Year 1|Adverse Event|0|||
37659066|NCT03318523|69131294|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
37659067|NCT03318523|69131295|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
37659068|NCT03318523|69131296|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
37748441|NCT01682720|69238806|FG003|Overall Study|Adverse Event|1|||
37748442|NCT01714544|69238825|FG000|Overall Study|Lost to Follow-up|1|||
37748443|NCT01714544|69238825|FG000|Overall Study|Physician Decision|1|||
37748444|NCT01714544|69238825|FG000|Overall Study|Withdrawal by Subject|1|||
37748445|NCT01703858|69238832|FG000|Overall Study|Withdrawal by Subject|0|||
37748446|NCT01703858|69238833|FG001|Overall Study|Withdrawal by Subject|1|||
37748447|NCT01703858|69238834|FG002|Overall Study|Withdrawal by Subject|0|||
37748448|NCT01714310|69238850|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
37748449|NCT01714310|69238851|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
37748450|NCT01714310|69238852|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
37748451|NCT01714310|69238850|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
37748452|NCT01714310|69238851|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
37748453|NCT01714310|69238852|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
37748454|NCT01714310|69238850|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
37748455|NCT01714310|69238851|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
37748456|NCT01714310|69238852|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
37748457|NCT01714310|69238850|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
37748458|NCT01714310|69238851|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
37748459|NCT01714310|69238852|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
37856082|NCT01217073|69539330|FG001|Extension Period|Non-compliance with study drug|0|||
37856083|NCT01217073|69539331|FG002|Extension Period|Non-compliance with study drug|0|||
37856084|NCT01217073|69539332|FG003|Extension Period|Non-compliance with study drug|0|||
37659069|NCT03318523|69131297|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
37748460|NCT01713998|69238873|FG000|Overall Study|Lost to Follow-up|2|||
37748461|NCT01713998|69238874|FG001|Overall Study|Lost to Follow-up|0|||
37748462|NCT01713998|69238875|FG002|Overall Study|Lost to Follow-up|2|||
37748463|NCT01713998|69238873|FG000|Overall Study|Withdrawal by Subject|1|||
37748464|NCT01713998|69238874|FG001|Overall Study|Withdrawal by Subject|0|||
37748465|NCT01713998|69238875|FG002|Overall Study|Withdrawal by Subject|0|||
37748466|NCT01681628|69238885|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
37748467|NCT01681628|69238886|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
37748468|NCT01681628|69238885|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
37748469|NCT01681628|69238886|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
37748470|NCT01681628|69238885|FG000|19 Months Follow-up|Death|1|||
37748471|NCT01681628|69238886|FG001|19 Months Follow-up|Death|0|||
37748472|NCT01681628|69238885|FG000|19 Months Follow-up|Lost to Follow-up|61|||
37748473|NCT01681628|69238886|FG001|19 Months Follow-up|Lost to Follow-up|43|||
37748474|NCT00016354|69238908|FG000|Overall Study|Lack of Efficacy|0|||
37748475|NCT00016354|69238909|FG001|Overall Study|Lack of Efficacy|0|||
37748476|NCT00016354|69238910|FG002|Overall Study|Lack of Efficacy|0|||
37748477|NCT00016354|69238911|FG003|Overall Study|Lack of Efficacy|0|||
37748478|NCT00016354|69238912|FG004|Overall Study|Lack of Efficacy|0|||
37748479|NCT00016354|69238913|FG005|Overall Study|Lack of Efficacy|0|||
37748480|NCT00016354|69238914|FG006|Overall Study|Lack of Efficacy|0|||
37856085|NCT01217073|69539333|FG004|Extension Period|Non-compliance with study drug|0|||
37856086|NCT01217073|69539334|FG005|Extension Period|Non-compliance with study drug|0|||
37856087|NCT01217073|69539335|FG006|Extension Period|Non-compliance with study drug|0|||
37856088|NCT01217073|69539336|FG007|Extension Period|Non-compliance with study drug|1|||
38033025|NCT02942576|69719023|FG001|Overall Study|Physician Decision|4|||
38033026|NCT02942576|69719022|FG000|Overall Study|Other|10|||
38033027|NCT02942576|69719023|FG001|Overall Study|Other|8|||
37748481|NCT00016354|69238915|FG007|Overall Study|Lack of Efficacy|1|||
37748482|NCT01681472|69238923|FG000|Overall Study|Adverse Event|0|||
37748483|NCT01681472|69238924|FG001|Overall Study|Adverse Event|1|||
37748484|NCT01681472|69238925|FG002|Overall Study|Adverse Event|0|||
37748485|NCT01681472|69238926|FG003|Overall Study|Adverse Event|0|||
37748486|NCT01049308|69238955|FG000|Pill Counts|Withdrawal by Subject|83|||
37748487|NCT01713686|69238962|FG000|Overall Study|Lost to Follow-up|9|||
37748488|NCT01713686|69238962|FG000|Overall Study|Withdrawal by Subject|6|||
37659070|NCT03318523|69131298|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
37659071|NCT03318523|69131299|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
37659072|NCT03318523|69131300|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
37659073|NCT03318523|69131301|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
37659074|NCT03318523|69131302|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
37659075|NCT03318523|69131303|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
37659076|NCT03318523|69131294|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
37659077|NCT03318523|69131295|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
37659078|NCT03318523|69131296|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
37659079|NCT03318523|69131297|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
37659080|NCT03318523|69131298|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
37659081|NCT03318523|69131299|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
37659082|NCT03318523|69131300|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
37659083|NCT03318523|69131301|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
37659084|NCT03318523|69131302|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
37659085|NCT03318523|69131303|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
37659086|NCT03318523|69131294|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
37659087|NCT03318523|69131295|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
37659088|NCT03318523|69131296|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
37659089|NCT03318523|69131297|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
37659090|NCT03318523|69131298|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
37659091|NCT03318523|69131299|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
37659092|NCT03318523|69131300|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
37659093|NCT03318523|69131301|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
37659094|NCT03318523|69131302|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
37659095|NCT03318523|69131303|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
37659096|NCT03318523|69131294|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
37748489|NCT01047436|69238968|FG000|Overall Study|Protocol Violation|1|||
37748490|NCT01047436|69238969|FG001|Overall Study|Protocol Violation|0|||
37748491|NCT01681004|69238977|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
37748492|NCT01681004|69238978|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
37748493|NCT01681004|69238977|FG000|Study Completion|Lost to Follow-up|8|||
37748494|NCT01681004|69238978|FG001|Study Completion|Lost to Follow-up|3|||
37748495|NCT01681004|69238977|FG000|Study Completion|Physician Decision|1|||
37748496|NCT01681004|69238978|FG001|Study Completion|Physician Decision|3|||
37748497|NCT01681004|69238977|FG000|Study Completion|Site Termination|2|||
37748498|NCT01681004|69238978|FG001|Study Completion|Site Termination|1|||
37748499|NCT01681004|69238977|FG000|Study Completion|Death|1|||
37748500|NCT01681004|69238978|FG001|Study Completion|Death|1|||
37748501|NCT01046110|69238990|FG000|Overall Study|Adverse Event|9|||
37748502|NCT01046110|69238991|FG001|Overall Study|Adverse Event|2|||
37748503|NCT01046110|69238990|FG000|Overall Study|Lack of Efficacy|0|||
37748504|NCT01046110|69238991|FG001|Overall Study|Lack of Efficacy|1|||
37748505|NCT01046110|69238990|FG000|Overall Study|Protocol Violation|7|||
37748506|NCT01046110|69238991|FG001|Overall Study|Protocol Violation|12|||
37748507|NCT01046110|69238990|FG000|Overall Study|Withdrawal Criteria|3|||
37748508|NCT01046110|69238991|FG001|Overall Study|Withdrawal Criteria|5|||
37748509|NCT01046110|69238990|FG000|Overall Study|Unclassified|36|||
37748510|NCT01046110|69238991|FG001|Overall Study|Unclassified|35|||
37748511|NCT01713530|69238999|FG000|Overall Study|Adverse Event|0|||
37748512|NCT01713530|69239000|FG001|Overall Study|Adverse Event|5|||
37748513|NCT01713530|69238999|FG000|Overall Study|Withdrawal criteria|21|||
37748514|NCT01713530|69239000|FG001|Overall Study|Withdrawal criteria|12|||
37748515|NCT01713530|69238999|FG000|Overall Study|Unclassified|4|||
37748516|NCT01713530|69239000|FG001|Overall Study|Unclassified|2|||
37748517|NCT01045798|69239008|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
37748518|NCT01045798|69239009|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
37748519|NCT01045798|69239008|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
37748520|NCT01045798|69239009|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
37748521|NCT01045798|69239008|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
37748522|NCT01045798|69239009|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
37748523|NCT01045798|69239008|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
37748524|NCT01045798|69239009|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
37923060|NCT00813150|69609836|FG001|Long Term Follow-up|Lost to Follow-up|0|||
37748525|NCT01712984|69239022|FG000|Overall Study|Adverse Event|0|||
37748526|NCT01712984|69239023|FG001|Overall Study|Adverse Event|0|||
37748527|NCT01712984|69239024|FG002|Overall Study|Adverse Event|1|||
37748528|NCT01712984|69239022|FG000|Overall Study|Protocol Violation|2|||
37923061|NCT00813150|69609835|FG000|Long Term Follow-up|Progression/Relapse|22|||
37923062|NCT00813150|69609836|FG001|Long Term Follow-up|Progression/Relapse|24|||
37923063|NCT00807846|69609844|FG000|Overall Study|Adverse Event|5|||
37923064|NCT00807846|69609845|FG001|Overall Study|Adverse Event|0|||
37748529|NCT01712984|69239023|FG001|Overall Study|Protocol Violation|0|||
37748530|NCT01712984|69239024|FG002|Overall Study|Protocol Violation|1|||
37748531|NCT01712984|69239022|FG000|Overall Study|Lost to Follow-up|8|||
37748532|NCT01712984|69239023|FG001|Overall Study|Lost to Follow-up|10|||
37748533|NCT01712984|69239024|FG002|Overall Study|Lost to Follow-up|1|||
37748534|NCT01712984|69239022|FG000|Overall Study|Withdrawal by Subject|6|||
37748535|NCT01712984|69239023|FG001|Overall Study|Withdrawal by Subject|6|||
37748536|NCT01712984|69239024|FG002|Overall Study|Withdrawal by Subject|7|||
37748537|NCT01042678|69239035|FG000|Overall Study|Physician Decision|1|||
37748538|NCT01042678|69239036|FG001|Overall Study|Physician Decision|0|||
37748539|NCT01042678|69239037|FG002|Overall Study|Physician Decision|0|||
37748540|NCT01042678|69239038|FG003|Overall Study|Physician Decision|0|||
37748541|NCT01042678|69239039|FG004|Overall Study|Physician Decision|0|||
37748542|NCT01042678|69239040|FG005|Overall Study|Physician Decision|0|||
37748543|NCT01042600|69239050|FG000|Overall Study|Ineligible|1|||
37748544|NCT01042600|69239051|FG001|Overall Study|Ineligible|0|||
37748545|NCT01041976|69239060|FG000|Overall Study|Withdrawal by Subject|3|||
37748546|NCT01041976|69239061|FG001|Overall Study|Withdrawal by Subject|0|||
37748547|NCT01041976|69239060|FG000|Overall Study|Incarceration|2|||
37748548|NCT01041976|69239061|FG001|Overall Study|Incarceration|0|||
37748549|NCT01041976|69239060|FG000|Overall Study|Death|0|||
37748550|NCT01041976|69239061|FG001|Overall Study|Death|4|||
37748551|NCT01712516|69239087|FG000|Overall Study|Technical problems|0|||
37748552|NCT01712516|69239088|FG001|Overall Study|Technical problems|0|||
37748553|NCT01712516|69239089|FG002|Overall Study|Technical problems|0|||
37748554|NCT01712516|69239090|FG003|Overall Study|Technical problems|2|||
37748555|NCT01712516|69239087|FG000|Overall Study|Lost to Follow-up|0|||
37748556|NCT01712516|69239088|FG001|Overall Study|Lost to Follow-up|0|||
37748557|NCT01712516|69239089|FG002|Overall Study|Lost to Follow-up|2|||
37748558|NCT01712516|69239090|FG003|Overall Study|Lost to Follow-up|1|||
37748559|NCT01712516|69239087|FG000|Overall Study|Death|0|||
37748560|NCT01712516|69239088|FG001|Overall Study|Death|1|||
37748561|NCT01712516|69239089|FG002|Overall Study|Death|0|||
37748562|NCT01712516|69239090|FG003|Overall Study|Death|0|||
37748563|NCT01712516|69239087|FG000|Overall Study|Protocol deviation|1|||
37748564|NCT01712516|69239088|FG001|Overall Study|Protocol deviation|0|||
37748565|NCT01712516|69239089|FG002|Overall Study|Protocol deviation|1|||
37748566|NCT01712516|69239090|FG003|Overall Study|Protocol deviation|0|||
37748567|NCT01712516|69239087|FG000|Overall Study|Physician Decision|2|||
37748568|NCT01712516|69239088|FG001|Overall Study|Physician Decision|0|||
37748569|NCT01712516|69239089|FG002|Overall Study|Physician Decision|0|||
37748570|NCT01712516|69239090|FG003|Overall Study|Physician Decision|1|||
37748571|NCT01712516|69239087|FG000|Overall Study|Withdrawal by Subject|3|||
37748572|NCT01712516|69239088|FG001|Overall Study|Withdrawal by Subject|9|||
37748573|NCT01712516|69239089|FG002|Overall Study|Withdrawal by Subject|3|||
37748574|NCT01712516|69239090|FG003|Overall Study|Withdrawal by Subject|9|||
37748575|NCT01703000|69239100|FG000|Overall Study|Death|1|||
37748576|NCT01040728|69239104|FG000|Overall Study|Adverse Event|4|||
37659097|NCT03318523|69131295|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
37659098|NCT03318523|69131296|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
37659099|NCT03318523|69131297|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
37659100|NCT03318523|69131298|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
37659101|NCT03318523|69131299|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
37659102|NCT03318523|69131300|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
37659103|NCT03318523|69131301|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
37659104|NCT03318523|69131302|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
37659105|NCT03318523|69131303|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
37659106|NCT03318523|69131294|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
37659107|NCT03318523|69131295|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
37659108|NCT03318523|69131296|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
37659109|NCT03318523|69131297|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
37659110|NCT03318523|69131298|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
37748577|NCT01040728|69239105|FG001|Overall Study|Adverse Event|8|||
37748578|NCT01040728|69239106|FG002|Overall Study|Adverse Event|0|||
37748579|NCT01040728|69239107|FG003|Overall Study|Adverse Event|4|||
37748580|NCT01040728|69239104|FG000|Overall Study|Withdrawal by Subject|0|||
37748581|NCT01040728|69239105|FG001|Overall Study|Withdrawal by Subject|1|||
37748582|NCT01040728|69239106|FG002|Overall Study|Withdrawal by Subject|1|||
37748583|NCT01040728|69239107|FG003|Overall Study|Withdrawal by Subject|0|||
37748584|NCT01040728|69239104|FG000|Overall Study|Protocol Violation|0|||
37748585|NCT01040728|69239105|FG001|Overall Study|Protocol Violation|0|||
37748586|NCT01040728|69239106|FG002|Overall Study|Protocol Violation|0|||
37748587|NCT01040728|69239107|FG003|Overall Study|Protocol Violation|1|||
37748588|NCT01040728|69239104|FG000|Overall Study|Lack of Efficacy|0|||
37748589|NCT01040728|69239105|FG001|Overall Study|Lack of Efficacy|1|||
37748590|NCT01040728|69239106|FG002|Overall Study|Lack of Efficacy|0|||
37748591|NCT01040728|69239107|FG003|Overall Study|Lack of Efficacy|1|||
37748592|NCT01040728|69239104|FG000|Overall Study|Other reasons not listed above|0|||
37748593|NCT01040728|69239105|FG001|Overall Study|Other reasons not listed above|1|||
37748594|NCT01040728|69239106|FG002|Overall Study|Other reasons not listed above|0|||
37748595|NCT01040728|69239107|FG003|Overall Study|Other reasons not listed above|0|||
37748596|NCT01593020|69239125|FG000|Overall Study|Adverse Event|1|||
37748597|NCT01593020|69239126|FG001|Overall Study|Adverse Event|1|||
37748598|NCT01593020|69239125|FG000|Overall Study|Death|0|||
37748599|NCT01593020|69239126|FG001|Overall Study|Death|1|||
37748600|NCT01593020|69239125|FG000|Overall Study|Ineligible|1|||
37748601|NCT01593020|69239126|FG001|Overall Study|Ineligible|0|||
37748602|NCT01040260|69239134|FG000|Overall Study|Withdrawal by Subject|12|||
37748603|NCT01040260|69239135|FG001|Overall Study|Withdrawal by Subject|6|||
37748604|NCT01040260|69239134|FG000|Overall Study|Lost to Follow-up|3|||
37748605|NCT01040260|69239135|FG001|Overall Study|Lost to Follow-up|5|||
37748606|NCT01712438|69239141|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
37748607|NCT01712438|69239141|FG000|Overall Study|Ongoing ITI treatment|6|||
37748608|NCT01712438|69239141|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
37748609|NCT01712438|69239141|FG000|Overall Study|Prematurely Discontinued|25|||
37748610|NCT01712204|69239152|FG000|Overall Study|Adverse Event|3|||
37748611|NCT01712204|69239153|FG001|Overall Study|Adverse Event|1|||
37748612|NCT01712204|69239152|FG000|Overall Study|Withdrawal by Subject|3|||
37748613|NCT01712204|69239153|FG001|Overall Study|Withdrawal by Subject|3|||
37748614|NCT01712204|69239152|FG000|Overall Study|Lost to Follow-up|1|||
37748615|NCT01712204|69239153|FG001|Overall Study|Lost to Follow-up|0|||
37748616|NCT01712204|69239152|FG000|Overall Study|Protocol Violation|1|||
37748617|NCT01712204|69239153|FG001|Overall Study|Protocol Violation|1|||
37748618|NCT01592864|69239161|FG000|Overall Study|Withdrawal by Subject|0|||
37748619|NCT01592864|69239162|FG001|Overall Study|Withdrawal by Subject|1|||
37748620|NCT01592786|69239168|FG000|Overall Study|Adverse Event|60|||
37748621|NCT01592786|69239168|FG000|Overall Study|Lack of Efficacy|19|||
37748622|NCT01592786|69239168|FG000|Overall Study|Protocol Violation|14|||
37748623|NCT01592786|69239168|FG000|Overall Study|Withdrawal by Subject|23|||
37748624|NCT01592786|69239168|FG000|Overall Study|Lost to Follow-up|19|||
37748625|NCT01592786|69239168|FG000|Overall Study|Other|3|||
37748626|NCT01711736|69239174|FG000|Overall Study|Lost to Follow-up|4|||
37748627|NCT01711736|69239175|FG001|Overall Study|Lost to Follow-up|1|||
37748628|NCT01711736|69239174|FG000|Overall Study|Withdrawal by Subject|6|||
37748629|NCT01711736|69239175|FG001|Overall Study|Withdrawal by Subject|6|||
37748630|NCT01711736|69239174|FG000|Overall Study|Migrated/moved from study area|2|||
37748631|NCT01711736|69239175|FG001|Overall Study|Migrated/moved from study area|1|||
37748632|NCT01592708|69239184|FG000|Overall Study|Protocol Violation|3|||
37748633|NCT01592708|69239185|FG001|Overall Study|Protocol Violation|0|||
37748634|NCT01042522|69239196|FG000|Overall Study|Adverse Event|1|||
37748635|NCT01042522|69239197|FG001|Overall Study|Adverse Event|2|||
37748636|NCT01042522|69239196|FG000|Overall Study|Disease Progression|5|||
37748637|NCT01042522|69239197|FG001|Overall Study|Disease Progression|0|||
37748638|NCT01042522|69239196|FG000|Overall Study|Death|1|||
37748639|NCT01042522|69239197|FG001|Overall Study|Death|0|||
37748640|NCT01042522|69239196|FG000|Overall Study|Patient Refused|0|||
37748641|NCT01042522|69239197|FG001|Overall Study|Patient Refused|3|||
37748642|NCT01042522|69239196|FG000|Overall Study|Withdrawal by Subject|1|||
37659111|NCT03318523|69131299|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
37659112|NCT03318523|69131300|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
37659113|NCT03318523|69131301|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
37659114|NCT03318523|69131302|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
37659115|NCT03318523|69131303|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
37659116|NCT03318523|69131294|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
37659117|NCT03318523|69131295|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
37659118|NCT03318523|69131296|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
37659119|NCT03318523|69131297|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
37659120|NCT03318523|69131298|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
37659121|NCT03318523|69131299|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
37659122|NCT03318523|69131300|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
37748643|NCT01042522|69239197|FG001|Overall Study|Withdrawal by Subject|1|||
37748644|NCT01702844|69239203|FG000|Overall Study|Adverse Event|9|||
37748645|NCT01702844|69239203|FG000|Overall Study|Death|1|||
37748646|NCT01702844|69239203|FG000|Overall Study|Withdrawal by Subject|3|||
37748647|NCT01702844|69239203|FG000|Overall Study|Physician Decision|6|||
37748648|NCT01702532|69239209|FG000|Overall Study|Adverse Event|0|||
37748649|NCT01702532|69239210|FG001|Overall Study|Adverse Event|1|||
37748650|NCT01702454|69239219|FG000|Overall Study|Consent withdrawal|0|||
37748651|NCT01702454|69239220|FG001|Overall Study|Consent withdrawal|1|||
37748652|NCT01702454|69239219|FG000|Overall Study|Migrated/moved from study area|0|||
37748653|NCT01702454|69239220|FG001|Overall Study|Migrated/moved from study area|1|||
37748654|NCT01702454|69239219|FG000|Overall Study|Lost to Follow-up|3|||
37659123|NCT03318523|69131301|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
37659124|NCT03318523|69131302|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
37659125|NCT03318523|69131303|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
37659126|NCT03318523|69131294|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
37659127|NCT03318523|69131295|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
37659128|NCT03318523|69131296|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
37659129|NCT03318523|69131297|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
37659130|NCT03318523|69131298|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
37659131|NCT03318523|69131299|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
37659132|NCT03318523|69131300|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
37659133|NCT03318523|69131301|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
37659134|NCT03318523|69131302|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
37659135|NCT03318523|69131303|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
37659136|NCT01678209|69131330|FG000|Overall Study|could not scan twice|1|||
37659137|NCT01678209|69131331|FG001|Overall Study|could not scan twice|1|||
37659138|NCT01678209|69131332|FG002|Overall Study|could not scan twice|1|||
37659139|NCT01678209|69131330|FG000|Overall Study|scheduling conflicts|0|||
37748655|NCT01702454|69239220|FG001|Overall Study|Lost to Follow-up|6|||
37748656|NCT01702298|69239233|FG000|Overall Study|Withdrawal by Subject|1|||
37748657|NCT01701362|69239239|FG000|Overall Study|Adverse events not related to study drug|1|||
37748658|NCT01701362|69239240|FG001|Overall Study|Adverse events not related to study drug|6|||
37748659|NCT01701362|69239239|FG000|Overall Study|Adverse events related to study drug|12|||
37748660|NCT01701362|69239240|FG001|Overall Study|Adverse events related to study drug|10|||
37748661|NCT01701362|69239239|FG000|Overall Study|Protocol Violation|5|||
37748662|NCT01701362|69239240|FG001|Overall Study|Protocol Violation|3|||
37856089|NCT01217073|69539329|FG000|Extension Period|Physician Decision|0|||
37856090|NCT01217073|69539330|FG001|Extension Period|Physician Decision|0|||
37856091|NCT01217073|69539331|FG002|Extension Period|Physician Decision|0|||
37856092|NCT01217073|69539332|FG003|Extension Period|Physician Decision|0|||
37856093|NCT01217073|69539333|FG004|Extension Period|Physician Decision|0|||
37856094|NCT01217073|69539334|FG005|Extension Period|Physician Decision|0|||
37856095|NCT01217073|69539335|FG006|Extension Period|Physician Decision|4|||
37856096|NCT01217073|69539336|FG007|Extension Period|Physician Decision|1|||
37856097|NCT01217073|69539329|FG000|Extension Period|Protocol Violation|0|||
37856098|NCT01217073|69539330|FG001|Extension Period|Protocol Violation|0|||
37856099|NCT01217073|69539331|FG002|Extension Period|Protocol Violation|0|||
37856100|NCT01217073|69539332|FG003|Extension Period|Protocol Violation|0|||
37856101|NCT01217073|69539333|FG004|Extension Period|Protocol Violation|0|||
37659140|NCT01678209|69131331|FG001|Overall Study|scheduling conflicts|0|||
37748663|NCT01701362|69239239|FG000|Overall Study|No longer willing to participate|8|||
37748664|NCT01701362|69239240|FG001|Overall Study|No longer willing to participate|14|||
37748665|NCT01701362|69239239|FG000|Overall Study|Lost to Follow-up|6|||
37748666|NCT01701362|69239240|FG001|Overall Study|Lost to Follow-up|9|||
37748667|NCT01701362|69239239|FG000|Overall Study|Insufficient clinical response|6|||
37748668|NCT01701362|69239240|FG001|Overall Study|Insufficient clinical response|6|||
37748669|NCT01701362|69239239|FG000|Overall Study|Death|0|||
37748670|NCT01701362|69239240|FG001|Overall Study|Death|1|||
37748671|NCT01701362|69239239|FG000|Overall Study|Randomized but not treated|1|||
37748672|NCT01701362|69239240|FG001|Overall Study|Randomized but not treated|2|||
37748673|NCT01701362|69239239|FG000|Overall Study|Reasons other than those mentioned above|3|||
37748674|NCT01701362|69239240|FG001|Overall Study|Reasons other than those mentioned above|5|||
37748675|NCT01710800|69239269|FG000|Overall Study|Withdrawal by Subject|21|||
37748676|NCT01710800|69239269|FG000|Overall Study|Protocol Violation|1|||
37748677|NCT01710020|69239275|FG000|Period 1|Protocol Violation|1|||
37748678|NCT01700348|69239281|FG000|Overall Study|Withdrawal by Subject|22|||
37748679|NCT01700348|69239281|FG000|Overall Study|Lost to Follow-up|1|||
37748680|NCT01700192|69239289|FG000|Overall Study|Adverse Event|73|||
37748681|NCT01700192|69239290|FG001|Overall Study|Adverse Event|18|||
37748682|NCT01700192|69239289|FG000|Overall Study|Lack of Efficacy|1|||
37748683|NCT01700192|69239290|FG001|Overall Study|Lack of Efficacy|0|||
37748684|NCT01700192|69239289|FG000|Overall Study|Lost to Follow-up|42|||
37748685|NCT01700192|69239290|FG001|Overall Study|Lost to Follow-up|29|||
37748686|NCT01700192|69239289|FG000|Overall Study|Noncompliance with study drug|0|||
37856102|NCT01217073|69539334|FG005|Extension Period|Protocol Violation|0|||
37856103|NCT01217073|69539335|FG006|Extension Period|Protocol Violation|2|||
37856104|NCT01217073|69539336|FG007|Extension Period|Protocol Violation|1|||
37856105|NCT01217073|69539329|FG000|Extension Period|Site discontinued study participation|0|||
37856106|NCT01217073|69539330|FG001|Extension Period|Site discontinued study participation|0|||
37856107|NCT01217073|69539331|FG002|Extension Period|Site discontinued study participation|0|||
37856108|NCT01217073|69539332|FG003|Extension Period|Site discontinued study participation|0|||
37856109|NCT01217073|69539333|FG004|Extension Period|Site discontinued study participation|0|||
37856110|NCT01217073|69539334|FG005|Extension Period|Site discontinued study participation|0|||
37748687|NCT01700192|69239290|FG001|Overall Study|Noncompliance with study drug|5|||
37659141|NCT01678209|69131332|FG002|Overall Study|scheduling conflicts|1|||
37659142|NCT01678209|69131330|FG000|Overall Study|screen fail|16|||
37659143|NCT01678209|69131331|FG001|Overall Study|screen fail|17|||
37659144|NCT01678209|69131332|FG002|Overall Study|screen fail|16|||
37659145|NCT02239120|69131342|FG000|Overall Study|Death|56|||
37659146|NCT02239120|69131343|FG001|Overall Study|Death|58|||
37659147|NCT02239120|69131342|FG000|Overall Study|Lost to Follow-up|19|||
37659148|NCT02239120|69131343|FG001|Overall Study|Lost to Follow-up|14|||
37659149|NCT01603407|69131352|FG000|Overall Study|Adverse Event|1|||
37659150|NCT01603407|69131353|FG001|Overall Study|Adverse Event|1|||
37659151|NCT01603407|69131354|FG002|Overall Study|Adverse Event|1|||
37659152|NCT01603407|69131352|FG000|Overall Study|Protocol Violation|2|||
37659153|NCT01603407|69131353|FG001|Overall Study|Protocol Violation|2|||
37659154|NCT01603407|69131354|FG002|Overall Study|Protocol Violation|0|||
37659155|NCT01603407|69131352|FG000|Overall Study|Withdrawal by Subject|8|||
37659156|NCT01603407|69131353|FG001|Overall Study|Withdrawal by Subject|5|||
37659157|NCT01603407|69131354|FG002|Overall Study|Withdrawal by Subject|7|||
37659158|NCT01603407|69131352|FG000|Overall Study|Lost to Follow-up|0|||
37659159|NCT01603407|69131353|FG001|Overall Study|Lost to Follow-up|3|||
37659160|NCT01603407|69131354|FG002|Overall Study|Lost to Follow-up|2|||
37659161|NCT02235454|69131384|FG000|Overall Study|Withdrawal by Subject|2|||
37659162|NCT02235298|69131390|FG000|Overall Study|Lost to Follow-up|6|||
37659163|NCT02235298|69131391|FG001|Overall Study|Lost to Follow-up|5|||
37659164|NCT02235298|69131390|FG000|Overall Study|Adverse Event|2|||
37659165|NCT02235298|69131391|FG001|Overall Study|Adverse Event|2|||
37659166|NCT02235298|69131390|FG000|Overall Study|Withdrawal by Subject|0|||
37659167|NCT02235298|69131391|FG001|Overall Study|Withdrawal by Subject|1|||
37659168|NCT02234596|69131397|FG000|Overall Study|Participant not treated|2|||
37659169|NCT02234362|69131401|FG000|Overall Study|Not eligible after first screening visit|17|||
37659170|NCT02234362|69131401|FG000|Overall Study|Lost to Follow-up|6|||
37659171|NCT02234362|69131401|FG000|Overall Study|Withdrawal by Subject|3|||
37659172|NCT02234284|69131407|FG000|Overall Study|Death|4|||
37659173|NCT02234284|69131408|FG001|Overall Study|Death|2|||
37659174|NCT02234284|69131407|FG000|Overall Study|Withdrawal by Subject|1|||
37659175|NCT02234284|69131408|FG001|Overall Study|Withdrawal by Subject|0|||
37659176|NCT02234284|69131407|FG000|Overall Study|Lost to Follow-up|20|||
37659177|NCT02234284|69131408|FG001|Overall Study|Lost to Follow-up|7|||
37659178|NCT02232880|69131418|FG000|Overall Study|study stopped prior to randomization|1|||
37659179|NCT02896855|69131424|FG000|Overall Study|Death|50|||
37659180|NCT02896855|69131425|FG001|Overall Study|Death|40|||
37659181|NCT02896855|69131424|FG000|Overall Study|Lost to Follow-up|15|||
37659182|NCT02896855|69131425|FG001|Overall Study|Lost to Follow-up|9|||
37659183|NCT02896855|69131424|FG000|Overall Study|Withdrawal by Subject|7|||
37659184|NCT02896855|69131425|FG001|Overall Study|Withdrawal by Subject|4|||
37659185|NCT02232802|69131436|FG000|Period 1|Sponsor request|1|||
37659186|NCT02232802|69131437|FG001|Period 1|Sponsor request|0|||
37659187|NCT02232802|69131436|FG000|Period 1|Adverse Event|1|||
37659188|NCT02232802|69131437|FG001|Period 1|Adverse Event|1|||
37659189|NCT02434328|69131445|FG000|Overall Study|Adverse Event|9|||
37659190|NCT02434328|69131446|FG001|Overall Study|Adverse Event|4|||
37659191|NCT02434328|69131445|FG000|Overall Study|Lack of Efficacy|0|||
37659192|NCT02434328|69131446|FG001|Overall Study|Lack of Efficacy|2|||
37659193|NCT02434328|69131445|FG000|Overall Study|Physician Decision|0|||
37659194|NCT02434328|69131446|FG001|Overall Study|Physician Decision|1|||
37659195|NCT02434328|69131445|FG000|Overall Study|Withdrawal by Subject|12|||
37748688|NCT01700192|69239289|FG000|Overall Study|Physician Decision|2|||
37748689|NCT01700192|69239290|FG001|Overall Study|Physician Decision|3|||
37748690|NCT01700192|69239289|FG000|Overall Study|Pregnancy|1|||
37748691|NCT01700192|69239290|FG001|Overall Study|Pregnancy|4|||
37748692|NCT01700192|69239289|FG000|Overall Study|Progressive disease|1|||
37748693|NCT01700192|69239290|FG001|Overall Study|Progressive disease|0|||
37748694|NCT01700192|69239289|FG000|Overall Study|Protocol Violation|3|||
37748695|NCT01700192|69239290|FG001|Overall Study|Protocol Violation|4|||
37748696|NCT01700192|69239289|FG000|Overall Study|Technical problems|0|||
37748697|NCT01700192|69239290|FG001|Overall Study|Technical problems|1|||
37856111|NCT01217073|69539335|FG006|Extension Period|Site discontinued study participation|7|||
37856112|NCT01217073|69539336|FG007|Extension Period|Site discontinued study participation|2|||
38033028|NCT02820298|69719031|FG000|Overall Study|Withdrawal by Subject|0|||
37659196|NCT02434328|69131446|FG001|Overall Study|Withdrawal by Subject|21|||
37659197|NCT02434328|69131445|FG000|Overall Study|Death|4|||
37659198|NCT02434328|69131446|FG001|Overall Study|Death|7|||
37659199|NCT02434328|69131445|FG000|Overall Study|Lost to Follow-up|1|||
37659200|NCT02434328|69131446|FG001|Overall Study|Lost to Follow-up|6|||
37659201|NCT02434328|69131445|FG000|Overall Study|Other|4|||
37659202|NCT02434328|69131446|FG001|Overall Study|Other|1|||
37659203|NCT02660229|69131455|FG000|Overall Study|Adverse Event|2|||
37659204|NCT02660229|69131456|FG001|Overall Study|Adverse Event|0|||
37659205|NCT02660229|69131455|FG000|Overall Study|Withdrawal by Subject|0|||
37748698|NCT01700192|69239289|FG000|Overall Study|Withdrawal by Subject|56|||
37748699|NCT01700192|69239290|FG001|Overall Study|Withdrawal by Subject|64|||
37748700|NCT01700192|69239289|FG000|Overall Study|Never received study drug|1|||
37748701|NCT01700192|69239290|FG001|Overall Study|Never received study drug|0|||
37748702|NCT01709864|69239307|FG000|Overall Study|Physician Decision|0|||
37748703|NCT01709864|69239308|FG001|Overall Study|Physician Decision|1|||
37748704|NCT01709864|69239307|FG000|Overall Study|subject/guardian decision|5|||
37748705|NCT01709864|69239308|FG001|Overall Study|subject/guardian decision|6|||
37748706|NCT01709864|69239307|FG000|Overall Study|Lost to Follow-up|1|||
37748707|NCT01709864|69239308|FG001|Overall Study|Lost to Follow-up|0|||
37748708|NCT01709864|69239307|FG000|Overall Study|non-compliance with study treatment|1|||
37748709|NCT01709864|69239308|FG001|Overall Study|non-compliance with study treatment|1|||
37748710|NCT01709864|69239307|FG000|Overall Study|Adverse Event|0|||
37748711|NCT01709864|69239308|FG001|Overall Study|Adverse Event|2|||
37748712|NCT01709864|69239307|FG000|Overall Study|Death|0|||
37748713|NCT01709864|69239308|FG001|Overall Study|Death|1|||
37748714|NCT01709708|69239316|FG000|Overall Study|Protocol Violation|1|||
37748715|NCT01709708|69239317|FG001|Overall Study|Protocol Violation|2|||
37748716|NCT01709318|69239340|FG000|Overall Study|Adverse Event|3|||
37748717|NCT01709318|69239341|FG001|Overall Study|Adverse Event|4|||
37748718|NCT01709318|69239342|FG002|Overall Study|Adverse Event|2|||
37748719|NCT01709318|69239343|FG003|Overall Study|Adverse Event|2|||
37748720|NCT01709318|69239344|FG004|Overall Study|Adverse Event|0|||
37748721|NCT01709318|69239345|FG005|Overall Study|Adverse Event|1|||
37748722|NCT01709318|69239346|FG006|Overall Study|Adverse Event|2|||
37748723|NCT01709318|69239340|FG000|Overall Study|Lost to Follow-up|2|||
37748724|NCT01709318|69239341|FG001|Overall Study|Lost to Follow-up|0|||
37748725|NCT01709318|69239342|FG002|Overall Study|Lost to Follow-up|0|||
37748726|NCT01709318|69239343|FG003|Overall Study|Lost to Follow-up|0|||
37748727|NCT01709318|69239344|FG004|Overall Study|Lost to Follow-up|1|||
37748728|NCT01709318|69239345|FG005|Overall Study|Lost to Follow-up|1|||
37748729|NCT01709318|69239346|FG006|Overall Study|Lost to Follow-up|1|||
37748730|NCT01709318|69239340|FG000|Overall Study|Non-compliance with Study Drug|0|||
37748731|NCT01709318|69239341|FG001|Overall Study|Non-compliance with Study Drug|2|||
37748732|NCT01709318|69239342|FG002|Overall Study|Non-compliance with Study Drug|1|||
37748733|NCT01709318|69239343|FG003|Overall Study|Non-compliance with Study Drug|1|||
37748734|NCT01709318|69239344|FG004|Overall Study|Non-compliance with Study Drug|0|||
37748735|NCT01709318|69239345|FG005|Overall Study|Non-compliance with Study Drug|0|||
37748736|NCT01709318|69239346|FG006|Overall Study|Non-compliance with Study Drug|2|||
37748737|NCT01709318|69239340|FG000|Overall Study|Physician Decision|0|||
37748738|NCT01709318|69239341|FG001|Overall Study|Physician Decision|0|||
37748739|NCT01709318|69239342|FG002|Overall Study|Physician Decision|0|||
37748740|NCT01709318|69239343|FG003|Overall Study|Physician Decision|0|||
37748741|NCT01709318|69239344|FG004|Overall Study|Physician Decision|0|||
37748742|NCT01709318|69239345|FG005|Overall Study|Physician Decision|0|||
37748743|NCT01709318|69239346|FG006|Overall Study|Physician Decision|1|||
37748744|NCT01709318|69239340|FG000|Overall Study|Pregnancy|0|||
37748745|NCT01709318|69239341|FG001|Overall Study|Pregnancy|0|||
37748746|NCT01709318|69239342|FG002|Overall Study|Pregnancy|0|||
37748747|NCT01709318|69239343|FG003|Overall Study|Pregnancy|0|||
37748748|NCT01709318|69239344|FG004|Overall Study|Pregnancy|1|||
37748749|NCT01709318|69239345|FG005|Overall Study|Pregnancy|0|||
37748750|NCT01709318|69239346|FG006|Overall Study|Pregnancy|0|||
37748751|NCT01709318|69239340|FG000|Overall Study|Protocol Violation|0|||
37748752|NCT01709318|69239341|FG001|Overall Study|Protocol Violation|0|||
37748753|NCT01709318|69239342|FG002|Overall Study|Protocol Violation|0|||
37748754|NCT01709318|69239343|FG003|Overall Study|Protocol Violation|0|||
37748755|NCT01709318|69239344|FG004|Overall Study|Protocol Violation|2|||
37748756|NCT01709318|69239345|FG005|Overall Study|Protocol Violation|0|||
37748757|NCT01709318|69239346|FG006|Overall Study|Protocol Violation|1|||
37748758|NCT01709318|69239340|FG000|Overall Study|Technical Problems|1|||
37748759|NCT01709318|69239341|FG001|Overall Study|Technical Problems|0|||
37748760|NCT01709318|69239342|FG002|Overall Study|Technical Problems|0|||
38033029|NCT02820298|69719032|FG001|Overall Study|Withdrawal by Subject|1|||
38033030|NCT02820298|69719031|FG000|Overall Study|Physician Decision|1|||
38033031|NCT02820298|69719032|FG001|Overall Study|Physician Decision|0|||
37748761|NCT01709318|69239343|FG003|Overall Study|Technical Problems|0|||
37748762|NCT01709318|69239344|FG004|Overall Study|Technical Problems|0|||
37748763|NCT01709318|69239345|FG005|Overall Study|Technical Problems|0|||
37748764|NCT01709318|69239346|FG006|Overall Study|Technical Problems|0|||
37748765|NCT01709318|69239340|FG000|Overall Study|Withdrawal by Subject|3|||
37748766|NCT01709318|69239341|FG001|Overall Study|Withdrawal by Subject|0|||
37748767|NCT01709318|69239342|FG002|Overall Study|Withdrawal by Subject|3|||
37748768|NCT01709318|69239343|FG003|Overall Study|Withdrawal by Subject|3|||
37748769|NCT01709318|69239344|FG004|Overall Study|Withdrawal by Subject|0|||
37748770|NCT01709318|69239345|FG005|Overall Study|Withdrawal by Subject|2|||
37748771|NCT01709318|69239346|FG006|Overall Study|Withdrawal by Subject|4|||
37748772|NCT01709318|69239340|FG000|Overall Study|Other Protocol Specified Criteria|0|||
37748773|NCT01709318|69239341|FG001|Overall Study|Other Protocol Specified Criteria|1|||
37748774|NCT01709318|69239342|FG002|Overall Study|Other Protocol Specified Criteria|0|||
37748775|NCT01709318|69239343|FG003|Overall Study|Other Protocol Specified Criteria|0|||
37748776|NCT01709318|69239344|FG004|Overall Study|Other Protocol Specified Criteria|0|||
37748777|NCT01709318|69239345|FG005|Overall Study|Other Protocol Specified Criteria|0|||
37748778|NCT01709318|69239346|FG006|Overall Study|Other Protocol Specified Criteria|0|||
37748779|NCT01699178|69239364|FG000|Overall Study|Adverse Event|1|||
37748780|NCT01699178|69239365|FG001|Overall Study|Adverse Event|5|||
37748781|NCT01699178|69239364|FG000|Overall Study|Lost to Follow-up|1|||
37659206|NCT02660229|69131456|FG001|Overall Study|Withdrawal by Subject|1|||
37659207|NCT02232178|69131465|FG000|Overall Study|Lost to Follow-up|0|||
37659208|NCT02232178|69131466|FG001|Overall Study|Lost to Follow-up|1|||
37659209|NCT02232178|69131467|FG002|Overall Study|Lost to Follow-up|0|||
37748782|NCT01699178|69239365|FG001|Overall Study|Lost to Follow-up|6|||
37748783|NCT01699178|69239364|FG000|Overall Study|Non-compliance with Study Drug|3|||
37748784|NCT01699178|69239365|FG001|Overall Study|Non-compliance with Study Drug|1|||
37748785|NCT01699178|69239364|FG000|Overall Study|Physician Decision|1|||
37748786|NCT01699178|69239365|FG001|Overall Study|Physician Decision|0|||
37748787|NCT01699178|69239364|FG000|Overall Study|Withdrawal by Subject|4|||
37748788|NCT01699178|69239365|FG001|Overall Study|Withdrawal by Subject|12|||
37748789|NCT01699178|69239364|FG000|Overall Study|Hematocrit >54%|1|||
37748790|NCT01699178|69239365|FG001|Overall Study|Hematocrit >54%|1|||
37748791|NCT01699178|69239364|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
37748792|NCT01699178|69239365|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
37748793|NCT01699178|69239364|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
37748794|NCT01699178|69239365|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
37748795|NCT01683409|69239376|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
37748796|NCT01683409|69239377|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
37748797|NCT01683409|69239378|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
37748798|NCT01683409|69239379|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
37748799|NCT01683409|69239380|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
37748800|NCT01683409|69239376|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
37748801|NCT01683409|69239377|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
37659210|NCT02232178|69131465|FG000|Overall Study|ineligibility|0|||
37748802|NCT01683409|69239378|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
37748803|NCT01683409|69239379|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
37748804|NCT01683409|69239380|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
37748805|NCT01683409|69239376|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
37748806|NCT01683409|69239377|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
37748807|NCT01683409|69239378|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
37748808|NCT01683409|69239379|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
37748809|NCT01683409|69239380|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
37748810|NCT01683409|69239376|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
37659211|NCT02232178|69131466|FG001|Overall Study|ineligibility|0|||
37659212|NCT02232178|69131467|FG002|Overall Study|ineligibility|1|||
37659213|NCT02232178|69131465|FG000|Overall Study|surgical complication|1|||
37659214|NCT02232178|69131466|FG001|Overall Study|surgical complication|0|||
37659215|NCT02232178|69131467|FG002|Overall Study|surgical complication|0|||
37659216|NCT01678131|69131478|FG000|Overall Study|Adverse Event|0|||
37659217|NCT01678131|69131479|FG001|Overall Study|Adverse Event|1|||
37659218|NCT01678131|69131480|FG002|Overall Study|Adverse Event|0|||
37659219|NCT01678131|69131478|FG000|Overall Study|Withdrawal by Subject|0|||
37659220|NCT01678131|69131479|FG001|Overall Study|Withdrawal by Subject|0|||
37659221|NCT01678131|69131480|FG002|Overall Study|Withdrawal by Subject|2|||
37659222|NCT02231164|69131490|FG000|Overall Study|Adverse Event|1|||
37659223|NCT02231164|69131491|FG001|Overall Study|Adverse Event|1|||
37748811|NCT01683409|69239377|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
37748812|NCT01683409|69239378|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
37748813|NCT01683409|69239379|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
37748814|NCT01683409|69239380|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
37748815|NCT01683409|69239376|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
37748816|NCT01683409|69239377|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
37748817|NCT01683409|69239378|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
37659224|NCT02231164|69131490|FG000|Overall Study|Lack of Efficacy|4|||
37659225|NCT02231164|69131491|FG001|Overall Study|Lack of Efficacy|3|||
37748818|NCT01683409|69239379|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
37659226|NCT02231164|69131490|FG000|Overall Study|Withdrawal by Subject|1|||
37659227|NCT02231164|69131491|FG001|Overall Study|Withdrawal by Subject|2|||
37659228|NCT02457182|69131499|FG000|Overall Study|Lost to Follow-up|1|||
37659229|NCT02457182|69131500|FG001|Overall Study|Lost to Follow-up|0|||
37748819|NCT01683409|69239380|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
37659230|NCT02230384|69131508|FG000|Phase 1|Lost to Follow-up|1|||
37659231|NCT02230384|69131509|FG001|Phase 1|Lost to Follow-up|0|||
37659232|NCT02230384|69131508|FG000|Phase 1|Physician Decision|0|||
37748820|NCT01683409|69239376|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
37748821|NCT01683409|69239377|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
37748822|NCT01683409|69239378|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
37659233|NCT02230384|69131509|FG001|Phase 1|Physician Decision|1|||
37659234|NCT02230384|69131508|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
37659235|NCT02230384|69131509|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
37659236|NCT02230384|69131508|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
37659237|NCT02230384|69131509|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
37659238|NCT02230384|69131508|FG000|Phase 2 - Switch|Adverse Event|2|||
37659239|NCT02230384|69131509|FG001|Phase 2 - Switch|Adverse Event|0|||
37659240|NCT02738801|69131525|FG000|Overall Study|Adverse Event|1|||
37659241|NCT02738801|69131526|FG001|Overall Study|Adverse Event|1|||
37659242|NCT02738801|69131525|FG000|Overall Study|Withdrawal by Subject|0|||
37659243|NCT02738801|69131526|FG001|Overall Study|Withdrawal by Subject|1|||
37659244|NCT02230306|69131542|FG000|Overall Study|Did not receive study treatment|1|||
37748823|NCT01683409|69239379|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
37748824|NCT01683409|69239380|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
37748825|NCT01683409|69239376|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
37748826|NCT01683409|69239377|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
37748827|NCT01683409|69239378|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
37748828|NCT01683409|69239379|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
37748829|NCT01683409|69239380|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
37748830|NCT01683409|69239376|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
37748831|NCT01683409|69239377|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
37748832|NCT01683409|69239378|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
37748833|NCT01683409|69239379|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
37748834|NCT01683409|69239380|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
37748835|NCT01683409|69239376|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
37748836|NCT01683409|69239377|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
37748837|NCT01683409|69239378|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
37748838|NCT01683409|69239379|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
37748839|NCT01683409|69239380|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
37748840|NCT01683409|69239376|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
37748841|NCT01683409|69239377|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
37748842|NCT01683409|69239378|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
37748843|NCT01683409|69239379|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
37748844|NCT01683409|69239380|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
37748845|NCT01683409|69239376|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
37748846|NCT01683409|69239377|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
37748847|NCT01683409|69239378|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
37748848|NCT01683409|69239379|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
37748849|NCT01683409|69239380|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
37748850|NCT01699022|69239406|FG000|Overall Study|Early discontinuation from the study|3|||
37748851|NCT01683019|69239414|FG000|Overall Study|Withdrawal by Subject|2|||
37748852|NCT01683019|69239415|FG001|Overall Study|Withdrawal by Subject|1|||
37748853|NCT01683019|69239416|FG002|Overall Study|Withdrawal by Subject|4|||
37748854|NCT01709162|69239426|FG000|Overall Study|Disease progression|3|||
37748855|NCT01709162|69239427|FG001|Overall Study|Disease progression|3|||
37748856|NCT01709162|69239426|FG000|Overall Study|Study drug toxicity|2|||
37748857|NCT01709162|69239427|FG001|Overall Study|Study drug toxicity|0|||
37748858|NCT01709162|69239426|FG000|Overall Study|Administrative reason by sponsor|0|||
37748859|NCT01709162|69239427|FG001|Overall Study|Administrative reason by sponsor|1|||
37748860|NCT01709162|69239426|FG000|Overall Study|Other|1|||
37856113|NCT01217073|69539329|FG000|Extension Period|Withdrawal by Subject|0|||
37856114|NCT01217073|69539330|FG001|Extension Period|Withdrawal by Subject|0|||
38033032|NCT02820298|69719031|FG000|Overall Study|Protocol Violation|0|||
38033033|NCT02820298|69719032|FG001|Overall Study|Protocol Violation|1|||
38033034|NCT02819440|69719046|FG000|Overall Study|Adverse Event|3|||
38033035|NCT02819440|69719047|FG001|Overall Study|Adverse Event|1|||
38033036|NCT02819440|69719046|FG000|Overall Study|Lost to Follow-up|1|||
38033037|NCT02819440|69719047|FG001|Overall Study|Lost to Follow-up|3|||
38033038|NCT02819440|69719046|FG000|Overall Study|Withdrawal by Subject|9|||
37659245|NCT01680861|69131548|FG000|Early Post-transplant Period|Protocol Violation|1|||
37659246|NCT01680861|69131549|FG001|Early Post-transplant Period|Protocol Violation|1|||
37659247|NCT02229214|69131559|FG000|Overall Study|Adverse Event|2|||
38033039|NCT02819440|69719047|FG001|Overall Study|Withdrawal by Subject|8|||
37659248|NCT02229214|69131560|FG001|Overall Study|Adverse Event|0|||
37659249|NCT02229214|69131559|FG000|Overall Study|Withdrawal by Subject|4|||
37659250|NCT02229214|69131560|FG001|Overall Study|Withdrawal by Subject|0|||
37659251|NCT02228980|69131572|FG000|Overall Study|Adverse Event|14|||
37659252|NCT02228980|69131573|FG001|Overall Study|Adverse Event|0|||
37659253|NCT02228980|69131574|FG002|Overall Study|Adverse Event|0|||
37659254|NCT02228980|69131575|FG003|Overall Study|Adverse Event|0|||
37748861|NCT01709162|69239427|FG001|Overall Study|Other|0|||
37748862|NCT01709162|69239426|FG000|Overall Study|Withdrawal by Subject|0|||
37748863|NCT01709162|69239427|FG001|Overall Study|Withdrawal by Subject|1|||
37748864|NCT01698554|69239437|FG000|Overall Study|Adverse Event|2|||
38033040|NCT03814720|69719058|FG000|Overall Study|Lost to Follow-up|0|||
38033041|NCT03814720|69719059|FG001|Overall Study|Lost to Follow-up|1|||
38033042|NCT03814720|69719060|FG002|Overall Study|Lost to Follow-up|0|||
38033043|NCT03814720|69719061|FG003|Overall Study|Lost to Follow-up|0|||
37659255|NCT02228980|69131572|FG000|Overall Study|Protocol Violation|7|||
37748865|NCT01698554|69239438|FG001|Overall Study|Adverse Event|5|||
37659256|NCT02228980|69131573|FG001|Overall Study|Protocol Violation|0|||
37659257|NCT02228980|69131574|FG002|Overall Study|Protocol Violation|0|||
37659258|NCT02228980|69131575|FG003|Overall Study|Protocol Violation|0|||
37659259|NCT02228980|69131572|FG000|Overall Study|Withdrawal by Subject|3|||
37659260|NCT02228980|69131573|FG001|Overall Study|Withdrawal by Subject|3|||
37659261|NCT02228980|69131574|FG002|Overall Study|Withdrawal by Subject|2|||
37659262|NCT02228980|69131575|FG003|Overall Study|Withdrawal by Subject|3|||
37659263|NCT02228590|69131589|FG000|Overall Study|Withdrawal by Subject|1|||
37659264|NCT02227108|69131594|FG000|Overall Study|Did not receive treatment|2|||
37659265|NCT02227108|69131594|FG000|Overall Study|Other|3|||
37659266|NCT02227108|69131594|FG000|Overall Study|Progressive disease|17|||
37659267|NCT02227108|69131594|FG000|Overall Study|Initiation of alternative therapy|2|||
37659268|NCT02227108|69131594|FG000|Overall Study|Investigator discretion|1|||
37659269|NCT02227108|69131594|FG000|Overall Study|Adverse Event|6|||
37659270|NCT03564145|69131598|FG000|Overall Study|Adverse Event|4|||
37659271|NCT03564145|69131598|FG000|Overall Study|Lost to Follow-up|21|||
37659272|NCT03564145|69131598|FG000|Overall Study|Protocol Violation|2|||
37659273|NCT03564145|69131598|FG000|Overall Study|Withdrawal by Subject|48|||
37748866|NCT01698554|69239439|FG002|Overall Study|Adverse Event|0|||
37748867|NCT01698554|69239440|FG003|Overall Study|Adverse Event|1|||
37748868|NCT01698554|69239437|FG000|Overall Study|Lost to Follow-up|1|||
37748869|NCT01698554|69239438|FG001|Overall Study|Lost to Follow-up|0|||
37748870|NCT01698554|69239439|FG002|Overall Study|Lost to Follow-up|0|||
37748871|NCT01698554|69239440|FG003|Overall Study|Lost to Follow-up|0|||
37748872|NCT01698554|69239437|FG000|Overall Study|Personal Reasons|0|||
37748873|NCT01698554|69239438|FG001|Overall Study|Personal Reasons|5|||
37748874|NCT01698554|69239439|FG002|Overall Study|Personal Reasons|1|||
37748875|NCT01698554|69239440|FG003|Overall Study|Personal Reasons|1|||
37748876|NCT01698554|69239437|FG000|Overall Study|Protocol Violation|2|||
37748877|NCT01698554|69239438|FG001|Overall Study|Protocol Violation|0|||
37748878|NCT01698554|69239439|FG002|Overall Study|Protocol Violation|1|||
37748879|NCT01698554|69239440|FG003|Overall Study|Protocol Violation|0|||
37748880|NCT01698554|69239437|FG000|Overall Study|Other Miscellaneous Reasons|1|||
37748881|NCT01698554|69239438|FG001|Overall Study|Other Miscellaneous Reasons|0|||
37748882|NCT01698554|69239439|FG002|Overall Study|Other Miscellaneous Reasons|0|||
37748883|NCT01698554|69239440|FG003|Overall Study|Other Miscellaneous Reasons|0|||
37748884|NCT01698320|69239452|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
37748885|NCT01698320|69239453|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
37748886|NCT01698320|69239454|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
37748887|NCT01698320|69239452|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
37748888|NCT01698320|69239453|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
37748889|NCT01698320|69239454|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
37748890|NCT01698320|69239452|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
37748891|NCT01698320|69239453|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
37748892|NCT01698320|69239454|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
37748893|NCT01698320|69239452|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
37748894|NCT01698320|69239453|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
37748895|NCT01698320|69239454|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
37748896|NCT01698320|69239452|FG000|12-Week Double-Blind Period|Adverse Event|0|||
37748897|NCT01698320|69239453|FG001|12-Week Double-Blind Period|Adverse Event|1|||
37748898|NCT01698320|69239454|FG002|12-Week Double-Blind Period|Adverse Event|1|||
37748899|NCT01698320|69239452|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
37748900|NCT01698320|69239453|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
37748901|NCT01698320|69239454|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
37748902|NCT01698320|69239452|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
37748903|NCT01698320|69239453|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
37923065|NCT00807846|69609844|FG000|Overall Study|Lack of Efficacy|2|||
37659274|NCT03564145|69131598|FG000|Overall Study|Study Terminated by Sponsor|146|||
37659275|NCT03564145|69131598|FG000|Overall Study|Physician Decision|1|||
37659276|NCT03564145|69131598|FG000|Overall Study|Other Than Specified|1|||
37659277|NCT03564145|69131598|FG000|Overall Study|Pregnancy|1|||
37659278|NCT02226562|69131604|FG000|Overall Study|Lost to Follow-up|0|||
37659279|NCT02226562|69131605|FG001|Overall Study|Lost to Follow-up|1|||
37659280|NCT02456636|69131639|FG000|Overall Study|Death|0|||
37659281|NCT02456636|69131640|FG001|Overall Study|Death|3|||
37748904|NCT01698320|69239454|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
37748905|NCT01698320|69239452|FG000|12-Week Double-Blind Period|Pregnancy|0|||
37748906|NCT01698320|69239453|FG001|12-Week Double-Blind Period|Pregnancy|1|||
37748907|NCT01698320|69239454|FG002|12-Week Double-Blind Period|Pregnancy|1|||
37748908|NCT01698320|69239452|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
37659282|NCT02456636|69131641|FG002|Overall Study|Death|0|||
37659283|NCT02456636|69131639|FG000|Overall Study|Pregnancy|1|||
37748909|NCT01698320|69239453|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
37748910|NCT01698320|69239454|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
37748911|NCT01698320|69239452|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
37748912|NCT01698320|69239453|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
37748913|NCT01698320|69239454|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
37748914|NCT01698320|69239452|FG000|40-Week Open-Label Period|Adverse Event|0|||
37748915|NCT01698320|69239453|FG001|40-Week Open-Label Period|Adverse Event|3|||
37748916|NCT01698320|69239454|FG002|40-Week Open-Label Period|Adverse Event|2|||
37748917|NCT01698320|69239452|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
37856115|NCT01217073|69539331|FG002|Extension Period|Withdrawal by Subject|0|||
37856116|NCT01217073|69539332|FG003|Extension Period|Withdrawal by Subject|0|||
37856117|NCT01217073|69539333|FG004|Extension Period|Withdrawal by Subject|0|||
37856118|NCT01217073|69539334|FG005|Extension Period|Withdrawal by Subject|0|||
37856119|NCT01217073|69539335|FG006|Extension Period|Withdrawal by Subject|30|||
37856120|NCT01217073|69539336|FG007|Extension Period|Withdrawal by Subject|8|||
37856121|NCT00985621|69539364|FG000|Overall Study|Adverse Event|2|||
37856122|NCT00985621|69539365|FG001|Overall Study|Adverse Event|3|||
37856123|NCT00985621|69539366|FG002|Overall Study|Adverse Event|4|||
37856124|NCT00985621|69539367|FG003|Overall Study|Adverse Event|16|||
37856125|NCT00985621|69539364|FG000|Overall Study|Lack of Efficacy|10|||
37856126|NCT00985621|69539365|FG001|Overall Study|Lack of Efficacy|6|||
37856127|NCT00985621|69539366|FG002|Overall Study|Lack of Efficacy|5|||
37856128|NCT00985621|69539367|FG003|Overall Study|Lack of Efficacy|12|||
37856129|NCT00985621|69539364|FG000|Overall Study|Lost to Follow-up|2|||
37856130|NCT00985621|69539365|FG001|Overall Study|Lost to Follow-up|3|||
37856131|NCT00985621|69539366|FG002|Overall Study|Lost to Follow-up|4|||
37856132|NCT00985621|69539367|FG003|Overall Study|Lost to Follow-up|4|||
37856133|NCT00985621|69539364|FG000|Overall Study|Study Terminated by Sponsor|89|||
37659284|NCT02456636|69131640|FG001|Overall Study|Pregnancy|3|||
37659285|NCT02456636|69131641|FG002|Overall Study|Pregnancy|5|||
37659286|NCT02456636|69131639|FG000|Overall Study|Physician Decision|4|||
37659287|NCT02456636|69131640|FG001|Overall Study|Physician Decision|5|||
37856134|NCT00985621|69539365|FG001|Overall Study|Study Terminated by Sponsor|108|||
37856135|NCT00985621|69539366|FG002|Overall Study|Study Terminated by Sponsor|99|||
37856136|NCT00985621|69539367|FG003|Overall Study|Study Terminated by Sponsor|92|||
37856137|NCT00985621|69539364|FG000|Overall Study|Protocol Violation|1|||
37856138|NCT00985621|69539365|FG001|Overall Study|Protocol Violation|1|||
37856139|NCT00985621|69539366|FG002|Overall Study|Protocol Violation|1|||
37856140|NCT00985621|69539367|FG003|Overall Study|Protocol Violation|0|||
37856141|NCT00985621|69539364|FG000|Overall Study|Withdrawal by Subject|8|||
38033044|NCT03814720|69719062|FG004|Overall Study|Lost to Follow-up|0|||
38033045|NCT02818036|69719078|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
37659288|NCT02456636|69131641|FG002|Overall Study|Physician Decision|4|||
37659289|NCT02456636|69131639|FG000|Overall Study|Withdrawal by Subject|13|||
37659290|NCT02456636|69131640|FG001|Overall Study|Withdrawal by Subject|14|||
37659291|NCT02456636|69131641|FG002|Overall Study|Withdrawal by Subject|16|||
37659292|NCT02456636|69131639|FG000|Overall Study|Lost to Follow-up|50|||
37659293|NCT02456636|69131640|FG001|Overall Study|Lost to Follow-up|44|||
37659294|NCT02456636|69131641|FG002|Overall Study|Lost to Follow-up|50|||
37659295|NCT02226172|69131649|FG000|Overall Study|Participant refused further follow-up|4|||
37659296|NCT02226172|69131649|FG000|Overall Study|Other|5|||
37659297|NCT02226172|69131649|FG000|Overall Study|Death|1|||
37659298|NCT02226172|69131649|FG000|Overall Study|Study terminated by sponsor|1|||
37659299|NCT02226172|69131649|FG000|Overall Study|Adverse Event|6|||
37856142|NCT00985621|69539365|FG001|Overall Study|Withdrawal by Subject|10|||
37856143|NCT00985621|69539366|FG002|Overall Study|Withdrawal by Subject|8|||
37856144|NCT00985621|69539367|FG003|Overall Study|Withdrawal by Subject|12|||
37856145|NCT00985621|69539364|FG000|Overall Study|Other|1|||
37856146|NCT00985621|69539365|FG001|Overall Study|Other|0|||
37856147|NCT00985621|69539366|FG002|Overall Study|Other|0|||
37856148|NCT00985621|69539367|FG003|Overall Study|Other|0|||
37856149|NCT00985621|69539364|FG000|Overall Study|Randomized but not Treated|1|||
37856150|NCT00985621|69539365|FG001|Overall Study|Randomized but not Treated|0|||
37856151|NCT00985621|69539366|FG002|Overall Study|Randomized but not Treated|2|||
38033046|NCT02818036|69719079|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
38033047|NCT02818036|69719078|FG000|Overall Study|Withdrawal by Subject|1|||
38033048|NCT02818036|69719079|FG001|Overall Study|Withdrawal by Subject|0|||
37659300|NCT01676961|69131653|FG000|Overall Study|Death|3|||
37659301|NCT01676961|69131653|FG000|Overall Study|Lost to Follow-up|1|||
37659302|NCT01676961|69131653|FG000|Overall Study|Withdrawal by Subject|1|||
37659303|NCT01676727|69131675|FG000|Overall Study|Death|18|||
37659304|NCT01676727|69131675|FG000|Overall Study|Withdrawal by Subject|6|||
37659305|NCT01676727|69131675|FG000|Overall Study|Screening failure|5|||
37659306|NCT01676727|69131675|FG000|Overall Study|Not willing to attend 1-year visit|2|||
37659307|NCT01676727|69131675|FG000|Overall Study|Valve explanted|1|||
37856152|NCT00985621|69539367|FG003|Overall Study|Randomized but not Treated|1|||
37659308|NCT02738879|69131682|FG000|Overall Study|Adverse Event|1|||
37659309|NCT02738879|69131683|FG001|Overall Study|Adverse Event|1|||
37659310|NCT02738879|69131682|FG000|Overall Study|Death|0|||
37659311|NCT02738879|69131683|FG001|Overall Study|Death|2|||
37659312|NCT02738879|69131682|FG000|Overall Study|Lost to Follow-up|1|||
37659313|NCT02738879|69131683|FG001|Overall Study|Lost to Follow-up|5|||
37659314|NCT02738879|69131682|FG000|Overall Study|Protocol Violation|1|||
37748918|NCT01698320|69239453|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
37748919|NCT01698320|69239454|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
37748920|NCT01698320|69239452|FG000|40-Week Open-Label Period|Pregnancy|0|||
37748921|NCT01698320|69239453|FG001|40-Week Open-Label Period|Pregnancy|2|||
37748922|NCT01698320|69239454|FG002|40-Week Open-Label Period|Pregnancy|1|||
37748923|NCT01698320|69239452|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
37748924|NCT01698320|69239453|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
37748925|NCT01698320|69239454|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
37748926|NCT01698320|69239452|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
37748927|NCT01698320|69239453|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
37748928|NCT01698320|69239454|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
37748929|NCT01697696|69239472|FG000|Overall Study|Study terminated by sponsor|0|||
37748930|NCT01697696|69239473|FG001|Overall Study|Study terminated by sponsor|3|||
37856153|NCT01215981|69539381|FG000|Overall Study|Physician Decision|0|||
37856154|NCT01215981|69539382|FG001|Overall Study|Physician Decision|1|||
37856155|NCT01215981|69539381|FG000|Overall Study|Protocol Violation|1|||
37856156|NCT01215981|69539382|FG001|Overall Study|Protocol Violation|0|||
37856157|NCT01215981|69539381|FG000|Overall Study|Withdrawal by Subject|1|||
37856158|NCT01215981|69539382|FG001|Overall Study|Withdrawal by Subject|0|||
37856159|NCT01215513|69539388|FG000|Overall Study|Not completed CS42|9|||
37856160|NCT01215513|69539388|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
37856161|NCT01215513|69539388|FG000|Overall Study|Adverse event (CS42A)|2|||
37856162|NCT01215513|69539388|FG000|Overall Study|Physician decision (CS42A)|6|||
37856163|NCT01215513|69539388|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
37856164|NCT01215513|69539388|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
37856165|NCT01215435|69539395|FG000|Overall Study|Adverse Event|1|||
37856166|NCT01215435|69539396|FG001|Overall Study|Adverse Event|0|||
37856167|NCT01215435|69539395|FG000|Overall Study|Protocol Violation|2|||
37856168|NCT01215435|69539396|FG001|Overall Study|Protocol Violation|0|||
37856169|NCT01215435|69539395|FG000|Overall Study|Withdrawal Criteria|8|||
37856170|NCT01215435|69539396|FG001|Overall Study|Withdrawal Criteria|11|||
37856171|NCT01215435|69539395|FG000|Overall Study|Lost to Follow-up|3|||
37856172|NCT01215435|69539396|FG001|Overall Study|Lost to Follow-up|0|||
37856173|NCT01215435|69539395|FG000|Overall Study|Unclassified|5|||
37856174|NCT01215435|69539396|FG001|Overall Study|Unclassified|5|||
37856175|NCT01215357|69539402|FG000|Overall Study|Withdrawal by Subject|3|||
37856176|NCT01215357|69539402|FG000|Overall Study|Protocol Violation|9|||
37856177|NCT00984295|69539409|FG000|Overall Study|Lost to Follow-up|31|||
37856178|NCT00984295|69539410|FG001|Overall Study|Lost to Follow-up|12|||
37856179|NCT00984295|69539411|FG002|Overall Study|Lost to Follow-up|13|||
37856180|NCT00984295|69539409|FG000|Overall Study|Protocol Violation|2|||
37856181|NCT00984295|69539410|FG001|Overall Study|Protocol Violation|1|||
37856182|NCT00984295|69539411|FG002|Overall Study|Protocol Violation|4|||
37856183|NCT00984295|69539409|FG000|Overall Study|Withdrawal by Subject|18|||
37856184|NCT00984295|69539410|FG001|Overall Study|Withdrawal by Subject|9|||
37856185|NCT00984295|69539411|FG002|Overall Study|Withdrawal by Subject|12|||
37748931|NCT01697696|69239472|FG000|Overall Study|Protocol deviation|1|||
37748932|NCT01697696|69239473|FG001|Overall Study|Protocol deviation|0|||
37856186|NCT00984295|69539409|FG000|Overall Study|CAE - discontinued test vaccine|0|||
37856187|NCT00984295|69539410|FG001|Overall Study|CAE - discontinued test vaccine|1|||
37856188|NCT00984295|69539411|FG002|Overall Study|CAE - discontinued test vaccine|3|||
37856189|NCT00984295|69539409|FG000|Overall Study|Missed one or more blood samplings|3|||
37856190|NCT00984295|69539410|FG001|Overall Study|Missed one or more blood samplings|7|||
37856191|NCT00984295|69539411|FG002|Overall Study|Missed one or more blood samplings|2|||
37856192|NCT00984295|69539409|FG000|Overall Study|Incomplete safety follow-up|11|||
37856193|NCT00984295|69539410|FG001|Overall Study|Incomplete safety follow-up|2|||
37856194|NCT00984295|69539411|FG002|Overall Study|Incomplete safety follow-up|3|||
37856195|NCT01017952|69539423|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
37856196|NCT01017952|69539424|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
37856197|NCT01017952|69539425|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
37748933|NCT01697696|69239472|FG000|Overall Study|Physician Decision|1|||
37856198|NCT01017952|69539426|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
37856199|NCT01017952|69539427|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
37856200|NCT01017952|69539423|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
37923066|NCT00807846|69609845|FG001|Overall Study|Lack of Efficacy|0|||
37659315|NCT02738879|69131683|FG001|Overall Study|Protocol Violation|3|||
37748934|NCT01697696|69239473|FG001|Overall Study|Physician Decision|0|||
37748935|NCT01697696|69239472|FG000|Overall Study|Death|4|||
37659316|NCT02738879|69131682|FG000|Overall Study|Physician Decision|3|||
37659317|NCT02738879|69131683|FG001|Overall Study|Physician Decision|4|||
37659318|NCT02738879|69131682|FG000|Overall Study|Pregnancy|0|||
37659319|NCT02738879|69131683|FG001|Overall Study|Pregnancy|1|||
37659320|NCT02738879|69131682|FG000|Overall Study|Screen Failure|1|||
37748936|NCT01697696|69239473|FG001|Overall Study|Death|2|||
37748937|NCT01697696|69239472|FG000|Overall Study|Lost to Follow-up|10|||
37748938|NCT01697696|69239473|FG001|Overall Study|Lost to Follow-up|7|||
37748939|NCT01697696|69239472|FG000|Overall Study|Subject/guardian decision|31|||
37748940|NCT01697696|69239473|FG001|Overall Study|Subject/guardian decision|35|||
37748941|NCT01569152|69239481|FG000|Phase IIa, Period 1|Early Escape|5|||
37748942|NCT01569152|69239482|FG001|Phase IIa, Period 1|Early Escape|22|||
37748943|NCT01569152|69239483|FG002|Phase IIa, Period 1|Early Escape|0|||
37659321|NCT02738879|69131683|FG001|Overall Study|Screen Failure|2|||
37659322|NCT02738879|69131682|FG000|Overall Study|Site Discontinued Study Participation|1|||
37659323|NCT02738879|69131683|FG001|Overall Study|Site Discontinued Study Participation|0|||
37659324|NCT02738879|69131682|FG000|Overall Study|Withdrawal by Subject|5|||
37659325|NCT02738879|69131683|FG001|Overall Study|Withdrawal by Subject|7|||
37659326|NCT03502811|69131689|FG000|Overall Study|Death|157|||
37659327|NCT03502811|69131689|FG000|Overall Study|Withdrawal by Subject|105|||
37659328|NCT03502811|69131689|FG000|Overall Study|Lost to Follow-up|26|||
37659329|NCT03502811|69131689|FG000|Overall Study|No Visits (Missed)|31|||
37659330|NCT00515671|69131701|FG000|Overall Study|Lost to Follow-up|13|||
37659331|NCT00515671|69131702|FG001|Overall Study|Lost to Follow-up|10|||
37659332|NCT00515671|69131701|FG000|Overall Study|Withdrawal by Subject|3|||
37659333|NCT00515671|69131702|FG001|Overall Study|Withdrawal by Subject|5|||
37659334|NCT00515671|69131701|FG000|Overall Study|incarcerated|1|||
37659335|NCT00515671|69131702|FG001|Overall Study|incarcerated|2|||
37659336|NCT01677195|69131711|FG000|Overall Study|Lost to Follow-up|14|||
37748944|NCT01569152|69239481|FG000|Phase IIa, Period 1|Adverse Event|4|||
37748945|NCT01569152|69239482|FG001|Phase IIa, Period 1|Adverse Event|0|||
37748946|NCT01569152|69239483|FG002|Phase IIa, Period 1|Adverse Event|0|||
37748947|NCT01569152|69239481|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
37748948|NCT01569152|69239482|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
37748949|NCT01569152|69239483|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
37748950|NCT01569152|69239481|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
37748951|NCT01569152|69239482|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
37748952|NCT01569152|69239483|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
37748953|NCT01569152|69239481|FG000|Phase IIa, Period 1|Protocol Violation|0|||
37856201|NCT01017952|69539424|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
37856202|NCT01017952|69539425|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
37856203|NCT01017952|69539426|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
37856204|NCT01017952|69539427|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
37923067|NCT00807846|69609844|FG000|Overall Study|Protocol Violation|2|||
37748954|NCT01569152|69239482|FG001|Phase IIa, Period 1|Protocol Violation|1|||
37923068|NCT00807846|69609845|FG001|Overall Study|Protocol Violation|1|||
38033049|NCT01287741|69719087|FG000|Overall Study|Withdrawal by Subject|35|||
37748955|NCT01569152|69239483|FG002|Phase IIa, Period 1|Protocol Violation|0|||
37856205|NCT01017952|69539423|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
37856206|NCT01017952|69539424|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
37856207|NCT01017952|69539425|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
37856208|NCT01017952|69539426|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
37856209|NCT01017952|69539427|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
37856210|NCT01017952|69539423|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
37856211|NCT01017952|69539424|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
37856212|NCT01017952|69539425|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
37856213|NCT01017952|69539426|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
37856214|NCT01017952|69539427|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
37856215|NCT01017952|69539423|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
37856216|NCT01017952|69539424|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
37856217|NCT01017952|69539425|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
37856218|NCT01017952|69539426|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
37856219|NCT01017952|69539427|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
37856220|NCT01017952|69539423|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
37856221|NCT01017952|69539424|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
37923069|NCT00807846|69609844|FG000|Overall Study|Withdrawal by Subject|2|||
37659337|NCT01677195|69131712|FG001|Overall Study|Lost to Follow-up|22|||
37659338|NCT01677195|69131713|FG002|Overall Study|Lost to Follow-up|22|||
37659339|NCT01677195|69131711|FG000|Overall Study|Withdrawal by Subject|1|||
37659340|NCT01677195|69131712|FG001|Overall Study|Withdrawal by Subject|0|||
37659341|NCT01677195|69131713|FG002|Overall Study|Withdrawal by Subject|1|||
37748956|NCT01569152|69239481|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
37748957|NCT01569152|69239482|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
37748958|NCT01569152|69239483|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
37659342|NCT01677195|69131711|FG000|Overall Study|Adverse Event|6|||
37748959|NCT01569152|69239481|FG000|Safety Extension, Period 3|Adverse Event|0|||
37748960|NCT01569152|69239482|FG001|Safety Extension, Period 3|Adverse Event|0|||
37748961|NCT01569152|69239483|FG002|Safety Extension, Period 3|Adverse Event|4|||
37748962|NCT01569152|69239481|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
37659343|NCT01677195|69131712|FG001|Overall Study|Adverse Event|4|||
37659344|NCT01677195|69131713|FG002|Overall Study|Adverse Event|1|||
37659345|NCT01677195|69131711|FG000|Overall Study|Physician Decision|1|||
37659346|NCT01677195|69131712|FG001|Overall Study|Physician Decision|2|||
37659347|NCT01677195|69131713|FG002|Overall Study|Physician Decision|2|||
37659348|NCT01677195|69131711|FG000|Overall Study|Pregnancy|0|||
37659349|NCT01677195|69131712|FG001|Overall Study|Pregnancy|1|||
37748963|NCT01569152|69239482|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
37748964|NCT01569152|69239483|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
37748965|NCT01569152|69239481|FG000|Safety Extension, Period 3|Physician Decision|0|||
37748966|NCT01569152|69239482|FG001|Safety Extension, Period 3|Physician Decision|0|||
37748967|NCT01569152|69239483|FG002|Safety Extension, Period 3|Physician Decision|2|||
37748968|NCT01569152|69239481|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
37659350|NCT01677195|69131713|FG002|Overall Study|Pregnancy|0|||
37659351|NCT01677195|69131711|FG000|Overall Study|Protocol Violation|7|||
37748969|NCT01569152|69239482|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
37748970|NCT01569152|69239483|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
37748971|NCT01569074|69239508|FG000|Overall Study|Study stopped|6|||
37748972|NCT01569074|69239509|FG001|Overall Study|Study stopped|6|||
37748973|NCT01569074|69239510|FG002|Overall Study|Study stopped|8|||
37748974|NCT01569074|69239511|FG003|Overall Study|Study stopped|7|||
37748975|NCT01569074|69239512|FG004|Overall Study|Study stopped|7|||
37748976|NCT01569074|69239508|FG000|Overall Study|Study-specific discontinuation criteria|0|||
37748977|NCT01569074|69239509|FG001|Overall Study|Study-specific discontinuation criteria|1|||
37748978|NCT01569074|69239510|FG002|Overall Study|Study-specific discontinuation criteria|0|||
37748979|NCT01569074|69239511|FG003|Overall Study|Study-specific discontinuation criteria|0|||
37659352|NCT01677195|69131712|FG001|Overall Study|Protocol Violation|3|||
37659353|NCT01677195|69131713|FG002|Overall Study|Protocol Violation|4|||
37748980|NCT01569074|69239512|FG004|Overall Study|Study-specific discontinuation criteria|0|||
37748981|NCT01569074|69239508|FG000|Overall Study|Severe non-compliance to protocol|0|||
37748982|NCT01569074|69239509|FG001|Overall Study|Severe non-compliance to protocol|0|||
37748983|NCT01569074|69239510|FG002|Overall Study|Severe non-compliance to protocol|1|||
37748984|NCT01569074|69239511|FG003|Overall Study|Severe non-compliance to protocol|0|||
37748985|NCT01569074|69239512|FG004|Overall Study|Severe non-compliance to protocol|0|||
37748986|NCT01569074|69239508|FG000|Overall Study|eg change in circumstances|0|||
37748987|NCT01569074|69239509|FG001|Overall Study|eg change in circumstances|2|||
37748988|NCT01569074|69239510|FG002|Overall Study|eg change in circumstances|0|||
37748989|NCT01569074|69239511|FG003|Overall Study|eg change in circumstances|1|||
37748990|NCT01569074|69239512|FG004|Overall Study|eg change in circumstances|1|||
37748991|NCT01569074|69239508|FG000|Overall Study|Adverse Event|1|||
37748992|NCT01569074|69239509|FG001|Overall Study|Adverse Event|0|||
37748993|NCT01569074|69239510|FG002|Overall Study|Adverse Event|3|||
37748994|NCT01569074|69239511|FG003|Overall Study|Adverse Event|0|||
37748995|NCT01569074|69239512|FG004|Overall Study|Adverse Event|0|||
37748996|NCT01604408|69239530|FG000|Treatment Period 1|Protocol Violation|0|||
37748997|NCT01604408|69239531|FG001|Treatment Period 1|Protocol Violation|1|||
37748998|NCT01604408|69239530|FG000|Treatment Period 2|Withdrawal by Subject|1|||
37748999|NCT01604408|69239531|FG001|Treatment Period 2|Withdrawal by Subject|1|||
37749000|NCT01604408|69239530|FG000|Treatment Period 2|Protocol Violation|1|||
37749001|NCT01604408|69239531|FG001|Treatment Period 2|Protocol Violation|0|||
37749002|NCT01604408|69239530|FG000|Treatment Period 2|Adverse Event|0|||
37749003|NCT01604408|69239531|FG001|Treatment Period 2|Adverse Event|1|||
37749004|NCT01604408|69239530|FG000|Treatment Period 3|Protocol Violation|1|||
37749005|NCT01604408|69239531|FG001|Treatment Period 3|Protocol Violation|1|||
37749006|NCT01604408|69239530|FG000|Treatment Period 3|Adverse Event|0|||
37659354|NCT00928447|69131725|FG000|Overall Study|Withdrawal by Subject|1|||
37659355|NCT00928447|69131725|FG000|Overall Study|Investigator's decision|1|||
37659356|NCT02224846|69131731|FG000|Period 1 (Month 3)|Adverse Event|2|||
37659357|NCT02224846|69131732|FG001|Period 1 (Month 3)|Adverse Event|1|||
37659358|NCT02224846|69131731|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
37749007|NCT01604408|69239531|FG001|Treatment Period 3|Adverse Event|3|||
37749008|NCT01604408|69239530|FG000|Treatment Period 3|Withdrawal by Subject|3|||
37749009|NCT01604408|69239531|FG001|Treatment Period 3|Withdrawal by Subject|1|||
37749010|NCT01604408|69239530|FG000|Treatment Period 3|Sponsor Decision|1|||
37749011|NCT01604408|69239531|FG001|Treatment Period 3|Sponsor Decision|0|||
37659359|NCT02224846|69131732|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
37659360|NCT02224846|69131731|FG000|Period 1 (Month 3)|Protocol Violation|4|||
37659361|NCT02224846|69131732|FG001|Period 1 (Month 3)|Protocol Violation|8|||
37749012|NCT01604408|69239530|FG000|Treatment Period 4|Death|1|||
37749013|NCT01604408|69239531|FG001|Treatment Period 4|Death|0|||
37659362|NCT02224846|69131731|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
37659363|NCT02224846|69131732|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
37659364|NCT02224846|69131731|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
37659365|NCT02224846|69131732|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
37659366|NCT02224846|69131731|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
37659367|NCT02224846|69131732|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
37659368|NCT02224846|69131731|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
37659369|NCT02224846|69131732|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
37659370|NCT02224846|69131731|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
37659371|NCT02224846|69131732|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
37659372|NCT02224846|69131731|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
37659373|NCT02224846|69131732|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
37659374|NCT02224846|69131731|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
37659375|NCT02224846|69131732|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
37659376|NCT02224846|69131731|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
37659377|NCT02224846|69131732|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
37659378|NCT02224846|69131731|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
37659379|NCT02224846|69131732|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
37659380|NCT02224846|69131731|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
37659381|NCT02224846|69131732|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
37659382|NCT02224846|69131731|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
37659383|NCT02224846|69131732|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
37659384|NCT02224846|69131731|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
37659385|NCT02224846|69131732|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
37659386|NCT02224846|69131731|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
37659387|NCT02224846|69131732|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
37659388|NCT02224846|69131731|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
37659389|NCT02224846|69131732|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
37659390|NCT01632280|69131740|FG000|Overall Study|Withdrawal by Subject|1|||
37659391|NCT01632280|69131741|FG001|Overall Study|Withdrawal by Subject|0|||
37659392|NCT02224690|69131749|FG000|Overall Study|Adverse Event|8|||
37659393|NCT02224690|69131750|FG001|Overall Study|Adverse Event|1|||
37659394|NCT02224690|69131749|FG000|Overall Study|Met Withdrawal Criteria|4|||
37659395|NCT02224690|69131750|FG001|Overall Study|Met Withdrawal Criteria|0|||
37659396|NCT02224690|69131749|FG000|Overall Study|Use of G-tube|1|||
37659397|NCT02224690|69131750|FG001|Overall Study|Use of G-tube|0|||
37659398|NCT02224690|69131749|FG000|Overall Study|Did not meet eligibility criteria|1|||
37659399|NCT02224690|69131750|FG001|Overall Study|Did not meet eligibility criteria|0|||
37659400|NCT01634152|69131759|FG000|Overall Study|Adverse Event|2|||
37659401|NCT01634152|69131760|FG001|Overall Study|Adverse Event|0|||
37659402|NCT01634152|69131761|FG002|Overall Study|Adverse Event|2|||
37659403|NCT01634152|69131759|FG000|Overall Study|Consent withdrawn not due to AE|1|||
37659404|NCT01634152|69131760|FG001|Overall Study|Consent withdrawn not due to AE|0|||
37659405|NCT01634152|69131761|FG002|Overall Study|Consent withdrawn not due to AE|1|||
37659406|NCT01634152|69131759|FG000|Overall Study|Not treated|0|||
37659407|NCT01634152|69131760|FG001|Overall Study|Not treated|1|||
37659408|NCT01634152|69131761|FG002|Overall Study|Not treated|0|||
37659409|NCT01634152|69131759|FG000|Overall Study|Other reason not defined above|1|||
37659410|NCT01634152|69131760|FG001|Overall Study|Other reason not defined above|0|||
37659411|NCT01634152|69131761|FG002|Overall Study|Other reason not defined above|1|||
37659412|NCT03862807|69131769|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
37659413|NCT01378429|69131793|FG000|Overall Study|Noncompliance with study drug|1|||
37659414|NCT01378429|69131794|FG001|Overall Study|Noncompliance with study drug|0|||
37659415|NCT01599754|69131805|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
37659416|NCT01599754|69131806|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
37659417|NCT01599754|69131805|FG000|Overall Study|Participant noncompliance|4|||
37659418|NCT01599754|69131806|FG001|Overall Study|Participant noncompliance|4|||
37659419|NCT01599754|69131805|FG000|Overall Study|Lost to Follow-up|13|||
37659420|NCT01599754|69131806|FG001|Overall Study|Lost to Follow-up|6|||
37659421|NCT01599754|69131805|FG000|Overall Study|Death|31|||
37659422|NCT01599754|69131806|FG001|Overall Study|Death|33|||
37659423|NCT01599754|69131805|FG000|Overall Study|Adverse Event|3|||
37659424|NCT01599754|69131806|FG001|Overall Study|Adverse Event|2|||
37659425|NCT01599754|69131805|FG000|Overall Study|Investigator decision|1|||
37659426|NCT01599754|69131806|FG001|Overall Study|Investigator decision|3|||
37659427|NCT01599754|69131805|FG000|Overall Study|Withdrawal by Subject|24|||
37659428|NCT01599754|69131806|FG001|Overall Study|Withdrawal by Subject|25|||
37659429|NCT01599754|69131805|FG000|Overall Study|Study terminated by sponsor|282|||
37659430|NCT01599754|69131806|FG001|Overall Study|Study terminated by sponsor|285|||
37659431|NCT02138110|69131812|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
37659432|NCT02138110|69131812|FG000|Overall Scaffold Implantation|Death|3|||
37659433|NCT02223754|69131818|FG000|Period 1|Adverse Event|1|||
37659434|NCT02223754|69131819|FG001|Period 1|Adverse Event|0|||
37659435|NCT02223754|69131818|FG000|Period 1|Lost to Follow-up|0|||
37659436|NCT02223754|69131819|FG001|Period 1|Lost to Follow-up|1|||
37659437|NCT02223754|69131818|FG000|Period 1|Protocol Violation|2|||
37659438|NCT02223754|69131819|FG001|Period 1|Protocol Violation|4|||
37659439|NCT02223754|69131818|FG000|Period 1|Withdrawal by Subject|0|||
37659440|NCT02223754|69131819|FG001|Period 1|Withdrawal by Subject|4|||
37659441|NCT02223754|69131818|FG000|Period 1|Test Article No Longer Available|1|||
37659442|NCT02223754|69131819|FG001|Period 1|Test Article No Longer Available|5|||
37659443|NCT02223754|69131818|FG000|Period 1|Unsatisfactory Visual Response|0|||
37659444|NCT02223754|69131819|FG001|Period 1|Unsatisfactory Visual Response|1|||
37659445|NCT02223754|69131818|FG000|Period 2|Adverse Event|0|||
37749014|NCT01604408|69239530|FG000|Treatment Period 4|Withdrawal by Subject|2|||
37749015|NCT01604408|69239531|FG001|Treatment Period 4|Withdrawal by Subject|1|||
37749016|NCT01604408|69239530|FG000|Treatment Period 4|Adverse Event|0|||
37749017|NCT01604408|69239531|FG001|Treatment Period 4|Adverse Event|1|||
37749018|NCT01604408|69239530|FG000|Treatment Period 5|Adverse Event|4|||
37749019|NCT01604408|69239531|FG001|Treatment Period 5|Adverse Event|0|||
37749020|NCT01604408|69239530|FG000|Treatment Period 6|Lost to Follow-up|0|||
37749021|NCT01604408|69239531|FG001|Treatment Period 6|Lost to Follow-up|1|||
37749022|NCT01604408|69239530|FG000|Treatment Period 6|Adverse Event|2|||
37749023|NCT01604408|69239531|FG001|Treatment Period 6|Adverse Event|0|||
37749024|NCT01604408|69239530|FG000|Treatment Period 6|Sponsor decision|0|||
37749025|NCT01604408|69239531|FG001|Treatment Period 6|Sponsor decision|1|||
37749026|NCT01604408|69239530|FG000|Observation Period|Adverse Event|1|||
37749027|NCT01604408|69239531|FG001|Observation Period|Adverse Event|1|||
37749028|NCT01604408|69239530|FG000|Observation Period|Withdrawal by Subject|0|||
37749029|NCT01604408|69239531|FG001|Observation Period|Withdrawal by Subject|2|||
37749030|NCT01567826|69239539|FG000|Overall Study|Lost to Follow-up|3|||
37749031|NCT01567826|69239540|FG001|Overall Study|Lost to Follow-up|2|||
37749032|NCT01697462|69239548|FG000|Overall Study|Disease Progression|1|||
37749033|NCT01697462|69239548|FG000|Overall Study|Adverse Event|6|||
37749034|NCT01697462|69239548|FG000|Overall Study|Lost to Follow-up|21|||
37749035|NCT01697462|69239548|FG000|Overall Study|Withdrawal by Subject|12|||
37749036|NCT01697462|69239548|FG000|Overall Study|Investigator Decision|21|||
37749037|NCT01697462|69239548|FG000|Overall Study|Death|1|||
37749038|NCT01697462|69239548|FG000|Overall Study|Other|10|||
37749039|NCT01697462|69239548|FG000|Overall Study|Missing|5|||
37749040|NCT01696994|69239554|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
37749041|NCT01696994|69239555|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
37749042|NCT01696994|69239554|FG000|Overall Study|Died Before Randomization|1|||
37749043|NCT01696994|69239555|FG001|Overall Study|Died Before Randomization|2|||
37749044|NCT01696994|69239554|FG000|Overall Study|Died Before ASU (Control)|73|||
37749045|NCT01696994|69239555|FG001|Overall Study|Died Before ASU (Control)|0|||
37749046|NCT01696994|69239554|FG000|Overall Study|No Ovaries at Baseline|4807|||
37749047|NCT01696994|69239555|FG001|Overall Study|No Ovaries at Baseline|4851|||
37749048|NCT01696994|69239554|FG000|Overall Study|Refused ASU (Control)|311|||
37749049|NCT01696994|69239555|FG001|Overall Study|Refused ASU (Control)|0|||
37749050|NCT01696994|69239554|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
37749051|NCT01696994|69239555|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
37749052|NCT01592240|69239715|FG000|Overall Study|Adverse Event|1|||
37749053|NCT01592240|69239716|FG001|Overall Study|Adverse Event|0|||
37749054|NCT01592240|69239717|FG002|Overall Study|Adverse Event|0|||
37749055|NCT01592240|69239718|FG003|Overall Study|Adverse Event|1|||
37749056|NCT01592240|69239719|FG004|Overall Study|Adverse Event|1|||
37749057|NCT01592240|69239720|FG005|Overall Study|Adverse Event|0|||
37749058|NCT01592240|69239721|FG006|Overall Study|Adverse Event|0|||
37749059|NCT01592240|69239715|FG000|Overall Study|Death|0|||
37749060|NCT01592240|69239716|FG001|Overall Study|Death|1|||
37749061|NCT01592240|69239717|FG002|Overall Study|Death|0|||
37659446|NCT02223754|69131819|FG001|Period 2|Adverse Event|1|||
37659447|NCT02223754|69131818|FG000|Period 2|Protocol Violation|1|||
37659448|NCT02223754|69131819|FG001|Period 2|Protocol Violation|0|||
37659449|NCT02223754|69131818|FG000|Period 2|Lens Discomfort|1|||
37659450|NCT02223754|69131819|FG001|Period 2|Lens Discomfort|1|||
37749062|NCT01592240|69239718|FG003|Overall Study|Death|0|||
37659451|NCT02223754|69131818|FG000|Period 2|Lost to Follow-up|1|||
37659452|NCT02223754|69131819|FG001|Period 2|Lost to Follow-up|0|||
37659453|NCT02223754|69131818|FG000|Period 2|Test Article No Longer Available|0|||
37659454|NCT02223754|69131819|FG001|Period 2|Test Article No Longer Available|1|||
37659455|NCT02223364|69131829|FG000|Overall Study|Protocol Violation|3|||
37749063|NCT01592240|69239719|FG004|Overall Study|Death|0|||
37749064|NCT01592240|69239720|FG005|Overall Study|Death|0|||
37749065|NCT01592240|69239721|FG006|Overall Study|Death|0|||
37749066|NCT01592240|69239715|FG000|Overall Study|Lost to Follow-up|1|||
37659456|NCT02223364|69131830|FG001|Overall Study|Protocol Violation|0|||
37659457|NCT02223364|69131831|FG002|Overall Study|Protocol Violation|3|||
37659458|NCT02223364|69131829|FG000|Overall Study|subject expired before surgery|1|||
37749067|NCT01592240|69239716|FG001|Overall Study|Lost to Follow-up|3|||
37749068|NCT01592240|69239717|FG002|Overall Study|Lost to Follow-up|1|||
37659459|NCT02223364|69131830|FG001|Overall Study|subject expired before surgery|0|||
37659460|NCT02223364|69131831|FG002|Overall Study|subject expired before surgery|0|||
37659461|NCT02223364|69131829|FG000|Overall Study|Physician Decision|1|||
37659462|NCT02223364|69131830|FG001|Overall Study|Physician Decision|0|||
37659463|NCT02223364|69131831|FG002|Overall Study|Physician Decision|0|||
37659464|NCT01378975|69131841|FG000|Overall Study|Death|77|||
37659465|NCT01378975|69131842|FG001|Overall Study|Death|46|||
37659466|NCT01378975|69131841|FG000|Overall Study|Investigator Request|1|||
37659467|NCT01378975|69131842|FG001|Overall Study|Investigator Request|0|||
37659468|NCT01378975|69131841|FG000|Overall Study|Lost to Follow-up|4|||
37659469|NCT01378975|69131842|FG001|Overall Study|Lost to Follow-up|1|||
37659470|NCT01378975|69131841|FG000|Overall Study|Withdrew Consent|4|||
37659471|NCT01378975|69131842|FG001|Overall Study|Withdrew Consent|3|||
37659472|NCT02222896|69131849|FG000|Abdomen|Did not qualify|34|||
37659473|NCT02222896|69131850|FG001|Abdomen|Did not qualify|10|||
37659474|NCT02222896|69131851|FG002|Abdomen|Did not qualify|32|||
37659475|NCT02222896|69131849|FG000|Groin|Did not qualify|43|||
37659476|NCT02222896|69131850|FG001|Groin|Did not qualify|9|||
37659477|NCT02222896|69131851|FG002|Groin|Did not qualify|40|||
37749069|NCT01592240|69239718|FG003|Overall Study|Lost to Follow-up|0|||
37749070|NCT01592240|69239719|FG004|Overall Study|Lost to Follow-up|3|||
37749071|NCT01592240|69239720|FG005|Overall Study|Lost to Follow-up|2|||
37749072|NCT01592240|69239721|FG006|Overall Study|Lost to Follow-up|0|||
37749073|NCT01592240|69239715|FG000|Overall Study|Protocol Violation|0|||
37749074|NCT01592240|69239716|FG001|Overall Study|Protocol Violation|0|||
37749075|NCT01592240|69239717|FG002|Overall Study|Protocol Violation|0|||
37749076|NCT01592240|69239718|FG003|Overall Study|Protocol Violation|0|||
37749077|NCT01592240|69239719|FG004|Overall Study|Protocol Violation|0|||
37749078|NCT01592240|69239720|FG005|Overall Study|Protocol Violation|1|||
37749079|NCT01592240|69239721|FG006|Overall Study|Protocol Violation|0|||
37749080|NCT01592240|69239715|FG000|Overall Study|Withdrawal by Subject|0|||
37749081|NCT01592240|69239716|FG001|Overall Study|Withdrawal by Subject|4|||
37749082|NCT01592240|69239717|FG002|Overall Study|Withdrawal by Subject|4|||
37749083|NCT01592240|69239718|FG003|Overall Study|Withdrawal by Subject|1|||
37749084|NCT01592240|69239719|FG004|Overall Study|Withdrawal by Subject|3|||
37749085|NCT01592240|69239720|FG005|Overall Study|Withdrawal by Subject|0|||
37749086|NCT01592240|69239721|FG006|Overall Study|Withdrawal by Subject|2|||
37749087|NCT01592240|69239715|FG000|Overall Study|Other|0|||
37749088|NCT01592240|69239716|FG001|Overall Study|Other|3|||
37749089|NCT01592240|69239717|FG002|Overall Study|Other|1|||
37749090|NCT01592240|69239718|FG003|Overall Study|Other|1|||
37749091|NCT01592240|69239719|FG004|Overall Study|Other|0|||
37749092|NCT01592240|69239720|FG005|Overall Study|Other|0|||
37749093|NCT01592240|69239721|FG006|Overall Study|Other|1|||
37749094|NCT01592240|69239715|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
37749095|NCT01592240|69239716|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
37749096|NCT01592240|69239717|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
37749097|NCT01592240|69239718|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
37749098|NCT01592240|69239719|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
37749099|NCT01592240|69239720|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
37749100|NCT01592240|69239721|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
37749101|NCT01591616|69239764|FG000|Overall Study|Withdrawal by Subject|1|||
37749102|NCT01591460|69239920|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
37749103|NCT01591460|69239920|FG000|Overall Study|Futility Rule (Week 12)|7|||
37749104|NCT01591460|69239920|FG000|Overall Study|Futility Rule (Week 24)|3|||
37749105|NCT01591460|69239920|FG000|Overall Study|Rebound or Breakthrough|3|||
37749106|NCT01591460|69239920|FG000|Overall Study|Treatment Discontinued by Error|1|||
37749107|NCT01591460|69239920|FG000|Overall Study|Lost to Follow-up|1|||
37749108|NCT01591460|69239920|FG000|Overall Study|Noncompliance|1|||
37749109|NCT01591460|69239920|FG000|Overall Study|Participant Refusal|3|||
37856222|NCT01017952|69539425|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
38033050|NCT01287741|69719088|FG001|Overall Study|Withdrawal by Subject|38|||
38033051|NCT01287741|69719087|FG000|Overall Study|Protocol Violation|2|||
38033052|NCT01287741|69719088|FG001|Overall Study|Protocol Violation|0|||
38033053|NCT01287741|69719087|FG000|Overall Study|Physician Decision|15|||
38033054|NCT01287741|69719088|FG001|Overall Study|Physician Decision|23|||
38033055|NCT01287741|69719087|FG000|Overall Study|Non-compliance|8|||
37659478|NCT02222818|69131864|FG000|Period 1|Eligibility criteria not met|0|||
37749110|NCT01591460|69239920|FG000|Overall Study|Withdrawal by Subject|1|||
37749111|NCT01591460|69239920|FG000|Overall Study|Protocol Violation|1|||
37749112|NCT01591382|69239943|FG000|Overall Study|Discharged Prior to Study Completion|2|||
37749113|NCT01591382|69239944|FG001|Overall Study|Discharged Prior to Study Completion|1|||
37749114|NCT01591382|69239943|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
37659479|NCT02222818|69131865|FG001|Period 1|Eligibility criteria not met|3|||
37659480|NCT01378195|69131876|FG000|Overall Study|Lost to Follow-up|29|||
37659481|NCT01378195|69131877|FG001|Overall Study|Lost to Follow-up|18|||
37749115|NCT01591382|69239944|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
37749116|NCT01696214|69239962|FG000|Overall Study|Lost to Follow-up|1|||
37749117|NCT01696214|69239963|FG001|Overall Study|Lost to Follow-up|0|||
37749118|NCT01696214|69239964|FG002|Overall Study|Lost to Follow-up|0|||
37749119|NCT01696214|69239965|FG003|Overall Study|Lost to Follow-up|0|||
37749120|NCT01543087|69239998|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
37749121|NCT01543087|69239999|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
37749122|NCT01543087|69240000|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
37749123|NCT01543087|69240001|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
37749124|NCT01543087|69240002|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
37749125|NCT01543087|69240003|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
37749126|NCT01543087|69239998|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
37749127|NCT01543087|69239999|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
37749128|NCT01543087|69240000|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
37749129|NCT01543087|69240001|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
37749130|NCT01543087|69240002|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
37749131|NCT01543087|69240003|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
37856223|NCT01017952|69539426|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
37856224|NCT01017952|69539427|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
37856225|NCT01017952|69539423|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
37856226|NCT01017952|69539424|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
37856227|NCT01017952|69539425|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
38033056|NCT01287741|69719088|FG001|Overall Study|Non-compliance|6|||
38033057|NCT01287741|69719087|FG000|Overall Study|Lost to Follow-up|10|||
38033058|NCT01287741|69719088|FG001|Overall Study|Lost to Follow-up|8|||
38033059|NCT01287741|69719087|FG000|Overall Study|Death|32|||
38033060|NCT01287741|69719088|FG001|Overall Study|Death|44|||
38033061|NCT01287741|69719087|FG000|Overall Study|Adverse Event|4|||
38033062|NCT01287741|69719088|FG001|Overall Study|Adverse Event|6|||
38033063|NCT01287741|69719087|FG000|Overall Study|Study terminated by Sponsor|307|||
38033064|NCT01287741|69719088|FG001|Overall Study|Study terminated by Sponsor|315|||
38033065|NCT01287741|69719087|FG000|Overall Study|Progressive disease|190|||
38033066|NCT01287741|69719088|FG001|Overall Study|Progressive disease|166|||
38033067|NCT01287741|69719087|FG000|Overall Study|Reason not specified|23|||
38033068|NCT01287741|69719088|FG001|Overall Study|Reason not specified|9|||
38033069|NCT05372315|69719101|FG000|Overall Study|Withdrawal by Subject|1|||
38033070|NCT05372315|69719102|FG001|Overall Study|Withdrawal by Subject|0|||
38033071|NCT04913675|69719122|FG000|Main Study (Up to Week 36)|Death|0|||
38033072|NCT04913675|69719123|FG001|Main Study (Up to Week 36)|Death|2|||
38033073|NCT04913675|69719124|FG002|Main Study (Up to Week 36)|Death|2|||
38033074|NCT04913675|69719125|FG003|Main Study (Up to Week 36)|Death|0|||
38033075|NCT04913675|69719122|FG000|Main Study (Up to Week 36)|Lost to Follow-up|12|||
38033076|NCT04913675|69719123|FG001|Main Study (Up to Week 36)|Lost to Follow-up|8|||
38033077|NCT04913675|69719124|FG002|Main Study (Up to Week 36)|Lost to Follow-up|4|||
37659482|NCT01378117|69131886|FG000|Overall Study|withdrawal|2|||
37659483|NCT01378117|69131887|FG001|Overall Study|withdrawal|1|||
37659484|NCT01378117|69131888|FG002|Overall Study|withdrawal|2|||
37659485|NCT01378117|69131886|FG000|Overall Study|discharged before med given|2|||
37749132|NCT01543087|69239998|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
37856228|NCT01017952|69539426|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
37856229|NCT01017952|69539427|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
37856230|NCT01017952|69539423|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
37856231|NCT01017952|69539424|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
37856232|NCT01017952|69539425|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
37856233|NCT01017952|69539426|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
37856234|NCT01017952|69539427|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
38033078|NCT04913675|69719125|FG003|Main Study (Up to Week 36)|Lost to Follow-up|0|||
38033079|NCT04913675|69719122|FG000|Main Study (Up to Week 36)|Physician Decision|0|||
37659486|NCT01378117|69131887|FG001|Overall Study|discharged before med given|0|||
37659487|NCT01378117|69131888|FG002|Overall Study|discharged before med given|1|||
37659488|NCT04254809|69131923|FG000|Overall Study|Lost to Follow-up|5|||
37659489|NCT04254809|69131924|FG001|Overall Study|Lost to Follow-up|10|||
37659490|NCT02736409|69131934|FG000|Overall Study|Withdrawal by Subject|4|||
37659491|NCT02736409|69131935|FG001|Overall Study|Withdrawal by Subject|2|||
37659492|NCT02736409|69131936|FG002|Overall Study|Withdrawal by Subject|17|||
37659493|NCT02736409|69131937|FG003|Overall Study|Withdrawal by Subject|3|||
37659494|NCT02736409|69131934|FG000|Overall Study|Non-Compliance with Study Drug|0|||
37659495|NCT02736409|69131935|FG001|Overall Study|Non-Compliance with Study Drug|0|||
37659496|NCT02736409|69131936|FG002|Overall Study|Non-Compliance with Study Drug|0|||
37659497|NCT02736409|69131937|FG003|Overall Study|Non-Compliance with Study Drug|1|||
37659498|NCT02736409|69131934|FG000|Overall Study|Adverse Event|0|||
37749133|NCT01543087|69239999|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
37749134|NCT01543087|69240000|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
38033080|NCT04913675|69719123|FG001|Main Study (Up to Week 36)|Physician Decision|1|||
37749135|NCT01543087|69240001|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
37659499|NCT02736409|69131935|FG001|Overall Study|Adverse Event|1|||
37659500|NCT02736409|69131936|FG002|Overall Study|Adverse Event|5|||
37659501|NCT02736409|69131937|FG003|Overall Study|Adverse Event|4|||
37659502|NCT02736409|69131934|FG000|Overall Study|Other|0|||
37659503|NCT02736409|69131935|FG001|Overall Study|Other|0|||
37659504|NCT02736409|69131936|FG002|Overall Study|Other|1|||
37659505|NCT02736409|69131937|FG003|Overall Study|Other|1|||
37659506|NCT02736409|69131934|FG000|Overall Study|Pregnancy|0|||
37659507|NCT02736409|69131935|FG001|Overall Study|Pregnancy|0|||
37659508|NCT02736409|69131936|FG002|Overall Study|Pregnancy|1|||
37659509|NCT02736409|69131937|FG003|Overall Study|Pregnancy|0|||
37659510|NCT02736409|69131934|FG000|Overall Study|Lost to Follow-up|0|||
37659511|NCT02736409|69131935|FG001|Overall Study|Lost to Follow-up|0|||
37659512|NCT02736409|69131936|FG002|Overall Study|Lost to Follow-up|2|||
37659513|NCT02736409|69131937|FG003|Overall Study|Lost to Follow-up|1|||
37659514|NCT02736409|69131934|FG000|Overall Study|Physician Decision|0|||
37659515|NCT02736409|69131935|FG001|Overall Study|Physician Decision|0|||
37659516|NCT02736409|69131936|FG002|Overall Study|Physician Decision|0|||
37659517|NCT02736409|69131937|FG003|Overall Study|Physician Decision|2|||
37659518|NCT03099707|69131950|FG000|Overall Study|Withdrawal by Subject|0|||
37659519|NCT03099707|69131951|FG001|Overall Study|Withdrawal by Subject|3|||
37659520|NCT03099707|69131950|FG000|Overall Study|Lost to Follow-up|0|||
37659521|NCT03099707|69131951|FG001|Overall Study|Lost to Follow-up|1|||
37659522|NCT02906033|69131959|FG000|Baseline|Protocol Violation|37|||
37659523|NCT02906033|69131960|FG001|Baseline|Protocol Violation|33|||
37659524|NCT02906033|69131959|FG000|Follow-up|Lost to Follow-up|46|||
37659525|NCT02906033|69131960|FG001|Follow-up|Lost to Follow-up|62|||
37659526|NCT02221882|69131972|FG000|Overall Study|Withdrawal by Subject|0|||
37659527|NCT02221882|69131973|FG001|Overall Study|Withdrawal by Subject|0|||
37659528|NCT02221882|69131974|FG002|Overall Study|Withdrawal by Subject|4|||
37659529|NCT02221882|69131975|FG003|Overall Study|Withdrawal by Subject|2|||
37659530|NCT02221882|69131976|FG004|Overall Study|Withdrawal by Subject|2|||
37659531|NCT02221882|69131977|FG005|Overall Study|Withdrawal by Subject|2|||
37659532|NCT02221882|69131972|FG000|Overall Study|Death|0|||
37659533|NCT02221882|69131973|FG001|Overall Study|Death|1|||
37659534|NCT02221882|69131974|FG002|Overall Study|Death|0|||
37659535|NCT02221882|69131975|FG003|Overall Study|Death|0|||
37659536|NCT02221882|69131976|FG004|Overall Study|Death|0|||
37659537|NCT02221882|69131977|FG005|Overall Study|Death|0|||
37659538|NCT02837783|69131998|FG000|Overall Study|Adverse Event|1|||
37659539|NCT02837783|69131999|FG001|Overall Study|Adverse Event|0|||
37659540|NCT02837783|69131998|FG000|Overall Study|Other, Not Specified|1|||
37659541|NCT02837783|69131999|FG001|Overall Study|Other, Not Specified|2|||
37659542|NCT02221648|69132007|FG000|Overall Study|Withdrawal by Subject|3|||
37659543|NCT02221648|69132008|FG001|Overall Study|Withdrawal by Subject|3|||
37659544|NCT02220712|69132018|FG000|Overall Study|Adverse Event|1|||
37659545|NCT02220712|69132018|FG000|Overall Study|Withdrawal by Subject|2|||
37659546|NCT02220712|69132018|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
37659547|NCT02219932|69132028|FG000|Overall Study|Other|5|||
37749136|NCT01543087|69240002|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
37749137|NCT01543087|69240003|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
37749138|NCT01543087|69239998|FG000|Stage 1 (48 Months)|Other than specified|5|||
37749139|NCT01543087|69239999|FG001|Stage 1 (48 Months)|Other than specified|0|||
37749140|NCT01543087|69240000|FG002|Stage 1 (48 Months)|Other than specified|9|||
37749141|NCT01543087|69240001|FG003|Stage 1 (48 Months)|Other than specified|0|||
37749142|NCT01543087|69240002|FG004|Stage 1 (48 Months)|Other than specified|0|||
37749143|NCT01543087|69240003|FG005|Stage 1 (48 Months)|Other than specified|0|||
37749144|NCT01543087|69239998|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
37749145|NCT01543087|69239999|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
37749146|NCT01543087|69240000|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
37749147|NCT01543087|69240001|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
38033081|NCT04913675|69719124|FG002|Main Study (Up to Week 36)|Physician Decision|1|||
38033082|NCT04913675|69719125|FG003|Main Study (Up to Week 36)|Physician Decision|0|||
37659548|NCT02219932|69132029|FG001|Overall Study|Other|11|||
37659549|NCT02219932|69132028|FG000|Overall Study|Death|1|||
37659550|NCT02219932|69132029|FG001|Overall Study|Death|1|||
37659551|NCT02219932|69132028|FG000|Overall Study|Investigator Decision|0|||
37659552|NCT02219932|69132029|FG001|Overall Study|Investigator Decision|1|||
37659553|NCT02219932|69132028|FG000|Overall Study|Consent Withdrawn|11|||
37659554|NCT02219932|69132029|FG001|Overall Study|Consent Withdrawn|7|||
38033083|NCT04913675|69719122|FG000|Main Study (Up to Week 36)|Withdrawal by Subject|25|||
37659555|NCT02219932|69132028|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
37659556|NCT02219932|69132029|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
37659557|NCT02219932|69132028|FG000|Overall Study|Protocol Violation|10|||
37659558|NCT02219932|69132029|FG001|Overall Study|Protocol Violation|6|||
37659559|NCT02219932|69132028|FG000|Overall Study|Pregnancy|1|||
37659560|NCT02219932|69132029|FG001|Overall Study|Pregnancy|0|||
37749148|NCT01543087|69240002|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
37749149|NCT01543087|69240003|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
37749150|NCT01543087|69239998|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
37749151|NCT01543087|69239999|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
37749152|NCT01543087|69240000|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
37749153|NCT01543087|69240001|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
37749154|NCT01543087|69240002|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
37749155|NCT01543087|69240003|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
37749156|NCT01543087|69239998|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
37749157|NCT01543087|69239999|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
37659561|NCT02219932|69132028|FG000|Overall Study|Lost to Follow-up|4|||
37659562|NCT02219932|69132029|FG001|Overall Study|Lost to Follow-up|2|||
37659563|NCT02219932|69132028|FG000|Overall Study|Adverse Event|23|||
37749158|NCT01543087|69240000|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
37749159|NCT01543087|69240001|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
37749160|NCT01543087|69240002|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
37749161|NCT01543087|69240003|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
37749162|NCT01696058|69240041|FG000|Overall Study|Adverse Event|21|||
37749163|NCT01696058|69240042|FG001|Overall Study|Adverse Event|11|||
37749164|NCT01696058|69240041|FG000|Overall Study|Lack of Efficacy|2|||
37749165|NCT01696058|69240042|FG001|Overall Study|Lack of Efficacy|3|||
37749166|NCT01696058|69240041|FG000|Overall Study|Protocol Violation|9|||
37749167|NCT01696058|69240042|FG001|Overall Study|Protocol Violation|3|||
37749168|NCT01696058|69240041|FG000|Overall Study|Lost to Follow-up|2|||
37749169|NCT01696058|69240042|FG001|Overall Study|Lost to Follow-up|5|||
37749170|NCT01696058|69240041|FG000|Overall Study|Withdrawal by Subject|4|||
37749171|NCT01696058|69240042|FG001|Overall Study|Withdrawal by Subject|6|||
37749172|NCT01696058|69240041|FG000|Overall Study|Other reason prematurely discontinued|5|||
37749173|NCT01696058|69240042|FG001|Overall Study|Other reason prematurely discontinued|3|||
37749174|NCT01695746|69240048|FG000|Overall Study|Adverse Event|1|||
37749175|NCT01695746|69240048|FG000|Overall Study|Non-compliance by the participant|3|||
37856235|NCT01017952|69539423|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
37856236|NCT01017952|69539424|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
37856237|NCT01017952|69539425|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
37856238|NCT01017952|69539426|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
37856239|NCT01017952|69539427|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
37856240|NCT01017952|69539423|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
37659564|NCT02219932|69132029|FG001|Overall Study|Adverse Event|21|||
37856241|NCT01017952|69539424|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
37856242|NCT01017952|69539425|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
37856243|NCT01017952|69539426|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
37856244|NCT01017952|69539427|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
37856245|NCT01017952|69539423|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
37856246|NCT01017952|69539424|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
37856247|NCT01017952|69539425|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
37856248|NCT01017952|69539426|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
37856249|NCT01017952|69539427|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
37856250|NCT01017952|69539423|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
37856251|NCT01017952|69539424|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
37856252|NCT01017952|69539425|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
37856253|NCT01017952|69539426|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
37856254|NCT01017952|69539427|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
37856255|NCT01017952|69539423|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
37659565|NCT02219464|69132041|FG000|Overall Study|Withdrawal by Subject|1|||
37659566|NCT02219464|69132042|FG001|Overall Study|Withdrawal by Subject|0|||
37659567|NCT02219464|69132041|FG000|Overall Study|case cancelled|1|||
37659568|NCT02219464|69132042|FG001|Overall Study|case cancelled|0|||
37659569|NCT02219464|69132041|FG000|Overall Study|catheter malfunction|1|||
37659570|NCT02219464|69132042|FG001|Overall Study|catheter malfunction|0|||
37659571|NCT02219308|69132050|FG000|Overall Study|Withdrawal by Subject|1|||
37659572|NCT02219308|69132051|FG001|Overall Study|Withdrawal by Subject|2|||
37659573|NCT02218372|69132059|FG000|Overall Study|Adverse Event|1|||
37749176|NCT01695746|69240048|FG000|Overall Study|Protocol Violation|5|||
37749177|NCT01695746|69240048|FG000|Overall Study|Participant not willing to participate|3|||
37749178|NCT01694420|69240059|FG000|Overall Study|Lost to Follow-up|3|||
37749179|NCT01675479|69240230|FG000|Overall Study|Lost to Follow-up|11|||
37749180|NCT00089973|69240361|FG000|Overall Study|Adverse Event|3|||
37856256|NCT01017952|69539424|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
37659574|NCT02218372|69132060|FG001|Overall Study|Adverse Event|1|||
37659575|NCT02218372|69132059|FG000|Overall Study|Miscellaneous|2|||
37659576|NCT02218372|69132060|FG001|Overall Study|Miscellaneous|1|||
37659577|NCT02218372|69132059|FG000|Overall Study|Randomized but did not receive treatment|2|||
37659578|NCT02218372|69132060|FG001|Overall Study|Randomized but did not receive treatment|3|||
37659579|NCT02218372|69132059|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
37659580|NCT02218372|69132060|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
37659581|NCT02218216|69132073|FG000|Overall Study|Study terminated before completed|6|||
37659582|NCT02218216|69132074|FG001|Overall Study|Study terminated before completed|0|||
37659583|NCT02218216|69132075|FG002|Overall Study|Study terminated before completed|0|||
37659584|NCT02217982|69132085|FG000|Overall Study|Trial discontinued|1|||
37659585|NCT02217982|69132086|FG001|Overall Study|Trial discontinued|0|||
37659586|NCT02217982|69132085|FG000|Overall Study|Adverse Event|0|||
37659587|NCT02217982|69132086|FG001|Overall Study|Adverse Event|1|||
37659588|NCT02254408|69132094|FG000|Overall Study|Randomized But Not Treated|1|||
37659589|NCT02254408|69132095|FG001|Overall Study|Randomized But Not Treated|3|||
37659590|NCT02254408|69132094|FG000|Overall Study|Adverse Event|1|||
37659591|NCT02254408|69132095|FG001|Overall Study|Adverse Event|0|||
37749181|NCT00089973|69240361|FG000|Overall Study|Withdrawal by Subject|1|||
37749182|NCT00089973|69240361|FG000|Overall Study|Disease progression|45|||
37749183|NCT00089973|69240361|FG000|Overall Study|Death|1|||
37749184|NCT00089661|69240379|FG000|Overall Study|Adverse Event|0|||
37749185|NCT00089661|69240380|FG001|Overall Study|Adverse Event|2|||
37749186|NCT00089661|69240379|FG000|Overall Study|Death|1|||
37749187|NCT00089661|69240380|FG001|Overall Study|Death|0|||
37749188|NCT00089661|69240379|FG000|Overall Study|Lost to Follow-up|0|||
37749189|NCT00089661|69240380|FG001|Overall Study|Lost to Follow-up|3|||
37749190|NCT00089661|69240379|FG000|Overall Study|Withdrawal by Subject|11|||
37749191|NCT00089661|69240380|FG001|Overall Study|Withdrawal by Subject|9|||
37749192|NCT00089661|69240379|FG000|Overall Study|Disease progression|1|||
37749193|NCT00089661|69240380|FG001|Overall Study|Disease progression|3|||
37749194|NCT00089661|69240379|FG000|Overall Study|Ineligibility determined|4|||
37749195|NCT00089661|69240380|FG001|Overall Study|Ineligibility determined|4|||
37749196|NCT00089661|69240379|FG000|Overall Study|Noncompliance|2|||
37749197|NCT00089661|69240380|FG001|Overall Study|Noncompliance|4|||
37749198|NCT00089661|69240379|FG000|Overall Study|Other|2|||
37749199|NCT00089661|69240380|FG001|Overall Study|Other|1|||
37749200|NCT00089583|69240397|FG000|Overall Study|Adverse Event|0|||
37749201|NCT00089583|69240398|FG001|Overall Study|Adverse Event|3|||
37749202|NCT00089583|69240397|FG000|Overall Study|Insufficient Viral Load Response|5|||
37749203|NCT00089583|69240398|FG001|Overall Study|Insufficient Viral Load Response|5|||
37749204|NCT00089583|69240397|FG000|Overall Study|Withdrawal by Subject|0|||
37749205|NCT00089583|69240398|FG001|Overall Study|Withdrawal by Subject|4|||
37749206|NCT00089583|69240397|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
37749207|NCT00089583|69240398|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
37749208|NCT00089583|69240397|FG000|Overall Study|Participant Refused Study Medication|0|||
37749209|NCT00089583|69240398|FG001|Overall Study|Participant Refused Study Medication|2|||
37749210|NCT00089583|69240397|FG000|Overall Study|Non-Compliance|0|||
37749211|NCT00089583|69240398|FG001|Overall Study|Non-Compliance|4|||
37749212|NCT00089583|69240397|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
37749213|NCT00089583|69240398|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
37749214|NCT00089583|69240397|FG000|Overall Study|Participant Management Criteria Met|0|||
37749215|NCT00089583|69240398|FG001|Overall Study|Participant Management Criteria Met|1|||
37749216|NCT00089583|69240397|FG000|Overall Study|Reason Not Provided|0|||
37856257|NCT01017952|69539425|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
37856258|NCT01017952|69539426|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
37856259|NCT01017952|69539427|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
37856260|NCT01017952|69539423|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
37856261|NCT01017952|69539424|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
37856262|NCT01017952|69539425|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
37856263|NCT01017952|69539426|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
37856264|NCT01017952|69539427|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
37749217|NCT00089583|69240398|FG001|Overall Study|Reason Not Provided|1|||
37856265|NCT01214655|69539440|FG000|Part A|Progressive Disease|7|||
37749218|NCT00089583|69240397|FG000|Overall Study|Protocol Violation|0|||
37749219|NCT00089583|69240398|FG001|Overall Study|Protocol Violation|3|||
37856266|NCT01214655|69539441|FG001|Part A|Progressive Disease|0|||
37856267|NCT01214655|69539442|FG002|Part A|Progressive Disease|0|||
37856268|NCT01214655|69539440|FG000|Part A|Physician Decision|1|||
37856269|NCT01214655|69539441|FG001|Part A|Physician Decision|0|||
37856270|NCT01214655|69539442|FG002|Part A|Physician Decision|0|||
38033084|NCT04913675|69719123|FG001|Main Study (Up to Week 36)|Withdrawal by Subject|33|||
37749220|NCT00089583|69240397|FG000|Overall Study|Principal Investigator Decision|0|||
37749221|NCT00089583|69240398|FG001|Overall Study|Principal Investigator Decision|10|||
37749222|NCT00089583|69240397|FG000|Overall Study|Start of Disallowed Medication|0|||
37749223|NCT00089583|69240398|FG001|Overall Study|Start of Disallowed Medication|1|||
37659592|NCT02254408|69132094|FG000|Overall Study|Death|2|||
37659593|NCT02254408|69132095|FG001|Overall Study|Death|3|||
37659594|NCT02254408|69132094|FG000|Overall Study|Investigator's Discretion|0|||
37659595|NCT02254408|69132095|FG001|Overall Study|Investigator's Discretion|1|||
37659596|NCT02254408|69132094|FG000|Overall Study|Withdrawal by Subject|3|||
37659597|NCT02254408|69132095|FG001|Overall Study|Withdrawal by Subject|3|||
37659598|NCT02254408|69132094|FG000|Overall Study|Lost to Follow-up|1|||
37659599|NCT02254408|69132095|FG001|Overall Study|Lost to Follow-up|0|||
37659600|NCT02207608|69132103|FG000|Overall Study|Adverse Event|1|||
37659601|NCT02207608|69132104|FG001|Overall Study|Adverse Event|0|||
37659602|NCT03530995|69132112|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
37659603|NCT03530995|69132113|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
37659604|NCT03530995|69132112|FG000|Part 1 Period 3|Protocol Violation|1|||
37659605|NCT03530995|69132113|FG001|Part 1 Period 3|Protocol Violation|0|||
37659606|NCT03530995|69132112|FG000|Part 1 Period 4|Physician Decision|1|||
37749224|NCT00089583|69240397|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
37749225|NCT00089583|69240398|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
37749226|NCT00089583|69240397|FG000|Overall Study|Participant Incarcerated|0|||
37749227|NCT00089583|69240398|FG001|Overall Study|Participant Incarcerated|1|||
37659607|NCT03530995|69132113|FG001|Part 1 Period 4|Physician Decision|0|||
37659608|NCT03530995|69132112|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
37659609|NCT03530995|69132113|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
37749228|NCT00088881|69240410|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
37749229|NCT00088881|69240410|FG000|Step 1 - R-CHOP|Adverse Event|1|||
37659610|NCT02217436|69132137|FG000|Overall Study|Protocol Violation|1|||
37659611|NCT02217436|69132138|FG001|Overall Study|Protocol Violation|1|||
37659612|NCT02217436|69132137|FG000|Overall Study|Incomplete data|0|||
37659613|NCT02217436|69132138|FG001|Overall Study|Incomplete data|1|||
37659614|NCT02207530|69132144|FG000|Overall Study|Worsening condition under investigation|78|||
37659615|NCT02207530|69132144|FG000|Overall Study|Patient decision to stop study treatment|5|||
37659616|NCT02207530|69132144|FG000|Overall Study|Adverse Event|8|||
37659617|NCT02207374|69132151|FG000|Overall Study|Withdrawal by Subject|5|||
37659618|NCT02207374|69132152|FG001|Overall Study|Withdrawal by Subject|9|||
37659619|NCT02207374|69132153|FG002|Overall Study|Withdrawal by Subject|4|||
37659620|NCT02207374|69132151|FG000|Overall Study|Death|1|||
37659621|NCT02207374|69132152|FG001|Overall Study|Death|0|||
37749230|NCT00088881|69240410|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
37749231|NCT00088881|69240410|FG000|Step 1 - R-CHOP|Physician Decision|1|||
37749232|NCT00088881|69240410|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
37749233|NCT00088881|69240410|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
37749234|NCT00088881|69240410|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
37749235|NCT00087555|69240458|FG000|Overall Study|Adverse Event|3|||
37749236|NCT00087555|69240459|FG001|Overall Study|Adverse Event|6|||
37749237|NCT00087555|69240460|FG002|Overall Study|Adverse Event|14|||
37749238|NCT00087555|69240458|FG000|Overall Study|Lost to Follow-up|0|||
37749239|NCT00087555|69240459|FG001|Overall Study|Lost to Follow-up|1|||
37749240|NCT00087555|69240460|FG002|Overall Study|Lost to Follow-up|1|||
37749241|NCT00087555|69240458|FG000|Overall Study|Non - Compliance|1|||
37749242|NCT00087555|69240459|FG001|Overall Study|Non - Compliance|0|||
37749243|NCT00087555|69240460|FG002|Overall Study|Non - Compliance|0|||
37749244|NCT00087555|69240458|FG000|Overall Study|Protocol Violation|0|||
37749245|NCT00087555|69240459|FG001|Overall Study|Protocol Violation|0|||
37749246|NCT00087555|69240460|FG002|Overall Study|Protocol Violation|2|||
37749247|NCT00087555|69240458|FG000|Overall Study|Screen Failure|1|||
37749248|NCT00087555|69240459|FG001|Overall Study|Screen Failure|1|||
37749249|NCT00087555|69240460|FG002|Overall Study|Screen Failure|0|||
37749250|NCT00087555|69240458|FG000|Overall Study|Pregnancy|0|||
37749251|NCT00087555|69240459|FG001|Overall Study|Pregnancy|1|||
37749252|NCT00087555|69240460|FG002|Overall Study|Pregnancy|1|||
37749253|NCT00087555|69240458|FG000|Overall Study|Withdrawal by Subject|3|||
37749254|NCT00087555|69240459|FG001|Overall Study|Withdrawal by Subject|2|||
37749255|NCT00087555|69240460|FG002|Overall Study|Withdrawal by Subject|1|||
37856271|NCT01214655|69539440|FG000|Part B|Progressive disease|0|||
37856272|NCT01214655|69539441|FG001|Part B|Progressive disease|10|||
37856273|NCT01214655|69539442|FG002|Part B|Progressive disease|0|||
37856274|NCT01214655|69539440|FG000|Part B|Death|0|||
37856275|NCT01214655|69539441|FG001|Part B|Death|1|||
37659622|NCT02207374|69132153|FG002|Overall Study|Death|1|||
37749256|NCT00087555|69240458|FG000|Overall Study|Lack of Efficacy|2|||
37749257|NCT00087555|69240459|FG001|Overall Study|Lack of Efficacy|0|||
37749258|NCT00087555|69240460|FG002|Overall Study|Lack of Efficacy|1|||
37856276|NCT01214655|69539442|FG002|Part B|Death|0|||
37749259|NCT00087555|69240458|FG000|Overall Study|Non Compliance|0|||
37749260|NCT00087555|69240459|FG001|Overall Study|Non Compliance|0|||
37749261|NCT00087555|69240460|FG002|Overall Study|Non Compliance|1|||
37749262|NCT00087555|69240458|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
37659623|NCT02207374|69132151|FG000|Overall Study|Missing follow-up information|0|||
37659624|NCT02207374|69132152|FG001|Overall Study|Missing follow-up information|1|||
37749263|NCT00087555|69240459|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
37856277|NCT01214655|69539440|FG000|Part B|Withdrawal by Subject|0|||
37856278|NCT01214655|69539441|FG001|Part B|Withdrawal by Subject|2|||
37749264|NCT00087555|69240460|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
37749265|NCT00087555|69240458|FG000|Overall Study|Patient wanted to go back on Med|1|||
37749266|NCT00087555|69240459|FG001|Overall Study|Patient wanted to go back on Med|0|||
37749267|NCT00087555|69240460|FG002|Overall Study|Patient wanted to go back on Med|0|||
37749268|NCT00086619|69240483|FG000|Overall Study|Withdrawal by Subject|6|||
37749269|NCT00086619|69240484|FG001|Overall Study|Withdrawal by Subject|6|||
37749270|NCT00086619|69240483|FG000|Overall Study|Adverse Event|8|||
37749271|NCT00086619|69240484|FG001|Overall Study|Adverse Event|10|||
37749272|NCT00086619|69240483|FG000|Overall Study|Protocol Violation|1|||
37659625|NCT02207374|69132153|FG002|Overall Study|Missing follow-up information|1|||
37659626|NCT02217280|69132161|FG000|Overall Study|Withdrawal by Subject|2|||
37659627|NCT02217280|69132161|FG000|Overall Study|Post-consent sceen fail|2|||
37659628|NCT02786537|69132172|FG000|As Randomized|Adverse Event|0|||
37659629|NCT02786537|69132173|FG001|As Randomized|Adverse Event|11|||
37659630|NCT02786537|69132174|FG002|As Randomized|Adverse Event|0|||
37659631|NCT02786537|69132175|FG003|As Randomized|Adverse Event|4|||
37659632|NCT02786537|69132176|FG004|As Randomized|Adverse Event|6|||
37659633|NCT02786537|69132177|FG005|As Randomized|Adverse Event|2|||
37659634|NCT02786537|69132172|FG000|As Randomized|Lack of Efficacy|0|||
37659635|NCT02786537|69132173|FG001|As Randomized|Lack of Efficacy|0|||
37659636|NCT02786537|69132174|FG002|As Randomized|Lack of Efficacy|0|||
37659637|NCT02786537|69132175|FG003|As Randomized|Lack of Efficacy|1|||
37659638|NCT02786537|69132176|FG004|As Randomized|Lack of Efficacy|0|||
37659639|NCT02786537|69132177|FG005|As Randomized|Lack of Efficacy|0|||
37659640|NCT02786537|69132172|FG000|As Randomized|Withdrawal by Subject|1|||
37659641|NCT02786537|69132173|FG001|As Randomized|Withdrawal by Subject|2|||
37659642|NCT02786537|69132174|FG002|As Randomized|Withdrawal by Subject|0|||
37749273|NCT00086619|69240484|FG001|Overall Study|Protocol Violation|1|||
37749274|NCT00085917|69240497|FG000|Overall Study|Adverse Event|4|||
37749275|NCT00085917|69240498|FG001|Overall Study|Adverse Event|3|||
37749276|NCT00084747|69240504|FG000|Overall Study|Relapsed|8|||
37749277|NCT00084747|69240504|FG000|Overall Study|Death|3|||
37749278|NCT00084747|69240504|FG000|Overall Study|Withdrawal by Subject|2|||
37749279|NCT00081159|69240539|FG000|Overall Study|Withdrawal by Subject|0|||
37749280|NCT00081159|69240540|FG001|Overall Study|Withdrawal by Subject|3|||
37659643|NCT02786537|69132175|FG003|As Randomized|Withdrawal by Subject|1|||
37659644|NCT02786537|69132176|FG004|As Randomized|Withdrawal by Subject|1|||
37659645|NCT02786537|69132177|FG005|As Randomized|Withdrawal by Subject|0|||
37659646|NCT02786537|69132172|FG000|As Randomized|Death|0|||
37659647|NCT02786537|69132173|FG001|As Randomized|Death|2|||
37659648|NCT02786537|69132174|FG002|As Randomized|Death|0|||
37659649|NCT02786537|69132175|FG003|As Randomized|Death|3|||
37659650|NCT02786537|69132176|FG004|As Randomized|Death|1|||
37659651|NCT02786537|69132177|FG005|As Randomized|Death|0|||
37659652|NCT02786537|69132172|FG000|As Randomized|Non-compliance with study drug|1|||
37659653|NCT02786537|69132173|FG001|As Randomized|Non-compliance with study drug|11|||
37659654|NCT02786537|69132174|FG002|As Randomized|Non-compliance with study drug|0|||
37659655|NCT02786537|69132175|FG003|As Randomized|Non-compliance with study drug|1|||
37659656|NCT02786537|69132176|FG004|As Randomized|Non-compliance with study drug|0|||
37659657|NCT02786537|69132177|FG005|As Randomized|Non-compliance with study drug|1|||
37749281|NCT00081159|69240539|FG000|Overall Study|Myelosuppression prior to treatment|0|||
37749282|NCT00081159|69240540|FG001|Overall Study|Myelosuppression prior to treatment|1|||
37749283|NCT00081159|69240539|FG000|Overall Study|Lost to Follow-up|2|||
37749284|NCT00081159|69240540|FG001|Overall Study|Lost to Follow-up|1|||
37749285|NCT00080223|69240555|FG000|Overall Study|Adverse Event|23|||
37749286|NCT00080223|69240555|FG000|Overall Study|Death|21|||
37749287|NCT00080223|69240555|FG000|Overall Study|Withdrawal by Subject|13|||
37749288|NCT00080223|69240555|FG000|Overall Study|Lung Transplantation|9|||
37749289|NCT00080223|69240555|FG000|Overall Study|Non-compliance With Study Treatment|7|||
37749290|NCT00080223|69240555|FG000|Overall Study|Participant unwilling to continue|2|||
37749291|NCT00080223|69240555|FG000|Overall Study|Physician Decision|1|||
37856279|NCT01214655|69539442|FG002|Part B|Withdrawal by Subject|0|||
37749292|NCT01899053|69241166|FG000|Overall Study|Progressive Disease|4|||
37856280|NCT01214655|69539440|FG000|Part C|Progressive Disease|0|||
37856281|NCT01214655|69539441|FG001|Part C|Progressive Disease|0|||
37856282|NCT01214655|69539442|FG002|Part C|Progressive Disease|5|||
37856283|NCT01214655|69539440|FG000|Part C|Death|0|||
37659658|NCT02786537|69132172|FG000|As Randomized|Lost to treatment follow-up|4|||
37659659|NCT02786537|69132173|FG001|As Randomized|Lost to treatment follow-up|32|||
37659660|NCT02786537|69132174|FG002|As Randomized|Lost to treatment follow-up|0|||
37659661|NCT02786537|69132175|FG003|As Randomized|Lost to treatment follow-up|24|||
37659662|NCT02786537|69132176|FG004|As Randomized|Lost to treatment follow-up|4|||
37659663|NCT02786537|69132177|FG005|As Randomized|Lost to treatment follow-up|4|||
37659664|NCT02786537|69132172|FG000|As Randomized|Incarceration|0|||
37659665|NCT02786537|69132173|FG001|As Randomized|Incarceration|1|||
37659666|NCT02786537|69132174|FG002|As Randomized|Incarceration|0|||
37856284|NCT01214655|69539441|FG001|Part C|Death|0|||
37659667|NCT02786537|69132175|FG003|As Randomized|Incarceration|0|||
37749293|NCT01899053|69241167|FG001|Overall Study|Progressive Disease|0|||
37749294|NCT01899053|69241168|FG002|Overall Study|Progressive Disease|3|||
37749295|NCT01899053|69241169|FG003|Overall Study|Progressive Disease|0|||
37749296|NCT01899053|69241170|FG004|Overall Study|Progressive Disease|3|||
37749297|NCT01899053|69241171|FG005|Overall Study|Progressive Disease|1|||
37749298|NCT01899053|69241172|FG006|Overall Study|Progressive Disease|1|||
37749299|NCT01899053|69241173|FG007|Overall Study|Progressive Disease|1|||
37749300|NCT01899053|69241174|FG008|Overall Study|Progressive Disease|4|||
37749301|NCT01899053|69241175|FG009|Overall Study|Progressive Disease|3|||
37749302|NCT01899053|69241176|FG010|Overall Study|Progressive Disease|12|||
37749303|NCT01899053|69241177|FG011|Overall Study|Progressive Disease|5|||
37749304|NCT01899053|69241178|FG012|Overall Study|Progressive Disease|8|||
37749305|NCT01899053|69241179|FG013|Overall Study|Progressive Disease|17|||
37749306|NCT01899053|69241166|FG000|Overall Study|Adverse Event|1|||
37749307|NCT01899053|69241167|FG001|Overall Study|Adverse Event|1|||
37749308|NCT01899053|69241168|FG002|Overall Study|Adverse Event|1|||
37749309|NCT01899053|69241169|FG003|Overall Study|Adverse Event|3|||
37749310|NCT01899053|69241170|FG004|Overall Study|Adverse Event|1|||
37749311|NCT01899053|69241171|FG005|Overall Study|Adverse Event|1|||
37749312|NCT01899053|69241172|FG006|Overall Study|Adverse Event|1|||
37659668|NCT02786537|69132176|FG004|As Randomized|Incarceration|0|||
37659669|NCT02786537|69132177|FG005|As Randomized|Incarceration|0|||
37749313|NCT01899053|69241173|FG007|Overall Study|Adverse Event|0|||
37923070|NCT00807846|69609845|FG001|Overall Study|Withdrawal by Subject|1|||
37659670|NCT02786537|69132172|FG000|As Randomized|Opiate Dependency Relapse|0|||
37659671|NCT02786537|69132173|FG001|As Randomized|Opiate Dependency Relapse|1|||
37659672|NCT02786537|69132174|FG002|As Randomized|Opiate Dependency Relapse|0|||
37659673|NCT02786537|69132175|FG003|As Randomized|Opiate Dependency Relapse|0|||
37659674|NCT02786537|69132176|FG004|As Randomized|Opiate Dependency Relapse|0|||
37659675|NCT02786537|69132177|FG005|As Randomized|Opiate Dependency Relapse|0|||
37659676|NCT02786537|69132172|FG000|As Randomized|HCV drugs stolen from pt|0|||
37659677|NCT02786537|69132173|FG001|As Randomized|HCV drugs stolen from pt|1|||
37659678|NCT02786537|69132174|FG002|As Randomized|HCV drugs stolen from pt|0|||
37659679|NCT02786537|69132175|FG003|As Randomized|HCV drugs stolen from pt|0|||
37659680|NCT02786537|69132176|FG004|As Randomized|HCV drugs stolen from pt|0|||
37659681|NCT02786537|69132177|FG005|As Randomized|HCV drugs stolen from pt|0|||
37659682|NCT02786537|69132172|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
37659683|NCT02786537|69132173|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
37659684|NCT02786537|69132174|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
37659685|NCT02786537|69132175|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
37659686|NCT02786537|69132176|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
37659687|NCT02786537|69132177|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
37659688|NCT02786537|69132172|FG000|As Randomized|Subject lost insurance|0|||
37659689|NCT02786537|69132173|FG001|As Randomized|Subject lost insurance|0|||
37659690|NCT02786537|69132174|FG002|As Randomized|Subject lost insurance|0|||
37659691|NCT02786537|69132175|FG003|As Randomized|Subject lost insurance|1|||
37659692|NCT02786537|69132176|FG004|As Randomized|Subject lost insurance|0|||
37659693|NCT02786537|69132177|FG005|As Randomized|Subject lost insurance|0|||
37659694|NCT02786537|69132172|FG000|As Treated|Adverse Event|0|||
37659695|NCT02786537|69132173|FG001|As Treated|Adverse Event|11|||
37659696|NCT02786537|69132174|FG002|As Treated|Adverse Event|0|||
37659697|NCT02786537|69132175|FG003|As Treated|Adverse Event|4|||
37659698|NCT02786537|69132176|FG004|As Treated|Adverse Event|6|||
37659699|NCT02786537|69132177|FG005|As Treated|Adverse Event|2|||
37659700|NCT02786537|69132172|FG000|As Treated|Death|0|||
37659701|NCT02786537|69132173|FG001|As Treated|Death|2|||
37659702|NCT02786537|69132174|FG002|As Treated|Death|0|||
37659703|NCT02786537|69132175|FG003|As Treated|Death|3|||
37659704|NCT02786537|69132176|FG004|As Treated|Death|1|||
37659705|NCT02786537|69132177|FG005|As Treated|Death|0|||
37659706|NCT02786537|69132172|FG000|As Treated|Lack of Efficacy|0|||
37749314|NCT01899053|69241174|FG008|Overall Study|Adverse Event|2|||
37749315|NCT01899053|69241175|FG009|Overall Study|Adverse Event|0|||
37749316|NCT01899053|69241176|FG010|Overall Study|Adverse Event|3|||
37749317|NCT01899053|69241177|FG011|Overall Study|Adverse Event|1|||
37749318|NCT01899053|69241178|FG012|Overall Study|Adverse Event|2|||
37923071|NCT00807846|69609844|FG000|Overall Study|Other|1|||
37923072|NCT00807846|69609845|FG001|Overall Study|Other|2|||
37659707|NCT02786537|69132173|FG001|As Treated|Lack of Efficacy|0|||
37659708|NCT02786537|69132174|FG002|As Treated|Lack of Efficacy|0|||
37659709|NCT02786537|69132175|FG003|As Treated|Lack of Efficacy|1|||
37749319|NCT01899053|69241179|FG013|Overall Study|Adverse Event|2|||
37659710|NCT02786537|69132176|FG004|As Treated|Lack of Efficacy|0|||
37659711|NCT02786537|69132177|FG005|As Treated|Lack of Efficacy|0|||
37659712|NCT02786537|69132172|FG000|As Treated|Lost to Follow-up|4|||
37659713|NCT02786537|69132173|FG001|As Treated|Lost to Follow-up|32|||
37659714|NCT02786537|69132174|FG002|As Treated|Lost to Follow-up|0|||
37659715|NCT02786537|69132175|FG003|As Treated|Lost to Follow-up|25|||
37659716|NCT02786537|69132176|FG004|As Treated|Lost to Follow-up|4|||
37923073|NCT00810108|69609853|FG000|Overall Study|Withdrawal by Subject|1|||
37659717|NCT02786537|69132177|FG005|As Treated|Lost to Follow-up|4|||
37659718|NCT02786537|69132172|FG000|As Treated|Non-compliance with study drug|1|||
37659719|NCT02786537|69132173|FG001|As Treated|Non-compliance with study drug|11|||
37659720|NCT02786537|69132174|FG002|As Treated|Non-compliance with study drug|0|||
37659721|NCT02786537|69132175|FG003|As Treated|Non-compliance with study drug|1|||
37659722|NCT02786537|69132176|FG004|As Treated|Non-compliance with study drug|0|||
37659723|NCT02786537|69132177|FG005|As Treated|Non-compliance with study drug|1|||
37659724|NCT02786537|69132172|FG000|As Treated|Lost insurance|0|||
37659725|NCT02786537|69132173|FG001|As Treated|Lost insurance|0|||
37659726|NCT02786537|69132174|FG002|As Treated|Lost insurance|0|||
37659727|NCT02786537|69132175|FG003|As Treated|Lost insurance|1|||
37659728|NCT02786537|69132176|FG004|As Treated|Lost insurance|0|||
37659729|NCT02786537|69132177|FG005|As Treated|Lost insurance|0|||
37659730|NCT02786537|69132172|FG000|As Treated|Withdrawal by Subject|1|||
37659731|NCT02786537|69132173|FG001|As Treated|Withdrawal by Subject|2|||
37659732|NCT02786537|69132174|FG002|As Treated|Withdrawal by Subject|0|||
37659733|NCT02786537|69132175|FG003|As Treated|Withdrawal by Subject|0|||
37659734|NCT02786537|69132176|FG004|As Treated|Withdrawal by Subject|1|||
37659735|NCT02786537|69132177|FG005|As Treated|Withdrawal by Subject|0|||
37749320|NCT01899053|69241166|FG000|Overall Study|Reason Not Specified|0|||
37749321|NCT01899053|69241167|FG001|Overall Study|Reason Not Specified|0|||
37749322|NCT01899053|69241168|FG002|Overall Study|Reason Not Specified|0|||
37749323|NCT01899053|69241169|FG003|Overall Study|Reason Not Specified|0|||
37749324|NCT01899053|69241170|FG004|Overall Study|Reason Not Specified|0|||
37749325|NCT01899053|69241171|FG005|Overall Study|Reason Not Specified|0|||
37749326|NCT01899053|69241172|FG006|Overall Study|Reason Not Specified|1|||
37749327|NCT01899053|69241173|FG007|Overall Study|Reason Not Specified|0|||
37749328|NCT01899053|69241174|FG008|Overall Study|Reason Not Specified|0|||
37749329|NCT01899053|69241175|FG009|Overall Study|Reason Not Specified|0|||
37749330|NCT01899053|69241176|FG010|Overall Study|Reason Not Specified|0|||
37749331|NCT01899053|69241177|FG011|Overall Study|Reason Not Specified|0|||
37749332|NCT01899053|69241178|FG012|Overall Study|Reason Not Specified|1|||
37749333|NCT01899053|69241179|FG013|Overall Study|Reason Not Specified|0|||
37749334|NCT01899053|69241166|FG000|Overall Study|Withdrawal by Subject|1|||
37749335|NCT01899053|69241167|FG001|Overall Study|Withdrawal by Subject|1|||
37749336|NCT01899053|69241168|FG002|Overall Study|Withdrawal by Subject|2|||
37749337|NCT01899053|69241169|FG003|Overall Study|Withdrawal by Subject|0|||
37749338|NCT01899053|69241170|FG004|Overall Study|Withdrawal by Subject|2|||
37749339|NCT01899053|69241171|FG005|Overall Study|Withdrawal by Subject|0|||
37659736|NCT02786537|69132172|FG000|As Treated|Incarceration|0|||
37659737|NCT02786537|69132173|FG001|As Treated|Incarceration|1|||
37749340|NCT01899053|69241172|FG006|Overall Study|Withdrawal by Subject|0|||
37749341|NCT01899053|69241173|FG007|Overall Study|Withdrawal by Subject|1|||
37749342|NCT01899053|69241174|FG008|Overall Study|Withdrawal by Subject|0|||
37749343|NCT01899053|69241175|FG009|Overall Study|Withdrawal by Subject|0|||
37749344|NCT01899053|69241176|FG010|Overall Study|Withdrawal by Subject|0|||
37749345|NCT01899053|69241177|FG011|Overall Study|Withdrawal by Subject|0|||
37749346|NCT01899053|69241178|FG012|Overall Study|Withdrawal by Subject|1|||
37749347|NCT01899053|69241179|FG013|Overall Study|Withdrawal by Subject|1|||
37856285|NCT01214655|69539442|FG002|Part C|Death|1|||
37856286|NCT01214655|69539440|FG000|Part C|Physician Decision|0|||
37856287|NCT01214655|69539441|FG001|Part C|Physician Decision|0|||
37856288|NCT01214655|69539442|FG002|Part C|Physician Decision|1|||
37856289|NCT01017874|69539490|FG000|Overall Study|Withdrawal by Subject|23|||
37856290|NCT01017874|69539491|FG001|Overall Study|Withdrawal by Subject|20|||
37856291|NCT01017874|69539490|FG000|Overall Study|Sponsor decision|3|||
37856292|NCT01017874|69539491|FG001|Overall Study|Sponsor decision|1|||
37856293|NCT01017874|69539490|FG000|Overall Study|Lost to Follow-up|3|||
37856294|NCT01017874|69539491|FG001|Overall Study|Lost to Follow-up|2|||
37856295|NCT01017874|69539490|FG000|Overall Study|Physician Decision|1|||
37856296|NCT01017874|69539491|FG001|Overall Study|Physician Decision|3|||
37856297|NCT01015768|69539497|FG000|Overall Study|Some subject data unuseable|4|||
37749348|NCT01899053|69241166|FG000|Overall Study|Protocol Violation|0|||
37749349|NCT01899053|69241167|FG001|Overall Study|Protocol Violation|0|||
37856298|NCT01015768|69539498|FG001|Overall Study|Some subject data unuseable|4|||
38033085|NCT04913675|69719124|FG002|Main Study (Up to Week 36)|Withdrawal by Subject|12|||
37749350|NCT01899053|69241168|FG002|Overall Study|Protocol Violation|1|||
37749351|NCT01899053|69241169|FG003|Overall Study|Protocol Violation|0|||
37856299|NCT04426630|69539506|FG000|Overall Study|Death|4|||
37749352|NCT01899053|69241170|FG004|Overall Study|Protocol Violation|0|||
37856300|NCT04426630|69539506|FG000|Overall Study|Lost to Follow-up|2|||
37659738|NCT02786537|69132174|FG002|As Treated|Incarceration|0|||
37659739|NCT02786537|69132175|FG003|As Treated|Incarceration|0|||
37659740|NCT02786537|69132176|FG004|As Treated|Incarceration|0|||
37659741|NCT02786537|69132177|FG005|As Treated|Incarceration|0|||
37659742|NCT02786537|69132172|FG000|As Treated|Opiate dependency relapse|0|||
37659743|NCT02786537|69132173|FG001|As Treated|Opiate dependency relapse|1|||
37749353|NCT01899053|69241171|FG005|Overall Study|Protocol Violation|0|||
37856301|NCT01010230|69539512|FG000|Overall Study|Withdrawal by Subject|6|||
37749354|NCT01899053|69241172|FG006|Overall Study|Protocol Violation|0|||
37749355|NCT01899053|69241173|FG007|Overall Study|Protocol Violation|0|||
37749356|NCT01899053|69241174|FG008|Overall Study|Protocol Violation|0|||
37749357|NCT01899053|69241175|FG009|Overall Study|Protocol Violation|0|||
37749358|NCT01899053|69241176|FG010|Overall Study|Protocol Violation|0|||
37856302|NCT01010230|69539513|FG001|Overall Study|Withdrawal by Subject|5|||
37856303|NCT01010230|69539512|FG000|Overall Study|Lost to Follow-up|4|||
37856304|NCT01010230|69539513|FG001|Overall Study|Lost to Follow-up|2|||
37856305|NCT01009840|69539519|FG000|Overall Study|Lost to Follow-up|1|||
37856306|NCT01009840|69539519|FG000|Overall Study|Adverse Event|4|||
37856307|NCT01009840|69539519|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
37856308|NCT01009840|69539519|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
37856309|NCT01009840|69539519|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
37856310|NCT00982657|69539527|FG000|Overall Study|Death|1|||
37856311|NCT00982657|69539528|FG001|Overall Study|Death|0|||
37856312|NCT00982657|69539529|FG002|Overall Study|Death|1|||
37856313|NCT00982657|69539530|FG003|Overall Study|Death|1|||
37856314|NCT00982657|69539527|FG000|Overall Study|Withdrawal by Subject|0|||
37856315|NCT00982657|69539528|FG001|Overall Study|Withdrawal by Subject|0|||
37856316|NCT00982657|69539529|FG002|Overall Study|Withdrawal by Subject|1|||
37856317|NCT00982657|69539530|FG003|Overall Study|Withdrawal by Subject|3|||
37856318|NCT00982657|69539527|FG000|Overall Study|Other|0|||
37659744|NCT02786537|69132174|FG002|As Treated|Opiate dependency relapse|0|||
37659745|NCT02786537|69132175|FG003|As Treated|Opiate dependency relapse|0|||
37659746|NCT02786537|69132176|FG004|As Treated|Opiate dependency relapse|0|||
37659747|NCT02786537|69132177|FG005|As Treated|Opiate dependency relapse|0|||
37659748|NCT02786537|69132172|FG000|As Treated|Drugs stolen from patient|0|||
37659749|NCT02786537|69132173|FG001|As Treated|Drugs stolen from patient|1|||
37659750|NCT02786537|69132174|FG002|As Treated|Drugs stolen from patient|0|||
37659751|NCT02786537|69132175|FG003|As Treated|Drugs stolen from patient|0|||
37659752|NCT02786537|69132176|FG004|As Treated|Drugs stolen from patient|0|||
37659753|NCT02786537|69132177|FG005|As Treated|Drugs stolen from patient|0|||
37659754|NCT02786537|69132172|FG000|As Treated|Advised to stop tx after loss of meds|0|||
37659755|NCT02786537|69132173|FG001|As Treated|Advised to stop tx after loss of meds|1|||
37659756|NCT02786537|69132174|FG002|As Treated|Advised to stop tx after loss of meds|0|||
37659757|NCT02786537|69132175|FG003|As Treated|Advised to stop tx after loss of meds|0|||
37659758|NCT02786537|69132176|FG004|As Treated|Advised to stop tx after loss of meds|0|||
37659759|NCT02786537|69132177|FG005|As Treated|Advised to stop tx after loss of meds|0|||
37659760|NCT02216812|69132285|FG000|Overall Study|Lost to Follow-up|10|||
37659761|NCT02216812|69132286|FG001|Overall Study|Lost to Follow-up|5|||
37659762|NCT02252536|69132294|FG000|Overall Study|Lost to Follow-up|5|||
37659763|NCT02252536|69132295|FG001|Overall Study|Lost to Follow-up|3|||
37659764|NCT02206828|69132301|FG000|Overall Study|Lost to Follow-up|7|||
37659765|NCT01209767|69132328|FG000|Overall Study|Withdrawal by Subject|1|||
37659766|NCT01209767|69132328|FG000|Overall Study|Lost to Follow-up|3|||
37659767|NCT02252146|69132336|FG000|Overall Study|Lack of Efficacy|4|||
37659768|NCT02252146|69132336|FG000|Overall Study|Entered hospice care|1|||
37659769|NCT02252146|69132336|FG000|Overall Study|Inability to travel to study site|1|||
37659770|NCT02251990|69132342|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
37659771|NCT02251990|69132343|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
37659772|NCT02251990|69132342|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
37659773|NCT02251990|69132343|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
37659774|NCT02251990|69132342|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
37659775|NCT02251990|69132343|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
37659776|NCT02251990|69132342|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
37659777|NCT02251990|69132343|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
37659778|NCT02251990|69132342|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
37659779|NCT02251990|69132343|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
37659780|NCT02251990|69132342|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
37856319|NCT00982657|69539528|FG001|Overall Study|Other|0|||
37856320|NCT00982657|69539529|FG002|Overall Study|Other|0|||
37856321|NCT00982657|69539530|FG003|Overall Study|Other|4|||
37856322|NCT00982657|69539527|FG000|Overall Study|On going at date of cut-off|0|||
37856323|NCT00982657|69539528|FG001|Overall Study|On going at date of cut-off|0|||
37659781|NCT02251990|69132343|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
37659782|NCT02251912|69132352|FG000|Overall Study|Withdrawal by Subject|2|||
37749359|NCT01899053|69241177|FG011|Overall Study|Protocol Violation|0|||
37856324|NCT00982657|69539529|FG002|Overall Study|On going at date of cut-off|0|||
37659783|NCT02251912|69132353|FG001|Overall Study|Withdrawal by Subject|3|||
37659784|NCT02251912|69132352|FG000|Overall Study|Adverse Event|0|||
37749360|NCT01899053|69241178|FG012|Overall Study|Protocol Violation|0|||
37749361|NCT01899053|69241179|FG013|Overall Study|Protocol Violation|0|||
37856325|NCT00982657|69539530|FG003|Overall Study|On going at date of cut-off|1|||
37856326|NCT01005316|69539553|FG000|Overall Study|Adverse Event|0|||
37856327|NCT01005316|69539554|FG001|Overall Study|Adverse Event|0|||
37856328|NCT01005316|69539555|FG002|Overall Study|Adverse Event|0|||
37659785|NCT02251912|69132353|FG001|Overall Study|Adverse Event|2|||
37659786|NCT02206048|69132368|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
37659787|NCT02205814|69132380|FG000|Overall Study|Lost to Follow-up|0|||
37659788|NCT02205814|69132381|FG001|Overall Study|Lost to Follow-up|0|||
37659789|NCT02205814|69132382|FG002|Overall Study|Lost to Follow-up|0|||
37659790|NCT02205814|69132383|FG003|Overall Study|Lost to Follow-up|1|||
37659791|NCT02205814|69132380|FG000|Overall Study|Lack of Efficacy|1|||
37659792|NCT02205814|69132381|FG001|Overall Study|Lack of Efficacy|0|||
37659793|NCT02205814|69132382|FG002|Overall Study|Lack of Efficacy|1|||
37659794|NCT02205814|69132383|FG003|Overall Study|Lack of Efficacy|1|||
37659795|NCT02205814|69132380|FG000|Overall Study|Physician Decision|0|||
37659796|NCT02205814|69132381|FG001|Overall Study|Physician Decision|0|||
37659797|NCT02205814|69132382|FG002|Overall Study|Physician Decision|1|||
37659798|NCT02205814|69132383|FG003|Overall Study|Physician Decision|0|||
37659799|NCT02205814|69132380|FG000|Overall Study|Protocol Violation|1|||
37659800|NCT02205814|69132381|FG001|Overall Study|Protocol Violation|0|||
37659801|NCT02205814|69132382|FG002|Overall Study|Protocol Violation|0|||
37659802|NCT02205814|69132383|FG003|Overall Study|Protocol Violation|1|||
37659803|NCT02205814|69132380|FG000|Overall Study|Withdrawal by Subject|0|||
37659804|NCT02205814|69132381|FG001|Overall Study|Withdrawal by Subject|1|||
37659805|NCT02205814|69132382|FG002|Overall Study|Withdrawal by Subject|2|||
37659806|NCT02205814|69132383|FG003|Overall Study|Withdrawal by Subject|1|||
37659807|NCT02205814|69132380|FG000|Overall Study|not compliant with study procedures|0|||
37659808|NCT02205814|69132381|FG001|Overall Study|not compliant with study procedures|0|||
37659809|NCT02205814|69132382|FG002|Overall Study|not compliant with study procedures|1|||
37659810|NCT02205814|69132383|FG003|Overall Study|not compliant with study procedures|0|||
37659811|NCT02662985|69132395|FG000|Treatment Period 1|Adverse Event|0|||
37659812|NCT02662985|69132396|FG001|Treatment Period 1|Adverse Event|2|||
37659813|NCT02662985|69132395|FG000|Treatment Period 1|Protocol Violation|0|||
37659814|NCT02662985|69132396|FG001|Treatment Period 1|Protocol Violation|1|||
37659815|NCT02662985|69132395|FG000|Treatment Period 1|Physician Decision|1|||
37659816|NCT02662985|69132396|FG001|Treatment Period 1|Physician Decision|0|||
37659817|NCT02662985|69132395|FG000|Treatment Period 1|Withdrawal by Subject|0|||
37659818|NCT02662985|69132396|FG001|Treatment Period 1|Withdrawal by Subject|1|||
37659819|NCT02662985|69132395|FG000|Treatment Period 2|Lack of Efficacy|0|||
37749362|NCT01899053|69241166|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
37749363|NCT01899053|69241167|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
37749364|NCT01899053|69241168|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
37749365|NCT01899053|69241169|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
37749366|NCT01899053|69241170|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
37749367|NCT01899053|69241171|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
37749368|NCT01899053|69241172|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
37856329|NCT01005316|69539556|FG003|Overall Study|Adverse Event|1|||
37856330|NCT01005316|69539553|FG000|Overall Study|Death|20|||
37856331|NCT01005316|69539554|FG001|Overall Study|Death|5|||
37856332|NCT01005316|69539555|FG002|Overall Study|Death|1|||
37749369|NCT01899053|69241173|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
37856333|NCT01005316|69539556|FG003|Overall Study|Death|15|||
37856334|NCT01005316|69539553|FG000|Overall Study|Study Termination|5|||
37749370|NCT01899053|69241174|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
37749371|NCT01899053|69241175|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
37749372|NCT01899053|69241176|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
37749373|NCT01899053|69241177|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
37749374|NCT01899053|69241178|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
37749375|NCT01899053|69241179|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
37749376|NCT01899053|69241166|FG000|Overall Study|Symptomatic Deterioration|0|||
37749377|NCT01899053|69241167|FG001|Overall Study|Symptomatic Deterioration|0|||
37749378|NCT01899053|69241168|FG002|Overall Study|Symptomatic Deterioration|0|||
37749379|NCT01899053|69241169|FG003|Overall Study|Symptomatic Deterioration|0|||
37749380|NCT01899053|69241170|FG004|Overall Study|Symptomatic Deterioration|0|||
37856335|NCT01005316|69539554|FG001|Overall Study|Study Termination|63|||
37856336|NCT01005316|69539555|FG002|Overall Study|Study Termination|9|||
37856337|NCT01005316|69539556|FG003|Overall Study|Study Termination|85|||
37856338|NCT01005316|69539553|FG000|Overall Study|Lost to Follow-up|1|||
37856339|NCT01005316|69539554|FG001|Overall Study|Lost to Follow-up|3|||
37659820|NCT02662985|69132396|FG001|Treatment Period 2|Lack of Efficacy|1|||
37659821|NCT02662985|69132395|FG000|Treatment Period 2|Lost to Follow-up|1|||
37659822|NCT02662985|69132396|FG001|Treatment Period 2|Lost to Follow-up|0|||
37659823|NCT02662985|69132395|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
37659824|NCT02662985|69132396|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
37659825|NCT02662985|69132395|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
37659826|NCT02662985|69132396|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
37659827|NCT02662985|69132395|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
37659828|NCT02662985|69132396|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
37856340|NCT01005316|69539555|FG002|Overall Study|Lost to Follow-up|0|||
37659829|NCT02662985|69132395|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
37659830|NCT02662985|69132396|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
37659831|NCT02662985|69132395|FG000|Treatment Period 3 (Extension Period)|Death|0|||
37659832|NCT02662985|69132396|FG001|Treatment Period 3 (Extension Period)|Death|1|||
37659833|NCT01631812|69132402|FG000|Overall Study|Adverse Event|25|||
37659834|NCT01631812|69132402|FG000|Overall Study|Lack of Efficacy|5|||
37659835|NCT01631812|69132402|FG000|Overall Study|Withdrawal by Subject|4|||
37659836|NCT01631812|69132402|FG000|Overall Study|Physician Decision|3|||
37659837|NCT02323295|69132408|FG000|Overall Study|Adverse Event|0|||
37659838|NCT02323295|69132409|FG001|Overall Study|Adverse Event|1|||
37659839|NCT02323295|69132408|FG000|Overall Study|Withdrawal by Subject|0|||
37659840|NCT02323295|69132409|FG001|Overall Study|Withdrawal by Subject|1|||
37659841|NCT02323295|69132408|FG000|Overall Study|Patient did not have surgery as planned.|0|||
37659842|NCT02323295|69132409|FG001|Overall Study|Patient did not have surgery as planned.|1|||
37659843|NCT02215954|69132418|FG000|Overall Study|Adverse Event|0|||
37659844|NCT02215954|69132419|FG001|Overall Study|Adverse Event|0|||
37659845|NCT02215954|69132420|FG002|Overall Study|Adverse Event|1|||
37659846|NCT02215954|69132418|FG000|Overall Study|Withdrawal by Subject|0|||
37659847|NCT02215954|69132419|FG001|Overall Study|Withdrawal by Subject|0|||
37659848|NCT02215954|69132420|FG002|Overall Study|Withdrawal by Subject|2|||
37659849|NCT02215954|69132418|FG000|Overall Study|Not exposed|1|||
37659850|NCT02215954|69132419|FG001|Overall Study|Not exposed|1|||
37659851|NCT02215954|69132420|FG002|Overall Study|Not exposed|3|||
37659852|NCT01941719|69132431|FG000|Overall Study|Lost to Follow-up|20|||
37659853|NCT01941719|69132432|FG001|Overall Study|Lost to Follow-up|19|||
37659854|NCT02215252|69132442|FG000|Overall Study|Adverse Event|1|||
37659855|NCT02215252|69132443|FG001|Overall Study|Adverse Event|5|||
37659856|NCT02215252|69132444|FG002|Overall Study|Adverse Event|2|||
37659857|NCT02215252|69132442|FG000|Overall Study|Lost to Follow-up|0|||
37659858|NCT02215252|69132443|FG001|Overall Study|Lost to Follow-up|0|||
37659859|NCT02215252|69132444|FG002|Overall Study|Lost to Follow-up|1|||
37659860|NCT02215252|69132442|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
37659861|NCT02215252|69132443|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
37659862|NCT02215252|69132444|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
37659863|NCT02215252|69132442|FG000|Overall Study|Protocol Violation|0|||
37659864|NCT02215252|69132443|FG001|Overall Study|Protocol Violation|1|||
37659865|NCT02215252|69132444|FG002|Overall Study|Protocol Violation|0|||
37659866|NCT02215252|69132442|FG000|Overall Study|Withdrawal by Subject|1|||
37659867|NCT02215252|69132443|FG001|Overall Study|Withdrawal by Subject|0|||
37659868|NCT02215252|69132444|FG002|Overall Study|Withdrawal by Subject|0|||
37659869|NCT02215252|69132442|FG000|Overall Study|Other|0|||
37659870|NCT02215252|69132443|FG001|Overall Study|Other|1|||
37659871|NCT02215252|69132444|FG002|Overall Study|Other|1|||
37659872|NCT02204410|69132456|FG000|Overall Study|Lost to Follow-up|5|||
37659873|NCT02204410|69132456|FG000|Overall Study|Physician Decision|2|||
37659874|NCT02204410|69132456|FG000|Overall Study|Protocol Violation|1|||
37659875|NCT02204410|69132456|FG000|Overall Study|Withdrawal by Subject|3|||
37659876|NCT02250274|69132462|FG000|Overall Study|Insufficient blood draw amount|7|||
37659877|NCT02250274|69132463|FG001|Overall Study|Insufficient blood draw amount|6|||
37659878|NCT02213458|69132477|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
37856341|NCT01005316|69539556|FG003|Overall Study|Lost to Follow-up|2|||
37856342|NCT01005316|69539553|FG000|Overall Study|Physician Decision|6|||
37856343|NCT01005316|69539554|FG001|Overall Study|Physician Decision|0|||
37856344|NCT01005316|69539555|FG002|Overall Study|Physician Decision|0|||
37856345|NCT01005316|69539556|FG003|Overall Study|Physician Decision|0|||
37856346|NCT01005316|69539553|FG000|Overall Study|Sponsor Decision|6|||
37856347|NCT01005316|69539554|FG001|Overall Study|Sponsor Decision|3|||
37856348|NCT01005316|69539555|FG002|Overall Study|Sponsor Decision|0|||
37856349|NCT01005316|69539556|FG003|Overall Study|Sponsor Decision|0|||
37856350|NCT01005316|69539553|FG000|Overall Study|Withdrawal by Subject|1|||
37856351|NCT01005316|69539554|FG001|Overall Study|Withdrawal by Subject|1|||
37856352|NCT01005316|69539555|FG002|Overall Study|Withdrawal by Subject|0|||
37659879|NCT02213458|69132478|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
37659880|NCT02213458|69132477|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
37659881|NCT02213458|69132478|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
37659882|NCT02213458|69132477|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
37659883|NCT02213458|69132478|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
37659884|NCT02213458|69132477|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
37659885|NCT02213458|69132478|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
37856353|NCT01005316|69539556|FG003|Overall Study|Withdrawal by Subject|2|||
37659886|NCT02213458|69132477|FG000|Overall Study|Refused re-consent|6|||
37659887|NCT02213458|69132478|FG001|Overall Study|Refused re-consent|0|||
37659888|NCT02213458|69132477|FG000|Overall Study|Lost to Follow-up|2|||
37856354|NCT01005316|69539553|FG000|Overall Study|Consented to Another Study|2|||
37856355|NCT01005316|69539554|FG001|Overall Study|Consented to Another Study|0|||
37749381|NCT01899053|69241171|FG005|Overall Study|Symptomatic Deterioration|1|||
37749382|NCT01899053|69241172|FG006|Overall Study|Symptomatic Deterioration|0|||
37749383|NCT01899053|69241173|FG007|Overall Study|Symptomatic Deterioration|1|||
37749384|NCT01899053|69241174|FG008|Overall Study|Symptomatic Deterioration|0|||
37749385|NCT01899053|69241175|FG009|Overall Study|Symptomatic Deterioration|0|||
37749386|NCT01899053|69241176|FG010|Overall Study|Symptomatic Deterioration|0|||
37749387|NCT01899053|69241177|FG011|Overall Study|Symptomatic Deterioration|1|||
37749388|NCT01899053|69241178|FG012|Overall Study|Symptomatic Deterioration|2|||
37749389|NCT01899053|69241179|FG013|Overall Study|Symptomatic Deterioration|0|||
37749390|NCT01888367|69241284|FG000|Overall Study|Physician Decision|3|||
37749391|NCT01888367|69241285|FG001|Overall Study|Physician Decision|4|||
37749392|NCT01888367|69241286|FG002|Overall Study|Physician Decision|2|||
37749393|NCT01888367|69241284|FG000|Overall Study|Death|2|||
37749394|NCT01888367|69241285|FG001|Overall Study|Death|0|||
37749395|NCT01888367|69241286|FG002|Overall Study|Death|1|||
37749396|NCT01888367|69241284|FG000|Overall Study|Withdrawal by Subject|1|||
37659889|NCT02213458|69132478|FG001|Overall Study|Lost to Follow-up|2|||
37659890|NCT02213458|69132477|FG000|Overall Study|Withdrawal by Subject|26|||
37659891|NCT02213458|69132478|FG001|Overall Study|Withdrawal by Subject|8|||
37659892|NCT02213380|69132486|FG000|Underwent Randomization|Withdrawal by Subject|2|||
37659893|NCT02213380|69132487|FG001|Underwent Randomization|Withdrawal by Subject|0|||
37659894|NCT02213380|69132486|FG000|Underwent Randomization|Not treated|3|||
37659895|NCT02213380|69132487|FG001|Underwent Randomization|Not treated|3|||
37659896|NCT02213380|69132486|FG000|Per-protocol Analysis|Protocol Violation|32|||
37659897|NCT02213380|69132487|FG001|Per-protocol Analysis|Protocol Violation|36|||
37749397|NCT01888367|69241285|FG001|Overall Study|Withdrawal by Subject|0|||
37749398|NCT01888367|69241286|FG002|Overall Study|Withdrawal by Subject|1|||
37749399|NCT01888367|69241284|FG000|Overall Study|Lost to Follow-up|1|||
37749400|NCT01888367|69241285|FG001|Overall Study|Lost to Follow-up|1|||
37749401|NCT01888367|69241286|FG002|Overall Study|Lost to Follow-up|0|||
37749402|NCT01888367|69241284|FG000|Overall Study|Protocol Violation|0|||
37749403|NCT01888367|69241285|FG001|Overall Study|Protocol Violation|0|||
37749404|NCT01888367|69241286|FG002|Overall Study|Protocol Violation|1|||
37749405|NCT01888367|69241284|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
37749406|NCT01888367|69241285|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
37749407|NCT01888367|69241286|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
37749408|NCT01898195|69241312|FG000|Smoking Abstinence|Did not have good measurements|35|||
37749409|NCT01898195|69241313|FG001|Smoking Abstinence|Did not have good measurements|38|||
37749410|NCT01898195|69241314|FG002|Smoking Abstinence|Did not have good measurements|36|||
37749411|NCT01897727|69241328|FG000|Overall Study|Exclusion: central sleep apnea|0|||
37749412|NCT01897727|69241329|FG001|Overall Study|Exclusion: central sleep apnea|1|||
37659898|NCT02202850|69132495|FG000|Overall Study|Other|2|||
37659899|NCT02202850|69132496|FG001|Overall Study|Other|2|||
37659900|NCT02202850|69132495|FG000|Overall Study|Enbrel treatment discontinued|15|||
37749413|NCT01897493|69241335|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
37749414|NCT01887353|69241344|FG000|Overall Study|Study stopped early|4|||
37749415|NCT01887353|69241345|FG001|Overall Study|Study stopped early|3|||
37749416|NCT01896869|69241367|FG000|Overall Study|Withdrawal by Subject|0|||
37856356|NCT01005316|69539555|FG002|Overall Study|Consented to Another Study|0|||
37856357|NCT01005316|69539556|FG003|Overall Study|Consented to Another Study|0|||
37856358|NCT01005316|69539553|FG000|Overall Study|Delisted|8|||
37856359|NCT01005316|69539554|FG001|Overall Study|Delisted|0|||
37856360|NCT01005316|69539555|FG002|Overall Study|Delisted|0|||
37856361|NCT01005316|69539556|FG003|Overall Study|Delisted|0|||
37856362|NCT01005316|69539553|FG000|Overall Study|Transferred Care|1|||
37856363|NCT01005316|69539554|FG001|Overall Study|Transferred Care|0|||
37856364|NCT01005316|69539555|FG002|Overall Study|Transferred Care|1|||
37856365|NCT01005316|69539556|FG003|Overall Study|Transferred Care|3|||
37856366|NCT01005316|69539553|FG000|Overall Study|Retransplanted|0|||
37856367|NCT01005316|69539554|FG001|Overall Study|Retransplanted|1|||
37659901|NCT02202850|69132496|FG001|Overall Study|Enbrel treatment discontinued|3|||
37659902|NCT02202850|69132495|FG000|Overall Study|Lost to Follow-up|7|||
37749417|NCT01896869|69241368|FG001|Overall Study|Withdrawal by Subject|6|||
37749418|NCT01896869|69241367|FG000|Overall Study|Lost to Follow-up|1|||
37749419|NCT01896869|69241368|FG001|Overall Study|Lost to Follow-up|0|||
37749420|NCT01896557|69241378|FG000|Clopidogrel Alone|Adverse Event|1|||
37749421|NCT01896557|69241379|FG001|Clopidogrel Alone|Adverse Event|0|||
37749422|NCT01896557|69241378|FG000|Clopidogrel + GI Protector|low adherence|1|||
37856368|NCT01005316|69539555|FG002|Overall Study|Retransplanted|0|||
37856369|NCT01005316|69539556|FG003|Overall Study|Retransplanted|0|||
37659903|NCT02202850|69132496|FG001|Overall Study|Lost to Follow-up|1|||
37659904|NCT02212678|69132502|FG000|Overall Study|Adverse Event|1|||
37749423|NCT01896557|69241379|FG001|Clopidogrel + GI Protector|low adherence|1|||
37749424|NCT01896557|69241378|FG000|Clopidogrel + GI Protector|Reading error|1|||
37749425|NCT01896557|69241379|FG001|Clopidogrel + GI Protector|Reading error|3|||
37749426|NCT01886105|69241394|FG000|Overall Study|Lack of Efficacy|3|||
37749427|NCT01895777|69241423|FG000|Overall Study|Adverse Event|1|||
37856370|NCT01004848|69539569|FG000|Overall Study|Lost to Follow-up|55|||
37659905|NCT03104075|69132508|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
37659906|NCT03104075|69132509|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
37749428|NCT01895777|69241424|FG001|Overall Study|Adverse Event|2|||
37749429|NCT01895777|69241423|FG000|Overall Study|Lost to Follow-up|2|||
37749430|NCT01895777|69241424|FG001|Overall Study|Lost to Follow-up|0|||
37749431|NCT01895777|69241423|FG000|Overall Study|Not treated|1|||
37749432|NCT01895777|69241424|FG001|Overall Study|Not treated|0|||
37749433|NCT01895777|69241423|FG000|Overall Study|Other reasons|3|||
37749434|NCT01895777|69241424|FG001|Overall Study|Other reasons|2|||
37749435|NCT01895777|69241423|FG000|Overall Study|Non-compliance with the CTP|2|||
37749436|NCT01895777|69241424|FG001|Overall Study|Non-compliance with the CTP|1|||
37749437|NCT01885559|69241452|FG000|Overall Study|Lost to Follow-up|15|||
37749438|NCT01885559|69241453|FG001|Overall Study|Lost to Follow-up|16|||
37749439|NCT01885559|69241452|FG000|Overall Study|Less than full participation|9|||
37749440|NCT01885559|69241453|FG001|Overall Study|Less than full participation|19|||
37749441|NCT01885559|69241452|FG000|Overall Study|Protocol Violation|0|||
37749442|NCT01885559|69241453|FG001|Overall Study|Protocol Violation|1|||
37749443|NCT01884545|69241463|FG000|Overall Study|Lost to Follow-up|6|||
37749444|NCT01884545|69241464|FG001|Overall Study|Lost to Follow-up|4|||
37749445|NCT01884545|69241465|FG002|Overall Study|Lost to Follow-up|9|||
37659907|NCT03038087|69132516|FG000|Overall Study|lost data|1|||
37659908|NCT02249182|69132527|FG000|Treatment Phase|Lost to Follow-up|4|||
37659909|NCT02249182|69132528|FG001|Treatment Phase|Lost to Follow-up|0|||
37659910|NCT02249182|69132529|FG002|Treatment Phase|Lost to Follow-up|0|||
37659911|NCT02249182|69132530|FG003|Treatment Phase|Lost to Follow-up|0|||
37659912|NCT02249182|69132531|FG004|Treatment Phase|Lost to Follow-up|0|||
37659913|NCT03641339|69132562|FG000|Overall Study|Physician Decision|1|||
37659914|NCT03641339|69132563|FG001|Overall Study|Physician Decision|0|||
37749446|NCT01884545|69241466|FG003|Overall Study|Lost to Follow-up|4|||
37749447|NCT01884545|69241463|FG000|Overall Study|Patient withdrawn|7|||
37749448|NCT01884545|69241464|FG001|Overall Study|Patient withdrawn|12|||
37749449|NCT01884545|69241465|FG002|Overall Study|Patient withdrawn|5|||
37749450|NCT01884545|69241466|FG003|Overall Study|Patient withdrawn|5|||
37749451|NCT01884545|69241463|FG000|Overall Study|Non-adherence|0|||
37749452|NCT01884545|69241464|FG001|Overall Study|Non-adherence|2|||
37749453|NCT01884545|69241465|FG002|Overall Study|Non-adherence|0|||
37749454|NCT01884545|69241466|FG003|Overall Study|Non-adherence|0|||
37749455|NCT01895543|69241476|FG000|Overall Study|Withdrawal by Subject|43|||
37749456|NCT01895543|69241476|FG000|Overall Study|Lost to Follow-up|25|||
37749457|NCT01895543|69241476|FG000|Overall Study|Adverse Event|28|||
37749458|NCT01895543|69241476|FG000|Overall Study|Subject's substantial non-compliance|6|||
37749459|NCT01895543|69241476|FG000|Overall Study|Protocol Violation|1|||
37749460|NCT01895543|69241476|FG000|Overall Study|Physician Decision|2|||
37749461|NCT01895543|69241476|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
37856371|NCT01004848|69539570|FG001|Overall Study|Lost to Follow-up|45|||
37659915|NCT03641339|69132564|FG002|Overall Study|Physician Decision|0|||
37856372|NCT01009294|69539578|FG000|Overall Study|Study discontinued by Sponsor|6|||
37659916|NCT03641339|69132565|FG003|Overall Study|Physician Decision|0|||
37659917|NCT03641339|69132566|FG004|Overall Study|Physician Decision|0|||
37659918|NCT03641339|69132567|FG005|Overall Study|Physician Decision|0|||
37659919|NCT03641339|69132562|FG000|Overall Study|Withdrawal by Subject|0|||
37659920|NCT03641339|69132563|FG001|Overall Study|Withdrawal by Subject|2|||
37659921|NCT03641339|69132564|FG002|Overall Study|Withdrawal by Subject|0|||
37659922|NCT03641339|69132565|FG003|Overall Study|Withdrawal by Subject|2|||
37659923|NCT03641339|69132566|FG004|Overall Study|Withdrawal by Subject|0|||
37659924|NCT03641339|69132567|FG005|Overall Study|Withdrawal by Subject|1|||
37659925|NCT02248480|69132583|FG000|Overall Study|Lack of Efficacy|4|||
37659926|NCT02248480|69132584|FG001|Overall Study|Lack of Efficacy|6|||
37659927|NCT02248480|69132583|FG000|Overall Study|Adverse Event|11|||
37659928|NCT02248480|69132584|FG001|Overall Study|Adverse Event|2|||
37659929|NCT02248480|69132583|FG000|Overall Study|Withdrawal by Subject|2|||
37659930|NCT02248480|69132584|FG001|Overall Study|Withdrawal by Subject|4|||
37856373|NCT01009060|69539584|FG000|Overall Study|Adverse Event|1|||
37856374|NCT01009060|69539585|FG001|Overall Study|Adverse Event|2|||
37856375|NCT01009060|69539584|FG000|Overall Study|Protocol Violation|0|||
37856376|NCT01009060|69539585|FG001|Overall Study|Protocol Violation|1|||
37856377|NCT01009060|69539584|FG000|Overall Study|Lost to Follow-up|1|||
37856378|NCT01009060|69539585|FG001|Overall Study|Lost to Follow-up|0|||
37856379|NCT01009060|69539584|FG000|Overall Study|Physician Decision|1|||
37856380|NCT01009060|69539585|FG001|Overall Study|Physician Decision|1|||
37856381|NCT01009060|69539584|FG000|Overall Study|Withdrawal by Subject|1|||
37856382|NCT01009060|69539585|FG001|Overall Study|Withdrawal by Subject|1|||
37856383|NCT00988429|69539598|FG000|Overall Study|Adverse Event|9|||
37856384|NCT00988429|69539599|FG001|Overall Study|Adverse Event|21|||
37856385|NCT00988429|69539600|FG002|Overall Study|Adverse Event|45|||
37856386|NCT00988429|69539598|FG000|Overall Study|Lack of Efficacy|0|||
37856387|NCT00988429|69539599|FG001|Overall Study|Lack of Efficacy|0|||
37856388|NCT00988429|69539600|FG002|Overall Study|Lack of Efficacy|1|||
37749462|NCT04828161|69241573|FG000|Overall Study|Withdrawal by Subject|0|||
37749463|NCT04828161|69241574|FG001|Overall Study|Withdrawal by Subject|3|||
37749464|NCT04828161|69241575|FG002|Overall Study|Withdrawal by Subject|3|||
37749465|NCT04828161|69241576|FG003|Overall Study|Withdrawal by Subject|4|||
37749466|NCT04828161|69241573|FG000|Overall Study|Lost to Follow-up|1|||
37749467|NCT04828161|69241574|FG001|Overall Study|Lost to Follow-up|4|||
37749468|NCT04828161|69241575|FG002|Overall Study|Lost to Follow-up|2|||
37749469|NCT04828161|69241576|FG003|Overall Study|Lost to Follow-up|2|||
37749470|NCT04828161|69241573|FG000|Overall Study|Other|2|||
37749471|NCT04828161|69241574|FG001|Overall Study|Other|0|||
37749472|NCT04828161|69241575|FG002|Overall Study|Other|2|||
37749473|NCT04828161|69241576|FG003|Overall Study|Other|0|||
37749474|NCT04828161|69241573|FG000|Overall Study|Death|0|||
37749475|NCT04828161|69241574|FG001|Overall Study|Death|0|||
37749476|NCT04828161|69241575|FG002|Overall Study|Death|0|||
37856389|NCT00988429|69539598|FG000|Overall Study|Non-Compliance with Study Drug|5|||
37856390|NCT00988429|69539599|FG001|Overall Study|Non-Compliance with Study Drug|1|||
37856391|NCT00988429|69539600|FG002|Overall Study|Non-Compliance with Study Drug|3|||
37856392|NCT00988429|69539598|FG000|Overall Study|Physician Decision|1|||
37856393|NCT00988429|69539599|FG001|Overall Study|Physician Decision|0|||
37856394|NCT00988429|69539600|FG002|Overall Study|Physician Decision|3|||
37856395|NCT00988429|69539598|FG000|Overall Study|Pregnancy|2|||
37856396|NCT00988429|69539599|FG001|Overall Study|Pregnancy|1|||
37856397|NCT00988429|69539600|FG002|Overall Study|Pregnancy|0|||
37856398|NCT00988429|69539598|FG000|Overall Study|Protocol Violation|4|||
37923074|NCT00810108|69609854|FG001|Overall Study|Withdrawal by Subject|0|||
37923075|NCT00827606|69609861|FG000|Overall Study|Protocol Violation|4|||
37923076|NCT00827606|69609862|FG001|Overall Study|Protocol Violation|3|||
37923077|NCT00827606|69609861|FG000|Overall Study|Lost to Follow-up|3|||
37923078|NCT00827606|69609862|FG001|Overall Study|Lost to Follow-up|1|||
37923079|NCT00827606|69609861|FG000|Overall Study|Withdrawal by Subject|7|||
37923080|NCT00827606|69609862|FG001|Overall Study|Withdrawal by Subject|6|||
37923081|NCT00827606|69609861|FG000|Overall Study|Pregnancy|0|||
37923082|NCT00827606|69609862|FG001|Overall Study|Pregnancy|1|||
37923083|NCT00827606|69609861|FG000|Overall Study|Other|5|||
37923084|NCT00827606|69609862|FG001|Overall Study|Other|13|||
37923085|NCT00827606|69609861|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
37923086|NCT00827606|69609862|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
37923087|NCT00827606|69609861|FG000|Overall Study|Adverse Event|4|||
37923088|NCT00827606|69609862|FG001|Overall Study|Adverse Event|2|||
37923089|NCT00663052|69609876|FG000|Overall Study|Adverse Event|6|||
37923090|NCT00663052|69609877|FG001|Overall Study|Adverse Event|3|||
37659931|NCT02248480|69132583|FG000|Overall Study|Entry Criteria Not Met|0|||
37659932|NCT02248480|69132584|FG001|Overall Study|Entry Criteria Not Met|1|||
37659933|NCT02248480|69132583|FG000|Overall Study|Other:Physician Decision|0|||
37659934|NCT02248480|69132584|FG001|Overall Study|Other:Physician Decision|1|||
37659935|NCT01653158|69132591|FG000|Overall Study|Death|0|||
37659936|NCT01653158|69132592|FG001|Overall Study|Death|0|||
37659937|NCT01653158|69132593|FG002|Overall Study|Death|0|||
37659938|NCT01653158|69132594|FG003|Overall Study|Death|1|||
37659939|NCT01653158|69132595|FG004|Overall Study|Death|0|||
37659940|NCT01653158|69132596|FG005|Overall Study|Death|0|||
37659941|NCT01653158|69132597|FG006|Overall Study|Death|0|||
37659942|NCT01653158|69132598|FG007|Overall Study|Death|2|||
37659943|NCT01653158|69132591|FG000|Overall Study|Adverse Event|0|||
37659944|NCT01653158|69132592|FG001|Overall Study|Adverse Event|0|||
37659945|NCT01653158|69132593|FG002|Overall Study|Adverse Event|0|||
37659946|NCT01653158|69132594|FG003|Overall Study|Adverse Event|1|||
37659947|NCT01653158|69132595|FG004|Overall Study|Adverse Event|0|||
37749477|NCT04828161|69241576|FG003|Overall Study|Death|2|||
37749478|NCT01895309|69241674|FG000|Overall Study|Adverse Event|13|||
37749479|NCT01895309|69241675|FG001|Overall Study|Adverse Event|17|||
37923091|NCT00663052|69609876|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
37923092|NCT00663052|69609877|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
37923093|NCT00663052|69609876|FG000|Overall Study|Protocol Violation|1|||
37923094|NCT00663052|69609877|FG001|Overall Study|Protocol Violation|0|||
37659948|NCT01653158|69132596|FG005|Overall Study|Adverse Event|0|||
37659949|NCT01653158|69132597|FG006|Overall Study|Adverse Event|0|||
37659950|NCT01653158|69132598|FG007|Overall Study|Adverse Event|3|||
37659951|NCT01653158|69132591|FG000|Overall Study|Other|0|||
37659952|NCT01653158|69132592|FG001|Overall Study|Other|0|||
37659953|NCT01653158|69132593|FG002|Overall Study|Other|0|||
37749480|NCT01895309|69241674|FG000|Overall Study|Protocol Violation|1|||
37856399|NCT00988429|69539599|FG001|Overall Study|Protocol Violation|3|||
37923095|NCT00663052|69609876|FG000|Overall Study|Withdrawal by Subject|2|||
37923096|NCT00663052|69609877|FG001|Overall Study|Withdrawal by Subject|5|||
37659954|NCT01653158|69132594|FG003|Overall Study|Other|0|||
37659955|NCT01653158|69132595|FG004|Overall Study|Other|0|||
37749481|NCT01895309|69241675|FG001|Overall Study|Protocol Violation|0|||
37749482|NCT01895309|69241674|FG000|Overall Study|Lack of Efficacy|1|||
37856400|NCT00988429|69539600|FG002|Overall Study|Protocol Violation|3|||
37749483|NCT01895309|69241675|FG001|Overall Study|Lack of Efficacy|3|||
37749484|NCT01895309|69241674|FG000|Overall Study|Lost to Follow-up|1|||
37749485|NCT01895309|69241675|FG001|Overall Study|Lost to Follow-up|3|||
37749486|NCT01895309|69241674|FG000|Overall Study|Physician Decision|15|||
37749487|NCT01895309|69241675|FG001|Overall Study|Physician Decision|10|||
37659956|NCT01653158|69132596|FG005|Overall Study|Other|0|||
37659957|NCT01653158|69132597|FG006|Overall Study|Other|0|||
37659958|NCT01653158|69132598|FG007|Overall Study|Other|1|||
37659959|NCT01653158|69132591|FG000|Overall Study|Progressive disease|0|||
37659960|NCT01653158|69132592|FG001|Overall Study|Progressive disease|0|||
37659961|NCT01653158|69132593|FG002|Overall Study|Progressive disease|0|||
37659962|NCT01653158|69132594|FG003|Overall Study|Progressive disease|0|||
37659963|NCT01653158|69132595|FG004|Overall Study|Progressive disease|1|||
37659964|NCT01653158|69132596|FG005|Overall Study|Progressive disease|1|||
37659965|NCT01653158|69132597|FG006|Overall Study|Progressive disease|2|||
37659966|NCT01653158|69132598|FG007|Overall Study|Progressive disease|9|||
37749488|NCT01895309|69241674|FG000|Overall Study|Withdrawal by Subject|9|||
37749489|NCT01895309|69241675|FG001|Overall Study|Withdrawal by Subject|18|||
37749490|NCT01884311|69241685|FG000|Overall Study|Withdrawal by Subject|3|||
37749491|NCT01884311|69241685|FG000|Overall Study|withdrew consent due to AEs|1|||
37749492|NCT01884311|69241685|FG000|Overall Study|Precautionary measure|1|||
37749493|NCT01884077|69241725|FG000|Overall Study|screen fail|0|||
37749494|NCT01884077|69241726|FG001|Overall Study|screen fail|2|||
37749495|NCT01884077|69241725|FG000|Overall Study|canceled surgery|2|||
37749496|NCT01884077|69241726|FG001|Overall Study|canceled surgery|0|||
37749497|NCT01884077|69241725|FG000|Overall Study|Lost to Follow-up|0|||
37749498|NCT01884077|69241726|FG001|Overall Study|Lost to Follow-up|4|||
37749499|NCT01884077|69241725|FG000|Overall Study|study closed|6|||
37749500|NCT01884077|69241726|FG001|Overall Study|study closed|4|||
37749501|NCT01894919|69241745|FG000|Overall Study|Withdrawal by Subject|1|||
37749502|NCT01894919|69241746|FG001|Overall Study|Withdrawal by Subject|0|||
37749503|NCT01894919|69241747|FG002|Overall Study|Withdrawal by Subject|0|||
37749504|NCT01894919|69241748|FG003|Overall Study|Withdrawal by Subject|0|||
37749505|NCT01894919|69241749|FG004|Overall Study|Withdrawal by Subject|1|||
37749506|NCT01894919|69241750|FG005|Overall Study|Withdrawal by Subject|0|||
37749507|NCT01894919|69241751|FG006|Overall Study|Withdrawal by Subject|0|||
37749508|NCT01894919|69241752|FG007|Overall Study|Withdrawal by Subject|0|||
37749509|NCT01894919|69241753|FG008|Overall Study|Withdrawal by Subject|0|||
37749510|NCT01894919|69241754|FG009|Overall Study|Withdrawal by Subject|1|||
37749511|NCT01894919|69241755|FG010|Overall Study|Withdrawal by Subject|1|||
37749512|NCT01894919|69241756|FG011|Overall Study|Withdrawal by Subject|0|||
37749513|NCT01894919|69241757|FG012|Overall Study|Withdrawal by Subject|0|||
37749514|NCT01894919|69241745|FG000|Overall Study|Adverse Event|0|||
37749515|NCT01894919|69241746|FG001|Overall Study|Adverse Event|0|||
37749516|NCT01894919|69241747|FG002|Overall Study|Adverse Event|0|||
37749517|NCT01894919|69241748|FG003|Overall Study|Adverse Event|0|||
37749518|NCT01894919|69241749|FG004|Overall Study|Adverse Event|0|||
37749519|NCT01894919|69241750|FG005|Overall Study|Adverse Event|0|||
37749520|NCT01894919|69241751|FG006|Overall Study|Adverse Event|0|||
37749521|NCT01894919|69241752|FG007|Overall Study|Adverse Event|0|||
37749522|NCT01894919|69241753|FG008|Overall Study|Adverse Event|0|||
37856401|NCT00988429|69539598|FG000|Overall Study|Withdrawal by Subject|7|||
37856402|NCT00988429|69539599|FG001|Overall Study|Withdrawal by Subject|7|||
37856403|NCT00988429|69539600|FG002|Overall Study|Withdrawal by Subject|12|||
37856404|NCT00988429|69539598|FG000|Overall Study|Administrative Reasons|1|||
37856405|NCT00988429|69539599|FG001|Overall Study|Administrative Reasons|2|||
37659967|NCT01653158|69132591|FG000|Overall Study|Withdrawal by Subject|1|||
37659968|NCT01653158|69132592|FG001|Overall Study|Withdrawal by Subject|0|||
37856406|NCT00988429|69539600|FG002|Overall Study|Administrative Reasons|1|||
37856407|NCT00988429|69539598|FG000|Overall Study|other reasons|8|||
37856408|NCT00988429|69539599|FG001|Overall Study|other reasons|8|||
37856409|NCT00988429|69539600|FG002|Overall Study|other reasons|1|||
37856410|NCT01008904|69539609|FG000|Overall Study|Lost to Follow-up|1|||
37856411|NCT01008904|69539609|FG000|Overall Study|Adverse Event|2|||
37856412|NCT01008904|69539609|FG000|Overall Study|unexpected unrelated surgery|1|||
37856413|NCT01004614|69539617|FG000|Washout|Withdrawal by Subject|0|||
37659969|NCT01653158|69132593|FG002|Overall Study|Withdrawal by Subject|0|||
37659970|NCT01653158|69132594|FG003|Overall Study|Withdrawal by Subject|0|||
37659971|NCT01653158|69132595|FG004|Overall Study|Withdrawal by Subject|0|||
37659972|NCT01653158|69132596|FG005|Overall Study|Withdrawal by Subject|0|||
37659973|NCT01653158|69132597|FG006|Overall Study|Withdrawal by Subject|0|||
37749523|NCT01894919|69241754|FG009|Overall Study|Adverse Event|0|||
37749524|NCT01894919|69241755|FG010|Overall Study|Adverse Event|1|||
37749525|NCT01894919|69241756|FG011|Overall Study|Adverse Event|0|||
37749526|NCT01894919|69241757|FG012|Overall Study|Adverse Event|0|||
37749527|NCT01894919|69241745|FG000|Overall Study|Other-Unspecified|1|||
37749528|NCT01894919|69241746|FG001|Overall Study|Other-Unspecified|0|||
37749529|NCT01894919|69241747|FG002|Overall Study|Other-Unspecified|0|||
37856414|NCT01004614|69539618|FG001|Washout|Withdrawal by Subject|1|||
37749530|NCT01894919|69241748|FG003|Overall Study|Other-Unspecified|0|||
37749531|NCT01894919|69241749|FG004|Overall Study|Other-Unspecified|0|||
37749532|NCT01894919|69241750|FG005|Overall Study|Other-Unspecified|0|||
37749533|NCT01894919|69241751|FG006|Overall Study|Other-Unspecified|0|||
37749534|NCT01894919|69241752|FG007|Overall Study|Other-Unspecified|0|||
37749535|NCT01894919|69241753|FG008|Overall Study|Other-Unspecified|0|||
37749536|NCT01894919|69241754|FG009|Overall Study|Other-Unspecified|0|||
37749537|NCT01894919|69241755|FG010|Overall Study|Other-Unspecified|0|||
37749538|NCT01894919|69241756|FG011|Overall Study|Other-Unspecified|0|||
37749539|NCT01894919|69241757|FG012|Overall Study|Other-Unspecified|0|||
37749540|NCT01894919|69241745|FG000|Overall Study|Lost to Follow-up|0|||
37749541|NCT01894919|69241746|FG001|Overall Study|Lost to Follow-up|0|||
37749542|NCT01894919|69241747|FG002|Overall Study|Lost to Follow-up|0|||
37749543|NCT01894919|69241748|FG003|Overall Study|Lost to Follow-up|0|||
37749544|NCT01894919|69241749|FG004|Overall Study|Lost to Follow-up|2|||
37749545|NCT01894919|69241750|FG005|Overall Study|Lost to Follow-up|0|||
37659974|NCT01653158|69132598|FG007|Overall Study|Withdrawal by Subject|0|||
37659975|NCT02247466|69132623|FG000|Overall Study|Procedure changed to open surgery|0|||
37659976|NCT02247466|69132624|FG001|Overall Study|Procedure changed to open surgery|3|||
37659977|NCT03317795|69132632|FG000|Overall Study|IUD Expulsion|1|||
37659978|NCT03317795|69132633|FG001|Overall Study|IUD Expulsion|0|||
37659979|NCT03317795|69132632|FG000|Overall Study|Lost to Follow-up|1|||
37659980|NCT03317795|69132633|FG001|Overall Study|Lost to Follow-up|3|||
37659981|NCT03317795|69132632|FG000|Overall Study|Treatment change|0|||
37659982|NCT03317795|69132633|FG001|Overall Study|Treatment change|3|||
37659983|NCT03317795|69132632|FG000|Overall Study|Intolerance of medication|0|||
37659984|NCT03317795|69132633|FG001|Overall Study|Intolerance of medication|1|||
37659985|NCT02202616|69132639|FG000|Overall Study|Screen failed|24|||
37659986|NCT02202616|69132639|FG000|Overall Study|Adverse Event|32|||
37659987|NCT02202616|69132639|FG000|Overall Study|Protocol deviation|18|||
37659988|NCT02202616|69132639|FG000|Overall Study|Patient withdrew consent|12|||
37659989|NCT02202616|69132639|FG000|Overall Study|Lost to Follow-up|6|||
37659990|NCT02202616|69132639|FG000|Overall Study|Administrative problems|6|||
37659991|NCT02202616|69132639|FG000|Overall Study|Abnormal test procedure result|1|||
37659992|NCT02202616|69132639|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
37659993|NCT02455388|69132646|FG000|Overall Study|Protocol Violation|1|||
37659994|NCT02455388|69132647|FG001|Overall Study|Protocol Violation|0|||
37659995|NCT02455388|69132648|FG002|Overall Study|Protocol Violation|4|||
37659996|NCT02455388|69132646|FG000|Overall Study|Withdrawal by Subject|0|||
37659997|NCT02455388|69132647|FG001|Overall Study|Withdrawal by Subject|0|||
37659998|NCT02455388|69132648|FG002|Overall Study|Withdrawal by Subject|7|||
37659999|NCT02455076|69132661|FG000|Inpatient|Withdrawal by Subject|1|||
37660000|NCT02455076|69132662|FG001|Inpatient|Withdrawal by Subject|0|||
37660001|NCT02455076|69132663|FG002|Inpatient|Withdrawal by Subject|0|||
37749546|NCT01894919|69241751|FG006|Overall Study|Lost to Follow-up|0|||
37749547|NCT01894919|69241752|FG007|Overall Study|Lost to Follow-up|0|||
37749548|NCT01894919|69241753|FG008|Overall Study|Lost to Follow-up|0|||
37749549|NCT01894919|69241754|FG009|Overall Study|Lost to Follow-up|0|||
37749550|NCT01894919|69241755|FG010|Overall Study|Lost to Follow-up|0|||
37749551|NCT01894919|69241756|FG011|Overall Study|Lost to Follow-up|0|||
37749552|NCT01894919|69241757|FG012|Overall Study|Lost to Follow-up|0|||
37749553|NCT01894841|69241801|FG000|Overall Study|Withdrawal by Subject|9|||
37749554|NCT01894841|69241802|FG001|Overall Study|Withdrawal by Subject|4|||
37749555|NCT01894841|69241801|FG000|Overall Study|Withdrawn by investigator|2|||
37749556|NCT01894841|69241802|FG001|Overall Study|Withdrawn by investigator|2|||
37749557|NCT01894841|69241801|FG000|Overall Study|Lost to Follow-up|7|||
37660002|NCT02455076|69132664|FG003|Inpatient|Withdrawal by Subject|0|||
37749558|NCT01894841|69241802|FG001|Overall Study|Lost to Follow-up|3|||
37749559|NCT01894607|69241812|FG000|Overall Study|Ineligible|1|||
37749560|NCT01883453|69241818|FG000|Overall Study|No episode of common cold|25|||
37660003|NCT02455076|69132665|FG004|Inpatient|Withdrawal by Subject|0|||
37660004|NCT02455076|69132661|FG000|Inpatient|Discharged <24 h after admission|0|||
37660005|NCT02455076|69132662|FG001|Inpatient|Discharged <24 h after admission|1|||
37660006|NCT02455076|69132663|FG002|Inpatient|Discharged <24 h after admission|0|||
37660007|NCT02455076|69132664|FG003|Inpatient|Discharged <24 h after admission|0|||
37660008|NCT02455076|69132665|FG004|Inpatient|Discharged <24 h after admission|0|||
37660009|NCT02455076|69132661|FG000|Inpatient|Adverse Event|3|||
37660010|NCT02455076|69132662|FG001|Inpatient|Adverse Event|0|||
37660011|NCT02455076|69132663|FG002|Inpatient|Adverse Event|0|||
37660012|NCT02455076|69132664|FG003|Inpatient|Adverse Event|0|||
37660013|NCT02455076|69132665|FG004|Inpatient|Adverse Event|0|||
37660014|NCT02455076|69132661|FG000|Outpatient|Adverse Event|0|||
37660015|NCT02455076|69132662|FG001|Outpatient|Adverse Event|0|||
37749561|NCT01883453|69241819|FG001|Overall Study|No episode of common cold|23|||
37749562|NCT01882985|69241853|FG000|Overall Study|Lost to Follow-up|1|||
37749563|NCT01882985|69241853|FG000|Overall Study|Withdrawal by Subject|1|||
37749564|NCT01893905|69241866|FG000|Overall Study|Withdrawal by Subject|1|||
37749565|NCT01893905|69241867|FG001|Overall Study|Withdrawal by Subject|0|||
37749566|NCT01893905|69241866|FG000|Overall Study|Adverse Event|9|||
37660016|NCT02455076|69132663|FG002|Outpatient|Adverse Event|0|||
37749567|NCT01893905|69241867|FG001|Overall Study|Adverse Event|3|||
37749568|NCT01893905|69241866|FG000|Overall Study|Lack of Efficacy|5|||
37749569|NCT01893905|69241867|FG001|Overall Study|Lack of Efficacy|7|||
37749570|NCT01893905|69241866|FG000|Overall Study|Lost to Follow-up|1|||
37749571|NCT01893905|69241867|FG001|Overall Study|Lost to Follow-up|0|||
37749572|NCT01893905|69241866|FG000|Overall Study|Protocol Violation|6|||
37749573|NCT01893905|69241867|FG001|Overall Study|Protocol Violation|1|||
37749574|NCT01893905|69241866|FG000|Overall Study|Lack of adherence to treatment|2|||
37660017|NCT02455076|69132664|FG003|Outpatient|Adverse Event|5|||
37660018|NCT02455076|69132665|FG004|Outpatient|Adverse Event|0|||
37660019|NCT02455076|69132661|FG000|Outpatient|Lost to Follow-up|0|||
37660020|NCT02455076|69132662|FG001|Outpatient|Lost to Follow-up|0|||
37660021|NCT02455076|69132663|FG002|Outpatient|Lost to Follow-up|0|||
37660022|NCT02455076|69132664|FG003|Outpatient|Lost to Follow-up|1|||
37660023|NCT02455076|69132665|FG004|Outpatient|Lost to Follow-up|12|||
37660024|NCT02433080|69132679|FG000|Overall Study|Lost to Follow-up|1|||
37660025|NCT02433080|69132680|FG001|Overall Study|Lost to Follow-up|2|||
37749575|NCT01893905|69241867|FG001|Overall Study|Lack of adherence to treatment|0|||
37749576|NCT01893905|69241866|FG000|Overall Study|Other reason|1|||
37749577|NCT01893905|69241867|FG001|Overall Study|Other reason|3|||
37749578|NCT01893827|69241880|FG000|Overall Study|Lost to Follow-up|19|||
37749579|NCT01893827|69241881|FG001|Overall Study|Lost to Follow-up|26|||
37749580|NCT01882907|69241889|FG000|Overall Study|Adverse Event|3|||
37749581|NCT01882907|69241890|FG001|Overall Study|Adverse Event|1|||
37749582|NCT01882907|69241889|FG000|Overall Study|Lack of Efficacy|0|||
37749583|NCT01882907|69241890|FG001|Overall Study|Lack of Efficacy|3|||
37749584|NCT01882907|69241889|FG000|Overall Study|Lost to Follow-up|1|||
37749585|NCT01882907|69241890|FG001|Overall Study|Lost to Follow-up|4|||
37749586|NCT01882907|69241889|FG000|Overall Study|Protocol Violation|10|||
37749587|NCT01882907|69241890|FG001|Overall Study|Protocol Violation|14|||
37749588|NCT01882907|69241889|FG000|Overall Study|Withdrawal by Subject|0|||
37749589|NCT01882907|69241890|FG001|Overall Study|Withdrawal by Subject|6|||
37749590|NCT01893281|69241912|FG000|Overall Study|Adverse Event|1|||
37749591|NCT01893281|69241912|FG000|Overall Study|Protocol Violation|1|||
37749592|NCT01893281|69241912|FG000|Overall Study|Withdrawal by Subject|1|||
37749593|NCT01893203|69241916|FG000|Overall Study|Withdrawal by Subject|1|||
37749594|NCT01882829|69241920|FG000|Overall Study|Adverse Event|4|||
37749595|NCT01882829|69241920|FG000|Overall Study|Protocol Violation|1|||
37749596|NCT01882829|69241920|FG000|Overall Study|Withdrawal by Subject|1|||
37660026|NCT02433080|69132679|FG000|Overall Study|Withdrawal by Subject|0|||
37660027|NCT02433080|69132680|FG001|Overall Study|Withdrawal by Subject|2|||
37660028|NCT03092219|69132689|FG000|Overall Study|Protocol Violation|7|||
37660029|NCT03092219|69132690|FG001|Overall Study|Protocol Violation|4|||
37660030|NCT02432846|69132705|FG000|Overall Study (4 Arms/Strata)|Death|3|||
37749597|NCT01882439|69242004|FG000|Overall Study|Adverse event related to study drug|3|||
37749598|NCT01882439|69242005|FG001|Overall Study|Adverse event related to study drug|8|||
37856415|NCT01004614|69539619|FG002|Washout|Withdrawal by Subject|0|||
37856416|NCT01004614|69539620|FG003|Washout|Withdrawal by Subject|0|||
37856417|NCT00981409|69539632|FG000|Overall Study|Adverse Event|4|||
37856418|NCT00981409|69539633|FG001|Overall Study|Adverse Event|0|||
37856419|NCT00981409|69539632|FG000|Overall Study|Protocol Violation|0|||
37856420|NCT00981409|69539633|FG001|Overall Study|Protocol Violation|1|||
37856421|NCT00981409|69539632|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
37856422|NCT00981409|69539633|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
37856423|NCT01008748|69539639|FG000|Overall Study|Lost to Follow-up|80|||
37856424|NCT01008748|69539639|FG000|Overall Study|Other|1|||
37856425|NCT01004146|69539645|FG000|Overall Study|Withdrawal by Subject|4|||
37856426|NCT01004146|69539646|FG001|Overall Study|Withdrawal by Subject|5|||
37856427|NCT01012414|69539652|FG000|Overall Study|Withdrawal by Subject|2|||
37856428|NCT01012414|69539652|FG000|Overall Study|Lost to Follow-up|1|||
37660031|NCT02432846|69132706|FG001|Overall Study (4 Arms/Strata)|Death|2|||
37660032|NCT02432846|69132707|FG002|Overall Study (4 Arms/Strata)|Death|4|||
37660033|NCT02432846|69132708|FG003|Overall Study (4 Arms/Strata)|Death|3|||
37660034|NCT02432846|69132709|FG004|Overall Study (4 Arms/Strata)|Death|0|||
37749599|NCT01882439|69242006|FG002|Overall Study|Adverse event related to study drug|1|||
37749600|NCT01882439|69242007|FG003|Overall Study|Adverse event related to study drug|2|||
37749601|NCT01882439|69242004|FG000|Overall Study|Pregnancy|0|||
37749602|NCT01882439|69242005|FG001|Overall Study|Pregnancy|1|||
37749603|NCT01882439|69242006|FG002|Overall Study|Pregnancy|0|||
37749604|NCT01882439|69242007|FG003|Overall Study|Pregnancy|0|||
37856429|NCT01012414|69539652|FG000|Overall Study|Trial was stopped before completed|7|||
37856430|NCT00975715|69539660|FG000|Titration Period|Adverse Event|6|||
37660035|NCT02432846|69132710|FG005|Overall Study (4 Arms/Strata)|Death|0|||
37660036|NCT02432846|69132705|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
37749605|NCT01882439|69242004|FG000|Overall Study|Protocol Violation|2|||
37749606|NCT01882439|69242005|FG001|Overall Study|Protocol Violation|2|||
37749607|NCT01882439|69242006|FG002|Overall Study|Protocol Violation|0|||
37856431|NCT00975715|69539661|FG001|Titration Period|Adverse Event|0|||
37856432|NCT00975715|69539660|FG000|Titration Period|Protocol Violation|1|||
37856433|NCT00975715|69539661|FG001|Titration Period|Protocol Violation|0|||
37856434|NCT00975715|69539660|FG000|Maintenance Period|Adverse Event|2|||
37856435|NCT00975715|69539661|FG001|Maintenance Period|Adverse Event|1|||
37856436|NCT03962491|69539669|FG000|Overall Study|Lost to Follow-up|4|||
37856437|NCT03962491|69539670|FG001|Overall Study|Lost to Follow-up|5|||
37856438|NCT00978757|69539678|FG000|Overall Study|Physician Decision|1|||
37856439|NCT00978757|69539679|FG001|Overall Study|Physician Decision|3|||
37856440|NCT01214421|69539689|FG000|Overall Study|Lost to Follow-up|7|||
37856441|NCT01214421|69539690|FG001|Overall Study|Lost to Follow-up|3|||
37749608|NCT01882439|69242007|FG003|Overall Study|Protocol Violation|1|||
37749609|NCT01882439|69242004|FG000|Overall Study|No longer willing to participate|1|||
37749610|NCT01882439|69242005|FG001|Overall Study|No longer willing to participate|4|||
37749611|NCT01882439|69242006|FG002|Overall Study|No longer willing to participate|2|||
37749612|NCT01882439|69242007|FG003|Overall Study|No longer willing to participate|3|||
37749613|NCT01882439|69242004|FG000|Overall Study|Medication error with no associated AE|0|||
37749614|NCT01882439|69242005|FG001|Overall Study|Medication error with no associated AE|0|||
37749615|NCT01882439|69242006|FG002|Overall Study|Medication error with no associated AE|2|||
37856442|NCT01214421|69539691|FG002|Overall Study|Lost to Follow-up|7|||
37856443|NCT01214421|69539692|FG003|Overall Study|Lost to Follow-up|3|||
37660037|NCT02432846|69132706|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
37660038|NCT02432846|69132707|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
37660039|NCT02432846|69132708|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
37660040|NCT02432846|69132709|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
37660041|NCT02432846|69132710|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
37660042|NCT02432846|69132705|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
37660043|NCT02432846|69132706|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
37660044|NCT02432846|69132707|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
37660045|NCT02432846|69132708|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
37660046|NCT02432846|69132709|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
37660047|NCT02432846|69132710|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
37660048|NCT02432846|69132705|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
37660049|NCT02432846|69132706|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
37660050|NCT02432846|69132707|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
37660051|NCT02432846|69132708|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
37660052|NCT02432846|69132709|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
37660053|NCT02432846|69132710|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
37660054|NCT02432846|69132705|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
37660055|NCT02432846|69132706|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
37660056|NCT02432846|69132707|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
37660057|NCT02432846|69132708|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
37660058|NCT02432846|69132709|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
37660059|NCT02432846|69132710|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
37660060|NCT02432846|69132705|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
37660061|NCT02432846|69132706|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
37660062|NCT02432846|69132707|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
37660063|NCT02432846|69132708|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
37749616|NCT01882439|69242007|FG003|Overall Study|Medication error with no associated AE|0|||
37749617|NCT01882439|69242004|FG000|Overall Study|Insufficient clinical response|1|||
37749618|NCT01882439|69242005|FG001|Overall Study|Insufficient clinical response|4|||
37749619|NCT01882439|69242006|FG002|Overall Study|Insufficient clinical response|4|||
37749620|NCT01882439|69242007|FG003|Overall Study|Insufficient clinical response|2|||
37749621|NCT01882439|69242004|FG000|Overall Study|Adverse event unrelated to study drug|2|||
37749622|NCT01882439|69242005|FG001|Overall Study|Adverse event unrelated to study drug|2|||
37749623|NCT01882439|69242006|FG002|Overall Study|Adverse event unrelated to study drug|1|||
37749624|NCT01882439|69242007|FG003|Overall Study|Adverse event unrelated to study drug|1|||
37749625|NCT01892657|69242054|FG000|Overall Study|Withdrawal by Subject|6|||
37749626|NCT01892657|69242054|FG000|Overall Study|Protocol Violation|12|||
37749627|NCT01881737|69242081|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
37856444|NCT01214421|69539689|FG000|Overall Study|Adverse Event|16|||
37856445|NCT01214421|69539690|FG001|Overall Study|Adverse Event|35|||
37856446|NCT01214421|69539691|FG002|Overall Study|Adverse Event|14|||
38033086|NCT04913675|69719125|FG003|Main Study (Up to Week 36)|Withdrawal by Subject|0|||
37660064|NCT02432846|69132709|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
37660065|NCT02432846|69132710|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
37856447|NCT01214421|69539692|FG003|Overall Study|Adverse Event|3|||
37856448|NCT01214421|69539689|FG000|Overall Study|Sponsor Discontinued Site|1|||
37660066|NCT02432846|69132705|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
37749628|NCT01881737|69242081|FG000|Overall Study|Withdrawal by Subject|1|||
37856449|NCT01214421|69539690|FG001|Overall Study|Sponsor Discontinued Site|2|||
37856450|NCT01214421|69539691|FG002|Overall Study|Sponsor Discontinued Site|0|||
37660067|NCT02432846|69132706|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
37660068|NCT02432846|69132707|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
37660069|NCT02432846|69132708|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
37660070|NCT02432846|69132709|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
37660071|NCT02432846|69132710|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
37660072|NCT02432846|69132705|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
37749629|NCT01881737|69242081|FG000|Overall Study|Worsening of baseline behavior|1|||
37749630|NCT01892501|69242117|FG000|Overall Study|Protocol Violation|2|||
37749631|NCT01892501|69242117|FG000|Overall Study|Puncture not carried out|9|||
37749632|NCT01892501|69242117|FG000|Overall Study|Radiological monitoring not carried out|5|||
37856451|NCT01214421|69539692|FG003|Overall Study|Sponsor Discontinued Site|0|||
37856452|NCT01214421|69539689|FG000|Overall Study|Withdrawal Criteria Met|3|||
37660073|NCT02432846|69132706|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
37660074|NCT02432846|69132707|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
37660075|NCT02432846|69132708|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
37660076|NCT02432846|69132709|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
37660077|NCT02432846|69132710|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
37660078|NCT02432846|69132705|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
37660079|NCT02432846|69132706|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
37660080|NCT02432846|69132707|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
37660081|NCT02432846|69132708|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
37660082|NCT02432846|69132709|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
37660083|NCT02432846|69132710|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
37660084|NCT02432846|69132705|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
37660085|NCT02432846|69132706|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
37660086|NCT02432846|69132707|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
37660087|NCT02432846|69132708|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
37660088|NCT02432846|69132709|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
37660089|NCT02432846|69132710|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
37660090|NCT02432846|69132705|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
37660091|NCT02432846|69132706|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
37660092|NCT02432846|69132707|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
37660093|NCT02432846|69132708|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
37660094|NCT02432846|69132709|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
37660095|NCT02432846|69132710|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
37660096|NCT02432846|69132705|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
37660097|NCT02432846|69132706|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
37660098|NCT02432846|69132707|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
37660099|NCT02432846|69132708|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
37660100|NCT02432846|69132709|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
37660101|NCT02432846|69132710|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
37660102|NCT02432846|69132705|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
37660103|NCT02432846|69132706|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
37660104|NCT02432846|69132707|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
37660105|NCT02432846|69132708|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
37660106|NCT02432846|69132709|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
37660107|NCT02432846|69132710|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
37660108|NCT02432846|69132705|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
37660109|NCT02432846|69132706|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
37660110|NCT02432846|69132707|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
37660111|NCT02432846|69132708|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
37660112|NCT02432846|69132709|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
37660113|NCT02432846|69132710|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
37660114|NCT02432144|69132723|FG000|Overall Study|Participant Non-Compliance|1|||
37660115|NCT02246998|69132731|FG000|Overall Study|Adverse Event|0|||
37660116|NCT02246998|69132732|FG001|Overall Study|Adverse Event|1|||
37660117|NCT02246998|69132733|FG002|Overall Study|Adverse Event|1|||
37856453|NCT01214421|69539690|FG001|Overall Study|Withdrawal Criteria Met|0|||
37856454|NCT01214421|69539691|FG002|Overall Study|Withdrawal Criteria Met|2|||
37856455|NCT01214421|69539692|FG003|Overall Study|Withdrawal Criteria Met|1|||
37856456|NCT01214421|69539689|FG000|Overall Study|Physician Decision|2|||
37856457|NCT01214421|69539690|FG001|Overall Study|Physician Decision|0|||
37660118|NCT02246998|69132734|FG003|Overall Study|Adverse Event|0|||
37660119|NCT02246998|69132731|FG000|Overall Study|Lost to Follow-up|1|||
37660120|NCT02246998|69132732|FG001|Overall Study|Lost to Follow-up|0|||
37749633|NCT01892501|69242117|FG000|Overall Study|Non-contributory histological result|12|||
37856458|NCT01214421|69539691|FG002|Overall Study|Physician Decision|4|||
37660121|NCT02246998|69132733|FG002|Overall Study|Lost to Follow-up|0|||
37660122|NCT02246998|69132734|FG003|Overall Study|Lost to Follow-up|1|||
37660123|NCT02246998|69132731|FG000|Overall Study|Randomized but Never Dosed|1|||
37660124|NCT02246998|69132732|FG001|Overall Study|Randomized but Never Dosed|2|||
37660125|NCT02246998|69132733|FG002|Overall Study|Randomized but Never Dosed|2|||
37660126|NCT02246998|69132734|FG003|Overall Study|Randomized but Never Dosed|1|||
37660127|NCT02486588|69132753|FG000|Overall Study|Randomized in error- ineligible|738|||
37660128|NCT02486588|69132754|FG001|Overall Study|Randomized in error- ineligible|750|||
37660129|NCT02486588|69132755|FG002|Overall Study|Randomized in error- ineligible|755|||
37660130|NCT02486588|69132756|FG003|Overall Study|Randomized in error- ineligible|738|||
37660131|NCT02486588|69132757|FG004|Overall Study|Randomized in error- ineligible|746|||
37660132|NCT02486588|69132758|FG005|Overall Study|Randomized in error- ineligible|746|||
37660133|NCT00805961|69132777|FG000|Modality Therapy|Withdrawal by Subject|1|||
37660134|NCT00805961|69132777|FG000|Modality Therapy|Adverse Event|1|||
37660135|NCT00805961|69132777|FG000|Modality Therapy|Disease Progression|2|||
37660136|NCT00805961|69132777|FG000|Treatment-Free Interval|Adverse Event|3|||
37749634|NCT01892345|69242132|FG000|Overall Study|Adverse Event|0|||
37749635|NCT01892345|69242133|FG001|Overall Study|Adverse Event|2|||
37749636|NCT01892345|69242132|FG000|Overall Study|Death|1|||
37749637|NCT01892345|69242133|FG001|Overall Study|Death|0|||
37749638|NCT01892345|69242132|FG000|Overall Study|Lost to Follow-up|3|||
37749639|NCT01892345|69242133|FG001|Overall Study|Lost to Follow-up|0|||
37749640|NCT01892345|69242132|FG000|Overall Study|Withdrawal by Subject|12|||
37749641|NCT01892345|69242133|FG001|Overall Study|Withdrawal by Subject|1|||
37749642|NCT01892189|69242210|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
37749643|NCT01892189|69242211|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
37749644|NCT01892189|69242212|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
37749645|NCT01892189|69242213|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
37660137|NCT00805961|69132777|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
37660138|NCT00805961|69132777|FG000|Treatment-Free Interval|Physician Decision|1|||
37660139|NCT00805961|69132777|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
37660140|NCT00805961|69132777|FG000|Maintenance Treatment|Lack of Efficacy|13|||
37660141|NCT00805961|69132777|FG000|Maintenance Treatment|Intercurrent Illness|7|||
37660142|NCT00805961|69132777|FG000|Maintenance Treatment|Adverse Event|6|||
37660143|NCT00805961|69132777|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
37660144|NCT00805961|69132777|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
37660145|NCT00805961|69132777|FG000|Maintenance Treatment|Withdrawn Consent|1|||
37660146|NCT02202538|69132781|FG000|Overall Study|Withdrawal by Subject|5|||
37660147|NCT02202538|69132781|FG000|Overall Study|Did not meet all inclusion criteria|2|||
37660148|NCT02202538|69132781|FG000|Overall Study|Investigator Decision|1|||
37660149|NCT02454608|69132788|FG000|Double-Blind Period|Lack of Efficacy|0|||
37660150|NCT02454608|69132789|FG001|Double-Blind Period|Lack of Efficacy|2|||
37660151|NCT02454608|69132790|FG002|Double-Blind Period|Lack of Efficacy|0|||
37660152|NCT02454608|69132788|FG000|Open Label Period|Lost to Follow-up|0|||
37660153|NCT02454608|69132789|FG001|Open Label Period|Lost to Follow-up|0|||
37660154|NCT02454608|69132790|FG002|Open Label Period|Lost to Follow-up|11|||
37660155|NCT02454608|69132788|FG000|Open Label Period|Withdrawal by Subject|0|||
37660156|NCT02454608|69132789|FG001|Open Label Period|Withdrawal by Subject|0|||
37660157|NCT02454608|69132790|FG002|Open Label Period|Withdrawal by Subject|8|||
37660158|NCT02246764|69132801|FG000|Overall Study|Adverse Event|15|||
37660159|NCT02246764|69132802|FG001|Overall Study|Adverse Event|29|||
37660160|NCT02246764|69132803|FG002|Overall Study|Adverse Event|1|||
37660161|NCT02246764|69132801|FG000|Overall Study|Withdrawal by Subject|0|||
37660162|NCT02246764|69132802|FG001|Overall Study|Withdrawal by Subject|0|||
37749646|NCT01892189|69242214|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
37749647|NCT01892189|69242215|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
37749648|NCT01892189|69242216|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
37749649|NCT01892189|69242217|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
37749650|NCT01892189|69242218|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
37749651|NCT01892189|69242210|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
37749652|NCT01892189|69242211|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
37749653|NCT01892189|69242212|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
37749654|NCT01892189|69242213|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
37856459|NCT01214421|69539692|FG003|Overall Study|Physician Decision|0|||
37749655|NCT01892189|69242214|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
37856460|NCT01214421|69539689|FG000|Overall Study|Withdrawal by Subject|21|||
37856461|NCT01214421|69539690|FG001|Overall Study|Withdrawal by Subject|18|||
37856462|NCT01214421|69539691|FG002|Overall Study|Withdrawal by Subject|11|||
37660163|NCT02246764|69132803|FG002|Overall Study|Withdrawal by Subject|1|||
37660164|NCT02246764|69132801|FG000|Overall Study|Disallowed Concomitant Medication|1|||
37660165|NCT02246764|69132802|FG001|Overall Study|Disallowed Concomitant Medication|0|||
37660166|NCT02246764|69132803|FG002|Overall Study|Disallowed Concomitant Medication|0|||
37660167|NCT02246764|69132801|FG000|Overall Study|Physician Decision|0|||
37856463|NCT01214421|69539692|FG003|Overall Study|Withdrawal by Subject|2|||
37856464|NCT04102111|69539704|FG000|Overall Study|Withdrawal by Subject|2|||
37749656|NCT01892189|69242215|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
37749657|NCT01892189|69242216|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
37749658|NCT01892189|69242217|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
37749659|NCT01892189|69242218|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
37749660|NCT01892189|69242210|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
37749661|NCT01892189|69242211|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
37660168|NCT02246764|69132802|FG001|Overall Study|Physician Decision|2|||
37660169|NCT02246764|69132803|FG002|Overall Study|Physician Decision|1|||
37660170|NCT02246764|69132801|FG000|Overall Study|Protocol Violation|2|||
37660171|NCT02246764|69132802|FG001|Overall Study|Protocol Violation|1|||
37660172|NCT02246764|69132803|FG002|Overall Study|Protocol Violation|1|||
37660173|NCT02454530|69132813|FG000|Overall Study|Other|8|||
37660174|NCT02454530|69132814|FG001|Overall Study|Other|13|||
37660175|NCT02454530|69132813|FG000|Overall Study|Missing information|56|||
37660176|NCT02454530|69132814|FG001|Overall Study|Missing information|69|||
37660177|NCT02454530|69132813|FG000|Overall Study|Death|2|||
37660178|NCT02454530|69132814|FG001|Overall Study|Death|41|||
37660179|NCT02454530|69132813|FG000|Overall Study|Lost to Follow-up|4|||
37660180|NCT02454530|69132814|FG001|Overall Study|Lost to Follow-up|4|||
37660181|NCT02431676|69132824|FG000|Overall Study|no lab obtained|0|||
37660182|NCT02431676|69132825|FG001|Overall Study|no lab obtained|1|||
37660183|NCT02431676|69132826|FG002|Overall Study|no lab obtained|2|||
37660184|NCT01654250|69132836|FG000|Overall Study|Lost to Follow-up|1|||
37660185|NCT01654250|69132837|FG001|Overall Study|Lost to Follow-up|0|||
37660186|NCT01652690|69132846|FG000|Overall Study|Withdrawal by Subject|16|||
37660187|NCT01652690|69132847|FG001|Overall Study|Withdrawal by Subject|4|||
37660188|NCT01652690|69132846|FG000|Overall Study|Other|8|||
37660189|NCT01652690|69132847|FG001|Overall Study|Other|9|||
37660190|NCT01652690|69132846|FG000|Overall Study|Lost to Follow-up|6|||
37660191|NCT01652690|69132847|FG001|Overall Study|Lost to Follow-up|6|||
37660192|NCT01652690|69132846|FG000|Overall Study|Death|5|||
37660193|NCT01652690|69132847|FG001|Overall Study|Death|2|||
37660194|NCT02429258|69132855|FG000|Overall Study|Withdrawal by Subject|2|||
37660195|NCT02429258|69132856|FG001|Overall Study|Withdrawal by Subject|0|||
37660196|NCT02429258|69132855|FG000|Overall Study|Protocol Violation|0|||
37660197|NCT02429258|69132856|FG001|Overall Study|Protocol Violation|1|||
37660198|NCT02201524|69132866|FG000|Overall Study|Adverse Event|0|||
37660199|NCT02201524|69132867|FG001|Overall Study|Adverse Event|2|||
37660200|NCT02201524|69132868|FG002|Overall Study|Adverse Event|1|||
37660201|NCT02201524|69132869|FG003|Overall Study|Adverse Event|0|||
37660202|NCT02201524|69132866|FG000|Overall Study|Insufficient clinical response|1|||
37660203|NCT02201524|69132867|FG001|Overall Study|Insufficient clinical response|0|||
37660204|NCT02201524|69132868|FG002|Overall Study|Insufficient clinical response|0|||
37660205|NCT02201524|69132869|FG003|Overall Study|Insufficient clinical response|0|||
37660206|NCT02201524|69132866|FG000|Overall Study|Lost to Follow-up|0|||
37660207|NCT02201524|69132867|FG001|Overall Study|Lost to Follow-up|0|||
37660208|NCT02201524|69132868|FG002|Overall Study|Lost to Follow-up|2|||
37749662|NCT01892189|69242212|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
37749663|NCT01892189|69242213|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
37749664|NCT01892189|69242214|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
37749665|NCT01892189|69242215|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
37749666|NCT01892189|69242216|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
37749667|NCT01892189|69242217|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
37749668|NCT01892189|69242218|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
37749669|NCT01881425|69242249|FG000|Overall Study|Death|5|||
37660209|NCT02201524|69132869|FG003|Overall Study|Lost to Follow-up|0|||
37660210|NCT02201524|69132866|FG000|Overall Study|No longer meets eligibility criteria|0|||
37749670|NCT01881425|69242250|FG001|Overall Study|Death|1|||
37749671|NCT01881425|69242249|FG000|Overall Study|Withdrawal by Subject|8|||
37749672|NCT01881425|69242250|FG001|Overall Study|Withdrawal by Subject|3|||
37749673|NCT01881425|69242249|FG000|Overall Study|Physician Decision|2|||
37749674|NCT01881425|69242250|FG001|Overall Study|Physician Decision|1|||
37856465|NCT04102111|69539705|FG001|Overall Study|Withdrawal by Subject|3|||
37856466|NCT04102111|69539704|FG000|Overall Study|Adverse Event|1|||
37660211|NCT02201524|69132867|FG001|Overall Study|No longer meets eligibility criteria|0|||
37660212|NCT02201524|69132868|FG002|Overall Study|No longer meets eligibility criteria|0|||
37660213|NCT02201524|69132869|FG003|Overall Study|No longer meets eligibility criteria|2|||
37660214|NCT02201524|69132866|FG000|Overall Study|Protocol Violation|0|||
37749675|NCT01881425|69242249|FG000|Overall Study|Adverse Event|3|||
37749676|NCT01881425|69242250|FG001|Overall Study|Adverse Event|0|||
37856467|NCT04102111|69539705|FG001|Overall Study|Adverse Event|1|||
37660215|NCT02201524|69132867|FG001|Overall Study|Protocol Violation|0|||
37660216|NCT02201524|69132868|FG002|Overall Study|Protocol Violation|0|||
37660217|NCT02201524|69132869|FG003|Overall Study|Protocol Violation|1|||
37660218|NCT02201524|69132866|FG000|Overall Study|Withdrawal by Subject|0|||
37660219|NCT02201524|69132867|FG001|Overall Study|Withdrawal by Subject|0|||
37660220|NCT02201524|69132868|FG002|Overall Study|Withdrawal by Subject|1|||
37660221|NCT02201524|69132869|FG003|Overall Study|Withdrawal by Subject|1|||
37660222|NCT02201524|69132866|FG000|Overall Study|Other|1|||
37660223|NCT02201524|69132867|FG001|Overall Study|Other|1|||
37749677|NCT01881425|69242249|FG000|Overall Study|General Anesthesia panic attack|0|||
37749678|NCT01881425|69242250|FG001|Overall Study|General Anesthesia panic attack|1|||
37749679|NCT01881425|69242249|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
37749680|NCT01881425|69242250|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
37749681|NCT01881425|69242249|FG000|Overall Study|Lost to Follow-up|7|||
37749682|NCT01881425|69242250|FG001|Overall Study|Lost to Follow-up|2|||
37660224|NCT02201524|69132868|FG002|Overall Study|Other|0|||
37660225|NCT02201524|69132869|FG003|Overall Study|Other|0|||
37660226|NCT02453048|69132884|FG000|Overall Study|Only part of initial 6 mo. study|0|||
37660227|NCT02453048|69132885|FG001|Overall Study|Only part of initial 6 mo. study|0|||
37660228|NCT02453048|69132886|FG002|Overall Study|Only part of initial 6 mo. study|0|||
37749683|NCT01891721|69242269|FG000|Overall Study|Lost to Follow-up|10|||
37749684|NCT01891721|69242270|FG001|Overall Study|Lost to Follow-up|5|||
37749685|NCT01891721|69242271|FG002|Overall Study|Lost to Follow-up|1|||
37749686|NCT01880957|69242290|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
37749687|NCT01880957|69242291|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
37749688|NCT01880957|69242290|FG000|Overall Study|Lost to Follow-up|11|||
37749689|NCT01880957|69242291|FG001|Overall Study|Lost to Follow-up|0|||
37749690|NCT01880957|69242290|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
37749691|NCT01880957|69242291|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
37749692|NCT04152837|69242306|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
37749693|NCT04152837|69242306|FG000|Maintenance Period|Adverse Event|1|||
37749694|NCT04152837|69242306|FG000|Maintenance Period|Withdrawal by Subject|1|||
37749695|NCT04152837|69242306|FG000|Maintenance Period|Sponsor Termination of Study|2|||
37749696|NCT01879553|69242325|FG000|Overall Study|Withdrawal by Subject|1|||
37749697|NCT01879553|69242326|FG001|Overall Study|Withdrawal by Subject|0|||
37749698|NCT01890785|69242347|FG000|Third Intervention|Withdrawal by Subject|0|||
37749699|NCT01890785|69242348|FG001|Third Intervention|Withdrawal by Subject|1|||
37749700|NCT01890785|69242349|FG002|Third Intervention|Withdrawal by Subject|0|||
37749701|NCT01890785|69242350|FG003|Third Intervention|Withdrawal by Subject|0|||
37749702|NCT01890785|69242351|FG004|Third Intervention|Withdrawal by Subject|0|||
37749703|NCT01890785|69242352|FG005|Third Intervention|Withdrawal by Subject|0|||
37749704|NCT01878383|69242376|FG000|Overall Study|Lost to Follow-up|0|||
37749705|NCT01878383|69242377|FG001|Overall Study|Lost to Follow-up|1499|||
37749706|NCT01878149|69242385|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
37749707|NCT01878149|69242386|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
37749708|NCT01863953|69242408|FG000|Overall Study|Adverse Event|0|||
37749709|NCT01863953|69242409|FG001|Overall Study|Adverse Event|0|||
37749710|NCT01863953|69242410|FG002|Overall Study|Adverse Event|1|||
37749711|NCT03049449|69242686|FG000|Overall Study|Did not receive treatment.|0|||
37749712|NCT03049449|69242687|FG001|Overall Study|Did not receive treatment.|0|||
37749713|NCT03049449|69242688|FG002|Overall Study|Did not receive treatment.|0|||
37749714|NCT03049449|69242689|FG003|Overall Study|Did not receive treatment.|0|||
37749715|NCT03049449|69242690|FG004|Overall Study|Did not receive treatment.|0|||
37749716|NCT03049449|69242691|FG005|Overall Study|Did not receive treatment.|0|||
37749717|NCT03049449|69242692|FG006|Overall Study|Did not receive treatment.|0|||
37749718|NCT03049449|69242693|FG007|Overall Study|Did not receive treatment.|0|||
37749719|NCT03049449|69242694|FG008|Overall Study|Did not receive treatment.|1|||
37749720|NCT03049449|69242695|FG009|Overall Study|Did not receive treatment.|0|||
37749721|NCT03049449|69242686|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
37923097|NCT00663052|69609876|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
37923098|NCT00663052|69609877|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
37923099|NCT00663052|69609876|FG000|Overall Study|Other|0|||
37923100|NCT00663052|69609877|FG001|Overall Study|Other|1|||
37923101|NCT00826748|69609886|FG000|Overall Study|Withdrawal by Subject|0|||
37923102|NCT00826748|69609887|FG001|Overall Study|Withdrawal by Subject|0|||
37923103|NCT00826748|69609888|FG002|Overall Study|Withdrawal by Subject|2|||
37923104|NCT00826748|69609886|FG000|Overall Study|Physician Decision|0|||
37923105|NCT00826748|69609887|FG001|Overall Study|Physician Decision|0|||
37923106|NCT00826748|69609888|FG002|Overall Study|Physician Decision|1|||
37923107|NCT00826748|69609886|FG000|Overall Study|Samples Did Not pass QC|0|||
37923108|NCT00826748|69609887|FG001|Overall Study|Samples Did Not pass QC|0|||
37923109|NCT00826748|69609888|FG002|Overall Study|Samples Did Not pass QC|1|||
37923110|NCT00806988|69609898|FG000|Overall Study|Death|15|||
37923111|NCT00806988|69609899|FG001|Overall Study|Death|16|||
37923112|NCT00806988|69609898|FG000|Overall Study|Withdrawal by Subject|8|||
37923113|NCT00806988|69609899|FG001|Overall Study|Withdrawal by Subject|8|||
37923114|NCT00806988|69609898|FG000|Overall Study|Lost to Follow-up|4|||
37923115|NCT00806988|69609899|FG001|Overall Study|Lost to Follow-up|19|||
37923116|NCT00807144|69609907|FG000|Overall Study|Lost to Follow-up|0|||
37923117|NCT00807144|69609908|FG001|Overall Study|Lost to Follow-up|1|||
37923118|NCT00591006|69609914|FG000|Overall Study|Withdrawal by Subject|0|||
37660229|NCT02453048|69132887|FG003|Overall Study|Only part of initial 6 mo. study|0|||
37749722|NCT03049449|69242687|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
37749723|NCT03049449|69242688|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
37749724|NCT03049449|69242689|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
37749725|NCT03049449|69242690|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
37749726|NCT03049449|69242691|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
37749727|NCT03049449|69242692|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
37749728|NCT03049449|69242693|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
37749729|NCT03049449|69242694|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
37749730|NCT03049449|69242695|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
37749731|NCT03049449|69242686|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
37749732|NCT03049449|69242687|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
37749733|NCT03049449|69242688|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
37749734|NCT03049449|69242689|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
37749735|NCT03049449|69242690|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
37749736|NCT03049449|69242691|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
37749737|NCT03049449|69242692|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
37749738|NCT03049449|69242693|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
37749739|NCT03049449|69242694|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
37749740|NCT03049449|69242695|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
37749741|NCT02989857|69242818|FG000|Randomization Phase|Not Treated|3|||
37749742|NCT02989857|69242819|FG001|Randomization Phase|Not Treated|2|||
37749743|NCT02989857|69242820|FG002|Randomization Phase|Not Treated|0|||
37749744|NCT01877915|69242831|FG000|Overall Study|Lost to Follow-up|10|||
37749745|NCT01877915|69242832|FG001|Overall Study|Lost to Follow-up|9|||
37749746|NCT01877915|69242831|FG000|Overall Study|Withdrawal by Subject|42|||
37749747|NCT01877915|69242832|FG001|Overall Study|Withdrawal by Subject|55|||
37749748|NCT01877915|69242831|FG000|Overall Study|Other|2|||
37749749|NCT01877915|69242832|FG001|Overall Study|Other|4|||
37749750|NCT01876979|69242840|FG000|Overall Study|Physician Decision|2|||
37749751|NCT01876979|69242841|FG001|Overall Study|Physician Decision|3|||
37749752|NCT01860989|69242847|FG000|Overall Study|Unsatisfactory therapeutic|5|||
37749753|NCT01860677|69242863|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
37749754|NCT01860677|69242864|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
37749755|NCT01876901|69242882|FG000|Overall Study|Protocol Violation|10|||
37749756|NCT01876901|69242883|FG001|Overall Study|Protocol Violation|2|||
37749757|NCT01876901|69242882|FG000|Overall Study|No or other surgical intervention|7|||
37749758|NCT01876901|69242883|FG001|Overall Study|No or other surgical intervention|5|||
37749759|NCT01876823|69242890|FG000|Overall Study|Withdrawal by Subject|5|||
37749760|NCT01876823|69242890|FG000|Overall Study|Physician Decision|2|||
37749761|NCT01876823|69242890|FG000|Overall Study|Patients moved|2|||
37749762|NCT01876511|69242897|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
37749763|NCT01876511|69242898|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
37749764|NCT01876511|69242899|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
37749765|NCT01876511|69242897|FG000|Overall Study|Death (unrelated)|3|||
37749766|NCT01876511|69242898|FG001|Overall Study|Death (unrelated)|0|||
37749767|NCT01876511|69242899|FG002|Overall Study|Death (unrelated)|2|||
37749768|NCT01876511|69242897|FG000|Overall Study|Drug-related Toxicity|5|||
37749769|NCT01876511|69242898|FG001|Overall Study|Drug-related Toxicity|1|||
37749770|NCT01876511|69242899|FG002|Overall Study|Drug-related Toxicity|6|||
37749771|NCT01876511|69242897|FG000|Overall Study|Patient Decision|3|||
37749772|NCT01876511|69242898|FG001|Overall Study|Patient Decision|0|||
37749773|NCT01876511|69242899|FG002|Overall Study|Patient Decision|6|||
37749774|NCT01876511|69242897|FG000|Overall Study|Physician Decision|1|||
37749775|NCT01876511|69242898|FG001|Overall Study|Physician Decision|0|||
37749776|NCT01876511|69242899|FG002|Overall Study|Physician Decision|1|||
37749777|NCT01993719|69242914|FG000|First Drug Administration|Not treated|1|||
37749778|NCT01993719|69242915|FG001|First Drug Administration|Not treated|0|||
37749779|NCT01993719|69242916|FG002|First Drug Administration|Not treated|0|||
37749780|NCT01993719|69242917|FG003|First Drug Administration|Not treated|0|||
37749781|NCT01993719|69242918|FG004|First Drug Administration|Not treated|0|||
37856468|NCT04102111|69539704|FG000|Overall Study|Study terminated by sponsor|1|||
37856469|NCT04102111|69539705|FG001|Overall Study|Study terminated by sponsor|3|||
37749782|NCT00638235|69242960|FG000|Overall Study|Lost to Follow-up|31|||
37856470|NCT01214187|69539713|FG000|Overall Study|Adverse Event|6|||
37856471|NCT01214187|69539714|FG001|Overall Study|Adverse Event|2|||
37856472|NCT01214187|69539713|FG000|Overall Study|Death|1|||
37856473|NCT01214187|69539714|FG001|Overall Study|Death|1|||
37856474|NCT01214187|69539713|FG000|Overall Study|Withdrawal by Subject|0|||
37749783|NCT00638235|69242961|FG001|Overall Study|Lost to Follow-up|3|||
37749784|NCT00638235|69242962|FG002|Overall Study|Lost to Follow-up|18|||
37749785|NCT00638235|69242963|FG003|Overall Study|Lost to Follow-up|10|||
37749786|NCT00638235|69242964|FG004|Overall Study|Lost to Follow-up|13|||
37749787|NCT00638235|69242965|FG005|Overall Study|Lost to Follow-up|26|||
37749788|NCT00638235|69242966|FG006|Overall Study|Lost to Follow-up|0|||
38033087|NCT04913675|69719122|FG000|Safety Sub-study (Up to Day 29)|Ongoing in this study|0|||
38033088|NCT04913675|69719123|FG001|Safety Sub-study (Up to Day 29)|Ongoing in this study|0|||
38033089|NCT04913675|69719124|FG002|Safety Sub-study (Up to Day 29)|Ongoing in this study|0|||
38033090|NCT04913675|69719125|FG003|Safety Sub-study (Up to Day 29)|Ongoing in this study|80|||
38033091|NCT04913675|69719122|FG000|Safety Sub-study (Up to Day 29)|Withdrawal by Subject|0|||
37749789|NCT00638235|69242967|FG007|Overall Study|Lost to Follow-up|1|||
37749790|NCT00638235|69242968|FG008|Overall Study|Lost to Follow-up|18|||
37749791|NCT00638157|69242997|FG000|Overall Study|Adverse Event|0|||
37749792|NCT00638157|69242998|FG001|Overall Study|Adverse Event|1|||
37749793|NCT00638157|69242997|FG000|Overall Study|Clinical (symptomatic) failure|1|||
37749794|NCT00638157|69242998|FG001|Overall Study|Clinical (symptomatic) failure|1|||
38033092|NCT04913675|69719123|FG001|Safety Sub-study (Up to Day 29)|Withdrawal by Subject|0|||
38033093|NCT04913675|69719124|FG002|Safety Sub-study (Up to Day 29)|Withdrawal by Subject|0|||
38033094|NCT04913675|69719125|FG003|Safety Sub-study (Up to Day 29)|Withdrawal by Subject|1|||
38033095|NCT04760314|69719142|FG000|Induction Period|Withdrawal by Subject|0|||
38033096|NCT04760314|69719143|FG001|Induction Period|Withdrawal by Subject|1|||
38033097|NCT04760314|69719144|FG002|Induction Period|Withdrawal by Subject|1|||
38033098|NCT04760314|69719145|FG003|Induction Period|Withdrawal by Subject|0|||
38033099|NCT04760314|69719146|FG004|Induction Period|Withdrawal by Subject|0|||
37749795|NCT00638157|69242997|FG000|Overall Study|Microbiological failure|1|||
37749796|NCT00638157|69242998|FG001|Overall Study|Microbiological failure|0|||
37749797|NCT00638157|69242997|FG000|Overall Study|Lost to Follow-up|1|||
37749798|NCT00638157|69242998|FG001|Overall Study|Lost to Follow-up|0|||
37749799|NCT00638157|69242997|FG000|Overall Study|Physician Decision|1|||
37749800|NCT00638157|69242998|FG001|Overall Study|Physician Decision|0|||
37749801|NCT00638157|69242997|FG000|Overall Study|Other|1|||
37749802|NCT00638157|69242998|FG001|Overall Study|Other|2|||
37749803|NCT00638157|69242997|FG000|Overall Study|Randomized, not treated|2|||
37749804|NCT00638157|69242998|FG001|Overall Study|Randomized, not treated|0|||
37749805|NCT00637377|69243009|FG000|Overall Study|Adverse Event|2|||
37749806|NCT00637377|69243010|FG001|Overall Study|Adverse Event|6|||
37749807|NCT00637377|69243011|FG002|Overall Study|Adverse Event|8|||
37749808|NCT00637377|69243012|FG003|Overall Study|Adverse Event|9|||
37749809|NCT00637377|69243009|FG000|Overall Study|Death|1|||
37749810|NCT00637377|69243010|FG001|Overall Study|Death|3|||
37749811|NCT00637377|69243011|FG002|Overall Study|Death|2|||
37749812|NCT00637377|69243012|FG003|Overall Study|Death|1|||
37749813|NCT00637377|69243009|FG000|Overall Study|Lack of Efficacy|0|||
37749814|NCT00637377|69243010|FG001|Overall Study|Lack of Efficacy|0|||
37749815|NCT00637377|69243011|FG002|Overall Study|Lack of Efficacy|1|||
37749816|NCT00637377|69243012|FG003|Overall Study|Lack of Efficacy|1|||
37749817|NCT00637377|69243009|FG000|Overall Study|Lost to Follow-up|4|||
37749818|NCT00637377|69243010|FG001|Overall Study|Lost to Follow-up|1|||
37749819|NCT00637377|69243011|FG002|Overall Study|Lost to Follow-up|2|||
37749820|NCT00637377|69243012|FG003|Overall Study|Lost to Follow-up|2|||
37749821|NCT00637377|69243009|FG000|Overall Study|Protocol Violation|2|||
37749822|NCT00637377|69243010|FG001|Overall Study|Protocol Violation|1|||
37749823|NCT00637377|69243011|FG002|Overall Study|Protocol Violation|1|||
37749824|NCT00637377|69243012|FG003|Overall Study|Protocol Violation|0|||
38033100|NCT04760314|69719147|FG005|Induction Period|Withdrawal by Subject|0|||
38033101|NCT04760314|69719148|FG006|Induction Period|Withdrawal by Subject|0|||
37749825|NCT00637377|69243009|FG000|Overall Study|Withdrawal by Subject|11|||
37856475|NCT01214187|69539714|FG001|Overall Study|Withdrawal by Subject|3|||
37856476|NCT01003990|69539723|FG000|Overall Study|Adverse Event|8|||
37749826|NCT00637377|69243010|FG001|Overall Study|Withdrawal by Subject|15|||
37856477|NCT01003990|69539724|FG001|Overall Study|Adverse Event|5|||
37856478|NCT01003990|69539725|FG002|Overall Study|Adverse Event|11|||
38033102|NCT04760314|69719149|FG007|Induction Period|Withdrawal by Subject|0|||
38033103|NCT04760314|69719150|FG008|Induction Period|Withdrawal by Subject|0|||
38033104|NCT04760314|69719151|FG009|Induction Period|Withdrawal by Subject|0|||
38033105|NCT04760314|69719152|FG010|Induction Period|Withdrawal by Subject|0|||
37749827|NCT00637377|69243011|FG002|Overall Study|Withdrawal by Subject|13|||
37749828|NCT00637377|69243012|FG003|Overall Study|Withdrawal by Subject|11|||
37749829|NCT00637377|69243009|FG000|Overall Study|Other (no further information available)|7|||
37749830|NCT00637377|69243010|FG001|Overall Study|Other (no further information available)|6|||
37749831|NCT00637377|69243011|FG002|Overall Study|Other (no further information available)|10|||
37749832|NCT00637377|69243012|FG003|Overall Study|Other (no further information available)|5|||
37749833|NCT00636987|69243022|FG000|Overall Study|Death|44|||
37749834|NCT00636987|69243022|FG000|Overall Study|Explanted|13|||
37749835|NCT00636987|69243022|FG000|Overall Study|Lost to Follow-up|63|||
37856479|NCT01003990|69539723|FG000|Overall Study|Death|0|||
38033106|NCT04760314|69719142|FG000|Induction Period|Adverse Event|0|||
38033107|NCT04760314|69719143|FG001|Induction Period|Adverse Event|0|||
38033108|NCT04760314|69719144|FG002|Induction Period|Adverse Event|2|||
37660230|NCT02453048|69132888|FG004|Overall Study|Only part of initial 6 mo. study|6|||
37749836|NCT00636987|69243022|FG000|Overall Study|5 year visit window not complete|69|||
37749837|NCT00636441|69243177|FG000|Overall Study|Adverse Event|0|||
37749838|NCT00636441|69243178|FG001|Overall Study|Adverse Event|1|||
37749839|NCT00636441|69243179|FG002|Overall Study|Adverse Event|1|||
37749840|NCT00636441|69243180|FG003|Overall Study|Adverse Event|0|||
37749841|NCT00636441|69243181|FG004|Overall Study|Adverse Event|0|||
37856480|NCT01003990|69539724|FG001|Overall Study|Death|8|||
37856481|NCT01003990|69539725|FG002|Overall Study|Death|1|||
37749842|NCT00636441|69243182|FG005|Overall Study|Adverse Event|1|||
37749843|NCT00636441|69243183|FG006|Overall Study|Adverse Event|0|||
37749844|NCT00636441|69243177|FG000|Overall Study|Late, ineligible|0|||
37749845|NCT00636441|69243178|FG001|Overall Study|Late, ineligible|0|||
37749846|NCT00636441|69243179|FG002|Overall Study|Late, ineligible|0|||
37749847|NCT00636441|69243180|FG003|Overall Study|Late, ineligible|0|||
37749848|NCT00636441|69243181|FG004|Overall Study|Late, ineligible|0|||
37749849|NCT00636441|69243182|FG005|Overall Study|Late, ineligible|0|||
37749850|NCT00636441|69243183|FG006|Overall Study|Late, ineligible|1|||
37749851|NCT00636441|69243177|FG000|Overall Study|Screen Failure|0|||
37749852|NCT00636441|69243178|FG001|Overall Study|Screen Failure|0|||
37749853|NCT00636441|69243179|FG002|Overall Study|Screen Failure|0|||
37749854|NCT00636441|69243180|FG003|Overall Study|Screen Failure|0|||
37749855|NCT00636441|69243181|FG004|Overall Study|Screen Failure|0|||
37749856|NCT00636441|69243182|FG005|Overall Study|Screen Failure|0|||
37749857|NCT00636441|69243183|FG006|Overall Study|Screen Failure|17|||
37749858|NCT00636363|69243206|FG000|Overall Study|Conjunctivitis|0|||
37749859|NCT00636363|69243207|FG001|Overall Study|Conjunctivitis|0|||
37749860|NCT00636363|69243208|FG002|Overall Study|Conjunctivitis|1|||
37749861|NCT00636363|69243206|FG000|Overall Study|Adverse Event|0|||
37749862|NCT00636363|69243207|FG001|Overall Study|Adverse Event|0|||
37856482|NCT01003990|69539723|FG000|Overall Study|Lack of Efficacy|10|||
37856483|NCT01003990|69539724|FG001|Overall Study|Lack of Efficacy|2|||
37856484|NCT01003990|69539725|FG002|Overall Study|Lack of Efficacy|3|||
37856485|NCT01003990|69539723|FG000|Overall Study|Lost to Follow-up|30|||
37856486|NCT01003990|69539724|FG001|Overall Study|Lost to Follow-up|12|||
37856487|NCT01003990|69539725|FG002|Overall Study|Lost to Follow-up|7|||
37856488|NCT01003990|69539723|FG000|Overall Study|Reasons Not Identified|14|||
37856489|NCT01003990|69539724|FG001|Overall Study|Reasons Not Identified|13|||
37660231|NCT02453048|69132884|FG000|Overall Study|Lost to Follow-up|0|||
37660232|NCT02453048|69132885|FG001|Overall Study|Lost to Follow-up|1|||
37660233|NCT02453048|69132886|FG002|Overall Study|Lost to Follow-up|2|||
37660234|NCT02453048|69132887|FG003|Overall Study|Lost to Follow-up|0|||
37660235|NCT02453048|69132888|FG004|Overall Study|Lost to Follow-up|0|||
37660236|NCT02137252|69132902|FG000|Overall Study|trial terminated early|2|||
37660237|NCT02137252|69132903|FG001|Overall Study|trial terminated early|1|||
37660238|NCT02201290|69132909|FG000|Overall Study|Withdrawal by Subject|2|||
37660239|NCT02201290|69132909|FG000|Overall Study|Lack of Efficacy|2|||
37660240|NCT02201290|69132909|FG000|Overall Study|Adverse Event|1|||
37660241|NCT02200510|69132915|FG000|Overall Study|Death|1|||
37660242|NCT02200510|69132916|FG001|Overall Study|Death|1|||
37660243|NCT02200510|69132915|FG000|Overall Study|Protocol Violation|0|||
37660244|NCT02200510|69132916|FG001|Overall Study|Protocol Violation|1|||
37660245|NCT02200510|69132915|FG000|Overall Study|Lost to Follow-up|7|||
37660246|NCT02200510|69132916|FG001|Overall Study|Lost to Follow-up|1|||
37660247|NCT02200510|69132915|FG000|Overall Study|potential COI - joined study team|1|||
37660248|NCT02200510|69132916|FG001|Overall Study|potential COI - joined study team|0|||
37749863|NCT00636363|69243208|FG002|Overall Study|Adverse Event|1|||
37749864|NCT00636363|69243206|FG000|Overall Study|Positive slit lamp finding|0|||
37749865|NCT00636363|69243207|FG001|Overall Study|Positive slit lamp finding|2|||
37749866|NCT00636363|69243208|FG002|Overall Study|Positive slit lamp finding|1|||
37749867|NCT00636363|69243206|FG000|Overall Study|Study related symptoms/complaints|8|||
37749868|NCT00636363|69243207|FG001|Overall Study|Study related symptoms/complaints|7|||
37749869|NCT00636363|69243208|FG002|Overall Study|Study related symptoms/complaints|4|||
37856490|NCT01003990|69539725|FG002|Overall Study|Reasons Not Identified|8|||
37856491|NCT01003990|69539723|FG000|Overall Study|Poor/Non-compliance|4|||
37856492|NCT01003990|69539724|FG001|Overall Study|Poor/Non-compliance|3|||
37856493|NCT01003990|69539725|FG002|Overall Study|Poor/Non-compliance|2|||
37856494|NCT01003990|69539723|FG000|Overall Study|Pregnancy|10|||
37856495|NCT01003990|69539724|FG001|Overall Study|Pregnancy|2|||
37856496|NCT01003990|69539725|FG002|Overall Study|Pregnancy|4|||
37856497|NCT01003990|69539723|FG000|Overall Study|No Longer Met Study Criteria|4|||
37856498|NCT01003990|69539724|FG001|Overall Study|No Longer Met Study Criteria|1|||
37856499|NCT01003990|69539725|FG002|Overall Study|No Longer Met Study Criteria|0|||
37856500|NCT01003990|69539723|FG000|Overall Study|Subject Withdrew Consent|12|||
37856501|NCT01003990|69539724|FG001|Overall Study|Subject Withdrew Consent|5|||
37856502|NCT01003990|69539725|FG002|Overall Study|Subject Withdrew Consent|7|||
37749870|NCT00636363|69243206|FG000|Overall Study|Met ineligibility criteria|0|||
37749871|NCT00636363|69243207|FG001|Overall Study|Met ineligibility criteria|0|||
37749872|NCT00636363|69243208|FG002|Overall Study|Met ineligibility criteria|3|||
37749873|NCT00636363|69243206|FG000|Overall Study|Missed > 1 visit|0|||
37749874|NCT00636363|69243207|FG001|Overall Study|Missed > 1 visit|1|||
37749875|NCT00636363|69243208|FG002|Overall Study|Missed > 1 visit|3|||
37749876|NCT00636363|69243206|FG000|Overall Study|Lack of motivation|1|||
37749877|NCT00636363|69243207|FG001|Overall Study|Lack of motivation|0|||
37749878|NCT00636363|69243208|FG002|Overall Study|Lack of motivation|1|||
37749879|NCT00636363|69243206|FG000|Overall Study|Protocol Violation|0|||
37749880|NCT00636363|69243207|FG001|Overall Study|Protocol Violation|3|||
37749881|NCT00636363|69243208|FG002|Overall Study|Protocol Violation|0|||
37749882|NCT00636363|69243206|FG000|Overall Study|Lost to Follow-up|3|||
37749883|NCT00636363|69243207|FG001|Overall Study|Lost to Follow-up|4|||
37749884|NCT00636363|69243208|FG002|Overall Study|Lost to Follow-up|2|||
37749885|NCT00636363|69243206|FG000|Overall Study|Withdrawal by Subject|1|||
37749886|NCT00636363|69243207|FG001|Overall Study|Withdrawal by Subject|3|||
37749887|NCT00636363|69243208|FG002|Overall Study|Withdrawal by Subject|2|||
37749888|NCT00636207|69243250|FG000|Overall Study|Adverse Event|1|||
37749889|NCT00636207|69243251|FG001|Overall Study|Adverse Event|0|||
37749890|NCT00636207|69243252|FG002|Overall Study|Adverse Event|0|||
37749891|NCT00636207|69243253|FG003|Overall Study|Adverse Event|0|||
37749892|NCT00636207|69243254|FG004|Overall Study|Adverse Event|0|||
37749893|NCT00636207|69243255|FG005|Overall Study|Adverse Event|0|||
37749894|NCT00636207|69243256|FG006|Overall Study|Adverse Event|0|||
37749895|NCT00636207|69243250|FG000|Overall Study|Withdrawal by Subject|0|||
37749896|NCT00636207|69243251|FG001|Overall Study|Withdrawal by Subject|1|||
37749897|NCT00636207|69243252|FG002|Overall Study|Withdrawal by Subject|0|||
37749898|NCT00636207|69243253|FG003|Overall Study|Withdrawal by Subject|0|||
37749899|NCT00636207|69243254|FG004|Overall Study|Withdrawal by Subject|1|||
37749900|NCT00636207|69243255|FG005|Overall Study|Withdrawal by Subject|0|||
37749901|NCT00636207|69243256|FG006|Overall Study|Withdrawal by Subject|0|||
37749902|NCT00635661|69243277|FG000|Overall Study|Withdrawal by Subject|4|||
37749903|NCT00635427|69243366|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
37749904|NCT00635427|69243367|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
37749905|NCT00635427|69243368|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
37749906|NCT00635427|69243369|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
37749907|NCT00635427|69243370|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
37749908|NCT00635427|69243366|FG000|Overall Study|Death|0|||
37749909|NCT00635427|69243367|FG001|Overall Study|Death|0|||
37749910|NCT00635427|69243368|FG002|Overall Study|Death|0|||
37749911|NCT00635427|69243369|FG003|Overall Study|Death|1|||
37749912|NCT00635427|69243370|FG004|Overall Study|Death|0|||
37749913|NCT00635427|69243366|FG000|Overall Study|Termination Of Study By Sponsor|12|||
37749914|NCT00635427|69243367|FG001|Overall Study|Termination Of Study By Sponsor|6|||
37749915|NCT00635427|69243368|FG002|Overall Study|Termination Of Study By Sponsor|10|||
37749916|NCT00635427|69243369|FG003|Overall Study|Termination Of Study By Sponsor|6|||
37749917|NCT00635427|69243370|FG004|Overall Study|Termination Of Study By Sponsor|6|||
37749918|NCT00635427|69243366|FG000|Overall Study|Withdrawal Of Consent|0|||
37749919|NCT00635427|69243367|FG001|Overall Study|Withdrawal Of Consent|0|||
37749920|NCT00635427|69243368|FG002|Overall Study|Withdrawal Of Consent|0|||
37749921|NCT00635427|69243369|FG003|Overall Study|Withdrawal Of Consent|2|||
37749922|NCT00635427|69243370|FG004|Overall Study|Withdrawal Of Consent|2|||
37749923|NCT00635349|69243382|FG000|Overall Study|Other|8|||
37749924|NCT00635349|69243383|FG001|Overall Study|Other|6|||
37749925|NCT00635349|69243382|FG000|Overall Study|Protocol Violation|18|||
37749926|NCT00635349|69243383|FG001|Overall Study|Protocol Violation|22|||
37749927|NCT00635349|69243382|FG000|Overall Study|Withdrawal by Subject|3|||
37749928|NCT00635349|69243383|FG001|Overall Study|Withdrawal by Subject|8|||
37749929|NCT00635349|69243382|FG000|Overall Study|Lost to Follow-up|4|||
37749930|NCT00635349|69243383|FG001|Overall Study|Lost to Follow-up|3|||
37749931|NCT00635349|69243382|FG000|Overall Study|Adverse Event|11|||
37749932|NCT00635349|69243383|FG001|Overall Study|Adverse Event|9|||
37749933|NCT00634803|69243392|FG000|Overall Study|Lost to Follow-up|6|||
37749934|NCT00634803|69243393|FG001|Overall Study|Lost to Follow-up|7|||
37749935|NCT00634803|69243394|FG002|Overall Study|Lost to Follow-up|7|||
37749936|NCT01217385|69243410|FG000|Overall Study|Withdrawal by Subject|3|||
37749937|NCT01217385|69243410|FG000|Overall Study|DOSI not performed/not eval|12|||
37749938|NCT01217385|69243410|FG000|Overall Study|Central Path not Available|1|||
37749939|NCT01217385|69243410|FG000|Overall Study|Normal Breast TOI not available|10|||
37749940|NCT01378104|69243762|FG000|Overall Study|Adverse Event|8|||
37749941|NCT01378104|69243763|FG001|Overall Study|Adverse Event|8|||
37749942|NCT01378104|69243762|FG000|Overall Study|Lack of Efficacy|7|||
37749943|NCT01378104|69243763|FG001|Overall Study|Lack of Efficacy|5|||
37749944|NCT01378104|69243762|FG000|Overall Study|Withdrawal by Subject|12|||
37749945|NCT01378104|69243763|FG001|Overall Study|Withdrawal by Subject|13|||
37749946|NCT01379274|69243804|FG000|Overall Study|funding withdrawn|1|||
37856503|NCT01003210|69539735|FG000|Overall Study|Lost to Follow-up|1|||
37749947|NCT00634569|69244005|FG000|Overall Study|Withdrawal by Subject|0|||
37660249|NCT02452892|69132926|FG000|Week 1 Initial Randommization|Adverse Event|1|||
37660250|NCT02452892|69132927|FG001|Week 1 Initial Randommization|Adverse Event|0|||
37660251|NCT02452892|69132928|FG002|Week 1 Initial Randommization|Adverse Event|0|||
37660252|NCT02452892|69132929|FG003|Week 1 Initial Randommization|Adverse Event|0|||
37660253|NCT02452892|69132926|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
37660254|NCT02452892|69132927|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
37660255|NCT02452892|69132928|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
37660256|NCT02452892|69132929|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
37660257|NCT02452892|69132926|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
37660258|NCT02452892|69132927|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
37660259|NCT02452892|69132928|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
37749948|NCT00634569|69244006|FG001|Overall Study|Withdrawal by Subject|4|||
37749949|NCT00634569|69244005|FG000|Overall Study|Physician Decision|0|||
37749950|NCT00634569|69244006|FG001|Overall Study|Physician Decision|1|||
37749951|NCT00634179|69244051|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
37749952|NCT03877926|69244126|FG000|Overall Study|Adverse Event|1|||
37749953|NCT03877926|69244127|FG001|Overall Study|Adverse Event|0|||
37749954|NCT03877926|69244128|FG002|Overall Study|Adverse Event|0|||
37749955|NCT03877926|69244129|FG003|Overall Study|Adverse Event|0|||
37749956|NCT03877926|69244126|FG000|Overall Study|Death|2|||
37749957|NCT03877926|69244127|FG001|Overall Study|Death|2|||
37749958|NCT03877926|69244128|FG002|Overall Study|Death|2|||
37749959|NCT03877926|69244129|FG003|Overall Study|Death|0|||
37749960|NCT03877926|69244126|FG000|Overall Study|Lost to Follow-up|41|||
37749961|NCT03877926|69244127|FG001|Overall Study|Lost to Follow-up|52|||
37749962|NCT03877926|69244128|FG002|Overall Study|Lost to Follow-up|45|||
37749963|NCT03877926|69244129|FG003|Overall Study|Lost to Follow-up|17|||
37749964|NCT03877926|69244126|FG000|Overall Study|Physician Decision|2|||
37749965|NCT03877926|69244127|FG001|Overall Study|Physician Decision|0|||
37749966|NCT03877926|69244128|FG002|Overall Study|Physician Decision|2|||
37749967|NCT03877926|69244129|FG003|Overall Study|Physician Decision|0|||
37749968|NCT03877926|69244126|FG000|Overall Study|Withdrawal by Subject|18|||
37749969|NCT03877926|69244127|FG001|Overall Study|Withdrawal by Subject|21|||
37749970|NCT03877926|69244128|FG002|Overall Study|Withdrawal by Subject|12|||
37749971|NCT03877926|69244129|FG003|Overall Study|Withdrawal by Subject|4|||
37749972|NCT03877926|69244126|FG000|Overall Study|Other - Various|4|||
37749973|NCT03877926|69244127|FG001|Overall Study|Other - Various|1|||
37749974|NCT03877926|69244128|FG002|Overall Study|Other - Various|1|||
37749975|NCT03877926|69244129|FG003|Overall Study|Other - Various|0|||
37749976|NCT03877926|69244126|FG000|Overall Study|Not Treated|3|||
37749977|NCT03877926|69244127|FG001|Overall Study|Not Treated|1|||
37749978|NCT03877926|69244128|FG002|Overall Study|Not Treated|1|||
37749979|NCT03877926|69244129|FG003|Overall Study|Not Treated|0|||
37749980|NCT02874144|69244341|FG000|Overall Study|Lost to Follow-up|3|||
37749981|NCT02874144|69244342|FG001|Overall Study|Lost to Follow-up|5|||
37749982|NCT02611830|69244372|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
37749983|NCT02611830|69244373|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
37749984|NCT02611830|69244374|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
37749985|NCT02611830|69244375|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
37749986|NCT02611830|69244372|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
37749987|NCT02611830|69244373|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
37749988|NCT02611830|69244374|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
37749989|NCT02611830|69244375|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
37749990|NCT02611830|69244372|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
37856504|NCT01003210|69539736|FG001|Overall Study|Lost to Follow-up|3|||
37856505|NCT01002820|69539742|FG000|Overall Study|Adverse Event|1|||
37749991|NCT02611830|69244373|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
37749992|NCT02611830|69244374|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
37749993|NCT02611830|69244375|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
37749994|NCT02611830|69244372|FG000|OL Induction Phase|Lack of Efficacy|9|||
37749995|NCT02611830|69244373|FG001|OL Induction Phase|Lack of Efficacy|0|||
37749996|NCT02611830|69244374|FG002|OL Induction Phase|Lack of Efficacy|0|||
37749997|NCT02611830|69244375|FG003|OL Induction Phase|Lack of Efficacy|0|||
37856506|NCT01002820|69539742|FG000|Overall Study|Withdrawal by Subject|2|||
37856507|NCT01002820|69539742|FG000|Overall Study|Lack of Efficacy|1|||
37856508|NCT01012258|69539746|FG000|Overall Study|Death|14|||
37856509|NCT01012258|69539746|FG000|Overall Study|Lost to Follow-up|1|||
37749998|NCT02611830|69244372|FG000|OL Induction Phase|Reason not specified|3|||
37749999|NCT02611830|69244373|FG001|OL Induction Phase|Reason not specified|0|||
37750000|NCT02611830|69244374|FG002|OL Induction Phase|Reason not specified|0|||
37750001|NCT02611830|69244375|FG003|OL Induction Phase|Reason not specified|0|||
37750002|NCT02611830|69244372|FG000|Maintenance Phase|Lack of Efficacy|0|||
37750003|NCT02611830|69244373|FG001|Maintenance Phase|Lack of Efficacy|29|||
37750004|NCT02611830|69244374|FG002|Maintenance Phase|Lack of Efficacy|18|||
37856510|NCT01012258|69539746|FG000|Overall Study|Adverse Event|1|||
37750005|NCT02611830|69244375|FG003|Maintenance Phase|Lack of Efficacy|6|||
37750006|NCT02611830|69244372|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
37750007|NCT02611830|69244373|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
37750008|NCT02611830|69244374|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
37750009|NCT02611830|69244375|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
37750010|NCT02611830|69244372|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
37750011|NCT02611830|69244373|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
37750012|NCT02611830|69244374|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
37750013|NCT02611830|69244375|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
37750014|NCT02611830|69244372|FG000|Maintenance Phase|Lost to Follow-up|0|||
37750015|NCT02611830|69244373|FG001|Maintenance Phase|Lost to Follow-up|0|||
37750016|NCT02611830|69244374|FG002|Maintenance Phase|Lost to Follow-up|0|||
37750017|NCT02611830|69244375|FG003|Maintenance Phase|Lost to Follow-up|1|||
37750018|NCT02611830|69244372|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
37750019|NCT02611830|69244373|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
37750020|NCT02611830|69244374|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
37750021|NCT02611830|69244375|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
37750022|NCT02611830|69244372|FG000|Maintenance Phase|Pregnancy|0|||
37856511|NCT01012258|69539746|FG000|Overall Study|Progressive Disease (PD)|18|||
37856512|NCT01012258|69539746|FG000|Overall Study|Symptomatic Deterioration|1|||
37856513|NCT01012258|69539746|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
37856514|NCT01012258|69539746|FG000|Overall Study|Another Tumor Discovered|1|||
37856515|NCT01012258|69539746|FG000|Overall Study|Ongoing|29|||
37856516|NCT01011946|69539751|FG000|Overall Study|Transferred to another hospital|2|||
37750023|NCT02611830|69244373|FG001|Maintenance Phase|Pregnancy|0|||
37750024|NCT02611830|69244374|FG002|Maintenance Phase|Pregnancy|1|||
37750025|NCT02611830|69244375|FG003|Maintenance Phase|Pregnancy|0|||
37750026|NCT02611830|69244372|FG000|Maintenance Phase|Reason not specified|0|||
37750027|NCT02611830|69244373|FG001|Maintenance Phase|Reason not specified|1|||
37750028|NCT02611830|69244374|FG002|Maintenance Phase|Reason not specified|4|||
37750029|NCT02611830|69244375|FG003|Maintenance Phase|Reason not specified|0|||
37750030|NCT01328574|69244561|FG000|Overall Study|Refused further treatment|1|||
37750031|NCT01328496|69244683|FG000|Overall Study|Significant Change in Health Status|1|||
37750032|NCT01328496|69244684|FG001|Overall Study|Significant Change in Health Status|0|||
37750033|NCT02734212|69244804|FG000|Overall Study|Lost to Follow-up|5|||
37750034|NCT02734212|69244805|FG001|Overall Study|Lost to Follow-up|10|||
37750035|NCT03786432|69244851|FG000|Overall Study|Screen Failure after consent|1|||
37750036|NCT03786432|69244851|FG000|Overall Study|Lost to Follow-up|4|||
37750037|NCT03786432|69244851|FG000|Overall Study|did not complete 12 month CT scan|1|||
37750038|NCT04604184|69244887|FG000|Overall Study|Adverse Event|5|||
37750039|NCT04604184|69244888|FG001|Overall Study|Adverse Event|5|||
37750040|NCT04604184|69244887|FG000|Overall Study|Death|2|||
37856517|NCT01011946|69539751|FG000|Overall Study|No pathological lab value|1|||
37856518|NCT00975481|69539755|FG000|Second Intervention Period|Adverse Event|2|||
37856519|NCT00975481|69539756|FG001|Second Intervention Period|Adverse Event|1|||
37856520|NCT00975481|69539757|FG002|Second Intervention Period|Adverse Event|0|||
37856521|NCT00975481|69539758|FG003|Second Intervention Period|Adverse Event|0|||
37856522|NCT00975481|69539759|FG004|Second Intervention Period|Adverse Event|0|||
37856523|NCT00975481|69539760|FG005|Second Intervention Period|Adverse Event|0|||
37856524|NCT00975481|69539755|FG000|Second Intervention Period|Withdrawal by Subject|0|||
37856525|NCT00975481|69539756|FG001|Second Intervention Period|Withdrawal by Subject|0|||
37856526|NCT00975481|69539757|FG002|Second Intervention Period|Withdrawal by Subject|1|||
37856527|NCT00975481|69539758|FG003|Second Intervention Period|Withdrawal by Subject|0|||
37856528|NCT00975481|69539759|FG004|Second Intervention Period|Withdrawal by Subject|0|||
37660260|NCT02452892|69132929|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
37660261|NCT02452892|69132926|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
37660262|NCT02452892|69132927|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
37660263|NCT02452892|69132928|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
37660264|NCT02452892|69132929|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
37660265|NCT02452892|69132926|FG000|Follow-up|Withdrawal by Subject|0|||
37660266|NCT02452892|69132927|FG001|Follow-up|Withdrawal by Subject|0|||
37660267|NCT02452892|69132928|FG002|Follow-up|Withdrawal by Subject|0|||
37660268|NCT02452892|69132929|FG003|Follow-up|Withdrawal by Subject|1|||
37660269|NCT02452892|69132926|FG000|Follow-up|Subject left town on Day 42|1|||
37660270|NCT02452892|69132927|FG001|Follow-up|Subject left town on Day 42|0|||
37750041|NCT04604184|69244888|FG001|Overall Study|Death|1|||
37660271|NCT02452892|69132928|FG002|Follow-up|Subject left town on Day 42|0|||
37856529|NCT00975481|69539760|FG005|Second Intervention Period|Withdrawal by Subject|0|||
37856530|NCT00975481|69539755|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
37856531|NCT00975481|69539756|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
37660272|NCT02452892|69132929|FG003|Follow-up|Subject left town on Day 42|0|||
37750042|NCT04604184|69244887|FG000|Overall Study|Withdrawal by Subject|1|||
37750043|NCT04604184|69244888|FG001|Overall Study|Withdrawal by Subject|3|||
37750044|NCT04604184|69244887|FG000|Overall Study|Not treated|2|||
37750045|NCT04604184|69244888|FG001|Overall Study|Not treated|2|||
37750046|NCT04604184|69244887|FG000|Overall Study|Due to sponsor decision|9|||
37750047|NCT04604184|69244888|FG001|Overall Study|Due to sponsor decision|7|||
37750048|NCT04604184|69244887|FG000|Overall Study|Physician Decision|0|||
37750049|NCT04604184|69244888|FG001|Overall Study|Physician Decision|1|||
37750050|NCT04604184|69244887|FG000|Overall Study|Transfer to healthcare|1|||
37750051|NCT04604184|69244888|FG001|Overall Study|Transfer to healthcare|0|||
37750052|NCT01859741|69245059|FG000|Overall Study|Death|3|||
37750053|NCT01859741|69245060|FG001|Overall Study|Death|2|||
37750054|NCT01859741|69245061|FG002|Overall Study|Death|4|||
37750055|NCT01859741|69245062|FG003|Overall Study|Death|3|||
37750056|NCT01859741|69245063|FG004|Overall Study|Death|5|||
37750057|NCT01859741|69245064|FG005|Overall Study|Death|4|||
37750058|NCT01859741|69245065|FG006|Overall Study|Death|51|||
37750059|NCT01859741|69245066|FG007|Overall Study|Death|51|||
37750060|NCT01859741|69245059|FG000|Overall Study|Lost to Follow-up|0|||
37750061|NCT01859741|69245060|FG001|Overall Study|Lost to Follow-up|0|||
37750062|NCT01859741|69245061|FG002|Overall Study|Lost to Follow-up|0|||
37750063|NCT01859741|69245062|FG003|Overall Study|Lost to Follow-up|0|||
37750064|NCT01859741|69245063|FG004|Overall Study|Lost to Follow-up|0|||
37750065|NCT01859741|69245064|FG005|Overall Study|Lost to Follow-up|1|||
37750066|NCT01859741|69245065|FG006|Overall Study|Lost to Follow-up|0|||
37750067|NCT01859741|69245066|FG007|Overall Study|Lost to Follow-up|4|||
37750068|NCT01859741|69245059|FG000|Overall Study|Withdrawal by Subject|0|||
37750069|NCT01859741|69245060|FG001|Overall Study|Withdrawal by Subject|1|||
37750070|NCT01859741|69245061|FG002|Overall Study|Withdrawal by Subject|2|||
37750071|NCT01859741|69245062|FG003|Overall Study|Withdrawal by Subject|0|||
37750072|NCT01859741|69245063|FG004|Overall Study|Withdrawal by Subject|0|||
37750073|NCT01859741|69245064|FG005|Overall Study|Withdrawal by Subject|1|||
37750074|NCT01859741|69245065|FG006|Overall Study|Withdrawal by Subject|1|||
37750075|NCT01859741|69245066|FG007|Overall Study|Withdrawal by Subject|1|||
37750076|NCT01859741|69245059|FG000|Overall Study|Study Terminated by Sponsor|0|||
37750077|NCT01859741|69245060|FG001|Overall Study|Study Terminated by Sponsor|0|||
37750078|NCT01859741|69245061|FG002|Overall Study|Study Terminated by Sponsor|0|||
37750079|NCT01859741|69245062|FG003|Overall Study|Study Terminated by Sponsor|0|||
37750080|NCT01859741|69245063|FG004|Overall Study|Study Terminated by Sponsor|1|||
37750081|NCT01859741|69245064|FG005|Overall Study|Study Terminated by Sponsor|0|||
37750082|NCT01859741|69245065|FG006|Overall Study|Study Terminated by Sponsor|16|||
37750083|NCT01859741|69245066|FG007|Overall Study|Study Terminated by Sponsor|14|||
37660273|NCT02135848|69132944|FG000|Overall Study|Adverse Event|2|||
37660274|NCT02135848|69132945|FG001|Overall Study|Adverse Event|0|||
37660275|NCT02135848|69132944|FG000|Overall Study|Withdrawal by Subject|1|||
37660276|NCT02135848|69132945|FG001|Overall Study|Withdrawal by Subject|1|||
37660277|NCT02738333|69132965|FG000|Overall Study|Death|1|||
37660278|NCT02738333|69132966|FG001|Overall Study|Death|0|||
37660279|NCT02738333|69132967|FG002|Overall Study|Death|0|||
37660280|NCT02738333|69132965|FG000|Overall Study|Lost to Follow-up|1|||
37660281|NCT02738333|69132966|FG001|Overall Study|Lost to Follow-up|0|||
37660282|NCT02738333|69132967|FG002|Overall Study|Lost to Follow-up|0|||
37660283|NCT02135692|69132975|FG000|Overall Study|Adverse Event|3|||
37660284|NCT02135692|69132975|FG000|Overall Study|Lack of Efficacy|2|||
37660285|NCT02135692|69132975|FG000|Overall Study|Protocol Violation|2|||
37660286|NCT02135692|69132975|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
37660287|NCT02135692|69132975|FG000|Overall Study|Product commercially available|159|||
37660288|NCT02135692|69132975|FG000|Overall Study|Study closed/terminated|153|||
37660289|NCT02135692|69132975|FG000|Overall Study|Lost to Follow-up|4|||
37660290|NCT02135692|69132975|FG000|Overall Study|Withdrawal by Subject|15|||
37660291|NCT02429414|69132981|FG000|Overall Study|Physician Decision|0|||
37660292|NCT02429414|69132982|FG001|Overall Study|Physician Decision|1|||
37750084|NCT01859741|69245059|FG000|Overall Study|Other|0|||
37750085|NCT01859741|69245060|FG001|Overall Study|Other|0|||
37750086|NCT01859741|69245061|FG002|Overall Study|Other|0|||
37750087|NCT01859741|69245062|FG003|Overall Study|Other|0|||
37750088|NCT01859741|69245063|FG004|Overall Study|Other|0|||
37750089|NCT01859741|69245064|FG005|Overall Study|Other|0|||
37750090|NCT01859741|69245065|FG006|Overall Study|Other|2|||
37660293|NCT02135614|69132990|FG000|Overall Study|Randomized but Not Treated|2|||
37660294|NCT02135614|69132991|FG001|Overall Study|Randomized but Not Treated|1|||
37750091|NCT01859741|69245066|FG007|Overall Study|Other|0|||
37750092|NCT01859507|69245112|FG000|Overall Study|left the country|4|||
37750093|NCT01876043|69245117|FG000|Overall Study|Death|1|||
37660295|NCT02135614|69132990|FG000|Overall Study|Adverse Event|0|||
37660296|NCT02135614|69132991|FG001|Overall Study|Adverse Event|1|||
37660297|NCT02135614|69132990|FG000|Overall Study|Death|1|||
37750094|NCT01876043|69245117|FG000|Overall Study|Withdrawal by Subject|1|||
37750095|NCT01875731|69245123|FG000|Overall Study|Fail to obtain lab sample|1|||
37750096|NCT01875731|69245124|FG001|Overall Study|Fail to obtain lab sample|0|||
37660298|NCT02135614|69132991|FG001|Overall Study|Death|0|||
37750097|NCT01873859|69245132|FG000|Overall Study|Withdrawal by Subject|0|||
37750098|NCT01873859|69245133|FG001|Overall Study|Withdrawal by Subject|4|||
37750099|NCT01857869|69245150|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
37750100|NCT01857869|69245151|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
37750101|NCT01857869|69245152|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
37750102|NCT01857869|69245153|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
37750103|NCT01857869|69245154|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
37750104|NCT01857869|69245155|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
37750105|NCT01857869|69245156|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
37750106|NCT01857869|69245157|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
37750107|NCT01857869|69245158|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
37750108|NCT01857869|69245159|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
37750109|NCT01857869|69245150|FG000|Primary/Challenge Phase|Pregnancy|1|||
37750110|NCT01857869|69245151|FG001|Primary/Challenge Phase|Pregnancy|0|||
37750111|NCT01857869|69245152|FG002|Primary/Challenge Phase|Pregnancy|0|||
37750112|NCT01857869|69245153|FG003|Primary/Challenge Phase|Pregnancy|0|||
37750113|NCT01857869|69245154|FG004|Primary/Challenge Phase|Pregnancy|0|||
37660299|NCT02135614|69132990|FG000|Overall Study|Investigator's Discretion|0|||
37660300|NCT02135614|69132991|FG001|Overall Study|Investigator's Discretion|1|||
37660301|NCT02135614|69132990|FG000|Overall Study|Withdrew Consent|2|||
37660302|NCT02135614|69132991|FG001|Overall Study|Withdrew Consent|2|||
37660303|NCT02135614|69132990|FG000|Overall Study|Lost to Follow-up|3|||
37660304|NCT02135614|69132991|FG001|Overall Study|Lost to Follow-up|0|||
37660305|NCT02168842|69132999|FG000|Overall Study|Withdrawal by Subject|5|||
37750114|NCT01857869|69245155|FG005|Primary/Challenge Phase|Pregnancy|0|||
37750115|NCT01857869|69245156|FG006|Primary/Challenge Phase|Pregnancy|0|||
37750116|NCT01857869|69245157|FG007|Primary/Challenge Phase|Pregnancy|0|||
37750117|NCT01857869|69245158|FG008|Primary/Challenge Phase|Pregnancy|0|||
37660306|NCT02168842|69133000|FG001|Overall Study|Withdrawal by Subject|3|||
37660307|NCT02168842|69132999|FG000|Overall Study|Lost to Follow-up|0|||
37750118|NCT01857869|69245159|FG009|Primary/Challenge Phase|Pregnancy|0|||
37750119|NCT01857869|69245150|FG000|Primary/Challenge Phase|Protocol Violation|1|||
37750120|NCT01857869|69245151|FG001|Primary/Challenge Phase|Protocol Violation|0|||
37750121|NCT01857869|69245152|FG002|Primary/Challenge Phase|Protocol Violation|0|||
37750122|NCT01857869|69245153|FG003|Primary/Challenge Phase|Protocol Violation|0|||
37750123|NCT01857869|69245154|FG004|Primary/Challenge Phase|Protocol Violation|0|||
37750124|NCT01857869|69245155|FG005|Primary/Challenge Phase|Protocol Violation|0|||
37750125|NCT01857869|69245156|FG006|Primary/Challenge Phase|Protocol Violation|0|||
37750126|NCT01857869|69245157|FG007|Primary/Challenge Phase|Protocol Violation|0|||
37750127|NCT01857869|69245158|FG008|Primary/Challenge Phase|Protocol Violation|0|||
37750128|NCT01857869|69245159|FG009|Primary/Challenge Phase|Protocol Violation|0|||
37750129|NCT01857869|69245150|FG000|Primary/Challenge Phase|Other|1|||
37750130|NCT01857869|69245151|FG001|Primary/Challenge Phase|Other|1|||
37750131|NCT01857869|69245152|FG002|Primary/Challenge Phase|Other|0|||
37750132|NCT01857869|69245153|FG003|Primary/Challenge Phase|Other|0|||
37750133|NCT01857869|69245154|FG004|Primary/Challenge Phase|Other|0|||
37750134|NCT01857869|69245155|FG005|Primary/Challenge Phase|Other|0|||
37750135|NCT01857869|69245156|FG006|Primary/Challenge Phase|Other|0|||
37750136|NCT01857869|69245157|FG007|Primary/Challenge Phase|Other|0|||
37750137|NCT01857869|69245158|FG008|Primary/Challenge Phase|Other|0|||
37750138|NCT01857869|69245159|FG009|Primary/Challenge Phase|Other|0|||
37750139|NCT01857869|69245150|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
37750140|NCT01857869|69245151|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
37750141|NCT01857869|69245152|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
37750142|NCT01857869|69245153|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
37750143|NCT01857869|69245154|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
37750144|NCT01857869|69245155|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
37750145|NCT01857869|69245156|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
37750146|NCT01857869|69245157|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
37856532|NCT00975481|69539757|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
37856533|NCT00975481|69539758|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
37660308|NCT02168842|69133000|FG001|Overall Study|Lost to Follow-up|2|||
37660309|NCT02168842|69132999|FG000|Overall Study|Death|2|||
37660310|NCT02168842|69133000|FG001|Overall Study|Death|1|||
37660311|NCT02168842|69132999|FG000|Overall Study|Physician Decision|1|||
37660312|NCT02168842|69133000|FG001|Overall Study|Physician Decision|2|||
37660313|NCT02200042|69133010|FG000|Overall Study|Withdrawal by Subject|0|||
37660314|NCT02200042|69133011|FG001|Overall Study|Withdrawal by Subject|1|||
37660315|NCT02199028|69133019|FG000|Week 1|Adverse Event|1|||
37750147|NCT01857869|69245158|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
37750148|NCT01857869|69245159|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
37750149|NCT01857869|69245150|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
37750150|NCT01857869|69245151|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
37856534|NCT00975481|69539759|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
37856535|NCT00975481|69539760|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
37856536|NCT00975481|69539755|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
37660316|NCT02199028|69133020|FG001|Week 1|Adverse Event|0|||
37660317|NCT02199028|69133019|FG000|Week 3|Adverse Event|1|||
37660318|NCT02199028|69133020|FG001|Week 3|Adverse Event|0|||
37660319|NCT03347123|69133029|FG000|Overall Study|Death|1|||
37660320|NCT03347123|69133030|FG001|Overall Study|Death|2|||
37660321|NCT03347123|69133031|FG002|Overall Study|Death|0|||
37660322|NCT03347123|69133032|FG003|Overall Study|Death|0|||
37660323|NCT03347123|69133033|FG004|Overall Study|Death|0|||
37660324|NCT03347123|69133034|FG005|Overall Study|Death|0|||
37660325|NCT03347123|69133035|FG006|Overall Study|Death|0|||
37660326|NCT03347123|69133029|FG000|Overall Study|Withdrawal by Subject|1|||
37660327|NCT03347123|69133030|FG001|Overall Study|Withdrawal by Subject|0|||
37660328|NCT03347123|69133031|FG002|Overall Study|Withdrawal by Subject|0|||
37660329|NCT03347123|69133032|FG003|Overall Study|Withdrawal by Subject|0|||
37660330|NCT03347123|69133033|FG004|Overall Study|Withdrawal by Subject|0|||
37660331|NCT03347123|69133034|FG005|Overall Study|Withdrawal by Subject|0|||
37660332|NCT03347123|69133035|FG006|Overall Study|Withdrawal by Subject|0|||
37660333|NCT03347123|69133029|FG000|Overall Study|Reason not Specified|3|||
37660334|NCT03347123|69133030|FG001|Overall Study|Reason not Specified|4|||
37660335|NCT03347123|69133031|FG002|Overall Study|Reason not Specified|0|||
37660336|NCT03347123|69133032|FG003|Overall Study|Reason not Specified|0|||
37660337|NCT03347123|69133033|FG004|Overall Study|Reason not Specified|0|||
37660338|NCT03347123|69133034|FG005|Overall Study|Reason not Specified|0|||
37660339|NCT03347123|69133035|FG006|Overall Study|Reason not Specified|0|||
37660340|NCT02198794|69133046|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
37660341|NCT02198794|69133047|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
37660342|NCT02198794|69133048|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
37660343|NCT02198794|69133049|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
37660344|NCT02198794|69133046|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
37660345|NCT02198794|69133047|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
37660346|NCT02198794|69133048|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
37660347|NCT02198794|69133049|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
37660348|NCT02198794|69133046|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
37660349|NCT02198794|69133047|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
37660350|NCT02198794|69133048|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
37660351|NCT02198794|69133049|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
37660352|NCT02198794|69133046|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
37660353|NCT02198794|69133047|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
37660354|NCT02198794|69133048|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
37660355|NCT02198794|69133049|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
37660356|NCT02198794|69133046|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
37660357|NCT02198794|69133047|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
37660358|NCT02198794|69133048|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
37660359|NCT02198794|69133049|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
37660360|NCT02198794|69133046|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
37660361|NCT02198794|69133047|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
37660362|NCT02198794|69133048|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
37660363|NCT02198794|69133049|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
37660364|NCT02198794|69133046|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
37660365|NCT02198794|69133047|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
37660366|NCT02198794|69133048|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
37660367|NCT02198794|69133049|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
37660368|NCT02198794|69133046|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
37660369|NCT02198794|69133047|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
37660370|NCT02198794|69133048|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
37660371|NCT02198794|69133049|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
37660372|NCT02198794|69133046|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
37660373|NCT02198794|69133047|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
37660374|NCT02198794|69133048|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
37660375|NCT02198794|69133049|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
37660376|NCT02198794|69133046|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
37660377|NCT02198794|69133047|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
37660378|NCT02198794|69133048|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
37660379|NCT02198794|69133049|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
37660380|NCT02198794|69133046|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
37660381|NCT02198794|69133047|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
37660382|NCT02198794|69133048|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
37750151|NCT01857869|69245152|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
37750152|NCT01857869|69245153|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
38033109|NCT04760314|69719145|FG003|Induction Period|Adverse Event|0|||
37660383|NCT02198794|69133049|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
37660384|NCT02198794|69133046|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
37660385|NCT02198794|69133047|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
37660386|NCT02198794|69133048|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
37660387|NCT02198794|69133049|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
37660388|NCT02198794|69133046|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
37660389|NCT02198794|69133047|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
37660390|NCT02198794|69133048|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
37660391|NCT02198794|69133049|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
37660392|NCT02198794|69133046|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
37660393|NCT02198794|69133047|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
37660394|NCT02198794|69133048|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
37660395|NCT02198794|69133049|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
37660396|NCT02198794|69133046|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
37660397|NCT02198794|69133047|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
37660398|NCT02198794|69133048|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
37660399|NCT02198794|69133049|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
37660400|NCT02133664|69133060|FG000|Overall Study|Lost to Follow-up|2|||
37660401|NCT02133664|69133061|FG001|Overall Study|Lost to Follow-up|1|||
37660402|NCT02133664|69133060|FG000|Overall Study|Adverse Event|3|||
37660403|NCT02133664|69133061|FG001|Overall Study|Adverse Event|6|||
37660404|NCT02133508|69133067|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
37660405|NCT02133508|69133067|FG000|Overall Study|Death|12|||
37660406|NCT02133508|69133067|FG000|Overall Study|Lost to Follow-up|2|||
37660407|NCT02133352|69133071|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
37660408|NCT02167594|69133078|FG000|Overall Study|Withdrawal by Subject|2|||
37660409|NCT02167594|69133079|FG001|Overall Study|Withdrawal by Subject|0|||
37660410|NCT02167594|69133080|FG002|Overall Study|Withdrawal by Subject|0|||
37660411|NCT02167594|69133078|FG000|Overall Study|Death|0|||
37660412|NCT02167594|69133079|FG001|Overall Study|Death|1|||
37660413|NCT02167594|69133080|FG002|Overall Study|Death|0|||
37660414|NCT02555657|69133091|FG000|Overall Study|Death|274|||
37660415|NCT02555657|69133092|FG001|Overall Study|Death|262|||
37660416|NCT02555657|69133091|FG000|Overall Study|Physician Decision|0|||
37660417|NCT02555657|69133092|FG001|Overall Study|Physician Decision|1|||
37660418|NCT02555657|69133091|FG000|Overall Study|Sponsor Decision|27|||
37660419|NCT02555657|69133092|FG001|Overall Study|Sponsor Decision|15|||
37750153|NCT01857869|69245154|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
37750154|NCT01857869|69245155|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
37750155|NCT01857869|69245156|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
37750156|NCT01857869|69245157|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
37750157|NCT01857869|69245158|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
37750158|NCT01857869|69245159|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
37750159|NCT04452318|69245247|FG000|Overall Study|Physician Decision|1|||
37750160|NCT04452318|69245248|FG001|Overall Study|Physician Decision|2|||
37750161|NCT04452318|69245249|FG002|Overall Study|Physician Decision|0|||
37750162|NCT04452318|69245250|FG003|Overall Study|Physician Decision|2|||
37750163|NCT04452318|69245251|FG004|Overall Study|Physician Decision|0|||
37750164|NCT04452318|69245252|FG005|Overall Study|Physician Decision|2|||
37750165|NCT04452318|69245253|FG006|Overall Study|Physician Decision|5|||
37750166|NCT04452318|69245247|FG000|Overall Study|Death|2|||
37750167|NCT04452318|69245248|FG001|Overall Study|Death|3|||
37750168|NCT04452318|69245249|FG002|Overall Study|Death|0|||
37660420|NCT02555657|69133091|FG000|Overall Study|Withdrawal by Subject|11|||
37660421|NCT02555657|69133092|FG001|Overall Study|Withdrawal by Subject|32|||
37660422|NCT02195518|69133124|FG000|Overall Study|Adverse Event|1|||
37750169|NCT04452318|69245250|FG003|Overall Study|Death|0|||
37750170|NCT04452318|69245251|FG004|Overall Study|Death|0|||
37750171|NCT04452318|69245252|FG005|Overall Study|Death|0|||
37750172|NCT04452318|69245253|FG006|Overall Study|Death|0|||
37750173|NCT04452318|69245247|FG000|Overall Study|Lost to Follow-up|38|||
37750174|NCT04452318|69245248|FG001|Overall Study|Lost to Follow-up|28|||
37750175|NCT04452318|69245249|FG002|Overall Study|Lost to Follow-up|0|||
37750176|NCT04452318|69245250|FG003|Overall Study|Lost to Follow-up|3|||
37750177|NCT04452318|69245251|FG004|Overall Study|Lost to Follow-up|3|||
37750178|NCT04452318|69245252|FG005|Overall Study|Lost to Follow-up|2|||
37750179|NCT04452318|69245253|FG006|Overall Study|Lost to Follow-up|1|||
37660423|NCT02195518|69133124|FG000|Overall Study|Protocol Violation|4|||
37750180|NCT04452318|69245247|FG000|Overall Study|Withdrawal by Subject|46|||
37750181|NCT04452318|69245248|FG001|Overall Study|Withdrawal by Subject|40|||
37660424|NCT02195518|69133124|FG000|Overall Study|Pregnancy|2|||
37660425|NCT02195518|69133124|FG000|Overall Study|Withdrawal by Subject|1|||
37660426|NCT02195518|69133124|FG000|Overall Study|Lost to Follow-up|1|||
37660427|NCT02133742|69133154|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
37750182|NCT04452318|69245249|FG002|Overall Study|Withdrawal by Subject|0|||
37750183|NCT04452318|69245250|FG003|Overall Study|Withdrawal by Subject|18|||
37750184|NCT04452318|69245251|FG004|Overall Study|Withdrawal by Subject|6|||
37856537|NCT00975481|69539756|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
37660428|NCT02133742|69133154|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
37660429|NCT02133742|69133154|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
37660430|NCT02133742|69133154|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
37660431|NCT02133742|69133154|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
37660432|NCT03032705|69133162|FG000|Overall Study|Lost to Follow-up|16|||
37660433|NCT03032705|69133163|FG001|Overall Study|Lost to Follow-up|17|||
37660434|NCT03032705|69133162|FG000|Overall Study|did not quality|6|||
37660435|NCT03032705|69133163|FG001|Overall Study|did not quality|6|||
37660436|NCT04476251|69133169|FG000|Overall Study|Not treated|1|||
37660437|NCT03795233|69133175|FG000|Overall Study|Withdrawal by Subject|2|||
37660438|NCT03795233|69133176|FG001|Overall Study|Withdrawal by Subject|1|||
37660439|NCT03795233|69133175|FG000|Overall Study|Lost to Follow-up|1|||
37660440|NCT03795233|69133176|FG001|Overall Study|Lost to Follow-up|0|||
37660441|NCT03795233|69133175|FG000|Overall Study|Death|1|||
37660442|NCT03795233|69133176|FG001|Overall Study|Death|0|||
37660443|NCT03645863|69133185|FG000|Overall Study|Withdrawal by Subject|1|||
37660444|NCT03645863|69133186|FG001|Overall Study|Withdrawal by Subject|0|||
37660445|NCT03645863|69133187|FG002|Overall Study|Withdrawal by Subject|0|||
37660446|NCT03564119|69133197|FG000|Overall Study|Adverse Event|4|||
37660447|NCT03564119|69133198|FG001|Overall Study|Adverse Event|0|||
37660448|NCT03564119|69133197|FG000|Overall Study|Lost to Follow-up|1|||
37660449|NCT03564119|69133198|FG001|Overall Study|Lost to Follow-up|4|||
37660450|NCT03564119|69133197|FG000|Overall Study|Protocol Violation|1|||
37750185|NCT04452318|69245252|FG005|Overall Study|Withdrawal by Subject|8|||
37750186|NCT04452318|69245253|FG006|Overall Study|Withdrawal by Subject|6|||
37750187|NCT00634101|69245430|FG000|Overall Study|Study Terminated|3|||
37750188|NCT00634101|69245431|FG001|Overall Study|Study Terminated|3|||
37750189|NCT00634101|69245430|FG000|Overall Study|Lost to Follow-up|2|||
37750190|NCT00634101|69245431|FG001|Overall Study|Lost to Follow-up|0|||
37750191|NCT00633477|69245448|FG000|Overall Study|Death|1|||
37750192|NCT00633477|69245449|FG001|Overall Study|Death|0|||
37750193|NCT00633477|69245448|FG000|Overall Study|Randomized but not treated|1|||
37750194|NCT00633477|69245449|FG001|Overall Study|Randomized but not treated|0|||
37750195|NCT00331773|69245474|FG000|Overall Study|Withdrawal by Subject|6|||
37750196|NCT00331773|69245475|FG001|Overall Study|Withdrawal by Subject|4|||
37750197|NCT00331773|69245474|FG000|Overall Study|Protocol Violation|10|||
37750198|NCT00331773|69245475|FG001|Overall Study|Protocol Violation|3|||
37750199|NCT00633243|69245508|FG000|Overall Study|Withdrawal by Subject|0|||
37750200|NCT00633243|69245509|FG001|Overall Study|Withdrawal by Subject|1|||
37750201|NCT00633243|69245508|FG000|Overall Study|incarceration|0|||
37750202|NCT00633243|69245509|FG001|Overall Study|incarceration|2|||
37750203|NCT00633243|69245508|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
37750204|NCT00633243|69245509|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
37750205|NCT00633243|69245508|FG000|Overall Study|Not comfortable with self-injecting|0|||
37750206|NCT00633243|69245509|FG001|Overall Study|Not comfortable with self-injecting|1|||
37750207|NCT00633243|69245508|FG000|Overall Study|Mental Health--Depression|0|||
37923119|NCT00591006|69609915|FG001|Overall Study|Withdrawal by Subject|0|||
37660451|NCT03564119|69133198|FG001|Overall Study|Protocol Violation|0|||
37750208|NCT00633243|69245509|FG001|Overall Study|Mental Health--Depression|1|||
37750209|NCT00633243|69245508|FG000|Overall Study|Couldn't tolerate side-effects|1|||
37750210|NCT00633243|69245509|FG001|Overall Study|Couldn't tolerate side-effects|1|||
37750211|NCT01872689|69245519|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
37856538|NCT00975481|69539757|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
37856539|NCT00975481|69539758|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
37856540|NCT00975481|69539759|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
37856541|NCT00975481|69539760|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
37856542|NCT01011868|69539781|FG000|After Week 18 Follow-up|Adverse Event|8|||
37856543|NCT01011868|69539782|FG001|After Week 18 Follow-up|Adverse Event|6|||
37856544|NCT01011868|69539783|FG002|After Week 18 Follow-up|Adverse Event|13|||
37856545|NCT01011868|69539781|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
37856546|NCT01011868|69539782|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
37856547|NCT01011868|69539783|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
37856548|NCT01011868|69539781|FG000|After Week 18 Follow-up|Protocol Violation|1|||
37923120|NCT00591006|69609916|FG002|Overall Study|Withdrawal by Subject|0|||
37750212|NCT01872689|69245520|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
37750213|NCT01872689|69245521|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
37856549|NCT01011868|69539782|FG001|After Week 18 Follow-up|Protocol Violation|1|||
37660452|NCT03564119|69133197|FG000|Overall Study|Withdrawal by Subject|9|||
37923121|NCT00591006|69609917|FG003|Overall Study|Withdrawal by Subject|0|||
37660453|NCT03564119|69133198|FG001|Overall Study|Withdrawal by Subject|4|||
37660454|NCT03564119|69133197|FG000|Overall Study|Other Than Specified|0|||
37660455|NCT03564119|69133198|FG001|Overall Study|Other Than Specified|1|||
37660456|NCT04531241|69133204|FG000|Period 1|Withdrawal by Subject|2|||
37660457|NCT04531241|69133205|FG001|Period 1|Withdrawal by Subject|0|||
37856550|NCT01011868|69539783|FG002|After Week 18 Follow-up|Protocol Violation|1|||
37750214|NCT01872689|69245522|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
37750215|NCT01872689|69245519|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
37750216|NCT01872689|69245520|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
37750217|NCT01872689|69245521|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
37750218|NCT01872689|69245522|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
37750219|NCT01872689|69245519|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
37750220|NCT01872689|69245520|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
37750221|NCT01872689|69245521|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
37750222|NCT01872689|69245522|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
37750223|NCT01872689|69245519|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
37750224|NCT01872689|69245520|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
37750225|NCT01872689|69245521|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
37750226|NCT01872689|69245522|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
37750227|NCT01872689|69245519|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
37750228|NCT01872689|69245520|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
37750229|NCT01872689|69245521|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
37750230|NCT01872689|69245522|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
37750231|NCT01872689|69245519|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
37750232|NCT01872689|69245520|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
37750233|NCT01872689|69245521|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
37750234|NCT01872689|69245522|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
37750235|NCT01872689|69245519|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
37750236|NCT01872689|69245520|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
37750237|NCT01872689|69245521|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
37750238|NCT01872689|69245522|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
37750239|NCT01872689|69245519|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
37750240|NCT01872689|69245520|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
37750241|NCT01872689|69245521|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
37750242|NCT01872689|69245522|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
37750243|NCT01872689|69245519|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
37750244|NCT01872689|69245520|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
37750245|NCT01872689|69245521|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
37750246|NCT01872689|69245522|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
37750247|NCT01872689|69245519|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
37750248|NCT01872689|69245520|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
37750249|NCT01872689|69245521|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
37750250|NCT01872689|69245522|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
37750251|NCT01872689|69245519|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
37750252|NCT01872689|69245520|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
37750253|NCT01872689|69245521|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
37750254|NCT01872689|69245522|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
37750255|NCT01872689|69245519|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
37750256|NCT01872689|69245520|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
37750257|NCT01872689|69245521|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
37750258|NCT01872689|69245522|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
37750259|NCT01872689|69245519|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
37750260|NCT01872689|69245520|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
37750261|NCT01872689|69245521|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
37750262|NCT01872689|69245522|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
37750263|NCT01872689|69245519|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
37750264|NCT01872689|69245520|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
37750265|NCT01872689|69245521|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
37750266|NCT01872689|69245522|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
37750267|NCT00632931|69245535|FG000|Part 1, Period 1|Protocol Violation|1|||
37750268|NCT00632931|69245536|FG001|Part 1, Period 1|Protocol Violation|0|||
37750269|NCT00632931|69245537|FG002|Part 1, Period 1|Protocol Violation|0|||
37750270|NCT00632931|69245535|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
37750271|NCT00632931|69245536|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
37750272|NCT00632931|69245537|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
37750273|NCT00632931|69245535|FG000|Part 2|Adverse Event|0|||
37750274|NCT00632931|69245536|FG001|Part 2|Adverse Event|0|||
37750275|NCT00632931|69245537|FG002|Part 2|Adverse Event|3|||
37750276|NCT00632931|69245535|FG000|Part 2|Death|0|||
37923122|NCT00591006|69609918|FG004|Overall Study|Withdrawal by Subject|0|||
37750277|NCT00632931|69245536|FG001|Part 2|Death|0|||
37750278|NCT00632931|69245537|FG002|Part 2|Death|1|||
37750279|NCT00632931|69245535|FG000|Part 2|Lack of Efficacy|0|||
37750280|NCT00632931|69245536|FG001|Part 2|Lack of Efficacy|0|||
37750281|NCT00632931|69245537|FG002|Part 2|Lack of Efficacy|17|||
37750282|NCT00632931|69245535|FG000|Part 2|Withdrawal by Subject|0|||
37750283|NCT00632931|69245536|FG001|Part 2|Withdrawal by Subject|0|||
37660458|NCT04531241|69133204|FG000|Period 1|Dispesed incorrect lens power|1|||
37660459|NCT04531241|69133205|FG001|Period 1|Dispesed incorrect lens power|0|||
37660460|NCT04531241|69133204|FG000|Period 1|Protocol Violation|1|||
37660461|NCT04531241|69133205|FG001|Period 1|Protocol Violation|0|||
37660462|NCT04531241|69133204|FG000|Period 1|No longer eligible|0|||
37660463|NCT04531241|69133205|FG001|Period 1|No longer eligible|1|||
37660464|NCT04531241|69133204|FG000|Period 1|Lens Discomfort|0|||
37660465|NCT04531241|69133205|FG001|Period 1|Lens Discomfort|1|||
37660466|NCT04531241|69133204|FG000|Period 2|Covid-19 Related|1|||
37660467|NCT04531241|69133205|FG001|Period 2|Covid-19 Related|1|||
37660468|NCT03181529|69133213|FG000|Overall Study|Withdrawal by Subject|1|||
37660469|NCT03181529|69133214|FG001|Overall Study|Withdrawal by Subject|1|||
37660470|NCT03181529|69133213|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
37660471|NCT03181529|69133214|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
37750284|NCT00632931|69245537|FG002|Part 2|Withdrawal by Subject|3|||
37750285|NCT01857323|69245542|FG000|Overall Study|Adverse Event|1|||
37750286|NCT01857323|69245542|FG000|Overall Study|Withdrawal by Subject|3|||
37750287|NCT01857323|69245542|FG000|Overall Study|Non-compliance|1|||
37750288|NCT01857323|69245542|FG000|Overall Study|Protocol Violation|6|||
37750289|NCT01857323|69245542|FG000|Overall Study|Lost to Follow-up|1|||
37750290|NCT01857323|69245542|FG000|Overall Study|Other|4|||
37750291|NCT01857323|69245542|FG000|Overall Study|Did not complete 180 doses|48|||
37750292|NCT00632541|69245546|FG000|Overall Study|Adverse Event|7|||
37750293|NCT01872611|69245552|FG000|Overall Study|Adverse Event|3|||
37750294|NCT01872611|69245553|FG001|Overall Study|Adverse Event|1|||
37750295|NCT01872611|69245552|FG000|Overall Study|Adverse Event, prior to treatment|0|||
37750296|NCT01872611|69245553|FG001|Overall Study|Adverse Event, prior to treatment|1|||
37750297|NCT01872611|69245552|FG000|Overall Study|Death|0|||
37750298|NCT01872611|69245553|FG001|Overall Study|Death|1|||
37750299|NCT01872611|69245552|FG000|Overall Study|Death, prior to treatment|0|||
37750300|NCT01872611|69245553|FG001|Overall Study|Death, prior to treatment|1|||
37750301|NCT01872611|69245552|FG000|Overall Study|Lost to Follow-up|8|||
37750302|NCT01872611|69245553|FG001|Overall Study|Lost to Follow-up|1|||
37750303|NCT01872611|69245552|FG000|Overall Study|Physician Decision|1|||
37750304|NCT01872611|69245553|FG001|Overall Study|Physician Decision|0|||
37750305|NCT01872611|69245552|FG000|Overall Study|Withdrawal by Subject|6|||
37750306|NCT01872611|69245553|FG001|Overall Study|Withdrawal by Subject|1|||
37750307|NCT01872611|69245552|FG000|Overall Study|Reason not provided|6|||
37856551|NCT01011868|69539781|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
37856552|NCT01011868|69539782|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
37856553|NCT01011868|69539783|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
37856554|NCT01011868|69539781|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
37856555|NCT01011868|69539782|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
37856556|NCT01011868|69539783|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
37856557|NCT01011868|69539781|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
37856558|NCT01011868|69539782|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
37856559|NCT01011868|69539783|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
37856560|NCT01011868|69539781|FG000|After Week 78 Follow-up|Adverse Event|14|||
37856561|NCT01011868|69539782|FG001|After Week 78 Follow-up|Adverse Event|18|||
37856562|NCT01011868|69539783|FG002|After Week 78 Follow-up|Adverse Event|21|||
37750308|NCT01872611|69245553|FG001|Overall Study|Reason not provided|6|||
37750309|NCT03089853|69245563|FG000|Overall Study|Lost to Follow-up|2|||
37750310|NCT03089853|69245564|FG001|Overall Study|Lost to Follow-up|1|||
37856563|NCT01011868|69539781|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
37856564|NCT01011868|69539782|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
37856565|NCT01011868|69539783|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
37856566|NCT01011868|69539781|FG000|After Week 78 Follow-up|Protocol Violation|9|||
38033110|NCT04760314|69719146|FG004|Induction Period|Adverse Event|0|||
38033111|NCT04760314|69719147|FG005|Induction Period|Adverse Event|0|||
37660472|NCT03470441|69133228|FG000|Overall Study|Death|0|||
37660473|NCT03470441|69133229|FG001|Overall Study|Death|1|||
37750311|NCT03086967|69245572|FG000|Overall Study|Screen Failure|2|||
37750312|NCT03086967|69245573|FG001|Overall Study|Screen Failure|2|||
37660474|NCT03470441|69133230|FG002|Overall Study|Death|1|||
37750313|NCT01856543|69245581|FG000|Overall Study|Treatment discontinued|6|||
37660475|NCT03470441|69133231|FG003|Overall Study|Death|0|||
37660476|NCT03470441|69133228|FG000|Overall Study|Adverse Event|0|||
37660477|NCT03470441|69133229|FG001|Overall Study|Adverse Event|0|||
37660478|NCT03470441|69133230|FG002|Overall Study|Adverse Event|0|||
37750314|NCT01856543|69245582|FG001|Overall Study|Treatment discontinued|3|||
37750315|NCT01856543|69245581|FG000|Overall Study|Withdrawn before start|7|||
37750316|NCT01856543|69245582|FG001|Overall Study|Withdrawn before start|3|||
37856567|NCT01011868|69539782|FG001|After Week 78 Follow-up|Protocol Violation|1|||
38033112|NCT04760314|69719148|FG006|Induction Period|Adverse Event|0|||
37750317|NCT00632463|69245592|FG000|Overall Study|Adverse Event|0|||
37750318|NCT00632463|69245593|FG001|Overall Study|Adverse Event|1|||
37750319|NCT00632463|69245594|FG002|Overall Study|Adverse Event|0|||
37750320|NCT00632229|69245604|FG000|Overall Study|Adverse Event|6|||
37750321|NCT00632229|69245605|FG001|Overall Study|Adverse Event|0|||
37750322|NCT00632229|69245604|FG000|Overall Study|Lost to Follow-up|0|||
37750323|NCT00632229|69245605|FG001|Overall Study|Lost to Follow-up|3|||
37750324|NCT00632229|69245604|FG000|Overall Study|Lack of Efficacy|0|||
37750325|NCT00632229|69245605|FG001|Overall Study|Lack of Efficacy|2|||
37750326|NCT00632229|69245604|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
37750327|NCT00632229|69245605|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
37750328|NCT00631137|69245613|FG000|Overall Study|Withdrawal by Subject|1|||
37750329|NCT00631137|69245614|FG001|Overall Study|Withdrawal by Subject|0|||
37750330|NCT00630825|69245633|FG000|Overall Study|Adverse Event|4|||
37750331|NCT00630825|69245634|FG001|Overall Study|Adverse Event|4|||
37750332|NCT00630825|69245635|FG002|Overall Study|Adverse Event|3|||
37750333|NCT00630825|69245636|FG003|Overall Study|Adverse Event|1|||
37750334|NCT00630825|69245633|FG000|Overall Study|Entry Criteria Not Met|1|||
37750335|NCT00630825|69245634|FG001|Overall Study|Entry Criteria Not Met|0|||
37750336|NCT00630825|69245635|FG002|Overall Study|Entry Criteria Not Met|2|||
37750337|NCT00630825|69245636|FG003|Overall Study|Entry Criteria Not Met|1|||
37750338|NCT00630825|69245633|FG000|Overall Study|Lost to Follow-up|1|||
37750339|NCT00630825|69245634|FG001|Overall Study|Lost to Follow-up|1|||
37750340|NCT00630825|69245635|FG002|Overall Study|Lost to Follow-up|1|||
37750341|NCT00630825|69245636|FG003|Overall Study|Lost to Follow-up|1|||
37750342|NCT00630825|69245633|FG000|Overall Study|Physician Decision|1|||
37750343|NCT00630825|69245634|FG001|Overall Study|Physician Decision|0|||
37750344|NCT00630825|69245635|FG002|Overall Study|Physician Decision|0|||
37750345|NCT00630825|69245636|FG003|Overall Study|Physician Decision|0|||
37750346|NCT00630825|69245633|FG000|Overall Study|Withdrawal by Subject|2|||
37750347|NCT00630825|69245634|FG001|Overall Study|Withdrawal by Subject|2|||
37750348|NCT00630825|69245635|FG002|Overall Study|Withdrawal by Subject|2|||
37750349|NCT00630825|69245636|FG003|Overall Study|Withdrawal by Subject|3|||
37750350|NCT04075734|69245933|FG000|Overall Study|Lost to Follow-up|1|||
37750351|NCT04075734|69245934|FG001|Overall Study|Lost to Follow-up|1|||
37750352|NCT04075734|69245935|FG002|Overall Study|Lost to Follow-up|0|||
37750353|NCT04075734|69245933|FG000|Overall Study|Withdrawal by Subject|3|||
37750354|NCT04075734|69245934|FG001|Overall Study|Withdrawal by Subject|0|||
37750355|NCT04075734|69245935|FG002|Overall Study|Withdrawal by Subject|0|||
37750356|NCT00989781|69245980|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
37750357|NCT00989781|69245981|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
37750358|NCT00989235|69246022|FG000|Overall Study|Death|0|||
37750359|NCT00989235|69246023|FG001|Overall Study|Death|1|||
37856568|NCT01011868|69539783|FG002|After Week 78 Follow-up|Protocol Violation|2|||
37856569|NCT01011868|69539781|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
38033113|NCT04760314|69719149|FG007|Induction Period|Adverse Event|0|||
38033114|NCT04760314|69719150|FG008|Induction Period|Adverse Event|0|||
38033115|NCT04760314|69719151|FG009|Induction Period|Adverse Event|0|||
38033116|NCT04760314|69719152|FG010|Induction Period|Adverse Event|0|||
38033117|NCT04760314|69719142|FG000|Maintenance Blinded Period|Withdrawal by Subject|0|||
38033118|NCT04760314|69719143|FG001|Maintenance Blinded Period|Withdrawal by Subject|0|||
38033119|NCT04760314|69719144|FG002|Maintenance Blinded Period|Withdrawal by Subject|0|||
38033120|NCT04760314|69719145|FG003|Maintenance Blinded Period|Withdrawal by Subject|1|||
38033121|NCT04760314|69719146|FG004|Maintenance Blinded Period|Withdrawal by Subject|2|||
38033122|NCT04760314|69719147|FG005|Maintenance Blinded Period|Withdrawal by Subject|1|||
38033123|NCT04760314|69719148|FG006|Maintenance Blinded Period|Withdrawal by Subject|2|||
38033124|NCT04760314|69719149|FG007|Maintenance Blinded Period|Withdrawal by Subject|0|||
38033125|NCT04760314|69719150|FG008|Maintenance Blinded Period|Withdrawal by Subject|0|||
38033126|NCT04760314|69719151|FG009|Maintenance Blinded Period|Withdrawal by Subject|0|||
38033127|NCT04760314|69719152|FG010|Maintenance Blinded Period|Withdrawal by Subject|0|||
38033128|NCT04760314|69719142|FG000|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
38033129|NCT04760314|69719143|FG001|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
38033130|NCT04760314|69719144|FG002|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
38033131|NCT04760314|69719145|FG003|Maintenance Blinded Period|Enrolled to Escape Arm|1|||
38033132|NCT04760314|69719146|FG004|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
38033133|NCT04760314|69719147|FG005|Maintenance Blinded Period|Enrolled to Escape Arm|4|||
38033134|NCT04760314|69719148|FG006|Maintenance Blinded Period|Enrolled to Escape Arm|3|||
38033135|NCT04760314|69719149|FG007|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
38033136|NCT04760314|69719150|FG008|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
38033137|NCT04760314|69719151|FG009|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
38033138|NCT04760314|69719152|FG010|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
38033139|NCT04760314|69719142|FG000|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
37750360|NCT00989235|69246022|FG000|Overall Study|Adverse Event|0|||
38033140|NCT04760314|69719143|FG001|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
38033141|NCT04760314|69719144|FG002|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
38033142|NCT04760314|69719145|FG003|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
37750361|NCT00989235|69246023|FG001|Overall Study|Adverse Event|1|||
37750362|NCT00989235|69246022|FG000|Overall Study|Lack of Efficacy|1|||
37750363|NCT00989235|69246023|FG001|Overall Study|Lack of Efficacy|0|||
37750364|NCT00989235|69246022|FG000|Overall Study|Withdrawal of Consent|1|||
37750365|NCT00989235|69246023|FG001|Overall Study|Withdrawal of Consent|1|||
37750366|NCT00989235|69246022|FG000|Overall Study|Desire to Become Pregnant|1|||
37750367|NCT00989235|69246023|FG001|Overall Study|Desire to Become Pregnant|0|||
37750368|NCT00989235|69246022|FG000|Overall Study|Randomized by Mistake|0|||
37750369|NCT00989235|69246023|FG001|Overall Study|Randomized by Mistake|2|||
37750370|NCT00989235|69246022|FG000|Overall Study|Lost to Follow-up|0|||
37750371|NCT00989235|69246023|FG001|Overall Study|Lost to Follow-up|1|||
37750372|NCT00988533|69246063|FG000|Overall Study|Lost to Follow-up|3|||
37750373|NCT03633396|69246095|FG000|Overall Study|Withdrawal by Subject|4|||
37750374|NCT03633396|69246096|FG001|Overall Study|Withdrawal by Subject|4|||
37750375|NCT03633396|69246095|FG000|Overall Study|Adverse Event|1|||
37750376|NCT03633396|69246096|FG001|Overall Study|Adverse Event|1|||
37750377|NCT03633396|69246095|FG000|Overall Study|Lack of Efficacy|1|||
37750378|NCT03633396|69246096|FG001|Overall Study|Lack of Efficacy|0|||
37750379|NCT03633396|69246095|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
37660479|NCT03470441|69133231|FG003|Overall Study|Adverse Event|1|||
37660480|NCT03470441|69133228|FG000|Overall Study|Withdrawal by Subject|1|||
37660481|NCT03470441|69133229|FG001|Overall Study|Withdrawal by Subject|4|||
37750380|NCT03633396|69246096|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
37750381|NCT00988065|69246109|FG000|Overall Study|Adverse Event|4|||
37750382|NCT00988065|69246110|FG001|Overall Study|Adverse Event|10|||
37923123|NCT00591006|69609919|FG005|Overall Study|Withdrawal by Subject|0|||
37660482|NCT03470441|69133230|FG002|Overall Study|Withdrawal by Subject|1|||
37660483|NCT03470441|69133231|FG003|Overall Study|Withdrawal by Subject|3|||
37660484|NCT03361865|69133243|FG000|Overall Study|Death|17|||
37660485|NCT03361865|69133244|FG001|Overall Study|Death|18|||
37660486|NCT03361865|69133243|FG000|Overall Study|Physician Decision|1|||
37660487|NCT03361865|69133244|FG001|Overall Study|Physician Decision|9|||
37660488|NCT03361865|69133243|FG000|Overall Study|Withdrawal by Subject|1|||
37660489|NCT03361865|69133244|FG001|Overall Study|Withdrawal by Subject|0|||
37660490|NCT02149121|69133258|FG000|Main Study Period|Lack of Efficacy|2|||
37660491|NCT02149121|69133259|FG001|Main Study Period|Lack of Efficacy|2|||
37660492|NCT02149121|69133260|FG002|Main Study Period|Lack of Efficacy|1|||
37660493|NCT02149121|69133261|FG003|Main Study Period|Lack of Efficacy|0|||
37660494|NCT02149121|69133262|FG004|Main Study Period|Lack of Efficacy|0|||
37660495|NCT02149121|69133263|FG005|Main Study Period|Lack of Efficacy|0|||
37660496|NCT02149121|69133264|FG006|Main Study Period|Lack of Efficacy|0|||
37660497|NCT02149121|69133258|FG000|Main Study Period|Withdrawal by Subject|9|||
37660498|NCT02149121|69133259|FG001|Main Study Period|Withdrawal by Subject|5|||
37660499|NCT02149121|69133260|FG002|Main Study Period|Withdrawal by Subject|1|||
37660500|NCT02149121|69133261|FG003|Main Study Period|Withdrawal by Subject|0|||
37660501|NCT02149121|69133262|FG004|Main Study Period|Withdrawal by Subject|0|||
37660502|NCT02149121|69133263|FG005|Main Study Period|Withdrawal by Subject|0|||
37660503|NCT02149121|69133264|FG006|Main Study Period|Withdrawal by Subject|0|||
37660504|NCT02149121|69133258|FG000|Main Study Period|Adverse Event|2|||
37660505|NCT02149121|69133259|FG001|Main Study Period|Adverse Event|5|||
37660506|NCT02149121|69133260|FG002|Main Study Period|Adverse Event|1|||
37660507|NCT02149121|69133261|FG003|Main Study Period|Adverse Event|0|||
37660508|NCT02149121|69133262|FG004|Main Study Period|Adverse Event|0|||
37660509|NCT02149121|69133263|FG005|Main Study Period|Adverse Event|0|||
37660510|NCT02149121|69133264|FG006|Main Study Period|Adverse Event|0|||
37660511|NCT02149121|69133258|FG000|Main Study Period|Protocol Violation|2|||
37660512|NCT02149121|69133259|FG001|Main Study Period|Protocol Violation|0|||
37660513|NCT02149121|69133260|FG002|Main Study Period|Protocol Violation|0|||
37660514|NCT02149121|69133261|FG003|Main Study Period|Protocol Violation|0|||
37660515|NCT02149121|69133262|FG004|Main Study Period|Protocol Violation|0|||
37660516|NCT02149121|69133263|FG005|Main Study Period|Protocol Violation|0|||
37660517|NCT02149121|69133264|FG006|Main Study Period|Protocol Violation|0|||
37660518|NCT02149121|69133258|FG000|Main Study Period|Lost to Follow-up|2|||
37660519|NCT02149121|69133259|FG001|Main Study Period|Lost to Follow-up|1|||
37660520|NCT02149121|69133260|FG002|Main Study Period|Lost to Follow-up|0|||
37660521|NCT02149121|69133261|FG003|Main Study Period|Lost to Follow-up|0|||
37660522|NCT02149121|69133262|FG004|Main Study Period|Lost to Follow-up|0|||
37660523|NCT02149121|69133263|FG005|Main Study Period|Lost to Follow-up|0|||
37750383|NCT00988065|69246111|FG002|Overall Study|Adverse Event|2|||
37750384|NCT00988065|69246109|FG000|Overall Study|Lost to Follow-up|1|||
37750385|NCT00988065|69246110|FG001|Overall Study|Lost to Follow-up|2|||
37923124|NCT00591006|69609920|FG006|Overall Study|Withdrawal by Subject|0|||
37923125|NCT00591006|69609921|FG007|Overall Study|Withdrawal by Subject|0|||
37923126|NCT00591006|69609922|FG008|Overall Study|Withdrawal by Subject|0|||
37923127|NCT00591006|69609923|FG009|Overall Study|Withdrawal by Subject|0|||
37750386|NCT00988065|69246111|FG002|Overall Study|Lost to Follow-up|2|||
37750387|NCT00988065|69246109|FG000|Overall Study|Subject withdrew consent|3|||
37750388|NCT00988065|69246110|FG001|Overall Study|Subject withdrew consent|5|||
37750389|NCT00988065|69246111|FG002|Overall Study|Subject withdrew consent|2|||
37750390|NCT00988065|69246109|FG000|Overall Study|Noncompliance with protocol|5|||
37750391|NCT00988065|69246110|FG001|Overall Study|Noncompliance with protocol|6|||
37750392|NCT00988065|69246111|FG002|Overall Study|Noncompliance with protocol|9|||
37750393|NCT00987831|69246135|FG000|Overall Study|Never flared in 12 months|1|||
37750394|NCT00987831|69246136|FG001|Overall Study|Never flared in 12 months|0|||
37750395|NCT00987831|69246137|FG002|Overall Study|Never flared in 12 months|0|||
37750396|NCT00987831|69246135|FG000|Overall Study|Lost to Follow-up|0|||
37750397|NCT00987831|69246136|FG001|Overall Study|Lost to Follow-up|3|||
37750398|NCT00987831|69246137|FG002|Overall Study|Lost to Follow-up|0|||
37750399|NCT00986973|69246168|FG000|Overall Study|Withdrawn by study team|1|||
37750400|NCT00986427|69246175|FG000|Overall Study|Lost to Follow-up|2|||
37750401|NCT00986427|69246176|FG001|Overall Study|Lost to Follow-up|0|||
37750402|NCT00986427|69246175|FG000|Overall Study|Lack of Efficacy|1|||
37750403|NCT00986427|69246176|FG001|Overall Study|Lack of Efficacy|0|||
37750404|NCT00986427|69246175|FG000|Overall Study|Withdrawal by Subject|1|||
37750405|NCT00986427|69246176|FG001|Overall Study|Withdrawal by Subject|0|||
37750406|NCT00986349|69246186|FG000|Overall Study|Unsuccessful implant procedure|3|||
37750407|NCT00986349|69246186|FG000|Overall Study|Adverse Event|2|||
37750408|NCT00986349|69246186|FG000|Overall Study|Physician Decision|1|||
37750409|NCT00986349|69246186|FG000|Overall Study|device migration|1|||
37750410|NCT00985959|69246209|FG000|Overall Study|Adverse Event|0|||
37856570|NCT01011868|69539782|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
37856571|NCT01011868|69539783|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
37856572|NCT01011868|69539781|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
37856573|NCT01011868|69539782|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
37856574|NCT01011868|69539783|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
37856575|NCT01011868|69539781|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
37856576|NCT01011868|69539782|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
37856577|NCT01011868|69539783|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
37856578|NCT01213251|69539794|FG000|Overall Study|Death|2|||
37923128|NCT00591006|69609924|FG010|Overall Study|Withdrawal by Subject|0|||
37923129|NCT00591006|69609925|FG011|Overall Study|Withdrawal by Subject|0|||
37923130|NCT00591006|69609926|FG012|Overall Study|Withdrawal by Subject|0|||
37923131|NCT00591006|69609927|FG013|Overall Study|Withdrawal by Subject|0|||
37660524|NCT02149121|69133264|FG006|Main Study Period|Lost to Follow-up|0|||
37660525|NCT02149121|69133258|FG000|Main Study Period|Death|1|||
37660526|NCT02149121|69133259|FG001|Main Study Period|Death|0|||
37660527|NCT02149121|69133260|FG002|Main Study Period|Death|0|||
37660528|NCT02149121|69133261|FG003|Main Study Period|Death|0|||
37660529|NCT02149121|69133262|FG004|Main Study Period|Death|0|||
37660530|NCT02149121|69133263|FG005|Main Study Period|Death|0|||
37660531|NCT02149121|69133264|FG006|Main Study Period|Death|0|||
37660532|NCT02149121|69133258|FG000|Main Study Period|Physician Decision|1|||
37660533|NCT02149121|69133259|FG001|Main Study Period|Physician Decision|0|||
37660534|NCT02149121|69133260|FG002|Main Study Period|Physician Decision|0|||
37660535|NCT02149121|69133261|FG003|Main Study Period|Physician Decision|0|||
37660536|NCT02149121|69133262|FG004|Main Study Period|Physician Decision|0|||
37660537|NCT02149121|69133263|FG005|Main Study Period|Physician Decision|0|||
37660538|NCT02149121|69133264|FG006|Main Study Period|Physician Decision|0|||
37660539|NCT02149121|69133258|FG000|Main Study Period|Developed any malignancy|0|||
37660540|NCT02149121|69133259|FG001|Main Study Period|Developed any malignancy|1|||
37750411|NCT00985959|69246210|FG001|Overall Study|Adverse Event|0|||
37923132|NCT00591006|69609928|FG014|Overall Study|Withdrawal by Subject|0|||
37923133|NCT00591006|69609929|FG015|Overall Study|Withdrawal by Subject|1|||
37923134|NCT00591006|69609930|FG016|Overall Study|Withdrawal by Subject|0|||
37923135|NCT00591006|69609931|FG017|Overall Study|Withdrawal by Subject|0|||
37923136|NCT00591006|69609932|FG018|Overall Study|Withdrawal by Subject|0|||
37923137|NCT00591006|69609933|FG019|Overall Study|Withdrawal by Subject|0|||
37923138|NCT00591006|69609934|FG020|Overall Study|Withdrawal by Subject|0|||
37923139|NCT00591006|69609935|FG021|Overall Study|Withdrawal by Subject|0|||
37923140|NCT00591006|69609936|FG022|Overall Study|Withdrawal by Subject|0|||
37923141|NCT00591006|69609937|FG023|Overall Study|Withdrawal by Subject|1|||
37923142|NCT00591006|69609914|FG000|Overall Study|Adverse Event|0|||
37923143|NCT00591006|69609915|FG001|Overall Study|Adverse Event|0|||
37923144|NCT00591006|69609916|FG002|Overall Study|Adverse Event|0|||
37923145|NCT00591006|69609917|FG003|Overall Study|Adverse Event|0|||
37660541|NCT02149121|69133260|FG002|Main Study Period|Developed any malignancy|1|||
37660542|NCT02149121|69133261|FG003|Main Study Period|Developed any malignancy|0|||
37856579|NCT01213251|69539795|FG001|Overall Study|Death|1|||
37923146|NCT00591006|69609918|FG004|Overall Study|Adverse Event|0|||
37923147|NCT00591006|69609919|FG005|Overall Study|Adverse Event|0|||
37660543|NCT02149121|69133262|FG004|Main Study Period|Developed any malignancy|0|||
37750412|NCT00985959|69246211|FG002|Overall Study|Adverse Event|19|||
37750413|NCT00985959|69246209|FG000|Overall Study|Withdrawal by Subject|0|||
37750414|NCT00985959|69246210|FG001|Overall Study|Withdrawal by Subject|0|||
37750415|NCT00985959|69246211|FG002|Overall Study|Withdrawal by Subject|8|||
37750416|NCT00985959|69246209|FG000|Overall Study|Progressive disease|1|||
37750417|NCT00985959|69246210|FG001|Overall Study|Progressive disease|2|||
38033143|NCT04760314|69719146|FG004|Maintenance Blinded Period|Assigned Treatment by Mistake|1|||
38033144|NCT04760314|69719147|FG005|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
38033145|NCT04760314|69719148|FG006|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
38033146|NCT04760314|69719149|FG007|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
37660544|NCT02149121|69133263|FG005|Main Study Period|Developed any malignancy|0|||
37660545|NCT02149121|69133264|FG006|Main Study Period|Developed any malignancy|0|||
37750418|NCT00985959|69246211|FG002|Overall Study|Progressive disease|8|||
37750419|NCT00985959|69246209|FG000|Overall Study|Unrecovered toxicity|0|||
37750420|NCT00985959|69246210|FG001|Overall Study|Unrecovered toxicity|0|||
37750421|NCT00985959|69246211|FG002|Overall Study|Unrecovered toxicity|7|||
37750422|NCT00985959|69246209|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
37750423|NCT00985959|69246210|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
37750424|NCT00985959|69246211|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
37750425|NCT00985959|69246209|FG000|Overall Study|Complete response observed over 2 cycles|0|||
37750426|NCT00985959|69246210|FG001|Overall Study|Complete response observed over 2 cycles|1|||
37750427|NCT00985959|69246211|FG002|Overall Study|Complete response observed over 2 cycles|4|||
37750428|NCT00985959|69246209|FG000|Overall Study|Other|0|||
37750429|NCT00985959|69246210|FG001|Overall Study|Other|0|||
37750430|NCT00985959|69246211|FG002|Overall Study|Other|11|||
37750431|NCT00985725|69246227|FG000|Overall Study|Adverse Event|4|||
37750432|NCT00985725|69246228|FG001|Overall Study|Adverse Event|1|||
37750433|NCT00985725|69246227|FG000|Overall Study|Protocol Violation|1|||
37750434|NCT00985725|69246228|FG001|Overall Study|Protocol Violation|3|||
37750435|NCT00985725|69246227|FG000|Overall Study|Withdrawal by Subject|4|||
37750436|NCT00985725|69246228|FG001|Overall Study|Withdrawal by Subject|4|||
37750437|NCT00985725|69246227|FG000|Overall Study|Lost to Follow-up|1|||
37750438|NCT00985725|69246228|FG001|Overall Study|Lost to Follow-up|1|||
37750439|NCT00985725|69246227|FG000|Overall Study|Lack of Efficacy|0|||
37750440|NCT00985725|69246228|FG001|Overall Study|Lack of Efficacy|1|||
37750441|NCT00985725|69246227|FG000|Overall Study|Non-compliance|1|||
37750442|NCT00985725|69246228|FG001|Overall Study|Non-compliance|2|||
37750443|NCT00985725|69246227|FG000|Overall Study|Out-of-window visits|0|||
37750444|NCT00985725|69246228|FG001|Overall Study|Out-of-window visits|1|||
37750445|NCT00985491|69246243|FG000|Overall Study|Adverse Event|8|||
37750446|NCT00985491|69246243|FG000|Overall Study|device migration|7|||
37750447|NCT00985491|69246243|FG000|Overall Study|Withdrawal by Subject|1|||
37750448|NCT00985491|69246243|FG000|Overall Study|implant failure|3|||
37750449|NCT00984867|69246278|FG000|Overall Study|Adverse Event|3|||
37750450|NCT00984867|69246279|FG001|Overall Study|Adverse Event|7|||
37750451|NCT00984867|69246278|FG000|Overall Study|Death|1|||
37856580|NCT01213251|69539796|FG002|Overall Study|Death|2|||
37660546|NCT02149121|69133258|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
37660547|NCT02149121|69133259|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
37660548|NCT02149121|69133260|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
37660549|NCT02149121|69133261|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
37660550|NCT02149121|69133262|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
37660551|NCT02149121|69133263|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
37660552|NCT02149121|69133264|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
37660553|NCT02149121|69133258|FG000|Main Study Period|Disease progression|0|||
37660554|NCT02149121|69133259|FG001|Main Study Period|Disease progression|1|||
37660555|NCT02149121|69133260|FG002|Main Study Period|Disease progression|0|||
37660556|NCT02149121|69133261|FG003|Main Study Period|Disease progression|0|||
37660557|NCT02149121|69133262|FG004|Main Study Period|Disease progression|0|||
37660558|NCT02149121|69133263|FG005|Main Study Period|Disease progression|0|||
37660559|NCT02149121|69133264|FG006|Main Study Period|Disease progression|0|||
37660560|NCT02149121|69133258|FG000|Extension Study Period|Withdrawal by Subject|0|||
37660561|NCT02149121|69133259|FG001|Extension Study Period|Withdrawal by Subject|0|||
37660562|NCT02149121|69133260|FG002|Extension Study Period|Withdrawal by Subject|0|||
37660563|NCT02149121|69133261|FG003|Extension Study Period|Withdrawal by Subject|1|||
37660564|NCT02149121|69133262|FG004|Extension Study Period|Withdrawal by Subject|0|||
37660565|NCT02149121|69133263|FG005|Extension Study Period|Withdrawal by Subject|2|||
37660566|NCT02149121|69133264|FG006|Extension Study Period|Withdrawal by Subject|0|||
37660567|NCT01865617|69133316|FG000|Overall Study|Death|27|||
37660568|NCT01865617|69133317|FG001|Overall Study|Death|3|||
37660569|NCT01865617|69133318|FG002|Overall Study|Death|1|||
37750452|NCT00984867|69246279|FG001|Overall Study|Death|0|||
37750453|NCT00984867|69246278|FG000|Overall Study|Withdrawal by Subject|13|||
37750454|NCT00984867|69246279|FG001|Overall Study|Withdrawal by Subject|4|||
37750455|NCT00984867|69246278|FG000|Overall Study|Lost to Follow-up|3|||
37750456|NCT00984867|69246279|FG001|Overall Study|Lost to Follow-up|4|||
37750457|NCT00984867|69246278|FG000|Overall Study|Poor/non-compliance|0|||
37750458|NCT00984867|69246279|FG001|Overall Study|Poor/non-compliance|1|||
37660570|NCT01865617|69133319|FG003|Overall Study|Death|1|||
37660571|NCT01865617|69133320|FG004|Overall Study|Death|5|||
37660572|NCT01865617|69133321|FG005|Overall Study|Death|1|||
37660573|NCT01865617|69133322|FG006|Overall Study|Death|11|||
37660574|NCT01865617|69133323|FG007|Overall Study|Death|1|||
37660575|NCT01865617|69133324|FG008|Overall Study|Death|11|||
37660576|NCT01865617|69133325|FG009|Overall Study|Death|3|||
37660577|NCT01865617|69133326|FG010|Overall Study|Death|32|||
37660578|NCT01865617|69133327|FG011|Overall Study|Death|6|||
37660579|NCT01865617|69133328|FG012|Overall Study|Death|13|||
37660580|NCT01865617|69133316|FG000|Overall Study|Lost to Follow-up|2|||
37660581|NCT01865617|69133317|FG001|Overall Study|Lost to Follow-up|0|||
37660582|NCT01865617|69133318|FG002|Overall Study|Lost to Follow-up|0|||
37660583|NCT01865617|69133319|FG003|Overall Study|Lost to Follow-up|0|||
37660584|NCT01865617|69133320|FG004|Overall Study|Lost to Follow-up|0|||
37660585|NCT01865617|69133321|FG005|Overall Study|Lost to Follow-up|0|||
37660586|NCT01865617|69133322|FG006|Overall Study|Lost to Follow-up|0|||
37750459|NCT00984867|69246278|FG000|Overall Study|Subject no longer meets study criteria|1|||
37750460|NCT00984867|69246279|FG001|Overall Study|Subject no longer meets study criteria|1|||
37750461|NCT00984867|69246278|FG000|Overall Study|site closing|1|||
37750462|NCT00984867|69246279|FG001|Overall Study|site closing|0|||
37750463|NCT00984867|69246278|FG000|Overall Study|lack of efficacy and subject compliance|1|||
37750464|NCT00984867|69246279|FG001|Overall Study|lack of efficacy and subject compliance|0|||
37750465|NCT00984009|69246319|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
37750466|NCT00983931|69246326|FG000|14 Day Washout Period|Physician Decision|1|||
37750467|NCT00983853|69246338|FG000|Overall Study|Lost to Follow-up|1|||
37750468|NCT00983853|69246339|FG001|Overall Study|Lost to Follow-up|1|||
37750469|NCT00983853|69246340|FG002|Overall Study|Lost to Follow-up|2|||
37750470|NCT00983853|69246341|FG003|Overall Study|Lost to Follow-up|2|||
37750471|NCT00983853|69246342|FG004|Overall Study|Lost to Follow-up|2|||
37750472|NCT00983853|69246343|FG005|Overall Study|Lost to Follow-up|1|||
37750473|NCT00983853|69246338|FG000|Overall Study|Withdrawal by Subject|0|||
37750474|NCT00983853|69246339|FG001|Overall Study|Withdrawal by Subject|0|||
37750475|NCT00983853|69246340|FG002|Overall Study|Withdrawal by Subject|1|||
37750476|NCT00983853|69246341|FG003|Overall Study|Withdrawal by Subject|0|||
37660587|NCT01865617|69133323|FG007|Overall Study|Lost to Follow-up|0|||
37750477|NCT00983853|69246342|FG004|Overall Study|Withdrawal by Subject|1|||
37750478|NCT00983853|69246343|FG005|Overall Study|Withdrawal by Subject|0|||
37750479|NCT00983853|69246338|FG000|Overall Study|Unable to come to study follow-up visits|0|||
37750480|NCT00983853|69246339|FG001|Overall Study|Unable to come to study follow-up visits|1|||
37750481|NCT00983853|69246340|FG002|Overall Study|Unable to come to study follow-up visits|0|||
37750482|NCT00983853|69246341|FG003|Overall Study|Unable to come to study follow-up visits|0|||
37750483|NCT00983853|69246342|FG004|Overall Study|Unable to come to study follow-up visits|0|||
37750484|NCT00983853|69246343|FG005|Overall Study|Unable to come to study follow-up visits|0|||
37750485|NCT00983073|69246359|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
37750486|NCT00983073|69246359|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
37750487|NCT00983073|69246359|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
37750488|NCT00983073|69246359|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
37750489|NCT00983073|69246359|FG000|Titration and Optimal Dose Period|Other reason|4|||
37660588|NCT01865617|69133324|FG008|Overall Study|Lost to Follow-up|0|||
37660589|NCT01865617|69133325|FG009|Overall Study|Lost to Follow-up|0|||
37660590|NCT01865617|69133326|FG010|Overall Study|Lost to Follow-up|0|||
37660591|NCT01865617|69133327|FG011|Overall Study|Lost to Follow-up|0|||
37660592|NCT01865617|69133328|FG012|Overall Study|Lost to Follow-up|0|||
37660593|NCT01865617|69133316|FG000|Overall Study|Withdrawal by Subject|1|||
37660594|NCT01865617|69133317|FG001|Overall Study|Withdrawal by Subject|0|||
37660595|NCT01865617|69133318|FG002|Overall Study|Withdrawal by Subject|0|||
37660596|NCT01865617|69133319|FG003|Overall Study|Withdrawal by Subject|0|||
37660597|NCT01865617|69133320|FG004|Overall Study|Withdrawal by Subject|0|||
37660598|NCT01865617|69133321|FG005|Overall Study|Withdrawal by Subject|0|||
37660599|NCT01865617|69133322|FG006|Overall Study|Withdrawal by Subject|0|||
37660600|NCT01865617|69133323|FG007|Overall Study|Withdrawal by Subject|0|||
37660601|NCT01865617|69133324|FG008|Overall Study|Withdrawal by Subject|0|||
37660602|NCT01865617|69133325|FG009|Overall Study|Withdrawal by Subject|0|||
37660603|NCT01865617|69133326|FG010|Overall Study|Withdrawal by Subject|0|||
37750490|NCT00983073|69246359|FG000|Maintenance Period|Adverse Event|5|||
37750491|NCT00983073|69246359|FG000|Maintenance Period|Withdrawal by Subject|2|||
37750492|NCT00983073|69246359|FG000|Maintenance Period|Lack of Efficacy|2|||
37750493|NCT00983073|69246359|FG000|Maintenance Period|Other Reason|7|||
37856581|NCT01213251|69539794|FG000|Overall Study|Exit|3|||
37856582|NCT01213251|69539795|FG001|Overall Study|Exit|2|||
37660604|NCT01865617|69133327|FG011|Overall Study|Withdrawal by Subject|0|||
37660605|NCT01865617|69133328|FG012|Overall Study|Withdrawal by Subject|0|||
37660606|NCT01865617|69133316|FG000|Overall Study|Patient proceeded to new therapy|0|||
37660607|NCT01865617|69133317|FG001|Overall Study|Patient proceeded to new therapy|0|||
37856583|NCT01213251|69539796|FG002|Overall Study|Exit|8|||
37750494|NCT00982137|69246368|FG000|Overall Study|Lost to Follow-up|0|||
37750495|NCT00982137|69246369|FG001|Overall Study|Lost to Follow-up|0|||
37660608|NCT01865617|69133318|FG002|Overall Study|Patient proceeded to new therapy|0|||
37660609|NCT01865617|69133319|FG003|Overall Study|Patient proceeded to new therapy|0|||
37660610|NCT01865617|69133320|FG004|Overall Study|Patient proceeded to new therapy|2|||
37660611|NCT01865617|69133321|FG005|Overall Study|Patient proceeded to new therapy|0|||
37660612|NCT01865617|69133322|FG006|Overall Study|Patient proceeded to new therapy|0|||
37660613|NCT01865617|69133323|FG007|Overall Study|Patient proceeded to new therapy|0|||
37660614|NCT01865617|69133324|FG008|Overall Study|Patient proceeded to new therapy|0|||
37660615|NCT01865617|69133325|FG009|Overall Study|Patient proceeded to new therapy|0|||
37660616|NCT01865617|69133326|FG010|Overall Study|Patient proceeded to new therapy|0|||
37660617|NCT01865617|69133327|FG011|Overall Study|Patient proceeded to new therapy|0|||
37660618|NCT01865617|69133328|FG012|Overall Study|Patient proceeded to new therapy|0|||
37660619|NCT01865617|69133316|FG000|Overall Study|Other|0|||
37660620|NCT01865617|69133317|FG001|Overall Study|Other|0|||
37660621|NCT01865617|69133318|FG002|Overall Study|Other|0|||
37660622|NCT01865617|69133319|FG003|Overall Study|Other|0|||
37660623|NCT01865617|69133320|FG004|Overall Study|Other|0|||
37660624|NCT01865617|69133321|FG005|Overall Study|Other|0|||
37660625|NCT01865617|69133322|FG006|Overall Study|Other|1|||
37660626|NCT01865617|69133323|FG007|Overall Study|Other|0|||
37750496|NCT00982137|69246370|FG002|Overall Study|Lost to Follow-up|0|||
37750497|NCT00982137|69246371|FG003|Overall Study|Lost to Follow-up|1|||
37750498|NCT00982137|69246368|FG000|Overall Study|Withdrawal by Subject|0|||
37750499|NCT00982137|69246369|FG001|Overall Study|Withdrawal by Subject|1|||
37750500|NCT00982137|69246370|FG002|Overall Study|Withdrawal by Subject|0|||
37856584|NCT01213251|69539794|FG000|Overall Study|Protocol Violation|1|||
37856585|NCT01213251|69539795|FG001|Overall Study|Protocol Violation|1|||
37856586|NCT01213251|69539796|FG002|Overall Study|Protocol Violation|0|||
37856587|NCT01213251|69539794|FG000|Overall Study|Missed 18-Month Follow-up|0|||
37660627|NCT01865617|69133324|FG008|Overall Study|Other|0|||
37660628|NCT01865617|69133325|FG009|Overall Study|Other|0|||
37660629|NCT01865617|69133326|FG010|Overall Study|Other|0|||
37660630|NCT01865617|69133327|FG011|Overall Study|Other|0|||
37660631|NCT01865617|69133328|FG012|Overall Study|Other|0|||
37660632|NCT02458313|69133361|FG000|Overall Study|Withdrawal by Subject|6|||
37660633|NCT02458313|69133362|FG001|Overall Study|Withdrawal by Subject|8|||
37660634|NCT02458313|69133361|FG000|Overall Study|Excluded for motion during MRI|1|||
37660635|NCT02458313|69133362|FG001|Overall Study|Excluded for motion during MRI|2|||
37660636|NCT01328431|69133379|FG000|Baseline|Protocol Violation|0|||
37660637|NCT01328431|69133380|FG001|Baseline|Protocol Violation|2|||
37660638|NCT01328431|69133379|FG000|1 Month (1M)|Lost to Follow-up|55|||
37660639|NCT01328431|69133380|FG001|1 Month (1M)|Lost to Follow-up|58|||
37660640|NCT01328431|69133379|FG000|3 Month (3M)|Death|2|||
37660641|NCT01328431|69133380|FG001|3 Month (3M)|Death|2|||
37660642|NCT01328431|69133379|FG000|3 Month (3M)|Lost to Follow-up|75|||
37660643|NCT01328431|69133380|FG001|3 Month (3M)|Lost to Follow-up|70|||
37660644|NCT01328431|69133379|FG000|12 Month (12M)|Death|2|||
37660645|NCT01328431|69133380|FG001|12 Month (12M)|Death|6|||
37660646|NCT01328431|69133379|FG000|12 Month (12M)|Lost to Follow-up|82|||
37660647|NCT01328431|69133380|FG001|12 Month (12M)|Lost to Follow-up|91|||
37660648|NCT00893789|69133390|FG000|Overall Study|Withdrawal by Subject|3|||
37660649|NCT00893789|69133391|FG001|Overall Study|Withdrawal by Subject|1|||
37660650|NCT00893789|69133392|FG002|Overall Study|Withdrawal by Subject|3|||
37660651|NCT00893789|69133393|FG003|Overall Study|Withdrawal by Subject|1|||
37660652|NCT00893789|69133390|FG000|Overall Study|Noncompliance With Study Drug|1|||
37660653|NCT00893789|69133391|FG001|Overall Study|Noncompliance With Study Drug|0|||
37660654|NCT00893789|69133392|FG002|Overall Study|Noncompliance With Study Drug|1|||
37660655|NCT00893789|69133393|FG003|Overall Study|Noncompliance With Study Drug|2|||
37660656|NCT00893789|69133390|FG000|Overall Study|Noncompliance With Study Procedures|1|||
37856588|NCT01213251|69539795|FG001|Overall Study|Missed 18-Month Follow-up|0|||
37856589|NCT01213251|69539796|FG002|Overall Study|Missed 18-Month Follow-up|1|||
37856590|NCT01213173|69539811|FG000|Overall Study|Protocol Violation|2|||
37750501|NCT00982137|69246371|FG003|Overall Study|Withdrawal by Subject|0|||
37750502|NCT00981747|69246388|FG000|Losartan|Withdrawal by Subject|1|||
37750503|NCT00981747|69246388|FG000|Losartan|Death|1|||
37660657|NCT00893789|69133391|FG001|Overall Study|Noncompliance With Study Procedures|0|||
37660658|NCT00893789|69133392|FG002|Overall Study|Noncompliance With Study Procedures|0|||
37660659|NCT00893789|69133393|FG003|Overall Study|Noncompliance With Study Procedures|0|||
37660660|NCT00893789|69133390|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
37856591|NCT01213173|69539812|FG001|Overall Study|Protocol Violation|0|||
37660661|NCT00893789|69133391|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
37660662|NCT00893789|69133392|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
37660663|NCT00893789|69133393|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
37660664|NCT00893789|69133390|FG000|Overall Study|Adverse Event|0|||
37660665|NCT00893789|69133391|FG001|Overall Study|Adverse Event|2|||
37660666|NCT00893789|69133392|FG002|Overall Study|Adverse Event|1|||
37750504|NCT00981747|69246388|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
37750505|NCT01856309|69246543|FG000|Overall Study|Death|4|||
37750506|NCT01856309|69246544|FG001|Overall Study|Death|6|||
37750507|NCT01856309|69246545|FG002|Overall Study|Death|11|||
37750508|NCT01856309|69246546|FG003|Overall Study|Death|6|||
37856592|NCT01213173|69539811|FG000|Overall Study|Adverse Event|4|||
37856593|NCT01213173|69539812|FG001|Overall Study|Adverse Event|8|||
37856594|NCT01213173|69539811|FG000|Overall Study|Withdrawal by Subject|5|||
37856595|NCT01213173|69539812|FG001|Overall Study|Withdrawal by Subject|5|||
37856596|NCT01213173|69539811|FG000|Overall Study|Incorrect Enrollment|1|||
37856597|NCT01213173|69539812|FG001|Overall Study|Incorrect Enrollment|3|||
37856598|NCT01212159|69539820|FG000|Overall Study|Withdrawal by Subject|12|||
37856599|NCT01212159|69539821|FG001|Overall Study|Withdrawal by Subject|12|||
37856600|NCT00973765|69539829|FG000|Overall Study|Lost to Follow-up|8|||
37856601|NCT00973765|69539830|FG001|Overall Study|Lost to Follow-up|14|||
37856602|NCT01211769|69539840|FG000|Overall Study|Lost to Follow-up|7|||
37660667|NCT00893789|69133393|FG003|Overall Study|Adverse Event|5|||
37660668|NCT00893789|69133390|FG000|Overall Study|Protocol Violation|0|||
37660669|NCT00893789|69133391|FG001|Overall Study|Protocol Violation|1|||
37660670|NCT00893789|69133392|FG002|Overall Study|Protocol Violation|1|||
37660671|NCT00893789|69133393|FG003|Overall Study|Protocol Violation|4|||
37660672|NCT00893789|69133390|FG000|Overall Study|Lost to Follow-up|0|||
37660673|NCT00893789|69133391|FG001|Overall Study|Lost to Follow-up|0|||
37660674|NCT00893789|69133392|FG002|Overall Study|Lost to Follow-up|0|||
37660675|NCT00893789|69133393|FG003|Overall Study|Lost to Follow-up|1|||
37660676|NCT02164864|69133406|FG000|Overall Study|Trial disease worsening|7|||
37750509|NCT01856309|69246543|FG000|Overall Study|Lost to Follow-up|6|||
37750510|NCT01856309|69246544|FG001|Overall Study|Lost to Follow-up|2|||
37750511|NCT01856309|69246545|FG002|Overall Study|Lost to Follow-up|4|||
37750512|NCT01856309|69246546|FG003|Overall Study|Lost to Follow-up|8|||
37750513|NCT01856309|69246543|FG000|Overall Study|Withdrawal by Subject|11|||
37750514|NCT01856309|69246544|FG001|Overall Study|Withdrawal by Subject|13|||
37750515|NCT01856309|69246545|FG002|Overall Study|Withdrawal by Subject|28|||
37750516|NCT01856309|69246546|FG003|Overall Study|Withdrawal by Subject|26|||
37750517|NCT01856309|69246543|FG000|Overall Study|Other|227|||
37750518|NCT01856309|69246544|FG001|Overall Study|Other|225|||
37750519|NCT01856309|69246545|FG002|Overall Study|Other|447|||
37750520|NCT01856309|69246546|FG003|Overall Study|Other|469|||
37750521|NCT01856309|69246543|FG000|Overall Study|Lack of Efficacy|14|||
37750522|NCT01856309|69246544|FG001|Overall Study|Lack of Efficacy|9|||
37750523|NCT01856309|69246545|FG002|Overall Study|Lack of Efficacy|40|||
37750524|NCT01856309|69246546|FG003|Overall Study|Lack of Efficacy|25|||
37750525|NCT01856309|69246543|FG000|Overall Study|Adverse Event|31|||
37750526|NCT01856309|69246544|FG001|Overall Study|Adverse Event|31|||
37750527|NCT01856309|69246545|FG002|Overall Study|Adverse Event|55|||
37750528|NCT01856309|69246546|FG003|Overall Study|Adverse Event|65|||
37750529|NCT01856309|69246543|FG000|Overall Study|Pregnancy|0|||
37750530|NCT01856309|69246544|FG001|Overall Study|Pregnancy|0|||
37750531|NCT01856309|69246545|FG002|Overall Study|Pregnancy|0|||
37750532|NCT01856309|69246546|FG003|Overall Study|Pregnancy|1|||
37750533|NCT01856309|69246543|FG000|Overall Study|Physician Decision|6|||
37750534|NCT01856309|69246544|FG001|Overall Study|Physician Decision|1|||
37750535|NCT01856309|69246545|FG002|Overall Study|Physician Decision|6|||
37750536|NCT01856309|69246546|FG003|Overall Study|Physician Decision|8|||
37750537|NCT01856309|69246543|FG000|Overall Study|Noncompliance With Study Drug|0|||
37750538|NCT01856309|69246544|FG001|Overall Study|Noncompliance With Study Drug|1|||
37750539|NCT01856309|69246545|FG002|Overall Study|Noncompliance With Study Drug|4|||
37750540|NCT01856309|69246546|FG003|Overall Study|Noncompliance With Study Drug|1|||
37750541|NCT01855919|69246744|FG000|Overall Study|Adverse Event|16|||
37750542|NCT01855919|69246745|FG001|Overall Study|Adverse Event|8|||
37750543|NCT01855919|69246744|FG000|Overall Study|Lack of Efficacy|1|||
37750544|NCT01855919|69246745|FG001|Overall Study|Lack of Efficacy|3|||
37750545|NCT01855919|69246744|FG000|Overall Study|Withdrawal by Subject|4|||
37750546|NCT01855919|69246745|FG001|Overall Study|Withdrawal by Subject|10|||
37750547|NCT01855919|69246744|FG000|Overall Study|Entry Criteria Not Met|1|||
37750548|NCT01855919|69246745|FG001|Overall Study|Entry Criteria Not Met|1|||
37750549|NCT01855919|69246744|FG000|Overall Study|Protocol Violation|1|||
37856603|NCT01211769|69539841|FG001|Overall Study|Lost to Follow-up|9|||
37750550|NCT01855919|69246745|FG001|Overall Study|Protocol Violation|4|||
37750551|NCT01871519|69246761|FG000|Overall Study|Death|26|||
37750552|NCT01871519|69246761|FG000|Overall Study|Lost to Follow-up|15|||
37750553|NCT01871519|69246761|FG000|Overall Study|Withdrawal by Subject|49|||
37750554|NCT01871285|69246768|FG000|First Intervention (1 Day)|Adverse Event|1|||
37750555|NCT01871285|69246769|FG001|First Intervention (1 Day)|Adverse Event|0|||
37856604|NCT01211769|69539842|FG002|Overall Study|Lost to Follow-up|5|||
37660677|NCT02164864|69133407|FG001|Overall Study|Trial disease worsening|5|||
37660678|NCT02164864|69133408|FG002|Overall Study|Trial disease worsening|1|||
37750556|NCT01871285|69246770|FG002|First Intervention (1 Day)|Adverse Event|0|||
37856605|NCT01211769|69539843|FG003|Overall Study|Lost to Follow-up|9|||
37750557|NCT01871285|69246771|FG003|First Intervention (1 Day)|Adverse Event|0|||
37750558|NCT01871285|69246768|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
37750559|NCT01871285|69246769|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
37750560|NCT01871285|69246770|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
37750561|NCT01871285|69246771|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
37750562|NCT01870973|69246797|FG000|Overall Study|Lost to Follow-up|10|||
37750563|NCT01870973|69246798|FG001|Overall Study|Lost to Follow-up|3|||
37750564|NCT01854827|69246817|FG000|Overall Study|Death|1|||
37750565|NCT01854047|69246960|FG000|Overall Study|Lack of Efficacy|1|||
37660679|NCT02164864|69133406|FG000|Overall Study|Other pre-existing disease worsening|6|||
37660680|NCT02164864|69133407|FG001|Overall Study|Other pre-existing disease worsening|4|||
37660681|NCT02164864|69133408|FG002|Overall Study|Other pre-existing disease worsening|9|||
37660682|NCT02164864|69133406|FG000|Overall Study|Other Adverse Event (AE)|52|||
37660683|NCT02164864|69133407|FG001|Overall Study|Other Adverse Event (AE)|32|||
37660684|NCT02164864|69133408|FG002|Overall Study|Other Adverse Event (AE)|49|||
37660685|NCT02164864|69133406|FG000|Overall Study|Protocol Violation|2|||
37660686|NCT02164864|69133407|FG001|Overall Study|Protocol Violation|4|||
37660687|NCT02164864|69133408|FG002|Overall Study|Protocol Violation|1|||
37856606|NCT01211769|69539840|FG000|Overall Study|Physician Decision|2|||
37856607|NCT01211769|69539841|FG001|Overall Study|Physician Decision|0|||
37856608|NCT01211769|69539842|FG002|Overall Study|Physician Decision|2|||
37856609|NCT01211769|69539843|FG003|Overall Study|Physician Decision|1|||
37856610|NCT01211769|69539840|FG000|Overall Study|Adverse Event|0|||
37856611|NCT01211769|69539841|FG001|Overall Study|Adverse Event|1|||
37856612|NCT01211769|69539842|FG002|Overall Study|Adverse Event|1|||
37856613|NCT01211769|69539843|FG003|Overall Study|Adverse Event|1|||
37856614|NCT01211613|69539856|FG000|Overall Study|Lost to Follow-up|2|||
37856615|NCT01211613|69539857|FG001|Overall Study|Lost to Follow-up|2|||
37856616|NCT01211613|69539858|FG002|Overall Study|Lost to Follow-up|2|||
37856617|NCT01211613|69539856|FG000|Overall Study|Withdrawal by Subject|1|||
37856618|NCT01211613|69539857|FG001|Overall Study|Withdrawal by Subject|0|||
37856619|NCT01211613|69539858|FG002|Overall Study|Withdrawal by Subject|0|||
37856620|NCT01211535|69539868|FG000|Overall Study|Adverse Event|0|||
37856621|NCT01211535|69539869|FG001|Overall Study|Adverse Event|1|||
37856622|NCT01011556|69539879|FG000|Overall Study|Adverse Event|1|||
37856623|NCT01011556|69539880|FG001|Overall Study|Adverse Event|3|||
37856624|NCT01011556|69539881|FG002|Overall Study|Adverse Event|2|||
37856625|NCT01011556|69539882|FG003|Overall Study|Adverse Event|1|||
37856626|NCT01011556|69539879|FG000|Overall Study|Lost to Follow-up|1|||
37856627|NCT01011556|69539880|FG001|Overall Study|Lost to Follow-up|0|||
37856628|NCT01011556|69539881|FG002|Overall Study|Lost to Follow-up|0|||
37856629|NCT01011556|69539882|FG003|Overall Study|Lost to Follow-up|0|||
37856630|NCT01011556|69539879|FG000|Overall Study|Physician Decision|1|||
37856631|NCT01011556|69539880|FG001|Overall Study|Physician Decision|0|||
37856632|NCT01011556|69539881|FG002|Overall Study|Physician Decision|0|||
37856633|NCT01011556|69539882|FG003|Overall Study|Physician Decision|1|||
37856634|NCT01011556|69539879|FG000|Overall Study|Protocol Violation|0|||
37856635|NCT01011556|69539880|FG001|Overall Study|Protocol Violation|1|||
37856636|NCT01011556|69539881|FG002|Overall Study|Protocol Violation|0|||
37856637|NCT01011556|69539882|FG003|Overall Study|Protocol Violation|0|||
37856638|NCT01011556|69539879|FG000|Overall Study|Withdrawal by Subject|1|||
37856639|NCT01011556|69539880|FG001|Overall Study|Withdrawal by Subject|2|||
37856640|NCT01011556|69539881|FG002|Overall Study|Withdrawal by Subject|4|||
37856641|NCT01011556|69539882|FG003|Overall Study|Withdrawal by Subject|4|||
37856642|NCT01011556|69539879|FG000|Overall Study|Sponsor decision|0|||
37856643|NCT01011556|69539880|FG001|Overall Study|Sponsor decision|1|||
37856644|NCT01011556|69539881|FG002|Overall Study|Sponsor decision|1|||
37856645|NCT01011556|69539882|FG003|Overall Study|Sponsor decision|2|||
37856646|NCT01011556|69539879|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
37856647|NCT01011556|69539880|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
37856648|NCT01011556|69539881|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
37856649|NCT01011556|69539882|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
37923148|NCT00591006|69609920|FG006|Overall Study|Adverse Event|0|||
37660688|NCT02164864|69133406|FG000|Overall Study|Lost to Follow-up|4|||
37856650|NCT01211145|69539899|FG000|Overall Study|Reason not specified|3|||
37750566|NCT01854047|69246961|FG001|Overall Study|Lack of Efficacy|0|||
37856651|NCT01211145|69539900|FG001|Overall Study|Reason not specified|2|||
37856652|NCT01211145|69539901|FG002|Overall Study|Reason not specified|2|||
37856653|NCT01211145|69539902|FG003|Overall Study|Reason not specified|1|||
37856654|NCT01211145|69539899|FG000|Overall Study|Lost to Follow-up|3|||
37856655|NCT01211145|69539900|FG001|Overall Study|Lost to Follow-up|2|||
37923149|NCT00591006|69609921|FG007|Overall Study|Adverse Event|0|||
37923150|NCT00591006|69609922|FG008|Overall Study|Adverse Event|0|||
37660689|NCT02164864|69133407|FG001|Overall Study|Lost to Follow-up|3|||
37660690|NCT02164864|69133408|FG002|Overall Study|Lost to Follow-up|2|||
37750567|NCT01854047|69246962|FG002|Overall Study|Lack of Efficacy|0|||
37856656|NCT01211145|69539901|FG002|Overall Study|Lost to Follow-up|1|||
37856657|NCT01211145|69539902|FG003|Overall Study|Lost to Follow-up|2|||
37660691|NCT02164864|69133406|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
37660692|NCT02164864|69133407|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
37660693|NCT02164864|69133408|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
37660694|NCT02164864|69133406|FG000|Overall Study|Other than stated|3|||
37660695|NCT02164864|69133407|FG001|Overall Study|Other than stated|4|||
37660696|NCT02164864|69133408|FG002|Overall Study|Other than stated|14|||
37660697|NCT02419807|69133419|FG000|Overall Study|Withdrawal by Subject|4|||
37660698|NCT02419807|69133419|FG000|Overall Study|Physician Decision|1|||
37660699|NCT02419807|69133419|FG000|Overall Study|Protocol Violation|5|||
37660700|NCT03857867|69133423|FG000|Overall Study|Physician Decision|1|||
37660701|NCT01628926|69133431|FG000|Overall Study|Adverse Event|13|||
37660702|NCT01628926|69133432|FG001|Overall Study|Adverse Event|11|||
37660703|NCT01628926|69133433|FG002|Overall Study|Adverse Event|9|||
37750568|NCT01854047|69246963|FG003|Overall Study|Lack of Efficacy|0|||
37750569|NCT01854047|69246964|FG004|Overall Study|Lack of Efficacy|0|||
37923151|NCT00591006|69609923|FG009|Overall Study|Adverse Event|0|||
37923152|NCT00591006|69609924|FG010|Overall Study|Adverse Event|0|||
37923153|NCT00591006|69609925|FG011|Overall Study|Adverse Event|0|||
37923154|NCT00591006|69609926|FG012|Overall Study|Adverse Event|0|||
37923155|NCT00591006|69609927|FG013|Overall Study|Adverse Event|0|||
37923156|NCT00591006|69609928|FG014|Overall Study|Adverse Event|0|||
37923157|NCT00591006|69609929|FG015|Overall Study|Adverse Event|0|||
37923158|NCT00591006|69609930|FG016|Overall Study|Adverse Event|0|||
37923159|NCT00591006|69609931|FG017|Overall Study|Adverse Event|0|||
37923160|NCT00591006|69609932|FG018|Overall Study|Adverse Event|0|||
37923161|NCT00591006|69609933|FG019|Overall Study|Adverse Event|0|||
37923162|NCT00591006|69609934|FG020|Overall Study|Adverse Event|0|||
37923163|NCT00591006|69609935|FG021|Overall Study|Adverse Event|0|||
37923164|NCT00591006|69609936|FG022|Overall Study|Adverse Event|1|||
37856658|NCT01211145|69539899|FG000|Overall Study|Study-specific withdrawal criteria|1|||
37856659|NCT01211145|69539900|FG001|Overall Study|Study-specific withdrawal criteria|0|||
37856660|NCT01211145|69539901|FG002|Overall Study|Study-specific withdrawal criteria|0|||
37856661|NCT01211145|69539902|FG003|Overall Study|Study-specific withdrawal criteria|0|||
37856662|NCT01211145|69539899|FG000|Overall Study|Severe noncompliance to protocol|1|||
37856663|NCT01211145|69539900|FG001|Overall Study|Severe noncompliance to protocol|0|||
37856664|NCT01211145|69539901|FG002|Overall Study|Severe noncompliance to protocol|0|||
37856665|NCT01211145|69539902|FG003|Overall Study|Severe noncompliance to protocol|0|||
37856666|NCT01211145|69539899|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
37856667|NCT01211145|69539900|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
37856668|NCT01211145|69539901|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
37856669|NCT01211145|69539902|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
37856670|NCT01211145|69539899|FG000|Overall Study|Patient decision|2|||
37856671|NCT01211145|69539900|FG001|Overall Study|Patient decision|1|||
37856672|NCT01211145|69539901|FG002|Overall Study|Patient decision|0|||
37923165|NCT00591006|69609937|FG023|Overall Study|Adverse Event|0|||
37923166|NCT00844844|69609954|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
37750570|NCT01854047|69246960|FG000|Overall Study|Poor compliance to protocol|3|||
37750571|NCT01854047|69246961|FG001|Overall Study|Poor compliance to protocol|0|||
37750572|NCT01854047|69246962|FG002|Overall Study|Poor compliance to protocol|2|||
37750573|NCT01854047|69246963|FG003|Overall Study|Poor compliance to protocol|0|||
37750574|NCT01854047|69246964|FG004|Overall Study|Poor compliance to protocol|0|||
37750575|NCT01854047|69246960|FG000|Overall Study|Adverse Event|5|||
37750576|NCT01854047|69246961|FG001|Overall Study|Adverse Event|4|||
37750577|NCT01854047|69246962|FG002|Overall Study|Adverse Event|6|||
37750578|NCT01854047|69246963|FG003|Overall Study|Adverse Event|10|||
37750579|NCT01854047|69246964|FG004|Overall Study|Adverse Event|7|||
37750580|NCT01854047|69246960|FG000|Overall Study|Randomized but not treated|0|||
37750581|NCT01854047|69246961|FG001|Overall Study|Randomized but not treated|1|||
37750582|NCT01854047|69246962|FG002|Overall Study|Randomized but not treated|2|||
37750583|NCT01854047|69246963|FG003|Overall Study|Randomized but not treated|0|||
37750584|NCT01854047|69246964|FG004|Overall Study|Randomized but not treated|4|||
37750585|NCT01854047|69246960|FG000|Overall Study|Other than specified above|3|||
37923167|NCT00844844|69609954|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
37923168|NCT00844844|69609954|FG000|Extension Treatment Period|Adverse Event|2|||
37923169|NCT00844844|69609954|FG000|Post Treatment Period|Withdrawal by Subject|1|||
37923170|NCT00660790|69609958|FG000|Baseline to 3 Months|Death|1|||
37750586|NCT01854047|69246961|FG001|Overall Study|Other than specified above|3|||
37750587|NCT01854047|69246962|FG002|Overall Study|Other than specified above|3|||
37750588|NCT01854047|69246963|FG003|Overall Study|Other than specified above|5|||
37923171|NCT00660790|69609958|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
37923172|NCT00660790|69609958|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
37923173|NCT00836810|69609964|FG000|Overall Study|New diagnosis|1|||
37750589|NCT01854047|69246964|FG004|Overall Study|Other than specified above|8|||
37923174|NCT00836810|69609965|FG001|Overall Study|New diagnosis|0|||
37660704|NCT01628926|69133431|FG000|Overall Study|Lack of Efficacy|2|||
37923175|NCT00658684|69609974|FG000|Overall Study|Adverse Event|10|||
37923176|NCT00658684|69609975|FG001|Overall Study|Adverse Event|8|||
37923177|NCT00658684|69609976|FG002|Overall Study|Adverse Event|2|||
37923178|NCT00658684|69609977|FG003|Overall Study|Adverse Event|0|||
37923179|NCT00658684|69609974|FG000|Overall Study|Withdrawal by Subject|6|||
37750590|NCT01870739|69247010|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
37750591|NCT01870739|69247011|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
37750592|NCT01870739|69247010|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
37750593|NCT01870739|69247011|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
37750594|NCT01870739|69247010|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
37750595|NCT01870739|69247011|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
37856673|NCT01211145|69539902|FG003|Overall Study|Patient decision|2|||
37856674|NCT00977665|69539914|FG000|Overall Study|Withdrawal by Subject|1|||
37856675|NCT00977665|69539915|FG001|Overall Study|Withdrawal by Subject|3|||
37856676|NCT00977665|69539914|FG000|Overall Study|Physician Decision|2|||
37856677|NCT00977665|69539915|FG001|Overall Study|Physician Decision|1|||
37856678|NCT00977665|69539914|FG000|Overall Study|Sponsor requested withdrawal|0|||
37856679|NCT00977665|69539915|FG001|Overall Study|Sponsor requested withdrawal|1|||
37856680|NCT00977665|69539914|FG000|Overall Study|Lost to Follow-up|1|||
37856681|NCT00977665|69539915|FG001|Overall Study|Lost to Follow-up|0|||
37856682|NCT00977665|69539914|FG000|Overall Study|Death|3|||
37856683|NCT00977665|69539915|FG001|Overall Study|Death|2|||
37856684|NCT00977665|69539914|FG000|Overall Study|Adverse Event|14|||
37856685|NCT00977665|69539915|FG001|Overall Study|Adverse Event|7|||
37856686|NCT00977665|69539914|FG000|Overall Study|Treatment failure|0|||
37856687|NCT00977665|69539915|FG001|Overall Study|Treatment failure|1|||
37856688|NCT01210443|69539921|FG000|Overall Study|Study terminated by sponsor|2|||
37856689|NCT01007812|69539925|FG000|Period 1, One Week|Lost to Follow-up|0|||
37856690|NCT01007812|69539926|FG001|Period 1, One Week|Lost to Follow-up|1|||
37856691|NCT01007812|69539925|FG000|Period 1, One Week|Discomfort|1|||
37856692|NCT01007812|69539926|FG001|Period 1, One Week|Discomfort|0|||
37856693|NCT01208961|69539932|FG000|High-Fat Period III|Protocol Violation|1|||
37856694|NCT01208961|69539933|FG001|High-Fat Period III|Protocol Violation|0|||
37856695|NCT01001572|69539940|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
37856696|NCT01001572|69539941|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
37856697|NCT01001572|69539942|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
37923180|NCT00658684|69609975|FG001|Overall Study|Withdrawal by Subject|4|||
37923181|NCT00658684|69609976|FG002|Overall Study|Withdrawal by Subject|1|||
37923182|NCT00658684|69609977|FG003|Overall Study|Withdrawal by Subject|1|||
37923183|NCT00658684|69609974|FG000|Overall Study|Lack of Efficacy|1|||
37923184|NCT00658684|69609975|FG001|Overall Study|Lack of Efficacy|1|||
37923185|NCT00658684|69609976|FG002|Overall Study|Lack of Efficacy|0|||
37923186|NCT00658684|69609977|FG003|Overall Study|Lack of Efficacy|0|||
37923187|NCT00658684|69609974|FG000|Overall Study|Protocol Violation|1|||
37923188|NCT00658684|69609975|FG001|Overall Study|Protocol Violation|1|||
37660705|NCT01628926|69133432|FG001|Overall Study|Lack of Efficacy|1|||
37660706|NCT01628926|69133433|FG002|Overall Study|Lack of Efficacy|5|||
37660707|NCT01628926|69133431|FG000|Overall Study|Withdrawal by Subject|6|||
37660708|NCT01628926|69133432|FG001|Overall Study|Withdrawal by Subject|4|||
37660709|NCT01628926|69133433|FG002|Overall Study|Withdrawal by Subject|2|||
37660710|NCT01628926|69133431|FG000|Overall Study|Protocol Violation|0|||
37660711|NCT01628926|69133432|FG001|Overall Study|Protocol Violation|1|||
37660712|NCT01628926|69133433|FG002|Overall Study|Protocol Violation|0|||
37660713|NCT01628926|69133431|FG000|Overall Study|Discontinuation criteria|3|||
37660714|NCT01628926|69133432|FG001|Overall Study|Discontinuation criteria|4|||
37750596|NCT01870739|69247010|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
37750597|NCT01870739|69247011|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
37750598|NCT01870739|69247010|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
37750599|NCT01870739|69247011|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
37750600|NCT01870739|69247010|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
37750601|NCT01870739|69247011|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
37750602|NCT01870739|69247010|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
37750603|NCT01870739|69247011|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
37750604|NCT01613417|69247038|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
37750605|NCT01613417|69247039|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
37750606|NCT01870583|69247067|FG000|Overall Study|Protocol Violation|0|||
37660715|NCT01628926|69133433|FG002|Overall Study|Discontinuation criteria|0|||
37660716|NCT01628926|69133431|FG000|Overall Study|Physician Decision|2|||
37660717|NCT01628926|69133432|FG001|Overall Study|Physician Decision|2|||
37750607|NCT01870583|69247068|FG001|Overall Study|Protocol Violation|5|||
37660718|NCT01628926|69133433|FG002|Overall Study|Physician Decision|1|||
37750608|NCT01870583|69247069|FG002|Overall Study|Protocol Violation|3|||
37750609|NCT01870583|69247067|FG000|Overall Study|Lost to Follow-up|11|||
37750610|NCT01870583|69247068|FG001|Overall Study|Lost to Follow-up|13|||
37856698|NCT01001572|69539940|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
37923189|NCT00658684|69609976|FG002|Overall Study|Protocol Violation|0|||
37923190|NCT00658684|69609977|FG003|Overall Study|Protocol Violation|0|||
37923191|NCT00658684|69609974|FG000|Overall Study|Pregnancy|1|||
37750611|NCT01870583|69247069|FG002|Overall Study|Lost to Follow-up|5|||
37750612|NCT01869959|69247127|FG000|Randomization Period|Physician Decision|0|||
37750613|NCT01869959|69247128|FG001|Randomization Period|Physician Decision|0|||
37750614|NCT01869959|69247129|FG002|Randomization Period|Physician Decision|0|||
37750615|NCT01869959|69247130|FG003|Randomization Period|Physician Decision|0|||
37750616|NCT01869959|69247131|FG004|Randomization Period|Physician Decision|1|||
37750617|NCT01869959|69247127|FG000|Treatment Period|Adverse Event|1|||
37750618|NCT01869959|69247128|FG001|Treatment Period|Adverse Event|0|||
37750619|NCT01869959|69247129|FG002|Treatment Period|Adverse Event|3|||
37750620|NCT01869959|69247130|FG003|Treatment Period|Adverse Event|1|||
37750621|NCT01869959|69247131|FG004|Treatment Period|Adverse Event|0|||
37750622|NCT01869959|69247127|FG000|Treatment Period|Sponsor decision|0|||
37750623|NCT01869959|69247128|FG001|Treatment Period|Sponsor decision|1|||
37750624|NCT01869959|69247129|FG002|Treatment Period|Sponsor decision|0|||
37660719|NCT01628848|69133444|FG000|Overall Study|Adverse Event|9|||
37660720|NCT01628848|69133445|FG001|Overall Study|Adverse Event|7|||
37660721|NCT01628848|69133444|FG000|Overall Study|Lack of Efficacy|0|||
37660722|NCT01628848|69133445|FG001|Overall Study|Lack of Efficacy|4|||
37660723|NCT01628848|69133444|FG000|Overall Study|Withdrawal by Subject|0|||
37660724|NCT01628848|69133445|FG001|Overall Study|Withdrawal by Subject|2|||
37750625|NCT01869959|69247130|FG003|Treatment Period|Sponsor decision|1|||
37750626|NCT01869959|69247131|FG004|Treatment Period|Sponsor decision|0|||
37750627|NCT01869959|69247127|FG000|Treatment Period|Withdrawal by Subject|0|||
37750628|NCT01869959|69247128|FG001|Treatment Period|Withdrawal by Subject|1|||
37750629|NCT01869959|69247129|FG002|Treatment Period|Withdrawal by Subject|0|||
37750630|NCT01869959|69247130|FG003|Treatment Period|Withdrawal by Subject|0|||
37750631|NCT01869959|69247131|FG004|Treatment Period|Withdrawal by Subject|0|||
37750632|NCT01613027|69247192|FG000|Overall Study|Lost to Follow-up|5|||
37750633|NCT01613027|69247192|FG000|Overall Study|Switched Physician|1|||
37750634|NCT01613027|69247192|FG000|Overall Study|Lack of Efficacy|1|||
37750635|NCT01613027|69247192|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
37750636|NCT01869725|69247210|FG000|Overall Study|ineligible after registration|1|||
37750637|NCT01869725|69247210|FG000|Overall Study|Death|1|||
37660725|NCT01628848|69133444|FG000|Overall Study|Physician Decision|3|||
37750638|NCT01869725|69247210|FG000|Overall Study|Lost to Follow-up|2|||
37750639|NCT01851863|69247231|FG000|Overall Study|Did not receive study medication|2|||
37750640|NCT01851863|69247232|FG001|Overall Study|Did not receive study medication|5|||
37750641|NCT01851863|69247233|FG002|Overall Study|Did not receive study medication|3|||
37750642|NCT01851863|69247234|FG003|Overall Study|Did not receive study medication|0|||
37750643|NCT01851863|69247231|FG000|Overall Study|Lost to Follow-up|3|||
37750644|NCT01851863|69247232|FG001|Overall Study|Lost to Follow-up|4|||
37750645|NCT01851863|69247233|FG002|Overall Study|Lost to Follow-up|2|||
37750646|NCT01851863|69247234|FG003|Overall Study|Lost to Follow-up|3|||
37750647|NCT01850615|69247262|FG000|Overall Study|Protocol Violation|4|||
37750648|NCT01850615|69247263|FG001|Overall Study|Protocol Violation|1|||
37750649|NCT01850615|69247262|FG000|Overall Study|Adverse Event|2|||
37750650|NCT01850615|69247263|FG001|Overall Study|Adverse Event|1|||
37750651|NCT01850615|69247262|FG000|Overall Study|Withdrawal by Subject|3|||
37750652|NCT01850615|69247263|FG001|Overall Study|Withdrawal by Subject|1|||
37750653|NCT01850615|69247262|FG000|Overall Study|Lost to Follow-up|0|||
37750654|NCT01850615|69247263|FG001|Overall Study|Lost to Follow-up|1|||
37750655|NCT01850615|69247262|FG000|Overall Study|Unclassified|0|||
37750656|NCT01850615|69247263|FG001|Overall Study|Unclassified|1|||
37750657|NCT01868477|69247348|FG000|Overall Study|Adverse Event|2|||
37750658|NCT01868477|69247349|FG001|Overall Study|Adverse Event|4|||
37750659|NCT01868477|69247348|FG000|Overall Study|Disease progression|1|||
37750660|NCT01868477|69247349|FG001|Overall Study|Disease progression|1|||
37750661|NCT01868477|69247348|FG000|Overall Study|Withdrawal by Subject|1|||
37660726|NCT01628848|69133445|FG001|Overall Study|Physician Decision|1|||
37660727|NCT02164318|69133455|FG000|Overall Study|Withdrawal by Subject|0|||
37750662|NCT01868477|69247349|FG001|Overall Study|Withdrawal by Subject|0|||
37750663|NCT01849289|69247364|FG000|Overall Study|Adverse Event|3|||
37750664|NCT01849289|69247365|FG001|Overall Study|Adverse Event|3|||
37923192|NCT00658684|69609975|FG001|Overall Study|Pregnancy|1|||
37660728|NCT02164318|69133456|FG001|Overall Study|Withdrawal by Subject|1|||
37660729|NCT02164318|69133457|FG002|Overall Study|Withdrawal by Subject|0|||
37660730|NCT02164318|69133458|FG003|Overall Study|Withdrawal by Subject|1|||
37660731|NCT03436199|69133471|FG000|Overall Study|Adverse Event|15|||
37660732|NCT03436199|69133472|FG001|Overall Study|Adverse Event|40|||
37660733|NCT03436199|69133473|FG002|Overall Study|Adverse Event|7|||
37660734|NCT03436199|69133471|FG000|Overall Study|Withdrawal by Subject|4|||
37750665|NCT01849289|69247364|FG000|Overall Study|Protocol Violation|3|||
37750666|NCT01849289|69247365|FG001|Overall Study|Protocol Violation|3|||
37750667|NCT01849289|69247364|FG000|Overall Study|Withdrawal criteria|1|||
37750668|NCT01849289|69247365|FG001|Overall Study|Withdrawal criteria|0|||
37750669|NCT01849289|69247364|FG000|Overall Study|Unclassified|25|||
37750670|NCT01849289|69247365|FG001|Overall Study|Unclassified|18|||
37750671|NCT01868243|69247373|FG000|Overall Study|Death|0|||
37750672|NCT01868243|69247374|FG001|Overall Study|Death|1|||
37750673|NCT01611935|69247382|FG000|Overall Study|Family Declined Participation|1|||
37750674|NCT01611935|69247383|FG001|Overall Study|Family Declined Participation|0|||
37750675|NCT01868165|69247389|FG000|Overall Study|Withdrawal by Subject|36|||
37750676|NCT01868165|69247389|FG000|Overall Study|Physician Decision|2|||
37750677|NCT01868165|69247389|FG000|Overall Study|Lost to Follow-up|3|||
37750678|NCT01868165|69247389|FG000|Overall Study|Death|4|||
37750679|NCT01868009|69247428|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
37750680|NCT01868009|69247429|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
37750681|NCT01868009|69247428|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
37750682|NCT01868009|69247429|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
37750683|NCT01868009|69247428|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
37750684|NCT01868009|69247429|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
37750685|NCT01849055|69247483|FG000|Overall Study|Withdrawal by Subject|0|||
37750686|NCT01849055|69247484|FG001|Overall Study|Withdrawal by Subject|0|||
37750687|NCT01849055|69247485|FG002|Overall Study|Withdrawal by Subject|1|||
37750688|NCT01849055|69247486|FG003|Overall Study|Withdrawal by Subject|0|||
37750689|NCT01849055|69247487|FG004|Overall Study|Withdrawal by Subject|0|||
37750690|NCT01849055|69247488|FG005|Overall Study|Withdrawal by Subject|0|||
37750691|NCT01848353|69247514|FG000|Phase 1|Withdrawal by Subject|3|||
37750692|NCT01848353|69247515|FG001|Phase 1|Withdrawal by Subject|1|||
37750693|NCT01848353|69247516|FG002|Phase 1|Withdrawal by Subject|0|||
37750694|NCT01848353|69247517|FG003|Phase 1|Withdrawal by Subject|0|||
37750695|NCT01848353|69247514|FG000|Phase 2|Withdrawal by Subject|3|||
37750696|NCT01848353|69247515|FG001|Phase 2|Withdrawal by Subject|2|||
37750697|NCT01848353|69247516|FG002|Phase 2|Withdrawal by Subject|0|||
37750698|NCT01848353|69247517|FG003|Phase 2|Withdrawal by Subject|0|||
37750699|NCT01848353|69247514|FG000|Phase 3|Withdrawal by Subject|1|||
37750700|NCT01848353|69247515|FG001|Phase 3|Withdrawal by Subject|1|||
37750701|NCT01848353|69247516|FG002|Phase 3|Withdrawal by Subject|0|||
37750702|NCT01848353|69247517|FG003|Phase 3|Withdrawal by Subject|0|||
37750703|NCT01847885|69247546|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
38033147|NCT04760314|69719150|FG008|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
38033148|NCT04760314|69719151|FG009|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
38033149|NCT04760314|69719152|FG010|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
38033150|NCT04760314|69719142|FG000|Maintenance Blinded Period|Protocol Deviation|0|||
38033151|NCT04760314|69719143|FG001|Maintenance Blinded Period|Protocol Deviation|0|||
38033152|NCT04760314|69719144|FG002|Maintenance Blinded Period|Protocol Deviation|0|||
38033153|NCT04760314|69719145|FG003|Maintenance Blinded Period|Protocol Deviation|0|||
37660735|NCT03436199|69133472|FG001|Overall Study|Withdrawal by Subject|10|||
37750704|NCT01847885|69247547|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
37750705|NCT01847885|69247548|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
37750706|NCT01847885|69247546|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
37750707|NCT01847885|69247547|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
37750708|NCT01847885|69247548|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
37750709|NCT01847885|69247546|FG000|Initial Enrollment (Consented)|Screen failure|39|||
37750710|NCT01847885|69247547|FG001|Initial Enrollment (Consented)|Screen failure|0|||
37750711|NCT01847885|69247548|FG002|Initial Enrollment (Consented)|Screen failure|0|||
37750712|NCT01847885|69247546|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
37750713|NCT01847885|69247547|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
37660736|NCT03436199|69133473|FG002|Overall Study|Withdrawal by Subject|3|||
37660737|NCT03436199|69133471|FG000|Overall Study|Lost to Follow-up|1|||
37660738|NCT03436199|69133472|FG001|Overall Study|Lost to Follow-up|0|||
37660739|NCT03436199|69133473|FG002|Overall Study|Lost to Follow-up|2|||
37660740|NCT03436199|69133471|FG000|Overall Study|Protocol Violation|1|||
37660741|NCT03436199|69133472|FG001|Overall Study|Protocol Violation|1|||
37750714|NCT01847885|69247548|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
37750715|NCT01847885|69247546|FG000|Randomization|Protocol Violation|0|||
37660742|NCT03436199|69133473|FG002|Overall Study|Protocol Violation|0|||
37660743|NCT03436199|69133471|FG000|Overall Study|Physician Decision|0|||
37660744|NCT03436199|69133472|FG001|Overall Study|Physician Decision|1|||
37660745|NCT03436199|69133473|FG002|Overall Study|Physician Decision|0|||
37750716|NCT01847885|69247547|FG001|Randomization|Protocol Violation|1|||
37750717|NCT01847885|69247548|FG002|Randomization|Protocol Violation|0|||
37856699|NCT01001572|69539941|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
37856700|NCT01001572|69539942|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
37856701|NCT01001572|69539940|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
37856702|NCT01001572|69539941|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
37660746|NCT03436199|69133471|FG000|Overall Study|Could not return to clinic|1|||
37660747|NCT03436199|69133472|FG001|Overall Study|Could not return to clinic|0|||
38033154|NCT04760314|69719146|FG004|Maintenance Blinded Period|Protocol Deviation|0|||
37750718|NCT01847885|69247546|FG000|Randomization|Withdrawal by Subject|0|||
37750719|NCT01847885|69247547|FG001|Randomization|Withdrawal by Subject|0|||
37750720|NCT01847885|69247548|FG002|Randomization|Withdrawal by Subject|2|||
37750721|NCT01847885|69247546|FG000|Randomization|Screen Failure|0|||
37660748|NCT03436199|69133473|FG002|Overall Study|Could not return to clinic|0|||
37660749|NCT03436199|69133471|FG000|Overall Study|Withdrawn per physician|0|||
37660750|NCT03436199|69133472|FG001|Overall Study|Withdrawn per physician|1|||
37660751|NCT03436199|69133473|FG002|Overall Study|Withdrawn per physician|0|||
37660752|NCT02131636|69133483|FG000|Overall Study|Personal Reasons|4|||
37660753|NCT02131636|69133484|FG001|Overall Study|Personal Reasons|4|||
37660754|NCT02131636|69133483|FG000|Overall Study|Lost to Follow-up|4|||
37750722|NCT01847885|69247547|FG001|Randomization|Screen Failure|3|||
37750723|NCT01847885|69247548|FG002|Randomization|Screen Failure|0|||
37750724|NCT01867307|69247586|FG000|Overall Study|Protocol Violation|2|||
37750725|NCT01867307|69247587|FG001|Overall Study|Protocol Violation|0|||
37750726|NCT01867307|69247586|FG000|Overall Study|Other Adverse Event|1|||
37750727|NCT01867307|69247587|FG001|Overall Study|Other Adverse Event|3|||
37750728|NCT01845077|69247596|FG000|Washout Period|Lost to Follow-up|0|||
37750729|NCT01845077|69247597|FG001|Washout Period|Lost to Follow-up|1|||
37750730|NCT01845077|69247598|FG002|Washout Period|Lost to Follow-up|0|||
37750731|NCT01845077|69247599|FG003|Washout Period|Lost to Follow-up|1|||
37750732|NCT01845077|69247600|FG004|Washout Period|Lost to Follow-up|0|||
37750733|NCT01845077|69247601|FG005|Washout Period|Lost to Follow-up|1|||
37750734|NCT01845077|69247596|FG000|Washout Period|Adverse Event|1|||
37750735|NCT01845077|69247597|FG001|Washout Period|Adverse Event|0|||
37750736|NCT01845077|69247598|FG002|Washout Period|Adverse Event|0|||
37750737|NCT01845077|69247599|FG003|Washout Period|Adverse Event|0|||
37750738|NCT01845077|69247600|FG004|Washout Period|Adverse Event|0|||
37750739|NCT01845077|69247601|FG005|Washout Period|Adverse Event|0|||
37750740|NCT01845077|69247596|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
37750741|NCT01845077|69247597|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
37750742|NCT01845077|69247598|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
37750743|NCT01845077|69247599|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
37856703|NCT01001572|69539942|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
37856704|NCT01001572|69539940|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
37856705|NCT01001572|69539941|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
37856706|NCT01001572|69539942|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
37856707|NCT01001572|69539940|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
37856708|NCT01001572|69539941|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
37856709|NCT01001572|69539942|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
37856710|NCT01001572|69539940|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
37856711|NCT01001572|69539941|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
37856712|NCT01001572|69539942|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
37856713|NCT01001572|69539940|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
37856714|NCT01001572|69539941|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
37856715|NCT01001572|69539942|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
37856716|NCT01001572|69539940|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
37856717|NCT01001572|69539941|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
37856718|NCT01001572|69539942|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
37856719|NCT01001572|69539940|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
37856720|NCT01001572|69539941|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
37856721|NCT01001572|69539942|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
37856722|NCT01001572|69539940|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
37856723|NCT01001572|69539941|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
37856724|NCT01001572|69539942|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
37856725|NCT01001572|69539940|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
37856726|NCT01001572|69539941|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
37856727|NCT01001572|69539942|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
37856728|NCT01001572|69539940|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
37856729|NCT01001572|69539941|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
37856730|NCT01001572|69539942|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
37856731|NCT01001572|69539940|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
37856732|NCT01001572|69539941|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
37660755|NCT02131636|69133484|FG001|Overall Study|Lost to Follow-up|0|||
37660756|NCT02131636|69133483|FG000|Overall Study|Adverse Event|4|||
37750744|NCT01845077|69247600|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
37750745|NCT01845077|69247601|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
37750746|NCT01845077|69247596|FG000|Washout Period|Protocol Violation|0|||
37856733|NCT01001572|69539942|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
37660757|NCT02131636|69133484|FG001|Overall Study|Adverse Event|1|||
37750747|NCT01845077|69247597|FG001|Washout Period|Protocol Violation|0|||
37750748|NCT01845077|69247598|FG002|Washout Period|Protocol Violation|0|||
37750749|NCT01845077|69247599|FG003|Washout Period|Protocol Violation|1|||
37660758|NCT02131324|69133492|FG000|Overall Study|Withdrawal by Subject|1|||
37750750|NCT01845077|69247600|FG004|Washout Period|Protocol Violation|1|||
37750751|NCT01845077|69247601|FG005|Washout Period|Protocol Violation|0|||
37750752|NCT01866917|69247618|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
37750753|NCT01866917|69247619|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
37750754|NCT01844765|69247754|FG000|Overall Study|Adverse Event|6|||
37750755|NCT01844765|69247755|FG001|Overall Study|Adverse Event|8|||
37750756|NCT01844765|69247754|FG000|Overall Study|Withdrawal by Subject|2|||
37750757|NCT01844765|69247755|FG001|Overall Study|Withdrawal by Subject|3|||
37750758|NCT01844765|69247754|FG000|Overall Study|Disease progression|1|||
37750759|NCT01844765|69247755|FG001|Overall Study|Disease progression|0|||
37750760|NCT01844765|69247754|FG000|Overall Study|Administrative problems|3|||
37750761|NCT01844765|69247755|FG001|Overall Study|Administrative problems|4|||
37750762|NCT01844765|69247754|FG000|Overall Study|Protocol deviation|2|||
37750763|NCT01844765|69247755|FG001|Overall Study|Protocol deviation|0|||
37750764|NCT01844765|69247754|FG000|Overall Study|Untreated|1|||
37750765|NCT01844765|69247755|FG001|Overall Study|Untreated|0|||
37750766|NCT01866293|69247770|FG000|Overall Study|Adverse Event|2|||
37750767|NCT01844687|69247774|FG000|Visit 1|Protocol Violation|3|||
37750768|NCT01844687|69247774|FG000|Visit 1|Lost to Follow-up|5|||
37750769|NCT01844687|69247774|FG000|Visit 2|Withdrawal by Subject|1|||
37750770|NCT01844687|69247774|FG000|Visit 2|Protocol Violation|1|||
37750771|NCT01844687|69247774|FG000|Visit 3|Lost to Follow-up|1|||
37750772|NCT01844687|69247774|FG000|Visit 3|Withdrawal by Subject|3|||
37750773|NCT01844687|69247774|FG000|Visit 3|child care problems|1|||
37750774|NCT01844687|69247774|FG000|Visit 4|Pregnancy|1|||
37750775|NCT01844687|69247774|FG000|Visit 4|Lost to Follow-up|1|||
37750776|NCT01844687|69247774|FG000|Visit 4|Withdrawal by Subject|2|||
37750777|NCT01844531|69247800|FG000|Overall Study|Withdrawal by Subject|0|||
37750778|NCT01844531|69247801|FG001|Overall Study|Withdrawal by Subject|1|||
37750779|NCT01844531|69247802|FG002|Overall Study|Withdrawal by Subject|0|||
37750780|NCT01844531|69247803|FG003|Overall Study|Withdrawal by Subject|0|||
37750781|NCT01844375|69247815|FG000|Overall Study|Protocol Violation|1|||
37750782|NCT01844375|69247816|FG001|Overall Study|Protocol Violation|1|||
37750783|NCT02367456|69247825|FG000|Overall Study|Death|8|||
37750784|NCT02367456|69247826|FG001|Overall Study|Death|21|||
37750785|NCT02367456|69247827|FG002|Overall Study|Death|14|||
37750786|NCT02367456|69247825|FG000|Overall Study|Lost to Follow-up|1|||
37750787|NCT02367456|69247826|FG001|Overall Study|Lost to Follow-up|3|||
37750788|NCT02367456|69247827|FG002|Overall Study|Lost to Follow-up|1|||
37750789|NCT02367456|69247825|FG000|Overall Study|Ongoing|0|||
37750790|NCT02367456|69247826|FG001|Overall Study|Ongoing|6|||
37750791|NCT02367456|69247827|FG002|Overall Study|Ongoing|15|||
37750792|NCT02367456|69247825|FG000|Overall Study|Other reason|3|||
37750793|NCT02367456|69247826|FG001|Overall Study|Other reason|0|||
37750794|NCT02367456|69247827|FG002|Overall Study|Other reason|0|||
37750795|NCT01865747|69247858|FG000|Overall Study (ITT)|Adverse Event|32|||
37750796|NCT01865747|69247859|FG001|Overall Study (ITT)|Adverse Event|31|||
37750797|NCT01865747|69247858|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
37750798|NCT01865747|69247859|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
37750799|NCT01865747|69247858|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
37750800|NCT01865747|69247859|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
37750801|NCT01865747|69247858|FG000|Overall Study (ITT)|Protocol Violation|1|||
37750802|NCT01865747|69247859|FG001|Overall Study (ITT)|Protocol Violation|1|||
37750803|NCT01865747|69247858|FG000|Overall Study (ITT)|Physician Decision|5|||
37750804|NCT01865747|69247859|FG001|Overall Study (ITT)|Physician Decision|2|||
37750805|NCT01865747|69247858|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
37750806|NCT01865747|69247859|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
37750807|NCT01865747|69247858|FG000|Overall Study (ITT)|Sponsor Decision|0|||
37750808|NCT01865747|69247859|FG001|Overall Study (ITT)|Sponsor Decision|1|||
37750809|NCT01865747|69247858|FG000|Overall Study (ITT)|Progressive Disease|122|||
37750810|NCT01865747|69247859|FG001|Overall Study (ITT)|Progressive Disease|158|||
37750811|NCT01865747|69247858|FG000|Overall Study (ITT)|Reason Not Provided|0|||
37750812|NCT01865747|69247859|FG001|Overall Study (ITT)|Reason Not Provided|1|||
37750813|NCT01865747|69247858|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
37750814|NCT01865747|69247859|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
37923193|NCT00658684|69609976|FG002|Overall Study|Pregnancy|0|||
38033155|NCT04760314|69719147|FG005|Maintenance Blinded Period|Protocol Deviation|1|||
37750815|NCT01865747|69247858|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
37750816|NCT01865747|69247859|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
37750817|NCT01865747|69247858|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
37750818|NCT01865747|69247859|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
37750819|NCT01865747|69247858|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
37750820|NCT01865747|69247859|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
37750821|NCT01865747|69247858|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
38033156|NCT04760314|69719148|FG006|Maintenance Blinded Period|Protocol Deviation|0|||
38033157|NCT04760314|69719149|FG007|Maintenance Blinded Period|Protocol Deviation|0|||
37750822|NCT01865747|69247859|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
37923194|NCT00658684|69609977|FG003|Overall Study|Pregnancy|0|||
37750823|NCT01865747|69247858|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
37750824|NCT01865747|69247859|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
37750825|NCT01865747|69247858|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
37750826|NCT01865747|69247859|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
37750827|NCT01865747|69247858|FG000|Primary Intent to Treat (PITT)|Other|0|||
37750828|NCT01865747|69247859|FG001|Primary Intent to Treat (PITT)|Other|1|||
37750829|NCT01843673|69247900|FG000|Overall Study|Lack of Efficacy|2|||
37750830|NCT01843673|69247900|FG000|Overall Study|Withdrawal by Subject|4|||
37750831|NCT01843205|69247919|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
37750832|NCT01843205|69247920|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
37750833|NCT01835015|69248007|FG000|Overall Study|Adverse Event|0|||
37750834|NCT01835015|69248008|FG001|Overall Study|Adverse Event|0|||
37750835|NCT01835015|69248009|FG002|Overall Study|Adverse Event|1|||
37750836|NCT01835015|69248010|FG003|Overall Study|Adverse Event|0|||
37750837|NCT01835015|69248011|FG004|Overall Study|Adverse Event|0|||
37750838|NCT01842581|69248039|FG000|Overall Study|Adverse Event|6|||
37750839|NCT01842581|69248040|FG001|Overall Study|Adverse Event|4|||
37750840|NCT01842581|69248039|FG000|Overall Study|HE breakthrough|26|||
37750841|NCT01842581|69248040|FG001|Overall Study|HE breakthrough|13|||
37750842|NCT01842581|69248039|FG000|Overall Study|Liver transplant|2|||
37750843|NCT01842581|69248040|FG001|Overall Study|Liver transplant|0|||
37750844|NCT01842581|69248039|FG000|Overall Study|Lost to Follow-up|2|||
37750845|NCT01842581|69248040|FG001|Overall Study|Lost to Follow-up|5|||
37750846|NCT01842581|69248039|FG000|Overall Study|Withdrawal by Subject|5|||
37750847|NCT01842581|69248040|FG001|Overall Study|Withdrawal by Subject|7|||
37750848|NCT01842581|69248039|FG000|Overall Study|Other than specified|3|||
37750849|NCT01842581|69248040|FG001|Overall Study|Other than specified|1|||
37750850|NCT01833533|69248048|FG000|Overall Study|Adverse Event|0|||
37750851|NCT01833533|69248049|FG001|Overall Study|Adverse Event|1|||
37660759|NCT02131324|69133493|FG001|Overall Study|Withdrawal by Subject|2|||
37660760|NCT02131324|69133492|FG000|Overall Study|Lost to Follow-up|1|||
37660761|NCT02131324|69133493|FG001|Overall Study|Lost to Follow-up|1|||
37660762|NCT02734693|69133502|FG000|Overall Study|Adverse Event|1|||
37660763|NCT02734693|69133503|FG001|Overall Study|Adverse Event|3|||
37660764|NCT02734693|69133504|FG002|Overall Study|Adverse Event|3|||
37660765|NCT02734693|69133502|FG000|Overall Study|Lack of Efficacy|1|||
37660766|NCT02734693|69133503|FG001|Overall Study|Lack of Efficacy|0|||
37660767|NCT02734693|69133504|FG002|Overall Study|Lack of Efficacy|0|||
37660768|NCT02734693|69133502|FG000|Overall Study|Lost to Follow-up|2|||
37660769|NCT02734693|69133503|FG001|Overall Study|Lost to Follow-up|0|||
37660770|NCT02734693|69133504|FG002|Overall Study|Lost to Follow-up|0|||
37660771|NCT02734693|69133502|FG000|Overall Study|Protocol Violation|1|||
37660772|NCT02734693|69133503|FG001|Overall Study|Protocol Violation|0|||
37660773|NCT02734693|69133504|FG002|Overall Study|Protocol Violation|0|||
37660774|NCT02734693|69133502|FG000|Overall Study|Withdrawal by Subject|1|||
37660775|NCT02734693|69133503|FG001|Overall Study|Withdrawal by Subject|0|||
37660776|NCT02734693|69133504|FG002|Overall Study|Withdrawal by Subject|0|||
37660777|NCT02193880|69133512|FG000|Overall Study|patients did not collect enough HPC|3|||
37660778|NCT01378325|69133518|FG000|Overall Study|Protocol Violation|0|||
37660779|NCT01378325|69133519|FG001|Overall Study|Protocol Violation|1|||
37660780|NCT01093573|69133528|FG000|Overall Study|Physician Decision|0|||
37660781|NCT01093573|69133529|FG001|Overall Study|Physician Decision|0|||
37660782|NCT01093573|69133530|FG002|Overall Study|Physician Decision|1|||
37660783|NCT01093573|69133528|FG000|Overall Study|Insurance Denied|0|||
37660784|NCT01093573|69133529|FG001|Overall Study|Insurance Denied|0|||
37750852|NCT01833533|69248048|FG000|Overall Study|Lost to Follow-up|4|||
37923195|NCT00660400|69609987|FG000|Overall Study|Lack of insurance approval|1|||
37923196|NCT00660400|69609987|FG000|Overall Study|Suboptimal organ function|1|||
37923197|NCT00660400|69609987|FG000|Overall Study|Intracranial hemorrhage|1|||
37923198|NCT00660400|69609987|FG000|Overall Study|Withdrawal by Subject|1|||
37923199|NCT00826514|69609993|FG000|Overall Study|Adverse Event|1|||
37660785|NCT01093573|69133530|FG002|Overall Study|Insurance Denied|1|||
37923200|NCT00826514|69609994|FG001|Overall Study|Adverse Event|1|||
37923201|NCT00826514|69609993|FG000|Overall Study|Lack of Efficacy|0|||
37923202|NCT00826514|69609994|FG001|Overall Study|Lack of Efficacy|1|||
37923203|NCT00826514|69609993|FG000|Overall Study|Withdrawal by Subject|2|||
37750853|NCT01833533|69248049|FG001|Overall Study|Lost to Follow-up|9|||
37750854|NCT01833533|69248048|FG000|Overall Study|To Enter an Extension Study|0|||
37750855|NCT01833533|69248049|FG001|Overall Study|To Enter an Extension Study|4|||
37750856|NCT01833533|69248048|FG000|Overall Study|Other|2|||
37923204|NCT00826514|69609994|FG001|Overall Study|Withdrawal by Subject|3|||
37660786|NCT02733367|69133558|FG000|Overall Study|Withdrawal by Subject|6|||
37660787|NCT03688555|69133565|FG000|Treatment Period|Adverse Event|0|||
37660788|NCT03688555|69133566|FG001|Treatment Period|Adverse Event|0|||
37660789|NCT03688555|69133567|FG002|Treatment Period|Adverse Event|1|||
37660790|NCT01328951|69133609|FG000|Overall Study|Disease Progression|17|||
37923205|NCT00826280|69610003|FG000|Overall Study|Randomized but drug not received|1|||
37923206|NCT00826280|69610004|FG001|Overall Study|Randomized but drug not received|0|||
37660791|NCT01328951|69133610|FG001|Overall Study|Disease Progression|14|||
37660792|NCT01328951|69133609|FG000|Overall Study|Adverse Event|2|||
37660793|NCT01328951|69133610|FG001|Overall Study|Adverse Event|0|||
37660794|NCT01328951|69133609|FG000|Overall Study|Death|243|||
37660795|NCT01328951|69133610|FG001|Overall Study|Death|258|||
37660796|NCT01328951|69133609|FG000|Overall Study|Lost to Follow-up|6|||
37660797|NCT01328951|69133610|FG001|Overall Study|Lost to Follow-up|7|||
37660798|NCT01328951|69133609|FG000|Overall Study|Withdrawal by Subject|6|||
37750857|NCT01833533|69248049|FG001|Overall Study|Other|7|||
37750858|NCT01833455|69248057|FG000|Overall Study|Withdrawal by Subject|1|||
37750859|NCT01833455|69248058|FG001|Overall Study|Withdrawal by Subject|0|||
37750860|NCT01833143|69248076|FG000|Overall Study|Not Treated|1|||
37750861|NCT01841567|69248080|FG000|Overall Study|Adverse Event|3|||
37750862|NCT01833065|69248087|FG000|Overall Study|Adverse Event|6|||
37750863|NCT01833065|69248088|FG001|Overall Study|Adverse Event|1|||
37750864|NCT01833065|69248089|FG002|Overall Study|Adverse Event|0|||
37750865|NCT01833065|69248090|FG003|Overall Study|Adverse Event|2|||
37750866|NCT01833065|69248091|FG004|Overall Study|Adverse Event|3|||
37750867|NCT01833065|69248087|FG000|Overall Study|Protocol Violation|1|||
37750868|NCT01833065|69248088|FG001|Overall Study|Protocol Violation|0|||
37750869|NCT01833065|69248089|FG002|Overall Study|Protocol Violation|0|||
37750870|NCT01833065|69248090|FG003|Overall Study|Protocol Violation|0|||
37750871|NCT01833065|69248091|FG004|Overall Study|Protocol Violation|2|||
37750872|NCT01833065|69248087|FG000|Overall Study|Lost to Follow-up|1|||
37750873|NCT01833065|69248088|FG001|Overall Study|Lost to Follow-up|0|||
37750874|NCT01833065|69248089|FG002|Overall Study|Lost to Follow-up|0|||
37750875|NCT01833065|69248090|FG003|Overall Study|Lost to Follow-up|0|||
37750876|NCT01833065|69248091|FG004|Overall Study|Lost to Follow-up|3|||
37750877|NCT01833065|69248087|FG000|Overall Study|Withdrawal by Subject|6|||
37750878|NCT01833065|69248088|FG001|Overall Study|Withdrawal by Subject|2|||
37750879|NCT01833065|69248089|FG002|Overall Study|Withdrawal by Subject|4|||
37750880|NCT01833065|69248090|FG003|Overall Study|Withdrawal by Subject|3|||
37750881|NCT01833065|69248091|FG004|Overall Study|Withdrawal by Subject|11|||
37750882|NCT01833065|69248087|FG000|Overall Study|Subject's substantial non-compliance|0|||
37750883|NCT01833065|69248088|FG001|Overall Study|Subject's substantial non-compliance|1|||
37750884|NCT01833065|69248089|FG002|Overall Study|Subject's substantial non-compliance|0|||
37750885|NCT01833065|69248090|FG003|Overall Study|Subject's substantial non-compliance|0|||
37750886|NCT01833065|69248091|FG004|Overall Study|Subject's substantial non-compliance|0|||
37750887|NCT01833065|69248087|FG000|Overall Study|Trial terminated by sponsor|8|||
37750888|NCT01833065|69248088|FG001|Overall Study|Trial terminated by sponsor|8|||
37750889|NCT01833065|69248089|FG002|Overall Study|Trial terminated by sponsor|7|||
37750890|NCT01833065|69248090|FG003|Overall Study|Trial terminated by sponsor|3|||
37750891|NCT01833065|69248091|FG004|Overall Study|Trial terminated by sponsor|13|||
37750892|NCT01833065|69248087|FG000|Overall Study|Others|2|||
37750893|NCT01833065|69248088|FG001|Overall Study|Others|1|||
37750894|NCT01833065|69248089|FG002|Overall Study|Others|1|||
37750895|NCT01833065|69248090|FG003|Overall Study|Others|1|||
37856734|NCT01001572|69539940|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
37856735|NCT01001572|69539941|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
37856736|NCT01001572|69539942|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
37660799|NCT01328951|69133610|FG001|Overall Study|Withdrawal by Subject|6|||
37660800|NCT01328951|69133609|FG000|Overall Study|Study Closed by the Sponsor|36|||
37750896|NCT01833065|69248091|FG004|Overall Study|Others|4|||
37856737|NCT01208415|69539948|FG000|Overall Study|Death|1|||
37856738|NCT01208415|69539948|FG000|Overall Study|Lost to Follow-up|2|||
37856739|NCT01208415|69539948|FG000|Overall Study|Withdrawal by Subject|3|||
37856740|NCT01208415|69539948|FG000|Overall Study|Device not placed|1|||
37856741|NCT01208415|69539948|FG000|Overall Study|Still be eligible for follow-up|33|||
37856742|NCT01208337|69539952|FG000|Overall Study|Death|3|||
37856743|NCT01208181|69539968|FG000|Part 1|Withdrawal by Subject|11|||
37856744|NCT01208181|69539969|FG001|Part 1|Withdrawal by Subject|10|||
37856745|NCT01208181|69539970|FG002|Part 1|Withdrawal by Subject|0|||
37856746|NCT01208181|69539971|FG003|Part 1|Withdrawal by Subject|0|||
37856747|NCT01208181|69539972|FG004|Part 1|Withdrawal by Subject|0|||
37856748|NCT01208181|69539968|FG000|Part 1|Technical problem|5|||
37856749|NCT01208181|69539969|FG001|Part 1|Technical problem|0|||
37856750|NCT01208181|69539970|FG002|Part 1|Technical problem|0|||
37660801|NCT01328951|69133610|FG001|Overall Study|Study Closed by the Sponsor|31|||
37750897|NCT01831817|69248105|FG000|Overall Study|Lost to Follow-up|1|||
37750898|NCT01831817|69248106|FG001|Overall Study|Lost to Follow-up|0|||
37750899|NCT01831817|69248107|FG002|Overall Study|Lost to Follow-up|0|||
37750900|NCT01831817|69248108|FG003|Overall Study|Lost to Follow-up|0|||
37750901|NCT01831817|69248105|FG000|Overall Study|Withdrawl of Consent|3|||
37750902|NCT01831817|69248106|FG001|Overall Study|Withdrawl of Consent|0|||
37856751|NCT01208181|69539971|FG003|Part 1|Technical problem|0|||
37856752|NCT01208181|69539972|FG004|Part 1|Technical problem|0|||
37660802|NCT01328951|69133609|FG000|Overall Study|Other|11|||
37660803|NCT01328951|69133610|FG001|Overall Study|Other|6|||
37660804|NCT02611817|69133623|FG000|Open-label Induction Phase|Reason not Specified|9|||
37923207|NCT00826280|69610005|FG002|Overall Study|Randomized but drug not received|1|||
37923208|NCT00826280|69610003|FG000|Overall Study|Adverse Event|1|||
37923209|NCT00826280|69610004|FG001|Overall Study|Adverse Event|3|||
37923210|NCT00826280|69610005|FG002|Overall Study|Adverse Event|0|||
37923211|NCT00826280|69610003|FG000|Overall Study|Lost to Follow-up|0|||
37660805|NCT02611817|69133624|FG001|Open-label Induction Phase|Reason not Specified|0|||
37660806|NCT02611817|69133625|FG002|Open-label Induction Phase|Reason not Specified|0|||
37660807|NCT02611817|69133623|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
37660808|NCT02611817|69133624|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
37660809|NCT02611817|69133625|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
37660810|NCT02611817|69133623|FG000|Open-label Induction Phase|Pregnancy|1|||
37660811|NCT02611817|69133624|FG001|Open-label Induction Phase|Pregnancy|0|||
37660812|NCT02611817|69133625|FG002|Open-label Induction Phase|Pregnancy|0|||
37660813|NCT02611817|69133623|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
37660814|NCT02611817|69133624|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
37660815|NCT02611817|69133625|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
37660816|NCT02611817|69133623|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
37660817|NCT02611817|69133624|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
37660818|NCT02611817|69133625|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
37660819|NCT02611817|69133623|FG000|Open-label Induction Phase|Protocol Violation|5|||
37660820|NCT02611817|69133624|FG001|Open-label Induction Phase|Protocol Violation|0|||
37660821|NCT02611817|69133625|FG002|Open-label Induction Phase|Protocol Violation|0|||
37660822|NCT02611817|69133623|FG000|Open-label Induction Phase|Adverse Event|16|||
37660823|NCT02611817|69133624|FG001|Open-label Induction Phase|Adverse Event|0|||
37660824|NCT02611817|69133625|FG002|Open-label Induction Phase|Adverse Event|0|||
37660825|NCT02611817|69133623|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
37660826|NCT02611817|69133624|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
37660827|NCT02611817|69133625|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
37660828|NCT02611817|69133623|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
37660829|NCT02611817|69133624|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
37660830|NCT02611817|69133625|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
37660831|NCT02611817|69133623|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
37660832|NCT02611817|69133624|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
37660833|NCT02611817|69133625|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
37660834|NCT02611817|69133623|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
37660835|NCT02611817|69133624|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
37660836|NCT02611817|69133625|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
37856753|NCT01208181|69539968|FG000|Part 1|Protocol Violation|10|||
37856754|NCT01208181|69539969|FG001|Part 1|Protocol Violation|5|||
37856755|NCT01208181|69539970|FG002|Part 1|Protocol Violation|0|||
37856756|NCT01208181|69539971|FG003|Part 1|Protocol Violation|0|||
37856757|NCT01208181|69539972|FG004|Part 1|Protocol Violation|0|||
37856758|NCT01208181|69539968|FG000|Part 1|Physician Decision|4|||
37856759|NCT01208181|69539969|FG001|Part 1|Physician Decision|0|||
37856760|NCT01208181|69539970|FG002|Part 1|Physician Decision|0|||
37856761|NCT01208181|69539971|FG003|Part 1|Physician Decision|0|||
37856762|NCT01208181|69539972|FG004|Part 1|Physician Decision|0|||
37856763|NCT01208181|69539968|FG000|Part 1|Non-compliance with study drug|1|||
37856764|NCT01208181|69539969|FG001|Part 1|Non-compliance with study drug|1|||
37856765|NCT01208181|69539970|FG002|Part 1|Non-compliance with study drug|0|||
37856766|NCT01208181|69539971|FG003|Part 1|Non-compliance with study drug|0|||
37856767|NCT01208181|69539972|FG004|Part 1|Non-compliance with study drug|0|||
37856768|NCT01208181|69539968|FG000|Part 1|Lost to Follow-up|5|||
37856769|NCT01208181|69539969|FG001|Part 1|Lost to Follow-up|3|||
37856770|NCT01208181|69539970|FG002|Part 1|Lost to Follow-up|0|||
37856771|NCT01208181|69539971|FG003|Part 1|Lost to Follow-up|0|||
37856772|NCT01208181|69539972|FG004|Part 1|Lost to Follow-up|1|||
37923212|NCT00826280|69610004|FG001|Overall Study|Lost to Follow-up|1|||
37923213|NCT00826280|69610005|FG002|Overall Study|Lost to Follow-up|0|||
37660837|NCT02611817|69133623|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
37660838|NCT02611817|69133624|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
37660839|NCT02611817|69133625|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
37660840|NCT02611817|69133623|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
37660841|NCT02611817|69133624|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
37660842|NCT02611817|69133625|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
37660843|NCT02611817|69133623|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
37856773|NCT01208181|69539968|FG000|Part 1|Lack of Efficacy|37|||
37856774|NCT01208181|69539969|FG001|Part 1|Lack of Efficacy|12|||
37856775|NCT01208181|69539970|FG002|Part 1|Lack of Efficacy|0|||
37856776|NCT01208181|69539971|FG003|Part 1|Lack of Efficacy|0|||
37856777|NCT01208181|69539972|FG004|Part 1|Lack of Efficacy|17|||
37856778|NCT01208181|69539968|FG000|Part 1|Adverse Event|26|||
37856779|NCT01208181|69539969|FG001|Part 1|Adverse Event|24|||
37923214|NCT00826280|69610003|FG000|Overall Study|Sponsor discontinued subject or study|1|||
37923215|NCT00826280|69610004|FG001|Overall Study|Sponsor discontinued subject or study|0|||
37660844|NCT02611817|69133624|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
37660845|NCT02611817|69133625|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
37660846|NCT02735915|69133632|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
37660847|NCT02735915|69133632|FG000|Overall Study|Withdrawal following SAE|2|||
37660848|NCT02735915|69133632|FG000|Overall Study|Withdrawal by Subject|1|||
37660849|NCT02557139|69133641|FG000|Overall Study|Significant liver elevation|1|||
37660850|NCT02557139|69133642|FG001|Overall Study|Significant liver elevation|0|||
37660851|NCT02557139|69133643|FG002|Overall Study|Significant liver elevation|1|||
37660852|NCT02557139|69133641|FG000|Overall Study|Withdrawal by Subject|1|||
37660853|NCT02557139|69133642|FG001|Overall Study|Withdrawal by Subject|0|||
37660854|NCT02557139|69133643|FG002|Overall Study|Withdrawal by Subject|0|||
37660855|NCT02557139|69133641|FG000|Overall Study|Illness of prohibited medication|0|||
37660856|NCT02557139|69133642|FG001|Overall Study|Illness of prohibited medication|0|||
37660857|NCT02557139|69133643|FG002|Overall Study|Illness of prohibited medication|1|||
37660858|NCT01328717|69133660|FG000|Overall Study|Adverse Event|1|||
37660859|NCT01677741|69133672|FG000|Overall Study|Death|0|||
37660860|NCT01677741|69133673|FG001|Overall Study|Death|0|||
37660861|NCT01677741|69133674|FG002|Overall Study|Death|0|||
37660862|NCT01677741|69133675|FG003|Overall Study|Death|1|||
37660863|NCT01677741|69133676|FG004|Overall Study|Death|0|||
37660864|NCT01677741|69133677|FG005|Overall Study|Death|1|||
37660865|NCT01677741|69133678|FG006|Overall Study|Death|0|||
37660866|NCT01677741|69133679|FG007|Overall Study|Death|0|||
37660867|NCT01677741|69133672|FG000|Overall Study|Withdrawal by Subject|2|||
37660868|NCT01677741|69133673|FG001|Overall Study|Withdrawal by Subject|7|||
37660869|NCT01677741|69133674|FG002|Overall Study|Withdrawal by Subject|5|||
37660870|NCT01677741|69133675|FG003|Overall Study|Withdrawal by Subject|4|||
37660871|NCT01677741|69133676|FG004|Overall Study|Withdrawal by Subject|11|||
37660872|NCT01677741|69133677|FG005|Overall Study|Withdrawal by Subject|20|||
37660873|NCT01677741|69133678|FG006|Overall Study|Withdrawal by Subject|4|||
37660874|NCT01677741|69133679|FG007|Overall Study|Withdrawal by Subject|2|||
37660875|NCT01677741|69133672|FG000|Overall Study|Enrolled in a rollover study|0|||
37660876|NCT01677741|69133673|FG001|Overall Study|Enrolled in a rollover study|3|||
37660877|NCT01677741|69133674|FG002|Overall Study|Enrolled in a rollover study|2|||
37660878|NCT01677741|69133675|FG003|Overall Study|Enrolled in a rollover study|1|||
37660879|NCT01677741|69133676|FG004|Overall Study|Enrolled in a rollover study|6|||
37660880|NCT01677741|69133677|FG005|Overall Study|Enrolled in a rollover study|6|||
37660881|NCT01677741|69133678|FG006|Overall Study|Enrolled in a rollover study|7|||
37660882|NCT01677741|69133679|FG007|Overall Study|Enrolled in a rollover study|0|||
37660883|NCT01677741|69133672|FG000|Overall Study|Progressive disease|1|||
37660884|NCT01677741|69133673|FG001|Overall Study|Progressive disease|0|||
37660885|NCT01677741|69133674|FG002|Overall Study|Progressive disease|1|||
37660886|NCT01677741|69133675|FG003|Overall Study|Progressive disease|0|||
37660887|NCT01677741|69133676|FG004|Overall Study|Progressive disease|0|||
37660888|NCT01677741|69133677|FG005|Overall Study|Progressive disease|1|||
37660889|NCT01677741|69133678|FG006|Overall Study|Progressive disease|0|||
37660890|NCT01677741|69133679|FG007|Overall Study|Progressive disease|0|||
37660891|NCT01677507|69133731|FG000|Initial Assignment|Adverse Event|0|||
37660892|NCT01677507|69133732|FG001|Initial Assignment|Adverse Event|1|||
37660893|NCT01677507|69133731|FG000|Initial Assignment|Protocol Violation|0|||
37660894|NCT01677507|69133732|FG001|Initial Assignment|Protocol Violation|1|||
37660895|NCT01677507|69133731|FG000|Second Assigment|Withdrawal by Subject|2|||
37660896|NCT01677507|69133732|FG001|Second Assigment|Withdrawal by Subject|2|||
37660897|NCT01677507|69133731|FG000|Second Assigment|Adverse Event|1|||
37660898|NCT01677507|69133732|FG001|Second Assigment|Adverse Event|3|||
37660899|NCT02732951|69133751|FG000|Overall Study|Other than listed|1|||
37660900|NCT02732951|69133752|FG001|Overall Study|Other than listed|0|||
37660901|NCT02732951|69133751|FG000|Overall Study|Lost to Follow-up|0|||
37660902|NCT02732951|69133752|FG001|Overall Study|Lost to Follow-up|1|||
37660903|NCT02732951|69133751|FG000|Overall Study|Adverse Event|4|||
37660904|NCT02732951|69133752|FG001|Overall Study|Adverse Event|4|||
37660905|NCT02732951|69133751|FG000|Overall Study|Protocol Violation|0|||
37660906|NCT02732951|69133752|FG001|Overall Study|Protocol Violation|1|||
37660907|NCT01377233|69133763|FG000|Open-label|Adverse Event|1|||
37660908|NCT01377233|69133764|FG001|Open-label|Adverse Event|0|||
37660909|NCT01377233|69133765|FG002|Open-label|Adverse Event|0|||
37856780|NCT01208181|69539970|FG002|Part 1|Adverse Event|0|||
37660910|NCT01377233|69133766|FG003|Open-label|Adverse Event|0|||
37660911|NCT01377233|69133767|FG004|Open-label|Adverse Event|0|||
37660912|NCT01377233|69133763|FG000|Open-label|Withdrawal by Subject|3|||
37660913|NCT01377233|69133764|FG001|Open-label|Withdrawal by Subject|0|||
37660914|NCT01377233|69133765|FG002|Open-label|Withdrawal by Subject|0|||
37660915|NCT01377233|69133766|FG003|Open-label|Withdrawal by Subject|0|||
37660916|NCT01377233|69133767|FG004|Open-label|Withdrawal by Subject|0|||
37856781|NCT01208181|69539971|FG003|Part 1|Adverse Event|0|||
37660917|NCT01377233|69133763|FG000|Double-blind|Adverse Event|0|||
37660918|NCT01377233|69133764|FG001|Double-blind|Adverse Event|1|||
37660919|NCT01377233|69133765|FG002|Double-blind|Adverse Event|2|||
37856782|NCT01208181|69539972|FG004|Part 1|Adverse Event|4|||
37660920|NCT01377233|69133766|FG003|Double-blind|Adverse Event|2|||
37660921|NCT01377233|69133767|FG004|Double-blind|Adverse Event|0|||
37660922|NCT01377233|69133763|FG000|Double-blind|Protocol Violation|0|||
37660923|NCT01377233|69133764|FG001|Double-blind|Protocol Violation|0|||
37660924|NCT01377233|69133765|FG002|Double-blind|Protocol Violation|0|||
37660925|NCT01377233|69133766|FG003|Double-blind|Protocol Violation|0|||
37660926|NCT01377233|69133767|FG004|Double-blind|Protocol Violation|1|||
37660927|NCT01377233|69133763|FG000|Double-blind|Withdrawal by Subject|0|||
37660928|NCT01377233|69133764|FG001|Double-blind|Withdrawal by Subject|0|||
37660929|NCT01377233|69133765|FG002|Double-blind|Withdrawal by Subject|0|||
37660930|NCT01377233|69133766|FG003|Double-blind|Withdrawal by Subject|1|||
37660931|NCT01377233|69133767|FG004|Double-blind|Withdrawal by Subject|0|||
37660932|NCT01377233|69133763|FG000|Double-blind|Administrative or other|0|||
37660933|NCT01377233|69133764|FG001|Double-blind|Administrative or other|0|||
37660934|NCT01377233|69133765|FG002|Double-blind|Administrative or other|0|||
37660935|NCT01377233|69133766|FG003|Double-blind|Administrative or other|1|||
37660936|NCT01377233|69133767|FG004|Double-blind|Administrative or other|1|||
37660937|NCT03248531|69133786|FG000|Overall Study|Adverse Event|0|||
37660938|NCT03248531|69133787|FG001|Overall Study|Adverse Event|0|||
37660939|NCT03248531|69133788|FG002|Overall Study|Adverse Event|1|||
37660940|NCT03248531|69133786|FG000|Overall Study|Lost to Follow-up|1|||
37660941|NCT03248531|69133787|FG001|Overall Study|Lost to Follow-up|0|||
37660942|NCT03248531|69133788|FG002|Overall Study|Lost to Follow-up|5|||
37660943|NCT03248531|69133786|FG000|Overall Study|Withdrawal by Subject|3|||
37660944|NCT03248531|69133787|FG001|Overall Study|Withdrawal by Subject|3|||
37660945|NCT03248531|69133788|FG002|Overall Study|Withdrawal by Subject|2|||
37660946|NCT03248531|69133786|FG000|Overall Study|Sponsor Request|0|||
37660947|NCT03248531|69133787|FG001|Overall Study|Sponsor Request|2|||
37660948|NCT03248531|69133788|FG002|Overall Study|Sponsor Request|0|||
37660949|NCT02656329|69133805|FG000|Overall Study|Lost to Follow-up|2|||
37660950|NCT02656329|69133806|FG001|Overall Study|Lost to Follow-up|3|||
37660951|NCT02656329|69133805|FG000|Overall Study|Withdrawal by Subject|7|||
37660952|NCT02656329|69133806|FG001|Overall Study|Withdrawal by Subject|6|||
37660953|NCT02656329|69133805|FG000|Overall Study|Study termination by Sponsor|150|||
37660954|NCT02656329|69133806|FG001|Overall Study|Study termination by Sponsor|142|||
37660955|NCT02656329|69133805|FG000|Overall Study|Other than specified above|5|||
37660956|NCT02656329|69133806|FG001|Overall Study|Other than specified above|6|||
37660957|NCT02712905|69133831|FG000|Monotherapy|Death|2|||
37660958|NCT02712905|69133832|FG001|Monotherapy|Death|5|||
37660959|NCT02712905|69133833|FG002|Monotherapy|Death|0|||
37660960|NCT02712905|69133834|FG003|Monotherapy|Death|3|||
37660961|NCT02712905|69133835|FG004|Monotherapy|Death|15|||
37660962|NCT02712905|69133836|FG005|Monotherapy|Death|1|||
37660963|NCT02712905|69133837|FG006|Monotherapy|Death|3|||
37660964|NCT02712905|69133838|FG007|Monotherapy|Death|3|||
37660965|NCT02712905|69133839|FG008|Monotherapy|Death|0|||
37660966|NCT02712905|69133840|FG009|Monotherapy|Death|27|||
37660967|NCT02712905|69133841|FG010|Monotherapy|Death|2|||
37660968|NCT02712905|69133842|FG011|Monotherapy|Death|5|||
37660969|NCT02712905|69133843|FG012|Monotherapy|Death|0|||
37660970|NCT02712905|69133844|FG013|Monotherapy|Death|0|||
37660971|NCT02712905|69133845|FG014|Monotherapy|Death|0|||
37660972|NCT02712905|69133846|FG015|Monotherapy|Death|0|||
37660973|NCT02712905|69133847|FG016|Monotherapy|Death|0|||
37660974|NCT02712905|69133848|FG017|Monotherapy|Death|0|||
37660975|NCT02712905|69133831|FG000|Monotherapy|Lost to Follow-up|0|||
37660976|NCT02712905|69133832|FG001|Monotherapy|Lost to Follow-up|1|||
37660977|NCT02712905|69133833|FG002|Monotherapy|Lost to Follow-up|0|||
37660978|NCT02712905|69133834|FG003|Monotherapy|Lost to Follow-up|1|||
37660979|NCT02712905|69133835|FG004|Monotherapy|Lost to Follow-up|0|||
37660980|NCT02712905|69133836|FG005|Monotherapy|Lost to Follow-up|0|||
37660981|NCT02712905|69133837|FG006|Monotherapy|Lost to Follow-up|0|||
37660982|NCT02712905|69133838|FG007|Monotherapy|Lost to Follow-up|0|||
37660983|NCT02712905|69133839|FG008|Monotherapy|Lost to Follow-up|0|||
37660984|NCT02712905|69133840|FG009|Monotherapy|Lost to Follow-up|2|||
37660985|NCT02712905|69133841|FG010|Monotherapy|Lost to Follow-up|0|||
37660986|NCT02712905|69133842|FG011|Monotherapy|Lost to Follow-up|0|||
37660987|NCT02712905|69133843|FG012|Monotherapy|Lost to Follow-up|0|||
37660988|NCT02712905|69133844|FG013|Monotherapy|Lost to Follow-up|0|||
37750903|NCT01831817|69248107|FG002|Overall Study|Withdrawl of Consent|0|||
37660989|NCT02712905|69133845|FG014|Monotherapy|Lost to Follow-up|0|||
37660990|NCT02712905|69133846|FG015|Monotherapy|Lost to Follow-up|0|||
37660991|NCT02712905|69133847|FG016|Monotherapy|Lost to Follow-up|0|||
37660992|NCT02712905|69133848|FG017|Monotherapy|Lost to Follow-up|0|||
37660993|NCT02712905|69133831|FG000|Monotherapy|Physician Decision|1|||
37660994|NCT02712905|69133832|FG001|Monotherapy|Physician Decision|0|||
37660995|NCT02712905|69133833|FG002|Monotherapy|Physician Decision|0|||
37660996|NCT02712905|69133834|FG003|Monotherapy|Physician Decision|1|||
37660997|NCT02712905|69133835|FG004|Monotherapy|Physician Decision|0|||
37660998|NCT02712905|69133836|FG005|Monotherapy|Physician Decision|0|||
37660999|NCT02712905|69133837|FG006|Monotherapy|Physician Decision|0|||
37661000|NCT02712905|69133838|FG007|Monotherapy|Physician Decision|0|||
37661001|NCT02712905|69133839|FG008|Monotherapy|Physician Decision|0|||
37661002|NCT02712905|69133840|FG009|Monotherapy|Physician Decision|1|||
37661003|NCT02712905|69133841|FG010|Monotherapy|Physician Decision|0|||
37661004|NCT02712905|69133842|FG011|Monotherapy|Physician Decision|0|||
37661005|NCT02712905|69133843|FG012|Monotherapy|Physician Decision|0|||
37661006|NCT02712905|69133844|FG013|Monotherapy|Physician Decision|0|||
37661007|NCT02712905|69133845|FG014|Monotherapy|Physician Decision|0|||
37661008|NCT02712905|69133846|FG015|Monotherapy|Physician Decision|0|||
37661009|NCT02712905|69133847|FG016|Monotherapy|Physician Decision|0|||
37661010|NCT02712905|69133848|FG017|Monotherapy|Physician Decision|0|||
37661011|NCT02712905|69133831|FG000|Monotherapy|Study Terminated by Sponsor|0|||
37661012|NCT02712905|69133832|FG001|Monotherapy|Study Terminated by Sponsor|0|||
37661013|NCT02712905|69133833|FG002|Monotherapy|Study Terminated by Sponsor|0|||
37661014|NCT02712905|69133834|FG003|Monotherapy|Study Terminated by Sponsor|0|||
37661015|NCT02712905|69133835|FG004|Monotherapy|Study Terminated by Sponsor|1|||
37661016|NCT02712905|69133836|FG005|Monotherapy|Study Terminated by Sponsor|0|||
37661017|NCT02712905|69133837|FG006|Monotherapy|Study Terminated by Sponsor|0|||
37661018|NCT02712905|69133838|FG007|Monotherapy|Study Terminated by Sponsor|0|||
37661019|NCT02712905|69133839|FG008|Monotherapy|Study Terminated by Sponsor|0|||
37661020|NCT02712905|69133840|FG009|Monotherapy|Study Terminated by Sponsor|2|||
37661021|NCT02712905|69133841|FG010|Monotherapy|Study Terminated by Sponsor|0|||
37661022|NCT02712905|69133842|FG011|Monotherapy|Study Terminated by Sponsor|0|||
37661023|NCT02712905|69133843|FG012|Monotherapy|Study Terminated by Sponsor|0|||
37661024|NCT02712905|69133844|FG013|Monotherapy|Study Terminated by Sponsor|0|||
37661025|NCT02712905|69133845|FG014|Monotherapy|Study Terminated by Sponsor|0|||
37661026|NCT02712905|69133846|FG015|Monotherapy|Study Terminated by Sponsor|0|||
37661027|NCT02712905|69133847|FG016|Monotherapy|Study Terminated by Sponsor|0|||
37661028|NCT02712905|69133848|FG017|Monotherapy|Study Terminated by Sponsor|0|||
37661029|NCT02712905|69133831|FG000|Monotherapy|Withdrawal by Subject|0|||
37661030|NCT02712905|69133832|FG001|Monotherapy|Withdrawal by Subject|0|||
37661031|NCT02712905|69133833|FG002|Monotherapy|Withdrawal by Subject|1|||
37661032|NCT02712905|69133834|FG003|Monotherapy|Withdrawal by Subject|0|||
37661033|NCT02712905|69133835|FG004|Monotherapy|Withdrawal by Subject|2|||
37661034|NCT02712905|69133836|FG005|Monotherapy|Withdrawal by Subject|0|||
37661035|NCT02712905|69133837|FG006|Monotherapy|Withdrawal by Subject|0|||
37661036|NCT02712905|69133838|FG007|Monotherapy|Withdrawal by Subject|0|||
37661037|NCT02712905|69133839|FG008|Monotherapy|Withdrawal by Subject|0|||
37661038|NCT02712905|69133840|FG009|Monotherapy|Withdrawal by Subject|4|||
37661039|NCT02712905|69133841|FG010|Monotherapy|Withdrawal by Subject|1|||
37661040|NCT02712905|69133842|FG011|Monotherapy|Withdrawal by Subject|2|||
37661041|NCT02712905|69133843|FG012|Monotherapy|Withdrawal by Subject|0|||
37661042|NCT02712905|69133844|FG013|Monotherapy|Withdrawal by Subject|0|||
37661043|NCT02712905|69133845|FG014|Monotherapy|Withdrawal by Subject|0|||
37661044|NCT02712905|69133846|FG015|Monotherapy|Withdrawal by Subject|0|||
37661045|NCT02712905|69133847|FG016|Monotherapy|Withdrawal by Subject|0|||
37661046|NCT02712905|69133848|FG017|Monotherapy|Withdrawal by Subject|0|||
37661047|NCT02712905|69133831|FG000|Monotherapy|Started New Cancer Drug|0|||
37661048|NCT02712905|69133832|FG001|Monotherapy|Started New Cancer Drug|0|||
37661049|NCT02712905|69133833|FG002|Monotherapy|Started New Cancer Drug|0|||
37661050|NCT02712905|69133834|FG003|Monotherapy|Started New Cancer Drug|0|||
37661051|NCT02712905|69133835|FG004|Monotherapy|Started New Cancer Drug|0|||
37661052|NCT02712905|69133836|FG005|Monotherapy|Started New Cancer Drug|1|||
37661053|NCT02712905|69133837|FG006|Monotherapy|Started New Cancer Drug|0|||
37661054|NCT02712905|69133838|FG007|Monotherapy|Started New Cancer Drug|0|||
37661055|NCT02712905|69133839|FG008|Monotherapy|Started New Cancer Drug|0|||
37661056|NCT02712905|69133840|FG009|Monotherapy|Started New Cancer Drug|0|||
37661057|NCT02712905|69133841|FG010|Monotherapy|Started New Cancer Drug|0|||
37661058|NCT02712905|69133842|FG011|Monotherapy|Started New Cancer Drug|0|||
37661059|NCT02712905|69133843|FG012|Monotherapy|Started New Cancer Drug|0|||
37661060|NCT02712905|69133844|FG013|Monotherapy|Started New Cancer Drug|0|||
37661061|NCT02712905|69133845|FG014|Monotherapy|Started New Cancer Drug|0|||
37661062|NCT02712905|69133846|FG015|Monotherapy|Started New Cancer Drug|0|||
37661063|NCT02712905|69133847|FG016|Monotherapy|Started New Cancer Drug|0|||
37661064|NCT02712905|69133848|FG017|Monotherapy|Started New Cancer Drug|0|||
37661065|NCT02712905|69133831|FG000|Monotherapy|Adverse Event|0|||
37661066|NCT02712905|69133832|FG001|Monotherapy|Adverse Event|0|||
37661067|NCT02712905|69133833|FG002|Monotherapy|Adverse Event|0|||
37661068|NCT02712905|69133834|FG003|Monotherapy|Adverse Event|0|||
37661069|NCT02712905|69133835|FG004|Monotherapy|Adverse Event|0|||
37661070|NCT02712905|69133836|FG005|Monotherapy|Adverse Event|0|||
37661071|NCT02712905|69133837|FG006|Monotherapy|Adverse Event|0|||
37661072|NCT02712905|69133838|FG007|Monotherapy|Adverse Event|0|||
37661073|NCT02712905|69133839|FG008|Monotherapy|Adverse Event|1|||
37661074|NCT02712905|69133840|FG009|Monotherapy|Adverse Event|0|||
37661075|NCT02712905|69133841|FG010|Monotherapy|Adverse Event|0|||
37661076|NCT02712905|69133842|FG011|Monotherapy|Adverse Event|0|||
37661077|NCT02712905|69133843|FG012|Monotherapy|Adverse Event|0|||
37661078|NCT02712905|69133844|FG013|Monotherapy|Adverse Event|0|||
37661079|NCT02712905|69133845|FG014|Monotherapy|Adverse Event|0|||
37661080|NCT02712905|69133846|FG015|Monotherapy|Adverse Event|0|||
37661081|NCT02712905|69133847|FG016|Monotherapy|Adverse Event|0|||
37661082|NCT02712905|69133848|FG017|Monotherapy|Adverse Event|0|||
37661083|NCT02712905|69133831|FG000|Combination Therapy|Death|0|||
37661084|NCT02712905|69133832|FG001|Combination Therapy|Death|0|||
37661085|NCT02712905|69133833|FG002|Combination Therapy|Death|0|||
37661086|NCT02712905|69133834|FG003|Combination Therapy|Death|0|||
37661087|NCT02712905|69133835|FG004|Combination Therapy|Death|0|||
37661088|NCT02712905|69133836|FG005|Combination Therapy|Death|0|||
37661089|NCT02712905|69133837|FG006|Combination Therapy|Death|0|||
37661090|NCT02712905|69133838|FG007|Combination Therapy|Death|0|||
37661091|NCT02712905|69133839|FG008|Combination Therapy|Death|0|||
37661092|NCT02712905|69133840|FG009|Combination Therapy|Death|0|||
37661093|NCT02712905|69133841|FG010|Combination Therapy|Death|0|||
37661094|NCT02712905|69133842|FG011|Combination Therapy|Death|0|||
37661095|NCT02712905|69133843|FG012|Combination Therapy|Death|5|||
37661096|NCT02712905|69133844|FG013|Combination Therapy|Death|6|||
37661097|NCT02712905|69133845|FG014|Combination Therapy|Death|1|||
37661098|NCT02712905|69133846|FG015|Combination Therapy|Death|3|||
37661099|NCT02712905|69133847|FG016|Combination Therapy|Death|1|||
37661100|NCT02712905|69133848|FG017|Combination Therapy|Death|3|||
37661101|NCT02712905|69133831|FG000|Combination Therapy|Study Terminated by Sponsor|0|||
37661102|NCT02712905|69133832|FG001|Combination Therapy|Study Terminated by Sponsor|0|||
37661103|NCT02712905|69133833|FG002|Combination Therapy|Study Terminated by Sponsor|0|||
37661104|NCT02712905|69133834|FG003|Combination Therapy|Study Terminated by Sponsor|0|||
37661105|NCT02712905|69133835|FG004|Combination Therapy|Study Terminated by Sponsor|0|||
37661106|NCT02712905|69133836|FG005|Combination Therapy|Study Terminated by Sponsor|0|||
37661107|NCT02712905|69133837|FG006|Combination Therapy|Study Terminated by Sponsor|0|||
37661108|NCT02712905|69133838|FG007|Combination Therapy|Study Terminated by Sponsor|0|||
37661109|NCT02712905|69133839|FG008|Combination Therapy|Study Terminated by Sponsor|0|||
37661110|NCT02712905|69133840|FG009|Combination Therapy|Study Terminated by Sponsor|0|||
37661111|NCT02712905|69133841|FG010|Combination Therapy|Study Terminated by Sponsor|0|||
37661112|NCT02712905|69133842|FG011|Combination Therapy|Study Terminated by Sponsor|0|||
37661113|NCT02712905|69133843|FG012|Combination Therapy|Study Terminated by Sponsor|0|||
37661114|NCT02712905|69133844|FG013|Combination Therapy|Study Terminated by Sponsor|1|||
37661115|NCT02712905|69133845|FG014|Combination Therapy|Study Terminated by Sponsor|0|||
37661116|NCT02712905|69133846|FG015|Combination Therapy|Study Terminated by Sponsor|2|||
37661117|NCT02712905|69133847|FG016|Combination Therapy|Study Terminated by Sponsor|0|||
37661118|NCT02712905|69133848|FG017|Combination Therapy|Study Terminated by Sponsor|1|||
37661119|NCT02712905|69133831|FG000|Combination Therapy|Withdrawal by Subject|0|||
37661120|NCT02712905|69133832|FG001|Combination Therapy|Withdrawal by Subject|0|||
37661121|NCT02712905|69133833|FG002|Combination Therapy|Withdrawal by Subject|0|||
37661122|NCT02712905|69133834|FG003|Combination Therapy|Withdrawal by Subject|0|||
37661123|NCT02712905|69133835|FG004|Combination Therapy|Withdrawal by Subject|0|||
37661124|NCT02712905|69133836|FG005|Combination Therapy|Withdrawal by Subject|0|||
37661125|NCT02712905|69133837|FG006|Combination Therapy|Withdrawal by Subject|0|||
37661126|NCT02712905|69133838|FG007|Combination Therapy|Withdrawal by Subject|0|||
37661127|NCT02712905|69133839|FG008|Combination Therapy|Withdrawal by Subject|0|||
37661128|NCT02712905|69133840|FG009|Combination Therapy|Withdrawal by Subject|0|||
37661129|NCT02712905|69133841|FG010|Combination Therapy|Withdrawal by Subject|0|||
37661130|NCT02712905|69133842|FG011|Combination Therapy|Withdrawal by Subject|0|||
37661131|NCT02712905|69133843|FG012|Combination Therapy|Withdrawal by Subject|0|||
37661132|NCT02712905|69133844|FG013|Combination Therapy|Withdrawal by Subject|0|||
37661133|NCT02712905|69133845|FG014|Combination Therapy|Withdrawal by Subject|0|||
37661134|NCT02712905|69133846|FG015|Combination Therapy|Withdrawal by Subject|1|||
37661135|NCT02712905|69133847|FG016|Combination Therapy|Withdrawal by Subject|0|||
37661136|NCT02712905|69133848|FG017|Combination Therapy|Withdrawal by Subject|2|||
37661137|NCT02712905|69133831|FG000|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
37661138|NCT02712905|69133832|FG001|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
37661139|NCT02712905|69133833|FG002|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
37661140|NCT02712905|69133834|FG003|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
37661141|NCT02712905|69133835|FG004|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
37661142|NCT02712905|69133836|FG005|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
37661143|NCT02712905|69133837|FG006|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
37661144|NCT02712905|69133838|FG007|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
37661145|NCT02712905|69133839|FG008|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
37661146|NCT02712905|69133840|FG009|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
37661147|NCT02712905|69133841|FG010|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
37661148|NCT02712905|69133842|FG011|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
37750904|NCT01831817|69248108|FG003|Overall Study|Withdrawl of Consent|0|||
37750905|NCT01840943|69248133|FG000|Overall Study|Withdrawal by Subject|5|||
37750906|NCT01840943|69248134|FG001|Overall Study|Withdrawal by Subject|6|||
37661149|NCT02712905|69133843|FG012|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
37661150|NCT02712905|69133844|FG013|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
37661151|NCT02712905|69133845|FG014|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
37661152|NCT02712905|69133846|FG015|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|1|||
37661153|NCT02712905|69133847|FG016|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
37661154|NCT02712905|69133848|FG017|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
37661155|NCT03776357|69133886|FG000|Overall Study|Lost to Follow-up|3|||
37661156|NCT04520997|69133892|FG000|Overall Study|Lost to Follow-up|1|||
37661157|NCT04520997|69133893|FG001|Overall Study|Lost to Follow-up|1|||
37661158|NCT04520997|69133892|FG000|Overall Study|Withdrawal by Subject|1|||
37661159|NCT04520997|69133893|FG001|Overall Study|Withdrawal by Subject|0|||
37661160|NCT04520997|69133892|FG000|Overall Study|Not Treated|0|||
37661161|NCT04520997|69133893|FG001|Overall Study|Not Treated|1|||
37661166|NCT02734433|69133925|FG000|Overall Study|Disease progression|1|||
37661167|NCT02734433|69133926|FG001|Overall Study|Disease progression|5|||
37661168|NCT02734433|69133925|FG000|Overall Study|Clinical progression|0|||
37661169|NCT02734433|69133926|FG001|Overall Study|Clinical progression|1|||
37661170|NCT02734433|69133925|FG000|Overall Study|Withdrawal by Subject|1|||
37661171|NCT02734433|69133926|FG001|Overall Study|Withdrawal by Subject|2|||
37661172|NCT02452424|69133952|FG000|Overall Study|Death|2|||
37661173|NCT02452424|69133953|FG001|Overall Study|Death|2|||
37661174|NCT02452424|69133954|FG002|Overall Study|Death|2|||
37661175|NCT02452424|69133955|FG003|Overall Study|Death|6|||
37661176|NCT02452424|69133956|FG004|Overall Study|Death|2|||
37661177|NCT02452424|69133957|FG005|Overall Study|Death|0|||
37661178|NCT02452424|69133958|FG006|Overall Study|Death|5|||
37661179|NCT02452424|69133959|FG007|Overall Study|Death|1|||
37661180|NCT02452424|69133960|FG008|Overall Study|Death|3|||
37661181|NCT02452424|69133961|FG009|Overall Study|Death|1|||
37661182|NCT02452424|69133962|FG010|Overall Study|Death|0|||
37661183|NCT02452424|69133952|FG000|Overall Study|Lost to Follow-up|0|||
37661184|NCT02452424|69133953|FG001|Overall Study|Lost to Follow-up|1|||
37661185|NCT02452424|69133954|FG002|Overall Study|Lost to Follow-up|1|||
37661186|NCT02452424|69133955|FG003|Overall Study|Lost to Follow-up|0|||
37661187|NCT02452424|69133956|FG004|Overall Study|Lost to Follow-up|0|||
37661188|NCT02452424|69133957|FG005|Overall Study|Lost to Follow-up|0|||
37661189|NCT02452424|69133958|FG006|Overall Study|Lost to Follow-up|0|||
37661190|NCT02452424|69133959|FG007|Overall Study|Lost to Follow-up|0|||
37750907|NCT01840943|69248133|FG000|Overall Study|Physician Decision|4|||
37750908|NCT01840943|69248134|FG001|Overall Study|Physician Decision|2|||
37750909|NCT01840943|69248133|FG000|Overall Study|Lost to Follow-up|4|||
37750910|NCT01840943|69248134|FG001|Overall Study|Lost to Follow-up|4|||
37750911|NCT01840163|69248142|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
37750912|NCT01840163|69248143|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
37750913|NCT01840163|69248142|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
37750914|NCT01840163|69248143|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
37750915|NCT01840163|69248142|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
37750916|NCT01840163|69248143|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
37750917|NCT01831427|69248296|FG000|Overall Study|Adverse Event|0|||
37750918|NCT01831427|69248297|FG001|Overall Study|Adverse Event|1|||
37750919|NCT01831427|69248298|FG002|Overall Study|Adverse Event|0|||
37750920|NCT01831427|69248299|FG003|Overall Study|Adverse Event|0|||
37750921|NCT01831427|69248300|FG004|Overall Study|Adverse Event|0|||
37856783|NCT01208181|69539968|FG000|Part 2|Adverse Event|0|||
37856784|NCT01208181|69539969|FG001|Part 2|Adverse Event|0|||
37856785|NCT01208181|69539970|FG002|Part 2|Adverse Event|6|||
37856786|NCT01208181|69539971|FG003|Part 2|Adverse Event|7|||
37856787|NCT01208181|69539972|FG004|Part 2|Adverse Event|0|||
37661191|NCT02452424|69133960|FG008|Overall Study|Lost to Follow-up|0|||
37661192|NCT02452424|69133961|FG009|Overall Study|Lost to Follow-up|0|||
37661193|NCT02452424|69133962|FG010|Overall Study|Lost to Follow-up|0|||
37661194|NCT02452424|69133952|FG000|Overall Study|Withdrawal by Subject|0|||
37661195|NCT02452424|69133953|FG001|Overall Study|Withdrawal by Subject|0|||
37661196|NCT02452424|69133954|FG002|Overall Study|Withdrawal by Subject|3|||
37750922|NCT01831427|69248301|FG005|Overall Study|Adverse Event|1|||
37750923|NCT01831427|69248302|FG006|Overall Study|Adverse Event|0|||
37750924|NCT01831427|69248303|FG007|Overall Study|Adverse Event|1|||
37750925|NCT01831427|69248304|FG008|Overall Study|Adverse Event|0|||
37750926|NCT01831427|69248305|FG009|Overall Study|Adverse Event|0|||
37856788|NCT01208181|69539968|FG000|Part 2|Withdrawal by Subject|0|||
37856789|NCT01208181|69539969|FG001|Part 2|Withdrawal by Subject|0|||
37750927|NCT01831427|69248306|FG010|Overall Study|Adverse Event|2|||
37750928|NCT01831427|69248296|FG000|Overall Study|Investigator's Discretion|0|||
37750929|NCT01831427|69248297|FG001|Overall Study|Investigator's Discretion|0|||
37750930|NCT01831427|69248298|FG002|Overall Study|Investigator's Discretion|0|||
37750931|NCT01831427|69248299|FG003|Overall Study|Investigator's Discretion|1|||
37750932|NCT01831427|69248300|FG004|Overall Study|Investigator's Discretion|0|||
37750933|NCT01831427|69248301|FG005|Overall Study|Investigator's Discretion|0|||
37750934|NCT01831427|69248302|FG006|Overall Study|Investigator's Discretion|0|||
37750935|NCT01831427|69248303|FG007|Overall Study|Investigator's Discretion|0|||
37750936|NCT01831427|69248304|FG008|Overall Study|Investigator's Discretion|0|||
37750937|NCT01831427|69248305|FG009|Overall Study|Investigator's Discretion|0|||
37750938|NCT01831427|69248306|FG010|Overall Study|Investigator's Discretion|0|||
37750939|NCT01831427|69248296|FG000|Overall Study|Withdrew Consent|0|||
37750940|NCT01831427|69248297|FG001|Overall Study|Withdrew Consent|0|||
37750941|NCT01831427|69248298|FG002|Overall Study|Withdrew Consent|0|||
37750942|NCT01831427|69248299|FG003|Overall Study|Withdrew Consent|0|||
37750943|NCT01831427|69248300|FG004|Overall Study|Withdrew Consent|0|||
37661197|NCT02452424|69133955|FG003|Overall Study|Withdrawal by Subject|2|||
37661198|NCT02452424|69133956|FG004|Overall Study|Withdrawal by Subject|0|||
37661199|NCT02452424|69133957|FG005|Overall Study|Withdrawal by Subject|0|||
37661200|NCT02452424|69133958|FG006|Overall Study|Withdrawal by Subject|1|||
37661201|NCT02452424|69133959|FG007|Overall Study|Withdrawal by Subject|0|||
37661202|NCT02452424|69133960|FG008|Overall Study|Withdrawal by Subject|1|||
37661203|NCT02452424|69133961|FG009|Overall Study|Withdrawal by Subject|1|||
37661204|NCT02452424|69133962|FG010|Overall Study|Withdrawal by Subject|0|||
37661205|NCT02452424|69133952|FG000|Overall Study|Other|0|||
37661206|NCT02452424|69133953|FG001|Overall Study|Other|0|||
37661207|NCT02452424|69133954|FG002|Overall Study|Other|1|||
37661208|NCT02452424|69133955|FG003|Overall Study|Other|0|||
37661209|NCT02452424|69133956|FG004|Overall Study|Other|0|||
37661210|NCT02452424|69133957|FG005|Overall Study|Other|1|||
37661211|NCT02452424|69133958|FG006|Overall Study|Other|4|||
37661212|NCT02452424|69133959|FG007|Overall Study|Other|3|||
37661213|NCT02452424|69133960|FG008|Overall Study|Other|0|||
37661214|NCT02452424|69133961|FG009|Overall Study|Other|0|||
37661215|NCT02452424|69133962|FG010|Overall Study|Other|1|||
37661216|NCT02452424|69133952|FG000|Overall Study|Progressive disease (per RECIST)|0|||
37661217|NCT02452424|69133953|FG001|Overall Study|Progressive disease (per RECIST)|0|||
37661218|NCT02452424|69133954|FG002|Overall Study|Progressive disease (per RECIST)|0|||
37661219|NCT02452424|69133955|FG003|Overall Study|Progressive disease (per RECIST)|0|||
37661220|NCT02452424|69133956|FG004|Overall Study|Progressive disease (per RECIST)|0|||
37661221|NCT02452424|69133957|FG005|Overall Study|Progressive disease (per RECIST)|0|||
37661222|NCT02452424|69133958|FG006|Overall Study|Progressive disease (per RECIST)|0|||
37661223|NCT02452424|69133959|FG007|Overall Study|Progressive disease (per RECIST)|0|||
37661224|NCT02452424|69133960|FG008|Overall Study|Progressive disease (per RECIST)|2|||
37661225|NCT02452424|69133961|FG009|Overall Study|Progressive disease (per RECIST)|0|||
37661226|NCT02452424|69133962|FG010|Overall Study|Progressive disease (per RECIST)|0|||
37661227|NCT02452424|69133952|FG000|Overall Study|Adverse Event|0|||
37661228|NCT02452424|69133953|FG001|Overall Study|Adverse Event|0|||
37661229|NCT02452424|69133954|FG002|Overall Study|Adverse Event|0|||
37661230|NCT02452424|69133955|FG003|Overall Study|Adverse Event|0|||
37661231|NCT02452424|69133956|FG004|Overall Study|Adverse Event|0|||
37661232|NCT02452424|69133957|FG005|Overall Study|Adverse Event|0|||
37661233|NCT02452424|69133958|FG006|Overall Study|Adverse Event|0|||
37661234|NCT02452424|69133959|FG007|Overall Study|Adverse Event|0|||
37661235|NCT02452424|69133960|FG008|Overall Study|Adverse Event|0|||
37661236|NCT02452424|69133961|FG009|Overall Study|Adverse Event|0|||
37661237|NCT02452424|69133962|FG010|Overall Study|Adverse Event|1|||
37661238|NCT02419508|69133990|FG000|Overall Study|Adverse Event|9|||
37750944|NCT01831427|69248301|FG005|Overall Study|Withdrew Consent|0|||
37750945|NCT01831427|69248302|FG006|Overall Study|Withdrew Consent|2|||
37750946|NCT01831427|69248303|FG007|Overall Study|Withdrew Consent|0|||
37750947|NCT01831427|69248304|FG008|Overall Study|Withdrew Consent|0|||
37750948|NCT01831427|69248305|FG009|Overall Study|Withdrew Consent|1|||
37750949|NCT01831427|69248306|FG010|Overall Study|Withdrew Consent|1|||
37856790|NCT01208181|69539970|FG002|Part 2|Withdrawal by Subject|1|||
37661239|NCT02419508|69133991|FG001|Overall Study|Adverse Event|3|||
37661240|NCT02419508|69133990|FG000|Overall Study|Withdrawal by Subject|1|||
37661241|NCT02419508|69133991|FG001|Overall Study|Withdrawal by Subject|0|||
37661242|NCT02419508|69133990|FG000|Overall Study|Other - Reason not specified|0|||
37661243|NCT02419508|69133991|FG001|Overall Study|Other - Reason not specified|1|||
37856791|NCT01208181|69539971|FG003|Part 2|Withdrawal by Subject|1|||
37661244|NCT01328249|69133999|FG000|Overall Study|Adverse Event|3|||
37661245|NCT01328249|69134000|FG001|Overall Study|Adverse Event|0|||
37661246|NCT01328249|69133999|FG000|Overall Study|Disease progression|1|||
37661247|NCT01328249|69134000|FG001|Overall Study|Disease progression|0|||
37750950|NCT01830881|69248352|FG000|Overall Study|Changed decision to have an abortion|0|||
37750951|NCT01830881|69248353|FG001|Overall Study|Changed decision to have an abortion|1|||
37661248|NCT01328249|69133999|FG000|Overall Study|Withdrawal by Subject|1|||
37661249|NCT01328249|69134000|FG001|Overall Study|Withdrawal by Subject|1|||
37661250|NCT01328249|69133999|FG000|Overall Study|Moved before end of treatment visit|1|||
37661251|NCT01328249|69134000|FG001|Overall Study|Moved before end of treatment visit|0|||
37661252|NCT01328249|69133999|FG000|Overall Study|Subject choice|1|||
37661253|NCT01328249|69134000|FG001|Overall Study|Subject choice|1|||
37750952|NCT01838681|69248389|FG000|Period A|Adverse Event|39|||
37750953|NCT01838681|69248390|FG001|Period A|Adverse Event|0|||
37750954|NCT01838681|69248391|FG002|Period A|Adverse Event|0|||
37750955|NCT01838681|69248392|FG003|Period A|Adverse Event|0|||
37750956|NCT01838681|69248389|FG000|Period A|Lack of Efficacy|21|||
37750957|NCT01838681|69248390|FG001|Period A|Lack of Efficacy|0|||
37750958|NCT01838681|69248391|FG002|Period A|Lack of Efficacy|0|||
37750959|NCT01838681|69248392|FG003|Period A|Lack of Efficacy|0|||
37750960|NCT01838681|69248389|FG000|Period A|Early response|148|||
37750961|NCT01838681|69248390|FG001|Period A|Early response|0|||
37750962|NCT01838681|69248391|FG002|Period A|Early response|0|||
37750963|NCT01838681|69248392|FG003|Period A|Early response|0|||
37750964|NCT01838681|69248389|FG000|Period A|Withdrawal by Subject|70|||
37750965|NCT01838681|69248390|FG001|Period A|Withdrawal by Subject|0|||
37750966|NCT01838681|69248391|FG002|Period A|Withdrawal by Subject|0|||
37750967|NCT01838681|69248392|FG003|Period A|Withdrawal by Subject|0|||
37750968|NCT01838681|69248389|FG000|Period A|Protocol Violation|16|||
37750969|NCT01838681|69248390|FG001|Period A|Protocol Violation|0|||
37750970|NCT01838681|69248391|FG002|Period A|Protocol Violation|0|||
37750971|NCT01838681|69248392|FG003|Period A|Protocol Violation|0|||
37750972|NCT01838681|69248389|FG000|Period A|Non-compliance with IMP|6|||
37750973|NCT01838681|69248390|FG001|Period A|Non-compliance with IMP|0|||
37750974|NCT01838681|69248391|FG002|Period A|Non-compliance with IMP|0|||
37750975|NCT01838681|69248392|FG003|Period A|Non-compliance with IMP|0|||
37750976|NCT01838681|69248389|FG000|Period A|Lost to Follow-up|4|||
37750977|NCT01838681|69248390|FG001|Period A|Lost to Follow-up|0|||
37750978|NCT01838681|69248391|FG002|Period A|Lost to Follow-up|0|||
37750979|NCT01838681|69248392|FG003|Period A|Lost to Follow-up|0|||
37750980|NCT01838681|69248389|FG000|Period A|Withdrawal before treatment|4|||
37750981|NCT01838681|69248390|FG001|Period A|Withdrawal before treatment|0|||
37750982|NCT01838681|69248391|FG002|Period A|Withdrawal before treatment|0|||
37750983|NCT01838681|69248392|FG003|Period A|Withdrawal before treatment|0|||
37750984|NCT01838681|69248389|FG000|Period A|Administrative or other reasons|17|||
37750985|NCT01838681|69248390|FG001|Period A|Administrative or other reasons|0|||
37750986|NCT01838681|69248391|FG002|Period A|Administrative or other reasons|0|||
37750987|NCT01838681|69248392|FG003|Period A|Administrative or other reasons|0|||
37661254|NCT01328249|69133999|FG000|Overall Study|Protocol Violation|0|||
37661255|NCT01328249|69134000|FG001|Overall Study|Protocol Violation|1|||
37661256|NCT01651052|69134008|FG000|Overall Study|Death|21|||
37661257|NCT01651052|69134008|FG000|Overall Study|Explant|1|||
37661258|NCT01651052|69134008|FG000|Overall Study|Withdrawal by Subject|1|||
37661259|NCT01651052|69134008|FG000|Overall Study|Lost to Follow-up|3|||
37661260|NCT02388074|69134012|FG000|Overall Study|Lost in Transit|2|||
37661261|NCT02388074|69134012|FG000|Overall Study|Sample Not Returned|1|||
37661262|NCT01602549|69134018|FG000|Overall Study|Protocol Violation|0|||
37661263|NCT01602549|69134019|FG001|Overall Study|Protocol Violation|1|||
37661264|NCT01602549|69134018|FG000|Overall Study|Withdrawal by Subject|1|||
37661265|NCT01602549|69134019|FG001|Overall Study|Withdrawal by Subject|0|||
37661266|NCT02427464|69134029|FG000|Overall Study|Adverse Event|6|||
37661267|NCT02427464|69134030|FG001|Overall Study|Adverse Event|1|||
37661268|NCT02427464|69134029|FG000|Overall Study|Lost to Follow-up|16|||
37661269|NCT02427464|69134030|FG001|Overall Study|Lost to Follow-up|5|||
37661270|NCT02427464|69134029|FG000|Overall Study|Physician Decision|2|||
37661271|NCT02427464|69134030|FG001|Overall Study|Physician Decision|0|||
37750988|NCT01838681|69248389|FG000|Period B/A+|Adverse Event|0|||
37750989|NCT01838681|69248390|FG001|Period B/A+|Adverse Event|13|||
37750990|NCT01838681|69248391|FG002|Period B/A+|Adverse Event|27|||
37750991|NCT01838681|69248392|FG003|Period B/A+|Adverse Event|16|||
37750992|NCT01838681|69248389|FG000|Period B/A+|Lack of Efficacy|0|||
37750993|NCT01838681|69248390|FG001|Period B/A+|Lack of Efficacy|9|||
37750994|NCT01838681|69248391|FG002|Period B/A+|Lack of Efficacy|11|||
37750995|NCT01838681|69248392|FG003|Period B/A+|Lack of Efficacy|6|||
37750996|NCT01838681|69248389|FG000|Period B/A+|Withdrawal by Subject|0|||
37661272|NCT02427464|69134029|FG000|Overall Study|Withdrawal by Subject|10|||
37661273|NCT02427464|69134030|FG001|Overall Study|Withdrawal by Subject|8|||
37661274|NCT02427464|69134029|FG000|Overall Study|Noncompliance|16|||
37661275|NCT02427464|69134030|FG001|Overall Study|Noncompliance|10|||
37661276|NCT02426918|69134039|FG000|Overall Study|Adverse Event|2|||
37750997|NCT01838681|69248390|FG001|Period B/A+|Withdrawal by Subject|28|||
37750998|NCT01838681|69248391|FG002|Period B/A+|Withdrawal by Subject|35|||
37750999|NCT01838681|69248392|FG003|Period B/A+|Withdrawal by Subject|47|||
37751000|NCT01838681|69248389|FG000|Period B/A+|Protocol Violation|0|||
37751001|NCT01838681|69248390|FG001|Period B/A+|Protocol Violation|1|||
37751002|NCT01838681|69248391|FG002|Period B/A+|Protocol Violation|4|||
37751003|NCT01838681|69248392|FG003|Period B/A+|Protocol Violation|6|||
37661277|NCT02426918|69134040|FG001|Overall Study|Adverse Event|2|||
37661278|NCT02426918|69134041|FG002|Overall Study|Adverse Event|0|||
37661279|NCT02426918|69134039|FG000|Overall Study|Physician Decision|1|||
37661280|NCT02426918|69134040|FG001|Overall Study|Physician Decision|1|||
37661281|NCT02426918|69134041|FG002|Overall Study|Physician Decision|1|||
37661282|NCT02426918|69134039|FG000|Overall Study|Withdrawal by Subject|5|||
37661283|NCT02426918|69134040|FG001|Overall Study|Withdrawal by Subject|5|||
37661284|NCT02426918|69134041|FG002|Overall Study|Withdrawal by Subject|4|||
37661285|NCT02426918|69134039|FG000|Overall Study|Other|9|||
37661286|NCT02426918|69134040|FG001|Overall Study|Other|11|||
37661287|NCT02426918|69134041|FG002|Overall Study|Other|9|||
37661288|NCT02387840|69134055|FG000|Overall Study|Death|0|||
37661289|NCT02387840|69134056|FG001|Overall Study|Death|0|||
37661290|NCT02387840|69134057|FG002|Overall Study|Death|0|||
37661291|NCT02387840|69134058|FG003|Overall Study|Death|0|||
37661292|NCT02387840|69134059|FG004|Overall Study|Death|0|||
37661293|NCT02387840|69134060|FG005|Overall Study|Death|1|||
37661294|NCT02387762|69134082|FG000|Overall Study|Withdrawal by Subject|1|||
37661295|NCT02387762|69134083|FG001|Overall Study|Withdrawal by Subject|0|||
37661296|NCT02418182|69134091|FG000|Overall Study|Unable to re-consent|18|||
37661297|NCT02418182|69134092|FG001|Overall Study|Unable to re-consent|15|||
37661298|NCT02418182|69134091|FG000|Overall Study|Lost to Follow-up|0|||
37751004|NCT01838681|69248389|FG000|Period B/A+|Non-compliance with IMP|0|||
37751005|NCT01838681|69248390|FG001|Period B/A+|Non-compliance with IMP|2|||
37751006|NCT01838681|69248391|FG002|Period B/A+|Non-compliance with IMP|3|||
37751007|NCT01838681|69248392|FG003|Period B/A+|Non-compliance with IMP|3|||
37751008|NCT01838681|69248389|FG000|Period B/A+|Lost to Follow-up|0|||
37751009|NCT01838681|69248390|FG001|Period B/A+|Lost to Follow-up|2|||
37751010|NCT01838681|69248391|FG002|Period B/A+|Lost to Follow-up|5|||
37751011|NCT01838681|69248392|FG003|Period B/A+|Lost to Follow-up|11|||
37751012|NCT01838681|69248389|FG000|Period B/A+|Withdrawal before treatment|0|||
37751013|NCT01838681|69248390|FG001|Period B/A+|Withdrawal before treatment|1|||
37751014|NCT01838681|69248391|FG002|Period B/A+|Withdrawal before treatment|0|||
37751015|NCT01838681|69248392|FG003|Period B/A+|Withdrawal before treatment|0|||
37751016|NCT01838681|69248389|FG000|Period B/A+|Administrative or other reasons|0|||
37751017|NCT01838681|69248390|FG001|Period B/A+|Administrative or other reasons|6|||
37751018|NCT01838681|69248391|FG002|Period B/A+|Administrative or other reasons|10|||
37751019|NCT01838681|69248392|FG003|Period B/A+|Administrative or other reasons|28|||
37751020|NCT01611857|69248450|FG000|Overall Study|Withdrawal by Subject|0|||
37751021|NCT01611857|69248451|FG001|Overall Study|Withdrawal by Subject|2|||
37751022|NCT01829477|69248474|FG000|Overall Study|Study Terminated by Sponsor|15|||
37751023|NCT01829477|69248475|FG001|Overall Study|Study Terminated by Sponsor|15|||
37751024|NCT01829477|69248474|FG000|Overall Study|Withdrawal by Subject|1|||
37751025|NCT01829477|69248475|FG001|Overall Study|Withdrawal by Subject|0|||
37751026|NCT01611155|69248491|FG000|Overall Study|Adverse Event|1|||
37751027|NCT01611155|69248492|FG001|Overall Study|Adverse Event|1|||
37751028|NCT01611155|69248491|FG000|Overall Study|Refused further treatment|6|||
37751029|NCT01611155|69248492|FG001|Overall Study|Refused further treatment|4|||
37751030|NCT01611155|69248491|FG000|Overall Study|Disease progression|1|||
37751031|NCT01611155|69248492|FG001|Overall Study|Disease progression|0|||
37751032|NCT01611155|69248491|FG000|Overall Study|Withdrawal by Subject|1|||
37751033|NCT01611155|69248492|FG001|Overall Study|Withdrawal by Subject|0|||
37751034|NCT01611155|69248491|FG000|Overall Study|Alternative treatment|0|||
37856792|NCT01208181|69539972|FG004|Part 2|Withdrawal by Subject|0|||
37856793|NCT01208181|69539968|FG000|Part 2|Protocol Violation|0|||
37661299|NCT02418182|69134092|FG001|Overall Study|Lost to Follow-up|2|||
37661300|NCT02387372|69134113|FG000|Overall Study|Not Treated|1|||
37661301|NCT02387372|69134114|FG001|Overall Study|Not Treated|0|||
37661302|NCT02426138|69134130|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
37661303|NCT02426138|69134131|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
37661304|NCT02426684|69134144|FG000|Overall Study|Physician Decision|1|||
37661305|NCT02656173|69134150|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
37661306|NCT02656173|69134151|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
37661307|NCT02656173|69134150|FG000|Overall Study|Adverse Event|7|||
37661308|NCT02656173|69134151|FG001|Overall Study|Adverse Event|5|||
37661309|NCT02656173|69134150|FG000|Overall Study|Withdrawal by Subject|1|||
37751035|NCT01611155|69248492|FG001|Overall Study|Alternative treatment|1|||
37751036|NCT01611155|69248491|FG000|Overall Study|Ineligible patient|0|||
37751037|NCT01611155|69248492|FG001|Overall Study|Ineligible patient|1|||
37751038|NCT01829243|69248507|FG000|First Intervention|Screen Failure|4|||
37751039|NCT01829243|69248508|FG001|First Intervention|Screen Failure|2|||
37751040|NCT01838447|69248518|FG000|Overall Study|Change in surgical plan|1|||
37751041|NCT01838447|69248519|FG001|Overall Study|Change in surgical plan|2|||
37751042|NCT01838447|69248518|FG000|Overall Study|Withdrawal by Subject|1|||
37751043|NCT01838447|69248519|FG001|Overall Study|Withdrawal by Subject|1|||
37751044|NCT01829165|69248527|FG000|Overall Study|Did not complete intervention|2|||
37751045|NCT01829165|69248528|FG001|Overall Study|Did not complete intervention|0|||
37751046|NCT01838213|69248536|FG000|Overall Study|Ineligible|166|||
37661310|NCT02656173|69134151|FG001|Overall Study|Withdrawal by Subject|3|||
37661311|NCT02656173|69134150|FG000|Overall Study|Protocol Violation|0|||
37661312|NCT02656173|69134151|FG001|Overall Study|Protocol Violation|1|||
37661313|NCT02656173|69134150|FG000|Overall Study|Miscellaneous|2|||
37661314|NCT02656173|69134151|FG001|Overall Study|Miscellaneous|0|||
37661315|NCT02656017|69134161|FG000|Overall Study|Study burden|3|||
37661316|NCT02656017|69134162|FG001|Overall Study|Study burden|3|||
37661317|NCT02656017|69134161|FG000|Overall Study|Adverse Event|2|||
37661318|NCT02656017|69134162|FG001|Overall Study|Adverse Event|1|||
37661319|NCT02656017|69134161|FG000|Overall Study|Unable/unwilling to take study medication|2|||
37661320|NCT02656017|69134162|FG001|Overall Study|Unable/unwilling to take study medication|1|||
37661321|NCT02656017|69134161|FG000|Overall Study|Began Tolvaptan|1|||
37661322|NCT02656017|69134162|FG001|Overall Study|Began Tolvaptan|1|||
37661323|NCT02656017|69134161|FG000|Overall Study|Withdrawal by Subject|1|||
37661324|NCT02656017|69134162|FG001|Overall Study|Withdrawal by Subject|0|||
37661325|NCT02657343|69134174|FG000|Overall Study|Death|0|||
37661326|NCT02657343|69134175|FG001|Overall Study|Death|2|||
37661327|NCT02657343|69134176|FG002|Overall Study|Death|0|||
37661328|NCT02657343|69134177|FG003|Overall Study|Death|0|||
37661329|NCT02657343|69134178|FG004|Overall Study|Death|0|||
37661330|NCT02657343|69134179|FG005|Overall Study|Death|0|||
37661331|NCT02657343|69134174|FG000|Overall Study|Patient went to hospice|1|||
37661332|NCT02657343|69134175|FG001|Overall Study|Patient went to hospice|0|||
37661333|NCT02657343|69134176|FG002|Overall Study|Patient went to hospice|0|||
37661334|NCT02657343|69134177|FG003|Overall Study|Patient went to hospice|0|||
37661335|NCT02657343|69134178|FG004|Overall Study|Patient went to hospice|0|||
37751047|NCT01838213|69248537|FG001|Overall Study|Ineligible|191|||
37751048|NCT01837823|69248543|FG000|Overall Study|Lost to Follow-up|6|||
37751049|NCT01828073|69248553|FG000|Overall Study|Lost to Follow-up|1|||
37751050|NCT01828073|69248554|FG001|Overall Study|Lost to Follow-up|2|||
37751051|NCT03819114|69248574|FG000|Overall Study|Protocol Violation|0|||
37751052|NCT03819114|69248575|FG001|Overall Study|Protocol Violation|1|||
37751053|NCT03819114|69248576|FG002|Overall Study|Protocol Violation|1|||
37751054|NCT03819114|69248577|FG003|Overall Study|Protocol Violation|0|||
37751055|NCT03819114|69248574|FG000|Overall Study|Lost to Follow-up|0|||
37751056|NCT03819114|69248575|FG001|Overall Study|Lost to Follow-up|0|||
37751057|NCT03819114|69248576|FG002|Overall Study|Lost to Follow-up|1|||
37751058|NCT03819114|69248577|FG003|Overall Study|Lost to Follow-up|0|||
37751059|NCT01827839|69248589|FG000|Overall Study|Adverse Event|1|||
37751060|NCT01827839|69248589|FG000|Overall Study|Consent Withdrawal|2|||
37751061|NCT01827371|69248604|FG000|Overall Study|Adverse Event|0|||
37751062|NCT01827371|69248605|FG001|Overall Study|Adverse Event|0|||
37751063|NCT01827371|69248606|FG002|Overall Study|Adverse Event|4|||
37751064|NCT01827371|69248607|FG003|Overall Study|Adverse Event|2|||
37751065|NCT01827371|69248604|FG000|Overall Study|Lost to Follow-up|0|||
37751066|NCT01827371|69248605|FG001|Overall Study|Lost to Follow-up|2|||
37751067|NCT01827371|69248606|FG002|Overall Study|Lost to Follow-up|0|||
37751068|NCT01827371|69248607|FG003|Overall Study|Lost to Follow-up|4|||
37751069|NCT01827371|69248604|FG000|Overall Study|Protocol Violation|1|||
37751070|NCT01827371|69248605|FG001|Overall Study|Protocol Violation|0|||
37751071|NCT01827371|69248606|FG002|Overall Study|Protocol Violation|0|||
37751072|NCT01827371|69248607|FG003|Overall Study|Protocol Violation|0|||
37751073|NCT01827371|69248604|FG000|Overall Study|Withdrawal by Subject|1|||
37751074|NCT01827371|69248605|FG001|Overall Study|Withdrawal by Subject|2|||
37751075|NCT01827371|69248606|FG002|Overall Study|Withdrawal by Subject|2|||
37751076|NCT01827371|69248607|FG003|Overall Study|Withdrawal by Subject|3|||
37751077|NCT01827371|69248604|FG000|Overall Study|Physician Decision|0|||
37751078|NCT01827371|69248605|FG001|Overall Study|Physician Decision|1|||
37751079|NCT01827371|69248606|FG002|Overall Study|Physician Decision|0|||
37856794|NCT01208181|69539969|FG001|Part 2|Protocol Violation|0|||
37661336|NCT02657343|69134179|FG005|Overall Study|Patient went to hospice|0|||
37661337|NCT02657343|69134174|FG000|Overall Study|Withdrawal by Subject|0|||
37661338|NCT02657343|69134175|FG001|Overall Study|Withdrawal by Subject|0|||
37661339|NCT02657343|69134176|FG002|Overall Study|Withdrawal by Subject|0|||
37661340|NCT02657343|69134177|FG003|Overall Study|Withdrawal by Subject|0|||
37661341|NCT02657343|69134178|FG004|Overall Study|Withdrawal by Subject|1|||
37661342|NCT02657343|69134179|FG005|Overall Study|Withdrawal by Subject|0|||
37661343|NCT02655237|69134195|FG000|Overall Study|Adverse Event|10|||
37751080|NCT01827371|69248607|FG003|Overall Study|Physician Decision|1|||
37751081|NCT01827371|69248604|FG000|Overall Study|Temporary study halt to vaccinations|11|||
37751082|NCT01827371|69248605|FG001|Overall Study|Temporary study halt to vaccinations|2|||
37751083|NCT01827371|69248606|FG002|Overall Study|Temporary study halt to vaccinations|5|||
37751084|NCT01827371|69248607|FG003|Overall Study|Temporary study halt to vaccinations|13|||
37751085|NCT04409262|69248786|FG000|Overall Study|Adverse Event|0|||
37751086|NCT04409262|69248787|FG001|Overall Study|Adverse Event|2|||
37751087|NCT04409262|69248786|FG000|Overall Study|Death|55|||
37751088|NCT04409262|69248787|FG001|Overall Study|Death|97|||
37661344|NCT02655237|69134196|FG001|Overall Study|Adverse Event|7|||
37661345|NCT02655237|69134195|FG000|Overall Study|Protocol Deviation|2|||
37751089|NCT04409262|69248786|FG000|Overall Study|Lost to Follow-up|12|||
37751090|NCT04409262|69248787|FG001|Overall Study|Lost to Follow-up|23|||
37751091|NCT04409262|69248786|FG000|Overall Study|Lack of Staff|0|||
37751092|NCT04409262|69248787|FG001|Overall Study|Lack of Staff|1|||
37751093|NCT04409262|69248786|FG000|Overall Study|Protocol Violation|3|||
37751094|NCT04409262|69248787|FG001|Overall Study|Protocol Violation|1|||
37751095|NCT04409262|69248786|FG000|Overall Study|Withdrawal by Subject|5|||
37751096|NCT04409262|69248787|FG001|Overall Study|Withdrawal by Subject|10|||
37751097|NCT04305912|69248831|FG000|First Intervention|COVID-19 Suspension|2|||
37751098|NCT04305912|69248832|FG001|First Intervention|COVID-19 Suspension|0|||
37751099|NCT04305912|69248831|FG000|First Intervention|Withdrawal by Subject|0|||
37751100|NCT04305912|69248832|FG001|First Intervention|Withdrawal by Subject|1|||
37661346|NCT02655237|69134196|FG001|Overall Study|Protocol Deviation|0|||
37661347|NCT02655237|69134195|FG000|Overall Study|Withdrawal by Participant|1|||
37751101|NCT04305912|69248831|FG000|Second Intervention|Adverse Event|0|||
37751102|NCT04305912|69248832|FG001|Second Intervention|Adverse Event|1|||
37751103|NCT00782184|69249061|FG000|Overall Study|Adverse Event|1|||
37751104|NCT00782184|69249062|FG001|Overall Study|Adverse Event|2|||
37751105|NCT00782184|69249061|FG000|Overall Study|Protocol Violation|0|||
37751106|NCT00782184|69249062|FG001|Overall Study|Protocol Violation|1|||
37751107|NCT00782184|69249061|FG000|Overall Study|Withdrawal by Subject|3|||
37751108|NCT00782184|69249062|FG001|Overall Study|Withdrawal by Subject|2|||
37751109|NCT02731638|69249098|FG000|Overall Study|Lost to Follow-up|6|||
37751110|NCT02731638|69249099|FG001|Overall Study|Lost to Follow-up|9|||
37751111|NCT03730662|69249546|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
37751112|NCT03730662|69249547|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
37751113|NCT03730662|69249548|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
37751114|NCT03730662|69249549|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
37751115|NCT03730662|69249546|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
37751116|NCT03730662|69249547|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
37856795|NCT01208181|69539970|FG002|Part 2|Protocol Violation|1|||
37856796|NCT01208181|69539971|FG003|Part 2|Protocol Violation|0|||
37856797|NCT01208181|69539972|FG004|Part 2|Protocol Violation|0|||
37856798|NCT01208181|69539968|FG000|Part 2|Physician Decision|0|||
37856799|NCT01208181|69539969|FG001|Part 2|Physician Decision|0|||
37856800|NCT01208181|69539970|FG002|Part 2|Physician Decision|1|||
37856801|NCT01208181|69539971|FG003|Part 2|Physician Decision|2|||
37856802|NCT01208181|69539972|FG004|Part 2|Physician Decision|0|||
37856803|NCT01208181|69539968|FG000|Part 2|Non-compliance with study drug|0|||
37856804|NCT01208181|69539969|FG001|Part 2|Non-compliance with study drug|0|||
37856805|NCT01208181|69539970|FG002|Part 2|Non-compliance with study drug|1|||
37856806|NCT01208181|69539971|FG003|Part 2|Non-compliance with study drug|1|||
37856807|NCT01208181|69539972|FG004|Part 2|Non-compliance with study drug|0|||
37856808|NCT01208181|69539968|FG000|Part 2|Lost to Follow-up|0|||
37856809|NCT01208181|69539969|FG001|Part 2|Lost to Follow-up|0|||
37856810|NCT01208181|69539970|FG002|Part 2|Lost to Follow-up|1|||
37856811|NCT01208181|69539971|FG003|Part 2|Lost to Follow-up|2|||
37856812|NCT01208181|69539972|FG004|Part 2|Lost to Follow-up|0|||
37856813|NCT01208181|69539968|FG000|Part 2|Lack of Efficacy|0|||
37856814|NCT01208181|69539969|FG001|Part 2|Lack of Efficacy|0|||
37856815|NCT01208181|69539970|FG002|Part 2|Lack of Efficacy|5|||
37856816|NCT01208181|69539971|FG003|Part 2|Lack of Efficacy|7|||
37856817|NCT01208181|69539972|FG004|Part 2|Lack of Efficacy|0|||
37856818|NCT01208103|69539989|FG000|Overall Study|Adverse Event|1|||
37856819|NCT01208103|69539989|FG000|Overall Study|Withdrawal by Subject|1|||
37856820|NCT01206777|69539994|FG000|Overall Study|Death|1|||
37856821|NCT01206777|69539994|FG000|Overall Study|Adverse Event|1|||
37661348|NCT02655237|69134196|FG001|Overall Study|Withdrawal by Participant|2|||
37661349|NCT02655237|69134195|FG000|Overall Study|Lack of Efficacy|0|||
37661350|NCT02655237|69134196|FG001|Overall Study|Lack of Efficacy|1|||
37661351|NCT02655237|69134195|FG000|Overall Study|Recovery Leading to Surgery|2|||
37661352|NCT02655237|69134196|FG001|Overall Study|Recovery Leading to Surgery|1|||
37856822|NCT01001494|69540001|FG000|Overall Study|Adverse Event|8|||
37856823|NCT01001494|69540002|FG001|Overall Study|Adverse Event|4|||
37856824|NCT01001494|69540003|FG002|Overall Study|Adverse Event|6|||
37856825|NCT01001494|69540001|FG000|Overall Study|Protocol Violation|0|||
37856826|NCT01001494|69540002|FG001|Overall Study|Protocol Violation|1|||
37856827|NCT01001494|69540003|FG002|Overall Study|Protocol Violation|1|||
37661353|NCT02655237|69134195|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
37751117|NCT03730662|69249548|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
37856828|NCT01001494|69540001|FG000|Overall Study|Lost to Follow-up|2|||
37856829|NCT01001494|69540002|FG001|Overall Study|Lost to Follow-up|0|||
37856830|NCT01001494|69540003|FG002|Overall Study|Lost to Follow-up|1|||
37751118|NCT03730662|69249549|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
37751119|NCT03730662|69249546|FG000|Treatment Period (52 Weeks)|Death|6|||
37751120|NCT03730662|69249547|FG001|Treatment Period (52 Weeks)|Death|2|||
37856831|NCT01001494|69540001|FG000|Overall Study|Withdrawal by Subject|9|||
37856832|NCT01001494|69540002|FG001|Overall Study|Withdrawal by Subject|7|||
37856833|NCT01001494|69540003|FG002|Overall Study|Withdrawal by Subject|17|||
37661354|NCT02655237|69134196|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
37751121|NCT03730662|69249548|FG002|Treatment Period (52 Weeks)|Death|2|||
37751122|NCT03730662|69249549|FG003|Treatment Period (52 Weeks)|Death|9|||
37751123|NCT03730662|69249546|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
37751124|NCT03730662|69249547|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
37751125|NCT03730662|69249548|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
37751126|NCT03730662|69249549|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
37751127|NCT03730662|69249546|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
37661355|NCT02655237|69134195|FG000|Overall Study|Randomized but Not Treated|1|||
37661356|NCT02655237|69134196|FG001|Overall Study|Randomized but Not Treated|0|||
37661357|NCT02657031|69134204|FG000|Overall Study|Adverse Event|1|||
37661358|NCT02657031|69134205|FG001|Overall Study|Adverse Event|2|||
37661359|NCT04375397|69134233|FG000|Overall Study|Death|1|||
37661360|NCT04375397|69134234|FG001|Overall Study|Death|1|||
37661361|NCT04375397|69134233|FG000|Overall Study|Withdrew consent|2|||
37661362|NCT04375397|69134234|FG001|Overall Study|Withdrew consent|0|||
37661363|NCT04375397|69134233|FG000|Overall Study|Lost to Follow-up|6|||
37661364|NCT04375397|69134234|FG001|Overall Study|Lost to Follow-up|4|||
37661365|NCT04375397|69134233|FG000|Overall Study|Other, not specified|0|||
37661366|NCT04375397|69134234|FG001|Overall Study|Other, not specified|1|||
37751128|NCT03730662|69249547|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
37751129|NCT03730662|69249548|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
37751130|NCT03730662|69249549|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
37751131|NCT03730662|69249546|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
37751132|NCT03730662|69249547|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
37751133|NCT03730662|69249548|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
37751134|NCT03730662|69249549|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
37751135|NCT03730662|69249546|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
37751136|NCT03730662|69249547|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
37751137|NCT03730662|69249548|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
37751138|NCT03730662|69249549|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
37751139|NCT03730662|69249546|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
37751140|NCT03730662|69249547|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
37751141|NCT03730662|69249548|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
37751142|NCT03730662|69249549|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
37751143|NCT03730662|69249546|FG000|Variable Treatment Period|Adverse Event|1|||
37751144|NCT03730662|69249547|FG001|Variable Treatment Period|Adverse Event|2|||
37751145|NCT03730662|69249548|FG002|Variable Treatment Period|Adverse Event|0|||
37661367|NCT02387216|69134242|FG000|Overall Study|Progressive disease|2|||
37661368|NCT02387216|69134243|FG001|Overall Study|Progressive disease|0|||
37751146|NCT03730662|69249549|FG003|Variable Treatment Period|Adverse Event|7|||
37751147|NCT03730662|69249546|FG000|Variable Treatment Period|Death|9|||
37751148|NCT03730662|69249547|FG001|Variable Treatment Period|Death|0|||
37751149|NCT03730662|69249548|FG002|Variable Treatment Period|Death|6|||
37751150|NCT03730662|69249549|FG003|Variable Treatment Period|Death|26|||
37751151|NCT03730662|69249546|FG000|Variable Treatment Period|Lost to Follow-up|2|||
37751152|NCT03730662|69249547|FG001|Variable Treatment Period|Lost to Follow-up|1|||
37751153|NCT03730662|69249548|FG002|Variable Treatment Period|Lost to Follow-up|4|||
37751154|NCT03730662|69249549|FG003|Variable Treatment Period|Lost to Follow-up|11|||
37751155|NCT03730662|69249546|FG000|Variable Treatment Period|Personal Reason|0|||
37751156|NCT03730662|69249547|FG001|Variable Treatment Period|Personal Reason|2|||
37751157|NCT03730662|69249548|FG002|Variable Treatment Period|Personal Reason|1|||
37751158|NCT03730662|69249549|FG003|Variable Treatment Period|Personal Reason|6|||
37751159|NCT03730662|69249546|FG000|Variable Treatment Period|Physician Decision|0|||
37856834|NCT01001494|69540001|FG000|Overall Study|COPD exacerbation|3|||
37856835|NCT01001494|69540002|FG001|Overall Study|COPD exacerbation|4|||
37661369|NCT02387216|69134242|FG000|Overall Study|Withdrawal by Subject|3|||
37661370|NCT02387216|69134243|FG001|Overall Study|Withdrawal by Subject|5|||
37661371|NCT02387216|69134242|FG000|Overall Study|Physician Decision|2|||
37661372|NCT02387216|69134243|FG001|Overall Study|Physician Decision|0|||
37661373|NCT02387216|69134242|FG000|Overall Study|Sponsor Decision|28|||
37661374|NCT02387216|69134243|FG001|Overall Study|Sponsor Decision|12|||
37661375|NCT02387216|69134242|FG000|Overall Study|Death|60|||
37661376|NCT02387216|69134243|FG001|Overall Study|Death|23|||
37751160|NCT03730662|69249547|FG001|Variable Treatment Period|Physician Decision|0|||
37751161|NCT03730662|69249548|FG002|Variable Treatment Period|Physician Decision|0|||
37661377|NCT02387216|69134242|FG000|Overall Study|Other|5|||
37661378|NCT02387216|69134243|FG001|Overall Study|Other|4|||
37751162|NCT03730662|69249549|FG003|Variable Treatment Period|Physician Decision|3|||
37751163|NCT03730662|69249546|FG000|Variable Treatment Period|Protocol Violation|0|||
37856836|NCT01001494|69540003|FG002|Overall Study|COPD exacerbation|5|||
37856837|NCT01001494|69540001|FG000|Overall Study|Lack of Efficacy|2|||
37661379|NCT02387216|69134242|FG000|Overall Study|Lost to Follow-up|0|||
37661380|NCT02387216|69134243|FG001|Overall Study|Lost to Follow-up|3|||
37661381|NCT02417246|69134251|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
37661382|NCT02417246|69134252|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
37661383|NCT02417246|69134251|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
37661384|NCT02417246|69134252|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
37661385|NCT02417246|69134251|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
37661386|NCT02417246|69134252|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
37751164|NCT03730662|69249547|FG001|Variable Treatment Period|Protocol Violation|1|||
37751165|NCT03730662|69249548|FG002|Variable Treatment Period|Protocol Violation|1|||
37751166|NCT03730662|69249549|FG003|Variable Treatment Period|Protocol Violation|1|||
37751167|NCT03730662|69249546|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
37751168|NCT03730662|69249547|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
37751169|NCT03730662|69249548|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
37751170|NCT03730662|69249549|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
37751171|NCT03185832|69249647|FG000|Overall Study|Death|9|||
37751172|NCT03185832|69249648|FG001|Overall Study|Death|14|||
37751173|NCT03185832|69249649|FG002|Overall Study|Death|9|||
37751174|NCT03185832|69249650|FG003|Overall Study|Death|7|||
37751175|NCT03185832|69249647|FG000|Overall Study|Withdrawn - vital status available|0|||
37751176|NCT03185832|69249648|FG001|Overall Study|Withdrawn - vital status available|1|||
37751177|NCT03185832|69249649|FG002|Overall Study|Withdrawn - vital status available|1|||
37751178|NCT03185832|69249650|FG003|Overall Study|Withdrawn - vital status available|4|||
37751179|NCT04569786|69249702|FG000|Overall Study|Lost to Follow-up|1|||
37751180|NCT04569786|69249703|FG001|Overall Study|Lost to Follow-up|0|||
37661387|NCT02417246|69134251|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
37661388|NCT02417246|69134252|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
37661389|NCT02424734|69134263|FG000|Overall Study|Treatment stopped to be discharged home|2|||
37661390|NCT02424734|69134264|FG001|Overall Study|Treatment stopped to be discharged home|2|||
37751181|NCT04569786|69249704|FG002|Overall Study|Lost to Follow-up|4|||
37751182|NCT04569786|69249705|FG003|Overall Study|Lost to Follow-up|1|||
37751183|NCT04569786|69249706|FG004|Overall Study|Lost to Follow-up|0|||
37751184|NCT04569786|69249702|FG000|Overall Study|Withdrawal by Subject|0|||
37751185|NCT04569786|69249703|FG001|Overall Study|Withdrawal by Subject|0|||
37751186|NCT04569786|69249704|FG002|Overall Study|Withdrawal by Subject|0|||
37751187|NCT04569786|69249705|FG003|Overall Study|Withdrawal by Subject|5|||
37751188|NCT04569786|69249706|FG004|Overall Study|Withdrawal by Subject|1|||
37751189|NCT04569786|69249702|FG000|Overall Study|Physician Decision|0|||
37751190|NCT04569786|69249703|FG001|Overall Study|Physician Decision|0|||
37751191|NCT04569786|69249704|FG002|Overall Study|Physician Decision|0|||
37751192|NCT04569786|69249705|FG003|Overall Study|Physician Decision|1|||
37751193|NCT04569786|69249706|FG004|Overall Study|Physician Decision|0|||
37751194|NCT01826981|69249882|FG000|Overall Study|Lack of Efficacy|0|||
37751195|NCT01826981|69249883|FG001|Overall Study|Lack of Efficacy|1|||
37751196|NCT01826981|69249884|FG002|Overall Study|Lack of Efficacy|0|||
37751197|NCT01826981|69249885|FG003|Overall Study|Lack of Efficacy|0|||
37751198|NCT01826981|69249886|FG004|Overall Study|Lack of Efficacy|5|||
37751199|NCT01826981|69249887|FG005|Overall Study|Lack of Efficacy|0|||
37751200|NCT01826981|69249888|FG006|Overall Study|Lack of Efficacy|0|||
37661391|NCT02424734|69134265|FG002|Overall Study|Treatment stopped to be discharged home|0|||
37661392|NCT02424578|69134276|FG000|Overall Study|Withdrawal by Subject|0|||
37661393|NCT02424578|69134277|FG001|Overall Study|Withdrawal by Subject|1|||
37661394|NCT02416934|69134285|FG000|Overall Study|given steroids|1|||
37661395|NCT02416934|69134286|FG001|Overall Study|given steroids|2|||
37661396|NCT02416934|69134285|FG000|Overall Study|Lost to Follow-up|0|||
37661397|NCT02416934|69134286|FG001|Overall Study|Lost to Follow-up|2|||
37661398|NCT02416934|69134285|FG000|Overall Study|Withdrawal by Subject|1|||
37661399|NCT02416934|69134286|FG001|Overall Study|Withdrawal by Subject|0|||
37661400|NCT02416934|69134285|FG000|Overall Study|recruited during continuing renewal proc|0|||
37661401|NCT02416934|69134286|FG001|Overall Study|recruited during continuing renewal proc|1|||
37661402|NCT02416934|69134285|FG000|Overall Study|Protocol Violation|0|||
37661403|NCT02416934|69134286|FG001|Overall Study|Protocol Violation|1|||
37661404|NCT02416934|69134285|FG000|Overall Study|surgery started late|0|||
37661405|NCT02416934|69134286|FG001|Overall Study|surgery started late|1|||
37661406|NCT02416934|69134285|FG000|Overall Study|re-operation|1|||
37661407|NCT02416934|69134286|FG001|Overall Study|re-operation|0|||
37661408|NCT02819635|69134306|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
37661409|NCT02819635|69134307|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
37751201|NCT01826981|69249889|FG007|Overall Study|Lack of Efficacy|8|||
37751202|NCT01826981|69249890|FG008|Overall Study|Lack of Efficacy|7|||
37661410|NCT02819635|69134308|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
37751203|NCT01826981|69249891|FG009|Overall Study|Lack of Efficacy|0|||
37751204|NCT01826981|69249892|FG010|Overall Study|Lack of Efficacy|1|||
37751205|NCT01826981|69249893|FG011|Overall Study|Lack of Efficacy|0|||
37751206|NCT01826981|69249894|FG012|Overall Study|Lack of Efficacy|0|||
37751207|NCT01826981|69249895|FG013|Overall Study|Lack of Efficacy|3|||
37751208|NCT01826981|69249896|FG014|Overall Study|Lack of Efficacy|0|||
37661411|NCT02819635|69134309|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
37751209|NCT01826981|69249882|FG000|Overall Study|Lost to Follow-up|0|||
37751210|NCT01826981|69249883|FG001|Overall Study|Lost to Follow-up|0|||
37661412|NCT02819635|69134310|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
37661413|NCT02819635|69134311|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
37661414|NCT02819635|69134312|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
37661415|NCT02819635|69134313|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
37661416|NCT02819635|69134314|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
37661417|NCT02819635|69134315|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
37661418|NCT02819635|69134316|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
37661419|NCT02819635|69134317|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
37661420|NCT02819635|69134306|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
37661421|NCT02819635|69134307|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
37661422|NCT02819635|69134308|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
37661423|NCT02819635|69134309|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
37661424|NCT02819635|69134310|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
37661425|NCT02819635|69134311|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
37661426|NCT02819635|69134312|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
37661427|NCT02819635|69134313|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
37661428|NCT02819635|69134314|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
37751211|NCT01826981|69249884|FG002|Overall Study|Lost to Follow-up|0|||
37751212|NCT01826981|69249885|FG003|Overall Study|Lost to Follow-up|0|||
37751213|NCT01826981|69249886|FG004|Overall Study|Lost to Follow-up|1|||
37751214|NCT01826981|69249887|FG005|Overall Study|Lost to Follow-up|1|||
37751215|NCT01826981|69249888|FG006|Overall Study|Lost to Follow-up|0|||
37751216|NCT01826981|69249889|FG007|Overall Study|Lost to Follow-up|1|||
37661429|NCT02819635|69134315|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
37661430|NCT02819635|69134316|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
37751217|NCT01826981|69249890|FG008|Overall Study|Lost to Follow-up|0|||
37751218|NCT01826981|69249891|FG009|Overall Study|Lost to Follow-up|1|||
37751219|NCT01826981|69249892|FG010|Overall Study|Lost to Follow-up|1|||
37751220|NCT01826981|69249893|FG011|Overall Study|Lost to Follow-up|1|||
37751221|NCT01826981|69249894|FG012|Overall Study|Lost to Follow-up|1|||
37751222|NCT01826981|69249895|FG013|Overall Study|Lost to Follow-up|0|||
37751223|NCT01826981|69249896|FG014|Overall Study|Lost to Follow-up|0|||
37751224|NCT01826981|69249882|FG000|Overall Study|Withdrew Consent|0|||
37751225|NCT01826981|69249883|FG001|Overall Study|Withdrew Consent|0|||
37751226|NCT01826981|69249884|FG002|Overall Study|Withdrew Consent|0|||
37751227|NCT01826981|69249885|FG003|Overall Study|Withdrew Consent|0|||
37751228|NCT01826981|69249886|FG004|Overall Study|Withdrew Consent|0|||
37751229|NCT01826981|69249887|FG005|Overall Study|Withdrew Consent|0|||
38033158|NCT04760314|69719150|FG008|Maintenance Blinded Period|Protocol Deviation|0|||
37661431|NCT02819635|69134317|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
37661432|NCT02819635|69134306|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
37661433|NCT02819635|69134307|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
37661434|NCT02819635|69134308|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
37661435|NCT02819635|69134309|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
37661436|NCT02819635|69134310|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
37661437|NCT02819635|69134311|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
37661438|NCT02819635|69134312|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
37661439|NCT02819635|69134313|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
37661440|NCT02819635|69134314|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
37661441|NCT02819635|69134315|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
37661442|NCT02819635|69134316|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
37751230|NCT01826981|69249888|FG006|Overall Study|Withdrew Consent|1|||
37751231|NCT01826981|69249889|FG007|Overall Study|Withdrew Consent|1|||
37751232|NCT01826981|69249890|FG008|Overall Study|Withdrew Consent|0|||
37751233|NCT01826981|69249891|FG009|Overall Study|Withdrew Consent|0|||
38033159|NCT04760314|69719151|FG009|Maintenance Blinded Period|Protocol Deviation|0|||
38033160|NCT04760314|69719152|FG010|Maintenance Blinded Period|Protocol Deviation|0|||
38033161|NCT04760314|69719142|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
38033162|NCT04760314|69719143|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
38033163|NCT04760314|69719144|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
38033164|NCT04760314|69719145|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
38033165|NCT04760314|69719146|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
38033166|NCT04760314|69719147|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
38033167|NCT04760314|69719148|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
38033168|NCT04760314|69719149|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
38033169|NCT04760314|69719150|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
38033170|NCT04760314|69719151|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
38033171|NCT04760314|69719152|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
38033172|NCT04760314|69719142|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
37751234|NCT01826981|69249892|FG010|Overall Study|Withdrew Consent|0|||
37751235|NCT01826981|69249893|FG011|Overall Study|Withdrew Consent|1|||
37751236|NCT01826981|69249894|FG012|Overall Study|Withdrew Consent|0|||
37751237|NCT01826981|69249895|FG013|Overall Study|Withdrew Consent|1|||
37751238|NCT01826981|69249896|FG014|Overall Study|Withdrew Consent|0|||
37751239|NCT01826981|69249882|FG000|Overall Study|Adverse Event|0|||
37751240|NCT01826981|69249883|FG001|Overall Study|Adverse Event|0|||
37751241|NCT01826981|69249884|FG002|Overall Study|Adverse Event|0|||
37751242|NCT01826981|69249885|FG003|Overall Study|Adverse Event|0|||
37661443|NCT02819635|69134317|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
37661444|NCT02819635|69134306|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
37751243|NCT01826981|69249886|FG004|Overall Study|Adverse Event|1|||
37751244|NCT01826981|69249887|FG005|Overall Study|Adverse Event|0|||
37751245|NCT01826981|69249888|FG006|Overall Study|Adverse Event|0|||
37751246|NCT01826981|69249889|FG007|Overall Study|Adverse Event|0|||
37751247|NCT01826981|69249890|FG008|Overall Study|Adverse Event|0|||
37751248|NCT01826981|69249891|FG009|Overall Study|Adverse Event|0|||
37661445|NCT02819635|69134307|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
37661446|NCT02819635|69134308|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
37661447|NCT02819635|69134309|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
37661448|NCT02819635|69134310|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
37661449|NCT02819635|69134311|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
37661450|NCT02819635|69134312|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
37661451|NCT02819635|69134313|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
37661452|NCT02819635|69134314|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
37661453|NCT02819635|69134315|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
37661454|NCT02819635|69134316|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
37661455|NCT02819635|69134317|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
37661456|NCT02819635|69134306|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
37661457|NCT02819635|69134307|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
37661458|NCT02819635|69134308|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
37661459|NCT02819635|69134309|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
37661460|NCT02819635|69134310|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
37661461|NCT02819635|69134311|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
37661462|NCT02819635|69134312|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
37661463|NCT02819635|69134313|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
37661464|NCT02819635|69134314|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
37661465|NCT02819635|69134315|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
37661466|NCT02819635|69134316|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
37661467|NCT02819635|69134317|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
37661468|NCT02819635|69134306|FG000|Substudy 2, Part 2|Adverse Event|0|||
37661469|NCT02819635|69134307|FG001|Substudy 2, Part 2|Adverse Event|0|||
37661470|NCT02819635|69134308|FG002|Substudy 2, Part 2|Adverse Event|0|||
37661471|NCT02819635|69134309|FG003|Substudy 2, Part 2|Adverse Event|0|||
37661472|NCT02819635|69134310|FG004|Substudy 2, Part 2|Adverse Event|0|||
37661473|NCT02819635|69134311|FG005|Substudy 2, Part 2|Adverse Event|4|||
37661474|NCT02819635|69134312|FG006|Substudy 2, Part 2|Adverse Event|0|||
37661475|NCT02819635|69134313|FG007|Substudy 2, Part 2|Adverse Event|0|||
37661476|NCT02819635|69134314|FG008|Substudy 2, Part 2|Adverse Event|0|||
37661477|NCT02819635|69134315|FG009|Substudy 2, Part 2|Adverse Event|0|||
37751249|NCT01826981|69249892|FG010|Overall Study|Adverse Event|0|||
37751250|NCT01826981|69249893|FG011|Overall Study|Adverse Event|0|||
37751251|NCT01826981|69249894|FG012|Overall Study|Adverse Event|0|||
37751252|NCT01826981|69249895|FG013|Overall Study|Adverse Event|0|||
37751253|NCT01826981|69249896|FG014|Overall Study|Adverse Event|0|||
37751254|NCT01826981|69249882|FG000|Overall Study|Upper G-I Haemorrhage|0|||
37751255|NCT01826981|69249883|FG001|Overall Study|Upper G-I Haemorrhage|0|||
37751256|NCT01826981|69249884|FG002|Overall Study|Upper G-I Haemorrhage|0|||
37751257|NCT01826981|69249885|FG003|Overall Study|Upper G-I Haemorrhage|0|||
37751258|NCT01826981|69249886|FG004|Overall Study|Upper G-I Haemorrhage|0|||
37751259|NCT01826981|69249887|FG005|Overall Study|Upper G-I Haemorrhage|0|||
37751260|NCT01826981|69249888|FG006|Overall Study|Upper G-I Haemorrhage|0|||
37751261|NCT01826981|69249889|FG007|Overall Study|Upper G-I Haemorrhage|0|||
37856838|NCT01001494|69540002|FG001|Overall Study|Lack of Efficacy|0|||
37856839|NCT01001494|69540003|FG002|Overall Study|Lack of Efficacy|8|||
37856840|NCT01001494|69540001|FG000|Overall Study|Other|0|||
37661478|NCT02819635|69134316|FG010|Substudy 2, Part 2|Adverse Event|0|||
37661479|NCT02819635|69134317|FG011|Substudy 2, Part 2|Adverse Event|0|||
37661480|NCT02819635|69134306|FG000|Substudy 2, Part 2|Withdrew consent|0|||
37751262|NCT01826981|69249890|FG008|Overall Study|Upper G-I Haemorrhage|0|||
37751263|NCT01826981|69249891|FG009|Overall Study|Upper G-I Haemorrhage|0|||
37751264|NCT01826981|69249892|FG010|Overall Study|Upper G-I Haemorrhage|0|||
37751265|NCT01826981|69249893|FG011|Overall Study|Upper G-I Haemorrhage|0|||
37751266|NCT01826981|69249894|FG012|Overall Study|Upper G-I Haemorrhage|0|||
37661481|NCT02819635|69134307|FG001|Substudy 2, Part 2|Withdrew consent|0|||
37661482|NCT02819635|69134308|FG002|Substudy 2, Part 2|Withdrew consent|0|||
37661483|NCT02819635|69134309|FG003|Substudy 2, Part 2|Withdrew consent|0|||
37661484|NCT02819635|69134310|FG004|Substudy 2, Part 2|Withdrew consent|0|||
37661485|NCT02819635|69134311|FG005|Substudy 2, Part 2|Withdrew consent|3|||
37661486|NCT02819635|69134312|FG006|Substudy 2, Part 2|Withdrew consent|1|||
37751267|NCT01826981|69249895|FG013|Overall Study|Upper G-I Haemorrhage|1|||
37751268|NCT01826981|69249896|FG014|Overall Study|Upper G-I Haemorrhage|0|||
37751269|NCT01826981|69249882|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
37751270|NCT01826981|69249883|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
37661487|NCT02819635|69134313|FG007|Substudy 2, Part 2|Withdrew consent|0|||
37661488|NCT02819635|69134314|FG008|Substudy 2, Part 2|Withdrew consent|0|||
37661489|NCT02819635|69134315|FG009|Substudy 2, Part 2|Withdrew consent|0|||
37751271|NCT01826981|69249884|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
37751272|NCT01826981|69249885|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
37751273|NCT01826981|69249886|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
37751274|NCT01826981|69249887|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
37751275|NCT01826981|69249888|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
37751276|NCT01826981|69249889|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
37751277|NCT01826981|69249890|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
37751278|NCT01826981|69249891|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
37751279|NCT01826981|69249892|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
37751280|NCT01826981|69249893|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
37751281|NCT01826981|69249894|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
37751282|NCT01826981|69249895|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
37751283|NCT01826981|69249896|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
37751284|NCT01804049|69249968|FG000|Overall Study|Adverse Event|2|||
37751285|NCT01804049|69249969|FG001|Overall Study|Adverse Event|10|||
37751286|NCT01804049|69249968|FG000|Overall Study|Lost to Follow-up|2|||
37751287|NCT01804049|69249969|FG001|Overall Study|Lost to Follow-up|1|||
37751288|NCT01804049|69249968|FG000|Overall Study|Decreased interest/personal|4|||
37751289|NCT01804049|69249969|FG001|Overall Study|Decreased interest/personal|5|||
37751290|NCT01804049|69249968|FG000|Overall Study|Other health concerns|2|||
37751291|NCT01804049|69249969|FG001|Overall Study|Other health concerns|7|||
37751292|NCT01804049|69249968|FG000|Overall Study|Moved out of area|0|||
37751293|NCT01804049|69249969|FG001|Overall Study|Moved out of area|7|||
37751294|NCT01804049|69249968|FG000|Overall Study|other MD recommended|1|||
37751295|NCT01804049|69249969|FG001|Overall Study|other MD recommended|1|||
37751296|NCT01804049|69249968|FG000|Overall Study|Enrollment in dual studies|0|||
37751297|NCT01804049|69249969|FG001|Overall Study|Enrollment in dual studies|1|||
37751298|NCT01826825|69249979|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
37751299|NCT01826825|69249980|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
37751300|NCT01803737|69249990|FG000|Overall Study|Lack of Time|1|||
37751301|NCT01803737|69249991|FG001|Overall Study|Lack of Time|0|||
37751302|NCT01803737|69249990|FG000|Overall Study|Medical Reason|0|||
37751303|NCT01803737|69249991|FG001|Overall Study|Medical Reason|1|||
37751304|NCT01803737|69249990|FG000|Overall Study|Lost to Follow-up|0|||
37751305|NCT01803737|69249991|FG001|Overall Study|Lost to Follow-up|2|||
37751306|NCT01826201|69249997|FG000|Overall Study|Non compliance with protocol|4|||
37751307|NCT01803269|69250028|FG000|Overall Study|Withdrawal by Subject|3|||
37751308|NCT01803269|69250029|FG001|Overall Study|Withdrawal by Subject|0|||
37751309|NCT01803269|69250030|FG002|Overall Study|Withdrawal by Subject|0|||
37751310|NCT01802879|69250038|FG000|Overall Study|Administrative problems|2|||
37751311|NCT01802879|69250038|FG000|Overall Study|Disease progression|6|||
37751312|NCT01825577|69250042|FG000|Overall Study|Physician Decision|2|||
37751313|NCT01825577|69250042|FG000|Overall Study|Withdrawal by Subject|1|||
37751314|NCT01825577|69250042|FG000|Overall Study|Withdrawn by family members|2|||
37751315|NCT01825577|69250042|FG000|Overall Study|Lack of Efficacy|3|||
37751316|NCT01802411|69250048|FG000|Overall Study|Death|2|||
37751317|NCT01802411|69250049|FG001|Overall Study|Death|1|||
37751318|NCT01802411|69250048|FG000|Overall Study|Adverse Event|2|||
37856841|NCT01001494|69540002|FG001|Overall Study|Other|1|||
37661490|NCT02819635|69134316|FG010|Substudy 2, Part 2|Withdrew consent|0|||
37661491|NCT02819635|69134317|FG011|Substudy 2, Part 2|Withdrew consent|0|||
37661492|NCT02819635|69134306|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
37751319|NCT01802411|69250049|FG001|Overall Study|Adverse Event|7|||
37751320|NCT01802411|69250048|FG000|Overall Study|Lack of Efficacy|8|||
37751321|NCT01802411|69250049|FG001|Overall Study|Lack of Efficacy|10|||
37751322|NCT01802411|69250048|FG000|Overall Study|Withdrawal by Subject|0|||
37751323|NCT01802411|69250049|FG001|Overall Study|Withdrawal by Subject|2|||
37751324|NCT01802411|69250048|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
37751325|NCT01802411|69250049|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
37751326|NCT01802411|69250048|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
37661493|NCT02819635|69134307|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
37661494|NCT02819635|69134308|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
37661495|NCT02819635|69134309|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
37751327|NCT01802411|69250049|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
37751328|NCT01802411|69250048|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
37751329|NCT01802411|69250049|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
37751330|NCT02963610|69250090|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
37751331|NCT01802333|69250311|FG000|Overall Study|Ineligible|2|||
37751332|NCT01802333|69250312|FG001|Overall Study|Ineligible|6|||
37751333|NCT01802333|69250313|FG002|Overall Study|Ineligible|8|||
37751334|NCT01802333|69250311|FG000|Overall Study|Adverse Event|1|||
37751335|NCT01802333|69250312|FG001|Overall Study|Adverse Event|8|||
37751336|NCT01802333|69250313|FG002|Overall Study|Adverse Event|8|||
37751337|NCT01802333|69250311|FG000|Overall Study|Withdrawal by Subject|6|||
37751338|NCT01802333|69250312|FG001|Overall Study|Withdrawal by Subject|6|||
37751339|NCT01802333|69250313|FG002|Overall Study|Withdrawal by Subject|5|||
37751340|NCT01802333|69250311|FG000|Overall Study|Progression/relapse|1|||
37751341|NCT01802333|69250312|FG001|Overall Study|Progression/relapse|3|||
37751342|NCT01802333|69250313|FG002|Overall Study|Progression/relapse|0|||
37751343|NCT01802333|69250311|FG000|Overall Study|Death|7|||
37751344|NCT01802333|69250312|FG001|Overall Study|Death|14|||
37751345|NCT01802333|69250313|FG002|Overall Study|Death|13|||
37751346|NCT01802333|69250311|FG000|Overall Study|Other - not protocol specified|32|||
37751347|NCT01802333|69250312|FG001|Overall Study|Other - not protocol specified|22|||
37751348|NCT01802333|69250313|FG002|Overall Study|Other - not protocol specified|24|||
37751349|NCT01802333|69250311|FG000|Overall Study|Did not start treatment|0|||
37751350|NCT01802333|69250312|FG001|Overall Study|Did not start treatment|2|||
37751351|NCT01802333|69250313|FG002|Overall Study|Did not start treatment|5|||
37751352|NCT00980655|69250358|FG000|Overall Study|Adverse Event|13|||
37751353|NCT00980655|69250359|FG001|Overall Study|Adverse Event|31|||
37751354|NCT00980655|69250358|FG000|Overall Study|Death|0|||
37751355|NCT00980655|69250359|FG001|Overall Study|Death|7|||
37751356|NCT00980655|69250358|FG000|Overall Study|Protocol Violation|2|||
37751357|NCT00980655|69250359|FG001|Overall Study|Protocol Violation|7|||
37751358|NCT00980655|69250358|FG000|Overall Study|Withdrawal by Subject|0|||
37751359|NCT00980655|69250359|FG001|Overall Study|Withdrawal by Subject|4|||
37751360|NCT00980655|69250358|FG000|Overall Study|Lost to Follow-up|0|||
37751361|NCT00980655|69250359|FG001|Overall Study|Lost to Follow-up|1|||
37751362|NCT00980655|69250358|FG000|Overall Study|Parent/legal guardian request|1|||
37751363|NCT00980655|69250359|FG001|Overall Study|Parent/legal guardian request|0|||
37751364|NCT00980655|69250358|FG000|Overall Study|Other|0|||
37856842|NCT01001494|69540003|FG002|Overall Study|Other|3|||
37856843|NCT01205685|69540011|FG000|Overall Study|Disease Progression|10|||
37661496|NCT02819635|69134310|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
37661497|NCT02819635|69134311|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
37661498|NCT02819635|69134312|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
37661499|NCT02819635|69134313|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
37661500|NCT02819635|69134314|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
37661501|NCT02819635|69134315|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
37661502|NCT02819635|69134316|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
37661503|NCT02819635|69134317|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
37661504|NCT02819635|69134306|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
37661505|NCT02819635|69134307|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
37661506|NCT02819635|69134308|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
37661507|NCT02819635|69134309|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
37661508|NCT02819635|69134310|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
37661509|NCT02819635|69134311|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
37661510|NCT02819635|69134312|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
37661511|NCT02819635|69134313|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
37661512|NCT02819635|69134314|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
37661513|NCT02819635|69134315|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
37661514|NCT02819635|69134316|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
37661515|NCT02819635|69134317|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
37661516|NCT02819635|69134306|FG000|Substudy 2, Part 2|Other, not specified|0|||
37661517|NCT02819635|69134307|FG001|Substudy 2, Part 2|Other, not specified|0|||
37751365|NCT00980655|69250359|FG001|Overall Study|Other|1|||
37751366|NCT01801865|69250401|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
37751367|NCT01801865|69250401|FG000|Overall Study|Physician Decision|7|||
37751368|NCT00980343|69250411|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
37751369|NCT00980343|69250412|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
37751370|NCT01801475|69250422|FG000|Overall Study|Withdrawal by Subject|0|||
37751371|NCT01801475|69250423|FG001|Overall Study|Withdrawal by Subject|0|||
37751372|NCT01801475|69250424|FG002|Overall Study|Withdrawal by Subject|0|||
37751373|NCT01801475|69250425|FG003|Overall Study|Withdrawal by Subject|0|||
37856844|NCT01205685|69540011|FG000|Overall Study|Withdrawal by Subject|1|||
37751374|NCT01801475|69250426|FG004|Overall Study|Withdrawal by Subject|1|||
37751375|NCT01822925|69250485|FG000|Overall Study|Adverse Event|1|||
37751376|NCT01822925|69250486|FG001|Overall Study|Adverse Event|1|||
37751377|NCT01822925|69250487|FG002|Overall Study|Adverse Event|1|||
37751378|NCT01822925|69250488|FG003|Overall Study|Adverse Event|1|||
37751379|NCT01822925|69250485|FG000|Overall Study|Lost to Follow-up|0|||
37751380|NCT01822925|69250486|FG001|Overall Study|Lost to Follow-up|1|||
37751381|NCT01822925|69250487|FG002|Overall Study|Lost to Follow-up|0|||
37751382|NCT01822925|69250488|FG003|Overall Study|Lost to Follow-up|0|||
37751383|NCT01822925|69250485|FG000|Overall Study|Protocol Violation|1|||
37751384|NCT01822925|69250486|FG001|Overall Study|Protocol Violation|0|||
37751385|NCT01822925|69250487|FG002|Overall Study|Protocol Violation|0|||
37751386|NCT01822925|69250488|FG003|Overall Study|Protocol Violation|1|||
37751387|NCT01822925|69250485|FG000|Overall Study|Withdrawal by Subject|2|||
37751388|NCT01822925|69250486|FG001|Overall Study|Withdrawal by Subject|0|||
37751389|NCT01822925|69250487|FG002|Overall Study|Withdrawal by Subject|2|||
37751390|NCT01822925|69250488|FG003|Overall Study|Withdrawal by Subject|2|||
37751391|NCT01822925|69250485|FG000|Overall Study|Taking prohibited medication|2|||
37751392|NCT01822925|69250486|FG001|Overall Study|Taking prohibited medication|0|||
37751393|NCT01822925|69250487|FG002|Overall Study|Taking prohibited medication|0|||
37751394|NCT01822925|69250488|FG003|Overall Study|Taking prohibited medication|1|||
37751395|NCT01801007|69250521|FG000|Overall Study|Adverse Event|2|||
37751396|NCT01801007|69250521|FG000|Overall Study|Lost to Follow-up|4|||
37751397|NCT01801007|69250521|FG000|Overall Study|Withdrawal by Subject|5|||
37751398|NCT01822691|69250525|FG000|Overall Study|Withdrawal by Subject|2|||
37661518|NCT02819635|69134308|FG002|Substudy 2, Part 2|Other, not specified|0|||
37661519|NCT02819635|69134309|FG003|Substudy 2, Part 2|Other, not specified|0|||
37661520|NCT02819635|69134310|FG004|Substudy 2, Part 2|Other, not specified|0|||
37661521|NCT02819635|69134311|FG005|Substudy 2, Part 2|Other, not specified|4|||
37661522|NCT02819635|69134312|FG006|Substudy 2, Part 2|Other, not specified|8|||
37661523|NCT02819635|69134313|FG007|Substudy 2, Part 2|Other, not specified|0|||
37661524|NCT02819635|69134314|FG008|Substudy 2, Part 2|Other, not specified|0|||
37751399|NCT01822535|69250531|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
37856845|NCT01205529|69540015|FG000|Overall Study|Procedure Cancelled|4|||
37856846|NCT01205529|69540015|FG000|Overall Study|Withdrawal by Subject|2|||
37856847|NCT01205529|69540015|FG000|Overall Study|Physician Decision|4|||
37856848|NCT01205529|69540015|FG000|Overall Study|Unstable post op|15|||
37856849|NCT01205529|69540015|FG000|Overall Study|No longer met criteria|30|||
37856850|NCT01205451|69540021|FG000|Overall Study|Lost to Follow-up|1|||
37856851|NCT01205451|69540022|FG001|Overall Study|Lost to Follow-up|1|||
37856852|NCT01205451|69540021|FG000|Overall Study|Withdrawal by Subject|5|||
37856853|NCT01205451|69540022|FG001|Overall Study|Withdrawal by Subject|9|||
37856854|NCT01001104|69540032|FG000|Overall Study|Adverse Event|2|||
37856855|NCT01001104|69540033|FG001|Overall Study|Adverse Event|1|||
37856856|NCT01001104|69540034|FG002|Overall Study|Adverse Event|0|||
37856857|NCT01001104|69540035|FG003|Overall Study|Adverse Event|0|||
37856858|NCT01001104|69540032|FG000|Overall Study|Lost to Follow-up|0|||
37856859|NCT01001104|69540033|FG001|Overall Study|Lost to Follow-up|0|||
37856860|NCT01001104|69540034|FG002|Overall Study|Lost to Follow-up|1|||
37856861|NCT01001104|69540035|FG003|Overall Study|Lost to Follow-up|0|||
37856862|NCT01001104|69540032|FG000|Overall Study|Entry Criteria Not Met|0|||
37856863|NCT01001104|69540033|FG001|Overall Study|Entry Criteria Not Met|0|||
37856864|NCT01001104|69540034|FG002|Overall Study|Entry Criteria Not Met|0|||
37856865|NCT01001104|69540035|FG003|Overall Study|Entry Criteria Not Met|1|||
37856866|NCT01001104|69540032|FG000|Overall Study|Withdrawal by Subject|0|||
37856867|NCT01001104|69540033|FG001|Overall Study|Withdrawal by Subject|0|||
37856868|NCT01001104|69540034|FG002|Overall Study|Withdrawal by Subject|0|||
37856869|NCT01001104|69540035|FG003|Overall Study|Withdrawal by Subject|2|||
37856870|NCT00998764|69540050|FG000|Overall Study|Lack of Efficacy|3|||
37856871|NCT00998764|69540051|FG001|Overall Study|Lack of Efficacy|6|||
37856872|NCT00998764|69540050|FG000|Overall Study|Adverse Event|17|||
37856873|NCT00998764|69540051|FG001|Overall Study|Adverse Event|12|||
37856874|NCT00998764|69540050|FG000|Overall Study|Withdrawal by Subject|19|||
37856875|NCT00998764|69540051|FG001|Overall Study|Withdrawal by Subject|25|||
37661525|NCT02819635|69134315|FG009|Substudy 2, Part 2|Other, not specified|0|||
37751400|NCT01822535|69250532|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
37856876|NCT00998764|69540050|FG000|Overall Study|Physician Decision|3|||
37751401|NCT01822535|69250531|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
37751402|NCT01822535|69250532|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
37751403|NCT01822535|69250531|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
37751404|NCT01822535|69250532|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
37661526|NCT02819635|69134316|FG010|Substudy 2, Part 2|Other, not specified|0|||
37751405|NCT01799993|69250618|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
37856877|NCT00998764|69540051|FG001|Overall Study|Physician Decision|3|||
37856878|NCT00998764|69540050|FG000|Overall Study|Death|3|||
37856879|NCT00998764|69540051|FG001|Overall Study|Death|1|||
37751406|NCT01799993|69250619|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
37751407|NCT01799993|69250618|FG000|Overall Study|Death|61|||
37751408|NCT01799993|69250619|FG001|Overall Study|Death|45|||
37751409|NCT01799993|69250618|FG000|Overall Study|Withdrawal by Subject|23|||
37751410|NCT01799993|69250619|FG001|Overall Study|Withdrawal by Subject|24|||
37751411|NCT01799993|69250618|FG000|Overall Study|Lost to Follow-up|5|||
37751412|NCT01799993|69250619|FG001|Overall Study|Lost to Follow-up|8|||
37751413|NCT01799993|69250618|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
37751414|NCT01799993|69250619|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
37751415|NCT01799993|69250618|FG000|Overall Study|Protocol driven decision point|0|||
37751416|NCT01799993|69250619|FG001|Overall Study|Protocol driven decision point|3|||
37661527|NCT02819635|69134317|FG011|Substudy 2, Part 2|Other, not specified|0|||
37661528|NCT02819635|69134306|FG000|Substudy 3|Adverse Event|0|||
37661529|NCT02819635|69134307|FG001|Substudy 3|Adverse Event|0|||
37661530|NCT02819635|69134308|FG002|Substudy 3|Adverse Event|0|||
37661531|NCT02819635|69134309|FG003|Substudy 3|Adverse Event|0|||
37661532|NCT02819635|69134310|FG004|Substudy 3|Adverse Event|0|||
37661533|NCT02819635|69134311|FG005|Substudy 3|Adverse Event|0|||
37661534|NCT02819635|69134312|FG006|Substudy 3|Adverse Event|0|||
37661535|NCT02819635|69134313|FG007|Substudy 3|Adverse Event|0|||
37661536|NCT02819635|69134314|FG008|Substudy 3|Adverse Event|32|||
37751417|NCT01799993|69250618|FG000|Overall Study|Protocol Violation|1|||
37751418|NCT01799993|69250619|FG001|Overall Study|Protocol Violation|1|||
37751419|NCT01799993|69250618|FG000|Overall Study|Deterioration of general conditions|2|||
37661537|NCT02819635|69134315|FG009|Substudy 3|Adverse Event|3|||
37751420|NCT01799993|69250619|FG001|Overall Study|Deterioration of general conditions|0|||
37751421|NCT01799993|69250618|FG000|Overall Study|Screen failure|0|||
37751422|NCT01799993|69250619|FG001|Overall Study|Screen failure|1|||
37751423|NCT01799993|69250618|FG000|Overall Study|Adverse Event|1|||
37751424|NCT01799993|69250619|FG001|Overall Study|Adverse Event|0|||
37751425|NCT01799993|69250618|FG000|Overall Study|Lack of Efficacy|1|||
37751426|NCT01799993|69250619|FG001|Overall Study|Lack of Efficacy|0|||
37751427|NCT01799993|69250618|FG000|Overall Study|Recovery|0|||
37751428|NCT01799993|69250619|FG001|Overall Study|Recovery|1|||
37751429|NCT01799993|69250618|FG000|Overall Study|Logistical difficulties|1|||
37751430|NCT01799993|69250619|FG001|Overall Study|Logistical difficulties|0|||
37751431|NCT01799993|69250618|FG000|Overall Study|Protocol deviation|1|||
37751432|NCT01799993|69250619|FG001|Overall Study|Protocol deviation|0|||
37751433|NCT01799993|69250618|FG000|Overall Study|Non-compliance with medical device|1|||
37751434|NCT01799993|69250619|FG001|Overall Study|Non-compliance with medical device|0|||
37751435|NCT01799993|69250618|FG000|Overall Study|Withdrawal by parent/guardian|0|||
37751436|NCT01799993|69250619|FG001|Overall Study|Withdrawal by parent/guardian|1|||
37751437|NCT01799993|69250618|FG000|Overall Study|Other|1|||
37751438|NCT01799993|69250619|FG001|Overall Study|Other|0|||
37751439|NCT01799993|69250618|FG000|Overall Study|Subject didn't return for follow-up|0|||
37751440|NCT01799993|69250619|FG001|Overall Study|Subject didn't return for follow-up|1|||
38033173|NCT04760314|69719143|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
38033174|NCT04760314|69719144|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
38033175|NCT04760314|69719145|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
38033176|NCT04760314|69719146|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
38033177|NCT04760314|69719147|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
38033178|NCT04760314|69719148|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
38033179|NCT04760314|69719149|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
38033180|NCT04760314|69719150|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
38033181|NCT04760314|69719151|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
38033182|NCT04760314|69719152|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
38033183|NCT04760314|69719142|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
38033184|NCT04760314|69719143|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
38033185|NCT04760314|69719144|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
38033186|NCT04760314|69719145|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
38033187|NCT04760314|69719146|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
37661538|NCT02819635|69134316|FG010|Substudy 3|Adverse Event|12|||
37661539|NCT02819635|69134317|FG011|Substudy 3|Adverse Event|18|||
37661540|NCT02819635|69134306|FG000|Substudy 3|Withdrew consent|0|||
37751441|NCT01822223|69250636|FG000|Overall Study|Death|0|||
37751442|NCT01822223|69250637|FG001|Overall Study|Death|1|||
37751443|NCT02228382|69250723|FG000|Overall Study|Death|5|||
37751444|NCT02228382|69250724|FG001|Overall Study|Death|7|||
37751445|NCT02228382|69250725|FG002|Overall Study|Death|5|||
37751446|NCT02228382|69250726|FG003|Overall Study|Death|0|||
37751447|NCT02228382|69250727|FG004|Overall Study|Death|2|||
37751448|NCT02228382|69250723|FG000|Overall Study|Participant refused further follow-up|0|||
37751449|NCT02228382|69250724|FG001|Overall Study|Participant refused further follow-up|0|||
37661541|NCT02819635|69134307|FG001|Substudy 3|Withdrew consent|0|||
37661542|NCT02819635|69134308|FG002|Substudy 3|Withdrew consent|0|||
37751450|NCT02228382|69250725|FG002|Overall Study|Participant refused further follow-up|1|||
37751451|NCT02228382|69250726|FG003|Overall Study|Participant refused further follow-up|0|||
37751452|NCT02228382|69250727|FG004|Overall Study|Participant refused further follow-up|0|||
37751453|NCT02228382|69250723|FG000|Overall Study|Study terminated by sponsor|3|||
37751454|NCT02228382|69250724|FG001|Overall Study|Study terminated by sponsor|5|||
37751455|NCT02228382|69250725|FG002|Overall Study|Study terminated by sponsor|7|||
37751456|NCT02228382|69250726|FG003|Overall Study|Study terminated by sponsor|0|||
37751457|NCT02228382|69250727|FG004|Overall Study|Study terminated by sponsor|0|||
37751458|NCT02228382|69250723|FG000|Overall Study|Lost to Follow-up|0|||
37661543|NCT02819635|69134309|FG003|Substudy 3|Withdrew consent|0|||
37661544|NCT02819635|69134310|FG004|Substudy 3|Withdrew consent|0|||
37661545|NCT02819635|69134311|FG005|Substudy 3|Withdrew consent|0|||
37661546|NCT02819635|69134312|FG006|Substudy 3|Withdrew consent|0|||
37751459|NCT02228382|69250724|FG001|Overall Study|Lost to Follow-up|0|||
37661547|NCT02819635|69134313|FG007|Substudy 3|Withdrew consent|0|||
37661548|NCT02819635|69134314|FG008|Substudy 3|Withdrew consent|11|||
37751460|NCT02228382|69250725|FG002|Overall Study|Lost to Follow-up|3|||
37751461|NCT02228382|69250726|FG003|Overall Study|Lost to Follow-up|1|||
37751462|NCT02228382|69250727|FG004|Overall Study|Lost to Follow-up|0|||
37751463|NCT02228382|69250723|FG000|Overall Study|Withdrawal by Subject|0|||
37751464|NCT02228382|69250724|FG001|Overall Study|Withdrawal by Subject|3|||
37751465|NCT02228382|69250725|FG002|Overall Study|Withdrawal by Subject|2|||
37751466|NCT02228382|69250726|FG003|Overall Study|Withdrawal by Subject|1|||
37751467|NCT02228382|69250727|FG004|Overall Study|Withdrawal by Subject|0|||
37751468|NCT02228382|69250723|FG000|Overall Study|Other|2|||
37751469|NCT02228382|69250724|FG001|Overall Study|Other|3|||
37751470|NCT02228382|69250725|FG002|Overall Study|Other|3|||
37751471|NCT02228382|69250726|FG003|Overall Study|Other|0|||
37751472|NCT02228382|69250727|FG004|Overall Study|Other|0|||
37751473|NCT01900002|69250771|FG000|Overall Study|Withdrawal by Subject|2|||
37751474|NCT01900002|69250771|FG000|Overall Study|ineligible for Y-90|4|||
37751475|NCT01377012|69250801|FG000|Core Study|Study terminated by Sponsor|47|||
37751476|NCT01377012|69250802|FG001|Core Study|Study terminated by Sponsor|54|||
37751477|NCT01377012|69250803|FG002|Core Study|Study terminated by Sponsor|46|||
37751478|NCT01377012|69250801|FG000|Core Study|Technical problems|1|||
37751479|NCT01377012|69250802|FG001|Core Study|Technical problems|0|||
37751480|NCT01377012|69250803|FG002|Core Study|Technical problems|0|||
37751481|NCT01377012|69250801|FG000|Core Study|Withdrawal by Subject|15|||
37751482|NCT01377012|69250802|FG001|Core Study|Withdrawal by Subject|23|||
37751483|NCT01377012|69250803|FG002|Core Study|Withdrawal by Subject|18|||
37751484|NCT01377012|69250801|FG000|Core Study|Protocol Violation|7|||
37751485|NCT01377012|69250802|FG001|Core Study|Protocol Violation|3|||
37751486|NCT01377012|69250803|FG002|Core Study|Protocol Violation|2|||
37751487|NCT01377012|69250801|FG000|Core Study|Pregnancy|0|||
37751488|NCT01377012|69250802|FG001|Core Study|Pregnancy|0|||
37751489|NCT01377012|69250803|FG002|Core Study|Pregnancy|1|||
37751490|NCT01377012|69250801|FG000|Core Study|Physician Decision|5|||
37751491|NCT01377012|69250802|FG001|Core Study|Physician Decision|4|||
37661549|NCT02819635|69134315|FG009|Substudy 3|Withdrew consent|1|||
37661550|NCT02819635|69134316|FG010|Substudy 3|Withdrew consent|4|||
37661551|NCT02819635|69134317|FG011|Substudy 3|Withdrew consent|9|||
37661552|NCT02819635|69134306|FG000|Substudy 3|Lost to Follow-up|0|||
37661553|NCT02819635|69134307|FG001|Substudy 3|Lost to Follow-up|0|||
37661554|NCT02819635|69134308|FG002|Substudy 3|Lost to Follow-up|0|||
37661555|NCT02819635|69134309|FG003|Substudy 3|Lost to Follow-up|0|||
37751492|NCT01377012|69250803|FG002|Core Study|Physician Decision|10|||
37751493|NCT01377012|69250801|FG000|Core Study|Non-Compliant with study treatment|0|||
37751494|NCT01377012|69250802|FG001|Core Study|Non-Compliant with study treatment|0|||
38033188|NCT04760314|69719147|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
38033189|NCT04760314|69719148|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
37661556|NCT02819635|69134310|FG004|Substudy 3|Lost to Follow-up|0|||
37661557|NCT02819635|69134311|FG005|Substudy 3|Lost to Follow-up|0|||
37751495|NCT01377012|69250803|FG002|Core Study|Non-Compliant with study treatment|1|||
37751496|NCT01377012|69250801|FG000|Core Study|No Longer require treatment|0|||
37751497|NCT01377012|69250802|FG001|Core Study|No Longer require treatment|0|||
37751498|NCT01377012|69250803|FG002|Core Study|No Longer require treatment|1|||
37751499|NCT01377012|69250801|FG000|Core Study|Lost to Follow-up|7|||
37751500|NCT01377012|69250802|FG001|Core Study|Lost to Follow-up|5|||
37751501|NCT01377012|69250803|FG002|Core Study|Lost to Follow-up|4|||
37751502|NCT01377012|69250801|FG000|Core Study|Lack of Efficacy|41|||
37751503|NCT01377012|69250802|FG001|Core Study|Lack of Efficacy|28|||
37751504|NCT01377012|69250803|FG002|Core Study|Lack of Efficacy|37|||
37751505|NCT01377012|69250801|FG000|Core Study|Death|1|||
37751506|NCT01377012|69250802|FG001|Core Study|Death|1|||
37751507|NCT01377012|69250803|FG002|Core Study|Death|1|||
37751508|NCT01377012|69250801|FG000|Core Study|Adverse Event|10|||
37661558|NCT02819635|69134312|FG006|Substudy 3|Lost to Follow-up|0|||
37661559|NCT02819635|69134313|FG007|Substudy 3|Lost to Follow-up|0|||
37751509|NCT01377012|69250802|FG001|Core Study|Adverse Event|14|||
37751510|NCT01377012|69250803|FG002|Core Study|Adverse Event|13|||
37751511|NCT01377012|69250801|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
37661560|NCT02819635|69134314|FG008|Substudy 3|Lost to Follow-up|1|||
37661561|NCT02819635|69134315|FG009|Substudy 3|Lost to Follow-up|0|||
37661562|NCT02819635|69134316|FG010|Substudy 3|Lost to Follow-up|1|||
37661563|NCT02819635|69134317|FG011|Substudy 3|Lost to Follow-up|1|||
37661564|NCT02819635|69134306|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
37661565|NCT02819635|69134307|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
37661566|NCT02819635|69134308|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
37661567|NCT02819635|69134309|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
37661568|NCT02819635|69134310|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
37661569|NCT02819635|69134311|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
37661570|NCT02819635|69134312|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
37661571|NCT02819635|69134313|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
37661572|NCT02819635|69134314|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
37751512|NCT01377012|69250802|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
37751513|NCT01377012|69250803|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
37751514|NCT01377012|69250801|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
37751515|NCT01377012|69250802|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
37751516|NCT01377012|69250803|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
37751517|NCT01377012|69250801|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
37751518|NCT01377012|69250802|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
37751519|NCT01377012|69250803|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
37661573|NCT02819635|69134315|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
37661574|NCT02819635|69134316|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
37661575|NCT02819635|69134317|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
37661576|NCT02819635|69134306|FG000|Substudy 3|Other, not specified|0|||
37661577|NCT02819635|69134307|FG001|Substudy 3|Other, not specified|0|||
37661578|NCT02819635|69134308|FG002|Substudy 3|Other, not specified|0|||
37661579|NCT02819635|69134309|FG003|Substudy 3|Other, not specified|0|||
37661580|NCT02819635|69134310|FG004|Substudy 3|Other, not specified|0|||
37661581|NCT02819635|69134311|FG005|Substudy 3|Other, not specified|0|||
37661582|NCT02819635|69134312|FG006|Substudy 3|Other, not specified|0|||
37661583|NCT02819635|69134313|FG007|Substudy 3|Other, not specified|0|||
37661584|NCT02819635|69134314|FG008|Substudy 3|Other, not specified|202|||
37661585|NCT02819635|69134315|FG009|Substudy 3|Other, not specified|5|||
37661586|NCT02819635|69134316|FG010|Substudy 3|Other, not specified|89|||
37661587|NCT02819635|69134317|FG011|Substudy 3|Other, not specified|39|||
37661588|NCT02424344|69134352|FG000|Overall Study|Lack of Efficacy|0|||
37751520|NCT01377012|69250801|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
37751521|NCT01377012|69250802|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
37661589|NCT02424344|69134353|FG001|Overall Study|Lack of Efficacy|1|||
37661590|NCT02424344|69134352|FG000|Overall Study|Withdrawal by Subject|2|||
37751522|NCT01377012|69250803|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
37751523|NCT01377012|69250801|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
37751524|NCT01377012|69250802|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
37751525|NCT01377012|69250803|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
37751526|NCT01377012|69250801|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
37751527|NCT01377012|69250802|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
37751528|NCT01377012|69250803|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
37751529|NCT01376310|69251052|FG000|Overall Study|Study closed/terminated|1|||
37751530|NCT01376310|69251053|FG001|Overall Study|Study closed/terminated|2|||
37751531|NCT01376310|69251052|FG000|Overall Study|Withdrawal by Subject|8|||
37751532|NCT01376310|69251053|FG001|Overall Study|Withdrawal by Subject|2|||
37751533|NCT01376310|69251052|FG000|Overall Study|Physician Decision|26|||
37751534|NCT01376310|69251053|FG001|Overall Study|Physician Decision|7|||
37751535|NCT01376310|69251052|FG000|Overall Study|Lost to Follow-up|1|||
37751536|NCT01376310|69251053|FG001|Overall Study|Lost to Follow-up|0|||
37751537|NCT01949506|69251059|FG000|Overall Study|Physician Decision|1|||
37751538|NCT00709098|69251156|FG000|Double-blind Period|Withdrawal of consent|3|||
37751539|NCT00709098|69251157|FG001|Double-blind Period|Withdrawal of consent|3|||
37751540|NCT00709098|69251158|FG002|Double-blind Period|Withdrawal of consent|0|||
37751541|NCT00709098|69251156|FG000|Double-blind Period|Administrative reason|1|||
37751542|NCT00709098|69251157|FG001|Double-blind Period|Administrative reason|3|||
37856880|NCT00998764|69540050|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
37856881|NCT00998764|69540051|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
37661591|NCT02424344|69134353|FG001|Overall Study|Withdrawal by Subject|1|||
37751543|NCT00709098|69251158|FG002|Double-blind Period|Administrative reason|0|||
37751544|NCT00709098|69251156|FG000|Double-blind Period|Death|1|||
37661592|NCT02424344|69134352|FG000|Overall Study|Lost to Follow-up|1|||
37661593|NCT02424344|69134353|FG001|Overall Study|Lost to Follow-up|0|||
37661594|NCT02424344|69134352|FG000|Overall Study|Adverse Event|4|||
37661595|NCT02424344|69134353|FG001|Overall Study|Adverse Event|8|||
37661596|NCT02423798|69134359|FG000|Overall Study|Withdrawal by Subject|3|||
37856882|NCT00998764|69540050|FG000|Overall Study|Protocol Violation|0|||
37751545|NCT00709098|69251157|FG001|Double-blind Period|Death|1|||
37856883|NCT00998764|69540051|FG001|Overall Study|Protocol Violation|1|||
37751546|NCT00709098|69251158|FG002|Double-blind Period|Death|0|||
37751547|NCT00709098|69251156|FG000|Double-blind Period|Lost to Follow-up|1|||
37751548|NCT00709098|69251157|FG001|Double-blind Period|Lost to Follow-up|1|||
37751549|NCT00709098|69251158|FG002|Double-blind Period|Lost to Follow-up|0|||
37751550|NCT00709098|69251156|FG000|Open-label Period|Withdrawal of consent|0|||
37751551|NCT00709098|69251157|FG001|Open-label Period|Withdrawal of consent|0|||
37751552|NCT00709098|69251158|FG002|Open-label Period|Withdrawal of consent|7|||
37751553|NCT00709098|69251156|FG000|Open-label Period|Administrative reason|0|||
37751554|NCT00709098|69251157|FG001|Open-label Period|Administrative reason|0|||
37751555|NCT00709098|69251158|FG002|Open-label Period|Administrative reason|5|||
37751556|NCT00709098|69251156|FG000|Open-label Period|Death|0|||
37751557|NCT00709098|69251157|FG001|Open-label Period|Death|0|||
37751558|NCT00709098|69251158|FG002|Open-label Period|Death|1|||
37751559|NCT00709098|69251156|FG000|Open-label Period|Lost to Follow-up|0|||
37751560|NCT00709098|69251157|FG001|Open-label Period|Lost to Follow-up|0|||
37751561|NCT00709098|69251158|FG002|Open-label Period|Lost to Follow-up|1|||
37751562|NCT01376700|69251167|FG000|Overall Study|Sponsor terminated study early|8|||
37751563|NCT01376700|69251167|FG000|Overall Study|Low or high titer inhibitor|8|||
37751564|NCT01797965|69251178|FG000|Overall Study|Adverse Event|104|||
37751565|NCT01797965|69251179|FG001|Overall Study|Adverse Event|129|||
37751566|NCT01797965|69251180|FG002|Overall Study|Adverse Event|4|||
37751567|NCT01797965|69251181|FG003|Overall Study|Adverse Event|21|||
37751568|NCT01797965|69251178|FG000|Overall Study|Lost to Follow-up|9|||
37751569|NCT01797965|69251179|FG001|Overall Study|Lost to Follow-up|8|||
37751570|NCT01797965|69251180|FG002|Overall Study|Lost to Follow-up|1|||
37751571|NCT01797965|69251181|FG003|Overall Study|Lost to Follow-up|2|||
37751572|NCT01797965|69251178|FG000|Overall Study|Consent withdrawn|130|||
37751573|NCT01797965|69251179|FG001|Overall Study|Consent withdrawn|117|||
37751574|NCT01797965|69251180|FG002|Overall Study|Consent withdrawn|3|||
37751575|NCT01797965|69251181|FG003|Overall Study|Consent withdrawn|35|||
37751576|NCT01797965|69251178|FG000|Overall Study|Investigator decision|21|||
37751577|NCT01797965|69251179|FG001|Overall Study|Investigator decision|15|||
37751578|NCT01797965|69251180|FG002|Overall Study|Investigator decision|0|||
37751579|NCT01797965|69251181|FG003|Overall Study|Investigator decision|0|||
37751580|NCT01797965|69251178|FG000|Overall Study|Death|2|||
37751581|NCT01797965|69251179|FG001|Overall Study|Death|4|||
37751582|NCT01797965|69251180|FG002|Overall Study|Death|0|||
37751583|NCT01797965|69251181|FG003|Overall Study|Death|0|||
37751584|NCT01797965|69251178|FG000|Overall Study|Disease progression, defined by protocol|3|||
37751585|NCT01797965|69251179|FG001|Overall Study|Disease progression, defined by protocol|1|||
37751586|NCT01797965|69251180|FG002|Overall Study|Disease progression, defined by protocol|0|||
37751587|NCT01797965|69251181|FG003|Overall Study|Disease progression, defined by protocol|0|||
37751588|NCT01797965|69251178|FG000|Overall Study|Reason Not Specified|280|||
37751589|NCT01797965|69251179|FG001|Overall Study|Reason Not Specified|295|||
37751590|NCT01797965|69251180|FG002|Overall Study|Reason Not Specified|0|||
37751591|NCT01797965|69251181|FG003|Overall Study|Reason Not Specified|15|||
37751592|NCT01376388|69251226|FG000|Overall Study|Adverse Event|13|||
37751593|NCT01376388|69251226|FG000|Overall Study|Lack of Efficacy|2|||
37751594|NCT01376388|69251226|FG000|Overall Study|Withdrawal by Subject|3|||
37751595|NCT01821677|69251247|FG000|Overall Study|Adverse Event|4|||
37751596|NCT01821677|69251248|FG001|Overall Study|Adverse Event|6|||
37661597|NCT01651208|69134382|FG000|Overall Study|Lost to Follow-up|14|||
37661598|NCT01651208|69134383|FG001|Overall Study|Lost to Follow-up|16|||
37661599|NCT02383940|69134392|FG000|Overall Study|Adverse Event|1|||
37661600|NCT02383940|69134393|FG001|Overall Study|Adverse Event|0|||
37661601|NCT02383940|69134392|FG000|Overall Study|Lost to Follow-up|2|||
37661602|NCT02383940|69134393|FG001|Overall Study|Lost to Follow-up|2|||
37661603|NCT02383940|69134392|FG000|Overall Study|Physician Decision|2|||
37661604|NCT02383940|69134393|FG001|Overall Study|Physician Decision|0|||
37661605|NCT02383940|69134392|FG000|Overall Study|Withdrawal by Subject|1|||
37661606|NCT02383940|69134393|FG001|Overall Study|Withdrawal by Subject|1|||
37661607|NCT02383940|69134392|FG000|Overall Study|Randomized but not treated|2|||
37661608|NCT02383940|69134393|FG001|Overall Study|Randomized but not treated|0|||
37661609|NCT02383940|69134392|FG000|Overall Study|Other than specified above|1|||
37751597|NCT01821677|69251249|FG002|Overall Study|Adverse Event|5|||
37751598|NCT01821677|69251247|FG000|Overall Study|Physician Decision|1|||
37751599|NCT01821677|69251248|FG001|Overall Study|Physician Decision|4|||
37751600|NCT01821677|69251249|FG002|Overall Study|Physician Decision|1|||
37856884|NCT00998764|69540050|FG000|Overall Study|Failed to Return|1|||
37751601|NCT01821677|69251247|FG000|Overall Study|Non-compliance|0|||
37751602|NCT01821677|69251248|FG001|Overall Study|Non-compliance|1|||
37751603|NCT01821677|69251249|FG002|Overall Study|Non-compliance|2|||
37751604|NCT01821677|69251247|FG000|Overall Study|Lost to Follow-up|2|||
37751605|NCT01821677|69251248|FG001|Overall Study|Lost to Follow-up|1|||
37751606|NCT01821677|69251249|FG002|Overall Study|Lost to Follow-up|3|||
37751607|NCT01821677|69251247|FG000|Overall Study|Protocol Violation|0|||
37751608|NCT01821677|69251248|FG001|Overall Study|Protocol Violation|0|||
37661610|NCT02383940|69134393|FG001|Overall Study|Other than specified above|0|||
37661611|NCT02383862|69134401|FG000|3 Month Follow up|Lost to Follow-up|23|||
37661612|NCT02383862|69134402|FG001|3 Month Follow up|Lost to Follow-up|21|||
37661613|NCT02383472|69134417|FG000|Overall Study|Withdrawal by Subject|1|||
37661614|NCT02383472|69134418|FG001|Overall Study|Withdrawal by Subject|1|||
37661615|NCT02234323|69134426|FG000|All Enrolled|Not Treated: Completed study in database|2|||
37661616|NCT02234323|69134426|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
37661617|NCT02234323|69134426|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
37661618|NCT02234323|69134426|FG000|All Treated|Death|1|||
37661619|NCT02234323|69134426|FG000|All Treated|Physician Decision|5|||
37661620|NCT02234323|69134426|FG000|All Treated|Lack of Efficacy|3|||
37661621|NCT02234323|69134426|FG000|All Treated|Exceeded lab value limit|2|||
37661622|NCT02234323|69134426|FG000|All Treated|Other|7|||
37661623|NCT02414828|69134436|FG000|Overall Study|Lost to Follow-up|0|||
37661624|NCT02414828|69134437|FG001|Overall Study|Lost to Follow-up|1|||
37661625|NCT02414828|69134438|FG002|Overall Study|Lost to Follow-up|1|||
37661626|NCT02414828|69134439|FG003|Overall Study|Lost to Follow-up|2|||
37661627|NCT02413346|69134452|FG000|Overall Study|Adverse Event|6|||
37661628|NCT02413346|69134453|FG001|Overall Study|Adverse Event|6|||
37661629|NCT02413346|69134452|FG000|Overall Study|Withdrawal by Subject|30|||
37751609|NCT01821677|69251249|FG002|Overall Study|Protocol Violation|2|||
37751610|NCT01821677|69251247|FG000|Overall Study|Withdrawal by Subject|7|||
37751611|NCT01821677|69251248|FG001|Overall Study|Withdrawal by Subject|3|||
37751612|NCT01821677|69251249|FG002|Overall Study|Withdrawal by Subject|2|||
37751613|NCT01821677|69251247|FG000|Overall Study|Other|9|||
37751614|NCT01821677|69251248|FG001|Overall Study|Other|0|||
37751615|NCT01821677|69251249|FG002|Overall Study|Other|0|||
37751616|NCT01797731|69251260|FG000|Overall Study|Didn't have proper radiographs required|3|||
37751617|NCT01797731|69251261|FG001|Overall Study|Didn't have proper radiographs required|3|||
37751618|NCT00709722|69251267|FG000|Overall Study|Adverse Event|1|||
37751619|NCT01820585|69251288|FG000|Overall Study|Adverse Event|9|||
37751620|NCT01820585|69251289|FG001|Overall Study|Adverse Event|13|||
37856885|NCT00998764|69540051|FG001|Overall Study|Failed to Return|1|||
37856886|NCT00998764|69540050|FG000|Overall Study|Lost to Follow-up|1|||
37661630|NCT02413346|69134453|FG001|Overall Study|Withdrawal by Subject|40|||
37661631|NCT02413346|69134452|FG000|Overall Study|Lost to Follow-up|17|||
37661632|NCT02413346|69134453|FG001|Overall Study|Lost to Follow-up|21|||
37661633|NCT02413346|69134452|FG000|Overall Study|Protocol Violation|2|||
37661634|NCT02413346|69134453|FG001|Overall Study|Protocol Violation|0|||
37661635|NCT02413346|69134452|FG000|Overall Study|Other Miscellaneous Reasons|4|||
37856887|NCT00998764|69540051|FG001|Overall Study|Lost to Follow-up|1|||
37661636|NCT02413346|69134453|FG001|Overall Study|Other Miscellaneous Reasons|3|||
37661637|NCT03390101|69134466|FG000|Weeks 0-12|Withdrawal by Subject|0|||
37661638|NCT03390101|69134467|FG001|Weeks 0-12|Withdrawal by Subject|1|||
37661639|NCT03390101|69134468|FG002|Weeks 0-12|Withdrawal by Subject|1|||
37661640|NCT03390101|69134466|FG000|Weeks 0-12|Lost to Follow-up|0|||
37661641|NCT03390101|69134467|FG001|Weeks 0-12|Lost to Follow-up|1|||
37661642|NCT03390101|69134468|FG002|Weeks 0-12|Lost to Follow-up|0|||
37661643|NCT03390101|69134466|FG000|Weeks 12-54|Withdrawal by Subject|0|||
37661644|NCT03390101|69134467|FG001|Weeks 12-54|Withdrawal by Subject|3|||
37661645|NCT03390101|69134468|FG002|Weeks 12-54|Withdrawal by Subject|1|||
37661646|NCT03390101|69134466|FG000|Weeks 12-54|Pregnancy|1|||
37661647|NCT03390101|69134467|FG001|Weeks 12-54|Pregnancy|0|||
37661648|NCT03390101|69134468|FG002|Weeks 12-54|Pregnancy|0|||
37661649|NCT03390101|69134466|FG000|Weeks 12-54|Adverse Event|2|||
37661650|NCT03390101|69134467|FG001|Weeks 12-54|Adverse Event|1|||
37661651|NCT03390101|69134468|FG002|Weeks 12-54|Adverse Event|1|||
37661652|NCT02732639|69134476|FG000|Overall Study|Lost to Follow-up|1|||
37661653|NCT02732561|69134482|FG000|Overall Study|Lost to Follow-up|1|||
37661654|NCT02732561|69134483|FG001|Overall Study|Lost to Follow-up|1|||
37661655|NCT02732561|69134482|FG000|Overall Study|Withdrawal by Subject|1|||
37661656|NCT02732561|69134483|FG001|Overall Study|Withdrawal by Subject|0|||
37661657|NCT02412878|69134491|FG000|Overall Study|Withdrawal by Subject|19|||
37661658|NCT02412878|69134492|FG001|Overall Study|Withdrawal by Subject|10|||
37661659|NCT02412878|69134491|FG000|Overall Study|Lost to Follow-up|2|||
37661660|NCT02412878|69134492|FG001|Overall Study|Lost to Follow-up|3|||
37661661|NCT02380742|69134500|FG000|Overall Study|Withdrawal by Subject|1|||
37661662|NCT02380742|69134501|FG001|Overall Study|Withdrawal by Subject|0|||
37661663|NCT02922725|69134510|FG000|Overall Study|Withdrawal by Subject|1|||
37661664|NCT02922725|69134511|FG001|Overall Study|Withdrawal by Subject|0|||
37661665|NCT02922725|69134512|FG002|Overall Study|Withdrawal by Subject|0|||
37661666|NCT02805257|69134521|FG000|Overall Study|Lost to Follow-up|7|||
37661667|NCT02805257|69134522|FG001|Overall Study|Lost to Follow-up|6|||
37661668|NCT02805257|69134521|FG000|Overall Study|Death|0|||
37661669|NCT02805257|69134522|FG001|Overall Study|Death|1|||
37661670|NCT04794803|69134530|FG000|Overall Study|Death|1|||
37661671|NCT04794803|69134531|FG001|Overall Study|Death|3|||
37661672|NCT04794803|69134530|FG000|Overall Study|Lost to Follow-up|2|||
37751621|NCT01820585|69251290|FG002|Overall Study|Adverse Event|23|||
37751622|NCT01820585|69251291|FG003|Overall Study|Adverse Event|34|||
37856888|NCT00998764|69540050|FG000|Overall Study|Loss of Caregiver|0|||
37661673|NCT04794803|69134531|FG001|Overall Study|Lost to Follow-up|2|||
37661674|NCT04794803|69134530|FG000|Overall Study|Withdrawal by Subject|1|||
37661675|NCT04794803|69134531|FG001|Overall Study|Withdrawal by Subject|0|||
37661676|NCT04794803|69134530|FG000|Overall Study|Physician Decision|1|||
37661677|NCT04794803|69134531|FG001|Overall Study|Physician Decision|1|||
37661678|NCT04794803|69134530|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
37661679|NCT04794803|69134531|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
37661680|NCT04794803|69134530|FG000|Overall Study|Refused to continue the treatment|1|||
37661681|NCT04794803|69134531|FG001|Overall Study|Refused to continue the treatment|0|||
37661682|NCT04794803|69134530|FG000|Overall Study|Patient admitted to ICU|0|||
37661683|NCT04794803|69134531|FG001|Overall Study|Patient admitted to ICU|1|||
37661684|NCT01791595|69134544|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
37661685|NCT01791595|69134545|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
37661686|NCT01791595|69134546|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
37661687|NCT01791595|69134547|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
37661688|NCT01791595|69134548|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
37661689|NCT01791595|69134549|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
37661690|NCT01791595|69134550|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
37661691|NCT01791595|69134544|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
37661692|NCT01791595|69134545|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
37661693|NCT01791595|69134546|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
37661694|NCT01791595|69134547|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
37751623|NCT01820585|69251288|FG000|Overall Study|Lack of Efficacy|9|||
37751624|NCT01820585|69251289|FG001|Overall Study|Lack of Efficacy|7|||
37751625|NCT01820585|69251290|FG002|Overall Study|Lack of Efficacy|5|||
37751626|NCT01820585|69251291|FG003|Overall Study|Lack of Efficacy|1|||
37751627|NCT01820585|69251288|FG000|Overall Study|Withdrawal by Subject|3|||
37751628|NCT01820585|69251289|FG001|Overall Study|Withdrawal by Subject|7|||
37751629|NCT01820585|69251290|FG002|Overall Study|Withdrawal by Subject|3|||
37751630|NCT01820585|69251291|FG003|Overall Study|Withdrawal by Subject|8|||
37751631|NCT01820585|69251288|FG000|Overall Study|Lost to Follow-up|3|||
37751632|NCT01820585|69251289|FG001|Overall Study|Lost to Follow-up|3|||
37751633|NCT01820585|69251290|FG002|Overall Study|Lost to Follow-up|0|||
37751634|NCT01820585|69251291|FG003|Overall Study|Lost to Follow-up|3|||
37751635|NCT01820585|69251288|FG000|Overall Study|Protocol Violation|3|||
37751636|NCT01820585|69251289|FG001|Overall Study|Protocol Violation|1|||
37751637|NCT01820585|69251290|FG002|Overall Study|Protocol Violation|1|||
37751638|NCT01820585|69251291|FG003|Overall Study|Protocol Violation|1|||
37751639|NCT01820585|69251288|FG000|Overall Study|Subject non-compliance|0|||
37751640|NCT01820585|69251289|FG001|Overall Study|Subject non-compliance|0|||
37751641|NCT01820585|69251290|FG002|Overall Study|Subject non-compliance|1|||
37751642|NCT01820585|69251291|FG003|Overall Study|Subject non-compliance|2|||
37751643|NCT01820585|69251288|FG000|Overall Study|at sponsor request|0|||
37751644|NCT01820585|69251289|FG001|Overall Study|at sponsor request|0|||
37751645|NCT01820585|69251290|FG002|Overall Study|at sponsor request|1|||
37751646|NCT01820585|69251291|FG003|Overall Study|at sponsor request|0|||
37751647|NCT01820585|69251288|FG000|Overall Study|Pregnancy|0|||
37751648|NCT01820585|69251289|FG001|Overall Study|Pregnancy|1|||
37751649|NCT01820585|69251290|FG002|Overall Study|Pregnancy|0|||
37751650|NCT01820585|69251291|FG003|Overall Study|Pregnancy|0|||
37751651|NCT01797263|69251303|FG000|Overall Study|Withdrawal by Subject|21|||
37751652|NCT01797263|69251304|FG001|Overall Study|Withdrawal by Subject|25|||
37751653|NCT01797263|69251303|FG000|Overall Study|Death|1|||
37751654|NCT01797263|69251304|FG001|Overall Study|Death|0|||
37751655|NCT01797263|69251303|FG000|Overall Study|Lost to Follow-up|15|||
37751656|NCT01797263|69251304|FG001|Overall Study|Lost to Follow-up|15|||
37751657|NCT01797185|69251359|FG000|Overall Study|Adverse Event|5|||
37751658|NCT01797185|69251360|FG001|Overall Study|Adverse Event|15|||
37751659|NCT01797185|69251361|FG002|Overall Study|Adverse Event|6|||
37751660|NCT01797185|69251359|FG000|Overall Study|Withdrawal by Subject|6|||
37751661|NCT01797185|69251360|FG001|Overall Study|Withdrawal by Subject|9|||
37751662|NCT01797185|69251361|FG002|Overall Study|Withdrawal by Subject|5|||
37751663|NCT01797185|69251359|FG000|Overall Study|Site terminated|8|||
37751664|NCT01797185|69251360|FG001|Overall Study|Site terminated|4|||
37751665|NCT01797185|69251361|FG002|Overall Study|Site terminated|0|||
37751666|NCT01797185|69251359|FG000|Overall Study|Lost to Follow-up|2|||
37751667|NCT01797185|69251360|FG001|Overall Study|Lost to Follow-up|6|||
37751668|NCT01797185|69251361|FG002|Overall Study|Lost to Follow-up|1|||
37751669|NCT01797185|69251359|FG000|Overall Study|Withdrawn per sponsor|5|||
37751670|NCT01797185|69251360|FG001|Overall Study|Withdrawn per sponsor|0|||
37751671|NCT01797185|69251361|FG002|Overall Study|Withdrawn per sponsor|0|||
37751672|NCT01797185|69251359|FG000|Overall Study|Physician Decision|1|||
37751673|NCT01797185|69251360|FG001|Overall Study|Physician Decision|3|||
37751674|NCT01797185|69251361|FG002|Overall Study|Physician Decision|0|||
37751675|NCT01797185|69251359|FG000|Overall Study|Protocol Violation|1|||
37751676|NCT01797185|69251360|FG001|Overall Study|Protocol Violation|1|||
37751677|NCT01797185|69251361|FG002|Overall Study|Protocol Violation|0|||
37751678|NCT01819727|69251417|FG000|Overall Study|Adverse Event|8|||
37751679|NCT01819727|69251418|FG001|Overall Study|Adverse Event|9|||
37751680|NCT01819727|69251417|FG000|Overall Study|Death|1|||
37751681|NCT01819727|69251418|FG001|Overall Study|Death|0|||
37751682|NCT01819727|69251417|FG000|Overall Study|Lost to Follow-up|1|||
37751683|NCT01819727|69251418|FG001|Overall Study|Lost to Follow-up|1|||
37751684|NCT01819727|69251417|FG000|Overall Study|Physician Decision|3|||
37751685|NCT01819727|69251418|FG001|Overall Study|Physician Decision|2|||
37751686|NCT01819727|69251417|FG000|Overall Study|Pregnancy|1|||
37751687|NCT01819727|69251418|FG001|Overall Study|Pregnancy|0|||
37751688|NCT01819727|69251417|FG000|Overall Study|Protocol Violation|0|||
37751689|NCT01819727|69251418|FG001|Overall Study|Protocol Violation|2|||
37751690|NCT01819727|69251417|FG000|Overall Study|Study Terminated by Sponsor|0|||
37751691|NCT01819727|69251418|FG001|Overall Study|Study Terminated by Sponsor|1|||
37751692|NCT01819727|69251417|FG000|Overall Study|Withdrawal by Subject|6|||
37751693|NCT01819727|69251418|FG001|Overall Study|Withdrawal by Subject|11|||
37751694|NCT01819727|69251417|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
37751695|NCT01819727|69251418|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
37751696|NCT01819727|69251417|FG000|Overall Study|Quit due to lack of health benifits|0|||
37751697|NCT01819727|69251418|FG001|Overall Study|Quit due to lack of health benifits|1|||
37751698|NCT01795937|69251477|FG000|Overall Study|Withdrawal by Subject|1|||
37751699|NCT01795937|69251478|FG001|Overall Study|Withdrawal by Subject|0|||
37751700|NCT01795937|69251479|FG002|Overall Study|Withdrawal by Subject|0|||
37751701|NCT01795937|69251477|FG000|Overall Study|Physician Decision|0|||
37751702|NCT01795937|69251478|FG001|Overall Study|Physician Decision|1|||
37751703|NCT01795937|69251479|FG002|Overall Study|Physician Decision|0|||
37751704|NCT01817777|69251521|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
37751705|NCT01817777|69251522|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
37751706|NCT01817777|69251523|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
37661695|NCT01791595|69134548|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
37661696|NCT01791595|69134549|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
37661697|NCT01791595|69134550|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
37661698|NCT01791595|69134544|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
37751707|NCT01817777|69251521|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
37751708|NCT01817777|69251522|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
37751709|NCT01817777|69251523|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
37661699|NCT01791595|69134545|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
37661700|NCT01791595|69134546|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
37661701|NCT01791595|69134547|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
37661702|NCT01791595|69134548|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
37661703|NCT01791595|69134549|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
37661704|NCT01791595|69134550|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
37661705|NCT01791595|69134544|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
37661706|NCT01791595|69134545|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
37661707|NCT01791595|69134546|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
37661708|NCT01791595|69134547|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
37661709|NCT01791595|69134548|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
37661710|NCT01791595|69134549|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
37661711|NCT01791595|69134550|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
37661712|NCT01791595|69134544|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
37661713|NCT01791595|69134545|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
37661714|NCT01791595|69134546|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
37661715|NCT01791595|69134547|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
37661716|NCT01791595|69134548|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
37661717|NCT01791595|69134549|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
37661718|NCT01791595|69134550|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
37661719|NCT01791595|69134544|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
37661720|NCT01791595|69134545|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
37661721|NCT01791595|69134546|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
37661722|NCT01791595|69134547|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
37661723|NCT01791595|69134548|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
37751710|NCT01817777|69251521|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
37751711|NCT01817777|69251522|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
37751712|NCT01817777|69251523|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
37751713|NCT01817777|69251521|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
37751714|NCT01817777|69251522|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
37751715|NCT01817777|69251523|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
37751716|NCT01817777|69251521|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
37856889|NCT00998764|69540051|FG001|Overall Study|Loss of Caregiver|3|||
37751717|NCT01817777|69251522|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
37751718|NCT01817777|69251523|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
37751719|NCT01795547|69251549|FG000|Overall Study|Adverse Event|16|||
37751720|NCT01795547|69251550|FG001|Overall Study|Adverse Event|27|||
37751721|NCT01795547|69251549|FG000|Overall Study|Lack of Efficacy|8|||
37751722|NCT01795547|69251550|FG001|Overall Study|Lack of Efficacy|3|||
37751723|NCT01795547|69251549|FG000|Overall Study|Protocol Violation|6|||
37751724|NCT01795547|69251550|FG001|Overall Study|Protocol Violation|4|||
37751725|NCT01795547|69251549|FG000|Overall Study|Lost to Follow-up|2|||
37751726|NCT01795547|69251550|FG001|Overall Study|Lost to Follow-up|5|||
37751727|NCT01795547|69251549|FG000|Overall Study|Withdrawal of consent|7|||
37751728|NCT01795547|69251550|FG001|Overall Study|Withdrawal of consent|12|||
37751729|NCT01795547|69251549|FG000|Overall Study|Not Treated|4|||
37751730|NCT01795547|69251550|FG001|Overall Study|Not Treated|10|||
37751731|NCT01795547|69251549|FG000|Overall Study|Non-compliance with IMP|1|||
37751732|NCT01795547|69251550|FG001|Overall Study|Non-compliance with IMP|1|||
37751733|NCT01795547|69251549|FG000|Overall Study|Others|4|||
37751734|NCT01795547|69251550|FG001|Overall Study|Others|1|||
37751735|NCT01795547|69251549|FG000|Overall Study|Not stated|0|||
37751736|NCT01795547|69251550|FG001|Overall Study|Not stated|1|||
37751737|NCT01794923|69251576|FG000|Overall Study|Adverse Event|0|||
37751738|NCT01794923|69251577|FG001|Overall Study|Adverse Event|0|||
37751739|NCT01794923|69251578|FG002|Overall Study|Adverse Event|1|||
37751740|NCT01794845|69251586|FG000|Overall Study|Withdrawal by Subject|1|||
37751741|NCT01794689|69251594|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
37751742|NCT01794689|69251595|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
37751743|NCT01794689|69251596|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
37751744|NCT01794689|69251597|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
37751745|NCT01794689|69251594|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
37751746|NCT01794689|69251595|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
37751747|NCT01794689|69251596|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
37751748|NCT01794689|69251597|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
37856890|NCT00998764|69540050|FG000|Overall Study|Other|4|||
37856891|NCT00998764|69540051|FG001|Overall Study|Other|4|||
37856892|NCT00998764|69540050|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
37856893|NCT00998764|69540051|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
37856894|NCT01204671|69540064|FG000|Overall Study|Adverse Event|4|||
37856895|NCT01204671|69540065|FG001|Overall Study|Adverse Event|3|||
38033190|NCT04760314|69719149|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
37661724|NCT01791595|69134549|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
37661725|NCT01791595|69134550|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
37661726|NCT01791595|69134544|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
37661727|NCT01791595|69134545|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
37661728|NCT01791595|69134546|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
37661729|NCT01791595|69134547|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
37661730|NCT01791595|69134548|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
37661731|NCT01791595|69134549|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
37661732|NCT01791595|69134550|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
37661733|NCT01791595|69134544|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
37661734|NCT01791595|69134545|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
37661735|NCT01791595|69134546|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
37661736|NCT01791595|69134547|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
37661737|NCT01791595|69134548|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
37661738|NCT01791595|69134549|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
37661739|NCT01791595|69134550|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
37661740|NCT01791595|69134544|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
37661741|NCT01791595|69134545|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
37661742|NCT01791595|69134546|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
37661743|NCT01791595|69134547|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
37661744|NCT01791595|69134548|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
37661745|NCT01791595|69134549|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
37661746|NCT01791595|69134550|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
37661747|NCT01791595|69134544|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
37751749|NCT01794689|69251594|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
37751750|NCT01794689|69251595|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
37751751|NCT01794689|69251596|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
37751752|NCT01794689|69251597|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
37751753|NCT01794689|69251594|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
37751754|NCT01794689|69251595|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
37751755|NCT01794689|69251596|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
37751756|NCT01794689|69251597|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
37856896|NCT01204671|69540066|FG002|Overall Study|Adverse Event|3|||
37661748|NCT01791595|69134545|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
37661749|NCT01791595|69134546|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
37661750|NCT01791595|69134547|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
37661751|NCT01791595|69134548|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
37661752|NCT01791595|69134549|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
37661753|NCT01791595|69134550|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
37661754|NCT01791595|69134544|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
37661755|NCT01791595|69134545|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
37661756|NCT01791595|69134546|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
37661757|NCT01791595|69134547|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
37661758|NCT01791595|69134548|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
37661759|NCT01791595|69134549|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
37661760|NCT01791595|69134550|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
37661761|NCT01791595|69134544|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
37661762|NCT01791595|69134545|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
37661763|NCT01791595|69134546|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
37661764|NCT01791595|69134547|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
37661765|NCT01791595|69134548|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
37661766|NCT01791595|69134549|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
37661767|NCT01791595|69134550|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
37661768|NCT01791595|69134544|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
37661769|NCT01791595|69134545|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
37661770|NCT01791595|69134546|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
37661771|NCT01791595|69134547|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
37661772|NCT01791595|69134548|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
37661773|NCT01791595|69134549|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
37661774|NCT01791595|69134550|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
37661775|NCT01791595|69134544|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
37661776|NCT01791595|69134545|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
37661777|NCT01791595|69134546|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
37661778|NCT01791595|69134547|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
37661779|NCT01791595|69134548|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
37661780|NCT01791595|69134549|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
37661781|NCT01791595|69134550|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
37661782|NCT01791595|69134544|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
37661783|NCT01791595|69134545|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
37661784|NCT01791595|69134546|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
37661785|NCT01791595|69134547|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
37661786|NCT01791595|69134548|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
37661787|NCT01791595|69134549|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
37661788|NCT01791595|69134550|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
37661789|NCT01791595|69134544|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
37661790|NCT01791595|69134545|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
37661791|NCT01791595|69134546|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
37751757|NCT01794299|69251613|FG000|Overall Study|ATIR manufacturing not possible|1|||
37751758|NCT01794299|69251613|FG000|Overall Study|Death|14|||
37751759|NCT01794299|69251613|FG000|Overall Study|Graft failure|1|||
37751760|NCT01794299|69251613|FG000|Overall Study|ATIR batch rejected|2|||
37751761|NCT01794299|69251613|FG000|Overall Study|Relapse|2|||
37751762|NCT01794299|69251613|FG000|Overall Study|Discontinued from active follow-up|1|||
37751763|NCT01794299|69251613|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
37751764|NCT01817075|69251619|FG000|Overall Study|Adverse Event|7|||
37751765|NCT01817075|69251620|FG001|Overall Study|Adverse Event|5|||
37751766|NCT01817075|69251619|FG000|Overall Study|Physician Decision|9|||
37751767|NCT01817075|69251620|FG001|Overall Study|Physician Decision|12|||
37751768|NCT01817075|69251619|FG000|Overall Study|Withdrawal by Subject|31|||
37923216|NCT00826280|69610005|FG002|Overall Study|Sponsor discontinued subject or study|0|||
37923217|NCT00826280|69610003|FG000|Overall Study|Reversible ischemic defect not present|43|||
37923218|NCT00826280|69610004|FG001|Overall Study|Reversible ischemic defect not present|40|||
37923219|NCT00826280|69610005|FG002|Overall Study|Reversible ischemic defect not present|44|||
37923220|NCT00826280|69610003|FG000|Overall Study|Interpretation Failure|1|||
37751769|NCT01817075|69251620|FG001|Overall Study|Withdrawal by Subject|15|||
37751770|NCT01817075|69251619|FG000|Overall Study|Received Sorafenib after enrollment|0|||
37751771|NCT01817075|69251620|FG001|Overall Study|Received Sorafenib after enrollment|1|||
37751772|NCT01817075|69251619|FG000|Overall Study|Ineligible|0|||
37751773|NCT01817075|69251620|FG001|Overall Study|Ineligible|2|||
37923221|NCT00826280|69610004|FG001|Overall Study|Interpretation Failure|0|||
37661792|NCT01791595|69134547|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
37661793|NCT01791595|69134548|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
37751774|NCT01816763|69251629|FG000|Overall Study|The main reason for an incomplete survey|4|||
37751775|NCT01816763|69251630|FG001|Overall Study|The main reason for an incomplete survey|15|||
37751776|NCT01816763|69251631|FG002|Overall Study|The main reason for an incomplete survey|11|||
37751777|NCT01816685|69251644|FG000|Overall Study|Lost to Follow-up|7|||
37751778|NCT01816685|69251645|FG001|Overall Study|Lost to Follow-up|9|||
37751779|NCT01816685|69251644|FG000|Overall Study|Surgery Cancelled|3|||
37751780|NCT01816685|69251645|FG001|Overall Study|Surgery Cancelled|2|||
37751781|NCT00708552|69251676|FG000|Overall Study|Adverse Event|10|||
37751782|NCT00708552|69251677|FG001|Overall Study|Adverse Event|3|||
37751783|NCT00708552|69251678|FG002|Overall Study|Adverse Event|4|||
37751784|NCT00708552|69251679|FG003|Overall Study|Adverse Event|6|||
37751785|NCT00708552|69251676|FG000|Overall Study|Lack of Efficacy|0|||
37751786|NCT00708552|69251677|FG001|Overall Study|Lack of Efficacy|4|||
37751787|NCT00708552|69251678|FG002|Overall Study|Lack of Efficacy|1|||
37751788|NCT00708552|69251679|FG003|Overall Study|Lack of Efficacy|0|||
37751789|NCT00708552|69251676|FG000|Overall Study|Protocol Violation|0|||
37751790|NCT00708552|69251677|FG001|Overall Study|Protocol Violation|0|||
37751791|NCT00708552|69251678|FG002|Overall Study|Protocol Violation|2|||
37751792|NCT00708552|69251679|FG003|Overall Study|Protocol Violation|4|||
37751793|NCT00708552|69251676|FG000|Overall Study|Lost to Follow-up|4|||
37751794|NCT00708552|69251677|FG001|Overall Study|Lost to Follow-up|2|||
37751795|NCT00708552|69251678|FG002|Overall Study|Lost to Follow-up|0|||
37751796|NCT00708552|69251679|FG003|Overall Study|Lost to Follow-up|1|||
37856897|NCT01204671|69540067|FG003|Overall Study|Adverse Event|3|||
37856898|NCT01204671|69540068|FG004|Overall Study|Adverse Event|1|||
37856899|NCT01204671|69540064|FG000|Overall Study|Withdrawal by Subject|2|||
37856900|NCT01204671|69540065|FG001|Overall Study|Withdrawal by Subject|3|||
37856901|NCT01204671|69540066|FG002|Overall Study|Withdrawal by Subject|4|||
37856902|NCT01204671|69540067|FG003|Overall Study|Withdrawal by Subject|5|||
37856903|NCT01204671|69540068|FG004|Overall Study|Withdrawal by Subject|3|||
37856904|NCT01204671|69540064|FG000|Overall Study|Lost to Follow-up|7|||
37856905|NCT01204671|69540065|FG001|Overall Study|Lost to Follow-up|8|||
37856906|NCT01204671|69540066|FG002|Overall Study|Lost to Follow-up|6|||
37856907|NCT01204671|69540067|FG003|Overall Study|Lost to Follow-up|4|||
37856908|NCT01204671|69540068|FG004|Overall Study|Lost to Follow-up|0|||
37856909|NCT01204671|69540064|FG000|Overall Study|Unknown Completion Status|1|||
37856910|NCT01204671|69540065|FG001|Overall Study|Unknown Completion Status|1|||
37856911|NCT01204671|69540066|FG002|Overall Study|Unknown Completion Status|0|||
37856912|NCT01204671|69540067|FG003|Overall Study|Unknown Completion Status|0|||
37856913|NCT01204671|69540068|FG004|Overall Study|Unknown Completion Status|0|||
37856914|NCT01204671|69540064|FG000|Overall Study|Physician Decision|0|||
37856915|NCT01204671|69540065|FG001|Overall Study|Physician Decision|0|||
37661794|NCT01791595|69134549|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
37661795|NCT01791595|69134550|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
37661796|NCT01791595|69134544|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
37661797|NCT01791595|69134545|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
37661798|NCT01791595|69134546|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
37661799|NCT01791595|69134547|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
37661800|NCT01791595|69134548|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
37661801|NCT01791595|69134549|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
37661802|NCT01791595|69134550|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
37661803|NCT01791595|69134544|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
37661804|NCT01791595|69134545|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
37661805|NCT01791595|69134546|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
37661806|NCT01791595|69134547|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
37661807|NCT01791595|69134548|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
37661808|NCT01791595|69134549|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
37751797|NCT00708552|69251676|FG000|Overall Study|Physician Decision|1|||
37751798|NCT00708552|69251677|FG001|Overall Study|Physician Decision|2|||
37856916|NCT01204671|69540066|FG002|Overall Study|Physician Decision|0|||
37856917|NCT01204671|69540067|FG003|Overall Study|Physician Decision|1|||
37856918|NCT01204671|69540068|FG004|Overall Study|Physician Decision|0|||
37856919|NCT01202955|69540086|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
37856920|NCT01202955|69540087|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
37856921|NCT01202877|69540096|FG000|Overall Study|Disease Progression|0|||
37856922|NCT01202877|69540097|FG001|Overall Study|Disease Progression|1|||
37856923|NCT01202877|69540098|FG002|Overall Study|Disease Progression|2|||
37856924|NCT01202877|69540096|FG000|Overall Study|Adverse Event|0|||
37856925|NCT01202877|69540097|FG001|Overall Study|Adverse Event|0|||
37856926|NCT01202877|69540098|FG002|Overall Study|Adverse Event|2|||
37856927|NCT01202877|69540096|FG000|Overall Study|Withdrawal by Subject|0|||
37856928|NCT01202877|69540097|FG001|Overall Study|Withdrawal by Subject|0|||
37856929|NCT01202877|69540098|FG002|Overall Study|Withdrawal by Subject|1|||
37751799|NCT00708552|69251678|FG002|Overall Study|Physician Decision|0|||
37751800|NCT00708552|69251679|FG003|Overall Study|Physician Decision|0|||
37751801|NCT00708552|69251676|FG000|Overall Study|Withdrawal by Subject|12|||
37751802|NCT00708552|69251677|FG001|Overall Study|Withdrawal by Subject|7|||
37751803|NCT00708552|69251678|FG002|Overall Study|Withdrawal by Subject|8|||
37751804|NCT00708552|69251679|FG003|Overall Study|Withdrawal by Subject|10|||
37751805|NCT01816295|69251809|FG000|Double Blind Phase|Adverse Event|11|||
37751806|NCT01816295|69251810|FG001|Double Blind Phase|Adverse Event|8|||
37751807|NCT01816295|69251809|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
37751808|NCT01816295|69251810|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
37751809|NCT01816295|69251809|FG000|Double Blind Phase|Lost to Follow-up|3|||
37751810|NCT01816295|69251810|FG001|Double Blind Phase|Lost to Follow-up|5|||
37751811|NCT01816295|69251809|FG000|Double Blind Phase|Physician Decision|2|||
37751812|NCT01816295|69251810|FG001|Double Blind Phase|Physician Decision|2|||
37751813|NCT01816295|69251809|FG000|Double Blind Phase|Protocol Violation|17|||
37751814|NCT01816295|69251810|FG001|Double Blind Phase|Protocol Violation|11|||
37751815|NCT01816295|69251809|FG000|Double Blind Phase|Sponsor Decision|8|||
37751816|NCT01816295|69251810|FG001|Double Blind Phase|Sponsor Decision|8|||
37751817|NCT01816295|69251809|FG000|Double Blind Phase|Withdrawal by Subject|22|||
37751818|NCT01816295|69251810|FG001|Double Blind Phase|Withdrawal by Subject|20|||
37751819|NCT01816295|69251809|FG000|OLE Phase|Adverse Event|17|||
37751820|NCT01816295|69251810|FG001|OLE Phase|Adverse Event|15|||
37751821|NCT01816295|69251809|FG000|OLE Phase|Death|1|||
37751822|NCT01816295|69251810|FG001|OLE Phase|Death|0|||
37751823|NCT01816295|69251809|FG000|OLE Phase|Entry Criteria Not Met|3|||
37751824|NCT01816295|69251810|FG001|OLE Phase|Entry Criteria Not Met|5|||
37751825|NCT01816295|69251809|FG000|OLE Phase|Lost to Follow-up|5|||
37751826|NCT01816295|69251810|FG001|OLE Phase|Lost to Follow-up|5|||
37751827|NCT01816295|69251809|FG000|OLE Phase|Physician Decision|3|||
37661809|NCT01791595|69134550|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
37661810|NCT01559363|69134603|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
37661811|NCT01559363|69134604|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
37661812|NCT01559363|69134605|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
37661813|NCT01559363|69134606|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
37661814|NCT01559363|69134607|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
37661815|NCT01559363|69134608|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
37661816|NCT01559363|69134603|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
37661817|NCT01559363|69134604|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
37661818|NCT01559363|69134605|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
37661819|NCT01559363|69134606|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
37661820|NCT01559363|69134607|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
37661821|NCT01559363|69134608|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
37661822|NCT01559363|69134603|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
37661823|NCT01559363|69134604|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
37661824|NCT01559363|69134605|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
37661825|NCT01559363|69134606|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
37661826|NCT01559363|69134607|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
37661827|NCT01559363|69134608|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
37661828|NCT01559363|69134603|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
37751828|NCT01816295|69251810|FG001|OLE Phase|Physician Decision|1|||
37751829|NCT01816295|69251809|FG000|OLE Phase|Protocol Violation|4|||
37751830|NCT01816295|69251810|FG001|OLE Phase|Protocol Violation|4|||
37751831|NCT01816295|69251809|FG000|OLE Phase|Sponsor Decision|7|||
37751832|NCT01816295|69251810|FG001|OLE Phase|Sponsor Decision|9|||
37751833|NCT01816295|69251809|FG000|OLE Phase|Withdrawal by Subject|10|||
37751834|NCT01816295|69251810|FG001|OLE Phase|Withdrawal by Subject|10|||
37856930|NCT01202877|69540096|FG000|Overall Study|Death|0|||
37856931|NCT01202877|69540097|FG001|Overall Study|Death|0|||
37661829|NCT01559363|69134604|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
37661830|NCT01559363|69134605|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
37661831|NCT01559363|69134606|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
37751835|NCT01816295|69251809|FG000|OLE Phase|Lack of Efficacy|3|||
37751836|NCT01816295|69251810|FG001|OLE Phase|Lack of Efficacy|7|||
37751837|NCT01610297|69251835|FG000|Overall Study|Lost to Follow-up|1|||
37661832|NCT01559363|69134607|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
37661833|NCT01559363|69134608|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
37751838|NCT01793051|69251846|FG000|Overall Study|Withdrawal by Subject|6|||
37751839|NCT01793051|69251847|FG001|Overall Study|Withdrawal by Subject|4|||
37751840|NCT01793051|69251846|FG000|Overall Study|Adverse Event|0|||
37751841|NCT01793051|69251847|FG001|Overall Study|Adverse Event|2|||
37751842|NCT01793051|69251846|FG000|Overall Study|Too ill to continue|1|||
37856932|NCT01202877|69540098|FG002|Overall Study|Death|1|||
37751843|NCT01793051|69251847|FG001|Overall Study|Too ill to continue|0|||
37751844|NCT01793051|69251846|FG000|Overall Study|Switched chemo|1|||
37751845|NCT01793051|69251847|FG001|Overall Study|Switched chemo|1|||
37661834|NCT01559363|69134603|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
37661835|NCT01559363|69134604|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
37661836|NCT01559363|69134605|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
37661837|NCT01559363|69134606|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
37661838|NCT01559363|69134607|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
37661839|NCT01559363|69134608|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
37661840|NCT01559363|69134603|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
37661841|NCT01559363|69134604|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
37661842|NCT01559363|69134605|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
37661843|NCT01559363|69134606|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
37661844|NCT01559363|69134607|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
37661845|NCT01559363|69134608|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
37751846|NCT01793051|69251846|FG000|Overall Study|Lack of compliance|1|||
37751847|NCT01793051|69251847|FG001|Overall Study|Lack of compliance|0|||
37751848|NCT01793051|69251846|FG000|Overall Study|Requested to be removed from the study|1|||
37751849|NCT01793051|69251847|FG001|Overall Study|Requested to be removed from the study|1|||
37751850|NCT01816061|69251880|FG000|Overall Study|Lost to Follow-up|13|||
37751851|NCT01816061|69251881|FG001|Overall Study|Lost to Follow-up|24|||
37751852|NCT01792115|69251907|FG000|Overall Study|Lost to Follow-up|0|||
37751853|NCT01792115|69251908|FG001|Overall Study|Lost to Follow-up|1|||
37751854|NCT01792115|69251909|FG002|Overall Study|Lost to Follow-up|0|||
37751855|NCT01791803|69251921|FG000|Overall Study|Withdrawal by Subject|0|||
37751856|NCT01791803|69251922|FG001|Overall Study|Withdrawal by Subject|0|||
37751857|NCT01791803|69251923|FG002|Overall Study|Withdrawal by Subject|0|||
37751858|NCT01791803|69251924|FG003|Overall Study|Withdrawal by Subject|2|||
37751859|NCT01791803|69251921|FG000|Overall Study|Physician Decision|0|||
37751860|NCT01791803|69251922|FG001|Overall Study|Physician Decision|2|||
37751861|NCT01791803|69251923|FG002|Overall Study|Physician Decision|0|||
37751862|NCT01791803|69251924|FG003|Overall Study|Physician Decision|1|||
37751863|NCT01791803|69251921|FG000|Overall Study|Death|0|||
37751864|NCT01791803|69251922|FG001|Overall Study|Death|0|||
37751865|NCT01791803|69251923|FG002|Overall Study|Death|2|||
37751866|NCT01791803|69251924|FG003|Overall Study|Death|2|||
37751867|NCT01791725|69251949|FG000|Overall Study|Withdrawal by Subject|0|||
37751868|NCT01791725|69251950|FG001|Overall Study|Withdrawal by Subject|1|||
37751869|NCT01791725|69251951|FG002|Overall Study|Withdrawal by Subject|0|||
37751870|NCT01791413|69251961|FG000|Overall Study|Lost to Follow-up|5|||
37751871|NCT01791413|69251962|FG001|Overall Study|Lost to Follow-up|1|||
37751872|NCT01610063|69251975|FG000|Overall Study|Lost to Follow-up|42|||
37751873|NCT01610063|69251976|FG001|Overall Study|Lost to Follow-up|20|||
37751874|NCT01813721|69251982|FG000|Overall Study|Ineligibility determined|63|||
37751875|NCT01813721|69251982|FG000|Overall Study|Withdrawal by Subject|1|||
37751876|NCT01790633|69252006|FG000|Overall Study|Protocol Violation|1|||
37751877|NCT01790633|69252007|FG001|Overall Study|Protocol Violation|2|||
37751878|NCT01790633|69252006|FG000|Overall Study|Did not have serology performed|47|||
37751879|NCT01790633|69252007|FG001|Overall Study|Did not have serology performed|0|||
37751880|NCT01790633|69252006|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
37751881|NCT01790633|69252007|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
37661846|NCT01559363|69134603|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
37661847|NCT01559363|69134604|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
37661848|NCT01559363|69134605|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
37661849|NCT01559363|69134606|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
37661850|NCT01559363|69134607|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
37661851|NCT01559363|69134608|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
37661852|NCT02732327|69134630|FG000|Overall Study|Protocol Violation|0|||
37661853|NCT02732327|69134631|FG001|Overall Study|Protocol Violation|1|||
37751882|NCT01788215|69252016|FG000|Overall Study|Withdrawal by Subject|0|||
37751883|NCT01788215|69252017|FG001|Overall Study|Withdrawal by Subject|1|||
37751884|NCT01788215|69252016|FG000|Overall Study|Lost to Follow-up|2|||
37751885|NCT01788215|69252017|FG001|Overall Study|Lost to Follow-up|0|||
37751886|NCT01787825|69252023|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
37751887|NCT01787825|69252024|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
37751888|NCT01787825|69252023|FG000|Overall Study|Data Not Analyzable|5|||
37751889|NCT01787825|69252024|FG001|Overall Study|Data Not Analyzable|1|||
37751890|NCT01813019|69252033|FG000|Overall Study|Adverse Event|0|||
37751891|NCT01813019|69252034|FG001|Overall Study|Adverse Event|3|||
37661854|NCT03179605|69134637|FG000|Overall Study|Withdrawal by Subject|1|||
37661855|NCT02412722|69134647|FG000|Overall Study|Adverse Event|0|||
37661856|NCT02412722|69134648|FG001|Overall Study|Adverse Event|2|||
37661857|NCT02412722|69134649|FG002|Overall Study|Adverse Event|0|||
37661858|NCT02412722|69134650|FG003|Overall Study|Adverse Event|3|||
37751892|NCT01813019|69252033|FG000|Overall Study|Withdrawal by Subject|3|||
37751893|NCT01813019|69252034|FG001|Overall Study|Withdrawal by Subject|2|||
37751894|NCT01813019|69252033|FG000|Overall Study|administrative problems|2|||
37751895|NCT01813019|69252034|FG001|Overall Study|administrative problems|0|||
37661859|NCT02412722|69134651|FG004|Overall Study|Adverse Event|0|||
37661860|NCT02412722|69134652|FG005|Overall Study|Adverse Event|3|||
37661861|NCT02412722|69134647|FG000|Overall Study|Progressive Disease|6|||
37661862|NCT02412722|69134648|FG001|Overall Study|Progressive Disease|4|||
37661863|NCT02412722|69134649|FG002|Overall Study|Progressive Disease|4|||
37661864|NCT02412722|69134650|FG003|Overall Study|Progressive Disease|9|||
37661865|NCT02412722|69134651|FG004|Overall Study|Progressive Disease|3|||
37661866|NCT02412722|69134652|FG005|Overall Study|Progressive Disease|3|||
37661867|NCT02412722|69134647|FG000|Overall Study|Withdrawal by Subject|2|||
37661868|NCT02412722|69134648|FG001|Overall Study|Withdrawal by Subject|0|||
37661869|NCT02412722|69134649|FG002|Overall Study|Withdrawal by Subject|1|||
37661870|NCT02412722|69134650|FG003|Overall Study|Withdrawal by Subject|2|||
37661871|NCT02412722|69134651|FG004|Overall Study|Withdrawal by Subject|1|||
37751896|NCT01813019|69252033|FG000|Overall Study|Protocol Deviation|2|||
37751897|NCT01813019|69252034|FG001|Overall Study|Protocol Deviation|1|||
37751898|NCT01787591|69252042|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
37661872|NCT02412722|69134652|FG005|Overall Study|Withdrawal by Subject|1|||
37661873|NCT02412722|69134647|FG000|Overall Study|Lost to Follow-up|0|||
37751899|NCT01787591|69252043|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
37751900|NCT01787591|69252044|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
37751901|NCT01787591|69252045|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
37751902|NCT01812707|69252060|FG000|Overall Study|Adverse Event|0|||
37856933|NCT01202409|69540106|FG000|Overall Study|Adverse Event|1|||
37856934|NCT01202409|69540106|FG000|Overall Study|Ineligible - KRAS mutants|7|||
37856935|NCT01202175|69540112|FG000|Overall Study|Lost to Follow-up|2|||
37923222|NCT00826280|69610005|FG002|Overall Study|Interpretation Failure|0|||
37923223|NCT00826280|69610003|FG000|Overall Study|Machine Failure|1|||
37923224|NCT00826280|69610004|FG001|Overall Study|Machine Failure|1|||
38033191|NCT04760314|69719150|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
38033192|NCT04760314|69719151|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
38033193|NCT04760314|69719152|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
38033194|NCT04760314|69719142|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
37856936|NCT01202175|69540112|FG000|Overall Study|Withdrawal by Subject|1|||
37856937|NCT01202175|69540112|FG000|Overall Study|Adverse Event|2|||
37856938|NCT01201785|69540117|FG000|Overall Study|Lost to Follow-up|16|||
37856939|NCT01201317|69540124|FG000|Overall Study|Withdrawal by Subject|5|||
37856940|NCT01201317|69540125|FG001|Overall Study|Withdrawal by Subject|0|||
38033195|NCT04760314|69719143|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
38033196|NCT04760314|69719144|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
38033197|NCT04760314|69719145|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
38033198|NCT04760314|69719146|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
38033199|NCT04760314|69719147|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
38033200|NCT04760314|69719148|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
38033201|NCT04760314|69719149|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
38033202|NCT04760314|69719150|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
38033203|NCT04760314|69719151|FG009|Maintenance Open Label Escape Arm|Adverse Event|1|||
38033204|NCT04760314|69719152|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
38033205|NCT04493684|69719195|FG000|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
38033206|NCT04493684|69719196|FG001|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
38033207|NCT04493684|69719197|FG002|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
38033208|NCT04493684|69719198|FG003|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
37856941|NCT01201317|69540126|FG002|Overall Study|Withdrawal by Subject|3|||
37856942|NCT01201317|69540124|FG000|Overall Study|Adverse Event|2|||
37856943|NCT01201317|69540125|FG001|Overall Study|Adverse Event|2|||
37856944|NCT01201317|69540126|FG002|Overall Study|Adverse Event|2|||
37856945|NCT01201317|69540124|FG000|Overall Study|Screen failure|1|||
37856946|NCT01201317|69540125|FG001|Overall Study|Screen failure|1|||
37856947|NCT01201317|69540126|FG002|Overall Study|Screen failure|0|||
37923225|NCT00826280|69610005|FG002|Overall Study|Machine Failure|0|||
38033209|NCT04493684|69719199|FG004|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
38033210|NCT04493684|69719200|FG005|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
38033211|NCT04493684|69719201|FG006|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
38033212|NCT04493684|69719202|FG007|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
37661874|NCT02412722|69134648|FG001|Overall Study|Lost to Follow-up|0|||
37661875|NCT02412722|69134649|FG002|Overall Study|Lost to Follow-up|0|||
37661876|NCT02412722|69134650|FG003|Overall Study|Lost to Follow-up|0|||
37661877|NCT02412722|69134651|FG004|Overall Study|Lost to Follow-up|1|||
37661878|NCT02412722|69134652|FG005|Overall Study|Lost to Follow-up|0|||
37661879|NCT02412722|69134647|FG000|Overall Study|Received drug in run-in and discontinued|0|||
37856948|NCT01201317|69540124|FG000|Overall Study|Protocol Violation|0|||
37856949|NCT01201317|69540125|FG001|Overall Study|Protocol Violation|1|||
37661880|NCT02412722|69134648|FG001|Overall Study|Received drug in run-in and discontinued|2|||
37751903|NCT01812707|69252061|FG001|Overall Study|Adverse Event|0|||
37856950|NCT01201317|69540126|FG002|Overall Study|Protocol Violation|1|||
37661881|NCT02412722|69134649|FG002|Overall Study|Received drug in run-in and discontinued|0|||
37661882|NCT02412722|69134650|FG003|Overall Study|Received drug in run-in and discontinued|0|||
37661883|NCT02412722|69134651|FG004|Overall Study|Received drug in run-in and discontinued|0|||
37661884|NCT02412722|69134652|FG005|Overall Study|Received drug in run-in and discontinued|0|||
37661885|NCT02412722|69134647|FG000|Overall Study|Reason not Specified|3|||
37661886|NCT02412722|69134648|FG001|Overall Study|Reason not Specified|0|||
37661887|NCT02412722|69134649|FG002|Overall Study|Reason not Specified|2|||
37661888|NCT02412722|69134650|FG003|Overall Study|Reason not Specified|1|||
37661889|NCT02412722|69134651|FG004|Overall Study|Reason not Specified|2|||
37661890|NCT02412722|69134652|FG005|Overall Study|Reason not Specified|6|||
37661891|NCT03074695|69134688|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
37661892|NCT03074695|69134689|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
37661893|NCT03074695|69134688|FG000|Overall Study|Research staff not available|1|||
37661894|NCT03074695|69134689|FG001|Overall Study|Research staff not available|2|||
37661895|NCT03074695|69134688|FG000|Overall Study|Did not receive neuraxial block|2|||
37661896|NCT03074695|69134689|FG001|Overall Study|Did not receive neuraxial block|2|||
37661897|NCT03469999|69134695|FG000|Overall Study|Lost to Follow-up|2|||
37661898|NCT02379728|69134702|FG000|Overall Study|Lost to Follow-up|1|||
37661899|NCT02379728|69134703|FG001|Overall Study|Lost to Follow-up|0|||
37661900|NCT02379728|69134704|FG002|Overall Study|Lost to Follow-up|3|||
37661901|NCT02379728|69134705|FG003|Overall Study|Lost to Follow-up|0|||
37661902|NCT02379728|69134702|FG000|Overall Study|Withdrawal by Subject|5|||
37661903|NCT02379728|69134703|FG001|Overall Study|Withdrawal by Subject|0|||
37661904|NCT02379728|69134704|FG002|Overall Study|Withdrawal by Subject|5|||
37661905|NCT02379728|69134705|FG003|Overall Study|Withdrawal by Subject|3|||
37661906|NCT02379728|69134702|FG000|Overall Study|Protocol Violation|0|||
37661907|NCT02379728|69134703|FG001|Overall Study|Protocol Violation|0|||
37661908|NCT02379728|69134704|FG002|Overall Study|Protocol Violation|2|||
37661909|NCT02379728|69134705|FG003|Overall Study|Protocol Violation|0|||
37661910|NCT03463993|69134716|FG000|Overall Study|Lost to Follow-up|7|||
37661911|NCT03463993|69134717|FG001|Overall Study|Lost to Follow-up|8|||
37661912|NCT03463993|69134716|FG000|Overall Study|Withdrawal by Subject|2|||
37661913|NCT03463993|69134717|FG001|Overall Study|Withdrawal by Subject|0|||
37661914|NCT03463993|69134716|FG000|Overall Study|Protocol Violation|4|||
37661915|NCT03463993|69134717|FG001|Overall Study|Protocol Violation|1|||
37661916|NCT03463993|69134716|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
37661917|NCT03463993|69134717|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
37661918|NCT03463993|69134716|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
37661919|NCT03463993|69134717|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
37661920|NCT02412488|69134732|FG000|Overall Study|Lost to Follow-up|10|||
37661921|NCT02412488|69134732|FG000|Overall Study|Withdrawal by Subject|5|||
37661922|NCT02412488|69134732|FG000|Overall Study|Physician Decision|1|||
37661923|NCT02412488|69134732|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
37661924|NCT02412488|69134732|FG000|Overall Study|Reveal LINQ explant|1|||
37661925|NCT02378480|69134738|FG000|Overall Study|Physician Decision|1|||
37661926|NCT02378480|69134739|FG001|Overall Study|Physician Decision|1|||
37661927|NCT02378480|69134738|FG000|Overall Study|Death|1|||
37661928|NCT02378480|69134739|FG001|Overall Study|Death|2|||
37661929|NCT02378480|69134738|FG000|Overall Study|Randomized, but Not Treated|6|||
37661930|NCT02378480|69134739|FG001|Overall Study|Randomized, but Not Treated|4|||
37661931|NCT02378480|69134738|FG000|Overall Study|Adverse Event|0|||
37923226|NCT00826280|69610003|FG000|Overall Study|One or more non-interpretable scan|0|||
38033213|NCT04493684|69719203|FG008|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
37661932|NCT02378480|69134739|FG001|Overall Study|Adverse Event|1|||
37661933|NCT02378480|69134738|FG000|Overall Study|Missed EOT/PTE Visit|1|||
37661934|NCT02378480|69134739|FG001|Overall Study|Missed EOT/PTE Visit|2|||
37661935|NCT02378480|69134738|FG000|Overall Study|Withdrawal by Subject|9|||
37661936|NCT02378480|69134739|FG001|Overall Study|Withdrawal by Subject|4|||
37661937|NCT02378480|69134738|FG000|Overall Study|Lost to Follow-up|10|||
37661938|NCT02378480|69134739|FG001|Overall Study|Lost to Follow-up|18|||
37661939|NCT02411396|69134745|FG000|Overall Study|Lost to Follow-up|31|||
37661940|NCT02411396|69134745|FG000|Overall Study|Death|10|||
37661941|NCT02345252|69134766|FG000|Double-Blind Phase|Adverse Event|2|||
37661942|NCT02345252|69134767|FG001|Double-Blind Phase|Adverse Event|3|||
37661943|NCT02345252|69134766|FG000|Double-Blind Phase|Death|1|||
37661944|NCT02345252|69134767|FG001|Double-Blind Phase|Death|2|||
37661945|NCT02345252|69134766|FG000|Double-Blind Phase|Lack of Efficacy|1|||
37661946|NCT02345252|69134767|FG001|Double-Blind Phase|Lack of Efficacy|0|||
37661947|NCT02345252|69134766|FG000|Double-Blind Phase|Investigator's Discretion|4|||
37661948|NCT02345252|69134767|FG001|Double-Blind Phase|Investigator's Discretion|6|||
37661949|NCT02345252|69134766|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
37661950|NCT02345252|69134767|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
37661951|NCT02345252|69134766|FG000|Double-Blind Phase|Protocol Violation|2|||
37661952|NCT02345252|69134767|FG001|Double-Blind Phase|Protocol Violation|1|||
37661953|NCT02345252|69134766|FG000|Double-Blind Phase|Withdrew Consent|21|||
37661954|NCT02345252|69134767|FG001|Double-Blind Phase|Withdrew Consent|23|||
37661955|NCT02345252|69134766|FG000|Double-Blind Phase|Lost to Follow-up|8|||
37661956|NCT02345252|69134767|FG001|Double-Blind Phase|Lost to Follow-up|10|||
37661957|NCT02345252|69134766|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
37661958|NCT02345252|69134767|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
37661959|NCT01239797|69134777|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
37661960|NCT01239797|69134778|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
37661961|NCT01239797|69134777|FG000|Randomized Participants|Participant withdrew consent|1|||
37661962|NCT01239797|69134778|FG001|Randomized Participants|Participant withdrew consent|7|||
37661963|NCT01239797|69134777|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
37661964|NCT01239797|69134778|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
37751904|NCT01812707|69252062|FG002|Overall Study|Adverse Event|0|||
37661965|NCT01239797|69134777|FG000|Treated Participants|Disease progression|185|||
37661966|NCT01239797|69134778|FG001|Treated Participants|Disease progression|185|||
37661967|NCT01239797|69134777|FG000|Treated Participants|Study drug toxicity|39|||
37661968|NCT01239797|69134778|FG001|Treated Participants|Study drug toxicity|45|||
37751905|NCT01812707|69252063|FG003|Overall Study|Adverse Event|2|||
37751906|NCT01812707|69252060|FG000|Overall Study|Poor compliance to protocol|1|||
37751907|NCT01812707|69252061|FG001|Overall Study|Poor compliance to protocol|0|||
37751908|NCT01812707|69252062|FG002|Overall Study|Poor compliance to protocol|0|||
37751909|NCT01812707|69252063|FG003|Overall Study|Poor compliance to protocol|0|||
37751910|NCT01812707|69252060|FG000|Overall Study|Consent withdrawn by participant|1|||
37751911|NCT01812707|69252061|FG001|Overall Study|Consent withdrawn by participant|0|||
37751912|NCT01812707|69252062|FG002|Overall Study|Consent withdrawn by participant|0|||
37661969|NCT01239797|69134777|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
37661970|NCT01239797|69134778|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
37661971|NCT01239797|69134777|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
37661972|NCT01239797|69134778|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
37661973|NCT01239797|69134777|FG000|Treated Participants|Administrative reason by sponsor|13|||
37661974|NCT01239797|69134778|FG001|Treated Participants|Administrative reason by sponsor|4|||
37661975|NCT01239797|69134777|FG000|Treated Participants|Other reasons|14|||
37661976|NCT01239797|69134778|FG001|Treated Participants|Other reasons|14|||
37661977|NCT01239797|69134777|FG000|Treated Participants|Participant withdrew consent|6|||
37661978|NCT01239797|69134778|FG001|Treated Participants|Participant withdrew consent|11|||
37661979|NCT01239797|69134777|FG000|Treated Participants|Death|1|||
37661980|NCT01239797|69134778|FG001|Treated Participants|Death|1|||
37661981|NCT01239797|69134777|FG000|Treated Participants|Participant no longer meets study criteria|1|||
37661982|NCT01239797|69134778|FG001|Treated Participants|Participant no longer meets study criteria|1|||
37661983|NCT01239797|69134777|FG000|Treated Participants|Poor/non-compliance|0|||
37661984|NCT01239797|69134778|FG001|Treated Participants|Poor/non-compliance|1|||
37661985|NCT01092143|69134789|FG000|Overall Study|Adverse Event|10|||
37751913|NCT01812707|69252063|FG003|Overall Study|Consent withdrawn by participant|0|||
37751914|NCT01787279|69252074|FG000|Overall Study|Lost to Follow-up|2|||
37751915|NCT01787279|69252074|FG000|Overall Study|Lack of Efficacy|1|||
37751916|NCT02728206|69252078|FG000|Overall Study|Death|1|||
37751917|NCT01811225|69252082|FG000|Treatment Period 1|Adverse Event|2|||
37751918|NCT01811225|69252083|FG001|Treatment Period 1|Adverse Event|3|||
37751919|NCT01811225|69252082|FG000|Treatment Period 1|Lost to Follow-up|12|||
37751920|NCT01811225|69252083|FG001|Treatment Period 1|Lost to Follow-up|8|||
37661986|NCT01092143|69134790|FG001|Overall Study|Adverse Event|5|||
37661987|NCT01092143|69134791|FG002|Overall Study|Adverse Event|1|||
37661988|NCT01092143|69134792|FG003|Overall Study|Adverse Event|4|||
37661989|NCT01092143|69134793|FG004|Overall Study|Adverse Event|3|||
37661990|NCT01092143|69134789|FG000|Overall Study|Lost to Follow-up|1|||
37661991|NCT01092143|69134790|FG001|Overall Study|Lost to Follow-up|0|||
37661992|NCT01092143|69134791|FG002|Overall Study|Lost to Follow-up|1|||
37661993|NCT01092143|69134792|FG003|Overall Study|Lost to Follow-up|0|||
37661994|NCT01092143|69134793|FG004|Overall Study|Lost to Follow-up|0|||
37661995|NCT01092143|69134789|FG000|Overall Study|Consent withdrawn|2|||
37661996|NCT01092143|69134790|FG001|Overall Study|Consent withdrawn|1|||
37661997|NCT01092143|69134791|FG002|Overall Study|Consent withdrawn|0|||
37661998|NCT01092143|69134792|FG003|Overall Study|Consent withdrawn|1|||
37661999|NCT01092143|69134793|FG004|Overall Study|Consent withdrawn|3|||
37751921|NCT01811225|69252082|FG000|Treatment Period 1|transporation|1|||
37662000|NCT01092143|69134789|FG000|Overall Study|Not treated|0|||
37662001|NCT01092143|69134790|FG001|Overall Study|Not treated|0|||
37662002|NCT01092143|69134791|FG002|Overall Study|Not treated|1|||
37751922|NCT01811225|69252083|FG001|Treatment Period 1|transporation|0|||
37751923|NCT01811225|69252082|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
37662003|NCT01092143|69134792|FG003|Overall Study|Not treated|0|||
37662004|NCT01092143|69134793|FG004|Overall Study|Not treated|0|||
37662005|NCT01092143|69134789|FG000|Overall Study|did not reversibility criteria|0|||
37856951|NCT01201317|69540124|FG000|Overall Study|Death|0|||
37662006|NCT01092143|69134790|FG001|Overall Study|did not reversibility criteria|0|||
37662007|NCT01092143|69134791|FG002|Overall Study|did not reversibility criteria|1|||
37662008|NCT01092143|69134792|FG003|Overall Study|did not reversibility criteria|0|||
37662009|NCT01092143|69134793|FG004|Overall Study|did not reversibility criteria|0|||
37662010|NCT01092143|69134789|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
37662011|NCT01092143|69134790|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
37662012|NCT01092143|69134791|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
37662013|NCT01092143|69134792|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
37662014|NCT01092143|69134793|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
37662015|NCT01092143|69134789|FG000|Overall Study|Ineligible patient|1|||
37662016|NCT01092143|69134790|FG001|Overall Study|Ineligible patient|0|||
37662017|NCT01092143|69134791|FG002|Overall Study|Ineligible patient|0|||
37662018|NCT01092143|69134792|FG003|Overall Study|Ineligible patient|0|||
37662019|NCT01092143|69134793|FG004|Overall Study|Ineligible patient|0|||
37662020|NCT01092143|69134789|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
37662021|NCT01092143|69134790|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
37662022|NCT01092143|69134791|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
37662023|NCT01092143|69134792|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
37662024|NCT01092143|69134793|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
37662025|NCT01092143|69134789|FG000|Overall Study|Patient travel|0|||
37662026|NCT01092143|69134790|FG001|Overall Study|Patient travel|0|||
37662027|NCT01092143|69134791|FG002|Overall Study|Patient travel|0|||
37662028|NCT01092143|69134792|FG003|Overall Study|Patient travel|0|||
37662029|NCT01092143|69134793|FG004|Overall Study|Patient travel|1|||
37662030|NCT01092143|69134789|FG000|Overall Study|Non compliance with study medication|0|||
37662031|NCT01092143|69134790|FG001|Overall Study|Non compliance with study medication|0|||
37662032|NCT01092143|69134791|FG002|Overall Study|Non compliance with study medication|0|||
37662033|NCT01092143|69134792|FG003|Overall Study|Non compliance with study medication|0|||
37662034|NCT01092143|69134793|FG004|Overall Study|Non compliance with study medication|1|||
37662035|NCT01092143|69134789|FG000|Overall Study|Randomized by mistake|0|||
37662036|NCT01092143|69134790|FG001|Overall Study|Randomized by mistake|0|||
37662037|NCT01092143|69134791|FG002|Overall Study|Randomized by mistake|0|||
37662038|NCT01092143|69134792|FG003|Overall Study|Randomized by mistake|1|||
37751924|NCT01811225|69252083|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
37751925|NCT01811225|69252082|FG000|Treatment Period 2|Lost to Follow-up|1|||
37751926|NCT01811225|69252083|FG001|Treatment Period 2|Lost to Follow-up|2|||
37751927|NCT01811225|69252082|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
37662039|NCT01092143|69134793|FG004|Overall Study|Randomized by mistake|0|||
37751928|NCT01811225|69252083|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
37751929|NCT01809197|69252091|FG000|Overall Study|Lost to Follow-up|4|||
37751930|NCT01809197|69252092|FG001|Overall Study|Lost to Follow-up|2|||
37751931|NCT01809197|69252091|FG000|Overall Study|Adverse Event|2|||
37751932|NCT01809197|69252092|FG001|Overall Study|Adverse Event|3|||
37751933|NCT01809197|69252091|FG000|Overall Study|Failed slit lamp exam|1|||
37751934|NCT01809197|69252092|FG001|Overall Study|Failed slit lamp exam|0|||
37751935|NCT01809197|69252091|FG000|Overall Study|Non-Compliance|1|||
37751936|NCT01809197|69252092|FG001|Overall Study|Non-Compliance|1|||
37751937|NCT01809197|69252091|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
37751938|NCT01809197|69252092|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
37751939|NCT01809197|69252091|FG000|Overall Study|Withdrawal by Subject|1|||
37751940|NCT01809197|69252092|FG001|Overall Study|Withdrawal by Subject|1|||
37751941|NCT01809197|69252091|FG000|Overall Study|Product not available|0|||
37751942|NCT01809197|69252092|FG001|Overall Study|Product not available|1|||
37751943|NCT01786109|69252101|FG000|Overall Study|fail manometry barostat tube placement|1|||
37751944|NCT01786109|69252102|FG001|Overall Study|fail manometry barostat tube placement|0|||
37751945|NCT01786109|69252103|FG002|Overall Study|fail manometry barostat tube placement|0|||
37751946|NCT01786109|69252101|FG000|Overall Study|unrelated illness|0|||
37751947|NCT01786109|69252102|FG001|Overall Study|unrelated illness|0|||
37751948|NCT01786109|69252103|FG002|Overall Study|unrelated illness|1|||
37751949|NCT01786109|69252101|FG000|Overall Study|adverse effects colon preparation|0|||
37751950|NCT01786109|69252102|FG001|Overall Study|adverse effects colon preparation|0|||
37751951|NCT01786109|69252103|FG002|Overall Study|adverse effects colon preparation|1|||
37662040|NCT01092143|69134789|FG000|Overall Study|Pregnancy|0|||
37662041|NCT01092143|69134790|FG001|Overall Study|Pregnancy|0|||
37662042|NCT01092143|69134791|FG002|Overall Study|Pregnancy|0|||
37662043|NCT01092143|69134792|FG003|Overall Study|Pregnancy|1|||
37662044|NCT01092143|69134793|FG004|Overall Study|Pregnancy|0|||
37662045|NCT02377466|69134807|FG000|Overall Study|Other: Randomized and not treated|0|||
37751952|NCT02728830|69252187|FG000|Overall Study|Exclusionary Surgery|9|||
37751953|NCT02728830|69252187|FG000|Overall Study|Exclusionary Pathology|6|||
37662046|NCT02377466|69134808|FG001|Overall Study|Other: Randomized and not treated|2|||
37751954|NCT02728830|69252187|FG000|Overall Study|Physician Decision|3|||
37751955|NCT02728830|69252187|FG000|Overall Study|Withdrawal by Subject|2|||
37751956|NCT02728830|69252187|FG000|Overall Study|Lost to Follow-up|1|||
37662047|NCT00950989|69134825|FG000|Overall Study|Death|0|||
37751957|NCT02728830|69252187|FG000|Overall Study|Exclusionary Lab Values|1|||
37751958|NCT02728830|69252187|FG000|Overall Study|Contraindicated Illness|1|||
37751959|NCT02728830|69252187|FG000|Overall Study|Language Barrier|1|||
37751960|NCT02728596|69252241|FG000|Overall Study|Refusal unrelated to adverse event|3|||
37751961|NCT02728596|69252242|FG001|Overall Study|Refusal unrelated to adverse event|6|||
37751962|NCT02728596|69252243|FG002|Overall Study|Refusal unrelated to adverse event|7|||
37751963|NCT02728596|69252244|FG003|Overall Study|Refusal unrelated to adverse event|7|||
37751964|NCT02728596|69252241|FG000|Overall Study|Death|44|||
37751965|NCT02728596|69252242|FG001|Overall Study|Death|42|||
37751966|NCT02728596|69252243|FG002|Overall Study|Death|123|||
37751967|NCT02728596|69252244|FG003|Overall Study|Death|68|||
37751968|NCT00708162|69252618|FG000|Randomized Phase|Randomized but Not Treated|7|||
37751969|NCT00708162|69252619|FG001|Randomized Phase|Randomized but Not Treated|5|||
37751970|NCT00708162|69252618|FG000|Randomized Phase|Participant Noncompliance|40|||
37751971|NCT00708162|69252619|FG001|Randomized Phase|Participant Noncompliance|32|||
37751972|NCT00708162|69252618|FG000|Randomized Phase|Lost to Follow-up|34|||
37751973|NCT00708162|69252619|FG001|Randomized Phase|Lost to Follow-up|34|||
37751974|NCT00708162|69252618|FG000|Randomized Phase|Withdrew Consent|31|||
37751975|NCT00708162|69252619|FG001|Randomized Phase|Withdrew Consent|22|||
37751976|NCT00708162|69252618|FG000|Randomized Phase|Lack of Efficacy|14|||
37751977|NCT00708162|69252619|FG001|Randomized Phase|Lack of Efficacy|19|||
37751978|NCT00708162|69252618|FG000|Randomized Phase|Protocol Violation|10|||
37751979|NCT00708162|69252619|FG001|Randomized Phase|Protocol Violation|11|||
37751980|NCT00708162|69252618|FG000|Randomized Phase|Adverse Event|8|||
37662048|NCT00950989|69134826|FG001|Overall Study|Death|0|||
37662049|NCT00950989|69134827|FG002|Overall Study|Death|1|||
37662050|NCT00950989|69134828|FG003|Overall Study|Death|0|||
37662051|NCT00950989|69134825|FG000|Overall Study|Administrative Decision|0|||
37662052|NCT00950989|69134826|FG001|Overall Study|Administrative Decision|1|||
37662053|NCT00950989|69134827|FG002|Overall Study|Administrative Decision|0|||
37662054|NCT00950989|69134828|FG003|Overall Study|Administrative Decision|0|||
37662055|NCT00950989|69134825|FG000|Overall Study|Disease Progression|0|||
37662056|NCT00950989|69134826|FG001|Overall Study|Disease Progression|0|||
37662057|NCT00950989|69134827|FG002|Overall Study|Disease Progression|1|||
37751981|NCT00708162|69252619|FG001|Randomized Phase|Adverse Event|12|||
37751982|NCT00708162|69252618|FG000|Randomized Phase|Investigator's Discretion|7|||
37751983|NCT00708162|69252619|FG001|Randomized Phase|Investigator's Discretion|10|||
37751984|NCT00708162|69252618|FG000|Randomized Phase|Death|2|||
37751985|NCT00708162|69252619|FG001|Randomized Phase|Death|9|||
37751986|NCT00708162|69252618|FG000|Randomized Phase|Pregnancy|3|||
37751987|NCT00708162|69252619|FG001|Randomized Phase|Pregnancy|0|||
37751988|NCT00708162|69252618|FG000|Open-Label Phase|Lost to Follow-up|10|||
37751989|NCT00708162|69252619|FG001|Open-Label Phase|Lost to Follow-up|8|||
37751990|NCT00708162|69252618|FG000|Open-Label Phase|Withdrew Consent|12|||
37751991|NCT00708162|69252619|FG001|Open-Label Phase|Withdrew Consent|6|||
37751992|NCT00708162|69252618|FG000|Open-Label Phase|Participant Noncompliance|7|||
37751993|NCT00708162|69252619|FG001|Open-Label Phase|Participant Noncompliance|7|||
37751994|NCT00708162|69252618|FG000|Open-Label Phase|Lack of Efficacy|7|||
37751995|NCT00708162|69252619|FG001|Open-Label Phase|Lack of Efficacy|4|||
37751996|NCT00708162|69252618|FG000|Open-Label Phase|Investigator's Discretion|3|||
37751997|NCT00708162|69252619|FG001|Open-Label Phase|Investigator's Discretion|2|||
37751998|NCT00708162|69252618|FG000|Open-Label Phase|Death|3|||
37751999|NCT00708162|69252619|FG001|Open-Label Phase|Death|1|||
37752000|NCT00708162|69252618|FG000|Open-Label Phase|Adverse Event|1|||
37752001|NCT00708162|69252619|FG001|Open-Label Phase|Adverse Event|2|||
37752002|NCT00708162|69252618|FG000|Open-Label Phase|Other|1|||
37752003|NCT00708162|69252619|FG001|Open-Label Phase|Other|0|||
37752004|NCT02245672|69252704|FG000|Overall Study|Adverse Event|4|||
37752005|NCT02245672|69252705|FG001|Overall Study|Adverse Event|4|||
37752006|NCT02245672|69252706|FG002|Overall Study|Adverse Event|4|||
37752007|NCT02245672|69252704|FG000|Overall Study|Lost to Follow-up|3|||
37752008|NCT02245672|69252705|FG001|Overall Study|Lost to Follow-up|5|||
37856952|NCT01201317|69540125|FG001|Overall Study|Death|1|||
37662058|NCT00950989|69134828|FG003|Overall Study|Disease Progression|0|||
37662059|NCT00950989|69134825|FG000|Overall Study|Withdrawal by Subject|2|||
37752009|NCT02245672|69252706|FG002|Overall Study|Lost to Follow-up|1|||
37752010|NCT02245672|69252704|FG000|Overall Study|Withdrawal by Subject|6|||
37752011|NCT02245672|69252705|FG001|Overall Study|Withdrawal by Subject|3|||
37752012|NCT02245672|69252706|FG002|Overall Study|Withdrawal by Subject|0|||
37856953|NCT01201317|69540126|FG002|Overall Study|Death|0|||
37662060|NCT00950989|69134826|FG001|Overall Study|Withdrawal by Subject|1|||
37662061|NCT00950989|69134827|FG002|Overall Study|Withdrawal by Subject|0|||
37662062|NCT00950989|69134828|FG003|Overall Study|Withdrawal by Subject|0|||
37752013|NCT02245672|69252704|FG000|Overall Study|Randomized in error (not treated)|0|||
37752014|NCT02245672|69252705|FG001|Overall Study|Randomized in error (not treated)|1|||
37752015|NCT02245672|69252706|FG002|Overall Study|Randomized in error (not treated)|0|||
37752016|NCT00706992|69252851|FG000|Overall Study|Study termination|5|||
37752017|NCT00706992|69252852|FG001|Overall Study|Study termination|5|||
37752018|NCT00706992|69252853|FG002|Overall Study|Study termination|6|||
37752019|NCT00706992|69252854|FG003|Overall Study|Study termination|2|||
37752020|NCT00706992|69252855|FG004|Overall Study|Study termination|3|||
37752021|NCT00706992|69252856|FG005|Overall Study|Study termination|2|||
37752022|NCT00706992|69252857|FG006|Overall Study|Study termination|3|||
37662063|NCT00950989|69134825|FG000|Overall Study|Adverse Event|2|||
37662064|NCT00950989|69134826|FG001|Overall Study|Adverse Event|1|||
37662065|NCT00950989|69134827|FG002|Overall Study|Adverse Event|1|||
37662066|NCT00950989|69134828|FG003|Overall Study|Adverse Event|0|||
37662067|NCT00593567|69134843|FG000|Overall Study|Adverse Event|2|||
37662068|NCT00593567|69134844|FG001|Overall Study|Adverse Event|0|||
37662069|NCT00593567|69134843|FG000|Overall Study|Physician Decision|2|||
37662070|NCT00593567|69134844|FG001|Overall Study|Physician Decision|0|||
37662071|NCT00593567|69134843|FG000|Overall Study|Protocol Violation|13|||
37662072|NCT00593567|69134844|FG001|Overall Study|Protocol Violation|7|||
37662073|NCT00593567|69134843|FG000|Overall Study|Lack of Efficacy|2|||
37662074|NCT00593567|69134844|FG001|Overall Study|Lack of Efficacy|1|||
37662075|NCT00593567|69134843|FG000|Overall Study|Withdrawal by Subject|1|||
37662076|NCT00593567|69134844|FG001|Overall Study|Withdrawal by Subject|2|||
37662077|NCT02411084|69134852|FG000|Overall Study|Lack of Efficacy|6|||
37662078|NCT02411084|69134853|FG001|Overall Study|Lack of Efficacy|3|||
37662079|NCT02411084|69134852|FG000|Overall Study|Death|5|||
37662080|NCT02411084|69134853|FG001|Overall Study|Death|4|||
37662081|NCT02411084|69134852|FG000|Overall Study|Adverse Event|2|||
37662082|NCT02411084|69134853|FG001|Overall Study|Adverse Event|1|||
37662083|NCT02411084|69134852|FG000|Overall Study|Other reasons|0|||
37662084|NCT02411084|69134853|FG001|Overall Study|Other reasons|5|||
37662085|NCT01602315|69134866|FG000|Overall Study|Protocol Violation|0|||
37662086|NCT01602315|69134867|FG001|Overall Study|Protocol Violation|0|||
37662087|NCT01602315|69134868|FG002|Overall Study|Protocol Violation|0|||
37752023|NCT00706992|69252851|FG000|Overall Study|Disease progression before treatment|0|||
37752024|NCT00706992|69252852|FG001|Overall Study|Disease progression before treatment|0|||
37752025|NCT00706992|69252853|FG002|Overall Study|Disease progression before treatment|0|||
37856954|NCT01201317|69540124|FG000|Overall Study|Study-specific withdrawal criteria|0|||
37856955|NCT01201317|69540125|FG001|Overall Study|Study-specific withdrawal criteria|0|||
37856956|NCT01201317|69540126|FG002|Overall Study|Study-specific withdrawal criteria|1|||
37856957|NCT01201317|69540124|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
37856958|NCT01201317|69540125|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
37856959|NCT01201317|69540126|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
37856960|NCT01201317|69540124|FG000|Overall Study|Decrease in renal function|0|||
37856961|NCT01201317|69540125|FG001|Overall Study|Decrease in renal function|1|||
37856962|NCT01201317|69540126|FG002|Overall Study|Decrease in renal function|0|||
37856963|NCT01201317|69540124|FG000|Overall Study|Lack of Efficacy|1|||
37856964|NCT01201317|69540125|FG001|Overall Study|Lack of Efficacy|0|||
37856965|NCT01201317|69540126|FG002|Overall Study|Lack of Efficacy|0|||
37856966|NCT01201317|69540124|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
37856967|NCT01201317|69540125|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
37856968|NCT01201317|69540126|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
37856969|NCT01200069|69540136|FG000|Overall Study|Withdrawal by Subject|0|||
37856970|NCT01200069|69540137|FG001|Overall Study|Withdrawal by Subject|1|||
37856971|NCT01199601|69540188|FG000|Overall Study|Lost to Follow-up|47|||
37856972|NCT01199601|69540189|FG001|Overall Study|Lost to Follow-up|66|||
37856973|NCT01199601|69540188|FG000|Overall Study|Withdrawal by Subject|15|||
37856974|NCT01199601|69540189|FG001|Overall Study|Withdrawal by Subject|3|||
37856975|NCT01199601|69540188|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
37856976|NCT01199601|69540189|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
37856977|NCT01199289|69540199|FG000|Overall Study|Ineligibility determined|2|||
37856978|NCT01199289|69540200|FG001|Overall Study|Ineligibility determined|1|||
37856979|NCT01199289|69540201|FG002|Overall Study|Ineligibility determined|0|||
37662088|NCT01602315|69134869|FG003|Overall Study|Protocol Violation|0|||
37662089|NCT01602315|69134870|FG004|Overall Study|Protocol Violation|0|||
37662090|NCT01602315|69134871|FG005|Overall Study|Protocol Violation|1|||
37662091|NCT01602315|69134872|FG006|Overall Study|Protocol Violation|0|||
37752026|NCT00706992|69252854|FG003|Overall Study|Disease progression before treatment|0|||
37752027|NCT00706992|69252855|FG004|Overall Study|Disease progression before treatment|1|||
37856980|NCT01199289|69540202|FG003|Overall Study|Ineligibility determined|0|||
37856981|NCT01199289|69540199|FG000|Overall Study|Protocol Violation|1|||
37856982|NCT01199289|69540200|FG001|Overall Study|Protocol Violation|0|||
37856983|NCT01199289|69540201|FG002|Overall Study|Protocol Violation|0|||
37856984|NCT01199289|69540202|FG003|Overall Study|Protocol Violation|1|||
37662092|NCT01602315|69134866|FG000|Overall Study|Physician Decision|2|||
37662093|NCT01602315|69134867|FG001|Overall Study|Physician Decision|0|||
37662094|NCT01602315|69134868|FG002|Overall Study|Physician Decision|0|||
37662095|NCT01602315|69134869|FG003|Overall Study|Physician Decision|0|||
37752028|NCT00706992|69252856|FG005|Overall Study|Disease progression before treatment|0|||
37662096|NCT01602315|69134870|FG004|Overall Study|Physician Decision|2|||
37662097|NCT01602315|69134871|FG005|Overall Study|Physician Decision|1|||
37662098|NCT01602315|69134872|FG006|Overall Study|Physician Decision|1|||
37662099|NCT01602315|69134866|FG000|Overall Study|Disease progression|6|||
37662100|NCT01602315|69134867|FG001|Overall Study|Disease progression|3|||
37662101|NCT01602315|69134868|FG002|Overall Study|Disease progression|10|||
37662102|NCT01602315|69134869|FG003|Overall Study|Disease progression|1|||
37662103|NCT01602315|69134870|FG004|Overall Study|Disease progression|41|||
37662104|NCT01602315|69134871|FG005|Overall Study|Disease progression|12|||
37662105|NCT01602315|69134872|FG006|Overall Study|Disease progression|15|||
37752029|NCT00706992|69252857|FG006|Overall Study|Disease progression before treatment|0|||
37752030|NCT01785875|69252910|FG000|Overall Study|Withdrawal by Subject|41|||
37752031|NCT01785875|69252911|FG001|Overall Study|Withdrawal by Subject|34|||
37752032|NCT01785875|69252912|FG002|Overall Study|Withdrawal by Subject|36|||
37752033|NCT01785875|69252910|FG000|Overall Study|Lost to Follow-up|19|||
37752034|NCT01785875|69252911|FG001|Overall Study|Lost to Follow-up|22|||
37752035|NCT01785875|69252912|FG002|Overall Study|Lost to Follow-up|6|||
37752036|NCT01785875|69252910|FG000|Overall Study|Death|27|||
37752037|NCT01785875|69252911|FG001|Overall Study|Death|16|||
37752038|NCT01785875|69252912|FG002|Overall Study|Death|7|||
37752039|NCT01785875|69252910|FG000|Overall Study|Sponsor Decision|0|||
37752040|NCT01785875|69252911|FG001|Overall Study|Sponsor Decision|2|||
37752041|NCT01785875|69252912|FG002|Overall Study|Sponsor Decision|0|||
37752042|NCT01785875|69252910|FG000|Overall Study|Protocol Specified Criteria|207|||
37752043|NCT01785875|69252911|FG001|Overall Study|Protocol Specified Criteria|214|||
37752044|NCT01785875|69252912|FG002|Overall Study|Protocol Specified Criteria|55|||
37752045|NCT01785875|69252910|FG000|Overall Study|Missing|0|||
37752046|NCT01785875|69252911|FG001|Overall Study|Missing|1|||
37752047|NCT01785875|69252912|FG002|Overall Study|Missing|3|||
37752048|NCT05567393|69252941|FG000|Overall Study|Voluntary Withdrawal|0|||
37752049|NCT05567393|69252942|FG001|Overall Study|Voluntary Withdrawal|0|||
37752050|NCT05567393|69252943|FG002|Overall Study|Voluntary Withdrawal|0|||
37752051|NCT05567393|69252944|FG003|Overall Study|Voluntary Withdrawal|0|||
37752052|NCT05567393|69252945|FG004|Overall Study|Voluntary Withdrawal|0|||
37752053|NCT05567393|69252946|FG005|Overall Study|Voluntary Withdrawal|0|||
37752054|NCT05567393|69252947|FG006|Overall Study|Voluntary Withdrawal|0|||
37752055|NCT05567393|69252948|FG007|Overall Study|Voluntary Withdrawal|0|||
37752056|NCT05567393|69252949|FG008|Overall Study|Voluntary Withdrawal|0|||
37752057|NCT05567393|69252950|FG009|Overall Study|Voluntary Withdrawal|0|||
37752058|NCT05567393|69252951|FG010|Overall Study|Voluntary Withdrawal|0|||
37752059|NCT05567393|69252952|FG011|Overall Study|Voluntary Withdrawal|0|||
37662106|NCT01602315|69134866|FG000|Overall Study|Death|1|||
37752060|NCT05567393|69252953|FG012|Overall Study|Voluntary Withdrawal|0|||
37752061|NCT05567393|69252954|FG013|Overall Study|Voluntary Withdrawal|1|||
37752062|NCT05567393|69252955|FG014|Overall Study|Voluntary Withdrawal|0|||
37752063|NCT05567393|69252956|FG015|Overall Study|Voluntary Withdrawal|0|||
37752064|NCT05567393|69252957|FG016|Overall Study|Voluntary Withdrawal|0|||
37752065|NCT05567393|69252958|FG017|Overall Study|Voluntary Withdrawal|0|||
37662107|NCT01602315|69134867|FG001|Overall Study|Death|1|||
37662108|NCT01602315|69134868|FG002|Overall Study|Death|1|||
37752066|NCT04973085|69253031|FG000|First Intervention|Claustrophobia in the MRI machine.|1|||
37752067|NCT04973085|69253032|FG001|First Intervention|Claustrophobia in the MRI machine.|0|||
37752068|NCT04542070|69253082|FG000|Overall Study|Adverse Event|10|||
37752069|NCT04542070|69253083|FG001|Overall Study|Adverse Event|3|||
37752070|NCT04542070|69253084|FG002|Overall Study|Adverse Event|1|||
37752071|NCT04542070|69253082|FG000|Overall Study|Lack of Efficacy|1|||
37752072|NCT04542070|69253083|FG001|Overall Study|Lack of Efficacy|2|||
37752073|NCT04542070|69253084|FG002|Overall Study|Lack of Efficacy|0|||
37752074|NCT04542070|69253082|FG000|Overall Study|Lost to Follow-up|3|||
37752075|NCT04542070|69253083|FG001|Overall Study|Lost to Follow-up|4|||
37752076|NCT04542070|69253084|FG002|Overall Study|Lost to Follow-up|2|||
37752077|NCT04542070|69253082|FG000|Overall Study|Physician Decision|1|||
38033214|NCT04493684|69719204|FG009|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
37662109|NCT01602315|69134869|FG003|Overall Study|Death|1|||
37662110|NCT01602315|69134870|FG004|Overall Study|Death|7|||
37662111|NCT01602315|69134871|FG005|Overall Study|Death|2|||
37752078|NCT04542070|69253083|FG001|Overall Study|Physician Decision|0|||
37752079|NCT04542070|69253084|FG002|Overall Study|Physician Decision|1|||
37752080|NCT04542070|69253082|FG000|Overall Study|Withdrawal by Subject|5|||
37752081|NCT04542070|69253083|FG001|Overall Study|Withdrawal by Subject|8|||
37662112|NCT01602315|69134872|FG006|Overall Study|Death|2|||
37662113|NCT01602315|69134866|FG000|Overall Study|Withdrawal by Subject|2|||
37662114|NCT01602315|69134867|FG001|Overall Study|Withdrawal by Subject|0|||
37662115|NCT01602315|69134868|FG002|Overall Study|Withdrawal by Subject|2|||
37752082|NCT04542070|69253084|FG002|Overall Study|Withdrawal by Subject|9|||
37752083|NCT04542070|69253082|FG000|Overall Study|Protocol Deviation|2|||
37662116|NCT01602315|69134869|FG003|Overall Study|Withdrawal by Subject|0|||
37662117|NCT01602315|69134870|FG004|Overall Study|Withdrawal by Subject|6|||
37752084|NCT04542070|69253083|FG001|Overall Study|Protocol Deviation|6|||
37752085|NCT04542070|69253084|FG002|Overall Study|Protocol Deviation|1|||
37752086|NCT04542070|69253082|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
37752087|NCT04542070|69253083|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
37752088|NCT04542070|69253084|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
37752089|NCT04538950|69253093|FG000|Overall Study|Pulmonary Issues|2|||
37752090|NCT04538950|69253093|FG000|Overall Study|illness|2|||
37752091|NCT04445688|69253106|FG000|Washout (One Week)|Adverse Event|2|||
37752092|NCT04445688|69253106|FG000|Washout (One Week)|Withdrawal by Subject|1|||
37752093|NCT04382755|69253116|FG000|Overall Study|Withdrawal by Subject|1|||
37752094|NCT04382755|69253117|FG001|Overall Study|Withdrawal by Subject|0|||
37752095|NCT04382755|69253116|FG000|Overall Study|did not receive allocated intervention due to clinical error|0|||
37752096|NCT04382755|69253117|FG001|Overall Study|did not receive allocated intervention due to clinical error|1|||
37752097|NCT04382755|69253116|FG000|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|0|||
37662118|NCT01602315|69134871|FG005|Overall Study|Withdrawal by Subject|0|||
37662119|NCT01602315|69134872|FG006|Overall Study|Withdrawal by Subject|1|||
37752098|NCT04382755|69253117|FG001|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|1|||
37752099|NCT04322539|69253126|FG000|Overall Study|Withdrawal of consent|14|||
37752100|NCT04322539|69253127|FG001|Overall Study|Withdrawal of consent|8|||
37752101|NCT04322539|69253126|FG000|Overall Study|Death|317|||
37752102|NCT04322539|69253127|FG001|Overall Study|Death|173|||
37752103|NCT04322539|69253126|FG000|Overall Study|Adverse Event|1|||
37662120|NCT01602315|69134866|FG000|Overall Study|Adverse Event|5|||
37662121|NCT01602315|69134867|FG001|Overall Study|Adverse Event|1|||
37662122|NCT01602315|69134868|FG002|Overall Study|Adverse Event|5|||
37662123|NCT01602315|69134869|FG003|Overall Study|Adverse Event|4|||
37662124|NCT01602315|69134870|FG004|Overall Study|Adverse Event|15|||
37662125|NCT01602315|69134871|FG005|Overall Study|Adverse Event|3|||
37662126|NCT01602315|69134872|FG006|Overall Study|Adverse Event|9|||
37752104|NCT04322539|69253127|FG001|Overall Study|Adverse Event|0|||
37752105|NCT04322539|69253126|FG000|Overall Study|Lost to Follow-up|3|||
37662127|NCT01602315|69134866|FG000|Overall Study|Subject/guardian decision|0|||
37662128|NCT01602315|69134867|FG001|Overall Study|Subject/guardian decision|0|||
37662129|NCT01602315|69134868|FG002|Overall Study|Subject/guardian decision|0|||
37662130|NCT01602315|69134869|FG003|Overall Study|Subject/guardian decision|0|||
37662131|NCT01602315|69134870|FG004|Overall Study|Subject/guardian decision|0|||
37662132|NCT01602315|69134871|FG005|Overall Study|Subject/guardian decision|0|||
37662133|NCT01602315|69134872|FG006|Overall Study|Subject/guardian decision|1|||
37662134|NCT01602315|69134866|FG000|Overall Study|Cross-over patients to combo treatment|0|||
37662135|NCT01602315|69134867|FG001|Overall Study|Cross-over patients to combo treatment|0|||
37662136|NCT01602315|69134868|FG002|Overall Study|Cross-over patients to combo treatment|0|||
37662137|NCT01602315|69134869|FG003|Overall Study|Cross-over patients to combo treatment|0|||
37752106|NCT04322539|69253127|FG001|Overall Study|Lost to Follow-up|0|||
37752107|NCT04322539|69253126|FG000|Overall Study|Other|2|||
37752108|NCT04322539|69253127|FG001|Overall Study|Other|3|||
37752109|NCT04322539|69253126|FG000|Overall Study|Ongoing|124|||
37752110|NCT04322539|69253127|FG001|Overall Study|Ongoing|46|||
37752111|NCT03928418|69253162|FG000|Overall Study|Lost to Follow-up|5|||
37752112|NCT03928418|69253163|FG001|Overall Study|Lost to Follow-up|3|||
37752113|NCT03928418|69253164|FG002|Overall Study|Lost to Follow-up|5|||
37752114|NCT03928418|69253162|FG000|Overall Study|Pilot participant - excluded from analyses|1|||
37752115|NCT03928418|69253163|FG001|Overall Study|Pilot participant - excluded from analyses|1|||
37752116|NCT03928418|69253164|FG002|Overall Study|Pilot participant - excluded from analyses|1|||
37752117|NCT03782376|69253217|FG000|Overall Study|Lost to Follow-up|2|||
37752118|NCT03782376|69253218|FG001|Overall Study|Lost to Follow-up|2|||
37752119|NCT03782376|69253217|FG000|Overall Study|Withdrawal by Subject|7|||
37752120|NCT03782376|69253218|FG001|Overall Study|Withdrawal by Subject|11|||
37752121|NCT03782376|69253217|FG000|Overall Study|Death|1|||
37752122|NCT03782376|69253218|FG001|Overall Study|Death|0|||
37752123|NCT03782376|69253217|FG000|Overall Study|Other|16|||
37752124|NCT03782376|69253218|FG001|Overall Study|Other|17|||
37752125|NCT03757130|69253232|FG000|Overall Study|Lost to Follow-up|0|||
37752126|NCT03757130|69253233|FG001|Overall Study|Lost to Follow-up|0|||
37752127|NCT03757130|69253234|FG002|Overall Study|Lost to Follow-up|0|||
37752128|NCT03757130|69253235|FG003|Overall Study|Lost to Follow-up|1|||
37752129|NCT03757130|69253236|FG004|Overall Study|Lost to Follow-up|0|||
37752130|NCT03757130|69253237|FG005|Overall Study|Lost to Follow-up|0|||
37752131|NCT03757130|69253238|FG006|Overall Study|Lost to Follow-up|0|||
37752132|NCT03757130|69253239|FG007|Overall Study|Lost to Follow-up|1|||
37752133|NCT03757130|69253232|FG000|Overall Study|Withdrawal by Subject|0|||
37752134|NCT03757130|69253233|FG001|Overall Study|Withdrawal by Subject|0|||
37752135|NCT03757130|69253234|FG002|Overall Study|Withdrawal by Subject|0|||
37662138|NCT01602315|69134870|FG004|Overall Study|Cross-over patients to combo treatment|0|||
37662139|NCT01602315|69134871|FG005|Overall Study|Cross-over patients to combo treatment|16|||
37662140|NCT01602315|69134872|FG006|Overall Study|Cross-over patients to combo treatment|0|||
37752136|NCT03757130|69253235|FG003|Overall Study|Withdrawal by Subject|0|||
37752137|NCT03757130|69253236|FG004|Overall Study|Withdrawal by Subject|0|||
37752138|NCT03757130|69253237|FG005|Overall Study|Withdrawal by Subject|0|||
37752139|NCT03757130|69253238|FG006|Overall Study|Withdrawal by Subject|1|||
37752140|NCT03757130|69253239|FG007|Overall Study|Withdrawal by Subject|0|||
37752141|NCT03555565|69253280|FG000|Overall Study|Case Report Forms Uncollected|2|||
37752142|NCT03555565|69253280|FG000|Overall Study|Protocol Deviation|13|||
37752143|NCT03553836|69253286|FG000|Overall Study|Ongoing in Study|460|||
37752144|NCT03553836|69253287|FG001|Overall Study|Ongoing in Study|459|||
37752145|NCT03553836|69253286|FG000|Overall Study|Withdrawal by Subject|9|||
37752146|NCT03553836|69253287|FG001|Overall Study|Withdrawal by Subject|10|||
37752147|NCT03553836|69253286|FG000|Overall Study|Lost to Follow-up|1|||
37752148|NCT03553836|69253287|FG001|Overall Study|Lost to Follow-up|3|||
37752149|NCT03553836|69253286|FG000|Overall Study|Death|17|||
37752150|NCT03553836|69253287|FG001|Overall Study|Death|17|||
37752151|NCT03519386|69253297|FG000|Overall Study|Withdrawal by Subject|4|||
37752152|NCT03519386|69253298|FG001|Overall Study|Withdrawal by Subject|1|||
37752153|NCT03519386|69253299|FG002|Overall Study|Withdrawal by Subject|2|||
37752154|NCT03519386|69253297|FG000|Overall Study|Physician Decision|1|||
37752155|NCT03519386|69253298|FG001|Overall Study|Physician Decision|1|||
37752156|NCT03519386|69253299|FG002|Overall Study|Physician Decision|1|||
37752157|NCT03519386|69253297|FG000|Overall Study|Lost to Follow-up|0|||
37752158|NCT03519386|69253298|FG001|Overall Study|Lost to Follow-up|1|||
37856985|NCT01199289|69540199|FG000|Overall Study|Noncompliance|1|||
37856986|NCT01199289|69540200|FG001|Overall Study|Noncompliance|0|||
37856987|NCT01199289|69540201|FG002|Overall Study|Noncompliance|2|||
37856988|NCT01199289|69540202|FG003|Overall Study|Noncompliance|0|||
37856989|NCT01199289|69540199|FG000|Overall Study|Adverse Event|0|||
37856990|NCT01199289|69540200|FG001|Overall Study|Adverse Event|3|||
37856991|NCT01199289|69540201|FG002|Overall Study|Adverse Event|1|||
37856992|NCT01199289|69540202|FG003|Overall Study|Adverse Event|4|||
37856993|NCT01199289|69540199|FG000|Overall Study|Full consent withdrawn|2|||
37856994|NCT01199289|69540200|FG001|Overall Study|Full consent withdrawn|2|||
37856995|NCT01199289|69540201|FG002|Overall Study|Full consent withdrawn|2|||
37856996|NCT01199289|69540202|FG003|Overall Study|Full consent withdrawn|3|||
37856997|NCT01199289|69540199|FG000|Overall Study|Administrative decision|0|||
37856998|NCT01199289|69540200|FG001|Overall Study|Administrative decision|0|||
37856999|NCT01199289|69540201|FG002|Overall Study|Administrative decision|0|||
37857000|NCT01199289|69540202|FG003|Overall Study|Administrative decision|1|||
37662141|NCT02344004|69134919|FG000|Overall Study|Adverse Event|11|||
37662142|NCT02344004|69134920|FG001|Overall Study|Adverse Event|1|||
37662143|NCT02344004|69134919|FG000|Overall Study|Death|9|||
37662144|NCT02344004|69134920|FG001|Overall Study|Death|7|||
37662145|NCT02344004|69134919|FG000|Overall Study|Physician Decision|4|||
37662146|NCT02344004|69134920|FG001|Overall Study|Physician Decision|1|||
37662147|NCT02344004|69134919|FG000|Overall Study|Withdrawal by Subject|22|||
37662148|NCT02344004|69134920|FG001|Overall Study|Withdrawal by Subject|5|||
37662149|NCT02344004|69134919|FG000|Overall Study|Rescue Medication|2|||
37662150|NCT02344004|69134920|FG001|Overall Study|Rescue Medication|0|||
37662151|NCT02344004|69134919|FG000|Overall Study|Other Not Specified|12|||
37662152|NCT02344004|69134920|FG001|Overall Study|Other Not Specified|0|||
37662153|NCT02344004|69134919|FG000|Overall Study|Protocol Violation|1|||
37662154|NCT02344004|69134920|FG001|Overall Study|Protocol Violation|0|||
37662155|NCT01328093|69134929|FG000|Double-Blind Phase|Adverse Event|78|||
37662156|NCT01328093|69134930|FG001|Double-Blind Phase|Adverse Event|15|||
37662157|NCT01328093|69134929|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
37662158|NCT01328093|69134930|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
37662159|NCT01328093|69134929|FG000|Double-Blind Phase|Lost to Follow-up|39|||
37662160|NCT01328093|69134930|FG001|Double-Blind Phase|Lost to Follow-up|14|||
37662161|NCT01328093|69134929|FG000|Double-Blind Phase|Protocol Violation|30|||
37662162|NCT01328093|69134930|FG001|Double-Blind Phase|Protocol Violation|10|||
37752159|NCT03519386|69253299|FG002|Overall Study|Lost to Follow-up|1|||
37752160|NCT03519386|69253297|FG000|Overall Study|Death|1|||
37752161|NCT03519386|69253298|FG001|Overall Study|Death|0|||
37752162|NCT03519386|69253299|FG002|Overall Study|Death|4|||
37752163|NCT03519386|69253297|FG000|Overall Study|Adverse Event|2|||
37752164|NCT03519386|69253298|FG001|Overall Study|Adverse Event|1|||
37752165|NCT03519386|69253299|FG002|Overall Study|Adverse Event|2|||
37752166|NCT03519386|69253297|FG000|Overall Study|Explanted|2|||
37857001|NCT01199289|69540199|FG000|Overall Study|Lost to Follow-up|0|||
37662163|NCT01328093|69134929|FG000|Double-Blind Phase|Lack of Efficacy|55|||
37662164|NCT01328093|69134930|FG001|Double-Blind Phase|Lack of Efficacy|13|||
37662165|NCT01328093|69134929|FG000|Double-Blind Phase|Sponsor Decision|17|||
37662166|NCT01328093|69134930|FG001|Double-Blind Phase|Sponsor Decision|3|||
37662167|NCT01328093|69134929|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
37752167|NCT03519386|69253298|FG001|Overall Study|Explanted|1|||
37752168|NCT03519386|69253299|FG002|Overall Study|Explanted|0|||
37857002|NCT01199289|69540200|FG001|Overall Study|Lost to Follow-up|0|||
37857003|NCT01199289|69540201|FG002|Overall Study|Lost to Follow-up|0|||
37752169|NCT03519386|69253297|FG000|Overall Study|Ongoing in study|190|||
37752170|NCT03519386|69253298|FG001|Overall Study|Ongoing in study|192|||
37752171|NCT03519386|69253299|FG002|Overall Study|Ongoing in study|183|||
37752172|NCT03412565|69253315|FG000|Overall Study|Other|0|||
37752173|NCT03412565|69253316|FG001|Overall Study|Other|0|||
37752174|NCT03412565|69253317|FG002|Overall Study|Other|0|||
37752175|NCT03412565|69253318|FG003|Overall Study|Other|3|||
37752176|NCT03412565|69253315|FG000|Overall Study|Withdrawal by Subject|0|||
37752177|NCT03412565|69253316|FG001|Overall Study|Withdrawal by Subject|0|||
37752178|NCT03412565|69253317|FG002|Overall Study|Withdrawal by Subject|1|||
37752179|NCT03412565|69253318|FG003|Overall Study|Withdrawal by Subject|5|||
37752180|NCT03412565|69253315|FG000|Overall Study|Physician Decision|0|||
37752181|NCT03412565|69253316|FG001|Overall Study|Physician Decision|1|||
37752182|NCT03412565|69253317|FG002|Overall Study|Physician Decision|0|||
37752183|NCT03412565|69253318|FG003|Overall Study|Physician Decision|1|||
37752184|NCT03412565|69253315|FG000|Overall Study|Death|1|||
37752185|NCT03412565|69253316|FG001|Overall Study|Death|2|||
37752186|NCT03412565|69253317|FG002|Overall Study|Death|2|||
37752187|NCT03412565|69253318|FG003|Overall Study|Death|4|||
37752188|NCT03412565|69253315|FG000|Overall Study|Still ongoing|0|||
37752189|NCT03412565|69253316|FG001|Overall Study|Still ongoing|62|||
37752190|NCT03412565|69253317|FG002|Overall Study|Still ongoing|59|||
37752191|NCT03412565|69253318|FG003|Overall Study|Still ongoing|41|||
37752192|NCT03369665|69253338|FG000|Overall Study|Adverse Event|3|||
37752193|NCT03369665|69253338|FG000|Overall Study|Lost to Follow-up|7|||
37752194|NCT03369665|69253338|FG000|Overall Study|Withdrawal by Subject|15|||
37752195|NCT03369665|69253338|FG000|Overall Study|Progression Disease|2|||
37752196|NCT03369665|69253338|FG000|Overall Study|Not classified|3|||
37752197|NCT03317405|69253356|FG000|Overall Study|Withdrawal by Subject|1|||
37752198|NCT03317405|69253357|FG001|Overall Study|Withdrawal by Subject|0|||
37752199|NCT03317405|69253358|FG002|Overall Study|Withdrawal by Subject|0|||
37752200|NCT03317405|69253356|FG000|Overall Study|Physician Decision|0|||
37752201|NCT03317405|69253357|FG001|Overall Study|Physician Decision|0|||
37752202|NCT03317405|69253358|FG002|Overall Study|Physician Decision|1|||
37752203|NCT03317405|69253356|FG000|Overall Study|Surgery Rescheduled|0|||
37857004|NCT01199289|69540202|FG003|Overall Study|Lost to Follow-up|1|||
37857005|NCT01199289|69540199|FG000|Overall Study|Protocol-specified criteria|3|||
37857006|NCT01199289|69540200|FG001|Overall Study|Protocol-specified criteria|0|||
37857007|NCT01199289|69540201|FG002|Overall Study|Protocol-specified criteria|0|||
37857008|NCT01199289|69540202|FG003|Overall Study|Protocol-specified criteria|1|||
37857009|NCT01199289|69540199|FG000|Overall Study|Pregnancy|0|||
37857010|NCT01199289|69540200|FG001|Overall Study|Pregnancy|1|||
37662168|NCT01328093|69134930|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
37662169|NCT01328093|69134929|FG000|Double-Blind Phase|Scheduling conflict|8|||
37662170|NCT01328093|69134930|FG001|Double-Blind Phase|Scheduling conflict|3|||
37662171|NCT01328093|69134929|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
37662172|NCT01328093|69134930|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
37662173|NCT01328093|69134929|FG000|Double-Blind Phase|Death|1|||
37662174|NCT01328093|69134930|FG001|Double-Blind Phase|Death|0|||
37662175|NCT01328093|69134929|FG000|Open-Label Phase|Sponsor Decision|98|||
37662176|NCT01328093|69134930|FG001|Open-Label Phase|Sponsor Decision|34|||
37662177|NCT01328093|69134929|FG000|Open-Label Phase|Protocol Violation|8|||
37662178|NCT01328093|69134930|FG001|Open-Label Phase|Protocol Violation|3|||
37662179|NCT01328093|69134929|FG000|Open-Label Phase|Lost to Follow-up|10|||
37662180|NCT01328093|69134930|FG001|Open-Label Phase|Lost to Follow-up|1|||
37662181|NCT01328093|69134929|FG000|Open-Label Phase|Adverse Event|10|||
37662182|NCT01328093|69134930|FG001|Open-Label Phase|Adverse Event|4|||
37662183|NCT01328093|69134929|FG000|Open-Label Phase|Lack of Efficacy|5|||
37662184|NCT01328093|69134930|FG001|Open-Label Phase|Lack of Efficacy|6|||
37662185|NCT01328093|69134929|FG000|Open-Label Phase|Withdrawal by Subject|4|||
37662186|NCT01328093|69134930|FG001|Open-Label Phase|Withdrawal by Subject|1|||
37752204|NCT03317405|69253357|FG001|Overall Study|Surgery Rescheduled|1|||
37752205|NCT03317405|69253358|FG002|Overall Study|Surgery Rescheduled|0|||
37752206|NCT03304249|69253372|FG000|Overall Study|Lost to Follow-up|8|||
37752207|NCT03304249|69253373|FG001|Overall Study|Lost to Follow-up|10|||
37752208|NCT03304249|69253372|FG000|Overall Study|Withdrawal by Subject|12|||
37752209|NCT03304249|69253373|FG001|Overall Study|Withdrawal by Subject|2|||
37752210|NCT03304249|69253372|FG000|Overall Study|Moved Out of District|4|||
37752211|NCT03304249|69253373|FG001|Overall Study|Moved Out of District|2|||
37752212|NCT03206203|69253421|FG000|Treatment|Death|38|||
37752213|NCT03206203|69253422|FG001|Treatment|Death|26|||
37752214|NCT03206203|69253423|FG002|Treatment|Death|0|||
37752215|NCT03206203|69253421|FG000|Treatment|Withdrawal by Subject|1|||
37752216|NCT03206203|69253422|FG001|Treatment|Withdrawal by Subject|0|||
37752217|NCT03206203|69253423|FG002|Treatment|Withdrawal by Subject|0|||
37857011|NCT01199289|69540201|FG002|Overall Study|Pregnancy|0|||
37662187|NCT01328093|69134929|FG000|Open-Label Phase|Scheduling conflict|2|||
37662188|NCT01328093|69134930|FG001|Open-Label Phase|Scheduling conflict|1|||
37752218|NCT03206203|69253421|FG000|Treatment|Lost to Follow-up|4|||
37752219|NCT03206203|69253422|FG001|Treatment|Lost to Follow-up|0|||
37662189|NCT01328093|69134929|FG000|Open-Label Phase|Subject is moving or has moved|2|||
37662190|NCT01328093|69134930|FG001|Open-Label Phase|Subject is moving or has moved|0|||
37662191|NCT01328093|69134929|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
37662192|NCT01328093|69134930|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
37662193|NCT02654145|69134937|FG000|Overall Study|Lack of Efficacy|1|||
37662194|NCT02654145|69134937|FG000|Overall Study|Protocol Violation|1|||
37662195|NCT02654145|69134937|FG000|Overall Study|Withdrawal by Subject|5|||
37662196|NCT01111565|69134941|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
37662197|NCT01111565|69134942|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
37662198|NCT01111565|69134943|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
37662199|NCT01111565|69134944|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
37662200|NCT01111565|69134945|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
37662201|NCT01111565|69134941|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
37662202|NCT01111565|69134942|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
37662203|NCT01111565|69134943|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
37662204|NCT01111565|69134944|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
37662205|NCT01111565|69134945|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
37662206|NCT01111565|69134941|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
37662207|NCT01111565|69134942|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
37662208|NCT01111565|69134943|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
37662209|NCT01111565|69134944|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
37662210|NCT01111565|69134945|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
37662211|NCT01111565|69134941|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
37662212|NCT01111565|69134942|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
37662213|NCT01111565|69134943|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
37662214|NCT01111565|69134944|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
37662215|NCT01111565|69134945|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
37662216|NCT01111565|69134941|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
37662217|NCT01111565|69134942|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
37662218|NCT01111565|69134943|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
37662219|NCT01111565|69134944|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
37662220|NCT01111565|69134945|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
37752220|NCT03206203|69253423|FG002|Treatment|Lost to Follow-up|0|||
37752221|NCT03206203|69253421|FG000|Treatment|N/A in Follow-Up|8|||
37752222|NCT03206203|69253422|FG001|Treatment|N/A in Follow-Up|1|||
37752223|NCT03206203|69253423|FG002|Treatment|N/A in Follow-Up|0|||
37752224|NCT03206203|69253421|FG000|Treatment|Disease progression|0|||
37752225|NCT03206203|69253422|FG001|Treatment|Disease progression|1|||
37752226|NCT03206203|69253423|FG002|Treatment|Disease progression|0|||
37752227|NCT03206203|69253421|FG000|Treatment|Refused follow-up|0|||
37752228|NCT03206203|69253422|FG001|Treatment|Refused follow-up|1|||
37752229|NCT03206203|69253423|FG002|Treatment|Refused follow-up|0|||
37752230|NCT03206203|69253421|FG000|Treatment|Cross over to Arm 1|0|||
37857012|NCT01199289|69540202|FG003|Overall Study|Pregnancy|1|||
37857013|NCT01199055|69540218|FG000|Overall Study|Death|0|||
37857014|NCT01199055|69540219|FG001|Overall Study|Death|1|||
37857015|NCT01199055|69540220|FG002|Overall Study|Death|0|||
37857016|NCT01199055|69540218|FG000|Overall Study|Physician Decision|0|||
37857017|NCT01199055|69540219|FG001|Overall Study|Physician Decision|1|||
37857018|NCT01199055|69540220|FG002|Overall Study|Physician Decision|1|||
37857019|NCT01199055|69540218|FG000|Overall Study|Progressive disease|2|||
37857020|NCT01199055|69540219|FG001|Overall Study|Progressive disease|1|||
37857021|NCT01199055|69540220|FG002|Overall Study|Progressive disease|2|||
37857022|NCT01199055|69540218|FG000|Overall Study|Withdrawal by Subject|0|||
37857023|NCT01199055|69540219|FG001|Overall Study|Withdrawal by Subject|0|||
37857024|NCT01199055|69540220|FG002|Overall Study|Withdrawal by Subject|1|||
37857025|NCT01198977|69540232|FG000|Overall Study|Lost to Follow-up|1|||
37857026|NCT01198977|69540233|FG001|Overall Study|Lost to Follow-up|0|||
37857027|NCT01198587|69540245|FG000|Overall Study|Lost to Follow-up|8|||
37662221|NCT01111565|69134941|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
37662222|NCT01111565|69134942|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
37662223|NCT01111565|69134943|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
37662224|NCT01111565|69134944|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
37752231|NCT03206203|69253422|FG001|Treatment|Cross over to Arm 1|19|||
37752232|NCT03206203|69253423|FG002|Treatment|Cross over to Arm 1|0|||
37752233|NCT03206203|69253421|FG000|Optional Cross-Over|Death|0|||
37752234|NCT03206203|69253422|FG001|Optional Cross-Over|Death|0|||
37752235|NCT03206203|69253423|FG002|Optional Cross-Over|Death|14|||
37752236|NCT03206203|69253421|FG000|Optional Cross-Over|Refused follow-up|0|||
37857028|NCT01198587|69540246|FG001|Overall Study|Lost to Follow-up|0|||
37923227|NCT00826280|69610004|FG001|Overall Study|One or more non-interpretable scan|1|||
37662225|NCT01111565|69134945|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
37662226|NCT01111565|69134941|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
37752237|NCT03206203|69253422|FG001|Optional Cross-Over|Refused follow-up|0|||
37857029|NCT01198587|69540247|FG002|Overall Study|Lost to Follow-up|9|||
37857030|NCT01198587|69540248|FG003|Overall Study|Lost to Follow-up|0|||
37662227|NCT01111565|69134942|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
37662228|NCT01111565|69134943|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
37662229|NCT01111565|69134944|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
37662230|NCT01111565|69134945|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
37857031|NCT01198509|69540269|FG000|Overall Study|Withdrawal by Subject|1|||
37857032|NCT01198509|69540270|FG001|Overall Study|Withdrawal by Subject|0|||
37857033|NCT01198509|69540271|FG002|Overall Study|Withdrawal by Subject|0|||
37857034|NCT01198509|69540272|FG003|Overall Study|Withdrawal by Subject|0|||
37857035|NCT01198509|69540273|FG004|Overall Study|Withdrawal by Subject|0|||
37857036|NCT01198509|69540274|FG005|Overall Study|Withdrawal by Subject|0|||
37857037|NCT01198275|69540288|FG000|Overall Study|Adverse Event|2|||
37857038|NCT01198275|69540289|FG001|Overall Study|Adverse Event|3|||
37857039|NCT01198275|69540288|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
37857040|NCT01198275|69540289|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
37857041|NCT01197417|69540297|FG000|Overall Study|Physician Decision|3|||
37857042|NCT01197417|69540298|FG001|Overall Study|Physician Decision|2|||
37857043|NCT01197417|69540297|FG000|Overall Study|Withdrawal by Subject|2|||
37857044|NCT01197417|69540298|FG001|Overall Study|Withdrawal by Subject|4|||
37857045|NCT01197417|69540297|FG000|Overall Study|Site miscommunication|0|||
37857046|NCT01197417|69540298|FG001|Overall Study|Site miscommunication|1|||
37857047|NCT01197417|69540297|FG000|Overall Study|Subject transferred to intensive care|0|||
37857048|NCT01197417|69540298|FG001|Overall Study|Subject transferred to intensive care|1|||
37857049|NCT01197417|69540297|FG000|Overall Study|Not consented in time to receive drug|0|||
37857050|NCT01197417|69540298|FG001|Overall Study|Not consented in time to receive drug|1|||
37857051|NCT01197417|69540297|FG000|Overall Study|Hypotension|1|||
37857052|NCT01197417|69540298|FG001|Overall Study|Hypotension|2|||
37857053|NCT01197417|69540297|FG000|Overall Study|Found to be ineligible|2|||
37857054|NCT01197417|69540298|FG001|Overall Study|Found to be ineligible|5|||
37857055|NCT01197417|69540297|FG000|Overall Study|No 25-hour magnesium level|0|||
37857056|NCT01197417|69540298|FG001|Overall Study|No 25-hour magnesium level|2|||
37857057|NCT00977431|69540309|FG000|Overall Study|Other than listed|1|||
37857058|NCT00977431|69540310|FG001|Overall Study|Other than listed|0|||
37857059|NCT00977431|69540311|FG002|Overall Study|Other than listed|0|||
37857060|NCT00977431|69540312|FG003|Overall Study|Other than listed|0|||
37857061|NCT00977431|69540313|FG004|Overall Study|Other than listed|2|||
37857062|NCT00977431|69540309|FG000|Overall Study|Protocol Violation|0|||
37857063|NCT00977431|69540310|FG001|Overall Study|Protocol Violation|0|||
37857064|NCT00977431|69540311|FG002|Overall Study|Protocol Violation|1|||
37857065|NCT00977431|69540312|FG003|Overall Study|Protocol Violation|0|||
37857066|NCT00977431|69540313|FG004|Overall Study|Protocol Violation|0|||
37857067|NCT00977431|69540309|FG000|Overall Study|Adverse Event|3|||
37662231|NCT01111565|69134941|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
37662232|NCT01111565|69134942|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
37662233|NCT01111565|69134943|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
37662234|NCT01111565|69134944|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
37662235|NCT01111565|69134945|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
37662236|NCT01111565|69134941|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
37662237|NCT01111565|69134942|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
37662238|NCT01111565|69134943|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
37752238|NCT03206203|69253423|FG002|Optional Cross-Over|Refused follow-up|2|||
37752239|NCT03201458|69253432|FG000|Overall Study|No longer eligible|2|||
37752240|NCT03201458|69253433|FG001|Overall Study|No longer eligible|5|||
37752241|NCT03201458|69253432|FG000|Overall Study|Health event before starting|1|||
37752242|NCT03201458|69253433|FG001|Overall Study|Health event before starting|0|||
37752243|NCT03201458|69253432|FG000|Overall Study|Physician Decision|1|||
37662239|NCT01111565|69134944|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
37857068|NCT00977431|69540310|FG001|Overall Study|Adverse Event|0|||
37923228|NCT00826280|69610005|FG002|Overall Study|One or more non-interpretable scan|1|||
37662240|NCT01111565|69134945|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
37752244|NCT03201458|69253433|FG001|Overall Study|Physician Decision|0|||
37752245|NCT03181893|69253450|FG000|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
37752246|NCT03181893|69253451|FG001|Baseline to Week 12 (All Stages)|Withdrawal by Subject|1|||
37752247|NCT03181893|69253452|FG002|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
37752248|NCT03181893|69253453|FG003|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
37857069|NCT00977431|69540311|FG002|Overall Study|Adverse Event|4|||
37857070|NCT00977431|69540312|FG003|Overall Study|Adverse Event|0|||
37857071|NCT00977431|69540313|FG004|Overall Study|Adverse Event|6|||
37857072|NCT00977431|69540309|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
37857073|NCT00977431|69540310|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
37857074|NCT00977431|69540311|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
37857075|NCT00977431|69540312|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
37662241|NCT01111565|69134941|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
37752249|NCT03181893|69253454|FG004|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
37752250|NCT03181893|69253455|FG005|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
37752251|NCT03181893|69253456|FG006|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
37752252|NCT03181893|69253457|FG007|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
37752253|NCT03181893|69253458|FG008|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
37752254|NCT03181893|69253459|FG009|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
37752255|NCT03181893|69253460|FG010|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
37752256|NCT03181893|69253450|FG000|Baseline to Week 12 (All Stages)|Adverse Event|1|||
37752257|NCT03181893|69253451|FG001|Baseline to Week 12 (All Stages)|Adverse Event|1|||
37752258|NCT03181893|69253452|FG002|Baseline to Week 12 (All Stages)|Adverse Event|0|||
37752259|NCT03181893|69253453|FG003|Baseline to Week 12 (All Stages)|Adverse Event|0|||
37752260|NCT03181893|69253454|FG004|Baseline to Week 12 (All Stages)|Adverse Event|0|||
37752261|NCT03181893|69253455|FG005|Baseline to Week 12 (All Stages)|Adverse Event|0|||
37752262|NCT03181893|69253456|FG006|Baseline to Week 12 (All Stages)|Adverse Event|0|||
37752263|NCT03181893|69253457|FG007|Baseline to Week 12 (All Stages)|Adverse Event|0|||
37752264|NCT03181893|69253458|FG008|Baseline to Week 12 (All Stages)|Adverse Event|0|||
37752265|NCT03181893|69253459|FG009|Baseline to Week 12 (All Stages)|Adverse Event|0|||
37752266|NCT03181893|69253460|FG010|Baseline to Week 12 (All Stages)|Adverse Event|0|||
37752267|NCT03181893|69253450|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
37752268|NCT03181893|69253451|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
37752269|NCT03181893|69253452|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
37752270|NCT03181893|69253453|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
37752271|NCT03181893|69253454|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
37752272|NCT03181893|69253455|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
37752273|NCT03181893|69253456|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
37752274|NCT03181893|69253457|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
37752275|NCT03181893|69253458|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
37752276|NCT03181893|69253459|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
37752277|NCT03181893|69253460|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
37752278|NCT03181893|69253450|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
37752279|NCT03181893|69253451|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
37752280|NCT03181893|69253452|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
37752281|NCT03181893|69253453|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
37662242|NCT01111565|69134942|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
37662243|NCT01111565|69134943|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
37662244|NCT01111565|69134944|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
37662245|NCT01111565|69134945|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
37752282|NCT03181893|69253454|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
37752283|NCT03181893|69253455|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
37662246|NCT01111565|69134941|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
37662247|NCT01111565|69134942|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
37662248|NCT01111565|69134943|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
37662249|NCT01111565|69134944|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
37662250|NCT01111565|69134945|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
37662251|NCT01111565|69134941|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
37662252|NCT01111565|69134942|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
37662253|NCT01111565|69134943|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
37662254|NCT01111565|69134944|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
37752284|NCT03181893|69253456|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
37752285|NCT03181893|69253457|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
37662255|NCT01111565|69134945|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
37662256|NCT02343458|69134959|FG000|Overall Study|Adverse Event|15|||
37662257|NCT02343458|69134960|FG001|Overall Study|Adverse Event|14|||
37752286|NCT03181893|69253458|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
37752287|NCT03181893|69253459|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|1|||
37752288|NCT03181893|69253460|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
37752289|NCT03181893|69253450|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
37752290|NCT03181893|69253451|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
37752291|NCT03181893|69253452|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
37752292|NCT03181893|69253453|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
37752293|NCT03181893|69253454|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
37752294|NCT03181893|69253455|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
37752295|NCT03181893|69253456|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
37662258|NCT02343458|69134961|FG002|Overall Study|Adverse Event|15|||
37662259|NCT02343458|69134962|FG003|Overall Study|Adverse Event|3|||
37662260|NCT02343458|69134959|FG000|Overall Study|Lack of Efficacy|3|||
37662261|NCT02343458|69134960|FG001|Overall Study|Lack of Efficacy|8|||
37662262|NCT02343458|69134961|FG002|Overall Study|Lack of Efficacy|4|||
37662263|NCT02343458|69134962|FG003|Overall Study|Lack of Efficacy|8|||
37662264|NCT02343458|69134959|FG000|Overall Study|Withdrawal by Subject|18|||
37662265|NCT02343458|69134960|FG001|Overall Study|Withdrawal by Subject|17|||
37662266|NCT02343458|69134961|FG002|Overall Study|Withdrawal by Subject|23|||
37662267|NCT02343458|69134962|FG003|Overall Study|Withdrawal by Subject|14|||
37662268|NCT02343458|69134959|FG000|Overall Study|Physician Decision|1|||
37662269|NCT02343458|69134960|FG001|Overall Study|Physician Decision|4|||
37662270|NCT02343458|69134961|FG002|Overall Study|Physician Decision|2|||
37662271|NCT02343458|69134962|FG003|Overall Study|Physician Decision|2|||
37752296|NCT03181893|69253457|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
37752297|NCT03181893|69253458|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
37752298|NCT03181893|69253459|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
37752299|NCT03181893|69253460|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|1|||
37752300|NCT03180840|69253485|FG000|Overall Study|Withdrawal by Subject|1|||
37752301|NCT03072238|69253496|FG000|Overall Study|Withdrawal by Subject|30|||
37752302|NCT03072238|69253497|FG001|Overall Study|Withdrawal by Subject|51|||
37752303|NCT03072238|69253496|FG000|Overall Study|Lost to Follow-up|7|||
37752304|NCT03072238|69253497|FG001|Overall Study|Lost to Follow-up|4|||
37752305|NCT03072238|69253496|FG000|Overall Study|Physician Decision|1|||
37752306|NCT03072238|69253497|FG001|Overall Study|Physician Decision|3|||
37752307|NCT03072238|69253496|FG000|Overall Study|Death|139|||
37752308|NCT03072238|69253497|FG001|Overall Study|Death|121|||
37752309|NCT03072238|69253496|FG000|Overall Study|Other|0|||
37662272|NCT02343458|69134959|FG000|Overall Study|Lost to Follow-up|5|||
37752310|NCT03072238|69253497|FG001|Overall Study|Other|1|||
37752311|NCT03072238|69253496|FG000|Overall Study|Ongoing on study|377|||
37752312|NCT03072238|69253497|FG001|Overall Study|Ongoing on study|367|||
37752313|NCT03064035|69253506|FG000|Overall Study|Did not receive allocated intervention|4|||
37752314|NCT03064035|69253507|FG001|Overall Study|Did not receive allocated intervention|2|||
37752315|NCT03064035|69253506|FG000|Overall Study|Lost to Follow-up|1|||
37752316|NCT03064035|69253507|FG001|Overall Study|Lost to Follow-up|1|||
37752317|NCT03014206|69253520|FG000|Overall Study|Registration Violation|12|||
37752318|NCT02822573|69253535|FG000|Overall Study|Lost to Follow-up|5|||
37752319|NCT02822573|69253536|FG001|Overall Study|Lost to Follow-up|3|||
37752320|NCT02822573|69253535|FG000|Overall Study|Physician Decision|1|||
37752321|NCT02822573|69253536|FG001|Overall Study|Physician Decision|1|||
37752322|NCT02822573|69253535|FG000|Overall Study|Withdrawal by Subject|9|||
37752323|NCT02822573|69253536|FG001|Overall Study|Withdrawal by Subject|5|||
37752324|NCT02822573|69253535|FG000|Overall Study|Protocol Violation|6|||
37752325|NCT02822573|69253536|FG001|Overall Study|Protocol Violation|4|||
37752326|NCT02822573|69253535|FG000|Overall Study|Too sick or ill|2|||
37752327|NCT02822573|69253536|FG001|Overall Study|Too sick or ill|1|||
37752328|NCT02822573|69253535|FG000|Overall Study|Disease Progression|1|||
37752329|NCT02822573|69253536|FG001|Overall Study|Disease Progression|1|||
37752330|NCT02822573|69253535|FG000|Overall Study|No reason given|6|||
37752331|NCT02822573|69253536|FG001|Overall Study|No reason given|4|||
37752332|NCT02795676|69253544|FG000|Overall Study|Adverse Event|2|||
37752333|NCT02795676|69253545|FG001|Overall Study|Adverse Event|0|||
37752334|NCT02795676|69253544|FG000|Overall Study|Withdrawal by Subject|3|||
37752335|NCT02795676|69253545|FG001|Overall Study|Withdrawal by Subject|1|||
37752336|NCT02784535|69253551|FG000|Overall Study|Adverse Event|1|||
37752337|NCT02784535|69253552|FG001|Overall Study|Adverse Event|0|||
37752338|NCT02784535|69253551|FG000|Overall Study|Withdrawal by Subject|0|||
37752339|NCT02784535|69253552|FG001|Overall Study|Withdrawal by Subject|1|||
37752340|NCT02784535|69253551|FG000|Overall Study|Physician Decision|0|||
37752341|NCT02784535|69253552|FG001|Overall Study|Physician Decision|1|||
37752342|NCT02617511|69253563|FG000|Overall Study|Withdrawal by Subject|1|||
37752343|NCT02617511|69253564|FG001|Overall Study|Withdrawal by Subject|0|||
37752344|NCT02587234|69253572|FG000|Overall Study|Withdrawal by Subject|1|||
37752345|NCT02587234|69253573|FG001|Overall Study|Withdrawal by Subject|1|||
37752346|NCT02587234|69253572|FG000|Overall Study|Lost to Follow-up|0|||
37752347|NCT02587234|69253573|FG001|Overall Study|Lost to Follow-up|2|||
37752348|NCT02516241|69253582|FG000|Overall Study|Death|255|||
37752349|NCT02516241|69253583|FG001|Overall Study|Death|262|||
37752350|NCT02516241|69253584|FG002|Overall Study|Death|270|||
37857076|NCT00977431|69540313|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
37752351|NCT02516241|69253582|FG000|Overall Study|Lost to Follow-up|1|||
37752352|NCT02516241|69253583|FG001|Overall Study|Lost to Follow-up|1|||
37752353|NCT02516241|69253584|FG002|Overall Study|Lost to Follow-up|3|||
37857077|NCT00977431|69540309|FG000|Overall Study|Progressive disease|2|||
37857078|NCT00977431|69540310|FG001|Overall Study|Progressive disease|6|||
37752354|NCT02516241|69253582|FG000|Overall Study|Withdrawal by Subject|2|||
37662273|NCT02343458|69134960|FG001|Overall Study|Lost to Follow-up|5|||
37752355|NCT02516241|69253583|FG001|Overall Study|Withdrawal by Subject|7|||
37752356|NCT02516241|69253584|FG002|Overall Study|Withdrawal by Subject|12|||
37752357|NCT02516241|69253582|FG000|Overall Study|participants ongoing at data cut-off|84|||
37857079|NCT00977431|69540311|FG002|Overall Study|Progressive disease|1|||
37857080|NCT00977431|69540312|FG003|Overall Study|Progressive disease|3|||
37857081|NCT00977431|69540313|FG004|Overall Study|Progressive disease|5|||
37857082|NCT00977197|69540331|FG000|Overall Study|Withdrawal by Subject|3|||
37857083|NCT00977197|69540332|FG001|Overall Study|Withdrawal by Subject|4|||
37857084|NCT00977197|69540331|FG000|Overall Study|Adverse Event|3|||
37857085|NCT00977197|69540332|FG001|Overall Study|Adverse Event|1|||
37857086|NCT00977197|69540331|FG000|Overall Study|Lack of Efficacy|1|||
37857087|NCT00977197|69540332|FG001|Overall Study|Lack of Efficacy|0|||
37857088|NCT00977197|69540331|FG000|Overall Study|Lost to Follow-up|1|||
37857089|NCT00977197|69540332|FG001|Overall Study|Lost to Follow-up|3|||
37857090|NCT00977197|69540331|FG000|Overall Study|Nonadherence|1|||
37857091|NCT00977197|69540332|FG001|Overall Study|Nonadherence|1|||
37857092|NCT00974311|69540340|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
37857093|NCT00974311|69540341|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
37857094|NCT00974311|69540340|FG000|DB Phase (up to 24 Months)|Death|561|||
37857095|NCT00974311|69540341|FG001|DB Phase (up to 24 Months)|Death|298|||
37857096|NCT00974311|69540340|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
37857097|NCT00974311|69540341|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
37857098|NCT00974311|69540340|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
37857099|NCT00974311|69540341|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
37857100|NCT00974311|69540340|FG000|DB Phase (up to 24 Months)|Other|1|||
37857101|NCT00974311|69540341|FG001|DB Phase (up to 24 Months)|Other|0|||
37857102|NCT00974311|69540340|FG000|OLE Phase (up to 77 Months)|Death|14|||
37857103|NCT00974311|69540341|FG001|OLE Phase (up to 77 Months)|Death|21|||
37857104|NCT00974311|69540340|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
37857105|NCT00974311|69540341|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
37857106|NCT00974311|69540340|FG000|OLE Phase (up to 77 Months)|Other|15|||
37857107|NCT00974311|69540341|FG001|OLE Phase (up to 77 Months)|Other|2|||
37857108|NCT00974311|69540340|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
37857109|NCT00974311|69540341|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
37857110|NCT00974233|69540350|FG000|Induction Chemoimmunotherapy|Death|2|||
37857111|NCT00974233|69540350|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
37857112|NCT00974233|69540350|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
37857113|NCT00974233|69540350|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
37857114|NCT00974233|69540350|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
37857115|NCT00974233|69540350|FG000|Maintenance Lenalidomide|Adverse Event|8|||
37857116|NCT00973921|69540362|FG000|Overall Study|IVUS results were not available|9|||
37857117|NCT00972595|69540366|FG000|Period 1|Adverse Event|1|||
37857118|NCT00972595|69540367|FG001|Period 1|Adverse Event|0|||
37857119|NCT01196091|69540376|FG000|Overall Study|Adverse Event|22|||
37857120|NCT01196091|69540377|FG001|Overall Study|Adverse Event|27|||
37857121|NCT01196091|69540378|FG002|Overall Study|Adverse Event|26|||
37857122|NCT01196091|69540376|FG000|Overall Study|Death|3|||
37857123|NCT01196091|69540377|FG001|Overall Study|Death|2|||
37857124|NCT01196091|69540378|FG002|Overall Study|Death|2|||
37857125|NCT01196091|69540376|FG000|Overall Study|Entry Criteria Not Met|11|||
37857126|NCT01196091|69540377|FG001|Overall Study|Entry Criteria Not Met|11|||
37857127|NCT01196091|69540378|FG002|Overall Study|Entry Criteria Not Met|10|||
37662274|NCT02343458|69134961|FG002|Overall Study|Lost to Follow-up|3|||
37662275|NCT02343458|69134962|FG003|Overall Study|Lost to Follow-up|1|||
37662276|NCT02343458|69134959|FG000|Overall Study|Protocol Violation|2|||
37662277|NCT02343458|69134960|FG001|Overall Study|Protocol Violation|5|||
37662278|NCT02343458|69134961|FG002|Overall Study|Protocol Violation|2|||
37662279|NCT02343458|69134962|FG003|Overall Study|Protocol Violation|2|||
37662280|NCT02343458|69134959|FG000|Overall Study|Protocol Specified Criteria|17|||
37662281|NCT02343458|69134960|FG001|Overall Study|Protocol Specified Criteria|13|||
37662282|NCT02343458|69134961|FG002|Overall Study|Protocol Specified Criteria|14|||
37662283|NCT02343458|69134962|FG003|Overall Study|Protocol Specified Criteria|8|||
37662284|NCT01328041|69134985|FG000|Overall Study|Adverse Event|7|||
37662285|NCT01328041|69134985|FG000|Overall Study|Lack of Efficacy|27|||
37662286|NCT01328041|69134985|FG000|Overall Study|Protocol Violation|7|||
37662287|NCT01328041|69134985|FG000|Overall Study|Lost to Follow-up|7|||
37857128|NCT01196091|69540376|FG000|Overall Study|Lack of Efficacy|15|||
37857129|NCT01196091|69540377|FG001|Overall Study|Lack of Efficacy|12|||
37857130|NCT01196091|69540378|FG002|Overall Study|Lack of Efficacy|17|||
37857131|NCT01196091|69540376|FG000|Overall Study|Lost to Follow-up|5|||
37857132|NCT01196091|69540377|FG001|Overall Study|Lost to Follow-up|5|||
37857133|NCT01196091|69540378|FG002|Overall Study|Lost to Follow-up|6|||
37752358|NCT02516241|69253583|FG001|Overall Study|participants ongoing at data cut-off|76|||
37857134|NCT01196091|69540376|FG000|Overall Study|Parent/Caregiver Decision|0|||
37857135|NCT01196091|69540377|FG001|Overall Study|Parent/Caregiver Decision|0|||
37857136|NCT01196091|69540378|FG002|Overall Study|Parent/Caregiver Decision|1|||
37857137|NCT01196091|69540376|FG000|Overall Study|Withdrawal by Subject|16|||
37662288|NCT01328041|69134985|FG000|Overall Study|Physician Decision|2|||
37662289|NCT01328041|69134985|FG000|Overall Study|Withdrawal by Subject|7|||
37752359|NCT02516241|69253584|FG002|Overall Study|participants ongoing at data cut-off|59|||
37752360|NCT02184195|69253599|FG000|Overall Study|Patient decision|5|||
37857138|NCT01196091|69540377|FG001|Overall Study|Withdrawal by Subject|19|||
37857139|NCT01196091|69540378|FG002|Overall Study|Withdrawal by Subject|22|||
37857140|NCT01196091|69540376|FG000|Overall Study|Physician Decision|3|||
37857141|NCT01196091|69540377|FG001|Overall Study|Physician Decision|3|||
37857142|NCT01196091|69540378|FG002|Overall Study|Physician Decision|4|||
37857143|NCT01196091|69540376|FG000|Overall Study|Protocol Violation|1|||
37857144|NCT01196091|69540377|FG001|Overall Study|Protocol Violation|3|||
37857145|NCT01196091|69540378|FG002|Overall Study|Protocol Violation|3|||
37857146|NCT01196091|69540376|FG000|Overall Study|Sponsor Decision|6|||
37857147|NCT01196091|69540377|FG001|Overall Study|Sponsor Decision|5|||
37857148|NCT01196091|69540378|FG002|Overall Study|Sponsor Decision|4|||
37857149|NCT01196091|69540376|FG000|Overall Study|Excluded Site|5|||
37857150|NCT01196091|69540377|FG001|Overall Study|Excluded Site|11|||
37857151|NCT01196091|69540378|FG002|Overall Study|Excluded Site|8|||
37857152|NCT01196091|69540376|FG000|Overall Study|Randomized, No Study Drug Received|1|||
37923229|NCT00864851|69610016|FG000|Overall Study|Withdrawal by Subject|0|||
37923230|NCT00864851|69610017|FG001|Overall Study|Withdrawal by Subject|1|||
37923231|NCT00864851|69610018|FG002|Overall Study|Withdrawal by Subject|0|||
37923232|NCT00864851|69610016|FG000|Overall Study|Physician Decision|1|||
37923233|NCT00864851|69610017|FG001|Overall Study|Physician Decision|0|||
37923234|NCT00864851|69610018|FG002|Overall Study|Physician Decision|0|||
37923235|NCT00864851|69610016|FG000|Overall Study|Death|1|||
37923236|NCT00864851|69610017|FG001|Overall Study|Death|0|||
37923237|NCT00864851|69610018|FG002|Overall Study|Death|0|||
37923238|NCT00864851|69610016|FG000|Overall Study|Patient uncooperative|1|||
37923239|NCT00864851|69610017|FG001|Overall Study|Patient uncooperative|0|||
37923240|NCT00864851|69610018|FG002|Overall Study|Patient uncooperative|0|||
37923241|NCT00857207|69610030|FG000|Overall Study|Withdrawal by Subject|13|||
37923242|NCT00857207|69610031|FG001|Overall Study|Withdrawal by Subject|0|||
37923243|NCT00857207|69610030|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
37923244|NCT00857207|69610031|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
37923245|NCT00857207|69610030|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
37923246|NCT00857207|69610031|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
37923247|NCT00836498|69610040|FG000|Overall Study|Adverse Event|1|||
37923248|NCT00836498|69610041|FG001|Overall Study|Adverse Event|0|||
37923249|NCT00836498|69610040|FG000|Overall Study|Lost to Follow-up|1|||
37923250|NCT00836498|69610041|FG001|Overall Study|Lost to Follow-up|0|||
37923251|NCT00836498|69610040|FG000|Overall Study|Withdrawal by Subject|2|||
37923252|NCT00836498|69610041|FG001|Overall Study|Withdrawal by Subject|1|||
37923253|NCT00856973|69610051|FG000|Overall Study|Adverse Event|5|||
37923254|NCT00856973|69610052|FG001|Overall Study|Adverse Event|5|||
37923255|NCT00856973|69610053|FG002|Overall Study|Adverse Event|3|||
37923256|NCT00856973|69610051|FG000|Overall Study|Lost to Follow-up|6|||
37923257|NCT00856973|69610052|FG001|Overall Study|Lost to Follow-up|3|||
37923258|NCT00856973|69610053|FG002|Overall Study|Lost to Follow-up|5|||
37923259|NCT00856973|69610051|FG000|Overall Study|Physician Decision|0|||
37923260|NCT00856973|69610052|FG001|Overall Study|Physician Decision|3|||
37923261|NCT00856973|69610053|FG002|Overall Study|Physician Decision|1|||
37923262|NCT00856973|69610051|FG000|Overall Study|Protocol Violation|1|||
37923263|NCT00856973|69610052|FG001|Overall Study|Protocol Violation|2|||
37923264|NCT00856973|69610053|FG002|Overall Study|Protocol Violation|1|||
37923265|NCT00856973|69610051|FG000|Overall Study|Withdrawal by Subject|13|||
37923266|NCT00856973|69610052|FG001|Overall Study|Withdrawal by Subject|16|||
37923267|NCT00856973|69610053|FG002|Overall Study|Withdrawal by Subject|15|||
37923268|NCT00856973|69610051|FG000|Overall Study|Other|11|||
37923269|NCT00856973|69610052|FG001|Overall Study|Other|12|||
37923270|NCT00856973|69610053|FG002|Overall Study|Other|13|||
38033215|NCT04493684|69719205|FG010|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
38033216|NCT04493684|69719206|FG011|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
37923271|NCT00844532|69610065|FG000|Overall Study|Death|16|||
37923272|NCT00844532|69610065|FG000|Overall Study|Withdrawal by Subject|16|||
38033217|NCT04493684|69719207|FG012|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
38033218|NCT04493684|69719208|FG013|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
37662290|NCT02410772|69134992|FG000|Overall Study|Death|3|||
37923273|NCT00844532|69610065|FG000|Overall Study|Lost to Follow-up|7|||
37662291|NCT02410772|69134993|FG001|Overall Study|Death|4|||
37923274|NCT00805194|69610071|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
37923275|NCT00805194|69610072|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
37923276|NCT00805194|69610071|FG000|Overall Study|Worsening or AE of underlying disease|64|||
37662292|NCT02410772|69134994|FG002|Overall Study|Death|8|||
37662293|NCT02410772|69134992|FG000|Overall Study|Lost to Follow-up|31|||
37662294|NCT02410772|69134993|FG001|Overall Study|Lost to Follow-up|23|||
37662295|NCT02410772|69134994|FG002|Overall Study|Lost to Follow-up|22|||
37662296|NCT02410772|69134992|FG000|Overall Study|Pregnancy|8|||
37752361|NCT02184195|69253600|FG001|Overall Study|Patient decision|2|||
37752362|NCT02184195|69253599|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
37752363|NCT02184195|69253600|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
37752364|NCT02184195|69253599|FG000|Overall Study|Death|67|||
37752365|NCT02184195|69253600|FG001|Overall Study|Death|44|||
37752366|NCT02184195|69253599|FG000|Overall Study|Lost to Follow-up|1|||
37752367|NCT02184195|69253600|FG001|Overall Study|Lost to Follow-up|5|||
37752368|NCT02184195|69253599|FG000|Overall Study|Other|0|||
37752369|NCT02184195|69253600|FG001|Overall Study|Other|3|||
37752370|NCT02181413|69253608|FG000|Overall Study|Adverse Event|7|||
37752371|NCT02181413|69253609|FG001|Overall Study|Adverse Event|24|||
37752372|NCT02181413|69253608|FG000|Overall Study|Progressive Disease|121|||
37752373|NCT02181413|69253609|FG001|Overall Study|Progressive Disease|143|||
37752374|NCT02181413|69253608|FG000|Overall Study|Withdrawal by Subject|5|||
37752375|NCT02181413|69253609|FG001|Overall Study|Withdrawal by Subject|8|||
37752376|NCT02181413|69253608|FG000|Overall Study|Reason Not Specified|19|||
37752377|NCT02181413|69253609|FG001|Overall Study|Reason Not Specified|20|||
37752378|NCT02181413|69253608|FG000|Overall Study|Ongoing Study Treatment|0|||
37752379|NCT02181413|69253609|FG001|Overall Study|Ongoing Study Treatment|1|||
37752380|NCT02181413|69253608|FG000|Overall Study|Lost to Follow-up|0|||
37752381|NCT02181413|69253609|FG001|Overall Study|Lost to Follow-up|1|||
37752382|NCT02152631|69253617|FG000|Overall Study|Adverse Event|32|||
37752383|NCT02152631|69253618|FG001|Overall Study|Adverse Event|4|||
37752384|NCT02152631|69253617|FG000|Overall Study|Withdrawal by Subject|13|||
37752385|NCT02152631|69253618|FG001|Overall Study|Withdrawal by Subject|16|||
37752386|NCT02152631|69253617|FG000|Overall Study|Noncompliance with study drug|1|||
37752387|NCT02152631|69253618|FG001|Overall Study|Noncompliance with study drug|0|||
37752388|NCT02152631|69253617|FG000|Overall Study|Physician Decision|1|||
37752389|NCT02152631|69253618|FG001|Overall Study|Physician Decision|2|||
37752390|NCT02152631|69253617|FG000|Overall Study|Lost to Follow-up|0|||
37752391|NCT02152631|69253618|FG001|Overall Study|Lost to Follow-up|1|||
37752392|NCT02152631|69253617|FG000|Overall Study|On Treatment|19|||
37752393|NCT02152631|69253618|FG001|Overall Study|On Treatment|3|||
37752394|NCT02151981|69253626|FG000|Overall Study|Death|184|||
37752395|NCT02151981|69253627|FG001|Overall Study|Death|88|||
37752396|NCT02151981|69253626|FG000|Overall Study|Lost to Follow-up|7|||
37752397|NCT02151981|69253627|FG001|Overall Study|Lost to Follow-up|1|||
37752398|NCT02151981|69253626|FG000|Overall Study|Withdrawal by Subject|27|||
37752399|NCT02151981|69253627|FG001|Overall Study|Withdrawal by Subject|21|||
37752400|NCT02151981|69253626|FG000|Overall Study|Ongoing Study at Data Cut-off|60|||
37752401|NCT02151981|69253627|FG001|Overall Study|Ongoing Study at Data Cut-off|27|||
37752402|NCT02151981|69253626|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
37752403|NCT02151981|69253627|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
37752404|NCT02151981|69253626|FG000|Overall Study|Patient had no clinical benefit|1|||
37752405|NCT02151981|69253627|FG001|Overall Study|Patient had no clinical benefit|0|||
37752406|NCT02151981|69253626|FG000|Overall Study|Unwilling to continue to follow up visit|0|||
37752407|NCT02151981|69253627|FG001|Overall Study|Unwilling to continue to follow up visit|1|||
37752408|NCT02151981|69253626|FG000|Overall Study|Study terminated|0|||
37752409|NCT02151981|69253627|FG001|Overall Study|Study terminated|1|||
37752410|NCT01981720|69253646|FG000|Overall Study|Adverse Event|1|||
37752411|NCT01981720|69253646|FG000|Overall Study|Withdrawal by Subject|3|||
37752412|NCT01981720|69253646|FG000|Overall Study|Pregnancy|1|||
37752413|NCT01974440|69253656|FG000|Overall Study|Lost to Follow-up|8|||
37752414|NCT01974440|69253657|FG001|Overall Study|Lost to Follow-up|7|||
37752415|NCT01974440|69253656|FG000|Overall Study|Withdrawal by Subject|20|||
37752416|NCT01974440|69253657|FG001|Overall Study|Withdrawal by Subject|19|||
37752417|NCT01974440|69253656|FG000|Overall Study|Ongoing|112|||
37752418|NCT01974440|69253657|FG001|Overall Study|Ongoing|116|||
37752419|NCT01802281|69253674|FG000|Overall Study|Death|1|||
37752420|NCT01802281|69253675|FG001|Overall Study|Death|2|||
37752421|NCT01802281|69253674|FG000|Overall Study|Withdrawal by Subject|2|||
37752422|NCT01802281|69253675|FG001|Overall Study|Withdrawal by Subject|1|||
37752423|NCT01802281|69253674|FG000|Overall Study|Ineligible|5|||
37752424|NCT01802281|69253675|FG001|Overall Study|Ineligible|3|||
37752425|NCT01678898|69253698|FG000|PB-102-F01|Adverse Event|0|||
37752426|NCT01678898|69253699|FG001|PB-102-F01|Adverse Event|1|||
37752427|NCT01678898|69253700|FG002|PB-102-F01|Adverse Event|0|||
37857153|NCT01196091|69540377|FG001|Overall Study|Randomized, No Study Drug Received|0|||
37752428|NCT01678898|69253698|FG000|PB-102-F01|Physician Decision|0|||
37857154|NCT01196091|69540378|FG002|Overall Study|Randomized, No Study Drug Received|1|||
38033219|NCT04493684|69719209|FG014|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
37752429|NCT01678898|69253699|FG001|PB-102-F01|Physician Decision|1|||
37752430|NCT01678898|69253700|FG002|PB-102-F01|Physician Decision|0|||
37752431|NCT01485861|69253727|FG000|Phase Ib|Death|1|||
37752432|NCT01485861|69253728|FG001|Phase Ib|Death|0|||
37752433|NCT01485861|69253729|FG002|Phase Ib|Death|0|||
37752434|NCT01485861|69253730|FG003|Phase Ib|Death|0|||
37752435|NCT01485861|69253731|FG004|Phase Ib|Death|0|||
37752436|NCT01485861|69253732|FG005|Phase Ib|Death|0|||
37752437|NCT01485861|69253727|FG000|Phase Ib|Physician Decision|1|||
37752438|NCT01485861|69253728|FG001|Phase Ib|Physician Decision|1|||
37752439|NCT01485861|69253729|FG002|Phase Ib|Physician Decision|0|||
37752440|NCT01485861|69253730|FG003|Phase Ib|Physician Decision|0|||
37752441|NCT01485861|69253731|FG004|Phase Ib|Physician Decision|0|||
37752442|NCT01485861|69253732|FG005|Phase Ib|Physician Decision|0|||
37752443|NCT01485861|69253727|FG000|Phase Ib|Adverse Event|0|||
37752444|NCT01485861|69253728|FG001|Phase Ib|Adverse Event|4|||
37752445|NCT01485861|69253729|FG002|Phase Ib|Adverse Event|0|||
37752446|NCT01485861|69253730|FG003|Phase Ib|Adverse Event|0|||
37752447|NCT01485861|69253731|FG004|Phase Ib|Adverse Event|0|||
37752448|NCT01485861|69253732|FG005|Phase Ib|Adverse Event|0|||
37752449|NCT01485861|69253727|FG000|Phase Ib|Progression of disease|5|||
37752450|NCT01485861|69253728|FG001|Phase Ib|Progression of disease|0|||
37752451|NCT01485861|69253729|FG002|Phase Ib|Progression of disease|0|||
37752452|NCT01485861|69253730|FG003|Phase Ib|Progression of disease|0|||
37752453|NCT01485861|69253731|FG004|Phase Ib|Progression of disease|0|||
37752454|NCT01485861|69253732|FG005|Phase Ib|Progression of disease|0|||
37752455|NCT01485861|69253727|FG000|Phase Ib|Other|3|||
37752456|NCT01485861|69253728|FG001|Phase Ib|Other|0|||
37752457|NCT01485861|69253729|FG002|Phase Ib|Other|0|||
37752458|NCT01485861|69253730|FG003|Phase Ib|Other|0|||
37752459|NCT01485861|69253731|FG004|Phase Ib|Other|0|||
37752460|NCT01485861|69253732|FG005|Phase Ib|Other|0|||
37752461|NCT01485861|69253727|FG000|Phase Ib|Withdrawal by Subject|4|||
37752462|NCT01485861|69253728|FG001|Phase Ib|Withdrawal by Subject|1|||
37752463|NCT01485861|69253729|FG002|Phase Ib|Withdrawal by Subject|0|||
37857155|NCT01195623|69540393|FG000|Overall Study|Lost to Follow-up|35|||
37857156|NCT01195623|69540394|FG001|Overall Study|Lost to Follow-up|37|||
37857157|NCT01195545|69540400|FG000|Overall Study|Protocol Violation|4|||
37857158|NCT01194999|69540404|FG000|Overall Study|Lost to Follow-up|17|||
37857159|NCT01194531|69540410|FG000|Overall Study|Withdrawal by Subject|1|||
37857160|NCT01194531|69540411|FG001|Overall Study|Withdrawal by Subject|0|||
37857161|NCT01194531|69540410|FG000|Overall Study|Protocol Violation|4|||
37857162|NCT01194531|69540411|FG001|Overall Study|Protocol Violation|1|||
37857163|NCT01194531|69540410|FG000|Overall Study|Physician Decision|0|||
37857164|NCT01194531|69540411|FG001|Overall Study|Physician Decision|2|||
37857165|NCT00972517|69540417|FG000|Overall Study|Adverse Event|0|||
37857166|NCT00972517|69540418|FG001|Overall Study|Adverse Event|0|||
37857167|NCT00972517|69540419|FG002|Overall Study|Adverse Event|0|||
37857168|NCT00972517|69540420|FG003|Overall Study|Adverse Event|1|||
37857169|NCT00972517|69540421|FG004|Overall Study|Adverse Event|0|||
37857170|NCT00972517|69540422|FG005|Overall Study|Adverse Event|0|||
37857171|NCT00972517|69540417|FG000|Overall Study|Withdrawal by Subject|0|||
37857172|NCT00972517|69540418|FG001|Overall Study|Withdrawal by Subject|1|||
37857173|NCT00972517|69540419|FG002|Overall Study|Withdrawal by Subject|0|||
37857174|NCT00972517|69540420|FG003|Overall Study|Withdrawal by Subject|2|||
37857175|NCT00972517|69540421|FG004|Overall Study|Withdrawal by Subject|1|||
37857176|NCT00972517|69540422|FG005|Overall Study|Withdrawal by Subject|0|||
37857177|NCT00972283|69540444|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
37857178|NCT00972283|69540445|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
37857179|NCT00972283|69540444|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
37857180|NCT00972283|69540445|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
37857181|NCT00972283|69540444|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
37857182|NCT00972283|69540445|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
37857183|NCT00972283|69540444|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
37857184|NCT00972283|69540445|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
37857185|NCT00972283|69540444|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
37857186|NCT00972283|69540445|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
37857187|NCT00972283|69540444|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
37857188|NCT00972283|69540445|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
37857189|NCT00972283|69540444|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
37857190|NCT00972283|69540445|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
37857191|NCT00972283|69540444|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
37857192|NCT00972283|69540445|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
37857193|NCT00972283|69540444|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
37857194|NCT00972283|69540445|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
37857195|NCT00972283|69540444|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
37923277|NCT00805194|69610072|FG001|Overall Study|Worsening or AE of underlying disease|70|||
37752464|NCT01485861|69253730|FG003|Phase Ib|Withdrawal by Subject|0|||
37752465|NCT01485861|69253731|FG004|Phase Ib|Withdrawal by Subject|0|||
37752466|NCT01485861|69253732|FG005|Phase Ib|Withdrawal by Subject|0|||
37752467|NCT01485861|69253727|FG000|Phase II|Death|0|||
37752468|NCT01485861|69253728|FG001|Phase II|Death|0|||
37752469|NCT01485861|69253729|FG002|Phase II|Death|67|||
37752470|NCT01485861|69253730|FG003|Phase II|Death|71|||
37752471|NCT01485861|69253731|FG004|Phase II|Death|68|||
37752472|NCT01485861|69253732|FG005|Phase II|Death|0|||
37752473|NCT01485861|69253727|FG000|Phase II|Progression of Disease|0|||
37752474|NCT01485861|69253728|FG001|Phase II|Progression of Disease|0|||
37752475|NCT01485861|69253729|FG002|Phase II|Progression of Disease|1|||
37752476|NCT01485861|69253730|FG003|Phase II|Progression of Disease|0|||
37752477|NCT01485861|69253731|FG004|Phase II|Progression of Disease|0|||
37752478|NCT01485861|69253732|FG005|Phase II|Progression of Disease|0|||
37752479|NCT01485861|69253727|FG000|Phase II|Other|0|||
37752480|NCT01485861|69253728|FG001|Phase II|Other|0|||
37752481|NCT01485861|69253729|FG002|Phase II|Other|0|||
37752482|NCT01485861|69253730|FG003|Phase II|Other|1|||
37752483|NCT01485861|69253731|FG004|Phase II|Other|0|||
37752484|NCT01485861|69253732|FG005|Phase II|Other|0|||
37752485|NCT01485861|69253727|FG000|Phase II|Withdrawal by Subject|0|||
37752486|NCT01485861|69253728|FG001|Phase II|Withdrawal by Subject|0|||
37752487|NCT01485861|69253729|FG002|Phase II|Withdrawal by Subject|6|||
37752488|NCT01485861|69253730|FG003|Phase II|Withdrawal by Subject|3|||
37752489|NCT01485861|69253731|FG004|Phase II|Withdrawal by Subject|4|||
37752490|NCT01485861|69253732|FG005|Phase II|Withdrawal by Subject|0|||
37752491|NCT01485861|69253727|FG000|Phase II|Lost to Follow-up|0|||
37752492|NCT01485861|69253728|FG001|Phase II|Lost to Follow-up|0|||
37752493|NCT01485861|69253729|FG002|Phase II|Lost to Follow-up|2|||
37752494|NCT01485861|69253730|FG003|Phase II|Lost to Follow-up|3|||
37752495|NCT01485861|69253731|FG004|Phase II|Lost to Follow-up|5|||
37752496|NCT01485861|69253732|FG005|Phase II|Lost to Follow-up|0|||
37752497|NCT01485861|69253727|FG000|Phase II|Study Ended|0|||
37752498|NCT01485861|69253728|FG001|Phase II|Study Ended|0|||
37752499|NCT01485861|69253729|FG002|Phase II|Study Ended|7|||
37857196|NCT00972283|69540445|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
37857197|NCT00969709|69540455|FG000|Overall Study|Adverse Event|3|||
37857198|NCT00969709|69540456|FG001|Overall Study|Adverse Event|13|||
37662297|NCT02410772|69134993|FG001|Overall Study|Pregnancy|4|||
37662298|NCT02410772|69134994|FG002|Overall Study|Pregnancy|5|||
37662299|NCT02410772|69134992|FG000|Overall Study|Protocol Violation|8|||
37662300|NCT02410772|69134993|FG001|Overall Study|Protocol Violation|8|||
37662301|NCT02410772|69134994|FG002|Overall Study|Protocol Violation|4|||
37662302|NCT02410772|69134992|FG000|Overall Study|Baseline Drug Resistance|49|||
37662303|NCT02410772|69134993|FG001|Overall Study|Baseline Drug Resistance|40|||
37662304|NCT02410772|69134994|FG002|Overall Study|Baseline Drug Resistance|51|||
37857199|NCT00969709|69540457|FG002|Overall Study|Adverse Event|26|||
37857200|NCT00969709|69540458|FG003|Overall Study|Adverse Event|12|||
37857201|NCT00969709|69540455|FG000|Overall Study|Lack of Efficacy|7|||
37857202|NCT00969709|69540456|FG001|Overall Study|Lack of Efficacy|4|||
37857203|NCT00969709|69540457|FG002|Overall Study|Lack of Efficacy|1|||
37857204|NCT00969709|69540458|FG003|Overall Study|Lack of Efficacy|3|||
37857205|NCT00969709|69540455|FG000|Overall Study|Protocol Violation|9|||
37857206|NCT00969709|69540456|FG001|Overall Study|Protocol Violation|5|||
37857207|NCT00969709|69540457|FG002|Overall Study|Protocol Violation|9|||
37857208|NCT00969709|69540458|FG003|Overall Study|Protocol Violation|10|||
37857209|NCT00969709|69540455|FG000|Overall Study|Withdrawal by Subject|9|||
37857210|NCT00969709|69540456|FG001|Overall Study|Withdrawal by Subject|12|||
37857211|NCT00969709|69540457|FG002|Overall Study|Withdrawal by Subject|11|||
37857212|NCT00969709|69540458|FG003|Overall Study|Withdrawal by Subject|23|||
37857213|NCT00969709|69540455|FG000|Overall Study|Lost to Follow-up|10|||
37857214|NCT00969709|69540456|FG001|Overall Study|Lost to Follow-up|14|||
37857215|NCT00969709|69540457|FG002|Overall Study|Lost to Follow-up|8|||
37857216|NCT00969709|69540458|FG003|Overall Study|Lost to Follow-up|15|||
37857217|NCT00969709|69540455|FG000|Overall Study|Other reasons|0|||
37857218|NCT00969709|69540456|FG001|Overall Study|Other reasons|0|||
37857219|NCT00969709|69540457|FG002|Overall Study|Other reasons|3|||
37857220|NCT00969709|69540458|FG003|Overall Study|Other reasons|0|||
37857221|NCT01193517|69540475|FG000|Overall Study|Early Progression|1|||
37857222|NCT01193517|69540476|FG001|Overall Study|Early Progression|0|||
37857223|NCT01193517|69540477|FG002|Overall Study|Early Progression|0|||
37857224|NCT01193283|69540486|FG000|Overall Study|Death|1|||
37857225|NCT00971425|69540492|FG000|Overall Study|Adverse Event|1|||
37662305|NCT02410772|69134992|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
37662306|NCT02410772|69134993|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
37752500|NCT01485861|69253730|FG003|Phase II|Study Ended|8|||
37752501|NCT01485861|69253731|FG004|Phase II|Study Ended|6|||
37752502|NCT01485861|69253732|FG005|Phase II|Study Ended|0|||
37752503|NCT01485861|69253727|FG000|Safety Phase|Death|0|||
37752504|NCT01485861|69253728|FG001|Safety Phase|Death|0|||
37752505|NCT01485861|69253729|FG002|Safety Phase|Death|0|||
37752506|NCT01485861|69253730|FG003|Safety Phase|Death|0|||
37752507|NCT01485861|69253731|FG004|Safety Phase|Death|0|||
37752508|NCT01485861|69253732|FG005|Safety Phase|Death|2|||
37752509|NCT01485861|69253727|FG000|Safety Phase|Adverse Event|0|||
37752510|NCT01485861|69253728|FG001|Safety Phase|Adverse Event|0|||
37857226|NCT00971425|69540493|FG001|Overall Study|Adverse Event|1|||
37857227|NCT00971425|69540492|FG000|Overall Study|Withdrawal by Subject|0|||
37857228|NCT00971425|69540493|FG001|Overall Study|Withdrawal by Subject|1|||
37752511|NCT01485861|69253729|FG002|Safety Phase|Adverse Event|0|||
37662307|NCT02410772|69134994|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
37662308|NCT02410772|69134992|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
37662309|NCT02410772|69134993|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
37752512|NCT01485861|69253730|FG003|Safety Phase|Adverse Event|0|||
37752513|NCT01485861|69253731|FG004|Safety Phase|Adverse Event|0|||
37752514|NCT01485861|69253732|FG005|Safety Phase|Adverse Event|1|||
37752515|NCT01485861|69253727|FG000|Safety Phase|Other|0|||
37752516|NCT01485861|69253728|FG001|Safety Phase|Other|0|||
37752517|NCT01485861|69253729|FG002|Safety Phase|Other|0|||
37752518|NCT01485861|69253730|FG003|Safety Phase|Other|0|||
37752519|NCT01485861|69253731|FG004|Safety Phase|Other|0|||
37752520|NCT01485861|69253732|FG005|Safety Phase|Other|5|||
37752521|NCT01485861|69253727|FG000|Safety Phase|Progression of Disease|0|||
37662310|NCT02410772|69134994|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
37662311|NCT01648790|69135011|FG000|Treatment 3|Withdrawal by Subject|0|||
37662312|NCT01648790|69135012|FG001|Treatment 3|Withdrawal by Subject|0|||
37662313|NCT01648790|69135013|FG002|Treatment 3|Withdrawal by Subject|0|||
37662314|NCT01648790|69135014|FG003|Treatment 3|Withdrawal by Subject|1|||
37662315|NCT01648790|69135015|FG004|Treatment 3|Withdrawal by Subject|0|||
37662316|NCT01936857|69135038|FG000|Overall Study|Sent to prison or 06 center|11|||
37662317|NCT01936857|69135039|FG001|Overall Study|Sent to prison or 06 center|12|||
37662318|NCT01936857|69135038|FG000|Overall Study|Lost to Follow-up|10|||
37662319|NCT01936857|69135039|FG001|Overall Study|Lost to Follow-up|7|||
37752522|NCT01485861|69253728|FG001|Safety Phase|Progression of Disease|0|||
37752523|NCT01485861|69253729|FG002|Safety Phase|Progression of Disease|0|||
37752524|NCT01485861|69253730|FG003|Safety Phase|Progression of Disease|0|||
37752525|NCT01485861|69253731|FG004|Safety Phase|Progression of Disease|0|||
37752526|NCT01485861|69253732|FG005|Safety Phase|Progression of Disease|9|||
37752527|NCT01485861|69253727|FG000|Safety Phase|Withdrawal by Subject|0|||
37752528|NCT01485861|69253728|FG001|Safety Phase|Withdrawal by Subject|0|||
37752529|NCT01485861|69253729|FG002|Safety Phase|Withdrawal by Subject|0|||
37752530|NCT01485861|69253730|FG003|Safety Phase|Withdrawal by Subject|0|||
37752531|NCT01485861|69253731|FG004|Safety Phase|Withdrawal by Subject|0|||
37857229|NCT01193127|69540503|FG000|Randomized|Surgery Cancelled|0|||
37857230|NCT01193127|69540504|FG001|Randomized|Surgery Cancelled|0|||
37857231|NCT01193127|69540505|FG002|Randomized|Surgery Cancelled|0|||
37662320|NCT01936857|69135038|FG000|Overall Study|Death|7|||
37662321|NCT01936857|69135039|FG001|Overall Study|Death|3|||
37662322|NCT01936857|69135038|FG000|Overall Study|Moved|2|||
37752532|NCT01485861|69253732|FG005|Safety Phase|Withdrawal by Subject|6|||
37752533|NCT01485861|69253727|FG000|Safety Phase|Discontinuation of Survival Follow-up|0|||
37857232|NCT01193127|69540506|FG003|Randomized|Surgery Cancelled|1|||
37857233|NCT01193127|69540503|FG000|Treated|Withdrawal by Subject|0|||
37857234|NCT01193127|69540504|FG001|Treated|Withdrawal by Subject|0|||
37857235|NCT01193127|69540505|FG002|Treated|Withdrawal by Subject|0|||
37857236|NCT01193127|69540506|FG003|Treated|Withdrawal by Subject|1|||
37857237|NCT01192815|69540518|FG000|Overall Study|Withdrawal by Subject|1|||
37857238|NCT01192815|69540518|FG000|Overall Study|Lack of Efficacy|1|||
37857239|NCT01192347|69540522|FG000|Overall Study|Death|3|||
37857240|NCT01192347|69540522|FG000|Overall Study|Lost to Follow-up|3|||
37857241|NCT01192347|69540522|FG000|Overall Study|Withdrawal by Subject|1|||
37857242|NCT01192347|69540522|FG000|Overall Study|Adverse Event|1|||
37857243|NCT01192347|69540522|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
37857244|NCT01192347|69540522|FG000|Overall Study|Patient seen in different hospital|1|||
37857245|NCT01192347|69540522|FG000|Overall Study|Patient not visiting hospital regularly|1|||
37857246|NCT01192347|69540522|FG000|Overall Study|Patient did not show up for visits|1|||
37857247|NCT01192191|69540528|FG000|Overall Study|Adverse Event|7|||
37857248|NCT01192191|69540529|FG001|Overall Study|Adverse Event|12|||
37857249|NCT01192191|69540528|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
37857250|NCT01192191|69540529|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
37857251|NCT01192191|69540528|FG000|Overall Study|Lost to Follow-up|0|||
37857252|NCT01192191|69540529|FG001|Overall Study|Lost to Follow-up|1|||
37857253|NCT01192191|69540528|FG000|Overall Study|Withdrawal by Subject|1|||
37752534|NCT01485861|69253728|FG001|Safety Phase|Discontinuation of Survival Follow-up|0|||
37752535|NCT01485861|69253729|FG002|Safety Phase|Discontinuation of Survival Follow-up|0|||
37752536|NCT01485861|69253730|FG003|Safety Phase|Discontinuation of Survival Follow-up|0|||
37857254|NCT01192191|69540529|FG001|Overall Study|Withdrawal by Subject|6|||
37857255|NCT01307267|69540558|FG000|Overall Study|Death|4|||
37857256|NCT01307267|69540559|FG001|Overall Study|Death|3|||
37857257|NCT01307267|69540560|FG002|Overall Study|Death|5|||
37857258|NCT01307267|69540561|FG003|Overall Study|Death|3|||
37857259|NCT01307267|69540562|FG004|Overall Study|Death|1|||
37857260|NCT01307267|69540563|FG005|Overall Study|Death|26|||
37662323|NCT01936857|69135039|FG001|Overall Study|Moved|1|||
37752537|NCT01485861|69253731|FG004|Safety Phase|Discontinuation of Survival Follow-up|0|||
37857261|NCT01307267|69540564|FG006|Overall Study|Death|2|||
37857262|NCT01307267|69540565|FG007|Overall Study|Death|2|||
37857263|NCT01307267|69540566|FG008|Overall Study|Death|21|||
37662324|NCT01936857|69135038|FG000|Overall Study|Withdrawal by Subject|1|||
37662325|NCT01936857|69135039|FG001|Overall Study|Withdrawal by Subject|0|||
37662326|NCT01936857|69135038|FG000|Overall Study|Side effect of medication|1|||
37662327|NCT01936857|69135039|FG001|Overall Study|Side effect of medication|0|||
37662328|NCT01936857|69135038|FG000|Overall Study|Other|2|||
37662329|NCT01936857|69135039|FG001|Overall Study|Other|2|||
37662330|NCT01602224|69135048|FG000|Overall Study|Adverse Event|0|||
37662331|NCT01602224|69135049|FG001|Overall Study|Adverse Event|1|||
37662332|NCT01602224|69135050|FG002|Overall Study|Adverse Event|0|||
37662333|NCT01602224|69135048|FG000|Overall Study|Investigator Decison|1|||
37752538|NCT01485861|69253732|FG005|Safety Phase|Discontinuation of Survival Follow-up|2|||
37752539|NCT01101438|69253766|FG000|Overall Study|Withdrawal by Subject|8|||
37752540|NCT01101438|69253767|FG001|Overall Study|Withdrawal by Subject|9|||
37752541|NCT00966979|69253777|FG000|Overall Study|Death|1|||
37752542|NCT00966979|69253777|FG000|Overall Study|Lost to Follow-up|6|||
37752543|NCT00966979|69253777|FG000|Overall Study|Withdrawal by Subject|14|||
37752544|NCT00966979|69253777|FG000|Overall Study|Adverse Event|5|||
37752545|NCT00966979|69253777|FG000|Overall Study|Sponsor terminated early|49|||
37752546|NCT00966979|69253777|FG000|Overall Study|Censored because surgery not done|2|||
37752547|NCT00966979|69253777|FG000|Overall Study|Censored because study device was not implanted|14|||
37752548|NCT00966979|69253777|FG000|Overall Study|Censored because of Inclusion/exclusion violation|7|||
37752549|NCT00931606|69253795|FG000|Overall Study|Death|1|||
37752550|NCT00931606|69253796|FG001|Overall Study|Death|3|||
37752551|NCT00931606|69253797|FG002|Overall Study|Death|2|||
37752552|NCT00931606|69253798|FG003|Overall Study|Death|0|||
37752553|NCT00931606|69253795|FG000|Overall Study|Lost to Follow-up|0|||
37752554|NCT00931606|69253796|FG001|Overall Study|Lost to Follow-up|1|||
37752555|NCT00931606|69253797|FG002|Overall Study|Lost to Follow-up|0|||
37752556|NCT00931606|69253798|FG003|Overall Study|Lost to Follow-up|0|||
37752557|NCT00931606|69253795|FG000|Overall Study|Physician Decision|0|||
37752558|NCT00931606|69253796|FG001|Overall Study|Physician Decision|0|||
37752559|NCT00931606|69253797|FG002|Overall Study|Physician Decision|3|||
37752560|NCT00931606|69253798|FG003|Overall Study|Physician Decision|0|||
37752561|NCT00931606|69253795|FG000|Overall Study|Sponsor Decision|1|||
37752562|NCT00931606|69253796|FG001|Overall Study|Sponsor Decision|4|||
37752563|NCT00931606|69253797|FG002|Overall Study|Sponsor Decision|0|||
37752564|NCT00931606|69253798|FG003|Overall Study|Sponsor Decision|2|||
37752565|NCT00931606|69253795|FG000|Overall Study|Withdrawal by Subject|3|||
37752566|NCT00931606|69253796|FG001|Overall Study|Withdrawal by Subject|1|||
37752567|NCT00931606|69253797|FG002|Overall Study|Withdrawal by Subject|1|||
37752568|NCT00931606|69253798|FG003|Overall Study|Withdrawal by Subject|1|||
37752569|NCT00706914|69253869|FG000|Overall Study|Lack of Efficacy|0|||
37752570|NCT00706914|69253870|FG001|Overall Study|Lack of Efficacy|1|||
37752571|NCT00706914|69253871|FG002|Overall Study|Lack of Efficacy|0|||
37752572|NCT00706914|69253869|FG000|Overall Study|Lost to Follow-up|1|||
37752573|NCT00706914|69253870|FG001|Overall Study|Lost to Follow-up|0|||
37752574|NCT00706914|69253871|FG002|Overall Study|Lost to Follow-up|0|||
37752575|NCT00706914|69253869|FG000|Overall Study|Adverse Event|2|||
37752576|NCT00706914|69253870|FG001|Overall Study|Adverse Event|2|||
37752577|NCT00706914|69253871|FG002|Overall Study|Adverse Event|0|||
37662334|NCT01602224|69135049|FG001|Overall Study|Investigator Decison|0|||
37662335|NCT01602224|69135050|FG002|Overall Study|Investigator Decison|0|||
37662336|NCT01602224|69135048|FG000|Overall Study|Lost to Follow-up|0|||
37662337|NCT01602224|69135049|FG001|Overall Study|Lost to Follow-up|0|||
37662338|NCT01602224|69135050|FG002|Overall Study|Lost to Follow-up|1|||
37662339|NCT01602224|69135048|FG000|Overall Study|Protocol Violation|0|||
37662340|NCT01602224|69135049|FG001|Overall Study|Protocol Violation|1|||
37662341|NCT01602224|69135050|FG002|Overall Study|Protocol Violation|0|||
37662342|NCT01602224|69135048|FG000|Overall Study|Sponsor Decision|2|||
37662343|NCT01602224|69135049|FG001|Overall Study|Sponsor Decision|3|||
37662344|NCT01602224|69135050|FG002|Overall Study|Sponsor Decision|2|||
37662345|NCT01602224|69135048|FG000|Overall Study|Withdrawal by Subject|5|||
37662346|NCT01602224|69135049|FG001|Overall Study|Withdrawal by Subject|3|||
37662347|NCT01602224|69135050|FG002|Overall Study|Withdrawal by Subject|3|||
37662348|NCT04498247|69135068|FG000|Overall Study|Lost to Follow-up|0|||
37662349|NCT04498247|69135069|FG001|Overall Study|Lost to Follow-up|0|||
37752578|NCT00706914|69253869|FG000|Overall Study|Protocol Violation|3|||
37662350|NCT04498247|69135070|FG002|Overall Study|Lost to Follow-up|0|||
37752579|NCT00706914|69253870|FG001|Overall Study|Protocol Violation|1|||
37662351|NCT04498247|69135071|FG003|Overall Study|Lost to Follow-up|1|||
37662352|NCT04498247|69135072|FG004|Overall Study|Lost to Follow-up|0|||
37662353|NCT04498247|69135073|FG005|Overall Study|Lost to Follow-up|0|||
37662354|NCT04498247|69135074|FG006|Overall Study|Lost to Follow-up|0|||
37662355|NCT04498247|69135075|FG007|Overall Study|Lost to Follow-up|0|||
37752580|NCT00706914|69253871|FG002|Overall Study|Protocol Violation|1|||
37752581|NCT01808651|69253978|FG000|Study Period 1|Lost to Follow-up|1|||
37752582|NCT01808651|69253979|FG001|Study Period 1|Lost to Follow-up|3|||
37752583|NCT01808651|69253980|FG002|Study Period 1|Lost to Follow-up|0|||
37662356|NCT04498247|69135068|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
37752584|NCT01808651|69253978|FG000|Study Period 1|Protocol Violation|1|||
37752585|NCT01808651|69253979|FG001|Study Period 1|Protocol Violation|0|||
37752586|NCT01808651|69253980|FG002|Study Period 1|Protocol Violation|1|||
37752587|NCT01808651|69253978|FG000|Study Period 1|Physician Decision|3|||
37752588|NCT01808651|69253979|FG001|Study Period 1|Physician Decision|2|||
37752589|NCT01808651|69253980|FG002|Study Period 1|Physician Decision|0|||
37752590|NCT01808651|69253978|FG000|Study Period 1|Lack of Efficacy|2|||
37752591|NCT01808651|69253979|FG001|Study Period 1|Lack of Efficacy|1|||
37752592|NCT01808651|69253980|FG002|Study Period 1|Lack of Efficacy|0|||
37752593|NCT01808651|69253978|FG000|Study Period 1|Adverse Event|10|||
37662357|NCT04498247|69135069|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
37662358|NCT04498247|69135070|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
37662359|NCT04498247|69135071|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
37662360|NCT04498247|69135072|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
37662361|NCT04498247|69135073|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
37662362|NCT04498247|69135074|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
37662363|NCT04498247|69135075|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
37662364|NCT04498247|69135068|FG000|Overall Study|Withdrawal by Subject|0|||
37752594|NCT01808651|69253979|FG001|Study Period 1|Adverse Event|4|||
37752595|NCT01808651|69253980|FG002|Study Period 1|Adverse Event|1|||
37752596|NCT01808651|69253978|FG000|Study Period 1|Participant Decision|9|||
37752597|NCT01808651|69253979|FG001|Study Period 1|Participant Decision|7|||
37752598|NCT01808651|69253980|FG002|Study Period 1|Participant Decision|3|||
37752599|NCT00706134|69254045|FG000|Overall Study|Adverse Event|8|||
37752600|NCT00706134|69254046|FG001|Overall Study|Adverse Event|7|||
37752601|NCT00706134|69254047|FG002|Overall Study|Adverse Event|2|||
37752602|NCT00706134|69254048|FG003|Overall Study|Adverse Event|3|||
37752603|NCT00706134|69254045|FG000|Overall Study|Lost to Follow-up|0|||
37752604|NCT00706134|69254046|FG001|Overall Study|Lost to Follow-up|1|||
37752605|NCT00706134|69254047|FG002|Overall Study|Lost to Follow-up|0|||
37752606|NCT00706134|69254048|FG003|Overall Study|Lost to Follow-up|0|||
37752607|NCT00706134|69254045|FG000|Overall Study|Protocol Violation|0|||
37752608|NCT00706134|69254046|FG001|Overall Study|Protocol Violation|6|||
37752609|NCT00706134|69254047|FG002|Overall Study|Protocol Violation|0|||
37752610|NCT00706134|69254048|FG003|Overall Study|Protocol Violation|3|||
37752611|NCT00706134|69254045|FG000|Overall Study|Withdrawal by Subject|1|||
37752612|NCT00706134|69254046|FG001|Overall Study|Withdrawal by Subject|2|||
37752613|NCT00706134|69254047|FG002|Overall Study|Withdrawal by Subject|1|||
37752614|NCT00706134|69254048|FG003|Overall Study|Withdrawal by Subject|0|||
37752615|NCT00706134|69254045|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
37752616|NCT00706134|69254046|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
37857264|NCT01307267|69540567|FG009|Overall Study|Death|2|||
37662365|NCT04498247|69135069|FG001|Overall Study|Withdrawal by Subject|8|||
37662366|NCT04498247|69135070|FG002|Overall Study|Withdrawal by Subject|0|||
37662367|NCT04498247|69135071|FG003|Overall Study|Withdrawal by Subject|7|||
37662368|NCT04498247|69135072|FG004|Overall Study|Withdrawal by Subject|0|||
37662369|NCT04498247|69135073|FG005|Overall Study|Withdrawal by Subject|0|||
37662370|NCT04498247|69135074|FG006|Overall Study|Withdrawal by Subject|1|||
37662371|NCT04498247|69135075|FG007|Overall Study|Withdrawal by Subject|0|||
37662372|NCT04498247|69135068|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
37662373|NCT04498247|69135069|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
37662374|NCT04498247|69135070|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
37662375|NCT04498247|69135071|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
37662376|NCT04498247|69135072|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
37662377|NCT04498247|69135073|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
37662378|NCT04498247|69135074|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
37662379|NCT04498247|69135075|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
37662380|NCT03887117|69135103|FG000|Overall Study|Discontinued prematurely|0|||
37662381|NCT03887117|69135104|FG001|Overall Study|Discontinued prematurely|1|||
37662382|NCT03887117|69135105|FG002|Overall Study|Discontinued prematurely|1|||
37662383|NCT03887117|69135106|FG003|Overall Study|Discontinued prematurely|2|||
37752617|NCT00706134|69254047|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
37752618|NCT00706134|69254048|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
37752619|NCT00706134|69254045|FG000|Overall Study|Did not meet study criteria|2|||
37752620|NCT00706134|69254046|FG001|Overall Study|Did not meet study criteria|0|||
37752621|NCT00706134|69254047|FG002|Overall Study|Did not meet study criteria|0|||
37752622|NCT00706134|69254048|FG003|Overall Study|Did not meet study criteria|0|||
37752623|NCT01808573|69254060|FG000|Overall Study|Death|212|||
37752624|NCT01808573|69254061|FG001|Overall Study|Death|240|||
37752625|NCT01808573|69254060|FG000|Overall Study|Withdrawal by Subject|12|||
37752626|NCT01808573|69254061|FG001|Overall Study|Withdrawal by Subject|10|||
37662384|NCT04038385|69135127|FG000|Overall Study|Completed baseline assessment only|7|||
37662385|NCT04038385|69135128|FG001|Overall Study|Completed baseline assessment only|4|||
37752627|NCT01808573|69254060|FG000|Overall Study|Lost to Follow-up|3|||
37752628|NCT01808573|69254061|FG001|Overall Study|Lost to Follow-up|0|||
37857265|NCT01307267|69540568|FG010|Overall Study|Death|3|||
37752629|NCT01808573|69254060|FG000|Overall Study|Discontinuation of study by sponsor|79|||
37752630|NCT01808573|69254061|FG001|Overall Study|Discontinuation of study by sponsor|64|||
37752631|NCT01808573|69254060|FG000|Overall Study|Randomized in Error|1|||
37752632|NCT01808573|69254061|FG001|Overall Study|Randomized in Error|0|||
37752633|NCT02246530|69254088|FG000|Overall Study|Lost to Follow-up|4|||
37752634|NCT02246530|69254089|FG001|Overall Study|Lost to Follow-up|0|||
37752635|NCT01808339|69254095|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
37752636|NCT01808339|69254096|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
37752637|NCT01808339|69254097|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
37752638|NCT01808339|69254098|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
37752639|NCT01808339|69254099|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
37752640|NCT01808339|69254100|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
37752641|NCT01808339|69254095|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
37752642|NCT01808339|69254096|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
37857266|NCT01307267|69540569|FG011|Overall Study|Death|9|||
37857267|NCT01307267|69540570|FG012|Overall Study|Death|0|||
37857268|NCT01307267|69540571|FG013|Overall Study|Death|0|||
37857269|NCT01307267|69540572|FG014|Overall Study|Death|0|||
38033220|NCT04493684|69719210|FG015|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
38033221|NCT04493684|69719211|FG016|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
38033222|NCT04493684|69719195|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|1|||
38033223|NCT04493684|69719196|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
38033224|NCT04493684|69719197|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
37662386|NCT04038385|69135127|FG000|Overall Study|Moved out of area|4|||
37662387|NCT04038385|69135128|FG001|Overall Study|Moved out of area|2|||
37662388|NCT04038385|69135127|FG000|Overall Study|Discontinued study involvement|6|||
37662389|NCT04038385|69135128|FG001|Overall Study|Discontinued study involvement|1|||
37662390|NCT00783263|69135138|FG000|Overall Study|Adverse Event|3|||
37662391|NCT00783263|69135139|FG001|Overall Study|Adverse Event|0|||
37662392|NCT00783263|69135140|FG002|Overall Study|Adverse Event|2|||
37662393|NCT00783263|69135141|FG003|Overall Study|Adverse Event|1|||
37662394|NCT00783263|69135138|FG000|Overall Study|Lost to Follow-up|1|||
37662395|NCT00783263|69135139|FG001|Overall Study|Lost to Follow-up|1|||
37662396|NCT00783263|69135140|FG002|Overall Study|Lost to Follow-up|0|||
37662397|NCT00783263|69135141|FG003|Overall Study|Lost to Follow-up|0|||
37662398|NCT00783263|69135138|FG000|Overall Study|Withdrawal by Subject|0|||
37662399|NCT00783263|69135139|FG001|Overall Study|Withdrawal by Subject|1|||
37662400|NCT00783263|69135140|FG002|Overall Study|Withdrawal by Subject|1|||
37662401|NCT00783263|69135141|FG003|Overall Study|Withdrawal by Subject|2|||
37662402|NCT03987919|69135168|FG000|Overall Study|Adverse Event|1|||
37662403|NCT03987919|69135169|FG001|Overall Study|Adverse Event|4|||
37662404|NCT03987919|69135170|FG002|Overall Study|Adverse Event|1|||
37662405|NCT03987919|69135171|FG003|Overall Study|Adverse Event|3|||
37662406|NCT03987919|69135168|FG000|Overall Study|Death|4|||
37662407|NCT03987919|69135169|FG001|Overall Study|Death|4|||
37662408|NCT03987919|69135170|FG002|Overall Study|Death|4|||
37662409|NCT03987919|69135171|FG003|Overall Study|Death|1|||
37662410|NCT03987919|69135168|FG000|Overall Study|Lost to Follow-up|5|||
37662411|NCT03987919|69135169|FG001|Overall Study|Lost to Follow-up|6|||
37662412|NCT03987919|69135170|FG002|Overall Study|Lost to Follow-up|8|||
37662413|NCT03987919|69135171|FG003|Overall Study|Lost to Follow-up|12|||
37662414|NCT03987919|69135168|FG000|Overall Study|Physician Decision|0|||
37662415|NCT03987919|69135169|FG001|Overall Study|Physician Decision|2|||
37662416|NCT03987919|69135170|FG002|Overall Study|Physician Decision|0|||
37662417|NCT03987919|69135171|FG003|Overall Study|Physician Decision|4|||
37662418|NCT03987919|69135168|FG000|Overall Study|Pregnancy|1|||
37662419|NCT03987919|69135169|FG001|Overall Study|Pregnancy|0|||
37662420|NCT03987919|69135170|FG002|Overall Study|Pregnancy|1|||
37662421|NCT03987919|69135171|FG003|Overall Study|Pregnancy|1|||
37662422|NCT03987919|69135168|FG000|Overall Study|Protocol Violation|0|||
37857270|NCT01307267|69540573|FG015|Overall Study|Death|0|||
37857271|NCT01307267|69540574|FG016|Overall Study|Death|1|||
37752643|NCT01808339|69254097|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
37857272|NCT01307267|69540575|FG017|Overall Study|Death|1|||
37662423|NCT03987919|69135169|FG001|Overall Study|Protocol Violation|1|||
37662424|NCT03987919|69135170|FG002|Overall Study|Protocol Violation|0|||
37857273|NCT01307267|69540576|FG018|Overall Study|Death|2|||
37857274|NCT01307267|69540577|FG019|Overall Study|Death|8|||
37662425|NCT03987919|69135171|FG003|Overall Study|Protocol Violation|0|||
37662426|NCT03987919|69135168|FG000|Overall Study|Site terminated by Sponsor|0|||
37662427|NCT03987919|69135169|FG001|Overall Study|Site terminated by Sponsor|0|||
37662428|NCT03987919|69135170|FG002|Overall Study|Site terminated by Sponsor|0|||
37662429|NCT03987919|69135171|FG003|Overall Study|Site terminated by Sponsor|1|||
37662430|NCT03987919|69135168|FG000|Overall Study|Withdrawal by Subject|7|||
37662431|NCT03987919|69135169|FG001|Overall Study|Withdrawal by Subject|7|||
37662432|NCT03987919|69135170|FG002|Overall Study|Withdrawal by Subject|8|||
38033225|NCT04493684|69719198|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
38033226|NCT04493684|69719199|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
38033227|NCT04493684|69719200|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
38033228|NCT04493684|69719201|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
38033229|NCT04493684|69719202|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
38033230|NCT04493684|69719203|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
38033231|NCT04493684|69719204|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
38033232|NCT04493684|69719205|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
38033233|NCT04493684|69719206|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
38033234|NCT04493684|69719207|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
38033235|NCT04493684|69719208|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
38033236|NCT04493684|69719209|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
38033237|NCT04493684|69719210|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
38033238|NCT04493684|69719211|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
37662433|NCT03987919|69135171|FG003|Overall Study|Withdrawal by Subject|4|||
37662434|NCT03987919|69135168|FG000|Overall Study|Other - as reported by the investigator|1|||
37662435|NCT03987919|69135169|FG001|Overall Study|Other - as reported by the investigator|3|||
37662436|NCT03987919|69135170|FG002|Overall Study|Other - as reported by the investigator|2|||
37662437|NCT03987919|69135171|FG003|Overall Study|Other - as reported by the investigator|0|||
37662438|NCT00535405|69135191|FG000|Overall Study|Adverse Event|6|||
38033239|NCT04493684|69719195|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
38033240|NCT04493684|69719196|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
38033241|NCT04493684|69719197|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
38033242|NCT04493684|69719198|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
38033243|NCT04493684|69719199|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
38033244|NCT04493684|69719200|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
38033245|NCT04493684|69719201|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|1|||
38033246|NCT04493684|69719202|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
38033247|NCT04493684|69719203|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
37662439|NCT00535405|69135192|FG001|Overall Study|Adverse Event|8|||
37662440|NCT00535405|69135193|FG002|Overall Study|Adverse Event|3|||
37662441|NCT00535405|69135194|FG003|Overall Study|Adverse Event|8|||
37752644|NCT01808339|69254098|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
37752645|NCT01808339|69254099|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
37752646|NCT01808339|69254100|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
37752647|NCT01808339|69254095|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
37752648|NCT01808339|69254096|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
37752649|NCT01808339|69254097|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
37752650|NCT01808339|69254098|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
37752651|NCT01808339|69254099|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
37752652|NCT01808339|69254100|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
37752653|NCT02727660|69254150|FG000|Overall Study|Lack of Efficacy|40|||
37752654|NCT02727660|69254151|FG001|Overall Study|Lack of Efficacy|40|||
37752655|NCT02727660|69254152|FG002|Overall Study|Lack of Efficacy|70|||
37752656|NCT02727660|69254150|FG000|Overall Study|Adverse Event|28|||
37752657|NCT02727660|69254151|FG001|Overall Study|Adverse Event|21|||
37752658|NCT02727660|69254152|FG002|Overall Study|Adverse Event|32|||
37752659|NCT02727660|69254150|FG000|Overall Study|Withdrawal by Subject|26|||
37752660|NCT02727660|69254151|FG001|Overall Study|Withdrawal by Subject|25|||
37752661|NCT02727660|69254152|FG002|Overall Study|Withdrawal by Subject|30|||
37752662|NCT02727660|69254150|FG000|Overall Study|Physician Decision|3|||
37752663|NCT02727660|69254151|FG001|Overall Study|Physician Decision|8|||
37752664|NCT02727660|69254152|FG002|Overall Study|Physician Decision|14|||
37752665|NCT02727660|69254150|FG000|Overall Study|Lost to Follow-up|5|||
38033248|NCT04493684|69719204|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
37752666|NCT02727660|69254151|FG001|Overall Study|Lost to Follow-up|9|||
37752667|NCT02727660|69254152|FG002|Overall Study|Lost to Follow-up|8|||
37752668|NCT02727660|69254150|FG000|Overall Study|Protocol Violation|7|||
37752669|NCT02727660|69254151|FG001|Overall Study|Protocol Violation|5|||
37752670|NCT02727660|69254152|FG002|Overall Study|Protocol Violation|5|||
37752671|NCT02727660|69254150|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
37752672|NCT02727660|69254151|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
37752673|NCT02727660|69254152|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
37752674|NCT02727660|69254150|FG000|Overall Study|Administrative Reasons|2|||
37752675|NCT02727660|69254151|FG001|Overall Study|Administrative Reasons|3|||
37752676|NCT02727660|69254152|FG002|Overall Study|Administrative Reasons|4|||
37662442|NCT00535405|69135195|FG004|Overall Study|Adverse Event|6|||
37662443|NCT00535405|69135191|FG000|Overall Study|Lost to Follow-up|1|||
37752677|NCT01784861|69254166|FG000|Overall Study|Adverse Event|0|||
37752678|NCT01784861|69254167|FG001|Overall Study|Adverse Event|0|||
37752679|NCT01784861|69254168|FG002|Overall Study|Adverse Event|1|||
37752680|NCT01784861|69254169|FG003|Overall Study|Adverse Event|2|||
37752681|NCT01784861|69254170|FG004|Overall Study|Adverse Event|1|||
37752682|NCT01784861|69254171|FG005|Overall Study|Adverse Event|0|||
37752683|NCT01784861|69254166|FG000|Overall Study|Withdrawal by Subject|0|||
37752684|NCT01784861|69254167|FG001|Overall Study|Withdrawal by Subject|0|||
37752685|NCT01784861|69254168|FG002|Overall Study|Withdrawal by Subject|0|||
37752686|NCT01784861|69254169|FG003|Overall Study|Withdrawal by Subject|1|||
37752687|NCT01784861|69254170|FG004|Overall Study|Withdrawal by Subject|0|||
37752688|NCT01784861|69254171|FG005|Overall Study|Withdrawal by Subject|0|||
37752689|NCT01784861|69254166|FG000|Overall Study|Physician Decision|0|||
38033249|NCT04493684|69719205|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
38033250|NCT04493684|69719206|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
38033251|NCT04493684|69719207|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
38033252|NCT04493684|69719208|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
38033253|NCT04493684|69719209|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
38033254|NCT04493684|69719210|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
38033255|NCT04493684|69719211|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
38033256|NCT04493684|69719195|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|1|||
38033257|NCT04493684|69719196|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
38033258|NCT04493684|69719197|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
37662444|NCT00535405|69135192|FG001|Overall Study|Lost to Follow-up|3|||
37662445|NCT00535405|69135193|FG002|Overall Study|Lost to Follow-up|3|||
37662446|NCT00535405|69135194|FG003|Overall Study|Lost to Follow-up|2|||
37662447|NCT00535405|69135195|FG004|Overall Study|Lost to Follow-up|1|||
37662448|NCT00535405|69135191|FG000|Overall Study|Physician Decision|3|||
37662449|NCT00535405|69135192|FG001|Overall Study|Physician Decision|2|||
37662450|NCT00535405|69135193|FG002|Overall Study|Physician Decision|0|||
37662451|NCT00535405|69135194|FG003|Overall Study|Physician Decision|1|||
37662452|NCT00535405|69135195|FG004|Overall Study|Physician Decision|1|||
37662453|NCT00535405|69135191|FG000|Overall Study|Protocol Violation|2|||
37662454|NCT00535405|69135192|FG001|Overall Study|Protocol Violation|2|||
37662455|NCT00535405|69135193|FG002|Overall Study|Protocol Violation|2|||
37662456|NCT00535405|69135194|FG003|Overall Study|Protocol Violation|1|||
37662457|NCT00535405|69135195|FG004|Overall Study|Protocol Violation|0|||
37662458|NCT00535405|69135191|FG000|Overall Study|Withdrawal by Subject|5|||
37662459|NCT00535405|69135192|FG001|Overall Study|Withdrawal by Subject|11|||
37662460|NCT00535405|69135193|FG002|Overall Study|Withdrawal by Subject|10|||
37662461|NCT00535405|69135194|FG003|Overall Study|Withdrawal by Subject|10|||
37662462|NCT00535405|69135195|FG004|Overall Study|Withdrawal by Subject|8|||
37662463|NCT00271817|69135210|FG000|Part 1|Adverse Event|68|||
37662464|NCT00271817|69135211|FG001|Part 1|Adverse Event|25|||
37662465|NCT00271817|69135212|FG002|Part 1|Adverse Event|156|||
37662466|NCT00271817|69135210|FG000|Part 1|Lost to Follow-up|6|||
37662467|NCT00271817|69135211|FG001|Part 1|Lost to Follow-up|8|||
37662468|NCT00271817|69135212|FG002|Part 1|Lost to Follow-up|24|||
37662469|NCT00271817|69135210|FG000|Part 1|Protocol Violation|5|||
37662470|NCT00271817|69135211|FG001|Part 1|Protocol Violation|4|||
37662471|NCT00271817|69135212|FG002|Part 1|Protocol Violation|7|||
37662472|NCT00271817|69135210|FG000|Part 1|Patient Moved|3|||
37662473|NCT00271817|69135211|FG001|Part 1|Patient Moved|1|||
37662474|NCT00271817|69135212|FG002|Part 1|Patient Moved|5|||
37662475|NCT00271817|69135210|FG000|Part 1|Withdrawal by Subject|23|||
37662476|NCT00271817|69135211|FG001|Part 1|Withdrawal by Subject|17|||
37662477|NCT00271817|69135212|FG002|Part 1|Withdrawal by Subject|45|||
37752690|NCT01784861|69254167|FG001|Overall Study|Physician Decision|0|||
37752691|NCT01784861|69254168|FG002|Overall Study|Physician Decision|0|||
37752692|NCT01784861|69254169|FG003|Overall Study|Physician Decision|2|||
37752693|NCT01784861|69254170|FG004|Overall Study|Physician Decision|0|||
37752694|NCT01784861|69254171|FG005|Overall Study|Physician Decision|1|||
37752695|NCT02727192|69254245|FG000|Overall Study|Lost to Follow-up|1|||
37752696|NCT02727192|69254246|FG001|Overall Study|Lost to Follow-up|0|||
37752697|NCT02727192|69254247|FG002|Overall Study|Lost to Follow-up|0|||
37752698|NCT00705666|69254267|FG000|Overall Study|No post-treatment questionnaire|279|||
37752699|NCT00705666|69254267|FG000|Overall Study|Withdrawal by Subject|21|||
37662478|NCT00271817|69135210|FG000|Part 1|LDL < 50 mg/dL|1|||
37662479|NCT00271817|69135211|FG001|Part 1|LDL < 50 mg/dL|4|||
37662480|NCT00271817|69135212|FG002|Part 1|LDL < 50 mg/dL|48|||
37662481|NCT00271817|69135210|FG000|Part 2|Adverse Event|0|||
37662482|NCT00271817|69135211|FG001|Part 2|Adverse Event|17|||
37662483|NCT00271817|69135212|FG002|Part 2|Adverse Event|33|||
37752700|NCT00705666|69254267|FG000|Overall Study|Physician Decision|7|||
37662484|NCT00271817|69135210|FG000|Part 2|Lack of Efficacy|0|||
37662485|NCT00271817|69135211|FG001|Part 2|Lack of Efficacy|1|||
37662486|NCT00271817|69135212|FG002|Part 2|Lack of Efficacy|6|||
37752701|NCT00705666|69254267|FG000|Overall Study|Lost to Follow-up|5|||
37752702|NCT00705666|69254267|FG000|Overall Study|Death|1|||
37662487|NCT00271817|69135210|FG000|Part 2|Lost to Follow-up|0|||
37662488|NCT00271817|69135211|FG001|Part 2|Lost to Follow-up|6|||
37662489|NCT00271817|69135212|FG002|Part 2|Lost to Follow-up|18|||
37662490|NCT00271817|69135210|FG000|Part 2|Protocol Violation|0|||
37662491|NCT00271817|69135211|FG001|Part 2|Protocol Violation|3|||
37662492|NCT00271817|69135212|FG002|Part 2|Protocol Violation|5|||
37662493|NCT00271817|69135210|FG000|Part 2|Patient Moved|0|||
37662494|NCT00271817|69135211|FG001|Part 2|Patient Moved|0|||
37752703|NCT00705666|69254267|FG000|Overall Study|Adverse Event|4|||
37752704|NCT00705666|69254267|FG000|Overall Study|Other|12|||
37752705|NCT00705666|69254267|FG000|Overall Study|Other|2|||
37752706|NCT00705666|69254267|FG000|Overall Study|Lack of data|3|||
37752707|NCT00705666|69254267|FG000|Overall Study|Untreated|5|||
37752708|NCT02725866|69254426|FG000|Overall Study|Failure to return|6|||
37752709|NCT02725866|69254426|FG000|Overall Study|Withdrew consent|3|||
37752710|NCT02725866|69254426|FG000|Overall Study|Insufficient virological response|1|||
37752711|NCT02725866|69254426|FG000|Overall Study|Other, not specified|4|||
37752712|NCT02726022|69254462|FG000|Overall Study|Adverse Event|14|||
37752713|NCT02726022|69254462|FG000|Overall Study|Treatment Failure|8|||
37752714|NCT02726022|69254462|FG000|Overall Study|Poor Compliance|13|||
37752715|NCT02726022|69254462|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
37662495|NCT00271817|69135212|FG002|Part 2|Patient Moved|5|||
37662496|NCT00271817|69135210|FG000|Part 2|Withdrawal by Subject|0|||
37662497|NCT00271817|69135211|FG001|Part 2|Withdrawal by Subject|2|||
37662498|NCT00271817|69135212|FG002|Part 2|Withdrawal by Subject|13|||
37752716|NCT02725788|69254477|FG000|Overall Study|Lost to Follow-up|1|||
37752717|NCT02725788|69254478|FG001|Overall Study|Lost to Follow-up|1|||
37752718|NCT02725788|69254477|FG000|Overall Study|Protocol Violation|0|||
37752719|NCT02725788|69254478|FG001|Overall Study|Protocol Violation|1|||
37752720|NCT02725710|69254617|FG000|Overall Study|Lost to Follow-up|1|||
37752721|NCT02725710|69254618|FG001|Overall Study|Lost to Follow-up|0|||
37752722|NCT02724462|69254649|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
37752723|NCT02724462|69254650|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
37752724|NCT02724462|69254649|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
37752725|NCT02724462|69254650|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
37752726|NCT02724462|69254649|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
37752727|NCT02724462|69254650|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
37752728|NCT02724462|69254649|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
37662499|NCT00271817|69135210|FG000|Part 2|LDL < 50 mg/dL|0|||
37662500|NCT00271817|69135211|FG001|Part 2|LDL < 50 mg/dL|3|||
37662501|NCT00271817|69135212|FG002|Part 2|LDL < 50 mg/dL|4|||
37662502|NCT02731157|69135224|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
37662503|NCT03268811|69135232|FG000|Overall Study|Adverse Event|0|||
37662504|NCT03268811|69135233|FG001|Overall Study|Adverse Event|1|||
37857275|NCT01307267|69540578|FG020|Overall Study|Death|1|||
37857276|NCT01307267|69540579|FG021|Overall Study|Death|2|||
37857277|NCT01307267|69540580|FG022|Overall Study|Death|2|||
37662505|NCT02732015|69135242|FG000|Overall Study|Lost to Follow-up|0|||
37662506|NCT02732015|69135243|FG001|Overall Study|Lost to Follow-up|1|||
37662507|NCT01441115|69135263|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
37662508|NCT02006147|69135274|FG000|Overall Study|Protocol Violation|1|||
37662509|NCT02006147|69135275|FG001|Overall Study|Protocol Violation|1|||
37752729|NCT02724462|69254650|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
37752730|NCT02724462|69254649|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
37752731|NCT02724462|69254650|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
37752732|NCT02724462|69254649|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
37857278|NCT01307267|69540558|FG000|Overall Study|Lost to Follow-up|0|||
37857279|NCT01307267|69540559|FG001|Overall Study|Lost to Follow-up|0|||
37857280|NCT01307267|69540560|FG002|Overall Study|Lost to Follow-up|0|||
37857281|NCT01307267|69540561|FG003|Overall Study|Lost to Follow-up|0|||
37857282|NCT01307267|69540562|FG004|Overall Study|Lost to Follow-up|0|||
37923278|NCT00805194|69610071|FG000|Overall Study|Other AE|84|||
37662510|NCT02006147|69135276|FG002|Overall Study|Protocol Violation|0|||
37662511|NCT02006147|69135277|FG003|Overall Study|Protocol Violation|0|||
37857283|NCT01307267|69540563|FG005|Overall Study|Lost to Follow-up|7|||
37662512|NCT02006147|69135274|FG000|Overall Study|Withdrawal by Subject|0|||
37662513|NCT02006147|69135275|FG001|Overall Study|Withdrawal by Subject|1|||
37662514|NCT02006147|69135276|FG002|Overall Study|Withdrawal by Subject|0|||
37662515|NCT02006147|69135277|FG003|Overall Study|Withdrawal by Subject|0|||
37662516|NCT02006147|69135274|FG000|Overall Study|Withdrawal by Sponsor|1|||
37662517|NCT02006147|69135275|FG001|Overall Study|Withdrawal by Sponsor|0|||
37752733|NCT02724462|69254650|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
37752734|NCT02725476|69254707|FG000|Overall Study|Physician Decision|2|||
37752735|NCT02725476|69254708|FG001|Overall Study|Physician Decision|0|||
37752736|NCT02725476|69254707|FG000|Overall Study|Adverse Event|1|||
37752737|NCT02725476|69254708|FG001|Overall Study|Adverse Event|1|||
37752738|NCT02725008|69254813|FG000|Overall Study|Lost to Follow-up|7|||
37857284|NCT01307267|69540564|FG006|Overall Study|Lost to Follow-up|0|||
37662518|NCT02006147|69135276|FG002|Overall Study|Withdrawal by Sponsor|0|||
37662519|NCT02006147|69135277|FG003|Overall Study|Withdrawal by Sponsor|0|||
37662520|NCT02732119|69135288|FG000|Phase I|Adverse Event|1|||
37752739|NCT02725008|69254814|FG001|Overall Study|Lost to Follow-up|9|||
37752740|NCT02725008|69254813|FG000|Overall Study|Withdrawal by Subject|2|||
37752741|NCT02725008|69254814|FG001|Overall Study|Withdrawal by Subject|2|||
37752742|NCT02725008|69254813|FG000|Overall Study|Admitted to hospital|0|||
37662521|NCT02732119|69135289|FG001|Phase I|Adverse Event|3|||
37662522|NCT02732119|69135290|FG002|Phase I|Adverse Event|1|||
37662523|NCT02732119|69135291|FG003|Phase I|Adverse Event|0|||
37662524|NCT02732119|69135292|FG004|Phase I|Adverse Event|0|||
37662525|NCT02732119|69135288|FG000|Phase I|Progressive disease|7|||
37662526|NCT02732119|69135289|FG001|Phase I|Progressive disease|3|||
37662527|NCT02732119|69135290|FG002|Phase I|Progressive disease|2|||
37662528|NCT02732119|69135291|FG003|Phase I|Progressive disease|0|||
37662529|NCT02732119|69135292|FG004|Phase I|Progressive disease|0|||
37662530|NCT02732119|69135288|FG000|Phase I|Protocol deviation|0|||
37662531|NCT02732119|69135289|FG001|Phase I|Protocol deviation|1|||
37662532|NCT02732119|69135290|FG002|Phase I|Protocol deviation|0|||
37662533|NCT02732119|69135291|FG003|Phase I|Protocol deviation|0|||
37752743|NCT02725008|69254814|FG001|Overall Study|Admitted to hospital|1|||
37752744|NCT01807949|69255086|FG000|Overall Study|Adverse Event|1|||
37752745|NCT01807949|69255087|FG001|Overall Study|Adverse Event|2|||
37662534|NCT02732119|69135292|FG004|Phase I|Protocol deviation|0|||
37662535|NCT02732119|69135288|FG000|Phase I|Physician Decision|0|||
37662536|NCT02732119|69135289|FG001|Phase I|Physician Decision|3|||
37662537|NCT02732119|69135290|FG002|Phase I|Physician Decision|4|||
37662538|NCT02732119|69135291|FG003|Phase I|Physician Decision|0|||
37662539|NCT02732119|69135292|FG004|Phase I|Physician Decision|0|||
37662540|NCT02732119|69135288|FG000|Phase II|Adverse Event|0|||
37662541|NCT02732119|69135289|FG001|Phase II|Adverse Event|0|||
37662542|NCT02732119|69135290|FG002|Phase II|Adverse Event|0|||
37662543|NCT02732119|69135291|FG003|Phase II|Adverse Event|3|||
37662544|NCT02732119|69135292|FG004|Phase II|Adverse Event|3|||
37662545|NCT02732119|69135288|FG000|Phase II|Death|0|||
37752746|NCT01807949|69255088|FG002|Overall Study|Adverse Event|2|||
37662546|NCT02732119|69135289|FG001|Phase II|Death|0|||
37662547|NCT02732119|69135290|FG002|Phase II|Death|0|||
37662548|NCT02732119|69135291|FG003|Phase II|Death|1|||
37662549|NCT02732119|69135292|FG004|Phase II|Death|0|||
37662550|NCT02732119|69135288|FG000|Phase II|Progressive dissease|0|||
37662551|NCT02732119|69135289|FG001|Phase II|Progressive dissease|0|||
37662552|NCT02732119|69135290|FG002|Phase II|Progressive dissease|0|||
37662553|NCT02732119|69135291|FG003|Phase II|Progressive dissease|30|||
37752747|NCT01807949|69255086|FG000|Overall Study|Withdrawal by Subject|1|||
37857285|NCT01307267|69540565|FG007|Overall Study|Lost to Follow-up|0|||
37857286|NCT01307267|69540566|FG008|Overall Study|Lost to Follow-up|1|||
37662554|NCT02732119|69135292|FG004|Phase II|Progressive dissease|23|||
37662555|NCT02732119|69135288|FG000|Phase II|Study terminated by sponsor|0|||
37662556|NCT02732119|69135289|FG001|Phase II|Study terminated by sponsor|0|||
37662557|NCT02732119|69135290|FG002|Phase II|Study terminated by sponsor|0|||
37662558|NCT02732119|69135291|FG003|Phase II|Study terminated by sponsor|2|||
37662559|NCT02732119|69135292|FG004|Phase II|Study terminated by sponsor|2|||
37662560|NCT02732119|69135288|FG000|Phase II|Other|0|||
37662561|NCT02732119|69135289|FG001|Phase II|Other|0|||
37662562|NCT02732119|69135290|FG002|Phase II|Other|0|||
37662563|NCT02732119|69135291|FG003|Phase II|Other|2|||
37662564|NCT02732119|69135292|FG004|Phase II|Other|0|||
37752748|NCT01807949|69255087|FG001|Overall Study|Withdrawal by Subject|2|||
37752749|NCT01807949|69255088|FG002|Overall Study|Withdrawal by Subject|2|||
37857287|NCT01307267|69540567|FG009|Overall Study|Lost to Follow-up|2|||
37857288|NCT01307267|69540568|FG010|Overall Study|Lost to Follow-up|1|||
37857289|NCT01307267|69540569|FG011|Overall Study|Lost to Follow-up|0|||
37857290|NCT01307267|69540570|FG012|Overall Study|Lost to Follow-up|0|||
37662565|NCT02732119|69135288|FG000|Phase II|Physician Decision|0|||
37662566|NCT02732119|69135289|FG001|Phase II|Physician Decision|0|||
37662567|NCT02732119|69135290|FG002|Phase II|Physician Decision|0|||
37662568|NCT02732119|69135291|FG003|Phase II|Physician Decision|8|||
37662569|NCT02732119|69135292|FG004|Phase II|Physician Decision|5|||
37662570|NCT03252925|69135315|FG000|Overall Study|Withdrawal by Subject|1|||
37662571|NCT03252925|69135316|FG001|Overall Study|Withdrawal by Subject|0|||
37662572|NCT03252925|69135315|FG000|Overall Study|Protocol Violation|6|||
37662573|NCT03252925|69135316|FG001|Overall Study|Protocol Violation|0|||
37662574|NCT03252925|69135315|FG000|Overall Study|Adverse Event|1|||
37662575|NCT03252925|69135316|FG001|Overall Study|Adverse Event|0|||
37857291|NCT01307267|69540571|FG013|Overall Study|Lost to Follow-up|0|||
37662576|NCT03252925|69135315|FG000|Overall Study|Lost to Follow-up|6|||
37662577|NCT03252925|69135316|FG001|Overall Study|Lost to Follow-up|6|||
37662578|NCT01327885|69135324|FG000|Overall Study|Disease progression-according to RECIST|173|||
37752750|NCT01807949|69255086|FG000|Overall Study|Non-Compliance|0|||
37752751|NCT01807949|69255087|FG001|Overall Study|Non-Compliance|0|||
37752752|NCT01807949|69255088|FG002|Overall Study|Non-Compliance|1|||
37752753|NCT01807949|69255086|FG000|Overall Study|Undefined|0|||
37752754|NCT01807949|69255087|FG001|Overall Study|Undefined|1|||
37752755|NCT01807949|69255088|FG002|Overall Study|Undefined|2|||
37752756|NCT01807949|69255086|FG000|Overall Study|Randomized But Not Treated|0|||
37752757|NCT01807949|69255087|FG001|Overall Study|Randomized But Not Treated|2|||
37752758|NCT01807949|69255088|FG002|Overall Study|Randomized But Not Treated|2|||
37752759|NCT01806779|69255100|FG000|Overall Study|Physician Decision|2|||
37752760|NCT01806779|69255101|FG001|Overall Study|Physician Decision|0|||
37662579|NCT01327885|69135325|FG001|Overall Study|Disease progression-according to RECIST|165|||
37662580|NCT01327885|69135324|FG000|Overall Study|Clinical progression|24|||
37662581|NCT01327885|69135325|FG001|Overall Study|Clinical progression|27|||
37662582|NCT01327885|69135324|FG000|Overall Study|Adverse Event|14|||
37662583|NCT01327885|69135325|FG001|Overall Study|Adverse Event|10|||
37662584|NCT01327885|69135324|FG000|Overall Study|Subject choice|5|||
37662585|NCT01327885|69135325|FG001|Overall Study|Subject choice|10|||
37662586|NCT01327885|69135324|FG000|Overall Study|Other|8|||
37662587|NCT01327885|69135325|FG001|Overall Study|Other|6|||
37662588|NCT01327885|69135324|FG000|Overall Study|Withdrawal of consent from study|3|||
37662589|NCT01327885|69135325|FG001|Overall Study|Withdrawal of consent from study|4|||
37662590|NCT01327885|69135324|FG000|Overall Study|Not treated|1|||
37752761|NCT01806779|69255102|FG002|Overall Study|Physician Decision|1|||
37752762|NCT01806779|69255100|FG000|Overall Study|Lack of Efficacy|1|||
37752763|NCT01806779|69255101|FG001|Overall Study|Lack of Efficacy|1|||
37752764|NCT01806779|69255102|FG002|Overall Study|Lack of Efficacy|0|||
37752765|NCT01806779|69255100|FG000|Overall Study|Lost to Follow-up|19|||
37752766|NCT01806779|69255101|FG001|Overall Study|Lost to Follow-up|20|||
37752767|NCT01806779|69255102|FG002|Overall Study|Lost to Follow-up|0|||
37752768|NCT01806779|69255100|FG000|Overall Study|Withdrawal by Subject|20|||
37752769|NCT01806779|69255101|FG001|Overall Study|Withdrawal by Subject|23|||
37752770|NCT01806779|69255102|FG002|Overall Study|Withdrawal by Subject|22|||
37752771|NCT01607957|69255176|FG000|Overall Study|Not treated|1|||
37752772|NCT01607957|69255177|FG001|Overall Study|Not treated|1|||
37752773|NCT01607957|69255176|FG000|Overall Study|Death|367|||
37752774|NCT01607957|69255177|FG001|Overall Study|Death|211|||
37752775|NCT01607957|69255176|FG000|Overall Study|Lost to Follow-up|3|||
37752776|NCT01607957|69255177|FG001|Overall Study|Lost to Follow-up|3|||
37752777|NCT01607957|69255176|FG000|Overall Study|Participant refusal|1|||
37752778|NCT01607957|69255177|FG001|Overall Study|Participant refusal|0|||
37752779|NCT01806623|69255197|FG000|Overall Study|Withdrawal by Subject|1|||
37752780|NCT01806623|69255197|FG000|Overall Study|Adverse Event|1|||
37752781|NCT01806623|69255197|FG000|Overall Study|Did not meet the inclusion criteria|56|||
37752782|NCT01806545|69255203|FG000|Overall Study|Adverse Event|2|||
37752783|NCT01806545|69255204|FG001|Overall Study|Adverse Event|3|||
37752784|NCT01806545|69255203|FG000|Overall Study|Lost to Follow-up|1|||
37752785|NCT01806545|69255204|FG001|Overall Study|Lost to Follow-up|0|||
37752786|NCT01806545|69255203|FG000|Overall Study|Withdrawal by Subject|3|||
37752787|NCT01806545|69255204|FG001|Overall Study|Withdrawal by Subject|2|||
37752788|NCT01806389|69255210|FG000|Overall Study|Withdrawal by Subject|4|||
37752789|NCT01782131|69255466|FG000|Overall Study|Death|93|||
37752790|NCT01782131|69255467|FG001|Overall Study|Death|96|||
37752791|NCT01782131|69255466|FG000|Overall Study|Lost to Follow-up|1|||
37752792|NCT01782131|69255467|FG001|Overall Study|Lost to Follow-up|3|||
37752793|NCT01782131|69255466|FG000|Overall Study|Withdrawal by Subject|10|||
37752794|NCT01782131|69255467|FG001|Overall Study|Withdrawal by Subject|10|||
37752795|NCT01782131|69255466|FG000|Overall Study|Randomized but not treated|5|||
37752796|NCT01782131|69255467|FG001|Overall Study|Randomized but not treated|5|||
37752797|NCT01782131|69255466|FG000|Overall Study|Reason not provided|0|||
37752798|NCT01782131|69255467|FG001|Overall Study|Reason not provided|1|||
37752799|NCT01781975|69255488|FG000|Overall Study|Death|1|||
37752800|NCT01781975|69255489|FG001|Overall Study|Death|0|||
37752801|NCT01781975|69255488|FG000|Overall Study|Withdrawal by Subject|1|||
37752802|NCT01781975|69255489|FG001|Overall Study|Withdrawal by Subject|1|||
37752803|NCT01804673|69255510|FG000|Overall Study|Adverse Event|4|||
37857292|NCT01307267|69540572|FG014|Overall Study|Lost to Follow-up|0|||
37752804|NCT01804673|69255510|FG000|Overall Study|Withdrawal by Subject|1|||
37752805|NCT01804673|69255510|FG000|Overall Study|Lack of Efficacy|9|||
37752806|NCT01804673|69255510|FG000|Overall Study|Change to Oral Therapy|37|||
37857293|NCT01307267|69540573|FG015|Overall Study|Lost to Follow-up|0|||
37662591|NCT01327885|69135325|FG001|Overall Study|Not treated|1|||
37662592|NCT01327885|69135324|FG000|Overall Study|Administrative decision|0|||
37662593|NCT01327885|69135325|FG001|Overall Study|Administrative decision|1|||
37662594|NCT03420781|69135343|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
37752807|NCT01804673|69255510|FG000|Overall Study|No Further Therapy Required|84|||
37752808|NCT01804673|69255510|FG000|Overall Study|Use of Prohibited Medication|1|||
37752809|NCT01804673|69255510|FG000|Overall Study|Other|4|||
37752810|NCT01774097|69255520|FG000|Overall Study|Withdrawal by Subject|1|||
37752811|NCT01774097|69255521|FG001|Overall Study|Withdrawal by Subject|1|||
37752812|NCT01774097|69255520|FG000|Overall Study|Adverse Event|1|||
37752813|NCT01774097|69255521|FG001|Overall Study|Adverse Event|1|||
37752814|NCT02859558|69255595|FG000|Step 1|Not Eligible|0|||
37752815|NCT02859558|69255596|FG001|Step 1|Not Eligible|0|||
37752816|NCT02859558|69255597|FG002|Step 1|Not Eligible|0|||
37752817|NCT02859558|69255598|FG003|Step 1|Not Eligible|0|||
37662595|NCT03420781|69135344|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
37662596|NCT03420781|69135345|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
37752818|NCT02859558|69255599|FG004|Step 1|Not Eligible|3|||
37662597|NCT03420781|69135346|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
37662598|NCT03420781|69135347|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
37662599|NCT03420781|69135343|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
37662600|NCT03420781|69135344|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
37662601|NCT03420781|69135345|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
37662602|NCT03420781|69135346|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
37662603|NCT03420781|69135347|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
37752819|NCT02859558|69255595|FG000|Step 1|Lost to Follow-up|1|||
37857294|NCT01307267|69540574|FG016|Overall Study|Lost to Follow-up|0|||
37662604|NCT03420781|69135343|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
37662605|NCT03420781|69135344|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
37662606|NCT03420781|69135345|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
37662607|NCT03420781|69135346|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
37662608|NCT03420781|69135347|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
37662609|NCT03420781|69135343|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
37662610|NCT03420781|69135344|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
37662611|NCT03420781|69135345|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
37662612|NCT03420781|69135346|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
37662613|NCT03420781|69135347|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
37662614|NCT03420781|69135343|FG000|Treatment Period (40 Weeks)|Death|2|||
37662615|NCT03420781|69135344|FG001|Treatment Period (40 Weeks)|Death|2|||
37662616|NCT03420781|69135345|FG002|Treatment Period (40 Weeks)|Death|0|||
37662617|NCT03420781|69135346|FG003|Treatment Period (40 Weeks)|Death|0|||
37752820|NCT02859558|69255596|FG001|Step 1|Lost to Follow-up|3|||
37752821|NCT02859558|69255597|FG002|Step 1|Lost to Follow-up|3|||
37857295|NCT01307267|69540575|FG017|Overall Study|Lost to Follow-up|0|||
37857296|NCT01307267|69540576|FG018|Overall Study|Lost to Follow-up|0|||
37857297|NCT01307267|69540577|FG019|Overall Study|Lost to Follow-up|2|||
37857298|NCT01307267|69540578|FG020|Overall Study|Lost to Follow-up|0|||
37857299|NCT01307267|69540579|FG021|Overall Study|Lost to Follow-up|0|||
37857300|NCT01307267|69540580|FG022|Overall Study|Lost to Follow-up|0|||
37857301|NCT01307267|69540558|FG000|Overall Study|Withdrawal by Subject|0|||
37857302|NCT01307267|69540559|FG001|Overall Study|Withdrawal by Subject|0|||
37857303|NCT01307267|69540560|FG002|Overall Study|Withdrawal by Subject|0|||
37857304|NCT01307267|69540561|FG003|Overall Study|Withdrawal by Subject|0|||
37857305|NCT01307267|69540562|FG004|Overall Study|Withdrawal by Subject|0|||
37857306|NCT01307267|69540563|FG005|Overall Study|Withdrawal by Subject|1|||
37857307|NCT01307267|69540564|FG006|Overall Study|Withdrawal by Subject|0|||
37857308|NCT01307267|69540565|FG007|Overall Study|Withdrawal by Subject|1|||
37857309|NCT01307267|69540566|FG008|Overall Study|Withdrawal by Subject|5|||
37857310|NCT01307267|69540567|FG009|Overall Study|Withdrawal by Subject|1|||
37857311|NCT01307267|69540568|FG010|Overall Study|Withdrawal by Subject|1|||
37857312|NCT01307267|69540569|FG011|Overall Study|Withdrawal by Subject|1|||
37857313|NCT01307267|69540570|FG012|Overall Study|Withdrawal by Subject|0|||
37857314|NCT01307267|69540571|FG013|Overall Study|Withdrawal by Subject|0|||
37857315|NCT01307267|69540572|FG014|Overall Study|Withdrawal by Subject|0|||
37857316|NCT01307267|69540573|FG015|Overall Study|Withdrawal by Subject|0|||
37857317|NCT01307267|69540574|FG016|Overall Study|Withdrawal by Subject|0|||
37857318|NCT01307267|69540575|FG017|Overall Study|Withdrawal by Subject|0|||
37857319|NCT01307267|69540576|FG018|Overall Study|Withdrawal by Subject|0|||
37857320|NCT01307267|69540577|FG019|Overall Study|Withdrawal by Subject|3|||
37857321|NCT01307267|69540578|FG020|Overall Study|Withdrawal by Subject|0|||
37857322|NCT01307267|69540579|FG021|Overall Study|Withdrawal by Subject|0|||
37857323|NCT01307267|69540580|FG022|Overall Study|Withdrawal by Subject|0|||
37857324|NCT01307267|69540558|FG000|Overall Study|Other|0|||
37662618|NCT03420781|69135347|FG004|Treatment Period (40 Weeks)|Death|0|||
37857325|NCT01307267|69540559|FG001|Overall Study|Other|0|||
37857326|NCT01307267|69540560|FG002|Overall Study|Other|0|||
37857327|NCT01307267|69540561|FG003|Overall Study|Other|0|||
37857328|NCT01307267|69540562|FG004|Overall Study|Other|0|||
37662619|NCT03420781|69135343|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
37662620|NCT03420781|69135344|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
37752822|NCT02859558|69255598|FG003|Step 1|Lost to Follow-up|0|||
37662621|NCT03420781|69135345|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
37662622|NCT03420781|69135346|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
37752823|NCT02859558|69255599|FG004|Step 1|Lost to Follow-up|0|||
37752824|NCT02859558|69255595|FG000|Step 1|Did Not Return to Clinic|2|||
37857329|NCT01307267|69540563|FG005|Overall Study|Other|7|||
37857330|NCT01307267|69540564|FG006|Overall Study|Other|0|||
37857331|NCT01307267|69540565|FG007|Overall Study|Other|1|||
37857332|NCT01307267|69540566|FG008|Overall Study|Other|3|||
37857333|NCT01307267|69540567|FG009|Overall Study|Other|0|||
37752825|NCT02859558|69255596|FG001|Step 1|Did Not Return to Clinic|3|||
37662623|NCT03420781|69135347|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
37662624|NCT03420781|69135343|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
37662625|NCT03420781|69135344|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
37662626|NCT03420781|69135345|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
37752826|NCT02859558|69255597|FG002|Step 1|Did Not Return to Clinic|4|||
37752827|NCT02859558|69255598|FG003|Step 1|Did Not Return to Clinic|0|||
37752828|NCT02859558|69255599|FG004|Step 1|Did Not Return to Clinic|0|||
37752829|NCT02859558|69255595|FG000|Step 1|Moved|0|||
37752830|NCT02859558|69255596|FG001|Step 1|Moved|1|||
37752831|NCT02859558|69255597|FG002|Step 1|Moved|1|||
37752832|NCT02859558|69255598|FG003|Step 1|Moved|0|||
37752833|NCT02859558|69255599|FG004|Step 1|Moved|0|||
37752834|NCT02859558|69255595|FG000|Step 1|Withdrawal By Participant|1|||
37752835|NCT02859558|69255596|FG001|Step 1|Withdrawal By Participant|2|||
37752836|NCT02859558|69255597|FG002|Step 1|Withdrawal By Participant|1|||
37752837|NCT02859558|69255598|FG003|Step 1|Withdrawal By Participant|0|||
37923279|NCT00805194|69610072|FG001|Overall Study|Other AE|73|||
37923280|NCT00805194|69610071|FG000|Overall Study|Protocol Violation|9|||
37923281|NCT00805194|69610072|FG001|Overall Study|Protocol Violation|9|||
37923282|NCT00805194|69610071|FG000|Overall Study|Lost to Follow-up|5|||
37923283|NCT00805194|69610072|FG001|Overall Study|Lost to Follow-up|5|||
37923284|NCT00805194|69610071|FG000|Overall Study|Withdrawal by Subject|60|||
37923285|NCT00805194|69610072|FG001|Overall Study|Withdrawal by Subject|42|||
37923286|NCT00805194|69610071|FG000|Overall Study|Not treated|3|||
37923287|NCT00805194|69610072|FG001|Overall Study|Not treated|4|||
37923288|NCT00805194|69610071|FG000|Overall Study|Reasons other than stated above|20|||
37923289|NCT00805194|69610072|FG001|Overall Study|Reasons other than stated above|16|||
37923290|NCT00836186|69610083|FG000|Overall Study|Blood could not be drawn|1|||
37923291|NCT00657046|69610091|FG000|Overall Study|Adverse Event|1|||
37923292|NCT00657046|69610092|FG001|Overall Study|Adverse Event|1|||
37923293|NCT00657046|69610093|FG002|Overall Study|Adverse Event|0|||
37923294|NCT00657046|69610091|FG000|Overall Study|Protocol Violation|2|||
37923295|NCT00657046|69610092|FG001|Overall Study|Protocol Violation|2|||
37923296|NCT00657046|69610093|FG002|Overall Study|Protocol Violation|0|||
37923297|NCT00657046|69610091|FG000|Overall Study|Withdrawal by Subject|1|||
37923298|NCT00657046|69610092|FG001|Overall Study|Withdrawal by Subject|0|||
37923299|NCT00657046|69610093|FG002|Overall Study|Withdrawal by Subject|0|||
37923300|NCT00657046|69610091|FG000|Overall Study|Death|0|||
37923301|NCT00657046|69610092|FG001|Overall Study|Death|0|||
37923302|NCT00657046|69610093|FG002|Overall Study|Death|1|||
37923303|NCT00657046|69610091|FG000|Overall Study|Surgery|0|||
37923304|NCT00657046|69610092|FG001|Overall Study|Surgery|0|||
37923305|NCT00657046|69610093|FG002|Overall Study|Surgery|1|||
37923306|NCT00856661|69610103|FG000|Overall Study|Death|15|||
37923307|NCT00856661|69610104|FG001|Overall Study|Death|18|||
37923308|NCT00856661|69610103|FG000|Overall Study|Protocol Violation|2|||
37923309|NCT00856661|69610104|FG001|Overall Study|Protocol Violation|1|||
37662627|NCT03420781|69135346|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
37662628|NCT03420781|69135347|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
37662629|NCT03420781|69135343|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
37662630|NCT03420781|69135344|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
37662631|NCT03420781|69135345|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
37662632|NCT03420781|69135346|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
37662633|NCT03420781|69135347|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
37662634|NCT03420781|69135343|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
37662635|NCT03420781|69135344|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
37662636|NCT03420781|69135345|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
37662637|NCT03420781|69135346|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
37662638|NCT03420781|69135347|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
37662639|NCT03420781|69135343|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
37752838|NCT02859558|69255599|FG004|Step 1|Withdrawal By Participant|0|||
37752839|NCT02859558|69255595|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
37752840|NCT02859558|69255596|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
37752841|NCT02859558|69255597|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
37752842|NCT02859558|69255598|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
37752843|NCT02859558|69255599|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
37752844|NCT02859558|69255595|FG000|Step 1|Incarceration|0|||
37752845|NCT02859558|69255596|FG001|Step 1|Incarceration|1|||
37752846|NCT02859558|69255597|FG002|Step 1|Incarceration|0|||
37752847|NCT02859558|69255598|FG003|Step 1|Incarceration|0|||
37752848|NCT02859558|69255599|FG004|Step 1|Incarceration|0|||
37752849|NCT02859558|69255595|FG000|Step 1|Non-Adherence to Study Drug|2|||
37923310|NCT00856661|69610103|FG000|Overall Study|Withdrawal by Subject|1|||
37923311|NCT00856661|69610104|FG001|Overall Study|Withdrawal by Subject|2|||
37923312|NCT00856661|69610103|FG000|Overall Study|Lost to Follow-up|1|||
37923313|NCT00856661|69610104|FG001|Overall Study|Lost to Follow-up|3|||
37662640|NCT03420781|69135344|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
37662641|NCT03420781|69135345|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
37662642|NCT03420781|69135346|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
37662643|NCT03420781|69135347|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
37662644|NCT03420781|69135343|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
37662645|NCT03420781|69135344|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
37662646|NCT03420781|69135345|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
37662647|NCT03420781|69135346|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
37662648|NCT03420781|69135347|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
37662649|NCT03420781|69135343|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
37752850|NCT02859558|69255596|FG001|Step 1|Non-Adherence to Study Drug|0|||
37752851|NCT02859558|69255597|FG002|Step 1|Non-Adherence to Study Drug|1|||
37752852|NCT02859558|69255598|FG003|Step 1|Non-Adherence to Study Drug|0|||
37752853|NCT02859558|69255599|FG004|Step 1|Non-Adherence to Study Drug|0|||
37752854|NCT02859558|69255595|FG000|Step 1|Non-Adherence to Study Requirements|3|||
37752855|NCT02859558|69255596|FG001|Step 1|Non-Adherence to Study Requirements|1|||
37752856|NCT02859558|69255597|FG002|Step 1|Non-Adherence to Study Requirements|0|||
37752857|NCT02859558|69255598|FG003|Step 1|Non-Adherence to Study Requirements|0|||
37752858|NCT02859558|69255599|FG004|Step 1|Non-Adherence to Study Requirements|0|||
37752859|NCT02859558|69255595|FG000|Step 1|Virologic Failure|2|||
37752860|NCT02859558|69255596|FG001|Step 1|Virologic Failure|1|||
37752861|NCT02859558|69255597|FG002|Step 1|Virologic Failure|1|||
37752862|NCT02859558|69255598|FG003|Step 1|Virologic Failure|0|||
37752863|NCT02859558|69255599|FG004|Step 1|Virologic Failure|0|||
37752864|NCT02859558|69255595|FG000|Step 2|Active On Study|23|||
37752865|NCT02859558|69255596|FG001|Step 2|Active On Study|38|||
37752866|NCT02859558|69255597|FG002|Step 2|Active On Study|20|||
37752867|NCT02859558|69255598|FG003|Step 2|Active On Study|0|||
37752868|NCT02859558|69255599|FG004|Step 2|Active On Study|0|||
37752869|NCT02859558|69255595|FG000|Step 2|Did Not Return to Clinic|2|||
37752870|NCT02859558|69255596|FG001|Step 2|Did Not Return to Clinic|0|||
37752871|NCT02859558|69255597|FG002|Step 2|Did Not Return to Clinic|0|||
37752872|NCT02859558|69255598|FG003|Step 2|Did Not Return to Clinic|0|||
37752873|NCT02859558|69255599|FG004|Step 2|Did Not Return to Clinic|0|||
37752874|NCT02859558|69255595|FG000|Step 2|Unexpected Closure of Site|0|||
37752875|NCT02859558|69255596|FG001|Step 2|Unexpected Closure of Site|1|||
37752876|NCT02859558|69255597|FG002|Step 2|Unexpected Closure of Site|1|||
37752877|NCT02859558|69255598|FG003|Step 2|Unexpected Closure of Site|0|||
37752878|NCT02859558|69255599|FG004|Step 2|Unexpected Closure of Site|0|||
37752879|NCT00705432|69255650|FG000|Treatment Period|Adverse Event|45|||
37752880|NCT00705432|69255651|FG001|Treatment Period|Adverse Event|37|||
37752881|NCT00705432|69255652|FG002|Treatment Period|Adverse Event|51|||
37752882|NCT00705432|69255653|FG003|Treatment Period|Adverse Event|12|||
37752883|NCT00705432|69255654|FG004|Treatment Period|Adverse Event|8|||
37752884|NCT00705432|69255655|FG005|Treatment Period|Adverse Event|9|||
37752885|NCT00705432|69255650|FG000|Treatment Period|Treatment failure|92|||
37752886|NCT00705432|69255651|FG001|Treatment Period|Treatment failure|42|||
37752887|NCT00705432|69255652|FG002|Treatment Period|Treatment failure|33|||
37752888|NCT00705432|69255653|FG003|Treatment Period|Treatment failure|25|||
37752889|NCT00705432|69255654|FG004|Treatment Period|Treatment failure|13|||
37752890|NCT00705432|69255655|FG005|Treatment Period|Treatment failure|14|||
37752891|NCT00705432|69255650|FG000|Treatment Period|Non medical reason|26|||
37752892|NCT00705432|69255651|FG001|Treatment Period|Non medical reason|32|||
37752893|NCT00705432|69255652|FG002|Treatment Period|Non medical reason|37|||
37752894|NCT00705432|69255653|FG003|Treatment Period|Non medical reason|4|||
37752895|NCT00705432|69255654|FG004|Treatment Period|Non medical reason|7|||
37752896|NCT00705432|69255655|FG005|Treatment Period|Non medical reason|7|||
37752897|NCT00705432|69255650|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
37752898|NCT00705432|69255651|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
37752899|NCT00705432|69255652|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
37752900|NCT00705432|69255653|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
37752901|NCT00705432|69255654|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
37752902|NCT00705432|69255655|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
37857334|NCT01307267|69540568|FG010|Overall Study|Other|1|||
37662650|NCT03420781|69135344|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
37662651|NCT03420781|69135345|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
37752903|NCT00705432|69255650|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
37752904|NCT00705432|69255651|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
37857335|NCT01307267|69540569|FG011|Overall Study|Other|1|||
37662652|NCT03420781|69135346|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
37752905|NCT00705432|69255652|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
37752906|NCT00705432|69255653|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
37752907|NCT00705432|69255654|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
37752908|NCT00705432|69255655|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
37857336|NCT01307267|69540570|FG012|Overall Study|Other|1|||
37752909|NCT00704964|69255666|FG000|Overall Study|Not completed on time|328|||
37752910|NCT00704808|69255682|FG000|Overall Study|Discontinued prior to starting treatment|14|||
37752911|NCT00704808|69255682|FG000|Overall Study|Death|7|||
37752912|NCT00704808|69255682|FG000|Overall Study|Tumor progression|80|||
37752913|NCT00704808|69255682|FG000|Overall Study|Patient's decision|11|||
37752914|NCT00704808|69255682|FG000|Overall Study|Early therapy discontinuation|16|||
37752915|NCT00704808|69255682|FG000|Overall Study|Adverse Event|1|||
37752916|NCT00704808|69255682|FG000|Overall Study|Lost to Follow-up|1|||
37752917|NCT00704808|69255682|FG000|Overall Study|Treatment change|1|||
37752918|NCT01375608|69255717|FG000|Overall Study|Withdrawal by Subject|2|||
37752919|NCT00704418|69255732|FG000|Overall Study|Withdrawal by Subject|2|||
37752920|NCT00704418|69255733|FG001|Overall Study|Withdrawal by Subject|0|||
37752921|NCT00704418|69255732|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
37752922|NCT00704418|69255733|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
37752923|NCT00704340|69255802|FG000|Overall Study|Lost to Follow-up|2|||
37752924|NCT00704340|69255803|FG001|Overall Study|Lost to Follow-up|1|||
37752925|NCT00704340|69255802|FG000|Overall Study|Death|0|||
37752926|NCT00704340|69255803|FG001|Overall Study|Death|1|||
37752927|NCT00552058|69255811|FG000|Overall Study|Adverse Event|8|||
37752928|NCT00552058|69255812|FG001|Overall Study|Adverse Event|7|||
37752929|NCT00552058|69255811|FG000|Overall Study|Lack of Efficacy|1|||
37752930|NCT00552058|69255812|FG001|Overall Study|Lack of Efficacy|5|||
37752931|NCT00552058|69255811|FG000|Overall Study|Lost to Follow-up|1|||
37752932|NCT00552058|69255812|FG001|Overall Study|Lost to Follow-up|0|||
37752933|NCT00552058|69255811|FG000|Overall Study|Withdrawal by Subject|4|||
37752934|NCT00552058|69255812|FG001|Overall Study|Withdrawal by Subject|4|||
37752935|NCT00552058|69255811|FG000|Overall Study|Other: Protocol Violation|0|||
37752936|NCT00552058|69255812|FG001|Overall Study|Other: Protocol Violation|1|||
37752937|NCT00552058|69255811|FG000|Overall Study|Other: Non Compliance|1|||
37752938|NCT00552058|69255812|FG001|Overall Study|Other: Non Compliance|2|||
37752939|NCT00552058|69255811|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
37752940|NCT00552058|69255812|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
37752941|NCT00552058|69255811|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
37752942|NCT00552058|69255812|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
37752943|NCT00552058|69255811|FG000|Overall Study|Other: Positive Stool Result|0|||
37752944|NCT00552058|69255812|FG001|Overall Study|Other: Positive Stool Result|1|||
37752945|NCT00552058|69255811|FG000|Overall Study|Other: Randomized in error|0|||
37752946|NCT00552058|69255812|FG001|Overall Study|Other: Randomized in error|1|||
37752947|NCT00552058|69255811|FG000|Overall Study|Other: Sponsors Decision|0|||
37752948|NCT00552058|69255812|FG001|Overall Study|Other: Sponsors Decision|1|||
37752949|NCT00552058|69255811|FG000|Overall Study|Other: Early Roll Over|1|||
37752950|NCT00552058|69255812|FG001|Overall Study|Other: Early Roll Over|0|||
37752951|NCT00550732|69255841|FG000|Overall Study|Death|4|||
37752952|NCT00550732|69255841|FG000|Overall Study|Withdrawal by Subject|2|||
37752953|NCT00550732|69255841|FG000|Overall Study|Physician Decision|2|||
37752954|NCT00550732|69255841|FG000|Overall Study|Lost to Follow-up|1|||
37752955|NCT00550732|69255841|FG000|Overall Study|Palliative care|1|||
37752956|NCT00550732|69255841|FG000|Overall Study|Adverse Event|1|||
37752957|NCT00550420|69255855|FG000|Overall Study|Adverse Event|28|||
37752958|NCT00550420|69255855|FG000|Overall Study|Lost to Follow-up|8|||
37752959|NCT00550420|69255855|FG000|Overall Study|Protocol Violation|11|||
37752960|NCT00550420|69255855|FG000|Overall Study|Withdrawal by Subject|30|||
37752961|NCT00550420|69255855|FG000|Overall Study|Still in study at termination|206|||
37752962|NCT00550420|69255855|FG000|Overall Study|Missing|2|||
37752963|NCT00550420|69255855|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
37752964|NCT00550420|69255855|FG000|Overall Study|Investigators opinion|1|||
37752965|NCT00550420|69255855|FG000|Overall Study|Lack of curative effect|1|||
37752966|NCT00550420|69255855|FG000|Overall Study|Unethical stop of enrollment|2|||
37752967|NCT00550420|69255855|FG000|Overall Study|Caregiver's decision to withdraw|1|||
37752968|NCT00550420|69255855|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
37752969|NCT00550420|69255855|FG000|Overall Study|Exclusion criteria|1|||
37752970|NCT00550420|69255855|FG000|Overall Study|Prohibited medicine|1|||
37752971|NCT00558064|69255867|FG000|Overall Study|Adverse Event|3|||
37752972|NCT00558064|69255868|FG001|Overall Study|Adverse Event|2|||
37752973|NCT00558064|69255867|FG000|Overall Study|Lack of Efficacy|0|||
37752974|NCT00558064|69255868|FG001|Overall Study|Lack of Efficacy|1|||
37752975|NCT00558064|69255867|FG000|Overall Study|Protocol Violation|1|||
37752976|NCT00558064|69255868|FG001|Overall Study|Protocol Violation|0|||
37752977|NCT00558064|69255867|FG000|Overall Study|Lost to Follow-up|0|||
37752978|NCT00558064|69255868|FG001|Overall Study|Lost to Follow-up|1|||
37752979|NCT00558064|69255867|FG000|Overall Study|Withdrawal by Subject|0|||
37752980|NCT00558064|69255868|FG001|Overall Study|Withdrawal by Subject|1|||
37752981|NCT00558064|69255867|FG000|Overall Study|No visit within allowance period|1|||
37752982|NCT00558064|69255868|FG001|Overall Study|No visit within allowance period|0|||
37857337|NCT01307267|69540571|FG013|Overall Study|Other|0|||
37857338|NCT01307267|69540572|FG014|Overall Study|Other|2|||
37857339|NCT01307267|69540573|FG015|Overall Study|Other|1|||
37752983|NCT00557830|69255877|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
37752984|NCT00557830|69255878|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
37752985|NCT00557830|69255879|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
37752986|NCT00557830|69255877|FG000|Screening Treatment Phase|Adverse Event|2|||
37752987|NCT00557830|69255878|FG001|Screening Treatment Phase|Adverse Event|0|||
37752988|NCT00557830|69255879|FG002|Screening Treatment Phase|Adverse Event|0|||
37752989|NCT00557830|69255877|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
37752990|NCT00557830|69255878|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
37752991|NCT00557830|69255879|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
37752992|NCT00557440|69255890|FG000|Treatment Period 1|Adverse Event|0|||
37752993|NCT00557440|69255891|FG001|Treatment Period 1|Adverse Event|0|||
37752994|NCT00557440|69255892|FG002|Treatment Period 1|Adverse Event|1|||
37752995|NCT00556894|69255903|FG000|Overall Study|Adverse Event|2|||
37752996|NCT00556894|69255904|FG001|Overall Study|Adverse Event|3|||
37857340|NCT01307267|69540574|FG016|Overall Study|Other|0|||
37857341|NCT01307267|69540575|FG017|Overall Study|Other|0|||
37662653|NCT03420781|69135347|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
37857342|NCT01307267|69540576|FG018|Overall Study|Other|0|||
37857343|NCT01307267|69540577|FG019|Overall Study|Other|19|||
38033259|NCT04493684|69719198|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
37662654|NCT03420781|69135343|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
37662655|NCT03420781|69135344|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
37662656|NCT03420781|69135345|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
37662657|NCT03420781|69135346|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
37662658|NCT03420781|69135347|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
37662659|NCT03269695|69135365|FG000|Overall Study|Adverse Event|2|||
37662660|NCT03269695|69135366|FG001|Overall Study|Adverse Event|1|||
37662661|NCT03269695|69135365|FG000|Overall Study|Lack of Efficacy|0|||
37662662|NCT03269695|69135366|FG001|Overall Study|Lack of Efficacy|1|||
37662663|NCT03269695|69135365|FG000|Overall Study|Withdrawal by Subject|0|||
37662664|NCT03269695|69135366|FG001|Overall Study|Withdrawal by Subject|1|||
37662665|NCT00462943|69135376|FG000|Overall Study|Failure to achieve a response|5|||
37662666|NCT00462943|69135377|FG001|Overall Study|Failure to achieve a response|5|||
37662667|NCT00462943|69135378|FG002|Overall Study|Failure to achieve a response|1|||
37662668|NCT00462943|69135376|FG000|Overall Study|Adverse Event|6|||
37662669|NCT00462943|69135377|FG001|Overall Study|Adverse Event|4|||
37662670|NCT00462943|69135378|FG002|Overall Study|Adverse Event|1|||
37662671|NCT00462943|69135376|FG000|Overall Study|Protocol Violation|1|||
37662672|NCT00462943|69135377|FG001|Overall Study|Protocol Violation|0|||
37662673|NCT00462943|69135378|FG002|Overall Study|Protocol Violation|0|||
37662674|NCT00462943|69135376|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
37662675|NCT00462943|69135377|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
37662676|NCT00462943|69135378|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
37662677|NCT00462943|69135376|FG000|Overall Study|Disease Progression|15|||
37662678|NCT00462943|69135377|FG001|Overall Study|Disease Progression|15|||
37662679|NCT00462943|69135378|FG002|Overall Study|Disease Progression|9|||
37662680|NCT00462943|69135376|FG000|Overall Study|Death|5|||
37662681|NCT00462943|69135377|FG001|Overall Study|Death|2|||
37662682|NCT00462943|69135378|FG002|Overall Study|Death|7|||
37662683|NCT00462943|69135376|FG000|Overall Study|Stem Cell Transplant|1|||
37662684|NCT00462943|69135377|FG001|Overall Study|Stem Cell Transplant|1|||
37662685|NCT00462943|69135378|FG002|Overall Study|Stem Cell Transplant|0|||
37662686|NCT00462943|69135376|FG000|Overall Study|Bone Marrow Transplant|1|||
37662687|NCT00462943|69135377|FG001|Overall Study|Bone Marrow Transplant|0|||
37662688|NCT00462943|69135378|FG002|Overall Study|Bone Marrow Transplant|0|||
37662689|NCT00462943|69135376|FG000|Overall Study|Required Lymphocyte Infusion|1|||
37662690|NCT00462943|69135377|FG001|Overall Study|Required Lymphocyte Infusion|0|||
37662691|NCT00462943|69135378|FG002|Overall Study|Required Lymphocyte Infusion|0|||
37662692|NCT00462943|69135376|FG000|Overall Study|Transplant - not specified|1|||
37662693|NCT00462943|69135377|FG001|Overall Study|Transplant - not specified|0|||
37662694|NCT00462943|69135378|FG002|Overall Study|Transplant - not specified|1|||
37662695|NCT00462943|69135376|FG000|Overall Study|Physician Decision|1|||
37662696|NCT00462943|69135377|FG001|Overall Study|Physician Decision|0|||
37662697|NCT00462943|69135378|FG002|Overall Study|Physician Decision|0|||
37662698|NCT00462943|69135376|FG000|Overall Study|Withdrawal by Subject|0|||
37662699|NCT00462943|69135377|FG001|Overall Study|Withdrawal by Subject|1|||
37752997|NCT00556894|69255905|FG002|Overall Study|Adverse Event|3|||
37857344|NCT01307267|69540578|FG020|Overall Study|Other|2|||
37662700|NCT00462943|69135378|FG002|Overall Study|Withdrawal by Subject|0|||
37662701|NCT02730793|69135402|FG000|Overall Study|Physician Decision|0|||
37662702|NCT02730793|69135403|FG001|Overall Study|Physician Decision|1|||
37662703|NCT02730793|69135402|FG000|Overall Study|Withdrawal by Subject|0|||
37662704|NCT02730793|69135403|FG001|Overall Study|Withdrawal by Subject|1|||
37662705|NCT02855125|69135411|FG000|Overall Study|Withdrawal by Subject|2|||
37857345|NCT01307267|69540579|FG021|Overall Study|Other|3|||
37662706|NCT02855125|69135412|FG001|Overall Study|Withdrawal by Subject|2|||
37662707|NCT02855125|69135411|FG000|Overall Study|Clinical Disease Progression|5|||
37662708|NCT02855125|69135412|FG001|Overall Study|Clinical Disease Progression|4|||
37662709|NCT02855125|69135411|FG000|Overall Study|Radiologic Disease Progression|36|||
37662710|NCT02855125|69135412|FG001|Overall Study|Radiologic Disease Progression|39|||
37662711|NCT02855125|69135411|FG000|Overall Study|Adverse Event|11|||
37662712|NCT02855125|69135412|FG001|Overall Study|Adverse Event|7|||
37752998|NCT00556894|69255903|FG000|Overall Study|Death|1|||
37752999|NCT00556894|69255904|FG001|Overall Study|Death|0|||
37753000|NCT00556894|69255905|FG002|Overall Study|Death|0|||
37753001|NCT00556894|69255903|FG000|Overall Study|regulatory decision in Bulgaria|10|||
37753002|NCT00556894|69255904|FG001|Overall Study|regulatory decision in Bulgaria|14|||
37753003|NCT00556894|69255905|FG002|Overall Study|regulatory decision in Bulgaria|13|||
37753004|NCT00556894|69255903|FG000|Overall Study|Change in therapy|2|||
37753005|NCT00556894|69255904|FG001|Overall Study|Change in therapy|1|||
37753006|NCT00556894|69255905|FG002|Overall Study|Change in therapy|2|||
37753007|NCT00556894|69255903|FG000|Overall Study|Withdrawal by Subject|1|||
37753008|NCT00556894|69255904|FG001|Overall Study|Withdrawal by Subject|1|||
37753009|NCT00556894|69255905|FG002|Overall Study|Withdrawal by Subject|1|||
37753010|NCT02722044|69255913|FG000|Overall Study|Adverse Event|2|||
37753011|NCT02722044|69255913|FG000|Overall Study|Physician Decision|1|||
37753012|NCT02722044|69255913|FG000|Overall Study|Withdrawal by Subject|1|||
37753013|NCT02722044|69255913|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
37753014|NCT00556426|69255918|FG000|Overall Study|Withdrawal by Subject|3|||
37753015|NCT00556426|69255918|FG000|Overall Study|Death|6|||
37753016|NCT00555568|69255926|FG000|Overall Study|Lost to Follow-up|26|||
37753017|NCT00555568|69255927|FG001|Overall Study|Lost to Follow-up|16|||
37753018|NCT00555568|69255928|FG002|Overall Study|Lost to Follow-up|16|||
37753019|NCT00702702|69255939|FG000|Overall Study|Study prematurely terminated|56|||
37753020|NCT02721966|69255950|FG000|Overall Study|Protocol Violation|1|||
37753021|NCT02721966|69255951|FG001|Overall Study|Protocol Violation|0|||
37753022|NCT02721966|69255952|FG002|Overall Study|Protocol Violation|0|||
37753023|NCT02721966|69255953|FG003|Overall Study|Protocol Violation|0|||
37753024|NCT02721966|69255954|FG004|Overall Study|Protocol Violation|0|||
37753025|NCT02721966|69255950|FG000|Overall Study|Withdrawal by Subject|9|||
37753026|NCT02721966|69255951|FG001|Overall Study|Withdrawal by Subject|2|||
37753027|NCT02721966|69255952|FG002|Overall Study|Withdrawal by Subject|3|||
37753028|NCT02721966|69255953|FG003|Overall Study|Withdrawal by Subject|7|||
37753029|NCT02721966|69255954|FG004|Overall Study|Withdrawal by Subject|0|||
37753030|NCT02721966|69255950|FG000|Overall Study|Adverse Event|4|||
37753031|NCT02721966|69255951|FG001|Overall Study|Adverse Event|4|||
37753032|NCT02721966|69255952|FG002|Overall Study|Adverse Event|3|||
37753033|NCT02721966|69255953|FG003|Overall Study|Adverse Event|0|||
37753034|NCT02721966|69255954|FG004|Overall Study|Adverse Event|0|||
37753035|NCT02721966|69255950|FG000|Overall Study|Death|1|||
37753036|NCT02721966|69255951|FG001|Overall Study|Death|0|||
37753037|NCT02721966|69255952|FG002|Overall Study|Death|0|||
37753038|NCT02721966|69255953|FG003|Overall Study|Death|0|||
37753039|NCT02721966|69255954|FG004|Overall Study|Death|0|||
37753040|NCT02721966|69255950|FG000|Overall Study|Lack of Efficacy|7|||
37753041|NCT02721966|69255951|FG001|Overall Study|Lack of Efficacy|4|||
37753042|NCT02721966|69255952|FG002|Overall Study|Lack of Efficacy|0|||
37753043|NCT02721966|69255953|FG003|Overall Study|Lack of Efficacy|0|||
37753044|NCT02721966|69255954|FG004|Overall Study|Lack of Efficacy|0|||
37753045|NCT02721966|69255950|FG000|Overall Study|Lost to Follow-up|0|||
37753046|NCT02721966|69255951|FG001|Overall Study|Lost to Follow-up|0|||
37753047|NCT02721966|69255952|FG002|Overall Study|Lost to Follow-up|3|||
37753048|NCT02721966|69255953|FG003|Overall Study|Lost to Follow-up|0|||
37753049|NCT02721966|69255954|FG004|Overall Study|Lost to Follow-up|0|||
37753050|NCT02721966|69255950|FG000|Overall Study|Physician Decision|1|||
37753051|NCT02721966|69255951|FG001|Overall Study|Physician Decision|1|||
37753052|NCT02721966|69255952|FG002|Overall Study|Physician Decision|0|||
37857346|NCT01307267|69540580|FG022|Overall Study|Other|2|||
37662713|NCT02855125|69135411|FG000|Overall Study|Physician Decision|1|||
37662714|NCT02855125|69135412|FG001|Overall Study|Physician Decision|0|||
37662715|NCT02855125|69135411|FG000|Overall Study|On Treatment|9|||
37662716|NCT02855125|69135412|FG001|Overall Study|On Treatment|11|||
37753053|NCT02721966|69255953|FG003|Overall Study|Physician Decision|0|||
37753054|NCT02721966|69255954|FG004|Overall Study|Physician Decision|0|||
37753055|NCT02721966|69255950|FG000|Overall Study|Pregnancy|1|||
37753056|NCT02721966|69255951|FG001|Overall Study|Pregnancy|0|||
37753057|NCT02721966|69255952|FG002|Overall Study|Pregnancy|0|||
37753058|NCT02721966|69255953|FG003|Overall Study|Pregnancy|0|||
37753059|NCT02721966|69255954|FG004|Overall Study|Pregnancy|0|||
37753060|NCT02721966|69255950|FG000|Overall Study|Did not continue to period 2|5|||
37753061|NCT02721966|69255951|FG001|Overall Study|Did not continue to period 2|12|||
37753062|NCT02721966|69255952|FG002|Overall Study|Did not continue to period 2|0|||
37753063|NCT02721966|69255953|FG003|Overall Study|Did not continue to period 2|0|||
37753064|NCT02721966|69255954|FG004|Overall Study|Did not continue to period 2|5|||
37753065|NCT00553462|69255962|FG000|Overall Study|Adverse Event|4|||
37753066|NCT00553462|69255962|FG000|Overall Study|Progression|4|||
37753067|NCT00553462|69255962|FG000|Overall Study|Withdrawal by Subject|5|||
37753068|NCT00553462|69255962|FG000|Overall Study|Physician Decision|1|||
37753069|NCT00553150|69255968|FG000|Overall Study|Withdrawal by Subject|0|||
37753070|NCT00553150|69255969|FG001|Overall Study|Withdrawal by Subject|0|||
37753071|NCT00553150|69255970|FG002|Overall Study|Withdrawal by Subject|0|||
37753072|NCT00553150|69255971|FG003|Overall Study|Withdrawal by Subject|2|||
37753073|NCT00553150|69255968|FG000|Overall Study|Protocol Violation|0|||
37753074|NCT00553150|69255969|FG001|Overall Study|Protocol Violation|0|||
37753075|NCT00553150|69255970|FG002|Overall Study|Protocol Violation|0|||
37753076|NCT00553150|69255971|FG003|Overall Study|Protocol Violation|1|||
37753077|NCT00553150|69255968|FG000|Overall Study|Ineligible|0|||
37753078|NCT00553150|69255969|FG001|Overall Study|Ineligible|0|||
37753079|NCT00553150|69255970|FG002|Overall Study|Ineligible|0|||
37753080|NCT00553150|69255971|FG003|Overall Study|Ineligible|1|||
37753081|NCT03301350|69255979|FG000|Overall Study|Withdrawal by Subject|4|||
37753082|NCT03301350|69255979|FG000|Overall Study|Adverse Event|1|||
37753083|NCT03301350|69255979|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
37753084|NCT03301350|69255979|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
37662717|NCT02855125|69135411|FG000|Overall Study|Randomized but not treated|0|||
37662718|NCT02855125|69135412|FG001|Overall Study|Randomized but not treated|1|||
37662719|NCT02730871|69135435|FG000|Overall Study|Adverse Event|6|||
37662720|NCT02730871|69135436|FG001|Overall Study|Adverse Event|0|||
37662721|NCT03376789|69135444|FG000|Overall Study|Withdrawal by Subject|3|||
37662722|NCT03376789|69135445|FG001|Overall Study|Withdrawal by Subject|5|||
37662723|NCT03376789|69135444|FG000|Overall Study|Protocol Violation|0|||
37753085|NCT03301350|69255979|FG000|Overall Study|no detail provided|1|||
37753086|NCT04735432|69255986|FG000|Overall Study|Other - due to personal reason|1|||
37753087|NCT04735432|69255987|FG001|Overall Study|Other - due to personal reason|0|||
37753088|NCT04735432|69255986|FG000|Overall Study|Adverse Event|2|||
37753089|NCT04735432|69255987|FG001|Overall Study|Adverse Event|0|||
37753090|NCT02722278|69255996|FG000|Overall Study|Withdrawal by Subject|5|||
37753091|NCT02722278|69255997|FG001|Overall Study|Withdrawal by Subject|3|||
37753092|NCT02722278|69255996|FG000|Overall Study|Adverse Event|4|||
37753093|NCT02722278|69255997|FG001|Overall Study|Adverse Event|1|||
37753094|NCT02722278|69255996|FG000|Overall Study|Lost to Follow-up|2|||
37753095|NCT02722278|69255997|FG001|Overall Study|Lost to Follow-up|0|||
37753096|NCT02722278|69255996|FG000|Overall Study|Protocol Violation|1|||
37753097|NCT02722278|69255997|FG001|Overall Study|Protocol Violation|0|||
37753098|NCT02722278|69255996|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
37753099|NCT02722278|69255997|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
37753100|NCT02722278|69255996|FG000|Overall Study|Subject declined after tx assignment|0|||
37753101|NCT02722278|69255997|FG001|Overall Study|Subject declined after tx assignment|1|||
37753102|NCT02722278|69255996|FG000|Overall Study|Site closure not study related|0|||
37753103|NCT02722278|69255997|FG001|Overall Study|Site closure not study related|1|||
37753104|NCT00703092|69256005|FG000|Overall Study|Withdrawal by Subject|2|||
37753105|NCT02720484|69256009|FG000|Treatment on Study|Adverse Event|1|||
37662724|NCT03376789|69135445|FG001|Overall Study|Protocol Violation|1|||
37753106|NCT02720484|69256009|FG000|Treatment on Study|Withdrawal by Subject|1|||
37753107|NCT02720484|69256009|FG000|Treatment on Study|Progressive Disease|4|||
37753108|NCT02720484|69256009|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
37753109|NCT02720484|69256009|FG000|Follow Up for 2 Years|Death|3|||
37753110|NCT02720484|69256009|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
37753111|NCT02715804|69256015|FG000|Overall Study|Death|222|||
37753112|NCT02715804|69256016|FG001|Overall Study|Death|106|||
37753113|NCT02715804|69256015|FG000|Overall Study|Withdrawal by Subject|5|||
37857347|NCT01307111|69540642|FG000|IUD Insertion|Lost to Follow-up|2|||
37857348|NCT01307111|69540643|FG001|IUD Insertion|Lost to Follow-up|0|||
37857349|NCT01307111|69540642|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
37857350|NCT01307111|69540643|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
37857351|NCT01306877|69540651|FG000|Overall Study|Lost to Follow-up|3|||
37857352|NCT01306877|69540652|FG001|Overall Study|Lost to Follow-up|3|||
37662725|NCT03376789|69135444|FG000|Overall Study|Adverse Event|0|||
37662726|NCT03376789|69135445|FG001|Overall Study|Adverse Event|1|||
37662727|NCT03376789|69135444|FG000|Overall Study|Lost to Follow-up|1|||
37753114|NCT02715804|69256016|FG001|Overall Study|Withdrawal by Subject|4|||
37753115|NCT02715804|69256015|FG000|Overall Study|Other than specified|2|||
37753116|NCT02715804|69256016|FG001|Overall Study|Other than specified|3|||
37753117|NCT02717832|69256022|FG000|Overall Study|Inability to place IV|3|||
37753118|NCT02717754|69256033|FG000|Overall Study|Incorrect Infusion Duration|0|||
37857353|NCT01306877|69540651|FG000|Overall Study|Physician Decision|0|||
37662728|NCT03376789|69135445|FG001|Overall Study|Lost to Follow-up|1|||
37662729|NCT03376789|69135444|FG000|Overall Study|Per sponsor due to noncompliance|1|||
37753119|NCT02717754|69256034|FG001|Overall Study|Incorrect Infusion Duration|0|||
37753120|NCT02717754|69256035|FG002|Overall Study|Incorrect Infusion Duration|0|||
37753121|NCT02717754|69256036|FG003|Overall Study|Incorrect Infusion Duration|10|||
37753122|NCT02717754|69256037|FG004|Overall Study|Incorrect Infusion Duration|20|||
37753123|NCT02717754|69256038|FG005|Overall Study|Incorrect Infusion Duration|20|||
37753124|NCT02717130|69256048|FG000|Overall Study|Withdrawal by Subject|1|||
37753125|NCT02717130|69256048|FG000|Overall Study|Adverse Event|1|||
37753126|NCT02717130|69256048|FG000|Overall Study|Physician Decision|1|||
37753127|NCT02717130|69256048|FG000|Overall Study|Study Closure|4|||
37753128|NCT02192502|69256068|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
37753129|NCT02192502|69256069|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
37753130|NCT02192502|69256068|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
37753131|NCT02192502|69256069|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
37753132|NCT02192502|69256068|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
37753133|NCT02192502|69256069|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
37753134|NCT01781429|69256090|FG000|Overall Study|Death|0|||
37753135|NCT01781429|69256091|FG001|Overall Study|Death|0|||
37753136|NCT01781429|69256092|FG002|Overall Study|Death|0|||
37753137|NCT01781429|69256093|FG003|Overall Study|Death|0|||
37662730|NCT03376789|69135445|FG001|Overall Study|Per sponsor due to noncompliance|0|||
37662731|NCT03376789|69135444|FG000|Overall Study|Subject off study medication|0|||
37662732|NCT03376789|69135445|FG001|Overall Study|Subject off study medication|1|||
37662733|NCT04032093|69135461|FG000|Overall Study|Lost to Follow-up|7|||
37662734|NCT04032093|69135462|FG001|Overall Study|Lost to Follow-up|7|||
37662735|NCT04032093|69135463|FG002|Overall Study|Lost to Follow-up|6|||
37753138|NCT01781429|69256094|FG004|Overall Study|Death|0|||
37753139|NCT01781429|69256095|FG005|Overall Study|Death|0|||
37753140|NCT01781429|69256096|FG006|Overall Study|Death|0|||
37753141|NCT01781429|69256097|FG007|Overall Study|Death|0|||
37753142|NCT01781429|69256098|FG008|Overall Study|Death|0|||
37753143|NCT01781429|69256099|FG009|Overall Study|Death|1|||
37753144|NCT01781429|69256100|FG010|Overall Study|Death|0|||
37753145|NCT01781429|69256101|FG011|Overall Study|Death|0|||
37662736|NCT04032093|69135464|FG003|Overall Study|Lost to Follow-up|10|||
37662737|NCT04032093|69135465|FG004|Overall Study|Lost to Follow-up|13|||
37662738|NCT04032093|69135466|FG005|Overall Study|Lost to Follow-up|7|||
37662739|NCT04032093|69135467|FG006|Overall Study|Lost to Follow-up|7|||
37662740|NCT04032093|69135468|FG007|Overall Study|Lost to Follow-up|5|||
37662741|NCT04032093|69135469|FG008|Overall Study|Lost to Follow-up|9|||
37662742|NCT04032093|69135470|FG009|Overall Study|Lost to Follow-up|12|||
37662743|NCT04032093|69135461|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
37662744|NCT04032093|69135462|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
37662745|NCT04032093|69135463|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
37662746|NCT04032093|69135464|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
37662747|NCT04032093|69135465|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
37753146|NCT01781429|69256102|FG012|Overall Study|Death|1|||
37753147|NCT01781429|69256103|FG013|Overall Study|Death|0|||
37753148|NCT01781429|69256104|FG014|Overall Study|Death|1|||
37753149|NCT01781429|69256105|FG015|Overall Study|Death|0|||
37662748|NCT04032093|69135466|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
37662749|NCT04032093|69135467|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
37662750|NCT04032093|69135468|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
37662751|NCT04032093|69135469|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
37662752|NCT04032093|69135470|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
37662753|NCT04032093|69135461|FG000|Overall Study|Other|1|||
37662754|NCT04032093|69135462|FG001|Overall Study|Other|0|||
37662755|NCT04032093|69135463|FG002|Overall Study|Other|0|||
37662756|NCT04032093|69135464|FG003|Overall Study|Other|1|||
37662757|NCT04032093|69135465|FG004|Overall Study|Other|1|||
37662758|NCT04032093|69135466|FG005|Overall Study|Other|0|||
37753150|NCT01781429|69256090|FG000|Overall Study|Withdrawal by Subject|0|||
37753151|NCT01781429|69256091|FG001|Overall Study|Withdrawal by Subject|0|||
37753152|NCT01781429|69256092|FG002|Overall Study|Withdrawal by Subject|0|||
37753153|NCT01781429|69256093|FG003|Overall Study|Withdrawal by Subject|0|||
37753154|NCT01781429|69256094|FG004|Overall Study|Withdrawal by Subject|0|||
37753155|NCT01781429|69256095|FG005|Overall Study|Withdrawal by Subject|0|||
37753156|NCT01781429|69256096|FG006|Overall Study|Withdrawal by Subject|0|||
37753157|NCT01781429|69256097|FG007|Overall Study|Withdrawal by Subject|0|||
37753158|NCT01781429|69256098|FG008|Overall Study|Withdrawal by Subject|1|||
37753159|NCT01781429|69256099|FG009|Overall Study|Withdrawal by Subject|3|||
37753160|NCT01781429|69256100|FG010|Overall Study|Withdrawal by Subject|1|||
37753161|NCT01781429|69256101|FG011|Overall Study|Withdrawal by Subject|1|||
37662759|NCT04032093|69135467|FG006|Overall Study|Other|0|||
37662760|NCT04032093|69135468|FG007|Overall Study|Other|0|||
37662761|NCT04032093|69135469|FG008|Overall Study|Other|0|||
37662762|NCT04032093|69135470|FG009|Overall Study|Other|1|||
37662763|NCT04032093|69135461|FG000|Overall Study|Withdrawal by Subject|1|||
37753162|NCT01781429|69256102|FG012|Overall Study|Withdrawal by Subject|5|||
37753163|NCT01781429|69256103|FG013|Overall Study|Withdrawal by Subject|2|||
37753164|NCT01781429|69256104|FG014|Overall Study|Withdrawal by Subject|3|||
37662764|NCT04032093|69135462|FG001|Overall Study|Withdrawal by Subject|3|||
37662765|NCT04032093|69135463|FG002|Overall Study|Withdrawal by Subject|2|||
37662766|NCT04032093|69135464|FG003|Overall Study|Withdrawal by Subject|2|||
37662767|NCT04032093|69135465|FG004|Overall Study|Withdrawal by Subject|3|||
37662768|NCT04032093|69135466|FG005|Overall Study|Withdrawal by Subject|0|||
37662769|NCT04032093|69135467|FG006|Overall Study|Withdrawal by Subject|0|||
37662770|NCT04032093|69135468|FG007|Overall Study|Withdrawal by Subject|0|||
37662771|NCT04032093|69135469|FG008|Overall Study|Withdrawal by Subject|0|||
37662772|NCT04032093|69135470|FG009|Overall Study|Withdrawal by Subject|0|||
37662773|NCT04032093|69135461|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
37753165|NCT01781429|69256105|FG015|Overall Study|Withdrawal by Subject|0|||
37753166|NCT01781429|69256090|FG000|Overall Study|Disease Progression|1|||
37753167|NCT01781429|69256091|FG001|Overall Study|Disease Progression|0|||
37753168|NCT01781429|69256092|FG002|Overall Study|Disease Progression|1|||
37753169|NCT01781429|69256093|FG003|Overall Study|Disease Progression|1|||
37753170|NCT01781429|69256094|FG004|Overall Study|Disease Progression|1|||
37753171|NCT01781429|69256095|FG005|Overall Study|Disease Progression|4|||
37753172|NCT01781429|69256096|FG006|Overall Study|Disease Progression|7|||
37753173|NCT01781429|69256097|FG007|Overall Study|Disease Progression|4|||
37753174|NCT01781429|69256098|FG008|Overall Study|Disease Progression|6|||
37753175|NCT01781429|69256099|FG009|Overall Study|Disease Progression|15|||
37753176|NCT01781429|69256100|FG010|Overall Study|Disease Progression|15|||
37753177|NCT01781429|69256101|FG011|Overall Study|Disease Progression|15|||
37753178|NCT01781429|69256102|FG012|Overall Study|Disease Progression|15|||
37753179|NCT01781429|69256103|FG013|Overall Study|Disease Progression|4|||
37753180|NCT01781429|69256104|FG014|Overall Study|Disease Progression|11|||
37753181|NCT01781429|69256105|FG015|Overall Study|Disease Progression|0|||
37857354|NCT01306877|69540652|FG001|Overall Study|Physician Decision|1|||
37662774|NCT04032093|69135462|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
37662775|NCT04032093|69135463|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
37662776|NCT04032093|69135464|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
37662777|NCT04032093|69135465|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
37662778|NCT04032093|69135466|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
37662779|NCT04032093|69135467|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
37662780|NCT04032093|69135468|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
37662781|NCT04032093|69135469|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
37662782|NCT04032093|69135470|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
37662783|NCT04032093|69135461|FG000|Overall Study|Adverse Event|0|||
37662784|NCT04032093|69135462|FG001|Overall Study|Adverse Event|0|||
37662785|NCT04032093|69135463|FG002|Overall Study|Adverse Event|0|||
37662786|NCT04032093|69135464|FG003|Overall Study|Adverse Event|0|||
37662787|NCT04032093|69135465|FG004|Overall Study|Adverse Event|0|||
37662788|NCT04032093|69135466|FG005|Overall Study|Adverse Event|0|||
37662789|NCT04032093|69135467|FG006|Overall Study|Adverse Event|0|||
37662790|NCT04032093|69135468|FG007|Overall Study|Adverse Event|0|||
37662791|NCT04032093|69135469|FG008|Overall Study|Adverse Event|0|||
37662792|NCT04032093|69135470|FG009|Overall Study|Adverse Event|1|||
37662793|NCT04032093|69135461|FG000|Overall Study|Physician Decision|0|||
37662794|NCT04032093|69135462|FG001|Overall Study|Physician Decision|0|||
37662795|NCT04032093|69135463|FG002|Overall Study|Physician Decision|0|||
37662796|NCT04032093|69135464|FG003|Overall Study|Physician Decision|0|||
37662797|NCT04032093|69135465|FG004|Overall Study|Physician Decision|0|||
37662798|NCT04032093|69135466|FG005|Overall Study|Physician Decision|1|||
37662799|NCT04032093|69135467|FG006|Overall Study|Physician Decision|0|||
37662800|NCT04032093|69135468|FG007|Overall Study|Physician Decision|0|||
37662801|NCT04032093|69135469|FG008|Overall Study|Physician Decision|0|||
37662802|NCT04032093|69135470|FG009|Overall Study|Physician Decision|0|||
37662803|NCT01675167|69135494|FG000|Open-label Titration Phase|Adverse Event|81|||
37662804|NCT01675167|69135495|FG001|Open-label Titration Phase|Adverse Event|0|||
37662805|NCT01675167|69135496|FG002|Open-label Titration Phase|Adverse Event|0|||
37753182|NCT01781429|69256090|FG000|Overall Study|Unacceptable Toxicity|0|||
37753183|NCT01781429|69256091|FG001|Overall Study|Unacceptable Toxicity|0|||
37857355|NCT01191801|69540660|FG000|Overall Study|Death|36|||
37753184|NCT01781429|69256092|FG002|Overall Study|Unacceptable Toxicity|0|||
37753185|NCT01781429|69256093|FG003|Overall Study|Unacceptable Toxicity|0|||
37857356|NCT01191801|69540661|FG001|Overall Study|Death|12|||
37857357|NCT01191801|69540660|FG000|Overall Study|Lack of Efficacy|176|||
37662806|NCT01675167|69135494|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
37662807|NCT01675167|69135495|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
37662808|NCT01675167|69135496|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
37662809|NCT01675167|69135494|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
37662810|NCT01675167|69135495|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
37662811|NCT01675167|69135496|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
37662812|NCT01675167|69135494|FG000|Open-label Titration Phase|Protocol Violation|43|||
37753186|NCT01781429|69256094|FG004|Overall Study|Unacceptable Toxicity|0|||
37753187|NCT01781429|69256095|FG005|Overall Study|Unacceptable Toxicity|0|||
37857358|NCT01191801|69540661|FG001|Overall Study|Lack of Efficacy|258|||
37662813|NCT01675167|69135495|FG001|Open-label Titration Phase|Protocol Violation|0|||
37662814|NCT01675167|69135496|FG002|Open-label Titration Phase|Protocol Violation|0|||
37662815|NCT01675167|69135494|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
37662816|NCT01675167|69135495|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
37662817|NCT01675167|69135496|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
37662818|NCT01675167|69135494|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
37662819|NCT01675167|69135495|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
37662820|NCT01675167|69135496|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
37662821|NCT01675167|69135494|FG000|Open-label Titration Phase|Other|55|||
37662822|NCT01675167|69135495|FG001|Open-label Titration Phase|Other|0|||
37662823|NCT01675167|69135496|FG002|Open-label Titration Phase|Other|0|||
37662824|NCT01675167|69135494|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
37662825|NCT01675167|69135495|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
37753188|NCT01781429|69256096|FG006|Overall Study|Unacceptable Toxicity|0|||
37753189|NCT01781429|69256097|FG007|Overall Study|Unacceptable Toxicity|0|||
37753190|NCT01781429|69256098|FG008|Overall Study|Unacceptable Toxicity|0|||
38033260|NCT04493684|69719199|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
37662826|NCT01675167|69135496|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
37662827|NCT01675167|69135494|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
37662828|NCT01675167|69135495|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
37857359|NCT01191801|69540660|FG000|Overall Study|Adverse Event|9|||
37857360|NCT01191801|69540661|FG001|Overall Study|Adverse Event|8|||
37857361|NCT01191801|69540660|FG000|Overall Study|Protocol Violation|2|||
37857362|NCT01191801|69540661|FG001|Overall Study|Protocol Violation|4|||
37857363|NCT01191801|69540660|FG000|Overall Study|Physician Decision|47|||
37857364|NCT01191801|69540661|FG001|Overall Study|Physician Decision|24|||
37857365|NCT01191801|69540660|FG000|Overall Study|Withdrawal by Subject|1|||
37857366|NCT01191801|69540661|FG001|Overall Study|Withdrawal by Subject|4|||
37857367|NCT01191801|69540660|FG000|Overall Study|Not Provided|45|||
37857368|NCT01191801|69540661|FG001|Overall Study|Not Provided|27|||
37857369|NCT01306643|69540667|FG000|Overall Study|Adverse Event|5|||
37857370|NCT01306643|69540667|FG000|Overall Study|Disease Progression|7|||
37857371|NCT01306643|69540667|FG000|Overall Study|Other: Change in Eligibility Status|1|||
37857372|NCT01306331|69540673|FG000|Overall Study|Adverse Event|28|||
37857373|NCT01306331|69540674|FG001|Overall Study|Adverse Event|25|||
37857374|NCT01306331|69540673|FG000|Overall Study|Lost to Follow-up|321|||
37857375|NCT01306331|69540674|FG001|Overall Study|Lost to Follow-up|323|||
37857376|NCT01306331|69540673|FG000|Overall Study|Physician Decision|26|||
37857377|NCT01306331|69540674|FG001|Overall Study|Physician Decision|22|||
37857378|NCT01306331|69540673|FG000|Overall Study|Pregnancy|136|||
37857379|NCT01306331|69540674|FG001|Overall Study|Pregnancy|151|||
37857380|NCT01306331|69540673|FG000|Overall Study|Protocol Violation|154|||
37857381|NCT01306331|69540674|FG001|Overall Study|Protocol Violation|124|||
37857382|NCT01306331|69540673|FG000|Overall Study|Withdrawal by Subject|163|||
37857383|NCT01306331|69540674|FG001|Overall Study|Withdrawal by Subject|152|||
37857384|NCT01306331|69540673|FG000|Overall Study|Not sexually active|29|||
37857385|NCT01306331|69540674|FG001|Overall Study|Not sexually active|28|||
37857386|NCT01306331|69540673|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
37857387|NCT01306331|69540674|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
37857388|NCT01306331|69540673|FG000|Overall Study|Other|34|||
37857389|NCT01306331|69540674|FG001|Overall Study|Other|32|||
37857390|NCT01306253|69540682|FG000|Overall Study|Lost to Follow-up|1|||
37857391|NCT01306253|69540683|FG001|Overall Study|Lost to Follow-up|1|||
37857392|NCT01305941|69540689|FG000|Overall Study|Adverse Event|6|||
37857393|NCT01305941|69540689|FG000|Overall Study|Clinical decline|2|||
37857394|NCT01305941|69540689|FG000|Overall Study|Withdrawal by Subject|1|||
37857395|NCT01305941|69540689|FG000|Overall Study|Death|1|||
37857396|NCT01305239|69540693|FG000|Overall Study|Adverse Event|22|||
37857397|NCT01305239|69540693|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
37857398|NCT01194219|69540699|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
37857399|NCT01194219|69540700|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
37857400|NCT01194219|69540701|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
37857401|NCT01194219|69540702|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
37857402|NCT01194219|69540703|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
37857403|NCT01194219|69540704|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
37857404|NCT01194219|69540705|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
37857405|NCT01194219|69540706|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
37857406|NCT01194219|69540707|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
37857407|NCT01194219|69540708|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
37662829|NCT01675167|69135496|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
37662830|NCT01675167|69135494|FG000|Double-blind Treatment Phase|Adverse Event|0|||
37857408|NCT01194219|69540699|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
37857409|NCT01194219|69540700|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
37857410|NCT01194219|69540701|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
37662831|NCT01675167|69135495|FG001|Double-blind Treatment Phase|Adverse Event|5|||
37662832|NCT01675167|69135496|FG002|Double-blind Treatment Phase|Adverse Event|13|||
37662833|NCT01675167|69135494|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
37662834|NCT01675167|69135495|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
37662835|NCT01675167|69135496|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
37662836|NCT01675167|69135494|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
37662837|NCT01675167|69135495|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
37662838|NCT01675167|69135496|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
37662839|NCT01675167|69135494|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
37662840|NCT01675167|69135495|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
37662841|NCT01675167|69135496|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
37662842|NCT01675167|69135494|FG000|Double-blind Treatment Phase|Other|0|||
37662843|NCT01675167|69135495|FG001|Double-blind Treatment Phase|Other|7|||
37662844|NCT01675167|69135496|FG002|Double-blind Treatment Phase|Other|5|||
37662845|NCT01675011|69135506|FG000|Overall Study|Trial terminated by Sponsor|3|||
37662846|NCT01675011|69135507|FG001|Overall Study|Trial terminated by Sponsor|1|||
37662847|NCT04109547|69135535|FG000|Overall Study|Withdrawal by Subject|3|||
37662848|NCT04109547|69135536|FG001|Overall Study|Withdrawal by Subject|2|||
37662849|NCT04109547|69135537|FG002|Overall Study|Withdrawal by Subject|6|||
37662850|NCT04109547|69135538|FG003|Overall Study|Withdrawal by Subject|6|||
37662851|NCT04109547|69135535|FG000|Overall Study|Lost to Follow-up|0|||
37662852|NCT04109547|69135536|FG001|Overall Study|Lost to Follow-up|0|||
37662853|NCT04109547|69135537|FG002|Overall Study|Lost to Follow-up|0|||
37753191|NCT01781429|69256099|FG009|Overall Study|Unacceptable Toxicity|0|||
37753192|NCT01781429|69256100|FG010|Overall Study|Unacceptable Toxicity|0|||
37753193|NCT01781429|69256101|FG011|Overall Study|Unacceptable Toxicity|2|||
37753194|NCT01781429|69256102|FG012|Overall Study|Unacceptable Toxicity|0|||
37753195|NCT01781429|69256103|FG013|Overall Study|Unacceptable Toxicity|0|||
37753196|NCT01781429|69256104|FG014|Overall Study|Unacceptable Toxicity|0|||
37753197|NCT01781429|69256105|FG015|Overall Study|Unacceptable Toxicity|0|||
37753198|NCT01781429|69256090|FG000|Overall Study|Patient Condition Changed|0|||
37753199|NCT01781429|69256091|FG001|Overall Study|Patient Condition Changed|0|||
37753200|NCT01781429|69256092|FG002|Overall Study|Patient Condition Changed|0|||
37753201|NCT01781429|69256093|FG003|Overall Study|Patient Condition Changed|0|||
37753202|NCT01781429|69256094|FG004|Overall Study|Patient Condition Changed|0|||
37753203|NCT01781429|69256095|FG005|Overall Study|Patient Condition Changed|0|||
37753204|NCT01781429|69256096|FG006|Overall Study|Patient Condition Changed|0|||
37753205|NCT01781429|69256097|FG007|Overall Study|Patient Condition Changed|0|||
37753206|NCT01781429|69256098|FG008|Overall Study|Patient Condition Changed|0|||
37753207|NCT01781429|69256099|FG009|Overall Study|Patient Condition Changed|4|||
37753208|NCT01781429|69256100|FG010|Overall Study|Patient Condition Changed|0|||
37662854|NCT04109547|69135538|FG003|Overall Study|Lost to Follow-up|1|||
37662855|NCT04109547|69135535|FG000|Overall Study|Physician Decision|1|||
37662856|NCT04109547|69135536|FG001|Overall Study|Physician Decision|2|||
37662857|NCT04109547|69135537|FG002|Overall Study|Physician Decision|0|||
37753209|NCT01781429|69256101|FG011|Overall Study|Patient Condition Changed|1|||
37753210|NCT01781429|69256102|FG012|Overall Study|Patient Condition Changed|0|||
37753211|NCT01781429|69256103|FG013|Overall Study|Patient Condition Changed|1|||
37753212|NCT01781429|69256104|FG014|Overall Study|Patient Condition Changed|0|||
37753213|NCT01781429|69256105|FG015|Overall Study|Patient Condition Changed|0|||
37753214|NCT01781429|69256090|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
37753215|NCT01781429|69256091|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
37753216|NCT01781429|69256092|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
37857411|NCT01194219|69540702|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
37857412|NCT01194219|69540703|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
37857413|NCT01194219|69540704|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
37857414|NCT01194219|69540705|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
37857415|NCT01194219|69540706|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
37857416|NCT01194219|69540707|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
37857417|NCT01194219|69540708|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
37857418|NCT01194219|69540699|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
37857419|NCT01194219|69540700|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
37857420|NCT01194219|69540701|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
37857421|NCT01194219|69540702|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
37857422|NCT01194219|69540703|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
37857423|NCT01194219|69540704|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
37662858|NCT04109547|69135538|FG003|Overall Study|Physician Decision|0|||
37662859|NCT02649231|69135561|FG000|Overall Study|Adverse Event|0|||
37662860|NCT02649231|69135562|FG001|Overall Study|Adverse Event|0|||
37662861|NCT02649231|69135563|FG002|Overall Study|Adverse Event|0|||
37662862|NCT02649231|69135564|FG003|Overall Study|Adverse Event|1|||
37662863|NCT02649231|69135561|FG000|Overall Study|Lost to Follow-up|2|||
37662864|NCT02649231|69135562|FG001|Overall Study|Lost to Follow-up|1|||
37662865|NCT02649231|69135563|FG002|Overall Study|Lost to Follow-up|1|||
37662866|NCT02649231|69135564|FG003|Overall Study|Lost to Follow-up|0|||
37662867|NCT02649231|69135561|FG000|Overall Study|Withdrawal by Subject|0|||
37662868|NCT02649231|69135562|FG001|Overall Study|Withdrawal by Subject|1|||
37662869|NCT02649231|69135563|FG002|Overall Study|Withdrawal by Subject|0|||
37662870|NCT02649231|69135564|FG003|Overall Study|Withdrawal by Subject|1|||
37662871|NCT02649231|69135561|FG000|Overall Study|Protocol Violation|2|||
37662872|NCT02649231|69135562|FG001|Overall Study|Protocol Violation|1|||
37662873|NCT02649231|69135563|FG002|Overall Study|Protocol Violation|1|||
37662874|NCT02649231|69135564|FG003|Overall Study|Protocol Violation|0|||
37662875|NCT01376245|69135578|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
37662876|NCT01376245|69135579|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
37662877|NCT01376245|69135580|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
37662878|NCT01376245|69135581|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
37662879|NCT01376245|69135582|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
37662880|NCT01376245|69135578|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
37662881|NCT01376245|69135579|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
37662882|NCT01376245|69135580|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
37662883|NCT01376245|69135581|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
37662884|NCT01376245|69135582|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
37662885|NCT01376245|69135578|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
37662886|NCT01376245|69135579|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
37662887|NCT01376245|69135580|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
37662888|NCT01376245|69135581|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
37662889|NCT01376245|69135582|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
37662890|NCT01376245|69135578|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
37662891|NCT01376245|69135579|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
37662892|NCT01376245|69135580|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
37662893|NCT01376245|69135581|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
37662894|NCT01376245|69135582|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
37662895|NCT01376245|69135578|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
37662896|NCT01376245|69135579|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
37662897|NCT01376245|69135580|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
37662898|NCT01376245|69135581|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
37662899|NCT01376245|69135582|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
37662900|NCT01376245|69135578|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
37662901|NCT01376245|69135579|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
37662902|NCT01376245|69135580|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
37662903|NCT01376245|69135581|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
37662904|NCT01376245|69135582|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
37662905|NCT01376245|69135578|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
37662906|NCT01376245|69135579|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
37662907|NCT01376245|69135580|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
37662908|NCT01376245|69135581|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
37662909|NCT01376245|69135582|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
37662910|NCT01376245|69135578|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
37662911|NCT01376245|69135579|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
37662912|NCT01376245|69135580|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
37662913|NCT01376245|69135581|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
37662914|NCT01376245|69135582|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
37662915|NCT01376245|69135578|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
37662916|NCT01376245|69135579|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
37662917|NCT01376245|69135580|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
37662918|NCT01376245|69135581|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
37662919|NCT01376245|69135582|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
37662920|NCT01376245|69135578|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
37662921|NCT01376245|69135579|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
37662922|NCT01376245|69135580|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
37662923|NCT01376245|69135581|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
37662924|NCT01376245|69135582|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
37662925|NCT01376245|69135578|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
37662926|NCT01376245|69135579|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
37662927|NCT01376245|69135580|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
37857424|NCT01194219|69540705|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
37662928|NCT01376245|69135581|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
37662929|NCT01376245|69135582|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
37753217|NCT01781429|69256093|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
37753218|NCT01781429|69256094|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
37753219|NCT01781429|69256095|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
37753220|NCT01781429|69256096|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
37753221|NCT01781429|69256097|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
37753222|NCT01781429|69256098|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
37753223|NCT01781429|69256099|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
37753224|NCT01781429|69256100|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
37753225|NCT01781429|69256101|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
37753226|NCT01781429|69256102|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
37753227|NCT01781429|69256103|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
37753228|NCT01781429|69256104|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
37753229|NCT01781429|69256105|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
37753230|NCT01781429|69256090|FG000|Overall Study|Enrolled, but not treated|0|||
37753231|NCT01781429|69256091|FG001|Overall Study|Enrolled, but not treated|0|||
37753232|NCT01781429|69256092|FG002|Overall Study|Enrolled, but not treated|0|||
37753233|NCT01781429|69256093|FG003|Overall Study|Enrolled, but not treated|0|||
37753234|NCT01781429|69256094|FG004|Overall Study|Enrolled, but not treated|0|||
37753235|NCT01781429|69256095|FG005|Overall Study|Enrolled, but not treated|0|||
37753236|NCT01781429|69256096|FG006|Overall Study|Enrolled, but not treated|0|||
37753237|NCT01781429|69256097|FG007|Overall Study|Enrolled, but not treated|0|||
37753238|NCT01781429|69256098|FG008|Overall Study|Enrolled, but not treated|0|||
37753239|NCT01781429|69256099|FG009|Overall Study|Enrolled, but not treated|0|||
37753240|NCT01781429|69256100|FG010|Overall Study|Enrolled, but not treated|1|||
37753241|NCT01781429|69256101|FG011|Overall Study|Enrolled, but not treated|0|||
37753242|NCT01781429|69256102|FG012|Overall Study|Enrolled, but not treated|0|||
37753243|NCT01781429|69256103|FG013|Overall Study|Enrolled, but not treated|0|||
37753244|NCT01781429|69256104|FG014|Overall Study|Enrolled, but not treated|0|||
37753245|NCT01781429|69256105|FG015|Overall Study|Enrolled, but not treated|0|||
37753246|NCT01773473|69256140|FG000|Overall Study|Adverse Event|3|||
37753247|NCT01773473|69256141|FG001|Overall Study|Adverse Event|2|||
37753248|NCT01773473|69256140|FG000|Overall Study|Protocol Violation|0|||
37753249|NCT01773473|69256141|FG001|Overall Study|Protocol Violation|4|||
37753250|NCT01773473|69256140|FG000|Overall Study|Physician Decision|3|||
37753251|NCT01773473|69256141|FG001|Overall Study|Physician Decision|5|||
37753252|NCT01773473|69256140|FG000|Overall Study|Sponsor Decision|2|||
37753253|NCT01773473|69256141|FG001|Overall Study|Sponsor Decision|0|||
37753254|NCT01773473|69256140|FG000|Overall Study|Lack of Efficacy|0|||
37753255|NCT01773473|69256141|FG001|Overall Study|Lack of Efficacy|1|||
37753256|NCT01773473|69256140|FG000|Overall Study|Non-Compliance with study drug|1|||
37753257|NCT01773473|69256141|FG001|Overall Study|Non-Compliance with study drug|4|||
37753258|NCT01773473|69256140|FG000|Overall Study|Withdrawal by Subject|5|||
37753259|NCT01773473|69256141|FG001|Overall Study|Withdrawal by Subject|3|||
37753260|NCT01773473|69256140|FG000|Overall Study|Lost to Follow-up|2|||
37753261|NCT01773473|69256141|FG001|Overall Study|Lost to Follow-up|0|||
37753262|NCT01772693|69256149|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
37753263|NCT01772693|69256150|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
37753264|NCT01772693|69256149|FG000|Overall Study|Withdrawal by Subject|2|||
37753265|NCT01772693|69256150|FG001|Overall Study|Withdrawal by Subject|0|||
37753266|NCT01772693|69256149|FG000|Overall Study|Alternative Treatment|2|||
37753267|NCT01772693|69256150|FG001|Overall Study|Alternative Treatment|0|||
37753268|NCT01779869|69256156|FG000|Overall Study|Physician Decision|2|||
37857425|NCT01194219|69540706|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
37662930|NCT01376245|69135578|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
37662931|NCT01376245|69135579|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
37662932|NCT01376245|69135580|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
37662933|NCT01376245|69135581|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
37662934|NCT01376245|69135582|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
37753269|NCT01772537|69256163|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
37753270|NCT01772537|69256164|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
37923314|NCT00856661|69610103|FG000|Overall Study|Physician Judgement|8|||
37753271|NCT01772537|69256165|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
37753272|NCT01772147|69256178|FG000|Overall Study|Adverse Event|13|||
37753273|NCT01772147|69256179|FG001|Overall Study|Adverse Event|10|||
37753274|NCT01772147|69256180|FG002|Overall Study|Adverse Event|6|||
37662935|NCT01674621|69135597|FG000|Overall Study|Adverse Event|3|||
37662936|NCT01674621|69135598|FG001|Overall Study|Adverse Event|2|||
37662937|NCT01674621|69135599|FG002|Overall Study|Adverse Event|5|||
37662938|NCT01674621|69135600|FG003|Overall Study|Adverse Event|5|||
37662939|NCT01674621|69135601|FG004|Overall Study|Adverse Event|1|||
37662940|NCT01674621|69135597|FG000|Overall Study|Inability to Complete Study Procedures|0|||
37753275|NCT01772147|69256178|FG000|Overall Study|Withdrew Consent|7|||
37662941|NCT01674621|69135598|FG001|Overall Study|Inability to Complete Study Procedures|0|||
37662942|NCT01674621|69135599|FG002|Overall Study|Inability to Complete Study Procedures|0|||
37662943|NCT01674621|69135600|FG003|Overall Study|Inability to Complete Study Procedures|0|||
37662944|NCT01674621|69135601|FG004|Overall Study|Inability to Complete Study Procedures|2|||
37662945|NCT01674621|69135597|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
37662946|NCT01674621|69135598|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
37662947|NCT01674621|69135599|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
37662948|NCT01674621|69135600|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
37662949|NCT01674621|69135601|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
37662950|NCT01674621|69135597|FG000|Overall Study|Withdrawal by Subject|2|||
37662951|NCT01674621|69135598|FG001|Overall Study|Withdrawal by Subject|5|||
37753276|NCT01772147|69256179|FG001|Overall Study|Withdrew Consent|8|||
37753277|NCT01772147|69256180|FG002|Overall Study|Withdrew Consent|4|||
37753278|NCT01772147|69256178|FG000|Overall Study|Lost to Follow-up|1|||
37753279|NCT01772147|69256179|FG001|Overall Study|Lost to Follow-up|0|||
37753280|NCT01772147|69256180|FG002|Overall Study|Lost to Follow-up|1|||
37753281|NCT01772147|69256178|FG000|Overall Study|Protocol Deviation|2|||
37753282|NCT01772147|69256179|FG001|Overall Study|Protocol Deviation|1|||
37753283|NCT01772147|69256180|FG002|Overall Study|Protocol Deviation|1|||
37753284|NCT01772147|69256178|FG000|Overall Study|Lack of Efficacy|8|||
37753285|NCT01772147|69256179|FG001|Overall Study|Lack of Efficacy|6|||
37753286|NCT01772147|69256180|FG002|Overall Study|Lack of Efficacy|6|||
37753287|NCT01771913|69256190|FG000|Overall Study|Withdrawal by Subject|1|||
37753288|NCT01771913|69256191|FG001|Overall Study|Withdrawal by Subject|0|||
37753289|NCT01606787|69256199|FG000|Overall Study|Withdrawal by Subject|4|||
37753290|NCT01606787|69256200|FG001|Overall Study|Withdrawal by Subject|5|||
37753291|NCT01606787|69256199|FG000|Overall Study|Surgery canceled|0|||
37753292|NCT01606787|69256200|FG001|Overall Study|Surgery canceled|2|||
37753293|NCT01778855|69256208|FG000|Overall Study|Death|0|||
37753294|NCT01778855|69256209|FG001|Overall Study|Death|1|||
37753295|NCT01777997|69256215|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
37753296|NCT01777997|69256215|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
37753297|NCT01777997|69256215|FG000|Weeks 48 to 72/96 on ART|Death|1|||
37753298|NCT01777997|69256215|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
37753299|NCT01770509|69256221|FG000|Overall Study|Injury|0|||
37753300|NCT01770509|69256222|FG001|Overall Study|Injury|1|||
37753301|NCT01770509|69256221|FG000|Overall Study|Lost to Follow-up|1|||
37753302|NCT01770509|69256222|FG001|Overall Study|Lost to Follow-up|2|||
37753303|NCT01770353|69256230|FG000|Overall Study|Progressive disease|2|||
37753304|NCT01770353|69256231|FG001|Overall Study|Progressive disease|1|||
37753305|NCT01770353|69256230|FG000|Overall Study|Adverse Event|0|||
37753306|NCT01770353|69256231|FG001|Overall Study|Adverse Event|1|||
37753307|NCT01770353|69256230|FG000|Overall Study|Protocol Violation|1|||
37753308|NCT01770353|69256231|FG001|Overall Study|Protocol Violation|0|||
37753309|NCT01770353|69256230|FG000|Overall Study|Physician Decision|0|||
37753310|NCT01770353|69256231|FG001|Overall Study|Physician Decision|3|||
37753311|NCT01770353|69256230|FG000|Overall Study|Clinical deterioration|3|||
37753312|NCT01770353|69256231|FG001|Overall Study|Clinical deterioration|6|||
37753313|NCT01770353|69256230|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
37753314|NCT01770353|69256231|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
37753315|NCT01777763|69256247|FG000|Overall Study|Adverse Event|2|||
37753316|NCT01777763|69256248|FG001|Overall Study|Adverse Event|32|||
37753317|NCT01777763|69256247|FG000|Overall Study|Protocol Violation|1|||
37753318|NCT01777763|69256248|FG001|Overall Study|Protocol Violation|7|||
37753319|NCT01777763|69256247|FG000|Overall Study|Withdrawal by Subject|0|||
37753320|NCT01777763|69256248|FG001|Overall Study|Withdrawal by Subject|2|||
37753321|NCT01777763|69256247|FG000|Overall Study|Treatment Failure|1|||
37753322|NCT01777763|69256248|FG001|Overall Study|Treatment Failure|6|||
37753323|NCT01769339|69256254|FG000|Overall Study|Lost to Follow-up|42|||
37753324|NCT01769339|69256254|FG000|Overall Study|Adverse Event|1|||
37857426|NCT01194219|69540707|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
37753325|NCT01769105|69256260|FG000|First Intervention|Protocol Violation|2|||
37753326|NCT01769105|69256261|FG001|First Intervention|Protocol Violation|2|||
37753327|NCT01769105|69256260|FG000|Cross-over|Lost to Follow-up|5|||
37753328|NCT01769105|69256261|FG001|Cross-over|Lost to Follow-up|0|||
37753329|NCT01777139|69256269|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
37753330|NCT01777139|69256270|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
37857427|NCT01194219|69540708|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
37753331|NCT01777139|69256269|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
37753332|NCT01777139|69256270|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
37753333|NCT01777139|69256269|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
37753334|NCT01777139|69256270|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
37753335|NCT01777139|69256269|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
37753336|NCT01777139|69256270|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
37662952|NCT01674621|69135599|FG002|Overall Study|Withdrawal by Subject|2|||
37753337|NCT01777139|69256269|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
37753338|NCT01777139|69256270|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
37753339|NCT01777139|69256269|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
37753340|NCT01777139|69256270|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
37753341|NCT01777139|69256269|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
37753342|NCT01777139|69256270|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
37753343|NCT01777139|69256269|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
37662953|NCT01674621|69135600|FG003|Overall Study|Withdrawal by Subject|0|||
37662954|NCT01674621|69135601|FG004|Overall Study|Withdrawal by Subject|1|||
37662955|NCT01674621|69135597|FG000|Overall Study|Other than specified|0|||
37662956|NCT01674621|69135598|FG001|Overall Study|Other than specified|1|||
37662957|NCT01674621|69135599|FG002|Overall Study|Other than specified|0|||
37662958|NCT01674621|69135600|FG003|Overall Study|Other than specified|0|||
37662959|NCT01674621|69135601|FG004|Overall Study|Other than specified|2|||
37753344|NCT01777139|69256270|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
37753345|NCT01768637|69256279|FG000|Overall Study|Lost to Follow-up|2|||
37662960|NCT02730169|69135618|FG000|Overall Study|Protocol Violation|1|||
37662961|NCT02730169|69135619|FG001|Overall Study|Protocol Violation|0|||
37753346|NCT01768637|69256280|FG001|Overall Study|Lost to Follow-up|7|||
37753347|NCT01768637|69256279|FG000|Overall Study|Difficult blood draw|1|||
37753348|NCT01768637|69256280|FG001|Overall Study|Difficult blood draw|0|||
37753349|NCT01768559|69256289|FG000|Overall Study|Randomized but not treated|0|||
37753350|NCT01768559|69256290|FG001|Overall Study|Randomized but not treated|0|||
37753351|NCT01768559|69256291|FG002|Overall Study|Randomized but not treated|1|||
37753352|NCT01768559|69256289|FG000|Overall Study|Adverse Event|15|||
37753353|NCT01768559|69256290|FG001|Overall Study|Adverse Event|2|||
37753354|NCT01768559|69256291|FG002|Overall Study|Adverse Event|5|||
37753355|NCT01768559|69256289|FG000|Overall Study|Lack of Efficacy|6|||
37753356|NCT01768559|69256290|FG001|Overall Study|Lack of Efficacy|4|||
37753357|NCT01768559|69256291|FG002|Overall Study|Lack of Efficacy|0|||
37753358|NCT01768559|69256289|FG000|Overall Study|Poor compliance to protocol|0|||
37753359|NCT01768559|69256290|FG001|Overall Study|Poor compliance to protocol|3|||
37753360|NCT01768559|69256291|FG002|Overall Study|Poor compliance to protocol|2|||
37753361|NCT01768559|69256289|FG000|Overall Study|Other than specified|9|||
37753362|NCT01768559|69256290|FG001|Overall Study|Other than specified|8|||
37753363|NCT01768559|69256291|FG002|Overall Study|Other than specified|5|||
37753364|NCT00983619|69256315|FG000|Overall Study|Lost to Follow-up|0|||
37753365|NCT00983619|69256316|FG001|Overall Study|Lost to Follow-up|1|||
37753366|NCT00983619|69256317|FG002|Overall Study|Lost to Follow-up|0|||
37753367|NCT00983619|69256318|FG003|Overall Study|Lost to Follow-up|0|||
37753368|NCT00983619|69256319|FG004|Overall Study|Lost to Follow-up|0|||
37753369|NCT00983619|69256320|FG005|Overall Study|Lost to Follow-up|2|||
37753370|NCT00983619|69256321|FG006|Overall Study|Lost to Follow-up|0|||
37857428|NCT01194219|69540699|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
37857429|NCT01194219|69540700|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
37857430|NCT01194219|69540701|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
37857431|NCT01194219|69540702|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
37857432|NCT01194219|69540703|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
37857433|NCT01194219|69540704|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
37857434|NCT01194219|69540705|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
37857435|NCT01194219|69540706|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
37857436|NCT01194219|69540707|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
37923315|NCT00856661|69610104|FG001|Overall Study|Physician Judgement|5|||
37662962|NCT02730169|69135620|FG002|Overall Study|Protocol Violation|0|||
37662963|NCT02730169|69135621|FG003|Overall Study|Protocol Violation|1|||
37662964|NCT02730169|69135618|FG000|Overall Study|Adverse Event|2|||
37662965|NCT02730169|69135619|FG001|Overall Study|Adverse Event|3|||
37662966|NCT02730169|69135620|FG002|Overall Study|Adverse Event|3|||
37662967|NCT02730169|69135621|FG003|Overall Study|Adverse Event|0|||
37662968|NCT02730169|69135618|FG000|Overall Study|Adverse Event of Special Interest|0|||
37923316|NCT00844376|69610110|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
37923317|NCT00844376|69610111|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
37662969|NCT02730169|69135619|FG001|Overall Study|Adverse Event of Special Interest|1|||
37662970|NCT02730169|69135620|FG002|Overall Study|Adverse Event of Special Interest|2|||
37662971|NCT02730169|69135621|FG003|Overall Study|Adverse Event of Special Interest|0|||
37662972|NCT02730169|69135618|FG000|Overall Study|Withdrawal by Subject|6|||
37753371|NCT00983619|69256322|FG007|Overall Study|Lost to Follow-up|0|||
37753372|NCT00983619|69256323|FG008|Overall Study|Lost to Follow-up|0|||
37753373|NCT00983619|69256324|FG009|Overall Study|Lost to Follow-up|0|||
37753374|NCT00983619|69256325|FG010|Overall Study|Lost to Follow-up|0|||
37753375|NCT00983619|69256326|FG011|Overall Study|Lost to Follow-up|2|||
37753376|NCT00983619|69256315|FG000|Overall Study|Withdrawal by Subject|2|||
37753377|NCT00983619|69256316|FG001|Overall Study|Withdrawal by Subject|1|||
37662973|NCT02730169|69135619|FG001|Overall Study|Withdrawal by Subject|11|||
37662974|NCT02730169|69135620|FG002|Overall Study|Withdrawal by Subject|6|||
37662975|NCT02730169|69135621|FG003|Overall Study|Withdrawal by Subject|8|||
37662976|NCT02730169|69135618|FG000|Overall Study|Lost to Follow-up|5|||
37662977|NCT02730169|69135619|FG001|Overall Study|Lost to Follow-up|6|||
37662978|NCT02730169|69135620|FG002|Overall Study|Lost to Follow-up|5|||
37662979|NCT02730169|69135621|FG003|Overall Study|Lost to Follow-up|6|||
37662980|NCT02730169|69135618|FG000|Overall Study|Other|0|||
37662981|NCT02730169|69135619|FG001|Overall Study|Other|0|||
37662982|NCT02730169|69135620|FG002|Overall Study|Other|1|||
37662983|NCT02730169|69135621|FG003|Overall Study|Other|1|||
37662984|NCT02648217|69135633|FG000|Overall Study|Adverse Event|0|||
37662985|NCT02648217|69135634|FG001|Overall Study|Adverse Event|1|||
37662986|NCT02648217|69135633|FG000|Overall Study|Lost to Follow-up|1|||
37662987|NCT02648217|69135634|FG001|Overall Study|Lost to Follow-up|1|||
37662988|NCT02648217|69135633|FG000|Overall Study|Withdrawal by Subject|4|||
37662989|NCT02648217|69135634|FG001|Overall Study|Withdrawal by Subject|3|||
37662990|NCT02648217|69135633|FG000|Overall Study|Unclassified|5|||
37662991|NCT02648217|69135634|FG001|Overall Study|Unclassified|0|||
37662992|NCT00709735|69135642|FG000|Overall Study|Lost to Follow-up|1|||
37662993|NCT00709735|69135643|FG001|Overall Study|Lost to Follow-up|1|||
37662994|NCT00709735|69135642|FG000|Overall Study|Relapse into Opioid Abuse|0|||
37662995|NCT00709735|69135643|FG001|Overall Study|Relapse into Opioid Abuse|1|||
37662996|NCT00709735|69135642|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
37662997|NCT00709735|69135643|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
37662998|NCT02647905|69135649|FG000|Overall Study|Lost to Follow-up|1|||
37662999|NCT02647905|69135649|FG000|Overall Study|Withdrawal by Subject|2|||
37663000|NCT04185909|69135662|FG000|Overall Study|Lost to Follow-up|1|||
37663001|NCT04076943|69135666|FG000|Overall Study|Withdrawal by Subject|12|||
37663002|NCT04076943|69135666|FG000|Overall Study|Adverse Event|1|||
37663003|NCT04076943|69135666|FG000|Overall Study|Progressive Disease|2|||
37663004|NCT04076943|69135666|FG000|Overall Study|Death|13|||
37663005|NCT04076943|69135666|FG000|Overall Study|Other than specified|6|||
37663006|NCT00708643|69135672|FG000|Overall Study|Adverse Event|0|||
37663007|NCT00708643|69135673|FG001|Overall Study|Adverse Event|1|||
37663008|NCT01285557|69135728|FG000|Overall Study|Death|173|||
37663009|NCT01285557|69135729|FG001|Overall Study|Death|90|||
37663010|NCT01285557|69135728|FG000|Overall Study|Lost to Follow-up|6|||
37663011|NCT01285557|69135729|FG001|Overall Study|Lost to Follow-up|2|||
37663012|NCT01285557|69135728|FG000|Overall Study|Withdrew Consent|6|||
37663013|NCT01285557|69135729|FG001|Overall Study|Withdrew Consent|1|||
37663014|NCT01285557|69135728|FG000|Overall Study|Sponsor Study Termination|23|||
37663015|NCT01285557|69135729|FG001|Overall Study|Sponsor Study Termination|13|||
37663016|NCT01285557|69135728|FG000|Overall Study|Randomized but not treated|1|||
37753378|NCT00983619|69256317|FG002|Overall Study|Withdrawal by Subject|1|||
37753379|NCT00983619|69256318|FG003|Overall Study|Withdrawal by Subject|3|||
37753380|NCT00983619|69256319|FG004|Overall Study|Withdrawal by Subject|1|||
37753381|NCT00983619|69256320|FG005|Overall Study|Withdrawal by Subject|23|||
37753382|NCT00983619|69256321|FG006|Overall Study|Withdrawal by Subject|0|||
37753383|NCT00983619|69256322|FG007|Overall Study|Withdrawal by Subject|0|||
37857437|NCT01194219|69540708|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
37857438|NCT01194219|69540699|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
37857439|NCT01194219|69540700|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
37857440|NCT01194219|69540701|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
37857441|NCT01194219|69540702|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
37857442|NCT01194219|69540703|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
37857443|NCT01194219|69540704|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
37857444|NCT01194219|69540705|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
37857445|NCT01194219|69540706|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
37857446|NCT01194219|69540707|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
37857447|NCT01194219|69540708|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
37663017|NCT01285557|69135729|FG001|Overall Study|Randomized but not treated|1|||
37753384|NCT00983619|69256323|FG008|Overall Study|Withdrawal by Subject|0|||
37753385|NCT00983619|69256324|FG009|Overall Study|Withdrawal by Subject|0|||
37857448|NCT01194219|69540699|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
37663018|NCT01285557|69135728|FG000|Overall Study|Study follow-up ongoing|28|||
37663019|NCT01285557|69135729|FG001|Overall Study|Study follow-up ongoing|14|||
37663020|NCT01285557|69135728|FG000|Overall Study|Sponsor Decision|2|||
37753386|NCT00983619|69256325|FG010|Overall Study|Withdrawal by Subject|1|||
37857449|NCT01194219|69540700|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
37857450|NCT01194219|69540701|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
37663021|NCT01285557|69135729|FG001|Overall Study|Sponsor Decision|1|||
37663022|NCT01376167|69135791|FG000|Overall Study|Lost to Follow-up|2|||
37663023|NCT01376167|69135792|FG001|Overall Study|Lost to Follow-up|4|||
37663024|NCT01376167|69135793|FG002|Overall Study|Lost to Follow-up|2|||
37663025|NCT01376167|69135791|FG000|Overall Study|Physician Decision|1|||
37753387|NCT00983619|69256326|FG011|Overall Study|Withdrawal by Subject|1|||
37753388|NCT00983619|69256315|FG000|Overall Study|Death|0|||
37753389|NCT00983619|69256316|FG001|Overall Study|Death|2|||
37753390|NCT00983619|69256317|FG002|Overall Study|Death|2|||
37753391|NCT00983619|69256318|FG003|Overall Study|Death|1|||
37753392|NCT00983619|69256319|FG004|Overall Study|Death|2|||
37753393|NCT00983619|69256320|FG005|Overall Study|Death|30|||
37753394|NCT00983619|69256321|FG006|Overall Study|Death|1|||
37753395|NCT00983619|69256322|FG007|Overall Study|Death|0|||
37753396|NCT00983619|69256323|FG008|Overall Study|Death|1|||
37753397|NCT00983619|69256324|FG009|Overall Study|Death|2|||
37753398|NCT00983619|69256325|FG010|Overall Study|Death|9|||
37753399|NCT00983619|69256326|FG011|Overall Study|Death|8|||
37753400|NCT00983619|69256315|FG000|Overall Study|Other|1|||
37753401|NCT00983619|69256316|FG001|Overall Study|Other|0|||
37753402|NCT00983619|69256317|FG002|Overall Study|Other|0|||
37753403|NCT00983619|69256318|FG003|Overall Study|Other|1|||
37753404|NCT00983619|69256319|FG004|Overall Study|Other|0|||
37753405|NCT00983619|69256320|FG005|Overall Study|Other|12|||
37753406|NCT00983619|69256321|FG006|Overall Study|Other|2|||
37753407|NCT00983619|69256322|FG007|Overall Study|Other|2|||
37753408|NCT00983619|69256323|FG008|Overall Study|Other|0|||
37753409|NCT00983619|69256324|FG009|Overall Study|Other|1|||
37753410|NCT00983619|69256325|FG010|Overall Study|Other|1|||
37753411|NCT00983619|69256326|FG011|Overall Study|Other|0|||
37753412|NCT01767857|69256374|FG000|Overall Study|Adverse Event|27|||
37753413|NCT01767857|69256375|FG001|Overall Study|Adverse Event|7|||
37753414|NCT01767857|69256374|FG000|Overall Study|Death|28|||
37753415|NCT01767857|69256375|FG001|Overall Study|Death|13|||
37753416|NCT01767857|69256374|FG000|Overall Study|Lack of Efficacy|299|||
37753417|NCT01767857|69256375|FG001|Overall Study|Lack of Efficacy|151|||
37753418|NCT01767857|69256374|FG000|Overall Study|Lost to Follow-up|1|||
37753419|NCT01767857|69256375|FG001|Overall Study|Lost to Follow-up|1|||
37753420|NCT01767857|69256374|FG000|Overall Study|Withdrawal by Subject|38|||
37663026|NCT01376167|69135792|FG001|Overall Study|Physician Decision|1|||
37663027|NCT01376167|69135793|FG002|Overall Study|Physician Decision|0|||
37663028|NCT01376167|69135791|FG000|Overall Study|Withdrawal by Subject|1|||
37663029|NCT01376167|69135792|FG001|Overall Study|Withdrawal by Subject|5|||
37753421|NCT01767857|69256375|FG001|Overall Study|Withdrawal by Subject|18|||
37753422|NCT01767857|69256374|FG000|Overall Study|Physician Decision|17|||
37753423|NCT01767857|69256375|FG001|Overall Study|Physician Decision|10|||
37857451|NCT01194219|69540702|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
37857452|NCT01194219|69540703|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
37857453|NCT01194219|69540704|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
37857454|NCT01194219|69540705|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
37857455|NCT01194219|69540706|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
37857456|NCT01194219|69540707|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
37857457|NCT01194219|69540708|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
37857458|NCT01194219|69540699|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
37857459|NCT01194219|69540700|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
37857460|NCT01194219|69540701|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
37857461|NCT01194219|69540702|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
37857462|NCT01194219|69540703|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
37857463|NCT01194219|69540704|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
37663030|NCT01376167|69135793|FG002|Overall Study|Withdrawal by Subject|4|||
37663031|NCT02647281|69135813|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
37663032|NCT02647281|69135814|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
37663033|NCT02647281|69135815|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
37663034|NCT02647281|69135816|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
37663035|NCT02647281|69135817|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
37857464|NCT01194219|69540705|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
37857465|NCT01194219|69540706|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
37857466|NCT01194219|69540707|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
37663036|NCT02647281|69135818|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
37663037|NCT02647281|69135819|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
37753424|NCT01767857|69256374|FG000|Overall Study|Protocol Terminated|1|||
37753425|NCT01767857|69256375|FG001|Overall Study|Protocol Terminated|0|||
37753426|NCT01767857|69256374|FG000|Overall Study|Randomized But Never Treated|19|||
37753427|NCT01767857|69256375|FG001|Overall Study|Randomized But Never Treated|13|||
37753428|NCT01775501|69256382|FG000|Overall Study|Discontinued prior to treatment|1|||
37753429|NCT01775189|69256411|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
37753430|NCT01775189|69256412|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
37753431|NCT01775189|69256413|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
37753432|NCT01775189|69256414|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
37753433|NCT01775189|69256415|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
37753434|NCT01775189|69256416|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
37753435|NCT01775189|69256417|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
37663038|NCT02647281|69135820|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
37663039|NCT02647281|69135821|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
37663040|NCT02729545|69135852|FG000|Overall Study|Pregnancy|1|||
37663041|NCT02729545|69135853|FG001|Overall Study|Pregnancy|1|||
37663042|NCT02729545|69135852|FG000|Overall Study|Lost to Follow-up|0|||
37663043|NCT02729545|69135853|FG001|Overall Study|Lost to Follow-up|1|||
37663044|NCT02729545|69135852|FG000|Overall Study|Withdrawal by Subject|2|||
37663045|NCT02729545|69135853|FG001|Overall Study|Withdrawal by Subject|3|||
37663046|NCT01376089|69135861|FG000|Overall Study|Patient received no contrast media|3|||
37663047|NCT01376089|69135862|FG001|Overall Study|Patient received no contrast media|4|||
37753436|NCT01775189|69256411|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
37753437|NCT01775189|69256412|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
37753438|NCT01775189|69256413|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
37753439|NCT01775189|69256414|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
37753440|NCT01775189|69256415|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
37753441|NCT01775189|69256416|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
37753442|NCT01775189|69256417|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
37753443|NCT01775189|69256411|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
37753444|NCT01775189|69256412|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
37753445|NCT01775189|69256413|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
37753446|NCT01775189|69256414|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
37753447|NCT01775189|69256415|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
37753448|NCT01775189|69256416|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
37753449|NCT01775189|69256417|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
37753450|NCT01775189|69256411|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
37753451|NCT01775189|69256412|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
37753452|NCT01775189|69256413|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
37753453|NCT01775189|69256414|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
37753454|NCT01775189|69256415|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
37923318|NCT00658606|69610119|FG000|Overall Study|Adverse Event|2|||
37923319|NCT00658606|69610120|FG001|Overall Study|Adverse Event|1|||
37923320|NCT00658606|69610119|FG000|Overall Study|Lack of Efficacy|6|||
37923321|NCT00658606|69610120|FG001|Overall Study|Lack of Efficacy|3|||
37663048|NCT00706849|69135874|FG000|Treatment Period|Adverse Event|0|||
37753455|NCT01775189|69256416|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
37753456|NCT01775189|69256417|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
37753457|NCT01775189|69256411|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
37753458|NCT01775189|69256412|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
37753459|NCT01775189|69256413|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
37753460|NCT01775189|69256414|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
37753461|NCT01775189|69256415|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
37753462|NCT01775189|69256416|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
37753463|NCT01775189|69256417|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
37753464|NCT01775189|69256411|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
37753465|NCT01775189|69256412|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
37753466|NCT01775189|69256413|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
37663049|NCT00706849|69135875|FG001|Treatment Period|Adverse Event|9|||
37753467|NCT01775189|69256414|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
37753468|NCT01775189|69256415|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
37753469|NCT01775189|69256416|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
37753470|NCT01775189|69256417|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
37753471|NCT01770743|69256483|FG000|Overall Study|Adverse Event|1|||
37753472|NCT01770743|69256484|FG001|Overall Study|Adverse Event|0|||
37753473|NCT01770743|69256485|FG002|Overall Study|Adverse Event|0|||
37753474|NCT01770743|69256486|FG003|Overall Study|Adverse Event|0|||
37753475|NCT01770743|69256487|FG004|Overall Study|Adverse Event|0|||
37753476|NCT01770743|69256483|FG000|Overall Study|Withdrawal by Subject|0|||
37663050|NCT00706849|69135874|FG000|Treatment Period|Other|0|||
37663051|NCT00706849|69135875|FG001|Treatment Period|Other|1|||
37753477|NCT01770743|69256484|FG001|Overall Study|Withdrawal by Subject|0|||
37753478|NCT01770743|69256485|FG002|Overall Study|Withdrawal by Subject|1|||
37753479|NCT01770743|69256486|FG003|Overall Study|Withdrawal by Subject|1|||
37753480|NCT01770743|69256487|FG004|Overall Study|Withdrawal by Subject|1|||
37753481|NCT01770743|69256483|FG000|Overall Study|Lost to Follow-up|0|||
37753482|NCT01770743|69256484|FG001|Overall Study|Lost to Follow-up|2|||
37923322|NCT00658606|69610119|FG000|Overall Study|Lost to Follow-up|1|||
37923323|NCT00658606|69610120|FG001|Overall Study|Lost to Follow-up|0|||
37663052|NCT00706849|69135874|FG000|Follow-up Period|Withdrawal by Subject|0|||
37663053|NCT00706849|69135875|FG001|Follow-up Period|Withdrawal by Subject|2|||
37663054|NCT00706849|69135874|FG000|Follow-up Period|Protocol non-compliance|0|||
37663055|NCT00706849|69135875|FG001|Follow-up Period|Protocol non-compliance|1|||
37753483|NCT01770743|69256485|FG002|Overall Study|Lost to Follow-up|0|||
37753484|NCT01770743|69256486|FG003|Overall Study|Lost to Follow-up|0|||
37753485|NCT01770743|69256487|FG004|Overall Study|Lost to Follow-up|1|||
37753486|NCT01770743|69256483|FG000|Overall Study|Sponsor Terminated Subject|1|||
37753487|NCT01770743|69256484|FG001|Overall Study|Sponsor Terminated Subject|0|||
37753488|NCT01770743|69256485|FG002|Overall Study|Sponsor Terminated Subject|0|||
37663056|NCT00707161|69135881|FG000|Overall Study|Physician Decision|6|||
37663057|NCT02130466|69135899|FG000|Overall Study|Death|4|||
37663058|NCT02130466|69135900|FG001|Overall Study|Death|1|||
37663059|NCT02130466|69135901|FG002|Overall Study|Death|1|||
37663060|NCT02130466|69135902|FG003|Overall Study|Death|3|||
37663061|NCT02130466|69135903|FG004|Overall Study|Death|2|||
37663062|NCT02130466|69135904|FG005|Overall Study|Death|30|||
37663063|NCT02130466|69135905|FG006|Overall Study|Death|45|||
37663064|NCT02130466|69135906|FG007|Overall Study|Death|2|||
37663065|NCT02130466|69135907|FG008|Overall Study|Death|3|||
37753489|NCT01770743|69256486|FG003|Overall Study|Sponsor Terminated Subject|1|||
37753490|NCT01770743|69256487|FG004|Overall Study|Sponsor Terminated Subject|0|||
37753491|NCT01770743|69256483|FG000|Overall Study|Moving Out of State|0|||
37753492|NCT01770743|69256484|FG001|Overall Study|Moving Out of State|1|||
37753493|NCT01770743|69256485|FG002|Overall Study|Moving Out of State|0|||
37753494|NCT01770743|69256486|FG003|Overall Study|Moving Out of State|0|||
37753495|NCT01770743|69256487|FG004|Overall Study|Moving Out of State|0|||
37753496|NCT01767467|69256583|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
37753497|NCT01767467|69256584|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
37753498|NCT01767467|69256583|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
37753499|NCT01767467|69256584|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
37753500|NCT01767467|69256583|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
37753501|NCT01767467|69256584|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
37663066|NCT02130466|69135908|FG009|Overall Study|Death|4|||
37663067|NCT02130466|69135909|FG010|Overall Study|Death|5|||
37663068|NCT02130466|69135910|FG011|Overall Study|Death|3|||
37663069|NCT02130466|69135911|FG012|Overall Study|Death|11|||
37663070|NCT02130466|69135912|FG013|Overall Study|Death|7|||
37663071|NCT02130466|69135899|FG000|Overall Study|Lost to Follow-up|1|||
37663072|NCT02130466|69135900|FG001|Overall Study|Lost to Follow-up|0|||
37663073|NCT02130466|69135901|FG002|Overall Study|Lost to Follow-up|0|||
37663074|NCT02130466|69135902|FG003|Overall Study|Lost to Follow-up|0|||
37663075|NCT02130466|69135903|FG004|Overall Study|Lost to Follow-up|0|||
37663076|NCT02130466|69135904|FG005|Overall Study|Lost to Follow-up|1|||
37663077|NCT02130466|69135905|FG006|Overall Study|Lost to Follow-up|0|||
37663078|NCT02130466|69135906|FG007|Overall Study|Lost to Follow-up|0|||
37663079|NCT02130466|69135907|FG008|Overall Study|Lost to Follow-up|0|||
37753502|NCT01767467|69256583|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
37753503|NCT01767467|69256584|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
37753504|NCT01767467|69256583|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
37753505|NCT01767467|69256584|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
37753506|NCT01767467|69256583|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
37753507|NCT01767467|69256584|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
37753508|NCT01767467|69256583|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
37663080|NCT02130466|69135908|FG009|Overall Study|Lost to Follow-up|0|||
37753509|NCT01767467|69256584|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
37753510|NCT01767467|69256583|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
37753511|NCT01767467|69256584|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
37753512|NCT01767467|69256583|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
37753513|NCT01767467|69256584|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
37753514|NCT01767467|69256583|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
37753515|NCT01767467|69256584|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
37753516|NCT01767467|69256583|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
37663081|NCT02130466|69135909|FG010|Overall Study|Lost to Follow-up|0|||
37663082|NCT02130466|69135910|FG011|Overall Study|Lost to Follow-up|0|||
37753517|NCT01767467|69256584|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
37753518|NCT01767467|69256583|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
37857467|NCT01194219|69540708|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
37857468|NCT01194219|69540699|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
37663083|NCT02130466|69135911|FG012|Overall Study|Lost to Follow-up|1|||
37663084|NCT02130466|69135912|FG013|Overall Study|Lost to Follow-up|0|||
37663085|NCT02130466|69135899|FG000|Overall Study|Physician Decision|0|||
37663086|NCT02130466|69135900|FG001|Overall Study|Physician Decision|0|||
37663087|NCT02130466|69135901|FG002|Overall Study|Physician Decision|0|||
37663088|NCT02130466|69135902|FG003|Overall Study|Physician Decision|0|||
37663089|NCT02130466|69135903|FG004|Overall Study|Physician Decision|0|||
37663090|NCT02130466|69135904|FG005|Overall Study|Physician Decision|1|||
37663091|NCT02130466|69135905|FG006|Overall Study|Physician Decision|1|||
37753519|NCT01767467|69256584|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
37753520|NCT01767467|69256583|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
37753521|NCT01767467|69256584|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
37753522|NCT01767467|69256583|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
37753523|NCT01767467|69256584|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
37753524|NCT04126083|69256657|FG000|Overall Study|Withdrawal by Subject|1|||
37753525|NCT01766921|69256697|FG000|Overall Study|Administrative Reason|5|||
37753526|NCT01766921|69256698|FG001|Overall Study|Administrative Reason|5|||
37753527|NCT01766921|69256697|FG000|Overall Study|Death|1|||
37753528|NCT01766921|69256698|FG001|Overall Study|Death|1|||
37753529|NCT01766921|69256697|FG000|Overall Study|Lost to Follow-up|1|||
37753530|NCT01766921|69256698|FG001|Overall Study|Lost to Follow-up|3|||
37753531|NCT01766921|69256697|FG000|Overall Study|Unclassified|2|||
37753532|NCT01766921|69256698|FG001|Overall Study|Unclassified|2|||
37753533|NCT01766921|69256697|FG000|Overall Study|Protocol Violation|1|||
37753534|NCT01766921|69256698|FG001|Overall Study|Protocol Violation|1|||
37753535|NCT01766921|69256697|FG000|Overall Study|Withdrawal by Subject|14|||
37753536|NCT01766921|69256698|FG001|Overall Study|Withdrawal by Subject|5|||
37753537|NCT01774799|69256716|FG000|Overall Study|Lost to Follow-up|1|||
37753538|NCT01774799|69256717|FG001|Overall Study|Lost to Follow-up|1|||
37753539|NCT01774799|69256718|FG002|Overall Study|Lost to Follow-up|0|||
37753540|NCT01774799|69256719|FG003|Overall Study|Lost to Follow-up|0|||
37753541|NCT01765751|69256761|FG000|Overall Study|Lost to Follow-up|0|||
37753542|NCT01765751|69256762|FG001|Overall Study|Lost to Follow-up|2|||
37753543|NCT01765751|69256763|FG002|Overall Study|Lost to Follow-up|1|||
37753544|NCT01736657|69256783|FG000|Overall Study|insufficient vascular access|1|||
37753545|NCT01736579|69256798|FG000|Overall Study|Termination of Study by Sponsor|2|||
37753546|NCT01736579|69256799|FG001|Overall Study|Termination of Study by Sponsor|2|||
37753547|NCT01765673|69256830|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
37753548|NCT01764659|69256837|FG000|Overall Study|Death|1|||
37753549|NCT01764659|69256837|FG000|Overall Study|Physician Decision|1|||
37753550|NCT01736189|69256843|FG000|Overall Study|Violation of registration criteria|41|||
37753551|NCT01736189|69256843|FG000|Overall Study|Protocol Violation|4|||
37753552|NCT01736189|69256843|FG000|Overall Study|Criteria and protocol violations|1|||
37753553|NCT01735175|69256875|FG000|Overall Study|Withdrawal by Subject|9|||
37753554|NCT01735175|69256876|FG001|Overall Study|Withdrawal by Subject|2|||
37753555|NCT01735175|69256875|FG000|Overall Study|Lost to Follow-up|4|||
37753556|NCT01735175|69256876|FG001|Overall Study|Lost to Follow-up|2|||
37663092|NCT02130466|69135906|FG007|Overall Study|Physician Decision|0|||
37663093|NCT02130466|69135907|FG008|Overall Study|Physician Decision|0|||
37663094|NCT02130466|69135908|FG009|Overall Study|Physician Decision|0|||
37663095|NCT02130466|69135909|FG010|Overall Study|Physician Decision|0|||
37663096|NCT02130466|69135910|FG011|Overall Study|Physician Decision|0|||
37663097|NCT02130466|69135911|FG012|Overall Study|Physician Decision|0|||
37663098|NCT02130466|69135912|FG013|Overall Study|Physician Decision|0|||
37753557|NCT01735175|69256875|FG000|Overall Study|Death|3|||
37753558|NCT01735175|69256876|FG001|Overall Study|Death|2|||
37753559|NCT01735175|69256875|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
37753560|NCT01735175|69256876|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
37753561|NCT01762943|69256888|FG000|Overall Study|Physician Decision|1|||
37753562|NCT01762943|69256889|FG001|Overall Study|Physician Decision|1|||
37753563|NCT01762943|69256888|FG000|Overall Study|Protocol Violation|1|||
37753564|NCT01762943|69256889|FG001|Overall Study|Protocol Violation|0|||
37753565|NCT01762943|69256888|FG000|Overall Study|Withdrawal by Subject|2|||
37923324|NCT00658606|69610119|FG000|Overall Study|Withdrawal by Subject|7|||
37923325|NCT00658606|69610120|FG001|Overall Study|Withdrawal by Subject|16|||
37923326|NCT00658606|69610119|FG000|Overall Study|Lack of Compliance|0|||
37923327|NCT00658606|69610120|FG001|Overall Study|Lack of Compliance|3|||
37923328|NCT00589290|69610126|FG000|Overall Study|Withdrawal by Subject|1|||
37923329|NCT00843518|69610134|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
37923330|NCT00843518|69610135|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
37923331|NCT00843518|69610134|FG000|Period 2 (Double-blind Treatment)|Death|0|||
37923332|NCT00843518|69610135|FG001|Period 2 (Double-blind Treatment)|Death|1|||
37663099|NCT02130466|69135899|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
37663100|NCT02130466|69135900|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
37663101|NCT02130466|69135901|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
37663102|NCT02130466|69135902|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
37923333|NCT00843518|69610134|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
37923334|NCT00843518|69610135|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
37923335|NCT00843518|69610134|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
37923336|NCT00843518|69610135|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
37923337|NCT00843518|69610134|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
37923338|NCT00843518|69610135|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
37663103|NCT02130466|69135903|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
37923339|NCT00843518|69610134|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
37923340|NCT00843518|69610135|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
37663104|NCT02130466|69135904|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
37663105|NCT02130466|69135905|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
37663106|NCT02130466|69135906|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
37663107|NCT02130466|69135907|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
37663108|NCT02130466|69135908|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
37663109|NCT02130466|69135909|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
37663110|NCT02130466|69135910|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
37663111|NCT02130466|69135911|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
37663112|NCT02130466|69135912|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
37663113|NCT02130466|69135899|FG000|Overall Study|Withdrawal by Subject|1|||
37923341|NCT00843518|69610134|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
37923342|NCT00843518|69610135|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
37857469|NCT01194219|69540700|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
37857470|NCT01194219|69540701|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
37857471|NCT01194219|69540702|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
37857472|NCT01194219|69540703|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
37857473|NCT01194219|69540704|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
37857474|NCT01194219|69540705|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
37857475|NCT01194219|69540706|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
37857476|NCT01194219|69540707|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
37857477|NCT01194219|69540708|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
37857478|NCT01194219|69540699|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
37857479|NCT01194219|69540700|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
37857480|NCT01194219|69540701|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
37857481|NCT01194219|69540702|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
37857482|NCT01194219|69540703|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
37857483|NCT01194219|69540704|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
37857484|NCT01194219|69540705|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
37857485|NCT01194219|69540706|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
37857486|NCT01194219|69540707|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
37857487|NCT01194219|69540708|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
37857488|NCT01194219|69540699|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
37857489|NCT01194219|69540700|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
37857490|NCT01194219|69540701|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
37857491|NCT01194219|69540702|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
37857492|NCT01194219|69540703|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
37857493|NCT01194219|69540704|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
37857494|NCT01194219|69540705|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
37857495|NCT01194219|69540706|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
37857496|NCT01194219|69540707|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
37857497|NCT01194219|69540708|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
37857498|NCT01194219|69540699|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
37857499|NCT01194219|69540700|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
37857500|NCT01194219|69540701|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
37857501|NCT01194219|69540702|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
37857502|NCT01194219|69540703|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
37857503|NCT01194219|69540704|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
37857504|NCT01194219|69540705|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
37857505|NCT01194219|69540706|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
37857506|NCT01194219|69540707|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
37857507|NCT01194219|69540708|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
37857508|NCT01194219|69540699|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
37857509|NCT01194219|69540700|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
37857510|NCT01194219|69540701|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
37923343|NCT00843284|69610145|FG000|Overall Study|Adverse Event|39|||
37923344|NCT00843284|69610145|FG000|Overall Study|Lack of Efficacy|5|||
37923345|NCT00843284|69610145|FG000|Overall Study|Lost to Follow-up|11|||
37923346|NCT00843284|69610145|FG000|Overall Study|Other|10|||
37923347|NCT00843284|69610145|FG000|Overall Study|Withdrawal by Subject|4|||
37663114|NCT02130466|69135900|FG001|Overall Study|Withdrawal by Subject|0|||
37663115|NCT02130466|69135901|FG002|Overall Study|Withdrawal by Subject|0|||
37753566|NCT01762943|69256889|FG001|Overall Study|Withdrawal by Subject|1|||
37753567|NCT01734785|69256952|FG000|Open-Label Period|Adverse Event|0|||
37857511|NCT01194219|69540702|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
37923348|NCT00843284|69610145|FG000|Overall Study|Death|3|||
37753568|NCT01734785|69256953|FG001|Open-Label Period|Adverse Event|0|||
37663116|NCT02130466|69135902|FG003|Overall Study|Withdrawal by Subject|0|||
37753569|NCT01734785|69256954|FG002|Open-Label Period|Adverse Event|0|||
37753570|NCT01734785|69256955|FG003|Open-Label Period|Adverse Event|9|||
37753571|NCT01734785|69256952|FG000|Open-Label Period|Lack of Efficacy|0|||
37753572|NCT01734785|69256953|FG001|Open-Label Period|Lack of Efficacy|0|||
37753573|NCT01734785|69256954|FG002|Open-Label Period|Lack of Efficacy|0|||
37753574|NCT01734785|69256955|FG003|Open-Label Period|Lack of Efficacy|1|||
37753575|NCT01734785|69256952|FG000|Open-Label Period|Protocol Violation|0|||
37753576|NCT01734785|69256953|FG001|Open-Label Period|Protocol Violation|0|||
37753577|NCT01734785|69256954|FG002|Open-Label Period|Protocol Violation|0|||
37753578|NCT01734785|69256955|FG003|Open-Label Period|Protocol Violation|13|||
37753579|NCT01734785|69256952|FG000|Open-Label Period|Lost to Follow-up|0|||
37753580|NCT01734785|69256953|FG001|Open-Label Period|Lost to Follow-up|0|||
37753581|NCT01734785|69256954|FG002|Open-Label Period|Lost to Follow-up|0|||
37753582|NCT01734785|69256955|FG003|Open-Label Period|Lost to Follow-up|14|||
37753583|NCT01734785|69256952|FG000|Open-Label Period|Withdrawal by Subject|0|||
37663117|NCT02130466|69135903|FG004|Overall Study|Withdrawal by Subject|0|||
37663118|NCT02130466|69135904|FG005|Overall Study|Withdrawal by Subject|1|||
37663119|NCT02130466|69135905|FG006|Overall Study|Withdrawal by Subject|0|||
37663120|NCT02130466|69135906|FG007|Overall Study|Withdrawal by Subject|0|||
37663121|NCT02130466|69135907|FG008|Overall Study|Withdrawal by Subject|1|||
37663122|NCT02130466|69135908|FG009|Overall Study|Withdrawal by Subject|0|||
37663123|NCT02130466|69135909|FG010|Overall Study|Withdrawal by Subject|0|||
37663124|NCT02130466|69135910|FG011|Overall Study|Withdrawal by Subject|0|||
37663125|NCT02130466|69135911|FG012|Overall Study|Withdrawal by Subject|0|||
37663126|NCT02130466|69135912|FG013|Overall Study|Withdrawal by Subject|0|||
37663127|NCT02163538|69135961|FG000|Overall Study|Protocol Violation|1|||
37663128|NCT02163538|69135962|FG001|Overall Study|Protocol Violation|0|||
37753584|NCT01734785|69256953|FG001|Open-Label Period|Withdrawal by Subject|0|||
37753585|NCT01734785|69256954|FG002|Open-Label Period|Withdrawal by Subject|0|||
37753586|NCT01734785|69256955|FG003|Open-Label Period|Withdrawal by Subject|12|||
37753587|NCT01734785|69256952|FG000|Open-Label Period|Other Reasons|0|||
37753588|NCT01734785|69256953|FG001|Open-Label Period|Other Reasons|0|||
37753589|NCT01734785|69256954|FG002|Open-Label Period|Other Reasons|0|||
37753590|NCT01734785|69256955|FG003|Open-Label Period|Other Reasons|224|||
37753591|NCT01734785|69256952|FG000|Double-Blind Period|Adverse Event|0|||
37753592|NCT01734785|69256953|FG001|Double-Blind Period|Adverse Event|3|||
37753593|NCT01734785|69256954|FG002|Double-Blind Period|Adverse Event|2|||
37753594|NCT01734785|69256955|FG003|Double-Blind Period|Adverse Event|0|||
37753595|NCT01734785|69256952|FG000|Double-Blind Period|Lack of Efficacy|0|||
37753596|NCT01734785|69256953|FG001|Double-Blind Period|Lack of Efficacy|1|||
37753597|NCT01734785|69256954|FG002|Double-Blind Period|Lack of Efficacy|0|||
37753598|NCT01734785|69256955|FG003|Double-Blind Period|Lack of Efficacy|0|||
37753599|NCT01734785|69256952|FG000|Double-Blind Period|Protocol Violation|0|||
37753600|NCT01734785|69256953|FG001|Double-Blind Period|Protocol Violation|1|||
37753601|NCT01734785|69256954|FG002|Double-Blind Period|Protocol Violation|1|||
37753602|NCT01734785|69256955|FG003|Double-Blind Period|Protocol Violation|0|||
37663129|NCT02163538|69135961|FG000|Overall Study|Physician Decision|0|||
37663130|NCT02163538|69135962|FG001|Overall Study|Physician Decision|1|||
37663131|NCT02163226|69135970|FG000|Overall Study|Death|2|||
37663132|NCT02163226|69135971|FG001|Overall Study|Death|1|||
37663133|NCT02163226|69135970|FG000|Overall Study|Withdrawal by Subject|5|||
37663134|NCT02163226|69135971|FG001|Overall Study|Withdrawal by Subject|2|||
37663135|NCT02163226|69135970|FG000|Overall Study|Returned home, local radiotherapy|3|||
37663136|NCT02163226|69135971|FG001|Overall Study|Returned home, local radiotherapy|0|||
37753603|NCT01734785|69256952|FG000|Double-Blind Period|Lost to Follow-up|2|||
37753604|NCT01734785|69256953|FG001|Double-Blind Period|Lost to Follow-up|4|||
37753605|NCT01734785|69256954|FG002|Double-Blind Period|Lost to Follow-up|2|||
37753606|NCT01734785|69256955|FG003|Double-Blind Period|Lost to Follow-up|0|||
37753607|NCT01734785|69256952|FG000|Double-Blind Period|Withdrawal by Subject|2|||
37753608|NCT01734785|69256953|FG001|Double-Blind Period|Withdrawal by Subject|0|||
37753609|NCT01734785|69256954|FG002|Double-Blind Period|Withdrawal by Subject|0|||
37753610|NCT01734785|69256955|FG003|Double-Blind Period|Withdrawal by Subject|0|||
37753611|NCT01734785|69256952|FG000|Double-Blind Period|Not treated|1|||
37857512|NCT01194219|69540703|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
37663137|NCT02163226|69135970|FG000|Overall Study|Repeat imaging showed no disease|2|||
37663138|NCT02163226|69135971|FG001|Overall Study|Repeat imaging showed no disease|0|||
37663139|NCT02163226|69135970|FG000|Overall Study|Incomplete radiotherapy|3|||
37663140|NCT02163226|69135971|FG001|Overall Study|Incomplete radiotherapy|0|||
37753612|NCT01734785|69256953|FG001|Double-Blind Period|Not treated|0|||
37663141|NCT02163226|69135970|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
37663142|NCT02163226|69135971|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
37753613|NCT01734785|69256954|FG002|Double-Blind Period|Not treated|0|||
37753614|NCT01734785|69256955|FG003|Double-Blind Period|Not treated|0|||
37753615|NCT01734395|69256964|FG000|Overall Study|Other|65|||
37753616|NCT01734395|69256964|FG000|Overall Study|Lost to Follow-up|287|||
37663143|NCT02163226|69135970|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
37663144|NCT02163226|69135971|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
37857513|NCT01194219|69540704|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
37857514|NCT01194219|69540705|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
37857515|NCT01194219|69540706|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
37753617|NCT01734395|69256964|FG000|Overall Study|Lack of Efficacy|5|||
37753618|NCT01734395|69256964|FG000|Overall Study|Adverse Event|40|||
37753619|NCT01734395|69256964|FG000|Overall Study|Withdrawal by Subject|10|||
37753620|NCT01734395|69256964|FG000|Overall Study|Missing the reasons for not completed|3|||
37753621|NCT01597505|69256998|FG000|Overall Study|Physician Decision|5|||
37753622|NCT01597505|69256999|FG001|Overall Study|Physician Decision|0|||
37753623|NCT01597505|69256998|FG000|Overall Study|Adverse Event|19|||
37753624|NCT01597505|69256999|FG001|Overall Study|Adverse Event|7|||
37753625|NCT01597505|69256998|FG000|Overall Study|Lost to Follow-up|4|||
37753626|NCT01597505|69256999|FG001|Overall Study|Lost to Follow-up|2|||
37753627|NCT01597505|69256998|FG000|Overall Study|Withdrawal by Subject|10|||
37857516|NCT01194219|69540707|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
37857517|NCT01194219|69540708|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
37857518|NCT01194219|69540699|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
37857519|NCT01194219|69540700|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
37857520|NCT01194219|69540701|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
37857521|NCT01194219|69540702|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
37857522|NCT01194219|69540703|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
37857523|NCT01194219|69540704|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
37857524|NCT01194219|69540705|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
37857525|NCT01194219|69540706|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
37857526|NCT01194219|69540707|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
37857527|NCT01194219|69540708|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
37663145|NCT02163226|69135970|FG000|Overall Study|ineligible|0|||
37663146|NCT02163226|69135971|FG001|Overall Study|ineligible|3|||
37663147|NCT02193178|69135977|FG000|Overall Study|Lost to Follow-up|1|||
37663148|NCT02193178|69135977|FG000|Overall Study|Dry eyes|1|||
37663149|NCT02129608|69135998|FG000|Overall Study|Lost to Follow-up|0|||
37663150|NCT02129608|69135999|FG001|Overall Study|Lost to Follow-up|1|||
37663151|NCT02129608|69136000|FG002|Overall Study|Lost to Follow-up|1|||
37663152|NCT02129608|69135998|FG000|Overall Study|Withdrawal by Subject|0|||
37663153|NCT02129608|69135999|FG001|Overall Study|Withdrawal by Subject|0|||
37663154|NCT02129608|69136000|FG002|Overall Study|Withdrawal by Subject|2|||
37663155|NCT01631188|69136008|FG000|Overall Study|Physician Decision|75|||
37663156|NCT02129062|69136012|FG000|Overall Study|Death|1|||
37663157|NCT02129062|69136012|FG000|Overall Study|Disease Progression|2|||
37663158|NCT02162758|69136018|FG000|Overall Study|Study termination|0|||
37663159|NCT02162758|69136019|FG001|Overall Study|Study termination|1|||
37663160|NCT02192164|69136025|FG000|Overall Study|Other|8|||
37663161|NCT02192164|69136025|FG000|Overall Study|Withdrawal by Subject|1|||
37663162|NCT02192164|69136025|FG000|Overall Study|Physician Decision|4|||
37663163|NCT02192164|69136025|FG000|Overall Study|Did not meet the exclusion criteria|1|||
37663164|NCT02191618|69136032|FG000|Overall Study|Withdrawal by Subject|3|||
37663165|NCT02191618|69136032|FG000|Overall Study|Missed Visit|4|||
37663166|NCT02646891|69136046|FG000|Overall Study|Adverse Event|0|||
37663167|NCT02646891|69136047|FG001|Overall Study|Adverse Event|1|||
37663168|NCT02646891|69136048|FG002|Overall Study|Adverse Event|0|||
37663169|NCT02646891|69136049|FG003|Overall Study|Adverse Event|0|||
37663170|NCT02646891|69136050|FG004|Overall Study|Adverse Event|0|||
37663171|NCT02646891|69136051|FG005|Overall Study|Adverse Event|0|||
37663172|NCT02646891|69136052|FG006|Overall Study|Adverse Event|0|||
37663173|NCT02646891|69136053|FG007|Overall Study|Adverse Event|0|||
37663174|NCT02646891|69136054|FG008|Overall Study|Adverse Event|0|||
37663175|NCT02646891|69136055|FG009|Overall Study|Adverse Event|0|||
37663176|NCT02646891|69136046|FG000|Overall Study|Lost to Follow-up|0|||
37857528|NCT01194219|69540699|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
37663177|NCT02646891|69136047|FG001|Overall Study|Lost to Follow-up|0|||
37663178|NCT02646891|69136048|FG002|Overall Study|Lost to Follow-up|0|||
37663179|NCT02646891|69136049|FG003|Overall Study|Lost to Follow-up|0|||
37753628|NCT01597505|69256999|FG001|Overall Study|Withdrawal by Subject|18|||
37753629|NCT01597505|69256998|FG000|Overall Study|Other|5|||
37857529|NCT01194219|69540700|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
37663180|NCT02646891|69136050|FG004|Overall Study|Lost to Follow-up|0|||
37663181|NCT02646891|69136051|FG005|Overall Study|Lost to Follow-up|0|||
37663182|NCT02646891|69136052|FG006|Overall Study|Lost to Follow-up|2|||
37663183|NCT02646891|69136053|FG007|Overall Study|Lost to Follow-up|2|||
37663184|NCT02646891|69136054|FG008|Overall Study|Lost to Follow-up|2|||
37663185|NCT02646891|69136055|FG009|Overall Study|Lost to Follow-up|2|||
37663186|NCT02646891|69136046|FG000|Overall Study|Protocol Violation|0|||
37663187|NCT02646891|69136047|FG001|Overall Study|Protocol Violation|0|||
37663188|NCT02646891|69136048|FG002|Overall Study|Protocol Violation|0|||
37663189|NCT02646891|69136049|FG003|Overall Study|Protocol Violation|0|||
37753630|NCT01597505|69256999|FG001|Overall Study|Other|6|||
37753631|NCT01597505|69256998|FG000|Overall Study|Missing|1|||
37753632|NCT01597505|69256999|FG001|Overall Study|Missing|0|||
37753633|NCT01760447|69257038|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
37753634|NCT01760447|69257039|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
37753635|NCT01760447|69257040|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
37753636|NCT01760447|69257041|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
37753637|NCT01760447|69257038|FG000|Weeks 0-20|Withdrawal by Subject|2|||
37753638|NCT01760447|69257039|FG001|Weeks 0-20|Withdrawal by Subject|0|||
37753639|NCT01760447|69257040|FG002|Weeks 0-20|Withdrawal by Subject|1|||
37753640|NCT01760447|69257041|FG003|Weeks 0-20|Withdrawal by Subject|0|||
37753641|NCT01760447|69257038|FG000|Weeks 0-20|Lost to Follow-up|1|||
37753642|NCT01760447|69257039|FG001|Weeks 0-20|Lost to Follow-up|0|||
37753643|NCT01760447|69257040|FG002|Weeks 0-20|Lost to Follow-up|1|||
37663190|NCT02646891|69136050|FG004|Overall Study|Protocol Violation|0|||
37663191|NCT02646891|69136051|FG005|Overall Study|Protocol Violation|0|||
37663192|NCT02646891|69136052|FG006|Overall Study|Protocol Violation|1|||
37663193|NCT02646891|69136053|FG007|Overall Study|Protocol Violation|1|||
37663194|NCT02646891|69136054|FG008|Overall Study|Protocol Violation|0|||
37663195|NCT02646891|69136055|FG009|Overall Study|Protocol Violation|0|||
37753644|NCT01760447|69257041|FG003|Weeks 0-20|Lost to Follow-up|1|||
37753645|NCT01760447|69257038|FG000|Weeks 0-20|Randomized but not treated|0|||
37753646|NCT01760447|69257039|FG001|Weeks 0-20|Randomized but not treated|0|||
37753647|NCT01760447|69257040|FG002|Weeks 0-20|Randomized but not treated|2|||
37753648|NCT01760447|69257041|FG003|Weeks 0-20|Randomized but not treated|0|||
37753649|NCT01760447|69257038|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
37753650|NCT01760447|69257039|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
37753651|NCT01760447|69257040|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
37753652|NCT01760447|69257041|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
37753653|NCT01760447|69257038|FG000|Weeks 20-54|Withdrawal by Subject|2|||
37753654|NCT01760447|69257039|FG001|Weeks 20-54|Withdrawal by Subject|1|||
37753655|NCT01760447|69257040|FG002|Weeks 20-54|Withdrawal by Subject|1|||
37753656|NCT01760447|69257041|FG003|Weeks 20-54|Withdrawal by Subject|2|||
37663196|NCT02646891|69136046|FG000|Overall Study|Withdrawal by Subject|2|||
37663197|NCT02646891|69136047|FG001|Overall Study|Withdrawal by Subject|0|||
37663198|NCT02646891|69136048|FG002|Overall Study|Withdrawal by Subject|1|||
37663199|NCT02646891|69136049|FG003|Overall Study|Withdrawal by Subject|0|||
37663200|NCT02646891|69136050|FG004|Overall Study|Withdrawal by Subject|0|||
37663201|NCT02646891|69136051|FG005|Overall Study|Withdrawal by Subject|0|||
37663202|NCT02646891|69136052|FG006|Overall Study|Withdrawal by Subject|5|||
37663203|NCT02646891|69136053|FG007|Overall Study|Withdrawal by Subject|9|||
37663204|NCT02646891|69136054|FG008|Overall Study|Withdrawal by Subject|7|||
37663205|NCT02646891|69136055|FG009|Overall Study|Withdrawal by Subject|3|||
37663206|NCT02646891|69136046|FG000|Overall Study|Death|0|||
37663207|NCT02646891|69136047|FG001|Overall Study|Death|0|||
37663208|NCT02646891|69136048|FG002|Overall Study|Death|0|||
37663209|NCT02646891|69136049|FG003|Overall Study|Death|0|||
37663210|NCT02646891|69136050|FG004|Overall Study|Death|0|||
37663211|NCT02646891|69136051|FG005|Overall Study|Death|0|||
37663212|NCT02646891|69136052|FG006|Overall Study|Death|1|||
37663213|NCT02646891|69136053|FG007|Overall Study|Death|1|||
37663214|NCT02646891|69136054|FG008|Overall Study|Death|1|||
37663215|NCT02646891|69136055|FG009|Overall Study|Death|0|||
37663216|NCT02646423|69136091|FG000|Overall Study|Adverse Event|5|||
37663217|NCT02646423|69136092|FG001|Overall Study|Adverse Event|7|||
37663218|NCT02646423|69136091|FG000|Overall Study|Ineligible|2|||
37663219|NCT02646423|69136092|FG001|Overall Study|Ineligible|1|||
37663220|NCT02647359|69136118|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
37663221|NCT02647359|69136119|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
37663222|NCT02647359|69136118|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
37663223|NCT02647359|69136119|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
37663224|NCT02647359|69136118|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
37663225|NCT02647359|69136119|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
37663226|NCT02647359|69136118|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
37753657|NCT01760447|69257038|FG000|Weeks 20-54|Lost to Follow-up|0|||
37663227|NCT02647359|69136119|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
37753658|NCT01760447|69257039|FG001|Weeks 20-54|Lost to Follow-up|0|||
37753659|NCT01760447|69257040|FG002|Weeks 20-54|Lost to Follow-up|1|||
37753660|NCT01760447|69257041|FG003|Weeks 20-54|Lost to Follow-up|2|||
37753661|NCT01732913|69257130|FG000|Overall Study|Study Terminated by Sponsor|105|||
37663228|NCT02647359|69136118|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
37663229|NCT02647359|69136119|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
37663230|NCT02647359|69136118|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
37663231|NCT02647359|69136119|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
37663232|NCT02645409|69136131|FG000|Overall Study|Withdrawal by Subject|3|||
37753662|NCT01732913|69257131|FG001|Overall Study|Study Terminated by Sponsor|55|||
37663233|NCT02645409|69136132|FG001|Overall Study|Withdrawal by Subject|0|||
37663234|NCT02645409|69136131|FG000|Overall Study|Physician Decision|1|||
37663235|NCT02645409|69136132|FG001|Overall Study|Physician Decision|0|||
37663236|NCT01597479|69136139|FG000|Overall Study|Protocol Violation|1|||
37663237|NCT01597479|69136140|FG001|Overall Study|Protocol Violation|0|||
37663238|NCT01597479|69136139|FG000|Overall Study|Lost to Follow-up|1|||
37663239|NCT01597479|69136140|FG001|Overall Study|Lost to Follow-up|0|||
37663240|NCT04248465|69136149|FG000|Randomized-Controlled Period|Death|12|||
37663241|NCT04248465|69136150|FG001|Randomized-Controlled Period|Death|5|||
37663242|NCT04248465|69136149|FG000|Randomized-Controlled Period|Adverse Event|2|||
37663243|NCT04248465|69136150|FG001|Randomized-Controlled Period|Adverse Event|0|||
37663244|NCT04248465|69136149|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
37663245|NCT04248465|69136150|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
37663246|NCT04248465|69136149|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
37663247|NCT04248465|69136150|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
37663248|NCT04248465|69136149|FG000|Randomized-Controlled Period|Physician Decision|1|||
37663249|NCT04248465|69136150|FG001|Randomized-Controlled Period|Physician Decision|1|||
37663250|NCT04248465|69136149|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
37663251|NCT04248465|69136150|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
37663252|NCT04248465|69136149|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
37663253|NCT04248465|69136150|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
37663254|NCT04248465|69136149|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
37663255|NCT04248465|69136150|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
37663256|NCT02643693|69136158|FG000|Overall Study|Physician Decision|0|||
37663257|NCT02643693|69136159|FG001|Overall Study|Physician Decision|1|||
37663258|NCT02643693|69136160|FG002|Overall Study|Physician Decision|0|||
37663259|NCT02643693|69136161|FG003|Overall Study|Physician Decision|0|||
37663260|NCT02643693|69136162|FG004|Overall Study|Physician Decision|0|||
37663261|NCT02643693|69136163|FG005|Overall Study|Physician Decision|0|||
37663262|NCT02643693|69136158|FG000|Overall Study|Withdrawal by Subject|0|||
37663263|NCT02643693|69136159|FG001|Overall Study|Withdrawal by Subject|1|||
37663264|NCT02643693|69136160|FG002|Overall Study|Withdrawal by Subject|0|||
37663265|NCT02643693|69136161|FG003|Overall Study|Withdrawal by Subject|0|||
37663266|NCT02643693|69136162|FG004|Overall Study|Withdrawal by Subject|0|||
37663267|NCT02643693|69136163|FG005|Overall Study|Withdrawal by Subject|0|||
37663268|NCT02643693|69136158|FG000|Overall Study|Protocol Adherence Issues|2|||
37663269|NCT02643693|69136159|FG001|Overall Study|Protocol Adherence Issues|0|||
37663270|NCT02643693|69136160|FG002|Overall Study|Protocol Adherence Issues|1|||
37663271|NCT02643693|69136161|FG003|Overall Study|Protocol Adherence Issues|0|||
37663272|NCT02643693|69136162|FG004|Overall Study|Protocol Adherence Issues|0|||
37663273|NCT02643693|69136163|FG005|Overall Study|Protocol Adherence Issues|1|||
37663274|NCT02726113|69136173|FG000|Total Enrollment|Physician Decision|0|||
37663275|NCT02726113|69136174|FG001|Total Enrollment|Physician Decision|1|||
37663276|NCT02726113|69136173|FG000|Total Enrollment|Protocol Violation|1|||
37663277|NCT02726113|69136174|FG001|Total Enrollment|Protocol Violation|0|||
37663278|NCT02726113|69136173|FG000|Total Enrollment|Withdrawal by Subject|2|||
37663279|NCT02726113|69136174|FG001|Total Enrollment|Withdrawal by Subject|1|||
37663280|NCT02726113|69136173|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
37663281|NCT02726113|69136174|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
37663282|NCT02726113|69136173|FG000|Genomic Analysis|Protocol Violation|1|||
37663283|NCT02726113|69136174|FG001|Genomic Analysis|Protocol Violation|0|||
37663284|NCT02726113|69136173|FG000|Genomic Analysis|Withdrawal by Subject|2|||
37663285|NCT02726113|69136174|FG001|Genomic Analysis|Withdrawal by Subject|1|||
37663286|NCT02726113|69136173|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
37663287|NCT02726113|69136174|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
37663288|NCT01361919|69136192|FG000|Overall Study|technical issues|10|||
37663289|NCT01361919|69136193|FG001|Overall Study|technical issues|12|||
37663290|NCT01361919|69136194|FG002|Overall Study|technical issues|10|||
37663291|NCT02642679|69136202|FG000|Overall Study|Withdrawal by Subject|1|||
37663292|NCT02642679|69136202|FG000|Overall Study|Physician Decision|1|||
37663293|NCT02642679|69136202|FG000|Overall Study|Physician Decision|1|||
37663294|NCT00705523|69136208|FG000|Overall Study|Lost to Follow-up|2|||
37753663|NCT01732913|69257130|FG000|Overall Study|Withdrawal by Subject|27|||
37753664|NCT01732913|69257131|FG001|Overall Study|Withdrawal by Subject|4|||
37753665|NCT01732913|69257130|FG000|Overall Study|Physician Decision|14|||
37753666|NCT01732913|69257131|FG001|Overall Study|Physician Decision|7|||
37663295|NCT00705523|69136209|FG001|Overall Study|Lost to Follow-up|3|||
37663296|NCT02725411|69136218|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
37663297|NCT02725411|69136219|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
37753667|NCT01732913|69257130|FG000|Overall Study|Other|7|||
37663298|NCT02725411|69136220|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
37663299|NCT02725411|69136218|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
37663300|NCT02725411|69136219|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
37753668|NCT01732913|69257131|FG001|Overall Study|Other|1|||
37663301|NCT02725411|69136220|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
37663302|NCT02725411|69136218|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
37663303|NCT02725411|69136219|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
37663304|NCT02725411|69136220|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
37753669|NCT01732913|69257130|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
37753670|NCT01732913|69257131|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
37753671|NCT01732835|69257162|FG000|6-month Primary Endpoint|Did not receive device|19|||
37753672|NCT01732835|69257162|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
37753673|NCT01732835|69257162|FG000|6-month Primary Endpoint|Adverse Event|3|||
37753674|NCT01732835|69257162|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
37753675|NCT01732835|69257162|FG000|2-year Extended Follow-up|Adverse Event|3|||
37753676|NCT01732835|69257162|FG000|2-year Extended Follow-up|Death|1|||
37753677|NCT01759511|69257216|FG000|Overall Study|Adverse Event|4|||
37753678|NCT01759511|69257216|FG000|Overall Study|Death|2|||
37753679|NCT01759511|69257216|FG000|Overall Study|Lack of Efficacy|2|||
37753680|NCT01759511|69257216|FG000|Overall Study|Physician Decision|1|||
37753681|NCT01759511|69257216|FG000|Overall Study|Progressive Disease|5|||
37753682|NCT01759511|69257216|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
37753683|NCT01759511|69257216|FG000|Overall Study|Study Terminated by Sponsor|13|||
37753684|NCT01759511|69257216|FG000|Overall Study|Withdrawal by Subject|3|||
37753685|NCT01732757|69257234|FG000|Overall Study|Lost to Follow-up|1|||
37753686|NCT01732757|69257235|FG001|Overall Study|Lost to Follow-up|0|||
37753687|NCT01732757|69257236|FG002|Overall Study|Lost to Follow-up|0|||
37753688|NCT01758731|69257244|FG000|Overall Study|Physician Decision|1|||
37753689|NCT01606319|69257254|FG000|Overall Study|Lost to Follow-up|17|||
37753690|NCT01606319|69257255|FG001|Overall Study|Lost to Follow-up|14|||
37753691|NCT01606319|69257254|FG000|Overall Study|Withdrawal by Subject|9|||
37753692|NCT01606319|69257255|FG001|Overall Study|Withdrawal by Subject|12|||
37753693|NCT01606319|69257254|FG000|Overall Study|Physician Decision|1|||
37753694|NCT01606319|69257255|FG001|Overall Study|Physician Decision|2|||
37753695|NCT01606319|69257254|FG000|Overall Study|Lack of Efficacy|6|||
37753696|NCT01606319|69257255|FG001|Overall Study|Lack of Efficacy|8|||
37753697|NCT01606319|69257254|FG000|Overall Study|Adverse Event|1|||
37753698|NCT01606319|69257255|FG001|Overall Study|Adverse Event|4|||
37753699|NCT01757405|69257263|FG000|Overall Study|Lost to Follow-up|1|||
37753700|NCT01757405|69257264|FG001|Overall Study|Lost to Follow-up|1|||
37753701|NCT01757405|69257263|FG000|Overall Study|Withdrawal by Subject|0|||
37753702|NCT01757405|69257264|FG001|Overall Study|Withdrawal by Subject|1|||
37753703|NCT01455597|69257270|FG000|Overall Study|Adverse Event|7|||
37753704|NCT01455597|69257271|FG001|Overall Study|Adverse Event|0|||
37753705|NCT01455597|69257272|FG002|Overall Study|Adverse Event|5|||
37753706|NCT01455597|69257273|FG003|Overall Study|Adverse Event|1|||
37753707|NCT01455597|69257270|FG000|Overall Study|Lack of Efficacy|0|||
37753708|NCT01455597|69257271|FG001|Overall Study|Lack of Efficacy|1|||
37753709|NCT01455597|69257272|FG002|Overall Study|Lack of Efficacy|2|||
37753710|NCT01455597|69257273|FG003|Overall Study|Lack of Efficacy|0|||
37753711|NCT01455597|69257270|FG000|Overall Study|Lost to Follow-up|3|||
37753712|NCT01455597|69257271|FG001|Overall Study|Lost to Follow-up|0|||
37753713|NCT01455597|69257272|FG002|Overall Study|Lost to Follow-up|2|||
37753714|NCT01455597|69257273|FG003|Overall Study|Lost to Follow-up|1|||
37753715|NCT01455597|69257270|FG000|Overall Study|Withdrew Consent|6|||
37753716|NCT01455597|69257271|FG001|Overall Study|Withdrew Consent|5|||
37753717|NCT01455597|69257272|FG002|Overall Study|Withdrew Consent|8|||
37753718|NCT01455597|69257273|FG003|Overall Study|Withdrew Consent|5|||
37753719|NCT01455597|69257270|FG000|Overall Study|Reason not Specified|1|||
37857530|NCT01194219|69540701|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
37663305|NCT02725411|69136218|FG000|Treatment Period (56 Weeks)|Other|1|||
37663306|NCT02725411|69136219|FG001|Treatment Period (56 Weeks)|Other|4|||
37663307|NCT02725411|69136220|FG002|Treatment Period (56 Weeks)|Other|5|||
37663308|NCT02725411|69136218|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
37663309|NCT02725411|69136219|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
37663310|NCT02725411|69136220|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
37663311|NCT02725411|69136218|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
37663312|NCT02725411|69136219|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
37753720|NCT01455597|69257271|FG001|Overall Study|Reason not Specified|2|||
37753721|NCT01455597|69257272|FG002|Overall Study|Reason not Specified|3|||
37753722|NCT01455597|69257273|FG003|Overall Study|Reason not Specified|3|||
37753723|NCT01757171|69257296|FG000|Overall Study|Adverse Event|5|||
37753724|NCT01757171|69257297|FG001|Overall Study|Adverse Event|1|||
37753725|NCT01757171|69257296|FG000|Overall Study|Disease Progression|1|||
37753726|NCT01757171|69257297|FG001|Overall Study|Disease Progression|0|||
37753727|NCT01757171|69257296|FG000|Overall Study|Hospitalization|1|||
37753728|NCT01757171|69257297|FG001|Overall Study|Hospitalization|0|||
37753729|NCT01757171|69257296|FG000|Overall Study|ECOG decline|1|||
37857531|NCT01194219|69540702|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
37857532|NCT01194219|69540703|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
37753730|NCT01757171|69257297|FG001|Overall Study|ECOG decline|0|||
37753731|NCT01756235|69257303|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
37753732|NCT01730729|69257307|FG000|Overall Study|Adverse Event|1|||
37753733|NCT01730729|69257307|FG000|Overall Study|Death|1|||
37753734|NCT01730729|69257307|FG000|Overall Study|Progressive Disease|12|||
37753735|NCT01756157|69257311|FG000|First Intervention Period|Withdrawal by Subject|1|||
37753736|NCT01756157|69257312|FG001|First Intervention Period|Withdrawal by Subject|0|||
37663313|NCT02725411|69136220|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
37663314|NCT02725411|69136218|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
37663315|NCT02725411|69136219|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
37663316|NCT02725411|69136220|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
37663317|NCT02725411|69136218|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
37663318|NCT02725411|69136219|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
37663319|NCT02725411|69136220|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
37663320|NCT02725411|69136218|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
37663321|NCT02725411|69136219|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
37663322|NCT02725411|69136220|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
37663323|NCT02725411|69136218|FG000|Follow-up Period (24 Weeks)|Other|1|||
37663324|NCT02725411|69136219|FG001|Follow-up Period (24 Weeks)|Other|4|||
37663325|NCT02725411|69136220|FG002|Follow-up Period (24 Weeks)|Other|2|||
37663326|NCT02725411|69136218|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
37663327|NCT02725411|69136219|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
37663328|NCT02725411|69136220|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
37663329|NCT02190604|69136256|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
37663330|NCT02190604|69136257|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
37663331|NCT02190604|69136258|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
37663332|NCT02190604|69136259|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
37663333|NCT02190604|69136260|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
37663334|NCT02190604|69136261|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
37663335|NCT02190604|69136262|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
37663336|NCT02190604|69136263|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
37663337|NCT02190604|69136264|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
37663338|NCT02190604|69136265|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
37857533|NCT01194219|69540704|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
37857534|NCT01194219|69540705|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
37663339|NCT02190604|69136266|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
37663340|NCT02190604|69136267|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
37663341|NCT02190604|69136268|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
37663342|NCT02190604|69136269|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
37663343|NCT02190604|69136270|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
37663344|NCT02190604|69136271|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
37663345|NCT02190604|69136272|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
37663346|NCT02190604|69136273|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
37663347|NCT02190604|69136274|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
37663348|NCT02190604|69136256|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
37663349|NCT02190604|69136257|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
37663350|NCT02190604|69136258|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
37753737|NCT01756157|69257311|FG000|First Intervention Period|Lost to Follow-up|0|||
37753738|NCT01756157|69257312|FG001|First Intervention Period|Lost to Follow-up|2|||
37753739|NCT01756079|69257318|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
37753740|NCT01756079|69257318|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
37753741|NCT01756079|69257318|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
37753742|NCT01756079|69257318|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
37753743|NCT01756079|69257318|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
37753744|NCT04967885|69257325|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
37753745|NCT04967885|69257326|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
37753746|NCT04967885|69257325|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
37753747|NCT04967885|69257326|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
37753748|NCT04967885|69257325|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
37753749|NCT04967885|69257326|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
37753750|NCT04967885|69257325|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
37753751|NCT04967885|69257326|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
37753752|NCT04967885|69257325|FG000|EMI-II Intervention|Lost to Follow-up|14|||
37753753|NCT04967885|69257326|FG001|EMI-II Intervention|Lost to Follow-up|10|||
37753754|NCT04571060|69257343|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
37753755|NCT04571060|69257344|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
37857535|NCT01194219|69540706|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
37857536|NCT01194219|69540707|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
37753756|NCT04571060|69257343|FG000|Overall Study|Never treated migraine|47|||
37753757|NCT04571060|69257344|FG001|Overall Study|Never treated migraine|36|||
37857537|NCT01194219|69540708|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
37857538|NCT01194219|69540699|FG000|Maintenance Phase Weeks16-32|Other|0|||
37857539|NCT01194219|69540700|FG001|Maintenance Phase Weeks16-32|Other|0|||
37753758|NCT04571060|69257343|FG000|Overall Study|Protocol Violation|4|||
37753759|NCT04571060|69257344|FG001|Overall Study|Protocol Violation|2|||
37753760|NCT04571060|69257343|FG000|Overall Study|Withdrawal by Subject|6|||
37753761|NCT04571060|69257344|FG001|Overall Study|Withdrawal by Subject|2|||
37753762|NCT04571060|69257343|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
37753763|NCT04571060|69257344|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
37753764|NCT04512066|69257354|FG000|Double-blind Treatment Period|Adverse Event|6|||
37753765|NCT04512066|69257355|FG001|Double-blind Treatment Period|Adverse Event|4|||
37753766|NCT04512066|69257356|FG002|Double-blind Treatment Period|Adverse Event|5|||
37753767|NCT04512066|69257357|FG003|Double-blind Treatment Period|Adverse Event|1|||
37753768|NCT04512066|69257358|FG004|Double-blind Treatment Period|Adverse Event|0|||
37753769|NCT04512066|69257359|FG005|Double-blind Treatment Period|Adverse Event|0|||
37753770|NCT04512066|69257354|FG000|Double-blind Treatment Period|Lack of Efficacy|3|||
37753771|NCT04512066|69257355|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
37753772|NCT04512066|69257356|FG002|Double-blind Treatment Period|Lack of Efficacy|5|||
37753773|NCT04512066|69257357|FG003|Double-blind Treatment Period|Lack of Efficacy|1|||
37753774|NCT04512066|69257358|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
37753775|NCT04512066|69257359|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
37753776|NCT04512066|69257354|FG000|Double-blind Treatment Period|Physician Decision|1|||
37753777|NCT04512066|69257355|FG001|Double-blind Treatment Period|Physician Decision|0|||
37753778|NCT04512066|69257356|FG002|Double-blind Treatment Period|Physician Decision|1|||
37753779|NCT04512066|69257357|FG003|Double-blind Treatment Period|Physician Decision|0|||
37753780|NCT04512066|69257358|FG004|Double-blind Treatment Period|Physician Decision|0|||
37753781|NCT04512066|69257359|FG005|Double-blind Treatment Period|Physician Decision|0|||
37753782|NCT04512066|69257354|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
37753783|NCT04512066|69257355|FG001|Double-blind Treatment Period|Withdrawal by Subject|9|||
37753784|NCT04512066|69257356|FG002|Double-blind Treatment Period|Withdrawal by Subject|5|||
37753785|NCT04512066|69257357|FG003|Double-blind Treatment Period|Withdrawal by Subject|12|||
37753786|NCT04512066|69257358|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
37753787|NCT04512066|69257359|FG005|Double-blind Treatment Period|Withdrawal by Subject|0|||
37753788|NCT04512066|69257354|FG000|Extension Period|Adverse Event|0|||
37753789|NCT04512066|69257355|FG001|Extension Period|Adverse Event|1|||
37753790|NCT04512066|69257356|FG002|Extension Period|Adverse Event|4|||
37753791|NCT04512066|69257357|FG003|Extension Period|Adverse Event|3|||
37753792|NCT04512066|69257358|FG004|Extension Period|Adverse Event|1|||
37753793|NCT04512066|69257359|FG005|Extension Period|Adverse Event|3|||
37753794|NCT04512066|69257354|FG000|Extension Period|Death|0|||
37753795|NCT04512066|69257355|FG001|Extension Period|Death|0|||
37753796|NCT04512066|69257356|FG002|Extension Period|Death|0|||
37753797|NCT04512066|69257357|FG003|Extension Period|Death|0|||
37753798|NCT04512066|69257358|FG004|Extension Period|Death|0|||
37753799|NCT04512066|69257359|FG005|Extension Period|Death|1|||
37663351|NCT02190604|69136259|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
37663352|NCT02190604|69136260|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
37663353|NCT02190604|69136261|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
37663354|NCT02190604|69136262|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
37663355|NCT02190604|69136263|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
37663356|NCT02190604|69136264|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
37663357|NCT02190604|69136265|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
37663358|NCT02190604|69136266|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
37663359|NCT02190604|69136267|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
37663360|NCT02190604|69136268|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
37663361|NCT02190604|69136269|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
37663362|NCT02190604|69136270|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
37663363|NCT02190604|69136271|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
37663364|NCT02190604|69136272|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
37663365|NCT02190604|69136273|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
37663366|NCT02190604|69136274|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
37663367|NCT02127970|69136333|FG000|Overall Study|Adverse Event|2|||
37663368|NCT02127970|69136334|FG001|Overall Study|Adverse Event|1|||
37663369|NCT02127970|69136333|FG000|Overall Study|Death|1|||
37663370|NCT02127970|69136334|FG001|Overall Study|Death|1|||
37663371|NCT02127970|69136333|FG000|Overall Study|Lost to Follow-up|14|||
37753800|NCT04512066|69257354|FG000|Extension Period|Lack of Efficacy|0|||
37753801|NCT04512066|69257355|FG001|Extension Period|Lack of Efficacy|4|||
37753802|NCT04512066|69257356|FG002|Extension Period|Lack of Efficacy|4|||
37753803|NCT04512066|69257357|FG003|Extension Period|Lack of Efficacy|1|||
37753804|NCT04512066|69257358|FG004|Extension Period|Lack of Efficacy|3|||
37753805|NCT04512066|69257359|FG005|Extension Period|Lack of Efficacy|3|||
37753806|NCT04512066|69257354|FG000|Extension Period|Lost to Follow-up|0|||
37753807|NCT04512066|69257355|FG001|Extension Period|Lost to Follow-up|1|||
37753808|NCT04512066|69257356|FG002|Extension Period|Lost to Follow-up|5|||
37753809|NCT04512066|69257357|FG003|Extension Period|Lost to Follow-up|2|||
37663372|NCT02127970|69136334|FG001|Overall Study|Lost to Follow-up|14|||
37663373|NCT02127970|69136333|FG000|Overall Study|Reason not Specified|4|||
37663374|NCT02127970|69136334|FG001|Overall Study|Reason not Specified|7|||
37663375|NCT02127970|69136333|FG000|Overall Study|Pregnancy|0|||
37663376|NCT02127970|69136334|FG001|Overall Study|Pregnancy|1|||
37663377|NCT02127970|69136333|FG000|Overall Study|Subject Withdrew Consent|5|||
37663378|NCT02127970|69136334|FG001|Overall Study|Subject Withdrew Consent|3|||
37663379|NCT03549871|69136342|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
37663380|NCT03549871|69136343|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
37663381|NCT03549871|69136342|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
37663382|NCT03549871|69136343|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
37663383|NCT03549871|69136342|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
37663384|NCT03549871|69136343|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
37663385|NCT03549871|69136342|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
37663386|NCT03549871|69136343|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
37663387|NCT03549871|69136342|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
37663388|NCT03549871|69136343|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
37663389|NCT03549871|69136342|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
37663390|NCT03549871|69136343|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
37663391|NCT03549871|69136342|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
37753810|NCT04512066|69257358|FG004|Extension Period|Lost to Follow-up|3|||
37753811|NCT04512066|69257359|FG005|Extension Period|Lost to Follow-up|2|||
37753812|NCT04512066|69257354|FG000|Extension Period|Non-compliance with study drug|0|||
37753813|NCT04512066|69257355|FG001|Extension Period|Non-compliance with study drug|1|||
37753814|NCT04512066|69257356|FG002|Extension Period|Non-compliance with study drug|0|||
37753815|NCT04512066|69257357|FG003|Extension Period|Non-compliance with study drug|0|||
37753816|NCT04512066|69257358|FG004|Extension Period|Non-compliance with study drug|0|||
37753817|NCT04512066|69257359|FG005|Extension Period|Non-compliance with study drug|1|||
37753818|NCT04512066|69257354|FG000|Extension Period|Other|0|||
37753819|NCT04512066|69257355|FG001|Extension Period|Other|2|||
37753820|NCT04512066|69257356|FG002|Extension Period|Other|0|||
37753821|NCT04512066|69257357|FG003|Extension Period|Other|0|||
37753822|NCT04512066|69257358|FG004|Extension Period|Other|0|||
37753823|NCT04512066|69257359|FG005|Extension Period|Other|0|||
37753824|NCT04512066|69257354|FG000|Extension Period|Physician Decision|0|||
37753825|NCT04512066|69257355|FG001|Extension Period|Physician Decision|2|||
37753826|NCT04512066|69257356|FG002|Extension Period|Physician Decision|0|||
37753827|NCT04512066|69257357|FG003|Extension Period|Physician Decision|1|||
37753828|NCT04512066|69257358|FG004|Extension Period|Physician Decision|1|||
37753829|NCT04512066|69257359|FG005|Extension Period|Physician Decision|0|||
37753830|NCT04512066|69257354|FG000|Extension Period|Withdrawal by Subject|0|||
37753831|NCT04512066|69257355|FG001|Extension Period|Withdrawal by Subject|3|||
37753832|NCT04512066|69257356|FG002|Extension Period|Withdrawal by Subject|7|||
37753833|NCT04512066|69257357|FG003|Extension Period|Withdrawal by Subject|11|||
37753834|NCT04512066|69257358|FG004|Extension Period|Withdrawal by Subject|8|||
37753835|NCT04512066|69257359|FG005|Extension Period|Withdrawal by Subject|4|||
37753836|NCT04426318|69257381|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
37663392|NCT03549871|69136343|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
37663393|NCT03549871|69136342|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
37663394|NCT03549871|69136343|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
37663395|NCT03549871|69136342|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
37753837|NCT04426318|69257382|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
37753838|NCT04356963|69257397|FG000|First Session|Withdrawal by Subject|1|||
37753839|NCT04356963|69257397|FG000|Second Session|Withdrawal by Subject|3|||
37753840|NCT04356963|69257397|FG000|Second Session|Lost to Follow-up|1|||
37753841|NCT04356963|69257397|FG000|Third Session|Lost to Follow-up|6|||
37753842|NCT04356963|69257397|FG000|Third Session|Withdrawal by Subject|1|||
37753843|NCT03941483|69257410|FG000|Overall Study|Miscellaneous|2|||
37663396|NCT03549871|69136343|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
37663397|NCT03549871|69136342|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
37663398|NCT03549871|69136343|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
37753844|NCT03941483|69257411|FG001|Overall Study|Miscellaneous|3|||
37753845|NCT03941483|69257412|FG002|Overall Study|Miscellaneous|0|||
37753846|NCT03941483|69257410|FG000|Overall Study|Study Terminated by Sponsor|1|||
37753847|NCT03941483|69257411|FG001|Overall Study|Study Terminated by Sponsor|0|||
37753848|NCT03941483|69257412|FG002|Overall Study|Study Terminated by Sponsor|0|||
37753849|NCT03941483|69257410|FG000|Overall Study|Withdrawal by Subject|1|||
37753850|NCT03941483|69257411|FG001|Overall Study|Withdrawal by Subject|4|||
37753851|NCT03941483|69257412|FG002|Overall Study|Withdrawal by Subject|1|||
37857540|NCT01194219|69540701|FG002|Maintenance Phase Weeks16-32|Other|2|||
37753852|NCT03941483|69257410|FG000|Overall Study|Lost to Follow-up|2|||
37923349|NCT00652834|69610162|FG000|Overall Study|Withdrawal by Subject|3|||
37923350|NCT00652834|69610162|FG000|Overall Study|Lost to Follow-up|2|||
37663399|NCT03549871|69136342|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
37663400|NCT03549871|69136343|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
37663401|NCT00705367|69136366|FG000|Long-term Extension Period|Adverse Event|2|||
37663402|NCT00705367|69136367|FG001|Long-term Extension Period|Adverse Event|0|||
37663403|NCT00705367|69136366|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
37663404|NCT00705367|69136367|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
37663405|NCT00705367|69136366|FG000|Long-term Extension Period|Lack of Efficacy|1|||
37663406|NCT00705367|69136367|FG001|Long-term Extension Period|Lack of Efficacy|0|||
37663407|NCT00705367|69136366|FG000|Long-term Extension Period|No longer met study criteria|1|||
37663408|NCT00705367|69136367|FG001|Long-term Extension Period|No longer met study criteria|0|||
37663409|NCT00705367|69136366|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
37663410|NCT00705367|69136367|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
37663411|NCT00705289|69136375|FG000|Overall Study|Subject or treating physician's choice|131|||
37663412|NCT02038777|69136404|FG000|Overall Study|Death|0|||
37663413|NCT02038777|69136405|FG001|Overall Study|Death|2|||
37663414|NCT02038777|69136406|FG002|Overall Study|Death|0|||
37663415|NCT02038777|69136407|FG003|Overall Study|Death|1|||
37663416|NCT02038777|69136408|FG004|Overall Study|Death|2|||
37663417|NCT02038777|69136409|FG005|Overall Study|Death|4|||
37663418|NCT02038777|69136410|FG006|Overall Study|Death|0|||
37663419|NCT02038777|69136411|FG007|Overall Study|Death|10|||
37663420|NCT02038777|69136404|FG000|Overall Study|Lost to Follow-up|0|||
37663421|NCT02038777|69136405|FG001|Overall Study|Lost to Follow-up|0|||
37663422|NCT02038777|69136406|FG002|Overall Study|Lost to Follow-up|0|||
37663423|NCT02038777|69136407|FG003|Overall Study|Lost to Follow-up|1|||
37663424|NCT02038777|69136408|FG004|Overall Study|Lost to Follow-up|0|||
37663425|NCT02038777|69136409|FG005|Overall Study|Lost to Follow-up|0|||
37663426|NCT02038777|69136410|FG006|Overall Study|Lost to Follow-up|0|||
37663427|NCT02038777|69136411|FG007|Overall Study|Lost to Follow-up|0|||
37663428|NCT02038777|69136404|FG000|Overall Study|Other|0|||
37663429|NCT02038777|69136405|FG001|Overall Study|Other|1|||
37663430|NCT02038777|69136406|FG002|Overall Study|Other|0|||
37663431|NCT02038777|69136407|FG003|Overall Study|Other|2|||
37663432|NCT02038777|69136408|FG004|Overall Study|Other|1|||
37663433|NCT02038777|69136409|FG005|Overall Study|Other|0|||
37663434|NCT02038777|69136410|FG006|Overall Study|Other|0|||
37663435|NCT02038777|69136411|FG007|Overall Study|Other|0|||
37663436|NCT02038777|69136404|FG000|Overall Study|Randomized but not treated|0|||
37663437|NCT02038777|69136405|FG001|Overall Study|Randomized but not treated|1|||
37663438|NCT02038777|69136406|FG002|Overall Study|Randomized but not treated|0|||
37663439|NCT02038777|69136407|FG003|Overall Study|Randomized but not treated|0|||
37663440|NCT02038777|69136408|FG004|Overall Study|Randomized but not treated|0|||
37663441|NCT02038777|69136409|FG005|Overall Study|Randomized but not treated|0|||
37663442|NCT02038777|69136410|FG006|Overall Study|Randomized but not treated|0|||
37663443|NCT02038777|69136411|FG007|Overall Study|Randomized but not treated|0|||
37663444|NCT02038777|69136404|FG000|Overall Study|Started Chemotherapy|1|||
37663445|NCT02038777|69136405|FG001|Overall Study|Started Chemotherapy|0|||
37663446|NCT02038777|69136406|FG002|Overall Study|Started Chemotherapy|3|||
37663447|NCT02038777|69136407|FG003|Overall Study|Started Chemotherapy|0|||
37663448|NCT02038777|69136408|FG004|Overall Study|Started Chemotherapy|0|||
37663449|NCT02038777|69136409|FG005|Overall Study|Started Chemotherapy|0|||
37663450|NCT02038777|69136410|FG006|Overall Study|Started Chemotherapy|0|||
37663451|NCT02038777|69136411|FG007|Overall Study|Started Chemotherapy|0|||
37663452|NCT00703963|69136430|FG000|Overall Study|Withdrawal by Subject|7|||
37663453|NCT00703963|69136431|FG001|Overall Study|Withdrawal by Subject|13|||
37663454|NCT00703963|69136430|FG000|Overall Study|Physician Decision|0|||
37663455|NCT00703963|69136431|FG001|Overall Study|Physician Decision|1|||
37663456|NCT02721355|69136439|FG000|Overall Study|Lost to Follow-up|6|||
37663457|NCT02721355|69136440|FG001|Overall Study|Lost to Follow-up|1|||
37663458|NCT02733991|69136448|FG000|Overall Study|Adverse Event|1|||
37663459|NCT02733991|69136449|FG001|Overall Study|Adverse Event|0|||
37663460|NCT02733991|69136448|FG000|Overall Study|Withdrawal by Subject|0|||
37663461|NCT02733991|69136449|FG001|Overall Study|Withdrawal by Subject|5|||
37663462|NCT00702949|69136458|FG000|Overall Study|Refusal|3|||
37663463|NCT00702949|69136459|FG001|Overall Study|Refusal|2|||
37663464|NCT00702949|69136460|FG002|Overall Study|Refusal|2|||
37663465|NCT00702949|69136458|FG000|Overall Study|Adverse Event|1|||
37663466|NCT00702949|69136459|FG001|Overall Study|Adverse Event|6|||
37663467|NCT00702949|69136460|FG002|Overall Study|Adverse Event|3|||
37663468|NCT00702949|69136458|FG000|Overall Study|Other Medical Reason/unknown|1|||
37663469|NCT00702949|69136459|FG001|Overall Study|Other Medical Reason/unknown|1|||
37663470|NCT00702949|69136460|FG002|Overall Study|Other Medical Reason/unknown|3|||
37663471|NCT00702715|69136472|FG000|Overall Study|Lost to Follow-up|1|||
37663472|NCT00702715|69136473|FG001|Overall Study|Lost to Follow-up|0|||
37753853|NCT03941483|69257411|FG001|Overall Study|Lost to Follow-up|1|||
37753854|NCT03941483|69257412|FG002|Overall Study|Lost to Follow-up|8|||
37753855|NCT03941483|69257410|FG000|Overall Study|Death|3|||
37753856|NCT03941483|69257411|FG001|Overall Study|Death|2|||
37753857|NCT03941483|69257412|FG002|Overall Study|Death|6|||
37753858|NCT03689855|69257448|FG000|Overall Study|Adverse Event|3|||
37753859|NCT03689855|69257448|FG000|Overall Study|Withdrawal by Subject|1|||
37753860|NCT03635996|69257452|FG000|Overall Study|Study terminated by Sponsor|94|||
37753861|NCT03635996|69257452|FG000|Overall Study|Withdrawal by Subject|20|||
37753862|NCT03635996|69257452|FG000|Overall Study|Ablation|26|||
37753863|NCT03635996|69257452|FG000|Overall Study|Adverse Event|7|||
37663473|NCT00702403|69136479|FG000|From Consent to Engraftment|Progressive leukemia|6|||
37663474|NCT00702403|69136479|FG000|From Consent to Engraftment|Critically ill|2|||
37663475|NCT00702403|69136479|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
37663476|NCT00702403|69136479|FG000|From Consent to Engraftment|Myocardial infarction|1|||
37663477|NCT00702403|69136479|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
37663478|NCT00702403|69136479|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
37663479|NCT00702403|69136479|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
37753864|NCT03635996|69257452|FG000|Overall Study|Physician Decision|3|||
37753865|NCT03635996|69257452|FG000|Overall Study|Prohibited medication|5|||
37753866|NCT03635996|69257452|FG000|Overall Study|Did not meet eligibility criteria|5|||
37753867|NCT03635996|69257452|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
37753868|NCT03635996|69257452|FG000|Overall Study|Protocol Violation|1|||
37753869|NCT03635996|69257452|FG000|Overall Study|Lost to Follow-up|1|||
37857541|NCT01194219|69540702|FG003|Maintenance Phase Weeks16-32|Other|1|||
37857542|NCT01194219|69540703|FG004|Maintenance Phase Weeks16-32|Other|0|||
37857543|NCT01194219|69540704|FG005|Maintenance Phase Weeks16-32|Other|0|||
37857544|NCT01194219|69540705|FG006|Maintenance Phase Weeks16-32|Other|0|||
37857545|NCT01194219|69540706|FG007|Maintenance Phase Weeks16-32|Other|0|||
37857546|NCT01194219|69540707|FG008|Maintenance Phase Weeks16-32|Other|0|||
37857547|NCT01194219|69540708|FG009|Maintenance Phase Weeks16-32|Other|0|||
37857548|NCT01194219|69540699|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
37857549|NCT01194219|69540700|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
37857550|NCT01194219|69540701|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
37857551|NCT01194219|69540702|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
37857552|NCT01194219|69540703|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
37857553|NCT01194219|69540704|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
37857554|NCT01194219|69540705|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
37857555|NCT01194219|69540706|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
37857556|NCT01194219|69540707|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
37857557|NCT01194219|69540708|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
37857558|NCT01194219|69540699|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
37857559|NCT01194219|69540700|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
37857560|NCT01194219|69540701|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
37857561|NCT01194219|69540702|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
37857562|NCT01194219|69540703|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
37857563|NCT01194219|69540704|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
37857564|NCT01194219|69540705|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
37857565|NCT01194219|69540706|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
37857566|NCT01194219|69540707|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
37857567|NCT01194219|69540708|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
37857568|NCT01194219|69540699|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
37857569|NCT01194219|69540700|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
37857570|NCT01194219|69540701|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
37857571|NCT01194219|69540702|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
37857572|NCT01194219|69540703|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
37857573|NCT01194219|69540704|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
37857574|NCT01194219|69540705|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
37857575|NCT01194219|69540706|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
37663480|NCT00702403|69136479|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
37663481|NCT00702403|69136479|FG000|From Engraftment to Study Completion|Non-compliance|2|||
37753870|NCT03595878|69257459|FG000|Overall Study|Death|2|||
37753871|NCT03595878|69257460|FG001|Overall Study|Death|1|||
37753872|NCT03595878|69257461|FG002|Overall Study|Death|0|||
37857576|NCT01194219|69540707|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
37923351|NCT00825812|69610170|FG000|Overall Study|Never entered follow up|0|||
37753873|NCT03595878|69257459|FG000|Overall Study|Disease progression|2|||
37753874|NCT03595878|69257460|FG001|Overall Study|Disease progression|1|||
37753875|NCT03595878|69257461|FG002|Overall Study|Disease progression|2|||
37753876|NCT03168464|69257507|FG000|Overall Study|Death|9|||
37663482|NCT00702403|69136479|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
37663483|NCT00702403|69136479|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
37753877|NCT03168464|69257507|FG000|Overall Study|Progression of disease|6|||
37753878|NCT02818920|69257511|FG000|Overall Study|Unresectable|4|||
37753879|NCT02818920|69257511|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
37753880|NCT02818920|69257511|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
37753881|NCT02818920|69257511|FG000|Overall Study|Adverse Event|3|||
37753882|NCT02818920|69257511|FG000|Overall Study|Developed Other Disease|1|||
37753883|NCT02818920|69257511|FG000|Overall Study|Refused Further Treatment|1|||
37753884|NCT01454401|69257537|FG000|Overall Study|Death|1|||
37857577|NCT01194219|69540708|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
37857578|NCT01194219|69540699|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
37857579|NCT01194219|69540700|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
37857580|NCT01194219|69540701|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
37857581|NCT01194219|69540702|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
37857582|NCT01194219|69540703|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
37857583|NCT01194219|69540704|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
37857584|NCT01194219|69540705|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
37857585|NCT01194219|69540706|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
37857586|NCT01194219|69540707|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
37857587|NCT01194219|69540708|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
37857588|NCT01194219|69540699|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
37857589|NCT01194219|69540700|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
37857590|NCT01194219|69540701|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
37857591|NCT01194219|69540702|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
37857592|NCT01194219|69540703|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
37857593|NCT01194219|69540704|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
37857594|NCT01194219|69540705|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
37857595|NCT01194219|69540706|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
37857596|NCT01194219|69540707|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
37857597|NCT01194219|69540708|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
37857598|NCT01194219|69540699|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
37857599|NCT01194219|69540700|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
37857600|NCT01194219|69540701|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
37857601|NCT01194219|69540702|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
37857602|NCT01194219|69540703|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
37857603|NCT01194219|69540704|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
37857604|NCT01194219|69540705|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
37857605|NCT01194219|69540706|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
37857606|NCT01194219|69540707|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
37857607|NCT01194219|69540708|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
37857608|NCT01194219|69540699|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
37857609|NCT01194219|69540700|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
37857610|NCT01194219|69540701|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
37857611|NCT01194219|69540702|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
37857612|NCT01194219|69540703|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
37857613|NCT01194219|69540704|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
37753885|NCT01454401|69257537|FG000|Overall Study|hospitalised|1|||
37753886|NCT01454401|69257537|FG000|Overall Study|osteomyelitis|2|||
37857614|NCT01194219|69540705|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
37857615|NCT01194219|69540706|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
37857616|NCT01194219|69540707|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
37923352|NCT00825812|69610171|FG001|Overall Study|Never entered follow up|0|||
37923353|NCT00825812|69610172|FG002|Overall Study|Never entered follow up|0|||
37923354|NCT00825812|69610173|FG003|Overall Study|Never entered follow up|1|||
37663484|NCT00702403|69136479|FG000|From Engraftment to Study Completion|Suicide|1|||
37663485|NCT00702403|69136479|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
37663486|NCT00702403|69136479|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
37663487|NCT00702403|69136479|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
37663488|NCT00702325|69136488|FG000|Overall Study|Adverse Event|1|||
37663489|NCT00702325|69136489|FG001|Overall Study|Adverse Event|0|||
37753887|NCT01454401|69257537|FG000|Overall Study|non-adherence|1|||
37753888|NCT01344018|69257543|FG000|Overall Study|Death|22|||
37753889|NCT01344018|69257544|FG001|Overall Study|Death|25|||
37753890|NCT01344018|69257543|FG000|Overall Study|Lost to Follow-up|4|||
37753891|NCT01344018|69257544|FG001|Overall Study|Lost to Follow-up|7|||
37753892|NCT01755767|69257577|FG000|Overall Study|Progressive Disease|8|||
37753893|NCT01755767|69257578|FG001|Overall Study|Progressive Disease|7|||
37753894|NCT01755767|69257579|FG002|Overall Study|Progressive Disease|91|||
37753895|NCT01755767|69257580|FG003|Overall Study|Progressive Disease|43|||
37753896|NCT01755767|69257577|FG000|Overall Study|Clinical Disease Progression|4|||
37753897|NCT01755767|69257578|FG001|Overall Study|Clinical Disease Progression|2|||
37753898|NCT01755767|69257579|FG002|Overall Study|Clinical Disease Progression|29|||
37753899|NCT01755767|69257580|FG003|Overall Study|Clinical Disease Progression|20|||
37753900|NCT01755767|69257577|FG000|Overall Study|Radiographic Disease Progression|9|||
37753901|NCT01755767|69257578|FG001|Overall Study|Radiographic Disease Progression|4|||
37753902|NCT01755767|69257579|FG002|Overall Study|Radiographic Disease Progression|44|||
37753903|NCT01755767|69257580|FG003|Overall Study|Radiographic Disease Progression|27|||
37753904|NCT01755767|69257577|FG000|Overall Study|Adverse Event|6|||
37663490|NCT00702325|69136488|FG000|Overall Study|Withdrawal by Subject|7|||
37663491|NCT00702325|69136489|FG001|Overall Study|Withdrawal by Subject|7|||
37663492|NCT00702325|69136488|FG000|Overall Study|Lost to Follow-up|3|||
37663493|NCT00702325|69136489|FG001|Overall Study|Lost to Follow-up|4|||
37663494|NCT00702325|69136488|FG000|Overall Study|Incorrect enrollment|5|||
37663495|NCT00702325|69136489|FG001|Overall Study|Incorrect enrollment|7|||
37663496|NCT00702325|69136488|FG000|Overall Study|Developed study discontinuation criteria|18|||
37663497|NCT00702325|69136489|FG001|Overall Study|Developed study discontinuation criteria|28|||
37663498|NCT00702325|69136488|FG000|Overall Study|Severe noncompliance to protocol|3|||
37663499|NCT00702325|69136489|FG001|Overall Study|Severe noncompliance to protocol|3|||
37663500|NCT00702325|69136488|FG000|Overall Study|Termination due to lab results|1|||
37663501|NCT00702325|69136489|FG001|Overall Study|Termination due to lab results|0|||
37663502|NCT00702325|69136488|FG000|Overall Study|Didn't follow study medication dosage|0|||
37663503|NCT00702325|69136489|FG001|Overall Study|Didn't follow study medication dosage|2|||
37753905|NCT01755767|69257578|FG001|Overall Study|Adverse Event|0|||
37753906|NCT01755767|69257579|FG002|Overall Study|Adverse Event|28|||
37753907|NCT01755767|69257580|FG003|Overall Study|Adverse Event|11|||
37753908|NCT01755767|69257577|FG000|Overall Study|Death|1|||
37753909|NCT01755767|69257578|FG001|Overall Study|Death|2|||
37753910|NCT01755767|69257579|FG002|Overall Study|Death|15|||
37753911|NCT01755767|69257580|FG003|Overall Study|Death|4|||
37753912|NCT01755767|69257577|FG000|Overall Study|Subject Decision|0|||
37753913|NCT01755767|69257578|FG001|Overall Study|Subject Decision|0|||
37753914|NCT01755767|69257579|FG002|Overall Study|Subject Decision|10|||
37753915|NCT01755767|69257580|FG003|Overall Study|Subject Decision|3|||
37753916|NCT01755767|69257577|FG000|Overall Study|Withdrawal by Subject|0|||
37753917|NCT01755767|69257578|FG001|Overall Study|Withdrawal by Subject|0|||
37753918|NCT01755767|69257579|FG002|Overall Study|Withdrawal by Subject|2|||
37753919|NCT01755767|69257580|FG003|Overall Study|Withdrawal by Subject|1|||
37753920|NCT01755767|69257577|FG000|Overall Study|Other|0|||
37753921|NCT01755767|69257578|FG001|Overall Study|Other|0|||
37753922|NCT01755767|69257579|FG002|Overall Study|Other|2|||
37753923|NCT01755767|69257580|FG003|Overall Study|Other|3|||
37753924|NCT01755767|69257577|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
37753925|NCT01755767|69257578|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
37753926|NCT01755767|69257579|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
37753927|NCT01755767|69257580|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
37753928|NCT01730339|69257676|FG000|Overall Study|Withdrawal by Subject|3|||
37753929|NCT01730339|69257677|FG001|Overall Study|Withdrawal by Subject|2|||
37753930|NCT01730339|69257676|FG000|Overall Study|Lost to Follow-up|1|||
37663504|NCT00702325|69136488|FG000|Overall Study|Withdrew consent|0|||
37663505|NCT00702325|69136489|FG001|Overall Study|Withdrew consent|1|||
37663506|NCT00702325|69136488|FG000|Overall Study|Incorrectly Discontinued|0|||
37663507|NCT00702325|69136489|FG001|Overall Study|Incorrectly Discontinued|1|||
37663508|NCT02719171|69136500|FG000|Overall Study|Adverse Event|1|||
37663509|NCT02719171|69136501|FG001|Overall Study|Adverse Event|2|||
37663510|NCT02719171|69136502|FG002|Overall Study|Adverse Event|0|||
37663511|NCT02719171|69136503|FG003|Overall Study|Adverse Event|0|||
37753931|NCT01730339|69257677|FG001|Overall Study|Lost to Follow-up|1|||
37753932|NCT01730339|69257676|FG000|Overall Study|Un-specified|1|||
37753933|NCT01730339|69257677|FG001|Overall Study|Un-specified|0|||
37753934|NCT01754753|69257734|FG000|Overall Study|Study close|43|||
37753935|NCT01754753|69257735|FG001|Overall Study|Study close|44|||
37663512|NCT02719171|69136504|FG004|Overall Study|Adverse Event|2|||
37663513|NCT02719171|69136500|FG000|Overall Study|Lost to Follow-up|0|||
37753936|NCT01754753|69257734|FG000|Overall Study|Lost to Follow-up|9|||
37923355|NCT00825812|69610170|FG000|Overall Study|Adverse Event|0|||
37923356|NCT00825812|69610171|FG001|Overall Study|Adverse Event|0|||
37663514|NCT02719171|69136501|FG001|Overall Study|Lost to Follow-up|0|||
37663515|NCT02719171|69136502|FG002|Overall Study|Lost to Follow-up|1|||
37753937|NCT01754753|69257735|FG001|Overall Study|Lost to Follow-up|5|||
37753938|NCT01729871|69257743|FG000|Overall Study|Adverse Event|7|||
37753939|NCT01729871|69257744|FG001|Overall Study|Adverse Event|7|||
37753940|NCT01729871|69257743|FG000|Overall Study|Death|0|||
37753941|NCT01729871|69257744|FG001|Overall Study|Death|1|||
37753942|NCT01729871|69257743|FG000|Overall Study|Lack of Efficacy|0|||
37753943|NCT01729871|69257744|FG001|Overall Study|Lack of Efficacy|1|||
37663516|NCT02719171|69136503|FG003|Overall Study|Lost to Follow-up|0|||
37663517|NCT02719171|69136504|FG004|Overall Study|Lost to Follow-up|0|||
37663518|NCT02719171|69136500|FG000|Overall Study|Subject Withdrawal|0|||
37753944|NCT01729871|69257743|FG000|Overall Study|Physician Decision|0|||
37753945|NCT01729871|69257744|FG001|Overall Study|Physician Decision|2|||
37753946|NCT01729871|69257743|FG000|Overall Study|Protocol Violation|1|||
37753947|NCT01729871|69257744|FG001|Overall Study|Protocol Violation|0|||
37753948|NCT01729871|69257743|FG000|Overall Study|Withdrawal by Subject|0|||
37753949|NCT01729871|69257744|FG001|Overall Study|Withdrawal by Subject|3|||
37753950|NCT01729871|69257743|FG000|Overall Study|Other|4|||
37753951|NCT01729871|69257744|FG001|Overall Study|Other|9|||
37753952|NCT02611323|69257761|FG000|Overall Study|Death|3|||
37753953|NCT02611323|69257762|FG001|Overall Study|Death|1|||
37753954|NCT02611323|69257763|FG002|Overall Study|Death|0|||
37753955|NCT02611323|69257764|FG003|Overall Study|Death|0|||
37753956|NCT02611323|69257765|FG004|Overall Study|Death|1|||
37753957|NCT02611323|69257766|FG005|Overall Study|Death|1|||
37753958|NCT02611323|69257767|FG006|Overall Study|Death|8|||
37753959|NCT02611323|69257768|FG007|Overall Study|Death|0|||
37753960|NCT02611323|69257769|FG008|Overall Study|Death|4|||
37753961|NCT02611323|69257770|FG009|Overall Study|Death|6|||
37753962|NCT02611323|69257771|FG010|Overall Study|Death|26|||
37753963|NCT02611323|69257761|FG000|Overall Study|Lost to Follow-up|1|||
37753964|NCT02611323|69257762|FG001|Overall Study|Lost to Follow-up|0|||
37753965|NCT02611323|69257763|FG002|Overall Study|Lost to Follow-up|0|||
37753966|NCT02611323|69257764|FG003|Overall Study|Lost to Follow-up|0|||
37753967|NCT02611323|69257765|FG004|Overall Study|Lost to Follow-up|0|||
37753968|NCT02611323|69257766|FG005|Overall Study|Lost to Follow-up|0|||
37753969|NCT02611323|69257767|FG006|Overall Study|Lost to Follow-up|3|||
37663519|NCT02719171|69136501|FG001|Overall Study|Subject Withdrawal|2|||
37663520|NCT02719171|69136502|FG002|Overall Study|Subject Withdrawal|2|||
37663521|NCT02719171|69136503|FG003|Overall Study|Subject Withdrawal|1|||
37663522|NCT02719171|69136504|FG004|Overall Study|Subject Withdrawal|0|||
37663523|NCT02719171|69136500|FG000|Overall Study|Other|0|||
37663524|NCT02719171|69136501|FG001|Overall Study|Other|0|||
37663525|NCT02719171|69136502|FG002|Overall Study|Other|0|||
37663526|NCT02719171|69136503|FG003|Overall Study|Other|1|||
37663527|NCT02719171|69136504|FG004|Overall Study|Other|0|||
37663528|NCT02718625|69136521|FG000|Overall Study|Adverse Event|0|||
37663529|NCT02718625|69136522|FG001|Overall Study|Adverse Event|1|||
37663530|NCT02718625|69136521|FG000|Overall Study|Termination of Study by Sponsor|0|||
37663531|NCT02718625|69136522|FG001|Overall Study|Termination of Study by Sponsor|1|||
37663532|NCT02716987|69136534|FG000|Overall Study|Ligand synthesis failure|0|||
37663533|NCT02716987|69136535|FG001|Overall Study|Ligand synthesis failure|0|||
37663534|NCT02716987|69136536|FG002|Overall Study|Ligand synthesis failure|1|||
37753970|NCT02611323|69257768|FG007|Overall Study|Lost to Follow-up|0|||
37753971|NCT02611323|69257769|FG008|Overall Study|Lost to Follow-up|0|||
37753972|NCT02611323|69257770|FG009|Overall Study|Lost to Follow-up|0|||
37753973|NCT02611323|69257771|FG010|Overall Study|Lost to Follow-up|2|||
37753974|NCT02611323|69257761|FG000|Overall Study|Found Another Malignancy After Starting Trial|0|||
37753975|NCT02611323|69257762|FG001|Overall Study|Found Another Malignancy After Starting Trial|0|||
37753976|NCT02611323|69257763|FG002|Overall Study|Found Another Malignancy After Starting Trial|0|||
37753977|NCT02611323|69257764|FG003|Overall Study|Found Another Malignancy After Starting Trial|0|||
37753978|NCT02611323|69257765|FG004|Overall Study|Found Another Malignancy After Starting Trial|0|||
37663535|NCT02716987|69136537|FG003|Overall Study|Ligand synthesis failure|0|||
37663536|NCT02716987|69136538|FG004|Overall Study|Ligand synthesis failure|0|||
37663537|NCT02716987|69136539|FG005|Overall Study|Ligand synthesis failure|0|||
37663538|NCT02716987|69136534|FG000|Overall Study|Withdrawal by Subject|0|||
37663539|NCT02716987|69136535|FG001|Overall Study|Withdrawal by Subject|0|||
37663540|NCT02716987|69136536|FG002|Overall Study|Withdrawal by Subject|0|||
37663541|NCT02716987|69136537|FG003|Overall Study|Withdrawal by Subject|0|||
37663542|NCT02716987|69136538|FG004|Overall Study|Withdrawal by Subject|1|||
37663543|NCT02716987|69136539|FG005|Overall Study|Withdrawal by Subject|1|||
37923357|NCT00825812|69610172|FG002|Overall Study|Adverse Event|0|||
37663544|NCT00701779|69136564|FG000|Overall Study|Adverse Event|6|||
37663545|NCT00701779|69136564|FG000|Overall Study|Lost to Follow-up|1|||
37663546|NCT00701779|69136564|FG000|Overall Study|Withdrawal by Subject|2|||
37753979|NCT02611323|69257766|FG005|Overall Study|Found Another Malignancy After Starting Trial|0|||
37753980|NCT02611323|69257767|FG006|Overall Study|Found Another Malignancy After Starting Trial|0|||
37753981|NCT02611323|69257768|FG007|Overall Study|Found Another Malignancy After Starting Trial|0|||
37753982|NCT02611323|69257769|FG008|Overall Study|Found Another Malignancy After Starting Trial|0|||
37753983|NCT02611323|69257770|FG009|Overall Study|Found Another Malignancy After Starting Trial|1|||
37753984|NCT02611323|69257771|FG010|Overall Study|Found Another Malignancy After Starting Trial|0|||
37923358|NCT00825812|69610173|FG003|Overall Study|Adverse Event|1|||
37753985|NCT02611323|69257761|FG000|Overall Study|Progressive Disease|0|||
37753986|NCT02611323|69257762|FG001|Overall Study|Progressive Disease|0|||
37663547|NCT03707977|69136587|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
37753987|NCT02611323|69257763|FG002|Overall Study|Progressive Disease|0|||
37753988|NCT02611323|69257764|FG003|Overall Study|Progressive Disease|0|||
37753989|NCT02611323|69257765|FG004|Overall Study|Progressive Disease|0|||
37753990|NCT02611323|69257766|FG005|Overall Study|Progressive Disease|0|||
37753991|NCT02611323|69257767|FG006|Overall Study|Progressive Disease|0|||
37753992|NCT02611323|69257768|FG007|Overall Study|Progressive Disease|0|||
37753993|NCT02611323|69257769|FG008|Overall Study|Progressive Disease|0|||
37753994|NCT02611323|69257770|FG009|Overall Study|Progressive Disease|0|||
37753995|NCT02611323|69257771|FG010|Overall Study|Progressive Disease|1|||
37753996|NCT02611323|69257761|FG000|Overall Study|Withdrawal by Subject|1|||
37753997|NCT02611323|69257762|FG001|Overall Study|Withdrawal by Subject|0|||
37753998|NCT02611323|69257763|FG002|Overall Study|Withdrawal by Subject|0|||
37753999|NCT02611323|69257764|FG003|Overall Study|Withdrawal by Subject|0|||
37754000|NCT02611323|69257765|FG004|Overall Study|Withdrawal by Subject|0|||
37754001|NCT02611323|69257766|FG005|Overall Study|Withdrawal by Subject|0|||
37754002|NCT02611323|69257767|FG006|Overall Study|Withdrawal by Subject|0|||
37754003|NCT02611323|69257768|FG007|Overall Study|Withdrawal by Subject|1|||
37754004|NCT02611323|69257769|FG008|Overall Study|Withdrawal by Subject|0|||
37754005|NCT02611323|69257770|FG009|Overall Study|Withdrawal by Subject|1|||
37754006|NCT02611323|69257771|FG010|Overall Study|Withdrawal by Subject|0|||
37754007|NCT01729559|69257810|FG000|Overall Study|Protocol Violation|31|||
37754008|NCT01729559|69257811|FG001|Overall Study|Protocol Violation|28|||
37754009|NCT01728779|69257830|FG000|Overall Study|Withdrawal by Subject|1|||
37754010|NCT01728623|69257841|FG000|Overall Study|Disease progression|26|||
37754011|NCT01728623|69257841|FG000|Overall Study|Adverse Event|1|||
37754012|NCT01728623|69257841|FG000|Overall Study|Withdrawal by Subject|1|||
37754013|NCT01754129|69257848|FG000|Overall Study|Death|13|||
37754014|NCT01754129|69257848|FG000|Overall Study|Duodopa discontinuation|9|||
37754015|NCT01754129|69257848|FG000|Overall Study|Lost to Follow-up|7|||
37754016|NCT01754129|69257848|FG000|Overall Study|Withdrew consent|1|||
37754017|NCT01754129|69257848|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
37754018|NCT01728077|69257861|FG000|Overall Study|Lack of Efficacy|3|||
37754019|NCT01728077|69257862|FG001|Overall Study|Lack of Efficacy|1|||
37754020|NCT01728077|69257861|FG000|Overall Study|Lost to Follow-up|1|||
37754021|NCT01728077|69257862|FG001|Overall Study|Lost to Follow-up|0|||
37754022|NCT01728077|69257861|FG000|Overall Study|Subject choice|2|||
37754023|NCT01728077|69257862|FG001|Overall Study|Subject choice|3|||
37754024|NCT01728077|69257861|FG000|Overall Study|Death|0|||
37754025|NCT01728077|69257862|FG001|Overall Study|Death|1|||
37754026|NCT01728077|69257861|FG000|Overall Study|Patient moving|1|||
37754027|NCT01728077|69257862|FG001|Overall Study|Patient moving|0|||
37754028|NCT01728077|69257861|FG000|Overall Study|Non compliance|1|||
37754029|NCT01728077|69257862|FG001|Overall Study|Non compliance|0|||
37754030|NCT01606007|69257881|FG000|Overall Study|Reason 'Other' in the protocol|0|||
37754031|NCT01606007|69257882|FG001|Overall Study|Reason 'Other' in the protocol|1|||
37754032|NCT01606007|69257883|FG002|Overall Study|Reason 'Other' in the protocol|1|||
37754033|NCT01606007|69257881|FG000|Overall Study|Pregnancy|0|||
37754034|NCT01606007|69257882|FG001|Overall Study|Pregnancy|1|||
37754035|NCT01606007|69257883|FG002|Overall Study|Pregnancy|1|||
37754036|NCT01606007|69257881|FG000|Overall Study|Withdrawal by Subject|8|||
37754037|NCT01606007|69257882|FG001|Overall Study|Withdrawal by Subject|6|||
37754038|NCT01606007|69257883|FG002|Overall Study|Withdrawal by Subject|1|||
37754039|NCT01606007|69257881|FG000|Overall Study|Adverse Event|0|||
37754040|NCT01606007|69257882|FG001|Overall Study|Adverse Event|1|||
37754041|NCT01606007|69257883|FG002|Overall Study|Adverse Event|1|||
37754042|NCT01606007|69257881|FG000|Overall Study|discontinue study treatment|0|||
37754043|NCT01606007|69257882|FG001|Overall Study|discontinue study treatment|2|||
37754044|NCT01606007|69257883|FG002|Overall Study|discontinue study treatment|1|||
37754045|NCT01606007|69257881|FG000|Overall Study|Lost to Follow-up|6|||
37754046|NCT01606007|69257882|FG001|Overall Study|Lost to Follow-up|8|||
37754047|NCT01606007|69257883|FG002|Overall Study|Lost to Follow-up|5|||
37754048|NCT01606007|69257881|FG000|Overall Study|Poor/Non-compliance|1|||
37857617|NCT01194219|69540708|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
37857618|NCT01194219|69540699|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
37857619|NCT01194219|69540700|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
37857620|NCT01194219|69540701|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
37857621|NCT01194219|69540702|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
37857622|NCT01194219|69540703|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
37857623|NCT01194219|69540704|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
37754049|NCT01606007|69257882|FG001|Overall Study|Poor/Non-compliance|0|||
37857624|NCT01194219|69540705|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
37754050|NCT01606007|69257883|FG002|Overall Study|Poor/Non-compliance|0|||
37754051|NCT01753193|69257962|FG000|Overall Study|Withdrawal by Subject|23|||
37754052|NCT01753193|69257962|FG000|Overall Study|Lost to Follow-up|6|||
37754053|NCT01753193|69257962|FG000|Overall Study|Death|1|||
37754054|NCT01753193|69257962|FG000|Overall Study|Other|16|||
37754055|NCT01727297|69258009|FG000|Overall Study|Death|13|||
37754056|NCT01727297|69258010|FG001|Overall Study|Death|0|||
37754057|NCT01727297|69258009|FG000|Overall Study|Protocol Violation|1|||
37754058|NCT01727297|69258010|FG001|Overall Study|Protocol Violation|10|||
37754059|NCT01727297|69258009|FG000|Overall Study|Adverse Event|3|||
37754060|NCT01727297|69258010|FG001|Overall Study|Adverse Event|1|||
37754061|NCT01727297|69258009|FG000|Overall Study|Lost to Follow-up|11|||
37754062|NCT01727297|69258010|FG001|Overall Study|Lost to Follow-up|0|||
37754063|NCT01727297|69258009|FG000|Overall Study|Withdrawal by Subject|26|||
37754064|NCT01727297|69258010|FG001|Overall Study|Withdrawal by Subject|27|||
37754065|NCT01727297|69258009|FG000|Overall Study|Physician Decision|19|||
37754066|NCT01727297|69258010|FG001|Overall Study|Physician Decision|5|||
37754067|NCT01727297|69258009|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
37754068|NCT01727297|69258010|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
37754069|NCT01753115|69258026|FG000|Overall Study|Lost to Follow-up|3|||
37754070|NCT01753115|69258027|FG001|Overall Study|Lost to Follow-up|6|||
37754071|NCT01753115|69258028|FG002|Overall Study|Lost to Follow-up|8|||
37754072|NCT01753115|69258026|FG000|Overall Study|Withdrawal by Subject|6|||
37754073|NCT01753115|69258027|FG001|Overall Study|Withdrawal by Subject|5|||
37754074|NCT01753115|69258028|FG002|Overall Study|Withdrawal by Subject|6|||
37754075|NCT01753115|69258026|FG000|Overall Study|Subject non-compliant|3|||
37754076|NCT01753115|69258027|FG001|Overall Study|Subject non-compliant|3|||
37754077|NCT01753115|69258028|FG002|Overall Study|Subject non-compliant|0|||
37754078|NCT01753115|69258026|FG000|Overall Study|Used excluded drug|0|||
37754079|NCT01753115|69258027|FG001|Overall Study|Used excluded drug|1|||
37754080|NCT01753115|69258028|FG002|Overall Study|Used excluded drug|0|||
37754081|NCT01727141|69258049|FG000|Overall Study|Physician Decision|0|||
37754082|NCT01727141|69258050|FG001|Overall Study|Physician Decision|1|||
37754083|NCT01727141|69258051|FG002|Overall Study|Physician Decision|0|||
37754084|NCT01727141|69258052|FG003|Overall Study|Physician Decision|2|||
37754085|NCT01727141|69258049|FG000|Overall Study|Lost to Follow-up|0|||
37754086|NCT01727141|69258050|FG001|Overall Study|Lost to Follow-up|2|||
37754087|NCT01727141|69258051|FG002|Overall Study|Lost to Follow-up|0|||
37754088|NCT01727141|69258052|FG003|Overall Study|Lost to Follow-up|0|||
37754089|NCT01727141|69258049|FG000|Overall Study|Death|0|||
37754090|NCT01727141|69258050|FG001|Overall Study|Death|1|||
37754091|NCT01727141|69258051|FG002|Overall Study|Death|1|||
37754092|NCT01727141|69258052|FG003|Overall Study|Death|1|||
37754093|NCT01727141|69258049|FG000|Overall Study|Protocol deviation|1|||
37754094|NCT01727141|69258050|FG001|Overall Study|Protocol deviation|1|||
37754095|NCT01727141|69258051|FG002|Overall Study|Protocol deviation|0|||
37754096|NCT01727141|69258052|FG003|Overall Study|Protocol deviation|1|||
37923359|NCT00825812|69610170|FG000|Overall Study|Subject withdrew consent|0|||
37923360|NCT00825812|69610171|FG001|Overall Study|Subject withdrew consent|0|||
37663548|NCT03707977|69136588|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
37663549|NCT03707977|69136589|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
37663550|NCT03707977|69136587|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
37663551|NCT03707977|69136588|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
37663552|NCT03707977|69136589|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
37663553|NCT03332095|69136605|FG000|Overall Study|Lost to Follow-up|1|||
37663554|NCT03332095|69136606|FG001|Overall Study|Lost to Follow-up|0|||
37663555|NCT03332095|69136605|FG000|Overall Study|Pregnancy|0|||
37663556|NCT03332095|69136606|FG001|Overall Study|Pregnancy|1|||
37663557|NCT02764489|69136613|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
37663558|NCT02764489|69136614|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
37663559|NCT02764489|69136613|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
37663560|NCT02764489|69136614|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
37663561|NCT02764489|69136613|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
37663562|NCT02764489|69136614|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
37663563|NCT02764489|69136613|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
37663564|NCT02764489|69136614|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
37663565|NCT02001623|69136639|FG000|Overall Study|Disease Progression|2|||
37663566|NCT02001623|69136640|FG001|Overall Study|Disease Progression|2|||
37663567|NCT02001623|69136641|FG002|Overall Study|Disease Progression|3|||
37663568|NCT02001623|69136642|FG003|Overall Study|Disease Progression|2|||
37754097|NCT01727141|69258049|FG000|Overall Study|Withdrawal by Subject|4|||
37754098|NCT01727141|69258050|FG001|Overall Study|Withdrawal by Subject|4|||
37754099|NCT01727141|69258051|FG002|Overall Study|Withdrawal by Subject|2|||
37754100|NCT01727141|69258052|FG003|Overall Study|Withdrawal by Subject|11|||
37663569|NCT02001623|69136643|FG004|Overall Study|Disease Progression|3|||
37663570|NCT02001623|69136644|FG005|Overall Study|Disease Progression|2|||
37754101|NCT01726517|69258076|FG000|Overall Study|Withdrawal by Subject|0|||
37754102|NCT01726517|69258077|FG001|Overall Study|Withdrawal by Subject|0|||
37754103|NCT01726517|69258078|FG002|Overall Study|Withdrawal by Subject|1|||
37754104|NCT01726517|69258079|FG003|Overall Study|Withdrawal by Subject|0|||
37754105|NCT01726517|69258080|FG004|Overall Study|Withdrawal by Subject|0|||
37754106|NCT01752023|69258094|FG000|Overall Study|Physician Decision|2|||
37754107|NCT01752023|69258095|FG001|Overall Study|Physician Decision|1|||
37754108|NCT01726049|69258107|FG000|Overall Study|Death|1|||
37754109|NCT01726049|69258108|FG001|Overall Study|Death|1|||
37754110|NCT01726049|69258107|FG000|Overall Study|Adverse Event|4|||
37754111|NCT01726049|69258108|FG001|Overall Study|Adverse Event|1|||
37754112|NCT01726049|69258107|FG000|Overall Study|refused second HC|0|||
37754113|NCT01726049|69258108|FG001|Overall Study|refused second HC|2|||
37754114|NCT01605617|69258129|FG000|First Intervention|Adverse Event|0|||
37754115|NCT01605617|69258130|FG001|First Intervention|Adverse Event|1|||
37754116|NCT01605617|69258129|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
37754117|NCT01605617|69258130|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
37754118|NCT01751867|69258147|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
37754119|NCT01751867|69258148|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
37754120|NCT01751867|69258147|FG000|Overall Study|Diease Progression|4|||
37754121|NCT01751867|69258148|FG001|Overall Study|Diease Progression|18|||
37754122|NCT01751867|69258147|FG000|Overall Study|Adverse Event|8|||
37754123|NCT01751867|69258148|FG001|Overall Study|Adverse Event|15|||
37754124|NCT01751867|69258147|FG000|Overall Study|Poor Compliance|0|||
37754125|NCT01751867|69258148|FG001|Overall Study|Poor Compliance|5|||
37754126|NCT01751867|69258147|FG000|Overall Study|Withdrawal by Subject|3|||
37754127|NCT01751867|69258148|FG001|Overall Study|Withdrawal by Subject|1|||
37754128|NCT01751867|69258147|FG000|Overall Study|Physician Decision|4|||
37754129|NCT01751867|69258148|FG001|Overall Study|Physician Decision|7|||
37754130|NCT01751867|69258147|FG000|Overall Study|Protocol Violation|0|||
37754131|NCT01751867|69258148|FG001|Overall Study|Protocol Violation|2|||
37754132|NCT01751867|69258147|FG000|Overall Study|Death|0|||
37754133|NCT01751867|69258148|FG001|Overall Study|Death|5|||
37754134|NCT01751867|69258147|FG000|Overall Study|Other|11|||
37754135|NCT01751867|69258148|FG001|Overall Study|Other|37|||
37754136|NCT01751867|69258147|FG000|Overall Study|Randomized but not treated.|2|||
37754137|NCT01751867|69258148|FG001|Overall Study|Randomized but not treated.|1|||
37754138|NCT01751165|69258174|FG000|Overall Study|Adverse event, serious fatal|1|||
37754139|NCT01751165|69258175|FG001|Overall Study|Adverse event, serious fatal|0|||
37754140|NCT01751165|69258176|FG002|Overall Study|Adverse event, serious fatal|1|||
37754141|NCT01751165|69258174|FG000|Overall Study|Withdrawal by Subject|0|||
37754142|NCT01751165|69258175|FG001|Overall Study|Withdrawal by Subject|0|||
37754143|NCT01751165|69258176|FG002|Overall Study|Withdrawal by Subject|1|||
37754144|NCT01751165|69258174|FG000|Overall Study|Serious adverse event|0|||
37754145|NCT01751165|69258175|FG001|Overall Study|Serious adverse event|2|||
37754146|NCT01751165|69258176|FG002|Overall Study|Serious adverse event|0|||
37754147|NCT01751165|69258174|FG000|Overall Study|Lost to Follow-up|1|||
37754148|NCT01751165|69258175|FG001|Overall Study|Lost to Follow-up|1|||
37754149|NCT01751165|69258176|FG002|Overall Study|Lost to Follow-up|1|||
37754150|NCT01751087|69258201|FG000|Overall Study|Withdrawal by Subject|1|||
37754151|NCT01751087|69258202|FG001|Overall Study|Withdrawal by Subject|0|||
37754152|NCT01751087|69258203|FG002|Overall Study|Withdrawal by Subject|0|||
37754153|NCT01751087|69258201|FG000|Overall Study|Physician Decision|0|||
37754154|NCT01751087|69258202|FG001|Overall Study|Physician Decision|0|||
37754155|NCT01751087|69258203|FG002|Overall Study|Physician Decision|1|||
37754156|NCT01750697|69258211|FG000|Overall Study|Transferred Back to Local Hospital|1|||
37754157|NCT01750697|69258211|FG000|Overall Study|Physician and Family Decision|1|||
37754158|NCT01750697|69258211|FG000|Overall Study|Transferred to Adult Services|5|||
37754159|NCT01750697|69258211|FG000|Overall Study|Physician Decision|1|||
37754160|NCT01750697|69258211|FG000|Overall Study|Withdrawal by Subject|1|||
37754161|NCT01750229|69258222|FG000|Randomized Crossover Phase|Adverse Event|1|||
37754162|NCT01750229|69258222|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
37857625|NCT01194219|69540706|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
37857626|NCT01194219|69540707|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
37663571|NCT02001623|69136645|FG006|Overall Study|Disease Progression|3|||
37663572|NCT02001623|69136646|FG007|Overall Study|Disease Progression|3|||
37663573|NCT02001623|69136647|FG008|Overall Study|Disease Progression|7|||
37663574|NCT02001623|69136648|FG009|Overall Study|Disease Progression|40|||
37663575|NCT02001623|69136649|FG010|Overall Study|Disease Progression|5|||
37663576|NCT02001623|69136650|FG011|Overall Study|Disease Progression|9|||
37663577|NCT02001623|69136651|FG012|Overall Study|Disease Progression|9|||
37663578|NCT02001623|69136652|FG013|Overall Study|Disease Progression|20|||
37663579|NCT02001623|69136653|FG014|Overall Study|Disease Progression|9|||
37754163|NCT01750229|69258222|FG000|Long-term Follow-up Phase|Adverse Event|2|||
37754164|NCT01750229|69258222|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
37754165|NCT01724489|69258234|FG000|Overall Study|Adverse Event|8|||
37754166|NCT01724489|69258235|FG001|Overall Study|Adverse Event|3|||
37754167|NCT01724489|69258234|FG000|Overall Study|Surgery, medication|1|||
37754168|NCT01724489|69258235|FG001|Overall Study|Surgery, medication|1|||
37754169|NCT01724489|69258234|FG000|Overall Study|Lost to Follow-up|1|||
37754170|NCT01724489|69258235|FG001|Overall Study|Lost to Follow-up|2|||
37754171|NCT01724489|69258234|FG000|Overall Study|Withdrawal by Subject|6|||
37754172|NCT01724489|69258235|FG001|Overall Study|Withdrawal by Subject|6|||
37663580|NCT02001623|69136639|FG000|Overall Study|Physician Decision|0|||
37754173|NCT01724177|69258250|FG000|Overall Study|Adverse Event|8|||
37754174|NCT01724177|69258250|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
37754175|NCT01724177|69258250|FG000|Overall Study|Nervous participant|1|||
37754176|NCT01724177|69258250|FG000|Overall Study|Serious Adverse Event Related|1|||
37754177|NCT04378270|69258269|FG000|Overall Study|Lack of Efficacy|1|||
37754178|NCT04378270|69258269|FG000|Overall Study|Withdrawal by Subject|1|||
37754179|NCT04378270|69258269|FG000|Overall Study|Screen Failure|1|||
37754180|NCT04378270|69258269|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
37754181|NCT01724021|69258275|FG000|Overall Study|Adverse Event|11|||
37754182|NCT01724021|69258276|FG001|Overall Study|Adverse Event|6|||
37754183|NCT01724021|69258275|FG000|Overall Study|Death|46|||
37754184|NCT01724021|69258276|FG001|Overall Study|Death|58|||
37754185|NCT01724021|69258275|FG000|Overall Study|Participant request/ Withdrew consent|18|||
37754186|NCT01724021|69258276|FG001|Overall Study|Participant request/ Withdrew consent|14|||
37857627|NCT01194219|69540708|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
37857628|NCT01194219|69540699|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
37857629|NCT01194219|69540700|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
37857630|NCT01194219|69540701|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
37857631|NCT01194219|69540702|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
37857632|NCT01194219|69540703|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
37857633|NCT01194219|69540704|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
37857634|NCT01194219|69540705|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
37857635|NCT01194219|69540706|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
37857636|NCT01194219|69540707|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
37857637|NCT01194219|69540708|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
37857638|NCT01194219|69540699|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
37857639|NCT01194219|69540700|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
37857640|NCT01194219|69540701|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
37857641|NCT01194219|69540702|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
37857642|NCT01194219|69540703|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
37857643|NCT01194219|69540704|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
37857644|NCT01194219|69540705|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
37857645|NCT01194219|69540706|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
37857646|NCT01194219|69540707|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
37857647|NCT01194219|69540708|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
37857648|NCT01194219|69540699|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
37857649|NCT01194219|69540700|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
37857650|NCT01194219|69540701|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
37857651|NCT01194219|69540702|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
37857652|NCT01194219|69540703|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
37857653|NCT01194219|69540704|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
37857654|NCT01194219|69540705|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
37857655|NCT01194219|69540706|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
37857656|NCT01194219|69540707|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
37663581|NCT02001623|69136640|FG001|Overall Study|Physician Decision|0|||
37663582|NCT02001623|69136641|FG002|Overall Study|Physician Decision|0|||
37663583|NCT02001623|69136642|FG003|Overall Study|Physician Decision|0|||
37663584|NCT02001623|69136643|FG004|Overall Study|Physician Decision|0|||
37663585|NCT02001623|69136644|FG005|Overall Study|Physician Decision|0|||
37663586|NCT02001623|69136645|FG006|Overall Study|Physician Decision|0|||
37663587|NCT02001623|69136646|FG007|Overall Study|Physician Decision|0|||
37663588|NCT02001623|69136647|FG008|Overall Study|Physician Decision|3|||
37663589|NCT02001623|69136648|FG009|Overall Study|Physician Decision|2|||
37663590|NCT02001623|69136649|FG010|Overall Study|Physician Decision|3|||
37663591|NCT02001623|69136650|FG011|Overall Study|Physician Decision|3|||
37663592|NCT02001623|69136651|FG012|Overall Study|Physician Decision|1|||
37663593|NCT02001623|69136652|FG013|Overall Study|Physician Decision|2|||
37663594|NCT02001623|69136653|FG014|Overall Study|Physician Decision|1|||
37754187|NCT01724021|69258275|FG000|Overall Study|Lost to Follow-up|15|||
37754188|NCT01724021|69258276|FG001|Overall Study|Lost to Follow-up|15|||
37754189|NCT01724021|69258275|FG000|Overall Study|Reason Not Specified|36|||
37857657|NCT01194219|69540708|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
37663595|NCT02001623|69136639|FG000|Overall Study|Death|0|||
37663596|NCT02001623|69136640|FG001|Overall Study|Death|1|||
37754190|NCT01724021|69258276|FG001|Overall Study|Reason Not Specified|39|||
37754191|NCT01724021|69258275|FG000|Overall Study|Missing|1|||
37754192|NCT01724021|69258276|FG001|Overall Study|Missing|1|||
37754193|NCT01723397|69258290|FG000|Study Period 1|Protocol Violation|0|||
37754194|NCT01723397|69258291|FG001|Study Period 1|Protocol Violation|1|||
37663597|NCT02001623|69136641|FG002|Overall Study|Death|0|||
37663598|NCT02001623|69136642|FG003|Overall Study|Death|0|||
37663599|NCT02001623|69136643|FG004|Overall Study|Death|0|||
37754195|NCT01723397|69258290|FG000|Study Period 2|Protocol Violation|0|||
37663600|NCT02001623|69136644|FG005|Overall Study|Death|0|||
37663601|NCT02001623|69136645|FG006|Overall Study|Death|0|||
37754196|NCT01723397|69258291|FG001|Study Period 2|Protocol Violation|1|||
37663602|NCT02001623|69136646|FG007|Overall Study|Death|0|||
37663603|NCT02001623|69136647|FG008|Overall Study|Death|0|||
37663604|NCT02001623|69136648|FG009|Overall Study|Death|0|||
37663605|NCT02001623|69136649|FG010|Overall Study|Death|0|||
37663606|NCT02001623|69136650|FG011|Overall Study|Death|0|||
37663607|NCT02001623|69136651|FG012|Overall Study|Death|0|||
37663608|NCT02001623|69136652|FG013|Overall Study|Death|0|||
37754197|NCT01723163|69258299|FG000|Treatment Phase|Withdrawal by Subject|14|||
37754198|NCT01723163|69258300|FG001|Treatment Phase|Withdrawal by Subject|6|||
37754199|NCT01723163|69258299|FG000|Treatment Phase|Withdrawal by PI|5|||
37754200|NCT01723163|69258300|FG001|Treatment Phase|Withdrawal by PI|1|||
37754201|NCT01723163|69258299|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
37754202|NCT01723163|69258300|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
37754203|NCT01723163|69258299|FG000|3-Month Follow-up|Unable to Contact|12|||
37754204|NCT01723163|69258300|FG001|3-Month Follow-up|Unable to Contact|19|||
37754205|NCT01723163|69258299|FG000|6-Month Follow-up|Death|1|||
37754206|NCT01723163|69258300|FG001|6-Month Follow-up|Death|0|||
37754207|NCT01723163|69258299|FG000|6-Month Follow-up|Unable to Contact|17|||
37754208|NCT01723163|69258300|FG001|6-Month Follow-up|Unable to Contact|15|||
37754209|NCT01723163|69258299|FG000|12-Month Follow-up|Death|1|||
37754210|NCT01723163|69258300|FG001|12-Month Follow-up|Death|0|||
37754211|NCT01723163|69258299|FG000|12-Month Follow-up|Unable to Contact|23|||
37754212|NCT01723163|69258300|FG001|12-Month Follow-up|Unable to Contact|28|||
37754213|NCT01722071|69258310|FG000|Overall Study|Protocol Violation|1|||
37754214|NCT01722071|69258311|FG001|Overall Study|Protocol Violation|0|||
37754215|NCT01721759|69258317|FG000|Treatment Period|Disease Progression|85|||
37754216|NCT01721759|69258317|FG000|Treatment Period|Study drug toxicity|14|||
37754217|NCT01721759|69258317|FG000|Treatment Period|Death|1|||
37754218|NCT01721759|69258317|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
37754219|NCT01721759|69258317|FG000|Treatment Period|Participant request to withdraw|3|||
37663609|NCT02001623|69136653|FG014|Overall Study|Death|0|||
37663610|NCT02001623|69136639|FG000|Overall Study|Adverse Event|0|||
37663611|NCT02001623|69136640|FG001|Overall Study|Adverse Event|0|||
37663612|NCT02001623|69136641|FG002|Overall Study|Adverse Event|0|||
37663613|NCT02001623|69136642|FG003|Overall Study|Adverse Event|0|||
37663614|NCT02001623|69136643|FG004|Overall Study|Adverse Event|0|||
37663615|NCT02001623|69136644|FG005|Overall Study|Adverse Event|1|||
37663616|NCT02001623|69136645|FG006|Overall Study|Adverse Event|0|||
37663617|NCT02001623|69136646|FG007|Overall Study|Adverse Event|3|||
37663618|NCT02001623|69136647|FG008|Overall Study|Adverse Event|4|||
37663619|NCT02001623|69136648|FG009|Overall Study|Adverse Event|6|||
37663620|NCT02001623|69136649|FG010|Overall Study|Adverse Event|4|||
37663621|NCT02001623|69136650|FG011|Overall Study|Adverse Event|0|||
37663622|NCT02001623|69136651|FG012|Overall Study|Adverse Event|3|||
37663623|NCT02001623|69136652|FG013|Overall Study|Adverse Event|5|||
37663624|NCT02001623|69136653|FG014|Overall Study|Adverse Event|6|||
37663625|NCT02001623|69136639|FG000|Overall Study|Other - Miscellaneous|0|||
37663626|NCT02001623|69136640|FG001|Overall Study|Other - Miscellaneous|0|||
37663627|NCT02001623|69136641|FG002|Overall Study|Other - Miscellaneous|0|||
37663628|NCT02001623|69136642|FG003|Overall Study|Other - Miscellaneous|0|||
37663629|NCT02001623|69136643|FG004|Overall Study|Other - Miscellaneous|0|||
37663630|NCT02001623|69136644|FG005|Overall Study|Other - Miscellaneous|0|||
37663631|NCT02001623|69136645|FG006|Overall Study|Other - Miscellaneous|0|||
37663632|NCT02001623|69136646|FG007|Overall Study|Other - Miscellaneous|0|||
37663633|NCT02001623|69136647|FG008|Overall Study|Other - Miscellaneous|0|||
37663634|NCT02001623|69136648|FG009|Overall Study|Other - Miscellaneous|1|||
37663635|NCT02001623|69136649|FG010|Overall Study|Other - Miscellaneous|0|||
37663636|NCT02001623|69136650|FG011|Overall Study|Other - Miscellaneous|0|||
37754220|NCT01721759|69258317|FG000|Treatment Period|Other Reasons|3|||
37754221|NCT01721759|69258317|FG000|End of Study Period|Participant Withdrew Consent|5|||
37663637|NCT02001623|69136651|FG012|Overall Study|Other - Miscellaneous|0|||
37663638|NCT02001623|69136652|FG013|Overall Study|Other - Miscellaneous|1|||
37663639|NCT02001623|69136653|FG014|Overall Study|Other - Miscellaneous|0|||
37663640|NCT02001623|69136639|FG000|Overall Study|Withdrawal by Subject|1|||
37663641|NCT02001623|69136640|FG001|Overall Study|Withdrawal by Subject|0|||
37663642|NCT02001623|69136641|FG002|Overall Study|Withdrawal by Subject|0|||
37754222|NCT01721759|69258317|FG000|End of Study Period|Death|101|||
37754223|NCT01721759|69258317|FG000|End of Study Period|Lost to Follow-up|1|||
37754224|NCT01721759|69258317|FG000|End of Study Period|Other Reasons|10|||
37754225|NCT01721369|69258326|FG000|Overall Study|Not initial etiological diagnosis|12|||
37754226|NCT01721057|69258388|FG000|Treatment Period|Withdrawal by Subject|11|||
37857658|NCT01194219|69540699|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
37663643|NCT02001623|69136642|FG003|Overall Study|Withdrawal by Subject|0|||
37663644|NCT02001623|69136643|FG004|Overall Study|Withdrawal by Subject|0|||
37663645|NCT02001623|69136644|FG005|Overall Study|Withdrawal by Subject|0|||
37663646|NCT02001623|69136645|FG006|Overall Study|Withdrawal by Subject|0|||
37663647|NCT02001623|69136646|FG007|Overall Study|Withdrawal by Subject|0|||
37663648|NCT02001623|69136647|FG008|Overall Study|Withdrawal by Subject|1|||
37663649|NCT02001623|69136648|FG009|Overall Study|Withdrawal by Subject|3|||
37663650|NCT02001623|69136649|FG010|Overall Study|Withdrawal by Subject|2|||
37663651|NCT02001623|69136650|FG011|Overall Study|Withdrawal by Subject|2|||
37663652|NCT02001623|69136651|FG012|Overall Study|Withdrawal by Subject|1|||
37663653|NCT02001623|69136652|FG013|Overall Study|Withdrawal by Subject|5|||
37663654|NCT02001623|69136653|FG014|Overall Study|Withdrawal by Subject|2|||
37663655|NCT02001623|69136639|FG000|Overall Study|Lost to Follow-up|0|||
37663656|NCT02001623|69136640|FG001|Overall Study|Lost to Follow-up|0|||
37663657|NCT02001623|69136641|FG002|Overall Study|Lost to Follow-up|0|||
37663658|NCT02001623|69136642|FG003|Overall Study|Lost to Follow-up|0|||
37663659|NCT02001623|69136643|FG004|Overall Study|Lost to Follow-up|0|||
37663660|NCT02001623|69136644|FG005|Overall Study|Lost to Follow-up|0|||
37663661|NCT02001623|69136645|FG006|Overall Study|Lost to Follow-up|0|||
37663662|NCT02001623|69136646|FG007|Overall Study|Lost to Follow-up|0|||
37663663|NCT02001623|69136647|FG008|Overall Study|Lost to Follow-up|0|||
37663664|NCT02001623|69136648|FG009|Overall Study|Lost to Follow-up|1|||
37663665|NCT02001623|69136649|FG010|Overall Study|Lost to Follow-up|0|||
37663666|NCT02001623|69136650|FG011|Overall Study|Lost to Follow-up|0|||
37663667|NCT02001623|69136651|FG012|Overall Study|Lost to Follow-up|0|||
37663668|NCT02001623|69136652|FG013|Overall Study|Lost to Follow-up|0|||
37663669|NCT02001623|69136653|FG014|Overall Study|Lost to Follow-up|0|||
37663670|NCT02001623|69136639|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
37663671|NCT02001623|69136640|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
37663672|NCT02001623|69136641|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
37663673|NCT02001623|69136642|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
37663674|NCT02001623|69136643|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
37663675|NCT02001623|69136644|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
37663676|NCT02001623|69136645|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
37663677|NCT02001623|69136646|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
37663678|NCT02001623|69136647|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
37663679|NCT02001623|69136648|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
37663680|NCT02001623|69136649|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
37663681|NCT02001623|69136650|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
37663682|NCT02001623|69136651|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
37663683|NCT02001623|69136652|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
37663684|NCT02001623|69136653|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
37663685|NCT02001623|69136639|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
37663686|NCT02001623|69136640|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
37663687|NCT02001623|69136641|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
37663688|NCT02001623|69136642|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
37663689|NCT02001623|69136643|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
37663690|NCT02001623|69136644|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
37663691|NCT02001623|69136645|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
37754227|NCT01721057|69258389|FG001|Treatment Period|Withdrawal by Subject|5|||
37754228|NCT01721057|69258390|FG002|Treatment Period|Withdrawal by Subject|8|||
37754229|NCT01721057|69258391|FG003|Treatment Period|Withdrawal by Subject|0|||
37754230|NCT01721057|69258392|FG004|Treatment Period|Withdrawal by Subject|0|||
37754231|NCT01721057|69258393|FG005|Treatment Period|Withdrawal by Subject|0|||
37754232|NCT01721057|69258394|FG006|Treatment Period|Withdrawal by Subject|0|||
37754233|NCT01721057|69258388|FG000|Treatment Period|Adverse Event|7|||
37754234|NCT01721057|69258389|FG001|Treatment Period|Adverse Event|10|||
37754235|NCT01721057|69258390|FG002|Treatment Period|Adverse Event|12|||
37754236|NCT01721057|69258391|FG003|Treatment Period|Adverse Event|0|||
37754237|NCT01721057|69258392|FG004|Treatment Period|Adverse Event|0|||
37754238|NCT01721057|69258393|FG005|Treatment Period|Adverse Event|0|||
37754239|NCT01721057|69258394|FG006|Treatment Period|Adverse Event|0|||
37754240|NCT01721057|69258388|FG000|Treatment Period|Lack of Efficacy|7|||
37754241|NCT01721057|69258389|FG001|Treatment Period|Lack of Efficacy|3|||
37754242|NCT01721057|69258390|FG002|Treatment Period|Lack of Efficacy|0|||
37754243|NCT01721057|69258391|FG003|Treatment Period|Lack of Efficacy|0|||
37754244|NCT01721057|69258392|FG004|Treatment Period|Lack of Efficacy|0|||
37754245|NCT01721057|69258393|FG005|Treatment Period|Lack of Efficacy|0|||
37754246|NCT01721057|69258394|FG006|Treatment Period|Lack of Efficacy|0|||
37754247|NCT01721057|69258388|FG000|Treatment Period|Lost to Follow-up|1|||
37663692|NCT02001623|69136646|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
37663693|NCT02001623|69136647|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
37663694|NCT02001623|69136648|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
37754248|NCT01721057|69258389|FG001|Treatment Period|Lost to Follow-up|0|||
37663695|NCT02001623|69136649|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
37663696|NCT02001623|69136650|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
37663697|NCT02001623|69136651|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
37754249|NCT01721057|69258390|FG002|Treatment Period|Lost to Follow-up|0|||
37754250|NCT01721057|69258391|FG003|Treatment Period|Lost to Follow-up|0|||
37754251|NCT01721057|69258392|FG004|Treatment Period|Lost to Follow-up|0|||
37754252|NCT01721057|69258393|FG005|Treatment Period|Lost to Follow-up|0|||
37754253|NCT01721057|69258394|FG006|Treatment Period|Lost to Follow-up|0|||
37754254|NCT01721057|69258388|FG000|Treatment Period|Physician Decision|0|||
37754255|NCT01721057|69258389|FG001|Treatment Period|Physician Decision|1|||
37754256|NCT01721057|69258390|FG002|Treatment Period|Physician Decision|3|||
37754257|NCT01721057|69258391|FG003|Treatment Period|Physician Decision|0|||
37754258|NCT01721057|69258392|FG004|Treatment Period|Physician Decision|0|||
37754259|NCT01721057|69258393|FG005|Treatment Period|Physician Decision|0|||
37754260|NCT01721057|69258394|FG006|Treatment Period|Physician Decision|0|||
37754261|NCT01721057|69258388|FG000|Treatment Period|Death|2|||
37754262|NCT01721057|69258389|FG001|Treatment Period|Death|0|||
37663698|NCT02001623|69136652|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
37754263|NCT01721057|69258390|FG002|Treatment Period|Death|0|||
37754264|NCT01721057|69258391|FG003|Treatment Period|Death|0|||
37754265|NCT01721057|69258392|FG004|Treatment Period|Death|0|||
37754266|NCT01721057|69258393|FG005|Treatment Period|Death|0|||
37754267|NCT01721057|69258394|FG006|Treatment Period|Death|0|||
37754268|NCT01721057|69258388|FG000|Rescue Period|Adverse Event|0|||
37754269|NCT01721057|69258389|FG001|Rescue Period|Adverse Event|0|||
37754270|NCT01721057|69258390|FG002|Rescue Period|Adverse Event|0|||
37754271|NCT01721057|69258391|FG003|Rescue Period|Adverse Event|1|||
37754272|NCT01721057|69258392|FG004|Rescue Period|Adverse Event|0|||
37857659|NCT01194219|69540700|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
37857660|NCT01194219|69540701|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
37857661|NCT01194219|69540702|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
37857662|NCT01194219|69540703|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
37857663|NCT01194219|69540704|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
37857664|NCT01194219|69540705|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
37857665|NCT01194219|69540706|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
37857666|NCT01194219|69540707|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
37857667|NCT01194219|69540708|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
37857668|NCT01194219|69540699|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
37857669|NCT01194219|69540700|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
37857670|NCT01194219|69540701|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
37857671|NCT01194219|69540702|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
37857672|NCT01194219|69540703|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
37857673|NCT01194219|69540704|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
37857674|NCT01194219|69540705|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
37857675|NCT01194219|69540706|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
37857676|NCT01194219|69540707|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
37857677|NCT01194219|69540708|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
37857678|NCT01194219|69540699|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
37857679|NCT01194219|69540700|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
37857680|NCT01194219|69540701|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
37857681|NCT01194219|69540702|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
37857682|NCT01194219|69540703|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
37857683|NCT01194219|69540704|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
37857684|NCT01194219|69540705|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
37857685|NCT01194219|69540706|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
37857686|NCT01194219|69540707|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
37857687|NCT01194219|69540708|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
37663699|NCT02001623|69136653|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
37663700|NCT02713867|69136704|FG000|Randomization|Other Reason|2|||
37663701|NCT02713867|69136705|FG001|Randomization|Other Reason|1|||
37663702|NCT02713867|69136704|FG000|Randomization|Participant Withdrew consent|0|||
37663703|NCT02713867|69136705|FG001|Randomization|Participant Withdrew consent|2|||
37663704|NCT02713867|69136704|FG000|Treatment Period|Other Reasons|22|||
37663705|NCT02713867|69136705|FG001|Treatment Period|Other Reasons|28|||
37663706|NCT02713867|69136704|FG000|Treatment Period|Administrative reason by sponsor|21|||
37663707|NCT02713867|69136705|FG001|Treatment Period|Administrative reason by sponsor|16|||
37857688|NCT01194219|69540699|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
37857689|NCT01194219|69540700|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
37857690|NCT01194219|69540701|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
37857691|NCT01194219|69540702|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
37663708|NCT02713867|69136704|FG000|Treatment Period|No longer meets study criteria|2|||
37754273|NCT01721057|69258393|FG005|Rescue Period|Adverse Event|0|||
37754274|NCT01721057|69258394|FG006|Rescue Period|Adverse Event|0|||
37754275|NCT01721057|69258388|FG000|Rescue Period|Lack of Efficacy|0|||
37754276|NCT01721057|69258389|FG001|Rescue Period|Lack of Efficacy|0|||
37754277|NCT01721057|69258390|FG002|Rescue Period|Lack of Efficacy|0|||
37754278|NCT01721057|69258391|FG003|Rescue Period|Lack of Efficacy|2|||
37754279|NCT01721057|69258392|FG004|Rescue Period|Lack of Efficacy|0|||
37754280|NCT01721057|69258393|FG005|Rescue Period|Lack of Efficacy|0|||
37663709|NCT02713867|69136705|FG001|Treatment Period|No longer meets study criteria|1|||
37663710|NCT02713867|69136704|FG000|Treatment Period|Poor/Non Compliance|1|||
37663711|NCT02713867|69136705|FG001|Treatment Period|Poor/Non Compliance|0|||
37663712|NCT02713867|69136704|FG000|Treatment Period|Maximum Clinical Benefit|5|||
37663713|NCT02713867|69136705|FG001|Treatment Period|Maximum Clinical Benefit|6|||
37663714|NCT02713867|69136704|FG000|Treatment Period|Withdrew consent|3|||
37663715|NCT02713867|69136705|FG001|Treatment Period|Withdrew consent|6|||
37663716|NCT02713867|69136704|FG000|Treatment Period|Requested to Discontinue|8|||
37663717|NCT02713867|69136705|FG001|Treatment Period|Requested to Discontinue|8|||
37663718|NCT02713867|69136704|FG000|Treatment Period|AE unrelated to Study Drug|11|||
37663719|NCT02713867|69136705|FG001|Treatment Period|AE unrelated to Study Drug|10|||
37663720|NCT02713867|69136704|FG000|Treatment Period|Death|7|||
37663721|NCT02713867|69136705|FG001|Treatment Period|Death|3|||
37663722|NCT02713867|69136704|FG000|Treatment Period|Study Drug Toxicity|16|||
37663723|NCT02713867|69136705|FG001|Treatment Period|Study Drug Toxicity|19|||
37663724|NCT02713867|69136704|FG000|Treatment Period|Disease Progression|82|||
37663725|NCT02713867|69136705|FG001|Treatment Period|Disease Progression|83|||
37663726|NCT02730455|69136714|FG000|Overall Study|Death|5|||
37663727|NCT02730455|69136715|FG001|Overall Study|Death|6|||
37663728|NCT02730455|69136716|FG002|Overall Study|Death|4|||
37663729|NCT02730455|69136714|FG000|Overall Study|Consent withdrawn|2|||
37663730|NCT02730455|69136715|FG001|Overall Study|Consent withdrawn|4|||
37663731|NCT02730455|69136716|FG002|Overall Study|Consent withdrawn|1|||
37663732|NCT02730455|69136714|FG000|Overall Study|Lost to Follow-up|3|||
37663733|NCT02730455|69136715|FG001|Overall Study|Lost to Follow-up|1|||
37663734|NCT02730455|69136716|FG002|Overall Study|Lost to Follow-up|4|||
37663735|NCT02730455|69136714|FG000|Overall Study|Other|1|||
37663736|NCT02730455|69136715|FG001|Overall Study|Other|1|||
37663737|NCT02730455|69136716|FG002|Overall Study|Other|2|||
37663738|NCT02730455|69136714|FG000|Overall Study|Other|2|||
37663739|NCT02730455|69136715|FG001|Overall Study|Other|2|||
37754281|NCT01721057|69258394|FG006|Rescue Period|Lack of Efficacy|0|||
37754282|NCT04570384|69258423|FG000|Overall Study|Adverse Event|2|||
37754283|NCT04570384|69258424|FG001|Overall Study|Adverse Event|1|||
37754284|NCT04570384|69258423|FG000|Overall Study|Death|2|||
37754285|NCT04570384|69258424|FG001|Overall Study|Death|5|||
37754286|NCT04570384|69258423|FG000|Overall Study|Lost to Follow-up|1|||
37754287|NCT04570384|69258424|FG001|Overall Study|Lost to Follow-up|0|||
37663740|NCT02730455|69136716|FG002|Overall Study|Other|0|||
37663741|NCT04440449|69136726|FG000|Overall Study|Lost to Follow-up|2|||
37663742|NCT04440449|69136727|FG001|Overall Study|Lost to Follow-up|0|||
37663743|NCT00701311|69136734|FG000|Overall Study|Lack of Efficacy|3|||
37663744|NCT00701311|69136734|FG000|Overall Study|Adverse Event|3|||
37663745|NCT00701311|69136734|FG000|Overall Study|Withdrawal by Subject|2|||
37663746|NCT02730377|69136744|FG000|Overall Study|Other|5|||
37754288|NCT04570384|69258423|FG000|Overall Study|Other|1|||
37754289|NCT04570384|69258424|FG001|Overall Study|Other|0|||
37754290|NCT04570384|69258423|FG000|Overall Study|Protocol Violation|0|||
37754291|NCT04570384|69258424|FG001|Overall Study|Protocol Violation|1|||
37754292|NCT04570384|69258423|FG000|Overall Study|Sponsor Decision|1|||
37754293|NCT04570384|69258424|FG001|Overall Study|Sponsor Decision|0|||
37754294|NCT04570384|69258423|FG000|Overall Study|Withdrawal by Subject|4|||
37754295|NCT04570384|69258424|FG001|Overall Study|Withdrawal by Subject|2|||
37754296|NCT02563522|69258477|FG000|Overall Study|Adverse Event|2|||
37754297|NCT02563522|69258478|FG001|Overall Study|Adverse Event|3|||
37754298|NCT02563522|69258477|FG000|Overall Study|Lost to Follow-up|1|||
37663747|NCT02730377|69136745|FG001|Overall Study|Other|4|||
37754299|NCT02563522|69258478|FG001|Overall Study|Lost to Follow-up|0|||
37754300|NCT02563522|69258477|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
37754301|NCT02563522|69258478|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
37663748|NCT02730377|69136744|FG000|Overall Study|Death|1|||
37663749|NCT02730377|69136745|FG001|Overall Study|Death|8|||
37663750|NCT02730377|69136744|FG000|Overall Study|Inadequate glycaemic control|368|||
37663751|NCT02730377|69136745|FG001|Overall Study|Inadequate glycaemic control|473|||
37663752|NCT02730377|69136744|FG000|Overall Study|Adverse Event|79|||
37663753|NCT02730377|69136745|FG001|Overall Study|Adverse Event|41|||
37663754|NCT02730377|69136744|FG000|Overall Study|Protocol Violation|23|||
37663755|NCT02730377|69136745|FG001|Overall Study|Protocol Violation|30|||
37663756|NCT02730377|69136744|FG000|Overall Study|Lack of Efficacy|4|||
37663757|NCT02730377|69136745|FG001|Overall Study|Lack of Efficacy|13|||
37857692|NCT01194219|69540703|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
37857693|NCT01194219|69540704|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
37857694|NCT01194219|69540705|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
37857695|NCT01194219|69540706|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
37663758|NCT02730377|69136744|FG000|Overall Study|Pregnancy|0|||
37663759|NCT02730377|69136745|FG001|Overall Study|Pregnancy|1|||
37754302|NCT03578146|69258490|FG000|Overall Study|Did Not Receive Treatment|1|||
37754303|NCT03578146|69258491|FG001|Overall Study|Did Not Receive Treatment|0|||
37754304|NCT03578146|69258492|FG002|Overall Study|Did Not Receive Treatment|0|||
37754305|NCT03578146|69258493|FG003|Overall Study|Did Not Receive Treatment|0|||
37754306|NCT03578146|69258494|FG004|Overall Study|Did Not Receive Treatment|0|||
37754307|NCT03578146|69258495|FG005|Overall Study|Did Not Receive Treatment|2|||
37754308|NCT03578146|69258490|FG000|Overall Study|Lost to Follow-up|0|||
37754309|NCT03578146|69258491|FG001|Overall Study|Lost to Follow-up|1|||
37857696|NCT01194219|69540707|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
37857697|NCT01194219|69540708|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
37857698|NCT01304693|69540736|FG000|Overall Study|Adverse Event|0|||
37857699|NCT01304693|69540737|FG001|Overall Study|Adverse Event|0|||
37857700|NCT01304693|69540738|FG002|Overall Study|Adverse Event|0|||
37857701|NCT01304693|69540739|FG003|Overall Study|Adverse Event|0|||
37857702|NCT01304693|69540740|FG004|Overall Study|Adverse Event|1|||
37857703|NCT01304693|69540736|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
37857704|NCT01304693|69540737|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
37857705|NCT01304693|69540738|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
37857706|NCT01304693|69540739|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
37857707|NCT01304693|69540740|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
37857708|NCT01304147|69540752|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
37663760|NCT02730377|69136744|FG000|Overall Study|Withdrawal by Subject|45|||
37663761|NCT02730377|69136745|FG001|Overall Study|Withdrawal by Subject|42|||
37663762|NCT02730377|69136744|FG000|Overall Study|Lost to Follow-up|25|||
37663763|NCT02730377|69136745|FG001|Overall Study|Lost to Follow-up|21|||
37663764|NCT02714569|69136762|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
37663765|NCT02714569|69136763|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
37857709|NCT01304147|69540753|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
37857710|NCT01303445|69540759|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
37857711|NCT01303445|69540760|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
37857712|NCT01303445|69540759|FG000|Second Intervention (7 Days)|Adverse Event|0|||
37857713|NCT01303445|69540760|FG001|Second Intervention (7 Days)|Adverse Event|2|||
37857714|NCT01303445|69540759|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
37857715|NCT01303445|69540760|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
37857716|NCT01303445|69540759|FG000|Washout (14 Days)|Protocol Violation|1|||
37857717|NCT01303445|69540760|FG001|Washout (14 Days)|Protocol Violation|0|||
37857718|NCT01303445|69540759|FG000|Washout (14 Days)|Lost to Follow-up|0|||
37857719|NCT01303445|69540760|FG001|Washout (14 Days)|Lost to Follow-up|2|||
37857720|NCT01303445|69540759|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
37857721|NCT01303445|69540760|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
37857722|NCT01303445|69540759|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
37857723|NCT01303445|69540760|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
37857724|NCT01188681|69540774|FG000|Overall Study|bladder cancer|0|||
37857725|NCT01188681|69540775|FG001|Overall Study|bladder cancer|0|||
37857726|NCT01188681|69540776|FG002|Overall Study|bladder cancer|1|||
37857727|NCT01188681|69540777|FG003|Overall Study|bladder cancer|0|||
37857728|NCT01188681|69540774|FG000|Overall Study|Withdrawal by Subject|0|||
37663766|NCT02714569|69136764|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
37663767|NCT02714569|69136765|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
37754310|NCT03578146|69258492|FG002|Overall Study|Lost to Follow-up|1|||
37754311|NCT03578146|69258493|FG003|Overall Study|Lost to Follow-up|0|||
37754312|NCT03578146|69258494|FG004|Overall Study|Lost to Follow-up|0|||
37754313|NCT03578146|69258495|FG005|Overall Study|Lost to Follow-up|1|||
37754314|NCT02716896|69258511|FG000|Overall Study|Physician Decision|0|||
37754315|NCT02716896|69258512|FG001|Overall Study|Physician Decision|1|||
37754316|NCT02715726|69258567|FG000|Overall Study|Adverse Event|2|||
37857729|NCT01188681|69540775|FG001|Overall Study|Withdrawal by Subject|0|||
37857730|NCT01188681|69540776|FG002|Overall Study|Withdrawal by Subject|0|||
37857731|NCT01188681|69540777|FG003|Overall Study|Withdrawal by Subject|1|||
37857732|NCT01302899|69540793|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
37857733|NCT01302899|69540794|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
37857734|NCT01302899|69540793|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
37857735|NCT01302899|69540794|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
37857736|NCT01187901|69540806|FG000|Overall Study|Protocol Violation|1|||
37857737|NCT01187901|69540807|FG001|Overall Study|Protocol Violation|0|||
37857738|NCT01187901|69540806|FG000|Overall Study|Lost to Follow-up|1|||
37857739|NCT01187901|69540807|FG001|Overall Study|Lost to Follow-up|2|||
38033261|NCT04493684|69719200|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
38033262|NCT04493684|69719201|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
38033263|NCT04493684|69719202|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
38033264|NCT04493684|69719203|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
38033265|NCT04493684|69719204|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
38033266|NCT04493684|69719205|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
38033267|NCT04493684|69719206|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
38033268|NCT04493684|69719207|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
38033269|NCT04493684|69719208|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
37754317|NCT02715726|69258568|FG001|Overall Study|Adverse Event|6|||
37754318|NCT02715726|69258567|FG000|Overall Study|Protocol Violation|1|||
37754319|NCT02715726|69258568|FG001|Overall Study|Protocol Violation|0|||
37754320|NCT02715726|69258567|FG000|Overall Study|Death|2|||
37754321|NCT02715726|69258568|FG001|Overall Study|Death|1|||
37754322|NCT02715726|69258567|FG000|Overall Study|Participant moved|1|||
37754323|NCT02715726|69258568|FG001|Overall Study|Participant moved|3|||
37754324|NCT02715726|69258567|FG000|Overall Study|Other than specified above|11|||
37754325|NCT02715726|69258568|FG001|Overall Study|Other than specified above|15|||
37754326|NCT02715726|69258567|FG000|Overall Study|Randomized but not treated|1|||
37754327|NCT02715726|69258568|FG001|Overall Study|Randomized but not treated|2|||
37663768|NCT02714569|69136766|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
37663769|NCT02714569|69136767|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
37754328|NCT04248816|69258581|FG000|Overall Study|Ineligible post-randomization|7|||
37754329|NCT04248816|69258582|FG001|Overall Study|Ineligible post-randomization|21|||
37754330|NCT04248816|69258583|FG002|Overall Study|Ineligible post-randomization|25|||
37754331|NCT02314156|69258620|FG000|Overall Study|Adverse Event|1|||
37754332|NCT02314156|69258621|FG001|Overall Study|Adverse Event|0|||
37754333|NCT02314156|69258620|FG000|Overall Study|Withdrawal by Subject|1|||
37663770|NCT02714569|69136768|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
37663771|NCT02714569|69136769|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
37663772|NCT02714569|69136770|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
37663773|NCT02714569|69136771|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
37663774|NCT02714569|69136772|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
37663775|NCT02714569|69136762|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
37663776|NCT02714569|69136763|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
37663777|NCT02714569|69136764|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
37663778|NCT02714569|69136765|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
37663779|NCT02714569|69136766|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
37663780|NCT02714569|69136767|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
37663781|NCT02714569|69136768|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
37663782|NCT02714569|69136769|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
37663783|NCT02714569|69136770|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
37663784|NCT02714569|69136771|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
37663785|NCT02714569|69136772|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
37663786|NCT02714569|69136762|FG000|Part A Third Intervention|Adverse Event|0|||
37663787|NCT02714569|69136763|FG001|Part A Third Intervention|Adverse Event|0|||
37663788|NCT02714569|69136764|FG002|Part A Third Intervention|Adverse Event|1|||
37663789|NCT02714569|69136765|FG003|Part A Third Intervention|Adverse Event|0|||
37663790|NCT02714569|69136766|FG004|Part A Third Intervention|Adverse Event|0|||
37663791|NCT02714569|69136767|FG005|Part A Third Intervention|Adverse Event|0|||
37663792|NCT02714569|69136768|FG006|Part A Third Intervention|Adverse Event|0|||
37663793|NCT02714569|69136769|FG007|Part A Third Intervention|Adverse Event|0|||
37754334|NCT02314156|69258621|FG001|Overall Study|Withdrawal by Subject|0|||
37754335|NCT02716584|69258841|FG000|Overall Study|Lost to Follow-up|8|||
37754336|NCT02716584|69258842|FG001|Overall Study|Lost to Follow-up|5|||
37754337|NCT02716194|69258923|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
37754338|NCT02716194|69258924|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
37754339|NCT02716194|69258925|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
37754340|NCT03773484|69258995|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
37754341|NCT02715258|69259178|FG000|Overall Study|Withdrawal by Subject|6|||
37754342|NCT02715258|69259179|FG001|Overall Study|Withdrawal by Subject|1|||
37754343|NCT02715258|69259178|FG000|Overall Study|Lost to Follow-up|7|||
37754344|NCT02715258|69259179|FG001|Overall Study|Lost to Follow-up|1|||
37754345|NCT02715258|69259178|FG000|Overall Study|Terminated by Sponsor|0|||
37754346|NCT02715258|69259179|FG001|Overall Study|Terminated by Sponsor|1|||
37754347|NCT02715258|69259178|FG000|Overall Study|Death|0|||
37754348|NCT02715258|69259179|FG001|Overall Study|Death|1|||
37754349|NCT02715258|69259178|FG000|Overall Study|Subject non-compliant|1|||
37754350|NCT02715258|69259179|FG001|Overall Study|Subject non-compliant|1|||
37754351|NCT02715258|69259178|FG000|Overall Study|GCP violation|2|||
37754352|NCT02715258|69259179|FG001|Overall Study|GCP violation|1|||
37663794|NCT02714569|69136770|FG008|Part A Third Intervention|Adverse Event|0|||
37663795|NCT02714569|69136771|FG009|Part A Third Intervention|Adverse Event|0|||
37663796|NCT02714569|69136772|FG010|Part A Third Intervention|Adverse Event|0|||
37663797|NCT02714569|69136762|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
37754353|NCT02714868|69259204|FG000|Overall Study|Withdrawal by Subject|3|||
37754354|NCT02714868|69259205|FG001|Overall Study|Withdrawal by Subject|0|||
37754355|NCT02714868|69259204|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
37754356|NCT02714868|69259205|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
37754357|NCT02714868|69259204|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
37754358|NCT02714868|69259205|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
37754359|NCT02713542|69259520|FG000|Overall Study|Use of prohibited medication|14|||
37754360|NCT02713542|69259521|FG001|Overall Study|Use of prohibited medication|5|||
37754361|NCT02713542|69259520|FG000|Overall Study|Withdrawal by Subject|4|||
37754362|NCT02713542|69259521|FG001|Overall Study|Withdrawal by Subject|1|||
37754363|NCT03548220|69259605|FG000|Overall Study|Lost to Follow-up|1|||
37754364|NCT03548220|69259606|FG001|Overall Study|Lost to Follow-up|0|||
37754365|NCT03548220|69259607|FG002|Overall Study|Lost to Follow-up|0|||
37754366|NCT03548220|69259608|FG003|Overall Study|Lost to Follow-up|0|||
37754367|NCT02712996|69259643|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
37754368|NCT02712996|69259644|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
37754369|NCT00701064|69259751|FG000|Overall Study|Protocol Violation|1|||
37754370|NCT00701064|69259752|FG001|Overall Study|Protocol Violation|1|||
37754371|NCT00701064|69259751|FG000|Overall Study|Withdrawal by Subject|1|||
37754372|NCT00701064|69259752|FG001|Overall Study|Withdrawal by Subject|1|||
37754373|NCT00701064|69259751|FG000|Overall Study|initiated other PTSD treatment|2|||
37754374|NCT00701064|69259752|FG001|Overall Study|initiated other PTSD treatment|2|||
37754375|NCT05779072|69259760|FG000|Overall Study|Lost to Follow-up|0|||
37754376|NCT05779072|69259761|FG001|Overall Study|Lost to Follow-up|1|||
37754377|NCT05779072|69259760|FG000|Overall Study|Withdrawal by Subject|1|||
37754378|NCT05779072|69259761|FG001|Overall Study|Withdrawal by Subject|5|||
37663798|NCT02714569|69136763|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
37663799|NCT02714569|69136764|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
37663800|NCT02714569|69136765|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
37663801|NCT02714569|69136766|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
37663802|NCT02714569|69136767|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
37663803|NCT02714569|69136768|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
37663804|NCT02714569|69136769|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
37663805|NCT02714569|69136770|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
37663806|NCT02714569|69136771|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
37663807|NCT02714569|69136772|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
37663808|NCT02714569|69136762|FG000|Part B (Overall)|Lost to Follow-up|0|||
37663809|NCT02714569|69136763|FG001|Part B (Overall)|Lost to Follow-up|0|||
37663810|NCT02714569|69136764|FG002|Part B (Overall)|Lost to Follow-up|0|||
37754379|NCT05089682|69259776|FG000|Overall Study|Withdrawal by Subject|2|||
37754380|NCT05055128|69259785|FG000|Overall Study|Adverse Event|0|||
37754381|NCT05055128|69259786|FG001|Overall Study|Adverse Event|0|||
37754382|NCT05055128|69259787|FG002|Overall Study|Adverse Event|0|||
37754383|NCT05055128|69259788|FG003|Overall Study|Adverse Event|1|||
37754384|NCT05055128|69259789|FG004|Overall Study|Adverse Event|1|||
37754385|NCT05055128|69259785|FG000|Overall Study|Protocol Violation|0|||
37754386|NCT05055128|69259786|FG001|Overall Study|Protocol Violation|0|||
37754387|NCT05055128|69259787|FG002|Overall Study|Protocol Violation|0|||
37754388|NCT05055128|69259788|FG003|Overall Study|Protocol Violation|1|||
37754389|NCT05055128|69259789|FG004|Overall Study|Protocol Violation|0|||
37754390|NCT05055128|69259785|FG000|Overall Study|Withdrawal by Subject|5|||
37754391|NCT05055128|69259786|FG001|Overall Study|Withdrawal by Subject|2|||
37754392|NCT05055128|69259787|FG002|Overall Study|Withdrawal by Subject|2|||
37754393|NCT05055128|69259788|FG003|Overall Study|Withdrawal by Subject|4|||
37754394|NCT05055128|69259789|FG004|Overall Study|Withdrawal by Subject|2|||
37754395|NCT05055128|69259785|FG000|Overall Study|Randomized By Mistake|0|||
37754396|NCT05055128|69259786|FG001|Overall Study|Randomized By Mistake|1|||
37754397|NCT05055128|69259787|FG002|Overall Study|Randomized By Mistake|0|||
37754398|NCT05055128|69259788|FG003|Overall Study|Randomized By Mistake|0|||
37754399|NCT05055128|69259789|FG004|Overall Study|Randomized By Mistake|0|||
37754400|NCT05055128|69259785|FG000|Overall Study|Other|1|||
37754401|NCT05055128|69259786|FG001|Overall Study|Other|0|||
37754402|NCT05055128|69259787|FG002|Overall Study|Other|0|||
37754403|NCT05055128|69259788|FG003|Overall Study|Other|0|||
37754404|NCT05055128|69259789|FG004|Overall Study|Other|0|||
37754405|NCT05038020|69259805|FG000|Overall Study|Early Termination|3|||
37754406|NCT05038020|69259806|FG001|Overall Study|Early Termination|0|||
37857740|NCT01187901|69540806|FG000|Overall Study|Unrelated Health Reasons|1|||
37663811|NCT02714569|69136765|FG003|Part B (Overall)|Lost to Follow-up|0|||
37663812|NCT02714569|69136766|FG004|Part B (Overall)|Lost to Follow-up|0|||
37663813|NCT02714569|69136767|FG005|Part B (Overall)|Lost to Follow-up|0|||
37754407|NCT05013905|69259812|FG000|Overall Study|Adverse Event|1|||
37754408|NCT05013905|69259812|FG000|Overall Study|Lack of Efficacy|1|||
37754409|NCT04796610|69259825|FG000|Overall Study|Withdrawal by Subject|1|||
37754410|NCT04796610|69259826|FG001|Overall Study|Withdrawal by Subject|0|||
37754411|NCT04796610|69259827|FG002|Overall Study|Withdrawal by Subject|0|||
37754412|NCT04796610|69259828|FG003|Overall Study|Withdrawal by Subject|0|||
37754413|NCT04796610|69259825|FG000|Overall Study|Lost to Follow-up|2|||
37754414|NCT04796610|69259826|FG001|Overall Study|Lost to Follow-up|0|||
37754415|NCT04796610|69259827|FG002|Overall Study|Lost to Follow-up|1|||
37754416|NCT04796610|69259828|FG003|Overall Study|Lost to Follow-up|1|||
37754417|NCT04702997|69259838|FG000|Overall Study|Withdrawal by Subject|1|||
37754418|NCT04702997|69259839|FG001|Overall Study|Withdrawal by Subject|1|||
37754419|NCT04173494|69259860|FG000|Randomized DB TP (Up to Week 24)|Adverse Event|16|||
37663814|NCT02714569|69136768|FG006|Part B (Overall)|Lost to Follow-up|1|||
37663815|NCT02714569|69136769|FG007|Part B (Overall)|Lost to Follow-up|0|||
37663816|NCT02714569|69136770|FG008|Part B (Overall)|Lost to Follow-up|0|||
37754420|NCT04173494|69259861|FG001|Randomized DB TP (Up to Week 24)|Adverse Event|11|||
37754421|NCT04173494|69259860|FG000|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|6|||
37754422|NCT04173494|69259861|FG001|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|5|||
37754423|NCT04173494|69259860|FG000|Randomized DB TP (Up to Week 24)|Lack of Efficacy|6|||
37754424|NCT04173494|69259861|FG001|Randomized DB TP (Up to Week 24)|Lack of Efficacy|3|||
37754425|NCT04173494|69259860|FG000|Randomized DB TP (Up to Week 24)|Death|4|||
37754426|NCT04173494|69259861|FG001|Randomized DB TP (Up to Week 24)|Death|3|||
37754427|NCT04173494|69259860|FG000|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
37754428|NCT04173494|69259861|FG001|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
37754429|NCT04173494|69259860|FG000|Randomized DB TP (Up to Week 24)|Disease Progression|1|||
37754430|NCT04173494|69259861|FG001|Randomized DB TP (Up to Week 24)|Disease Progression|2|||
37754431|NCT04173494|69259860|FG000|Randomized DB TP (Up to Week 24)|Lost to Follow-up|1|||
37754432|NCT04173494|69259861|FG001|Randomized DB TP (Up to Week 24)|Lost to Follow-up|0|||
37754433|NCT04173494|69259860|FG000|Randomized DB TP (Up to Week 24)|Physician Decision|0|||
37754434|NCT04173494|69259861|FG001|Randomized DB TP (Up to Week 24)|Physician Decision|1|||
37754435|NCT04173494|69259860|FG000|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|11|||
37754436|NCT04173494|69259861|FG001|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|1|||
37754437|NCT04173494|69259860|FG000|Open-Label Extended TP(Weeks 24 to 151)|Death|6|||
37754438|NCT04173494|69259861|FG001|Open-Label Extended TP(Weeks 24 to 151)|Death|3|||
37754439|NCT04173494|69259860|FG000|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|6|||
37754440|NCT04173494|69259861|FG001|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|2|||
37754441|NCT04173494|69259860|FG000|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|4|||
37754442|NCT04173494|69259861|FG001|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|3|||
37754443|NCT04173494|69259860|FG000|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|4|||
37754444|NCT04173494|69259861|FG001|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|3|||
37754445|NCT04173494|69259860|FG000|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|0|||
37754446|NCT04173494|69259861|FG001|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|1|||
37754447|NCT04173494|69259860|FG000|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
37754448|NCT04173494|69259861|FG001|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
37754449|NCT04173494|69259860|FG000|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|61|||
37754450|NCT04173494|69259861|FG001|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|27|||
37857741|NCT01187901|69540807|FG001|Overall Study|Unrelated Health Reasons|2|||
37857742|NCT01187901|69540806|FG000|Overall Study|Suspected Allergic Reaction|1|||
37857743|NCT01187901|69540807|FG001|Overall Study|Suspected Allergic Reaction|1|||
37857744|NCT01187901|69540806|FG000|Overall Study|Adverse Event|3|||
37857745|NCT01187901|69540807|FG001|Overall Study|Adverse Event|0|||
37857746|NCT01187901|69540806|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
37857747|NCT01187901|69540807|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
37857748|NCT01187901|69540806|FG000|Overall Study|Pregnancy|0|||
37663817|NCT02714569|69136771|FG009|Part B (Overall)|Lost to Follow-up|0|||
37663818|NCT02714569|69136772|FG010|Part B (Overall)|Lost to Follow-up|0|||
37857749|NCT01187901|69540807|FG001|Overall Study|Pregnancy|2|||
37857750|NCT01302119|69540815|FG000|Overall Study|Withdrawal by Subject|30|||
37857751|NCT01302119|69540816|FG001|Overall Study|Withdrawal by Subject|20|||
37857752|NCT01302119|69540815|FG000|Overall Study|Lost to Follow-up|10|||
37857753|NCT01302119|69540816|FG001|Overall Study|Lost to Follow-up|4|||
37857754|NCT01302119|69540815|FG000|Overall Study|Adverse Event|2|||
37857755|NCT01302119|69540816|FG001|Overall Study|Adverse Event|1|||
37857756|NCT01302119|69540815|FG000|Overall Study|Non-compliance|4|||
37857757|NCT01302119|69540816|FG001|Overall Study|Non-compliance|2|||
37857758|NCT01302119|69540815|FG000|Overall Study|Non-specific|4|||
37857759|NCT01302119|69540816|FG001|Overall Study|Non-specific|1|||
37857760|NCT05038982|69540824|FG000|Overall Study|Withdrawal by Subject|0|||
37857761|NCT05038982|69540825|FG001|Overall Study|Withdrawal by Subject|2|||
37857762|NCT04867785|69540844|FG000|Overall Study|Adverse Event|1|||
37663819|NCT02714569|69136762|FG000|Part B (Overall)|Withdrawal by Subject|0|||
37663820|NCT02714569|69136763|FG001|Part B (Overall)|Withdrawal by Subject|0|||
37663821|NCT02714569|69136764|FG002|Part B (Overall)|Withdrawal by Subject|0|||
37857763|NCT04867785|69540845|FG001|Overall Study|Adverse Event|0|||
37663822|NCT02714569|69136765|FG003|Part B (Overall)|Withdrawal by Subject|0|||
37663823|NCT02714569|69136766|FG004|Part B (Overall)|Withdrawal by Subject|0|||
37663824|NCT02714569|69136767|FG005|Part B (Overall)|Withdrawal by Subject|0|||
37857764|NCT04867785|69540846|FG002|Overall Study|Adverse Event|1|||
37857765|NCT04867785|69540847|FG003|Overall Study|Adverse Event|0|||
37857766|NCT04867785|69540848|FG004|Overall Study|Adverse Event|0|||
37857767|NCT04867785|69540849|FG005|Overall Study|Adverse Event|0|||
37754451|NCT03920215|69259886|FG000|Overall Study|Lost to Follow-up|1|||
37754452|NCT03920215|69259887|FG001|Overall Study|Lost to Follow-up|2|||
37754453|NCT03920215|69259888|FG002|Overall Study|Lost to Follow-up|0|||
37754454|NCT03920215|69259889|FG003|Overall Study|Lost to Follow-up|0|||
37754455|NCT03920215|69259886|FG000|Overall Study|Death|0|||
37754456|NCT03920215|69259887|FG001|Overall Study|Death|0|||
37754457|NCT03920215|69259888|FG002|Overall Study|Death|0|||
37754458|NCT03920215|69259889|FG003|Overall Study|Death|1|||
37754459|NCT03878134|69259899|FG000|Overall Study|Scanner downtime or scheduling conflict|11|||
37754460|NCT03874429|69259905|FG000|Overall Study|Adverse Event|2|||
37754461|NCT03874429|69259906|FG001|Overall Study|Adverse Event|2|||
37754462|NCT03874429|69259905|FG000|Overall Study|Lack of Efficacy|0|||
37754463|NCT03874429|69259906|FG001|Overall Study|Lack of Efficacy|1|||
37754464|NCT03874429|69259905|FG000|Overall Study|Covid-19 pandemic|4|||
37857768|NCT04867785|69540850|FG006|Overall Study|Adverse Event|0|||
37857769|NCT04867785|69540851|FG007|Overall Study|Adverse Event|2|||
37857770|NCT04867785|69540844|FG000|Overall Study|Lost to Follow-up|4|||
37857771|NCT04867785|69540845|FG001|Overall Study|Lost to Follow-up|4|||
37857772|NCT04867785|69540846|FG002|Overall Study|Lost to Follow-up|3|||
37857773|NCT04867785|69540847|FG003|Overall Study|Lost to Follow-up|2|||
37857774|NCT04867785|69540848|FG004|Overall Study|Lost to Follow-up|0|||
37857775|NCT04867785|69540849|FG005|Overall Study|Lost to Follow-up|1|||
37857776|NCT04867785|69540850|FG006|Overall Study|Lost to Follow-up|0|||
37857777|NCT04867785|69540851|FG007|Overall Study|Lost to Follow-up|1|||
37857778|NCT04867785|69540844|FG000|Overall Study|Withdrawal by Subject|6|||
37857779|NCT04867785|69540845|FG001|Overall Study|Withdrawal by Subject|2|||
37857780|NCT04867785|69540846|FG002|Overall Study|Withdrawal by Subject|2|||
37857781|NCT04867785|69540847|FG003|Overall Study|Withdrawal by Subject|1|||
37857782|NCT04867785|69540848|FG004|Overall Study|Withdrawal by Subject|2|||
37857783|NCT04867785|69540849|FG005|Overall Study|Withdrawal by Subject|0|||
37857784|NCT04867785|69540850|FG006|Overall Study|Withdrawal by Subject|2|||
37857785|NCT04867785|69540851|FG007|Overall Study|Withdrawal by Subject|5|||
37857786|NCT04867785|69540844|FG000|Overall Study|Physician Decision|0|||
37857787|NCT04867785|69540845|FG001|Overall Study|Physician Decision|0|||
37857788|NCT04867785|69540846|FG002|Overall Study|Physician Decision|0|||
37857789|NCT04867785|69540847|FG003|Overall Study|Physician Decision|0|||
37857790|NCT04867785|69540848|FG004|Overall Study|Physician Decision|0|||
37857791|NCT04867785|69540849|FG005|Overall Study|Physician Decision|0|||
37857792|NCT04867785|69540850|FG006|Overall Study|Physician Decision|0|||
37857793|NCT04867785|69540851|FG007|Overall Study|Physician Decision|1|||
37857794|NCT04867785|69540844|FG000|Overall Study|Inadvertent Enrollment|0|||
37857795|NCT04867785|69540845|FG001|Overall Study|Inadvertent Enrollment|0|||
37857796|NCT04867785|69540846|FG002|Overall Study|Inadvertent Enrollment|0|||
37923361|NCT00825812|69610172|FG002|Overall Study|Subject withdrew consent|3|||
37923362|NCT00825812|69610173|FG003|Overall Study|Subject withdrew consent|2|||
37923363|NCT00825812|69610170|FG000|Overall Study|Non-compliance with protocol|0|||
37923364|NCT00825812|69610171|FG001|Overall Study|Non-compliance with protocol|0|||
37923365|NCT00825812|69610172|FG002|Overall Study|Non-compliance with protocol|0|||
37923366|NCT00825812|69610173|FG003|Overall Study|Non-compliance with protocol|1|||
37923367|NCT00825812|69610170|FG000|Overall Study|Administrative|0|||
37923368|NCT00825812|69610171|FG001|Overall Study|Administrative|1|||
37923369|NCT00825812|69610172|FG002|Overall Study|Administrative|3|||
37923370|NCT00825812|69610173|FG003|Overall Study|Administrative|5|||
37923371|NCT00824720|69610186|FG000|Overall Study|failed plug insertion|3|||
37663825|NCT02714569|69136768|FG006|Part B (Overall)|Withdrawal by Subject|0|||
37663826|NCT02714569|69136769|FG007|Part B (Overall)|Withdrawal by Subject|1|||
37663827|NCT02714569|69136770|FG008|Part B (Overall)|Withdrawal by Subject|0|||
37663828|NCT02714569|69136771|FG009|Part B (Overall)|Withdrawal by Subject|1|||
37663829|NCT02714569|69136772|FG010|Part B (Overall)|Withdrawal by Subject|0|||
37663830|NCT02714569|69136762|FG000|Part B (Overall)|Adverse Event|0|||
37663831|NCT02714569|69136763|FG001|Part B (Overall)|Adverse Event|0|||
37754465|NCT03874429|69259906|FG001|Overall Study|Covid-19 pandemic|2|||
37754466|NCT03733730|69259936|FG000|Overall Study|Lost to Follow-up|1|||
37754467|NCT03733730|69259937|FG001|Overall Study|Lost to Follow-up|32|||
37923372|NCT00824720|69610187|FG001|Overall Study|failed plug insertion|1|||
37923373|NCT00824720|69610188|FG002|Overall Study|failed plug insertion|0|||
37923374|NCT00824720|69610186|FG000|Overall Study|Protocol Violation|0|||
37923375|NCT00824720|69610187|FG001|Overall Study|Protocol Violation|0|||
37663832|NCT02714569|69136764|FG002|Part B (Overall)|Adverse Event|0|||
37663833|NCT02714569|69136765|FG003|Part B (Overall)|Adverse Event|0|||
37754468|NCT03733730|69259936|FG000|Overall Study|Other|1|||
37754469|NCT03733730|69259937|FG001|Overall Study|Other|0|||
37857797|NCT04867785|69540847|FG003|Overall Study|Inadvertent Enrollment|1|||
37857798|NCT04867785|69540848|FG004|Overall Study|Inadvertent Enrollment|1|||
37857799|NCT04867785|69540849|FG005|Overall Study|Inadvertent Enrollment|0|||
37857800|NCT04867785|69540850|FG006|Overall Study|Inadvertent Enrollment|0|||
37754470|NCT03733730|69259936|FG000|Overall Study|Adverse Event|0|||
37754471|NCT03733730|69259937|FG001|Overall Study|Adverse Event|4|||
37754472|NCT03733730|69259936|FG000|Overall Study|Death|0|||
37754473|NCT03733730|69259937|FG001|Overall Study|Death|5|||
37754474|NCT03733730|69259936|FG000|Overall Study|Withdrawal by Subject|0|||
37754475|NCT03733730|69259937|FG001|Overall Study|Withdrawal by Subject|8|||
37754476|NCT03713632|69259954|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
37754477|NCT03713632|69259955|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
37754478|NCT03713632|69259956|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|8|||
37754479|NCT03713632|69259957|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
37754480|NCT03713632|69259958|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
37754481|NCT03713632|69259954|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
37754482|NCT03713632|69259955|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
37754483|NCT03713632|69259956|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
37754484|NCT03713632|69259957|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
37754485|NCT03713632|69259958|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
37754486|NCT03713632|69259954|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
37857801|NCT04867785|69540851|FG007|Overall Study|Inadvertent Enrollment|1|||
37857802|NCT04867785|69540844|FG000|Overall Study|Eligibility Criteria Not Met|0|||
37857803|NCT04867785|69540845|FG001|Overall Study|Eligibility Criteria Not Met|0|||
37857804|NCT04867785|69540846|FG002|Overall Study|Eligibility Criteria Not Met|0|||
37857805|NCT04867785|69540847|FG003|Overall Study|Eligibility Criteria Not Met|0|||
37857806|NCT04867785|69540848|FG004|Overall Study|Eligibility Criteria Not Met|0|||
37857807|NCT04867785|69540849|FG005|Overall Study|Eligibility Criteria Not Met|0|||
37857808|NCT04867785|69540850|FG006|Overall Study|Eligibility Criteria Not Met|0|||
37857809|NCT04867785|69540851|FG007|Overall Study|Eligibility Criteria Not Met|1|||
37857810|NCT04541004|69540878|FG000|Overall Study|Adverse Event|2|||
37857811|NCT04091646|69540885|FG000|Overall Study|Adverse Event|2|||
37857812|NCT04091646|69540886|FG001|Overall Study|Adverse Event|1|||
37857813|NCT04091646|69540885|FG000|Overall Study|Lost to Follow-up|6|||
37663834|NCT02714569|69136766|FG004|Part B (Overall)|Adverse Event|0|||
37663835|NCT02714569|69136767|FG005|Part B (Overall)|Adverse Event|0|||
37663836|NCT02714569|69136768|FG006|Part B (Overall)|Adverse Event|0|||
37663837|NCT02714569|69136769|FG007|Part B (Overall)|Adverse Event|0|||
37663838|NCT02714569|69136770|FG008|Part B (Overall)|Adverse Event|0|||
37663839|NCT02714569|69136771|FG009|Part B (Overall)|Adverse Event|1|||
37663840|NCT02714569|69136772|FG010|Part B (Overall)|Adverse Event|0|||
37663841|NCT02713789|69136835|FG000|Overall Study|Lost to Follow-up|0|||
37663842|NCT02713789|69136836|FG001|Overall Study|Lost to Follow-up|1|||
37663843|NCT02713789|69136837|FG002|Overall Study|Lost to Follow-up|1|||
37663844|NCT04445051|69136847|FG000|Overall Study|Adverse Event|0|||
37663845|NCT04445051|69136848|FG001|Overall Study|Adverse Event|0|||
37663846|NCT04445051|69136849|FG002|Overall Study|Adverse Event|1|||
37663847|NCT04445051|69136850|FG003|Overall Study|Adverse Event|0|||
37663848|NCT04445051|69136851|FG004|Overall Study|Adverse Event|0|||
37663849|NCT04445051|69136852|FG005|Overall Study|Adverse Event|0|||
37663850|NCT04086121|69136866|FG000|Overall Study|Other than listed|8|||
37663851|NCT04086121|69136866|FG000|Overall Study|Withdrawal by Subject|3|||
37663852|NCT04086121|69136866|FG000|Overall Study|Lost to Follow-up|2|||
37663853|NCT04086121|69136866|FG000|Overall Study|Adverse Event|1|||
37663854|NCT02729909|69136873|FG000|Overall Study|Lost to Follow-up|0|||
37663855|NCT02729909|69136874|FG001|Overall Study|Lost to Follow-up|1|||
37663856|NCT02729909|69136873|FG000|Overall Study|Lack of Efficacy|0|||
37663857|NCT02729909|69136874|FG001|Overall Study|Lack of Efficacy|2|||
37663858|NCT02729909|69136873|FG000|Overall Study|Significant Protocol Deviation|0|||
37663859|NCT02729909|69136874|FG001|Overall Study|Significant Protocol Deviation|2|||
37663860|NCT02729909|69136873|FG000|Overall Study|Voluntary Withdrawal|1|||
37663861|NCT02729909|69136874|FG001|Overall Study|Voluntary Withdrawal|0|||
37663862|NCT02713243|69136882|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
37663863|NCT02713243|69136883|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
37663864|NCT02713243|69136882|FG000|Overall Study|Administrative problems|0|||
37663865|NCT02713243|69136883|FG001|Overall Study|Administrative problems|1|||
37663866|NCT02713243|69136882|FG000|Overall Study|Protocol deviation|0|||
37663867|NCT02713243|69136883|FG001|Overall Study|Protocol deviation|1|||
37663868|NCT03434041|69136891|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
37663869|NCT03434041|69136892|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
37663870|NCT03434041|69136891|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
37663871|NCT03434041|69136892|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
37663872|NCT03434041|69136891|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
37663873|NCT03434041|69136892|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
37663874|NCT03434041|69136891|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
37663875|NCT03434041|69136892|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
37754487|NCT03713632|69259955|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
37857814|NCT04091646|69540886|FG001|Overall Study|Lost to Follow-up|2|||
37663876|NCT03434041|69136891|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
37663877|NCT03434041|69136892|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
37663878|NCT03434041|69136891|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
37663879|NCT03434041|69136892|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
37754488|NCT03713632|69259956|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
37754489|NCT03713632|69259957|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
37754490|NCT03713632|69259958|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
37663880|NCT03434041|69136891|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
37663881|NCT03434041|69136892|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
37663882|NCT03434041|69136891|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
37663883|NCT03434041|69136892|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
37663884|NCT03434041|69136891|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
37663885|NCT03434041|69136892|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
37663886|NCT03434041|69136891|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
37663887|NCT03434041|69136892|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
37663888|NCT03434041|69136891|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
37663889|NCT03434041|69136892|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
37663890|NCT00708461|69136907|FG000|Overall Study|Lost to Follow-up|18|||
37663891|NCT00708461|69136908|FG001|Overall Study|Lost to Follow-up|11|||
37663892|NCT00708461|69136907|FG000|Overall Study|Withdrawal by Subject|8|||
37663893|NCT00708461|69136908|FG001|Overall Study|Withdrawal by Subject|9|||
37663894|NCT00708461|69136907|FG000|Overall Study|left workforce|115|||
37663895|NCT00708461|69136908|FG001|Overall Study|left workforce|180|||
37663896|NCT00700999|69136916|FG000|Overall Study|Lost to Follow-up|7|||
37663897|NCT00700999|69136917|FG001|Overall Study|Lost to Follow-up|7|||
37663898|NCT00700999|69136916|FG000|Overall Study|Excluded - did not meet study criteria|0|||
37663899|NCT00700999|69136917|FG001|Overall Study|Excluded - did not meet study criteria|1|||
37663900|NCT00700999|69136916|FG000|Overall Study|Withdrawal by Subject|8|||
37663901|NCT00700999|69136917|FG001|Overall Study|Withdrawal by Subject|1|||
37663902|NCT02729831|69136927|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
37663903|NCT02729831|69136928|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
37754491|NCT03713632|69259954|FG000|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
37754492|NCT03713632|69259955|FG001|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
37754493|NCT03713632|69259956|FG002|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
37754494|NCT03713632|69259957|FG003|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
37663904|NCT02729831|69136929|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
37663905|NCT02729831|69136930|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
37663906|NCT02729831|69136927|FG000|1 Week Post-visit|Lost to Follow-up|43|||
37663907|NCT02729831|69136928|FG001|1 Week Post-visit|Lost to Follow-up|40|||
37754495|NCT03713632|69259958|FG004|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
37754496|NCT03713632|69259954|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
37754497|NCT03713632|69259955|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
37754498|NCT03713632|69259956|FG002|Treatment Period 1 (Until Week 16)|Technical problems|1|||
37754499|NCT03713632|69259957|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
37754500|NCT03713632|69259958|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
37754501|NCT03713632|69259954|FG000|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
37754502|NCT03713632|69259955|FG001|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
37754503|NCT03713632|69259956|FG002|Treatment Period 1 (Until Week 16)|Pregnancy|1|||
37754504|NCT03713632|69259957|FG003|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
37754505|NCT03713632|69259958|FG004|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
37754506|NCT03713632|69259954|FG000|Treatment Period 1 (Until Week 16)|Misrandomized Subject|1|||
37754507|NCT03713632|69259955|FG001|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
37754508|NCT03713632|69259956|FG002|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
37754509|NCT03713632|69259957|FG003|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
37857815|NCT04091646|69540885|FG000|Overall Study|Protocol Violation|0|||
37857816|NCT04091646|69540886|FG001|Overall Study|Protocol Violation|1|||
37857817|NCT04091646|69540885|FG000|Overall Study|Withdrawal by Subject|4|||
37663908|NCT02729831|69136929|FG002|1 Week Post-visit|Lost to Follow-up|38|||
37857818|NCT04091646|69540886|FG001|Overall Study|Withdrawal by Subject|1|||
37857819|NCT04091646|69540885|FG000|Overall Study|Participant Incarcerated|1|||
37857820|NCT04091646|69540886|FG001|Overall Study|Participant Incarcerated|0|||
37857821|NCT04040933|69540898|FG000|Overall Study|Protocol Violation|1|||
37857822|NCT04040933|69540898|FG000|Overall Study|Withdrawal by Subject|2|||
37857823|NCT03995355|69540911|FG000|Overall Study|Adverse Event|1|||
37857824|NCT03995355|69540912|FG001|Overall Study|Adverse Event|0|||
37857825|NCT03995355|69540911|FG000|Overall Study|Withdrawal by Subject|1|||
37857826|NCT03995355|69540912|FG001|Overall Study|Withdrawal by Subject|0|||
37857827|NCT03995355|69540911|FG000|Overall Study|Scheduling Issues|0|||
37663909|NCT02729831|69136930|FG003|1 Week Post-visit|Lost to Follow-up|36|||
37663910|NCT02729831|69136927|FG000|6 Month Follow-up|Lost to Follow-up|54|||
37857828|NCT03995355|69540912|FG001|Overall Study|Scheduling Issues|1|||
37663911|NCT02729831|69136928|FG001|6 Month Follow-up|Lost to Follow-up|51|||
37663912|NCT02729831|69136929|FG002|6 Month Follow-up|Lost to Follow-up|48|||
37663913|NCT02729831|69136930|FG003|6 Month Follow-up|Lost to Follow-up|42|||
37663914|NCT02729831|69136927|FG000|6 Month Follow-up|Death|1|||
37663915|NCT02729831|69136928|FG001|6 Month Follow-up|Death|3|||
37663916|NCT02729831|69136929|FG002|6 Month Follow-up|Death|0|||
37663917|NCT02729831|69136930|FG003|6 Month Follow-up|Death|1|||
37663918|NCT02729753|69136942|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
37663919|NCT02729753|69136943|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
37663920|NCT00709319|69136952|FG000|Overall Study|Death|4|||
37663921|NCT00709319|69136952|FG000|Overall Study|Withdrawal by Subject|2|||
37663922|NCT02729051|69136997|FG000|Overall Study|Adverse Event|21|||
37663923|NCT02729051|69136998|FG001|Overall Study|Adverse Event|11|||
37663924|NCT02729051|69136997|FG000|Overall Study|Lack of Efficacy|1|||
37663925|NCT02729051|69136998|FG001|Overall Study|Lack of Efficacy|1|||
37663926|NCT02729051|69136997|FG000|Overall Study|Lost to Follow-up|1|||
37663927|NCT02729051|69136998|FG001|Overall Study|Lost to Follow-up|2|||
37663928|NCT02729051|69136997|FG000|Overall Study|Physician Decision|1|||
37663929|NCT02729051|69136998|FG001|Overall Study|Physician Decision|1|||
37663930|NCT02729051|69136997|FG000|Overall Study|Withdrawal by Subject|6|||
37663931|NCT02729051|69136998|FG001|Overall Study|Withdrawal by Subject|17|||
37663932|NCT00707993|69137006|FG000|Overall Study|Adverse Event|16|||
37663933|NCT00707993|69137007|FG001|Overall Study|Adverse Event|20|||
37663934|NCT00707993|69137006|FG000|Overall Study|Protocol Violation|4|||
37663935|NCT00707993|69137007|FG001|Overall Study|Protocol Violation|7|||
37663936|NCT00707993|69137006|FG000|Overall Study|Lost to Follow-up|0|||
37663937|NCT00707993|69137007|FG001|Overall Study|Lost to Follow-up|4|||
37663938|NCT00707993|69137006|FG000|Overall Study|Withdrawal by Subject|12|||
37663939|NCT00707993|69137007|FG001|Overall Study|Withdrawal by Subject|16|||
37663940|NCT00707993|69137006|FG000|Overall Study|Hyperglycemic Rescue|55|||
37663941|NCT00707993|69137007|FG001|Overall Study|Hyperglycemic Rescue|47|||
37663942|NCT00707993|69137006|FG000|Overall Study|Other|2|||
37663943|NCT00707993|69137007|FG001|Overall Study|Other|0|||
37663944|NCT00708227|69137017|FG000|Overall Study|Physician Decision|0|||
37663945|NCT00708227|69137018|FG001|Overall Study|Physician Decision|3|||
37663946|NCT00708227|69137019|FG002|Overall Study|Physician Decision|1|||
37663947|NCT00708227|69137020|FG003|Overall Study|Physician Decision|2|||
37663948|NCT00708227|69137017|FG000|Overall Study|Withdrawal by Subject|1|||
37663949|NCT00708227|69137018|FG001|Overall Study|Withdrawal by Subject|2|||
37663950|NCT00708227|69137019|FG002|Overall Study|Withdrawal by Subject|0|||
37663951|NCT00708227|69137020|FG003|Overall Study|Withdrawal by Subject|1|||
37663952|NCT02425891|69137052|FG000|Overall Study|Death|333|||
37663953|NCT02425891|69137053|FG001|Overall Study|Death|314|||
37663954|NCT02425891|69137052|FG000|Overall Study|Lost to Follow-up|4|||
37663955|NCT02425891|69137053|FG001|Overall Study|Lost to Follow-up|6|||
37663956|NCT02425891|69137052|FG000|Overall Study|Non-Compliance|1|||
37663957|NCT02425891|69137053|FG001|Overall Study|Non-Compliance|1|||
37663958|NCT02425891|69137052|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
37663959|NCT02425891|69137053|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
37663960|NCT02425891|69137052|FG000|Overall Study|Physician Decision|0|||
37663961|NCT02425891|69137053|FG001|Overall Study|Physician Decision|1|||
37663962|NCT02425891|69137052|FG000|Overall Study|Protocol Violation|1|||
37663963|NCT02425891|69137053|FG001|Overall Study|Protocol Violation|1|||
37663964|NCT02425891|69137052|FG000|Overall Study|Study Terminated By Sponsor|85|||
37663965|NCT02425891|69137053|FG001|Overall Study|Study Terminated By Sponsor|95|||
37663966|NCT02425891|69137052|FG000|Overall Study|Withdrawal by Subject|27|||
37663967|NCT02425891|69137053|FG001|Overall Study|Withdrawal by Subject|32|||
37663968|NCT03241225|69137063|FG000|Overall Study|Lost to Follow-up|2|||
37857829|NCT03933397|69540920|FG000|Overall Study|No emergency department visit|65|||
37857830|NCT03933397|69540921|FG001|Overall Study|No emergency department visit|71|||
37663969|NCT03241225|69137064|FG001|Overall Study|Lost to Follow-up|1|||
37663970|NCT03241225|69137063|FG000|Overall Study|Protocol Violation|4|||
37857831|NCT03933397|69540920|FG000|Overall Study|Missed emergency department visit|25|||
37857832|NCT03933397|69540921|FG001|Overall Study|Missed emergency department visit|30|||
37663971|NCT03241225|69137064|FG001|Overall Study|Protocol Violation|1|||
37663972|NCT03241225|69137063|FG000|Overall Study|Withdrawal by Subject|1|||
37663973|NCT03241225|69137064|FG001|Overall Study|Withdrawal by Subject|0|||
37663974|NCT01597245|69137074|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
37663975|NCT01597245|69137075|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
37663976|NCT01597245|69137076|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
37663977|NCT01597245|69137077|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
37663978|NCT01597245|69137078|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
37663979|NCT01597245|69137079|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
37663980|NCT01597245|69137080|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
37663981|NCT01597245|69137081|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
37663982|NCT01597245|69137082|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
37663983|NCT01597245|69137083|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
37663984|NCT01597245|69137084|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
37663985|NCT01597245|69137085|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
37663986|NCT01597245|69137086|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
37663987|NCT01597245|69137087|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
37663988|NCT01597245|69137088|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
37663989|NCT01597245|69137089|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
37663990|NCT01597245|69137090|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
37663991|NCT01597245|69137091|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
37663992|NCT01597245|69137092|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
37663993|NCT01597245|69137093|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
37663994|NCT01597245|69137094|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
37663995|NCT01597245|69137074|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
37663996|NCT01597245|69137075|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
37663997|NCT01597245|69137076|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
37663998|NCT01597245|69137077|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
37663999|NCT01597245|69137078|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
37664000|NCT01597245|69137079|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
37664001|NCT01597245|69137080|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
37664002|NCT01597245|69137081|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
37664003|NCT01597245|69137082|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
37664004|NCT01597245|69137083|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
37664005|NCT01597245|69137084|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
37664006|NCT01597245|69137085|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
37754510|NCT03713632|69259958|FG004|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
37754511|NCT03713632|69259954|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
37754512|NCT03713632|69259955|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|18|||
37754513|NCT03713632|69259956|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
37754514|NCT03713632|69259957|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
37754515|NCT03713632|69259958|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|12|||
37754516|NCT03713632|69259954|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
37754517|NCT03713632|69259955|FG001|Treatment Period 2 (After Week 16)|Adverse Event|3|||
37754518|NCT03713632|69259956|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
37754519|NCT03713632|69259957|FG003|Treatment Period 2 (After Week 16)|Adverse Event|2|||
37664007|NCT01597245|69137086|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
37664008|NCT01597245|69137087|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
37664009|NCT01597245|69137088|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
37664010|NCT01597245|69137089|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
37664011|NCT01597245|69137090|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
37664012|NCT01597245|69137091|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
37664013|NCT01597245|69137092|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
37664014|NCT01597245|69137093|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
37664015|NCT01597245|69137094|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
37664016|NCT01597245|69137074|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
37754520|NCT03713632|69259958|FG004|Treatment Period 2 (After Week 16)|Adverse Event|1|||
37754521|NCT03713632|69259954|FG000|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
37754522|NCT03713632|69259955|FG001|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
37754523|NCT03713632|69259956|FG002|Treatment Period 2 (After Week 16)|Lack of Efficacy|0|||
37754524|NCT03713632|69259957|FG003|Treatment Period 2 (After Week 16)|Lack of Efficacy|1|||
37754525|NCT03713632|69259958|FG004|Treatment Period 2 (After Week 16)|Lack of Efficacy|2|||
37754526|NCT03713632|69259954|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
37754527|NCT03713632|69259955|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|8|||
37754528|NCT03713632|69259956|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
37754529|NCT03713632|69259957|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
37754530|NCT03713632|69259958|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
37754531|NCT03713632|69259954|FG000|Treatment Period 2 (After Week 16)|Physician Decision|1|||
37754532|NCT03713632|69259955|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
37754533|NCT03713632|69259956|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
37754534|NCT03713632|69259957|FG003|Treatment Period 2 (After Week 16)|Physician Decision|0|||
37754535|NCT03713632|69259958|FG004|Treatment Period 2 (After Week 16)|Physician Decision|2|||
37754536|NCT03713632|69259954|FG000|Treatment Period 2 (After Week 16)|Technical Problems|1|||
37754537|NCT03713632|69259955|FG001|Treatment Period 2 (After Week 16)|Technical Problems|0|||
37754538|NCT03713632|69259956|FG002|Treatment Period 2 (After Week 16)|Technical Problems|0|||
37754539|NCT03713632|69259957|FG003|Treatment Period 2 (After Week 16)|Technical Problems|0|||
37754540|NCT03713632|69259958|FG004|Treatment Period 2 (After Week 16)|Technical Problems|0|||
37664017|NCT01597245|69137075|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
37754541|NCT03713632|69259954|FG000|Treatment Period 2 (After Week 16)|Death|0|||
37754542|NCT03713632|69259955|FG001|Treatment Period 2 (After Week 16)|Death|1|||
37754543|NCT03713632|69259956|FG002|Treatment Period 2 (After Week 16)|Death|0|||
37754544|NCT03713632|69259957|FG003|Treatment Period 2 (After Week 16)|Death|0|||
37754545|NCT03713632|69259958|FG004|Treatment Period 2 (After Week 16)|Death|0|||
37754546|NCT03713632|69259954|FG000|Treatment Period 2 (After Week 16)|Pregnancy|0|||
37754547|NCT03713632|69259955|FG001|Treatment Period 2 (After Week 16)|Pregnancy|1|||
37754548|NCT03713632|69259956|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
37754549|NCT03713632|69259957|FG003|Treatment Period 2 (After Week 16)|Pregnancy|0|||
37754550|NCT03713632|69259958|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
37754551|NCT03517436|69259980|FG000|Overall Study|Death|3|||
37754552|NCT03517436|69259980|FG000|Overall Study|Withdrawal by Subject|4|||
37754553|NCT03517436|69259980|FG000|Overall Study|Did not receive study valve.|1|||
37754554|NCT03237286|69259987|FG000|Overall Study|Withdrawal by Subject|1|||
37754555|NCT03237286|69259988|FG001|Overall Study|Withdrawal by Subject|0|||
37754556|NCT03237286|69259989|FG002|Overall Study|Withdrawal by Subject|2|||
37754557|NCT03237286|69259987|FG000|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
37754558|NCT03237286|69259988|FG001|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
37754559|NCT03237286|69259989|FG002|Overall Study|Study withdrew participant due to repeated non-compliance|1|||
37754560|NCT03215706|69259998|FG000|Randomization|Adverse Event unrelated to study drug|1|||
37754561|NCT03215706|69259999|FG001|Randomization|Adverse Event unrelated to study drug|0|||
37754562|NCT03215706|69259998|FG000|Randomization|participant withdrew consent|1|||
37754563|NCT03215706|69259999|FG001|Randomization|participant withdrew consent|3|||
37754564|NCT03215706|69259998|FG000|Randomization|no longer meets study criteria|1|||
37754565|NCT03215706|69259999|FG001|Randomization|no longer meets study criteria|4|||
37754566|NCT03215706|69259998|FG000|Randomization|other reasons|0|||
37754567|NCT03215706|69259999|FG001|Randomization|other reasons|2|||
37754568|NCT03215706|69259998|FG000|Treatment Period|Disease Progression|150|||
37754569|NCT03215706|69259999|FG001|Treatment Period|Disease Progression|142|||
37754570|NCT03215706|69259998|FG000|Treatment Period|Study Drug Toxicity|53|||
37754571|NCT03215706|69259999|FG001|Treatment Period|Study Drug Toxicity|21|||
37754572|NCT03215706|69259998|FG000|Treatment Period|Death|2|||
37754573|NCT03215706|69259999|FG001|Treatment Period|Death|1|||
37754574|NCT03215706|69259998|FG000|Treatment Period|Adverse event unrelated to study drug|24|||
37754575|NCT03215706|69259999|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
37754576|NCT03215706|69259998|FG000|Treatment Period|Request to D/C treatment|1|||
37754577|NCT03215706|69259999|FG001|Treatment Period|Request to D/C treatment|6|||
37754578|NCT03215706|69259998|FG000|Treatment Period|Participant withdrew consent|3|||
37754579|NCT03215706|69259999|FG001|Treatment Period|Participant withdrew consent|4|||
37754580|NCT03215706|69259998|FG000|Treatment Period|Lost to Follow-up|0|||
37754581|NCT03215706|69259999|FG001|Treatment Period|Lost to Follow-up|1|||
37754582|NCT03215706|69259998|FG000|Treatment Period|Other Reasons|4|||
37664018|NCT01597245|69137076|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
37664019|NCT01597245|69137077|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
37664020|NCT01597245|69137078|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
37664021|NCT01597245|69137079|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
37664022|NCT01597245|69137080|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
37664023|NCT01597245|69137081|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
37664024|NCT01597245|69137082|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
37664025|NCT01597245|69137083|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
37664026|NCT01597245|69137084|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
37664027|NCT01597245|69137085|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
37664028|NCT01597245|69137086|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
37664029|NCT01597245|69137087|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
37664030|NCT01597245|69137088|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
37664031|NCT01597245|69137089|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
37664032|NCT01597245|69137090|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
37664033|NCT01597245|69137091|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
37664034|NCT01597245|69137092|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
37664035|NCT01597245|69137093|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
37664036|NCT01597245|69137094|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
37664037|NCT01597245|69137074|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
37754583|NCT03215706|69259999|FG001|Treatment Period|Other Reasons|5|||
37754584|NCT03215706|69259998|FG000|Treatment Period|Ongoing in the treatment period|105|||
37754585|NCT03215706|69259999|FG001|Treatment Period|Ongoing in the treatment period|43|||
37754586|NCT03170349|69260005|FG000|At 30 Days Follow-up|Death|1|||
37664038|NCT01597245|69137075|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
37664039|NCT01597245|69137076|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
37754587|NCT03170349|69260005|FG000|At 6 Months Follow-up|Exited for Other Reasons|5|||
37754588|NCT03170349|69260005|FG000|At 6 Months Follow-up|Withdrawal by Subject|1|||
37754589|NCT03170349|69260005|FG000|At 6 Months Follow-up|Death|3|||
37754590|NCT03170349|69260005|FG000|At 1 Year Follow-up|Exited for Other Reasons|2|||
37754591|NCT03170349|69260005|FG000|At 1 Year Follow-up|Death|6|||
37754592|NCT03170349|69260005|FG000|At 2 Year Follow-up|Missed Visit|4|||
37754593|NCT03170349|69260005|FG000|At 2 Year Follow-up|Death|13|||
37754594|NCT03170349|69260005|FG000|At 2 Year Follow-up|Withdrawal by Subject|1|||
37754595|NCT03100149|69260012|FG000|Overall Study|Adverse Event|0|||
37754596|NCT03100149|69260013|FG001|Overall Study|Adverse Event|1|||
37754597|NCT03100149|69260014|FG002|Overall Study|Adverse Event|0|||
37754598|NCT03100149|69260012|FG000|Overall Study|Participant Moved out of Country|0|||
37754599|NCT03100149|69260013|FG001|Overall Study|Participant Moved out of Country|0|||
37754600|NCT03100149|69260014|FG002|Overall Study|Participant Moved out of Country|1|||
37754601|NCT03100149|69260012|FG000|Overall Study|Withdrawal by Subject|0|||
37754602|NCT03100149|69260013|FG001|Overall Study|Withdrawal by Subject|3|||
37754603|NCT03100149|69260014|FG002|Overall Study|Withdrawal by Subject|1|||
37754604|NCT02836236|69260038|FG000|Overall Study|Randomized but Never Treated|1|||
37754605|NCT02836236|69260039|FG001|Overall Study|Randomized but Never Treated|0|||
37754606|NCT02836236|69260038|FG000|Overall Study|Withdrew Consent|2|||
37754607|NCT02836236|69260039|FG001|Overall Study|Withdrew Consent|0|||
37754608|NCT02836236|69260038|FG000|Overall Study|Adverse Event|0|||
37754609|NCT02836236|69260039|FG001|Overall Study|Adverse Event|1|||
37754610|NCT02836236|69260038|FG000|Overall Study|Investigator's Discretion|1|||
37754611|NCT02836236|69260039|FG001|Overall Study|Investigator's Discretion|0|||
37754612|NCT02836236|69260038|FG000|Overall Study|Still on Study|101|||
37754613|NCT02836236|69260039|FG001|Overall Study|Still on Study|49|||
37754614|NCT02670525|69260047|FG000|Overall Study|Death|94|||
37754615|NCT02670525|69260048|FG001|Overall Study|Death|14|||
37754616|NCT02670525|69260047|FG000|Overall Study|Lost to Follow-up|4|||
37754617|NCT02670525|69260048|FG001|Overall Study|Lost to Follow-up|1|||
37754618|NCT02670525|69260047|FG000|Overall Study|Subject withdrew consent|1|||
37754619|NCT02670525|69260048|FG001|Overall Study|Subject withdrew consent|0|||
37754620|NCT02670525|69260047|FG000|Overall Study|Unknown, data entry delayed|123|||
37754621|NCT02670525|69260048|FG001|Overall Study|Unknown, data entry delayed|78|||
37754622|NCT02562235|69260054|FG000|Overall Study|Adverse Event|3|||
37754623|NCT02394795|69260065|FG000|Overall Study|Adverse Event|92|||
37754624|NCT02394795|69260066|FG001|Overall Study|Adverse Event|70|||
37754625|NCT02394795|69260065|FG000|Overall Study|Lost to Follow-up|0|||
37754626|NCT02394795|69260066|FG001|Overall Study|Lost to Follow-up|1|||
37754627|NCT02394795|69260065|FG000|Overall Study|Withdrawal by Subject|17|||
37754628|NCT02394795|69260066|FG001|Overall Study|Withdrawal by Subject|26|||
37754629|NCT02394795|69260065|FG000|Overall Study|Lack of Efficacy|181|||
37754630|NCT02394795|69260066|FG001|Overall Study|Lack of Efficacy|211|||
37754631|NCT02394795|69260065|FG000|Overall Study|Death|4|||
37754632|NCT02394795|69260066|FG001|Overall Study|Death|5|||
37754633|NCT02394795|69260065|FG000|Overall Study|Physician Decision|109|||
37754634|NCT02394795|69260066|FG001|Overall Study|Physician Decision|93|||
37754635|NCT02255422|69260079|FG000|Overall Study|Withdrawal by Subject|0|||
37664040|NCT01597245|69137077|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
37664041|NCT01597245|69137078|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
37664042|NCT01597245|69137079|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
37664043|NCT01597245|69137080|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
37664044|NCT01597245|69137081|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
37664045|NCT01597245|69137082|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
37664046|NCT01597245|69137083|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
37664047|NCT01597245|69137084|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
37664048|NCT01597245|69137085|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
37664049|NCT01597245|69137086|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
37664050|NCT01597245|69137087|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
37664051|NCT01597245|69137088|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
37664052|NCT01597245|69137089|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
37664053|NCT01597245|69137090|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
37664054|NCT01597245|69137091|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
37664055|NCT01597245|69137092|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
37664056|NCT01597245|69137093|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
37664057|NCT01597245|69137094|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
37754636|NCT02255422|69260080|FG001|Overall Study|Withdrawal by Subject|0|||
37754637|NCT02255422|69260081|FG002|Overall Study|Withdrawal by Subject|0|||
37754638|NCT02255422|69260082|FG003|Overall Study|Withdrawal by Subject|0|||
37754639|NCT02255422|69260083|FG004|Overall Study|Withdrawal by Subject|0|||
37754640|NCT02255422|69260084|FG005|Overall Study|Withdrawal by Subject|0|||
37923376|NCT00824720|69610188|FG002|Overall Study|Protocol Violation|1|||
37664058|NCT01597245|69137074|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
37754641|NCT02255422|69260085|FG006|Overall Study|Withdrawal by Subject|2|||
37754642|NCT02255422|69260079|FG000|Overall Study|Lost to Follow-up|0|||
37754643|NCT02255422|69260080|FG001|Overall Study|Lost to Follow-up|0|||
37754644|NCT02255422|69260081|FG002|Overall Study|Lost to Follow-up|1|||
37754645|NCT02255422|69260082|FG003|Overall Study|Lost to Follow-up|0|||
37754646|NCT02255422|69260083|FG004|Overall Study|Lost to Follow-up|0|||
37754647|NCT02255422|69260084|FG005|Overall Study|Lost to Follow-up|0|||
37754648|NCT02255422|69260085|FG006|Overall Study|Lost to Follow-up|0|||
37754649|NCT02142959|69260104|FG000|Overall Study|Adverse Event|1|||
37754650|NCT02142959|69260105|FG001|Overall Study|Adverse Event|0|||
37754651|NCT02142959|69260106|FG002|Overall Study|Adverse Event|0|||
37754652|NCT02142959|69260104|FG000|Overall Study|Death|0|||
37664059|NCT01597245|69137075|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
37664060|NCT01597245|69137076|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
37664061|NCT01597245|69137077|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
37664062|NCT01597245|69137078|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
37664063|NCT01597245|69137079|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
37754653|NCT02142959|69260105|FG001|Overall Study|Death|1|||
37664064|NCT01597245|69137080|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
37664065|NCT01597245|69137081|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
37664066|NCT01597245|69137082|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
37664067|NCT01597245|69137083|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
37754654|NCT02142959|69260106|FG002|Overall Study|Death|0|||
37754655|NCT02142959|69260104|FG000|Overall Study|Withdrawal by Subject|3|||
37754656|NCT02142959|69260105|FG001|Overall Study|Withdrawal by Subject|1|||
37754657|NCT02142959|69260106|FG002|Overall Study|Withdrawal by Subject|3|||
37754658|NCT02142959|69260104|FG000|Overall Study|Administrative Reasons|1|||
37754659|NCT02142959|69260105|FG001|Overall Study|Administrative Reasons|0|||
37754660|NCT02142959|69260106|FG002|Overall Study|Administrative Reasons|1|||
37754661|NCT02142959|69260104|FG000|Overall Study|Missing|0|||
37754662|NCT02142959|69260105|FG001|Overall Study|Missing|1|||
37664068|NCT01597245|69137084|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
37664069|NCT01597245|69137085|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
37664070|NCT01597245|69137086|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
37754663|NCT02142959|69260106|FG002|Overall Study|Missing|0|||
37754664|NCT02142959|69260104|FG000|Overall Study|Treatment changed from radiation treatment to chemo|0|||
37754665|NCT02142959|69260105|FG001|Overall Study|Treatment changed from radiation treatment to chemo|0|||
37754666|NCT02142959|69260106|FG002|Overall Study|Treatment changed from radiation treatment to chemo|1|||
37754667|NCT02142959|69260104|FG000|Overall Study|Patient didn't complete end of study visit|0|||
37754668|NCT02142959|69260105|FG001|Overall Study|Patient didn't complete end of study visit|0|||
37754669|NCT02142959|69260106|FG002|Overall Study|Patient didn't complete end of study visit|1|||
37754670|NCT02128113|69260117|FG000|Overall Study|Withdrawal by Subject|3|||
37754671|NCT02128113|69260118|FG001|Overall Study|Withdrawal by Subject|1|||
37754672|NCT02128113|69260119|FG002|Overall Study|Withdrawal by Subject|0|||
37754673|NCT02128113|69260117|FG000|Overall Study|Protocol Violation|0|||
37754674|NCT02128113|69260118|FG001|Overall Study|Protocol Violation|1|||
37754675|NCT02128113|69260119|FG002|Overall Study|Protocol Violation|0|||
37754676|NCT02128113|69260117|FG000|Overall Study|Surgery cancelled|0|||
37754677|NCT02128113|69260118|FG001|Overall Study|Surgery cancelled|1|||
37754678|NCT02128113|69260119|FG002|Overall Study|Surgery cancelled|0|||
37754679|NCT02128113|69260117|FG000|Overall Study|Adverse Event|0|||
37754680|NCT02128113|69260118|FG001|Overall Study|Adverse Event|0|||
37754681|NCT02128113|69260119|FG002|Overall Study|Adverse Event|1|||
37754682|NCT02036970|69260156|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
37754683|NCT02036970|69260157|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
37754684|NCT02036970|69260158|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
37754685|NCT02036970|69260159|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
37754686|NCT02036970|69260160|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
37754687|NCT02036970|69260161|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
37754688|NCT02036970|69260162|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
37857833|NCT03933397|69540920|FG000|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|18|||
37857834|NCT03933397|69540921|FG001|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|15|||
37857835|NCT03933397|69540920|FG000|Overall Study|Withdrawal by Subject|1|||
37857836|NCT03933397|69540921|FG001|Overall Study|Withdrawal by Subject|0|||
37857837|NCT03933397|69540920|FG000|Overall Study|Physician Decision|1|||
37857838|NCT03933397|69540921|FG001|Overall Study|Physician Decision|1|||
37857839|NCT03933397|69540920|FG000|Overall Study|missing pain score|1|||
37857840|NCT03933397|69540921|FG001|Overall Study|missing pain score|1|||
37857841|NCT03933397|69540920|FG000|Overall Study|Confirmed COVID-19|1|||
37754689|NCT02036970|69260163|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
37754690|NCT02036970|69260164|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
37754691|NCT02036970|69260165|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
37754692|NCT02036970|69260156|FG000|Part 1: Day 1 Through Week 16|Death|0|||
37754693|NCT02036970|69260157|FG001|Part 1: Day 1 Through Week 16|Death|0|||
37754694|NCT02036970|69260158|FG002|Part 1: Day 1 Through Week 16|Death|0|||
37754695|NCT02036970|69260159|FG003|Part 1: Day 1 Through Week 16|Death|0|||
37754696|NCT02036970|69260160|FG004|Part 1: Day 1 Through Week 16|Death|0|||
37754697|NCT02036970|69260161|FG005|Part 1: Day 1 Through Week 16|Death|0|||
37754698|NCT02036970|69260162|FG006|Part 1: Day 1 Through Week 16|Death|0|||
37754699|NCT02036970|69260163|FG007|Part 1: Day 1 Through Week 16|Death|0|||
37754700|NCT02036970|69260164|FG008|Part 1: Day 1 Through Week 16|Death|1|||
37754701|NCT02036970|69260165|FG009|Part 1: Day 1 Through Week 16|Death|0|||
37754702|NCT02036970|69260156|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
37754703|NCT02036970|69260157|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
37754704|NCT02036970|69260158|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
37754705|NCT02036970|69260159|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
37754706|NCT02036970|69260160|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
37754707|NCT02036970|69260161|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
37754708|NCT02036970|69260162|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
37754709|NCT02036970|69260163|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
37754710|NCT02036970|69260164|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
37754711|NCT02036970|69260165|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
37754712|NCT02036970|69260156|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
37754713|NCT02036970|69260157|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
37754714|NCT02036970|69260158|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
37754715|NCT02036970|69260159|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
37754716|NCT02036970|69260160|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
37754717|NCT02036970|69260161|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
37754718|NCT02036970|69260162|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
37754719|NCT02036970|69260163|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
37754720|NCT02036970|69260164|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
37754721|NCT02036970|69260165|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
37754722|NCT02036970|69260156|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
37754723|NCT02036970|69260157|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
37754724|NCT02036970|69260158|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
37754725|NCT02036970|69260159|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
37754726|NCT02036970|69260160|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
37754727|NCT02036970|69260161|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
37754728|NCT02036970|69260162|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
37754729|NCT02036970|69260163|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
37754730|NCT02036970|69260164|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
37754731|NCT02036970|69260165|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
37754732|NCT02036970|69260156|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
37754733|NCT02036970|69260157|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
37754734|NCT02036970|69260158|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
37754735|NCT02036970|69260159|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
37754736|NCT02036970|69260160|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
37754737|NCT02036970|69260161|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
37754738|NCT02036970|69260162|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
37754739|NCT02036970|69260163|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
37754740|NCT02036970|69260164|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
37754741|NCT02036970|69260165|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
37754742|NCT02036970|69260156|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
37754743|NCT02036970|69260157|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
37923377|NCT03704064|69610198|FG000|Overall Study|Lost to Follow-up|8|||
37664071|NCT01597245|69137087|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
37664072|NCT01597245|69137088|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
37664073|NCT01597245|69137089|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
37664074|NCT01597245|69137090|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
37664075|NCT01597245|69137091|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
37664076|NCT01597245|69137092|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
37664077|NCT01597245|69137093|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
37664078|NCT01597245|69137094|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
37664079|NCT01597245|69137074|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
37664080|NCT01597245|69137075|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
37664081|NCT01597245|69137076|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
37664082|NCT01597245|69137077|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
37664083|NCT01597245|69137078|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
37664084|NCT01597245|69137079|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
37664085|NCT01597245|69137080|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
37664086|NCT01597245|69137081|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
37664087|NCT01597245|69137082|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
37664088|NCT01597245|69137083|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
37664089|NCT01597245|69137084|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
37754744|NCT02036970|69260158|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
37754745|NCT02036970|69260159|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
37754746|NCT02036970|69260160|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
37754747|NCT02036970|69260161|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
37754748|NCT02036970|69260162|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
37754749|NCT02036970|69260163|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
37754750|NCT02036970|69260164|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
37754751|NCT02036970|69260165|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
37857842|NCT03933397|69540921|FG001|Overall Study|Confirmed COVID-19|2|||
37857843|NCT03624881|69540962|FG000|Overall Study|Screen Failure|14|||
37857844|NCT03624881|69540963|FG001|Overall Study|Screen Failure|0|||
37857845|NCT03624881|69540962|FG000|Overall Study|No Catheter Inserted|6|||
37857846|NCT03624881|69540963|FG001|Overall Study|No Catheter Inserted|1|||
37857847|NCT03624881|69540962|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
37857848|NCT03624881|69540963|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
37857849|NCT03624881|69540962|FG000|Overall Study|Death|2|||
37857850|NCT03624881|69540963|FG001|Overall Study|Death|0|||
37857851|NCT03624881|69540962|FG000|Overall Study|Lost to Follow-up|10|||
37857852|NCT03624881|69540963|FG001|Overall Study|Lost to Follow-up|4|||
37857853|NCT03624881|69540962|FG000|Overall Study|Withdrawal by Subject|12|||
37857854|NCT03624881|69540963|FG001|Overall Study|Withdrawal by Subject|1|||
37857855|NCT03428997|69540986|FG000|Overall Study|Sponsor decision.|1|||
37664090|NCT01597245|69137085|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
37664091|NCT01597245|69137086|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
37664092|NCT01597245|69137087|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
37857856|NCT03428997|69540986|FG000|Overall Study|Withdrawal by Subject|3|||
37857857|NCT03428997|69540986|FG000|Overall Study|Lost to Follow-up|4|||
37857858|NCT03118674|69541019|FG000|Overall Study|Lost to Follow-up|2|||
37857859|NCT03118674|69541019|FG000|Overall Study|Screen Faliure|8|||
37857860|NCT03118674|69541019|FG000|Overall Study|Withdrawal by Subject|5|||
37857861|NCT03069352|69541025|FG000|Overall Study|Ongoing|12|||
37857862|NCT03069352|69541026|FG001|Overall Study|Ongoing|40|||
37857863|NCT02993523|69541037|FG000|Overall Study|Withdrew Consent|0|||
37857864|NCT02993523|69541038|FG001|Overall Study|Withdrew Consent|0|||
37857865|NCT02993523|69541039|FG002|Overall Study|Withdrew Consent|2|||
37857866|NCT02993523|69541040|FG003|Overall Study|Withdrew Consent|9|||
37857867|NCT02993523|69541041|FG004|Overall Study|Withdrew Consent|0|||
37857868|NCT02993523|69541037|FG000|Overall Study|Lost to Follow-up|0|||
37857869|NCT02993523|69541038|FG001|Overall Study|Lost to Follow-up|0|||
37857870|NCT02993523|69541039|FG002|Overall Study|Lost to Follow-up|3|||
37857871|NCT02993523|69541040|FG003|Overall Study|Lost to Follow-up|6|||
37857872|NCT02993523|69541041|FG004|Overall Study|Lost to Follow-up|0|||
37857873|NCT02993523|69541037|FG000|Overall Study|Death|1|||
37857874|NCT02993523|69541038|FG001|Overall Study|Death|1|||
37857875|NCT02993523|69541039|FG002|Overall Study|Death|138|||
37664093|NCT01597245|69137088|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
37664094|NCT01597245|69137089|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
37664095|NCT01597245|69137090|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
37664096|NCT01597245|69137091|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
37664097|NCT01597245|69137092|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
37664098|NCT01597245|69137093|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
37664099|NCT01597245|69137094|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
37664100|NCT01597245|69137074|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
37664101|NCT01597245|69137075|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
37664102|NCT01597245|69137076|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
37664103|NCT01597245|69137077|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
37664104|NCT01597245|69137078|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
37664105|NCT01597245|69137079|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
37664106|NCT01597245|69137080|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
37664107|NCT01597245|69137081|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
37664108|NCT01597245|69137082|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
37664109|NCT01597245|69137083|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
37664110|NCT01597245|69137084|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
37754752|NCT02036970|69260156|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
37754753|NCT02036970|69260157|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
37754754|NCT02036970|69260158|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
37857876|NCT02993523|69541040|FG003|Overall Study|Death|222|||
37857877|NCT02993523|69541041|FG004|Overall Study|Death|6|||
37754755|NCT02036970|69260159|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
37857878|NCT02993523|69541037|FG000|Overall Study|Reason not Specified|0|||
37857879|NCT02993523|69541038|FG001|Overall Study|Reason not Specified|0|||
37857880|NCT02993523|69541039|FG002|Overall Study|Reason not Specified|1|||
37923378|NCT03704064|69610199|FG001|Overall Study|Lost to Follow-up|4|||
37857881|NCT02993523|69541040|FG003|Overall Study|Reason not Specified|1|||
37923379|NCT03704064|69610198|FG000|Overall Study|Withdrawal by Subject|1|||
37857882|NCT02993523|69541041|FG004|Overall Study|Reason not Specified|0|||
37754756|NCT02036970|69260160|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
37754757|NCT02036970|69260161|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
37754758|NCT02036970|69260162|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
37754759|NCT02036970|69260163|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
37754760|NCT02036970|69260164|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
37754761|NCT02036970|69260165|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
37754762|NCT02036970|69260156|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
37754763|NCT02036970|69260157|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
37754764|NCT02036970|69260158|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
37754765|NCT02036970|69260159|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
37754766|NCT02036970|69260160|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
37754767|NCT02036970|69260161|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
37754768|NCT02036970|69260162|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
37754769|NCT02036970|69260163|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
37754770|NCT02036970|69260164|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
37754771|NCT02036970|69260165|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
37754772|NCT01748825|69260355|FG000|Dose Escalation|Refused further treatment|2|||
37754773|NCT01748825|69260356|FG001|Dose Escalation|Refused further treatment|2|||
37754774|NCT01748825|69260357|FG002|Dose Escalation|Refused further treatment|0|||
37754775|NCT01748825|69260358|FG003|Dose Escalation|Refused further treatment|0|||
37754776|NCT01748825|69260359|FG004|Dose Escalation|Refused further treatment|1|||
37754777|NCT01748825|69260360|FG005|Dose Escalation|Refused further treatment|2|||
37754778|NCT01748825|69260361|FG006|Dose Escalation|Refused further treatment|0|||
37754779|NCT01748825|69260362|FG007|Dose Escalation|Refused further treatment|0|||
37754780|NCT01748825|69260363|FG008|Dose Escalation|Refused further treatment|0|||
37754781|NCT01748825|69260364|FG009|Dose Escalation|Refused further treatment|0|||
37754782|NCT01748825|69260355|FG000|Dose Escalation|Switched to alternative treatment|0|||
37754783|NCT01748825|69260356|FG001|Dose Escalation|Switched to alternative treatment|0|||
37754784|NCT01748825|69260357|FG002|Dose Escalation|Switched to alternative treatment|0|||
37754785|NCT01748825|69260358|FG003|Dose Escalation|Switched to alternative treatment|1|||
37754786|NCT01748825|69260359|FG004|Dose Escalation|Switched to alternative treatment|0|||
37754787|NCT01748825|69260360|FG005|Dose Escalation|Switched to alternative treatment|0|||
37754788|NCT01748825|69260361|FG006|Dose Escalation|Switched to alternative treatment|0|||
37754789|NCT01748825|69260362|FG007|Dose Escalation|Switched to alternative treatment|0|||
37754790|NCT01748825|69260363|FG008|Dose Escalation|Switched to alternative treatment|0|||
37754791|NCT01748825|69260364|FG009|Dose Escalation|Switched to alternative treatment|0|||
37754792|NCT01748825|69260355|FG000|Dose Escalation|Adverse Event|0|||
37664111|NCT01597245|69137085|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
37664112|NCT01597245|69137086|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
37664113|NCT01597245|69137087|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
37664114|NCT01597245|69137088|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
37664115|NCT01597245|69137089|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
37664116|NCT01597245|69137090|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
37664117|NCT01597245|69137091|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
37664118|NCT01597245|69137092|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
37664119|NCT01597245|69137093|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
37664120|NCT01597245|69137094|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
37664121|NCT01597245|69137074|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
37664122|NCT01597245|69137075|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
37664123|NCT01597245|69137076|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
37664124|NCT01597245|69137077|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
37664125|NCT01597245|69137078|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
37754793|NCT01748825|69260356|FG001|Dose Escalation|Adverse Event|0|||
37754794|NCT01748825|69260357|FG002|Dose Escalation|Adverse Event|0|||
37754795|NCT01748825|69260358|FG003|Dose Escalation|Adverse Event|0|||
37754796|NCT01748825|69260359|FG004|Dose Escalation|Adverse Event|0|||
37754797|NCT01748825|69260360|FG005|Dose Escalation|Adverse Event|0|||
37754798|NCT01748825|69260361|FG006|Dose Escalation|Adverse Event|1|||
37754799|NCT01748825|69260362|FG007|Dose Escalation|Adverse Event|0|||
37754800|NCT01748825|69260363|FG008|Dose Escalation|Adverse Event|0|||
37754801|NCT01748825|69260364|FG009|Dose Escalation|Adverse Event|0|||
37754802|NCT01748825|69260355|FG000|Dose Expansion|Refused further treatment|0|||
37754803|NCT01748825|69260356|FG001|Dose Expansion|Refused further treatment|0|||
37754804|NCT01748825|69260357|FG002|Dose Expansion|Refused further treatment|0|||
37754805|NCT01748825|69260358|FG003|Dose Expansion|Refused further treatment|0|||
37754806|NCT01748825|69260359|FG004|Dose Expansion|Refused further treatment|0|||
37754807|NCT01748825|69260360|FG005|Dose Expansion|Refused further treatment|0|||
37754808|NCT01748825|69260361|FG006|Dose Expansion|Refused further treatment|0|||
37754809|NCT01748825|69260362|FG007|Dose Expansion|Refused further treatment|0|||
37754810|NCT01748825|69260363|FG008|Dose Expansion|Refused further treatment|1|||
37664126|NCT01597245|69137079|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
37754811|NCT01748825|69260364|FG009|Dose Expansion|Refused further treatment|1|||
37754812|NCT01748825|69260355|FG000|Dose Expansion|Switched to alternative treatment|0|||
37754813|NCT01748825|69260356|FG001|Dose Expansion|Switched to alternative treatment|0|||
37754814|NCT01748825|69260357|FG002|Dose Expansion|Switched to alternative treatment|0|||
37754815|NCT01748825|69260358|FG003|Dose Expansion|Switched to alternative treatment|0|||
37754816|NCT01748825|69260359|FG004|Dose Expansion|Switched to alternative treatment|0|||
37754817|NCT01748825|69260360|FG005|Dose Expansion|Switched to alternative treatment|0|||
37754818|NCT01748825|69260361|FG006|Dose Expansion|Switched to alternative treatment|0|||
37754819|NCT01748825|69260362|FG007|Dose Expansion|Switched to alternative treatment|0|||
37754820|NCT01748825|69260363|FG008|Dose Expansion|Switched to alternative treatment|0|||
37754821|NCT01748825|69260364|FG009|Dose Expansion|Switched to alternative treatment|1|||
37754822|NCT01748825|69260355|FG000|Dose Expansion|Adverse Event|0|||
37754823|NCT01748825|69260356|FG001|Dose Expansion|Adverse Event|0|||
37754824|NCT01748825|69260357|FG002|Dose Expansion|Adverse Event|0|||
37754825|NCT01748825|69260358|FG003|Dose Expansion|Adverse Event|0|||
37754826|NCT01748825|69260359|FG004|Dose Expansion|Adverse Event|0|||
37754827|NCT01748825|69260360|FG005|Dose Expansion|Adverse Event|0|||
37754828|NCT01748825|69260361|FG006|Dose Expansion|Adverse Event|0|||
37754829|NCT01748825|69260362|FG007|Dose Expansion|Adverse Event|0|||
37754830|NCT01748825|69260363|FG008|Dose Expansion|Adverse Event|0|||
37754831|NCT01748825|69260364|FG009|Dose Expansion|Adverse Event|3|||
37754832|NCT01748825|69260355|FG000|Dose Expansion|Physician Decision|0|||
37754833|NCT01748825|69260356|FG001|Dose Expansion|Physician Decision|0|||
37754834|NCT01748825|69260357|FG002|Dose Expansion|Physician Decision|0|||
37754835|NCT01748825|69260358|FG003|Dose Expansion|Physician Decision|0|||
37754836|NCT01748825|69260359|FG004|Dose Expansion|Physician Decision|0|||
37754837|NCT01748825|69260360|FG005|Dose Expansion|Physician Decision|0|||
37754838|NCT01748825|69260361|FG006|Dose Expansion|Physician Decision|0|||
37754839|NCT01748825|69260362|FG007|Dose Expansion|Physician Decision|0|||
37754840|NCT01748825|69260363|FG008|Dose Expansion|Physician Decision|1|||
37754841|NCT01748825|69260364|FG009|Dose Expansion|Physician Decision|0|||
37754842|NCT01720667|69260426|FG000|Overall Study|Adverse Event|1|||
37754843|NCT01720667|69260427|FG001|Overall Study|Adverse Event|1|||
37754844|NCT01720667|69260426|FG000|Overall Study|Withdrawal by Subject|3|||
37664127|NCT01597245|69137080|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
37664128|NCT01597245|69137081|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
37664129|NCT01597245|69137082|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
37664130|NCT01597245|69137083|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
37664131|NCT01597245|69137084|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
37664132|NCT01597245|69137085|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
37664133|NCT01597245|69137086|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
37664134|NCT01597245|69137087|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
37664135|NCT01597245|69137088|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
37664136|NCT01597245|69137089|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
37664137|NCT01597245|69137090|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
37754845|NCT01720667|69260427|FG001|Overall Study|Withdrawal by Subject|0|||
37754846|NCT01720043|69260435|FG000|Overall Study|Withdrawal by Subject|1|||
37754847|NCT00700752|69260439|FG000|First Intervention|Withdrawal by Subject|0|||
37754848|NCT00700752|69260440|FG001|First Intervention|Withdrawal by Subject|2|||
37754849|NCT01747811|69260457|FG000|Overall Study|Lack of Efficacy|2|||
37754850|NCT01747811|69260458|FG001|Overall Study|Lack of Efficacy|4|||
37857883|NCT02795429|69541054|FG000|Overall Study|Adverse Event|1|||
37857884|NCT02795429|69541055|FG001|Overall Study|Adverse Event|2|||
37857885|NCT02795429|69541056|FG002|Overall Study|Adverse Event|1|||
37664138|NCT01597245|69137091|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
37664139|NCT01597245|69137092|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
37664140|NCT01597245|69137093|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
37664141|NCT01597245|69137094|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
37664142|NCT01597245|69137074|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
37664143|NCT01597245|69137075|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
37664144|NCT01597245|69137076|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
37664145|NCT01597245|69137077|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
37664146|NCT01597245|69137078|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
37664147|NCT01597245|69137079|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
37754851|NCT01747655|69260466|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
37857886|NCT02795429|69541057|FG003|Overall Study|Adverse Event|2|||
37857887|NCT02795429|69541058|FG004|Overall Study|Adverse Event|1|||
37857888|NCT02795429|69541054|FG000|Overall Study|Death|1|||
37754852|NCT01747655|69260467|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
37754853|NCT01747655|69260466|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
37664148|NCT01597245|69137080|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
37754854|NCT01747655|69260467|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
37857889|NCT02795429|69541055|FG001|Overall Study|Death|0|||
37664149|NCT01597245|69137081|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
37664150|NCT01597245|69137082|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
37664151|NCT01597245|69137083|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
37664152|NCT01597245|69137084|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
37664153|NCT01597245|69137085|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
37664154|NCT01597245|69137086|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
37664155|NCT01597245|69137087|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
37664156|NCT01597245|69137088|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
37664157|NCT01597245|69137089|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
37664158|NCT01597245|69137090|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
37664159|NCT01597245|69137091|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
37664160|NCT01597245|69137092|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
37664161|NCT01597245|69137093|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
37664162|NCT01597245|69137094|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
37664163|NCT01597245|69137074|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
37664164|NCT01597245|69137075|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
37664165|NCT01597245|69137076|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
37664166|NCT01597245|69137077|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
37664167|NCT01597245|69137078|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
37754855|NCT01747655|69260466|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
37754856|NCT01747655|69260467|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
37754857|NCT01718483|69260475|FG000|Overall Study|Withdrawal by Subject|14|||
37754858|NCT01718483|69260476|FG001|Overall Study|Withdrawal by Subject|12|||
37754859|NCT01718483|69260475|FG000|Overall Study|Adverse Event|5|||
37754860|NCT01718483|69260476|FG001|Overall Study|Adverse Event|12|||
37754861|NCT01718483|69260475|FG000|Overall Study|Lost to Follow-up|8|||
37754862|NCT01718483|69260476|FG001|Overall Study|Lost to Follow-up|3|||
37664168|NCT01597245|69137079|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
37754863|NCT01718483|69260475|FG000|Overall Study|Protocol Violation|4|||
37754864|NCT01718483|69260476|FG001|Overall Study|Protocol Violation|2|||
37754865|NCT01718483|69260475|FG000|Overall Study|Other|1|||
37754866|NCT01718483|69260476|FG001|Overall Study|Other|4|||
37754867|NCT01718483|69260475|FG000|Overall Study|Pregnancy|1|||
37754868|NCT01718483|69260476|FG001|Overall Study|Pregnancy|1|||
37754869|NCT01718483|69260475|FG000|Overall Study|Lack of Efficacy|1|||
37754870|NCT01718483|69260476|FG001|Overall Study|Lack of Efficacy|0|||
37754871|NCT01717859|69260482|FG000|Overall Study|Adverse Event|5|||
37754872|NCT01717859|69260482|FG000|Overall Study|Moved out of state|1|||
37754873|NCT01717859|69260482|FG000|Overall Study|Patient concerned about mental health|1|||
37754874|NCT01717859|69260482|FG000|Overall Study|Lost to Follow-up|1|||
37664169|NCT01597245|69137080|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
37664170|NCT01597245|69137081|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
37664171|NCT01597245|69137082|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
37664172|NCT01597245|69137083|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
37664173|NCT01597245|69137084|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
37664174|NCT01597245|69137085|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
37664175|NCT01597245|69137086|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
37754875|NCT01717859|69260482|FG000|Overall Study|Withdrawal by Subject|2|||
37754876|NCT01747499|69260775|FG000|Overall Study|Steroid refractory aGvHD|1|||
37754877|NCT01747499|69260776|FG001|Overall Study|Steroid refractory aGvHD|0|||
37754878|NCT01747499|69260777|FG002|Overall Study|Steroid refractory aGvHD|0|||
37754879|NCT01747499|69260778|FG003|Overall Study|Steroid refractory aGvHD|1|||
37754880|NCT01747499|69260779|FG004|Overall Study|Steroid refractory aGvHD|4|||
37754881|NCT01747499|69260775|FG000|Overall Study|Physician Decision|0|||
37754882|NCT01747499|69260776|FG001|Overall Study|Physician Decision|1|||
37754883|NCT01747499|69260777|FG002|Overall Study|Physician Decision|0|||
37754884|NCT01747499|69260778|FG003|Overall Study|Physician Decision|0|||
37754885|NCT01747499|69260779|FG004|Overall Study|Physician Decision|2|||
37754886|NCT01747499|69260775|FG000|Overall Study|Death|0|||
37754887|NCT01747499|69260776|FG001|Overall Study|Death|0|||
37754888|NCT01747499|69260777|FG002|Overall Study|Death|0|||
37754889|NCT01747499|69260778|FG003|Overall Study|Death|1|||
38033270|NCT04493684|69719209|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
37664176|NCT01597245|69137087|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
37664177|NCT01597245|69137088|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
37754890|NCT01747499|69260779|FG004|Overall Study|Death|1|||
37754891|NCT01747499|69260775|FG000|Overall Study|Withdrawal by Subject|0|||
37754892|NCT01747499|69260776|FG001|Overall Study|Withdrawal by Subject|0|||
37664178|NCT01597245|69137089|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
37754893|NCT01747499|69260777|FG002|Overall Study|Withdrawal by Subject|0|||
37754894|NCT01747499|69260778|FG003|Overall Study|Withdrawal by Subject|0|||
37754895|NCT01747499|69260779|FG004|Overall Study|Withdrawal by Subject|6|||
37754896|NCT01747499|69260775|FG000|Overall Study|Developed AML and death|0|||
37754897|NCT01747499|69260776|FG001|Overall Study|Developed AML and death|0|||
37754898|NCT01747499|69260777|FG002|Overall Study|Developed AML and death|0|||
37754899|NCT01747499|69260778|FG003|Overall Study|Developed AML and death|0|||
37754900|NCT01747499|69260779|FG004|Overall Study|Developed AML and death|1|||
37754901|NCT01747499|69260775|FG000|Overall Study|Determined not to be eligible|0|||
37754902|NCT01747499|69260776|FG001|Overall Study|Determined not to be eligible|0|||
37754903|NCT01747499|69260777|FG002|Overall Study|Determined not to be eligible|0|||
37754904|NCT01747499|69260778|FG003|Overall Study|Determined not to be eligible|0|||
37754905|NCT01747499|69260779|FG004|Overall Study|Determined not to be eligible|1|||
37754906|NCT01717391|69260811|FG000|Overall Study|Withdrawal by Subject|5|||
37754907|NCT01717391|69260811|FG000|Overall Study|Physician Decision|1|||
37754908|NCT01717391|69260811|FG000|Overall Study|FLT technical failure|3|||
37754909|NCT01746017|69260954|FG000|Period 1|Withdrawal by Subject|0|||
37754910|NCT01746017|69260955|FG001|Period 1|Withdrawal by Subject|0|||
37754911|NCT01746017|69260956|FG002|Period 1|Withdrawal by Subject|0|||
37754912|NCT01746017|69260957|FG003|Period 1|Withdrawal by Subject|0|||
37754913|NCT01746017|69260958|FG004|Period 1|Withdrawal by Subject|0|||
37754914|NCT01746017|69260959|FG005|Period 1|Withdrawal by Subject|0|||
37754915|NCT01746017|69260960|FG006|Period 1|Withdrawal by Subject|1|||
37754916|NCT01746017|69260961|FG007|Period 1|Withdrawal by Subject|0|||
37754917|NCT01746017|69260962|FG008|Period 1|Withdrawal by Subject|0|||
37754918|NCT01746017|69260963|FG009|Period 1|Withdrawal by Subject|0|||
37754919|NCT01746017|69260964|FG010|Period 1|Withdrawal by Subject|0|||
37754920|NCT01746017|69260954|FG000|Period 3|Withdrawal by Subject|0|||
37754921|NCT01746017|69260955|FG001|Period 3|Withdrawal by Subject|0|||
37857890|NCT02795429|69541056|FG002|Overall Study|Death|1|||
37857891|NCT02795429|69541057|FG003|Overall Study|Death|2|||
37857892|NCT02795429|69541058|FG004|Overall Study|Death|1|||
37857893|NCT02795429|69541054|FG000|Overall Study|Physician Decision|0|||
37857894|NCT02795429|69541055|FG001|Overall Study|Physician Decision|0|||
37857895|NCT02795429|69541056|FG002|Overall Study|Physician Decision|2|||
37857896|NCT02795429|69541057|FG003|Overall Study|Physician Decision|1|||
37857897|NCT02795429|69541058|FG004|Overall Study|Physician Decision|5|||
37857898|NCT02795429|69541054|FG000|Overall Study|Progressive disease|3|||
37857899|NCT02795429|69541055|FG001|Overall Study|Progressive disease|7|||
37857900|NCT02795429|69541056|FG002|Overall Study|Progressive disease|6|||
37857901|NCT02795429|69541057|FG003|Overall Study|Progressive disease|26|||
37857902|NCT02795429|69541058|FG004|Overall Study|Progressive disease|20|||
37857903|NCT02795429|69541054|FG000|Overall Study|Subject/guardian decision|1|||
37857904|NCT02795429|69541055|FG001|Overall Study|Subject/guardian decision|1|||
37857905|NCT02795429|69541056|FG002|Overall Study|Subject/guardian decision|1|||
37857906|NCT02795429|69541057|FG003|Overall Study|Subject/guardian decision|1|||
37857907|NCT02795429|69541058|FG004|Overall Study|Subject/guardian decision|3|||
37857908|NCT02652949|69541081|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
37857909|NCT02652949|69541081|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
37857910|NCT02652949|69541081|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
37857911|NCT02652949|69541081|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
37857912|NCT02652949|69541081|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
37857913|NCT02652949|69541081|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
37857914|NCT02652949|69541081|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
37857915|NCT02652949|69541081|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
37857916|NCT02652949|69541081|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
37857917|NCT02652949|69541081|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
37857918|NCT02652949|69541081|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
37857919|NCT02652949|69541081|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
37664179|NCT01597245|69137090|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
37664180|NCT01597245|69137091|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
37664181|NCT01597245|69137092|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
37664182|NCT01597245|69137093|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
37664183|NCT01597245|69137094|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
37664184|NCT01597245|69137074|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
37664185|NCT01597245|69137075|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
37664186|NCT01597245|69137076|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
37754922|NCT01746017|69260956|FG002|Period 3|Withdrawal by Subject|0|||
37754923|NCT01746017|69260957|FG003|Period 3|Withdrawal by Subject|0|||
37754924|NCT01746017|69260958|FG004|Period 3|Withdrawal by Subject|0|||
37857920|NCT02652949|69541081|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
37857921|NCT02652949|69541081|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
37857922|NCT02652949|69541081|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
37857923|NCT02632344|69541092|FG000|Overall Study|Adverse Event|3|||
37754925|NCT01746017|69260959|FG005|Period 3|Withdrawal by Subject|1|||
37754926|NCT01746017|69260960|FG006|Period 3|Withdrawal by Subject|0|||
37754927|NCT01746017|69260961|FG007|Period 3|Withdrawal by Subject|0|||
37754928|NCT01746017|69260962|FG008|Period 3|Withdrawal by Subject|0|||
37754929|NCT01746017|69260963|FG009|Period 3|Withdrawal by Subject|0|||
37754930|NCT01746017|69260964|FG010|Period 3|Withdrawal by Subject|0|||
37754931|NCT01717313|69261026|FG000|Phase A (Weeks 0 to 24)|Death|0|||
37754932|NCT01717313|69261027|FG001|Phase A (Weeks 0 to 24)|Death|1|||
37754933|NCT01717313|69261026|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
37754934|NCT01717313|69261027|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
37754935|NCT01717313|69261026|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
37754936|NCT01717313|69261027|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
37754937|NCT01717313|69261026|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
37664187|NCT01597245|69137077|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
37664188|NCT01597245|69137078|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
37664189|NCT01597245|69137079|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
37664190|NCT01597245|69137080|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
37664191|NCT01597245|69137081|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
37664192|NCT01597245|69137082|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
37664193|NCT01597245|69137083|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
37664194|NCT01597245|69137084|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
37664195|NCT01597245|69137085|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
37664196|NCT01597245|69137086|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
37664197|NCT01597245|69137087|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
37664198|NCT01597245|69137088|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
37664199|NCT01597245|69137089|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
37664200|NCT01597245|69137090|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
37664201|NCT01597245|69137091|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
37664202|NCT01597245|69137092|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
37664203|NCT01597245|69137093|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
37664204|NCT01597245|69137094|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
37664205|NCT01597245|69137074|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
37664206|NCT01597245|69137075|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
37664207|NCT01597245|69137076|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
37664208|NCT01597245|69137077|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
37664209|NCT01597245|69137078|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
37664210|NCT01597245|69137079|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
37664211|NCT01597245|69137080|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
37664212|NCT01597245|69137081|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
37664213|NCT01597245|69137082|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
37664214|NCT01597245|69137083|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
37664215|NCT01597245|69137084|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
37664216|NCT01597245|69137085|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
37664217|NCT01597245|69137086|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
37664218|NCT01597245|69137087|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
37664219|NCT01597245|69137088|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
37664220|NCT01597245|69137089|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
37664221|NCT01597245|69137090|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
37664222|NCT01597245|69137091|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
37664223|NCT01597245|69137092|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
37664224|NCT01597245|69137093|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
37664225|NCT01597245|69137094|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
37664226|NCT01597245|69137074|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
37664227|NCT01597245|69137075|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
37664228|NCT01597245|69137076|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
37664229|NCT01597245|69137077|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
37664230|NCT01597245|69137078|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
37754938|NCT01717313|69261027|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
37754939|NCT01717313|69261026|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
37754940|NCT01717313|69261027|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
37754941|NCT01717313|69261026|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
37754942|NCT01717313|69261027|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
37754943|NCT01717313|69261026|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
37754944|NCT01717313|69261027|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
37754945|NCT01717313|69261026|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
37754946|NCT01717313|69261027|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
37754947|NCT01717313|69261026|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
37754948|NCT01717313|69261027|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
37754949|NCT01745393|69261039|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
37664231|NCT01597245|69137079|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
37664232|NCT01597245|69137080|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
37664233|NCT01597245|69137081|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
37664234|NCT01597245|69137082|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
37664235|NCT01597245|69137083|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
37664236|NCT01597245|69137084|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
37664237|NCT01597245|69137085|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
37664238|NCT01597245|69137086|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
37664239|NCT01597245|69137087|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
37754950|NCT01745393|69261040|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
37754951|NCT01745393|69261039|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
37754952|NCT01745393|69261040|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
37754953|NCT01745393|69261039|FG000|12-month Follow-up|Lost to Follow-up|6|||
37754954|NCT01745393|69261040|FG001|12-month Follow-up|Lost to Follow-up|5|||
37754955|NCT01744691|69261071|FG000|Overall Study|Progressive Disease|18|||
37754956|NCT01744691|69261071|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
37857924|NCT02632344|69541092|FG000|Overall Study|Lack of Efficacy|3|||
37857925|NCT02632344|69541092|FG000|Overall Study|Withdrawal by Subject|2|||
37857926|NCT02625324|69541096|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
37857927|NCT02625324|69541096|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
37857928|NCT02625324|69541096|FG000|6-Month Follow-up Subject Accountability|Death|5|||
37857929|NCT02625324|69541096|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
37857930|NCT02625324|69541096|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
37857931|NCT02625324|69541096|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
37857932|NCT02625324|69541096|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
37857933|NCT02625324|69541096|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
37857934|NCT02625324|69541096|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
37857935|NCT02625324|69541096|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
37857936|NCT02625324|69541096|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
37857937|NCT02625324|69541096|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
37857938|NCT02625324|69541096|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
37857939|NCT02625324|69541096|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
37857940|NCT02625324|69541096|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
37857941|NCT02477696|69541125|FG000|Overall Study|Adverse Event|40|||
37857942|NCT02477696|69541126|FG001|Overall Study|Adverse Event|59|||
37857943|NCT02477696|69541125|FG000|Overall Study|CLL Disease Progression|82|||
37857944|NCT02477696|69541126|FG001|Overall Study|CLL Disease Progression|68|||
37857945|NCT02477696|69541125|FG000|Overall Study|Includes Non-compliance, Relocation, Subject's Decision and Medical Monitor's Decision.|2|||
37857946|NCT02477696|69541126|FG001|Overall Study|Includes Non-compliance, Relocation, Subject's Decision and Medical Monitor's Decision.|10|||
37857947|NCT02477696|69541125|FG000|Overall Study|Death|5|||
37857948|NCT02477696|69541126|FG001|Overall Study|Death|6|||
37857949|NCT02477696|69541125|FG000|Overall Study|Withdrawal by Subject|7|||
37857950|NCT02477696|69541126|FG001|Overall Study|Withdrawal by Subject|7|||
37857951|NCT02477696|69541125|FG000|Overall Study|Physician Decision|5|||
37857952|NCT02477696|69541126|FG001|Overall Study|Physician Decision|5|||
37857953|NCT02213328|69541141|FG000|Overall Study|Withdrawal by Subject|10|||
37857954|NCT02213328|69541141|FG000|Overall Study|Physician Decision|2|||
37664240|NCT01597245|69137088|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
37664241|NCT01597245|69137089|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
37664242|NCT01597245|69137090|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
37664243|NCT01597245|69137091|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
37664244|NCT01597245|69137092|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
37664245|NCT01597245|69137093|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
37664246|NCT01597245|69137094|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
37664247|NCT01597245|69137074|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
37664248|NCT01597245|69137075|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
37664249|NCT01597245|69137076|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
37664250|NCT01597245|69137077|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
37664251|NCT01597245|69137078|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
37754957|NCT01744691|69261071|FG000|Overall Study|Withdrawal of consent for treatment|3|||
37754958|NCT01744691|69261071|FG000|Overall Study|Physician Decision|4|||
37754959|NCT01716533|69261106|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
37857955|NCT02213328|69541141|FG000|Overall Study|Lost to Follow-up|16|||
37857956|NCT02085408|69541170|FG000|Step 1: Induction|Disease Progression|19|||
37857957|NCT02085408|69541171|FG001|Step 1: Induction|Disease Progression|19|||
37857958|NCT02085408|69541170|FG000|Step 1: Induction|Adverse Event|18|||
37754960|NCT01716533|69261107|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
37754961|NCT01716533|69261108|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
37664252|NCT01597245|69137079|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
37664253|NCT01597245|69137080|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
37664254|NCT01597245|69137081|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
37664255|NCT01597245|69137082|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
37664256|NCT01597245|69137083|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
37664257|NCT01597245|69137084|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
37664258|NCT01597245|69137085|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
37664259|NCT01597245|69137086|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
37664260|NCT01597245|69137087|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
37664261|NCT01597245|69137088|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
37664262|NCT01597245|69137089|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
37664263|NCT01597245|69137090|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
37664264|NCT01597245|69137091|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
37664265|NCT01597245|69137092|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
37664266|NCT01597245|69137093|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
37664267|NCT01597245|69137094|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
37664268|NCT01597245|69137074|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
37754962|NCT01716533|69261109|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
37754963|NCT01716533|69261106|FG000|Overall Study|Withdrawal by Subject|0|||
37754964|NCT01716533|69261107|FG001|Overall Study|Withdrawal by Subject|0|||
37754965|NCT01716533|69261108|FG002|Overall Study|Withdrawal by Subject|0|||
37754966|NCT01716533|69261109|FG003|Overall Study|Withdrawal by Subject|5|||
37754967|NCT01716533|69261106|FG000|Overall Study|Death|0|||
37664269|NCT01597245|69137075|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
37664270|NCT01597245|69137076|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
37664271|NCT01597245|69137077|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
37664272|NCT01597245|69137078|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
37664273|NCT01597245|69137079|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
37664274|NCT01597245|69137080|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
37664275|NCT01597245|69137081|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
37664276|NCT01597245|69137082|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
37664277|NCT01597245|69137083|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
37664278|NCT01597245|69137084|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
37664279|NCT01597245|69137085|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
37664280|NCT01597245|69137086|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
37664281|NCT01597245|69137087|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
37754968|NCT01716533|69261107|FG001|Overall Study|Death|0|||
37754969|NCT01716533|69261108|FG002|Overall Study|Death|0|||
37754970|NCT01716533|69261109|FG003|Overall Study|Death|2|||
37754971|NCT01716533|69261106|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
37754972|NCT01716533|69261107|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
37754973|NCT01716533|69261108|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
37754974|NCT01716533|69261109|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
37754975|NCT01375374|69261123|FG000|Overall Study|Adverse Event|1|||
37754976|NCT01743989|69261721|FG000|Treatment Phase|Unstable MR4.0|0|||
37857959|NCT02085408|69541171|FG001|Step 1: Induction|Adverse Event|17|||
37857960|NCT02085408|69541170|FG000|Step 1: Induction|Death|33|||
37857961|NCT02085408|69541171|FG001|Step 1: Induction|Death|30|||
37754977|NCT01743989|69261722|FG001|Treatment Phase|Unstable MR4.0|6|||
37754978|NCT01743989|69261723|FG002|Treatment Phase|Unstable MR4.0|263|||
37754979|NCT01743989|69261721|FG000|Treatment Phase|Adverse Event|0|||
37754980|NCT01743989|69261722|FG001|Treatment Phase|Adverse Event|4|||
37754981|NCT01743989|69261723|FG002|Treatment Phase|Adverse Event|67|||
37754982|NCT01743989|69261721|FG000|Treatment Phase|Withdrawal by Subject|1|||
37754983|NCT01743989|69261722|FG001|Treatment Phase|Withdrawal by Subject|3|||
37754984|NCT01743989|69261723|FG002|Treatment Phase|Withdrawal by Subject|28|||
37754985|NCT01743989|69261721|FG000|Treatment Phase|Death|0|||
37857962|NCT02085408|69541170|FG000|Step 1: Induction|Withdrawal by Subject|16|||
37857963|NCT02085408|69541171|FG001|Step 1: Induction|Withdrawal by Subject|8|||
37857964|NCT02085408|69541170|FG000|Step 1: Induction|Alternative Therapy|15|||
37857965|NCT02085408|69541171|FG001|Step 1: Induction|Alternative Therapy|19|||
38033271|NCT04493684|69719210|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
37754986|NCT01743989|69261722|FG001|Treatment Phase|Death|1|||
37754987|NCT01743989|69261723|FG002|Treatment Phase|Death|3|||
37754988|NCT01743989|69261721|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
37754989|NCT01743989|69261722|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
37857966|NCT02085408|69541170|FG000|Step 1: Induction|Complicating Disease|2|||
37857967|NCT02085408|69541171|FG001|Step 1: Induction|Complicating Disease|3|||
37857968|NCT02085408|69541170|FG000|Step 1: Induction|Other|27|||
37923380|NCT03704064|69610199|FG001|Overall Study|Withdrawal by Subject|1|||
37664282|NCT01597245|69137088|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
37664283|NCT01597245|69137089|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
37664284|NCT01597245|69137090|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
37664285|NCT01597245|69137091|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
37664286|NCT01597245|69137092|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
37664287|NCT01597245|69137093|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
37664288|NCT01597245|69137094|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
37857969|NCT02085408|69541171|FG001|Step 1: Induction|Other|39|||
37857970|NCT02085408|69541170|FG000|Step 1: Induction|Never started treatment|6|||
37857971|NCT02085408|69541171|FG001|Step 1: Induction|Never started treatment|4|||
37857972|NCT02085408|69541170|FG000|Step 2: Consolidation|Disease Progression|5|||
37857973|NCT02085408|69541171|FG001|Step 2: Consolidation|Disease Progression|20|||
37857974|NCT02085408|69541170|FG000|Step 2: Consolidation|Adverse Event|9|||
37857975|NCT02085408|69541171|FG001|Step 2: Consolidation|Adverse Event|8|||
37857976|NCT02085408|69541170|FG000|Step 2: Consolidation|Death|4|||
37857977|NCT02085408|69541171|FG001|Step 2: Consolidation|Death|3|||
37857978|NCT02085408|69541170|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
37857979|NCT02085408|69541171|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
37857980|NCT02085408|69541170|FG000|Step 2: Consolidation|Alternative Therapy|9|||
37857981|NCT02085408|69541171|FG001|Step 2: Consolidation|Alternative Therapy|3|||
37857982|NCT02085408|69541170|FG000|Step 2: Consolidation|Complicating Disease|0|||
37857983|NCT02085408|69541171|FG001|Step 2: Consolidation|Complicating Disease|2|||
37857984|NCT02085408|69541170|FG000|Step 2: Consolidation|Other|6|||
37754990|NCT01743989|69261723|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
37754991|NCT01743989|69261721|FG000|Treatment Phase|Protocol deviation|0|||
37754992|NCT01743989|69261722|FG001|Treatment Phase|Protocol deviation|0|||
37754993|NCT01743989|69261723|FG002|Treatment Phase|Protocol deviation|3|||
37754994|NCT01743989|69261721|FG000|Treatment Phase|Pregnancy|0|||
37754995|NCT01743989|69261722|FG001|Treatment Phase|Pregnancy|0|||
37754996|NCT01743989|69261723|FG002|Treatment Phase|Pregnancy|2|||
37754997|NCT01743989|69261721|FG000|Treatment Phase|Lost to Follow-up|0|||
37754998|NCT01743989|69261722|FG001|Treatment Phase|Lost to Follow-up|0|||
37754999|NCT01743989|69261723|FG002|Treatment Phase|Lost to Follow-up|2|||
37755000|NCT01743989|69261721|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
37755001|NCT01743989|69261722|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
37755002|NCT01743989|69261723|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
37755003|NCT01743989|69261721|FG000|Treatment Phase|Administrative problems|0|||
37755004|NCT01743989|69261722|FG001|Treatment Phase|Administrative problems|0|||
37755005|NCT01743989|69261723|FG002|Treatment Phase|Administrative problems|1|||
37755006|NCT01743989|69261721|FG000|Treatment Phase|New cancer (CML) therapy|0|||
37755007|NCT01743989|69261722|FG001|Treatment Phase|New cancer (CML) therapy|1|||
37755008|NCT01743989|69261723|FG002|Treatment Phase|New cancer (CML) therapy|0|||
37755009|NCT01743989|69261721|FG000|Treatment Phase|Physician Decision|0|||
37755010|NCT01743989|69261722|FG001|Treatment Phase|Physician Decision|0|||
37755011|NCT01743989|69261723|FG002|Treatment Phase|Physician Decision|3|||
37755012|NCT01743989|69261721|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
37755013|NCT01743989|69261722|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
37755014|NCT01743989|69261723|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
37755015|NCT01743989|69261721|FG000|Treatment Phase|Not randomized by mistake|0|||
37755016|NCT01743989|69261722|FG001|Treatment Phase|Not randomized by mistake|0|||
37755017|NCT01743989|69261723|FG002|Treatment Phase|Not randomized by mistake|1|||
37755018|NCT01743989|69261721|FG000|Treatment Phase|Included by mistake|0|||
37755019|NCT01743989|69261722|FG001|Treatment Phase|Included by mistake|0|||
37755020|NCT01743989|69261723|FG002|Treatment Phase|Included by mistake|1|||
37755021|NCT01743989|69261721|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
37755022|NCT01743989|69261722|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
37755023|NCT01743989|69261723|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
37755024|NCT01743989|69261721|FG000|TFR Phase|Adverse Event|0|||
37755025|NCT01743989|69261722|FG001|TFR Phase|Adverse Event|1|||
37755026|NCT01743989|69261723|FG002|TFR Phase|Adverse Event|0|||
37755027|NCT01743989|69261721|FG000|TFR Phase|Lost to Follow-up|0|||
37755028|NCT01743989|69261722|FG001|TFR Phase|Lost to Follow-up|2|||
37755029|NCT01743989|69261723|FG002|TFR Phase|Lost to Follow-up|0|||
37857985|NCT02085408|69541171|FG001|Step 2: Consolidation|Other|6|||
37755030|NCT01743989|69261721|FG000|TFR Phase|Physician Decision|0|||
37857986|NCT02085408|69541170|FG000|Step 2: Consolidation|Never started treatment|4|||
37857987|NCT02085408|69541171|FG001|Step 2: Consolidation|Never started treatment|3|||
37857988|NCT02085408|69541170|FG000|Step 3: Maintenance|Disease Progression|13|||
37755031|NCT01743989|69261722|FG001|TFR Phase|Physician Decision|1|||
37857989|NCT02085408|69541171|FG001|Step 3: Maintenance|Disease Progression|11|||
37857990|NCT02085408|69541170|FG000|Step 3: Maintenance|Adverse Event|2|||
37755032|NCT01743989|69261723|FG002|TFR Phase|Physician Decision|0|||
37755033|NCT01743989|69261721|FG000|TFR Phase|Logistical problems|0|||
37755034|NCT01743989|69261722|FG001|TFR Phase|Logistical problems|2|||
37755035|NCT01743989|69261723|FG002|TFR Phase|Logistical problems|0|||
37664289|NCT01597245|69137074|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
37664290|NCT01597245|69137075|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
37664291|NCT01597245|69137076|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
37664292|NCT01597245|69137077|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
37664293|NCT01597245|69137078|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
37664294|NCT01597245|69137079|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
37664295|NCT01597245|69137080|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
37755036|NCT01743989|69261721|FG000|TFR Phase|Protocol deviation|0|||
37755037|NCT01743989|69261722|FG001|TFR Phase|Protocol deviation|1|||
37755038|NCT01743989|69261723|FG002|TFR Phase|Protocol deviation|0|||
37755039|NCT01743989|69261721|FG000|TFR Phase|Withdrawal by Subject|0|||
37755040|NCT01743989|69261722|FG001|TFR Phase|Withdrawal by Subject|2|||
37755041|NCT01743989|69261723|FG002|TFR Phase|Withdrawal by Subject|0|||
37755042|NCT01743989|69261721|FG000|Re-treatment Phase|Adverse Event|8|||
37755043|NCT01743989|69261722|FG001|Re-treatment Phase|Adverse Event|4|||
37755044|NCT01743989|69261723|FG002|Re-treatment Phase|Adverse Event|0|||
37755045|NCT01743989|69261721|FG000|Re-treatment Phase|Death|1|||
37755046|NCT01743989|69261722|FG001|Re-treatment Phase|Death|1|||
37755047|NCT01743989|69261723|FG002|Re-treatment Phase|Death|0|||
37755048|NCT01743989|69261721|FG000|Re-treatment Phase|Administrative problems|1|||
37755049|NCT01743989|69261722|FG001|Re-treatment Phase|Administrative problems|1|||
37755050|NCT01743989|69261723|FG002|Re-treatment Phase|Administrative problems|0|||
37755051|NCT01743989|69261721|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
37755052|NCT01743989|69261722|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
37755053|NCT01743989|69261723|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
37755054|NCT01743989|69261721|FG000|Re-treatment Phase|Unstable MR|1|||
37755055|NCT01743989|69261722|FG001|Re-treatment Phase|Unstable MR|0|||
37755056|NCT01743989|69261723|FG002|Re-treatment Phase|Unstable MR|0|||
37755057|NCT01743989|69261721|FG000|Re-treatment Phase|Physician Decision|0|||
37755058|NCT01743989|69261722|FG001|Re-treatment Phase|Physician Decision|1|||
37755059|NCT01743989|69261723|FG002|Re-treatment Phase|Physician Decision|0|||
37755060|NCT01743989|69261721|FG000|Re-treatment Phase|Lost to Follow-up|0|||
37755061|NCT01743989|69261722|FG001|Re-treatment Phase|Lost to Follow-up|1|||
37755062|NCT01743989|69261723|FG002|Re-treatment Phase|Lost to Follow-up|0|||
37755063|NCT01605461|69261756|FG000|Overall Study|Lost to Follow-up|3|||
37755064|NCT01605461|69261756|FG000|Overall Study|Withdrawal by Subject|1|||
37755065|NCT01742897|69261760|FG000|Overall Study|Adverse Event|3|||
37755066|NCT01742897|69261760|FG000|Overall Study|Withdrawal by Subject|1|||
37755067|NCT01742897|69261760|FG000|Overall Study|Other|1|||
37755068|NCT01715831|69261764|FG000|Overall Study|Adverse Event|1|||
37755069|NCT01741259|69261770|FG000|Overall Study|Protocol Violation|6|||
37755070|NCT01741259|69261771|FG001|Overall Study|Protocol Violation|4|||
37755071|NCT01741259|69261770|FG000|Overall Study|Withdrawal by Subject|0|||
37755072|NCT01741259|69261771|FG001|Overall Study|Withdrawal by Subject|2|||
37755073|NCT01715129|69261777|FG000|Overall Study|Adverse Event, fatal|1|||
37755074|NCT01715129|69261777|FG000|Overall Study|Lack of Efficacy|3|||
37755075|NCT01715129|69261777|FG000|Overall Study|Protocol Violation|1|||
37755076|NCT01715129|69261777|FG000|Overall Study|Consent Withdrawn|2|||
37755077|NCT01715129|69261777|FG000|Overall Study|Lost to Follow-up|1|||
37755078|NCT01715129|69261777|FG000|Overall Study|Other|1|||
37755079|NCT01740791|69261870|FG000|Overall Study|Randomized but never treated|5|||
37755080|NCT01740791|69261871|FG001|Overall Study|Randomized but never treated|3|||
37755081|NCT01740791|69261872|FG002|Overall Study|Randomized but never treated|2|||
37755082|NCT01740791|69261873|FG003|Overall Study|Randomized but never treated|2|||
37755083|NCT01740791|69261874|FG004|Overall Study|Randomized but never treated|1|||
37755084|NCT01740791|69261875|FG005|Overall Study|Randomized but never treated|3|||
37755085|NCT01740791|69261870|FG000|Overall Study|Lost to Follow-up|2|||
37755086|NCT01740791|69261871|FG001|Overall Study|Lost to Follow-up|0|||
37755087|NCT01740791|69261872|FG002|Overall Study|Lost to Follow-up|2|||
37755088|NCT01740791|69261873|FG003|Overall Study|Lost to Follow-up|3|||
37755089|NCT01740791|69261874|FG004|Overall Study|Lost to Follow-up|2|||
37755090|NCT01740791|69261875|FG005|Overall Study|Lost to Follow-up|3|||
37857991|NCT02085408|69541171|FG001|Step 3: Maintenance|Adverse Event|4|||
37755091|NCT01740791|69261870|FG000|Overall Study|Withdrew Consent|4|||
37755092|NCT01740791|69261871|FG001|Overall Study|Withdrew Consent|0|||
37755093|NCT01740791|69261872|FG002|Overall Study|Withdrew Consent|1|||
37755094|NCT01740791|69261873|FG003|Overall Study|Withdrew Consent|2|||
37857992|NCT02085408|69541170|FG000|Step 3: Maintenance|Death|1|||
37857993|NCT02085408|69541171|FG001|Step 3: Maintenance|Death|2|||
37857994|NCT02085408|69541170|FG000|Step 3: Maintenance|Alternative Therapy|1|||
37857995|NCT02085408|69541171|FG001|Step 3: Maintenance|Alternative Therapy|1|||
37664296|NCT01597245|69137081|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
37664297|NCT01597245|69137082|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
37664298|NCT01597245|69137083|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
37664299|NCT01597245|69137084|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
37664300|NCT01597245|69137085|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
37664301|NCT01597245|69137086|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
37664302|NCT01597245|69137087|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
37664303|NCT01597245|69137088|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
37664304|NCT01597245|69137089|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
37664305|NCT01597245|69137090|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
37664306|NCT01597245|69137091|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
37664307|NCT01597245|69137092|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
37664308|NCT01597245|69137093|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
37664309|NCT01597245|69137094|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
37664310|NCT01597245|69137074|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
37664311|NCT01597245|69137075|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
37664312|NCT01597245|69137076|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
37664313|NCT01597245|69137077|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
37664314|NCT01597245|69137078|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
37755095|NCT01740791|69261874|FG004|Overall Study|Withdrew Consent|0|||
37755096|NCT01740791|69261875|FG005|Overall Study|Withdrew Consent|3|||
37755097|NCT01740791|69261870|FG000|Overall Study|Investigator's discretion|1|||
37755098|NCT01740791|69261871|FG001|Overall Study|Investigator's discretion|0|||
37755099|NCT01740791|69261872|FG002|Overall Study|Investigator's discretion|1|||
37755100|NCT01740791|69261873|FG003|Overall Study|Investigator's discretion|0|||
37755101|NCT01740791|69261874|FG004|Overall Study|Investigator's discretion|0|||
37755102|NCT01740791|69261875|FG005|Overall Study|Investigator's discretion|1|||
37755103|NCT01740791|69261870|FG000|Overall Study|Adverse Event|0|||
37755104|NCT01740791|69261871|FG001|Overall Study|Adverse Event|0|||
37755105|NCT01740791|69261872|FG002|Overall Study|Adverse Event|0|||
37755106|NCT01740791|69261873|FG003|Overall Study|Adverse Event|0|||
37755107|NCT01740791|69261874|FG004|Overall Study|Adverse Event|0|||
37755108|NCT01740791|69261875|FG005|Overall Study|Adverse Event|1|||
37755109|NCT01740323|69261932|FG000|Overall Study|Adverse Event|1|||
37755110|NCT01740323|69261933|FG001|Overall Study|Adverse Event|0|||
37755111|NCT01740323|69261932|FG000|Overall Study|Randomized but did not take study drug|1|||
37755112|NCT01740323|69261933|FG001|Overall Study|Randomized but did not take study drug|0|||
37755113|NCT01740089|69261951|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
37755114|NCT01740089|69261952|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
37755115|NCT01740089|69261953|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
37755116|NCT01740089|69261951|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
37755117|NCT01740089|69261952|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
37755118|NCT01740089|69261953|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
37755119|NCT01740089|69261951|FG000|After 12 Weeks|Lack of Efficacy|3|||
37755120|NCT01740089|69261952|FG001|After 12 Weeks|Lack of Efficacy|1|||
37755121|NCT01740089|69261953|FG002|After 12 Weeks|Lack of Efficacy|4|||
37755122|NCT01740089|69261951|FG000|After 12 Weeks|Adverse Event|2|||
37755123|NCT01740089|69261952|FG001|After 12 Weeks|Adverse Event|0|||
37755124|NCT01740089|69261953|FG002|After 12 Weeks|Adverse Event|5|||
37755125|NCT01740089|69261951|FG000|After 12 Weeks|Protocol Violation|1|||
37755126|NCT01740089|69261952|FG001|After 12 Weeks|Protocol Violation|1|||
37755127|NCT01740089|69261953|FG002|After 12 Weeks|Protocol Violation|1|||
37755128|NCT01740089|69261951|FG000|After 12 Weeks|Withdrawal by Subject|1|||
37755129|NCT01740089|69261952|FG001|After 12 Weeks|Withdrawal by Subject|1|||
37755130|NCT01740089|69261953|FG002|After 12 Weeks|Withdrawal by Subject|1|||
37755131|NCT01739933|69261964|FG000|Overall Study|Death|89|||
37755132|NCT01739933|69261965|FG001|Overall Study|Death|86|||
37755133|NCT01739933|69261964|FG000|Overall Study|Withdrawal by Subject|10|||
37755134|NCT01739933|69261965|FG001|Overall Study|Withdrawal by Subject|8|||
37755135|NCT01739933|69261964|FG000|Overall Study|Lost to Follow-up|3|||
37755136|NCT01739933|69261965|FG001|Overall Study|Lost to Follow-up|10|||
37755137|NCT01739933|69261964|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
37755138|NCT01739933|69261965|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
37755139|NCT01738919|69261982|FG000|Overall Study|Lost to Follow-up|1|||
37755140|NCT01738919|69261983|FG001|Overall Study|Lost to Follow-up|0|||
37755141|NCT01738919|69261982|FG000|Overall Study|Immigrated|0|||
37755142|NCT01738919|69261983|FG001|Overall Study|Immigrated|1|||
37755143|NCT01738919|69261982|FG000|Overall Study|Withdrawal by Subject|0|||
37755144|NCT01738919|69261983|FG001|Overall Study|Withdrawal by Subject|1|||
37755145|NCT01738919|69261982|FG000|Overall Study|Not treated in accordance to guidelines|0|||
37755146|NCT01738919|69261983|FG001|Overall Study|Not treated in accordance to guidelines|1|||
37755147|NCT01712399|69262004|FG000|Overall Study|Lost to Follow-up|1|||
37755148|NCT01712399|69262004|FG000|Overall Study|Withdrawal by Subject|39|||
37755149|NCT01712399|69262004|FG000|Overall Study|Death|1|||
37755150|NCT01712399|69262004|FG000|Overall Study|Adverse Event|11|||
37755151|NCT01712399|69262004|FG000|Overall Study|Study closure|345|||
37755152|NCT03225846|69262111|FG000|Overall Study|Adverse Event|0|||
37755153|NCT03225846|69262112|FG001|Overall Study|Adverse Event|0|||
37755154|NCT03225846|69262113|FG002|Overall Study|Adverse Event|0|||
37755155|NCT03225846|69262114|FG003|Overall Study|Adverse Event|0|||
37755156|NCT03225846|69262115|FG004|Overall Study|Adverse Event|0|||
37664315|NCT01597245|69137079|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
37664316|NCT01597245|69137080|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
37664317|NCT01597245|69137081|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
37664318|NCT01597245|69137082|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
37664319|NCT01597245|69137083|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
37664320|NCT01597245|69137084|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
37664321|NCT01597245|69137085|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
37664322|NCT01597245|69137086|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
37664323|NCT01597245|69137087|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
37755157|NCT03225846|69262116|FG005|Overall Study|Adverse Event|0|||
37755158|NCT03225846|69262117|FG006|Overall Study|Adverse Event|6|||
37755159|NCT03225846|69262111|FG000|Overall Study|Withdrawal by Subject|0|||
37755160|NCT03225846|69262112|FG001|Overall Study|Withdrawal by Subject|1|||
37755161|NCT03225846|69262113|FG002|Overall Study|Withdrawal by Subject|0|||
37755162|NCT03225846|69262114|FG003|Overall Study|Withdrawal by Subject|0|||
37755163|NCT03225846|69262115|FG004|Overall Study|Withdrawal by Subject|0|||
37755164|NCT03225846|69262116|FG005|Overall Study|Withdrawal by Subject|0|||
37755165|NCT03225846|69262117|FG006|Overall Study|Withdrawal by Subject|0|||
37755166|NCT03225846|69262111|FG000|Overall Study|Death|0|||
37755167|NCT03225846|69262112|FG001|Overall Study|Death|1|||
37755168|NCT03225846|69262113|FG002|Overall Study|Death|0|||
37755169|NCT03225846|69262114|FG003|Overall Study|Death|0|||
37755170|NCT03225846|69262115|FG004|Overall Study|Death|0|||
37755171|NCT03225846|69262116|FG005|Overall Study|Death|0|||
37755172|NCT03225846|69262117|FG006|Overall Study|Death|0|||
37755173|NCT03225846|69262111|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
37755174|NCT03225846|69262112|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
37755175|NCT03225846|69262113|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
37755176|NCT03225846|69262114|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
37755177|NCT03225846|69262115|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
37755178|NCT03225846|69262116|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
37755179|NCT03225846|69262117|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
37755180|NCT03225846|69262111|FG000|Overall Study|Patient decision|0|||
37755181|NCT03225846|69262112|FG001|Overall Study|Patient decision|0|||
37755182|NCT03225846|69262113|FG002|Overall Study|Patient decision|0|||
37755183|NCT03225846|69262114|FG003|Overall Study|Patient decision|0|||
37857996|NCT02085408|69541170|FG000|Step 3: Maintenance|Complicating Disease|0|||
37664324|NCT01597245|69137088|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
37664325|NCT01597245|69137089|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
37664326|NCT01597245|69137090|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
37664327|NCT01597245|69137091|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
37664328|NCT01597245|69137092|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
37664329|NCT01597245|69137093|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
37664330|NCT01597245|69137094|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
37664331|NCT01597245|69137074|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
37664332|NCT01597245|69137075|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
37664333|NCT01597245|69137076|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
37664334|NCT01597245|69137077|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
37664335|NCT01597245|69137078|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
37664336|NCT01597245|69137079|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
37664337|NCT01597245|69137080|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
37664338|NCT01597245|69137081|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
37664339|NCT01597245|69137082|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
37664340|NCT01597245|69137083|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
37664341|NCT01597245|69137084|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
37664342|NCT01597245|69137085|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
37664343|NCT01597245|69137086|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
37664344|NCT01597245|69137087|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
37755184|NCT03225846|69262115|FG004|Overall Study|Patient decision|0|||
37755185|NCT03225846|69262116|FG005|Overall Study|Patient decision|0|||
37755186|NCT03225846|69262117|FG006|Overall Study|Patient decision|1|||
37755187|NCT01712009|69262182|FG000|Overall Study|Withdrawal by Subject|24|||
37755188|NCT01712009|69262183|FG001|Overall Study|Withdrawal by Subject|15|||
37755189|NCT01712009|69262184|FG002|Overall Study|Withdrawal by Subject|8|||
37755190|NCT01712009|69262182|FG000|Overall Study|Lost to Follow-up|2|||
37755191|NCT01712009|69262183|FG001|Overall Study|Lost to Follow-up|0|||
37755192|NCT01712009|69262184|FG002|Overall Study|Lost to Follow-up|1|||
37857997|NCT02085408|69541171|FG001|Step 3: Maintenance|Complicating Disease|1|||
37755193|NCT01712009|69262182|FG000|Overall Study|Decision by Sponsor|12|||
37755194|NCT01712009|69262183|FG001|Overall Study|Decision by Sponsor|14|||
37755195|NCT01712009|69262184|FG002|Overall Study|Decision by Sponsor|12|||
37755196|NCT01711853|69262213|FG000|Overall Study|Not treated|3|||
37857998|NCT02085408|69541170|FG000|Step 3: Maintenance|Other|3|||
37857999|NCT02085408|69541171|FG001|Step 3: Maintenance|Other|2|||
37858000|NCT02085408|69541170|FG000|Step 3: Maintenance|Never started treatment|5|||
37858001|NCT02085408|69541171|FG001|Step 3: Maintenance|Never started treatment|1|||
37858002|NCT01867606|69541188|FG000|Overall Study|Withdrawal by Subject|10|||
37858003|NCT01867606|69541189|FG001|Overall Study|Withdrawal by Subject|14|||
37858004|NCT01867606|69541188|FG000|Overall Study|Protocol Violation|0|||
37858005|NCT01867606|69541189|FG001|Overall Study|Protocol Violation|1|||
37858006|NCT01475786|69541204|FG000|Overall Study|Adverse Event|0|||
37858007|NCT01475786|69541205|FG001|Overall Study|Adverse Event|1|||
37858008|NCT01475786|69541206|FG002|Overall Study|Adverse Event|0|||
37858009|NCT01475786|69541204|FG000|Overall Study|Lost to Follow-up|1|||
37858010|NCT01475786|69541205|FG001|Overall Study|Lost to Follow-up|2|||
37858011|NCT01475786|69541206|FG002|Overall Study|Lost to Follow-up|1|||
37858012|NCT01475786|69541204|FG000|Overall Study|Withdrawal by Subject|0|||
37858013|NCT01475786|69541205|FG001|Overall Study|Withdrawal by Subject|1|||
37858014|NCT01475786|69541206|FG002|Overall Study|Withdrawal by Subject|1|||
37858015|NCT01475786|69541204|FG000|Overall Study|Subject discontinued prior to study treatment|1|||
37858016|NCT01475786|69541205|FG001|Overall Study|Subject discontinued prior to study treatment|0|||
37858017|NCT01475786|69541206|FG002|Overall Study|Subject discontinued prior to study treatment|0|||
37858018|NCT01290692|69541214|FG000|Overall Study|Lack of sufficient efficacy as patients were immunocompromised|7|||
37858019|NCT00700882|69541250|FG000|Overall Study|Never received treatment|6|||
37858020|NCT00700882|69541250|FG000|Overall Study|Ineligible|2|||
37858021|NCT00700882|69541250|FG000|Overall Study|No KIT mutation|51|||
37858022|NCT00666835|69541288|FG000|Overall Study|Withdrawal by Subject|5|||
37858023|NCT00666835|69541289|FG001|Overall Study|Withdrawal by Subject|2|||
37858024|NCT00666835|69541288|FG000|Overall Study|Lack of Efficacy|0|||
37858025|NCT00666835|69541289|FG001|Overall Study|Lack of Efficacy|1|||
37858026|NCT00666835|69541288|FG000|Overall Study|Incl./excl. not fulfilled|7|||
37858027|NCT00666835|69541289|FG001|Overall Study|Incl./excl. not fulfilled|2|||
37858028|NCT00666835|69541288|FG000|Overall Study|Adverse Event|7|||
37858029|NCT00666835|69541289|FG001|Overall Study|Adverse Event|6|||
37858030|NCT00666835|69541288|FG000|Overall Study|Protocol Violation|2|||
37858031|NCT00666835|69541289|FG001|Overall Study|Protocol Violation|0|||
37858032|NCT00666835|69541288|FG000|Overall Study|Death|15|||
37858033|NCT00666835|69541289|FG001|Overall Study|Death|4|||
37858034|NCT00666835|69541288|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
37858035|NCT00666835|69541289|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
37858036|NCT00666835|69541288|FG000|Overall Study|Hemoglobulin concentration|4|||
37858037|NCT00666835|69541289|FG001|Overall Study|Hemoglobulin concentration|3|||
37858038|NCT00666835|69541288|FG000|Overall Study|Planned operation|2|||
37858039|NCT00666835|69541289|FG001|Overall Study|Planned operation|0|||
37858040|NCT00666835|69541288|FG000|Overall Study|Physician Decision|1|||
37858041|NCT00666835|69541289|FG001|Overall Study|Physician Decision|2|||
37858042|NCT00551759|69541296|FG000|Overall Study|Adverse Event|7|||
37858043|NCT00551759|69541296|FG000|Overall Study|Death|5|||
37858044|NCT00551759|69541296|FG000|Overall Study|Ineligible|1|||
37858045|NCT00335140|69541300|FG000|Overall Study|Ineligible|1|||
37858046|NCT00304239|69541306|FG000|Overall Study|Protocol Deviations/Violations|15|||
37858047|NCT00304239|69541307|FG001|Overall Study|Protocol Deviations/Violations|0|||
37664345|NCT01597245|69137088|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
37664346|NCT01597245|69137089|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
37664347|NCT01597245|69137090|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
37664348|NCT01597245|69137091|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
37664349|NCT01597245|69137092|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
37664350|NCT01597245|69137093|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
37664351|NCT01597245|69137094|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
37664352|NCT01597245|69137074|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
37664353|NCT01597245|69137075|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
37664354|NCT01597245|69137076|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
37858048|NCT00304239|69541306|FG000|Overall Study|Adverse Event|2|||
37858049|NCT00304239|69541307|FG001|Overall Study|Adverse Event|0|||
37858050|NCT00101283|69541315|FG000|Overall Study|Withdrawal by Subject|0|||
37755197|NCT01708187|69262219|FG000|Overall Study|Lost to Follow-up|0|||
37755198|NCT01708187|69262220|FG001|Overall Study|Lost to Follow-up|1|||
37858051|NCT00101283|69541316|FG001|Overall Study|Withdrawal by Subject|1|||
37858052|NCT00101283|69541315|FG000|Overall Study|Insurance Refusal|0|||
37858053|NCT00101283|69541316|FG001|Overall Study|Insurance Refusal|1|||
37858054|NCT00101283|69541315|FG000|Overall Study|Prostate Cancer Recurrence|0|||
37755199|NCT01740401|69262296|FG000|Overall Study|Progression of disease|6|||
37858055|NCT00101283|69541316|FG001|Overall Study|Prostate Cancer Recurrence|1|||
37755200|NCT01740401|69262296|FG000|Overall Study|Adverse Event|2|||
37755201|NCT01740401|69262296|FG000|Overall Study|Did not reach primary endpoint|2|||
37755202|NCT01711619|69262317|FG000|Overall Study|Early study termination|10|||
37755203|NCT01711619|69262318|FG001|Overall Study|Early study termination|14|||
37755204|NCT01711619|69262317|FG000|Overall Study|Withdrawal by Subject|3|||
37755205|NCT01711619|69262318|FG001|Overall Study|Withdrawal by Subject|7|||
37755206|NCT01711619|69262317|FG000|Overall Study|Protocol Violation|2|||
37755207|NCT01711619|69262318|FG001|Overall Study|Protocol Violation|3|||
37755208|NCT01711619|69262317|FG000|Overall Study|Adverse Event|2|||
37755209|NCT01711619|69262318|FG001|Overall Study|Adverse Event|0|||
37755210|NCT01711619|69262317|FG000|Overall Study|Lost to Follow-up|1|||
37755211|NCT01711619|69262318|FG001|Overall Study|Lost to Follow-up|0|||
37755212|NCT01710527|69262333|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
37755213|NCT01710527|69262334|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
37755214|NCT01706939|69262342|FG000|Pre Randomization|Screen Failure|1|||
37755215|NCT01706939|69262343|FG001|Pre Randomization|Screen Failure|0|||
37755216|NCT01706939|69262344|FG002|Pre Randomization|Screen Failure|0|||
37755217|NCT01706939|69262342|FG000|Pre Randomization|Ineligible for Randomization|1|||
37755218|NCT01706939|69262343|FG001|Pre Randomization|Ineligible for Randomization|0|||
37755219|NCT01706939|69262344|FG002|Pre Randomization|Ineligible for Randomization|0|||
37755220|NCT01706939|69262342|FG000|Pre Randomization|Withdrawal by Subject|1|||
37755221|NCT01706939|69262343|FG001|Pre Randomization|Withdrawal by Subject|0|||
37755222|NCT01706939|69262344|FG002|Pre Randomization|Withdrawal by Subject|0|||
37755223|NCT01706939|69262342|FG000|Randomization|Insufficient QoL survey compliance|0|||
37755224|NCT01706939|69262343|FG001|Randomization|Insufficient QoL survey compliance|1|||
37755225|NCT01706939|69262344|FG002|Randomization|Insufficient QoL survey compliance|1|||
37755226|NCT01706939|69262342|FG000|Randomization|Progression of disease|0|||
37755227|NCT01706939|69262343|FG001|Randomization|Progression of disease|2|||
37755228|NCT01706939|69262344|FG002|Randomization|Progression of disease|1|||
37755229|NCT01709903|69262353|FG000|Overall Study|administrative problems|2|||
37755230|NCT01709903|69262354|FG001|Overall Study|administrative problems|6|||
37755231|NCT01709903|69262353|FG000|Overall Study|Abnormal test procedure results|1|||
37755232|NCT01709903|69262354|FG001|Overall Study|Abnormal test procedure results|0|||
37755233|NCT01709903|69262353|FG000|Overall Study|In ability to use device|1|||
37755234|NCT01709903|69262354|FG001|Overall Study|In ability to use device|1|||
37755235|NCT01709903|69262353|FG000|Overall Study|no longer needed study drug|0|||
37755236|NCT01709903|69262354|FG001|Overall Study|no longer needed study drug|1|||
37755237|NCT01709903|69262353|FG000|Overall Study|Lost to Follow-up|0|||
37664355|NCT01597245|69137077|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
37664356|NCT01597245|69137078|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
37664357|NCT01597245|69137079|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
37755238|NCT01709903|69262354|FG001|Overall Study|Lost to Follow-up|2|||
37755239|NCT01709903|69262353|FG000|Overall Study|Death|2|||
37755240|NCT01709903|69262354|FG001|Overall Study|Death|0|||
37755241|NCT01709903|69262353|FG000|Overall Study|Protocol Violation|3|||
37755242|NCT01709903|69262354|FG001|Overall Study|Protocol Violation|2|||
37755243|NCT01709903|69262353|FG000|Overall Study|Lack of Efficacy|3|||
37755244|NCT01709903|69262354|FG001|Overall Study|Lack of Efficacy|3|||
37858056|NCT01302041|69541322|FG000|Overall Study|Death|5|||
37858057|NCT01302041|69541322|FG000|Overall Study|Withdrawal by Subject|4|||
37858058|NCT01302041|69541322|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
37858059|NCT01302041|69541322|FG000|Overall Study|Other-Miscellaneous Reason|2|||
37858060|NCT01301729|69541327|FG000|Overall Study|Withdrawal by Subject|2|||
37858061|NCT01301729|69541327|FG000|Overall Study|Participant did not Return for Treatment|1|||
37858062|NCT01301729|69541327|FG000|Overall Study|Violated Selection Criteria|1|||
37858063|NCT01187043|69541337|FG000|Overall Study|Adverse Event|0|||
37858064|NCT01187043|69541338|FG001|Overall Study|Adverse Event|0|||
37858065|NCT01187043|69541339|FG002|Overall Study|Adverse Event|0|||
37858066|NCT01187043|69541340|FG003|Overall Study|Adverse Event|0|||
37858067|NCT01187043|69541341|FG004|Overall Study|Adverse Event|1|||
37664358|NCT01597245|69137080|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
37664359|NCT01597245|69137081|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
37664360|NCT01597245|69137082|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
37664361|NCT01597245|69137083|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
37664362|NCT01597245|69137084|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
37858068|NCT01187043|69541337|FG000|Overall Study|Unable to make scheduled visits|1|||
37858069|NCT01187043|69541338|FG001|Overall Study|Unable to make scheduled visits|0|||
37858070|NCT01187043|69541339|FG002|Overall Study|Unable to make scheduled visits|4|||
37858071|NCT01187043|69541340|FG003|Overall Study|Unable to make scheduled visits|0|||
37858072|NCT01187043|69541341|FG004|Overall Study|Unable to make scheduled visits|1|||
37858073|NCT01186809|69541353|FG000|Overall Study|Death|30|||
37755245|NCT01709903|69262353|FG000|Overall Study|Withdrawal by Subject|6|||
37755246|NCT01709903|69262354|FG001|Overall Study|Withdrawal by Subject|6|||
37923381|NCT03704064|69610198|FG000|Overall Study|No longer available for study visits|0|||
37664363|NCT01597245|69137085|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
37664364|NCT01597245|69137086|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
37664365|NCT01597245|69137087|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
37664366|NCT01597245|69137088|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
37664367|NCT01597245|69137089|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
37664368|NCT01597245|69137090|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
37664369|NCT01597245|69137091|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
37664370|NCT01597245|69137092|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
37664371|NCT01597245|69137093|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
37664372|NCT01597245|69137094|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
37664373|NCT01597245|69137074|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
37664374|NCT01597245|69137075|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
37664375|NCT01597245|69137076|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
37664376|NCT01597245|69137077|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
37664377|NCT01597245|69137078|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
37664378|NCT01597245|69137079|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
37664379|NCT01597245|69137080|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
37664380|NCT01597245|69137081|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
37664381|NCT01597245|69137082|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
37664382|NCT01597245|69137083|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
37664383|NCT01597245|69137084|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
37664384|NCT01597245|69137085|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
37664385|NCT01597245|69137086|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
37664386|NCT01597245|69137087|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
37664387|NCT01597245|69137088|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
37664388|NCT01597245|69137089|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
37664389|NCT01597245|69137090|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
37664390|NCT01597245|69137091|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
37664391|NCT01597245|69137092|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
37664392|NCT01597245|69137093|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
37664393|NCT01597245|69137094|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
37664394|NCT01597245|69137074|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
37664395|NCT01597245|69137075|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
37664396|NCT01597245|69137076|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
37664397|NCT01597245|69137077|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
37664398|NCT01597245|69137078|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
37664399|NCT01597245|69137079|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
37664400|NCT01597245|69137080|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
37664401|NCT01597245|69137081|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
37664402|NCT01597245|69137082|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
37664403|NCT01597245|69137083|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
37664404|NCT01597245|69137084|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
37664405|NCT01597245|69137085|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
37664406|NCT01597245|69137086|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
37664407|NCT01597245|69137087|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
37664408|NCT01597245|69137088|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
37664409|NCT01597245|69137089|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
37664410|NCT01597245|69137090|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
37664411|NCT01597245|69137091|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
37664412|NCT01597245|69137092|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
37664413|NCT01597245|69137093|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
37664414|NCT01597245|69137094|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
37664415|NCT01597245|69137074|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
37664416|NCT01597245|69137075|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
37664417|NCT01597245|69137076|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
37664418|NCT01597245|69137077|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
37664419|NCT01597245|69137078|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
37664420|NCT01597245|69137079|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
37664421|NCT01597245|69137080|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
37664422|NCT01597245|69137081|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
37664423|NCT01597245|69137082|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
37664424|NCT01597245|69137083|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
37664425|NCT01597245|69137084|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
37664426|NCT01597245|69137085|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
37755247|NCT01709903|69262353|FG000|Overall Study|Adverse Event|11|||
37664427|NCT01597245|69137086|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
37664428|NCT01597245|69137087|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
37664429|NCT01597245|69137088|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
37664430|NCT01597245|69137089|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
37664431|NCT01597245|69137090|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
37664432|NCT01597245|69137091|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
37664433|NCT01597245|69137092|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
37664434|NCT01597245|69137093|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
37664435|NCT01597245|69137094|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
37664436|NCT01597245|69137074|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
37664437|NCT01597245|69137075|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
37664438|NCT01597245|69137076|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
37664439|NCT01597245|69137077|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
37664440|NCT01597245|69137078|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
37664441|NCT01597245|69137079|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
37664442|NCT01597245|69137080|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
37755248|NCT01709903|69262354|FG001|Overall Study|Adverse Event|18|||
37755249|NCT04492618|69262360|FG000|Overall Study|Withdrawal by Subject|1|||
37755250|NCT04978090|69262364|FG000|Overall Study|unable to adequately fit device|2|||
37755251|NCT04677504|69262370|FG000|Overall Study|Death|31|||
37755252|NCT04677504|69262371|FG001|Overall Study|Death|24|||
37755253|NCT04677504|69262370|FG000|Overall Study|Progressive Disease|1|||
37755254|NCT04677504|69262371|FG001|Overall Study|Progressive Disease|0|||
37755255|NCT04677504|69262370|FG000|Overall Study|Symptomatic Deterioration|1|||
37755256|NCT04677504|69262371|FG001|Overall Study|Symptomatic Deterioration|0|||
37755257|NCT04677504|69262370|FG000|Overall Study|Withdrawal by Subject|2|||
37755258|NCT04677504|69262371|FG001|Overall Study|Withdrawal by Subject|5|||
37755259|NCT04677504|69262370|FG000|Overall Study|Ongoing in study|48|||
37664443|NCT01597245|69137081|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
37664444|NCT01597245|69137082|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
37664445|NCT01597245|69137083|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
37664446|NCT01597245|69137084|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
37755260|NCT04677504|69262371|FG001|Overall Study|Ongoing in study|50|||
37755261|NCT04635631|69262379|FG000|Overall Study|Adverse Event|1|||
37755262|NCT04635631|69262379|FG000|Overall Study|Progressive disease|13|||
37755263|NCT04635631|69262379|FG000|Overall Study|Withdrawal by Subject|1|||
37755264|NCT04269395|69262396|FG000|Overall Study|Lost to Follow-up|1|||
37755265|NCT04269395|69262397|FG001|Overall Study|Lost to Follow-up|0|||
37755266|NCT04269395|69262396|FG000|Overall Study|Study terminated by Sponsor|13|||
37755267|NCT04269395|69262397|FG001|Overall Study|Study terminated by Sponsor|10|||
37755268|NCT04143594|69262407|FG000|Overall Study|Still on study|48|||
37755269|NCT04143594|69262408|FG001|Overall Study|Still on study|42|||
37755270|NCT04143594|69262409|FG002|Overall Study|Still on study|48|||
37755271|NCT04143594|69262410|FG003|Overall Study|Still on study|18|||
37755272|NCT04143594|69262407|FG000|Overall Study|Withdrew consent|0|||
37755273|NCT04143594|69262408|FG001|Overall Study|Withdrew consent|6|||
37755274|NCT04143594|69262409|FG002|Overall Study|Withdrew consent|1|||
37664447|NCT01597245|69137085|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
37664448|NCT01597245|69137086|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
37664449|NCT01597245|69137087|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
37664450|NCT01597245|69137088|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
37664451|NCT01597245|69137089|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
37664452|NCT01597245|69137090|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
37664453|NCT01597245|69137091|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
37755275|NCT04143594|69262410|FG003|Overall Study|Withdrew consent|1|||
37755276|NCT04143594|69262407|FG000|Overall Study|Lost to Follow-up|2|||
37755277|NCT04143594|69262408|FG001|Overall Study|Lost to Follow-up|2|||
37755278|NCT04143594|69262409|FG002|Overall Study|Lost to Follow-up|3|||
37755279|NCT04143594|69262410|FG003|Overall Study|Lost to Follow-up|0|||
37755280|NCT04143594|69262407|FG000|Overall Study|Investigator's discretion|1|||
37755281|NCT04143594|69262408|FG001|Overall Study|Investigator's discretion|2|||
37755282|NCT04143594|69262409|FG002|Overall Study|Investigator's discretion|0|||
37755283|NCT04143594|69262410|FG003|Overall Study|Investigator's discretion|0|||
37755284|NCT04143594|69262407|FG000|Overall Study|Lack of Efficacy|0|||
37755285|NCT04143594|69262408|FG001|Overall Study|Lack of Efficacy|1|||
37755286|NCT04143594|69262409|FG002|Overall Study|Lack of Efficacy|0|||
37755287|NCT04143594|69262410|FG003|Overall Study|Lack of Efficacy|0|||
37755288|NCT04143594|69262407|FG000|Overall Study|Protocol Violation|0|||
37858074|NCT01186419|69541359|FG000|Overall Study|Withdrawal by Subject|5|||
37755289|NCT04143594|69262408|FG001|Overall Study|Protocol Violation|0|||
37755290|NCT04143594|69262409|FG002|Overall Study|Protocol Violation|0|||
37858075|NCT01186419|69541360|FG001|Overall Study|Withdrawal by Subject|3|||
37755291|NCT04143594|69262410|FG003|Overall Study|Protocol Violation|1|||
37755292|NCT04046549|69262427|FG000|Overall Study|Adverse Event|1|||
37755293|NCT04046549|69262427|FG000|Overall Study|Physician Decision|1|||
37755294|NCT04046549|69262427|FG000|Overall Study|Withdrawal by Subject|3|||
37755295|NCT04046549|69262427|FG000|Overall Study|Other, Not Specified|5|||
37755296|NCT03403205|69262436|FG000|Overall Study|Randomized but not treated|1|||
37755297|NCT03403205|69262437|FG001|Overall Study|Randomized but not treated|0|||
37755298|NCT03403205|69262438|FG002|Overall Study|Randomized but not treated|4|||
37755299|NCT03403205|69262439|FG003|Overall Study|Randomized but not treated|2|||
37755300|NCT03403205|69262436|FG000|Overall Study|Withdrawal by Subject|4|||
37755301|NCT03403205|69262437|FG001|Overall Study|Withdrawal by Subject|2|||
37755302|NCT03403205|69262438|FG002|Overall Study|Withdrawal by Subject|2|||
37755303|NCT03403205|69262439|FG003|Overall Study|Withdrawal by Subject|1|||
37755304|NCT03403205|69262436|FG000|Overall Study|Adverse Event|4|||
37755305|NCT03403205|69262437|FG001|Overall Study|Adverse Event|0|||
37755306|NCT03403205|69262438|FG002|Overall Study|Adverse Event|1|||
37755307|NCT03403205|69262439|FG003|Overall Study|Adverse Event|0|||
37755308|NCT03403205|69262436|FG000|Overall Study|Death|1|||
37755309|NCT03403205|69262437|FG001|Overall Study|Death|0|||
37755310|NCT03403205|69262438|FG002|Overall Study|Death|1|||
37755311|NCT03403205|69262439|FG003|Overall Study|Death|0|||
37755312|NCT03403205|69262436|FG000|Overall Study|Lost to Follow-up|1|||
37755313|NCT03403205|69262437|FG001|Overall Study|Lost to Follow-up|1|||
37755314|NCT03403205|69262438|FG002|Overall Study|Lost to Follow-up|0|||
37755315|NCT03403205|69262439|FG003|Overall Study|Lost to Follow-up|0|||
37755316|NCT03403205|69262436|FG000|Overall Study|Pregnancy|1|||
37755317|NCT03403205|69262437|FG001|Overall Study|Pregnancy|0|||
37755318|NCT03403205|69262438|FG002|Overall Study|Pregnancy|0|||
37755319|NCT03403205|69262439|FG003|Overall Study|Pregnancy|0|||
37755320|NCT03403205|69262436|FG000|Overall Study|Protocol Deviation|0|||
37755321|NCT03403205|69262437|FG001|Overall Study|Protocol Deviation|1|||
37755322|NCT03403205|69262438|FG002|Overall Study|Protocol Deviation|0|||
37755323|NCT03403205|69262439|FG003|Overall Study|Protocol Deviation|0|||
37755324|NCT03375112|69262451|FG000|Overall Study|Withdrawal by Subject|3|||
37755325|NCT03375112|69262452|FG001|Overall Study|Withdrawal by Subject|0|||
37755326|NCT03298451|69262462|FG000|Overall Study|Death|275|||
37755327|NCT03298451|69262463|FG001|Overall Study|Death|260|||
37858076|NCT01186419|69541359|FG000|Overall Study|Adverse Event|1|||
37664454|NCT01597245|69137092|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
37664455|NCT01597245|69137093|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
37664456|NCT01597245|69137094|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
37664457|NCT01597245|69137074|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
37664458|NCT01597245|69137075|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
37664459|NCT01597245|69137076|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
37664460|NCT01597245|69137077|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
37664461|NCT01597245|69137078|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
37664462|NCT01597245|69137079|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
37664463|NCT01597245|69137080|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
37664464|NCT01597245|69137081|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
37664465|NCT01597245|69137082|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
37664466|NCT01597245|69137083|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
37664467|NCT01597245|69137084|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
37664468|NCT01597245|69137085|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
37664469|NCT01597245|69137086|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
37664470|NCT01597245|69137087|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
37664471|NCT01597245|69137088|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
37664472|NCT01597245|69137089|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
37664473|NCT01597245|69137090|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
37664474|NCT01597245|69137091|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
37664475|NCT01597245|69137092|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
37664476|NCT01597245|69137093|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
37664477|NCT01597245|69137094|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
37664478|NCT01597245|69137074|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
37755328|NCT03298451|69262464|FG002|Overall Study|Death|122|||
37755329|NCT03298451|69262465|FG003|Overall Study|Death|280|||
37755330|NCT03298451|69262462|FG000|Overall Study|Lost to Follow-up|1|||
37858077|NCT01186419|69541360|FG001|Overall Study|Adverse Event|2|||
37755331|NCT03298451|69262463|FG001|Overall Study|Lost to Follow-up|1|||
37755332|NCT03298451|69262464|FG002|Overall Study|Lost to Follow-up|0|||
37755333|NCT03298451|69262465|FG003|Overall Study|Lost to Follow-up|7|||
37755334|NCT03298451|69262462|FG000|Overall Study|Withdrawal by Subject|9|||
37755335|NCT03298451|69262463|FG001|Overall Study|Withdrawal by Subject|7|||
37755336|NCT03298451|69262464|FG002|Overall Study|Withdrawal by Subject|1|||
37755337|NCT03298451|69262465|FG003|Overall Study|Withdrawal by Subject|20|||
37755338|NCT03122106|69262475|FG000|Overall Study|Not enough tissue|1|||
37858078|NCT01186419|69541359|FG000|Overall Study|Physician Decision|0|||
37755339|NCT03122106|69262475|FG000|Overall Study|Disease progression during screening|2|||
37755340|NCT03122106|69262475|FG000|Overall Study|Poor RNA quality for vaccine|1|||
37755341|NCT02923739|69262483|FG000|Overall Study|Withdrawal by Subject|2|||
37755342|NCT02923739|69262484|FG001|Overall Study|Withdrawal by Subject|0|||
37755343|NCT02923739|69262485|FG002|Overall Study|Withdrawal by Subject|0|||
37755344|NCT02923739|69262486|FG003|Overall Study|Withdrawal by Subject|0|||
37755345|NCT02923739|69262483|FG000|Overall Study|Failed Screening|3|||
37755346|NCT02923739|69262484|FG001|Overall Study|Failed Screening|0|||
37755347|NCT02923739|69262485|FG002|Overall Study|Failed Screening|0|||
37755348|NCT02923739|69262486|FG003|Overall Study|Failed Screening|0|||
37755349|NCT02920892|69262498|FG000|Placebo Lead-In Period|Withdrawal by Subject|1|||
37755350|NCT02920892|69262499|FG001|Placebo Lead-In Period|Withdrawal by Subject|0|||
37755351|NCT02920892|69262500|FG002|Placebo Lead-In Period|Withdrawal by Subject|0|||
37755352|NCT02920892|69262498|FG000|Placebo Lead-In Period|Subject Ineligible|6|||
38033272|NCT04493684|69719211|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
38033273|NCT04493684|69719195|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
38033274|NCT04493684|69719196|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
38033275|NCT04493684|69719197|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
38033276|NCT04493684|69719198|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
37755353|NCT02920892|69262499|FG001|Placebo Lead-In Period|Subject Ineligible|0|||
37755354|NCT02920892|69262500|FG002|Placebo Lead-In Period|Subject Ineligible|0|||
37664479|NCT01597245|69137075|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
37664480|NCT01597245|69137076|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
37664481|NCT01597245|69137077|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
37664482|NCT01597245|69137078|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
37664483|NCT01597245|69137079|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
37664484|NCT01597245|69137080|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
37664485|NCT01597245|69137081|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
37664486|NCT01597245|69137082|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
37755355|NCT02920892|69262498|FG000|Placebo Lead-In Period|Subject Screen Fail|4|||
37755356|NCT02920892|69262499|FG001|Placebo Lead-In Period|Subject Screen Fail|0|||
38033277|NCT04493684|69719199|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
38033278|NCT04493684|69719200|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|1|||
37664487|NCT01597245|69137083|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
37664488|NCT01597245|69137084|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
37755357|NCT02920892|69262500|FG002|Placebo Lead-In Period|Subject Screen Fail|0|||
37755358|NCT02920892|69262498|FG000|Placebo-Controlled Period|Withdrawal by Subject|0|||
37755359|NCT02920892|69262499|FG001|Placebo-Controlled Period|Withdrawal by Subject|3|||
37755360|NCT02920892|69262500|FG002|Placebo-Controlled Period|Withdrawal by Subject|5|||
37664489|NCT01597245|69137085|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
37664490|NCT01597245|69137086|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
37664491|NCT01597245|69137087|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
37664492|NCT01597245|69137088|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
37664493|NCT01597245|69137089|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
37664494|NCT01597245|69137090|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
37664495|NCT01597245|69137091|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
37755361|NCT02920892|69262498|FG000|Placebo-Controlled Period|Physician Decision|0|||
37755362|NCT02920892|69262499|FG001|Placebo-Controlled Period|Physician Decision|0|||
37755363|NCT02920892|69262500|FG002|Placebo-Controlled Period|Physician Decision|1|||
37755364|NCT02920892|69262498|FG000|Placebo-Controlled Period|Lost to Follow-up|0|||
37755365|NCT02920892|69262499|FG001|Placebo-Controlled Period|Lost to Follow-up|0|||
37755366|NCT02920892|69262500|FG002|Placebo-Controlled Period|Lost to Follow-up|1|||
37755367|NCT02920892|69262498|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
37755368|NCT02920892|69262499|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
37755369|NCT02920892|69262500|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
37755370|NCT02920892|69262498|FG000|Open-Label Extension (OLE) Period|Study Drug Expiration|0|||
37755371|NCT02920892|69262499|FG001|Open-Label Extension (OLE) Period|Study Drug Expiration|4|||
37755372|NCT02920892|69262500|FG002|Open-Label Extension (OLE) Period|Study Drug Expiration|2|||
37755373|NCT02509052|69262511|FG000|Overall Study|Non compliance|0|||
37755374|NCT02509052|69262512|FG001|Overall Study|Non compliance|0|||
37755375|NCT02509052|69262513|FG002|Overall Study|Non compliance|1|||
37755376|NCT02365597|69262526|FG000|Overall Study|Lost to Follow-up|0|||
37755377|NCT02365597|69262527|FG001|Overall Study|Lost to Follow-up|1|||
37755378|NCT02365597|69262528|FG002|Overall Study|Lost to Follow-up|0|||
37755379|NCT02365597|69262529|FG003|Overall Study|Lost to Follow-up|1|||
37755380|NCT02365597|69262526|FG000|Overall Study|Withdrawal by Subject|1|||
37755381|NCT02365597|69262527|FG001|Overall Study|Withdrawal by Subject|8|||
37755382|NCT02365597|69262528|FG002|Overall Study|Withdrawal by Subject|5|||
37664496|NCT01597245|69137092|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
37664497|NCT01597245|69137093|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
37664498|NCT01597245|69137094|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
37664499|NCT01597245|69137074|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
37664500|NCT01597245|69137075|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
37664501|NCT01597245|69137076|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
37664502|NCT01597245|69137077|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
37664503|NCT01597245|69137078|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
37664504|NCT01597245|69137079|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
37664505|NCT01597245|69137080|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
37664506|NCT01597245|69137081|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
37664507|NCT01597245|69137082|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
37664508|NCT01597245|69137083|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
37664509|NCT01597245|69137084|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
37664510|NCT01597245|69137085|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
37664511|NCT01597245|69137086|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
37664512|NCT01597245|69137087|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
37755383|NCT02365597|69262529|FG003|Overall Study|Withdrawal by Subject|1|||
37755384|NCT02365597|69262526|FG000|Overall Study|Sponsor's decision|1|||
37755385|NCT02365597|69262527|FG001|Overall Study|Sponsor's decision|3|||
37755386|NCT02365597|69262528|FG002|Overall Study|Sponsor's decision|13|||
37755387|NCT02365597|69262529|FG003|Overall Study|Sponsor's decision|0|||
37755388|NCT02365597|69262526|FG000|Overall Study|Other|0|||
37755389|NCT02365597|69262527|FG001|Overall Study|Other|4|||
37755390|NCT02365597|69262528|FG002|Overall Study|Other|0|||
37755391|NCT02365597|69262529|FG003|Overall Study|Other|0|||
37755392|NCT02365597|69262526|FG000|Overall Study|Enrolled but not treated|0|||
37755393|NCT02365597|69262527|FG001|Overall Study|Enrolled but not treated|1|||
37755394|NCT02365597|69262528|FG002|Overall Study|Enrolled but not treated|1|||
37755395|NCT02365597|69262529|FG003|Overall Study|Enrolled but not treated|0|||
37755396|NCT02365597|69262526|FG000|Overall Study|Ongoing|0|||
37755397|NCT02365597|69262527|FG001|Overall Study|Ongoing|0|||
37755398|NCT02365597|69262528|FG002|Overall Study|Ongoing|0|||
37755399|NCT02365597|69262529|FG003|Overall Study|Ongoing|17|||
37755400|NCT02220894|69262546|FG000|Overall Study|Adverse Event|127|||
37755401|NCT02220894|69262547|FG001|Overall Study|Adverse Event|74|||
37755402|NCT02220894|69262546|FG000|Overall Study|Death|418|||
37755403|NCT02220894|69262547|FG001|Overall Study|Death|508|||
37755404|NCT02220894|69262546|FG000|Overall Study|Lost to Follow-up|0|||
37755405|NCT02220894|69262547|FG001|Overall Study|Lost to Follow-up|4|||
37755406|NCT02220894|69262546|FG000|Overall Study|Site Terminated by Sponsor|2|||
37755407|NCT02220894|69262547|FG001|Overall Study|Site Terminated by Sponsor|0|||
37755408|NCT02220894|69262546|FG000|Overall Study|Participation in Study Terminated by Sponsor|80|||
37755409|NCT02220894|69262547|FG001|Overall Study|Participation in Study Terminated by Sponsor|41|||
37755410|NCT02220894|69262546|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
37755411|NCT02220894|69262547|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
37755412|NCT02220894|69262546|FG000|Overall Study|Withdrawal by Subject|10|||
37755413|NCT02220894|69262547|FG001|Overall Study|Withdrawal by Subject|9|||
37755414|NCT02087423|69262557|FG000|Overall Study|Withdrawal by Subject|20|||
37755415|NCT02087423|69262558|FG001|Overall Study|Withdrawal by Subject|20|||
37755416|NCT02087423|69262559|FG002|Overall Study|Withdrawal by Subject|3|||
37755417|NCT02087423|69262557|FG000|Overall Study|Death|68|||
37755418|NCT02087423|69262558|FG001|Overall Study|Death|207|||
37755419|NCT02087423|69262559|FG002|Overall Study|Death|40|||
37755420|NCT02087423|69262557|FG000|Overall Study|Lost to Follow-up|0|||
37755421|NCT02087423|69262558|FG001|Overall Study|Lost to Follow-up|2|||
37755422|NCT02087423|69262559|FG002|Overall Study|Lost to Follow-up|0|||
37755423|NCT02087423|69262557|FG000|Overall Study|Terminated from study at final DCO|23|||
37755424|NCT02087423|69262558|FG001|Overall Study|Terminated from study at final DCO|36|||
37755425|NCT02087423|69262559|FG002|Overall Study|Terminated from study at final DCO|25|||
37755426|NCT02068092|69262569|FG000|Overall Study|Physician Decision|2|||
37755427|NCT02068092|69262569|FG000|Overall Study|Adverse Event|2|||
37755428|NCT02068092|69262569|FG000|Overall Study|Lost to Follow-up|4|||
37755429|NCT02068092|69262569|FG000|Overall Study|Withdrawal by Subject|2|||
37755430|NCT01959672|69262573|FG000|Overall Study|Death|1|||
37755431|NCT00071760|69262601|FG000|Overall Study|Adverse Event|2|||
37755432|NCT00071760|69262602|FG001|Overall Study|Adverse Event|1|||
37755433|NCT00071760|69262601|FG000|Overall Study|Lost to Follow-up|0|||
37664513|NCT01597245|69137088|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
37664514|NCT01597245|69137089|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
37755434|NCT00071760|69262602|FG001|Overall Study|Lost to Follow-up|3|||
37755435|NCT00071760|69262601|FG000|Overall Study|Protocol Violation|1|||
37755436|NCT00071760|69262602|FG001|Overall Study|Protocol Violation|0|||
37755437|NCT00071760|69262601|FG000|Overall Study|Withdrawal by Subject|0|||
37755438|NCT00071760|69262602|FG001|Overall Study|Withdrawal by Subject|1|||
37755439|NCT00071760|69262601|FG000|Overall Study|Insufficient Viral Load Response|1|||
37755440|NCT00071760|69262602|FG001|Overall Study|Insufficient Viral Load Response|1|||
37755441|NCT00071760|69262601|FG000|Overall Study|Lack of availability of RTV|1|||
37755442|NCT00071760|69262602|FG001|Overall Study|Lack of availability of RTV|0|||
37755443|NCT00071760|69262601|FG000|Overall Study|Physician Decision|2|||
37755444|NCT00071760|69262602|FG001|Overall Study|Physician Decision|1|||
37755445|NCT00071760|69262601|FG000|Overall Study|Relocation|0|||
37755446|NCT00071760|69262602|FG001|Overall Study|Relocation|1|||
37755447|NCT01605227|69262620|FG000|Overall Study|Did not receive study treatment|2|||
37755448|NCT01605227|69262621|FG001|Overall Study|Did not receive study treatment|3|||
37664515|NCT01597245|69137090|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
37664516|NCT01597245|69137091|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
37755449|NCT01605227|69262620|FG000|Overall Study|Adverse Event|228|||
37755450|NCT01605227|69262621|FG001|Overall Study|Adverse Event|42|||
37755451|NCT01605227|69262620|FG000|Overall Study|Progressive Disease|132|||
37755452|NCT01605227|69262621|FG001|Overall Study|Progressive Disease|128|||
37755453|NCT01605227|69262620|FG000|Overall Study|Clinical Deterioration|227|||
37755454|NCT01605227|69262621|FG001|Overall Study|Clinical Deterioration|133|||
37755455|NCT01605227|69262620|FG000|Overall Study|Lost to Follow-up|1|||
37755456|NCT01605227|69262621|FG001|Overall Study|Lost to Follow-up|0|||
37755457|NCT01605227|69262620|FG000|Overall Study|Protocol Violation|1|||
37755458|NCT01605227|69262621|FG001|Overall Study|Protocol Violation|0|||
37755459|NCT01605227|69262620|FG000|Overall Study|Physician Decision|9|||
37755460|NCT01605227|69262621|FG001|Overall Study|Physician Decision|7|||
37755461|NCT01605227|69262620|FG000|Overall Study|Withdrawal by Subject|18|||
37755462|NCT01605227|69262621|FG001|Overall Study|Withdrawal by Subject|14|||
37664517|NCT01597245|69137092|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
37664518|NCT01597245|69137093|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
37664519|NCT01597245|69137094|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
37664520|NCT01597245|69137074|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
37664521|NCT01597245|69137075|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
37664522|NCT01597245|69137076|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
37664523|NCT01597245|69137077|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
37664524|NCT01597245|69137078|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
37664525|NCT01597245|69137079|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
37664526|NCT01597245|69137080|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
37664527|NCT01597245|69137081|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
37664528|NCT01597245|69137082|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
37664529|NCT01597245|69137083|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
37664530|NCT01597245|69137084|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
37664531|NCT01597245|69137085|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
37664532|NCT01597245|69137086|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
37664533|NCT01597245|69137087|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
37664534|NCT01597245|69137088|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
37664535|NCT01597245|69137089|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
37664536|NCT01597245|69137090|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
37664537|NCT01597245|69137091|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
37664538|NCT01597245|69137092|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
37664539|NCT01597245|69137093|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
37664540|NCT01597245|69137094|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
37664541|NCT01597245|69137074|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
37664542|NCT01597245|69137075|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
37664543|NCT01597245|69137076|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
37664544|NCT01597245|69137077|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
37664545|NCT01597245|69137078|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
37664546|NCT01597245|69137079|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
37664547|NCT01597245|69137080|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
37664548|NCT01597245|69137081|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
37755463|NCT01605227|69262620|FG000|Overall Study|Sponsor Decision|2|||
37755464|NCT01605227|69262621|FG001|Overall Study|Sponsor Decision|0|||
37755465|NCT01605227|69262620|FG000|Overall Study|Started New Therapy|1|||
37755466|NCT01605227|69262621|FG001|Overall Study|Started New Therapy|0|||
37664549|NCT01597245|69137082|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
37664550|NCT01597245|69137083|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
37664551|NCT01597245|69137084|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
37755467|NCT01605227|69262620|FG000|Overall Study|Subject Decision|0|||
37755468|NCT01605227|69262621|FG001|Overall Study|Subject Decision|1|||
37755469|NCT01605227|69262620|FG000|Overall Study|Dose Held >6 weeks|0|||
37755470|NCT01605227|69262621|FG001|Overall Study|Dose Held >6 weeks|1|||
37755471|NCT01709513|69262630|FG000|Overall Study|Randomized but not treated|0|||
37755472|NCT01709513|69262631|FG001|Overall Study|Randomized but not treated|1|||
37755473|NCT01709513|69262632|FG002|Overall Study|Randomized but not treated|0|||
37755474|NCT01709513|69262630|FG000|Overall Study|Adverse Event|16|||
37755475|NCT01709513|69262631|FG001|Overall Study|Adverse Event|31|||
37755476|NCT01709513|69262632|FG002|Overall Study|Adverse Event|23|||
37755477|NCT01709513|69262630|FG000|Overall Study|Poor compliance to protocol|2|||
37755478|NCT01709513|69262631|FG001|Overall Study|Poor compliance to protocol|0|||
37755479|NCT01709513|69262632|FG002|Overall Study|Poor compliance to protocol|0|||
37755480|NCT01709513|69262630|FG000|Overall Study|Other|3|||
37755481|NCT01709513|69262631|FG001|Overall Study|Other|11|||
37755482|NCT01709513|69262632|FG002|Overall Study|Other|7|||
37755483|NCT01605071|69262645|FG000|Overall Study|Withdrawal by Subject|3|||
37755484|NCT01605071|69262646|FG001|Overall Study|Withdrawal by Subject|2|||
37755485|NCT02710422|69262656|FG000|Overall Study|Termination of study|9|||
37755486|NCT02710422|69262657|FG001|Overall Study|Termination of study|9|||
37755487|NCT01706159|69262667|FG000|Overall Study|Withdrawal Criteria|2|||
37664552|NCT01597245|69137085|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
37664553|NCT01597245|69137086|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
37664554|NCT01597245|69137087|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
37664555|NCT01597245|69137088|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
37755488|NCT01706159|69262668|FG001|Overall Study|Withdrawal Criteria|1|||
37755489|NCT01706159|69262667|FG000|Overall Study|Unclassified|6|||
37755490|NCT01706159|69262668|FG001|Overall Study|Unclassified|1|||
37755491|NCT01706003|69262676|FG000|Overall Study|Withdrawal by Subject|2|||
37755492|NCT01706003|69262677|FG001|Overall Study|Withdrawal by Subject|0|||
37755493|NCT01706003|69262676|FG000|Overall Study|Not scheduled|3|||
37755494|NCT01706003|69262677|FG001|Overall Study|Not scheduled|0|||
37755495|NCT01706003|69262676|FG000|Overall Study|Lost to Follow-up|6|||
37755496|NCT01706003|69262677|FG001|Overall Study|Lost to Follow-up|4|||
37755497|NCT01705691|69262685|FG000|Overall Study|Death|1|||
37755498|NCT01705691|69262686|FG001|Overall Study|Death|2|||
37755499|NCT01705691|69262685|FG000|Overall Study|Withdrawal by Subject|1|||
37755500|NCT01705691|69262686|FG001|Overall Study|Withdrawal by Subject|2|||
37755501|NCT01705691|69262685|FG000|Overall Study|Lost to Follow-up|1|||
37755502|NCT01705691|69262686|FG001|Overall Study|Lost to Follow-up|1|||
38033279|NCT04493684|69719201|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
38033280|NCT04493684|69719202|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
38033281|NCT04493684|69719203|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
38033282|NCT04493684|69719204|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
38033283|NCT04493684|69719205|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
38033284|NCT04493684|69719206|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
38033285|NCT04493684|69719207|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
38033286|NCT04493684|69719208|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
38033287|NCT04493684|69719209|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
38033288|NCT04493684|69719210|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
38033289|NCT04493684|69719211|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
38033290|NCT04493684|69719195|FG000|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
38033291|NCT04493684|69719196|FG001|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
38033292|NCT04493684|69719197|FG002|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
38033293|NCT04493684|69719198|FG003|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
38033294|NCT04493684|69719199|FG004|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
38033295|NCT04493684|69719200|FG005|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
38033296|NCT04493684|69719201|FG006|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
37664556|NCT01597245|69137089|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
37664557|NCT01597245|69137090|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
37664558|NCT01597245|69137091|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
37664559|NCT01597245|69137092|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
37664560|NCT01597245|69137093|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
37664561|NCT01597245|69137094|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
37664562|NCT01597245|69137074|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
37664563|NCT01597245|69137075|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
37664564|NCT01597245|69137076|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
37755503|NCT01705691|69262685|FG000|Overall Study|Other|0|||
37755504|NCT01705691|69262686|FG001|Overall Study|Other|1|||
37755505|NCT03766906|69262692|FG000|Overall Study|Withdrawal by Subject|6|||
37755506|NCT01705145|69262696|FG000|Part B|Adverse Event|1|||
37755507|NCT01704755|69262714|FG000|Overall Study|Adverse Event|4|||
37755508|NCT01704755|69262715|FG001|Overall Study|Adverse Event|1|||
37755509|NCT01704755|69262714|FG000|Overall Study|Lost to Follow-up|3|||
37755510|NCT01704755|69262715|FG001|Overall Study|Lost to Follow-up|4|||
37755511|NCT01704755|69262714|FG000|Overall Study|Withdrew consent|1|||
37664565|NCT01597245|69137077|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
37664566|NCT01597245|69137078|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
37664567|NCT01597245|69137079|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
37664568|NCT01597245|69137080|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
37664569|NCT01597245|69137081|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
37664570|NCT01597245|69137082|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
37664571|NCT01597245|69137083|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
37664572|NCT01597245|69137084|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
37664573|NCT01597245|69137085|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
37664574|NCT01597245|69137086|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
37664575|NCT01597245|69137087|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
37664576|NCT01597245|69137088|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
37664577|NCT01597245|69137089|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
37664578|NCT01597245|69137090|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
37664579|NCT01597245|69137091|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
37755512|NCT01704755|69262715|FG001|Overall Study|Withdrew consent|1|||
37755513|NCT01704755|69262714|FG000|Overall Study|Other (not specified)|3|||
37755514|NCT01704755|69262715|FG001|Overall Study|Other (not specified)|1|||
37755515|NCT01704755|69262714|FG000|Overall Study|Withdrew consent and personal issues|1|||
37755516|NCT01704755|69262715|FG001|Overall Study|Withdrew consent and personal issues|0|||
37755517|NCT01704599|69262721|FG000|Overall Study|Adverse Event|1|||
37858079|NCT01186419|69541360|FG001|Overall Study|Physician Decision|3|||
37858080|NCT01186419|69541359|FG000|Overall Study|Other|1|||
37858081|NCT01186419|69541360|FG001|Overall Study|Other|1|||
37858082|NCT01301027|69541367|FG000|Overall Study|Physician Decision|2|||
37858083|NCT01301027|69541368|FG001|Overall Study|Physician Decision|0|||
37858084|NCT01301027|69541367|FG000|Overall Study|Withdrawal by Subject|2|||
37858085|NCT01301027|69541368|FG001|Overall Study|Withdrawal by Subject|3|||
37858086|NCT01301027|69541367|FG000|Overall Study|Adverse Event|0|||
37858087|NCT01301027|69541368|FG001|Overall Study|Adverse Event|2|||
37858088|NCT01301027|69541367|FG000|Overall Study|Fracture|1|||
37755518|NCT03599518|69262753|FG000|Overall Study|Clinical progression|0|||
37755519|NCT03599518|69262754|FG001|Overall Study|Clinical progression|0|||
37755520|NCT03599518|69262755|FG002|Overall Study|Clinical progression|0|||
37755521|NCT03599518|69262756|FG003|Overall Study|Clinical progression|0|||
37755522|NCT03599518|69262757|FG004|Overall Study|Clinical progression|1|||
37755523|NCT03599518|69262753|FG000|Overall Study|Adverse Event|0|||
37755524|NCT03599518|69262754|FG001|Overall Study|Adverse Event|0|||
37755525|NCT03599518|69262755|FG002|Overall Study|Adverse Event|0|||
37755526|NCT03599518|69262756|FG003|Overall Study|Adverse Event|0|||
37755527|NCT03599518|69262757|FG004|Overall Study|Adverse Event|1|||
37858089|NCT01301027|69541368|FG001|Overall Study|Fracture|3|||
37858090|NCT01301027|69541367|FG000|Overall Study|Transplant|0|||
37858091|NCT01301027|69541368|FG001|Overall Study|Transplant|2|||
37858092|NCT01301027|69541367|FG000|Overall Study|Volume Overload|3|||
37858093|NCT01301027|69541368|FG001|Overall Study|Volume Overload|0|||
37858094|NCT01185639|69541374|FG000|Overall Study|Progressed and didn't receive therapy|2|||
37858095|NCT01185561|69541380|FG000|Overall Study|Lost to Follow-up|0|||
37858096|NCT01185561|69541381|FG001|Overall Study|Lost to Follow-up|4|||
37858097|NCT01185561|69541380|FG000|Overall Study|Withdrawal by Subject|2|||
37858098|NCT01185561|69541381|FG001|Overall Study|Withdrawal by Subject|8|||
37858099|NCT01185249|69541387|FG000|Overall Study|Patients discharged or change in status|42|||
37858100|NCT01184859|69541397|FG000|Period 1: Single Dose|Insufficient urine production|0|||
37858101|NCT01184859|69541398|FG001|Period 1: Single Dose|Insufficient urine production|1|||
37858102|NCT01184859|69541399|FG002|Period 1: Single Dose|Insufficient urine production|0|||
37858103|NCT01184859|69541400|FG003|Period 1: Single Dose|Insufficient urine production|0|||
37858104|NCT01184859|69541401|FG004|Period 1: Single Dose|Insufficient urine production|0|||
37858105|NCT01184859|69541397|FG000|Period 1: Single Dose|Protocol Violation|0|||
38033297|NCT04493684|69719202|FG007|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
37664580|NCT01597245|69137092|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
37664581|NCT01597245|69137093|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
37664582|NCT01597245|69137094|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
37858106|NCT01184859|69541398|FG001|Period 1: Single Dose|Protocol Violation|1|||
37858107|NCT01184859|69541399|FG002|Period 1: Single Dose|Protocol Violation|0|||
37858108|NCT01184859|69541400|FG003|Period 1: Single Dose|Protocol Violation|0|||
37858109|NCT01184859|69541401|FG004|Period 1: Single Dose|Protocol Violation|0|||
37858110|NCT01184859|69541397|FG000|Period 1: Single Dose|Adverse Event|0|||
37858111|NCT01184859|69541398|FG001|Period 1: Single Dose|Adverse Event|0|||
37858112|NCT01184859|69541399|FG002|Period 1: Single Dose|Adverse Event|0|||
37755528|NCT03599518|69262753|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
37858113|NCT01184859|69541400|FG003|Period 1: Single Dose|Adverse Event|0|||
37755529|NCT03599518|69262754|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
37755530|NCT03599518|69262755|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
37755531|NCT03599518|69262756|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
37755532|NCT03599518|69262757|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
37755533|NCT03599518|69262753|FG000|Overall Study|Participant withdrawal from study treatment|0|||
37755534|NCT03599518|69262754|FG001|Overall Study|Participant withdrawal from study treatment|0|||
37755535|NCT03599518|69262755|FG002|Overall Study|Participant withdrawal from study treatment|1|||
37755536|NCT03599518|69262756|FG003|Overall Study|Participant withdrawal from study treatment|0|||
37755537|NCT03599518|69262757|FG004|Overall Study|Participant withdrawal from study treatment|0|||
37755538|NCT02709486|69262834|FG000|Overall Study|Adverse Event|2|||
37755539|NCT02709486|69262835|FG001|Overall Study|Adverse Event|5|||
37755540|NCT02709486|69262836|FG002|Overall Study|Adverse Event|3|||
37858114|NCT01184859|69541401|FG004|Period 1: Single Dose|Adverse Event|1|||
37858115|NCT01184859|69541397|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
37858116|NCT01184859|69541398|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
38033298|NCT04493684|69719203|FG008|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
38033299|NCT04493684|69719204|FG009|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
38033300|NCT04493684|69719205|FG010|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
38033301|NCT04493684|69719206|FG011|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|1|||
38033302|NCT04493684|69719207|FG012|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
38033303|NCT04493684|69719208|FG013|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
38033304|NCT04493684|69719209|FG014|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
38033305|NCT04493684|69719210|FG015|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
38033306|NCT04493684|69719211|FG016|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
38033307|NCT04493684|69719195|FG000|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
38033308|NCT04493684|69719196|FG001|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
38033309|NCT04493684|69719197|FG002|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
38033310|NCT04493684|69719198|FG003|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
38033311|NCT04493684|69719199|FG004|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
38033312|NCT04493684|69719200|FG005|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
37664583|NCT01597245|69137074|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
37664584|NCT01597245|69137075|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
37664585|NCT01597245|69137076|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
37664586|NCT01597245|69137077|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
37664587|NCT01597245|69137078|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
37664588|NCT01597245|69137079|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
37858117|NCT01184859|69541399|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
37858118|NCT01184859|69541400|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
37858119|NCT01184859|69541401|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
37858120|NCT01184859|69541397|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
37858121|NCT01184859|69541398|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
37858122|NCT01184859|69541399|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
37858123|NCT01184859|69541400|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
37664589|NCT01597245|69137080|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
37664590|NCT01597245|69137081|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
37664591|NCT01597245|69137082|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
37664592|NCT01597245|69137083|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
37664593|NCT01597245|69137084|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
37664594|NCT01597245|69137085|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
37664595|NCT01597245|69137086|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
37664596|NCT01597245|69137087|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
37664597|NCT01597245|69137088|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
37664598|NCT01597245|69137089|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
37664599|NCT01597245|69137090|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
37664600|NCT01597245|69137091|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
37664601|NCT01597245|69137092|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
37755541|NCT02709486|69262834|FG000|Overall Study|Death|0|||
37755542|NCT02709486|69262835|FG001|Overall Study|Death|0|||
37858124|NCT01184859|69541401|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
38033313|NCT04493684|69719201|FG006|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
38033314|NCT04493684|69719202|FG007|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
38033315|NCT04493684|69719203|FG008|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
38033316|NCT04493684|69719204|FG009|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
37755543|NCT02709486|69262836|FG002|Overall Study|Death|2|||
37664602|NCT01597245|69137093|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
37664603|NCT01597245|69137094|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
37664604|NCT01597245|69137074|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
37664605|NCT01597245|69137075|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
37664606|NCT01597245|69137076|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
37664607|NCT01597245|69137077|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
37664608|NCT01597245|69137078|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
37664609|NCT01597245|69137079|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
37664610|NCT01597245|69137080|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
37755544|NCT02709486|69262834|FG000|Overall Study|Insufficient clinical response|7|||
37755545|NCT02709486|69262835|FG001|Overall Study|Insufficient clinical response|3|||
37755546|NCT02709486|69262836|FG002|Overall Study|Insufficient clinical response|3|||
37755547|NCT02709486|69262834|FG000|Overall Study|Lost to Follow-up|3|||
37755548|NCT02709486|69262835|FG001|Overall Study|Lost to Follow-up|2|||
37755549|NCT02709486|69262836|FG002|Overall Study|Lost to Follow-up|2|||
37755550|NCT02709486|69262834|FG000|Overall Study|Other|0|||
37755551|NCT02709486|69262835|FG001|Overall Study|Other|2|||
37755552|NCT02709486|69262836|FG002|Overall Study|Other|3|||
37755553|NCT02709486|69262834|FG000|Overall Study|Withdrawal by Subject|32|||
37664611|NCT01597245|69137081|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
37664612|NCT01597245|69137082|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
37664613|NCT01597245|69137083|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
37664614|NCT01597245|69137084|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
37664615|NCT01597245|69137085|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
37664616|NCT01597245|69137086|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
37755554|NCT02709486|69262835|FG001|Overall Study|Withdrawal by Subject|22|||
37755555|NCT02709486|69262836|FG002|Overall Study|Withdrawal by Subject|32|||
37755556|NCT03110770|69262853|FG000|Overall Study|Death|1|||
37755557|NCT03110770|69262854|FG001|Overall Study|Death|0|||
37755558|NCT03110770|69262855|FG002|Overall Study|Death|0|||
37664617|NCT01597245|69137087|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
37664618|NCT01597245|69137088|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
37664619|NCT01597245|69137089|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
37755559|NCT03110770|69262856|FG003|Overall Study|Death|1|||
37755560|NCT03110770|69262857|FG004|Overall Study|Death|0|||
37755561|NCT03110770|69262853|FG000|Overall Study|Enrolled but did not receive product|0|||
37755562|NCT03110770|69262854|FG001|Overall Study|Enrolled but did not receive product|0|||
37755563|NCT03110770|69262855|FG002|Overall Study|Enrolled but did not receive product|0|||
37755564|NCT03110770|69262856|FG003|Overall Study|Enrolled but did not receive product|8|||
37755565|NCT03110770|69262857|FG004|Overall Study|Enrolled but did not receive product|7|||
37755566|NCT03110770|69262853|FG000|Overall Study|Lost to Follow-up|0|||
37755567|NCT03110770|69262854|FG001|Overall Study|Lost to Follow-up|0|||
37755568|NCT03110770|69262855|FG002|Overall Study|Lost to Follow-up|0|||
37755569|NCT03110770|69262856|FG003|Overall Study|Lost to Follow-up|53|||
37755570|NCT03110770|69262857|FG004|Overall Study|Lost to Follow-up|45|||
37755571|NCT03110770|69262853|FG000|Overall Study|Investigator Decision|0|||
37755572|NCT03110770|69262854|FG001|Overall Study|Investigator Decision|0|||
37755573|NCT03110770|69262855|FG002|Overall Study|Investigator Decision|0|||
37755574|NCT03110770|69262856|FG003|Overall Study|Investigator Decision|5|||
37755575|NCT03110770|69262857|FG004|Overall Study|Investigator Decision|3|||
37755576|NCT03110770|69262853|FG000|Overall Study|Withdrawal by Subject|0|||
37755577|NCT03110770|69262854|FG001|Overall Study|Withdrawal by Subject|0|||
37755578|NCT03110770|69262855|FG002|Overall Study|Withdrawal by Subject|0|||
37858125|NCT01184079|69541420|FG000|Overall Study|Lost to Follow-up|14|||
37858126|NCT01184079|69541421|FG001|Overall Study|Lost to Follow-up|2|||
37858127|NCT01190865|69541429|FG000|Overall Study|Withdrawal by Subject|1|||
37858128|NCT01190865|69541429|FG000|Overall Study|Non-compliance|2|||
37858129|NCT01190475|69541436|FG000|Overall Study|Withdrawal by Subject|0|||
37858130|NCT01190475|69541437|FG001|Overall Study|Withdrawal by Subject|0|||
37858131|NCT01190475|69541438|FG002|Overall Study|Withdrawal by Subject|1|||
37858132|NCT01289990|69541461|FG000|Overall Study|Death|0|||
37858133|NCT01289990|69541462|FG001|Overall Study|Death|0|||
37858134|NCT01289990|69541463|FG002|Overall Study|Death|0|||
37858135|NCT01289990|69541464|FG003|Overall Study|Death|1|||
37755579|NCT03110770|69262856|FG003|Overall Study|Withdrawal by Subject|24|||
37755580|NCT03110770|69262857|FG004|Overall Study|Withdrawal by Subject|24|||
37755581|NCT03110770|69262853|FG000|Overall Study|Moved from area|5|||
37755582|NCT03110770|69262854|FG001|Overall Study|Moved from area|0|||
37755583|NCT03110770|69262855|FG002|Overall Study|Moved from area|2|||
37755584|NCT03110770|69262856|FG003|Overall Study|Moved from area|42|||
37858136|NCT01289990|69541465|FG004|Overall Study|Death|2|||
37755585|NCT03110770|69262857|FG004|Overall Study|Moved from area|43|||
37858137|NCT01289990|69541466|FG005|Overall Study|Death|1|||
37858138|NCT01289990|69541467|FG006|Overall Study|Death|0|||
37755586|NCT03110770|69262853|FG000|Overall Study|Illness/Injury unrelated to product|0|||
37755587|NCT03110770|69262854|FG001|Overall Study|Illness/Injury unrelated to product|0|||
37755588|NCT03110770|69262855|FG002|Overall Study|Illness/Injury unrelated to product|0|||
37755589|NCT03110770|69262856|FG003|Overall Study|Illness/Injury unrelated to product|0|||
37755590|NCT03110770|69262857|FG004|Overall Study|Illness/Injury unrelated to product|1|||
37755591|NCT00703326|69263063|FG000|Overall Study|Lost to Follow-up|47|||
37755592|NCT00703326|69263064|FG001|Overall Study|Lost to Follow-up|18|||
37755593|NCT00703326|69263063|FG000|Overall Study|Withdrawal by Subject|54|||
37755594|NCT00703326|69263064|FG001|Overall Study|Withdrawal by Subject|20|||
37755595|NCT00703326|69263063|FG000|Overall Study|Adverse Event|1|||
37755596|NCT00703326|69263064|FG001|Overall Study|Adverse Event|0|||
37755597|NCT04868500|69263117|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
37755598|NCT04868500|69263118|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
37755599|NCT04868500|69263117|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
37755600|NCT04868500|69263118|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
37755601|NCT04372186|69263126|FG000|Overall Study|Death|24|||
37755602|NCT04372186|69263127|FG001|Overall Study|Death|11|||
37755603|NCT04372186|69263126|FG000|Overall Study|Transferred to a different facility for care|0|||
37755604|NCT04372186|69263127|FG001|Overall Study|Transferred to a different facility for care|2|||
37755605|NCT04317040|69263157|FG000|Overall Study|Lost to Follow-up|2|||
37755606|NCT04317040|69263158|FG001|Overall Study|Lost to Follow-up|0|||
37755607|NCT04317040|69263157|FG000|Overall Study|Death|16|||
37755608|NCT04317040|69263158|FG001|Overall Study|Death|18|||
37755609|NCT04317040|69263157|FG000|Overall Study|Withdrawal by Subject|0|||
37755610|NCT04317040|69263158|FG001|Overall Study|Withdrawal by Subject|1|||
37755611|NCT04317040|69263157|FG000|Overall Study|Incomplete assessments|0|||
37755612|NCT04317040|69263158|FG001|Overall Study|Incomplete assessments|1|||
37755613|NCT00703014|69263238|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
37858139|NCT01289990|69541468|FG007|Overall Study|Death|0|||
37858140|NCT01289990|69541469|FG008|Overall Study|Death|0|||
37858141|NCT01289990|69541470|FG009|Overall Study|Death|0|||
37858142|NCT01289990|69541471|FG010|Overall Study|Death|0|||
37858143|NCT01289990|69541472|FG011|Overall Study|Death|1|||
37858144|NCT01289990|69541473|FG012|Overall Study|Death|0|||
37858145|NCT01289990|69541461|FG000|Overall Study|Lost to Follow-up|3|||
37858146|NCT01289990|69541462|FG001|Overall Study|Lost to Follow-up|2|||
37858147|NCT01289990|69541463|FG002|Overall Study|Lost to Follow-up|5|||
37858148|NCT01289990|69541464|FG003|Overall Study|Lost to Follow-up|5|||
37858149|NCT01289990|69541465|FG004|Overall Study|Lost to Follow-up|3|||
37858150|NCT01289990|69541466|FG005|Overall Study|Lost to Follow-up|4|||
37858151|NCT01289990|69541467|FG006|Overall Study|Lost to Follow-up|2|||
37858152|NCT01289990|69541468|FG007|Overall Study|Lost to Follow-up|2|||
37858153|NCT01289990|69541469|FG008|Overall Study|Lost to Follow-up|1|||
37858154|NCT01289990|69541470|FG009|Overall Study|Lost to Follow-up|4|||
37858155|NCT01289990|69541471|FG010|Overall Study|Lost to Follow-up|2|||
37858156|NCT01289990|69541472|FG011|Overall Study|Lost to Follow-up|1|||
37858157|NCT01289990|69541473|FG012|Overall Study|Lost to Follow-up|2|||
37858158|NCT01289990|69541461|FG000|Overall Study|Withdrawal by Subject|15|||
37755614|NCT00703014|69263239|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
37858159|NCT01289990|69541462|FG001|Overall Study|Withdrawal by Subject|14|||
37858160|NCT01289990|69541463|FG002|Overall Study|Withdrawal by Subject|12|||
37858161|NCT01289990|69541464|FG003|Overall Study|Withdrawal by Subject|13|||
37858162|NCT01289990|69541465|FG004|Overall Study|Withdrawal by Subject|8|||
37858163|NCT01289990|69541466|FG005|Overall Study|Withdrawal by Subject|7|||
37858164|NCT01289990|69541467|FG006|Overall Study|Withdrawal by Subject|13|||
37858165|NCT01289990|69541468|FG007|Overall Study|Withdrawal by Subject|9|||
37858166|NCT01289990|69541469|FG008|Overall Study|Withdrawal by Subject|12|||
37858167|NCT01289990|69541470|FG009|Overall Study|Withdrawal by Subject|13|||
37858168|NCT01289990|69541471|FG010|Overall Study|Withdrawal by Subject|11|||
37858169|NCT01289990|69541472|FG011|Overall Study|Withdrawal by Subject|13|||
37858170|NCT01289990|69541473|FG012|Overall Study|Withdrawal by Subject|16|||
37858171|NCT01289990|69541461|FG000|Overall Study|discontinued in preceding trial|18|||
37858172|NCT01289990|69541462|FG001|Overall Study|discontinued in preceding trial|20|||
37858173|NCT01289990|69541463|FG002|Overall Study|discontinued in preceding trial|41|||
37858174|NCT01289990|69541464|FG003|Overall Study|discontinued in preceding trial|17|||
37755615|NCT00703014|69263240|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
37755616|NCT00703014|69263241|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
37858175|NCT01289990|69541465|FG004|Overall Study|discontinued in preceding trial|11|||
37858176|NCT01289990|69541466|FG005|Overall Study|discontinued in preceding trial|12|||
37858177|NCT01289990|69541467|FG006|Overall Study|discontinued in preceding trial|18|||
37858178|NCT01289990|69541468|FG007|Overall Study|discontinued in preceding trial|8|||
37858179|NCT01289990|69541469|FG008|Overall Study|discontinued in preceding trial|17|||
37858180|NCT01289990|69541470|FG009|Overall Study|discontinued in preceding trial|21|||
37858181|NCT01289990|69541471|FG010|Overall Study|discontinued in preceding trial|17|||
37755617|NCT00703014|69263238|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
37755618|NCT00703014|69263239|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
37755619|NCT00703014|69263240|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
37755620|NCT00703014|69263241|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
37755621|NCT03915496|69263289|FG000|Overall Study|Adverse Event|2|||
37755622|NCT03915496|69263290|FG001|Overall Study|Adverse Event|1|||
37755623|NCT03915496|69263291|FG002|Overall Study|Adverse Event|2|||
37755624|NCT02709330|69263308|FG000|Overall Study|Death|5|||
37755625|NCT02709330|69263309|FG001|Overall Study|Death|0|||
37755626|NCT02709330|69263308|FG000|Overall Study|Lost to Follow-up|2|||
37755627|NCT02709330|69263309|FG001|Overall Study|Lost to Follow-up|0|||
37858182|NCT01289990|69541472|FG011|Overall Study|discontinued in preceding trial|17|||
37858183|NCT01289990|69541473|FG012|Overall Study|discontinued in preceding trial|24|||
37858184|NCT01289990|69541461|FG000|Overall Study|did not continue in extension|41|||
37858185|NCT01289990|69541462|FG001|Overall Study|did not continue in extension|45|||
37858186|NCT01289990|69541463|FG002|Overall Study|did not continue in extension|51|||
37858187|NCT01289990|69541464|FG003|Overall Study|did not continue in extension|51|||
37858188|NCT01289990|69541465|FG004|Overall Study|did not continue in extension|48|||
37858189|NCT01289990|69541466|FG005|Overall Study|did not continue in extension|50|||
37858190|NCT01289990|69541467|FG006|Overall Study|did not continue in extension|54|||
37858191|NCT01289990|69541468|FG007|Overall Study|did not continue in extension|36|||
37858192|NCT01289990|69541469|FG008|Overall Study|did not continue in extension|44|||
37858193|NCT01289990|69541470|FG009|Overall Study|did not continue in extension|48|||
37858194|NCT01289990|69541471|FG010|Overall Study|did not continue in extension|45|||
37858195|NCT01289990|69541472|FG011|Overall Study|did not continue in extension|34|||
37858196|NCT01289990|69541473|FG012|Overall Study|did not continue in extension|56|||
37858197|NCT01289990|69541461|FG000|Overall Study|Not treated|0|||
37858198|NCT01289990|69541462|FG001|Overall Study|Not treated|0|||
37858199|NCT01289990|69541463|FG002|Overall Study|Not treated|0|||
37858200|NCT01289990|69541464|FG003|Overall Study|Not treated|0|||
37858201|NCT01289990|69541465|FG004|Overall Study|Not treated|0|||
37858202|NCT01289990|69541466|FG005|Overall Study|Not treated|0|||
37858203|NCT01289990|69541467|FG006|Overall Study|Not treated|1|||
37858204|NCT01289990|69541468|FG007|Overall Study|Not treated|0|||
37858205|NCT01289990|69541469|FG008|Overall Study|Not treated|1|||
37858206|NCT01289990|69541470|FG009|Overall Study|Not treated|0|||
37858207|NCT01289990|69541471|FG010|Overall Study|Not treated|1|||
37858208|NCT01289990|69541472|FG011|Overall Study|Not treated|2|||
37858209|NCT01289990|69541473|FG012|Overall Study|Not treated|0|||
37858210|NCT01190007|69541501|FG000|Overall Study|Withdrawal by Subject|4|||
37858211|NCT01190007|69541501|FG000|Overall Study|Adverse Event|8|||
37858212|NCT01190007|69541501|FG000|Overall Study|Difficulty of visit for complications|1|||
37858213|NCT01190007|69541501|FG000|Overall Study|Participant was arrested|1|||
37858214|NCT01189461|69541505|FG000|Overall Study|Lack of Efficacy|13|||
37858215|NCT01189461|69541505|FG000|Overall Study|Lost to Follow-up|1|||
37858216|NCT01189461|69541505|FG000|Overall Study|Withdrawal by Subject|6|||
37858217|NCT01189461|69541505|FG000|Overall Study|Protocol Violation|1|||
37858218|NCT01189461|69541505|FG000|Overall Study|Adverse Event|2|||
37858219|NCT01189461|69541505|FG000|Overall Study|Did not meet entrance criteria|3|||
37858220|NCT01189461|69541505|FG000|Overall Study|Other|8|||
37858221|NCT01189227|69541511|FG000|Overall Study|Study terminated due to low accrual|6|||
37858222|NCT01189227|69541512|FG001|Overall Study|Study terminated due to low accrual|3|||
38033317|NCT04493684|69719205|FG010|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
37755628|NCT02709330|69263308|FG000|Overall Study|Physician Decision|2|||
37755629|NCT02709330|69263309|FG001|Overall Study|Physician Decision|0|||
37755630|NCT02709330|69263308|FG000|Overall Study|Withdrawal by Subject|4|||
37755631|NCT02709330|69263309|FG001|Overall Study|Withdrawal by Subject|0|||
37755632|NCT02709096|69263317|FG000|Overall Study|non-compliance|1|||
37755633|NCT02709096|69263318|FG001|Overall Study|non-compliance|1|||
37755634|NCT01372410|69263324|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
37755635|NCT01372410|69263325|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
37858223|NCT01300247|69541520|FG000|Overall Study|Death|1|||
37858224|NCT01300247|69541521|FG001|Overall Study|Death|1|||
37858225|NCT01300247|69541520|FG000|Overall Study|Lost to Follow-up|2|||
37858226|NCT01300247|69541521|FG001|Overall Study|Lost to Follow-up|0|||
37858227|NCT01300247|69541520|FG000|Overall Study|Withdrawal by Subject|1|||
37858228|NCT01300247|69541521|FG001|Overall Study|Withdrawal by Subject|0|||
37858229|NCT01300247|69541520|FG000|Overall Study|Non-Compliance|0|||
37858230|NCT01300247|69541521|FG001|Overall Study|Non-Compliance|1|||
37858231|NCT01289678|69541527|FG000|Overall Study|Physician Decision|6|||
37755636|NCT01372410|69263326|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
37755637|NCT01372410|69263327|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
37858232|NCT01289210|69541531|FG000|Overall Study|Adverse Event|1|||
37858233|NCT01183221|69541537|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
37858234|NCT01183221|69541538|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
37858235|NCT01183143|69541544|FG000|Overall Study|Protocol Violation|115|||
37755638|NCT01372410|69263328|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
37755639|NCT01372410|69263329|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
37755640|NCT01372410|69263330|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
37755641|NCT01372410|69263331|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
37755642|NCT01372410|69263324|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
37755643|NCT01372410|69263325|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
37755644|NCT01372410|69263326|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
37755645|NCT01372410|69263327|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
37755646|NCT01372410|69263328|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
37755647|NCT01372410|69263329|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
37755648|NCT01372410|69263330|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
37755649|NCT01372410|69263331|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
37755650|NCT01372410|69263324|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
37755651|NCT01372410|69263325|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
37755652|NCT01372410|69263326|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
37755653|NCT01372410|69263327|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
37755654|NCT01372410|69263328|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
37755655|NCT01372410|69263329|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
37755656|NCT01372410|69263330|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
37755657|NCT01372410|69263331|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
37755658|NCT01372410|69263324|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
37755659|NCT01372410|69263325|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
37755660|NCT01372410|69263326|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
37755661|NCT01372410|69263327|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
37755662|NCT01372410|69263328|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
37755663|NCT01372410|69263329|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
37755664|NCT01372410|69263330|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
37755665|NCT01372410|69263331|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
37755666|NCT01372410|69263324|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
37755667|NCT01372410|69263325|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
37755668|NCT01372410|69263326|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
37755669|NCT01372410|69263327|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
37755670|NCT01372410|69263328|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
37755671|NCT01372410|69263329|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
37755672|NCT01372410|69263330|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
37755673|NCT01372410|69263331|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
37755674|NCT01372410|69263324|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
37755675|NCT01372410|69263325|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
37755676|NCT01372410|69263326|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
37755677|NCT01372410|69263327|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
37755678|NCT01372410|69263328|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
37755679|NCT01372410|69263329|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
37755680|NCT01372410|69263330|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
37755681|NCT01372410|69263331|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
37755682|NCT01372410|69263324|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
37755683|NCT01372410|69263325|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
37755684|NCT01372410|69263326|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
37755685|NCT01372410|69263327|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
37755686|NCT01372410|69263328|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
37755687|NCT01372410|69263329|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
37755688|NCT01372410|69263330|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
37755689|NCT01372410|69263331|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
37755690|NCT01372410|69263324|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
37755691|NCT01372410|69263325|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
37755692|NCT01372410|69263326|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
37755693|NCT01372410|69263327|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
37755694|NCT01372410|69263328|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
37664620|NCT01597245|69137090|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
37664621|NCT01597245|69137091|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
37664622|NCT01597245|69137092|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
37664623|NCT01597245|69137093|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
37664624|NCT01597245|69137094|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
37664625|NCT01597245|69137074|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
37664626|NCT01597245|69137075|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
37664627|NCT01597245|69137076|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
37755695|NCT01372410|69263329|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
37664628|NCT01597245|69137077|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
37664629|NCT01597245|69137078|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
37664630|NCT01597245|69137079|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
37664631|NCT01597245|69137080|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
37664632|NCT01597245|69137081|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
37664633|NCT01597245|69137082|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
37664634|NCT01597245|69137083|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
37664635|NCT01597245|69137084|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
37664636|NCT01597245|69137085|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
37664637|NCT01597245|69137086|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
37664638|NCT01597245|69137087|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
37664639|NCT01597245|69137088|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
37664640|NCT01597245|69137089|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
37755696|NCT01372410|69263330|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
37755697|NCT01372410|69263331|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
37755698|NCT01372410|69263324|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
37755699|NCT01372410|69263325|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
37755700|NCT01372410|69263326|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
37755701|NCT01372410|69263327|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
37755702|NCT01372410|69263328|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
37755703|NCT01372410|69263329|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
37755704|NCT01372410|69263330|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
37755705|NCT01372410|69263331|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
37755706|NCT01372410|69263324|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
37755707|NCT01372410|69263325|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
37755708|NCT01372410|69263326|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
37755709|NCT01372410|69263327|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
37755710|NCT01372410|69263328|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
37755711|NCT01372410|69263329|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
37755712|NCT01372410|69263330|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
37755713|NCT01372410|69263331|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
37755714|NCT01704287|69263369|FG000|Initial Treatment Period|Death|139|||
37755715|NCT01704287|69263370|FG001|Initial Treatment Period|Death|129|||
37755716|NCT01704287|69263371|FG002|Initial Treatment Period|Death|71|||
37755717|NCT01704287|69263372|FG003|Initial Treatment Period|Death|0|||
37755718|NCT01704287|69263373|FG004|Initial Treatment Period|Death|0|||
37755719|NCT01704287|69263369|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
37755720|NCT01704287|69263370|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
37755721|NCT01704287|69263371|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
37755722|NCT01704287|69263372|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
37755723|NCT01704287|69263373|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
37755724|NCT01704287|69263369|FG000|Initial Treatment Period|Lost to Follow-up|5|||
37755725|NCT01704287|69263370|FG001|Initial Treatment Period|Lost to Follow-up|3|||
37755726|NCT01704287|69263371|FG002|Initial Treatment Period|Lost to Follow-up|0|||
37755727|NCT01704287|69263372|FG003|Initial Treatment Period|Lost to Follow-up|0|||
37755728|NCT01704287|69263373|FG004|Initial Treatment Period|Lost to Follow-up|0|||
37664641|NCT01597245|69137090|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
37664642|NCT01597245|69137091|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
37755729|NCT01704287|69263369|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
37755730|NCT01704287|69263370|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
37755731|NCT01704287|69263371|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
37755732|NCT01704287|69263372|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
37755733|NCT01704287|69263373|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
37755734|NCT01704287|69263369|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
37755735|NCT01704287|69263370|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
37755736|NCT01704287|69263371|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
37664643|NCT01597245|69137092|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
37664644|NCT01597245|69137093|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
37664645|NCT01597245|69137094|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
37664646|NCT01597245|69137074|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
37755737|NCT01704287|69263372|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
37755738|NCT01704287|69263373|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
37755739|NCT01704287|69263369|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
37755740|NCT01704287|69263370|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
37755741|NCT01704287|69263371|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
37755742|NCT01704287|69263372|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
37755743|NCT01704287|69263373|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
37755744|NCT01704287|69263369|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
37755745|NCT01704287|69263370|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
37755746|NCT01704287|69263371|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
37755747|NCT01704287|69263372|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
37755748|NCT01704287|69263373|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
37755749|NCT01682837|69263401|FG000|Baseline|Withdrawal by Subject|5|||
37755750|NCT01703819|69263438|FG000|Overall Study|Adverse Event|0|||
37755751|NCT01703819|69263439|FG001|Overall Study|Adverse Event|1|||
37755752|NCT01703819|69263438|FG000|Overall Study|Withdrawal by Subject|0|||
37755753|NCT01703819|69263439|FG001|Overall Study|Withdrawal by Subject|1|||
37755754|NCT01682759|69263451|FG000|Overall Study|Death|2|||
37755755|NCT01682759|69263452|FG001|Overall Study|Death|1|||
37755756|NCT01682759|69263451|FG000|Overall Study|Lost to Follow-up|10|||
37755757|NCT01682759|69263452|FG001|Overall Study|Lost to Follow-up|13|||
37755758|NCT01682759|69263451|FG000|Overall Study|Physician Decision|1|||
37664647|NCT01597245|69137075|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
37664648|NCT01597245|69137076|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
37664649|NCT01597245|69137077|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
37664650|NCT01597245|69137078|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
37664651|NCT01597245|69137079|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
37664652|NCT01597245|69137080|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
37664653|NCT01597245|69137081|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
37664654|NCT01597245|69137082|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
37664655|NCT01597245|69137083|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
37664656|NCT01597245|69137084|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
37664657|NCT01597245|69137085|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
37664658|NCT01597245|69137086|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
37755759|NCT01682759|69263452|FG001|Overall Study|Physician Decision|1|||
37755760|NCT01682759|69263451|FG000|Overall Study|Withdrawal by Subject|56|||
37755761|NCT01682759|69263452|FG001|Overall Study|Withdrawal by Subject|55|||
37755762|NCT01682681|69263462|FG000|Overall Study|Lack of Efficacy|62|||
37755763|NCT01682681|69263462|FG000|Overall Study|Withdrawal by Subject|1|||
37755764|NCT01682681|69263462|FG000|Overall Study|Moved to other hospital|10|||
37755765|NCT01682681|69263462|FG000|Overall Study|Lost to Follow-up|174|||
37755766|NCT01682681|69263462|FG000|Overall Study|Adverse Event|46|||
37755767|NCT01682681|69263462|FG000|Overall Study|tapering of topiramate|5|||
37755768|NCT01682681|69263462|FG000|Overall Study|Other|21|||
37755769|NCT01682681|69263462|FG000|Overall Study|Low compliance|13|||
37755770|NCT01682603|69263466|FG000|Overall Study|Lost to Follow-up|3|||
37755771|NCT01682213|69263482|FG000|Overall Study|Withdrawal by Subject|2|||
37755772|NCT01703741|69263491|FG000|Overall Study|Withdrawal by Subject|6|||
37755773|NCT01703741|69263491|FG000|Overall Study|Adverse Event|2|||
37755774|NCT01703741|69263491|FG000|Overall Study|Physician Decision|2|||
37755775|NCT01703741|69263491|FG000|Overall Study|Protocol Violation|1|||
37755776|NCT01703741|69263491|FG000|Overall Study|Lost to Follow-up|3|||
37664659|NCT01597245|69137087|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
37664660|NCT01597245|69137088|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
37664661|NCT01597245|69137089|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
37664662|NCT01597245|69137090|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
37664663|NCT01597245|69137091|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
37664664|NCT01597245|69137092|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
37664665|NCT01597245|69137093|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
37664666|NCT01597245|69137094|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
37664667|NCT01597245|69137074|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
37755777|NCT01703741|69263491|FG000|Overall Study|Subject did not want to continue|2|||
37755778|NCT01703741|69263491|FG000|Overall Study|Subject cannot comply with study visits|1|||
37755779|NCT01703741|69263491|FG000|Overall Study|Subject started testosterone injections|1|||
37755780|NCT01681511|69263497|FG000|Overall Study|No Treatment Received|1|||
37755781|NCT01681511|69263498|FG001|Overall Study|No Treatment Received|3|||
37755782|NCT01681511|69263497|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
37755783|NCT01681511|69263498|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
37755784|NCT01681511|69263497|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
37858236|NCT01183143|69541544|FG000|Overall Study|Withdrawal by Subject|19|||
37664668|NCT01597245|69137075|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
37755785|NCT01681511|69263498|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
37755786|NCT01681511|69263497|FG000|Overall Study|No Daily Urine Sample Collected|0|||
37755787|NCT01681511|69263498|FG001|Overall Study|No Daily Urine Sample Collected|1|||
37755788|NCT01681511|69263497|FG000|Overall Study|No post-catheter sample collected|11|||
37755789|NCT01681511|69263498|FG001|Overall Study|No post-catheter sample collected|4|||
37755790|NCT01681433|69263506|FG000|Overall Study|Lack of Efficacy|23|||
37755791|NCT01681433|69263507|FG001|Overall Study|Lack of Efficacy|23|||
37755792|NCT01681433|69263506|FG000|Overall Study|Withdrawal by Subject|5|||
37755793|NCT01681433|69263507|FG001|Overall Study|Withdrawal by Subject|5|||
37755794|NCT01681433|69263506|FG000|Overall Study|Protocol Violation|2|||
37755795|NCT01681433|69263507|FG001|Overall Study|Protocol Violation|0|||
37755796|NCT01681433|69263506|FG000|Overall Study|Adverse Event|2|||
37755797|NCT01681433|69263507|FG001|Overall Study|Adverse Event|4|||
37755798|NCT01681433|69263506|FG000|Overall Study|Lost to Follow-up|0|||
37755799|NCT01681433|69263507|FG001|Overall Study|Lost to Follow-up|1|||
37755800|NCT01681277|69263518|FG000|Overall Study|Adverse Event|1|||
37755801|NCT01681277|69263519|FG001|Overall Study|Adverse Event|0|||
37755802|NCT01681277|69263520|FG002|Overall Study|Adverse Event|0|||
37755803|NCT01681277|69263521|FG003|Overall Study|Adverse Event|0|||
37755804|NCT01681277|69263522|FG004|Overall Study|Adverse Event|0|||
37755805|NCT01703117|69263540|FG000|Overall Study|Adverse Event|4|||
37755806|NCT01703117|69263541|FG001|Overall Study|Adverse Event|3|||
37755807|NCT01703117|69263540|FG000|Overall Study|Withdrawal by Subject|0|||
37755808|NCT01703117|69263541|FG001|Overall Study|Withdrawal by Subject|1|||
37755809|NCT01702961|69263549|FG000|Overall Study|Additional treatment|3|||
37755810|NCT01702961|69263549|FG000|Overall Study|Progressive disease|5|||
37755811|NCT01702961|69263549|FG000|Overall Study|Relapse|20|||
37755812|NCT01702961|69263549|FG000|Overall Study|Death|6|||
37755813|NCT01702961|69263549|FG000|Overall Study|Lost to Follow-up|2|||
37755814|NCT01702961|69263549|FG000|Overall Study|Ongoing|11|||
37755815|NCT01593917|69263553|FG000|Overall Study|Death|67|||
37755816|NCT01593917|69263553|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
37755817|NCT01593917|69263553|FG000|Overall Study|Withdrawal by Subject|23|||
37755818|NCT01593917|69263553|FG000|Overall Study|Lost to Follow-up|12|||
37755819|NCT01593917|69263553|FG000|Overall Study|Protocol Violation|5|||
37755820|NCT01593917|69263553|FG000|Overall Study|Physician Decision|3|||
37755821|NCT01593761|69263557|FG000|Overall Study|Lost to Follow-up|1|||
37755822|NCT01593761|69263557|FG000|Overall Study|culture negative for MRSA at baseline|5|||
37755823|NCT01593761|69263557|FG000|Overall Study|positive for hepatitis C virus|1|||
37755824|NCT01593761|69263557|FG000|Overall Study|secondary cellulitis|1|||
37755825|NCT02706834|69263578|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
37755826|NCT02706834|69263579|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
37755827|NCT02706834|69263580|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
37755828|NCT02706834|69263581|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
37755829|NCT02706834|69263582|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
37755830|NCT02706834|69263583|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
37755831|NCT02706834|69263584|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
37755832|NCT02706834|69263585|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
37755833|NCT02706834|69263586|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
37755834|NCT02706834|69263587|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
37755835|NCT02706834|69263588|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
37755836|NCT02706834|69263578|FG000|Overall Study|Lost to Follow-up|0|||
37755837|NCT02706834|69263579|FG001|Overall Study|Lost to Follow-up|0|||
37664669|NCT01597245|69137076|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
37664670|NCT01597245|69137077|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
37664671|NCT01597245|69137078|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
37664672|NCT01597245|69137079|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
37664673|NCT01597245|69137080|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
37664674|NCT01597245|69137081|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
37664675|NCT01597245|69137082|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
37664676|NCT01597245|69137083|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
37664677|NCT01597245|69137084|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
37664678|NCT01597245|69137085|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
37664679|NCT01597245|69137086|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
37664680|NCT01597245|69137087|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
37755838|NCT02706834|69263580|FG002|Overall Study|Lost to Follow-up|1|||
37755839|NCT02706834|69263581|FG003|Overall Study|Lost to Follow-up|0|||
37755840|NCT02706834|69263582|FG004|Overall Study|Lost to Follow-up|0|||
37755841|NCT02706834|69263583|FG005|Overall Study|Lost to Follow-up|0|||
37755842|NCT02706834|69263584|FG006|Overall Study|Lost to Follow-up|0|||
37858237|NCT01183143|69541544|FG000|Overall Study|Subject Questionnaires not returned|5|||
37858238|NCT01183143|69541544|FG000|Overall Study|Subjects enrolled, but not treated|11|||
37858239|NCT01183065|69541548|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
37755843|NCT02706834|69263585|FG007|Overall Study|Lost to Follow-up|0|||
37755844|NCT02706834|69263586|FG008|Overall Study|Lost to Follow-up|0|||
37755845|NCT02706834|69263587|FG009|Overall Study|Lost to Follow-up|0|||
37755846|NCT02706834|69263588|FG010|Overall Study|Lost to Follow-up|0|||
37755847|NCT02706834|69263578|FG000|Overall Study|Voluntary Withdrawal|1|||
37755848|NCT02706834|69263579|FG001|Overall Study|Voluntary Withdrawal|0|||
37755849|NCT02706834|69263580|FG002|Overall Study|Voluntary Withdrawal|0|||
37755850|NCT02706834|69263581|FG003|Overall Study|Voluntary Withdrawal|0|||
37664681|NCT01597245|69137088|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
37664682|NCT01597245|69137089|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
37664683|NCT01597245|69137090|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
37664684|NCT01597245|69137091|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
37664685|NCT01597245|69137092|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
37664686|NCT01597245|69137093|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
37664687|NCT01597245|69137094|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
37664688|NCT00707057|69137129|FG000|Overall Study|Withdrawal by Subject|8|||
37755851|NCT02706834|69263582|FG004|Overall Study|Voluntary Withdrawal|0|||
37755852|NCT02706834|69263583|FG005|Overall Study|Voluntary Withdrawal|0|||
37755853|NCT02706834|69263584|FG006|Overall Study|Voluntary Withdrawal|0|||
37755854|NCT02706834|69263585|FG007|Overall Study|Voluntary Withdrawal|0|||
37755855|NCT02706834|69263586|FG008|Overall Study|Voluntary Withdrawal|0|||
37755856|NCT02706834|69263587|FG009|Overall Study|Voluntary Withdrawal|1|||
37755857|NCT02706834|69263588|FG010|Overall Study|Voluntary Withdrawal|0|||
37755858|NCT02706834|69263578|FG000|Overall Study|Other Reason Not Specified|1|||
37755859|NCT02706834|69263579|FG001|Overall Study|Other Reason Not Specified|0|||
37755860|NCT02706834|69263580|FG002|Overall Study|Other Reason Not Specified|0|||
37755861|NCT02706834|69263581|FG003|Overall Study|Other Reason Not Specified|0|||
37755862|NCT02706834|69263582|FG004|Overall Study|Other Reason Not Specified|1|||
37755863|NCT02706834|69263583|FG005|Overall Study|Other Reason Not Specified|0|||
37755864|NCT02706834|69263584|FG006|Overall Study|Other Reason Not Specified|0|||
37755865|NCT02706834|69263585|FG007|Overall Study|Other Reason Not Specified|0|||
37755866|NCT02706834|69263586|FG008|Overall Study|Other Reason Not Specified|0|||
37755867|NCT02706834|69263587|FG009|Overall Study|Other Reason Not Specified|0|||
37755868|NCT02706834|69263588|FG010|Overall Study|Other Reason Not Specified|0|||
37755869|NCT01702025|69263637|FG000|Overall Study|Equipment failure|1|||
37755870|NCT01702025|69263638|FG001|Overall Study|Equipment failure|0|||
37755871|NCT01702025|69263639|FG002|Overall Study|Equipment failure|0|||
37755872|NCT01702025|69263640|FG003|Overall Study|Equipment failure|0|||
37755873|NCT01702025|69263637|FG000|Overall Study|Adverse Event|1|||
37755874|NCT01702025|69263638|FG001|Overall Study|Adverse Event|1|||
37923382|NCT03704064|69610199|FG001|Overall Study|No longer available for study visits|1|||
37923383|NCT03704064|69610198|FG000|Overall Study|Censoring event|1|||
37923384|NCT03704064|69610199|FG001|Overall Study|Censoring event|0|||
37923385|NCT00824564|69610207|FG000|Overall Study|Lost to Follow-up|5|||
37923386|NCT00824564|69610208|FG001|Overall Study|Lost to Follow-up|7|||
37923387|NCT00824564|69610207|FG000|Overall Study|Withdrawal by Subject|1|||
37755875|NCT01702025|69263639|FG002|Overall Study|Adverse Event|1|||
37755876|NCT01702025|69263640|FG003|Overall Study|Adverse Event|0|||
37755877|NCT01592747|69263657|FG000|Overall Study|Loss of Therapeutic Response|107|||
37755878|NCT01592747|69263658|FG001|Overall Study|Loss of Therapeutic Response|108|||
37755879|NCT01592747|69263659|FG002|Overall Study|Loss of Therapeutic Response|100|||
37755880|NCT01592747|69263657|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
37664689|NCT00707057|69137130|FG001|Overall Study|Withdrawal by Subject|3|||
37664690|NCT00707057|69137129|FG000|Overall Study|Dosed incorrectly|0|||
37664691|NCT00707057|69137130|FG001|Overall Study|Dosed incorrectly|1|||
37664692|NCT02639247|69137138|FG000|Overall Study|Lost to Follow-up|2|||
37664693|NCT02639247|69137139|FG001|Overall Study|Lost to Follow-up|1|||
37664694|NCT02639247|69137138|FG000|Overall Study|Death|2|||
37664695|NCT02639247|69137139|FG001|Overall Study|Death|0|||
37664696|NCT02639247|69137138|FG000|Overall Study|Withdrew Consent|0|||
37664697|NCT02639247|69137139|FG001|Overall Study|Withdrew Consent|1|||
37664698|NCT02639247|69137138|FG000|Overall Study|Protocol Violation|1|||
37664699|NCT02639247|69137139|FG001|Overall Study|Protocol Violation|0|||
37664700|NCT00706901|69137148|FG000|Overall Study|Lost to Follow-up|2|||
37664701|NCT00706901|69137149|FG001|Overall Study|Lost to Follow-up|3|||
37664702|NCT00706901|69137150|FG002|Overall Study|Lost to Follow-up|2|||
37755881|NCT01592747|69263658|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
37755882|NCT01592747|69263659|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
37755883|NCT01592747|69263657|FG000|Overall Study|Adverse Event|1|||
37755884|NCT01592747|69263658|FG001|Overall Study|Adverse Event|0|||
37664703|NCT00706901|69137148|FG000|Overall Study|Withdrawal by Subject|4|||
37755885|NCT01592747|69263659|FG002|Overall Study|Adverse Event|0|||
37755886|NCT01592747|69263657|FG000|Overall Study|Protocol Violation|4|||
37923388|NCT00824564|69610208|FG001|Overall Study|Withdrawal by Subject|1|||
37664704|NCT00706901|69137149|FG001|Overall Study|Withdrawal by Subject|2|||
37664705|NCT00706901|69137150|FG002|Overall Study|Withdrawal by Subject|5|||
37755887|NCT01592747|69263658|FG001|Overall Study|Protocol Violation|0|||
37755888|NCT01592747|69263659|FG002|Overall Study|Protocol Violation|4|||
37755889|NCT01592747|69263657|FG000|Overall Study|Lack of Efficacy|0|||
37755890|NCT01592747|69263658|FG001|Overall Study|Lack of Efficacy|1|||
37755891|NCT01592747|69263659|FG002|Overall Study|Lack of Efficacy|0|||
37755892|NCT01592747|69263657|FG000|Overall Study|Withdrawal by Subject|2|||
37755893|NCT01592747|69263658|FG001|Overall Study|Withdrawal by Subject|0|||
37755894|NCT01592747|69263659|FG002|Overall Study|Withdrawal by Subject|2|||
37755895|NCT01592747|69263657|FG000|Overall Study|Lost to Follow-up|1|||
37755896|NCT01592747|69263658|FG001|Overall Study|Lost to Follow-up|0|||
37755897|NCT01592747|69263659|FG002|Overall Study|Lost to Follow-up|1|||
37755898|NCT01592747|69263657|FG000|Overall Study|Other Reasons|1|||
37755899|NCT01592747|69263658|FG001|Overall Study|Other Reasons|1|||
37755900|NCT01592747|69263659|FG002|Overall Study|Other Reasons|0|||
37755901|NCT02051608|69263672|FG000|Part 1: Double Blind Treatment|Death|3|||
37755902|NCT02051608|69263673|FG001|Part 1: Double Blind Treatment|Death|3|||
37755903|NCT02051608|69263674|FG002|Part 1: Double Blind Treatment|Death|0|||
37755904|NCT02051608|69263675|FG003|Part 1: Double Blind Treatment|Death|0|||
37755905|NCT02051608|69263672|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
37755906|NCT02051608|69263673|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
37755907|NCT02051608|69263674|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
37755908|NCT02051608|69263675|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
37755909|NCT02051608|69263672|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
37755910|NCT02051608|69263673|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
37755911|NCT02051608|69263674|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
37755912|NCT02051608|69263675|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
37755913|NCT02051608|69263672|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
37755914|NCT02051608|69263673|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
37755915|NCT02051608|69263674|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
37755916|NCT02051608|69263675|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
37755917|NCT02051608|69263672|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
37755918|NCT02051608|69263673|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
37755919|NCT02051608|69263674|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
37755920|NCT02051608|69263675|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
37755921|NCT02051608|69263672|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
37755922|NCT02051608|69263673|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
37755923|NCT02051608|69263674|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
37755924|NCT02051608|69263675|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
37755925|NCT02051608|69263672|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
37755926|NCT02051608|69263673|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
37664706|NCT00706901|69137148|FG000|Overall Study|In Jail|1|||
37664707|NCT00706901|69137149|FG001|Overall Study|In Jail|0|||
37664708|NCT00706901|69137150|FG002|Overall Study|In Jail|1|||
37755927|NCT02051608|69263674|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
37755928|NCT02051608|69263675|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
37755929|NCT02051608|69263672|FG000|Part 1: Double Blind Treatment|Other|6|||
37755930|NCT02051608|69263673|FG001|Part 1: Double Blind Treatment|Other|3|||
37755931|NCT02051608|69263674|FG002|Part 1: Double Blind Treatment|Other|0|||
37755932|NCT02051608|69263675|FG003|Part 1: Double Blind Treatment|Other|0|||
37755933|NCT02051608|69263672|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
37755934|NCT02051608|69263673|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
37755935|NCT02051608|69263674|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
37755936|NCT02051608|69263675|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
37755937|NCT02051608|69263672|FG000|Part 2: Open-label Extension|Adverse Event|0|||
37755938|NCT02051608|69263673|FG001|Part 2: Open-label Extension|Adverse Event|0|||
37755939|NCT02051608|69263674|FG002|Part 2: Open-label Extension|Adverse Event|6|||
37755940|NCT02051608|69263675|FG003|Part 2: Open-label Extension|Adverse Event|8|||
37755941|NCT02051608|69263672|FG000|Part 2: Open-label Extension|Death|0|||
37755942|NCT02051608|69263673|FG001|Part 2: Open-label Extension|Death|0|||
37755943|NCT02051608|69263674|FG002|Part 2: Open-label Extension|Death|7|||
37858240|NCT01182441|69541554|FG000|Overall Study|Patient Still in Follow-up|152|||
37858241|NCT01182441|69541555|FG001|Overall Study|Patient Still in Follow-up|72|||
37858242|NCT01182441|69541554|FG000|Overall Study|Death|37|||
37858243|NCT01182441|69541555|FG001|Overall Study|Death|25|||
37858244|NCT01182441|69541554|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
37664709|NCT00706901|69137148|FG000|Overall Study|Death|1|||
37664710|NCT00706901|69137149|FG001|Overall Study|Death|0|||
37664711|NCT00706901|69137150|FG002|Overall Study|Death|0|||
37664712|NCT05274217|69137161|FG000|Overall Study|Study terminated.|11|||
37858245|NCT01182441|69541555|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
37664713|NCT05274217|69137162|FG001|Overall Study|Study terminated.|0|||
37664714|NCT05070546|69137174|FG000|Overall Study|Death|0|||
37664715|NCT05070546|69137175|FG001|Overall Study|Death|0|||
37664716|NCT05070546|69137176|FG002|Overall Study|Death|0|||
37664717|NCT05070546|69137177|FG003|Overall Study|Death|0|||
37755944|NCT02051608|69263675|FG003|Part 2: Open-label Extension|Death|4|||
37755945|NCT02051608|69263672|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
37755946|NCT02051608|69263673|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
37755947|NCT02051608|69263674|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
37755948|NCT02051608|69263675|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
37755949|NCT02051608|69263672|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
37858246|NCT01182441|69541554|FG000|Overall Study|Lost to Follow-up|5|||
37664718|NCT05070546|69137178|FG004|Overall Study|Death|0|||
37664719|NCT05070546|69137179|FG005|Overall Study|Death|1|||
37664720|NCT05070546|69137174|FG000|Overall Study|Lost to Follow-up|8|||
37664721|NCT05070546|69137175|FG001|Overall Study|Lost to Follow-up|2|||
37664722|NCT05070546|69137176|FG002|Overall Study|Lost to Follow-up|7|||
37664723|NCT05070546|69137177|FG003|Overall Study|Lost to Follow-up|1|||
37664724|NCT05070546|69137178|FG004|Overall Study|Lost to Follow-up|2|||
37755950|NCT02051608|69263673|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
37755951|NCT02051608|69263674|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
37755952|NCT02051608|69263675|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
37755953|NCT02051608|69263672|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
37755954|NCT02051608|69263673|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
37755955|NCT02051608|69263674|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
37755956|NCT02051608|69263675|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
37755957|NCT02051608|69263672|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
37755958|NCT02051608|69263673|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
37755959|NCT02051608|69263674|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
37755960|NCT02051608|69263675|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
37755961|NCT02051608|69263672|FG000|Part 2: Open-label Extension|Physician Decision|0|||
37755962|NCT02051608|69263673|FG001|Part 2: Open-label Extension|Physician Decision|0|||
37755963|NCT02051608|69263674|FG002|Part 2: Open-label Extension|Physician Decision|8|||
37755964|NCT02051608|69263675|FG003|Part 2: Open-label Extension|Physician Decision|5|||
37755965|NCT02051608|69263672|FG000|Part 2: Open-label Extension|Other|0|||
37755966|NCT02051608|69263673|FG001|Part 2: Open-label Extension|Other|0|||
37755967|NCT02051608|69263674|FG002|Part 2: Open-label Extension|Other|9|||
37755968|NCT02051608|69263675|FG003|Part 2: Open-label Extension|Other|9|||
37755969|NCT02705586|69263688|FG000|Overall Study|Health Issues|2|||
37755970|NCT02705586|69263688|FG000|Overall Study|Transportation Difficulties|5|||
37858247|NCT01182441|69541555|FG001|Overall Study|Lost to Follow-up|8|||
37858248|NCT01182441|69541554|FG000|Overall Study|Withdrawal by Subject|6|||
37858249|NCT01182441|69541555|FG001|Overall Study|Withdrawal by Subject|13|||
37858250|NCT01182441|69541554|FG000|Overall Study|Implant Not Attempted|4|||
37858251|NCT01182441|69541555|FG001|Overall Study|Implant Not Attempted|0|||
37858252|NCT01182441|69541554|FG000|Overall Study|Adverse Event|2|||
37858253|NCT01182441|69541555|FG001|Overall Study|Adverse Event|0|||
37664725|NCT05070546|69137179|FG005|Overall Study|Lost to Follow-up|0|||
37664726|NCT05070546|69137174|FG000|Overall Study|Withdrawal by Subject|1|||
37858254|NCT01182441|69541554|FG000|Overall Study|Physician Decision|1|||
37858255|NCT01182441|69541555|FG001|Overall Study|Physician Decision|1|||
37858256|NCT01182285|69541561|FG000|First Intervention Week 1-10|Disease progression|1|||
37858257|NCT01182285|69541562|FG001|First Intervention Week 1-10|Disease progression|0|||
37858258|NCT01182285|69541563|FG002|First Intervention Week 1-10|Disease progression|0|||
37858259|NCT01182285|69541561|FG000|First Intervention Week 1-10|Adverse Event|1|||
37858260|NCT01182285|69541562|FG001|First Intervention Week 1-10|Adverse Event|0|||
37858261|NCT01182285|69541563|FG002|First Intervention Week 1-10|Adverse Event|0|||
37858262|NCT01182285|69541561|FG000|First Intervention Week 1-10|Non-compliance|1|||
37858263|NCT01182285|69541562|FG001|First Intervention Week 1-10|Non-compliance|0|||
37858264|NCT01182285|69541563|FG002|First Intervention Week 1-10|Non-compliance|0|||
37858265|NCT01182285|69541561|FG000|Third Intervention Week 11-52|Disease Progression|0|||
37858266|NCT01182285|69541562|FG001|Third Intervention Week 11-52|Disease Progression|0|||
37858267|NCT01182285|69541563|FG002|Third Intervention Week 11-52|Disease Progression|6|||
37858268|NCT01182285|69541561|FG000|Third Intervention Week 11-52|Other|0|||
37858269|NCT01182285|69541562|FG001|Third Intervention Week 11-52|Other|0|||
37858270|NCT01182285|69541563|FG002|Third Intervention Week 11-52|Other|2|||
37858271|NCT01182207|69541572|FG000|First Intervention|Positive Hepatitis Results|0|||
37858272|NCT01182207|69541573|FG001|First Intervention|Positive Hepatitis Results|1|||
37664727|NCT05070546|69137175|FG001|Overall Study|Withdrawal by Subject|1|||
37755971|NCT02705586|69263688|FG000|Overall Study|Vacation/Planned Absence|1|||
37755972|NCT01592045|69263694|FG000|Overall Study|Disease Progression|1|||
37858273|NCT01182207|69541572|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
37858274|NCT01182207|69541573|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
37664728|NCT05070546|69137176|FG002|Overall Study|Withdrawal by Subject|3|||
37755973|NCT01592045|69263695|FG001|Overall Study|Disease Progression|1|||
37858275|NCT01181895|69541582|FG000|Overall Study|Adverse Event|3|||
37858276|NCT01181895|69541583|FG001|Overall Study|Adverse Event|1|||
37858277|NCT01181895|69541584|FG002|Overall Study|Adverse Event|1|||
37858278|NCT01181895|69541582|FG000|Overall Study|Lack of Efficacy|8|||
37858279|NCT01181895|69541583|FG001|Overall Study|Lack of Efficacy|9|||
37664729|NCT05070546|69137177|FG003|Overall Study|Withdrawal by Subject|0|||
37664730|NCT05070546|69137178|FG004|Overall Study|Withdrawal by Subject|0|||
37664731|NCT05070546|69137179|FG005|Overall Study|Withdrawal by Subject|0|||
37664732|NCT05070546|69137174|FG000|Overall Study|Other|0|||
37755974|NCT01592045|69263694|FG000|Overall Study|Adverse Event|1|||
37755975|NCT01592045|69263695|FG001|Overall Study|Adverse Event|1|||
37664733|NCT05070546|69137175|FG001|Overall Study|Other|0|||
37664734|NCT05070546|69137176|FG002|Overall Study|Other|0|||
37858280|NCT01181895|69541584|FG002|Overall Study|Lack of Efficacy|9|||
37858281|NCT01181895|69541582|FG000|Overall Study|Protocol Violation|2|||
37923389|NCT00824564|69610207|FG000|Overall Study|Other|1|||
37923390|NCT00824564|69610208|FG001|Overall Study|Other|2|||
37923391|NCT00824564|69610207|FG000|Overall Study|Randomized, but not treated|1|||
37923392|NCT00824564|69610208|FG001|Overall Study|Randomized, but not treated|0|||
37923393|NCT00658528|69610216|FG000|Overall Study|Adverse Event|5|||
37923394|NCT00658528|69610217|FG001|Overall Study|Adverse Event|7|||
37923395|NCT00658528|69610216|FG000|Overall Study|Lost to Follow-up|14|||
37923396|NCT00658528|69610217|FG001|Overall Study|Lost to Follow-up|22|||
37923397|NCT00658528|69610216|FG000|Overall Study|Withdrawal by Subject|8|||
37923398|NCT00658528|69610217|FG001|Overall Study|Withdrawal by Subject|6|||
37923399|NCT00658528|69610216|FG000|Overall Study|Withdrawal of consent|5|||
37923400|NCT00658528|69610217|FG001|Overall Study|Withdrawal of consent|6|||
37923401|NCT00658528|69610216|FG000|Overall Study|Other|8|||
37923402|NCT00658528|69610217|FG001|Overall Study|Other|4|||
37923403|NCT00856583|69610225|FG000|Overall Study|Lack of Efficacy|389|||
37923404|NCT00856583|69610226|FG001|Overall Study|Lack of Efficacy|377|||
37923405|NCT00856583|69610225|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
37923406|NCT00856583|69610226|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
37923407|NCT00856583|69610225|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
37923408|NCT00856583|69610226|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
37923409|NCT00856583|69610225|FG000|Overall Study|Non-compliance|305|||
37923410|NCT00856583|69610226|FG001|Overall Study|Non-compliance|262|||
37923411|NCT00856583|69610225|FG000|Overall Study|Withdrawal by Subject|1092|||
37923412|NCT00856583|69610226|FG001|Overall Study|Withdrawal by Subject|919|||
37923413|NCT00856583|69610225|FG000|Overall Study|Physician Decision|59|||
37923414|NCT00856583|69610226|FG001|Overall Study|Physician Decision|82|||
37664735|NCT05070546|69137177|FG003|Overall Study|Other|0|||
37664736|NCT05070546|69137178|FG004|Overall Study|Other|3|||
37664737|NCT05070546|69137179|FG005|Overall Study|Other|0|||
37664738|NCT05070546|69137174|FG000|Overall Study|Randomized but not vaccinated|1|||
37858282|NCT01181895|69541583|FG001|Overall Study|Protocol Violation|1|||
37858283|NCT01181895|69541584|FG002|Overall Study|Protocol Violation|0|||
37858284|NCT01181895|69541582|FG000|Overall Study|Lost to Follow-up|0|||
37858285|NCT01181895|69541583|FG001|Overall Study|Lost to Follow-up|1|||
37664739|NCT05070546|69137175|FG001|Overall Study|Randomized but not vaccinated|0|||
37664740|NCT05070546|69137176|FG002|Overall Study|Randomized but not vaccinated|1|||
37664741|NCT05070546|69137177|FG003|Overall Study|Randomized but not vaccinated|1|||
37664742|NCT05070546|69137178|FG004|Overall Study|Randomized but not vaccinated|3|||
37664743|NCT05070546|69137179|FG005|Overall Study|Randomized but not vaccinated|0|||
37664744|NCT05032950|69137198|FG000|Overall Study|Adverse Event|0|||
37664745|NCT05032950|69137199|FG001|Overall Study|Adverse Event|0|||
37664746|NCT05032950|69137200|FG002|Overall Study|Adverse Event|1|||
37664747|NCT05032950|69137201|FG003|Overall Study|Adverse Event|1|||
37664748|NCT05032950|69137202|FG004|Overall Study|Adverse Event|0|||
37664749|NCT05032950|69137203|FG005|Overall Study|Adverse Event|0|||
37755976|NCT01592045|69263694|FG000|Overall Study|Withdrawal by Subject|1|||
37755977|NCT01592045|69263695|FG001|Overall Study|Withdrawal by Subject|0|||
37755978|NCT01592045|69263694|FG000|Overall Study|Moved out of country|2|||
37755979|NCT01592045|69263695|FG001|Overall Study|Moved out of country|0|||
37755980|NCT01591499|69263703|FG000|Baseline Visit|Withdrawal by Subject|0|||
37755981|NCT01591499|69263704|FG001|Baseline Visit|Withdrawal by Subject|2|||
37755982|NCT01591499|69263705|FG002|Baseline Visit|Withdrawal by Subject|0|||
37858286|NCT01181895|69541584|FG002|Overall Study|Lost to Follow-up|2|||
37858287|NCT01181895|69541582|FG000|Overall Study|Investigator Discretion|1|||
37858288|NCT01181895|69541583|FG001|Overall Study|Investigator Discretion|2|||
37858289|NCT01181895|69541584|FG002|Overall Study|Investigator Discretion|1|||
37923415|NCT00856583|69610225|FG000|Overall Study|Pregnancy|14|||
37923416|NCT00856583|69610226|FG001|Overall Study|Pregnancy|5|||
37923417|NCT00856583|69610225|FG000|Overall Study|Other|92|||
37923418|NCT00856583|69610226|FG001|Overall Study|Other|104|||
38033318|NCT04493684|69719206|FG011|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
37664750|NCT04776161|69137223|FG000|Overall Study|Withdrew after randomization but prior to intervention|1|||
37664751|NCT04776161|69137224|FG001|Overall Study|Withdrew after randomization but prior to intervention|3|||
37664752|NCT04776161|69137225|FG002|Overall Study|Withdrew after randomization but prior to intervention|2|||
37664753|NCT04776161|69137223|FG000|Overall Study|Withdrawal by Subject|1|||
37755983|NCT01591499|69263706|FG003|Baseline Visit|Withdrawal by Subject|2|||
37858290|NCT01181895|69541582|FG000|Overall Study|Withdrawal by Subject|3|||
37858291|NCT01181895|69541583|FG001|Overall Study|Withdrawal by Subject|0|||
37858292|NCT01181895|69541584|FG002|Overall Study|Withdrawal by Subject|5|||
37858293|NCT01181271|69541592|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
37858294|NCT01181271|69541592|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
37923419|NCT00856583|69610225|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
37664754|NCT04776161|69137224|FG001|Overall Study|Withdrawal by Subject|0|||
37755984|NCT01591499|69263703|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
37755985|NCT01591499|69263704|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
37755986|NCT01591499|69263705|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
37755987|NCT01591499|69263706|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
37755988|NCT01591499|69263703|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
37755989|NCT01591499|69263704|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
37755990|NCT01591499|69263705|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
37755991|NCT01591499|69263706|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
37755992|NCT01590797|69263732|FG000|Overall Study|Adverse Event|4|||
37755993|NCT01590797|69263733|FG001|Overall Study|Adverse Event|3|||
37755994|NCT01590797|69263732|FG000|Overall Study|Lack of Efficacy|0|||
37755995|NCT01590797|69263733|FG001|Overall Study|Lack of Efficacy|2|||
37755996|NCT01590797|69263732|FG000|Overall Study|Lost to Follow-up|0|||
37755997|NCT01590797|69263733|FG001|Overall Study|Lost to Follow-up|1|||
37755998|NCT01590797|69263732|FG000|Overall Study|Protocol Violation|4|||
37755999|NCT01590797|69263733|FG001|Overall Study|Protocol Violation|1|||
37756000|NCT01590797|69263732|FG000|Overall Study|Withdrawal by Subject|7|||
37756001|NCT01590797|69263733|FG001|Overall Study|Withdrawal by Subject|5|||
37756002|NCT01590797|69263732|FG000|Overall Study|Other Protocol Specified Criteria|2|||
37756003|NCT01590797|69263733|FG001|Overall Study|Other Protocol Specified Criteria|4|||
37756004|NCT01590563|69263739|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
37756005|NCT01701401|69263748|FG000|Overall Study|Randomized But Not Treated|3|||
37756006|NCT01701401|69263749|FG001|Overall Study|Randomized But Not Treated|1|||
37756007|NCT01701401|69263750|FG002|Overall Study|Randomized But Not Treated|0|||
37756008|NCT01701401|69263751|FG003|Overall Study|Randomized But Not Treated|1|||
37756009|NCT01701401|69263748|FG000|Overall Study|Lost to Follow-up|5|||
37756010|NCT01701401|69263749|FG001|Overall Study|Lost to Follow-up|5|||
37756011|NCT01701401|69263750|FG002|Overall Study|Lost to Follow-up|1|||
37756012|NCT01701401|69263751|FG003|Overall Study|Lost to Follow-up|3|||
37756013|NCT01701401|69263748|FG000|Overall Study|Withdrew Consent|0|||
37756014|NCT01701401|69263749|FG001|Overall Study|Withdrew Consent|3|||
37756015|NCT01701401|69263750|FG002|Overall Study|Withdrew Consent|1|||
37756016|NCT01701401|69263751|FG003|Overall Study|Withdrew Consent|2|||
37756017|NCT01701401|69263748|FG000|Overall Study|Lack of Efficacy|1|||
37756018|NCT01701401|69263749|FG001|Overall Study|Lack of Efficacy|0|||
37756019|NCT01701401|69263750|FG002|Overall Study|Lack of Efficacy|2|||
37756020|NCT01701401|69263751|FG003|Overall Study|Lack of Efficacy|0|||
37756021|NCT01701401|69263748|FG000|Overall Study|Adverse Event|1|||
37756022|NCT01701401|69263749|FG001|Overall Study|Adverse Event|0|||
37664755|NCT04776161|69137225|FG002|Overall Study|Withdrawal by Subject|1|||
37664756|NCT04776161|69137223|FG000|Overall Study|Adverse Event|0|||
37664757|NCT04776161|69137224|FG001|Overall Study|Adverse Event|1|||
37664758|NCT04776161|69137225|FG002|Overall Study|Adverse Event|1|||
37664759|NCT04268823|69137239|FG000|Overall Study|Adverse Event|1|||
37664760|NCT04268823|69137240|FG001|Overall Study|Adverse Event|0|||
37664761|NCT04268823|69137239|FG000|Overall Study|Participant Decision|1|||
37664762|NCT04268823|69137240|FG001|Overall Study|Participant Decision|0|||
37664763|NCT04226495|69137249|FG000|Overall Study|Withdrawal by Subject|3|||
37664764|NCT04226495|69137250|FG001|Overall Study|Withdrawal by Subject|3|||
37664765|NCT04226495|69137249|FG000|Overall Study|PI discretion|2|||
37664766|NCT04226495|69137250|FG001|Overall Study|PI discretion|4|||
37664767|NCT04060212|69137256|FG000|Overall Study|Withdrawal by Subject|7|||
37664768|NCT04024462|69137262|FG000|Overall Study|Withdrawal by Subject|6|||
37664769|NCT04024462|69137263|FG001|Overall Study|Withdrawal by Subject|7|||
37664770|NCT04024462|69137262|FG000|Overall Study|Progressive Disease|0|||
37664771|NCT04024462|69137263|FG001|Overall Study|Progressive Disease|1|||
37664772|NCT04024462|69137262|FG000|Overall Study|Adverse Event|0|||
37664773|NCT04024462|69137263|FG001|Overall Study|Adverse Event|1|||
37664774|NCT04024462|69137262|FG000|Overall Study|Death|0|||
37664775|NCT04024462|69137263|FG001|Overall Study|Death|1|||
37664776|NCT04024462|69137262|FG000|Overall Study|Lost to Follow-up|1|||
37858295|NCT01181271|69541592|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
37664777|NCT04024462|69137263|FG001|Overall Study|Lost to Follow-up|0|||
37664778|NCT04024462|69137262|FG000|Overall Study|Ongoing in the Study|94|||
37664779|NCT04024462|69137263|FG001|Overall Study|Ongoing in the Study|89|||
37664780|NCT04007991|69137271|FG000|Overall Study|Withdrawal by Subject|1|||
37664781|NCT04007991|69137272|FG001|Overall Study|Withdrawal by Subject|1|||
37664782|NCT04007991|69137271|FG000|Overall Study|Physician Decision|1|||
37756023|NCT01701401|69263750|FG002|Overall Study|Adverse Event|0|||
37756024|NCT01701401|69263751|FG003|Overall Study|Adverse Event|0|||
37756025|NCT01701401|69263748|FG000|Overall Study|Protocol Violation|0|||
37756026|NCT01701401|69263749|FG001|Overall Study|Protocol Violation|0|||
37756027|NCT01701401|69263750|FG002|Overall Study|Protocol Violation|1|||
37756028|NCT01701401|69263751|FG003|Overall Study|Protocol Violation|0|||
37756029|NCT01701245|69263763|FG000|Overall Study|Protocol Violation|1|||
37756030|NCT01701245|69263764|FG001|Overall Study|Protocol Violation|3|||
37756031|NCT01701245|69263763|FG000|Overall Study|Did not complete the open label period|11|||
37756032|NCT01701245|69263764|FG001|Overall Study|Did not complete the open label period|12|||
37756033|NCT01590017|69263770|FG000|Overall Study|Adverse Event|1|||
37756034|NCT01590017|69263770|FG000|Overall Study|Withdrawal by Subject|1|||
37756035|NCT01590017|69263770|FG000|Overall Study|Lack of Efficacy|1|||
37756036|NCT01590017|69263770|FG000|Overall Study|Physician Decision|1|||
37756037|NCT01700621|69263776|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
37756038|NCT01700621|69263777|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
37756039|NCT01700621|69263776|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
37756040|NCT01700621|69263777|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
37756041|NCT01700621|69263776|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
37756042|NCT01700621|69263777|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
37756043|NCT01589237|69263788|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
37756044|NCT01589237|69263789|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
37756045|NCT01589237|69263790|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
37756046|NCT01589237|69263791|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
37756047|NCT01589237|69263788|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
37756048|NCT01589237|69263789|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
37756049|NCT01589237|69263790|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
37756050|NCT01589237|69263791|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
37756051|NCT01589237|69263788|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
37756052|NCT01589237|69263789|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
37756053|NCT01589237|69263790|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
37756054|NCT01589237|69263791|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
37756055|NCT01589237|69263788|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
37756056|NCT01589237|69263789|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
37756057|NCT01589237|69263790|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
37756058|NCT01589237|69263791|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
37756059|NCT01700387|69263807|FG000|Overall Study|Withdrawal by Subject|1|||
37756060|NCT01700387|69263808|FG001|Overall Study|Withdrawal by Subject|2|||
37756061|NCT01700387|69263807|FG000|Overall Study|Adverse Event|1|||
37756062|NCT01700387|69263808|FG001|Overall Study|Adverse Event|1|||
37756063|NCT01700387|69263807|FG000|Overall Study|Lost to Follow-up|2|||
37756064|NCT01700387|69263808|FG001|Overall Study|Lost to Follow-up|1|||
37756065|NCT01699685|69263820|FG000|Period 1|Adverse Event|1|||
37756066|NCT01699685|69263821|FG001|Period 1|Adverse Event|1|||
37756067|NCT01699685|69263820|FG000|Period 1|Medical or ethical, noncompliance|2|||
37756068|NCT01699685|69263821|FG001|Period 1|Medical or ethical, noncompliance|0|||
37756069|NCT01699685|69263820|FG000|Period 1|Other|0|||
37756070|NCT01699685|69263821|FG001|Period 1|Other|1|||
37756071|NCT01699685|69263820|FG000|Period 1|Patient request|0|||
37756072|NCT01699685|69263821|FG001|Period 1|Patient request|1|||
37756073|NCT01699685|69263820|FG000|Period 2|Lost to Follow-up|1|||
37756074|NCT01699685|69263821|FG001|Period 2|Lost to Follow-up|0|||
37756075|NCT01587989|69263829|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
37756076|NCT01587989|69263830|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
37756077|NCT01587989|69263831|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
37756078|NCT01587989|69263829|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
37756079|NCT01587989|69263830|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
37756080|NCT01587989|69263831|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
37756081|NCT01587989|69263829|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
37756082|NCT01587989|69263830|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
37756083|NCT01587989|69263831|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
37756084|NCT01587989|69263829|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
37756085|NCT01587989|69263830|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
37756086|NCT01587989|69263831|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
37756087|NCT01587989|69263829|FG000|Randomized Study Treatment|Screening failure|0|||
37756088|NCT01587989|69263830|FG001|Randomized Study Treatment|Screening failure|1|||
37756089|NCT01587989|69263831|FG002|Randomized Study Treatment|Screening failure|0|||
37923420|NCT00856583|69610226|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
37923421|NCT00856349|69610232|FG000|Overall Study|Death|418|||
37923422|NCT00856349|69610232|FG000|Overall Study|Withdrawal by Subject|116|||
37923423|NCT00856349|69610232|FG000|Overall Study|Lost to Follow-up|91|||
37923424|NCT00856349|69610232|FG000|Overall Study|Protocol Violation|38|||
37756090|NCT01587989|69263829|FG000|Randomized Study Treatment|Physician Decision|0|||
37756091|NCT01587989|69263830|FG001|Randomized Study Treatment|Physician Decision|0|||
37756092|NCT01587989|69263831|FG002|Randomized Study Treatment|Physician Decision|1|||
37756093|NCT01697969|69263837|FG000|Overall Study|Did not meet inc/exc criteria|3|||
37756094|NCT01586819|69263844|FG000|Overall Study|Withdrawal by Subject|1|||
37756095|NCT01586819|69263845|FG001|Overall Study|Withdrawal by Subject|0|||
37756096|NCT01697579|69263856|FG000|Base Study-Cycle 1|Adverse Event|1|||
37756097|NCT01697579|69263857|FG001|Base Study-Cycle 1|Adverse Event|0|||
37756098|NCT01697579|69263858|FG002|Base Study-Cycle 1|Adverse Event|0|||
37756099|NCT01697579|69263859|FG003|Base Study-Cycle 1|Adverse Event|0|||
37756100|NCT01697579|69263860|FG004|Base Study-Cycle 1|Adverse Event|0|||
37756101|NCT01697579|69263861|FG005|Base Study-Cycle 1|Adverse Event|0|||
37756102|NCT01697579|69263862|FG006|Base Study-Cycle 1|Adverse Event|0|||
37756103|NCT01697579|69263856|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
37756104|NCT01697579|69263857|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
37756105|NCT01697579|69263858|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
37756106|NCT01697579|69263859|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
37756107|NCT01697579|69263860|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
37756108|NCT01697579|69263861|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
37756109|NCT01697579|69263862|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
37756110|NCT01697579|69263856|FG000|Base Study-Cycle 1|Protocol Violation|0|||
37756111|NCT01697579|69263857|FG001|Base Study-Cycle 1|Protocol Violation|0|||
37756112|NCT01697579|69263858|FG002|Base Study-Cycle 1|Protocol Violation|0|||
37756113|NCT01697579|69263859|FG003|Base Study-Cycle 1|Protocol Violation|0|||
37756114|NCT01697579|69263860|FG004|Base Study-Cycle 1|Protocol Violation|3|||
37756115|NCT01697579|69263861|FG005|Base Study-Cycle 1|Protocol Violation|0|||
37756116|NCT01697579|69263862|FG006|Base Study-Cycle 1|Protocol Violation|0|||
37756117|NCT01697579|69263856|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
37756118|NCT01697579|69263857|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
37756119|NCT01697579|69263858|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
37756120|NCT01697579|69263859|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
37756121|NCT01697579|69263860|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
37756122|NCT01697579|69263861|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
37756123|NCT01697579|69263862|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
37756124|NCT01697579|69263856|FG000|Base Study-Cycle 1|Technical Problems|0|||
37756125|NCT01697579|69263857|FG001|Base Study-Cycle 1|Technical Problems|0|||
37756126|NCT01697579|69263858|FG002|Base Study-Cycle 1|Technical Problems|1|||
37756127|NCT01697579|69263859|FG003|Base Study-Cycle 1|Technical Problems|1|||
37756128|NCT01697579|69263860|FG004|Base Study-Cycle 1|Technical Problems|0|||
37756129|NCT01697579|69263861|FG005|Base Study-Cycle 1|Technical Problems|0|||
37756130|NCT01697579|69263862|FG006|Base Study-Cycle 1|Technical Problems|0|||
37756131|NCT01697579|69263856|FG000|Optional Extension-Cycles 2-6|Death|0|||
37756132|NCT01697579|69263857|FG001|Optional Extension-Cycles 2-6|Death|0|||
37756133|NCT01697579|69263858|FG002|Optional Extension-Cycles 2-6|Death|0|||
37756134|NCT01697579|69263859|FG003|Optional Extension-Cycles 2-6|Death|0|||
37756135|NCT01697579|69263860|FG004|Optional Extension-Cycles 2-6|Death|0|||
37756136|NCT01697579|69263861|FG005|Optional Extension-Cycles 2-6|Death|0|||
37756137|NCT01697579|69263862|FG006|Optional Extension-Cycles 2-6|Death|2|||
37756138|NCT01697579|69263856|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
37756139|NCT01697579|69263857|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
37664783|NCT04007991|69137272|FG001|Overall Study|Physician Decision|1|||
37664784|NCT04007991|69137271|FG000|Overall Study|Non-compliance with Study Drug|0|||
37664785|NCT04007991|69137272|FG001|Overall Study|Non-compliance with Study Drug|1|||
37664786|NCT04007991|69137271|FG000|Overall Study|Withdrawal by Parent/Caregiver|1|||
37756140|NCT01697579|69263858|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
37756141|NCT01697579|69263859|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
37756142|NCT01697579|69263860|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
37756143|NCT01697579|69263861|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
37756144|NCT01697579|69263862|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
37756145|NCT01697579|69263856|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
37756146|NCT01697579|69263857|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
37858296|NCT01181271|69541592|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
37858297|NCT01180647|69541598|FG000|Overall Study|Lost to Follow-up|5|||
37664787|NCT04007991|69137272|FG001|Overall Study|Withdrawal by Parent/Caregiver|2|||
37664788|NCT04007991|69137271|FG000|Overall Study|Adverse event, non-fatal|5|||
37664789|NCT04007991|69137272|FG001|Overall Study|Adverse event, non-fatal|0|||
37664790|NCT04007991|69137271|FG000|Overall Study|Lost to Follow-up|2|||
37664791|NCT04007991|69137272|FG001|Overall Study|Lost to Follow-up|1|||
37664792|NCT03935217|69137293|FG000|Overall Study|Adverse Event|1|||
37858298|NCT01180647|69541599|FG001|Overall Study|Lost to Follow-up|6|||
37858299|NCT00969553|69541614|FG000|Overall Study|Progressive disease (PD)|2|||
37858300|NCT00969553|69541615|FG001|Overall Study|Progressive disease (PD)|2|||
37858301|NCT00969553|69541616|FG002|Overall Study|Progressive disease (PD)|6|||
37664793|NCT03935217|69137294|FG001|Overall Study|Adverse Event|0|||
37756147|NCT01697579|69263858|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
37756148|NCT01697579|69263859|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
37756149|NCT01697579|69263860|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
37756150|NCT01697579|69263861|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
37756151|NCT01697579|69263862|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
37756152|NCT01697579|69263856|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
37756153|NCT01697579|69263857|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
37756154|NCT01697579|69263858|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
37756155|NCT01697579|69263859|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
37858302|NCT00969553|69541617|FG003|Overall Study|Progressive disease (PD)|9|||
37858303|NCT00969553|69541618|FG004|Overall Study|Progressive disease (PD)|2|||
37858304|NCT00969553|69541619|FG005|Overall Study|Progressive disease (PD)|4|||
37858305|NCT00969553|69541620|FG006|Overall Study|Progressive disease (PD)|2|||
37858306|NCT00969553|69541621|FG007|Overall Study|Progressive disease (PD)|12|||
37858307|NCT00969553|69541622|FG008|Overall Study|Progressive disease (PD)|3|||
37858308|NCT00969553|69541614|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
37858309|NCT00969553|69541615|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
37858310|NCT00969553|69541616|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
37858311|NCT00969553|69541617|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
37858312|NCT00969553|69541618|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
37858313|NCT00969553|69541619|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
37858314|NCT00969553|69541620|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
37858315|NCT00969553|69541621|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
37858316|NCT00969553|69541622|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
37858317|NCT00969553|69541614|FG000|Overall Study|Other Adverse Event|0|||
37858318|NCT00969553|69541615|FG001|Overall Study|Other Adverse Event|0|||
37858319|NCT00969553|69541616|FG002|Overall Study|Other Adverse Event|0|||
37858320|NCT00969553|69541617|FG003|Overall Study|Other Adverse Event|1|||
37858321|NCT00969553|69541618|FG004|Overall Study|Other Adverse Event|0|||
37858322|NCT00969553|69541619|FG005|Overall Study|Other Adverse Event|0|||
37858323|NCT00969553|69541620|FG006|Overall Study|Other Adverse Event|1|||
37858324|NCT00969553|69541621|FG007|Overall Study|Other Adverse Event|0|||
37858325|NCT00969553|69541622|FG008|Overall Study|Other Adverse Event|0|||
37858326|NCT00969553|69541614|FG000|Overall Study|Refused cont. medication|1|||
37858327|NCT00969553|69541615|FG001|Overall Study|Refused cont. medication|1|||
37858328|NCT00969553|69541616|FG002|Overall Study|Refused cont. medication|0|||
37858329|NCT00969553|69541617|FG003|Overall Study|Refused cont. medication|2|||
37858330|NCT00969553|69541618|FG004|Overall Study|Refused cont. medication|0|||
37858331|NCT00969553|69541619|FG005|Overall Study|Refused cont. medication|0|||
37858332|NCT00969553|69541620|FG006|Overall Study|Refused cont. medication|0|||
37858333|NCT00969553|69541621|FG007|Overall Study|Refused cont. medication|1|||
37858334|NCT00969553|69541622|FG008|Overall Study|Refused cont. medication|0|||
37858335|NCT00969553|69541614|FG000|Overall Study|Not specified above|0|||
37664794|NCT03935217|69137293|FG000|Overall Study|Lost to Follow-up|0|||
37664795|NCT03935217|69137294|FG001|Overall Study|Lost to Follow-up|1|||
37664796|NCT03935217|69137293|FG000|Overall Study|Withdrawal by Subject|0|||
37664797|NCT03935217|69137294|FG001|Overall Study|Withdrawal by Subject|2|||
37664798|NCT03806933|69137308|FG000|Main Period|Physician Decision|0|||
37664799|NCT03806933|69137309|FG001|Main Period|Physician Decision|0|||
37664800|NCT03806933|69137310|FG002|Main Period|Physician Decision|0|||
37664801|NCT03806933|69137311|FG003|Main Period|Physician Decision|1|||
37664802|NCT03806933|69137308|FG000|Main Period|Pregnancy|0|||
37664803|NCT03806933|69137309|FG001|Main Period|Pregnancy|0|||
37664804|NCT03806933|69137310|FG002|Main Period|Pregnancy|1|||
37664805|NCT03806933|69137311|FG003|Main Period|Pregnancy|0|||
37664806|NCT03806933|69137308|FG000|Main Period|Withdrawal by Subject|2|||
37664807|NCT03806933|69137309|FG001|Main Period|Withdrawal by Subject|1|||
37664808|NCT03806933|69137310|FG002|Main Period|Withdrawal by Subject|1|||
37664809|NCT03806933|69137311|FG003|Main Period|Withdrawal by Subject|2|||
37664810|NCT03806933|69137308|FG000|Main Period|Lost to Follow-up|2|||
37858336|NCT00969553|69541615|FG001|Overall Study|Not specified above|0|||
37858337|NCT00969553|69541616|FG002|Overall Study|Not specified above|0|||
37858338|NCT00969553|69541617|FG003|Overall Study|Not specified above|4|||
37858339|NCT00969553|69541618|FG004|Overall Study|Not specified above|0|||
37858340|NCT00969553|69541619|FG005|Overall Study|Not specified above|0|||
37858341|NCT00969553|69541620|FG006|Overall Study|Not specified above|1|||
37858342|NCT00969553|69541621|FG007|Overall Study|Not specified above|1|||
37923425|NCT00856349|69610232|FG000|Overall Study|Physician Decision|13|||
38033319|NCT04493684|69719207|FG012|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
38033320|NCT04493684|69719208|FG013|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
37858343|NCT00969553|69541622|FG008|Overall Study|Not specified above|0|||
37858344|NCT01179477|69541650|FG000|Overall Study|Death|542|||
37858345|NCT01179477|69541650|FG000|Overall Study|Unsuccessful implant|80|||
37858346|NCT01179477|69541650|FG000|Overall Study|Non-death withdrawal|438|||
37858347|NCT01179477|69541650|FG000|Overall Study|Did not complete final visit|27|||
37923426|NCT00856349|69610232|FG000|Overall Study|Subject relocation|104|||
37664811|NCT03806933|69137309|FG001|Main Period|Lost to Follow-up|2|||
37664812|NCT03806933|69137310|FG002|Main Period|Lost to Follow-up|0|||
37664813|NCT03806933|69137311|FG003|Main Period|Lost to Follow-up|0|||
37664814|NCT03806933|69137308|FG000|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
37664815|NCT03806933|69137309|FG001|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
37923427|NCT00856349|69610232|FG000|Overall Study|Device explant|33|||
37756156|NCT01697579|69263860|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
37756157|NCT01697579|69263861|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
37756158|NCT01697579|69263862|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
37756159|NCT01697579|69263856|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
37756160|NCT01697579|69263857|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
37756161|NCT01697579|69263858|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
37756162|NCT01697579|69263859|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
37756163|NCT01697579|69263860|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
37756164|NCT01697579|69263861|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
37756165|NCT01697579|69263862|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
37756166|NCT01697579|69263856|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
37756167|NCT01697579|69263857|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
37756168|NCT01697579|69263858|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
37756169|NCT01697579|69263859|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
37756170|NCT01697579|69263860|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
37756171|NCT01697579|69263861|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
37664816|NCT03806933|69137310|FG002|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
37664817|NCT03806933|69137311|FG003|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|1|||
37664818|NCT03735121|69137335|FG000|Overall Study|Death|3|||
37664819|NCT03735121|69137336|FG001|Overall Study|Death|6|||
37664820|NCT03735121|69137337|FG002|Overall Study|Death|8|||
37756172|NCT01697579|69263862|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
37756173|NCT01697579|69263856|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
37756174|NCT01697579|69263857|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
37664821|NCT03735121|69137338|FG003|Overall Study|Death|37|||
37664822|NCT03735121|69137339|FG004|Overall Study|Death|86|||
37664823|NCT03735121|69137335|FG000|Overall Study|Withdrawal by Subject|1|||
37664824|NCT03735121|69137336|FG001|Overall Study|Withdrawal by Subject|1|||
37664825|NCT03735121|69137337|FG002|Overall Study|Withdrawal by Subject|3|||
37664826|NCT03735121|69137338|FG003|Overall Study|Withdrawal by Subject|4|||
37664827|NCT03735121|69137339|FG004|Overall Study|Withdrawal by Subject|2|||
37664828|NCT03735121|69137335|FG000|Overall Study|Progressive Disease|0|||
37664829|NCT03735121|69137336|FG001|Overall Study|Progressive Disease|0|||
37664830|NCT03735121|69137337|FG002|Overall Study|Progressive Disease|1|||
37664831|NCT03735121|69137338|FG003|Overall Study|Progressive Disease|0|||
37664832|NCT03735121|69137339|FG004|Overall Study|Progressive Disease|0|||
37664833|NCT03735121|69137335|FG000|Overall Study|Lost to Follow-up|0|||
37664834|NCT03735121|69137336|FG001|Overall Study|Lost to Follow-up|0|||
37664835|NCT03735121|69137337|FG002|Overall Study|Lost to Follow-up|0|||
37756175|NCT01697579|69263858|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
37756176|NCT01697579|69263859|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
37756177|NCT01697579|69263860|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
37756178|NCT01697579|69263861|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
37756179|NCT01697579|69263862|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
37756180|NCT01697579|69263856|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
37756181|NCT01697579|69263857|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
37756182|NCT01697579|69263858|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
37756183|NCT01697579|69263859|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
37756184|NCT01697579|69263860|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
37756185|NCT01697579|69263861|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
37756186|NCT01697579|69263862|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
37756187|NCT01697579|69263856|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
37756188|NCT01697579|69263857|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
37756189|NCT01697579|69263858|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
37756190|NCT01697579|69263859|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
37756191|NCT01697579|69263860|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
37756192|NCT01697579|69263861|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
37756193|NCT01697579|69263862|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
37664836|NCT03735121|69137338|FG003|Overall Study|Lost to Follow-up|0|||
37756194|NCT01697579|69263856|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
37664837|NCT03735121|69137339|FG004|Overall Study|Lost to Follow-up|1|||
37664838|NCT03735121|69137335|FG000|Overall Study|Ongoing|3|||
37756195|NCT01697579|69263857|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
37664839|NCT03735121|69137336|FG001|Overall Study|Ongoing|3|||
37664840|NCT03735121|69137337|FG002|Overall Study|Ongoing|26|||
37664841|NCT03735121|69137338|FG003|Overall Study|Ongoing|83|||
37664842|NCT03735121|69137339|FG004|Overall Study|Ongoing|158|||
37664843|NCT03590613|69137375|FG000|Period 2, 4 Days|Physician Decision|0|||
37664844|NCT03590613|69137376|FG001|Period 2, 4 Days|Physician Decision|0|||
37664845|NCT03590613|69137377|FG002|Period 2, 4 Days|Physician Decision|0|||
37664846|NCT03590613|69137378|FG003|Period 2, 4 Days|Physician Decision|1|||
37664847|NCT02689258|69137419|FG000|Overall Study|Subject Non-Compliance|0|||
37858348|NCT01179399|69541654|FG000|Overall Study|Adverse Event|1|||
37858349|NCT01179399|69541654|FG000|Overall Study|Lack of Efficacy|30|||
37858350|NCT01179399|69541654|FG000|Overall Study|Withdrawal by Subject|1|||
37858351|NCT01178853|69541660|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
37858352|NCT01178853|69541661|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
37858353|NCT01178853|69541660|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
37858354|NCT01178853|69541661|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
37858355|NCT01178853|69541660|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
37858356|NCT01178853|69541661|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
37858357|NCT01178853|69541660|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
37858358|NCT01178853|69541661|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
37858359|NCT01178853|69541660|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
37858360|NCT01178853|69541661|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
37858361|NCT01178385|69541669|FG000|Overall Study|Withdrawal by Subject|2|||
37858362|NCT01178385|69541670|FG001|Overall Study|Withdrawal by Subject|0|||
37858363|NCT01288976|69541679|FG000|Overall Study|Withdrawal by Subject|58|||
37858364|NCT01288976|69541680|FG001|Overall Study|Withdrawal by Subject|12|||
37858365|NCT01288976|69541681|FG002|Overall Study|Withdrawal by Subject|9|||
37858366|NCT01288976|69541679|FG000|Overall Study|Death|98|||
37664848|NCT02689258|69137420|FG001|Overall Study|Subject Non-Compliance|1|||
37664849|NCT02689258|69137421|FG002|Overall Study|Subject Non-Compliance|0|||
37664850|NCT02689258|69137422|FG003|Overall Study|Subject Non-Compliance|0|||
37664851|NCT02689258|69137423|FG004|Overall Study|Subject Non-Compliance|0|||
37664852|NCT02689258|69137424|FG005|Overall Study|Subject Non-Compliance|0|||
37664853|NCT02689258|69137425|FG006|Overall Study|Subject Non-Compliance|0|||
37664854|NCT02689258|69137426|FG007|Overall Study|Subject Non-Compliance|0|||
37664855|NCT02689258|69137427|FG008|Overall Study|Subject Non-Compliance|0|||
37664856|NCT02689258|69137428|FG009|Overall Study|Subject Non-Compliance|0|||
37664857|NCT02689258|69137429|FG010|Overall Study|Subject Non-Compliance|0|||
37664858|NCT02689258|69137430|FG011|Overall Study|Subject Non-Compliance|0|||
37664859|NCT02689258|69137419|FG000|Overall Study|Subject Refusal to Continue|0|||
37756196|NCT01697579|69263858|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
37756197|NCT01697579|69263859|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
37756198|NCT01697579|69263860|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
37756199|NCT01697579|69263861|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
37756200|NCT01697579|69263862|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
37756201|NCT01697579|69263856|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
37756202|NCT01697579|69263857|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
37756203|NCT01697579|69263858|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
37756204|NCT01697579|69263859|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
37756205|NCT01697579|69263860|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
37858367|NCT01288976|69541680|FG001|Overall Study|Death|6|||
37858368|NCT01288976|69541681|FG002|Overall Study|Death|4|||
37858369|NCT01288976|69541679|FG000|Overall Study|Data unavailable|22|||
37858370|NCT01288976|69541680|FG001|Overall Study|Data unavailable|9|||
37858371|NCT01288976|69541681|FG002|Overall Study|Data unavailable|7|||
37858372|NCT00970489|69541689|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
37858373|NCT00970489|69541690|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
37858374|NCT00968617|69541696|FG000|Overall Study|Study terminated by sponsor|6|||
37858375|NCT00968539|69541702|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
37858376|NCT00968539|69541703|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
37858377|NCT00976573|69541712|FG000|Overall Study|Ineligible|0|||
37858378|NCT00976573|69541713|FG001|Overall Study|Ineligible|1|||
37858379|NCT00976573|69541712|FG000|Overall Study|Cancel prior to receiving treatment|4|||
37858380|NCT00976573|69541713|FG001|Overall Study|Cancel prior to receiving treatment|2|||
37858381|NCT00976495|69541722|FG000|Overall Study|Withdrawal by Subject|0|||
37858382|NCT00976495|69541723|FG001|Overall Study|Withdrawal by Subject|1|||
37858383|NCT00976495|69541724|FG002|Overall Study|Withdrawal by Subject|0|||
37858384|NCT01288430|69541742|FG000|Part 1|Progressive disease|2|||
37858385|NCT01288430|69541743|FG001|Part 1|Progressive disease|1|||
37858386|NCT01288430|69541744|FG002|Part 1|Progressive disease|1|||
37923428|NCT00856349|69610232|FG000|Overall Study|Site closure|78|||
37664860|NCT02689258|69137420|FG001|Overall Study|Subject Refusal to Continue|1|||
37664861|NCT02689258|69137421|FG002|Overall Study|Subject Refusal to Continue|0|||
37664862|NCT02689258|69137422|FG003|Overall Study|Subject Refusal to Continue|0|||
37756206|NCT01697579|69263861|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
37858387|NCT01288430|69541745|FG003|Part 1|Progressive disease|6|||
37858388|NCT01288430|69541746|FG004|Part 1|Progressive disease|2|||
37858389|NCT01288430|69541747|FG005|Part 1|Progressive disease|4|||
37858390|NCT01288430|69541748|FG006|Part 1|Progressive disease|2|||
37858391|NCT01288430|69541749|FG007|Part 1|Progressive disease|0|||
37858392|NCT01288430|69541750|FG008|Part 1|Progressive disease|0|||
37664863|NCT02689258|69137423|FG004|Overall Study|Subject Refusal to Continue|0|||
37664864|NCT02689258|69137424|FG005|Overall Study|Subject Refusal to Continue|0|||
37664865|NCT02689258|69137425|FG006|Overall Study|Subject Refusal to Continue|0|||
37664866|NCT02689258|69137426|FG007|Overall Study|Subject Refusal to Continue|0|||
37664867|NCT02689258|69137427|FG008|Overall Study|Subject Refusal to Continue|1|||
37664868|NCT02689258|69137428|FG009|Overall Study|Subject Refusal to Continue|0|||
37664869|NCT02689258|69137429|FG010|Overall Study|Subject Refusal to Continue|0|||
37664870|NCT02689258|69137430|FG011|Overall Study|Subject Refusal to Continue|1|||
37664871|NCT02689258|69137419|FG000|Overall Study|Other|0|||
37664872|NCT02689258|69137420|FG001|Overall Study|Other|2|||
37664873|NCT02689258|69137421|FG002|Overall Study|Other|0|||
37664874|NCT02689258|69137422|FG003|Overall Study|Other|0|||
37664875|NCT02689258|69137423|FG004|Overall Study|Other|1|||
37664876|NCT02689258|69137424|FG005|Overall Study|Other|0|||
37664877|NCT02689258|69137425|FG006|Overall Study|Other|0|||
37756207|NCT01697579|69263862|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
37756208|NCT01697579|69263856|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
37756209|NCT01697579|69263857|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
37756210|NCT01697579|69263858|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
37756211|NCT01697579|69263859|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
37756212|NCT01697579|69263860|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
37756213|NCT01697579|69263861|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
37756214|NCT01697579|69263862|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
37756215|NCT01697579|69263856|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
37756216|NCT01697579|69263857|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
37756217|NCT01697579|69263858|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
37756218|NCT01697579|69263859|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
37756219|NCT01697579|69263860|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
37756220|NCT01697579|69263861|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
37756221|NCT01697579|69263862|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
37756222|NCT01586195|69263890|FG000|Overall Study|Death|11|||
37756223|NCT01586195|69263890|FG000|Overall Study|Withdrawal of Consent|5|||
37756224|NCT01586195|69263890|FG000|Overall Study|Started new anti-melanoma therapy|1|||
37756225|NCT01586195|69263890|FG000|Overall Study|Reason not specified|9|||
37664878|NCT02689258|69137426|FG007|Overall Study|Other|0|||
37664879|NCT02689258|69137427|FG008|Overall Study|Other|1|||
37664880|NCT02689258|69137428|FG009|Overall Study|Other|0|||
37664881|NCT02689258|69137429|FG010|Overall Study|Other|0|||
37664882|NCT02689258|69137430|FG011|Overall Study|Other|0|||
37664883|NCT02685735|69137453|FG000|Overall Study|Missing construct or pain data|23|||
37664884|NCT02685735|69137454|FG001|Overall Study|Missing construct or pain data|22|||
37664885|NCT02606136|69137479|FG000|Overall Study|Participant/Legal Guardian Decision|5|||
37756226|NCT01585961|69263894|FG000|Overall Study|Death|6|||
37756227|NCT01585961|69263894|FG000|Overall Study|Physician Decision|1|||
37756228|NCT01585961|69263894|FG000|Overall Study|Decision to use non-study catheter|1|||
37756229|NCT01585961|69263894|FG000|Overall Study|Withdrawal by Subject|1|||
37756230|NCT01585961|69263894|FG000|Overall Study|Lost to Follow-up|23|||
37756231|NCT01585961|69263894|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
37756232|NCT01697501|69263898|FG000|Overall Study|Protocol Violation|2|||
37756233|NCT01697345|69263911|FG000|Overall Study|Withdrawal by Subject|1|||
37756234|NCT01697267|69263980|FG000|Overall Study|Death|3|||
37756235|NCT01697267|69263981|FG001|Overall Study|Death|1|||
37756236|NCT01697267|69263980|FG000|Overall Study|Withdrawal by Subject|5|||
37756237|NCT01697267|69263981|FG001|Overall Study|Withdrawal by Subject|5|||
37756238|NCT01697267|69263980|FG000|Overall Study|Adverse Event|2|||
37756239|NCT01697267|69263981|FG001|Overall Study|Adverse Event|1|||
37756240|NCT01697267|69263980|FG000|Overall Study|Lost to Follow-up|2|||
37756241|NCT01697267|69263981|FG001|Overall Study|Lost to Follow-up|4|||
37756242|NCT01697267|69263980|FG000|Overall Study|Physician Decision|2|||
37756243|NCT01697267|69263981|FG001|Overall Study|Physician Decision|4|||
37756244|NCT01696955|69264043|FG000|Main Study|Protocol Violation|1|||
37756245|NCT01696955|69264044|FG001|Main Study|Protocol Violation|0|||
37664886|NCT02606136|69137479|FG000|Overall Study|Withdrawal by Subject|1|||
37756246|NCT01696955|69264043|FG000|Main Study|Withdrawal by Subject|1|||
37923429|NCT00856349|69610232|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
37923430|NCT00803244|69610240|FG000|Overall Study|Adverse Event|1|||
37923431|NCT00803244|69610241|FG001|Overall Study|Adverse Event|2|||
37923432|NCT00803244|69610240|FG000|Overall Study|Withdrawal by Subject|2|||
37923433|NCT00803244|69610241|FG001|Overall Study|Withdrawal by Subject|3|||
37923434|NCT00803244|69610240|FG000|Overall Study|Any other reason not above-mentioned|4|||
37756247|NCT01696955|69264044|FG001|Main Study|Withdrawal by Subject|1|||
37756248|NCT02702388|69264068|FG000|Overall Study|Disease Progression|18|||
37756249|NCT02702388|69264069|FG001|Overall Study|Disease Progression|25|||
37756250|NCT02702388|69264068|FG000|Overall Study|Withdrawal by Subject|9|||
37756251|NCT02702388|69264069|FG001|Overall Study|Withdrawal by Subject|7|||
37756252|NCT02702388|69264068|FG000|Overall Study|Adverse Event|11|||
37756253|NCT02702388|69264069|FG001|Overall Study|Adverse Event|15|||
37756254|NCT02702388|69264068|FG000|Overall Study|Other|2|||
37756255|NCT02702388|69264069|FG001|Overall Study|Other|4|||
37756256|NCT01696877|69264095|FG000|Overall Study|Adverse Event|0|||
37756257|NCT01696877|69264096|FG001|Overall Study|Adverse Event|1|||
37756258|NCT02703636|69264283|FG000|Overall Study|Adverse Event|14|||
37756259|NCT02703636|69264283|FG000|Overall Study|Study stopped by sponsor|1|||
37756260|NCT02703636|69264283|FG000|Overall Study|Withdrawal by Subject|1|||
37756261|NCT02703324|69264511|FG000|Period Two|Withdrawal by Subject|0|||
37756262|NCT02703324|69264512|FG001|Period Two|Withdrawal by Subject|0|||
37756263|NCT02703324|69264513|FG002|Period Two|Withdrawal by Subject|1|||
37756264|NCT02703324|69264514|FG003|Period Two|Withdrawal by Subject|0|||
37756265|NCT02703324|69264515|FG004|Period Two|Withdrawal by Subject|0|||
37756266|NCT02703324|69264516|FG005|Period Two|Withdrawal by Subject|0|||
37756267|NCT02701764|69264527|FG000|Overall Study|Lost to Follow-up|0|||
37756268|NCT02701764|69264528|FG001|Overall Study|Lost to Follow-up|1|||
37756269|NCT01696643|69264709|FG000|Overall Study|Adverse Event|15|||
37756270|NCT01696643|69264710|FG001|Overall Study|Adverse Event|7|||
37756271|NCT01696643|69264709|FG000|Overall Study|Death|1|||
37756272|NCT01696643|69264710|FG001|Overall Study|Death|2|||
37756273|NCT01696643|69264709|FG000|Overall Study|Lack of Efficacy|3|||
37756274|NCT01696643|69264710|FG001|Overall Study|Lack of Efficacy|0|||
37756275|NCT01696643|69264709|FG000|Overall Study|Lost to Follow-up|67|||
37756276|NCT01696643|69264710|FG001|Overall Study|Lost to Follow-up|67|||
37756277|NCT01696643|69264709|FG000|Overall Study|Physician Decision|3|||
37756278|NCT01696643|69264710|FG001|Overall Study|Physician Decision|2|||
37756279|NCT01696643|69264709|FG000|Overall Study|Pregnancy|0|||
37756280|NCT01696643|69264710|FG001|Overall Study|Pregnancy|1|||
37858393|NCT01288430|69541751|FG009|Part 1|Progressive disease|0|||
37858394|NCT01288430|69541742|FG000|Part 1|Clinical disease progression|0|||
37858395|NCT01288430|69541743|FG001|Part 1|Clinical disease progression|0|||
37858396|NCT01288430|69541744|FG002|Part 1|Clinical disease progression|1|||
37858397|NCT01288430|69541745|FG003|Part 1|Clinical disease progression|0|||
37858398|NCT01288430|69541746|FG004|Part 1|Clinical disease progression|0|||
37858399|NCT01288430|69541747|FG005|Part 1|Clinical disease progression|2|||
37858400|NCT01288430|69541748|FG006|Part 1|Clinical disease progression|2|||
37858401|NCT01288430|69541749|FG007|Part 1|Clinical disease progression|0|||
37858402|NCT01288430|69541750|FG008|Part 1|Clinical disease progression|0|||
37858403|NCT01288430|69541751|FG009|Part 1|Clinical disease progression|0|||
37858404|NCT01288430|69541742|FG000|Part 1|Death due to disease progression|0|||
37858405|NCT01288430|69541743|FG001|Part 1|Death due to disease progression|0|||
37858406|NCT01288430|69541744|FG002|Part 1|Death due to disease progression|0|||
37858407|NCT01288430|69541745|FG003|Part 1|Death due to disease progression|0|||
37858408|NCT01288430|69541746|FG004|Part 1|Death due to disease progression|1|||
37858409|NCT01288430|69541747|FG005|Part 1|Death due to disease progression|0|||
37858410|NCT01288430|69541748|FG006|Part 1|Death due to disease progression|0|||
37858411|NCT01288430|69541749|FG007|Part 1|Death due to disease progression|0|||
37858412|NCT01288430|69541750|FG008|Part 1|Death due to disease progression|0|||
37858413|NCT01288430|69541751|FG009|Part 1|Death due to disease progression|0|||
37858414|NCT01288430|69541742|FG000|Part 1|Adverse Event|0|||
37858415|NCT01288430|69541743|FG001|Part 1|Adverse Event|0|||
37858416|NCT01288430|69541744|FG002|Part 1|Adverse Event|3|||
37858417|NCT01288430|69541745|FG003|Part 1|Adverse Event|1|||
37858418|NCT01288430|69541746|FG004|Part 1|Adverse Event|0|||
37858419|NCT01288430|69541747|FG005|Part 1|Adverse Event|0|||
37858420|NCT01288430|69541748|FG006|Part 1|Adverse Event|2|||
37923435|NCT00803244|69610241|FG001|Overall Study|Any other reason not above-mentioned|10|||
37923436|NCT00804570|69610249|FG000|Overall Study|Adverse Event|14|||
37923437|NCT00804570|69610250|FG001|Overall Study|Adverse Event|7|||
37923438|NCT00804570|69610249|FG000|Overall Study|Lack of Efficacy|0|||
37923439|NCT00804570|69610250|FG001|Overall Study|Lack of Efficacy|1|||
37923440|NCT00804570|69610249|FG000|Overall Study|Lost to Follow-up|18|||
37923441|NCT00804570|69610250|FG001|Overall Study|Lost to Follow-up|21|||
37923442|NCT00804570|69610249|FG000|Overall Study|Entry criteria not met|5|||
37858421|NCT01288430|69541749|FG007|Part 1|Adverse Event|0|||
37923443|NCT00804570|69610250|FG001|Overall Study|Entry criteria not met|5|||
37923444|NCT00804570|69610249|FG000|Overall Study|Protocol Violation|12|||
37664903|NCT02292706|69137533|FG000|Overall Study|Lost to Follow-up|20|||
37858422|NCT01288430|69541750|FG008|Part 1|Adverse Event|0|||
37756281|NCT01696643|69264709|FG000|Overall Study|Protocol Violation|7|||
37756282|NCT01696643|69264710|FG001|Overall Study|Protocol Violation|7|||
37756283|NCT01696643|69264709|FG000|Overall Study|Study Terminated by Sponsor|286|||
37756284|NCT01696643|69264710|FG001|Overall Study|Study Terminated by Sponsor|294|||
37756285|NCT01696643|69264709|FG000|Overall Study|Withdrawal by Subject|142|||
37756286|NCT01696643|69264710|FG001|Overall Study|Withdrawal by Subject|149|||
37756287|NCT01696643|69264709|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
37858423|NCT01288430|69541751|FG009|Part 1|Adverse Event|0|||
37858424|NCT01288430|69541742|FG000|Part 1|Other|0|||
37858425|NCT01288430|69541743|FG001|Part 1|Other|2|||
37858426|NCT01288430|69541744|FG002|Part 1|Other|0|||
37664904|NCT02292706|69137534|FG001|Overall Study|Lost to Follow-up|44|||
37756288|NCT01696643|69264710|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
37756289|NCT01696643|69264709|FG000|Overall Study|Site Error|2|||
37756290|NCT01696643|69264710|FG001|Overall Study|Site Error|1|||
37756291|NCT01696643|69264709|FG000|Overall Study|Participant Incarcerated|0|||
37756292|NCT01696643|69264710|FG001|Overall Study|Participant Incarcerated|1|||
37756293|NCT01696643|69264709|FG000|Overall Study|Medical Monitor Decision|0|||
37756294|NCT01696643|69264710|FG001|Overall Study|Medical Monitor Decision|2|||
37756295|NCT01696643|69264709|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
37756296|NCT01696643|69264710|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
37756297|NCT01695317|69264722|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
37756298|NCT01695317|69264723|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
37756299|NCT01695317|69264722|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
37756300|NCT01695317|69264723|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
37756301|NCT02701296|69264779|FG000|Overall Study|Incomplete Data|0|||
37756302|NCT02701296|69264780|FG001|Overall Study|Incomplete Data|2|||
37756303|NCT01582451|69264797|FG000|Overall Study|Adverse Event|1|||
37756304|NCT01582451|69264798|FG001|Overall Study|Adverse Event|3|||
37756305|NCT01582451|69264797|FG000|Overall Study|Death|3|||
37756306|NCT01582451|69264798|FG001|Overall Study|Death|3|||
37756307|NCT01582451|69264797|FG000|Overall Study|Lost to Follow-up|0|||
37756308|NCT01582451|69264798|FG001|Overall Study|Lost to Follow-up|2|||
37756309|NCT01582451|69264797|FG000|Overall Study|Protocol Violation|11|||
37756310|NCT01582451|69264798|FG001|Overall Study|Protocol Violation|3|||
37756311|NCT01582451|69264797|FG000|Overall Study|Withdrawal by Subject|13|||
37756312|NCT01582451|69264798|FG001|Overall Study|Withdrawal by Subject|9|||
37756313|NCT01582451|69264797|FG000|Overall Study|Physician Decision|3|||
37756314|NCT01582451|69264798|FG001|Overall Study|Physician Decision|0|||
37756315|NCT01582451|69264797|FG000|Overall Study|Sponsor Decision|1|||
37756316|NCT01582451|69264798|FG001|Overall Study|Sponsor Decision|0|||
37756317|NCT02700984|69264882|FG000|Overall Study|Death|2|||
37858427|NCT01288430|69541745|FG003|Part 1|Other|0|||
37664905|NCT02292706|69137535|FG002|Overall Study|Lost to Follow-up|24|||
37664906|NCT02292706|69137536|FG003|Overall Study|Lost to Follow-up|61|||
37664907|NCT02292706|69137537|FG004|Overall Study|Lost to Follow-up|21|||
37664908|NCT02292706|69137538|FG005|Overall Study|Lost to Follow-up|52|||
37664909|NCT02292706|69137539|FG006|Overall Study|Lost to Follow-up|25|||
37664910|NCT02292706|69137540|FG007|Overall Study|Lost to Follow-up|0|||
37664911|NCT02292706|69137533|FG000|Overall Study|Withdrew consent|15|||
37664912|NCT02292706|69137534|FG001|Overall Study|Withdrew consent|56|||
37664913|NCT02292706|69137535|FG002|Overall Study|Withdrew consent|43|||
37664914|NCT02292706|69137536|FG003|Overall Study|Withdrew consent|36|||
37664915|NCT02292706|69137537|FG004|Overall Study|Withdrew consent|13|||
37664916|NCT02292706|69137538|FG005|Overall Study|Withdrew consent|51|||
37664917|NCT02292706|69137539|FG006|Overall Study|Withdrew consent|20|||
37664918|NCT02292706|69137540|FG007|Overall Study|Withdrew consent|0|||
37664919|NCT02292706|69137533|FG000|Overall Study|Death|3|||
37664920|NCT02292706|69137534|FG001|Overall Study|Death|11|||
37664921|NCT02292706|69137535|FG002|Overall Study|Death|16|||
37664922|NCT02292706|69137536|FG003|Overall Study|Death|22|||
37664923|NCT02292706|69137537|FG004|Overall Study|Death|8|||
37664924|NCT02292706|69137538|FG005|Overall Study|Death|17|||
37664925|NCT02292706|69137539|FG006|Overall Study|Death|3|||
37664926|NCT02292706|69137540|FG007|Overall Study|Death|0|||
37664927|NCT02292706|69137533|FG000|Overall Study|Study terminated by sponsor|0|||
37664928|NCT02292706|69137534|FG001|Overall Study|Study terminated by sponsor|9|||
37664929|NCT02292706|69137535|FG002|Overall Study|Study terminated by sponsor|4|||
37664930|NCT02292706|69137536|FG003|Overall Study|Study terminated by sponsor|21|||
37664931|NCT02292706|69137537|FG004|Overall Study|Study terminated by sponsor|11|||
37664932|NCT02292706|69137538|FG005|Overall Study|Study terminated by sponsor|13|||
37664933|NCT02292706|69137539|FG006|Overall Study|Study terminated by sponsor|3|||
37664934|NCT02292706|69137540|FG007|Overall Study|Study terminated by sponsor|0|||
37664935|NCT02292706|69137533|FG000|Overall Study|Investigator's discretion|4|||
37664936|NCT02292706|69137534|FG001|Overall Study|Investigator's discretion|9|||
37664937|NCT02292706|69137535|FG002|Overall Study|Investigator's discretion|7|||
37664938|NCT02292706|69137536|FG003|Overall Study|Investigator's discretion|11|||
37664939|NCT02292706|69137537|FG004|Overall Study|Investigator's discretion|4|||
37664940|NCT02292706|69137538|FG005|Overall Study|Investigator's discretion|10|||
37664941|NCT02292706|69137539|FG006|Overall Study|Investigator's discretion|1|||
37664942|NCT02292706|69137540|FG007|Overall Study|Investigator's discretion|0|||
37664943|NCT02292706|69137533|FG000|Overall Study|Liver transplant|1|||
37756318|NCT02700984|69264883|FG001|Overall Study|Death|1|||
37756319|NCT02700984|69264882|FG000|Overall Study|Lost to Follow-up|2|||
37756320|NCT02700984|69264883|FG001|Overall Study|Lost to Follow-up|1|||
37756321|NCT02700984|69264882|FG000|Overall Study|Physician Decision|0|||
37756322|NCT02700984|69264883|FG001|Overall Study|Physician Decision|1|||
37756323|NCT02700984|69264882|FG000|Overall Study|Withdrawal by Subject|8|||
37756324|NCT02700984|69264883|FG001|Overall Study|Withdrawal by Subject|9|||
37756325|NCT02700984|69264882|FG000|Overall Study|Reason not specified|3|||
37664944|NCT02292706|69137534|FG001|Overall Study|Liver transplant|1|||
37664945|NCT02292706|69137535|FG002|Overall Study|Liver transplant|11|||
37664946|NCT02292706|69137536|FG003|Overall Study|Liver transplant|16|||
37664947|NCT02292706|69137537|FG004|Overall Study|Liver transplant|5|||
37664948|NCT02292706|69137538|FG005|Overall Study|Liver transplant|6|||
37664949|NCT02292706|69137539|FG006|Overall Study|Liver transplant|5|||
37664950|NCT02292706|69137540|FG007|Overall Study|Liver transplant|0|||
37664951|NCT02292706|69137533|FG000|Overall Study|Enrolled but not met eligibility criteria|1|||
37664952|NCT02292706|69137534|FG001|Overall Study|Enrolled but not met eligibility criteria|2|||
37756326|NCT02700984|69264883|FG001|Overall Study|Reason not specified|2|||
37756327|NCT02696850|69264957|FG000|Overall Study|Withdrawal by Subject|3|||
37756328|NCT02696850|69264958|FG001|Overall Study|Withdrawal by Subject|3|||
37756329|NCT02696850|69264957|FG000|Overall Study|Lost to Follow-up|8|||
37756330|NCT02696850|69264958|FG001|Overall Study|Lost to Follow-up|5|||
37756331|NCT02698410|69265112|FG000|Overall Study|Adverse Event|2|||
37756332|NCT02698410|69265112|FG000|Overall Study|Withdrawal by Subject|1|||
37756333|NCT02698410|69265112|FG000|Overall Study|Other|1|||
37756334|NCT02699892|69265116|FG000|Overall Study|Other|36|||
37756335|NCT02698176|69265123|FG000|Overall Study|Progressive disease|4|||
37756336|NCT02698176|69265124|FG001|Overall Study|Progressive disease|3|||
37756337|NCT02698176|69265125|FG002|Overall Study|Progressive disease|1|||
37756338|NCT02698176|69265126|FG003|Overall Study|Progressive disease|0|||
37756339|NCT02698176|69265123|FG000|Overall Study|Adverse Event|2|||
37756340|NCT02698176|69265124|FG001|Overall Study|Adverse Event|0|||
37756341|NCT02698176|69265125|FG002|Overall Study|Adverse Event|0|||
37756342|NCT02698176|69265126|FG003|Overall Study|Adverse Event|0|||
37756343|NCT02698176|69265123|FG000|Overall Study|Clinical progression|3|||
37756344|NCT02698176|69265124|FG001|Overall Study|Clinical progression|0|||
37756345|NCT02698176|69265125|FG002|Overall Study|Clinical progression|0|||
37756346|NCT02698176|69265126|FG003|Overall Study|Clinical progression|0|||
37756347|NCT02693418|69265142|FG000|Overall Study|Lost to Follow-up|1|||
37756348|NCT02693418|69265143|FG001|Overall Study|Lost to Follow-up|2|||
37756349|NCT02693418|69265144|FG002|Overall Study|Lost to Follow-up|0|||
37756350|NCT02693418|69265145|FG003|Overall Study|Lost to Follow-up|0|||
37756351|NCT02693418|69265146|FG004|Overall Study|Lost to Follow-up|0|||
37756352|NCT02693418|69265142|FG000|Overall Study|Menses during study period|0|||
37756353|NCT02693418|69265143|FG001|Overall Study|Menses during study period|0|||
37756354|NCT02693418|69265144|FG002|Overall Study|Menses during study period|2|||
37756355|NCT02693418|69265145|FG003|Overall Study|Menses during study period|0|||
37756356|NCT02693418|69265146|FG004|Overall Study|Menses during study period|0|||
37756357|NCT02693106|69265179|FG000|Overall Study|No time|3|||
37756358|NCT02546986|69265191|FG000|Treatment Period|Progressive Disease|20|||
37756359|NCT02546986|69265192|FG001|Treatment Period|Progressive Disease|22|||
37756360|NCT02546986|69265191|FG000|Treatment Period|Adverse Event|14|||
37756361|NCT02546986|69265192|FG001|Treatment Period|Adverse Event|6|||
37756362|NCT02546986|69265191|FG000|Treatment Period|Symptomatic Deterioration|4|||
37756363|NCT02546986|69265192|FG001|Treatment Period|Symptomatic Deterioration|3|||
37756364|NCT02546986|69265191|FG000|Treatment Period|Death|3|||
37756365|NCT02546986|69265192|FG001|Treatment Period|Death|4|||
37756366|NCT02546986|69265191|FG000|Treatment Period|Physician Decision|1|||
37756367|NCT02546986|69265192|FG001|Treatment Period|Physician Decision|2|||
37756368|NCT02546986|69265191|FG000|Treatment Period|Protocol Violation|1|||
37756369|NCT02546986|69265192|FG001|Treatment Period|Protocol Violation|0|||
37756370|NCT02546986|69265191|FG000|Treatment Period|Withdrawal by Subject|1|||
37756371|NCT02546986|69265192|FG001|Treatment Period|Withdrawal by Subject|1|||
37756372|NCT02546986|69265191|FG000|Treatment Period|Non-compliance with Study Drug|0|||
37756373|NCT02546986|69265192|FG001|Treatment Period|Non-compliance with Study Drug|1|||
37756374|NCT02546986|69265191|FG000|Treatment Period|Study Terminated by Sponsor|0|||
37858428|NCT01288430|69541746|FG004|Part 1|Other|0|||
37858429|NCT01288430|69541747|FG005|Part 1|Other|0|||
37858430|NCT01288430|69541748|FG006|Part 1|Other|1|||
37664953|NCT02292706|69137535|FG002|Overall Study|Enrolled but not met eligibility criteria|2|||
37664954|NCT02292706|69137536|FG003|Overall Study|Enrolled but not met eligibility criteria|2|||
37664955|NCT02292706|69137537|FG004|Overall Study|Enrolled but not met eligibility criteria|2|||
37756375|NCT02546986|69265192|FG001|Treatment Period|Study Terminated by Sponsor|1|||
37756376|NCT02546986|69265191|FG000|Treatment Period|Miscellaneous|7|||
37756377|NCT02546986|69265192|FG001|Treatment Period|Miscellaneous|9|||
37756378|NCT02546986|69265191|FG000|Survival Follow-Up Phase|Missing Status|3|||
37756379|NCT02546986|69265192|FG001|Survival Follow-Up Phase|Missing Status|5|||
37756380|NCT02546986|69265191|FG000|Survival Follow-Up Phase|Death|18|||
37756381|NCT02546986|69265192|FG001|Survival Follow-Up Phase|Death|12|||
37756382|NCT02546986|69265191|FG000|Survival Follow-Up Phase|Alive|13|||
37756383|NCT02546986|69265192|FG001|Survival Follow-Up Phase|Alive|16|||
37756384|NCT02546986|69265191|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
37756385|NCT02546986|69265192|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
37756386|NCT02689206|69265203|FG000|Overall Study|Adverse Event|0|||
37756387|NCT02689206|69265204|FG001|Overall Study|Adverse Event|0|||
37858431|NCT01288430|69541749|FG007|Part 1|Other|0|||
37756388|NCT02689206|69265205|FG002|Overall Study|Adverse Event|1|||
37756389|NCT02689206|69265206|FG003|Overall Study|Adverse Event|0|||
37756390|NCT02689206|69265207|FG004|Overall Study|Adverse Event|2|||
37756391|NCT02689206|69265203|FG000|Overall Study|Protocol Violation|1|||
37756392|NCT02689206|69265204|FG001|Overall Study|Protocol Violation|0|||
37756393|NCT02689206|69265205|FG002|Overall Study|Protocol Violation|0|||
37756394|NCT02689206|69265206|FG003|Overall Study|Protocol Violation|1|||
37756395|NCT02689206|69265207|FG004|Overall Study|Protocol Violation|2|||
37756396|NCT02689206|69265203|FG000|Overall Study|Other: Reached stopping criteria|0|||
37756397|NCT02689206|69265204|FG001|Overall Study|Other: Reached stopping criteria|1|||
37756398|NCT02689206|69265205|FG002|Overall Study|Other: Reached stopping criteria|2|||
37756399|NCT02689206|69265206|FG003|Overall Study|Other: Reached stopping criteria|3|||
37756400|NCT02689206|69265207|FG004|Overall Study|Other: Reached stopping criteria|4|||
37756401|NCT02689206|69265203|FG000|Overall Study|Physician Decision|1|||
37756402|NCT02689206|69265204|FG001|Overall Study|Physician Decision|0|||
37756403|NCT02689206|69265205|FG002|Overall Study|Physician Decision|0|||
37756404|NCT02689206|69265206|FG003|Overall Study|Physician Decision|0|||
37756405|NCT02689206|69265207|FG004|Overall Study|Physician Decision|0|||
37756406|NCT02689206|69265203|FG000|Overall Study|Withdrawal by Subject|1|||
37858432|NCT01288430|69541750|FG008|Part 1|Other|0|||
37858433|NCT01288430|69541751|FG009|Part 1|Other|0|||
37858434|NCT01288430|69541742|FG000|Part 2|Progressive disease|0|||
37858435|NCT01288430|69541743|FG001|Part 2|Progressive disease|0|||
37858436|NCT01288430|69541744|FG002|Part 2|Progressive disease|0|||
37858437|NCT01288430|69541745|FG003|Part 2|Progressive disease|0|||
37858438|NCT01288430|69541746|FG004|Part 2|Progressive disease|0|||
37858439|NCT01288430|69541747|FG005|Part 2|Progressive disease|0|||
37858440|NCT01288430|69541748|FG006|Part 2|Progressive disease|0|||
37858441|NCT01288430|69541749|FG007|Part 2|Progressive disease|8|||
37664956|NCT02292706|69137538|FG005|Overall Study|Enrolled but not met eligibility criteria|6|||
37664957|NCT02292706|69137539|FG006|Overall Study|Enrolled but not met eligibility criteria|2|||
37664958|NCT02292706|69137540|FG007|Overall Study|Enrolled but not met eligibility criteria|19|||
37664959|NCT02292706|69137533|FG000|Overall Study|Subject terminated by sponsor|1|||
37664960|NCT02292706|69137534|FG001|Overall Study|Subject terminated by sponsor|0|||
37664961|NCT02292706|69137535|FG002|Overall Study|Subject terminated by sponsor|0|||
37858442|NCT01288430|69541750|FG008|Part 2|Progressive disease|7|||
37858443|NCT01288430|69541751|FG009|Part 2|Progressive disease|2|||
37858444|NCT01288430|69541742|FG000|Part 2|Clinical disease progression|0|||
37858445|NCT01288430|69541743|FG001|Part 2|Clinical disease progression|0|||
37858446|NCT01288430|69541744|FG002|Part 2|Clinical disease progression|0|||
37858447|NCT01288430|69541745|FG003|Part 2|Clinical disease progression|0|||
37858448|NCT01288430|69541746|FG004|Part 2|Clinical disease progression|0|||
37664962|NCT02292706|69137536|FG003|Overall Study|Subject terminated by sponsor|2|||
37664963|NCT02292706|69137537|FG004|Overall Study|Subject terminated by sponsor|1|||
37664964|NCT02292706|69137538|FG005|Overall Study|Subject terminated by sponsor|0|||
37664965|NCT02292706|69137539|FG006|Overall Study|Subject terminated by sponsor|0|||
37664966|NCT02292706|69137540|FG007|Overall Study|Subject terminated by sponsor|0|||
37664967|NCT02292706|69137533|FG000|Overall Study|Missing|0|||
37664968|NCT02292706|69137534|FG001|Overall Study|Missing|0|||
37664969|NCT02292706|69137535|FG002|Overall Study|Missing|1|||
37664970|NCT02292706|69137536|FG003|Overall Study|Missing|1|||
37664971|NCT02292706|69137537|FG004|Overall Study|Missing|0|||
37664972|NCT02292706|69137538|FG005|Overall Study|Missing|1|||
37664973|NCT02292706|69137539|FG006|Overall Study|Missing|0|||
37664974|NCT02292706|69137540|FG007|Overall Study|Missing|0|||
37664975|NCT02292706|69137533|FG000|Overall Study|Virologic relapse or reinfection|1|||
37664976|NCT02292706|69137534|FG001|Overall Study|Virologic relapse or reinfection|0|||
37664977|NCT02292706|69137535|FG002|Overall Study|Virologic relapse or reinfection|0|||
37664978|NCT02292706|69137536|FG003|Overall Study|Virologic relapse or reinfection|1|||
37664979|NCT02292706|69137537|FG004|Overall Study|Virologic relapse or reinfection|0|||
37664980|NCT02292706|69137538|FG005|Overall Study|Virologic relapse or reinfection|1|||
37664981|NCT02292706|69137539|FG006|Overall Study|Virologic relapse or reinfection|0|||
37664982|NCT02292706|69137540|FG007|Overall Study|Virologic relapse or reinfection|0|||
37664983|NCT01930539|69137564|FG000|Overall Study|Withdrawal by Subject|2|||
37756407|NCT02689206|69265204|FG001|Overall Study|Withdrawal by Subject|0|||
37858449|NCT01288430|69541747|FG005|Part 2|Clinical disease progression|0|||
37858450|NCT01288430|69541748|FG006|Part 2|Clinical disease progression|0|||
37858451|NCT01288430|69541749|FG007|Part 2|Clinical disease progression|2|||
37858452|NCT01288430|69541750|FG008|Part 2|Clinical disease progression|0|||
37664984|NCT01930539|69137565|FG001|Overall Study|Withdrawal by Subject|2|||
37858453|NCT01288430|69541751|FG009|Part 2|Clinical disease progression|0|||
37858454|NCT01288430|69541742|FG000|Part 2|Withdrawal by Subject|0|||
37858455|NCT01288430|69541743|FG001|Part 2|Withdrawal by Subject|0|||
37858456|NCT01288430|69541744|FG002|Part 2|Withdrawal by Subject|0|||
37756408|NCT02689206|69265205|FG002|Overall Study|Withdrawal by Subject|1|||
37756409|NCT02689206|69265206|FG003|Overall Study|Withdrawal by Subject|0|||
37756410|NCT02689206|69265207|FG004|Overall Study|Withdrawal by Subject|0|||
37756411|NCT01695239|69265227|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
37756412|NCT01695239|69265228|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
37756413|NCT01695239|69265229|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
37756414|NCT01695239|69265230|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
37664985|NCT01928394|69137594|FG000|Treatment Period|Disease progression|17|||
37664986|NCT01928394|69137595|FG001|Treatment Period|Disease progression|2|||
37664987|NCT01928394|69137596|FG002|Treatment Period|Disease progression|12|||
37664988|NCT01928394|69137597|FG003|Treatment Period|Disease progression|48|||
37664989|NCT01928394|69137598|FG004|Treatment Period|Disease progression|3|||
37664990|NCT01928394|69137599|FG005|Treatment Period|Disease progression|25|||
37664991|NCT01928394|69137600|FG006|Treatment Period|Disease progression|38|||
37664992|NCT01928394|69137601|FG007|Treatment Period|Disease progression|16|||
37664993|NCT01928394|69137602|FG008|Treatment Period|Disease progression|3|||
37756415|NCT01695239|69265231|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
37756416|NCT01695239|69265232|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
37756417|NCT01695239|69265233|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
37756418|NCT01695239|69265234|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
37756419|NCT01695239|69265235|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
37756420|NCT01695239|69265236|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
37756421|NCT01695239|69265237|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
37756422|NCT01695239|69265238|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
37756423|NCT01695239|69265239|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
37756424|NCT01695239|69265240|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
37756425|NCT01695239|69265227|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
37756426|NCT01695239|69265228|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
37756427|NCT01695239|69265229|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
37756428|NCT01695239|69265230|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
37756429|NCT01695239|69265231|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
37756430|NCT01695239|69265232|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
37756431|NCT01695239|69265233|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
37756432|NCT01695239|69265234|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
37756433|NCT01695239|69265235|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
37756434|NCT01695239|69265236|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
37756435|NCT01695239|69265237|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
37756436|NCT01695239|69265238|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
37756437|NCT01695239|69265239|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
37756438|NCT01695239|69265240|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
37756439|NCT01695239|69265227|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
37756440|NCT01695239|69265228|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
37756441|NCT01695239|69265229|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
37756442|NCT01695239|69265230|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
37756443|NCT01695239|69265231|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
37756444|NCT01695239|69265232|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
37756445|NCT01695239|69265233|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
37756446|NCT01695239|69265234|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
37756447|NCT01695239|69265235|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
37756448|NCT01695239|69265236|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
37756449|NCT01695239|69265237|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
37756450|NCT01695239|69265238|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
37756451|NCT01695239|69265239|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
37756452|NCT01695239|69265240|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
37756453|NCT01695239|69265227|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
37756454|NCT01695239|69265228|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
37756455|NCT01695239|69265229|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
37756456|NCT01695239|69265230|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
37664994|NCT01928394|69137603|FG009|Treatment Period|Disease progression|11|||
37664995|NCT01928394|69137604|FG010|Treatment Period|Disease progression|22|||
37664996|NCT01928394|69137605|FG011|Treatment Period|Disease progression|73|||
37664997|NCT01928394|69137606|FG012|Treatment Period|Disease progression|38|||
37664998|NCT01928394|69137607|FG013|Treatment Period|Disease progression|118|||
37664999|NCT01928394|69137608|FG014|Treatment Period|Disease progression|59|||
37665000|NCT01928394|69137609|FG015|Treatment Period|Disease progression|1|||
37665001|NCT01928394|69137610|FG016|Treatment Period|Disease progression|43|||
37665002|NCT01928394|69137611|FG017|Treatment Period|Disease progression|56|||
37665003|NCT01928394|69137612|FG018|Treatment Period|Disease progression|50|||
37756457|NCT01695239|69265231|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
37756458|NCT01695239|69265232|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
38033321|NCT04493684|69719209|FG014|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
38033322|NCT04493684|69719210|FG015|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|1|||
37756459|NCT01695239|69265233|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
37756460|NCT01695239|69265234|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
37756461|NCT01695239|69265235|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
37756462|NCT01695239|69265236|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
37756463|NCT01695239|69265237|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
37756464|NCT01695239|69265238|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
37665004|NCT01928394|69137613|FG019|Treatment Period|Disease progression|71|||
37665005|NCT01928394|69137614|FG020|Treatment Period|Disease progression|30|||
37665006|NCT01928394|69137615|FG021|Treatment Period|Disease progression|31|||
37665007|NCT01928394|69137616|FG022|Treatment Period|Disease progression|31|||
37665008|NCT01928394|69137594|FG000|Treatment Period|Study drug toxicity|1|||
37665009|NCT01928394|69137595|FG001|Treatment Period|Study drug toxicity|1|||
37665010|NCT01928394|69137596|FG002|Treatment Period|Study drug toxicity|3|||
37665011|NCT01928394|69137597|FG003|Treatment Period|Study drug toxicity|3|||
37665012|NCT01928394|69137598|FG004|Treatment Period|Study drug toxicity|0|||
37756465|NCT01695239|69265239|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
37756466|NCT01695239|69265240|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
37756467|NCT01695239|69265227|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
37756468|NCT01695239|69265228|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
37756469|NCT01695239|69265229|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
37756470|NCT01695239|69265230|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
37756471|NCT01695239|69265231|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
37756472|NCT01695239|69265232|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
37756473|NCT01695239|69265233|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
37756474|NCT01695239|69265234|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
37756475|NCT01695239|69265235|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
37756476|NCT01695239|69265236|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
37756477|NCT01695239|69265237|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
37756478|NCT01695239|69265238|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
37756479|NCT01695239|69265239|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
37756480|NCT01695239|69265240|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
37756481|NCT01695239|69265227|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
37756482|NCT01695239|69265228|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
37756483|NCT01695239|69265229|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
37756484|NCT01695239|69265230|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
37756485|NCT01695239|69265231|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
37756486|NCT01695239|69265232|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
37756487|NCT01695239|69265233|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
37756488|NCT01695239|69265234|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
37756489|NCT01695239|69265235|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
37756490|NCT01695239|69265236|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
37756491|NCT01695239|69265237|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
37756492|NCT01695239|69265238|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
37756493|NCT01695239|69265239|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
37756494|NCT01695239|69265240|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
37756495|NCT01695239|69265227|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
37756496|NCT01695239|69265228|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
37665013|NCT01928394|69137599|FG005|Treatment Period|Study drug toxicity|9|||
37665014|NCT01928394|69137600|FG006|Treatment Period|Study drug toxicity|7|||
37665015|NCT01928394|69137601|FG007|Treatment Period|Study drug toxicity|1|||
37665016|NCT01928394|69137602|FG008|Treatment Period|Study drug toxicity|0|||
37665017|NCT01928394|69137603|FG009|Treatment Period|Study drug toxicity|5|||
37756497|NCT01695239|69265229|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
37756498|NCT01695239|69265230|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
37756499|NCT01695239|69265231|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
37756500|NCT01695239|69265232|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
37756501|NCT01695239|69265233|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
37756502|NCT01695239|69265234|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
37756503|NCT01695239|69265235|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
37756504|NCT01695239|69265236|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
37756505|NCT01695239|69265237|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
37756506|NCT01695239|69265238|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
37756507|NCT01695239|69265239|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
37665018|NCT01928394|69137604|FG010|Treatment Period|Study drug toxicity|2|||
37665019|NCT01928394|69137605|FG011|Treatment Period|Study drug toxicity|3|||
37665020|NCT01928394|69137606|FG012|Treatment Period|Study drug toxicity|7|||
37756508|NCT01695239|69265240|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
37756509|NCT01695239|69265227|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
37756510|NCT01695239|69265228|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
37756511|NCT01695239|69265229|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
37756512|NCT01695239|69265230|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
37756513|NCT01695239|69265231|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
37756514|NCT01695239|69265232|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
37756515|NCT01695239|69265233|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
37756516|NCT01695239|69265234|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
37756517|NCT01695239|69265235|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
37756518|NCT01695239|69265236|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
37756519|NCT01695239|69265237|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
37756520|NCT01695239|69265238|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
37756521|NCT01695239|69265239|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
37756522|NCT01695239|69265240|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
37756523|NCT01695239|69265227|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
37756524|NCT01695239|69265228|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
37756525|NCT01695239|69265229|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
37756526|NCT01695239|69265230|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
37756527|NCT01695239|69265231|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
37756528|NCT01695239|69265232|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
37756529|NCT01695239|69265233|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
37756530|NCT01695239|69265234|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
37756531|NCT01695239|69265235|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
37756532|NCT01695239|69265236|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
37756533|NCT01695239|69265237|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
37756534|NCT01695239|69265238|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
37756535|NCT01695239|69265239|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
37756536|NCT01695239|69265240|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
37756537|NCT01695239|69265227|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
37756538|NCT01695239|69265228|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
37756539|NCT01695239|69265229|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
37665021|NCT01928394|69137607|FG013|Treatment Period|Study drug toxicity|5|||
37665022|NCT01928394|69137608|FG014|Treatment Period|Study drug toxicity|12|||
37665023|NCT01928394|69137609|FG015|Treatment Period|Study drug toxicity|0|||
37665024|NCT01928394|69137610|FG016|Treatment Period|Study drug toxicity|3|||
37756540|NCT01695239|69265230|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
37665025|NCT01928394|69137611|FG017|Treatment Period|Study drug toxicity|3|||
37665026|NCT01928394|69137612|FG018|Treatment Period|Study drug toxicity|12|||
37665027|NCT01928394|69137613|FG019|Treatment Period|Study drug toxicity|15|||
37665028|NCT01928394|69137614|FG020|Treatment Period|Study drug toxicity|4|||
37665029|NCT01928394|69137615|FG021|Treatment Period|Study drug toxicity|7|||
37756541|NCT01695239|69265231|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
37756542|NCT01695239|69265232|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
37756543|NCT01695239|69265233|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
37756544|NCT01695239|69265234|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
37756545|NCT01695239|69265235|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
37756546|NCT01695239|69265236|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
37756547|NCT01695239|69265237|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
37756548|NCT01695239|69265238|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
37756549|NCT01695239|69265239|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
37756550|NCT01695239|69265240|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
37756551|NCT01695239|69265227|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
37756552|NCT01695239|69265228|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
37756553|NCT01695239|69265229|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
37756554|NCT01695239|69265230|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
37858457|NCT01288430|69541745|FG003|Part 2|Withdrawal by Subject|0|||
37858458|NCT01288430|69541746|FG004|Part 2|Withdrawal by Subject|0|||
37858459|NCT01288430|69541747|FG005|Part 2|Withdrawal by Subject|0|||
37858460|NCT01288430|69541748|FG006|Part 2|Withdrawal by Subject|0|||
37858461|NCT01288430|69541749|FG007|Part 2|Withdrawal by Subject|1|||
37858462|NCT01288430|69541750|FG008|Part 2|Withdrawal by Subject|4|||
37756555|NCT01695239|69265231|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
37858463|NCT01288430|69541751|FG009|Part 2|Withdrawal by Subject|0|||
37858464|NCT01288430|69541742|FG000|Part 2|Adverse Event|0|||
37858465|NCT01288430|69541743|FG001|Part 2|Adverse Event|0|||
37923445|NCT00804570|69610250|FG001|Overall Study|Protocol Violation|16|||
37923446|NCT00804570|69610249|FG000|Overall Study|Physician Decision|1|||
37665030|NCT01928394|69137616|FG022|Treatment Period|Study drug toxicity|4|||
37756556|NCT01695239|69265232|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
37756557|NCT01695239|69265233|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
37756558|NCT01695239|69265234|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
37756559|NCT01695239|69265235|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
37756560|NCT01695239|69265236|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
37756561|NCT01695239|69265237|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
37756562|NCT01695239|69265238|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
37756563|NCT01695239|69265239|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
37756564|NCT01695239|69265240|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
37756565|NCT01695239|69265227|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
37756566|NCT01695239|69265228|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
37756567|NCT01695239|69265229|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
37756568|NCT01695239|69265230|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
37756569|NCT01695239|69265231|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
37756570|NCT01695239|69265232|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
37756571|NCT01695239|69265233|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
37756572|NCT01695239|69265234|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
37756573|NCT01695239|69265235|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
37756574|NCT01695239|69265236|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
37756575|NCT01695239|69265237|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
37756576|NCT01695239|69265238|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
37756577|NCT01695239|69265239|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
37756578|NCT01695239|69265240|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
37756579|NCT01695239|69265227|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
37756580|NCT01695239|69265228|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
37756581|NCT01695239|69265229|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
37756582|NCT01695239|69265230|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
37756583|NCT01695239|69265231|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
37756584|NCT01695239|69265232|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
37756585|NCT01695239|69265233|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
37756586|NCT01695239|69265234|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
37756587|NCT01695239|69265235|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
37756588|NCT01695239|69265236|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
37756589|NCT01695239|69265237|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
37756590|NCT01695239|69265238|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
37756591|NCT01695239|69265239|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
37756592|NCT01695239|69265240|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
37756593|NCT01695239|69265227|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
37756594|NCT01695239|69265228|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
37756595|NCT01695239|69265229|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
37756596|NCT01695239|69265230|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
37756597|NCT01695239|69265231|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
37756598|NCT01695239|69265232|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
37756599|NCT01695239|69265233|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
37665031|NCT01928394|69137594|FG000|Treatment Period|AE unrelated to study drug|0|||
37665032|NCT01928394|69137595|FG001|Treatment Period|AE unrelated to study drug|0|||
37665033|NCT01928394|69137596|FG002|Treatment Period|AE unrelated to study drug|2|||
37665034|NCT01928394|69137597|FG003|Treatment Period|AE unrelated to study drug|3|||
37665035|NCT01928394|69137598|FG004|Treatment Period|AE unrelated to study drug|0|||
37665036|NCT01928394|69137599|FG005|Treatment Period|AE unrelated to study drug|5|||
37665037|NCT01928394|69137600|FG006|Treatment Period|AE unrelated to study drug|1|||
37665038|NCT01928394|69137601|FG007|Treatment Period|AE unrelated to study drug|0|||
37665039|NCT01928394|69137602|FG008|Treatment Period|AE unrelated to study drug|0|||
37665040|NCT01928394|69137603|FG009|Treatment Period|AE unrelated to study drug|2|||
37665041|NCT01928394|69137604|FG010|Treatment Period|AE unrelated to study drug|0|||
37665042|NCT01928394|69137605|FG011|Treatment Period|AE unrelated to study drug|12|||
37665043|NCT01928394|69137606|FG012|Treatment Period|AE unrelated to study drug|6|||
37665044|NCT01928394|69137607|FG013|Treatment Period|AE unrelated to study drug|13|||
37665045|NCT01928394|69137608|FG014|Treatment Period|AE unrelated to study drug|6|||
37665046|NCT01928394|69137609|FG015|Treatment Period|AE unrelated to study drug|1|||
37665047|NCT01928394|69137610|FG016|Treatment Period|AE unrelated to study drug|1|||
37665048|NCT01928394|69137611|FG017|Treatment Period|AE unrelated to study drug|6|||
37756600|NCT01695239|69265234|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
37756601|NCT01695239|69265235|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
37756602|NCT01695239|69265236|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
37756603|NCT01695239|69265237|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
37756604|NCT01695239|69265238|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
37756605|NCT01695239|69265239|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
37756606|NCT01695239|69265240|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
37756607|NCT01695239|69265227|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
37756608|NCT01695239|69265228|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
37756609|NCT01695239|69265229|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
37665049|NCT01928394|69137612|FG018|Treatment Period|AE unrelated to study drug|3|||
37665050|NCT01928394|69137613|FG019|Treatment Period|AE unrelated to study drug|5|||
37665051|NCT01928394|69137614|FG020|Treatment Period|AE unrelated to study drug|1|||
37665052|NCT01928394|69137615|FG021|Treatment Period|AE unrelated to study drug|1|||
37665053|NCT01928394|69137616|FG022|Treatment Period|AE unrelated to study drug|0|||
37665054|NCT01928394|69137594|FG000|Treatment Period|Participant request to stop therapy|0|||
37665055|NCT01928394|69137595|FG001|Treatment Period|Participant request to stop therapy|0|||
37858466|NCT01288430|69541744|FG002|Part 2|Adverse Event|0|||
37665056|NCT01928394|69137596|FG002|Treatment Period|Participant request to stop therapy|0|||
37665057|NCT01928394|69137597|FG003|Treatment Period|Participant request to stop therapy|0|||
37665058|NCT01928394|69137598|FG004|Treatment Period|Participant request to stop therapy|0|||
37665059|NCT01928394|69137599|FG005|Treatment Period|Participant request to stop therapy|3|||
37665060|NCT01928394|69137600|FG006|Treatment Period|Participant request to stop therapy|3|||
37665061|NCT01928394|69137601|FG007|Treatment Period|Participant request to stop therapy|0|||
37665062|NCT01928394|69137602|FG008|Treatment Period|Participant request to stop therapy|0|||
37665063|NCT01928394|69137603|FG009|Treatment Period|Participant request to stop therapy|0|||
37665064|NCT01928394|69137604|FG010|Treatment Period|Participant request to stop therapy|3|||
37665065|NCT01928394|69137605|FG011|Treatment Period|Participant request to stop therapy|2|||
37665066|NCT01928394|69137606|FG012|Treatment Period|Participant request to stop therapy|1|||
37665067|NCT01928394|69137607|FG013|Treatment Period|Participant request to stop therapy|2|||
37756610|NCT01695239|69265230|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
37756611|NCT01695239|69265231|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
37756612|NCT01695239|69265232|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
37756613|NCT01695239|69265233|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
37756614|NCT01695239|69265234|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
37756615|NCT01695239|69265235|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
37756616|NCT01695239|69265236|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
37756617|NCT01695239|69265237|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
37665068|NCT01928394|69137608|FG014|Treatment Period|Participant request to stop therapy|4|||
37665069|NCT01928394|69137609|FG015|Treatment Period|Participant request to stop therapy|0|||
37665070|NCT01928394|69137610|FG016|Treatment Period|Participant request to stop therapy|1|||
37665071|NCT01928394|69137611|FG017|Treatment Period|Participant request to stop therapy|3|||
37665072|NCT01928394|69137612|FG018|Treatment Period|Participant request to stop therapy|1|||
37665073|NCT01928394|69137613|FG019|Treatment Period|Participant request to stop therapy|1|||
37665074|NCT01928394|69137614|FG020|Treatment Period|Participant request to stop therapy|3|||
37665075|NCT01928394|69137615|FG021|Treatment Period|Participant request to stop therapy|1|||
37665076|NCT01928394|69137616|FG022|Treatment Period|Participant request to stop therapy|3|||
37665077|NCT01928394|69137594|FG000|Treatment Period|Participant withdrew consent|0|||
37665078|NCT01928394|69137595|FG001|Treatment Period|Participant withdrew consent|0|||
37665079|NCT01928394|69137596|FG002|Treatment Period|Participant withdrew consent|1|||
37665080|NCT01928394|69137597|FG003|Treatment Period|Participant withdrew consent|1|||
37665081|NCT01928394|69137598|FG004|Treatment Period|Participant withdrew consent|0|||
37665082|NCT01928394|69137599|FG005|Treatment Period|Participant withdrew consent|1|||
37665083|NCT01928394|69137600|FG006|Treatment Period|Participant withdrew consent|0|||
37665084|NCT01928394|69137601|FG007|Treatment Period|Participant withdrew consent|1|||
37665085|NCT01928394|69137602|FG008|Treatment Period|Participant withdrew consent|0|||
37665086|NCT01928394|69137603|FG009|Treatment Period|Participant withdrew consent|0|||
37665087|NCT01928394|69137604|FG010|Treatment Period|Participant withdrew consent|1|||
37665088|NCT01928394|69137605|FG011|Treatment Period|Participant withdrew consent|1|||
37665089|NCT01928394|69137606|FG012|Treatment Period|Participant withdrew consent|1|||
37665090|NCT01928394|69137607|FG013|Treatment Period|Participant withdrew consent|0|||
37665091|NCT01928394|69137608|FG014|Treatment Period|Participant withdrew consent|2|||
37665092|NCT01928394|69137609|FG015|Treatment Period|Participant withdrew consent|0|||
37665093|NCT01928394|69137610|FG016|Treatment Period|Participant withdrew consent|2|||
37665094|NCT01928394|69137611|FG017|Treatment Period|Participant withdrew consent|1|||
37665095|NCT01928394|69137612|FG018|Treatment Period|Participant withdrew consent|1|||
37665096|NCT01928394|69137613|FG019|Treatment Period|Participant withdrew consent|1|||
37665097|NCT01928394|69137614|FG020|Treatment Period|Participant withdrew consent|0|||
37665098|NCT01928394|69137615|FG021|Treatment Period|Participant withdrew consent|2|||
37756618|NCT01695239|69265238|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
37756619|NCT01695239|69265239|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
37858467|NCT01288430|69541745|FG003|Part 2|Adverse Event|0|||
37756620|NCT01695239|69265240|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
37756621|NCT01695239|69265227|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
37756622|NCT01695239|69265228|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
37756623|NCT01695239|69265229|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
37756624|NCT01695239|69265230|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
37756625|NCT01695239|69265231|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
37756626|NCT01695239|69265232|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
37756627|NCT01695239|69265233|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
37756628|NCT01695239|69265234|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
37756629|NCT01695239|69265235|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
37756630|NCT01695239|69265236|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
37756631|NCT01695239|69265237|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
37756632|NCT01695239|69265238|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
37756633|NCT01695239|69265239|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
37756634|NCT01695239|69265240|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
37756635|NCT01695239|69265227|FG000|Extension Long-Term Extension Periods|Death|0|||
37756636|NCT01695239|69265228|FG001|Extension Long-Term Extension Periods|Death|0|||
37756637|NCT01695239|69265229|FG002|Extension Long-Term Extension Periods|Death|0|||
37756638|NCT01695239|69265230|FG003|Extension Long-Term Extension Periods|Death|0|||
37756639|NCT01695239|69265231|FG004|Extension Long-Term Extension Periods|Death|0|||
37756640|NCT01695239|69265232|FG005|Extension Long-Term Extension Periods|Death|0|||
37756641|NCT01695239|69265233|FG006|Extension Long-Term Extension Periods|Death|0|||
37756642|NCT01695239|69265234|FG007|Extension Long-Term Extension Periods|Death|0|||
37756643|NCT01695239|69265235|FG008|Extension Long-Term Extension Periods|Death|1|||
37756644|NCT01695239|69265236|FG009|Extension Long-Term Extension Periods|Death|0|||
37756645|NCT01695239|69265237|FG010|Extension Long-Term Extension Periods|Death|0|||
37756646|NCT01695239|69265238|FG011|Extension Long-Term Extension Periods|Death|0|||
37756647|NCT01695239|69265239|FG012|Extension Long-Term Extension Periods|Death|0|||
37756648|NCT01695239|69265240|FG013|Extension Long-Term Extension Periods|Death|0|||
37756649|NCT01695239|69265227|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
37756650|NCT01695239|69265228|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
37756651|NCT01695239|69265229|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
37756652|NCT01695239|69265230|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
37756653|NCT01695239|69265231|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
37756654|NCT01695239|69265232|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
37665099|NCT01928394|69137616|FG022|Treatment Period|Participant withdrew consent|0|||
37665100|NCT01928394|69137594|FG000|Treatment Period|Poor/non-compliance|0|||
37665101|NCT01928394|69137595|FG001|Treatment Period|Poor/non-compliance|0|||
37665102|NCT01928394|69137596|FG002|Treatment Period|Poor/non-compliance|0|||
37665103|NCT01928394|69137597|FG003|Treatment Period|Poor/non-compliance|1|||
37665104|NCT01928394|69137598|FG004|Treatment Period|Poor/non-compliance|0|||
37665105|NCT01928394|69137599|FG005|Treatment Period|Poor/non-compliance|0|||
37756655|NCT01695239|69265233|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
37756656|NCT01695239|69265234|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
37756657|NCT01695239|69265235|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
37756658|NCT01695239|69265236|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
37756659|NCT01695239|69265237|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
37756660|NCT01695239|69265238|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
37756661|NCT01695239|69265239|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
37756662|NCT01695239|69265240|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
37756663|NCT01695239|69265227|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
37756664|NCT01695239|69265228|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
37756665|NCT01695239|69265229|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
37756666|NCT01695239|69265230|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
37756667|NCT01695239|69265231|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
37756668|NCT01695239|69265232|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
37756669|NCT01695239|69265233|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
37756670|NCT01695239|69265234|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
37756671|NCT01695239|69265235|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
37756672|NCT01695239|69265236|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
37756673|NCT01695239|69265237|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
37756674|NCT01695239|69265238|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
37665106|NCT01928394|69137600|FG006|Treatment Period|Poor/non-compliance|0|||
37665107|NCT01928394|69137601|FG007|Treatment Period|Poor/non-compliance|0|||
37756675|NCT01695239|69265239|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
37756676|NCT01695239|69265240|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
37756677|NCT01695239|69265227|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
37756678|NCT01695239|69265228|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
37756679|NCT01695239|69265229|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
37756680|NCT01695239|69265230|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
37756681|NCT01695239|69265231|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
37665108|NCT01928394|69137602|FG008|Treatment Period|Poor/non-compliance|0|||
37665109|NCT01928394|69137603|FG009|Treatment Period|Poor/non-compliance|0|||
37665110|NCT01928394|69137604|FG010|Treatment Period|Poor/non-compliance|0|||
37665111|NCT01928394|69137605|FG011|Treatment Period|Poor/non-compliance|0|||
37665112|NCT01928394|69137606|FG012|Treatment Period|Poor/non-compliance|1|||
37665113|NCT01928394|69137607|FG013|Treatment Period|Poor/non-compliance|0|||
37665114|NCT01928394|69137608|FG014|Treatment Period|Poor/non-compliance|1|||
37665115|NCT01928394|69137609|FG015|Treatment Period|Poor/non-compliance|0|||
37756682|NCT01695239|69265232|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
37756683|NCT01695239|69265233|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
37756684|NCT01695239|69265234|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
37756685|NCT01695239|69265235|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
37756686|NCT01695239|69265236|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
37756687|NCT01695239|69265237|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
37756688|NCT01695239|69265238|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
37756689|NCT01695239|69265239|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
37756690|NCT01695239|69265240|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
37756691|NCT01695239|69265227|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
37756692|NCT01695239|69265228|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
37756693|NCT01695239|69265229|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
37756694|NCT01695239|69265230|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
37756695|NCT01695239|69265231|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
37756696|NCT01695239|69265232|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
37756697|NCT01695239|69265233|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
37756698|NCT01695239|69265234|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
37756699|NCT01695239|69265235|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
37756700|NCT01695239|69265236|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
37756701|NCT01695239|69265237|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
37756702|NCT01695239|69265238|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
37756703|NCT01695239|69265239|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
37756704|NCT01695239|69265240|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
37756705|NCT02163694|69265264|FG000|Overall Study|Adverse event- related to progression|3|||
37756706|NCT02163694|69265265|FG001|Overall Study|Adverse event- related to progression|8|||
37756707|NCT02163694|69265264|FG000|Overall Study|Adverse event- not related to progression|7|||
37756708|NCT02163694|69265265|FG001|Overall Study|Adverse event- not related to progression|17|||
37756709|NCT02163694|69265264|FG000|Overall Study|Withdrew consent|8|||
37756710|NCT02163694|69265265|FG001|Overall Study|Withdrew consent|21|||
37756711|NCT02163694|69265264|FG000|Overall Study|Lost to Follow-up|1|||
37756712|NCT02163694|69265265|FG001|Overall Study|Lost to Follow-up|2|||
37756713|NCT02163694|69265264|FG000|Overall Study|Progressive disease per protocol|122|||
37756714|NCT02163694|69265265|FG001|Overall Study|Progressive disease per protocol|197|||
37756715|NCT02163694|69265264|FG000|Overall Study|Other, not specified|13|||
37756716|NCT02163694|69265265|FG001|Overall Study|Other, not specified|22|||
37756717|NCT01694849|69265299|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
37756718|NCT01694849|69265300|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
37756719|NCT01694849|69265301|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
37665116|NCT01928394|69137610|FG016|Treatment Period|Poor/non-compliance|0|||
37665117|NCT01928394|69137611|FG017|Treatment Period|Poor/non-compliance|1|||
37665118|NCT01928394|69137612|FG018|Treatment Period|Poor/non-compliance|0|||
37665119|NCT01928394|69137613|FG019|Treatment Period|Poor/non-compliance|1|||
37665120|NCT01928394|69137614|FG020|Treatment Period|Poor/non-compliance|0|||
37665121|NCT01928394|69137615|FG021|Treatment Period|Poor/non-compliance|0|||
37665122|NCT01928394|69137616|FG022|Treatment Period|Poor/non-compliance|0|||
37665123|NCT01928394|69137594|FG000|Treatment Period|other reason|0|||
37665124|NCT01928394|69137595|FG001|Treatment Period|other reason|0|||
37665125|NCT01928394|69137596|FG002|Treatment Period|other reason|0|||
37665126|NCT01928394|69137597|FG003|Treatment Period|other reason|0|||
37665127|NCT01928394|69137598|FG004|Treatment Period|other reason|0|||
37665128|NCT01928394|69137599|FG005|Treatment Period|other reason|0|||
37665129|NCT01928394|69137600|FG006|Treatment Period|other reason|0|||
37665130|NCT01928394|69137601|FG007|Treatment Period|other reason|0|||
37665131|NCT01928394|69137602|FG008|Treatment Period|other reason|0|||
37665132|NCT01928394|69137603|FG009|Treatment Period|other reason|0|||
37665133|NCT01928394|69137604|FG010|Treatment Period|other reason|1|||
37665134|NCT01928394|69137605|FG011|Treatment Period|other reason|1|||
37665135|NCT01928394|69137606|FG012|Treatment Period|other reason|1|||
37665136|NCT01928394|69137607|FG013|Treatment Period|other reason|0|||
37665137|NCT01928394|69137608|FG014|Treatment Period|other reason|1|||
37665138|NCT01928394|69137609|FG015|Treatment Period|other reason|0|||
37665139|NCT01928394|69137610|FG016|Treatment Period|other reason|0|||
37665140|NCT01928394|69137611|FG017|Treatment Period|other reason|0|||
37665141|NCT01928394|69137612|FG018|Treatment Period|other reason|2|||
37665142|NCT01928394|69137613|FG019|Treatment Period|other reason|2|||
37665143|NCT01928394|69137614|FG020|Treatment Period|other reason|0|||
37665144|NCT01928394|69137615|FG021|Treatment Period|other reason|0|||
37665145|NCT01928394|69137616|FG022|Treatment Period|other reason|0|||
37665146|NCT01928394|69137594|FG000|Treatment Period|Maximum clinical benefit|0|||
37665147|NCT01928394|69137595|FG001|Treatment Period|Maximum clinical benefit|0|||
37756720|NCT01694849|69265299|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
37756721|NCT01694849|69265300|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
37756722|NCT01694849|69265301|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
37756723|NCT01694849|69265299|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
37756724|NCT01694849|69265300|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
37756725|NCT01694849|69265301|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
37756726|NCT01694849|69265299|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
37756727|NCT01694849|69265300|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
37756728|NCT01694849|69265301|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
37756729|NCT01694849|69265299|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
37756730|NCT01694849|69265300|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
37756731|NCT01694849|69265301|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
37756732|NCT01694849|69265299|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
37756733|NCT01694849|69265300|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
37756734|NCT01694849|69265301|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
37756735|NCT01694849|69265299|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
37665148|NCT01928394|69137596|FG002|Treatment Period|Maximum clinical benefit|0|||
37665149|NCT01928394|69137597|FG003|Treatment Period|Maximum clinical benefit|0|||
37665150|NCT01928394|69137598|FG004|Treatment Period|Maximum clinical benefit|0|||
37665151|NCT01928394|69137599|FG005|Treatment Period|Maximum clinical benefit|0|||
37665152|NCT01928394|69137600|FG006|Treatment Period|Maximum clinical benefit|0|||
37665153|NCT01928394|69137601|FG007|Treatment Period|Maximum clinical benefit|0|||
37756736|NCT01694849|69265300|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
37756737|NCT01694849|69265301|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
37756738|NCT01694849|69265299|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
37756739|NCT01694849|69265300|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
37756740|NCT01694849|69265301|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
37756741|NCT01694771|69265350|FG000|Overall Study|Adverse Event|18|||
37756742|NCT01694771|69265351|FG001|Overall Study|Adverse Event|16|||
37756743|NCT01694771|69265350|FG000|Overall Study|Lack of Efficacy|1|||
37756744|NCT01694771|69265351|FG001|Overall Study|Lack of Efficacy|0|||
37756745|NCT01694771|69265350|FG000|Overall Study|Non compliance protocol|7|||
37756746|NCT01694771|69265351|FG001|Overall Study|Non compliance protocol|6|||
37756747|NCT01694771|69265350|FG000|Overall Study|Lost to Follow-up|2|||
37756748|NCT01694771|69265351|FG001|Overall Study|Lost to Follow-up|3|||
37756749|NCT01694771|69265350|FG000|Overall Study|Consent withdrawn|7|||
37756750|NCT01694771|69265351|FG001|Overall Study|Consent withdrawn|9|||
37858468|NCT01288430|69541746|FG004|Part 2|Adverse Event|0|||
37858469|NCT01288430|69541747|FG005|Part 2|Adverse Event|0|||
37665154|NCT01928394|69137602|FG008|Treatment Period|Maximum clinical benefit|0|||
37665155|NCT01928394|69137603|FG009|Treatment Period|Maximum clinical benefit|0|||
37665156|NCT01928394|69137604|FG010|Treatment Period|Maximum clinical benefit|1|||
37665157|NCT01928394|69137605|FG011|Treatment Period|Maximum clinical benefit|1|||
37665158|NCT01928394|69137606|FG012|Treatment Period|Maximum clinical benefit|0|||
37665159|NCT01928394|69137607|FG013|Treatment Period|Maximum clinical benefit|0|||
37665160|NCT01928394|69137608|FG014|Treatment Period|Maximum clinical benefit|1|||
37665161|NCT01928394|69137609|FG015|Treatment Period|Maximum clinical benefit|0|||
37665162|NCT01928394|69137610|FG016|Treatment Period|Maximum clinical benefit|0|||
37665163|NCT01928394|69137611|FG017|Treatment Period|Maximum clinical benefit|1|||
37665164|NCT01928394|69137612|FG018|Treatment Period|Maximum clinical benefit|1|||
37756751|NCT01694771|69265350|FG000|Overall Study|Other reasons|5|||
37756752|NCT01694771|69265351|FG001|Overall Study|Other reasons|6|||
37756753|NCT01582061|69265380|FG000|Overall Study|Lack of Efficacy|3|||
37756754|NCT01582061|69265381|FG001|Overall Study|Lack of Efficacy|23|||
37858470|NCT01288430|69541748|FG006|Part 2|Adverse Event|0|||
37858471|NCT01288430|69541749|FG007|Part 2|Adverse Event|1|||
37665165|NCT01928394|69137613|FG019|Treatment Period|Maximum clinical benefit|0|||
37665166|NCT01928394|69137614|FG020|Treatment Period|Maximum clinical benefit|2|||
37665167|NCT01928394|69137615|FG021|Treatment Period|Maximum clinical benefit|0|||
37756755|NCT01582061|69265380|FG000|Overall Study|Adverse Event|12|||
37756756|NCT01582061|69265381|FG001|Overall Study|Adverse Event|8|||
37858472|NCT01288430|69541750|FG008|Part 2|Adverse Event|1|||
37756757|NCT01582061|69265380|FG000|Overall Study|Withdrawal by Subject|10|||
37858473|NCT01288430|69541751|FG009|Part 2|Adverse Event|0|||
37858474|NCT01288430|69541742|FG000|Part 2|Other|0|||
37665168|NCT01928394|69137616|FG022|Treatment Period|Maximum clinical benefit|0|||
37665169|NCT01928394|69137594|FG000|Treatment Period|Lost to Follow-up|0|||
37665170|NCT01928394|69137595|FG001|Treatment Period|Lost to Follow-up|0|||
37665171|NCT01928394|69137596|FG002|Treatment Period|Lost to Follow-up|0|||
37665172|NCT01928394|69137597|FG003|Treatment Period|Lost to Follow-up|0|||
37665173|NCT01928394|69137598|FG004|Treatment Period|Lost to Follow-up|0|||
37665174|NCT01928394|69137599|FG005|Treatment Period|Lost to Follow-up|0|||
37665175|NCT01928394|69137600|FG006|Treatment Period|Lost to Follow-up|0|||
37665176|NCT01928394|69137601|FG007|Treatment Period|Lost to Follow-up|0|||
37756758|NCT01582061|69265381|FG001|Overall Study|Withdrawal by Subject|4|||
37756759|NCT01582061|69265380|FG000|Overall Study|Abnormal laboratory value(s)|1|||
37756760|NCT01582061|69265381|FG001|Overall Study|Abnormal laboratory value(s)|0|||
37756761|NCT01582061|69265380|FG000|Overall Study|Death|0|||
37756762|NCT01582061|69265381|FG001|Overall Study|Death|1|||
37756763|NCT01582061|69265380|FG000|Overall Study|condition no longer requires study drug|1|||
37756764|NCT01582061|69265381|FG001|Overall Study|condition no longer requires study drug|0|||
37756765|NCT01582061|69265380|FG000|Overall Study|Lost to Follow-up|1|||
37756766|NCT01582061|69265381|FG001|Overall Study|Lost to Follow-up|0|||
37756767|NCT01693523|69265400|FG000|Overall Study|Adverse Event|2|||
37756768|NCT01693523|69265401|FG001|Overall Study|Adverse Event|1|||
37756769|NCT01693523|69265402|FG002|Overall Study|Adverse Event|0|||
37756770|NCT01693523|69265400|FG000|Overall Study|Death|0|||
37756771|NCT01693523|69265401|FG001|Overall Study|Death|1|||
37756772|NCT01693523|69265402|FG002|Overall Study|Death|1|||
37756773|NCT01693523|69265400|FG000|Overall Study|Lost to Follow-up|0|||
37756774|NCT01693523|69265401|FG001|Overall Study|Lost to Follow-up|0|||
37756775|NCT01693523|69265402|FG002|Overall Study|Lost to Follow-up|4|||
37756776|NCT01693523|69265400|FG000|Overall Study|Physician Decision|0|||
37665177|NCT01928394|69137602|FG008|Treatment Period|Lost to Follow-up|0|||
37665178|NCT01928394|69137603|FG009|Treatment Period|Lost to Follow-up|0|||
37756777|NCT01693523|69265401|FG001|Overall Study|Physician Decision|0|||
37756778|NCT01693523|69265402|FG002|Overall Study|Physician Decision|1|||
37756779|NCT01693523|69265400|FG000|Overall Study|Withdrawal by Subject|1|||
37756780|NCT01693523|69265401|FG001|Overall Study|Withdrawal by Subject|2|||
37756781|NCT01693523|69265402|FG002|Overall Study|Withdrawal by Subject|2|||
37756782|NCT01693523|69265400|FG000|Overall Study|Lack of compliance study medication|1|||
37756783|NCT01693523|69265401|FG001|Overall Study|Lack of compliance study medication|2|||
37756784|NCT01693523|69265402|FG002|Overall Study|Lack of compliance study medication|0|||
37756785|NCT01693523|69265400|FG000|Overall Study|Chemotherapy was held|1|||
37756786|NCT01693523|69265401|FG001|Overall Study|Chemotherapy was held|2|||
37756787|NCT01693523|69265402|FG002|Overall Study|Chemotherapy was held|0|||
37756788|NCT01581593|69265418|FG000|Overall Study|Withdrawal by Subject|1|||
37756789|NCT01581281|69265429|FG000|Overall Study|Early Study Closure|15|||
37756790|NCT01581281|69265430|FG001|Overall Study|Early Study Closure|6|||
37756791|NCT01581281|69265431|FG002|Overall Study|Early Study Closure|12|||
37756792|NCT02692716|69265442|FG000|Overall Study|Lost to Follow-up|2|||
37756793|NCT02692716|69265443|FG001|Overall Study|Lost to Follow-up|5|||
37756794|NCT02692716|69265442|FG000|Overall Study|Withdrawal by Subject|3|||
37756795|NCT02692716|69265443|FG001|Overall Study|Withdrawal by Subject|1|||
37756796|NCT01580969|69265452|FG000|Overall Study|Physician Decision|3|||
37756797|NCT01580969|69265453|FG001|Overall Study|Physician Decision|0|||
37665179|NCT01928394|69137604|FG010|Treatment Period|Lost to Follow-up|0|||
37665180|NCT01928394|69137605|FG011|Treatment Period|Lost to Follow-up|0|||
37665181|NCT01928394|69137606|FG012|Treatment Period|Lost to Follow-up|0|||
37665182|NCT01928394|69137607|FG013|Treatment Period|Lost to Follow-up|0|||
37665183|NCT01928394|69137608|FG014|Treatment Period|Lost to Follow-up|0|||
37665184|NCT01928394|69137609|FG015|Treatment Period|Lost to Follow-up|0|||
37665185|NCT01928394|69137610|FG016|Treatment Period|Lost to Follow-up|0|||
37665186|NCT01928394|69137611|FG017|Treatment Period|Lost to Follow-up|0|||
37665187|NCT01928394|69137612|FG018|Treatment Period|Lost to Follow-up|0|||
37665188|NCT01928394|69137613|FG019|Treatment Period|Lost to Follow-up|0|||
37756798|NCT01580969|69265454|FG002|Overall Study|Physician Decision|0|||
37756799|NCT01693367|69265464|FG000|Overall Study|Withdrawal by Subject|1|||
37756800|NCT01693367|69265465|FG001|Overall Study|Withdrawal by Subject|1|||
37756801|NCT01693367|69265464|FG000|Overall Study|Physician Decision|0|||
37756802|NCT01693367|69265465|FG001|Overall Study|Physician Decision|1|||
37665189|NCT01928394|69137614|FG020|Treatment Period|Lost to Follow-up|0|||
37665190|NCT01928394|69137615|FG021|Treatment Period|Lost to Follow-up|0|||
37665191|NCT01928394|69137616|FG022|Treatment Period|Lost to Follow-up|1|||
37756803|NCT02696226|69265475|FG000|Overall Study|Study terminated - lack of enrollment|1|||
37756804|NCT02696226|69265476|FG001|Overall Study|Study terminated - lack of enrollment|0|||
37756805|NCT02696226|69265477|FG002|Overall Study|Study terminated - lack of enrollment|2|||
37756806|NCT02696226|69265478|FG003|Overall Study|Study terminated - lack of enrollment|0|||
37756807|NCT01692275|69265494|FG000|Overall Study|Lost to Follow-up|57|||
37756808|NCT01692275|69265495|FG001|Overall Study|Lost to Follow-up|48|||
37756809|NCT01692275|69265494|FG000|Overall Study|Withdrawal by Subject|9|||
37756810|NCT01692275|69265495|FG001|Overall Study|Withdrawal by Subject|11|||
37756811|NCT02692560|69265515|FG000|Overall Study|Withdrawal by Subject|0|||
37756812|NCT02692560|69265516|FG001|Overall Study|Withdrawal by Subject|6|||
37756813|NCT02688192|69265524|FG000|Overall Study|Lost to Follow-up|11|||
37756814|NCT02688192|69265525|FG001|Overall Study|Lost to Follow-up|5|||
37756815|NCT02688192|69265524|FG000|Overall Study|Physician Decision|1|||
37756816|NCT02688192|69265525|FG001|Overall Study|Physician Decision|0|||
37756817|NCT01579565|69265534|FG000|Randomized|Adverse Event|1|||
37756818|NCT01579565|69265535|FG001|Randomized|Adverse Event|3|||
37756819|NCT01579565|69265534|FG000|Randomized|Withdrawal by Subject|3|||
37756820|NCT01579565|69265535|FG001|Randomized|Withdrawal by Subject|0|||
37756821|NCT01579565|69265534|FG000|Randomized|inadequate preoperative pupil dilation|0|||
37756822|NCT01579565|69265535|FG001|Randomized|inadequate preoperative pupil dilation|1|||
37756823|NCT01579565|69265534|FG000|Randomized|prohibited preoperative eating|1|||
37756824|NCT01579565|69265535|FG001|Randomized|prohibited preoperative eating|0|||
37665192|NCT01928394|69137594|FG000|Treatment Period|Death|0|||
37665193|NCT01928394|69137595|FG001|Treatment Period|Death|0|||
37665194|NCT01928394|69137596|FG002|Treatment Period|Death|0|||
37756825|NCT01579565|69265534|FG000|Randomized|prohibited preoperative medication|0|||
37756826|NCT01579565|69265535|FG001|Randomized|prohibited preoperative medication|1|||
37756827|NCT01579565|69265534|FG000|Treated|Physician Decision|0|||
37756828|NCT01579565|69265535|FG001|Treated|Physician Decision|1|||
37756829|NCT01579565|69265534|FG000|Treated|Lost to Follow-up|2|||
37756830|NCT01579565|69265535|FG001|Treated|Lost to Follow-up|1|||
37756831|NCT01579565|69265534|FG000|Treated|declined to return for final visit|0|||
37756832|NCT01579565|69265535|FG001|Treated|declined to return for final visit|1|||
37756833|NCT01578785|69265545|FG000|Overall Study|Withdrawal by Subject|0|||
37756834|NCT01578785|69265546|FG001|Overall Study|Withdrawal by Subject|1|||
37756835|NCT01578785|69265545|FG000|Overall Study|Study terminated by sponsor|59|||
37756836|NCT01578785|69265546|FG001|Overall Study|Study terminated by sponsor|118|||
37756837|NCT02692482|69265554|FG000|Overall Study|Death|2|||
37756838|NCT02692482|69265555|FG001|Overall Study|Death|2|||
37756839|NCT02692482|69265554|FG000|Overall Study|Withdrawal by Subject|1|||
37756840|NCT02692482|69265555|FG001|Overall Study|Withdrawal by Subject|2|||
37756841|NCT01578551|69265564|FG000|Overall Study|Adverse Event|1|||
37756842|NCT01578551|69265565|FG001|Overall Study|Adverse Event|0|||
37756843|NCT01692197|69265572|FG000|Overall Study|Failed Screening|3|||
37756844|NCT01692119|69265579|FG000|Overall Study|Protocol Violation|3|||
37756845|NCT01692119|69265580|FG001|Overall Study|Protocol Violation|1|||
37756846|NCT01692119|69265579|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
37756847|NCT01692119|69265580|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
37756848|NCT01691885|69265586|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
37756849|NCT01691885|69265587|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
37756850|NCT01691885|69265586|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
37756851|NCT01691885|69265587|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
37756852|NCT01587703|69265620|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
37756853|NCT01587703|69265621|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
37756854|NCT01587703|69265622|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
37756855|NCT01587703|69265623|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
37756856|NCT01587703|69265624|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
37756857|NCT01587703|69265625|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
37665195|NCT01928394|69137597|FG003|Treatment Period|Death|0|||
37756858|NCT01587703|69265626|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
37858475|NCT01288430|69541743|FG001|Part 2|Other|0|||
37858476|NCT01288430|69541744|FG002|Part 2|Other|0|||
37665196|NCT01928394|69137598|FG004|Treatment Period|Death|0|||
37665197|NCT01928394|69137599|FG005|Treatment Period|Death|0|||
37665198|NCT01928394|69137600|FG006|Treatment Period|Death|0|||
37665199|NCT01928394|69137601|FG007|Treatment Period|Death|0|||
37665200|NCT01928394|69137602|FG008|Treatment Period|Death|0|||
37665201|NCT01928394|69137603|FG009|Treatment Period|Death|0|||
37665202|NCT01928394|69137604|FG010|Treatment Period|Death|0|||
37665203|NCT01928394|69137605|FG011|Treatment Period|Death|0|||
37665204|NCT01928394|69137606|FG012|Treatment Period|Death|0|||
37665205|NCT01928394|69137607|FG013|Treatment Period|Death|1|||
37858477|NCT01288430|69541745|FG003|Part 2|Other|0|||
37756859|NCT01587703|69265627|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
37756860|NCT01587703|69265628|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
37756861|NCT01587703|69265629|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
37756862|NCT01587703|69265630|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
37756863|NCT01587703|69265631|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
37665206|NCT01928394|69137608|FG014|Treatment Period|Death|2|||
37665207|NCT01928394|69137609|FG015|Treatment Period|Death|0|||
37858478|NCT01288430|69541746|FG004|Part 2|Other|0|||
37858479|NCT01288430|69541747|FG005|Part 2|Other|0|||
37665208|NCT01928394|69137610|FG016|Treatment Period|Death|0|||
37665209|NCT01928394|69137611|FG017|Treatment Period|Death|0|||
37756864|NCT01587703|69265632|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
37756865|NCT01587703|69265633|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
37756866|NCT01587703|69265634|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
37756867|NCT01587703|69265635|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
37858480|NCT01288430|69541748|FG006|Part 2|Other|0|||
38033323|NCT04493684|69719211|FG016|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
38033324|NCT04493684|69719195|FG000|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
38033325|NCT04493684|69719196|FG001|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
38033326|NCT04493684|69719197|FG002|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
38033327|NCT04493684|69719198|FG003|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
37665210|NCT01928394|69137612|FG018|Treatment Period|Death|0|||
37665211|NCT01928394|69137613|FG019|Treatment Period|Death|0|||
37665212|NCT01928394|69137614|FG020|Treatment Period|Death|0|||
37665213|NCT01928394|69137615|FG021|Treatment Period|Death|0|||
37665214|NCT01928394|69137616|FG022|Treatment Period|Death|0|||
37665215|NCT01928394|69137594|FG000|Follow-up Period|Participant withdrew consent|3|||
37665216|NCT01928394|69137595|FG001|Follow-up Period|Participant withdrew consent|0|||
37665217|NCT01928394|69137596|FG002|Follow-up Period|Participant withdrew consent|1|||
37665218|NCT01928394|69137597|FG003|Follow-up Period|Participant withdrew consent|4|||
37665219|NCT01928394|69137598|FG004|Follow-up Period|Participant withdrew consent|0|||
37665220|NCT01928394|69137599|FG005|Follow-up Period|Participant withdrew consent|2|||
37665221|NCT01928394|69137600|FG006|Follow-up Period|Participant withdrew consent|5|||
37665222|NCT01928394|69137601|FG007|Follow-up Period|Participant withdrew consent|1|||
37665223|NCT01928394|69137602|FG008|Follow-up Period|Participant withdrew consent|0|||
37665224|NCT01928394|69137603|FG009|Follow-up Period|Participant withdrew consent|0|||
37665225|NCT01928394|69137604|FG010|Follow-up Period|Participant withdrew consent|5|||
37665226|NCT01928394|69137605|FG011|Follow-up Period|Participant withdrew consent|8|||
37665227|NCT01928394|69137606|FG012|Follow-up Period|Participant withdrew consent|2|||
37665228|NCT01928394|69137607|FG013|Follow-up Period|Participant withdrew consent|12|||
37665229|NCT01928394|69137608|FG014|Follow-up Period|Participant withdrew consent|7|||
37665230|NCT01928394|69137609|FG015|Follow-up Period|Participant withdrew consent|0|||
37665231|NCT01928394|69137610|FG016|Follow-up Period|Participant withdrew consent|5|||
37665232|NCT01928394|69137611|FG017|Follow-up Period|Participant withdrew consent|3|||
37665233|NCT01928394|69137612|FG018|Follow-up Period|Participant withdrew consent|2|||
37665234|NCT01928394|69137613|FG019|Follow-up Period|Participant withdrew consent|7|||
37665235|NCT01928394|69137614|FG020|Follow-up Period|Participant withdrew consent|4|||
37665236|NCT01928394|69137615|FG021|Follow-up Period|Participant withdrew consent|6|||
37665237|NCT01928394|69137616|FG022|Follow-up Period|Participant withdrew consent|2|||
37665238|NCT01928394|69137594|FG000|Follow-up Period|Death|0|||
37665239|NCT01928394|69137595|FG001|Follow-up Period|Death|0|||
37665240|NCT01928394|69137596|FG002|Follow-up Period|Death|2|||
37665241|NCT01928394|69137597|FG003|Follow-up Period|Death|6|||
37665242|NCT01928394|69137598|FG004|Follow-up Period|Death|0|||
37665243|NCT01928394|69137599|FG005|Follow-up Period|Death|6|||
37665244|NCT01928394|69137600|FG006|Follow-up Period|Death|6|||
37665245|NCT01928394|69137601|FG007|Follow-up Period|Death|2|||
37665246|NCT01928394|69137602|FG008|Follow-up Period|Death|1|||
37665247|NCT01928394|69137603|FG009|Follow-up Period|Death|2|||
37665248|NCT01928394|69137604|FG010|Follow-up Period|Death|4|||
37665249|NCT01928394|69137605|FG011|Follow-up Period|Death|12|||
37665250|NCT01928394|69137606|FG012|Follow-up Period|Death|11|||
37665251|NCT01928394|69137607|FG013|Follow-up Period|Death|25|||
37665252|NCT01928394|69137608|FG014|Follow-up Period|Death|18|||
37665253|NCT01928394|69137609|FG015|Follow-up Period|Death|0|||
37665254|NCT01928394|69137610|FG016|Follow-up Period|Death|6|||
37665255|NCT01928394|69137611|FG017|Follow-up Period|Death|5|||
37665256|NCT01928394|69137612|FG018|Follow-up Period|Death|13|||
37665257|NCT01928394|69137613|FG019|Follow-up Period|Death|13|||
37665258|NCT01928394|69137614|FG020|Follow-up Period|Death|5|||
37665259|NCT01928394|69137615|FG021|Follow-up Period|Death|3|||
37665260|NCT01928394|69137616|FG022|Follow-up Period|Death|2|||
37665261|NCT01928394|69137594|FG000|Follow-up Period|other reason|0|||
37665262|NCT01928394|69137595|FG001|Follow-up Period|other reason|0|||
37665263|NCT01928394|69137596|FG002|Follow-up Period|other reason|0|||
37665264|NCT01928394|69137597|FG003|Follow-up Period|other reason|0|||
37665265|NCT01928394|69137598|FG004|Follow-up Period|other reason|0|||
37665266|NCT01928394|69137599|FG005|Follow-up Period|other reason|0|||
37665267|NCT01928394|69137600|FG006|Follow-up Period|other reason|1|||
37665268|NCT01928394|69137601|FG007|Follow-up Period|other reason|3|||
37665269|NCT01928394|69137602|FG008|Follow-up Period|other reason|0|||
38033328|NCT04493684|69719199|FG004|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
37665270|NCT01928394|69137603|FG009|Follow-up Period|other reason|0|||
37665271|NCT01928394|69137604|FG010|Follow-up Period|other reason|2|||
37665272|NCT01928394|69137605|FG011|Follow-up Period|other reason|1|||
37665273|NCT01928394|69137606|FG012|Follow-up Period|other reason|0|||
37665274|NCT01928394|69137607|FG013|Follow-up Period|other reason|1|||
37665275|NCT01928394|69137608|FG014|Follow-up Period|other reason|4|||
37665276|NCT01928394|69137609|FG015|Follow-up Period|other reason|0|||
37665277|NCT01928394|69137610|FG016|Follow-up Period|other reason|2|||
37665278|NCT01928394|69137611|FG017|Follow-up Period|other reason|0|||
37665279|NCT01928394|69137612|FG018|Follow-up Period|other reason|1|||
37665280|NCT01928394|69137613|FG019|Follow-up Period|other reason|1|||
37665281|NCT01928394|69137614|FG020|Follow-up Period|other reason|0|||
37665282|NCT01928394|69137615|FG021|Follow-up Period|other reason|0|||
37665283|NCT01928394|69137616|FG022|Follow-up Period|other reason|1|||
37665284|NCT01928394|69137594|FG000|Follow-up Period|Lost to Follow-up|0|||
37665285|NCT01928394|69137595|FG001|Follow-up Period|Lost to Follow-up|0|||
37665286|NCT01928394|69137596|FG002|Follow-up Period|Lost to Follow-up|0|||
37665287|NCT01928394|69137597|FG003|Follow-up Period|Lost to Follow-up|0|||
37665288|NCT01928394|69137598|FG004|Follow-up Period|Lost to Follow-up|0|||
37665289|NCT01928394|69137599|FG005|Follow-up Period|Lost to Follow-up|0|||
37665290|NCT01928394|69137600|FG006|Follow-up Period|Lost to Follow-up|0|||
37665291|NCT01928394|69137601|FG007|Follow-up Period|Lost to Follow-up|0|||
37665292|NCT01928394|69137602|FG008|Follow-up Period|Lost to Follow-up|0|||
37665293|NCT01928394|69137603|FG009|Follow-up Period|Lost to Follow-up|0|||
37665294|NCT01928394|69137604|FG010|Follow-up Period|Lost to Follow-up|0|||
37665295|NCT01928394|69137605|FG011|Follow-up Period|Lost to Follow-up|1|||
37665296|NCT01928394|69137606|FG012|Follow-up Period|Lost to Follow-up|1|||
37665297|NCT01928394|69137607|FG013|Follow-up Period|Lost to Follow-up|0|||
37665298|NCT01928394|69137608|FG014|Follow-up Period|Lost to Follow-up|1|||
37665299|NCT01928394|69137609|FG015|Follow-up Period|Lost to Follow-up|0|||
37665300|NCT01928394|69137610|FG016|Follow-up Period|Lost to Follow-up|1|||
37665301|NCT01928394|69137611|FG017|Follow-up Period|Lost to Follow-up|0|||
37665302|NCT01928394|69137612|FG018|Follow-up Period|Lost to Follow-up|0|||
37665303|NCT01928394|69137613|FG019|Follow-up Period|Lost to Follow-up|0|||
37665304|NCT01928394|69137614|FG020|Follow-up Period|Lost to Follow-up|0|||
37665305|NCT01928394|69137615|FG021|Follow-up Period|Lost to Follow-up|0|||
37665306|NCT01928394|69137616|FG022|Follow-up Period|Lost to Follow-up|1|||
37665307|NCT01459068|69137666|FG000|Overall Study|Withdrawal by Subject|8|||
37665308|NCT01459068|69137667|FG001|Overall Study|Withdrawal by Subject|18|||
37665309|NCT01459068|69137666|FG000|Overall Study|Lost to Follow-up|31|||
37665310|NCT01459068|69137667|FG001|Overall Study|Lost to Follow-up|15|||
37665311|NCT01459068|69137666|FG000|Overall Study|Death|0|||
37665312|NCT01459068|69137667|FG001|Overall Study|Death|1|||
37665313|NCT01358877|69137675|FG000|Overall Study|Death|80|||
37665314|NCT01358877|69137676|FG001|Overall Study|Death|89|||
37665315|NCT01358877|69137675|FG000|Overall Study|Ongoing follow-up for post-recurrence|87|||
37665316|NCT01358877|69137676|FG001|Overall Study|Ongoing follow-up for post-recurrence|108|||
37665317|NCT01358877|69137675|FG000|Overall Study|Ongoing follow-up for IDFS event|2084|||
37665318|NCT01358877|69137676|FG001|Overall Study|Ongoing follow-up for IDFS event|2073|||
37756868|NCT01587703|69265636|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
37756869|NCT01587703|69265637|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
37756870|NCT01587703|69265638|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
37756871|NCT01587703|69265620|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
37756872|NCT01587703|69265621|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
37756873|NCT01587703|69265622|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
37756874|NCT01587703|69265623|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
37756875|NCT01587703|69265624|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
37858481|NCT01288430|69541749|FG007|Part 2|Other|0|||
37858482|NCT01288430|69541750|FG008|Part 2|Other|0|||
37858483|NCT01288430|69541751|FG009|Part 2|Other|1|||
37858484|NCT01287416|69541780|FG000|Pre-post Training|Withdrawal by Subject|17|||
37858485|NCT01287416|69541781|FG001|Pre-post Training|Withdrawal by Subject|24|||
37858486|NCT01287416|69541780|FG000|Pre-post Training|Lost to Follow-up|5|||
37858487|NCT01287416|69541781|FG001|Pre-post Training|Lost to Follow-up|1|||
37665319|NCT01358877|69137675|FG000|Overall Study|Ongoing follow-up for overall survival|7|||
37665320|NCT01358877|69137676|FG001|Overall Study|Ongoing follow-up for overall survival|5|||
37665321|NCT01358877|69137675|FG000|Overall Study|Other|142|||
37665322|NCT01358877|69137676|FG001|Overall Study|Other|129|||
37665323|NCT01216202|69137684|FG000|Overall Study|Withdrawal by Subject|8|||
37665324|NCT01216202|69137685|FG001|Overall Study|Withdrawal by Subject|0|||
37665325|NCT01216202|69137684|FG000|Overall Study|Death|0|||
37665326|NCT01216202|69137685|FG001|Overall Study|Death|2|||
37665327|NCT01216202|69137684|FG000|Overall Study|Lost to Follow-up|14|||
37665328|NCT01216202|69137685|FG001|Overall Study|Lost to Follow-up|0|||
37665329|NCT01186016|69137695|FG000|Overall Study|Withdrawal by Subject|46|||
37665330|NCT01186016|69137696|FG001|Overall Study|Withdrawal by Subject|29|||
37665331|NCT01113749|69137704|FG000|Overall Study|Lost to Follow-up|1|||
37665332|NCT01113749|69137705|FG001|Overall Study|Lost to Follow-up|2|||
37665333|NCT01081951|69137713|FG000|Overall Study|Death|54|||
37665334|NCT01081951|69137714|FG001|Overall Study|Death|47|||
37665335|NCT01081951|69137713|FG000|Overall Study|Withdrawal by Subject|2|||
37665336|NCT01081951|69137714|FG001|Overall Study|Withdrawal by Subject|6|||
37665337|NCT01081951|69137713|FG000|Overall Study|Allocated treatment but did not take it|0|||
37665338|NCT01081951|69137714|FG001|Overall Study|Allocated treatment but did not take it|1|||
37665339|NCT01081951|69137713|FG000|Overall Study|Lost to Follow-up|0|||
37665340|NCT01081951|69137714|FG001|Overall Study|Lost to Follow-up|1|||
37665341|NCT01060384|69137720|FG000|Overall Study|Withdrawal by Subject|0|||
37665342|NCT01060384|69137721|FG001|Overall Study|Withdrawal by Subject|1|||
37665343|NCT01060384|69137722|FG002|Overall Study|Withdrawal by Subject|0|||
37665344|NCT01060384|69137723|FG003|Overall Study|Withdrawal by Subject|0|||
37665345|NCT01060384|69137724|FG004|Overall Study|Withdrawal by Subject|0|||
37665346|NCT01060384|69137720|FG000|Overall Study|Death|0|||
37665347|NCT01060384|69137721|FG001|Overall Study|Death|0|||
37665348|NCT01060384|69137722|FG002|Overall Study|Death|0|||
37665349|NCT01060384|69137723|FG003|Overall Study|Death|0|||
37665350|NCT01060384|69137724|FG004|Overall Study|Death|1|||
37665351|NCT01060384|69137720|FG000|Overall Study|Intercurrent illness|0|||
37665352|NCT01060384|69137721|FG001|Overall Study|Intercurrent illness|0|||
37665353|NCT01060384|69137722|FG002|Overall Study|Intercurrent illness|0|||
37665354|NCT01060384|69137723|FG003|Overall Study|Intercurrent illness|0|||
37665355|NCT01060384|69137724|FG004|Overall Study|Intercurrent illness|1|||
37665356|NCT00580047|69137747|FG000|Overall Study|Lost to Follow-up|1|||
37665357|NCT00580047|69137748|FG001|Overall Study|Lost to Follow-up|1|||
37665358|NCT00580047|69137749|FG002|Overall Study|Lost to Follow-up|0|||
37665359|NCT00580047|69137747|FG000|Overall Study|Withdrawal by Subject|1|||
37665360|NCT00580047|69137748|FG001|Overall Study|Withdrawal by Subject|1|||
37665361|NCT00580047|69137749|FG002|Overall Study|Withdrawal by Subject|2|||
37665362|NCT00580047|69137747|FG000|Overall Study|Withdrawal by Subject|1|||
37665363|NCT00580047|69137748|FG001|Overall Study|Withdrawal by Subject|0|||
37665364|NCT00580047|69137749|FG002|Overall Study|Withdrawal by Subject|0|||
37665365|NCT00561340|69137762|FG000|Overall Study|refused to drink pediasure|6|||
37665366|NCT00561340|69137763|FG001|Overall Study|refused to drink pediasure|0|||
37665367|NCT00292045|69137769|FG000|Core Study (Through Week 13)|Adverse Event|1|||
37665368|NCT00292045|69137769|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
37665369|NCT00084799|69137775|FG000|Overall Study|Disease Progression|1|||
37665370|NCT00084799|69137776|FG001|Overall Study|Disease Progression|0|||
37665371|NCT00072410|69137784|FG000|Overall Study|Progressive disease|0|||
37665372|NCT00072410|69137785|FG001|Overall Study|Progressive disease|3|||
37665373|NCT00066729|69137791|FG000|Overall Study|Lost to Follow-up|1|||
37756876|NCT01587703|69265625|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
37756877|NCT01587703|69265626|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
37756878|NCT01587703|69265627|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
37756879|NCT01587703|69265628|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
37756880|NCT01587703|69265629|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
37756881|NCT01587703|69265630|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
37756882|NCT01587703|69265631|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
37756883|NCT01587703|69265632|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
37756884|NCT01587703|69265633|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
37756885|NCT01587703|69265634|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
37756886|NCT01587703|69265635|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
37756887|NCT01587703|69265636|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
37756888|NCT01587703|69265637|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
37756889|NCT01587703|69265638|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
37756890|NCT01587703|69265620|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
37756891|NCT01587703|69265621|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
37756892|NCT01587703|69265622|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
37756893|NCT01587703|69265623|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
37756894|NCT01587703|69265624|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
37756895|NCT01587703|69265625|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
37756896|NCT01587703|69265626|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
37665374|NCT00066729|69137791|FG000|Overall Study|Disease progression|1|||
37665375|NCT00006046|69137809|FG000|Overall Study|Adverse Event|3|||
37665376|NCT00006046|69137810|FG001|Overall Study|Adverse Event|0|||
37665377|NCT00006046|69137811|FG002|Overall Study|Adverse Event|0|||
37665378|NCT00006046|69137812|FG003|Overall Study|Adverse Event|0|||
37665379|NCT00006046|69137813|FG004|Overall Study|Adverse Event|0|||
37665380|NCT00006046|69137809|FG000|Overall Study|Disease Progression|2|||
37665381|NCT00006046|69137810|FG001|Overall Study|Disease Progression|0|||
37665382|NCT00006046|69137811|FG002|Overall Study|Disease Progression|0|||
37665383|NCT00006046|69137812|FG003|Overall Study|Disease Progression|0|||
37665384|NCT00006046|69137813|FG004|Overall Study|Disease Progression|0|||
37665385|NCT00003102|69137828|FG000|Overall Study|Physician Decision|1|||
37665386|NCT00003102|69137829|FG001|Overall Study|Physician Decision|1|||
37665387|NCT00003102|69137830|FG002|Overall Study|Physician Decision|0|||
37665388|NCT00003102|69137828|FG000|Overall Study|Progressive Disease|0|||
37665389|NCT00003102|69137829|FG001|Overall Study|Progressive Disease|1|||
37756897|NCT01587703|69265627|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
37756898|NCT01587703|69265628|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
37756899|NCT01587703|69265629|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
37756900|NCT01587703|69265630|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
37756901|NCT01587703|69265631|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
37756902|NCT01587703|69265632|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
37756903|NCT01587703|69265633|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
37756904|NCT01587703|69265634|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
37756905|NCT01587703|69265635|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
37756906|NCT01587703|69265636|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
37756907|NCT01587703|69265637|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
37756908|NCT01587703|69265638|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
37756909|NCT01587703|69265620|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
37756910|NCT01587703|69265621|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
37756911|NCT01587703|69265622|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
37756912|NCT01587703|69265623|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
37756913|NCT01587703|69265624|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
37756914|NCT01587703|69265625|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
37756915|NCT01587703|69265626|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
37756916|NCT01587703|69265627|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
37756917|NCT01587703|69265628|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
37756918|NCT01587703|69265629|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
37756919|NCT01587703|69265630|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
37756920|NCT01587703|69265631|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
37756921|NCT01587703|69265632|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
37756922|NCT01587703|69265633|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
37756923|NCT01587703|69265634|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
37756924|NCT01587703|69265635|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
37756925|NCT01587703|69265636|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
37756926|NCT01587703|69265637|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
37756927|NCT01587703|69265638|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
37756928|NCT01587703|69265620|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
37756929|NCT01587703|69265621|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
37756930|NCT01587703|69265622|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
37756931|NCT01587703|69265623|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
37756932|NCT01587703|69265624|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
37756933|NCT01587703|69265625|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
37756934|NCT01587703|69265626|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
37756935|NCT01587703|69265627|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
37756936|NCT01587703|69265628|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
37756937|NCT01587703|69265629|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
37756938|NCT01587703|69265630|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
37756939|NCT01587703|69265631|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
37756940|NCT01587703|69265632|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
37756941|NCT01587703|69265633|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
37756942|NCT01587703|69265634|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
37756943|NCT01587703|69265635|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
37756944|NCT01587703|69265636|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
37756945|NCT01587703|69265637|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
37756946|NCT01587703|69265638|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
37756947|NCT01587703|69265620|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
37756948|NCT01587703|69265621|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
37756949|NCT01587703|69265622|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
37756950|NCT01587703|69265623|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
37756951|NCT01587703|69265624|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
37756952|NCT01587703|69265625|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
37756953|NCT01587703|69265626|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
37756954|NCT01587703|69265627|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
37756955|NCT01587703|69265628|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
37756956|NCT01587703|69265629|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
37756957|NCT01587703|69265630|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
37756958|NCT01587703|69265631|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
37756959|NCT01587703|69265632|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
37756960|NCT01587703|69265633|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
37756961|NCT01587703|69265634|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
37756962|NCT01587703|69265635|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
37756963|NCT01587703|69265636|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
37756964|NCT01587703|69265637|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
37756965|NCT01587703|69265638|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
37756966|NCT01587703|69265620|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
37756967|NCT01587703|69265621|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
37756968|NCT01587703|69265622|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
37756969|NCT01587703|69265623|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
37756970|NCT01587703|69265624|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
37756971|NCT01587703|69265625|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
37756972|NCT01587703|69265626|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
37756973|NCT01587703|69265627|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
37756974|NCT01587703|69265628|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
37756975|NCT01587703|69265629|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
37756976|NCT01587703|69265630|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
37756977|NCT01587703|69265631|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
37756978|NCT01587703|69265632|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
37756979|NCT01587703|69265633|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
37756980|NCT01587703|69265634|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
37756981|NCT01587703|69265635|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
37665390|NCT00003102|69137830|FG002|Overall Study|Progressive Disease|0|||
37665391|NCT00003102|69137828|FG000|Overall Study|Adverse Event|0|||
37665392|NCT00003102|69137829|FG001|Overall Study|Adverse Event|1|||
37665393|NCT00003102|69137830|FG002|Overall Study|Adverse Event|1|||
37665394|NCT00003102|69137828|FG000|Overall Study|Death|0|||
37665395|NCT00003102|69137829|FG001|Overall Study|Death|0|||
37665396|NCT00003102|69137830|FG002|Overall Study|Death|1|||
37665397|NCT01673373|69137838|FG000|Overall Study|Death|2|||
37665398|NCT01236547|69137847|FG000|Overall Study|Protocol Violation|0|||
37665399|NCT01236547|69137848|FG001|Overall Study|Protocol Violation|1|||
37665400|NCT01236547|69137849|FG002|Overall Study|Protocol Violation|1|||
37665401|NCT01236547|69137850|FG003|Overall Study|Protocol Violation|6|||
37665402|NCT01236547|69137851|FG004|Overall Study|Protocol Violation|12|||
37665403|NCT02167945|69137864|FG000|Overall Study|Adverse Event|16|||
37665404|NCT02167945|69137864|FG000|Overall Study|Withdrew Consent|42|||
37665405|NCT02167945|69137864|FG000|Overall Study|Lost to Follow-up|122|||
37665406|NCT02167945|69137864|FG000|Overall Study|COVID-19 logistical restrictions|6|||
37665407|NCT02167945|69137864|FG000|Overall Study|Other, not specified|63|||
37665408|NCT01375075|69137882|FG000|Overall Study|Adverse Event|0|||
37665409|NCT01375075|69137883|FG001|Overall Study|Adverse Event|0|||
37665410|NCT01375075|69137884|FG002|Overall Study|Adverse Event|3|||
37665411|NCT01375075|69137885|FG003|Overall Study|Adverse Event|1|||
37665412|NCT01375075|69137886|FG004|Overall Study|Adverse Event|0|||
37665413|NCT01375075|69137887|FG005|Overall Study|Adverse Event|1|||
37665414|NCT01375075|69137882|FG000|Overall Study|Entry Criterion Not Met|1|||
37665415|NCT01375075|69137883|FG001|Overall Study|Entry Criterion Not Met|0|||
37665416|NCT01375075|69137884|FG002|Overall Study|Entry Criterion Not Met|0|||
37756982|NCT01587703|69265636|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
37756983|NCT01587703|69265637|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
37756984|NCT01587703|69265638|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
37756985|NCT01587703|69265620|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
37756986|NCT01587703|69265621|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
37756987|NCT01587703|69265622|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
37756988|NCT01587703|69265623|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
37756989|NCT01587703|69265624|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
37756990|NCT01587703|69265625|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
37756991|NCT01587703|69265626|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
37756992|NCT01587703|69265627|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
37665417|NCT01375075|69137885|FG003|Overall Study|Entry Criterion Not Met|0|||
37665418|NCT01375075|69137886|FG004|Overall Study|Entry Criterion Not Met|0|||
37665419|NCT01375075|69137887|FG005|Overall Study|Entry Criterion Not Met|1|||
37665420|NCT01375075|69137882|FG000|Overall Study|Withdrawal by Subject|0|||
37665421|NCT01375075|69137883|FG001|Overall Study|Withdrawal by Subject|1|||
37665422|NCT01375075|69137884|FG002|Overall Study|Withdrawal by Subject|0|||
37665423|NCT01375075|69137885|FG003|Overall Study|Withdrawal by Subject|0|||
37665424|NCT01375075|69137886|FG004|Overall Study|Withdrawal by Subject|0|||
37665425|NCT01375075|69137887|FG005|Overall Study|Withdrawal by Subject|1|||
37665426|NCT00706433|69137909|FG000|Overall Study|Lost to Follow-up|3|||
37665427|NCT00706433|69137910|FG001|Overall Study|Lost to Follow-up|1|||
37665428|NCT00706433|69137911|FG002|Overall Study|Lost to Follow-up|6|||
37665429|NCT00706433|69137912|FG003|Overall Study|Lost to Follow-up|0|||
37665430|NCT00706433|69137909|FG000|Overall Study|Withdrawal by Subject|1|||
37665431|NCT00706433|69137910|FG001|Overall Study|Withdrawal by Subject|2|||
37665432|NCT00706433|69137911|FG002|Overall Study|Withdrawal by Subject|3|||
37756993|NCT01587703|69265628|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
37756994|NCT01587703|69265629|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
37756995|NCT01587703|69265630|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
37756996|NCT01587703|69265631|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
37756997|NCT01587703|69265632|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
37756998|NCT01587703|69265633|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
37756999|NCT01587703|69265634|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
37757000|NCT01587703|69265635|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
37757001|NCT01587703|69265636|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
37757002|NCT01587703|69265637|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
37757003|NCT01587703|69265638|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
37757004|NCT01587703|69265620|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
37757005|NCT01587703|69265621|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
37757006|NCT01587703|69265622|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
37757007|NCT01587703|69265623|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
37757008|NCT01587703|69265624|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
37757009|NCT01587703|69265625|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
37757010|NCT01587703|69265626|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
37757011|NCT01587703|69265627|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
37757012|NCT01587703|69265628|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
37757013|NCT01587703|69265629|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
37757014|NCT01587703|69265630|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
37757015|NCT01587703|69265631|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
37757016|NCT01587703|69265632|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
37665433|NCT00706433|69137912|FG003|Overall Study|Withdrawal by Subject|1|||
37665434|NCT00706433|69137909|FG000|Overall Study|Adverse Event|0|||
37665435|NCT00706433|69137910|FG001|Overall Study|Adverse Event|0|||
37665436|NCT00706433|69137911|FG002|Overall Study|Adverse Event|1|||
37665437|NCT00706433|69137912|FG003|Overall Study|Adverse Event|0|||
37665438|NCT00706433|69137909|FG000|Overall Study|Protocol Violation|1|||
37757017|NCT01587703|69265633|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
37757018|NCT01587703|69265634|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
37757019|NCT01587703|69265635|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
37757020|NCT01587703|69265636|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
37757021|NCT01587703|69265637|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
37757022|NCT01587703|69265638|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
37757023|NCT01587703|69265620|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
37757024|NCT01587703|69265621|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
38033329|NCT04493684|69719200|FG005|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
38033330|NCT04493684|69719201|FG006|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
38033331|NCT04493684|69719202|FG007|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
38033332|NCT04493684|69719203|FG008|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
37665439|NCT00706433|69137910|FG001|Overall Study|Protocol Violation|0|||
37665440|NCT00706433|69137911|FG002|Overall Study|Protocol Violation|0|||
37665441|NCT00706433|69137912|FG003|Overall Study|Protocol Violation|0|||
37665442|NCT00706433|69137909|FG000|Overall Study|new job|0|||
37757025|NCT01587703|69265622|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
37757026|NCT01587703|69265623|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
37757027|NCT01587703|69265624|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
37757028|NCT01587703|69265625|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
37757029|NCT01587703|69265626|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
37757030|NCT01587703|69265627|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
37923447|NCT00804570|69610250|FG001|Overall Study|Physician Decision|2|||
38033333|NCT04493684|69719204|FG009|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
38033334|NCT04493684|69719205|FG010|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
38033335|NCT04493684|69719206|FG011|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
38033336|NCT04493684|69719207|FG012|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
38033337|NCT04493684|69719208|FG013|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
38033338|NCT04493684|69719209|FG014|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
38033339|NCT04493684|69719210|FG015|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|1|||
38033340|NCT04493684|69719211|FG016|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
38033341|NCT04289298|69719276|FG000|Overall Study|Lost to Follow-up|5|||
38033342|NCT04289298|69719277|FG001|Overall Study|Lost to Follow-up|0|||
37665443|NCT00706433|69137910|FG001|Overall Study|new job|0|||
37665444|NCT00706433|69137911|FG002|Overall Study|new job|0|||
37665445|NCT00706433|69137912|FG003|Overall Study|new job|1|||
37757031|NCT01587703|69265628|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
37757032|NCT01587703|69265629|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
37757033|NCT01587703|69265630|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
37757034|NCT01587703|69265631|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
37757035|NCT01587703|69265632|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
37757036|NCT01587703|69265633|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
37757037|NCT01587703|69265634|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
37757038|NCT01587703|69265635|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
37757039|NCT01587703|69265636|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
37757040|NCT01587703|69265637|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
37757041|NCT01587703|69265638|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
37757042|NCT01587703|69265620|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
37757043|NCT01587703|69265621|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
37757044|NCT01587703|69265622|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
37757045|NCT01587703|69265623|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
37757046|NCT01587703|69265624|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
37757047|NCT01587703|69265625|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
38033343|NCT04289298|69719276|FG000|Overall Study|Withdrawal by Subject|2|||
37665446|NCT02638623|69137924|FG000|Overall Study|Surgery timing|5|||
37665447|NCT02638623|69137925|FG001|Overall Study|Surgery timing|6|||
37665448|NCT02638623|69137924|FG000|Overall Study|Not given intervention|2|||
37665449|NCT02638623|69137925|FG001|Overall Study|Not given intervention|0|||
37665450|NCT02637141|69137934|FG000|Overall Study|Adverse Event|1|||
37665451|NCT02637141|69137935|FG001|Overall Study|Adverse Event|1|||
37665452|NCT02637141|69137936|FG002|Overall Study|Adverse Event|0|||
37665453|NCT02637141|69137934|FG000|Overall Study|Withdrawal by Subject|1|||
37665454|NCT02637141|69137935|FG001|Overall Study|Withdrawal by Subject|1|||
37665455|NCT02637141|69137936|FG002|Overall Study|Withdrawal by Subject|1|||
37665456|NCT02637063|69137947|FG000|Overall Study|Lost to Follow-up|3|||
37665457|NCT02637063|69137948|FG001|Overall Study|Lost to Follow-up|2|||
37665458|NCT02637063|69137949|FG002|Overall Study|Lost to Follow-up|3|||
37665459|NCT02637063|69137947|FG000|Overall Study|Withdrawal by Subject|2|||
37665460|NCT02637063|69137948|FG001|Overall Study|Withdrawal by Subject|2|||
37665461|NCT02637063|69137949|FG002|Overall Study|Withdrawal by Subject|3|||
37665462|NCT02635737|69137957|FG000|Overall Study|Protocol Violation|1|||
37665463|NCT02636907|69137961|FG000|Autoinjector Assessment Period|Adverse Event|2|||
37665464|NCT02636907|69137961|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
37665465|NCT02636907|69137961|FG000|Extension Phase|Adverse Event|2|||
37665466|NCT02636907|69137961|FG000|Extension Phase|Withdrawal by Subject|4|||
37665467|NCT02636907|69137961|FG000|Extension Phase|Physician Decision|1|||
37665468|NCT02636907|69137961|FG000|Extension Phase|Lost to Follow-up|2|||
37665469|NCT02636907|69137961|FG000|Extension Phase|Lack of Efficacy|1|||
37665470|NCT01374919|69137965|FG000|Overall Study|Withdrawal by Subject|2|||
37665471|NCT02726945|69137976|FG000|Overall Study|Withdrawal by Subject|0|||
37665472|NCT02726945|69137977|FG001|Overall Study|Withdrawal by Subject|0|||
37665473|NCT02726945|69137978|FG002|Overall Study|Withdrawal by Subject|1|||
37665474|NCT02726945|69137976|FG000|Overall Study|Elected to have total knee replacement|0|||
37665475|NCT02726945|69137977|FG001|Overall Study|Elected to have total knee replacement|1|||
37665476|NCT02726945|69137978|FG002|Overall Study|Elected to have total knee replacement|0|||
37665477|NCT02635347|69137988|FG000|Overall Study|Failed screening|20|||
37665478|NCT02635347|69137989|FG001|Overall Study|Failed screening|7|||
37665479|NCT02726399|69138009|FG000|Overall Study|Participant Non-Compliance|1|||
37665480|NCT02726399|69138009|FG000|Overall Study|Adverse Event|2|||
37665481|NCT02726399|69138009|FG000|Overall Study|Progression of disease|4|||
37665482|NCT02634801|69138016|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
37665483|NCT02634801|69138017|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
38033344|NCT04289298|69719277|FG001|Overall Study|Withdrawal by Subject|0|||
37665484|NCT02634801|69138018|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
37665485|NCT02634801|69138016|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
37665486|NCT02634801|69138017|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
37665487|NCT02634801|69138018|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
37665488|NCT02634801|69138016|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
37665489|NCT02634801|69138017|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
37757048|NCT01587703|69265626|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
37923448|NCT00804570|69610249|FG000|Overall Study|Sponsor decision|1|||
38033345|NCT04116710|69719288|FG000|Overall Study|Death|4|||
37665490|NCT02634801|69138018|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
37665491|NCT02634801|69138016|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
37665492|NCT02634801|69138017|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
37665493|NCT02634801|69138018|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
37665494|NCT02634801|69138016|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
37665495|NCT02634801|69138017|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
37757049|NCT01587703|69265627|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
37757050|NCT01587703|69265628|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
37757051|NCT01587703|69265629|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
37757052|NCT01587703|69265630|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
37757053|NCT01587703|69265631|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
37757054|NCT01587703|69265632|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
37757055|NCT01587703|69265633|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
37757056|NCT01587703|69265634|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
37757057|NCT01587703|69265635|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
37757058|NCT01587703|69265636|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
37757059|NCT01587703|69265637|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
37665496|NCT02634801|69138018|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
37665497|NCT02634801|69138016|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
37665498|NCT02634801|69138017|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
37665499|NCT02634801|69138018|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
37665500|NCT02634801|69138016|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
37757060|NCT01587703|69265638|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
37757061|NCT01587703|69265620|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
37665501|NCT02634801|69138017|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
37665502|NCT02634801|69138018|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
37757062|NCT01587703|69265621|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
37757063|NCT01587703|69265622|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
37757064|NCT01587703|69265623|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
37757065|NCT01587703|69265624|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
37757066|NCT01587703|69265625|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
37757067|NCT01587703|69265626|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
37757068|NCT01587703|69265627|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
37757069|NCT01587703|69265628|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
37757070|NCT01587703|69265629|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
37757071|NCT01587703|69265630|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
37757072|NCT01587703|69265631|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
37757073|NCT01587703|69265632|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
37757074|NCT01587703|69265633|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
37757075|NCT01587703|69265634|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
37757076|NCT01587703|69265635|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
37665503|NCT02634801|69138016|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
37757077|NCT01587703|69265636|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
37757078|NCT01587703|69265637|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
37757079|NCT01587703|69265638|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
37757080|NCT01587703|69265620|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
37757081|NCT01587703|69265621|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
37757082|NCT01587703|69265622|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
37757083|NCT01587703|69265623|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
37757084|NCT01587703|69265624|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
37757085|NCT01587703|69265625|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
37757086|NCT01587703|69265626|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
37757087|NCT01587703|69265627|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
37757088|NCT01587703|69265628|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
37757089|NCT01587703|69265629|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
37757090|NCT01587703|69265630|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
37757091|NCT01587703|69265631|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
37757092|NCT01587703|69265632|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
37757093|NCT01587703|69265633|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
37757094|NCT01587703|69265634|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
37757095|NCT01587703|69265635|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
37757096|NCT01587703|69265636|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
37757097|NCT01587703|69265637|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
37757098|NCT01587703|69265638|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
37757099|NCT01587703|69265620|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
37757100|NCT01587703|69265621|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
37757101|NCT01587703|69265622|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
37665504|NCT02634801|69138017|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
37665505|NCT02634801|69138018|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
37757102|NCT01587703|69265623|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
37757103|NCT01587703|69265624|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
37923449|NCT00804570|69610250|FG001|Overall Study|Sponsor decision|4|||
37665506|NCT02634801|69138016|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
37757104|NCT01587703|69265625|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
37757105|NCT01587703|69265626|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
37665507|NCT02634801|69138017|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
37665508|NCT02634801|69138018|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
37757106|NCT01587703|69265627|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
37757107|NCT01587703|69265628|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
37757108|NCT01587703|69265629|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
37757109|NCT01587703|69265630|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
37757110|NCT01587703|69265631|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
37757111|NCT01587703|69265632|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
37757112|NCT01587703|69265633|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
37757113|NCT01587703|69265634|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
37757114|NCT01587703|69265635|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
37757115|NCT01587703|69265636|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
37757116|NCT01587703|69265637|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
37757117|NCT01587703|69265638|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
37757118|NCT01587703|69265620|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
37665509|NCT02634801|69138016|FG000|Follow-up Period|Lost to Follow-up|3|||
37665510|NCT02634801|69138017|FG001|Follow-up Period|Lost to Follow-up|1|||
37665511|NCT02634801|69138018|FG002|Follow-up Period|Lost to Follow-up|2|||
37665512|NCT02634801|69138016|FG000|Follow-up Period|Physician Decision|0|||
37665513|NCT02634801|69138017|FG001|Follow-up Period|Physician Decision|0|||
37665514|NCT02634801|69138018|FG002|Follow-up Period|Physician Decision|1|||
37757119|NCT01587703|69265621|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
37757120|NCT01587703|69265622|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
37757121|NCT01587703|69265623|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
37757122|NCT01587703|69265624|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
37757123|NCT01587703|69265625|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
37757124|NCT01587703|69265626|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
37757125|NCT01587703|69265627|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
37757126|NCT01587703|69265628|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
37757127|NCT01587703|69265629|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
37757128|NCT01587703|69265630|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
37757129|NCT01587703|69265631|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
37757130|NCT01587703|69265632|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
37757131|NCT01587703|69265633|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
37757132|NCT01587703|69265634|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
37665515|NCT02634801|69138016|FG000|Follow-up Period|Withdrawal by Subject|1|||
37665516|NCT02634801|69138017|FG001|Follow-up Period|Withdrawal by Subject|2|||
37757133|NCT01587703|69265635|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
37757134|NCT01587703|69265636|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
37757135|NCT01587703|69265637|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
37757136|NCT01587703|69265638|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
37757137|NCT01577381|69265701|FG000|Overall Study|Discontinued|2|||
37757138|NCT01577381|69265702|FG001|Overall Study|Discontinued|1|||
37757139|NCT01577381|69265703|FG002|Overall Study|Discontinued|2|||
38033346|NCT04116710|69719289|FG001|Overall Study|Death|6|||
38033347|NCT04116710|69719290|FG002|Overall Study|Death|3|||
38033348|NCT04116710|69719291|FG003|Overall Study|Death|1|||
38033349|NCT04116710|69719288|FG000|Overall Study|Withdrawal by Subject|0|||
38033350|NCT04116710|69719289|FG001|Overall Study|Withdrawal by Subject|0|||
37665517|NCT02634801|69138018|FG002|Follow-up Period|Withdrawal by Subject|5|||
37665518|NCT02634801|69138016|FG000|Follow-up Period|Adverse Event|1|||
37757140|NCT01577381|69265704|FG003|Overall Study|Discontinued|2|||
37757141|NCT01577381|69265701|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
37757142|NCT01577381|69265702|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
37757143|NCT01577381|69265703|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
37757144|NCT01577381|69265704|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
37757145|NCT02686164|69265714|FG000|Overall Study|Adverse Event|1|||
37757146|NCT02686164|69265714|FG000|Overall Study|Withdrawal of consent|1|||
37757147|NCT02686164|69265714|FG000|Overall Study|Clinical progression|1|||
37757148|NCT01691105|69265735|FG000|1 Month Follow-up|Lost to Follow-up|41|||
37757149|NCT01691105|69265736|FG001|1 Month Follow-up|Lost to Follow-up|38|||
37757150|NCT01691105|69265735|FG000|1 Month Follow-up|Death|2|||
37757151|NCT01691105|69265736|FG001|1 Month Follow-up|Death|3|||
37757152|NCT01691105|69265735|FG000|6 Month Follow-up|Lost to Follow-up|39|||
37757153|NCT01691105|69265736|FG001|6 Month Follow-up|Lost to Follow-up|58|||
37757154|NCT01691105|69265735|FG000|6 Month Follow-up|Death|13|||
37757155|NCT01691105|69265736|FG001|6 Month Follow-up|Death|13|||
37757156|NCT01691105|69265735|FG000|12 Month Follow-up|Lost to Follow-up|50|||
37665519|NCT02634801|69138017|FG001|Follow-up Period|Adverse Event|5|||
37665520|NCT02634801|69138018|FG002|Follow-up Period|Adverse Event|0|||
37665521|NCT02724839|69138033|FG000|Overall Study|Withdrawal by Subject|1|||
37757157|NCT01691105|69265736|FG001|12 Month Follow-up|Lost to Follow-up|71|||
37757158|NCT01691105|69265735|FG000|12 Month Follow-up|Death|22|||
37757159|NCT01691105|69265736|FG001|12 Month Follow-up|Death|30|||
37757160|NCT01691105|69265735|FG000|12 Month Biochemical Verification|Death|22|||
37757161|NCT01691105|69265736|FG001|12 Month Biochemical Verification|Death|30|||
37757162|NCT01691105|69265735|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
37757163|NCT01691105|69265736|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
37757164|NCT01691105|69265735|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
37757165|NCT01691105|69265736|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
37757166|NCT02685072|69265744|FG000|Treatment Period|Lost to Follow-up|12|||
37757167|NCT02685072|69265745|FG001|Treatment Period|Lost to Follow-up|6|||
37757168|NCT02685072|69265744|FG000|Treatment Period|Withdrawal by Subject|1|||
37757169|NCT02685072|69265745|FG001|Treatment Period|Withdrawal by Subject|3|||
37757170|NCT02685072|69265744|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
37757171|NCT02685072|69265745|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
37757172|NCT02695524|69265815|FG000|Overall Study|Lost to Follow-up|3|||
37757173|NCT02695524|69265816|FG001|Overall Study|Lost to Follow-up|2|||
37757174|NCT02695524|69265815|FG000|Overall Study|Death|0|||
37757175|NCT02695524|69265816|FG001|Overall Study|Death|1|||
37757176|NCT01576367|69265822|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
37757177|NCT01576367|69265822|FG000|Overall Study|Moved to commercial use after 6 months|1|||
37757178|NCT01689857|69265833|FG000|Overall Study|Lost to Follow-up|5|||
37757179|NCT01689857|69265834|FG001|Overall Study|Lost to Follow-up|2|||
37757180|NCT01587079|69265849|FG000|Overall Study|Protocol-specified criteria|9|||
37757181|NCT01587079|69265849|FG000|Overall Study|Protocol Violation|5|||
37757182|NCT01587079|69265849|FG000|Overall Study|Lost to Follow-up|2|||
37757183|NCT01587079|69265849|FG000|Overall Study|Physician Decision|2|||
37757184|NCT01587079|69265849|FG000|Overall Study|Withdrawal by Subject|7|||
37757185|NCT01587079|69265849|FG000|Overall Study|Adverse Event|14|||
37757186|NCT01587001|69265902|FG000|Overall Study|Lost to Follow-up|2|||
37757187|NCT01587001|69265903|FG001|Overall Study|Lost to Follow-up|0|||
37757188|NCT01587001|69265902|FG000|Overall Study|Insufficient samples to complete testing|4|||
37757189|NCT01587001|69265903|FG001|Overall Study|Insufficient samples to complete testing|1|||
37757190|NCT01568047|69265933|FG000|Overall Study|Ineligibility|1|||
37757191|NCT01568047|69265934|FG001|Overall Study|Ineligibility|0|||
37757192|NCT01568047|69265935|FG002|Overall Study|Ineligibility|0|||
37757193|NCT01568047|69265936|FG003|Overall Study|Ineligibility|0|||
37757194|NCT01568047|69265933|FG000|Overall Study|Withdrawal by Subject|0|||
37757195|NCT01568047|69265934|FG001|Overall Study|Withdrawal by Subject|1|||
37757196|NCT01568047|69265935|FG002|Overall Study|Withdrawal by Subject|0|||
37757197|NCT01568047|69265936|FG003|Overall Study|Withdrawal by Subject|0|||
37757198|NCT01568047|69265933|FG000|Overall Study|Adverse Event|0|||
37757199|NCT01568047|69265934|FG001|Overall Study|Adverse Event|0|||
37757200|NCT01568047|69265935|FG002|Overall Study|Adverse Event|1|||
37757201|NCT01568047|69265936|FG003|Overall Study|Adverse Event|1|||
37757202|NCT01688999|69265949|FG000|Overall Study|Withdrawal by Subject|5|||
37757203|NCT01688999|69265950|FG001|Overall Study|Withdrawal by Subject|1|||
37858488|NCT01287416|69541780|FG000|6 Month Follow-up|Lost to Follow-up|3|||
37858489|NCT01287416|69541781|FG001|6 Month Follow-up|Lost to Follow-up|2|||
37858490|NCT00998296|69541798|FG000|Overall Study|Progressive disease|0|||
37858491|NCT00998296|69541799|FG001|Overall Study|Progressive disease|1|||
37858492|NCT00998296|69541800|FG002|Overall Study|Progressive disease|0|||
37858493|NCT00998296|69541801|FG003|Overall Study|Progressive disease|0|||
37858494|NCT00998296|69541802|FG004|Overall Study|Progressive disease|0|||
37858495|NCT00998296|69541803|FG005|Overall Study|Progressive disease|0|||
37858496|NCT00998296|69541804|FG006|Overall Study|Progressive disease|1|||
37858497|NCT00998296|69541805|FG007|Overall Study|Progressive disease|0|||
37757204|NCT01688999|69265951|FG002|Overall Study|Withdrawal by Subject|1|||
37757205|NCT01688999|69265949|FG000|Overall Study|Adverse Event|2|||
37757206|NCT01688999|69265950|FG001|Overall Study|Adverse Event|0|||
37757207|NCT01688999|69265951|FG002|Overall Study|Adverse Event|2|||
37757208|NCT01688999|69265949|FG000|Overall Study|Ineligible/Not treated|1|||
37757209|NCT01688999|69265950|FG001|Overall Study|Ineligible/Not treated|0|||
37757210|NCT01688999|69265951|FG002|Overall Study|Ineligible/Not treated|0|||
37757211|NCT01541917|69265975|FG000|Overall Study|Lost to Follow-up|2|||
37757212|NCT01541917|69265976|FG001|Overall Study|Lost to Follow-up|2|||
37757213|NCT01541917|69265975|FG000|Overall Study|Withdrawal by Subject|13|||
37757214|NCT01541917|69265976|FG001|Overall Study|Withdrawal by Subject|7|||
37757215|NCT01688921|69265996|FG000|Overall Study|Lost to Follow-up|7|||
37757216|NCT01688921|69265997|FG001|Overall Study|Lost to Follow-up|13|||
37757217|NCT01688921|69265996|FG000|Overall Study|Physician Decision|6|||
37757218|NCT01688921|69265997|FG001|Overall Study|Physician Decision|1|||
37757219|NCT01688921|69265996|FG000|Overall Study|Protocol Violation|0|||
37757220|NCT01688921|69265997|FG001|Overall Study|Protocol Violation|1|||
37757221|NCT01688921|69265996|FG000|Overall Study|informed consent|3|||
37757222|NCT01688921|69265997|FG001|Overall Study|informed consent|0|||
37757223|NCT01541371|69266019|FG000|Overall Study|Withdrawal by Subject|14|||
37757224|NCT01541371|69266019|FG000|Overall Study|Lost to Follow-up|21|||
37757225|NCT01541371|69266019|FG000|Overall Study|Adverse Event|15|||
37757226|NCT01541371|69266019|FG000|Overall Study|Lack of Efficacy|12|||
37757227|NCT01541371|69266019|FG000|Overall Study|Protocol Violation|6|||
37757228|NCT01541371|69266019|FG000|Overall Study|Study medication non-compliance|3|||
37757229|NCT01541371|69266019|FG000|Overall Study|Other|6|||
37757230|NCT01687673|69266052|FG000|Overall Study|Physician Decision|1|||
37757231|NCT01687595|69266132|FG000|Overall Study|Withdrawal by Subject|8|||
37757232|NCT01687595|69266133|FG001|Overall Study|Withdrawal by Subject|0|||
37757233|NCT01687595|69266132|FG000|Overall Study|Lost to Follow-up|3|||
37757234|NCT01687595|69266133|FG001|Overall Study|Lost to Follow-up|1|||
37757235|NCT01687595|69266132|FG000|Overall Study|Investigator's decision|1|||
37757236|NCT01687595|69266133|FG001|Overall Study|Investigator's decision|0|||
37757237|NCT01687595|69266132|FG000|Overall Study|Sponsor's decision|1|||
37757238|NCT01687595|69266133|FG001|Overall Study|Sponsor's decision|0|||
37757239|NCT01687595|69266132|FG000|Overall Study|Noncompliance|1|||
37757240|NCT01687595|69266133|FG001|Overall Study|Noncompliance|2|||
37757241|NCT01687595|69266132|FG000|Overall Study|Other than specified|56|||
37757242|NCT01687595|69266133|FG001|Overall Study|Other than specified|7|||
37757243|NCT01687283|69266141|FG000|Overall Study|Adverse Event|11|||
37757244|NCT01687283|69266142|FG001|Overall Study|Adverse Event|4|||
37757245|NCT01687283|69266141|FG000|Overall Study|Lack of Efficacy|3|||
37757246|NCT01687283|69266142|FG001|Overall Study|Lack of Efficacy|1|||
37757247|NCT01687283|69266141|FG000|Overall Study|Protocol Violation|1|||
37757248|NCT01687283|69266142|FG001|Overall Study|Protocol Violation|3|||
37665522|NCT02724839|69138034|FG001|Overall Study|Withdrawal by Subject|1|||
37665523|NCT02724839|69138035|FG002|Overall Study|Withdrawal by Subject|0|||
37665524|NCT02724839|69138033|FG000|Overall Study|Lost to Follow-up|0|||
37665525|NCT02724839|69138034|FG001|Overall Study|Lost to Follow-up|3|||
37665526|NCT02724839|69138035|FG002|Overall Study|Lost to Follow-up|2|||
37665527|NCT02724839|69138033|FG000|Overall Study|Physician Decision|0|||
37757249|NCT01687283|69266141|FG000|Overall Study|protocol defined stopping criteria|8|||
37757250|NCT01687283|69266142|FG001|Overall Study|protocol defined stopping criteria|10|||
37757251|NCT01687283|69266141|FG000|Overall Study|Lost to Follow-up|1|||
37757252|NCT01687283|69266142|FG001|Overall Study|Lost to Follow-up|1|||
37757253|NCT01687283|69266141|FG000|Overall Study|Investigator discretion|2|||
37757254|NCT01687283|69266142|FG001|Overall Study|Investigator discretion|0|||
37757255|NCT01687283|69266141|FG000|Overall Study|Withdrawal by Subject|9|||
37757256|NCT01687283|69266142|FG001|Overall Study|Withdrawal by Subject|8|||
37757257|NCT02684370|69266151|FG000|Part A|Adverse Event|2|||
37757258|NCT02684370|69266152|FG001|Part A|Adverse Event|0|||
37757259|NCT02684370|69266153|FG002|Part A|Adverse Event|1|||
37757260|NCT02684370|69266154|FG003|Part A|Adverse Event|0|||
37757261|NCT02684370|69266155|FG004|Part A|Adverse Event|0|||
37757262|NCT02684370|69266156|FG005|Part A|Adverse Event|0|||
37858498|NCT00998296|69541806|FG008|Overall Study|Progressive disease|0|||
37665528|NCT02724839|69138034|FG001|Overall Study|Physician Decision|0|||
37665529|NCT02724839|69138035|FG002|Overall Study|Physician Decision|3|||
37665530|NCT01375751|69138053|FG000|Overall Study|Other|0|||
37665531|NCT01375751|69138054|FG001|Overall Study|Other|1|||
37665532|NCT01375751|69138055|FG002|Overall Study|Other|0|||
37665533|NCT00705575|69138065|FG000|Overall Study|Abnormal laboratory value(s)|0|||
37665534|NCT00705575|69138066|FG001|Overall Study|Abnormal laboratory value(s)|3|||
37665535|NCT00705575|69138065|FG000|Overall Study|Abnormal test procedure result(s)|2|||
37665536|NCT00705575|69138066|FG001|Overall Study|Abnormal test procedure result(s)|12|||
37665537|NCT00705575|69138065|FG000|Overall Study|Adverse Event|11|||
37665538|NCT00705575|69138066|FG001|Overall Study|Adverse Event|15|||
37665539|NCT00705575|69138065|FG000|Overall Study|Lost to Follow-up|3|||
37665540|NCT00705575|69138066|FG001|Overall Study|Lost to Follow-up|4|||
37757263|NCT02684370|69266151|FG000|Part A|Lost to Follow-up|1|||
37757264|NCT02684370|69266152|FG001|Part A|Lost to Follow-up|1|||
37757265|NCT02684370|69266153|FG002|Part A|Lost to Follow-up|0|||
37757266|NCT02684370|69266154|FG003|Part A|Lost to Follow-up|0|||
37757267|NCT02684370|69266155|FG004|Part A|Lost to Follow-up|0|||
37757268|NCT02684370|69266156|FG005|Part A|Lost to Follow-up|0|||
37757269|NCT02684370|69266151|FG000|Part A|Subject Withdrawal|1|||
37665541|NCT00705575|69138065|FG000|Overall Study|Protocol Violation|2|||
37665542|NCT00705575|69138066|FG001|Overall Study|Protocol Violation|2|||
37665543|NCT00705575|69138065|FG000|Overall Study|Withdrawal by Subject|5|||
37665544|NCT00705575|69138066|FG001|Overall Study|Withdrawal by Subject|10|||
37665545|NCT02636595|69138072|FG000|Overall Study|Lost to Follow-up|1|||
37665546|NCT02636595|69138072|FG000|Overall Study|Other|1|||
37665547|NCT02636361|69138076|FG000|Period 4|Physician Decision|0|||
37665548|NCT02636361|69138077|FG001|Period 4|Physician Decision|0|||
37665549|NCT02636361|69138078|FG002|Period 4|Physician Decision|0|||
37757270|NCT02684370|69266152|FG001|Part A|Subject Withdrawal|0|||
37757271|NCT02684370|69266153|FG002|Part A|Subject Withdrawal|3|||
37757272|NCT02684370|69266154|FG003|Part A|Subject Withdrawal|0|||
37757273|NCT02684370|69266155|FG004|Part A|Subject Withdrawal|0|||
37757274|NCT02684370|69266156|FG005|Part A|Subject Withdrawal|0|||
37757275|NCT02684370|69266151|FG000|Part A|Other|0|||
37665550|NCT02636361|69138079|FG003|Period 4|Physician Decision|1|||
37665551|NCT02636361|69138080|FG004|Period 4|Physician Decision|0|||
37665552|NCT02636283|69138096|FG000|Overall Study|Adverse Event|2|||
37665553|NCT02636283|69138097|FG001|Overall Study|Adverse Event|0|||
37665554|NCT02636283|69138096|FG000|Overall Study|Trial Terminated Prematurely|0|||
37665555|NCT02636283|69138097|FG001|Overall Study|Trial Terminated Prematurely|3|||
37665556|NCT04430855|69138105|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
37757276|NCT02684370|69266152|FG001|Part A|Other|0|||
37757277|NCT02684370|69266153|FG002|Part A|Other|1|||
37665557|NCT04430855|69138106|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
37665558|NCT04430855|69138105|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
37665559|NCT04430855|69138106|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
37665560|NCT04430855|69138105|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
37665561|NCT04430855|69138106|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
37665562|NCT04430855|69138105|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
37665563|NCT04430855|69138106|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
37665564|NCT04430855|69138105|FG000|Period 1 (Weeks 1-12)|Other|0|||
37665565|NCT04430855|69138106|FG001|Period 1 (Weeks 1-12)|Other|1|||
37665566|NCT04430855|69138105|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
37665567|NCT04430855|69138106|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
37665568|NCT04430855|69138105|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
37665569|NCT04430855|69138106|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
37665570|NCT04430855|69138105|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
37665571|NCT04430855|69138106|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
37665572|NCT01375673|69138116|FG000|Overall Study|Withdrawal by Subject|0|||
37665573|NCT01375673|69138117|FG001|Overall Study|Withdrawal by Subject|1|||
37665574|NCT03652961|69138123|FG000|Overall Study|Lost to Follow-up|3|||
37665575|NCT03652961|69138123|FG000|Overall Study|Screen Failure|1|||
37665576|NCT02723591|69138129|FG000|Overall Study|Adverse Event|48|||
37665577|NCT02723591|69138130|FG001|Overall Study|Adverse Event|40|||
37665578|NCT02723591|69138129|FG000|Overall Study|Death|2|||
37665579|NCT02723591|69138130|FG001|Overall Study|Death|2|||
37665580|NCT02723591|69138129|FG000|Overall Study|Lack of Efficacy|4|||
37665581|NCT02723591|69138130|FG001|Overall Study|Lack of Efficacy|3|||
37665582|NCT02723591|69138129|FG000|Overall Study|Lost to Follow-up|1|||
37665583|NCT02723591|69138130|FG001|Overall Study|Lost to Follow-up|7|||
37665584|NCT02723591|69138129|FG000|Overall Study|Protocol Violation|20|||
37665585|NCT02723591|69138130|FG001|Overall Study|Protocol Violation|23|||
37665586|NCT02723591|69138129|FG000|Overall Study|Withdrawal by Subject|4|||
37757278|NCT02684370|69266154|FG003|Part A|Other|0|||
37757279|NCT02684370|69266155|FG004|Part A|Other|0|||
37757280|NCT02684370|69266156|FG005|Part A|Other|0|||
37757281|NCT02684370|69266151|FG000|Part B|Adverse Event|0|||
37757282|NCT02684370|69266152|FG001|Part B|Adverse Event|0|||
37757283|NCT02684370|69266153|FG002|Part B|Adverse Event|0|||
37757284|NCT02684370|69266154|FG003|Part B|Adverse Event|0|||
37757285|NCT02684370|69266155|FG004|Part B|Adverse Event|2|||
37757286|NCT02684370|69266156|FG005|Part B|Adverse Event|1|||
37757287|NCT02684370|69266151|FG000|Part B|Lost to Follow-up|0|||
37757288|NCT02684370|69266152|FG001|Part B|Lost to Follow-up|0|||
37757289|NCT02684370|69266153|FG002|Part B|Lost to Follow-up|0|||
37757290|NCT02684370|69266154|FG003|Part B|Lost to Follow-up|1|||
37757291|NCT02684370|69266155|FG004|Part B|Lost to Follow-up|2|||
37757292|NCT02684370|69266156|FG005|Part B|Lost to Follow-up|5|||
37757293|NCT02684370|69266151|FG000|Part B|Subject Withdrawal|0|||
37757294|NCT02684370|69266152|FG001|Part B|Subject Withdrawal|0|||
37757295|NCT02684370|69266153|FG002|Part B|Subject Withdrawal|0|||
37757296|NCT02684370|69266154|FG003|Part B|Subject Withdrawal|1|||
37757297|NCT02684370|69266155|FG004|Part B|Subject Withdrawal|1|||
37757298|NCT02684370|69266156|FG005|Part B|Subject Withdrawal|2|||
37665587|NCT02723591|69138130|FG001|Overall Study|Withdrawal by Subject|8|||
37665588|NCT02723591|69138129|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
37665589|NCT02723591|69138130|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
37665590|NCT02723591|69138129|FG000|Overall Study|Miscellaneous|5|||
37665591|NCT02723591|69138130|FG001|Overall Study|Miscellaneous|6|||
37665592|NCT00705341|69138138|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
37665593|NCT00705341|69138139|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
37665594|NCT00705341|69138140|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
37665595|NCT00705341|69138141|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
37665596|NCT00705341|69138138|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
37665597|NCT00705341|69138139|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
37665598|NCT00705341|69138140|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
37665599|NCT00705341|69138141|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
37665600|NCT02723201|69138152|FG000|Second Intervention Period|Protocol Violation|1|||
37757299|NCT01686581|69266183|FG000|Overall Study|Side-effects or Health Problems|15|||
37757300|NCT01686581|69266183|FG000|Overall Study|Lack of Efficacy|90|||
37757301|NCT01686581|69266183|FG000|Overall Study|Participant Concerned about Risks|6|||
37757302|NCT01686581|69266183|FG000|Overall Study|Thinks Injections Too Painful|8|||
37757303|NCT01686581|69266183|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
37757304|NCT01686581|69266183|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
37757305|NCT01686581|69266183|FG000|Overall Study|Thinks it is Inconvenient|17|||
37757306|NCT01686581|69266183|FG000|Overall Study|Other Miscellaneous Reasons|36|||
37757307|NCT01686581|69266183|FG000|Overall Study|Reason Missing|1|||
37757308|NCT02691936|69266201|FG000|Overall Study|Withdrawal by Subject|2|||
37757309|NCT02691936|69266202|FG001|Overall Study|Withdrawal by Subject|5|||
37757310|NCT01685801|69266249|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
37757311|NCT01685801|69266250|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
37665601|NCT02723201|69138153|FG001|Second Intervention Period|Protocol Violation|0|||
37665602|NCT02723201|69138154|FG002|Second Intervention Period|Protocol Violation|0|||
37665603|NCT02723201|69138152|FG000|Second Intervention Period|Adverse Event|1|||
37665604|NCT02723201|69138153|FG001|Second Intervention Period|Adverse Event|0|||
37665605|NCT02723201|69138154|FG002|Second Intervention Period|Adverse Event|0|||
37665606|NCT03846479|69138168|FG000|Overall Study|Death|8|||
37665607|NCT03846479|69138168|FG000|Overall Study|Lost to Follow-up|1|||
37665608|NCT00705263|69138172|FG000|Overall Study|Withdrawal by Subject|2|||
37665609|NCT00704405|69138190|FG000|Overall Study (NC Population)|Adverse Event|1|||
37665610|NCT00704405|69138191|FG001|Overall Study (NC Population)|Adverse Event|0|||
37665611|NCT00704405|69138192|FG002|Overall Study (NC Population)|Adverse Event|0|||
37665612|NCT00704405|69138193|FG003|Overall Study (NC Population)|Adverse Event|0|||
37665613|NCT00704405|69138194|FG004|Overall Study (NC Population)|Adverse Event|0|||
37665614|NCT00704405|69138190|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
37665615|NCT00704405|69138191|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
37665616|NCT00704405|69138192|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
37665617|NCT00704405|69138193|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
37665618|NCT00704405|69138194|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
37665619|NCT00704405|69138190|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
37665620|NCT00704405|69138191|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
37665621|NCT00704405|69138192|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
37665622|NCT00704405|69138193|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
37665623|NCT00704405|69138194|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
37665624|NCT00704405|69138190|FG000|Overall Study (NC Population)|Other|0|||
37665625|NCT00704405|69138191|FG001|Overall Study (NC Population)|Other|0|||
37665626|NCT00704405|69138192|FG002|Overall Study (NC Population)|Other|0|||
37665627|NCT00704405|69138193|FG003|Overall Study (NC Population)|Other|0|||
37665628|NCT00704405|69138194|FG004|Overall Study (NC Population)|Other|1|||
37665629|NCT00704405|69138190|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
37665630|NCT00704405|69138191|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
37665631|NCT00704405|69138192|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
37665632|NCT00704405|69138193|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
37665633|NCT00704405|69138194|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
37665634|NCT00704405|69138190|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
37665635|NCT00704405|69138191|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
37665636|NCT00704405|69138192|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
37665637|NCT00704405|69138193|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
37665638|NCT00704405|69138194|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
37665639|NCT01534481|69138214|FG000|Overall Study|Lost to Follow-up|29|||
37665640|NCT01534481|69138215|FG001|Overall Study|Lost to Follow-up|24|||
37665641|NCT01534481|69138214|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
37665642|NCT01534481|69138215|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
37665643|NCT00704171|69138223|FG000|Overall Study|Withdrawal by Subject|1|||
37665644|NCT00704171|69138224|FG001|Overall Study|Withdrawal by Subject|0|||
37665645|NCT00703781|69138232|FG000|Overall Study|Withdrawal by Subject|1|||
37665646|NCT00703781|69138233|FG001|Overall Study|Withdrawal by Subject|2|||
37665647|NCT00703781|69138232|FG000|Overall Study|Cancelled surgery|1|||
37665648|NCT00703781|69138233|FG001|Overall Study|Cancelled surgery|0|||
37665649|NCT00703157|69138241|FG000|Overall Study|Lost to Follow-up|0|||
37665650|NCT00703157|69138242|FG001|Overall Study|Lost to Follow-up|1|||
37665651|NCT00703157|69138241|FG000|Overall Study|source data permanently lost/ other|4|||
37665652|NCT00703157|69138242|FG001|Overall Study|source data permanently lost/ other|1|||
37665653|NCT03307967|69138250|FG000|Overall Study|Lost to Follow-up|4|||
37665654|NCT02722967|69138257|FG000|Overall Study|Adverse Event|1|||
37665655|NCT02722967|69138258|FG001|Overall Study|Adverse Event|0|||
37665656|NCT02722967|69138259|FG002|Overall Study|Adverse Event|0|||
37665657|NCT02722967|69138257|FG000|Overall Study|Lost to Follow-up|0|||
37665658|NCT02722967|69138258|FG001|Overall Study|Lost to Follow-up|1|||
37665659|NCT02722967|69138259|FG002|Overall Study|Lost to Follow-up|0|||
37665660|NCT02722967|69138257|FG000|Overall Study|Non-compliance with patch wearing|2|||
37665661|NCT02722967|69138258|FG001|Overall Study|Non-compliance with patch wearing|1|||
37665662|NCT02722967|69138259|FG002|Overall Study|Non-compliance with patch wearing|1|||
37665663|NCT02722967|69138257|FG000|Overall Study|Withdrawal by Subject|1|||
37665664|NCT02722967|69138258|FG001|Overall Study|Withdrawal by Subject|0|||
37665665|NCT02722967|69138259|FG002|Overall Study|Withdrawal by Subject|1|||
37757312|NCT01685801|69266251|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
37665666|NCT02722967|69138257|FG000|Overall Study|Physician Decision|1|||
37757313|NCT01685801|69266252|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
37757314|NCT01685801|69266249|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
37757315|NCT01685801|69266250|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
37757316|NCT01685801|69266251|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
37858499|NCT00998296|69541807|FG009|Overall Study|Progressive disease|14|||
37858500|NCT00998296|69541808|FG010|Overall Study|Progressive disease|5|||
37858501|NCT00998296|69541798|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
37858502|NCT00998296|69541799|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
37858503|NCT00998296|69541800|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
37858504|NCT00998296|69541801|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
37858505|NCT00998296|69541802|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
37858506|NCT00998296|69541803|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
37858507|NCT00998296|69541804|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
37858508|NCT00998296|69541805|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
37858509|NCT00998296|69541806|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
37858510|NCT00998296|69541807|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
37858511|NCT00998296|69541808|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
37858512|NCT00998296|69541798|FG000|Overall Study|Other adverse event|0|||
37858513|NCT00998296|69541799|FG001|Overall Study|Other adverse event|0|||
37858514|NCT00998296|69541800|FG002|Overall Study|Other adverse event|0|||
37858515|NCT00998296|69541801|FG003|Overall Study|Other adverse event|0|||
37858516|NCT00998296|69541802|FG004|Overall Study|Other adverse event|1|||
37858517|NCT00998296|69541803|FG005|Overall Study|Other adverse event|0|||
37858518|NCT00998296|69541804|FG006|Overall Study|Other adverse event|0|||
37858519|NCT00998296|69541805|FG007|Overall Study|Other adverse event|0|||
37858520|NCT00998296|69541806|FG008|Overall Study|Other adverse event|0|||
37858521|NCT00998296|69541807|FG009|Overall Study|Other adverse event|1|||
37858522|NCT00998296|69541808|FG010|Overall Study|Other adverse event|2|||
37858523|NCT00998296|69541798|FG000|Overall Study|Refused to continue taking trial med.|0|||
37858524|NCT00998296|69541799|FG001|Overall Study|Refused to continue taking trial med.|0|||
37858525|NCT00998296|69541800|FG002|Overall Study|Refused to continue taking trial med.|0|||
37858526|NCT00998296|69541801|FG003|Overall Study|Refused to continue taking trial med.|0|||
37858527|NCT00998296|69541802|FG004|Overall Study|Refused to continue taking trial med.|0|||
37858528|NCT00998296|69541803|FG005|Overall Study|Refused to continue taking trial med.|0|||
37858529|NCT00998296|69541804|FG006|Overall Study|Refused to continue taking trial med.|0|||
37858530|NCT00998296|69541805|FG007|Overall Study|Refused to continue taking trial med.|0|||
37858531|NCT00998296|69541806|FG008|Overall Study|Refused to continue taking trial med.|0|||
37858532|NCT00998296|69541807|FG009|Overall Study|Refused to continue taking trial med.|2|||
37858533|NCT00998296|69541808|FG010|Overall Study|Refused to continue taking trial med.|0|||
37858534|NCT00998296|69541798|FG000|Overall Study|Reason other than those specified above|0|||
37858535|NCT00998296|69541799|FG001|Overall Study|Reason other than those specified above|0|||
37858536|NCT00998296|69541800|FG002|Overall Study|Reason other than those specified above|0|||
37665667|NCT02722967|69138258|FG001|Overall Study|Physician Decision|0|||
37665668|NCT02722967|69138259|FG002|Overall Study|Physician Decision|0|||
37665669|NCT02722967|69138257|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
37665670|NCT02722967|69138258|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
37665671|NCT02722967|69138259|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
37665672|NCT02722499|69138270|FG000|Overall Study|Lost to Follow-up|2|||
37665673|NCT02722499|69138271|FG001|Overall Study|Lost to Follow-up|0|||
37665674|NCT02722499|69138272|FG002|Overall Study|Lost to Follow-up|1|||
37665675|NCT02721875|69138282|FG000|Overall Study|Progressive disease/relapse|1|||
37665676|NCT02721875|69138283|FG001|Overall Study|Progressive disease/relapse|0|||
37665677|NCT02721251|69138292|FG000|Overall Study|Withdrawal by Subject|8|||
37665678|NCT02721251|69138293|FG001|Overall Study|Withdrawal by Subject|7|||
37665679|NCT02721251|69138294|FG002|Overall Study|Withdrawal by Subject|9|||
37665680|NCT02721251|69138292|FG000|Overall Study|poor adherence|2|||
37665681|NCT02721251|69138293|FG001|Overall Study|poor adherence|2|||
37665682|NCT02721251|69138294|FG002|Overall Study|poor adherence|2|||
37858537|NCT00998296|69541801|FG003|Overall Study|Reason other than those specified above|0|||
37858538|NCT00998296|69541802|FG004|Overall Study|Reason other than those specified above|0|||
37858539|NCT00998296|69541803|FG005|Overall Study|Reason other than those specified above|0|||
37858540|NCT00998296|69541804|FG006|Overall Study|Reason other than those specified above|0|||
37858541|NCT00998296|69541805|FG007|Overall Study|Reason other than those specified above|0|||
37858542|NCT00998296|69541806|FG008|Overall Study|Reason other than those specified above|0|||
37858543|NCT00998296|69541807|FG009|Overall Study|Reason other than those specified above|1|||
37665683|NCT00702221|69138305|FG000|Overall Study|Adverse Event|4|||
37665684|NCT00702221|69138306|FG001|Overall Study|Adverse Event|3|||
37665685|NCT00702143|69138315|FG000|Overall Study|Lost to Follow-up|0|||
37665686|NCT00702143|69138316|FG001|Overall Study|Lost to Follow-up|0|||
37757317|NCT01685801|69266252|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
37757318|NCT01353222|69266271|FG000|Overall Study|Death|30|||
37665687|NCT00702143|69138317|FG002|Overall Study|Lost to Follow-up|1|||
37665688|NCT00702923|69138323|FG000|Overall Study|Adverse Event|1|||
37757319|NCT01353222|69266272|FG001|Overall Study|Death|30|||
37757320|NCT01353222|69266271|FG000|Overall Study|Withdrawal by Subject|8|||
37757321|NCT01353222|69266272|FG001|Overall Study|Withdrawal by Subject|5|||
37757322|NCT01353222|69266271|FG000|Overall Study|Study Terminated|31|||
37757323|NCT01353222|69266272|FG001|Overall Study|Study Terminated|37|||
37757324|NCT01353222|69266271|FG000|Overall Study|Site closed research department|1|||
37757325|NCT01353222|69266272|FG001|Overall Study|Site closed research department|0|||
37757326|NCT01684943|69266302|FG000|Overall Study|Inadequate Venous Access|3|||
37757327|NCT01684943|69266303|FG001|Overall Study|Inadequate Venous Access|0|||
37757328|NCT01684943|69266304|FG002|Overall Study|Inadequate Venous Access|0|||
37757329|NCT01684943|69266302|FG000|Overall Study|Principal Investigator Determination|1|||
37757330|NCT01684943|69266303|FG001|Overall Study|Principal Investigator Determination|0|||
37757331|NCT01684943|69266304|FG002|Overall Study|Principal Investigator Determination|0|||
37757332|NCT01684943|69266302|FG000|Overall Study|Excluded from Analysis|1|||
37757333|NCT01684943|69266303|FG001|Overall Study|Excluded from Analysis|1|||
37757334|NCT01684943|69266304|FG002|Overall Study|Excluded from Analysis|1|||
37757335|NCT01684943|69266302|FG000|Overall Study|Lost to Follow-up|3|||
37757336|NCT01684943|69266303|FG001|Overall Study|Lost to Follow-up|0|||
38033351|NCT04116710|69719290|FG002|Overall Study|Withdrawal by Subject|0|||
38033352|NCT04116710|69719291|FG003|Overall Study|Withdrawal by Subject|1|||
38033353|NCT02946515|69719330|FG000|Overall Study|Lost to Follow-up|2|||
38033354|NCT02946515|69719331|FG001|Overall Study|Lost to Follow-up|1|||
38033355|NCT02586623|69719344|FG000|Open-Label (Up to 16 Weeks)|Adverse Event|53|||
38033356|NCT02586623|69719345|FG001|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
38033357|NCT02586623|69719346|FG002|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
38033358|NCT02586623|69719344|FG000|Open-Label (Up to 16 Weeks)|Lost to Follow-up|4|||
37665689|NCT02633787|69138328|FG000|Overall Study|Withdrawal by Subject|1|||
37665690|NCT02719691|69138339|FG000|Overall Study|Physician Decision|0|||
37665691|NCT02719691|69138340|FG001|Overall Study|Physician Decision|0|||
37665692|NCT02719691|69138341|FG002|Overall Study|Physician Decision|1|||
37757337|NCT01684943|69266304|FG002|Overall Study|Lost to Follow-up|0|||
37858544|NCT00998296|69541808|FG010|Overall Study|Reason other than those specified above|0|||
37858545|NCT01178073|69541840|FG000|Overall Study|Adverse Event|34|||
37858546|NCT01178073|69541841|FG001|Overall Study|Adverse Event|27|||
37858547|NCT01178073|69541842|FG002|Overall Study|Adverse Event|24|||
37858548|NCT01178073|69541840|FG000|Overall Study|Protocol Violation|1|||
37858549|NCT01178073|69541841|FG001|Overall Study|Protocol Violation|1|||
37858550|NCT01178073|69541842|FG002|Overall Study|Protocol Violation|1|||
37858551|NCT01178073|69541840|FG000|Overall Study|Lost to Follow-up|2|||
37858552|NCT01178073|69541841|FG001|Overall Study|Lost to Follow-up|0|||
37858553|NCT01178073|69541842|FG002|Overall Study|Lost to Follow-up|3|||
37858554|NCT01178073|69541840|FG000|Overall Study|Physician Decision|14|||
37858555|NCT01178073|69541841|FG001|Overall Study|Physician Decision|10|||
37858556|NCT01178073|69541842|FG002|Overall Study|Physician Decision|10|||
37858557|NCT01178073|69541840|FG000|Overall Study|Withdrawal by Subject|10|||
37858558|NCT01178073|69541841|FG001|Overall Study|Withdrawal by Subject|6|||
37858559|NCT01178073|69541842|FG002|Overall Study|Withdrawal by Subject|8|||
37665693|NCT02719691|69138342|FG003|Overall Study|Physician Decision|0|||
37665694|NCT02719691|69138343|FG004|Overall Study|Physician Decision|0|||
37665695|NCT02719691|69138344|FG005|Overall Study|Physician Decision|0|||
37665696|NCT02719691|69138345|FG006|Overall Study|Physician Decision|0|||
37665697|NCT02719691|69138339|FG000|Overall Study|Withdrawal by Subject|0|||
37665698|NCT02719691|69138340|FG001|Overall Study|Withdrawal by Subject|0|||
37858560|NCT01178073|69541840|FG000|Overall Study|Missing Completion Status|1|||
37858561|NCT01178073|69541841|FG001|Overall Study|Missing Completion Status|0|||
37858562|NCT01178073|69541842|FG002|Overall Study|Missing Completion Status|0|||
38033359|NCT02586623|69719345|FG001|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
38033360|NCT02586623|69719346|FG002|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
38033361|NCT02586623|69719344|FG000|Open-Label (Up to 16 Weeks)|Non-Compliance|6|||
37665699|NCT02719691|69138341|FG002|Overall Study|Withdrawal by Subject|0|||
37757338|NCT01684943|69266302|FG000|Overall Study|Planning Pregnancy|1|||
37757339|NCT01684943|69266303|FG001|Overall Study|Planning Pregnancy|0|||
37757340|NCT01684943|69266304|FG002|Overall Study|Planning Pregnancy|0|||
37757341|NCT01683383|69266319|FG000|Overall Study|Infant was not transported|1|||
37858563|NCT00997984|69541854|FG000|Overall Study|Adverse Event|1|||
37858564|NCT00997984|69541855|FG001|Overall Study|Adverse Event|8|||
37858565|NCT00997984|69541856|FG002|Overall Study|Adverse Event|8|||
37757342|NCT01683383|69266320|FG001|Overall Study|Infant was not transported|0|||
37858566|NCT00997984|69541854|FG000|Overall Study|Protocol Violation|1|||
37858567|NCT00997984|69541855|FG001|Overall Study|Protocol Violation|3|||
37858568|NCT00997984|69541856|FG002|Overall Study|Protocol Violation|0|||
37858569|NCT00997984|69541854|FG000|Overall Study|Withdrawal by Subject|6|||
37858570|NCT00997984|69541855|FG001|Overall Study|Withdrawal by Subject|9|||
37757343|NCT02694744|69266328|FG000|Overall Study|Adverse Event|2|||
37757344|NCT02694744|69266329|FG001|Overall Study|Adverse Event|1|||
37757345|NCT02694744|69266328|FG000|Overall Study|Withdrawal by Subject|2|||
37757346|NCT02694744|69266329|FG001|Overall Study|Withdrawal by Subject|1|||
37757347|NCT02694744|69266328|FG000|Overall Study|Physician Decision|1|||
37757348|NCT02694744|69266329|FG001|Overall Study|Physician Decision|2|||
37757349|NCT02694744|69266328|FG000|Overall Study|Lost to Follow-up|1|||
37757350|NCT02694744|69266329|FG001|Overall Study|Lost to Follow-up|0|||
37757351|NCT02694744|69266328|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
37757352|NCT02694744|69266329|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
37757353|NCT01683071|69266343|FG000|Part 1|Lack of Efficacy|1|||
37757354|NCT01683071|69266344|FG001|Part 1|Lack of Efficacy|0|||
37665700|NCT02719691|69138342|FG003|Overall Study|Withdrawal by Subject|0|||
37665701|NCT02719691|69138343|FG004|Overall Study|Withdrawal by Subject|0|||
37665702|NCT02719691|69138344|FG005|Overall Study|Withdrawal by Subject|1|||
37665703|NCT02719691|69138345|FG006|Overall Study|Withdrawal by Subject|0|||
37665704|NCT02720081|69138364|FG000|Overall Study|Adverse Event|0|||
37665705|NCT02720081|69138365|FG001|Overall Study|Adverse Event|3|||
37665706|NCT02720081|69138364|FG000|Overall Study|Protocol Violation|4|||
37665707|NCT02720081|69138365|FG001|Overall Study|Protocol Violation|1|||
37665708|NCT04248933|69138371|FG000|Overall Study|Lost to Follow-up|9|||
37665709|NCT04248933|69138371|FG000|Overall Study|Withdrawal by Subject|2|||
37665710|NCT02718131|69138377|FG000|Overall Study|Withdrawal by Subject|1|||
37665711|NCT02718131|69138378|FG001|Overall Study|Withdrawal by Subject|0|||
37665712|NCT02718131|69138377|FG000|Overall Study|Adverse Event|1|||
37665713|NCT02718131|69138378|FG001|Overall Study|Adverse Event|0|||
37665714|NCT02718131|69138377|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
37665715|NCT02718131|69138378|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
37665716|NCT02717195|69138413|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
37665717|NCT02717195|69138414|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
37665718|NCT02717195|69138415|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
37665719|NCT02717195|69138416|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
37665720|NCT02717195|69138417|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
37665721|NCT02717195|69138413|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
37665722|NCT02717195|69138414|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
37665723|NCT02717195|69138415|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
37665724|NCT02717195|69138416|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
37665725|NCT02717195|69138417|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
37665726|NCT02717195|69138413|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
37665727|NCT02717195|69138414|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
37665728|NCT02717195|69138415|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
37665729|NCT02717195|69138416|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
37665730|NCT02717195|69138417|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
37665731|NCT02717195|69138413|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
37757355|NCT01683071|69266345|FG002|Part 1|Lack of Efficacy|0|||
37757356|NCT01683071|69266346|FG003|Part 1|Lack of Efficacy|3|||
37757357|NCT01683071|69266347|FG004|Part 1|Lack of Efficacy|0|||
37757358|NCT01683071|69266348|FG005|Part 1|Lack of Efficacy|0|||
37757359|NCT01683071|69266343|FG000|Part 1|Withdrawal by Subject|1|||
37757360|NCT01683071|69266344|FG001|Part 1|Withdrawal by Subject|2|||
37757361|NCT01683071|69266345|FG002|Part 1|Withdrawal by Subject|2|||
37757362|NCT01683071|69266346|FG003|Part 1|Withdrawal by Subject|1|||
37757363|NCT01683071|69266347|FG004|Part 1|Withdrawal by Subject|0|||
37757364|NCT01683071|69266348|FG005|Part 1|Withdrawal by Subject|0|||
37923450|NCT00804570|69610249|FG000|Overall Study|Withdrawal by Subject|21|||
37665732|NCT02717195|69138414|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
37665733|NCT02717195|69138415|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
37665734|NCT02717195|69138416|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
37665735|NCT02717195|69138417|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
37665736|NCT02717195|69138413|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
37665737|NCT02717195|69138414|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
37757365|NCT01683071|69266343|FG000|Part 1|Surgery Cancelled|1|||
37757366|NCT01683071|69266344|FG001|Part 1|Surgery Cancelled|0|||
37757367|NCT01683071|69266345|FG002|Part 1|Surgery Cancelled|0|||
37757368|NCT01683071|69266346|FG003|Part 1|Surgery Cancelled|0|||
37757369|NCT01683071|69266347|FG004|Part 1|Surgery Cancelled|0|||
37757370|NCT01683071|69266348|FG005|Part 1|Surgery Cancelled|0|||
37757371|NCT01683071|69266343|FG000|Part 1|Did not receive study drug|1|||
37757372|NCT01683071|69266344|FG001|Part 1|Did not receive study drug|0|||
37757373|NCT01683071|69266345|FG002|Part 1|Did not receive study drug|0|||
37757374|NCT01683071|69266346|FG003|Part 1|Did not receive study drug|1|||
37757375|NCT01683071|69266347|FG004|Part 1|Did not receive study drug|0|||
37757376|NCT01683071|69266348|FG005|Part 1|Did not receive study drug|0|||
37757377|NCT01683071|69266343|FG000|Part 1|Early termination; met exclusion criteria|0|||
37757378|NCT01683071|69266344|FG001|Part 1|Early termination; met exclusion criteria|2|||
37757379|NCT01683071|69266345|FG002|Part 1|Early termination; met exclusion criteria|1|||
37757380|NCT01683071|69266346|FG003|Part 1|Early termination; met exclusion criteria|0|||
37757381|NCT01683071|69266347|FG004|Part 1|Early termination; met exclusion criteria|0|||
37757382|NCT01683071|69266348|FG005|Part 1|Early termination; met exclusion criteria|0|||
37757383|NCT01683071|69266343|FG000|Part 2|Lack of Efficacy|0|||
37757384|NCT01683071|69266344|FG001|Part 2|Lack of Efficacy|0|||
37757385|NCT01683071|69266345|FG002|Part 2|Lack of Efficacy|0|||
37757386|NCT01683071|69266346|FG003|Part 2|Lack of Efficacy|0|||
37757387|NCT01683071|69266347|FG004|Part 2|Lack of Efficacy|3|||
37757388|NCT01683071|69266348|FG005|Part 2|Lack of Efficacy|4|||
37757389|NCT01683071|69266343|FG000|Part 2|Lost to Follow-up|0|||
37665738|NCT02717195|69138415|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
37665739|NCT02717195|69138416|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
37665740|NCT02717195|69138417|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
37665741|NCT02717195|69138413|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
37665742|NCT02717195|69138414|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
37665743|NCT02717195|69138415|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
37665744|NCT02717195|69138416|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
37665745|NCT02717195|69138417|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
37665746|NCT02717195|69138413|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
37665747|NCT02717195|69138414|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
37665748|NCT02717195|69138415|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
37665749|NCT02717195|69138416|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
37665750|NCT02717195|69138417|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
37665751|NCT02717195|69138413|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
37665752|NCT02717195|69138414|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
37665753|NCT02717195|69138415|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
37665754|NCT02717195|69138416|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
37665755|NCT02717195|69138417|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
37665756|NCT02717195|69138413|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
37665757|NCT02717195|69138414|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
37665758|NCT02717195|69138415|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
37665759|NCT02717195|69138416|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
37665760|NCT02717195|69138417|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
37665761|NCT02717195|69138413|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
37665762|NCT02717195|69138414|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
37665763|NCT02717195|69138415|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
37665764|NCT02717195|69138416|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
37665765|NCT02717195|69138417|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
37665766|NCT02717195|69138413|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
37665767|NCT02717195|69138414|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
37665768|NCT02717195|69138415|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
37665769|NCT02717195|69138416|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
37665770|NCT02717195|69138417|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
37665771|NCT02717195|69138413|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
37665772|NCT02717195|69138414|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
37665773|NCT02717195|69138415|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
37665774|NCT02717195|69138416|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
37665775|NCT02717195|69138417|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
37665776|NCT02717195|69138413|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
37665777|NCT02717195|69138414|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
37665778|NCT02717195|69138415|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
37665779|NCT02717195|69138416|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
37665780|NCT02717195|69138417|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
37665781|NCT02717195|69138413|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
37665782|NCT02717195|69138414|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
37665783|NCT02717195|69138415|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
37665784|NCT02717195|69138416|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
37665785|NCT02717195|69138417|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
37757390|NCT01683071|69266344|FG001|Part 2|Lost to Follow-up|0|||
37757391|NCT01683071|69266345|FG002|Part 2|Lost to Follow-up|0|||
37757392|NCT01683071|69266346|FG003|Part 2|Lost to Follow-up|0|||
37757393|NCT01683071|69266347|FG004|Part 2|Lost to Follow-up|2|||
37757394|NCT01683071|69266348|FG005|Part 2|Lost to Follow-up|0|||
37757395|NCT01683071|69266343|FG000|Part 2|Withdrawal by Subject|0|||
37665786|NCT02717195|69138413|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
37757396|NCT01683071|69266344|FG001|Part 2|Withdrawal by Subject|0|||
37757397|NCT01683071|69266345|FG002|Part 2|Withdrawal by Subject|0|||
37757398|NCT01683071|69266346|FG003|Part 2|Withdrawal by Subject|0|||
37757399|NCT01683071|69266347|FG004|Part 2|Withdrawal by Subject|3|||
37757400|NCT01683071|69266348|FG005|Part 2|Withdrawal by Subject|3|||
37757401|NCT01683071|69266343|FG000|Part 2|Surgery cancelled|0|||
37757402|NCT01683071|69266344|FG001|Part 2|Surgery cancelled|0|||
37757403|NCT01683071|69266345|FG002|Part 2|Surgery cancelled|0|||
37757404|NCT01683071|69266346|FG003|Part 2|Surgery cancelled|0|||
37757405|NCT01683071|69266347|FG004|Part 2|Surgery cancelled|4|||
37757406|NCT01683071|69266348|FG005|Part 2|Surgery cancelled|2|||
37757407|NCT01683071|69266343|FG000|Part 2|Did not receive study drug|0|||
37757408|NCT01683071|69266344|FG001|Part 2|Did not receive study drug|0|||
38033362|NCT02586623|69719345|FG001|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
38033363|NCT02586623|69719346|FG002|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
38033364|NCT02586623|69719344|FG000|Open-Label (Up to 16 Weeks)|Physician Decision|11|||
38033365|NCT02586623|69719345|FG001|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
38033366|NCT02586623|69719346|FG002|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
37665787|NCT02717195|69138414|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
37665788|NCT02717195|69138415|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
37665789|NCT02717195|69138416|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
37665790|NCT02717195|69138417|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
37665791|NCT02717195|69138413|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
37665792|NCT02717195|69138414|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
37665793|NCT02717195|69138415|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
37665794|NCT02717195|69138416|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
37665795|NCT02717195|69138417|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
37665796|NCT02717195|69138413|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
37665797|NCT02717195|69138414|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
37665798|NCT02717195|69138415|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
37665799|NCT02717195|69138416|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
37665800|NCT02717195|69138417|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
37665801|NCT02717195|69138413|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
37665802|NCT02717195|69138414|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
37665803|NCT02717195|69138415|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
37665804|NCT02717195|69138416|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
37665805|NCT02717195|69138417|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
37665806|NCT02717195|69138413|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
37665807|NCT02717195|69138414|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
37665808|NCT02717195|69138415|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
37665809|NCT02717195|69138416|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
37665810|NCT02717195|69138417|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
37665811|NCT02717195|69138413|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
37665812|NCT02717195|69138414|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
37665813|NCT02717195|69138415|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
37665814|NCT02717195|69138416|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
37665815|NCT02717195|69138417|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
37665816|NCT02717195|69138413|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
37665817|NCT02717195|69138414|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
37665818|NCT02717195|69138415|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
37665819|NCT02717195|69138416|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
37665820|NCT02717195|69138417|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
37665821|NCT02717195|69138413|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
37665822|NCT02717195|69138414|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
37665823|NCT02717195|69138415|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
37665824|NCT02717195|69138416|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
37665825|NCT02717195|69138417|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
37665826|NCT02717195|69138413|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
37665827|NCT02717195|69138414|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
37757409|NCT01683071|69266345|FG002|Part 2|Did not receive study drug|0|||
37757410|NCT01683071|69266346|FG003|Part 2|Did not receive study drug|0|||
37757411|NCT01683071|69266347|FG004|Part 2|Did not receive study drug|2|||
37757412|NCT01683071|69266348|FG005|Part 2|Did not receive study drug|1|||
37757413|NCT01683071|69266343|FG000|Part 2|Met exclusion criterion|0|||
37757414|NCT01683071|69266344|FG001|Part 2|Met exclusion criterion|0|||
37757415|NCT01683071|69266345|FG002|Part 2|Met exclusion criterion|0|||
37757416|NCT01683071|69266346|FG003|Part 2|Met exclusion criterion|0|||
37757417|NCT01683071|69266347|FG004|Part 2|Met exclusion criterion|1|||
37757418|NCT01683071|69266348|FG005|Part 2|Met exclusion criterion|1|||
37858571|NCT00997984|69541856|FG002|Overall Study|Withdrawal by Subject|5|||
37858572|NCT00997984|69541854|FG000|Overall Study|Lost to Follow-up|8|||
37858573|NCT00997984|69541855|FG001|Overall Study|Lost to Follow-up|5|||
37858574|NCT00997984|69541856|FG002|Overall Study|Lost to Follow-up|4|||
37858575|NCT00997984|69541854|FG000|Overall Study|Lack of Efficacy|20|||
37858576|NCT00997984|69541855|FG001|Overall Study|Lack of Efficacy|6|||
37858577|NCT00997984|69541856|FG002|Overall Study|Lack of Efficacy|3|||
37858578|NCT00997984|69541854|FG000|Overall Study|Met exclusion criteria|1|||
37858579|NCT00997984|69541855|FG001|Overall Study|Met exclusion criteria|0|||
37665828|NCT02717195|69138415|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
37665829|NCT02717195|69138416|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
37665830|NCT02717195|69138417|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
37665831|NCT02717195|69138413|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
37665832|NCT02717195|69138414|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
37665833|NCT02717195|69138415|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
37665834|NCT02717195|69138416|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
37665835|NCT02717195|69138417|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
37665836|NCT02717195|69138413|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
37665837|NCT02717195|69138414|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
37665838|NCT02717195|69138415|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
37665839|NCT02717195|69138416|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
37665840|NCT02717195|69138417|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
37665841|NCT02717195|69138413|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
37665842|NCT02717195|69138414|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
37665843|NCT02717195|69138415|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
37665844|NCT02717195|69138416|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
37665845|NCT02717195|69138417|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
37665846|NCT02717195|69138413|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
37665847|NCT02717195|69138414|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
37665848|NCT02717195|69138415|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
37665849|NCT02717195|69138416|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
37665850|NCT02717195|69138417|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
37665851|NCT02717195|69138413|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
37665852|NCT02717195|69138414|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
37665853|NCT02717195|69138415|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
37665854|NCT02717195|69138416|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
37665855|NCT02717195|69138417|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
37665856|NCT02717195|69138413|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
37665857|NCT02717195|69138414|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
37665858|NCT02717195|69138415|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
37665859|NCT02717195|69138416|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
37665860|NCT02717195|69138417|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
37665861|NCT02717195|69138413|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
37665862|NCT02717195|69138414|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
37665863|NCT02717195|69138415|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
37665864|NCT02717195|69138416|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
37665865|NCT02717195|69138417|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
37665866|NCT02717195|69138413|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
37665867|NCT02717195|69138414|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
37665868|NCT02717195|69138415|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
37665869|NCT02717195|69138416|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
37665870|NCT02717195|69138417|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
37665871|NCT02717195|69138413|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
37665872|NCT02717195|69138414|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
37665873|NCT02717195|69138415|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
37665874|NCT02717195|69138416|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
37665875|NCT02717195|69138417|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
37665876|NCT02717195|69138413|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
37665877|NCT02717195|69138414|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
37665878|NCT02717195|69138415|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
37665879|NCT02717195|69138416|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
37665880|NCT02717195|69138417|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
37757419|NCT01683071|69266343|FG000|Part 2|Protocol deviation|0|||
37757420|NCT01683071|69266344|FG001|Part 2|Protocol deviation|0|||
37858580|NCT00997984|69541856|FG002|Overall Study|Met exclusion criteria|0|||
37757421|NCT01683071|69266345|FG002|Part 2|Protocol deviation|0|||
37757422|NCT01683071|69266346|FG003|Part 2|Protocol deviation|0|||
37757423|NCT01683071|69266347|FG004|Part 2|Protocol deviation|1|||
37757424|NCT01683071|69266348|FG005|Part 2|Protocol deviation|2|||
37757425|NCT01683071|69266343|FG000|Part 2|Withdrawal by investigator decision|0|||
37757426|NCT01683071|69266344|FG001|Part 2|Withdrawal by investigator decision|0|||
37757427|NCT01683071|69266345|FG002|Part 2|Withdrawal by investigator decision|0|||
37757428|NCT01683071|69266346|FG003|Part 2|Withdrawal by investigator decision|0|||
37858581|NCT00997984|69541854|FG000|Overall Study|non-compliance|0|||
37858582|NCT00997984|69541855|FG001|Overall Study|non-compliance|2|||
37858583|NCT00997984|69541856|FG002|Overall Study|non-compliance|3|||
37858584|NCT00997984|69541854|FG000|Overall Study|Wrong medication dispensed|0|||
37858585|NCT00997984|69541855|FG001|Overall Study|Wrong medication dispensed|1|||
37858586|NCT00997984|69541856|FG002|Overall Study|Wrong medication dispensed|0|||
37858587|NCT00997984|69541854|FG000|Overall Study|Suicidal ideation|0|||
37858588|NCT00997984|69541855|FG001|Overall Study|Suicidal ideation|0|||
37858589|NCT00997984|69541856|FG002|Overall Study|Suicidal ideation|1|||
37858590|NCT00997984|69541854|FG000|Overall Study|Work schedule|0|||
37858591|NCT00997984|69541855|FG001|Overall Study|Work schedule|0|||
37858592|NCT00997984|69541856|FG002|Overall Study|Work schedule|2|||
37858593|NCT01177293|69541866|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
37858594|NCT01177293|69541867|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
37858595|NCT01177137|69541876|FG000|Overall Study|Withdrawal by Subject|10|||
37858596|NCT01177137|69541877|FG001|Overall Study|Withdrawal by Subject|10|||
37858597|NCT01177137|69541878|FG002|Overall Study|Withdrawal by Subject|2|||
37858598|NCT01177059|69541889|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
37858599|NCT01177059|69541889|FG000|Overall Study|Withdrew consent|2|||
37858600|NCT01177059|69541889|FG000|Overall Study|Lost to Follow-up|18|||
37858601|NCT01176513|69541893|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
37858602|NCT01299389|69541899|FG000|Double-blind|Adverse Event|45|||
37858603|NCT01299389|69541900|FG001|Double-blind|Adverse Event|27|||
37858604|NCT01299389|69541901|FG002|Double-blind|Adverse Event|0|||
37858605|NCT01299389|69541902|FG003|Double-blind|Adverse Event|0|||
37858606|NCT01299389|69541899|FG000|Double-blind|Lack of Efficacy|45|||
37858607|NCT01299389|69541900|FG001|Double-blind|Lack of Efficacy|21|||
37858608|NCT01299389|69541901|FG002|Double-blind|Lack of Efficacy|0|||
37858609|NCT01299389|69541902|FG003|Double-blind|Lack of Efficacy|0|||
37858610|NCT01299389|69541899|FG000|Double-blind|Lost to Follow-up|2|||
37858611|NCT01299389|69541900|FG001|Double-blind|Lost to Follow-up|1|||
37858612|NCT01299389|69541901|FG002|Double-blind|Lost to Follow-up|0|||
37858613|NCT01299389|69541902|FG003|Double-blind|Lost to Follow-up|0|||
37858614|NCT01299389|69541899|FG000|Double-blind|Withdrawal by Subject|16|||
37858615|NCT01299389|69541900|FG001|Double-blind|Withdrawal by Subject|13|||
37858616|NCT01299389|69541901|FG002|Double-blind|Withdrawal by Subject|0|||
37858617|NCT01299389|69541902|FG003|Double-blind|Withdrawal by Subject|0|||
37858618|NCT01299389|69541899|FG000|Double-blind|Other|1|||
37858619|NCT01299389|69541900|FG001|Double-blind|Other|1|||
37858620|NCT01299389|69541901|FG002|Double-blind|Other|0|||
37858621|NCT01299389|69541902|FG003|Double-blind|Other|0|||
37858622|NCT01299389|69541899|FG000|Double-blind|"fail to meet study population criteria"|0|||
37858623|NCT01299389|69541900|FG001|Double-blind|"fail to meet study population criteria"|1|||
37923451|NCT00804570|69610250|FG001|Overall Study|Withdrawal by Subject|38|||
37923452|NCT00824408|69610262|FG000|Run-in Phase|Progressive disease|4|||
37923453|NCT00824408|69610263|FG001|Run-in Phase|Progressive disease|4|||
37923454|NCT00824408|69610264|FG002|Run-in Phase|Progressive disease|0|||
37923455|NCT00824408|69610265|FG003|Run-in Phase|Progressive disease|0|||
37923456|NCT00824408|69610266|FG004|Run-in Phase|Progressive disease|0|||
37923457|NCT00824408|69610262|FG000|Run-in Phase|Adverse Event|1|||
37923458|NCT00824408|69610263|FG001|Run-in Phase|Adverse Event|1|||
37858624|NCT01299389|69541901|FG002|Double-blind|"fail to meet study population criteria"|0|||
37858625|NCT01299389|69541902|FG003|Double-blind|"fail to meet study population criteria"|0|||
37858626|NCT01299389|69541899|FG000|Post-observational|Other|0|||
37858627|NCT01299389|69541900|FG001|Post-observational|Other|0|||
37858628|NCT01299389|69541901|FG002|Post-observational|Other|12|||
37858629|NCT01299389|69541902|FG003|Post-observational|Other|6|||
37858630|NCT01298999|69541913|FG000|Overall Study|Physician Decision|0|||
37858631|NCT01298999|69541914|FG001|Overall Study|Physician Decision|1|||
37858632|NCT01298999|69541913|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
37923459|NCT00824408|69610264|FG002|Run-in Phase|Adverse Event|0|||
37858633|NCT01298999|69541914|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
37923460|NCT00824408|69610265|FG003|Run-in Phase|Adverse Event|0|||
37923461|NCT00824408|69610266|FG004|Run-in Phase|Adverse Event|0|||
37858634|NCT01007032|69541924|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
37858635|NCT01007032|69541925|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
37757429|NCT01683071|69266347|FG004|Part 2|Withdrawal by investigator decision|1|||
37757430|NCT01683071|69266348|FG005|Part 2|Withdrawal by investigator decision|2|||
37923462|NCT00824408|69610262|FG000|Run-in Phase|Refused to continue medication|1|||
37757431|NCT01567865|69266372|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
37757432|NCT01567865|69266373|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
37757433|NCT01567865|69266374|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
37757434|NCT01567865|69266375|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
37757435|NCT01567865|69266372|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
37757436|NCT01567865|69266373|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
37757437|NCT01567865|69266374|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
37757438|NCT01567865|69266375|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
37757439|NCT01567163|69266386|FG000|Overall Study|Progressive Disease|2|||
37858636|NCT01007032|69541926|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
37858637|NCT01007032|69541927|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
37858638|NCT01007032|69541924|FG000|Overall Study|Withdrawal by Subject|0|||
37858639|NCT01007032|69541925|FG001|Overall Study|Withdrawal by Subject|0|||
37858640|NCT01007032|69541926|FG002|Overall Study|Withdrawal by Subject|0|||
37858641|NCT01007032|69541927|FG003|Overall Study|Withdrawal by Subject|1|||
37858642|NCT00976027|69541944|FG000|Overall Study|Serious Adverse Event|36|||
37858643|NCT00976027|69541945|FG001|Overall Study|Serious Adverse Event|17|||
37858644|NCT00976027|69541944|FG000|Overall Study|Adverse Event|0|||
37858645|NCT00976027|69541945|FG001|Overall Study|Adverse Event|2|||
37858646|NCT00976027|69541944|FG000|Overall Study|Protocol Violation|60|||
37858647|NCT00976027|69541945|FG001|Overall Study|Protocol Violation|27|||
37858648|NCT00976027|69541944|FG000|Overall Study|Lost to Follow-up|208|||
37858649|NCT00976027|69541945|FG001|Overall Study|Lost to Follow-up|103|||
37858650|NCT00976027|69541944|FG000|Overall Study|Withdrawal by Subject|107|||
37858651|NCT00976027|69541945|FG001|Overall Study|Withdrawal by Subject|66|||
37858652|NCT01298765|69541951|FG000|Titration Period|Adverse Event|26|||
37858653|NCT01298765|69541951|FG000|Titration Period|Death|1|||
37858654|NCT01298765|69541951|FG000|Titration Period|Lack of Efficacy|21|||
37858655|NCT01298765|69541951|FG000|Titration Period|Lost to Follow-up|9|||
37858656|NCT01298765|69541951|FG000|Titration Period|Physician Decision|1|||
37858657|NCT01298765|69541951|FG000|Titration Period|Withdrawal by Subject|10|||
37858658|NCT01298765|69541951|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
37858659|NCT01298765|69541951|FG000|Long-Term Treatment Period|Adverse Event|19|||
37858660|NCT01298765|69541951|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
37858661|NCT01298765|69541951|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
37858662|NCT01298765|69541951|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
37858663|NCT01298765|69541951|FG000|Long-Term Treatment Period|Physician Decision|1|||
37858664|NCT01298765|69541951|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
37858665|NCT00997438|69541958|FG000|Overall Study|Blood draw difficulty|2|||
37858666|NCT00997438|69541959|FG001|Overall Study|Blood draw difficulty|0|||
37858667|NCT00997438|69541960|FG002|Overall Study|Blood draw difficulty|1|||
37858668|NCT00997438|69541958|FG000|Overall Study|Withdrawal by Subject|1|||
37858669|NCT00997438|69541959|FG001|Overall Study|Withdrawal by Subject|1|||
37858670|NCT00997438|69541960|FG002|Overall Study|Withdrawal by Subject|0|||
37858671|NCT00997438|69541958|FG000|Overall Study|Exclusion criteria at visit 1|2|||
37858672|NCT00997438|69541959|FG001|Overall Study|Exclusion criteria at visit 1|2|||
37858673|NCT00997438|69541960|FG002|Overall Study|Exclusion criteria at visit 1|3|||
37858674|NCT00997126|69541971|FG000|Overall Study|Physician Decision|7|||
37858675|NCT00997126|69541972|FG001|Overall Study|Physician Decision|11|||
37858676|NCT01000636|69541978|FG000|Overall Study|Withdrawal by Subject|1|||
37858677|NCT01000636|69541978|FG000|Overall Study|Adverse Event|1|||
37858678|NCT00965419|69541982|FG000|Open Label Treatment for Responders|Adverse Event|33|||
37858679|NCT00965419|69541982|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
37858680|NCT00965419|69541982|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
37858681|NCT00965419|69541982|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
37858682|NCT00965419|69541982|FG000|Open Label Treatment for Responders|Physician Decision|6|||
37858683|NCT00965419|69541982|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
37858684|NCT00965419|69541982|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
37858685|NCT00965419|69541982|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
37665881|NCT02717195|69138413|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
37665882|NCT02717195|69138414|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
37665883|NCT02717195|69138415|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
37665884|NCT02717195|69138416|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
37665885|NCT02717195|69138417|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
37665886|NCT02717195|69138413|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
37665887|NCT02717195|69138414|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
37665888|NCT02717195|69138415|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
37757440|NCT01567163|69266386|FG000|Overall Study|Lost to Follow-up|2|||
37757441|NCT01567085|69266395|FG000|Overall Study|Death|6|||
37757442|NCT01567085|69266395|FG000|Overall Study|Adverse Event|6|||
37757443|NCT01567085|69266395|FG000|Overall Study|Lost to Follow-up|3|||
37757444|NCT01567085|69266395|FG000|Overall Study|Graft loss|2|||
37757445|NCT01567085|69266395|FG000|Overall Study|Renal transplantectomy|1|||
37757446|NCT01567085|69266395|FG000|Overall Study|Returned to chronic dialysis|1|||
37757447|NCT01567085|69266395|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
37757448|NCT01566773|69266399|FG000|Overall Study|Protocol specified criteria|4|||
37757449|NCT01566773|69266399|FG000|Overall Study|Protocol Violation|4|||
37757450|NCT01566773|69266399|FG000|Overall Study|Withdrawal by Subject|9|||
37757451|NCT01566773|69266399|FG000|Overall Study|Administrative reason|1|||
37858686|NCT00965419|69541982|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
37858687|NCT00965419|69541982|FG000|Follow-up Phase|Adverse Event|9|||
37858688|NCT00965419|69541982|FG000|Follow-up Phase|Protocol Violation|4|||
37858689|NCT00965419|69541982|FG000|Follow-up Phase|Withdrawal by Subject|8|||
37858690|NCT00965419|69541982|FG000|Follow-up Phase|Physician Decision|4|||
38033367|NCT02586623|69719344|FG000|Open-Label (Up to 16 Weeks)|Protocol Violation|9|||
37665889|NCT02717195|69138416|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
37665890|NCT02717195|69138417|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
37665891|NCT02717195|69138413|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
37665892|NCT02717195|69138414|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
37665893|NCT02717195|69138415|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
37665894|NCT02717195|69138416|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
37665895|NCT02717195|69138417|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
37665896|NCT00701441|69138432|FG000|Overall Study|failure in cpap compliance|0|||
37665897|NCT00701441|69138433|FG001|Overall Study|failure in cpap compliance|4|||
37665898|NCT02628873|69138445|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
37665899|NCT02628873|69138446|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
37665900|NCT02628873|69138445|FG000|Second Test (1 Hour)|Physician Decision|1|||
37665901|NCT02628873|69138446|FG001|Second Test (1 Hour)|Physician Decision|0|||
37665902|NCT02629965|69138456|FG000|Period 1|Adverse Event|1|||
37665903|NCT02629965|69138457|FG001|Period 1|Adverse Event|0|||
37665904|NCT02629965|69138456|FG000|Period 1|Unexpected worsening of disease|2|||
37665905|NCT02629965|69138457|FG001|Period 1|Unexpected worsening of disease|0|||
37665906|NCT02629965|69138456|FG000|Period 1|Other than listed above|1|||
37665907|NCT02629965|69138457|FG001|Period 1|Other than listed above|2|||
37665908|NCT02629965|69138456|FG000|Period 2|Adverse Event|1|||
37665909|NCT02629965|69138457|FG001|Period 2|Adverse Event|0|||
37665910|NCT01671111|69138463|FG000|Overall Study|Adverse Event|2|||
37665911|NCT01671111|69138463|FG000|Overall Study|Lack of Efficacy|1|||
37665912|NCT01671111|69138463|FG000|Overall Study|Withdrawal by Subject|2|||
37665913|NCT01671111|69138463|FG000|Overall Study|Physician Decision|1|||
37665914|NCT01671111|69138463|FG000|Overall Study|Other|24|||
37665915|NCT01671345|69138469|FG000|Overall Study|Lost to Follow-up|10|||
37665916|NCT01671345|69138470|FG001|Overall Study|Lost to Follow-up|6|||
37665917|NCT01671345|69138469|FG000|Overall Study|visit with non-participating physician|3|||
37665918|NCT01671345|69138470|FG001|Overall Study|visit with non-participating physician|3|||
37665919|NCT02487095|69138489|FG000|Dose Expansion|Unable to scan/restage participant|0|||
37665920|NCT02487095|69138490|FG001|Dose Expansion|Unable to scan/restage participant|0|||
37665921|NCT02487095|69138491|FG002|Dose Expansion|Unable to scan/restage participant|0|||
37665922|NCT02487095|69138492|FG003|Dose Expansion|Unable to scan/restage participant|0|||
37665923|NCT02487095|69138493|FG004|Dose Expansion|Unable to scan/restage participant|1|||
37665924|NCT03855137|69138516|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
37665925|NCT03855137|69138517|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
37665926|NCT03855137|69138518|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
37665927|NCT03855137|69138516|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
37665928|NCT03855137|69138517|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
37665929|NCT03855137|69138518|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
37665930|NCT03855137|69138516|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
37665931|NCT03855137|69138517|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
37665932|NCT03855137|69138518|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
37665933|NCT03855137|69138516|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
37665934|NCT03855137|69138517|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
37665935|NCT03855137|69138518|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
37665936|NCT03855137|69138516|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
37665937|NCT03855137|69138517|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
37665938|NCT03855137|69138518|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
37665939|NCT03855137|69138516|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
37665940|NCT03855137|69138517|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
37665941|NCT03855137|69138518|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
37757452|NCT01566773|69266399|FG000|Overall Study|Adverse Event|10|||
37757453|NCT01566773|69266399|FG000|Overall Study|Physician Decision|2|||
37757454|NCT01566149|69266421|FG000|Overall Study|Adverse Event|0|||
37757455|NCT01566149|69266422|FG001|Overall Study|Adverse Event|1|||
37757456|NCT01566149|69266421|FG000|Overall Study|Non-compliance with study medication|2|||
37757457|NCT01566149|69266422|FG001|Overall Study|Non-compliance with study medication|0|||
37757458|NCT01566149|69266421|FG000|Overall Study|Protocol Violation|0|||
37757459|NCT01566149|69266422|FG001|Overall Study|Protocol Violation|1|||
37757460|NCT01566149|69266421|FG000|Overall Study|Withdrawal by Subject|1|||
37757461|NCT01566149|69266422|FG001|Overall Study|Withdrawal by Subject|0|||
37757462|NCT01565993|69266430|FG000|Overall Study|Physician Decision|0|||
37757463|NCT01565993|69266431|FG001|Overall Study|Physician Decision|3|||
37757464|NCT01565291|69266439|FG000|Overall Study|Withdrawal by Subject|1|||
37757465|NCT01565291|69266440|FG001|Overall Study|Withdrawal by Subject|0|||
37757466|NCT02691702|69266457|FG000|Overall Study|Adverse Event|1|||
37757467|NCT02691702|69266458|FG001|Overall Study|Adverse Event|0|||
37757468|NCT02691702|69266459|FG002|Overall Study|Adverse Event|0|||
37757469|NCT02691702|69266460|FG003|Overall Study|Adverse Event|0|||
37757470|NCT02691702|69266461|FG004|Overall Study|Adverse Event|0|||
37757471|NCT02691702|69266462|FG005|Overall Study|Adverse Event|0|||
37757472|NCT02691702|69266463|FG006|Overall Study|Adverse Event|0|||
37757473|NCT02691702|69266464|FG007|Overall Study|Adverse Event|0|||
37757474|NCT02691702|69266465|FG008|Overall Study|Adverse Event|1|||
37757475|NCT02691702|69266466|FG009|Overall Study|Adverse Event|0|||
37757476|NCT02691702|69266467|FG010|Overall Study|Adverse Event|1|||
37757477|NCT02691702|69266457|FG000|Overall Study|Lost to Follow-up|0|||
37757478|NCT02691702|69266458|FG001|Overall Study|Lost to Follow-up|0|||
37757479|NCT02691702|69266459|FG002|Overall Study|Lost to Follow-up|1|||
37757480|NCT02691702|69266460|FG003|Overall Study|Lost to Follow-up|0|||
37757481|NCT02691702|69266461|FG004|Overall Study|Lost to Follow-up|0|||
37757482|NCT02691702|69266462|FG005|Overall Study|Lost to Follow-up|2|||
37757483|NCT02691702|69266463|FG006|Overall Study|Lost to Follow-up|0|||
37757484|NCT02691702|69266464|FG007|Overall Study|Lost to Follow-up|0|||
37757485|NCT02691702|69266465|FG008|Overall Study|Lost to Follow-up|0|||
37757486|NCT02691702|69266466|FG009|Overall Study|Lost to Follow-up|0|||
37757487|NCT02691702|69266467|FG010|Overall Study|Lost to Follow-up|1|||
37757488|NCT02691702|69266457|FG000|Overall Study|Withdrawal by Subject|1|||
37757489|NCT02691702|69266458|FG001|Overall Study|Withdrawal by Subject|1|||
37757490|NCT02691702|69266459|FG002|Overall Study|Withdrawal by Subject|0|||
37757491|NCT02691702|69266460|FG003|Overall Study|Withdrawal by Subject|0|||
37757492|NCT02691702|69266461|FG004|Overall Study|Withdrawal by Subject|0|||
37757493|NCT02691702|69266462|FG005|Overall Study|Withdrawal by Subject|1|||
37858691|NCT00965419|69541982|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
37858692|NCT00965419|69541982|FG000|Follow-up Phase|Lack of Efficacy|28|||
37858693|NCT01000480|69541987|FG000|Induction Phase|Adverse Event|2|||
37858694|NCT01000480|69541987|FG000|Induction Phase|Lost to Follow-up|1|||
37858695|NCT01000480|69541987|FG000|Induction Phase|Physician Decision|1|||
37858696|NCT01000480|69541987|FG000|Induction Phase|Entry Criteria Not Met|3|||
37858697|NCT01000480|69541987|FG000|Concurrent Therapy Phase|Adverse Event|4|||
37858698|NCT01000480|69541987|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
37858699|NCT01000480|69541987|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
37858700|NCT01000480|69541987|FG000|Concurrent Therapy Phase|Physician Decision|1|||
37858701|NCT00965341|69541993|FG000|Overall Study|Withdrew consent|1|||
37858702|NCT00965341|69541994|FG001|Overall Study|Withdrew consent|5|||
37858703|NCT00965341|69541993|FG000|Overall Study|Lost to Follow-up|1|||
37858704|NCT00965341|69541994|FG001|Overall Study|Lost to Follow-up|0|||
37858705|NCT00965341|69541993|FG000|Overall Study|Transportation issues|4|||
37858706|NCT00965341|69541994|FG001|Overall Study|Transportation issues|3|||
37923463|NCT00824408|69610263|FG001|Run-in Phase|Refused to continue medication|0|||
37923464|NCT00824408|69610264|FG002|Run-in Phase|Refused to continue medication|0|||
37757494|NCT02691702|69266463|FG006|Overall Study|Withdrawal by Subject|2|||
37757495|NCT02691702|69266464|FG007|Overall Study|Withdrawal by Subject|0|||
37858707|NCT01175811|69542002|FG000|Overall Study|Adverse Event|1|||
37858708|NCT01175811|69542003|FG001|Overall Study|Adverse Event|1|||
37858709|NCT01175811|69542002|FG000|Overall Study|Entry criteria not met|3|||
37858710|NCT01175811|69542003|FG001|Overall Study|Entry criteria not met|1|||
37858711|NCT01175811|69542002|FG000|Overall Study|Lack of Efficacy|1|||
37858712|NCT01175811|69542003|FG001|Overall Study|Lack of Efficacy|0|||
37858713|NCT01175811|69542002|FG000|Overall Study|Lost to Follow-up|3|||
37858714|NCT01175811|69542003|FG001|Overall Study|Lost to Follow-up|2|||
37858715|NCT01175811|69542002|FG000|Overall Study|Physician Decision|1|||
37757496|NCT02691702|69266465|FG008|Overall Study|Withdrawal by Subject|0|||
37757497|NCT02691702|69266466|FG009|Overall Study|Withdrawal by Subject|0|||
37757498|NCT02691702|69266467|FG010|Overall Study|Withdrawal by Subject|0|||
37757499|NCT02691702|69266457|FG000|Overall Study|Other|0|||
37757500|NCT02691702|69266458|FG001|Overall Study|Other|0|||
37757501|NCT02691702|69266459|FG002|Overall Study|Other|0|||
37757502|NCT02691702|69266460|FG003|Overall Study|Other|0|||
37757503|NCT02691702|69266461|FG004|Overall Study|Other|0|||
37757504|NCT02691702|69266462|FG005|Overall Study|Other|0|||
37757505|NCT02691702|69266463|FG006|Overall Study|Other|1|||
37757506|NCT02691702|69266464|FG007|Overall Study|Other|0|||
37757507|NCT02691702|69266465|FG008|Overall Study|Other|1|||
37757508|NCT02691702|69266466|FG009|Overall Study|Other|0|||
37757509|NCT02691702|69266467|FG010|Overall Study|Other|0|||
37757510|NCT02691702|69266457|FG000|Overall Study|Protocol Violation|0|||
37757511|NCT02691702|69266458|FG001|Overall Study|Protocol Violation|0|||
37757512|NCT02691702|69266459|FG002|Overall Study|Protocol Violation|0|||
37757513|NCT02691702|69266460|FG003|Overall Study|Protocol Violation|0|||
37757514|NCT02691702|69266461|FG004|Overall Study|Protocol Violation|0|||
37757515|NCT02691702|69266462|FG005|Overall Study|Protocol Violation|0|||
37757516|NCT02691702|69266463|FG006|Overall Study|Protocol Violation|0|||
37757517|NCT02691702|69266464|FG007|Overall Study|Protocol Violation|0|||
37757518|NCT02691702|69266465|FG008|Overall Study|Protocol Violation|0|||
37757519|NCT02691702|69266466|FG009|Overall Study|Protocol Violation|2|||
37757520|NCT02691702|69266467|FG010|Overall Study|Protocol Violation|0|||
37757521|NCT01564277|69266501|FG000|Overall Study|Protocol Violation|0|||
37757522|NCT01564277|69266502|FG001|Overall Study|Protocol Violation|1|||
37757523|NCT01564277|69266501|FG000|Overall Study|Physician Decision|1|||
37757524|NCT01564277|69266502|FG001|Overall Study|Physician Decision|0|||
37757525|NCT02679222|69266508|FG000|Overall Study|No time for project|1|||
37757526|NCT01563185|69266520|FG000|Overall Study|Withdrawal by Subject|1|||
38033368|NCT02586623|69719345|FG001|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
38033369|NCT02586623|69719346|FG002|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
38033370|NCT02586623|69719344|FG000|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|56|||
38033371|NCT02586623|69719345|FG001|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
38033372|NCT02586623|69719346|FG002|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
38033373|NCT02586623|69719344|FG000|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|30|||
38033374|NCT02586623|69719345|FG001|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
38033375|NCT02586623|69719346|FG002|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
38033376|NCT02586623|69719344|FG000|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|17|||
38033377|NCT02586623|69719345|FG001|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
38033378|NCT02586623|69719346|FG002|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
38033379|NCT02586623|69719344|FG000|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|2|||
38033380|NCT02586623|69719345|FG001|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
38033381|NCT02586623|69719346|FG002|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
38033382|NCT02586623|69719344|FG000|Open-Label (Up to 16 Weeks)|Met stopping criteria|4|||
38033383|NCT02586623|69719345|FG001|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
37757527|NCT01563185|69266520|FG000|Overall Study|Non-Compliance with study drug|1|||
37757528|NCT03305848|69266524|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
37757529|NCT03305848|69266524|FG000|Overall Study|Physician Decision|2|||
37757530|NCT01563029|69266533|FG000|Overall Study|Adverse Event|1|||
37757531|NCT01563029|69266534|FG001|Overall Study|Adverse Event|0|||
37757532|NCT01563029|69266535|FG002|Overall Study|Adverse Event|1|||
37757533|NCT01563029|69266536|FG003|Overall Study|Adverse Event|2|||
37757534|NCT01563029|69266537|FG004|Overall Study|Adverse Event|1|||
37858716|NCT01175811|69542003|FG001|Overall Study|Physician Decision|1|||
37858717|NCT01175811|69542002|FG000|Overall Study|Protocol Violation|1|||
37858718|NCT01175811|69542003|FG001|Overall Study|Protocol Violation|2|||
37858719|NCT01175811|69542002|FG000|Overall Study|Withdrawal by Subject|6|||
37858720|NCT01175811|69542003|FG001|Overall Study|Withdrawal by Subject|7|||
37858721|NCT00965263|69542011|FG000|Overall Study|Physician Decision|2|||
37858722|NCT00965263|69542012|FG001|Overall Study|Physician Decision|0|||
37858723|NCT00965263|69542011|FG000|Overall Study|Family emergency|0|||
37858724|NCT00965263|69542012|FG001|Overall Study|Family emergency|1|||
37858725|NCT00965263|69542011|FG000|Overall Study|Protocol Violation|0|||
37858726|NCT00965263|69542012|FG001|Overall Study|Protocol Violation|2|||
37858727|NCT00965185|69542038|FG000|Overall Study|Lost to Follow-up|2|||
37858728|NCT00965185|69542039|FG001|Overall Study|Lost to Follow-up|0|||
37858729|NCT00965185|69542038|FG000|Overall Study|Withdrawal by Subject|0|||
37858730|NCT00965185|69542039|FG001|Overall Study|Withdrawal by Subject|1|||
37858731|NCT01174563|69542047|FG000|Overall Study|Progressive Disease|45|||
37858732|NCT01174563|69542047|FG000|Overall Study|Death|5|||
37858733|NCT01174563|69542047|FG000|Overall Study|Investigator's Discretion|5|||
37858734|NCT01174563|69542047|FG000|Overall Study|Participant Withdrew Consent|3|||
37858735|NCT01174563|69542047|FG000|Overall Study|Rash Adverse Event|1|||
37858736|NCT01174563|69542047|FG000|Overall Study|Sponsor's decision|1|||
37858737|NCT01298531|69542053|FG000|Overall Study|Lack of Efficacy|0|||
37858738|NCT01298531|69542054|FG001|Overall Study|Lack of Efficacy|1|||
38033384|NCT02586623|69719346|FG002|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
38033385|NCT02586623|69719344|FG000|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|3|||
37757535|NCT01563029|69266533|FG000|Overall Study|Lack of Efficacy|42|||
37757536|NCT01563029|69266534|FG001|Overall Study|Lack of Efficacy|16|||
37757537|NCT01563029|69266535|FG002|Overall Study|Lack of Efficacy|23|||
37757538|NCT01563029|69266536|FG003|Overall Study|Lack of Efficacy|21|||
37757539|NCT01563029|69266537|FG004|Overall Study|Lack of Efficacy|19|||
37757540|NCT01563029|69266533|FG000|Overall Study|Protocol Violation|1|||
37858739|NCT01298531|69542053|FG000|Overall Study|Lost to Follow-up|2|||
37757541|NCT01563029|69266534|FG001|Overall Study|Protocol Violation|2|||
37757542|NCT01563029|69266535|FG002|Overall Study|Protocol Violation|3|||
37757543|NCT01563029|69266536|FG003|Overall Study|Protocol Violation|1|||
37757544|NCT01563029|69266537|FG004|Overall Study|Protocol Violation|3|||
37757545|NCT01563029|69266533|FG000|Overall Study|Protocol defined stopping criteria|1|||
37757546|NCT01563029|69266534|FG001|Overall Study|Protocol defined stopping criteria|0|||
37757547|NCT01563029|69266535|FG002|Overall Study|Protocol defined stopping criteria|0|||
37757548|NCT01563029|69266536|FG003|Overall Study|Protocol defined stopping criteria|0|||
37757549|NCT01563029|69266537|FG004|Overall Study|Protocol defined stopping criteria|0|||
37757550|NCT01563029|69266533|FG000|Overall Study|Lost to Follow-up|1|||
37757551|NCT01563029|69266534|FG001|Overall Study|Lost to Follow-up|0|||
37757552|NCT01563029|69266535|FG002|Overall Study|Lost to Follow-up|1|||
37757553|NCT01563029|69266536|FG003|Overall Study|Lost to Follow-up|1|||
37757554|NCT01563029|69266537|FG004|Overall Study|Lost to Follow-up|1|||
37757555|NCT01563029|69266533|FG000|Overall Study|Physician Decision|3|||
37757556|NCT01563029|69266534|FG001|Overall Study|Physician Decision|5|||
37757557|NCT01563029|69266535|FG002|Overall Study|Physician Decision|2|||
37757558|NCT01563029|69266536|FG003|Overall Study|Physician Decision|4|||
37757559|NCT01563029|69266537|FG004|Overall Study|Physician Decision|2|||
37757560|NCT01563029|69266533|FG000|Overall Study|Withdrawal by Subject|4|||
37757561|NCT01563029|69266534|FG001|Overall Study|Withdrawal by Subject|1|||
37757562|NCT01563029|69266535|FG002|Overall Study|Withdrawal by Subject|3|||
37757563|NCT01563029|69266536|FG003|Overall Study|Withdrawal by Subject|4|||
37757564|NCT01563029|69266537|FG004|Overall Study|Withdrawal by Subject|3|||
37757565|NCT01562873|69266550|FG000|Overall Study|Disease Progression per RECIST|10|||
37757566|NCT01562873|69266551|FG001|Overall Study|Disease Progression per RECIST|0|||
37757567|NCT01562873|69266550|FG000|Overall Study|Adverse Event|1|||
37757568|NCT01562873|69266551|FG001|Overall Study|Adverse Event|0|||
37757569|NCT01562873|69266550|FG000|Overall Study|Clinical Disease Progression|9|||
37757570|NCT01562873|69266551|FG001|Overall Study|Clinical Disease Progression|0|||
37665942|NCT03855137|69138516|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
37665943|NCT03855137|69138517|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
37665944|NCT03855137|69138518|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
37665945|NCT03855137|69138516|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
37665946|NCT03855137|69138517|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
37665947|NCT03855137|69138518|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
37757571|NCT01562873|69266550|FG000|Overall Study|Clinical PD and adverse event|1|||
37757572|NCT01562873|69266551|FG001|Overall Study|Clinical PD and adverse event|0|||
37757573|NCT03273712|69266555|FG000|Overall Study|Death|5|||
37757574|NCT03273712|69266555|FG000|Overall Study|Adverse Event|1|||
37757575|NCT03273712|69266555|FG000|Overall Study|Disease Progression|1|||
37757576|NCT01562327|69266560|FG000|Overall Study|Adverse Event|2|||
37757577|NCT01562327|69266560|FG000|Overall Study|Lack of Efficacy|1|||
37757578|NCT01562327|69266560|FG000|Overall Study|Participant drop-out|1|||
37757579|NCT01562327|69266560|FG000|Overall Study|Infusion not received at 6 month window|4|||
37757580|NCT01561313|69266567|FG000|Overall Study|Withdrawal by Subject|1|||
37757581|NCT01561313|69266568|FG001|Overall Study|Withdrawal by Subject|0|||
37757582|NCT01561313|69266567|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
37757583|NCT01561313|69266568|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
37757584|NCT01561079|69266574|FG000|Overall Study|Physician Decision|17|||
37757585|NCT01561079|69266574|FG000|Overall Study|Withdrawal by Subject|59|||
37757586|NCT01561079|69266574|FG000|Overall Study|Protocol Violation|2|||
37757587|NCT01559675|69266619|FG000|Overall Study|Protocol Violation|1|||
37757588|NCT01559675|69266620|FG001|Overall Study|Protocol Violation|2|||
37757589|NCT01559675|69266619|FG000|Overall Study|2nd operation on same patient excluded|14|||
37757590|NCT01559675|69266620|FG001|Overall Study|2nd operation on same patient excluded|12|||
37757591|NCT01374906|69266628|FG000|Overall Study|Abnormal laboratory value(s)|0|||
37757592|NCT01374906|69266629|FG001|Overall Study|Abnormal laboratory value(s)|3|||
37757593|NCT01374906|69266628|FG000|Overall Study|Administrative problems|2|||
37757594|NCT01374906|69266629|FG001|Overall Study|Administrative problems|2|||
37757595|NCT01374906|69266628|FG000|Overall Study|Adverse Event|10|||
37757596|NCT01374906|69266629|FG001|Overall Study|Adverse Event|11|||
37757597|NCT01374906|69266628|FG000|Overall Study|Death|0|||
37665948|NCT03855137|69138516|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
37665949|NCT03855137|69138517|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
37757598|NCT01374906|69266629|FG001|Overall Study|Death|2|||
37757599|NCT01374906|69266628|FG000|Overall Study|Protocol Violation|2|||
37757600|NCT01374906|69266629|FG001|Overall Study|Protocol Violation|2|||
37757601|NCT01374906|69266628|FG000|Overall Study|Withdrawal by Subject|15|||
37757602|NCT01374906|69266629|FG001|Overall Study|Withdrawal by Subject|9|||
37757603|NCT01374906|69266628|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
37757604|NCT01374906|69266629|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
37757605|NCT02683746|69266659|FG000|Overall Study|Adverse Event|3|||
37757606|NCT02683746|69266660|FG001|Overall Study|Adverse Event|2|||
37757607|NCT02683746|69266659|FG000|Overall Study|Lost to Follow-up|5|||
37757608|NCT02683746|69266660|FG001|Overall Study|Lost to Follow-up|6|||
37757609|NCT02683746|69266659|FG000|Overall Study|Withdrawal by Subject|6|||
37757610|NCT02683746|69266660|FG001|Overall Study|Withdrawal by Subject|5|||
37757611|NCT02683746|69266659|FG000|Overall Study|Physician Decision|2|||
37757612|NCT02683746|69266660|FG001|Overall Study|Physician Decision|1|||
37757613|NCT02691468|69266668|FG000|Overall Study|Bronchial blocker use|2|||
37757614|NCT02691468|69266669|FG001|Overall Study|Bronchial blocker use|1|||
37757615|NCT02691468|69266668|FG000|Overall Study|Lost to Follow-up|2|||
37757616|NCT02691468|69266669|FG001|Overall Study|Lost to Follow-up|1|||
37757617|NCT02691468|69266668|FG000|Overall Study|Failure to advance FOB|2|||
37757618|NCT02691468|69266669|FG001|Overall Study|Failure to advance FOB|0|||
37757619|NCT02678676|69266677|FG000|Overall Study|Death|619|||
37757620|NCT02678676|69266678|FG001|Overall Study|Death|649|||
37757621|NCT02678676|69266677|FG000|Overall Study|Withdrawal by Subject|13|||
37757622|NCT02678676|69266678|FG001|Overall Study|Withdrawal by Subject|5|||
37757623|NCT02678676|69266677|FG000|Overall Study|Lost to Follow-up|171|||
37757624|NCT02678676|69266678|FG001|Overall Study|Lost to Follow-up|151|||
37757625|NCT02678676|69266677|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
37757626|NCT02678676|69266678|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
37757627|NCT01558739|69266684|FG000|Overall Study|Adverse Event|7|||
37757628|NCT01558739|69266684|FG000|Overall Study|Withdrawal by Subject|2|||
37757629|NCT01558739|69266684|FG000|Overall Study|Death|3|||
37757630|NCT01558739|69266684|FG000|Overall Study|Disease Progression|4|||
37757631|NCT01558739|69266684|FG000|Overall Study|Protocol Violation|1|||
37757632|NCT02683668|69266688|FG000|Period 2|Withdrawal by Subject|0|||
37757633|NCT02683668|69266689|FG001|Period 2|Withdrawal by Subject|1|||
37757634|NCT02683668|69266690|FG002|Period 2|Withdrawal by Subject|0|||
37757635|NCT02678286|69266698|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
37757636|NCT02678286|69266699|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
37757637|NCT02678286|69266698|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
37665950|NCT03855137|69138518|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
37665951|NCT03855137|69138516|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
37665952|NCT03855137|69138517|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
37665953|NCT03855137|69138518|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
37665954|NCT00701363|69138540|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
37665955|NCT00701363|69138541|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
37757638|NCT02678286|69266699|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
37757639|NCT02678286|69266698|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
37757640|NCT02678286|69266699|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
37757641|NCT02678286|69266698|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
37757642|NCT02678286|69266699|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
37757643|NCT02678286|69266698|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
37757644|NCT02678286|69266699|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
37757645|NCT02682264|69266707|FG000|Overall Study|Withdrawal by Subject|56|||
37757646|NCT02682264|69266708|FG001|Overall Study|Withdrawal by Subject|45|||
37757647|NCT02682264|69266707|FG000|Overall Study|Lost to Follow-up|49|||
37757648|NCT02682264|69266708|FG001|Overall Study|Lost to Follow-up|41|||
37757649|NCT02682264|69266707|FG000|Overall Study|Lack of Efficacy|14|||
37757650|NCT02682264|69266708|FG001|Overall Study|Lack of Efficacy|16|||
37665956|NCT00701363|69138542|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
37665957|NCT00701363|69138543|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
37665958|NCT00701363|69138540|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
37665959|NCT00701363|69138541|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
37665960|NCT00701363|69138542|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
37665961|NCT00701363|69138543|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
37665962|NCT00701363|69138540|FG000|Treatment Phase 1|Adverse Event|7|||
37665963|NCT00701363|69138541|FG001|Treatment Phase 1|Adverse Event|0|||
37665964|NCT00701363|69138542|FG002|Treatment Phase 1|Adverse Event|0|||
37665965|NCT00701363|69138543|FG003|Treatment Phase 1|Adverse Event|0|||
37665966|NCT00701363|69138540|FG000|Treatment Phase 1|Protocol Violation|1|||
37665967|NCT00701363|69138541|FG001|Treatment Phase 1|Protocol Violation|0|||
37665968|NCT00701363|69138542|FG002|Treatment Phase 1|Protocol Violation|0|||
37665969|NCT00701363|69138543|FG003|Treatment Phase 1|Protocol Violation|0|||
37665970|NCT00701363|69138540|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
37665971|NCT00701363|69138541|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
37665972|NCT00701363|69138542|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
37665973|NCT00701363|69138543|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
37665974|NCT00701363|69138540|FG000|Treatment Phase 1|Lack of Efficacy|1|||
37757651|NCT02682264|69266707|FG000|Overall Study|Withdrawal by Parent|6|||
37757652|NCT02682264|69266708|FG001|Overall Study|Withdrawal by Parent|7|||
37757653|NCT02682264|69266707|FG000|Overall Study|Adverse Event|9|||
37757654|NCT02682264|69266708|FG001|Overall Study|Adverse Event|0|||
37757655|NCT02682264|69266707|FG000|Overall Study|Noncompliance with study drug|1|||
37757656|NCT02682264|69266708|FG001|Overall Study|Noncompliance with study drug|4|||
37757657|NCT02682264|69266707|FG000|Overall Study|Pregnancy|1|||
37757658|NCT02682264|69266708|FG001|Overall Study|Pregnancy|2|||
37757659|NCT02682264|69266707|FG000|Overall Study|Recovery|1|||
37757660|NCT02682264|69266708|FG001|Overall Study|Recovery|2|||
37757661|NCT02682264|69266707|FG000|Overall Study|Progressive Disease|1|||
37757662|NCT02682264|69266708|FG001|Overall Study|Progressive Disease|0|||
37757663|NCT02682264|69266707|FG000|Overall Study|Technical Problems|0|||
37757664|NCT02682264|69266708|FG001|Overall Study|Technical Problems|1|||
37757665|NCT02682264|69266707|FG000|Overall Study|Moved abroad and unable to continue|0|||
37757666|NCT02682264|69266708|FG001|Overall Study|Moved abroad and unable to continue|3|||
37757667|NCT02682264|69266707|FG000|Overall Study|Stopped test article application|0|||
37757668|NCT02682264|69266708|FG001|Overall Study|Stopped test article application|1|||
37757669|NCT01566721|69266716|FG000|Treatment Period|Withdrawal by Subject|35|||
37757670|NCT01566721|69266717|FG001|Treatment Period|Withdrawal by Subject|9|||
37757671|NCT01566721|69266716|FG000|Treatment Period|Disease Progression/Recurrence|37|||
37757672|NCT01566721|69266717|FG001|Treatment Period|Disease Progression/Recurrence|13|||
37757673|NCT01566721|69266716|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
37757674|NCT01566721|69266717|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
37757675|NCT01566721|69266716|FG000|Treatment Period|Other|13|||
37757676|NCT01566721|69266717|FG001|Treatment Period|Other|2|||
37757677|NCT01566721|69266716|FG000|Treatment Period|Lack of Compliance|5|||
37757678|NCT01566721|69266717|FG001|Treatment Period|Lack of Compliance|1|||
37757679|NCT01566721|69266716|FG000|Treatment Period|Adverse Event|100|||
37757680|NCT01566721|69266717|FG001|Treatment Period|Adverse Event|30|||
37757681|NCT01566721|69266716|FG000|Treatment Period|Pregnancy|1|||
37665975|NCT00701363|69138541|FG001|Treatment Phase 1|Lack of Efficacy|0|||
37665976|NCT00701363|69138542|FG002|Treatment Phase 1|Lack of Efficacy|0|||
37665977|NCT00701363|69138543|FG003|Treatment Phase 1|Lack of Efficacy|0|||
37665978|NCT00701363|69138540|FG000|Treatment Phase 2|Adverse Event|0|||
37665979|NCT00701363|69138541|FG001|Treatment Phase 2|Adverse Event|0|||
37665980|NCT00701363|69138542|FG002|Treatment Phase 2|Adverse Event|1|||
37665981|NCT00701363|69138543|FG003|Treatment Phase 2|Adverse Event|0|||
37665982|NCT00701363|69138540|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
37665983|NCT00701363|69138541|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
37665984|NCT00701363|69138542|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
37665985|NCT00701363|69138543|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
37665986|NCT01670877|69138567|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
37665987|NCT01670877|69138568|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
37665988|NCT01670877|69138569|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
37665989|NCT01670877|69138570|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
37665990|NCT01670877|69138571|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
37665991|NCT01670877|69138572|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
37665992|NCT01670877|69138567|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
37665993|NCT01670877|69138568|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
37665994|NCT01670877|69138569|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
37665995|NCT01670877|69138570|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
37665996|NCT01670877|69138571|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
37665997|NCT01670877|69138572|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
37665998|NCT01670877|69138567|FG000|Part I and Part 2|Grade 2 vomiting|0|||
37665999|NCT01670877|69138568|FG001|Part I and Part 2|Grade 2 vomiting|0|||
37666000|NCT01670877|69138569|FG002|Part I and Part 2|Grade 2 vomiting|0|||
37666001|NCT01670877|69138570|FG003|Part I and Part 2|Grade 2 vomiting|1|||
37666002|NCT01670877|69138571|FG004|Part I and Part 2|Grade 2 vomiting|0|||
37666003|NCT01670877|69138572|FG005|Part I and Part 2|Grade 2 vomiting|0|||
37666004|NCT01670877|69138567|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
37666005|NCT01670877|69138568|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
37666006|NCT01670877|69138569|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
37666007|NCT01670877|69138570|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
37666008|NCT01670877|69138571|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
37666009|NCT01670877|69138572|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
37666010|NCT01670877|69138567|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
37666011|NCT01670877|69138568|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
37666012|NCT01670877|69138569|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
37666013|NCT01670877|69138570|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
37666014|NCT01670877|69138571|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
37666015|NCT01670877|69138572|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
37666016|NCT00701129|69138586|FG000|Overall Study|Death|2|||
37666017|NCT01670721|69138590|FG000|Overall Study|Participant's decision|15|||
37666018|NCT01670721|69138590|FG000|Overall Study|Other than specified above|38|||
37666019|NCT02711137|69138609|FG000|Overall Study|Death|1|||
37666020|NCT02711137|69138610|FG001|Overall Study|Death|4|||
37757682|NCT01566721|69266717|FG001|Treatment Period|Pregnancy|0|||
37757683|NCT01566721|69266716|FG000|Safety Follow-up|Physician Decision|6|||
37757684|NCT01566721|69266717|FG001|Safety Follow-up|Physician Decision|4|||
37757685|NCT01566721|69266716|FG000|Safety Follow-up|Lost to Follow-up|101|||
37757686|NCT01566721|69266717|FG001|Safety Follow-up|Lost to Follow-up|48|||
37757687|NCT01566721|69266716|FG000|Safety Follow-up|Withdrawal by Subject|155|||
37757688|NCT01566721|69266717|FG001|Safety Follow-up|Withdrawal by Subject|49|||
37757689|NCT01566721|69266716|FG000|Safety Follow-up|Death|28|||
37757690|NCT01566721|69266717|FG001|Safety Follow-up|Death|4|||
37757691|NCT01566721|69266716|FG000|Safety Follow-up|Non-compliance|7|||
37757692|NCT01566721|69266717|FG001|Safety Follow-up|Non-compliance|3|||
37757693|NCT01566721|69266716|FG000|Safety Follow-up|Protocol Violation|7|||
37757694|NCT01566721|69266717|FG001|Safety Follow-up|Protocol Violation|0|||
37757695|NCT01566721|69266716|FG000|Safety Follow-up|Site closure|2|||
37757696|NCT01566721|69266717|FG001|Safety Follow-up|Site closure|3|||
37757697|NCT01566721|69266716|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
37757698|NCT01566721|69266717|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
37757699|NCT01566721|69266716|FG000|Safety Follow-up|Missing|7|||
37757700|NCT01566721|69266717|FG001|Safety Follow-up|Missing|2|||
37757701|NCT01566721|69266716|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
37757702|NCT01566721|69266717|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
37757703|NCT01566721|69266716|FG000|Safety Follow-up|Sponsor decision|1|||
37757704|NCT01566721|69266717|FG001|Safety Follow-up|Sponsor decision|0|||
37757705|NCT01566721|69266716|FG000|Safety Follow-up|Adverse Event|8|||
37757706|NCT01566721|69266717|FG001|Safety Follow-up|Adverse Event|4|||
37757707|NCT01541215|69266732|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
37757708|NCT01541215|69266733|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
37757709|NCT01541215|69266732|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
37757710|NCT01541215|69266733|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
37757711|NCT01541215|69266732|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
37757712|NCT01541215|69266733|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
37757713|NCT01541215|69266732|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
37757714|NCT01541215|69266733|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
37757715|NCT01541215|69266732|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
37757716|NCT01541215|69266733|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
37757717|NCT01541215|69266732|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
37757718|NCT01541215|69266733|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
37757719|NCT01540981|69266745|FG000|Overall Study|Withdrawal by Subject|1|||
37757720|NCT01540981|69266746|FG001|Overall Study|Withdrawal by Subject|0|||
37757721|NCT01585987|69266754|FG000|Randomized|Withdrawal by Subject|0|||
37757722|NCT01585987|69266755|FG001|Randomized|Withdrawal by Subject|4|||
37666021|NCT02711137|69138611|FG002|Overall Study|Death|5|||
37666022|NCT02711137|69138612|FG003|Overall Study|Death|5|||
37666023|NCT02711137|69138613|FG004|Overall Study|Death|3|||
37666024|NCT02711137|69138614|FG005|Overall Study|Death|1|||
37666025|NCT02711137|69138615|FG006|Overall Study|Death|61|||
37666026|NCT02711137|69138616|FG007|Overall Study|Death|3|||
37666027|NCT02711137|69138617|FG008|Overall Study|Death|0|||
37666028|NCT02711137|69138618|FG009|Overall Study|Death|1|||
37666029|NCT02711137|69138619|FG010|Overall Study|Death|1|||
37666030|NCT02711137|69138620|FG011|Overall Study|Death|1|||
37666031|NCT02711137|69138621|FG012|Overall Study|Death|0|||
37666032|NCT02711137|69138622|FG013|Overall Study|Death|0|||
37666033|NCT02711137|69138623|FG014|Overall Study|Death|0|||
37666034|NCT02711137|69138609|FG000|Overall Study|Study Terminated by Sponsor|0|||
37666035|NCT02711137|69138610|FG001|Overall Study|Study Terminated by Sponsor|0|||
37666036|NCT02711137|69138611|FG002|Overall Study|Study Terminated by Sponsor|1|||
37666037|NCT02711137|69138612|FG003|Overall Study|Study Terminated by Sponsor|0|||
37666038|NCT02711137|69138613|FG004|Overall Study|Study Terminated by Sponsor|0|||
37757723|NCT01585987|69266754|FG000|Randomized|No longer met criteria|0|||
37757724|NCT01585987|69266755|FG001|Randomized|No longer met criteria|2|||
37757725|NCT01585987|69266754|FG000|Treated|Disease Progression|39|||
37757726|NCT01585987|69266755|FG001|Treated|Disease Progression|36|||
37757727|NCT01585987|69266754|FG000|Treated|Study Drug Toxicity|9|||
37757728|NCT01585987|69266755|FG001|Treated|Study Drug Toxicity|5|||
37666039|NCT02711137|69138614|FG005|Overall Study|Study Terminated by Sponsor|0|||
37666040|NCT02711137|69138615|FG006|Overall Study|Study Terminated by Sponsor|1|||
37757729|NCT01585987|69266754|FG000|Treated|Adverse Event|3|||
37757730|NCT01585987|69266755|FG001|Treated|Adverse Event|0|||
37757731|NCT01585987|69266754|FG000|Treated|Withdrawal by Subject|1|||
37757732|NCT01585987|69266755|FG001|Treated|Withdrawal by Subject|2|||
37757733|NCT01585987|69266754|FG000|Treated|Death|1|||
37757734|NCT01585987|69266755|FG001|Treated|Death|0|||
37757735|NCT01585987|69266754|FG000|Treated|Lost to Follow-up|0|||
37666041|NCT02711137|69138616|FG007|Overall Study|Study Terminated by Sponsor|0|||
37666042|NCT02711137|69138617|FG008|Overall Study|Study Terminated by Sponsor|0|||
37666043|NCT02711137|69138618|FG009|Overall Study|Study Terminated by Sponsor|0|||
37757736|NCT01585987|69266755|FG001|Treated|Lost to Follow-up|1|||
37757737|NCT01585987|69266754|FG000|Treated|Maximum Clinical Benefit|0|||
37757738|NCT01585987|69266755|FG001|Treated|Maximum Clinical Benefit|1|||
37757739|NCT01585987|69266754|FG000|Treated|Non-Specified|1|||
37757740|NCT01585987|69266755|FG001|Treated|Non-Specified|2|||
37757741|NCT01585987|69266754|FG000|Treated|Subject Request|0|||
37757742|NCT01585987|69266755|FG001|Treated|Subject Request|1|||
37757743|NCT01585987|69266754|FG000|Treated|Poor/Non-Compliance|0|||
37757744|NCT01585987|69266755|FG001|Treated|Poor/Non-Compliance|1|||
37757745|NCT01585831|69266764|FG000|Overall Study|Physician Decision|0|||
37757746|NCT01585831|69266765|FG001|Overall Study|Physician Decision|1|||
37757747|NCT01585831|69266764|FG000|Overall Study|Withdrawal by Subject|2|||
37757748|NCT01585831|69266765|FG001|Overall Study|Withdrawal by Subject|1|||
37757749|NCT01565941|69266773|FG000|Overall Study|Withdrawn by parent/guardian|3|||
37757750|NCT01565941|69266774|FG001|Overall Study|Withdrawn by parent/guardian|2|||
37757751|NCT01565941|69266773|FG000|Overall Study|Randomized; did not receive intevention|8|||
37757752|NCT01565941|69266774|FG001|Overall Study|Randomized; did not receive intevention|2|||
37757753|NCT01558271|69266785|FG000|Overall Study|Adverse Event|6|||
37757754|NCT01558271|69266786|FG001|Overall Study|Adverse Event|3|||
37858740|NCT01298531|69542054|FG001|Overall Study|Lost to Follow-up|0|||
37858741|NCT01298531|69542053|FG000|Overall Study|Protocol Violation|1|||
37858742|NCT01298531|69542054|FG001|Overall Study|Protocol Violation|1|||
37858743|NCT01298531|69542053|FG000|Overall Study|Adverse Event|4|||
37858744|NCT01298531|69542054|FG001|Overall Study|Adverse Event|3|||
37858745|NCT01298531|69542053|FG000|Overall Study|Does not meet entrance criteria|0|||
37858746|NCT01298531|69542054|FG001|Overall Study|Does not meet entrance criteria|1|||
37858747|NCT01298531|69542053|FG000|Overall Study|Other|2|||
37666044|NCT02711137|69138619|FG010|Overall Study|Study Terminated by Sponsor|0|||
37666045|NCT02711137|69138620|FG011|Overall Study|Study Terminated by Sponsor|0|||
37666046|NCT02711137|69138621|FG012|Overall Study|Study Terminated by Sponsor|0|||
37666047|NCT02711137|69138622|FG013|Overall Study|Study Terminated by Sponsor|0|||
37666048|NCT02711137|69138623|FG014|Overall Study|Study Terminated by Sponsor|0|||
37666049|NCT02711137|69138609|FG000|Overall Study|Physician Decision|1|||
37666050|NCT02711137|69138610|FG001|Overall Study|Physician Decision|0|||
37666051|NCT02711137|69138611|FG002|Overall Study|Physician Decision|2|||
37666052|NCT02711137|69138612|FG003|Overall Study|Physician Decision|1|||
37666053|NCT02711137|69138613|FG004|Overall Study|Physician Decision|1|||
37666054|NCT02711137|69138614|FG005|Overall Study|Physician Decision|0|||
37666055|NCT02711137|69138615|FG006|Overall Study|Physician Decision|12|||
37666056|NCT02711137|69138616|FG007|Overall Study|Physician Decision|2|||
37666057|NCT02711137|69138617|FG008|Overall Study|Physician Decision|1|||
37666058|NCT02711137|69138618|FG009|Overall Study|Physician Decision|1|||
37666059|NCT02711137|69138619|FG010|Overall Study|Physician Decision|3|||
37666060|NCT02711137|69138620|FG011|Overall Study|Physician Decision|2|||
37666061|NCT02711137|69138621|FG012|Overall Study|Physician Decision|1|||
37666062|NCT02711137|69138622|FG013|Overall Study|Physician Decision|1|||
37666063|NCT02711137|69138623|FG014|Overall Study|Physician Decision|2|||
37666064|NCT02711137|69138609|FG000|Overall Study|Other|0|||
37666065|NCT02711137|69138610|FG001|Overall Study|Other|1|||
37666066|NCT02711137|69138611|FG002|Overall Study|Other|0|||
37666067|NCT02711137|69138612|FG003|Overall Study|Other|0|||
37666068|NCT02711137|69138613|FG004|Overall Study|Other|0|||
37666069|NCT02711137|69138614|FG005|Overall Study|Other|0|||
37666070|NCT02711137|69138615|FG006|Overall Study|Other|3|||
37757755|NCT01558271|69266787|FG002|Overall Study|Adverse Event|4|||
37757756|NCT01558271|69266785|FG000|Overall Study|Lost to Follow-up|1|||
37757757|NCT01558271|69266786|FG001|Overall Study|Lost to Follow-up|0|||
37757758|NCT01558271|69266787|FG002|Overall Study|Lost to Follow-up|0|||
37666071|NCT02711137|69138616|FG007|Overall Study|Other|0|||
37666072|NCT02711137|69138617|FG008|Overall Study|Other|0|||
37666073|NCT02711137|69138618|FG009|Overall Study|Other|0|||
37666074|NCT02711137|69138619|FG010|Overall Study|Other|0|||
37666075|NCT02711137|69138620|FG011|Overall Study|Other|0|||
37666076|NCT02711137|69138621|FG012|Overall Study|Other|0|||
37666077|NCT02711137|69138622|FG013|Overall Study|Other|0|||
37666078|NCT02711137|69138623|FG014|Overall Study|Other|1|||
37666079|NCT02711137|69138609|FG000|Overall Study|Withdrawal by Subject|1|||
37666080|NCT02711137|69138610|FG001|Overall Study|Withdrawal by Subject|0|||
37666081|NCT02711137|69138611|FG002|Overall Study|Withdrawal by Subject|0|||
37757759|NCT01558271|69266785|FG000|Overall Study|Protocol Violation|1|||
37757760|NCT01558271|69266786|FG001|Overall Study|Protocol Violation|0|||
37858748|NCT01298531|69542054|FG001|Overall Study|Other|1|||
37858749|NCT01174173|69542061|FG000|Overall Study|drug-drug interaction|1|||
37858750|NCT00964795|69542066|FG000|Overall Study|Withdrawal by Subject|79|||
37858751|NCT00964795|69542066|FG000|Overall Study|Adverse Event|12|||
37858752|NCT00964795|69542066|FG000|Overall Study|Death|14|||
37666082|NCT02711137|69138612|FG003|Overall Study|Withdrawal by Subject|1|||
37757761|NCT01558271|69266787|FG002|Overall Study|Protocol Violation|0|||
37757762|NCT01558271|69266785|FG000|Overall Study|Withdrawal by Subject|10|||
37666083|NCT02711137|69138613|FG004|Overall Study|Withdrawal by Subject|1|||
37666084|NCT02711137|69138614|FG005|Overall Study|Withdrawal by Subject|0|||
37666085|NCT02711137|69138615|FG006|Overall Study|Withdrawal by Subject|7|||
37666086|NCT02711137|69138616|FG007|Overall Study|Withdrawal by Subject|0|||
37666087|NCT02711137|69138617|FG008|Overall Study|Withdrawal by Subject|0|||
37757763|NCT01558271|69266786|FG001|Overall Study|Withdrawal by Subject|6|||
37757764|NCT01558271|69266787|FG002|Overall Study|Withdrawal by Subject|12|||
37757765|NCT01558271|69266785|FG000|Overall Study|Physician Decision|0|||
37757766|NCT01558271|69266786|FG001|Overall Study|Physician Decision|2|||
37666088|NCT02711137|69138618|FG009|Overall Study|Withdrawal by Subject|0|||
37666089|NCT02711137|69138619|FG010|Overall Study|Withdrawal by Subject|0|||
37666090|NCT02711137|69138620|FG011|Overall Study|Withdrawal by Subject|0|||
37666091|NCT02711137|69138621|FG012|Overall Study|Withdrawal by Subject|0|||
37666092|NCT02711137|69138622|FG013|Overall Study|Withdrawal by Subject|1|||
37666093|NCT02711137|69138623|FG014|Overall Study|Withdrawal by Subject|0|||
37666094|NCT02711137|69138609|FG000|Overall Study|Lost to Follow-up|1|||
37666095|NCT02711137|69138610|FG001|Overall Study|Lost to Follow-up|0|||
37666096|NCT02711137|69138611|FG002|Overall Study|Lost to Follow-up|0|||
37666097|NCT02711137|69138612|FG003|Overall Study|Lost to Follow-up|0|||
37666098|NCT02711137|69138613|FG004|Overall Study|Lost to Follow-up|0|||
37666099|NCT02711137|69138614|FG005|Overall Study|Lost to Follow-up|0|||
37666100|NCT02711137|69138615|FG006|Overall Study|Lost to Follow-up|2|||
37666101|NCT02711137|69138616|FG007|Overall Study|Lost to Follow-up|0|||
37666102|NCT02711137|69138617|FG008|Overall Study|Lost to Follow-up|0|||
37666103|NCT02711137|69138618|FG009|Overall Study|Lost to Follow-up|0|||
37666104|NCT02711137|69138619|FG010|Overall Study|Lost to Follow-up|0|||
37666105|NCT02711137|69138620|FG011|Overall Study|Lost to Follow-up|0|||
37666106|NCT02711137|69138621|FG012|Overall Study|Lost to Follow-up|0|||
37666107|NCT02711137|69138622|FG013|Overall Study|Lost to Follow-up|0|||
37666108|NCT02711137|69138623|FG014|Overall Study|Lost to Follow-up|0|||
37666109|NCT02710045|69138663|FG000|Overall Study|Death|1|||
37666110|NCT02710045|69138664|FG001|Overall Study|Death|2|||
37666111|NCT02710045|69138665|FG002|Overall Study|Death|0|||
37666112|NCT02710045|69138663|FG000|Overall Study|Withdrawal by Subject|6|||
37666113|NCT02710045|69138664|FG001|Overall Study|Withdrawal by Subject|6|||
37666114|NCT02710045|69138665|FG002|Overall Study|Withdrawal by Subject|2|||
37666115|NCT02710045|69138663|FG000|Overall Study|Protocol Violation|1|||
37666116|NCT02710045|69138664|FG001|Overall Study|Protocol Violation|2|||
37666117|NCT02710045|69138665|FG002|Overall Study|Protocol Violation|3|||
37666118|NCT02710045|69138663|FG000|Overall Study|Lost to Follow-up|3|||
37666119|NCT02710045|69138664|FG001|Overall Study|Lost to Follow-up|6|||
37666120|NCT02710045|69138665|FG002|Overall Study|Lost to Follow-up|7|||
37666121|NCT02710045|69138663|FG000|Overall Study|Physician Decision|0|||
37757767|NCT01558271|69266787|FG002|Overall Study|Physician Decision|1|||
37757768|NCT01565707|69266803|FG000|Overall Study|Adverse Event|1|||
37757769|NCT01565707|69266804|FG001|Overall Study|Adverse Event|6|||
37757770|NCT01565707|69266805|FG002|Overall Study|Adverse Event|2|||
37757771|NCT01565707|69266806|FG003|Overall Study|Adverse Event|1|||
37757772|NCT01565707|69266803|FG000|Overall Study|Lost to Follow-up|1|||
37757773|NCT01565707|69266804|FG001|Overall Study|Lost to Follow-up|0|||
37757774|NCT01565707|69266805|FG002|Overall Study|Lost to Follow-up|0|||
37757775|NCT01565707|69266806|FG003|Overall Study|Lost to Follow-up|0|||
37757776|NCT01565707|69266803|FG000|Overall Study|Protocol Violation|1|||
37757777|NCT01565707|69266804|FG001|Overall Study|Protocol Violation|0|||
37757778|NCT01565707|69266805|FG002|Overall Study|Protocol Violation|0|||
37757779|NCT01565707|69266806|FG003|Overall Study|Protocol Violation|1|||
37757780|NCT01565707|69266803|FG000|Overall Study|Withdrawal by Subject|3|||
37757781|NCT01565707|69266804|FG001|Overall Study|Withdrawal by Subject|1|||
37757782|NCT01565707|69266805|FG002|Overall Study|Withdrawal by Subject|1|||
37757783|NCT01565707|69266806|FG003|Overall Study|Withdrawal by Subject|1|||
37757784|NCT01565707|69266803|FG000|Overall Study|Randomized but not evaluable|2|||
37757785|NCT01565707|69266804|FG001|Overall Study|Randomized but not evaluable|0|||
37757786|NCT01565707|69266805|FG002|Overall Study|Randomized but not evaluable|0|||
37757787|NCT01565707|69266806|FG003|Overall Study|Randomized but not evaluable|0|||
37757788|NCT01565707|69266803|FG000|Overall Study|Miscellaneous|1|||
37757789|NCT01565707|69266804|FG001|Overall Study|Miscellaneous|1|||
37757790|NCT01565707|69266805|FG002|Overall Study|Miscellaneous|0|||
37757791|NCT01565707|69266806|FG003|Overall Study|Miscellaneous|2|||
37757792|NCT01557569|69266825|FG000|Overall Study|Adverse Event|2|||
37757793|NCT01557569|69266826|FG001|Overall Study|Adverse Event|0|||
37666122|NCT02710045|69138664|FG001|Overall Study|Physician Decision|0|||
37666123|NCT02710045|69138665|FG002|Overall Study|Physician Decision|1|||
37666124|NCT02710045|69138663|FG000|Overall Study|Poor Attendance|0|||
37757794|NCT01557569|69266825|FG000|Overall Study|high blood pressure|0|||
37757795|NCT01557569|69266826|FG001|Overall Study|high blood pressure|1|||
37757796|NCT01557569|69266825|FG000|Overall Study|Withdrawal by Subject|3|||
37757797|NCT01557569|69266826|FG001|Overall Study|Withdrawal by Subject|5|||
37757798|NCT01557569|69266825|FG000|Overall Study|noncompliance with rules of residential|0|||
37757799|NCT01557569|69266826|FG001|Overall Study|noncompliance with rules of residential|1|||
37757800|NCT01538719|69266834|FG000|Overall Study|Lost to Follow-up|2|||
37666125|NCT02710045|69138664|FG001|Overall Study|Poor Attendance|1|||
37666126|NCT02710045|69138665|FG002|Overall Study|Poor Attendance|0|||
37666127|NCT02714153|69138673|FG000|Overall Study|Death|1|||
37666128|NCT04369469|69138679|FG000|Overall Study|Lost to Follow-up|2|||
37757801|NCT01538719|69266835|FG001|Overall Study|Lost to Follow-up|0|||
37757802|NCT01537783|69266843|FG000|Overall Study|Lost to Follow-up|11|||
37757803|NCT01537783|69266844|FG001|Overall Study|Lost to Follow-up|2|||
37757804|NCT01556165|69266852|FG000|Overall Study|Adverse Event|5|||
37757805|NCT01556165|69266853|FG001|Overall Study|Adverse Event|3|||
37757806|NCT01556165|69266852|FG000|Overall Study|Protocol Violation|0|||
37757807|NCT01556165|69266853|FG001|Overall Study|Protocol Violation|3|||
37757808|NCT01556165|69266852|FG000|Overall Study|Withdrawal of Consent|7|||
37757809|NCT01556165|69266853|FG001|Overall Study|Withdrawal of Consent|1|||
37757810|NCT01537549|69266859|FG000|Overall Study|Lost to Follow-up|1|||
37757811|NCT01537549|69266859|FG000|Overall Study|Withdrawal by Subject|2|||
37757812|NCT01555931|69266867|FG000|Overall Study|Lost to Follow-up|2|||
37757813|NCT01555931|69266868|FG001|Overall Study|Lost to Follow-up|5|||
37757814|NCT01583179|69266876|FG000|Overall Study|Screen failure|1|||
37757815|NCT01583179|69266877|FG001|Overall Study|Screen failure|2|||
37757816|NCT01582945|69266883|FG000|Overall Study|Intolerable side-effects|1|||
37757817|NCT01582945|69266883|FG000|Overall Study|Scheduling conflicts|1|||
37757818|NCT01565083|69266889|FG000|Overall Study|Withdrawal by Subject|6|||
37757819|NCT01565083|69266890|FG001|Overall Study|Withdrawal by Subject|4|||
37757820|NCT01565083|69266889|FG000|Overall Study|Lost to Follow-up|2|||
37757821|NCT01565083|69266890|FG001|Overall Study|Lost to Follow-up|7|||
37757822|NCT01565083|69266889|FG000|Overall Study|Death|22|||
37757823|NCT01565083|69266890|FG001|Overall Study|Death|23|||
37757824|NCT01565083|69266889|FG000|Overall Study|Other|3|||
37757825|NCT01565083|69266890|FG001|Overall Study|Other|5|||
37757826|NCT01582789|69266896|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
37757827|NCT01582789|69266897|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
37757828|NCT01537393|69266907|FG000|Overall Study|Exclude prior to study|32|||
37757829|NCT01537393|69266908|FG001|Overall Study|Exclude prior to study|44|||
37757830|NCT01537393|69266907|FG000|Overall Study|Death|20|||
37757831|NCT01537393|69266908|FG001|Overall Study|Death|32|||
37757832|NCT01537393|69266907|FG000|Overall Study|Withdrawal by Subject|18|||
37757833|NCT01537393|69266908|FG001|Overall Study|Withdrawal by Subject|17|||
37757834|NCT01537393|69266907|FG000|Overall Study|Lost to Follow-up|53|||
37757835|NCT01537393|69266908|FG001|Overall Study|Lost to Follow-up|48|||
37757836|NCT01537393|69266907|FG000|Overall Study|Failure - Regrafted|28|||
37757837|NCT01537393|69266908|FG001|Overall Study|Failure - Regrafted|43|||
37757838|NCT01537393|69266907|FG000|Overall Study|Failure - Not regrafted|2|||
37666129|NCT04369469|69138680|FG001|Overall Study|Lost to Follow-up|4|||
37666130|NCT04369469|69138679|FG000|Overall Study|Physician Decision|2|||
37666131|NCT04369469|69138680|FG001|Overall Study|Physician Decision|1|||
37666132|NCT04369469|69138679|FG000|Overall Study|Withdrawal by Subject|2|||
37666133|NCT04369469|69138680|FG001|Overall Study|Withdrawal by Subject|3|||
37666134|NCT04369469|69138679|FG000|Overall Study|Adverse Event|1|||
37666135|NCT04369469|69138680|FG001|Overall Study|Adverse Event|0|||
37666136|NCT04369469|69138679|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
37666137|NCT04369469|69138680|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
37666138|NCT04369469|69138679|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
37666139|NCT04369469|69138680|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
37666140|NCT04369469|69138679|FG000|Overall Study|Unable to Provide Consent|0|||
37666141|NCT04369469|69138680|FG001|Overall Study|Unable to Provide Consent|1|||
37666142|NCT04647383|69138703|FG000|Treatment Period 2 (8 Days)|Adverse Event|0|||
37666143|NCT04647383|69138704|FG001|Treatment Period 2 (8 Days)|Adverse Event|1|||
37666144|NCT04647383|69138705|FG002|Treatment Period 2 (8 Days)|Adverse Event|0|||
37666145|NCT04647383|69138706|FG003|Treatment Period 2 (8 Days)|Adverse Event|0|||
37666146|NCT01670097|69138718|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
37666147|NCT01670097|69138719|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
37666148|NCT01670097|69138718|FG000|Overall Study|Study burden|1|||
37666149|NCT01670097|69138719|FG001|Overall Study|Study burden|0|||
37666150|NCT01670097|69138718|FG000|Overall Study|COPD exacerbation|0|||
37666151|NCT01670097|69138719|FG001|Overall Study|COPD exacerbation|1|||
37757839|NCT01537393|69266908|FG001|Overall Study|Failure - Not regrafted|6|||
37757840|NCT01537393|69266907|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
37757841|NCT01537393|69266908|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
37757842|NCT01555151|69266918|FG000|Overall Study|Withdrawal by Subject|6|||
37757843|NCT01555151|69266919|FG001|Overall Study|Withdrawal by Subject|2|||
37757844|NCT01555151|69266920|FG002|Overall Study|Withdrawal by Subject|0|||
37923465|NCT00824408|69610265|FG003|Run-in Phase|Refused to continue medication|0|||
37666152|NCT01670097|69138718|FG000|Overall Study|Neutropenia|0|||
37666153|NCT01670097|69138719|FG001|Overall Study|Neutropenia|1|||
37666154|NCT01670097|69138718|FG000|Overall Study|Clinical deterioration|0|||
37666155|NCT01670097|69138719|FG001|Overall Study|Clinical deterioration|1|||
37757845|NCT01555151|69266921|FG003|Overall Study|Withdrawal by Subject|2|||
37757846|NCT01555151|69266918|FG000|Overall Study|Administrative|3|||
37757847|NCT01555151|69266919|FG001|Overall Study|Administrative|1|||
37757848|NCT01555151|69266920|FG002|Overall Study|Administrative|2|||
37666156|NCT01670097|69138718|FG000|Overall Study|Disease progression|0|||
37757849|NCT01555151|69266921|FG003|Overall Study|Administrative|0|||
37666157|NCT01670097|69138719|FG001|Overall Study|Disease progression|1|||
37666158|NCT01670019|69138727|FG000|Overall Study|Adverse Event|3|||
37666159|NCT01670019|69138728|FG001|Overall Study|Adverse Event|0|||
37666160|NCT01670019|69138727|FG000|Overall Study|Withdrawal by Subject|6|||
37666161|NCT01670019|69138728|FG001|Overall Study|Withdrawal by Subject|0|||
37666162|NCT01669629|69138734|FG000|Period 1|protocol deviation|1|||
37666163|NCT01669629|69138735|FG001|Period 1|protocol deviation|2|||
37757850|NCT01555151|69266918|FG000|Overall Study|Protocol Violation|3|||
37757851|NCT01555151|69266919|FG001|Overall Study|Protocol Violation|3|||
37757852|NCT01555151|69266920|FG002|Overall Study|Protocol Violation|3|||
37757853|NCT01555151|69266921|FG003|Overall Study|Protocol Violation|5|||
37757854|NCT01555151|69266918|FG000|Overall Study|Adverse Event|1|||
37757855|NCT01555151|69266919|FG001|Overall Study|Adverse Event|2|||
37757856|NCT01555151|69266920|FG002|Overall Study|Adverse Event|1|||
37757857|NCT01555151|69266921|FG003|Overall Study|Adverse Event|2|||
37757858|NCT01555151|69266918|FG000|Overall Study|Lost to Follow-up|0|||
37757859|NCT01555151|69266919|FG001|Overall Study|Lost to Follow-up|0|||
37757860|NCT01555151|69266920|FG002|Overall Study|Lost to Follow-up|0|||
37757861|NCT01555151|69266921|FG003|Overall Study|Lost to Follow-up|1|||
37757862|NCT01537081|69266935|FG000|Overall Study|Adverse Event|5|||
37757863|NCT01537081|69266936|FG001|Overall Study|Adverse Event|2|||
37757864|NCT01537081|69266937|FG002|Overall Study|Adverse Event|2|||
37757865|NCT01537081|69266935|FG000|Overall Study|Lack of Efficacy|2|||
37757866|NCT01537081|69266936|FG001|Overall Study|Lack of Efficacy|1|||
37757867|NCT01537081|69266937|FG002|Overall Study|Lack of Efficacy|0|||
37757868|NCT01537081|69266935|FG000|Overall Study|Lost to Follow-up|17|||
37757869|NCT01537081|69266936|FG001|Overall Study|Lost to Follow-up|15|||
37757870|NCT01537081|69266937|FG002|Overall Study|Lost to Follow-up|9|||
37757871|NCT01537081|69266935|FG000|Overall Study|Protocol Violation|3|||
37757872|NCT01537081|69266936|FG001|Overall Study|Protocol Violation|2|||
37757873|NCT01537081|69266937|FG002|Overall Study|Protocol Violation|2|||
37757874|NCT01537081|69266935|FG000|Overall Study|Withdrawal by Subject|6|||
37757875|NCT01537081|69266936|FG001|Overall Study|Withdrawal by Subject|11|||
37757876|NCT01537081|69266937|FG002|Overall Study|Withdrawal by Subject|3|||
37757877|NCT01537081|69266935|FG000|Overall Study|Physician Decision|5|||
37757878|NCT01537081|69266936|FG001|Overall Study|Physician Decision|6|||
37757879|NCT01537081|69266937|FG002|Overall Study|Physician Decision|0|||
37757880|NCT01537081|69266935|FG000|Overall Study|Sponsor decision|0|||
37757881|NCT01537081|69266936|FG001|Overall Study|Sponsor decision|1|||
37757882|NCT01537081|69266937|FG002|Overall Study|Sponsor decision|0|||
37757883|NCT01537081|69266935|FG000|Overall Study|Assigned but never dosed|1|||
37757884|NCT01537081|69266936|FG001|Overall Study|Assigned but never dosed|0|||
37757885|NCT01537081|69266937|FG002|Overall Study|Assigned but never dosed|0|||
37757886|NCT01564459|69266949|FG000|Run-In|Adverse Event|7|||
37757887|NCT01564459|69266950|FG001|Run-In|Adverse Event|0|||
37757888|NCT01564459|69266951|FG002|Run-In|Adverse Event|0|||
37757889|NCT01564459|69266949|FG000|Run-In|Lost to Follow-up|1|||
37757890|NCT01564459|69266950|FG001|Run-In|Lost to Follow-up|0|||
37757891|NCT01564459|69266951|FG002|Run-In|Lost to Follow-up|0|||
37757892|NCT01564459|69266949|FG000|Run-In|Non-compliance with study drug|2|||
37757893|NCT01564459|69266950|FG001|Run-In|Non-compliance with study drug|0|||
37757894|NCT01564459|69266951|FG002|Run-In|Non-compliance with study drug|0|||
37757895|NCT01564459|69266949|FG000|Run-In|Protocol Violation|1|||
37666164|NCT00701051|69138743|FG000|Screening|Failed Screening|40|||
37666165|NCT00701051|69138744|FG001|Screening|Failed Screening|0|||
37666166|NCT00701051|69138745|FG002|Screening|Failed Screening|0|||
37666167|NCT00701051|69138743|FG000|Screening|Time conflicts|19|||
37666168|NCT00701051|69138744|FG001|Screening|Time conflicts|0|||
37666169|NCT00701051|69138745|FG002|Screening|Time conflicts|0|||
37666170|NCT00701051|69138743|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
37666171|NCT00701051|69138744|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
37666172|NCT00701051|69138745|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
37666173|NCT00700817|69138756|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
37666174|NCT00700817|69138757|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
37666175|NCT00700817|69138758|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
37666176|NCT00700817|69138759|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
37666177|NCT00700817|69138760|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
37666178|NCT00700817|69138756|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
37666179|NCT00700817|69138757|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
37666180|NCT00700817|69138758|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
37666181|NCT00700817|69138759|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
37666182|NCT00700817|69138760|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
37666183|NCT00700817|69138756|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
37666184|NCT00700817|69138757|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
37666185|NCT00700817|69138758|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
37666186|NCT00700817|69138759|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
37666187|NCT00700817|69138760|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
37757896|NCT01564459|69266950|FG001|Run-In|Protocol Violation|0|||
37757897|NCT01564459|69266951|FG002|Run-In|Protocol Violation|0|||
37757898|NCT01564459|69266949|FG000|Run-In|Withdrawal by Subject|1|||
37757899|NCT01564459|69266950|FG001|Run-In|Withdrawal by Subject|0|||
37757900|NCT01564459|69266951|FG002|Run-In|Withdrawal by Subject|0|||
37757901|NCT01564459|69266949|FG000|Double-blind Treatment|Adverse Event|0|||
37757902|NCT01564459|69266950|FG001|Double-blind Treatment|Adverse Event|0|||
37757903|NCT01564459|69266951|FG002|Double-blind Treatment|Adverse Event|1|||
37757904|NCT01555073|69266966|FG000|Overall Study|Lost to Follow-up|1|||
37757905|NCT01555073|69266967|FG001|Overall Study|Lost to Follow-up|2|||
37757906|NCT01555073|69266968|FG002|Overall Study|Lost to Follow-up|0|||
37757907|NCT01555073|69266969|FG003|Overall Study|Lost to Follow-up|5|||
37757908|NCT01582243|69266979|FG000|Overall Study|Withdrawal by Subject|1|||
37757909|NCT01582243|69266979|FG000|Overall Study|Adverse Event|1|||
37757910|NCT01582243|69266979|FG000|Overall Study|Lost to Follow-up|1|||
37757911|NCT01536535|69266985|FG000|Overall Study|Withdrawal by Subject|10|||
37757912|NCT01536535|69266986|FG001|Overall Study|Withdrawal by Subject|5|||
37757913|NCT01536535|69266985|FG000|Overall Study|Lost to Follow-up|4|||
37757914|NCT01536535|69266986|FG001|Overall Study|Lost to Follow-up|6|||
37757915|NCT01536535|69266985|FG000|Overall Study|Physician Decision|1|||
37757916|NCT01536535|69266986|FG001|Overall Study|Physician Decision|1|||
37757917|NCT01536535|69266985|FG000|Overall Study|Participant moved|0|||
37666188|NCT00700817|69138756|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
37666189|NCT00700817|69138757|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
37666190|NCT00700817|69138758|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
37666191|NCT00700817|69138759|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
37666192|NCT00700817|69138760|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
37666193|NCT00700817|69138756|FG000|Week 0-26 (Main Period)|Unclassified|14|||
37666194|NCT00700817|69138757|FG001|Week 0-26 (Main Period)|Unclassified|4|||
37666195|NCT00700817|69138758|FG002|Week 0-26 (Main Period)|Unclassified|8|||
37666196|NCT00700817|69138759|FG003|Week 0-26 (Main Period)|Unclassified|0|||
37666197|NCT00700817|69138760|FG004|Week 0-26 (Main Period)|Unclassified|0|||
37666198|NCT00700817|69138756|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
37666199|NCT00700817|69138757|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
37666200|NCT00700817|69138758|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
37666201|NCT00700817|69138759|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
37757918|NCT01536535|69266986|FG001|Overall Study|Participant moved|1|||
37757919|NCT01554527|69266996|FG000|Overall Study|Withdrawal by Subject|1|||
37757920|NCT01554527|69266997|FG001|Overall Study|Withdrawal by Subject|0|||
37757921|NCT01554527|69266998|FG002|Overall Study|Withdrawal by Subject|3|||
37757922|NCT01554527|69266996|FG000|Overall Study|Lost to Follow-up|0|||
37757923|NCT01554527|69266997|FG001|Overall Study|Lost to Follow-up|0|||
37757924|NCT01554527|69266998|FG002|Overall Study|Lost to Follow-up|4|||
37757925|NCT01554527|69266996|FG000|Overall Study|Physician Decision|0|||
37757926|NCT01554527|69266997|FG001|Overall Study|Physician Decision|0|||
37757927|NCT01554527|69266998|FG002|Overall Study|Physician Decision|1|||
37757928|NCT01563913|69267009|FG000|Overall Study|Physician Decision|1|||
37757929|NCT01563913|69267010|FG001|Overall Study|Physician Decision|0|||
37757930|NCT01563913|69267009|FG000|Overall Study|Spouse Passed Away|1|||
37757931|NCT01563913|69267010|FG001|Overall Study|Spouse Passed Away|0|||
37757932|NCT01553747|69267019|FG000|Overall Study|Protocol Violation|0|||
37757933|NCT01553747|69267020|FG001|Overall Study|Protocol Violation|2|||
37757934|NCT01553747|69267021|FG002|Overall Study|Protocol Violation|0|||
37757935|NCT01553747|69267019|FG000|Overall Study|Voluntarily withdrew|70|||
37757936|NCT01553747|69267020|FG001|Overall Study|Voluntarily withdrew|66|||
37757937|NCT01553747|69267021|FG002|Overall Study|Voluntarily withdrew|74|||
37757938|NCT01553747|69267019|FG000|Overall Study|Adverse event or SAE|32|||
37757939|NCT01553747|69267020|FG001|Overall Study|Adverse event or SAE|28|||
37757940|NCT01553747|69267021|FG002|Overall Study|Adverse event or SAE|19|||
37757941|NCT01553747|69267019|FG000|Overall Study|Physician decision: other|10|||
37666202|NCT00700817|69138760|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
37666203|NCT00700817|69138756|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
37666204|NCT00700817|69138757|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
37666205|NCT00700817|69138758|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
37757942|NCT01553747|69267020|FG001|Overall Study|Physician decision: other|8|||
37757943|NCT01553747|69267021|FG002|Overall Study|Physician decision: other|7|||
37757944|NCT01553747|69267019|FG000|Overall Study|Lost to Follow-up|11|||
37666206|NCT00700817|69138759|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
37666207|NCT00700817|69138760|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
37757945|NCT01553747|69267020|FG001|Overall Study|Lost to Follow-up|5|||
37757946|NCT01553747|69267021|FG002|Overall Study|Lost to Follow-up|6|||
37757947|NCT01553747|69267019|FG000|Overall Study|Sponsor decision, specify|7|||
37757948|NCT01553747|69267020|FG001|Overall Study|Sponsor decision, specify|5|||
37757949|NCT01553747|69267021|FG002|Overall Study|Sponsor decision, specify|0|||
37757950|NCT01553747|69267019|FG000|Overall Study|Physician decision: lack of efficacy|1|||
37757951|NCT01553747|69267020|FG001|Overall Study|Physician decision: lack of efficacy|5|||
37757952|NCT01553747|69267021|FG002|Overall Study|Physician decision: lack of efficacy|3|||
37757953|NCT01536379|69267034|FG000|Overall Study|Adverse Event|1|||
37757954|NCT01536379|69267035|FG001|Overall Study|Adverse Event|2|||
37757955|NCT01536379|69267034|FG000|Overall Study|Withdrawal by Subject|1|||
37757956|NCT01536379|69267035|FG001|Overall Study|Withdrawal by Subject|1|||
37757957|NCT01536145|69267041|FG000|Overall Study|Progressive disease|3|||
37757958|NCT01536145|69267042|FG001|Overall Study|Progressive disease|4|||
37757959|NCT01536145|69267043|FG002|Overall Study|Progressive disease|1|||
37757960|NCT01536145|69267044|FG003|Overall Study|Progressive disease|2|||
37757961|NCT01536145|69267045|FG004|Overall Study|Progressive disease|1|||
37757962|NCT01536145|69267046|FG005|Overall Study|Progressive disease|2|||
37757963|NCT01536145|69267047|FG006|Overall Study|Progressive disease|1|||
37757964|NCT01536145|69267048|FG007|Overall Study|Progressive disease|2|||
37757965|NCT01536145|69267049|FG008|Overall Study|Progressive disease|1|||
37757966|NCT01536145|69267050|FG009|Overall Study|Progressive disease|3|||
37757967|NCT01536145|69267051|FG010|Overall Study|Progressive disease|3|||
37757968|NCT01536145|69267041|FG000|Overall Study|Withdrawal by Subject|0|||
37757969|NCT01536145|69267042|FG001|Overall Study|Withdrawal by Subject|0|||
37757970|NCT01536145|69267043|FG002|Overall Study|Withdrawal by Subject|1|||
37757971|NCT01536145|69267044|FG003|Overall Study|Withdrawal by Subject|0|||
37757972|NCT01536145|69267045|FG004|Overall Study|Withdrawal by Subject|0|||
37757973|NCT01536145|69267046|FG005|Overall Study|Withdrawal by Subject|1|||
37757974|NCT01536145|69267047|FG006|Overall Study|Withdrawal by Subject|0|||
37757975|NCT01536145|69267048|FG007|Overall Study|Withdrawal by Subject|0|||
37757976|NCT01536145|69267049|FG008|Overall Study|Withdrawal by Subject|2|||
37757977|NCT01536145|69267050|FG009|Overall Study|Withdrawal by Subject|0|||
37757978|NCT01536145|69267051|FG010|Overall Study|Withdrawal by Subject|2|||
37757979|NCT01536145|69267041|FG000|Overall Study|Other|0|||
37757980|NCT01536145|69267042|FG001|Overall Study|Other|0|||
37757981|NCT01536145|69267043|FG002|Overall Study|Other|0|||
37757982|NCT01536145|69267044|FG003|Overall Study|Other|0|||
37757983|NCT01536145|69267045|FG004|Overall Study|Other|1|||
37757984|NCT01536145|69267046|FG005|Overall Study|Other|0|||
37757985|NCT01536145|69267047|FG006|Overall Study|Other|0|||
37757986|NCT01536145|69267048|FG007|Overall Study|Other|0|||
37757987|NCT01536145|69267049|FG008|Overall Study|Other|0|||
37757988|NCT01536145|69267050|FG009|Overall Study|Other|3|||
37757989|NCT01536145|69267051|FG010|Overall Study|Other|2|||
37757990|NCT01536145|69267041|FG000|Overall Study|Death|0|||
37757991|NCT01536145|69267042|FG001|Overall Study|Death|0|||
37757992|NCT01536145|69267043|FG002|Overall Study|Death|0|||
37757993|NCT01536145|69267044|FG003|Overall Study|Death|0|||
37757994|NCT01536145|69267045|FG004|Overall Study|Death|0|||
37757995|NCT01536145|69267046|FG005|Overall Study|Death|0|||
37757996|NCT01536145|69267047|FG006|Overall Study|Death|1|||
37757997|NCT01536145|69267048|FG007|Overall Study|Death|0|||
37757998|NCT01536145|69267049|FG008|Overall Study|Death|0|||
37757999|NCT01536145|69267050|FG009|Overall Study|Death|0|||
37758000|NCT01536145|69267051|FG010|Overall Study|Death|0|||
37758001|NCT01536145|69267041|FG000|Overall Study|Adverse Event|0|||
37758002|NCT01536145|69267042|FG001|Overall Study|Adverse Event|0|||
37758003|NCT01536145|69267043|FG002|Overall Study|Adverse Event|0|||
37758004|NCT01536145|69267044|FG003|Overall Study|Adverse Event|0|||
37758005|NCT01536145|69267045|FG004|Overall Study|Adverse Event|0|||
37758006|NCT01536145|69267046|FG005|Overall Study|Adverse Event|0|||
37666208|NCT00700817|69138756|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
37666209|NCT00700817|69138757|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
37666210|NCT00700817|69138758|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
37666211|NCT00700817|69138759|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
37666212|NCT00700817|69138760|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
37666213|NCT00700817|69138756|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
37666214|NCT00700817|69138757|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
37666215|NCT00700817|69138758|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
37666216|NCT00700817|69138759|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
37758007|NCT01536145|69267047|FG006|Overall Study|Adverse Event|0|||
37758008|NCT01536145|69267048|FG007|Overall Study|Adverse Event|2|||
37758009|NCT01536145|69267049|FG008|Overall Study|Adverse Event|0|||
37666217|NCT00700817|69138760|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
37758010|NCT01536145|69267050|FG009|Overall Study|Adverse Event|0|||
37758011|NCT01536145|69267051|FG010|Overall Study|Adverse Event|3|||
37758012|NCT01536067|69267082|FG000|Overall Study|Disease Progression|1|||
37758013|NCT01582009|69267086|FG000|Overall Study|Withdrawal by Subject|1|||
37758014|NCT01582009|69267086|FG000|Overall Study|Physician Decision|1|||
37758015|NCT01553591|69267093|FG000|Overall Study|Voluntarily withdrew|94|||
37758016|NCT01553591|69267094|FG001|Overall Study|Voluntarily withdrew|79|||
37758017|NCT01553591|69267095|FG002|Overall Study|Voluntarily withdrew|96|||
37758018|NCT01553591|69267093|FG000|Overall Study|Adverse Event|36|||
37758019|NCT01553591|69267094|FG001|Overall Study|Adverse Event|45|||
37758020|NCT01553591|69267095|FG002|Overall Study|Adverse Event|16|||
37758021|NCT01553591|69267093|FG000|Overall Study|Lost to Follow-up|25|||
37758022|NCT01553591|69267094|FG001|Overall Study|Lost to Follow-up|23|||
37758023|NCT01553591|69267095|FG002|Overall Study|Lost to Follow-up|16|||
37758024|NCT01553591|69267093|FG000|Overall Study|Physician decision: other|11|||
37758025|NCT01553591|69267094|FG001|Overall Study|Physician decision: other|14|||
37758026|NCT01553591|69267095|FG002|Overall Study|Physician decision: other|16|||
37758027|NCT01553591|69267093|FG000|Overall Study|Physician decision: lack of efficacy|2|||
37758028|NCT01553591|69267094|FG001|Overall Study|Physician decision: lack of efficacy|3|||
37758029|NCT01553591|69267095|FG002|Overall Study|Physician decision: lack of efficacy|7|||
37758030|NCT01553591|69267093|FG000|Overall Study|Protocol Violation|3|||
37758031|NCT01553591|69267094|FG001|Overall Study|Protocol Violation|4|||
37758032|NCT01553591|69267095|FG002|Overall Study|Protocol Violation|4|||
37758033|NCT01553591|69267093|FG000|Overall Study|Sponsor decision|1|||
37758034|NCT01553591|69267094|FG001|Overall Study|Sponsor decision|0|||
37758035|NCT01553591|69267095|FG002|Overall Study|Sponsor decision|3|||
37758036|NCT01553591|69267093|FG000|Overall Study|Randomized and never dispensed drug|0|||
37758037|NCT01553591|69267094|FG001|Overall Study|Randomized and never dispensed drug|1|||
37758038|NCT01553591|69267095|FG002|Overall Study|Randomized and never dispensed drug|0|||
37666218|NCT00700817|69138756|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
37666219|NCT00700817|69138757|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
37666220|NCT00700817|69138758|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
37758039|NCT01581931|69267103|FG000|Washout|Adverse Event|0|||
37758040|NCT01581931|69267104|FG001|Washout|Adverse Event|1|||
37758041|NCT01581619|69267110|FG000|Overall Study|Withdrawal by Subject|1|||
37758042|NCT01581619|69267110|FG000|Overall Study|Lost to Follow-up|1|||
37758043|NCT01581307|69267116|FG000|Overall Study|Withdrawal by Subject|1|||
37758044|NCT01580995|69267122|FG000|Overall Study|Lost to Follow-up|2|||
37758045|NCT01580995|69267123|FG001|Overall Study|Lost to Follow-up|2|||
37758046|NCT01535599|69267131|FG000|Overall Study|Adverse Event|6|||
37758047|NCT01535599|69267132|FG001|Overall Study|Adverse Event|15|||
37758048|NCT01535599|69267131|FG000|Overall Study|Lost to Follow-up|3|||
37758049|NCT01535599|69267132|FG001|Overall Study|Lost to Follow-up|4|||
37758050|NCT01535599|69267131|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
37758051|NCT01535599|69267132|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
37758052|NCT01535599|69267131|FG000|Overall Study|Treatment Failure|33|||
37666221|NCT00700817|69138759|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
37666222|NCT00700817|69138760|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
37666223|NCT00700817|69138756|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
37758053|NCT01535599|69267132|FG001|Overall Study|Treatment Failure|66|||
37758054|NCT01535599|69267131|FG000|Overall Study|BL Culture + for Group A Strep|0|||
37758055|NCT01535599|69267132|FG001|Overall Study|BL Culture + for Group A Strep|1|||
37758056|NCT01535599|69267131|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
37758057|NCT01535599|69267132|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
37758058|NCT01535599|69267131|FG000|Overall Study|Randomized in Error|2|||
37758059|NCT01535599|69267132|FG001|Overall Study|Randomized in Error|4|||
37758060|NCT01535599|69267131|FG000|Overall Study|Did not use product|1|||
37758061|NCT01535599|69267132|FG001|Overall Study|Did not use product|0|||
37666224|NCT00700817|69138757|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
37666225|NCT00700817|69138758|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
37666226|NCT00700817|69138759|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
37666227|NCT00700817|69138760|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
37666228|NCT00700817|69138756|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
37666229|NCT00700817|69138757|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
37666230|NCT00700817|69138758|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
37666231|NCT00700817|69138759|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
37666232|NCT00700817|69138760|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
37666233|NCT00700817|69138756|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
37666234|NCT00700817|69138757|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
37666235|NCT00700817|69138758|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
37666236|NCT00700817|69138759|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
37666237|NCT00700817|69138760|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
37666238|NCT00700817|69138756|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
37758062|NCT01535599|69267131|FG000|Overall Study|Other|1|||
37758063|NCT01535599|69267132|FG001|Overall Study|Other|0|||
37666239|NCT00700817|69138757|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
37758064|NCT01535599|69267131|FG000|Overall Study|Stopped medication|0|||
37758065|NCT01535599|69267132|FG001|Overall Study|Stopped medication|1|||
37758066|NCT01535599|69267131|FG000|Overall Study|Noncompliance|0|||
37758067|NCT01535599|69267132|FG001|Overall Study|Noncompliance|1|||
37758068|NCT01553279|69267140|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
37758069|NCT01553279|69267141|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
37758070|NCT01553279|69267140|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
37758071|NCT01553279|69267141|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
37758072|NCT01553279|69267140|FG000|Interim Period|Withdrawal by Subject|2|||
37758073|NCT01553279|69267141|FG001|Interim Period|Withdrawal by Subject|2|||
37758074|NCT01553279|69267140|FG000|Interim Period|Lost to Follow-up|1|||
37758075|NCT01553279|69267141|FG001|Interim Period|Lost to Follow-up|0|||
37758076|NCT01553279|69267140|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
37758077|NCT01553279|69267141|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
37758078|NCT01553279|69267140|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
37758079|NCT01553279|69267141|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
37758080|NCT01562743|69267148|FG000|Overall Study|Adverse Event|29|||
37758081|NCT01562743|69267148|FG000|Overall Study|Lack of Efficacy|3|||
37758082|NCT01562743|69267148|FG000|Overall Study|Withdrawal by Subject|13|||
37758083|NCT01562743|69267148|FG000|Overall Study|Protocol Violation|1|||
37758084|NCT01562743|69267148|FG000|Overall Study|Discontinuation criteria|2|||
37666240|NCT00700817|69138758|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
37666241|NCT00700817|69138759|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
37666242|NCT00700817|69138760|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
37666243|NCT00700817|69138756|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
37666244|NCT00700817|69138757|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
37666245|NCT00700817|69138758|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
37666246|NCT00700817|69138759|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
37666247|NCT00700817|69138760|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
37666248|NCT02625909|69138772|FG000|Overall Study|Death|2|||
37758085|NCT01562743|69267148|FG000|Overall Study|Lost to Follow-up|2|||
37758086|NCT01562743|69267148|FG000|Overall Study|Physician Decision|2|||
37758087|NCT01535443|69267152|FG000|Overall Study|Physician Decision|3|||
37758088|NCT01535287|69267159|FG000|Overall Study|drug not prepared in time|5|||
37758089|NCT01535287|69267160|FG001|Overall Study|drug not prepared in time|6|||
37758090|NCT01551173|69267168|FG000|Overall Study|Withdrawal by Subject|11|||
37758091|NCT01551173|69267169|FG001|Overall Study|Withdrawal by Subject|16|||
37758092|NCT01551173|69267168|FG000|Overall Study|Adverse Event|7|||
37758093|NCT01551173|69267169|FG001|Overall Study|Adverse Event|6|||
37758094|NCT01551173|69267168|FG000|Overall Study|Lost to Follow-up|5|||
37758095|NCT01551173|69267169|FG001|Overall Study|Lost to Follow-up|7|||
37758096|NCT01551173|69267168|FG000|Overall Study|Other|5|||
37758097|NCT01551173|69267169|FG001|Overall Study|Other|3|||
37758098|NCT01549613|69267178|FG000|Overall Study|Lost to Follow-up|11|||
37758099|NCT01549613|69267179|FG001|Overall Study|Lost to Follow-up|11|||
37758100|NCT01548599|69267187|FG000|Overall Study|Lost to Follow-up|0|||
37758101|NCT01548599|69267188|FG001|Overall Study|Lost to Follow-up|1|||
37758102|NCT01548599|69267187|FG000|Overall Study|Withdrawal by Subject|4|||
37758103|NCT01548599|69267188|FG001|Overall Study|Withdrawal by Subject|0|||
37758104|NCT01548599|69267187|FG000|Overall Study|Death|2|||
37758105|NCT01548599|69267188|FG001|Overall Study|Death|1|||
37758106|NCT01548287|69267201|FG000|Screening|No reason provided|0|||
37758107|NCT01548287|69267202|FG001|Screening|No reason provided|0|||
37758108|NCT01548287|69267203|FG002|Screening|No reason provided|0|||
37758109|NCT01548287|69267204|FG003|Screening|No reason provided|0|||
37758110|NCT01548287|69267205|FG004|Screening|No reason provided|9|||
37666249|NCT02625909|69138773|FG001|Overall Study|Death|0|||
37666250|NCT02625909|69138772|FG000|Overall Study|Lost to Follow-up|3|||
37666251|NCT02625909|69138773|FG001|Overall Study|Lost to Follow-up|5|||
37666252|NCT02625909|69138772|FG000|Overall Study|Lack of Efficacy|9|||
37758111|NCT01548287|69267201|FG000|Screening|Did not meet eligibility criteria|0|||
37758112|NCT01548287|69267202|FG001|Screening|Did not meet eligibility criteria|0|||
37858753|NCT00964795|69542066|FG000|Overall Study|Lost to Follow-up|7|||
37858754|NCT00964795|69542066|FG000|Overall Study|Termination of Study by Sponsor|169|||
37858755|NCT00964795|69542066|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
37858756|NCT00964795|69542066|FG000|Overall Study|Other|23|||
37858757|NCT01173471|69542075|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
37858758|NCT01173471|69542076|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
37858759|NCT01173471|69542077|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
37858760|NCT01173471|69542078|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
37858761|NCT01173471|69542075|FG000|Overall Study|Condition under investigation worsened|2|||
37858762|NCT01173471|69542076|FG001|Overall Study|Condition under investigation worsened|0|||
37666253|NCT02625909|69138773|FG001|Overall Study|Lack of Efficacy|2|||
37666254|NCT02625909|69138772|FG000|Overall Study|Reinfection|3|||
37666255|NCT02625909|69138773|FG001|Overall Study|Reinfection|2|||
37758113|NCT01548287|69267203|FG002|Screening|Did not meet eligibility criteria|0|||
37758114|NCT01548287|69267204|FG003|Screening|Did not meet eligibility criteria|0|||
37758115|NCT01548287|69267205|FG004|Screening|Did not meet eligibility criteria|74|||
37758116|NCT01548287|69267201|FG000|Randomized Period|Did not meet inclusion criteria|0|||
37758117|NCT01548287|69267202|FG001|Randomized Period|Did not meet inclusion criteria|0|||
37758118|NCT01548287|69267203|FG002|Randomized Period|Did not meet inclusion criteria|2|||
37758119|NCT01548287|69267204|FG003|Randomized Period|Did not meet inclusion criteria|0|||
37758120|NCT01548287|69267205|FG004|Randomized Period|Did not meet inclusion criteria|0|||
37758121|NCT01548287|69267201|FG000|Randomized Period|Adverse Event|0|||
37666256|NCT02623959|69138781|FG000|Overall Study|Progression|0|||
37666257|NCT02623959|69138782|FG001|Overall Study|Progression|1|||
37666258|NCT00700739|69138792|FG000|Overall Study|Lost to Follow-up|4|||
37666259|NCT00700739|69138793|FG001|Overall Study|Lost to Follow-up|4|||
37666260|NCT02623335|69138802|FG000|Overall Study|Death|8|||
37666261|NCT02623335|69138803|FG001|Overall Study|Death|7|||
37666262|NCT02623335|69138802|FG000|Overall Study|Lost to Follow-up|15|||
37666263|NCT02623335|69138803|FG001|Overall Study|Lost to Follow-up|23|||
37666264|NCT02623335|69138802|FG000|Overall Study|Withdrawal by Subject|2|||
37666265|NCT02623335|69138803|FG001|Overall Study|Withdrawal by Subject|5|||
37758122|NCT01548287|69267202|FG001|Randomized Period|Adverse Event|2|||
37758123|NCT01548287|69267203|FG002|Randomized Period|Adverse Event|5|||
37666266|NCT02623335|69138802|FG000|Overall Study|Protocol Violation|2|||
37666267|NCT02623335|69138803|FG001|Overall Study|Protocol Violation|1|||
37758124|NCT01548287|69267204|FG003|Randomized Period|Adverse Event|0|||
37758125|NCT01548287|69267205|FG004|Randomized Period|Adverse Event|0|||
37758126|NCT01546883|69267215|FG000|Overall Study|Withdrawal by Subject|3|||
37758127|NCT01546883|69267215|FG000|Overall Study|Adverse Event|4|||
37758128|NCT01546883|69267215|FG000|Overall Study|Lost to Follow-up|2|||
37758129|NCT01546883|69267215|FG000|Overall Study|early closure of study|2|||
37758130|NCT01546883|69267215|FG000|Overall Study|other unrelated illness|1|||
37758131|NCT01546649|69267221|FG000|Overall Study|Adverse Event|4|||
37758132|NCT01546649|69267222|FG001|Overall Study|Adverse Event|5|||
37758133|NCT01546649|69267221|FG000|Overall Study|Protocol Violation|1|||
37758134|NCT01546649|69267222|FG001|Overall Study|Protocol Violation|0|||
37758135|NCT01546649|69267221|FG000|Overall Study|Lack of Efficacy|1|||
37758136|NCT01546649|69267222|FG001|Overall Study|Lack of Efficacy|0|||
37758137|NCT01546649|69267221|FG000|Overall Study|Recurrence|1|||
37758138|NCT01546649|69267222|FG001|Overall Study|Recurrence|1|||
37858763|NCT01173471|69542077|FG002|Overall Study|Condition under investigation worsened|0|||
37858764|NCT01173471|69542078|FG003|Overall Study|Condition under investigation worsened|0|||
37858765|NCT01173471|69542075|FG000|Overall Study|Lost to Follow-up|0|||
37858766|NCT01173471|69542076|FG001|Overall Study|Lost to Follow-up|0|||
37858767|NCT01173471|69542077|FG002|Overall Study|Lost to Follow-up|1|||
37858768|NCT01173471|69542078|FG003|Overall Study|Lost to Follow-up|0|||
37858769|NCT01173471|69542075|FG000|Overall Study|Reason given as Other|0|||
37858770|NCT01173471|69542076|FG001|Overall Study|Reason given as Other|0|||
37858771|NCT01173471|69542077|FG002|Overall Study|Reason given as Other|1|||
37858772|NCT01173471|69542078|FG003|Overall Study|Reason given as Other|0|||
37858773|NCT01172847|69542088|FG000|Overall Study|Withdrawal by Subject|3|||
37858774|NCT00966355|69542101|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
37858775|NCT00966355|69542102|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
37858776|NCT00966355|69542103|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
37858777|NCT00966355|69542101|FG000|Overall Study|newly diagnosed advanced HCC|11|||
37858778|NCT00966355|69542102|FG001|Overall Study|newly diagnosed advanced HCC|12|||
37858779|NCT00966355|69542103|FG002|Overall Study|newly diagnosed advanced HCC|10|||
37858780|NCT00966355|69542101|FG000|Overall Study|Lost to Follow-up|5|||
37858781|NCT00966355|69542102|FG001|Overall Study|Lost to Follow-up|4|||
37858782|NCT00966355|69542103|FG002|Overall Study|Lost to Follow-up|3|||
37858783|NCT01172535|69542111|FG000|Overall Study|Death|3|||
37858784|NCT01172535|69542111|FG000|Overall Study|Withdrawal by Subject|2|||
37858785|NCT01172535|69542111|FG000|Overall Study|Lost to Follow-up|1|||
37858786|NCT01172535|69542111|FG000|Overall Study|Ineligible at study entry|1|||
37858787|NCT01172535|69542111|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
37858788|NCT00966277|69542120|FG000|Overall Study|Withdrawal by Subject|3|||
37858789|NCT00966277|69542121|FG001|Overall Study|Withdrawal by Subject|0|||
37858790|NCT00966277|69542120|FG000|Overall Study|Ineligible|1|||
37858791|NCT00966277|69542121|FG001|Overall Study|Ineligible|3|||
37858792|NCT00966277|69542120|FG000|Overall Study|Treatment Plan Changed|0|||
37858793|NCT00966277|69542121|FG001|Overall Study|Treatment Plan Changed|1|||
37666268|NCT00700427|69138813|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
37758139|NCT01546649|69267221|FG000|Overall Study|Discovery of secondary cancer|0|||
37758140|NCT01546649|69267222|FG001|Overall Study|Discovery of secondary cancer|1|||
37858794|NCT01298141|69542127|FG000|Overall Study|Adverse Event|3|||
37858795|NCT01298141|69542127|FG000|Overall Study|Refusal of Required Study Procedures|1|||
37858796|NCT01298141|69542127|FG000|Overall Study|Withdrawal by Subject|6|||
37858797|NCT01298141|69542127|FG000|Overall Study|Termination of Study by the Investigator|5|||
37858798|NCT01298141|69542127|FG000|Overall Study|Other|5|||
37858799|NCT01298141|69542127|FG000|Overall Study|Lost to Follow-up|1|||
37858800|NCT01298141|69542127|FG000|Overall Study|Death|6|||
37858801|NCT01298141|69542127|FG000|Overall Study|Not treated|4|||
37666269|NCT00700427|69138814|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
37666270|NCT00700427|69138815|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
37758141|NCT01546649|69267221|FG000|Overall Study|Withdrawal by Subject|1|||
37758142|NCT01546649|69267222|FG001|Overall Study|Withdrawal by Subject|2|||
37758143|NCT01544309|69267230|FG000|Overall Study|Withdrawal by Subject|12|||
37758144|NCT01544309|69267231|FG001|Overall Study|Withdrawal by Subject|7|||
37666271|NCT00700427|69138816|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
37666272|NCT00700427|69138817|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
37666273|NCT00700427|69138813|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
37666274|NCT00700427|69138814|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
37758145|NCT01544309|69267230|FG000|Overall Study|Protocol Violation|2|||
37758146|NCT01544309|69267231|FG001|Overall Study|Protocol Violation|1|||
37758147|NCT01544309|69267230|FG000|Overall Study|Physician Decision|4|||
37758148|NCT01544309|69267231|FG001|Overall Study|Physician Decision|1|||
37758149|NCT01544309|69267230|FG000|Overall Study|Not performed pre-dose examination|1|||
37758150|NCT01544309|69267231|FG001|Overall Study|Not performed pre-dose examination|2|||
37758151|NCT01544309|69267230|FG000|Overall Study|Administered prohibit prior medication|1|||
37758152|NCT01544309|69267231|FG001|Overall Study|Administered prohibit prior medication|0|||
37758153|NCT01544153|69267243|FG000|Overall Study|Under 18|0|||
37758154|NCT01544153|69267244|FG001|Overall Study|Under 18|1|||
37758155|NCT01544153|69267245|FG002|Overall Study|Under 18|0|||
37758156|NCT01544153|69267246|FG003|Overall Study|Under 18|0|||
37758157|NCT01544153|69267243|FG000|Overall Study|Non-smoker|0|||
37758158|NCT01544153|69267244|FG001|Overall Study|Non-smoker|0|||
37758159|NCT01544153|69267245|FG002|Overall Study|Non-smoker|1|||
37758160|NCT01544153|69267246|FG003|Overall Study|Non-smoker|0|||
37758161|NCT01543685|69267261|FG000|Overall Study|Lack of Efficacy|1|||
37758162|NCT01543685|69267262|FG001|Overall Study|Lack of Efficacy|2|||
37758163|NCT01543685|69267263|FG002|Overall Study|Lack of Efficacy|2|||
37758164|NCT01543685|69267264|FG003|Overall Study|Lack of Efficacy|0|||
37758165|NCT01543685|69267265|FG004|Overall Study|Lack of Efficacy|2|||
37758166|NCT01543685|69267261|FG000|Overall Study|Adverse Event|2|||
37758167|NCT01543685|69267262|FG001|Overall Study|Adverse Event|1|||
37758168|NCT01543685|69267263|FG002|Overall Study|Adverse Event|0|||
37758169|NCT01543685|69267264|FG003|Overall Study|Adverse Event|0|||
37758170|NCT01543685|69267265|FG004|Overall Study|Adverse Event|2|||
37758171|NCT01541969|69267279|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
37758172|NCT01541969|69267280|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
37758173|NCT01541969|69267279|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
37758174|NCT01541969|69267280|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
37758175|NCT01541969|69267279|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
37758176|NCT01541969|69267280|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
37758177|NCT01541969|69267279|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
37758178|NCT01541969|69267280|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
37758179|NCT01541969|69267279|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
37758180|NCT01541969|69267280|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
37758181|NCT01541969|69267279|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
37758182|NCT01541969|69267280|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
37758183|NCT01541969|69267279|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
37758184|NCT01541969|69267280|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
37858802|NCT01171989|69542134|FG000|Overall Study|Lost to Follow-up|0|||
37858803|NCT01171989|69542135|FG001|Overall Study|Lost to Follow-up|0|||
37858804|NCT01171989|69542136|FG002|Overall Study|Lost to Follow-up|1|||
37858805|NCT01297517|69542147|FG000|Overall Study|Adverse Event|21|||
37858806|NCT01297517|69542148|FG001|Overall Study|Adverse Event|7|||
37858807|NCT01297517|69542149|FG002|Overall Study|Adverse Event|16|||
37858808|NCT01297517|69542147|FG000|Overall Study|Lost to Follow-up|1|||
37858809|NCT01297517|69542148|FG001|Overall Study|Lost to Follow-up|0|||
37858810|NCT01297517|69542149|FG002|Overall Study|Lost to Follow-up|1|||
37858811|NCT01297517|69542147|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
37858812|NCT01297517|69542148|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
37858813|NCT01297517|69542149|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
37858814|NCT01297517|69542147|FG000|Overall Study|Noncompliance|1|||
37858815|NCT01297517|69542148|FG001|Overall Study|Noncompliance|0|||
37923466|NCT00824408|69610266|FG004|Run-in Phase|Refused to continue medication|0|||
37923467|NCT00824408|69610262|FG000|Run-in Phase|Other reason not defined above|0|||
37666275|NCT00700427|69138815|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
37666276|NCT00700427|69138816|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
37858816|NCT01297517|69542149|FG002|Overall Study|Noncompliance|0|||
37858817|NCT01297517|69542147|FG000|Overall Study|Protocol Violation|1|||
37858818|NCT01297517|69542148|FG001|Overall Study|Protocol Violation|1|||
37858819|NCT01297517|69542149|FG002|Overall Study|Protocol Violation|1|||
37666277|NCT00700427|69138817|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
37666278|NCT00700427|69138813|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
37758185|NCT01541969|69267279|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
37858820|NCT01297517|69542147|FG000|Overall Study|Inadequate Control of IOP|1|||
37758186|NCT01541969|69267280|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
37758187|NCT01541969|69267279|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
37758188|NCT01541969|69267280|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
37666279|NCT00700427|69138814|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
37666280|NCT00700427|69138815|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
37666281|NCT00700427|69138816|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
37666282|NCT00700427|69138817|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
37666283|NCT00700427|69138813|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
37666284|NCT00700427|69138814|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
37666285|NCT00700427|69138815|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
37666286|NCT00700427|69138816|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
37758189|NCT01541969|69267279|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
37758190|NCT01541969|69267280|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
37758191|NCT01540565|69267289|FG000|Overall Study|Ineligible|2|||
37758192|NCT01540487|69267295|FG000|Overall Study|Protocol Violation|1|||
37758193|NCT01540487|69267296|FG001|Overall Study|Protocol Violation|0|||
37758194|NCT01539317|69267308|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
37666287|NCT00700427|69138817|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
37666288|NCT00700427|69138813|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
37666289|NCT00700427|69138814|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
37666290|NCT00700427|69138815|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
37666291|NCT00700427|69138816|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
37666292|NCT00700427|69138817|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
37666293|NCT00700427|69138813|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
37666294|NCT00700427|69138814|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
37666295|NCT00700427|69138815|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
37666296|NCT00700427|69138816|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
37666297|NCT00700427|69138817|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
37666298|NCT00700427|69138813|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
37758195|NCT01539317|69267309|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
37858821|NCT01297517|69542148|FG001|Overall Study|Inadequate Control of IOP|1|||
37858822|NCT01297517|69542149|FG002|Overall Study|Inadequate Control of IOP|2|||
37858823|NCT01171677|69542159|FG000|Overall Study|Withdrawal by Subject|0|||
37858824|NCT01171677|69542160|FG001|Overall Study|Withdrawal by Subject|3|||
37858825|NCT01171677|69542159|FG000|Overall Study|Adverse Event|1|||
37858826|NCT01171677|69542160|FG001|Overall Study|Adverse Event|0|||
37858827|NCT01171677|69542159|FG000|Overall Study|completed <70% IntenSati classes|5|||
37858828|NCT01171677|69542160|FG001|Overall Study|completed <70% IntenSati classes|0|||
37858829|NCT01171521|69542166|FG000|Overall Study|Lost to Follow-up|5|||
37858830|NCT01171521|69542166|FG000|Overall Study|screen failure|1|||
37858831|NCT01296347|69542172|FG000|Allocation|Withdrawal by Subject|1|||
37858832|NCT01296347|69542173|FG001|Allocation|Withdrawal by Subject|2|||
37858833|NCT01296347|69542172|FG000|Allocation|Lack of Efficacy|1|||
37858834|NCT01296347|69542173|FG001|Allocation|Lack of Efficacy|2|||
37858835|NCT01296347|69542172|FG000|Allocation|not received infusion|1|||
37858836|NCT01296347|69542173|FG001|Allocation|not received infusion|0|||
37858837|NCT01296347|69542172|FG000|6 Week Follow up|Death|0|||
37858838|NCT01296347|69542173|FG001|6 Week Follow up|Death|1|||
37858839|NCT01296347|69542172|FG000|3 Month Follow up|Death|1|||
37858840|NCT01296347|69542173|FG001|3 Month Follow up|Death|0|||
37858841|NCT01296347|69542172|FG000|3 Month Follow up|Lost to Follow-up|0|||
37858842|NCT01296347|69542173|FG001|3 Month Follow up|Lost to Follow-up|1|||
37858843|NCT01296347|69542172|FG000|6 Month Follow up|Death|2|||
37858844|NCT01296347|69542173|FG001|6 Month Follow up|Death|1|||
37858845|NCT01296347|69542172|FG000|6 Month Follow up|Lost to Follow-up|0|||
37858846|NCT01296347|69542173|FG001|6 Month Follow up|Lost to Follow-up|1|||
37858847|NCT01296347|69542172|FG000|12 Month Follow up|Lost to Follow-up|3|||
37858848|NCT01296347|69542173|FG001|12 Month Follow up|Lost to Follow-up|1|||
37858849|NCT01296347|69542172|FG000|12 Month Follow up|Death|1|||
37858850|NCT01296347|69542173|FG001|12 Month Follow up|Death|1|||
37858851|NCT01296347|69542172|FG000|12 Month Follow up|Withdrawal by Subject|0|||
37923468|NCT00824408|69610263|FG001|Run-in Phase|Other reason not defined above|1|||
37923469|NCT00824408|69610264|FG002|Run-in Phase|Other reason not defined above|0|||
37758196|NCT01539239|69267320|FG000|Overall Study|Death|5|||
37858852|NCT01296347|69542173|FG001|12 Month Follow up|Withdrawal by Subject|1|||
37858853|NCT01296035|69542182|FG000|Overall Study|Withdrawal by Subject|1|||
37858854|NCT01294787|69542186|FG000|Period 1|Adverse Event|0|||
37858855|NCT01294787|69542187|FG001|Period 1|Adverse Event|0|||
37858856|NCT01294787|69542188|FG002|Period 1|Adverse Event|0|||
37858857|NCT01294787|69542189|FG003|Period 1|Adverse Event|0|||
37858858|NCT01294787|69542190|FG004|Period 1|Adverse Event|1|||
37858859|NCT01294787|69542191|FG005|Period 1|Adverse Event|0|||
37858860|NCT01294787|69542186|FG000|Period 1|Withdrawal by Subject|0|||
37858861|NCT01294787|69542187|FG001|Period 1|Withdrawal by Subject|0|||
37858862|NCT01294787|69542188|FG002|Period 1|Withdrawal by Subject|0|||
37858863|NCT01294787|69542189|FG003|Period 1|Withdrawal by Subject|1|||
37858864|NCT01294787|69542190|FG004|Period 1|Withdrawal by Subject|1|||
37758197|NCT01539239|69267321|FG001|Overall Study|Death|5|||
37758198|NCT01539239|69267320|FG000|Overall Study|Lost to Follow-up|7|||
37758199|NCT01539239|69267321|FG001|Overall Study|Lost to Follow-up|12|||
37758200|NCT01539083|69267327|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
37758201|NCT01539083|69267328|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
37758202|NCT01539083|69267329|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
37758203|NCT01539083|69267327|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
37758204|NCT01539083|69267328|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
37758205|NCT01539083|69267329|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
37758206|NCT01539083|69267327|FG000|Before Randomization (VCD Induction)|Death|6|||
37758207|NCT01539083|69267328|FG001|Before Randomization (VCD Induction)|Death|0|||
37758208|NCT01539083|69267329|FG002|Before Randomization (VCD Induction)|Death|0|||
37758209|NCT01539083|69267327|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
37758210|NCT01539083|69267328|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
37758211|NCT01539083|69267329|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
37758212|NCT01539083|69267327|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
37758213|NCT01539083|69267328|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
37758214|NCT01539083|69267329|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
37758215|NCT01539083|69267327|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
37758216|NCT01539083|69267328|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
37758217|NCT01539083|69267329|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
37758218|NCT01539083|69267327|FG000|Before Randomization (VCD Induction)|Other|5|||
37758219|NCT01539083|69267328|FG001|Before Randomization (VCD Induction)|Other|0|||
37758220|NCT01539083|69267329|FG002|Before Randomization (VCD Induction)|Other|0|||
37758221|NCT01539083|69267327|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
37758222|NCT01539083|69267328|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
37758223|NCT01539083|69267329|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
37758224|NCT01539083|69267327|FG000|After Randomization (TP and VTP)|Other|0|||
37758225|NCT01539083|69267328|FG001|After Randomization (TP and VTP)|Other|1|||
37758226|NCT01539083|69267329|FG002|After Randomization (TP and VTP)|Other|1|||
37758227|NCT01539083|69267327|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
37758228|NCT01539083|69267328|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
37758229|NCT01539083|69267329|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
37758230|NCT01539083|69267327|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
37758231|NCT01539083|69267328|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
37758232|NCT01539083|69267329|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
37758233|NCT01539083|69267327|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
37758234|NCT01539083|69267328|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
37858865|NCT01294787|69542191|FG005|Period 1|Withdrawal by Subject|1|||
37858866|NCT01294787|69542186|FG000|Period 1|Administrative problem|0|||
38033386|NCT02586623|69719345|FG001|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
38033387|NCT02586623|69719346|FG002|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
38033388|NCT02586623|69719344|FG000|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|2|||
37666299|NCT00700427|69138814|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
37666300|NCT00700427|69138815|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
37666301|NCT00700427|69138816|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
37666302|NCT00700427|69138817|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
37666303|NCT00700427|69138813|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
37666304|NCT00700427|69138814|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
37666305|NCT00700427|69138815|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
37666306|NCT00700427|69138816|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
37666307|NCT00700427|69138817|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
37666308|NCT00700427|69138813|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
37666309|NCT00700427|69138814|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
37666310|NCT00700427|69138815|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
37666311|NCT00700427|69138816|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
37666312|NCT00700427|69138817|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
37666313|NCT00700427|69138813|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
37666314|NCT00700427|69138814|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
37666315|NCT00700427|69138815|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
37666316|NCT00700427|69138816|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
37666317|NCT00700427|69138817|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
37666318|NCT00700427|69138813|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
37758235|NCT01539083|69267329|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
37758236|NCT01539083|69267327|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
37758237|NCT01539083|69267328|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
37758238|NCT01539083|69267329|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
37758239|NCT01539083|69267327|FG000|After Randomization (TP and VTP)|Death|0|||
37758240|NCT01539083|69267328|FG001|After Randomization (TP and VTP)|Death|6|||
37858867|NCT01294787|69542187|FG001|Period 1|Administrative problem|0|||
37858868|NCT01294787|69542188|FG002|Period 1|Administrative problem|1|||
37858869|NCT01294787|69542189|FG003|Period 1|Administrative problem|0|||
37858870|NCT01294787|69542190|FG004|Period 1|Administrative problem|0|||
37858871|NCT01294787|69542191|FG005|Period 1|Administrative problem|1|||
37858872|NCT01294787|69542186|FG000|Period 2|Adverse Event|0|||
37858873|NCT01294787|69542187|FG001|Period 2|Adverse Event|3|||
37858874|NCT01294787|69542188|FG002|Period 2|Adverse Event|0|||
37858875|NCT01294787|69542189|FG003|Period 2|Adverse Event|1|||
37858876|NCT01294787|69542190|FG004|Period 2|Adverse Event|0|||
37858877|NCT01294787|69542191|FG005|Period 2|Adverse Event|0|||
37858878|NCT01294787|69542186|FG000|Period 2|No longer needs study drug|0|||
37858879|NCT01294787|69542187|FG001|Period 2|No longer needs study drug|0|||
37858880|NCT01294787|69542188|FG002|Period 2|No longer needs study drug|0|||
37858881|NCT01294787|69542189|FG003|Period 2|No longer needs study drug|1|||
37858882|NCT01294787|69542190|FG004|Period 2|No longer needs study drug|0|||
37858883|NCT01294787|69542191|FG005|Period 2|No longer needs study drug|0|||
37858884|NCT01294787|69542186|FG000|Period 3|Adverse Event|0|||
37858885|NCT01294787|69542187|FG001|Period 3|Adverse Event|0|||
37858886|NCT01294787|69542188|FG002|Period 3|Adverse Event|0|||
37858887|NCT01294787|69542189|FG003|Period 3|Adverse Event|0|||
37858888|NCT01294787|69542190|FG004|Period 3|Adverse Event|1|||
37858889|NCT01294787|69542191|FG005|Period 3|Adverse Event|0|||
37858890|NCT01294553|69542202|FG000|Overall Study|Duplicated Participants|1|||
37858891|NCT01294553|69542202|FG000|Overall Study|Protocol Violation|268|||
37858892|NCT01294397|69542207|FG000|Overall Study|Withdrawal by Subject|1|||
37858893|NCT01294397|69542207|FG000|Overall Study|Administrative Decision|1|||
37858894|NCT01293695|69542215|FG000|Overall Study|Withdrawal by Subject|7|||
37858895|NCT01293695|69542216|FG001|Overall Study|Withdrawal by Subject|1|||
37858896|NCT01293695|69542215|FG000|Overall Study|Lost to Follow-up|8|||
37858897|NCT01293695|69542216|FG001|Overall Study|Lost to Follow-up|6|||
37858898|NCT01293539|69542225|FG000|Overall Study|Physician Decision|1|||
37858899|NCT01292837|69542229|FG000|Overall Study|Adverse Event|1|||
37858900|NCT01292837|69542229|FG000|Overall Study|Further treatment determined|1|||
37858901|NCT00965731|69542235|FG000|Overall Study|Death|0|||
37858902|NCT00965731|69542236|FG001|Overall Study|Death|4|||
37858903|NCT00965731|69542235|FG000|Overall Study|Withdrawal by Subject|0|||
37858904|NCT00965731|69542236|FG001|Overall Study|Withdrawal by Subject|1|||
37858905|NCT00965731|69542235|FG000|Overall Study|Other|7|||
37858906|NCT00965731|69542236|FG001|Overall Study|Other|15|||
37858907|NCT00965575|69542249|FG000|Overall Study|subject unwillingness to swallow study c|1|||
37858908|NCT00965575|69542250|FG001|Overall Study|subject unwillingness to swallow study c|0|||
37858909|NCT00965497|69542258|FG000|Overall Study|Physician Decision|1|||
37858910|NCT00963937|69542265|FG000|Overall Study|Protocol Violation|1|||
37858911|NCT00963937|69542266|FG001|Overall Study|Protocol Violation|1|||
37858912|NCT00963937|69542267|FG002|Overall Study|Protocol Violation|0|||
37858913|NCT00963937|69542265|FG000|Overall Study|Physician Decision|18|||
37666319|NCT00700427|69138814|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
37666320|NCT00700427|69138815|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
37666321|NCT00700427|69138816|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
37666322|NCT00700427|69138817|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
37666323|NCT00700427|69138813|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
37666324|NCT00700427|69138814|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
37666325|NCT00700427|69138815|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
37758241|NCT01539083|69267329|FG002|After Randomization (TP and VTP)|Death|11|||
37758242|NCT01537211|69267338|FG000|Overall Study|Lost to Follow-up|0|||
37758243|NCT01537211|69267339|FG001|Overall Study|Lost to Follow-up|1|||
37758244|NCT01537133|69267353|FG000|Overall Study|Withdrawal by Subject|2|||
37858914|NCT00963937|69542266|FG001|Overall Study|Physician Decision|10|||
37858915|NCT00963937|69542267|FG002|Overall Study|Physician Decision|4|||
37858916|NCT01170663|69542280|FG000|Overall Study|Lost to Follow-up|3|||
37858917|NCT01170663|69542281|FG001|Overall Study|Lost to Follow-up|9|||
37858918|NCT01170663|69542280|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
37858919|NCT01170663|69542281|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
37858920|NCT01170273|69542289|FG000|Overall Study|Lost to Follow-up|6|||
37858921|NCT01170273|69542290|FG001|Overall Study|Lost to Follow-up|8|||
37858922|NCT01170273|69542289|FG000|Overall Study|Protocol Violation|1|||
37858923|NCT01170273|69542290|FG001|Overall Study|Protocol Violation|0|||
37858924|NCT01170273|69542289|FG000|Overall Study|Death|1|||
37858925|NCT01170273|69542290|FG001|Overall Study|Death|0|||
37858926|NCT01170273|69542289|FG000|Overall Study|Adverse Event|0|||
37858927|NCT01170273|69542290|FG001|Overall Study|Adverse Event|1|||
37858928|NCT01170039|69542298|FG000|Overall Study|Withdrawal by Subject|5|||
37858929|NCT01170039|69542299|FG001|Overall Study|Withdrawal by Subject|3|||
37858930|NCT01170039|69542298|FG000|Overall Study|Lack of funding, drug not available|3|||
37758245|NCT01537133|69267354|FG001|Overall Study|Withdrawal by Subject|0|||
37758246|NCT01537133|69267355|FG002|Overall Study|Withdrawal by Subject|0|||
37758247|NCT01537133|69267356|FG003|Overall Study|Withdrawal by Subject|0|||
37758248|NCT01537133|69267353|FG000|Overall Study|Lost to Follow-up|1|||
37758249|NCT01537133|69267354|FG001|Overall Study|Lost to Follow-up|0|||
37758250|NCT01537133|69267355|FG002|Overall Study|Lost to Follow-up|0|||
37758251|NCT01537133|69267356|FG003|Overall Study|Lost to Follow-up|0|||
37758252|NCT01536587|69267364|FG000|Overall Study|Adverse Event|2|||
37758253|NCT01536119|69267370|FG000|Overall Study|Lost to Follow-up|17|||
37758254|NCT01536119|69267371|FG001|Overall Study|Lost to Follow-up|14|||
37758255|NCT01535729|69267377|FG000|Overall Study|Withdrawal by Subject|2|||
37758256|NCT01535729|69267377|FG000|Overall Study|Disease progression|230|||
37758257|NCT01535729|69267377|FG000|Overall Study|Discontinued treatment|25|||
37758258|NCT01535729|69267377|FG000|Overall Study|Lost to Follow-up|8|||
37758259|NCT01535729|69267377|FG000|Overall Study|Death|52|||
37758260|NCT01535729|69267377|FG000|Overall Study|Other|19|||
37758261|NCT01535729|69267377|FG000|Overall Study|Did not sign informed consent|1|||
37758262|NCT01535729|69267377|FG000|Overall Study|No previous chemotherapy|33|||
37758263|NCT01535729|69267377|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
37758264|NCT01535729|69267377|FG000|Overall Study|Protocol Violation|11|||
37758265|NCT01535729|69267377|FG000|Overall Study|Screening failure|1|||
37758266|NCT01535729|69267377|FG000|Overall Study|Not treated|9|||
37758267|NCT01535729|69267377|FG000|Overall Study|No participant record available|5|||
37758268|NCT01535261|69267381|FG000|Overall Study|Physician Decision|8|||
37758269|NCT01535261|69267381|FG000|Overall Study|Protocol Violation|3|||
37758270|NCT01535261|69267381|FG000|Overall Study|Death|5|||
37758271|NCT01535261|69267381|FG000|Overall Study|Lost to Follow-up|8|||
37758272|NCT01535261|69267381|FG000|Overall Study|Withdrawal by Subject|14|||
37758273|NCT01535261|69267381|FG000|Overall Study|Adverse Event|12|||
37758274|NCT01534637|69267385|FG000|Overall Study|Physician Decision|3|||
37758275|NCT01534637|69267385|FG000|Overall Study|Lack of Efficacy|3|||
37758276|NCT01534637|69267385|FG000|Overall Study|Withdrawal by Subject|1|||
37758277|NCT01534637|69267385|FG000|Overall Study|Adverse Event|1|||
37758278|NCT01534637|69267385|FG000|Overall Study|Liver Mets before treatment|1|||
37758279|NCT02655016|69267391|FG000|Overall Study|Disease progression|6|||
37758280|NCT02655016|69267392|FG001|Overall Study|Disease progression|4|||
37758281|NCT02655016|69267391|FG000|Overall Study|Site closed|0|||
37758282|NCT02655016|69267392|FG001|Overall Study|Site closed|1|||
37758283|NCT02655016|69267391|FG000|Overall Study|Death|30|||
37758284|NCT02655016|69267392|FG001|Overall Study|Death|48|||
37758285|NCT02655016|69267391|FG000|Overall Study|Lost to Follow-up|1|||
37758286|NCT02655016|69267392|FG001|Overall Study|Lost to Follow-up|1|||
37758287|NCT02655016|69267391|FG000|Overall Study|Withdrawal by Subject|18|||
37758288|NCT02655016|69267392|FG001|Overall Study|Withdrawal by Subject|36|||
37758289|NCT01533935|69267399|FG000|Overall Study|Adverse Event|5|||
37758290|NCT01533935|69267400|FG001|Overall Study|Adverse Event|7|||
37758291|NCT01533935|69267401|FG002|Overall Study|Adverse Event|1|||
37758292|NCT01533935|69267402|FG003|Overall Study|Adverse Event|5|||
37758293|NCT01533935|69267403|FG004|Overall Study|Adverse Event|3|||
37758294|NCT01533935|69267399|FG000|Overall Study|Protocol Violation|0|||
37758295|NCT01533935|69267400|FG001|Overall Study|Protocol Violation|2|||
37758296|NCT01533935|69267401|FG002|Overall Study|Protocol Violation|0|||
37758297|NCT01533935|69267402|FG003|Overall Study|Protocol Violation|0|||
37666326|NCT00700427|69138816|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
37666327|NCT00700427|69138817|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
37666328|NCT00700427|69138813|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
37666329|NCT00700427|69138814|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
37666330|NCT00700427|69138815|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
37666331|NCT00700427|69138816|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
37666332|NCT00700427|69138817|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
37758298|NCT01533935|69267403|FG004|Overall Study|Protocol Violation|0|||
37758299|NCT01533935|69267399|FG000|Overall Study|Lost to Follow-up|0|||
37758300|NCT01533935|69267400|FG001|Overall Study|Lost to Follow-up|0|||
37758301|NCT01533935|69267401|FG002|Overall Study|Lost to Follow-up|1|||
37758302|NCT01533935|69267402|FG003|Overall Study|Lost to Follow-up|0|||
37758303|NCT01533935|69267403|FG004|Overall Study|Lost to Follow-up|0|||
37758304|NCT01533935|69267399|FG000|Overall Study|Withdrawal by Subject|0|||
37758305|NCT01533935|69267400|FG001|Overall Study|Withdrawal by Subject|4|||
37758306|NCT01533935|69267401|FG002|Overall Study|Withdrawal by Subject|5|||
37758307|NCT01533935|69267402|FG003|Overall Study|Withdrawal by Subject|2|||
37758308|NCT01533935|69267403|FG004|Overall Study|Withdrawal by Subject|4|||
37758309|NCT01533935|69267399|FG000|Overall Study|Other reason not defined above|1|||
37758310|NCT01533935|69267400|FG001|Overall Study|Other reason not defined above|0|||
37758311|NCT01533935|69267401|FG002|Overall Study|Other reason not defined above|1|||
37758312|NCT01533935|69267402|FG003|Overall Study|Other reason not defined above|0|||
37758313|NCT01533935|69267403|FG004|Overall Study|Other reason not defined above|1|||
37758314|NCT01532999|69267417|FG000|Overall Study|Lost to Follow-up|14|||
37666333|NCT00700427|69138813|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
37666334|NCT00700427|69138814|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
37758315|NCT01532999|69267418|FG001|Overall Study|Lost to Follow-up|8|||
37758316|NCT01532999|69267417|FG000|Overall Study|Physician Decision|1|||
37758317|NCT01532999|69267418|FG001|Overall Study|Physician Decision|2|||
37758318|NCT01532999|69267417|FG000|Overall Study|Withdrawal by Subject|5|||
37758319|NCT01532999|69267418|FG001|Overall Study|Withdrawal by Subject|0|||
37758320|NCT01532999|69267417|FG000|Overall Study|Relocated|2|||
37758321|NCT01532999|69267418|FG001|Overall Study|Relocated|0|||
37758322|NCT01532999|69267417|FG000|Overall Study|should not have been randomized|1|||
37758323|NCT01532999|69267418|FG001|Overall Study|should not have been randomized|0|||
37758324|NCT01532999|69267417|FG000|Overall Study|substantial noncompliance|2|||
37758325|NCT01532999|69267418|FG001|Overall Study|substantial noncompliance|0|||
37758326|NCT01532999|69267417|FG000|Overall Study|no show for week 9 assessments|6|||
37758327|NCT01532999|69267418|FG001|Overall Study|no show for week 9 assessments|4|||
37758328|NCT01532999|69267417|FG000|Overall Study|Adverse Event|0|||
37758329|NCT01532999|69267418|FG001|Overall Study|Adverse Event|1|||
37758330|NCT01532999|69267417|FG000|Overall Study|incarcerated|0|||
37758331|NCT01532999|69267418|FG001|Overall Study|incarcerated|1|||
37758332|NCT01532999|69267417|FG000|Overall Study|New job|0|||
37758333|NCT01532999|69267418|FG001|Overall Study|New job|2|||
37758334|NCT01532921|69267424|FG000|Overall Study|Death|3|||
37758335|NCT01532921|69267424|FG000|Overall Study|Withdrawal by Subject|2|||
37758336|NCT01532921|69267424|FG000|Overall Study|Lost to Follow-up|3|||
37758337|NCT01532921|69267424|FG000|Overall Study|Physician Decision|7|||
37758338|NCT01532921|69267424|FG000|Overall Study|Device was explanted during procedure|1|||
37758339|NCT01532687|69267434|FG000|Overall Study|Death|2|||
37758340|NCT01532687|69267435|FG001|Overall Study|Death|0|||
37758341|NCT01532687|69267434|FG000|Overall Study|Adverse Event|6|||
37758342|NCT01532687|69267435|FG001|Overall Study|Adverse Event|1|||
37758343|NCT01532687|69267434|FG000|Overall Study|Withdrawal by Subject|1|||
37758344|NCT01532687|69267435|FG001|Overall Study|Withdrawal by Subject|0|||
37758345|NCT01532687|69267434|FG000|Overall Study|Physician Decision|2|||
37758346|NCT01532687|69267435|FG001|Overall Study|Physician Decision|1|||
37758347|NCT01532687|69267434|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
37758348|NCT01532687|69267435|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
37758349|NCT02677116|69267452|FG000|Overall Study|Adverse Event|0|||
37758350|NCT02677116|69267453|FG001|Overall Study|Adverse Event|1|||
37758351|NCT02677116|69267454|FG002|Overall Study|Adverse Event|0|||
37666335|NCT00700427|69138815|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
37666336|NCT00700427|69138816|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
37666337|NCT00700427|69138817|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
37666338|NCT00700427|69138813|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
37666339|NCT00700427|69138814|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
37666340|NCT00700427|69138815|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
37666341|NCT00700427|69138816|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
37666342|NCT00700427|69138817|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
37666343|NCT00700427|69138813|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
37666344|NCT00700427|69138814|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
37666345|NCT00700427|69138815|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
37666346|NCT00700427|69138816|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
37666347|NCT00700427|69138817|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
37666348|NCT00700427|69138813|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
37666349|NCT00700427|69138814|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
37666350|NCT00700427|69138815|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
37666351|NCT00700427|69138816|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
37666352|NCT00700427|69138817|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
37666353|NCT00700427|69138813|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
37666354|NCT00700427|69138814|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
37666355|NCT00700427|69138815|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
37666356|NCT00700427|69138816|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
37666357|NCT00700427|69138817|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
37758352|NCT02677116|69267455|FG003|Overall Study|Adverse Event|0|||
37758353|NCT02677116|69267456|FG004|Overall Study|Adverse Event|0|||
37758354|NCT02677116|69267457|FG005|Overall Study|Adverse Event|1|||
37758355|NCT02677116|69267458|FG006|Overall Study|Adverse Event|1|||
37758356|NCT02677116|69267459|FG007|Overall Study|Adverse Event|0|||
37758357|NCT02677116|69267460|FG008|Overall Study|Adverse Event|0|||
37758358|NCT02677116|69267452|FG000|Overall Study|Physician Decision|0|||
37758359|NCT02677116|69267453|FG001|Overall Study|Physician Decision|2|||
37758360|NCT02677116|69267454|FG002|Overall Study|Physician Decision|3|||
37758361|NCT02677116|69267455|FG003|Overall Study|Physician Decision|2|||
37758362|NCT02677116|69267456|FG004|Overall Study|Physician Decision|1|||
37758363|NCT02677116|69267457|FG005|Overall Study|Physician Decision|3|||
37858931|NCT01170039|69542299|FG001|Overall Study|Lack of funding, drug not available|3|||
37858932|NCT01169649|69542305|FG000|Overall Study|Patient Not Treated|3|||
37858933|NCT01169493|69542315|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
37858934|NCT01169493|69542316|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
37858935|NCT01169493|69542317|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
37858936|NCT01169493|69542318|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
37858937|NCT01169493|69542319|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
37858938|NCT01169493|69542320|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
37858939|NCT01169493|69542315|FG000|Period 3 (6 Months)|Adverse Event|0|||
37858940|NCT01169493|69542316|FG001|Period 3 (6 Months)|Adverse Event|1|||
37858941|NCT01169493|69542317|FG002|Period 3 (6 Months)|Adverse Event|0|||
37758364|NCT02677116|69267458|FG006|Overall Study|Physician Decision|1|||
37758365|NCT02677116|69267459|FG007|Overall Study|Physician Decision|1|||
37858942|NCT01169493|69542318|FG003|Period 3 (6 Months)|Adverse Event|0|||
37858943|NCT01169493|69542319|FG004|Period 3 (6 Months)|Adverse Event|0|||
37858944|NCT01169493|69542320|FG005|Period 3 (6 Months)|Adverse Event|0|||
37758366|NCT02677116|69267460|FG008|Overall Study|Physician Decision|2|||
37758367|NCT02677116|69267452|FG000|Overall Study|Withdrawal by parent or guardian|2|||
37858945|NCT01169493|69542315|FG000|Period 3 (6 Months)|Physician Decision|0|||
37858946|NCT01169493|69542316|FG001|Period 3 (6 Months)|Physician Decision|1|||
37858947|NCT01169493|69542317|FG002|Period 3 (6 Months)|Physician Decision|1|||
37858948|NCT01169493|69542318|FG003|Period 3 (6 Months)|Physician Decision|0|||
37858949|NCT01169493|69542319|FG004|Period 3 (6 Months)|Physician Decision|0|||
37858950|NCT01169493|69542320|FG005|Period 3 (6 Months)|Physician Decision|0|||
37858951|NCT01287104|69542332|FG000|Overall Study|Patient developed progressive disease|1|||
37858952|NCT01287104|69542333|FG001|Overall Study|Patient developed progressive disease|1|||
37858953|NCT01287104|69542334|FG002|Overall Study|Patient developed progressive disease|3|||
37858954|NCT01287104|69542335|FG003|Overall Study|Patient developed progressive disease|2|||
37858955|NCT01287104|69542332|FG000|Overall Study|Donor anaphylaxis|0|||
37858956|NCT01287104|69542333|FG001|Overall Study|Donor anaphylaxis|1|||
37858957|NCT01287104|69542334|FG002|Overall Study|Donor anaphylaxis|0|||
37858958|NCT01287104|69542335|FG003|Overall Study|Donor anaphylaxis|1|||
37858959|NCT01287104|69542332|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
37858960|NCT01287104|69542333|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
37858961|NCT01287104|69542334|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
37858962|NCT01287104|69542335|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
37858963|NCT01287104|69542332|FG000|Overall Study|Low donor chimerism|0|||
37858964|NCT01287104|69542333|FG001|Overall Study|Low donor chimerism|1|||
37858965|NCT01287104|69542334|FG002|Overall Study|Low donor chimerism|0|||
37858966|NCT01287104|69542335|FG003|Overall Study|Low donor chimerism|0|||
37858967|NCT01287104|69542332|FG000|Overall Study|NK cells did not meet release criteria|0|||
37858968|NCT01287104|69542333|FG001|Overall Study|NK cells did not meet release criteria|1|||
37923470|NCT00824408|69610265|FG003|Run-in Phase|Other reason not defined above|0|||
37666358|NCT00700427|69138813|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
37666359|NCT00700427|69138814|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
37666360|NCT00700427|69138815|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
37666361|NCT00700427|69138816|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
37666362|NCT00700427|69138817|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
37666363|NCT00700427|69138813|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
37666364|NCT00700427|69138814|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
37666365|NCT00700427|69138815|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
37666366|NCT00700427|69138816|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
37666367|NCT00700427|69138817|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
37758368|NCT02677116|69267453|FG001|Overall Study|Withdrawal by parent or guardian|1|||
37758369|NCT02677116|69267454|FG002|Overall Study|Withdrawal by parent or guardian|0|||
37758370|NCT02677116|69267455|FG003|Overall Study|Withdrawal by parent or guardian|1|||
37758371|NCT02677116|69267456|FG004|Overall Study|Withdrawal by parent or guardian|0|||
37758372|NCT02677116|69267457|FG005|Overall Study|Withdrawal by parent or guardian|0|||
37758373|NCT02677116|69267458|FG006|Overall Study|Withdrawal by parent or guardian|2|||
37758374|NCT02677116|69267459|FG007|Overall Study|Withdrawal by parent or guardian|1|||
37758375|NCT02677116|69267460|FG008|Overall Study|Withdrawal by parent or guardian|0|||
37858969|NCT01287104|69542334|FG002|Overall Study|NK cells did not meet release criteria|0|||
37858970|NCT01287104|69542335|FG003|Overall Study|NK cells did not meet release criteria|0|||
37858971|NCT01286558|69542354|FG000|Overall Study|Adverse Event|1|||
37858972|NCT01286558|69542355|FG001|Overall Study|Adverse Event|1|||
37858973|NCT01286558|69542354|FG000|Overall Study|Withdrawal by Subject|0|||
37858974|NCT01286558|69542355|FG001|Overall Study|Withdrawal by Subject|1|||
37858975|NCT01169103|69542363|FG000|Overall Study|Lost to Follow-up|3|||
37858976|NCT01169103|69542364|FG001|Overall Study|Lost to Follow-up|3|||
37858977|NCT01169103|69542363|FG000|Overall Study|Withdrawal by Subject|3|||
37858978|NCT01169103|69542364|FG001|Overall Study|Withdrawal by Subject|1|||
37666368|NCT00700427|69138813|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
37858979|NCT01286480|69542372|FG000|Overall Study|Withdrawal by Subject|5|||
37858980|NCT01286480|69542373|FG001|Overall Study|Withdrawal by Subject|3|||
37858981|NCT01286168|69542379|FG000|Overall Study|Withdrawal by Subject|1|||
37858982|NCT01286168|69542379|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
37858983|NCT01286012|69542386|FG000|Overall Study|Adverse Event|3|||
37858984|NCT01286012|69542387|FG001|Overall Study|Adverse Event|3|||
37858985|NCT01286012|69542386|FG000|Overall Study|Death|2|||
37858986|NCT01286012|69542387|FG001|Overall Study|Death|3|||
37858987|NCT01286012|69542386|FG000|Overall Study|Protocol Violation|1|||
37858988|NCT01286012|69542387|FG001|Overall Study|Protocol Violation|1|||
37858989|NCT01286012|69542386|FG000|Overall Study|Withdrawal by Subject|4|||
37858990|NCT01286012|69542387|FG001|Overall Study|Withdrawal by Subject|4|||
37858991|NCT01286012|69542386|FG000|Overall Study|Physician Decision|2|||
37858992|NCT01286012|69542387|FG001|Overall Study|Physician Decision|0|||
37858993|NCT01286012|69542386|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
37858994|NCT01286012|69542387|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
37858995|NCT00963547|69542398|FG000|Overall Study|Adverse Event|0|||
37858996|NCT00963547|69542399|FG001|Overall Study|Adverse Event|1|||
37858997|NCT00963547|69542400|FG002|Overall Study|Adverse Event|0|||
37858998|NCT00963547|69542401|FG003|Overall Study|Adverse Event|1|||
37858999|NCT00963547|69542402|FG004|Overall Study|Adverse Event|0|||
37859000|NCT00963547|69542403|FG005|Overall Study|Adverse Event|0|||
37859001|NCT00963547|69542404|FG006|Overall Study|Adverse Event|0|||
37859002|NCT00963547|69542398|FG000|Overall Study|Physician Decision|1|||
37859003|NCT00963547|69542399|FG001|Overall Study|Physician Decision|1|||
37859004|NCT00963547|69542400|FG002|Overall Study|Physician Decision|0|||
37859005|NCT00963547|69542401|FG003|Overall Study|Physician Decision|0|||
37859006|NCT00963547|69542402|FG004|Overall Study|Physician Decision|0|||
37859007|NCT00963547|69542403|FG005|Overall Study|Physician Decision|0|||
37859008|NCT00963547|69542404|FG006|Overall Study|Physician Decision|0|||
37859009|NCT00963547|69542398|FG000|Overall Study|Progressive Disease|3|||
37859010|NCT00963547|69542399|FG001|Overall Study|Progressive Disease|8|||
37859011|NCT00963547|69542400|FG002|Overall Study|Progressive Disease|9|||
37859012|NCT00963547|69542401|FG003|Overall Study|Progressive Disease|5|||
37859013|NCT00963547|69542402|FG004|Overall Study|Progressive Disease|0|||
37859014|NCT00963547|69542403|FG005|Overall Study|Progressive Disease|0|||
37859015|NCT00963547|69542404|FG006|Overall Study|Progressive Disease|0|||
37859016|NCT00963547|69542398|FG000|Overall Study|Withdrawal by Subject|0|||
37859017|NCT00963547|69542399|FG001|Overall Study|Withdrawal by Subject|0|||
37859018|NCT00963547|69542400|FG002|Overall Study|Withdrawal by Subject|3|||
37859019|NCT00963547|69542401|FG003|Overall Study|Withdrawal by Subject|0|||
37859020|NCT00963547|69542402|FG004|Overall Study|Withdrawal by Subject|0|||
37859021|NCT00963547|69542403|FG005|Overall Study|Withdrawal by Subject|0|||
37859022|NCT00963547|69542404|FG006|Overall Study|Withdrawal by Subject|0|||
37859023|NCT00963547|69542398|FG000|Overall Study|Reason Unknown|0|||
37859024|NCT00963547|69542399|FG001|Overall Study|Reason Unknown|1|||
37859025|NCT00963547|69542400|FG002|Overall Study|Reason Unknown|0|||
37859026|NCT00963547|69542401|FG003|Overall Study|Reason Unknown|0|||
37859027|NCT00963547|69542402|FG004|Overall Study|Reason Unknown|0|||
37859028|NCT00963547|69542403|FG005|Overall Study|Reason Unknown|0|||
37859029|NCT00963547|69542404|FG006|Overall Study|Reason Unknown|0|||
37859030|NCT01285310|69542420|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
37859031|NCT01285310|69542421|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
37859032|NCT01285310|69542422|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
37859033|NCT01285310|69542423|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
37859034|NCT01285310|69542424|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
37859035|NCT01285310|69542420|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
37859036|NCT01285310|69542421|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
37859037|NCT01285310|69542422|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
37859038|NCT01285310|69542423|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
37859039|NCT01285310|69542424|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
37859040|NCT01285310|69542420|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
37859041|NCT01285310|69542421|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
37859042|NCT01285310|69542422|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
37859043|NCT01285310|69542423|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
37859044|NCT01285310|69542424|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
37859045|NCT01285310|69542420|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
37859046|NCT01285310|69542421|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
37859047|NCT01285310|69542422|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
37859048|NCT01285310|69542423|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
37859049|NCT01285310|69542424|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
37859050|NCT01285310|69542420|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
37859051|NCT01285310|69542421|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
37859052|NCT01285310|69542422|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
37859053|NCT01285310|69542423|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
37859054|NCT01285310|69542424|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
37859055|NCT01285310|69542420|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
37859056|NCT01285310|69542421|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
37859057|NCT01285310|69542422|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
37666369|NCT00700427|69138814|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
37666370|NCT00700427|69138815|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
37666371|NCT00700427|69138816|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
37666372|NCT00700427|69138817|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
37666373|NCT00700427|69138813|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
37758376|NCT02677116|69267452|FG000|Overall Study|Withdrawal by Subject|1|||
37758377|NCT02677116|69267453|FG001|Overall Study|Withdrawal by Subject|0|||
37758378|NCT02677116|69267454|FG002|Overall Study|Withdrawal by Subject|0|||
37758379|NCT02677116|69267455|FG003|Overall Study|Withdrawal by Subject|0|||
37758380|NCT02677116|69267456|FG004|Overall Study|Withdrawal by Subject|0|||
37758381|NCT02677116|69267457|FG005|Overall Study|Withdrawal by Subject|0|||
37758382|NCT02677116|69267458|FG006|Overall Study|Withdrawal by Subject|0|||
37758383|NCT02677116|69267459|FG007|Overall Study|Withdrawal by Subject|0|||
37758384|NCT02677116|69267460|FG008|Overall Study|Withdrawal by Subject|0|||
37758385|NCT02689518|69267503|FG000|Overall Study|Withdrawal by Subject|3|||
37923471|NCT00824408|69610266|FG004|Run-in Phase|Other reason not defined above|0|||
37758386|NCT02681094|69267510|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
37758387|NCT02681094|69267511|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
37758388|NCT02681094|69267512|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
37758389|NCT02681094|69267510|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
37758390|NCT02681094|69267511|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
37758391|NCT02681094|69267512|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
37758392|NCT02681094|69267510|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
37758393|NCT02681094|69267511|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
37758394|NCT02681094|69267512|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
37758395|NCT02681094|69267510|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
37758396|NCT02681094|69267511|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
37758397|NCT02681094|69267512|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
37758398|NCT02681094|69267510|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
37758399|NCT02681094|69267511|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
37758400|NCT02681094|69267512|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
37758401|NCT02681094|69267510|FG000|1 -Modified Enrolled Participants Set|Other|6|||
37758402|NCT02681094|69267511|FG001|1 -Modified Enrolled Participants Set|Other|6|||
37758403|NCT02681094|69267512|FG002|1 -Modified Enrolled Participants Set|Other|7|||
37758404|NCT02681094|69267510|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
37758405|NCT02681094|69267511|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
37758406|NCT02681094|69267512|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
37758407|NCT02681094|69267510|FG000|2 - Enrolled Participants Set|Participant decision|7|||
37758408|NCT02681094|69267511|FG001|2 - Enrolled Participants Set|Participant decision|10|||
37758409|NCT02681094|69267512|FG002|2 - Enrolled Participants Set|Participant decision|9|||
37758410|NCT02681094|69267510|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
37758411|NCT02681094|69267511|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
37758412|NCT02681094|69267512|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
37758413|NCT02681094|69267510|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
37758414|NCT02681094|69267511|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
37758415|NCT02681094|69267512|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
37758416|NCT02681094|69267510|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
37758417|NCT02681094|69267511|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
37758418|NCT02681094|69267512|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
37859058|NCT01285310|69542423|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
37666374|NCT00700427|69138814|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
37666375|NCT00700427|69138815|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
37666376|NCT00700427|69138816|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
37666377|NCT00700427|69138817|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
37758419|NCT02681094|69267510|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
37758420|NCT02681094|69267511|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
37758421|NCT02681094|69267512|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
37758422|NCT02681094|69267510|FG000|2 - Enrolled Participants Set|Other|6|||
37758423|NCT02681094|69267511|FG001|2 - Enrolled Participants Set|Other|6|||
37859059|NCT01285310|69542424|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
37666378|NCT00700427|69138813|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
37666379|NCT00700427|69138814|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
37666380|NCT00700427|69138815|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
37666381|NCT00700427|69138816|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
37859060|NCT01285310|69542420|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
37859061|NCT01285310|69542421|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
37859062|NCT01285310|69542422|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
37859063|NCT01285310|69542423|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
37859064|NCT01285310|69542424|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
37859065|NCT01285310|69542420|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
37859066|NCT01285310|69542421|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
37859067|NCT01285310|69542422|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
37859068|NCT01285310|69542423|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
37859069|NCT01285310|69542424|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
37859070|NCT01285310|69542420|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
37859071|NCT01285310|69542421|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
37859072|NCT01285310|69542422|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
37859073|NCT01285310|69542423|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
37859074|NCT01285310|69542424|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
37859075|NCT01285310|69542420|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
37859076|NCT01285310|69542421|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
37859077|NCT01285310|69542422|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
37859078|NCT01285310|69542423|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
37859079|NCT01285310|69542424|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
37859080|NCT01285310|69542420|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
37859081|NCT01285310|69542421|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
37859082|NCT01285310|69542422|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
37859083|NCT01285310|69542423|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
37859084|NCT01285310|69542424|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
37859085|NCT01285310|69542420|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
37859086|NCT01285310|69542421|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
37859087|NCT01285310|69542422|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
37859088|NCT01285310|69542423|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
37859089|NCT01285310|69542424|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
37859090|NCT01254630|69542466|FG000|Overall Study|Adverse Event|36|||
37859091|NCT01254630|69542467|FG001|Overall Study|Adverse Event|15|||
37859092|NCT01254630|69542468|FG002|Overall Study|Adverse Event|40|||
37859093|NCT01254630|69542469|FG003|Overall Study|Adverse Event|8|||
37859094|NCT01254630|69542466|FG000|Overall Study|Death|461|||
37859095|NCT01254630|69542467|FG001|Overall Study|Death|151|||
37859096|NCT01254630|69542468|FG002|Overall Study|Death|478|||
37859097|NCT01254630|69542469|FG003|Overall Study|Death|139|||
37859098|NCT01254630|69542466|FG000|Overall Study|Lost to Follow-up|80|||
37859099|NCT01254630|69542467|FG001|Overall Study|Lost to Follow-up|26|||
37859100|NCT01254630|69542468|FG002|Overall Study|Lost to Follow-up|89|||
37859101|NCT01254630|69542469|FG003|Overall Study|Lost to Follow-up|32|||
37859102|NCT01254630|69542466|FG000|Overall Study|Physician Decision|24|||
37859103|NCT01254630|69542467|FG001|Overall Study|Physician Decision|8|||
37859104|NCT01254630|69542468|FG002|Overall Study|Physician Decision|16|||
37859105|NCT01254630|69542469|FG003|Overall Study|Physician Decision|7|||
37859106|NCT01254630|69542466|FG000|Overall Study|Withdrawal by Subject|201|||
37859107|NCT01254630|69542467|FG001|Overall Study|Withdrawal by Subject|94|||
37859108|NCT01254630|69542468|FG002|Overall Study|Withdrawal by Subject|188|||
37859109|NCT01254630|69542469|FG003|Overall Study|Withdrawal by Subject|89|||
37859110|NCT01254630|69542466|FG000|Overall Study|Study terminated by sponsor|0|||
37859111|NCT01254630|69542467|FG001|Overall Study|Study terminated by sponsor|994|||
37859112|NCT01254630|69542468|FG002|Overall Study|Study terminated by sponsor|0|||
37859113|NCT01254630|69542469|FG003|Overall Study|Study terminated by sponsor|1010|||
37859114|NCT01254630|69542466|FG000|Overall Study|Status not recorded|0|||
37859115|NCT01254630|69542467|FG001|Overall Study|Status not recorded|0|||
37859116|NCT01254630|69542468|FG002|Overall Study|Status not recorded|1|||
37666382|NCT00700427|69138817|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
37666383|NCT00700427|69138813|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
37859117|NCT01254630|69542469|FG003|Overall Study|Status not recorded|0|||
37859118|NCT01284140|69542479|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
37859119|NCT01284140|69542480|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
37758424|NCT02681094|69267512|FG002|2 - Enrolled Participants Set|Other|7|||
37859120|NCT01284140|69542479|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
37859121|NCT01284140|69542480|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
37923472|NCT00824408|69610262|FG000|Randomized Phase|Not treated|0|||
37666384|NCT00700427|69138814|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
37859122|NCT01254318|69542486|FG000|Overall Study|Lost to Follow-up|5|||
37923473|NCT00824408|69610263|FG001|Randomized Phase|Not treated|0|||
37859123|NCT01254318|69542486|FG000|Overall Study|Death|47|||
37859124|NCT01284062|69542494|FG000|Overall Study|Adverse Event|4|||
37859125|NCT01284062|69542495|FG001|Overall Study|Adverse Event|5|||
37859126|NCT01284062|69542496|FG002|Overall Study|Adverse Event|0|||
37859127|NCT01284062|69542497|FG003|Overall Study|Adverse Event|5|||
37859128|NCT01284062|69542494|FG000|Overall Study|Lack of Efficacy|3|||
37859129|NCT01284062|69542495|FG001|Overall Study|Lack of Efficacy|2|||
37859130|NCT01284062|69542496|FG002|Overall Study|Lack of Efficacy|2|||
37859131|NCT01284062|69542497|FG003|Overall Study|Lack of Efficacy|1|||
37859132|NCT01284062|69542494|FG000|Overall Study|Medication error without adverse event|0|||
37859133|NCT01284062|69542495|FG001|Overall Study|Medication error without adverse event|0|||
37859134|NCT01284062|69542496|FG002|Overall Study|Medication error without adverse event|1|||
37859135|NCT01284062|69542497|FG003|Overall Study|Medication error without adverse event|0|||
37859136|NCT01284062|69542494|FG000|Overall Study|Protocol Violation|1|||
37859137|NCT01284062|69542495|FG001|Overall Study|Protocol Violation|0|||
37859138|NCT01284062|69542496|FG002|Overall Study|Protocol Violation|0|||
37859139|NCT01284062|69542497|FG003|Overall Study|Protocol Violation|2|||
37859140|NCT01284062|69542494|FG000|Overall Study|Withdrawal by Subject|3|||
37859141|NCT01284062|69542495|FG001|Overall Study|Withdrawal by Subject|1|||
37859142|NCT01284062|69542496|FG002|Overall Study|Withdrawal by Subject|2|||
37859143|NCT01284062|69542497|FG003|Overall Study|Withdrawal by Subject|5|||
37859144|NCT01284062|69542494|FG000|Overall Study|Other|0|||
37923474|NCT00824408|69610264|FG002|Randomized Phase|Not treated|1|||
37923475|NCT00824408|69610265|FG003|Randomized Phase|Not treated|1|||
37859145|NCT01284062|69542495|FG001|Overall Study|Other|0|||
37859146|NCT01284062|69542496|FG002|Overall Study|Other|0|||
37859147|NCT01284062|69542497|FG003|Overall Study|Other|1|||
37859148|NCT01284062|69542494|FG000|Overall Study|Site Closed|0|||
37859149|NCT01284062|69542495|FG001|Overall Study|Site Closed|0|||
37859150|NCT01284062|69542496|FG002|Overall Study|Site Closed|1|||
37859151|NCT01284062|69542497|FG003|Overall Study|Site Closed|0|||
37859152|NCT01253304|69542514|FG000|Overall Study|Adverse Event|0|||
37859153|NCT01253304|69542515|FG001|Overall Study|Adverse Event|0|||
37859154|NCT01253304|69542516|FG002|Overall Study|Adverse Event|0|||
37859155|NCT01253304|69542517|FG003|Overall Study|Adverse Event|1|||
37859156|NCT01253226|69542532|FG000|Overall Study|Adverse Event|0|||
37859157|NCT01253226|69542533|FG001|Overall Study|Adverse Event|0|||
37859158|NCT01253226|69542534|FG002|Overall Study|Adverse Event|1|||
37859159|NCT01253226|69542535|FG003|Overall Study|Adverse Event|0|||
37859160|NCT01253226|69542536|FG004|Overall Study|Adverse Event|0|||
37859161|NCT01253226|69542532|FG000|Overall Study|Death|0|||
37859162|NCT01253226|69542533|FG001|Overall Study|Death|1|||
37859163|NCT01253226|69542534|FG002|Overall Study|Death|0|||
37859164|NCT01253226|69542535|FG003|Overall Study|Death|0|||
37859165|NCT01253226|69542536|FG004|Overall Study|Death|0|||
37859166|NCT01253226|69542532|FG000|Overall Study|Physician Decision|0|||
37859167|NCT01253226|69542533|FG001|Overall Study|Physician Decision|0|||
37859168|NCT01253226|69542534|FG002|Overall Study|Physician Decision|0|||
37859169|NCT01253226|69542535|FG003|Overall Study|Physician Decision|0|||
37859170|NCT01253226|69542536|FG004|Overall Study|Physician Decision|2|||
37859171|NCT01253226|69542532|FG000|Overall Study|Withdrawal by Subject|0|||
37859172|NCT01253226|69542533|FG001|Overall Study|Withdrawal by Subject|0|||
37859173|NCT01253226|69542534|FG002|Overall Study|Withdrawal by Subject|0|||
37859174|NCT01253226|69542535|FG003|Overall Study|Withdrawal by Subject|1|||
37859175|NCT01253226|69542536|FG004|Overall Study|Withdrawal by Subject|0|||
37859176|NCT01252290|69542548|FG000|Overall Study|Withdrawal by Subject|1|||
37859177|NCT01252134|69542552|FG000|Period 1, 8 Hours|Personal Reasons|0|||
37859178|NCT01252134|69542553|FG001|Period 1, 8 Hours|Personal Reasons|1|||
37859179|NCT01252134|69542554|FG002|Period 1, 8 Hours|Personal Reasons|1|||
37923476|NCT00824408|69610266|FG004|Randomized Phase|Not treated|1|||
37923477|NCT00824408|69610262|FG000|Randomized Phase|Progressive disease|0|||
37923478|NCT00824408|69610263|FG001|Randomized Phase|Progressive disease|0|||
37859180|NCT01252134|69542555|FG003|Period 1, 8 Hours|Personal Reasons|0|||
37859181|NCT01252134|69542556|FG004|Period 1, 8 Hours|Personal Reasons|0|||
37859182|NCT01252134|69542557|FG005|Period 1, 8 Hours|Personal Reasons|0|||
37859183|NCT01251744|69542567|FG000|Overall Study|Lost to Follow-up|1|||
37859184|NCT01251744|69542568|FG001|Overall Study|Lost to Follow-up|0|||
37859185|NCT01251354|69542581|FG000|Overall Study|Adverse Event|1|||
37859186|NCT01251354|69542581|FG000|Overall Study|Investigator's Decision|1|||
37859187|NCT01251354|69542581|FG000|Overall Study|Disease Progression|4|||
37859188|NCT01251276|69542587|FG000|Overall Study|Protocol Violation|1|||
37859189|NCT01251276|69542588|FG001|Overall Study|Protocol Violation|0|||
37859190|NCT01251276|69542587|FG000|Overall Study|Lost to Follow-up|0|||
37859191|NCT01251276|69542588|FG001|Overall Study|Lost to Follow-up|1|||
37859192|NCT01251120|69542596|FG000|Overall Study|Lack of Efficacy|0|||
37859193|NCT01251120|69542597|FG001|Overall Study|Lack of Efficacy|1|||
37859194|NCT01250418|69542605|FG000|Overall Study|monitor data failure|1|||
37859195|NCT01250418|69542606|FG001|Overall Study|monitor data failure|1|||
37859196|NCT01292603|69542617|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
37859197|NCT01292603|69542618|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
37859198|NCT01292603|69542619|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
37859199|NCT01292603|69542620|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
37859200|NCT01292603|69542621|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
37859201|NCT01292603|69542622|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
37859202|NCT01292603|69542617|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
37859203|NCT01292603|69542618|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
37859204|NCT01292603|69542619|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
37859205|NCT01292603|69542620|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
37859206|NCT01292603|69542621|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
37859207|NCT01292603|69542622|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
37859208|NCT01292603|69542617|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
37859209|NCT01292603|69542618|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
37859210|NCT01292603|69542619|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
37859211|NCT01292603|69542620|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
37859212|NCT01292603|69542621|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
37859213|NCT01292603|69542622|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
37859214|NCT01292603|69542617|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
37859215|NCT01292603|69542618|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
37859216|NCT01292603|69542619|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
37859217|NCT01292603|69542620|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
37859218|NCT01292603|69542621|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
37859219|NCT01292603|69542622|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
37859220|NCT01292603|69542617|FG000|Part 1: Regular Follow-Up Period|Death|3|||
37859221|NCT01292603|69542618|FG001|Part 1: Regular Follow-Up Period|Death|1|||
37859222|NCT01292603|69542619|FG002|Part 1: Regular Follow-Up Period|Death|3|||
37859223|NCT01292603|69542620|FG003|Part 1: Regular Follow-Up Period|Death|1|||
37859224|NCT01292603|69542621|FG004|Part 1: Regular Follow-Up Period|Death|0|||
37859225|NCT01292603|69542622|FG005|Part 1: Regular Follow-Up Period|Death|0|||
37859226|NCT01292603|69542617|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
37859227|NCT01292603|69542618|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
37859228|NCT01292603|69542619|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
37859229|NCT01292603|69542620|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
37859230|NCT01292603|69542621|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
37859231|NCT01292603|69542622|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
37859232|NCT01292603|69542617|FG000|Part 2: Dose Confirmation Period|Death|0|||
37859233|NCT01292603|69542618|FG001|Part 2: Dose Confirmation Period|Death|0|||
37859234|NCT01292603|69542619|FG002|Part 2: Dose Confirmation Period|Death|0|||
37859235|NCT01292603|69542620|FG003|Part 2: Dose Confirmation Period|Death|0|||
37859236|NCT01292603|69542621|FG004|Part 2: Dose Confirmation Period|Death|1|||
37758425|NCT02681094|69267510|FG000|2 - Enrolled Participants Set|No treatment given|0|||
37758426|NCT02681094|69267511|FG001|2 - Enrolled Participants Set|No treatment given|1|||
37758427|NCT02681094|69267512|FG002|2 - Enrolled Participants Set|No treatment given|1|||
37758428|NCT02689284|69267523|FG000|Overall Study|Adverse Event|1|||
37758429|NCT02689284|69267524|FG001|Overall Study|Adverse Event|8|||
37758430|NCT02689284|69267523|FG000|Overall Study|Death|0|||
37758431|NCT02689284|69267524|FG001|Overall Study|Death|1|||
37758432|NCT02689284|69267523|FG000|Overall Study|Physician Decision|1|||
37758433|NCT02689284|69267524|FG001|Overall Study|Physician Decision|2|||
37758434|NCT02689284|69267523|FG000|Overall Study|Withdrawal by Subject|0|||
37758435|NCT02689284|69267524|FG001|Overall Study|Withdrawal by Subject|1|||
37758436|NCT02689284|69267523|FG000|Overall Study|progression of cancer|1|||
37758437|NCT02689284|69267524|FG001|Overall Study|progression of cancer|72|||
37758438|NCT02689284|69267523|FG000|Overall Study|decreased heart function|0|||
37758439|NCT02689284|69267524|FG001|Overall Study|decreased heart function|1|||
37758440|NCT02689284|69267523|FG000|Overall Study|concern for anemia|0|||
37758441|NCT02689284|69267524|FG001|Overall Study|concern for anemia|1|||
37758442|NCT02689284|69267523|FG000|Overall Study|no measurable cancer for evaluation|0|||
37758443|NCT02689284|69267524|FG001|Overall Study|no measurable cancer for evaluation|1|||
37758444|NCT02676882|69267533|FG000|Overall Study|Adverse Event|1|||
37758445|NCT02676882|69267534|FG001|Overall Study|Adverse Event|0|||
37758446|NCT02676882|69267533|FG000|Overall Study|Lost to Follow-up|1|||
37859237|NCT01292603|69542622|FG005|Part 2: Dose Confirmation Period|Death|0|||
37923479|NCT00824408|69610264|FG002|Randomized Phase|Progressive disease|25|||
37923480|NCT00824408|69610265|FG003|Randomized Phase|Progressive disease|36|||
37923481|NCT00824408|69610266|FG004|Randomized Phase|Progressive disease|34|||
37923482|NCT00824408|69610262|FG000|Randomized Phase|Adverse Event|0|||
37758447|NCT02676882|69267534|FG001|Overall Study|Lost to Follow-up|0|||
37758448|NCT02676882|69267533|FG000|Overall Study|Withdrawal by Subject|1|||
37758449|NCT02676882|69267534|FG001|Overall Study|Withdrawal by Subject|2|||
37758450|NCT02674386|69267543|FG000|Overall Study|Lost to Follow-up|0|||
37758451|NCT02674386|69267544|FG001|Overall Study|Lost to Follow-up|1|||
37758452|NCT02674386|69267545|FG002|Overall Study|Lost to Follow-up|1|||
37758453|NCT02674386|69267543|FG000|Overall Study|Withdrawal by Subject|0|||
37758454|NCT02674386|69267544|FG001|Overall Study|Withdrawal by Subject|4|||
37758455|NCT02674386|69267545|FG002|Overall Study|Withdrawal by Subject|0|||
37758456|NCT02674386|69267543|FG000|Overall Study|Other|0|||
37758457|NCT02674386|69267544|FG001|Overall Study|Other|1|||
37758458|NCT02674386|69267545|FG002|Overall Study|Other|0|||
37758459|NCT02674386|69267543|FG000|Overall Study|Enrolled but not evaluated|0|||
37758460|NCT02674386|69267544|FG001|Overall Study|Enrolled but not evaluated|4|||
37758461|NCT02674386|69267545|FG002|Overall Study|Enrolled but not evaluated|0|||
37758462|NCT02680002|69267564|FG000|Overall Study|Lost to Follow-up|5|||
37758463|NCT02680002|69267565|FG001|Overall Study|Lost to Follow-up|1|||
37758464|NCT02680002|69267566|FG002|Overall Study|Lost to Follow-up|4|||
37758465|NCT02680002|69267567|FG003|Overall Study|Lost to Follow-up|2|||
37758466|NCT02680002|69267568|FG004|Overall Study|Lost to Follow-up|0|||
37758467|NCT02680002|69267569|FG005|Overall Study|Lost to Follow-up|2|||
37758468|NCT02680002|69267564|FG000|Overall Study|Physician Decision|5|||
37758469|NCT02680002|69267565|FG001|Overall Study|Physician Decision|1|||
37758470|NCT02680002|69267566|FG002|Overall Study|Physician Decision|1|||
37758471|NCT02680002|69267567|FG003|Overall Study|Physician Decision|1|||
37758472|NCT02680002|69267568|FG004|Overall Study|Physician Decision|1|||
37758473|NCT02680002|69267569|FG005|Overall Study|Physician Decision|1|||
37758474|NCT02680002|69267564|FG000|Overall Study|Protocol Violation|1|||
37758475|NCT02680002|69267565|FG001|Overall Study|Protocol Violation|0|||
37758476|NCT02680002|69267566|FG002|Overall Study|Protocol Violation|1|||
37758477|NCT02680002|69267567|FG003|Overall Study|Protocol Violation|0|||
37758478|NCT02680002|69267568|FG004|Overall Study|Protocol Violation|1|||
37758479|NCT02680002|69267569|FG005|Overall Study|Protocol Violation|2|||
37758480|NCT02680002|69267564|FG000|Overall Study|Withdrawal by Subject|0|||
37758481|NCT02680002|69267565|FG001|Overall Study|Withdrawal by Subject|0|||
37758482|NCT02680002|69267566|FG002|Overall Study|Withdrawal by Subject|1|||
37758483|NCT02680002|69267567|FG003|Overall Study|Withdrawal by Subject|0|||
37758484|NCT02680002|69267568|FG004|Overall Study|Withdrawal by Subject|2|||
37758485|NCT02680002|69267569|FG005|Overall Study|Withdrawal by Subject|2|||
37758486|NCT02680002|69267564|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
37758487|NCT02680002|69267565|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
37758488|NCT02680002|69267566|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
37758489|NCT02680002|69267567|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
37758490|NCT02680002|69267568|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
37758491|NCT02680002|69267569|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
37758492|NCT02680002|69267564|FG000|Overall Study|Other|0|||
37758493|NCT02680002|69267565|FG001|Overall Study|Other|1|||
37758494|NCT02680002|69267566|FG002|Overall Study|Other|0|||
37758495|NCT02680002|69267567|FG003|Overall Study|Other|0|||
37758496|NCT02680002|69267568|FG004|Overall Study|Other|1|||
37758497|NCT02680002|69267569|FG005|Overall Study|Other|0|||
37758498|NCT02680002|69267564|FG000|Overall Study|Adverse Event|0|||
37758499|NCT02680002|69267565|FG001|Overall Study|Adverse Event|0|||
37758500|NCT02680002|69267566|FG002|Overall Study|Adverse Event|0|||
37923483|NCT00824408|69610263|FG001|Randomized Phase|Adverse Event|0|||
37923484|NCT00824408|69610264|FG002|Randomized Phase|Adverse Event|4|||
37923485|NCT00824408|69610265|FG003|Randomized Phase|Adverse Event|5|||
37923486|NCT00824408|69610266|FG004|Randomized Phase|Adverse Event|5|||
37923487|NCT00824408|69610262|FG000|Randomized Phase|Refused to continue medication|0|||
37923488|NCT00824408|69610263|FG001|Randomized Phase|Refused to continue medication|0|||
37923489|NCT00824408|69610264|FG002|Randomized Phase|Refused to continue medication|2|||
37923490|NCT00824408|69610265|FG003|Randomized Phase|Refused to continue medication|2|||
37923491|NCT00824408|69610266|FG004|Randomized Phase|Refused to continue medication|2|||
37923492|NCT00824408|69610262|FG000|Randomized Phase|Other reason not defined above|0|||
37923493|NCT00824408|69610263|FG001|Randomized Phase|Other reason not defined above|0|||
37923494|NCT00824408|69610264|FG002|Randomized Phase|Other reason not defined above|4|||
37923495|NCT00824408|69610265|FG003|Randomized Phase|Other reason not defined above|2|||
37758501|NCT02680002|69267567|FG003|Overall Study|Adverse Event|0|||
37758502|NCT02680002|69267568|FG004|Overall Study|Adverse Event|1|||
37758503|NCT02680002|69267569|FG005|Overall Study|Adverse Event|2|||
37758504|NCT04557384|69267586|FG000|Overall Study|Study Terminated by Sponsor|1|||
37758505|NCT04557384|69267586|FG000|Overall Study|Death|1|||
37758506|NCT02673684|69267592|FG000|Overall Study|Study not completed d/t loss of funding|9|||
37758507|NCT02673684|69267593|FG001|Overall Study|Study not completed d/t loss of funding|8|||
37758508|NCT02675634|69267601|FG000|Test Period 1|Adverse Event|0|||
37758509|NCT02675634|69267602|FG001|Test Period 1|Adverse Event|1|||
37758510|NCT02675634|69267603|FG002|Test Period 1|Adverse Event|0|||
37758511|NCT02675634|69267604|FG003|Test Period 1|Adverse Event|1|||
37758512|NCT02675634|69267605|FG004|Test Period 1|Adverse Event|0|||
37758513|NCT02675634|69267606|FG005|Test Period 1|Adverse Event|0|||
37758514|NCT02675634|69267601|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
37758515|NCT02675634|69267602|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
37758516|NCT02675634|69267603|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
37758517|NCT02675634|69267604|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
37758518|NCT02675634|69267605|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
37758519|NCT02675634|69267606|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
37758520|NCT02675634|69267601|FG000|Test Period 2|Lack of Efficacy|1|||
37758521|NCT02675634|69267602|FG001|Test Period 2|Lack of Efficacy|0|||
37758522|NCT02675634|69267603|FG002|Test Period 2|Lack of Efficacy|0|||
37758523|NCT02675634|69267604|FG003|Test Period 2|Lack of Efficacy|0|||
37758524|NCT02675634|69267605|FG004|Test Period 2|Lack of Efficacy|0|||
37758525|NCT02675634|69267606|FG005|Test Period 2|Lack of Efficacy|0|||
37758526|NCT02675634|69267601|FG000|Test Period 2|Adverse Event|0|||
37758527|NCT02675634|69267602|FG001|Test Period 2|Adverse Event|0|||
37758528|NCT02675634|69267603|FG002|Test Period 2|Adverse Event|0|||
37758529|NCT02675634|69267604|FG003|Test Period 2|Adverse Event|0|||
37758530|NCT02675634|69267605|FG004|Test Period 2|Adverse Event|0|||
37758531|NCT02675634|69267606|FG005|Test Period 2|Adverse Event|1|||
37758532|NCT02671500|69267614|FG000|Overall Study|Lack of Efficacy|12|||
37758533|NCT02671500|69267614|FG000|Overall Study|Lost to Follow-up|2|||
37758534|NCT02671422|69267622|FG000|Overall Study|Lost to Follow-up|1|||
37758535|NCT02671422|69267622|FG000|Overall Study|Adverse Event|68|||
37758536|NCT02671422|69267622|FG000|Overall Study|Lack of Efficacy|1|||
37758537|NCT02671422|69267622|FG000|Overall Study|Lost to Follow-up|4|||
37758538|NCT02671422|69267622|FG000|Overall Study|Withdrawal by Subject|7|||
37758539|NCT02671422|69267622|FG000|Overall Study|Progressive Disease|156|||
37758540|NCT02671422|69267622|FG000|Overall Study|Worsening of Disease|4|||
37758541|NCT02671422|69267622|FG000|Overall Study|Sponsor decision|5|||
37758542|NCT02671422|69267622|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
37758543|NCT02671422|69267622|FG000|Overall Study|Not treated with Vargatef®|3|||
37758544|NCT02671422|69267622|FG000|Overall Study|Other not defined above|3|||
37758545|NCT02671266|69267628|FG000|Overall Study|Withdrawal by Subject|1|||
37758546|NCT02671266|69267629|FG001|Overall Study|Withdrawal by Subject|1|||
37758547|NCT03320070|69267637|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
37758548|NCT03320070|69267638|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
37758549|NCT03320070|69267637|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
37758550|NCT03320070|69267638|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
37758551|NCT03320070|69267637|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
37758552|NCT03320070|69267638|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
37923496|NCT00824408|69610266|FG004|Randomized Phase|Other reason not defined above|4|||
37923497|NCT00866333|69610287|FG000|Overall Study|Withdrawal of consent|0|||
37923498|NCT00866333|69610288|FG001|Overall Study|Withdrawal of consent|1|||
37923499|NCT00866333|69610289|FG002|Overall Study|Withdrawal of consent|2|||
37923500|NCT00866333|69610287|FG000|Overall Study|Reason not Specified|3|||
37923501|NCT00866333|69610288|FG001|Overall Study|Reason not Specified|1|||
37923502|NCT00866333|69610289|FG002|Overall Study|Reason not Specified|1|||
37923503|NCT00866333|69610287|FG000|Overall Study|Study Terminated by Sponsor|2|||
37923504|NCT00866333|69610288|FG001|Overall Study|Study Terminated by Sponsor|5|||
37923505|NCT00866333|69610289|FG002|Overall Study|Study Terminated by Sponsor|9|||
37923506|NCT00834080|69610297|FG000|Overall Study|Adverse Event|7|||
37923507|NCT00834080|69610297|FG000|Overall Study|Lost to Follow-up|7|||
38043552|NCT03238248|69731701|FG000|Overall Study|N/A participant is still on treatment|1|||
37758553|NCT03320070|69267637|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
37758554|NCT03320070|69267638|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
37758555|NCT03320070|69267637|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
37758556|NCT03320070|69267638|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
37758557|NCT03320070|69267637|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
37758558|NCT03320070|69267638|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
37758559|NCT02667912|69267649|FG000|Overall Study|Death|3|||
37758560|NCT02667912|69267650|FG001|Overall Study|Death|1|||
37758561|NCT02667912|69267649|FG000|Overall Study|Withdrawal by Subject|1|||
37758562|NCT02667912|69267650|FG001|Overall Study|Withdrawal by Subject|2|||
37859238|NCT01292603|69542617|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
37859239|NCT01292603|69542618|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
37859240|NCT01292603|69542619|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
37859241|NCT01292603|69542620|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
37859242|NCT01292603|69542621|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
37859243|NCT01292603|69542622|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
37859244|NCT01292603|69542617|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
37859245|NCT01292603|69542618|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
37859246|NCT01292603|69542619|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
37859247|NCT01292603|69542620|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
37859248|NCT01292603|69542621|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
37859249|NCT01292603|69542622|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
37859250|NCT01292603|69542617|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
37923508|NCT00834080|69610297|FG000|Overall Study|Withdrawal by Subject|5|||
37923509|NCT00834080|69610297|FG000|Overall Study|Other - Pregnancy|1|||
37923510|NCT00834080|69610297|FG000|Overall Study|Other - False positive tests of the UDS|1|||
37923511|NCT00834080|69610297|FG000|Overall Study|Physician Decision|1|||
37923512|NCT00834080|69610297|FG000|Overall Study|Subject Relocated|1|||
37923513|NCT00823472|69610303|FG000|Overall Study|Physician Decision|24|||
37923514|NCT00823472|69610304|FG001|Overall Study|Physician Decision|28|||
37923515|NCT00856193|69610310|FG000|Period 2|Abnormal test procedure results|0|||
37923516|NCT00856193|69610311|FG001|Period 2|Abnormal test procedure results|1|||
37923517|NCT00856193|69610310|FG000|Period 2|Lost to Follow-up|0|||
37923518|NCT00856193|69610311|FG001|Period 2|Lost to Follow-up|1|||
37923519|NCT00652366|69610322|FG000|Overall Study|Adverse Event|8|||
37923520|NCT00652366|69610323|FG001|Overall Study|Adverse Event|4|||
37923521|NCT00652366|69610324|FG002|Overall Study|Adverse Event|7|||
37923522|NCT00652366|69610325|FG003|Overall Study|Adverse Event|17|||
37923523|NCT00652366|69610326|FG004|Overall Study|Adverse Event|13|||
37923524|NCT00652366|69610322|FG000|Overall Study|Death|5|||
37923525|NCT00652366|69610323|FG001|Overall Study|Death|4|||
37923526|NCT00652366|69610324|FG002|Overall Study|Death|1|||
37923527|NCT00652366|69610325|FG003|Overall Study|Death|8|||
37923528|NCT00652366|69610326|FG004|Overall Study|Death|5|||
37923529|NCT00652366|69610322|FG000|Overall Study|Lack of Efficacy|84|||
37923530|NCT00652366|69610323|FG001|Overall Study|Lack of Efficacy|58|||
37923531|NCT00652366|69610324|FG002|Overall Study|Lack of Efficacy|53|||
37923532|NCT00652366|69610325|FG003|Overall Study|Lack of Efficacy|133|||
37923533|NCT00652366|69610326|FG004|Overall Study|Lack of Efficacy|13|||
37923534|NCT00652366|69610322|FG000|Overall Study|Violation of Selection Criteria|0|||
37923535|NCT00652366|69610323|FG001|Overall Study|Violation of Selection Criteria|0|||
37923536|NCT00652366|69610324|FG002|Overall Study|Violation of Selection Criteria|1|||
37923537|NCT00652366|69610325|FG003|Overall Study|Violation of Selection Criteria|0|||
37923538|NCT00652366|69610326|FG004|Overall Study|Violation of Selection Criteria|0|||
37923539|NCT00652366|69610322|FG000|Overall Study|Protocol Violation|1|||
37666385|NCT00700427|69138815|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
37758563|NCT02667912|69267649|FG000|Overall Study|Withdrawal by Subject|1|||
37758564|NCT02667912|69267650|FG001|Overall Study|Withdrawal by Subject|0|||
37758565|NCT01373346|69267656|FG000|Overall Study|Death|1|||
37758566|NCT03284424|69267667|FG000|Overall Study|Death|56|||
37758567|NCT03284424|69267668|FG001|Overall Study|Death|13|||
37758568|NCT03284424|69267667|FG000|Overall Study|Lost to Follow-up|1|||
37758569|NCT03284424|69267668|FG001|Overall Study|Lost to Follow-up|0|||
37758570|NCT03284424|69267667|FG000|Overall Study|Physician Decision|1|||
37758571|NCT03284424|69267668|FG001|Overall Study|Physician Decision|0|||
37758572|NCT03284424|69267667|FG000|Overall Study|Withdrawal by Subject|3|||
37758573|NCT03284424|69267668|FG001|Overall Study|Withdrawal by Subject|2|||
37758574|NCT03284424|69267667|FG000|Overall Study|Ongoing in study|44|||
37758575|NCT03284424|69267668|FG001|Overall Study|Ongoing in study|39|||
37758576|NCT02674854|69267676|FG000|Overall Study|Adverse Event|17|||
37758577|NCT02674854|69267677|FG001|Overall Study|Adverse Event|15|||
37758578|NCT02674854|69267678|FG002|Overall Study|Adverse Event|5|||
37758579|NCT02674854|69267676|FG000|Overall Study|Withdrawal by Subject|1|||
37758580|NCT02674854|69267677|FG001|Overall Study|Withdrawal by Subject|5|||
37758581|NCT02674854|69267678|FG002|Overall Study|Withdrawal by Subject|4|||
37758582|NCT02674854|69267676|FG000|Overall Study|No-compliant subject|1|||
37758583|NCT02674854|69267677|FG001|Overall Study|No-compliant subject|0|||
37758584|NCT02674854|69267678|FG002|Overall Study|No-compliant subject|1|||
37758585|NCT02674854|69267676|FG000|Overall Study|Lost to Follow-up|1|||
37666386|NCT00700427|69138816|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
37666387|NCT00700427|69138817|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
37666388|NCT00700427|69138813|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
37666389|NCT00700427|69138814|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
37666390|NCT00700427|69138815|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
37758586|NCT02674854|69267677|FG001|Overall Study|Lost to Follow-up|0|||
37923540|NCT00652366|69610323|FG001|Overall Study|Protocol Violation|0|||
37923541|NCT00652366|69610324|FG002|Overall Study|Protocol Violation|0|||
37923542|NCT00652366|69610325|FG003|Overall Study|Protocol Violation|0|||
37923543|NCT00652366|69610326|FG004|Overall Study|Protocol Violation|0|||
37923544|NCT00652366|69610322|FG000|Overall Study|Refused treatment|3|||
37923545|NCT00652366|69610323|FG001|Overall Study|Refused treatment|7|||
37758587|NCT02674854|69267678|FG002|Overall Study|Lost to Follow-up|2|||
37758588|NCT02674854|69267676|FG000|Overall Study|Lack of Efficacy|0|||
37758589|NCT02674854|69267677|FG001|Overall Study|Lack of Efficacy|3|||
37923546|NCT00652366|69610324|FG002|Overall Study|Refused treatment|6|||
37923547|NCT00652366|69610325|FG003|Overall Study|Refused treatment|17|||
37923548|NCT00652366|69610326|FG004|Overall Study|Refused treatment|5|||
37923549|NCT00652366|69610322|FG000|Overall Study|Other|5|||
37923550|NCT00652366|69610323|FG001|Overall Study|Other|2|||
37758590|NCT02674854|69267678|FG002|Overall Study|Lack of Efficacy|0|||
37758591|NCT02674854|69267676|FG000|Overall Study|Disallowed Concurrent Medication|2|||
37923551|NCT00652366|69610324|FG002|Overall Study|Other|3|||
37923552|NCT00652366|69610325|FG003|Overall Study|Other|4|||
37923553|NCT00652366|69610326|FG004|Overall Study|Other|0|||
37923554|NCT00841568|69610340|FG000|Overall Study|Adverse Event|1|||
37923555|NCT00841568|69610340|FG000|Overall Study|Death|1|||
37923556|NCT00841568|69610340|FG000|Overall Study|Withdrawal by Subject|2|||
37923557|NCT00841568|69610340|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
37923558|NCT00855959|69610348|FG000|Overall Study|Adverse Event|2|||
37923559|NCT00855959|69610348|FG000|Overall Study|Lost to Follow-up|2|||
37923560|NCT00855959|69610348|FG000|Overall Study|Withdrawal by Subject|3|||
37923561|NCT00855959|69610348|FG000|Overall Study|Pregnancy|1|||
37923562|NCT00855959|69610348|FG000|Overall Study|Incorrect enrolment|1|||
37923563|NCT00841100|69610352|FG000|Phase 1 (28 Days)|Adverse Event|1|||
37923564|NCT00841100|69610352|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
37923565|NCT00651820|69610356|FG000|Overall Study|Lost to Follow-up|2|||
37923566|NCT00866177|69610362|FG000|Overall Study|Withdrawal by Subject|1|||
37923567|NCT00866177|69610362|FG000|Overall Study|Not Treated|151|||
37923568|NCT00833924|69610366|FG000|Overall Study|Death|21|||
37923569|NCT00833924|69610366|FG000|Overall Study|Conversion|2|||
37923570|NCT00833924|69610366|FG000|Overall Study|Lost to Follow-up|2|||
37923571|NCT00833924|69610366|FG000|Overall Study|Withdrawal by Subject|13|||
37923572|NCT00833924|69610366|FG000|Overall Study|In study follow-up|71|||
37923573|NCT00840086|69610370|FG000|Overall Study|Adverse Event|1|||
37923574|NCT00840086|69610370|FG000|Overall Study|Protocol Violation|2|||
37923575|NCT00840086|69610370|FG000|Overall Study|Lost to Follow-up|1|||
37923576|NCT00822926|69610379|FG000|Second Injection Visit|Lost to Follow-up|1|||
37923577|NCT00822926|69610380|FG001|Second Injection Visit|Lost to Follow-up|0|||
37923578|NCT00822926|69610379|FG000|Second Injection Visit|Withdrawal by Subject|0|||
37923579|NCT00822926|69610380|FG001|Second Injection Visit|Withdrawal by Subject|1|||
37923580|NCT00822770|69610391|FG000|Overall Study|Not treated|1|||
37923581|NCT00822770|69610392|FG001|Overall Study|Not treated|0|||
37923582|NCT00822770|69610391|FG000|Overall Study|Complication/Incomplete treatment|1|||
37923583|NCT00822770|69610392|FG001|Overall Study|Complication/Incomplete treatment|0|||
37923584|NCT00822770|69610391|FG000|Overall Study|Death|1|||
37923585|NCT00822770|69610392|FG001|Overall Study|Death|1|||
37923586|NCT00822692|69610400|FG000|Overall Study|Lost to Follow-up|17|||
37923587|NCT00822692|69610401|FG001|Overall Study|Lost to Follow-up|25|||
37923588|NCT00806442|69610407|FG000|Overall Study|Lost to Follow-up|3|||
37923589|NCT00806442|69610408|FG001|Overall Study|Lost to Follow-up|2|||
37758592|NCT02674854|69267677|FG001|Overall Study|Disallowed Concurrent Medication|2|||
37758593|NCT02674854|69267678|FG002|Overall Study|Disallowed Concurrent Medication|0|||
37758594|NCT02674854|69267676|FG000|Overall Study|Protocol Violation|1|||
37758595|NCT02674854|69267677|FG001|Overall Study|Protocol Violation|1|||
37758596|NCT02674854|69267678|FG002|Overall Study|Protocol Violation|2|||
37758597|NCT02674854|69267676|FG000|Overall Study|Death|0|||
37758598|NCT02674854|69267677|FG001|Overall Study|Death|1|||
37758599|NCT02674854|69267678|FG002|Overall Study|Death|0|||
37758600|NCT02674854|69267676|FG000|Overall Study|Subject missed V6.2|1|||
37923590|NCT00806442|69610407|FG000|Overall Study|Withdrawal by Subject|1|||
37923591|NCT00806442|69610408|FG001|Overall Study|Withdrawal by Subject|5|||
37923592|NCT00821678|69610418|FG000|Overall Study|Withdrawal by Subject|8|||
37923593|NCT00821678|69610419|FG001|Overall Study|Withdrawal by Subject|0|||
37923594|NCT00821678|69610418|FG000|Overall Study|Lost to Follow-up|13|||
37923595|NCT00821678|69610419|FG001|Overall Study|Lost to Follow-up|12|||
37923596|NCT00821678|69610418|FG000|Overall Study|Death|0|||
37923597|NCT00821678|69610419|FG001|Overall Study|Death|2|||
37923598|NCT00839852|69610427|FG000|Overall Study|Adverse Event|10|||
37923599|NCT00839852|69610427|FG000|Overall Study|Insufficient Therapeutic Response|3|||
37923600|NCT00839852|69610427|FG000|Overall Study|Protocol Violation|9|||
37923601|NCT00839852|69610427|FG000|Overall Study|Withdrawal of Consent|16|||
37923602|NCT00839852|69610427|FG000|Overall Study|Lost to Follow-up|7|||
37923603|NCT00839852|69610427|FG000|Overall Study|Lack of Compliance While in Jail|1|||
37923604|NCT00839852|69610427|FG000|Overall Study|Pregnancy|1|||
37758601|NCT02674854|69267677|FG001|Overall Study|Subject missed V6.2|0|||
37758602|NCT02674854|69267678|FG002|Overall Study|Subject missed V6.2|0|||
37923605|NCT00833690|69610434|FG000|Overall Study|Withdrawal by Subject|1|||
37923606|NCT00833690|69610435|FG001|Overall Study|Withdrawal by Subject|0|||
37923607|NCT00833690|69610436|FG002|Overall Study|Withdrawal by Subject|0|||
37923608|NCT00833690|69610434|FG000|Overall Study|Discontinued study drug|3|||
37923609|NCT00833690|69610435|FG001|Overall Study|Discontinued study drug|2|||
37923610|NCT00833690|69610436|FG002|Overall Study|Discontinued study drug|0|||
37923611|NCT00820898|69610444|FG000|Overall Study|Inelgible - wrong primary site|1|||
37923612|NCT00865709|69610456|FG000|Treatment|Adverse Event|9|||
37923613|NCT00865709|69610457|FG001|Treatment|Adverse Event|6|||
37758603|NCT02667288|69267686|FG000|Overall Study|Protocol Violation|5|||
37758604|NCT02667288|69267686|FG000|Overall Study|Lost to Follow-up|3|||
37758605|NCT02667288|69267686|FG000|Overall Study|Withdrawal by Subject|5|||
37923614|NCT00865709|69610456|FG000|Treatment|Withdrawal by Subject|10|||
37923615|NCT00865709|69610457|FG001|Treatment|Withdrawal by Subject|7|||
37923616|NCT00865709|69610456|FG000|Treatment|Physician Decision|3|||
37923617|NCT00865709|69610457|FG001|Treatment|Physician Decision|2|||
37923618|NCT00865709|69610456|FG000|Treatment|Surgery|8|||
37923619|NCT00865709|69610457|FG001|Treatment|Surgery|3|||
37923620|NCT00839306|69610467|FG000|Overall Study|Adverse Event|3|||
37923621|NCT00839306|69610468|FG001|Overall Study|Adverse Event|5|||
37923622|NCT00839306|69610467|FG000|Overall Study|Lost to Follow-up|6|||
37923623|NCT00839306|69610468|FG001|Overall Study|Lost to Follow-up|9|||
37923624|NCT00839306|69610467|FG000|Overall Study|Withdrawal by Subject|5|||
37923625|NCT00839306|69610468|FG001|Overall Study|Withdrawal by Subject|7|||
37923626|NCT00839306|69610467|FG000|Overall Study|Lack of Efficacy|5|||
37923627|NCT00839306|69610468|FG001|Overall Study|Lack of Efficacy|4|||
37923628|NCT00839306|69610467|FG000|Overall Study|Other|6|||
37923629|NCT00839306|69610468|FG001|Overall Study|Other|18|||
37923630|NCT00839072|69610475|FG000|First Intervention Period|Withdrawal by Subject|1|||
37666391|NCT00700427|69138816|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
37666392|NCT00700427|69138817|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
37666393|NCT00700427|69138813|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
37666394|NCT00700427|69138814|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
37666395|NCT00700427|69138815|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
37666396|NCT00700427|69138816|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
37666397|NCT00700427|69138817|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
37666398|NCT00700427|69138813|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
37666399|NCT00700427|69138814|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
37758606|NCT02670330|69267692|FG000|Overall Study|Protocol Deviation|1|||
37758607|NCT02670330|69267693|FG001|Overall Study|Protocol Deviation|0|||
37758608|NCT02670330|69267692|FG000|Overall Study|Study Terminated By Sponsor|36|||
37758609|NCT02670330|69267693|FG001|Overall Study|Study Terminated By Sponsor|43|||
37758610|NCT02670330|69267692|FG000|Overall Study|Adverse Event|1|||
37758611|NCT02670330|69267693|FG001|Overall Study|Adverse Event|3|||
37758612|NCT02670330|69267692|FG000|Overall Study|Withdrawal by Subject|34|||
37758613|NCT02670330|69267693|FG001|Overall Study|Withdrawal by Subject|29|||
37758614|NCT02670330|69267692|FG000|Overall Study|Lost to Follow-up|3|||
37758615|NCT02670330|69267693|FG001|Overall Study|Lost to Follow-up|2|||
37758616|NCT02669940|69267701|FG000|Overall Study|Failure to return|0|||
37758617|NCT02669940|69267702|FG001|Overall Study|Failure to return|3|||
37758618|NCT02669940|69267701|FG000|Overall Study|Insufficient follow-up data|1|||
37758619|NCT02669940|69267702|FG001|Overall Study|Insufficient follow-up data|0|||
37758620|NCT02669862|69267718|FG000|Overall Study|Lost to Follow-up|0|||
37758621|NCT02669862|69267719|FG001|Overall Study|Lost to Follow-up|2|||
37758622|NCT02669862|69267720|FG002|Overall Study|Lost to Follow-up|1|||
37758623|NCT02669862|69267718|FG000|Overall Study|Withdrawal by Subject|2|||
37758624|NCT02669862|69267719|FG001|Overall Study|Withdrawal by Subject|2|||
37758625|NCT02669862|69267720|FG002|Overall Study|Withdrawal by Subject|3|||
37758626|NCT02669862|69267718|FG000|Overall Study|moved|0|||
37758627|NCT02669862|69267719|FG001|Overall Study|moved|1|||
37758628|NCT02669862|69267720|FG002|Overall Study|moved|0|||
37758629|NCT02669862|69267718|FG000|Overall Study|Protocol Violation|0|||
37758630|NCT02669862|69267719|FG001|Overall Study|Protocol Violation|0|||
37758631|NCT02669862|69267720|FG002|Overall Study|Protocol Violation|1|||
37758632|NCT01531673|69267744|FG000|Overall Study|Non-Compliance|0|||
37758633|NCT01531673|69267745|FG001|Overall Study|Non-Compliance|0|||
37758634|NCT01531673|69267746|FG002|Overall Study|Non-Compliance|0|||
37758635|NCT01531673|69267747|FG003|Overall Study|Non-Compliance|0|||
37758636|NCT01531673|69267748|FG004|Overall Study|Non-Compliance|0|||
37758637|NCT01531673|69267749|FG005|Overall Study|Non-Compliance|1|||
37758638|NCT01531673|69267750|FG006|Overall Study|Non-Compliance|0|||
37758639|NCT01531673|69267751|FG007|Overall Study|Non-Compliance|0|||
37758640|NCT01531673|69267752|FG008|Overall Study|Non-Compliance|0|||
37758641|NCT01531673|69267753|FG009|Overall Study|Non-Compliance|0|||
37923631|NCT00839072|69610476|FG001|First Intervention Period|Withdrawal by Subject|0|||
37923632|NCT00839072|69610475|FG000|First Intervention Period|Adverse Event|1|||
37923633|NCT00839072|69610476|FG001|First Intervention Period|Adverse Event|1|||
37923634|NCT00839072|69610475|FG000|Second Intervention Period|Withdrawal by Subject|1|||
37923635|NCT00839072|69610476|FG001|Second Intervention Period|Withdrawal by Subject|0|||
37923636|NCT00855803|69610482|FG000|Overall Study|Death|2|||
37923637|NCT00855803|69610482|FG000|Overall Study|Lost to Follow-up|2|||
37923638|NCT00855803|69610482|FG000|Overall Study|Technical inability to undergo procedure|2|||
37923639|NCT00855803|69610482|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
37923640|NCT00855803|69610482|FG000|Overall Study|Withdrawal by Subject|3|||
37923641|NCT00855803|69610482|FG000|Overall Study|Physician Decision|3|||
37923642|NCT00838916|69610488|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
37923643|NCT00838916|69610489|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
37923644|NCT00838916|69610488|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
37923645|NCT00838916|69610489|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
37923646|NCT00838916|69610488|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
37923647|NCT00838916|69610489|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
37923648|NCT00838916|69610488|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
37923649|NCT00838916|69610489|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
37923650|NCT00838916|69610488|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
37923651|NCT00838916|69610489|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
37923652|NCT00838916|69610488|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
37923653|NCT00838916|69610489|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
37923654|NCT00838916|69610488|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
37923655|NCT00838916|69610489|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
37923656|NCT00838916|69610488|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
37923657|NCT00838916|69610489|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
37923658|NCT00838916|69610488|FG000|Treatment Period (156 Weeks)|Missing|3|||
37923659|NCT00838916|69610489|FG001|Treatment Period (156 Weeks)|Missing|1|||
37923660|NCT00838916|69610488|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
37923661|NCT00838916|69610489|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
37923662|NCT00838916|69610488|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
37923663|NCT00838916|69610489|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
37923664|NCT00838916|69610488|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
37923665|NCT00838916|69610489|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
37923666|NCT00838916|69610488|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
37923667|NCT00838916|69610489|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
37758642|NCT01531673|69267754|FG010|Overall Study|Non-Compliance|0|||
37758643|NCT01531673|69267755|FG011|Overall Study|Non-Compliance|0|||
37923668|NCT00838916|69610488|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
37758644|NCT01531673|69267756|FG012|Overall Study|Non-Compliance|0|||
37923669|NCT00838916|69610489|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
37923670|NCT00838916|69610488|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
37923671|NCT00838916|69610489|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
37923672|NCT00838916|69610488|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
37923673|NCT00838916|69610489|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
37923674|NCT00838916|69610488|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
37923675|NCT00838916|69610489|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
37923676|NCT00838916|69610488|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
37923677|NCT00838916|69610489|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
37923678|NCT00838916|69610488|FG000|Follow-up Period (8 Weeks)|Missing|3|||
37923679|NCT00838916|69610489|FG001|Follow-up Period (8 Weeks)|Missing|0|||
37923680|NCT00838682|69610497|FG000|Overall Study|Lost to Follow-up|21|||
37923681|NCT00838682|69610498|FG001|Overall Study|Lost to Follow-up|14|||
37923682|NCT00838682|69610497|FG000|Overall Study|detection of exclusion criteria|4|||
37923683|NCT00838682|69610498|FG001|Overall Study|detection of exclusion criteria|3|||
37923684|NCT00838682|69610497|FG000|Overall Study|Protocol Violation|0|||
37923685|NCT00838682|69610498|FG001|Overall Study|Protocol Violation|1|||
37923686|NCT00838682|69610497|FG000|Overall Study|Withdrawal by Subject|0|||
37923687|NCT00838682|69610498|FG001|Overall Study|Withdrawal by Subject|1|||
37923688|NCT00820040|69610504|FG000|Overall Study|Death|1|||
37923689|NCT00820040|69610504|FG000|Overall Study|Sponsor terminated study|1|||
37923690|NCT00820040|69610504|FG000|Overall Study|Screen failure|1|||
37923691|NCT00803712|69610510|FG000|Overall Study|Noncompliance|3|||
37923692|NCT00803712|69610511|FG001|Overall Study|Noncompliance|0|||
37923693|NCT00803712|69610510|FG000|Overall Study|Adverse Event|5|||
37923694|NCT00803712|69610511|FG001|Overall Study|Adverse Event|0|||
37758645|NCT01531673|69267744|FG000|Overall Study|Adverse Event|0|||
37758646|NCT01531673|69267745|FG001|Overall Study|Adverse Event|1|||
37758647|NCT01531673|69267746|FG002|Overall Study|Adverse Event|0|||
37758648|NCT01531673|69267747|FG003|Overall Study|Adverse Event|0|||
37758649|NCT01531673|69267748|FG004|Overall Study|Adverse Event|0|||
37758650|NCT01531673|69267749|FG005|Overall Study|Adverse Event|0|||
37758651|NCT01531673|69267750|FG006|Overall Study|Adverse Event|0|||
37758652|NCT01531673|69267751|FG007|Overall Study|Adverse Event|0|||
37758653|NCT01531673|69267752|FG008|Overall Study|Adverse Event|0|||
37758654|NCT01531673|69267753|FG009|Overall Study|Adverse Event|0|||
37758655|NCT01531673|69267754|FG010|Overall Study|Adverse Event|0|||
37758656|NCT01531673|69267755|FG011|Overall Study|Adverse Event|0|||
37758657|NCT01531673|69267756|FG012|Overall Study|Adverse Event|0|||
37758658|NCT01531673|69267744|FG000|Overall Study|Lost to Follow-up|0|||
37758659|NCT01531673|69267745|FG001|Overall Study|Lost to Follow-up|0|||
37758660|NCT01531673|69267746|FG002|Overall Study|Lost to Follow-up|0|||
37923695|NCT00803712|69610510|FG000|Overall Study|Death|8|||
37923696|NCT00803712|69610511|FG001|Overall Study|Death|7|||
37923697|NCT00803712|69610510|FG000|Overall Study|Lost to Follow-up|3|||
37923698|NCT00803712|69610511|FG001|Overall Study|Lost to Follow-up|1|||
37923699|NCT00803712|69610510|FG000|Overall Study|Withdrawal by Subject|2|||
37923700|NCT00803712|69610511|FG001|Overall Study|Withdrawal by Subject|4|||
37923701|NCT00803712|69610510|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
37758661|NCT01531673|69267747|FG003|Overall Study|Lost to Follow-up|0|||
37758662|NCT01531673|69267748|FG004|Overall Study|Lost to Follow-up|1|||
37758663|NCT01531673|69267749|FG005|Overall Study|Lost to Follow-up|0|||
37758664|NCT01531673|69267750|FG006|Overall Study|Lost to Follow-up|0|||
37758665|NCT01531673|69267751|FG007|Overall Study|Lost to Follow-up|0|||
37758666|NCT01531673|69267752|FG008|Overall Study|Lost to Follow-up|0|||
37758667|NCT01531673|69267753|FG009|Overall Study|Lost to Follow-up|0|||
37758668|NCT01531673|69267754|FG010|Overall Study|Lost to Follow-up|0|||
37758669|NCT01531673|69267755|FG011|Overall Study|Lost to Follow-up|0|||
37758670|NCT01531673|69267756|FG012|Overall Study|Lost to Follow-up|0|||
37758671|NCT01531673|69267744|FG000|Overall Study|Other|0|||
37758672|NCT01531673|69267745|FG001|Overall Study|Other|0|||
37923702|NCT00803712|69610511|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
37923703|NCT00803712|69610510|FG000|Overall Study|Protocol criteria (other)|0|||
37923704|NCT00803712|69610511|FG001|Overall Study|Protocol criteria (other)|2|||
37923705|NCT00803712|69610510|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
37923706|NCT00803712|69610511|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
37923707|NCT00803712|69610510|FG000|Overall Study|Administrative decision|2|||
37923708|NCT00803712|69610511|FG001|Overall Study|Administrative decision|3|||
37923709|NCT00803712|69610510|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
37923710|NCT00803712|69610511|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
37923711|NCT00591344|69610519|FG000|Overall Study|Transportation issues|1|||
37923712|NCT00591344|69610520|FG001|Overall Study|Transportation issues|0|||
37923713|NCT00591344|69610519|FG000|Overall Study|Moved out of state|1|||
37923714|NCT00591344|69610520|FG001|Overall Study|Moved out of state|0|||
37923715|NCT00591344|69610519|FG000|Overall Study|Medical complications|1|||
37923716|NCT00591344|69610520|FG001|Overall Study|Medical complications|3|||
37923717|NCT00591344|69610519|FG000|Overall Study|Underwent DBS|2|||
37923718|NCT00591344|69610520|FG001|Overall Study|Underwent DBS|2|||
37923719|NCT00591344|69610519|FG000|Overall Study|Death|0|||
37923720|NCT00591344|69610520|FG001|Overall Study|Death|1|||
37923721|NCT00591344|69610519|FG000|Overall Study|Lost to Follow-up|0|||
37666400|NCT00700427|69138815|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
37666401|NCT00700427|69138816|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
37666402|NCT00700427|69138817|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
37666403|NCT00700427|69138813|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
37666404|NCT00700427|69138814|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
37666405|NCT00700427|69138815|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
37666406|NCT00700427|69138816|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
37666407|NCT00700427|69138817|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
37666408|NCT00700427|69138813|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
37758673|NCT01531673|69267746|FG002|Overall Study|Other|0|||
37758674|NCT01531673|69267747|FG003|Overall Study|Other|1|||
37758675|NCT01531673|69267748|FG004|Overall Study|Other|0|||
37758676|NCT01531673|69267749|FG005|Overall Study|Other|0|||
37758677|NCT01531673|69267750|FG006|Overall Study|Other|0|||
37758678|NCT01531673|69267751|FG007|Overall Study|Other|0|||
37758679|NCT01531673|69267752|FG008|Overall Study|Other|0|||
37666409|NCT00700427|69138814|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
37666410|NCT00700427|69138815|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
37666411|NCT00700427|69138816|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
37666412|NCT00700427|69138817|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
37666413|NCT00700427|69138813|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
37666414|NCT00700427|69138814|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
37666415|NCT00700427|69138815|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
37666416|NCT00700427|69138816|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
37666417|NCT00700427|69138817|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
37666418|NCT00700427|69138813|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
37666419|NCT00700427|69138814|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
37666420|NCT00700427|69138815|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
37666421|NCT00700427|69138816|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
37666422|NCT00700427|69138817|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
37666423|NCT00700427|69138813|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
37666424|NCT00700427|69138814|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
37758680|NCT01531673|69267753|FG009|Overall Study|Other|1|||
37923722|NCT00591344|69610520|FG001|Overall Study|Lost to Follow-up|1|||
37666425|NCT00700427|69138815|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
37666426|NCT00700427|69138816|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
37758681|NCT01531673|69267754|FG010|Overall Study|Other|0|||
37758682|NCT01531673|69267755|FG011|Overall Study|Other|0|||
37758683|NCT01531673|69267756|FG012|Overall Study|Other|0|||
37758684|NCT01531205|69267808|FG000|Overall Study|Did not proceed to surgery|1|||
37758685|NCT01529645|69267824|FG000|Overall Study|Lost to Follow-up|0|||
37923723|NCT00591344|69610519|FG000|Overall Study|Did not want to come off medication|0|||
37923724|NCT00591344|69610520|FG001|Overall Study|Did not want to come off medication|1|||
37923725|NCT00803634|69610532|FG000|Overall Study|Withdrew Consent|1|||
37923726|NCT00803634|69610533|FG001|Overall Study|Withdrew Consent|0|||
37923727|NCT00803634|69610532|FG000|Overall Study|Lost to Follow-up|2|||
37923728|NCT00803634|69610533|FG001|Overall Study|Lost to Follow-up|3|||
37923729|NCT00803634|69610532|FG000|Overall Study|Death|3|||
37923730|NCT00803634|69610533|FG001|Overall Study|Death|2|||
37923731|NCT00838526|69610542|FG000|Overall Study|Adverse Event|3|||
37923732|NCT00838526|69610543|FG001|Overall Study|Adverse Event|12|||
37923733|NCT00838526|69610542|FG000|Overall Study|Lost to Follow-up|4|||
37923734|NCT00838526|69610543|FG001|Overall Study|Lost to Follow-up|12|||
37923735|NCT00838526|69610542|FG000|Overall Study|Withdrawal by Subject|4|||
37923736|NCT00838526|69610543|FG001|Overall Study|Withdrawal by Subject|5|||
37923737|NCT00838526|69610542|FG000|Overall Study|Lack of Efficacy|2|||
37923738|NCT00838526|69610543|FG001|Overall Study|Lack of Efficacy|3|||
37923739|NCT00838526|69610542|FG000|Overall Study|Other|11|||
37923740|NCT00838526|69610543|FG001|Overall Study|Other|7|||
37923741|NCT00818246|69610562|FG000|Overall Study|Impossible to match pictures|5|||
37923742|NCT00818168|69610566|FG000|Overall Study|Lack of Efficacy|18|||
37923743|NCT00818168|69610566|FG000|Overall Study|Pregnancy|2|||
37923744|NCT00818168|69610566|FG000|Overall Study|Withdrawal by Subject|16|||
37923745|NCT00818168|69610566|FG000|Overall Study|Lost to Follow-up|7|||
37923746|NCT00818168|69610566|FG000|Overall Study|Adverse Event|19|||
37923747|NCT00818168|69610566|FG000|Overall Study|Reason for Non-completion Not reported|6|||
37923748|NCT00818168|69610566|FG000|Overall Study|Participant Moved|2|||
37923749|NCT00817778|69610572|FG000|Overall Study|Adverse Event|1|||
37923750|NCT00817778|69610573|FG001|Overall Study|Adverse Event|0|||
37923751|NCT00817778|69610572|FG000|Overall Study|Withdrawal by Subject|1|||
37923752|NCT00817778|69610573|FG001|Overall Study|Withdrawal by Subject|1|||
37923753|NCT00817778|69610572|FG000|Overall Study|Protocol Violation|0|||
37923754|NCT00817778|69610573|FG001|Overall Study|Protocol Violation|1|||
37923755|NCT00817778|69610572|FG000|Overall Study|Study-specific discontinuation criteria|0|||
37923756|NCT00817778|69610573|FG001|Overall Study|Study-specific discontinuation criteria|1|||
37923757|NCT00817778|69610572|FG000|Overall Study|Poor venous access|1|||
37923758|NCT00817778|69610573|FG001|Overall Study|Poor venous access|0|||
37923759|NCT00813098|69610582|FG000|Overall Study|Adverse Event|2|||
37923760|NCT00813098|69610583|FG001|Overall Study|Adverse Event|4|||
37923761|NCT00813098|69610584|FG002|Overall Study|Adverse Event|1|||
37923762|NCT00813098|69610582|FG000|Overall Study|Withdrawal by Subject|0|||
37923763|NCT00813098|69610583|FG001|Overall Study|Withdrawal by Subject|1|||
37923764|NCT00813098|69610584|FG002|Overall Study|Withdrawal by Subject|0|||
37923765|NCT00813098|69610582|FG000|Overall Study|Inability to complete study procedures|1|||
37923766|NCT00813098|69610583|FG001|Overall Study|Inability to complete study procedures|0|||
37923767|NCT00813098|69610584|FG002|Overall Study|Inability to complete study procedures|0|||
37923768|NCT00813098|69610582|FG000|Overall Study|Lost to Follow-up|0|||
37923769|NCT00813098|69610583|FG001|Overall Study|Lost to Follow-up|1|||
37923770|NCT00813098|69610584|FG002|Overall Study|Lost to Follow-up|0|||
37923771|NCT00813098|69610582|FG000|Overall Study|Protocol Violation|0|||
37923772|NCT00813098|69610583|FG001|Overall Study|Protocol Violation|0|||
37923773|NCT00813098|69610584|FG002|Overall Study|Protocol Violation|1|||
37923774|NCT00813098|69610582|FG000|Overall Study|Principal Investigator decision|0|||
37923775|NCT00813098|69610583|FG001|Overall Study|Principal Investigator decision|1|||
37923776|NCT00813098|69610584|FG002|Overall Study|Principal Investigator decision|0|||
37923777|NCT00813098|69610582|FG000|Overall Study|Withdrew Consent|0|||
37923778|NCT00813098|69610583|FG001|Overall Study|Withdrew Consent|1|||
37923779|NCT00813098|69610584|FG002|Overall Study|Withdrew Consent|0|||
37923780|NCT00796653|69610596|FG000|Overall Study|Adverse Event|19|||
37923781|NCT00796653|69610597|FG001|Overall Study|Adverse Event|16|||
37923782|NCT00796653|69610598|FG002|Overall Study|Adverse Event|16|||
37923783|NCT00796653|69610599|FG003|Overall Study|Adverse Event|16|||
37923784|NCT00796653|69610596|FG000|Overall Study|Lost to Follow-up|2|||
37923785|NCT00796653|69610597|FG001|Overall Study|Lost to Follow-up|1|||
37923786|NCT00796653|69610598|FG002|Overall Study|Lost to Follow-up|2|||
37923787|NCT00796653|69610599|FG003|Overall Study|Lost to Follow-up|3|||
37923788|NCT00796653|69610596|FG000|Overall Study|Withdrawal by Subject|16|||
37923789|NCT00796653|69610597|FG001|Overall Study|Withdrawal by Subject|8|||
37923790|NCT00796653|69610598|FG002|Overall Study|Withdrawal by Subject|8|||
37923791|NCT00796653|69610599|FG003|Overall Study|Withdrawal by Subject|13|||
37923792|NCT00796653|69610596|FG000|Overall Study|Lack of Efficacy|8|||
37923793|NCT00796653|69610597|FG001|Overall Study|Lack of Efficacy|1|||
37923794|NCT00796653|69610598|FG002|Overall Study|Lack of Efficacy|3|||
37923795|NCT00796653|69610599|FG003|Overall Study|Lack of Efficacy|2|||
37923796|NCT00796653|69610596|FG000|Overall Study|Non compliance with protocol|2|||
37923797|NCT00796653|69610597|FG001|Overall Study|Non compliance with protocol|2|||
37923798|NCT00796653|69610598|FG002|Overall Study|Non compliance with protocol|0|||
37923799|NCT00796653|69610599|FG003|Overall Study|Non compliance with protocol|2|||
37923800|NCT00796653|69610596|FG000|Overall Study|Other reason not described above|4|||
37923801|NCT00796653|69610597|FG001|Overall Study|Other reason not described above|9|||
37923802|NCT00796653|69610598|FG002|Overall Study|Other reason not described above|7|||
37923803|NCT00796653|69610599|FG003|Overall Study|Other reason not described above|4|||
37923804|NCT00806286|69610620|FG000|Overall Study|Adverse Event|5|||
37923805|NCT00806286|69610621|FG001|Overall Study|Adverse Event|2|||
37923806|NCT00806286|69610622|FG002|Overall Study|Adverse Event|0|||
37923807|NCT00806286|69610620|FG000|Overall Study|Disease progression|31|||
37923808|NCT00806286|69610621|FG001|Overall Study|Disease progression|38|||
37923809|NCT00806286|69610622|FG002|Overall Study|Disease progression|1|||
37923810|NCT00806286|69610620|FG000|Overall Study|Death|1|||
37923811|NCT00806286|69610621|FG001|Overall Study|Death|6|||
37923812|NCT00806286|69610622|FG002|Overall Study|Death|0|||
37923813|NCT00806286|69610620|FG000|Overall Study|Lost to Follow-up|0|||
37923814|NCT00806286|69610621|FG001|Overall Study|Lost to Follow-up|1|||
37923815|NCT00806286|69610622|FG002|Overall Study|Lost to Follow-up|0|||
37923816|NCT00806286|69610620|FG000|Overall Study|Withdrawal by Subject|8|||
37923817|NCT00806286|69610621|FG001|Overall Study|Withdrawal by Subject|3|||
37923818|NCT00806286|69610622|FG002|Overall Study|Withdrawal by Subject|1|||
37923819|NCT00806286|69610620|FG000|Overall Study|Physician Decision|2|||
37923820|NCT00806286|69610621|FG001|Overall Study|Physician Decision|2|||
37923821|NCT00806286|69610622|FG002|Overall Study|Physician Decision|0|||
37923822|NCT00806286|69610620|FG000|Overall Study|Due to a variety of reasons|7|||
37923823|NCT00806286|69610621|FG001|Overall Study|Due to a variety of reasons|2|||
37923824|NCT00806286|69610622|FG002|Overall Study|Due to a variety of reasons|1|||
37923825|NCT00590538|69610630|FG000|Overall Study|Study terminated before completed|2|||
37923826|NCT00796419|69610636|FG000|Overall Study|Death|0|||
37923827|NCT00796419|69610637|FG001|Overall Study|Death|1|||
37923828|NCT00796107|69610643|FG000|Overall Study|Lack of Efficacy|1|||
37923829|NCT00796107|69610643|FG000|Overall Study|Progressive Disease|5|||
37923830|NCT00795951|69610647|FG000|Overall Study|Lost to Follow-up|1|||
37923831|NCT00795951|69610647|FG000|Overall Study|Withdrawal by Subject|1|||
37923832|NCT00795717|69610654|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
37923833|NCT00795717|69610655|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
37923834|NCT00795717|69610654|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
37923835|NCT00795717|69610655|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
37923836|NCT00795717|69610654|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
37923837|NCT00795717|69610655|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
37923838|NCT00795717|69610654|FG000|Phase II|too busy|0|||
37923839|NCT00795717|69610655|FG001|Phase II|too busy|1|||
37923840|NCT00805740|69610664|FG000|Overall Study|Death|7|||
37923841|NCT00805740|69610665|FG001|Overall Study|Death|4|||
37923842|NCT00805740|69610664|FG000|Overall Study|Withdrawal by Subject|1|||
37923843|NCT00805740|69610665|FG001|Overall Study|Withdrawal by Subject|0|||
37923844|NCT00805740|69610664|FG000|Overall Study|Lost to Follow-up|1|||
37923845|NCT00805740|69610665|FG001|Overall Study|Lost to Follow-up|0|||
37923846|NCT00805740|69610664|FG000|Overall Study|Randomized, but not treated|2|||
37923847|NCT00805740|69610665|FG001|Overall Study|Randomized, but not treated|0|||
37923848|NCT00795639|69610673|FG000|Overall Study|Death|1|||
37923849|NCT00795639|69610674|FG001|Overall Study|Death|6|||
37923850|NCT00795639|69610673|FG000|Overall Study|Withdrawal by Subject|1|||
37923851|NCT00795639|69610674|FG001|Overall Study|Withdrawal by Subject|3|||
37923852|NCT00795639|69610673|FG000|Overall Study|Pregnancy|1|||
37923853|NCT00795639|69610674|FG001|Overall Study|Pregnancy|0|||
37923854|NCT00795639|69610673|FG000|Overall Study|Adverse Event|5|||
37923855|NCT00795639|69610674|FG001|Overall Study|Adverse Event|2|||
37923856|NCT00795639|69610673|FG000|Overall Study|Other|0|||
37923857|NCT00795639|69610674|FG001|Overall Study|Other|2|||
37923858|NCT00795639|69610673|FG000|Overall Study|Terminated by sponsor|13|||
37923859|NCT00795639|69610674|FG001|Overall Study|Terminated by sponsor|12|||
37923860|NCT00795639|69610673|FG000|Overall Study|Randomized and not treated|0|||
37923861|NCT00795639|69610674|FG001|Overall Study|Randomized and not treated|1|||
37923862|NCT00589602|69610680|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
37923863|NCT00794157|69610689|FG000|Overall Study|Adverse Event|4|||
37923864|NCT00794157|69610690|FG001|Overall Study|Adverse Event|1|||
37923865|NCT00794157|69610691|FG002|Overall Study|Adverse Event|8|||
37666427|NCT00700427|69138817|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
37923866|NCT00794157|69610689|FG000|Overall Study|Subject withdrew consent|2|||
37923867|NCT00794157|69610690|FG001|Overall Study|Subject withdrew consent|0|||
37923868|NCT00794157|69610691|FG002|Overall Study|Subject withdrew consent|3|||
37923869|NCT00794157|69610689|FG000|Overall Study|Lost to Follow-up|2|||
37666428|NCT00700427|69138813|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
37923870|NCT00794157|69610690|FG001|Overall Study|Lost to Follow-up|0|||
37923871|NCT00794157|69610691|FG002|Overall Study|Lost to Follow-up|1|||
37923872|NCT00794157|69610689|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
37923873|NCT00794157|69610690|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
37923874|NCT00794157|69610691|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
37923875|NCT00794157|69610689|FG000|Overall Study|Administrative problems|1|||
37923876|NCT00794157|69610690|FG001|Overall Study|Administrative problems|7|||
37923877|NCT00794157|69610691|FG002|Overall Study|Administrative problems|4|||
37923878|NCT00794157|69610689|FG000|Overall Study|Abnormal test procedure result(s)|0|||
37666429|NCT00700427|69138814|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
37666430|NCT00700427|69138815|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
37666431|NCT00700427|69138816|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
37758686|NCT01529645|69267825|FG001|Overall Study|Lost to Follow-up|1|||
37758687|NCT01529645|69267826|FG002|Overall Study|Lost to Follow-up|1|||
37758688|NCT01529645|69267827|FG003|Overall Study|Lost to Follow-up|1|||
37758689|NCT01529645|69267828|FG004|Overall Study|Lost to Follow-up|1|||
37758690|NCT01529645|69267829|FG005|Overall Study|Lost to Follow-up|0|||
37758691|NCT01529645|69267830|FG006|Overall Study|Lost to Follow-up|2|||
37758692|NCT01529645|69267831|FG007|Overall Study|Lost to Follow-up|0|||
37758693|NCT01529645|69267832|FG008|Overall Study|Lost to Follow-up|1|||
37758694|NCT01529645|69267833|FG009|Overall Study|Lost to Follow-up|0|||
37758695|NCT01529645|69267824|FG000|Overall Study|SAE - Premature contractions|0|||
37758696|NCT01529645|69267825|FG001|Overall Study|SAE - Premature contractions|0|||
37758697|NCT01529645|69267826|FG002|Overall Study|SAE - Premature contractions|1|||
37758698|NCT01529645|69267827|FG003|Overall Study|SAE - Premature contractions|0|||
37758699|NCT01529645|69267828|FG004|Overall Study|SAE - Premature contractions|0|||
37758700|NCT01529645|69267829|FG005|Overall Study|SAE - Premature contractions|0|||
37758701|NCT01529645|69267830|FG006|Overall Study|SAE - Premature contractions|0|||
37758702|NCT01529645|69267831|FG007|Overall Study|SAE - Premature contractions|0|||
37758703|NCT01529645|69267832|FG008|Overall Study|SAE - Premature contractions|0|||
37758704|NCT01529645|69267833|FG009|Overall Study|SAE - Premature contractions|0|||
37758705|NCT01529645|69267824|FG000|Overall Study|Withdrawal by Subject|2|||
37758706|NCT01529645|69267825|FG001|Overall Study|Withdrawal by Subject|0|||
37758707|NCT01529645|69267826|FG002|Overall Study|Withdrawal by Subject|0|||
37758708|NCT01529645|69267827|FG003|Overall Study|Withdrawal by Subject|1|||
37758709|NCT01529645|69267828|FG004|Overall Study|Withdrawal by Subject|1|||
37758710|NCT01529645|69267829|FG005|Overall Study|Withdrawal by Subject|1|||
37758711|NCT01529645|69267830|FG006|Overall Study|Withdrawal by Subject|0|||
37758712|NCT01529645|69267831|FG007|Overall Study|Withdrawal by Subject|0|||
37758713|NCT01529645|69267832|FG008|Overall Study|Withdrawal by Subject|0|||
37758714|NCT01529645|69267833|FG009|Overall Study|Withdrawal by Subject|0|||
37758715|NCT01528787|69267867|FG000|Overall Study|Withdrawal by Subject|0|||
37758716|NCT01528787|69267868|FG001|Overall Study|Withdrawal by Subject|0|||
37758717|NCT01528787|69267869|FG002|Overall Study|Withdrawal by Subject|0|||
37758718|NCT01528787|69267870|FG003|Overall Study|Withdrawal by Subject|1|||
37758719|NCT01528787|69267867|FG000|Overall Study|Family Emergency|0|||
37758720|NCT01528787|69267868|FG001|Overall Study|Family Emergency|0|||
37758721|NCT01528787|69267869|FG002|Overall Study|Family Emergency|1|||
37758722|NCT01528787|69267870|FG003|Overall Study|Family Emergency|0|||
37758723|NCT01528709|69267882|FG000|Overall Study|Death|2|||
37758724|NCT01528709|69267883|FG001|Overall Study|Death|0|||
37758725|NCT01528709|69267882|FG000|Overall Study|Withdrawal by Subject|10|||
37923879|NCT00794157|69610690|FG001|Overall Study|Abnormal test procedure result(s)|1|||
37923880|NCT00794157|69610691|FG002|Overall Study|Abnormal test procedure result(s)|0|||
37758726|NCT01528709|69267883|FG001|Overall Study|Withdrawal by Subject|15|||
37758727|NCT01528709|69267882|FG000|Overall Study|allergy|1|||
37758728|NCT01528709|69267883|FG001|Overall Study|allergy|0|||
37758729|NCT01527383|69267891|FG000|Overall Study|Adverse Event|5|||
37758730|NCT01527383|69267892|FG001|Overall Study|Adverse Event|0|||
37758731|NCT01527383|69267891|FG000|Overall Study|Lost to Follow-up|3|||
37758732|NCT01527383|69267892|FG001|Overall Study|Lost to Follow-up|0|||
37758733|NCT01527383|69267891|FG000|Overall Study|Physician Decision|2|||
37758734|NCT01527383|69267892|FG001|Overall Study|Physician Decision|0|||
37666432|NCT00700427|69138817|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
37666433|NCT00700427|69138813|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
37666434|NCT00700427|69138814|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
37666435|NCT00700427|69138815|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
37758735|NCT01527383|69267891|FG000|Overall Study|Pregnancy|1|||
37758736|NCT01527383|69267892|FG001|Overall Study|Pregnancy|0|||
37758737|NCT01527383|69267891|FG000|Overall Study|Protocol Violation|1|||
37758738|NCT01527383|69267892|FG001|Overall Study|Protocol Violation|0|||
37758739|NCT01527383|69267891|FG000|Overall Study|Screen failure|1|||
37758740|NCT01527383|69267892|FG001|Overall Study|Screen failure|0|||
37758741|NCT01527383|69267891|FG000|Overall Study|Participant moved|0|||
37758742|NCT01527383|69267892|FG001|Overall Study|Participant moved|1|||
37758743|NCT01527383|69267891|FG000|Overall Study|Withdrawal by Subject|2|||
37923881|NCT00794157|69610689|FG000|Overall Study|Protocol deviation|0|||
37666436|NCT00700427|69138816|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
37758744|NCT01527383|69267892|FG001|Overall Study|Withdrawal by Subject|3|||
37758745|NCT01526057|69267901|FG000|Overall Study|Withdrawal by Subject|3|||
37758746|NCT01526057|69267902|FG001|Overall Study|Withdrawal by Subject|2|||
37758747|NCT01526057|69267903|FG002|Overall Study|Withdrawal by Subject|2|||
37758748|NCT01526057|69267901|FG000|Overall Study|Adverse Event|3|||
37758749|NCT01526057|69267902|FG001|Overall Study|Adverse Event|1|||
37758750|NCT01526057|69267903|FG002|Overall Study|Adverse Event|1|||
37923882|NCT00794157|69610690|FG001|Overall Study|Protocol deviation|1|||
37923883|NCT00794157|69610691|FG002|Overall Study|Protocol deviation|1|||
37923884|NCT00588237|69610699|FG000|Overall Study|Evaluable for toxicity only|3|||
37923885|NCT00588237|69610699|FG000|Overall Study|Patien not treated|1|||
37923886|NCT00790023|69610706|FG000|Overall Study|Adverse Event|2|||
37923887|NCT00790023|69610707|FG001|Overall Study|Adverse Event|1|||
37923888|NCT00790023|69610708|FG002|Overall Study|Adverse Event|4|||
37923889|NCT00790023|69610706|FG000|Overall Study|Protocol Violation|2|||
37923890|NCT00790023|69610707|FG001|Overall Study|Protocol Violation|4|||
37923891|NCT00790023|69610708|FG002|Overall Study|Protocol Violation|2|||
37758751|NCT01526057|69267901|FG000|Overall Study|Death|1|||
37758752|NCT01526057|69267902|FG001|Overall Study|Death|0|||
37758753|NCT01526057|69267903|FG002|Overall Study|Death|0|||
37758754|NCT01526057|69267901|FG000|Overall Study|Lost to Follow-up|1|||
37758755|NCT01526057|69267902|FG001|Overall Study|Lost to Follow-up|0|||
37758756|NCT01526057|69267903|FG002|Overall Study|Lost to Follow-up|1|||
37758757|NCT01526057|69267901|FG000|Overall Study|Other|1|||
37758758|NCT01526057|69267902|FG001|Overall Study|Other|0|||
37758759|NCT01526057|69267903|FG002|Overall Study|Other|1|||
37758760|NCT01526057|69267901|FG000|Overall Study|Protocol Violation|0|||
37758761|NCT01526057|69267902|FG001|Overall Study|Protocol Violation|0|||
37758762|NCT01526057|69267903|FG002|Overall Study|Protocol Violation|1|||
37758763|NCT01525901|69267915|FG000|Period 2: 12 Weeks|Adverse Event|0|||
37758764|NCT01525901|69267916|FG001|Period 2: 12 Weeks|Adverse Event|1|||
37758765|NCT01525901|69267917|FG002|Period 2: 12 Weeks|Adverse Event|0|||
37758766|NCT01525901|69267918|FG003|Period 2: 12 Weeks|Adverse Event|0|||
37758767|NCT01525589|69268031|FG000|Overall Study|Non-treatment-related AE|1|||
37758768|NCT01525589|69268032|FG001|Overall Study|Non-treatment-related AE|0|||
37758769|NCT01525589|69268033|FG002|Overall Study|Non-treatment-related AE|0|||
37758770|NCT01525589|69268031|FG000|Overall Study|Progressive disease|48|||
37758771|NCT01525589|69268032|FG001|Overall Study|Progressive disease|15|||
37758772|NCT01525589|69268033|FG002|Overall Study|Progressive disease|29|||
37758773|NCT01525589|69268031|FG000|Overall Study|Never treated|2|||
37758774|NCT01525589|69268032|FG001|Overall Study|Never treated|0|||
37758775|NCT01525589|69268033|FG002|Overall Study|Never treated|0|||
37758776|NCT01525589|69268031|FG000|Overall Study|Physician Decision|4|||
37758777|NCT01525589|69268032|FG001|Overall Study|Physician Decision|2|||
37758778|NCT01525589|69268033|FG002|Overall Study|Physician Decision|2|||
37758779|NCT01525589|69268031|FG000|Overall Study|Death|0|||
37758780|NCT01525589|69268032|FG001|Overall Study|Death|0|||
37758781|NCT01525589|69268033|FG002|Overall Study|Death|2|||
37758782|NCT01525589|69268031|FG000|Overall Study|Treatment-related AE|1|||
37758783|NCT01525589|69268032|FG001|Overall Study|Treatment-related AE|1|||
37758784|NCT01525589|69268033|FG002|Overall Study|Treatment-related AE|2|||
37758785|NCT01525589|69268031|FG000|Overall Study|Other reasons|0|||
37758786|NCT01525589|69268032|FG001|Overall Study|Other reasons|1|||
37758787|NCT01525589|69268033|FG002|Overall Study|Other reasons|0|||
37758788|NCT01525589|69268031|FG000|Overall Study|Withdrawal by Subject|0|||
37758789|NCT01525589|69268032|FG001|Overall Study|Withdrawal by Subject|1|||
37758790|NCT01525589|69268033|FG002|Overall Study|Withdrawal by Subject|0|||
37758791|NCT01524887|69268044|FG000|Overall Study|Withdrawal by Subject|6|||
37758792|NCT01524887|69268045|FG001|Overall Study|Withdrawal by Subject|2|||
37758793|NCT01524887|69268046|FG002|Overall Study|Withdrawal by Subject|3|||
37758794|NCT01524887|69268044|FG000|Overall Study|Adverse Event|5|||
37923892|NCT00790023|69610706|FG000|Overall Study|Withdrawal by Subject|2|||
37923893|NCT00790023|69610707|FG001|Overall Study|Withdrawal by Subject|0|||
37666437|NCT00700427|69138817|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
37666438|NCT00700427|69138813|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
37666439|NCT00700427|69138814|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
37666440|NCT00700427|69138815|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
37666441|NCT00700427|69138816|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
37666442|NCT00700427|69138817|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
37666443|NCT00700427|69138813|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
37666444|NCT00700427|69138814|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
37758795|NCT01524887|69268045|FG001|Overall Study|Adverse Event|1|||
37758796|NCT01524887|69268046|FG002|Overall Study|Adverse Event|1|||
37758797|NCT01524887|69268044|FG000|Overall Study|Protocol Violation|0|||
37758798|NCT01524887|69268045|FG001|Overall Study|Protocol Violation|0|||
37758799|NCT01524887|69268046|FG002|Overall Study|Protocol Violation|1|||
37758800|NCT01524887|69268044|FG000|Overall Study|Study termination|73|||
37758801|NCT01524887|69268045|FG001|Overall Study|Study termination|87|||
37923894|NCT00790023|69610708|FG002|Overall Study|Withdrawal by Subject|6|||
37923895|NCT00790023|69610706|FG000|Overall Study|Lost to Follow-up|0|||
37758802|NCT01524887|69268046|FG002|Overall Study|Study termination|79|||
37923896|NCT00790023|69610707|FG001|Overall Study|Lost to Follow-up|0|||
37923897|NCT00790023|69610708|FG002|Overall Study|Lost to Follow-up|1|||
37923898|NCT00790023|69610706|FG000|Overall Study|Other|5|||
37758803|NCT01524887|69268044|FG000|Overall Study|Withdrawal by Caregiver|0|||
37758804|NCT01524887|69268045|FG001|Overall Study|Withdrawal by Caregiver|0|||
37758805|NCT01524887|69268046|FG002|Overall Study|Withdrawal by Caregiver|2|||
37758806|NCT01524887|69268044|FG000|Overall Study|Use of prohibited medication|1|||
37758807|NCT01524887|69268045|FG001|Overall Study|Use of prohibited medication|0|||
37758808|NCT01524887|69268046|FG002|Overall Study|Use of prohibited medication|0|||
37758809|NCT01523873|69268072|FG000|Overall Study|Protocol Violation|422|||
37758810|NCT01522235|69268097|FG000|Overall Study|Physician Decision|1|||
37758811|NCT01522235|69268098|FG001|Overall Study|Physician Decision|1|||
37758812|NCT01521923|69268135|FG000|Overall Study|AE, serious fatal|1|||
37758813|NCT01521923|69268136|FG001|Overall Study|AE, serious fatal|0|||
37758814|NCT01521923|69268137|FG002|Overall Study|AE, serious fatal|0|||
37758815|NCT01521923|69268138|FG003|Overall Study|AE, serious fatal|0|||
37758816|NCT01521923|69268135|FG000|Overall Study|SAE, non-fatal|0|||
37758817|NCT01521923|69268136|FG001|Overall Study|SAE, non-fatal|2|||
37758818|NCT01521923|69268137|FG002|Overall Study|SAE, non-fatal|2|||
37758819|NCT01521923|69268138|FG003|Overall Study|SAE, non-fatal|0|||
37758820|NCT01521923|69268135|FG000|Overall Study|AE, non-serious, non-fatal|1|||
37758821|NCT01521923|69268136|FG001|Overall Study|AE, non-serious, non-fatal|3|||
37758822|NCT01521923|69268137|FG002|Overall Study|AE, non-serious, non-fatal|6|||
37758823|NCT01521923|69268138|FG003|Overall Study|AE, non-serious, non-fatal|2|||
37758824|NCT01521923|69268135|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
37758825|NCT01521923|69268136|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
37758826|NCT01521923|69268137|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
37758827|NCT01521923|69268138|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
37758828|NCT01521923|69268135|FG000|Overall Study|Lack of Efficacy|1|||
37758829|NCT01521923|69268136|FG001|Overall Study|Lack of Efficacy|1|||
37758830|NCT01521923|69268137|FG002|Overall Study|Lack of Efficacy|0|||
37758831|NCT01521923|69268138|FG003|Overall Study|Lack of Efficacy|0|||
37758832|NCT01521923|69268135|FG000|Overall Study|Protocol Violation|0|||
37758833|NCT01521923|69268136|FG001|Overall Study|Protocol Violation|0|||
37758834|NCT01521923|69268137|FG002|Overall Study|Protocol Violation|1|||
37758835|NCT01521923|69268138|FG003|Overall Study|Protocol Violation|0|||
37758836|NCT01521923|69268135|FG000|Overall Study|Lost to Follow-up|1|||
37758837|NCT01521923|69268136|FG001|Overall Study|Lost to Follow-up|0|||
37758838|NCT01521923|69268137|FG002|Overall Study|Lost to Follow-up|2|||
37758839|NCT01521923|69268138|FG003|Overall Study|Lost to Follow-up|1|||
37758840|NCT01521923|69268135|FG000|Overall Study|Withdrawal by Subject|1|||
37758841|NCT01521923|69268136|FG001|Overall Study|Withdrawal by Subject|1|||
37758842|NCT01521923|69268137|FG002|Overall Study|Withdrawal by Subject|1|||
37758843|NCT01521923|69268138|FG003|Overall Study|Withdrawal by Subject|2|||
37758844|NCT01521923|69268135|FG000|Overall Study|Other|2|||
37758845|NCT01521923|69268136|FG001|Overall Study|Other|1|||
37758846|NCT01521923|69268137|FG002|Overall Study|Other|3|||
37758847|NCT01521923|69268138|FG003|Overall Study|Other|6|||
37758848|NCT01521923|69268135|FG000|Overall Study|AE, captured in Period 1|0|||
37758849|NCT01521923|69268136|FG001|Overall Study|AE, captured in Period 1|1|||
37758850|NCT01521923|69268137|FG002|Overall Study|AE, captured in Period 1|0|||
37758851|NCT01521923|69268138|FG003|Overall Study|AE, captured in Period 1|1|||
37758852|NCT01520987|69268262|FG000|Overall Study|Withdrawal by Subject|1|||
37758853|NCT01520987|69268263|FG001|Overall Study|Withdrawal by Subject|0|||
37758854|NCT01520987|69268264|FG002|Overall Study|Withdrawal by Subject|0|||
37758855|NCT01520987|69268265|FG003|Overall Study|Withdrawal by Subject|0|||
37758856|NCT01520987|69268266|FG004|Overall Study|Withdrawal by Subject|0|||
37758857|NCT01520987|69268267|FG005|Overall Study|Withdrawal by Subject|1|||
37758858|NCT01520987|69268268|FG006|Overall Study|Withdrawal by Subject|0|||
37758859|NCT01520987|69268269|FG007|Overall Study|Withdrawal by Subject|0|||
37758860|NCT01562275|69268343|FG000|Stage 1|Adverse Event|0|||
37758861|NCT01562275|69268344|FG001|Stage 1|Adverse Event|0|||
37923899|NCT00790023|69610707|FG001|Overall Study|Other|5|||
37666445|NCT00700427|69138815|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
37666446|NCT00700427|69138816|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
37666447|NCT00700427|69138817|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
37666448|NCT00700427|69138813|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
37666449|NCT00700427|69138814|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
37666450|NCT00700427|69138815|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
37666451|NCT00700427|69138816|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
37666452|NCT00700427|69138817|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
37758862|NCT01562275|69268345|FG002|Stage 1|Adverse Event|0|||
37758863|NCT01562275|69268346|FG003|Stage 1|Adverse Event|1|||
37758864|NCT01562275|69268347|FG004|Stage 1|Adverse Event|1|||
37758865|NCT01562275|69268348|FG005|Stage 1|Adverse Event|0|||
37758866|NCT01562275|69268349|FG006|Stage 1|Adverse Event|0|||
37758867|NCT01562275|69268350|FG007|Stage 1|Adverse Event|0|||
37923900|NCT00790023|69610708|FG002|Overall Study|Other|8|||
37666453|NCT00700427|69138813|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
37758868|NCT01562275|69268351|FG008|Stage 1|Adverse Event|0|||
37923901|NCT00588822|69610717|FG000|Overall Study|progression of disease|8|||
37758869|NCT01562275|69268352|FG009|Stage 1|Adverse Event|1|||
37758870|NCT01562275|69268353|FG010|Stage 1|Adverse Event|0|||
37758871|NCT01562275|69268354|FG011|Stage 1|Adverse Event|0|||
37758872|NCT01562275|69268355|FG012|Stage 1|Adverse Event|0|||
37758873|NCT01562275|69268343|FG000|Stage 1|Death|1|||
37758874|NCT01562275|69268344|FG001|Stage 1|Death|0|||
37758875|NCT01562275|69268345|FG002|Stage 1|Death|0|||
37758876|NCT01562275|69268346|FG003|Stage 1|Death|0|||
37758877|NCT01562275|69268347|FG004|Stage 1|Death|0|||
37758878|NCT01562275|69268348|FG005|Stage 1|Death|0|||
37758879|NCT01562275|69268349|FG006|Stage 1|Death|0|||
37758880|NCT01562275|69268350|FG007|Stage 1|Death|0|||
37758881|NCT01562275|69268351|FG008|Stage 1|Death|0|||
37758882|NCT01562275|69268352|FG009|Stage 1|Death|0|||
37758883|NCT01562275|69268353|FG010|Stage 1|Death|0|||
37758884|NCT01562275|69268354|FG011|Stage 1|Death|0|||
37758885|NCT01562275|69268355|FG012|Stage 1|Death|0|||
37758886|NCT01562275|69268343|FG000|Stage 1|Non Compliance|0|||
37758887|NCT01562275|69268344|FG001|Stage 1|Non Compliance|0|||
37758888|NCT01562275|69268345|FG002|Stage 1|Non Compliance|1|||
37758889|NCT01562275|69268346|FG003|Stage 1|Non Compliance|0|||
37758890|NCT01562275|69268347|FG004|Stage 1|Non Compliance|0|||
37758891|NCT01562275|69268348|FG005|Stage 1|Non Compliance|0|||
37758892|NCT01562275|69268349|FG006|Stage 1|Non Compliance|0|||
37758893|NCT01562275|69268350|FG007|Stage 1|Non Compliance|0|||
37758894|NCT01562275|69268351|FG008|Stage 1|Non Compliance|0|||
37758895|NCT01562275|69268352|FG009|Stage 1|Non Compliance|0|||
37758896|NCT01562275|69268353|FG010|Stage 1|Non Compliance|0|||
37758897|NCT01562275|69268354|FG011|Stage 1|Non Compliance|0|||
37758898|NCT01562275|69268355|FG012|Stage 1|Non Compliance|0|||
37758899|NCT01562275|69268343|FG000|Stage 1|Physician Decision|0|||
37758900|NCT01562275|69268344|FG001|Stage 1|Physician Decision|0|||
37758901|NCT01562275|69268345|FG002|Stage 1|Physician Decision|0|||
37758902|NCT01562275|69268346|FG003|Stage 1|Physician Decision|0|||
37758903|NCT01562275|69268347|FG004|Stage 1|Physician Decision|1|||
37758904|NCT01562275|69268348|FG005|Stage 1|Physician Decision|0|||
37758905|NCT01562275|69268349|FG006|Stage 1|Physician Decision|1|||
37758906|NCT01562275|69268350|FG007|Stage 1|Physician Decision|0|||
37758907|NCT01562275|69268351|FG008|Stage 1|Physician Decision|1|||
37758908|NCT01562275|69268352|FG009|Stage 1|Physician Decision|0|||
37758909|NCT01562275|69268353|FG010|Stage 1|Physician Decision|0|||
37758910|NCT01562275|69268354|FG011|Stage 1|Physician Decision|0|||
37758911|NCT01562275|69268355|FG012|Stage 1|Physician Decision|0|||
37758912|NCT01562275|69268343|FG000|Stage 1|Progression of Disease|2|||
37758913|NCT01562275|69268344|FG001|Stage 1|Progression of Disease|6|||
37758914|NCT01562275|69268345|FG002|Stage 1|Progression of Disease|2|||
37758915|NCT01562275|69268346|FG003|Stage 1|Progression of Disease|1|||
37758916|NCT01562275|69268347|FG004|Stage 1|Progression of Disease|2|||
37758917|NCT01562275|69268348|FG005|Stage 1|Progression of Disease|4|||
37758918|NCT01562275|69268349|FG006|Stage 1|Progression of Disease|1|||
37758919|NCT01562275|69268350|FG007|Stage 1|Progression of Disease|7|||
37758920|NCT01562275|69268351|FG008|Stage 1|Progression of Disease|2|||
37758921|NCT01562275|69268352|FG009|Stage 1|Progression of Disease|5|||
37758922|NCT01562275|69268353|FG010|Stage 1|Progression of Disease|3|||
37758923|NCT01562275|69268354|FG011|Stage 1|Progression of Disease|0|||
37758924|NCT01562275|69268355|FG012|Stage 1|Progression of Disease|0|||
37758925|NCT01562275|69268343|FG000|Stage 1|Withdrawal by Subject|0|||
37758926|NCT01562275|69268344|FG001|Stage 1|Withdrawal by Subject|1|||
37758927|NCT01562275|69268345|FG002|Stage 1|Withdrawal by Subject|0|||
37758928|NCT01562275|69268346|FG003|Stage 1|Withdrawal by Subject|2|||
37758929|NCT01562275|69268347|FG004|Stage 1|Withdrawal by Subject|0|||
37758930|NCT01562275|69268348|FG005|Stage 1|Withdrawal by Subject|0|||
37758931|NCT01562275|69268349|FG006|Stage 1|Withdrawal by Subject|1|||
37923902|NCT00589914|69610723|FG000|Overall Study|Adverse Event|19|||
37923903|NCT00589914|69610724|FG001|Overall Study|Adverse Event|10|||
37758932|NCT01562275|69268350|FG007|Stage 1|Withdrawal by Subject|0|||
37758933|NCT01562275|69268351|FG008|Stage 1|Withdrawal by Subject|0|||
37758934|NCT01562275|69268352|FG009|Stage 1|Withdrawal by Subject|1|||
37923904|NCT00589914|69610723|FG000|Overall Study|Death|2|||
37758935|NCT01562275|69268353|FG010|Stage 1|Withdrawal by Subject|0|||
37758936|NCT01562275|69268354|FG011|Stage 1|Withdrawal by Subject|0|||
37758937|NCT01562275|69268355|FG012|Stage 1|Withdrawal by Subject|0|||
37758938|NCT01562275|69268343|FG000|Stage 2|Death|0|||
37758939|NCT01562275|69268344|FG001|Stage 2|Death|0|||
37758940|NCT01562275|69268345|FG002|Stage 2|Death|0|||
37923905|NCT00589914|69610724|FG001|Overall Study|Death|0|||
37758941|NCT01562275|69268346|FG003|Stage 2|Death|0|||
37758942|NCT01562275|69268347|FG004|Stage 2|Death|0|||
37758943|NCT01562275|69268348|FG005|Stage 2|Death|0|||
37758944|NCT01562275|69268349|FG006|Stage 2|Death|0|||
37758945|NCT01562275|69268350|FG007|Stage 2|Death|0|||
37758946|NCT01562275|69268351|FG008|Stage 2|Death|0|||
37758947|NCT01562275|69268352|FG009|Stage 2|Death|0|||
37758948|NCT01562275|69268353|FG010|Stage 2|Death|0|||
37758949|NCT01562275|69268354|FG011|Stage 2|Death|2|||
37758950|NCT01562275|69268355|FG012|Stage 2|Death|1|||
37758951|NCT01562275|69268343|FG000|Stage 2|Progression of Disease|0|||
37758952|NCT01562275|69268344|FG001|Stage 2|Progression of Disease|0|||
37758953|NCT01562275|69268345|FG002|Stage 2|Progression of Disease|0|||
37758954|NCT01562275|69268346|FG003|Stage 2|Progression of Disease|0|||
37758955|NCT01562275|69268347|FG004|Stage 2|Progression of Disease|0|||
37758956|NCT01562275|69268348|FG005|Stage 2|Progression of Disease|0|||
37758957|NCT01562275|69268349|FG006|Stage 2|Progression of Disease|0|||
37758958|NCT01562275|69268350|FG007|Stage 2|Progression of Disease|0|||
37758959|NCT01562275|69268351|FG008|Stage 2|Progression of Disease|0|||
37758960|NCT01562275|69268352|FG009|Stage 2|Progression of Disease|0|||
37758961|NCT01562275|69268353|FG010|Stage 2|Progression of Disease|0|||
37758962|NCT01562275|69268354|FG011|Stage 2|Progression of Disease|12|||
37758963|NCT01562275|69268355|FG012|Stage 2|Progression of Disease|4|||
37758964|NCT01535053|69268387|FG000|Overall Study|Ineligible|1|||
37758965|NCT01535053|69268388|FG001|Overall Study|Ineligible|2|||
37758966|NCT01534663|69268396|FG000|Overall Study|Lost to Follow-up|0|||
37758967|NCT01534663|69268397|FG001|Overall Study|Lost to Follow-up|2|||
37758968|NCT01534663|69268396|FG000|Overall Study|Adverse Event|2|||
37758969|NCT01534663|69268397|FG001|Overall Study|Adverse Event|1|||
37758970|NCT01520909|69268405|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
37758971|NCT01520909|69268406|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
37758972|NCT01520909|69268407|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
37758973|NCT01520909|69268405|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
37758974|NCT01520909|69268406|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
37758975|NCT01520909|69268407|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
37758976|NCT01520909|69268405|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
37758977|NCT01520909|69268406|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
37758978|NCT01520909|69268407|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
37758979|NCT01520909|69268405|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
37758980|NCT01520909|69268406|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
37758981|NCT01520909|69268407|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
37758982|NCT01520363|69268429|FG000|Overall Study|Withdrawal by Subject|2|||
37758983|NCT01520363|69268430|FG001|Overall Study|Withdrawal by Subject|0|||
37758984|NCT01578499|69268462|FG000|Overall Study|Reason not Specified|0|||
37758985|NCT01578499|69268463|FG001|Overall Study|Reason not Specified|1|||
37758986|NCT01578499|69268462|FG000|Overall Study|Lost to Follow-up|2|||
37758987|NCT01578499|69268463|FG001|Overall Study|Lost to Follow-up|1|||
37758988|NCT01578499|69268462|FG000|Overall Study|Withdrawal by Subject|10|||
37758989|NCT01578499|69268463|FG001|Overall Study|Withdrawal by Subject|16|||
37758990|NCT01578499|69268462|FG000|Overall Study|Death|20|||
37758991|NCT01578499|69268463|FG001|Overall Study|Death|25|||
37758992|NCT01578499|69268462|FG000|Overall Study|Died and End of Study Page not Completed|2|||
37758993|NCT01578499|69268463|FG001|Overall Study|Died and End of Study Page not Completed|0|||
37758994|NCT01578187|69268473|FG000|Usability Phase|Withdrawal by Subject|1|||
37758995|NCT01561963|69268479|FG000|Overall Study|Adverse Event|1|||
37758996|NCT01576783|69268490|FG000|Overall Study|Change in Medical Care|1|||
37758997|NCT01576783|69268491|FG001|Overall Study|Change in Medical Care|0|||
37758998|NCT01576783|69268490|FG000|Overall Study|Lost to Follow-up|14|||
37758999|NCT01576783|69268491|FG001|Overall Study|Lost to Follow-up|16|||
37759000|NCT01576783|69268490|FG000|Overall Study|Withdrawal by Subject|5|||
37759001|NCT01576783|69268491|FG001|Overall Study|Withdrawal by Subject|1|||
37759002|NCT01534351|69268500|FG000|Overall Study|Study Terminated Early|1|||
37759003|NCT01534351|69268501|FG001|Overall Study|Study Terminated Early|0|||
37759004|NCT01534351|69268502|FG002|Overall Study|Study Terminated Early|0|||
37759005|NCT01534273|69268514|FG000|Period 1|Physician Decision|0|||
37759006|NCT01534273|69268515|FG001|Period 1|Physician Decision|0|||
37759007|NCT01534273|69268516|FG002|Period 1|Physician Decision|0|||
37759008|NCT01534273|69268517|FG003|Period 1|Physician Decision|1|||
37759009|NCT01534273|69268518|FG004|Period 1|Physician Decision|0|||
37759010|NCT01534273|69268519|FG005|Period 1|Physician Decision|0|||
37759011|NCT01534273|69268520|FG006|Period 1|Physician Decision|0|||
37759012|NCT01534195|69268543|FG000|Overall Study|Withdrawal by Subject|1|||
37759013|NCT01534195|69268544|FG001|Overall Study|Withdrawal by Subject|1|||
37759014|NCT01560949|69268550|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
37759015|NCT01560949|69268550|FG000|Surgery Phase|Physician Decision|3|||
37759016|NCT01372878|69268558|FG000|Overall Study|Withdrawal by Subject|63|||
37759017|NCT01372878|69268558|FG000|Overall Study|Protocol Violation|17|||
37759018|NCT01372878|69268558|FG000|Overall Study|incomplete study procedure|104|||
37759019|NCT01533493|69268564|FG000|Overall Study|Adverse Event|2|||
37759020|NCT01533493|69268565|FG001|Overall Study|Adverse Event|1|||
37759021|NCT01533493|69268564|FG000|Overall Study|Withdrawal by Subject|1|||
37759022|NCT01533493|69268565|FG001|Overall Study|Withdrawal by Subject|2|||
37759023|NCT01533493|69268564|FG000|Overall Study|Lost to Follow-up|2|||
37759024|NCT01533493|69268565|FG001|Overall Study|Lost to Follow-up|0|||
37759025|NCT01533181|69268641|FG000|Overall Study|Disease progression pre-active treatment|0|||
37759026|NCT01533181|69268642|FG001|Overall Study|Disease progression pre-active treatment|1|||
37759027|NCT01533181|69268641|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
37759028|NCT01533181|69268642|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
37759029|NCT02669082|69268648|FG000|Overall Study|Adverse Event|1|||
37759030|NCT02668692|69268712|FG000|Overall Study|Adverse Event|1|||
37759031|NCT02668692|69268713|FG001|Overall Study|Adverse Event|0|||
37759032|NCT02662764|69268727|FG000|Overall Study|Adverse Event|6|||
37759033|NCT02662764|69268727|FG000|Overall Study|Lack of Efficacy|8|||
37759034|NCT02662764|69268727|FG000|Overall Study|Protocol Violation|1|||
37759035|NCT02662764|69268727|FG000|Overall Study|Withdrawal by Subject|5|||
37759036|NCT02662764|69268727|FG000|Overall Study|Device failure|4|||
37759037|NCT02662764|69268727|FG000|Overall Study|Patient changed treatment|1|||
37759038|NCT02662764|69268727|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
37759039|NCT01519817|69268736|FG000|Overall Study|Withdrawal by Subject|1|||
37759040|NCT01519817|69268737|FG001|Overall Study|Withdrawal by Subject|0|||
37759041|NCT01519817|69268738|FG002|Overall Study|Withdrawal by Subject|0|||
37759042|NCT01519817|69268739|FG003|Overall Study|Withdrawal by Subject|0|||
37759043|NCT01519817|69268736|FG000|Overall Study|Off study due to infection|0|||
37759044|NCT01519817|69268737|FG001|Overall Study|Off study due to infection|0|||
37759045|NCT01519817|69268738|FG002|Overall Study|Off study due to infection|0|||
37759046|NCT01519817|69268739|FG003|Overall Study|Off study due to infection|1|||
37759047|NCT01519661|69268749|FG000|Overall Study|Protocol deviation|6|||
37759048|NCT01519661|69268749|FG000|Overall Study|Lost to Follow-up|3|||
37759049|NCT01519661|69268749|FG000|Overall Study|Withdrawal by Subject|17|||
37759050|NCT01519661|69268749|FG000|Overall Study|Lack of Efficacy|6|||
37759051|NCT01519661|69268749|FG000|Overall Study|Adverse Event|29|||
37759052|NCT01519427|69268754|FG000|Overall Study|disease progression|2|||
37759053|NCT01518257|69268760|FG000|Overall Study|Lost to Follow-up|1|||
37759054|NCT01518257|69268761|FG001|Overall Study|Lost to Follow-up|0|||
37859251|NCT01292603|69542618|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
38033389|NCT02586623|69719345|FG001|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
37666454|NCT00700427|69138814|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
37666455|NCT00700427|69138815|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
37666456|NCT00700427|69138816|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
37666457|NCT00700427|69138817|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
37666458|NCT02128763|69138827|FG000|Overall Study|Death|1|||
37666459|NCT02128763|69138828|FG001|Overall Study|Death|0|||
37666460|NCT02128763|69138827|FG000|Overall Study|Lost to Follow-up|19|||
37666461|NCT02128763|69138828|FG001|Overall Study|Lost to Follow-up|16|||
37666462|NCT02124772|69138850|FG000|Overall Study|Lack of Efficacy|2|||
37666463|NCT02124772|69138851|FG001|Overall Study|Lack of Efficacy|0|||
37666464|NCT02124772|69138852|FG002|Overall Study|Lack of Efficacy|0|||
37666465|NCT02124772|69138853|FG003|Overall Study|Lack of Efficacy|1|||
37666466|NCT02124772|69138854|FG004|Overall Study|Lack of Efficacy|2|||
37666467|NCT02124772|69138855|FG005|Overall Study|Lack of Efficacy|3|||
37666468|NCT02124772|69138856|FG006|Overall Study|Lack of Efficacy|0|||
37666469|NCT02124772|69138857|FG007|Overall Study|Lack of Efficacy|2|||
37666470|NCT02124772|69138858|FG008|Overall Study|Lack of Efficacy|0|||
37666471|NCT02124772|69138859|FG009|Overall Study|Lack of Efficacy|1|||
37666472|NCT02124772|69138860|FG010|Overall Study|Lack of Efficacy|0|||
37666473|NCT02124772|69138861|FG011|Overall Study|Lack of Efficacy|0|||
37666474|NCT02124772|69138862|FG012|Overall Study|Lack of Efficacy|1|||
37666475|NCT02124772|69138850|FG000|Overall Study|Adverse Event|1|||
37666476|NCT02124772|69138851|FG001|Overall Study|Adverse Event|4|||
37666477|NCT02124772|69138852|FG002|Overall Study|Adverse Event|1|||
37666478|NCT02124772|69138853|FG003|Overall Study|Adverse Event|5|||
37666479|NCT02124772|69138854|FG004|Overall Study|Adverse Event|2|||
37666480|NCT02124772|69138855|FG005|Overall Study|Adverse Event|1|||
37666481|NCT02124772|69138856|FG006|Overall Study|Adverse Event|1|||
37666482|NCT02124772|69138857|FG007|Overall Study|Adverse Event|5|||
37666483|NCT02124772|69138858|FG008|Overall Study|Adverse Event|0|||
37666484|NCT02124772|69138859|FG009|Overall Study|Adverse Event|3|||
37666485|NCT02124772|69138860|FG010|Overall Study|Adverse Event|1|||
37666486|NCT02124772|69138861|FG011|Overall Study|Adverse Event|3|||
37666487|NCT02124772|69138862|FG012|Overall Study|Adverse Event|1|||
37666488|NCT02124772|69138850|FG000|Overall Study|Withdrawal consent|0|||
37666489|NCT02124772|69138851|FG001|Overall Study|Withdrawal consent|1|||
37859252|NCT01292603|69542619|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
37859253|NCT01292603|69542620|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
37859254|NCT01292603|69542621|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
37859255|NCT01292603|69542622|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
37859256|NCT01292603|69542617|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
37859257|NCT01292603|69542618|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
37666490|NCT02124772|69138852|FG002|Overall Study|Withdrawal consent|1|||
37666491|NCT02124772|69138853|FG003|Overall Study|Withdrawal consent|1|||
37759055|NCT01518257|69268760|FG000|Overall Study|Other Miscellaneous Reason|1|||
37759056|NCT01518257|69268761|FG001|Overall Study|Other Miscellaneous Reason|0|||
37759057|NCT02668302|69268769|FG000|Overall Study|Withdrawal by Subject|1|||
37759058|NCT02668302|69268770|FG001|Overall Study|Withdrawal by Subject|0|||
37759059|NCT01517867|69268778|FG000|Overall Study|never started treatment|29|||
37923906|NCT00589914|69610723|FG000|Overall Study|Lack of Efficacy|40|||
37923907|NCT00589914|69610724|FG001|Overall Study|Lack of Efficacy|43|||
37923908|NCT00589914|69610723|FG000|Overall Study|Lost to Follow-up|11|||
37923909|NCT00589914|69610724|FG001|Overall Study|Lost to Follow-up|18|||
37923910|NCT00589914|69610723|FG000|Overall Study|Pregnancy|1|||
37923911|NCT00589914|69610724|FG001|Overall Study|Pregnancy|0|||
37923912|NCT00589914|69610723|FG000|Overall Study|Withdrawal by Subject|55|||
37923913|NCT00589914|69610724|FG001|Overall Study|Withdrawal by Subject|49|||
37923914|NCT00589914|69610723|FG000|Overall Study|Other|22|||
37923915|NCT00589914|69610724|FG001|Overall Study|Other|17|||
37923916|NCT00789555|69610733|FG000|Overall Study|Protocol Amendment|78|||
37923917|NCT00789555|69610734|FG001|Overall Study|Protocol Amendment|76|||
37923918|NCT00789555|69610735|FG002|Overall Study|Protocol Amendment|80|||
37923919|NCT00789555|69610733|FG000|Overall Study|Adverse Event|17|||
37923920|NCT00789555|69610734|FG001|Overall Study|Adverse Event|7|||
37923921|NCT00789555|69610735|FG002|Overall Study|Adverse Event|10|||
37923922|NCT00789555|69610733|FG000|Overall Study|Lost to Follow-up|9|||
37923923|NCT00789555|69610734|FG001|Overall Study|Lost to Follow-up|10|||
37923924|NCT00789555|69610735|FG002|Overall Study|Lost to Follow-up|18|||
37923925|NCT00789555|69610733|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
37923926|NCT00789555|69610734|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
37923927|NCT00789555|69610735|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
37923928|NCT00789555|69610733|FG000|Overall Study|Treatment failure|11|||
37923929|NCT00789555|69610734|FG001|Overall Study|Treatment failure|8|||
37923930|NCT00789555|69610735|FG002|Overall Study|Treatment failure|12|||
37923931|NCT00789555|69610733|FG000|Overall Study|Protocol Violation|6|||
37923932|NCT00789555|69610734|FG001|Overall Study|Protocol Violation|9|||
37923933|NCT00789555|69610735|FG002|Overall Study|Protocol Violation|13|||
37923934|NCT00451321|69610751|FG000|Overall Study|Lost to Follow-up|3|||
37923935|NCT00451321|69610752|FG001|Overall Study|Lost to Follow-up|3|||
37923936|NCT00451321|69610753|FG002|Overall Study|Lost to Follow-up|1|||
37923937|NCT00451321|69610754|FG003|Overall Study|Lost to Follow-up|3|||
37923938|NCT00451321|69610755|FG004|Overall Study|Lost to Follow-up|0|||
37923939|NCT00451321|69610756|FG005|Overall Study|Lost to Follow-up|1|||
37923940|NCT00451321|69610757|FG006|Overall Study|Lost to Follow-up|0|||
37923941|NCT00451321|69610758|FG007|Overall Study|Lost to Follow-up|0|||
37923942|NCT00451321|69610751|FG000|Overall Study|Withdrawal by Subject|3|||
37923943|NCT00451321|69610752|FG001|Overall Study|Withdrawal by Subject|1|||
37923944|NCT00451321|69610753|FG002|Overall Study|Withdrawal by Subject|0|||
37923945|NCT00451321|69610754|FG003|Overall Study|Withdrawal by Subject|4|||
37923946|NCT00451321|69610755|FG004|Overall Study|Withdrawal by Subject|0|||
37923947|NCT00451321|69610756|FG005|Overall Study|Withdrawal by Subject|0|||
37923948|NCT00451321|69610757|FG006|Overall Study|Withdrawal by Subject|0|||
37923949|NCT00451321|69610758|FG007|Overall Study|Withdrawal by Subject|0|||
37923950|NCT00451321|69610751|FG000|Overall Study|Study closed/terminated|1|||
37923951|NCT00451321|69610752|FG001|Overall Study|Study closed/terminated|1|||
37923952|NCT00451321|69610753|FG002|Overall Study|Study closed/terminated|17|||
37923953|NCT00451321|69610754|FG003|Overall Study|Study closed/terminated|5|||
37923954|NCT00451321|69610755|FG004|Overall Study|Study closed/terminated|7|||
37923955|NCT00451321|69610756|FG005|Overall Study|Study closed/terminated|7|||
37923956|NCT00451321|69610757|FG006|Overall Study|Study closed/terminated|5|||
37923957|NCT00451321|69610758|FG007|Overall Study|Study closed/terminated|3|||
37923958|NCT00451321|69610751|FG000|Overall Study|Sponsor decision to amend protocol|0|||
37923959|NCT00451321|69610752|FG001|Overall Study|Sponsor decision to amend protocol|0|||
37923960|NCT00451321|69610753|FG002|Overall Study|Sponsor decision to amend protocol|0|||
37923961|NCT00451321|69610754|FG003|Overall Study|Sponsor decision to amend protocol|0|||
37923962|NCT00451321|69610755|FG004|Overall Study|Sponsor decision to amend protocol|0|||
37923963|NCT00451321|69610756|FG005|Overall Study|Sponsor decision to amend protocol|1|||
37923964|NCT00451321|69610757|FG006|Overall Study|Sponsor decision to amend protocol|1|||
37923965|NCT00451321|69610758|FG007|Overall Study|Sponsor decision to amend protocol|3|||
37923966|NCT00802464|69610784|FG000|Month 0 - Month 8|Adverse Event|0|||
37923967|NCT00802464|69610785|FG001|Month 0 - Month 8|Adverse Event|1|||
37923968|NCT00802464|69610786|FG002|Month 0 - Month 8|Adverse Event|1|||
37923969|NCT00802464|69610787|FG003|Month 0 - Month 8|Adverse Event|2|||
37666492|NCT02124772|69138854|FG004|Overall Study|Withdrawal consent|0|||
37923970|NCT00802464|69610784|FG000|Month 0 - Month 8|Protocol Violation|0|||
37923971|NCT00802464|69610785|FG001|Month 0 - Month 8|Protocol Violation|0|||
37923972|NCT00802464|69610786|FG002|Month 0 - Month 8|Protocol Violation|1|||
37923973|NCT00802464|69610787|FG003|Month 0 - Month 8|Protocol Violation|0|||
37923974|NCT00802464|69610784|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
37923975|NCT00802464|69610785|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
37923976|NCT00802464|69610786|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
37923977|NCT00802464|69610787|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
37923978|NCT00802464|69610784|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
37923979|NCT00802464|69610785|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
37923980|NCT00802464|69610786|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
37923981|NCT00802464|69610787|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
37923982|NCT00802464|69610784|FG000|Month 0 - Month 8|Other|0|||
37923983|NCT00802464|69610785|FG001|Month 0 - Month 8|Other|0|||
37923984|NCT00802464|69610786|FG002|Month 0 - Month 8|Other|1|||
37923985|NCT00802464|69610787|FG003|Month 0 - Month 8|Other|0|||
37923986|NCT00802464|69610784|FG000|Month 8 - Month 14|Adverse Event|0|||
37923987|NCT00802464|69610785|FG001|Month 8 - Month 14|Adverse Event|1|||
37923988|NCT00802464|69610786|FG002|Month 8 - Month 14|Adverse Event|0|||
37923989|NCT00802464|69610787|FG003|Month 8 - Month 14|Adverse Event|0|||
37923990|NCT00802464|69610784|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
37923991|NCT00802464|69610785|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
37923992|NCT00802464|69610786|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
37923993|NCT00802464|69610787|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
37923994|NCT00802464|69610784|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
37923995|NCT00802464|69610785|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
37923996|NCT00802464|69610786|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
37923997|NCT00802464|69610787|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
37923998|NCT00450619|69610801|FG000|Overall Study|refused treatment after randomization|2|||
37923999|NCT00450619|69610802|FG001|Overall Study|refused treatment after randomization|0|||
37924000|NCT00450619|69610801|FG000|Overall Study|did not progress; refused further trmt|1|||
37924001|NCT00450619|69610802|FG001|Overall Study|did not progress; refused further trmt|1|||
37924002|NCT00450619|69610801|FG000|Overall Study|Adverse Event|1|||
38033390|NCT02586623|69719346|FG002|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
37759060|NCT01517867|69268779|FG001|Overall Study|never started treatment|32|||
37759061|NCT01517867|69268778|FG000|Overall Study|Withdrawal by Subject|34|||
37759062|NCT01517867|69268779|FG001|Overall Study|Withdrawal by Subject|30|||
37759063|NCT01517867|69268778|FG000|Overall Study|Still in treatment at study end|0|||
37759064|NCT01517867|69268779|FG001|Overall Study|Still in treatment at study end|3|||
37759065|NCT01514357|69268787|FG000|Overall Study|Screen failure|2|||
37759066|NCT01514357|69268788|FG001|Overall Study|Screen failure|0|||
37759067|NCT01514357|69268787|FG000|Overall Study|Withdrawal by Subject|2|||
37759068|NCT01514357|69268788|FG001|Overall Study|Withdrawal by Subject|0|||
37759069|NCT01532869|69268796|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
37759070|NCT01532869|69268797|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
37759071|NCT01532869|69268796|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
37759072|NCT01532869|69268797|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
38033391|NCT02586623|69719344|FG000|Open-Label (Up to 16 Weeks)|Site closing|3|||
38033392|NCT02586623|69719345|FG001|Open-Label (Up to 16 Weeks)|Site closing|0|||
37666493|NCT02124772|69138855|FG005|Overall Study|Withdrawal consent|1|||
37666494|NCT02124772|69138856|FG006|Overall Study|Withdrawal consent|1|||
37759073|NCT01532869|69268796|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
37759074|NCT01532869|69268797|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
37759075|NCT01532869|69268796|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
37759076|NCT01532869|69268797|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
37759077|NCT01532869|69268796|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
37759078|NCT01532869|69268797|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
37759079|NCT01532869|69268796|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
37666495|NCT02124772|69138857|FG007|Overall Study|Withdrawal consent|0|||
37666496|NCT02124772|69138858|FG008|Overall Study|Withdrawal consent|0|||
37666497|NCT02124772|69138859|FG009|Overall Study|Withdrawal consent|1|||
37666498|NCT02124772|69138860|FG010|Overall Study|Withdrawal consent|0|||
37666499|NCT02124772|69138861|FG011|Overall Study|Withdrawal consent|1|||
37666500|NCT02124772|69138862|FG012|Overall Study|Withdrawal consent|0|||
37666501|NCT02124772|69138850|FG000|Overall Study|Investigator discretion|0|||
37666502|NCT02124772|69138851|FG001|Overall Study|Investigator discretion|2|||
37666503|NCT02124772|69138852|FG002|Overall Study|Investigator discretion|2|||
37666504|NCT02124772|69138853|FG003|Overall Study|Investigator discretion|1|||
37666505|NCT02124772|69138854|FG004|Overall Study|Investigator discretion|1|||
37666506|NCT02124772|69138855|FG005|Overall Study|Investigator discretion|0|||
37759080|NCT01532869|69268797|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
37759081|NCT01532869|69268796|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
37859258|NCT01292603|69542619|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
37859259|NCT01292603|69542620|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
37859260|NCT01292603|69542621|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
37859261|NCT01292603|69542622|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
37859262|NCT01292603|69542617|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
37859263|NCT01292603|69542618|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
37859264|NCT01292603|69542619|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
37859265|NCT01292603|69542620|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
37924003|NCT00450619|69610802|FG001|Overall Study|Adverse Event|0|||
37924004|NCT00802074|69610815|FG000|Overall Study|Adverse Event|1|||
37924005|NCT00802074|69610816|FG001|Overall Study|Adverse Event|1|||
37924006|NCT00802074|69610817|FG002|Overall Study|Adverse Event|1|||
37666507|NCT02124772|69138856|FG006|Overall Study|Investigator discretion|1|||
37924007|NCT00802074|69610818|FG003|Overall Study|Adverse Event|0|||
37924008|NCT00802074|69610819|FG004|Overall Study|Adverse Event|0|||
37924009|NCT00802074|69610820|FG005|Overall Study|Adverse Event|0|||
37924010|NCT00802074|69610815|FG000|Overall Study|Withdrawal by Subject|1|||
37924011|NCT00802074|69610816|FG001|Overall Study|Withdrawal by Subject|0|||
37924012|NCT00802074|69610817|FG002|Overall Study|Withdrawal by Subject|0|||
37924013|NCT00802074|69610818|FG003|Overall Study|Withdrawal by Subject|0|||
37924014|NCT00802074|69610819|FG004|Overall Study|Withdrawal by Subject|0|||
37924015|NCT00802074|69610820|FG005|Overall Study|Withdrawal by Subject|0|||
37924016|NCT00450385|69610837|FG000|Overall Study|Death|3|||
37924017|NCT00450385|69610837|FG000|Overall Study|Protocol Violation|1|||
37924018|NCT00450385|69610837|FG000|Overall Study|Withdrawal by Subject|2|||
37924019|NCT00450385|69610837|FG000|Overall Study|Lack of Efficacy|2|||
37924020|NCT00450385|69610837|FG000|Overall Study|Adverse Event|1|||
37924021|NCT00450385|69610837|FG000|Overall Study|Physician Decision|1|||
37924022|NCT00450385|69610837|FG000|Overall Study|Other|3|||
37924023|NCT00588354|69610844|FG000|Baseline to 2 Weeks|Adverse Event|1|||
37924024|NCT00588354|69610845|FG001|Baseline to 2 Weeks|Adverse Event|0|||
37759082|NCT01532869|69268797|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
37759083|NCT01532869|69268796|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
37759084|NCT01532869|69268797|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
37759085|NCT01532869|69268796|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
37759086|NCT01532869|69268797|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
37759087|NCT01532869|69268796|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
37759088|NCT01532869|69268797|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
37759089|NCT01532869|69268796|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
37759090|NCT01532869|69268797|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
37759091|NCT01532869|69268796|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
37759092|NCT01532869|69268797|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
37759093|NCT01532869|69268796|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
37759094|NCT01532869|69268797|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
37759095|NCT01532869|69268796|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
37759096|NCT01532869|69268797|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
37759097|NCT01532869|69268796|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
37759098|NCT01532869|69268797|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
37759099|NCT01532869|69268796|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
37759100|NCT01532869|69268797|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
37759101|NCT01532869|69268796|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
37759102|NCT01532869|69268797|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
37759103|NCT01531387|69268810|FG000|Overall Study|Early termination of study|11|||
37759104|NCT01531387|69268811|FG001|Overall Study|Early termination of study|11|||
37759105|NCT01531153|69268820|FG000|Overall Study|Withdrawal by Subject|10|||
37759106|NCT01531153|69268821|FG001|Overall Study|Withdrawal by Subject|9|||
37759107|NCT01531153|69268822|FG002|Overall Study|Withdrawal by Subject|15|||
37759108|NCT01529749|69268837|FG000|Overall Study|Lost to Follow-up|0|||
37759109|NCT01529749|69268838|FG001|Overall Study|Lost to Follow-up|1|||
37759110|NCT01529749|69268839|FG002|Overall Study|Lost to Follow-up|1|||
37759111|NCT01529749|69268840|FG003|Overall Study|Lost to Follow-up|0|||
37759112|NCT01529749|69268837|FG000|Overall Study|Physician Decision|0|||
37759113|NCT01529749|69268838|FG001|Overall Study|Physician Decision|0|||
37759114|NCT01529749|69268839|FG002|Overall Study|Physician Decision|0|||
37759115|NCT01529749|69268840|FG003|Overall Study|Physician Decision|1|||
37759116|NCT01529749|69268837|FG000|Overall Study|Withdrawal by Subject|0|||
37924025|NCT00588354|69610844|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
37924026|NCT00588354|69610845|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
37666508|NCT02124772|69138857|FG007|Overall Study|Investigator discretion|0|||
37666509|NCT02124772|69138858|FG008|Overall Study|Investigator discretion|0|||
37666510|NCT02124772|69138859|FG009|Overall Study|Investigator discretion|1|||
37666511|NCT02124772|69138860|FG010|Overall Study|Investigator discretion|0|||
37666512|NCT02124772|69138861|FG011|Overall Study|Investigator discretion|1|||
37666513|NCT02124772|69138862|FG012|Overall Study|Investigator discretion|0|||
37666514|NCT02124772|69138850|FG000|Overall Study|Progressive disease|0|||
37666515|NCT02124772|69138851|FG001|Overall Study|Progressive disease|0|||
37759117|NCT01529749|69268838|FG001|Overall Study|Withdrawal by Subject|1|||
37759118|NCT01529749|69268839|FG002|Overall Study|Withdrawal by Subject|1|||
37759119|NCT01529749|69268840|FG003|Overall Study|Withdrawal by Subject|0|||
37759120|NCT01529749|69268837|FG000|Overall Study|Protocol Violation|0|||
37759121|NCT01529749|69268838|FG001|Overall Study|Protocol Violation|0|||
37924027|NCT00588354|69610844|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
37924028|NCT00588354|69610845|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
37924029|NCT00449761|69610852|FG000|Overall Study|Disease progression|12|||
37924030|NCT00449761|69610852|FG000|Overall Study|Death|5|||
37666516|NCT02124772|69138852|FG002|Overall Study|Progressive disease|0|||
37666517|NCT02124772|69138853|FG003|Overall Study|Progressive disease|0|||
37859266|NCT01292603|69542621|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
37924031|NCT00449761|69610852|FG000|Overall Study|New cancer therapy|1|||
37924032|NCT00800982|69610859|FG000|Overall Study|Lost to Follow-up|1|||
37924033|NCT00800982|69610860|FG001|Overall Study|Lost to Follow-up|2|||
37924034|NCT00800982|69610859|FG000|Overall Study|Withdrawal by Subject|0|||
37924035|NCT00800982|69610860|FG001|Overall Study|Withdrawal by Subject|1|||
37924036|NCT00800982|69610859|FG000|Overall Study|Patient moved out of state|1|||
37924037|NCT00800982|69610860|FG001|Overall Study|Patient moved out of state|0|||
37924038|NCT00830960|69610872|FG000|Overall Study|Death|5|||
37924039|NCT00830960|69610873|FG001|Overall Study|Death|4|||
37924040|NCT00830960|69610874|FG002|Overall Study|Death|3|||
37924041|NCT00830960|69610875|FG003|Overall Study|Death|2|||
37924042|NCT00830960|69610876|FG004|Overall Study|Death|6|||
37924043|NCT00830960|69610877|FG005|Overall Study|Death|1|||
37924044|NCT00830960|69610872|FG000|Overall Study|Lost to Follow-up|1|||
37924045|NCT00830960|69610873|FG001|Overall Study|Lost to Follow-up|1|||
37924046|NCT00830960|69610874|FG002|Overall Study|Lost to Follow-up|1|||
37924047|NCT00830960|69610875|FG003|Overall Study|Lost to Follow-up|0|||
37924048|NCT00830960|69610876|FG004|Overall Study|Lost to Follow-up|0|||
37924049|NCT00830960|69610877|FG005|Overall Study|Lost to Follow-up|1|||
37924050|NCT00830960|69610872|FG000|Overall Study|Withdrawal by Subject|19|||
37666518|NCT02124772|69138854|FG004|Overall Study|Progressive disease|0|||
37924051|NCT00830960|69610873|FG001|Overall Study|Withdrawal by Subject|19|||
37924052|NCT00830960|69610874|FG002|Overall Study|Withdrawal by Subject|18|||
37924053|NCT00830960|69610875|FG003|Overall Study|Withdrawal by Subject|23|||
37924054|NCT00830960|69610876|FG004|Overall Study|Withdrawal by Subject|16|||
37924055|NCT00830960|69610877|FG005|Overall Study|Withdrawal by Subject|21|||
37924056|NCT00830960|69610872|FG000|Overall Study|Sponsor Decision|1|||
37924057|NCT00830960|69610873|FG001|Overall Study|Sponsor Decision|2|||
37924058|NCT00830960|69610874|FG002|Overall Study|Sponsor Decision|3|||
37924059|NCT00830960|69610875|FG003|Overall Study|Sponsor Decision|4|||
37924060|NCT00830960|69610876|FG004|Overall Study|Sponsor Decision|5|||
37924061|NCT00830960|69610877|FG005|Overall Study|Sponsor Decision|7|||
37924062|NCT00830960|69610872|FG000|Overall Study|No study drug received|7|||
37924063|NCT00830960|69610873|FG001|Overall Study|No study drug received|2|||
37924064|NCT00830960|69610874|FG002|Overall Study|No study drug received|4|||
37924065|NCT00830960|69610875|FG003|Overall Study|No study drug received|3|||
37924066|NCT00830960|69610876|FG004|Overall Study|No study drug received|5|||
37924067|NCT00830960|69610877|FG005|Overall Study|No study drug received|7|||
37924068|NCT00830804|69610914|FG000|Overall Study|Lost to Follow-up|4|||
37924069|NCT00830804|69610914|FG000|Overall Study|Death|1|||
37924070|NCT00830804|69610914|FG000|Overall Study|Unable to get to clinic|7|||
37924071|NCT00830804|69610914|FG000|Overall Study|Consent withdrawn|2|||
37924072|NCT00830804|69610914|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
37924073|NCT00789477|69610924|FG000|Overall Study|Withdrawal by Subject|2|||
37924074|NCT00789477|69610925|FG001|Overall Study|Withdrawal by Subject|1|||
37666519|NCT02124772|69138855|FG005|Overall Study|Progressive disease|0|||
37666520|NCT02124772|69138856|FG006|Overall Study|Progressive disease|1|||
37666521|NCT02124772|69138857|FG007|Overall Study|Progressive disease|1|||
37666522|NCT02124772|69138858|FG008|Overall Study|Progressive disease|0|||
37666523|NCT02124772|69138859|FG009|Overall Study|Progressive disease|0|||
37666524|NCT02124772|69138860|FG010|Overall Study|Progressive disease|0|||
37666525|NCT02124772|69138861|FG011|Overall Study|Progressive disease|0|||
37666526|NCT02124772|69138862|FG012|Overall Study|Progressive disease|0|||
37666527|NCT02124772|69138850|FG000|Overall Study|Other|0|||
37666528|NCT02124772|69138851|FG001|Overall Study|Other|7|||
37666529|NCT02124772|69138852|FG002|Overall Study|Other|2|||
37859267|NCT01292603|69542622|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
37859268|NCT01292603|69542617|FG000|Part 2: Regular Follow-Up|Death|0|||
37859269|NCT01292603|69542618|FG001|Part 2: Regular Follow-Up|Death|0|||
37859270|NCT01292603|69542619|FG002|Part 2: Regular Follow-Up|Death|0|||
37859271|NCT01292603|69542620|FG003|Part 2: Regular Follow-Up|Death|0|||
37859272|NCT01292603|69542621|FG004|Part 2: Regular Follow-Up|Death|6|||
37859273|NCT01292603|69542622|FG005|Part 2: Regular Follow-Up|Death|3|||
37859274|NCT01292603|69542617|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
37924075|NCT00789477|69610926|FG002|Overall Study|Withdrawal by Subject|3|||
37924076|NCT00789477|69610927|FG003|Overall Study|Withdrawal by Subject|2|||
37924077|NCT00789477|69610928|FG004|Overall Study|Withdrawal by Subject|3|||
37924078|NCT00789477|69610924|FG000|Overall Study|Protocol Violation|1|||
37924079|NCT00789477|69610925|FG001|Overall Study|Protocol Violation|0|||
37924080|NCT00789477|69610926|FG002|Overall Study|Protocol Violation|0|||
37924081|NCT00789477|69610927|FG003|Overall Study|Protocol Violation|1|||
37666530|NCT02124772|69138853|FG003|Overall Study|Other|5|||
37666531|NCT02124772|69138854|FG004|Overall Study|Other|4|||
37666532|NCT02124772|69138855|FG005|Overall Study|Other|3|||
37666533|NCT02124772|69138856|FG006|Overall Study|Other|4|||
37924082|NCT00789477|69610928|FG004|Overall Study|Protocol Violation|0|||
37924083|NCT00789477|69610924|FG000|Overall Study|Adverse Event|3|||
37924084|NCT00789477|69610925|FG001|Overall Study|Adverse Event|3|||
37759122|NCT01529749|69268839|FG002|Overall Study|Protocol Violation|0|||
37759123|NCT01529749|69268840|FG003|Overall Study|Protocol Violation|1|||
37759124|NCT01529515|69268852|FG000|TRANSITION PHASE|Adverse Event|16|||
37924085|NCT00789477|69610926|FG002|Overall Study|Adverse Event|1|||
37924086|NCT00789477|69610927|FG003|Overall Study|Adverse Event|0|||
37924087|NCT00789477|69610928|FG004|Overall Study|Adverse Event|0|||
37924088|NCT00789477|69610924|FG000|Overall Study|Death|1|||
37924089|NCT00789477|69610925|FG001|Overall Study|Death|1|||
37924090|NCT00789477|69610926|FG002|Overall Study|Death|2|||
37924091|NCT00789477|69610927|FG003|Overall Study|Death|2|||
37924092|NCT00789477|69610928|FG004|Overall Study|Death|0|||
37924093|NCT00789477|69610924|FG000|Overall Study|Lost to Follow-up|0|||
37924094|NCT00789477|69610925|FG001|Overall Study|Lost to Follow-up|1|||
37924095|NCT00789477|69610926|FG002|Overall Study|Lost to Follow-up|4|||
37924096|NCT00789477|69610927|FG003|Overall Study|Lost to Follow-up|2|||
37924097|NCT00789477|69610928|FG004|Overall Study|Lost to Follow-up|4|||
37924098|NCT00789477|69610924|FG000|Overall Study|Lack of Efficacy|2|||
37924099|NCT00789477|69610925|FG001|Overall Study|Lack of Efficacy|0|||
37924100|NCT00789477|69610926|FG002|Overall Study|Lack of Efficacy|0|||
37924101|NCT00789477|69610927|FG003|Overall Study|Lack of Efficacy|0|||
37924102|NCT00789477|69610928|FG004|Overall Study|Lack of Efficacy|0|||
37924103|NCT00789477|69610924|FG000|Overall Study|Other|2|||
37924104|NCT00789477|69610925|FG001|Overall Study|Other|0|||
37759125|NCT01529515|69268853|FG001|TRANSITION PHASE|Adverse Event|0|||
37759126|NCT01529515|69268854|FG002|TRANSITION PHASE|Adverse Event|0|||
37759127|NCT01529515|69268855|FG003|TRANSITION PHASE|Adverse Event|0|||
37759128|NCT01529515|69268852|FG000|TRANSITION PHASE|Death|1|||
37759129|NCT01529515|69268853|FG001|TRANSITION PHASE|Death|0|||
37759130|NCT01529515|69268854|FG002|TRANSITION PHASE|Death|0|||
37759131|NCT01529515|69268855|FG003|TRANSITION PHASE|Death|0|||
37759132|NCT01529515|69268852|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
37759133|NCT01529515|69268853|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
37759134|NCT01529515|69268854|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
37759135|NCT01529515|69268855|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
37759136|NCT01529515|69268852|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
37666534|NCT02124772|69138857|FG007|Overall Study|Other|1|||
37666535|NCT02124772|69138858|FG008|Overall Study|Other|1|||
37759137|NCT01529515|69268853|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
37759138|NCT01529515|69268854|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
37759139|NCT01529515|69268855|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
37759140|NCT01529515|69268852|FG000|TRANSITION PHASE|Protocol Violation|4|||
37759141|NCT01529515|69268853|FG001|TRANSITION PHASE|Protocol Violation|0|||
37759142|NCT01529515|69268854|FG002|TRANSITION PHASE|Protocol Violation|0|||
37759143|NCT01529515|69268855|FG003|TRANSITION PHASE|Protocol Violation|0|||
37759144|NCT01529515|69268852|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
37759145|NCT01529515|69268853|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
37759146|NCT01529515|69268854|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
37759147|NCT01529515|69268855|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
37759148|NCT01529515|69268852|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
37759149|NCT01529515|69268853|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
37759150|NCT01529515|69268854|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
37759151|NCT01529515|69268855|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
37759152|NCT01529515|69268852|FG000|TRANSITION PHASE|Other|9|||
37759153|NCT01529515|69268853|FG001|TRANSITION PHASE|Other|0|||
37759154|NCT01529515|69268854|FG002|TRANSITION PHASE|Other|0|||
37924105|NCT00789477|69610926|FG002|Overall Study|Other|1|||
37924106|NCT00789477|69610927|FG003|Overall Study|Other|3|||
37666536|NCT02124772|69138859|FG009|Overall Study|Other|1|||
37666537|NCT02124772|69138860|FG010|Overall Study|Other|1|||
37666538|NCT02124772|69138861|FG011|Overall Study|Other|1|||
37666539|NCT02124772|69138862|FG012|Overall Study|Other|0|||
37666540|NCT02159482|69138914|FG000|Overall Study|Withdrawal by Subject|2|||
37666541|NCT02159482|69138914|FG000|Overall Study|Physician Decision|3|||
37666542|NCT02622321|69138922|FG000|Overall Study|Withdrawal by Subject|2|||
37759155|NCT01529515|69268855|FG003|TRANSITION PHASE|Other|0|||
37924107|NCT00789477|69610928|FG004|Overall Study|Other|0|||
37924108|NCT00796614|69610946|FG000|Overall Study|Adverse Event|1|||
37924109|NCT00796614|69610947|FG001|Overall Study|Adverse Event|2|||
37666543|NCT02622321|69138923|FG001|Overall Study|Withdrawal by Subject|0|||
37759156|NCT01529515|69268852|FG000|MAINTENANCE PHASE|Adverse Event|0|||
37759157|NCT01529515|69268853|FG001|MAINTENANCE PHASE|Adverse Event|10|||
37759158|NCT01529515|69268854|FG002|MAINTENANCE PHASE|Adverse Event|0|||
37759159|NCT01529515|69268855|FG003|MAINTENANCE PHASE|Adverse Event|0|||
37759160|NCT01529515|69268852|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
37759161|NCT01529515|69268853|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
37924110|NCT00796614|69610948|FG002|Overall Study|Adverse Event|0|||
37924111|NCT00796614|69610949|FG003|Overall Study|Adverse Event|0|||
37924112|NCT00796614|69610946|FG000|Overall Study|Protocol Violation|0|||
37924113|NCT00796614|69610947|FG001|Overall Study|Protocol Violation|0|||
37924114|NCT00796614|69610948|FG002|Overall Study|Protocol Violation|2|||
37924115|NCT00796614|69610949|FG003|Overall Study|Protocol Violation|0|||
37924116|NCT00796614|69610946|FG000|Overall Study|Lost to Follow-up|2|||
37924117|NCT00796614|69610947|FG001|Overall Study|Lost to Follow-up|2|||
37924118|NCT00796614|69610948|FG002|Overall Study|Lost to Follow-up|1|||
37924119|NCT00796614|69610949|FG003|Overall Study|Lost to Follow-up|0|||
37924120|NCT00796614|69610946|FG000|Overall Study|Withdrawal by Subject|1|||
37924121|NCT00796614|69610947|FG001|Overall Study|Withdrawal by Subject|0|||
37924122|NCT00796614|69610948|FG002|Overall Study|Withdrawal by Subject|0|||
37924123|NCT00796614|69610949|FG003|Overall Study|Withdrawal by Subject|1|||
37924124|NCT00796614|69610946|FG000|Overall Study|Other than stated|1|||
37924125|NCT00796614|69610947|FG001|Overall Study|Other than stated|0|||
37924126|NCT00796614|69610948|FG002|Overall Study|Other than stated|0|||
37924127|NCT00796614|69610949|FG003|Overall Study|Other than stated|0|||
37924128|NCT00448747|69610961|FG000|Overall Study|collapsed veins|1|||
37924129|NCT00448747|69610962|FG001|Overall Study|collapsed veins|0|||
37924130|NCT00830180|69610978|FG000|Overall Study|Adverse Event|6|||
37924131|NCT00830180|69610978|FG000|Overall Study|Death|11|||
37924132|NCT00830180|69610978|FG000|Overall Study|Insufficient clinical response|1|||
37924133|NCT00830180|69610978|FG000|Overall Study|Withdrawal by Subject|5|||
37924134|NCT00830180|69610978|FG000|Overall Study|Progressive disease|2|||
37924135|NCT00830180|69610978|FG000|Overall Study|Other - Unspecified|1|||
37924136|NCT00789321|69610986|FG000|Overall Study|Adverse Event|0|||
37924137|NCT00789321|69610987|FG001|Overall Study|Adverse Event|1|||
37924138|NCT00811928|69610995|FG000|Overall Study|AEs and SAEs Including Death|7|||
37924139|NCT00811928|69610996|FG001|Overall Study|AEs and SAEs Including Death|11|||
37924140|NCT00811928|69610995|FG000|Overall Study|Withdrawal by Subject|18|||
37924141|NCT00811928|69610996|FG001|Overall Study|Withdrawal by Subject|12|||
37924142|NCT00811928|69610995|FG000|Overall Study|Did Not Take Study Drug|3|||
37924143|NCT00811928|69610996|FG001|Overall Study|Did Not Take Study Drug|0|||
37924144|NCT00811928|69610995|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
37924145|NCT00811928|69610996|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
37924146|NCT00811928|69610995|FG000|Overall Study|Investigator Decision|2|||
37924147|NCT00811928|69610996|FG001|Overall Study|Investigator Decision|1|||
37924148|NCT00811928|69610995|FG000|Overall Study|Poor Compliance|2|||
37924149|NCT00811928|69610996|FG001|Overall Study|Poor Compliance|5|||
37924150|NCT00788775|69611004|FG000|Overall Study|Progressive Disease|8|||
37924151|NCT00788775|69611005|FG001|Overall Study|Progressive Disease|6|||
37924152|NCT00788775|69611004|FG000|Overall Study|Withdrawal by Subject|0|||
37924153|NCT00788775|69611005|FG001|Overall Study|Withdrawal by Subject|2|||
37924154|NCT00788775|69611004|FG000|Overall Study|Patient Non-Compliance|1|||
37924155|NCT00788775|69611005|FG001|Overall Study|Patient Non-Compliance|0|||
37924156|NCT00788775|69611004|FG000|Overall Study|Patient's measurable disease resected.|1|||
37924157|NCT00788775|69611005|FG001|Overall Study|Patient's measurable disease resected.|0|||
37924158|NCT00448669|69611013|FG000|Overall Study|Lost to Follow-up|52|||
37924159|NCT00448669|69611014|FG001|Overall Study|Lost to Follow-up|63|||
37924160|NCT00448669|69611013|FG000|Overall Study|Withdrawal by Subject|90|||
37924161|NCT00448669|69611014|FG001|Overall Study|Withdrawal by Subject|74|||
37924162|NCT00448669|69611013|FG000|Overall Study|Relocated|49|||
37924163|NCT00448669|69611014|FG001|Overall Study|Relocated|36|||
37924164|NCT00448669|69611013|FG000|Overall Study|Were withdrawn by investigator|10|||
37924165|NCT00448669|69611014|FG001|Overall Study|Were withdrawn by investigator|6|||
37924166|NCT00448669|69611013|FG000|Overall Study|Death|2|||
37924167|NCT00448669|69611014|FG001|Overall Study|Death|4|||
38033393|NCT02586623|69719346|FG002|Open-Label (Up to 16 Weeks)|Site closing|0|||
38033394|NCT02586623|69719344|FG000|Double-Blind (Up to 12 Weeks)|Adverse Event|0|||
38033395|NCT02586623|69719345|FG001|Double-Blind (Up to 12 Weeks)|Adverse Event|6|||
38033396|NCT02586623|69719346|FG002|Double-Blind (Up to 12 Weeks)|Adverse Event|4|||
38033397|NCT02586623|69719344|FG000|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|0|||
38033398|NCT02586623|69719345|FG001|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|1|||
38033399|NCT02586623|69719346|FG002|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|2|||
38033400|NCT02586623|69719344|FG000|Double-Blind (Up to 12 Weeks)|Non-compliance|0|||
38033401|NCT02586623|69719345|FG001|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
37666544|NCT02622321|69138924|FG002|Overall Study|Withdrawal by Subject|0|||
37924168|NCT00448669|69611013|FG000|Overall Study|Had other reasons|5|||
37924169|NCT00448669|69611014|FG001|Overall Study|Had other reasons|6|||
37924170|NCT00448669|69611013|FG000|Overall Study|HIV-infected at enrollment|1|||
37924171|NCT00448669|69611014|FG001|Overall Study|HIV-infected at enrollment|2|||
37924172|NCT00448669|69611013|FG000|Overall Study|Never started drug|9|||
37924173|NCT00448669|69611014|FG001|Overall Study|Never started drug|7|||
38033402|NCT02586623|69719346|FG002|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
37666545|NCT02622321|69138925|FG003|Overall Study|Withdrawal by Subject|0|||
37924174|NCT00591734|69611022|FG000|Overall Study|Lack of Efficacy|35|||
37924175|NCT00591734|69611022|FG000|Overall Study|Adverse Event|5|||
37924176|NCT00591734|69611022|FG000|Overall Study|Physician Decision|5|||
37924177|NCT00591734|69611022|FG000|Overall Study|Intercurrent Illness|8|||
37924178|NCT00788697|69611026|FG000|Overall Study|No study drug administered|12|||
37924179|NCT00788697|69611026|FG000|Overall Study|Training Patients|74|||
37924180|NCT00788697|69611026|FG000|Overall Study|no truth standard procedure available|5|||
37924181|NCT00788697|69611026|FG000|Overall Study|Technically inadequate truth standard|1|||
37924182|NCT00788697|69611026|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
37924183|NCT00848549|69611040|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
37924184|NCT00848549|69611041|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
37924185|NCT00848549|69611040|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
37924186|NCT00848549|69611041|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
37924187|NCT00848549|69611040|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
37924188|NCT00848549|69611041|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
37924189|NCT00848549|69611040|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
37924190|NCT00848549|69611041|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
37924191|NCT00848549|69611040|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
38033403|NCT02586623|69719344|FG000|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
38033404|NCT02586623|69719345|FG001|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
37666546|NCT02622321|69138922|FG000|Overall Study|Death|0|||
37666547|NCT02622321|69138923|FG001|Overall Study|Death|0|||
37666548|NCT02622321|69138924|FG002|Overall Study|Death|1|||
37666549|NCT02622321|69138925|FG003|Overall Study|Death|0|||
37759162|NCT01529515|69268854|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
37759163|NCT01529515|69268855|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
37666550|NCT02622321|69138922|FG000|Overall Study|Physician Decision|1|||
37666551|NCT02622321|69138923|FG001|Overall Study|Physician Decision|0|||
37666552|NCT02622321|69138924|FG002|Overall Study|Physician Decision|0|||
37666553|NCT02622321|69138925|FG003|Overall Study|Physician Decision|0|||
37666554|NCT02187172|69138951|FG000|Overall Study|Lost to Follow-up|1|||
37666555|NCT02187172|69138952|FG001|Overall Study|Lost to Follow-up|2|||
37666556|NCT02187172|69138951|FG000|Overall Study|Lack of Efficacy|1|||
37666557|NCT02187172|69138952|FG001|Overall Study|Lack of Efficacy|2|||
37666558|NCT02187172|69138951|FG000|Overall Study|Adverse Event|0|||
37666559|NCT02187172|69138952|FG001|Overall Study|Adverse Event|1|||
37666560|NCT02187172|69138951|FG000|Overall Study|Physician Decision|1|||
37666561|NCT02187172|69138952|FG001|Overall Study|Physician Decision|1|||
37666562|NCT02621931|69138963|FG000|Overall Study|Death|0|||
37666563|NCT02621931|69138964|FG001|Overall Study|Death|1|||
37666564|NCT02621931|69138965|FG002|Overall Study|Death|0|||
37666565|NCT02621931|69138963|FG000|Overall Study|Adverse Event|8|||
37666566|NCT02621931|69138964|FG001|Overall Study|Adverse Event|5|||
37666567|NCT02621931|69138965|FG002|Overall Study|Adverse Event|7|||
37666568|NCT02621931|69138963|FG000|Overall Study|Withdrawal by Subject|12|||
37666569|NCT02621931|69138964|FG001|Overall Study|Withdrawal by Subject|10|||
37666570|NCT02621931|69138965|FG002|Overall Study|Withdrawal by Subject|11|||
37666571|NCT02621931|69138963|FG000|Overall Study|Protocol Violation|2|||
37666572|NCT02621931|69138964|FG001|Overall Study|Protocol Violation|2|||
37666573|NCT02621931|69138965|FG002|Overall Study|Protocol Violation|2|||
37666574|NCT02621931|69138963|FG000|Overall Study|Pregnancy|2|||
37666575|NCT02621931|69138964|FG001|Overall Study|Pregnancy|0|||
37666576|NCT02621931|69138965|FG002|Overall Study|Pregnancy|0|||
37666577|NCT02621931|69138963|FG000|Overall Study|Noncompliance to study procedures|0|||
37666578|NCT02621931|69138964|FG001|Overall Study|Noncompliance to study procedures|1|||
37666579|NCT02621931|69138965|FG002|Overall Study|Noncompliance to study procedures|2|||
37666580|NCT02621931|69138963|FG000|Overall Study|Lost to Follow-up|8|||
37666581|NCT02621931|69138964|FG001|Overall Study|Lost to Follow-up|7|||
37759164|NCT01529515|69268852|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
37759165|NCT01529515|69268853|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
37759166|NCT01529515|69268854|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
37759167|NCT01529515|69268855|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
37759168|NCT01529515|69268852|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
37759169|NCT01529515|69268853|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
37759170|NCT01529515|69268854|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
37924192|NCT00848549|69611041|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
37924193|NCT00848549|69611040|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
37924194|NCT00848549|69611041|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
37924195|NCT00848549|69611040|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
38033405|NCT02586623|69719346|FG002|Double-Blind (Up to 12 Weeks)|Physician Decision|1|||
37666582|NCT02621931|69138965|FG002|Overall Study|Lost to Follow-up|10|||
37666583|NCT02621931|69138963|FG000|Overall Study|Lack of Efficacy|0|||
37666584|NCT02621931|69138964|FG001|Overall Study|Lack of Efficacy|0|||
37666585|NCT02621931|69138965|FG002|Overall Study|Lack of Efficacy|1|||
38033406|NCT02586623|69719344|FG000|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
37666586|NCT02621931|69138963|FG000|Overall Study|Other|1|||
37666587|NCT02621931|69138964|FG001|Overall Study|Other|1|||
37759171|NCT01529515|69268855|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
38033407|NCT02586623|69719345|FG001|Double-Blind (Up to 12 Weeks)|Protocol Violation|3|||
37666588|NCT02621931|69138965|FG002|Overall Study|Other|3|||
37666589|NCT02621073|69138977|FG000|Overall Study|Lost to Follow-up|0|||
37924196|NCT00848549|69611041|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
37924197|NCT00848549|69611040|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
37924198|NCT00848549|69611041|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
37924199|NCT00848549|69611040|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
37924200|NCT00848549|69611041|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
37924201|NCT00848549|69611040|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
37924202|NCT00848549|69611041|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
37924203|NCT00848549|69611040|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
37924204|NCT00848549|69611041|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
37924205|NCT00848549|69611040|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
37924206|NCT00848549|69611041|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
37924207|NCT00848549|69611040|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
37924208|NCT00848549|69611041|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
37924209|NCT00848549|69611040|FG000|E2090-E044-314 (Extension Study)|Other|5|||
37924210|NCT00848549|69611041|FG001|E2090-E044-314 (Extension Study)|Other|6|||
37924211|NCT00788151|69611051|FG000|Overall Study|Other adverse event|0|||
37924212|NCT00788151|69611052|FG001|Overall Study|Other adverse event|2|||
37924213|NCT00788151|69611051|FG000|Overall Study|Protocol Violation|0|||
37759172|NCT01529515|69268852|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
37759173|NCT01529515|69268853|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
37759174|NCT01529515|69268854|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
37759175|NCT01529515|69268855|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
37759176|NCT01529515|69268852|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
37759177|NCT01529515|69268853|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
37759178|NCT01529515|69268854|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
37759179|NCT01529515|69268855|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
37924214|NCT00788151|69611052|FG001|Overall Study|Protocol Violation|1|||
37924215|NCT00788151|69611051|FG000|Overall Study|Withdrawal by Subject|13|||
37924216|NCT00788151|69611052|FG001|Overall Study|Withdrawal by Subject|6|||
37924217|NCT00788151|69611051|FG000|Overall Study|Enrolled but not treated|1|||
37924218|NCT00788151|69611052|FG001|Overall Study|Enrolled but not treated|1|||
37924219|NCT00788073|69611060|FG000|STX209 Then Placebo|Adverse Event|1|||
37924220|NCT00788073|69611061|FG001|STX209 Then Placebo|Adverse Event|0|||
37924221|NCT00788073|69611060|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
37924222|NCT00788073|69611061|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
37924223|NCT00788073|69611060|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
37924224|NCT00788073|69611061|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
37924225|NCT00788073|69611060|FG000|STX209 Then Placebo|unable to return due to travel|0|||
37924226|NCT00788073|69611061|FG001|STX209 Then Placebo|unable to return due to travel|1|||
37924227|NCT00788073|69611060|FG000|Placebo Then STX209|Adverse Event|2|||
37924228|NCT00788073|69611061|FG001|Placebo Then STX209|Adverse Event|0|||
37924229|NCT00788073|69611060|FG000|Placebo Then STX209|Protocol Violation|0|||
37924230|NCT00788073|69611061|FG001|Placebo Then STX209|Protocol Violation|1|||
37924231|NCT00848393|69611070|FG000|Overall Study|Protocol Violation|0|||
37924232|NCT00848393|69611071|FG001|Overall Study|Protocol Violation|0|||
37924233|NCT00848393|69611072|FG002|Overall Study|Protocol Violation|1|||
37924234|NCT00848393|69611070|FG000|Overall Study|surgical complications unrelated to stud|0|||
37924235|NCT00848393|69611071|FG001|Overall Study|surgical complications unrelated to stud|0|||
37924236|NCT00848393|69611072|FG002|Overall Study|surgical complications unrelated to stud|2|||
37924237|NCT00815516|69611086|FG000|Overall Study|Death|3|||
37924238|NCT00815516|69611087|FG001|Overall Study|Death|1|||
37924239|NCT00815516|69611086|FG000|Overall Study|Physician Decision|1|||
37924240|NCT00815516|69611087|FG001|Overall Study|Physician Decision|0|||
37924241|NCT00787917|69611095|FG000|Blinded Treatment|Adverse Event|1|||
37924242|NCT00787917|69611096|FG001|Blinded Treatment|Adverse Event|0|||
37924243|NCT00787917|69611095|FG000|Blinded Treatment|Lack of Efficacy|1|||
37924244|NCT00787917|69611096|FG001|Blinded Treatment|Lack of Efficacy|0|||
37666590|NCT02621073|69138978|FG001|Overall Study|Lost to Follow-up|1|||
37666591|NCT02621073|69138977|FG000|Overall Study|Physician Decision|3|||
37666592|NCT02621073|69138978|FG001|Overall Study|Physician Decision|2|||
37666593|NCT02158936|69138986|FG000|Overall Study|Study closed/ terminated|57|||
37666594|NCT02158936|69138987|FG001|Overall Study|Study closed/ terminated|77|||
37666595|NCT02158936|69138986|FG000|Overall Study|Azacitidine tx discontinued|53|||
37666596|NCT02158936|69138987|FG001|Overall Study|Azacitidine tx discontinued|46|||
37924245|NCT00787917|69611095|FG000|Blinded Treatment|Administrative problems|3|||
37924246|NCT00787917|69611096|FG001|Blinded Treatment|Administrative problems|2|||
37924247|NCT00787917|69611095|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
37924248|NCT00787917|69611096|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
37924249|NCT00787917|69611095|FG000|Open Label|Administrative problems|3|||
37924250|NCT00787917|69611096|FG001|Open Label|Administrative problems|0|||
37666597|NCT02158936|69138986|FG000|Overall Study|Adverse Event|39|||
37666598|NCT02158936|69138987|FG001|Overall Study|Adverse Event|24|||
37666599|NCT02158936|69138986|FG000|Overall Study|Withdrawal by Subject|15|||
37759180|NCT01529515|69268852|FG000|MAINTENANCE PHASE|Other|0|||
37924251|NCT00814892|69611104|FG000|Overall Study|Disease Progression|1|||
37924252|NCT00814892|69611104|FG000|Overall Study|Study Termination|1|||
37924253|NCT00787839|69611108|FG000|Overall Study|Failure to have the OGTT was most common|404|||
37924254|NCT00829244|69611131|FG000|Overall Study|Adverse Event|1|||
37924255|NCT00829244|69611132|FG001|Overall Study|Adverse Event|3|||
37924256|NCT00829244|69611131|FG000|Overall Study|Protocol Violation|1|||
37924257|NCT00829244|69611132|FG001|Overall Study|Protocol Violation|0|||
37924258|NCT00829244|69611131|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
37924259|NCT00829244|69611132|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
37924260|NCT00829244|69611131|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
37924261|NCT00829244|69611132|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
37924262|NCT00829244|69611131|FG000|Overall Study|No fertilization|2|||
37924263|NCT00829244|69611132|FG001|Overall Study|No fertilization|2|||
37924264|NCT00829244|69611131|FG000|Overall Study|All embryos discarded|0|||
37924265|NCT00829244|69611132|FG001|Overall Study|All embryos discarded|3|||
37924266|NCT00829244|69611131|FG000|Overall Study|No embryo cleavage|0|||
37924267|NCT00829244|69611132|FG001|Overall Study|No embryo cleavage|2|||
37924268|NCT00787605|69611140|FG000|Overall Study|Administrative Problems|3|||
37924269|NCT00787605|69611141|FG001|Overall Study|Administrative Problems|0|||
37924270|NCT00787605|69611140|FG000|Overall Study|Adverse Event|14|||
37924271|NCT00787605|69611141|FG001|Overall Study|Adverse Event|25|||
37924272|NCT00787605|69611140|FG000|Overall Study|Lost to Follow-up|3|||
37924273|NCT00787605|69611141|FG001|Overall Study|Lost to Follow-up|6|||
37924274|NCT00787605|69611140|FG000|Overall Study|Protocol Violation|7|||
37924275|NCT00787605|69611141|FG001|Overall Study|Protocol Violation|3|||
37924276|NCT00787605|69611140|FG000|Overall Study|Withdrawal by Subject|6|||
37924277|NCT00787605|69611141|FG001|Overall Study|Withdrawal by Subject|13|||
37924278|NCT00787605|69611140|FG000|Overall Study|Lack of Efficacy|13|||
37924279|NCT00787605|69611141|FG001|Overall Study|Lack of Efficacy|9|||
37924280|NCT00448591|69611147|FG000|Overall Study|Withdrawal by Subject|178|||
37924281|NCT00448591|69611147|FG000|Overall Study|Progressive Disease|1382|||
37924282|NCT00448591|69611147|FG000|Overall Study|Adverse Event|382|||
37924283|NCT00448591|69611147|FG000|Overall Study|Protocol Violation|41|||
37924284|NCT00448591|69611147|FG000|Overall Study|Lost to Follow-up|19|||
37924285|NCT00448591|69611147|FG000|Overall Study|Treatment Regimen Completed|70|||
37924286|NCT00448591|69611147|FG000|Overall Study|Other|154|||
37924287|NCT00448591|69611147|FG000|Overall Study|Termination of Study|70|||
37924288|NCT00651664|69611163|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
37924289|NCT00651664|69611164|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
37759181|NCT01529515|69268853|FG001|MAINTENANCE PHASE|Other|10|||
37759182|NCT01529515|69268854|FG002|MAINTENANCE PHASE|Other|0|||
37759183|NCT01529515|69268855|FG003|MAINTENANCE PHASE|Other|0|||
37759184|NCT01529515|69268852|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
37759185|NCT01529515|69268853|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
37924290|NCT00651664|69611165|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
37666600|NCT02158936|69138987|FG001|Overall Study|Withdrawal by Subject|16|||
37666601|NCT02158936|69138986|FG000|Overall Study|Physician Decision|15|||
37666602|NCT02158936|69138987|FG001|Overall Study|Physician Decision|13|||
37666603|NCT02158936|69138986|FG000|Overall Study|Lost to Follow-up|0|||
37666604|NCT02158936|69138987|FG001|Overall Study|Lost to Follow-up|1|||
37666605|NCT02158546|69138997|FG000|Overall Study|Physician Decision|0|||
37666606|NCT02158546|69138998|FG001|Overall Study|Physician Decision|1|||
37924291|NCT00651664|69611166|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
37924292|NCT00651664|69611167|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
37924293|NCT00651664|69611168|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
37924294|NCT00651664|69611169|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
37924295|NCT00651664|69611170|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
37924296|NCT00651664|69611171|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
37666607|NCT02158546|69138999|FG002|Overall Study|Physician Decision|0|||
37666608|NCT02158546|69139000|FG003|Overall Study|Physician Decision|0|||
37666609|NCT02158546|69138997|FG000|Overall Study|Non-compliance|0|||
37666610|NCT02158546|69138998|FG001|Overall Study|Non-compliance|1|||
37924297|NCT00651664|69611172|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
37924298|NCT00651664|69611163|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
37924299|NCT00651664|69611164|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
37924300|NCT00651664|69611165|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
37924301|NCT00651664|69611166|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
37924302|NCT00651664|69611167|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
37924303|NCT00651664|69611168|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
37924304|NCT00651664|69611169|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
37666611|NCT02158546|69138999|FG002|Overall Study|Non-compliance|0|||
37666612|NCT02158546|69139000|FG003|Overall Study|Non-compliance|1|||
37666613|NCT02158546|69138997|FG000|Overall Study|Failure to meet eligibility criteria|0|||
37666614|NCT02158546|69138998|FG001|Overall Study|Failure to meet eligibility criteria|1|||
37759186|NCT01529515|69268854|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
37759187|NCT01529515|69268855|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
37759188|NCT01529515|69268852|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
37759189|NCT01529515|69268853|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
37759190|NCT01529515|69268854|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
37759191|NCT01529515|69268855|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
37759192|NCT01529515|69268852|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
37759193|NCT01529515|69268853|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
37759194|NCT01529515|69268854|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
37759195|NCT01529515|69268855|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
37759196|NCT01529515|69268852|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
37759197|NCT01529515|69268853|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
37759198|NCT01529515|69268854|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
37759199|NCT01529515|69268855|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
37924305|NCT00651664|69611170|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
37924306|NCT00651664|69611171|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
37924307|NCT00651664|69611172|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
37924308|NCT00651664|69611163|FG000|Overall Study|Progressive Disease|3|||
37924309|NCT00651664|69611164|FG001|Overall Study|Progressive Disease|3|||
37924310|NCT00651664|69611165|FG002|Overall Study|Progressive Disease|3|||
37924311|NCT00651664|69611166|FG003|Overall Study|Progressive Disease|12|||
37924312|NCT00651664|69611167|FG004|Overall Study|Progressive Disease|4|||
37924313|NCT00651664|69611168|FG005|Overall Study|Progressive Disease|1|||
37924314|NCT00651664|69611169|FG006|Overall Study|Progressive Disease|3|||
37924315|NCT00651664|69611170|FG007|Overall Study|Progressive Disease|6|||
37924316|NCT00651664|69611171|FG008|Overall Study|Progressive Disease|5|||
37924317|NCT00651664|69611172|FG009|Overall Study|Progressive Disease|5|||
37924318|NCT00651664|69611163|FG000|Overall Study|Patient Declined Further Treatment|0|||
37924319|NCT00651664|69611164|FG001|Overall Study|Patient Declined Further Treatment|0|||
37924320|NCT00651664|69611165|FG002|Overall Study|Patient Declined Further Treatment|0|||
37924321|NCT00651664|69611166|FG003|Overall Study|Patient Declined Further Treatment|1|||
37924322|NCT00651664|69611167|FG004|Overall Study|Patient Declined Further Treatment|1|||
37924323|NCT00651664|69611168|FG005|Overall Study|Patient Declined Further Treatment|1|||
37924324|NCT00651664|69611169|FG006|Overall Study|Patient Declined Further Treatment|0|||
37924325|NCT00651664|69611170|FG007|Overall Study|Patient Declined Further Treatment|0|||
37924326|NCT00651664|69611171|FG008|Overall Study|Patient Declined Further Treatment|0|||
37924327|NCT00651664|69611172|FG009|Overall Study|Patient Declined Further Treatment|1|||
37924328|NCT00651664|69611163|FG000|Overall Study|Symptomatic Deterioration|0|||
37924329|NCT00651664|69611164|FG001|Overall Study|Symptomatic Deterioration|0|||
37924330|NCT00651664|69611165|FG002|Overall Study|Symptomatic Deterioration|0|||
37924331|NCT00651664|69611166|FG003|Overall Study|Symptomatic Deterioration|1|||
37924332|NCT00651664|69611167|FG004|Overall Study|Symptomatic Deterioration|0|||
37924333|NCT00651664|69611168|FG005|Overall Study|Symptomatic Deterioration|0|||
37924334|NCT00651664|69611169|FG006|Overall Study|Symptomatic Deterioration|1|||
37924335|NCT00651664|69611170|FG007|Overall Study|Symptomatic Deterioration|0|||
37924336|NCT00651664|69611171|FG008|Overall Study|Symptomatic Deterioration|1|||
37924337|NCT00651664|69611172|FG009|Overall Study|Symptomatic Deterioration|0|||
37924338|NCT00651664|69611163|FG000|Overall Study|Reason not Specified|0|||
37924339|NCT00651664|69611164|FG001|Overall Study|Reason not Specified|0|||
37924340|NCT00651664|69611165|FG002|Overall Study|Reason not Specified|0|||
37924341|NCT00651664|69611166|FG003|Overall Study|Reason not Specified|0|||
37924342|NCT00651664|69611167|FG004|Overall Study|Reason not Specified|0|||
37924343|NCT00651664|69611168|FG005|Overall Study|Reason not Specified|0|||
37924344|NCT00651664|69611169|FG006|Overall Study|Reason not Specified|1|||
37924345|NCT00651664|69611170|FG007|Overall Study|Reason not Specified|0|||
37924346|NCT00651664|69611171|FG008|Overall Study|Reason not Specified|0|||
37924347|NCT00651664|69611172|FG009|Overall Study|Reason not Specified|0|||
37924348|NCT00787527|69611198|FG000|Overall Study|Toxicity|3|||
37924349|NCT00787137|69611209|FG000|Overall Study|Study Termination|0|||
37666615|NCT02158546|69138999|FG002|Overall Study|Failure to meet eligibility criteria|0|||
37666616|NCT02158546|69139000|FG003|Overall Study|Failure to meet eligibility criteria|0|||
37666617|NCT02158546|69138997|FG000|Overall Study|Lack of Efficacy|1|||
37666618|NCT02158546|69138998|FG001|Overall Study|Lack of Efficacy|1|||
37666619|NCT02158546|69138999|FG002|Overall Study|Lack of Efficacy|0|||
37666620|NCT02158546|69139000|FG003|Overall Study|Lack of Efficacy|0|||
37666621|NCT02158546|69138997|FG000|Overall Study|Adverse Event|2|||
37666622|NCT02158546|69138998|FG001|Overall Study|Adverse Event|2|||
37666623|NCT02158546|69138999|FG002|Overall Study|Adverse Event|0|||
37666624|NCT02158546|69139000|FG003|Overall Study|Adverse Event|0|||
37666625|NCT02158546|69138997|FG000|Overall Study|Withdrawal by Subject|6|||
37666626|NCT02158546|69138998|FG001|Overall Study|Withdrawal by Subject|2|||
37666627|NCT02158546|69138999|FG002|Overall Study|Withdrawal by Subject|1|||
37666628|NCT02158546|69139000|FG003|Overall Study|Withdrawal by Subject|0|||
37666629|NCT02158546|69138997|FG000|Overall Study|Lost to Follow-up|5|||
37924350|NCT00787137|69611210|FG001|Overall Study|Study Termination|0|||
37759200|NCT01529515|69268852|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
37759201|NCT01529515|69268853|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
37759202|NCT01529515|69268854|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
37666630|NCT02158546|69138998|FG001|Overall Study|Lost to Follow-up|4|||
37666631|NCT02158546|69138999|FG002|Overall Study|Lost to Follow-up|0|||
37666632|NCT02158546|69139000|FG003|Overall Study|Lost to Follow-up|1|||
37666633|NCT02158546|69138997|FG000|Overall Study|Site Excluded|5|||
37666634|NCT02158546|69138998|FG001|Overall Study|Site Excluded|5|||
37666635|NCT02158546|69138999|FG002|Overall Study|Site Excluded|3|||
37666636|NCT02158546|69139000|FG003|Overall Study|Site Excluded|4|||
37666637|NCT02123446|69139010|FG000|Washout Period (1 Day)|Physician Decision|1|||
37666638|NCT02123446|69139011|FG001|Washout Period (1 Day)|Physician Decision|0|||
37666639|NCT02123134|69139019|FG000|Overall Study|Withdrawal of consent|3|||
37666640|NCT02123134|69139020|FG001|Overall Study|Withdrawal of consent|2|||
37759203|NCT01529515|69268855|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
37759204|NCT01529515|69268852|FG000|DOUBLE BLIND PHASE|Other|0|||
37759205|NCT01529515|69268853|FG001|DOUBLE BLIND PHASE|Other|0|||
37759206|NCT01529515|69268854|FG002|DOUBLE BLIND PHASE|Other|9|||
37759207|NCT01529515|69268855|FG003|DOUBLE BLIND PHASE|Other|2|||
37759208|NCT01528969|69268864|FG000|Overall Study|absent from the school at baseline|2|||
37759209|NCT01528969|69268865|FG001|Overall Study|absent from the school at baseline|0|||
37759210|NCT01514201|69268875|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
37759211|NCT01514201|69268876|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
37759212|NCT01514201|69268877|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
37759213|NCT01514201|69268878|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
37759214|NCT01514201|69268875|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
37759215|NCT01514201|69268876|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
37759216|NCT01514201|69268877|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
37759217|NCT01514201|69268878|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
37759218|NCT01514201|69268875|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
37759219|NCT01514201|69268876|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
37759220|NCT01514201|69268877|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
37759221|NCT01514201|69268878|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
37759222|NCT01514201|69268875|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
37759223|NCT01514201|69268876|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
37759224|NCT01514201|69268877|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
37759225|NCT01514201|69268878|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
37759226|NCT01514201|69268875|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
37759227|NCT01514201|69268876|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
37759228|NCT01514201|69268877|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
37759229|NCT01514201|69268878|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
37759230|NCT01514201|69268875|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
37759231|NCT01514201|69268876|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
37759232|NCT01514201|69268877|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
37859275|NCT01292603|69542618|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
38033408|NCT02586623|69719346|FG002|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
38033409|NCT02586623|69719344|FG000|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|0|||
38033410|NCT02586623|69719345|FG001|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|6|||
38033411|NCT02586623|69719346|FG002|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|5|||
38033412|NCT02586623|69719344|FG000|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|0|||
38033413|NCT02586623|69719345|FG001|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|31|||
38033414|NCT02586623|69719346|FG002|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|27|||
38033415|NCT02586623|69719344|FG000|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
38033416|NCT02586623|69719345|FG001|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|1|||
38033417|NCT02586623|69719346|FG002|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
38033418|NCT01819831|69719353|FG000|Overall Study|Withdrawal by Subject|1|||
38033419|NCT00078949|69719370|FG000|Overall Study|No treated|4|||
38033420|NCT00078949|69719371|FG001|Overall Study|No treated|5|||
38033421|NCT00078949|69719372|FG002|Overall Study|No treated|3|||
38033422|NCT00078949|69719373|FG003|Overall Study|No treated|3|||
38033423|NCT03739203|69719388|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
38033424|NCT03739203|69719389|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
38033425|NCT03739203|69719390|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
38033426|NCT03739203|69719388|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
38033427|NCT03739203|69719389|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
37924351|NCT00787137|69611211|FG002|Overall Study|Study Termination|1|||
38033428|NCT03739203|69719390|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
38033429|NCT03739203|69719388|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
38033430|NCT03739203|69719389|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
38033431|NCT03739203|69719390|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
37759233|NCT01514201|69268878|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
37666641|NCT02123134|69139019|FG000|Overall Study|Administrative decision|0|||
37666642|NCT02123134|69139020|FG001|Overall Study|Administrative decision|1|||
37666643|NCT02185534|69139032|FG000|First Period|Withdrawal by Subject|0|||
37666644|NCT02185534|69139033|FG001|First Period|Withdrawal by Subject|0|||
37666645|NCT02185534|69139034|FG002|First Period|Withdrawal by Subject|0|||
37666646|NCT02185534|69139035|FG003|First Period|Withdrawal by Subject|1|||
37666647|NCT02185534|69139036|FG004|First Period|Withdrawal by Subject|0|||
37666648|NCT02185534|69139037|FG005|First Period|Withdrawal by Subject|0|||
37666649|NCT02185534|69139032|FG000|First Washout Period|Withdrawal by Subject|1|||
37666650|NCT02185534|69139033|FG001|First Washout Period|Withdrawal by Subject|0|||
37666651|NCT02185534|69139034|FG002|First Washout Period|Withdrawal by Subject|0|||
37666652|NCT02185534|69139035|FG003|First Washout Period|Withdrawal by Subject|0|||
37666653|NCT02185534|69139036|FG004|First Washout Period|Withdrawal by Subject|1|||
37666654|NCT02185534|69139037|FG005|First Washout Period|Withdrawal by Subject|0|||
37666655|NCT02185534|69139032|FG000|First Washout Period|Protocol Violation|0|||
37666656|NCT02185534|69139033|FG001|First Washout Period|Protocol Violation|0|||
37666657|NCT02185534|69139034|FG002|First Washout Period|Protocol Violation|0|||
37666658|NCT02185534|69139035|FG003|First Washout Period|Protocol Violation|0|||
37666659|NCT02185534|69139036|FG004|First Washout Period|Protocol Violation|0|||
37666660|NCT02185534|69139037|FG005|First Washout Period|Protocol Violation|1|||
37666661|NCT02121808|69139046|FG000|Overall Study|Technical problem|3|||
37666662|NCT02157376|69139057|FG000|Overall Study|Death|10|||
37666663|NCT02157376|69139058|FG001|Overall Study|Death|4|||
37666664|NCT02157376|69139057|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
37924352|NCT00448435|69611219|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
37924353|NCT00448435|69611220|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
37924354|NCT00448279|69611231|FG000|Overall Study|Lost to Follow-up|2|||
37924355|NCT00448279|69611232|FG001|Overall Study|Lost to Follow-up|2|||
37924356|NCT00448279|69611231|FG000|Overall Study|Adverse Event|1|||
37924357|NCT00448279|69611232|FG001|Overall Study|Adverse Event|1|||
37924358|NCT00448279|69611231|FG000|Overall Study|Disease progression|16|||
37924359|NCT00448279|69611232|FG001|Overall Study|Disease progression|18|||
37924360|NCT00448279|69611231|FG000|Overall Study|Withdrawal by Subject|4|||
37924361|NCT00448279|69611232|FG001|Overall Study|Withdrawal by Subject|3|||
37924362|NCT00448279|69611231|FG000|Overall Study|Other|6|||
37924363|NCT00448279|69611232|FG001|Overall Study|Other|4|||
37924364|NCT00448279|69611231|FG000|Overall Study|Protocol Violation|0|||
37924365|NCT00448279|69611232|FG001|Overall Study|Protocol Violation|1|||
37924366|NCT00448123|69611240|FG000|Overall Study|Lost to Follow-up|9|||
37924367|NCT00448123|69611241|FG001|Overall Study|Lost to Follow-up|6|||
37924368|NCT00448123|69611240|FG000|Overall Study|Physician Decision|6|||
37924369|NCT00448123|69611241|FG001|Overall Study|Physician Decision|6|||
37924370|NCT00447499|69611250|FG000|Overall Study|Adverse Event|1|||
37759234|NCT01514201|69268875|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
37759235|NCT01514201|69268876|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
37759236|NCT01514201|69268877|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
37759237|NCT01514201|69268878|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
37759238|NCT01514201|69268875|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
37759239|NCT01514201|69268876|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
37759240|NCT01514201|69268877|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
37759241|NCT01514201|69268878|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
37759242|NCT01514201|69268875|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
37759243|NCT01514201|69268876|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
37759244|NCT01514201|69268877|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
37759245|NCT01514201|69268878|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
37759246|NCT01514201|69268875|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
37924371|NCT00447499|69611250|FG000|Overall Study|Patient Decision|4|||
37924372|NCT00447499|69611250|FG000|Overall Study|Sponsor Decision|1|||
37924373|NCT00447499|69611250|FG000|Overall Study|Physician Decision|1|||
37924374|NCT00800436|69611263|FG000|Overall Study|Withdrawal by Subject|0|||
37924375|NCT00800436|69611264|FG001|Overall Study|Withdrawal by Subject|0|||
37924376|NCT00800436|69611265|FG002|Overall Study|Withdrawal by Subject|1|||
37666665|NCT02157376|69139058|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
37666666|NCT02157376|69139057|FG000|Overall Study|Withdrawal by Subject|3|||
37666667|NCT02157376|69139058|FG001|Overall Study|Withdrawal by Subject|8|||
37666668|NCT02157376|69139057|FG000|Overall Study|Not treated|8|||
37666669|NCT02157376|69139058|FG001|Overall Study|Not treated|3|||
37666670|NCT02157376|69139057|FG000|Overall Study|Investigator's misjudgement|1|||
37666671|NCT02157376|69139058|FG001|Overall Study|Investigator's misjudgement|2|||
37924377|NCT00800436|69611266|FG003|Overall Study|Withdrawal by Subject|1|||
37924378|NCT00800436|69611267|FG004|Overall Study|Withdrawal by Subject|0|||
37924379|NCT00800436|69611268|FG005|Overall Study|Withdrawal by Subject|0|||
37924380|NCT00800436|69611269|FG006|Overall Study|Withdrawal by Subject|0|||
37924381|NCT00655564|69611285|FG000|Overall Study|Adverse Event|1|||
37666672|NCT02157298|69139066|FG000|Overall Study|Adverse Event|1|||
37666673|NCT02157298|69139067|FG001|Overall Study|Adverse Event|0|||
37759247|NCT01514201|69268876|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
37759248|NCT01514201|69268877|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
37759249|NCT01514201|69268878|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
37759250|NCT01514201|69268875|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
37759251|NCT01514201|69268876|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
37759252|NCT01514201|69268877|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
37759253|NCT01514201|69268878|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
37759254|NCT01514201|69268875|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
37759255|NCT01514201|69268876|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
37759256|NCT01514201|69268877|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
37759257|NCT01514201|69268878|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
37759258|NCT02666664|69268900|FG000|Overall Study|Physician Decision|0|||
37759259|NCT02666664|69268901|FG001|Overall Study|Physician Decision|1|||
37924382|NCT00655564|69611285|FG000|Overall Study|Lost to Follow-up|1|||
37924383|NCT00655564|69611285|FG000|Overall Study|Desired Alternate Therapy|1|||
37924384|NCT00447421|69611290|FG000|Overall Study|Lack of Efficacy|1|||
37924385|NCT00447421|69611290|FG000|Overall Study|Adverse Event|3|||
37924386|NCT00447421|69611290|FG000|Overall Study|Sponsor Decision|2|||
37924387|NCT00651118|69611298|FG000|Overall Study|Adverse Event|4|||
37924388|NCT00651118|69611299|FG001|Overall Study|Adverse Event|0|||
37759260|NCT02666664|69268900|FG000|Overall Study|Protocol Violation|0|||
37759261|NCT02666664|69268901|FG001|Overall Study|Protocol Violation|2|||
37759262|NCT02666664|69268900|FG000|Overall Study|Other|0|||
37759263|NCT02666664|69268901|FG001|Overall Study|Other|1|||
37759264|NCT02666664|69268900|FG000|Overall Study|Adverse Event|12|||
37759265|NCT02666664|69268901|FG001|Overall Study|Adverse Event|37|||
37759266|NCT02666664|69268900|FG000|Overall Study|Withdrawal by participant|23|||
37759267|NCT02666664|69268901|FG001|Overall Study|Withdrawal by participant|40|||
37924389|NCT00651118|69611300|FG002|Overall Study|Adverse Event|1|||
37924390|NCT00651118|69611301|FG003|Overall Study|Adverse Event|1|||
37924391|NCT00651118|69611298|FG000|Overall Study|Protocol Violation|2|||
37924392|NCT00651118|69611299|FG001|Overall Study|Protocol Violation|2|||
37924393|NCT00651118|69611300|FG002|Overall Study|Protocol Violation|6|||
37924394|NCT00651118|69611301|FG003|Overall Study|Protocol Violation|2|||
37924395|NCT00651118|69611298|FG000|Overall Study|Lost to Follow-up|2|||
37924396|NCT00651118|69611299|FG001|Overall Study|Lost to Follow-up|0|||
37924397|NCT00651118|69611300|FG002|Overall Study|Lost to Follow-up|1|||
37666674|NCT02157298|69139066|FG000|Overall Study|Subject no longer meets study criteria|1|||
37666675|NCT02157298|69139067|FG001|Overall Study|Subject no longer meets study criteria|2|||
37666676|NCT02157298|69139066|FG000|Overall Study|Poor/Non-compliance|1|||
37666677|NCT02157298|69139067|FG001|Overall Study|Poor/Non-compliance|0|||
37666678|NCT02157298|69139066|FG000|Overall Study|Withdrawal by Subject|1|||
37666679|NCT02157298|69139067|FG001|Overall Study|Withdrawal by Subject|0|||
37666680|NCT02184988|69139073|FG000|Overall Study|Pregnancy|2|||
37666681|NCT02184988|69139073|FG000|Overall Study|Adverse Event|2|||
37666682|NCT02184988|69139073|FG000|Overall Study|moving away/travelling/unable to complet|6|||
37666683|NCT02184988|69139073|FG000|Overall Study|work scheduling issues|4|||
37666684|NCT02184988|69139073|FG000|Overall Study|various other reasons|9|||
37666685|NCT02184988|69139073|FG000|Overall Study|Lost to Follow-up|32|||
37666686|NCT02121262|69139079|FG000|Overall Study|Adverse Event|6|||
37666687|NCT02121262|69139080|FG001|Overall Study|Adverse Event|3|||
37666688|NCT02121262|69139079|FG000|Overall Study|Lack of Efficacy|3|||
37666689|NCT02121262|69139080|FG001|Overall Study|Lack of Efficacy|0|||
37666690|NCT02121262|69139079|FG000|Overall Study|Personal Reasons|19|||
37666691|NCT02121262|69139080|FG001|Overall Study|Personal Reasons|5|||
37666692|NCT02121262|69139079|FG000|Overall Study|Protocol Violation|1|||
37759268|NCT02666664|69268900|FG000|Overall Study|Sponsor decision|0|||
37859276|NCT01292603|69542619|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
37859277|NCT01292603|69542620|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
37859278|NCT01292603|69542621|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
37859279|NCT01292603|69542622|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
37859280|NCT01292603|69542617|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
37859281|NCT01292603|69542618|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
37859282|NCT01292603|69542619|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
37859283|NCT01292603|69542620|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
37924398|NCT00651118|69611301|FG003|Overall Study|Lost to Follow-up|2|||
37924399|NCT00651118|69611298|FG000|Overall Study|administrative|1|||
37924400|NCT00651118|69611299|FG001|Overall Study|administrative|4|||
37924401|NCT00651118|69611300|FG002|Overall Study|administrative|2|||
37666693|NCT02121262|69139080|FG001|Overall Study|Protocol Violation|1|||
37759269|NCT02666664|69268901|FG001|Overall Study|Sponsor decision|1|||
37759270|NCT02666664|69268900|FG000|Overall Study|Lost to Follow-up|1|||
37759271|NCT02666664|69268901|FG001|Overall Study|Lost to Follow-up|2|||
37759272|NCT01528735|69268909|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
38033432|NCT03739203|69719388|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
37666694|NCT02121262|69139079|FG000|Overall Study|Participant Dropped-out|0|||
37924402|NCT00651118|69611301|FG003|Overall Study|administrative|1|||
37924403|NCT00651118|69611298|FG000|Overall Study|Withdrawal by Subject|0|||
37924404|NCT00651118|69611299|FG001|Overall Study|Withdrawal by Subject|1|||
37924405|NCT00651118|69611300|FG002|Overall Study|Withdrawal by Subject|1|||
37924406|NCT00651118|69611301|FG003|Overall Study|Withdrawal by Subject|1|||
37924407|NCT00447265|69611314|FG000|Overall Study|Physician Decision|1|||
37924408|NCT00447265|69611315|FG001|Overall Study|Physician Decision|0|||
37924409|NCT00657358|69611319|FG000|Overall Study|Lack of Efficacy|6|||
37924410|NCT00457639|69611324|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
37924411|NCT00457639|69611325|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
37924412|NCT00457639|69611324|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
37924413|NCT00457639|69611325|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
37924414|NCT00457639|69611324|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
37924415|NCT00457639|69611325|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
37924416|NCT00800202|69611333|FG000|Overall Study|Adverse Event|7|||
37924417|NCT00800202|69611334|FG001|Overall Study|Adverse Event|6|||
37924418|NCT00800202|69611333|FG000|Overall Study|Death|1|||
37924419|NCT00800202|69611334|FG001|Overall Study|Death|0|||
37924420|NCT00800202|69611333|FG000|Overall Study|Other|5|||
37924421|NCT00800202|69611334|FG001|Overall Study|Other|0|||
37924422|NCT00800202|69611333|FG000|Overall Study|Disease Progression|54|||
37924423|NCT00800202|69611334|FG001|Overall Study|Disease Progression|18|||
37924424|NCT00655486|69611340|FG000|Overall Study|Adverse Event|10|||
37924425|NCT00655486|69611340|FG000|Overall Study|Lack of Efficacy|8|||
37924426|NCT00655486|69611340|FG000|Overall Study|Withdrawal by Subject|4|||
37924427|NCT00655486|69611340|FG000|Overall Study|Protocol Violation|1|||
37924428|NCT00655486|69611340|FG000|Overall Study|Unsatisfactory compliance|2|||
37924429|NCT00655486|69611340|FG000|Overall Study|Other: Pregnancy|1|||
37924430|NCT00655486|69611340|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
37924431|NCT00655486|69611340|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
37924432|NCT00457249|69611346|FG000|Overall Study|Lost to Follow-up|3|||
37924433|NCT00457249|69611347|FG001|Overall Study|Lost to Follow-up|0|||
37924434|NCT00457249|69611346|FG000|Overall Study|Protocol Violation|4|||
37924435|NCT00457249|69611347|FG001|Overall Study|Protocol Violation|1|||
37924436|NCT00457249|69611346|FG000|Overall Study|Withdrawal by Subject|3|||
37924437|NCT00457249|69611347|FG001|Overall Study|Withdrawal by Subject|1|||
37924438|NCT00457249|69611346|FG000|Overall Study|Serious Adverse Events|2|||
37924439|NCT00457249|69611347|FG001|Overall Study|Serious Adverse Events|0|||
37924440|NCT00457015|69611357|FG000|Overall Study|Left study site against medical advice|0|||
37924441|NCT00457015|69611358|FG001|Overall Study|Left study site against medical advice|1|||
37924442|NCT00654940|69611366|FG000|Period 1|Adverse Event|0|||
37924443|NCT00654940|69611367|FG001|Period 1|Adverse Event|1|||
37924444|NCT00654940|69611366|FG000|Period 1|Intolerable Pain Level|1|||
37924445|NCT00654940|69611367|FG001|Period 1|Intolerable Pain Level|0|||
37924446|NCT00588666|69611379|FG000|Overall Study|Adverse Event|4|||
37924447|NCT00793182|69611394|FG000|Overall Study|Adverse Event|0|||
37924448|NCT00793182|69611395|FG001|Overall Study|Adverse Event|1|||
37924449|NCT00793104|69611401|FG000|Overall Study|Lost to Follow-up|1|||
37924450|NCT00446797|69611407|FG000|Overall Study|Lack of Efficacy|0|||
37759273|NCT01528735|69268910|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
37759274|NCT01528735|69268909|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
37759275|NCT01528735|69268910|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
37759276|NCT02661594|69268922|FG000|Overall Study|Protocol Violation|1|||
37759277|NCT02661594|69268923|FG001|Overall Study|Protocol Violation|0|||
37759278|NCT02661594|69268924|FG002|Overall Study|Protocol Violation|1|||
37759279|NCT02661594|69268925|FG003|Overall Study|Protocol Violation|0|||
37759280|NCT01528345|69268937|FG000|Overall Study|Adverse Event|10|||
37759281|NCT01528345|69268938|FG001|Overall Study|Adverse Event|1|||
37759282|NCT01528345|69268937|FG000|Overall Study|Death|1|||
37759283|NCT01528345|69268938|FG001|Overall Study|Death|1|||
37924451|NCT00446797|69611408|FG001|Overall Study|Lack of Efficacy|2|||
37924452|NCT00446797|69611407|FG000|Overall Study|Lost to Follow-up|5|||
37759284|NCT01528345|69268937|FG000|Overall Study|Non-compliance with study treatment|1|||
37759285|NCT01528345|69268938|FG001|Overall Study|Non-compliance with study treatment|0|||
37924453|NCT00446797|69611408|FG001|Overall Study|Lost to Follow-up|3|||
37924454|NCT00446797|69611407|FG000|Overall Study|Withdrawal by Subject|2|||
37924455|NCT00446797|69611408|FG001|Overall Study|Withdrawal by Subject|2|||
37924456|NCT00446797|69611407|FG000|Overall Study|Protocol Violation|1|||
37924457|NCT00446797|69611408|FG001|Overall Study|Protocol Violation|3|||
37924458|NCT00446797|69611407|FG000|Overall Study|subject entered at another site|0|||
37759286|NCT01528345|69268937|FG000|Overall Study|Progressive Disease|26|||
37759287|NCT01528345|69268938|FG001|Overall Study|Progressive Disease|40|||
37759288|NCT01528345|69268937|FG000|Overall Study|Study Terminated by Sponsor|4|||
37759289|NCT01528345|69268938|FG001|Overall Study|Study Terminated by Sponsor|8|||
37759290|NCT01528345|69268937|FG000|Overall Study|Subject/Guardian Decision|5|||
37924459|NCT00446797|69611408|FG001|Overall Study|subject entered at another site|1|||
37924460|NCT00446797|69611407|FG000|Overall Study|did not meet entrance criteria|0|||
37924461|NCT00446797|69611408|FG001|Overall Study|did not meet entrance criteria|1|||
37924462|NCT00855335|69611419|FG000|Overall Study|Lost to Follow-up|0|||
37924463|NCT00855335|69611420|FG001|Overall Study|Lost to Follow-up|0|||
37924464|NCT00855335|69611421|FG002|Overall Study|Lost to Follow-up|3|||
37924465|NCT00855335|69611422|FG003|Overall Study|Lost to Follow-up|1|||
37924466|NCT00855335|69611423|FG004|Overall Study|Lost to Follow-up|0|||
37924467|NCT00855335|69611419|FG000|Overall Study|Withdrawal by Subject|0|||
37924468|NCT00855335|69611420|FG001|Overall Study|Withdrawal by Subject|0|||
37924469|NCT00855335|69611421|FG002|Overall Study|Withdrawal by Subject|0|||
37924470|NCT00855335|69611422|FG003|Overall Study|Withdrawal by Subject|1|||
37924471|NCT00855335|69611423|FG004|Overall Study|Withdrawal by Subject|0|||
37924472|NCT00855335|69611419|FG000|Overall Study|Adverse Event|2|||
37924473|NCT00855335|69611420|FG001|Overall Study|Adverse Event|0|||
37924474|NCT00855335|69611421|FG002|Overall Study|Adverse Event|0|||
37924475|NCT00855335|69611422|FG003|Overall Study|Adverse Event|0|||
37924476|NCT00855335|69611423|FG004|Overall Study|Adverse Event|0|||
37924477|NCT00855335|69611419|FG000|Overall Study|Physician Decision|1|||
37924478|NCT00855335|69611420|FG001|Overall Study|Physician Decision|1|||
37924479|NCT00855335|69611421|FG002|Overall Study|Physician Decision|0|||
37924480|NCT00855335|69611422|FG003|Overall Study|Physician Decision|0|||
37924481|NCT00855335|69611423|FG004|Overall Study|Physician Decision|0|||
37924482|NCT00855335|69611419|FG000|Overall Study|Other|2|||
37924483|NCT00855335|69611420|FG001|Overall Study|Other|1|||
37924484|NCT00855335|69611421|FG002|Overall Study|Other|2|||
37924485|NCT00855335|69611422|FG003|Overall Study|Other|5|||
37924486|NCT00855335|69611423|FG004|Overall Study|Other|1|||
37924487|NCT00799422|69611448|FG000|First Week of Wear|Lost to Follow-up|0|||
37924488|NCT00799422|69611449|FG001|First Week of Wear|Lost to Follow-up|0|||
37924489|NCT00799422|69611450|FG002|First Week of Wear|Lost to Follow-up|1|||
37924490|NCT00799422|69611451|FG003|First Week of Wear|Lost to Follow-up|0|||
37924491|NCT00799422|69611452|FG004|First Week of Wear|Lost to Follow-up|0|||
37924492|NCT00799422|69611453|FG005|First Week of Wear|Lost to Follow-up|0|||
37924493|NCT00799422|69611448|FG000|First Week of Wear|Adverse Event|0|||
37924494|NCT00799422|69611449|FG001|First Week of Wear|Adverse Event|0|||
37924495|NCT00799422|69611450|FG002|First Week of Wear|Adverse Event|0|||
37924496|NCT00799422|69611451|FG003|First Week of Wear|Adverse Event|1|||
37924497|NCT00799422|69611452|FG004|First Week of Wear|Adverse Event|0|||
37924498|NCT00799422|69611453|FG005|First Week of Wear|Adverse Event|0|||
38033433|NCT03739203|69719389|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
38033434|NCT03739203|69719390|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
38033435|NCT03739203|69719388|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
38033436|NCT03739203|69719389|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
38033437|NCT03739203|69719390|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
38033438|NCT03739203|69719388|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
38033439|NCT03739203|69719389|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
38033440|NCT03739203|69719390|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
38033441|NCT03739203|69719388|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
38033442|NCT03739203|69719389|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
38033443|NCT03739203|69719390|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
38033444|NCT03739203|69719388|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
38033445|NCT03739203|69719389|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
38033446|NCT03739203|69719390|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
38033447|NCT03739203|69719388|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
38033448|NCT03739203|69719389|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
38033449|NCT03739203|69719390|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
38033450|NCT03739203|69719388|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
38033451|NCT03739203|69719389|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
38033452|NCT03739203|69719390|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
38033453|NCT03739203|69719388|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
37924499|NCT00593489|69611463|FG000|Allocation|did not attend workshop; allocation not|2|||
37924500|NCT00593489|69611464|FG001|Allocation|did not attend workshop; allocation not|1|||
37924501|NCT00446641|69611474|FG000|Overall Study|Withdrawal by Subject|8|||
37924502|NCT00446641|69611475|FG001|Overall Study|Withdrawal by Subject|3|||
37924503|NCT00446641|69611474|FG000|Overall Study|poor compliance|8|||
37924504|NCT00446641|69611475|FG001|Overall Study|poor compliance|6|||
38033454|NCT03739203|69719389|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
37924505|NCT00446641|69611474|FG000|Overall Study|Lost to Follow-up|1|||
37924506|NCT00446641|69611475|FG001|Overall Study|Lost to Follow-up|1|||
37924507|NCT00646282|69611483|FG000|Overall Study|Protocol terminated|4|||
38033455|NCT03739203|69719390|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
37924508|NCT00646282|69611484|FG001|Overall Study|Protocol terminated|4|||
37924509|NCT00792636|69611493|FG000|Overall Study|Protocol Violation|17|||
37924510|NCT00792636|69611494|FG001|Overall Study|Protocol Violation|23|||
37924511|NCT00792636|69611495|FG002|Overall Study|Protocol Violation|20|||
37924512|NCT00792636|69611493|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
37924513|NCT00792636|69611494|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
37924514|NCT00792636|69611495|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
37924515|NCT00792636|69611493|FG000|Overall Study|Lost to Follow-up|13|||
37924516|NCT00792636|69611494|FG001|Overall Study|Lost to Follow-up|19|||
37924517|NCT00792636|69611495|FG002|Overall Study|Lost to Follow-up|14|||
37924518|NCT00792636|69611493|FG000|Overall Study|Withdrew Consent|10|||
37924519|NCT00792636|69611494|FG001|Overall Study|Withdrew Consent|13|||
37924520|NCT00792636|69611495|FG002|Overall Study|Withdrew Consent|9|||
37924521|NCT00792636|69611493|FG000|Overall Study|Lack of Efficacy|3|||
37924522|NCT00792636|69611494|FG001|Overall Study|Lack of Efficacy|4|||
37924523|NCT00792636|69611495|FG002|Overall Study|Lack of Efficacy|13|||
37924524|NCT00792636|69611493|FG000|Overall Study|Adverse Event|4|||
37924525|NCT00792636|69611494|FG001|Overall Study|Adverse Event|2|||
37924526|NCT00792636|69611495|FG002|Overall Study|Adverse Event|3|||
37924527|NCT00792636|69611493|FG000|Overall Study|Investigator Discretion|2|||
37924528|NCT00792636|69611494|FG001|Overall Study|Investigator Discretion|0|||
37924529|NCT00792636|69611495|FG002|Overall Study|Investigator Discretion|2|||
37924530|NCT00446563|69611507|FG000|Overall Study|Adverse Event|4|||
37924531|NCT00446563|69611508|FG001|Overall Study|Adverse Event|3|||
37924532|NCT00446563|69611507|FG000|Overall Study|Abnormal laboratory value(s)|0|||
37924533|NCT00446563|69611508|FG001|Overall Study|Abnormal laboratory value(s)|1|||
37924534|NCT00446563|69611507|FG000|Overall Study|Abnormal test procedure result(s)|1|||
37924535|NCT00446563|69611508|FG001|Overall Study|Abnormal test procedure result(s)|0|||
37924536|NCT00446563|69611507|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
37924537|NCT00446563|69611508|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
37924538|NCT00446563|69611507|FG000|Overall Study|Withdrawal by Subject|2|||
37924539|NCT00446563|69611508|FG001|Overall Study|Withdrawal by Subject|1|||
37924540|NCT00446563|69611507|FG000|Overall Study|Administrative problems|0|||
37924541|NCT00446563|69611508|FG001|Overall Study|Administrative problems|1|||
37924542|NCT00650806|69611518|FG000|Overall Study|Adverse Event|0|||
37924543|NCT00650806|69611519|FG001|Overall Study|Adverse Event|5|||
37924544|NCT00650806|69611520|FG002|Overall Study|Adverse Event|3|||
37924545|NCT00650806|69611521|FG003|Overall Study|Adverse Event|4|||
37924546|NCT00650806|69611518|FG000|Overall Study|Lost to Follow-up|7|||
37924547|NCT00650806|69611519|FG001|Overall Study|Lost to Follow-up|6|||
37924548|NCT00650806|69611520|FG002|Overall Study|Lost to Follow-up|11|||
37924549|NCT00650806|69611521|FG003|Overall Study|Lost to Follow-up|10|||
37924550|NCT00650806|69611518|FG000|Overall Study|Protocol Violation|0|||
37924551|NCT00650806|69611519|FG001|Overall Study|Protocol Violation|0|||
37924552|NCT00650806|69611520|FG002|Overall Study|Protocol Violation|0|||
38033456|NCT02942264|69719407|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
38033457|NCT02942264|69719408|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
38033458|NCT02942264|69719409|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
38033459|NCT02942264|69719410|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
38033460|NCT02942264|69719411|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
38033461|NCT02942264|69719412|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
38033462|NCT02942264|69719413|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
38033463|NCT02942264|69719414|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
38033464|NCT02942264|69719415|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
38033465|NCT02942264|69719407|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
38033466|NCT02942264|69719408|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
38033467|NCT02942264|69719409|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
38033468|NCT02942264|69719410|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
38033469|NCT02942264|69719411|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
38033470|NCT02942264|69719412|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
38033471|NCT02942264|69719413|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
37666695|NCT02121262|69139080|FG001|Overall Study|Participant Dropped-out|1|||
38033472|NCT02942264|69719414|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
37666696|NCT02121262|69139079|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
37666697|NCT02121262|69139080|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
37666698|NCT02121262|69139079|FG000|Overall Study|Consent Withdrawn|1|||
37666699|NCT02121262|69139080|FG001|Overall Study|Consent Withdrawn|0|||
37666700|NCT02120950|69139088|FG000|Overall Study|Adverse Event|5|||
37666701|NCT02120950|69139089|FG001|Overall Study|Adverse Event|4|||
37666702|NCT02120950|69139090|FG002|Overall Study|Adverse Event|3|||
37666703|NCT02120950|69139088|FG000|Overall Study|Death|3|||
37666704|NCT02120950|69139089|FG001|Overall Study|Death|0|||
37924553|NCT00650806|69611521|FG003|Overall Study|Protocol Violation|1|||
37924554|NCT00650806|69611518|FG000|Overall Study|Pregnancy|0|||
37924555|NCT00650806|69611519|FG001|Overall Study|Pregnancy|0|||
37924556|NCT00650806|69611520|FG002|Overall Study|Pregnancy|0|||
38033473|NCT02942264|69719415|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
37924557|NCT00650806|69611521|FG003|Overall Study|Pregnancy|1|||
37924558|NCT00650806|69611518|FG000|Overall Study|Withdrawal by Subject|7|||
37759291|NCT01528345|69268938|FG001|Overall Study|Subject/Guardian Decision|0|||
37759292|NCT01513967|69268952|FG000|Overall Study|Pregnancy|0|||
37759293|NCT01513967|69268953|FG001|Overall Study|Pregnancy|0|||
37759294|NCT01513967|69268954|FG002|Overall Study|Pregnancy|0|||
37759295|NCT01513967|69268955|FG003|Overall Study|Pregnancy|0|||
37759296|NCT01513967|69268956|FG004|Overall Study|Pregnancy|0|||
37759297|NCT01513967|69268957|FG005|Overall Study|Pregnancy|0|||
37759298|NCT01513967|69268958|FG006|Overall Study|Pregnancy|1|||
37759299|NCT01513967|69268959|FG007|Overall Study|Pregnancy|0|||
37759300|NCT01513967|69268952|FG000|Overall Study|missed a study visit|0|||
37759301|NCT01513967|69268953|FG001|Overall Study|missed a study visit|0|||
37759302|NCT01513967|69268954|FG002|Overall Study|missed a study visit|0|||
37759303|NCT01513967|69268955|FG003|Overall Study|missed a study visit|0|||
37759304|NCT01513967|69268956|FG004|Overall Study|missed a study visit|0|||
37759305|NCT01513967|69268957|FG005|Overall Study|missed a study visit|0|||
37759306|NCT01513967|69268958|FG006|Overall Study|missed a study visit|1|||
37759307|NCT01513967|69268959|FG007|Overall Study|missed a study visit|0|||
37759308|NCT01513967|69268952|FG000|Overall Study|excluded due to positive drug screen|0|||
37759309|NCT01513967|69268953|FG001|Overall Study|excluded due to positive drug screen|0|||
37759310|NCT01513967|69268954|FG002|Overall Study|excluded due to positive drug screen|0|||
37759311|NCT01513967|69268955|FG003|Overall Study|excluded due to positive drug screen|0|||
37759312|NCT01513967|69268956|FG004|Overall Study|excluded due to positive drug screen|0|||
37759313|NCT01513967|69268957|FG005|Overall Study|excluded due to positive drug screen|0|||
37666705|NCT02120950|69139090|FG002|Overall Study|Death|1|||
37924559|NCT00650806|69611519|FG001|Overall Study|Withdrawal by Subject|5|||
37924560|NCT00650806|69611520|FG002|Overall Study|Withdrawal by Subject|8|||
37924561|NCT00650806|69611521|FG003|Overall Study|Withdrawal by Subject|6|||
37666706|NCT02120950|69139088|FG000|Overall Study|Withdrawal by Subject|6|||
37666707|NCT02120950|69139089|FG001|Overall Study|Withdrawal by Subject|3|||
37759314|NCT01513967|69268958|FG006|Overall Study|excluded due to positive drug screen|0|||
37759315|NCT01513967|69268959|FG007|Overall Study|excluded due to positive drug screen|2|||
37759316|NCT01513967|69268952|FG000|Overall Study|Physician Decision|0|||
37759317|NCT01513967|69268953|FG001|Overall Study|Physician Decision|0|||
37759318|NCT01513967|69268954|FG002|Overall Study|Physician Decision|0|||
37759319|NCT01513967|69268955|FG003|Overall Study|Physician Decision|0|||
37759320|NCT01513967|69268956|FG004|Overall Study|Physician Decision|0|||
37759321|NCT01513967|69268957|FG005|Overall Study|Physician Decision|1|||
37759322|NCT01513967|69268958|FG006|Overall Study|Physician Decision|0|||
37759323|NCT01513967|69268959|FG007|Overall Study|Physician Decision|0|||
37759324|NCT01511939|69269003|FG000|Overall Study|Withdrawal by Subject|2|||
37759325|NCT01511939|69269004|FG001|Overall Study|Withdrawal by Subject|1|||
37759326|NCT01511939|69269005|FG002|Overall Study|Withdrawal by Subject|0|||
37759327|NCT01576705|69269017|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
37759328|NCT01576705|69269018|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
37759329|NCT01576705|69269019|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
37759330|NCT01576705|69269020|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
37924562|NCT00650806|69611518|FG000|Overall Study|Noncompliance with study drug regimen|1|||
37924563|NCT00650806|69611519|FG001|Overall Study|Noncompliance with study drug regimen|1|||
37924564|NCT00650806|69611520|FG002|Overall Study|Noncompliance with study drug regimen|0|||
37924565|NCT00650806|69611521|FG003|Overall Study|Noncompliance with study drug regimen|0|||
37666708|NCT02120950|69139090|FG002|Overall Study|Withdrawal by Subject|2|||
37666709|NCT02120950|69139088|FG000|Overall Study|Protocol Violation|1|||
37666710|NCT02120950|69139089|FG001|Overall Study|Protocol Violation|1|||
37666711|NCT02120950|69139090|FG002|Overall Study|Protocol Violation|7|||
37666712|NCT02120950|69139088|FG000|Overall Study|Other reasons|5|||
37666713|NCT02120950|69139089|FG001|Overall Study|Other reasons|4|||
37759331|NCT01576705|69269017|FG000|Overall Study|invalid ICF|0|||
37666714|NCT02120950|69139090|FG002|Overall Study|Other reasons|1|||
37759332|NCT01576705|69269018|FG001|Overall Study|invalid ICF|1|||
37759333|NCT01576705|69269019|FG002|Overall Study|invalid ICF|0|||
37759334|NCT01576705|69269020|FG003|Overall Study|invalid ICF|0|||
37759335|NCT02666430|69269032|FG000|Period 1|Lost to Follow-up|1|||
37759336|NCT02666430|69269033|FG001|Period 1|Lost to Follow-up|0|||
37759337|NCT02666430|69269032|FG000|Period 1|Adverse Event|0|||
37859284|NCT01292603|69542621|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
37759338|NCT02666430|69269033|FG001|Period 1|Adverse Event|1|||
37759339|NCT02666430|69269032|FG000|Period 2|Withdrawal by Subject|1|||
37859285|NCT01292603|69542622|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
37859286|NCT01292603|69542617|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
37859287|NCT01292603|69542618|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
37859288|NCT01292603|69542619|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
37859289|NCT01292603|69542620|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
37859290|NCT01292603|69542621|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
37859291|NCT01292603|69542622|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
37859292|NCT01292603|69542617|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
37924566|NCT00650806|69611518|FG000|Overall Study|Study terminated by sponsor|2|||
37924567|NCT00650806|69611519|FG001|Overall Study|Study terminated by sponsor|3|||
37924568|NCT00650806|69611520|FG002|Overall Study|Study terminated by sponsor|5|||
37924569|NCT00650806|69611521|FG003|Overall Study|Study terminated by sponsor|4|||
37924570|NCT00650806|69611518|FG000|Overall Study|Other|1|||
37924571|NCT00650806|69611519|FG001|Overall Study|Other|1|||
37924572|NCT00650806|69611520|FG002|Overall Study|Other|2|||
37924573|NCT00650806|69611521|FG003|Overall Study|Other|0|||
37924574|NCT00863057|69611537|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
37924575|NCT00863057|69611538|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
37924576|NCT00863057|69611539|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
37924577|NCT00863057|69611540|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
37924578|NCT00863057|69611537|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
37924579|NCT00863057|69611538|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
37924580|NCT00863057|69611539|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
37924581|NCT00863057|69611540|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
37924582|NCT00863057|69611537|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
37924583|NCT00863057|69611538|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
37924584|NCT00863057|69611539|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
37924585|NCT00863057|69611540|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
37924586|NCT00863057|69611537|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
37924587|NCT00863057|69611538|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
37924588|NCT00863057|69611539|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
37924589|NCT00863057|69611540|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
37924590|NCT00829166|69611558|FG000|Overall Study|Death|305|||
37924591|NCT00829166|69611559|FG001|Overall Study|Death|333|||
37924592|NCT00829166|69611558|FG000|Overall Study|Lost to Follow-up|5|||
37924593|NCT00829166|69611559|FG001|Overall Study|Lost to Follow-up|4|||
37924594|NCT00829166|69611558|FG000|Overall Study|Physician's Decision|4|||
37924595|NCT00829166|69611559|FG001|Overall Study|Physician's Decision|3|||
37924596|NCT00829166|69611558|FG000|Overall Study|Subject's Decision|41|||
37924597|NCT00829166|69611559|FG001|Overall Study|Subject's Decision|55|||
37924598|NCT00829166|69611558|FG000|Overall Study|Sponsor's Decision|137|||
37924599|NCT00829166|69611559|FG001|Overall Study|Sponsor's Decision|98|||
37924600|NCT00829166|69611558|FG000|Overall Study|Reason Not Specified|3|||
37924601|NCT00829166|69611559|FG001|Overall Study|Reason Not Specified|3|||
37924602|NCT00799266|69611568|FG000|Overall Study|Adverse Event|0|||
37924603|NCT00799266|69611569|FG001|Overall Study|Adverse Event|1|||
37924604|NCT00799266|69611568|FG000|Overall Study|Subject withdrew consent|3|||
37924605|NCT00799266|69611569|FG001|Overall Study|Subject withdrew consent|0|||
37924606|NCT00650104|69611575|FG000|Overall Study|Adverse Event|17|||
37924607|NCT00650104|69611575|FG000|Overall Study|Death|2|||
37924608|NCT00650104|69611575|FG000|Overall Study|Withdrawal by Subject|11|||
37924609|NCT00650104|69611575|FG000|Overall Study|Physician Decision|7|||
37924610|NCT00650104|69611575|FG000|Overall Study|Lost to Follow-up|1|||
37924611|NCT00650104|69611575|FG000|Overall Study|Non-compliance|2|||
37924612|NCT00650104|69611575|FG000|Overall Study|Sponsor Terminated Dosing|1|||
37924613|NCT00654238|69611579|FG000|Overall Study|Screen Failures|4|||
37924614|NCT00862979|69611586|FG000|Overall Study|Adverse Event|6|||
37924615|NCT00862979|69611587|FG001|Overall Study|Adverse Event|3|||
37924616|NCT00862979|69611586|FG000|Overall Study|Protocol Violation|0|||
37924617|NCT00862979|69611587|FG001|Overall Study|Protocol Violation|1|||
37924618|NCT00862979|69611586|FG000|Overall Study|Patient withdrew consent|2|||
37924619|NCT00862979|69611587|FG001|Overall Study|Patient withdrew consent|1|||
37924620|NCT00862979|69611586|FG000|Overall Study|Administrative problems|0|||
37924621|NCT00862979|69611587|FG001|Overall Study|Administrative problems|1|||
37924622|NCT00862979|69611586|FG000|Overall Study|Death|0|||
37924623|NCT00862979|69611587|FG001|Overall Study|Death|1|||
37924624|NCT00483379|69611595|FG000|Treatment Period|Adverse Event|1|||
37924625|NCT00483379|69611596|FG001|Treatment Period|Adverse Event|0|||
37924626|NCT00483379|69611595|FG000|Treatment Period|Withdrawal by Subject|1|||
37924627|NCT00483379|69611596|FG001|Treatment Period|Withdrawal by Subject|0|||
37924628|NCT00446251|69611604|FG000|Overall Study|On-study Transplants|2|||
37924629|NCT00446251|69611604|FG000|Overall Study|Rituximab Infusion Reaction|2|||
37924630|NCT00446251|69611604|FG000|Overall Study|Lost to Follow-up|1|||
37924631|NCT00796224|69611610|FG000|Overall Study|Adverse Event|1|||
37924632|NCT00796224|69611611|FG001|Overall Study|Adverse Event|0|||
37924633|NCT00796224|69611610|FG000|Overall Study|Protocol Violation|0|||
37924634|NCT00796224|69611611|FG001|Overall Study|Protocol Violation|1|||
37924635|NCT00791934|69611619|FG000|Overall Study|Withdrawal by Subject|2|||
37924636|NCT00791934|69611619|FG000|Overall Study|Did not consent for extended follow-up|13|||
37924637|NCT00848081|69611625|FG000|Overall Study|Adverse Event|6|||
37924638|NCT00848081|69611626|FG001|Overall Study|Adverse Event|7|||
37924639|NCT00848081|69611625|FG000|Overall Study|Protocol Violation|8|||
37924640|NCT00848081|69611626|FG001|Overall Study|Protocol Violation|5|||
37924641|NCT00848081|69611625|FG000|Overall Study|Lost to Follow-up|1|||
37924642|NCT00848081|69611626|FG001|Overall Study|Lost to Follow-up|0|||
37924643|NCT00848081|69611625|FG000|Overall Study|Physician Decision|0|||
37924644|NCT00848081|69611626|FG001|Overall Study|Physician Decision|3|||
37924645|NCT00848081|69611625|FG000|Overall Study|Withdrawal by Subject|5|||
37924646|NCT00848081|69611626|FG001|Overall Study|Withdrawal by Subject|3|||
37924647|NCT00654004|69611634|FG000|Overall Study|Lost to Follow-up|1|||
37924648|NCT00654004|69611635|FG001|Overall Study|Lost to Follow-up|0|||
37924649|NCT00791778|69611643|FG000|Double-blind Treatment|Adverse Event|49|||
37924650|NCT00791778|69611644|FG001|Double-blind Treatment|Adverse Event|9|||
37924651|NCT00791778|69611643|FG000|Double-blind Treatment|Physician Decision|6|||
37924652|NCT00791778|69611644|FG001|Double-blind Treatment|Physician Decision|26|||
37924653|NCT00791778|69611643|FG000|Double-blind Treatment|Protocol Violation|0|||
37924654|NCT00791778|69611644|FG001|Double-blind Treatment|Protocol Violation|4|||
37924655|NCT00791778|69611643|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
37924656|NCT00791778|69611644|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
37924657|NCT00791778|69611643|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
37924658|NCT00791778|69611644|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
37924659|NCT00791778|69611643|FG000|Follow-up|Withdrawal by Subject|3|||
37924660|NCT00791778|69611644|FG001|Follow-up|Withdrawal by Subject|0|||
37924661|NCT00791778|69611643|FG000|Follow-up|Lost to Follow-up|2|||
37924662|NCT00791778|69611644|FG001|Follow-up|Lost to Follow-up|1|||
37924663|NCT00798174|69611650|FG000|Overall Study|inability to implant azygos coil|3|||
37924664|NCT00798174|69611651|FG001|Overall Study|inability to implant azygos coil|3|||
37924665|NCT00798174|69611650|FG000|Overall Study|Inability to sedate for DFT testing|1|||
37924666|NCT00798174|69611651|FG001|Overall Study|Inability to sedate for DFT testing|0|||
37924667|NCT00798096|69611655|FG000|Overall Study|Ongoing|2|||
37924668|NCT00795600|69611661|FG000|Overall Study|Adverse Event|1|||
37924669|NCT00795600|69611662|FG001|Overall Study|Adverse Event|1|||
37924670|NCT00795600|69611661|FG000|Overall Study|Protocol Violation|1|||
37924671|NCT00795600|69611662|FG001|Overall Study|Protocol Violation|2|||
37924672|NCT00795600|69611661|FG000|Overall Study|Withdrawal by Subject|1|||
37924673|NCT00795600|69611662|FG001|Overall Study|Withdrawal by Subject|0|||
37924674|NCT00795600|69611661|FG000|Overall Study|Unclassified|1|||
37924675|NCT00795600|69611662|FG001|Overall Study|Unclassified|1|||
37924676|NCT00795132|69611668|FG000|Overall Study|Death|1|||
37924677|NCT00795132|69611668|FG000|Overall Study|Relapse|2|||
37924678|NCT00647296|69611684|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
37924679|NCT00647296|69611685|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
37924680|NCT00647296|69611686|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
37924681|NCT00647296|69611687|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
37924682|NCT00647296|69611684|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
37924683|NCT00647296|69611685|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
37924684|NCT00647296|69611686|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
37924685|NCT00647296|69611687|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
37924686|NCT00647296|69611684|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
37924687|NCT00647296|69611685|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
37924688|NCT00647296|69611686|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
37924689|NCT00647296|69611687|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
37924690|NCT00647296|69611684|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
37924691|NCT00647296|69611685|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
37924692|NCT00647296|69611686|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
37924693|NCT00647296|69611687|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
37924694|NCT00647296|69611684|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
37924695|NCT00647296|69611685|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
37924696|NCT00647296|69611686|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
37924697|NCT00647296|69611687|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
37924698|NCT00647296|69611684|FG000|Part 2: 4-week Placebo Washout|Death|3|||
37924699|NCT00647296|69611685|FG001|Part 2: 4-week Placebo Washout|Death|0|||
37924700|NCT00647296|69611686|FG002|Part 2: 4-week Placebo Washout|Death|0|||
37924701|NCT00647296|69611687|FG003|Part 2: 4-week Placebo Washout|Death|0|||
37924702|NCT00647296|69611684|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
37924703|NCT00647296|69611685|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
37759340|NCT02666430|69269033|FG001|Period 2|Withdrawal by Subject|4|||
37759341|NCT02666430|69269032|FG000|Period 3|Lost to Follow-up|1|||
37759342|NCT02666430|69269033|FG001|Period 3|Lost to Follow-up|0|||
37759343|NCT01576549|69269039|FG000|Overall Study|Sponsor Decision|2|||
37759344|NCT01576159|69269052|FG000|Overall Study|Withdrawal by Subject|0|||
37759345|NCT01576159|69269053|FG001|Overall Study|Withdrawal by Subject|1|||
37924704|NCT00647296|69611686|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
37759346|NCT01576159|69269054|FG002|Overall Study|Withdrawal by Subject|0|||
37759347|NCT01576159|69269055|FG003|Overall Study|Withdrawal by Subject|0|||
37759348|NCT01576159|69269052|FG000|Overall Study|Physician Decision|0|||
37924705|NCT00647296|69611687|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
37924706|NCT00647296|69611684|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
37924707|NCT00647296|69611685|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
37924708|NCT00647296|69611686|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
37924709|NCT00647296|69611687|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
37924710|NCT00647296|69611684|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
37924711|NCT00647296|69611685|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
37924712|NCT00647296|69611686|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
37924713|NCT00647296|69611687|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
37924714|NCT00647296|69611684|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
37924715|NCT00647296|69611685|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
37924716|NCT00647296|69611686|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
37924717|NCT00647296|69611687|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
37924718|NCT00647296|69611684|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
37924719|NCT00647296|69611685|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
37924720|NCT00647296|69611686|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
37924721|NCT00647296|69611687|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
37924722|NCT00644878|69611709|FG000|Overall Study|Adverse Event|2|||
37924723|NCT00644878|69611709|FG000|Overall Study|Abnormal laboratory value|3|||
37924724|NCT00644878|69611709|FG000|Overall Study|Protocol deviation|2|||
37924725|NCT00644878|69611709|FG000|Overall Study|Treatment duration completed as per protocol|11|||
37924726|NCT00646906|69611717|FG000|Crossover Period 1|Withdrawal by Subject|1|||
37924727|NCT00646906|69611718|FG001|Crossover Period 1|Withdrawal by Subject|0|||
37924728|NCT00646906|69611719|FG002|Crossover Period 1|Withdrawal by Subject|0|||
37924729|NCT00646906|69611720|FG003|Crossover Period 1|Withdrawal by Subject|0|||
37924730|NCT00646906|69611721|FG004|Crossover Period 1|Withdrawal by Subject|0|||
37924731|NCT00646906|69611722|FG005|Crossover Period 1|Withdrawal by Subject|1|||
37924732|NCT00646906|69611723|FG006|Crossover Period 1|Withdrawal by Subject|0|||
37924733|NCT00646906|69611717|FG000|Crossover Period 2|Withdrawal by Subject|0|||
37924734|NCT00646906|69611718|FG001|Crossover Period 2|Withdrawal by Subject|1|||
37924735|NCT00646906|69611719|FG002|Crossover Period 2|Withdrawal by Subject|2|||
37924736|NCT00646906|69611720|FG003|Crossover Period 2|Withdrawal by Subject|1|||
37924737|NCT00646906|69611721|FG004|Crossover Period 2|Withdrawal by Subject|0|||
37924738|NCT00646906|69611722|FG005|Crossover Period 2|Withdrawal by Subject|0|||
37924739|NCT00646906|69611723|FG006|Crossover Period 2|Withdrawal by Subject|0|||
37924740|NCT00646906|69611717|FG000|Crossover Period 2|Physician Decision|0|||
37924741|NCT00646906|69611718|FG001|Crossover Period 2|Physician Decision|0|||
37924742|NCT00646906|69611719|FG002|Crossover Period 2|Physician Decision|0|||
37924743|NCT00646906|69611720|FG003|Crossover Period 2|Physician Decision|0|||
37924744|NCT00646906|69611721|FG004|Crossover Period 2|Physician Decision|0|||
37924745|NCT00646906|69611722|FG005|Crossover Period 2|Physician Decision|0|||
37924746|NCT00646906|69611723|FG006|Crossover Period 2|Physician Decision|1|||
37924747|NCT00642772|69611736|FG000|Overall Study|Lost to Follow-up|3|||
37924748|NCT00642772|69611736|FG000|Overall Study|Withdrawal by Subject|7|||
37924749|NCT00446095|69611745|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
38033474|NCT03322514|69719442|FG000|Overall Study|Withdrawal by Subject|1|||
38033475|NCT03322514|69719443|FG001|Overall Study|Withdrawal by Subject|1|||
38033476|NCT03325712|69719457|FG000|Overall Study|Protocol Violation|0|||
37666715|NCT02120950|69139088|FG000|Overall Study|Lost to Follow-up|0|||
37666716|NCT02120950|69139089|FG001|Overall Study|Lost to Follow-up|2|||
37666717|NCT02120950|69139090|FG002|Overall Study|Lost to Follow-up|1|||
37666718|NCT02120794|69139097|FG000|Overall Study|Withdrawal by Subject|43|||
37666719|NCT02120794|69139097|FG000|Overall Study|Adverse Event|10|||
37666720|NCT02120794|69139097|FG000|Overall Study|Physician Decision|4|||
37666721|NCT02120794|69139097|FG000|Overall Study|Due to insurance coverage|1|||
37859293|NCT01292603|69542618|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
37859294|NCT01292603|69542619|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
37859295|NCT01292603|69542620|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
37859296|NCT01292603|69542621|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
37859297|NCT01292603|69542622|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
37859298|NCT01292603|69542617|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
37859299|NCT01292603|69542618|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
37859300|NCT01292603|69542619|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
37859301|NCT01292603|69542620|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
37859302|NCT01292603|69542621|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
37859303|NCT01292603|69542622|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
37859304|NCT01292603|69542617|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
37859305|NCT01292603|69542618|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
37859306|NCT01292603|69542619|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
37859307|NCT01292603|69542620|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
37666722|NCT02184442|69139103|FG000|Overall Study|Death|61|||
37666723|NCT02184442|69139104|FG001|Overall Study|Death|65|||
37666724|NCT02184442|69139103|FG000|Overall Study|Withdrawal by Subject|3|||
37924750|NCT00446095|69611746|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
37924751|NCT00446095|69611747|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
37924752|NCT00446095|69611748|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
37924753|NCT00446095|69611749|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
37924754|NCT00446095|69611745|FG000|Phase II (8 Weeks)|Adverse Event|0|||
37924755|NCT00446095|69611746|FG001|Phase II (8 Weeks)|Adverse Event|1|||
37924756|NCT00446095|69611747|FG002|Phase II (8 Weeks)|Adverse Event|1|||
37924757|NCT00446095|69611748|FG003|Phase II (8 Weeks)|Adverse Event|0|||
37924758|NCT00446095|69611749|FG004|Phase II (8 Weeks)|Adverse Event|0|||
37924759|NCT00446095|69611745|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
37924760|NCT00446095|69611746|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
37924761|NCT00446095|69611747|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
37924762|NCT00446095|69611748|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
37924763|NCT00446095|69611749|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
37924764|NCT00446095|69611745|FG000|Phase II (8 Weeks)|Physician Decision|1|||
37924765|NCT00446095|69611746|FG001|Phase II (8 Weeks)|Physician Decision|0|||
37924766|NCT00446095|69611747|FG002|Phase II (8 Weeks)|Physician Decision|0|||
37924767|NCT00446095|69611748|FG003|Phase II (8 Weeks)|Physician Decision|0|||
37924768|NCT00446095|69611749|FG004|Phase II (8 Weeks)|Physician Decision|0|||
37924769|NCT00446095|69611745|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
37924770|NCT00446095|69611746|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
37924771|NCT00446095|69611747|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
37924772|NCT00446095|69611748|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
37924773|NCT00446095|69611749|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
37924774|NCT00446095|69611745|FG000|Phase II (8 Weeks)|Ongoing|0|||
37924775|NCT00446095|69611746|FG001|Phase II (8 Weeks)|Ongoing|0|||
37924776|NCT00446095|69611747|FG002|Phase II (8 Weeks)|Ongoing|1|||
37924777|NCT00446095|69611748|FG003|Phase II (8 Weeks)|Ongoing|0|||
37924778|NCT00446095|69611749|FG004|Phase II (8 Weeks)|Ongoing|0|||
37924779|NCT00446095|69611745|FG000|Phase I (28 Days)|Adverse Event|0|||
37924780|NCT00446095|69611746|FG001|Phase I (28 Days)|Adverse Event|0|||
37924781|NCT00446095|69611747|FG002|Phase I (28 Days)|Adverse Event|0|||
37924782|NCT00446095|69611748|FG003|Phase I (28 Days)|Adverse Event|1|||
37924783|NCT00446095|69611749|FG004|Phase I (28 Days)|Adverse Event|0|||
37924784|NCT00446095|69611745|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
37924785|NCT00446095|69611746|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
37924786|NCT00446095|69611747|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
37924787|NCT00446095|69611748|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
37924788|NCT00446095|69611749|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
37924789|NCT00829010|69611765|FG000|Overall Study|Adverse Event|1|||
37924790|NCT00829010|69611766|FG001|Overall Study|Adverse Event|0|||
37924791|NCT00829010|69611767|FG002|Overall Study|Adverse Event|0|||
37924792|NCT00829010|69611768|FG003|Overall Study|Adverse Event|0|||
37924793|NCT00829010|69611769|FG004|Overall Study|Adverse Event|0|||
37924794|NCT00829010|69611765|FG000|Overall Study|Withdrawal by Subject|0|||
37924795|NCT00829010|69611766|FG001|Overall Study|Withdrawal by Subject|1|||
37924796|NCT00829010|69611767|FG002|Overall Study|Withdrawal by Subject|1|||
37924797|NCT00829010|69611768|FG003|Overall Study|Withdrawal by Subject|0|||
37924798|NCT00829010|69611769|FG004|Overall Study|Withdrawal by Subject|2|||
37924799|NCT00829010|69611765|FG000|Overall Study|Lost to Follow-up|1|||
37924800|NCT00829010|69611766|FG001|Overall Study|Lost to Follow-up|0|||
37924801|NCT00829010|69611767|FG002|Overall Study|Lost to Follow-up|2|||
37924802|NCT00829010|69611768|FG003|Overall Study|Lost to Follow-up|0|||
37924803|NCT00829010|69611769|FG004|Overall Study|Lost to Follow-up|0|||
37924804|NCT00829010|69611765|FG000|Overall Study|Fatality|5|||
37924805|NCT00829010|69611766|FG001|Overall Study|Fatality|4|||
37924806|NCT00829010|69611767|FG002|Overall Study|Fatality|0|||
37924807|NCT00829010|69611768|FG003|Overall Study|Fatality|3|||
37924808|NCT00829010|69611769|FG004|Overall Study|Fatality|0|||
37924809|NCT00829010|69611765|FG000|Overall Study|Migrated/Moved from study area|3|||
37924810|NCT00829010|69611766|FG001|Overall Study|Migrated/Moved from study area|4|||
37666725|NCT02184442|69139104|FG001|Overall Study|Withdrawal by Subject|11|||
37924811|NCT00829010|69611767|FG002|Overall Study|Migrated/Moved from study area|0|||
37924812|NCT00829010|69611768|FG003|Overall Study|Migrated/Moved from study area|5|||
37924813|NCT00829010|69611769|FG004|Overall Study|Migrated/Moved from study area|0|||
37924814|NCT00644332|69611781|FG000|Overall Study|Adverse Event|11|||
37924815|NCT00644332|69611781|FG000|Overall Study|Withdrawal by Subject|6|||
37924816|NCT00644332|69611781|FG000|Overall Study|Completion Status Unknown|2|||
37924817|NCT00644332|69611781|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
37924818|NCT00644332|69611781|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
37924819|NCT00445939|69611788|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
37759349|NCT01576159|69269053|FG001|Overall Study|Physician Decision|0|||
37924820|NCT00445939|69611789|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
37924821|NCT00445939|69611790|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
37924822|NCT00445939|69611791|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
37924823|NCT00445939|69611788|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
38033477|NCT03325712|69719458|FG001|Overall Study|Protocol Violation|0|||
37924824|NCT00445939|69611789|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
37924825|NCT00445939|69611790|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
37924826|NCT00445939|69611791|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
37924827|NCT00482053|69611811|FG000|Inter-treatment Period|Disease progression|1|||
37924828|NCT00455923|69611817|FG000|Overall Study|Pregnancy|0|||
37924829|NCT00455923|69611818|FG001|Overall Study|Pregnancy|2|||
37924830|NCT00455923|69611817|FG000|Overall Study|Other|3|||
37924831|NCT00455923|69611818|FG001|Overall Study|Other|1|||
37924832|NCT00642616|69611828|FG000|Overall Study|Adverse Event|2|||
37924833|NCT00642616|69611829|FG001|Overall Study|Adverse Event|0|||
37924834|NCT00642616|69611830|FG002|Overall Study|Adverse Event|1|||
37924835|NCT00642616|69611831|FG003|Overall Study|Adverse Event|0|||
37924836|NCT00642616|69611828|FG000|Overall Study|Study Terminated by Sponsor|7|||
37924837|NCT00642616|69611829|FG001|Overall Study|Study Terminated by Sponsor|6|||
37924838|NCT00642616|69611830|FG002|Overall Study|Study Terminated by Sponsor|4|||
37924839|NCT00642616|69611831|FG003|Overall Study|Study Terminated by Sponsor|5|||
37924840|NCT00642616|69611828|FG000|Overall Study|Withdrawal by Subject|0|||
37924841|NCT00642616|69611829|FG001|Overall Study|Withdrawal by Subject|1|||
37924842|NCT00642616|69611830|FG002|Overall Study|Withdrawal by Subject|1|||
37924843|NCT00642616|69611831|FG003|Overall Study|Withdrawal by Subject|1|||
37924844|NCT00642616|69611828|FG000|Overall Study|Protocol Violation|0|||
37924845|NCT00642616|69611829|FG001|Overall Study|Protocol Violation|0|||
37924846|NCT00642616|69611830|FG002|Overall Study|Protocol Violation|2|||
37924847|NCT00642616|69611831|FG003|Overall Study|Protocol Violation|0|||
37924848|NCT00642616|69611828|FG000|Overall Study|Physician Decision|0|||
37924849|NCT00642616|69611829|FG001|Overall Study|Physician Decision|0|||
37924850|NCT00642616|69611830|FG002|Overall Study|Physician Decision|1|||
37924851|NCT00642616|69611831|FG003|Overall Study|Physician Decision|1|||
37924852|NCT03844945|69611847|FG000|Overall Study|Adverse Event|1|||
37924853|NCT03844945|69611848|FG001|Overall Study|Adverse Event|1|||
37924854|NCT03844945|69611849|FG002|Overall Study|Adverse Event|4|||
37924855|NCT03844945|69611850|FG003|Overall Study|Adverse Event|0|||
37924856|NCT03844945|69611847|FG000|Overall Study|Withdrawal by Subject|0|||
37924857|NCT03844945|69611848|FG001|Overall Study|Withdrawal by Subject|0|||
37924858|NCT03844945|69611849|FG002|Overall Study|Withdrawal by Subject|1|||
37924859|NCT03844945|69611850|FG003|Overall Study|Withdrawal by Subject|0|||
37924860|NCT03844945|69611847|FG000|Overall Study|Lack of Efficacy|0|||
37924861|NCT03844945|69611848|FG001|Overall Study|Lack of Efficacy|0|||
37924862|NCT03844945|69611849|FG002|Overall Study|Lack of Efficacy|0|||
37924863|NCT03844945|69611850|FG003|Overall Study|Lack of Efficacy|1|||
37924864|NCT00445549|69611860|FG000|Overall Study|progressive disease|12|||
37924865|NCT00445003|69611867|FG000|Overall Study|Death|1|||
37924866|NCT00445003|69611868|FG001|Overall Study|Death|2|||
37924867|NCT00445003|69611869|FG002|Overall Study|Death|1|||
37924868|NCT00445003|69611867|FG000|Overall Study|Missed Visit|3|||
37924869|NCT00445003|69611868|FG001|Overall Study|Missed Visit|5|||
37924870|NCT00445003|69611869|FG002|Overall Study|Missed Visit|1|||
37924871|NCT00445003|69611867|FG000|Overall Study|Dropped|1|||
37924872|NCT00445003|69611868|FG001|Overall Study|Dropped|3|||
37924873|NCT00445003|69611869|FG002|Overall Study|Dropped|2|||
37924874|NCT00811070|69611883|FG000|Overall Study|Death|0|||
37924875|NCT00811070|69611884|FG001|Overall Study|Death|0|||
37924876|NCT00811070|69611885|FG002|Overall Study|Death|0|||
37924877|NCT00811070|69611886|FG003|Overall Study|Death|2|||
37924878|NCT00811070|69611887|FG004|Overall Study|Death|5|||
37924879|NCT00811070|69611888|FG005|Overall Study|Death|0|||
37924880|NCT00811070|69611883|FG000|Overall Study|Other|1|||
37924881|NCT00811070|69611884|FG001|Overall Study|Other|0|||
37924882|NCT00811070|69611885|FG002|Overall Study|Other|0|||
37924883|NCT00811070|69611886|FG003|Overall Study|Other|0|||
37924884|NCT00811070|69611887|FG004|Overall Study|Other|0|||
37924885|NCT00811070|69611888|FG005|Overall Study|Other|0|||
37924886|NCT00811070|69611883|FG000|Overall Study|Withdrawal by Subject|0|||
38033478|NCT03325712|69719459|FG002|Overall Study|Protocol Violation|0|||
38033479|NCT03325712|69719460|FG003|Overall Study|Protocol Violation|0|||
37924887|NCT00811070|69611884|FG001|Overall Study|Withdrawal by Subject|1|||
37924888|NCT00811070|69611885|FG002|Overall Study|Withdrawal by Subject|0|||
37924889|NCT00811070|69611886|FG003|Overall Study|Withdrawal by Subject|0|||
37924890|NCT00811070|69611887|FG004|Overall Study|Withdrawal by Subject|0|||
37924891|NCT00811070|69611888|FG005|Overall Study|Withdrawal by Subject|0|||
37924892|NCT00811070|69611883|FG000|Overall Study|Physician Decision|0|||
37924893|NCT00811070|69611884|FG001|Overall Study|Physician Decision|0|||
37924894|NCT00811070|69611885|FG002|Overall Study|Physician Decision|0|||
37924895|NCT00811070|69611886|FG003|Overall Study|Physician Decision|0|||
37924896|NCT00811070|69611887|FG004|Overall Study|Physician Decision|0|||
37924897|NCT00811070|69611888|FG005|Overall Study|Physician Decision|1|||
37924898|NCT00642460|69611906|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
37924899|NCT00642460|69611907|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
37924900|NCT00642460|69611908|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
37924901|NCT00642460|69611909|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
37924902|NCT00642460|69611910|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
37924903|NCT00642460|69611911|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
37924904|NCT00642460|69611906|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
37924905|NCT00642460|69611907|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
37924906|NCT00642460|69611908|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
37924907|NCT00642460|69611909|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
37924908|NCT00642460|69611910|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
37924909|NCT00642460|69611911|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
37924910|NCT00642460|69611906|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
37924911|NCT00642460|69611907|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
37924912|NCT00642460|69611908|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
37924913|NCT00642460|69611909|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
37924914|NCT00642460|69611910|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
37924915|NCT00642460|69611911|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
37924916|NCT00642460|69611906|FG000|Part II: Open-Label Up to Week 92|Death|0|||
37924917|NCT00642460|69611907|FG001|Part II: Open-Label Up to Week 92|Death|1|||
37924918|NCT00642460|69611908|FG002|Part II: Open-Label Up to Week 92|Death|0|||
37924919|NCT00642460|69611909|FG003|Part II: Open-Label Up to Week 92|Death|2|||
37924920|NCT00642460|69611910|FG004|Part II: Open-Label Up to Week 92|Death|0|||
37924921|NCT00642460|69611911|FG005|Part II: Open-Label Up to Week 92|Death|0|||
37924922|NCT00642460|69611906|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
37924923|NCT00642460|69611907|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
37924924|NCT00642460|69611908|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
37924925|NCT00642460|69611909|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
37924926|NCT00642460|69611910|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
37924927|NCT00642460|69611911|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
37924928|NCT00642460|69611906|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
37924929|NCT00642460|69611907|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
37924930|NCT00642460|69611908|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
37924931|NCT00642460|69611909|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
37924932|NCT00642460|69611910|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
37924933|NCT00642460|69611911|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
37924934|NCT00642460|69611906|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
37924935|NCT00642460|69611907|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
37924936|NCT00642460|69611908|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
37924937|NCT00642460|69611909|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
37924938|NCT00642460|69611910|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
37924939|NCT00642460|69611911|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
37924940|NCT00642460|69611906|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
37924941|NCT00642460|69611907|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
37924942|NCT00642460|69611908|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
37924943|NCT00642460|69611909|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
37924944|NCT00642460|69611910|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
37924945|NCT00642460|69611911|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
37924946|NCT00642460|69611906|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
37924947|NCT00642460|69611907|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
37924948|NCT00642460|69611908|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
37924949|NCT00642460|69611909|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
37924950|NCT00642460|69611910|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
38033480|NCT03325712|69719461|FG004|Overall Study|Protocol Violation|1|||
37924951|NCT00642460|69611911|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
37924952|NCT00642460|69611906|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
37924953|NCT00642460|69611907|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
37924954|NCT00642460|69611908|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
37924955|NCT00642460|69611909|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
37924956|NCT00642460|69611910|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
37924957|NCT00642460|69611911|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
37924958|NCT00642460|69611906|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
37924959|NCT00642460|69611907|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
37924960|NCT00642460|69611908|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
37924961|NCT00642460|69611909|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
37924962|NCT00642460|69611910|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
38033481|NCT03325712|69719462|FG005|Overall Study|Protocol Violation|0|||
37924963|NCT00642460|69611911|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
37924964|NCT00642460|69611906|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
38033482|NCT03325712|69719463|FG006|Overall Study|Protocol Violation|0|||
38033483|NCT03325712|69719464|FG007|Overall Study|Protocol Violation|0|||
37924965|NCT00642460|69611907|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
37924966|NCT00642460|69611908|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
37759350|NCT01576159|69269054|FG002|Overall Study|Physician Decision|1|||
37759351|NCT01576159|69269055|FG003|Overall Study|Physician Decision|0|||
37759352|NCT01576159|69269052|FG000|Overall Study|Lost to Follow-up|0|||
37759353|NCT01576159|69269053|FG001|Overall Study|Lost to Follow-up|0|||
37759354|NCT01576159|69269054|FG002|Overall Study|Lost to Follow-up|0|||
37759355|NCT01576159|69269055|FG003|Overall Study|Lost to Follow-up|1|||
37759356|NCT01576159|69269052|FG000|Overall Study|Protocol Violation|1|||
37759357|NCT01576159|69269053|FG001|Overall Study|Protocol Violation|0|||
37759358|NCT01576159|69269054|FG002|Overall Study|Protocol Violation|0|||
37759359|NCT01576159|69269055|FG003|Overall Study|Protocol Violation|0|||
37759360|NCT01510769|69269086|FG000|Overall Study|Adverse Event|7|||
37759361|NCT01510769|69269087|FG001|Overall Study|Adverse Event|6|||
37759362|NCT01510769|69269088|FG002|Overall Study|Adverse Event|4|||
37759363|NCT01510769|69269086|FG000|Overall Study|Gout Flare|0|||
37759364|NCT01510769|69269087|FG001|Overall Study|Gout Flare|3|||
37759365|NCT01510769|69269088|FG002|Overall Study|Gout Flare|1|||
37759366|NCT01510769|69269086|FG000|Overall Study|Protocol Violation|11|||
37759367|NCT01510769|69269087|FG001|Overall Study|Protocol Violation|10|||
37759368|NCT01510769|69269088|FG002|Overall Study|Protocol Violation|9|||
37759369|NCT01510769|69269086|FG000|Overall Study|Lost to Follow-up|5|||
37759370|NCT01510769|69269087|FG001|Overall Study|Lost to Follow-up|1|||
37759371|NCT01510769|69269088|FG002|Overall Study|Lost to Follow-up|5|||
37759372|NCT01510769|69269086|FG000|Overall Study|Withdrawal by Subject|3|||
37759373|NCT01510769|69269087|FG001|Overall Study|Withdrawal by Subject|4|||
37759374|NCT01510769|69269088|FG002|Overall Study|Withdrawal by Subject|3|||
37759375|NCT01510769|69269086|FG000|Overall Study|Death|1|||
37759376|NCT01510769|69269087|FG001|Overall Study|Death|1|||
37759377|NCT01510769|69269088|FG002|Overall Study|Death|0|||
37759378|NCT01575769|69269096|FG000|Overall Study|Adverse Event|1|||
37759379|NCT01575769|69269096|FG000|Overall Study|Study terminated by sponsor|40|||
37759380|NCT01510145|69269102|FG000|Overall Study|Adverse Event|6|||
37759381|NCT01510145|69269102|FG000|Overall Study|Lost to Follow-up|5|||
37759382|NCT01510145|69269102|FG000|Overall Study|Withdrawal by Subject|6|||
37759383|NCT01510145|69269102|FG000|Overall Study|Relative reported subject withdrew|1|||
37759384|NCT01528033|69269108|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
37759385|NCT01528033|69269109|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
37759386|NCT01528033|69269108|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
37759387|NCT01528033|69269109|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
37759388|NCT01528033|69269108|FG000|Primary Endpoint Assessment ITT|Death|2|||
37759389|NCT01528033|69269109|FG001|Primary Endpoint Assessment ITT|Death|2|||
37759390|NCT01528033|69269108|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
37759391|NCT01528033|69269109|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
37759392|NCT01528033|69269108|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
37759393|NCT01528033|69269109|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
37759394|NCT01528033|69269108|FG000|Follow Up|No data available|46|||
37759395|NCT01528033|69269109|FG001|Follow Up|No data available|44|||
37759396|NCT01560871|69269126|FG000|Overall Study|transportation issues|2|||
37759397|NCT01560871|69269127|FG001|Overall Study|transportation issues|1|||
37759398|NCT01560871|69269126|FG000|Overall Study|relocation|1|||
37759399|NCT01560871|69269127|FG001|Overall Study|relocation|0|||
37759400|NCT01560871|69269126|FG000|Overall Study|readmission to a hospital|2|||
37759401|NCT01560871|69269127|FG001|Overall Study|readmission to a hospital|1|||
37759402|NCT01560871|69269126|FG000|Overall Study|Lost to Follow-up|1|||
37759403|NCT01560871|69269127|FG001|Overall Study|Lost to Follow-up|0|||
37759404|NCT01509053|69269134|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
37759405|NCT01509053|69269134|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
37759406|NCT01509053|69269134|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
37759407|NCT01509053|69269134|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
37759408|NCT01509053|69269134|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
37759409|NCT01509053|69269134|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
37759410|NCT01560403|69269148|FG000|Overall Study|Lost to Follow-up|0|||
37759411|NCT01560403|69269149|FG001|Overall Study|Lost to Follow-up|1|||
37924967|NCT00642460|69611909|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
37759412|NCT01527487|69269196|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
37759413|NCT01527487|69269197|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
37759414|NCT01527487|69269196|FG000|Overall Study|Disease Progression|4|||
37759415|NCT01527487|69269197|FG001|Overall Study|Disease Progression|1|||
37759416|NCT01527487|69269196|FG000|Overall Study|Adverse Event|1|||
37759417|NCT01527487|69269197|FG001|Overall Study|Adverse Event|1|||
37759418|NCT01527487|69269196|FG000|Overall Study|Death|0|||
37759419|NCT01527487|69269197|FG001|Overall Study|Death|1|||
37759420|NCT01506947|69269208|FG000|Overall Study|Lost to Follow-up|7|||
37759421|NCT01506947|69269208|FG000|Overall Study|Adverse Event|5|||
37759422|NCT01506947|69269208|FG000|Overall Study|Death|1|||
37924968|NCT00642460|69611910|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
37924969|NCT00642460|69611911|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
37924970|NCT00642460|69611906|FG000|Part III: Open-Label Up to Week 260|Other|0|||
37924971|NCT00642460|69611907|FG001|Part III: Open-Label Up to Week 260|Other|0|||
37924972|NCT00642460|69611908|FG002|Part III: Open-Label Up to Week 260|Other|0|||
37924973|NCT00642460|69611909|FG003|Part III: Open-Label Up to Week 260|Other|0|||
37924974|NCT00642460|69611910|FG004|Part III: Open-Label Up to Week 260|Other|2|||
37924975|NCT00642460|69611911|FG005|Part III: Open-Label Up to Week 260|Other|2|||
37924976|NCT00642460|69611906|FG000|Part III: Open-Label Up to Week 260|Death|0|||
37924977|NCT00642460|69611907|FG001|Part III: Open-Label Up to Week 260|Death|0|||
37924978|NCT00642460|69611908|FG002|Part III: Open-Label Up to Week 260|Death|0|||
37924979|NCT00642460|69611909|FG003|Part III: Open-Label Up to Week 260|Death|0|||
37924980|NCT00642460|69611910|FG004|Part III: Open-Label Up to Week 260|Death|0|||
37924981|NCT00642460|69611911|FG005|Part III: Open-Label Up to Week 260|Death|3|||
37924982|NCT00642460|69611906|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
37924983|NCT00642460|69611907|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
37924984|NCT00642460|69611908|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
37924985|NCT00642460|69611909|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
37924986|NCT00642460|69611910|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
37924987|NCT00642460|69611911|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
37924988|NCT00642460|69611906|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
37924989|NCT00642460|69611907|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
37924990|NCT00642460|69611908|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
37924991|NCT00642460|69611909|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
37924992|NCT00642460|69611910|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
37924993|NCT00642460|69611911|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
37924994|NCT00814658|69611923|FG000|Overall Study|Lost to Follow-up|0|||
37924995|NCT00814658|69611924|FG001|Overall Study|Lost to Follow-up|1|||
37924996|NCT00814658|69611923|FG000|Overall Study|Physician Decision|1|||
37924997|NCT00814658|69611924|FG001|Overall Study|Physician Decision|0|||
37924998|NCT00814658|69611923|FG000|Overall Study|Adverse Event|3|||
37924999|NCT00814658|69611924|FG001|Overall Study|Adverse Event|3|||
37925000|NCT00642304|69611940|FG000|Overall Study|Adverse Event|1|||
37925001|NCT00642304|69611940|FG000|Overall Study|Death|1|||
37925002|NCT00642304|69611940|FG000|Overall Study|Blood transfusion|2|||
37925003|NCT00642304|69611940|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
37925004|NCT00642304|69611940|FG000|Overall Study|Transplantation|1|||
37925005|NCT00814580|69611946|FG000|Overall Study|Adverse Event|6|||
37925006|NCT00814580|69611947|FG001|Overall Study|Adverse Event|15|||
37925007|NCT00814580|69611946|FG000|Overall Study|Lack of Efficacy|18|||
37925008|NCT00814580|69611947|FG001|Overall Study|Lack of Efficacy|25|||
37925009|NCT00814580|69611946|FG000|Overall Study|Protocol Violation|2|||
37925010|NCT00814580|69611947|FG001|Overall Study|Protocol Violation|0|||
37925011|NCT00814580|69611946|FG000|Overall Study|Withdrawal by Subject|2|||
37925012|NCT00814580|69611947|FG001|Overall Study|Withdrawal by Subject|2|||
37925013|NCT00814580|69611946|FG000|Overall Study|Other|1|||
37925014|NCT00814580|69611947|FG001|Overall Study|Other|3|||
37925015|NCT00814580|69611946|FG000|Overall Study|Did Not Take Drug|2|||
37925016|NCT00814580|69611947|FG001|Overall Study|Did Not Take Drug|2|||
37925017|NCT00643162|69611967|FG000|Overall Study|Withdrawal by Subject|1|||
37925018|NCT00643162|69611968|FG001|Overall Study|Withdrawal by Subject|1|||
37925019|NCT00643006|69611976|FG000|Overall Study|Lost to Follow-up|5|||
37925020|NCT00643006|69611977|FG001|Overall Study|Lost to Follow-up|4|||
37925021|NCT00814502|69611987|FG000|Overall Study|Adverse Event|1|||
37925022|NCT00814502|69611988|FG001|Overall Study|Adverse Event|0|||
37925023|NCT00814502|69611987|FG000|Overall Study|Withdrawal by Subject|0|||
37925024|NCT00814502|69611988|FG001|Overall Study|Withdrawal by Subject|2|||
37925025|NCT00653224|69611998|FG000|Overall Study|Adverse Event|2|||
37925026|NCT00653224|69611999|FG001|Overall Study|Adverse Event|1|||
37925027|NCT00653224|69611998|FG000|Overall Study|Lack of Efficacy|1|||
37925028|NCT00653224|69611999|FG001|Overall Study|Lack of Efficacy|2|||
37925029|NCT00653224|69611998|FG000|Overall Study|Loss of efficacy|1|||
37925030|NCT00653224|69611999|FG001|Overall Study|Loss of efficacy|0|||
37925031|NCT00653224|69611998|FG000|Overall Study|Lost to Follow-up|1|||
38033484|NCT03325712|69719457|FG000|Overall Study|Adverse Event|0|||
38033485|NCT03325712|69719458|FG001|Overall Study|Adverse Event|0|||
38033486|NCT03325712|69719459|FG002|Overall Study|Adverse Event|0|||
37925032|NCT00653224|69611999|FG001|Overall Study|Lost to Follow-up|0|||
37925033|NCT00653224|69611998|FG000|Overall Study|Other|2|||
37925034|NCT00653224|69611999|FG001|Overall Study|Other|4|||
38033487|NCT03325712|69719460|FG003|Overall Study|Adverse Event|0|||
38033488|NCT03325712|69719461|FG004|Overall Study|Adverse Event|1|||
37925035|NCT00444925|69612008|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
37925036|NCT00444925|69612009|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
37925037|NCT00444925|69612010|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
37925038|NCT00444925|69612008|FG000|Double-blind Treatment Period|Death|2|||
37925039|NCT00444925|69612009|FG001|Double-blind Treatment Period|Death|0|||
37925040|NCT00444925|69612010|FG002|Double-blind Treatment Period|Death|0|||
37925041|NCT00444925|69612008|FG000|Double-blind Treatment Period|Adverse Event|6|||
37925042|NCT00444925|69612009|FG001|Double-blind Treatment Period|Adverse Event|28|||
37925043|NCT00444925|69612010|FG002|Double-blind Treatment Period|Adverse Event|44|||
37925044|NCT00444925|69612008|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
37925045|NCT00444925|69612009|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
37925046|NCT00444925|69612010|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
37925047|NCT00444925|69612008|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
37925048|NCT00444925|69612009|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
37925049|NCT00444925|69612010|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
37925050|NCT00444925|69612008|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
37925051|NCT00444925|69612009|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
37925052|NCT00444925|69612010|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
37925053|NCT00444925|69612008|FG000|Double-blind Treatment Period|Other|7|||
37925054|NCT00444925|69612009|FG001|Double-blind Treatment Period|Other|7|||
37925055|NCT00444925|69612010|FG002|Double-blind Treatment Period|Other|12|||
37925056|NCT00641056|69612020|FG000|Overall Study|Adverse Event|12|||
37925057|NCT00641056|69612021|FG001|Overall Study|Adverse Event|2|||
37925058|NCT00641056|69612020|FG000|Overall Study|Lost to Follow-up|2|||
37925059|NCT00641056|69612021|FG001|Overall Study|Lost to Follow-up|1|||
37925060|NCT00641056|69612020|FG000|Overall Study|Physician Decision|3|||
37925061|NCT00641056|69612021|FG001|Overall Study|Physician Decision|1|||
37925062|NCT00641056|69612020|FG000|Overall Study|Protocol Violation|2|||
37925063|NCT00641056|69612021|FG001|Overall Study|Protocol Violation|0|||
37925064|NCT00641056|69612020|FG000|Overall Study|Entry Criteria Not Met|3|||
37925065|NCT00641056|69612021|FG001|Overall Study|Entry Criteria Not Met|0|||
37925066|NCT00641056|69612020|FG000|Overall Study|Subject Decision|6|||
37925067|NCT00641056|69612021|FG001|Overall Study|Subject Decision|19|||
37925068|NCT00641056|69612020|FG000|Overall Study|Sponsor Decision|1|||
37925069|NCT00641056|69612021|FG001|Overall Study|Sponsor Decision|2|||
37925070|NCT00814346|69612033|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
37925071|NCT00814346|69612034|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
37925072|NCT00814346|69612033|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
37925073|NCT00814346|69612034|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
37925074|NCT00814346|69612033|FG000|Open Phase (17 Months)|Adverse Event|5|||
37925075|NCT00814346|69612034|FG001|Open Phase (17 Months)|Adverse Event|0|||
37925076|NCT00814346|69612033|FG000|Open Phase (17 Months)|Consent|2|||
37925077|NCT00814346|69612034|FG001|Open Phase (17 Months)|Consent|0|||
37925078|NCT00814346|69612033|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
37925079|NCT00814346|69612034|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
37925080|NCT00814346|69612033|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
37925081|NCT00814346|69612034|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
37925082|NCT00569374|69612053|FG000|Overall Study|Withdrawal by Subject|4|||
37925083|NCT00828464|69612057|FG000|Overall Study|Withdrawal by Subject|1|||
37925084|NCT00810602|69612061|FG000|Overall Study|Withdrawal by Subject|8|||
37925085|NCT00810602|69612062|FG001|Overall Study|Withdrawal by Subject|3|||
37925086|NCT00791700|69612070|FG000|Overall Study|Insufficient clinical response|1|||
37925087|NCT00791700|69612071|FG001|Overall Study|Insufficient clinical response|4|||
37925088|NCT00791700|69612072|FG002|Overall Study|Insufficient clinical response|1|||
37925089|NCT00791700|69612073|FG003|Overall Study|Insufficient clinical response|8|||
37925090|NCT00791700|69612070|FG000|Overall Study|No longer willing to participate|1|||
37925091|NCT00791700|69612071|FG001|Overall Study|No longer willing to participate|1|||
37925092|NCT00791700|69612072|FG002|Overall Study|No longer willing to participate|0|||
37925093|NCT00791700|69612073|FG003|Overall Study|No longer willing to participate|8|||
37666726|NCT02155738|69139114|FG000|Overall Study|Missing critical information|1|||
37666727|NCT02155738|69139115|FG001|Overall Study|Missing critical information|0|||
37666728|NCT02155738|69139116|FG002|Overall Study|Missing critical information|0|||
37925094|NCT00791700|69612070|FG000|Overall Study|Non-compliance with study treatment|0|||
37925095|NCT00791700|69612071|FG001|Overall Study|Non-compliance with study treatment|2|||
37925096|NCT00791700|69612072|FG002|Overall Study|Non-compliance with study treatment|0|||
37925097|NCT00791700|69612073|FG003|Overall Study|Non-compliance with study treatment|4|||
37925098|NCT00791700|69612070|FG000|Overall Study|Withdrawn due to pregnancy|0|||
37925099|NCT00791700|69612071|FG001|Overall Study|Withdrawn due to pregnancy|0|||
37925100|NCT00791700|69612072|FG002|Overall Study|Withdrawn due to pregnancy|0|||
37925101|NCT00791700|69612073|FG003|Overall Study|Withdrawn due to pregnancy|1|||
37925102|NCT00791700|69612070|FG000|Overall Study|Other|0|||
37925103|NCT00791700|69612071|FG001|Overall Study|Other|1|||
37925104|NCT00791700|69612072|FG002|Overall Study|Other|0|||
37925105|NCT00791700|69612073|FG003|Overall Study|Other|1|||
37925106|NCT00791700|69612070|FG000|Overall Study|Death|0|||
37925107|NCT00791700|69612071|FG001|Overall Study|Death|0|||
37925108|NCT00791700|69612072|FG002|Overall Study|Death|0|||
37925109|NCT00791700|69612073|FG003|Overall Study|Death|1|||
37925110|NCT00791700|69612070|FG000|Overall Study|Lost to Follow-up|4|||
37925111|NCT00791700|69612071|FG001|Overall Study|Lost to Follow-up|3|||
37925112|NCT00791700|69612072|FG002|Overall Study|Lost to Follow-up|4|||
37925113|NCT00791700|69612073|FG003|Overall Study|Lost to Follow-up|6|||
37925114|NCT00791700|69612070|FG000|Overall Study|Adverse Event|0|||
37925115|NCT00791700|69612071|FG001|Overall Study|Adverse Event|0|||
37925116|NCT00791700|69612072|FG002|Overall Study|Adverse Event|1|||
37925117|NCT00791700|69612073|FG003|Overall Study|Adverse Event|1|||
37925118|NCT00810368|69612096|FG000|Overall Study|Lost to Follow-up|4|||
37925119|NCT00810368|69612097|FG001|Overall Study|Lost to Follow-up|2|||
37925120|NCT00810368|69612096|FG000|Overall Study|Lack of Efficacy|2|||
37925121|NCT00810368|69612097|FG001|Overall Study|Lack of Efficacy|0|||
37925122|NCT00628108|69612107|FG000|Overall Study|Adverse Event|0|||
37925123|NCT00628108|69612108|FG001|Overall Study|Adverse Event|3|||
37925124|NCT00628108|69612107|FG000|Overall Study|Withdrawal by Subject|1|||
37925125|NCT00628108|69612108|FG001|Overall Study|Withdrawal by Subject|0|||
37925126|NCT00628030|69612116|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
37925127|NCT00628030|69612117|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
37925128|NCT00628030|69612116|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
37925129|NCT00628030|69612117|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
37925130|NCT00628030|69612116|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
37925131|NCT00628030|69612117|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
37925132|NCT00591578|69612126|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
37925133|NCT00591578|69612127|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
37925134|NCT00591578|69612128|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
37925135|NCT00591578|69612126|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
37925136|NCT00591578|69612127|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
37925137|NCT00591578|69612128|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
37925138|NCT00591578|69612126|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
37925139|NCT00591578|69612127|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
37925140|NCT00591578|69612128|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
37925141|NCT00591578|69612126|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
37925142|NCT00591578|69612127|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
37925143|NCT00591578|69612128|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
37666729|NCT02155738|69139117|FG003|Overall Study|Missing critical information|1|||
37925144|NCT00591578|69612126|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
37925145|NCT00591578|69612127|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
37925146|NCT00591578|69612128|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
37925147|NCT00591578|69612126|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
37925148|NCT00591578|69612127|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
37925149|NCT00591578|69612128|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
37925150|NCT00591578|69612126|FG000|Double-Blind Treatment Phase|Other|4|||
37925151|NCT00591578|69612127|FG001|Double-Blind Treatment Phase|Other|9|||
37925152|NCT00591578|69612128|FG002|Double-Blind Treatment Phase|Other|4|||
37925153|NCT00591578|69612126|FG000|Open-Label Extension Phase|Adverse Event|3|||
37925154|NCT00591578|69612127|FG001|Open-Label Extension Phase|Adverse Event|5|||
37925155|NCT00591578|69612128|FG002|Open-Label Extension Phase|Adverse Event|0|||
37925156|NCT00591578|69612126|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
37925157|NCT00591578|69612127|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
37925158|NCT00591578|69612128|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
37666730|NCT02181790|69139129|FG000|Overall Study|study terminated|2|||
37666731|NCT02181790|69139130|FG001|Overall Study|study terminated|0|||
37666732|NCT02618967|69139146|FG000|Overall Study|Lost to Follow-up|0|||
37666733|NCT02618967|69139147|FG001|Overall Study|Lost to Follow-up|0|||
37666734|NCT02618967|69139148|FG002|Overall Study|Lost to Follow-up|1|||
37666735|NCT02618967|69139149|FG003|Overall Study|Lost to Follow-up|0|||
37666736|NCT02618967|69139150|FG004|Overall Study|Lost to Follow-up|2|||
37925159|NCT00591578|69612126|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
37925160|NCT00591578|69612127|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
37925161|NCT00591578|69612128|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
37925162|NCT00591578|69612126|FG000|Open-Label Extension Phase|Other|1|||
37925163|NCT00591578|69612127|FG001|Open-Label Extension Phase|Other|0|||
37925164|NCT00591578|69612128|FG002|Open-Label Extension Phase|Other|0|||
37925165|NCT00797862|69612140|FG000|Overall Study|Adverse Event|86|||
37925166|NCT00797862|69612141|FG001|Overall Study|Adverse Event|44|||
37925167|NCT00797862|69612142|FG002|Overall Study|Adverse Event|58|||
37925168|NCT00797862|69612140|FG000|Overall Study|Abnormal Test Procedure Result|0|||
37925169|NCT00797862|69612141|FG001|Overall Study|Abnormal Test Procedure Result|1|||
37925170|NCT00797862|69612142|FG002|Overall Study|Abnormal Test Procedure Result|1|||
37925171|NCT00797862|69612140|FG000|Overall Study|Lack of Efficacy|1|||
37925172|NCT00797862|69612141|FG001|Overall Study|Lack of Efficacy|7|||
37925173|NCT00797862|69612142|FG002|Overall Study|Lack of Efficacy|6|||
37925174|NCT00797862|69612140|FG000|Overall Study|No longer required study medication|1|||
37925175|NCT00797862|69612141|FG001|Overall Study|No longer required study medication|0|||
37925176|NCT00797862|69612142|FG002|Overall Study|No longer required study medication|0|||
37759423|NCT01506947|69269208|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
37759424|NCT02665338|69269225|FG000|Overall Study|Withdrawal by Subject|0|||
37759425|NCT02665338|69269226|FG001|Overall Study|Withdrawal by Subject|1|||
38033489|NCT03325712|69719462|FG005|Overall Study|Adverse Event|0|||
38033490|NCT03325712|69719463|FG006|Overall Study|Adverse Event|0|||
37666737|NCT02618967|69139151|FG005|Overall Study|Lost to Follow-up|0|||
37666738|NCT02618967|69139152|FG006|Overall Study|Lost to Follow-up|0|||
37666739|NCT02618967|69139153|FG007|Overall Study|Lost to Follow-up|0|||
37666740|NCT02618967|69139146|FG000|Overall Study|Withdrawal by Subject|1|||
37666741|NCT02618967|69139147|FG001|Overall Study|Withdrawal by Subject|0|||
37666742|NCT02618967|69139148|FG002|Overall Study|Withdrawal by Subject|0|||
37666743|NCT02618967|69139149|FG003|Overall Study|Withdrawal by Subject|0|||
37666744|NCT02618967|69139150|FG004|Overall Study|Withdrawal by Subject|0|||
37666745|NCT02618967|69139151|FG005|Overall Study|Withdrawal by Subject|0|||
37666746|NCT02618967|69139152|FG006|Overall Study|Withdrawal by Subject|0|||
37666747|NCT02618967|69139153|FG007|Overall Study|Withdrawal by Subject|0|||
37666748|NCT02616783|69139173|FG000|Overall Study|Randomized but Not Treated|1|||
37666749|NCT02616783|69139174|FG001|Overall Study|Randomized but Not Treated|0|||
37666750|NCT02616783|69139173|FG000|Overall Study|Adverse Event|1|||
37666751|NCT02616783|69139174|FG001|Overall Study|Adverse Event|0|||
37666752|NCT02616783|69139173|FG000|Overall Study|Death|1|||
37666753|NCT02616783|69139174|FG001|Overall Study|Death|0|||
37666754|NCT02616783|69139173|FG000|Overall Study|Non-Compliance with Study Drug|1|||
37666755|NCT02616783|69139174|FG001|Overall Study|Non-Compliance with Study Drug|0|||
37666756|NCT02616783|69139173|FG000|Overall Study|Protocol Violation|1|||
37666757|NCT02616783|69139174|FG001|Overall Study|Protocol Violation|1|||
37666758|NCT02616783|69139173|FG000|Overall Study|Withdrew Consent|1|||
37666759|NCT02616783|69139174|FG001|Overall Study|Withdrew Consent|1|||
37666760|NCT02616393|69139183|FG000|Overall Study|Death|5|||
37759426|NCT01506479|69269235|FG000|Overall Study|Lost to Follow-up|1|||
37759427|NCT01506479|69269236|FG001|Overall Study|Lost to Follow-up|2|||
37759428|NCT01506479|69269237|FG002|Overall Study|Lost to Follow-up|2|||
37759429|NCT01506479|69269235|FG000|Overall Study|Withdrawal by Subject|1|||
37666761|NCT02616393|69139184|FG001|Overall Study|Death|12|||
37666762|NCT02616393|69139185|FG002|Overall Study|Death|1|||
37666763|NCT02616393|69139183|FG000|Overall Study|Termination by Sponsor|4|||
37666764|NCT02616393|69139184|FG001|Overall Study|Termination by Sponsor|5|||
37666765|NCT02616393|69139185|FG002|Overall Study|Termination by Sponsor|2|||
37666766|NCT02616393|69139183|FG000|Overall Study|Other|3|||
37666767|NCT02616393|69139184|FG001|Overall Study|Other|0|||
37666768|NCT02616393|69139185|FG002|Overall Study|Other|0|||
37666769|NCT02616393|69139183|FG000|Overall Study|Withdrawal by Subject|1|||
37666770|NCT02616393|69139184|FG001|Overall Study|Withdrawal by Subject|1|||
37666771|NCT02616393|69139185|FG002|Overall Study|Withdrawal by Subject|0|||
37666772|NCT02616393|69139183|FG000|Overall Study|Lost to Follow-up|0|||
37666773|NCT02616393|69139184|FG001|Overall Study|Lost to Follow-up|2|||
37666774|NCT02616393|69139185|FG002|Overall Study|Lost to Follow-up|0|||
37666775|NCT02155660|69139213|FG000|Overall Study|Other Reason|8|||
37666776|NCT02155660|69139214|FG001|Overall Study|Other Reason|6|||
37666777|NCT02155660|69139215|FG002|Overall Study|Other Reason|10|||
37666778|NCT02155660|69139216|FG003|Overall Study|Other Reason|10|||
37666779|NCT02155660|69139213|FG000|Overall Study|Study-specific withdrawal criteria|0|||
37666780|NCT02155660|69139214|FG001|Overall Study|Study-specific withdrawal criteria|1|||
37925177|NCT00797862|69612140|FG000|Overall Study|Withdrawal by Subject|14|||
37925178|NCT00797862|69612141|FG001|Overall Study|Withdrawal by Subject|7|||
37925179|NCT00797862|69612142|FG002|Overall Study|Withdrawal by Subject|7|||
37925180|NCT00797862|69612140|FG000|Overall Study|Lost to Follow-up|11|||
37925181|NCT00797862|69612141|FG001|Overall Study|Lost to Follow-up|0|||
37925182|NCT00797862|69612142|FG002|Overall Study|Lost to Follow-up|5|||
37925183|NCT00797862|69612140|FG000|Overall Study|Administrative Problem|4|||
37925184|NCT00797862|69612141|FG001|Overall Study|Administrative Problem|0|||
37925185|NCT00797862|69612142|FG002|Overall Study|Administrative Problem|0|||
37925186|NCT00797862|69612140|FG000|Overall Study|Protocol Violation|4|||
37925187|NCT00797862|69612141|FG001|Overall Study|Protocol Violation|6|||
37925188|NCT00797862|69612142|FG002|Overall Study|Protocol Violation|8|||
37925189|NCT00797862|69612140|FG000|Overall Study|Mis-randomized|3|||
37925190|NCT00797862|69612141|FG001|Overall Study|Mis-randomized|3|||
38033491|NCT03325712|69719464|FG007|Overall Study|Adverse Event|0|||
37666781|NCT02155660|69139215|FG002|Overall Study|Study-specific withdrawal criteria|1|||
37666782|NCT02155660|69139216|FG003|Overall Study|Study-specific withdrawal criteria|1|||
37666783|NCT02155660|69139213|FG000|Overall Study|Severe non-compliance|0|||
37666784|NCT02155660|69139214|FG001|Overall Study|Severe non-compliance|4|||
37666785|NCT02155660|69139215|FG002|Overall Study|Severe non-compliance|0|||
37759430|NCT01506479|69269236|FG001|Overall Study|Withdrawal by Subject|2|||
37925191|NCT00797862|69612142|FG002|Overall Study|Mis-randomized|1|||
37925192|NCT00794820|69612150|FG000|Overall Study|Adverse Event|11|||
37925193|NCT00794820|69612150|FG000|Overall Study|Secondary Malignancies|2|||
37925194|NCT00794820|69612150|FG000|Overall Study|Resistant Disease|2|||
37925195|NCT00794820|69612150|FG000|Overall Study|Ineligible/Screen Failure|1|||
37925196|NCT00455533|69612156|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
37925197|NCT00455533|69612157|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
37925198|NCT00455533|69612158|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
37925199|NCT00455533|69612156|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
37925200|NCT00455533|69612157|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
37925201|NCT00455533|69612158|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
37925202|NCT00455533|69612156|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
37925203|NCT00455533|69612157|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
37925204|NCT00455533|69612158|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
37925205|NCT00455533|69612156|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
37925206|NCT00455533|69612157|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
37925207|NCT00455533|69612158|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
37925208|NCT00455533|69612156|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
37925209|NCT00455533|69612157|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
37925210|NCT00455533|69612158|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
37925211|NCT00455533|69612156|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
37925212|NCT00455533|69612157|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
37925213|NCT00455533|69612158|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
37925214|NCT00455533|69612156|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
37925215|NCT00455533|69612157|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
37925216|NCT00455533|69612158|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
37925217|NCT00455533|69612156|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
37925218|NCT00455533|69612157|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
37925219|NCT00455533|69612158|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
37925220|NCT00455533|69612156|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
37925221|NCT00455533|69612157|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
37925222|NCT00455533|69612158|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
37925223|NCT00455533|69612156|FG000|Period Two: Randomized Period|Death|0|||
37925224|NCT00455533|69612157|FG001|Period Two: Randomized Period|Death|0|||
37925225|NCT00455533|69612158|FG002|Period Two: Randomized Period|Death|3|||
37925226|NCT00455533|69612156|FG000|Period Two: Randomized Period|Disease Progression|0|||
37925227|NCT00455533|69612157|FG001|Period Two: Randomized Period|Disease Progression|1|||
37925228|NCT00455533|69612158|FG002|Period Two: Randomized Period|Disease Progression|1|||
37925229|NCT00455533|69612156|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
37925230|NCT00455533|69612157|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
37925231|NCT00455533|69612158|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
37925232|NCT00455533|69612156|FG000|Period Two: Randomized Period|Other - need reasons|0|||
37925233|NCT00455533|69612157|FG001|Period Two: Randomized Period|Other - need reasons|1|||
37925234|NCT00455533|69612158|FG002|Period Two: Randomized Period|Other - need reasons|0|||
37925235|NCT00455533|69612156|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
37759431|NCT01506479|69269237|FG002|Overall Study|Withdrawal by Subject|1|||
37759432|NCT01506479|69269235|FG000|Overall Study|Missing assessment|1|||
37759433|NCT01506479|69269236|FG001|Overall Study|Missing assessment|0|||
37759434|NCT01506479|69269237|FG002|Overall Study|Missing assessment|0|||
37759435|NCT01506479|69269235|FG000|Overall Study|Adverse Event|0|||
37759436|NCT01506479|69269236|FG001|Overall Study|Adverse Event|1|||
37759437|NCT01506479|69269237|FG002|Overall Study|Adverse Event|0|||
37759438|NCT01506323|69269261|FG000|Overall Study|Lost to Follow-up|5|||
37925236|NCT00455533|69612157|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
37925237|NCT00455533|69612158|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
37925238|NCT00455533|69612156|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
37925239|NCT00455533|69612157|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
37925240|NCT00455533|69612158|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
37925241|NCT00627094|69612168|FG000|Overall Study|Adverse Event|8|||
37925242|NCT00627094|69612169|FG001|Overall Study|Adverse Event|7|||
37925243|NCT00627094|69612168|FG000|Overall Study|Lost to Follow-up|1|||
37925244|NCT00627094|69612169|FG001|Overall Study|Lost to Follow-up|0|||
37925245|NCT00627094|69612168|FG000|Overall Study|Withdrawal by Subject|1|||
37925246|NCT00627094|69612169|FG001|Overall Study|Withdrawal by Subject|1|||
37925247|NCT00627094|69612168|FG000|Overall Study|ulcer healed|1|||
37925248|NCT00627094|69612169|FG001|Overall Study|ulcer healed|7|||
37759439|NCT01506323|69269262|FG001|Overall Study|Lost to Follow-up|4|||
37925249|NCT00627094|69612168|FG000|Overall Study|Other reason|1|||
37925250|NCT00627094|69612169|FG001|Overall Study|Other reason|0|||
37925251|NCT00642850|69612177|FG000|Overall Study|Death|7|||
37925252|NCT00642850|69612177|FG000|Overall Study|Adverse Event|2|||
37759440|NCT01506323|69269261|FG000|Overall Study|Withdrawal by Subject|4|||
37759441|NCT01506323|69269262|FG001|Overall Study|Withdrawal by Subject|4|||
37759442|NCT01506323|69269261|FG000|Overall Study|Lack of Efficacy|1|||
37925253|NCT00642850|69612177|FG000|Overall Study|Lack of Efficacy|1|||
37925254|NCT00642850|69612177|FG000|Overall Study|Protocol Violation|2|||
37925255|NCT00642850|69612177|FG000|Overall Study|Kidney transplantation|8|||
37925256|NCT00642850|69612177|FG000|Overall Study|Blood transfusion|6|||
37925257|NCT00642850|69612177|FG000|Overall Study|Other reasons|7|||
37925258|NCT00455455|69612181|FG000|Washout|Withdrawal by Subject|0|||
37925259|NCT00455455|69612182|FG001|Washout|Withdrawal by Subject|1|||
37925260|NCT00455455|69612181|FG000|Washout|Withdrawal by Subject|1|||
37925261|NCT00455455|69612182|FG001|Washout|Withdrawal by Subject|0|||
37925262|NCT03840811|69612194|FG000|Overall Study|Lost to Follow-up|0|||
37925263|NCT03840811|69612195|FG001|Overall Study|Lost to Follow-up|0|||
37925264|NCT03840811|69612196|FG002|Overall Study|Lost to Follow-up|1|||
37925265|NCT00640510|69612206|FG000|Overall Study|Lack of Efficacy|0|||
37925266|NCT00640510|69612207|FG001|Overall Study|Lack of Efficacy|1|||
37925267|NCT00640510|69612206|FG000|Overall Study|Protocol Violation|1|||
37925268|NCT00640510|69612207|FG001|Overall Study|Protocol Violation|0|||
37925269|NCT00640510|69612206|FG000|Overall Study|Physician Decision|0|||
37925270|NCT00640510|69612207|FG001|Overall Study|Physician Decision|1|||
37925271|NCT00813800|69612213|FG000|Overall Study|Screen Failure after Consent|2|||
37925272|NCT00813800|69612213|FG000|Overall Study|Adverse Event|1|||
37925273|NCT00813800|69612213|FG000|Overall Study|Worsening of depression|2|||
37925274|NCT00813800|69612213|FG000|Overall Study|Physician Decision|1|||
37925275|NCT00627016|69612219|FG000|Overall Study|Adverse Event|1|||
37925276|NCT00627016|69612220|FG001|Overall Study|Adverse Event|1|||
37925277|NCT00627016|69612219|FG000|Overall Study|Protocol Violation|0|||
37925278|NCT00627016|69612220|FG001|Overall Study|Protocol Violation|2|||
37925279|NCT00627016|69612219|FG000|Overall Study|Lost to Follow-up|0|||
37925280|NCT00627016|69612220|FG001|Overall Study|Lost to Follow-up|1|||
37925281|NCT00627016|69612219|FG000|Overall Study|Withdrawal by Subject|2|||
37925282|NCT00627016|69612220|FG001|Overall Study|Withdrawal by Subject|1|||
37925283|NCT00627016|69612219|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
37925284|NCT00627016|69612220|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
37925285|NCT00627016|69612219|FG000|Overall Study|Lack of Efficacy|1|||
37925286|NCT00627016|69612220|FG001|Overall Study|Lack of Efficacy|0|||
37925287|NCT00627016|69612219|FG000|Overall Study|Placed on Excluded Drugs|1|||
37925288|NCT00627016|69612220|FG001|Overall Study|Placed on Excluded Drugs|0|||
37925289|NCT00627016|69612219|FG000|Overall Study|Pregnancy|1|||
37925290|NCT00627016|69612220|FG001|Overall Study|Pregnancy|0|||
37759443|NCT01506323|69269262|FG001|Overall Study|Lack of Efficacy|3|||
37759444|NCT01506323|69269261|FG000|Overall Study|Moved out of area|5|||
37759445|NCT01506323|69269262|FG001|Overall Study|Moved out of area|2|||
37759446|NCT01506323|69269261|FG000|Overall Study|Schedule or Transportation conflict|8|||
37925291|NCT00794664|69612228|FG000|Treatment Period|Withdrawal by Subject|0|||
37925292|NCT00794664|69612229|FG001|Treatment Period|Withdrawal by Subject|2|||
37925293|NCT00794664|69612228|FG000|Treatment Period|Protocol non-compliance|0|||
37925294|NCT00794664|69612229|FG001|Treatment Period|Protocol non-compliance|1|||
37925295|NCT00794664|69612228|FG000|Treatment Period|Other|0|||
37925296|NCT00794664|69612229|FG001|Treatment Period|Other|1|||
37925297|NCT00794664|69612228|FG000|Treatment Period|Adverse Event|1|||
37925298|NCT00794664|69612229|FG001|Treatment Period|Adverse Event|8|||
37925299|NCT00794664|69612228|FG000|Follow-up Period|Other|1|||
37925300|NCT00794664|69612229|FG001|Follow-up Period|Other|2|||
37925301|NCT00794664|69612228|FG000|Follow-up Period|Withdrawal by Subject|0|||
37925302|NCT00794664|69612229|FG001|Follow-up Period|Withdrawal by Subject|2|||
37666786|NCT02155660|69139216|FG003|Overall Study|Severe non-compliance|1|||
37666787|NCT02155660|69139213|FG000|Overall Study|Adverse Event|2|||
37666788|NCT02155660|69139214|FG001|Overall Study|Adverse Event|6|||
37666789|NCT02155660|69139215|FG002|Overall Study|Adverse Event|3|||
37666790|NCT02155660|69139216|FG003|Overall Study|Adverse Event|1|||
37666791|NCT02155660|69139213|FG000|Overall Study|Lost to Follow-up|3|||
37666792|NCT02155660|69139214|FG001|Overall Study|Lost to Follow-up|6|||
37925303|NCT00794664|69612228|FG000|Follow-up Period|Protocol non-compliance|0|||
37666793|NCT02155660|69139215|FG002|Overall Study|Lost to Follow-up|5|||
37666794|NCT02155660|69139216|FG003|Overall Study|Lost to Follow-up|8|||
37666795|NCT02155660|69139213|FG000|Overall Study|Death|17|||
37666796|NCT02155660|69139214|FG001|Overall Study|Death|19|||
37666797|NCT02155660|69139215|FG002|Overall Study|Death|17|||
37666798|NCT02155660|69139216|FG003|Overall Study|Death|19|||
37666799|NCT02155660|69139213|FG000|Overall Study|Withdrawal by Subject|28|||
37925304|NCT00794664|69612229|FG001|Follow-up Period|Protocol non-compliance|1|||
37925305|NCT00444535|69612235|FG000|Overall Study|Withdrawal by Subject|5|||
37666800|NCT02155660|69139214|FG001|Overall Study|Withdrawal by Subject|31|||
37666801|NCT02155660|69139215|FG002|Overall Study|Withdrawal by Subject|24|||
37759447|NCT01506323|69269262|FG001|Overall Study|Schedule or Transportation conflict|0|||
37925306|NCT00444535|69612235|FG000|Overall Study|Physician Decision|5|||
37925307|NCT00444535|69612235|FG000|Overall Study|progressive disease|1|||
37925308|NCT00444535|69612235|FG000|Overall Study|Adverse Event|2|||
37925309|NCT00847613|69612243|FG000|Overall Study|Ongoing at cut-off date|250|||
37925310|NCT00847613|69612244|FG001|Overall Study|Ongoing at cut-off date|265|||
37759448|NCT01506323|69269261|FG000|Overall Study|Started another treatment|1|||
37759449|NCT01506323|69269262|FG001|Overall Study|Started another treatment|0|||
37925311|NCT00847613|69612245|FG002|Overall Study|Ongoing at cut-off date|64|||
37925312|NCT00847613|69612246|FG003|Overall Study|Ongoing at cut-off date|64|||
37925313|NCT00847613|69612243|FG000|Overall Study|Death|1|||
37925314|NCT00847613|69612244|FG001|Overall Study|Death|1|||
37925315|NCT00847613|69612245|FG002|Overall Study|Death|0|||
37925316|NCT00847613|69612246|FG003|Overall Study|Death|0|||
37925317|NCT00847613|69612243|FG000|Overall Study|Adverse Event|36|||
37925318|NCT00847613|69612244|FG001|Overall Study|Adverse Event|26|||
37759450|NCT01505387|69269275|FG000|Overall Study|Protocol Violation|1|||
37759451|NCT01505387|69269276|FG001|Overall Study|Protocol Violation|0|||
37759452|NCT01505387|69269275|FG000|Overall Study|Withdrawal by Subject|1|||
37759453|NCT01505387|69269276|FG001|Overall Study|Withdrawal by Subject|1|||
37925319|NCT00847613|69612245|FG002|Overall Study|Adverse Event|5|||
37925320|NCT00847613|69612246|FG003|Overall Study|Adverse Event|6|||
37925321|NCT00847613|69612243|FG000|Overall Study|Lack of Efficacy|7|||
37925322|NCT00847613|69612244|FG001|Overall Study|Lack of Efficacy|3|||
37925323|NCT00847613|69612245|FG002|Overall Study|Lack of Efficacy|3|||
37925324|NCT00847613|69612246|FG003|Overall Study|Lack of Efficacy|1|||
37925325|NCT00847613|69612243|FG000|Overall Study|Study terminated by Sponsor|1|||
37925326|NCT00847613|69612244|FG001|Overall Study|Study terminated by Sponsor|0|||
37925327|NCT00847613|69612245|FG002|Overall Study|Study terminated by Sponsor|2|||
37925328|NCT00847613|69612246|FG003|Overall Study|Study terminated by Sponsor|1|||
37925329|NCT00847613|69612243|FG000|Overall Study|Lost to Follow-up|5|||
37925330|NCT00847613|69612244|FG001|Overall Study|Lost to Follow-up|0|||
37925331|NCT00847613|69612245|FG002|Overall Study|Lost to Follow-up|0|||
37925332|NCT00847613|69612246|FG003|Overall Study|Lost to Follow-up|3|||
37925333|NCT00847613|69612243|FG000|Overall Study|Protocol Violation|6|||
37925334|NCT00847613|69612244|FG001|Overall Study|Protocol Violation|6|||
37925335|NCT00847613|69612245|FG002|Overall Study|Protocol Violation|3|||
37759454|NCT01504841|69269364|FG000|Overall Study|Withdrawal by Subject|1|||
37759455|NCT01504841|69269365|FG001|Overall Study|Withdrawal by Subject|1|||
37759456|NCT01504841|69269366|FG002|Overall Study|Withdrawal by Subject|0|||
37759457|NCT01502423|69269379|FG000|Overall Study|Withdrawal by Subject|0|||
37759458|NCT01502423|69269380|FG001|Overall Study|Withdrawal by Subject|1|||
37759459|NCT01502033|69269386|FG000|Overall Study|1 participant had scalp discomfort|1|||
37759460|NCT01502033|69269386|FG000|Overall Study|1 participant had worsening depression|1|||
37759461|NCT01502033|69269386|FG000|Overall Study|1 participant went back to school|1|||
37759462|NCT01500629|69269394|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
37759463|NCT01500629|69269395|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
37759464|NCT01500317|69269411|FG000|Overall Study|Withdrawal by Subject|3|||
37759465|NCT01500317|69269412|FG001|Overall Study|Withdrawal by Subject|2|||
37759466|NCT01500317|69269413|FG002|Overall Study|Withdrawal by Subject|0|||
37759467|NCT01500083|69269468|FG000|Overall Study|Adverse Event|4|||
37759468|NCT01500083|69269469|FG001|Overall Study|Adverse Event|17|||
37759469|NCT01500083|69269468|FG000|Overall Study|Death|0|||
37759470|NCT01500083|69269469|FG001|Overall Study|Death|2|||
37759471|NCT01500083|69269468|FG000|Overall Study|Lost to Follow-up|1|||
37759472|NCT01500083|69269469|FG001|Overall Study|Lost to Follow-up|0|||
37759473|NCT01500083|69269468|FG000|Overall Study|Withdrawal of Consent|0|||
37925336|NCT00847613|69612246|FG003|Overall Study|Protocol Violation|1|||
37925337|NCT00847613|69612243|FG000|Overall Study|Pregnancy|1|||
37925338|NCT00847613|69612244|FG001|Overall Study|Pregnancy|1|||
37925339|NCT00847613|69612245|FG002|Overall Study|Pregnancy|0|||
37925340|NCT00847613|69612246|FG003|Overall Study|Pregnancy|0|||
38033492|NCT03734679|69719492|FG000|Overall Study|Missed Visit|1|||
37759474|NCT01500083|69269469|FG001|Overall Study|Withdrawal of Consent|1|||
37759475|NCT01500083|69269468|FG000|Overall Study|Disease Progression|2|||
37759476|NCT01500083|69269469|FG001|Overall Study|Disease Progression|10|||
37759477|NCT01500083|69269468|FG000|Overall Study|Investigator Discretion|3|||
37759478|NCT01500083|69269469|FG001|Overall Study|Investigator Discretion|8|||
37759479|NCT01500083|69269468|FG000|Overall Study|Other Reasons|2|||
37759480|NCT01500083|69269469|FG001|Overall Study|Other Reasons|5|||
37759481|NCT01499849|69269499|FG000|Overall Study|Adverse Event|28|||
37759482|NCT01499849|69269500|FG001|Overall Study|Adverse Event|32|||
37925341|NCT00847613|69612243|FG000|Overall Study|Site closure|1|||
37925342|NCT00847613|69612244|FG001|Overall Study|Site closure|0|||
37925343|NCT00847613|69612245|FG002|Overall Study|Site closure|0|||
37925344|NCT00847613|69612246|FG003|Overall Study|Site closure|1|||
37925345|NCT00847613|69612243|FG000|Overall Study|Withdrawal by Subject|8|||
37925346|NCT00847613|69612244|FG001|Overall Study|Withdrawal by Subject|11|||
37925347|NCT00847613|69612245|FG002|Overall Study|Withdrawal by Subject|2|||
37925348|NCT00847613|69612246|FG003|Overall Study|Withdrawal by Subject|2|||
37925349|NCT00847613|69612243|FG000|Overall Study|Participant moved|4|||
37925350|NCT00847613|69612244|FG001|Overall Study|Participant moved|1|||
37925351|NCT00847613|69612245|FG002|Overall Study|Participant moved|0|||
37925352|NCT00847613|69612246|FG003|Overall Study|Participant moved|0|||
37925353|NCT00847613|69612243|FG000|Overall Study|Sponsor request|0|||
37759483|NCT01499849|69269499|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
37759484|NCT01499849|69269500|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
37925354|NCT00847613|69612244|FG001|Overall Study|Sponsor request|1|||
37925355|NCT00847613|69612245|FG002|Overall Study|Sponsor request|0|||
37759485|NCT01499849|69269499|FG000|Overall Study|Withdrawal by Subject|43|||
37759486|NCT01499849|69269500|FG001|Overall Study|Withdrawal by Subject|43|||
37759487|NCT01499849|69269499|FG000|Overall Study|Death|5|||
37759488|NCT01499849|69269500|FG001|Overall Study|Death|7|||
37759489|NCT01499849|69269499|FG000|Overall Study|Disease Progression|11|||
37759490|NCT01499849|69269500|FG001|Overall Study|Disease Progression|10|||
37759491|NCT01499849|69269499|FG000|Overall Study|Protocol Violation|11|||
37759492|NCT01499849|69269500|FG001|Overall Study|Protocol Violation|11|||
37759493|NCT01499849|69269499|FG000|Overall Study|Physician Decision|20|||
37759494|NCT01499849|69269500|FG001|Overall Study|Physician Decision|19|||
37759495|NCT01499849|69269499|FG000|Overall Study|Lack of Efficacy|3|||
37759496|NCT01499849|69269500|FG001|Overall Study|Lack of Efficacy|4|||
37925356|NCT00847613|69612246|FG003|Overall Study|Sponsor request|0|||
37925357|NCT00847613|69612243|FG000|Overall Study|Randomized, but not treated|0|||
37925358|NCT00847613|69612244|FG001|Overall Study|Randomized, but not treated|3|||
37925359|NCT00847613|69612245|FG002|Overall Study|Randomized, but not treated|0|||
37925360|NCT00847613|69612246|FG003|Overall Study|Randomized, but not treated|0|||
37925361|NCT00847613|69612243|FG000|Overall Study|Other|1|||
37925362|NCT00847613|69612244|FG001|Overall Study|Other|1|||
37925363|NCT00847613|69612245|FG002|Overall Study|Other|2|||
37925364|NCT00847613|69612246|FG003|Overall Study|Other|0|||
37925365|NCT00794196|69612265|FG000|Overall Study|Lost to Follow-up|5|||
37925366|NCT00794196|69612266|FG001|Overall Study|Lost to Follow-up|23|||
37925367|NCT00807092|69612274|FG000|Overall Study|Adverse Event|0|||
37925368|NCT00807092|69612275|FG001|Overall Study|Adverse Event|1|||
37925369|NCT00807092|69612274|FG000|Overall Study|Protocol Violation|0|||
37925370|NCT00807092|69612275|FG001|Overall Study|Protocol Violation|2|||
37925371|NCT00807092|69612274|FG000|Overall Study|Withdrawal by Subject|1|||
37925372|NCT00807092|69612275|FG001|Overall Study|Withdrawal by Subject|0|||
37925373|NCT00807092|69612274|FG000|Overall Study|CGMS data collection failed|0|||
37925374|NCT00807092|69612275|FG001|Overall Study|CGMS data collection failed|1|||
37925375|NCT00794118|69612281|FG000|Overall Study|Lost to Follow-up|16|||
37925376|NCT00794118|69612281|FG000|Overall Study|Withdrawal by Subject|9|||
37925377|NCT00794118|69612281|FG000|Overall Study|Changed hospital center|2|||
37925378|NCT00640042|69612285|FG000|Enrollment|Did not receive study drug|83|||
37925379|NCT00807014|69612291|FG000|Overall Study|Participant Considered Disease Cured|13|||
37925380|NCT00807014|69612292|FG001|Overall Study|Participant Considered Disease Cured|2|||
37925381|NCT00807014|69612291|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
37925382|NCT00807014|69612292|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
37925383|NCT00807014|69612291|FG000|Overall Study|Protocol Violation|2|||
37925384|NCT00807014|69612292|FG001|Overall Study|Protocol Violation|8|||
37925385|NCT00807014|69612291|FG000|Overall Study|Adverse Event|0|||
37925386|NCT00807014|69612292|FG001|Overall Study|Adverse Event|2|||
37925387|NCT00807014|69612291|FG000|Overall Study|Lost to Follow-up|9|||
37925388|NCT00807014|69612292|FG001|Overall Study|Lost to Follow-up|7|||
37925389|NCT00807014|69612291|FG000|Overall Study|Recovery|1|||
37666802|NCT02155660|69139216|FG003|Overall Study|Withdrawal by Subject|21|||
37666803|NCT02119936|69139226|FG000|Overall Study|Lost to Follow-up|10|||
37666804|NCT02181634|69139230|FG000|Overall Study|Lack of Efficacy|33|||
37666805|NCT02181634|69139230|FG000|Overall Study|Adverse Event|17|||
37666806|NCT02181634|69139230|FG000|Overall Study|Physician Decision|8|||
37666807|NCT02181634|69139230|FG000|Overall Study|Withdrawal by Subject|5|||
37666808|NCT02181634|69139230|FG000|Overall Study|Death|2|||
37666809|NCT02181634|69139230|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
37666810|NCT02181634|69139230|FG000|Overall Study|Ineligible|1|||
37666811|NCT02181634|69139230|FG000|Overall Study|Max number of dose reduction|1|||
37759497|NCT01499849|69269499|FG000|Overall Study|Lost to Follow-up|6|||
37759498|NCT01499849|69269500|FG001|Overall Study|Lost to Follow-up|3|||
37925390|NCT00807014|69612292|FG001|Overall Study|Recovery|0|||
37925391|NCT00807014|69612291|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
37925392|NCT00807014|69612292|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
37925393|NCT00592631|69612300|FG000|Overall Study|Lost to Follow-up|0|||
38033493|NCT03325556|69719496|FG000|Open-label Period|Lack of Response in OL period|70|||
38033494|NCT03325556|69719497|FG001|Open-label Period|Lack of Response in OL period|0|||
38033495|NCT03325556|69719498|FG002|Open-label Period|Lack of Response in OL period|0|||
37759499|NCT01499849|69269499|FG000|Overall Study|Other Reasons|27|||
37759500|NCT01499849|69269500|FG001|Overall Study|Other Reasons|30|||
37925394|NCT00592631|69612301|FG001|Overall Study|Lost to Follow-up|2|||
37925395|NCT00791388|69612312|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
37925396|NCT00791388|69612313|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
37925397|NCT00791388|69612314|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
37925398|NCT00791388|69612315|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
37759501|NCT01499303|69269519|FG000|Overall Study|Ongoing|2|||
37925399|NCT00791388|69612316|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
37925400|NCT00791388|69612312|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
37925401|NCT00791388|69612313|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
37925402|NCT00791388|69612314|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
37925403|NCT00791388|69612315|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
37925404|NCT00791388|69612316|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
37925405|NCT00791388|69612312|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
37925406|NCT00791388|69612313|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
37925407|NCT00791388|69612314|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
37925408|NCT00791388|69612315|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
37925409|NCT00791388|69612316|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
37925410|NCT00794040|69612330|FG000|Overall Study|Withdrawal by Subject|3|||
37925411|NCT00794040|69612331|FG001|Overall Study|Withdrawal by Subject|4|||
37925412|NCT00794040|69612330|FG000|Overall Study|Physician Decision|0|||
37925413|NCT00794040|69612331|FG001|Overall Study|Physician Decision|1|||
37925414|NCT00813488|69612337|FG000|Titration Period 1|Adverse Event|6|||
37925415|NCT00813488|69612338|FG001|Titration Period 1|Adverse Event|1|||
37925416|NCT00813488|69612337|FG000|Titration Period 1|Lack of Efficacy|9|||
37925417|NCT00813488|69612338|FG001|Titration Period 1|Lack of Efficacy|7|||
37925418|NCT00813488|69612337|FG000|Titration Period 1|Withdrawal by Subject|2|||
37925419|NCT00813488|69612338|FG001|Titration Period 1|Withdrawal by Subject|2|||
37925420|NCT00813488|69612337|FG000|Titration Period 1|Protocol Violation|4|||
37925421|NCT00813488|69612338|FG001|Titration Period 1|Protocol Violation|3|||
38033496|NCT03325556|69719496|FG000|Open-label Period|Adverse Event|27|||
38033497|NCT03325556|69719497|FG001|Open-label Period|Adverse Event|0|||
38033498|NCT03325556|69719498|FG002|Open-label Period|Adverse Event|0|||
38033499|NCT03325556|69719496|FG000|Open-label Period|Death|1|||
37666812|NCT02181634|69139230|FG000|Overall Study|Symptomatic progression|1|||
37666813|NCT02181634|69139230|FG000|Overall Study|Patient opted to proceed to surgery|1|||
37666814|NCT01595529|69139236|FG000|Overall Study|Adverse Event|2|||
37666815|NCT01595529|69139237|FG001|Overall Study|Adverse Event|0|||
37666816|NCT01595529|69139236|FG000|Overall Study|Subject Non-Compliant|2|||
37666817|NCT01595529|69139237|FG001|Overall Study|Subject Non-Compliant|0|||
37666818|NCT01595529|69139236|FG000|Overall Study|Lost to Follow-up|8|||
37666819|NCT01595529|69139237|FG001|Overall Study|Lost to Follow-up|14|||
37666820|NCT01595529|69139236|FG000|Overall Study|Protocol Violation|1|||
37859308|NCT01292603|69542621|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
37859309|NCT01292603|69542622|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
37859310|NCT01292603|69542617|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
37859311|NCT01292603|69542618|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
37859312|NCT01292603|69542619|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
37859313|NCT01292603|69542620|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
37859314|NCT01292603|69542621|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
37859315|NCT01292603|69542622|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
37859316|NCT01292603|69542617|FG000|Overall Survival Status|Death|3|||
37859317|NCT01292603|69542618|FG001|Overall Survival Status|Death|1|||
37859318|NCT01292603|69542619|FG002|Overall Survival Status|Death|3|||
37859319|NCT01292603|69542620|FG003|Overall Survival Status|Death|1|||
37859320|NCT01292603|69542621|FG004|Overall Survival Status|Death|16|||
37859321|NCT01292603|69542622|FG005|Overall Survival Status|Death|10|||
37859322|NCT01292057|69542645|FG000|Overall Study|Protocol Violation|1|||
37859323|NCT01292057|69542646|FG001|Overall Study|Protocol Violation|1|||
37859324|NCT01292057|69542645|FG000|Overall Study|Lost to Follow-up|1|||
37859325|NCT01292057|69542646|FG001|Overall Study|Lost to Follow-up|1|||
37859326|NCT01291277|69542654|FG000|Overall Study|Death|2|||
37859327|NCT01291277|69542655|FG001|Overall Study|Death|2|||
37859328|NCT01291277|69542654|FG000|Overall Study|Lost to Follow-up|3|||
37859329|NCT01291277|69542655|FG001|Overall Study|Lost to Follow-up|1|||
37859330|NCT01290887|69542663|FG000|Overall Study|Adverse Event|6|||
37859331|NCT01290887|69542664|FG001|Overall Study|Adverse Event|11|||
37859332|NCT01290887|69542663|FG000|Overall Study|Lack of Efficacy|4|||
37859333|NCT01290887|69542664|FG001|Overall Study|Lack of Efficacy|5|||
37859334|NCT01290887|69542663|FG000|Overall Study|Withdrawal by Subject|26|||
37859335|NCT01290887|69542664|FG001|Overall Study|Withdrawal by Subject|32|||
37859336|NCT01290887|69542663|FG000|Overall Study|Protocol Violation|2|||
37859337|NCT01290887|69542664|FG001|Overall Study|Protocol Violation|1|||
37859338|NCT01290887|69542663|FG000|Overall Study|Lost to Follow-up|4|||
37859339|NCT01290887|69542664|FG001|Overall Study|Lost to Follow-up|4|||
37859340|NCT01290887|69542663|FG000|Overall Study|Non-compliance to study procedures|0|||
37859341|NCT01290887|69542664|FG001|Overall Study|Non-compliance to study procedures|1|||
37859342|NCT01290887|69542663|FG000|Overall Study|Non-compliance to study medications|1|||
37859343|NCT01290887|69542664|FG001|Overall Study|Non-compliance to study medications|0|||
38033500|NCT03325556|69719497|FG001|Open-label Period|Death|0|||
37859344|NCT01290887|69542663|FG000|Overall Study|Sponsor closure of study|420|||
37859345|NCT01290887|69542664|FG001|Overall Study|Sponsor closure of study|476|||
37859346|NCT01290887|69542663|FG000|Overall Study|Other|3|||
37859347|NCT01290887|69542664|FG001|Overall Study|Other|6|||
37925422|NCT00813488|69612337|FG000|Titration Period 1|Non-compliance to study medication|4|||
37925423|NCT00813488|69612338|FG001|Titration Period 1|Non-compliance to study medication|1|||
37925424|NCT00813488|69612337|FG000|Titration Period 1|Non-compliance to study procedures|2|||
37925425|NCT00813488|69612338|FG001|Titration Period 1|Non-compliance to study procedures|2|||
37925426|NCT00813488|69612337|FG000|Titration Period 1|Technical Difficulties|0|||
37925427|NCT00813488|69612338|FG001|Titration Period 1|Technical Difficulties|1|||
37925428|NCT00813488|69612337|FG000|Titration Period 2|Adverse Event|2|||
37925429|NCT00813488|69612338|FG001|Titration Period 2|Adverse Event|3|||
37925430|NCT00813488|69612337|FG000|Titration Period 2|Lack of Efficacy|8|||
37925431|NCT00813488|69612338|FG001|Titration Period 2|Lack of Efficacy|4|||
37925432|NCT00813488|69612337|FG000|Titration Period 2|Protocol Violation|3|||
37925433|NCT00813488|69612338|FG001|Titration Period 2|Protocol Violation|2|||
37925434|NCT00813488|69612337|FG000|Titration Period 2|Lost to Follow-up|1|||
37925435|NCT00813488|69612338|FG001|Titration Period 2|Lost to Follow-up|0|||
37925436|NCT00813488|69612337|FG000|Titration Period 2|Non-compliance with study procedures|2|||
37925437|NCT00813488|69612338|FG001|Titration Period 2|Non-compliance with study procedures|1|||
37925438|NCT00813488|69612337|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
37925439|NCT00813488|69612338|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
37925440|NCT00813488|69612337|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
37925441|NCT00813488|69612338|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
37925442|NCT00813488|69612337|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
37925443|NCT00813488|69612338|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
37925444|NCT00813488|69612337|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
37925445|NCT00813488|69612338|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
37925446|NCT00813488|69612337|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
37925447|NCT00813488|69612338|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
37925448|NCT00813488|69612337|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
37925449|NCT00813488|69612338|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
37925450|NCT00813488|69612337|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
37925451|NCT00813488|69612338|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
37925452|NCT00813488|69612337|FG000|Double-blind Treatment Period 2|Other|1|||
37925453|NCT00813488|69612338|FG001|Double-blind Treatment Period 2|Other|0|||
37925454|NCT00813488|69612337|FG000|Open-label Extension|Adverse Event|1|||
37925455|NCT00813488|69612338|FG001|Open-label Extension|Adverse Event|2|||
37925456|NCT00813488|69612337|FG000|Open-label Extension|Lack of Efficacy|3|||
37925457|NCT00813488|69612338|FG001|Open-label Extension|Lack of Efficacy|0|||
37925458|NCT00813488|69612337|FG000|Open-label Extension|Withdrawal by Subject|0|||
37925459|NCT00813488|69612338|FG001|Open-label Extension|Withdrawal by Subject|2|||
37925460|NCT00813488|69612337|FG000|Open-label Extension|Protocol Violation|1|||
37925461|NCT00813488|69612338|FG001|Open-label Extension|Protocol Violation|2|||
37925462|NCT00813488|69612337|FG000|Open-label Extension|Non-compliance study medication|4|||
37925463|NCT00813488|69612338|FG001|Open-label Extension|Non-compliance study medication|0|||
37925464|NCT00813488|69612337|FG000|Open-label Extension|Non-compliance study procedures|2|||
37925465|NCT00813488|69612338|FG001|Open-label Extension|Non-compliance study procedures|1|||
37925466|NCT00813488|69612337|FG000|Open-label Extension|Other|1|||
37925467|NCT00813488|69612338|FG001|Open-label Extension|Other|0|||
37925468|NCT00797316|69612350|FG000|Overall Study|Administrative problems|1|||
37925469|NCT00797316|69612351|FG001|Overall Study|Administrative problems|0|||
37925470|NCT00797316|69612350|FG000|Overall Study|Adverse Event|5|||
37925471|NCT00797316|69612351|FG001|Overall Study|Adverse Event|3|||
37925472|NCT00797316|69612350|FG000|Overall Study|Lost to Follow-up|4|||
37925473|NCT00797316|69612351|FG001|Overall Study|Lost to Follow-up|8|||
37925474|NCT00797316|69612350|FG000|Overall Study|Protocol Deviation|1|||
37925475|NCT00797316|69612351|FG001|Overall Study|Protocol Deviation|2|||
37925476|NCT00797316|69612350|FG000|Overall Study|Patient withdrew consent|12|||
37925477|NCT00797316|69612351|FG001|Overall Study|Patient withdrew consent|6|||
37925478|NCT00797316|69612350|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
37925479|NCT00797316|69612351|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
37925480|NCT00587964|69612357|FG000|Overall Study|Withdrawal by Subject|1|||
37925481|NCT00587964|69612357|FG000|Overall Study|Lost to Follow-up|1|||
37925482|NCT00587964|69612357|FG000|Overall Study|Patient found to be ineligible|1|||
37925483|NCT00587964|69612357|FG000|Overall Study|Patient did not receive intervention|5|||
37925484|NCT00587964|69612357|FG000|Overall Study|Progression of Disease|4|||
37925485|NCT00590954|69612361|FG000|Overall Study|Inevaluable|2|||
37925486|NCT00791076|69612367|FG000|Overall Study|Study was terminated,PI left institution|8|||
37925487|NCT00590720|69612375|FG000|Overall Study|Lost to Follow-up|1|||
37666821|NCT01595529|69139237|FG001|Overall Study|Protocol Violation|2|||
37759502|NCT01499303|69269520|FG001|Overall Study|Ongoing|1|||
37925488|NCT00590720|69612376|FG001|Overall Study|Lost to Follow-up|0|||
37925489|NCT00590720|69612375|FG000|Overall Study|Withdrawal by Subject|0|||
37925490|NCT00590720|69612376|FG001|Overall Study|Withdrawal by Subject|1|||
37925491|NCT00625378|69612384|FG000|Overall Study|Adverse Event|22|||
37666822|NCT01595529|69139236|FG000|Overall Study|Physician Decision|1|||
37666823|NCT01595529|69139237|FG001|Overall Study|Physician Decision|0|||
37666824|NCT01595529|69139236|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
37666825|NCT01595529|69139237|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
37666826|NCT01595529|69139236|FG000|Overall Study|Administrative Decision|1|||
37666827|NCT01595529|69139237|FG001|Overall Study|Administrative Decision|0|||
37666828|NCT01595529|69139236|FG000|Overall Study|Entry Failure/Screening Failure|6|||
37666829|NCT01595529|69139237|FG001|Overall Study|Entry Failure/Screening Failure|1|||
37759503|NCT01499303|69269519|FG000|Overall Study|Withdrawal by Subject|0|||
37759504|NCT01499303|69269520|FG001|Overall Study|Withdrawal by Subject|1|||
37759505|NCT01499303|69269519|FG000|Overall Study|Adverse Event|1|||
37759506|NCT01499303|69269520|FG001|Overall Study|Adverse Event|4|||
37759507|NCT01499303|69269519|FG000|Overall Study|Other|0|||
37759508|NCT01499303|69269520|FG001|Overall Study|Other|1|||
37759509|NCT01498679|69269541|FG000|Overall Study|Adverse Event|1|||
37759510|NCT01498679|69269542|FG001|Overall Study|Adverse Event|4|||
37666830|NCT02615145|69139246|FG000|Overall Study|Did Not Start Treatment|0|||
37666831|NCT02615145|69139247|FG001|Overall Study|Did Not Start Treatment|0|||
37666832|NCT02615145|69139248|FG002|Overall Study|Did Not Start Treatment|1|||
37666833|NCT02615145|69139249|FG003|Overall Study|Did Not Start Treatment|1|||
37666834|NCT02615145|69139246|FG000|Overall Study|Failure to Return|20|||
37666835|NCT02615145|69139247|FG001|Overall Study|Failure to Return|10|||
37666836|NCT02615145|69139248|FG002|Overall Study|Failure to Return|7|||
37666837|NCT02615145|69139249|FG003|Overall Study|Failure to Return|0|||
37666838|NCT02615145|69139246|FG000|Overall Study|Death|2|||
37666839|NCT02615145|69139247|FG001|Overall Study|Death|3|||
37666840|NCT02615145|69139248|FG002|Overall Study|Death|0|||
37666841|NCT02615145|69139249|FG003|Overall Study|Death|0|||
37666842|NCT02615145|69139246|FG000|Overall Study|Other, Not Specified|5|||
37666843|NCT02615145|69139247|FG001|Overall Study|Other, Not Specified|2|||
37666844|NCT02615145|69139248|FG002|Overall Study|Other, Not Specified|0|||
37666845|NCT02615145|69139249|FG003|Overall Study|Other, Not Specified|0|||
37666846|NCT02119156|69139278|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
37666847|NCT02119156|69139279|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
37666848|NCT02119156|69139280|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
37666849|NCT02119156|69139278|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
37666850|NCT02119156|69139279|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
37666851|NCT02119156|69139280|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
37666852|NCT02119156|69139278|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
37666853|NCT02119156|69139279|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
37666854|NCT02119156|69139280|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
37666855|NCT02119156|69139278|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
37666856|NCT02119156|69139279|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
37666857|NCT02119156|69139280|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
37666858|NCT02119156|69139278|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
37666859|NCT02119156|69139279|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
37666860|NCT02119156|69139280|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
37666861|NCT02181556|69139295|FG000|Overall Study|Withdrawal by Subject|1|||
37666862|NCT02614131|69139306|FG000|Overall Study|Withdrawal by Subject|1|||
37666863|NCT02614131|69139307|FG001|Overall Study|Withdrawal by Subject|0|||
37666864|NCT02614131|69139308|FG002|Overall Study|Withdrawal by Subject|0|||
37666865|NCT02614131|69139309|FG003|Overall Study|Withdrawal by Subject|0|||
37666866|NCT02614131|69139310|FG004|Overall Study|Withdrawal by Subject|0|||
37666867|NCT02614131|69139311|FG005|Overall Study|Withdrawal by Subject|0|||
37666868|NCT02614131|69139312|FG006|Overall Study|Withdrawal by Subject|0|||
37759511|NCT01498679|69269541|FG000|Overall Study|Lack of Efficacy|72|||
37759512|NCT01498679|69269542|FG001|Overall Study|Lack of Efficacy|12|||
37759513|NCT01498679|69269541|FG000|Overall Study|Protocol Violation|4|||
37759514|NCT01498679|69269542|FG001|Overall Study|Protocol Violation|0|||
37759515|NCT01498679|69269541|FG000|Overall Study|Physician Decision|0|||
37759516|NCT01498679|69269542|FG001|Overall Study|Physician Decision|2|||
37859348|NCT01290731|69542670|FG000|Overall Study|Withdrawal by Subject|1|||
37859349|NCT01290341|69542676|FG000|Overall Study|Protocol Violation|7|||
37859350|NCT01290341|69542677|FG001|Overall Study|Protocol Violation|3|||
37859351|NCT01290341|69542676|FG000|Overall Study|Adverse Event|1|||
37859352|NCT01290341|69542677|FG001|Overall Study|Adverse Event|0|||
37859353|NCT01290341|69542676|FG000|Overall Study|Lost to Follow-up|21|||
37859354|NCT01290341|69542677|FG001|Overall Study|Lost to Follow-up|10|||
37859355|NCT01290341|69542676|FG000|Overall Study|Withdrawal by Subject|19|||
37859356|NCT01290341|69542677|FG001|Overall Study|Withdrawal by Subject|5|||
37859357|NCT01290341|69542676|FG000|Overall Study|Negative baseline culture and others|44|||
37859358|NCT01290341|69542677|FG001|Overall Study|Negative baseline culture and others|11|||
37759517|NCT01498679|69269541|FG000|Overall Study|Withdrawal by Subject|12|||
37859359|NCT01290263|69542685|FG000|Overall Study|Adverse Event|0|||
37759518|NCT01498679|69269542|FG001|Overall Study|Withdrawal by Subject|4|||
37925492|NCT00625378|69612385|FG001|Overall Study|Adverse Event|0|||
37925493|NCT00625378|69612384|FG000|Overall Study|Withdrawal by Subject|16|||
37925494|NCT00625378|69612385|FG001|Overall Study|Withdrawal by Subject|0|||
37925495|NCT00625378|69612384|FG000|Overall Study|Death|38|||
37925496|NCT00625378|69612385|FG001|Overall Study|Death|0|||
37925497|NCT00625378|69612384|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
37925498|NCT00625378|69612385|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
37925499|NCT00625378|69612384|FG000|Overall Study|Lost to Follow-up|17|||
37925500|NCT00625378|69612385|FG001|Overall Study|Lost to Follow-up|0|||
37925501|NCT00625378|69612384|FG000|Overall Study|Non-compliant with study medication|3|||
37925502|NCT00625378|69612385|FG001|Overall Study|Non-compliant with study medication|0|||
37925503|NCT00625378|69612384|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
37925504|NCT00625378|69612385|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
37925505|NCT00625378|69612384|FG000|Overall Study|Medical decision|1|||
37925506|NCT00625378|69612385|FG001|Overall Study|Medical decision|0|||
37925507|NCT00625378|69612384|FG000|Overall Study|Multiple toxicities|1|||
37925508|NCT00625378|69612385|FG001|Overall Study|Multiple toxicities|0|||
37925509|NCT00625378|69612384|FG000|Overall Study|New cancer|1|||
37925510|NCT00625378|69612385|FG001|Overall Study|New cancer|0|||
37925511|NCT00625378|69612384|FG000|Overall Study|PTA program|2|||
37925512|NCT00625378|69612385|FG001|Overall Study|PTA program|0|||
37925513|NCT00625378|69612384|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
37925514|NCT00625378|69612385|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
37925515|NCT00625378|69612384|FG000|Overall Study|Sponsor decision|1|||
37925516|NCT00625378|69612385|FG001|Overall Study|Sponsor decision|0|||
37925517|NCT00625378|69612384|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
37925518|NCT00625378|69612385|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
37925519|NCT00625378|69612384|FG000|Overall Study|Switch to commercial drug|6|||
37925520|NCT00625378|69612385|FG001|Overall Study|Switch to commercial drug|1|||
37925521|NCT00625378|69612384|FG000|Overall Study|Missing|2|||
37925522|NCT00625378|69612385|FG001|Overall Study|Missing|0|||
37925523|NCT00625378|69612384|FG000|Overall Study|End of treatment not available|2|||
37925524|NCT00625378|69612385|FG001|Overall Study|End of treatment not available|0|||
37925525|NCT00625378|69612384|FG000|Overall Study|Never treated|2|||
37925526|NCT00625378|69612385|FG001|Overall Study|Never treated|0|||
37925527|NCT00806624|69612394|FG000|Overall Study|Adverse Event|2|||
37925528|NCT00806624|69612395|FG001|Overall Study|Adverse Event|8|||
37925529|NCT00806624|69612396|FG002|Overall Study|Adverse Event|0|||
37925530|NCT00806624|69612394|FG000|Overall Study|Death|0|||
37925531|NCT00806624|69612395|FG001|Overall Study|Death|1|||
37925532|NCT00806624|69612396|FG002|Overall Study|Death|1|||
37925533|NCT00806624|69612394|FG000|Overall Study|Lost to Follow-up|1|||
37925534|NCT00806624|69612395|FG001|Overall Study|Lost to Follow-up|0|||
37925535|NCT00806624|69612396|FG002|Overall Study|Lost to Follow-up|1|||
37925536|NCT00806624|69612394|FG000|Overall Study|Withdrawal by Subject|6|||
37925537|NCT00806624|69612395|FG001|Overall Study|Withdrawal by Subject|3|||
37925538|NCT00806624|69612396|FG002|Overall Study|Withdrawal by Subject|3|||
37925539|NCT00806624|69612394|FG000|Overall Study|discontinued before start of treatment|0|||
37925540|NCT00806624|69612395|FG001|Overall Study|discontinued before start of treatment|0|||
37925541|NCT00806624|69612396|FG002|Overall Study|discontinued before start of treatment|1|||
37925542|NCT00806546|69612404|FG000|Overall Study|Enrolled, not treated|35|||
37925543|NCT00806546|69612404|FG000|Overall Study|Lost to Follow-up|32|||
37925544|NCT00806546|69612404|FG000|Overall Study|Adverse Event|74|||
37925545|NCT00806546|69612404|FG000|Overall Study|Withdrawal by Subject|75|||
37666869|NCT02614131|69139306|FG000|Overall Study|Adverse Event|0|||
37925546|NCT00806546|69612404|FG000|Overall Study|Protocol Violation|49|||
37925547|NCT00806546|69612404|FG000|Overall Study|Various|42|||
37666870|NCT02614131|69139307|FG001|Overall Study|Adverse Event|0|||
37666871|NCT02614131|69139308|FG002|Overall Study|Adverse Event|0|||
37666872|NCT02614131|69139309|FG003|Overall Study|Adverse Event|0|||
37666873|NCT02614131|69139310|FG004|Overall Study|Adverse Event|0|||
37666874|NCT02614131|69139311|FG005|Overall Study|Adverse Event|0|||
37666875|NCT02614131|69139312|FG006|Overall Study|Adverse Event|1|||
37666876|NCT01903733|69139338|FG000|Overall Study|Death|23|||
37666877|NCT01903733|69139339|FG001|Overall Study|Death|54|||
37925548|NCT00624832|69612412|FG000|Overall Study|Adverse Event|0|||
37925549|NCT00624832|69612413|FG001|Overall Study|Adverse Event|1|||
37925550|NCT00624832|69612414|FG002|Overall Study|Adverse Event|0|||
37925551|NCT00624832|69612415|FG003|Overall Study|Adverse Event|1|||
37925552|NCT00624832|69612412|FG000|Overall Study|Abnormal Laboratory Value|2|||
37925553|NCT00624832|69612413|FG001|Overall Study|Abnormal Laboratory Value|0|||
37925554|NCT00624832|69612414|FG002|Overall Study|Abnormal Laboratory Value|0|||
37925555|NCT00624832|69612415|FG003|Overall Study|Abnormal Laboratory Value|0|||
37925556|NCT00633880|69612427|FG000|Open Label Titration|Lack of Efficacy|1|||
37925557|NCT00633880|69612428|FG001|Open Label Titration|Lack of Efficacy|0|||
37925558|NCT00633880|69612429|FG002|Open Label Titration|Lack of Efficacy|0|||
37925559|NCT00633880|69612427|FG000|Open Label Titration|Adverse Event|13|||
37925560|NCT00633880|69612428|FG001|Open Label Titration|Adverse Event|0|||
37925561|NCT00633880|69612429|FG002|Open Label Titration|Adverse Event|0|||
37925562|NCT00633880|69612427|FG000|Open Label Titration|Treatment Failure|55|||
37925563|NCT00633880|69612428|FG001|Open Label Titration|Treatment Failure|0|||
38033501|NCT03325556|69719498|FG002|Open-label Period|Death|0|||
37859360|NCT01290263|69542686|FG001|Overall Study|Adverse Event|0|||
37859361|NCT01290263|69542687|FG002|Overall Study|Adverse Event|0|||
37859362|NCT01290263|69542688|FG003|Overall Study|Adverse Event|1|||
37859363|NCT01290263|69542689|FG004|Overall Study|Adverse Event|1|||
37859364|NCT01290263|69542685|FG000|Overall Study|Lack of Efficacy|8|||
37859365|NCT01290263|69542686|FG001|Overall Study|Lack of Efficacy|2|||
37859366|NCT01290263|69542687|FG002|Overall Study|Lack of Efficacy|7|||
37859367|NCT01290263|69542688|FG003|Overall Study|Lack of Efficacy|24|||
37859368|NCT01290263|69542689|FG004|Overall Study|Lack of Efficacy|33|||
37859369|NCT01290263|69542685|FG000|Overall Study|Withdrawal by Subject|3|||
37859370|NCT01290263|69542686|FG001|Overall Study|Withdrawal by Subject|1|||
37859371|NCT01290263|69542687|FG002|Overall Study|Withdrawal by Subject|0|||
37859372|NCT01290263|69542688|FG003|Overall Study|Withdrawal by Subject|1|||
37859373|NCT01290263|69542689|FG004|Overall Study|Withdrawal by Subject|2|||
37859374|NCT01290263|69542685|FG000|Overall Study|Participant Non-Compliance|0|||
37859375|NCT01290263|69542686|FG001|Overall Study|Participant Non-Compliance|0|||
37859376|NCT01290263|69542687|FG002|Overall Study|Participant Non-Compliance|0|||
37859377|NCT01290263|69542688|FG003|Overall Study|Participant Non-Compliance|1|||
37859378|NCT01290263|69542689|FG004|Overall Study|Participant Non-Compliance|1|||
37859379|NCT01290029|69542697|FG000|Overall Study|Other|2|||
37859380|NCT01289639|69542704|FG000|Overall Study|Lost to Follow-up|1|||
37859381|NCT01289639|69542705|FG001|Overall Study|Lost to Follow-up|0|||
37859382|NCT01289639|69542706|FG002|Overall Study|Lost to Follow-up|0|||
37859383|NCT01289015|69542716|FG000|Overall Study|Protocol Violation|12|||
37859384|NCT01289015|69542717|FG001|Overall Study|Protocol Violation|9|||
37859385|NCT01289015|69542716|FG000|Overall Study|Adverse Event|3|||
37859386|NCT01289015|69542717|FG001|Overall Study|Adverse Event|0|||
37859387|NCT01289015|69542716|FG000|Overall Study|Lost to Follow-up|33|||
37859388|NCT01289015|69542717|FG001|Overall Study|Lost to Follow-up|17|||
37859389|NCT01289015|69542716|FG000|Overall Study|Withdrawal by Subject|17|||
37859390|NCT01289015|69542717|FG001|Overall Study|Withdrawal by Subject|8|||
37859391|NCT01289015|69542716|FG000|Overall Study|Disease progression|1|||
37859392|NCT01289015|69542717|FG001|Overall Study|Disease progression|0|||
37859393|NCT01289015|69542716|FG000|Overall Study|Negative baseline culture and others|33|||
37859394|NCT01289015|69542717|FG001|Overall Study|Negative baseline culture and others|20|||
37859395|NCT01288937|69542725|FG000|Overall Study|Adverse Event|1|||
37859396|NCT01288937|69542726|FG001|Overall Study|Adverse Event|0|||
37859397|NCT01288469|69542735|FG000|Overall Study|Adverse Event|4|||
37859398|NCT01288469|69542736|FG001|Overall Study|Adverse Event|1|||
37859399|NCT01288469|69542737|FG002|Overall Study|Adverse Event|1|||
37859400|NCT01288469|69542735|FG000|Overall Study|Poor compliance to protocol|0|||
37859401|NCT01288469|69542736|FG001|Overall Study|Poor compliance to protocol|1|||
37859402|NCT01288469|69542737|FG002|Overall Study|Poor compliance to protocol|0|||
37859403|NCT01288469|69542735|FG000|Overall Study|Participant Moved|1|||
37859404|NCT01288469|69542736|FG001|Overall Study|Participant Moved|0|||
37859405|NCT01288469|69542737|FG002|Overall Study|Participant Moved|0|||
37859406|NCT01288469|69542735|FG000|Overall Study|Consent withdrawn by subject|1|||
37859407|NCT01288469|69542736|FG001|Overall Study|Consent withdrawn by subject|1|||
37859408|NCT01288469|69542737|FG002|Overall Study|Consent withdrawn by subject|1|||
37859409|NCT01288469|69542735|FG000|Overall Study|Exclusion criteria finally met|1|||
37859410|NCT01288469|69542736|FG001|Overall Study|Exclusion criteria finally met|0|||
37859411|NCT01288469|69542737|FG002|Overall Study|Exclusion criteria finally met|0|||
37859412|NCT01288079|69542749|FG000|Overall Study|Withdrawal by Subject|2|||
37859413|NCT01288079|69542750|FG001|Overall Study|Withdrawal by Subject|4|||
37859414|NCT01288079|69542751|FG002|Overall Study|Withdrawal by Subject|1|||
37859415|NCT01288079|69542752|FG003|Overall Study|Withdrawal by Subject|0|||
37859416|NCT01288079|69542749|FG000|Overall Study|Adverse Event|2|||
37859417|NCT01288079|69542750|FG001|Overall Study|Adverse Event|1|||
37859418|NCT01288079|69542751|FG002|Overall Study|Adverse Event|2|||
37859419|NCT01288079|69542752|FG003|Overall Study|Adverse Event|3|||
37859420|NCT01288079|69542749|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
37859421|NCT01288079|69542750|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
37859422|NCT01288079|69542751|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
37859423|NCT01288079|69542752|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
37859424|NCT01288079|69542749|FG000|Overall Study|Condition under Investigation Worsened|0|||
37859425|NCT01288079|69542750|FG001|Overall Study|Condition under Investigation Worsened|0|||
37859426|NCT01288079|69542751|FG002|Overall Study|Condition under Investigation Worsened|0|||
37859427|NCT01288079|69542752|FG003|Overall Study|Condition under Investigation Worsened|1|||
37859428|NCT01288079|69542749|FG000|Overall Study|Lack of Efficacy|2|||
37859429|NCT01288079|69542750|FG001|Overall Study|Lack of Efficacy|2|||
37859430|NCT01288079|69542751|FG002|Overall Study|Lack of Efficacy|0|||
37925564|NCT00633880|69612429|FG002|Open Label Titration|Treatment Failure|0|||
37925565|NCT00633880|69612427|FG000|Open Label Titration|Protocol Violation|6|||
37925566|NCT00633880|69612428|FG001|Open Label Titration|Protocol Violation|0|||
37925567|NCT00633880|69612429|FG002|Open Label Titration|Protocol Violation|0|||
37925568|NCT00633880|69612427|FG000|Open Label Titration|Physician Decision|1|||
37925569|NCT00633880|69612428|FG001|Open Label Titration|Physician Decision|0|||
37925570|NCT00633880|69612429|FG002|Open Label Titration|Physician Decision|0|||
37925571|NCT00633880|69612427|FG000|Open Label Titration|Withdrawal by Subject|4|||
37925572|NCT00633880|69612428|FG001|Open Label Titration|Withdrawal by Subject|0|||
37925573|NCT00633880|69612429|FG002|Open Label Titration|Withdrawal by Subject|0|||
37925574|NCT00590564|69612436|FG000|Overall Study|Withdrawal by Subject|4|||
37925575|NCT00590564|69612436|FG000|Overall Study|Lost to Follow-up|6|||
37925576|NCT00590564|69612436|FG000|Overall Study|Protocol Violation|1|||
37925577|NCT00590564|69612436|FG000|Overall Study|Patient Found to be Ineligible|1|||
37925578|NCT00590564|69612436|FG000|Overall Study|Patient Non-compliance|6|||
37925579|NCT00631696|69612442|FG000|Overall Study|Entered, not randomized to treatment|1|||
37925580|NCT00631696|69612443|FG001|Overall Study|Entered, not randomized to treatment|1|||
37925581|NCT00631696|69612442|FG000|Overall Study|Discontinued after database release date|1|||
37925582|NCT00631696|69612443|FG001|Overall Study|Discontinued after database release date|0|||
37925583|NCT00631696|69612442|FG000|Overall Study|Follow up after database release date|1|||
37925584|NCT00631696|69612443|FG001|Overall Study|Follow up after database release date|0|||
37925585|NCT00631696|69612442|FG000|Overall Study|Lost to Follow-up|7|||
37925586|NCT00631696|69612443|FG001|Overall Study|Lost to Follow-up|10|||
37925587|NCT00631696|69612442|FG000|Overall Study|Withdrawal by Subject|2|||
37925588|NCT00631696|69612443|FG001|Overall Study|Withdrawal by Subject|9|||
37925589|NCT00631696|69612442|FG000|Overall Study|Other|8|||
37925590|NCT00631696|69612443|FG001|Overall Study|Other|8|||
37925591|NCT00631696|69612442|FG000|Overall Study|Protocol Violation|9|||
37925592|NCT00631696|69612443|FG001|Overall Study|Protocol Violation|9|||
37925593|NCT00631696|69612442|FG000|Overall Study|Study terminated by sponsor|3|||
37925594|NCT00631696|69612443|FG001|Overall Study|Study terminated by sponsor|3|||
37925595|NCT00631696|69612442|FG000|Overall Study|Adverse Event|5|||
37925596|NCT00631696|69612443|FG001|Overall Study|Adverse Event|0|||
37925597|NCT00631540|69612449|FG000|Overall Study|Withdrawal by Subject|5|||
37925598|NCT00631540|69612449|FG000|Overall Study|Death|4|||
37925599|NCT00631540|69612449|FG000|Overall Study|Lost to Follow-up|2|||
37925600|NCT00631540|69612449|FG000|Overall Study|Core Lab Data Unavailable|3|||
37925601|NCT00630916|69612453|FG000|Overall Study|Death|110|||
37925602|NCT00630916|69612453|FG000|Overall Study|Explant|8|||
37925603|NCT00630916|69612453|FG000|Overall Study|Lost to Follow-up|5|||
37925604|NCT00630916|69612453|FG000|Overall Study|Withdrawal by Subject|30|||
37925605|NCT00630916|69612453|FG000|Overall Study|Protocol Violation|7|||
37925606|NCT00630916|69612453|FG000|Overall Study|Physician Decision|47|||
37925607|NCT00630916|69612453|FG000|Overall Study|Lack of Efficacy|3|||
37925608|NCT00630292|69612457|FG000|Overall Study|Withdrawal by Subject|1|||
37925609|NCT00626548|69612463|FG000|Overall Study|Adverse Event|164|||
37925610|NCT00626548|69612464|FG001|Overall Study|Adverse Event|44|||
37925611|NCT00626548|69612463|FG000|Overall Study|Withdrawal by Subject|42|||
37925612|NCT00626548|69612464|FG001|Overall Study|Withdrawal by Subject|46|||
37925613|NCT00626548|69612463|FG000|Overall Study|Protocol Violation|4|||
37925614|NCT00626548|69612464|FG001|Overall Study|Protocol Violation|11|||
37666878|NCT01903733|69139340|FG002|Overall Study|Death|30|||
37666879|NCT01903733|69139341|FG003|Overall Study|Death|98|||
37666880|NCT01903733|69139338|FG000|Overall Study|Participant refused further follow-up|35|||
37666881|NCT01903733|69139339|FG001|Overall Study|Participant refused further follow-up|38|||
37666882|NCT01903733|69139340|FG002|Overall Study|Participant refused further follow-up|13|||
37925615|NCT00626548|69612463|FG000|Overall Study|Lost to Follow-up|2|||
37666883|NCT01903733|69139341|FG003|Overall Study|Participant refused further follow-up|9|||
37666884|NCT01903733|69139338|FG000|Overall Study|Lost to Follow-up|18|||
37666885|NCT01903733|69139339|FG001|Overall Study|Lost to Follow-up|19|||
37666886|NCT01903733|69139340|FG002|Overall Study|Lost to Follow-up|6|||
37666887|NCT01903733|69139341|FG003|Overall Study|Lost to Follow-up|9|||
37925616|NCT00626548|69612464|FG001|Overall Study|Lost to Follow-up|2|||
37925617|NCT00626548|69612463|FG000|Overall Study|Other termination reason|493|||
37666888|NCT01903733|69139338|FG000|Overall Study|Other|10|||
37925618|NCT00626548|69612464|FG001|Overall Study|Other termination reason|613|||
37925619|NCT00847379|69612473|FG000|Overall Study|Study terminated by Sponsor|59|||
37925620|NCT00847379|69612474|FG001|Overall Study|Study terminated by Sponsor|57|||
37925621|NCT00847379|69612475|FG002|Overall Study|Study terminated by Sponsor|57|||
37925622|NCT00847301|69612485|FG000|Overall Study|Adverse Event|35|||
37925623|NCT00847301|69612485|FG000|Overall Study|Switch to other anticoagulants|16|||
37666889|NCT01903733|69139339|FG001|Overall Study|Other|15|||
37925624|NCT00847301|69612485|FG000|Overall Study|Lost to Follow-up|1|||
37925625|NCT00847301|69612485|FG000|Overall Study|No prescription after hospital discharge|1|||
37925626|NCT00847301|69612485|FG000|Overall Study|Other reason not defined above|1|||
37925627|NCT00624520|69612491|FG000|Overall Study|Withdrawal by Subject|12|||
37925628|NCT00624520|69612492|FG001|Overall Study|Withdrawal by Subject|7|||
37925629|NCT00624520|69612491|FG000|Overall Study|Death|0|||
37925630|NCT00624520|69612492|FG001|Overall Study|Death|1|||
37925631|NCT00847145|69612506|FG000|Overall Study|AE or Death|0|||
37925632|NCT00847145|69612507|FG001|Overall Study|AE or Death|1|||
37925633|NCT00847145|69612508|FG002|Overall Study|AE or Death|1|||
37925634|NCT00847145|69612509|FG003|Overall Study|AE or Death|0|||
37925635|NCT00847145|69612510|FG004|Overall Study|AE or Death|0|||
37925636|NCT00847145|69612511|FG005|Overall Study|AE or Death|0|||
37925637|NCT00847145|69612512|FG006|Overall Study|AE or Death|0|||
37925638|NCT00847145|69612513|FG007|Overall Study|AE or Death|0|||
37759519|NCT01526785|69269565|FG000|Overall Study|Study Terminated by Sponsor|8|||
37759520|NCT01526785|69269565|FG000|Overall Study|Death|2|||
37759521|NCT01526785|69269565|FG000|Overall Study|Physician Decision|1|||
37759522|NCT01526785|69269565|FG000|Overall Study|Withdrawal by Subject|2|||
37759523|NCT01559389|69269571|FG000|Overall Study|Withdrawal by Subject|20|||
37759524|NCT01559389|69269572|FG001|Overall Study|Withdrawal by Subject|20|||
37759525|NCT01526551|69269582|FG000|Overall Study|Lack of returned parental consent form|424|||
37759526|NCT01559311|69269660|FG000|Overall Study|Protocol Violation|0|||
37759527|NCT01559311|69269661|FG001|Overall Study|Protocol Violation|0|||
37759528|NCT01559311|69269662|FG002|Overall Study|Protocol Violation|2|||
37759529|NCT01559311|69269660|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
37759530|NCT01559311|69269661|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
37759531|NCT01559311|69269662|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
37759532|NCT01559311|69269660|FG000|Overall Study|Withdrawal by Subject|2|||
37759533|NCT01559311|69269661|FG001|Overall Study|Withdrawal by Subject|1|||
37759534|NCT01559311|69269662|FG002|Overall Study|Withdrawal by Subject|0|||
37759535|NCT01559311|69269660|FG000|Overall Study|Death|0|||
37759536|NCT01559311|69269661|FG001|Overall Study|Death|2|||
37759537|NCT01559311|69269662|FG002|Overall Study|Death|3|||
37759538|NCT01559311|69269660|FG000|Overall Study|Lost to Follow-up|0|||
37759539|NCT01559311|69269661|FG001|Overall Study|Lost to Follow-up|3|||
37759540|NCT01559311|69269662|FG002|Overall Study|Lost to Follow-up|2|||
37759541|NCT01559311|69269660|FG000|Overall Study|Adverse Event|0|||
37759542|NCT01559311|69269661|FG001|Overall Study|Adverse Event|0|||
37759543|NCT01559311|69269662|FG002|Overall Study|Adverse Event|1|||
37759544|NCT01498445|69269685|FG000|Overall Study|Lack of Efficacy|0|||
37759545|NCT01498445|69269686|FG001|Overall Study|Lack of Efficacy|0|||
37759546|NCT01498445|69269687|FG002|Overall Study|Lack of Efficacy|1|||
37759547|NCT01498445|69269688|FG003|Overall Study|Lack of Efficacy|2|||
37759548|NCT01498445|69269689|FG004|Overall Study|Lack of Efficacy|0|||
37759549|NCT01498445|69269690|FG005|Overall Study|Lack of Efficacy|0|||
37759550|NCT01498445|69269685|FG000|Overall Study|Screen Failure|0|||
37759551|NCT01498445|69269686|FG001|Overall Study|Screen Failure|0|||
37759552|NCT01498445|69269687|FG002|Overall Study|Screen Failure|0|||
37759553|NCT01498445|69269688|FG003|Overall Study|Screen Failure|0|||
37759554|NCT01498445|69269689|FG004|Overall Study|Screen Failure|1|||
37759555|NCT01498445|69269690|FG005|Overall Study|Screen Failure|1|||
37759556|NCT01558297|69269707|FG000|Overall Study|Withdrawal by Subject|2|||
37759557|NCT01558297|69269708|FG001|Overall Study|Withdrawal by Subject|2|||
37759558|NCT01558297|69269709|FG002|Overall Study|Withdrawal by Subject|1|||
37759559|NCT01525849|69269719|FG000|Overall Study|Lost to Follow-up|3|||
37759560|NCT01525849|69269720|FG001|Overall Study|Lost to Follow-up|2|||
37759561|NCT01525849|69269719|FG000|Overall Study|Withdrawal by Subject|1|||
37759562|NCT01525849|69269720|FG001|Overall Study|Withdrawal by Subject|9|||
37759563|NCT01525849|69269719|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
37759564|NCT01525849|69269720|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
37759565|NCT01525849|69269719|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
37759566|NCT01525849|69269720|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
37759567|NCT01525615|69269739|FG000|Overall Study|Adverse Event|11|||
37759568|NCT01525615|69269740|FG001|Overall Study|Adverse Event|7|||
37759569|NCT01525615|69269741|FG002|Overall Study|Adverse Event|5|||
37759570|NCT01525615|69269739|FG000|Overall Study|Lost to Follow-up|1|||
37666890|NCT01903733|69139340|FG002|Overall Study|Other|12|||
37759571|NCT01525615|69269740|FG001|Overall Study|Lost to Follow-up|0|||
37759572|NCT01525615|69269741|FG002|Overall Study|Lost to Follow-up|0|||
37759573|NCT01525615|69269739|FG000|Overall Study|Withdrawal by Subject|1|||
37759574|NCT01525615|69269740|FG001|Overall Study|Withdrawal by Subject|0|||
37759575|NCT01525615|69269741|FG002|Overall Study|Withdrawal by Subject|0|||
37925639|NCT00847145|69612506|FG000|Overall Study|Withdrawal by Subject|3|||
37925640|NCT00847145|69612507|FG001|Overall Study|Withdrawal by Subject|4|||
37759576|NCT01525615|69269739|FG000|Overall Study|Other reason not described above|1|||
37666891|NCT01903733|69139341|FG003|Overall Study|Other|3|||
37759577|NCT01525615|69269740|FG001|Overall Study|Other reason not described above|0|||
37759578|NCT01525615|69269741|FG002|Overall Study|Other reason not described above|1|||
37759579|NCT01525225|69269783|FG000|Enrollment|No longer met study criteria|1|||
37925641|NCT00847145|69612508|FG002|Overall Study|Withdrawal by Subject|6|||
37925642|NCT00847145|69612509|FG003|Overall Study|Withdrawal by Subject|1|||
37759580|NCT01525225|69269783|FG000|Enrollment|Other|1|||
37759581|NCT02660580|69269802|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
37759582|NCT02660580|69269803|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
37759583|NCT02660580|69269804|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
37759584|NCT02660580|69269805|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
37759585|NCT02660580|69269806|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
37759586|NCT02660580|69269802|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
37759587|NCT02660580|69269803|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
37759588|NCT02660580|69269804|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
37759589|NCT02660580|69269805|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
37925643|NCT00847145|69612510|FG004|Overall Study|Withdrawal by Subject|0|||
37925644|NCT00847145|69612511|FG005|Overall Study|Withdrawal by Subject|0|||
37925645|NCT00847145|69612512|FG006|Overall Study|Withdrawal by Subject|1|||
37925646|NCT00847145|69612513|FG007|Overall Study|Withdrawal by Subject|1|||
37925647|NCT00847145|69612506|FG000|Overall Study|Lost to Follow-up|3|||
37925648|NCT00847145|69612507|FG001|Overall Study|Lost to Follow-up|1|||
37925649|NCT00847145|69612508|FG002|Overall Study|Lost to Follow-up|1|||
37925650|NCT00847145|69612509|FG003|Overall Study|Lost to Follow-up|0|||
37925651|NCT00847145|69612510|FG004|Overall Study|Lost to Follow-up|4|||
37925652|NCT00847145|69612511|FG005|Overall Study|Lost to Follow-up|4|||
37925653|NCT00847145|69612512|FG006|Overall Study|Lost to Follow-up|8|||
37925654|NCT00847145|69612513|FG007|Overall Study|Lost to Follow-up|2|||
37925655|NCT00847145|69612506|FG000|Overall Study|Inappropriate enrollment|0|||
37925656|NCT00847145|69612507|FG001|Overall Study|Inappropriate enrollment|0|||
37925657|NCT00847145|69612508|FG002|Overall Study|Inappropriate enrollment|0|||
37925658|NCT00847145|69612509|FG003|Overall Study|Inappropriate enrollment|0|||
37925659|NCT00847145|69612510|FG004|Overall Study|Inappropriate enrollment|1|||
37925660|NCT00847145|69612511|FG005|Overall Study|Inappropriate enrollment|0|||
37925661|NCT00847145|69612512|FG006|Overall Study|Inappropriate enrollment|0|||
37925662|NCT00847145|69612513|FG007|Overall Study|Inappropriate enrollment|0|||
37925663|NCT00847145|69612506|FG000|Overall Study|Protocol Violation|0|||
37925664|NCT00847145|69612507|FG001|Overall Study|Protocol Violation|0|||
37925665|NCT00847145|69612508|FG002|Overall Study|Protocol Violation|3|||
37925666|NCT00847145|69612509|FG003|Overall Study|Protocol Violation|0|||
37925667|NCT00847145|69612510|FG004|Overall Study|Protocol Violation|1|||
37925668|NCT00847145|69612511|FG005|Overall Study|Protocol Violation|0|||
37925669|NCT00847145|69612512|FG006|Overall Study|Protocol Violation|0|||
37925670|NCT00847145|69612513|FG007|Overall Study|Protocol Violation|1|||
37925671|NCT00846521|69612540|FG000|Overall Study|Withdrawal by Subject|5|||
37925672|NCT00846521|69612540|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
37925673|NCT00846521|69612540|FG000|Overall Study|Protocol Violation|1|||
37925674|NCT00862823|69612544|FG000|First Intervention|Withdrawal by Subject|1|||
37925675|NCT00862823|69612545|FG001|First Intervention|Withdrawal by Subject|1|||
37925676|NCT00790842|69612553|FG000|Dose Level 1|Adverse Event|1|||
37759590|NCT02660580|69269806|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
37759591|NCT02660580|69269802|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
37759592|NCT02660580|69269803|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
37759593|NCT02660580|69269804|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
37759594|NCT02660580|69269805|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
37759595|NCT02660580|69269806|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
37759596|NCT02660580|69269802|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
37759597|NCT02660580|69269803|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
37759598|NCT02660580|69269804|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
37759599|NCT02660580|69269805|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
37759600|NCT02660580|69269806|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
37759601|NCT02660580|69269802|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
37759602|NCT02660580|69269803|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
37759603|NCT02660580|69269804|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
37759604|NCT02660580|69269805|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
37759605|NCT02660580|69269806|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
37925677|NCT00790842|69612554|FG001|Dose Level 1|Adverse Event|0|||
37925678|NCT00790842|69612555|FG002|Dose Level 1|Adverse Event|0|||
37925679|NCT00790842|69612556|FG003|Dose Level 1|Adverse Event|2|||
37925680|NCT00790842|69612557|FG004|Dose Level 1|Adverse Event|0|||
37925681|NCT00790842|69612558|FG005|Dose Level 1|Adverse Event|0|||
37925682|NCT00790842|69612559|FG006|Dose Level 1|Adverse Event|0|||
37925683|NCT00790842|69612560|FG007|Dose Level 1|Adverse Event|1|||
37925684|NCT00790842|69612561|FG008|Dose Level 1|Adverse Event|0|||
37925685|NCT00790842|69612562|FG009|Dose Level 1|Adverse Event|0|||
37925686|NCT00790842|69612563|FG010|Dose Level 1|Adverse Event|0|||
37759606|NCT02660580|69269802|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
37925687|NCT00790842|69612553|FG000|Dose Level 1|Physician Decision|1|||
37925688|NCT00790842|69612554|FG001|Dose Level 1|Physician Decision|0|||
37759607|NCT02660580|69269803|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
37759608|NCT02660580|69269804|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
37759609|NCT02660580|69269805|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
37759610|NCT02660580|69269806|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
37759611|NCT02660580|69269802|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
37759612|NCT02660580|69269803|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
37759613|NCT02660580|69269804|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
37759614|NCT02660580|69269805|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
37759615|NCT02660580|69269806|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
37759616|NCT02660580|69269802|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
37759617|NCT02660580|69269803|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
37759618|NCT02660580|69269804|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
37759619|NCT02660580|69269805|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
37759620|NCT02660580|69269806|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
37759621|NCT02660580|69269802|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
37759622|NCT02660580|69269803|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
37759623|NCT02660580|69269804|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
37759624|NCT02660580|69269805|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
37759625|NCT02660580|69269806|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
37759626|NCT02660580|69269802|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
37759627|NCT02660580|69269803|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
37759628|NCT02660580|69269804|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
37759629|NCT02660580|69269805|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
37759630|NCT02660580|69269806|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
37759631|NCT02660580|69269802|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
37759632|NCT02660580|69269803|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
37759633|NCT02660580|69269804|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
37759634|NCT02660580|69269805|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
37759635|NCT02660580|69269806|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
37759636|NCT02660580|69269802|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
37759637|NCT02660580|69269803|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
37759638|NCT02660580|69269804|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
37759639|NCT02660580|69269805|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
37759640|NCT02660580|69269806|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
37759641|NCT02660580|69269802|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
37759642|NCT02660580|69269803|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
37759643|NCT02660580|69269804|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
37759644|NCT02660580|69269805|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
37759645|NCT02660580|69269806|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
37759646|NCT01524991|69269825|FG000|Overall Study|Adverse Event|12|||
37759647|NCT01524991|69269825|FG000|Overall Study|Death|1|||
37759648|NCT01524991|69269825|FG000|Overall Study|Disease ProgressionDu|17|||
37759649|NCT01524991|69269825|FG000|Overall Study|Other complicating disease|1|||
37759650|NCT01524991|69269825|FG000|Overall Study|Withdrawal by Subject|2|||
37759651|NCT01524991|69269825|FG000|Overall Study|Symptomatic Deterioration|1|||
37759652|NCT01524913|69269832|FG000|Overall Study|Lost to Follow-up|4|||
37759653|NCT01524913|69269833|FG001|Overall Study|Lost to Follow-up|0|||
37759654|NCT01524913|69269834|FG002|Overall Study|Lost to Follow-up|0|||
37759655|NCT01524679|69269844|FG000|Overall Study|Lost to Follow-up|1|||
37759656|NCT01524679|69269845|FG001|Overall Study|Lost to Follow-up|4|||
37759657|NCT01524679|69269844|FG000|Overall Study|Withdrawal by Subject|4|||
37759658|NCT01524679|69269845|FG001|Overall Study|Withdrawal by Subject|4|||
37759659|NCT01524679|69269844|FG000|Overall Study|Adverse Event|9|||
37759660|NCT01524679|69269845|FG001|Overall Study|Adverse Event|0|||
37759661|NCT01524679|69269844|FG000|Overall Study|Protocol Violation|1|||
37759662|NCT01524679|69269845|FG001|Overall Study|Protocol Violation|0|||
37759663|NCT01524679|69269844|FG000|Overall Study|Lack of Efficacy|2|||
37759664|NCT01524679|69269845|FG001|Overall Study|Lack of Efficacy|0|||
37759665|NCT01524679|69269844|FG000|Overall Study|e.g.wish for children, relocation|6|||
37759666|NCT01524679|69269845|FG001|Overall Study|e.g.wish for children, relocation|1|||
37759667|NCT01524289|69269862|FG000|Overall Study|Lost to Follow-up|0|||
37759668|NCT01524289|69269863|FG001|Overall Study|Lost to Follow-up|1|||
37759669|NCT01524289|69269862|FG000|Overall Study|Physician Decision|1|||
37759670|NCT01524289|69269863|FG001|Overall Study|Physician Decision|0|||
37759671|NCT01524289|69269862|FG000|Overall Study|Protocol Violation|5|||
37759672|NCT01524289|69269863|FG001|Overall Study|Protocol Violation|1|||
37759673|NCT01524289|69269862|FG000|Overall Study|Withdrawal by Subject|11|||
37759674|NCT01524289|69269863|FG001|Overall Study|Withdrawal by Subject|7|||
37759675|NCT01524289|69269862|FG000|Overall Study|Adverse Event|12|||
37759676|NCT01524289|69269863|FG001|Overall Study|Adverse Event|5|||
37759677|NCT01524289|69269862|FG000|Overall Study|Did not take study medication|1|||
37759678|NCT01524289|69269863|FG001|Overall Study|Did not take study medication|0|||
37759679|NCT01498289|69269873|FG000|Overall Study|Adverse Event|16|||
37759680|NCT01498289|69269874|FG001|Overall Study|Adverse Event|18|||
37759681|NCT01498289|69269873|FG000|Overall Study|Death|6|||
37759682|NCT01498289|69269874|FG001|Overall Study|Death|8|||
37759683|NCT01498289|69269873|FG000|Overall Study|Withdrawal unrelated to AE|16|||
37925689|NCT00790842|69612555|FG002|Dose Level 1|Physician Decision|0|||
37925690|NCT00790842|69612556|FG003|Dose Level 1|Physician Decision|0|||
37925691|NCT00790842|69612557|FG004|Dose Level 1|Physician Decision|0|||
37925692|NCT00790842|69612558|FG005|Dose Level 1|Physician Decision|0|||
37925693|NCT00790842|69612559|FG006|Dose Level 1|Physician Decision|0|||
37925694|NCT00790842|69612560|FG007|Dose Level 1|Physician Decision|1|||
37925695|NCT00790842|69612561|FG008|Dose Level 1|Physician Decision|0|||
37925696|NCT00790842|69612562|FG009|Dose Level 1|Physician Decision|0|||
37759684|NCT01498289|69269874|FG001|Overall Study|Withdrawal unrelated to AE|16|||
37759685|NCT01498289|69269873|FG000|Overall Study|Progression/relapse|53|||
37759686|NCT01498289|69269874|FG001|Overall Study|Progression/relapse|59|||
37925697|NCT00790842|69612563|FG010|Dose Level 1|Physician Decision|0|||
37925698|NCT00790842|69612553|FG000|Dose Level 1|Withdrawal by Subject|1|||
37925699|NCT00790842|69612554|FG001|Dose Level 1|Withdrawal by Subject|0|||
38033502|NCT03325556|69719496|FG000|Open-label Period|Lost to Follow-up|1|||
37759687|NCT01498289|69269873|FG000|Overall Study|Not protocol specified|7|||
37759688|NCT01498289|69269874|FG001|Overall Study|Not protocol specified|2|||
37759689|NCT01498289|69269873|FG000|Overall Study|Reason under review|0|||
37759690|NCT01498289|69269874|FG001|Overall Study|Reason under review|1|||
37925700|NCT00790842|69612555|FG002|Dose Level 1|Withdrawal by Subject|0|||
37925701|NCT00790842|69612556|FG003|Dose Level 1|Withdrawal by Subject|0|||
37925702|NCT00790842|69612557|FG004|Dose Level 1|Withdrawal by Subject|0|||
37925703|NCT00790842|69612558|FG005|Dose Level 1|Withdrawal by Subject|0|||
37925704|NCT00790842|69612559|FG006|Dose Level 1|Withdrawal by Subject|0|||
37925705|NCT00790842|69612560|FG007|Dose Level 1|Withdrawal by Subject|0|||
37925706|NCT00790842|69612561|FG008|Dose Level 1|Withdrawal by Subject|0|||
37925707|NCT00790842|69612562|FG009|Dose Level 1|Withdrawal by Subject|0|||
37925708|NCT00790842|69612563|FG010|Dose Level 1|Withdrawal by Subject|0|||
37925709|NCT00790842|69612553|FG000|Dose Level 2|Death|0|||
37925710|NCT00790842|69612554|FG001|Dose Level 2|Death|1|||
37925711|NCT00790842|69612555|FG002|Dose Level 2|Death|0|||
37925712|NCT00790842|69612556|FG003|Dose Level 2|Death|0|||
37925713|NCT00790842|69612557|FG004|Dose Level 2|Death|1|||
37925714|NCT00790842|69612558|FG005|Dose Level 2|Death|0|||
37925715|NCT00790842|69612559|FG006|Dose Level 2|Death|0|||
37925716|NCT00790842|69612560|FG007|Dose Level 2|Death|0|||
37925717|NCT00790842|69612561|FG008|Dose Level 2|Death|0|||
37925718|NCT00790842|69612562|FG009|Dose Level 2|Death|0|||
37925719|NCT00790842|69612563|FG010|Dose Level 2|Death|0|||
37925720|NCT00790842|69612553|FG000|Dose Level 2|Physician Decision|0|||
37925721|NCT00790842|69612554|FG001|Dose Level 2|Physician Decision|1|||
37925722|NCT00790842|69612555|FG002|Dose Level 2|Physician Decision|0|||
37925723|NCT00790842|69612556|FG003|Dose Level 2|Physician Decision|0|||
37925724|NCT00790842|69612557|FG004|Dose Level 2|Physician Decision|0|||
37925725|NCT00790842|69612558|FG005|Dose Level 2|Physician Decision|0|||
37925726|NCT00790842|69612559|FG006|Dose Level 2|Physician Decision|0|||
37925727|NCT00790842|69612560|FG007|Dose Level 2|Physician Decision|0|||
37925728|NCT00790842|69612561|FG008|Dose Level 2|Physician Decision|0|||
37925729|NCT00790842|69612562|FG009|Dose Level 2|Physician Decision|0|||
38033503|NCT03325556|69719497|FG001|Open-label Period|Lost to Follow-up|0|||
37759691|NCT01524133|69269887|FG000|Treatment Phase|Withdrawal by Subject|13|||
37759692|NCT01524133|69269888|FG001|Treatment Phase|Withdrawal by Subject|28|||
37759693|NCT01524133|69269889|FG002|Treatment Phase|Withdrawal by Subject|31|||
37759694|NCT01524133|69269887|FG000|Treatment Phase|Physician Decision|6|||
37759695|NCT01524133|69269888|FG001|Treatment Phase|Physician Decision|3|||
37759696|NCT01524133|69269889|FG002|Treatment Phase|Physician Decision|3|||
37925730|NCT00790842|69612563|FG010|Dose Level 2|Physician Decision|0|||
38033504|NCT03325556|69719498|FG002|Open-label Period|Lost to Follow-up|0|||
37759697|NCT01524133|69269887|FG000|Treatment Phase|Lost to Follow-up|0|||
37759698|NCT01524133|69269888|FG001|Treatment Phase|Lost to Follow-up|1|||
37759699|NCT01524133|69269889|FG002|Treatment Phase|Lost to Follow-up|2|||
37925731|NCT00790842|69612553|FG000|Dose Level 2|Withdrawal by Subject|0|||
37925732|NCT00790842|69612554|FG001|Dose Level 2|Withdrawal by Subject|1|||
37925733|NCT00790842|69612555|FG002|Dose Level 2|Withdrawal by Subject|0|||
37925734|NCT00790842|69612556|FG003|Dose Level 2|Withdrawal by Subject|0|||
37925735|NCT00790842|69612557|FG004|Dose Level 2|Withdrawal by Subject|0|||
37925736|NCT00790842|69612558|FG005|Dose Level 2|Withdrawal by Subject|0|||
37925737|NCT00790842|69612559|FG006|Dose Level 2|Withdrawal by Subject|0|||
38033505|NCT03325556|69719496|FG000|Open-label Period|Non-compliance with study drug|5|||
37925738|NCT00790842|69612560|FG007|Dose Level 2|Withdrawal by Subject|0|||
37925739|NCT00790842|69612561|FG008|Dose Level 2|Withdrawal by Subject|0|||
37925740|NCT00790842|69612562|FG009|Dose Level 2|Withdrawal by Subject|0|||
37925741|NCT00790842|69612563|FG010|Dose Level 2|Withdrawal by Subject|0|||
37925742|NCT00790842|69612553|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
37925743|NCT00790842|69612554|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
37925744|NCT00790842|69612555|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
37925745|NCT00790842|69612556|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
37925746|NCT00790842|69612557|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
37925747|NCT00790842|69612558|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
37925748|NCT00790842|69612559|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
37925749|NCT00790842|69612560|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
37925750|NCT00790842|69612561|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
37925751|NCT00790842|69612562|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
37925752|NCT00790842|69612563|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
37925753|NCT00790842|69612553|FG000|Dose Level 3|Adverse Event|0|||
37925754|NCT00790842|69612554|FG001|Dose Level 3|Adverse Event|0|||
37925755|NCT00790842|69612555|FG002|Dose Level 3|Adverse Event|1|||
37925756|NCT00790842|69612556|FG003|Dose Level 3|Adverse Event|0|||
37925757|NCT00790842|69612557|FG004|Dose Level 3|Adverse Event|0|||
37925758|NCT00790842|69612558|FG005|Dose Level 3|Adverse Event|0|||
37925759|NCT00790842|69612559|FG006|Dose Level 3|Adverse Event|0|||
37925760|NCT00790842|69612560|FG007|Dose Level 3|Adverse Event|0|||
37925761|NCT00790842|69612561|FG008|Dose Level 3|Adverse Event|0|||
37925762|NCT00790842|69612562|FG009|Dose Level 3|Adverse Event|0|||
37925763|NCT00790842|69612563|FG010|Dose Level 3|Adverse Event|0|||
37925764|NCT00790842|69612553|FG000|Dose Level 3|Withdrawal by Subject|0|||
37759700|NCT01524133|69269887|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
37759701|NCT01524133|69269888|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
37759702|NCT01524133|69269889|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
37759703|NCT01524133|69269887|FG000|Overall Study 52 Weeks|Physician Decision|1|||
37759704|NCT01524133|69269888|FG001|Overall Study 52 Weeks|Physician Decision|0|||
37759705|NCT01524133|69269889|FG002|Overall Study 52 Weeks|Physician Decision|2|||
37925765|NCT00790842|69612554|FG001|Dose Level 3|Withdrawal by Subject|0|||
37925766|NCT00790842|69612555|FG002|Dose Level 3|Withdrawal by Subject|3|||
37925767|NCT00790842|69612556|FG003|Dose Level 3|Withdrawal by Subject|0|||
37925768|NCT00790842|69612557|FG004|Dose Level 3|Withdrawal by Subject|0|||
37925769|NCT00790842|69612558|FG005|Dose Level 3|Withdrawal by Subject|0|||
37925770|NCT00790842|69612559|FG006|Dose Level 3|Withdrawal by Subject|0|||
37925771|NCT00790842|69612560|FG007|Dose Level 3|Withdrawal by Subject|0|||
37759706|NCT01524133|69269887|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
37759707|NCT01524133|69269888|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
37759708|NCT01524133|69269889|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
37759709|NCT04304534|69269923|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
37759710|NCT04304534|69269924|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
37759711|NCT04304534|69269925|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
37759712|NCT04304534|69269926|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
37759713|NCT04304534|69269923|FG000|Overall Study|Non-Compliance with study drug|0|||
37759714|NCT04304534|69269924|FG001|Overall Study|Non-Compliance with study drug|1|||
37759715|NCT04304534|69269925|FG002|Overall Study|Non-Compliance with study drug|1|||
37759716|NCT04304534|69269926|FG003|Overall Study|Non-Compliance with study drug|1|||
37759717|NCT04304534|69269923|FG000|Overall Study|Lost to Follow-up|0|||
37759718|NCT04304534|69269924|FG001|Overall Study|Lost to Follow-up|1|||
37759719|NCT04304534|69269925|FG002|Overall Study|Lost to Follow-up|2|||
37759720|NCT04304534|69269926|FG003|Overall Study|Lost to Follow-up|3|||
37759721|NCT04304534|69269923|FG000|Overall Study|Unspecific|4|||
37759722|NCT04304534|69269924|FG001|Overall Study|Unspecific|2|||
37759723|NCT04304534|69269925|FG002|Overall Study|Unspecific|2|||
37759724|NCT04304534|69269926|FG003|Overall Study|Unspecific|2|||
37925772|NCT00790842|69612561|FG008|Dose Level 3|Withdrawal by Subject|0|||
37925773|NCT00790842|69612562|FG009|Dose Level 3|Withdrawal by Subject|2|||
37925774|NCT00790842|69612563|FG010|Dose Level 3|Withdrawal by Subject|0|||
37925775|NCT00790842|69612553|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
37925776|NCT00790842|69612554|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
37925777|NCT00790842|69612555|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
37759725|NCT04304534|69269923|FG000|Overall Study|Technical Problems|2|||
37759726|NCT04304534|69269924|FG001|Overall Study|Technical Problems|2|||
37759727|NCT04304534|69269925|FG002|Overall Study|Technical Problems|3|||
37925778|NCT00790842|69612556|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
37925779|NCT00790842|69612557|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
37925780|NCT00790842|69612558|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
37925781|NCT00790842|69612559|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
38033506|NCT03325556|69719497|FG001|Open-label Period|Non-compliance with study drug|0|||
37759728|NCT04304534|69269926|FG003|Overall Study|Technical Problems|4|||
37925782|NCT00790842|69612560|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
37925783|NCT00790842|69612561|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
37759729|NCT04304534|69269923|FG000|Overall Study|Death|7|||
37759730|NCT04304534|69269924|FG001|Overall Study|Death|2|||
37759731|NCT04304534|69269925|FG002|Overall Study|Death|4|||
37925784|NCT00790842|69612562|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
37925785|NCT00790842|69612563|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
37925786|NCT00790842|69612553|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
37925787|NCT00790842|69612554|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
37925788|NCT00790842|69612555|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
37925789|NCT00790842|69612556|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
37925790|NCT00790842|69612557|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
37925791|NCT00790842|69612558|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
37925792|NCT00790842|69612559|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
37925793|NCT00790842|69612560|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
37925794|NCT00790842|69612561|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
37925795|NCT00790842|69612562|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
37925796|NCT00790842|69612563|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
37925797|NCT00790842|69612553|FG000|Dose Level 4|Adverse Event|0|||
37925798|NCT00790842|69612554|FG001|Dose Level 4|Adverse Event|0|||
37925799|NCT00790842|69612555|FG002|Dose Level 4|Adverse Event|0|||
37925800|NCT00790842|69612556|FG003|Dose Level 4|Adverse Event|0|||
37925801|NCT00790842|69612557|FG004|Dose Level 4|Adverse Event|0|||
37925802|NCT00790842|69612558|FG005|Dose Level 4|Adverse Event|0|||
37925803|NCT00790842|69612559|FG006|Dose Level 4|Adverse Event|1|||
37925804|NCT00790842|69612560|FG007|Dose Level 4|Adverse Event|0|||
37925805|NCT00790842|69612561|FG008|Dose Level 4|Adverse Event|0|||
37925806|NCT00790842|69612562|FG009|Dose Level 4|Adverse Event|0|||
37925807|NCT00790842|69612563|FG010|Dose Level 4|Adverse Event|0|||
37925808|NCT00790842|69612553|FG000|Dose Level 4|Physician Decision|0|||
37925809|NCT00790842|69612554|FG001|Dose Level 4|Physician Decision|0|||
37925810|NCT00790842|69612555|FG002|Dose Level 4|Physician Decision|0|||
37925811|NCT00790842|69612556|FG003|Dose Level 4|Physician Decision|0|||
37925812|NCT00790842|69612557|FG004|Dose Level 4|Physician Decision|0|||
37925813|NCT00790842|69612558|FG005|Dose Level 4|Physician Decision|0|||
37925814|NCT00790842|69612559|FG006|Dose Level 4|Physician Decision|1|||
37925815|NCT00790842|69612560|FG007|Dose Level 4|Physician Decision|0|||
37925816|NCT00790842|69612561|FG008|Dose Level 4|Physician Decision|0|||
37925817|NCT00790842|69612562|FG009|Dose Level 4|Physician Decision|0|||
37925818|NCT00790842|69612563|FG010|Dose Level 4|Physician Decision|1|||
37925819|NCT00790842|69612553|FG000|Dose Level 4|Withdrawal by Subject|0|||
37925820|NCT00790842|69612554|FG001|Dose Level 4|Withdrawal by Subject|0|||
37925821|NCT00790842|69612555|FG002|Dose Level 4|Withdrawal by Subject|0|||
37925822|NCT00790842|69612556|FG003|Dose Level 4|Withdrawal by Subject|0|||
37925823|NCT00790842|69612557|FG004|Dose Level 4|Withdrawal by Subject|0|||
37925824|NCT00790842|69612558|FG005|Dose Level 4|Withdrawal by Subject|0|||
37925825|NCT00790842|69612559|FG006|Dose Level 4|Withdrawal by Subject|0|||
37925826|NCT00790842|69612560|FG007|Dose Level 4|Withdrawal by Subject|0|||
37925827|NCT00790842|69612561|FG008|Dose Level 4|Withdrawal by Subject|0|||
37925828|NCT00790842|69612562|FG009|Dose Level 4|Withdrawal by Subject|0|||
37925829|NCT00790842|69612563|FG010|Dose Level 4|Withdrawal by Subject|1|||
37925830|NCT00790842|69612553|FG000|Expansion Cohort|Adverse Event|0|||
38033507|NCT03325556|69719498|FG002|Open-label Period|Non-compliance with study drug|0|||
37666892|NCT01903733|69139338|FG000|Overall Study|Missing|2|||
37666893|NCT01903733|69139339|FG001|Overall Study|Missing|0|||
37666894|NCT01903733|69139340|FG002|Overall Study|Missing|0|||
37666895|NCT01903733|69139341|FG003|Overall Study|Missing|0|||
37666896|NCT01903733|69139338|FG000|Overall Study|Investigator request|18|||
37666897|NCT01903733|69139339|FG001|Overall Study|Investigator request|0|||
37666898|NCT01903733|69139340|FG002|Overall Study|Investigator request|0|||
37666899|NCT01903733|69139341|FG003|Overall Study|Investigator request|0|||
37666900|NCT01375205|69139363|FG000|Overall Study|Lost to Follow-up|15|||
37666901|NCT01375205|69139364|FG001|Overall Study|Lost to Follow-up|12|||
37759732|NCT04304534|69269926|FG003|Overall Study|Death|3|||
37759733|NCT04304534|69269923|FG000|Overall Study|Withdrawal by Subject|7|||
37925831|NCT00790842|69612554|FG001|Expansion Cohort|Adverse Event|0|||
37925832|NCT00790842|69612555|FG002|Expansion Cohort|Adverse Event|0|||
37925833|NCT00790842|69612556|FG003|Expansion Cohort|Adverse Event|0|||
37925834|NCT00790842|69612557|FG004|Expansion Cohort|Adverse Event|0|||
37925835|NCT00790842|69612558|FG005|Expansion Cohort|Adverse Event|0|||
37925836|NCT00790842|69612559|FG006|Expansion Cohort|Adverse Event|1|||
37925837|NCT00790842|69612560|FG007|Expansion Cohort|Adverse Event|0|||
37925838|NCT00790842|69612561|FG008|Expansion Cohort|Adverse Event|0|||
37925839|NCT00790842|69612562|FG009|Expansion Cohort|Adverse Event|0|||
37925840|NCT00790842|69612563|FG010|Expansion Cohort|Adverse Event|0|||
37925841|NCT00790842|69612553|FG000|Expansion Cohort|Death|0|||
37925842|NCT00790842|69612554|FG001|Expansion Cohort|Death|0|||
38033508|NCT03325556|69719496|FG000|Open-label Period|Use of prohibited medication|1|||
37666902|NCT01375205|69139363|FG000|Overall Study|Withdrawal by Subject|6|||
37759734|NCT04304534|69269924|FG001|Overall Study|Withdrawal by Subject|2|||
37925843|NCT00790842|69612555|FG002|Expansion Cohort|Death|2|||
37925844|NCT00790842|69612556|FG003|Expansion Cohort|Death|0|||
37925845|NCT00790842|69612557|FG004|Expansion Cohort|Death|0|||
37925846|NCT00790842|69612558|FG005|Expansion Cohort|Death|0|||
37925847|NCT00790842|69612559|FG006|Expansion Cohort|Death|0|||
37925848|NCT00790842|69612560|FG007|Expansion Cohort|Death|0|||
37925849|NCT00790842|69612561|FG008|Expansion Cohort|Death|0|||
37925850|NCT00790842|69612562|FG009|Expansion Cohort|Death|0|||
37925851|NCT00790842|69612563|FG010|Expansion Cohort|Death|0|||
37925852|NCT00790842|69612553|FG000|Expansion Cohort|Physician Decision|0|||
37925853|NCT00790842|69612554|FG001|Expansion Cohort|Physician Decision|0|||
37925854|NCT00790842|69612555|FG002|Expansion Cohort|Physician Decision|1|||
37925855|NCT00790842|69612556|FG003|Expansion Cohort|Physician Decision|0|||
37925856|NCT00790842|69612557|FG004|Expansion Cohort|Physician Decision|0|||
37925857|NCT00790842|69612558|FG005|Expansion Cohort|Physician Decision|0|||
37925858|NCT00790842|69612559|FG006|Expansion Cohort|Physician Decision|0|||
37925859|NCT00790842|69612560|FG007|Expansion Cohort|Physician Decision|0|||
37925860|NCT00790842|69612561|FG008|Expansion Cohort|Physician Decision|0|||
37925861|NCT00790842|69612562|FG009|Expansion Cohort|Physician Decision|0|||
37925862|NCT00790842|69612563|FG010|Expansion Cohort|Physician Decision|0|||
37925863|NCT00790842|69612553|FG000|Expansion Cohort|Withdrawal by Subject|0|||
37925864|NCT00790842|69612554|FG001|Expansion Cohort|Withdrawal by Subject|0|||
37925865|NCT00790842|69612555|FG002|Expansion Cohort|Withdrawal by Subject|3|||
37925866|NCT00790842|69612556|FG003|Expansion Cohort|Withdrawal by Subject|0|||
37925867|NCT00790842|69612557|FG004|Expansion Cohort|Withdrawal by Subject|0|||
37925868|NCT00790842|69612558|FG005|Expansion Cohort|Withdrawal by Subject|0|||
37925869|NCT00790842|69612559|FG006|Expansion Cohort|Withdrawal by Subject|0|||
37925870|NCT00790842|69612560|FG007|Expansion Cohort|Withdrawal by Subject|0|||
37925871|NCT00790842|69612561|FG008|Expansion Cohort|Withdrawal by Subject|0|||
37925872|NCT00790842|69612562|FG009|Expansion Cohort|Withdrawal by Subject|0|||
37925873|NCT00790842|69612563|FG010|Expansion Cohort|Withdrawal by Subject|0|||
37925874|NCT00790842|69612553|FG000|Expansion Cohort|Study Closure|0|||
37925875|NCT00790842|69612554|FG001|Expansion Cohort|Study Closure|0|||
37925876|NCT00790842|69612555|FG002|Expansion Cohort|Study Closure|1|||
37925877|NCT00790842|69612556|FG003|Expansion Cohort|Study Closure|0|||
37925878|NCT00790842|69612557|FG004|Expansion Cohort|Study Closure|0|||
37925879|NCT00790842|69612558|FG005|Expansion Cohort|Study Closure|0|||
37925880|NCT00790842|69612559|FG006|Expansion Cohort|Study Closure|0|||
37925881|NCT00790842|69612560|FG007|Expansion Cohort|Study Closure|0|||
37925882|NCT00790842|69612561|FG008|Expansion Cohort|Study Closure|0|||
37925883|NCT00790842|69612562|FG009|Expansion Cohort|Study Closure|0|||
37925884|NCT00790842|69612563|FG010|Expansion Cohort|Study Closure|0|||
37925885|NCT00574288|69612618|FG000|Overall Study|Adverse Event|2|||
37925886|NCT00574288|69612619|FG001|Overall Study|Adverse Event|0|||
37925887|NCT00574288|69612620|FG002|Overall Study|Adverse Event|0|||
37925888|NCT00574288|69612621|FG003|Overall Study|Adverse Event|0|||
37925889|NCT00574288|69612622|FG004|Overall Study|Adverse Event|1|||
37925890|NCT00574288|69612623|FG005|Overall Study|Adverse Event|0|||
37925891|NCT00574288|69612624|FG006|Overall Study|Adverse Event|0|||
37925892|NCT00574288|69612618|FG000|Overall Study|Death|0|||
37925893|NCT00574288|69612619|FG001|Overall Study|Death|0|||
37925894|NCT00574288|69612620|FG002|Overall Study|Death|0|||
37925895|NCT00574288|69612621|FG003|Overall Study|Death|0|||
37925896|NCT00574288|69612622|FG004|Overall Study|Death|0|||
37925897|NCT00574288|69612623|FG005|Overall Study|Death|25|||
37925898|NCT00574288|69612624|FG006|Overall Study|Death|21|||
37925899|NCT00574288|69612618|FG000|Overall Study|Lost to Follow-up|0|||
37925900|NCT00574288|69612619|FG001|Overall Study|Lost to Follow-up|0|||
37925901|NCT00574288|69612620|FG002|Overall Study|Lost to Follow-up|0|||
37925902|NCT00574288|69612621|FG003|Overall Study|Lost to Follow-up|0|||
37925903|NCT00574288|69612622|FG004|Overall Study|Lost to Follow-up|0|||
37925904|NCT00574288|69612623|FG005|Overall Study|Lost to Follow-up|1|||
37925905|NCT00574288|69612624|FG006|Overall Study|Lost to Follow-up|2|||
37925906|NCT00574288|69612618|FG000|Overall Study|Study Terminated By Sponsor|0|||
37925907|NCT00574288|69612619|FG001|Overall Study|Study Terminated By Sponsor|0|||
37925908|NCT00574288|69612620|FG002|Overall Study|Study Terminated By Sponsor|0|||
37925909|NCT00574288|69612621|FG003|Overall Study|Study Terminated By Sponsor|0|||
37925910|NCT00574288|69612622|FG004|Overall Study|Study Terminated By Sponsor|0|||
37925911|NCT00574288|69612623|FG005|Overall Study|Study Terminated By Sponsor|0|||
37925912|NCT00574288|69612624|FG006|Overall Study|Study Terminated By Sponsor|5|||
37925913|NCT00574288|69612618|FG000|Overall Study|Progressive Disease|17|||
37925914|NCT00574288|69612619|FG001|Overall Study|Progressive Disease|2|||
37925915|NCT00574288|69612620|FG002|Overall Study|Progressive Disease|3|||
37925916|NCT00574288|69612621|FG003|Overall Study|Progressive Disease|2|||
37925917|NCT00574288|69612622|FG004|Overall Study|Progressive Disease|1|||
37925918|NCT00574288|69612623|FG005|Overall Study|Progressive Disease|0|||
37925919|NCT00574288|69612624|FG006|Overall Study|Progressive Disease|0|||
37925920|NCT00574288|69612618|FG000|Overall Study|Other|1|||
37925921|NCT00574288|69612619|FG001|Overall Study|Other|1|||
37925922|NCT00574288|69612620|FG002|Overall Study|Other|0|||
37925923|NCT00574288|69612621|FG003|Overall Study|Other|0|||
37925924|NCT00574288|69612622|FG004|Overall Study|Other|0|||
37925925|NCT00574288|69612623|FG005|Overall Study|Other|0|||
37925926|NCT00574288|69612624|FG006|Overall Study|Other|0|||
37925927|NCT00790452|69612652|FG000|Overall Study|Drug supply issue|1|||
37925928|NCT00790452|69612653|FG001|Overall Study|Drug supply issue|0|||
37925929|NCT00626392|69612665|FG000|Run-in Period|Adverse Event|0|||
37925930|NCT00626392|69612666|FG001|Run-in Period|Adverse Event|0|||
37759735|NCT04304534|69269925|FG002|Overall Study|Withdrawal by Subject|7|||
37759736|NCT04304534|69269926|FG003|Overall Study|Withdrawal by Subject|4|||
37759737|NCT04304534|69269923|FG000|Overall Study|Physician Decision|4|||
37759738|NCT04304534|69269924|FG001|Overall Study|Physician Decision|9|||
37759739|NCT04304534|69269925|FG002|Overall Study|Physician Decision|9|||
37759740|NCT04304534|69269926|FG003|Overall Study|Physician Decision|5|||
37759741|NCT04304534|69269923|FG000|Overall Study|Subject Decision|34|||
37759742|NCT04304534|69269924|FG001|Overall Study|Subject Decision|25|||
37759743|NCT04304534|69269925|FG002|Overall Study|Subject Decision|25|||
37759744|NCT04304534|69269926|FG003|Overall Study|Subject Decision|26|||
37759745|NCT04304534|69269923|FG000|Overall Study|Adverse Event|35|||
37759746|NCT04304534|69269924|FG001|Overall Study|Adverse Event|40|||
37759747|NCT04304534|69269925|FG002|Overall Study|Adverse Event|39|||
37759748|NCT04304534|69269926|FG003|Overall Study|Adverse Event|44|||
37759749|NCT04223609|69269939|FG000|Overall Study|Adverse Event|0|||
37759750|NCT04223609|69269940|FG001|Overall Study|Adverse Event|1|||
37925931|NCT00626392|69612667|FG002|Run-in Period|Adverse Event|1|||
37925932|NCT00626392|69612668|FG003|Run-in Period|Adverse Event|0|||
37925933|NCT00626392|69612669|FG004|Run-in Period|Adverse Event|1|||
37925934|NCT00626392|69612670|FG005|Run-in Period|Adverse Event|0|||
37925935|NCT00626392|69612665|FG000|Run-in Period|Withdrawal by Subject|0|||
37925936|NCT00626392|69612666|FG001|Run-in Period|Withdrawal by Subject|1|||
37925937|NCT00626392|69612667|FG002|Run-in Period|Withdrawal by Subject|1|||
37925938|NCT00626392|69612668|FG003|Run-in Period|Withdrawal by Subject|1|||
37925939|NCT00626392|69612669|FG004|Run-in Period|Withdrawal by Subject|3|||
37925940|NCT00626392|69612670|FG005|Run-in Period|Withdrawal by Subject|1|||
37925941|NCT00626392|69612665|FG000|Run-in Period|Noncompliance|1|||
37925942|NCT00626392|69612666|FG001|Run-in Period|Noncompliance|0|||
37925943|NCT00626392|69612667|FG002|Run-in Period|Noncompliance|1|||
37925944|NCT00626392|69612668|FG003|Run-in Period|Noncompliance|0|||
37925945|NCT00626392|69612669|FG004|Run-in Period|Noncompliance|0|||
37925946|NCT00626392|69612670|FG005|Run-in Period|Noncompliance|0|||
37925947|NCT00626392|69612665|FG000|Coadministration Period|Adverse Event|3|||
37925948|NCT00626392|69612666|FG001|Coadministration Period|Adverse Event|1|||
37925949|NCT00626392|69612667|FG002|Coadministration Period|Adverse Event|7|||
37925950|NCT00626392|69612668|FG003|Coadministration Period|Adverse Event|4|||
37925951|NCT00626392|69612669|FG004|Coadministration Period|Adverse Event|3|||
37666903|NCT01375205|69139364|FG001|Overall Study|Withdrawal by Subject|1|||
37666904|NCT00700271|69139372|FG000|Overall Study|Adverse Event|4|||
37666905|NCT00700271|69139373|FG001|Overall Study|Adverse Event|6|||
37666906|NCT00700271|69139372|FG000|Overall Study|Protocol Violation|1|||
37666907|NCT00700271|69139373|FG001|Overall Study|Protocol Violation|0|||
37666908|NCT00700271|69139372|FG000|Overall Study|Administrative Reasons|1|||
37666909|NCT00700271|69139373|FG001|Overall Study|Administrative Reasons|0|||
37666910|NCT00700271|69139372|FG000|Overall Study|Withdrawal by Subject|6|||
37666911|NCT00700271|69139373|FG001|Overall Study|Withdrawal by Subject|4|||
37666912|NCT00700271|69139372|FG000|Overall Study|Lost to Follow-up|2|||
37666913|NCT00700271|69139373|FG001|Overall Study|Lost to Follow-up|2|||
37666914|NCT01375049|69139379|FG000|Overall Study|Adverse Event|2|||
37666915|NCT01375049|69139379|FG000|Overall Study|Lost to Follow-up|1|||
37666916|NCT01375049|69139379|FG000|Overall Study|Withdrawal by Subject|2|||
37666917|NCT01375049|69139379|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
37666918|NCT01594749|69139389|FG000|Overall Study|Adverse Event|2|||
37666919|NCT01594749|69139390|FG001|Overall Study|Adverse Event|1|||
37666920|NCT01594749|69139389|FG000|Overall Study|Withdrawal by Subject|2|||
37759751|NCT04223609|69269939|FG000|Overall Study|Missed last visit|0|||
37759752|NCT04223609|69269940|FG001|Overall Study|Missed last visit|1|||
37759753|NCT04176458|69269946|FG000|Overall Study|Covid 19|4|||
37759754|NCT03941548|69269952|FG000|Overall Study|Adverse Event|0|||
37759755|NCT03941548|69269953|FG001|Overall Study|Adverse Event|1|||
37925952|NCT00626392|69612670|FG005|Coadministration Period|Adverse Event|4|||
37666921|NCT01594749|69139390|FG001|Overall Study|Withdrawal by Subject|2|||
37666922|NCT01594749|69139389|FG000|Overall Study|Protocol Violation|2|||
37666923|NCT01594749|69139390|FG001|Overall Study|Protocol Violation|0|||
37925953|NCT00626392|69612665|FG000|Coadministration Period|Withdrawal by Subject|1|||
37925954|NCT00626392|69612666|FG001|Coadministration Period|Withdrawal by Subject|1|||
37925955|NCT00626392|69612667|FG002|Coadministration Period|Withdrawal by Subject|0|||
37759756|NCT03941548|69269952|FG000|Overall Study|Lost to Follow-up|0|||
37925956|NCT00626392|69612668|FG003|Coadministration Period|Withdrawal by Subject|1|||
37925957|NCT00626392|69612669|FG004|Coadministration Period|Withdrawal by Subject|0|||
37925958|NCT00626392|69612670|FG005|Coadministration Period|Withdrawal by Subject|1|||
37925959|NCT00626392|69612665|FG000|Coadministration Period|Protocol Violation|0|||
37925960|NCT00626392|69612666|FG001|Coadministration Period|Protocol Violation|1|||
37925961|NCT00626392|69612667|FG002|Coadministration Period|Protocol Violation|0|||
37925962|NCT00626392|69612668|FG003|Coadministration Period|Protocol Violation|1|||
37925963|NCT00626392|69612669|FG004|Coadministration Period|Protocol Violation|1|||
37925964|NCT00626392|69612670|FG005|Coadministration Period|Protocol Violation|0|||
37925965|NCT00626392|69612665|FG000|Coadministration Period|Other|0|||
37925966|NCT00626392|69612666|FG001|Coadministration Period|Other|2|||
37925967|NCT00626392|69612667|FG002|Coadministration Period|Other|3|||
37925968|NCT00626392|69612668|FG003|Coadministration Period|Other|1|||
37925969|NCT00626392|69612669|FG004|Coadministration Period|Other|1|||
37925970|NCT00626392|69612670|FG005|Coadministration Period|Other|1|||
37925971|NCT00624286|69612678|FG000|Overall Study|Protocol Deviation|7|||
37925972|NCT00624286|69612679|FG001|Overall Study|Protocol Deviation|9|||
37925973|NCT00624286|69612678|FG000|Overall Study|Adverse Event|6|||
37925974|NCT00624286|69612679|FG001|Overall Study|Adverse Event|3|||
37925975|NCT00624286|69612678|FG000|Overall Study|Withdrawal by Subject|5|||
37925976|NCT00624286|69612679|FG001|Overall Study|Withdrawal by Subject|4|||
37925977|NCT00624286|69612678|FG000|Overall Study|Lost to Follow-up|3|||
37925978|NCT00624286|69612679|FG001|Overall Study|Lost to Follow-up|2|||
37925979|NCT00624286|69612678|FG000|Overall Study|Administrative problems|3|||
37925980|NCT00624286|69612679|FG001|Overall Study|Administrative problems|0|||
37925981|NCT00624286|69612678|FG000|Overall Study|Lack of Efficacy|1|||
37925982|NCT00624286|69612679|FG001|Overall Study|Lack of Efficacy|6|||
37925983|NCT00624286|69612678|FG000|Overall Study|Not stated|0|||
37925984|NCT00624286|69612679|FG001|Overall Study|Not stated|1|||
37925985|NCT00624286|69612678|FG000|Overall Study|Abnormal test procedure result(s)|0|||
37925986|NCT00624286|69612679|FG001|Overall Study|Abnormal test procedure result(s)|1|||
37925987|NCT00624286|69612678|FG000|Overall Study|Death|0|||
37925988|NCT00624286|69612679|FG001|Overall Study|Death|1|||
37925989|NCT00624052|69612689|FG000|Overall Study|Adverse Event|7|||
37925990|NCT00624052|69612690|FG001|Overall Study|Adverse Event|6|||
37925991|NCT00624052|69612691|FG002|Overall Study|Adverse Event|0|||
37925992|NCT00624052|69612692|FG003|Overall Study|Adverse Event|3|||
37925993|NCT00624052|69612689|FG000|Overall Study|Lack of Efficacy|1|||
37925994|NCT00624052|69612690|FG001|Overall Study|Lack of Efficacy|1|||
37925995|NCT00624052|69612691|FG002|Overall Study|Lack of Efficacy|0|||
37925996|NCT00624052|69612692|FG003|Overall Study|Lack of Efficacy|0|||
37925997|NCT00624052|69612689|FG000|Overall Study|Lost to Follow-up|2|||
37925998|NCT00624052|69612690|FG001|Overall Study|Lost to Follow-up|3|||
37925999|NCT00624052|69612691|FG002|Overall Study|Lost to Follow-up|1|||
37926000|NCT00624052|69612692|FG003|Overall Study|Lost to Follow-up|0|||
37926001|NCT00624052|69612689|FG000|Overall Study|Non compliant with the protocol|2|||
37926002|NCT00624052|69612690|FG001|Overall Study|Non compliant with the protocol|1|||
37926003|NCT00624052|69612691|FG002|Overall Study|Non compliant with the protocol|1|||
37926004|NCT00624052|69612692|FG003|Overall Study|Non compliant with the protocol|1|||
37926005|NCT00624052|69612689|FG000|Overall Study|Consent withdrawn|3|||
37926006|NCT00624052|69612690|FG001|Overall Study|Consent withdrawn|1|||
37926007|NCT00624052|69612691|FG002|Overall Study|Consent withdrawn|1|||
37926008|NCT00624052|69612692|FG003|Overall Study|Consent withdrawn|0|||
37926009|NCT00624052|69612689|FG000|Overall Study|Changed job/ran out if meds|0|||
37926010|NCT00624052|69612690|FG001|Overall Study|Changed job/ran out if meds|2|||
37926011|NCT00624052|69612691|FG002|Overall Study|Changed job/ran out if meds|0|||
37926012|NCT00624052|69612692|FG003|Overall Study|Changed job/ran out if meds|0|||
37926013|NCT00785577|69612711|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
37926014|NCT00785577|69612712|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
37926015|NCT00785577|69612713|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
37926016|NCT00785577|69612714|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
37926017|NCT00785577|69612715|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
37926018|NCT00785577|69612711|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
37666924|NCT01594749|69139389|FG000|Overall Study|Physician Decision|1|||
37666925|NCT01594749|69139390|FG001|Overall Study|Physician Decision|1|||
37666926|NCT01594749|69139389|FG000|Overall Study|Non-compliance with Protocol|0|||
37666927|NCT01594749|69139390|FG001|Overall Study|Non-compliance with Protocol|1|||
37666928|NCT01594749|69139389|FG000|Overall Study|Lost to Follow-up|1|||
37666929|NCT01594749|69139390|FG001|Overall Study|Lost to Follow-up|0|||
37926019|NCT00785577|69612712|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
37926020|NCT00785577|69612713|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
37926021|NCT00785577|69612714|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
37926022|NCT00785577|69612715|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
37666930|NCT01594749|69139389|FG000|Overall Study|Death|9|||
37926023|NCT00785577|69612711|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
37926024|NCT00785577|69612712|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
37926025|NCT00785577|69612713|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
37926026|NCT00785577|69612714|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
37926027|NCT00785577|69612715|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
37926028|NCT00785577|69612711|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
37926029|NCT00785577|69612712|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
37926030|NCT00785577|69612713|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
37926031|NCT00785577|69612714|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
37926032|NCT00785577|69612715|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
37926033|NCT00785577|69612711|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
37926034|NCT00785577|69612712|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
37926035|NCT00785577|69612713|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
37926036|NCT00785577|69612714|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
37926037|NCT00785577|69612715|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
37926038|NCT00785577|69612711|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
37926039|NCT00785577|69612712|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
37926040|NCT00785577|69612713|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
37926041|NCT00785577|69612714|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
37926042|NCT00785577|69612715|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
37926043|NCT00785577|69612711|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
37926044|NCT00785577|69612712|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
37926045|NCT00785577|69612713|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
37926046|NCT00785577|69612714|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
37926047|NCT00785577|69612715|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
37926048|NCT00785577|69612711|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
37926049|NCT00785577|69612712|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
37926050|NCT00785577|69612713|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
37926051|NCT00785577|69612714|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
37926052|NCT00785577|69612715|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
37926053|NCT00785577|69612711|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
37926054|NCT00785577|69612712|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
37926055|NCT00785577|69612713|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
37926056|NCT00785577|69612714|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
37926057|NCT00785577|69612715|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
37926058|NCT00785577|69612711|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
37926059|NCT00785577|69612712|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
37926060|NCT00785577|69612713|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
37926061|NCT00785577|69612714|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
37926062|NCT00785577|69612715|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
37926063|NCT00789828|69612739|FG000|Core Period (48 Weeks)|Administrative problems|0|||
37926064|NCT00789828|69612740|FG001|Core Period (48 Weeks)|Administrative problems|1|||
37926065|NCT00789828|69612739|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
37926066|NCT00789828|69612740|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
37926067|NCT00789828|69612739|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
37926068|NCT00789828|69612740|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
37926069|NCT00789828|69612739|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
37926070|NCT00789828|69612740|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
37926071|NCT00789828|69612739|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
37666931|NCT01594749|69139390|FG001|Overall Study|Death|3|||
37666932|NCT01594749|69139389|FG000|Overall Study|Not Treated|4|||
37666933|NCT01594749|69139390|FG001|Overall Study|Not Treated|10|||
37666934|NCT01594749|69139389|FG000|Overall Study|Lost Source Documentation|1|||
37666935|NCT01594749|69139390|FG001|Overall Study|Lost Source Documentation|0|||
37666936|NCT02179918|69139401|FG000|Overall Study|Death|0|||
37666937|NCT02179918|69139402|FG001|Overall Study|Death|0|||
37666938|NCT02179918|69139403|FG002|Overall Study|Death|0|||
37666939|NCT02179918|69139404|FG003|Overall Study|Death|1|||
37666940|NCT02179918|69139405|FG004|Overall Study|Death|0|||
37666941|NCT02179918|69139401|FG000|Overall Study|Lost to Follow-up|0|||
37759757|NCT03941548|69269953|FG001|Overall Study|Lost to Follow-up|1|||
37759758|NCT03941548|69269952|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
37759759|NCT03941548|69269953|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
37759760|NCT03925727|69269962|FG000|Overall Study|Adverse Event|4|||
37759761|NCT03925727|69269963|FG001|Overall Study|Adverse Event|0|||
37759762|NCT03925727|69269964|FG002|Overall Study|Adverse Event|3|||
37759763|NCT03925727|69269962|FG000|Overall Study|Protocol Violation|1|||
37759764|NCT03925727|69269963|FG001|Overall Study|Protocol Violation|2|||
37926072|NCT00789828|69612740|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
37926073|NCT00789828|69612739|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
37926074|NCT00789828|69612740|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
37926075|NCT00789828|69612739|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
37926076|NCT00789828|69612740|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
37666942|NCT02179918|69139402|FG001|Overall Study|Lost to Follow-up|0|||
37666943|NCT02179918|69139403|FG002|Overall Study|Lost to Follow-up|1|||
37759765|NCT03925727|69269964|FG002|Overall Study|Protocol Violation|2|||
37926077|NCT00789828|69612739|FG000|Open-label Extension Period (4 Years)|Death|1|||
37926078|NCT00789828|69612740|FG001|Open-label Extension Period (4 Years)|Death|0|||
37926079|NCT00789828|69612739|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
37926080|NCT00789828|69612740|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
37926081|NCT00789828|69612739|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
37926082|NCT00789828|69612740|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
37926083|NCT00790296|69612751|FG000|Overall Study|Did not meet study eligibility criteria|1|||
37926084|NCT00790296|69612752|FG001|Overall Study|Did not meet study eligibility criteria|1|||
37926085|NCT00790296|69612751|FG000|Overall Study|Adverse Event|0|||
37926086|NCT00790296|69612752|FG001|Overall Study|Adverse Event|1|||
37926087|NCT00623194|69612758|FG000|Overall Study|Lack of Efficacy|1|||
37926088|NCT00623194|69612758|FG000|Overall Study|Protocol Violation|3|||
37926089|NCT00623194|69612758|FG000|Overall Study|Unclassified|1|||
37926090|NCT00784368|69612765|FG000|Overall Study|Physician Decision|0|||
37926091|NCT00784368|69612766|FG001|Overall Study|Physician Decision|0|||
37926092|NCT00784368|69612767|FG002|Overall Study|Physician Decision|6|||
37926093|NCT00784368|69612765|FG000|Overall Study|Lack of Efficacy|2|||
37926094|NCT00784368|69612766|FG001|Overall Study|Lack of Efficacy|0|||
37926095|NCT00784368|69612767|FG002|Overall Study|Lack of Efficacy|1|||
37926096|NCT00784368|69612765|FG000|Overall Study|Adverse Event|6|||
37926097|NCT00784368|69612766|FG001|Overall Study|Adverse Event|9|||
37926098|NCT00784368|69612767|FG002|Overall Study|Adverse Event|2|||
37926099|NCT00784368|69612765|FG000|Overall Study|Diagnosis of fever|0|||
37926100|NCT00784368|69612766|FG001|Overall Study|Diagnosis of fever|0|||
37666944|NCT02179918|69139404|FG003|Overall Study|Lost to Follow-up|0|||
37666945|NCT02179918|69139405|FG004|Overall Study|Lost to Follow-up|0|||
37666946|NCT02179918|69139401|FG000|Overall Study|Progressive Disease|4|||
37666947|NCT02179918|69139402|FG001|Overall Study|Progressive Disease|1|||
37666948|NCT02179918|69139403|FG002|Overall Study|Progressive Disease|1|||
37666949|NCT02179918|69139404|FG003|Overall Study|Progressive Disease|2|||
37666950|NCT02179918|69139405|FG004|Overall Study|Progressive Disease|6|||
37666951|NCT02179918|69139401|FG000|Overall Study|Other|0|||
37666952|NCT02179918|69139402|FG001|Overall Study|Other|1|||
37666953|NCT02179918|69139403|FG002|Overall Study|Other|0|||
37666954|NCT02179918|69139404|FG003|Overall Study|Other|0|||
37666955|NCT02179918|69139405|FG004|Overall Study|Other|1|||
37759766|NCT03925727|69269962|FG000|Overall Study|Withdrawal by Subject|3|||
37759767|NCT03925727|69269963|FG001|Overall Study|Withdrawal by Subject|2|||
37759768|NCT03925727|69269964|FG002|Overall Study|Withdrawal by Subject|4|||
37759769|NCT03925727|69269962|FG000|Overall Study|Administrative Reasons|3|||
37759770|NCT03925727|69269963|FG001|Overall Study|Administrative Reasons|1|||
37759771|NCT03925727|69269964|FG002|Overall Study|Administrative Reasons|2|||
37759772|NCT03925727|69269962|FG000|Overall Study|Randomized in error or Disqualified|8|||
37759773|NCT03925727|69269963|FG001|Overall Study|Randomized in error or Disqualified|1|||
37759774|NCT03925727|69269964|FG002|Overall Study|Randomized in error or Disqualified|7|||
37666956|NCT02179918|69139401|FG000|Overall Study|Subject refused further follow-up|0|||
37666957|NCT02179918|69139402|FG001|Overall Study|Subject refused further follow-up|1|||
37666958|NCT02179918|69139403|FG002|Overall Study|Subject refused further follow-up|0|||
37666959|NCT02179918|69139404|FG003|Overall Study|Subject refused further follow-up|0|||
37666960|NCT02179918|69139405|FG004|Overall Study|Subject refused further follow-up|1|||
37666961|NCT02611479|69139418|FG000|Baseline Enrollment|Exited study|13|||
37666962|NCT02611479|69139418|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
37666963|NCT02611479|69139418|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
37666964|NCT02611479|69139418|FG000|Data Cleaning|No baseline function or pain metrics|2|||
37666965|NCT02153788|69139424|FG000|Overall Study|Physician Decision|2|||
37666966|NCT02153788|69139425|FG001|Overall Study|Physician Decision|1|||
37666967|NCT02153398|69139436|FG000|Overall Study|Withdrawal by Subject|1|||
37666968|NCT02153398|69139437|FG001|Overall Study|Withdrawal by Subject|0|||
37666969|NCT02153398|69139438|FG002|Overall Study|Withdrawal by Subject|0|||
37666970|NCT02153398|69139439|FG003|Overall Study|Withdrawal by Subject|0|||
37759775|NCT03387150|69269981|FG000|Overall Study|Withdrawal by Subject|3|||
37759776|NCT03387150|69269982|FG001|Overall Study|Withdrawal by Subject|0|||
37759777|NCT03387150|69269983|FG002|Overall Study|Withdrawal by Subject|3|||
37759778|NCT03387150|69269984|FG003|Overall Study|Withdrawal by Subject|4|||
37759779|NCT03387150|69269985|FG004|Overall Study|Withdrawal by Subject|1|||
37759780|NCT03387150|69269986|FG005|Overall Study|Withdrawal by Subject|2|||
37759781|NCT03387150|69269987|FG006|Overall Study|Withdrawal by Subject|0|||
37926101|NCT00784368|69612767|FG002|Overall Study|Diagnosis of fever|1|||
37926102|NCT00784368|69612765|FG000|Overall Study|Worsening of complications|0|||
37926103|NCT00784368|69612766|FG001|Overall Study|Worsening of complications|0|||
37926104|NCT00784368|69612767|FG002|Overall Study|Worsening of complications|1|||
37926105|NCT00784368|69612765|FG000|Overall Study|Worsening of symptoms|0|||
37926106|NCT00784368|69612766|FG001|Overall Study|Worsening of symptoms|1|||
37759782|NCT03387150|69269981|FG000|Overall Study|Lost to Follow-up|3|||
37759783|NCT03387150|69269982|FG001|Overall Study|Lost to Follow-up|2|||
37926107|NCT00784368|69612767|FG002|Overall Study|Worsening of symptoms|0|||
37926108|NCT00784368|69612765|FG000|Overall Study|Withdrawal of informed consent|0|||
37926109|NCT00784368|69612766|FG001|Overall Study|Withdrawal of informed consent|1|||
37926110|NCT00784368|69612767|FG002|Overall Study|Withdrawal of informed consent|0|||
37926111|NCT00622726|69612780|FG000|March, 2008 to August, 2010|Death|5|||
37926112|NCT00622726|69612781|FG001|March, 2008 to August, 2010|Death|2|||
37926113|NCT00622726|69612780|FG000|August, 2010 to April, 2013|Death|1|||
37926114|NCT00622726|69612781|FG001|August, 2010 to April, 2013|Death|5|||
37926115|NCT00623428|69612793|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
37926116|NCT00623428|69612794|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
37926117|NCT00623428|69612793|FG000|Treatment Period|Death|0|||
37926118|NCT00623428|69612794|FG001|Treatment Period|Death|1|||
37926119|NCT00623428|69612793|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
37926120|NCT00623428|69612794|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
37926121|NCT00623428|69612793|FG000|Treatment Period|Insufficient therapeutic response|0|||
37926122|NCT00623428|69612794|FG001|Treatment Period|Insufficient therapeutic response|2|||
37926123|NCT00623428|69612793|FG000|Treatment Period|Other|0|||
37926124|NCT00623428|69612794|FG001|Treatment Period|Other|1|||
37926125|NCT00623428|69612793|FG000|Treatment Period|Withdrawal by Subject|0|||
37926126|NCT00623428|69612794|FG001|Treatment Period|Withdrawal by Subject|1|||
37926127|NCT00623428|69612793|FG000|Follow-up Period|Relapse post-treatment|11|||
37926128|NCT00623428|69612794|FG001|Follow-up Period|Relapse post-treatment|3|||
37926129|NCT00623428|69612793|FG000|Follow-up Period|Failure to return|10|||
37926130|NCT00623428|69612794|FG001|Follow-up Period|Failure to return|2|||
37926131|NCT00623428|69612793|FG000|Follow-up Period|Patient withdrew consent|5|||
37926132|NCT00623428|69612794|FG001|Follow-up Period|Patient withdrew consent|4|||
37926133|NCT00623428|69612793|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
37926134|NCT00623428|69612794|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
37926135|NCT00623428|69612793|FG000|Follow-up Period|Did not cooperate|0|||
37926136|NCT00623428|69612794|FG001|Follow-up Period|Did not cooperate|3|||
37926137|NCT00623428|69612793|FG000|Follow-up Period|Reason not specified|1|||
37926138|NCT00623428|69612794|FG001|Follow-up Period|Reason not specified|1|||
37926139|NCT00623428|69612793|FG000|Follow-up Period|Death|0|||
37926140|NCT00623428|69612794|FG001|Follow-up Period|Death|1|||
37926141|NCT00784134|69612802|FG000|Overall Study|Lost to Follow-up|3|||
37926142|NCT00784134|69612803|FG001|Overall Study|Lost to Follow-up|6|||
37926143|NCT00776100|69612811|FG000|Overall Study|Disease Progression|1|||
37926144|NCT00776100|69612812|FG001|Overall Study|Disease Progression|0|||
37926145|NCT00783432|69612820|FG000|Overall Study|Adverse Event|22|||
37926146|NCT00783432|69612821|FG001|Overall Study|Adverse Event|17|||
37926147|NCT00783432|69612820|FG000|Overall Study|Lack of Efficacy|20|||
37926148|NCT00783432|69612821|FG001|Overall Study|Lack of Efficacy|21|||
37926149|NCT00783432|69612820|FG000|Overall Study|Lost to Follow-up|11|||
37926150|NCT00783432|69612821|FG001|Overall Study|Lost to Follow-up|6|||
37926151|NCT00783432|69612820|FG000|Overall Study|Withdrawal by Subject|23|||
37926152|NCT00783432|69612821|FG001|Overall Study|Withdrawal by Subject|20|||
37926153|NCT00783432|69612820|FG000|Overall Study|subject moved|3|||
37666971|NCT02153398|69139440|FG004|Overall Study|Withdrawal by Subject|0|||
37666972|NCT02153398|69139436|FG000|Overall Study|Adverse Event|0|||
37926154|NCT00783432|69612821|FG001|Overall Study|subject moved|5|||
37666973|NCT02153398|69139437|FG001|Overall Study|Adverse Event|0|||
37666974|NCT02153398|69139438|FG002|Overall Study|Adverse Event|1|||
37666975|NCT02153398|69139439|FG003|Overall Study|Adverse Event|1|||
37666976|NCT02153398|69139440|FG004|Overall Study|Adverse Event|0|||
37666977|NCT02118766|69139454|FG000|Overall Study|Adverse Event|7|||
37926155|NCT00783432|69612820|FG000|Overall Study|Protocol Violation|6|||
37926156|NCT00783432|69612821|FG001|Overall Study|Protocol Violation|9|||
37926157|NCT00783198|69612830|FG000|Overall Study|Adverse Event|15|||
37666978|NCT02118766|69139455|FG001|Overall Study|Adverse Event|2|||
37666979|NCT02118766|69139454|FG000|Overall Study|Withdrawal by Subject|3|||
37926158|NCT00783198|69612831|FG001|Overall Study|Adverse Event|19|||
37926159|NCT00783198|69612832|FG002|Overall Study|Adverse Event|3|||
37926160|NCT00783198|69612830|FG000|Overall Study|Lost to Follow-up|11|||
37926161|NCT00783198|69612831|FG001|Overall Study|Lost to Follow-up|1|||
37666980|NCT02118766|69139455|FG001|Overall Study|Withdrawal by Subject|6|||
37666981|NCT02118766|69139454|FG000|Overall Study|Lost to Follow-up|5|||
37926162|NCT00783198|69612832|FG002|Overall Study|Lost to Follow-up|7|||
37926163|NCT00783198|69612830|FG000|Overall Study|Withdrawal by Subject|22|||
37926164|NCT00783198|69612831|FG001|Overall Study|Withdrawal by Subject|14|||
37926165|NCT00783198|69612832|FG002|Overall Study|Withdrawal by Subject|20|||
37926166|NCT00783198|69612830|FG000|Overall Study|Noncompliance with protocol|7|||
37666982|NCT02118766|69139455|FG001|Overall Study|Lost to Follow-up|4|||
37666983|NCT02118766|69139454|FG000|Overall Study|Withdrawal by parent/guardian|12|||
37926167|NCT00783198|69612831|FG001|Overall Study|Noncompliance with protocol|7|||
37926168|NCT00783198|69612832|FG002|Overall Study|Noncompliance with protocol|10|||
37926169|NCT00783198|69612830|FG000|Overall Study|Did not meet protocol eligibility|0|||
37926170|NCT00783198|69612831|FG001|Overall Study|Did not meet protocol eligibility|1|||
37926171|NCT00783198|69612832|FG002|Overall Study|Did not meet protocol eligibility|0|||
37926172|NCT00783198|69612830|FG000|Overall Study|Administrative|2|||
37926173|NCT00783198|69612831|FG001|Overall Study|Administrative|1|||
37926174|NCT00783198|69612832|FG002|Overall Study|Administrative|2|||
37926175|NCT00789360|69612842|FG000|Overall Study|Protocol Violation|3|||
37926176|NCT00789360|69612843|FG001|Overall Study|Protocol Violation|1|||
37926177|NCT00782496|69612852|FG000|Overall Study|Lost to Follow-up|14|||
37926178|NCT00782496|69612853|FG001|Overall Study|Lost to Follow-up|15|||
37926179|NCT00782418|69612860|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
37926180|NCT00782418|69612861|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
37926181|NCT00782418|69612862|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
37926182|NCT00782418|69612863|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
37926183|NCT00782418|69612864|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
37926184|NCT00782418|69612865|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
37926185|NCT00782418|69612866|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
37926186|NCT00782418|69612860|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
37926187|NCT00782418|69612861|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
37926188|NCT00782418|69612862|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
37926189|NCT00782418|69612863|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
37926190|NCT00782418|69612864|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
37926191|NCT00782418|69612865|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
37926192|NCT00782418|69612866|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
37926193|NCT00782340|69612883|FG000|Open Label Titration|Adverse Event|12|||
37926194|NCT00782340|69612884|FG001|Open Label Titration|Adverse Event|0|||
37926195|NCT00782340|69612885|FG002|Open Label Titration|Adverse Event|0|||
37926196|NCT00782340|69612883|FG000|Open Label Titration|Treatment failure|50|||
37926197|NCT00782340|69612884|FG001|Open Label Titration|Treatment failure|0|||
37926198|NCT00782340|69612885|FG002|Open Label Titration|Treatment failure|0|||
37926199|NCT00782340|69612883|FG000|Open Label Titration|Protocol Violation|5|||
37926200|NCT00782340|69612884|FG001|Open Label Titration|Protocol Violation|0|||
37926201|NCT00782340|69612885|FG002|Open Label Titration|Protocol Violation|0|||
37926202|NCT00782340|69612883|FG000|Open Label Titration|Withdrawal by Subject|5|||
37926203|NCT00782340|69612884|FG001|Open Label Titration|Withdrawal by Subject|0|||
37926204|NCT00782340|69612885|FG002|Open Label Titration|Withdrawal by Subject|0|||
37926205|NCT00782340|69612883|FG000|Open Label Titration|Enrollment capped|16|||
37926206|NCT00782340|69612884|FG001|Open Label Titration|Enrollment capped|0|||
37926207|NCT00782340|69612885|FG002|Open Label Titration|Enrollment capped|0|||
37926208|NCT00782340|69612883|FG000|Open Label Titration|Did not meet responder criteria|2|||
37926209|NCT00782340|69612884|FG001|Open Label Titration|Did not meet responder criteria|0|||
37926210|NCT00782340|69612885|FG002|Open Label Titration|Did not meet responder criteria|0|||
37926211|NCT00782340|69612883|FG000|Open Label Titration|Lost to Follow-up|5|||
37926212|NCT00782340|69612884|FG001|Open Label Titration|Lost to Follow-up|0|||
37926213|NCT00782340|69612885|FG002|Open Label Titration|Lost to Follow-up|0|||
37926214|NCT00782340|69612883|FG000|Open Label Titration|Randomized in error|6|||
37926215|NCT00782340|69612884|FG001|Open Label Titration|Randomized in error|0|||
37926216|NCT00782340|69612885|FG002|Open Label Titration|Randomized in error|0|||
37926217|NCT00774852|69612894|FG000|Overall Study|Adverse Event|9|||
37926218|NCT00774852|69612895|FG001|Overall Study|Adverse Event|6|||
37926219|NCT00774852|69612894|FG000|Overall Study|Death|2|||
37926220|NCT00774852|69612895|FG001|Overall Study|Death|1|||
37926221|NCT00774852|69612894|FG000|Overall Study|Lack of Efficacy|3|||
37926222|NCT00774852|69612895|FG001|Overall Study|Lack of Efficacy|7|||
37926223|NCT00774852|69612894|FG000|Overall Study|Lost to Follow-up|9|||
37926224|NCT00774852|69612895|FG001|Overall Study|Lost to Follow-up|5|||
37926225|NCT00774852|69612894|FG000|Overall Study|Physician Decision|2|||
37926226|NCT00774852|69612895|FG001|Overall Study|Physician Decision|6|||
37926227|NCT00774852|69612894|FG000|Overall Study|Pregnancy|1|||
37926228|NCT00774852|69612895|FG001|Overall Study|Pregnancy|2|||
37926229|NCT00774852|69612894|FG000|Overall Study|Withdrawal by Subject|2|||
37926230|NCT00774852|69612895|FG001|Overall Study|Withdrawal by Subject|2|||
37926231|NCT00774852|69612894|FG000|Overall Study|Non-responder|15|||
37926232|NCT00774852|69612895|FG001|Overall Study|Non-responder|11|||
37926233|NCT00774852|69612894|FG000|Overall Study|Subject non-compliance|0|||
37926234|NCT00774852|69612895|FG001|Overall Study|Subject non-compliance|1|||
37926235|NCT00774852|69612894|FG000|Overall Study|Protocol Violation|1|||
37926236|NCT00774852|69612895|FG001|Overall Study|Protocol Violation|0|||
37926237|NCT00774852|69612894|FG000|Overall Study|Subject received prohibited medication|1|||
37926238|NCT00774852|69612895|FG001|Overall Study|Subject received prohibited medication|0|||
37926239|NCT00774306|69612915|FG000|Overall Study|Adverse Event|3|||
37926240|NCT00774306|69612916|FG001|Overall Study|Adverse Event|0|||
37759784|NCT03387150|69269983|FG002|Overall Study|Lost to Follow-up|2|||
37926241|NCT00774306|69612917|FG002|Overall Study|Adverse Event|0|||
37926242|NCT00774306|69612918|FG003|Overall Study|Adverse Event|0|||
37926243|NCT00774306|69612915|FG000|Overall Study|Protocol Violation|2|||
37926244|NCT00774306|69612916|FG001|Overall Study|Protocol Violation|0|||
37926245|NCT00774306|69612917|FG002|Overall Study|Protocol Violation|3|||
37926246|NCT00774306|69612918|FG003|Overall Study|Protocol Violation|0|||
37926247|NCT00774306|69612915|FG000|Overall Study|Withdrawal by Subject|6|||
37926248|NCT00774306|69612916|FG001|Overall Study|Withdrawal by Subject|1|||
37926249|NCT00774306|69612917|FG002|Overall Study|Withdrawal by Subject|1|||
37926250|NCT00774306|69612918|FG003|Overall Study|Withdrawal by Subject|0|||
37926251|NCT00774306|69612915|FG000|Overall Study|Lost to Follow-up|6|||
37926252|NCT00774306|69612916|FG001|Overall Study|Lost to Follow-up|0|||
37926253|NCT00774306|69612917|FG002|Overall Study|Lost to Follow-up|4|||
37926254|NCT00774306|69612918|FG003|Overall Study|Lost to Follow-up|5|||
37926255|NCT00774306|69612915|FG000|Overall Study|Death|1|||
37926256|NCT00774306|69612916|FG001|Overall Study|Death|1|||
37926257|NCT00774306|69612917|FG002|Overall Study|Death|0|||
37926258|NCT00774306|69612918|FG003|Overall Study|Death|0|||
37926259|NCT00781326|69612928|FG000|Phase I|Adverse Event|1|||
37666984|NCT02118766|69139455|FG001|Overall Study|Withdrawal by parent/guardian|18|||
37926260|NCT00781326|69612928|FG000|Phase I|Withdrawal by Subject|1|||
37926261|NCT00781326|69612928|FG000|Phase I|Physician Decision|2|||
37926262|NCT00787800|69612934|FG000|Overall Study|Withdrawal by Subject|3|||
37926263|NCT00787800|69612935|FG001|Overall Study|Withdrawal by Subject|5|||
37926264|NCT00787800|69612934|FG000|Overall Study|Death|0|||
37926265|NCT00787800|69612935|FG001|Overall Study|Death|2|||
37926266|NCT00773838|69612942|FG000|Overall Study|Adverse Event|29|||
37926267|NCT00773838|69612942|FG000|Overall Study|Lost to Follow-up|1|||
37926268|NCT00773838|69612942|FG000|Overall Study|Physician Decision|8|||
37926269|NCT00773838|69612942|FG000|Overall Study|Progressive Disease|82|||
37926270|NCT00773838|69612942|FG000|Overall Study|Protocol Violation|2|||
37926271|NCT00773838|69612942|FG000|Overall Study|Withdrawal by Subject|21|||
37926272|NCT00787644|69612948|FG000|Overall Study|Lost to Follow-up|1|||
37926273|NCT00787644|69612949|FG001|Overall Study|Lost to Follow-up|1|||
37926274|NCT00787644|69612948|FG000|Overall Study|Withdrawal by Subject|1|||
37926275|NCT00787644|69612949|FG001|Overall Study|Withdrawal by Subject|1|||
37926276|NCT00787566|69612958|FG000|Overall Study|AE related to chemotherapy|0|||
37926277|NCT00787566|69612959|FG001|Overall Study|AE related to chemotherapy|1|||
37926278|NCT00787566|69612960|FG002|Overall Study|AE related to chemotherapy|0|||
37926279|NCT00787254|69612970|FG000|Overall Study|Adverse Event|24|||
37926280|NCT00787254|69612971|FG001|Overall Study|Adverse Event|23|||
37926281|NCT00787254|69612970|FG000|Overall Study|Protocol Violation|26|||
37926282|NCT00787254|69612971|FG001|Overall Study|Protocol Violation|23|||
37926283|NCT00787254|69612970|FG000|Overall Study|Withdrawal by Subject|16|||
37926284|NCT00787254|69612971|FG001|Overall Study|Withdrawal by Subject|11|||
37926285|NCT00787254|69612970|FG000|Overall Study|Lack of Efficacy|4|||
37926286|NCT00787254|69612971|FG001|Overall Study|Lack of Efficacy|15|||
37926287|NCT00787254|69612970|FG000|Overall Study|NSAIDs discontinuation|1|||
37926288|NCT00787254|69612971|FG001|Overall Study|NSAIDs discontinuation|2|||
37926289|NCT00787254|69612970|FG000|Overall Study|Institution closed|1|||
37926290|NCT00787254|69612971|FG001|Overall Study|Institution closed|0|||
37926291|NCT00787254|69612970|FG000|Overall Study|Physician Decision|4|||
37926292|NCT00787254|69612971|FG001|Overall Study|Physician Decision|8|||
37666985|NCT02118766|69139454|FG000|Overall Study|Other|3|||
37666986|NCT02118766|69139455|FG001|Overall Study|Other|1|||
37666987|NCT02614287|69139463|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
37926293|NCT00625846|69612981|FG000|Overall Study|Withdrawal by Subject|2|||
37926294|NCT00625846|69612982|FG001|Overall Study|Withdrawal by Subject|0|||
37926295|NCT00625846|69612983|FG002|Overall Study|Withdrawal by Subject|1|||
37666988|NCT02614287|69139464|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
37666989|NCT02614287|69139463|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
37666990|NCT02614287|69139464|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
37666991|NCT02614287|69139463|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
37666992|NCT02614287|69139464|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
37666993|NCT02614287|69139463|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
37666994|NCT02614287|69139464|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
37666995|NCT02614287|69139463|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
37666996|NCT02614287|69139464|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
37666997|NCT02614287|69139463|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
37666998|NCT02614287|69139464|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
37666999|NCT02614287|69139463|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
37667000|NCT02614287|69139464|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
37667001|NCT02614287|69139463|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
37667002|NCT02614287|69139464|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
37926296|NCT00625846|69612984|FG003|Overall Study|Withdrawal by Subject|2|||
37926297|NCT00773292|69612998|FG000|Treatment 48 Weeks|Adverse Event|1|||
37926298|NCT00773292|69612998|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
37926299|NCT00786864|69613004|FG000|Overall Study|Lost to Follow-up|0|||
37926300|NCT00786864|69613005|FG001|Overall Study|Lost to Follow-up|1|||
37926301|NCT00786864|69613004|FG000|Overall Study|Sustained serious back injury|1|||
37926302|NCT00786864|69613005|FG001|Overall Study|Sustained serious back injury|0|||
37926303|NCT00621322|69613017|FG000|Overall Study|Lost to Follow-up|0|||
37926304|NCT00621322|69613018|FG001|Overall Study|Lost to Follow-up|0|||
37926305|NCT00621322|69613019|FG002|Overall Study|Lost to Follow-up|0|||
37926306|NCT00621322|69613020|FG003|Overall Study|Lost to Follow-up|0|||
37759785|NCT03387150|69269984|FG003|Overall Study|Lost to Follow-up|3|||
37926307|NCT00621322|69613021|FG004|Overall Study|Lost to Follow-up|1|||
37926308|NCT00621322|69613022|FG005|Overall Study|Lost to Follow-up|0|||
37759786|NCT03387150|69269985|FG004|Overall Study|Lost to Follow-up|3|||
37759787|NCT03387150|69269986|FG005|Overall Study|Lost to Follow-up|3|||
37759788|NCT03387150|69269987|FG006|Overall Study|Lost to Follow-up|0|||
37759789|NCT03387150|69269981|FG000|Overall Study|Participant unable to adhere to visit|0|||
37759790|NCT03387150|69269982|FG001|Overall Study|Participant unable to adhere to visit|1|||
37759791|NCT03387150|69269983|FG002|Overall Study|Participant unable to adhere to visit|0|||
37759792|NCT03387150|69269984|FG003|Overall Study|Participant unable to adhere to visit|0|||
37759793|NCT03387150|69269985|FG004|Overall Study|Participant unable to adhere to visit|2|||
37926309|NCT00621322|69613017|FG000|Overall Study|Physician Decision|0|||
37926310|NCT00621322|69613018|FG001|Overall Study|Physician Decision|0|||
37759794|NCT03387150|69269986|FG005|Overall Study|Participant unable to adhere to visit|2|||
37759795|NCT03387150|69269987|FG006|Overall Study|Participant unable to adhere to visit|0|||
37759796|NCT03289208|69270019|FG000|Overall Study|Adverse Event|1|||
37759797|NCT03289208|69270020|FG001|Overall Study|Adverse Event|0|||
37759798|NCT03289208|69270021|FG002|Overall Study|Adverse Event|0|||
37759799|NCT03244059|69270031|FG000|Specific Aim 1|Physician Decision|1|||
37759800|NCT03244059|69270032|FG001|Specific Aim 1|Physician Decision|0|||
37926311|NCT00621322|69613019|FG002|Overall Study|Physician Decision|1|||
37926312|NCT00621322|69613020|FG003|Overall Study|Physician Decision|1|||
37926313|NCT00621322|69613021|FG004|Overall Study|Physician Decision|0|||
37926314|NCT00621322|69613022|FG005|Overall Study|Physician Decision|0|||
37926315|NCT00621322|69613017|FG000|Overall Study|Withdrawal by Subject|0|||
37926316|NCT00621322|69613018|FG001|Overall Study|Withdrawal by Subject|0|||
37926317|NCT00621322|69613019|FG002|Overall Study|Withdrawal by Subject|0|||
37926318|NCT00621322|69613020|FG003|Overall Study|Withdrawal by Subject|1|||
37926319|NCT00621322|69613021|FG004|Overall Study|Withdrawal by Subject|0|||
37926320|NCT00621322|69613022|FG005|Overall Study|Withdrawal by Subject|2|||
37926321|NCT00621322|69613017|FG000|Overall Study|Migrated/moved from study area|1|||
37926322|NCT00621322|69613018|FG001|Overall Study|Migrated/moved from study area|0|||
37926323|NCT00621322|69613019|FG002|Overall Study|Migrated/moved from study area|1|||
37926324|NCT00621322|69613020|FG003|Overall Study|Migrated/moved from study area|1|||
37926325|NCT00621322|69613021|FG004|Overall Study|Migrated/moved from study area|0|||
37926326|NCT00621322|69613022|FG005|Overall Study|Migrated/moved from study area|2|||
37926327|NCT00853385|69613041|FG000|Overall Study|Death|0|||
37926328|NCT00853385|69613042|FG001|Overall Study|Death|0|||
37926329|NCT00853385|69613043|FG002|Overall Study|Death|0|||
37926330|NCT00853385|69613044|FG003|Overall Study|Death|0|||
37926331|NCT00853385|69613045|FG004|Overall Study|Death|1|||
37926332|NCT00853385|69613041|FG000|Overall Study|Adverse Event|24|||
37926333|NCT00853385|69613042|FG001|Overall Study|Adverse Event|24|||
37926334|NCT00853385|69613043|FG002|Overall Study|Adverse Event|2|||
37926335|NCT00853385|69613044|FG003|Overall Study|Adverse Event|5|||
37926336|NCT00853385|69613045|FG004|Overall Study|Adverse Event|22|||
37926337|NCT00853385|69613041|FG000|Overall Study|Lack of Efficacy|6|||
37926338|NCT00853385|69613042|FG001|Overall Study|Lack of Efficacy|7|||
37926339|NCT00853385|69613043|FG002|Overall Study|Lack of Efficacy|3|||
37667003|NCT01374971|69139475|FG000|Overall Study|Withdrawal by Subject|1|||
37667004|NCT02178592|69139481|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
37667005|NCT02178592|69139482|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
37667006|NCT02178592|69139481|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
37667007|NCT02178592|69139482|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
37667008|NCT02178592|69139481|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
37667009|NCT02178592|69139482|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
37667010|NCT02178592|69139481|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
37667011|NCT02178592|69139482|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
37667012|NCT02178592|69139481|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
37759801|NCT03244059|69270031|FG000|Specific Aim 2|Physician Decision|1|||
37759802|NCT03244059|69270032|FG001|Specific Aim 2|Physician Decision|0|||
37759803|NCT03036566|69270038|FG000|Overall Study|Lost to Follow-up|3|||
37759804|NCT02754141|69270069|FG000|Overall Study|Disease progression|11|||
37759805|NCT02754141|69270070|FG001|Overall Study|Disease progression|7|||
37926340|NCT00853385|69613044|FG003|Overall Study|Lack of Efficacy|3|||
37926341|NCT00853385|69613045|FG004|Overall Study|Lack of Efficacy|6|||
37926342|NCT00853385|69613041|FG000|Overall Study|Lost to Follow-up|2|||
37926343|NCT00853385|69613042|FG001|Overall Study|Lost to Follow-up|1|||
37926344|NCT00853385|69613043|FG002|Overall Study|Lost to Follow-up|0|||
37926345|NCT00853385|69613044|FG003|Overall Study|Lost to Follow-up|0|||
37926346|NCT00853385|69613045|FG004|Overall Study|Lost to Follow-up|0|||
37926347|NCT00853385|69613041|FG000|Overall Study|Withdrawal by Subject|4|||
37759806|NCT02754141|69270071|FG002|Overall Study|Disease progression|8|||
37926348|NCT00853385|69613042|FG001|Overall Study|Withdrawal by Subject|2|||
37926349|NCT00853385|69613043|FG002|Overall Study|Withdrawal by Subject|0|||
37926350|NCT00853385|69613044|FG003|Overall Study|Withdrawal by Subject|1|||
37926351|NCT00853385|69613045|FG004|Overall Study|Withdrawal by Subject|1|||
37759807|NCT02754141|69270072|FG003|Overall Study|Disease progression|5|||
37759808|NCT02754141|69270073|FG004|Overall Study|Disease progression|7|||
37759809|NCT02754141|69270074|FG005|Overall Study|Disease progression|7|||
37759810|NCT02754141|69270075|FG006|Overall Study|Disease progression|7|||
37759811|NCT02754141|69270076|FG007|Overall Study|Disease progression|6|||
37759812|NCT02754141|69270077|FG008|Overall Study|Disease progression|11|||
37759813|NCT02754141|69270078|FG009|Overall Study|Disease progression|16|||
37759814|NCT02754141|69270079|FG010|Overall Study|Disease progression|18|||
37759815|NCT02754141|69270080|FG011|Overall Study|Disease progression|13|||
37759816|NCT02754141|69270081|FG012|Overall Study|Disease progression|10|||
37759817|NCT02754141|69270082|FG013|Overall Study|Disease progression|12|||
37759818|NCT02754141|69270083|FG014|Overall Study|Disease progression|12|||
37759819|NCT02754141|69270084|FG015|Overall Study|Disease progression|14|||
37759820|NCT02754141|69270085|FG016|Overall Study|Disease progression|0|||
37759821|NCT02754141|69270086|FG017|Overall Study|Disease progression|1|||
37759822|NCT02754141|69270069|FG000|Overall Study|Study drug toxicity|1|||
37759823|NCT02754141|69270070|FG001|Overall Study|Study drug toxicity|1|||
37759824|NCT02754141|69270071|FG002|Overall Study|Study drug toxicity|0|||
37759825|NCT02754141|69270072|FG003|Overall Study|Study drug toxicity|0|||
37926352|NCT00853385|69613041|FG000|Overall Study|Other|18|||
37926353|NCT00853385|69613042|FG001|Overall Study|Other|9|||
37926354|NCT00853385|69613043|FG002|Overall Study|Other|4|||
37926355|NCT00853385|69613044|FG003|Overall Study|Other|4|||
37926356|NCT00853385|69613045|FG004|Overall Study|Other|12|||
37926357|NCT00622336|69613067|FG000|Treatment Phase|Progression of Disease|181|||
37926358|NCT00622336|69613067|FG000|Treatment Phase|Adverse Event|46|||
37926359|NCT00622336|69613067|FG000|Treatment Phase|Other|40|||
37926360|NCT00622336|69613067|FG000|Treatment Phase|Death|14|||
37926361|NCT00622336|69613067|FG000|Treatment Phase|Lack of therapeutic effect|13|||
37926362|NCT00622336|69613067|FG000|Treatment Phase|Withdrawal by Subject|13|||
37926363|NCT00622336|69613067|FG000|Treatment Phase|Lost to Follow-up|2|||
37667013|NCT02178592|69139482|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
37667014|NCT02178592|69139481|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
37667015|NCT02178592|69139482|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
37667016|NCT02178592|69139481|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
37667017|NCT02178592|69139482|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
37667018|NCT02178592|69139481|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
37667019|NCT02178592|69139482|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
37667020|NCT02178592|69139481|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
37667021|NCT02178592|69139482|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
37667022|NCT02178592|69139481|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
37667023|NCT02178592|69139482|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
37667024|NCT02178592|69139481|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
37667025|NCT02178592|69139482|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
37667026|NCT02178592|69139481|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
37667027|NCT02178592|69139482|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
37667028|NCT02610777|69139493|FG000|Overall Study|Lost to Follow-up|1|||
37667029|NCT02610777|69139494|FG001|Overall Study|Lost to Follow-up|0|||
37667030|NCT02610777|69139493|FG000|Overall Study|Site Terminated by Sponsor|9|||
37667031|NCT02610777|69139494|FG001|Overall Study|Site Terminated by Sponsor|8|||
37667032|NCT02610777|69139493|FG000|Overall Study|Withdrawal by Subject|2|||
37667033|NCT02610777|69139494|FG001|Overall Study|Withdrawal by Subject|2|||
37667034|NCT02610777|69139493|FG000|Overall Study|Reason not Specified|0|||
37667035|NCT02610777|69139494|FG001|Overall Study|Reason not Specified|1|||
37667036|NCT02610777|69139493|FG000|Overall Study|Death|50|||
37667037|NCT02610777|69139494|FG001|Overall Study|Death|47|||
37667038|NCT01628692|69139508|FG000|Overall Study|Lack of Efficacy|4|||
37667039|NCT01628692|69139509|FG001|Overall Study|Lack of Efficacy|4|||
37667040|NCT01628692|69139510|FG002|Overall Study|Lack of Efficacy|5|||
37667041|NCT01628692|69139511|FG003|Overall Study|Lack of Efficacy|1|||
37667042|NCT01628692|69139512|FG004|Overall Study|Lack of Efficacy|4|||
37667043|NCT01628692|69139513|FG005|Overall Study|Lack of Efficacy|7|||
37759826|NCT02754141|69270073|FG004|Overall Study|Study drug toxicity|0|||
37759827|NCT02754141|69270074|FG005|Overall Study|Study drug toxicity|0|||
37759828|NCT02754141|69270075|FG006|Overall Study|Study drug toxicity|0|||
37926364|NCT00622336|69613067|FG000|Extension Phase|Adverse Event|2|||
37926365|NCT00622336|69613067|FG000|Extension Phase|Progressive Disease|6|||
37667044|NCT01628692|69139508|FG000|Overall Study|Adverse Event|2|||
37759829|NCT02754141|69270076|FG007|Overall Study|Study drug toxicity|0|||
37759830|NCT02754141|69270077|FG008|Overall Study|Study drug toxicity|0|||
37759831|NCT02754141|69270078|FG009|Overall Study|Study drug toxicity|0|||
37926366|NCT00622336|69613067|FG000|Extension Phase|Lack of therapeutic effect|2|||
37926367|NCT00622336|69613067|FG000|Extension Phase|Withdrawal by Subject|1|||
37759832|NCT02754141|69270079|FG010|Overall Study|Study drug toxicity|2|||
37759833|NCT02754141|69270080|FG011|Overall Study|Study drug toxicity|1|||
37926368|NCT00622336|69613067|FG000|Extension Phase|Lost to Follow-up|1|||
37926369|NCT00622336|69613067|FG000|Extension Phase|Other|9|||
37926370|NCT00779766|69613075|FG000|Month 24|Serious Adverse Event|2|||
37926371|NCT00779766|69613076|FG001|Month 24|Serious Adverse Event|3|||
37926372|NCT00779766|69613075|FG000|Month 24|Adverse Event|3|||
37926373|NCT00779766|69613076|FG001|Month 24|Adverse Event|3|||
37926374|NCT00779766|69613075|FG000|Month 24|Protocol Violation|3|||
37926375|NCT00779766|69613076|FG001|Month 24|Protocol Violation|1|||
37926376|NCT00779766|69613075|FG000|Month 24|Withdrawal by Subject|159|||
37926377|NCT00779766|69613076|FG001|Month 24|Withdrawal by Subject|127|||
37926378|NCT00779766|69613075|FG000|Month 24|Migrated/moved from study area|138|||
37926379|NCT00779766|69613076|FG001|Month 24|Migrated/moved from study area|162|||
37926380|NCT00779766|69613075|FG000|Month 24|Lost to Follow-up|9|||
37926381|NCT00779766|69613076|FG001|Month 24|Lost to Follow-up|9|||
37926382|NCT00779766|69613075|FG000|Month 24|Other|18|||
37926383|NCT00779766|69613076|FG001|Month 24|Other|27|||
37926384|NCT00779766|69613075|FG000|Month 48|Withdrawal by Subject|68|||
37926385|NCT00779766|69613076|FG001|Month 48|Withdrawal by Subject|63|||
37926386|NCT00779766|69613075|FG000|Month 48|Migrated/moved from study area|76|||
37926387|NCT00779766|69613076|FG001|Month 48|Migrated/moved from study area|75|||
37926388|NCT00779766|69613075|FG000|Month 48|Lost to Follow-up|29|||
37926389|NCT00779766|69613076|FG001|Month 48|Lost to Follow-up|30|||
37926390|NCT00779766|69613075|FG000|Month 48|Other|1|||
37926391|NCT00779766|69613076|FG001|Month 48|Other|0|||
37926392|NCT00779766|69613075|FG000|Month 72|Withdrawal by Subject|55|||
37926393|NCT00779766|69613076|FG001|Month 72|Withdrawal by Subject|71|||
37926394|NCT00779766|69613075|FG000|Month 72|Migrated/moved from study area|124|||
37926395|NCT00779766|69613076|FG001|Month 72|Migrated/moved from study area|109|||
37926396|NCT00779766|69613075|FG000|Month 72|Lost to Follow-up|6|||
37759834|NCT02754141|69270081|FG012|Overall Study|Study drug toxicity|1|||
37759835|NCT02754141|69270082|FG013|Overall Study|Study drug toxicity|0|||
37759836|NCT02754141|69270083|FG014|Overall Study|Study drug toxicity|0|||
37759837|NCT02754141|69270084|FG015|Overall Study|Study drug toxicity|0|||
37759838|NCT02754141|69270085|FG016|Overall Study|Study drug toxicity|0|||
37759839|NCT02754141|69270086|FG017|Overall Study|Study drug toxicity|0|||
37759840|NCT02754141|69270069|FG000|Overall Study|AE unrelated to study drug|1|||
37759841|NCT02754141|69270070|FG001|Overall Study|AE unrelated to study drug|1|||
37759842|NCT02754141|69270071|FG002|Overall Study|AE unrelated to study drug|0|||
37759843|NCT02754141|69270072|FG003|Overall Study|AE unrelated to study drug|1|||
37759844|NCT02754141|69270073|FG004|Overall Study|AE unrelated to study drug|3|||
37759845|NCT02754141|69270074|FG005|Overall Study|AE unrelated to study drug|2|||
37759846|NCT02754141|69270075|FG006|Overall Study|AE unrelated to study drug|1|||
37759847|NCT02754141|69270076|FG007|Overall Study|AE unrelated to study drug|0|||
37759848|NCT02754141|69270077|FG008|Overall Study|AE unrelated to study drug|0|||
37759849|NCT02754141|69270078|FG009|Overall Study|AE unrelated to study drug|0|||
37759850|NCT02754141|69270079|FG010|Overall Study|AE unrelated to study drug|0|||
37759851|NCT02754141|69270080|FG011|Overall Study|AE unrelated to study drug|0|||
37759852|NCT02754141|69270081|FG012|Overall Study|AE unrelated to study drug|0|||
37926397|NCT00779766|69613076|FG001|Month 72|Lost to Follow-up|8|||
37926398|NCT00779766|69613075|FG000|Month 72|Other|0|||
37926399|NCT00779766|69613076|FG001|Month 72|Other|1|||
37926400|NCT00846365|69613086|FG000|Overall Study|Adverse Event|20|||
37926401|NCT00846365|69613087|FG001|Overall Study|Adverse Event|30|||
37926402|NCT00846365|69613088|FG002|Overall Study|Adverse Event|11|||
37926403|NCT00846365|69613086|FG000|Overall Study|Protocol Violation|5|||
37926404|NCT00846365|69613087|FG001|Overall Study|Protocol Violation|4|||
37926405|NCT00846365|69613088|FG002|Overall Study|Protocol Violation|0|||
37926406|NCT00846365|69613086|FG000|Overall Study|Lost to Follow-up|8|||
37926407|NCT00846365|69613087|FG001|Overall Study|Lost to Follow-up|2|||
38033509|NCT03325556|69719497|FG001|Open-label Period|Use of prohibited medication|0|||
38033510|NCT03325556|69719498|FG002|Open-label Period|Use of prohibited medication|0|||
37759853|NCT02754141|69270082|FG013|Overall Study|AE unrelated to study drug|0|||
37759854|NCT02754141|69270083|FG014|Overall Study|AE unrelated to study drug|0|||
37759855|NCT02754141|69270084|FG015|Overall Study|AE unrelated to study drug|0|||
37759856|NCT02754141|69270085|FG016|Overall Study|AE unrelated to study drug|0|||
37926408|NCT00846365|69613088|FG002|Overall Study|Lost to Follow-up|5|||
37926409|NCT00846365|69613086|FG000|Overall Study|Withdrawal by Subject|11|||
37926410|NCT00846365|69613087|FG001|Overall Study|Withdrawal by Subject|11|||
37926411|NCT00846365|69613088|FG002|Overall Study|Withdrawal by Subject|9|||
37926412|NCT00846365|69613086|FG000|Overall Study|Pregnancy|1|||
37926413|NCT00846365|69613087|FG001|Overall Study|Pregnancy|0|||
37759857|NCT02754141|69270086|FG017|Overall Study|AE unrelated to study drug|0|||
37759858|NCT02754141|69270069|FG000|Overall Study|Request to discontinue|0|||
37759859|NCT02754141|69270070|FG001|Overall Study|Request to discontinue|0|||
37926414|NCT00846365|69613088|FG002|Overall Study|Pregnancy|0|||
37926415|NCT00846365|69613086|FG000|Overall Study|Lack of Efficacy|1|||
37926416|NCT00846365|69613087|FG001|Overall Study|Lack of Efficacy|1|||
37926417|NCT00846365|69613088|FG002|Overall Study|Lack of Efficacy|2|||
37926418|NCT00846365|69613086|FG000|Overall Study|Other|9|||
37926419|NCT00846365|69613087|FG001|Overall Study|Other|1|||
37926420|NCT00846365|69613088|FG002|Overall Study|Other|6|||
37926421|NCT00779142|69613096|FG000|Overall Study|Screen Failures|3|||
37926422|NCT00622180|69613101|FG000|Overall Study|Lost to Follow-up|1|||
37926423|NCT00622180|69613102|FG001|Overall Study|Lost to Follow-up|2|||
37759860|NCT02754141|69270071|FG002|Overall Study|Request to discontinue|0|||
37759861|NCT02754141|69270072|FG003|Overall Study|Request to discontinue|0|||
37759862|NCT02754141|69270073|FG004|Overall Study|Request to discontinue|0|||
37759863|NCT02754141|69270074|FG005|Overall Study|Request to discontinue|0|||
37759864|NCT02754141|69270075|FG006|Overall Study|Request to discontinue|0|||
37759865|NCT02754141|69270076|FG007|Overall Study|Request to discontinue|0|||
37759866|NCT02754141|69270077|FG008|Overall Study|Request to discontinue|1|||
37759867|NCT02754141|69270078|FG009|Overall Study|Request to discontinue|0|||
37926424|NCT00773136|69613108|FG000|Overall Study|Physician Decision|2|||
37926425|NCT00853307|69613115|FG000|Overall Study|Adverse Event|1|||
37926426|NCT00853307|69613116|FG001|Overall Study|Adverse Event|2|||
37926427|NCT00853307|69613115|FG000|Overall Study|Withdrawal by Subject|1|||
37926428|NCT00853307|69613116|FG001|Overall Study|Withdrawal by Subject|2|||
37926429|NCT00853307|69613115|FG000|Overall Study|Reason Not Specified|0|||
37926430|NCT00853307|69613116|FG001|Overall Study|Reason Not Specified|1|||
37926431|NCT00778830|69613124|FG000|Overall Study|Ongoing at data cut-off|0|||
37926432|NCT00778830|69613125|FG001|Overall Study|Ongoing at data cut-off|1|||
37926433|NCT00772668|69613131|FG000|Overall Study|Physician Decision|3|||
37926434|NCT00786474|69613138|FG000|Overall Study|Death|5|||
37926435|NCT00786474|69613139|FG001|Overall Study|Death|4|||
37926436|NCT00786474|69613138|FG000|Overall Study|Withdrawal by Subject|23|||
37926437|NCT00786474|69613139|FG001|Overall Study|Withdrawal by Subject|31|||
37926438|NCT00786474|69613138|FG000|Overall Study|Lost to Follow-up|3|||
37926439|NCT00786474|69613139|FG001|Overall Study|Lost to Follow-up|3|||
37926440|NCT00786474|69613138|FG000|Overall Study|Physician Decision|2|||
37926441|NCT00786474|69613139|FG001|Overall Study|Physician Decision|1|||
37926442|NCT00786474|69613138|FG000|Overall Study|Other|4|||
37926443|NCT00786474|69613139|FG001|Overall Study|Other|4|||
37926444|NCT00784875|69613149|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
37926445|NCT00784875|69613150|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
37926446|NCT00784875|69613151|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
37926447|NCT00784875|69613152|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
37926448|NCT00784875|69613149|FG000|Period A - Baseline|Adverse Event|0|||
37926449|NCT00784875|69613150|FG001|Period A - Baseline|Adverse Event|0|||
37926450|NCT00784875|69613151|FG002|Period A - Baseline|Adverse Event|0|||
37926451|NCT00784875|69613152|FG003|Period A - Baseline|Adverse Event|8|||
37926452|NCT00784875|69613149|FG000|Period A - Baseline|Protocol Violation|0|||
37926453|NCT00784875|69613150|FG001|Period A - Baseline|Protocol Violation|0|||
37926454|NCT00784875|69613151|FG002|Period A - Baseline|Protocol Violation|0|||
37926455|NCT00784875|69613152|FG003|Period A - Baseline|Protocol Violation|25|||
37926456|NCT00784875|69613149|FG000|Period A - Baseline|Withdrawal by Subject|0|||
37926457|NCT00784875|69613150|FG001|Period A - Baseline|Withdrawal by Subject|0|||
37926458|NCT00784875|69613151|FG002|Period A - Baseline|Withdrawal by Subject|0|||
37926459|NCT00784875|69613152|FG003|Period A - Baseline|Withdrawal by Subject|27|||
37926460|NCT00784875|69613149|FG000|Period A - Baseline|Physician Decision|0|||
37926461|NCT00784875|69613150|FG001|Period A - Baseline|Physician Decision|0|||
37926462|NCT00784875|69613151|FG002|Period A - Baseline|Physician Decision|0|||
37926463|NCT00784875|69613152|FG003|Period A - Baseline|Physician Decision|2|||
37926464|NCT00784875|69613149|FG000|Period A - Baseline|Sponsor Decision|0|||
37926465|NCT00784875|69613150|FG001|Period A - Baseline|Sponsor Decision|0|||
37926466|NCT00784875|69613151|FG002|Period A - Baseline|Sponsor Decision|0|||
37926467|NCT00784875|69613152|FG003|Period A - Baseline|Sponsor Decision|113|||
37926468|NCT00784875|69613149|FG000|Period A - Baseline|Lost to Follow-up|0|||
37926469|NCT00784875|69613150|FG001|Period A - Baseline|Lost to Follow-up|0|||
37926470|NCT00784875|69613151|FG002|Period A - Baseline|Lost to Follow-up|0|||
37926471|NCT00784875|69613152|FG003|Period A - Baseline|Lost to Follow-up|2|||
37926472|NCT00784875|69613149|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
37926473|NCT00784875|69613150|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
37926474|NCT00784875|69613151|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
37926475|NCT00784875|69613152|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
37926476|NCT00784875|69613149|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
37926477|NCT00784875|69613150|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
37926478|NCT00784875|69613151|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
37926479|NCT00784875|69613152|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
37926480|NCT00784875|69613149|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
37926481|NCT00784875|69613150|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
37926482|NCT00784875|69613151|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
37926483|NCT00784875|69613152|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
37759868|NCT02754141|69270079|FG010|Overall Study|Request to discontinue|0|||
37926484|NCT00784875|69613149|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
37926485|NCT00784875|69613150|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
37926486|NCT00784875|69613151|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
37926487|NCT00784875|69613152|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
37926488|NCT00784875|69613149|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
37926489|NCT00784875|69613150|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
37926490|NCT00784875|69613151|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
37926491|NCT00784875|69613152|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
37926492|NCT00784875|69613149|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
37926493|NCT00784875|69613150|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
37926494|NCT00784875|69613151|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
37926495|NCT00784875|69613152|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
37926496|NCT00784875|69613149|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
37759869|NCT02754141|69270080|FG011|Overall Study|Request to discontinue|0|||
37759870|NCT02754141|69270081|FG012|Overall Study|Request to discontinue|0|||
37759871|NCT02754141|69270082|FG013|Overall Study|Request to discontinue|1|||
37759872|NCT02754141|69270083|FG014|Overall Study|Request to discontinue|1|||
37759873|NCT02754141|69270084|FG015|Overall Study|Request to discontinue|0|||
37759874|NCT02754141|69270085|FG016|Overall Study|Request to discontinue|0|||
37759875|NCT02754141|69270086|FG017|Overall Study|Request to discontinue|0|||
37759876|NCT02754141|69270069|FG000|Overall Study|Withdrew consent|0|||
37759877|NCT02754141|69270070|FG001|Overall Study|Withdrew consent|0|||
37926497|NCT00784875|69613150|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
37926498|NCT00784875|69613151|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
37926499|NCT00784875|69613152|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
37926500|NCT00784875|69613149|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
37926501|NCT00784875|69613150|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
37926502|NCT00784875|69613151|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
38033511|NCT03325556|69719496|FG000|Open-label Period|Protocol Violation|4|||
37667045|NCT01628692|69139509|FG001|Overall Study|Adverse Event|0|||
37667046|NCT01628692|69139510|FG002|Overall Study|Adverse Event|2|||
37667047|NCT01628692|69139511|FG003|Overall Study|Adverse Event|0|||
37667048|NCT01628692|69139512|FG004|Overall Study|Adverse Event|0|||
37667049|NCT01628692|69139513|FG005|Overall Study|Adverse Event|0|||
37667050|NCT01628692|69139508|FG000|Overall Study|Withdrawal by Subject|0|||
37667051|NCT01628692|69139509|FG001|Overall Study|Withdrawal by Subject|1|||
37667052|NCT01628692|69139510|FG002|Overall Study|Withdrawal by Subject|1|||
37667053|NCT01628692|69139511|FG003|Overall Study|Withdrawal by Subject|0|||
37667054|NCT01628692|69139512|FG004|Overall Study|Withdrawal by Subject|0|||
37667055|NCT01628692|69139513|FG005|Overall Study|Withdrawal by Subject|0|||
37759878|NCT02754141|69270071|FG002|Overall Study|Withdrew consent|0|||
37759879|NCT02754141|69270072|FG003|Overall Study|Withdrew consent|0|||
37667056|NCT01628692|69139508|FG000|Overall Study|Death|0|||
37667057|NCT01628692|69139509|FG001|Overall Study|Death|1|||
37667058|NCT01628692|69139510|FG002|Overall Study|Death|0|||
37667059|NCT01628692|69139511|FG003|Overall Study|Death|0|||
37667060|NCT01628692|69139512|FG004|Overall Study|Death|0|||
37667061|NCT01628692|69139513|FG005|Overall Study|Death|0|||
37667062|NCT01628692|69139508|FG000|Overall Study|Poor compliance/noncompliance|1|||
37667063|NCT01628692|69139509|FG001|Overall Study|Poor compliance/noncompliance|0|||
37667064|NCT01628692|69139510|FG002|Overall Study|Poor compliance/noncompliance|0|||
37667065|NCT01628692|69139511|FG003|Overall Study|Poor compliance/noncompliance|0|||
37667066|NCT01628692|69139512|FG004|Overall Study|Poor compliance/noncompliance|0|||
37667067|NCT01628692|69139513|FG005|Overall Study|Poor compliance/noncompliance|0|||
37667068|NCT01628692|69139508|FG000|Overall Study|Administrative reason by sponsor|0|||
37667069|NCT01628692|69139509|FG001|Overall Study|Administrative reason by sponsor|0|||
37759880|NCT02754141|69270073|FG004|Overall Study|Withdrew consent|0|||
37926503|NCT00784875|69613152|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
37926504|NCT00784875|69613149|FG000|Period C|Adverse Event|1|||
37926505|NCT00784875|69613150|FG001|Period C|Adverse Event|0|||
37926506|NCT00784875|69613151|FG002|Period C|Adverse Event|4|||
37926507|NCT00784875|69613152|FG003|Period C|Adverse Event|2|||
37926508|NCT00784875|69613149|FG000|Period C|Protocol Violation|0|||
38033512|NCT03325556|69719497|FG001|Open-label Period|Protocol Violation|0|||
38033513|NCT03325556|69719498|FG002|Open-label Period|Protocol Violation|0|||
38033514|NCT03325556|69719496|FG000|Open-label Period|Withdrawal by Subject|17|||
38033515|NCT03325556|69719497|FG001|Open-label Period|Withdrawal by Subject|0|||
37759881|NCT02754141|69270074|FG005|Overall Study|Withdrew consent|0|||
37926509|NCT00784875|69613150|FG001|Period C|Protocol Violation|0|||
37926510|NCT00784875|69613151|FG002|Period C|Protocol Violation|1|||
37926511|NCT00784875|69613152|FG003|Period C|Protocol Violation|2|||
37667070|NCT01628692|69139510|FG002|Overall Study|Administrative reason by sponsor|0|||
37667071|NCT01628692|69139511|FG003|Overall Study|Administrative reason by sponsor|0|||
37667072|NCT01628692|69139512|FG004|Overall Study|Administrative reason by sponsor|0|||
37667073|NCT01628692|69139513|FG005|Overall Study|Administrative reason by sponsor|1|||
37926512|NCT00784875|69613149|FG000|Period C|Lack of Efficacy|0|||
37926513|NCT00784875|69613150|FG001|Period C|Lack of Efficacy|0|||
37926514|NCT00784875|69613151|FG002|Period C|Lack of Efficacy|1|||
37926515|NCT00784875|69613152|FG003|Period C|Lack of Efficacy|0|||
37926516|NCT00784875|69613149|FG000|Period C|Withdrawal by Subject|1|||
37926517|NCT00784875|69613150|FG001|Period C|Withdrawal by Subject|1|||
37926518|NCT00784875|69613151|FG002|Period C|Withdrawal by Subject|2|||
37926519|NCT00784875|69613152|FG003|Period C|Withdrawal by Subject|0|||
37926520|NCT00784875|69613149|FG000|Period C|Physician Decision|0|||
37926521|NCT00784875|69613150|FG001|Period C|Physician Decision|0|||
37926522|NCT00784875|69613151|FG002|Period C|Physician Decision|1|||
37926523|NCT00784875|69613152|FG003|Period C|Physician Decision|1|||
37926524|NCT00784875|69613149|FG000|Period C|Sponsor Decision|5|||
37926525|NCT00784875|69613150|FG001|Period C|Sponsor Decision|5|||
37926526|NCT00784875|69613151|FG002|Period C|Sponsor Decision|4|||
37926527|NCT00784875|69613152|FG003|Period C|Sponsor Decision|2|||
37926528|NCT00784875|69613149|FG000|Period D|Adverse Event|0|||
37926529|NCT00784875|69613150|FG001|Period D|Adverse Event|2|||
37926530|NCT00784875|69613151|FG002|Period D|Adverse Event|2|||
37926531|NCT00784875|69613152|FG003|Period D|Adverse Event|0|||
37926532|NCT00784875|69613149|FG000|Period D|Protocol Violation|1|||
37926533|NCT00784875|69613150|FG001|Period D|Protocol Violation|0|||
37926534|NCT00784875|69613151|FG002|Period D|Protocol Violation|0|||
37926535|NCT00784875|69613152|FG003|Period D|Protocol Violation|0|||
37926536|NCT00784875|69613149|FG000|Period D|Withdrawal by Subject|2|||
37926537|NCT00784875|69613150|FG001|Period D|Withdrawal by Subject|0|||
37926538|NCT00784875|69613151|FG002|Period D|Withdrawal by Subject|2|||
37926539|NCT00784875|69613152|FG003|Period D|Withdrawal by Subject|0|||
37926540|NCT00784875|69613149|FG000|Period D|Physician Decision|0|||
37926541|NCT00784875|69613150|FG001|Period D|Physician Decision|1|||
37926542|NCT00784875|69613151|FG002|Period D|Physician Decision|0|||
37926543|NCT00784875|69613152|FG003|Period D|Physician Decision|0|||
37926544|NCT00784875|69613149|FG000|Period D|Sponsor Decision|1|||
37926545|NCT00784875|69613150|FG001|Period D|Sponsor Decision|1|||
37926546|NCT00784875|69613151|FG002|Period D|Sponsor Decision|1|||
38033516|NCT03325556|69719498|FG002|Open-label Period|Withdrawal by Subject|0|||
38033517|NCT03325556|69719496|FG000|Open-label Period|Not otherwise specified|8|||
37667074|NCT01628692|69139508|FG000|Overall Study|Completed 12 Week only|0|||
37667075|NCT01628692|69139509|FG001|Overall Study|Completed 12 Week only|0|||
37667076|NCT01628692|69139510|FG002|Overall Study|Completed 12 Week only|0|||
37667077|NCT01628692|69139511|FG003|Overall Study|Completed 12 Week only|0|||
37667078|NCT01628692|69139512|FG004|Overall Study|Completed 12 Week only|0|||
37667079|NCT01628692|69139513|FG005|Overall Study|Completed 12 Week only|1|||
37667080|NCT02612727|69139532|FG000|Overall Study|Parent request|4|||
37667081|NCT02612727|69139533|FG001|Overall Study|Parent request|1|||
37667082|NCT02612727|69139532|FG000|Overall Study|Needed treatment incompatible with PT|1|||
37667083|NCT02612727|69139533|FG001|Overall Study|Needed treatment incompatible with PT|1|||
37759882|NCT02754141|69270075|FG006|Overall Study|Withdrew consent|0|||
37759883|NCT02754141|69270076|FG007|Overall Study|Withdrew consent|0|||
37759884|NCT02754141|69270077|FG008|Overall Study|Withdrew consent|0|||
37926547|NCT00784875|69613152|FG003|Period D|Sponsor Decision|0|||
37926548|NCT00784875|69613149|FG000|Period D|Lost to Follow-up|1|||
37926549|NCT00784875|69613150|FG001|Period D|Lost to Follow-up|0|||
37926550|NCT00784875|69613151|FG002|Period D|Lost to Follow-up|1|||
37926551|NCT00784875|69613152|FG003|Period D|Lost to Follow-up|1|||
37926552|NCT00592553|69613178|FG000|Overall Study|Protocol Noncompliance|1|||
37926553|NCT00592553|69613179|FG001|Overall Study|Protocol Noncompliance|0|||
37926554|NCT00592553|69613180|FG002|Overall Study|Protocol Noncompliance|0|||
37926555|NCT00853229|69613190|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
37926556|NCT00853229|69613191|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
37926557|NCT00853151|69613203|FG000|Overall Study|Adverse Event|1|||
37926558|NCT00853151|69613204|FG001|Overall Study|Adverse Event|4|||
37926559|NCT00853151|69613205|FG002|Overall Study|Adverse Event|2|||
37926560|NCT00853151|69613206|FG003|Overall Study|Adverse Event|0|||
37926561|NCT00853151|69613203|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
37926562|NCT00853151|69613204|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
38033518|NCT03325556|69719497|FG001|Open-label Period|Not otherwise specified|0|||
37926563|NCT00853151|69613205|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
37926564|NCT00853151|69613206|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
37926565|NCT00853151|69613203|FG000|Overall Study|Lost to Follow-up|2|||
37667084|NCT02612727|69139532|FG000|Overall Study|Direct hyperbilirubinemia|0|||
37667085|NCT02612727|69139533|FG001|Overall Study|Direct hyperbilirubinemia|2|||
37926566|NCT00853151|69613204|FG001|Overall Study|Lost to Follow-up|0|||
37926567|NCT00853151|69613205|FG002|Overall Study|Lost to Follow-up|3|||
37926568|NCT00853151|69613206|FG003|Overall Study|Lost to Follow-up|0|||
37926569|NCT00853151|69613203|FG000|Overall Study|Death|1|||
37926570|NCT00853151|69613204|FG001|Overall Study|Death|0|||
37926571|NCT00853151|69613205|FG002|Overall Study|Death|0|||
37926572|NCT00853151|69613206|FG003|Overall Study|Death|1|||
37759885|NCT02754141|69270078|FG009|Overall Study|Withdrew consent|1|||
37759886|NCT02754141|69270079|FG010|Overall Study|Withdrew consent|0|||
37759887|NCT02754141|69270080|FG011|Overall Study|Withdrew consent|0|||
37759888|NCT02754141|69270081|FG012|Overall Study|Withdrew consent|0|||
37759889|NCT02754141|69270082|FG013|Overall Study|Withdrew consent|0|||
37759890|NCT02754141|69270083|FG014|Overall Study|Withdrew consent|0|||
37759891|NCT02754141|69270084|FG015|Overall Study|Withdrew consent|0|||
37759892|NCT02754141|69270085|FG016|Overall Study|Withdrew consent|0|||
37759893|NCT02754141|69270086|FG017|Overall Study|Withdrew consent|0|||
37759894|NCT02754141|69270069|FG000|Overall Study|Maximum clinical benefit|0|||
37759895|NCT02754141|69270070|FG001|Overall Study|Maximum clinical benefit|0|||
37759896|NCT02754141|69270071|FG002|Overall Study|Maximum clinical benefit|0|||
37759897|NCT02754141|69270072|FG003|Overall Study|Maximum clinical benefit|1|||
37759898|NCT02754141|69270073|FG004|Overall Study|Maximum clinical benefit|0|||
37759899|NCT02754141|69270074|FG005|Overall Study|Maximum clinical benefit|0|||
37759900|NCT02754141|69270075|FG006|Overall Study|Maximum clinical benefit|0|||
37759901|NCT02754141|69270076|FG007|Overall Study|Maximum clinical benefit|0|||
37759902|NCT02754141|69270077|FG008|Overall Study|Maximum clinical benefit|0|||
37759903|NCT02754141|69270078|FG009|Overall Study|Maximum clinical benefit|0|||
37759904|NCT02754141|69270079|FG010|Overall Study|Maximum clinical benefit|0|||
37759905|NCT02754141|69270080|FG011|Overall Study|Maximum clinical benefit|0|||
37759906|NCT02754141|69270081|FG012|Overall Study|Maximum clinical benefit|0|||
37759907|NCT02754141|69270082|FG013|Overall Study|Maximum clinical benefit|0|||
37926573|NCT00853151|69613203|FG000|Overall Study|Protocol Violation|0|||
37926574|NCT00853151|69613204|FG001|Overall Study|Protocol Violation|0|||
37926575|NCT00853151|69613205|FG002|Overall Study|Protocol Violation|0|||
37926576|NCT00853151|69613206|FG003|Overall Study|Protocol Violation|1|||
37926577|NCT00853151|69613203|FG000|Overall Study|Withdrawal by Subject|5|||
37926578|NCT00853151|69613204|FG001|Overall Study|Withdrawal by Subject|4|||
37926579|NCT00853151|69613205|FG002|Overall Study|Withdrawal by Subject|2|||
37926580|NCT00853151|69613206|FG003|Overall Study|Withdrawal by Subject|1|||
37926581|NCT00853151|69613203|FG000|Overall Study|Physician Decision|0|||
37926582|NCT00853151|69613204|FG001|Overall Study|Physician Decision|2|||
37926583|NCT00853151|69613205|FG002|Overall Study|Physician Decision|1|||
37926584|NCT00853151|69613206|FG003|Overall Study|Physician Decision|0|||
37926585|NCT00853151|69613203|FG000|Overall Study|Sponsor Decision|0|||
37926586|NCT00853151|69613204|FG001|Overall Study|Sponsor Decision|3|||
37926587|NCT00853151|69613205|FG002|Overall Study|Sponsor Decision|0|||
37926588|NCT00853151|69613206|FG003|Overall Study|Sponsor Decision|0|||
37926589|NCT00853073|69613221|FG000|Overall Study|Withdrawal by Subject|3|||
37926590|NCT00853073|69613222|FG001|Overall Study|Withdrawal by Subject|2|||
37926591|NCT00846053|69613230|FG000|Overall Study|Physician Decision|3|||
37926592|NCT00846053|69613231|FG001|Overall Study|Physician Decision|0|||
37926593|NCT00845897|69613242|FG000|Overall Study|Lost to Follow-up|1|||
37926594|NCT00845897|69613243|FG001|Overall Study|Lost to Follow-up|1|||
37926595|NCT00845897|69613244|FG002|Overall Study|Lost to Follow-up|0|||
37926596|NCT00845897|69613242|FG000|Overall Study|Withdrawal by Subject|0|||
37926597|NCT00845897|69613243|FG001|Overall Study|Withdrawal by Subject|3|||
37926598|NCT00845897|69613244|FG002|Overall Study|Withdrawal by Subject|2|||
37926599|NCT00845897|69613242|FG000|Overall Study|Ulcer did not heal|1|||
37926600|NCT00845897|69613243|FG001|Overall Study|Ulcer did not heal|0|||
37926601|NCT00845897|69613244|FG002|Overall Study|Ulcer did not heal|1|||
37926602|NCT00845897|69613242|FG000|Overall Study|Too ill to participate|0|||
37926603|NCT00845897|69613243|FG001|Overall Study|Too ill to participate|1|||
37926604|NCT00845897|69613244|FG002|Overall Study|Too ill to participate|0|||
37926605|NCT00862277|69613255|FG000|Overall Study|Protocol Violation|1|||
37926606|NCT00862277|69613256|FG001|Overall Study|Protocol Violation|2|||
37926607|NCT00862277|69613257|FG002|Overall Study|Protocol Violation|5|||
37926608|NCT00852995|69613270|FG000|Overall Study|Adverse Event|1|||
37926609|NCT00852995|69613271|FG001|Overall Study|Adverse Event|0|||
37926610|NCT00852995|69613272|FG002|Overall Study|Adverse Event|4|||
37926611|NCT00852995|69613273|FG003|Overall Study|Adverse Event|0|||
37926612|NCT00852995|69613274|FG004|Overall Study|Adverse Event|0|||
37926613|NCT00852995|69613270|FG000|Overall Study|Lost to Follow-up|0|||
37926614|NCT00852995|69613271|FG001|Overall Study|Lost to Follow-up|1|||
37926615|NCT00852995|69613272|FG002|Overall Study|Lost to Follow-up|1|||
37926616|NCT00852995|69613273|FG003|Overall Study|Lost to Follow-up|0|||
37926617|NCT00852995|69613274|FG004|Overall Study|Lost to Follow-up|0|||
37759908|NCT02754141|69270083|FG014|Overall Study|Maximum clinical benefit|0|||
37926618|NCT00852995|69613270|FG000|Overall Study|Withdrawal by Subject|4|||
37926619|NCT00852995|69613271|FG001|Overall Study|Withdrawal by Subject|0|||
37926620|NCT00852995|69613272|FG002|Overall Study|Withdrawal by Subject|0|||
37926621|NCT00852995|69613273|FG003|Overall Study|Withdrawal by Subject|1|||
37759909|NCT02754141|69270084|FG015|Overall Study|Maximum clinical benefit|0|||
37759910|NCT02754141|69270085|FG016|Overall Study|Maximum clinical benefit|0|||
37759911|NCT02754141|69270086|FG017|Overall Study|Maximum clinical benefit|0|||
37926622|NCT00852995|69613274|FG004|Overall Study|Withdrawal by Subject|2|||
37926623|NCT00852995|69613270|FG000|Overall Study|Non-Compliance|0|||
37759912|NCT02754141|69270069|FG000|Overall Study|No longer meets study criteria|0|||
37759913|NCT02754141|69270070|FG001|Overall Study|No longer meets study criteria|0|||
37759914|NCT02754141|69270071|FG002|Overall Study|No longer meets study criteria|0|||
37759915|NCT02754141|69270072|FG003|Overall Study|No longer meets study criteria|1|||
37759916|NCT02754141|69270073|FG004|Overall Study|No longer meets study criteria|0|||
37926624|NCT00852995|69613271|FG001|Overall Study|Non-Compliance|0|||
37926625|NCT00852995|69613272|FG002|Overall Study|Non-Compliance|0|||
37926626|NCT00852995|69613273|FG003|Overall Study|Non-Compliance|2|||
37926627|NCT00852995|69613274|FG004|Overall Study|Non-Compliance|0|||
37926628|NCT00852995|69613270|FG000|Overall Study|Progressive Disease|1|||
37926629|NCT00852995|69613271|FG001|Overall Study|Progressive Disease|0|||
37926630|NCT00852995|69613272|FG002|Overall Study|Progressive Disease|0|||
37926631|NCT00852995|69613273|FG003|Overall Study|Progressive Disease|2|||
37926632|NCT00852995|69613274|FG004|Overall Study|Progressive Disease|1|||
37926633|NCT00852995|69613270|FG000|Overall Study|Physician Decision|1|||
37926634|NCT00852995|69613271|FG001|Overall Study|Physician Decision|0|||
37926635|NCT00852995|69613272|FG002|Overall Study|Physician Decision|0|||
37926636|NCT00852995|69613273|FG003|Overall Study|Physician Decision|0|||
37926637|NCT00852995|69613274|FG004|Overall Study|Physician Decision|0|||
37926638|NCT00852995|69613270|FG000|Overall Study|Protocol Violation|0|||
37926639|NCT00852995|69613271|FG001|Overall Study|Protocol Violation|0|||
37926640|NCT00852995|69613272|FG002|Overall Study|Protocol Violation|0|||
37926641|NCT00852995|69613273|FG003|Overall Study|Protocol Violation|0|||
37926642|NCT00852995|69613274|FG004|Overall Study|Protocol Violation|1|||
37926643|NCT00852995|69613270|FG000|Overall Study|Moved Out of Area|1|||
37926644|NCT00852995|69613271|FG001|Overall Study|Moved Out of Area|0|||
37926645|NCT00852995|69613272|FG002|Overall Study|Moved Out of Area|0|||
37926646|NCT00852995|69613273|FG003|Overall Study|Moved Out of Area|0|||
37926647|NCT00852995|69613274|FG004|Overall Study|Moved Out of Area|0|||
37926648|NCT00592319|69613293|FG000|Overall Study|Lost to Follow-up|0|||
37926649|NCT00592319|69613294|FG001|Overall Study|Lost to Follow-up|3|||
37926650|NCT00862121|69613304|FG000|Overall Study|Adverse Event|1|||
37926651|NCT00862121|69613305|FG001|Overall Study|Adverse Event|2|||
37926652|NCT00862121|69613304|FG000|Overall Study|Lack of Efficacy|0|||
37926653|NCT00862121|69613305|FG001|Overall Study|Lack of Efficacy|3|||
37926654|NCT00862121|69613304|FG000|Overall Study|Protocol Violation|0|||
37926655|NCT00862121|69613305|FG001|Overall Study|Protocol Violation|1|||
37926656|NCT00862121|69613304|FG000|Overall Study|Exclusion criterion violation|0|||
37926657|NCT00862121|69613305|FG001|Overall Study|Exclusion criterion violation|1|||
37926658|NCT00862121|69613304|FG000|Overall Study|Incorrect randomisation|0|||
37926659|NCT00862121|69613305|FG001|Overall Study|Incorrect randomisation|1|||
37926660|NCT00784719|69613318|FG000|Overall Study|Adverse Event|0|||
38033519|NCT03325556|69719498|FG002|Open-label Period|Not otherwise specified|0|||
38033520|NCT03325556|69719496|FG000|Open-label Period|Administrative discont. at study termination|41|||
37759917|NCT02754141|69270074|FG005|Overall Study|No longer meets study criteria|0|||
37759918|NCT02754141|69270075|FG006|Overall Study|No longer meets study criteria|0|||
37759919|NCT02754141|69270076|FG007|Overall Study|No longer meets study criteria|0|||
37759920|NCT02754141|69270077|FG008|Overall Study|No longer meets study criteria|0|||
37759921|NCT02754141|69270078|FG009|Overall Study|No longer meets study criteria|0|||
37759922|NCT02754141|69270079|FG010|Overall Study|No longer meets study criteria|0|||
37759923|NCT02754141|69270080|FG011|Overall Study|No longer meets study criteria|0|||
37759924|NCT02754141|69270081|FG012|Overall Study|No longer meets study criteria|0|||
37926661|NCT00784719|69613319|FG001|Overall Study|Adverse Event|2|||
37926662|NCT00784719|69613320|FG002|Overall Study|Adverse Event|0|||
37926663|NCT00784719|69613321|FG003|Overall Study|Adverse Event|0|||
37926664|NCT00784719|69613322|FG004|Overall Study|Adverse Event|1|||
37926665|NCT00784719|69613323|FG005|Overall Study|Adverse Event|1|||
37926666|NCT00784719|69613324|FG006|Overall Study|Adverse Event|1|||
37926667|NCT00784719|69613318|FG000|Overall Study|Lost to Follow-up|0|||
37926668|NCT00784719|69613319|FG001|Overall Study|Lost to Follow-up|0|||
37926669|NCT00784719|69613320|FG002|Overall Study|Lost to Follow-up|0|||
37926670|NCT00784719|69613321|FG003|Overall Study|Lost to Follow-up|0|||
37926671|NCT00784719|69613322|FG004|Overall Study|Lost to Follow-up|1|||
37926672|NCT00784719|69613323|FG005|Overall Study|Lost to Follow-up|1|||
37926673|NCT00784719|69613324|FG006|Overall Study|Lost to Follow-up|0|||
38033521|NCT03325556|69719497|FG001|Open-label Period|Administrative discont. at study termination|0|||
38033522|NCT03325556|69719498|FG002|Open-label Period|Administrative discont. at study termination|0|||
37926674|NCT00784719|69613318|FG000|Overall Study|Other|2|||
37926675|NCT00784719|69613319|FG001|Overall Study|Other|1|||
37667086|NCT01594827|69139541|FG000|Overall Study|Adverse Event|1|||
37926676|NCT00784719|69613320|FG002|Overall Study|Other|1|||
37926677|NCT00784719|69613321|FG003|Overall Study|Other|0|||
37926678|NCT00784719|69613322|FG004|Overall Study|Other|2|||
37926679|NCT00784719|69613323|FG005|Overall Study|Other|1|||
37926680|NCT00784719|69613324|FG006|Overall Study|Other|3|||
37926681|NCT00784719|69613318|FG000|Overall Study|Withdrawal by Subject|1|||
37926682|NCT00784719|69613319|FG001|Overall Study|Withdrawal by Subject|0|||
37667087|NCT01594827|69139542|FG001|Overall Study|Adverse Event|0|||
37926683|NCT00784719|69613320|FG002|Overall Study|Withdrawal by Subject|0|||
37926684|NCT00784719|69613321|FG003|Overall Study|Withdrawal by Subject|0|||
37926685|NCT00784719|69613322|FG004|Overall Study|Withdrawal by Subject|2|||
37926686|NCT00784719|69613323|FG005|Overall Study|Withdrawal by Subject|0|||
37926687|NCT00784719|69613324|FG006|Overall Study|Withdrawal by Subject|1|||
37926688|NCT00852917|69613344|FG000|Overall Study|Adverse Event|13|||
37926689|NCT00852917|69613345|FG001|Overall Study|Adverse Event|20|||
37926690|NCT00852917|69613346|FG002|Overall Study|Adverse Event|35|||
37926691|NCT00852917|69613347|FG003|Overall Study|Adverse Event|17|||
37926692|NCT00852917|69613344|FG000|Overall Study|Lack of Efficacy|21|||
37926693|NCT00852917|69613345|FG001|Overall Study|Lack of Efficacy|11|||
37926694|NCT00852917|69613346|FG002|Overall Study|Lack of Efficacy|11|||
37926695|NCT00852917|69613347|FG003|Overall Study|Lack of Efficacy|47|||
37926696|NCT00852917|69613344|FG000|Overall Study|Withdrawal by Subject|4|||
37926697|NCT00852917|69613345|FG001|Overall Study|Withdrawal by Subject|8|||
37926698|NCT00852917|69613346|FG002|Overall Study|Withdrawal by Subject|10|||
37926699|NCT00852917|69613347|FG003|Overall Study|Withdrawal by Subject|9|||
37926700|NCT00852917|69613344|FG000|Overall Study|Physician Decision|6|||
37926701|NCT00852917|69613345|FG001|Overall Study|Physician Decision|7|||
37926702|NCT00852917|69613346|FG002|Overall Study|Physician Decision|2|||
37926703|NCT00852917|69613347|FG003|Overall Study|Physician Decision|19|||
37926704|NCT00852917|69613344|FG000|Overall Study|Death|0|||
37926705|NCT00852917|69613345|FG001|Overall Study|Death|0|||
37926706|NCT00852917|69613346|FG002|Overall Study|Death|0|||
37926707|NCT00852917|69613347|FG003|Overall Study|Death|1|||
37926708|NCT00845429|69613360|FG000|Overall Study|Protocol Violation|5|||
37926709|NCT00845429|69613361|FG001|Overall Study|Protocol Violation|4|||
37926710|NCT00845429|69613362|FG002|Overall Study|Protocol Violation|7|||
37926711|NCT00845429|69613360|FG000|Overall Study|Lost to Follow-up|7|||
37926712|NCT00845429|69613361|FG001|Overall Study|Lost to Follow-up|9|||
37926713|NCT00845429|69613362|FG002|Overall Study|Lost to Follow-up|10|||
37926714|NCT00845429|69613360|FG000|Overall Study|Withdrawal by Subject|2|||
37926715|NCT00845429|69613361|FG001|Overall Study|Withdrawal by Subject|2|||
37926716|NCT00845429|69613362|FG002|Overall Study|Withdrawal by Subject|2|||
37926717|NCT00845429|69613360|FG000|Overall Study|Serious adverse event|0|||
37926718|NCT00845429|69613361|FG001|Overall Study|Serious adverse event|0|||
37926719|NCT00845429|69613362|FG002|Overall Study|Serious adverse event|1|||
37926720|NCT00593333|69613372|FG000|Overall Study|Lost to Follow-up|10|||
37926721|NCT00593333|69613373|FG001|Overall Study|Lost to Follow-up|11|||
37926722|NCT00844883|69613379|FG000|Overall Study|Bridged to liver transplant|3|||
37926723|NCT00844883|69613379|FG000|Overall Study|Bridged to resection|1|||
37926724|NCT00851903|69613383|FG000|Overall Study|Withdrawal by Subject|2|||
37926725|NCT00587457|69613390|FG000|Overall Study|Adverse Event|1|||
37926726|NCT00587457|69613391|FG001|Overall Study|Adverse Event|2|||
37926727|NCT00587457|69613392|FG002|Overall Study|Adverse Event|1|||
37926728|NCT00587457|69613390|FG000|Overall Study|Disease progression|2|||
37926729|NCT00587457|69613391|FG001|Overall Study|Disease progression|0|||
37926730|NCT00587457|69613392|FG002|Overall Study|Disease progression|2|||
37926731|NCT00587457|69613390|FG000|Overall Study|Initiation of alternative therapy|0|||
37926732|NCT00587457|69613391|FG001|Overall Study|Initiation of alternative therapy|1|||
37926733|NCT00587457|69613392|FG002|Overall Study|Initiation of alternative therapy|0|||
37926734|NCT00587457|69613390|FG000|Overall Study|Undefined|0|||
37926735|NCT00587457|69613391|FG001|Overall Study|Undefined|0|||
37926736|NCT00587457|69613392|FG002|Overall Study|Undefined|1|||
37926737|NCT00587457|69613390|FG000|Overall Study|Development of neutralizing Abs|0|||
37926738|NCT00587457|69613391|FG001|Overall Study|Development of neutralizing Abs|0|||
37926739|NCT00587457|69613392|FG002|Overall Study|Development of neutralizing Abs|1|||
37926740|NCT00851747|69613403|FG000|Overall Study|Physician Decision|6|||
37926741|NCT00851747|69613404|FG001|Overall Study|Physician Decision|6|||
37926742|NCT00851747|69613405|FG002|Overall Study|Physician Decision|6|||
37926743|NCT00767325|69613412|FG000|Overall Study|Lack of Efficacy|2|||
37926744|NCT00767325|69613412|FG000|Overall Study|Adverse Event|7|||
37926745|NCT00767325|69613412|FG000|Overall Study|Lost to Follow-up|3|||
37926746|NCT00767325|69613412|FG000|Overall Study|No longer met study criteria|2|||
37926747|NCT00767325|69613412|FG000|Overall Study|Missed visit due to family reasons|1|||
37926748|NCT00851591|69613418|FG000|Overall Study|Withdrawal by Subject|2|||
37926749|NCT00851591|69613419|FG001|Overall Study|Withdrawal by Subject|0|||
37926750|NCT00861341|69613425|FG000|Overall Study|Withdrawal by Subject|2|||
37926751|NCT00766467|69613431|FG000|Overall Study|Withdrawal by Subject|7|||
37926752|NCT00766467|69613432|FG001|Overall Study|Withdrawal by Subject|2|||
37926753|NCT00766467|69613431|FG000|Overall Study|Adverse Event|1|||
37926754|NCT00766467|69613432|FG001|Overall Study|Adverse Event|1|||
37926755|NCT00766467|69613431|FG000|Overall Study|Protocol Violation|2|||
37926756|NCT00766467|69613432|FG001|Overall Study|Protocol Violation|4|||
37926757|NCT00766467|69613431|FG000|Overall Study|Tumor Progression on Study|0|||
37926758|NCT00766467|69613432|FG001|Overall Study|Tumor Progression on Study|1|||
37926759|NCT00766467|69613431|FG000|Overall Study|Physician Decision|1|||
37926760|NCT00766467|69613432|FG001|Overall Study|Physician Decision|0|||
37926761|NCT00850499|69613440|FG000|Overall Study|Adverse Event|3|||
37759925|NCT02754141|69270082|FG013|Overall Study|No longer meets study criteria|0|||
37759926|NCT02754141|69270083|FG014|Overall Study|No longer meets study criteria|0|||
37759927|NCT02754141|69270084|FG015|Overall Study|No longer meets study criteria|0|||
37759928|NCT02754141|69270085|FG016|Overall Study|No longer meets study criteria|0|||
37759929|NCT02754141|69270086|FG017|Overall Study|No longer meets study criteria|0|||
37759930|NCT02754141|69270069|FG000|Overall Study|Other reasons|0|||
37759931|NCT02754141|69270070|FG001|Overall Study|Other reasons|0|||
37759932|NCT02754141|69270071|FG002|Overall Study|Other reasons|0|||
37759933|NCT02754141|69270072|FG003|Overall Study|Other reasons|0|||
37759934|NCT02754141|69270073|FG004|Overall Study|Other reasons|0|||
37926762|NCT00850499|69613441|FG001|Overall Study|Adverse Event|1|||
37926763|NCT00850499|69613440|FG000|Overall Study|Lack of Efficacy|0|||
37926764|NCT00850499|69613441|FG001|Overall Study|Lack of Efficacy|1|||
37926765|NCT00860951|69613447|FG000|Overall Study|Withdrawal by Subject|2|||
37926766|NCT00860951|69613447|FG000|Overall Study|Lost to Follow-up|5|||
37926767|NCT00844805|69613465|FG000|Treatment Phase|Adverse Event|5|||
37926768|NCT00844805|69613466|FG001|Treatment Phase|Adverse Event|1|||
37926769|NCT00844805|69613467|FG002|Treatment Phase|Adverse Event|0|||
37926770|NCT00844805|69613468|FG003|Treatment Phase|Adverse Event|0|||
37926771|NCT00844805|69613465|FG000|Treatment Phase|Withdrawal by Subject|3|||
37926772|NCT00844805|69613466|FG001|Treatment Phase|Withdrawal by Subject|4|||
37926773|NCT00844805|69613467|FG002|Treatment Phase|Withdrawal by Subject|0|||
37926774|NCT00844805|69613468|FG003|Treatment Phase|Withdrawal by Subject|0|||
37926775|NCT00844805|69613465|FG000|Treatment Phase|Noncompliance With Protocol|1|||
37926776|NCT00844805|69613466|FG001|Treatment Phase|Noncompliance With Protocol|0|||
37926777|NCT00844805|69613467|FG002|Treatment Phase|Noncompliance With Protocol|0|||
37926778|NCT00844805|69613468|FG003|Treatment Phase|Noncompliance With Protocol|0|||
37926779|NCT00844805|69613465|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
37926780|NCT00844805|69613466|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
37926781|NCT00844805|69613467|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
37926782|NCT00844805|69613468|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
37926783|NCT00844805|69613465|FG000|Follow-Up Phase|Adverse Event|0|||
37926784|NCT00844805|69613466|FG001|Follow-Up Phase|Adverse Event|0|||
37926785|NCT00844805|69613467|FG002|Follow-Up Phase|Adverse Event|1|||
37926786|NCT00844805|69613468|FG003|Follow-Up Phase|Adverse Event|0|||
37926787|NCT00844805|69613465|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
37926788|NCT00844805|69613466|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
37926789|NCT00844805|69613467|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
37926790|NCT00844805|69613468|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
37926791|NCT00844805|69613465|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
37926792|NCT00844805|69613466|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
37926793|NCT00844805|69613467|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
37926794|NCT00844805|69613468|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
37926795|NCT00844805|69613465|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
37926796|NCT00844805|69613466|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
37926797|NCT00844805|69613467|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
37926798|NCT00844805|69613468|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
37926799|NCT00844805|69613465|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
37926800|NCT00844805|69613466|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
37667088|NCT01594827|69139541|FG000|Overall Study|Physician Decision|3|||
37667089|NCT01594827|69139542|FG001|Overall Study|Physician Decision|0|||
37667090|NCT02610231|69139550|FG000|Overall Study|Withdrawal by Subject|27|||
37667091|NCT02610231|69139550|FG000|Overall Study|Adverse Event|20|||
37667092|NCT02610231|69139550|FG000|Overall Study|Death|5|||
37667093|NCT02610231|69139550|FG000|Overall Study|Surgery|2|||
37667094|NCT02610231|69139550|FG000|Overall Study|Physician Decision|1|||
37667095|NCT02610231|69139550|FG000|Overall Study|Non Compliance|2|||
37667096|NCT02610231|69139550|FG000|Overall Study|Other|3|||
37667097|NCT02178358|69139560|FG000|Overall Study|Withdrawal by Subject|0|||
37667098|NCT02178358|69139561|FG001|Overall Study|Withdrawal by Subject|2|||
37667099|NCT02178358|69139562|FG002|Overall Study|Withdrawal by Subject|2|||
37667100|NCT02178358|69139560|FG000|Overall Study|Lost to Follow-up|1|||
37667101|NCT02178358|69139561|FG001|Overall Study|Lost to Follow-up|0|||
37667102|NCT02178358|69139562|FG002|Overall Study|Lost to Follow-up|0|||
37667103|NCT01598896|69139573|FG000|Overall Study|Withdrawal by Subject|0|||
37759935|NCT02754141|69270074|FG005|Overall Study|Other reasons|0|||
37759936|NCT02754141|69270075|FG006|Overall Study|Other reasons|0|||
37759937|NCT02754141|69270076|FG007|Overall Study|Other reasons|1|||
37926801|NCT00844805|69613467|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
37926802|NCT00844805|69613468|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
37926803|NCT00765999|69613479|FG000|Overall Study|Adverse Event|203|||
37926804|NCT00765999|69613479|FG000|Overall Study|Insufficient Therapeutic Response|100|||
37926805|NCT00765999|69613479|FG000|Overall Study|Protocol Violation|95|||
37926806|NCT00765999|69613479|FG000|Overall Study|Consent Withdrawn|202|||
37926807|NCT00765999|69613479|FG000|Overall Study|Lost to Follow-up|131|||
37926808|NCT00765999|69613479|FG000|Overall Study|Study Terminated by Sponsor|2|||
37926809|NCT00765999|69613479|FG000|Overall Study|Other Miscellaneous Reasons|51|||
37926810|NCT00765843|69613488|FG000|Overall Study|Lost to Follow-up|1|||
37926811|NCT00765843|69613489|FG001|Overall Study|Lost to Follow-up|3|||
37926812|NCT00765843|69613490|FG002|Overall Study|Lost to Follow-up|2|||
37926813|NCT00765843|69613488|FG000|Overall Study|did not return to receive intervention|0|||
37926814|NCT00765843|69613489|FG001|Overall Study|did not return to receive intervention|1|||
37926815|NCT00765843|69613490|FG002|Overall Study|did not return to receive intervention|0|||
37926816|NCT00765843|69613488|FG000|Overall Study|Adverse Event|0|||
37926817|NCT00765843|69613489|FG001|Overall Study|Adverse Event|0|||
37926818|NCT00765843|69613490|FG002|Overall Study|Adverse Event|1|||
37926819|NCT00765063|69613498|FG000|Overall Study|Lack of Efficacy|5|||
37926820|NCT00765063|69613498|FG000|Overall Study|Withdrawal by Subject|1|||
37926821|NCT00765063|69613498|FG000|Overall Study|Other|16|||
37926822|NCT00765063|69613498|FG000|Overall Study|Protocol Violation|6|||
37926823|NCT00765063|69613498|FG000|Overall Study|Adverse Event|4|||
37926824|NCT00764751|69613504|FG000|Overall Study|Adverse Event|1|||
37926825|NCT00764751|69613505|FG001|Overall Study|Adverse Event|1|||
37926826|NCT00764751|69613504|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
37926827|NCT00764751|69613505|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
37926828|NCT00764673|69613516|FG000|Overall Study|Death|1|||
37926829|NCT00764673|69613516|FG000|Overall Study|Lost to Follow-up|3|||
37926830|NCT00764673|69613516|FG000|Overall Study|Withdrawal by Subject|6|||
37926831|NCT00764673|69613516|FG000|Overall Study|Revision of Device|2|||
37926832|NCT00764517|69613522|FG000|Overall Study|Adverse Event|9|||
37926833|NCT00764517|69613523|FG001|Overall Study|Adverse Event|3|||
37926834|NCT00764517|69613522|FG000|Overall Study|Death|3|||
37926835|NCT00764517|69613523|FG001|Overall Study|Death|11|||
37926836|NCT00764517|69613522|FG000|Overall Study|Physician Decision|3|||
37926837|NCT00764517|69613523|FG001|Overall Study|Physician Decision|0|||
37667104|NCT01598896|69139574|FG001|Overall Study|Withdrawal by Subject|1|||
37926838|NCT00764361|69613531|FG000|Overall Study|Withdrawal by Subject|2|||
37926839|NCT00764361|69613532|FG001|Overall Study|Withdrawal by Subject|3|||
37926840|NCT00764361|69613531|FG000|Overall Study|Adverse Event|0|||
37926841|NCT00764361|69613532|FG001|Overall Study|Adverse Event|1|||
37926842|NCT00763971|69613541|FG000|Overall Study|Adverse Event|5|||
37926843|NCT00763971|69613542|FG001|Overall Study|Adverse Event|2|||
37926844|NCT00763971|69613543|FG002|Overall Study|Adverse Event|4|||
37926845|NCT00763971|69613541|FG000|Overall Study|Protocol Violation|3|||
37926846|NCT00763971|69613542|FG001|Overall Study|Protocol Violation|3|||
37926847|NCT00763971|69613543|FG002|Overall Study|Protocol Violation|2|||
37926848|NCT00763971|69613541|FG000|Overall Study|Withdrawal by Subject|4|||
37926849|NCT00763971|69613542|FG001|Overall Study|Withdrawal by Subject|5|||
37926850|NCT00763971|69613543|FG002|Overall Study|Withdrawal by Subject|5|||
37926851|NCT00763971|69613541|FG000|Overall Study|Lost to Follow-up|0|||
37926852|NCT00763971|69613542|FG001|Overall Study|Lost to Follow-up|1|||
37926853|NCT00763971|69613543|FG002|Overall Study|Lost to Follow-up|0|||
37926854|NCT00763971|69613541|FG000|Overall Study|Lack of Efficacy|11|||
37926855|NCT00763971|69613542|FG001|Overall Study|Lack of Efficacy|22|||
37926856|NCT00763971|69613543|FG002|Overall Study|Lack of Efficacy|54|||
37926857|NCT00763971|69613541|FG000|Overall Study|Unable to swallow capsule|2|||
37926858|NCT00763971|69613542|FG001|Overall Study|Unable to swallow capsule|1|||
37926859|NCT00763971|69613543|FG002|Overall Study|Unable to swallow capsule|1|||
37926860|NCT00763971|69613541|FG000|Overall Study|Personal reason|3|||
37926861|NCT00763971|69613542|FG001|Overall Study|Personal reason|0|||
37926862|NCT00763971|69613543|FG002|Overall Study|Personal reason|0|||
37926863|NCT00763971|69613541|FG000|Overall Study|Exclusion criteria met|1|||
37926864|NCT00763971|69613542|FG001|Overall Study|Exclusion criteria met|0|||
37926865|NCT00763971|69613543|FG002|Overall Study|Exclusion criteria met|0|||
37926866|NCT00763971|69613541|FG000|Overall Study|Sponsor decision|1|||
37926867|NCT00763971|69613542|FG001|Overall Study|Sponsor decision|0|||
37926868|NCT00763971|69613543|FG002|Overall Study|Sponsor decision|0|||
37926869|NCT00763971|69613541|FG000|Overall Study|Due to holiday season|2|||
37926870|NCT00763971|69613542|FG001|Overall Study|Due to holiday season|0|||
37667105|NCT01598896|69139573|FG000|Overall Study|Lack of Efficacy|0|||
37926871|NCT00763971|69613543|FG002|Overall Study|Due to holiday season|1|||
37667106|NCT01598896|69139574|FG001|Overall Study|Lack of Efficacy|1|||
37667107|NCT01598662|69139582|FG000|Overall Study|Lost to Follow-up|10|||
37926872|NCT00763971|69613541|FG000|Overall Study|Randomization error|0|||
37926873|NCT00763971|69613542|FG001|Overall Study|Randomization error|0|||
37926874|NCT00763971|69613543|FG002|Overall Study|Randomization error|1|||
37926875|NCT00763971|69613541|FG000|Overall Study|Medical monitor decision|0|||
37926876|NCT00763971|69613542|FG001|Overall Study|Medical monitor decision|0|||
37926877|NCT00763971|69613543|FG002|Overall Study|Medical monitor decision|1|||
37926878|NCT00763971|69613541|FG000|Overall Study|Moved to another country|0|||
37926879|NCT00763971|69613542|FG001|Overall Study|Moved to another country|1|||
37926880|NCT00763971|69613543|FG002|Overall Study|Moved to another country|0|||
37926881|NCT00763971|69613541|FG000|Overall Study|Subject wanted dose reduction|0|||
37926882|NCT00763971|69613542|FG001|Overall Study|Subject wanted dose reduction|1|||
37926883|NCT00763971|69613543|FG002|Overall Study|Subject wanted dose reduction|0|||
37926884|NCT00763971|69613541|FG000|Overall Study|Lack of availability|0|||
37926885|NCT00763971|69613542|FG001|Overall Study|Lack of availability|1|||
37926886|NCT00763971|69613543|FG002|Overall Study|Lack of availability|0|||
37926887|NCT00763971|69613541|FG000|Overall Study|Performed final visit on phone|0|||
37926888|NCT00763971|69613542|FG001|Overall Study|Performed final visit on phone|1|||
37926889|NCT00763971|69613543|FG002|Overall Study|Performed final visit on phone|0|||
37926890|NCT00763971|69613541|FG000|Overall Study|Participation in 489-326 required|1|||
37926891|NCT00763971|69613542|FG001|Overall Study|Participation in 489-326 required|0|||
37926892|NCT00763971|69613543|FG002|Overall Study|Participation in 489-326 required|0|||
37926893|NCT00763815|69613553|FG000|Overall Study|Adverse Event|14|||
37926894|NCT00763815|69613554|FG001|Overall Study|Adverse Event|29|||
37926895|NCT00763815|69613553|FG000|Overall Study|Lack of Efficacy|10|||
37926896|NCT00763815|69613554|FG001|Overall Study|Lack of Efficacy|11|||
37926897|NCT00763815|69613553|FG000|Overall Study|Poor Compliance to Protocol|6|||
37926898|NCT00763815|69613554|FG001|Overall Study|Poor Compliance to Protocol|6|||
37926899|NCT00763815|69613553|FG000|Overall Study|Lost to Follow-up|2|||
37926900|NCT00763815|69613554|FG001|Overall Study|Lost to Follow-up|4|||
37926901|NCT00763815|69613553|FG000|Overall Study|Early Termination|1|||
37926902|NCT00763815|69613554|FG001|Overall Study|Early Termination|0|||
37926903|NCT00763815|69613553|FG000|Overall Study|Familial and Personal Reasons|9|||
37926904|NCT00763815|69613554|FG001|Overall Study|Familial and Personal Reasons|16|||
37926905|NCT00763815|69613553|FG000|Overall Study|Physician Decision|1|||
37926906|NCT00763815|69613554|FG001|Overall Study|Physician Decision|0|||
37926907|NCT00763815|69613553|FG000|Overall Study|Withdrawal by Subject|7|||
37926908|NCT00763815|69613554|FG001|Overall Study|Withdrawal by Subject|12|||
37926909|NCT00763815|69613553|FG000|Overall Study|Protocol Violation|2|||
37926910|NCT00763815|69613554|FG001|Overall Study|Protocol Violation|5|||
37926911|NCT00763815|69613553|FG000|Overall Study|Sponsor's Decision|0|||
37926912|NCT00763815|69613554|FG001|Overall Study|Sponsor's Decision|1|||
37926913|NCT00763269|69613562|FG000|Overall Study|Lost to Follow-up|12|||
37926914|NCT00763269|69613563|FG001|Overall Study|Lost to Follow-up|13|||
37926915|NCT00763035|69613569|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
37926916|NCT00763035|69613570|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
37926917|NCT00763035|69613569|FG000|First Intervention|Adverse Event|0|||
37926918|NCT00763035|69613570|FG001|First Intervention|Adverse Event|1|||
37926919|NCT00763035|69613569|FG000|Second Intervention|Adverse Event|1|||
37926920|NCT00763035|69613570|FG001|Second Intervention|Adverse Event|0|||
37926921|NCT00763035|69613569|FG000|Second Intervention|Physician Decision|2|||
37926922|NCT00763035|69613570|FG001|Second Intervention|Physician Decision|0|||
37926923|NCT00844649|69613578|FG000|Overall Study|Progressive Disease|196|||
37926924|NCT00844649|69613579|FG001|Overall Study|Progressive Disease|245|||
37926925|NCT00844649|69613578|FG000|Overall Study|Adverse Event|128|||
37926926|NCT00844649|69613579|FG001|Overall Study|Adverse Event|73|||
37926927|NCT00844649|69613578|FG000|Overall Study|Physician Decision|25|||
37926928|NCT00844649|69613579|FG001|Overall Study|Physician Decision|18|||
37926929|NCT00844649|69613578|FG000|Overall Study|Protocol Violation|10|||
37926930|NCT00844649|69613579|FG001|Overall Study|Protocol Violation|6|||
37926931|NCT00844649|69613578|FG000|Overall Study|Withdrawal by Subject|28|||
37926932|NCT00844649|69613579|FG001|Overall Study|Withdrawal by Subject|39|||
37926933|NCT00844649|69613578|FG000|Overall Study|Other|7|||
37926934|NCT00844649|69613579|FG001|Overall Study|Other|10|||
37926935|NCT00844649|69613578|FG000|Overall Study|Withdrew prior to starting treatment|11|||
37926936|NCT00844649|69613579|FG001|Overall Study|Withdrew prior to starting treatment|27|||
37926937|NCT00762723|69613590|FG000|Overall Study|Study Terminated slow enrollement|5|||
37667108|NCT01598662|69139583|FG001|Overall Study|Lost to Follow-up|17|||
37667109|NCT01598662|69139582|FG000|Overall Study|Physician Decision|1|||
37667110|NCT01598662|69139583|FG001|Overall Study|Physician Decision|2|||
37667111|NCT01598662|69139582|FG000|Overall Study|IUD expelled before month 6|0|||
37667112|NCT01598662|69139583|FG001|Overall Study|IUD expelled before month 6|2|||
37667113|NCT01629706|69139589|FG000|Phase 1 PureVision|Screen Failure|4|||
37667114|NCT01629706|69139589|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
37667115|NCT01629706|69139589|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
37667116|NCT01629706|69139589|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
37667117|NCT01629706|69139589|FG000|Phase 2 Habitual|Screen Failure|6|||
37926938|NCT00762723|69613591|FG001|Overall Study|Study Terminated slow enrollement|5|||
37926939|NCT00762723|69613592|FG002|Overall Study|Study Terminated slow enrollement|3|||
37926940|NCT00850343|69613604|FG000|Overall Study|Withdrawal by Subject|11|||
37926941|NCT00850343|69613605|FG001|Overall Study|Withdrawal by Subject|0|||
37926942|NCT00850343|69613606|FG002|Overall Study|Withdrawal by Subject|3|||
37667118|NCT01629706|69139589|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
37926943|NCT00850343|69613607|FG003|Overall Study|Withdrawal by Subject|2|||
37926944|NCT00850343|69613604|FG000|Overall Study|Adverse Event|15|||
37926945|NCT00850343|69613605|FG001|Overall Study|Adverse Event|2|||
37926946|NCT00850343|69613606|FG002|Overall Study|Adverse Event|6|||
37926947|NCT00850343|69613607|FG003|Overall Study|Adverse Event|6|||
37926948|NCT00850343|69613604|FG000|Overall Study|Pregnancy|0|||
37926949|NCT00850343|69613605|FG001|Overall Study|Pregnancy|0|||
37926950|NCT00850343|69613606|FG002|Overall Study|Pregnancy|0|||
37926951|NCT00850343|69613607|FG003|Overall Study|Pregnancy|1|||
37926952|NCT00850343|69613604|FG000|Overall Study|Lack of Efficacy|17|||
37926953|NCT00850343|69613605|FG001|Overall Study|Lack of Efficacy|0|||
37926954|NCT00850343|69613606|FG002|Overall Study|Lack of Efficacy|3|||
37926955|NCT00850343|69613607|FG003|Overall Study|Lack of Efficacy|2|||
37926956|NCT00850343|69613604|FG000|Overall Study|Non-compliance with Study Procedures|1|||
37926957|NCT00850343|69613605|FG001|Overall Study|Non-compliance with Study Procedures|0|||
37926958|NCT00850343|69613606|FG002|Overall Study|Non-compliance with Study Procedures|1|||
37926959|NCT00850343|69613607|FG003|Overall Study|Non-compliance with Study Procedures|1|||
37926960|NCT00850343|69613604|FG000|Overall Study|Physician Decision|2|||
37926961|NCT00850343|69613605|FG001|Overall Study|Physician Decision|1|||
37926962|NCT00850343|69613606|FG002|Overall Study|Physician Decision|1|||
37926963|NCT00850343|69613607|FG003|Overall Study|Physician Decision|1|||
37926964|NCT00849875|69613620|FG000|Overall Study|Death|28|||
37926965|NCT00849875|69613620|FG000|Overall Study|Ongoing (unknown completion status)|11|||
37926966|NCT00849875|69613620|FG000|Overall Study|Others|6|||
37926967|NCT00849875|69613620|FG000|Overall Study|Lost to Follow-up|2|||
37926968|NCT00844415|69613631|FG000|Overall Study|Withdrawal by Subject|1|||
37926969|NCT00843635|69613639|FG000|Overall Study|Adverse Event|2|||
37926970|NCT00843635|69613640|FG001|Overall Study|Adverse Event|2|||
37926971|NCT00843635|69613641|FG002|Overall Study|Adverse Event|0|||
37926972|NCT00843167|69613655|FG000|Treatment Period|Adverse Event|1|||
37926973|NCT00843167|69613656|FG001|Treatment Period|Adverse Event|5|||
37926974|NCT00843167|69613655|FG000|Treatment Period|Withdrawal by Subject|2|||
37926975|NCT00843167|69613656|FG001|Treatment Period|Withdrawal by Subject|3|||
37926976|NCT00849017|69613669|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
37926977|NCT00849017|69613670|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
37926978|NCT00849017|69613671|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
37926979|NCT00849017|69613669|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
37926980|NCT00849017|69613670|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
37926981|NCT00849017|69613671|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
37926982|NCT00849017|69613669|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
37926983|NCT00849017|69613670|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
37926984|NCT00849017|69613671|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
37926985|NCT00849017|69613669|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
37926986|NCT00849017|69613670|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
37926987|NCT00849017|69613671|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
37926988|NCT00849017|69613669|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
37926989|NCT00849017|69613670|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
37926990|NCT00849017|69613671|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
37926991|NCT00849017|69613669|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
37926992|NCT00849017|69613670|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
37926993|NCT00849017|69613671|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
37926994|NCT00849017|69613669|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
37926995|NCT00849017|69613670|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
37926996|NCT00849017|69613671|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
37926997|NCT00849017|69613669|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
37926998|NCT00849017|69613670|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
37926999|NCT00849017|69613671|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
37927000|NCT00849017|69613669|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
37927001|NCT00849017|69613670|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
37927002|NCT00849017|69613671|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
37927003|NCT00849017|69613669|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
37927004|NCT00849017|69613670|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
37927005|NCT00849017|69613671|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
37927006|NCT00849017|69613669|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
37927007|NCT00849017|69613670|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
37927008|NCT00849017|69613671|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
37927009|NCT00849017|69613669|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
37927010|NCT00849017|69613670|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
37927011|NCT00849017|69613671|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
37927012|NCT00849017|69613669|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
37927013|NCT00849017|69613670|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
37927014|NCT00849017|69613671|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
37927015|NCT00849017|69613669|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
37927016|NCT00849017|69613670|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
37927017|NCT00849017|69613671|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
37759938|NCT02754141|69270077|FG008|Overall Study|Other reasons|0|||
37927018|NCT00849017|69613669|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
37927019|NCT00849017|69613670|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
37927020|NCT00849017|69613671|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
37927021|NCT00849017|69613669|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
37927022|NCT00849017|69613670|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
37927023|NCT00849017|69613671|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
37927024|NCT00849017|69613669|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
37927025|NCT00849017|69613670|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
37927026|NCT00849017|69613671|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
37927027|NCT00849017|69613669|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
37927028|NCT00849017|69613670|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
37927029|NCT00849017|69613671|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
37927030|NCT00849017|69613669|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
37927031|NCT00849017|69613670|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
37927032|NCT00849017|69613671|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
37927033|NCT00842543|69613687|FG000|Overall Study|Withdrawal by Subject|2|||
37927034|NCT00842543|69613688|FG001|Overall Study|Withdrawal by Subject|0|||
37927035|NCT00842543|69613689|FG002|Overall Study|Withdrawal by Subject|3|||
37927036|NCT00842543|69613690|FG003|Overall Study|Withdrawal by Subject|4|||
37927037|NCT00785928|69613709|FG000|Treatment Phase|Adverse Event|1|||
37927038|NCT00785928|69613710|FG001|Treatment Phase|Adverse Event|1|||
37927039|NCT00785928|69613711|FG002|Treatment Phase|Adverse Event|2|||
37927040|NCT00785928|69613712|FG003|Treatment Phase|Adverse Event|0|||
37927041|NCT00785928|69613713|FG004|Treatment Phase|Adverse Event|0|||
37927042|NCT00785928|69613714|FG005|Treatment Phase|Adverse Event|0|||
37927043|NCT00785928|69613715|FG006|Treatment Phase|Adverse Event|2|||
37927044|NCT00785928|69613709|FG000|Treatment Phase|Inadequate Response|0|||
37927045|NCT00785928|69613710|FG001|Treatment Phase|Inadequate Response|1|||
37927046|NCT00785928|69613711|FG002|Treatment Phase|Inadequate Response|0|||
37927047|NCT00785928|69613712|FG003|Treatment Phase|Inadequate Response|0|||
37927048|NCT00785928|69613713|FG004|Treatment Phase|Inadequate Response|0|||
37927049|NCT00785928|69613714|FG005|Treatment Phase|Inadequate Response|0|||
37927050|NCT00785928|69613715|FG006|Treatment Phase|Inadequate Response|0|||
37927051|NCT00785928|69613709|FG000|Treatment Phase|Lack of Efficacy|0|||
37927052|NCT00785928|69613710|FG001|Treatment Phase|Lack of Efficacy|1|||
37927053|NCT00785928|69613711|FG002|Treatment Phase|Lack of Efficacy|1|||
37927054|NCT00785928|69613712|FG003|Treatment Phase|Lack of Efficacy|0|||
37927055|NCT00785928|69613713|FG004|Treatment Phase|Lack of Efficacy|0|||
37927056|NCT00785928|69613714|FG005|Treatment Phase|Lack of Efficacy|0|||
37927057|NCT00785928|69613715|FG006|Treatment Phase|Lack of Efficacy|0|||
37927058|NCT00785928|69613709|FG000|Treatment Phase|Physician Decision|0|||
37927059|NCT00785928|69613710|FG001|Treatment Phase|Physician Decision|0|||
38033523|NCT03325556|69719496|FG000|Double-blind Period|Relapse|0|||
38033524|NCT03325556|69719497|FG001|Double-blind Period|Relapse|15|||
37667119|NCT01629706|69139589|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
37927060|NCT00785928|69613711|FG002|Treatment Phase|Physician Decision|0|||
37667120|NCT01629706|69139589|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
37667121|NCT01629706|69139589|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
37667122|NCT02153086|69139597|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
37667123|NCT02153086|69139597|FG000|Overall Study|Other|2|||
37667124|NCT02117050|69139601|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
37667125|NCT02728895|69139608|FG000|Overall Study|Other|1|||
37667126|NCT02728895|69139609|FG001|Overall Study|Other|2|||
37667127|NCT02728895|69139608|FG000|Overall Study|Withdrawal by Subject|0|||
37667128|NCT02728895|69139609|FG001|Overall Study|Withdrawal by Subject|3|||
37667129|NCT02606877|69139617|FG000|Overall Study|Adverse Event|3|||
37667130|NCT02606877|69139618|FG001|Overall Study|Adverse Event|0|||
37667131|NCT02606877|69139617|FG000|Overall Study|Non-compliance with protocol|0|||
37667132|NCT02606877|69139618|FG001|Overall Study|Non-compliance with protocol|1|||
37667133|NCT02606877|69139617|FG000|Overall Study|Other than listed above|1|||
37667134|NCT02606877|69139618|FG001|Overall Study|Other than listed above|0|||
37667135|NCT02606643|69139628|FG000|Overall Study|did not meet inclusion criteria|1|||
37667136|NCT02606643|69139629|FG001|Overall Study|did not meet inclusion criteria|3|||
37667137|NCT02609607|69139660|FG000|Overall Study|Lost to Follow-up|0|||
37667138|NCT02609607|69139661|FG001|Overall Study|Lost to Follow-up|1|||
37667139|NCT02606253|69139670|FG000|Overall Study|Adverse Event|2|||
37667140|NCT02606253|69139671|FG001|Overall Study|Adverse Event|0|||
37927061|NCT00785928|69613712|FG003|Treatment Phase|Physician Decision|0|||
38033525|NCT03325556|69719498|FG002|Double-blind Period|Relapse|34|||
37667141|NCT02606253|69139672|FG002|Overall Study|Adverse Event|0|||
37667142|NCT02606253|69139670|FG000|Overall Study|Protocol Violation|2|||
37667143|NCT02606253|69139671|FG001|Overall Study|Protocol Violation|1|||
37927062|NCT00785928|69613713|FG004|Treatment Phase|Physician Decision|1|||
37927063|NCT00785928|69613714|FG005|Treatment Phase|Physician Decision|0|||
38033526|NCT03325556|69719496|FG000|Double-blind Period|Adverse Event|0|||
37759939|NCT02754141|69270078|FG009|Overall Study|Other reasons|0|||
37759940|NCT02754141|69270079|FG010|Overall Study|Other reasons|0|||
37759941|NCT02754141|69270080|FG011|Overall Study|Other reasons|0|||
37759942|NCT02754141|69270081|FG012|Overall Study|Other reasons|2|||
37759943|NCT02754141|69270082|FG013|Overall Study|Other reasons|0|||
37759944|NCT02754141|69270083|FG014|Overall Study|Other reasons|0|||
37759945|NCT02754141|69270084|FG015|Overall Study|Other reasons|0|||
37759946|NCT02754141|69270085|FG016|Overall Study|Other reasons|0|||
37759947|NCT02754141|69270086|FG017|Overall Study|Other reasons|0|||
37759948|NCT02754141|69270069|FG000|Overall Study|Completed treatment as per protocol|0|||
37759949|NCT02754141|69270070|FG001|Overall Study|Completed treatment as per protocol|1|||
37759950|NCT02754141|69270071|FG002|Overall Study|Completed treatment as per protocol|0|||
37759951|NCT02754141|69270072|FG003|Overall Study|Completed treatment as per protocol|0|||
37759952|NCT02754141|69270073|FG004|Overall Study|Completed treatment as per protocol|0|||
37759953|NCT02754141|69270074|FG005|Overall Study|Completed treatment as per protocol|0|||
37759954|NCT02754141|69270075|FG006|Overall Study|Completed treatment as per protocol|0|||
37759955|NCT02754141|69270076|FG007|Overall Study|Completed treatment as per protocol|0|||
37759956|NCT02754141|69270077|FG008|Overall Study|Completed treatment as per protocol|0|||
37759957|NCT02754141|69270078|FG009|Overall Study|Completed treatment as per protocol|0|||
37759958|NCT02754141|69270079|FG010|Overall Study|Completed treatment as per protocol|0|||
37759959|NCT02754141|69270080|FG011|Overall Study|Completed treatment as per protocol|0|||
37759960|NCT02754141|69270081|FG012|Overall Study|Completed treatment as per protocol|1|||
37759961|NCT02754141|69270082|FG013|Overall Study|Completed treatment as per protocol|0|||
37759962|NCT02754141|69270083|FG014|Overall Study|Completed treatment as per protocol|0|||
37759963|NCT02754141|69270084|FG015|Overall Study|Completed treatment as per protocol|0|||
37759964|NCT02754141|69270085|FG016|Overall Study|Completed treatment as per protocol|0|||
37759965|NCT02754141|69270086|FG017|Overall Study|Completed treatment as per protocol|0|||
37759966|NCT02754141|69270069|FG000|Overall Study|Not completing monotherapy|0|||
37759967|NCT02754141|69270070|FG001|Overall Study|Not completing monotherapy|0|||
37759968|NCT02754141|69270071|FG002|Overall Study|Not completing monotherapy|0|||
37759969|NCT02754141|69270072|FG003|Overall Study|Not completing monotherapy|0|||
37759970|NCT02754141|69270073|FG004|Overall Study|Not completing monotherapy|0|||
37759971|NCT02754141|69270074|FG005|Overall Study|Not completing monotherapy|0|||
37759972|NCT02754141|69270075|FG006|Overall Study|Not completing monotherapy|0|||
37759973|NCT02754141|69270076|FG007|Overall Study|Not completing monotherapy|0|||
37759974|NCT02754141|69270077|FG008|Overall Study|Not completing monotherapy|0|||
37759975|NCT02754141|69270078|FG009|Overall Study|Not completing monotherapy|0|||
37759976|NCT02754141|69270079|FG010|Overall Study|Not completing monotherapy|0|||
37759977|NCT02754141|69270080|FG011|Overall Study|Not completing monotherapy|0|||
37759978|NCT02754141|69270081|FG012|Overall Study|Not completing monotherapy|0|||
37759979|NCT02754141|69270082|FG013|Overall Study|Not completing monotherapy|1|||
37759980|NCT02754141|69270083|FG014|Overall Study|Not completing monotherapy|0|||
37759981|NCT02754141|69270084|FG015|Overall Study|Not completing monotherapy|0|||
37759982|NCT02754141|69270085|FG016|Overall Study|Not completing monotherapy|0|||
37759983|NCT02754141|69270086|FG017|Overall Study|Not completing monotherapy|0|||
37759984|NCT02659059|69270165|FG000|Overall Study|Other reasons|6|||
37759985|NCT02659059|69270166|FG001|Overall Study|Other reasons|1|||
37759986|NCT02659059|69270165|FG000|Overall Study|Disease Progression|143|||
37759987|NCT02659059|69270166|FG001|Overall Study|Disease Progression|16|||
37759988|NCT02659059|69270165|FG000|Overall Study|Study Drug toxicity|56|||
37927064|NCT00785928|69613715|FG006|Treatment Phase|Physician Decision|0|||
37927065|NCT00785928|69613709|FG000|Treatment Phase|Sponsor Decision|1|||
37927066|NCT00785928|69613710|FG001|Treatment Phase|Sponsor Decision|0|||
37927067|NCT00785928|69613711|FG002|Treatment Phase|Sponsor Decision|0|||
37927068|NCT00785928|69613712|FG003|Treatment Phase|Sponsor Decision|0|||
37927069|NCT00785928|69613713|FG004|Treatment Phase|Sponsor Decision|0|||
37927070|NCT00785928|69613714|FG005|Treatment Phase|Sponsor Decision|0|||
37927071|NCT00785928|69613715|FG006|Treatment Phase|Sponsor Decision|1|||
37927072|NCT00785928|69613709|FG000|Treatment Phase|Withdrawal by Subject|1|||
37927073|NCT00785928|69613710|FG001|Treatment Phase|Withdrawal by Subject|2|||
37927074|NCT00785928|69613711|FG002|Treatment Phase|Withdrawal by Subject|0|||
37927075|NCT00785928|69613712|FG003|Treatment Phase|Withdrawal by Subject|0|||
37927076|NCT00785928|69613713|FG004|Treatment Phase|Withdrawal by Subject|1|||
38033527|NCT03325556|69719497|FG001|Double-blind Period|Adverse Event|3|||
37759989|NCT02659059|69270166|FG001|Overall Study|Study Drug toxicity|9|||
37759990|NCT02659059|69270165|FG000|Overall Study|Death|3|||
37759991|NCT02659059|69270166|FG001|Overall Study|Death|1|||
37759992|NCT02659059|69270165|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
37759993|NCT02659059|69270166|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
37759994|NCT02659059|69270165|FG000|Overall Study|Participant request to discontinue study treatment|5|||
37759995|NCT02659059|69270166|FG001|Overall Study|Participant request to discontinue study treatment|0|||
37759996|NCT02659059|69270165|FG000|Overall Study|Participant withdrew consent|6|||
37927077|NCT00785928|69613714|FG005|Treatment Phase|Withdrawal by Subject|0|||
37927078|NCT00785928|69613715|FG006|Treatment Phase|Withdrawal by Subject|0|||
37927079|NCT00842309|69613755|FG000|Overall Study|Withdrawal by Subject|3|||
37927080|NCT00842309|69613756|FG001|Overall Study|Withdrawal by Subject|1|||
37927081|NCT00842153|69613764|FG000|Overall Study|Adverse Event|0|||
37927082|NCT00842153|69613765|FG001|Overall Study|Adverse Event|1|||
37927083|NCT00842153|69613764|FG000|Overall Study|Lost to Follow-up|1|||
37927084|NCT00842153|69613765|FG001|Overall Study|Lost to Follow-up|2|||
37927085|NCT00762411|69613773|FG000|Initial Treatment|Death|7|||
37927086|NCT00762411|69613774|FG001|Initial Treatment|Death|6|||
37927087|NCT00762411|69613773|FG000|Initial Treatment|Adverse Event|132|||
37927088|NCT00762411|69613774|FG001|Initial Treatment|Adverse Event|40|||
37927089|NCT00762411|69613773|FG000|Initial Treatment|Protocol Violation|4|||
37927090|NCT00762411|69613774|FG001|Initial Treatment|Protocol Violation|1|||
37927091|NCT00762411|69613773|FG000|Initial Treatment|Withdrawal by Subject|65|||
37927092|NCT00762411|69613774|FG001|Initial Treatment|Withdrawal by Subject|52|||
37927093|NCT00762411|69613773|FG000|Initial Treatment|Physician Decision|1|||
37927094|NCT00762411|69613774|FG001|Initial Treatment|Physician Decision|0|||
37927095|NCT00762411|69613773|FG000|Initial Treatment|Sponsor Decision|293|||
37927096|NCT00762411|69613774|FG001|Initial Treatment|Sponsor Decision|401|||
37927097|NCT00762411|69613773|FG000|Initial Treatment|Lost to Follow-up|5|||
37927098|NCT00762411|69613774|FG001|Initial Treatment|Lost to Follow-up|0|||
37927099|NCT00762411|69613773|FG000|Initial Treatment|Caregiver Decision|21|||
37927100|NCT00762411|69613774|FG001|Initial Treatment|Caregiver Decision|16|||
37927101|NCT00762411|69613773|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
37927102|NCT00762411|69613774|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
37927103|NCT00762411|69613773|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
37927104|NCT00762411|69613774|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
37927105|NCT00762411|69613773|FG000|Delayed Start|Adverse Event|0|||
37927106|NCT00762411|69613774|FG001|Delayed Start|Adverse Event|4|||
37927107|NCT00762411|69613773|FG000|Delayed Start|Protocol Violation|0|||
37927108|NCT00762411|69613774|FG001|Delayed Start|Protocol Violation|1|||
37927109|NCT00762411|69613773|FG000|Delayed Start|Sponsor Decision|16|||
37927110|NCT00762411|69613774|FG001|Delayed Start|Sponsor Decision|20|||
37927111|NCT00762411|69613773|FG000|Delayed Start|Caregiver Decision|1|||
37927112|NCT00762411|69613774|FG001|Delayed Start|Caregiver Decision|1|||
37927113|NCT00762411|69613773|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
37927114|NCT00762411|69613774|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
37927115|NCT00762411|69613773|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
37927116|NCT00762411|69613774|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
37927117|NCT00762411|69613773|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
37927118|NCT00762411|69613774|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
37927119|NCT00762411|69613773|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
37927120|NCT00762411|69613774|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
37927121|NCT00762411|69613773|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
37927122|NCT00762411|69613774|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
37927123|NCT00762411|69613773|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
37927124|NCT00762411|69613774|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
37927125|NCT00761865|69613786|FG000|Overall Study|Lost to Follow-up|8|||
37927126|NCT00761865|69613787|FG001|Overall Study|Lost to Follow-up|7|||
37927127|NCT00841763|69613795|FG000|Overall Study|Withdrawal by Subject|60|||
37927128|NCT00841763|69613796|FG001|Overall Study|Withdrawal by Subject|17|||
37927129|NCT00841763|69613797|FG002|Overall Study|Withdrawal by Subject|4|||
37927130|NCT00841763|69613798|FG003|Overall Study|Withdrawal by Subject|1|||
37927131|NCT00841763|69613795|FG000|Overall Study|Adverse Event|9|||
37927132|NCT00841763|69613796|FG001|Overall Study|Adverse Event|10|||
37927133|NCT00841763|69613797|FG002|Overall Study|Adverse Event|3|||
37927134|NCT00841763|69613798|FG003|Overall Study|Adverse Event|2|||
37927135|NCT00841763|69613795|FG000|Overall Study|Lost to Follow-up|63|||
37927136|NCT00841763|69613796|FG001|Overall Study|Lost to Follow-up|25|||
37927137|NCT00841763|69613797|FG002|Overall Study|Lost to Follow-up|0|||
37927138|NCT00841763|69613798|FG003|Overall Study|Lost to Follow-up|0|||
37927139|NCT00841763|69613795|FG000|Overall Study|Protocol Violation|20|||
37927140|NCT00841763|69613796|FG001|Overall Study|Protocol Violation|3|||
37927141|NCT00841763|69613797|FG002|Overall Study|Protocol Violation|1|||
37927142|NCT00841763|69613798|FG003|Overall Study|Protocol Violation|0|||
37927143|NCT00841763|69613795|FG000|Overall Study|Administrative Reasons|3|||
37927144|NCT00841763|69613796|FG001|Overall Study|Administrative Reasons|1|||
37927145|NCT00841763|69613797|FG002|Overall Study|Administrative Reasons|0|||
37927146|NCT00841763|69613798|FG003|Overall Study|Administrative Reasons|0|||
37927147|NCT00841763|69613795|FG000|Overall Study|Unable to Classify|7|||
37927148|NCT00841763|69613796|FG001|Overall Study|Unable to Classify|1|||
37927149|NCT00841763|69613797|FG002|Overall Study|Unable to Classify|0|||
37927150|NCT00841763|69613798|FG003|Overall Study|Unable to Classify|0|||
37927151|NCT00838331|69613843|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
37759997|NCT02659059|69270166|FG001|Overall Study|Participant withdrew consent|1|||
37927152|NCT00785538|69613851|FG000|Treatment Period|Adverse Event|1|||
37927153|NCT00785538|69613852|FG001|Treatment Period|Adverse Event|2|||
37927154|NCT00785538|69613853|FG002|Treatment Period|Adverse Event|2|||
37927155|NCT00785538|69613854|FG003|Treatment Period|Adverse Event|0|||
37927156|NCT00785538|69613851|FG000|Treatment Period|Withdrawal by Subject|0|||
37927157|NCT00785538|69613852|FG001|Treatment Period|Withdrawal by Subject|0|||
37927158|NCT00785538|69613853|FG002|Treatment Period|Withdrawal by Subject|0|||
37927159|NCT00785538|69613854|FG003|Treatment Period|Withdrawal by Subject|1|||
37927160|NCT00860405|69613867|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
37927161|NCT00860405|69613868|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
37927162|NCT00838097|69613874|FG000|Overall Study|Ineligibility determined|6|||
37927163|NCT00838097|69613874|FG000|Overall Study|Adverse Event|2|||
37927164|NCT00838097|69613874|FG000|Overall Study|Withdrawal by Subject|3|||
37927165|NCT00838097|69613874|FG000|Overall Study|Requirement for alternative therapy|2|||
37927166|NCT00838097|69613874|FG000|Overall Study|Physician Decision|4|||
37927167|NCT00838097|69613874|FG000|Overall Study|Lost to Follow-up|11|||
37927168|NCT00838097|69613874|FG000|Overall Study|Death|6|||
37927169|NCT00838097|69613874|FG000|Overall Study|Protocol-specified criteria|142|||
37927170|NCT00840827|69613878|FG000|Overall Study|Adverse Event|1|||
37927171|NCT00840827|69613878|FG000|Overall Study|Lack of Efficacy|4|||
37927172|NCT00840827|69613878|FG000|Overall Study|Physician Decision|1|||
37927173|NCT00860249|69613885|FG000|Overall Study|trial was terminated prior to completion|21|||
37927174|NCT00860249|69613886|FG001|Overall Study|trial was terminated prior to completion|18|||
37927175|NCT00860249|69613887|FG002|Overall Study|trial was terminated prior to completion|21|||
37927176|NCT00840749|69613897|FG000|Overall Study|Death|1|||
37927177|NCT00840749|69613898|FG001|Overall Study|Death|2|||
37927178|NCT00840749|69613897|FG000|Overall Study|not treated on study arm|11|||
37927179|NCT00840749|69613898|FG001|Overall Study|not treated on study arm|11|||
37927180|NCT00840749|69613897|FG000|Overall Study|study closed|19|||
37927181|NCT00840749|69613898|FG001|Overall Study|study closed|14|||
37927182|NCT00859937|69613906|FG000|Overall Study|Protocol Violation|1|||
37927183|NCT00859937|69613907|FG001|Overall Study|Protocol Violation|0|||
37927184|NCT00592007|69613913|FG000|Overall Study|Withdrawal by Subject|1|||
37927185|NCT00592007|69613913|FG000|Overall Study|patient ineligible (out of lab range)|1|||
37927186|NCT00837473|69613917|FG000|Overall Study|Lost to Follow-up|1|||
37927187|NCT00837473|69613917|FG000|Overall Study|Withdrawal by Subject|2|||
37927188|NCT00839423|69613925|FG000|Overall Study|Adverse Event|4|||
37927189|NCT00839423|69613926|FG001|Overall Study|Adverse Event|3|||
37927190|NCT00839423|69613927|FG002|Overall Study|Adverse Event|7|||
37927191|NCT00839423|69613928|FG003|Overall Study|Adverse Event|16|||
37927192|NCT00839423|69613925|FG000|Overall Study|Lack of Efficacy|6|||
37927193|NCT00839423|69613926|FG001|Overall Study|Lack of Efficacy|6|||
37927194|NCT00839423|69613927|FG002|Overall Study|Lack of Efficacy|3|||
37927195|NCT00839423|69613928|FG003|Overall Study|Lack of Efficacy|2|||
37927196|NCT00839423|69613925|FG000|Overall Study|Non-compliance|0|||
37927197|NCT00839423|69613926|FG001|Overall Study|Non-compliance|0|||
37927198|NCT00839423|69613927|FG002|Overall Study|Non-compliance|0|||
37927199|NCT00839423|69613928|FG003|Overall Study|Non-compliance|1|||
37927200|NCT00839423|69613925|FG000|Overall Study|Protocol Violation|0|||
37927201|NCT00839423|69613926|FG001|Overall Study|Protocol Violation|1|||
37667144|NCT02606253|69139672|FG002|Overall Study|Protocol Violation|0|||
37667145|NCT02606253|69139670|FG000|Overall Study|Physician Decision|1|||
37667146|NCT02606253|69139671|FG001|Overall Study|Physician Decision|1|||
37667147|NCT02606253|69139672|FG002|Overall Study|Physician Decision|0|||
37667148|NCT02607735|69139682|FG000|Primary Study|Randomized but Never Treated|1|||
37667149|NCT02607735|69139683|FG001|Primary Study|Randomized but Never Treated|0|||
37667150|NCT02607735|69139684|FG002|Primary Study|Randomized but Never Treated|0|||
37667151|NCT02607735|69139682|FG000|Primary Study|Lost to Follow-up|4|||
37667152|NCT02607735|69139683|FG001|Primary Study|Lost to Follow-up|0|||
37667153|NCT02607735|69139684|FG002|Primary Study|Lost to Follow-up|0|||
37667154|NCT02607735|69139682|FG000|Primary Study|Withdrew Consent|2|||
37927202|NCT00839423|69613927|FG002|Overall Study|Protocol Violation|2|||
37927203|NCT00839423|69613928|FG003|Overall Study|Protocol Violation|0|||
37927204|NCT00839423|69613925|FG000|Overall Study|Withdrawal of consent|4|||
37927205|NCT00839423|69613926|FG001|Overall Study|Withdrawal of consent|0|||
37927206|NCT00839423|69613927|FG002|Overall Study|Withdrawal of consent|4|||
37927207|NCT00839423|69613928|FG003|Overall Study|Withdrawal of consent|1|||
37927208|NCT00839423|69613925|FG000|Overall Study|Lost to Follow-up|1|||
37927209|NCT00839423|69613926|FG001|Overall Study|Lost to Follow-up|0|||
37927210|NCT00839423|69613927|FG002|Overall Study|Lost to Follow-up|1|||
37667155|NCT02607735|69139683|FG001|Primary Study|Withdrew Consent|0|||
37759998|NCT01164891|69270181|FG000|Overall Study|Disease Progression|5|||
37927211|NCT00839423|69613928|FG003|Overall Study|Lost to Follow-up|0|||
37927212|NCT00839423|69613925|FG000|Overall Study|Administrative or other reasons|3|||
37927213|NCT00839423|69613926|FG001|Overall Study|Administrative or other reasons|0|||
37927214|NCT00839423|69613927|FG002|Overall Study|Administrative or other reasons|1|||
37927215|NCT00839423|69613928|FG003|Overall Study|Administrative or other reasons|0|||
37759999|NCT01164891|69270181|FG000|Overall Study|Adverse Event|1|||
37927216|NCT00837161|69613938|FG000|Overall Study|refused hysterectomy|2|||
37927217|NCT00859547|69613942|FG000|Overall Study|Lost to Follow-up|1|||
37667156|NCT02607735|69139684|FG002|Primary Study|Withdrew Consent|0|||
37927218|NCT00859547|69613942|FG000|Overall Study|Parent withdrew consent|1|||
37927219|NCT00859469|69613946|FG000|Overall Study|Adverse Event|2|||
37927220|NCT00859469|69613946|FG000|Overall Study|Lack of Efficacy|9|||
37927221|NCT00859469|69613946|FG000|Overall Study|Withdrawal by Subject|1|||
37927222|NCT00859469|69613946|FG000|Overall Study|Death|16|||
37927223|NCT00859313|69613950|FG000|Overall Study|Lack of Efficacy|2|||
37927224|NCT00859313|69613950|FG000|Overall Study|Adverse Event|1|||
37927225|NCT00859313|69613950|FG000|Overall Study|staff error|1|||
37927226|NCT00771810|69613957|FG000|Overall Study|Adverse Event|3|||
37927227|NCT00771810|69613958|FG001|Overall Study|Adverse Event|0|||
37927228|NCT00771810|69613959|FG002|Overall Study|Adverse Event|2|||
37927229|NCT00771810|69613957|FG000|Overall Study|Lost to Follow-up|0|||
37927230|NCT00771810|69613958|FG001|Overall Study|Lost to Follow-up|0|||
37927231|NCT00771810|69613959|FG002|Overall Study|Lost to Follow-up|1|||
37927232|NCT00771810|69613957|FG000|Overall Study|Physician Decision|1|||
37927233|NCT00771810|69613958|FG001|Overall Study|Physician Decision|2|||
37927234|NCT00771810|69613959|FG002|Overall Study|Physician Decision|2|||
37927235|NCT00771810|69613957|FG000|Overall Study|Protocol Violation|0|||
37927236|NCT00771810|69613958|FG001|Overall Study|Protocol Violation|1|||
37927237|NCT00771810|69613959|FG002|Overall Study|Protocol Violation|1|||
37927238|NCT00771810|69613957|FG000|Overall Study|Withdrawal by Subject|1|||
37927239|NCT00771810|69613958|FG001|Overall Study|Withdrawal by Subject|2|||
37927240|NCT00771810|69613959|FG002|Overall Study|Withdrawal by Subject|0|||
37927241|NCT00771810|69613957|FG000|Overall Study|Other|0|||
37927242|NCT00771810|69613958|FG001|Overall Study|Other|0|||
37927243|NCT00771810|69613959|FG002|Overall Study|Other|1|||
37927244|NCT00836927|69613973|FG000|Overall Study|Progressive disease|2|||
37927245|NCT00836927|69613974|FG001|Overall Study|Progressive disease|0|||
37760000|NCT01497899|69270190|FG000|Double-Blind Phase|Randomized but not Treated|1|||
37760001|NCT01497899|69270191|FG001|Double-Blind Phase|Randomized but not Treated|0|||
37760002|NCT01497899|69270192|FG002|Double-Blind Phase|Randomized but not Treated|0|||
37760003|NCT01497899|69270193|FG003|Double-Blind Phase|Randomized but not Treated|0|||
37760004|NCT01497899|69270190|FG000|Double-Blind Phase|Adverse Event|1|||
37760005|NCT01497899|69270191|FG001|Double-Blind Phase|Adverse Event|0|||
37760006|NCT01497899|69270192|FG002|Double-Blind Phase|Adverse Event|0|||
37760007|NCT01497899|69270193|FG003|Double-Blind Phase|Adverse Event|0|||
37927246|NCT00836927|69613975|FG002|Overall Study|Progressive disease|0|||
37927247|NCT00836927|69613976|FG003|Overall Study|Progressive disease|1|||
37927248|NCT00836927|69613977|FG004|Overall Study|Progressive disease|1|||
37927249|NCT00836927|69613973|FG000|Overall Study|Withdrawal by Subject|1|||
37927250|NCT00836927|69613974|FG001|Overall Study|Withdrawal by Subject|0|||
37927251|NCT00836927|69613975|FG002|Overall Study|Withdrawal by Subject|0|||
37927252|NCT00836927|69613976|FG003|Overall Study|Withdrawal by Subject|0|||
37927253|NCT00836927|69613977|FG004|Overall Study|Withdrawal by Subject|0|||
37927254|NCT00771030|69613998|FG000|Overall Study|Adverse Event|0|||
37927255|NCT00771030|69613999|FG001|Overall Study|Adverse Event|1|||
37927256|NCT00771030|69614000|FG002|Overall Study|Adverse Event|0|||
37927257|NCT00771030|69614001|FG003|Overall Study|Adverse Event|0|||
37927258|NCT00771030|69614002|FG004|Overall Study|Adverse Event|0|||
37927259|NCT00771030|69614003|FG005|Overall Study|Adverse Event|0|||
37927260|NCT00771030|69614004|FG006|Overall Study|Adverse Event|0|||
38033528|NCT03325556|69719498|FG002|Double-blind Period|Adverse Event|1|||
38033529|NCT03325556|69719496|FG000|Double-blind Period|Noncompliance with study drug|0|||
37667157|NCT02607735|69139682|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
37667158|NCT02607735|69139683|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
37667159|NCT02607735|69139684|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
37667160|NCT02607735|69139682|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
37667161|NCT02607735|69139683|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
37667162|NCT02607735|69139684|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
37667163|NCT04772313|69139692|FG000|Pegloticase + MTX Treatment Period|Lost to Follow-up|3|||
37667164|NCT04772313|69139692|FG000|Pegloticase + MTX Treatment Period|Withdrawal by Subject|3|||
37667165|NCT01668537|69139699|FG000|Overall Study|Request to Discontinue Prematurely|1|||
37667166|NCT01668537|69139700|FG001|Overall Study|Request to Discontinue Prematurely|1|||
37667167|NCT01668537|69139699|FG000|Overall Study|Subject unwilling/unable to comply|5|||
37667168|NCT01668537|69139700|FG001|Overall Study|Subject unwilling/unable to comply|0|||
37927261|NCT00768300|69614027|FG000|Overall Study|Randomized but not treated|1|||
37927262|NCT00768300|69614028|FG001|Overall Study|Randomized but not treated|1|||
37927263|NCT00768300|69614027|FG000|Overall Study|Adverse Event|10|||
37927264|NCT00768300|69614028|FG001|Overall Study|Adverse Event|2|||
38033530|NCT03325556|69719497|FG001|Double-blind Period|Noncompliance with study drug|0|||
37667169|NCT01668537|69139699|FG000|Overall Study|Reason Precludes Participation|1|||
37667170|NCT01668537|69139700|FG001|Overall Study|Reason Precludes Participation|0|||
37760008|NCT01497899|69270190|FG000|Double-Blind Phase|Lack of Efficacy|0|||
37927265|NCT00768300|69614027|FG000|Overall Study|Protocol Violation|6|||
37927266|NCT00768300|69614028|FG001|Overall Study|Protocol Violation|1|||
38033531|NCT03325556|69719498|FG002|Double-blind Period|Noncompliance with study drug|1|||
37927267|NCT00768300|69614027|FG000|Overall Study|Withdrawal by Subject|13|||
37760009|NCT01497899|69270191|FG001|Double-Blind Phase|Lack of Efficacy|1|||
38033532|NCT03325556|69719496|FG000|Double-blind Period|Use of prohibited medication|0|||
38033533|NCT03325556|69719497|FG001|Double-blind Period|Use of prohibited medication|1|||
38033534|NCT03325556|69719498|FG002|Double-blind Period|Use of prohibited medication|0|||
37760010|NCT01497899|69270192|FG002|Double-Blind Phase|Lack of Efficacy|0|||
37760011|NCT01497899|69270193|FG003|Double-Blind Phase|Lack of Efficacy|0|||
37760012|NCT01497899|69270190|FG000|Double-Blind Phase|Investigator's Discretion|1|||
37667171|NCT01668537|69139699|FG000|Overall Study|Lost to Follow-up|13|||
37667172|NCT01668537|69139700|FG001|Overall Study|Lost to Follow-up|6|||
37667173|NCT01668537|69139699|FG000|Overall Study|Other|2|||
37667174|NCT01668537|69139700|FG001|Overall Study|Other|3|||
37667175|NCT01668147|69139706|FG000|Overall Study|Withdrawal by Subject|6|||
37667176|NCT02600559|69139723|FG000|Overall Study|Withdrawal by Subject|3|||
37667177|NCT02600559|69139723|FG000|Overall Study|Lost to Follow-up|20|||
37667178|NCT02601573|69139732|FG000|Overall Study|Lost to Follow-up|0|||
37667179|NCT02601573|69139733|FG001|Overall Study|Lost to Follow-up|3|||
37667180|NCT02601573|69139734|FG002|Overall Study|Lost to Follow-up|1|||
37667181|NCT02601573|69139735|FG003|Overall Study|Lost to Follow-up|0|||
37667182|NCT02601573|69139736|FG004|Overall Study|Lost to Follow-up|2|||
37667183|NCT02601573|69139732|FG000|Overall Study|Withdrawal by Subject|0|||
37667184|NCT02601573|69139733|FG001|Overall Study|Withdrawal by Subject|1|||
37667185|NCT02601573|69139734|FG002|Overall Study|Withdrawal by Subject|0|||
37760013|NCT01497899|69270191|FG001|Double-Blind Phase|Investigator's Discretion|0|||
37760014|NCT01497899|69270192|FG002|Double-Blind Phase|Investigator's Discretion|0|||
37760015|NCT01497899|69270193|FG003|Double-Blind Phase|Investigator's Discretion|0|||
37760016|NCT01497899|69270190|FG000|Double-Blind Phase|Withdrew Consent|0|||
37760017|NCT01497899|69270191|FG001|Double-Blind Phase|Withdrew Consent|1|||
37927268|NCT00768300|69614028|FG001|Overall Study|Withdrawal by Subject|7|||
37927269|NCT00768300|69614027|FG000|Overall Study|Physician Decision|2|||
37927270|NCT00768300|69614028|FG001|Overall Study|Physician Decision|3|||
38033535|NCT03325556|69719496|FG000|Double-blind Period|Physician Decision|0|||
38033536|NCT03325556|69719497|FG001|Double-blind Period|Physician Decision|0|||
38033537|NCT03325556|69719498|FG002|Double-blind Period|Physician Decision|1|||
38033538|NCT03325556|69719496|FG000|Double-blind Period|Withdrawal by Subject|0|||
37667186|NCT02601573|69139735|FG003|Overall Study|Withdrawal by Subject|1|||
37667187|NCT02601573|69139736|FG004|Overall Study|Withdrawal by Subject|0|||
37667188|NCT02601027|69139750|FG000|Registration to Surgery|Withdrawal by Subject|20|||
37667189|NCT02601027|69139751|FG001|Registration to Surgery|Withdrawal by Subject|10|||
37667190|NCT02600871|69139759|FG000|Overall Study|Lost to Follow-up|13|||
37667191|NCT02600871|69139760|FG001|Overall Study|Lost to Follow-up|10|||
37667192|NCT02598297|69139769|FG000|Overall Study|Study terminated by Sponsor|21|||
37927271|NCT00768300|69614027|FG000|Overall Study|Study discontinued by Sponsor|271|||
37927272|NCT00768300|69614028|FG001|Overall Study|Study discontinued by Sponsor|140|||
37927273|NCT00768300|69614027|FG000|Overall Study|Death|21|||
37927274|NCT00768300|69614028|FG001|Overall Study|Death|5|||
37927275|NCT00768300|69614027|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
37927276|NCT00768300|69614028|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
37927277|NCT00768300|69614027|FG000|Overall Study|Screen failure following randomization|1|||
37927278|NCT00768300|69614028|FG001|Overall Study|Screen failure following randomization|0|||
37927279|NCT00768300|69614027|FG000|Overall Study|Received lung transplant|1|||
37927280|NCT00768300|69614028|FG001|Overall Study|Received lung transplant|1|||
37927281|NCT00768300|69614027|FG000|Overall Study|Lost to Follow-up|0|||
37927282|NCT00768300|69614028|FG001|Overall Study|Lost to Follow-up|1|||
37927283|NCT00768300|69614027|FG000|Overall Study|Began prohibited concomitant medication|0|||
37927284|NCT00768300|69614028|FG001|Overall Study|Began prohibited concomitant medication|1|||
37927285|NCT00768300|69614027|FG000|Overall Study|Treated but never dosed with Study drug|1|||
37927286|NCT00768300|69614028|FG001|Overall Study|Treated but never dosed with Study drug|0|||
37927287|NCT00768300|69614027|FG000|Overall Study|Missing data|1|||
37927288|NCT00768300|69614028|FG001|Overall Study|Missing data|0|||
37927289|NCT00768222|69614036|FG000|Overall Study|Lost to Follow-up|1|||
37927290|NCT00768222|69614037|FG001|Overall Study|Lost to Follow-up|1|||
37927291|NCT00768222|69614036|FG000|Overall Study|Withdrawal by Subject|3|||
37927292|NCT00768222|69614037|FG001|Overall Study|Withdrawal by Subject|1|||
37927293|NCT00768222|69614036|FG000|Overall Study|Protocol Violation|0|||
37927294|NCT00768222|69614037|FG001|Overall Study|Protocol Violation|2|||
37927295|NCT00768144|69614043|FG000|Overall Study|Adverse Event|13|||
37927296|NCT00768144|69614043|FG000|Overall Study|Progressive Disease|21|||
37927297|NCT00768144|69614043|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
37927298|NCT00768144|69614043|FG000|Overall Study|Pt Withdrew Consent|1|||
38033539|NCT03325556|69719497|FG001|Double-blind Period|Withdrawal by Subject|6|||
37667193|NCT02598297|69139770|FG001|Overall Study|Study terminated by Sponsor|23|||
37667194|NCT02598297|69139769|FG000|Overall Study|Adverse Event|1|||
37760018|NCT01497899|69270192|FG002|Double-Blind Phase|Withdrew Consent|0|||
37927299|NCT00784836|69614047|FG000|Overall Study|Early Study Termination|3|||
37667195|NCT02598297|69139770|FG001|Overall Study|Adverse Event|1|||
37927300|NCT00784758|69614053|FG000|Overall Study|Withdrawal by Subject|3|||
37927301|NCT00784758|69614054|FG001|Overall Study|Withdrawal by Subject|0|||
37927302|NCT00784758|69614053|FG000|Overall Study|Adverse Event|1|||
37927303|NCT00784758|69614054|FG001|Overall Study|Adverse Event|0|||
37927304|NCT00768066|69614065|FG000|Overall Study|Did not receive study product injection.|3|||
37927305|NCT00768066|69614066|FG001|Overall Study|Did not receive study product injection.|3|||
37927306|NCT00768066|69614067|FG002|Overall Study|Did not receive study product injection.|0|||
37927307|NCT00767676|69614075|FG000|Overall Study|Investigator error|54|||
37927308|NCT00767520|69614081|FG000|Overall Study|Participants still on treatment|11|||
37927309|NCT00767520|69614082|FG001|Overall Study|Participants still on treatment|15|||
37927310|NCT00767520|69614081|FG000|Overall Study|Randomized in error and Never treated|0|||
37927311|NCT00767520|69614082|FG001|Overall Study|Randomized in error and Never treated|2|||
37927312|NCT00838565|69614094|FG000|Overall Study|Withdrawal by Subject|0|||
37927313|NCT00838565|69614095|FG001|Overall Study|Withdrawal by Subject|0|||
37927314|NCT00838565|69614096|FG002|Overall Study|Withdrawal by Subject|1|||
37927315|NCT00838565|69614097|FG003|Overall Study|Withdrawal by Subject|0|||
37927316|NCT00838565|69614098|FG004|Overall Study|Withdrawal by Subject|0|||
37927317|NCT00838565|69614099|FG005|Overall Study|Withdrawal by Subject|2|||
37927318|NCT00838565|69614094|FG000|Overall Study|Other|0|||
37927319|NCT00838565|69614095|FG001|Overall Study|Other|2|||
37927320|NCT00838565|69614096|FG002|Overall Study|Other|0|||
37927321|NCT00838565|69614097|FG003|Overall Study|Other|0|||
37927322|NCT00838565|69614098|FG004|Overall Study|Other|0|||
37927323|NCT00838565|69614099|FG005|Overall Study|Other|0|||
37927324|NCT00838565|69614094|FG000|Overall Study|Randomized but not Treated|0|||
37927325|NCT00838565|69614095|FG001|Overall Study|Randomized but not Treated|1|||
37927326|NCT00838565|69614096|FG002|Overall Study|Randomized but not Treated|0|||
37927327|NCT00838565|69614097|FG003|Overall Study|Randomized but not Treated|0|||
37927328|NCT00838565|69614098|FG004|Overall Study|Randomized but not Treated|0|||
37927329|NCT00838565|69614099|FG005|Overall Study|Randomized but not Treated|0|||
37927330|NCT00858845|69614120|FG000|Overall Study|Patient underwent heart transplant.|0|||
37927331|NCT00858845|69614121|FG001|Overall Study|Patient underwent heart transplant.|1|||
37927332|NCT00770562|69614129|FG000|Overall Study|Did not take treatment|1|||
37927333|NCT00770562|69614130|FG001|Overall Study|Did not take treatment|1|||
37927334|NCT00836693|69614139|FG000|Overall Study|Adverse Event|4|||
37927335|NCT00836693|69614140|FG001|Overall Study|Adverse Event|1|||
37927336|NCT00836693|69614139|FG000|Overall Study|Sponsor Decision|0|||
37927337|NCT00836693|69614140|FG001|Overall Study|Sponsor Decision|1|||
37927338|NCT00836693|69614139|FG000|Overall Study|Physician Decision|2|||
37927339|NCT00836693|69614140|FG001|Overall Study|Physician Decision|0|||
37927340|NCT00836693|69614139|FG000|Overall Study|Withdrawal by Subject|9|||
37927341|NCT00836693|69614140|FG001|Overall Study|Withdrawal by Subject|4|||
37927342|NCT00836693|69614139|FG000|Overall Study|Protocol Violation|1|||
37927343|NCT00836693|69614140|FG001|Overall Study|Protocol Violation|0|||
37927344|NCT00836693|69614139|FG000|Overall Study|Lost to Follow-up|1|||
37927345|NCT00836693|69614140|FG001|Overall Study|Lost to Follow-up|0|||
37927346|NCT00770484|69614148|FG000|Overall Study|Withdrawal by Subject|1|||
37927347|NCT00770484|69614149|FG001|Overall Study|Withdrawal by Subject|0|||
37927348|NCT00835679|69614159|FG000|Overall Study|Withdrawal by Subject|1|||
37927349|NCT00835679|69614160|FG001|Overall Study|Withdrawal by Subject|0|||
37927350|NCT00835679|69614161|FG002|Overall Study|Withdrawal by Subject|0|||
37927351|NCT00835679|69614162|FG003|Overall Study|Withdrawal by Subject|0|||
37927352|NCT00766506|69614178|FG000|Overall Study|Use rescue medication after 3 hours|3|||
37927353|NCT00766506|69614179|FG001|Overall Study|Use rescue medication after 3 hours|0|||
37927354|NCT00766506|69614178|FG000|Overall Study|Other|2|||
37927355|NCT00766506|69614179|FG001|Overall Study|Other|2|||
37927356|NCT00770328|69614187|FG000|Overall Study|Adverse Event|11|||
37927357|NCT00770328|69614188|FG001|Overall Study|Adverse Event|2|||
37927358|NCT00770328|69614187|FG000|Overall Study|Lost to Follow-up|2|||
37927359|NCT00770328|69614188|FG001|Overall Study|Lost to Follow-up|2|||
37927360|NCT00766038|69614196|FG000|Overall Study|Lost to Follow-up|15|||
37927361|NCT00766038|69614197|FG001|Overall Study|Lost to Follow-up|14|||
37927362|NCT00765882|69614208|FG000|Overall Study|Adverse Event|10|||
37927363|NCT00765882|69614209|FG001|Overall Study|Adverse Event|21|||
37927364|NCT00765882|69614210|FG002|Overall Study|Adverse Event|20|||
37927365|NCT00765882|69614208|FG000|Overall Study|Lack of Efficacy|4|||
37927366|NCT00765882|69614209|FG001|Overall Study|Lack of Efficacy|0|||
38033540|NCT03325556|69719498|FG002|Double-blind Period|Withdrawal by Subject|4|||
38033541|NCT03325556|69719496|FG000|Double-blind Period|Not otherwise specified|0|||
38033542|NCT03325556|69719497|FG001|Double-blind Period|Not otherwise specified|1|||
37667196|NCT02598297|69139769|FG000|Overall Study|Physician Decision|1|||
37927367|NCT00765882|69614210|FG002|Overall Study|Lack of Efficacy|1|||
37927368|NCT00765882|69614208|FG000|Overall Study|Protocol Violation|4|||
37927369|NCT00765882|69614209|FG001|Overall Study|Protocol Violation|3|||
37927370|NCT00765882|69614210|FG002|Overall Study|Protocol Violation|1|||
37927371|NCT00765882|69614208|FG000|Overall Study|Withdrawal by Subject|2|||
37927372|NCT00765882|69614209|FG001|Overall Study|Withdrawal by Subject|6|||
37927373|NCT00765882|69614210|FG002|Overall Study|Withdrawal by Subject|6|||
37927374|NCT00765882|69614208|FG000|Overall Study|Lost to Follow-up|1|||
37927375|NCT00765882|69614209|FG001|Overall Study|Lost to Follow-up|9|||
37927376|NCT00765882|69614210|FG002|Overall Study|Lost to Follow-up|6|||
37927377|NCT00765882|69614208|FG000|Overall Study|Other Reason|3|||
37927378|NCT00765882|69614209|FG001|Overall Study|Other Reason|1|||
37927379|NCT00765882|69614210|FG002|Overall Study|Other Reason|2|||
37927380|NCT00769860|69614220|FG000|Overall Study|Withdrawal by Subject|2|||
37927381|NCT00769860|69614221|FG001|Overall Study|Withdrawal by Subject|0|||
37927382|NCT00858143|69614227|FG000|Overall Study|Adverse Event|16|||
37927383|NCT00858143|69614227|FG000|Overall Study|Lack of Efficacy|4|||
37927384|NCT00858143|69614227|FG000|Overall Study|Death|7|||
37927385|NCT00858143|69614227|FG000|Overall Study|Other|23|||
37927386|NCT00828113|69614233|FG000|Overall Study|Withdrawal by Subject|27|||
37927387|NCT00828113|69614234|FG001|Overall Study|Withdrawal by Subject|26|||
37927388|NCT00828113|69614233|FG000|Overall Study|Lost to Follow-up|3|||
37927389|NCT00828113|69614234|FG001|Overall Study|Lost to Follow-up|5|||
37927390|NCT00769704|69614242|FG000|Overall Study|Lost to Follow-up|3|||
37927391|NCT00769704|69614243|FG001|Overall Study|Lost to Follow-up|2|||
37927392|NCT00769704|69614242|FG000|Overall Study|Death|95|||
37927393|NCT00769704|69614243|FG001|Overall Study|Death|190|||
37927394|NCT00769704|69614242|FG000|Overall Study|Withdrawal by Subject|12|||
37927395|NCT00769704|69614243|FG001|Overall Study|Withdrawal by Subject|5|||
37927396|NCT00769704|69614242|FG000|Overall Study|Other|1|||
37927397|NCT00769704|69614243|FG001|Overall Study|Other|2|||
37927398|NCT00818753|69614253|FG000|Overall Study|Protocol Violation|1|||
37927399|NCT00818753|69614254|FG001|Overall Study|Protocol Violation|0|||
37927400|NCT00818753|69614255|FG002|Overall Study|Protocol Violation|0|||
37927401|NCT00818753|69614253|FG000|Overall Study|Other reason (not specified)|0|||
37927402|NCT00818753|69614254|FG001|Overall Study|Other reason (not specified)|0|||
37927403|NCT00818753|69614255|FG002|Overall Study|Other reason (not specified)|1|||
37927404|NCT00818753|69614253|FG000|Overall Study|Randomised and not treated|2|||
37927405|NCT00818753|69614254|FG001|Overall Study|Randomised and not treated|0|||
37927406|NCT00818753|69614255|FG002|Overall Study|Randomised and not treated|0|||
37927407|NCT00765726|69614263|FG000|Overall Study|Withdrawal by Subject|1|||
37927408|NCT00765726|69614263|FG000|Overall Study|Discontinuation of study by sponsor|8|||
37927409|NCT00765336|69614269|FG000|Overall Study|Protocol Violation|4|||
37927410|NCT00765336|69614270|FG001|Overall Study|Protocol Violation|2|||
37927411|NCT00765336|69614269|FG000|Overall Study|Withdrawal by Subject|6|||
37927412|NCT00765336|69614270|FG001|Overall Study|Withdrawal by Subject|4|||
37927413|NCT00765336|69614269|FG000|Overall Study|Lost to Follow-up|7|||
37927414|NCT00765336|69614270|FG001|Overall Study|Lost to Follow-up|9|||
37927415|NCT00765336|69614269|FG000|Overall Study|Adverse Event|2|||
37927416|NCT00765336|69614270|FG001|Overall Study|Adverse Event|1|||
37927417|NCT00818519|69614278|FG000|Overall Study|Adverse Event|2|||
37927418|NCT00818519|69614279|FG001|Overall Study|Adverse Event|2|||
37667197|NCT02598297|69139770|FG001|Overall Study|Physician Decision|0|||
37667198|NCT02598297|69139769|FG000|Overall Study|Subject/guardian decision|1|||
37667199|NCT02598297|69139770|FG001|Overall Study|Subject/guardian decision|0|||
37667200|NCT02598297|69139769|FG000|Overall Study|Followed for survival|1|||
37667201|NCT02598297|69139770|FG001|Overall Study|Followed for survival|0|||
37667202|NCT02596893|69139780|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
37667203|NCT02596893|69139781|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
37667204|NCT02596893|69139782|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
37667205|NCT02596893|69139783|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
37667206|NCT02596893|69139780|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
37667207|NCT02596893|69139781|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
37667208|NCT02596893|69139782|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
37927419|NCT00818519|69614278|FG000|Overall Study|Lost to Follow-up|4|||
37927420|NCT00818519|69614279|FG001|Overall Study|Lost to Follow-up|6|||
37927421|NCT00818519|69614278|FG000|Overall Study|Protocol Violation|2|||
37927422|NCT00818519|69614279|FG001|Overall Study|Protocol Violation|1|||
37927423|NCT00818519|69614278|FG000|Overall Study|Pregnancy|0|||
37927424|NCT00818519|69614279|FG001|Overall Study|Pregnancy|1|||
37927425|NCT00818519|69614278|FG000|Overall Study|Withdrawal by Subject|4|||
37927426|NCT00818519|69614279|FG001|Overall Study|Withdrawal by Subject|9|||
37667209|NCT02596893|69139783|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
37927427|NCT00818519|69614278|FG000|Overall Study|participant recovered completely|1|||
37927428|NCT00818519|69614279|FG001|Overall Study|participant recovered completely|0|||
37927429|NCT00818519|69614278|FG000|Overall Study|participant will leave for long tme|1|||
37927430|NCT00818519|69614279|FG001|Overall Study|participant will leave for long tme|0|||
37927431|NCT00827567|69614285|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
37927432|NCT00765102|69614289|FG000|Overall Study|Progressive disease|18|||
37927433|NCT00765102|69614289|FG000|Overall Study|Adverse Event|6|||
37927434|NCT00765102|69614289|FG000|Overall Study|Physician Decision|4|||
37927435|NCT00765102|69614289|FG000|Overall Study|Withdrawal by Subject|2|||
37927436|NCT00765102|69614289|FG000|Overall Study|Protocol Violation|1|||
37927437|NCT00809354|69614305|FG000|Overall Study|Adverse Event|32|||
37927438|NCT00809354|69614306|FG001|Overall Study|Adverse Event|45|||
37927439|NCT00809354|69614307|FG002|Overall Study|Adverse Event|37|||
37927440|NCT00809354|69614308|FG003|Overall Study|Adverse Event|53|||
37927441|NCT00809354|69614309|FG004|Overall Study|Adverse Event|26|||
37927442|NCT00809354|69614310|FG005|Overall Study|Adverse Event|33|||
37927443|NCT00809354|69614311|FG006|Overall Study|Adverse Event|44|||
37927444|NCT00809354|69614312|FG007|Overall Study|Adverse Event|40|||
37927445|NCT00809354|69614313|FG008|Overall Study|Adverse Event|46|||
37927446|NCT00809354|69614314|FG009|Overall Study|Adverse Event|26|||
37927447|NCT00809354|69614305|FG000|Overall Study|Lack of Efficacy|23|||
37927448|NCT00809354|69614306|FG001|Overall Study|Lack of Efficacy|23|||
37927449|NCT00809354|69614307|FG002|Overall Study|Lack of Efficacy|22|||
37927450|NCT00809354|69614308|FG003|Overall Study|Lack of Efficacy|15|||
37927451|NCT00809354|69614309|FG004|Overall Study|Lack of Efficacy|40|||
37927452|NCT00809354|69614310|FG005|Overall Study|Lack of Efficacy|19|||
37927453|NCT00809354|69614311|FG006|Overall Study|Lack of Efficacy|21|||
37927454|NCT00809354|69614312|FG007|Overall Study|Lack of Efficacy|15|||
37927455|NCT00809354|69614313|FG008|Overall Study|Lack of Efficacy|18|||
37927456|NCT00809354|69614314|FG009|Overall Study|Lack of Efficacy|38|||
37927457|NCT00809354|69614305|FG000|Overall Study|Lost to Follow-up|10|||
37927458|NCT00809354|69614306|FG001|Overall Study|Lost to Follow-up|11|||
37927459|NCT00809354|69614307|FG002|Overall Study|Lost to Follow-up|8|||
37927460|NCT00809354|69614308|FG003|Overall Study|Lost to Follow-up|13|||
37927461|NCT00809354|69614309|FG004|Overall Study|Lost to Follow-up|6|||
37927462|NCT00809354|69614310|FG005|Overall Study|Lost to Follow-up|2|||
37927463|NCT00809354|69614311|FG006|Overall Study|Lost to Follow-up|0|||
37927464|NCT00809354|69614312|FG007|Overall Study|Lost to Follow-up|5|||
37927465|NCT00809354|69614313|FG008|Overall Study|Lost to Follow-up|4|||
37927466|NCT00809354|69614314|FG009|Overall Study|Lost to Follow-up|0|||
37927467|NCT00809354|69614305|FG000|Overall Study|Protocol Violation|7|||
37927468|NCT00809354|69614306|FG001|Overall Study|Protocol Violation|14|||
37927469|NCT00809354|69614307|FG002|Overall Study|Protocol Violation|14|||
37927470|NCT00809354|69614308|FG003|Overall Study|Protocol Violation|12|||
37927471|NCT00809354|69614309|FG004|Overall Study|Protocol Violation|14|||
37927472|NCT00809354|69614310|FG005|Overall Study|Protocol Violation|6|||
37927473|NCT00809354|69614311|FG006|Overall Study|Protocol Violation|4|||
37927474|NCT00809354|69614312|FG007|Overall Study|Protocol Violation|6|||
37927475|NCT00809354|69614313|FG008|Overall Study|Protocol Violation|9|||
37927476|NCT00809354|69614314|FG009|Overall Study|Protocol Violation|3|||
37927477|NCT00809354|69614305|FG000|Overall Study|Withdrawal by Subject|32|||
37927478|NCT00809354|69614306|FG001|Overall Study|Withdrawal by Subject|27|||
37927479|NCT00809354|69614307|FG002|Overall Study|Withdrawal by Subject|31|||
37927480|NCT00809354|69614308|FG003|Overall Study|Withdrawal by Subject|33|||
37927481|NCT00809354|69614309|FG004|Overall Study|Withdrawal by Subject|34|||
37927482|NCT00809354|69614310|FG005|Overall Study|Withdrawal by Subject|29|||
37927483|NCT00809354|69614311|FG006|Overall Study|Withdrawal by Subject|27|||
37760019|NCT01497899|69270193|FG003|Double-Blind Phase|Withdrew Consent|0|||
37927484|NCT00809354|69614312|FG007|Overall Study|Withdrawal by Subject|19|||
37927485|NCT00809354|69614313|FG008|Overall Study|Withdrawal by Subject|18|||
37927486|NCT00809354|69614314|FG009|Overall Study|Withdrawal by Subject|20|||
37927487|NCT00809354|69614305|FG000|Overall Study|Other|10|||
37927488|NCT00809354|69614306|FG001|Overall Study|Other|2|||
37927489|NCT00809354|69614307|FG002|Overall Study|Other|7|||
37927490|NCT00809354|69614308|FG003|Overall Study|Other|10|||
37927491|NCT00809354|69614309|FG004|Overall Study|Other|5|||
37927492|NCT00809354|69614310|FG005|Overall Study|Other|3|||
37927493|NCT00809354|69614311|FG006|Overall Study|Other|2|||
37927494|NCT00809354|69614312|FG007|Overall Study|Other|3|||
37760020|NCT01497899|69270190|FG000|Double-Blind Phase|Lost to Follow-up|3|||
37760021|NCT01497899|69270191|FG001|Double-Blind Phase|Lost to Follow-up|2|||
37927495|NCT00809354|69614313|FG008|Overall Study|Other|4|||
37927496|NCT00809354|69614314|FG009|Overall Study|Other|3|||
37927497|NCT00809354|69614305|FG000|Overall Study|Study terminated by sponsor|138|||
37927498|NCT00809354|69614306|FG001|Overall Study|Study terminated by sponsor|134|||
37927499|NCT00809354|69614307|FG002|Overall Study|Study terminated by sponsor|129|||
37927500|NCT00809354|69614308|FG003|Overall Study|Study terminated by sponsor|120|||
37927501|NCT00809354|69614309|FG004|Overall Study|Study terminated by sponsor|126|||
37760022|NCT01497899|69270192|FG002|Double-Blind Phase|Lost to Follow-up|0|||
37927502|NCT00809354|69614310|FG005|Overall Study|Study terminated by sponsor|133|||
37927503|NCT00809354|69614311|FG006|Overall Study|Study terminated by sponsor|124|||
37927504|NCT00809354|69614312|FG007|Overall Study|Study terminated by sponsor|148|||
37760023|NCT01497899|69270193|FG003|Double-Blind Phase|Lost to Follow-up|0|||
37927505|NCT00809354|69614313|FG008|Overall Study|Study terminated by sponsor|127|||
37927506|NCT00809354|69614314|FG009|Overall Study|Study terminated by sponsor|135|||
37927507|NCT00809354|69614305|FG000|Overall Study|Withdrawn due to pregnancy|0|||
37927508|NCT00809354|69614306|FG001|Overall Study|Withdrawn due to pregnancy|1|||
37927509|NCT00809354|69614307|FG002|Overall Study|Withdrawn due to pregnancy|0|||
37927510|NCT00809354|69614308|FG003|Overall Study|Withdrawn due to pregnancy|0|||
37927511|NCT00809354|69614309|FG004|Overall Study|Withdrawn due to pregnancy|0|||
37927512|NCT00809354|69614310|FG005|Overall Study|Withdrawn due to pregnancy|0|||
37927513|NCT00809354|69614311|FG006|Overall Study|Withdrawn due to pregnancy|0|||
37927514|NCT00809354|69614312|FG007|Overall Study|Withdrawn due to pregnancy|0|||
37927515|NCT00809354|69614313|FG008|Overall Study|Withdrawn due to pregnancy|0|||
37927516|NCT00809354|69614314|FG009|Overall Study|Withdrawn due to pregnancy|0|||
37927517|NCT00809354|69614305|FG000|Overall Study|Randomized but not Treated|3|||
37927518|NCT00809354|69614306|FG001|Overall Study|Randomized but not Treated|1|||
37927519|NCT00809354|69614307|FG002|Overall Study|Randomized but not Treated|6|||
37927520|NCT00809354|69614308|FG003|Overall Study|Randomized but not Treated|0|||
37927521|NCT00809354|69614309|FG004|Overall Study|Randomized but not Treated|5|||
37927522|NCT00809354|69614310|FG005|Overall Study|Randomized but not Treated|0|||
37927523|NCT00809354|69614311|FG006|Overall Study|Randomized but not Treated|1|||
37927524|NCT00809354|69614312|FG007|Overall Study|Randomized but not Treated|1|||
37927525|NCT00809354|69614313|FG008|Overall Study|Randomized but not Treated|2|||
37927526|NCT00809354|69614314|FG009|Overall Study|Randomized but not Treated|1|||
37927527|NCT00809354|69614305|FG000|Overall Study|Death|0|||
37927528|NCT00809354|69614306|FG001|Overall Study|Death|0|||
37927529|NCT00809354|69614307|FG002|Overall Study|Death|0|||
37927530|NCT00809354|69614308|FG003|Overall Study|Death|0|||
37927531|NCT00809354|69614309|FG004|Overall Study|Death|0|||
37927532|NCT00809354|69614310|FG005|Overall Study|Death|0|||
37927533|NCT00809354|69614311|FG006|Overall Study|Death|0|||
37927534|NCT00809354|69614312|FG007|Overall Study|Death|1|||
37927535|NCT00809354|69614313|FG008|Overall Study|Death|0|||
37927536|NCT00809354|69614314|FG009|Overall Study|Death|0|||
37927537|NCT00834899|69614343|FG000|Overall Study|Withdrawal by Subject|1|||
37927538|NCT00834899|69614344|FG001|Overall Study|Withdrawal by Subject|1|||
37927539|NCT00764946|69614353|FG000|Overall Study|Lack of Efficacy|1|||
37927540|NCT00764946|69614354|FG001|Overall Study|Lack of Efficacy|0|||
37927541|NCT00764946|69614355|FG002|Overall Study|Lack of Efficacy|0|||
37927542|NCT00764946|69614353|FG000|Overall Study|Lost to Follow-up|3|||
37927543|NCT00764946|69614354|FG001|Overall Study|Lost to Follow-up|4|||
37927544|NCT00764946|69614355|FG002|Overall Study|Lost to Follow-up|0|||
37927545|NCT00764946|69614353|FG000|Overall Study|Physician Decision|2|||
37927546|NCT00764946|69614354|FG001|Overall Study|Physician Decision|4|||
37927547|NCT00764946|69614355|FG002|Overall Study|Physician Decision|0|||
37927548|NCT00764946|69614353|FG000|Overall Study|Adverse Event|3|||
37927549|NCT00764946|69614354|FG001|Overall Study|Adverse Event|2|||
37927550|NCT00764946|69614355|FG002|Overall Study|Adverse Event|1|||
37927551|NCT00764946|69614353|FG000|Overall Study|Withdrawal by Subject|3|||
37927552|NCT00764946|69614354|FG001|Overall Study|Withdrawal by Subject|6|||
37927553|NCT00764946|69614355|FG002|Overall Study|Withdrawal by Subject|2|||
37927554|NCT00764946|69614353|FG000|Overall Study|Never Treated|1|||
37927555|NCT00764946|69614354|FG001|Overall Study|Never Treated|1|||
37927556|NCT00764946|69614355|FG002|Overall Study|Never Treated|1|||
37927557|NCT00764868|69614369|FG000|Overall Study|Adverse Event|18|||
37927558|NCT00764868|69614369|FG000|Overall Study|Withdrawal by Subject|31|||
37927559|NCT00764868|69614369|FG000|Overall Study|Non-compliance|16|||
37927560|NCT00764868|69614369|FG000|Overall Study|Lost to Follow-up|25|||
38033543|NCT03325556|69719498|FG002|Double-blind Period|Not otherwise specified|5|||
37760024|NCT01497899|69270190|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
37760025|NCT01497899|69270191|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
37760026|NCT01497899|69270192|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
37760027|NCT01497899|69270193|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
37760028|NCT01497899|69270190|FG000|Open-Label Extension Phase|Adverse Event|1|||
37760029|NCT01497899|69270191|FG001|Open-Label Extension Phase|Adverse Event|0|||
37760030|NCT01497899|69270192|FG002|Open-Label Extension Phase|Adverse Event|0|||
37760031|NCT01497899|69270193|FG003|Open-Label Extension Phase|Adverse Event|0|||
37760032|NCT01497899|69270190|FG000|Open-Label Extension Phase|Death|1|||
37760033|NCT01497899|69270191|FG001|Open-Label Extension Phase|Death|0|||
37760034|NCT01497899|69270192|FG002|Open-Label Extension Phase|Death|0|||
37927561|NCT00764868|69614369|FG000|Overall Study|Lack of Efficacy|5|||
37927562|NCT00764868|69614369|FG000|Overall Study|Subject moved|7|||
37927563|NCT00764868|69614369|FG000|Overall Study|Pregnancy|3|||
37927564|NCT00764868|69614369|FG000|Overall Study|Prohibited medication|1|||
37927565|NCT00764868|69614369|FG000|Overall Study|Out of town|1|||
37760035|NCT01497899|69270193|FG003|Open-Label Extension Phase|Death|0|||
37760036|NCT01497899|69270190|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
37760037|NCT01497899|69270191|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
37927566|NCT00764868|69614369|FG000|Overall Study|Misuse and compliance of study drug|1|||
37927567|NCT00764868|69614369|FG000|Overall Study|Subject sent to boarding school|1|||
37927568|NCT00764868|69614369|FG000|Overall Study|Met an exclusion criteria|1|||
37927569|NCT00764868|69614369|FG000|Overall Study|Positive drug screen|2|||
37927570|NCT00764868|69614369|FG000|Overall Study|Sponsor requested withdrawal|1|||
37927571|NCT00764790|69614376|FG000|Overall Study|Protocol Violation|0|||
37927572|NCT00764790|69614377|FG001|Overall Study|Protocol Violation|0|||
37927573|NCT00764790|69614378|FG002|Overall Study|Protocol Violation|1|||
37927574|NCT00764790|69614376|FG000|Overall Study|Withdrawal by Subject|10|||
37927575|NCT00764790|69614377|FG001|Overall Study|Withdrawal by Subject|12|||
37760038|NCT01497899|69270192|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
37760039|NCT01497899|69270193|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
37760040|NCT01497899|69270190|FG000|Open-Label Extension Phase|Pregnancy|0|||
37760041|NCT01497899|69270191|FG001|Open-Label Extension Phase|Pregnancy|1|||
37760042|NCT01497899|69270192|FG002|Open-Label Extension Phase|Pregnancy|1|||
37927576|NCT00764790|69614378|FG002|Overall Study|Withdrawal by Subject|6|||
37927577|NCT00764790|69614376|FG000|Overall Study|Lost to Follow-up|28|||
37927578|NCT00764790|69614377|FG001|Overall Study|Lost to Follow-up|29|||
37927579|NCT00764790|69614378|FG002|Overall Study|Lost to Follow-up|23|||
37927580|NCT00756444|69614388|FG000|Overall Study|Adverse Event|1|||
37927581|NCT00756444|69614389|FG001|Overall Study|Adverse Event|1|||
37927582|NCT00756444|69614388|FG000|Overall Study|Withdrawal by Subject|6|||
37927583|NCT00756444|69614389|FG001|Overall Study|Withdrawal by Subject|8|||
37927584|NCT00756444|69614388|FG000|Overall Study|Lost to Follow-up|0|||
37927585|NCT00756444|69614389|FG001|Overall Study|Lost to Follow-up|1|||
37927586|NCT00756444|69614388|FG000|Overall Study|Death|5|||
37927587|NCT00756444|69614389|FG001|Overall Study|Death|4|||
37927588|NCT00756444|69614388|FG000|Overall Study|Disease Progression|2|||
37927589|NCT00756444|69614389|FG001|Overall Study|Disease Progression|7|||
37927590|NCT00756444|69614388|FG000|Overall Study|Ineligibility Determined|1|||
37927591|NCT00756444|69614389|FG001|Overall Study|Ineligibility Determined|0|||
37927592|NCT00769002|69614400|FG000|Overall Study|Study was not completed, no data|9|||
37927593|NCT00769002|69614401|FG001|Overall Study|Study was not completed, no data|9|||
37927594|NCT00753012|69614408|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
37927595|NCT00753012|69614409|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
37927596|NCT00753012|69614408|FG000|Overall Study|Adverse Event|2|||
37927597|NCT00753012|69614409|FG001|Overall Study|Adverse Event|0|||
37927598|NCT00753012|69614408|FG000|Overall Study|Withdrawal by Subject|0|||
37927599|NCT00753012|69614409|FG001|Overall Study|Withdrawal by Subject|1|||
37927600|NCT00753012|69614408|FG000|Overall Study|Lost to Follow-up|4|||
37927601|NCT00753012|69614409|FG001|Overall Study|Lost to Follow-up|0|||
37927602|NCT00753012|69614408|FG000|Overall Study|Confounded endpoint data|1|||
37927603|NCT00753012|69614409|FG001|Overall Study|Confounded endpoint data|0|||
37927604|NCT00806156|69614418|FG000|Overall Study|Death|35|||
37927605|NCT00806156|69614419|FG001|Overall Study|Death|95|||
37927606|NCT00806156|69614418|FG000|Overall Study|Did not meet eligibility criteria|1|||
37927607|NCT00806156|69614419|FG001|Overall Study|Did not meet eligibility criteria|0|||
37927608|NCT00806156|69614418|FG000|Overall Study|Study terminated by Sponsor|2|||
37927609|NCT00806156|69614419|FG001|Overall Study|Study terminated by Sponsor|40|||
37927610|NCT00806156|69614418|FG000|Overall Study|Consent withdrawn by subject|1|||
37927611|NCT00806156|69614419|FG001|Overall Study|Consent withdrawn by subject|3|||
37927612|NCT00806156|69614418|FG000|Overall Study|Lost to Follow-up|0|||
37927613|NCT00806156|69614419|FG001|Overall Study|Lost to Follow-up|1|||
37927614|NCT00764478|69614440|FG000|Overall Study|Adverse Event|1|||
37927615|NCT00764478|69614441|FG001|Overall Study|Adverse Event|1|||
37927616|NCT00764478|69614442|FG002|Overall Study|Adverse Event|1|||
37927617|NCT00764478|69614440|FG000|Overall Study|Withdrawal by Subject|7|||
37927618|NCT00764478|69614441|FG001|Overall Study|Withdrawal by Subject|12|||
37927619|NCT00764478|69614442|FG002|Overall Study|Withdrawal by Subject|1|||
37927620|NCT00764478|69614440|FG000|Overall Study|Lost to Follow-up|7|||
37667210|NCT02596893|69139780|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
37667211|NCT02596893|69139781|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
37667212|NCT02596893|69139782|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
37667213|NCT02596893|69139783|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
37667214|NCT02596893|69139780|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
37667215|NCT02596893|69139781|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
37667216|NCT02596893|69139782|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
37667217|NCT02596893|69139783|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
37667218|NCT02596893|69139780|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
37667219|NCT02596893|69139781|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
37760043|NCT01497899|69270193|FG003|Open-Label Extension Phase|Pregnancy|0|||
37760044|NCT01497899|69270190|FG000|Open-Label Extension Phase|Protocol Violation|0|||
37760045|NCT01497899|69270191|FG001|Open-Label Extension Phase|Protocol Violation|0|||
37760046|NCT01497899|69270192|FG002|Open-Label Extension Phase|Protocol Violation|1|||
37760047|NCT01497899|69270193|FG003|Open-Label Extension Phase|Protocol Violation|0|||
37927621|NCT00764478|69614441|FG001|Overall Study|Lost to Follow-up|8|||
37927622|NCT00764478|69614442|FG002|Overall Study|Lost to Follow-up|5|||
37927623|NCT00764478|69614440|FG000|Overall Study|Protocol Violation|0|||
37927624|NCT00764478|69614441|FG001|Overall Study|Protocol Violation|1|||
37927625|NCT00764478|69614442|FG002|Overall Study|Protocol Violation|1|||
37927626|NCT00805766|69614450|FG000|Screening Period|Adverse Event|1|||
37927627|NCT00805766|69614450|FG000|Screening Period|Lack of Efficacy|2|||
37927628|NCT00805766|69614450|FG000|Screening Period|Pregnancy|1|||
37760048|NCT01497899|69270190|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
37760049|NCT01497899|69270191|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
37927629|NCT00805766|69614450|FG000|Screening Period|Responder|2|||
37927630|NCT00805766|69614450|FG000|Increased Dose Period|Adverse Event|4|||
37667220|NCT02596893|69139782|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
37667221|NCT02596893|69139783|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
37667222|NCT02596893|69139780|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
37760050|NCT01497899|69270192|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
37760051|NCT01497899|69270193|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
37760052|NCT01497275|69270200|FG000|Overall Study|Death|1|||
37760053|NCT01497275|69270200|FG000|Overall Study|Adverse Event|1|||
37760054|NCT01557517|69270206|FG000|Overall Study|Death|1|||
37760055|NCT01557517|69270207|FG001|Overall Study|Death|0|||
37760056|NCT01557517|69270206|FG000|Overall Study|Refused further treatment|0|||
37760057|NCT01557517|69270207|FG001|Overall Study|Refused further treatment|2|||
37760058|NCT01557517|69270206|FG000|Overall Study|Adverse Event|0|||
37760059|NCT01557517|69270207|FG001|Overall Study|Adverse Event|2|||
37760060|NCT01557517|69270206|FG000|Overall Study|Pt declined before treatment started|1|||
37760061|NCT01557517|69270207|FG001|Overall Study|Pt declined before treatment started|0|||
37760062|NCT01497197|69270222|FG000|Overall Study|Lost to Follow-up|1|||
37760063|NCT01497197|69270223|FG001|Overall Study|Lost to Follow-up|0|||
37760064|NCT01497197|69270222|FG000|Overall Study|Protocol Violation|0|||
37760065|NCT01497197|69270223|FG001|Overall Study|Protocol Violation|2|||
37667223|NCT02596893|69139781|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
37667224|NCT02596893|69139782|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
37667225|NCT02596893|69139783|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
37667226|NCT02596893|69139780|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
37667227|NCT02596893|69139781|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
37667228|NCT02596893|69139782|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
37667229|NCT02596893|69139783|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
37667230|NCT02596893|69139780|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
37667231|NCT02596893|69139781|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
37667232|NCT02596893|69139782|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
37667233|NCT02596893|69139783|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
37667234|NCT02596893|69139780|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
37667235|NCT02596893|69139781|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
37667236|NCT02596893|69139782|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
37667237|NCT02596893|69139783|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
37667238|NCT02596893|69139780|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
37667239|NCT02596893|69139781|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
37667240|NCT02596893|69139782|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
37667241|NCT02596893|69139783|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
37667242|NCT02596893|69139780|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
37667243|NCT02596893|69139781|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
37667244|NCT02596893|69139782|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
37667245|NCT02596893|69139783|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
37667246|NCT02592447|69139799|FG000|Overall Study|Lost to Follow-up|1|||
37667247|NCT02592447|69139800|FG001|Overall Study|Lost to Follow-up|0|||
37667248|NCT02592447|69139799|FG000|Overall Study|Ineligible after randomization|1|||
37667249|NCT02592447|69139800|FG001|Overall Study|Ineligible after randomization|0|||
37667250|NCT02592447|69139799|FG000|Overall Study|Withdrawal by Subject|0|||
37667251|NCT02592447|69139800|FG001|Overall Study|Withdrawal by Subject|1|||
37667252|NCT02595723|69139809|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
37667253|NCT02595723|69139810|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
37667254|NCT02595723|69139811|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
37667255|NCT02595723|69139809|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
37667256|NCT02595723|69139810|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
37667257|NCT02595723|69139811|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
37667258|NCT01667679|69139821|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
37667259|NCT01667679|69139822|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
37760066|NCT01497197|69270222|FG000|Overall Study|Withdrawal by Subject|2|||
37760067|NCT01497197|69270223|FG001|Overall Study|Withdrawal by Subject|1|||
37760068|NCT01497197|69270222|FG000|Overall Study|Excessive/lack of response to treatment|1|||
37760069|NCT01497197|69270223|FG001|Overall Study|Excessive/lack of response to treatment|0|||
37760070|NCT01497197|69270222|FG000|Overall Study|Risk of OHSS|1|||
37760071|NCT01497197|69270223|FG001|Overall Study|Risk of OHSS|0|||
37667260|NCT01667679|69139821|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
37667261|NCT01667679|69139822|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
37760072|NCT01497197|69270222|FG000|Overall Study|No oocytes retrieved|3|||
37760073|NCT01497197|69270223|FG001|Overall Study|No oocytes retrieved|2|||
37760074|NCT01497197|69270222|FG000|Overall Study|No fertilisation|6|||
37760075|NCT01497197|69270223|FG001|Overall Study|No fertilisation|5|||
37760076|NCT01497197|69270222|FG000|Overall Study|Intention to freeze all embryos|0|||
37760077|NCT01497197|69270223|FG001|Overall Study|Intention to freeze all embryos|1|||
37760078|NCT01497197|69270222|FG000|Overall Study|All embryos discarded|0|||
37760079|NCT01497197|69270223|FG001|Overall Study|All embryos discarded|3|||
37760080|NCT01497197|69270222|FG000|Overall Study|Other|3|||
37760081|NCT01497197|69270223|FG001|Overall Study|Other|1|||
37760082|NCT01496885|69270229|FG000|Overall Study|Lost to Follow-up|13|||
37760083|NCT01496885|69270229|FG000|Overall Study|Withdrawal by Subject|7|||
37760084|NCT01496885|69270229|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
37927631|NCT00805766|69614450|FG000|Increased Dose Period|Lack of Efficacy|7|||
37927632|NCT00805766|69614450|FG000|Increased Dose Period|Pregnancy|1|||
37927633|NCT00805766|69614450|FG000|Increased Dose Period|Withdrawal by Subject|1|||
37927634|NCT00805532|69614460|FG000|Overall Study|invalid data|0|||
37927635|NCT00805532|69614461|FG001|Overall Study|invalid data|1|||
37927636|NCT00764322|69614471|FG000|Overall Study|Withdrawal by Subject|11|||
37927637|NCT00764322|69614471|FG000|Overall Study|No CYP2D6 genotyping|9|||
37927638|NCT00752856|69614490|FG000|Overall Study|randomized but did not do viral kinetics|0|||
37927639|NCT00752856|69614491|FG001|Overall Study|randomized but did not do viral kinetics|1|||
37927640|NCT00755196|69614497|FG000|Overall Study|Lost to Follow-up|1|||
37927641|NCT00755196|69614497|FG000|Overall Study|Lack of Efficiency|1|||
37927642|NCT00805142|69614504|FG000|Titration Period|Adverse Event|3|||
37927643|NCT00805142|69614505|FG001|Titration Period|Adverse Event|3|||
37927644|NCT00805142|69614504|FG000|Titration Period|Lack of Efficacy|1|||
37927645|NCT00805142|69614505|FG001|Titration Period|Lack of Efficacy|1|||
37927646|NCT00805142|69614504|FG000|Titration Period|Lost to Follow-up|0|||
37927647|NCT00805142|69614505|FG001|Titration Period|Lost to Follow-up|1|||
37927648|NCT00805142|69614504|FG000|Titration Period|Disease Progression|2|||
37927649|NCT00805142|69614505|FG001|Titration Period|Disease Progression|1|||
37927650|NCT00805142|69614504|FG000|Titration Period|Withdrawal of consent|0|||
37667262|NCT01667679|69139821|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
37667263|NCT01667679|69139822|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
37927651|NCT00805142|69614505|FG001|Titration Period|Withdrawal of consent|1|||
37927652|NCT00805142|69614504|FG000|Titration Period|Other|0|||
37927653|NCT00805142|69614505|FG001|Titration Period|Other|3|||
37927654|NCT00805142|69614504|FG000|Maintenance Period|Adverse Event|0|||
37927655|NCT00805142|69614505|FG001|Maintenance Period|Adverse Event|1|||
37927656|NCT00805142|69614504|FG000|Maintenance Period|Other|0|||
37927657|NCT00805142|69614505|FG001|Maintenance Period|Other|1|||
37927658|NCT00761631|69614522|FG000|Overall Study|Parent/legal guardian request|8|||
37927659|NCT00761631|69614523|FG001|Overall Study|Parent/legal guardian request|3|||
37927660|NCT00761631|69614524|FG002|Overall Study|Parent/legal guardian request|8|||
37927661|NCT00761631|69614525|FG003|Overall Study|Parent/legal guardian request|0|||
37927662|NCT00761631|69614526|FG004|Overall Study|Parent/legal guardian request|5|||
38033544|NCT03325556|69719496|FG000|Double-blind Period|Administrative discont. at study termination|0|||
38033545|NCT03325556|69719497|FG001|Double-blind Period|Administrative discont. at study termination|35|||
38033546|NCT03325556|69719498|FG002|Double-blind Period|Administrative discont. at study termination|31|||
38033547|NCT03320564|69719505|FG000|Overall Study|Protocol Violation|1|||
37667264|NCT01667679|69139821|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
37667265|NCT01667679|69139822|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
37667266|NCT01667679|69139821|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
37667267|NCT01667679|69139822|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
37667268|NCT01667679|69139821|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
37667269|NCT01667679|69139822|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
37927663|NCT00761631|69614527|FG005|Overall Study|Parent/legal guardian request|0|||
37927664|NCT00761631|69614522|FG000|Overall Study|Lost to Follow-up|2|||
37667270|NCT01667679|69139821|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
37667271|NCT01667679|69139822|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
37667272|NCT01667679|69139821|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
37667273|NCT01667679|69139822|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
37760085|NCT01496885|69270229|FG000|Overall Study|Death|1|||
37760086|NCT01557283|69270233|FG000|Overall Study|Lost to Follow-up|7|||
37760087|NCT01557283|69270233|FG000|Overall Study|Non-responder|19|||
37760088|NCT01557283|69270233|FG000|Overall Study|Adverse Event|7|||
37760089|NCT01557283|69270233|FG000|Overall Study|Lack of Efficacy|1|||
37927665|NCT00761631|69614523|FG001|Overall Study|Lost to Follow-up|4|||
37927666|NCT00761631|69614524|FG002|Overall Study|Lost to Follow-up|7|||
37927667|NCT00761631|69614525|FG003|Overall Study|Lost to Follow-up|1|||
37927668|NCT00761631|69614526|FG004|Overall Study|Lost to Follow-up|6|||
38033548|NCT03325166|69719509|FG000|Overall Study|Adverse Event|1|||
38033549|NCT02888756|69719516|FG000|Analytical Treatment Interruption|Physician Decision|10|||
38033550|NCT02888756|69719517|FG001|Analytical Treatment Interruption|Physician Decision|6|||
38033551|NCT02888756|69719518|FG002|Analytical Treatment Interruption|Physician Decision|5|||
37927669|NCT00761631|69614527|FG005|Overall Study|Lost to Follow-up|1|||
37927670|NCT00761631|69614522|FG000|Overall Study|Protocol Violation|2|||
37927671|NCT00761631|69614523|FG001|Overall Study|Protocol Violation|0|||
37927672|NCT00761631|69614524|FG002|Overall Study|Protocol Violation|0|||
37927673|NCT00761631|69614525|FG003|Overall Study|Protocol Violation|1|||
37927674|NCT00761631|69614526|FG004|Overall Study|Protocol Violation|5|||
37927675|NCT00761631|69614527|FG005|Overall Study|Protocol Violation|1|||
37927676|NCT00761631|69614522|FG000|Overall Study|Randomized, not treated|1|||
37927677|NCT00761631|69614523|FG001|Overall Study|Randomized, not treated|0|||
37927678|NCT00761631|69614524|FG002|Overall Study|Randomized, not treated|0|||
37927679|NCT00761631|69614525|FG003|Overall Study|Randomized, not treated|0|||
37927680|NCT00761631|69614526|FG004|Overall Study|Randomized, not treated|0|||
37927681|NCT00761631|69614527|FG005|Overall Study|Randomized, not treated|0|||
37927682|NCT00761631|69614522|FG000|Overall Study|Failed to return|1|||
37927683|NCT00761631|69614523|FG001|Overall Study|Failed to return|0|||
37927684|NCT00761631|69614524|FG002|Overall Study|Failed to return|1|||
37927685|NCT00761631|69614525|FG003|Overall Study|Failed to return|1|||
37927686|NCT00761631|69614526|FG004|Overall Study|Failed to return|5|||
37927687|NCT00761631|69614527|FG005|Overall Study|Failed to return|2|||
37927688|NCT00761631|69614522|FG000|Overall Study|Physician Decision|1|||
37927689|NCT00761631|69614523|FG001|Overall Study|Physician Decision|0|||
37927690|NCT00761631|69614524|FG002|Overall Study|Physician Decision|0|||
37927691|NCT00761631|69614525|FG003|Overall Study|Physician Decision|0|||
37927692|NCT00761631|69614526|FG004|Overall Study|Physician Decision|0|||
37927693|NCT00761631|69614527|FG005|Overall Study|Physician Decision|0|||
37927694|NCT00761631|69614522|FG000|Overall Study|Other|0|||
37927695|NCT00761631|69614523|FG001|Overall Study|Other|0|||
37927696|NCT00761631|69614524|FG002|Overall Study|Other|0|||
37927697|NCT00761631|69614525|FG003|Overall Study|Other|0|||
37927698|NCT00761631|69614526|FG004|Overall Study|Other|1|||
37927699|NCT00761631|69614527|FG005|Overall Study|Other|1|||
37927700|NCT00763698|69614550|FG000|Overall Study|Unsuccessful Implant|5|||
37927701|NCT00763698|69614550|FG000|Overall Study|Death|4|||
37927702|NCT00763698|69614550|FG000|Overall Study|Withdrawal by Subject|1|||
37927703|NCT00763386|69614557|FG000|Overall Study|Adverse Event|43|||
37927704|NCT00763386|69614558|FG001|Overall Study|Adverse Event|33|||
37927705|NCT00763386|69614557|FG000|Overall Study|Death|1|||
37927706|NCT00763386|69614558|FG001|Overall Study|Death|2|||
37927707|NCT00763386|69614557|FG000|Overall Study|Lost to Follow-up|3|||
37927708|NCT00763386|69614558|FG001|Overall Study|Lost to Follow-up|3|||
37927709|NCT00763386|69614557|FG000|Overall Study|Withdrawal by Subject|0|||
37927710|NCT00763386|69614558|FG001|Overall Study|Withdrawal by Subject|1|||
37927711|NCT00763386|69614557|FG000|Overall Study|CRF missing|0|||
37927712|NCT00763386|69614558|FG001|Overall Study|CRF missing|1|||
37927713|NCT00763386|69614557|FG000|Overall Study|Study Prosthesis Removed|1|||
37927714|NCT00763386|69614558|FG001|Overall Study|Study Prosthesis Removed|0|||
37927715|NCT00761319|69614566|FG000|Overall Study|Protocol Violation|21|||
37927716|NCT00761319|69614567|FG001|Overall Study|Protocol Violation|14|||
37927717|NCT00761319|69614566|FG000|Overall Study|Adverse Event|11|||
37927718|NCT00761319|69614567|FG001|Overall Study|Adverse Event|7|||
37927719|NCT00761319|69614566|FG000|Overall Study|Withdrawal by Subject|8|||
37927720|NCT00761319|69614567|FG001|Overall Study|Withdrawal by Subject|7|||
37927721|NCT00761319|69614566|FG000|Overall Study|Noncompliance|4|||
37927722|NCT00761319|69614567|FG001|Overall Study|Noncompliance|3|||
37927723|NCT00761319|69614566|FG000|Overall Study|Lost to Follow-up|1|||
37927724|NCT00761319|69614567|FG001|Overall Study|Lost to Follow-up|1|||
37927725|NCT00761319|69614566|FG000|Overall Study|Nonspecified|2|||
37927726|NCT00761319|69614567|FG001|Overall Study|Nonspecified|2|||
37927727|NCT00761319|69614566|FG000|Overall Study|Missing|1|||
37927728|NCT00761319|69614567|FG001|Overall Study|Missing|0|||
37927729|NCT00762996|69614573|FG000|Period One|Protocol Violation|0|||
37927730|NCT00762996|69614574|FG001|Period One|Protocol Violation|0|||
37927731|NCT00762996|69614575|FG002|Period One|Protocol Violation|1|||
37927732|NCT00762996|69614576|FG003|Period One|Protocol Violation|0|||
37927733|NCT00762996|69614573|FG000|Period One|ineligible|0|||
37927734|NCT00762996|69614574|FG001|Period One|ineligible|0|||
37760090|NCT01557283|69270233|FG000|Overall Study|Non-compliance|1|||
37927735|NCT00762996|69614575|FG002|Period One|ineligible|1|||
37927736|NCT00762996|69614576|FG003|Period One|ineligible|1|||
37927737|NCT00762996|69614573|FG000|Period One|Adverse Event|0|||
37927738|NCT00762996|69614574|FG001|Period One|Adverse Event|0|||
37927739|NCT00762996|69614575|FG002|Period One|Adverse Event|1|||
37927740|NCT00762996|69614576|FG003|Period One|Adverse Event|0|||
37927741|NCT00762996|69614573|FG000|Period One|Withdrawal by Subject|0|||
37927742|NCT00762996|69614574|FG001|Period One|Withdrawal by Subject|0|||
37927743|NCT00762996|69614575|FG002|Period One|Withdrawal by Subject|1|||
37927744|NCT00762996|69614576|FG003|Period One|Withdrawal by Subject|0|||
37927745|NCT00762606|69614586|FG000|Overall Study|Lost to Follow-up|18|||
37927746|NCT00762606|69614587|FG001|Overall Study|Lost to Follow-up|13|||
37927747|NCT00818441|69614595|FG000|Overall Study|Death|69|||
37927748|NCT00818441|69614596|FG001|Overall Study|Death|26|||
37927749|NCT00818441|69614595|FG000|Overall Study|Other|5|||
37927750|NCT00818441|69614596|FG001|Overall Study|Other|0|||
37927751|NCT00818441|69614595|FG000|Overall Study|Lost to Follow-up|2|||
37927752|NCT00818441|69614596|FG001|Overall Study|Lost to Follow-up|1|||
37760091|NCT01557283|69270233|FG000|Overall Study|Withdrawal by Subject|1|||
37760092|NCT01557283|69270233|FG000|Overall Study|Participant's weight too high for dose|1|||
37760093|NCT01557283|69270233|FG000|Overall Study|Worsening of psoriasis|1|||
37760094|NCT01557283|69270233|FG000|Overall Study|Other|6|||
37760095|NCT01523743|69270250|FG000|Period 1|Adverse Event|1|||
37760096|NCT01523743|69270251|FG001|Period 1|Adverse Event|0|||
37760097|NCT01523743|69270250|FG000|Period 1|Withdrawal by Subject|6|||
37760098|NCT01523743|69270251|FG001|Period 1|Withdrawal by Subject|2|||
37760099|NCT01523743|69270250|FG000|Period 1|Lost to Follow-up|1|||
37760100|NCT01523743|69270251|FG001|Period 1|Lost to Follow-up|0|||
37760101|NCT01523743|69270250|FG000|Period 1|Lack of Efficacy|1|||
37760102|NCT01523743|69270251|FG001|Period 1|Lack of Efficacy|0|||
37760103|NCT01523743|69270250|FG000|Period 1|Felt unable to empty bladder|1|||
37760104|NCT01523743|69270251|FG001|Period 1|Felt unable to empty bladder|0|||
37760105|NCT01523743|69270250|FG000|Period 2|Withdrawal by Subject|0|||
37760106|NCT01523743|69270251|FG001|Period 2|Withdrawal by Subject|2|||
37760107|NCT01523743|69270250|FG000|Period 2|Adverse Event|1|||
37760108|NCT01523743|69270251|FG001|Period 2|Adverse Event|0|||
37760109|NCT01496807|69270266|FG000|Overall Study|Progressive Disease|21|||
37760110|NCT01496807|69270266|FG000|Overall Study|Participant preference/toxicity|8|||
37760111|NCT01496807|69270266|FG000|Overall Study|Change in diagnosis|1|||
37760112|NCT01496183|69270272|FG000|Overall Study|Physician Decision|3|||
37760113|NCT01496183|69270273|FG001|Overall Study|Physician Decision|1|||
37760114|NCT01496183|69270272|FG000|Overall Study|Withdrawal by Subject|0|||
37760115|NCT01496183|69270273|FG001|Overall Study|Withdrawal by Subject|1|||
37760116|NCT01495793|69270280|FG000|Overall Study|Lost to Follow-up|1|||
37760117|NCT01495793|69270280|FG000|Overall Study|Violation of inclusion criteria|1|||
37760118|NCT01494467|69270286|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
37760119|NCT01494467|69270287|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
37760120|NCT01494467|69270286|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
37760121|NCT01494467|69270287|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
37927753|NCT00818441|69614595|FG000|Overall Study|Withdrawal by Subject|2|||
37927754|NCT00818441|69614596|FG001|Overall Study|Withdrawal by Subject|0|||
38033552|NCT03305666|69719528|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
37667274|NCT01667679|69139821|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
37667275|NCT01667679|69139822|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
37667276|NCT01667679|69139821|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
37667277|NCT01667679|69139822|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
37667278|NCT01667679|69139821|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
37667279|NCT01667679|69139822|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
37667280|NCT01667679|69139821|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
37667281|NCT01667679|69139822|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
37667282|NCT01667679|69139821|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
37667283|NCT01667679|69139822|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
37667284|NCT01667679|69139821|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
37667285|NCT01667679|69139822|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
37667286|NCT01667679|69139821|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
37667287|NCT01667679|69139822|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
37667288|NCT01667679|69139821|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
37667289|NCT01667679|69139822|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
37667290|NCT01667679|69139821|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
37667291|NCT01667679|69139822|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
37667292|NCT01667679|69139821|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
37667293|NCT01667679|69139822|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
37667294|NCT01667679|69139821|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
37667295|NCT01667679|69139822|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
37667296|NCT01667679|69139821|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
37667297|NCT01667679|69139822|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
37667298|NCT01667679|69139821|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
37667299|NCT01667679|69139822|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
37760122|NCT01494467|69270286|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
37760123|NCT01494467|69270287|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
37760124|NCT01494467|69270286|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
37760125|NCT01494467|69270287|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
37760126|NCT01494467|69270286|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
37760127|NCT01494467|69270287|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
37927755|NCT00818441|69614595|FG000|Overall Study|Adverse Event|0|||
37667300|NCT02597049|69139833|FG000|Overall Study|Lost to Follow-up|0|||
37760128|NCT01494467|69270286|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
37760129|NCT01494467|69270287|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
37760130|NCT01494467|69270286|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
37760131|NCT01494467|69270287|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
37760132|NCT01494467|69270286|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
37760133|NCT01494467|69270287|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
37760134|NCT01494467|69270286|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
37760135|NCT01494467|69270287|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
37667301|NCT02597049|69139834|FG001|Overall Study|Lost to Follow-up|3|||
37667302|NCT02597049|69139835|FG002|Overall Study|Lost to Follow-up|2|||
37667303|NCT02597049|69139833|FG000|Overall Study|Withdrawal by Subject|2|||
37667304|NCT02597049|69139834|FG001|Overall Study|Withdrawal by Subject|2|||
37667305|NCT02597049|69139835|FG002|Overall Study|Withdrawal by Subject|1|||
37667306|NCT02597049|69139833|FG000|Overall Study|Adverse Event|2|||
37667307|NCT02597049|69139834|FG001|Overall Study|Adverse Event|0|||
37667308|NCT02597049|69139835|FG002|Overall Study|Adverse Event|0|||
37667309|NCT02597049|69139833|FG000|Overall Study|Death|2|||
37667310|NCT02597049|69139834|FG001|Overall Study|Death|0|||
37667311|NCT02597049|69139835|FG002|Overall Study|Death|0|||
37667312|NCT02597049|69139833|FG000|Overall Study|Noncompliant with Study Visits|1|||
37667313|NCT02597049|69139834|FG001|Overall Study|Noncompliant with Study Visits|0|||
37667314|NCT02597049|69139835|FG002|Overall Study|Noncompliant with Study Visits|0|||
37667315|NCT02594163|69139845|FG000|Treatment Period|Progressive disease|2|||
37667316|NCT02594163|69139846|FG001|Treatment Period|Progressive disease|3|||
37667317|NCT02594163|69139845|FG000|Treatment Period|Adverse Event|1|||
37667318|NCT02594163|69139846|FG001|Treatment Period|Adverse Event|5|||
37667319|NCT02594163|69139845|FG000|Treatment Period|Physician Decision|1|||
37667320|NCT02594163|69139846|FG001|Treatment Period|Physician Decision|3|||
37667321|NCT02594163|69139845|FG000|Treatment Period|Study termination by sponsor|2|||
37667322|NCT02594163|69139846|FG001|Treatment Period|Study termination by sponsor|1|||
37667323|NCT02594163|69139845|FG000|Treatment Period|Other, Non-AE|1|||
37667324|NCT02594163|69139846|FG001|Treatment Period|Other, Non-AE|0|||
37667325|NCT02594163|69139845|FG000|Follow-up Period|Withdrawal by Subject|0|||
37667326|NCT02594163|69139846|FG001|Follow-up Period|Withdrawal by Subject|1|||
37667327|NCT02594163|69139845|FG000|Follow-up Period|Study Termination by Sponsor|6|||
37667328|NCT02594163|69139846|FG001|Follow-up Period|Study Termination by Sponsor|4|||
37667329|NCT02594163|69139845|FG000|Follow-up Period|Lost to Follow-up|1|||
37667330|NCT02594163|69139846|FG001|Follow-up Period|Lost to Follow-up|0|||
37667331|NCT02594163|69139845|FG000|Follow-up Period|Death|2|||
37667332|NCT02594163|69139846|FG001|Follow-up Period|Death|5|||
37667333|NCT02594163|69139845|FG000|Follow-up Period|Adverse Event|0|||
37667334|NCT02594163|69139846|FG001|Follow-up Period|Adverse Event|1|||
37667335|NCT02594163|69139845|FG000|Follow-up Period|Progressive Disease|2|||
37667336|NCT02594163|69139846|FG001|Follow-up Period|Progressive Disease|0|||
37667337|NCT02594163|69139845|FG000|Follow-up Period|Physician Decision|0|||
37667338|NCT02594163|69139846|FG001|Follow-up Period|Physician Decision|1|||
37667339|NCT02712983|69139861|FG000|Treatment Phase|Adverse Event|3|||
37667340|NCT02712983|69139862|FG001|Treatment Phase|Adverse Event|1|||
37667341|NCT02712983|69139863|FG002|Treatment Phase|Adverse Event|1|||
37667342|NCT02712983|69139864|FG003|Treatment Phase|Adverse Event|4|||
37667343|NCT02712983|69139865|FG004|Treatment Phase|Adverse Event|3|||
37667344|NCT02712983|69139866|FG005|Treatment Phase|Adverse Event|0|||
37667345|NCT02712983|69139867|FG006|Treatment Phase|Adverse Event|6|||
37667346|NCT02712983|69139868|FG007|Treatment Phase|Adverse Event|6|||
37667347|NCT02712983|69139869|FG008|Treatment Phase|Adverse Event|1|||
37667348|NCT02712983|69139861|FG000|Treatment Phase|Protocol Deviation|0|||
37667349|NCT02712983|69139862|FG001|Treatment Phase|Protocol Deviation|0|||
37667350|NCT02712983|69139863|FG002|Treatment Phase|Protocol Deviation|0|||
37667351|NCT02712983|69139864|FG003|Treatment Phase|Protocol Deviation|2|||
37667352|NCT02712983|69139865|FG004|Treatment Phase|Protocol Deviation|0|||
37667353|NCT02712983|69139866|FG005|Treatment Phase|Protocol Deviation|0|||
37760136|NCT01494467|69270286|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
37859431|NCT01288079|69542752|FG003|Overall Study|Lack of Efficacy|2|||
37859432|NCT01288079|69542749|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
37667354|NCT02712983|69139867|FG006|Treatment Phase|Protocol Deviation|1|||
37667355|NCT02712983|69139868|FG007|Treatment Phase|Protocol Deviation|0|||
37667356|NCT02712983|69139869|FG008|Treatment Phase|Protocol Deviation|0|||
37667357|NCT02712983|69139861|FG000|Treatment Phase|Technical Problems|0|||
37667358|NCT02712983|69139862|FG001|Treatment Phase|Technical Problems|0|||
37667359|NCT02712983|69139863|FG002|Treatment Phase|Technical Problems|0|||
37667360|NCT02712983|69139864|FG003|Treatment Phase|Technical Problems|0|||
37667361|NCT02712983|69139865|FG004|Treatment Phase|Technical Problems|0|||
37667362|NCT02712983|69139866|FG005|Treatment Phase|Technical Problems|0|||
37667363|NCT02712983|69139867|FG006|Treatment Phase|Technical Problems|1|||
37667364|NCT02712983|69139868|FG007|Treatment Phase|Technical Problems|0|||
37667365|NCT02712983|69139869|FG008|Treatment Phase|Technical Problems|0|||
37927756|NCT00818441|69614596|FG001|Overall Study|Adverse Event|1|||
37927757|NCT00818441|69614595|FG000|Overall Study|Study terminated by sponsor|11|||
37667366|NCT02712983|69139861|FG000|Treatment Phase|Physician Decision|0|||
37667367|NCT02712983|69139862|FG001|Treatment Phase|Physician Decision|0|||
37667368|NCT02712983|69139863|FG002|Treatment Phase|Physician Decision|0|||
37667369|NCT02712983|69139864|FG003|Treatment Phase|Physician Decision|0|||
37667370|NCT02712983|69139865|FG004|Treatment Phase|Physician Decision|0|||
37667371|NCT02712983|69139866|FG005|Treatment Phase|Physician Decision|0|||
37667372|NCT02712983|69139867|FG006|Treatment Phase|Physician Decision|0|||
37667373|NCT02712983|69139868|FG007|Treatment Phase|Physician Decision|1|||
37667374|NCT02712983|69139869|FG008|Treatment Phase|Physician Decision|1|||
37667375|NCT02712983|69139861|FG000|Treatment Phase|Subject Decision|2|||
37667376|NCT02712983|69139862|FG001|Treatment Phase|Subject Decision|0|||
37667377|NCT02712983|69139863|FG002|Treatment Phase|Subject Decision|0|||
37667378|NCT02712983|69139864|FG003|Treatment Phase|Subject Decision|2|||
37667379|NCT02712983|69139865|FG004|Treatment Phase|Subject Decision|1|||
37667380|NCT02712983|69139866|FG005|Treatment Phase|Subject Decision|0|||
37667381|NCT02712983|69139867|FG006|Treatment Phase|Subject Decision|1|||
37667382|NCT02712983|69139868|FG007|Treatment Phase|Subject Decision|2|||
37667383|NCT02712983|69139869|FG008|Treatment Phase|Subject Decision|0|||
37667384|NCT02712983|69139861|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
37667385|NCT02712983|69139862|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
37667386|NCT02712983|69139863|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
37667387|NCT02712983|69139864|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
37667388|NCT02712983|69139865|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
37667389|NCT02712983|69139866|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
37667390|NCT02712983|69139867|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
37667391|NCT02712983|69139868|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
37667392|NCT02712983|69139869|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
37667393|NCT02712983|69139861|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
37667394|NCT02712983|69139862|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
37667395|NCT02712983|69139863|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
37667396|NCT02712983|69139864|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
37667397|NCT02712983|69139865|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
37667398|NCT02712983|69139866|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
37667399|NCT02712983|69139867|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
37667400|NCT02712983|69139868|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
37667401|NCT02712983|69139869|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
37667402|NCT02712983|69139861|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
37667403|NCT02712983|69139862|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
37667404|NCT02712983|69139863|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
37667405|NCT02712983|69139864|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
37667406|NCT02712983|69139865|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
37667407|NCT02712983|69139866|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
37667408|NCT02712983|69139867|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
37667409|NCT02712983|69139868|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
37667410|NCT02712983|69139869|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
37667411|NCT02596971|69139892|FG000|Overall Study|Death|5|||
37667412|NCT02596971|69139893|FG001|Overall Study|Death|1|||
37667413|NCT02596971|69139894|FG002|Overall Study|Death|5|||
37667414|NCT02596971|69139892|FG000|Overall Study|Withdrawal by Subject|5|||
37667415|NCT02596971|69139893|FG001|Overall Study|Withdrawal by Subject|1|||
37667416|NCT02596971|69139894|FG002|Overall Study|Withdrawal by Subject|4|||
37667417|NCT02593773|69139905|FG000|Overall Study|Voluntary Withdrawal|3|||
37667418|NCT02593773|69139905|FG000|Overall Study|Study Terminated by Sponsor|31|||
37667419|NCT02593773|69139905|FG000|Overall Study|Death|1|||
37667420|NCT02593539|69139909|FG000|Overall Study|Adverse Event|1|||
37667421|NCT00919763|69139918|FG000|Overall Study|Adverse Event|7|||
37667422|NCT00919763|69139919|FG001|Overall Study|Adverse Event|1|||
37667423|NCT00919763|69139918|FG000|Overall Study|Lost to Follow-up|1|||
37667424|NCT00919763|69139919|FG001|Overall Study|Lost to Follow-up|0|||
37667425|NCT00919763|69139918|FG000|Overall Study|Protocol Violation|1|||
37667426|NCT00919763|69139919|FG001|Overall Study|Protocol Violation|1|||
37667427|NCT00919763|69139918|FG000|Overall Study|Withdrawal by Subject|3|||
37667428|NCT00919763|69139919|FG001|Overall Study|Withdrawal by Subject|1|||
37667429|NCT00919763|69139918|FG000|Overall Study|Non-compliance|0|||
37667430|NCT00919763|69139919|FG001|Overall Study|Non-compliance|1|||
37667431|NCT02593305|69139937|FG000|Post 1|Comparison only group. No intervention.|0|||
37667432|NCT02593305|69139938|FG001|Post 1|Comparison only group. No intervention.|0|||
37667433|NCT02593305|69139939|FG002|Post 1|Comparison only group. No intervention.|10|||
37667434|NCT02593149|69139950|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
37667435|NCT02593149|69139951|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
37667436|NCT02593149|69139950|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
37760137|NCT01494467|69270287|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
37760138|NCT01494467|69270286|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
37760139|NCT01494467|69270287|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
37760140|NCT01494467|69270286|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
37760141|NCT01494467|69270287|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
37760142|NCT01494467|69270286|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
37760143|NCT01494467|69270287|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
37760144|NCT01494467|69270286|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
37760145|NCT01494467|69270287|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
37760146|NCT01493687|69270301|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
37760147|NCT01493687|69270302|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
37760148|NCT01493687|69270301|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
37927758|NCT00818441|69614596|FG001|Overall Study|Study terminated by sponsor|2|||
37927759|NCT00826943|69614603|FG000|Overall Study|Withdrawal by Subject|0|||
37927760|NCT00826943|69614604|FG001|Overall Study|Withdrawal by Subject|0|||
37927761|NCT00826943|69614605|FG002|Overall Study|Withdrawal by Subject|0|||
37927762|NCT00826943|69614606|FG003|Overall Study|Withdrawal by Subject|0|||
37927763|NCT00826943|69614607|FG004|Overall Study|Withdrawal by Subject|1|||
37927764|NCT00826943|69614608|FG005|Overall Study|Withdrawal by Subject|0|||
37927765|NCT00834041|69614618|FG000|Overall Study|Withdrawal by Subject|1|||
37927766|NCT00834041|69614619|FG001|Overall Study|Withdrawal by Subject|0|||
37667437|NCT02593149|69139951|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
37667438|NCT02177812|69139966|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
37927767|NCT00834041|69614618|FG000|Overall Study|Lost to Follow-up|0|||
37927768|NCT00834041|69614619|FG001|Overall Study|Lost to Follow-up|1|||
37927769|NCT00760929|69614629|FG000|Overall Study|Adverse Event|2|||
37927770|NCT00760929|69614630|FG001|Overall Study|Adverse Event|0|||
37927771|NCT00760929|69614631|FG002|Overall Study|Adverse Event|6|||
37927772|NCT00760929|69614632|FG003|Overall Study|Adverse Event|10|||
37927773|NCT00760929|69614629|FG000|Overall Study|Lack of Efficacy|0|||
37667439|NCT02177812|69139967|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
37667440|NCT02177812|69139968|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
37667441|NCT02177812|69139969|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
37667442|NCT02177812|69139970|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
37667443|NCT02177812|69139971|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
37667444|NCT02177812|69139972|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
37667445|NCT02177812|69139973|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
37667446|NCT02177812|69139974|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
37667447|NCT02177812|69139966|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
37667448|NCT02177812|69139967|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
37667449|NCT02177812|69139968|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
37667450|NCT02177812|69139969|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
37667451|NCT02177812|69139970|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
37667452|NCT02177812|69139971|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
37667453|NCT02177812|69139972|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
37667454|NCT02177812|69139973|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
37667455|NCT02177812|69139974|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
37760149|NCT01493687|69270302|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
37760150|NCT01493687|69270301|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
37760151|NCT01493687|69270302|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
37927774|NCT00760929|69614630|FG001|Overall Study|Lack of Efficacy|2|||
37927775|NCT00760929|69614631|FG002|Overall Study|Lack of Efficacy|1|||
37927776|NCT00760929|69614632|FG003|Overall Study|Lack of Efficacy|0|||
37927777|NCT00760929|69614629|FG000|Overall Study|Withdrawal by Subject|1|||
37927778|NCT00760929|69614630|FG001|Overall Study|Withdrawal by Subject|0|||
37927779|NCT00760929|69614631|FG002|Overall Study|Withdrawal by Subject|9|||
37927780|NCT00760929|69614632|FG003|Overall Study|Withdrawal by Subject|1|||
37927781|NCT00760929|69614629|FG000|Overall Study|Lost to Follow-up|0|||
38043553|NCT03238248|69731701|FG000|Overall Study|Decline in condition|1|||
37667456|NCT02177812|69139966|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
37667457|NCT02177812|69139967|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
37667458|NCT02177812|69139968|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
37667459|NCT02177812|69139969|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
37667460|NCT02177812|69139970|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
37667461|NCT02177812|69139971|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
37667462|NCT02177812|69139972|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
37927782|NCT00760929|69614630|FG001|Overall Study|Lost to Follow-up|0|||
37927783|NCT00760929|69614631|FG002|Overall Study|Lost to Follow-up|1|||
37927784|NCT00760929|69614632|FG003|Overall Study|Lost to Follow-up|0|||
37927785|NCT00760929|69614629|FG000|Overall Study|Progression of Disease|21|||
37927786|NCT00760929|69614630|FG001|Overall Study|Progression of Disease|26|||
37927787|NCT00760929|69614631|FG002|Overall Study|Progression of Disease|38|||
37760152|NCT01493687|69270301|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
37760153|NCT01493687|69270302|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
37760154|NCT01493687|69270301|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
37760155|NCT01493687|69270302|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
37760156|NCT01493687|69270301|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
37760157|NCT01493687|69270302|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
37760158|NCT01493687|69270301|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
37760159|NCT01493687|69270302|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
37760160|NCT01493687|69270301|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
37760161|NCT01493687|69270302|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
37760162|NCT01493687|69270301|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
37760163|NCT01493687|69270302|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
37760164|NCT01493687|69270301|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
37760165|NCT01493687|69270302|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
37760166|NCT01493687|69270301|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
37760167|NCT01493687|69270302|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
37760168|NCT01493687|69270301|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
37760169|NCT01493687|69270302|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
37760170|NCT01493687|69270301|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
37760171|NCT01493687|69270302|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
37760172|NCT01493687|69270301|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
37760173|NCT01493687|69270302|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
37760174|NCT01493687|69270301|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
37760175|NCT01493687|69270302|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
37760176|NCT01523587|69270334|FG000|Overall Study|Other than listed|5|||
37760177|NCT01523587|69270335|FG001|Overall Study|Other than listed|5|||
37760178|NCT01523587|69270334|FG000|Overall Study|Worsening of underlying cancer disease|19|||
37760179|NCT01523587|69270335|FG001|Overall Study|Worsening of underlying cancer disease|34|||
37760180|NCT01523587|69270334|FG000|Overall Study|Adverse Event|68|||
37760181|NCT01523587|69270335|FG001|Overall Study|Adverse Event|52|||
37760182|NCT01523587|69270334|FG000|Overall Study|Protocol Violation|5|||
37760183|NCT01523587|69270335|FG001|Overall Study|Protocol Violation|3|||
37760184|NCT01523587|69270334|FG000|Overall Study|Lost to Follow-up|2|||
37760185|NCT01523587|69270335|FG001|Overall Study|Lost to Follow-up|2|||
37760186|NCT01523587|69270334|FG000|Overall Study|Withdrawal by Subject|28|||
37760187|NCT01523587|69270335|FG001|Overall Study|Withdrawal by Subject|20|||
37760188|NCT01523587|69270334|FG000|Overall Study|Withdrew due to Progressive disease|265|||
37760189|NCT01523587|69270335|FG001|Overall Study|Withdrew due to Progressive disease|279|||
37760190|NCT01523587|69270334|FG000|Overall Study|Randomised but bot treated|6|||
37760191|NCT01523587|69270335|FG001|Overall Study|Randomised but bot treated|2|||
37760192|NCT01493531|69270364|FG000|Overall Study|Adverse Event|4|||
37760193|NCT01493531|69270365|FG001|Overall Study|Adverse Event|12|||
37760194|NCT01493531|69270366|FG002|Overall Study|Adverse Event|9|||
37760195|NCT01493531|69270364|FG000|Overall Study|Gout flare|3|||
37760196|NCT01493531|69270365|FG001|Overall Study|Gout flare|0|||
37667463|NCT02177812|69139973|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
37667464|NCT02177812|69139974|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
37667465|NCT01626352|69140018|FG000|Overall Study|Disease Progression|3|||
37667466|NCT01626352|69140018|FG000|Overall Study|Intercurrent Illness|2|||
37667467|NCT01626352|69140018|FG000|Overall Study|Death|2|||
37667468|NCT01626352|69140018|FG000|Overall Study|Withdrawal by Subject|1|||
37667469|NCT01626352|69140018|FG000|Overall Study|Non-Compliance|1|||
37667470|NCT01626352|69140018|FG000|Overall Study|Never Treated|1|||
37667471|NCT01626118|69140029|FG000|Overall Study|Lack of Efficacy|1|||
37667472|NCT01626118|69140030|FG001|Overall Study|Lack of Efficacy|0|||
37667473|NCT01626118|69140031|FG002|Overall Study|Lack of Efficacy|1|||
37667474|NCT01626118|69140032|FG003|Overall Study|Lack of Efficacy|3|||
37667475|NCT01626118|69140029|FG000|Overall Study|Lost to Follow-up|1|||
37667476|NCT01626118|69140030|FG001|Overall Study|Lost to Follow-up|0|||
37927788|NCT00760929|69614632|FG003|Overall Study|Progression of Disease|42|||
37667477|NCT01626118|69140031|FG002|Overall Study|Lost to Follow-up|0|||
37667478|NCT01626118|69140032|FG003|Overall Study|Lost to Follow-up|0|||
37667479|NCT01626118|69140029|FG000|Overall Study|Adverse Event|0|||
37667480|NCT01626118|69140030|FG001|Overall Study|Adverse Event|1|||
37760197|NCT01493531|69270366|FG002|Overall Study|Gout flare|2|||
37760198|NCT01493531|69270364|FG000|Overall Study|Protocol Violation|8|||
37760199|NCT01493531|69270365|FG001|Overall Study|Protocol Violation|15|||
37760200|NCT01493531|69270366|FG002|Overall Study|Protocol Violation|12|||
37760201|NCT01493531|69270364|FG000|Overall Study|Sponsor terminated study|5|||
37667481|NCT01626118|69140031|FG002|Overall Study|Adverse Event|1|||
37667482|NCT01626118|69140032|FG003|Overall Study|Adverse Event|0|||
37667483|NCT01626118|69140029|FG000|Overall Study|Investigator Decision|0|||
37667484|NCT01626118|69140030|FG001|Overall Study|Investigator Decision|1|||
37760202|NCT01493531|69270365|FG001|Overall Study|Sponsor terminated study|2|||
37760203|NCT01493531|69270366|FG002|Overall Study|Sponsor terminated study|3|||
37760204|NCT01493531|69270364|FG000|Overall Study|Lost to Follow-up|5|||
37760205|NCT01493531|69270365|FG001|Overall Study|Lost to Follow-up|7|||
37760206|NCT01493531|69270366|FG002|Overall Study|Lost to Follow-up|11|||
37760207|NCT01493531|69270364|FG000|Overall Study|Withdrawal by Subject|16|||
37760208|NCT01493531|69270365|FG001|Overall Study|Withdrawal by Subject|13|||
37760209|NCT01493531|69270366|FG002|Overall Study|Withdrawal by Subject|11|||
37760210|NCT01493531|69270364|FG000|Overall Study|Death|0|||
37760211|NCT01493531|69270365|FG001|Overall Study|Death|1|||
37760212|NCT01493531|69270366|FG002|Overall Study|Death|0|||
37927789|NCT00760929|69614629|FG000|Overall Study|Other|2|||
37927790|NCT00760929|69614630|FG001|Overall Study|Other|0|||
37927791|NCT00760929|69614631|FG002|Overall Study|Other|2|||
37927792|NCT00760929|69614632|FG003|Overall Study|Other|1|||
37927793|NCT00760929|69614629|FG000|Overall Study|Death|0|||
37927794|NCT00760929|69614630|FG001|Overall Study|Death|0|||
37927795|NCT00760929|69614631|FG002|Overall Study|Death|1|||
37927796|NCT00760929|69614632|FG003|Overall Study|Death|0|||
37927797|NCT00760929|69614629|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
37927798|NCT00760929|69614630|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
37927799|NCT00760929|69614631|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
37927800|NCT00760929|69614632|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
37927801|NCT00818207|69614643|FG000|Overall Study|Adverse Event|6|||
37927802|NCT00818207|69614644|FG001|Overall Study|Adverse Event|0|||
37927803|NCT00818207|69614643|FG000|Overall Study|Lost to Follow-up|160|||
37927804|NCT00818207|69614644|FG001|Overall Study|Lost to Follow-up|146|||
37927805|NCT00818207|69614643|FG000|Overall Study|Multiple reasons|11|||
37927806|NCT00818207|69614644|FG001|Overall Study|Multiple reasons|12|||
37927807|NCT00818207|69614643|FG000|Overall Study|Withdrawal by Subject|42|||
37927808|NCT00818207|69614644|FG001|Overall Study|Withdrawal by Subject|104|||
37927809|NCT00818207|69614643|FG000|Overall Study|Death|3|||
37927810|NCT00818207|69614644|FG001|Overall Study|Death|5|||
37927811|NCT00760617|69614653|FG000|Overall Study|Adverse Event|5|||
37927812|NCT00760617|69614654|FG001|Overall Study|Adverse Event|2|||
37927813|NCT00760617|69614655|FG002|Overall Study|Adverse Event|0|||
37927814|NCT00760617|69614653|FG000|Overall Study|Lost to Follow-up|0|||
37927815|NCT00760617|69614654|FG001|Overall Study|Lost to Follow-up|0|||
37927816|NCT00760617|69614655|FG002|Overall Study|Lost to Follow-up|5|||
37927817|NCT00760383|69614665|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
37927818|NCT00760383|69614666|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
37927819|NCT00759915|69614674|FG000|Overall Study|Withdrawal by Subject|1|||
37927820|NCT00759915|69614675|FG001|Overall Study|Withdrawal by Subject|0|||
37927821|NCT00759915|69614674|FG000|Overall Study|Adverse Event|0|||
37927822|NCT00759915|69614675|FG001|Overall Study|Adverse Event|1|||
37927823|NCT00759759|69614683|FG000|Overall Study|didn't return for period 2|1|||
37927824|NCT00759759|69614684|FG001|Overall Study|didn't return for period 2|0|||
37927825|NCT00759759|69614683|FG000|Overall Study|Didn't receive drug in period 2|1|||
37927826|NCT00759759|69614684|FG001|Overall Study|Didn't receive drug in period 2|0|||
37927827|NCT00759759|69614683|FG000|Overall Study|Withdrawal by Subject|2|||
37927828|NCT00759759|69614684|FG001|Overall Study|Withdrawal by Subject|1|||
37927829|NCT00759681|69614692|FG000|Overall Study|Death|2|||
37927830|NCT00759681|69614693|FG001|Overall Study|Death|5|||
37927831|NCT00759681|69614692|FG000|Overall Study|Lost to Follow-up|8|||
37927832|NCT00759681|69614693|FG001|Overall Study|Lost to Follow-up|5|||
37927833|NCT00826241|69614700|FG000|Overall Study|Withdrawal from Follow-up|1|||
37927834|NCT00826241|69614700|FG000|Overall Study|Withdrew consent|2|||
37927835|NCT00826241|69614700|FG000|Overall Study|Death|4|||
37927836|NCT00826241|69614700|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
37927837|NCT00826241|69614700|FG000|Overall Study|Non-compliance|1|||
38033553|NCT03305666|69719529|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
37760213|NCT01523275|69270390|FG000|Overall Study|Lost to Follow-up|1|||
37927838|NCT00826241|69614700|FG000|Overall Study|Progression of disease|1|||
37927839|NCT00826241|69614700|FG000|Overall Study|Patient refused follow-up|3|||
38033554|NCT03304184|69719537|FG000|Overall Study|Withdrawal by Subject|1|||
37927840|NCT00826241|69614700|FG000|Overall Study|Lost to Follow-up|9|||
38033555|NCT03304184|69719538|FG001|Overall Study|Withdrawal by Subject|2|||
37760214|NCT01523275|69270391|FG001|Overall Study|Lost to Follow-up|2|||
37760215|NCT01523275|69270390|FG000|Overall Study|Withdrawal by Subject|1|||
37760216|NCT01523275|69270391|FG001|Overall Study|Withdrawal by Subject|0|||
37927841|NCT00826241|69614700|FG000|Overall Study|Could not obtain records|1|||
37927842|NCT00826241|69614700|FG000|Overall Study|Screen failure|2|||
37927843|NCT00826241|69614700|FG000|Overall Study|Pt unable to proceed to registration|1|||
37927844|NCT00826241|69614700|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
37927845|NCT00758589|69614708|FG000|Overall Study|Adverse Event|3|||
37927846|NCT00758589|69614709|FG001|Overall Study|Adverse Event|2|||
37927847|NCT00758589|69614710|FG002|Overall Study|Adverse Event|5|||
37927848|NCT00758589|69614711|FG003|Overall Study|Adverse Event|4|||
37927849|NCT00758589|69614708|FG000|Overall Study|Withdrawal by Subject|0|||
37927850|NCT00758589|69614709|FG001|Overall Study|Withdrawal by Subject|1|||
37927851|NCT00758589|69614710|FG002|Overall Study|Withdrawal by Subject|1|||
37927852|NCT00758589|69614711|FG003|Overall Study|Withdrawal by Subject|1|||
37927853|NCT00758589|69614708|FG000|Overall Study|Palm stopped to work|0|||
37927854|NCT00758589|69614709|FG001|Overall Study|Palm stopped to work|0|||
37667485|NCT01626118|69140031|FG002|Overall Study|Investigator Decision|0|||
37667486|NCT01626118|69140032|FG003|Overall Study|Investigator Decision|0|||
37667487|NCT02152384|69140042|FG000|Period 1|Withdrawal by Subject|0|||
37667488|NCT02152384|69140043|FG001|Period 1|Withdrawal by Subject|1|||
37927855|NCT00758589|69614710|FG002|Overall Study|Palm stopped to work|0|||
37927856|NCT00758589|69614711|FG003|Overall Study|Palm stopped to work|1|||
37927857|NCT00833417|69614723|FG000|Overall Study|Adverse Event|5|||
37927858|NCT00833417|69614724|FG001|Overall Study|Adverse Event|16|||
37927859|NCT00833417|69614723|FG000|Overall Study|Death|1|||
37927860|NCT00833417|69614724|FG001|Overall Study|Death|3|||
37927861|NCT00833417|69614723|FG000|Overall Study|Lost to Follow-up|1|||
37927862|NCT00833417|69614724|FG001|Overall Study|Lost to Follow-up|2|||
37927863|NCT00833417|69614723|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
37927864|NCT00833417|69614724|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
37927865|NCT00833417|69614723|FG000|Overall Study|Patient Decision to Withdraw|4|||
37927866|NCT00833417|69614724|FG001|Overall Study|Patient Decision to Withdraw|23|||
37927867|NCT00833417|69614723|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
37927868|NCT00833417|69614724|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
37927869|NCT00833417|69614723|FG000|Overall Study|Disease Progression|18|||
37927870|NCT00833417|69614724|FG001|Overall Study|Disease Progression|17|||
37927871|NCT00833417|69614723|FG000|Overall Study|Reason Not Specified|0|||
37927872|NCT00833417|69614724|FG001|Overall Study|Reason Not Specified|1|||
37927873|NCT00762372|69614734|FG000|Overall Study|Adverse Event|1|||
37927874|NCT00762372|69614735|FG001|Overall Study|Adverse Event|0|||
37927875|NCT00762372|69614736|FG002|Overall Study|Adverse Event|0|||
37927876|NCT00833261|69614750|FG000|Overall Study|Withdrawal by Subject|4|||
37927877|NCT00833105|69614754|FG000|Overall Study|Withdrawal by Subject|1|||
37927878|NCT00833105|69614754|FG000|Overall Study|Adverse Event|2|||
37927879|NCT00833027|69614760|FG000|Overall Study|Adverse Event|33|||
37927880|NCT00833027|69614760|FG000|Overall Study|Death|1|||
37927881|NCT00833027|69614760|FG000|Overall Study|Lack of Efficacy|12|||
37927882|NCT00833027|69614760|FG000|Overall Study|Lost to Follow-up|24|||
37927883|NCT00833027|69614760|FG000|Overall Study|Protocol Violation|115|||
37927884|NCT00833027|69614760|FG000|Overall Study|Withdrawal by Subject|16|||
37927885|NCT00833027|69614760|FG000|Overall Study|Missing|10|||
37927886|NCT00752622|69614764|FG000|Induction Phase|Adverse Event|3|||
37927887|NCT00752622|69614764|FG000|Induction Phase|Other|3|||
37927888|NCT00752622|69614764|FG000|Induction Phase|Non-responder|14|||
37927889|NCT00752622|69614764|FG000|Induction Phase|Withdrawal by Subject|1|||
37927890|NCT00752622|69614764|FG000|Induction Phase|Premature study termination|14|||
37927891|NCT00752622|69614764|FG000|Observational Phase|Premature Study Termination|36|||
37927892|NCT00752622|69614764|FG000|Observational Phase|Non-responder|2|||
37927893|NCT00752622|69614764|FG000|Observational Phase|Withdrawal by Subject|2|||
37927894|NCT00752622|69614764|FG000|Observational Phase|Adverse Event|1|||
37927895|NCT00752622|69614764|FG000|Observational Phase|Other|2|||
37927896|NCT00752622|69614764|FG000|Interventional Phase|Non-responder|2|||
37927897|NCT00752622|69614764|FG000|Interventional Phase|Physician Decision|1|||
37927898|NCT00752622|69614764|FG000|Interventional Phase|Premature Study Termination|5|||
37927899|NCT00754650|69614769|FG000|Overall Study|Disease Progression|2|||
37927900|NCT00761748|69614773|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
37927901|NCT00761748|69614774|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
37927902|NCT00761748|69614773|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
37667489|NCT02152384|69140042|FG000|Period 1|Adverse Event|1|||
37667490|NCT02152384|69140043|FG001|Period 1|Adverse Event|1|||
37667491|NCT02177266|69140055|FG000|Overall Study|Adverse Event|0|||
37667492|NCT02177266|69140056|FG001|Overall Study|Adverse Event|1|||
37667493|NCT02177266|69140055|FG000|Overall Study|Withdrawal by Subject|1|||
37667494|NCT02177266|69140056|FG001|Overall Study|Withdrawal by Subject|0|||
37667495|NCT02177032|69140066|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
37667496|NCT02177032|69140067|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
37667497|NCT02177032|69140068|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
37667498|NCT02177032|69140069|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
37667499|NCT02177032|69140066|FG000|Overall Study|Lost to Follow-up|0|||
37927903|NCT00761748|69614774|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
37927904|NCT00825305|69614782|FG000|Overall Study|Adverse Event|1|||
37927905|NCT00825305|69614783|FG001|Overall Study|Adverse Event|1|||
37927906|NCT00825305|69614782|FG000|Overall Study|Withdrawal by Subject|6|||
37927907|NCT00825305|69614783|FG001|Overall Study|Withdrawal by Subject|12|||
37927908|NCT00825305|69614782|FG000|Overall Study|Inappropriate inclusion|1|||
37927909|NCT00825305|69614783|FG001|Overall Study|Inappropriate inclusion|0|||
37927910|NCT00825305|69614782|FG000|Overall Study|Protocol Violation|9|||
37927911|NCT00825305|69614783|FG001|Overall Study|Protocol Violation|9|||
37927912|NCT00825305|69614782|FG000|Overall Study|Can not be classified|0|||
37927913|NCT00825305|69614783|FG001|Overall Study|Can not be classified|1|||
37927914|NCT00754572|69614789|FG000|Overall Study|Adverse Event|19|||
37927915|NCT00754572|69614789|FG000|Overall Study|Other|39|||
37927916|NCT00754572|69614789|FG000|Overall Study|Protocol Violation|3|||
37927917|NCT00754572|69614789|FG000|Overall Study|Withdrawal by Subject|3|||
37927918|NCT00754572|69614789|FG000|Overall Study|Lack of Efficacy|2|||
37927919|NCT00754572|69614789|FG000|Overall Study|Death|1|||
37927920|NCT00754572|69614789|FG000|Overall Study|Administrative Reason|3|||
37927921|NCT00754572|69614789|FG000|Overall Study|Lost to Follow-up|1|||
37927922|NCT00824993|69614795|FG000|Overall Study|Withdrawal by Subject|1|||
37927923|NCT00824993|69614796|FG001|Overall Study|Withdrawal by Subject|1|||
37927924|NCT00824993|69614795|FG000|Overall Study|Malignancy Relapse|9|||
37927925|NCT00824993|69614796|FG001|Overall Study|Malignancy Relapse|10|||
37927926|NCT00824993|69614795|FG000|Overall Study|Rapid Bone Loss|0|||
37927927|NCT00824993|69614796|FG001|Overall Study|Rapid Bone Loss|1|||
37927928|NCT00824993|69614795|FG000|Overall Study|Non-Compliant|2|||
37927929|NCT00824993|69614796|FG001|Overall Study|Non-Compliant|1|||
37927930|NCT00824993|69614795|FG000|Overall Study|Insurance Issue|2|||
37927931|NCT00824993|69614796|FG001|Overall Study|Insurance Issue|1|||
37927932|NCT00824993|69614795|FG000|Overall Study|Death|0|||
37927933|NCT00824993|69614796|FG001|Overall Study|Death|3|||
37927934|NCT00832091|69614804|FG000|Overall Study|Adverse Event|1|||
37927935|NCT00832091|69614805|FG001|Overall Study|Adverse Event|1|||
37927936|NCT00832091|69614804|FG000|Overall Study|Protocol Violation|1|||
37927937|NCT00832091|69614805|FG001|Overall Study|Protocol Violation|0|||
37927938|NCT00832091|69614804|FG000|Overall Study|Withdrawal by Subject|2|||
37927939|NCT00832091|69614805|FG001|Overall Study|Withdrawal by Subject|1|||
37927940|NCT00832091|69614804|FG000|Overall Study|Prohibited Medication|1|||
37927941|NCT00832091|69614805|FG001|Overall Study|Prohibited Medication|0|||
37927942|NCT00761514|69614811|FG000|Overall Study|Adverse Event|1|||
37927943|NCT00761514|69614811|FG000|Overall Study|Withdrawal by Subject|2|||
37927944|NCT00761514|69614811|FG000|Overall Study|Lost to Follow-up|1|||
37927945|NCT00761514|69614811|FG000|Overall Study|Health insurance didn't cover study drug|1|||
37927946|NCT00761514|69614811|FG000|Overall Study|Problem complying with study visit|1|||
37927947|NCT00761514|69614811|FG000|Overall Study|Unable to pay for medications|1|||
37927948|NCT00831779|69614817|FG000|Overall Study|Lost to Follow-up|1|||
37927949|NCT00831779|69614818|FG001|Overall Study|Lost to Follow-up|0|||
37927950|NCT00831779|69614817|FG000|Overall Study|No longer met criteria|0|||
37927951|NCT00831779|69614818|FG001|Overall Study|No longer met criteria|1|||
37927952|NCT00758043|69614828|FG000|Overall Study|Adverse Event|1|||
37927953|NCT00758043|69614829|FG001|Overall Study|Adverse Event|20|||
37927954|NCT00758043|69614830|FG002|Overall Study|Adverse Event|12|||
37927955|NCT00758043|69614831|FG003|Overall Study|Adverse Event|62|||
37927956|NCT00758043|69614828|FG000|Overall Study|Lack of Efficacy|0|||
37927957|NCT00758043|69614829|FG001|Overall Study|Lack of Efficacy|6|||
37927958|NCT00758043|69614830|FG002|Overall Study|Lack of Efficacy|18|||
37927959|NCT00758043|69614831|FG003|Overall Study|Lack of Efficacy|12|||
37927960|NCT00758043|69614828|FG000|Overall Study|Refused Further Treatment|0|||
37927961|NCT00758043|69614829|FG001|Overall Study|Refused Further Treatment|11|||
37927962|NCT00758043|69614830|FG002|Overall Study|Refused Further Treatment|5|||
37927963|NCT00758043|69614831|FG003|Overall Study|Refused Further Treatment|8|||
37927964|NCT00758043|69614828|FG000|Overall Study|Lost to Follow-up|0|||
37927965|NCT00758043|69614829|FG001|Overall Study|Lost to Follow-up|2|||
37927966|NCT00758043|69614830|FG002|Overall Study|Lost to Follow-up|2|||
37927967|NCT00758043|69614831|FG003|Overall Study|Lost to Follow-up|5|||
37927968|NCT00758043|69614828|FG000|Overall Study|Withdrawal by Subject|0|||
37927969|NCT00758043|69614829|FG001|Overall Study|Withdrawal by Subject|1|||
37927970|NCT00758043|69614830|FG002|Overall Study|Withdrawal by Subject|1|||
37927971|NCT00758043|69614831|FG003|Overall Study|Withdrawal by Subject|4|||
37927972|NCT00758043|69614828|FG000|Overall Study|Required Prohibited Medication|0|||
37927973|NCT00758043|69614829|FG001|Overall Study|Required Prohibited Medication|0|||
37927974|NCT00758043|69614830|FG002|Overall Study|Required Prohibited Medication|1|||
37927975|NCT00758043|69614831|FG003|Overall Study|Required Prohibited Medication|3|||
37927976|NCT00758043|69614828|FG000|Overall Study|Non-Compliant With study Drug|0|||
37927977|NCT00758043|69614829|FG001|Overall Study|Non-Compliant With study Drug|0|||
37927978|NCT00758043|69614830|FG002|Overall Study|Non-Compliant With study Drug|0|||
38033556|NCT03736785|69719548|FG000|Overall Study|Adverse Event|1|||
37927979|NCT00758043|69614831|FG003|Overall Study|Non-Compliant With study Drug|1|||
37927980|NCT00758043|69614828|FG000|Overall Study|Other Reasons|0|||
37927981|NCT00758043|69614829|FG001|Overall Study|Other Reasons|1|||
37927982|NCT00758043|69614830|FG002|Overall Study|Other Reasons|0|||
37927983|NCT00758043|69614831|FG003|Overall Study|Other Reasons|5|||
37927984|NCT00831701|69614849|FG000|Overall Study|Withdrawal by Subject|2|||
37927985|NCT00831701|69614850|FG001|Overall Study|Withdrawal by Subject|0|||
37927986|NCT00831701|69614849|FG000|Overall Study|Stone expulsion before first medication|2|||
38033557|NCT03736785|69719549|FG001|Overall Study|Adverse Event|1|||
37927987|NCT00831701|69614850|FG001|Overall Study|Stone expulsion before first medication|2|||
37927988|NCT00831701|69614849|FG000|Overall Study|Lost to Follow-up|1|||
37927989|NCT00831701|69614850|FG001|Overall Study|Lost to Follow-up|3|||
37927990|NCT00752895|69614858|FG000|Overall Study|Withdrawal by Subject|8|||
37927991|NCT00752895|69614859|FG001|Overall Study|Withdrawal by Subject|3|||
37927992|NCT00831389|69614867|FG000|Overall Study|Withdrawal by Subject|0|||
37927993|NCT00831389|69614868|FG001|Overall Study|Withdrawal by Subject|1|||
37927994|NCT00831311|69614876|FG000|Overall Study|Definitive Contraindication|3|||
37927995|NCT00831311|69614877|FG001|Overall Study|Definitive Contraindication|3|||
37927996|NCT00831311|69614876|FG000|Overall Study|Lost to Follow-up|3|||
37927997|NCT00831311|69614877|FG001|Overall Study|Lost to Follow-up|0|||
37927998|NCT00831311|69614876|FG000|Overall Study|Physician Decision|0|||
37927999|NCT00831311|69614877|FG001|Overall Study|Physician Decision|1|||
37928000|NCT00831311|69614876|FG000|Overall Study|Withdrawal by Subject|6|||
37928001|NCT00831311|69614877|FG001|Overall Study|Withdrawal by Subject|4|||
37928002|NCT00831233|69614886|FG000|Overall Study|Adverse Event|0|||
37928003|NCT00831233|69614887|FG001|Overall Study|Adverse Event|1|||
37928004|NCT00831233|69614886|FG000|Overall Study|Protocol Violation|1|||
37928005|NCT00831233|69614887|FG001|Overall Study|Protocol Violation|0|||
37928006|NCT00831233|69614886|FG000|Overall Study|Selection Criteria Not Met|2|||
37928007|NCT00831233|69614887|FG001|Overall Study|Selection Criteria Not Met|0|||
37928008|NCT00761280|69614904|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
37928009|NCT00761280|69614905|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
38033558|NCT03736785|69719550|FG002|Overall Study|Adverse Event|1|||
38033559|NCT03736785|69719548|FG000|Overall Study|Death|1|||
38033560|NCT03736785|69719549|FG001|Overall Study|Death|0|||
38033561|NCT03736785|69719550|FG002|Overall Study|Death|1|||
38033562|NCT03736785|69719548|FG000|Overall Study|Lost to Follow-up|0|||
38033563|NCT03736785|69719549|FG001|Overall Study|Lost to Follow-up|2|||
38033564|NCT03736785|69719550|FG002|Overall Study|Lost to Follow-up|3|||
38033565|NCT03736785|69719548|FG000|Overall Study|Non compliance with study drug|1|||
38033566|NCT03736785|69719549|FG001|Overall Study|Non compliance with study drug|1|||
38033567|NCT03736785|69719550|FG002|Overall Study|Non compliance with study drug|0|||
38033568|NCT03736785|69719548|FG000|Overall Study|Physician Decision|0|||
38033569|NCT03736785|69719549|FG001|Overall Study|Physician Decision|1|||
38033570|NCT03736785|69719550|FG002|Overall Study|Physician Decision|1|||
38033571|NCT03736785|69719548|FG000|Overall Study|Protocol Violation|1|||
38033572|NCT03736785|69719549|FG001|Overall Study|Protocol Violation|4|||
38033573|NCT03736785|69719550|FG002|Overall Study|Protocol Violation|3|||
38033574|NCT03736785|69719548|FG000|Overall Study|Sponsor Decision|1|||
38033575|NCT03736785|69719549|FG001|Overall Study|Sponsor Decision|0|||
38033576|NCT03736785|69719550|FG002|Overall Study|Sponsor Decision|0|||
37760217|NCT01492439|69270408|FG000|Overall Study|Withdrew from RTE|4|||
37760218|NCT01492439|69270409|FG001|Overall Study|Withdrew from RTE|9|||
37760219|NCT01572727|69270444|FG000|Overall Study|Adverse Event|43|||
37760220|NCT01572727|69270445|FG001|Overall Study|Adverse Event|15|||
37760221|NCT01572727|69270444|FG000|Overall Study|Lost to Follow-up|1|||
37760222|NCT01572727|69270445|FG001|Overall Study|Lost to Follow-up|1|||
37760223|NCT01572727|69270444|FG000|Overall Study|Physician Decision|23|||
37760224|NCT01572727|69270445|FG001|Overall Study|Physician Decision|9|||
37760225|NCT01572727|69270444|FG000|Overall Study|Progressive disease|59|||
37760226|NCT01572727|69270445|FG001|Overall Study|Progressive disease|82|||
37760227|NCT01572727|69270444|FG000|Overall Study|Protocol Violation|0|||
37760228|NCT01572727|69270445|FG001|Overall Study|Protocol Violation|1|||
37760229|NCT01572727|69270444|FG000|Overall Study|Study terminated by sponsor|61|||
37760230|NCT01572727|69270445|FG001|Overall Study|Study terminated by sponsor|83|||
37760231|NCT01572727|69270444|FG000|Overall Study|Parent/guardian decision|14|||
37760232|NCT01572727|69270445|FG001|Overall Study|Parent/guardian decision|9|||
37760233|NCT01572727|69270444|FG000|Overall Study|Death|2|||
37760234|NCT01572727|69270445|FG001|Overall Study|Death|2|||
37760235|NCT01572727|69270444|FG000|Overall Study|Untreated|4|||
38033577|NCT03736785|69719548|FG000|Overall Study|Unknown/Missing data|3|||
38033578|NCT03736785|69719549|FG001|Overall Study|Unknown/Missing data|2|||
38033579|NCT03736785|69719550|FG002|Overall Study|Unknown/Missing data|1|||
38033580|NCT03736785|69719548|FG000|Overall Study|Withdrawal by Subject|9|||
38033581|NCT03736785|69719549|FG001|Overall Study|Withdrawal by Subject|6|||
38033582|NCT03736785|69719550|FG002|Overall Study|Withdrawal by Subject|4|||
38033583|NCT03734991|69719561|FG000|Overall Study|Adverse Event|4|||
38033584|NCT03734991|69719562|FG001|Overall Study|Adverse Event|0|||
37760236|NCT01572727|69270445|FG001|Overall Study|Untreated|7|||
37760237|NCT01522651|69270492|FG000|Overall Study|Adverse Event|3|||
37760238|NCT01522651|69270493|FG001|Overall Study|Adverse Event|4|||
37760239|NCT01522651|69270494|FG002|Overall Study|Adverse Event|4|||
37760240|NCT01522651|69270495|FG003|Overall Study|Adverse Event|5|||
37760241|NCT01522651|69270496|FG004|Overall Study|Adverse Event|4|||
37928010|NCT00761280|69614904|FG000|Randomization to First Dose|Sponsor decision|1|||
37928011|NCT00761280|69614905|FG001|Randomization to First Dose|Sponsor decision|0|||
37928012|NCT00761280|69614904|FG000|Randomization to First Dose|Other|1|||
37928013|NCT00761280|69614905|FG001|Randomization to First Dose|Other|0|||
37760242|NCT01522651|69270492|FG000|Overall Study|Cardioversion|1|||
37760243|NCT01522651|69270493|FG001|Overall Study|Cardioversion|0|||
37928014|NCT00761280|69614904|FG000|First Dose to End of Study|End of trial|5|||
37928015|NCT00761280|69614905|FG001|First Dose to End of Study|End of trial|5|||
37928016|NCT00761280|69614904|FG000|First Dose to End of Study|Progressive disease|5|||
38033585|NCT03734991|69719561|FG000|Overall Study|Lost to Follow-up|4|||
38033586|NCT03734991|69719562|FG001|Overall Study|Lost to Follow-up|0|||
38033587|NCT03734991|69719561|FG000|Overall Study|Physician Decision|0|||
38033588|NCT03734991|69719562|FG001|Overall Study|Physician Decision|1|||
38033589|NCT03734991|69719561|FG000|Overall Study|Pregnancy|1|||
38033590|NCT03734991|69719562|FG001|Overall Study|Pregnancy|0|||
38033591|NCT03734991|69719561|FG000|Overall Study|Withdrawal by Subject|6|||
38033592|NCT03734991|69719562|FG001|Overall Study|Withdrawal by Subject|3|||
38033593|NCT03734991|69719561|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
38033594|NCT03734991|69719562|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
38033595|NCT03734991|69719561|FG000|Overall Study|Other|2|||
38033596|NCT03734991|69719562|FG001|Overall Study|Other|2|||
38033597|NCT03303092|69719571|FG000|Overall Study|Adverse Event|1|||
38033598|NCT03303092|69719572|FG001|Overall Study|Adverse Event|0|||
38033599|NCT03303092|69719573|FG002|Overall Study|Adverse Event|1|||
38033600|NCT03303092|69719571|FG000|Overall Study|Protocol Violation|1|||
38033601|NCT03303092|69719572|FG001|Overall Study|Protocol Violation|5|||
38033602|NCT03303092|69719573|FG002|Overall Study|Protocol Violation|1|||
38033603|NCT03303092|69719571|FG000|Overall Study|Withdrawal by Subject|1|||
38033604|NCT03303092|69719572|FG001|Overall Study|Withdrawal by Subject|1|||
38033605|NCT03303092|69719573|FG002|Overall Study|Withdrawal by Subject|3|||
38033606|NCT03302936|69719583|FG000|Overall Study|Protocol Violation|3|||
38033607|NCT03302936|69719584|FG001|Overall Study|Protocol Violation|4|||
38033608|NCT03733899|69719594|FG000|Period 1|Protocol Violation|0|||
38033609|NCT03733899|69719595|FG001|Period 1|Protocol Violation|0|||
38033610|NCT03733899|69719596|FG002|Period 1|Protocol Violation|0|||
38033611|NCT03733899|69719597|FG003|Period 1|Protocol Violation|0|||
38033612|NCT03733899|69719598|FG004|Period 1|Protocol Violation|0|||
38033613|NCT03733899|69719599|FG005|Period 1|Protocol Violation|1|||
38033614|NCT03733899|69719594|FG000|Period 2|Unscuccessful Treatment|0|||
38033615|NCT03733899|69719595|FG001|Period 2|Unscuccessful Treatment|1|||
38033616|NCT03733899|69719596|FG002|Period 2|Unscuccessful Treatment|0|||
38033617|NCT03733899|69719597|FG003|Period 2|Unscuccessful Treatment|0|||
38033618|NCT03733899|69719598|FG004|Period 2|Unscuccessful Treatment|0|||
38033619|NCT03733899|69719599|FG005|Period 2|Unscuccessful Treatment|0|||
38033620|NCT03733899|69719594|FG000|Period 3|Withdrawal by Subject|1|||
38033621|NCT03733899|69719595|FG001|Period 3|Withdrawal by Subject|0|||
38033622|NCT03733899|69719596|FG002|Period 3|Withdrawal by Subject|0|||
38033623|NCT03733899|69719597|FG003|Period 3|Withdrawal by Subject|0|||
37760244|NCT01522651|69270494|FG002|Overall Study|Cardioversion|0|||
37760245|NCT01522651|69270495|FG003|Overall Study|Cardioversion|0|||
37760246|NCT01522651|69270496|FG004|Overall Study|Cardioversion|0|||
37760247|NCT01522651|69270492|FG000|Overall Study|Device Malfunction|0|||
37760248|NCT01522651|69270493|FG001|Overall Study|Device Malfunction|1|||
37760249|NCT01522651|69270494|FG002|Overall Study|Device Malfunction|0|||
37760250|NCT01522651|69270495|FG003|Overall Study|Device Malfunction|0|||
37760251|NCT01522651|69270496|FG004|Overall Study|Device Malfunction|0|||
37760252|NCT01522651|69270492|FG000|Overall Study|Investigator's Discretion|0|||
37760253|NCT01522651|69270493|FG001|Overall Study|Investigator's Discretion|1|||
37760254|NCT01522651|69270494|FG002|Overall Study|Investigator's Discretion|0|||
37760255|NCT01522651|69270495|FG003|Overall Study|Investigator's Discretion|0|||
37760256|NCT01522651|69270496|FG004|Overall Study|Investigator's Discretion|0|||
37760257|NCT01522651|69270492|FG000|Overall Study|Protocol Violation|3|||
37760258|NCT01522651|69270493|FG001|Overall Study|Protocol Violation|0|||
37760259|NCT01522651|69270494|FG002|Overall Study|Protocol Violation|0|||
38033624|NCT03733899|69719598|FG004|Period 3|Withdrawal by Subject|0|||
38033625|NCT03733899|69719599|FG005|Period 3|Withdrawal by Subject|0|||
38033626|NCT03727347|69719612|FG000|Overall Study|Withdrawal by Subject|2|||
38033627|NCT03727347|69719612|FG000|Overall Study|Lost to Follow-up|1|||
38033628|NCT03915626|69719625|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
38033629|NCT03301844|69719637|FG000|Overall Study|suspected colon cancer|1|||
38033630|NCT03301844|69719638|FG001|Overall Study|suspected colon cancer|1|||
37667500|NCT02177032|69140067|FG001|Overall Study|Lost to Follow-up|2|||
38033631|NCT03313310|69719646|FG000|Phase 2|Lost to Follow-up|4|||
38033632|NCT03313310|69719647|FG001|Phase 2|Lost to Follow-up|0|||
38033633|NCT03313310|69719646|FG000|Phase 3|Lost to Follow-up|0|||
38033634|NCT03313310|69719647|FG001|Phase 3|Lost to Follow-up|1|||
37928017|NCT00761280|69614905|FG001|First Dose to End of Study|Progressive disease|3|||
37928018|NCT00761280|69614904|FG000|First Dose to End of Study|Sponsor decision|1|||
38033635|NCT03313076|69719657|FG000|Overall Study|Withdrawal by Subject|2|||
38033636|NCT03313076|69719658|FG001|Overall Study|Withdrawal by Subject|0|||
38033637|NCT03313076|69719659|FG002|Overall Study|Withdrawal by Subject|0|||
38033638|NCT03313076|69719660|FG003|Overall Study|Withdrawal by Subject|0|||
37760260|NCT01522651|69270495|FG003|Overall Study|Protocol Violation|0|||
37760261|NCT01522651|69270496|FG004|Overall Study|Protocol Violation|0|||
37760262|NCT01522651|69270492|FG000|Overall Study|Reason Not Specified|0|||
37760263|NCT01522651|69270493|FG001|Overall Study|Reason Not Specified|0|||
37760264|NCT01522651|69270494|FG002|Overall Study|Reason Not Specified|0|||
37760265|NCT01522651|69270495|FG003|Overall Study|Reason Not Specified|1|||
37760266|NCT01522651|69270496|FG004|Overall Study|Reason Not Specified|0|||
37760267|NCT01522651|69270492|FG000|Overall Study|Participant Non-Compliance|1|||
37760268|NCT01522651|69270493|FG001|Overall Study|Participant Non-Compliance|0|||
37760269|NCT01522651|69270494|FG002|Overall Study|Participant Non-Compliance|0|||
37928019|NCT00761280|69614905|FG001|First Dose to End of Study|Sponsor decision|2|||
37928020|NCT00761280|69614904|FG000|First Dose to End of Study|Death|1|||
37928021|NCT00761280|69614905|FG001|First Dose to End of Study|Death|0|||
37928022|NCT00761280|69614904|FG000|First Dose to End of Study|Lost to Follow-up|0|||
37928023|NCT00761280|69614905|FG001|First Dose to End of Study|Lost to Follow-up|1|||
37928024|NCT00824369|69614917|FG000|Overall Study|Nolonger willing to participate in study|1|||
37928025|NCT00824369|69614918|FG001|Overall Study|Nolonger willing to participate in study|0|||
37928026|NCT00824369|69614919|FG002|Overall Study|Nolonger willing to participate in study|1|||
37928027|NCT00824369|69614920|FG003|Overall Study|Nolonger willing to participate in study|2|||
37928028|NCT00824369|69614921|FG004|Overall Study|Nolonger willing to participate in study|0|||
37928029|NCT00824369|69614922|FG005|Overall Study|Nolonger willing to participate in study|1|||
37928030|NCT00824369|69614917|FG000|Overall Study|Lost to Follow-up|0|||
37928031|NCT00824369|69614918|FG001|Overall Study|Lost to Follow-up|0|||
37928032|NCT00824369|69614919|FG002|Overall Study|Lost to Follow-up|0|||
37928033|NCT00824369|69614920|FG003|Overall Study|Lost to Follow-up|0|||
37928034|NCT00824369|69614921|FG004|Overall Study|Lost to Follow-up|1|||
37928035|NCT00824369|69614922|FG005|Overall Study|Lost to Follow-up|0|||
37928036|NCT00824291|69614938|FG000|Overall Study|Adverse Event|15|||
37928037|NCT00824291|69614939|FG001|Overall Study|Adverse Event|6|||
37928038|NCT00824291|69614938|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
37928039|NCT00824291|69614939|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
37928040|NCT00824291|69614938|FG000|Overall Study|Lost to Follow-up|11|||
37928041|NCT00824291|69614939|FG001|Overall Study|Lost to Follow-up|9|||
37928042|NCT00824291|69614938|FG000|Overall Study|Non-compliance|1|||
37928043|NCT00824291|69614939|FG001|Overall Study|Non-compliance|1|||
37928044|NCT00824291|69614938|FG000|Overall Study|Protocol Violation|4|||
37928045|NCT00824291|69614939|FG001|Overall Study|Protocol Violation|1|||
37928046|NCT00824291|69614938|FG000|Overall Study|Withdrawal by Subject|14|||
37928047|NCT00824291|69614939|FG001|Overall Study|Withdrawal by Subject|8|||
37928048|NCT00824291|69614938|FG000|Overall Study|Lack of Efficacy|7|||
37928049|NCT00824291|69614939|FG001|Overall Study|Lack of Efficacy|8|||
37928050|NCT00824291|69614938|FG000|Overall Study|Participant on prohibited medication|1|||
37928051|NCT00824291|69614939|FG001|Overall Study|Participant on prohibited medication|0|||
37928052|NCT00804986|69614951|FG000|Overall Study|Adverse Event|0|||
37928053|NCT00804986|69614952|FG001|Overall Study|Adverse Event|1|||
37928054|NCT00804986|69614953|FG002|Overall Study|Adverse Event|2|||
37928055|NCT00804986|69614954|FG003|Overall Study|Adverse Event|1|||
37928056|NCT00804986|69614955|FG004|Overall Study|Adverse Event|3|||
37928057|NCT00804986|69614956|FG005|Overall Study|Adverse Event|0|||
37928058|NCT00804986|69614951|FG000|Overall Study|Lack of Efficacy|0|||
37760270|NCT01522651|69270495|FG003|Overall Study|Participant Non-Compliance|0|||
37760271|NCT01522651|69270496|FG004|Overall Study|Participant Non-Compliance|0|||
37760272|NCT01522651|69270492|FG000|Overall Study|Withdrew Consent|1|||
37760273|NCT01522651|69270493|FG001|Overall Study|Withdrew Consent|1|||
37760274|NCT01522651|69270494|FG002|Overall Study|Withdrew Consent|0|||
37760275|NCT01522651|69270495|FG003|Overall Study|Withdrew Consent|1|||
37760276|NCT01522651|69270496|FG004|Overall Study|Withdrew Consent|1|||
37760277|NCT01522651|69270492|FG000|Overall Study|Randomized but Never Treated|0|||
37760278|NCT01522651|69270493|FG001|Overall Study|Randomized but Never Treated|1|||
37760279|NCT01522651|69270494|FG002|Overall Study|Randomized but Never Treated|0|||
37760280|NCT01522651|69270495|FG003|Overall Study|Randomized but Never Treated|1|||
37760281|NCT01522651|69270496|FG004|Overall Study|Randomized but Never Treated|1|||
37760282|NCT01554241|69270523|FG000|Overall Study|Death|3|||
37760283|NCT01554241|69270524|FG001|Overall Study|Death|1|||
37760284|NCT01554241|69270525|FG002|Overall Study|Death|1|||
37928059|NCT00804986|69614952|FG001|Overall Study|Lack of Efficacy|0|||
37760285|NCT01554241|69270526|FG003|Overall Study|Death|0|||
37760286|NCT01554241|69270523|FG000|Overall Study|protocol specified renal stone|0|||
37760287|NCT01554241|69270524|FG001|Overall Study|protocol specified renal stone|0|||
37760288|NCT01554241|69270525|FG002|Overall Study|protocol specified renal stone|0|||
37760289|NCT01554241|69270526|FG003|Overall Study|protocol specified renal stone|1|||
37928060|NCT00804986|69614953|FG002|Overall Study|Lack of Efficacy|0|||
37928061|NCT00804986|69614954|FG003|Overall Study|Lack of Efficacy|1|||
37928062|NCT00804986|69614955|FG004|Overall Study|Lack of Efficacy|0|||
37928063|NCT00804986|69614956|FG005|Overall Study|Lack of Efficacy|3|||
37928064|NCT00804986|69614951|FG000|Overall Study|Lost to Follow-up|0|||
37760290|NCT01554241|69270523|FG000|Overall Study|protocol specified change in eGFR|0|||
37760291|NCT01554241|69270524|FG001|Overall Study|protocol specified change in eGFR|0|||
37760292|NCT01554241|69270525|FG002|Overall Study|protocol specified change in eGFR|1|||
37760293|NCT01554241|69270526|FG003|Overall Study|protocol specified change in eGFR|0|||
37760294|NCT01554241|69270523|FG000|Overall Study|Withdrawal by Subject|0|||
37760295|NCT01554241|69270524|FG001|Overall Study|Withdrawal by Subject|0|||
37760296|NCT01554241|69270525|FG002|Overall Study|Withdrawal by Subject|2|||
37760297|NCT01554241|69270526|FG003|Overall Study|Withdrawal by Subject|0|||
37760298|NCT01521559|69270538|FG000|Overall Study|Adverse Event|0|||
37760299|NCT01521559|69270539|FG001|Overall Study|Adverse Event|4|||
37760300|NCT01521559|69270538|FG000|Overall Study|Death|1|||
37760301|NCT01521559|69270539|FG001|Overall Study|Death|0|||
37760302|NCT01521559|69270538|FG000|Overall Study|Withdrawal by Subject|9|||
37928065|NCT00804986|69614952|FG001|Overall Study|Lost to Follow-up|0|||
37928066|NCT00804986|69614953|FG002|Overall Study|Lost to Follow-up|0|||
37928067|NCT00804986|69614954|FG003|Overall Study|Lost to Follow-up|1|||
37928068|NCT00804986|69614955|FG004|Overall Study|Lost to Follow-up|1|||
37928069|NCT00804986|69614956|FG005|Overall Study|Lost to Follow-up|3|||
37928070|NCT00804986|69614951|FG000|Overall Study|Protocol Violation|0|||
37928071|NCT00804986|69614952|FG001|Overall Study|Protocol Violation|1|||
37928072|NCT00804986|69614953|FG002|Overall Study|Protocol Violation|0|||
37928073|NCT00804986|69614954|FG003|Overall Study|Protocol Violation|1|||
37928074|NCT00804986|69614955|FG004|Overall Study|Protocol Violation|0|||
37928075|NCT00804986|69614956|FG005|Overall Study|Protocol Violation|0|||
37928076|NCT00804986|69614951|FG000|Overall Study|Withdrawal by Subject|0|||
37928077|NCT00804986|69614952|FG001|Overall Study|Withdrawal by Subject|3|||
37928078|NCT00804986|69614953|FG002|Overall Study|Withdrawal by Subject|0|||
37928079|NCT00804986|69614954|FG003|Overall Study|Withdrawal by Subject|3|||
37928080|NCT00804986|69614955|FG004|Overall Study|Withdrawal by Subject|5|||
37928081|NCT00804986|69614956|FG005|Overall Study|Withdrawal by Subject|3|||
37928082|NCT00804986|69614951|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
37928083|NCT00804986|69614952|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
37928084|NCT00804986|69614953|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
37928085|NCT00804986|69614954|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
38033639|NCT03313076|69719657|FG000|Overall Study|Lost to Follow-up|0|||
37667501|NCT02177032|69140068|FG002|Overall Study|Lost to Follow-up|0|||
37667502|NCT02177032|69140069|FG003|Overall Study|Lost to Follow-up|0|||
37667503|NCT02177032|69140066|FG000|Overall Study|OTHER|2|||
37667504|NCT02177032|69140067|FG001|Overall Study|OTHER|0|||
37667505|NCT02177032|69140068|FG002|Overall Study|OTHER|1|||
37667506|NCT02177032|69140069|FG003|Overall Study|OTHER|0|||
37667507|NCT02177032|69140066|FG000|Overall Study|Withdrawal by Subject|1|||
37667508|NCT02177032|69140067|FG001|Overall Study|Withdrawal by Subject|0|||
37667509|NCT02177032|69140068|FG002|Overall Study|Withdrawal by Subject|1|||
37667510|NCT02177032|69140069|FG003|Overall Study|Withdrawal by Subject|0|||
37667511|NCT02116972|69140093|FG000|Overall Study|Adverse Event|4|||
37667512|NCT02116972|69140094|FG001|Overall Study|Adverse Event|4|||
37667513|NCT02116972|69140095|FG002|Overall Study|Adverse Event|1|||
37667514|NCT02116972|69140093|FG000|Overall Study|Withdrawal by Subject|1|||
37667515|NCT02116972|69140094|FG001|Overall Study|Withdrawal by Subject|1|||
37667516|NCT02116972|69140095|FG002|Overall Study|Withdrawal by Subject|5|||
37667517|NCT02116972|69140093|FG000|Overall Study|Protocol Violation|1|||
37667518|NCT02116972|69140094|FG001|Overall Study|Protocol Violation|0|||
37667519|NCT02116972|69140095|FG002|Overall Study|Protocol Violation|1|||
37667520|NCT02116972|69140093|FG000|Overall Study|Lost to Follow-up|4|||
37667521|NCT02116972|69140094|FG001|Overall Study|Lost to Follow-up|3|||
37667522|NCT02116972|69140095|FG002|Overall Study|Lost to Follow-up|1|||
37667523|NCT02116972|69140093|FG000|Overall Study|Lack of Efficacy|6|||
37667524|NCT02116972|69140094|FG001|Overall Study|Lack of Efficacy|6|||
37667525|NCT02116972|69140095|FG002|Overall Study|Lack of Efficacy|5|||
37667526|NCT02116972|69140093|FG000|Overall Study|scheduling conflicts and relocation|3|||
37760303|NCT01521559|69270539|FG001|Overall Study|Withdrawal by Subject|11|||
37760304|NCT01521559|69270538|FG000|Overall Study|Lost to Follow-up|3|||
37667527|NCT02116972|69140094|FG001|Overall Study|scheduling conflicts and relocation|3|||
37667528|NCT02116972|69140095|FG002|Overall Study|scheduling conflicts and relocation|6|||
37667529|NCT02176642|69140107|FG000|Overall Study|Withdrawal by Subject|0|||
37667530|NCT02176642|69140108|FG001|Overall Study|Withdrawal by Subject|1|||
37760305|NCT01521559|69270539|FG001|Overall Study|Lost to Follow-up|1|||
37760306|NCT01521559|69270538|FG000|Overall Study|Protocol Violation|1|||
37928086|NCT00804986|69614955|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
37760307|NCT01521559|69270539|FG001|Overall Study|Protocol Violation|0|||
37760308|NCT01521559|69270538|FG000|Overall Study|Other|1|||
37667531|NCT02116660|69140116|FG000|Overall Study|Deteriorating renal function|0|||
37667532|NCT02116660|69140117|FG001|Overall Study|Deteriorating renal function|1|||
37667533|NCT02116660|69140116|FG000|Overall Study|Adverse Event|1|||
37667534|NCT02116660|69140117|FG001|Overall Study|Adverse Event|1|||
37667535|NCT02116660|69140116|FG000|Overall Study|Withdrawal by Subject|0|||
37928087|NCT00804986|69614956|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
37928088|NCT00804986|69614951|FG000|Overall Study|Sponsor Decision|0|||
37928089|NCT00804986|69614952|FG001|Overall Study|Sponsor Decision|1|||
37928090|NCT00804986|69614953|FG002|Overall Study|Sponsor Decision|0|||
37928091|NCT00804986|69614954|FG003|Overall Study|Sponsor Decision|0|||
37928092|NCT00804986|69614955|FG004|Overall Study|Sponsor Decision|0|||
37928093|NCT00804986|69614956|FG005|Overall Study|Sponsor Decision|0|||
37928094|NCT00804986|69614951|FG000|Overall Study|Physician Decision|1|||
37928095|NCT00804986|69614952|FG001|Overall Study|Physician Decision|0|||
37928096|NCT00804986|69614953|FG002|Overall Study|Physician Decision|0|||
37928097|NCT00804986|69614954|FG003|Overall Study|Physician Decision|0|||
37667536|NCT02116660|69140117|FG001|Overall Study|Withdrawal by Subject|2|||
37667537|NCT02116660|69140116|FG000|Overall Study|Organization reason|1|||
37667538|NCT02116660|69140117|FG001|Overall Study|Organization reason|0|||
37667539|NCT02589405|69140125|FG000|Overall Study|Adverse Event|3|||
37667540|NCT02589405|69140125|FG000|Overall Study|Withdrawal by Subject|1|||
37667541|NCT02176018|69140131|FG000|Overall Study|Adverse Event|0|||
37667542|NCT02176018|69140132|FG001|Overall Study|Adverse Event|2|||
37667543|NCT02176018|69140131|FG000|Overall Study|Lost to Follow-up|3|||
37667544|NCT02176018|69140132|FG001|Overall Study|Lost to Follow-up|1|||
37667545|NCT02176018|69140131|FG000|Overall Study|Protocol Violation|1|||
37667546|NCT02176018|69140132|FG001|Overall Study|Protocol Violation|1|||
37667547|NCT02176018|69140131|FG000|Overall Study|Withdrawal by Subject|1|||
37667548|NCT02176018|69140132|FG001|Overall Study|Withdrawal by Subject|2|||
37667549|NCT02116582|69140138|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
37667550|NCT02116582|69140138|FG000|Overall Study|Adverse Event|22|||
37667551|NCT02116582|69140138|FG000|Overall Study|Death|9|||
37667552|NCT02116582|69140138|FG000|Overall Study|Progressive Disease|148|||
37667553|NCT02116582|69140138|FG000|Overall Study|Protocol Violation|3|||
37667554|NCT02116582|69140138|FG000|Overall Study|Withdrawal by Subject|8|||
37667555|NCT02116582|69140138|FG000|Overall Study|Other: Miscellaneous|11|||
37667556|NCT02116582|69140138|FG000|Overall Study|Lost to Follow-up|1|||
37667557|NCT02116582|69140138|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
37667558|NCT02589639|69140145|FG000|Overall Study|Lost to Follow-up|1|||
37667559|NCT02589639|69140146|FG001|Overall Study|Lost to Follow-up|0|||
37667560|NCT02589639|69140147|FG002|Overall Study|Lost to Follow-up|0|||
37667561|NCT02589639|69140145|FG000|Overall Study|Protocol Violation|1|||
37667562|NCT02589639|69140146|FG001|Overall Study|Protocol Violation|0|||
37667563|NCT02589639|69140147|FG002|Overall Study|Protocol Violation|0|||
37667564|NCT02589639|69140145|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
37667565|NCT02589639|69140146|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
37667566|NCT02589639|69140147|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
37667567|NCT02589639|69140145|FG000|Overall Study|Adverse Event|4|||
37667568|NCT02589639|69140146|FG001|Overall Study|Adverse Event|5|||
37760309|NCT01521559|69270539|FG001|Overall Study|Other|2|||
37928098|NCT00804986|69614955|FG004|Overall Study|Physician Decision|0|||
37928099|NCT00804986|69614956|FG005|Overall Study|Physician Decision|0|||
37928100|NCT00752232|69614977|FG000|Overall Study|Protocol Violation|0|||
37928101|NCT00752232|69614978|FG001|Overall Study|Protocol Violation|0|||
37928102|NCT00752232|69614979|FG002|Overall Study|Protocol Violation|0|||
37928103|NCT00752232|69614980|FG003|Overall Study|Protocol Violation|0|||
37928104|NCT00752232|69614981|FG004|Overall Study|Protocol Violation|0|||
37928105|NCT00752232|69614982|FG005|Overall Study|Protocol Violation|1|||
37928106|NCT00752232|69614983|FG006|Overall Study|Protocol Violation|0|||
37928107|NCT00752232|69614977|FG000|Overall Study|Caregiver request|2|||
37928108|NCT00752232|69614978|FG001|Overall Study|Caregiver request|0|||
37928109|NCT00752232|69614979|FG002|Overall Study|Caregiver request|0|||
37928110|NCT00752232|69614980|FG003|Overall Study|Caregiver request|0|||
37928111|NCT00752232|69614981|FG004|Overall Study|Caregiver request|1|||
37928112|NCT00752232|69614982|FG005|Overall Study|Caregiver request|0|||
37928113|NCT00752232|69614983|FG006|Overall Study|Caregiver request|0|||
37928114|NCT00752232|69614977|FG000|Overall Study|Investigator request|0|||
37928115|NCT00752232|69614978|FG001|Overall Study|Investigator request|0|||
37928116|NCT00752232|69614979|FG002|Overall Study|Investigator request|0|||
37667569|NCT02589639|69140147|FG002|Overall Study|Adverse Event|3|||
37667570|NCT02589639|69140145|FG000|Overall Study|Other reason than specified above|1|||
37667571|NCT02589639|69140146|FG001|Overall Study|Other reason than specified above|2|||
37760310|NCT01554163|69270548|FG000|Overall Study|Adverse Event|3|||
37928117|NCT00752232|69614980|FG003|Overall Study|Investigator request|0|||
37928118|NCT00752232|69614981|FG004|Overall Study|Investigator request|1|||
37928119|NCT00752232|69614982|FG005|Overall Study|Investigator request|0|||
37667572|NCT02589639|69140147|FG002|Overall Study|Other reason than specified above|1|||
37667573|NCT02589639|69140145|FG000|Overall Study|Not Treated|0|||
37667574|NCT02589639|69140146|FG001|Overall Study|Not Treated|3|||
37667575|NCT02589639|69140147|FG002|Overall Study|Not Treated|0|||
37667576|NCT02151682|69140157|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
37667577|NCT02151682|69140158|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
37667578|NCT02151682|69140159|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
37928120|NCT00752232|69614983|FG006|Overall Study|Investigator request|0|||
37928121|NCT00752232|69614977|FG000|Overall Study|Subject request|0|||
37928122|NCT00752232|69614978|FG001|Overall Study|Subject request|0|||
37928123|NCT00752232|69614979|FG002|Overall Study|Subject request|1|||
37928124|NCT00752232|69614980|FG003|Overall Study|Subject request|0|||
37928125|NCT00752232|69614981|FG004|Overall Study|Subject request|0|||
37928126|NCT00752232|69614982|FG005|Overall Study|Subject request|0|||
37928127|NCT00752232|69614983|FG006|Overall Study|Subject request|0|||
37928128|NCT00752232|69614977|FG000|Overall Study|Group home admission|0|||
37928129|NCT00752232|69614978|FG001|Overall Study|Group home admission|0|||
37928130|NCT00752232|69614979|FG002|Overall Study|Group home admission|0|||
37928131|NCT00752232|69614980|FG003|Overall Study|Group home admission|1|||
37928132|NCT00752232|69614981|FG004|Overall Study|Group home admission|0|||
37928133|NCT00752232|69614982|FG005|Overall Study|Group home admission|0|||
37928134|NCT00752232|69614983|FG006|Overall Study|Group home admission|0|||
37928135|NCT00752232|69614977|FG000|Overall Study|Caregiver could not attend the subject|0|||
37928136|NCT00752232|69614978|FG001|Overall Study|Caregiver could not attend the subject|0|||
37928137|NCT00752232|69614979|FG002|Overall Study|Caregiver could not attend the subject|0|||
37928138|NCT00752232|69614980|FG003|Overall Study|Caregiver could not attend the subject|0|||
37928139|NCT00752232|69614981|FG004|Overall Study|Caregiver could not attend the subject|1|||
37928140|NCT00752232|69614982|FG005|Overall Study|Caregiver could not attend the subject|0|||
37928141|NCT00752232|69614983|FG006|Overall Study|Caregiver could not attend the subject|0|||
37928142|NCT00760266|69615002|FG000|Overall Study|Adverse Event|13|||
37928143|NCT00760266|69615003|FG001|Overall Study|Adverse Event|7|||
37928144|NCT00760266|69615002|FG000|Overall Study|Abnormal laboratory value(s)|1|||
37928145|NCT00760266|69615003|FG001|Overall Study|Abnormal laboratory value(s)|0|||
37928146|NCT00760266|69615002|FG000|Overall Study|Abnormal test procedure result(s)|1|||
37928147|NCT00760266|69615003|FG001|Overall Study|Abnormal test procedure result(s)|0|||
37928148|NCT00760266|69615002|FG000|Overall Study|Lack of Efficacy|2|||
37928149|NCT00760266|69615003|FG001|Overall Study|Lack of Efficacy|2|||
37928150|NCT00760266|69615002|FG000|Overall Study|Protocol deviation|2|||
37928151|NCT00760266|69615003|FG001|Overall Study|Protocol deviation|4|||
37928152|NCT00760266|69615002|FG000|Overall Study|Patient withdrew consent|3|||
37928153|NCT00760266|69615003|FG001|Overall Study|Patient withdrew consent|3|||
37928154|NCT00760266|69615002|FG000|Overall Study|Lost to Follow-up|2|||
37928155|NCT00760266|69615003|FG001|Overall Study|Lost to Follow-up|1|||
37928156|NCT00760266|69615002|FG000|Overall Study|Administrative Problems|0|||
37928157|NCT00760266|69615003|FG001|Overall Study|Administrative Problems|1|||
37928158|NCT00753714|69615011|FG000|Overall Study|Lack of Efficacy|21|||
37928159|NCT00753714|69615012|FG001|Overall Study|Lack of Efficacy|34|||
37928160|NCT00753714|69615011|FG000|Overall Study|Adverse Event|26|||
37928161|NCT00753714|69615012|FG001|Overall Study|Adverse Event|18|||
37667579|NCT02151682|69140160|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
37667580|NCT02151682|69140161|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
37667581|NCT02151682|69140162|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
37667582|NCT02151682|69140157|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
37667583|NCT02151682|69140158|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
37667584|NCT02151682|69140159|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
37928162|NCT00753714|69615011|FG000|Overall Study|Protocol Violation|1|||
37928163|NCT00753714|69615012|FG001|Overall Study|Protocol Violation|0|||
37928164|NCT00753714|69615011|FG000|Overall Study|Lost to Follow-up|0|||
37928165|NCT00753714|69615012|FG001|Overall Study|Lost to Follow-up|1|||
37928166|NCT00753714|69615011|FG000|Overall Study|Withdrawal by Subject|2|||
37928167|NCT00753714|69615012|FG001|Overall Study|Withdrawal by Subject|1|||
37928168|NCT00753714|69615011|FG000|Overall Study|Death|3|||
37928169|NCT00753714|69615012|FG001|Overall Study|Death|3|||
37928170|NCT00753714|69615011|FG000|Overall Study|Other|7|||
37928171|NCT00753714|69615012|FG001|Overall Study|Other|5|||
37928172|NCT00759954|69615023|FG000|Overall Study|Personal reason|1|||
37928173|NCT00759954|69615024|FG001|Overall Study|Personal reason|0|||
37928174|NCT00759954|69615023|FG000|Overall Study|Adverse Event|1|||
37667585|NCT02151682|69140160|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
37667586|NCT02151682|69140161|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
37667587|NCT02151682|69140162|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
37667588|NCT02151682|69140157|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
37928175|NCT00759954|69615024|FG001|Overall Study|Adverse Event|2|||
37928176|NCT00804908|69615033|FG000|Overall Study|Other|115|||
37928177|NCT00804908|69615034|FG001|Overall Study|Other|116|||
37928178|NCT00804908|69615035|FG002|Overall Study|Other|114|||
37928179|NCT00808808|69615046|FG000|Overall Study|Vaccinated; survey not completed|131|||
37928180|NCT00808808|69615047|FG001|Overall Study|Vaccinated; survey not completed|169|||
37928181|NCT00808808|69615048|FG002|Overall Study|Vaccinated; survey not completed|302|||
37928182|NCT00808808|69615046|FG000|Overall Study|Employee was not vaccinated.|2686|||
37928183|NCT00808808|69615047|FG001|Overall Study|Employee was not vaccinated.|2268|||
38033640|NCT03313076|69719658|FG001|Overall Study|Lost to Follow-up|2|||
37667589|NCT02151682|69140158|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
37667590|NCT02151682|69140159|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
37667591|NCT02151682|69140160|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
37928184|NCT00808808|69615048|FG002|Overall Study|Employee was not vaccinated.|2255|||
37928185|NCT00589784|69615064|FG000|Overall Study|Withdrawal by Subject|0|||
37928186|NCT00589784|69615065|FG001|Overall Study|Withdrawal by Subject|6|||
37928187|NCT00589784|69615064|FG000|Overall Study|Patient inevaluable|1|||
37928188|NCT00589784|69615065|FG001|Overall Study|Patient inevaluable|0|||
37928189|NCT00589784|69615064|FG000|Overall Study|Adverse Event|0|||
37928190|NCT00589784|69615065|FG001|Overall Study|Adverse Event|4|||
37928191|NCT00759876|69615070|FG000|Overall Study|Sponsor terminated study early|36|||
37928192|NCT00823979|69615077|FG000|Overall Study|Lack of Efficacy|13|||
37928193|NCT00823979|69615078|FG001|Overall Study|Lack of Efficacy|16|||
37928194|NCT00823979|69615079|FG002|Overall Study|Lack of Efficacy|9|||
37928195|NCT00823979|69615077|FG000|Overall Study|Lost to Follow-up|2|||
37928196|NCT00823979|69615078|FG001|Overall Study|Lost to Follow-up|1|||
37928197|NCT00823979|69615079|FG002|Overall Study|Lost to Follow-up|0|||
37928198|NCT00823979|69615077|FG000|Overall Study|Withdrawal by Subject|2|||
37928199|NCT00823979|69615078|FG001|Overall Study|Withdrawal by Subject|3|||
37928200|NCT00823979|69615079|FG002|Overall Study|Withdrawal by Subject|2|||
37928201|NCT00823979|69615077|FG000|Overall Study|Protocol Violation|1|||
37928202|NCT00823979|69615078|FG001|Overall Study|Protocol Violation|1|||
37928203|NCT00823979|69615079|FG002|Overall Study|Protocol Violation|0|||
37928204|NCT00823979|69615077|FG000|Overall Study|Pregnancy|0|||
37928205|NCT00823979|69615078|FG001|Overall Study|Pregnancy|1|||
37928206|NCT00823979|69615079|FG002|Overall Study|Pregnancy|0|||
37928207|NCT00823979|69615077|FG000|Overall Study|Adverse Event|0|||
37928208|NCT00823979|69615078|FG001|Overall Study|Adverse Event|2|||
37928209|NCT00823979|69615079|FG002|Overall Study|Adverse Event|4|||
37928210|NCT00823979|69615077|FG000|Overall Study|Other|2|||
37928211|NCT00823979|69615078|FG001|Overall Study|Other|0|||
37928212|NCT00823979|69615079|FG002|Overall Study|Other|1|||
37928213|NCT00823979|69615077|FG000|Overall Study|Randomized but not Treated|4|||
37928214|NCT00823979|69615078|FG001|Overall Study|Randomized but not Treated|3|||
37928215|NCT00823979|69615079|FG002|Overall Study|Randomized but not Treated|1|||
37928216|NCT00823979|69615077|FG000|Overall Study|Study Terminated by Sponsor|5|||
37928217|NCT00823979|69615078|FG001|Overall Study|Study Terminated by Sponsor|5|||
37928218|NCT00823979|69615079|FG002|Overall Study|Study Terminated by Sponsor|7|||
37928219|NCT00823901|69615089|FG000|Overall Study|Adverse Event|1|||
37928220|NCT00823901|69615090|FG001|Overall Study|Adverse Event|1|||
37928221|NCT00823901|69615089|FG000|Overall Study|Lack of Efficacy|1|||
37928222|NCT00823901|69615090|FG001|Overall Study|Lack of Efficacy|0|||
37928223|NCT00823901|69615089|FG000|Overall Study|Lost to Follow-up|2|||
37928224|NCT00823901|69615090|FG001|Overall Study|Lost to Follow-up|1|||
37928225|NCT00823823|69615098|FG000|Overall Study|Lost to Follow-up|3|||
37928226|NCT00823823|69615099|FG001|Overall Study|Lost to Follow-up|1|||
37928227|NCT00823823|69615098|FG000|Overall Study|Protocol Violation|5|||
37928228|NCT00823823|69615099|FG001|Overall Study|Protocol Violation|5|||
37928229|NCT00759564|69615119|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
37928230|NCT00759564|69615120|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
37928231|NCT00759564|69615121|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
37928232|NCT00759564|69615122|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
37928233|NCT00759564|69615123|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
37928234|NCT00816023|69615159|FG000|Overall Study|Lost to Follow-up|1|||
37928235|NCT00816023|69615160|FG001|Overall Study|Lost to Follow-up|1|||
37928236|NCT00816023|69615161|FG002|Overall Study|Lost to Follow-up|0|||
37760311|NCT01554163|69270549|FG001|Overall Study|Adverse Event|0|||
37928237|NCT00816023|69615162|FG003|Overall Study|Lost to Follow-up|0|||
37928238|NCT00816023|69615159|FG000|Overall Study|Withdrawal by Subject|1|||
37667592|NCT02151682|69140161|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
37667593|NCT02151682|69140162|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
37667594|NCT02151682|69140157|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
37667595|NCT02151682|69140158|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
37667596|NCT02151682|69140159|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
37667597|NCT02151682|69140160|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
37667598|NCT02151682|69140161|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
37667599|NCT02151682|69140162|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
37928239|NCT00816023|69615160|FG001|Overall Study|Withdrawal by Subject|0|||
37928240|NCT00816023|69615161|FG002|Overall Study|Withdrawal by Subject|0|||
37928241|NCT00816023|69615162|FG003|Overall Study|Withdrawal by Subject|0|||
37928242|NCT00816023|69615159|FG000|Overall Study|Physician Decision|0|||
37928243|NCT00816023|69615160|FG001|Overall Study|Physician Decision|0|||
37928244|NCT00816023|69615161|FG002|Overall Study|Physician Decision|1|||
37928245|NCT00816023|69615162|FG003|Overall Study|Physician Decision|0|||
37928246|NCT00816023|69615159|FG000|Overall Study|assessments complete prior to window|1|||
37928247|NCT00816023|69615160|FG001|Overall Study|assessments complete prior to window|1|||
37928248|NCT00816023|69615161|FG002|Overall Study|assessments complete prior to window|2|||
37928249|NCT00816023|69615162|FG003|Overall Study|assessments complete prior to window|1|||
37928250|NCT00816023|69615159|FG000|Overall Study|Randomized Not Treated|6|||
37928251|NCT00816023|69615160|FG001|Overall Study|Randomized Not Treated|4|||
37928252|NCT00816023|69615161|FG002|Overall Study|Randomized Not Treated|6|||
37928253|NCT00816023|69615162|FG003|Overall Study|Randomized Not Treated|11|||
37928254|NCT00759174|69615174|FG000|Overall Study|Other|0|||
37928255|NCT00759174|69615175|FG001|Overall Study|Other|2|||
37928256|NCT00815633|69615182|FG000|Overall Study|study terminated|1|||
37760312|NCT01554163|69270548|FG000|Overall Study|Lack of Efficacy|1|||
37760313|NCT01554163|69270549|FG001|Overall Study|Lack of Efficacy|0|||
37760314|NCT01554163|69270548|FG000|Overall Study|Lost to Follow-up|1|||
37760315|NCT01554163|69270549|FG001|Overall Study|Lost to Follow-up|0|||
37760316|NCT01554163|69270548|FG000|Overall Study|Non-Compliance With Study Drug|1|||
37760317|NCT01554163|69270549|FG001|Overall Study|Non-Compliance With Study Drug|1|||
37928257|NCT00830765|69615188|FG000|Overall Study|Protocol Violation|3|||
37928258|NCT00830765|69615189|FG001|Overall Study|Protocol Violation|2|||
37928259|NCT00830375|69615195|FG000|Overall Study|Lost to Follow-up|1|||
37928260|NCT00803270|69615201|FG000|Overall Study|Lost to Follow-up|1|||
37928261|NCT00803270|69615202|FG001|Overall Study|Lost to Follow-up|2|||
37928262|NCT00751998|69615208|FG000|Overall Study|Lost to Follow-up|7|||
37928263|NCT00751998|69615208|FG000|Overall Study|Death|11|||
37928264|NCT00751998|69615208|FG000|Overall Study|Withdrawal by Subject|2|||
37928265|NCT00803738|69615214|FG000|Overall Study|Adverse Event|3|||
37928266|NCT00803738|69615215|FG001|Overall Study|Adverse Event|5|||
37928267|NCT00803738|69615214|FG000|Overall Study|Lost to Follow-up|4|||
37928268|NCT00803738|69615215|FG001|Overall Study|Lost to Follow-up|4|||
37928269|NCT00803738|69615214|FG000|Overall Study|Protocol Violation|18|||
37928270|NCT00803738|69615215|FG001|Overall Study|Protocol Violation|10|||
37928271|NCT00803738|69615214|FG000|Overall Study|Withdrawal by Subject|1|||
37928272|NCT00803738|69615215|FG001|Overall Study|Withdrawal by Subject|4|||
37928273|NCT00803738|69615214|FG000|Overall Study|Lack of Efficacy|10|||
37928274|NCT00803738|69615215|FG001|Overall Study|Lack of Efficacy|16|||
37928275|NCT00803738|69615214|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
37928276|NCT00803738|69615215|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
37928277|NCT00803738|69615214|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
37928278|NCT00803738|69615215|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
37760318|NCT01554163|69270548|FG000|Overall Study|Protocol Violation|0|||
37760319|NCT01554163|69270549|FG001|Overall Study|Protocol Violation|4|||
37760320|NCT01554163|69270548|FG000|Overall Study|Withdrawal by Subject|1|||
37760321|NCT01554163|69270549|FG001|Overall Study|Withdrawal by Subject|5|||
37760322|NCT01554163|69270548|FG000|Overall Study|Not Treated|1|||
37928279|NCT00758706|69615223|FG000|Overall Study|Adverse Event|4|||
37928280|NCT00758706|69615224|FG001|Overall Study|Adverse Event|4|||
37928281|NCT00591266|69615233|FG000|Overall Study|Adverse Event|2|||
37928282|NCT00591266|69615234|FG001|Overall Study|Adverse Event|2|||
37928283|NCT00591266|69615235|FG002|Overall Study|Adverse Event|3|||
37928284|NCT00591266|69615233|FG000|Overall Study|Lost to Follow-up|0|||
37928285|NCT00591266|69615234|FG001|Overall Study|Lost to Follow-up|1|||
37928286|NCT00591266|69615235|FG002|Overall Study|Lost to Follow-up|0|||
37928287|NCT00591266|69615233|FG000|Overall Study|Protocol Violation|0|||
37928288|NCT00591266|69615234|FG001|Overall Study|Protocol Violation|0|||
37928289|NCT00591266|69615235|FG002|Overall Study|Protocol Violation|1|||
37928290|NCT00591266|69615233|FG000|Overall Study|Withdrawal by Subject|6|||
37928291|NCT00591266|69615234|FG001|Overall Study|Withdrawal by Subject|2|||
37928292|NCT00591266|69615235|FG002|Overall Study|Withdrawal by Subject|5|||
37667600|NCT02151682|69140157|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
37667601|NCT02151682|69140158|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
37667602|NCT02151682|69140159|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
37667603|NCT02151682|69140160|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
37667604|NCT02151682|69140161|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
37667605|NCT02151682|69140162|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
37667606|NCT02151682|69140157|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
37667607|NCT02151682|69140158|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
37760323|NCT01554163|69270549|FG001|Overall Study|Not Treated|0|||
37760324|NCT01553851|69270555|FG000|Overall Study|Adverse Event|2|||
37760325|NCT01553851|69270555|FG000|Overall Study|constipation|1|||
37667608|NCT02151682|69140159|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
37760326|NCT01552915|69270575|FG000|Overall Study|Adverse Event|3|||
37928293|NCT00591266|69615233|FG000|Overall Study|Lack of Efficacy|0|||
37928294|NCT00591266|69615234|FG001|Overall Study|Lack of Efficacy|2|||
37928295|NCT00591266|69615235|FG002|Overall Study|Lack of Efficacy|0|||
37928296|NCT00591266|69615233|FG000|Overall Study|Other|1|||
37928297|NCT00591266|69615234|FG001|Overall Study|Other|4|||
37928298|NCT00591266|69615235|FG002|Overall Study|Other|5|||
37928299|NCT00758394|69615247|FG000|2nd Intervention Order|Lost to Follow-up|0|||
37928300|NCT00758394|69615248|FG001|2nd Intervention Order|Lost to Follow-up|1|||
37928301|NCT00758394|69615249|FG002|2nd Intervention Order|Lost to Follow-up|0|||
37928302|NCT00758394|69615250|FG003|2nd Intervention Order|Lost to Follow-up|0|||
37928303|NCT00758394|69615247|FG000|3rd Intervention|Lost to Follow-up|1|||
37928304|NCT00758394|69615248|FG001|3rd Intervention|Lost to Follow-up|0|||
37928305|NCT00758394|69615249|FG002|3rd Intervention|Lost to Follow-up|0|||
37928306|NCT00758394|69615250|FG003|3rd Intervention|Lost to Follow-up|1|||
37928307|NCT04450394|69615263|FG000|Overall Study|Adverse Event|2|||
37928308|NCT04450394|69615264|FG001|Overall Study|Adverse Event|0|||
37928309|NCT04450394|69615265|FG002|Overall Study|Adverse Event|0|||
37760327|NCT01552915|69270576|FG001|Overall Study|Adverse Event|14|||
37760328|NCT01552915|69270577|FG002|Overall Study|Adverse Event|3|||
37760329|NCT01552915|69270575|FG000|Overall Study|Lost to Follow-up|4|||
37760330|NCT01552915|69270576|FG001|Overall Study|Lost to Follow-up|6|||
37760331|NCT01552915|69270577|FG002|Overall Study|Lost to Follow-up|5|||
37760332|NCT01552915|69270575|FG000|Overall Study|Withdrawal by Subject|6|||
37760333|NCT01552915|69270576|FG001|Overall Study|Withdrawal by Subject|4|||
37760334|NCT01552915|69270577|FG002|Overall Study|Withdrawal by Subject|5|||
37760335|NCT01552915|69270575|FG000|Overall Study|Protocol Violation|0|||
37760336|NCT01552915|69270576|FG001|Overall Study|Protocol Violation|4|||
37760337|NCT01552915|69270577|FG002|Overall Study|Protocol Violation|4|||
37760338|NCT01552915|69270575|FG000|Overall Study|Lack of Efficacy|8|||
37760339|NCT01552915|69270576|FG001|Overall Study|Lack of Efficacy|1|||
37760340|NCT01552915|69270577|FG002|Overall Study|Lack of Efficacy|4|||
37760341|NCT01552915|69270575|FG000|Overall Study|Other|2|||
37760342|NCT01552915|69270576|FG001|Overall Study|Other|0|||
37760343|NCT01552915|69270577|FG002|Overall Study|Other|6|||
37760344|NCT01552681|69270606|FG000|Overall Study|Withdrawal by Subject|4|||
37760345|NCT01552681|69270607|FG001|Overall Study|Withdrawal by Subject|0|||
37760346|NCT01552681|69270606|FG000|Overall Study|Physician Decision|1|||
37760347|NCT01552681|69270607|FG001|Overall Study|Physician Decision|0|||
37760348|NCT01552681|69270606|FG000|Overall Study|Subject moved away|0|||
37760349|NCT01552681|69270607|FG001|Overall Study|Subject moved away|1|||
37760350|NCT01570387|69270639|FG000|Overall Study|Adverse Event|1|||
37760351|NCT01570387|69270640|FG001|Overall Study|Adverse Event|0|||
37760352|NCT01570387|69270641|FG002|Overall Study|Adverse Event|0|||
37760353|NCT01570387|69270642|FG003|Overall Study|Adverse Event|0|||
37760354|NCT01570387|69270639|FG000|Overall Study|Death|0|||
37760355|NCT01570387|69270640|FG001|Overall Study|Death|0|||
37760356|NCT01570387|69270641|FG002|Overall Study|Death|0|||
37760357|NCT01570387|69270642|FG003|Overall Study|Death|1|||
37760358|NCT01570387|69270639|FG000|Overall Study|Withdrawal by Subject|0|||
37760359|NCT01570387|69270640|FG001|Overall Study|Withdrawal by Subject|0|||
37760360|NCT01570387|69270641|FG002|Overall Study|Withdrawal by Subject|0|||
37760361|NCT01570387|69270642|FG003|Overall Study|Withdrawal by Subject|1|||
37760362|NCT01570309|69270651|FG000|Overall Study|Withdrawal by Subject|3|||
37760363|NCT01570309|69270652|FG001|Overall Study|Withdrawal by Subject|3|||
37760364|NCT01519921|69270664|FG000|Overall Study|Adverse Event|10|||
37760365|NCT01519921|69270665|FG001|Overall Study|Adverse Event|9|||
37760366|NCT01519921|69270664|FG000|Overall Study|Lack of Efficacy|4|||
37760367|NCT01519921|69270665|FG001|Overall Study|Lack of Efficacy|3|||
37760368|NCT01519921|69270664|FG000|Overall Study|Withdrawal by Subject|3|||
37760369|NCT01519921|69270665|FG001|Overall Study|Withdrawal by Subject|0|||
37760370|NCT01519921|69270664|FG000|Overall Study|Lost to Follow-up|2|||
37928310|NCT04450394|69615263|FG000|Overall Study|Death|0|||
37928311|NCT04450394|69615264|FG001|Overall Study|Death|1|||
37928312|NCT04450394|69615265|FG002|Overall Study|Death|0|||
37928313|NCT04450394|69615263|FG000|Overall Study|Lost to Follow-up|0|||
37928314|NCT04450394|69615264|FG001|Overall Study|Lost to Follow-up|3|||
37928315|NCT04450394|69615265|FG002|Overall Study|Lost to Follow-up|0|||
37928316|NCT04450394|69615263|FG000|Overall Study|Physician Decision|0|||
37928317|NCT04450394|69615264|FG001|Overall Study|Physician Decision|1|||
37928318|NCT04450394|69615265|FG002|Overall Study|Physician Decision|0|||
37760371|NCT01519921|69270665|FG001|Overall Study|Lost to Follow-up|1|||
37760372|NCT01519921|69270664|FG000|Overall Study|Treatment refusal|2|||
37760373|NCT01519921|69270665|FG001|Overall Study|Treatment refusal|1|||
37760374|NCT01519921|69270664|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
37760375|NCT01519921|69270665|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
37760376|NCT01519765|69270673|FG000|Overall Study|Adverse Event|0|||
37760377|NCT01519765|69270674|FG001|Overall Study|Adverse Event|1|||
37760378|NCT01519765|69270673|FG000|Overall Study|Lack of Efficacy|2|||
37760379|NCT01519765|69270674|FG001|Overall Study|Lack of Efficacy|0|||
37760380|NCT01519765|69270673|FG000|Overall Study|Protocol Violation|1|||
37760381|NCT01519765|69270674|FG001|Overall Study|Protocol Violation|0|||
37928319|NCT04450394|69615263|FG000|Overall Study|Protocol Violation|2|||
37928320|NCT04450394|69615264|FG001|Overall Study|Protocol Violation|0|||
37928321|NCT04450394|69615265|FG002|Overall Study|Protocol Violation|0|||
37760382|NCT01519765|69270673|FG000|Overall Study|Withdrawal by Subject|0|||
37760383|NCT01519765|69270674|FG001|Overall Study|Withdrawal by Subject|1|||
37760384|NCT01552603|69270681|FG000|Overall Study|Physician Decision|1|||
37928322|NCT04450394|69615263|FG000|Overall Study|Withdrawal by Subject|6|||
37760385|NCT01552369|69270687|FG000|Overall Study|Did not consent to extended follow up|8|||
37760386|NCT01552369|69270688|FG001|Overall Study|Did not consent to extended follow up|9|||
37760387|NCT01552057|69270698|FG000|Overall Study|Adverse Event|14|||
37760388|NCT01552057|69270699|FG001|Overall Study|Adverse Event|15|||
37760389|NCT01552057|69270698|FG000|Overall Study|Lack of Efficacy|8|||
37760390|NCT01552057|69270699|FG001|Overall Study|Lack of Efficacy|23|||
37760391|NCT01552057|69270698|FG000|Overall Study|Withdrawal by Subject|5|||
37760392|NCT01552057|69270699|FG001|Overall Study|Withdrawal by Subject|8|||
37760393|NCT01552057|69270698|FG000|Overall Study|Entry Criteria Not Met|2|||
37760394|NCT01552057|69270699|FG001|Overall Study|Entry Criteria Not Met|2|||
37760395|NCT01552057|69270698|FG000|Overall Study|Physician Decision|1|||
37760396|NCT01552057|69270699|FG001|Overall Study|Physician Decision|0|||
37760397|NCT01551745|69270705|FG000|Overall Study|Withdrawal by Subject|1|||
37760398|NCT01551745|69270705|FG000|Overall Study|Disease Progression|2|||
37760399|NCT01551355|69270715|FG000|Overall Study|Lost to Follow-up|51|||
37760400|NCT01551355|69270716|FG001|Overall Study|Lost to Follow-up|49|||
37760401|NCT01551355|69270717|FG002|Overall Study|Lost to Follow-up|34|||
37928323|NCT04450394|69615264|FG001|Overall Study|Withdrawal by Subject|9|||
37928324|NCT04450394|69615265|FG002|Overall Study|Withdrawal by Subject|0|||
37928325|NCT00758160|69615272|FG000|Overall Study|No Longer Requires Study Medication|4|||
37928326|NCT00758160|69615272|FG000|Overall Study|Administration Problems|3|||
37928327|NCT00758160|69615272|FG000|Overall Study|Adverse Event|15|||
37928328|NCT00758160|69615272|FG000|Overall Study|Lack of Efficacy|10|||
37928329|NCT00758160|69615272|FG000|Overall Study|Lost to Follow-up|14|||
37928330|NCT00758160|69615272|FG000|Overall Study|Protocol Violation|12|||
37928331|NCT00758160|69615272|FG000|Overall Study|Withdrawal by Subject|8|||
37928332|NCT00757848|69615282|FG000|Overall Study|Voluntary discontinuation|1|||
37928333|NCT00757848|69615283|FG001|Overall Study|Voluntary discontinuation|0|||
37928334|NCT00757848|69615282|FG000|Overall Study|Adverse Event|1|||
37928335|NCT00757848|69615283|FG001|Overall Study|Adverse Event|2|||
37928336|NCT00757848|69615282|FG000|Overall Study|Incorrect enrolment|1|||
37928337|NCT00757848|69615283|FG001|Overall Study|Incorrect enrolment|0|||
37928338|NCT00751296|69615289|FG000|Overall Study|Adverse Event|2|||
37928339|NCT00751140|69615293|FG000|Overall Study|benign angioma excluded from analysis|1|||
37928340|NCT00751881|69615304|FG000|Core Treatment Period|Not treated|1|||
37928341|NCT00751881|69615305|FG001|Core Treatment Period|Not treated|1|||
37928342|NCT00751881|69615306|FG002|Core Treatment Period|Not treated|2|||
37928343|NCT00751881|69615304|FG000|Core Treatment Period|Adverse Event|26|||
37928344|NCT00751881|69615305|FG001|Core Treatment Period|Adverse Event|54|||
37928345|NCT00751881|69615306|FG002|Core Treatment Period|Adverse Event|58|||
37928346|NCT00751881|69615304|FG000|Core Treatment Period|Lack of Efficacy|37|||
37928347|NCT00751881|69615305|FG001|Core Treatment Period|Lack of Efficacy|30|||
37928348|NCT00751881|69615306|FG002|Core Treatment Period|Lack of Efficacy|20|||
37928349|NCT00751881|69615304|FG000|Core Treatment Period|Poor compliance to protocol|15|||
37928350|NCT00751881|69615305|FG001|Core Treatment Period|Poor compliance to protocol|3|||
37928351|NCT00751881|69615306|FG002|Core Treatment Period|Poor compliance to protocol|4|||
37760402|NCT01551355|69270718|FG003|Overall Study|Lost to Follow-up|24|||
37760403|NCT01551355|69270719|FG004|Overall Study|Lost to Follow-up|9|||
37760404|NCT01551355|69270720|FG005|Overall Study|Lost to Follow-up|6|||
37760405|NCT01569841|69270728|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
37760406|NCT01569841|69270729|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
37760407|NCT01569763|69270739|FG000|Overall Study|Lack of Efficacy|2|||
37760408|NCT01569763|69270740|FG001|Overall Study|Lack of Efficacy|7|||
37760409|NCT01569763|69270739|FG000|Overall Study|Adverse Event|1|||
37760410|NCT01569763|69270740|FG001|Overall Study|Adverse Event|0|||
37760411|NCT01550965|69270746|FG000|Overall Study|Adverse Event|26|||
37760412|NCT01550965|69270746|FG000|Overall Study|Withdrawal by Subject|10|||
37760413|NCT01550965|69270746|FG000|Overall Study|Lost to Follow-up|2|||
37760414|NCT01550965|69270746|FG000|Overall Study|Lack of Efficacy|59|||
37760415|NCT01550965|69270746|FG000|Overall Study|Other|13|||
37760416|NCT01569295|69270867|FG000|Overall Study|Progressive Disease|75|||
37760417|NCT01569295|69270868|FG001|Overall Study|Progressive Disease|139|||
37760418|NCT01569295|69270867|FG000|Overall Study|Adverse Event|39|||
37760419|NCT01569295|69270868|FG001|Overall Study|Adverse Event|14|||
37928352|NCT00751881|69615304|FG000|Core Treatment Period|Lost to Follow-up|6|||
37928353|NCT00751881|69615305|FG001|Core Treatment Period|Lost to Follow-up|4|||
37928354|NCT00751881|69615306|FG002|Core Treatment Period|Lost to Follow-up|3|||
37928355|NCT00751881|69615304|FG000|Core Treatment Period|Other: protocol deviation|3|||
37928356|NCT00751881|69615305|FG001|Core Treatment Period|Other: protocol deviation|3|||
37928357|NCT00751881|69615306|FG002|Core Treatment Period|Other: protocol deviation|7|||
37928358|NCT00751881|69615304|FG000|Core Treatment Period|Other: wish to parent|5|||
37928359|NCT00751881|69615305|FG001|Core Treatment Period|Other: wish to parent|7|||
37928360|NCT00751881|69615306|FG002|Core Treatment Period|Other: wish to parent|4|||
37760420|NCT01569295|69270867|FG000|Overall Study|Withdrawal by Subject|25|||
37760421|NCT01569295|69270868|FG001|Overall Study|Withdrawal by Subject|12|||
37760422|NCT01569295|69270867|FG000|Overall Study|Death|19|||
37760423|NCT01569295|69270868|FG001|Overall Study|Death|15|||
37928361|NCT00751881|69615304|FG000|Core Treatment Period|Other: personal/family constraints|6|||
37928362|NCT00751881|69615305|FG001|Core Treatment Period|Other: personal/family constraints|7|||
37928363|NCT00751881|69615306|FG002|Core Treatment Period|Other: personal/family constraints|10|||
37928364|NCT00751881|69615304|FG000|Core Treatment Period|Other: MS treatment change|6|||
37928365|NCT00751881|69615305|FG001|Core Treatment Period|Other: MS treatment change|4|||
37928366|NCT00751881|69615306|FG002|Core Treatment Period|Other: MS treatment change|4|||
37928367|NCT00751881|69615304|FG000|Core Treatment Period|Other: tolerability complaints|2|||
37928368|NCT00751881|69615305|FG001|Core Treatment Period|Other: tolerability complaints|0|||
37928369|NCT00751881|69615306|FG002|Core Treatment Period|Other: tolerability complaints|0|||
37928370|NCT00751881|69615304|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
37928371|NCT00751881|69615305|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
37928372|NCT00751881|69615306|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
37928373|NCT00751881|69615304|FG000|Extension Study Period|Adverse Event|18|||
37928374|NCT00751881|69615305|FG001|Extension Study Period|Adverse Event|20|||
37928375|NCT00751881|69615306|FG002|Extension Study Period|Adverse Event|21|||
37928376|NCT00751881|69615304|FG000|Extension Study Period|Lack of Efficacy|14|||
37928377|NCT00751881|69615305|FG001|Extension Study Period|Lack of Efficacy|10|||
37928378|NCT00751881|69615306|FG002|Extension Study Period|Lack of Efficacy|20|||
37928379|NCT00751881|69615304|FG000|Extension Study Period|Lost to Follow-up|4|||
37928380|NCT00751881|69615305|FG001|Extension Study Period|Lost to Follow-up|9|||
37928381|NCT00751881|69615306|FG002|Extension Study Period|Lost to Follow-up|6|||
37928382|NCT00751881|69615304|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
37928383|NCT00751881|69615305|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
37928384|NCT00751881|69615306|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
37928385|NCT00751881|69615304|FG000|Extension Study Period|Other than specified above|26|||
37928386|NCT00751881|69615305|FG001|Extension Study Period|Other than specified above|30|||
37928387|NCT00751881|69615306|FG002|Extension Study Period|Other than specified above|18|||
37928388|NCT00747474|69615320|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
37928389|NCT00747474|69615321|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
37928390|NCT00747474|69615322|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
37928391|NCT00747474|69615323|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
37928392|NCT00747474|69615324|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
37928393|NCT00747474|69615325|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
37928394|NCT00747474|69615326|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
37928395|NCT00747474|69615327|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
37928396|NCT00747474|69615328|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
37928397|NCT00747474|69615329|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
37928398|NCT00747474|69615330|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
37928399|NCT00747474|69615331|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
37928400|NCT00830063|69615340|FG000|Overall Study|Adverse Event|7|||
37928401|NCT00830063|69615341|FG001|Overall Study|Adverse Event|13|||
37928402|NCT00830063|69615342|FG002|Overall Study|Adverse Event|16|||
37928403|NCT00830063|69615343|FG003|Overall Study|Adverse Event|13|||
37928404|NCT00830063|69615340|FG000|Overall Study|Death|1|||
37928405|NCT00830063|69615341|FG001|Overall Study|Death|0|||
37928406|NCT00830063|69615342|FG002|Overall Study|Death|0|||
37928407|NCT00830063|69615343|FG003|Overall Study|Death|0|||
37928408|NCT00830063|69615340|FG000|Overall Study|Lost to Follow-up|0|||
37928409|NCT00830063|69615341|FG001|Overall Study|Lost to Follow-up|0|||
37928410|NCT00830063|69615342|FG002|Overall Study|Lost to Follow-up|3|||
37928411|NCT00830063|69615343|FG003|Overall Study|Lost to Follow-up|1|||
37928412|NCT00830063|69615340|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
37928413|NCT00830063|69615341|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
37928414|NCT00830063|69615342|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
37928415|NCT00830063|69615343|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
37928416|NCT00830063|69615340|FG000|Overall Study|Lack of Efficacy|51|||
37928417|NCT00830063|69615341|FG001|Overall Study|Lack of Efficacy|23|||
37928418|NCT00830063|69615342|FG002|Overall Study|Lack of Efficacy|25|||
37928419|NCT00830063|69615343|FG003|Overall Study|Lack of Efficacy|32|||
37928420|NCT00830063|69615340|FG000|Overall Study|Other|5|||
37928421|NCT00830063|69615341|FG001|Overall Study|Other|5|||
37928422|NCT00830063|69615342|FG002|Overall Study|Other|8|||
37928423|NCT00830063|69615343|FG003|Overall Study|Other|6|||
37928424|NCT00830063|69615340|FG000|Overall Study|Withdrawal by Subject|16|||
37928425|NCT00830063|69615341|FG001|Overall Study|Withdrawal by Subject|10|||
37928426|NCT00830063|69615342|FG002|Overall Study|Withdrawal by Subject|16|||
37760424|NCT01569295|69270867|FG000|Overall Study|Physician Decision|13|||
37928427|NCT00830063|69615343|FG003|Overall Study|Withdrawal by Subject|13|||
37928428|NCT00830063|69615340|FG000|Overall Study|Protocol Violation|1|||
37928429|NCT00830063|69615341|FG001|Overall Study|Protocol Violation|0|||
37928430|NCT00830063|69615342|FG002|Overall Study|Protocol Violation|3|||
37760425|NCT01569295|69270868|FG001|Overall Study|Physician Decision|18|||
37928431|NCT00830063|69615343|FG003|Overall Study|Protocol Violation|2|||
37928432|NCT00830063|69615340|FG000|Overall Study|Randomized But Not Treated|0|||
37928433|NCT00830063|69615341|FG001|Overall Study|Randomized But Not Treated|2|||
37928434|NCT00830063|69615342|FG002|Overall Study|Randomized But Not Treated|0|||
37928435|NCT00830063|69615343|FG003|Overall Study|Randomized But Not Treated|2|||
37928436|NCT00750438|69615357|FG000|Overall Study|Protocol Violation|4|||
37928437|NCT00750438|69615358|FG001|Overall Study|Protocol Violation|1|||
37928438|NCT00750438|69615357|FG000|Overall Study|Physician Decision|2|||
37928439|NCT00750438|69615358|FG001|Overall Study|Physician Decision|2|||
37928440|NCT00750438|69615357|FG000|Overall Study|Withdrawal by Subject|1|||
37928441|NCT00750438|69615358|FG001|Overall Study|Withdrawal by Subject|1|||
37928442|NCT00586326|69615364|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
37928443|NCT00586326|69615364|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
37928444|NCT00586326|69615364|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
37928445|NCT00586326|69615364|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
37928446|NCT00586326|69615364|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
37928447|NCT00586326|69615364|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
37928448|NCT00586326|69615364|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
37928449|NCT00586326|69615364|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
37928450|NCT00586326|69615364|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
37928451|NCT00586326|69615364|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
37928452|NCT00586326|69615364|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
37928453|NCT00586326|69615364|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
37928454|NCT00586326|69615364|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
37928455|NCT00586326|69615364|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
37928456|NCT00586326|69615364|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
37928457|NCT00586326|69615364|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
37928458|NCT00586326|69615364|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
37928459|NCT00751101|69615374|FG000|Overall Study|Withdrawal by Subject|1|||
37928460|NCT00751101|69615375|FG001|Overall Study|Withdrawal by Subject|0|||
37928461|NCT00751101|69615374|FG000|Overall Study|No HFS / Never Started Patch/|0|||
37928462|NCT00751101|69615375|FG001|Overall Study|No HFS / Never Started Patch/|4|||
37928463|NCT00751101|69615374|FG000|Overall Study|Never began capecitabine|1|||
37928464|NCT00751101|69615375|FG001|Overall Study|Never began capecitabine|0|||
37928465|NCT00751101|69615374|FG000|Overall Study|Physician Decision|0|||
37928466|NCT00751101|69615375|FG001|Overall Study|Physician Decision|1|||
37928467|NCT00750204|69615387|FG000|Overall Study|study halted prematurely|1|||
37928468|NCT00750204|69615388|FG001|Overall Study|study halted prematurely|1|||
37928469|NCT00751023|69615396|FG000|Overall Study|Lost to Follow-up|11|||
37928470|NCT00751023|69615397|FG001|Overall Study|Lost to Follow-up|7|||
37760426|NCT01569295|69270867|FG000|Overall Study|Study Terminated by Sponsor|24|||
37760427|NCT01569295|69270868|FG001|Overall Study|Study Terminated by Sponsor|2|||
37760428|NCT01569295|69270867|FG000|Overall Study|Other Reason not Specified|3|||
37760429|NCT01569295|69270868|FG001|Overall Study|Other Reason not Specified|5|||
37760430|NCT01569295|69270867|FG000|Overall Study|Non-Compliance with Study Drug|6|||
37760431|NCT01569295|69270868|FG001|Overall Study|Non-Compliance with Study Drug|1|||
37760432|NCT01569295|69270867|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
37760433|NCT01569295|69270868|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
37760434|NCT01569295|69270867|FG000|Overall Study|Lost to Follow-up|1|||
37760435|NCT01569295|69270868|FG001|Overall Study|Lost to Follow-up|1|||
37760436|NCT01549951|69270925|FG000|Overall Study|Adverse Event|15|||
37760437|NCT01549951|69270925|FG000|Overall Study|Withdrawal by Subject|2|||
37760438|NCT01549951|69270925|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
37928471|NCT00591773|69615406|FG000|Overall Study|Adverse Event|9|||
37928472|NCT00591773|69615407|FG001|Overall Study|Adverse Event|9|||
37928473|NCT00591773|69615408|FG002|Overall Study|Adverse Event|6|||
37928474|NCT00591773|69615406|FG000|Overall Study|Protocol Violation|2|||
37928475|NCT00591773|69615407|FG001|Overall Study|Protocol Violation|3|||
37928476|NCT00591773|69615408|FG002|Overall Study|Protocol Violation|0|||
37928477|NCT00591773|69615406|FG000|Overall Study|Lost to Follow-up|1|||
37928478|NCT00591773|69615407|FG001|Overall Study|Lost to Follow-up|4|||
37928479|NCT00591773|69615408|FG002|Overall Study|Lost to Follow-up|1|||
37928480|NCT00591773|69615406|FG000|Overall Study|Withdrawal by Subject|2|||
37928481|NCT00591773|69615407|FG001|Overall Study|Withdrawal by Subject|5|||
37928482|NCT00591773|69615408|FG002|Overall Study|Withdrawal by Subject|3|||
37928483|NCT00591773|69615406|FG000|Overall Study|Lack of Efficacy|1|||
37928484|NCT00591773|69615407|FG001|Overall Study|Lack of Efficacy|2|||
37928485|NCT00591773|69615408|FG002|Overall Study|Lack of Efficacy|2|||
37928486|NCT00591773|69615406|FG000|Overall Study|Other|1|||
37928487|NCT00591773|69615407|FG001|Overall Study|Other|1|||
37928488|NCT00591773|69615408|FG002|Overall Study|Other|4|||
37928489|NCT00750867|69615416|FG000|Overall Study|Adverse Event|2|||
37928490|NCT00744042|69615420|FG000|Overall Study|Withdrawal by Subject|1|||
37928491|NCT00829829|69615433|FG000|Overall Study|Protocol Violation|0|||
37760439|NCT01549951|69270925|FG000|Overall Study|Progressive disease|29|||
37928492|NCT00829829|69615434|FG001|Overall Study|Protocol Violation|3|||
37928493|NCT00829829|69615435|FG002|Overall Study|Protocol Violation|0|||
37928494|NCT00829829|69615433|FG000|Overall Study|Adverse Event|4|||
37928495|NCT00829829|69615434|FG001|Overall Study|Adverse Event|4|||
37928496|NCT00829829|69615435|FG002|Overall Study|Adverse Event|3|||
37928497|NCT00829829|69615433|FG000|Overall Study|Withdrawal by Subject|8|||
37928498|NCT00829829|69615434|FG001|Overall Study|Withdrawal by Subject|4|||
37928499|NCT00829829|69615435|FG002|Overall Study|Withdrawal by Subject|2|||
37928500|NCT00829829|69615433|FG000|Overall Study|Decision by the Sponsor|1|||
37928501|NCT00829829|69615434|FG001|Overall Study|Decision by the Sponsor|0|||
37928502|NCT00829829|69615435|FG002|Overall Study|Decision by the Sponsor|2|||
37928503|NCT00829829|69615433|FG000|Overall Study|Lost to Follow-up|7|||
37928504|NCT00829829|69615434|FG001|Overall Study|Lost to Follow-up|3|||
37928505|NCT00829829|69615435|FG002|Overall Study|Lost to Follow-up|3|||
37928506|NCT00829829|69615433|FG000|Overall Study|Other than specified above|2|||
37928507|NCT00829829|69615434|FG001|Overall Study|Other than specified above|2|||
37928508|NCT00829829|69615435|FG002|Overall Study|Other than specified above|1|||
37928509|NCT00823199|69615444|FG000|Overall Study|Withdrawal by Subject|2|||
37928510|NCT00829439|69615449|FG000|Overall Study|Adverse Event|0|||
37928511|NCT00829439|69615450|FG001|Overall Study|Adverse Event|0|||
37928512|NCT00829439|69615451|FG002|Overall Study|Adverse Event|1|||
37928513|NCT00829439|69615452|FG003|Overall Study|Adverse Event|0|||
37928514|NCT00749775|69615456|FG000|Overall Study|Protocol Violation|24|||
37928515|NCT00749775|69615456|FG000|Overall Study|Lost to Follow-up|36|||
37928516|NCT00749775|69615456|FG000|Overall Study|No visit after first day of treatment|44|||
37928517|NCT00749775|69615456|FG000|Overall Study|No drug administration|3|||
37928518|NCT00829283|69615472|FG000|Overall Study|Lost to Follow-up|7|||
37760440|NCT01549951|69270925|FG000|Overall Study|Symptomatic deterioration|1|||
37760441|NCT01549951|69270925|FG000|Overall Study|Other|2|||
37760442|NCT01517893|69270931|FG000|Overall Study|Withdrawal by Subject|3|||
37760443|NCT01517893|69270932|FG001|Overall Study|Withdrawal by Subject|0|||
37760444|NCT01489891|69270940|FG000|Overall Study|Endoscopy failure|1|||
37760445|NCT01489891|69270941|FG001|Overall Study|Endoscopy failure|0|||
37760446|NCT04062240|69271023|FG000|Overall Study|equipment malfunction|1|||
37760447|NCT02790138|69271029|FG000|Overall Study|Adverse Event|5|||
37760448|NCT02790138|69271030|FG001|Overall Study|Adverse Event|2|||
37760449|NCT02790138|69271029|FG000|Overall Study|Significant Protocol Deviation|0|||
37760450|NCT02790138|69271030|FG001|Overall Study|Significant Protocol Deviation|1|||
37760451|NCT02790138|69271029|FG000|Overall Study|Lost to Follow-up|1|||
37760452|NCT02790138|69271030|FG001|Overall Study|Lost to Follow-up|0|||
37760453|NCT02790138|69271029|FG000|Overall Study|Voluntary Withdrawal|8|||
37760454|NCT02790138|69271030|FG001|Overall Study|Voluntary Withdrawal|9|||
37760455|NCT02790138|69271029|FG000|Overall Study|Lack of Efficacy|6|||
37760456|NCT02790138|69271030|FG001|Overall Study|Lack of Efficacy|7|||
37760457|NCT02790138|69271029|FG000|Overall Study|Reason not Specified|1|||
37760458|NCT02790138|69271030|FG001|Overall Study|Reason not Specified|0|||
37760459|NCT05385224|69271183|FG000|Overall Study|Unable to swallow capsule|2|||
37760460|NCT05385224|69271183|FG000|Overall Study|Withdrawal by Subject|2|||
37760461|NCT05385224|69271183|FG000|Overall Study|Did not meet study criteria|1|||
37760462|NCT04710979|69271189|FG000|Overall Study|Lost to Follow-up|2|||
37760463|NCT04710979|69271190|FG001|Overall Study|Lost to Follow-up|4|||
37760464|NCT04710979|69271189|FG000|Overall Study|Withdrawal by Subject|1|||
37760465|NCT04710979|69271190|FG001|Overall Study|Withdrawal by Subject|0|||
37760466|NCT04682639|69271200|FG000|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
37760467|NCT04682639|69271201|FG001|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
37760468|NCT04682639|69271202|FG002|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
37760469|NCT04682639|69271203|FG003|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
37760470|NCT04682639|69271204|FG004|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
37760471|NCT04682639|69271200|FG000|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
37760472|NCT04682639|69271201|FG001|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
37760473|NCT04682639|69271202|FG002|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
37760474|NCT04682639|69271203|FG003|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
37760475|NCT04682639|69271204|FG004|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
37760476|NCT04682639|69271200|FG000|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|2|||
37760477|NCT04682639|69271201|FG001|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|1|||
37760478|NCT04682639|69271202|FG002|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
37760479|NCT04682639|69271203|FG003|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
37760480|NCT04682639|69271204|FG004|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
37928519|NCT00829283|69615473|FG001|Overall Study|Lost to Follow-up|25|||
37928520|NCT00821873|69615479|FG000|Overall Study|Lost to Follow-up|4|||
37928521|NCT00749463|69615486|FG000|Overall Study|Adverse Event|0|||
37928522|NCT00749463|69615487|FG001|Overall Study|Adverse Event|4|||
37928523|NCT00749463|69615488|FG002|Overall Study|Adverse Event|1|||
37760481|NCT04682639|69271200|FG000|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
37760482|NCT04682639|69271201|FG001|Double-Blind Treatment Period (24 Weeks)|Pregnancy|1|||
37760483|NCT04682639|69271202|FG002|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
37760484|NCT04682639|69271203|FG003|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
37760485|NCT04682639|69271204|FG004|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
37760486|NCT04682639|69271200|FG000|Double-Blind Treatment Period (24 Weeks)|Non-compliance|2|||
37760487|NCT04682639|69271201|FG001|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
37760488|NCT04682639|69271202|FG002|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
37760489|NCT04682639|69271203|FG003|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
37760490|NCT04682639|69271204|FG004|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
37760491|NCT04682639|69271200|FG000|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
37760492|NCT04682639|69271201|FG001|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
37760493|NCT04682639|69271202|FG002|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
37760494|NCT04682639|69271203|FG003|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
37760495|NCT04682639|69271204|FG004|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
37760496|NCT04682639|69271200|FG000|OLE Period (28 Weeks)|Non-compliance|1|||
37760497|NCT04682639|69271201|FG001|OLE Period (28 Weeks)|Non-compliance|0|||
37760498|NCT04682639|69271202|FG002|OLE Period (28 Weeks)|Non-compliance|0|||
37760499|NCT04682639|69271203|FG003|OLE Period (28 Weeks)|Non-compliance|0|||
37760500|NCT04682639|69271204|FG004|OLE Period (28 Weeks)|Non-compliance|1|||
37760501|NCT04682639|69271200|FG000|OLE Period (28 Weeks)|Other|1|||
37760502|NCT04682639|69271201|FG001|OLE Period (28 Weeks)|Other|2|||
37760503|NCT04682639|69271202|FG002|OLE Period (28 Weeks)|Other|0|||
37760504|NCT04682639|69271203|FG003|OLE Period (28 Weeks)|Other|0|||
37760505|NCT04682639|69271204|FG004|OLE Period (28 Weeks)|Other|1|||
37760506|NCT04682639|69271200|FG000|OLE Period (28 Weeks)|Lack of Efficacy|2|||
37760507|NCT04682639|69271201|FG001|OLE Period (28 Weeks)|Lack of Efficacy|1|||
37760508|NCT04682639|69271202|FG002|OLE Period (28 Weeks)|Lack of Efficacy|0|||
37760509|NCT04682639|69271203|FG003|OLE Period (28 Weeks)|Lack of Efficacy|0|||
37760510|NCT04682639|69271204|FG004|OLE Period (28 Weeks)|Lack of Efficacy|0|||
37760511|NCT04682639|69271200|FG000|OLE Period (28 Weeks)|Lost to Follow-up|1|||
37760512|NCT04682639|69271201|FG001|OLE Period (28 Weeks)|Lost to Follow-up|1|||
37760513|NCT04682639|69271202|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
37760514|NCT04682639|69271203|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
37760515|NCT04682639|69271204|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
37760516|NCT04682639|69271200|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
37760517|NCT04682639|69271201|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
37760518|NCT04682639|69271202|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
37760519|NCT04682639|69271203|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
37760520|NCT04682639|69271204|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
37760521|NCT04682639|69271200|FG000|OLE Period (28 Weeks)|Adverse Event|3|||
37760522|NCT04682639|69271201|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
37760523|NCT04682639|69271202|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
37760524|NCT04682639|69271203|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
37760525|NCT04682639|69271204|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
37760526|NCT04470050|69271223|FG000|Double-blind Treatment Phase|Adverse Event|0|||
37760527|NCT04470050|69271224|FG001|Double-blind Treatment Phase|Adverse Event|0|||
37760528|NCT04470050|69271225|FG002|Double-blind Treatment Phase|Adverse Event|0|||
37760529|NCT04470050|69271226|FG003|Double-blind Treatment Phase|Adverse Event|1|||
37760530|NCT04470050|69271227|FG004|Double-blind Treatment Phase|Adverse Event|0|||
37760531|NCT04470050|69271228|FG005|Double-blind Treatment Phase|Adverse Event|0|||
37760532|NCT04470050|69271229|FG006|Double-blind Treatment Phase|Adverse Event|0|||
37760533|NCT04470050|69271223|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
37760534|NCT04470050|69271224|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
37760535|NCT04470050|69271225|FG002|Double-blind Treatment Phase|Lost to Follow-up|0|||
37760536|NCT04470050|69271226|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
37760537|NCT04470050|69271227|FG004|Double-blind Treatment Phase|Lost to Follow-up|1|||
37760538|NCT04470050|69271228|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
37760539|NCT04470050|69271229|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
37760540|NCT04470050|69271223|FG000|Double-blind Treatment Phase|Withdrawal by Subject|10|||
37760541|NCT04470050|69271224|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
37760542|NCT04470050|69271225|FG002|Double-blind Treatment Phase|Withdrawal by Subject|15|||
37760543|NCT04470050|69271226|FG003|Double-blind Treatment Phase|Withdrawal by Subject|11|||
37760544|NCT04470050|69271227|FG004|Double-blind Treatment Phase|Withdrawal by Subject|15|||
37760545|NCT04470050|69271228|FG005|Double-blind Treatment Phase|Withdrawal by Subject|9|||
37760546|NCT04470050|69271229|FG006|Double-blind Treatment Phase|Withdrawal by Subject|19|||
37760547|NCT03887052|69271361|FG000|Overall Study|Adverse Event|2|||
37760548|NCT03887052|69271361|FG000|Overall Study|Physician Decision|2|||
37760549|NCT03887052|69271361|FG000|Overall Study|Withdrawal by Subject|3|||
37760550|NCT03887052|69271361|FG000|Overall Study|Motor Vehicle Accident, unrelated to study participation|1|||
37760551|NCT03887052|69271361|FG000|Overall Study|Subject Hospitalized, unrelated to study participation|1|||
37760552|NCT03758066|69271365|FG000|Overall Study|Lost to Follow-up|14|||
37760553|NCT03728933|69271384|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
37760554|NCT03728933|69271385|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
37760555|NCT03728933|69271386|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
37760556|NCT03728933|69271384|FG000|Overall Study|Withdrawal by Subject|0|||
37760557|NCT03728933|69271385|FG001|Overall Study|Withdrawal by Subject|0|||
37760558|NCT03728933|69271386|FG002|Overall Study|Withdrawal by Subject|1|||
37760559|NCT03728933|69271384|FG000|Overall Study|Lost to Follow-up|0|||
37760560|NCT03728933|69271385|FG001|Overall Study|Lost to Follow-up|1|||
37760561|NCT03728933|69271386|FG002|Overall Study|Lost to Follow-up|0|||
37760562|NCT03728933|69271384|FG000|Overall Study|Adverse Event|1|||
37760563|NCT03728933|69271385|FG001|Overall Study|Adverse Event|0|||
37760564|NCT03728933|69271386|FG002|Overall Study|Adverse Event|0|||
37760565|NCT03599713|69271405|FG000|Overall Study|Death|26|||
37760566|NCT03599713|69271406|FG001|Overall Study|Death|3|||
37760567|NCT03599713|69271405|FG000|Overall Study|Withdrawal by Subject|6|||
37760568|NCT03599713|69271406|FG001|Overall Study|Withdrawal by Subject|0|||
37928524|NCT00749463|69615486|FG000|Overall Study|Withdrawal by Subject|1|||
37928525|NCT00749463|69615487|FG001|Overall Study|Withdrawal by Subject|0|||
37928526|NCT00749463|69615488|FG002|Overall Study|Withdrawal by Subject|0|||
37928527|NCT00821327|69615496|FG000|Overall Study|Adverse Event|13|||
37928528|NCT00821327|69615496|FG000|Overall Study|Patient Request|1|||
37928529|NCT00821327|69615496|FG000|Overall Study|Investigator Request|2|||
37928530|NCT00821327|69615496|FG000|Overall Study|Sponsor Request|1|||
37928531|NCT00821327|69615496|FG000|Overall Study|Disease Progression|13|||
37928532|NCT00821327|69615496|FG000|Overall Study|Other/Unknown|5|||
37928533|NCT00821093|69615502|FG000|Overall Study|Adverse Event|20|||
37928534|NCT00821093|69615503|FG001|Overall Study|Adverse Event|12|||
37928535|NCT00821093|69615502|FG000|Overall Study|Withdrawal by Subject|9|||
37928536|NCT00821093|69615503|FG001|Overall Study|Withdrawal by Subject|13|||
37928537|NCT00821093|69615502|FG000|Overall Study|Lost to Follow-up|9|||
37928538|NCT00821093|69615503|FG001|Overall Study|Lost to Follow-up|3|||
37928539|NCT00821093|69615502|FG000|Overall Study|Protocol deviation|3|||
37928540|NCT00821093|69615503|FG001|Overall Study|Protocol deviation|6|||
37928541|NCT00821093|69615502|FG000|Overall Study|Abnormal laboratory value(s)|2|||
37928542|NCT00821093|69615503|FG001|Overall Study|Abnormal laboratory value(s)|0|||
37928543|NCT00821093|69615502|FG000|Overall Study|Lack of Efficacy|2|||
37928544|NCT00821093|69615503|FG001|Overall Study|Lack of Efficacy|2|||
37928545|NCT00821093|69615502|FG000|Overall Study|Death|2|||
37667609|NCT02151682|69140160|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
37667610|NCT02151682|69140161|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
37667611|NCT02151682|69140162|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
37667612|NCT02151682|69140157|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
37667613|NCT02151682|69140158|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
37667614|NCT02151682|69140159|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
37667615|NCT02151682|69140160|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
37667616|NCT02151682|69140161|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
37760569|NCT03599713|69271405|FG000|Overall Study|Ongoing|69|||
37760570|NCT03599713|69271406|FG001|Overall Study|Ongoing|3|||
37760571|NCT03557281|69271423|FG000|Overall Study|Investigator discretion|0|||
37760572|NCT03557281|69271424|FG001|Overall Study|Investigator discretion|0|||
37928546|NCT00821093|69615503|FG001|Overall Study|Death|1|||
37928547|NCT00821093|69615502|FG000|Overall Study|Abnormal test procedure result(s)|1|||
37928548|NCT00821093|69615503|FG001|Overall Study|Abnormal test procedure result(s)|1|||
37928549|NCT00821093|69615502|FG000|Overall Study|Administrative problems|1|||
37928550|NCT00821093|69615503|FG001|Overall Study|Administrative problems|2|||
37928551|NCT00821015|69615509|FG000|Overall Study|Lost to Follow-up|12|||
37928552|NCT00814463|69615513|FG000|Overall Study|Lost to Follow-up|1|||
37928553|NCT00743652|69615523|FG000|Overall Study|Parent/Legal Guardian Request|3|||
37928554|NCT00743652|69615524|FG001|Overall Study|Parent/Legal Guardian Request|2|||
37928555|NCT00743652|69615525|FG002|Overall Study|Parent/Legal Guardian Request|2|||
37928556|NCT00743652|69615526|FG003|Overall Study|Parent/Legal Guardian Request|2|||
37928557|NCT00743652|69615527|FG004|Overall Study|Parent/Legal Guardian Request|0|||
37928558|NCT00743652|69615523|FG000|Overall Study|Adverse Event|3|||
37928559|NCT00743652|69615524|FG001|Overall Study|Adverse Event|0|||
37928560|NCT00743652|69615525|FG002|Overall Study|Adverse Event|0|||
37928561|NCT00743652|69615526|FG003|Overall Study|Adverse Event|0|||
37928562|NCT00743652|69615527|FG004|Overall Study|Adverse Event|0|||
37667617|NCT02151682|69140162|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
37760573|NCT03557281|69271425|FG002|Overall Study|Investigator discretion|1|||
37760574|NCT03557281|69271426|FG003|Overall Study|Investigator discretion|0|||
37760575|NCT03557281|69271427|FG004|Overall Study|Investigator discretion|0|||
37928563|NCT00743652|69615523|FG000|Overall Study|Death|2|||
37928564|NCT00743652|69615524|FG001|Overall Study|Death|0|||
37667618|NCT02151682|69140157|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
37928565|NCT00743652|69615525|FG002|Overall Study|Death|0|||
37928566|NCT00743652|69615526|FG003|Overall Study|Death|0|||
37928567|NCT00743652|69615527|FG004|Overall Study|Death|0|||
37760576|NCT03557281|69271423|FG000|Overall Study|Withdrawal by Subject|0|||
37760577|NCT03557281|69271424|FG001|Overall Study|Withdrawal by Subject|1|||
37760578|NCT03557281|69271425|FG002|Overall Study|Withdrawal by Subject|1|||
37760579|NCT03557281|69271426|FG003|Overall Study|Withdrawal by Subject|1|||
37760580|NCT03557281|69271427|FG004|Overall Study|Withdrawal by Subject|2|||
37928568|NCT00743652|69615523|FG000|Overall Study|Investigator Request|0|||
37928569|NCT00743652|69615524|FG001|Overall Study|Investigator Request|0|||
37928570|NCT00743652|69615525|FG002|Overall Study|Investigator Request|0|||
37928571|NCT00743652|69615526|FG003|Overall Study|Investigator Request|2|||
37928572|NCT00743652|69615527|FG004|Overall Study|Investigator Request|0|||
37928573|NCT00743652|69615523|FG000|Overall Study|Other|1|||
37928574|NCT00743652|69615524|FG001|Overall Study|Other|1|||
37928575|NCT00743652|69615525|FG002|Overall Study|Other|0|||
37928576|NCT00743652|69615526|FG003|Overall Study|Other|0|||
37928577|NCT00743652|69615527|FG004|Overall Study|Other|0|||
37928578|NCT00743652|69615523|FG000|Overall Study|Lost to Follow-up|1|||
37928579|NCT00743652|69615524|FG001|Overall Study|Lost to Follow-up|0|||
37928580|NCT00743652|69615525|FG002|Overall Study|Lost to Follow-up|0|||
37928581|NCT00743652|69615526|FG003|Overall Study|Lost to Follow-up|0|||
37928582|NCT00743652|69615527|FG004|Overall Study|Lost to Follow-up|0|||
37928583|NCT00748215|69615545|FG000|Overall Study|Withdrawal by Subject|7|||
37928584|NCT00748215|69615546|FG001|Overall Study|Withdrawal by Subject|7|||
38033641|NCT03313076|69719659|FG002|Overall Study|Lost to Follow-up|2|||
37667619|NCT02151682|69140158|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
37667620|NCT02151682|69140159|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
37667621|NCT02151682|69140160|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
37667622|NCT02151682|69140161|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
37667623|NCT02151682|69140162|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
37667624|NCT02151682|69140157|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
37667625|NCT02151682|69140158|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
37667626|NCT02151682|69140159|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
37667627|NCT02151682|69140160|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
37667628|NCT02151682|69140161|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
37667629|NCT02151682|69140162|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
37667630|NCT02151682|69140157|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
37667631|NCT02151682|69140158|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
37667632|NCT02151682|69140159|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
37667633|NCT02151682|69140160|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
37667634|NCT02151682|69140161|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
37667635|NCT02151682|69140162|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
37667636|NCT02151682|69140157|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
37667637|NCT02151682|69140158|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
37667638|NCT02151682|69140159|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
37667639|NCT02151682|69140160|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
37667640|NCT02151682|69140161|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
37667641|NCT02151682|69140162|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
37667642|NCT02151682|69140157|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
37667643|NCT02151682|69140158|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
37667644|NCT02151682|69140159|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
37667645|NCT02151682|69140160|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
37760581|NCT03557281|69271423|FG000|Overall Study|Randomized, but did not receive treatment|0|||
37760582|NCT03557281|69271424|FG001|Overall Study|Randomized, but did not receive treatment|0|||
37760583|NCT03557281|69271425|FG002|Overall Study|Randomized, but did not receive treatment|0|||
37760584|NCT03557281|69271426|FG003|Overall Study|Randomized, but did not receive treatment|0|||
37760585|NCT03557281|69271427|FG004|Overall Study|Randomized, but did not receive treatment|1|||
37760586|NCT03538041|69271445|FG000|12-Week Treatment Period|Adverse Event|1|||
37760587|NCT03538041|69271446|FG001|12-Week Treatment Period|Adverse Event|1|||
37760588|NCT03538041|69271445|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
37760589|NCT03538041|69271446|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
37928585|NCT00748215|69615545|FG000|Overall Study|Treatment change|2|||
37928586|NCT00748215|69615546|FG001|Overall Study|Treatment change|1|||
38033642|NCT03313076|69719660|FG003|Overall Study|Lost to Follow-up|2|||
38033643|NCT02940626|69719678|FG000|Overall Study|Death|40|||
37760590|NCT03538041|69271445|FG000|Treatment Extension Period|Adverse Event|4|||
37760591|NCT03538041|69271446|FG001|Treatment Extension Period|Adverse Event|0|||
37760592|NCT03538041|69271445|FG000|Treatment Extension Period|Physician Decision|1|||
37667646|NCT02151682|69140161|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
37928587|NCT00748215|69615545|FG000|Overall Study|Change in patient condition|0|||
37928588|NCT00748215|69615546|FG001|Overall Study|Change in patient condition|3|||
38033644|NCT02940626|69719679|FG001|Overall Study|Death|32|||
38033645|NCT02940626|69719678|FG000|Overall Study|Lost to Follow-up|5|||
37760593|NCT03538041|69271446|FG001|Treatment Extension Period|Physician Decision|0|||
37760594|NCT03538041|69271445|FG000|Treatment Extension Period|Lack of Efficacy|1|||
37760595|NCT03538041|69271446|FG001|Treatment Extension Period|Lack of Efficacy|3|||
37760596|NCT03538041|69271445|FG000|Treatment Extension Period|Ongoing; Still Receiving Treatment|1|||
37760597|NCT03538041|69271446|FG001|Treatment Extension Period|Ongoing; Still Receiving Treatment|7|||
37760598|NCT03260894|69271461|FG000|Overall Study|Death|6|||
37760599|NCT03260894|69271462|FG001|Overall Study|Death|8|||
37760600|NCT03260894|69271461|FG000|Overall Study|Withdrawal by Subject|4|||
37760601|NCT03260894|69271462|FG001|Overall Study|Withdrawal by Subject|11|||
37760602|NCT03260894|69271461|FG000|Overall Study|On-going at clinical cut off date|36|||
37760603|NCT03260894|69271462|FG001|Overall Study|On-going at clinical cut off date|31|||
37760604|NCT03258593|69271470|FG000|Run-In Maintenance Phase|Disease recurrence|4|||
37760605|NCT03258593|69271471|FG001|Run-In Maintenance Phase|Disease recurrence|0|||
37760606|NCT03258593|69271472|FG002|Run-In Maintenance Phase|Disease recurrence|0|||
37760607|NCT03258593|69271473|FG003|Run-In Maintenance Phase|Disease recurrence|0|||
37760608|NCT03258593|69271470|FG000|Run-In Maintenance Phase|Disease progression|3|||
37760609|NCT03258593|69271471|FG001|Run-In Maintenance Phase|Disease progression|0|||
37760610|NCT03258593|69271472|FG002|Run-In Maintenance Phase|Disease progression|0|||
37760611|NCT03258593|69271473|FG003|Run-In Maintenance Phase|Disease progression|0|||
37760612|NCT03258593|69271470|FG000|Expansion Maintenance Phase|Withdrawal by Subject|0|||
37760613|NCT03258593|69271471|FG001|Expansion Maintenance Phase|Withdrawal by Subject|1|||
37760614|NCT03258593|69271472|FG002|Expansion Maintenance Phase|Withdrawal by Subject|0|||
37760615|NCT03258593|69271473|FG003|Expansion Maintenance Phase|Withdrawal by Subject|0|||
37760616|NCT03258593|69271470|FG000|Expansion Maintenance Phase|Physician Decision|0|||
37760617|NCT03258593|69271471|FG001|Expansion Maintenance Phase|Physician Decision|1|||
37760618|NCT03258593|69271472|FG002|Expansion Maintenance Phase|Physician Decision|0|||
37760619|NCT03258593|69271473|FG003|Expansion Maintenance Phase|Physician Decision|0|||
37928589|NCT00748215|69615545|FG000|Overall Study|Non-compliant|0|||
37928590|NCT00748215|69615546|FG001|Overall Study|Non-compliant|2|||
37928591|NCT00748215|69615545|FG000|Overall Study|Adverse Event|0|||
37928592|NCT00748215|69615546|FG001|Overall Study|Adverse Event|5|||
37928593|NCT00749892|69615552|FG000|Overall Study|Withdrawal by Subject|3|||
37928594|NCT00749580|69615558|FG000|Overall Study|Lost to Follow-up|4|||
37928595|NCT00749580|69615559|FG001|Overall Study|Lost to Follow-up|8|||
37928596|NCT00749580|69615558|FG000|Overall Study|Adverse Event|0|||
37928597|NCT00749580|69615559|FG001|Overall Study|Adverse Event|1|||
37928598|NCT00747006|69615568|FG000|Overall Study|Adverse Event|1|||
37928599|NCT00747006|69615569|FG001|Overall Study|Adverse Event|0|||
37928600|NCT00747006|69615570|FG002|Overall Study|Adverse Event|0|||
37928601|NCT00747006|69615568|FG000|Overall Study|Lost to Follow-up|0|||
37928602|NCT00747006|69615569|FG001|Overall Study|Lost to Follow-up|1|||
37928603|NCT00747006|69615570|FG002|Overall Study|Lost to Follow-up|0|||
37928604|NCT00747006|69615568|FG000|Overall Study|Physician Decision|2|||
37928605|NCT00747006|69615569|FG001|Overall Study|Physician Decision|0|||
37928606|NCT00747006|69615570|FG002|Overall Study|Physician Decision|1|||
37928607|NCT00743340|69615581|FG000|Overall Study|Study medication non-compliance|1|||
37928608|NCT00743340|69615581|FG000|Overall Study|Lost to Follow-up|1|||
37928609|NCT00743340|69615581|FG000|Overall Study|Withdrawal from the Study|5|||
37928610|NCT00743340|69615581|FG000|Overall Study|Protocol Violation|1|||
37928611|NCT00743340|69615581|FG000|Overall Study|Virologic failure|8|||
37928612|NCT00743340|69615581|FG000|Overall Study|Pregnancy|1|||
37928613|NCT00743340|69615581|FG000|Overall Study|Rolled over to other Gilead Study|23|||
37928614|NCT00743340|69615581|FG000|Overall Study|Participant Relocated|1|||
37928615|NCT00749190|69615592|FG000|Overall Study|Adverse Event|0|||
37928616|NCT00749190|69615593|FG001|Overall Study|Adverse Event|2|||
37928617|NCT00749190|69615594|FG002|Overall Study|Adverse Event|0|||
37928618|NCT00749190|69615595|FG003|Overall Study|Adverse Event|4|||
37928619|NCT00749190|69615596|FG004|Overall Study|Adverse Event|0|||
37928620|NCT00749190|69615597|FG005|Overall Study|Adverse Event|3|||
37928621|NCT00749190|69615598|FG006|Overall Study|Adverse Event|0|||
37928622|NCT00749190|69615592|FG000|Overall Study|Lack of Efficacy|3|||
37928623|NCT00749190|69615593|FG001|Overall Study|Lack of Efficacy|1|||
37760620|NCT03197935|69271486|FG000|Overall Study|Death due to any cause|26|||
37928624|NCT00749190|69615594|FG002|Overall Study|Lack of Efficacy|1|||
37928625|NCT00749190|69615595|FG003|Overall Study|Lack of Efficacy|0|||
37928626|NCT00749190|69615596|FG004|Overall Study|Lack of Efficacy|0|||
37760621|NCT03197935|69271487|FG001|Overall Study|Death due to any cause|15|||
37760622|NCT03197935|69271486|FG000|Overall Study|Lost to Follow-up|3|||
37760623|NCT03197935|69271487|FG001|Overall Study|Lost to Follow-up|5|||
37760624|NCT03197935|69271486|FG000|Overall Study|Physician Decision|2|||
37928627|NCT00749190|69615597|FG005|Overall Study|Lack of Efficacy|1|||
37928628|NCT00749190|69615598|FG006|Overall Study|Lack of Efficacy|0|||
37928629|NCT00749190|69615592|FG000|Overall Study|Withdrawal by Subject|2|||
37928630|NCT00749190|69615593|FG001|Overall Study|Withdrawal by Subject|1|||
37928631|NCT00749190|69615594|FG002|Overall Study|Withdrawal by Subject|0|||
37928632|NCT00749190|69615595|FG003|Overall Study|Withdrawal by Subject|0|||
37928633|NCT00749190|69615596|FG004|Overall Study|Withdrawal by Subject|0|||
37928634|NCT00749190|69615597|FG005|Overall Study|Withdrawal by Subject|1|||
37928635|NCT00749190|69615598|FG006|Overall Study|Withdrawal by Subject|0|||
37928636|NCT00749190|69615592|FG000|Overall Study|Protocol Violation|0|||
37928637|NCT00749190|69615593|FG001|Overall Study|Protocol Violation|1|||
37928638|NCT00749190|69615594|FG002|Overall Study|Protocol Violation|0|||
37928639|NCT00749190|69615595|FG003|Overall Study|Protocol Violation|0|||
37928640|NCT00749190|69615596|FG004|Overall Study|Protocol Violation|0|||
37928641|NCT00749190|69615597|FG005|Overall Study|Protocol Violation|0|||
37928642|NCT00749190|69615598|FG006|Overall Study|Protocol Violation|1|||
37928643|NCT00749190|69615592|FG000|Overall Study|Other reason not defined above|0|||
37928644|NCT00749190|69615593|FG001|Overall Study|Other reason not defined above|0|||
37928645|NCT00749190|69615594|FG002|Overall Study|Other reason not defined above|0|||
37928646|NCT00749190|69615595|FG003|Overall Study|Other reason not defined above|1|||
37928647|NCT00749190|69615596|FG004|Overall Study|Other reason not defined above|0|||
37928648|NCT00749190|69615597|FG005|Overall Study|Other reason not defined above|0|||
37928649|NCT00749190|69615598|FG006|Overall Study|Other reason not defined above|0|||
37928650|NCT00748566|69615619|FG000|Overall Study|Adverse Event|49|||
37928651|NCT00748566|69615619|FG000|Overall Study|Death|1|||
37928652|NCT00748566|69615619|FG000|Overall Study|Lack of Efficacy|12|||
37928653|NCT00748566|69615619|FG000|Overall Study|Lost to Follow-up|1|||
37928654|NCT00748566|69615619|FG000|Overall Study|Protocol Violation|13|||
37928655|NCT00748566|69615619|FG000|Overall Study|Withdrawal by Subject|22|||
37928656|NCT00748566|69615619|FG000|Overall Study|Study terminated by sponsor|5|||
37928657|NCT00748566|69615619|FG000|Overall Study|Other|9|||
37928658|NCT00743106|69615625|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
37928659|NCT00743106|69615626|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
37928660|NCT00738699|69615634|FG000|Overall Study|Withdrawal by Subject|5|||
37928661|NCT00738699|69615635|FG001|Overall Study|Withdrawal by Subject|0|||
37928662|NCT00738699|69615634|FG000|Overall Study|Lost to Follow-up|1|||
37928663|NCT00738699|69615635|FG001|Overall Study|Lost to Follow-up|0|||
37928664|NCT00738699|69615634|FG000|Overall Study|Death|144|||
37928665|NCT00738699|69615635|FG001|Overall Study|Death|68|||
37928666|NCT00738699|69615634|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
37928667|NCT00738699|69615635|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
37928668|NCT00738699|69615634|FG000|Overall Study|Other|2|||
37928669|NCT00738699|69615635|FG001|Overall Study|Other|0|||
37928670|NCT00814307|69615645|FG000|Overall Study|Randomized but not treated|1|||
37928671|NCT00814307|69615646|FG001|Overall Study|Randomized but not treated|0|||
37928672|NCT00814307|69615647|FG002|Overall Study|Randomized but not treated|0|||
37928673|NCT00814307|69615648|FG003|Overall Study|Randomized but not treated|0|||
37928674|NCT00814307|69615645|FG000|Overall Study|Adverse Event|3|||
37928675|NCT00814307|69615646|FG001|Overall Study|Adverse Event|9|||
37928676|NCT00814307|69615647|FG002|Overall Study|Adverse Event|3|||
37928677|NCT00814307|69615648|FG003|Overall Study|Adverse Event|2|||
37928678|NCT00814307|69615645|FG000|Overall Study|Lack of Efficacy|1|||
37928679|NCT00814307|69615646|FG001|Overall Study|Lack of Efficacy|1|||
37928680|NCT00814307|69615647|FG002|Overall Study|Lack of Efficacy|3|||
37928681|NCT00814307|69615648|FG003|Overall Study|Lack of Efficacy|4|||
37928682|NCT00814307|69615645|FG000|Overall Study|Other|1|||
37928683|NCT00814307|69615646|FG001|Overall Study|Other|2|||
37928684|NCT00814307|69615647|FG002|Overall Study|Other|0|||
37928685|NCT00814307|69615648|FG003|Overall Study|Other|1|||
37928686|NCT00814307|69615645|FG000|Overall Study|Protocol Violation|2|||
37928687|NCT00814307|69615646|FG001|Overall Study|Protocol Violation|8|||
37928688|NCT00814307|69615647|FG002|Overall Study|Protocol Violation|1|||
37928689|NCT00814307|69615648|FG003|Overall Study|Protocol Violation|1|||
37928690|NCT00814307|69615645|FG000|Overall Study|Withdrawal by Subject|4|||
37928691|NCT00814307|69615646|FG001|Overall Study|Withdrawal by Subject|6|||
37928692|NCT00814307|69615647|FG002|Overall Study|Withdrawal by Subject|0|||
37928693|NCT00814307|69615648|FG003|Overall Study|Withdrawal by Subject|2|||
37928694|NCT00814307|69615645|FG000|Overall Study|Death|0|||
37928695|NCT00814307|69615646|FG001|Overall Study|Death|1|||
37928696|NCT00814307|69615647|FG002|Overall Study|Death|0|||
37928697|NCT00814307|69615648|FG003|Overall Study|Death|0|||
37928698|NCT00748098|69615660|FG000|First Treatment Intervention Period|Adverse Event|1|||
37928699|NCT00748098|69615661|FG001|First Treatment Intervention Period|Adverse Event|1|||
37928700|NCT00748098|69615660|FG000|First Treatment Intervention Period|Protocol Violation|1|||
37928701|NCT00748098|69615661|FG001|First Treatment Intervention Period|Protocol Violation|0|||
37928702|NCT00748098|69615660|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
37928703|NCT00748098|69615661|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
37928704|NCT00748098|69615660|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
37928705|NCT00748098|69615661|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
37928706|NCT00748098|69615660|FG000|First Taper Period|Protocol Violation|1|||
37928707|NCT00748098|69615661|FG001|First Taper Period|Protocol Violation|0|||
37928708|NCT00748098|69615660|FG000|First Taper Period|Withdrawal by Subject|2|||
37928709|NCT00748098|69615661|FG001|First Taper Period|Withdrawal by Subject|0|||
37928710|NCT00748098|69615660|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
37928711|NCT00748098|69615661|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
37928712|NCT00748098|69615660|FG000|1-Week Washout Period|Adverse Event|0|||
37928713|NCT00748098|69615661|FG001|1-Week Washout Period|Adverse Event|1|||
37928714|NCT00748098|69615660|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
37928715|NCT00748098|69615661|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
37928716|NCT00748098|69615660|FG000|Second Treatment Intervention Period|Adverse Event|4|||
37928717|NCT00748098|69615661|FG001|Second Treatment Intervention Period|Adverse Event|1|||
37928718|NCT00748098|69615660|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
37928719|NCT00748098|69615661|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
37928720|NCT00748098|69615660|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
37928721|NCT00748098|69615661|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
37928722|NCT00813995|69615670|FG000|Overall Study|Clinical adverse event|9|||
37928723|NCT00813995|69615671|FG001|Overall Study|Clinical adverse event|3|||
37928724|NCT00813995|69615670|FG000|Overall Study|Laboratory adverse event|0|||
37928725|NCT00813995|69615671|FG001|Overall Study|Laboratory adverse event|2|||
37928726|NCT00813995|69615670|FG000|Overall Study|Lack of Efficacy|1|||
37928727|NCT00813995|69615671|FG001|Overall Study|Lack of Efficacy|0|||
37928728|NCT00813995|69615670|FG000|Overall Study|Lost to Follow-up|4|||
37928729|NCT00813995|69615671|FG001|Overall Study|Lost to Follow-up|2|||
37928730|NCT00813995|69615670|FG000|Overall Study|Other reason|2|||
37928731|NCT00813995|69615671|FG001|Overall Study|Other reason|2|||
37928732|NCT00813995|69615670|FG000|Overall Study|Protocol Violation|3|||
37928733|NCT00813995|69615671|FG001|Overall Study|Protocol Violation|2|||
37928734|NCT00813995|69615670|FG000|Overall Study|Subject moved|4|||
37928735|NCT00813995|69615671|FG001|Overall Study|Subject moved|0|||
37928736|NCT00813995|69615670|FG000|Overall Study|Withdrawal by Subject|0|||
37928737|NCT00813995|69615671|FG001|Overall Study|Withdrawal by Subject|5|||
37928738|NCT00737529|69615681|FG000|Overall Study|Disease Progression|95|||
37928739|NCT00737529|69615681|FG000|Overall Study|Adverse Event|24|||
37928740|NCT00737529|69615681|FG000|Overall Study|Withdrawal by Subject|5|||
37928741|NCT00737529|69615681|FG000|Overall Study|Death|4|||
37928742|NCT00737529|69615681|FG000|Overall Study|Protocol Violation|1|||
37928743|NCT00737529|69615681|FG000|Overall Study|Other|4|||
37928744|NCT00813917|69615687|FG000|Overall Study|Adverse Event|0|||
37928745|NCT00813917|69615688|FG001|Overall Study|Adverse Event|1|||
37928746|NCT00813917|69615687|FG000|Overall Study|Withdrawal by Subject|3|||
37928747|NCT00813917|69615688|FG001|Overall Study|Withdrawal by Subject|4|||
37928748|NCT00813917|69615687|FG000|Overall Study|Lost to Follow-up|3|||
37928749|NCT00813917|69615688|FG001|Overall Study|Lost to Follow-up|1|||
37928750|NCT00737061|69615694|FG000|Waiting Period|Lost to Follow-up|6|||
37928751|NCT00737061|69615694|FG000|Waiting Period|Withdrawal by Subject|1|||
37928752|NCT00737061|69615694|FG000|Waiting Period|Bilateral placement failure|34|||
37928753|NCT00737061|69615694|FG000|Waiting Period|Deemed patent following HSG|26|||
37928754|NCT00737061|69615694|FG000|Waiting Period|Alternative contraception failure|3|||
37928755|NCT00737061|69615694|FG000|Waiting Period|Elected surgical tubal ligation|5|||
37928756|NCT00737061|69615694|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
37928757|NCT00737061|69615694|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
37928758|NCT00737061|69615694|FG000|1 Year Wearing Period|Discontinued reilance|3|||
37928759|NCT00737061|69615694|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
37667647|NCT02151682|69140162|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
37667648|NCT02151682|69140157|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
37667649|NCT02151682|69140158|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
37667650|NCT02151682|69140159|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
37667651|NCT02151682|69140160|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
37928760|NCT00585975|69615700|FG000|Overall Study|Withdrawal by Subject|3|||
37928761|NCT00585975|69615701|FG001|Overall Study|Withdrawal by Subject|3|||
37928762|NCT00585975|69615700|FG000|Overall Study|Lost to Follow-up|2|||
37928763|NCT00585975|69615701|FG001|Overall Study|Lost to Follow-up|1|||
37928764|NCT00585975|69615700|FG000|Overall Study|Enrollment met/over-enrolled|10|||
37928765|NCT00585975|69615701|FG001|Overall Study|Enrollment met/over-enrolled|9|||
37928766|NCT00585585|69615707|FG000|Overall Study|Adverse Event|1|||
37928767|NCT00734097|69615711|FG000|Screening|Protocol Violation|12|||
37928768|NCT00734097|69615711|FG000|Screening|Withdrawal by Subject|5|||
37928769|NCT00734097|69615711|FG000|Screening|Lost to Follow-up|2|||
37928770|NCT00734097|69615711|FG000|Screening|Unconfirmed pregnancy|1|||
37667652|NCT02151682|69140161|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
37760625|NCT03197935|69271487|FG001|Overall Study|Physician Decision|1|||
37667653|NCT02151682|69140162|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
37667654|NCT02151682|69140157|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
37667655|NCT02151682|69140158|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
37667656|NCT02151682|69140159|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
37667657|NCT02151682|69140160|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
37760626|NCT03197935|69271486|FG000|Overall Study|Withdrawal by Subject|16|||
37760627|NCT03197935|69271487|FG001|Overall Study|Withdrawal by Subject|8|||
37760628|NCT03144674|69271499|FG000|Overall Study|Participants Still Ongoing in the Study|1|||
37760629|NCT03144674|69271500|FG001|Overall Study|Participants Still Ongoing in the Study|4|||
37760630|NCT03144674|69271501|FG002|Overall Study|Participants Still Ongoing in the Study|24|||
37760631|NCT03144674|69271502|FG003|Overall Study|Participants Still Ongoing in the Study|54|||
37760632|NCT03144674|69271499|FG000|Overall Study|Death|3|||
37760633|NCT03144674|69271500|FG001|Overall Study|Death|1|||
37760634|NCT03144674|69271501|FG002|Overall Study|Death|1|||
37760635|NCT03144674|69271502|FG003|Overall Study|Death|10|||
37760636|NCT03144674|69271499|FG000|Overall Study|Lost to Follow-up|0|||
37760637|NCT03144674|69271500|FG001|Overall Study|Lost to Follow-up|1|||
37760638|NCT03144674|69271501|FG002|Overall Study|Lost to Follow-up|1|||
37928771|NCT00734097|69615711|FG000|Open Label|Lost to Follow-up|7|||
37928772|NCT00734097|69615711|FG000|Open Label|Withdrawal by Subject|5|||
37928773|NCT00734097|69615711|FG000|Open Label|Protocol Violation|4|||
37928774|NCT00819767|69615717|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
37928775|NCT00819767|69615718|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
37928776|NCT00733005|69615726|FG000|Overall Study|Adverse Event|0|||
37928777|NCT00733005|69615727|FG001|Overall Study|Adverse Event|1|||
37760639|NCT03144674|69271502|FG003|Overall Study|Lost to Follow-up|1|||
37760640|NCT03144674|69271499|FG000|Overall Study|Withdrawal by Participant|0|||
37928778|NCT00733005|69615726|FG000|Overall Study|Treatment Failure|0|||
37928779|NCT00733005|69615727|FG001|Overall Study|Treatment Failure|1|||
37928780|NCT00733005|69615726|FG000|Overall Study|Withdrawal by Subject|0|||
37928781|NCT00733005|69615727|FG001|Overall Study|Withdrawal by Subject|1|||
37928782|NCT00733005|69615726|FG000|Overall Study|Protocol Violation|2|||
37928783|NCT00733005|69615727|FG001|Overall Study|Protocol Violation|0|||
37928784|NCT00812981|69615735|FG000|Overall Study|Other|0|||
37928785|NCT00812981|69615736|FG001|Overall Study|Other|1|||
37928786|NCT00732615|69615744|FG000|Overall Study|Withdrawal by Subject|3|||
37928787|NCT00732615|69615745|FG001|Overall Study|Withdrawal by Subject|1|||
37928788|NCT00732615|69615744|FG000|Overall Study|Lost to Follow-up|0|||
37928789|NCT00732615|69615745|FG001|Overall Study|Lost to Follow-up|1|||
37928790|NCT00732615|69615744|FG000|Overall Study|Adverse Event|0|||
37928791|NCT00732615|69615745|FG001|Overall Study|Adverse Event|2|||
37928792|NCT00732615|69615744|FG000|Overall Study|Physician Decision|3|||
37928793|NCT00732615|69615745|FG001|Overall Study|Physician Decision|0|||
37928794|NCT00732615|69615744|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
37928795|NCT00732615|69615745|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
37928796|NCT00732381|69615754|FG000|Overall Study|Adverse Event|1|||
37928797|NCT00732381|69615755|FG001|Overall Study|Adverse Event|0|||
37928798|NCT00732381|69615754|FG000|Overall Study|Treatment Failure|1|||
37928799|NCT00732381|69615755|FG001|Overall Study|Treatment Failure|1|||
37928800|NCT00732303|69615761|FG000|Overall Study|Study Terminated|2|||
37928801|NCT00813761|69615767|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
37928802|NCT00813761|69615768|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
37928803|NCT00813761|69615769|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
37928804|NCT00813761|69615770|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
37928805|NCT00813761|69615767|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
37928806|NCT00813761|69615768|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
37928807|NCT00813761|69615769|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
37928808|NCT00813761|69615770|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
37928809|NCT00813761|69615767|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
37928810|NCT00813761|69615768|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
37928811|NCT00813761|69615769|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
37928812|NCT00813761|69615770|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
37928813|NCT00813761|69615767|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
37928814|NCT00813761|69615768|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
37928815|NCT00813761|69615769|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
37928816|NCT00813761|69615770|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
37928817|NCT00813761|69615767|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
37928818|NCT00813761|69615768|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
37760641|NCT03144674|69271500|FG001|Overall Study|Withdrawal by Participant|0|||
37760642|NCT03144674|69271501|FG002|Overall Study|Withdrawal by Participant|0|||
37760643|NCT03144674|69271502|FG003|Overall Study|Withdrawal by Participant|3|||
37928819|NCT00813761|69615769|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
37928820|NCT00813761|69615770|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
37928821|NCT00813761|69615767|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
37928822|NCT00813761|69615768|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
37928823|NCT00813761|69615769|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
37928824|NCT00813761|69615770|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
37928825|NCT00813761|69615767|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
37928826|NCT00813761|69615768|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
37760644|NCT03144674|69271499|FG000|Overall Study|Reason not Specified|0|||
37928827|NCT00813761|69615769|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
37928828|NCT00813761|69615770|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
37928829|NCT00813761|69615767|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
37928830|NCT00813761|69615768|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
37928831|NCT00813761|69615769|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
37928832|NCT00813761|69615770|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
37928833|NCT00813761|69615767|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
37928834|NCT00813761|69615768|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
37928835|NCT00813761|69615769|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
37928836|NCT00813761|69615770|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
37928837|NCT00813761|69615767|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
37928838|NCT00813761|69615768|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
37928839|NCT00813761|69615769|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
37928840|NCT00813761|69615770|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
37928841|NCT00813761|69615767|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
37928842|NCT00813761|69615768|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
37928843|NCT00813761|69615769|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
37928844|NCT00813761|69615770|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
37667658|NCT02151682|69140161|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
37667659|NCT02151682|69140162|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
37667660|NCT02151682|69140157|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
37667661|NCT02151682|69140158|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
37667662|NCT02151682|69140159|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
37667663|NCT02151682|69140160|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
37928845|NCT00813761|69615767|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
37928846|NCT00813761|69615768|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
37928847|NCT00813761|69615769|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
37928848|NCT00813761|69615770|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
37928849|NCT00732069|69615786|FG000|Washout After First Study Drug|Adverse Event|1|||
37928850|NCT00732069|69615787|FG001|Washout After First Study Drug|Adverse Event|0|||
37928851|NCT00732069|69615788|FG002|Washout After First Study Drug|Adverse Event|0|||
37928852|NCT00732069|69615789|FG003|Washout After First Study Drug|Adverse Event|0|||
37928853|NCT00732069|69615790|FG004|Washout After First Study Drug|Adverse Event|0|||
37928854|NCT00732069|69615791|FG005|Washout After First Study Drug|Adverse Event|0|||
37928855|NCT00731679|69615801|FG000|Overall Study|Adverse Event|7|||
37667664|NCT02151682|69140161|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
37667665|NCT02151682|69140162|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
37760645|NCT03144674|69271500|FG001|Overall Study|Reason not Specified|0|||
37760646|NCT03144674|69271501|FG002|Overall Study|Reason not Specified|2|||
37760647|NCT03144674|69271502|FG003|Overall Study|Reason not Specified|4|||
37760648|NCT03136965|69271520|FG000|Overall Study|Lost to Follow-up|0|||
37760649|NCT03136965|69271521|FG001|Overall Study|Lost to Follow-up|1|||
37760650|NCT03136965|69271522|FG002|Overall Study|Lost to Follow-up|0|||
37760651|NCT03115151|69271532|FG000|Overall Study|Intervention discontinue due to clinical condition|2|||
37760652|NCT03115151|69271533|FG001|Overall Study|Intervention discontinue due to clinical condition|2|||
37667666|NCT02151682|69140157|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
37667667|NCT02151682|69140158|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
37667668|NCT02151682|69140159|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
37667669|NCT02151682|69140160|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
37667670|NCT02151682|69140161|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
37667671|NCT02151682|69140162|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
37667672|NCT02151682|69140157|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
37667673|NCT02151682|69140158|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
37667674|NCT02151682|69140159|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
37667675|NCT02151682|69140160|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
37667676|NCT02151682|69140161|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
37667677|NCT02151682|69140162|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
37667678|NCT02151682|69140157|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
37667679|NCT02151682|69140158|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
37760653|NCT03115151|69271532|FG000|Overall Study|Epidural catheter removal|1|||
37760654|NCT03115151|69271533|FG001|Overall Study|Epidural catheter removal|0|||
37928856|NCT00731679|69615802|FG001|Overall Study|Adverse Event|8|||
37667680|NCT02151682|69140159|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
37667681|NCT02151682|69140160|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
37667682|NCT02151682|69140161|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
37760655|NCT03115151|69271532|FG000|Overall Study|Withdrawal by Subject|0|||
37760656|NCT03115151|69271533|FG001|Overall Study|Withdrawal by Subject|1|||
37760657|NCT03115151|69271532|FG000|Overall Study|Intervention not received according to the protocol.|1|||
37928857|NCT00731679|69615801|FG000|Overall Study|Withdrawal by Subject|8|||
37760658|NCT03115151|69271533|FG001|Overall Study|Intervention not received according to the protocol.|1|||
37760659|NCT03115151|69271532|FG000|Overall Study|Physician Decision|1|||
37760660|NCT03115151|69271533|FG001|Overall Study|Physician Decision|0|||
37760661|NCT03115151|69271532|FG000|Overall Study|Randomization not applied|1|||
37760662|NCT03115151|69271533|FG001|Overall Study|Randomization not applied|1|||
37760663|NCT03068130|69271539|FG000|Overall Study|Adverse Event|19|||
37760664|NCT03068130|69271539|FG000|Overall Study|Death|14|||
37928858|NCT00731679|69615802|FG001|Overall Study|Withdrawal by Subject|8|||
37928859|NCT00731679|69615801|FG000|Overall Study|Lost to Follow-up|7|||
37928860|NCT00731679|69615802|FG001|Overall Study|Lost to Follow-up|8|||
37928861|NCT00731679|69615801|FG000|Overall Study|Noncompliance|0|||
37928862|NCT00731679|69615802|FG001|Overall Study|Noncompliance|1|||
37928863|NCT00731679|69615801|FG000|Overall Study|Pregnancy|0|||
37928864|NCT00731679|69615802|FG001|Overall Study|Pregnancy|1|||
37928865|NCT00731133|69615808|FG000|Overall Study|Withdrawal by Subject|10|||
37928866|NCT00730275|69615816|FG000|Overall Study|Withdrawal by Subject|0|||
37928867|NCT00730275|69615817|FG001|Overall Study|Withdrawal by Subject|0|||
37928868|NCT00730275|69615818|FG002|Overall Study|Withdrawal by Subject|0|||
37928869|NCT00730275|69615819|FG003|Overall Study|Withdrawal by Subject|1|||
37928870|NCT00730041|69615837|FG000|Overall Study|Lost to Follow-up|0|||
37928871|NCT00730041|69615838|FG001|Overall Study|Lost to Follow-up|2|||
37667683|NCT02151682|69140162|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
37667684|NCT02174848|69140182|FG000|Overall Study|Adverse Event|2|||
37928872|NCT00729651|69615846|FG000|Overall Study|Withdrawal by Subject|5|||
37928873|NCT00729651|69615847|FG001|Overall Study|Withdrawal by Subject|6|||
37928874|NCT00729651|69615846|FG000|Overall Study|Lost to Follow-up|5|||
37928875|NCT00729651|69615847|FG001|Overall Study|Lost to Follow-up|4|||
37928876|NCT00729651|69615846|FG000|Overall Study|Protocol Violation|0|||
37928877|NCT00729651|69615847|FG001|Overall Study|Protocol Violation|1|||
37928878|NCT00729651|69615846|FG000|Overall Study|Adverse Event|7|||
37928879|NCT00729651|69615847|FG001|Overall Study|Adverse Event|3|||
37928880|NCT00729651|69615846|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
37928881|NCT00729651|69615847|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
37928882|NCT00729651|69615846|FG000|Overall Study|Subject's private reason|2|||
37928883|NCT00729651|69615847|FG001|Overall Study|Subject's private reason|0|||
37928884|NCT00729183|69615855|FG000|Overall Study|Adverse Event|11|||
37928885|NCT00729183|69615856|FG001|Overall Study|Adverse Event|5|||
37928886|NCT00729183|69615855|FG000|Overall Study|Lack of Efficacy|0|||
37928887|NCT00729183|69615856|FG001|Overall Study|Lack of Efficacy|1|||
37928888|NCT00729183|69615855|FG000|Overall Study|Lost to Follow-up|3|||
37928889|NCT00729183|69615856|FG001|Overall Study|Lost to Follow-up|1|||
37928890|NCT00729183|69615855|FG000|Overall Study|Physician Decision|1|||
37667685|NCT02174848|69140183|FG001|Overall Study|Adverse Event|1|||
37667686|NCT02174848|69140182|FG000|Overall Study|Withdrawal by Subject|3|||
37667687|NCT02174848|69140183|FG001|Overall Study|Withdrawal by Subject|3|||
37667688|NCT02174848|69140182|FG000|Overall Study|Lost to Follow-up|0|||
37667689|NCT02174848|69140183|FG001|Overall Study|Lost to Follow-up|1|||
37667690|NCT02174848|69140182|FG000|Overall Study|Worsening of disease|1|||
37667691|NCT02174848|69140183|FG001|Overall Study|Worsening of disease|1|||
37667692|NCT02174848|69140182|FG000|Overall Study|Unable to comply with study requirements|1|||
37667693|NCT02174848|69140183|FG001|Overall Study|Unable to comply with study requirements|0|||
37667694|NCT02151058|69140197|FG000|Overall Study|Withdrawal by Subject|1|||
37928891|NCT00729183|69615856|FG001|Overall Study|Physician Decision|1|||
37928892|NCT00729183|69615855|FG000|Overall Study|Protocol Violation|1|||
37928893|NCT00729183|69615856|FG001|Overall Study|Protocol Violation|0|||
37928894|NCT00729183|69615855|FG000|Overall Study|Withdrawal by Subject|9|||
37928895|NCT00729183|69615856|FG001|Overall Study|Withdrawal by Subject|7|||
37928896|NCT00811733|69615864|FG000|Overall Study|Investigator Discretion|10|||
37928897|NCT00811733|69615865|FG001|Overall Study|Investigator Discretion|8|||
37928898|NCT00811733|69615864|FG000|Overall Study|Withdrawal by Subject|1|||
37928899|NCT00811733|69615865|FG001|Overall Study|Withdrawal by Subject|2|||
37928900|NCT00728949|69615873|FG000|Overall Study|Adverse Event|8|||
37928901|NCT00728949|69615874|FG001|Overall Study|Adverse Event|0|||
37928902|NCT00728949|69615873|FG000|Overall Study|Withdrawal by Subject|2|||
37928903|NCT00728949|69615874|FG001|Overall Study|Withdrawal by Subject|2|||
37928904|NCT00728949|69615873|FG000|Overall Study|Abnormal Lab Results|0|||
37928905|NCT00728949|69615874|FG001|Overall Study|Abnormal Lab Results|2|||
38033646|NCT02940626|69719679|FG001|Overall Study|Lost to Follow-up|2|||
37667695|NCT02151058|69140198|FG001|Overall Study|Withdrawal by Subject|1|||
37667696|NCT02151058|69140199|FG002|Overall Study|Withdrawal by Subject|3|||
37667697|NCT02151058|69140197|FG000|Overall Study|Lost to Follow-up|1|||
37667698|NCT02151058|69140198|FG001|Overall Study|Lost to Follow-up|0|||
37760665|NCT03068130|69271539|FG000|Overall Study|Lost to Follow-up|4|||
37760666|NCT03068130|69271539|FG000|Overall Study|Withdrawal by Subject|26|||
37760667|NCT03068130|69271539|FG000|Overall Study|Administrative Reasons|3|||
37928906|NCT00728949|69615873|FG000|Overall Study|On treatment at cutoff date|1|||
37928907|NCT00728949|69615874|FG001|Overall Study|On treatment at cutoff date|0|||
37928908|NCT00728481|69615882|FG000|Overall Study|Withdrawal by Subject|0|||
37928909|NCT00728481|69615883|FG001|Overall Study|Withdrawal by Subject|1|||
37928910|NCT00728481|69615882|FG000|Overall Study|Adverse Event|0|||
37928911|NCT00728481|69615883|FG001|Overall Study|Adverse Event|1|||
37928912|NCT00728481|69615882|FG000|Overall Study|Study medication non-compliance|0|||
37928913|NCT00728481|69615883|FG001|Overall Study|Study medication non-compliance|2|||
37928914|NCT00728481|69615882|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
37928915|NCT00728481|69615883|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
37928916|NCT00811655|69615889|FG000|Overall Study|Physician Decision|1|||
37928917|NCT00727311|69615893|FG000|Overall Study|Did not receive drug|316|||
37760668|NCT03068130|69271539|FG000|Overall Study|Protocol specified withdrawal criterion|1|||
37760669|NCT03068130|69271539|FG000|Overall Study|Study terminated by sponsor|194|||
37760670|NCT03019185|69271546|FG000|Overall Study|Lost to Follow-up|3|||
37760671|NCT03019185|69271547|FG001|Overall Study|Lost to Follow-up|0|||
37928918|NCT00727311|69615893|FG000|Overall Study|Missing end of therapy data|205|||
37928919|NCT00727311|69615893|FG000|Overall Study|Adverse Event|58|||
37928920|NCT00727311|69615893|FG000|Overall Study|Lack of Efficacy|242|||
37928921|NCT00727311|69615893|FG000|Overall Study|Lost to Follow-up|73|||
37928922|NCT00727311|69615893|FG000|Overall Study|Withdrawal by Subject|77|||
37928923|NCT00727311|69615893|FG000|Overall Study|Other|97|||
37928924|NCT00727311|69615893|FG000|Overall Study|Multiple reasons|39|||
37928925|NCT00726999|69615899|FG000|Overall Study|Physician Decision|0|||
37928926|NCT00726999|69615900|FG001|Overall Study|Physician Decision|1|||
37928927|NCT00726999|69615899|FG000|Overall Study|Withdrawal by Subject|2|||
37928928|NCT00726999|69615900|FG001|Overall Study|Withdrawal by Subject|0|||
37928929|NCT00726999|69615899|FG000|Overall Study|Protocol Violation|1|||
37928930|NCT00726999|69615900|FG001|Overall Study|Protocol Violation|0|||
37928931|NCT00585351|69615914|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
37928932|NCT00585351|69615915|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
37928933|NCT00585351|69615916|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
37928934|NCT00585351|69615917|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
37928935|NCT00585351|69615918|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
37928936|NCT00585351|69615919|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
37928937|NCT00585351|69615920|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
37928938|NCT00585351|69615921|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
37928939|NCT00585351|69615914|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
37928940|NCT00585351|69615915|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
37928941|NCT00585351|69615916|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
37928942|NCT00585351|69615917|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
37928943|NCT00585351|69615918|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
38033647|NCT02940626|69719678|FG000|Overall Study|Withdrawal by Subject|1|||
38033648|NCT02940626|69719679|FG001|Overall Study|Withdrawal by Subject|0|||
38033649|NCT02940626|69719678|FG000|Overall Study|Transfer to Hospice Care|1|||
38033650|NCT02940626|69719679|FG001|Overall Study|Transfer to Hospice Care|0|||
38033651|NCT02940626|69719678|FG000|Overall Study|Prohibited Concomitant Medication|0|||
38033652|NCT02940626|69719679|FG001|Overall Study|Prohibited Concomitant Medication|1|||
38033653|NCT03300050|69719692|FG000|Overall Study|Lost to Follow-up|2|||
38033654|NCT03300050|69719693|FG001|Overall Study|Lost to Follow-up|1|||
38033655|NCT03300050|69719694|FG002|Overall Study|Lost to Follow-up|0|||
38033656|NCT03300050|69719695|FG003|Overall Study|Lost to Follow-up|0|||
38033657|NCT03300050|69719696|FG004|Overall Study|Lost to Follow-up|1|||
38033658|NCT03300050|69719692|FG000|Overall Study|Withdrawal by Subject|1|||
38033659|NCT03300050|69719693|FG001|Overall Study|Withdrawal by Subject|1|||
38033660|NCT03300050|69719694|FG002|Overall Study|Withdrawal by Subject|1|||
38033661|NCT03300050|69719695|FG003|Overall Study|Withdrawal by Subject|0|||
37667699|NCT02151058|69140199|FG002|Overall Study|Lost to Follow-up|2|||
37667700|NCT02149810|69140209|FG000|Overall Study|Physician Decision|1|||
37667701|NCT02149810|69140210|FG001|Overall Study|Physician Decision|2|||
37667702|NCT02149810|69140209|FG000|Overall Study|Lost to Follow-up|2|||
37667703|NCT02149810|69140210|FG001|Overall Study|Lost to Follow-up|1|||
37667704|NCT02149810|69140209|FG000|Overall Study|Withdrawal by Subject|5|||
37667705|NCT02149810|69140210|FG001|Overall Study|Withdrawal by Subject|1|||
37667706|NCT02149420|69140219|FG000|Core Study|Administrative problems|0|||
37667707|NCT02149420|69140220|FG001|Core Study|Administrative problems|1|||
37667708|NCT02149420|69140221|FG002|Core Study|Administrative problems|2|||
37760672|NCT03019185|69271548|FG002|Overall Study|Lost to Follow-up|2|||
37928944|NCT00585351|69615919|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
38033662|NCT03300050|69719696|FG004|Overall Study|Withdrawal by Subject|0|||
38033663|NCT03300050|69719692|FG000|Overall Study|Death|0|||
38033664|NCT03300050|69719693|FG001|Overall Study|Death|0|||
37760673|NCT03019185|69271546|FG000|Overall Study|Withdrawal by Subject|1|||
37928945|NCT00585351|69615920|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
37928946|NCT00585351|69615921|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
37928947|NCT00585351|69615914|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
37760674|NCT03019185|69271547|FG001|Overall Study|Withdrawal by Subject|1|||
37928948|NCT00585351|69615915|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
37928949|NCT00585351|69615916|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
37928950|NCT00585351|69615917|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
37928951|NCT00585351|69615918|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
37928952|NCT00585351|69615919|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
37928953|NCT00585351|69615920|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
37928954|NCT00585351|69615921|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
37928955|NCT00585351|69615914|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
37928956|NCT00585351|69615915|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
37928957|NCT00585351|69615916|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
37760675|NCT03019185|69271548|FG002|Overall Study|Withdrawal by Subject|0|||
37928958|NCT00585351|69615917|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
37928959|NCT00585351|69615918|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
37928960|NCT00585351|69615919|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
37928961|NCT00585351|69615920|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
37928962|NCT00585351|69615921|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
37928963|NCT00585351|69615914|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
37928964|NCT00585351|69615915|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
37928965|NCT00585351|69615916|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
37928966|NCT00585351|69615917|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
37928967|NCT00585351|69615918|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
37928968|NCT00585351|69615919|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
37928969|NCT00585351|69615920|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
37928970|NCT00585351|69615921|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
37928971|NCT00585351|69615914|FG000|Enrollment Period (Intervention)|Death|0|||
37928972|NCT00585351|69615915|FG001|Enrollment Period (Intervention)|Death|0|||
37928973|NCT00585351|69615916|FG002|Enrollment Period (Intervention)|Death|0|||
37928974|NCT00585351|69615917|FG003|Enrollment Period (Intervention)|Death|0|||
37928975|NCT00585351|69615918|FG004|Enrollment Period (Intervention)|Death|1|||
37928976|NCT00585351|69615919|FG005|Enrollment Period (Intervention)|Death|0|||
37928977|NCT00585351|69615920|FG006|Enrollment Period (Intervention)|Death|1|||
37928978|NCT00585351|69615921|FG007|Enrollment Period (Intervention)|Death|0|||
37928979|NCT00585351|69615914|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
37928980|NCT00585351|69615915|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
37928981|NCT00585351|69615916|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
37928982|NCT00585351|69615917|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
37928983|NCT00585351|69615918|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
37928984|NCT00585351|69615919|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
37928985|NCT00585351|69615920|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
37928986|NCT00585351|69615921|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
37928987|NCT00726609|69615935|FG000|Overall Study|Adverse Event|10|||
37760676|NCT03019185|69271546|FG000|Overall Study|Inability to continue due to increased serum creatinine|1|||
37760677|NCT03019185|69271547|FG001|Overall Study|Inability to continue due to increased serum creatinine|0|||
37760678|NCT03019185|69271548|FG002|Overall Study|Inability to continue due to increased serum creatinine|0|||
37760679|NCT03019185|69271546|FG000|Overall Study|ESKD Resulting in Kidney Transplant|1|||
37760680|NCT03019185|69271547|FG001|Overall Study|ESKD Resulting in Kidney Transplant|0|||
37760681|NCT03019185|69271548|FG002|Overall Study|ESKD Resulting in Kidney Transplant|0|||
37760682|NCT02908685|69271568|FG000|Part 1 Exploratory|Withdrawal by Subject|0|||
37760683|NCT02908685|69271569|FG001|Part 1 Exploratory|Withdrawal by Subject|1|||
37760684|NCT02908685|69271570|FG002|Part 1 Exploratory|Withdrawal by Subject|0|||
37928988|NCT00726609|69615935|FG000|Overall Study|Withdrawal by Subject|2|||
37928989|NCT00726609|69615935|FG000|Overall Study|Lack of Efficacy|25|||
37928990|NCT00726609|69615935|FG000|Overall Study|Other|16|||
37928991|NCT00726609|69615935|FG000|Overall Study|Missing|42|||
37928992|NCT00726609|69615935|FG000|Overall Study|Other|3|||
37928993|NCT00726453|69615941|FG000|Primary Enrollment Group|Death|18|||
37928994|NCT00726453|69615942|FG001|Primary Enrollment Group|Death|0|||
37928995|NCT00726453|69615941|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
37928996|NCT00726453|69615942|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
37928997|NCT00726453|69615941|FG000|38 mm Length Group|Death|0|||
37928998|NCT00726453|69615942|FG001|38 mm Length Group|Death|3|||
37928999|NCT00726063|69615949|FG000|Overall Study|Adverse Event|9|||
37929000|NCT00726063|69615950|FG001|Overall Study|Adverse Event|7|||
37929001|NCT00808028|69615960|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
37929002|NCT00808028|69615961|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
37929003|NCT00808028|69615962|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
37929004|NCT00808028|69615963|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
37929005|NCT00808028|69615960|FG000|Stage 1 (6 Months)|Other|1|||
37929006|NCT00808028|69615961|FG001|Stage 1 (6 Months)|Other|0|||
37929007|NCT00808028|69615962|FG002|Stage 1 (6 Months)|Other|2|||
37929008|NCT00808028|69615963|FG003|Stage 1 (6 Months)|Other|4|||
37929009|NCT00808028|69615960|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
37929010|NCT00808028|69615961|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
37929011|NCT00808028|69615962|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
37929012|NCT00808028|69615963|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
37929013|NCT00808028|69615960|FG000|Stage 1 (6 Months)|Adverse Event|0|||
37929014|NCT00808028|69615961|FG001|Stage 1 (6 Months)|Adverse Event|0|||
37929015|NCT00808028|69615962|FG002|Stage 1 (6 Months)|Adverse Event|1|||
37929016|NCT00808028|69615963|FG003|Stage 1 (6 Months)|Adverse Event|2|||
37929017|NCT00808028|69615960|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
37929018|NCT00808028|69615961|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
37929019|NCT00808028|69615962|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
37929020|NCT00808028|69615963|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
37929021|NCT00808028|69615960|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
37929022|NCT00808028|69615961|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
37929023|NCT00808028|69615962|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
37929024|NCT00808028|69615963|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
37929025|NCT00808028|69615960|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
37929026|NCT00808028|69615961|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
37760685|NCT02908685|69271571|FG003|Part 1 Exploratory|Withdrawal by Subject|0|||
37929027|NCT00808028|69615962|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
37929028|NCT00808028|69615963|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
37929029|NCT00808028|69615960|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
37929030|NCT00808028|69615961|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
37929031|NCT00808028|69615962|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
37929032|NCT00808028|69615963|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
37929033|NCT00808028|69615960|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
37929034|NCT00808028|69615961|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
37929035|NCT00808028|69615962|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
37929036|NCT00808028|69615963|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
37929037|NCT00808028|69615960|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
37929038|NCT00808028|69615961|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
37929039|NCT00808028|69615962|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
37929040|NCT00808028|69615963|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
37929041|NCT00808028|69615960|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
37929042|NCT00808028|69615961|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
37929043|NCT00808028|69615962|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
37929044|NCT00808028|69615963|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
38033665|NCT03300050|69719694|FG002|Overall Study|Death|1|||
38033666|NCT03300050|69719695|FG003|Overall Study|Death|0|||
37760686|NCT02908685|69271572|FG004|Part 1 Exploratory|Withdrawal by Subject|0|||
37760687|NCT02908685|69271573|FG005|Part 1 Exploratory|Withdrawal by Subject|0|||
37760688|NCT02908685|69271574|FG006|Part 1 Exploratory|Withdrawal by Subject|0|||
37760689|NCT02908685|69271575|FG007|Part 1 Exploratory|Withdrawal by Subject|0|||
37760690|NCT02908685|69271576|FG008|Part 1 Exploratory|Withdrawal by Subject|0|||
37760691|NCT02908685|69271577|FG009|Part 1 Exploratory|Withdrawal by Subject|0|||
37760692|NCT02908685|69271578|FG010|Part 1 Exploratory|Withdrawal by Subject|0|||
37760693|NCT02908685|69271579|FG011|Part 1 Exploratory|Withdrawal by Subject|0|||
37929045|NCT00808028|69615960|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
37929046|NCT00808028|69615961|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
37929047|NCT00808028|69615962|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
37929048|NCT00808028|69615963|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
37929049|NCT00808028|69615960|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
37929050|NCT00808028|69615961|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
37929051|NCT00808028|69615962|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
37929052|NCT00808028|69615963|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
37929053|NCT00808028|69615960|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
37929054|NCT00808028|69615961|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
37760694|NCT02908685|69271568|FG000|Part 2 Confirmatory|Changed to Spinraza|0|||
37929055|NCT00808028|69615962|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
37929056|NCT00808028|69615963|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
37929057|NCT00808028|69615960|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
37929058|NCT00808028|69615961|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
37929059|NCT00808028|69615962|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
37929060|NCT00808028|69615963|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
37760695|NCT02908685|69271569|FG001|Part 2 Confirmatory|Changed to Spinraza|0|||
37929061|NCT00809783|69615986|FG000|Overall Study|Death|1|||
37929062|NCT00809783|69615987|FG001|Overall Study|Death|0|||
37929063|NCT00809783|69615988|FG002|Overall Study|Death|0|||
37929064|NCT00809783|69615986|FG000|Overall Study|Adverse Event|34|||
37929065|NCT00809783|69615987|FG001|Overall Study|Adverse Event|52|||
37929066|NCT00809783|69615988|FG002|Overall Study|Adverse Event|71|||
37929067|NCT00809783|69615986|FG000|Overall Study|Lack of Efficacy|39|||
37929068|NCT00809783|69615987|FG001|Overall Study|Lack of Efficacy|52|||
37929069|NCT00809783|69615988|FG002|Overall Study|Lack of Efficacy|63|||
37929070|NCT00809783|69615986|FG000|Overall Study|Lost to Follow-up|0|||
37929071|NCT00809783|69615987|FG001|Overall Study|Lost to Follow-up|3|||
37929072|NCT00809783|69615988|FG002|Overall Study|Lost to Follow-up|4|||
37929073|NCT00809783|69615986|FG000|Overall Study|Withdrawal by Subject|47|||
37929074|NCT00809783|69615987|FG001|Overall Study|Withdrawal by Subject|72|||
37929075|NCT00809783|69615988|FG002|Overall Study|Withdrawal by Subject|64|||
37929076|NCT00809783|69615986|FG000|Overall Study|Protocol Violation|2|||
37929077|NCT00809783|69615987|FG001|Overall Study|Protocol Violation|6|||
37929078|NCT00809783|69615988|FG002|Overall Study|Protocol Violation|5|||
37929079|NCT00809783|69615986|FG000|Overall Study|Randomized, but not treated|3|||
37929080|NCT00809783|69615987|FG001|Overall Study|Randomized, but not treated|0|||
37929081|NCT00809783|69615988|FG002|Overall Study|Randomized, but not treated|2|||
37929082|NCT00809783|69615986|FG000|Overall Study|Study Terminated by Sponsor|378|||
37929083|NCT00809783|69615987|FG001|Overall Study|Study Terminated by Sponsor|626|||
37929084|NCT00809783|69615988|FG002|Overall Study|Study Terminated by Sponsor|565|||
37667709|NCT02149420|69140219|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
37667710|NCT02149420|69140220|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
37667711|NCT02149420|69140221|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
37667712|NCT02149264|69140234|FG000|Overall Study|Withdrawal by Subject|9|||
37667713|NCT02149264|69140234|FG000|Overall Study|Adverse Event|7|||
37667714|NCT02149264|69140234|FG000|Overall Study|Physician Decision|3|||
37667715|NCT02149264|69140234|FG000|Overall Study|Protocol Violation|1|||
37667716|NCT02115256|69140240|FG000|Overall Study|Withdrawal by Subject|0|||
37667717|NCT02115256|69140241|FG001|Overall Study|Withdrawal by Subject|1|||
37667718|NCT02173054|69140250|FG000|Overall Study|lack of compliance|1|||
37667719|NCT02173054|69140251|FG001|Overall Study|lack of compliance|0|||
37667720|NCT02173054|69140252|FG002|Overall Study|lack of compliance|0|||
37667721|NCT02173054|69140250|FG000|Overall Study|Withdrawal by Subject|0|||
37667722|NCT02173054|69140251|FG001|Overall Study|Withdrawal by Subject|0|||
37667723|NCT02173054|69140252|FG002|Overall Study|Withdrawal by Subject|1|||
37667724|NCT02149108|69140297|FG000|Overall Study|Not treated|1|||
37667725|NCT02149108|69140298|FG001|Overall Study|Not treated|2|||
37667726|NCT02149108|69140297|FG000|Overall Study|Progressive Disease (PD)|324|||
37667727|NCT02149108|69140298|FG001|Overall Study|Progressive Disease (PD)|318|||
37667728|NCT02149108|69140297|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
37667729|NCT02149108|69140298|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
37667730|NCT02149108|69140297|FG000|Overall Study|Other Adverse Event (AE)|8|||
37667731|NCT02149108|69140298|FG001|Overall Study|Other Adverse Event (AE)|18|||
37667732|NCT02149108|69140297|FG000|Overall Study|Other not defined above|0|||
37929085|NCT00809783|69615986|FG000|Overall Study|Other|21|||
37929086|NCT00809783|69615987|FG001|Overall Study|Other|21|||
37929087|NCT00809783|69615988|FG002|Overall Study|Other|16|||
37929088|NCT00809471|69615999|FG000|Overall Study|Protocol non-compliance|15|||
37929089|NCT00809471|69616000|FG001|Overall Study|Protocol non-compliance|15|||
37929090|NCT00809471|69616001|FG002|Overall Study|Protocol non-compliance|6|||
37929091|NCT00809471|69615999|FG000|Overall Study|Lost to Follow-up|4|||
37929092|NCT00809471|69616000|FG001|Overall Study|Lost to Follow-up|2|||
37929093|NCT00809471|69616001|FG002|Overall Study|Lost to Follow-up|9|||
37929094|NCT00809471|69615999|FG000|Overall Study|Adverse Event|0|||
37929095|NCT00809471|69616000|FG001|Overall Study|Adverse Event|2|||
37929096|NCT00809471|69616001|FG002|Overall Study|Adverse Event|2|||
37929097|NCT00809471|69615999|FG000|Overall Study|Requirement for restricted medication|1|||
37929098|NCT00809471|69616000|FG001|Overall Study|Requirement for restricted medication|1|||
37929099|NCT00809471|69616001|FG002|Overall Study|Requirement for restricted medication|0|||
37929100|NCT00807248|69616013|FG000|Overall Study|Adverse Event|1|||
37929101|NCT00807248|69616014|FG001|Overall Study|Adverse Event|2|||
37667733|NCT02149108|69140298|FG001|Overall Study|Other not defined above|2|||
37667734|NCT02149108|69140297|FG000|Overall Study|Refusal to continue trial medication|15|||
37667735|NCT02149108|69140298|FG001|Overall Study|Refusal to continue trial medication|11|||
37667736|NCT02149108|69140297|FG000|Overall Study|Lost to Follow-up|1|||
37667737|NCT02149108|69140298|FG001|Overall Study|Lost to Follow-up|0|||
37667738|NCT02148952|69140306|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
37667739|NCT02148952|69140307|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
37667740|NCT02148952|69140306|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
37667741|NCT02148952|69140307|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
37667742|NCT02148952|69140306|FG000|Follow-Up|Lost to Follow-up|219|||
37929102|NCT00807248|69616015|FG002|Overall Study|Adverse Event|2|||
37929103|NCT00807248|69616016|FG003|Overall Study|Adverse Event|6|||
37929104|NCT00807248|69616013|FG000|Overall Study|Lack of Efficacy|14|||
37929105|NCT00807248|69616014|FG001|Overall Study|Lack of Efficacy|4|||
37929106|NCT00807248|69616015|FG002|Overall Study|Lack of Efficacy|8|||
37929107|NCT00807248|69616016|FG003|Overall Study|Lack of Efficacy|3|||
37929108|NCT00807248|69616013|FG000|Overall Study|Protocol Violation|0|||
37929109|NCT00807248|69616014|FG001|Overall Study|Protocol Violation|1|||
37929110|NCT00807248|69616015|FG002|Overall Study|Protocol Violation|1|||
37929111|NCT00807248|69616016|FG003|Overall Study|Protocol Violation|0|||
37929112|NCT00807248|69616013|FG000|Overall Study|Withdrawal of Consent|5|||
37929113|NCT00807248|69616014|FG001|Overall Study|Withdrawal of Consent|5|||
37929114|NCT00807248|69616015|FG002|Overall Study|Withdrawal of Consent|5|||
37929115|NCT00807248|69616016|FG003|Overall Study|Withdrawal of Consent|5|||
37929116|NCT00807248|69616013|FG000|Overall Study|Lost to Follow-up|1|||
37929117|NCT00807248|69616014|FG001|Overall Study|Lost to Follow-up|0|||
37929118|NCT00807248|69616015|FG002|Overall Study|Lost to Follow-up|0|||
37929119|NCT00807248|69616016|FG003|Overall Study|Lost to Follow-up|0|||
37929120|NCT00807248|69616013|FG000|Overall Study|Other Reason|0|||
37929121|NCT00807248|69616014|FG001|Overall Study|Other Reason|0|||
37929122|NCT00807248|69616015|FG002|Overall Study|Other Reason|2|||
37929123|NCT00807248|69616016|FG003|Overall Study|Other Reason|0|||
37929124|NCT00589628|69616028|FG000|Overall Study|Lost to Follow-up|0|||
37929125|NCT00589628|69616029|FG001|Overall Study|Lost to Follow-up|1|||
37929126|NCT00588848|69616037|FG000|Overall Study|Physician Decision|0|||
37929127|NCT00588848|69616038|FG001|Overall Study|Physician Decision|3|||
37929128|NCT00797108|69616049|FG000|Overall Study|Adverse Event|1|||
37929129|NCT00797108|69616050|FG001|Overall Study|Adverse Event|0|||
37929130|NCT00797108|69616051|FG002|Overall Study|Adverse Event|3|||
37929131|NCT00797108|69616049|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
37929132|NCT00797108|69616050|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
37929133|NCT00797108|69616051|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
37929134|NCT00797108|69616049|FG000|Overall Study|Global Deterioration of Health Status|0|||
37929135|NCT00797108|69616050|FG001|Overall Study|Global Deterioration of Health Status|1|||
37929136|NCT00797108|69616051|FG002|Overall Study|Global Deterioration of Health Status|0|||
37929137|NCT00797108|69616049|FG000|Overall Study|Lack of Efficacy|1|||
37929138|NCT00797108|69616050|FG001|Overall Study|Lack of Efficacy|0|||
37929139|NCT00797108|69616051|FG002|Overall Study|Lack of Efficacy|1|||
37929140|NCT00797108|69616049|FG000|Overall Study|Other|0|||
37929141|NCT00797108|69616050|FG001|Overall Study|Other|0|||
37929142|NCT00797108|69616051|FG002|Overall Study|Other|2|||
37929143|NCT00797108|69616049|FG000|Overall Study|Randomized but not Treated|2|||
37929144|NCT00797108|69616050|FG001|Overall Study|Randomized but not Treated|0|||
37929145|NCT00797108|69616051|FG002|Overall Study|Randomized but not Treated|0|||
37929146|NCT00742560|69616064|FG000|Overall Study|Adverse Event|0|||
37929147|NCT00742560|69616065|FG001|Overall Study|Adverse Event|0|||
37929148|NCT00742560|69616066|FG002|Overall Study|Adverse Event|1|||
37929149|NCT00742560|69616067|FG003|Overall Study|Adverse Event|1|||
37929150|NCT00742560|69616068|FG004|Overall Study|Adverse Event|1|||
37929151|NCT00742560|69616064|FG000|Overall Study|Death|0|||
37929152|NCT00742560|69616065|FG001|Overall Study|Death|2|||
37929153|NCT00742560|69616066|FG002|Overall Study|Death|0|||
37929154|NCT00742560|69616067|FG003|Overall Study|Death|2|||
37929155|NCT00742560|69616068|FG004|Overall Study|Death|3|||
37929156|NCT00742560|69616064|FG000|Overall Study|Subject's Decision|1|||
37929157|NCT00742560|69616065|FG001|Overall Study|Subject's Decision|0|||
37929158|NCT00742560|69616066|FG002|Overall Study|Subject's Decision|2|||
37929159|NCT00742560|69616067|FG003|Overall Study|Subject's Decision|3|||
37929160|NCT00742560|69616068|FG004|Overall Study|Subject's Decision|3|||
37929161|NCT00742560|69616064|FG000|Overall Study|Investigator's Decision|0|||
37929162|NCT00742560|69616065|FG001|Overall Study|Investigator's Decision|0|||
37929163|NCT00742560|69616066|FG002|Overall Study|Investigator's Decision|4|||
37929164|NCT00742560|69616067|FG003|Overall Study|Investigator's Decision|1|||
37929165|NCT00742560|69616068|FG004|Overall Study|Investigator's Decision|0|||
37929166|NCT00742560|69616064|FG000|Overall Study|Disease Progression|1|||
37929167|NCT00742560|69616065|FG001|Overall Study|Disease Progression|0|||
37929168|NCT00742560|69616066|FG002|Overall Study|Disease Progression|5|||
37929169|NCT00742560|69616067|FG003|Overall Study|Disease Progression|17|||
37929170|NCT00742560|69616068|FG004|Overall Study|Disease Progression|16|||
37929171|NCT00742560|69616064|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
37929172|NCT00742560|69616065|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
37929173|NCT00742560|69616066|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
37929174|NCT00742560|69616067|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
37929175|NCT00742560|69616068|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
37929176|NCT00742560|69616064|FG000|Overall Study|Other|0|||
37929177|NCT00742560|69616065|FG001|Overall Study|Other|1|||
37929178|NCT00742560|69616066|FG002|Overall Study|Other|8|||
37929179|NCT00742560|69616067|FG003|Overall Study|Other|9|||
37929180|NCT00742560|69616068|FG004|Overall Study|Other|9|||
37929181|NCT00742560|69616064|FG000|Overall Study|MIssing|0|||
37929182|NCT00742560|69616065|FG001|Overall Study|MIssing|0|||
37929183|NCT00742560|69616066|FG002|Overall Study|MIssing|0|||
37929184|NCT00742560|69616067|FG003|Overall Study|MIssing|0|||
37929185|NCT00742560|69616068|FG004|Overall Study|MIssing|1|||
37929186|NCT00740220|69616099|FG000|Overall Study|screen failures (non-COPD patients)|9|||
37929187|NCT00796718|69616103|FG000|Overall Study|Adverse Event|2|||
37929188|NCT00796718|69616103|FG000|Overall Study|Exclusion Criteria|1|||
37929189|NCT00796718|69616103|FG000|Overall Study|Lost to Follow-up|5|||
37929190|NCT00796718|69616103|FG000|Overall Study|Withdrawal by Informed Consent|1|||
37929191|NCT00809159|69616111|FG000|Part 1|Adverse Event|1|||
37667743|NCT02148952|69140307|FG001|Follow-Up|Lost to Follow-up|231|||
37667744|NCT02148952|69140306|FG000|Follow-Up|Withdrawal by Subject|46|||
37667745|NCT02148952|69140307|FG001|Follow-Up|Withdrawal by Subject|48|||
37667746|NCT02148718|69140331|FG000|Overall Study|Protocol Violation|26|||
37667747|NCT02148718|69140331|FG000|Overall Study|Discontinued Study Prematurely|5|||
37667748|NCT02148250|69140335|FG000|Screening|Withdrawal by Subject|5|||
37929192|NCT00809159|69616112|FG001|Part 1|Adverse Event|1|||
37929193|NCT00809159|69616113|FG002|Part 1|Adverse Event|0|||
37760696|NCT02908685|69271570|FG002|Part 2 Confirmatory|Changed to Spinraza|0|||
37760697|NCT02908685|69271571|FG003|Part 2 Confirmatory|Changed to Spinraza|0|||
37760698|NCT02908685|69271572|FG004|Part 2 Confirmatory|Changed to Spinraza|0|||
37760699|NCT02908685|69271573|FG005|Part 2 Confirmatory|Changed to Spinraza|0|||
37760700|NCT02908685|69271574|FG006|Part 2 Confirmatory|Changed to Spinraza|0|||
37760701|NCT02908685|69271575|FG007|Part 2 Confirmatory|Changed to Spinraza|0|||
37929194|NCT00809159|69616114|FG003|Part 1|Adverse Event|0|||
37929195|NCT00809159|69616115|FG004|Part 1|Adverse Event|0|||
37929196|NCT00809159|69616116|FG005|Part 1|Adverse Event|0|||
37929197|NCT00809159|69616111|FG000|Part 1|Lost to Follow-up|1|||
37929198|NCT00809159|69616112|FG001|Part 1|Lost to Follow-up|0|||
37929199|NCT00809159|69616113|FG002|Part 1|Lost to Follow-up|0|||
37929200|NCT00809159|69616114|FG003|Part 1|Lost to Follow-up|0|||
37929201|NCT00809159|69616115|FG004|Part 1|Lost to Follow-up|0|||
37929202|NCT00809159|69616116|FG005|Part 1|Lost to Follow-up|0|||
37929203|NCT00809159|69616111|FG000|Part 1|Withdrawal by Subject|3|||
37929204|NCT00809159|69616112|FG001|Part 1|Withdrawal by Subject|1|||
37929205|NCT00809159|69616113|FG002|Part 1|Withdrawal by Subject|0|||
37929206|NCT00809159|69616114|FG003|Part 1|Withdrawal by Subject|0|||
37929207|NCT00809159|69616115|FG004|Part 1|Withdrawal by Subject|0|||
37929208|NCT00809159|69616116|FG005|Part 1|Withdrawal by Subject|0|||
37929209|NCT00809159|69616111|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
37929210|NCT00809159|69616112|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
37929211|NCT00809159|69616113|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
37929212|NCT00809159|69616114|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
37929213|NCT00809159|69616115|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
37929214|NCT00809159|69616116|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
37929215|NCT00809159|69616111|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
37929216|NCT00809159|69616112|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
37929217|NCT00809159|69616113|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
37929218|NCT00809159|69616114|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
37929219|NCT00809159|69616115|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
37929220|NCT00809159|69616116|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
37929221|NCT00809159|69616111|FG000|Part 1 and 2|Administrative problems|0|||
37929222|NCT00809159|69616112|FG001|Part 1 and 2|Administrative problems|0|||
37929223|NCT00809159|69616113|FG002|Part 1 and 2|Administrative problems|0|||
37929224|NCT00809159|69616114|FG003|Part 1 and 2|Administrative problems|1|||
37760702|NCT02908685|69271576|FG008|Part 2 Confirmatory|Changed to Spinraza|0|||
37929225|NCT00809159|69616115|FG004|Part 1 and 2|Administrative problems|0|||
37929226|NCT00809159|69616116|FG005|Part 1 and 2|Administrative problems|0|||
37929227|NCT00809159|69616111|FG000|Part 1 and 2|Adverse Event|0|||
37667749|NCT02148250|69140336|FG001|Screening|Withdrawal by Subject|0|||
37667750|NCT02147626|69140345|FG000|Overall Study|Lost to Follow-up|4|||
37667751|NCT02147626|69140346|FG001|Overall Study|Lost to Follow-up|4|||
37667752|NCT02147626|69140345|FG000|Overall Study|Pregnancy|1|||
37760703|NCT02908685|69271577|FG009|Part 2 Confirmatory|Changed to Spinraza|0|||
37760704|NCT02908685|69271578|FG010|Part 2 Confirmatory|Changed to Spinraza|2|||
37760705|NCT02908685|69271579|FG011|Part 2 Confirmatory|Changed to Spinraza|1|||
37760706|NCT02908685|69271568|FG000|Part 2 Confirmatory|Changed to other treatment|0|||
37929228|NCT00809159|69616112|FG001|Part 1 and 2|Adverse Event|0|||
37929229|NCT00809159|69616113|FG002|Part 1 and 2|Adverse Event|1|||
37929230|NCT00809159|69616114|FG003|Part 1 and 2|Adverse Event|0|||
37929231|NCT00809159|69616115|FG004|Part 1 and 2|Adverse Event|1|||
37929232|NCT00809159|69616116|FG005|Part 1 and 2|Adverse Event|1|||
37929233|NCT00809159|69616111|FG000|Part 1 and 2|Lost to Follow-up|0|||
37929234|NCT00809159|69616112|FG001|Part 1 and 2|Lost to Follow-up|0|||
37667753|NCT02147626|69140346|FG001|Overall Study|Pregnancy|2|||
37667754|NCT02147626|69140345|FG000|Overall Study|Withdrawal by Subject|0|||
37667755|NCT02147626|69140346|FG001|Overall Study|Withdrawal by Subject|1|||
37929235|NCT00809159|69616113|FG002|Part 1 and 2|Lost to Follow-up|1|||
37929236|NCT00809159|69616114|FG003|Part 1 and 2|Lost to Follow-up|1|||
37929237|NCT00809159|69616115|FG004|Part 1 and 2|Lost to Follow-up|0|||
37929238|NCT00809159|69616116|FG005|Part 1 and 2|Lost to Follow-up|0|||
37929239|NCT00809159|69616111|FG000|Part 1 and 2|Withdrawal by Subject|0|||
37929240|NCT00809159|69616112|FG001|Part 1 and 2|Withdrawal by Subject|0|||
37929241|NCT00809159|69616113|FG002|Part 1 and 2|Withdrawal by Subject|4|||
37929242|NCT00809159|69616114|FG003|Part 1 and 2|Withdrawal by Subject|0|||
37929243|NCT00809159|69616115|FG004|Part 1 and 2|Withdrawal by Subject|0|||
38033667|NCT03300050|69719696|FG004|Overall Study|Death|0|||
38033668|NCT03300050|69719692|FG000|Overall Study|Not Eligible at Randomization|0|||
38033669|NCT03300050|69719693|FG001|Overall Study|Not Eligible at Randomization|0|||
38033670|NCT03300050|69719694|FG002|Overall Study|Not Eligible at Randomization|1|||
38033671|NCT03300050|69719695|FG003|Overall Study|Not Eligible at Randomization|1|||
38033672|NCT03300050|69719696|FG004|Overall Study|Not Eligible at Randomization|0|||
38033673|NCT03725085|69719708|FG000|Overall Study|Lost to Follow-up|2|||
38033674|NCT02940392|69719713|FG000|Overall Study|Lost to Follow-up|3|||
38033675|NCT02940392|69719713|FG000|Overall Study|Retreatment|3|||
38033676|NCT02940392|69719713|FG000|Overall Study|Death|2|||
38033677|NCT03298412|69719726|FG000|Run-in Period|Other, Not Specified|1|||
38033678|NCT03298412|69719726|FG000|Run-in Period|Disease Progression|1|||
38033679|NCT03298412|69719726|FG000|Run-in Period|Ineligibility Determined|1|||
38033680|NCT03298412|69719726|FG000|Run-in Period|Decision by Sponsor|6|||
38033681|NCT03297398|69719733|FG000|Overall Study|Sponsor's decision|6|||
38033682|NCT03297398|69719734|FG001|Overall Study|Sponsor's decision|9|||
38033683|NCT03297398|69719735|FG002|Overall Study|Sponsor's decision|7|||
38033684|NCT03297398|69719733|FG000|Overall Study|Adverse Event|1|||
38033685|NCT03297398|69719734|FG001|Overall Study|Adverse Event|4|||
38033686|NCT03297398|69719735|FG002|Overall Study|Adverse Event|4|||
38033687|NCT03297398|69719733|FG000|Overall Study|Withdrawal by Subject|1|||
38033688|NCT03297398|69719734|FG001|Overall Study|Withdrawal by Subject|2|||
38033689|NCT03297398|69719735|FG002|Overall Study|Withdrawal by Subject|2|||
38033690|NCT03297398|69719733|FG000|Overall Study|Protocol Violation|0|||
38033691|NCT03297398|69719734|FG001|Overall Study|Protocol Violation|2|||
38033692|NCT03297398|69719735|FG002|Overall Study|Protocol Violation|0|||
38033693|NCT03297398|69719733|FG000|Overall Study|Physician Decision|0|||
38033694|NCT03297398|69719734|FG001|Overall Study|Physician Decision|0|||
38033695|NCT03297398|69719735|FG002|Overall Study|Physician Decision|1|||
38033696|NCT03297398|69719733|FG000|Overall Study|Lost to Follow-up|0|||
38033697|NCT03297398|69719734|FG001|Overall Study|Lost to Follow-up|0|||
38033698|NCT03297398|69719735|FG002|Overall Study|Lost to Follow-up|1|||
38033699|NCT03293654|69719746|FG000|Overall Study|Lost to Follow-up|0|||
38033700|NCT03293654|69719747|FG001|Overall Study|Lost to Follow-up|1|||
38033701|NCT03293654|69719748|FG002|Overall Study|Lost to Follow-up|0|||
38033702|NCT03312218|69719758|FG000|Overall Study|Never signed in to access the app|54|||
38033703|NCT03312218|69719759|FG001|Overall Study|Never signed in to access the app|58|||
38033704|NCT03930615|69719767|FG000|Overall Study|Death|9|||
38033705|NCT03930615|69719768|FG001|Overall Study|Death|3|||
38033706|NCT03930615|69719767|FG000|Overall Study|Lost to Follow-up|1|||
38033707|NCT03930615|69719768|FG001|Overall Study|Lost to Follow-up|2|||
38033708|NCT03930615|69719767|FG000|Overall Study|Physician Decision|3|||
38033709|NCT03930615|69719768|FG001|Overall Study|Physician Decision|4|||
38033710|NCT03930615|69719767|FG000|Overall Study|Withdrawal by Subject|13|||
37760707|NCT02908685|69271569|FG001|Part 2 Confirmatory|Changed to other treatment|0|||
37760708|NCT02908685|69271570|FG002|Part 2 Confirmatory|Changed to other treatment|0|||
38033711|NCT03930615|69719768|FG001|Overall Study|Withdrawal by Subject|2|||
38033712|NCT03930615|69719767|FG000|Overall Study|Not treated|1|||
38033713|NCT03930615|69719768|FG001|Overall Study|Not treated|1|||
38033714|NCT03292640|69719776|FG000|Overall Study|Withdrawal by Subject|17|||
38033715|NCT03292640|69719777|FG001|Overall Study|Withdrawal by Subject|16|||
38033716|NCT03292640|69719776|FG000|Overall Study|Adverse Event|20|||
38033717|NCT03292640|69719777|FG001|Overall Study|Adverse Event|2|||
38033718|NCT03292640|69719776|FG000|Overall Study|Lost to Follow-up|24|||
38033719|NCT03292640|69719777|FG001|Overall Study|Lost to Follow-up|24|||
38033720|NCT03292406|69719790|FG000|Overall Study|Progressive Disease|6|||
38033721|NCT03292406|69719791|FG001|Overall Study|Progressive Disease|3|||
38033722|NCT03292406|69719792|FG002|Overall Study|Progressive Disease|4|||
38033723|NCT03292406|69719790|FG000|Overall Study|Adverse Event|7|||
38033724|NCT03292406|69719791|FG001|Overall Study|Adverse Event|1|||
38033725|NCT03292406|69719792|FG002|Overall Study|Adverse Event|4|||
38033726|NCT03292406|69719790|FG000|Overall Study|Withdrawal by Subject|0|||
38033727|NCT03292406|69719791|FG001|Overall Study|Withdrawal by Subject|7|||
38033728|NCT03292406|69719792|FG002|Overall Study|Withdrawal by Subject|2|||
38033729|NCT03292406|69719790|FG000|Overall Study|Protocol Violation|0|||
38033730|NCT03292406|69719791|FG001|Overall Study|Protocol Violation|1|||
38033731|NCT03292406|69719792|FG002|Overall Study|Protocol Violation|1|||
38033732|NCT03292406|69719790|FG000|Overall Study|Other|0|||
38033733|NCT03292406|69719791|FG001|Overall Study|Other|1|||
38033734|NCT03292406|69719792|FG002|Overall Study|Other|2|||
38033735|NCT03292016|69719829|FG000|Second Washout|Adverse Event|0|||
38033736|NCT03292016|69719830|FG001|Second Washout|Adverse Event|1|||
38033737|NCT03292016|69719831|FG002|Second Washout|Adverse Event|0|||
38033738|NCT03292016|69719832|FG003|Second Washout|Adverse Event|0|||
38033739|NCT03292016|69719833|FG004|Second Washout|Adverse Event|0|||
38033740|NCT03292016|69719834|FG005|Second Washout|Adverse Event|0|||
37929244|NCT00809159|69616116|FG005|Part 1 and 2|Withdrawal by Subject|1|||
37929245|NCT00745368|69616130|FG000|Overall Study|Unable to provide sample|3|||
37929246|NCT00589472|69616134|FG000|Overall Study|Adverse Event|1|||
37929247|NCT00811577|69616140|FG000|Overall Study|Lost to Follow-up|7|||
37929248|NCT00811577|69616141|FG001|Overall Study|Lost to Follow-up|1|||
37929249|NCT00811577|69616140|FG000|Overall Study|Withdrawal by Subject|3|||
37929250|NCT00811577|69616141|FG001|Overall Study|Withdrawal by Subject|0|||
37929251|NCT00802178|69616190|FG000|Overall Study|Lack of Efficacy|36|||
37929252|NCT00802178|69616190|FG000|Overall Study|Insufficient tolerability (IT)|17|||
37929253|NCT00802178|69616190|FG000|Overall Study|Withdrawal by Subject|18|||
37929254|NCT00802178|69616190|FG000|Overall Study|Other|32|||
37929255|NCT00802178|69616190|FG000|Overall Study|Lack of efficacy and patient wish|1|||
37929256|NCT00802178|69616190|FG000|Overall Study|IT and patient wish|8|||
37929257|NCT00802178|69616190|FG000|Overall Study|Patients wish and other reason|1|||
37929258|NCT00744978|69616196|FG000|Period 1|Lost to Follow-up|1|||
37929259|NCT00744978|69616197|FG001|Period 1|Lost to Follow-up|0|||
37929260|NCT00744978|69616196|FG000|Period 1|Withdrawal by Subject|0|||
37929261|NCT00744978|69616197|FG001|Period 1|Withdrawal by Subject|2|||
37929262|NCT00744978|69616196|FG000|Period 1|Other|0|||
37929263|NCT00744978|69616197|FG001|Period 1|Other|2|||
37929264|NCT00744978|69616196|FG000|Period 1|Adverse Event|4|||
37929265|NCT00744978|69616197|FG001|Period 1|Adverse Event|0|||
37929266|NCT00744978|69616196|FG000|Period 1|Randomized but not Treated|1|||
37929267|NCT00744978|69616197|FG001|Period 1|Randomized but not Treated|1|||
37929268|NCT00744978|69616196|FG000|Period 2|Adverse Event|0|||
37929269|NCT00744978|69616197|FG001|Period 2|Adverse Event|1|||
37929270|NCT00739908|69616205|FG000|Overall Study|Adverse Event|5|||
37929271|NCT00739908|69616206|FG001|Overall Study|Adverse Event|6|||
37929272|NCT00739908|69616205|FG000|Overall Study|Withdrawal by Subject|4|||
37929273|NCT00739908|69616206|FG001|Overall Study|Withdrawal by Subject|2|||
37929274|NCT00739908|69616205|FG000|Overall Study|Lost to Follow-up|14|||
37929275|NCT00739908|69616206|FG001|Overall Study|Lost to Follow-up|9|||
37929276|NCT00739908|69616205|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
37929277|NCT00739908|69616206|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
37929278|NCT00739908|69616205|FG000|Overall Study|Non-Compliance With Study Medication|0|||
37929279|NCT00739908|69616206|FG001|Overall Study|Non-Compliance With Study Medication|3|||
37929280|NCT00739908|69616205|FG000|Overall Study|Lack of Efficacy|0|||
37929281|NCT00739908|69616206|FG001|Overall Study|Lack of Efficacy|1|||
37929282|NCT00739908|69616205|FG000|Overall Study|Relocation|0|||
37929283|NCT00739908|69616206|FG001|Overall Study|Relocation|1|||
37929284|NCT00739596|69616216|FG000|Overall Study|Adverse Event|12|||
37929285|NCT00739596|69616217|FG001|Overall Study|Adverse Event|6|||
38033741|NCT03290300|69719842|FG000|Overall Study|Lost to Follow-up|3|||
38033742|NCT03289676|69719855|FG000|Overall Study|Withdrawal by Subject|2|||
38033743|NCT03289676|69719856|FG001|Overall Study|Withdrawal by Subject|0|||
37760709|NCT02908685|69271571|FG003|Part 2 Confirmatory|Changed to other treatment|0|||
37760710|NCT02908685|69271572|FG004|Part 2 Confirmatory|Changed to other treatment|0|||
37760711|NCT02908685|69271573|FG005|Part 2 Confirmatory|Changed to other treatment|0|||
37760712|NCT02908685|69271574|FG006|Part 2 Confirmatory|Changed to other treatment|0|||
37760713|NCT02908685|69271575|FG007|Part 2 Confirmatory|Changed to other treatment|0|||
37760714|NCT02908685|69271576|FG008|Part 2 Confirmatory|Changed to other treatment|0|||
38033744|NCT03289676|69719855|FG000|Overall Study|Protocol Violation|2|||
38033745|NCT03289676|69719856|FG001|Overall Study|Protocol Violation|0|||
38033746|NCT03289676|69719855|FG000|Overall Study|Lost to Follow-up|0|||
37667756|NCT02172664|69140352|FG000|Overall Study|Lost to Follow-up|4|||
37667757|NCT02172664|69140353|FG001|Overall Study|Lost to Follow-up|4|||
37667758|NCT02172664|69140352|FG000|Overall Study|Death|1|||
37667759|NCT02172664|69140353|FG001|Overall Study|Death|1|||
37667760|NCT02172664|69140352|FG000|Overall Study|Moved out of area|1|||
37667761|NCT02172664|69140353|FG001|Overall Study|Moved out of area|1|||
37667762|NCT02172040|69140362|FG000|Overall Study|Adverse Event|0|||
37667763|NCT02172040|69140363|FG001|Overall Study|Adverse Event|2|||
37667764|NCT02172040|69140364|FG002|Overall Study|Adverse Event|0|||
37667765|NCT02172040|69140365|FG003|Overall Study|Adverse Event|0|||
37760715|NCT02908685|69271577|FG009|Part 2 Confirmatory|Changed to other treatment|0|||
37760716|NCT02908685|69271578|FG010|Part 2 Confirmatory|Changed to other treatment|1|||
37929286|NCT00739596|69616216|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
37667766|NCT02172040|69140362|FG000|Overall Study|Protocol Violation|0|||
37929287|NCT00739596|69616217|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
37929288|NCT00739596|69616216|FG000|Overall Study|Patient Withdrew Consent|8|||
37929289|NCT00739596|69616217|FG001|Overall Study|Patient Withdrew Consent|8|||
37929290|NCT00739596|69616216|FG000|Overall Study|Lost to Follow-up|0|||
37929291|NCT00739596|69616217|FG001|Overall Study|Lost to Follow-up|2|||
37929292|NCT00739596|69616216|FG000|Overall Study|Protocol Deviation|1|||
37929293|NCT00739596|69616217|FG001|Overall Study|Protocol Deviation|1|||
37929294|NCT00742326|69616225|FG000|Overall Study|Physician Decision|0|||
37929295|NCT00742326|69616226|FG001|Overall Study|Physician Decision|1|||
37929296|NCT00741936|69616234|FG000|Overall Study|Lost to Follow-up|1|||
37929297|NCT00741936|69616235|FG001|Overall Study|Lost to Follow-up|1|||
37929298|NCT00741936|69616234|FG000|Overall Study|Adverse Event|3|||
37929299|NCT00741936|69616235|FG001|Overall Study|Adverse Event|4|||
37929300|NCT00741936|69616234|FG000|Overall Study|Pregnancy|0|||
37929301|NCT00741936|69616235|FG001|Overall Study|Pregnancy|1|||
37929302|NCT00741936|69616234|FG000|Overall Study|Protocol Violation|2|||
37929303|NCT00741936|69616235|FG001|Overall Study|Protocol Violation|0|||
37929304|NCT00741936|69616234|FG000|Overall Study|Lack of Efficacy|0|||
37929305|NCT00741936|69616235|FG001|Overall Study|Lack of Efficacy|2|||
37929306|NCT00741936|69616234|FG000|Overall Study|Low compliance|3|||
37929307|NCT00741936|69616235|FG001|Overall Study|Low compliance|0|||
37929308|NCT00811187|69616243|FG000|Overall Study|Unable to place device / procedure abort|3|||
37929309|NCT00811187|69616244|FG001|Overall Study|Unable to place device / procedure abort|3|||
37929310|NCT00591149|69616250|FG000|Overall Study|Adverse Event|4|||
37929311|NCT00591149|69616250|FG000|Overall Study|Withdrawal by Subject|1|||
37929312|NCT00735072|69616256|FG000|Overall Study|interrupted study med during ARV change|1|||
37929313|NCT00735072|69616257|FG001|Overall Study|interrupted study med during ARV change|0|||
37929314|NCT00735072|69616256|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
37929315|NCT00735072|69616257|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
37929316|NCT00810641|69616268|FG000|Overall Study|Withdrawal by Subject|0|||
37667767|NCT02172040|69140363|FG001|Overall Study|Protocol Violation|1|||
37667768|NCT02172040|69140364|FG002|Overall Study|Protocol Violation|0|||
37667769|NCT02172040|69140365|FG003|Overall Study|Protocol Violation|0|||
37667770|NCT02172040|69140362|FG000|Overall Study|Withdrawal by Subject|0|||
37667771|NCT02172040|69140363|FG001|Overall Study|Withdrawal by Subject|0|||
37667772|NCT02172040|69140364|FG002|Overall Study|Withdrawal by Subject|1|||
37667773|NCT02172040|69140365|FG003|Overall Study|Withdrawal by Subject|0|||
37667774|NCT02172040|69140362|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
37667775|NCT02172040|69140363|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
37667776|NCT02172040|69140364|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
37667777|NCT02172040|69140365|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
37667778|NCT02172040|69140362|FG000|Overall Study|Family emergency abroad|0|||
37667779|NCT02172040|69140363|FG001|Overall Study|Family emergency abroad|0|||
37667780|NCT02172040|69140364|FG002|Overall Study|Family emergency abroad|0|||
37667781|NCT02172040|69140365|FG003|Overall Study|Family emergency abroad|1|||
37667782|NCT02112994|69140391|FG000|Overall Study|Progressive Disease|0|||
37667783|NCT02112994|69140392|FG001|Overall Study|Progressive Disease|0|||
37667784|NCT02112994|69140393|FG002|Overall Study|Progressive Disease|1|||
37667785|NCT02112994|69140391|FG000|Overall Study|Pregnancy|0|||
37667786|NCT02112994|69140392|FG001|Overall Study|Pregnancy|1|||
37667787|NCT02112994|69140393|FG002|Overall Study|Pregnancy|1|||
37667788|NCT02112994|69140391|FG000|Overall Study|Liver Transplant|0|||
37667789|NCT02112994|69140392|FG001|Overall Study|Liver Transplant|1|||
37667790|NCT02112994|69140393|FG002|Overall Study|Liver Transplant|0|||
37667791|NCT02112994|69140391|FG000|Overall Study|Withdrawal by Subject|0|||
37667792|NCT02112994|69140392|FG001|Overall Study|Withdrawal by Subject|0|||
37667793|NCT02112994|69140393|FG002|Overall Study|Withdrawal by Subject|1|||
37667794|NCT02147158|69140411|FG000|Treatment Course 1|Adverse Event|1|||
37667795|NCT02147158|69140412|FG001|Treatment Course 1|Adverse Event|4|||
37667796|NCT02147158|69140413|FG002|Treatment Course 1|Adverse Event|3|||
37929317|NCT00810641|69616269|FG001|Overall Study|Withdrawal by Subject|1|||
37929318|NCT00810641|69616270|FG002|Overall Study|Withdrawal by Subject|2|||
37929319|NCT00793598|69616283|FG000|Overall Study|Patient Request|0|||
37929320|NCT00793598|69616284|FG001|Overall Study|Patient Request|1|||
37929321|NCT00793598|69616285|FG002|Overall Study|Patient Request|0|||
37929322|NCT00793598|69616286|FG003|Overall Study|Patient Request|0|||
37929323|NCT00793598|69616287|FG004|Overall Study|Patient Request|0|||
37929324|NCT00793598|69616288|FG005|Overall Study|Patient Request|0|||
37929325|NCT00793598|69616289|FG006|Overall Study|Patient Request|0|||
37929326|NCT00793598|69616290|FG007|Overall Study|Patient Request|0|||
37929327|NCT00793598|69616283|FG000|Overall Study|Protocol Violation|0|||
37929328|NCT00793598|69616284|FG001|Overall Study|Protocol Violation|0|||
37929329|NCT00793598|69616285|FG002|Overall Study|Protocol Violation|0|||
37667797|NCT02147158|69140414|FG003|Treatment Course 1|Adverse Event|4|||
37667798|NCT02147158|69140415|FG004|Treatment Course 1|Adverse Event|1|||
37667799|NCT02147158|69140416|FG005|Treatment Course 1|Adverse Event|2|||
37667800|NCT02147158|69140411|FG000|Treatment Course 1|Lost to Follow-up|2|||
37667801|NCT02147158|69140412|FG001|Treatment Course 1|Lost to Follow-up|4|||
37667802|NCT02147158|69140413|FG002|Treatment Course 1|Lost to Follow-up|3|||
37667803|NCT02147158|69140414|FG003|Treatment Course 1|Lost to Follow-up|3|||
37929330|NCT00793598|69616286|FG003|Overall Study|Protocol Violation|0|||
37929331|NCT00793598|69616287|FG004|Overall Study|Protocol Violation|0|||
37929332|NCT00793598|69616288|FG005|Overall Study|Protocol Violation|0|||
37929333|NCT00793598|69616289|FG006|Overall Study|Protocol Violation|0|||
37929334|NCT00793598|69616290|FG007|Overall Study|Protocol Violation|1|||
37929335|NCT00793598|69616283|FG000|Overall Study|Subject not dosed|0|||
37929336|NCT00793598|69616284|FG001|Overall Study|Subject not dosed|0|||
37929337|NCT00793598|69616285|FG002|Overall Study|Subject not dosed|0|||
37760717|NCT02908685|69271579|FG011|Part 2 Confirmatory|Changed to other treatment|0|||
37760718|NCT02772276|69271609|FG000|Overall Study|Lost to Follow-up|0|||
37760719|NCT02772276|69271610|FG001|Overall Study|Lost to Follow-up|0|||
37760720|NCT02772276|69271611|FG002|Overall Study|Lost to Follow-up|0|||
37760721|NCT02772276|69271612|FG003|Overall Study|Lost to Follow-up|0|||
37929338|NCT00793598|69616286|FG003|Overall Study|Subject not dosed|0|||
37929339|NCT00793598|69616287|FG004|Overall Study|Subject not dosed|0|||
37929340|NCT00793598|69616288|FG005|Overall Study|Subject not dosed|1|||
37929341|NCT00793598|69616289|FG006|Overall Study|Subject not dosed|0|||
37929342|NCT00793598|69616290|FG007|Overall Study|Subject not dosed|0|||
37929343|NCT00796562|69616312|FG000|Overall Study|Death|49|||
37929344|NCT00801632|69616316|FG000|Overall Study|Re-transplant|1|||
37929345|NCT00806819|69616322|FG000|Overall Study|progressive disease (modified RECIST )|217|||
37929346|NCT00806819|69616323|FG001|Overall Study|progressive disease (modified RECIST )|216|||
37929347|NCT00806819|69616322|FG000|Overall Study|Worsening or AE of underlying disease|18|||
37929348|NCT00806819|69616323|FG001|Overall Study|Worsening or AE of underlying disease|25|||
37929349|NCT00806819|69616322|FG000|Overall Study|Other AE|38|||
37929350|NCT00806819|69616323|FG001|Overall Study|Other AE|40|||
37929351|NCT00806819|69616322|FG000|Overall Study|Protocol Violation|9|||
37929352|NCT00806819|69616323|FG001|Overall Study|Protocol Violation|4|||
37929353|NCT00806819|69616322|FG000|Overall Study|Lost to Follow-up|1|||
37929354|NCT00806819|69616323|FG001|Overall Study|Lost to Follow-up|0|||
37929355|NCT00806819|69616322|FG000|Overall Study|Withdrawal by Subject|32|||
37929356|NCT00806819|69616323|FG001|Overall Study|Withdrawal by Subject|29|||
37929357|NCT00806819|69616322|FG000|Overall Study|Not treated|6|||
37929358|NCT00806819|69616323|FG001|Overall Study|Not treated|3|||
37929359|NCT00806819|69616322|FG000|Overall Study|Reasons other than stated above|25|||
37929360|NCT00806819|69616323|FG001|Overall Study|Reasons other than stated above|41|||
37929361|NCT00801242|69616330|FG000|Overall Study|Adverse Event|10|||
37929362|NCT00801242|69616330|FG000|Overall Study|Withdrawal by Subject|13|||
37929363|NCT00801242|69616330|FG000|Overall Study|Protocol Violation|5|||
37929364|NCT00801242|69616330|FG000|Overall Study|Physician Decision|3|||
37929365|NCT00801242|69616330|FG000|Overall Study|Lost to Follow-up|1|||
37929366|NCT00801242|69616330|FG000|Overall Study|Miscellaneous reasons|20|||
37929367|NCT00800540|69616343|FG000|Period One: 6 Weeks|Noncompliance|1|||
37929368|NCT00800540|69616344|FG001|Period One: 6 Weeks|Noncompliance|0|||
37929369|NCT00800540|69616343|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
37929370|NCT00800540|69616344|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
37929371|NCT00800540|69616343|FG000|Period 2: 6 Weeks|Adverse Event|0|||
37929372|NCT00800540|69616344|FG001|Period 2: 6 Weeks|Adverse Event|1|||
37929373|NCT00800384|69616352|FG000|Overall Study|Withdrawal by Subject|24|||
37929374|NCT00800384|69616353|FG001|Overall Study|Withdrawal by Subject|17|||
37929375|NCT00800384|69616352|FG000|Overall Study|Lost to Follow-up|17|||
37929376|NCT00800384|69616353|FG001|Overall Study|Lost to Follow-up|26|||
37929377|NCT00796328|69616360|FG000|Overall Study|experienced hypotension requiring tx|6|||
37929378|NCT00588692|69616366|FG000|Overall Study|Withdrawal by Subject|4|||
37929379|NCT00588692|69616367|FG001|Overall Study|Withdrawal by Subject|2|||
37929380|NCT00588692|69616366|FG000|Overall Study|Hip Surgery|0|||
37929381|NCT00588692|69616367|FG001|Overall Study|Hip Surgery|1|||
37929382|NCT00588692|69616366|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
37929383|NCT00588692|69616367|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
37929384|NCT00588692|69616366|FG000|Overall Study|Cancer|1|||
37929385|NCT00588692|69616367|FG001|Overall Study|Cancer|0|||
37929386|NCT00588692|69616366|FG000|Overall Study|Death|1|||
37929387|NCT00588692|69616367|FG001|Overall Study|Death|0|||
37929388|NCT00588146|69616375|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
37929389|NCT00588146|69616376|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
37929390|NCT00795704|69616384|FG000|Overall Study|Withdrawal by Subject|3|||
37929391|NCT00795704|69616385|FG001|Overall Study|Withdrawal by Subject|2|||
37929392|NCT00795704|69616384|FG000|Overall Study|Adverse Event|1|||
37929393|NCT00795704|69616385|FG001|Overall Study|Adverse Event|1|||
37667804|NCT02147158|69140415|FG004|Treatment Course 1|Lost to Follow-up|2|||
37667805|NCT02147158|69140416|FG005|Treatment Course 1|Lost to Follow-up|4|||
37667806|NCT02147158|69140411|FG000|Treatment Course 1|Protocol Violation|0|||
37667807|NCT02147158|69140412|FG001|Treatment Course 1|Protocol Violation|0|||
37667808|NCT02147158|69140413|FG002|Treatment Course 1|Protocol Violation|1|||
37929394|NCT00444457|69616395|FG000|Infant Series|Other|0|||
37929395|NCT00444457|69616396|FG001|Infant Series|Other|1|||
37929396|NCT00444457|69616397|FG002|Infant Series|Other|0|||
37929397|NCT00444457|69616398|FG003|Infant Series|Other|0|||
37929398|NCT00444457|69616395|FG000|Infant Series|Parent or legal guardian request|18|||
37760722|NCT02772276|69271613|FG004|Overall Study|Lost to Follow-up|0|||
37929399|NCT00444457|69616396|FG001|Infant Series|Parent or legal guardian request|29|||
37929400|NCT00444457|69616397|FG002|Infant Series|Parent or legal guardian request|34|||
37929401|NCT00444457|69616398|FG003|Infant Series|Parent or legal guardian request|14|||
37929402|NCT00444457|69616395|FG000|Infant Series|Lost to Follow-up|10|||
37929403|NCT00444457|69616396|FG001|Infant Series|Lost to Follow-up|11|||
37929404|NCT00444457|69616397|FG002|Infant Series|Lost to Follow-up|7|||
37667809|NCT02147158|69140414|FG003|Treatment Course 1|Protocol Violation|1|||
37667810|NCT02147158|69140415|FG004|Treatment Course 1|Protocol Violation|0|||
37667811|NCT02147158|69140416|FG005|Treatment Course 1|Protocol Violation|0|||
37667812|NCT02147158|69140411|FG000|Treatment Course 1|Withdrawal of Consent|1|||
37667813|NCT02147158|69140412|FG001|Treatment Course 1|Withdrawal of Consent|1|||
37667814|NCT02147158|69140413|FG002|Treatment Course 1|Withdrawal of Consent|1|||
37667815|NCT02147158|69140414|FG003|Treatment Course 1|Withdrawal of Consent|5|||
37667816|NCT02147158|69140415|FG004|Treatment Course 1|Withdrawal of Consent|3|||
37667817|NCT02147158|69140416|FG005|Treatment Course 1|Withdrawal of Consent|2|||
37667818|NCT02147158|69140411|FG000|Off-Treatment Interval 1|Adverse Event|1|||
37667819|NCT02147158|69140412|FG001|Off-Treatment Interval 1|Adverse Event|0|||
37667820|NCT02147158|69140413|FG002|Off-Treatment Interval 1|Adverse Event|0|||
37667821|NCT02147158|69140414|FG003|Off-Treatment Interval 1|Adverse Event|1|||
37667822|NCT02147158|69140415|FG004|Off-Treatment Interval 1|Adverse Event|0|||
37667823|NCT02147158|69140416|FG005|Off-Treatment Interval 1|Adverse Event|0|||
37667824|NCT02147158|69140411|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
37667825|NCT02147158|69140412|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
37667826|NCT02147158|69140413|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
37667827|NCT02147158|69140414|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
37667828|NCT02147158|69140415|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
37667829|NCT02147158|69140416|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
37667830|NCT02147158|69140411|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
37667831|NCT02147158|69140412|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
37667832|NCT02147158|69140413|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
37667833|NCT02147158|69140414|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
37667834|NCT02147158|69140415|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
37667835|NCT02147158|69140416|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
37667836|NCT02147158|69140411|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
37667837|NCT02147158|69140412|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
37667838|NCT02147158|69140413|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
37667839|NCT02147158|69140414|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
37667840|NCT02147158|69140415|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
37667841|NCT02147158|69140416|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
37667842|NCT02147158|69140411|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
37667843|NCT02147158|69140412|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
37667844|NCT02147158|69140413|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
37667845|NCT02147158|69140414|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
37667846|NCT02147158|69140415|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
37667847|NCT02147158|69140416|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
37667848|NCT02147158|69140411|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
37667849|NCT02147158|69140412|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
37667850|NCT02147158|69140413|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
37667851|NCT02147158|69140414|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
37667852|NCT02147158|69140415|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
37667853|NCT02147158|69140416|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
37667854|NCT02147158|69140411|FG000|Treatment Course 2|Adverse Event|0|||
37667855|NCT02147158|69140412|FG001|Treatment Course 2|Adverse Event|4|||
37667856|NCT02147158|69140413|FG002|Treatment Course 2|Adverse Event|2|||
37667857|NCT02147158|69140414|FG003|Treatment Course 2|Adverse Event|1|||
37667858|NCT02147158|69140415|FG004|Treatment Course 2|Adverse Event|0|||
37667859|NCT02147158|69140416|FG005|Treatment Course 2|Adverse Event|1|||
37667860|NCT02147158|69140411|FG000|Treatment Course 2|Withdrawal of Consent|0|||
37667861|NCT02147158|69140412|FG001|Treatment Course 2|Withdrawal of Consent|1|||
37667862|NCT02147158|69140413|FG002|Treatment Course 2|Withdrawal of Consent|2|||
37667863|NCT02147158|69140414|FG003|Treatment Course 2|Withdrawal of Consent|3|||
37667864|NCT02147158|69140415|FG004|Treatment Course 2|Withdrawal of Consent|0|||
37929405|NCT00444457|69616398|FG003|Infant Series|Lost to Follow-up|6|||
37929406|NCT00444457|69616395|FG000|Infant Series|Protocol Violation|16|||
37929407|NCT00444457|69616396|FG001|Infant Series|Protocol Violation|8|||
37929408|NCT00444457|69616397|FG002|Infant Series|Protocol Violation|6|||
37929409|NCT00444457|69616398|FG003|Infant Series|Protocol Violation|3|||
37929410|NCT00444457|69616395|FG000|Infant Series|Failed to return|5|||
37667865|NCT02147158|69140416|FG005|Treatment Course 2|Withdrawal of Consent|0|||
37667866|NCT02147158|69140411|FG000|Treatment Course 2|Lost to Follow-up|1|||
37667867|NCT02147158|69140412|FG001|Treatment Course 2|Lost to Follow-up|0|||
37667868|NCT02147158|69140413|FG002|Treatment Course 2|Lost to Follow-up|1|||
37667869|NCT02147158|69140414|FG003|Treatment Course 2|Lost to Follow-up|1|||
37667870|NCT02147158|69140415|FG004|Treatment Course 2|Lost to Follow-up|0|||
37667871|NCT02147158|69140416|FG005|Treatment Course 2|Lost to Follow-up|1|||
37929411|NCT00444457|69616396|FG001|Infant Series|Failed to return|4|||
37667872|NCT02147158|69140411|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
37667873|NCT02147158|69140412|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
37929412|NCT00444457|69616397|FG002|Infant Series|Failed to return|4|||
37929413|NCT00444457|69616398|FG003|Infant Series|Failed to return|2|||
37929414|NCT00444457|69616395|FG000|Infant Series|Investigator request|4|||
37929415|NCT00444457|69616396|FG001|Infant Series|Investigator request|3|||
37929416|NCT00444457|69616397|FG002|Infant Series|Investigator request|3|||
37929417|NCT00444457|69616398|FG003|Infant Series|Investigator request|2|||
37929418|NCT00444457|69616395|FG000|Infant Series|Other|0|||
37929419|NCT00444457|69616396|FG001|Infant Series|Other|2|||
37929420|NCT00444457|69616397|FG002|Infant Series|Other|4|||
37929421|NCT00444457|69616398|FG003|Infant Series|Other|0|||
37929422|NCT00444457|69616395|FG000|Infant Series|Adverse Event|1|||
37929423|NCT00444457|69616396|FG001|Infant Series|Adverse Event|2|||
37929424|NCT00444457|69616397|FG002|Infant Series|Adverse Event|2|||
37929425|NCT00444457|69616398|FG003|Infant Series|Adverse Event|0|||
37929426|NCT00444457|69616395|FG000|Infant Series|Death|0|||
37929427|NCT00444457|69616396|FG001|Infant Series|Death|1|||
37929428|NCT00444457|69616397|FG002|Infant Series|Death|1|||
37929429|NCT00444457|69616398|FG003|Infant Series|Death|1|||
37929430|NCT00444457|69616395|FG000|After Infant Series|Other|0|||
37929431|NCT00444457|69616396|FG001|After Infant Series|Other|1|||
37929432|NCT00444457|69616397|FG002|After Infant Series|Other|1|||
37929433|NCT00444457|69616398|FG003|After Infant Series|Other|1|||
37929434|NCT00444457|69616395|FG000|After Infant Series|Parent or legal guardian request|4|||
37929435|NCT00444457|69616396|FG001|After Infant Series|Parent or legal guardian request|11|||
37929436|NCT00444457|69616397|FG002|After Infant Series|Parent or legal guardian request|6|||
37929437|NCT00444457|69616398|FG003|After Infant Series|Parent or legal guardian request|3|||
37929438|NCT00444457|69616395|FG000|After Infant Series|Failed to return|7|||
37929439|NCT00444457|69616396|FG001|After Infant Series|Failed to return|6|||
37929440|NCT00444457|69616397|FG002|After Infant Series|Failed to return|5|||
37929441|NCT00444457|69616398|FG003|After Infant Series|Failed to return|1|||
37760723|NCT02772276|69271614|FG005|Overall Study|Lost to Follow-up|0|||
37760724|NCT02772276|69271615|FG006|Overall Study|Lost to Follow-up|1|||
37760725|NCT02772276|69271616|FG007|Overall Study|Lost to Follow-up|0|||
37760726|NCT02772276|69271617|FG008|Overall Study|Lost to Follow-up|0|||
37760727|NCT02772276|69271618|FG009|Overall Study|Lost to Follow-up|0|||
37760728|NCT02772276|69271619|FG010|Overall Study|Lost to Follow-up|0|||
37760729|NCT02772276|69271620|FG011|Overall Study|Lost to Follow-up|0|||
37760730|NCT02772276|69271621|FG012|Overall Study|Lost to Follow-up|0|||
37760731|NCT02772276|69271609|FG000|Overall Study|Withdrew consent|0|||
37760732|NCT02772276|69271610|FG001|Overall Study|Withdrew consent|0|||
37760733|NCT02772276|69271611|FG002|Overall Study|Withdrew consent|0|||
37760734|NCT02772276|69271612|FG003|Overall Study|Withdrew consent|0|||
37760735|NCT02772276|69271613|FG004|Overall Study|Withdrew consent|0|||
37760736|NCT02772276|69271614|FG005|Overall Study|Withdrew consent|0|||
37760737|NCT02772276|69271615|FG006|Overall Study|Withdrew consent|0|||
37760738|NCT02772276|69271616|FG007|Overall Study|Withdrew consent|1|||
37760739|NCT02772276|69271617|FG008|Overall Study|Withdrew consent|0|||
37760740|NCT02772276|69271618|FG009|Overall Study|Withdrew consent|0|||
37760741|NCT02772276|69271619|FG010|Overall Study|Withdrew consent|0|||
37929442|NCT00444457|69616395|FG000|After Infant Series|Lost to Follow-up|5|||
37929443|NCT00444457|69616396|FG001|After Infant Series|Lost to Follow-up|5|||
37929444|NCT00444457|69616397|FG002|After Infant Series|Lost to Follow-up|5|||
37929445|NCT00444457|69616398|FG003|After Infant Series|Lost to Follow-up|2|||
37929446|NCT00444457|69616395|FG000|After Infant Series|Protocol Violation|2|||
37929447|NCT00444457|69616396|FG001|After Infant Series|Protocol Violation|4|||
37929448|NCT00444457|69616397|FG002|After Infant Series|Protocol Violation|2|||
37929449|NCT00444457|69616398|FG003|After Infant Series|Protocol Violation|2|||
37929450|NCT00444457|69616395|FG000|After Infant Series|Adverse Event|2|||
37929451|NCT00444457|69616396|FG001|After Infant Series|Adverse Event|2|||
37929452|NCT00444457|69616397|FG002|After Infant Series|Adverse Event|0|||
37929453|NCT00444457|69616398|FG003|After Infant Series|Adverse Event|0|||
37929454|NCT00444457|69616395|FG000|After Infant Series|Investigator request|0|||
37929455|NCT00444457|69616396|FG001|After Infant Series|Investigator request|0|||
37929456|NCT00444457|69616397|FG002|After Infant Series|Investigator request|0|||
37929457|NCT00444457|69616398|FG003|After Infant Series|Investigator request|1|||
37929458|NCT00444457|69616395|FG000|After Infant Series|Other|0|||
37929459|NCT00444457|69616396|FG001|After Infant Series|Other|1|||
37929460|NCT00444457|69616397|FG002|After Infant Series|Other|0|||
37929461|NCT00444457|69616398|FG003|After Infant Series|Other|0|||
37929462|NCT00444457|69616395|FG000|Toddler Dose|Lost to Follow-up|4|||
37929463|NCT00444457|69616396|FG001|Toddler Dose|Lost to Follow-up|1|||
37760742|NCT02772276|69271620|FG011|Overall Study|Withdrew consent|0|||
37760743|NCT02772276|69271621|FG012|Overall Study|Withdrew consent|0|||
37760744|NCT02601313|69271674|FG000|Overall Study|Death|2|||
37760745|NCT02601313|69271675|FG001|Overall Study|Death|16|||
37760746|NCT02601313|69271676|FG002|Overall Study|Death|4|||
37760747|NCT02601313|69271674|FG000|Overall Study|Enrolled, did not initiate CTE/KTE-X19|0|||
37929464|NCT00444457|69616397|FG002|Toddler Dose|Lost to Follow-up|1|||
37929465|NCT00444457|69616398|FG003|Toddler Dose|Lost to Follow-up|3|||
37929466|NCT00444457|69616395|FG000|Toddler Dose|Failed to return|2|||
37929467|NCT00444457|69616396|FG001|Toddler Dose|Failed to return|2|||
37929468|NCT00444457|69616397|FG002|Toddler Dose|Failed to return|1|||
37929469|NCT00444457|69616398|FG003|Toddler Dose|Failed to return|3|||
37929470|NCT00444457|69616395|FG000|Toddler Dose|Parent or legal guardian request|0|||
37929471|NCT00444457|69616396|FG001|Toddler Dose|Parent or legal guardian request|3|||
37929472|NCT00444457|69616397|FG002|Toddler Dose|Parent or legal guardian request|2|||
37929473|NCT00444457|69616398|FG003|Toddler Dose|Parent or legal guardian request|1|||
37929474|NCT00444457|69616395|FG000|Toddler Dose|Protocol Violation|1|||
37929475|NCT00444457|69616396|FG001|Toddler Dose|Protocol Violation|0|||
37929476|NCT00444457|69616397|FG002|Toddler Dose|Protocol Violation|0|||
37929477|NCT00444457|69616398|FG003|Toddler Dose|Protocol Violation|1|||
37929478|NCT00799058|69616422|FG000|Overall Study|Withdrawal by Subject|2|||
37929479|NCT00799058|69616423|FG001|Overall Study|Withdrawal by Subject|2|||
37929480|NCT00799058|69616424|FG002|Overall Study|Withdrawal by Subject|2|||
37929481|NCT00799058|69616422|FG000|Overall Study|Lost to Follow-up|1|||
37929482|NCT00799058|69616423|FG001|Overall Study|Lost to Follow-up|2|||
37929483|NCT00799058|69616424|FG002|Overall Study|Lost to Follow-up|1|||
37929484|NCT00799058|69616422|FG000|Overall Study|Adverse Event|0|||
37929485|NCT00799058|69616423|FG001|Overall Study|Adverse Event|2|||
37929486|NCT00799058|69616424|FG002|Overall Study|Adverse Event|0|||
37929487|NCT00799058|69616422|FG000|Overall Study|Pregnancy|1|||
37929488|NCT00799058|69616423|FG001|Overall Study|Pregnancy|0|||
37929489|NCT00799058|69616424|FG002|Overall Study|Pregnancy|0|||
37929490|NCT00799058|69616422|FG000|Overall Study|Not adherent|3|||
37929491|NCT00799058|69616423|FG001|Overall Study|Not adherent|2|||
37929492|NCT00799058|69616424|FG002|Overall Study|Not adherent|1|||
37929493|NCT00799058|69616422|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
37929494|NCT00799058|69616423|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
37929495|NCT00799058|69616424|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
37929496|NCT00799058|69616422|FG000|Overall Study|IP dispensing error|1|||
37929497|NCT00799058|69616423|FG001|Overall Study|IP dispensing error|0|||
37929498|NCT00799058|69616424|FG002|Overall Study|IP dispensing error|0|||
37929499|NCT00799058|69616422|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
37929500|NCT00799058|69616423|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
37929501|NCT00799058|69616424|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
37929502|NCT00799058|69616422|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
37929503|NCT00799058|69616423|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
37929504|NCT00799058|69616424|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
37929505|NCT00799058|69616422|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
37929506|NCT00799058|69616423|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
37929507|NCT00799058|69616424|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
37929508|NCT00799058|69616422|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
38033747|NCT03289676|69719856|FG001|Overall Study|Lost to Follow-up|1|||
38033748|NCT03287804|69719872|FG000|Overall Study|Death|1|||
38033749|NCT03287804|69719872|FG000|Overall Study|Physician Decision|2|||
38033750|NCT03287804|69719872|FG000|Overall Study|Progressive disease|8|||
38033751|NCT03286400|69719877|FG000|Overall Study|Death|10|||
38033752|NCT03286400|69719877|FG000|Overall Study|Lost to Follow-up|10|||
38033753|NCT03286400|69719877|FG000|Overall Study|Physician Decision|1|||
38033754|NCT03286400|69719877|FG000|Overall Study|Scheduling difficulty|4|||
38033755|NCT03310970|69719881|FG000|Overall Study|Withdrawal by Subject|0|||
38033756|NCT03310970|69719882|FG001|Overall Study|Withdrawal by Subject|1|||
38033757|NCT03285308|69719891|FG000|Overall Study|Adverse Event|3|||
38033758|NCT03285308|69719892|FG001|Overall Study|Adverse Event|7|||
38033759|NCT03285308|69719891|FG000|Overall Study|Withdrawal by Subject|8|||
38033760|NCT03285308|69719892|FG001|Overall Study|Withdrawal by Subject|9|||
38033761|NCT03285308|69719891|FG000|Overall Study|Lost to Follow-up|3|||
37667874|NCT02147158|69140413|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
37667875|NCT02147158|69140414|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
37667876|NCT02147158|69140415|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
37667877|NCT02147158|69140416|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
37667878|NCT02147158|69140411|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
37929509|NCT00799058|69616423|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
37929510|NCT00799058|69616424|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
37929511|NCT00725985|69616437|FG000|ITP- Treatment Disposition|Adverse Event|20|||
37929512|NCT00725985|69616438|FG001|ITP- Treatment Disposition|Adverse Event|10|||
37929513|NCT00725985|69616439|FG002|ITP- Treatment Disposition|Adverse Event|5|||
37929514|NCT00725985|69616440|FG003|ITP- Treatment Disposition|Adverse Event|0|||
37929515|NCT00725985|69616441|FG004|ITP- Treatment Disposition|Adverse Event|0|||
37929516|NCT00725985|69616442|FG005|ITP- Treatment Disposition|Adverse Event|0|||
37929517|NCT00725985|69616443|FG006|ITP- Treatment Disposition|Adverse Event|0|||
37929518|NCT00725985|69616444|FG007|ITP- Treatment Disposition|Adverse Event|0|||
38033762|NCT03285308|69719892|FG001|Overall Study|Lost to Follow-up|1|||
38033763|NCT03285308|69719891|FG000|Overall Study|Protocol Deviation|6|||
38033764|NCT03285308|69719892|FG001|Overall Study|Protocol Deviation|5|||
37929519|NCT00725985|69616445|FG008|ITP- Treatment Disposition|Adverse Event|0|||
37929520|NCT00725985|69616446|FG009|ITP- Treatment Disposition|Adverse Event|0|||
37929521|NCT00725985|69616447|FG010|ITP- Treatment Disposition|Adverse Event|0|||
37929522|NCT00725985|69616448|FG011|ITP- Treatment Disposition|Adverse Event|0|||
37929523|NCT00725985|69616437|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
37929524|NCT00725985|69616438|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
37929525|NCT00725985|69616439|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
37929526|NCT00725985|69616440|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
37929527|NCT00725985|69616441|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
37929528|NCT00725985|69616442|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
37929529|NCT00725985|69616443|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
37929530|NCT00725985|69616444|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
37929531|NCT00725985|69616445|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
37929532|NCT00725985|69616446|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
37929533|NCT00725985|69616447|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
37929534|NCT00725985|69616448|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
37929535|NCT00725985|69616437|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
37929536|NCT00725985|69616438|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
37929537|NCT00725985|69616439|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
37929538|NCT00725985|69616440|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
37929539|NCT00725985|69616441|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
37929540|NCT00725985|69616442|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
37929541|NCT00725985|69616443|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
37929542|NCT00725985|69616444|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
37929543|NCT00725985|69616445|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
37929544|NCT00725985|69616446|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
37929545|NCT00725985|69616447|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
37929546|NCT00725985|69616448|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
37929547|NCT00725985|69616437|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
37929548|NCT00725985|69616438|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
37929549|NCT00725985|69616439|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
37929550|NCT00725985|69616440|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
37929551|NCT00725985|69616441|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
37929552|NCT00725985|69616442|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
37929553|NCT00725985|69616443|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
37929554|NCT00725985|69616444|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
37929555|NCT00725985|69616445|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
37929556|NCT00725985|69616446|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
37929557|NCT00725985|69616447|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
37929558|NCT00725985|69616448|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
37929559|NCT00725985|69616437|FG000|ITP- Treatment Disposition|Other|50|||
37929560|NCT00725985|69616438|FG001|ITP- Treatment Disposition|Other|38|||
37929561|NCT00725985|69616439|FG002|ITP- Treatment Disposition|Other|24|||
37929562|NCT00725985|69616440|FG003|ITP- Treatment Disposition|Other|0|||
37929563|NCT00725985|69616441|FG004|ITP- Treatment Disposition|Other|0|||
37929564|NCT00725985|69616442|FG005|ITP- Treatment Disposition|Other|0|||
37929565|NCT00725985|69616443|FG006|ITP- Treatment Disposition|Other|0|||
37929566|NCT00725985|69616444|FG007|ITP- Treatment Disposition|Other|0|||
37929567|NCT00725985|69616445|FG008|ITP- Treatment Disposition|Other|0|||
37929568|NCT00725985|69616446|FG009|ITP- Treatment Disposition|Other|0|||
37929569|NCT00725985|69616447|FG010|ITP- Treatment Disposition|Other|0|||
37929570|NCT00725985|69616448|FG011|ITP- Treatment Disposition|Other|0|||
37929571|NCT00725985|69616437|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
37929572|NCT00725985|69616438|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
37929573|NCT00725985|69616439|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
37929574|NCT00725985|69616440|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
37929575|NCT00725985|69616441|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
37929576|NCT00725985|69616442|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
37929577|NCT00725985|69616443|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
37929578|NCT00725985|69616444|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
37929579|NCT00725985|69616445|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
37929580|NCT00725985|69616446|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
37929581|NCT00725985|69616447|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
38033765|NCT03285308|69719891|FG000|Overall Study|Reason not Specified|0|||
38033766|NCT03285308|69719892|FG001|Overall Study|Reason not Specified|1|||
37929582|NCT00725985|69616448|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
38033767|NCT03723915|69719908|FG000|Screening|Failed to meet screening requirements.|2|||
37929583|NCT00725985|69616437|FG000|OLMP (Up to 96 Weeks)|Death|0|||
37929584|NCT00725985|69616438|FG001|OLMP (Up to 96 Weeks)|Death|0|||
37929585|NCT00725985|69616439|FG002|OLMP (Up to 96 Weeks)|Death|0|||
37929586|NCT00725985|69616440|FG003|OLMP (Up to 96 Weeks)|Death|0|||
37929587|NCT00725985|69616441|FG004|OLMP (Up to 96 Weeks)|Death|1|||
37929588|NCT00725985|69616442|FG005|OLMP (Up to 96 Weeks)|Death|0|||
37929589|NCT00725985|69616443|FG006|OLMP (Up to 96 Weeks)|Death|0|||
37929590|NCT00725985|69616444|FG007|OLMP (Up to 96 Weeks)|Death|0|||
37929591|NCT00725985|69616445|FG008|OLMP (Up to 96 Weeks)|Death|0|||
37929592|NCT00725985|69616446|FG009|OLMP (Up to 96 Weeks)|Death|0|||
37929593|NCT00725985|69616447|FG010|OLMP (Up to 96 Weeks)|Death|0|||
37929594|NCT00725985|69616448|FG011|OLMP (Up to 96 Weeks)|Death|0|||
37929595|NCT00725985|69616437|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
37929596|NCT00725985|69616438|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
37929597|NCT00725985|69616439|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
37929598|NCT00725985|69616440|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
37929599|NCT00725985|69616441|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
37929600|NCT00725985|69616442|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
37929601|NCT00725985|69616443|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
37929602|NCT00725985|69616444|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
37929603|NCT00725985|69616445|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
37929604|NCT00725985|69616446|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
37929605|NCT00725985|69616447|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
37929606|NCT00725985|69616448|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
37929607|NCT00725985|69616437|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
37929608|NCT00725985|69616438|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
37929609|NCT00725985|69616439|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
37929610|NCT00725985|69616440|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
37929611|NCT00725985|69616441|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
37929612|NCT00725985|69616442|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
37929613|NCT00725985|69616443|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
37929614|NCT00725985|69616444|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
37929615|NCT00725985|69616445|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
37929616|NCT00725985|69616446|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
37929617|NCT00725985|69616447|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
37929618|NCT00725985|69616448|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
37929619|NCT00725985|69616437|FG000|OLMP (Up to 96 Weeks)|Other|0|||
37929620|NCT00725985|69616438|FG001|OLMP (Up to 96 Weeks)|Other|0|||
37929621|NCT00725985|69616439|FG002|OLMP (Up to 96 Weeks)|Other|0|||
37929622|NCT00725985|69616440|FG003|OLMP (Up to 96 Weeks)|Other|15|||
37667879|NCT02147158|69140412|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
37667880|NCT02147158|69140413|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
37667881|NCT02147158|69140414|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
37667882|NCT02147158|69140415|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
37667883|NCT02147158|69140416|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
37667884|NCT02147158|69140411|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
37667885|NCT02147158|69140412|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
37667886|NCT02147158|69140413|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
37667887|NCT02147158|69140414|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
37667888|NCT02147158|69140415|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
37667889|NCT02147158|69140416|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
37667890|NCT02147158|69140411|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
37667891|NCT02147158|69140412|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
37667892|NCT02147158|69140413|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
37667893|NCT02147158|69140414|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
37667894|NCT02147158|69140415|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
37667895|NCT02147158|69140416|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
37667896|NCT02147158|69140411|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
37667897|NCT02147158|69140412|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
37667898|NCT02147158|69140413|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
37667899|NCT02147158|69140414|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
37667900|NCT02147158|69140415|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
37667901|NCT02147158|69140416|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
37667902|NCT02112448|69140435|FG000|Overall Study|lab values precluding use of ketorolac|2|||
37667903|NCT02112448|69140436|FG001|Overall Study|lab values precluding use of ketorolac|2|||
37667904|NCT02112448|69140435|FG000|Overall Study|Protocol Violation|1|||
37667905|NCT02112448|69140436|FG001|Overall Study|Protocol Violation|2|||
37667906|NCT02112448|69140435|FG000|Overall Study|Physician Decision|4|||
37667907|NCT02112448|69140436|FG001|Overall Study|Physician Decision|6|||
37667908|NCT02112448|69140435|FG000|Overall Study|required heparin so could not use ketoro|1|||
37667909|NCT02112448|69140436|FG001|Overall Study|required heparin so could not use ketoro|0|||
37667910|NCT02171260|69140448|FG000|Overall Study|Death|0|||
37667911|NCT02171260|69140449|FG001|Overall Study|Death|0|||
37760748|NCT02601313|69271675|FG001|Overall Study|Enrolled, did not initiate CTE/KTE-X19|5|||
37760749|NCT02601313|69271676|FG002|Overall Study|Enrolled, did not initiate CTE/KTE-X19|2|||
37760750|NCT02601313|69271674|FG000|Overall Study|Enrolled, did not initiate KTE-X19|0|||
37929623|NCT00725985|69616441|FG004|OLMP (Up to 96 Weeks)|Other|20|||
37929624|NCT00725985|69616442|FG005|OLMP (Up to 96 Weeks)|Other|44|||
37929625|NCT00725985|69616443|FG006|OLMP (Up to 96 Weeks)|Other|0|||
37929626|NCT00725985|69616444|FG007|OLMP (Up to 96 Weeks)|Other|0|||
37929627|NCT00725985|69616445|FG008|OLMP (Up to 96 Weeks)|Other|0|||
37929628|NCT00725985|69616446|FG009|OLMP (Up to 96 Weeks)|Other|0|||
37929629|NCT00725985|69616447|FG010|OLMP (Up to 96 Weeks)|Other|0|||
37929630|NCT00725985|69616448|FG011|OLMP (Up to 96 Weeks)|Other|0|||
37929631|NCT00725985|69616437|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
37929632|NCT00725985|69616438|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
37929633|NCT00725985|69616439|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
37929634|NCT00725985|69616440|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
37929635|NCT00725985|69616441|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
37929636|NCT00725985|69616442|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
37929637|NCT00725985|69616443|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
37929638|NCT00725985|69616444|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
37929639|NCT00725985|69616445|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
37929640|NCT00725985|69616446|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
37929641|NCT00725985|69616447|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
37760751|NCT02601313|69271675|FG001|Overall Study|Enrolled, did not initiate KTE-X19|1|||
37760752|NCT02601313|69271676|FG002|Overall Study|Enrolled, did not initiate KTE-X19|1|||
37929642|NCT00725985|69616448|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
37929643|NCT00725985|69616437|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
37929644|NCT00725985|69616438|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
37929645|NCT00725985|69616439|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
37929646|NCT00725985|69616440|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
37929647|NCT00725985|69616441|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
37929648|NCT00725985|69616442|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
37929649|NCT00725985|69616443|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
37929650|NCT00725985|69616444|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
37929651|NCT00725985|69616445|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
37929652|NCT00725985|69616446|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
37929653|NCT00725985|69616447|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
37929654|NCT00725985|69616448|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
37929655|NCT00725985|69616437|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
37929656|NCT00725985|69616438|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
37929657|NCT00725985|69616439|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
37929658|NCT00725985|69616440|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
37929659|NCT00725985|69616441|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
37929660|NCT00725985|69616442|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
37929661|NCT00725985|69616443|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
37929662|NCT00725985|69616444|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
37929663|NCT00725985|69616445|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
37929664|NCT00725985|69616446|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
37929665|NCT00725985|69616447|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
37929666|NCT00725985|69616448|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
37929667|NCT00725985|69616437|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
37929668|NCT00725985|69616438|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
37929669|NCT00725985|69616439|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
37929670|NCT00725985|69616440|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
37929671|NCT00725985|69616441|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
37929672|NCT00725985|69616442|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
37929673|NCT00725985|69616443|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
37929674|NCT00725985|69616444|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
37760753|NCT02601313|69271674|FG000|Overall Study|Still on study|0|||
37760754|NCT02601313|69271675|FG001|Overall Study|Still on study|52|||
37760755|NCT02601313|69271676|FG002|Overall Study|Still on study|10|||
37760756|NCT02601313|69271674|FG000|Overall Study|Enrolled, did not initiate AC|4|||
37760757|NCT02601313|69271675|FG001|Overall Study|Enrolled, did not initiate AC|0|||
37760758|NCT02601313|69271676|FG002|Overall Study|Enrolled, did not initiate AC|0|||
37760759|NCT02577354|69271686|FG000|Overall Study|Lack of Efficacy|4|||
37760760|NCT02577354|69271687|FG001|Overall Study|Lack of Efficacy|4|||
37760761|NCT02577354|69271686|FG000|Overall Study|Lost to Follow-up|3|||
37760762|NCT02577354|69271687|FG001|Overall Study|Lost to Follow-up|1|||
37760763|NCT02577354|69271686|FG000|Overall Study|Missed Visit|4|||
37760764|NCT02577354|69271687|FG001|Overall Study|Missed Visit|3|||
37760765|NCT02577354|69271686|FG000|Overall Study|Adverse Event|4|||
37929675|NCT00725985|69616445|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
37929676|NCT00725985|69616446|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
37929677|NCT00725985|69616447|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
37929678|NCT00725985|69616448|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
37929679|NCT00793910|69616476|FG000|Overall Study|discarded study pills|0|||
38043554|NCT03238248|69731701|FG000|Overall Study|Alternative therapy|2|||
37760766|NCT02577354|69271687|FG001|Overall Study|Adverse Event|5|||
37760767|NCT02550652|69271705|FG000|Overall Study|Death|1|||
37760768|NCT02550652|69271706|FG001|Overall Study|Death|4|||
37929680|NCT00793910|69616477|FG001|Overall Study|discarded study pills|1|||
37929681|NCT00793910|69616476|FG000|Overall Study|did not pick up medications|1|||
37929682|NCT00793910|69616477|FG001|Overall Study|did not pick up medications|1|||
37929683|NCT00793910|69616476|FG000|Overall Study|ineligible based on entry criteria|2|||
37929684|NCT00793910|69616477|FG001|Overall Study|ineligible based on entry criteria|3|||
37929685|NCT00793910|69616476|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
37929686|NCT00793910|69616477|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
37929687|NCT00793910|69616476|FG000|Overall Study|Withdrawal by Subject|0|||
37929688|NCT00793910|69616477|FG001|Overall Study|Withdrawal by Subject|1|||
37929689|NCT00444145|69616483|FG000|Overall Study|Withdrawal by Subject|2|||
37929690|NCT00444145|69616483|FG000|Overall Study|Lost to Follow-up|1|||
37929691|NCT00444145|69616483|FG000|Overall Study|non-compliant|11|||
37929692|NCT00444145|69616483|FG000|Overall Study|Screen Failures|5|||
37929693|NCT00725283|69616487|FG000|Overall Study|Missing Code|3|||
37929694|NCT00725283|69616487|FG000|Overall Study|Death|5|||
37929695|NCT00725283|69616487|FG000|Overall Study|Other|6|||
37929696|NCT00725283|69616487|FG000|Overall Study|Withdrawal by Subject|10|||
37929697|NCT00444067|69616493|FG000|Overall Study|Lost to Follow-up|0|||
37929698|NCT00444067|69616494|FG001|Overall Study|Lost to Follow-up|1|||
37929699|NCT00789854|69616503|FG000|Overall Study|Adverse Event|28|||
37929700|NCT00789854|69616504|FG001|Overall Study|Adverse Event|23|||
37929701|NCT00789854|69616505|FG002|Overall Study|Adverse Event|18|||
37929702|NCT00789854|69616503|FG000|Overall Study|Lost to Follow-up|1|||
37929703|NCT00789854|69616504|FG001|Overall Study|Lost to Follow-up|1|||
37929704|NCT00789854|69616505|FG002|Overall Study|Lost to Follow-up|4|||
37929705|NCT00789854|69616503|FG000|Overall Study|Withdrawal by Subject|9|||
37929706|NCT00789854|69616504|FG001|Overall Study|Withdrawal by Subject|6|||
37929707|NCT00789854|69616505|FG002|Overall Study|Withdrawal by Subject|17|||
37929708|NCT00789854|69616503|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
37929709|NCT00789854|69616504|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
37929710|NCT00789854|69616505|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
37929711|NCT00789854|69616503|FG000|Overall Study|Severe non-compliance to the protocol|3|||
37929712|NCT00789854|69616504|FG001|Overall Study|Severe non-compliance to the protocol|0|||
37929713|NCT00789854|69616505|FG002|Overall Study|Severe non-compliance to the protocol|0|||
37929714|NCT00789854|69616503|FG000|Overall Study|Safety reasons|0|||
37929715|NCT00789854|69616504|FG001|Overall Study|Safety reasons|0|||
37929716|NCT00789854|69616505|FG002|Overall Study|Safety reasons|2|||
37929717|NCT00789854|69616503|FG000|Overall Study|Other|6|||
37929718|NCT00789854|69616504|FG001|Overall Study|Other|0|||
37929719|NCT00789854|69616505|FG002|Overall Study|Other|5|||
37929720|NCT00725205|69616513|FG000|Overall Study|Adverse Event|22|||
37929721|NCT00725205|69616513|FG000|Overall Study|Investigator Discontinued|1|||
37929722|NCT00725205|69616513|FG000|Overall Study|Non-compliance With Protocol|14|||
37929723|NCT00725205|69616513|FG000|Overall Study|Other|8|||
37929724|NCT00725205|69616513|FG000|Overall Study|Protocol Defined Clinical Event|1|||
37929725|NCT00725205|69616513|FG000|Overall Study|Treatment Failure|41|||
37929726|NCT00443755|69616519|FG000|Overall Study|Withdrawal by Subject|2|||
37929727|NCT00443755|69616520|FG001|Overall Study|Withdrawal by Subject|1|||
37929728|NCT00724971|69616526|FG000|Overall Study|Adverse Event|5|||
37929729|NCT00724971|69616526|FG000|Overall Study|Withdrawal by Subject|1|||
38033768|NCT03723915|69719908|FG000|On Treatment|Failed to meet treatment requirements|2|||
37929730|NCT00443599|69616532|FG000|Overall Study|Physician Decision|2|||
37929731|NCT00443599|69616533|FG001|Overall Study|Physician Decision|1|||
37929732|NCT00443599|69616532|FG000|Overall Study|Death|1|||
37929733|NCT00443599|69616533|FG001|Overall Study|Death|1|||
37929734|NCT00443599|69616532|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
37929735|NCT00443599|69616533|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
37929736|NCT00455143|69616539|FG000|Overall Study|Physician Decision|1|||
37929737|NCT00455143|69616539|FG000|Overall Study|Withdrawal by Subject|1|||
37929738|NCT00455143|69616539|FG000|Overall Study|Staff was not avail to follow patient|2|||
37929739|NCT00455143|69616539|FG000|Overall Study|No longer met Inclusion Criteria|1|||
37929740|NCT00455143|69616539|FG000|Overall Study|Surgical time, staff not available|1|||
38033769|NCT03281876|69719914|FG000|Overall Study|Adverse Event|4|||
37760769|NCT02550652|69271705|FG000|Overall Study|Lack of Efficacy|1|||
37760770|NCT02550652|69271706|FG001|Overall Study|Lack of Efficacy|0|||
37760771|NCT02550652|69271705|FG000|Overall Study|Withdrawal by Subject|3|||
37929741|NCT00454987|69616547|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
37929742|NCT00454987|69616548|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
37929743|NCT00454987|69616549|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
37929744|NCT00454987|69616547|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
37929745|NCT00454987|69616548|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
37929746|NCT00454987|69616549|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
37929747|NCT00454987|69616547|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
37929748|NCT00454987|69616548|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
37929749|NCT00454987|69616549|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
37929750|NCT00724893|69616560|FG000|Overall Study|Adverse Event|76|||
37929751|NCT00724893|69616561|FG001|Overall Study|Adverse Event|142|||
37929752|NCT00724893|69616560|FG000|Overall Study|Withdrawal by Subject|0|||
37929753|NCT00724893|69616561|FG001|Overall Study|Withdrawal by Subject|1|||
37929754|NCT00724893|69616560|FG000|Overall Study|Lack of virologic response|94|||
37929755|NCT00724893|69616561|FG001|Overall Study|Lack of virologic response|202|||
37929756|NCT00724893|69616560|FG000|Overall Study|Reason not specified|193|||
37929757|NCT00724893|69616561|FG001|Overall Study|Reason not specified|7|||
37929758|NCT00724893|69616560|FG000|Overall Study|Patient choice|0|||
37929759|NCT00724893|69616561|FG001|Overall Study|Patient choice|26|||
37929760|NCT00724893|69616560|FG000|Overall Study|Geographic reasons|0|||
38033770|NCT03281876|69719915|FG001|Overall Study|Adverse Event|15|||
38033771|NCT03281876|69719914|FG000|Overall Study|Lost to Follow-up|1|||
38033772|NCT03281876|69719915|FG001|Overall Study|Lost to Follow-up|4|||
38033773|NCT03281876|69719914|FG000|Overall Study|Withdrawal by Subject|11|||
38033774|NCT03281876|69719915|FG001|Overall Study|Withdrawal by Subject|15|||
38033775|NCT03281876|69719914|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
38033776|NCT03281876|69719915|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
38033777|NCT03281876|69719914|FG000|Overall Study|OTHER|5|||
38033778|NCT03281876|69719915|FG001|Overall Study|OTHER|5|||
38033779|NCT03310580|69719924|FG000|Overall Study|Adverse Event|0|||
38033780|NCT03310580|69719925|FG001|Overall Study|Adverse Event|1|||
38033781|NCT03310580|69719926|FG002|Overall Study|Adverse Event|0|||
38033782|NCT03415022|69719949|FG000|Overall Study|Withdrawal by Subject|1|||
38033783|NCT03415022|69719950|FG001|Overall Study|Withdrawal by Subject|2|||
38033784|NCT03415022|69719949|FG000|Overall Study|COVID-19 Suspension|2|||
38033785|NCT03415022|69719950|FG001|Overall Study|COVID-19 Suspension|3|||
38033786|NCT03415022|69719949|FG000|Overall Study|Lost to Follow-up|2|||
38033787|NCT03415022|69719950|FG001|Overall Study|Lost to Follow-up|0|||
38033788|NCT02816398|69719956|FG000|Overall Study|Death|5|||
38033789|NCT02816398|69719956|FG000|Overall Study|Lack of Efficacy|8|||
38033790|NCT02816398|69719956|FG000|Overall Study|Lost to Follow-up|1|||
38033791|NCT02812186|69719962|FG000|Period 1|Post randomization screen failure|5|||
38033792|NCT02812186|69719963|FG001|Period 1|Post randomization screen failure|9|||
38033793|NCT02812186|69719962|FG000|Period 1|nonevaluable data sets|6|||
38033794|NCT02812186|69719963|FG001|Period 1|nonevaluable data sets|6|||
38033795|NCT02811640|69719972|FG000|Overall Study|Technology malfunction|2|||
38033796|NCT03310268|69719979|FG000|Overall Study|(Not specified)|1|||
38033797|NCT03310268|69719980|FG001|Overall Study|(Not specified)|5|||
38033798|NCT03310268|69719981|FG002|Overall Study|(Not specified)|0|||
38033799|NCT02810392|69719991|FG000|Overall Study|Subject too ill to continue|1|||
38033800|NCT02810392|69719992|FG001|Overall Study|Subject too ill to continue|0|||
38033801|NCT02810392|69719991|FG000|Overall Study|COVID 19 research restrictions|0|||
38033802|NCT02810392|69719992|FG001|Overall Study|COVID 19 research restrictions|1|||
38033803|NCT02815540|69719998|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
38033804|NCT03280550|69720004|FG000|Overall Study|Withdrawal by Subject|2|||
38033805|NCT03280550|69720005|FG001|Overall Study|Withdrawal by Subject|2|||
38033806|NCT03280550|69720004|FG000|Overall Study|Physician Decision|0|||
38033807|NCT03280550|69720005|FG001|Overall Study|Physician Decision|1|||
38033808|NCT03276026|69720013|FG000|Overall Study|Protocol Violation|1|||
38033809|NCT03276026|69720014|FG001|Overall Study|Protocol Violation|0|||
38033810|NCT01589523|69720020|FG000|Overall Study|Withdrawal by Subject|1|||
38033811|NCT03277352|69720026|FG000|Overall Study|Study Terminated By Sponsor|2|||
38033812|NCT03277352|69720026|FG000|Overall Study|Withdrawal by Subject|4|||
38033813|NCT03277352|69720026|FG000|Overall Study|Death|4|||
38033814|NCT02814838|69720033|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
38033815|NCT02814838|69720034|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
38033816|NCT02814838|69720033|FG000|Overall Study|Consent withdrawal|1|||
38033817|NCT02814838|69720034|FG001|Overall Study|Consent withdrawal|1|||
38033818|NCT03276728|69720048|FG000|Overall Study|Lost to Follow-up|0|||
38033819|NCT03276728|69720049|FG001|Overall Study|Lost to Follow-up|0|||
38033820|NCT03276728|69720050|FG002|Overall Study|Lost to Follow-up|2|||
38033821|NCT03276728|69720051|FG003|Overall Study|Lost to Follow-up|2|||
38033822|NCT03276728|69720052|FG004|Overall Study|Lost to Follow-up|0|||
38033823|NCT03276728|69720053|FG005|Overall Study|Lost to Follow-up|0|||
38033824|NCT03276728|69720054|FG006|Overall Study|Lost to Follow-up|0|||
37929761|NCT00724893|69616561|FG001|Overall Study|Geographic reasons|11|||
37929762|NCT00724893|69616560|FG000|Overall Study|Incarceration|0|||
37929763|NCT00724893|69616561|FG001|Overall Study|Incarceration|9|||
38033825|NCT03276728|69720055|FG007|Overall Study|Lost to Follow-up|0|||
38033826|NCT03276728|69720048|FG000|Overall Study|Withdrawal by Subject|0|||
38033827|NCT03276728|69720049|FG001|Overall Study|Withdrawal by Subject|0|||
38033828|NCT03276728|69720050|FG002|Overall Study|Withdrawal by Subject|0|||
38033829|NCT03276728|69720051|FG003|Overall Study|Withdrawal by Subject|3|||
38033830|NCT03276728|69720052|FG004|Overall Study|Withdrawal by Subject|0|||
38033831|NCT03276728|69720053|FG005|Overall Study|Withdrawal by Subject|0|||
38033832|NCT03276728|69720054|FG006|Overall Study|Withdrawal by Subject|0|||
37929764|NCT00724893|69616560|FG000|Overall Study|Substance abuse|0|||
37929765|NCT00724893|69616561|FG001|Overall Study|Substance abuse|3|||
37929766|NCT00724893|69616560|FG000|Overall Study|Financial reasons|0|||
37929767|NCT00724893|69616561|FG001|Overall Study|Financial reasons|2|||
37929768|NCT00724893|69616560|FG000|Overall Study|Assigned shorter treatment|0|||
37929769|NCT00724893|69616561|FG001|Overall Study|Assigned shorter treatment|2|||
37929770|NCT00724893|69616560|FG000|Overall Study|Lost to Follow-up|0|||
37929771|NCT00724893|69616561|FG001|Overall Study|Lost to Follow-up|52|||
37929772|NCT00724893|69616560|FG000|Overall Study|Unknown, missing data|1|||
37929773|NCT00724893|69616561|FG001|Overall Study|Unknown, missing data|1|||
37929774|NCT00789698|69616586|FG000|Overall Study|Lack of Efficacy|10|||
37929775|NCT00789698|69616587|FG001|Overall Study|Lack of Efficacy|4|||
37929776|NCT00789698|69616588|FG002|Overall Study|Lack of Efficacy|5|||
37929777|NCT00789698|69616589|FG003|Overall Study|Lack of Efficacy|18|||
37929778|NCT00789698|69616586|FG000|Overall Study|Adverse Event|5|||
37929779|NCT00789698|69616587|FG001|Overall Study|Adverse Event|5|||
37929780|NCT00789698|69616588|FG002|Overall Study|Adverse Event|3|||
37929781|NCT00789698|69616589|FG003|Overall Study|Adverse Event|4|||
37929782|NCT00789698|69616586|FG000|Overall Study|Lost to Follow-up|5|||
37929783|NCT00789698|69616587|FG001|Overall Study|Lost to Follow-up|5|||
37929784|NCT00789698|69616588|FG002|Overall Study|Lost to Follow-up|2|||
37929785|NCT00789698|69616589|FG003|Overall Study|Lost to Follow-up|9|||
37929786|NCT00789698|69616586|FG000|Overall Study|Protocol Violation|6|||
37929787|NCT00789698|69616587|FG001|Overall Study|Protocol Violation|1|||
37929788|NCT00789698|69616588|FG002|Overall Study|Protocol Violation|2|||
37929789|NCT00789698|69616589|FG003|Overall Study|Protocol Violation|1|||
37929790|NCT00789698|69616586|FG000|Overall Study|Withdrawal by Subject|14|||
37929791|NCT00789698|69616587|FG001|Overall Study|Withdrawal by Subject|15|||
37929792|NCT00789698|69616588|FG002|Overall Study|Withdrawal by Subject|12|||
37929793|NCT00789698|69616589|FG003|Overall Study|Withdrawal by Subject|19|||
37929794|NCT00789698|69616586|FG000|Overall Study|Administrative|0|||
37929795|NCT00789698|69616587|FG001|Overall Study|Administrative|3|||
37929796|NCT00789698|69616588|FG002|Overall Study|Administrative|3|||
37929797|NCT00789698|69616589|FG003|Overall Study|Administrative|1|||
37929798|NCT00724815|69616600|FG000|Overall Study|Randomized, not treated|31|||
37929799|NCT00724815|69616601|FG001|Overall Study|Randomized, not treated|30|||
37929800|NCT00724815|69616600|FG000|Overall Study|Adverse Event|5|||
37929801|NCT00724815|69616601|FG001|Overall Study|Adverse Event|3|||
37929802|NCT00724815|69616600|FG000|Overall Study|Lost to Follow-up|4|||
37929803|NCT00724815|69616601|FG001|Overall Study|Lost to Follow-up|1|||
37929804|NCT00724815|69616600|FG000|Overall Study|Other Various|3|||
37929805|NCT00724815|69616601|FG001|Overall Study|Other Various|5|||
37929806|NCT00454909|69616610|FG000|Overall Study|Withdrawal by Subject|1|||
37929807|NCT00454909|69616611|FG001|Overall Study|Withdrawal by Subject|0|||
37929808|NCT00454909|69616612|FG002|Overall Study|Withdrawal by Subject|0|||
37929809|NCT00454909|69616610|FG000|Overall Study|Migrated/moved from study area|0|||
37929810|NCT00454909|69616611|FG001|Overall Study|Migrated/moved from study area|0|||
37929811|NCT00454909|69616612|FG002|Overall Study|Migrated/moved from study area|1|||
37929812|NCT00454909|69616610|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
37929813|NCT00454909|69616611|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
37929814|NCT00454909|69616612|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
37929815|NCT00454909|69616610|FG000|Overall Study|Others|1|||
38033833|NCT03276728|69720055|FG007|Overall Study|Withdrawal by Subject|0|||
38033834|NCT03276728|69720048|FG000|Overall Study|Decision by sponsor|0|||
38033835|NCT03276728|69720049|FG001|Overall Study|Decision by sponsor|0|||
38033836|NCT03276728|69720050|FG002|Overall Study|Decision by sponsor|0|||
38033837|NCT03276728|69720051|FG003|Overall Study|Decision by sponsor|0|||
38033838|NCT03276728|69720052|FG004|Overall Study|Decision by sponsor|1|||
38033839|NCT03276728|69720053|FG005|Overall Study|Decision by sponsor|0|||
38033840|NCT03276728|69720054|FG006|Overall Study|Decision by sponsor|2|||
38033841|NCT03276728|69720055|FG007|Overall Study|Decision by sponsor|1|||
37929816|NCT00454909|69616611|FG001|Overall Study|Others|0|||
37929817|NCT00454909|69616612|FG002|Overall Study|Others|0|||
37929818|NCT00798590|69616623|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
37929819|NCT00798590|69616624|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
37929820|NCT00481195|69616632|FG000|Overall Study|Adverse Event|16|||
37929821|NCT00481195|69616633|FG001|Overall Study|Adverse Event|11|||
37929822|NCT00481195|69616632|FG000|Overall Study|Lack of Efficacy|1|||
37929823|NCT00481195|69616633|FG001|Overall Study|Lack of Efficacy|3|||
37929824|NCT00481195|69616632|FG000|Overall Study|Lost to Follow-up|4|||
37929825|NCT00481195|69616633|FG001|Overall Study|Lost to Follow-up|6|||
37929826|NCT00481195|69616632|FG000|Overall Study|Physician Decision|3|||
37929827|NCT00481195|69616633|FG001|Overall Study|Physician Decision|1|||
37929828|NCT00481195|69616632|FG000|Overall Study|Protocol Violation|10|||
37929829|NCT00481195|69616633|FG001|Overall Study|Protocol Violation|7|||
37929830|NCT00481195|69616632|FG000|Overall Study|Withdrawal by Subject|3|||
38033842|NCT03275246|69720075|FG000|Overall Study|Protocol Violation|5|||
38033843|NCT03275246|69720075|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
37929831|NCT00481195|69616633|FG001|Overall Study|Withdrawal by Subject|9|||
37929832|NCT00481195|69616632|FG000|Overall Study|Miscellaneous|2|||
37929833|NCT00481195|69616633|FG001|Overall Study|Miscellaneous|2|||
37760772|NCT02550652|69271706|FG001|Overall Study|Withdrawal by Subject|7|||
37760773|NCT02550652|69271705|FG000|Overall Study|Post Trial Access|1|||
37760774|NCT02550652|69271706|FG001|Overall Study|Post Trial Access|0|||
37760775|NCT02550652|69271705|FG000|Overall Study|Lost to Follow-up|1|||
37760776|NCT02550652|69271706|FG001|Overall Study|Lost to Follow-up|3|||
37760777|NCT02550652|69271705|FG000|Overall Study|Physician Decision|0|||
37760778|NCT02550652|69271706|FG001|Overall Study|Physician Decision|2|||
37760779|NCT02550652|69271705|FG000|Overall Study|Ongoing in safety/B-cell follow-up period|14|||
37760780|NCT02550652|69271706|FG001|Overall Study|Ongoing in safety/B-cell follow-up period|5|||
37760781|NCT02484443|69271712|FG000|Overall Study|Lack of Efficacy|28|||
37760782|NCT02484443|69271712|FG000|Overall Study|Physician Decision|2|||
37760783|NCT02484443|69271712|FG000|Overall Study|Ineligible|2|||
37760784|NCT01708954|69271741|FG000|Step 1|Disease progression|26|||
37929834|NCT00454363|69616650|FG000|Overall Study|Adverse Event|1|||
37929835|NCT00454363|69616651|FG001|Overall Study|Adverse Event|2|||
37929836|NCT00454363|69616650|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
37929837|NCT00454363|69616651|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
37929838|NCT00454207|69616658|FG000|Overall Study|Adverse Event|3|||
37929839|NCT00454207|69616659|FG001|Overall Study|Adverse Event|1|||
37929840|NCT00454207|69616658|FG000|Overall Study|Lack of Efficacy|1|||
37929841|NCT00454207|69616659|FG001|Overall Study|Lack of Efficacy|0|||
37929842|NCT00454207|69616658|FG000|Overall Study|Protocol Violation|0|||
37929843|NCT00454207|69616659|FG001|Overall Study|Protocol Violation|1|||
37929844|NCT00738894|69616679|FG000|Overall Study|Lost to Follow-up|23|||
37929845|NCT00738894|69616680|FG001|Overall Study|Lost to Follow-up|13|||
37929846|NCT00738894|69616679|FG000|Overall Study|Withdrawal by Subject|10|||
37929847|NCT00738894|69616680|FG001|Overall Study|Withdrawal by Subject|15|||
37929848|NCT00738894|69616679|FG000|Overall Study|Physician Decision|4|||
37929849|NCT00738894|69616680|FG001|Overall Study|Physician Decision|5|||
37929850|NCT00738894|69616679|FG000|Overall Study|Death|2|||
37929851|NCT00738894|69616680|FG001|Overall Study|Death|0|||
37929852|NCT00480493|69616688|FG000|Overall Study|moved|2|||
37929853|NCT00480493|69616689|FG001|Overall Study|moved|7|||
37929854|NCT00734994|69616697|FG000|Overall Study|Withdrawal by Subject|1|||
37929855|NCT00798434|69616704|FG000|Double-Blind|Adverse Event|22|||
37929856|NCT00798434|69616705|FG001|Double-Blind|Adverse Event|46|||
37929857|NCT00798434|69616704|FG000|Double-Blind|Death|0|||
37929858|NCT00798434|69616705|FG001|Double-Blind|Death|1|||
37929859|NCT00798434|69616704|FG000|Double-Blind|Lost to Follow-up|1|||
37929860|NCT00798434|69616705|FG001|Double-Blind|Lost to Follow-up|0|||
37929861|NCT00798434|69616704|FG000|Double-Blind|Lack of Efficacy|8|||
37929862|NCT00798434|69616705|FG001|Double-Blind|Lack of Efficacy|12|||
37929863|NCT00798434|69616704|FG000|Double-Blind|Withdrawal by Subject|17|||
37929864|NCT00798434|69616705|FG001|Double-Blind|Withdrawal by Subject|14|||
37929865|NCT00798434|69616704|FG000|Double-Blind|Protocol Violation|1|||
37929866|NCT00798434|69616705|FG001|Double-Blind|Protocol Violation|4|||
37929867|NCT00798434|69616704|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
37929868|NCT00798434|69616705|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
37929869|NCT00798434|69616704|FG000|Double-Blind|Other|1|||
37929870|NCT00798434|69616705|FG001|Double-Blind|Other|0|||
37929871|NCT00798434|69616704|FG000|Double-Blind|Not Treated|3|||
37929872|NCT00798434|69616705|FG001|Double-Blind|Not Treated|6|||
37929873|NCT00798434|69616704|FG000|Open-Label|Adverse Event|33|||
37929874|NCT00798434|69616705|FG001|Open-Label|Adverse Event|11|||
37929875|NCT00798434|69616704|FG000|Open-Label|Lack of Efficacy|5|||
37929876|NCT00798434|69616705|FG001|Open-Label|Lack of Efficacy|11|||
37760785|NCT01708954|69271742|FG001|Step 1|Disease progression|17|||
37929877|NCT00798434|69616704|FG000|Open-Label|Withdrawal by Subject|2|||
37929878|NCT00798434|69616705|FG001|Open-Label|Withdrawal by Subject|7|||
37929879|NCT00798434|69616704|FG000|Open-Label|Protocol Violation|1|||
37929880|NCT00798434|69616705|FG001|Open-Label|Protocol Violation|0|||
37929881|NCT00798434|69616704|FG000|Open-Label|Other|1|||
37929882|NCT00798434|69616705|FG001|Open-Label|Other|2|||
37929883|NCT00798434|69616704|FG000|Open-Label|Not Treated|0|||
37929884|NCT00798434|69616705|FG001|Open-Label|Not Treated|1|||
37929885|NCT00724503|69616718|FG000|Overall Study|Lost to Follow-up|4|||
37929886|NCT00724503|69616719|FG001|Overall Study|Lost to Follow-up|8|||
37929887|NCT00724503|69616718|FG000|Overall Study|Withdrawal by Subject|11|||
37929888|NCT00724503|69616719|FG001|Overall Study|Withdrawal by Subject|23|||
37929889|NCT00724503|69616718|FG000|Overall Study|Death|190|||
37760786|NCT01708954|69271743|FG002|Step 1|Disease progression|14|||
37760787|NCT01708954|69271741|FG000|Step 1|Adverse Event|3|||
37760788|NCT01708954|69271742|FG001|Step 1|Adverse Event|11|||
37929890|NCT00724503|69616719|FG001|Overall Study|Death|182|||
37929891|NCT00724503|69616718|FG000|Overall Study|Adverse Event|1|||
37760789|NCT01708954|69271743|FG002|Step 1|Adverse Event|13|||
37929892|NCT00724503|69616719|FG001|Overall Study|Adverse Event|0|||
37929893|NCT00724503|69616718|FG000|Overall Study|Not otherwise specified|4|||
37760790|NCT01708954|69271741|FG000|Step 1|Death|3|||
37760791|NCT01708954|69271742|FG001|Step 1|Death|2|||
37760792|NCT01708954|69271743|FG002|Step 1|Death|3|||
37760793|NCT01708954|69271741|FG000|Step 1|Withdrawal by Subject|2|||
37760794|NCT01708954|69271742|FG001|Step 1|Withdrawal by Subject|5|||
37760795|NCT01708954|69271743|FG002|Step 1|Withdrawal by Subject|3|||
37760796|NCT01708954|69271741|FG000|Step 1|Other complicating disease|0|||
37760797|NCT01708954|69271742|FG001|Step 1|Other complicating disease|2|||
37760798|NCT01708954|69271743|FG002|Step 1|Other complicating disease|0|||
37760799|NCT01708954|69271741|FG000|Step 1|Crossed over to Step 2|2|||
37667912|NCT02171260|69140450|FG002|Overall Study|Death|0|||
37667913|NCT02171260|69140451|FG003|Overall Study|Death|1|||
37667914|NCT02171260|69140448|FG000|Overall Study|Physician Decision|1|||
37667915|NCT02171260|69140449|FG001|Overall Study|Physician Decision|0|||
37667916|NCT02171260|69140450|FG002|Overall Study|Physician Decision|1|||
37667917|NCT02171260|69140451|FG003|Overall Study|Physician Decision|0|||
37667918|NCT02171260|69140448|FG000|Overall Study|Withdrawal by Subject|1|||
37667919|NCT02171260|69140449|FG001|Overall Study|Withdrawal by Subject|0|||
37667920|NCT02171260|69140450|FG002|Overall Study|Withdrawal by Subject|0|||
37667921|NCT02171260|69140451|FG003|Overall Study|Withdrawal by Subject|0|||
37667922|NCT02171260|69140448|FG000|Overall Study|Evidence of progressive disease|4|||
37667923|NCT02171260|69140449|FG001|Overall Study|Evidence of progressive disease|6|||
37667924|NCT02171260|69140450|FG002|Overall Study|Evidence of progressive disease|4|||
37667925|NCT02171260|69140451|FG003|Overall Study|Evidence of progressive disease|4|||
37667926|NCT02110732|69140469|FG000|Overall Study|Physician Decision|5|||
37667927|NCT02110732|69140470|FG001|Overall Study|Physician Decision|2|||
37667928|NCT02110732|69140469|FG000|Overall Study|Lost to Follow-up|1|||
37667929|NCT02110732|69140470|FG001|Overall Study|Lost to Follow-up|1|||
37667930|NCT02109562|69140479|FG000|Overall Study|Insufficient clinical response|2|||
37667931|NCT02109562|69140480|FG001|Overall Study|Insufficient clinical response|0|||
37667932|NCT02109562|69140481|FG002|Overall Study|Insufficient clinical response|4|||
37667933|NCT02109562|69140479|FG000|Overall Study|Adverse Event|0|||
37667934|NCT02109562|69140480|FG001|Overall Study|Adverse Event|2|||
37667935|NCT02109562|69140481|FG002|Overall Study|Adverse Event|3|||
37667936|NCT02109562|69140479|FG000|Overall Study|Lost to Follow-up|1|||
37667937|NCT02109562|69140480|FG001|Overall Study|Lost to Follow-up|0|||
37667938|NCT02109562|69140481|FG002|Overall Study|Lost to Follow-up|1|||
37667939|NCT02109562|69140479|FG000|Overall Study|Protocol Violation|0|||
37667940|NCT02109562|69140480|FG001|Overall Study|Protocol Violation|3|||
37667941|NCT02109562|69140481|FG002|Overall Study|Protocol Violation|1|||
37667942|NCT02109562|69140479|FG000|Overall Study|Withdrawal by Subject|20|||
37667943|NCT02109562|69140480|FG001|Overall Study|Withdrawal by Subject|25|||
37667944|NCT02109562|69140481|FG002|Overall Study|Withdrawal by Subject|21|||
37667945|NCT02109562|69140479|FG000|Overall Study|Physician Decision|3|||
37667946|NCT02109562|69140480|FG001|Overall Study|Physician Decision|4|||
37667947|NCT02109562|69140481|FG002|Overall Study|Physician Decision|5|||
37667948|NCT02109484|69140497|FG000|Overall Study|Lost to Follow-up|0|||
37667949|NCT02109484|69140498|FG001|Overall Study|Lost to Follow-up|0|||
37667950|NCT02109484|69140499|FG002|Overall Study|Lost to Follow-up|0|||
37667951|NCT02109484|69140500|FG003|Overall Study|Lost to Follow-up|1|||
37667952|NCT02109484|69140501|FG004|Overall Study|Lost to Follow-up|1|||
37667953|NCT02109484|69140502|FG005|Overall Study|Lost to Follow-up|0|||
37667954|NCT02109484|69140503|FG006|Overall Study|Lost to Follow-up|1|||
37667955|NCT02109484|69140504|FG007|Overall Study|Lost to Follow-up|0|||
37667956|NCT02109484|69140497|FG000|Overall Study|Withdrawal by Subject|0|||
37667957|NCT02109484|69140498|FG001|Overall Study|Withdrawal by Subject|0|||
37667958|NCT02109484|69140499|FG002|Overall Study|Withdrawal by Subject|0|||
37667959|NCT02109484|69140500|FG003|Overall Study|Withdrawal by Subject|0|||
37667960|NCT02109484|69140501|FG004|Overall Study|Withdrawal by Subject|1|||
37760800|NCT01708954|69271742|FG001|Step 1|Crossed over to Step 2|0|||
37667961|NCT02109484|69140502|FG005|Overall Study|Withdrawal by Subject|1|||
37667962|NCT02109484|69140503|FG006|Overall Study|Withdrawal by Subject|1|||
37667963|NCT02109484|69140504|FG007|Overall Study|Withdrawal by Subject|0|||
37667964|NCT02109484|69140497|FG000|Overall Study|Physician Decision|0|||
37667965|NCT02109484|69140498|FG001|Overall Study|Physician Decision|0|||
37667966|NCT02109484|69140499|FG002|Overall Study|Physician Decision|0|||
37667967|NCT02109484|69140500|FG003|Overall Study|Physician Decision|0|||
37667968|NCT02109484|69140501|FG004|Overall Study|Physician Decision|2|||
38033844|NCT02940860|69720081|FG000|Overall Study|Non-serious AE|1|||
37667969|NCT02109484|69140502|FG005|Overall Study|Physician Decision|0|||
37667970|NCT02109484|69140503|FG006|Overall Study|Physician Decision|0|||
37667971|NCT02109484|69140504|FG007|Overall Study|Physician Decision|0|||
37667972|NCT02109484|69140497|FG000|Overall Study|Death|0|||
37667973|NCT02109484|69140498|FG001|Overall Study|Death|0|||
37667974|NCT02109484|69140499|FG002|Overall Study|Death|0|||
37760801|NCT01708954|69271743|FG002|Step 1|Crossed over to Step 2|0|||
37760802|NCT01708954|69271741|FG000|Step 1|Symptomatic deterioration|1|||
37667975|NCT02109484|69140500|FG003|Overall Study|Death|0|||
37760803|NCT01708954|69271742|FG001|Step 1|Symptomatic deterioration|0|||
37760804|NCT01708954|69271743|FG002|Step 1|Symptomatic deterioration|1|||
37929894|NCT00724503|69616719|FG001|Overall Study|Not otherwise specified|7|||
37929895|NCT00791648|69616729|FG000|Overall Study|Physician Decision|0|||
37929896|NCT00791648|69616730|FG001|Overall Study|Physician Decision|1|||
37929897|NCT00791648|69616729|FG000|Overall Study|Withdrawal by Subject|0|||
37929898|NCT00791648|69616730|FG001|Overall Study|Withdrawal by Subject|1|||
37929899|NCT00791492|69616738|FG000|Overall Study|Withdrawal by Subject|1|||
37929900|NCT00791492|69616739|FG001|Overall Study|Withdrawal by Subject|2|||
37929901|NCT00791492|69616738|FG000|Overall Study|Liver transplantation|5|||
37929902|NCT00791492|69616739|FG001|Overall Study|Liver transplantation|1|||
37929903|NCT00723957|69616747|FG000|Overall Study|Adverse event unrelated to study drug|1|||
37929904|NCT00723957|69616748|FG001|Overall Study|Adverse event unrelated to study drug|4|||
37929905|NCT00723957|69616747|FG000|Overall Study|Death|3|||
37929906|NCT00723957|69616748|FG001|Overall Study|Death|4|||
37929907|NCT00723957|69616747|FG000|Overall Study|Disease progression|27|||
37929908|NCT00723957|69616748|FG001|Overall Study|Disease progression|25|||
37929909|NCT00723957|69616747|FG000|Overall Study|Maximum clinical benefit|4|||
37929910|NCT00723957|69616748|FG001|Overall Study|Maximum clinical benefit|5|||
37929911|NCT00723957|69616747|FG000|Overall Study|Investigator decision|1|||
37929912|NCT00723957|69616748|FG001|Overall Study|Investigator decision|1|||
37929913|NCT00723957|69616747|FG000|Overall Study|Study drug toxicity|4|||
37929914|NCT00723957|69616748|FG001|Overall Study|Study drug toxicity|6|||
37929915|NCT00723957|69616747|FG000|Overall Study|Withdrawal by Subject|7|||
37929916|NCT00723957|69616748|FG001|Overall Study|Withdrawal by Subject|5|||
37929917|NCT00723957|69616747|FG000|Overall Study|Reason not analyzed|1|||
37929918|NCT00723957|69616748|FG001|Overall Study|Reason not analyzed|0|||
37929919|NCT00723957|69616747|FG000|Overall Study|Never received treatment|3|||
37929920|NCT00723957|69616748|FG001|Overall Study|Never received treatment|3|||
37929921|NCT00723801|69616756|FG000|Overall Study|Lost to Follow-up|1|||
37929922|NCT00723801|69616757|FG001|Overall Study|Lost to Follow-up|2|||
37929923|NCT00723801|69616756|FG000|Overall Study|Protocol Violation|2|||
37929924|NCT00723801|69616757|FG001|Overall Study|Protocol Violation|1|||
37929925|NCT00797966|69616767|FG000|Phase A|Lost to Follow-up|0|||
37929926|NCT00797966|69616768|FG001|Phase A|Lost to Follow-up|0|||
37929927|NCT00797966|69616769|FG002|Phase A|Lost to Follow-up|0|||
37929928|NCT00797966|69616770|FG003|Phase A|Lost to Follow-up|0|||
37929929|NCT00797966|69616771|FG004|Phase A|Lost to Follow-up|33|||
37929930|NCT00797966|69616772|FG005|Phase A|Lost to Follow-up|0|||
37929931|NCT00797966|69616767|FG000|Phase A|Adverse Event|0|||
37929932|NCT00797966|69616768|FG001|Phase A|Adverse Event|0|||
37929933|NCT00797966|69616769|FG002|Phase A|Adverse Event|0|||
37929934|NCT00797966|69616770|FG003|Phase A|Adverse Event|0|||
37929935|NCT00797966|69616771|FG004|Phase A|Adverse Event|46|||
37929936|NCT00797966|69616772|FG005|Phase A|Adverse Event|0|||
37929937|NCT00797966|69616767|FG000|Phase A|Met withdrawal criteria|0|||
37929938|NCT00797966|69616768|FG001|Phase A|Met withdrawal criteria|0|||
37929939|NCT00797966|69616769|FG002|Phase A|Met withdrawal criteria|0|||
37929940|NCT00797966|69616770|FG003|Phase A|Met withdrawal criteria|0|||
37929941|NCT00797966|69616771|FG004|Phase A|Met withdrawal criteria|4|||
37929942|NCT00797966|69616772|FG005|Phase A|Met withdrawal criteria|0|||
37929943|NCT00797966|69616767|FG000|Phase A|Physician Decision|0|||
37929944|NCT00797966|69616768|FG001|Phase A|Physician Decision|0|||
37929945|NCT00797966|69616769|FG002|Phase A|Physician Decision|0|||
37929946|NCT00797966|69616770|FG003|Phase A|Physician Decision|0|||
37929947|NCT00797966|69616771|FG004|Phase A|Physician Decision|13|||
37929948|NCT00797966|69616772|FG005|Phase A|Physician Decision|0|||
37929949|NCT00797966|69616767|FG000|Phase A|Withdrawal by Subject|0|||
37929950|NCT00797966|69616768|FG001|Phase A|Withdrawal by Subject|0|||
37929951|NCT00797966|69616769|FG002|Phase A|Withdrawal by Subject|0|||
37929952|NCT00797966|69616770|FG003|Phase A|Withdrawal by Subject|0|||
37929953|NCT00797966|69616771|FG004|Phase A|Withdrawal by Subject|33|||
37929954|NCT00797966|69616772|FG005|Phase A|Withdrawal by Subject|0|||
37929955|NCT00797966|69616767|FG000|Phase A|Protocol deviation|0|||
37929956|NCT00797966|69616768|FG001|Phase A|Protocol deviation|0|||
37929957|NCT00797966|69616769|FG002|Phase A|Protocol deviation|0|||
37929958|NCT00797966|69616770|FG003|Phase A|Protocol deviation|0|||
37929959|NCT00797966|69616771|FG004|Phase A|Protocol deviation|56|||
37929960|NCT00797966|69616772|FG005|Phase A|Protocol deviation|0|||
37929961|NCT00797966|69616767|FG000|Phase B|Lost to Follow-up|0|||
38033845|NCT02940860|69720082|FG001|Overall Study|Non-serious AE|2|||
38033846|NCT02940860|69720081|FG000|Overall Study|Serious AE|7|||
38033847|NCT02940860|69720082|FG001|Overall Study|Serious AE|3|||
37929962|NCT00797966|69616768|FG001|Phase B|Lost to Follow-up|1|||
37929963|NCT00797966|69616769|FG002|Phase B|Lost to Follow-up|3|||
37929964|NCT00797966|69616770|FG003|Phase B|Lost to Follow-up|0|||
37929965|NCT00797966|69616771|FG004|Phase B|Lost to Follow-up|0|||
37929966|NCT00797966|69616772|FG005|Phase B|Lost to Follow-up|0|||
37929967|NCT00797966|69616767|FG000|Phase B|Adverse Event|2|||
37929968|NCT00797966|69616768|FG001|Phase B|Adverse Event|1|||
37929969|NCT00797966|69616769|FG002|Phase B|Adverse Event|3|||
37929970|NCT00797966|69616770|FG003|Phase B|Adverse Event|1|||
37929971|NCT00797966|69616771|FG004|Phase B|Adverse Event|0|||
37929972|NCT00797966|69616772|FG005|Phase B|Adverse Event|0|||
37929973|NCT00797966|69616767|FG000|Phase B|Met Withdrawal Criteria|3|||
37929974|NCT00797966|69616768|FG001|Phase B|Met Withdrawal Criteria|3|||
37929975|NCT00797966|69616769|FG002|Phase B|Met Withdrawal Criteria|6|||
37929976|NCT00797966|69616770|FG003|Phase B|Met Withdrawal Criteria|1|||
37929977|NCT00797966|69616771|FG004|Phase B|Met Withdrawal Criteria|0|||
37929978|NCT00797966|69616772|FG005|Phase B|Met Withdrawal Criteria|0|||
37929979|NCT00797966|69616767|FG000|Phase B|Physician Decision|1|||
37929980|NCT00797966|69616768|FG001|Phase B|Physician Decision|0|||
37929981|NCT00797966|69616769|FG002|Phase B|Physician Decision|3|||
37929982|NCT00797966|69616770|FG003|Phase B|Physician Decision|1|||
37929983|NCT00797966|69616771|FG004|Phase B|Physician Decision|0|||
37929984|NCT00797966|69616772|FG005|Phase B|Physician Decision|0|||
37929985|NCT00797966|69616767|FG000|Phase B|Withdrawal by Subject|1|||
37929986|NCT00797966|69616768|FG001|Phase B|Withdrawal by Subject|4|||
37929987|NCT00797966|69616769|FG002|Phase B|Withdrawal by Subject|3|||
37929988|NCT00797966|69616770|FG003|Phase B|Withdrawal by Subject|3|||
37929989|NCT00797966|69616771|FG004|Phase B|Withdrawal by Subject|0|||
37929990|NCT00797966|69616772|FG005|Phase B|Withdrawal by Subject|0|||
37929991|NCT00797966|69616767|FG000|Phase B|Protocol Deviation|4|||
37929992|NCT00797966|69616768|FG001|Phase B|Protocol Deviation|8|||
37929993|NCT00797966|69616769|FG002|Phase B|Protocol Deviation|2|||
37929994|NCT00797966|69616770|FG003|Phase B|Protocol Deviation|6|||
37929995|NCT00797966|69616771|FG004|Phase B|Protocol Deviation|0|||
37929996|NCT00797966|69616772|FG005|Phase B|Protocol Deviation|0|||
37929997|NCT00797966|69616767|FG000|Phase B|Lack of Efficacy|0|||
37929998|NCT00797966|69616768|FG001|Phase B|Lack of Efficacy|1|||
37929999|NCT00797966|69616769|FG002|Phase B|Lack of Efficacy|1|||
37930000|NCT00797966|69616770|FG003|Phase B|Lack of Efficacy|4|||
37930001|NCT00797966|69616771|FG004|Phase B|Lack of Efficacy|0|||
37930002|NCT00797966|69616772|FG005|Phase B|Lack of Efficacy|0|||
37930003|NCT00797966|69616767|FG000|Phase A+|Lost to Follow-up|0|||
37930004|NCT00797966|69616768|FG001|Phase A+|Lost to Follow-up|0|||
37930005|NCT00797966|69616769|FG002|Phase A+|Lost to Follow-up|0|||
37930006|NCT00797966|69616770|FG003|Phase A+|Lost to Follow-up|0|||
37930007|NCT00797966|69616771|FG004|Phase A+|Lost to Follow-up|0|||
37930008|NCT00797966|69616772|FG005|Phase A+|Lost to Follow-up|9|||
37930009|NCT00797966|69616767|FG000|Phase A+|Met withdrawal criteria|0|||
37930010|NCT00797966|69616768|FG001|Phase A+|Met withdrawal criteria|0|||
37930011|NCT00797966|69616769|FG002|Phase A+|Met withdrawal criteria|0|||
37930012|NCT00797966|69616770|FG003|Phase A+|Met withdrawal criteria|0|||
37930013|NCT00797966|69616771|FG004|Phase A+|Met withdrawal criteria|0|||
37930014|NCT00797966|69616772|FG005|Phase A+|Met withdrawal criteria|5|||
37930015|NCT00797966|69616767|FG000|Phase A+|Withdrawal by Subject|0|||
37930016|NCT00797966|69616768|FG001|Phase A+|Withdrawal by Subject|0|||
37930017|NCT00797966|69616769|FG002|Phase A+|Withdrawal by Subject|0|||
37930018|NCT00797966|69616770|FG003|Phase A+|Withdrawal by Subject|0|||
37930019|NCT00797966|69616771|FG004|Phase A+|Withdrawal by Subject|0|||
37930020|NCT00797966|69616772|FG005|Phase A+|Withdrawal by Subject|6|||
37930021|NCT00797966|69616767|FG000|Phase A+|Adverse Event|0|||
37760805|NCT01708954|69271741|FG000|Step 1|Off-treatment reason not submitted|1|||
37760806|NCT01708954|69271742|FG001|Step 1|Off-treatment reason not submitted|1|||
37760807|NCT01708954|69271743|FG002|Step 1|Off-treatment reason not submitted|1|||
37760808|NCT01708954|69271741|FG000|Step 1|Ineligible or never received treatment|4|||
37930022|NCT00797966|69616768|FG001|Phase A+|Adverse Event|0|||
37930023|NCT00797966|69616769|FG002|Phase A+|Adverse Event|0|||
37930024|NCT00797966|69616770|FG003|Phase A+|Adverse Event|0|||
37930025|NCT00797966|69616771|FG004|Phase A+|Adverse Event|0|||
37930026|NCT00797966|69616772|FG005|Phase A+|Adverse Event|4|||
37930027|NCT00797966|69616767|FG000|Phase A+|Protocol deviation|0|||
37930028|NCT00797966|69616768|FG001|Phase A+|Protocol deviation|0|||
37930029|NCT00797966|69616769|FG002|Phase A+|Protocol deviation|0|||
37930030|NCT00797966|69616770|FG003|Phase A+|Protocol deviation|0|||
37930031|NCT00797966|69616771|FG004|Phase A+|Protocol deviation|0|||
37930032|NCT00797966|69616772|FG005|Phase A+|Protocol deviation|4|||
37930033|NCT00723489|69616788|FG000|Overall Study|Physician Decision|0|||
37760809|NCT01708954|69271742|FG001|Step 1|Ineligible or never received treatment|2|||
37760810|NCT01708954|69271743|FG002|Step 1|Ineligible or never received treatment|8|||
37930034|NCT00723489|69616789|FG001|Overall Study|Physician Decision|1|||
38033848|NCT02940860|69720081|FG000|Overall Study|Withdrawal by Subject|19|||
37760811|NCT01708954|69271741|FG000|Step 2|Disease progression|9|||
37930035|NCT00723489|69616790|FG002|Overall Study|Physician Decision|0|||
37930036|NCT00723489|69616791|FG003|Overall Study|Physician Decision|0|||
37930037|NCT00723489|69616788|FG000|Overall Study|Pregnancy|0|||
37930038|NCT00723489|69616789|FG001|Overall Study|Pregnancy|0|||
37930039|NCT00723489|69616790|FG002|Overall Study|Pregnancy|0|||
37930040|NCT00723489|69616791|FG003|Overall Study|Pregnancy|1|||
37930041|NCT00723489|69616788|FG000|Overall Study|Withdrawal by Subject|0|||
38033849|NCT02940860|69720082|FG001|Overall Study|Withdrawal by Subject|9|||
37930042|NCT00723489|69616789|FG001|Overall Study|Withdrawal by Subject|0|||
37930043|NCT00723489|69616790|FG002|Overall Study|Withdrawal by Subject|0|||
37930044|NCT00723489|69616791|FG003|Overall Study|Withdrawal by Subject|1|||
37930045|NCT00723489|69616788|FG000|Overall Study|Seropositive at baseline|1|||
37930046|NCT00723489|69616789|FG001|Overall Study|Seropositive at baseline|0|||
37930047|NCT00723489|69616790|FG002|Overall Study|Seropositive at baseline|0|||
37930048|NCT00723489|69616791|FG003|Overall Study|Seropositive at baseline|0|||
37930049|NCT00723489|69616788|FG000|Overall Study|Prohibited Medication|0|||
37930050|NCT00723489|69616789|FG001|Overall Study|Prohibited Medication|0|||
37930051|NCT00723489|69616790|FG002|Overall Study|Prohibited Medication|0|||
37930052|NCT00723489|69616791|FG003|Overall Study|Prohibited Medication|1|||
37930053|NCT00723489|69616788|FG000|Overall Study|Samples Collected Out of Window|0|||
37930054|NCT00723489|69616789|FG001|Overall Study|Samples Collected Out of Window|3|||
37930055|NCT00723489|69616790|FG002|Overall Study|Samples Collected Out of Window|0|||
37930056|NCT00723489|69616791|FG003|Overall Study|Samples Collected Out of Window|0|||
37930057|NCT00587990|69616804|FG000|Overall Study|Death|0|||
37930058|NCT00587990|69616805|FG001|Overall Study|Death|0|||
37930059|NCT00587990|69616806|FG002|Overall Study|Death|1|||
37930060|NCT00723255|69616814|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
37930061|NCT00723255|69616814|FG000|Overall Study|Ineligible: Second primary|1|||
37930062|NCT00723255|69616814|FG000|Overall Study|Ineligible: Wrong Primary|2|||
37930063|NCT00791258|69616830|FG000|Overall Study|Adverse Event|87|||
37930064|NCT00791258|69616830|FG000|Overall Study|Lost to Follow-up|18|||
37930065|NCT00791258|69616830|FG000|Overall Study|Protocol Violation|109|||
37930066|NCT00791258|69616830|FG000|Overall Study|Withdrawal by Subject|40|||
37930067|NCT00791258|69616830|FG000|Overall Study|Did not take medication for >3 days|1|||
37930068|NCT00791258|69616830|FG000|Overall Study|subject left area|2|||
37930069|NCT00791258|69616830|FG000|Overall Study|non-compliance|3|||
37930070|NCT00791258|69616830|FG000|Overall Study|Subject incarcerated|1|||
37930071|NCT00791258|69616830|FG000|Overall Study|Subject required restricted medication|1|||
37930072|NCT00791258|69616830|FG000|Overall Study|Lack of Efficacy|1|||
37930073|NCT00808067|69616836|FG000|Overall Study|Major/minor bleed|30|||
37930074|NCT00808067|69616837|FG001|Overall Study|Major/minor bleed|44|||
37930075|NCT00808067|69616836|FG000|Overall Study|Outcome event - other|33|||
37930076|NCT00808067|69616837|FG001|Overall Study|Outcome event - other|25|||
37930077|NCT00808067|69616836|FG000|Overall Study|Adverse Event|111|||
37930078|NCT00808067|69616837|FG001|Overall Study|Adverse Event|121|||
37930079|NCT00808067|69616836|FG000|Overall Study|Hospitalization (not including surgery)|18|||
37930080|NCT00808067|69616837|FG001|Overall Study|Hospitalization (not including surgery)|17|||
37930081|NCT00808067|69616836|FG000|Overall Study|Hospitalization due to surgery|37|||
37930082|NCT00808067|69616837|FG001|Overall Study|Hospitalization due to surgery|40|||
37930083|NCT00808067|69616836|FG000|Overall Study|Reduced creatinine clearance|53|||
37930084|NCT00808067|69616837|FG001|Overall Study|Reduced creatinine clearance|55|||
37930085|NCT00808067|69616836|FG000|Overall Study|Elevated LFT results|7|||
37930086|NCT00808067|69616837|FG001|Overall Study|Elevated LFT results|3|||
37930087|NCT00808067|69616836|FG000|Overall Study|Patient refused to take study medication|65|||
37930088|NCT00808067|69616837|FG001|Overall Study|Patient refused to take study medication|76|||
37930089|NCT00808067|69616836|FG000|Overall Study|Missing|1|||
37930090|NCT00808067|69616837|FG001|Overall Study|Missing|0|||
37930091|NCT00808067|69616836|FG000|Overall Study|Death|1|||
37930092|NCT00808067|69616837|FG001|Overall Study|Death|1|||
37930093|NCT00808067|69616836|FG000|Overall Study|Procedure|6|||
37930094|NCT00808067|69616837|FG001|Overall Study|Procedure|7|||
37930095|NCT00808067|69616836|FG000|Overall Study|Withdrawal by Subject|21|||
37930096|NCT00808067|69616837|FG001|Overall Study|Withdrawal by Subject|25|||
37930097|NCT00808067|69616836|FG000|Overall Study|Site closed|4|||
37930098|NCT00808067|69616837|FG001|Overall Study|Site closed|3|||
37930099|NCT00808067|69616836|FG000|Overall Study|Physician Decision|47|||
37930100|NCT00808067|69616837|FG001|Overall Study|Physician Decision|38|||
37930101|NCT00808067|69616836|FG000|Overall Study|Protocol Violation|3|||
37930102|NCT00808067|69616837|FG001|Overall Study|Protocol Violation|11|||
37930103|NCT00808067|69616836|FG000|Overall Study|Patient elected|7|||
37930104|NCT00808067|69616837|FG001|Overall Study|Patient elected|9|||
37930105|NCT00808067|69616836|FG000|Overall Study|Site closed for cause|19|||
37930106|NCT00808067|69616837|FG001|Overall Study|Site closed for cause|19|||
37930107|NCT00808067|69616836|FG000|Overall Study|Other reason not defined above|5|||
37930108|NCT00808067|69616837|FG001|Overall Study|Other reason not defined above|5|||
37930109|NCT00808067|69616836|FG000|Overall Study|Excluded from analysis|13|||
37930110|NCT00808067|69616837|FG001|Overall Study|Excluded from analysis|19|||
37930111|NCT00723021|69616843|FG000|Intervention Period 4|Adverse Event|0|||
37930112|NCT00723021|69616844|FG001|Intervention Period 4|Adverse Event|0|||
37930113|NCT00723021|69616845|FG002|Intervention Period 4|Adverse Event|0|||
37930114|NCT00723021|69616846|FG003|Intervention Period 4|Adverse Event|0|||
37930115|NCT00723021|69616847|FG004|Intervention Period 4|Adverse Event|1|||
37930116|NCT00721227|69616868|FG000|Overall Study|Lost to Follow-up|3|||
37930117|NCT00721227|69616869|FG001|Overall Study|Lost to Follow-up|0|||
37930118|NCT00721227|69616868|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
37930119|NCT00721227|69616869|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
37930120|NCT00807599|69616877|FG000|Overall Study|Not treated on protocol study|0|||
37930121|NCT00807599|69616878|FG001|Overall Study|Not treated on protocol study|0|||
37930122|NCT00807599|69616879|FG002|Overall Study|Not treated on protocol study|2|||
37930123|NCT00807599|69616877|FG000|Overall Study|Adverse Event|0|||
37930124|NCT00807599|69616878|FG001|Overall Study|Adverse Event|0|||
37930125|NCT00807599|69616879|FG002|Overall Study|Adverse Event|5|||
37930126|NCT00807599|69616877|FG000|Overall Study|Inadequate response to induction|0|||
37930127|NCT00807599|69616878|FG001|Overall Study|Inadequate response to induction|0|||
37930128|NCT00807599|69616879|FG002|Overall Study|Inadequate response to induction|9|||
37930129|NCT00807599|69616877|FG000|Overall Study|Withdrawal by Subject|0|||
37930130|NCT00807599|69616878|FG001|Overall Study|Withdrawal by Subject|0|||
37930131|NCT00807599|69616879|FG002|Overall Study|Withdrawal by Subject|1|||
37930132|NCT00721149|69616885|FG000|Overall Study|Physician Decision|1|||
37930133|NCT00788372|69616889|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
37930134|NCT00788372|69616889|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
37930135|NCT00788372|69616889|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
37930136|NCT00788372|69616889|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
37930137|NCT00788372|69616889|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
37930138|NCT00788372|69616889|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
37930139|NCT00788372|69616889|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
37930140|NCT00738582|69616893|FG000|Combination Therapy|Completed Combination Therapy|1|||
37930141|NCT00738582|69616894|FG001|Combination Therapy|Completed Combination Therapy|0|||
37930142|NCT00738582|69616893|FG000|Combination Therapy|Physician Decision|1|||
37930143|NCT00738582|69616894|FG001|Combination Therapy|Physician Decision|0|||
37930144|NCT00738582|69616893|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
37930145|NCT00738582|69616894|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
37930146|NCT00738582|69616893|FG000|Combination Therapy|Other|5|||
37930147|NCT00738582|69616894|FG001|Combination Therapy|Other|0|||
37930148|NCT00738582|69616893|FG000|Combination Therapy|Adverse Event|16|||
37930149|NCT00738582|69616894|FG001|Combination Therapy|Adverse Event|0|||
37930150|NCT00738582|69616893|FG000|Combination Therapy|Progressive Disease|9|||
37930151|NCT00738582|69616894|FG001|Combination Therapy|Progressive Disease|0|||
37930152|NCT00738582|69616893|FG000|Maintenance Therapy|Other|0|||
37930153|NCT00738582|69616894|FG001|Maintenance Therapy|Other|2|||
37930154|NCT00738582|69616893|FG000|Maintenance Therapy|Adverse Event|0|||
37930155|NCT00738582|69616894|FG001|Maintenance Therapy|Adverse Event|6|||
37930156|NCT00738582|69616893|FG000|Maintenance Therapy|Progressive Disease|0|||
37930157|NCT00738582|69616894|FG001|Maintenance Therapy|Progressive Disease|47|||
37930158|NCT00738582|69616893|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
37930159|NCT00738582|69616894|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
37930160|NCT00720759|69616905|FG000|Overall Study|Lost to Follow-up|0|||
37930161|NCT00720759|69616906|FG001|Overall Study|Lost to Follow-up|1|||
37930162|NCT00720759|69616907|FG002|Overall Study|Lost to Follow-up|1|||
37930163|NCT00720759|69616908|FG003|Overall Study|Lost to Follow-up|0|||
37930164|NCT00720213|69616918|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
37930165|NCT00720213|69616919|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
37930166|NCT00720213|69616920|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
37930167|NCT00810407|69616928|FG000|Overall Study|Protocol Violation|3|||
37930168|NCT00810407|69616928|FG000|Overall Study|No Visit After First Day of Treatment|3|||
37930169|NCT00720057|69616934|FG000|Overall Study|Lost to Follow-up|0|||
37930170|NCT00720057|69616935|FG001|Overall Study|Lost to Follow-up|2|||
37930171|NCT00720057|69616934|FG000|Overall Study|Protocol Violation|1|||
37930172|NCT00720057|69616935|FG001|Overall Study|Protocol Violation|0|||
37930173|NCT00720057|69616934|FG000|Overall Study|Withdrawal by Subject|0|||
37930174|NCT00720057|69616935|FG001|Overall Study|Withdrawal by Subject|1|||
37667976|NCT02109484|69140501|FG004|Overall Study|Death|0|||
37667977|NCT02109484|69140502|FG005|Overall Study|Death|0|||
37667978|NCT02109484|69140503|FG006|Overall Study|Death|0|||
37667979|NCT02109484|69140504|FG007|Overall Study|Death|2|||
37667980|NCT02109484|69140497|FG000|Overall Study|Moved away from study area|0|||
37667981|NCT02109484|69140498|FG001|Overall Study|Moved away from study area|0|||
37667982|NCT02109484|69140499|FG002|Overall Study|Moved away from study area|0|||
37930175|NCT00790868|69616943|FG000|Overall Study|Withdrawal by Subject|4|||
37930176|NCT00790868|69616944|FG001|Overall Study|Withdrawal by Subject|5|||
37930177|NCT00790868|69616943|FG000|Overall Study|Lost to Follow-up|2|||
37930178|NCT00790868|69616944|FG001|Overall Study|Lost to Follow-up|12|||
37930179|NCT00719901|69616952|FG000|Overall Study|Adverse Event|5|||
37930180|NCT00719901|69616952|FG000|Overall Study|Withdrawal by Subject|1|||
37930181|NCT00719901|69616952|FG000|Overall Study|Alternate Treatment|1|||
37667983|NCT02109484|69140500|FG003|Overall Study|Moved away from study area|0|||
37667984|NCT02109484|69140501|FG004|Overall Study|Moved away from study area|0|||
37667985|NCT02109484|69140502|FG005|Overall Study|Moved away from study area|0|||
37930182|NCT00719901|69616952|FG000|Overall Study|Disease Progression|3|||
37930183|NCT00719901|69616952|FG000|Overall Study|Availability of Study Drug|1|||
37930184|NCT00807365|69616956|FG000|Overall Study|Study Terminated|5|||
37930185|NCT00719355|69616962|FG000|Overall Study|Death|0|||
37930186|NCT00719355|69616963|FG001|Overall Study|Death|1|||
37930187|NCT00719355|69616962|FG000|Overall Study|Medical|14|||
37930188|NCT00719355|69616963|FG001|Overall Study|Medical|5|||
37930189|NCT00719355|69616962|FG000|Overall Study|Compliance|4|||
37930190|NCT00719355|69616963|FG001|Overall Study|Compliance|6|||
37930191|NCT00719355|69616962|FG000|Overall Study|Moved|0|||
37930192|NCT00719355|69616963|FG001|Overall Study|Moved|1|||
37930193|NCT00590759|69616969|FG000|Overall Study|Death|52|||
37930194|NCT00590759|69616969|FG000|Overall Study|Lost to Follow-up|28|||
37930195|NCT00734604|69616979|FG000|Overall Study|Adverse Event|0|||
37930196|NCT00734604|69616980|FG001|Overall Study|Adverse Event|2|||
37930197|NCT00734604|69616981|FG002|Overall Study|Adverse Event|0|||
37930198|NCT00734604|69616982|FG003|Overall Study|Adverse Event|2|||
37930199|NCT00734604|69616983|FG004|Overall Study|Adverse Event|1|||
37930200|NCT00734604|69616984|FG005|Overall Study|Adverse Event|1|||
37930201|NCT00734604|69616979|FG000|Overall Study|Serious Adverse Event|1|||
37930202|NCT00734604|69616980|FG001|Overall Study|Serious Adverse Event|0|||
37930203|NCT00734604|69616981|FG002|Overall Study|Serious Adverse Event|1|||
37930204|NCT00734604|69616982|FG003|Overall Study|Serious Adverse Event|2|||
37930205|NCT00734604|69616983|FG004|Overall Study|Serious Adverse Event|0|||
37930206|NCT00734604|69616984|FG005|Overall Study|Serious Adverse Event|1|||
37930207|NCT00734604|69616979|FG000|Overall Study|Lost to Follow-up|1|||
37930208|NCT00734604|69616980|FG001|Overall Study|Lost to Follow-up|2|||
37930209|NCT00734604|69616981|FG002|Overall Study|Lost to Follow-up|2|||
37930210|NCT00734604|69616982|FG003|Overall Study|Lost to Follow-up|4|||
37930211|NCT00734604|69616983|FG004|Overall Study|Lost to Follow-up|2|||
37930212|NCT00734604|69616984|FG005|Overall Study|Lost to Follow-up|3|||
37930213|NCT00734604|69616979|FG000|Overall Study|Physician Decision|0|||
37930214|NCT00734604|69616980|FG001|Overall Study|Physician Decision|1|||
37930215|NCT00734604|69616981|FG002|Overall Study|Physician Decision|1|||
37930216|NCT00734604|69616982|FG003|Overall Study|Physician Decision|0|||
37930217|NCT00734604|69616983|FG004|Overall Study|Physician Decision|0|||
37930218|NCT00734604|69616984|FG005|Overall Study|Physician Decision|0|||
37930219|NCT00734604|69616979|FG000|Overall Study|Protocol Violation|0|||
37930220|NCT00734604|69616980|FG001|Overall Study|Protocol Violation|2|||
37930221|NCT00734604|69616981|FG002|Overall Study|Protocol Violation|0|||
37930222|NCT00734604|69616982|FG003|Overall Study|Protocol Violation|0|||
37930223|NCT00734604|69616983|FG004|Overall Study|Protocol Violation|1|||
37930224|NCT00734604|69616984|FG005|Overall Study|Protocol Violation|0|||
37930225|NCT00734604|69616979|FG000|Overall Study|Sponsor Decision|1|||
37930226|NCT00734604|69616980|FG001|Overall Study|Sponsor Decision|2|||
37930227|NCT00734604|69616981|FG002|Overall Study|Sponsor Decision|1|||
37930228|NCT00734604|69616982|FG003|Overall Study|Sponsor Decision|0|||
37930229|NCT00734604|69616983|FG004|Overall Study|Sponsor Decision|2|||
37930230|NCT00734604|69616984|FG005|Overall Study|Sponsor Decision|0|||
37930231|NCT00734604|69616979|FG000|Overall Study|Withdrawal by Subject|0|||
37930232|NCT00734604|69616980|FG001|Overall Study|Withdrawal by Subject|2|||
37930233|NCT00734604|69616981|FG002|Overall Study|Withdrawal by Subject|0|||
37930234|NCT00734604|69616982|FG003|Overall Study|Withdrawal by Subject|1|||
37930235|NCT00734604|69616983|FG004|Overall Study|Withdrawal by Subject|2|||
37930236|NCT00734604|69616984|FG005|Overall Study|Withdrawal by Subject|1|||
37930237|NCT00734604|69616979|FG000|Overall Study|Lack of Efficacy|0|||
37930238|NCT00734604|69616980|FG001|Overall Study|Lack of Efficacy|1|||
37930239|NCT00734604|69616981|FG002|Overall Study|Lack of Efficacy|1|||
37930240|NCT00734604|69616982|FG003|Overall Study|Lack of Efficacy|0|||
37930241|NCT00734604|69616983|FG004|Overall Study|Lack of Efficacy|0|||
37930242|NCT00734604|69616984|FG005|Overall Study|Lack of Efficacy|0|||
37930243|NCT00590681|69616995|FG000|Overall Study|Withdrawal by Subject|7|||
37930244|NCT00590681|69616995|FG000|Overall Study|Adverse Event|8|||
37930245|NCT00590681|69616995|FG000|Overall Study|Death|3|||
37930246|NCT00590681|69616995|FG000|Overall Study|Lost to Follow-up|1|||
37930247|NCT00590681|69616995|FG000|Overall Study|disease progression|1|||
37930248|NCT00727272|69616999|FG000|Washout Period A|Adverse Event|0|||
37930249|NCT00727272|69617000|FG001|Washout Period A|Adverse Event|0|||
37930250|NCT00727272|69617001|FG002|Washout Period A|Adverse Event|1|||
37930251|NCT00727272|69616999|FG000|Washout Period B|Withdrawal by Subject|0|||
37930252|NCT00727272|69617000|FG001|Washout Period B|Withdrawal by Subject|0|||
37930253|NCT00727272|69617001|FG002|Washout Period B|Withdrawal by Subject|1|||
37930254|NCT00805025|69617011|FG000|Overall Study|Screened but not enrolled/treated|42|||
37930255|NCT00805025|69617011|FG000|Overall Study|Adverse Event|4|||
37930256|NCT00805025|69617011|FG000|Overall Study|Withdrawal by Subject|2|||
37930257|NCT00805025|69617011|FG000|Overall Study|Physician Decision|1|||
37930258|NCT00734214|69617017|FG000|Overall Study|Withdrawal by Subject|3|||
37930259|NCT00734214|69617018|FG001|Overall Study|Withdrawal by Subject|4|||
37930260|NCT00734214|69617017|FG000|Overall Study|MD withdrawal|1|||
37930261|NCT00734214|69617018|FG001|Overall Study|MD withdrawal|0|||
37930262|NCT00787202|69617029|FG000|Overall Study|Adverse Event|3|||
37930263|NCT00787202|69617030|FG001|Overall Study|Adverse Event|2|||
37930264|NCT00787202|69617031|FG002|Overall Study|Adverse Event|0|||
37930265|NCT00787202|69617032|FG003|Overall Study|Adverse Event|0|||
37930266|NCT00787202|69617033|FG004|Overall Study|Adverse Event|2|||
37930267|NCT00787202|69617029|FG000|Overall Study|Lack of Efficacy|5|||
37930268|NCT00787202|69617030|FG001|Overall Study|Lack of Efficacy|6|||
37930269|NCT00787202|69617031|FG002|Overall Study|Lack of Efficacy|5|||
37930270|NCT00787202|69617032|FG003|Overall Study|Lack of Efficacy|2|||
37930271|NCT00787202|69617033|FG004|Overall Study|Lack of Efficacy|1|||
37930272|NCT00787202|69617029|FG000|Overall Study|Lost to Follow-up|1|||
37930273|NCT00787202|69617030|FG001|Overall Study|Lost to Follow-up|0|||
37930274|NCT00787202|69617031|FG002|Overall Study|Lost to Follow-up|0|||
37930275|NCT00787202|69617032|FG003|Overall Study|Lost to Follow-up|0|||
37930276|NCT00787202|69617033|FG004|Overall Study|Lost to Follow-up|0|||
37930277|NCT00787202|69617029|FG000|Overall Study|Withdrawal by Subject|2|||
37930278|NCT00787202|69617030|FG001|Overall Study|Withdrawal by Subject|2|||
37930279|NCT00787202|69617031|FG002|Overall Study|Withdrawal by Subject|2|||
37930280|NCT00787202|69617032|FG003|Overall Study|Withdrawal by Subject|0|||
37930281|NCT00787202|69617033|FG004|Overall Study|Withdrawal by Subject|0|||
37930282|NCT00787202|69617029|FG000|Overall Study|Protocol Violation|2|||
37930283|NCT00787202|69617030|FG001|Overall Study|Protocol Violation|1|||
37930284|NCT00787202|69617031|FG002|Overall Study|Protocol Violation|0|||
37930285|NCT00787202|69617032|FG003|Overall Study|Protocol Violation|0|||
37930286|NCT00787202|69617033|FG004|Overall Study|Protocol Violation|1|||
37930287|NCT00787202|69617029|FG000|Overall Study|Randomized, not treated|1|||
37930288|NCT00787202|69617030|FG001|Overall Study|Randomized, not treated|0|||
37930289|NCT00787202|69617031|FG002|Overall Study|Randomized, not treated|0|||
37930290|NCT00787202|69617032|FG003|Overall Study|Randomized, not treated|0|||
37930291|NCT00787202|69617033|FG004|Overall Study|Randomized, not treated|0|||
37930292|NCT04033367|69617051|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
37930293|NCT04033367|69617052|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
37930294|NCT04033367|69617051|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
37930295|NCT04033367|69617052|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
37930296|NCT04033367|69617051|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
37930297|NCT04033367|69617052|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
37930298|NCT04033367|69617051|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
37930299|NCT04033367|69617052|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
37930300|NCT00733980|69617064|FG000|Overall Study|Adverse Event|5|||
37930301|NCT00733980|69617065|FG001|Overall Study|Adverse Event|2|||
37930302|NCT00733980|69617064|FG000|Overall Study|Lack of Efficacy|0|||
37930303|NCT00733980|69617065|FG001|Overall Study|Lack of Efficacy|1|||
37930304|NCT00733980|69617064|FG000|Overall Study|Protocol Violation|2|||
37930305|NCT00733980|69617065|FG001|Overall Study|Protocol Violation|1|||
37930306|NCT00733980|69617064|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
37930307|NCT00733980|69617065|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
37930308|NCT00733980|69617064|FG000|Overall Study|Lost to Follow-up|6|||
37930309|NCT00733980|69617065|FG001|Overall Study|Lost to Follow-up|11|||
37930310|NCT00733980|69617064|FG000|Overall Study|Physician Decision|2|||
37930311|NCT00733980|69617065|FG001|Overall Study|Physician Decision|3|||
37930312|NCT00733980|69617064|FG000|Overall Study|Withdrawal by Subject|6|||
37930313|NCT00733980|69617065|FG001|Overall Study|Withdrawal by Subject|2|||
37930314|NCT00806585|69617077|FG000|Overall Study|Study terminated by Sponsor|0|||
37930315|NCT00806585|69617078|FG001|Overall Study|Study terminated by Sponsor|0|||
37930316|NCT00806585|69617079|FG002|Overall Study|Study terminated by Sponsor|1|||
37930317|NCT00806585|69617080|FG003|Overall Study|Study terminated by Sponsor|2|||
37930318|NCT00806585|69617081|FG004|Overall Study|Study terminated by Sponsor|0|||
37930319|NCT00806585|69617077|FG000|Overall Study|Protocol Violation|3|||
37930320|NCT00806585|69617078|FG001|Overall Study|Protocol Violation|1|||
37930321|NCT00806585|69617079|FG002|Overall Study|Protocol Violation|2|||
37930322|NCT00806585|69617080|FG003|Overall Study|Protocol Violation|0|||
37930323|NCT00806585|69617081|FG004|Overall Study|Protocol Violation|0|||
37930324|NCT00806585|69617077|FG000|Overall Study|Physician Decision|0|||
38033850|NCT02940860|69720081|FG000|Overall Study|Lost to Follow-up|13|||
38033851|NCT02940860|69720082|FG001|Overall Study|Lost to Follow-up|7|||
38033852|NCT02940860|69720081|FG000|Overall Study|Physician Decision|5|||
38033853|NCT02940860|69720082|FG001|Overall Study|Physician Decision|3|||
38033854|NCT02940860|69720081|FG000|Overall Study|Sponsor Decision|0|||
37930325|NCT00806585|69617078|FG001|Overall Study|Physician Decision|2|||
37930326|NCT00806585|69617079|FG002|Overall Study|Physician Decision|3|||
37930327|NCT00806585|69617080|FG003|Overall Study|Physician Decision|0|||
38033855|NCT02940860|69720082|FG001|Overall Study|Sponsor Decision|1|||
38033856|NCT02940860|69720081|FG000|Overall Study|Protocol Violation|0|||
37930328|NCT00806585|69617081|FG004|Overall Study|Physician Decision|1|||
37930329|NCT00806585|69617077|FG000|Overall Study|Lost to Follow-up|2|||
37930330|NCT00806585|69617078|FG001|Overall Study|Lost to Follow-up|1|||
37930331|NCT00806585|69617079|FG002|Overall Study|Lost to Follow-up|2|||
37930332|NCT00806585|69617080|FG003|Overall Study|Lost to Follow-up|2|||
37930333|NCT00806585|69617081|FG004|Overall Study|Lost to Follow-up|5|||
37930334|NCT00806585|69617077|FG000|Overall Study|Lack of Efficacy|1|||
37930335|NCT00806585|69617078|FG001|Overall Study|Lack of Efficacy|0|||
37930336|NCT00806585|69617079|FG002|Overall Study|Lack of Efficacy|0|||
37930337|NCT00806585|69617080|FG003|Overall Study|Lack of Efficacy|0|||
37930338|NCT00806585|69617081|FG004|Overall Study|Lack of Efficacy|0|||
37930339|NCT00806585|69617077|FG000|Overall Study|Adverse Event|1|||
37930340|NCT00806585|69617078|FG001|Overall Study|Adverse Event|5|||
37930341|NCT00806585|69617079|FG002|Overall Study|Adverse Event|3|||
37930342|NCT00806585|69617080|FG003|Overall Study|Adverse Event|4|||
37930343|NCT00806585|69617081|FG004|Overall Study|Adverse Event|2|||
37930344|NCT00806585|69617077|FG000|Overall Study|Withdrawal by Subject|10|||
37930345|NCT00806585|69617078|FG001|Overall Study|Withdrawal by Subject|8|||
37930346|NCT00806585|69617079|FG002|Overall Study|Withdrawal by Subject|9|||
37930347|NCT00806585|69617080|FG003|Overall Study|Withdrawal by Subject|3|||
37930348|NCT00806585|69617081|FG004|Overall Study|Withdrawal by Subject|11|||
37930349|NCT00806585|69617077|FG000|Overall Study|Completion status unknown|15|||
37930350|NCT00806585|69617078|FG001|Overall Study|Completion status unknown|14|||
37930351|NCT00806585|69617079|FG002|Overall Study|Completion status unknown|12|||
37930352|NCT00806585|69617080|FG003|Overall Study|Completion status unknown|4|||
37930353|NCT00806585|69617081|FG004|Overall Study|Completion status unknown|12|||
37930354|NCT00480025|69617095|FG000|Overall Study|Protocol Violation|12|||
37930355|NCT00480025|69617096|FG001|Overall Study|Protocol Violation|7|||
37930356|NCT00480025|69617095|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
37930357|NCT00480025|69617096|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
37930358|NCT00480025|69617095|FG000|Overall Study|Disease Progression / Recurrence|449|||
37930359|NCT00480025|69617096|FG001|Overall Study|Disease Progression / Recurrence|224|||
37930360|NCT00480025|69617095|FG000|Overall Study|Adverse Event|44|||
37930361|NCT00480025|69617096|FG001|Overall Study|Adverse Event|12|||
37930362|NCT00480025|69617095|FG000|Overall Study|Other|70|||
37930363|NCT00480025|69617096|FG001|Overall Study|Other|29|||
37930364|NCT00480025|69617095|FG000|Overall Study|SAE including intercurrent illness|76|||
37930365|NCT00480025|69617096|FG001|Overall Study|SAE including intercurrent illness|42|||
37930366|NCT00806351|69617110|FG000|Overall Study|Death|5|||
37930367|NCT00806351|69617111|FG001|Overall Study|Death|4|||
37930368|NCT00733902|69617121|FG000|Overall Study|Death|0|||
37930369|NCT00733902|69617122|FG001|Overall Study|Death|0|||
37930370|NCT00733902|69617123|FG002|Overall Study|Death|0|||
37930371|NCT00733902|69617124|FG003|Overall Study|Death|1|||
37930372|NCT00733902|69617121|FG000|Overall Study|Adverse Event|3|||
37930373|NCT00733902|69617122|FG001|Overall Study|Adverse Event|4|||
37930374|NCT00733902|69617123|FG002|Overall Study|Adverse Event|7|||
37930375|NCT00733902|69617124|FG003|Overall Study|Adverse Event|11|||
37930376|NCT00733902|69617121|FG000|Overall Study|Lack of Efficacy|56|||
37930377|NCT00733902|69617122|FG001|Overall Study|Lack of Efficacy|21|||
37930378|NCT00733902|69617123|FG002|Overall Study|Lack of Efficacy|34|||
37930379|NCT00733902|69617124|FG003|Overall Study|Lack of Efficacy|23|||
37930380|NCT00733902|69617121|FG000|Overall Study|Protocol Violation|4|||
37930381|NCT00733902|69617122|FG001|Overall Study|Protocol Violation|6|||
37930382|NCT00733902|69617123|FG002|Overall Study|Protocol Violation|3|||
37930383|NCT00733902|69617124|FG003|Overall Study|Protocol Violation|3|||
37930384|NCT00733902|69617121|FG000|Overall Study|Withdrawal by Subject|10|||
37930385|NCT00733902|69617122|FG001|Overall Study|Withdrawal by Subject|5|||
37930386|NCT00733902|69617123|FG002|Overall Study|Withdrawal by Subject|4|||
37930387|NCT00733902|69617124|FG003|Overall Study|Withdrawal by Subject|16|||
37930388|NCT00733902|69617121|FG000|Overall Study|Entered extension study|89|||
37930389|NCT00733902|69617122|FG001|Overall Study|Entered extension study|124|||
37930390|NCT00733902|69617123|FG002|Overall Study|Entered extension study|111|||
37930391|NCT00733902|69617124|FG003|Overall Study|Entered extension study|109|||
37930392|NCT00733902|69617121|FG000|Overall Study|Randomized but not treated|2|||
37930393|NCT00733902|69617122|FG001|Overall Study|Randomized but not treated|2|||
37930394|NCT00733902|69617123|FG002|Overall Study|Randomized but not treated|2|||
37930395|NCT00733902|69617124|FG003|Overall Study|Randomized but not treated|1|||
37930396|NCT00790790|69617137|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
37930397|NCT00790790|69617138|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
37930398|NCT00790790|69617139|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
38033857|NCT02940860|69720082|FG001|Overall Study|Protocol Violation|2|||
38033858|NCT02940860|69720081|FG000|Overall Study|Death|3|||
37930399|NCT00790790|69617137|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
37930400|NCT00790790|69617138|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
37930401|NCT00790790|69617139|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
37930402|NCT00790790|69617137|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
37930403|NCT00790790|69617138|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
37930404|NCT00790790|69617139|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
37930405|NCT00790790|69617137|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
37930406|NCT00790790|69617138|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
37930407|NCT00790790|69617139|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
37930408|NCT00790790|69617137|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
37930409|NCT00790790|69617138|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
37930410|NCT00790790|69617139|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
37930411|NCT00719043|69617159|FG000|Overall Study|Adverse Event|5|||
37930412|NCT00719043|69617160|FG001|Overall Study|Adverse Event|1|||
37930413|NCT00719043|69617161|FG002|Overall Study|Adverse Event|2|||
37930414|NCT00719043|69617162|FG003|Overall Study|Adverse Event|2|||
37930415|NCT00719043|69617163|FG004|Overall Study|Adverse Event|1|||
37930416|NCT00719043|69617164|FG005|Overall Study|Adverse Event|4|||
37930417|NCT00719043|69617165|FG006|Overall Study|Adverse Event|4|||
37930418|NCT00719043|69617159|FG000|Overall Study|Lost to Follow-up|14|||
37930419|NCT00719043|69617160|FG001|Overall Study|Lost to Follow-up|10|||
37930420|NCT00719043|69617161|FG002|Overall Study|Lost to Follow-up|8|||
37930421|NCT00719043|69617162|FG003|Overall Study|Lost to Follow-up|9|||
37930422|NCT00719043|69617163|FG004|Overall Study|Lost to Follow-up|10|||
37930423|NCT00719043|69617164|FG005|Overall Study|Lost to Follow-up|9|||
37930424|NCT00719043|69617165|FG006|Overall Study|Lost to Follow-up|9|||
37930425|NCT00719043|69617159|FG000|Overall Study|Protocol Violation|0|||
37930426|NCT00719043|69617160|FG001|Overall Study|Protocol Violation|0|||
37930427|NCT00719043|69617161|FG002|Overall Study|Protocol Violation|0|||
37930428|NCT00719043|69617162|FG003|Overall Study|Protocol Violation|0|||
37930429|NCT00719043|69617163|FG004|Overall Study|Protocol Violation|0|||
37930430|NCT00719043|69617164|FG005|Overall Study|Protocol Violation|1|||
37930431|NCT00719043|69617165|FG006|Overall Study|Protocol Violation|0|||
37930432|NCT00719043|69617159|FG000|Overall Study|Other|1|||
37930433|NCT00719043|69617160|FG001|Overall Study|Other|0|||
37930434|NCT00719043|69617161|FG002|Overall Study|Other|1|||
37930435|NCT00719043|69617162|FG003|Overall Study|Other|2|||
37930436|NCT00719043|69617163|FG004|Overall Study|Other|0|||
37930437|NCT00719043|69617164|FG005|Overall Study|Other|2|||
37930438|NCT00719043|69617165|FG006|Overall Study|Other|1|||
37930439|NCT00719043|69617159|FG000|Overall Study|Withdrawal by Subject|12|||
37930440|NCT00719043|69617160|FG001|Overall Study|Withdrawal by Subject|14|||
37930441|NCT00719043|69617161|FG002|Overall Study|Withdrawal by Subject|9|||
37930442|NCT00719043|69617162|FG003|Overall Study|Withdrawal by Subject|10|||
37930443|NCT00719043|69617163|FG004|Overall Study|Withdrawal by Subject|16|||
37930444|NCT00719043|69617164|FG005|Overall Study|Withdrawal by Subject|18|||
37930445|NCT00719043|69617165|FG006|Overall Study|Withdrawal by Subject|14|||
37930446|NCT00786422|69617193|FG000|Rivaroxaban Treatment|Death|2|||
37930447|NCT00786422|69617193|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
37930448|NCT00786422|69617193|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
37930449|NCT00786422|69617193|FG000|Rivaroxaban Treatment|Physician Decision|1|||
37930450|NCT00786422|69617193|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
37930451|NCT00786422|69617193|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
37930452|NCT00786422|69617193|FG000|Rivaroxaban Treatment|Adverse Event|2|||
37930453|NCT00786422|69617193|FG000|Follow-up Period|Death|1|||
37930454|NCT00786422|69617193|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
37930455|NCT00718887|69617201|FG000|Overall Study|Withdrawal by Subject|3|||
37930456|NCT00718887|69617202|FG001|Overall Study|Withdrawal by Subject|2|||
37930457|NCT00718887|69617201|FG000|Overall Study|Not identified|2|||
37930458|NCT00718887|69617202|FG001|Overall Study|Not identified|7|||
37930459|NCT00786188|69617216|FG000|Overall Study|Adverse Event|3|||
37930460|NCT00786188|69617217|FG001|Overall Study|Adverse Event|1|||
37930461|NCT00786188|69617216|FG000|Overall Study|Withdrawal by Subject|2|||
37930462|NCT00786188|69617217|FG001|Overall Study|Withdrawal by Subject|0|||
37930463|NCT00790556|69617225|FG000|Treatment Period 1|Physician Decision|1|||
37930464|NCT00790556|69617226|FG001|Treatment Period 1|Physician Decision|0|||
37930465|NCT00790556|69617225|FG000|Treatment Period 1|Withdrawal by Subject|1|||
37930466|NCT00790556|69617226|FG001|Treatment Period 1|Withdrawal by Subject|0|||
37930467|NCT00733824|69617237|FG000|Phase I|Withdrawal by Subject|1|||
37930468|NCT00733824|69617238|FG001|Phase I|Withdrawal by Subject|0|||
37930469|NCT00733824|69617239|FG002|Phase I|Withdrawal by Subject|0|||
37930470|NCT00733824|69617240|FG003|Phase I|Withdrawal by Subject|0|||
37930471|NCT00733824|69617241|FG004|Phase I|Withdrawal by Subject|0|||
37760812|NCT01708954|69271742|FG001|Step 2|Disease progression|4|||
37760813|NCT01708954|69271743|FG002|Step 2|Disease progression|0|||
37760814|NCT01708954|69271741|FG000|Step 2|Adverse Event|3|||
37930472|NCT00718809|69617257|FG000|Overall Study|Disease progression|9|||
37930473|NCT00718809|69617258|FG001|Overall Study|Disease progression|7|||
37930474|NCT00718809|69617257|FG000|Overall Study|Adverse Event|1|||
37930475|NCT00718809|69617258|FG001|Overall Study|Adverse Event|1|||
37930476|NCT00718809|69617257|FG000|Overall Study|Withdrawal by Subject|0|||
37930477|NCT00718809|69617258|FG001|Overall Study|Withdrawal by Subject|1|||
37930478|NCT00718809|69617257|FG000|Overall Study|Lost to Follow-up|1|||
37930479|NCT00718809|69617258|FG001|Overall Study|Lost to Follow-up|0|||
37930480|NCT00718809|69617257|FG000|Overall Study|Noncompliance|1|||
37930481|NCT00718809|69617258|FG001|Overall Study|Noncompliance|0|||
37930482|NCT00585039|69617266|FG000|Overall Study|medication spilled|2|||
37930483|NCT00585039|69617267|FG001|Overall Study|medication spilled|0|||
37930484|NCT00806195|69617279|FG000|Overall Study|Death|6|||
37760815|NCT01708954|69271742|FG001|Step 2|Adverse Event|2|||
37930485|NCT00806195|69617280|FG001|Overall Study|Death|0|||
37930486|NCT00806195|69617281|FG002|Overall Study|Death|1|||
37760816|NCT01708954|69271743|FG002|Step 2|Adverse Event|0|||
37930487|NCT00806195|69617282|FG003|Overall Study|Death|0|||
37930488|NCT00806195|69617279|FG000|Overall Study|Adverse Event|25|||
37930489|NCT00806195|69617280|FG001|Overall Study|Adverse Event|5|||
37930490|NCT00806195|69617281|FG002|Overall Study|Adverse Event|11|||
37930491|NCT00806195|69617282|FG003|Overall Study|Adverse Event|2|||
37930492|NCT00806195|69617279|FG000|Overall Study|Withdrawal by Subject|119|||
37930493|NCT00806195|69617280|FG001|Overall Study|Withdrawal by Subject|31|||
37930494|NCT00806195|69617281|FG002|Overall Study|Withdrawal by Subject|76|||
37930495|NCT00806195|69617282|FG003|Overall Study|Withdrawal by Subject|35|||
37930496|NCT00806195|69617279|FG000|Overall Study|Lost to Follow-up|217|||
37930497|NCT00806195|69617280|FG001|Overall Study|Lost to Follow-up|66|||
37930498|NCT00806195|69617281|FG002|Overall Study|Lost to Follow-up|90|||
37930499|NCT00806195|69617282|FG003|Overall Study|Lost to Follow-up|34|||
37930500|NCT00806195|69617279|FG000|Overall Study|Inappropriate Enrollment|0|||
37930501|NCT00806195|69617280|FG001|Overall Study|Inappropriate Enrollment|1|||
37930502|NCT00806195|69617281|FG002|Overall Study|Inappropriate Enrollment|0|||
37930503|NCT00806195|69617282|FG003|Overall Study|Inappropriate Enrollment|0|||
37930504|NCT00806195|69617279|FG000|Overall Study|Administrative Reason|113|||
37930505|NCT00806195|69617280|FG001|Overall Study|Administrative Reason|35|||
37930506|NCT00806195|69617281|FG002|Overall Study|Administrative Reason|66|||
37930507|NCT00806195|69617282|FG003|Overall Study|Administrative Reason|26|||
37930508|NCT00806195|69617279|FG000|Overall Study|Protocol Violation|34|||
37930509|NCT00806195|69617280|FG001|Overall Study|Protocol Violation|24|||
37930510|NCT00806195|69617281|FG002|Overall Study|Protocol Violation|26|||
37667986|NCT02109484|69140503|FG006|Overall Study|Moved away from study area|1|||
37667987|NCT02109484|69140504|FG007|Overall Study|Moved away from study area|1|||
37667988|NCT02105974|69140541|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
37667989|NCT02105974|69140542|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
37667990|NCT02105974|69140543|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
37667991|NCT02105974|69140541|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
37667992|NCT02105974|69140542|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
37667993|NCT02105974|69140543|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
37667994|NCT02105974|69140541|FG000|2 Week Run-in Period|Adverse Event|6|||
37667995|NCT02105974|69140542|FG001|2 Week Run-in Period|Adverse Event|0|||
37667996|NCT02105974|69140543|FG002|2 Week Run-in Period|Adverse Event|0|||
37667997|NCT02105974|69140541|FG000|2 Week Run-in Period|Study closed/terminated|1|||
37930511|NCT00806195|69617282|FG003|Overall Study|Protocol Violation|9|||
37930512|NCT00733746|69617294|FG000|Overall Study|Ineligible|5|||
37930513|NCT00718419|69617300|FG000|Overall Study|Adverse Event|2|||
37930514|NCT00718419|69617301|FG001|Overall Study|Adverse Event|1|||
37930515|NCT00718419|69617300|FG000|Overall Study|Physician Decision|1|||
37930516|NCT00718419|69617301|FG001|Overall Study|Physician Decision|6|||
37930517|NCT00718419|69617300|FG000|Overall Study|Sponsor decision|0|||
37930518|NCT00718419|69617301|FG001|Overall Study|Sponsor decision|1|||
37930519|NCT00718419|69617300|FG000|Overall Study|Withdrawal by Subject|0|||
37930520|NCT00718419|69617301|FG001|Overall Study|Withdrawal by Subject|5|||
37930521|NCT00718419|69617300|FG000|Overall Study|Progressive Disease|7|||
37930522|NCT00718419|69617301|FG001|Overall Study|Progressive Disease|25|||
37930523|NCT00718419|69617300|FG000|Overall Study|Death Due to Progressive Disease|2|||
37930524|NCT00718419|69617301|FG001|Overall Study|Death Due to Progressive Disease|0|||
37930525|NCT00718419|69617300|FG000|Overall Study|Death Due to Study Drug Related|0|||
37930526|NCT00718419|69617301|FG001|Overall Study|Death Due to Study Drug Related|1|||
37930527|NCT00718419|69617300|FG000|Overall Study|Death Due to Adverse Events|1|||
37930528|NCT00718419|69617301|FG001|Overall Study|Death Due to Adverse Events|0|||
37930529|NCT00717249|69617309|FG000|Overall Study|Lens Discomfort|4|||
37930530|NCT00717249|69617310|FG001|Overall Study|Lens Discomfort|1|||
37930531|NCT00717249|69617309|FG000|Overall Study|Unsatisfactory visual Response|0|||
37930532|NCT00717249|69617310|FG001|Overall Study|Unsatisfactory visual Response|2|||
37930533|NCT00717249|69617309|FG000|Overall Study|Adverse Event|4|||
37930534|NCT00717249|69617310|FG001|Overall Study|Adverse Event|2|||
37930535|NCT00717249|69617309|FG000|Overall Study|Lost to Follow-up|2|||
37930536|NCT00717249|69617310|FG001|Overall Study|Lost to Follow-up|0|||
37930537|NCT00717249|69617309|FG000|Overall Study|Withdrawal by Subject|1|||
37930538|NCT00717249|69617310|FG001|Overall Study|Withdrawal by Subject|2|||
37930539|NCT00717249|69617309|FG000|Overall Study|Pregnancy|6|||
37930540|NCT00717249|69617310|FG001|Overall Study|Pregnancy|3|||
37930541|NCT00717249|69617309|FG000|Overall Study|Protocol Violation|0|||
37930542|NCT00717249|69617310|FG001|Overall Study|Protocol Violation|2|||
37930543|NCT00717249|69617309|FG000|Overall Study|Subject became Ineligible|1|||
37930544|NCT00717249|69617310|FG001|Overall Study|Subject became Ineligible|1|||
37930545|NCT00717249|69617309|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
37930546|NCT00717249|69617310|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
37930547|NCT00717249|69617309|FG000|Overall Study|Gastric Surgery|0|||
37930548|NCT00717249|69617310|FG001|Overall Study|Gastric Surgery|1|||
37930549|NCT00717249|69617309|FG000|Overall Study|Diagnosed with Diabetes|1|||
37930550|NCT00717249|69617310|FG001|Overall Study|Diagnosed with Diabetes|0|||
37930551|NCT00717249|69617309|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
37930552|NCT00717249|69617310|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
37930553|NCT00717249|69617309|FG000|Overall Study|Subject relocated|1|||
37667998|NCT02105974|69140542|FG001|2 Week Run-in Period|Study closed/terminated|0|||
37667999|NCT02105974|69140543|FG002|2 Week Run-in Period|Study closed/terminated|0|||
37668000|NCT02105974|69140541|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
37668001|NCT02105974|69140542|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
37668002|NCT02105974|69140543|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
37668003|NCT02105974|69140541|FG000|2 Week Run-in Period|Withdrew consent|23|||
37668004|NCT02105974|69140542|FG001|2 Week Run-in Period|Withdrew consent|0|||
37668005|NCT02105974|69140543|FG002|2 Week Run-in Period|Withdrew consent|0|||
37668006|NCT02105974|69140541|FG000|2 Week Run-in Period|Investigator discretion|8|||
37668007|NCT02105974|69140542|FG001|2 Week Run-in Period|Investigator discretion|0|||
37668008|NCT02105974|69140543|FG002|2 Week Run-in Period|Investigator discretion|0|||
37668009|NCT02105974|69140541|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
37668010|NCT02105974|69140542|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
37668011|NCT02105974|69140543|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
37668012|NCT02105974|69140541|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
37668013|NCT02105974|69140542|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
37668014|NCT02105974|69140543|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
37668015|NCT02105974|69140541|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
37668016|NCT02105974|69140542|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
37668017|NCT02105974|69140543|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
37668018|NCT02105974|69140541|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
37668019|NCT02105974|69140542|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
37668020|NCT02105974|69140543|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
37668021|NCT02105974|69140541|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
37668022|NCT02105974|69140542|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
37668023|NCT02105974|69140543|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
37668024|NCT02105974|69140541|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
37668025|NCT02105974|69140542|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
37668026|NCT02105974|69140543|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
37668027|NCT02105974|69140541|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
37668028|NCT02105974|69140542|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
37668029|NCT02105974|69140543|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
37668030|NCT02105662|69140549|FG000|Overall Study|Lost to Follow-up|5|||
37668031|NCT02105662|69140549|FG000|Overall Study|Withdrawal by Subject|1|||
37668032|NCT02143102|69140555|FG000|Overall Study|Lost to Follow-up|11|||
37668033|NCT02143102|69140556|FG001|Overall Study|Lost to Follow-up|0|||
37668034|NCT02143024|69140564|FG000|Overall Study|Lost to Follow-up|1|||
37668035|NCT02143024|69140565|FG001|Overall Study|Lost to Follow-up|1|||
37668036|NCT02143024|69140564|FG000|Overall Study|Withdrawal by Subject|1|||
37668037|NCT02143024|69140565|FG001|Overall Study|Withdrawal by Subject|0|||
37668038|NCT02142712|69140574|FG000|Overall Study|Lost to Follow-up|1|||
37668039|NCT02142712|69140575|FG001|Overall Study|Lost to Follow-up|1|||
37668040|NCT02142712|69140576|FG002|Overall Study|Lost to Follow-up|1|||
37668041|NCT02142712|69140577|FG003|Overall Study|Lost to Follow-up|0|||
37668042|NCT02105272|69140588|FG000|Overall Study|Adverse Event|1|||
37668043|NCT02105272|69140589|FG001|Overall Study|Adverse Event|2|||
37668044|NCT02105272|69140588|FG000|Overall Study|Physician Decision|0|||
37668045|NCT02105272|69140589|FG001|Overall Study|Physician Decision|1|||
37668046|NCT02105272|69140588|FG000|Overall Study|Protocol Violation|2|||
37668047|NCT02105272|69140589|FG001|Overall Study|Protocol Violation|0|||
37668048|NCT02105272|69140588|FG000|Overall Study|Withdrawal by Subject|2|||
37668049|NCT02105272|69140589|FG001|Overall Study|Withdrawal by Subject|0|||
37930554|NCT00717249|69617310|FG001|Overall Study|Subject relocated|0|||
37930555|NCT00717249|69617309|FG000|Overall Study|Headaches|1|||
37930556|NCT00717249|69617310|FG001|Overall Study|Headaches|0|||
37930557|NCT00727194|69617316|FG000|Screening Period|Low QMG scores|0|||
37930558|NCT00727194|69617317|FG001|Screening Period|Low QMG scores|0|||
37930559|NCT00727194|69617318|FG002|Screening Period|Low QMG scores|6|||
37930560|NCT00727194|69617316|FG000|Screening Period|Lacked AChR antibodies|0|||
37668050|NCT02141854|69140600|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
37668051|NCT02141854|69140601|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
37668052|NCT02141854|69140602|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
37668053|NCT02141854|69140603|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
37760817|NCT01708954|69271741|FG000|Step 2|Withdrawal by Subject|1|||
37668054|NCT02141854|69140604|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
37760818|NCT01708954|69271742|FG001|Step 2|Withdrawal by Subject|1|||
37760819|NCT01708954|69271743|FG002|Step 2|Withdrawal by Subject|0|||
37930561|NCT00727194|69617317|FG001|Screening Period|Lacked AChR antibodies|0|||
37930562|NCT00727194|69617318|FG002|Screening Period|Lacked AChR antibodies|5|||
38033859|NCT02940860|69720082|FG001|Overall Study|Death|2|||
37930563|NCT00727194|69617316|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
37930564|NCT00727194|69617317|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
37930565|NCT00727194|69617318|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
37930566|NCT00727194|69617316|FG000|Screening Period|Severe infections|0|||
37930567|NCT00727194|69617317|FG001|Screening Period|Severe infections|0|||
37930568|NCT00727194|69617318|FG002|Screening Period|Severe infections|2|||
37930569|NCT00727194|69617316|FG000|Screening Period|History of thymoma|0|||
37930570|NCT00727194|69617317|FG001|Screening Period|History of thymoma|0|||
37930571|NCT00727194|69617318|FG002|Screening Period|History of thymoma|1|||
37930572|NCT00727194|69617316|FG000|Treatment Period 2|Lack of Efficacy|0|||
37930573|NCT00727194|69617317|FG001|Treatment Period 2|Lack of Efficacy|1|||
37930574|NCT00727194|69617318|FG002|Treatment Period 2|Lack of Efficacy|0|||
37930575|NCT00717093|69617334|FG000|Overall Study|Adverse Event|19|||
37930576|NCT00717093|69617335|FG001|Overall Study|Adverse Event|9|||
37930577|NCT00717093|69617334|FG000|Overall Study|Lack of Efficacy|3|||
37930578|NCT00717093|69617335|FG001|Overall Study|Lack of Efficacy|13|||
37930579|NCT00717093|69617334|FG000|Overall Study|Lost to Follow-up|9|||
37930580|NCT00717093|69617335|FG001|Overall Study|Lost to Follow-up|6|||
37930581|NCT00717093|69617334|FG000|Overall Study|Withdrawal by Subject|12|||
37930582|NCT00717093|69617335|FG001|Overall Study|Withdrawal by Subject|19|||
37930583|NCT00717093|69617334|FG000|Overall Study|Other|0|||
37930584|NCT00717093|69617335|FG001|Overall Study|Other|1|||
37930585|NCT00717093|69617334|FG000|Overall Study|Randomized but not treated|1|||
37930586|NCT00717093|69617335|FG001|Overall Study|Randomized but not treated|0|||
37930587|NCT00716859|69617343|FG000|Overall Study|Adverse Event|4|||
37930588|NCT00716859|69617344|FG001|Overall Study|Adverse Event|1|||
37930589|NCT00716859|69617343|FG000|Overall Study|Lack of Efficacy|3|||
37930590|NCT00716859|69617344|FG001|Overall Study|Lack of Efficacy|0|||
37930591|NCT00716859|69617343|FG000|Overall Study|Withdrawal by Subject|1|||
37930592|NCT00716859|69617344|FG001|Overall Study|Withdrawal by Subject|3|||
37930593|NCT00716859|69617343|FG000|Overall Study|Not treated|1|||
37930594|NCT00716859|69617344|FG001|Overall Study|Not treated|1|||
37930595|NCT00589121|69617352|FG000|Overall Study|Protocol Violation|2|||
37930596|NCT00589121|69617353|FG001|Overall Study|Protocol Violation|6|||
37930597|NCT00589121|69617352|FG000|Overall Study|No protocol treatment received|0|||
37930598|NCT00589121|69617353|FG001|Overall Study|No protocol treatment received|1|||
37930599|NCT00590135|69617362|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
37930600|NCT00589667|69617367|FG000|Overall Study|Adverse Event|2|||
37930601|NCT00589667|69617367|FG000|Overall Study|Withdrawal by Subject|1|||
37930602|NCT00737568|69617373|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
37930603|NCT00737568|69617374|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
37930604|NCT00737568|69617373|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
37930605|NCT00737568|69617374|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
37930606|NCT00737568|69617373|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
37930607|NCT00737568|69617374|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
37930608|NCT00737568|69617373|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
37930609|NCT00737568|69617374|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
37930610|NCT00737568|69617373|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
37930611|NCT00737568|69617374|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
37930612|NCT00737568|69617373|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
37930613|NCT00737568|69617374|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
37930614|NCT00737568|69617373|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
37930615|NCT00737568|69617374|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
37930616|NCT00737568|69617373|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
37930617|NCT00737568|69617374|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
37930618|NCT00737568|69617373|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
37930619|NCT00737568|69617374|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
38033860|NCT02940860|69720081|FG000|Overall Study|Moved, poor venous access, transport|6|||
38033861|NCT02940860|69720082|FG001|Overall Study|Moved, poor venous access, transport|4|||
38033862|NCT02940860|69720081|FG000|Overall Study|Not treated|2|||
38033863|NCT02940860|69720082|FG001|Overall Study|Not treated|2|||
38033864|NCT03309020|69720092|FG000|Overall Study|Death|1|||
38033865|NCT03309020|69720093|FG001|Overall Study|Death|0|||
37930620|NCT00737100|69617383|FG000|Overall Study|Adverse Event|6|||
37930621|NCT00737100|69617384|FG001|Overall Study|Adverse Event|5|||
37930622|NCT00737100|69617385|FG002|Overall Study|Adverse Event|3|||
37668055|NCT02141854|69140605|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
37930623|NCT00737100|69617383|FG000|Overall Study|Lost to Follow-up|0|||
37930624|NCT00737100|69617384|FG001|Overall Study|Lost to Follow-up|1|||
37930625|NCT00737100|69617385|FG002|Overall Study|Lost to Follow-up|0|||
37930626|NCT00737100|69617383|FG000|Overall Study|Withdrawal by Subject|0|||
38033866|NCT03309020|69720092|FG000|Overall Study|Did not undergo surgery|2|||
38033867|NCT03309020|69720093|FG001|Overall Study|Did not undergo surgery|1|||
37930627|NCT00737100|69617384|FG001|Overall Study|Withdrawal by Subject|0|||
37930628|NCT00737100|69617385|FG002|Overall Study|Withdrawal by Subject|3|||
37930629|NCT00737100|69617383|FG000|Overall Study|Reason discontinued not explained above|1|||
37930630|NCT00737100|69617384|FG001|Overall Study|Reason discontinued not explained above|1|||
37930631|NCT00737100|69617385|FG002|Overall Study|Reason discontinued not explained above|1|||
37930632|NCT00732498|69617395|FG000|Overall Study|Ineligible|1|||
37930633|NCT00732498|69617395|FG000|Overall Study|Adverse Event|2|||
37930634|NCT00732498|69617395|FG000|Overall Study|Physician Decision|3|||
37930635|NCT00726882|69617399|FG000|Overall Study|Withdrawal by Subject|5|||
37930636|NCT00726882|69617399|FG000|Overall Study|Lost to Follow-up|7|||
37930637|NCT00726882|69617399|FG000|Overall Study|Other|10|||
37930638|NCT00790400|69617407|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
37930639|NCT00790400|69617408|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
37930640|NCT00790400|69617407|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
37930641|NCT00790400|69617408|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
37930642|NCT00790400|69617407|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
37930643|NCT00790400|69617408|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
37930644|NCT00790400|69617407|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
37930645|NCT00790400|69617408|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
37930646|NCT00790400|69617407|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
37930647|NCT00790400|69617408|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
37930648|NCT00790400|69617407|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
37930649|NCT00790400|69617408|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
37930650|NCT00790400|69617407|FG000|Double-blind Period (Core Phase)|Death|1|||
37930651|NCT00790400|69617408|FG001|Double-blind Period (Core Phase)|Death|0|||
37930652|NCT00790400|69617407|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
37930653|NCT00790400|69617408|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
37930654|NCT00790400|69617407|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
37930655|NCT00790400|69617408|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
37930656|NCT00790400|69617407|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
37930657|NCT00790400|69617408|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
37930658|NCT00790400|69617407|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
37930659|NCT00790400|69617408|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
37930660|NCT00790400|69617407|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
37930661|NCT00790400|69617408|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
37930662|NCT00790400|69617407|FG000|Everolimus Period (Core or Extension)|Death|1|||
37930663|NCT00790400|69617408|FG001|Everolimus Period (Core or Extension)|Death|0|||
37930664|NCT00790400|69617407|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
37930665|NCT00790400|69617408|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
37930666|NCT00790400|69617407|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
37930667|NCT00790400|69617408|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
37930668|NCT00790400|69617407|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
37930669|NCT00790400|69617408|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
37930670|NCT00786032|69617417|FG000|Overall Study|Death|4|||
37930671|NCT00786032|69617417|FG000|Overall Study|Withdrawal by Subject|14|||
37930672|NCT00786032|69617417|FG000|Overall Study|Did not complete in the timeframe|6|||
37930673|NCT00785486|69617423|FG000|Midazolam Alone|Withdrawal by Subject|1|||
37930674|NCT00589979|69617446|FG000|Run-In Period|Adverse Event|5|||
37930675|NCT00589979|69617447|FG001|Run-In Period|Adverse Event|0|||
37930676|NCT00589979|69617448|FG002|Run-In Period|Adverse Event|0|||
37930677|NCT00589979|69617446|FG000|Run-In Period|Protocol Violation|3|||
37930678|NCT00589979|69617447|FG001|Run-In Period|Protocol Violation|0|||
37930679|NCT00589979|69617448|FG002|Run-In Period|Protocol Violation|0|||
37930680|NCT00589979|69617446|FG000|Run-In Period|Did not qualify for randomization|54|||
37930681|NCT00589979|69617447|FG001|Run-In Period|Did not qualify for randomization|0|||
37930682|NCT00589979|69617448|FG002|Run-In Period|Did not qualify for randomization|0|||
37930683|NCT00589979|69617446|FG000|Run-In Period|Withdrawal by Subject|10|||
37930684|NCT00589979|69617447|FG001|Run-In Period|Withdrawal by Subject|0|||
37930685|NCT00589979|69617448|FG002|Run-In Period|Withdrawal by Subject|0|||
37930686|NCT00589979|69617446|FG000|Run-In Period|Informed Consent Withdrawn|4|||
37930687|NCT00589979|69617447|FG001|Run-In Period|Informed Consent Withdrawn|0|||
37930688|NCT00589979|69617448|FG002|Run-In Period|Informed Consent Withdrawn|0|||
37930689|NCT00589979|69617446|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
37930690|NCT00589979|69617447|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
37930691|NCT00589979|69617448|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
37930692|NCT00589979|69617446|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
37930693|NCT00589979|69617447|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
37930694|NCT00589979|69617448|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
37930695|NCT00589979|69617446|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
37930696|NCT00589979|69617447|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
37930697|NCT00589979|69617448|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
37930698|NCT00589979|69617446|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
37930699|NCT00589979|69617447|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
37930700|NCT00589979|69617448|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
37930701|NCT00589979|69617446|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
37930702|NCT00589979|69617447|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
37930703|NCT00589979|69617448|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
37930704|NCT00589979|69617446|FG000|Double-Blind Treatment Period 2|Other|0|||
37930705|NCT00589979|69617447|FG001|Double-Blind Treatment Period 2|Other|0|||
37930706|NCT00589979|69617448|FG002|Double-Blind Treatment Period 2|Other|1|||
37930707|NCT00589979|69617446|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
37930708|NCT00589979|69617447|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
37930709|NCT00589979|69617448|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
37930710|NCT00589979|69617446|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
37930711|NCT00589979|69617447|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
37930712|NCT00589979|69617448|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
37930713|NCT00797732|69617462|FG000|Overall Study|Withdrawal by Subject|3|||
37930714|NCT00797732|69617463|FG001|Overall Study|Withdrawal by Subject|3|||
37930715|NCT00797732|69617464|FG002|Overall Study|Withdrawal by Subject|0|||
37930716|NCT00797732|69617462|FG000|Overall Study|Lost to Follow-up|1|||
37930717|NCT00797732|69617463|FG001|Overall Study|Lost to Follow-up|0|||
37930718|NCT00797732|69617464|FG002|Overall Study|Lost to Follow-up|0|||
37930719|NCT00797732|69617462|FG000|Overall Study|Death|1|||
37930720|NCT00797732|69617463|FG001|Overall Study|Death|0|||
37930721|NCT00797732|69617464|FG002|Overall Study|Death|0|||
37930722|NCT00797732|69617462|FG000|Overall Study|Not meet inclusion criteria|0|||
37930723|NCT00797732|69617463|FG001|Overall Study|Not meet inclusion criteria|0|||
37930724|NCT00797732|69617464|FG002|Overall Study|Not meet inclusion criteria|7|||
37930725|NCT00797732|69617462|FG000|Overall Study|Excluded due to time constraints|0|||
37930726|NCT00797732|69617463|FG001|Overall Study|Excluded due to time constraints|0|||
37930727|NCT00797732|69617464|FG002|Overall Study|Excluded due to time constraints|24|||
37930728|NCT00797732|69617462|FG000|Overall Study|Refused to Participate|0|||
37930729|NCT00797732|69617463|FG001|Overall Study|Refused to Participate|0|||
37930730|NCT00797732|69617464|FG002|Overall Study|Refused to Participate|123|||
37930731|NCT00790088|69617470|FG000|Overall Study|Protocol Violation|11|||
37930732|NCT00790088|69617470|FG000|Overall Study|Withdrawal by Subject|17|||
37930733|NCT00790088|69617470|FG000|Overall Study|Lost to Follow-up|7|||
37930734|NCT00790088|69617470|FG000|Overall Study|Physician Decision|4|||
37930735|NCT00736944|69617476|FG000|Induction|Death|1|||
37930736|NCT00736944|69617476|FG000|Definitive Treatment|Physician Decision|1|||
37930737|NCT00736476|69617485|FG000|Overall Study|Adverse Event|1|||
37930738|NCT00736476|69617486|FG001|Overall Study|Adverse Event|0|||
37930739|NCT00715299|69617498|FG000|Overall Study|Withdrawal by Subject|1|||
37930740|NCT00715299|69617498|FG000|Overall Study|Adverse Event|3|||
37930741|NCT00715299|69617498|FG000|Overall Study|failed the pre-screen exercise test|2|||
37930742|NCT00730236|69617502|FG000|Overall Study|Adverse Event|4|||
37930743|NCT00730236|69617502|FG000|Overall Study|Withdrawal by Subject|1|||
37930744|NCT00730236|69617502|FG000|Overall Study|Non-compliance|1|||
37930745|NCT00714285|69617510|FG000|Overall Study|Lost to Follow-up|0|||
37930746|NCT00714285|69617511|FG001|Overall Study|Lost to Follow-up|2|||
37930747|NCT00714285|69617512|FG002|Overall Study|Lost to Follow-up|0|||
37930748|NCT00714285|69617513|FG003|Overall Study|Lost to Follow-up|1|||
37930749|NCT00714285|69617510|FG000|Overall Study|Migrated/moved from study area|0|||
37930750|NCT00714285|69617511|FG001|Overall Study|Migrated/moved from study area|1|||
37930751|NCT00714285|69617512|FG002|Overall Study|Migrated/moved from study area|0|||
37930752|NCT00714285|69617513|FG003|Overall Study|Migrated/moved from study area|0|||
37930753|NCT00776984|69617527|FG000|Overall Study|Adverse Event|8|||
37930754|NCT00776984|69617528|FG001|Overall Study|Adverse Event|2|||
37930755|NCT00776984|69617527|FG000|Overall Study|Protocol Violation|4|||
37930756|NCT00776984|69617528|FG001|Overall Study|Protocol Violation|2|||
37930757|NCT00776984|69617527|FG000|Overall Study|Lost to Follow-up|2|||
37930758|NCT00776984|69617528|FG001|Overall Study|Lost to Follow-up|0|||
37930759|NCT00776984|69617527|FG000|Overall Study|Withdrawal by Subject|12|||
37930760|NCT00776984|69617528|FG001|Overall Study|Withdrawal by Subject|7|||
37930761|NCT00776984|69617527|FG000|Overall Study|Lack of Efficacy|0|||
37930762|NCT00776984|69617528|FG001|Overall Study|Lack of Efficacy|1|||
37930763|NCT00776984|69617527|FG000|Overall Study|Other|5|||
38033868|NCT02806960|69720101|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
37930764|NCT00776984|69617528|FG001|Overall Study|Other|9|||
37930765|NCT00714051|69617536|FG000|Overall Study|Withdrawal by Subject|1|||
37930766|NCT00714051|69617537|FG001|Overall Study|Withdrawal by Subject|0|||
37930767|NCT00714051|69617536|FG000|Overall Study|Death|0|||
37930768|NCT00714051|69617537|FG001|Overall Study|Death|1|||
37930769|NCT00784784|69617545|FG000|Overall Study|Withdrawal by Subject|2|||
37930770|NCT00784784|69617546|FG001|Overall Study|Withdrawal by Subject|2|||
37930771|NCT00801983|69617554|FG000|Period 1|Lost to Follow-up|2|||
37930772|NCT00801983|69617555|FG001|Period 1|Lost to Follow-up|0|||
37930773|NCT00801983|69617554|FG000|Period 1|Withdrawal by Subject|2|||
37930774|NCT00801983|69617555|FG001|Period 1|Withdrawal by Subject|8|||
37930775|NCT00801983|69617554|FG000|Period 2|Withdrawal by Subject|2|||
37930776|NCT00801983|69617555|FG001|Period 2|Withdrawal by Subject|1|||
37930777|NCT00587288|69617563|FG000|Overall Study|Adverse Event|0|||
37930778|NCT00587288|69617564|FG001|Overall Study|Adverse Event|1|||
37930779|NCT00587288|69617563|FG000|Overall Study|Lack of Efficacy|2|||
37930780|NCT00587288|69617564|FG001|Overall Study|Lack of Efficacy|8|||
37930781|NCT00587288|69617563|FG000|Overall Study|Protocol Violation|1|||
37930782|NCT00587288|69617564|FG001|Overall Study|Protocol Violation|0|||
37930783|NCT00800735|69617572|FG000|Overall Study|Administrative/Other|2|||
37930784|NCT00800735|69617572|FG000|Overall Study|Insufficient Therapeutic Response|2|||
37930785|NCT00800735|69617572|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
37930786|NCT00800735|69617572|FG000|Overall Study|Withdrew Consent|3|||
37930787|NCT00730158|69617578|FG000|Overall Study|Withdrawal by Subject|1|||
37930788|NCT00730158|69617579|FG001|Overall Study|Withdrawal by Subject|1|||
37930789|NCT00784550|69617591|FG000|Overall Study|Adverse Event|12|||
37930790|NCT00784550|69617592|FG001|Overall Study|Adverse Event|10|||
37930791|NCT00784550|69617591|FG000|Overall Study|Lack of Efficacy|0|||
37930792|NCT00784550|69617592|FG001|Overall Study|Lack of Efficacy|1|||
37930793|NCT00784550|69617591|FG000|Overall Study|Protocol Violation|10|||
37930794|NCT00784550|69617592|FG001|Overall Study|Protocol Violation|10|||
37930795|NCT00784550|69617591|FG000|Overall Study|Lost to Follow-up|8|||
37930796|NCT00784550|69617592|FG001|Overall Study|Lost to Follow-up|5|||
37930797|NCT00784550|69617591|FG000|Overall Study|Physician Decision|2|||
38033869|NCT02806960|69720102|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
38033870|NCT02806960|69720103|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
38033871|NCT02806960|69720104|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
38033872|NCT03718143|69720114|FG000|Overall Study|Death|1|||
38033873|NCT03718143|69720115|FG001|Overall Study|Death|0|||
38033874|NCT03718143|69720116|FG002|Overall Study|Death|0|||
38033875|NCT03718143|69720114|FG000|Overall Study|Progression of Disease|1|||
38033876|NCT03718143|69720115|FG001|Overall Study|Progression of Disease|0|||
38033877|NCT03718143|69720116|FG002|Overall Study|Progression of Disease|0|||
38033878|NCT03718143|69720114|FG000|Overall Study|Withdrawal of Informed Consent|1|||
38033879|NCT03718143|69720115|FG001|Overall Study|Withdrawal of Informed Consent|2|||
38033880|NCT03718143|69720116|FG002|Overall Study|Withdrawal of Informed Consent|1|||
38033881|NCT03274466|69720126|FG000|Overall Study|Withdrawal by Subject|7|||
38033882|NCT03274466|69720127|FG001|Overall Study|Withdrawal by Subject|3|||
38033883|NCT03274466|69720126|FG000|Overall Study|Protocol Specified Withdrawal|5|||
38033884|NCT03274466|69720127|FG001|Overall Study|Protocol Specified Withdrawal|11|||
38033885|NCT03274466|69720126|FG000|Overall Study|Lost to Follow-up|5|||
38033886|NCT03274466|69720127|FG001|Overall Study|Lost to Follow-up|7|||
38033887|NCT03274466|69720126|FG000|Overall Study|Subject Non-compliance|0|||
38033888|NCT03274466|69720127|FG001|Overall Study|Subject Non-compliance|1|||
38033889|NCT03274466|69720126|FG000|Overall Study|Adverse Event|3|||
38033890|NCT03274466|69720127|FG001|Overall Study|Adverse Event|3|||
38033891|NCT03274466|69720126|FG000|Overall Study|Physician Decision|0|||
38033892|NCT03274466|69720127|FG001|Overall Study|Physician Decision|1|||
38033893|NCT03274466|69720126|FG000|Overall Study|Protocol Violation|3|||
38033894|NCT03274466|69720127|FG001|Overall Study|Protocol Violation|3|||
38033895|NCT02806726|69720133|FG000|Overall Study|Lost to Follow-up|1|||
38033896|NCT02806414|69720138|FG000|Overall Study|Lost to Follow-up|2|||
38033897|NCT02806024|69720144|FG000|Overall Study|Night Delivery|1|||
38033898|NCT02806024|69720145|FG001|Overall Study|Night Delivery|1|||
38033899|NCT02806024|69720144|FG000|Overall Study|DVT during antepartum admission|0|||
38033900|NCT02806024|69720145|FG001|Overall Study|DVT during antepartum admission|1|||
38033901|NCT02805790|69720153|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
38033902|NCT02805790|69720154|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
38033903|NCT02802592|69720160|FG000|Overall Study|Study terminated due to loss of funding|4|||
38033904|NCT02803138|69720165|FG000|Overall Study|Failure to return|38|||
38033905|NCT02803138|69720165|FG000|Overall Study|Insufficient virological response|2|||
37930798|NCT00784550|69617592|FG001|Overall Study|Physician Decision|3|||
37930799|NCT00784550|69617591|FG000|Overall Study|Withdrawal by Subject|4|||
37930800|NCT00784550|69617592|FG001|Overall Study|Withdrawal by Subject|13|||
37930801|NCT00729690|69617601|FG000|Overall Study|IT Catheter Malfunction|0|||
37930802|NCT00729690|69617602|FG001|Overall Study|IT Catheter Malfunction|2|||
37930803|NCT00729690|69617603|FG002|Overall Study|IT Catheter Malfunction|2|||
38033906|NCT02803138|69720165|FG000|Overall Study|Withdrawn consent|1|||
38033907|NCT02803138|69720165|FG000|Overall Study|Death|1|||
38033908|NCT02803138|69720165|FG000|Overall Study|Other, not specified|28|||
37930804|NCT00784238|69617611|FG000|Overall Study|Adverse Event|14|||
37930805|NCT00784238|69617611|FG000|Overall Study|Death|2|||
37930806|NCT00784238|69617611|FG000|Overall Study|Lack of Efficacy|33|||
37930807|NCT00784238|69617611|FG000|Overall Study|Lost to Follow-up|29|||
37930808|NCT00784238|69617611|FG000|Overall Study|Pregnancy|1|||
37930809|NCT00784238|69617611|FG000|Overall Study|Withdrawal by Subject|26|||
37930810|NCT00784238|69617611|FG000|Overall Study|Other|14|||
37930811|NCT00729612|69617618|FG000|Overall Study|Non evaluable for response|10|||
37930812|NCT00585546|69617622|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
37930813|NCT00585546|69617622|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
37930814|NCT00768248|69617628|FG000|Overall Study|Research coordinator didn't collect data|1|||
37930815|NCT00768248|69617629|FG001|Overall Study|Research coordinator didn't collect data|1|||
37930816|NCT00775268|69617637|FG000|Baseline|Drug not synthesize dose|1|||
37930817|NCT00775268|69617638|FG001|Baseline|Drug not synthesize dose|0|||
37930818|NCT00775268|69617637|FG000|Baseline|Not treated-ineligible per CT|0|||
37930819|NCT00775268|69617638|FG001|Baseline|Not treated-ineligible per CT|1|||
37930820|NCT00775268|69617637|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
37930821|NCT00775268|69617638|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
37930822|NCT00775268|69617637|FG000|After Completion|Participant missed scan appointment|1|||
37930823|NCT00775268|69617638|FG001|After Completion|Participant missed scan appointment|0|||
37930824|NCT00775190|69617657|FG000|Overall Study|Lost to Follow-up|2|||
37930825|NCT00775190|69617658|FG001|Overall Study|Lost to Follow-up|3|||
37930826|NCT00775190|69617657|FG000|Overall Study|Withdrawal by Subject|1|||
37930827|NCT00775190|69617658|FG001|Overall Study|Withdrawal by Subject|2|||
37930828|NCT00775190|69617657|FG000|Overall Study|Protocol Violation|1|||
37930829|NCT00775190|69617658|FG001|Overall Study|Protocol Violation|0|||
37930830|NCT00479557|69617671|FG000|Overall Study|Death|0|||
37930831|NCT00479557|69617672|FG001|Overall Study|Death|0|||
37930832|NCT00479557|69617673|FG002|Overall Study|Death|0|||
37930833|NCT00479557|69617674|FG003|Overall Study|Death|0|||
37930834|NCT00479557|69617675|FG004|Overall Study|Death|0|||
37930835|NCT00479557|69617676|FG005|Overall Study|Death|1|||
37930836|NCT00479557|69617677|FG006|Overall Study|Death|0|||
38033909|NCT02801578|69720171|FG000|Overall Study|Adverse Event|2|||
38033910|NCT02799472|69720177|FG000|Overall Study|Withdrawal by Subject|2|||
38033911|NCT02799472|69720178|FG001|Overall Study|Withdrawal by Subject|4|||
38033912|NCT02799472|69720177|FG000|Overall Study|Lack of Efficacy|2|||
38033913|NCT02799472|69720178|FG001|Overall Study|Lack of Efficacy|0|||
38033914|NCT02799472|69720177|FG000|Overall Study|Lost to Follow-up|0|||
38033915|NCT02799472|69720178|FG001|Overall Study|Lost to Follow-up|1|||
38033916|NCT03245450|69720191|FG000|Overall Study|Radiological disease progression|3|||
38033917|NCT03245450|69720192|FG001|Overall Study|Radiological disease progression|3|||
38033918|NCT03245450|69720193|FG002|Overall Study|Radiological disease progression|2|||
38033919|NCT03245450|69720194|FG003|Overall Study|Radiological disease progression|2|||
38033920|NCT03245450|69720195|FG004|Overall Study|Radiological disease progression|7|||
38033921|NCT03245450|69720196|FG005|Overall Study|Radiological disease progression|6|||
38033922|NCT03245450|69720197|FG006|Overall Study|Radiological disease progression|6|||
38033923|NCT03245450|69720191|FG000|Overall Study|Clinical disease progression|0|||
38033924|NCT03245450|69720192|FG001|Overall Study|Clinical disease progression|0|||
38033925|NCT03245450|69720193|FG002|Overall Study|Clinical disease progression|1|||
38033926|NCT03245450|69720194|FG003|Overall Study|Clinical disease progression|0|||
38033927|NCT03245450|69720195|FG004|Overall Study|Clinical disease progression|0|||
38033928|NCT03245450|69720196|FG005|Overall Study|Clinical disease progression|2|||
38033929|NCT03245450|69720197|FG006|Overall Study|Clinical disease progression|0|||
38033930|NCT03245450|69720191|FG000|Overall Study|Other|0|||
38033931|NCT03245450|69720192|FG001|Overall Study|Other|0|||
38033932|NCT03245450|69720193|FG002|Overall Study|Other|0|||
38033933|NCT03245450|69720194|FG003|Overall Study|Other|1|||
38033934|NCT03245450|69720195|FG004|Overall Study|Other|1|||
37930837|NCT00479557|69617671|FG000|Overall Study|Lack of Efficacy|1|||
37930838|NCT00479557|69617672|FG001|Overall Study|Lack of Efficacy|0|||
37930839|NCT00479557|69617673|FG002|Overall Study|Lack of Efficacy|0|||
37930840|NCT00479557|69617674|FG003|Overall Study|Lack of Efficacy|0|||
37930841|NCT00479557|69617675|FG004|Overall Study|Lack of Efficacy|0|||
37930842|NCT00479557|69617676|FG005|Overall Study|Lack of Efficacy|0|||
37930843|NCT00479557|69617677|FG006|Overall Study|Lack of Efficacy|0|||
38033935|NCT03245450|69720196|FG005|Overall Study|Other|1|||
38033936|NCT03245450|69720197|FG006|Overall Study|Other|1|||
37930844|NCT00479557|69617671|FG000|Overall Study|Lost to Follow-up|0|||
37930845|NCT00479557|69617672|FG001|Overall Study|Lost to Follow-up|2|||
37930846|NCT00479557|69617673|FG002|Overall Study|Lost to Follow-up|0|||
37930847|NCT00479557|69617674|FG003|Overall Study|Lost to Follow-up|2|||
37930848|NCT00479557|69617675|FG004|Overall Study|Lost to Follow-up|0|||
37930849|NCT00479557|69617676|FG005|Overall Study|Lost to Follow-up|0|||
37930850|NCT00479557|69617677|FG006|Overall Study|Lost to Follow-up|0|||
37930851|NCT00479557|69617671|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
37930852|NCT00479557|69617672|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
37930853|NCT00479557|69617673|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
37930854|NCT00479557|69617674|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
37930855|NCT00479557|69617675|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
37930856|NCT00479557|69617676|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
37930857|NCT00479557|69617677|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
37930858|NCT00479557|69617671|FG000|Overall Study|AE not related to Study Drug|1|||
37668056|NCT02141854|69140600|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
37668057|NCT02141854|69140601|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
37668058|NCT02141854|69140602|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
37930859|NCT00479557|69617672|FG001|Overall Study|AE not related to Study Drug|3|||
37930860|NCT00479557|69617673|FG002|Overall Study|AE not related to Study Drug|0|||
37930861|NCT00479557|69617674|FG003|Overall Study|AE not related to Study Drug|0|||
37930862|NCT00479557|69617675|FG004|Overall Study|AE not related to Study Drug|2|||
37930863|NCT00479557|69617676|FG005|Overall Study|AE not related to Study Drug|2|||
37930864|NCT00479557|69617677|FG006|Overall Study|AE not related to Study Drug|1|||
37930865|NCT00479557|69617671|FG000|Overall Study|Caregiver Request|2|||
37930866|NCT00479557|69617672|FG001|Overall Study|Caregiver Request|2|||
37930867|NCT00479557|69617673|FG002|Overall Study|Caregiver Request|2|||
37930868|NCT00479557|69617674|FG003|Overall Study|Caregiver Request|0|||
37930869|NCT00479557|69617675|FG004|Overall Study|Caregiver Request|1|||
37930870|NCT00479557|69617676|FG005|Overall Study|Caregiver Request|2|||
37930871|NCT00479557|69617677|FG006|Overall Study|Caregiver Request|0|||
37668059|NCT02141854|69140603|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
37668060|NCT02141854|69140604|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
37668061|NCT02141854|69140605|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
37668062|NCT02141854|69140600|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
37668063|NCT02141854|69140601|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
37668064|NCT02141854|69140602|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
37668065|NCT02141854|69140603|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
37668066|NCT02141854|69140604|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
37668067|NCT02141854|69140605|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
37668068|NCT02141854|69140600|FG000|Run-In Period (Pre-assignment)|Other|14|||
37668069|NCT02141854|69140601|FG001|Run-In Period (Pre-assignment)|Other|0|||
37668070|NCT02141854|69140602|FG002|Run-In Period (Pre-assignment)|Other|0|||
37668071|NCT02141854|69140603|FG003|Run-In Period (Pre-assignment)|Other|0|||
37668072|NCT02141854|69140604|FG004|Run-In Period (Pre-assignment)|Other|0|||
37668073|NCT02141854|69140605|FG005|Run-In Period (Pre-assignment)|Other|0|||
37668074|NCT02141854|69140600|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
37668075|NCT02141854|69140601|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
37668076|NCT02141854|69140602|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
37668077|NCT02141854|69140603|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
37668078|NCT02141854|69140604|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
37668079|NCT02141854|69140605|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
37668080|NCT02141854|69140600|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
37668081|NCT02141854|69140601|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
37668082|NCT02141854|69140602|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
37668083|NCT02141854|69140603|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
37668084|NCT02141854|69140604|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
37668085|NCT02141854|69140605|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
38033937|NCT03245450|69720191|FG000|Overall Study|Withdrawal by Subject|0|||
38033938|NCT03245450|69720192|FG001|Overall Study|Withdrawal by Subject|1|||
38033939|NCT03245450|69720193|FG002|Overall Study|Withdrawal by Subject|0|||
38033940|NCT03245450|69720194|FG003|Overall Study|Withdrawal by Subject|0|||
37668086|NCT02141854|69140600|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
37668087|NCT02141854|69140601|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
37668088|NCT02141854|69140602|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
37668089|NCT02141854|69140603|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
37668090|NCT02141854|69140604|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
37668091|NCT02141854|69140605|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
37668092|NCT02141854|69140600|FG000|Treatment Period|Protocol Violation|0|||
37930872|NCT00479557|69617671|FG000|Overall Study|Investigator Request|0|||
37930873|NCT00479557|69617672|FG001|Overall Study|Investigator Request|0|||
37930874|NCT00479557|69617673|FG002|Overall Study|Investigator Request|1|||
37930875|NCT00479557|69617674|FG003|Overall Study|Investigator Request|0|||
37930876|NCT00479557|69617675|FG004|Overall Study|Investigator Request|0|||
37930877|NCT00479557|69617676|FG005|Overall Study|Investigator Request|0|||
37930878|NCT00479557|69617677|FG006|Overall Study|Investigator Request|0|||
37930879|NCT00479557|69617671|FG000|Overall Study|Subject Request|3|||
38033941|NCT03245450|69720195|FG004|Overall Study|Withdrawal by Subject|0|||
38033942|NCT03245450|69720196|FG005|Overall Study|Withdrawal by Subject|0|||
38043555|NCT02927262|69731711|FG000|Overall Study|Adverse Event|7|||
37930880|NCT00479557|69617672|FG001|Overall Study|Subject Request|0|||
37930881|NCT00479557|69617673|FG002|Overall Study|Subject Request|1|||
37930882|NCT00479557|69617674|FG003|Overall Study|Subject Request|1|||
37930883|NCT00479557|69617675|FG004|Overall Study|Subject Request|1|||
37930884|NCT00479557|69617676|FG005|Overall Study|Subject Request|4|||
37930885|NCT00479557|69617677|FG006|Overall Study|Subject Request|1|||
37930886|NCT00479557|69617671|FG000|Overall Study|Other|2|||
37930887|NCT00479557|69617672|FG001|Overall Study|Other|3|||
37930888|NCT00479557|69617673|FG002|Overall Study|Other|1|||
37930889|NCT00479557|69617674|FG003|Overall Study|Other|0|||
37930890|NCT00479557|69617675|FG004|Overall Study|Other|0|||
37930891|NCT00479557|69617676|FG005|Overall Study|Other|3|||
37930892|NCT00479557|69617677|FG006|Overall Study|Other|0|||
37930893|NCT00774800|69617699|FG000|Intervention 4|Withdrawal by Subject|1|||
37930894|NCT00439309|69617711|FG000|Follow-Up|Death|1|||
37930895|NCT00439309|69617712|FG001|Follow-Up|Death|0|||
37930896|NCT00439309|69617711|FG000|Follow-Up|Lost to Follow-up|2|||
37930897|NCT00439309|69617712|FG001|Follow-Up|Lost to Follow-up|0|||
37930898|NCT00439309|69617711|FG000|Follow-Up|Withdrawal by Subject|0|||
37930899|NCT00439309|69617712|FG001|Follow-Up|Withdrawal by Subject|1|||
37930900|NCT00439309|69617711|FG000|Follow-Up|Late response by subject|0|||
37930901|NCT00439309|69617712|FG001|Follow-Up|Late response by subject|1|||
37930902|NCT00479167|69617718|FG000|Overall Study|Withdrawal by Subject|1|||
37930903|NCT00725712|69617725|FG000|Overall Study|Withdrawal by Subject|2|||
37930904|NCT00725712|69617726|FG001|Overall Study|Withdrawal by Subject|1|||
37930905|NCT00725712|69617725|FG000|Overall Study|Protocol Violation|1|||
37930906|NCT00725712|69617726|FG001|Overall Study|Protocol Violation|0|||
37930907|NCT00725712|69617725|FG000|Overall Study|Progressive disease|37|||
37930908|NCT00725712|69617726|FG001|Overall Study|Progressive disease|16|||
37930909|NCT00725712|69617725|FG000|Overall Study|Clinical progression not based on RECIST|0|||
37930910|NCT00725712|69617726|FG001|Overall Study|Clinical progression not based on RECIST|3|||
37930911|NCT00725712|69617725|FG000|Overall Study|Adverse Event|5|||
37930912|NCT00725712|69617726|FG001|Overall Study|Adverse Event|5|||
37930913|NCT00725712|69617725|FG000|Overall Study|Death|2|||
37930914|NCT00725712|69617726|FG001|Overall Study|Death|0|||
37930915|NCT00725712|69617725|FG000|Overall Study|Other: Death|1|||
37930916|NCT00725712|69617726|FG001|Overall Study|Other: Death|0|||
37930917|NCT00725712|69617725|FG000|Overall Study|Hospitalized, unable to continue|0|||
37930918|NCT00725712|69617726|FG001|Overall Study|Hospitalized, unable to continue|1|||
37930919|NCT00729378|69617738|FG000|Baseline|Did not complete study measurements|72|||
37930920|NCT00729378|69617739|FG001|Baseline|Did not complete study measurements|33|||
37930921|NCT00729378|69617738|FG000|Baseline|Withdrawal by Subject|66|||
37930922|NCT00729378|69617739|FG001|Baseline|Withdrawal by Subject|59|||
37930923|NCT00729378|69617738|FG000|12-months|Lost to Follow-up|100|||
37930924|NCT00729378|69617739|FG001|12-months|Lost to Follow-up|65|||
37930925|NCT00729378|69617738|FG000|24-months|Lost to Follow-up|72|||
37930926|NCT00729378|69617739|FG001|24-months|Lost to Follow-up|51|||
37930927|NCT00729378|69617738|FG000|36-months|Lost to Follow-up|15|||
37930928|NCT00729378|69617739|FG001|36-months|Lost to Follow-up|6|||
37930929|NCT00478933|69617748|FG000|Overall Study|Protocol Violation|22|||
37930930|NCT00478933|69617748|FG000|Overall Study|Informed consent not verified|3|||
37930931|NCT00478933|69617748|FG000|Overall Study|Inadequate data available|53|||
37930932|NCT00725322|69617774|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
37930933|NCT00725322|69617775|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
37930934|NCT00725322|69617774|FG000|Washout (28 Days)|Protocol Violation|0|||
37930935|NCT00725322|69617775|FG001|Washout (28 Days)|Protocol Violation|1|||
37930936|NCT00725010|69617781|FG000|Overall Study|Toxicity|9|||
37930937|NCT00725010|69617781|FG000|Overall Study|Tumor Progression|7|||
37930938|NCT00725010|69617781|FG000|Overall Study|Withdrawal by Subject|2|||
37930939|NCT00725010|69617781|FG000|Overall Study|Death|1|||
37930940|NCT00725010|69617781|FG000|Overall Study|Lost to Follow-up|1|||
37930941|NCT00725010|69617781|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
37930942|NCT00725010|69617781|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
37930943|NCT00725010|69617781|FG000|Overall Study|No further documentation|1|||
37930944|NCT00725010|69617781|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
37930945|NCT00767000|69617792|FG000|54-week Study|Adverse Event|4|||
37930946|NCT00767000|69617793|FG001|54-week Study|Adverse Event|6|||
37930947|NCT00767000|69617794|FG002|54-week Study|Adverse Event|6|||
37930948|NCT00767000|69617795|FG003|54-week Study|Adverse Event|8|||
37930949|NCT00767000|69617796|FG004|54-week Study|Adverse Event|4|||
37930950|NCT00767000|69617792|FG000|54-week Study|Creaninine/creatinine clearance|2|||
37930951|NCT00767000|69617793|FG001|54-week Study|Creaninine/creatinine clearance|1|||
37930952|NCT00767000|69617794|FG002|54-week Study|Creaninine/creatinine clearance|2|||
37930953|NCT00767000|69617795|FG003|54-week Study|Creaninine/creatinine clearance|2|||
37930954|NCT00767000|69617796|FG004|54-week Study|Creaninine/creatinine clearance|4|||
37930955|NCT00767000|69617792|FG000|54-week Study|Hyperglycemia|0|||
37930956|NCT00767000|69617793|FG001|54-week Study|Hyperglycemia|0|||
37930957|NCT00767000|69617794|FG002|54-week Study|Hyperglycemia|1|||
37930958|NCT00767000|69617795|FG003|54-week Study|Hyperglycemia|0|||
37930959|NCT00767000|69617796|FG004|54-week Study|Hyperglycemia|1|||
37930960|NCT00767000|69617792|FG000|54-week Study|Hypoglycemia|0|||
37930961|NCT00767000|69617793|FG001|54-week Study|Hypoglycemia|1|||
37930962|NCT00767000|69617794|FG002|54-week Study|Hypoglycemia|0|||
37930963|NCT00767000|69617795|FG003|54-week Study|Hypoglycemia|0|||
37930964|NCT00767000|69617796|FG004|54-week Study|Hypoglycemia|0|||
37930965|NCT00767000|69617792|FG000|54-week Study|Interruption of study medication|0|||
37930966|NCT00767000|69617793|FG001|54-week Study|Interruption of study medication|0|||
37930967|NCT00767000|69617794|FG002|54-week Study|Interruption of study medication|1|||
37930968|NCT00767000|69617795|FG003|54-week Study|Interruption of study medication|0|||
37930969|NCT00767000|69617796|FG004|54-week Study|Interruption of study medication|0|||
37930970|NCT00767000|69617792|FG000|54-week Study|Lack of Efficacy|2|||
37930971|NCT00767000|69617793|FG001|54-week Study|Lack of Efficacy|0|||
37930972|NCT00767000|69617794|FG002|54-week Study|Lack of Efficacy|1|||
37930973|NCT00767000|69617795|FG003|54-week Study|Lack of Efficacy|0|||
37930974|NCT00767000|69617796|FG004|54-week Study|Lack of Efficacy|5|||
37930975|NCT00767000|69617792|FG000|54-week Study|Lost to Follow-up|4|||
37930976|NCT00767000|69617793|FG001|54-week Study|Lost to Follow-up|0|||
37930977|NCT00767000|69617794|FG002|54-week Study|Lost to Follow-up|1|||
37930978|NCT00767000|69617795|FG003|54-week Study|Lost to Follow-up|4|||
37930979|NCT00767000|69617796|FG004|54-week Study|Lost to Follow-up|2|||
37930980|NCT00767000|69617792|FG000|54-week Study|Physician Decision|4|||
37930981|NCT00767000|69617793|FG001|54-week Study|Physician Decision|0|||
37930982|NCT00767000|69617794|FG002|54-week Study|Physician Decision|1|||
37930983|NCT00767000|69617795|FG003|54-week Study|Physician Decision|1|||
37930984|NCT00767000|69617796|FG004|54-week Study|Physician Decision|1|||
37930985|NCT00767000|69617792|FG000|54-week Study|Progressive disease|0|||
37930986|NCT00767000|69617793|FG001|54-week Study|Progressive disease|0|||
37930987|NCT00767000|69617794|FG002|54-week Study|Progressive disease|1|||
37930988|NCT00767000|69617795|FG003|54-week Study|Progressive disease|0|||
37930989|NCT00767000|69617796|FG004|54-week Study|Progressive disease|0|||
37930990|NCT00767000|69617792|FG000|54-week Study|Protocol Violation|0|||
37930991|NCT00767000|69617793|FG001|54-week Study|Protocol Violation|0|||
37930992|NCT00767000|69617794|FG002|54-week Study|Protocol Violation|1|||
37930993|NCT00767000|69617795|FG003|54-week Study|Protocol Violation|2|||
37930994|NCT00767000|69617796|FG004|54-week Study|Protocol Violation|0|||
37930995|NCT00767000|69617792|FG000|54-week Study|Withdrawal by Subject|2|||
37930996|NCT00767000|69617793|FG001|54-week Study|Withdrawal by Subject|3|||
37930997|NCT00767000|69617794|FG002|54-week Study|Withdrawal by Subject|5|||
37930998|NCT00767000|69617795|FG003|54-week Study|Withdrawal by Subject|11|||
37930999|NCT00767000|69617796|FG004|54-week Study|Withdrawal by Subject|13|||
37931000|NCT00767000|69617792|FG000|54-week Study|Study terminated by sponsor|90|||
37931001|NCT00767000|69617793|FG001|54-week Study|Study terminated by sponsor|102|||
37931002|NCT00767000|69617794|FG002|54-week Study|Study terminated by sponsor|89|||
37931003|NCT00767000|69617795|FG003|54-week Study|Study terminated by sponsor|196|||
37931004|NCT00767000|69617796|FG004|54-week Study|Study terminated by sponsor|194|||
37931005|NCT00767000|69617792|FG000|54-week Study|Reason not reported|0|||
37931006|NCT00767000|69617793|FG001|54-week Study|Reason not reported|0|||
37931007|NCT00767000|69617794|FG002|54-week Study|Reason not reported|0|||
37931008|NCT00767000|69617795|FG003|54-week Study|Reason not reported|1|||
37931009|NCT00767000|69617796|FG004|54-week Study|Reason not reported|0|||
37931010|NCT00767000|69617792|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
37931011|NCT00767000|69617793|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
37931012|NCT00767000|69617794|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
37931013|NCT00767000|69617795|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
37931014|NCT00767000|69617796|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
37931015|NCT00724932|69617810|FG000|Overall Study|Lost to Follow-up|1|||
37931016|NCT00724932|69617811|FG001|Overall Study|Lost to Follow-up|0|||
37931017|NCT00724932|69617810|FG000|Overall Study|Not treated|4|||
37931018|NCT00724932|69617811|FG001|Overall Study|Not treated|3|||
37931019|NCT00766532|69617819|FG000|Overall Study|Protocol Violation|2|||
37931020|NCT00774566|69617825|FG000|Overall Study|Protocol Violation|18|||
37931021|NCT00774566|69617826|FG001|Overall Study|Protocol Violation|15|||
38033943|NCT03245450|69720197|FG006|Overall Study|Withdrawal by Subject|0|||
37931022|NCT00766376|69617832|FG000|Overall Study|Withdrawal by Subject|27|||
37931023|NCT00587054|69617836|FG000|Overall Study|Patient not treated|9|||
37931024|NCT00766142|69617840|FG000|Overall Study|Protocol Violation|4|||
38033944|NCT03245450|69720191|FG000|Overall Study|Adverse Event|0|||
37668093|NCT02141854|69140601|FG001|Treatment Period|Protocol Violation|1|||
37931025|NCT00724854|69617846|FG000|Overall Study|Lack of Efficacy|187|||
37931026|NCT00724854|69617847|FG001|Overall Study|Lack of Efficacy|13|||
37931027|NCT00724854|69617846|FG000|Overall Study|Lost to Follow-up|87|||
37931028|NCT00724854|69617847|FG001|Overall Study|Lost to Follow-up|10|||
37931029|NCT00724854|69617846|FG000|Overall Study|Adverse Event|62|||
37931030|NCT00724854|69617847|FG001|Overall Study|Adverse Event|4|||
37931031|NCT00724854|69617846|FG000|Overall Study|Other|42|||
37931032|NCT00724854|69617847|FG001|Overall Study|Other|3|||
37931033|NCT00724854|69617846|FG000|Overall Study|Death|11|||
37931034|NCT00724854|69617847|FG001|Overall Study|Death|0|||
37931035|NCT00724854|69617846|FG000|Overall Study|Change of treatment|7|||
37931036|NCT00724854|69617847|FG001|Overall Study|Change of treatment|0|||
37931037|NCT00724854|69617846|FG000|Overall Study|Withdrawal by Subject|5|||
37931038|NCT00724854|69617847|FG001|Overall Study|Withdrawal by Subject|0|||
37931039|NCT00724854|69617846|FG000|Overall Study|Adverse event + lack of efficacy|2|||
37931040|NCT00724854|69617847|FG001|Overall Study|Adverse event + lack of efficacy|1|||
37931041|NCT00728988|69617856|FG000|Overall Study|Not Treated|2|||
37931042|NCT00728988|69617857|FG001|Overall Study|Not Treated|2|||
37931043|NCT00728988|69617856|FG000|Overall Study|Death|1|||
37931044|NCT00728988|69617857|FG001|Overall Study|Death|1|||
37931045|NCT00728988|69617856|FG000|Overall Study|Adverse Event|3|||
37931046|NCT00728988|69617857|FG001|Overall Study|Adverse Event|2|||
37931047|NCT00728988|69617856|FG000|Overall Study|Other|85|||
37931048|NCT00728988|69617857|FG001|Overall Study|Other|77|||
37931049|NCT00728988|69617856|FG000|Overall Study|Withdrawal by Subject|2|||
37931050|NCT00728988|69617857|FG001|Overall Study|Withdrawal by Subject|6|||
37931051|NCT00728754|69617866|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
37931052|NCT00728754|69617867|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
37931053|NCT00728754|69617866|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
37931054|NCT00728754|69617867|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
37931055|NCT00728754|69617866|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
37668094|NCT02141854|69140602|FG002|Treatment Period|Protocol Violation|0|||
37668095|NCT02141854|69140603|FG003|Treatment Period|Protocol Violation|2|||
37668096|NCT02141854|69140604|FG004|Treatment Period|Protocol Violation|2|||
37668097|NCT02141854|69140605|FG005|Treatment Period|Protocol Violation|1|||
37668098|NCT02141854|69140600|FG000|Treatment Period|Noncompliance|0|||
37668099|NCT02141854|69140601|FG001|Treatment Period|Noncompliance|0|||
37668100|NCT02141854|69140602|FG002|Treatment Period|Noncompliance|0|||
37668101|NCT02141854|69140603|FG003|Treatment Period|Noncompliance|1|||
37668102|NCT02141854|69140604|FG004|Treatment Period|Noncompliance|0|||
37668103|NCT02141854|69140605|FG005|Treatment Period|Noncompliance|0|||
37668104|NCT02141854|69140600|FG000|Treatment Period|Lack of Efficacy|0|||
37668105|NCT02141854|69140601|FG001|Treatment Period|Lack of Efficacy|0|||
37668106|NCT02141854|69140602|FG002|Treatment Period|Lack of Efficacy|0|||
37668107|NCT02141854|69140603|FG003|Treatment Period|Lack of Efficacy|1|||
37668108|NCT02141854|69140604|FG004|Treatment Period|Lack of Efficacy|1|||
37668109|NCT02141854|69140605|FG005|Treatment Period|Lack of Efficacy|7|||
37668110|NCT02141854|69140600|FG000|Treatment Period|Pregnancy|0|||
37668111|NCT02141854|69140601|FG001|Treatment Period|Pregnancy|1|||
37668112|NCT02141854|69140602|FG002|Treatment Period|Pregnancy|0|||
37668113|NCT02141854|69140603|FG003|Treatment Period|Pregnancy|0|||
37668114|NCT02141854|69140604|FG004|Treatment Period|Pregnancy|0|||
37668115|NCT02141854|69140605|FG005|Treatment Period|Pregnancy|0|||
37668116|NCT02141854|69140600|FG000|Treatment Period|Other|0|||
37668117|NCT02141854|69140601|FG001|Treatment Period|Other|1|||
37668118|NCT02141854|69140602|FG002|Treatment Period|Other|2|||
37668119|NCT02141854|69140603|FG003|Treatment Period|Other|0|||
37668120|NCT02141854|69140604|FG004|Treatment Period|Other|1|||
37668121|NCT02141854|69140605|FG005|Treatment Period|Other|2|||
37668122|NCT02141854|69140600|FG000|Treatment Period|Adverse Event|0|||
37668123|NCT02141854|69140601|FG001|Treatment Period|Adverse Event|2|||
37668124|NCT02141854|69140602|FG002|Treatment Period|Adverse Event|2|||
37668125|NCT02141854|69140603|FG003|Treatment Period|Adverse Event|0|||
37931056|NCT00728754|69617867|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
37931057|NCT00728130|69617873|FG000|Overall Study|Withdrawal by Subject|1|||
37931058|NCT00728130|69617873|FG000|Overall Study|Paperwork not completed in time|1|||
37931059|NCT00728130|69617873|FG000|Overall Study|Physician Decision|1|||
37931060|NCT00735696|69617877|FG000|Overall Study|Withdrawal by Subject|1|||
37931061|NCT00735696|69617877|FG000|Overall Study|Enrolled but never Treated|1|||
37931062|NCT00478231|69617886|FG000|Overall Study|Death|7|||
37931063|NCT00478231|69617886|FG000|Overall Study|Lack of Efficacy|47|||
37931064|NCT00478231|69617886|FG000|Overall Study|Lost to Follow-up|7|||
37931065|NCT00478231|69617886|FG000|Overall Study|Withdrawal by Subject|6|||
38033945|NCT03245450|69720192|FG001|Overall Study|Adverse Event|0|||
37668126|NCT02141854|69140604|FG004|Treatment Period|Adverse Event|2|||
37668127|NCT02141854|69140605|FG005|Treatment Period|Adverse Event|2|||
37668128|NCT02141854|69140600|FG000|Treatment Period|Withdrawal by Subject|0|||
37931066|NCT00478231|69617886|FG000|Overall Study|Other|9|||
37931067|NCT00478231|69617886|FG000|Overall Study|Adverse Event|5|||
37931068|NCT00478231|69617886|FG000|Overall Study|Randomized, not treated|3|||
37931069|NCT00474175|69617893|FG000|Overall Study|Lack of Efficacy|0|||
37931070|NCT00474175|69617894|FG001|Overall Study|Lack of Efficacy|0|||
37668129|NCT02141854|69140601|FG001|Treatment Period|Withdrawal by Subject|2|||
37668130|NCT02141854|69140602|FG002|Treatment Period|Withdrawal by Subject|3|||
37668131|NCT02141854|69140603|FG003|Treatment Period|Withdrawal by Subject|3|||
37668132|NCT02141854|69140604|FG004|Treatment Period|Withdrawal by Subject|4|||
37668133|NCT02141854|69140605|FG005|Treatment Period|Withdrawal by Subject|7|||
38033946|NCT03245450|69720193|FG002|Overall Study|Adverse Event|0|||
37931071|NCT00474175|69617895|FG002|Overall Study|Lack of Efficacy|1|||
37931072|NCT00474175|69617893|FG000|Overall Study|Withdrawal by Subject|0|||
37931073|NCT00474175|69617894|FG001|Overall Study|Withdrawal by Subject|1|||
37931074|NCT00474175|69617895|FG002|Overall Study|Withdrawal by Subject|1|||
37931075|NCT00474175|69617893|FG000|Overall Study|Ineligible|1|||
37931076|NCT00474175|69617894|FG001|Overall Study|Ineligible|3|||
37931077|NCT00474175|69617895|FG002|Overall Study|Ineligible|1|||
37931078|NCT00474175|69617893|FG000|Overall Study|Protocol Violation|0|||
37931079|NCT00474175|69617894|FG001|Overall Study|Protocol Violation|2|||
37931080|NCT00474175|69617895|FG002|Overall Study|Protocol Violation|1|||
37931081|NCT00474175|69617893|FG000|Overall Study|Administrative|0|||
37931082|NCT00474175|69617894|FG001|Overall Study|Administrative|1|||
37931083|NCT00474175|69617895|FG002|Overall Study|Administrative|0|||
37931084|NCT00443209|69617926|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
37931085|NCT00443209|69617927|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
37931086|NCT00443209|69617926|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
37931087|NCT00443209|69617927|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
37931088|NCT00443209|69617926|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
37931089|NCT00443209|69617927|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
37931090|NCT00443209|69617926|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
37931091|NCT00443209|69617927|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
37931092|NCT00443209|69617926|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
37931093|NCT00443209|69617927|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
37931094|NCT00443209|69617926|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
37931095|NCT00443209|69617927|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
37931096|NCT00443209|69617926|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
37931097|NCT00443209|69617927|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
37931098|NCT00443209|69617926|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
37931099|NCT00443209|69617927|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
37931100|NCT00443209|69617926|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
37931101|NCT00443209|69617927|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
37931102|NCT00443209|69617926|FG000|Months 1 to 12 Treatment Period|Missing|2|||
37931103|NCT00443209|69617927|FG001|Months 1 to 12 Treatment Period|Missing|1|||
37931104|NCT00443209|69617926|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
37931105|NCT00443209|69617927|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
37931106|NCT00443209|69617926|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
37931107|NCT00443209|69617927|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
37931108|NCT00443209|69617926|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
37931109|NCT00443209|69617927|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
37931110|NCT00443209|69617926|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
37931111|NCT00443209|69617927|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
37931112|NCT00443209|69617926|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
37931113|NCT00443209|69617927|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
37931114|NCT00443209|69617926|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
37931115|NCT00443209|69617927|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
37931116|NCT00443209|69617926|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
37931117|NCT00443209|69617927|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
37931118|NCT00439231|69617933|FG000|Overall Study|Lack of Efficacy|28|||
37931119|NCT00437983|69617939|FG000|Overall Study|Adverse Event|6|||
37931120|NCT00437983|69617940|FG001|Overall Study|Adverse Event|6|||
37931121|NCT00437983|69617939|FG000|Overall Study|Protocol Violation|2|||
37931122|NCT00437983|69617940|FG001|Overall Study|Protocol Violation|1|||
37931123|NCT00437983|69617939|FG000|Overall Study|Withdrawal by Subject|5|||
37931124|NCT00437983|69617940|FG001|Overall Study|Withdrawal by Subject|6|||
37931125|NCT00783692|69617949|FG000|Induction Phase|Adverse Event|7|||
37931126|NCT00783692|69617950|FG001|Induction Phase|Adverse Event|9|||
37931127|NCT00783692|69617951|FG002|Induction Phase|Adverse Event|24|||
37931128|NCT00783692|69617952|FG003|Induction Phase|Adverse Event|0|||
37931129|NCT00783692|69617953|FG004|Induction Phase|Adverse Event|0|||
37931130|NCT00783692|69617954|FG005|Induction Phase|Adverse Event|0|||
37931131|NCT00783692|69617955|FG006|Induction Phase|Adverse Event|0|||
37931132|NCT00783692|69617949|FG000|Induction Phase|Protocol Violation|0|||
37931133|NCT00783692|69617950|FG001|Induction Phase|Protocol Violation|0|||
38033947|NCT03245450|69720194|FG003|Overall Study|Adverse Event|0|||
38033948|NCT03245450|69720195|FG004|Overall Study|Adverse Event|1|||
37668134|NCT02141854|69140600|FG000|Treatment Period|Disease progression|0|||
37931134|NCT00783692|69617951|FG002|Induction Phase|Protocol Violation|1|||
37931135|NCT00783692|69617952|FG003|Induction Phase|Protocol Violation|0|||
37931136|NCT00783692|69617953|FG004|Induction Phase|Protocol Violation|0|||
37931137|NCT00783692|69617954|FG005|Induction Phase|Protocol Violation|0|||
37931138|NCT00783692|69617955|FG006|Induction Phase|Protocol Violation|0|||
37931139|NCT00783692|69617949|FG000|Induction Phase|Lack of Efficacy|1|||
37931140|NCT00783692|69617950|FG001|Induction Phase|Lack of Efficacy|3|||
37931141|NCT00783692|69617951|FG002|Induction Phase|Lack of Efficacy|28|||
37931142|NCT00783692|69617952|FG003|Induction Phase|Lack of Efficacy|0|||
37931143|NCT00783692|69617953|FG004|Induction Phase|Lack of Efficacy|0|||
37931144|NCT00783692|69617954|FG005|Induction Phase|Lack of Efficacy|0|||
37931145|NCT00783692|69617955|FG006|Induction Phase|Lack of Efficacy|0|||
37931146|NCT00783692|69617949|FG000|Induction Phase|Withdrawal by Subject|3|||
37931147|NCT00783692|69617950|FG001|Induction Phase|Withdrawal by Subject|9|||
37931148|NCT00783692|69617951|FG002|Induction Phase|Withdrawal by Subject|16|||
37931149|NCT00783692|69617952|FG003|Induction Phase|Withdrawal by Subject|0|||
37931150|NCT00783692|69617953|FG004|Induction Phase|Withdrawal by Subject|0|||
37931151|NCT00783692|69617954|FG005|Induction Phase|Withdrawal by Subject|0|||
37931152|NCT00783692|69617955|FG006|Induction Phase|Withdrawal by Subject|0|||
37931153|NCT00783692|69617949|FG000|Induction Phase|Lost to Follow-up|0|||
37931154|NCT00783692|69617950|FG001|Induction Phase|Lost to Follow-up|0|||
37931155|NCT00783692|69617951|FG002|Induction Phase|Lost to Follow-up|3|||
37931156|NCT00783692|69617952|FG003|Induction Phase|Lost to Follow-up|0|||
37931157|NCT00783692|69617953|FG004|Induction Phase|Lost to Follow-up|0|||
37931158|NCT00783692|69617954|FG005|Induction Phase|Lost to Follow-up|0|||
37931159|NCT00783692|69617955|FG006|Induction Phase|Lost to Follow-up|0|||
37931160|NCT00783692|69617949|FG000|Induction Phase|Other|0|||
37931161|NCT00783692|69617950|FG001|Induction Phase|Other|0|||
37931162|NCT00783692|69617951|FG002|Induction Phase|Other|2|||
37931163|NCT00783692|69617952|FG003|Induction Phase|Other|0|||
37931164|NCT00783692|69617953|FG004|Induction Phase|Other|0|||
37931165|NCT00783692|69617954|FG005|Induction Phase|Other|0|||
37931166|NCT00783692|69617955|FG006|Induction Phase|Other|0|||
37931167|NCT00783692|69617949|FG000|Maintenance Phase|Adverse Event|7|||
37931168|NCT00783692|69617950|FG001|Maintenance Phase|Adverse Event|0|||
37931169|NCT00783692|69617951|FG002|Maintenance Phase|Adverse Event|0|||
37931170|NCT00783692|69617952|FG003|Maintenance Phase|Adverse Event|15|||
37931171|NCT00783692|69617953|FG004|Maintenance Phase|Adverse Event|12|||
37931172|NCT00783692|69617954|FG005|Maintenance Phase|Adverse Event|9|||
37931173|NCT00783692|69617955|FG006|Maintenance Phase|Adverse Event|38|||
37931174|NCT00783692|69617949|FG000|Maintenance Phase|Protocol Violation|0|||
37931175|NCT00783692|69617950|FG001|Maintenance Phase|Protocol Violation|0|||
37931176|NCT00783692|69617951|FG002|Maintenance Phase|Protocol Violation|0|||
37931177|NCT00783692|69617952|FG003|Maintenance Phase|Protocol Violation|1|||
37931178|NCT00783692|69617953|FG004|Maintenance Phase|Protocol Violation|2|||
37931179|NCT00783692|69617954|FG005|Maintenance Phase|Protocol Violation|3|||
37931180|NCT00783692|69617955|FG006|Maintenance Phase|Protocol Violation|4|||
37931181|NCT00783692|69617949|FG000|Maintenance Phase|Lack of Efficacy|79|||
37931182|NCT00783692|69617950|FG001|Maintenance Phase|Lack of Efficacy|0|||
37931183|NCT00783692|69617951|FG002|Maintenance Phase|Lack of Efficacy|0|||
37931184|NCT00783692|69617952|FG003|Maintenance Phase|Lack of Efficacy|64|||
37931185|NCT00783692|69617953|FG004|Maintenance Phase|Lack of Efficacy|58|||
37931186|NCT00783692|69617954|FG005|Maintenance Phase|Lack of Efficacy|48|||
37931187|NCT00783692|69617955|FG006|Maintenance Phase|Lack of Efficacy|177|||
37931188|NCT00783692|69617949|FG000|Maintenance Phase|Withdrawal by Subject|7|||
37931189|NCT00783692|69617950|FG001|Maintenance Phase|Withdrawal by Subject|0|||
37931190|NCT00783692|69617951|FG002|Maintenance Phase|Withdrawal by Subject|0|||
37931191|NCT00783692|69617952|FG003|Maintenance Phase|Withdrawal by Subject|7|||
37931192|NCT00783692|69617953|FG004|Maintenance Phase|Withdrawal by Subject|6|||
37931193|NCT00783692|69617954|FG005|Maintenance Phase|Withdrawal by Subject|9|||
37931194|NCT00783692|69617955|FG006|Maintenance Phase|Withdrawal by Subject|24|||
37931195|NCT00783692|69617949|FG000|Maintenance Phase|Lost to Follow-up|2|||
37931196|NCT00783692|69617950|FG001|Maintenance Phase|Lost to Follow-up|0|||
37931197|NCT00783692|69617951|FG002|Maintenance Phase|Lost to Follow-up|0|||
37931198|NCT00783692|69617952|FG003|Maintenance Phase|Lost to Follow-up|1|||
37931199|NCT00783692|69617953|FG004|Maintenance Phase|Lost to Follow-up|3|||
37931200|NCT00783692|69617954|FG005|Maintenance Phase|Lost to Follow-up|2|||
37931201|NCT00783692|69617955|FG006|Maintenance Phase|Lost to Follow-up|5|||
37931202|NCT00783692|69617949|FG000|Maintenance Phase|Other|0|||
37931203|NCT00783692|69617950|FG001|Maintenance Phase|Other|0|||
37931204|NCT00783692|69617951|FG002|Maintenance Phase|Other|0|||
37931205|NCT00783692|69617952|FG003|Maintenance Phase|Other|1|||
37931206|NCT00783692|69617953|FG004|Maintenance Phase|Other|0|||
37931207|NCT00783692|69617954|FG005|Maintenance Phase|Other|1|||
37931208|NCT00783692|69617955|FG006|Maintenance Phase|Other|1|||
37931209|NCT04992273|69617970|FG000|Overall Study|Lost to Follow-up|0|||
37931210|NCT04992273|69617971|FG001|Overall Study|Lost to Follow-up|1|||
37931211|NCT00783302|69617978|FG000|Overall Study|Lost to Follow-up|17|||
37931212|NCT00783302|69617978|FG000|Overall Study|Technical Problems|11|||
37931213|NCT00783302|69617978|FG000|Overall Study|Protocol Violation|3|||
37931214|NCT00783302|69617978|FG000|Overall Study|Physician Decision|1|||
38033949|NCT03245450|69720196|FG005|Overall Study|Adverse Event|0|||
37931215|NCT00783302|69617978|FG000|Overall Study|Withdrawal by Subject|3|||
37931216|NCT00783224|69618000|FG000|Overall Study|Adverse Event|0|||
37931217|NCT00783224|69618001|FG001|Overall Study|Adverse Event|0|||
37931218|NCT00783224|69618002|FG002|Overall Study|Adverse Event|1|||
37931219|NCT00783224|69618003|FG003|Overall Study|Adverse Event|0|||
37931220|NCT00783224|69618000|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
37931221|NCT00783224|69618001|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
37931222|NCT00783224|69618002|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
37931223|NCT00783224|69618003|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
37931224|NCT00783224|69618000|FG000|Overall Study|Inappropriate as a study subject|0|||
37931225|NCT00783224|69618001|FG001|Overall Study|Inappropriate as a study subject|0|||
37931226|NCT00783224|69618002|FG002|Overall Study|Inappropriate as a study subject|0|||
37931227|NCT00783224|69618003|FG003|Overall Study|Inappropriate as a study subject|1|||
37931228|NCT00782834|69618012|FG000|Treatment Phase|fibrous tumor not GIST|1|||
37931229|NCT00584805|69618016|FG000|Overall Study|No longer at risk of exposure|39|||
37931230|NCT00584805|69618016|FG000|Overall Study|Relocation|36|||
37931231|NCT00584805|69618016|FG000|Overall Study|Withdrawal by Subject|18|||
37931232|NCT00584805|69618016|FG000|Overall Study|Non-compliance|1|||
37931233|NCT00584805|69618016|FG000|Overall Study|Lost to follow up|3|||
37931234|NCT00584805|69618016|FG000|Overall Study|Screen failures|2|||
37931235|NCT00765674|69618026|FG000|Overall Study|Adverse Event|7|||
37931236|NCT00765674|69618027|FG001|Overall Study|Adverse Event|2|||
37931237|NCT00765674|69618028|FG002|Overall Study|Adverse Event|8|||
37931238|NCT00765674|69618029|FG003|Overall Study|Adverse Event|11|||
37931239|NCT00765674|69618026|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
37931240|NCT00765674|69618027|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
37931241|NCT00765674|69618028|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
37931242|NCT00765674|69618029|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
37931243|NCT00765674|69618026|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
37931244|NCT00765674|69618027|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
37931245|NCT00765674|69618028|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
37931246|NCT00765674|69618029|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
37931247|NCT00765674|69618026|FG000|Overall Study|Lack of Efficacy|2|||
37931248|NCT00765674|69618027|FG001|Overall Study|Lack of Efficacy|3|||
37931249|NCT00765674|69618028|FG002|Overall Study|Lack of Efficacy|1|||
37931250|NCT00765674|69618029|FG003|Overall Study|Lack of Efficacy|2|||
37931251|NCT00765674|69618026|FG000|Overall Study|Protocol Violation|2|||
37931252|NCT00765674|69618027|FG001|Overall Study|Protocol Violation|0|||
37931253|NCT00765674|69618028|FG002|Overall Study|Protocol Violation|1|||
37931254|NCT00765674|69618029|FG003|Overall Study|Protocol Violation|0|||
37931255|NCT00765674|69618026|FG000|Overall Study|Withdrawal by Subject|5|||
37931256|NCT00765674|69618027|FG001|Overall Study|Withdrawal by Subject|7|||
37931257|NCT00765674|69618028|FG002|Overall Study|Withdrawal by Subject|3|||
37931258|NCT00765674|69618029|FG003|Overall Study|Withdrawal by Subject|8|||
37931259|NCT00765674|69618026|FG000|Overall Study|Lost to Follow-up|4|||
37931260|NCT00765674|69618027|FG001|Overall Study|Lost to Follow-up|6|||
37931261|NCT00765674|69618028|FG002|Overall Study|Lost to Follow-up|2|||
37931262|NCT00765674|69618029|FG003|Overall Study|Lost to Follow-up|1|||
37931263|NCT00765674|69618026|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
37931264|NCT00765674|69618027|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
37931265|NCT00765674|69618028|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
37931266|NCT00765674|69618029|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
37931267|NCT00765362|69618039|FG000|Overall Study|Death|9|||
37931268|NCT00765362|69618039|FG000|Overall Study|Adverse Event|2|||
37931269|NCT00765362|69618039|FG000|Overall Study|Protocol Violation|18|||
37931270|NCT00765362|69618039|FG000|Overall Study|Withdrawal by Subject|13|||
37931271|NCT00765362|69618039|FG000|Overall Study|Lost to Follow-up|95|||
37931272|NCT00586898|69618043|FG000|Overall Study|Adverse Event|1|||
37931273|NCT00586898|69618043|FG000|Overall Study|Patiemt Non-compliance|1|||
37931274|NCT00586898|69618043|FG000|Overall Study|Evaluable for Toxicity Only|5|||
37931275|NCT04912245|69618047|FG000|Overall Study|Withdrawal by Subject|21|||
37931276|NCT04912245|69618048|FG001|Overall Study|Withdrawal by Subject|4|||
37931277|NCT04912245|69618047|FG000|Overall Study|Lost to Follow-up|5|||
37931278|NCT04912245|69618048|FG001|Overall Study|Lost to Follow-up|11|||
37931279|NCT00796991|69618055|FG000|Overall Study|Adverse Event|0|||
37931280|NCT00796991|69618056|FG001|Overall Study|Adverse Event|0|||
37931281|NCT00796991|69618057|FG002|Overall Study|Adverse Event|1|||
37931282|NCT00796991|69618055|FG000|Overall Study|Death|2|||
37931283|NCT00796991|69618056|FG001|Overall Study|Death|0|||
37931284|NCT00796991|69618057|FG002|Overall Study|Death|0|||
37931285|NCT00796991|69618055|FG000|Overall Study|Disease Progression|10|||
37931286|NCT00796991|69618056|FG001|Overall Study|Disease Progression|9|||
37931287|NCT00796991|69618057|FG002|Overall Study|Disease Progression|7|||
37931288|NCT00796991|69618055|FG000|Overall Study|Study Drug Toxicity|3|||
37931289|NCT00796991|69618056|FG001|Overall Study|Study Drug Toxicity|3|||
37931290|NCT00796991|69618057|FG002|Overall Study|Study Drug Toxicity|5|||
37931291|NCT00796991|69618055|FG000|Overall Study|Withdrawal by Subject|0|||
37931292|NCT00796991|69618056|FG001|Overall Study|Withdrawal by Subject|0|||
37931293|NCT00796991|69618057|FG002|Overall Study|Withdrawal by Subject|1|||
37931294|NCT00799487|69618068|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
37931295|NCT00799487|69618069|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
37931296|NCT00799487|69618070|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
37931297|NCT00799487|69618068|FG000|Dose Adjustment Period|Adverse Event|2|||
37931298|NCT00799487|69618069|FG001|Dose Adjustment Period|Adverse Event|0|||
37931299|NCT00799487|69618070|FG002|Dose Adjustment Period|Adverse Event|0|||
37931300|NCT00799487|69618068|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
37931301|NCT00799487|69618069|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
37931302|NCT00799487|69618070|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
37931303|NCT00799487|69618068|FG000|Dose Adjustment Period|Investigator Discretion|2|||
37931304|NCT00799487|69618069|FG001|Dose Adjustment Period|Investigator Discretion|0|||
37931305|NCT00799487|69618070|FG002|Dose Adjustment Period|Investigator Discretion|0|||
37931306|NCT00799487|69618068|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
37931307|NCT00799487|69618069|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
37931308|NCT00799487|69618070|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
37931309|NCT00799487|69618068|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
37931310|NCT00799487|69618069|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
37931311|NCT00799487|69618070|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
37931312|NCT00799487|69618068|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
37931313|NCT00799487|69618069|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
37931314|NCT00799487|69618070|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
37931315|NCT00799487|69618068|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
37931316|NCT00799487|69618069|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
37931317|NCT00799487|69618070|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
37931318|NCT00799487|69618068|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
37931319|NCT00799487|69618069|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
37931320|NCT00799487|69618070|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
37931321|NCT00799487|69618068|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
37931322|NCT00799487|69618069|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
37931323|NCT00799487|69618070|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
37668135|NCT02141854|69140601|FG001|Treatment Period|Disease progression|2|||
37760852|NCT01559129|69271771|FG000|Treatment Phase|Adverse Event|0|||
37760853|NCT01559129|69271772|FG001|Treatment Phase|Adverse Event|2|||
37760854|NCT01559129|69271771|FG000|Treatment Phase|Progressive Disease|1|||
37760855|NCT01559129|69271772|FG001|Treatment Phase|Progressive Disease|1|||
37760856|NCT01559129|69271771|FG000|Treatment Phase|Lack of Efficacy|0|||
37760857|NCT01559129|69271772|FG001|Treatment Phase|Lack of Efficacy|1|||
37931324|NCT00799487|69618068|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
38033950|NCT03245450|69720197|FG006|Overall Study|Adverse Event|2|||
37668136|NCT02141854|69140602|FG002|Treatment Period|Disease progression|1|||
37668137|NCT02141854|69140603|FG003|Treatment Period|Disease progression|3|||
37668138|NCT02141854|69140604|FG004|Treatment Period|Disease progression|0|||
37668139|NCT02141854|69140605|FG005|Treatment Period|Disease progression|18|||
37668140|NCT02141854|69140600|FG000|Treatment Period|Lost to Follow-up|0|||
37668141|NCT02141854|69140601|FG001|Treatment Period|Lost to Follow-up|1|||
37668142|NCT02141854|69140602|FG002|Treatment Period|Lost to Follow-up|1|||
37668143|NCT02141854|69140603|FG003|Treatment Period|Lost to Follow-up|1|||
37760858|NCT01559129|69271771|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
37760859|NCT01559129|69271772|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
37760860|NCT01559129|69271771|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
37931325|NCT00799487|69618069|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
37931326|NCT00799487|69618070|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
37931327|NCT00799487|69618068|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
37931328|NCT00799487|69618069|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
37931329|NCT00799487|69618070|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
37931330|NCT00584727|69618081|FG000|First Intervention|Discontinuation|0|||
37931331|NCT00584727|69618082|FG001|First Intervention|Discontinuation|0|||
37931332|NCT00584727|69618083|FG002|First Intervention|Discontinuation|1|||
37931333|NCT00584727|69618084|FG003|First Intervention|Discontinuation|0|||
37931334|NCT00584727|69618085|FG004|First Intervention|Discontinuation|0|||
37931335|NCT00584727|69618086|FG005|First Intervention|Discontinuation|0|||
37931336|NCT00584727|69618081|FG000|Third Intervention|Protocol Violation|0|||
37931337|NCT00584727|69618082|FG001|Third Intervention|Protocol Violation|0|||
37931338|NCT00584727|69618083|FG002|Third Intervention|Protocol Violation|1|||
37931339|NCT00584727|69618084|FG003|Third Intervention|Protocol Violation|0|||
37931340|NCT00584727|69618085|FG004|Third Intervention|Protocol Violation|4|||
37931341|NCT00584727|69618086|FG005|Third Intervention|Protocol Violation|2|||
37931342|NCT00799409|69618100|FG000|Overall Study|Withdrawal by Subject|1|||
37931343|NCT00799409|69618101|FG001|Overall Study|Withdrawal by Subject|0|||
37931344|NCT00799409|69618102|FG002|Overall Study|Withdrawal by Subject|0|||
37931345|NCT00799409|69618100|FG000|Overall Study|Lost to Follow-up|1|||
37931346|NCT00799409|69618101|FG001|Overall Study|Lost to Follow-up|0|||
37931347|NCT00799409|69618102|FG002|Overall Study|Lost to Follow-up|0|||
37931348|NCT00799409|69618100|FG000|Overall Study|Optimal Dose Not Achieved|2|||
37931349|NCT00799409|69618101|FG001|Overall Study|Optimal Dose Not Achieved|0|||
37931350|NCT00799409|69618102|FG002|Overall Study|Optimal Dose Not Achieved|0|||
37931351|NCT00799409|69618100|FG000|Overall Study|Failure to follow study protocol)|1|||
37931352|NCT00799409|69618101|FG001|Overall Study|Failure to follow study protocol)|0|||
37931353|NCT00799409|69618102|FG002|Overall Study|Failure to follow study protocol)|0|||
37931354|NCT00799409|69618100|FG000|Overall Study|Did not attend lab school day 1|1|||
37931355|NCT00799409|69618101|FG001|Overall Study|Did not attend lab school day 1|0|||
37931356|NCT00799409|69618102|FG002|Overall Study|Did not attend lab school day 1|0|||
37931357|NCT00799409|69618100|FG000|Overall Study|medication compliance|1|||
37931358|NCT00799409|69618101|FG001|Overall Study|medication compliance|0|||
37931359|NCT00799409|69618102|FG002|Overall Study|medication compliance|0|||
37931360|NCT00782210|69618113|FG000|Overall Study|Adverse Event|21|||
37931361|NCT00782210|69618114|FG001|Overall Study|Adverse Event|17|||
37931362|NCT00782210|69618115|FG002|Overall Study|Adverse Event|16|||
37931363|NCT00782210|69618113|FG000|Overall Study|Lost to Follow-up|2|||
37931364|NCT00782210|69618114|FG001|Overall Study|Lost to Follow-up|1|||
37931365|NCT00782210|69618115|FG002|Overall Study|Lost to Follow-up|2|||
37931366|NCT00782210|69618113|FG000|Overall Study|Withdrawal by Subject|11|||
37931367|NCT00782210|69618114|FG001|Overall Study|Withdrawal by Subject|8|||
37931368|NCT00782210|69618115|FG002|Overall Study|Withdrawal by Subject|11|||
37931369|NCT00782210|69618113|FG000|Overall Study|Non compliance with protocol|0|||
37931370|NCT00782210|69618114|FG001|Overall Study|Non compliance with protocol|3|||
37931371|NCT00782210|69618115|FG002|Overall Study|Non compliance with protocol|2|||
37931372|NCT00782210|69618113|FG000|Overall Study|Lack of Efficacy|13|||
37931373|NCT00782210|69618114|FG001|Overall Study|Lack of Efficacy|4|||
37931374|NCT00782210|69618115|FG002|Overall Study|Lack of Efficacy|1|||
37931375|NCT00782210|69618113|FG000|Overall Study|Other reason not described above|3|||
37931376|NCT00782210|69618114|FG001|Overall Study|Other reason not described above|2|||
37931377|NCT00782210|69618115|FG002|Overall Study|Other reason not described above|3|||
37931378|NCT01558115|69618132|FG000|Overall Study|Withdrawal by Subject|3|||
37931379|NCT01558115|69618132|FG000|Overall Study|Study closed due to poor enrollment|4|||
37931380|NCT00764660|69618146|FG000|Overall Study|Adverse Event|6|||
37931381|NCT00764660|69618147|FG001|Overall Study|Adverse Event|3|||
37931382|NCT00764660|69618146|FG000|Overall Study|Lost to Follow-up|3|||
37931383|NCT00764660|69618147|FG001|Overall Study|Lost to Follow-up|4|||
37931384|NCT00764660|69618146|FG000|Overall Study|Withdrawal by Subject|7|||
37931385|NCT00764660|69618147|FG001|Overall Study|Withdrawal by Subject|3|||
37931386|NCT00764660|69618146|FG000|Overall Study|Noncompliance With Protocol|5|||
37931387|NCT00764660|69618147|FG001|Overall Study|Noncompliance With Protocol|1|||
37931388|NCT00764660|69618146|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
37931389|NCT00764660|69618147|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
37931390|NCT00584415|69618153|FG000|Overall Study|Adverse Event|7|||
37931391|NCT00764504|69618161|FG000|Overall Study|Death|12|||
38033951|NCT03712917|69720222|FG000|Overall Study|Pregnancy|0|||
37931392|NCT00764504|69618162|FG001|Overall Study|Death|6|||
37931393|NCT00764504|69618163|FG002|Overall Study|Death|13|||
37931394|NCT00764504|69618161|FG000|Overall Study|Revision of Device|12|||
37931395|NCT00764504|69618162|FG001|Overall Study|Revision of Device|23|||
37931396|NCT00764504|69618163|FG002|Overall Study|Revision of Device|14|||
37931397|NCT00764504|69618161|FG000|Overall Study|Physician Decision|1|||
37931398|NCT00764504|69618162|FG001|Overall Study|Physician Decision|0|||
37931399|NCT00764504|69618163|FG002|Overall Study|Physician Decision|0|||
37668144|NCT02141854|69140604|FG004|Treatment Period|Lost to Follow-up|0|||
37668145|NCT02141854|69140605|FG005|Treatment Period|Lost to Follow-up|1|||
37668146|NCT02587221|69140619|FG000|Overall Study|Adverse Event|3|||
37668147|NCT02587221|69140620|FG001|Overall Study|Adverse Event|3|||
37668148|NCT02587221|69140619|FG000|Overall Study|Death|33|||
37668149|NCT02587221|69140620|FG001|Overall Study|Death|34|||
37668150|NCT02587221|69140619|FG000|Overall Study|Withdrawal by Subject|66|||
37668151|NCT02587221|69140620|FG001|Overall Study|Withdrawal by Subject|61|||
37668152|NCT02587221|69140619|FG000|Overall Study|Lost to Follow-up|21|||
37668153|NCT02587221|69140620|FG001|Overall Study|Lost to Follow-up|19|||
37668154|NCT02587221|69140619|FG000|Overall Study|Protocol Violation|6|||
37668155|NCT02587221|69140620|FG001|Overall Study|Protocol Violation|5|||
37668156|NCT02587221|69140619|FG000|Overall Study|Other Reason or Unspecified|2|||
37668157|NCT02587221|69140620|FG001|Overall Study|Other Reason or Unspecified|1|||
37668158|NCT02141620|69140626|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
37668159|NCT02141620|69140627|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
37668160|NCT02106910|69140635|FG000|Overall Study|Lost to Follow-up|1|||
37668161|NCT02106910|69140636|FG001|Overall Study|Lost to Follow-up|1|||
37668162|NCT01664949|69140645|FG000|Overall Study|Adverse Event|11|||
37668163|NCT01664949|69140646|FG001|Overall Study|Adverse Event|12|||
37668164|NCT01664949|69140645|FG000|Overall Study|Lack of Efficacy|1|||
37668165|NCT01664949|69140646|FG001|Overall Study|Lack of Efficacy|1|||
37668166|NCT01664949|69140645|FG000|Overall Study|Lost to Follow-up|1|||
37668167|NCT01664949|69140646|FG001|Overall Study|Lost to Follow-up|2|||
37668168|NCT01664949|69140645|FG000|Overall Study|Personal Reasons|3|||
37668169|NCT01664949|69140646|FG001|Overall Study|Personal Reasons|4|||
37668170|NCT01664949|69140645|FG000|Overall Study|Protocol Violation|5|||
37668171|NCT01664949|69140646|FG001|Overall Study|Protocol Violation|5|||
37668172|NCT01664949|69140645|FG000|Overall Study|Other Miscellaneous Reasons|3|||
37668173|NCT01664949|69140646|FG001|Overall Study|Other Miscellaneous Reasons|1|||
37668174|NCT02587143|69140654|FG000|Overall Study|Adverse Event|1|||
37668175|NCT02587143|69140655|FG001|Overall Study|Adverse Event|0|||
37668176|NCT02106832|69140665|FG000|Overall Study|Adverse Event|1|||
37668177|NCT02106832|69140666|FG001|Overall Study|Adverse Event|2|||
37668178|NCT02106832|69140667|FG002|Overall Study|Adverse Event|3|||
37668179|NCT02106832|69140668|FG003|Overall Study|Adverse Event|0|||
37668180|NCT02106832|69140665|FG000|Overall Study|Death|4|||
37668181|NCT02106832|69140666|FG001|Overall Study|Death|4|||
37668182|NCT02106832|69140667|FG002|Overall Study|Death|1|||
37668183|NCT02106832|69140668|FG003|Overall Study|Death|4|||
37668184|NCT02106832|69140665|FG000|Overall Study|Deterioration of general conditions|0|||
37668185|NCT02106832|69140666|FG001|Overall Study|Deterioration of general conditions|0|||
37668186|NCT02106832|69140667|FG002|Overall Study|Deterioration of general conditions|1|||
37668187|NCT02106832|69140668|FG003|Overall Study|Deterioration of general conditions|0|||
37668188|NCT02106832|69140665|FG000|Overall Study|Lost to Follow-up|0|||
37668189|NCT02106832|69140666|FG001|Overall Study|Lost to Follow-up|1|||
37668190|NCT02106832|69140667|FG002|Overall Study|Lost to Follow-up|1|||
37668191|NCT02106832|69140668|FG003|Overall Study|Lost to Follow-up|3|||
37668192|NCT02106832|69140665|FG000|Overall Study|Physician Decision|1|||
37668193|NCT02106832|69140666|FG001|Overall Study|Physician Decision|0|||
37668194|NCT02106832|69140667|FG002|Overall Study|Physician Decision|0|||
37668195|NCT02106832|69140668|FG003|Overall Study|Physician Decision|0|||
37668196|NCT02106832|69140665|FG000|Overall Study|Protocol Violation|0|||
37668197|NCT02106832|69140666|FG001|Overall Study|Protocol Violation|0|||
37668198|NCT02106832|69140667|FG002|Overall Study|Protocol Violation|0|||
37668199|NCT02106832|69140668|FG003|Overall Study|Protocol Violation|1|||
37668200|NCT02106832|69140665|FG000|Overall Study|Withdrawal by Subject|17|||
37668201|NCT02106832|69140666|FG001|Overall Study|Withdrawal by Subject|17|||
37668202|NCT02106832|69140667|FG002|Overall Study|Withdrawal by Subject|10|||
37668203|NCT02106832|69140668|FG003|Overall Study|Withdrawal by Subject|7|||
37931400|NCT00764504|69618161|FG000|Overall Study|Withdrawal by Subject|1|||
37931401|NCT00764504|69618162|FG001|Overall Study|Withdrawal by Subject|7|||
37931402|NCT00764504|69618163|FG002|Overall Study|Withdrawal by Subject|4|||
37931403|NCT00764504|69618161|FG000|Overall Study|Lost to Follow-up|40|||
37931404|NCT00764504|69618162|FG001|Overall Study|Lost to Follow-up|34|||
37931405|NCT00764504|69618163|FG002|Overall Study|Lost to Follow-up|72|||
37931406|NCT00763958|69618173|FG000|Overall Study|did not meet final criteria|4|||
37931407|NCT00763958|69618174|FG001|Overall Study|did not meet final criteria|4|||
37931408|NCT00763958|69618173|FG000|Overall Study|Lost to Follow-up|10|||
37668204|NCT02106832|69140665|FG000|Overall Study|Technical problems|0|||
37668205|NCT02106832|69140666|FG001|Overall Study|Technical problems|1|||
37668206|NCT02106832|69140667|FG002|Overall Study|Technical problems|0|||
37668207|NCT02106832|69140668|FG003|Overall Study|Technical problems|0|||
37668208|NCT02106442|69140680|FG000|Overall Study|Case Report Forms Uncollected|7|||
37668209|NCT02106442|69140680|FG000|Overall Study|Protocol Deviation|30|||
37668210|NCT02105116|69140684|FG000|Overall Study|not eligible for step 2 of trial|5|||
37931409|NCT00763958|69618174|FG001|Overall Study|Lost to Follow-up|2|||
37931410|NCT00763958|69618173|FG000|Overall Study|Believed they were receiving placebo|0|||
37931411|NCT00763958|69618174|FG001|Overall Study|Believed they were receiving placebo|5|||
37931412|NCT00763256|69618183|FG000|Overall Study|Didn't return for appointments|7|||
37931413|NCT00763256|69618184|FG001|Overall Study|Didn't return for appointments|10|||
37931414|NCT00762788|69618196|FG000|Overall Study|Lost to Follow-up|26|||
37931415|NCT00762788|69618197|FG001|Overall Study|Lost to Follow-up|37|||
37931416|NCT00762788|69618198|FG002|Overall Study|Lost to Follow-up|21|||
37931417|NCT00762788|69618199|FG003|Overall Study|Lost to Follow-up|26|||
37931418|NCT00762788|69618200|FG004|Overall Study|Lost to Follow-up|13|||
37931419|NCT00762788|69618201|FG005|Overall Study|Lost to Follow-up|21|||
37931420|NCT00583947|69618217|FG000|Cross-over Period|Adverse Event|2|||
37931421|NCT00583947|69618218|FG001|Cross-over Period|Adverse Event|0|||
37931422|NCT00583947|69618217|FG000|Cross-over Period|Withdrawal by Subject|2|||
37931423|NCT00583947|69618218|FG001|Cross-over Period|Withdrawal by Subject|0|||
37931424|NCT00583947|69618217|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
37931425|NCT00583947|69618218|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
37931426|NCT00583947|69618217|FG000|Cross-over Period|Other|1|||
37931427|NCT00583947|69618218|FG001|Cross-over Period|Other|1|||
37931428|NCT00772928|69618228|FG000|Overall Study|Lost to Follow-up|9|||
37931429|NCT00772928|69618229|FG001|Overall Study|Lost to Follow-up|6|||
37931430|NCT00772928|69618228|FG000|Overall Study|Protocol Violation|10|||
37931431|NCT00772928|69618229|FG001|Overall Study|Protocol Violation|12|||
37931432|NCT00772928|69618228|FG000|Overall Study|Withdrawal by Subject|25|||
37931433|NCT00772928|69618229|FG001|Overall Study|Withdrawal by Subject|22|||
37931434|NCT00772928|69618228|FG000|Overall Study|Did not receive vaccine|0|||
37931435|NCT00772928|69618229|FG001|Overall Study|Did not receive vaccine|1|||
37931436|NCT00762476|69618237|FG000|Overall Study|Adverse Event|7|||
37931437|NCT00762476|69618238|FG001|Overall Study|Adverse Event|1|||
37931438|NCT00762476|69618237|FG000|Overall Study|Lost to Follow-up|2|||
37931439|NCT00762476|69618238|FG001|Overall Study|Lost to Follow-up|0|||
37931440|NCT00762476|69618237|FG000|Overall Study|Protocol Violation|5|||
37931441|NCT00762476|69618238|FG001|Overall Study|Protocol Violation|6|||
37931442|NCT00762476|69618237|FG000|Overall Study|Physician Decision|2|||
37931443|NCT00762476|69618238|FG001|Overall Study|Physician Decision|14|||
37931444|NCT00762476|69618237|FG000|Overall Study|Withdrawal by Subject|6|||
37931445|NCT00762476|69618238|FG001|Overall Study|Withdrawal by Subject|12|||
37931446|NCT00762476|69618237|FG000|Overall Study|antibiotic use|0|||
37931447|NCT00762476|69618238|FG001|Overall Study|antibiotic use|1|||
37931448|NCT00762476|69618237|FG000|Overall Study|non-compliance with study visits|0|||
37931449|NCT00762476|69618238|FG001|Overall Study|non-compliance with study visits|2|||
37931450|NCT00762476|69618237|FG000|Overall Study|Seasonal allergies|1|||
37931451|NCT00762476|69618238|FG001|Overall Study|Seasonal allergies|0|||
37931452|NCT00762164|69618247|FG000|Overall Study|Lost to Follow-up|1|||
37931453|NCT00762164|69618248|FG001|Overall Study|Lost to Follow-up|1|||
37931454|NCT00762164|69618247|FG000|Overall Study|Discontinued medication|2|||
37931455|NCT00762164|69618248|FG001|Overall Study|Discontinued medication|0|||
37931456|NCT00762164|69618247|FG000|Overall Study|Withdrawal by Subject|0|||
37931457|NCT00762164|69618248|FG001|Overall Study|Withdrawal by Subject|1|||
37931458|NCT00762086|69618256|FG000|Overall Study|Adverse Event|2|||
37931459|NCT00762086|69618257|FG001|Overall Study|Adverse Event|0|||
37931460|NCT00762086|69618256|FG000|Overall Study|Lost to Follow-up|0|||
37931461|NCT00762086|69618257|FG001|Overall Study|Lost to Follow-up|2|||
37931462|NCT00762086|69618256|FG000|Overall Study|Non compliance|1|||
37931463|NCT00762086|69618257|FG001|Overall Study|Non compliance|0|||
37931464|NCT00762086|69618256|FG000|Overall Study|Withdrawal by Subject|2|||
37931465|NCT00762086|69618257|FG001|Overall Study|Withdrawal by Subject|2|||
37931466|NCT00762086|69618256|FG000|Overall Study|Ineligible to participate in the study|1|||
37931467|NCT00762086|69618257|FG001|Overall Study|Ineligible to participate in the study|0|||
37931468|NCT00761774|69618263|FG000|Overall Study|Adverse Event|17|||
37931469|NCT00761774|69618263|FG000|Overall Study|Lack of Efficacy|37|||
37931470|NCT00761774|69618263|FG000|Overall Study|Lost to Follow-up|2|||
38033952|NCT03712917|69720223|FG001|Overall Study|Pregnancy|0|||
38033953|NCT03712917|69720224|FG002|Overall Study|Pregnancy|1|||
37931471|NCT00761774|69618263|FG000|Overall Study|Withdrawal by Subject|9|||
37931472|NCT00761774|69618263|FG000|Overall Study|Non-compliance|4|||
37931473|NCT00761774|69618263|FG000|Overall Study|End of study|2|||
38033954|NCT03712917|69720222|FG000|Overall Study|Adverse Event|0|||
37931474|NCT00761774|69618263|FG000|Overall Study|Reclassification of seizures|1|||
38033955|NCT03712917|69720223|FG001|Overall Study|Adverse Event|4|||
38033956|NCT03712917|69720224|FG002|Overall Study|Adverse Event|3|||
38033957|NCT03712917|69720222|FG000|Overall Study|Lost to Follow-up|9|||
37931475|NCT00761774|69618263|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
37931476|NCT00761774|69618263|FG000|Overall Study|Sponsor decision|1|||
37931477|NCT00761774|69618263|FG000|Overall Study|Investigator clinical judgement|1|||
37931478|NCT00761774|69618263|FG000|Overall Study|Patient moved out of study area|1|||
37931479|NCT00761774|69618263|FG000|Overall Study|Coordinator leaving site|1|||
37931480|NCT00761774|69618263|FG000|Overall Study|Subject IP non-compliance|1|||
37931481|NCT00761774|69618263|FG000|Overall Study|IP stopped by hospital physician|1|||
37931482|NCT00583791|69618269|FG000|Overall Study|Other|67|||
37931483|NCT00583791|69618269|FG000|Overall Study|Death|6|||
37931484|NCT00781274|69618273|FG000|Overall Study|Withdrawal by Subject|2|||
37931485|NCT00780416|69618279|FG000|Overall Study|Physician Decision|3|||
37931486|NCT00780416|69618280|FG001|Overall Study|Physician Decision|3|||
37931487|NCT00780416|69618279|FG000|Overall Study|Protocol Violation|1|||
37931488|NCT00780416|69618280|FG001|Overall Study|Protocol Violation|0|||
37931489|NCT00780416|69618279|FG000|Overall Study|Withdrawal by Subject|8|||
37931490|NCT00780416|69618280|FG001|Overall Study|Withdrawal by Subject|6|||
37931491|NCT00761462|69618288|FG000|Treatment|Subjects never received study medication|23|||
37931492|NCT00761462|69618289|FG001|Treatment|Subjects never received study medication|12|||
37931493|NCT00761462|69618288|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
37931494|NCT00761462|69618289|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
37931495|NCT00761462|69618288|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
37931496|NCT00761462|69618289|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
37931497|NCT00761462|69618288|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
37931498|NCT00761462|69618289|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
37931499|NCT00761306|69618295|FG000|Overall Study|Adverse Event|5|||
37931500|NCT00761306|69618295|FG000|Overall Study|Lack of Efficacy|4|||
37931501|NCT00761306|69618295|FG000|Overall Study|Protocol Violation|2|||
37931502|NCT00761306|69618295|FG000|Overall Study|Withdrawal of Consent|3|||
37931503|NCT00761306|69618295|FG000|Overall Study|Lost to Follow-up|1|||
37931504|NCT00761306|69618295|FG000|Overall Study|Administrative or Other Reasons|5|||
37931505|NCT00772538|69618301|FG000|Overall Study|Adverse Event|6|||
37931506|NCT00772538|69618302|FG001|Overall Study|Adverse Event|6|||
37931507|NCT00772538|69618301|FG000|Overall Study|Protocol Violation|3|||
37931508|NCT00772538|69618302|FG001|Overall Study|Protocol Violation|3|||
37931509|NCT00772538|69618301|FG000|Overall Study|Lost to Follow-up|1|||
37931510|NCT00772538|69618302|FG001|Overall Study|Lost to Follow-up|1|||
37931511|NCT00772538|69618301|FG000|Overall Study|Withdrawal by Subject|3|||
37931512|NCT00772538|69618302|FG001|Overall Study|Withdrawal by Subject|8|||
37931513|NCT00772538|69618301|FG000|Overall Study|Lack of Efficacy|0|||
37931514|NCT00772538|69618302|FG001|Overall Study|Lack of Efficacy|1|||
37931515|NCT00772538|69618301|FG000|Overall Study|Other|7|||
37931516|NCT00772538|69618302|FG001|Overall Study|Other|7|||
37931517|NCT00761150|69618311|FG000|Open-label Period|Adverse Event|36|||
37931518|NCT00761150|69618312|FG001|Open-label Period|Adverse Event|0|||
37931519|NCT00761150|69618313|FG002|Open-label Period|Adverse Event|0|||
37931520|NCT00761150|69618311|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
37931521|NCT00761150|69618312|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
37931522|NCT00761150|69618313|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
37931523|NCT00761150|69618311|FG000|Open-label Period|Lost to Follow-up|7|||
37931524|NCT00761150|69618312|FG001|Open-label Period|Lost to Follow-up|0|||
37931525|NCT00761150|69618313|FG002|Open-label Period|Lost to Follow-up|0|||
37931526|NCT00761150|69618311|FG000|Open-label Period|Lack of Efficacy|4|||
37931527|NCT00761150|69618312|FG001|Open-label Period|Lack of Efficacy|0|||
37931528|NCT00761150|69618313|FG002|Open-label Period|Lack of Efficacy|0|||
37931529|NCT00761150|69618311|FG000|Open-label Period|Withdrawal by Subject|5|||
37931530|NCT00761150|69618312|FG001|Open-label Period|Withdrawal by Subject|0|||
37931531|NCT00761150|69618313|FG002|Open-label Period|Withdrawal by Subject|0|||
37668211|NCT02105116|69140684|FG000|Overall Study|Death|1|||
37668212|NCT02104804|69140690|FG000|Overall Study|Did not take study medication|0|||
37668213|NCT02104804|69140691|FG001|Overall Study|Did not take study medication|1|||
37668214|NCT02104804|69140690|FG000|Overall Study|Study specific discontinuation criteria|6|||
37668215|NCT02104804|69140691|FG001|Overall Study|Study specific discontinuation criteria|1|||
37760861|NCT01559129|69271772|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
37760862|NCT01559129|69271771|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
37668216|NCT02104804|69140690|FG000|Overall Study|Other listed|2|||
37668217|NCT02104804|69140691|FG001|Overall Study|Other listed|1|||
37668218|NCT02104804|69140690|FG000|Overall Study|Protocol Violation|0|||
37668219|NCT02104804|69140691|FG001|Overall Study|Protocol Violation|1|||
37668220|NCT02104804|69140690|FG000|Overall Study|Adverse Event|4|||
37668221|NCT02104804|69140691|FG001|Overall Study|Adverse Event|3|||
37931532|NCT00761150|69618311|FG000|Open-label Period|Noncompliance|2|||
37668222|NCT02104804|69140690|FG000|Overall Study|Withdrawal by Subject|4|||
37931533|NCT00761150|69618312|FG001|Open-label Period|Noncompliance|0|||
37931534|NCT00761150|69618313|FG002|Open-label Period|Noncompliance|0|||
37931535|NCT00761150|69618311|FG000|Open-label Period|Other|5|||
37668223|NCT02104804|69140691|FG001|Overall Study|Withdrawal by Subject|12|||
37668224|NCT02075008|69140697|FG000|Overall Study|Technical problems|1|||
37931536|NCT00761150|69618312|FG001|Open-label Period|Other|0|||
37931537|NCT00761150|69618313|FG002|Open-label Period|Other|0|||
37931538|NCT00761150|69618311|FG000|Double-blind Period|Lack of Efficacy|0|||
37931539|NCT00761150|69618312|FG001|Double-blind Period|Lack of Efficacy|2|||
37931540|NCT00761150|69618313|FG002|Double-blind Period|Lack of Efficacy|19|||
37668225|NCT02075008|69140697|FG000|Overall Study|Pregnancy|1|||
37931541|NCT00761150|69618311|FG000|Double-blind Period|Adverse Event|0|||
37931542|NCT00761150|69618312|FG001|Double-blind Period|Adverse Event|3|||
37931543|NCT00761150|69618313|FG002|Double-blind Period|Adverse Event|3|||
37931544|NCT00761150|69618311|FG000|Double-blind Period|Withdrawal by Subject|0|||
37931545|NCT00761150|69618312|FG001|Double-blind Period|Withdrawal by Subject|3|||
37931546|NCT00761150|69618313|FG002|Double-blind Period|Withdrawal by Subject|2|||
37931547|NCT00761150|69618311|FG000|Double-blind Period|Lost to Follow-up|0|||
37931548|NCT00761150|69618312|FG001|Double-blind Period|Lost to Follow-up|2|||
37931549|NCT00761150|69618313|FG002|Double-blind Period|Lost to Follow-up|1|||
37931550|NCT00761150|69618311|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
37931551|NCT00761150|69618312|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
37931552|NCT00761150|69618313|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
37931553|NCT00761150|69618311|FG000|Double-blind Period|Noncompliance|0|||
37931554|NCT00761150|69618312|FG001|Double-blind Period|Noncompliance|1|||
37931555|NCT00761150|69618313|FG002|Double-blind Period|Noncompliance|0|||
37668226|NCT02075008|69140697|FG000|Overall Study|Physician Decision|1|||
37668227|NCT02075008|69140697|FG000|Overall Study|Lost to Follow-up|1|||
37668228|NCT02075008|69140697|FG000|Overall Study|Lack of Efficacy|1|||
37668229|NCT02075008|69140697|FG000|Overall Study|Death|1|||
37668230|NCT02075008|69140697|FG000|Overall Study|Adverse Event|5|||
37668231|NCT02075008|69140697|FG000|Overall Study|Withdrawal by Subject|6|||
37668232|NCT02075008|69140697|FG000|Overall Study|Study terminated by Sponsor|159|||
37668233|NCT01666119|69140728|FG000|Overall Study|Adverse Event|6|||
37668234|NCT01666119|69140728|FG000|Overall Study|Withdrawal by Subject|16|||
37668235|NCT01666119|69140728|FG000|Overall Study|Lost to Follow-up|7|||
37668236|NCT01666119|69140728|FG000|Overall Study|non compliance with study medication, pa|18|||
37668237|NCT01666119|69140728|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
37668238|NCT05128773|69140732|FG000|Overall Study|Sponsor decision to terminate study|3|||
37668239|NCT01665807|69140740|FG000|Overall Study|Withdrawal by Subject|2|||
37668240|NCT01665807|69140741|FG001|Overall Study|Withdrawal by Subject|0|||
37668241|NCT01665807|69140742|FG002|Overall Study|Withdrawal by Subject|1|||
37668242|NCT02584959|69140753|FG000|Period 1|Withdrawn from study|3|||
37668243|NCT02584959|69140754|FG001|Period 1|Withdrawn from study|4|||
37668244|NCT02584959|69140755|FG002|Period 1|Withdrawn from study|0|||
37668245|NCT02584959|69140753|FG000|Period 2|Withdrawn from study|6|||
37668246|NCT02584959|69140754|FG001|Period 2|Withdrawn from study|1|||
37668247|NCT02584959|69140755|FG002|Period 2|Withdrawn from study|2|||
37668248|NCT02584257|69140772|FG000|Period 1|Withdrawal by Subject|0|||
37668249|NCT02584257|69140773|FG001|Period 1|Withdrawal by Subject|0|||
37668250|NCT02584257|69140774|FG002|Period 1|Withdrawal by Subject|0|||
37668251|NCT02584257|69140775|FG003|Period 1|Withdrawal by Subject|0|||
37668252|NCT02584257|69140776|FG004|Period 1|Withdrawal by Subject|0|||
37668253|NCT02584257|69140777|FG005|Period 1|Withdrawal by Subject|0|||
37668254|NCT02584257|69140778|FG006|Period 1|Withdrawal by Subject|1|||
37668255|NCT02584257|69140779|FG007|Period 1|Withdrawal by Subject|0|||
37668256|NCT02584257|69140780|FG008|Period 1|Withdrawal by Subject|0|||
37668257|NCT02584257|69140772|FG000|Period 2|Physician Decision|1|||
37668258|NCT02584257|69140773|FG001|Period 2|Physician Decision|0|||
37668259|NCT02584257|69140774|FG002|Period 2|Physician Decision|0|||
37668260|NCT02584257|69140775|FG003|Period 2|Physician Decision|0|||
37668261|NCT02584257|69140776|FG004|Period 2|Physician Decision|0|||
37668262|NCT02584257|69140777|FG005|Period 2|Physician Decision|0|||
37668263|NCT02584257|69140778|FG006|Period 2|Physician Decision|0|||
37668264|NCT02584257|69140779|FG007|Period 2|Physician Decision|0|||
37668265|NCT02584257|69140780|FG008|Period 2|Physician Decision|0|||
37668266|NCT02584257|69140772|FG000|Period 2|Adverse Event|0|||
37668267|NCT02584257|69140773|FG001|Period 2|Adverse Event|1|||
37668268|NCT02584257|69140774|FG002|Period 2|Adverse Event|0|||
37668269|NCT02584257|69140775|FG003|Period 2|Adverse Event|0|||
37668270|NCT02584257|69140776|FG004|Period 2|Adverse Event|0|||
37668271|NCT02584257|69140777|FG005|Period 2|Adverse Event|0|||
37668272|NCT02584257|69140778|FG006|Period 2|Adverse Event|0|||
37668273|NCT02584257|69140779|FG007|Period 2|Adverse Event|0|||
37931556|NCT00761150|69618311|FG000|Double-blind Period|Other|0|||
37931557|NCT00761150|69618312|FG001|Double-blind Period|Other|3|||
37931558|NCT00761150|69618313|FG002|Double-blind Period|Other|3|||
37931559|NCT00760994|69618323|FG000|Overall Study|Lost to Follow-up|4|||
37668274|NCT02584257|69140780|FG008|Period 2|Adverse Event|0|||
37668275|NCT02583711|69140795|FG000|Overall Study|Withdrawal by Subject|0|||
37668276|NCT02583711|69140796|FG001|Overall Study|Withdrawal by Subject|10|||
37668277|NCT02583711|69140797|FG002|Overall Study|Withdrawal by Subject|0|||
37668278|NCT02583477|69140809|FG000|Overall Study|Adverse Event|0|||
37668279|NCT02583477|69140810|FG001|Overall Study|Adverse Event|2|||
37668280|NCT02583477|69140809|FG000|Overall Study|Death|1|||
37668281|NCT02583477|69140810|FG001|Overall Study|Death|16|||
37668282|NCT02583477|69140809|FG000|Overall Study|Study terminated|2|||
37668283|NCT02583477|69140810|FG001|Overall Study|Study terminated|2|||
37668284|NCT02583399|69140817|FG000|Overall Study|Able to be discharged|3|||
37668285|NCT02583399|69140817|FG000|Overall Study|Wanted to use a restricted medication|3|||
37931560|NCT00760994|69618324|FG001|Overall Study|Lost to Follow-up|4|||
37931561|NCT00760994|69618325|FG002|Overall Study|Lost to Follow-up|3|||
37931562|NCT00583557|69618335|FG000|Overall Study|Withdrawal by Subject|18|||
37931563|NCT00583557|69618335|FG000|Overall Study|Adverse Event|9|||
37931564|NCT00583557|69618335|FG000|Overall Study|Lack of Efficacy|31|||
37931565|NCT00583557|69618335|FG000|Overall Study|Lack of Compliance|5|||
37931566|NCT00583557|69618335|FG000|Overall Study|Other|5|||
37931567|NCT00583557|69618335|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
37931568|NCT00586820|69618341|FG000|Overall Study|Unsuccessful PCI|1|||
37931569|NCT00586820|69618342|FG001|Overall Study|Unsuccessful PCI|0|||
37931570|NCT00760838|69618350|FG000|Overall Study|Adverse Event|1|||
37931571|NCT00760838|69618351|FG001|Overall Study|Adverse Event|1|||
37931572|NCT00760838|69618350|FG000|Overall Study|Lack of Efficacy|1|||
37931573|NCT00760838|69618351|FG001|Overall Study|Lack of Efficacy|0|||
37931574|NCT00760838|69618350|FG000|Overall Study|Lost to Follow-up|2|||
37931575|NCT00760838|69618351|FG001|Overall Study|Lost to Follow-up|0|||
37931576|NCT00760838|69618350|FG000|Overall Study|Withdrawal by Subject|1|||
37931577|NCT00760838|69618351|FG001|Overall Study|Withdrawal by Subject|1|||
37931578|NCT00586664|69618360|FG000|Overall Study|Withdrawal by Subject|3|||
37931579|NCT00586664|69618361|FG001|Overall Study|Withdrawal by Subject|7|||
37931580|NCT00586664|69618362|FG002|Overall Study|Withdrawal by Subject|1|||
37931581|NCT00586664|69618360|FG000|Overall Study|Exclusion criteria met|2|||
37931582|NCT00586664|69618361|FG001|Overall Study|Exclusion criteria met|0|||
37931583|NCT00586664|69618362|FG002|Overall Study|Exclusion criteria met|0|||
37931584|NCT00437281|69618390|FG000|Overall Study|Adverse Event|0|||
37931585|NCT00437281|69618391|FG001|Overall Study|Adverse Event|0|||
37931586|NCT00437281|69618392|FG002|Overall Study|Adverse Event|0|||
37931587|NCT00437281|69618393|FG003|Overall Study|Adverse Event|1|||
37931588|NCT00437281|69618394|FG004|Overall Study|Adverse Event|0|||
37931589|NCT00437281|69618395|FG005|Overall Study|Adverse Event|1|||
37931590|NCT00437281|69618396|FG006|Overall Study|Adverse Event|0|||
37931591|NCT00437281|69618397|FG007|Overall Study|Adverse Event|0|||
37931592|NCT00437281|69618398|FG008|Overall Study|Adverse Event|0|||
37931593|NCT00437281|69618399|FG009|Overall Study|Adverse Event|1|||
37931594|NCT00437281|69618400|FG010|Overall Study|Adverse Event|0|||
37931595|NCT00437281|69618401|FG011|Overall Study|Adverse Event|0|||
37931596|NCT00437281|69618402|FG012|Overall Study|Adverse Event|0|||
37931597|NCT00437281|69618403|FG013|Overall Study|Adverse Event|1|||
37931598|NCT00437281|69618404|FG014|Overall Study|Adverse Event|1|||
37931599|NCT00437281|69618405|FG015|Overall Study|Adverse Event|0|||
37931600|NCT00437281|69618406|FG016|Overall Study|Adverse Event|0|||
37931601|NCT00437281|69618407|FG017|Overall Study|Adverse Event|0|||
37931602|NCT00437281|69618408|FG018|Overall Study|Adverse Event|1|||
37931603|NCT00437281|69618409|FG019|Overall Study|Adverse Event|0|||
37931604|NCT00437281|69618390|FG000|Overall Study|Lost to Follow-up|0|||
37931605|NCT00437281|69618391|FG001|Overall Study|Lost to Follow-up|0|||
37931606|NCT00437281|69618392|FG002|Overall Study|Lost to Follow-up|0|||
37931607|NCT00437281|69618393|FG003|Overall Study|Lost to Follow-up|0|||
37931608|NCT00437281|69618394|FG004|Overall Study|Lost to Follow-up|0|||
37931609|NCT00437281|69618395|FG005|Overall Study|Lost to Follow-up|0|||
37931610|NCT00437281|69618396|FG006|Overall Study|Lost to Follow-up|0|||
37931611|NCT00437281|69618397|FG007|Overall Study|Lost to Follow-up|0|||
37931612|NCT00437281|69618398|FG008|Overall Study|Lost to Follow-up|0|||
37931613|NCT00437281|69618399|FG009|Overall Study|Lost to Follow-up|0|||
37931614|NCT00437281|69618400|FG010|Overall Study|Lost to Follow-up|0|||
37931615|NCT00437281|69618401|FG011|Overall Study|Lost to Follow-up|0|||
37931616|NCT00437281|69618402|FG012|Overall Study|Lost to Follow-up|0|||
37931617|NCT00437281|69618403|FG013|Overall Study|Lost to Follow-up|0|||
37931618|NCT00437281|69618404|FG014|Overall Study|Lost to Follow-up|0|||
37931619|NCT00437281|69618405|FG015|Overall Study|Lost to Follow-up|0|||
37931620|NCT00437281|69618406|FG016|Overall Study|Lost to Follow-up|0|||
37931621|NCT00437281|69618407|FG017|Overall Study|Lost to Follow-up|0|||
37931622|NCT00437281|69618408|FG018|Overall Study|Lost to Follow-up|0|||
37931623|NCT00437281|69618409|FG019|Overall Study|Lost to Follow-up|1|||
37931624|NCT00741039|69618483|FG000|Overall Study|Patient non-compliance|2|||
37931625|NCT00741039|69618484|FG001|Overall Study|Patient non-compliance|0|||
37931626|NCT00772382|69618490|FG000|Overall Study|Adverse Event|19|||
37931627|NCT00772382|69618490|FG000|Overall Study|Death|6|||
37931628|NCT00772382|69618490|FG000|Overall Study|Lack of Efficacy|4|||
37931629|NCT00772382|69618490|FG000|Overall Study|Physician Decision|5|||
37931630|NCT00772382|69618490|FG000|Overall Study|Protocol Violation|1|||
37931631|NCT00772382|69618490|FG000|Overall Study|Withdrawal by Subject|10|||
37931632|NCT00772382|69618490|FG000|Overall Study|Other Reasons|10|||
37931633|NCT00798707|69618497|FG000|Overall Study|Adverse Event|6|||
37931634|NCT00798707|69618498|FG001|Overall Study|Adverse Event|8|||
37931635|NCT00798707|69618499|FG002|Overall Study|Adverse Event|8|||
37931636|NCT00798707|69618497|FG000|Overall Study|Failed to return|2|||
37931637|NCT00798707|69618498|FG001|Overall Study|Failed to return|2|||
37931638|NCT00798707|69618499|FG002|Overall Study|Failed to return|0|||
37931639|NCT00798707|69618497|FG000|Overall Study|Investigator|0|||
37931640|NCT00798707|69618498|FG001|Overall Study|Investigator|1|||
37931641|NCT00798707|69618499|FG002|Overall Study|Investigator|2|||
37931642|NCT00798707|69618497|FG000|Overall Study|Lack of Efficacy|2|||
37931643|NCT00798707|69618498|FG001|Overall Study|Lack of Efficacy|2|||
37931644|NCT00798707|69618499|FG002|Overall Study|Lack of Efficacy|1|||
37931645|NCT00798707|69618497|FG000|Overall Study|Lost to Follow-up|5|||
37931646|NCT00798707|69618498|FG001|Overall Study|Lost to Follow-up|6|||
37931647|NCT00798707|69618499|FG002|Overall Study|Lost to Follow-up|6|||
37931648|NCT00798707|69618497|FG000|Overall Study|Other|0|||
37931649|NCT00798707|69618498|FG001|Overall Study|Other|1|||
37931650|NCT00798707|69618499|FG002|Overall Study|Other|0|||
37931651|NCT00798707|69618497|FG000|Overall Study|Protocol Violation|4|||
37931652|NCT00798707|69618498|FG001|Overall Study|Protocol Violation|0|||
37931653|NCT00798707|69618499|FG002|Overall Study|Protocol Violation|2|||
37931654|NCT00798707|69618497|FG000|Overall Study|Withdrawal by Subject|3|||
37931655|NCT00798707|69618498|FG001|Overall Study|Withdrawal by Subject|8|||
37931656|NCT00798707|69618499|FG002|Overall Study|Withdrawal by Subject|2|||
37931657|NCT00798707|69618497|FG000|Overall Study|Randomized not treated|4|||
37931658|NCT00798707|69618498|FG001|Overall Study|Randomized not treated|5|||
37931659|NCT00798707|69618499|FG002|Overall Study|Randomized not treated|1|||
37931660|NCT00760214|69618510|FG000|Overall Study|Adverse Event|8|||
37931661|NCT00760214|69618511|FG001|Overall Study|Adverse Event|9|||
37931662|NCT00760214|69618512|FG002|Overall Study|Adverse Event|12|||
38033958|NCT03712917|69720223|FG001|Overall Study|Lost to Follow-up|4|||
38033959|NCT03712917|69720224|FG002|Overall Study|Lost to Follow-up|5|||
38033960|NCT02748694|69720247|FG000|Overall Study|Voluntary Withdrawal|0|||
38033961|NCT02748694|69720248|FG001|Overall Study|Voluntary Withdrawal|0|||
38033962|NCT02748694|69720249|FG002|Overall Study|Voluntary Withdrawal|0|||
38033963|NCT02748694|69720250|FG003|Overall Study|Voluntary Withdrawal|0|||
38033964|NCT02748694|69720251|FG004|Overall Study|Voluntary Withdrawal|0|||
38033965|NCT02748694|69720252|FG005|Overall Study|Voluntary Withdrawal|0|||
38033966|NCT02748694|69720253|FG006|Overall Study|Voluntary Withdrawal|0|||
38033967|NCT02748694|69720254|FG007|Overall Study|Voluntary Withdrawal|0|||
38033968|NCT02748694|69720255|FG008|Overall Study|Voluntary Withdrawal|0|||
38033969|NCT02748694|69720256|FG009|Overall Study|Voluntary Withdrawal|0|||
38033970|NCT02748694|69720257|FG010|Overall Study|Voluntary Withdrawal|0|||
38033971|NCT02748694|69720258|FG011|Overall Study|Voluntary Withdrawal|0|||
38033972|NCT02748694|69720259|FG012|Overall Study|Voluntary Withdrawal|0|||
38033973|NCT02748694|69720260|FG013|Overall Study|Voluntary Withdrawal|0|||
38033974|NCT02748694|69720261|FG014|Overall Study|Voluntary Withdrawal|2|||
38033975|NCT02800642|69720317|FG000|Overall Study|Death|3|||
38033976|NCT02800642|69720317|FG000|Overall Study|Other|10|||
38033977|NCT02800642|69720317|FG000|Overall Study|Physician Decision|2|||
38033978|NCT02800642|69720317|FG000|Overall Study|Adverse Event|6|||
38033979|NCT02800642|69720317|FG000|Overall Study|Withdrawal by Subject|3|||
38033980|NCT02800642|69720317|FG000|Overall Study|Lost to Follow-up|1|||
38033981|NCT02799784|69720321|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
38033982|NCT02799784|69720322|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
38033983|NCT02799784|69720321|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
38033984|NCT02799784|69720322|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
38033985|NCT02799784|69720321|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
38033986|NCT02799784|69720322|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
38033987|NCT02799784|69720321|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
38033988|NCT02799784|69720322|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
38033989|NCT02799784|69720321|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
37931663|NCT00760214|69618510|FG000|Overall Study|Protocol Violation|3|||
37931664|NCT00760214|69618511|FG001|Overall Study|Protocol Violation|0|||
37931665|NCT00760214|69618512|FG002|Overall Study|Protocol Violation|3|||
37931666|NCT00760214|69618510|FG000|Overall Study|Lost to Follow-up|0|||
37931667|NCT00760214|69618511|FG001|Overall Study|Lost to Follow-up|0|||
37931668|NCT00760214|69618512|FG002|Overall Study|Lost to Follow-up|1|||
37931669|NCT00760214|69618510|FG000|Overall Study|Withdrawal by Subject|12|||
37931670|NCT00760214|69618511|FG001|Overall Study|Withdrawal by Subject|14|||
38033990|NCT02799784|69720322|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
38033991|NCT02799784|69720321|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
37931671|NCT00760214|69618512|FG002|Overall Study|Withdrawal by Subject|13|||
37931672|NCT00760214|69618510|FG000|Overall Study|Lack of Efficacy|3|||
37931673|NCT00760214|69618511|FG001|Overall Study|Lack of Efficacy|2|||
37931674|NCT00760214|69618512|FG002|Overall Study|Lack of Efficacy|4|||
37931675|NCT00760214|69618510|FG000|Overall Study|Pregnancy|0|||
37931676|NCT00760214|69618511|FG001|Overall Study|Pregnancy|0|||
37931677|NCT00760214|69618512|FG002|Overall Study|Pregnancy|1|||
37931678|NCT00760214|69618510|FG000|Overall Study|Physician Decision|1|||
37931679|NCT00760214|69618511|FG001|Overall Study|Physician Decision|1|||
38033992|NCT02799784|69720322|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
37931680|NCT00760214|69618512|FG002|Overall Study|Physician Decision|1|||
37931681|NCT00760214|69618510|FG000|Overall Study|Other|3|||
37931682|NCT00760214|69618511|FG001|Overall Study|Other|4|||
37931683|NCT00760214|69618512|FG002|Overall Study|Other|6|||
37931684|NCT00802841|69618522|FG000|Overall Study|Administrative problems|1|||
37931685|NCT00802841|69618523|FG001|Overall Study|Administrative problems|0|||
37931686|NCT00802841|69618522|FG000|Overall Study|Lost to Follow-up|2|||
37931687|NCT00802841|69618523|FG001|Overall Study|Lost to Follow-up|1|||
37931688|NCT00802841|69618522|FG000|Overall Study|Death|1|||
37931689|NCT00802841|69618523|FG001|Overall Study|Death|2|||
37931690|NCT00802841|69618522|FG000|Overall Study|Adverse Event|8|||
37931691|NCT00802841|69618523|FG001|Overall Study|Adverse Event|2|||
37931692|NCT00802841|69618522|FG000|Overall Study|Disease progression|7|||
37931693|NCT00802841|69618523|FG001|Overall Study|Disease progression|3|||
37931694|NCT00802841|69618522|FG000|Overall Study|Withdrawal by Subject|9|||
37931695|NCT00802841|69618523|FG001|Overall Study|Withdrawal by Subject|5|||
37931696|NCT00802841|69618522|FG000|Overall Study|Protocol deviation|2|||
37931697|NCT00802841|69618523|FG001|Overall Study|Protocol deviation|6|||
37931698|NCT00802841|69618522|FG000|Overall Study|Treatment duration completed|66|||
37931699|NCT00802841|69618523|FG001|Overall Study|Treatment duration completed|76|||
37931700|NCT00772148|69618533|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
37931701|NCT00772148|69618534|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
37931702|NCT00772148|69618533|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
37931703|NCT00772148|69618534|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
37931704|NCT00772148|69618533|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
37931705|NCT00772148|69618534|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
37931706|NCT00772148|69618533|FG000|Maintenance Phase (Week 52)|Death|2|||
37931707|NCT00772148|69618534|FG001|Maintenance Phase (Week 52)|Death|2|||
37931708|NCT00772148|69618533|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
37931709|NCT00772148|69618534|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
37931710|NCT00772148|69618533|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
37931711|NCT00772148|69618534|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
37931712|NCT00772148|69618533|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
37931713|NCT00772148|69618534|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
37931714|NCT00759902|69618542|FG000|Overall Study|Adverse Event|0|||
37931715|NCT00759902|69618543|FG001|Overall Study|Adverse Event|1|||
37931716|NCT00772070|69618551|FG000|Overall Study|Lost to Follow-up|0|||
37931717|NCT00772070|69618552|FG001|Overall Study|Lost to Follow-up|8|||
37931718|NCT00772070|69618551|FG000|Overall Study|Withdrawal by Subject|0|||
37931719|NCT00772070|69618552|FG001|Overall Study|Withdrawal by Subject|2|||
37931720|NCT00772070|69618551|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
37931721|NCT00772070|69618552|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
37931722|NCT00796757|69618558|FG000|Overall Study|Withdrawal by Subject|14|||
37931723|NCT00796757|69618558|FG000|Overall Study|Death|61|||
37931724|NCT00796757|69618558|FG000|Overall Study|Protocol Violation|1|||
37931725|NCT00796757|69618558|FG000|Overall Study|Participant noncompliance|1|||
37931726|NCT00796757|69618558|FG000|Overall Study|Investigator's decision|2|||
37931727|NCT00796757|69618558|FG000|Overall Study|Other|7|||
37931728|NCT00759356|69618564|FG000|Overall Study|Adverse Event|0|||
37931729|NCT00759356|69618565|FG001|Overall Study|Adverse Event|1|||
37931730|NCT00759356|69618564|FG000|Overall Study|Withdrawal by Subject|0|||
37931731|NCT00759356|69618565|FG001|Overall Study|Withdrawal by Subject|2|||
37931732|NCT00759356|69618564|FG000|Overall Study|Subject was unable to return|1|||
37931733|NCT00759356|69618565|FG001|Overall Study|Subject was unable to return|0|||
37931734|NCT00721734|69618576|FG000|Overall Study|Progressive Disease|3|||
37931735|NCT00721734|69618577|FG001|Overall Study|Progressive Disease|10|||
37931736|NCT00721734|69618578|FG002|Overall Study|Progressive Disease|4|||
37931737|NCT00721734|69618579|FG003|Overall Study|Progressive Disease|5|||
37931738|NCT00721734|69618580|FG004|Overall Study|Progressive Disease|2|||
37931739|NCT00721734|69618576|FG000|Overall Study|Adverse Event|3|||
37931740|NCT00721734|69618577|FG001|Overall Study|Adverse Event|1|||
37931741|NCT00721734|69618578|FG002|Overall Study|Adverse Event|4|||
37931742|NCT00721734|69618579|FG003|Overall Study|Adverse Event|0|||
37931743|NCT00721734|69618580|FG004|Overall Study|Adverse Event|3|||
37931744|NCT00721734|69618576|FG000|Overall Study|Withdrawal by Subject|2|||
37931745|NCT00721734|69618577|FG001|Overall Study|Withdrawal by Subject|1|||
37931746|NCT00721734|69618578|FG002|Overall Study|Withdrawal by Subject|0|||
37931747|NCT00721734|69618579|FG003|Overall Study|Withdrawal by Subject|0|||
37931748|NCT00721734|69618580|FG004|Overall Study|Withdrawal by Subject|1|||
37931749|NCT00721734|69618576|FG000|Overall Study|Other|0|||
37931750|NCT00721734|69618577|FG001|Overall Study|Other|0|||
37931751|NCT00721734|69618578|FG002|Overall Study|Other|0|||
37931752|NCT00721734|69618579|FG003|Overall Study|Other|1|||
37931753|NCT00721734|69618580|FG004|Overall Study|Other|0|||
37931754|NCT00798317|69618594|FG000|Overall Study|Physician Decision|0|||
37931755|NCT00798317|69618595|FG001|Overall Study|Physician Decision|1|||
37931756|NCT00798317|69618594|FG000|Overall Study|Withdrawal by Subject|5|||
37931757|NCT00798317|69618595|FG001|Overall Study|Withdrawal by Subject|4|||
37931758|NCT00798317|69618594|FG000|Overall Study|Lost to Follow-up|2|||
37931759|NCT00798317|69618595|FG001|Overall Study|Lost to Follow-up|2|||
37931760|NCT00798317|69618594|FG000|Overall Study|Adverse Event|2|||
37931761|NCT00798317|69618595|FG001|Overall Study|Adverse Event|0|||
37931762|NCT00798317|69618594|FG000|Overall Study|Death|1|||
37931763|NCT00798317|69618595|FG001|Overall Study|Death|0|||
37931764|NCT00779402|69618603|FG000|Treatment Phase 1|Disease Progression|1|||
37931765|NCT00779402|69618604|FG001|Treatment Phase 1|Disease Progression|0|||
37931766|NCT00779402|69618603|FG000|Treatment Phase 1|Adverse Event|2|||
37931767|NCT00779402|69618604|FG001|Treatment Phase 1|Adverse Event|0|||
37931768|NCT00779402|69618603|FG000|Treatment Phase 1|Protocol Violation|1|||
37931769|NCT00779402|69618604|FG001|Treatment Phase 1|Protocol Violation|0|||
37931770|NCT00779402|69618603|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
37931771|NCT00779402|69618604|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
37931772|NCT00779402|69618603|FG000|Treatment Phase 1|Lost to Follow-up|0|||
37931773|NCT00779402|69618604|FG001|Treatment Phase 1|Lost to Follow-up|1|||
37931774|NCT00779402|69618603|FG000|Treatment Phase 1|Death|0|||
37931775|NCT00779402|69618604|FG001|Treatment Phase 1|Death|1|||
37931776|NCT00779402|69618603|FG000|Treatment Phase 1|Intercurrent Illness|1|||
37931777|NCT00779402|69618604|FG001|Treatment Phase 1|Intercurrent Illness|1|||
37931778|NCT00779402|69618603|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
37931779|NCT00779402|69618604|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
37931780|NCT00779402|69618603|FG000|Treatment Phase 1|Other|4|||
37931781|NCT00779402|69618604|FG001|Treatment Phase 1|Other|2|||
37931782|NCT00779402|69618603|FG000|Treatment Phase 1|Closure of Study|3|||
37931783|NCT00779402|69618604|FG001|Treatment Phase 1|Closure of Study|2|||
37931784|NCT00779402|69618603|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
37931785|NCT00779402|69618604|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
37931786|NCT00779402|69618603|FG000|Surveillance Phase|Protocol Violation|0|||
37931787|NCT00779402|69618604|FG001|Surveillance Phase|Protocol Violation|1|||
37931788|NCT00779402|69618603|FG000|Surveillance Phase|Patient refused to continue|22|||
37931789|NCT00779402|69618604|FG001|Surveillance Phase|Patient refused to continue|14|||
37931790|NCT00779402|69618603|FG000|Surveillance Phase|Lost to Follow-up|2|||
37931791|NCT00779402|69618604|FG001|Surveillance Phase|Lost to Follow-up|1|||
37931792|NCT00779402|69618603|FG000|Surveillance Phase|Death|0|||
37931793|NCT00779402|69618604|FG001|Surveillance Phase|Death|1|||
37931794|NCT00779402|69618603|FG000|Surveillance Phase|Intercurrent Illness|2|||
37931795|NCT00779402|69618604|FG001|Surveillance Phase|Intercurrent Illness|0|||
37931796|NCT00779402|69618603|FG000|Surveillance Phase|Other|5|||
37931797|NCT00779402|69618604|FG001|Surveillance Phase|Other|5|||
37931798|NCT00779402|69618603|FG000|Surveillance Phase|Withdrawal by Subject|4|||
37931799|NCT00779402|69618604|FG001|Surveillance Phase|Withdrawal by Subject|1|||
37931800|NCT00779402|69618603|FG000|Surveillance Phase|Closure of study|5|||
37931801|NCT00779402|69618604|FG001|Surveillance Phase|Closure of study|6|||
37931802|NCT00779402|69618603|FG000|Surveillance Phase|Completed Protocol Visits|3|||
37931803|NCT00779402|69618604|FG001|Surveillance Phase|Completed Protocol Visits|2|||
37931804|NCT00779402|69618603|FG000|Long-term Follow-up|Patient refused to continue|2|||
37931805|NCT00779402|69618604|FG001|Long-term Follow-up|Patient refused to continue|0|||
37931806|NCT00779402|69618603|FG000|Long-term Follow-up|Other|5|||
37931807|NCT00779402|69618604|FG001|Long-term Follow-up|Other|0|||
37931808|NCT00779402|69618603|FG000|Long-term Follow-up|Closure of Study|8|||
37931809|NCT00779402|69618604|FG001|Long-term Follow-up|Closure of Study|4|||
37931810|NCT00779402|69618603|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
37931811|NCT00779402|69618604|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
37931812|NCT00771914|69618614|FG000|Overall Study|Physician Decision|0|||
37931813|NCT00771914|69618615|FG001|Overall Study|Physician Decision|0|||
37931814|NCT00771914|69618616|FG002|Overall Study|Physician Decision|0|||
37931815|NCT00771914|69618617|FG003|Overall Study|Physician Decision|1|||
38033993|NCT02054806|69720328|FG000|Overall Study|Sponsor Decision|31|||
38033994|NCT02054806|69720328|FG000|Overall Study|Withdrawal by Subject|43|||
38033995|NCT02054806|69720328|FG000|Overall Study|Protocol Violation|2|||
38033996|NCT02054806|69720328|FG000|Overall Study|Lost to Follow-up|10|||
37668286|NCT02580591|69140825|FG000|Overall Study|Adverse Event|0|||
37931816|NCT00771914|69618614|FG000|Overall Study|Lost to Follow-up|0|||
37931817|NCT00771914|69618615|FG001|Overall Study|Lost to Follow-up|0|||
37931818|NCT00771914|69618616|FG002|Overall Study|Lost to Follow-up|0|||
37931819|NCT00771914|69618617|FG003|Overall Study|Lost to Follow-up|1|||
37931820|NCT00779324|69618629|FG000|Overall Study|Lost to Follow-up|2|||
37931821|NCT00779324|69618630|FG001|Overall Study|Lost to Follow-up|1|||
37931822|NCT00779324|69618629|FG000|Overall Study|Withdrawal by Subject|4|||
37931823|NCT00779324|69618630|FG001|Overall Study|Withdrawal by Subject|2|||
37931824|NCT00779324|69618629|FG000|Overall Study|Missed visit|1|||
37931825|NCT00779324|69618630|FG001|Overall Study|Missed visit|1|||
37931826|NCT00779246|69618638|FG000|Overall Study|Missing sufficient data for analysis|33|||
37668287|NCT02580591|69140826|FG001|Overall Study|Adverse Event|1|||
37931827|NCT00779246|69618639|FG001|Overall Study|Missing sufficient data for analysis|53|||
37931828|NCT00771758|69618648|FG000|Overall Study|Adverse Event|2|||
37931829|NCT00771758|69618649|FG001|Overall Study|Adverse Event|8|||
37668288|NCT02580591|69140827|FG002|Overall Study|Adverse Event|2|||
37931830|NCT00771758|69618650|FG002|Overall Study|Adverse Event|1|||
37931831|NCT00771758|69618648|FG000|Overall Study|Lack of Efficacy|0|||
37931832|NCT00771758|69618649|FG001|Overall Study|Lack of Efficacy|2|||
37931833|NCT00771758|69618650|FG002|Overall Study|Lack of Efficacy|1|||
37931834|NCT00771758|69618648|FG000|Overall Study|Lost to Follow-up|1|||
37931835|NCT00771758|69618649|FG001|Overall Study|Lost to Follow-up|0|||
37931836|NCT00771758|69618650|FG002|Overall Study|Lost to Follow-up|0|||
37931837|NCT00771758|69618648|FG000|Overall Study|Protocol Violation|1|||
37931838|NCT00771758|69618649|FG001|Overall Study|Protocol Violation|0|||
37931839|NCT00771758|69618650|FG002|Overall Study|Protocol Violation|0|||
37931840|NCT00771758|69618648|FG000|Overall Study|Withdrawal by Subject|1|||
37931841|NCT00771758|69618649|FG001|Overall Study|Withdrawal by Subject|0|||
37931842|NCT00771758|69618650|FG002|Overall Study|Withdrawal by Subject|0|||
37931843|NCT00771758|69618648|FG000|Overall Study|Other|3|||
37931844|NCT00771758|69618649|FG001|Overall Study|Other|2|||
37931845|NCT00771758|69618650|FG002|Overall Study|Other|0|||
37931846|NCT00758498|69618678|FG000|Overall Study|Adverse Event|2|||
37931847|NCT00758498|69618679|FG001|Overall Study|Adverse Event|2|||
37931848|NCT00758498|69618680|FG002|Overall Study|Adverse Event|3|||
37931849|NCT00758498|69618678|FG000|Overall Study|Subject legally detained out of state|1|||
37931850|NCT00758498|69618679|FG001|Overall Study|Subject legally detained out of state|0|||
37931851|NCT00758498|69618680|FG002|Overall Study|Subject legally detained out of state|0|||
37931852|NCT00758498|69618678|FG000|Overall Study|Withdrawal by Subject|0|||
37931853|NCT00758498|69618679|FG001|Overall Study|Withdrawal by Subject|0|||
37931854|NCT00758498|69618680|FG002|Overall Study|Withdrawal by Subject|1|||
37931855|NCT00758498|69618678|FG000|Overall Study|Noncompliance to study procedures|0|||
37931856|NCT00758498|69618679|FG001|Overall Study|Noncompliance to study procedures|0|||
37931857|NCT00758498|69618680|FG002|Overall Study|Noncompliance to study procedures|1|||
37931858|NCT00798161|69618695|FG000|Overall Study|Adverse Event|3|||
37931859|NCT00798161|69618696|FG001|Overall Study|Adverse Event|4|||
37931860|NCT00798161|69618697|FG002|Overall Study|Adverse Event|6|||
37931861|NCT00798161|69618698|FG003|Overall Study|Adverse Event|6|||
37931862|NCT00798161|69618699|FG004|Overall Study|Adverse Event|5|||
37931863|NCT00798161|69618700|FG005|Overall Study|Adverse Event|2|||
37931864|NCT00798161|69618701|FG006|Overall Study|Adverse Event|4|||
37931865|NCT00798161|69618695|FG000|Overall Study|Protocol Violation|2|||
37931866|NCT00798161|69618696|FG001|Overall Study|Protocol Violation|1|||
37931867|NCT00798161|69618697|FG002|Overall Study|Protocol Violation|3|||
37931868|NCT00798161|69618698|FG003|Overall Study|Protocol Violation|3|||
37931869|NCT00798161|69618699|FG004|Overall Study|Protocol Violation|3|||
37931870|NCT00798161|69618700|FG005|Overall Study|Protocol Violation|2|||
37931871|NCT00798161|69618701|FG006|Overall Study|Protocol Violation|0|||
37931872|NCT00798161|69618695|FG000|Overall Study|Lost to Follow-up|1|||
37931873|NCT00798161|69618696|FG001|Overall Study|Lost to Follow-up|3|||
37931874|NCT00798161|69618697|FG002|Overall Study|Lost to Follow-up|4|||
37931875|NCT00798161|69618698|FG003|Overall Study|Lost to Follow-up|3|||
37931876|NCT00798161|69618699|FG004|Overall Study|Lost to Follow-up|4|||
37931877|NCT00798161|69618700|FG005|Overall Study|Lost to Follow-up|0|||
37931878|NCT00798161|69618701|FG006|Overall Study|Lost to Follow-up|0|||
37931879|NCT00798161|69618695|FG000|Overall Study|Withdrawal by Subject|5|||
37931880|NCT00798161|69618696|FG001|Overall Study|Withdrawal by Subject|4|||
37931881|NCT00798161|69618697|FG002|Overall Study|Withdrawal by Subject|5|||
37931882|NCT00798161|69618698|FG003|Overall Study|Withdrawal by Subject|4|||
37931883|NCT00798161|69618699|FG004|Overall Study|Withdrawal by Subject|2|||
37931884|NCT00798161|69618700|FG005|Overall Study|Withdrawal by Subject|3|||
37931885|NCT00798161|69618701|FG006|Overall Study|Withdrawal by Subject|1|||
37931886|NCT00798161|69618695|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
37931887|NCT00798161|69618696|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
37931888|NCT00798161|69618697|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
37931889|NCT00798161|69618698|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
37931890|NCT00798161|69618699|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
37931891|NCT00798161|69618700|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
37931892|NCT00798161|69618701|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
37931893|NCT00588341|69618717|FG000|Overall Study|Withdrawal by Subject|3|||
37931894|NCT00588341|69618717|FG000|Overall Study|Not treated due to metastatic disease|1|||
37931895|NCT00588341|69618717|FG000|Overall Study|Patient ineligible|1|||
37931896|NCT00802529|69618723|FG000|Overall Study|Lost to Follow-up|0|||
37931897|NCT00802529|69618724|FG001|Overall Study|Lost to Follow-up|1|||
37931898|NCT00758264|69618733|FG000|Active Phase|Withdrawal by Subject|0|||
37931899|NCT00758264|69618734|FG001|Active Phase|Withdrawal by Subject|0|||
37931900|NCT00758264|69618735|FG002|Active Phase|Withdrawal by Subject|1|||
37931901|NCT00758264|69618733|FG000|Active Phase|Lost to Follow-up|1|||
37931902|NCT00758264|69618734|FG001|Active Phase|Lost to Follow-up|0|||
37760863|NCT01559129|69271772|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
37931903|NCT00758264|69618735|FG002|Active Phase|Lost to Follow-up|0|||
37931904|NCT00758264|69618733|FG000|Active Phase|Other|0|||
37931905|NCT00758264|69618734|FG001|Active Phase|Other|0|||
37931906|NCT00758264|69618735|FG002|Active Phase|Other|4|||
37931907|NCT00588731|69618745|FG000|Overall Study|Withdrawal by Subject|3|||
37931908|NCT00588731|69618746|FG001|Overall Study|Withdrawal by Subject|2|||
37931909|NCT00757172|69618752|FG000|Overall Study|Withdrawal by Subject|4|||
37931910|NCT00757172|69618752|FG000|Overall Study|Physician Decision|3|||
37931911|NCT00757172|69618752|FG000|Overall Study|Progression|4|||
37931912|NCT00797225|69618760|FG000|Weeks 1 to 12|Adverse Event|0|||
37931913|NCT00797225|69618761|FG001|Weeks 1 to 12|Adverse Event|0|||
37931914|NCT00797225|69618762|FG002|Weeks 1 to 12|Adverse Event|1|||
37931915|NCT00797225|69618763|FG003|Weeks 1 to 12|Adverse Event|0|||
37931916|NCT00797225|69618764|FG004|Weeks 1 to 12|Adverse Event|0|||
37931917|NCT00797225|69618765|FG005|Weeks 1 to 12|Adverse Event|0|||
37931918|NCT00797225|69618766|FG006|Weeks 1 to 12|Adverse Event|0|||
37931919|NCT00797225|69618767|FG007|Weeks 1 to 12|Adverse Event|0|||
37931920|NCT00797225|69618760|FG000|Weeks 1 to 12|Non-compliance|0|||
37931921|NCT00797225|69618761|FG001|Weeks 1 to 12|Non-compliance|1|||
37931922|NCT00797225|69618762|FG002|Weeks 1 to 12|Non-compliance|0|||
37931923|NCT00797225|69618763|FG003|Weeks 1 to 12|Non-compliance|0|||
37931924|NCT00797225|69618764|FG004|Weeks 1 to 12|Non-compliance|0|||
37931925|NCT00797225|69618765|FG005|Weeks 1 to 12|Non-compliance|0|||
37931926|NCT00797225|69618766|FG006|Weeks 1 to 12|Non-compliance|0|||
37931927|NCT00797225|69618767|FG007|Weeks 1 to 12|Non-compliance|0|||
37931928|NCT00797225|69618760|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
37931929|NCT00797225|69618761|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
37931930|NCT00797225|69618762|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
37931931|NCT00797225|69618763|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
37931932|NCT00797225|69618764|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
37931933|NCT00797225|69618765|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
37931934|NCT00797225|69618766|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
37931935|NCT00797225|69618767|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
37931936|NCT00797225|69618760|FG000|Weeks 1 to 12|Sponsor Decision|1|||
37931937|NCT00797225|69618761|FG001|Weeks 1 to 12|Sponsor Decision|0|||
37931938|NCT00797225|69618762|FG002|Weeks 1 to 12|Sponsor Decision|0|||
37931939|NCT00797225|69618763|FG003|Weeks 1 to 12|Sponsor Decision|0|||
37931940|NCT00797225|69618764|FG004|Weeks 1 to 12|Sponsor Decision|0|||
37931941|NCT00797225|69618765|FG005|Weeks 1 to 12|Sponsor Decision|0|||
37931942|NCT00797225|69618766|FG006|Weeks 1 to 12|Sponsor Decision|0|||
37931943|NCT00797225|69618767|FG007|Weeks 1 to 12|Sponsor Decision|0|||
37931944|NCT00797225|69618760|FG000|Weeks 13 to 24|Non-compliance|0|||
37931945|NCT00797225|69618761|FG001|Weeks 13 to 24|Non-compliance|2|||
37931946|NCT00797225|69618762|FG002|Weeks 13 to 24|Non-compliance|0|||
37931947|NCT00797225|69618763|FG003|Weeks 13 to 24|Non-compliance|0|||
37931948|NCT00797225|69618764|FG004|Weeks 13 to 24|Non-compliance|0|||
37931949|NCT00797225|69618765|FG005|Weeks 13 to 24|Non-compliance|0|||
37931950|NCT00797225|69618766|FG006|Weeks 13 to 24|Non-compliance|0|||
37931951|NCT00797225|69618767|FG007|Weeks 13 to 24|Non-compliance|0|||
37931952|NCT00797225|69618760|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
37931953|NCT00797225|69618761|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
37931954|NCT00797225|69618762|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
37931955|NCT00797225|69618763|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
37931956|NCT00797225|69618764|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
37931957|NCT00797225|69618765|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
37931958|NCT00797225|69618766|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
37931959|NCT00797225|69618767|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
37931960|NCT00797225|69618760|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
37931961|NCT00797225|69618761|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
37931962|NCT00797225|69618762|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
37931963|NCT00797225|69618763|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
37931964|NCT00797225|69618764|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
37931965|NCT00797225|69618765|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
37931966|NCT00797225|69618766|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
37931967|NCT00797225|69618767|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
37931968|NCT00797225|69618760|FG000|Weeks 13 to 24|Adverse Event|0|||
37931969|NCT00797225|69618761|FG001|Weeks 13 to 24|Adverse Event|1|||
37931970|NCT00797225|69618762|FG002|Weeks 13 to 24|Adverse Event|0|||
38033997|NCT02054806|69720328|FG000|Overall Study|Death|391|||
38033998|NCT01333072|69720361|FG000|Overall Study|Lost to Follow-up|3|||
38033999|NCT01333072|69720362|FG001|Overall Study|Lost to Follow-up|0|||
37668289|NCT02580591|69140828|FG003|Overall Study|Adverse Event|5|||
37931971|NCT00797225|69618763|FG003|Weeks 13 to 24|Adverse Event|0|||
37931972|NCT00797225|69618764|FG004|Weeks 13 to 24|Adverse Event|0|||
37931973|NCT00797225|69618765|FG005|Weeks 13 to 24|Adverse Event|0|||
37931974|NCT00797225|69618766|FG006|Weeks 13 to 24|Adverse Event|1|||
37931975|NCT00797225|69618767|FG007|Weeks 13 to 24|Adverse Event|0|||
37931976|NCT00797225|69618760|FG000|Weeks 13 to 24|Sponsor Decision|0|||
37931977|NCT00797225|69618761|FG001|Weeks 13 to 24|Sponsor Decision|0|||
37931978|NCT00797225|69618762|FG002|Weeks 13 to 24|Sponsor Decision|0|||
37931979|NCT00797225|69618763|FG003|Weeks 13 to 24|Sponsor Decision|0|||
37931980|NCT00797225|69618764|FG004|Weeks 13 to 24|Sponsor Decision|0|||
37931981|NCT00797225|69618765|FG005|Weeks 13 to 24|Sponsor Decision|0|||
38034000|NCT01333072|69720361|FG000|Overall Study|Adverse Event|2|||
37931982|NCT00797225|69618766|FG006|Weeks 13 to 24|Sponsor Decision|1|||
37931983|NCT00797225|69618767|FG007|Weeks 13 to 24|Sponsor Decision|0|||
37931984|NCT00778700|69618787|FG000|Overall Study|Adverse Event|6|||
37931985|NCT00778700|69618788|FG001|Overall Study|Adverse Event|1|||
37931986|NCT00778700|69618789|FG002|Overall Study|Adverse Event|3|||
37931987|NCT00778700|69618790|FG003|Overall Study|Adverse Event|5|||
37931988|NCT00778700|69618787|FG000|Overall Study|Protocol Violation|1|||
37931989|NCT00778700|69618788|FG001|Overall Study|Protocol Violation|1|||
37931990|NCT00778700|69618789|FG002|Overall Study|Protocol Violation|0|||
37931991|NCT00778700|69618790|FG003|Overall Study|Protocol Violation|0|||
37931992|NCT00778700|69618787|FG000|Overall Study|Subject Withdrew Consent|6|||
37931993|NCT00778700|69618788|FG001|Overall Study|Subject Withdrew Consent|4|||
37931994|NCT00778700|69618789|FG002|Overall Study|Subject Withdrew Consent|1|||
37931995|NCT00778700|69618790|FG003|Overall Study|Subject Withdrew Consent|4|||
37931996|NCT00778700|69618787|FG000|Overall Study|Lost to Follow-up|3|||
37931997|NCT00778700|69618788|FG001|Overall Study|Lost to Follow-up|1|||
37931998|NCT00778700|69618789|FG002|Overall Study|Lost to Follow-up|0|||
37931999|NCT00778700|69618790|FG003|Overall Study|Lost to Follow-up|1|||
37932000|NCT00778700|69618787|FG000|Overall Study|Reason not Specified|2|||
37932001|NCT00778700|69618788|FG001|Overall Study|Reason not Specified|0|||
37932002|NCT00778700|69618789|FG002|Overall Study|Reason not Specified|1|||
37932003|NCT00778700|69618790|FG003|Overall Study|Reason not Specified|3|||
37932004|NCT00778700|69618787|FG000|Overall Study|Other|0|||
37932005|NCT00778700|69618788|FG001|Overall Study|Other|0|||
37932006|NCT00778700|69618789|FG002|Overall Study|Other|1|||
37932007|NCT00778700|69618790|FG003|Overall Study|Other|0|||
37932008|NCT00793403|69618804|FG000|Overall Study|Other|73|||
37932009|NCT00793325|69618808|FG000|Overall Study|Protocol Violation|18|||
37932010|NCT00793325|69618808|FG000|Overall Study|Lost to Follow-up|1|||
37932011|NCT00778622|69618834|FG000|Overall Study|Adverse Event|5|||
37932012|NCT00778622|69618835|FG001|Overall Study|Adverse Event|4|||
37932013|NCT00778622|69618836|FG002|Overall Study|Adverse Event|7|||
37932014|NCT00778622|69618834|FG000|Overall Study|Withdrawal by Subject|4|||
37932015|NCT00778622|69618835|FG001|Overall Study|Withdrawal by Subject|5|||
37932016|NCT00778622|69618836|FG002|Overall Study|Withdrawal by Subject|5|||
37932017|NCT00778622|69618834|FG000|Overall Study|Lost to Follow-up|3|||
37932018|NCT00778622|69618835|FG001|Overall Study|Lost to Follow-up|3|||
37932019|NCT00778622|69618836|FG002|Overall Study|Lost to Follow-up|2|||
37932020|NCT00778622|69618834|FG000|Overall Study|Protocol Violation|0|||
37932021|NCT00778622|69618835|FG001|Overall Study|Protocol Violation|3|||
37932022|NCT00778622|69618836|FG002|Overall Study|Protocol Violation|0|||
37932023|NCT00778622|69618834|FG000|Overall Study|Lack of Efficacy|2|||
37932024|NCT00778622|69618835|FG001|Overall Study|Lack of Efficacy|0|||
37932025|NCT00778622|69618836|FG002|Overall Study|Lack of Efficacy|0|||
37932026|NCT00778622|69618834|FG000|Overall Study|immigration|1|||
37932027|NCT00778622|69618835|FG001|Overall Study|immigration|0|||
37932028|NCT00778622|69618836|FG002|Overall Study|immigration|0|||
37932029|NCT00778622|69618834|FG000|Overall Study|Other|1|||
37932030|NCT00778622|69618835|FG001|Overall Study|Other|0|||
37932031|NCT00778622|69618836|FG002|Overall Study|Other|1|||
37932032|NCT00777920|69618848|FG000|Overall Study|Adverse Event|39|||
37932033|NCT00777920|69618848|FG000|Overall Study|Withdrawal of Consent|4|||
37932034|NCT00777920|69618848|FG000|Overall Study|Lost to Follow-up|1|||
37932035|NCT00777920|69618848|FG000|Overall Study|Investigator's discretion|1|||
37932036|NCT00777920|69618848|FG000|Overall Study|Clinical status did not improve|1|||
37932037|NCT00777920|69618848|FG000|Overall Study|Other, not specified|4|||
37932038|NCT04236141|69618854|FG000|Overall Study|Death|18|||
37932039|NCT04236141|69618855|FG001|Overall Study|Death|10|||
37932040|NCT04236141|69618854|FG000|Overall Study|Withdrawal by Participant|1|||
37932041|NCT04236141|69618855|FG001|Overall Study|Withdrawal by Participant|0|||
37932042|NCT04236141|69618854|FG000|Overall Study|Reason not Specified|1|||
37932043|NCT04236141|69618855|FG001|Overall Study|Reason not Specified|0|||
37932044|NCT04236141|69618854|FG000|Overall Study|Study terminated by Sponsor|8|||
37932045|NCT04236141|69618855|FG001|Overall Study|Study terminated by Sponsor|4|||
38034001|NCT01333072|69720362|FG001|Overall Study|Adverse Event|4|||
37668290|NCT02580591|69140825|FG000|Overall Study|Protocol Violation|3|||
37668291|NCT02580591|69140826|FG001|Overall Study|Protocol Violation|2|||
37668292|NCT02580591|69140827|FG002|Overall Study|Protocol Violation|1|||
37668293|NCT02580591|69140828|FG003|Overall Study|Protocol Violation|1|||
37668294|NCT02580591|69140825|FG000|Overall Study|Lost to Follow-up|5|||
37932046|NCT00796445|69618863|FG000|Overall Study|Protocol Violation|5|||
37932047|NCT00796445|69618864|FG001|Overall Study|Protocol Violation|3|||
37932048|NCT00796445|69618863|FG000|Overall Study|Adverse event, serious fatal|10|||
38034002|NCT01333072|69720361|FG000|Overall Study|Physician Decision|1|||
37932049|NCT00796445|69618864|FG001|Overall Study|Adverse event, serious fatal|5|||
37932050|NCT00796445|69618863|FG000|Overall Study|Adverse event, non-fatal|4|||
37932051|NCT00796445|69618864|FG001|Overall Study|Adverse event, non-fatal|0|||
37932052|NCT00796445|69618863|FG000|Overall Study|Disease progression/recurrence|537|||
37932053|NCT00796445|69618864|FG001|Overall Study|Disease progression/recurrence|268|||
38034003|NCT01333072|69720362|FG001|Overall Study|Physician Decision|0|||
37932054|NCT00796445|69618863|FG000|Overall Study|Other|10|||
37668295|NCT02580591|69140826|FG001|Overall Study|Lost to Follow-up|3|||
37760864|NCT01559129|69271771|FG000|Open-label Extension Period|Adverse Event|1|||
37932055|NCT00796445|69618864|FG001|Overall Study|Other|7|||
37932056|NCT00796445|69618863|FG000|Overall Study|Withdrawal by Subject|18|||
37932057|NCT00796445|69618864|FG001|Overall Study|Withdrawal by Subject|9|||
37932058|NCT00796445|69618863|FG000|Overall Study|Invalid Informed Consent Form|1|||
37932059|NCT00796445|69618864|FG001|Overall Study|Invalid Informed Consent Form|0|||
37932060|NCT03939819|69618880|FG000|Overall Study|Death|2|||
37932061|NCT03939819|69618881|FG001|Overall Study|Death|0|||
37932062|NCT00756938|69618890|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
37932063|NCT00756938|69618891|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
37932064|NCT00756938|69618892|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
37932065|NCT00756938|69618893|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
37932066|NCT00756938|69618890|FG000|12-week Base Study|Protocol Violation|0|||
37932067|NCT00756938|69618891|FG001|12-week Base Study|Protocol Violation|0|||
37932068|NCT00756938|69618892|FG002|12-week Base Study|Protocol Violation|1|||
37932069|NCT00756938|69618893|FG003|12-week Base Study|Protocol Violation|0|||
37932070|NCT00756938|69618890|FG000|12-week Base Study|Lost to Follow-up|1|||
37932071|NCT00756938|69618891|FG001|12-week Base Study|Lost to Follow-up|0|||
37932072|NCT00756938|69618892|FG002|12-week Base Study|Lost to Follow-up|0|||
37932073|NCT00756938|69618893|FG003|12-week Base Study|Lost to Follow-up|0|||
37932074|NCT00756938|69618890|FG000|Optional Extension|Lack of Efficacy|0|||
37932075|NCT00756938|69618891|FG001|Optional Extension|Lack of Efficacy|0|||
37932076|NCT00756938|69618892|FG002|Optional Extension|Lack of Efficacy|0|||
37932077|NCT00756938|69618893|FG003|Optional Extension|Lack of Efficacy|1|||
37932078|NCT00756938|69618890|FG000|Optional Extension|End of Study|0|||
37932079|NCT00756938|69618891|FG001|Optional Extension|End of Study|0|||
37932080|NCT00756938|69618892|FG002|Optional Extension|End of Study|0|||
37932081|NCT00756938|69618893|FG003|Optional Extension|End of Study|11|||
37932082|NCT00756938|69618890|FG000|Optional Extension|Protocol-specific criteria met|0|||
37932083|NCT00756938|69618891|FG001|Optional Extension|Protocol-specific criteria met|0|||
37932084|NCT00756938|69618892|FG002|Optional Extension|Protocol-specific criteria met|0|||
37932085|NCT00756938|69618893|FG003|Optional Extension|Protocol-specific criteria met|9|||
37932086|NCT00756938|69618890|FG000|Optional Extension|Physician Decision|0|||
37932087|NCT00756938|69618891|FG001|Optional Extension|Physician Decision|0|||
37932088|NCT00756938|69618892|FG002|Optional Extension|Physician Decision|0|||
37932089|NCT00756938|69618893|FG003|Optional Extension|Physician Decision|3|||
37932090|NCT00756938|69618890|FG000|Optional Extension|Lost to Follow-up|0|||
37932091|NCT00756938|69618891|FG001|Optional Extension|Lost to Follow-up|0|||
37932092|NCT00756938|69618892|FG002|Optional Extension|Lost to Follow-up|0|||
37932093|NCT00756938|69618893|FG003|Optional Extension|Lost to Follow-up|1|||
37932094|NCT00756938|69618890|FG000|Optional Extension|Protocol Violation|0|||
37932095|NCT00756938|69618891|FG001|Optional Extension|Protocol Violation|0|||
37932096|NCT00756938|69618892|FG002|Optional Extension|Protocol Violation|0|||
37932097|NCT00756938|69618893|FG003|Optional Extension|Protocol Violation|1|||
37932098|NCT00756938|69618890|FG000|Optional Extension|Withdrawal by Subject|0|||
37932099|NCT00756938|69618891|FG001|Optional Extension|Withdrawal by Subject|0|||
37932100|NCT00756938|69618892|FG002|Optional Extension|Withdrawal by Subject|0|||
37932101|NCT00756938|69618893|FG003|Optional Extension|Withdrawal by Subject|10|||
37932102|NCT00756938|69618890|FG000|Optional Extension|Adverse Event|0|||
37932103|NCT00756938|69618891|FG001|Optional Extension|Adverse Event|0|||
37932104|NCT00756938|69618892|FG002|Optional Extension|Adverse Event|0|||
37932105|NCT00756938|69618893|FG003|Optional Extension|Adverse Event|1|||
37932106|NCT00796367|69618914|FG000|Overall Study|Adverse Event|6|||
37932107|NCT00796367|69618915|FG001|Overall Study|Adverse Event|4|||
37932108|NCT00796367|69618916|FG002|Overall Study|Adverse Event|7|||
37932109|NCT00796367|69618914|FG000|Overall Study|Lost to Follow-up|5|||
37932110|NCT00796367|69618915|FG001|Overall Study|Lost to Follow-up|4|||
37932111|NCT00796367|69618916|FG002|Overall Study|Lost to Follow-up|21|||
37932112|NCT00796367|69618914|FG000|Overall Study|Withdrawal by Subject|9|||
37932113|NCT00796367|69618915|FG001|Overall Study|Withdrawal by Subject|11|||
37932114|NCT00796367|69618916|FG002|Overall Study|Withdrawal by Subject|12|||
37932115|NCT00796367|69618914|FG000|Overall Study|Lack of Efficacy|2|||
37932116|NCT00796367|69618915|FG001|Overall Study|Lack of Efficacy|1|||
37932117|NCT00796367|69618916|FG002|Overall Study|Lack of Efficacy|0|||
37932118|NCT00796367|69618914|FG000|Overall Study|non compliance|3|||
37932119|NCT00796367|69618915|FG001|Overall Study|non compliance|1|||
37932120|NCT00796367|69618916|FG002|Overall Study|non compliance|1|||
37932121|NCT00796367|69618914|FG000|Overall Study|Pregnancy|1|||
37932122|NCT00796367|69618915|FG001|Overall Study|Pregnancy|0|||
37932123|NCT00796367|69618916|FG002|Overall Study|Pregnancy|1|||
37932124|NCT00796367|69618914|FG000|Overall Study|Requirement for restricted medication|2|||
37932125|NCT00796367|69618915|FG001|Overall Study|Requirement for restricted medication|0|||
37932126|NCT00796367|69618916|FG002|Overall Study|Requirement for restricted medication|2|||
37932127|NCT00796367|69618914|FG000|Overall Study|other|2|||
37932128|NCT00796367|69618915|FG001|Overall Study|other|4|||
37932129|NCT00796367|69618916|FG002|Overall Study|other|3|||
37932130|NCT00770588|69618926|FG000|Overall Study|Adverse Event|9|||
37932131|NCT00770588|69618927|FG001|Overall Study|Adverse Event|2|||
37932132|NCT00770588|69618926|FG000|Overall Study|Death caused by progression of disease|70|||
37932133|NCT00770588|69618927|FG001|Overall Study|Death caused by progression of disease|91|||
37932134|NCT00770588|69618926|FG000|Overall Study|Lost to Follow-up|1|||
37932135|NCT00770588|69618927|FG001|Overall Study|Lost to Follow-up|1|||
37932136|NCT00770588|69618926|FG000|Overall Study|Withdrawal by Subject|1|||
37932137|NCT00770588|69618927|FG001|Overall Study|Withdrawal by Subject|1|||
37932138|NCT00777608|69618936|FG000|Overall Study|Lost to Follow-up|1|||
37932139|NCT00777608|69618937|FG001|Overall Study|Lost to Follow-up|1|||
37932140|NCT00777608|69618936|FG000|Overall Study|Withdrawal by Subject|1|||
37932141|NCT00777608|69618937|FG001|Overall Study|Withdrawal by Subject|3|||
37932142|NCT00777608|69618936|FG000|Overall Study|Protocol Violation|1|||
37932143|NCT00777608|69618937|FG001|Overall Study|Protocol Violation|0|||
37932144|NCT00777608|69618936|FG000|Overall Study|Investigator Decision|1|||
37932145|NCT00777608|69618937|FG001|Overall Study|Investigator Decision|2|||
37932146|NCT00792935|69618945|FG000|Overall Study|Adverse Event|2|||
37932147|NCT00792935|69618946|FG001|Overall Study|Adverse Event|1|||
37932148|NCT00792935|69618945|FG000|Overall Study|Lost to Follow-up|0|||
37932149|NCT00792935|69618946|FG001|Overall Study|Lost to Follow-up|1|||
37932150|NCT00792935|69618945|FG000|Overall Study|Protocol Violation|2|||
37932151|NCT00792935|69618946|FG001|Overall Study|Protocol Violation|0|||
37932152|NCT00792935|69618945|FG000|Overall Study|Withdrawal by Subject|0|||
37932153|NCT00792935|69618946|FG001|Overall Study|Withdrawal by Subject|1|||
37932154|NCT00770510|69618952|FG000|Overall Study|Lost to Follow-up|2|||
37932155|NCT00770510|69618952|FG000|Overall Study|Pregnancy|1|||
37932156|NCT00770510|69618952|FG000|Overall Study|Withdrawal by Subject|2|||
37932157|NCT00770432|69618966|FG000|Overall Study|Other|4|||
37932158|NCT00770432|69618967|FG001|Overall Study|Other|6|||
37932159|NCT00770432|69618966|FG000|Overall Study|Non-compliance|0|||
37932160|NCT00770432|69618967|FG001|Overall Study|Non-compliance|1|||
37932161|NCT00792701|69618975|FG000|Overall Study|Adverse Event|0|||
37932162|NCT00792701|69618976|FG001|Overall Study|Adverse Event|22|||
37932163|NCT00792701|69618975|FG000|Overall Study|Ineligible|1|||
37932164|NCT00792701|69618976|FG001|Overall Study|Ineligible|3|||
37932165|NCT00792701|69618975|FG000|Overall Study|Withdrawal by Subject|1|||
37932166|NCT00792701|69618976|FG001|Overall Study|Withdrawal by Subject|19|||
37932167|NCT00792701|69618975|FG000|Overall Study|Not protocol specified|17|||
37932168|NCT00792701|69618976|FG001|Overall Study|Not protocol specified|0|||
37932169|NCT00777296|69618988|FG000|Overall Study|Adverse Event|0|||
37932170|NCT00777296|69618989|FG001|Overall Study|Adverse Event|1|||
37932171|NCT00777296|69618990|FG002|Overall Study|Adverse Event|0|||
37932172|NCT00777296|69618991|FG003|Overall Study|Adverse Event|1|||
37932173|NCT00777296|69618988|FG000|Overall Study|Withdrawal by Subject|1|||
37932174|NCT00777296|69618989|FG001|Overall Study|Withdrawal by Subject|0|||
37932175|NCT00777296|69618990|FG002|Overall Study|Withdrawal by Subject|0|||
37932176|NCT00777296|69618991|FG003|Overall Study|Withdrawal by Subject|0|||
37932177|NCT00777296|69618988|FG000|Overall Study|CRF form not completed|0|||
37932178|NCT00777296|69618989|FG001|Overall Study|CRF form not completed|0|||
37932179|NCT00777296|69618990|FG002|Overall Study|CRF form not completed|2|||
37668296|NCT02580591|69140827|FG002|Overall Study|Lost to Follow-up|3|||
37668297|NCT02580591|69140828|FG003|Overall Study|Lost to Follow-up|1|||
37668298|NCT02580591|69140825|FG000|Overall Study|Withdrawal by Subject|6|||
37668299|NCT02580591|69140826|FG001|Overall Study|Withdrawal by Subject|1|||
37668300|NCT02580591|69140827|FG002|Overall Study|Withdrawal by Subject|2|||
37668301|NCT02580591|69140828|FG003|Overall Study|Withdrawal by Subject|3|||
37668302|NCT02580591|69140825|FG000|Overall Study|Not treated|1|||
37668303|NCT02580591|69140826|FG001|Overall Study|Not treated|1|||
37932180|NCT00777296|69618991|FG003|Overall Study|CRF form not completed|0|||
37932181|NCT00756470|69619013|FG000|Overall Study|Withdrawal by Subject|1|||
37932182|NCT00756470|69619013|FG000|Overall Study|Adverse Event|4|||
37932183|NCT00792623|69619017|FG000|Overall Study|Adverse Event|2|||
37932184|NCT00792623|69619017|FG000|Overall Study|Withdrawal by Subject|5|||
37932185|NCT00756314|69619024|FG000|Overall Study|Lost to Follow-up|2|||
37932186|NCT00756314|69619025|FG001|Overall Study|Lost to Follow-up|59|||
37932187|NCT00727506|69619037|FG000|Overall Study|Adverse Event|0|||
37932188|NCT00727506|69619038|FG001|Overall Study|Adverse Event|0|||
37932189|NCT00727506|69619039|FG002|Overall Study|Adverse Event|4|||
37932190|NCT00727506|69619040|FG003|Overall Study|Adverse Event|4|||
37932191|NCT00727506|69619041|FG004|Overall Study|Adverse Event|1|||
37932192|NCT00727506|69619042|FG005|Overall Study|Adverse Event|8|||
37932193|NCT00727506|69619037|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
37932194|NCT00727506|69619038|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
37932195|NCT00727506|69619039|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
37668304|NCT02580591|69140827|FG002|Overall Study|Not treated|0|||
37668305|NCT02580591|69140828|FG003|Overall Study|Not treated|0|||
37932196|NCT00727506|69619040|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
37932197|NCT00727506|69619041|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
37932198|NCT00727506|69619042|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
37932199|NCT00727506|69619037|FG000|Overall Study|Progressive disease|4|||
37932200|NCT00727506|69619038|FG001|Overall Study|Progressive disease|7|||
37932201|NCT00727506|69619039|FG002|Overall Study|Progressive disease|9|||
37932202|NCT00727506|69619040|FG003|Overall Study|Progressive disease|28|||
37932203|NCT00727506|69619041|FG004|Overall Study|Progressive disease|38|||
37932204|NCT00727506|69619042|FG005|Overall Study|Progressive disease|28|||
37932205|NCT00727506|69619037|FG000|Overall Study|Refused to continue medication|0|||
37932206|NCT00727506|69619038|FG001|Overall Study|Refused to continue medication|1|||
37932207|NCT00727506|69619039|FG002|Overall Study|Refused to continue medication|2|||
37932208|NCT00727506|69619040|FG003|Overall Study|Refused to continue medication|3|||
37932209|NCT00727506|69619041|FG004|Overall Study|Refused to continue medication|1|||
37932210|NCT00727506|69619042|FG005|Overall Study|Refused to continue medication|2|||
37932211|NCT00727506|69619037|FG000|Overall Study|Other reason not described above|0|||
37932212|NCT00727506|69619038|FG001|Overall Study|Other reason not described above|0|||
37932213|NCT00727506|69619039|FG002|Overall Study|Other reason not described above|1|||
37932214|NCT00727506|69619040|FG003|Overall Study|Other reason not described above|4|||
37932215|NCT00727506|69619041|FG004|Overall Study|Other reason not described above|1|||
37932216|NCT00727506|69619042|FG005|Overall Study|Other reason not described above|1|||
37932217|NCT00789815|69619064|FG000|Overall Study|Protocol Violation|6|||
37932218|NCT00789815|69619065|FG001|Overall Study|Protocol Violation|1|||
37932219|NCT00789815|69619064|FG000|Overall Study|Intubation due to massive bleeding|1|||
37932220|NCT00789815|69619065|FG001|Overall Study|Intubation due to massive bleeding|0|||
37932221|NCT00721578|69619071|FG000|Overall Study|Death|1|||
37932222|NCT00721578|69619072|FG001|Overall Study|Death|1|||
37932223|NCT00721578|69619071|FG000|Overall Study|Withdrawal by Subject|1|||
37932224|NCT00721578|69619072|FG001|Overall Study|Withdrawal by Subject|1|||
37932225|NCT00789737|69619080|FG000|Overall Study|Withdrawal by Subject|13|||
37932226|NCT00789737|69619081|FG001|Overall Study|Withdrawal by Subject|22|||
37932227|NCT00789737|69619080|FG000|Overall Study|Lost to Follow-up|10|||
37932228|NCT00789737|69619081|FG001|Overall Study|Lost to Follow-up|14|||
37932229|NCT00789737|69619080|FG000|Overall Study|Adverse Event|8|||
37932230|NCT00789737|69619081|FG001|Overall Study|Adverse Event|8|||
37932231|NCT00789737|69619080|FG000|Overall Study|Protocol Violation|3|||
37932232|NCT00789737|69619081|FG001|Overall Study|Protocol Violation|0|||
37932233|NCT00789737|69619080|FG000|Overall Study|Lack of Efficacy|3|||
37932234|NCT00789737|69619081|FG001|Overall Study|Lack of Efficacy|0|||
37932235|NCT00789737|69619080|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
37932236|NCT00789737|69619081|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
37932237|NCT00789737|69619080|FG000|Overall Study|Other|11|||
37932238|NCT00789737|69619081|FG001|Overall Study|Other|7|||
37932239|NCT00792467|69619087|FG000|Overall Study|progression of disease|17|||
37932240|NCT00792467|69619087|FG000|Overall Study|Adverse Event|1|||
37932241|NCT00792467|69619087|FG000|Overall Study|patient request|1|||
37932242|NCT00792467|69619087|FG000|Overall Study|Lost to Follow-up|1|||
37932243|NCT00792467|69619087|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
37932244|NCT00792467|69619087|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
37932245|NCT00585468|69619092|FG000|First Intervention|Withdrawal by Subject|1|||
37932246|NCT00585468|69619093|FG001|First Intervention|Withdrawal by Subject|1|||
37932247|NCT00724152|69619106|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
37932248|NCT00724152|69619107|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
37932249|NCT00724152|69619108|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
37932250|NCT00724152|69619106|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
37932251|NCT00724152|69619107|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
37932252|NCT00724152|69619108|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
37932253|NCT00721110|69619122|FG000|Overall Study|Ultram use|1|||
37932254|NCT00721110|69619123|FG001|Overall Study|Ultram use|0|||
37932255|NCT00721110|69619124|FG002|Overall Study|Ultram use|0|||
37932256|NCT00721110|69619125|FG003|Overall Study|Ultram use|0|||
37932257|NCT00721110|69619122|FG000|Overall Study|vertical incision|0|||
37932258|NCT00721110|69619123|FG001|Overall Study|vertical incision|0|||
37932259|NCT00721110|69619124|FG002|Overall Study|vertical incision|1|||
37932260|NCT00721110|69619125|FG003|Overall Study|vertical incision|0|||
37932261|NCT00791999|69619139|FG000|Overall Study|Protocol planed withdrawal|14|||
37932262|NCT00791999|69619140|FG001|Overall Study|Protocol planed withdrawal|11|||
37932263|NCT00791999|69619141|FG002|Overall Study|Protocol planed withdrawal|11|||
37932264|NCT00791999|69619142|FG003|Overall Study|Protocol planed withdrawal|45|||
37932265|NCT00791999|69619139|FG000|Overall Study|Withdrawal by Subject|0|||
37932266|NCT00791999|69619140|FG001|Overall Study|Withdrawal by Subject|1|||
37932267|NCT00791999|69619141|FG002|Overall Study|Withdrawal by Subject|0|||
37932268|NCT00791999|69619142|FG003|Overall Study|Withdrawal by Subject|2|||
37932269|NCT00791999|69619139|FG000|Overall Study|Protocol Violation|3|||
37932270|NCT00791999|69619140|FG001|Overall Study|Protocol Violation|0|||
37932271|NCT00791999|69619141|FG002|Overall Study|Protocol Violation|1|||
37932272|NCT00791999|69619142|FG003|Overall Study|Protocol Violation|0|||
37932273|NCT00791999|69619139|FG000|Overall Study|Adverse Event|3|||
37932274|NCT00791999|69619140|FG001|Overall Study|Adverse Event|3|||
37932275|NCT00791999|69619141|FG002|Overall Study|Adverse Event|7|||
38034004|NCT01315353|69720371|FG000|Overall Study|Death|2|||
38034005|NCT01315353|69720372|FG001|Overall Study|Death|1|||
38034006|NCT01315353|69720373|FG002|Overall Study|Death|0|||
38034007|NCT01315353|69720371|FG000|Overall Study|Withdrawal by Subject|2|||
38034008|NCT01315353|69720372|FG001|Overall Study|Withdrawal by Subject|6|||
38034009|NCT01315353|69720373|FG002|Overall Study|Withdrawal by Subject|1|||
38034010|NCT01315353|69720371|FG000|Overall Study|Lost to Follow-up|13|||
38034011|NCT01315353|69720372|FG001|Overall Study|Lost to Follow-up|6|||
38034012|NCT01315353|69720373|FG002|Overall Study|Lost to Follow-up|6|||
38034013|NCT01315353|69720371|FG000|Overall Study|Unwilling to adhere to requirements|5|||
38034014|NCT01315353|69720372|FG001|Overall Study|Unwilling to adhere to requirements|5|||
38034015|NCT01315353|69720373|FG002|Overall Study|Unwilling to adhere to requirements|4|||
38034016|NCT01315353|69720371|FG000|Overall Study|Site closing|7|||
38034017|NCT01315353|69720372|FG001|Overall Study|Site closing|4|||
38034018|NCT01315353|69720373|FG002|Overall Study|Site closing|0|||
38034019|NCT01315353|69720371|FG000|Overall Study|Taken off study by site in error|0|||
38034020|NCT01315353|69720372|FG001|Overall Study|Taken off study by site in error|1|||
38034021|NCT01315353|69720373|FG002|Overall Study|Taken off study by site in error|0|||
38034022|NCT01315353|69720371|FG000|Overall Study|Inadvertent randomization/assignment|0|||
38034023|NCT01315353|69720372|FG001|Overall Study|Inadvertent randomization/assignment|0|||
38034024|NCT01315353|69720373|FG002|Overall Study|Inadvertent randomization/assignment|2|||
38034025|NCT03517540|69720385|FG000|Overall Study|Protocol Violation|2|||
38034026|NCT03517540|69720386|FG001|Overall Study|Protocol Violation|0|||
37760865|NCT01559129|69271772|FG001|Open-label Extension Period|Adverse Event|0|||
37760866|NCT01559129|69271771|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
37760867|NCT01559129|69271772|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
37760868|NCT01385176|69271786|FG000|Randomization Phase|Death|1|||
37760869|NCT01385176|69271787|FG001|Randomization Phase|Death|2|||
37760870|NCT01385176|69271786|FG000|6-18 Month All VNS Active|Death|1|||
37760871|NCT01385176|69271787|FG001|6-18 Month All VNS Active|Death|2|||
37760872|NCT01385176|69271786|FG000|6-18 Month All VNS Active|Physician Decision|0|||
37760873|NCT01385176|69271787|FG001|6-18 Month All VNS Active|Physician Decision|1|||
37760874|NCT01385176|69271786|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
37760875|NCT01385176|69271787|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
37760876|NCT01385176|69271786|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
37760877|NCT01385176|69271787|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
37932276|NCT00791999|69619142|FG003|Overall Study|Adverse Event|3|||
37932277|NCT00791999|69619139|FG000|Overall Study|Lack of Efficacy|0|||
38034027|NCT03517540|69720387|FG002|Overall Study|Protocol Violation|0|||
38034028|NCT03517540|69720388|FG003|Overall Study|Protocol Violation|1|||
38034029|NCT03517540|69720385|FG000|Overall Study|Adverse Event|9|||
38034030|NCT03517540|69720386|FG001|Overall Study|Adverse Event|3|||
38034031|NCT03517540|69720387|FG002|Overall Study|Adverse Event|8|||
38034032|NCT03517540|69720388|FG003|Overall Study|Adverse Event|1|||
38034033|NCT03517540|69720385|FG000|Overall Study|Withdrawal by Subject|3|||
38034034|NCT03517540|69720386|FG001|Overall Study|Withdrawal by Subject|4|||
38034035|NCT03517540|69720387|FG002|Overall Study|Withdrawal by Subject|1|||
38034036|NCT03517540|69720388|FG003|Overall Study|Withdrawal by Subject|3|||
38034037|NCT02799082|69720400|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
38034038|NCT02799082|69720401|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
38034039|NCT02799082|69720400|FG000|Overall Study|Protocol Violation|0|||
37932278|NCT00791999|69619140|FG001|Overall Study|Lack of Efficacy|1|||
37932279|NCT00791999|69619141|FG002|Overall Study|Lack of Efficacy|0|||
37932280|NCT00791999|69619142|FG003|Overall Study|Lack of Efficacy|2|||
37932281|NCT00791999|69619139|FG000|Overall Study|Reason other than those above|1|||
37932282|NCT00791999|69619140|FG001|Overall Study|Reason other than those above|0|||
37932283|NCT00791999|69619141|FG002|Overall Study|Reason other than those above|1|||
37932284|NCT00791999|69619142|FG003|Overall Study|Reason other than those above|0|||
37932285|NCT00585078|69619156|FG000|Overall Study|Withdrawal by Subject|4|||
37932286|NCT00585078|69619156|FG000|Overall Study|Poor performance status|1|||
37932287|NCT00585078|69619156|FG000|Overall Study|Disease Progression|24|||
37932288|NCT00585078|69619156|FG000|Overall Study|Adverse Event|10|||
37932289|NCT00585078|69619156|FG000|Overall Study|Death|1|||
37932290|NCT00720876|69619160|FG000|Overall Study|found to be ineligible after starting tx|2|||
38034040|NCT02799082|69720401|FG001|Overall Study|Protocol Violation|1|||
38034041|NCT03710889|69720407|FG000|Overall Study|Adverse Event|2|||
38034042|NCT03710889|69720407|FG000|Overall Study|Protocol Deviation|1|||
38034043|NCT02797678|69720411|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
37668306|NCT02580591|69140825|FG000|Overall Study|Other than specified|3|||
38034044|NCT02797678|69720412|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
38034045|NCT02797678|69720413|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
37932291|NCT00723840|69619164|FG000|Overall Study|Lost to Follow-up|2|||
37932292|NCT00723840|69619164|FG000|Overall Study|Failure to return|18|||
37932293|NCT00723840|69619164|FG000|Overall Study|Withdrawal by Subject|55|||
37932294|NCT00723840|69619164|FG000|Overall Study|Serious Adverse Events|3|||
37932295|NCT00723840|69619164|FG000|Overall Study|Other Medical Event|2|||
37932296|NCT00723840|69619164|FG000|Overall Study|Unspecified reason|2|||
37932297|NCT00789581|69619177|FG000|AC Therapy|Adverse Event|2|||
37932298|NCT00789581|69619178|FG001|AC Therapy|Adverse Event|3|||
37932299|NCT00789581|69619177|FG000|AC Therapy|Withdrawal by Subject|4|||
37932300|NCT00789581|69619178|FG001|AC Therapy|Withdrawal by Subject|7|||
37932301|NCT00789581|69619177|FG000|AC Therapy|Disease recurrence|3|||
37932302|NCT00789581|69619178|FG001|AC Therapy|Disease recurrence|1|||
37932303|NCT00789581|69619177|FG000|AC Therapy|Intercurrent Illness|1|||
37932304|NCT00789581|69619178|FG001|AC Therapy|Intercurrent Illness|0|||
37932305|NCT00789581|69619177|FG000|AC Therapy|Never Treated|1|||
37932306|NCT00789581|69619178|FG001|AC Therapy|Never Treated|4|||
37932307|NCT00789581|69619177|FG000|AC Therapy|Other|0|||
37932308|NCT00789581|69619178|FG001|AC Therapy|Other|2|||
37932309|NCT00789581|69619177|FG000|Adjuvant Therapy|Never treated|2|||
37932310|NCT00789581|69619178|FG001|Adjuvant Therapy|Never treated|2|||
37932311|NCT00789581|69619177|FG000|Adjuvant Therapy|Adverse Event|20|||
37932312|NCT00789581|69619178|FG001|Adjuvant Therapy|Adverse Event|44|||
37932313|NCT00789581|69619177|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
37932314|NCT00789581|69619178|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
37932315|NCT00789581|69619177|FG000|Adjuvant Therapy|Disease recurrence|2|||
37932316|NCT00789581|69619178|FG001|Adjuvant Therapy|Disease recurrence|1|||
37932317|NCT00789581|69619177|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
37932318|NCT00789581|69619178|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
37932319|NCT00789581|69619177|FG000|Adjuvant Therapy|Protocol Violation|1|||
37932320|NCT00789581|69619178|FG001|Adjuvant Therapy|Protocol Violation|1|||
37932321|NCT00789581|69619177|FG000|Adjuvant Therapy|Other|0|||
37932322|NCT00789581|69619178|FG001|Adjuvant Therapy|Other|1|||
37932323|NCT00717756|69619185|FG000|Overall Study|Withdrawal by Subject|1|||
37932324|NCT00717522|69619189|FG000|Overall Study|Disease Progression|5|||
37932325|NCT00717522|69619189|FG000|Overall Study|Adverse Event|1|||
37932326|NCT00717522|69619189|FG000|Overall Study|Death|1|||
37932327|NCT00791921|69619195|FG000|Overall Study|Protocol planed|24|||
37932328|NCT00791921|69619196|FG001|Overall Study|Protocol planed|88|||
37932329|NCT00791921|69619195|FG000|Overall Study|Withdrawal by Subject|1|||
37932330|NCT00791921|69619196|FG001|Overall Study|Withdrawal by Subject|2|||
37932331|NCT00791921|69619195|FG000|Overall Study|Adverse Event|8|||
37932332|NCT00791921|69619196|FG001|Overall Study|Adverse Event|2|||
37932333|NCT00791921|69619195|FG000|Overall Study|Lack of Efficacy|0|||
37932334|NCT00791921|69619196|FG001|Overall Study|Lack of Efficacy|2|||
37932335|NCT00791921|69619195|FG000|Overall Study|Lack of study drug administration|1|||
37932336|NCT00791921|69619196|FG001|Overall Study|Lack of study drug administration|1|||
37932337|NCT00791921|69619195|FG000|Overall Study|Reason other than those above|0|||
37932338|NCT00791921|69619196|FG001|Overall Study|Reason other than those above|1|||
37932339|NCT00582933|69619202|FG000|Overall Study|Physician Decision|3|||
37932340|NCT00791765|69619208|FG000|Weeks 1 to 12|Adverse Event|0|||
37932341|NCT00791765|69619209|FG001|Weeks 1 to 12|Adverse Event|1|||
37932342|NCT00791765|69619208|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
37932343|NCT00791765|69619209|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
37932344|NCT00791765|69619208|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
37932345|NCT00791765|69619209|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
37932346|NCT00791765|69619208|FG000|Weeks 1 to 12|Physician Decision|1|||
37932347|NCT00791765|69619209|FG001|Weeks 1 to 12|Physician Decision|0|||
37932348|NCT00791765|69619208|FG000|Weeks 1 to 12|Disease progression|3|||
37932349|NCT00791765|69619209|FG001|Weeks 1 to 12|Disease progression|0|||
37932350|NCT00791765|69619208|FG000|Weeks 1 to 12|Ineligibility determined|0|||
37932351|NCT00791765|69619209|FG001|Weeks 1 to 12|Ineligibility determined|3|||
37932352|NCT00791765|69619208|FG000|Weeks 13 to 24|Protocol deviation|2|||
37932353|NCT00791765|69619209|FG001|Weeks 13 to 24|Protocol deviation|0|||
37932354|NCT00791765|69619208|FG000|Weeks 13 to 24|Adverse Event|0|||
37932355|NCT00791765|69619209|FG001|Weeks 13 to 24|Adverse Event|3|||
37932356|NCT00791765|69619208|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
37932357|NCT00791765|69619209|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
37932358|NCT00791765|69619208|FG000|Weeks 13 to 24|Disease progression|0|||
37932359|NCT00791765|69619209|FG001|Weeks 13 to 24|Disease progression|1|||
37932360|NCT00791765|69619208|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
37932361|NCT00791765|69619209|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
37932362|NCT00791765|69619208|FG000|Weeks 13 to 24|Other|0|||
37932363|NCT00791765|69619209|FG001|Weeks 13 to 24|Other|1|||
37932364|NCT00789191|69619217|FG000|Overall Study|Adverse Event|2|||
37932365|NCT00789191|69619218|FG001|Overall Study|Adverse Event|4|||
37932366|NCT00789191|69619217|FG000|Overall Study|Lack of Efficacy|0|||
37932367|NCT00789191|69619218|FG001|Overall Study|Lack of Efficacy|5|||
37932368|NCT00789191|69619217|FG000|Overall Study|Protocol Violation|5|||
37932369|NCT00789191|69619218|FG001|Overall Study|Protocol Violation|3|||
37932370|NCT00789191|69619217|FG000|Overall Study|Withdrawal Criteria|2|||
37932371|NCT00789191|69619218|FG001|Overall Study|Withdrawal Criteria|4|||
37932372|NCT00789191|69619217|FG000|Overall Study|Unclassified|5|||
37932373|NCT00789191|69619218|FG001|Overall Study|Unclassified|3|||
37932374|NCT00789035|69619229|FG000|Overall Study|Adverse Event|0|||
37932375|NCT00789035|69619230|FG001|Overall Study|Adverse Event|2|||
37932376|NCT00789035|69619231|FG002|Overall Study|Adverse Event|0|||
37932377|NCT00789035|69619232|FG003|Overall Study|Adverse Event|1|||
37932378|NCT00789035|69619233|FG004|Overall Study|Adverse Event|3|||
37932379|NCT00789035|69619229|FG000|Overall Study|Lack of Efficacy|3|||
37932380|NCT00789035|69619230|FG001|Overall Study|Lack of Efficacy|0|||
37932381|NCT00789035|69619231|FG002|Overall Study|Lack of Efficacy|0|||
37932382|NCT00789035|69619232|FG003|Overall Study|Lack of Efficacy|0|||
37932383|NCT00789035|69619233|FG004|Overall Study|Lack of Efficacy|2|||
37932384|NCT00789035|69619229|FG000|Overall Study|Protocol Violation|1|||
37932385|NCT00789035|69619230|FG001|Overall Study|Protocol Violation|0|||
37932386|NCT00789035|69619231|FG002|Overall Study|Protocol Violation|0|||
37932387|NCT00789035|69619232|FG003|Overall Study|Protocol Violation|0|||
37932388|NCT00789035|69619233|FG004|Overall Study|Protocol Violation|0|||
37932389|NCT00789035|69619229|FG000|Overall Study|Withdrawal by Subject|0|||
37932390|NCT00789035|69619230|FG001|Overall Study|Withdrawal by Subject|2|||
37932391|NCT00789035|69619231|FG002|Overall Study|Withdrawal by Subject|0|||
37932392|NCT00789035|69619232|FG003|Overall Study|Withdrawal by Subject|0|||
37932393|NCT00789035|69619233|FG004|Overall Study|Withdrawal by Subject|0|||
37932394|NCT00789035|69619229|FG000|Overall Study|Other reason not defined above|2|||
37932395|NCT00789035|69619230|FG001|Overall Study|Other reason not defined above|3|||
37932396|NCT00789035|69619231|FG002|Overall Study|Other reason not defined above|1|||
37932397|NCT00789035|69619232|FG003|Overall Study|Other reason not defined above|0|||
37932398|NCT00789035|69619233|FG004|Overall Study|Other reason not defined above|1|||
37932399|NCT03326193|69619257|FG000|Overall Study|Treatment ongoing at the time of analysis|26|||
37932400|NCT03326193|69619257|FG000|Overall Study|Death|19|||
37932401|NCT03326193|69619257|FG000|Overall Study|Withdrawal by Subject|8|||
37932402|NCT00437203|69619280|FG000|Overall Study|Death|0|||
37932403|NCT00437203|69619281|FG001|Overall Study|Death|0|||
37932404|NCT00437203|69619282|FG002|Overall Study|Death|1|||
37932405|NCT00437203|69619283|FG003|Overall Study|Death|0|||
37932406|NCT00437203|69619284|FG004|Overall Study|Death|0|||
37932407|NCT00437203|69619285|FG005|Overall Study|Death|0|||
37932408|NCT00437203|69619286|FG006|Overall Study|Death|0|||
37932409|NCT00437203|69619287|FG007|Overall Study|Death|1|||
37932410|NCT00437203|69619288|FG008|Overall Study|Death|0|||
37932411|NCT00437203|69619289|FG009|Overall Study|Death|1|||
37932412|NCT00437203|69619280|FG000|Overall Study|Adverse Event|1|||
37932413|NCT00437203|69619281|FG001|Overall Study|Adverse Event|1|||
37932414|NCT00437203|69619282|FG002|Overall Study|Adverse Event|0|||
37932415|NCT00437203|69619283|FG003|Overall Study|Adverse Event|0|||
37932416|NCT00437203|69619284|FG004|Overall Study|Adverse Event|0|||
37932417|NCT00437203|69619285|FG005|Overall Study|Adverse Event|0|||
37932418|NCT00437203|69619286|FG006|Overall Study|Adverse Event|0|||
37932419|NCT00437203|69619287|FG007|Overall Study|Adverse Event|1|||
37932420|NCT00437203|69619288|FG008|Overall Study|Adverse Event|0|||
37932421|NCT00437203|69619289|FG009|Overall Study|Adverse Event|1|||
37932422|NCT00437203|69619280|FG000|Overall Study|Study terminated by sponsor|0|||
37932423|NCT00437203|69619281|FG001|Overall Study|Study terminated by sponsor|0|||
37932424|NCT00437203|69619282|FG002|Overall Study|Study terminated by sponsor|0|||
37932425|NCT00437203|69619283|FG003|Overall Study|Study terminated by sponsor|0|||
37932426|NCT00437203|69619284|FG004|Overall Study|Study terminated by sponsor|0|||
37932427|NCT00437203|69619285|FG005|Overall Study|Study terminated by sponsor|0|||
37932428|NCT00437203|69619286|FG006|Overall Study|Study terminated by sponsor|0|||
37932429|NCT00437203|69619287|FG007|Overall Study|Study terminated by sponsor|0|||
37932430|NCT00437203|69619288|FG008|Overall Study|Study terminated by sponsor|1|||
37932431|NCT00437203|69619289|FG009|Overall Study|Study terminated by sponsor|0|||
37932432|NCT00437203|69619280|FG000|Overall Study|Objective progression or relapse|5|||
37932433|NCT00437203|69619281|FG001|Overall Study|Objective progression or relapse|6|||
37932434|NCT00437203|69619282|FG002|Overall Study|Objective progression or relapse|2|||
37668307|NCT02580591|69140826|FG001|Overall Study|Other than specified|2|||
37668308|NCT02580591|69140827|FG002|Overall Study|Other than specified|5|||
37932435|NCT00437203|69619283|FG003|Overall Study|Objective progression or relapse|3|||
37932436|NCT00437203|69619284|FG004|Overall Study|Objective progression or relapse|3|||
37932437|NCT00437203|69619285|FG005|Overall Study|Objective progression or relapse|3|||
37932438|NCT00437203|69619286|FG006|Overall Study|Objective progression or relapse|6|||
37932439|NCT00437203|69619287|FG007|Overall Study|Objective progression or relapse|1|||
37932440|NCT00437203|69619288|FG008|Overall Study|Objective progression or relapse|2|||
37932441|NCT00437203|69619289|FG009|Overall Study|Objective progression or relapse|2|||
37932442|NCT00437203|69619280|FG000|Overall Study|Other|0|||
37932443|NCT00437203|69619281|FG001|Overall Study|Other|1|||
37932444|NCT00437203|69619282|FG002|Overall Study|Other|0|||
37932445|NCT00437203|69619283|FG003|Overall Study|Other|0|||
37932446|NCT00437203|69619284|FG004|Overall Study|Other|0|||
37932447|NCT00437203|69619285|FG005|Overall Study|Other|0|||
37932448|NCT00437203|69619286|FG006|Overall Study|Other|1|||
37932449|NCT00437203|69619287|FG007|Overall Study|Other|0|||
37932450|NCT00437203|69619288|FG008|Overall Study|Other|0|||
37932451|NCT00437203|69619289|FG009|Overall Study|Other|0|||
37932452|NCT00753272|69619322|FG000|Overall Study|Adverse Event|878|||
37932453|NCT00753272|69619323|FG001|Overall Study|Adverse Event|869|||
37932454|NCT00753272|69619322|FG000|Overall Study|Protocol Violation|28|||
37932455|NCT00753272|69619323|FG001|Overall Study|Protocol Violation|46|||
37932456|NCT00753272|69619322|FG000|Overall Study|Withdrawal by Subject|2481|||
37932457|NCT00753272|69619323|FG001|Overall Study|Withdrawal by Subject|2407|||
37932458|NCT00753272|69619322|FG000|Overall Study|Lost to Follow-up|491|||
37932459|NCT00753272|69619323|FG001|Overall Study|Lost to Follow-up|497|||
37932460|NCT00753272|69619322|FG000|Overall Study|Other|1104|||
37932461|NCT00753272|69619323|FG001|Overall Study|Other|1088|||
37932462|NCT00437125|69619332|FG000|Overall Study|Adverse Event|12|||
37932463|NCT00437125|69619332|FG000|Overall Study|Death|1|||
37932464|NCT00437125|69619332|FG000|Overall Study|Clinical Relapse|1|||
37932465|NCT00437125|69619332|FG000|Overall Study|Lack of Efficacy|1|||
37932466|NCT00437125|69619332|FG000|Overall Study|Lost to Follow-up|1|||
37932467|NCT00437125|69619332|FG000|Overall Study|Withdrawal by Subject|13|||
37932468|NCT00437125|69619332|FG000|Overall Study|Withdrawal by Caregiver|2|||
37932469|NCT00437125|69619332|FG000|Overall Study|Physician Decision|1|||
37932470|NCT00582309|69619348|FG000|Overall Study|Protocol Violation|0|||
37932471|NCT00582309|69619349|FG001|Overall Study|Protocol Violation|0|||
37932472|NCT00582309|69619350|FG002|Overall Study|Protocol Violation|2|||
37932473|NCT00443053|69619360|FG000|Overall Study|Adverse Event|2|||
37932474|NCT00443053|69619361|FG001|Overall Study|Adverse Event|1|||
37932475|NCT00443053|69619360|FG000|Overall Study|Withdrawal by Subject|9|||
37932476|NCT00443053|69619361|FG001|Overall Study|Withdrawal by Subject|18|||
37932477|NCT00443053|69619360|FG000|Overall Study|Lost to Follow-up|4|||
37932478|NCT00443053|69619361|FG001|Overall Study|Lost to Follow-up|5|||
37932479|NCT00443053|69619360|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
37932480|NCT00443053|69619361|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
37932481|NCT00443053|69619360|FG000|Overall Study|Noncompliance|2|||
37932482|NCT00443053|69619361|FG001|Overall Study|Noncompliance|1|||
37932483|NCT00443053|69619360|FG000|Overall Study|Other|3|||
37932484|NCT00443053|69619361|FG001|Overall Study|Other|4|||
37932485|NCT00443053|69619360|FG000|Overall Study|Physician Decision|0|||
37932486|NCT00443053|69619361|FG001|Overall Study|Physician Decision|4|||
37932487|NCT00720798|69619367|FG000|Overall Study|Adverse Event|304|||
37932488|NCT00720798|69619367|FG000|Overall Study|Death|39|||
37932489|NCT00720798|69619367|FG000|Overall Study|Insufficient Therapeutic Response|129|||
37932490|NCT00720798|69619367|FG000|Overall Study|Protocol Violation|4|||
37932491|NCT00720798|69619367|FG000|Overall Study|Refused Treatment|151|||
37932492|NCT00720798|69619367|FG000|Overall Study|Failure to Return|46|||
37932493|NCT00720798|69619367|FG000|Overall Study|Reason not Specified|83|||
37932494|NCT00756002|69619377|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
37932495|NCT00756002|69619378|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
37932496|NCT00756002|69619377|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
37932497|NCT00756002|69619378|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
37668309|NCT02580591|69140828|FG003|Overall Study|Other than specified|2|||
37668310|NCT02580357|69140841|FG000|Overall Study|Lost to Follow-up|2|||
37668311|NCT02580357|69140842|FG001|Overall Study|Lost to Follow-up|0|||
37668312|NCT02580357|69140843|FG002|Overall Study|Lost to Follow-up|0|||
37668313|NCT02580357|69140841|FG000|Overall Study|Protocol Violation|1|||
37668314|NCT02580357|69140842|FG001|Overall Study|Protocol Violation|0|||
37668315|NCT02580357|69140843|FG002|Overall Study|Protocol Violation|0|||
37668316|NCT01664091|69140851|FG000|Overall Study|Death|1|||
37668317|NCT01664091|69140851|FG000|Overall Study|Disease Progression|2|||
37668318|NCT01664091|69140851|FG000|Overall Study|Lost to Follow-up|2|||
37668319|NCT01664091|69140851|FG000|Overall Study|Withdrawal by Subject|1|||
37668320|NCT02577315|69140858|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
37932498|NCT00756002|69619377|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
37932499|NCT00756002|69619378|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
37932500|NCT00756002|69619377|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
37932501|NCT00756002|69619378|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
37932502|NCT00756002|69619377|FG000|Double-Blind Treatment Period|Other|2|||
37932503|NCT00756002|69619378|FG001|Double-Blind Treatment Period|Other|2|||
37932504|NCT00717366|69619386|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
37932505|NCT00717366|69619387|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
37932506|NCT00717366|69619386|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
37932507|NCT00717366|69619387|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
37932508|NCT00717366|69619386|FG000|Core Study Period (20 Weeks)|Death|0|||
37932509|NCT00717366|69619387|FG001|Core Study Period (20 Weeks)|Death|1|||
37932510|NCT00717366|69619386|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
38034046|NCT02797678|69720414|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
38034047|NCT02797678|69720411|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
38034048|NCT02797678|69720412|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
38034049|NCT02797678|69720413|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
38034050|NCT02797678|69720414|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
38034051|NCT02797678|69720411|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
38034052|NCT02797678|69720412|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
38034053|NCT02797678|69720413|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
38034054|NCT02797678|69720414|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
38034055|NCT03308786|69720427|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
38034056|NCT03274076|69720434|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
38034057|NCT03274076|69720435|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
38034058|NCT03274076|69720436|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
38034059|NCT03274076|69720437|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
38034060|NCT03274076|69720434|FG000|24 Weeks Open Label|Adverse Event|0|||
38034061|NCT03274076|69720435|FG001|24 Weeks Open Label|Adverse Event|0|||
38034062|NCT03274076|69720436|FG002|24 Weeks Open Label|Adverse Event|2|||
38034063|NCT03274076|69720437|FG003|24 Weeks Open Label|Adverse Event|0|||
38034064|NCT03274076|69720434|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
38034065|NCT03274076|69720435|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
38034066|NCT03274076|69720436|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
38034067|NCT03274076|69720437|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
38034068|NCT02797522|69720467|FG000|Overall Study|Study Terminated by Sponsor|0|||
38034069|NCT02797522|69720468|FG001|Overall Study|Study Terminated by Sponsor|0|||
38034070|NCT02797522|69720469|FG002|Overall Study|Study Terminated by Sponsor|0|||
38034071|NCT02797522|69720470|FG003|Overall Study|Study Terminated by Sponsor|0|||
38034072|NCT02797522|69720471|FG004|Overall Study|Study Terminated by Sponsor|0|||
38034073|NCT02797522|69720472|FG005|Overall Study|Study Terminated by Sponsor|0|||
38034074|NCT02797522|69720473|FG006|Overall Study|Study Terminated by Sponsor|0|||
38034075|NCT02797522|69720474|FG007|Overall Study|Study Terminated by Sponsor|4|||
38034076|NCT02797522|69720475|FG008|Overall Study|Study Terminated by Sponsor|2|||
37668321|NCT02577315|69140859|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
37668322|NCT02711345|69140875|FG000|Overall Study|Adverse Event|0|||
37668323|NCT02711345|69140876|FG001|Overall Study|Adverse Event|0|||
37668324|NCT02711345|69140877|FG002|Overall Study|Adverse Event|0|||
37668325|NCT02711345|69140878|FG003|Overall Study|Adverse Event|1|||
38034077|NCT02797522|69720476|FG009|Overall Study|Study Terminated by Sponsor|4|||
38034078|NCT02797522|69720477|FG010|Overall Study|Study Terminated by Sponsor|1|||
38034079|NCT02659514|69720516|FG000|Overall Study|Adverse Event|3|||
38034080|NCT02659514|69720517|FG001|Overall Study|Adverse Event|12|||
37668326|NCT02711345|69140879|FG004|Overall Study|Adverse Event|1|||
37668327|NCT02711345|69140880|FG005|Overall Study|Adverse Event|2|||
37668328|NCT02711345|69140881|FG006|Overall Study|Adverse Event|1|||
37668329|NCT02711345|69140882|FG007|Overall Study|Adverse Event|0|||
37668330|NCT02711345|69140883|FG008|Overall Study|Adverse Event|0|||
37668331|NCT02711345|69140884|FG009|Overall Study|Adverse Event|2|||
37668332|NCT02711345|69140875|FG000|Overall Study|Physician Decision|0|||
37668333|NCT02711345|69140876|FG001|Overall Study|Physician Decision|0|||
37668334|NCT02711345|69140877|FG002|Overall Study|Physician Decision|1|||
37668335|NCT02711345|69140878|FG003|Overall Study|Physician Decision|0|||
37668336|NCT02711345|69140879|FG004|Overall Study|Physician Decision|0|||
37668337|NCT02711345|69140880|FG005|Overall Study|Physician Decision|0|||
37668338|NCT02711345|69140881|FG006|Overall Study|Physician Decision|0|||
37668339|NCT02711345|69140882|FG007|Overall Study|Physician Decision|0|||
37668340|NCT02711345|69140883|FG008|Overall Study|Physician Decision|1|||
37668341|NCT02711345|69140884|FG009|Overall Study|Physician Decision|0|||
37668342|NCT02711345|69140875|FG000|Overall Study|Progressive disease|1|||
38034081|NCT02659514|69720516|FG000|Overall Study|Disease Progression|23|||
38034082|NCT02659514|69720517|FG001|Overall Study|Disease Progression|13|||
38034083|NCT02659514|69720516|FG000|Overall Study|Withdrawal by Subject|0|||
37668343|NCT02711345|69140876|FG001|Overall Study|Progressive disease|3|||
37668344|NCT02711345|69140877|FG002|Overall Study|Progressive disease|5|||
37668345|NCT02711345|69140878|FG003|Overall Study|Progressive disease|3|||
37668346|NCT02711345|69140879|FG004|Overall Study|Progressive disease|7|||
38034084|NCT02659514|69720517|FG001|Overall Study|Withdrawal by Subject|4|||
38034085|NCT02659514|69720516|FG000|Overall Study|Lost to Follow-up|0|||
38034086|NCT02659514|69720517|FG001|Overall Study|Lost to Follow-up|1|||
38034087|NCT02659514|69720516|FG000|Overall Study|Death|6|||
38034088|NCT02659514|69720517|FG001|Overall Study|Death|1|||
38034089|NCT02659514|69720516|FG000|Overall Study|Reason Unspecified|0|||
38034090|NCT02659514|69720517|FG001|Overall Study|Reason Unspecified|3|||
38034091|NCT04570670|69720525|FG000|Overall Study|Withdrawal by Subject|1|||
37932511|NCT00717366|69619387|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
37932512|NCT00717366|69619386|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
37932513|NCT00717366|69619387|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
37932514|NCT00717366|69619386|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
38034092|NCT04570670|69720526|FG001|Overall Study|Withdrawal by Subject|0|||
38034093|NCT02797132|69720532|FG000|Part A (15 Days)|Adverse Event|1|||
38034094|NCT02797132|69720532|FG000|Part B (24 Weeks)|Adverse Event|3|||
38034095|NCT03270644|69720545|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
38034096|NCT03270644|69720545|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
38034097|NCT03269552|69720556|FG000|Overall Study|Adverse Event|2|||
38034098|NCT02796664|69720563|FG000|Overall Study|Withdrawal by Subject|0|||
38034099|NCT02796664|69720564|FG001|Overall Study|Withdrawal by Subject|3|||
38034100|NCT02796664|69720563|FG000|Overall Study|Noncompliance|1|||
38034101|NCT02796664|69720564|FG001|Overall Study|Noncompliance|1|||
38034102|NCT02796664|69720563|FG000|Overall Study|Death|0|||
38034103|NCT02796664|69720564|FG001|Overall Study|Death|1|||
38034104|NCT04233879|69720574|FG000|Overall Study|Death|2|||
38034105|NCT04233879|69720575|FG001|Overall Study|Death|0|||
38034106|NCT04233879|69720574|FG000|Overall Study|Lost to Follow-up|3|||
38034107|NCT04233879|69720575|FG001|Overall Study|Lost to Follow-up|8|||
38034108|NCT04233879|69720574|FG000|Overall Study|Physician Decision|4|||
38034109|NCT04233879|69720575|FG001|Overall Study|Physician Decision|4|||
38034110|NCT04233879|69720574|FG000|Overall Study|Withdrawal by Subject|7|||
38034111|NCT04233879|69720575|FG001|Overall Study|Withdrawal by Subject|10|||
38034112|NCT04233879|69720574|FG000|Overall Study|Other|281|||
38034113|NCT04233879|69720575|FG001|Overall Study|Other|279|||
38034114|NCT01370356|69720583|FG000|Overall Study|Death|1|||
38034115|NCT01370356|69720584|FG001|Overall Study|Death|0|||
38034116|NCT01370356|69720583|FG000|Overall Study|Lack of Efficacy|6|||
38034117|NCT01370356|69720584|FG001|Overall Study|Lack of Efficacy|28|||
38034118|NCT01370356|69720583|FG000|Overall Study|Lost to Follow-up|76|||
38034119|NCT01370356|69720584|FG001|Overall Study|Lost to Follow-up|81|||
38034120|NCT01370356|69720583|FG000|Overall Study|Withdrawal by Subject|54|||
38034121|NCT01370356|69720584|FG001|Overall Study|Withdrawal by Subject|59|||
38034122|NCT01370356|69720583|FG000|Overall Study|Reason not specified|39|||
38034123|NCT01370356|69720584|FG001|Overall Study|Reason not specified|43|||
38034124|NCT01370356|69720583|FG000|Overall Study|Protocol Violation|3|||
38034125|NCT01370356|69720584|FG001|Overall Study|Protocol Violation|3|||
38034126|NCT01370356|69720583|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
38034127|NCT01370356|69720584|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
38034128|NCT01370356|69720583|FG000|Overall Study|AE Not Related to Study Drug|1|||
38034129|NCT01370356|69720584|FG001|Overall Study|AE Not Related to Study Drug|4|||
38034130|NCT02794870|69720592|FG000|Overall Study|Withdrawal by Subject|2|||
38034131|NCT02794870|69720593|FG001|Overall Study|Withdrawal by Subject|0|||
38034132|NCT01370590|69720601|FG000|Period 1|Adverse Event|8|||
38034133|NCT01370590|69720602|FG001|Period 1|Adverse Event|4|||
38034134|NCT01370590|69720601|FG000|Period 1|Lost to Follow-up|2|||
38034135|NCT01370590|69720602|FG001|Period 1|Lost to Follow-up|2|||
38034136|NCT01370590|69720601|FG000|Period 1|Protocol Violation|2|||
38034137|NCT01370590|69720602|FG001|Period 1|Protocol Violation|2|||
38034138|NCT01370590|69720601|FG000|Period 1|Withdrawal by Subject|4|||
38034139|NCT01370590|69720602|FG001|Period 1|Withdrawal by Subject|2|||
38034140|NCT01370590|69720601|FG000|Period 1|Could not access randomization system|0|||
38034141|NCT01370590|69720602|FG001|Period 1|Could not access randomization system|1|||
37668347|NCT02711345|69140880|FG005|Overall Study|Progressive disease|2|||
37668348|NCT02711345|69140881|FG006|Overall Study|Progressive disease|8|||
38034142|NCT01370590|69720601|FG000|Crossover Washout Period|Adverse Event|1|||
38034143|NCT01370590|69720602|FG001|Crossover Washout Period|Adverse Event|4|||
38034144|NCT01370590|69720601|FG000|Crossover Washout Period|Lost to Follow-up|2|||
38034145|NCT01370590|69720602|FG001|Crossover Washout Period|Lost to Follow-up|0|||
38034146|NCT01370590|69720601|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
38034147|NCT01370590|69720602|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
37668349|NCT02711345|69140882|FG007|Overall Study|Progressive disease|4|||
37668350|NCT02711345|69140883|FG008|Overall Study|Progressive disease|5|||
37932515|NCT00717366|69619387|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
38034148|NCT01370590|69720601|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
38034149|NCT01370590|69720602|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
37668351|NCT02711345|69140884|FG009|Overall Study|Progressive disease|6|||
38034150|NCT01370590|69720601|FG000|Period 2|Adverse Event|0|||
37932516|NCT00717366|69619386|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
37932517|NCT00717366|69619387|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
37932518|NCT00723606|69619406|FG000|Overall Study|Adverse Event|2|||
37932519|NCT00723606|69619407|FG001|Overall Study|Adverse Event|5|||
37932520|NCT00723606|69619406|FG000|Overall Study|Other|2|||
37932521|NCT00723606|69619407|FG001|Overall Study|Other|0|||
37932522|NCT00723606|69619406|FG000|Overall Study|Withdrawal by Subject|0|||
37932523|NCT00723606|69619407|FG001|Overall Study|Withdrawal by Subject|2|||
37932524|NCT00442351|69619415|FG000|Overall Study|Administrative|6|||
37932525|NCT00442351|69619416|FG001|Overall Study|Administrative|5|||
37932526|NCT00442351|69619415|FG000|Overall Study|Did not meet protocol eligibility|1|||
37932527|NCT00442351|69619416|FG001|Overall Study|Did not meet protocol eligibility|0|||
37932528|NCT00442351|69619415|FG000|Overall Study|Other|0|||
37932529|NCT00442351|69619416|FG001|Overall Study|Other|1|||
37932530|NCT00436501|69619424|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
37932531|NCT00436501|69619425|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
37932532|NCT00436501|69619424|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
37932533|NCT00436501|69619425|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
37932534|NCT00755846|69619438|FG000|Overall Study|Adverse Event|0|||
37932535|NCT00755846|69619439|FG001|Overall Study|Adverse Event|0|||
37932536|NCT00755846|69619440|FG002|Overall Study|Adverse Event|0|||
37932537|NCT00755846|69619441|FG003|Overall Study|Adverse Event|1|||
37932538|NCT00755846|69619442|FG004|Overall Study|Adverse Event|3|||
37932539|NCT00755846|69619443|FG005|Overall Study|Adverse Event|2|||
37932540|NCT00755846|69619438|FG000|Overall Study|Protocol Violation|1|||
37932541|NCT00755846|69619439|FG001|Overall Study|Protocol Violation|1|||
37932542|NCT00755846|69619440|FG002|Overall Study|Protocol Violation|1|||
37932543|NCT00755846|69619441|FG003|Overall Study|Protocol Violation|1|||
37932544|NCT00755846|69619442|FG004|Overall Study|Protocol Violation|1|||
37932545|NCT00755846|69619443|FG005|Overall Study|Protocol Violation|1|||
37932546|NCT00755846|69619438|FG000|Overall Study|Lost to Follow-up|0|||
37932547|NCT00755846|69619439|FG001|Overall Study|Lost to Follow-up|2|||
37932548|NCT00755846|69619440|FG002|Overall Study|Lost to Follow-up|1|||
37932549|NCT00755846|69619441|FG003|Overall Study|Lost to Follow-up|0|||
37932550|NCT00755846|69619442|FG004|Overall Study|Lost to Follow-up|4|||
37932551|NCT00755846|69619443|FG005|Overall Study|Lost to Follow-up|2|||
37932552|NCT00755846|69619438|FG000|Overall Study|Withdrawal by Subject|2|||
37932553|NCT00755846|69619439|FG001|Overall Study|Withdrawal by Subject|3|||
37932554|NCT00755846|69619440|FG002|Overall Study|Withdrawal by Subject|5|||
37932555|NCT00755846|69619441|FG003|Overall Study|Withdrawal by Subject|2|||
37932556|NCT00755846|69619442|FG004|Overall Study|Withdrawal by Subject|0|||
37932557|NCT00755846|69619443|FG005|Overall Study|Withdrawal by Subject|1|||
37932558|NCT00755846|69619438|FG000|Overall Study|Hyperglycemic Rescue|21|||
37932559|NCT00755846|69619439|FG001|Overall Study|Hyperglycemic Rescue|7|||
37932560|NCT00755846|69619440|FG002|Overall Study|Hyperglycemic Rescue|5|||
37932561|NCT00755846|69619441|FG003|Overall Study|Hyperglycemic Rescue|8|||
37932562|NCT00755846|69619442|FG004|Overall Study|Hyperglycemic Rescue|8|||
37932563|NCT00755846|69619443|FG005|Overall Study|Hyperglycemic Rescue|7|||
37932564|NCT00755846|69619438|FG000|Overall Study|Physician Decision|1|||
37932565|NCT00755846|69619439|FG001|Overall Study|Physician Decision|3|||
37932566|NCT00755846|69619440|FG002|Overall Study|Physician Decision|0|||
37932567|NCT00755846|69619441|FG003|Overall Study|Physician Decision|1|||
37932568|NCT00755846|69619442|FG004|Overall Study|Physician Decision|0|||
37932569|NCT00755846|69619443|FG005|Overall Study|Physician Decision|1|||
37932570|NCT00755846|69619438|FG000|Overall Study|Administrative Error|0|||
37932571|NCT00755846|69619439|FG001|Overall Study|Administrative Error|1|||
37932572|NCT00755846|69619440|FG002|Overall Study|Administrative Error|0|||
37932573|NCT00755846|69619441|FG003|Overall Study|Administrative Error|0|||
37932574|NCT00755846|69619442|FG004|Overall Study|Administrative Error|0|||
37932575|NCT00755846|69619443|FG005|Overall Study|Administrative Error|0|||
37932576|NCT00755846|69619438|FG000|Overall Study|Participant Non-compliance|0|||
37932577|NCT00755846|69619439|FG001|Overall Study|Participant Non-compliance|0|||
37932578|NCT00755846|69619440|FG002|Overall Study|Participant Non-compliance|0|||
37932579|NCT00755846|69619441|FG003|Overall Study|Participant Non-compliance|0|||
37932580|NCT00755846|69619442|FG004|Overall Study|Participant Non-compliance|1|||
37932581|NCT00755846|69619443|FG005|Overall Study|Participant Non-compliance|0|||
37932582|NCT03850093|69619460|FG000|Overall Study|Withdrawal by Subject|1|||
37932583|NCT03850093|69619461|FG001|Overall Study|Withdrawal by Subject|0|||
37932584|NCT03850093|69619462|FG002|Overall Study|Withdrawal by Subject|2|||
37932585|NCT00442117|69619472|FG000|Overall Study|Adverse Event|3|||
37932586|NCT00442117|69619473|FG001|Overall Study|Adverse Event|2|||
37932587|NCT00442117|69619472|FG000|Overall Study|Lack of Efficacy|2|||
37932588|NCT00442117|69619473|FG001|Overall Study|Lack of Efficacy|6|||
37932589|NCT00442117|69619472|FG000|Overall Study|Lost to Follow-up|1|||
37932590|NCT00442117|69619473|FG001|Overall Study|Lost to Follow-up|2|||
37932591|NCT00442117|69619472|FG000|Overall Study|Withdrawal by Subject|2|||
37932592|NCT00442117|69619473|FG001|Overall Study|Withdrawal by Subject|2|||
38034151|NCT01370590|69720602|FG001|Period 2|Adverse Event|1|||
38034152|NCT01370590|69720601|FG000|Period 2|Withdrawal by Subject|1|||
38034153|NCT01370590|69720602|FG001|Period 2|Withdrawal by Subject|1|||
38034154|NCT05200455|69720613|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
38034155|NCT04646109|69720620|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
38034156|NCT04646109|69720621|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
38034157|NCT04502979|69720630|FG000|Overall Study|Lost to Follow-up|1|||
38034158|NCT04502979|69720631|FG001|Overall Study|Lost to Follow-up|3|||
38034159|NCT04502979|69720630|FG000|Overall Study|Withdrawal by Subject|2|||
38034160|NCT04502979|69720631|FG001|Overall Study|Withdrawal by Subject|1|||
38034161|NCT04590027|69720639|FG000|Overall Study|Lost to Follow-up|17|||
38034162|NCT04590027|69720640|FG001|Overall Study|Lost to Follow-up|14|||
38034163|NCT04590027|69720639|FG000|Overall Study|Protocol Violation|0|||
38034164|NCT04590027|69720640|FG001|Overall Study|Protocol Violation|3|||
38034165|NCT04587453|69720652|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
38034166|NCT04587453|69720653|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
38034167|NCT02793232|69720670|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
38034168|NCT02793232|69720671|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
38034169|NCT02793232|69720672|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
38034170|NCT02793232|69720673|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
38034171|NCT02793232|69720674|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
38034172|NCT02793232|69720675|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
38034173|NCT02793232|69720676|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
38034174|NCT02793232|69720677|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
38034175|NCT02793232|69720678|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
38034176|NCT04584645|69720714|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
38034177|NCT04584645|69720715|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
38034178|NCT03695367|69720741|FG000|Overall Study|Missed the Day 28 visit.|1|||
38034179|NCT03695367|69720742|FG001|Overall Study|Missed the Day 28 visit.|0|||
38034180|NCT03695367|69720741|FG000|Overall Study|Lost to Follow-up|0|||
38034181|NCT03695367|69720742|FG001|Overall Study|Lost to Follow-up|1|||
38034182|NCT03695367|69720741|FG000|Overall Study|Withdrawal by Subject|0|||
38034183|NCT03695367|69720742|FG001|Overall Study|Withdrawal by Subject|1|||
37932593|NCT00442117|69619472|FG000|Overall Study|Major Deviation|25|||
37932594|NCT00442117|69619473|FG001|Overall Study|Major Deviation|20|||
37932595|NCT00442117|69619472|FG000|Overall Study|Non compliance with protocol|3|||
37932596|NCT00442117|69619473|FG001|Overall Study|Non compliance with protocol|5|||
37932597|NCT00442117|69619472|FG000|Overall Study|Met Withdrawal Criteria|2|||
37932598|NCT00442117|69619473|FG001|Overall Study|Met Withdrawal Criteria|1|||
37932599|NCT00752726|69619481|FG000|Overall Study|Lost to Follow-up|2|||
37932600|NCT00752726|69619482|FG001|Overall Study|Lost to Follow-up|1|||
37932601|NCT00752726|69619481|FG000|Overall Study|Adverse Event|3|||
37932602|NCT00752726|69619482|FG001|Overall Study|Adverse Event|0|||
37932603|NCT00752726|69619481|FG000|Overall Study|Withdrawal by Subject|5|||
37932604|NCT00752726|69619482|FG001|Overall Study|Withdrawal by Subject|10|||
38034184|NCT03695367|69720741|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
38034185|NCT03695367|69720742|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
38034186|NCT02794480|69720750|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
38034187|NCT02794480|69720751|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
38034188|NCT02794480|69720752|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
38034189|NCT02794480|69720753|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
38034190|NCT02794480|69720750|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
38034191|NCT02794480|69720751|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
38034192|NCT02794480|69720752|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
38034193|NCT02794480|69720753|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
38034194|NCT02794480|69720750|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
38034195|NCT02794480|69720751|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
38034196|NCT02794480|69720752|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
38034197|NCT02794480|69720753|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
38034198|NCT02794480|69720750|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
37932605|NCT00752726|69619481|FG000|Overall Study|Other Reason|1|||
37932606|NCT00752726|69619482|FG001|Overall Study|Other Reason|2|||
38043556|NCT02927262|69731712|FG001|Overall Study|Adverse Event|1|||
37932607|NCT00755222|69619490|FG000|Overall Study|Withdrawal by Subject|4|||
37932608|NCT00755222|69619491|FG001|Overall Study|Withdrawal by Subject|2|||
37932609|NCT00755222|69619490|FG000|Overall Study|Adverse Event|2|||
37932610|NCT00755222|69619491|FG001|Overall Study|Adverse Event|0|||
37932611|NCT00755222|69619490|FG000|Overall Study|Protocol Violation|2|||
38034199|NCT02794480|69720751|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
38034200|NCT02794480|69720752|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
38034201|NCT02794480|69720753|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
38034202|NCT02794480|69720750|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
38034203|NCT02794480|69720751|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
38034204|NCT02794480|69720752|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
38034205|NCT02794480|69720753|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
38034206|NCT04558125|69720761|FG000|Overall Study|Death|1|||
38034207|NCT02793622|69720767|FG000|Overall Study|Lost to Follow-up|31|||
38034208|NCT02793622|69720768|FG001|Overall Study|Lost to Follow-up|19|||
38034209|NCT02793622|69720767|FG000|Overall Study|Withdrawal by Subject|21|||
38034210|NCT02793622|69720768|FG001|Overall Study|Withdrawal by Subject|17|||
38034211|NCT02793622|69720767|FG000|Overall Study|Adverse Event|0|||
38034212|NCT02793622|69720768|FG001|Overall Study|Adverse Event|1|||
38034213|NCT02793622|69720767|FG000|Overall Study|Protocol Violation|1|||
38034214|NCT02793622|69720768|FG001|Overall Study|Protocol Violation|5|||
38034215|NCT04493931|69720781|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
38034216|NCT04493931|69720782|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
38034217|NCT04493931|69720783|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
38034218|NCT04493931|69720784|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
38034219|NCT04493931|69720785|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
38034220|NCT04493931|69720786|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
38034221|NCT04493931|69720787|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
38034222|NCT04493931|69720781|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
38034223|NCT04493931|69720782|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
38034224|NCT04493931|69720783|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
38034225|NCT04493931|69720784|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
38034226|NCT04493931|69720785|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
38034227|NCT04493931|69720786|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
38034228|NCT04493931|69720787|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
38034229|NCT04493931|69720781|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
38034230|NCT04493931|69720782|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
38034231|NCT04493931|69720783|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
37932612|NCT00755222|69619491|FG001|Overall Study|Protocol Violation|0|||
37932613|NCT00441727|69619500|FG000|Overall Study|Protocol Violation|19|||
37932614|NCT00441727|69619501|FG001|Overall Study|Protocol Violation|28|||
37932615|NCT00441727|69619502|FG002|Overall Study|Protocol Violation|32|||
37932616|NCT00441727|69619500|FG000|Overall Study|Adverse Event|26|||
37932617|NCT00441727|69619501|FG001|Overall Study|Adverse Event|33|||
37932618|NCT00441727|69619502|FG002|Overall Study|Adverse Event|28|||
37932619|NCT00441727|69619500|FG000|Overall Study|Lack of Efficacy|7|||
37932620|NCT00441727|69619501|FG001|Overall Study|Lack of Efficacy|8|||
37932621|NCT00441727|69619502|FG002|Overall Study|Lack of Efficacy|48|||
37932622|NCT00441727|69619500|FG000|Overall Study|Withdrawal by Subject|40|||
37932623|NCT00441727|69619501|FG001|Overall Study|Withdrawal by Subject|34|||
37932624|NCT00441727|69619502|FG002|Overall Study|Withdrawal by Subject|47|||
37932625|NCT00441727|69619500|FG000|Overall Study|Lost to Follow-up|5|||
37932626|NCT00441727|69619501|FG001|Overall Study|Lost to Follow-up|6|||
37932627|NCT00441727|69619502|FG002|Overall Study|Lost to Follow-up|5|||
37932628|NCT00441727|69619500|FG000|Overall Study|Safety Reasons|3|||
37932629|NCT00441727|69619501|FG001|Overall Study|Safety Reasons|1|||
37932630|NCT00441727|69619502|FG002|Overall Study|Safety Reasons|3|||
37932631|NCT00441727|69619500|FG000|Overall Study|Various reason specified|6|||
37932632|NCT00441727|69619501|FG001|Overall Study|Various reason specified|8|||
37932633|NCT00441727|69619502|FG002|Overall Study|Various reason specified|5|||
37932634|NCT00770120|69619524|FG000|Overall Study|Progression|31|||
37932635|NCT00770120|69619524|FG000|Overall Study|Adverse Event|11|||
37932636|NCT00770120|69619524|FG000|Overall Study|Not Protocol Specified|11|||
37932637|NCT00770120|69619524|FG000|Overall Study|Death|3|||
37932638|NCT00770120|69619524|FG000|Overall Study|Withdrawal by Subject|2|||
37932639|NCT00770120|69619524|FG000|Overall Study|Ineligible|1|||
37932640|NCT00770120|69619524|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
37932641|NCT00770120|69619524|FG000|Overall Study|Reason under Review|1|||
37932642|NCT00436345|69619531|FG000|Overall Study|ICU resident beyond follow-up period|3|||
37932643|NCT00436345|69619532|FG001|Overall Study|ICU resident beyond follow-up period|0|||
37932644|NCT00769184|69619539|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
37932645|NCT00769184|69619540|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
37932646|NCT00769184|69619539|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
38034232|NCT04493931|69720784|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
38043557|NCT02927262|69731711|FG000|Overall Study|Death|1|||
38034233|NCT04493931|69720785|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
38034234|NCT04493931|69720786|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
38034235|NCT04493931|69720787|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
38034236|NCT04493931|69720781|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
38034237|NCT04493931|69720782|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
38034238|NCT04493931|69720783|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
38034239|NCT04493931|69720784|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
38034240|NCT04493931|69720785|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
38034241|NCT04493931|69720786|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
38034242|NCT04493931|69720787|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
38034243|NCT03437278|69720820|FG000|Overall Study|Adverse Event|0|||
38034244|NCT03437278|69720821|FG001|Overall Study|Adverse Event|0|||
38034245|NCT03437278|69720822|FG002|Overall Study|Adverse Event|1|||
38034246|NCT03437278|69720820|FG000|Overall Study|Progressive disease|1|||
38034247|NCT03437278|69720821|FG001|Overall Study|Progressive disease|0|||
38034248|NCT03437278|69720822|FG002|Overall Study|Progressive disease|0|||
38034249|NCT03437278|69720820|FG000|Overall Study|Physician Decision|1|||
38034250|NCT03437278|69720821|FG001|Overall Study|Physician Decision|0|||
38034251|NCT03437278|69720822|FG002|Overall Study|Physician Decision|1|||
38034252|NCT04553913|69720832|FG000|Overall Study|patient's block resolved prior to PACU|1|||
38034253|NCT04553913|69720832|FG000|Overall Study|did not use the device properly|5|||
38034254|NCT04490499|69720837|FG000|Overall Study|Withdrawal by Subject|2|||
38034255|NCT01332994|69720841|FG000|Overall Study|Adverse Event|34|||
38034256|NCT01332994|69720841|FG000|Overall Study|Death|1|||
38034257|NCT01332994|69720841|FG000|Overall Study|Lack of Efficacy|1|||
38034258|NCT01332994|69720841|FG000|Overall Study|Lost to Follow-up|4|||
38034259|NCT01332994|69720841|FG000|Overall Study|Protocol Violation|6|||
38034260|NCT01332994|69720841|FG000|Overall Study|Withdrawal by Subject|15|||
38034261|NCT01332994|69720841|FG000|Overall Study|Administrative Problem|2|||
38034262|NCT01332994|69720841|FG000|Overall Study|Other|8|||
38034263|NCT03698331|69720847|FG000|Overall Study|Adverse Event|2|||
38034264|NCT03698331|69720848|FG001|Overall Study|Adverse Event|3|||
38034265|NCT03698331|69720847|FG000|Overall Study|Withdrawal by Subject|1|||
38034266|NCT03698331|69720848|FG001|Overall Study|Withdrawal by Subject|1|||
38034267|NCT03698331|69720847|FG000|Overall Study|Lost to Follow-up|0|||
38034268|NCT03698331|69720848|FG001|Overall Study|Lost to Follow-up|2|||
38034269|NCT03698331|69720847|FG000|Overall Study|Non-compliance with study drug|1|||
38034270|NCT03698331|69720848|FG001|Overall Study|Non-compliance with study drug|0|||
38034271|NCT04889625|69720854|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
38034272|NCT04889625|69720855|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
38034273|NCT04889625|69720854|FG000|Period 1|Subject out of window|0|||
38034274|NCT04889625|69720855|FG001|Period 1|Subject out of window|1|||
38034275|NCT04889625|69720854|FG000|Period 1|Wrong add power dispensed|0|||
38034276|NCT04889625|69720855|FG001|Period 1|Wrong add power dispensed|1|||
38034277|NCT04889625|69720854|FG000|Period 1|Discontinued due to fitting guide error|1|||
38034278|NCT04889625|69720855|FG001|Period 1|Discontinued due to fitting guide error|1|||
38034279|NCT04889625|69720854|FG000|Period 2|Test article no longer available|1|||
38034280|NCT04889625|69720855|FG001|Period 2|Test article no longer available|0|||
38034281|NCT04889625|69720854|FG000|Period 2|Incorrect lens dispensed|1|||
38034282|NCT04889625|69720855|FG001|Period 2|Incorrect lens dispensed|0|||
38034283|NCT04889625|69720854|FG000|Period 2|Wrong add power dispensed|0|||
38034284|NCT04889625|69720855|FG001|Period 2|Wrong add power dispensed|1|||
38034285|NCT04883541|69720863|FG000|Overall Study|Not attending regular yoga class|16|||
38034286|NCT04883541|69720864|FG001|Overall Study|Not attending regular yoga class|0|||
38034287|NCT04883541|69720863|FG000|Overall Study|Not attending the pregnancy school|0|||
38034288|NCT04883541|69720864|FG001|Overall Study|Not attending the pregnancy school|9|||
38034289|NCT04882995|69720872|FG000|Overall Study|Withdrawal by Subject|1|||
38034290|NCT04882995|69720873|FG001|Overall Study|Withdrawal by Subject|2|||
38034291|NCT04882995|69720872|FG000|Overall Study|Protocol Violation|4|||
38034292|NCT04882995|69720873|FG001|Overall Study|Protocol Violation|4|||
38034293|NCT04882995|69720872|FG000|Overall Study|Surgery postponed due to COVID|1|||
38034294|NCT04882995|69720873|FG001|Overall Study|Surgery postponed due to COVID|1|||
38034295|NCT04483011|69720881|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
38034296|NCT04483011|69720882|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
38034297|NCT04545567|69720892|FG000|Overall Study|tested positive for SARS-co-V2|1|||
38034298|NCT04545567|69720893|FG001|Overall Study|tested positive for SARS-co-V2|1|||
38034299|NCT04545567|69720892|FG000|Overall Study|Withdrawal by Subject|0|||
38034300|NCT04545567|69720893|FG001|Overall Study|Withdrawal by Subject|1|||
38034301|NCT04534491|69720899|FG000|Overall Study|Not completed end-of-study interview|24|||
38034302|NCT04534491|69720899|FG000|Overall Study|Non-users|70|||
38034303|NCT04534491|69720899|FG000|Overall Study|Non-verifiable users|58|||
38034304|NCT03694821|69720906|FG000|Overall Study|Study terminated|4|||
38034305|NCT03694821|69720907|FG001|Overall Study|Study terminated|8|||
38034306|NCT03694821|69720908|FG002|Overall Study|Study terminated|4|||
38034307|NCT04531527|69720916|FG000|Overall Study|Found to be Ineligible|3|||
38034308|NCT04474197|69720924|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
38034309|NCT04474197|69720925|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
38034310|NCT04474197|69720926|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
38034311|NCT04474197|69720927|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
38034312|NCT02079766|69720944|FG000|Overall Study|Physician Decision|1|||
38034313|NCT02079766|69720945|FG001|Overall Study|Physician Decision|0|||
38034314|NCT02079766|69720944|FG000|Overall Study|Withdrawal by Subject|1|||
38034315|NCT02079766|69720945|FG001|Overall Study|Withdrawal by Subject|0|||
38034316|NCT04841577|69720953|FG000|Overall Study|Adverse Event|5|||
38034317|NCT04841577|69720954|FG001|Overall Study|Adverse Event|10|||
38034318|NCT04841577|69720953|FG000|Overall Study|Lost to Follow-up|8|||
38034319|NCT04841577|69720954|FG001|Overall Study|Lost to Follow-up|7|||
38034320|NCT04841577|69720953|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
38034321|NCT04841577|69720954|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
38034322|NCT04841577|69720953|FG000|Overall Study|Other|0|||
38034323|NCT04841577|69720954|FG001|Overall Study|Other|1|||
38034324|NCT04529109|69720960|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
38034325|NCT04529109|69720961|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
38034326|NCT04528641|69720973|FG000|Overall Study|Withdrawal by Subject|0|||
38034327|NCT04528641|69720974|FG001|Overall Study|Withdrawal by Subject|0|||
38034328|NCT04528641|69720975|FG002|Overall Study|Withdrawal by Subject|0|||
38034329|NCT04528641|69720976|FG003|Overall Study|Withdrawal by Subject|1|||
38034330|NCT04528641|69720977|FG004|Overall Study|Withdrawal by Subject|0|||
38034331|NCT04528641|69720978|FG005|Overall Study|Withdrawal by Subject|1|||
38034332|NCT04527471|69720997|FG000|Overall Study|Adverse Event|1|||
38034333|NCT04527471|69720998|FG001|Overall Study|Adverse Event|0|||
38034334|NCT04527471|69720997|FG000|Overall Study|Lost to Follow-up|1|||
38034335|NCT04527471|69720998|FG001|Overall Study|Lost to Follow-up|0|||
38034336|NCT04471935|69721004|FG000|Overall Study|Withdrawal by Subject|1|||
38034337|NCT04471935|69721004|FG000|Overall Study|Deemed ineligible to participate|1|||
38034338|NCT04468347|69721012|FG000|Overall Study|Withdrawal by Subject|0|||
38034339|NCT04468347|69721013|FG001|Overall Study|Withdrawal by Subject|1|||
38034340|NCT04468347|69721014|FG002|Overall Study|Withdrawal by Subject|3|||
37932647|NCT00769184|69619540|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
37932648|NCT00769184|69619539|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
37932649|NCT00769184|69619540|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
37932650|NCT00768560|69619554|FG000|Intervention Set 1|Adverse Event|0|||
37932651|NCT00768560|69619555|FG001|Intervention Set 1|Adverse Event|1|||
37932652|NCT00768560|69619556|FG002|Intervention Set 1|Adverse Event|0|||
37932653|NCT00768560|69619557|FG003|Intervention Set 1|Adverse Event|0|||
37932654|NCT00768560|69619558|FG004|Intervention Set 1|Adverse Event|0|||
37932655|NCT00768560|69619559|FG005|Intervention Set 1|Adverse Event|0|||
37932656|NCT00468559|69619569|FG000|Open-label Treatment Phase|Adverse Event|5|||
37932657|NCT00468559|69619570|FG001|Open-label Treatment Phase|Adverse Event|0|||
37932658|NCT00468559|69619571|FG002|Open-label Treatment Phase|Adverse Event|0|||
37932659|NCT00468559|69619569|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
37932660|NCT00468559|69619570|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
37932661|NCT00468559|69619571|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
37932662|NCT00468559|69619569|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
37932663|NCT00468559|69619570|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
37932664|NCT00468559|69619571|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
37932665|NCT00468559|69619569|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
37932666|NCT00468559|69619570|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
37932667|NCT00468559|69619571|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
37932668|NCT00468559|69619569|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
37932669|NCT00468559|69619570|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
37932670|NCT00468559|69619571|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
37932671|NCT00754442|69619581|FG000|Overall Study|Withdrawal by Subject|5|||
37932672|NCT00754442|69619582|FG001|Overall Study|Withdrawal by Subject|3|||
38034341|NCT04468347|69721015|FG003|Overall Study|Withdrawal by Subject|3|||
38034342|NCT04468347|69721012|FG000|Overall Study|Lost to Follow-up|0|||
38034343|NCT04468347|69721013|FG001|Overall Study|Lost to Follow-up|0|||
38034344|NCT04468347|69721014|FG002|Overall Study|Lost to Follow-up|1|||
38034345|NCT04468347|69721015|FG003|Overall Study|Lost to Follow-up|1|||
37932673|NCT00754052|69619591|FG000|Overall Study|Study terminated by Sponsor|5|||
38034346|NCT04468347|69721012|FG000|Overall Study|Physician Decision|1|||
38034347|NCT04468347|69721013|FG001|Overall Study|Physician Decision|0|||
38034348|NCT04468347|69721014|FG002|Overall Study|Physician Decision|2|||
38034349|NCT04468347|69721015|FG003|Overall Study|Physician Decision|0|||
38034350|NCT04468347|69721012|FG000|Overall Study|Protocol Violation|1|||
37932674|NCT00754052|69619592|FG001|Overall Study|Study terminated by Sponsor|3|||
38034351|NCT04468347|69721013|FG001|Overall Study|Protocol Violation|0|||
38034352|NCT04468347|69721014|FG002|Overall Study|Protocol Violation|0|||
38034353|NCT04468347|69721015|FG003|Overall Study|Protocol Violation|0|||
38034354|NCT04822701|69721031|FG000|Overall Study|Not treated|2|||
38034355|NCT04822701|69721032|FG001|Overall Study|Not treated|0|||
38034356|NCT04822701|69721031|FG000|Overall Study|Lost to Follow-up|1|||
38034357|NCT04822701|69721032|FG001|Overall Study|Lost to Follow-up|0|||
38034358|NCT04822701|69721031|FG000|Overall Study|Withdrawal by Subject|1|||
38034359|NCT04822701|69721032|FG001|Overall Study|Withdrawal by Subject|0|||
38034360|NCT04461795|69721038|FG000|Overall Study|Lost to Follow-up|2|||
38034361|NCT04461795|69721038|FG000|Overall Study|Withdrawal by Subject|2|||
38034362|NCT04461795|69721038|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
38034363|NCT04461015|69721045|FG000|Overall Study|IV access lost during the study|0|||
38034364|NCT04461015|69721046|FG001|Overall Study|IV access lost during the study|1|||
38034365|NCT04461015|69721045|FG000|Overall Study|Withdrawal by Subject|0|||
38034366|NCT04461015|69721046|FG001|Overall Study|Withdrawal by Subject|1|||
38034367|NCT04810221|69721052|FG000|Overall Study|Physician Decision|3|||
38034368|NCT03694353|69721056|FG000|Overall Study|Withdrawal by Subject|1|||
38034369|NCT03694353|69721056|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
38034370|NCT04521777|69721060|FG000|Overall Study|Death|2|||
38034371|NCT04521777|69721060|FG000|Overall Study|Withdrawal by Subject|2|||
38034372|NCT03700671|69721066|FG000|Overall Study|Lack of Efficacy|1|||
38034373|NCT03700671|69721067|FG001|Overall Study|Lack of Efficacy|2|||
38034374|NCT04764669|69721079|FG000|Overall Study|Adverse Event|1|||
38034375|NCT04764669|69721080|FG001|Overall Study|Adverse Event|0|||
38034376|NCT04764669|69721081|FG002|Overall Study|Adverse Event|1|||
38034377|NCT04764669|69721082|FG003|Overall Study|Adverse Event|0|||
38034378|NCT04764669|69721079|FG000|Overall Study|Subject Choice|0|||
38034379|NCT04764669|69721080|FG001|Overall Study|Subject Choice|0|||
38034380|NCT04764669|69721081|FG002|Overall Study|Subject Choice|1|||
38034381|NCT04764669|69721082|FG003|Overall Study|Subject Choice|0|||
38034382|NCT04764669|69721079|FG000|Overall Study|Withdrawal by Subject|2|||
38034383|NCT04764669|69721080|FG001|Overall Study|Withdrawal by Subject|0|||
38034384|NCT04764669|69721081|FG002|Overall Study|Withdrawal by Subject|0|||
38034385|NCT04764669|69721082|FG003|Overall Study|Withdrawal by Subject|0|||
38034386|NCT04439253|69721092|FG000|Overall Study|Adverse Event|1|||
38034387|NCT04439253|69721092|FG000|Overall Study|Disease progression|2|||
38034388|NCT04439253|69721092|FG000|Overall Study|Complicating disease|1|||
38034389|NCT04438785|69721098|FG000|Overall Study|change of weight, give up intervention|2|||
38034390|NCT04438785|69721099|FG001|Overall Study|change of weight, give up intervention|10|||
38034391|NCT04741503|69721107|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
38034392|NCT04741503|69721108|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
38034393|NCT04741503|69721109|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
38034394|NCT04741503|69721107|FG000|Initial Enrollment|Overquotas removed|0|||
38034395|NCT04741503|69721108|FG001|Initial Enrollment|Overquotas removed|0|||
38034396|NCT04741503|69721109|FG002|Initial Enrollment|Overquotas removed|186|||
38034397|NCT04741503|69721107|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
38034398|NCT04741503|69721108|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
38034399|NCT04741503|69721109|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
38034400|NCT04734873|69721118|FG000|Overall Study|Lost to Follow-up|1|||
38034401|NCT04734873|69721119|FG001|Overall Study|Lost to Follow-up|3|||
38034402|NCT04734873|69721120|FG002|Overall Study|Lost to Follow-up|2|||
38034403|NCT04734873|69721118|FG000|Overall Study|Randomized but not dosed|1|||
38034404|NCT04734873|69721119|FG001|Overall Study|Randomized but not dosed|0|||
38034405|NCT04734873|69721120|FG002|Overall Study|Randomized but not dosed|1|||
38034406|NCT04435665|69721132|FG000|Overall Study|Lost to Follow-up|0|||
38034407|NCT04435665|69721133|FG001|Overall Study|Lost to Follow-up|0|||
38034408|NCT04435665|69721134|FG002|Overall Study|Lost to Follow-up|0|||
38034409|NCT04435665|69721135|FG003|Overall Study|Lost to Follow-up|1|||
38034410|NCT04428411|69721145|FG000|Overall Study|Lost to Follow-up|114|||
38034411|NCT04422561|69721154|FG000|Overall Study|Lost to Follow-up|25|||
38034412|NCT04422561|69721155|FG001|Overall Study|Lost to Follow-up|11|||
38034413|NCT01369498|69721165|FG000|Overall Study|Lack of Efficacy|9|||
38034414|NCT01369498|69721166|FG001|Overall Study|Lack of Efficacy|9|||
38034415|NCT01369498|69721167|FG002|Overall Study|Lack of Efficacy|1|||
38034416|NCT01369498|69721168|FG003|Overall Study|Lack of Efficacy|3|||
38034417|NCT01369498|69721165|FG000|Overall Study|Adverse Event|1|||
38034418|NCT01369498|69721166|FG001|Overall Study|Adverse Event|2|||
38034419|NCT01369498|69721167|FG002|Overall Study|Adverse Event|0|||
38034420|NCT01369498|69721168|FG003|Overall Study|Adverse Event|1|||
38034421|NCT01369498|69721165|FG000|Overall Study|Withdrawal of Consent|0|||
38034422|NCT01369498|69721166|FG001|Overall Study|Withdrawal of Consent|1|||
38034423|NCT01369498|69721167|FG002|Overall Study|Withdrawal of Consent|1|||
38034424|NCT01369498|69721168|FG003|Overall Study|Withdrawal of Consent|1|||
38034425|NCT01369498|69721165|FG000|Overall Study|Death|0|||
38034426|NCT01369498|69721166|FG001|Overall Study|Death|0|||
38034427|NCT01369498|69721167|FG002|Overall Study|Death|1|||
38034428|NCT01369498|69721168|FG003|Overall Study|Death|0|||
38034429|NCT01369498|69721165|FG000|Overall Study|Investigator's Discretion|1|||
38034430|NCT01369498|69721166|FG001|Overall Study|Investigator's Discretion|0|||
38034431|NCT01369498|69721167|FG002|Overall Study|Investigator's Discretion|1|||
38034432|NCT01369498|69721168|FG003|Overall Study|Investigator's Discretion|3|||
38034433|NCT01369498|69721165|FG000|Overall Study|Unknown Reason|1|||
38034434|NCT01369498|69721166|FG001|Overall Study|Unknown Reason|0|||
38034435|NCT01369498|69721167|FG002|Overall Study|Unknown Reason|11|||
38034436|NCT01369498|69721168|FG003|Overall Study|Unknown Reason|6|||
38034437|NCT01369498|69721165|FG000|Overall Study|Disease Progression|0|||
38034438|NCT01369498|69721166|FG001|Overall Study|Disease Progression|0|||
38034439|NCT01369498|69721167|FG002|Overall Study|Disease Progression|0|||
38034440|NCT01369498|69721168|FG003|Overall Study|Disease Progression|1|||
38034441|NCT04709835|69721182|FG000|Overall Study|Withdrawal by Subject|0|||
38034442|NCT04709835|69721183|FG001|Overall Study|Withdrawal by Subject|1|||
38034443|NCT04709835|69721184|FG002|Overall Study|Withdrawal by Subject|0|||
38034444|NCT04407507|69721198|FG000|Overall Study|Withdrawal by Subject|0|||
38034445|NCT04407507|69721199|FG001|Overall Study|Withdrawal by Subject|1|||
38034446|NCT04698993|69721207|FG000|Overall Study|PCR results not accessible|2|||
38034447|NCT04698993|69721208|FG001|Overall Study|PCR results not accessible|7|||
38034448|NCT04698993|69721207|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
38034449|NCT04698993|69721208|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
38034450|NCT04359771|69721216|FG000|Overall Study|Lack of Efficacy|2|||
38034451|NCT04359771|69721217|FG001|Overall Study|Lack of Efficacy|2|||
38034452|NCT04356573|69721225|FG000|Overall Study|Didn't Qualify|1|||
38034453|NCT04356573|69721226|FG001|Overall Study|Didn't Qualify|0|||
38034454|NCT04352127|69721242|FG000|Overall Study|Unable to obtain readings|4|||
38034455|NCT04352127|69721243|FG001|Overall Study|Unable to obtain readings|1|||
38034456|NCT04351269|69721252|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
38034457|NCT04351269|69721253|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
38034458|NCT04351269|69721254|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
38034459|NCT04351269|69721252|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
38034460|NCT04351269|69721253|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
38034461|NCT04351269|69721254|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
38034462|NCT04351269|69721252|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
38034463|NCT04351269|69721253|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
38034464|NCT04351269|69721254|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
38034465|NCT04351269|69721252|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
38034466|NCT04351269|69721253|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
38034467|NCT04351269|69721254|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
38034468|NCT04351269|69721252|FG000|Overall Study|Lost to Follow-up|1|||
38034469|NCT04351269|69721253|FG001|Overall Study|Lost to Follow-up|3|||
38034470|NCT04351269|69721254|FG002|Overall Study|Lost to Follow-up|0|||
38034471|NCT04348851|69721269|FG000|Post-Test 1|Withdrawal by Subject|0|||
38034472|NCT04348851|69721270|FG001|Post-Test 1|Withdrawal by Subject|1|||
38034473|NCT04348851|69721271|FG002|Post-Test 1|Withdrawal by Subject|0|||
38034474|NCT04348851|69721272|FG003|Post-Test 1|Withdrawal by Subject|0|||
38034475|NCT04348851|69721269|FG000|Post-Test 1|Lost to Follow-up|0|||
38034476|NCT04348851|69721270|FG001|Post-Test 1|Lost to Follow-up|1|||
38034477|NCT04348851|69721271|FG002|Post-Test 1|Lost to Follow-up|0|||
38034478|NCT04348851|69721272|FG003|Post-Test 1|Lost to Follow-up|0|||
38034479|NCT04348851|69721269|FG000|Post-Test 2|Stroke survivor death|0|||
38034480|NCT04348851|69721270|FG001|Post-Test 2|Stroke survivor death|1|||
38034481|NCT04348851|69721271|FG002|Post-Test 2|Stroke survivor death|0|||
38034482|NCT04348851|69721272|FG003|Post-Test 2|Stroke survivor death|1|||
38034483|NCT04346199|69721284|FG000|Overall Study|Death|8|||
38034484|NCT04346199|69721285|FG001|Overall Study|Death|9|||
38034485|NCT04346199|69721284|FG000|Overall Study|Lost to Follow-up|0|||
38034486|NCT04346199|69721285|FG001|Overall Study|Lost to Follow-up|1|||
38034487|NCT04346199|69721284|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
38034488|NCT04346199|69721285|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
38034489|NCT04346199|69721284|FG000|Overall Study|Withdrawal by Subject|5|||
38034490|NCT04346199|69721285|FG001|Overall Study|Withdrawal by Subject|1|||
38034491|NCT04345653|69721291|FG000|Overall Study|Withdrawal by Subject|2|||
38034492|NCT04342689|69721298|FG000|Overall Study|Withdrawal by Subject|32|||
38034493|NCT04342689|69721299|FG001|Overall Study|Withdrawal by Subject|33|||
38034494|NCT04342689|69721298|FG000|Overall Study|Lost to Follow-up|10|||
38034495|NCT04342689|69721299|FG001|Overall Study|Lost to Follow-up|12|||
38034496|NCT04169061|69721307|FG000|Overall Study|Adverse Event|2|||
38034497|NCT04169061|69721307|FG000|Overall Study|Death|1|||
38034498|NCT04169061|69721307|FG000|Overall Study|Withdrawal by Subject|1|||
38034499|NCT04169061|69721307|FG000|Overall Study|Protocol Violation|1|||
38034500|NCT02792218|69721313|FG000|Overall Study|Patient/guardian decision|15|||
38034501|NCT02792218|69721314|FG001|Overall Study|Patient/guardian decision|42|||
38034502|NCT02792218|69721313|FG000|Overall Study|Adverse Event|15|||
38034503|NCT02792218|69721314|FG001|Overall Study|Adverse Event|14|||
38034504|NCT02792218|69721313|FG000|Overall Study|Lost to Follow-up|10|||
38034505|NCT02792218|69721314|FG001|Overall Study|Lost to Follow-up|5|||
38034506|NCT02792218|69721313|FG000|Overall Study|Lack of Efficacy|1|||
38034507|NCT02792218|69721314|FG001|Overall Study|Lack of Efficacy|12|||
38034508|NCT02792218|69721313|FG000|Overall Study|Physician Decision|4|||
38034509|NCT02792218|69721314|FG001|Overall Study|Physician Decision|4|||
38034510|NCT02792218|69721313|FG000|Overall Study|Protocol deviation|3|||
38034511|NCT02792218|69721314|FG001|Overall Study|Protocol deviation|2|||
38034512|NCT02792218|69721313|FG000|Overall Study|New therapy for study indication|0|||
38034513|NCT02792218|69721314|FG001|Overall Study|New therapy for study indication|1|||
38034514|NCT02792218|69721313|FG000|Overall Study|Non-compliance with study treatment|0|||
38034515|NCT02792218|69721314|FG001|Overall Study|Non-compliance with study treatment|1|||
38034516|NCT02792218|69721313|FG000|Overall Study|Pregnancy|1|||
38034517|NCT02792218|69721314|FG001|Overall Study|Pregnancy|0|||
38034518|NCT00153101|69721325|FG000|Overall Study|Lost to Follow-up|14|||
38034519|NCT00153101|69721326|FG001|Overall Study|Lost to Follow-up|14|||
38034520|NCT00153101|69721327|FG002|Overall Study|Lost to Follow-up|12|||
38034521|NCT00153101|69721328|FG003|Overall Study|Lost to Follow-up|5|||
38034522|NCT00153101|69721329|FG004|Overall Study|Lost to Follow-up|5|||
38034523|NCT00153101|69721325|FG000|Overall Study|Withdrawal by Subject|3|||
38034524|NCT00153101|69721326|FG001|Overall Study|Withdrawal by Subject|4|||
38034525|NCT00153101|69721327|FG002|Overall Study|Withdrawal by Subject|3|||
38034526|NCT00153101|69721328|FG003|Overall Study|Withdrawal by Subject|3|||
38034527|NCT00153101|69721329|FG004|Overall Study|Withdrawal by Subject|5|||
38034528|NCT04401579|69721345|FG000|Overall Study|Death|23|||
38034529|NCT04401579|69721346|FG001|Overall Study|Death|36|||
38034530|NCT04401579|69721345|FG000|Overall Study|Lost to Follow-up|40|||
38034531|NCT04401579|69721346|FG001|Overall Study|Lost to Follow-up|41|||
38034532|NCT04401579|69721345|FG000|Overall Study|Withdrawal by Subject|8|||
38034533|NCT04401579|69721346|FG001|Overall Study|Withdrawal by Subject|16|||
38034534|NCT04401579|69721345|FG000|Overall Study|Physician Decision|1|||
38034535|NCT04401579|69721346|FG001|Overall Study|Physician Decision|2|||
38034536|NCT04401579|69721345|FG000|Overall Study|Became ineligible after enrollment|1|||
38034537|NCT04401579|69721346|FG001|Overall Study|Became ineligible after enrollment|1|||
38034538|NCT04401579|69721345|FG000|Overall Study|Enrolled but treatment not administered|7|||
38034539|NCT04401579|69721346|FG001|Overall Study|Enrolled but treatment not administered|9|||
38034540|NCT04401579|69721345|FG000|Overall Study|Adverse Event|2|||
38034541|NCT04401579|69721346|FG001|Overall Study|Adverse Event|1|||
38034542|NCT04401579|69721345|FG000|Overall Study|Scheduling error|1|||
38034543|NCT04401579|69721346|FG001|Overall Study|Scheduling error|2|||
38034544|NCT04401579|69721345|FG000|Overall Study|Transferred to another hospital|1|||
38034545|NCT04401579|69721346|FG001|Overall Study|Transferred to another hospital|2|||
38034546|NCT04161807|69721352|FG000|Overall Study|Withdrawal by Subject|2|||
38034547|NCT04161807|69721352|FG000|Overall Study|Performed only 1 treatment|2|||
38034548|NCT04401423|69721358|FG000|Overall Study|Withdrawal by Subject|3|||
38034549|NCT04401423|69721359|FG001|Overall Study|Withdrawal by Subject|1|||
38034550|NCT04401423|69721358|FG000|Overall Study|Physician Decision|2|||
38034551|NCT04401423|69721359|FG001|Overall Study|Physician Decision|1|||
38034552|NCT04399161|69721370|FG000|Overall Study|Withdrawal by Subject|1|||
38034553|NCT04399161|69721371|FG001|Overall Study|Withdrawal by Subject|0|||
38034554|NCT04399161|69721372|FG002|Overall Study|Withdrawal by Subject|2|||
38034555|NCT04399161|69721370|FG000|Overall Study|Protocol Violation|1|||
38034556|NCT04399161|69721371|FG001|Overall Study|Protocol Violation|2|||
38034557|NCT04399161|69721372|FG002|Overall Study|Protocol Violation|0|||
38034558|NCT02076178|69721382|FG000|Oral Phase|Adverse Event|0|||
38034559|NCT02076178|69721383|FG001|Oral Phase|Adverse Event|7|||
38034560|NCT02076178|69721382|FG000|Oral Phase|Withdrawal by Subject|0|||
38034561|NCT02076178|69721383|FG001|Oral Phase|Withdrawal by Subject|4|||
38034562|NCT02076178|69721382|FG000|Oral Phase|Physician Decision|0|||
38034563|NCT02076178|69721383|FG001|Oral Phase|Physician Decision|1|||
38034564|NCT02076178|69721382|FG000|Injection Phase|Protocol defined stopping criteria|1|||
38034565|NCT02076178|69721383|FG001|Injection Phase|Protocol defined stopping criteria|0|||
38034566|NCT02076178|69721382|FG000|Injection Phase|Withdrawal by Subject|0|||
38034567|NCT02076178|69721383|FG001|Injection Phase|Withdrawal by Subject|3|||
38034568|NCT02076178|69721382|FG000|Injection Phase|Physician Decision|0|||
38034569|NCT02076178|69721383|FG001|Injection Phase|Physician Decision|3|||
38034570|NCT02076178|69721382|FG000|Injection Phase|Lost to Follow-up|0|||
38034571|NCT02076178|69721383|FG001|Injection Phase|Lost to Follow-up|1|||
38034572|NCT04160091|69721395|FG000|Overall Study|Terminated by Sponsor|7|||
38034573|NCT04160091|69721396|FG001|Overall Study|Terminated by Sponsor|3|||
38034574|NCT04160091|69721397|FG002|Overall Study|Terminated by Sponsor|5|||
38034575|NCT04160091|69721398|FG003|Overall Study|Terminated by Sponsor|2|||
38034576|NCT04160091|69721395|FG000|Overall Study|Noncompliance|0|||
38034577|NCT04160091|69721396|FG001|Overall Study|Noncompliance|0|||
38034578|NCT04160091|69721397|FG002|Overall Study|Noncompliance|0|||
38034579|NCT04160091|69721398|FG003|Overall Study|Noncompliance|1|||
38034580|NCT04160091|69721395|FG000|Overall Study|Withdrawal by Subject|0|||
38034581|NCT04160091|69721396|FG001|Overall Study|Withdrawal by Subject|0|||
38034582|NCT04160091|69721397|FG002|Overall Study|Withdrawal by Subject|0|||
38034583|NCT04160091|69721398|FG003|Overall Study|Withdrawal by Subject|1|||
38034584|NCT00149825|69721410|FG000|Overall Study|Intolerance to medication side effects|1|||
38034585|NCT00149825|69721411|FG001|Overall Study|Intolerance to medication side effects|2|||
38034586|NCT00149825|69721410|FG000|Overall Study|Time commitments|2|||
38034587|NCT00149825|69721411|FG001|Overall Study|Time commitments|1|||
38034588|NCT00149825|69721410|FG000|Overall Study|Not liking insomnia therapy|1|||
38034589|NCT00149825|69721411|FG001|Overall Study|Not liking insomnia therapy|0|||
38034590|NCT00149825|69721410|FG000|Overall Study|Other|1|||
38034591|NCT00149825|69721411|FG001|Overall Study|Other|0|||
38034592|NCT04397757|69721419|FG000|Overall Study|Death|3|||
38034593|NCT04397757|69721420|FG001|Overall Study|Death|11|||
38034594|NCT04397757|69721419|FG000|Overall Study|Withdrawal by Subject|2|||
38034595|NCT04397757|69721420|FG001|Overall Study|Withdrawal by Subject|0|||
38034596|NCT04397757|69721419|FG000|Overall Study|Lost to Follow-up|4|||
38034597|NCT04397757|69721420|FG001|Overall Study|Lost to Follow-up|3|||
38034598|NCT02792062|69721437|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
38034599|NCT02792062|69721438|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
38034600|NCT02792062|69721439|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
38034601|NCT02792062|69721440|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
38034602|NCT02792062|69721441|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
38034603|NCT02792062|69721442|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
38034604|NCT00196937|69721453|FG000|Overall Study|Serious Adverse Event|1|||
38034605|NCT00196937|69721454|FG001|Overall Study|Serious Adverse Event|0|||
38034606|NCT00196937|69721455|FG002|Overall Study|Serious Adverse Event|0|||
38034607|NCT00196937|69721453|FG000|Overall Study|Non-serious adverse event|1|||
38034608|NCT00196937|69721454|FG001|Overall Study|Non-serious adverse event|1|||
38034609|NCT00196937|69721455|FG002|Overall Study|Non-serious adverse event|1|||
38034610|NCT00196937|69721453|FG000|Overall Study|Withdrawal by Subject|0|||
38034611|NCT00196937|69721454|FG001|Overall Study|Withdrawal by Subject|0|||
37668352|NCT02711345|69140875|FG000|Overall Study|Subject/guardian decision|0|||
37668353|NCT02711345|69140876|FG001|Overall Study|Subject/guardian decision|0|||
37668354|NCT02711345|69140877|FG002|Overall Study|Subject/guardian decision|0|||
37668355|NCT02711345|69140878|FG003|Overall Study|Subject/guardian decision|0|||
37668356|NCT02711345|69140879|FG004|Overall Study|Subject/guardian decision|0|||
37668357|NCT02711345|69140880|FG005|Overall Study|Subject/guardian decision|2|||
37668358|NCT02711345|69140881|FG006|Overall Study|Subject/guardian decision|3|||
37668359|NCT02711345|69140882|FG007|Overall Study|Subject/guardian decision|1|||
37668360|NCT02711345|69140883|FG008|Overall Study|Subject/guardian decision|0|||
37668361|NCT02711345|69140884|FG009|Overall Study|Subject/guardian decision|4|||
37668362|NCT02711345|69140875|FG000|Overall Study|Death|1|||
37668363|NCT02711345|69140876|FG001|Overall Study|Death|0|||
37668364|NCT02711345|69140877|FG002|Overall Study|Death|0|||
37668365|NCT02711345|69140878|FG003|Overall Study|Death|0|||
37668366|NCT02711345|69140879|FG004|Overall Study|Death|0|||
37668367|NCT02711345|69140880|FG005|Overall Study|Death|0|||
37668368|NCT02711345|69140881|FG006|Overall Study|Death|0|||
37668369|NCT02711345|69140882|FG007|Overall Study|Death|1|||
37668370|NCT02711345|69140883|FG008|Overall Study|Death|0|||
37668371|NCT02711345|69140884|FG009|Overall Study|Death|0|||
37668372|NCT02581995|69140921|FG000|Overall Study|Unspecified other|3|||
37668373|NCT02581995|69140921|FG000|Overall Study|Adverse Event|6|||
37668374|NCT02581995|69140921|FG000|Overall Study|Lost to Follow-up|5|||
37668375|NCT02581995|69140921|FG000|Overall Study|Withdrawal by participant|12|||
37932675|NCT00747812|69619600|FG000|Overall Study|Research Site Staff Relocation|5|||
37932676|NCT00747812|69619601|FG001|Overall Study|Research Site Staff Relocation|3|||
37932677|NCT02927067|69619609|FG000|Overall Study|Withdrawn Consent|20|||
37932678|NCT02927067|69619610|FG001|Overall Study|Withdrawn Consent|12|||
37668376|NCT02581995|69140921|FG000|Overall Study|Physician Decision|1|||
37668377|NCT02581995|69140921|FG000|Overall Study|Death|4|||
38034612|NCT00196937|69721455|FG002|Overall Study|Withdrawal by Subject|2|||
38034613|NCT00196937|69721453|FG000|Overall Study|Lost to Follow-up|4|||
38034614|NCT00196937|69721454|FG001|Overall Study|Lost to Follow-up|3|||
37932679|NCT02927067|69619609|FG000|Overall Study|Death|18|||
38034615|NCT00196937|69721455|FG002|Overall Study|Lost to Follow-up|3|||
38034616|NCT00196937|69721453|FG000|Overall Study|Other|3|||
38034617|NCT00196937|69721454|FG001|Overall Study|Other|1|||
38034618|NCT00196937|69721455|FG002|Overall Study|Other|1|||
37668378|NCT02577003|69140927|FG000|Overall Study|Adverse Event|2|||
37668379|NCT02577003|69140928|FG001|Overall Study|Adverse Event|4|||
38034619|NCT04397445|69721464|FG000|Overall Study|Withdrawal by Subject|1|||
38034620|NCT04397445|69721465|FG001|Overall Study|Withdrawal by Subject|0|||
38034621|NCT04397445|69721466|FG002|Overall Study|Withdrawal by Subject|0|||
38034622|NCT04397445|69721467|FG003|Overall Study|Withdrawal by Subject|0|||
38034623|NCT00191945|69721484|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
38034624|NCT00191945|69721485|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
38034625|NCT00191945|69721484|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
38034626|NCT00191945|69721485|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
38034627|NCT00191945|69721484|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
38034628|NCT00191945|69721485|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
38034629|NCT00191945|69721484|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
38034630|NCT00191945|69721485|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
38034631|NCT01369342|69721495|FG000|Overall Study|Withdrawal by Subject|7|||
38034632|NCT01369342|69721496|FG001|Overall Study|Withdrawal by Subject|7|||
38034633|NCT01369342|69721497|FG002|Overall Study|Withdrawal by Subject|2|||
38034634|NCT01369342|69721495|FG000|Overall Study|Lost to Follow-up|5|||
38034635|NCT01369342|69721496|FG001|Overall Study|Lost to Follow-up|2|||
38034636|NCT01369342|69721497|FG002|Overall Study|Lost to Follow-up|1|||
38034637|NCT01369342|69721495|FG000|Overall Study|Not Treated|1|||
38034638|NCT01369342|69721496|FG001|Overall Study|Not Treated|0|||
38034639|NCT01369342|69721497|FG002|Overall Study|Not Treated|0|||
38034640|NCT00191477|69721507|FG000|Overall Study|Tumor Recurrence|49|||
38034641|NCT00191477|69721508|FG001|Overall Study|Tumor Recurrence|48|||
38034642|NCT00191477|69721507|FG000|Overall Study|Death, Study Disease|1|||
38034643|NCT00191477|69721508|FG001|Overall Study|Death, Study Disease|1|||
38034644|NCT00191477|69721507|FG000|Overall Study|Death, Other Cause|3|||
38034645|NCT00191477|69721508|FG001|Overall Study|Death, Other Cause|6|||
38034646|NCT00191477|69721507|FG000|Overall Study|Lost to Follow-up|23|||
38034647|NCT00191477|69721508|FG001|Overall Study|Lost to Follow-up|21|||
38034648|NCT00191477|69721507|FG000|Overall Study|Protocol Violation|1|||
38034649|NCT00191477|69721508|FG001|Overall Study|Protocol Violation|1|||
38034650|NCT00191477|69721507|FG000|Overall Study|Treatment Change|2|||
38034651|NCT00191477|69721508|FG001|Overall Study|Treatment Change|0|||
38034652|NCT00191477|69721507|FG000|Overall Study|Withdrawal by Subject|2|||
38034653|NCT00191477|69721508|FG001|Overall Study|Withdrawal by Subject|0|||
38034654|NCT00191477|69721507|FG000|Overall Study|Other|2|||
38034655|NCT00191477|69721508|FG001|Overall Study|Other|0|||
38034656|NCT00191477|69721507|FG000|Overall Study|Not Eligible|41|||
38034657|NCT00191477|69721508|FG001|Overall Study|Not Eligible|38|||
38034658|NCT00191477|69721507|FG000|Overall Study|Pathological Specimen Lost|1|||
38034659|NCT00191477|69721508|FG001|Overall Study|Pathological Specimen Lost|0|||
38034660|NCT00191477|69721507|FG000|Overall Study|Discontinued Prior to Instillation|13|||
38034661|NCT00191477|69721508|FG001|Overall Study|Discontinued Prior to Instillation|14|||
38034662|NCT04320615|69721516|FG000|Overall Study|Withdrawal by Subject|4|||
38034663|NCT04320615|69721517|FG001|Overall Study|Withdrawal by Subject|10|||
38034664|NCT04320615|69721516|FG000|Overall Study|Physician Decision|2|||
38034665|NCT04320615|69721517|FG001|Overall Study|Physician Decision|0|||
38034666|NCT04320615|69721516|FG000|Overall Study|Other|2|||
38034667|NCT04320615|69721517|FG001|Overall Study|Other|0|||
38034668|NCT04320615|69721516|FG000|Overall Study|Lost to Follow-up|5|||
38034669|NCT04320615|69721517|FG001|Overall Study|Lost to Follow-up|23|||
38034670|NCT04320615|69721516|FG000|Overall Study|Death|35|||
37668380|NCT02577003|69140927|FG000|Overall Study|Withdrawal by Subject|0|||
37668381|NCT02577003|69140928|FG001|Overall Study|Withdrawal by Subject|1|||
37668382|NCT02446899|69140936|FG000|Overall Study|Adverse Event|4|||
37932680|NCT02927067|69619610|FG001|Overall Study|Death|31|||
37932681|NCT02927067|69619609|FG000|Overall Study|Adverse Event|13|||
37932682|NCT02927067|69619610|FG001|Overall Study|Adverse Event|10|||
37932683|NCT02927067|69619609|FG000|Overall Study|Noncompliance|5|||
37932684|NCT02927067|69619610|FG001|Overall Study|Noncompliance|2|||
37932685|NCT02927067|69619609|FG000|Overall Study|Reason not Specified|4|||
38034671|NCT04320615|69721517|FG001|Overall Study|Death|71|||
38034672|NCT00149747|69721529|FG000|Overall Study|Death|1|||
38034673|NCT00149747|69721530|FG001|Overall Study|Death|0|||
37668383|NCT02446899|69140937|FG001|Overall Study|Adverse Event|7|||
37668384|NCT02446899|69140936|FG000|Overall Study|Condition Under Investigation Worsened|1|||
37932686|NCT02927067|69619610|FG001|Overall Study|Reason not Specified|6|||
38034674|NCT00149747|69721529|FG000|Overall Study|Withdrawal by Subject|3|||
38034675|NCT00149747|69721530|FG001|Overall Study|Withdrawal by Subject|3|||
38034676|NCT00187889|69721538|FG000|Overall Study|Withdrawal by Subject|6|||
38034677|NCT00187889|69721539|FG001|Overall Study|Withdrawal by Subject|4|||
38034678|NCT00148343|69721548|FG000|Overall Study|Withdrawal by Subject|12|||
38034679|NCT00148343|69721549|FG001|Overall Study|Withdrawal by Subject|7|||
38034680|NCT00148343|69721548|FG000|Overall Study|Physician Decision|3|||
38034681|NCT00148343|69721549|FG001|Overall Study|Physician Decision|4|||
38034682|NCT04150341|69721555|FG000|Overall Study|Physician Decision|0|||
38034683|NCT04150341|69721556|FG001|Overall Study|Physician Decision|0|||
37932687|NCT01751685|69619620|FG000|6-mo Followup|Missed study visit|1|||
38034684|NCT04150341|69721557|FG002|Overall Study|Physician Decision|1|||
38034685|NCT04150341|69721558|FG003|Overall Study|Physician Decision|0|||
38034686|NCT04150341|69721559|FG004|Overall Study|Physician Decision|0|||
38034687|NCT04150341|69721560|FG005|Overall Study|Physician Decision|0|||
38034688|NCT04150341|69721555|FG000|Overall Study|Adverse Event|0|||
38034689|NCT04150341|69721556|FG001|Overall Study|Adverse Event|0|||
38034690|NCT04150341|69721557|FG002|Overall Study|Adverse Event|0|||
38034691|NCT04150341|69721558|FG003|Overall Study|Adverse Event|0|||
38034692|NCT04150341|69721559|FG004|Overall Study|Adverse Event|1|||
38034693|NCT04150341|69721560|FG005|Overall Study|Adverse Event|0|||
38034694|NCT00148109|69721572|FG000|Overall Study|Lack of Efficacy|10|||
38034695|NCT00148109|69721573|FG001|Overall Study|Lack of Efficacy|18|||
38034696|NCT00148109|69721572|FG000|Overall Study|Adverse Event|0|||
38034697|NCT00148109|69721573|FG001|Overall Study|Adverse Event|2|||
38034698|NCT00148109|69721572|FG000|Overall Study|Withdrawal by Subject|2|||
38034699|NCT00148109|69721573|FG001|Overall Study|Withdrawal by Subject|0|||
38034700|NCT00186485|69721579|FG000|Overall Study|Lost to Follow-up|3|||
38034701|NCT00147251|69721585|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
38034702|NCT00147251|69721586|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
38034703|NCT04390191|69721596|FG000|Overall Study|Withdrawal by Subject|1|||
38034704|NCT04390191|69721597|FG001|Overall Study|Withdrawal by Subject|0|||
38034705|NCT04405076|69721609|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
38034706|NCT04405076|69721610|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
38034707|NCT04405076|69721611|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
38034708|NCT04405076|69721612|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
38034709|NCT04405076|69721613|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
38034710|NCT04405076|69721614|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
38034711|NCT04405076|69721615|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
38034712|NCT04405076|69721616|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
38034713|NCT04405076|69721617|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
38034714|NCT04405076|69721609|FG000|Part A (Blinded Phase)|Physician Decision|1|||
38034715|NCT04405076|69721610|FG001|Part A (Blinded Phase)|Physician Decision|2|||
38034716|NCT04405076|69721611|FG002|Part A (Blinded Phase)|Physician Decision|0|||
38034717|NCT04405076|69721612|FG003|Part A (Blinded Phase)|Physician Decision|0|||
38034718|NCT04405076|69721613|FG004|Part A (Blinded Phase)|Physician Decision|0|||
38034719|NCT04405076|69721614|FG005|Part A (Blinded Phase)|Physician Decision|0|||
38034720|NCT04405076|69721615|FG006|Part A (Blinded Phase)|Physician Decision|0|||
38034721|NCT04405076|69721616|FG007|Part A (Blinded Phase)|Physician Decision|0|||
38034722|NCT04405076|69721617|FG008|Part A (Blinded Phase)|Physician Decision|0|||
38034723|NCT04405076|69721609|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
38034724|NCT04405076|69721610|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
38034725|NCT04405076|69721611|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
38034726|NCT04405076|69721612|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
38034727|NCT04405076|69721613|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
38034728|NCT04405076|69721614|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
38034729|NCT04405076|69721615|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
38034730|NCT04405076|69721616|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
38034731|NCT04405076|69721617|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
38034732|NCT04405076|69721609|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
38034733|NCT04405076|69721610|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
38034734|NCT04405076|69721611|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
38034735|NCT04405076|69721612|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
38034736|NCT04405076|69721613|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
38034737|NCT04405076|69721614|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
38034738|NCT04405076|69721615|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
38034739|NCT04405076|69721616|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
38034740|NCT04405076|69721617|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
38034741|NCT04405076|69721609|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
38034742|NCT04405076|69721610|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
38034743|NCT04405076|69721611|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
38034744|NCT04405076|69721612|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
37932688|NCT01751685|69619621|FG001|6-mo Followup|Missed study visit|0|||
37932689|NCT01751685|69619620|FG000|6-mo Followup|Withdrawal by Subject|2|||
37932690|NCT01751685|69619621|FG001|6-mo Followup|Withdrawal by Subject|2|||
38034745|NCT04405076|69721613|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
38034746|NCT04405076|69721614|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
38034747|NCT04405076|69721615|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
38034748|NCT04405076|69721616|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
38034749|NCT04405076|69721617|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
38034750|NCT04405076|69721609|FG000|Part A (Blinded Phase)|Other than Specified|0|||
38034751|NCT04405076|69721610|FG001|Part A (Blinded Phase)|Other than Specified|0|||
38034752|NCT04405076|69721611|FG002|Part A (Blinded Phase)|Other than Specified|3|||
38034753|NCT04405076|69721612|FG003|Part A (Blinded Phase)|Other than Specified|0|||
38034754|NCT04405076|69721613|FG004|Part A (Blinded Phase)|Other than Specified|0|||
38034755|NCT04405076|69721614|FG005|Part A (Blinded Phase)|Other than Specified|0|||
38034756|NCT04405076|69721615|FG006|Part A (Blinded Phase)|Other than Specified|0|||
38034757|NCT04405076|69721616|FG007|Part A (Blinded Phase)|Other than Specified|0|||
38034758|NCT04405076|69721617|FG008|Part A (Blinded Phase)|Other than Specified|0|||
38034759|NCT04405076|69721609|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
38034760|NCT04405076|69721610|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
38034761|NCT04405076|69721611|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
38034762|NCT04405076|69721612|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
38034763|NCT04405076|69721613|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
38034764|NCT04405076|69721614|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
38034765|NCT04405076|69721615|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
38034766|NCT04405076|69721616|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
38034767|NCT04405076|69721617|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
38034768|NCT04405076|69721609|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
38034769|NCT04405076|69721610|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
38034770|NCT04405076|69721611|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
38034771|NCT04405076|69721612|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
38034772|NCT04405076|69721613|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
38034773|NCT04405076|69721614|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
38034774|NCT04405076|69721615|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
38034775|NCT04405076|69721616|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
38034776|NCT04405076|69721617|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
38034777|NCT04405076|69721609|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
38034778|NCT04405076|69721610|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
38034779|NCT04405076|69721611|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
38034780|NCT04405076|69721612|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
38034781|NCT04405076|69721613|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
38034782|NCT04405076|69721614|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
38034783|NCT04405076|69721615|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
38034784|NCT04405076|69721616|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
38034785|NCT04405076|69721617|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
38034786|NCT04405076|69721609|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
38034787|NCT04405076|69721610|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
38034788|NCT04405076|69721611|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
38034789|NCT04405076|69721612|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
38034790|NCT04405076|69721613|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
38034791|NCT04405076|69721614|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
38034792|NCT04405076|69721615|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
38034793|NCT04405076|69721616|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
38034794|NCT04405076|69721617|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
38034795|NCT04405076|69721609|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
38034796|NCT04405076|69721610|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
38034797|NCT04405076|69721611|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
38034798|NCT04405076|69721612|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
38034799|NCT04405076|69721613|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
38034800|NCT04405076|69721614|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
38034801|NCT04405076|69721615|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
38034802|NCT04405076|69721616|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
38034803|NCT04405076|69721617|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
38034804|NCT04311177|69721645|FG000|Overall Study|Adverse Event|3|||
38034805|NCT04311177|69721646|FG001|Overall Study|Adverse Event|1|||
38034806|NCT04311177|69721645|FG000|Overall Study|Physician Decision|4|||
38034807|NCT04311177|69721646|FG001|Overall Study|Physician Decision|3|||
38034808|NCT04311177|69721645|FG000|Overall Study|Withdrawal by Subject|1|||
37932691|NCT01751685|69619620|FG000|6-mo Followup|Lost to Follow-up|0|||
37932692|NCT01751685|69619621|FG001|6-mo Followup|Lost to Follow-up|1|||
37932693|NCT01751685|69619620|FG000|12-mo Followup|Lost to Follow-up|5|||
37932694|NCT01751685|69619621|FG001|12-mo Followup|Lost to Follow-up|0|||
38034809|NCT04311177|69721646|FG001|Overall Study|Withdrawal by Subject|0|||
38034810|NCT03267212|69721652|FG000|First Intervention|Lost to Follow-up|0|||
38034811|NCT03267212|69721653|FG001|First Intervention|Lost to Follow-up|2|||
38043558|NCT02927262|69731712|FG001|Overall Study|Death|0|||
37932695|NCT00586508|69619629|FG000|Overall Study|Progressive disease|52|||
38034812|NCT03267212|69721652|FG000|First Intervention|Withdrawal by Subject|1|||
38034813|NCT03267212|69721653|FG001|First Intervention|Withdrawal by Subject|1|||
38034814|NCT03267212|69721652|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
38034815|NCT03267212|69721653|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
38034816|NCT04292535|69721673|FG000|Overall Study|Withdrawal by Subject|0|||
38034817|NCT04292535|69721674|FG001|Overall Study|Withdrawal by Subject|0|||
38034818|NCT04292535|69721675|FG002|Overall Study|Withdrawal by Subject|0|||
38034819|NCT04292535|69721676|FG003|Overall Study|Withdrawal by Subject|0|||
38034820|NCT04292535|69721677|FG004|Overall Study|Withdrawal by Subject|0|||
38034821|NCT04292535|69721678|FG005|Overall Study|Withdrawal by Subject|0|||
38034822|NCT04292535|69721679|FG006|Overall Study|Withdrawal by Subject|0|||
38034823|NCT04292535|69721680|FG007|Overall Study|Withdrawal by Subject|1|||
38034824|NCT04292535|69721681|FG008|Overall Study|Withdrawal by Subject|0|||
38034825|NCT04292535|69721682|FG009|Overall Study|Withdrawal by Subject|0|||
38034826|NCT04292535|69721683|FG010|Overall Study|Withdrawal by Subject|0|||
38034827|NCT04292535|69721684|FG011|Overall Study|Withdrawal by Subject|0|||
38034828|NCT04292535|69721685|FG012|Overall Study|Withdrawal by Subject|0|||
38034829|NCT04292535|69721686|FG013|Overall Study|Withdrawal by Subject|0|||
38034830|NCT04292535|69721673|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
38034831|NCT04292535|69721674|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
38034832|NCT04292535|69721675|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
38034833|NCT04292535|69721676|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
38034834|NCT04292535|69721677|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
38034835|NCT04292535|69721678|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
38034836|NCT04292535|69721679|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
38034837|NCT04292535|69721680|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
38034838|NCT04292535|69721681|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
38034839|NCT04292535|69721682|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
38034840|NCT04292535|69721683|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
38034841|NCT04292535|69721684|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
38034842|NCT04292535|69721685|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
38034843|NCT04292535|69721686|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
38034844|NCT04292535|69721673|FG000|Overall Study|Report of Dizziness|0|||
38034845|NCT04292535|69721674|FG001|Overall Study|Report of Dizziness|0|||
38034846|NCT04292535|69721675|FG002|Overall Study|Report of Dizziness|0|||
38034847|NCT04292535|69721676|FG003|Overall Study|Report of Dizziness|0|||
38034848|NCT04292535|69721677|FG004|Overall Study|Report of Dizziness|0|||
38034849|NCT04292535|69721678|FG005|Overall Study|Report of Dizziness|0|||
38034850|NCT04292535|69721679|FG006|Overall Study|Report of Dizziness|0|||
38034851|NCT04292535|69721680|FG007|Overall Study|Report of Dizziness|0|||
38034852|NCT04292535|69721681|FG008|Overall Study|Report of Dizziness|0|||
38034853|NCT04292535|69721682|FG009|Overall Study|Report of Dizziness|0|||
38034854|NCT04292535|69721683|FG010|Overall Study|Report of Dizziness|0|||
38034855|NCT04292535|69721684|FG011|Overall Study|Report of Dizziness|0|||
38034856|NCT04292535|69721685|FG012|Overall Study|Report of Dizziness|0|||
38034857|NCT04292535|69721686|FG013|Overall Study|Report of Dizziness|1|||
38034858|NCT04292535|69721673|FG000|Overall Study|Equipment Failure|0|||
38034859|NCT04292535|69721674|FG001|Overall Study|Equipment Failure|0|||
38034860|NCT04292535|69721675|FG002|Overall Study|Equipment Failure|0|||
38034861|NCT04292535|69721676|FG003|Overall Study|Equipment Failure|0|||
38034862|NCT04292535|69721677|FG004|Overall Study|Equipment Failure|0|||
38034863|NCT04292535|69721678|FG005|Overall Study|Equipment Failure|0|||
38034864|NCT04292535|69721679|FG006|Overall Study|Equipment Failure|0|||
38034865|NCT04292535|69721680|FG007|Overall Study|Equipment Failure|0|||
38034866|NCT04292535|69721681|FG008|Overall Study|Equipment Failure|0|||
38034867|NCT04292535|69721682|FG009|Overall Study|Equipment Failure|0|||
38034868|NCT04292535|69721683|FG010|Overall Study|Equipment Failure|0|||
38034869|NCT04292535|69721684|FG011|Overall Study|Equipment Failure|1|||
38034870|NCT04292535|69721685|FG012|Overall Study|Equipment Failure|0|||
38034871|NCT04292535|69721686|FG013|Overall Study|Equipment Failure|0|||
38034872|NCT04385199|69721718|FG000|Overall Study|Withdrawal by Subject|1|||
37668385|NCT02446899|69140937|FG001|Overall Study|Condition Under Investigation Worsened|4|||
37668386|NCT02446899|69140936|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
37668387|NCT02446899|69140937|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
37668388|NCT02446899|69140936|FG000|Overall Study|Lack of Efficacy|2|||
38034873|NCT04385199|69721719|FG001|Overall Study|Withdrawal by Subject|0|||
38034874|NCT04284813|69721725|FG000|Overall Study|Withdrawal by Subject|1|||
38034875|NCT03263780|69721729|FG000|Overall Study|Withdrawal by Subject|3|||
38034876|NCT03263780|69721729|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
38034877|NCT02791438|69721735|FG000|Treatment Period|Adverse Event|1|||
38034878|NCT02791438|69721736|FG001|Treatment Period|Adverse Event|0|||
37932696|NCT00586508|69619630|FG001|Overall Study|Progressive disease|8|||
38034879|NCT02791438|69721735|FG000|Treatment Period|Withdrawal by Subject|0|||
38034880|NCT02791438|69721736|FG001|Treatment Period|Withdrawal by Subject|1|||
38034881|NCT02791438|69721735|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
38034882|NCT02791438|69721736|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
38034883|NCT03712124|69721744|FG000|Overall Study|Protocol Violation|1|||
38034884|NCT03712124|69721745|FG001|Overall Study|Protocol Violation|0|||
38034885|NCT02791516|69721759|FG000|Overall Study|Withdrawal by Subject|1|||
38034886|NCT02791516|69721760|FG001|Overall Study|Withdrawal by Subject|1|||
38034887|NCT03263702|69721768|FG000|Overall Study|Lost to Follow-up|2|||
38034888|NCT03263702|69721769|FG001|Overall Study|Lost to Follow-up|2|||
38034889|NCT03263702|69721768|FG000|Overall Study|Withdrawal by Subject|1|||
38034890|NCT03263702|69721769|FG001|Overall Study|Withdrawal by Subject|2|||
38034891|NCT04130919|69721778|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
38034892|NCT04130919|69721779|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
38034893|NCT04130919|69721780|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
38034894|NCT04130919|69721781|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
38034895|NCT04130919|69721782|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
38034896|NCT04130919|69721783|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
38034897|NCT04130919|69721778|FG000|Blinded Treatment Phase|Adverse Event|0|||
38034898|NCT04130919|69721779|FG001|Blinded Treatment Phase|Adverse Event|0|||
38034899|NCT04130919|69721780|FG002|Blinded Treatment Phase|Adverse Event|1|||
38034900|NCT04130919|69721781|FG003|Blinded Treatment Phase|Adverse Event|0|||
38034901|NCT04130919|69721782|FG004|Blinded Treatment Phase|Adverse Event|0|||
38034902|NCT04130919|69721783|FG005|Blinded Treatment Phase|Adverse Event|0|||
38034903|NCT04130919|69721778|FG000|Blinded Treatment Phase|Disease worsening|0|||
38034904|NCT04130919|69721779|FG001|Blinded Treatment Phase|Disease worsening|0|||
38034905|NCT04130919|69721780|FG002|Blinded Treatment Phase|Disease worsening|1|||
38034906|NCT04130919|69721781|FG003|Blinded Treatment Phase|Disease worsening|0|||
38034907|NCT04130919|69721782|FG004|Blinded Treatment Phase|Disease worsening|0|||
38034908|NCT04130919|69721783|FG005|Blinded Treatment Phase|Disease worsening|0|||
38034909|NCT04130919|69721778|FG000|Blinded Treatment Phase|Investigator's decision|0|||
38034910|NCT04130919|69721779|FG001|Blinded Treatment Phase|Investigator's decision|1|||
38034911|NCT04130919|69721780|FG002|Blinded Treatment Phase|Investigator's decision|0|||
38034912|NCT04130919|69721781|FG003|Blinded Treatment Phase|Investigator's decision|0|||
37668389|NCT02446899|69140937|FG001|Overall Study|Lack of Efficacy|8|||
37668390|NCT02446899|69140936|FG000|Overall Study|Lost to Follow-up|1|||
37668391|NCT02446899|69140937|FG001|Overall Study|Lost to Follow-up|3|||
37668392|NCT02446899|69140936|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
37668393|NCT02446899|69140937|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
37668394|NCT02446899|69140936|FG000|Overall Study|Withdrawal by Subject|11|||
37668395|NCT02446899|69140937|FG001|Overall Study|Withdrawal by Subject|19|||
37668396|NCT02446899|69140936|FG000|Overall Study|Miscellaneous|5|||
37668397|NCT02446899|69140937|FG001|Overall Study|Miscellaneous|4|||
37668398|NCT02446899|69140936|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
37668399|NCT02446899|69140937|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
37668400|NCT02709785|69140946|FG000|Overall Study|Withdrawal by Subject|1|||
37668401|NCT02709785|69140947|FG001|Overall Study|Withdrawal by Subject|2|||
37668402|NCT02709785|69140948|FG002|Overall Study|Withdrawal by Subject|1|||
37668403|NCT02356887|69140956|FG000|Overall Study|poor compliance|2|||
37668404|NCT01604265|69140968|FG000|Overall Study|Adverse Event|1|||
37668405|NCT01604265|69140969|FG001|Overall Study|Adverse Event|0|||
37668406|NCT01604265|69140968|FG000|Overall Study|Withdrawal by Subject|1|||
37668407|NCT01604265|69140969|FG001|Overall Study|Withdrawal by Subject|0|||
37668408|NCT01664247|69140977|FG000|Overall Study|Adverse Event|5|||
37668409|NCT01664247|69140978|FG001|Overall Study|Adverse Event|3|||
37668410|NCT01664247|69140977|FG000|Overall Study|Protocol Violation|3|||
37668411|NCT01664247|69140978|FG001|Overall Study|Protocol Violation|5|||
37668412|NCT01664247|69140977|FG000|Overall Study|Withdrawal Criteria|1|||
37668413|NCT01664247|69140978|FG001|Overall Study|Withdrawal Criteria|4|||
37668414|NCT01664247|69140977|FG000|Overall Study|Unclassified|5|||
37668415|NCT01664247|69140978|FG001|Overall Study|Unclassified|29|||
38034913|NCT04130919|69721782|FG004|Blinded Treatment Phase|Investigator's decision|0|||
38034914|NCT04130919|69721783|FG005|Blinded Treatment Phase|Investigator's decision|0|||
38034915|NCT04130919|69721778|FG000|Blinded Treatment Phase|Withdrew consent|1|||
38034916|NCT04130919|69721779|FG001|Blinded Treatment Phase|Withdrew consent|0|||
37668416|NCT03191903|69141002|FG000|Overall Study|Withdrawal by Subject|6|||
37668417|NCT03191903|69141003|FG001|Overall Study|Withdrawal by Subject|5|||
37668418|NCT03191903|69141004|FG002|Overall Study|Withdrawal by Subject|4|||
37668419|NCT03191903|69141002|FG000|Overall Study|Adverse Event|1|||
37668420|NCT03191903|69141003|FG001|Overall Study|Adverse Event|0|||
38034917|NCT04130919|69721780|FG002|Blinded Treatment Phase|Withdrew consent|0|||
38034918|NCT04130919|69721781|FG003|Blinded Treatment Phase|Withdrew consent|0|||
37668421|NCT03191903|69141004|FG002|Overall Study|Adverse Event|0|||
37668422|NCT02576145|69141019|FG000|Overall Study|Adverse Event|1|||
37932697|NCT00586508|69619629|FG000|Overall Study|Death|0|||
37668423|NCT02576145|69141020|FG001|Overall Study|Adverse Event|0|||
37668424|NCT02576145|69141019|FG000|Overall Study|Withdrawal by Subject|1|||
37668425|NCT02576145|69141020|FG001|Overall Study|Withdrawal by Subject|0|||
37668426|NCT02576145|69141019|FG000|Overall Study|Acute rejection|1|||
37668427|NCT02576145|69141020|FG001|Overall Study|Acute rejection|0|||
37668428|NCT02576145|69141019|FG000|Overall Study|Tetanus Titers Decreased|0|||
37668429|NCT02576145|69141020|FG001|Overall Study|Tetanus Titers Decreased|1|||
37668430|NCT02576067|69141065|FG000|Overall Study|Death|0|||
37668431|NCT02576067|69141066|FG001|Overall Study|Death|1|||
37668432|NCT02576067|69141065|FG000|Overall Study|Lack of Efficacy|1|||
37668433|NCT02576067|69141066|FG001|Overall Study|Lack of Efficacy|0|||
37668434|NCT02576067|69141065|FG000|Overall Study|Lost to Follow-up|11|||
37668435|NCT02576067|69141066|FG001|Overall Study|Lost to Follow-up|0|||
37668436|NCT02576067|69141065|FG000|Overall Study|Withdrawal by Subject|11|||
37668437|NCT02576067|69141066|FG001|Overall Study|Withdrawal by Subject|2|||
37668438|NCT02576067|69141065|FG000|Overall Study|study closure of main CIRT trial)|0|||
37668439|NCT02576067|69141066|FG001|Overall Study|study closure of main CIRT trial)|8|||
37668440|NCT02576067|69141065|FG000|Overall Study|not randomized, failed run-in|7|||
37668441|NCT02576067|69141066|FG001|Overall Study|not randomized, failed run-in|0|||
37668442|NCT02576067|69141065|FG000|Overall Study|screen failure/ re-enrolled|0|||
37668443|NCT02576067|69141066|FG001|Overall Study|screen failure/ re-enrolled|25|||
37668444|NCT02576067|69141065|FG000|Overall Study|Physician Decision|4|||
37668445|NCT02576067|69141066|FG001|Overall Study|Physician Decision|0|||
37668446|NCT02575911|69141072|FG000|Overall Study|Lost to Follow-up|1|||
37668447|NCT02575833|69141086|FG000|Overall Study|Withdrawal by Subject|0|||
37668448|NCT02575833|69141087|FG001|Overall Study|Withdrawal by Subject|1|||
37668449|NCT02575833|69141086|FG000|Overall Study|Lost to Follow-up|1|||
37668450|NCT02575833|69141087|FG001|Overall Study|Lost to Follow-up|0|||
37668451|NCT02709083|69141093|FG000|Overall Study|Original PI left institution|7|||
37668452|NCT02709005|69141099|FG000|Overall Study|Lost to Follow-up|1|||
37668453|NCT02709005|69141100|FG001|Overall Study|Lost to Follow-up|1|||
37668454|NCT02709005|69141099|FG000|Overall Study|Withdrawal by Subject|3|||
37668455|NCT02709005|69141100|FG001|Overall Study|Withdrawal by Subject|0|||
37668456|NCT02573883|69141108|FG000|Six Month Follow Up|Lost to Follow-up|1|||
37668457|NCT02573883|69141109|FG001|Six Month Follow Up|Lost to Follow-up|0|||
37668458|NCT02573883|69141110|FG002|Six Month Follow Up|Lost to Follow-up|0|||
37668459|NCT02573883|69141111|FG003|Six Month Follow Up|Lost to Follow-up|0|||
37668460|NCT02573883|69141108|FG000|One Year Follow Up|Lost to Follow-up|2|||
37668461|NCT02573883|69141109|FG001|One Year Follow Up|Lost to Follow-up|1|||
37668462|NCT02573883|69141110|FG002|One Year Follow Up|Lost to Follow-up|0|||
37668463|NCT02573883|69141111|FG003|One Year Follow Up|Lost to Follow-up|0|||
37668464|NCT02575365|69141126|FG000|Overall Study|Lost to Follow-up|4|||
37668465|NCT02707991|69141132|FG000|Overall Study|Protocol Violation|1|||
37668466|NCT02707991|69141133|FG001|Overall Study|Protocol Violation|0|||
37668467|NCT02707991|69141132|FG000|Overall Study|Became ineligible|0|||
37668468|NCT02707991|69141133|FG001|Overall Study|Became ineligible|1|||
37668469|NCT02707757|69141141|FG000|Overall Study|Protocol Violation|3|||
37668470|NCT02707757|69141142|FG001|Overall Study|Protocol Violation|2|||
37668471|NCT02707757|69141141|FG000|Overall Study|Withdrawal by Subject|2|||
37668472|NCT02707757|69141142|FG001|Overall Study|Withdrawal by Subject|0|||
37668473|NCT02707757|69141141|FG000|Overall Study|Death|0|||
37668474|NCT02707757|69141142|FG001|Overall Study|Death|1|||
37668475|NCT02707757|69141141|FG000|Overall Study|Adverse Event|6|||
37668476|NCT02707757|69141142|FG001|Overall Study|Adverse Event|4|||
37668477|NCT02707757|69141141|FG000|Overall Study|Renal transplant/elective operation|1|||
37668478|NCT02707757|69141142|FG001|Overall Study|Renal transplant/elective operation|5|||
37668479|NCT02572401|69141152|FG000|Overall Study|Lost to Follow-up|5|||
37668480|NCT02572401|69141153|FG001|Overall Study|Lost to Follow-up|8|||
37668481|NCT02572401|69141154|FG002|Overall Study|Lost to Follow-up|9|||
37668482|NCT02572401|69141155|FG003|Overall Study|Lost to Follow-up|9|||
37668483|NCT02572401|69141152|FG000|Overall Study|Death|0|||
37668484|NCT02572401|69141153|FG001|Overall Study|Death|0|||
37668485|NCT02572401|69141154|FG002|Overall Study|Death|0|||
37668486|NCT02572401|69141155|FG003|Overall Study|Death|1|||
37668487|NCT02431325|69141167|FG000|Overall Study|Adverse Event|3|||
37668488|NCT02431325|69141168|FG001|Overall Study|Adverse Event|0|||
37668489|NCT02431325|69141167|FG000|Overall Study|Lost to Follow-up|0|||
37668490|NCT02431325|69141168|FG001|Overall Study|Lost to Follow-up|1|||
37668491|NCT02431325|69141167|FG000|Overall Study|Withdrawal by Subject|1|||
37668492|NCT02431325|69141168|FG001|Overall Study|Withdrawal by Subject|2|||
37668493|NCT02431325|69141167|FG000|Overall Study|Declined to take study medication|1|||
37668494|NCT02431325|69141168|FG001|Overall Study|Declined to take study medication|0|||
37668495|NCT02431325|69141167|FG000|Overall Study|Withdrew before starting study medication|1|||
37668496|NCT02431325|69141168|FG001|Overall Study|Withdrew before starting study medication|0|||
37668497|NCT02431325|69141167|FG000|Overall Study|Placebo shortage|2|||
37668498|NCT02431325|69141168|FG001|Overall Study|Placebo shortage|0|||
37668499|NCT02103478|69141181|FG000|Overall Study|Adverse Event|0|||
37668500|NCT02103478|69141182|FG001|Overall Study|Adverse Event|0|||
37668501|NCT02103478|69141183|FG002|Overall Study|Adverse Event|1|||
37668502|NCT02103478|69141184|FG003|Overall Study|Adverse Event|1|||
37668503|NCT02103478|69141185|FG004|Overall Study|Adverse Event|2|||
37932698|NCT00586508|69619630|FG001|Overall Study|Death|1|||
37932699|NCT00586508|69619629|FG000|Overall Study|Adverse Event|12|||
37932700|NCT00586508|69619630|FG001|Overall Study|Adverse Event|4|||
37932701|NCT00586508|69619629|FG000|Overall Study|Withdrawal by Subject|4|||
37932702|NCT00586508|69619630|FG001|Overall Study|Withdrawal by Subject|0|||
37932703|NCT00581919|69619636|FG000|Overall Study|Adverse Event|8|||
37932704|NCT00581919|69619636|FG000|Overall Study|Death|1|||
37932705|NCT00581919|69619636|FG000|Overall Study|Disease Progression|10|||
37932706|NCT00581919|69619636|FG000|Overall Study|Physician Decision|1|||
37932707|NCT00581919|69619636|FG000|Overall Study|Other Complicating Disease|1|||
37932708|NCT00581919|69619636|FG000|Overall Study|Started Non-Protocol Therapy|2|||
37932709|NCT00581919|69619636|FG000|Overall Study|Withdrawal by Subject|1|||
37932710|NCT00723528|69619644|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
37932711|NCT00723528|69619645|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
37932712|NCT00723528|69619646|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
37932713|NCT00723528|69619647|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
37932714|NCT00723528|69619648|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
37932715|NCT00723528|69619649|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
37932716|NCT00723528|69619650|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
37932717|NCT00723528|69619644|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
37932718|NCT00723528|69619645|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
37932719|NCT00723528|69619646|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
37932720|NCT00723528|69619647|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
37932721|NCT00723528|69619648|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
37932722|NCT00723528|69619649|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
37932723|NCT00723528|69619650|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
37932724|NCT00723528|69619644|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
37932725|NCT00723528|69619645|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
37932726|NCT00723528|69619646|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
37932727|NCT00723528|69619647|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
37932728|NCT00723528|69619648|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
37932729|NCT00723528|69619649|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
37932730|NCT00723528|69619650|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
37932731|NCT00723528|69619644|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
37932732|NCT00723528|69619645|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
37932733|NCT00723528|69619646|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
37932734|NCT00723528|69619647|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
37932735|NCT00723528|69619648|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
37932736|NCT00723528|69619649|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
37932737|NCT00723528|69619650|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
37932738|NCT00723528|69619644|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
37932739|NCT00723528|69619645|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
37932740|NCT00723528|69619646|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
37932741|NCT00723528|69619647|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
37932742|NCT00723528|69619648|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
37932743|NCT00723528|69619649|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
37932744|NCT00723528|69619650|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
37932745|NCT00723528|69619644|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
37932746|NCT00723528|69619645|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
37932747|NCT00723528|69619646|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
37932748|NCT00723528|69619647|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
37932749|NCT00723528|69619648|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
37932750|NCT00723528|69619649|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
37932751|NCT00723528|69619650|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
37932752|NCT00723528|69619644|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
37932753|NCT00723528|69619645|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
37932754|NCT00723528|69619646|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
37932755|NCT00723528|69619647|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
37932756|NCT00723528|69619648|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
37932757|NCT00723528|69619649|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
37932758|NCT00723528|69619650|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
37668504|NCT02103478|69141186|FG005|Overall Study|Adverse Event|1|||
38034919|NCT04130919|69721782|FG004|Blinded Treatment Phase|Withdrew consent|0|||
37668505|NCT02103478|69141187|FG006|Overall Study|Adverse Event|0|||
37668506|NCT02103478|69141188|FG007|Overall Study|Adverse Event|0|||
37668507|NCT02103478|69141189|FG008|Overall Study|Adverse Event|0|||
37668508|NCT02103478|69141181|FG000|Overall Study|Death|2|||
37668509|NCT02103478|69141182|FG001|Overall Study|Death|2|||
37668510|NCT02103478|69141183|FG002|Overall Study|Death|1|||
37668511|NCT02103478|69141184|FG003|Overall Study|Death|1|||
37668512|NCT02103478|69141185|FG004|Overall Study|Death|5|||
37668513|NCT02103478|69141186|FG005|Overall Study|Death|15|||
37668514|NCT02103478|69141187|FG006|Overall Study|Death|14|||
37668515|NCT02103478|69141188|FG007|Overall Study|Death|10|||
37668516|NCT02103478|69141189|FG008|Overall Study|Death|11|||
37668517|NCT02103478|69141181|FG000|Overall Study|Progressive Disease|2|||
37668518|NCT02103478|69141182|FG001|Overall Study|Progressive Disease|1|||
37668519|NCT02103478|69141183|FG002|Overall Study|Progressive Disease|2|||
37668520|NCT02103478|69141184|FG003|Overall Study|Progressive Disease|0|||
37668521|NCT02103478|69141185|FG004|Overall Study|Progressive Disease|9|||
37668522|NCT02103478|69141186|FG005|Overall Study|Progressive Disease|1|||
37668523|NCT02103478|69141187|FG006|Overall Study|Progressive Disease|2|||
37668524|NCT02103478|69141188|FG007|Overall Study|Progressive Disease|0|||
37668525|NCT02103478|69141189|FG008|Overall Study|Progressive Disease|1|||
37668526|NCT02103478|69141181|FG000|Overall Study|Withdrawal by Subject|2|||
37668527|NCT02103478|69141182|FG001|Overall Study|Withdrawal by Subject|0|||
37668528|NCT02103478|69141183|FG002|Overall Study|Withdrawal by Subject|0|||
37668529|NCT02103478|69141184|FG003|Overall Study|Withdrawal by Subject|4|||
37668530|NCT02103478|69141185|FG004|Overall Study|Withdrawal by Subject|0|||
37668531|NCT02103478|69141186|FG005|Overall Study|Withdrawal by Subject|0|||
37668532|NCT02103478|69141187|FG006|Overall Study|Withdrawal by Subject|1|||
37668533|NCT02103478|69141188|FG007|Overall Study|Withdrawal by Subject|1|||
37668534|NCT02103478|69141189|FG008|Overall Study|Withdrawal by Subject|0|||
37668535|NCT02103478|69141181|FG000|Overall Study|Lost to Follow-up|0|||
37668536|NCT02103478|69141182|FG001|Overall Study|Lost to Follow-up|0|||
37668537|NCT02103478|69141183|FG002|Overall Study|Lost to Follow-up|0|||
37668538|NCT02103478|69141184|FG003|Overall Study|Lost to Follow-up|0|||
37760926|NCT01041027|69271819|FG000|Overall Study|Withdrawal by Subject|2|||
37760927|NCT01041027|69271819|FG000|Overall Study|Protocol Violation|1|||
37760928|NCT01041027|69271819|FG000|Overall Study|Delayed Radiation Therapy|1|||
37760929|NCT01041027|69271819|FG000|Overall Study|Adverse Event|4|||
37760930|NCT00389610|69271825|FG000|Overall Study|Disease Progression|0|||
37760931|NCT00389610|69271826|FG001|Overall Study|Disease Progression|19|||
37760932|NCT00389610|69271825|FG000|Overall Study|Death|0|||
37760933|NCT00389610|69271826|FG001|Overall Study|Death|1|||
37760934|NCT00389610|69271825|FG000|Overall Study|Physician Decision|0|||
37760935|NCT00389610|69271826|FG001|Overall Study|Physician Decision|1|||
37668539|NCT02103478|69141185|FG004|Overall Study|Lost to Follow-up|0|||
37760936|NCT00389610|69271825|FG000|Overall Study|Withdrawal by Subject|0|||
37760937|NCT00389610|69271826|FG001|Overall Study|Withdrawal by Subject|1|||
37760938|NCT01489189|69271834|FG000|Overall Study|Withdrawal by Subject|20|||
37668540|NCT02103478|69141186|FG005|Overall Study|Lost to Follow-up|0|||
37668541|NCT02103478|69141187|FG006|Overall Study|Lost to Follow-up|0|||
37668542|NCT02103478|69141188|FG007|Overall Study|Lost to Follow-up|1|||
37668543|NCT02103478|69141189|FG008|Overall Study|Lost to Follow-up|0|||
37668544|NCT02103478|69141181|FG000|Overall Study|Other|1|||
37668545|NCT02103478|69141182|FG001|Overall Study|Other|3|||
37760939|NCT01489189|69271835|FG001|Overall Study|Withdrawal by Subject|23|||
37760940|NCT01489189|69271834|FG000|Overall Study|Death|10|||
37760941|NCT01489189|69271835|FG001|Overall Study|Death|8|||
37760942|NCT01489189|69271834|FG000|Overall Study|Missed Visit|1|||
37668546|NCT02103478|69141183|FG002|Overall Study|Other|2|||
37760943|NCT01489189|69271835|FG001|Overall Study|Missed Visit|4|||
37668547|NCT02103478|69141184|FG003|Overall Study|Other|0|||
37668548|NCT02103478|69141185|FG004|Overall Study|Other|3|||
37668549|NCT02103478|69141186|FG005|Overall Study|Other|8|||
37668550|NCT02103478|69141187|FG006|Overall Study|Other|8|||
37668551|NCT02103478|69141188|FG007|Overall Study|Other|4|||
37668552|NCT02103478|69141189|FG008|Overall Study|Other|2|||
37668553|NCT02102464|69141221|FG000|Randomized Study|Withdrawal by Subject|0|||
37668554|NCT02102464|69141222|FG001|Randomized Study|Withdrawal by Subject|1|||
37668555|NCT02102464|69141223|FG002|Randomized Study|Withdrawal by Subject|0|||
37668556|NCT02707601|69141234|FG000|Overall Study|Death|0|||
37668557|NCT02707601|69141235|FG001|Overall Study|Death|1|||
37668558|NCT02707601|69141234|FG000|Overall Study|Lack of Efficacy|0|||
37668559|NCT02707601|69141235|FG001|Overall Study|Lack of Efficacy|1|||
37668560|NCT02707601|69141234|FG000|Overall Study|Investigator's Discretion|1|||
37668561|NCT02707601|69141235|FG001|Overall Study|Investigator's Discretion|0|||
37668562|NCT02707601|69141234|FG000|Overall Study|Withdrew Consent|0|||
37668563|NCT02707601|69141235|FG001|Overall Study|Withdrew Consent|1|||
37668564|NCT02707601|69141234|FG000|Overall Study|Lost to Follow-up|1|||
37668565|NCT02707601|69141235|FG001|Overall Study|Lost to Follow-up|1|||
37668566|NCT02707601|69141234|FG000|Overall Study|Participants Randomized but Not Treated|2|||
37668567|NCT02707601|69141235|FG001|Overall Study|Participants Randomized but Not Treated|0|||
37668568|NCT02707055|69141247|FG000|Phase 1|Withdrawal by Subject|1|||
37668569|NCT02707055|69141248|FG001|Phase 1|Withdrawal by Subject|2|||
37668570|NCT02707055|69141247|FG000|Phase 1|Physician Decision|0|||
37668571|NCT02707055|69141248|FG001|Phase 1|Physician Decision|1|||
37668572|NCT02707055|69141247|FG000|Phase 2|Adverse Event|1|||
37668573|NCT02707055|69141248|FG001|Phase 2|Adverse Event|2|||
37668574|NCT02073682|69141256|FG000|Overall Study|Low Creatinine Clearance|1|||
37668575|NCT02073682|69141257|FG001|Overall Study|Low Creatinine Clearance|2|||
37668576|NCT02073682|69141256|FG000|Overall Study|Death|86|||
37668577|NCT02073682|69141257|FG001|Overall Study|Death|100|||
37668578|NCT02073682|69141256|FG000|Overall Study|Cancer Cured|10|||
37668579|NCT02073682|69141257|FG001|Overall Study|Cancer Cured|15|||
37668580|NCT02073682|69141256|FG000|Overall Study|ID: Patient Noncompliance|1|||
37668581|NCT02073682|69141257|FG001|Overall Study|ID: Patient Noncompliance|2|||
37668582|NCT02073682|69141256|FG000|Overall Study|ID: Palliative Treatment Only|10|||
37668583|NCT02073682|69141257|FG001|Overall Study|ID: Palliative Treatment Only|7|||
37668584|NCT02073682|69141256|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
37668585|NCT02073682|69141257|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
37668586|NCT02073682|69141256|FG000|Overall Study|Platelet Count <50,000/mL|1|||
37668587|NCT02073682|69141257|FG001|Overall Study|Platelet Count <50,000/mL|2|||
37668588|NCT02073682|69141256|FG000|Overall Study|Surgery/Medical Procedure|3|||
37668589|NCT02073682|69141257|FG001|Overall Study|Surgery/Medical Procedure|1|||
37668590|NCT02073682|69141256|FG000|Overall Study|Withdrawal by Subject|6|||
37668591|NCT02073682|69141257|FG001|Overall Study|Withdrawal by Subject|8|||
37668592|NCT02073682|69141256|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
37668593|NCT02073682|69141257|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
37668594|NCT02073682|69141256|FG000|Overall Study|Cancer Progression|53|||
37668595|NCT02073682|69141257|FG001|Overall Study|Cancer Progression|33|||
37668596|NCT02073682|69141256|FG000|Overall Study|Protocol Violation|1|||
37668597|NCT02073682|69141257|FG001|Overall Study|Protocol Violation|0|||
37668598|NCT02073682|69141256|FG000|Overall Study|Adverse Event|79|||
37668599|NCT02073682|69141257|FG001|Overall Study|Adverse Event|62|||
37668600|NCT02073682|69141256|FG000|Overall Study|No reason provided|11|||
37668601|NCT02073682|69141257|FG001|Overall Study|No reason provided|9|||
37668602|NCT02073682|69141256|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
37668603|NCT02073682|69141257|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
37668604|NCT02073682|69141256|FG000|Overall Study|Lost to Follow-up|1|||
37668605|NCT02073682|69141257|FG001|Overall Study|Lost to Follow-up|1|||
37668606|NCT02073682|69141256|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
37668607|NCT02073682|69141257|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
37668608|NCT02072980|69141263|FG000|Period 2, Second Wear|Adverse Event|0|||
37668609|NCT02072980|69141264|FG001|Period 2, Second Wear|Adverse Event|1|||
37668610|NCT02706899|69141272|FG000|Overall Study|Withdrawal by Subject|1|||
37668611|NCT02706899|69141273|FG001|Overall Study|Withdrawal by Subject|0|||
37668612|NCT02706899|69141272|FG000|Overall Study|Death|8|||
37668613|NCT02706899|69141273|FG001|Overall Study|Death|0|||
37668614|NCT02706899|69141272|FG000|Overall Study|Study Termination by Sponsor|4|||
37668615|NCT02706899|69141273|FG001|Overall Study|Study Termination by Sponsor|6|||
37668616|NCT02072824|69141282|FG000|Overall Study|Insufficient clinical response|1|||
37668617|NCT02072824|69141283|FG001|Overall Study|Insufficient clinical response|0|||
37760944|NCT01549873|69271844|FG000|Overall Study|Physician Decision|0|||
37668618|NCT02072824|69141284|FG002|Overall Study|Insufficient clinical response|1|||
37668619|NCT02072824|69141282|FG000|Overall Study|No longer willing to participate|1|||
37668620|NCT02072824|69141283|FG001|Overall Study|No longer willing to participate|0|||
37668621|NCT02072824|69141284|FG002|Overall Study|No longer willing to participate|1|||
37668622|NCT02072824|69141282|FG000|Overall Study|Medication error|0|||
37760945|NCT01549873|69271845|FG001|Overall Study|Physician Decision|1|||
37668623|NCT02072824|69141283|FG001|Overall Study|Medication error|1|||
37668624|NCT02072824|69141284|FG002|Overall Study|Medication error|0|||
37668625|NCT02072824|69141282|FG000|Overall Study|Adverse Event|0|||
37668626|NCT02072824|69141283|FG001|Overall Study|Adverse Event|0|||
37668627|NCT02072824|69141284|FG002|Overall Study|Adverse Event|1|||
37668628|NCT02072668|69141292|FG000|Second Intervention|Lost to Follow-up|1|||
37668629|NCT02072668|69141293|FG001|Second Intervention|Lost to Follow-up|0|||
37668630|NCT02140762|69141303|FG000|Overall Study|Adverse Event|1|||
37668631|NCT02140762|69141304|FG001|Overall Study|Adverse Event|1|||
37668632|NCT02140762|69141303|FG000|Overall Study|Lost to Follow-up|9|||
37668633|NCT02140762|69141304|FG001|Overall Study|Lost to Follow-up|5|||
37668634|NCT02140762|69141303|FG000|Overall Study|Protocol Violation|1|||
37668635|NCT02140762|69141304|FG001|Overall Study|Protocol Violation|1|||
37668636|NCT02140762|69141303|FG000|Overall Study|Withdrawal by Subject|6|||
37668637|NCT02140762|69141304|FG001|Overall Study|Withdrawal by Subject|4|||
37668638|NCT02140762|69141303|FG000|Overall Study|Other|0|||
37668639|NCT02140762|69141304|FG001|Overall Study|Other|1|||
37668640|NCT02101294|69141315|FG000|Overall Study|Withdrawal by Subject|5|||
37668641|NCT02101294|69141315|FG000|Overall Study|Lost to Follow-up|6|||
37668642|NCT01598506|69141322|FG000|Overall Study|Withdrawal by Subject|2|||
37668643|NCT02140060|69141333|FG000|Overall Study|Adverse Event|0|||
37668644|NCT02140060|69141334|FG001|Overall Study|Adverse Event|0|||
37668645|NCT02140060|69141335|FG002|Overall Study|Adverse Event|0|||
37668646|NCT02140060|69141336|FG003|Overall Study|Adverse Event|1|||
37668647|NCT02140060|69141337|FG004|Overall Study|Adverse Event|1|||
37668648|NCT02140060|69141338|FG005|Overall Study|Adverse Event|1|||
37668649|NCT02140060|69141333|FG000|Overall Study|Lack of Efficacy|0|||
37668650|NCT02140060|69141334|FG001|Overall Study|Lack of Efficacy|0|||
37668651|NCT02140060|69141335|FG002|Overall Study|Lack of Efficacy|0|||
37668652|NCT02140060|69141336|FG003|Overall Study|Lack of Efficacy|1|||
37668653|NCT02140060|69141337|FG004|Overall Study|Lack of Efficacy|0|||
37668654|NCT02140060|69141338|FG005|Overall Study|Lack of Efficacy|0|||
37668655|NCT02139982|69141363|FG000|Overall Study|Lack of Efficacy|0|||
37668656|NCT02139982|69141364|FG001|Overall Study|Lack of Efficacy|1|||
37668657|NCT02139982|69141365|FG002|Overall Study|Lack of Efficacy|0|||
37668658|NCT02139982|69141366|FG003|Overall Study|Lack of Efficacy|1|||
37668659|NCT02139982|69141367|FG004|Overall Study|Lack of Efficacy|0|||
37668660|NCT02139982|69141368|FG005|Overall Study|Lack of Efficacy|0|||
37668661|NCT02139982|69141369|FG006|Overall Study|Lack of Efficacy|0|||
37668662|NCT02139982|69141370|FG007|Overall Study|Lack of Efficacy|0|||
37668663|NCT02139982|69141371|FG008|Overall Study|Lack of Efficacy|0|||
37668664|NCT02139982|69141372|FG009|Overall Study|Lack of Efficacy|0|||
37668665|NCT02139826|69141394|FG000|Overall Study|Adverse Event|1|||
37668666|NCT02139592|69141404|FG000|Overall Study|Case Report Forms Uncollected|8|||
37668667|NCT02139280|69141410|FG000|Overall Study|No longer eligible|2|||
37668668|NCT02139280|69141411|FG001|Overall Study|No longer eligible|0|||
37668669|NCT02072434|69141419|FG000|Overall Study|Protocol Violation|10|||
37668670|NCT02072434|69141420|FG001|Overall Study|Protocol Violation|9|||
37668671|NCT02072434|69141419|FG000|Overall Study|Physician Decision|5|||
37668672|NCT02072434|69141420|FG001|Overall Study|Physician Decision|10|||
37668673|NCT02072434|69141419|FG000|Overall Study|Adverse event, serious fatal|1|||
37760946|NCT01489111|69271851|FG000|Overall Study|Withdrawal criterion|1|||
37760947|NCT01488487|69271855|FG000|Overall Study|Adverse Event|6|||
37760948|NCT01488487|69271855|FG000|Overall Study|Death|1|||
37760949|NCT01488487|69271855|FG000|Overall Study|Withdrawal by Subject|2|||
37760950|NCT01488097|69271859|FG000|Overall Study|Lost to Follow-up|1|||
37760951|NCT01516879|69271865|FG000|Overall Study|Withdrawal by Subject|9|||
37760952|NCT01516879|69271866|FG001|Overall Study|Withdrawal by Subject|11|||
37760953|NCT01516879|69271865|FG000|Overall Study|Death|0|||
37760954|NCT01516879|69271866|FG001|Overall Study|Death|2|||
37760955|NCT01516879|69271865|FG000|Overall Study|Lost to Follow-up|2|||
37760956|NCT01516879|69271866|FG001|Overall Study|Lost to Follow-up|11|||
37760957|NCT01516879|69271865|FG000|Overall Study|Other|5|||
37760958|NCT01516879|69271866|FG001|Overall Study|Other|10|||
37932759|NCT00723528|69619644|FG000|Period 2: After Controlled Period|Other|0|||
37932760|NCT00723528|69619645|FG001|Period 2: After Controlled Period|Other|0|||
37668674|NCT02072434|69141420|FG001|Overall Study|Adverse event, serious fatal|6|||
37668675|NCT02072434|69141419|FG000|Overall Study|Adverse Event|7|||
37668676|NCT02072434|69141420|FG001|Overall Study|Adverse Event|6|||
37668677|NCT02072434|69141419|FG000|Overall Study|Withdrawal by Subject|17|||
37668678|NCT02072434|69141420|FG001|Overall Study|Withdrawal by Subject|29|||
37668679|NCT02072434|69141419|FG000|Overall Study|Other|14|||
37668680|NCT02072434|69141420|FG001|Overall Study|Other|29|||
37668681|NCT02072434|69141419|FG000|Overall Study|Lost to Follow-up|0|||
37668682|NCT02072434|69141420|FG001|Overall Study|Lost to Follow-up|1|||
37668683|NCT02101060|69141428|FG000|Overall Study|Adverse Event|1|||
37932761|NCT00723528|69619646|FG002|Period 2: After Controlled Period|Other|0|||
37668684|NCT02101060|69141429|FG001|Overall Study|Adverse Event|0|||
37668685|NCT02101060|69141428|FG000|Overall Study|Withdrawal by Subject|1|||
37760959|NCT01515865|69271872|FG000|Part A (Open-label)|Other|3|||
37668686|NCT02101060|69141429|FG001|Overall Study|Withdrawal by Subject|1|||
37668687|NCT02101060|69141428|FG000|Overall Study|Lost to Follow-up|3|||
37668688|NCT02101060|69141429|FG001|Overall Study|Lost to Follow-up|3|||
37668689|NCT02139124|69141440|FG000|Overall Study|Adverse Event|2|||
37668690|NCT02139124|69141441|FG001|Overall Study|Adverse Event|0|||
37668691|NCT02139124|69141442|FG002|Overall Study|Adverse Event|1|||
37668692|NCT02139124|69141443|FG003|Overall Study|Adverse Event|2|||
37668693|NCT02139124|69141444|FG004|Overall Study|Adverse Event|5|||
37668694|NCT02139124|69141440|FG000|Overall Study|Withdrawal by Subject|2|||
37668695|NCT02139124|69141441|FG001|Overall Study|Withdrawal by Subject|2|||
37668696|NCT02139124|69141442|FG002|Overall Study|Withdrawal by Subject|2|||
37668697|NCT02139124|69141443|FG003|Overall Study|Withdrawal by Subject|2|||
37668698|NCT02139124|69141444|FG004|Overall Study|Withdrawal by Subject|3|||
37668699|NCT02139124|69141440|FG000|Overall Study|Protocol Violation|0|||
37668700|NCT02139124|69141441|FG001|Overall Study|Protocol Violation|0|||
37932762|NCT00723528|69619647|FG003|Period 2: After Controlled Period|Other|0|||
37932763|NCT00723528|69619648|FG004|Period 2: After Controlled Period|Other|1|||
37932764|NCT00723528|69619649|FG005|Period 2: After Controlled Period|Other|4|||
37932765|NCT00723528|69619650|FG006|Period 2: After Controlled Period|Other|0|||
37932766|NCT00723528|69619644|FG000|Period 2: After Controlled Period|Adverse Event|0|||
37932767|NCT00723528|69619645|FG001|Period 2: After Controlled Period|Adverse Event|0|||
37932768|NCT00723528|69619646|FG002|Period 2: After Controlled Period|Adverse Event|0|||
37932769|NCT00723528|69619647|FG003|Period 2: After Controlled Period|Adverse Event|0|||
37932770|NCT00723528|69619648|FG004|Period 2: After Controlled Period|Adverse Event|1|||
37932771|NCT00723528|69619649|FG005|Period 2: After Controlled Period|Adverse Event|0|||
37932772|NCT00723528|69619650|FG006|Period 2: After Controlled Period|Adverse Event|1|||
37932773|NCT00723528|69619644|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
37932774|NCT00723528|69619645|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
37932775|NCT00723528|69619646|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
37932776|NCT00723528|69619647|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
37932777|NCT00723528|69619648|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
37932778|NCT00723528|69619649|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
37932779|NCT00723528|69619650|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
37932780|NCT00723528|69619644|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
37932781|NCT00723528|69619645|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
37932782|NCT00723528|69619646|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
37932783|NCT00723528|69619647|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
37932784|NCT00723528|69619648|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
37932785|NCT00723528|69619649|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
37932786|NCT00723528|69619650|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
37932787|NCT00751790|69619666|FG000|Overall Study|Lost to Follow-up|1|||
37932788|NCT00751790|69619666|FG000|Overall Study|Death|3|||
37932789|NCT00751790|69619666|FG000|Overall Study|Withdrawal by Subject|1|||
37932790|NCT00723450|69619672|FG000|Open-Label Phase|Adverse Event|26|||
37932791|NCT00723450|69619673|FG001|Open-Label Phase|Adverse Event|0|||
37932792|NCT00723450|69619674|FG002|Open-Label Phase|Adverse Event|0|||
37932793|NCT00723450|69619672|FG000|Open-Label Phase|Lack of Efficacy|18|||
37760960|NCT01515865|69271873|FG001|Part A (Open-label)|Other|0|||
37760961|NCT01515865|69271874|FG002|Part A (Open-label)|Other|0|||
37760962|NCT01515865|69271872|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
37668701|NCT02139124|69141442|FG002|Overall Study|Protocol Violation|0|||
37668702|NCT02139124|69141443|FG003|Overall Study|Protocol Violation|1|||
37668703|NCT02139124|69141444|FG004|Overall Study|Protocol Violation|1|||
37668704|NCT02139124|69141440|FG000|Overall Study|non-compliant|1|||
37668705|NCT02139124|69141441|FG001|Overall Study|non-compliant|0|||
37668706|NCT02139124|69141442|FG002|Overall Study|non-compliant|0|||
37668707|NCT02139124|69141443|FG003|Overall Study|non-compliant|2|||
37668708|NCT02139124|69141444|FG004|Overall Study|non-compliant|0|||
37760963|NCT01515865|69271873|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
37760964|NCT01515865|69271874|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
37932794|NCT00723450|69619673|FG001|Open-Label Phase|Lack of Efficacy|0|||
37668709|NCT02139124|69141440|FG000|Overall Study|incarceration|0|||
37668710|NCT02139124|69141441|FG001|Overall Study|incarceration|0|||
37932795|NCT00723450|69619674|FG002|Open-Label Phase|Lack of Efficacy|0|||
37932796|NCT00723450|69619672|FG000|Open-Label Phase|Protocol Violation|35|||
37932797|NCT00723450|69619673|FG001|Open-Label Phase|Protocol Violation|0|||
37932798|NCT00723450|69619674|FG002|Open-Label Phase|Protocol Violation|0|||
37668711|NCT02139124|69141442|FG002|Overall Study|incarceration|1|||
37668712|NCT02139124|69141443|FG003|Overall Study|incarceration|0|||
37668713|NCT02139124|69141444|FG004|Overall Study|incarceration|0|||
37668714|NCT02139124|69141440|FG000|Overall Study|subject moved|1|||
37668715|NCT02139124|69141441|FG001|Overall Study|subject moved|0|||
37668716|NCT02139124|69141442|FG002|Overall Study|subject moved|0|||
37668717|NCT02139124|69141443|FG003|Overall Study|subject moved|0|||
37668718|NCT02139124|69141444|FG004|Overall Study|subject moved|0|||
37668719|NCT02139124|69141440|FG000|Overall Study|Lost to Follow-up|3|||
37668720|NCT02139124|69141441|FG001|Overall Study|Lost to Follow-up|2|||
37668721|NCT02139124|69141442|FG002|Overall Study|Lost to Follow-up|0|||
37668722|NCT02139124|69141443|FG003|Overall Study|Lost to Follow-up|5|||
37668723|NCT02139124|69141444|FG004|Overall Study|Lost to Follow-up|4|||
37668724|NCT02139046|69141461|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
37668725|NCT02139046|69141462|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
37668726|NCT02139046|69141463|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
37668727|NCT02139046|69141464|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
37668728|NCT02139046|69141465|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
37668729|NCT02139046|69141461|FG000|Overall Study|Major Protocol Deviation|9|||
37668730|NCT02139046|69141462|FG001|Overall Study|Major Protocol Deviation|10|||
37668731|NCT02139046|69141463|FG002|Overall Study|Major Protocol Deviation|16|||
37668732|NCT02139046|69141464|FG003|Overall Study|Major Protocol Deviation|12|||
37668733|NCT02139046|69141465|FG004|Overall Study|Major Protocol Deviation|6|||
37668734|NCT02139046|69141461|FG000|Overall Study|Lost to Follow-up|13|||
37668735|NCT02139046|69141462|FG001|Overall Study|Lost to Follow-up|16|||
37668736|NCT02139046|69141463|FG002|Overall Study|Lost to Follow-up|16|||
37668737|NCT02139046|69141464|FG003|Overall Study|Lost to Follow-up|18|||
37668738|NCT02139046|69141465|FG004|Overall Study|Lost to Follow-up|13|||
37668739|NCT02139046|69141461|FG000|Overall Study|Voluntary Withdrawal|20|||
37668740|NCT02139046|69141462|FG001|Overall Study|Voluntary Withdrawal|8|||
37668741|NCT02139046|69141463|FG002|Overall Study|Voluntary Withdrawal|10|||
37668742|NCT02139046|69141464|FG003|Overall Study|Voluntary Withdrawal|15|||
37668743|NCT02139046|69141465|FG004|Overall Study|Voluntary Withdrawal|16|||
37668744|NCT02139046|69141461|FG000|Overall Study|Lack of Efficacy|0|||
37668745|NCT02139046|69141462|FG001|Overall Study|Lack of Efficacy|1|||
37668746|NCT02139046|69141463|FG002|Overall Study|Lack of Efficacy|2|||
37668747|NCT02139046|69141464|FG003|Overall Study|Lack of Efficacy|1|||
37668748|NCT02139046|69141465|FG004|Overall Study|Lack of Efficacy|2|||
37668749|NCT02139046|69141461|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
37668750|NCT02139046|69141462|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
37668751|NCT02139046|69141463|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
37668752|NCT02139046|69141464|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
37668753|NCT02139046|69141465|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
37668754|NCT02139046|69141461|FG000|Overall Study|Other Miscellaneous Reasons|10|||
37668755|NCT02139046|69141462|FG001|Overall Study|Other Miscellaneous Reasons|9|||
37668756|NCT02139046|69141463|FG002|Overall Study|Other Miscellaneous Reasons|4|||
37668757|NCT02139046|69141464|FG003|Overall Study|Other Miscellaneous Reasons|9|||
37668758|NCT02139046|69141465|FG004|Overall Study|Other Miscellaneous Reasons|12|||
37668759|NCT02138890|69141479|FG000|Overall Study|Adverse Event|1|||
37668760|NCT02138890|69141480|FG001|Overall Study|Adverse Event|0|||
37668761|NCT02100670|69141491|FG000|Overall Study|Adverse Event|10|||
37668762|NCT02100670|69141492|FG001|Overall Study|Adverse Event|3|||
37668763|NCT02100670|69141493|FG002|Overall Study|Adverse Event|3|||
37668764|NCT02100670|69141494|FG003|Overall Study|Adverse Event|0|||
37668765|NCT02100670|69141491|FG000|Overall Study|Lost to Follow-up|1|||
37668766|NCT02100670|69141492|FG001|Overall Study|Lost to Follow-up|0|||
37668767|NCT02100670|69141493|FG002|Overall Study|Lost to Follow-up|0|||
37668768|NCT02100670|69141494|FG003|Overall Study|Lost to Follow-up|0|||
37668769|NCT02100670|69141491|FG000|Overall Study|Protocol Violation|0|||
37668770|NCT02100670|69141492|FG001|Overall Study|Protocol Violation|1|||
37668771|NCT02100670|69141493|FG002|Overall Study|Protocol Violation|0|||
37668772|NCT02100670|69141494|FG003|Overall Study|Protocol Violation|1|||
37668773|NCT02100670|69141491|FG000|Overall Study|Withdrawal of Consent|0|||
37668774|NCT02100670|69141492|FG001|Overall Study|Withdrawal of Consent|1|||
37668775|NCT02100670|69141493|FG002|Overall Study|Withdrawal of Consent|1|||
37668776|NCT02100670|69141494|FG003|Overall Study|Withdrawal of Consent|0|||
37668777|NCT02100670|69141491|FG000|Overall Study|No swelling no pain|1|||
37668778|NCT02100670|69141492|FG001|Overall Study|No swelling no pain|0|||
37668779|NCT02100670|69141493|FG002|Overall Study|No swelling no pain|0|||
37668780|NCT02100670|69141494|FG003|Overall Study|No swelling no pain|0|||
37668781|NCT02100670|69141491|FG000|Overall Study|Poor Efficacy|0|||
37668782|NCT02100670|69141492|FG001|Overall Study|Poor Efficacy|1|||
37668783|NCT02100670|69141493|FG002|Overall Study|Poor Efficacy|0|||
37668784|NCT02100670|69141494|FG003|Overall Study|Poor Efficacy|0|||
37668785|NCT02100670|69141491|FG000|Overall Study|Physician Decision|0|||
37668786|NCT02100670|69141492|FG001|Overall Study|Physician Decision|1|||
37668787|NCT02100670|69141493|FG002|Overall Study|Physician Decision|0|||
37668788|NCT02100670|69141494|FG003|Overall Study|Physician Decision|0|||
37668789|NCT02100670|69141491|FG000|Overall Study|Withdrawal by Subject|1|||
37668790|NCT02100670|69141492|FG001|Overall Study|Withdrawal by Subject|0|||
37668791|NCT02100670|69141493|FG002|Overall Study|Withdrawal by Subject|0|||
37668792|NCT02100670|69141494|FG003|Overall Study|Withdrawal by Subject|0|||
37668793|NCT02070484|69141513|FG000|Overall Study|Withdrawal by Subject|1|||
37668794|NCT02070484|69141514|FG001|Overall Study|Withdrawal by Subject|0|||
37668795|NCT02100514|69141522|FG000|Treatment Period|Adverse Event|0|||
37668796|NCT02100514|69141523|FG001|Treatment Period|Adverse Event|5|||
37668797|NCT02100514|69141524|FG002|Treatment Period|Adverse Event|0|||
37668798|NCT02100514|69141525|FG003|Treatment Period|Adverse Event|0|||
37668799|NCT02100514|69141526|FG004|Treatment Period|Adverse Event|0|||
37668800|NCT02100514|69141522|FG000|Treatment Period|Death|2|||
37668801|NCT02100514|69141523|FG001|Treatment Period|Death|2|||
37668802|NCT02100514|69141524|FG002|Treatment Period|Death|0|||
37668803|NCT02100514|69141525|FG003|Treatment Period|Death|0|||
37668804|NCT02100514|69141526|FG004|Treatment Period|Death|0|||
37668805|NCT02100514|69141522|FG000|Treatment Period|Lost to Follow-up|5|||
37668806|NCT02100514|69141523|FG001|Treatment Period|Lost to Follow-up|17|||
37668807|NCT02100514|69141524|FG002|Treatment Period|Lost to Follow-up|0|||
37668808|NCT02100514|69141525|FG003|Treatment Period|Lost to Follow-up|0|||
37668809|NCT02100514|69141526|FG004|Treatment Period|Lost to Follow-up|0|||
37668810|NCT02100514|69141522|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
37668811|NCT02100514|69141523|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
37668812|NCT02100514|69141524|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
37668813|NCT02100514|69141525|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
37668814|NCT02100514|69141526|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
37668815|NCT02100514|69141522|FG000|Treatment Period|Protocol Violation|1|||
37668816|NCT02100514|69141523|FG001|Treatment Period|Protocol Violation|1|||
37668817|NCT02100514|69141524|FG002|Treatment Period|Protocol Violation|0|||
37668818|NCT02100514|69141525|FG003|Treatment Period|Protocol Violation|0|||
37668819|NCT02100514|69141526|FG004|Treatment Period|Protocol Violation|0|||
37668820|NCT02100514|69141522|FG000|Treatment Period|Withdrawal by Subject|12|||
37668821|NCT02100514|69141523|FG001|Treatment Period|Withdrawal by Subject|37|||
37668822|NCT02100514|69141524|FG002|Treatment Period|Withdrawal by Subject|0|||
37668823|NCT02100514|69141525|FG003|Treatment Period|Withdrawal by Subject|0|||
37668824|NCT02100514|69141526|FG004|Treatment Period|Withdrawal by Subject|0|||
37668825|NCT02100514|69141522|FG000|Treatment Period|Other|9|||
37668826|NCT02100514|69141523|FG001|Treatment Period|Other|11|||
37668827|NCT02100514|69141524|FG002|Treatment Period|Other|0|||
37668828|NCT02100514|69141525|FG003|Treatment Period|Other|0|||
37668829|NCT02100514|69141526|FG004|Treatment Period|Other|0|||
37668830|NCT02100514|69141522|FG000|Extension Period|Withdrew consent|0|||
37668831|NCT02100514|69141523|FG001|Extension Period|Withdrew consent|0|||
37668832|NCT02100514|69141524|FG002|Extension Period|Withdrew consent|2|||
37668833|NCT02100514|69141525|FG003|Extension Period|Withdrew consent|0|||
37668834|NCT02100514|69141526|FG004|Extension Period|Withdrew consent|0|||
37668835|NCT02069392|69141542|FG000|Overall Study|Withdrawal by Subject|4|||
37668836|NCT02069392|69141543|FG001|Overall Study|Withdrawal by Subject|2|||
37668837|NCT02047318|69141551|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
37668838|NCT02047318|69141551|FG000|Core Study Period|Adverse Event|1|||
37668839|NCT02047318|69141551|FG000|Core Study Period|Withdrawal by caregiver|3|||
37668840|NCT02047318|69141551|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
37668841|NCT02100124|69141569|FG000|Overall Study|Lost to Follow-up|5|||
37668842|NCT02100124|69141570|FG001|Overall Study|Lost to Follow-up|11|||
37668843|NCT02100124|69141571|FG002|Overall Study|Lost to Follow-up|3|||
37668844|NCT02100124|69141569|FG000|Overall Study|Withdrawal by Subject|1|||
37760965|NCT01515865|69271872|FG000|Part B (Open-label)|Other|1|||
37760966|NCT01515865|69271873|FG001|Part B (Open-label)|Other|0|||
37760967|NCT01515865|69271874|FG002|Part B (Open-label)|Other|0|||
37760968|NCT01547299|69271884|FG000|Overall Study|Withdrawal by Subject|2|||
37760969|NCT01547299|69271885|FG001|Overall Study|Withdrawal by Subject|2|||
37760970|NCT01515475|69271895|FG000|Overall Study|Lost to Follow-up|20|||
37760971|NCT01515475|69271896|FG001|Overall Study|Lost to Follow-up|15|||
37760972|NCT01515475|69271897|FG002|Overall Study|Lost to Follow-up|12|||
37760973|NCT01515475|69271898|FG003|Overall Study|Lost to Follow-up|12|||
37760974|NCT01515319|69271984|FG000|Overall Study|Withdrawal by Subject|0|||
37760975|NCT01515319|69271985|FG001|Overall Study|Withdrawal by Subject|0|||
37760976|NCT01515319|69271986|FG002|Overall Study|Withdrawal by Subject|0|||
37760977|NCT01515319|69271987|FG003|Overall Study|Withdrawal by Subject|0|||
37760978|NCT01515319|69271988|FG004|Overall Study|Withdrawal by Subject|0|||
37668845|NCT02100124|69141570|FG001|Overall Study|Withdrawal by Subject|0|||
37668846|NCT02100124|69141571|FG002|Overall Study|Withdrawal by Subject|0|||
37668847|NCT02068768|69141579|FG000|Overall Study|Lost to Follow-up|5|||
37668848|NCT02068768|69141579|FG000|Overall Study|Early Termination by Sponsor|2|||
37668849|NCT02046616|69141583|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
37668850|NCT02046616|69141583|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
37760979|NCT01515319|69271989|FG005|Overall Study|Withdrawal by Subject|0|||
37668851|NCT02046616|69141583|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
37668852|NCT02046616|69141583|FG000|24-Week Treatment Period|Physician Decision|3|||
37668853|NCT02046616|69141583|FG000|24-Week Treatment Period|Other|1|||
37668854|NCT02046616|69141583|FG000|8-Week FU Period|Lost to Follow-up|1|||
37760980|NCT01515319|69271990|FG006|Overall Study|Withdrawal by Subject|1|||
37668855|NCT02099344|69141589|FG000|Overall Study|Physician Decision|1|||
37668856|NCT02099344|69141590|FG001|Overall Study|Physician Decision|0|||
37668857|NCT02068222|69141598|FG000|Overall Study|Lost to Follow-up|1|||
37668858|NCT02099110|69141607|FG000|Overall Study|Protocol Violation|2|||
37668859|NCT02099110|69141608|FG001|Overall Study|Protocol Violation|1|||
37668860|NCT02099110|69141609|FG002|Overall Study|Protocol Violation|0|||
37668861|NCT02099110|69141610|FG003|Overall Study|Protocol Violation|3|||
37668862|NCT02099110|69141611|FG004|Overall Study|Protocol Violation|1|||
37668863|NCT02099110|69141607|FG000|Overall Study|Participant moved|1|||
37668864|NCT02099110|69141608|FG001|Overall Study|Participant moved|1|||
37668865|NCT02099110|69141609|FG002|Overall Study|Participant moved|1|||
37932799|NCT00723450|69619672|FG000|Open-Label Phase|Lost to Follow-up|7|||
37932800|NCT00723450|69619673|FG001|Open-Label Phase|Lost to Follow-up|0|||
37932801|NCT00723450|69619674|FG002|Open-Label Phase|Lost to Follow-up|0|||
37668866|NCT02099110|69141610|FG003|Overall Study|Participant moved|0|||
37668867|NCT02099110|69141611|FG004|Overall Study|Participant moved|2|||
37668868|NCT02099110|69141607|FG000|Overall Study|Withdrawal by Subject|7|||
37668869|NCT02099110|69141608|FG001|Overall Study|Withdrawal by Subject|11|||
37668870|NCT02099110|69141609|FG002|Overall Study|Withdrawal by Subject|13|||
37668871|NCT02099110|69141610|FG003|Overall Study|Withdrawal by Subject|9|||
37668872|NCT02099110|69141611|FG004|Overall Study|Withdrawal by Subject|13|||
37668873|NCT02099110|69141607|FG000|Overall Study|Adverse Event|3|||
37668874|NCT02099110|69141608|FG001|Overall Study|Adverse Event|5|||
37668875|NCT02099110|69141609|FG002|Overall Study|Adverse Event|2|||
37668876|NCT02099110|69141610|FG003|Overall Study|Adverse Event|3|||
37668877|NCT02099110|69141611|FG004|Overall Study|Adverse Event|2|||
37668878|NCT02099110|69141607|FG000|Overall Study|Lost to Follow-up|6|||
37668879|NCT02099110|69141608|FG001|Overall Study|Lost to Follow-up|12|||
37668880|NCT02099110|69141609|FG002|Overall Study|Lost to Follow-up|11|||
37668881|NCT02099110|69141610|FG003|Overall Study|Lost to Follow-up|5|||
37668882|NCT02099110|69141611|FG004|Overall Study|Lost to Follow-up|6|||
37668883|NCT02099110|69141607|FG000|Overall Study|Death|0|||
37668884|NCT02099110|69141608|FG001|Overall Study|Death|1|||
37668885|NCT02099110|69141609|FG002|Overall Study|Death|0|||
37668886|NCT02099110|69141610|FG003|Overall Study|Death|0|||
37668887|NCT02099110|69141611|FG004|Overall Study|Death|0|||
37668888|NCT02099110|69141607|FG000|Overall Study|Screen failure|0|||
37668889|NCT02099110|69141608|FG001|Overall Study|Screen failure|0|||
37668890|NCT02099110|69141609|FG002|Overall Study|Screen failure|0|||
37668891|NCT02099110|69141610|FG003|Overall Study|Screen failure|0|||
37668892|NCT02099110|69141611|FG004|Overall Study|Screen failure|1|||
37668893|NCT02099110|69141607|FG000|Overall Study|Non-compliance with study drug|2|||
37668894|NCT02099110|69141608|FG001|Overall Study|Non-compliance with study drug|0|||
37668895|NCT02099110|69141609|FG002|Overall Study|Non-compliance with study drug|0|||
37668896|NCT02099110|69141610|FG003|Overall Study|Non-compliance with study drug|0|||
37668897|NCT02099110|69141611|FG004|Overall Study|Non-compliance with study drug|1|||
37668898|NCT02099110|69141607|FG000|Overall Study|Physician Decision|3|||
37668899|NCT02099110|69141608|FG001|Overall Study|Physician Decision|0|||
37668900|NCT02099110|69141609|FG002|Overall Study|Physician Decision|1|||
37668901|NCT02099110|69141610|FG003|Overall Study|Physician Decision|2|||
37668902|NCT02099110|69141611|FG004|Overall Study|Physician Decision|1|||
37668903|NCT02098876|69141625|FG000|Overall Study|Withdrawal by Subject|5|||
37668904|NCT02098876|69141626|FG001|Overall Study|Withdrawal by Subject|5|||
37668905|NCT01624090|69141636|FG000|Overall Study|DLT, taken off therapy|0|||
37668906|NCT01624090|69141637|FG001|Overall Study|DLT, taken off therapy|1|||
37668907|NCT01624090|69141638|FG002|Overall Study|DLT, taken off therapy|0|||
37668908|NCT01624090|69141639|FG003|Overall Study|DLT, taken off therapy|0|||
37668909|NCT01624090|69141636|FG000|Overall Study|Withdrew prior to treatment|0|||
37668910|NCT01624090|69141637|FG001|Overall Study|Withdrew prior to treatment|1|||
37668911|NCT01624090|69141638|FG002|Overall Study|Withdrew prior to treatment|0|||
37932802|NCT00723450|69619672|FG000|Open-Label Phase|Physician Decision|2|||
37932803|NCT00723450|69619673|FG001|Open-Label Phase|Physician Decision|0|||
37932804|NCT00723450|69619674|FG002|Open-Label Phase|Physician Decision|0|||
37932805|NCT00723450|69619672|FG000|Open-Label Phase|Withdrawal by Subject|37|||
37668912|NCT01624090|69141639|FG003|Overall Study|Withdrew prior to treatment|0|||
37668913|NCT01624090|69141636|FG000|Overall Study|Died on study|0|||
37668914|NCT01624090|69141637|FG001|Overall Study|Died on study|0|||
37668915|NCT01624090|69141638|FG002|Overall Study|Died on study|2|||
37668916|NCT01624090|69141639|FG003|Overall Study|Died on study|0|||
37668917|NCT01624090|69141636|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
37668918|NCT01624090|69141637|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
37668919|NCT01624090|69141638|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
37668920|NCT01624090|69141639|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
37668921|NCT01624090|69141636|FG000|Overall Study|Dose escalated|0|||
37668922|NCT01624090|69141637|FG001|Overall Study|Dose escalated|0|||
37668923|NCT01624090|69141638|FG002|Overall Study|Dose escalated|3|||
37668924|NCT01624090|69141639|FG003|Overall Study|Dose escalated|0|||
37668925|NCT02571777|69141654|FG000|Overall Study|Subject/guardian decision|34|||
37668926|NCT02571777|69141655|FG001|Overall Study|Subject/guardian decision|26|||
37668927|NCT02571777|69141656|FG002|Overall Study|Subject/guardian decision|26|||
37668928|NCT02571777|69141657|FG003|Overall Study|Subject/guardian decision|25|||
37668929|NCT02571777|69141658|FG004|Overall Study|Subject/guardian decision|27|||
37668930|NCT02571777|69141654|FG000|Overall Study|Protocol Deviation|2|||
37668931|NCT02571777|69141655|FG001|Overall Study|Protocol Deviation|3|||
37668932|NCT02571777|69141656|FG002|Overall Study|Protocol Deviation|4|||
37668933|NCT02571777|69141657|FG003|Overall Study|Protocol Deviation|8|||
37668934|NCT02571777|69141658|FG004|Overall Study|Protocol Deviation|4|||
37668935|NCT02571777|69141654|FG000|Overall Study|Death|1|||
37668936|NCT02571777|69141655|FG001|Overall Study|Death|1|||
37668937|NCT02571777|69141656|FG002|Overall Study|Death|4|||
37668938|NCT02571777|69141657|FG003|Overall Study|Death|0|||
37668939|NCT02571777|69141658|FG004|Overall Study|Death|0|||
37668940|NCT02571777|69141654|FG000|Overall Study|Lost to Follow-up|1|||
37668941|NCT02571777|69141655|FG001|Overall Study|Lost to Follow-up|1|||
37668942|NCT02571777|69141656|FG002|Overall Study|Lost to Follow-up|2|||
37668943|NCT02571777|69141657|FG003|Overall Study|Lost to Follow-up|0|||
37668944|NCT02571777|69141658|FG004|Overall Study|Lost to Follow-up|1|||
37668945|NCT02571777|69141654|FG000|Overall Study|Physician Decision|1|||
37668946|NCT02571777|69141655|FG001|Overall Study|Physician Decision|7|||
37668947|NCT02571777|69141656|FG002|Overall Study|Physician Decision|5|||
37668948|NCT02571777|69141657|FG003|Overall Study|Physician Decision|2|||
37668949|NCT02571777|69141658|FG004|Overall Study|Physician Decision|4|||
37668950|NCT02571777|69141654|FG000|Overall Study|Pregnancy|0|||
37668951|NCT02571777|69141655|FG001|Overall Study|Pregnancy|0|||
37668952|NCT02571777|69141656|FG002|Overall Study|Pregnancy|0|||
37668953|NCT02571777|69141657|FG003|Overall Study|Pregnancy|2|||
37668954|NCT02571777|69141658|FG004|Overall Study|Pregnancy|0|||
37668955|NCT02571075|69141672|FG000|Overall Study|Lost to Follow-up|20|||
37668956|NCT02571075|69141673|FG001|Overall Study|Lost to Follow-up|24|||
37668957|NCT02705105|69141687|FG000|Treatment|Objective Disease Progression|1|||
37668958|NCT02705105|69141688|FG001|Treatment|Objective Disease Progression|50|||
37668959|NCT02705105|69141687|FG000|Treatment|Withdrawal by Subject|3|||
37668960|NCT02705105|69141688|FG001|Treatment|Withdrawal by Subject|5|||
37668961|NCT02705105|69141687|FG000|Treatment|Adverse Event|0|||
37668962|NCT02705105|69141688|FG001|Treatment|Adverse Event|17|||
37668963|NCT02705105|69141687|FG000|Treatment|Clinical Disease Progression|0|||
37668964|NCT02705105|69141688|FG001|Treatment|Clinical Disease Progression|32|||
37668965|NCT02705105|69141687|FG000|Treatment|Physician Decision|0|||
37668966|NCT02705105|69141688|FG001|Treatment|Physician Decision|3|||
37668967|NCT02705105|69141687|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
37668968|NCT02705105|69141688|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
37668969|NCT02705105|69141687|FG000|Follow-Up|Death|3|||
37668970|NCT02705105|69141688|FG001|Follow-Up|Death|68|||
37668971|NCT02705105|69141687|FG000|Follow-Up|Withdrawal by Subject|1|||
37668972|NCT02705105|69141688|FG001|Follow-Up|Withdrawal by Subject|14|||
37668973|NCT02705105|69141687|FG000|Follow-Up|Study Terminated|0|||
37668974|NCT02705105|69141688|FG001|Follow-Up|Study Terminated|26|||
37668975|NCT02705105|69141687|FG000|Follow-Up|Discontinued per Amendment 3|0|||
37668976|NCT02705105|69141688|FG001|Follow-Up|Discontinued per Amendment 3|2|||
37668977|NCT02097472|69141714|FG000|Received Vaccination 2|Adverse Event|0|||
37668978|NCT02097472|69141715|FG001|Received Vaccination 2|Adverse Event|0|||
37668979|NCT02097472|69141716|FG002|Received Vaccination 2|Adverse Event|0|||
37668980|NCT02097472|69141717|FG003|Received Vaccination 2|Adverse Event|0|||
37668981|NCT02097472|69141718|FG004|Received Vaccination 2|Adverse Event|0|||
37668982|NCT02097472|69141719|FG005|Received Vaccination 2|Adverse Event|0|||
37668983|NCT02097472|69141720|FG006|Received Vaccination 2|Adverse Event|1|||
37668984|NCT02097472|69141721|FG007|Received Vaccination 2|Adverse Event|0|||
37668985|NCT01623310|69141805|FG000|Overall Study|Adverse Event|21|||
37668986|NCT01623310|69141805|FG000|Overall Study|Lost to Follow-up|18|||
37668987|NCT01623310|69141805|FG000|Overall Study|Lack of Efficacy|6|||
37668988|NCT01623310|69141805|FG000|Overall Study|Protocol Violation|6|||
37859433|NCT01288079|69542750|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
37668989|NCT01623310|69141805|FG000|Overall Study|Withdrawal by Subject|25|||
37668990|NCT01623310|69141805|FG000|Overall Study|Became potentially child-bearing|1|||
37668991|NCT01623310|69141805|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
37668992|NCT01623310|69141805|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
37668993|NCT02046226|69141809|FG000|Overall Study|Lost to Follow-up|7|||
37859434|NCT01288079|69542751|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
37859435|NCT01288079|69542752|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
37859436|NCT01288079|69542749|FG000|Overall Study|Lost to Follow-up|1|||
37668994|NCT02046148|69141816|FG000|Overall Study|Lost to Follow-up|1|||
37668995|NCT02046148|69141817|FG001|Overall Study|Lost to Follow-up|1|||
37668996|NCT02046148|69141816|FG000|Overall Study|Withdrawal by Subject|0|||
37668997|NCT02046148|69141817|FG001|Overall Study|Withdrawal by Subject|2|||
37668998|NCT02097238|69141823|FG000|Overall Study|Death|1|||
37668999|NCT02097238|69141823|FG000|Overall Study|Physician Decision|1|||
37669000|NCT02097238|69141823|FG000|Overall Study|Progressive Disease|17|||
37669001|NCT02704091|69141830|FG000|Overall Study|Adverse Event|4|||
37669002|NCT02704091|69141831|FG001|Overall Study|Adverse Event|3|||
37669003|NCT02704091|69141830|FG000|Overall Study|Protocol Violation|5|||
37669004|NCT02704091|69141831|FG001|Overall Study|Protocol Violation|3|||
37669005|NCT02704091|69141830|FG000|Overall Study|Consent withdrawn|4|||
37669006|NCT02704091|69141831|FG001|Overall Study|Consent withdrawn|4|||
37669007|NCT02704091|69141830|FG000|Overall Study|Lost to Follow-up|13|||
37669008|NCT02704091|69141831|FG001|Overall Study|Lost to Follow-up|5|||
37669009|NCT02704091|69141830|FG000|Overall Study|Other|2|||
37669010|NCT02704091|69141831|FG001|Overall Study|Other|8|||
37669011|NCT02702609|69141839|FG000|Overall Study|Lost to Follow-up|8|||
37669012|NCT02702609|69141840|FG001|Overall Study|Lost to Follow-up|4|||
37669013|NCT02702609|69141839|FG000|Overall Study|Physician Decision|1|||
37669014|NCT02702609|69141840|FG001|Overall Study|Physician Decision|0|||
37669015|NCT02046070|69141849|FG000|Overall Study|Progressive Disease|18|||
37669016|NCT02046070|69141850|FG001|Overall Study|Progressive Disease|11|||
37669017|NCT02046070|69141851|FG002|Overall Study|Progressive Disease|40|||
37669018|NCT02046070|69141849|FG000|Overall Study|Adverse Event|8|||
37669019|NCT02046070|69141850|FG001|Overall Study|Adverse Event|10|||
37669020|NCT02046070|69141851|FG002|Overall Study|Adverse Event|17|||
37669021|NCT02046070|69141849|FG000|Overall Study|Withdrawal by Subject|1|||
37669022|NCT02046070|69141850|FG001|Overall Study|Withdrawal by Subject|2|||
37669023|NCT02046070|69141851|FG002|Overall Study|Withdrawal by Subject|6|||
37669024|NCT02046070|69141849|FG000|Overall Study|Study Terminated by Sponsor|1|||
37669025|NCT02046070|69141850|FG001|Overall Study|Study Terminated by Sponsor|1|||
37669026|NCT02046070|69141851|FG002|Overall Study|Study Terminated by Sponsor|1|||
37669027|NCT02046070|69141849|FG000|Overall Study|Reason not Specified|4|||
37669028|NCT02046070|69141850|FG001|Overall Study|Reason not Specified|4|||
37669029|NCT02046070|69141851|FG002|Overall Study|Reason not Specified|6|||
37669030|NCT01663857|69141863|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
37669031|NCT01663857|69141864|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
37669032|NCT01663857|69141865|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
37669033|NCT01663857|69141866|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
37669034|NCT01663857|69141863|FG000|Overall Study|Lost to Follow-up|0|||
37669035|NCT01663857|69141864|FG001|Overall Study|Lost to Follow-up|0|||
37669036|NCT01663857|69141865|FG002|Overall Study|Lost to Follow-up|3|||
37669037|NCT01663857|69141866|FG003|Overall Study|Lost to Follow-up|1|||
37669038|NCT02094898|69141882|FG000|Overall Study|Clinical Worsening|2|||
37669039|NCT02094898|69141882|FG000|Overall Study|Adverse Event|2|||
37669040|NCT02094898|69141882|FG000|Overall Study|Lack of Efficacy|1|||
37669041|NCT02045836|69141890|FG000|Overall Study|Adverse Event|4|||
37669042|NCT02045836|69141891|FG001|Overall Study|Adverse Event|4|||
37669043|NCT02045836|69141890|FG000|Overall Study|Withdrawal by Subject|1|||
37669044|NCT02045836|69141891|FG001|Overall Study|Withdrawal by Subject|1|||
37669045|NCT02045836|69141890|FG000|Overall Study|Lost to Follow-up|4|||
37669046|NCT02045836|69141891|FG001|Overall Study|Lost to Follow-up|7|||
37669047|NCT02045836|69141890|FG000|Overall Study|Migrated from study area|0|||
37669048|NCT02045836|69141891|FG001|Overall Study|Migrated from study area|2|||
37669049|NCT02569437|69141900|FG000|Overall Study|Lost to Follow-up|12|||
37669050|NCT02569437|69141901|FG001|Overall Study|Lost to Follow-up|14|||
37669051|NCT02045212|69141909|FG000|Overall Study|Adverse Event|0|||
37669052|NCT02045212|69141910|FG001|Overall Study|Adverse Event|1|||
37669053|NCT02045212|69141909|FG000|Overall Study|Withdrawal by Subject|1|||
37669054|NCT02045212|69141910|FG001|Overall Study|Withdrawal by Subject|0|||
37669055|NCT02045212|69141909|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
37669056|NCT02045212|69141910|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
37669057|NCT02044822|69141920|FG000|Overall Study|Study Terminated by Sponsor|77|||
37669058|NCT02044822|69141920|FG000|Overall Study|Investigator's Discretion|10|||
37669059|NCT02044822|69141920|FG000|Overall Study|Withdrew Consent|3|||
37669060|NCT02044822|69141920|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
37669061|NCT02044822|69141920|FG000|Overall Study|Lost to Follow-up|1|||
37669062|NCT02044510|69141926|FG000|Overall Study|Adverse Event|1|||
37669063|NCT02044510|69141927|FG001|Overall Study|Adverse Event|2|||
37669064|NCT02067676|69141939|FG000|Overall Study|Withdrawal by Subject|1|||
37669065|NCT02067676|69141940|FG001|Overall Study|Withdrawal by Subject|0|||
37669066|NCT02067676|69141941|FG002|Overall Study|Withdrawal by Subject|0|||
37859437|NCT01288079|69542750|FG001|Overall Study|Lost to Follow-up|1|||
37669067|NCT02067676|69141942|FG003|Overall Study|Withdrawal by Subject|0|||
37669068|NCT02067676|69141943|FG004|Overall Study|Withdrawal by Subject|0|||
37669069|NCT02067676|69141944|FG005|Overall Study|Withdrawal by Subject|0|||
37669070|NCT01623154|69141963|FG000|Overall Study|Did not drink Pranactin Citric|4|||
37669071|NCT00702689|69141969|FG000|Overall Study|Withdrawal by Subject|4|||
37669072|NCT00702689|69141969|FG000|Overall Study|Recurrent malignancy|1|||
37669073|NCT00702689|69141969|FG000|Overall Study|Adverse Event|1|||
37669074|NCT02065570|69141975|FG000|Induction Study|Adverse Event|5|||
37669075|NCT02065570|69141976|FG001|Induction Study|Adverse Event|12|||
37859438|NCT01288079|69542751|FG002|Overall Study|Lost to Follow-up|1|||
37669076|NCT02065570|69141977|FG002|Induction Study|Adverse Event|0|||
37669077|NCT02065570|69141978|FG003|Induction Study|Adverse Event|0|||
37669078|NCT02065570|69141975|FG000|Induction Study|Withdrawal by Subject|2|||
37669079|NCT02065570|69141976|FG001|Induction Study|Withdrawal by Subject|3|||
37669080|NCT02065570|69141977|FG002|Induction Study|Withdrawal by Subject|0|||
37669081|NCT02065570|69141978|FG003|Induction Study|Withdrawal by Subject|0|||
37669082|NCT02065570|69141975|FG000|Induction Study|Lost to Follow-up|1|||
37669083|NCT02065570|69141976|FG001|Induction Study|Lost to Follow-up|1|||
37669084|NCT02065570|69141977|FG002|Induction Study|Lost to Follow-up|0|||
37669085|NCT02065570|69141978|FG003|Induction Study|Lost to Follow-up|0|||
37669086|NCT02065570|69141975|FG000|Induction Study|Other, Not Specified|6|||
37669087|NCT02065570|69141976|FG001|Induction Study|Other, Not Specified|5|||
37669088|NCT02065570|69141977|FG002|Induction Study|Other, Not Specified|0|||
37669089|NCT02065570|69141978|FG003|Induction Study|Other, Not Specified|0|||
37669090|NCT02065570|69141975|FG000|Maintenance Study|Adverse Event|0|||
37669091|NCT02065570|69141976|FG001|Maintenance Study|Adverse Event|0|||
37669092|NCT02065570|69141977|FG002|Maintenance Study|Adverse Event|8|||
37669093|NCT02065570|69141978|FG003|Maintenance Study|Adverse Event|8|||
37669094|NCT02065570|69141975|FG000|Maintenance Study|Withdrawal by Subject|0|||
37669095|NCT02065570|69141976|FG001|Maintenance Study|Withdrawal by Subject|0|||
37669096|NCT02065570|69141977|FG002|Maintenance Study|Withdrawal by Subject|1|||
37669097|NCT02065570|69141978|FG003|Maintenance Study|Withdrawal by Subject|4|||
37669098|NCT02065570|69141975|FG000|Maintenance Study|Lost to Follow-up|0|||
37669099|NCT02065570|69141976|FG001|Maintenance Study|Lost to Follow-up|0|||
37669100|NCT02065570|69141977|FG002|Maintenance Study|Lost to Follow-up|2|||
37669101|NCT02065570|69141978|FG003|Maintenance Study|Lost to Follow-up|2|||
37669102|NCT02065570|69141975|FG000|Maintenance Study|Other, Not Specified|0|||
37669103|NCT02065570|69141976|FG001|Maintenance Study|Other, Not Specified|0|||
37669104|NCT02065570|69141977|FG002|Maintenance Study|Other, Not Specified|11|||
37669105|NCT02065570|69141978|FG003|Maintenance Study|Other, Not Specified|5|||
37669106|NCT02566005|69141991|FG000|Overall Study|vaginal bleeding|0|||
37669107|NCT02566005|69141992|FG001|Overall Study|vaginal bleeding|1|||
37669108|NCT02566005|69141991|FG000|Overall Study|received foley|8|||
37669109|NCT02566005|69141992|FG001|Overall Study|received foley|0|||
37669110|NCT02566005|69141991|FG000|Overall Study|did not receive foley|0|||
37669111|NCT02566005|69141992|FG001|Overall Study|did not receive foley|1|||
37669112|NCT02566005|69141991|FG000|Overall Study|labor after randomization|0|||
37669113|NCT02566005|69141992|FG001|Overall Study|labor after randomization|4|||
37669114|NCT02065336|69142010|FG000|Extension Phase|Study Terminated by Sponsor|0|||
37669115|NCT02065336|69142011|FG001|Extension Phase|Study Terminated by Sponsor|0|||
37669116|NCT02065336|69142012|FG002|Extension Phase|Study Terminated by Sponsor|0|||
37669117|NCT02065336|69142013|FG003|Extension Phase|Study Terminated by Sponsor|0|||
37669118|NCT02065336|69142014|FG004|Extension Phase|Study Terminated by Sponsor|0|||
37669119|NCT02065336|69142015|FG005|Extension Phase|Study Terminated by Sponsor|0|||
37669120|NCT02065336|69142016|FG006|Extension Phase|Study Terminated by Sponsor|0|||
37669121|NCT02065336|69142017|FG007|Extension Phase|Study Terminated by Sponsor|0|||
37669122|NCT02065336|69142018|FG008|Extension Phase|Study Terminated by Sponsor|2|||
37669123|NCT02065336|69142019|FG009|Extension Phase|Study Terminated by Sponsor|8|||
37669124|NCT02701985|69142052|FG000|Overall Study|Withdrawal by Subject|1|||
37669125|NCT02701985|69142053|FG001|Overall Study|Withdrawal by Subject|1|||
37669126|NCT02701985|69142052|FG000|Overall Study|Lost to Follow-up|1|||
37669127|NCT02701985|69142053|FG001|Overall Study|Lost to Follow-up|0|||
37669128|NCT02701985|69142052|FG000|Overall Study|Death|1|||
37669129|NCT02701985|69142053|FG001|Overall Study|Death|0|||
37669130|NCT02701985|69142052|FG000|Overall Study|Adverse Event|0|||
37669131|NCT02701985|69142053|FG001|Overall Study|Adverse Event|5|||
37669132|NCT02064868|69142062|FG000|Overall Study|Lost to Follow-up|14|||
37669133|NCT02064868|69142063|FG001|Overall Study|Lost to Follow-up|8|||
37669134|NCT02064868|69142062|FG000|Overall Study|Physician Decision|1|||
37669135|NCT02064868|69142063|FG001|Overall Study|Physician Decision|0|||
37669136|NCT02064868|69142062|FG000|Overall Study|Withdrawal by Subject|14|||
37760981|NCT01515319|69271991|FG007|Overall Study|Withdrawal by Subject|0|||
37760982|NCT01515319|69271992|FG008|Overall Study|Withdrawal by Subject|0|||
37669137|NCT02064868|69142063|FG001|Overall Study|Withdrawal by Subject|3|||
37669138|NCT02064868|69142062|FG000|Overall Study|Technical Problems or Missing|5|||
37669139|NCT02064868|69142063|FG001|Overall Study|Technical Problems or Missing|2|||
37669140|NCT02064166|69142071|FG000|Overall Study|Adverse Event|1|||
37669141|NCT02064166|69142072|FG001|Overall Study|Adverse Event|0|||
37760983|NCT01515319|69271993|FG009|Overall Study|Withdrawal by Subject|0|||
37669142|NCT02565615|69142105|FG000|Overall Study|Death|0|||
37669143|NCT02565615|69142106|FG001|Overall Study|Death|1|||
37669144|NCT02565615|69142107|FG002|Overall Study|Death|0|||
37669145|NCT02565615|69142108|FG003|Overall Study|Death|0|||
37669146|NCT02565615|69142109|FG004|Overall Study|Death|4|||
37669147|NCT02565615|69142105|FG000|Overall Study|Not willing to participate in study|2|||
37669148|NCT02565615|69142106|FG001|Overall Study|Not willing to participate in study|21|||
37669149|NCT02565615|69142107|FG002|Overall Study|Not willing to participate in study|0|||
37669150|NCT02565615|69142108|FG003|Overall Study|Not willing to participate in study|1|||
37669151|NCT02565615|69142109|FG004|Overall Study|Not willing to participate in study|169|||
37669152|NCT02565615|69142105|FG000|Overall Study|Lost to Follow-up|0|||
37669153|NCT02565615|69142106|FG001|Overall Study|Lost to Follow-up|4|||
37669154|NCT02565615|69142107|FG002|Overall Study|Lost to Follow-up|0|||
37669155|NCT02565615|69142108|FG003|Overall Study|Lost to Follow-up|1|||
37669156|NCT02565615|69142109|FG004|Overall Study|Lost to Follow-up|765|||
37669157|NCT02565615|69142105|FG000|Overall Study|Not meeting eligibility criteria|0|||
37669158|NCT02565615|69142106|FG001|Overall Study|Not meeting eligibility criteria|7|||
37669159|NCT02565615|69142107|FG002|Overall Study|Not meeting eligibility criteria|0|||
37669160|NCT02565615|69142108|FG003|Overall Study|Not meeting eligibility criteria|0|||
37669161|NCT02565615|69142109|FG004|Overall Study|Not meeting eligibility criteria|25|||
37669162|NCT02565615|69142105|FG000|Overall Study|Reason not defined|0|||
37669163|NCT02565615|69142106|FG001|Overall Study|Reason not defined|2|||
37669164|NCT02565615|69142107|FG002|Overall Study|Reason not defined|0|||
37669165|NCT02565615|69142108|FG003|Overall Study|Reason not defined|1|||
37669166|NCT02565615|69142109|FG004|Overall Study|Reason not defined|62|||
37669167|NCT02565615|69142105|FG000|Overall Study|Adverse Event|1|||
37669168|NCT02565615|69142106|FG001|Overall Study|Adverse Event|1|||
37669169|NCT02565615|69142107|FG002|Overall Study|Adverse Event|0|||
37669170|NCT02565615|69142108|FG003|Overall Study|Adverse Event|0|||
37669171|NCT02565615|69142109|FG004|Overall Study|Adverse Event|9|||
37669172|NCT02565615|69142105|FG000|Overall Study|Untreated|0|||
37669173|NCT02565615|69142106|FG001|Overall Study|Untreated|0|||
37669174|NCT02565615|69142107|FG002|Overall Study|Untreated|0|||
37669175|NCT02565615|69142108|FG003|Overall Study|Untreated|0|||
37669176|NCT02565615|69142109|FG004|Overall Study|Untreated|567|||
37669177|NCT02701361|69142124|FG000|Overall Study|Lost to Follow-up|5|||
37669178|NCT02701361|69142125|FG001|Overall Study|Lost to Follow-up|2|||
37669179|NCT02701361|69142126|FG002|Overall Study|Lost to Follow-up|1|||
37669180|NCT02701361|69142124|FG000|Overall Study|Withdrawal by Subject|4|||
37669181|NCT02701361|69142125|FG001|Overall Study|Withdrawal by Subject|0|||
37669182|NCT02701361|69142126|FG002|Overall Study|Withdrawal by Subject|0|||
37669183|NCT02701361|69142124|FG000|Overall Study|timed out in rehab center|0|||
37669184|NCT02701361|69142125|FG001|Overall Study|timed out in rehab center|1|||
37669185|NCT02701361|69142126|FG002|Overall Study|timed out in rehab center|0|||
37669186|NCT02701361|69142124|FG000|Overall Study|incarceration|0|||
37669187|NCT02701361|69142125|FG001|Overall Study|incarceration|0|||
37669188|NCT02701361|69142126|FG002|Overall Study|incarceration|1|||
37669189|NCT01662999|69142151|FG000|Period 3|Withdrawal by Subject|0|||
37669190|NCT01662999|69142152|FG001|Period 3|Withdrawal by Subject|1|||
37669191|NCT01662999|69142153|FG002|Period 3|Withdrawal by Subject|0|||
37669192|NCT01662999|69142154|FG003|Period 3|Withdrawal by Subject|0|||
37669193|NCT01662999|69142155|FG004|Period 3|Withdrawal by Subject|0|||
37669194|NCT01662999|69142156|FG005|Period 3|Withdrawal by Subject|0|||
37669195|NCT02565381|69142189|FG000|Overall Study|Lost to Follow-up|1|||
37669196|NCT02565381|69142190|FG001|Overall Study|Lost to Follow-up|0|||
37669197|NCT02565381|69142191|FG002|Overall Study|Lost to Follow-up|1|||
37669198|NCT02063854|69142206|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
37669199|NCT02063854|69142207|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
37669200|NCT02063854|69142208|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
37669201|NCT02063854|69142209|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
37669202|NCT02063854|69142210|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
37669203|NCT02063854|69142211|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
37669204|NCT02063854|69142212|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
37669205|NCT02063854|69142206|FG000|Overall Study|Major Protocol Deviation|0|||
37669206|NCT02063854|69142207|FG001|Overall Study|Major Protocol Deviation|0|||
37669207|NCT02063854|69142208|FG002|Overall Study|Major Protocol Deviation|3|||
37669208|NCT02063854|69142209|FG003|Overall Study|Major Protocol Deviation|0|||
37669209|NCT02063854|69142210|FG004|Overall Study|Major Protocol Deviation|0|||
37669210|NCT02063854|69142211|FG005|Overall Study|Major Protocol Deviation|0|||
37669211|NCT02063854|69142212|FG006|Overall Study|Major Protocol Deviation|0|||
37760984|NCT01515319|69271984|FG000|Overall Study|Adverse Event|0|||
37932806|NCT00723450|69619673|FG001|Open-Label Phase|Withdrawal by Subject|0|||
38034920|NCT04130919|69721783|FG005|Blinded Treatment Phase|Withdrew consent|0|||
37669212|NCT02063854|69142206|FG000|Overall Study|Voluntary Withdrawal|2|||
37669213|NCT02063854|69142207|FG001|Overall Study|Voluntary Withdrawal|0|||
37669214|NCT02063854|69142208|FG002|Overall Study|Voluntary Withdrawal|8|||
37669215|NCT02063854|69142209|FG003|Overall Study|Voluntary Withdrawal|1|||
37669216|NCT02063854|69142210|FG004|Overall Study|Voluntary Withdrawal|3|||
37669217|NCT02063854|69142211|FG005|Overall Study|Voluntary Withdrawal|6|||
37932807|NCT00723450|69619674|FG002|Open-Label Phase|Withdrawal by Subject|0|||
37669218|NCT02063854|69142212|FG006|Overall Study|Voluntary Withdrawal|1|||
37669219|NCT02063854|69142206|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
37669220|NCT02063854|69142207|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
37669221|NCT02063854|69142208|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
37760985|NCT01515319|69271985|FG001|Overall Study|Adverse Event|0|||
37669222|NCT02063854|69142209|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
37669223|NCT02063854|69142210|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
37669224|NCT02063854|69142211|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
37669225|NCT02063854|69142212|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
37669226|NCT02063854|69142206|FG000|Overall Study|Reason Not Specified|1|||
37669227|NCT02063854|69142207|FG001|Overall Study|Reason Not Specified|0|||
37669228|NCT02063854|69142208|FG002|Overall Study|Reason Not Specified|0|||
37669229|NCT02063854|69142209|FG003|Overall Study|Reason Not Specified|0|||
37669230|NCT02063854|69142210|FG004|Overall Study|Reason Not Specified|0|||
37669231|NCT02063854|69142211|FG005|Overall Study|Reason Not Specified|0|||
37669232|NCT02063854|69142212|FG006|Overall Study|Reason Not Specified|0|||
37669233|NCT02063854|69142206|FG000|Overall Study|Did Not Receive Study Drug|0|||
37669234|NCT02063854|69142207|FG001|Overall Study|Did Not Receive Study Drug|0|||
37669235|NCT02063854|69142208|FG002|Overall Study|Did Not Receive Study Drug|0|||
37669236|NCT02063854|69142209|FG003|Overall Study|Did Not Receive Study Drug|0|||
37669237|NCT02063854|69142210|FG004|Overall Study|Did Not Receive Study Drug|0|||
37669238|NCT02063854|69142211|FG005|Overall Study|Did Not Receive Study Drug|1|||
37669239|NCT02063854|69142212|FG006|Overall Study|Did Not Receive Study Drug|0|||
37669240|NCT02063698|69142232|FG000|Overall Study|did not complete booklet for days 2-8|1|||
37669241|NCT02063698|69142233|FG001|Overall Study|did not complete booklet for days 2-8|2|||
37669242|NCT04701333|69142241|FG000|Overall Study|Lost to Follow-up|3|||
37669243|NCT04701333|69142242|FG001|Overall Study|Lost to Follow-up|7|||
37669244|NCT04701333|69142241|FG000|Overall Study|Withdrawal by Subject|0|||
37669245|NCT04701333|69142242|FG001|Overall Study|Withdrawal by Subject|1|||
37669246|NCT02062450|69142250|FG000|Overall Study|No follow-up visit|124|||
37669247|NCT02561247|69142258|FG000|Overall Study|Protocol Violation|1|||
37669248|NCT02561247|69142258|FG000|Overall Study|Withdrawal by Subject|1|||
37669249|NCT02561247|69142258|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
37669250|NCT02061592|69142264|FG000|Period 1|Withdrawal by Subject|1|||
37669251|NCT02061592|69142265|FG001|Period 1|Withdrawal by Subject|0|||
37669252|NCT02061592|69142264|FG000|Period 1|Protocol Violation|1|||
37932808|NCT00723450|69619672|FG000|Randomized Phase|Adverse Event|0|||
37932809|NCT00723450|69619673|FG001|Randomized Phase|Adverse Event|26|||
37932810|NCT00723450|69619674|FG002|Randomized Phase|Adverse Event|17|||
37932811|NCT00723450|69619672|FG000|Randomized Phase|Lack of Efficacy|0|||
37932812|NCT00723450|69619673|FG001|Randomized Phase|Lack of Efficacy|11|||
37932813|NCT00723450|69619674|FG002|Randomized Phase|Lack of Efficacy|11|||
37932814|NCT00723450|69619672|FG000|Randomized Phase|Protocol Violation|0|||
37932815|NCT00723450|69619673|FG001|Randomized Phase|Protocol Violation|9|||
37932816|NCT00723450|69619674|FG002|Randomized Phase|Protocol Violation|13|||
37932817|NCT00723450|69619672|FG000|Randomized Phase|Lost to Follow-up|0|||
37932818|NCT00723450|69619673|FG001|Randomized Phase|Lost to Follow-up|2|||
37932819|NCT00723450|69619674|FG002|Randomized Phase|Lost to Follow-up|3|||
37932820|NCT00723450|69619672|FG000|Randomized Phase|Physician Decision|0|||
37932821|NCT00723450|69619673|FG001|Randomized Phase|Physician Decision|3|||
37932822|NCT00723450|69619674|FG002|Randomized Phase|Physician Decision|1|||
37932823|NCT00723450|69619672|FG000|Randomized Phase|Withdrawal by Subject|0|||
37932824|NCT00723450|69619673|FG001|Randomized Phase|Withdrawal by Subject|14|||
37932825|NCT00723450|69619674|FG002|Randomized Phase|Withdrawal by Subject|22|||
37932826|NCT00751400|69619683|FG000|Overall Study|Lost to Follow-up|10|||
37932827|NCT00585312|69619689|FG000|Overall Study|Adverse Event|3|||
37932828|NCT00585312|69619690|FG001|Overall Study|Adverse Event|0|||
37932829|NCT00585312|69619689|FG000|Overall Study|Lack of Efficacy|6|||
37932830|NCT00585312|69619690|FG001|Overall Study|Lack of Efficacy|11|||
37932831|NCT00585312|69619689|FG000|Overall Study|Lost to Follow-up|1|||
37932832|NCT00585312|69619690|FG001|Overall Study|Lost to Follow-up|1|||
37932833|NCT00585312|69619689|FG000|Overall Study|Reason not specified|2|||
37932834|NCT00585312|69619690|FG001|Overall Study|Reason not specified|0|||
37932835|NCT00585312|69619689|FG000|Overall Study|Withdrawal by Subject|5|||
37932836|NCT00585312|69619690|FG001|Overall Study|Withdrawal by Subject|1|||
37669253|NCT02061592|69142265|FG001|Period 1|Protocol Violation|0|||
37669254|NCT02061592|69142264|FG000|Period 2|Lost to Follow-up|0|||
37932837|NCT00585312|69619689|FG000|Overall Study|Study terminated by the sponsor|34|||
37669255|NCT02061592|69142265|FG001|Period 2|Lost to Follow-up|1|||
37669256|NCT01663623|69142275|FG000|Overall Study|Adverse Event|3|||
37669257|NCT01663623|69142276|FG001|Overall Study|Adverse Event|7|||
37669258|NCT01663623|69142275|FG000|Overall Study|Lack of Efficacy|5|||
37669259|NCT01663623|69142276|FG001|Overall Study|Lack of Efficacy|6|||
37669260|NCT01663623|69142275|FG000|Overall Study|Protocol Violation|0|||
37669261|NCT01663623|69142276|FG001|Overall Study|Protocol Violation|1|||
37669262|NCT01663623|69142275|FG000|Overall Study|Other-Study closed/terminated|1|||
37932838|NCT00585312|69619690|FG001|Overall Study|Study terminated by the sponsor|31|||
37932839|NCT00753506|69619698|FG000|Overall Study|Withdrawal by Subject|4|||
37932840|NCT00753506|69619699|FG001|Overall Study|Withdrawal by Subject|1|||
37932841|NCT00753506|69619698|FG000|Overall Study|Lost to Follow-up|2|||
37932842|NCT00753506|69619699|FG001|Overall Study|Lost to Follow-up|0|||
37669263|NCT01663623|69142276|FG001|Overall Study|Other-Study closed/terminated|1|||
37669264|NCT01663623|69142275|FG000|Overall Study|Physician Decision|1|||
37669265|NCT01663623|69142276|FG001|Overall Study|Physician Decision|4|||
37669266|NCT01663623|69142275|FG000|Overall Study|Withdrawal by Subject|2|||
37669267|NCT01663623|69142276|FG001|Overall Study|Withdrawal by Subject|1|||
37669268|NCT02042950|69142282|FG000|Overall Study|Progressive Disease|4|||
37669269|NCT02042404|69142286|FG000|Overall Study|Death|1|||
37669270|NCT02042404|69142287|FG001|Overall Study|Death|0|||
37669271|NCT02042404|69142286|FG000|Overall Study|Unrelated Adverse Event|3|||
37669272|NCT02042404|69142287|FG001|Overall Study|Unrelated Adverse Event|0|||
37669273|NCT02042404|69142286|FG000|Overall Study|Inability to meet time requirements|1|||
37669274|NCT02042404|69142287|FG001|Overall Study|Inability to meet time requirements|0|||
37669275|NCT02042014|69142294|FG000|Overall Study|Adverse Event|1|||
37669276|NCT02042014|69142294|FG000|Overall Study|Physician Decision|7|||
37669277|NCT02041702|69142300|FG000|Overall Study|Lost to Follow-up|1|||
37669278|NCT02041702|69142301|FG001|Overall Study|Lost to Follow-up|6|||
37669279|NCT02041702|69142300|FG000|Overall Study|Death|4|||
37669280|NCT02041702|69142301|FG001|Overall Study|Death|0|||
37669281|NCT02041702|69142300|FG000|Overall Study|Withdrawal by Subject|4|||
37669282|NCT02041702|69142301|FG001|Overall Study|Withdrawal by Subject|3|||
37669283|NCT02041702|69142300|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
37669284|NCT02041702|69142301|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
37669285|NCT02041702|69142300|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
37669286|NCT02041702|69142301|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
37669287|NCT02565147|69142309|FG000|Overall Study|Withdrawal by Subject|5|||
37669288|NCT02565147|69142310|FG001|Overall Study|Withdrawal by Subject|1|||
37669289|NCT02565147|69142309|FG000|Overall Study|Lost to Follow-up|0|||
37669290|NCT02565147|69142310|FG001|Overall Study|Lost to Follow-up|1|||
37669291|NCT02565147|69142309|FG000|Overall Study|Death|1|||
37669292|NCT02565147|69142310|FG001|Overall Study|Death|1|||
37669293|NCT02061280|69142318|FG000|Overall Study|Protocol Violation|12|||
37669294|NCT02061280|69142319|FG001|Overall Study|Protocol Violation|8|||
37669295|NCT02061280|69142318|FG000|Overall Study|moved out of state|0|||
37669296|NCT02061280|69142319|FG001|Overall Study|moved out of state|1|||
37669297|NCT02061280|69142318|FG000|Overall Study|Withdrawal by Subject|1|||
37669298|NCT02061280|69142319|FG001|Overall Study|Withdrawal by Subject|2|||
37669299|NCT02061280|69142318|FG000|Overall Study|Lost to Follow-up|5|||
37669300|NCT02061280|69142319|FG001|Overall Study|Lost to Follow-up|1|||
37669301|NCT02061202|69142330|FG000|Overall Study|Lost to Follow-up|1|||
37669302|NCT02061202|69142331|FG001|Overall Study|Lost to Follow-up|1|||
37669303|NCT02059408|69142340|FG000|Overall Study|Did not get tested|0|||
37669304|NCT02059408|69142341|FG001|Overall Study|Did not get tested|330|||
37669305|NCT02059408|69142342|FG002|Overall Study|Did not get tested|358|||
37669306|NCT01625338|69142355|FG000|Overall Study|Enrolled but not Treated|0|||
37669307|NCT01625338|69142356|FG001|Overall Study|Enrolled but not Treated|0|||
37669308|NCT01625338|69142357|FG002|Overall Study|Enrolled but not Treated|1|||
37669309|NCT01625338|69142355|FG000|Overall Study|Efficacy Failure|27|||
37669310|NCT01625338|69142356|FG001|Overall Study|Efficacy Failure|39|||
37669311|NCT01625338|69142357|FG002|Overall Study|Efficacy Failure|31|||
37669312|NCT01625338|69142355|FG000|Overall Study|Lost to Follow-up|3|||
37669313|NCT01625338|69142356|FG001|Overall Study|Lost to Follow-up|3|||
37669314|NCT01625338|69142357|FG002|Overall Study|Lost to Follow-up|2|||
37669315|NCT01625338|69142355|FG000|Overall Study|Investigator Decision|0|||
37669316|NCT01625338|69142356|FG001|Overall Study|Investigator Decision|2|||
37669317|NCT01625338|69142357|FG002|Overall Study|Investigator Decision|1|||
37669318|NCT01625338|69142355|FG000|Overall Study|Subject Withdrew Consent|1|||
37669319|NCT01625338|69142356|FG001|Overall Study|Subject Withdrew Consent|0|||
37669320|NCT01625338|69142357|FG002|Overall Study|Subject Withdrew Consent|2|||
37669321|NCT01625338|69142355|FG000|Overall Study|Adverse Event|1|||
37932843|NCT00753506|69619698|FG000|Overall Study|Other reason|1|||
37932844|NCT00753506|69619699|FG001|Overall Study|Other reason|1|||
37669322|NCT01625338|69142356|FG001|Overall Study|Adverse Event|0|||
37669323|NCT01625338|69142357|FG002|Overall Study|Adverse Event|1|||
37760986|NCT01515319|69271986|FG002|Overall Study|Adverse Event|0|||
37932845|NCT00720096|69619707|FG000|Overall Study|Withdrawal by Subject|0|||
37669324|NCT01625338|69142355|FG000|Overall Study|Study Discontinued by Sponsor|0|||
37669325|NCT01625338|69142356|FG001|Overall Study|Study Discontinued by Sponsor|0|||
37760987|NCT01515319|69271987|FG003|Overall Study|Adverse Event|0|||
37669326|NCT01625338|69142357|FG002|Overall Study|Study Discontinued by Sponsor|1|||
37669327|NCT02560623|69142369|FG000|Overall Study|Unable to swallow sponge|0|||
37669328|NCT02560623|69142370|FG001|Overall Study|Unable to swallow sponge|1|||
37669329|NCT02560623|69142371|FG002|Overall Study|Unable to swallow sponge|0|||
37669330|NCT02560623|69142372|FG003|Overall Study|Unable to swallow sponge|0|||
37760988|NCT01515319|69271988|FG004|Overall Study|Adverse Event|0|||
37760989|NCT01515319|69271989|FG005|Overall Study|Adverse Event|0|||
37669331|NCT02560623|69142369|FG000|Overall Study|Intervention prior to sponge administration|0|||
37669332|NCT02560623|69142370|FG001|Overall Study|Intervention prior to sponge administration|1|||
37669333|NCT02560623|69142371|FG002|Overall Study|Intervention prior to sponge administration|0|||
37669334|NCT02560623|69142372|FG003|Overall Study|Intervention prior to sponge administration|0|||
37669335|NCT02560389|69142385|FG000|Overall Study|Lost to Follow-up|1|||
37669336|NCT02560389|69142386|FG001|Overall Study|Lost to Follow-up|2|||
37669337|NCT02560389|69142387|FG002|Overall Study|Lost to Follow-up|2|||
37669338|NCT02560389|69142385|FG000|Overall Study|Tested positive for illicit substance|0|||
37669339|NCT02560389|69142386|FG001|Overall Study|Tested positive for illicit substance|1|||
37669340|NCT02560389|69142387|FG002|Overall Study|Tested positive for illicit substance|0|||
37669341|NCT02564211|69142395|FG000|Overall Study|Adverse Event|4|||
37669342|NCT02093026|69142399|FG000|Overall Study|Adverse Event|26|||
37669343|NCT02093026|69142399|FG000|Overall Study|Death|10|||
37669344|NCT02093026|69142399|FG000|Overall Study|Other|157|||
37669345|NCT02040844|69142407|FG000|Overall Study|Adverse Event|0|||
37669346|NCT02040844|69142408|FG001|Overall Study|Adverse Event|0|||
37669347|NCT02040844|69142409|FG002|Overall Study|Adverse Event|1|||
37669348|NCT02040844|69142407|FG000|Overall Study|Withdrawal by Subject|16|||
37669349|NCT02040844|69142408|FG001|Overall Study|Withdrawal by Subject|22|||
37760990|NCT01515319|69271990|FG006|Overall Study|Adverse Event|0|||
37932846|NCT00720096|69619708|FG001|Overall Study|Withdrawal by Subject|2|||
37932847|NCT00723294|69619714|FG000|Overall Study|Lobular histology|2|||
37760991|NCT01515319|69271991|FG007|Overall Study|Adverse Event|0|||
37760992|NCT01515319|69271992|FG008|Overall Study|Adverse Event|3|||
37760993|NCT01515319|69271993|FG009|Overall Study|Adverse Event|0|||
37760994|NCT01515319|69271984|FG000|Overall Study|Protocol Violation|0|||
37760995|NCT01515319|69271985|FG001|Overall Study|Protocol Violation|0|||
37760996|NCT01515319|69271986|FG002|Overall Study|Protocol Violation|0|||
37760997|NCT01515319|69271987|FG003|Overall Study|Protocol Violation|0|||
37760998|NCT01515319|69271988|FG004|Overall Study|Protocol Violation|0|||
37760999|NCT01515319|69271989|FG005|Overall Study|Protocol Violation|0|||
37761000|NCT01515319|69271990|FG006|Overall Study|Protocol Violation|0|||
37761001|NCT01515319|69271991|FG007|Overall Study|Protocol Violation|0|||
37761002|NCT01515319|69271992|FG008|Overall Study|Protocol Violation|2|||
37761003|NCT01515319|69271993|FG009|Overall Study|Protocol Violation|0|||
37761004|NCT01492361|69272030|FG000|Overall Study|Withdrawal by Subject|281|||
37761005|NCT01492361|69272031|FG001|Overall Study|Withdrawal by Subject|297|||
37761006|NCT01492361|69272030|FG000|Overall Study|Physician Decision|12|||
37761007|NCT01492361|69272031|FG001|Overall Study|Physician Decision|12|||
37761008|NCT01492361|69272030|FG000|Overall Study|Lost to Follow-up|6|||
37761009|NCT01492361|69272031|FG001|Overall Study|Lost to Follow-up|13|||
37761010|NCT01492361|69272030|FG000|Overall Study|Other than specified above|106|||
37761011|NCT01492361|69272031|FG001|Overall Study|Other than specified above|138|||
37761012|NCT01514461|69272110|FG000|Overall Study|Adverse Event|2|||
37761013|NCT01514461|69272111|FG001|Overall Study|Adverse Event|1|||
37761014|NCT01514461|69272112|FG002|Overall Study|Adverse Event|3|||
37761015|NCT01514461|69272110|FG000|Overall Study|Physician Decision|1|||
37761016|NCT01514461|69272111|FG001|Overall Study|Physician Decision|1|||
37761017|NCT01514461|69272112|FG002|Overall Study|Physician Decision|0|||
37761018|NCT01514461|69272110|FG000|Overall Study|Patient/guardian decision|1|||
37761019|NCT01514461|69272111|FG001|Overall Study|Patient/guardian decision|1|||
37761020|NCT01514461|69272112|FG002|Overall Study|Patient/guardian decision|1|||
37761021|NCT01514461|69272110|FG000|Overall Study|Death|1|||
37761022|NCT01514461|69272111|FG001|Overall Study|Death|0|||
37932848|NCT00723294|69619714|FG000|Overall Study|>25% intraductal component|1|||
37932849|NCT00723294|69619714|FG000|Overall Study|No MRI tumor enhancement|1|||
37932850|NCT00723294|69619714|FG000|Overall Study|1.0-Tesla MRI|1|||
37932851|NCT00723294|69619714|FG000|Overall Study|No cryoabalation|2|||
37932852|NCT00723294|69619714|FG000|Overall Study|Did not undergo surgery|1|||
37932853|NCT00723294|69619714|FG000|Overall Study|Treated prior to registration|1|||
37669350|NCT02040844|69142409|FG002|Overall Study|Withdrawal by Subject|25|||
37761023|NCT01514461|69272112|FG002|Overall Study|Death|0|||
37761024|NCT01491737|69272158|FG000|Overall Study|Withdrawal by Subject|20|||
37761025|NCT01491737|69272159|FG001|Overall Study|Withdrawal by Subject|17|||
37761026|NCT01491737|69272158|FG000|Overall Study|Lost to Follow-up|2|||
37761027|NCT01491737|69272159|FG001|Overall Study|Lost to Follow-up|10|||
37761028|NCT01491737|69272158|FG000|Overall Study|Death|63|||
37669351|NCT02040844|69142407|FG000|Overall Study|Lost to Follow-up|12|||
37669352|NCT02040844|69142408|FG001|Overall Study|Lost to Follow-up|9|||
37669353|NCT02040844|69142409|FG002|Overall Study|Lost to Follow-up|13|||
37669354|NCT02040844|69142407|FG000|Overall Study|Missing|13|||
37761029|NCT01491737|69272159|FG001|Overall Study|Death|57|||
37859439|NCT01288079|69542752|FG003|Overall Study|Lost to Follow-up|0|||
37859440|NCT01288079|69542749|FG000|Overall Study|Other or Study Termination|11|||
37859441|NCT01288079|69542750|FG001|Overall Study|Other or Study Termination|15|||
37859442|NCT01288079|69542751|FG002|Overall Study|Other or Study Termination|14|||
37859443|NCT01288079|69542752|FG003|Overall Study|Other or Study Termination|8|||
37859444|NCT01287221|69542764|FG000|Overall Study|Lack of Perceived Benefit|1|||
37859445|NCT01287221|69542765|FG001|Overall Study|Lack of Perceived Benefit|1|||
37859446|NCT01287221|69542764|FG000|Overall Study|Adverse Event|3|||
37761030|NCT01491737|69272158|FG000|Overall Study|Study Termination by Sponsor|36|||
37761031|NCT01491737|69272159|FG001|Overall Study|Study Termination by Sponsor|36|||
37761032|NCT01491737|69272158|FG000|Overall Study|Reason Not Specified|8|||
37761033|NCT01491737|69272159|FG001|Overall Study|Reason Not Specified|9|||
37761034|NCT01487863|69272171|FG000|Overall Study|Death|19|||
37761035|NCT01487863|69272172|FG001|Overall Study|Death|19|||
37761036|NCT01487161|69272191|FG000|Overall Study|Adverse Event|1|||
37761037|NCT01487161|69272192|FG001|Overall Study|Adverse Event|0|||
37761038|NCT01487161|69272193|FG002|Overall Study|Adverse Event|0|||
37761039|NCT01487161|69272194|FG003|Overall Study|Adverse Event|0|||
37761040|NCT01487161|69272191|FG000|Overall Study|Withdrawal by Subject|1|||
37761041|NCT01487161|69272192|FG001|Overall Study|Withdrawal by Subject|1|||
37761042|NCT01487161|69272193|FG002|Overall Study|Withdrawal by Subject|1|||
37761043|NCT01487161|69272194|FG003|Overall Study|Withdrawal by Subject|2|||
37761044|NCT01487161|69272191|FG000|Overall Study|missing data|0|||
37761045|NCT01487161|69272192|FG001|Overall Study|missing data|1|||
37761046|NCT01487161|69272193|FG002|Overall Study|missing data|0|||
37761047|NCT01487161|69272194|FG003|Overall Study|missing data|0|||
37761048|NCT01491035|69272249|FG000|Overall Study|Lost to Follow-up|0|||
37761049|NCT01491035|69272250|FG001|Overall Study|Lost to Follow-up|0|||
37761050|NCT01491035|69272251|FG002|Overall Study|Lost to Follow-up|0|||
37761051|NCT01491035|69272252|FG003|Overall Study|Lost to Follow-up|0|||
37761052|NCT01491035|69272253|FG004|Overall Study|Lost to Follow-up|1|||
37761053|NCT01491035|69272254|FG005|Overall Study|Lost to Follow-up|0|||
37761054|NCT01491035|69272255|FG006|Overall Study|Lost to Follow-up|0|||
37932854|NCT00723294|69619714|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
37932855|NCT00723294|69619714|FG000|Overall Study|Benign lesion|1|||
37932856|NCT00723294|69619714|FG000|Overall Study|Withdrawal by Subject|1|||
37932857|NCT00723294|69619714|FG000|Overall Study|No treatment due to probe failure|1|||
38034921|NCT04130919|69721778|FG000|Open-label Treatment Phase|Withdrew consent|0|||
38034922|NCT04130919|69721779|FG001|Open-label Treatment Phase|Withdrew consent|0|||
38034923|NCT04130919|69721780|FG002|Open-label Treatment Phase|Withdrew consent|0|||
38034924|NCT04130919|69721781|FG003|Open-label Treatment Phase|Withdrew consent|1|||
38034925|NCT04130919|69721782|FG004|Open-label Treatment Phase|Withdrew consent|1|||
38034926|NCT04130919|69721783|FG005|Open-label Treatment Phase|Withdrew consent|1|||
38034927|NCT04130919|69721778|FG000|Open-label Treatment Phase|Disease worsening|0|||
38034928|NCT04130919|69721779|FG001|Open-label Treatment Phase|Disease worsening|0|||
38034929|NCT04130919|69721780|FG002|Open-label Treatment Phase|Disease worsening|0|||
38034930|NCT04130919|69721781|FG003|Open-label Treatment Phase|Disease worsening|1|||
38034931|NCT04130919|69721782|FG004|Open-label Treatment Phase|Disease worsening|0|||
38034932|NCT04130919|69721783|FG005|Open-label Treatment Phase|Disease worsening|1|||
38034933|NCT04130919|69721778|FG000|Open-label Treatment Phase|Investigator's decision|0|||
37761055|NCT01491035|69272256|FG007|Overall Study|Lost to Follow-up|0|||
37761056|NCT01488071|69272280|FG000|Overall Study|Adverse Event|15|||
38034934|NCT04130919|69721779|FG001|Open-label Treatment Phase|Investigator's decision|0|||
38034935|NCT04130919|69721780|FG002|Open-label Treatment Phase|Investigator's decision|0|||
38034936|NCT04130919|69721781|FG003|Open-label Treatment Phase|Investigator's decision|1|||
38034937|NCT04130919|69721782|FG004|Open-label Treatment Phase|Investigator's decision|0|||
38034938|NCT04130919|69721783|FG005|Open-label Treatment Phase|Investigator's decision|0|||
38034939|NCT04130919|69721778|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
38034940|NCT04130919|69721779|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
38034941|NCT04130919|69721780|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
38034942|NCT04130919|69721781|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
38034943|NCT04130919|69721782|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
38034944|NCT04130919|69721783|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
38034945|NCT04130919|69721778|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
38034946|NCT04130919|69721779|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
37761057|NCT01488071|69272281|FG001|Overall Study|Adverse Event|23|||
37761058|NCT01488071|69272280|FG000|Overall Study|Lack of Efficacy|11|||
37761059|NCT01488071|69272281|FG001|Overall Study|Lack of Efficacy|17|||
38034947|NCT04130919|69721780|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
38034948|NCT04130919|69721781|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
38034949|NCT04130919|69721782|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
38034950|NCT04130919|69721783|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
38034951|NCT04128267|69721797|FG000|Overall Study|Withdrawal by Subject|6|||
38034952|NCT04128267|69721797|FG000|Overall Study|Death|2|||
38034953|NCT04128267|69721797|FG000|Overall Study|Disease progression|1|||
38034954|NCT04128267|69721797|FG000|Overall Study|Participant had other medical issues|4|||
38034955|NCT04128267|69721797|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
38034956|NCT03691779|69721801|FG000|Part B (24 Weeks)|Adverse Event|0|||
37761060|NCT01488071|69272280|FG000|Overall Study|Non-compliance with study drug|2|||
37761061|NCT01488071|69272281|FG001|Overall Study|Non-compliance with study drug|0|||
37761062|NCT01488071|69272280|FG000|Overall Study|Protocol Violation|5|||
37761063|NCT01488071|69272281|FG001|Overall Study|Protocol Violation|7|||
37761064|NCT01488071|69272280|FG000|Overall Study|Withdrawal of Consent|14|||
37761065|NCT01488071|69272281|FG001|Overall Study|Withdrawal of Consent|12|||
37761066|NCT01488071|69272280|FG000|Overall Study|Lost to Follow-up|1|||
37761067|NCT01488071|69272281|FG001|Overall Study|Lost to Follow-up|0|||
37761068|NCT01488071|69272280|FG000|Overall Study|Administrative or Other Reason(s)|5|||
37761069|NCT01488071|69272281|FG001|Overall Study|Administrative or Other Reason(s)|4|||
37761070|NCT01487525|69272289|FG000|Overall Study|Withdrawal by Subject|0|||
37761071|NCT01487525|69272290|FG001|Overall Study|Withdrawal by Subject|1|||
37761072|NCT01486199|69272298|FG000|Two Year Period Between Study Days|Physician Decision|1|||
37761073|NCT01486199|69272299|FG001|Two Year Period Between Study Days|Physician Decision|0|||
37761074|NCT01485887|69272305|FG000|Overall Study|Withdrawal by Subject|2|||
38034957|NCT03691779|69721802|FG001|Part B (24 Weeks)|Adverse Event|1|||
38034958|NCT03691779|69721801|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
38034959|NCT03691779|69721802|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
37669355|NCT02040844|69142408|FG001|Overall Study|Missing|3|||
37669356|NCT02040844|69142409|FG002|Overall Study|Missing|2|||
37669357|NCT02040844|69142407|FG000|Overall Study|Non-specified|8|||
37669358|NCT02040844|69142408|FG001|Overall Study|Non-specified|2|||
37669359|NCT02040844|69142409|FG002|Overall Study|Non-specified|5|||
37669360|NCT02040844|69142407|FG000|Overall Study|Concomitant medication|1|||
37669361|NCT02040844|69142408|FG001|Overall Study|Concomitant medication|3|||
37669362|NCT02040844|69142409|FG002|Overall Study|Concomitant medication|1|||
37669363|NCT02059174|69142417|FG000|Period 1|Withdrawal by Subject|0|||
37669364|NCT02059174|69142418|FG001|Period 1|Withdrawal by Subject|2|||
37669365|NCT02059174|69142417|FG000|Period 2|Withdrawal by Subject|0|||
37669366|NCT02059174|69142418|FG001|Period 2|Withdrawal by Subject|2|||
37669367|NCT02059174|69142417|FG000|Period 2|Protocol Violation|1|||
37669368|NCT02059174|69142418|FG001|Period 2|Protocol Violation|0|||
37669369|NCT02059174|69142417|FG000|Period 3|Physician Decision|1|||
37669370|NCT02059174|69142418|FG001|Period 3|Physician Decision|0|||
37669371|NCT02092324|69142426|FG000|Overall Study|Adverse Event|1|||
37669372|NCT02092324|69142426|FG000|Overall Study|Lack of Efficacy|6|||
37669373|NCT02092324|69142426|FG000|Overall Study|Proceed to Transplant|3|||
37669374|NCT02092324|69142426|FG000|Overall Study|Physician Decision|7|||
37669375|NCT02092324|69142426|FG000|Overall Study|Misdiagnosis|2|||
37669376|NCT02040766|69142438|FG000|Overall Study|Adverse Event|1|||
37669377|NCT02040766|69142439|FG001|Overall Study|Adverse Event|1|||
37669378|NCT02040766|69142440|FG002|Overall Study|Adverse Event|1|||
37669379|NCT02040766|69142441|FG003|Overall Study|Adverse Event|0|||
37669380|NCT02040766|69142442|FG004|Overall Study|Adverse Event|2|||
37669381|NCT02040766|69142438|FG000|Overall Study|Withdrawal by Subject|4|||
37669382|NCT02040766|69142439|FG001|Overall Study|Withdrawal by Subject|3|||
37669383|NCT02040766|69142440|FG002|Overall Study|Withdrawal by Subject|2|||
37669384|NCT02040766|69142441|FG003|Overall Study|Withdrawal by Subject|3|||
37669385|NCT02040766|69142442|FG004|Overall Study|Withdrawal by Subject|2|||
37669386|NCT02040766|69142438|FG000|Overall Study|Non-compliance|0|||
37669387|NCT02040766|69142439|FG001|Overall Study|Non-compliance|1|||
37669388|NCT02040766|69142440|FG002|Overall Study|Non-compliance|0|||
37669389|NCT02040766|69142441|FG003|Overall Study|Non-compliance|0|||
37669390|NCT02040766|69142442|FG004|Overall Study|Non-compliance|0|||
37669391|NCT02040766|69142438|FG000|Overall Study|Protocol Violation|2|||
37669392|NCT02040766|69142439|FG001|Overall Study|Protocol Violation|1|||
37669393|NCT02040766|69142440|FG002|Overall Study|Protocol Violation|2|||
37669394|NCT02040766|69142441|FG003|Overall Study|Protocol Violation|3|||
37669395|NCT02040766|69142442|FG004|Overall Study|Protocol Violation|0|||
37669396|NCT02040766|69142438|FG000|Overall Study|Lost to Follow-up|4|||
37669397|NCT02040766|69142439|FG001|Overall Study|Lost to Follow-up|1|||
37669398|NCT02040766|69142440|FG002|Overall Study|Lost to Follow-up|3|||
37669399|NCT02040766|69142441|FG003|Overall Study|Lost to Follow-up|1|||
37669400|NCT02040766|69142442|FG004|Overall Study|Lost to Follow-up|4|||
37669401|NCT02040766|69142438|FG000|Overall Study|Not reported|1|||
37669402|NCT02040766|69142439|FG001|Overall Study|Not reported|0|||
37669403|NCT02040766|69142440|FG002|Overall Study|Not reported|0|||
37669404|NCT02040766|69142441|FG003|Overall Study|Not reported|0|||
37669405|NCT02040766|69142442|FG004|Overall Study|Not reported|0|||
37669406|NCT02040766|69142438|FG000|Overall Study|Lack of Efficacy|6|||
37669407|NCT02040766|69142439|FG001|Overall Study|Lack of Efficacy|3|||
37669408|NCT02040766|69142440|FG002|Overall Study|Lack of Efficacy|4|||
37669409|NCT02040766|69142441|FG003|Overall Study|Lack of Efficacy|6|||
37669410|NCT02040766|69142442|FG004|Overall Study|Lack of Efficacy|5|||
37669411|NCT02040532|69142455|FG000|Overall Study|Lost to Follow-up|1|||
37669412|NCT02040532|69142455|FG000|Overall Study|Physician Decision|4|||
37669413|NCT02040532|69142455|FG000|Overall Study|Adverse Event|4|||
37669414|NCT02040532|69142455|FG000|Overall Study|Withdrawal by Subject|3|||
37669415|NCT02039908|69142459|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
37761075|NCT01485887|69272305|FG000|Overall Study|Adverse Event|8|||
37761076|NCT01485887|69272305|FG000|Overall Study|Deterioration of primary disease|1|||
37761077|NCT01485887|69272305|FG000|Overall Study|Primary disease markedly improved|1|||
37761078|NCT01546519|69272313|FG000|Overall Study|Adverse Event|0|||
37761079|NCT01546519|69272314|FG001|Overall Study|Adverse Event|0|||
37761080|NCT01546519|69272315|FG002|Overall Study|Adverse Event|1|||
37761081|NCT01546519|69272316|FG003|Overall Study|Adverse Event|1|||
37761082|NCT01546519|69272313|FG000|Overall Study|Death|0|||
37761083|NCT01546519|69272314|FG001|Overall Study|Death|1|||
37761084|NCT01546519|69272315|FG002|Overall Study|Death|3|||
37761085|NCT01546519|69272316|FG003|Overall Study|Death|1|||
37761086|NCT01546519|69272313|FG000|Overall Study|related to disease progression|2|||
37761087|NCT01546519|69272314|FG001|Overall Study|related to disease progression|2|||
37761088|NCT01546519|69272315|FG002|Overall Study|related to disease progression|2|||
37761089|NCT01546519|69272316|FG003|Overall Study|related to disease progression|1|||
37761090|NCT01546519|69272313|FG000|Overall Study|Physician Decision|6|||
37761091|NCT01546519|69272314|FG001|Overall Study|Physician Decision|5|||
37761092|NCT01546519|69272315|FG002|Overall Study|Physician Decision|2|||
37761093|NCT01546519|69272316|FG003|Overall Study|Physician Decision|3|||
37761094|NCT01546519|69272313|FG000|Overall Study|Withdrawal by Subject|1|||
37761095|NCT01546519|69272314|FG001|Overall Study|Withdrawal by Subject|0|||
37761096|NCT01546519|69272315|FG002|Overall Study|Withdrawal by Subject|0|||
37761097|NCT01546519|69272316|FG003|Overall Study|Withdrawal by Subject|0|||
37761098|NCT01484951|69272330|FG000|Overall Study|Adverse Event|3|||
37761099|NCT01484951|69272330|FG000|Overall Study|Personal Reasons|1|||
37761100|NCT01484951|69272330|FG000|Overall Study|Non-Compliance|1|||
37761101|NCT01484873|69272334|FG000|Overall Study|Withdrawal by Subject|2|||
37761102|NCT01486927|69272339|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
37761103|NCT01486927|69272339|FG000|Overall Study|Physician Decision|1|||
37761104|NCT01486927|69272339|FG000|Overall Study|50 Exposure days not reached|2|||
37761105|NCT01486927|69272339|FG000|Overall Study|Withdrawal by Subject|8|||
37761106|NCT01486927|69272339|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
37761107|NCT01513759|69272372|FG000|Overall Study|Protocol Violation|4|||
37761108|NCT01513759|69272372|FG000|Overall Study|Death during catheter placement|1|||
37761109|NCT01484561|69272378|FG000|Overall Study|Lack of Efficacy|3|||
37761110|NCT01484561|69272379|FG001|Overall Study|Lack of Efficacy|1|||
37761111|NCT01484561|69272378|FG000|Overall Study|Lost to Follow-up|1|||
37761112|NCT01484561|69272379|FG001|Overall Study|Lost to Follow-up|0|||
37761113|NCT01484561|69272378|FG000|Overall Study|Withdrawal by Subject|3|||
37669416|NCT02039908|69142460|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
37669417|NCT02039908|69142461|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
37669418|NCT02039908|69142462|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
37669419|NCT02039908|69142459|FG000|Phase 1-Summer|Protocol Violation|6|||
37669420|NCT02039908|69142460|FG001|Phase 1-Summer|Protocol Violation|0|||
37669421|NCT02039908|69142461|FG002|Phase 1-Summer|Protocol Violation|0|||
37669422|NCT02039908|69142462|FG003|Phase 1-Summer|Protocol Violation|0|||
37669423|NCT02039908|69142459|FG000|Phase 2-School Year|Lost to Follow-up|0|||
37669424|NCT02039908|69142460|FG001|Phase 2-School Year|Lost to Follow-up|0|||
37669425|NCT02039908|69142461|FG002|Phase 2-School Year|Lost to Follow-up|1|||
37669426|NCT02039908|69142462|FG003|Phase 2-School Year|Lost to Follow-up|3|||
37669427|NCT02039908|69142459|FG000|Phase 2-School Year|Protocol Violation|0|||
37669428|NCT02039908|69142460|FG001|Phase 2-School Year|Protocol Violation|0|||
37761114|NCT01484561|69272379|FG001|Overall Study|Withdrawal by Subject|0|||
37761115|NCT01484561|69272378|FG000|Overall Study|Other|1|||
37761116|NCT01484561|69272379|FG001|Overall Study|Other|1|||
37761117|NCT01484561|69272378|FG000|Overall Study|Adverse Event|1|||
37761118|NCT01484561|69272379|FG001|Overall Study|Adverse Event|4|||
37761119|NCT01546207|69272385|FG000|Overall Study|Death|1|||
37761120|NCT01513291|69272391|FG000|Treatment Period|Adverse Event|8|||
37761121|NCT01513291|69272392|FG001|Treatment Period|Adverse Event|4|||
37761122|NCT01513291|69272393|FG002|Treatment Period|Adverse Event|0|||
37761123|NCT01513291|69272394|FG003|Treatment Period|Adverse Event|0|||
37761124|NCT01513291|69272395|FG004|Treatment Period|Adverse Event|0|||
37761125|NCT01513291|69272391|FG000|Treatment Period|Lack of Efficacy|3|||
37761126|NCT01513291|69272392|FG001|Treatment Period|Lack of Efficacy|0|||
37761127|NCT01513291|69272393|FG002|Treatment Period|Lack of Efficacy|0|||
37761128|NCT01513291|69272394|FG003|Treatment Period|Lack of Efficacy|0|||
37761129|NCT01513291|69272395|FG004|Treatment Period|Lack of Efficacy|0|||
37761130|NCT01513291|69272391|FG000|Treatment Period|Lost to Follow-up|2|||
37761131|NCT01513291|69272392|FG001|Treatment Period|Lost to Follow-up|3|||
37761132|NCT01513291|69272393|FG002|Treatment Period|Lost to Follow-up|0|||
37761133|NCT01513291|69272394|FG003|Treatment Period|Lost to Follow-up|0|||
37761134|NCT01513291|69272395|FG004|Treatment Period|Lost to Follow-up|0|||
37761135|NCT01513291|69272391|FG000|Treatment Period|Physician Decision|1|||
37761136|NCT01513291|69272392|FG001|Treatment Period|Physician Decision|0|||
37761137|NCT01513291|69272393|FG002|Treatment Period|Physician Decision|0|||
37761138|NCT01513291|69272394|FG003|Treatment Period|Physician Decision|0|||
37761139|NCT01513291|69272395|FG004|Treatment Period|Physician Decision|0|||
37761140|NCT01513291|69272391|FG000|Treatment Period|Protocol Violation|1|||
37761141|NCT01513291|69272392|FG001|Treatment Period|Protocol Violation|2|||
37761142|NCT01513291|69272393|FG002|Treatment Period|Protocol Violation|0|||
37761143|NCT01513291|69272394|FG003|Treatment Period|Protocol Violation|0|||
37761144|NCT01513291|69272395|FG004|Treatment Period|Protocol Violation|0|||
37761145|NCT01513291|69272391|FG000|Treatment Period|Withdrawal by Subject|8|||
37761146|NCT01513291|69272392|FG001|Treatment Period|Withdrawal by Subject|5|||
37761147|NCT01513291|69272393|FG002|Treatment Period|Withdrawal by Subject|0|||
37761148|NCT01513291|69272394|FG003|Treatment Period|Withdrawal by Subject|0|||
37761149|NCT01513291|69272395|FG004|Treatment Period|Withdrawal by Subject|0|||
37761150|NCT01513291|69272391|FG000|Treatment Period|Randomized not treated|0|||
37761151|NCT01513291|69272392|FG001|Treatment Period|Randomized not treated|2|||
37761152|NCT01513291|69272393|FG002|Treatment Period|Randomized not treated|0|||
37761153|NCT01513291|69272394|FG003|Treatment Period|Randomized not treated|0|||
37761154|NCT01513291|69272395|FG004|Treatment Period|Randomized not treated|0|||
37761155|NCT01513291|69272391|FG000|Run-out Period|Lost to Follow-up|0|||
37761156|NCT01513291|69272392|FG001|Run-out Period|Lost to Follow-up|0|||
37761157|NCT01513291|69272393|FG002|Run-out Period|Lost to Follow-up|0|||
37761158|NCT01513291|69272394|FG003|Run-out Period|Lost to Follow-up|1|||
37761159|NCT01513291|69272395|FG004|Run-out Period|Lost to Follow-up|0|||
37761160|NCT01513291|69272391|FG000|Run-out Period|Withdrawal by Subject|0|||
37761161|NCT01513291|69272392|FG001|Run-out Period|Withdrawal by Subject|0|||
37761162|NCT01513291|69272393|FG002|Run-out Period|Withdrawal by Subject|0|||
37761163|NCT01513291|69272394|FG003|Run-out Period|Withdrawal by Subject|1|||
37761164|NCT01513291|69272395|FG004|Run-out Period|Withdrawal by Subject|0|||
37761165|NCT01483937|69272409|FG000|Overall Study|Withdrawal by Subject|4|||
37761166|NCT01483937|69272410|FG001|Overall Study|Withdrawal by Subject|3|||
37761167|NCT01483625|69272421|FG000|Overall Study|Adverse Event|1|||
37761168|NCT01483625|69272422|FG001|Overall Study|Adverse Event|1|||
37761169|NCT01483625|69272421|FG000|Overall Study|Refused to continue medication|2|||
37761170|NCT01483625|69272422|FG001|Overall Study|Refused to continue medication|1|||
37761171|NCT01483625|69272421|FG000|Overall Study|Due to other reason|1|||
37761172|NCT01483625|69272422|FG001|Overall Study|Due to other reason|0|||
37761173|NCT01485991|69272430|FG000|Overall Study|Adverse Event|0|||
37761174|NCT01485991|69272431|FG001|Overall Study|Adverse Event|4|||
37761175|NCT01485991|69272430|FG000|Overall Study|Lost to Follow-up|13|||
37761176|NCT01485991|69272431|FG001|Overall Study|Lost to Follow-up|10|||
37761177|NCT01485991|69272430|FG000|Overall Study|Withdrawal by Subject|13|||
37761178|NCT01485991|69272431|FG001|Overall Study|Withdrawal by Subject|20|||
37761179|NCT01485991|69272430|FG000|Overall Study|randomized but not treated|6|||
37761180|NCT01485991|69272431|FG001|Overall Study|randomized but not treated|2|||
37761181|NCT01482767|69272463|FG000|Overall Study|Death|1|||
37761182|NCT01482767|69272464|FG001|Overall Study|Death|1|||
37761183|NCT01482767|69272463|FG000|Overall Study|Withdrawal by Subject|7|||
37761184|NCT01482767|69272464|FG001|Overall Study|Withdrawal by Subject|5|||
37761185|NCT01482767|69272463|FG000|Overall Study|Lost to Follow-up|12|||
37761186|NCT01482767|69272464|FG001|Overall Study|Lost to Follow-up|6|||
37761187|NCT01482767|69272463|FG000|Overall Study|Adverse Event|0|||
37761188|NCT01482767|69272464|FG001|Overall Study|Adverse Event|3|||
37761189|NCT01482767|69272463|FG000|Overall Study|Site closure|22|||
37761190|NCT01482767|69272464|FG001|Overall Study|Site closure|14|||
37761191|NCT01482767|69272463|FG000|Overall Study|Non-adherence to study requirements|4|||
37761192|NCT01482767|69272464|FG001|Overall Study|Non-adherence to study requirements|7|||
37761193|NCT01482767|69272463|FG000|Overall Study|Alternate HCV treatment|7|||
37761194|NCT01482767|69272464|FG001|Overall Study|Alternate HCV treatment|8|||
37761195|NCT01482767|69272463|FG000|Overall Study|Ineligible|0|||
37932858|NCT00747344|69619720|FG000|Controlled Period|Adverse Event|3|||
38034960|NCT04258995|69721811|FG000|Overall Study|Lost to Follow-up|1|||
37761196|NCT01482767|69272464|FG001|Overall Study|Ineligible|5|||
37761197|NCT01482767|69272463|FG000|Overall Study|Nurse error|1|||
37761198|NCT01482767|69272464|FG001|Overall Study|Nurse error|0|||
37761199|NCT01482221|69272493|FG000|Overall Study|Lack of Efficacy|1|||
37761200|NCT01482221|69272494|FG001|Overall Study|Lack of Efficacy|0|||
37932859|NCT00747344|69619721|FG001|Controlled Period|Adverse Event|0|||
38034961|NCT04258995|69721812|FG001|Overall Study|Lost to Follow-up|1|||
37761201|NCT01482221|69272495|FG002|Overall Study|Lack of Efficacy|1|||
37761202|NCT01482221|69272493|FG000|Overall Study|Lost to Follow-up|3|||
37761203|NCT01482221|69272494|FG001|Overall Study|Lost to Follow-up|2|||
38034962|NCT04247061|69721818|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
37761204|NCT01482221|69272495|FG002|Overall Study|Lost to Follow-up|1|||
37761205|NCT01482221|69272493|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
37761206|NCT01482221|69272494|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
37761207|NCT01482221|69272495|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
37761208|NCT01482221|69272493|FG000|Overall Study|Condition under Investigation Worsened|3|||
37761209|NCT01482221|69272494|FG001|Overall Study|Condition under Investigation Worsened|2|||
37761210|NCT01482221|69272495|FG002|Overall Study|Condition under Investigation Worsened|4|||
37761211|NCT01482221|69272493|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
37761212|NCT01482221|69272494|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
37761213|NCT01482221|69272495|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
37761214|NCT01482221|69272493|FG000|Overall Study|Adverse Event|1|||
37761215|NCT01482221|69272494|FG001|Overall Study|Adverse Event|7|||
37932860|NCT00747344|69619722|FG002|Controlled Period|Adverse Event|0|||
37932861|NCT00747344|69619723|FG003|Controlled Period|Adverse Event|0|||
37932862|NCT00747344|69619720|FG000|Controlled Period|Lack of Efficacy|2|||
37932863|NCT00747344|69619721|FG001|Controlled Period|Lack of Efficacy|1|||
37761216|NCT01482221|69272495|FG002|Overall Study|Adverse Event|3|||
37761217|NCT01482221|69272493|FG000|Overall Study|Withdrawal by Subject|10|||
37761218|NCT01482221|69272494|FG001|Overall Study|Withdrawal by Subject|7|||
37761219|NCT01482221|69272495|FG002|Overall Study|Withdrawal by Subject|12|||
37761220|NCT01482221|69272493|FG000|Overall Study|Incorrect randomization|0|||
37761221|NCT01482221|69272494|FG001|Overall Study|Incorrect randomization|1|||
37761222|NCT01482221|69272495|FG002|Overall Study|Incorrect randomization|0|||
37761223|NCT01482221|69272493|FG000|Overall Study|Physician Decision|0|||
37761224|NCT01482221|69272494|FG001|Overall Study|Physician Decision|1|||
37761225|NCT01482221|69272495|FG002|Overall Study|Physician Decision|0|||
37761226|NCT01482065|69272505|FG000|Overall Study|Withdrawal by Subject|0|||
37761227|NCT01482065|69272506|FG001|Overall Study|Withdrawal by Subject|1|||
37761228|NCT01545817|69272521|FG000|Pazopanib|Disease progression|51|||
37761229|NCT01545817|69272522|FG001|Pazopanib|Disease progression|0|||
37761230|NCT01545817|69272521|FG000|Pazopanib|Adverse Event|19|||
37761231|NCT01545817|69272522|FG001|Pazopanib|Adverse Event|0|||
37761232|NCT01545817|69272521|FG000|Pazopanib|Other reason|4|||
37761233|NCT01545817|69272522|FG001|Pazopanib|Other reason|0|||
37761234|NCT01545817|69272521|FG000|Everolimus|Other reason|0|||
37761235|NCT01545817|69272522|FG001|Everolimus|Other reason|7|||
37761236|NCT01545817|69272521|FG000|Everolimus|Disease progression|0|||
37761237|NCT01545817|69272522|FG001|Everolimus|Disease progression|25|||
37932864|NCT00747344|69619722|FG002|Controlled Period|Lack of Efficacy|0|||
37932865|NCT00747344|69619723|FG003|Controlled Period|Lack of Efficacy|0|||
37932866|NCT00747344|69619720|FG000|Controlled Period|Other|0|||
37932867|NCT00747344|69619721|FG001|Controlled Period|Other|3|||
37932868|NCT00747344|69619722|FG002|Controlled Period|Other|0|||
37932869|NCT00747344|69619723|FG003|Controlled Period|Other|0|||
37932870|NCT00747344|69619720|FG000|After Controlled Period|Adverse Event|0|||
37932871|NCT00747344|69619721|FG001|After Controlled Period|Adverse Event|0|||
37932872|NCT00747344|69619722|FG002|After Controlled Period|Adverse Event|0|||
37932873|NCT00747344|69619723|FG003|After Controlled Period|Adverse Event|1|||
37932874|NCT00580983|69619731|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
37932875|NCT00753896|69619735|FG000|Overall Study|Adverse Event|4|||
37932876|NCT00753896|69619735|FG000|Overall Study|Death|1|||
37932877|NCT00753896|69619735|FG000|Overall Study|Lost to Follow-up|2|||
37932878|NCT00753896|69619735|FG000|Overall Study|Protocol Violation|1|||
37932879|NCT00753896|69619735|FG000|Overall Study|Withdrawal by Subject|4|||
37932880|NCT00753896|69619735|FG000|Overall Study|Entry Criteria Not Met|4|||
37932881|NCT00743444|69619739|FG000|First Intervention|Catheter placement problems|0|||
37932882|NCT00743444|69619740|FG001|First Intervention|Catheter placement problems|1|||
37932883|NCT00743444|69619739|FG000|Washout Period|Adverse Event|0|||
37932884|NCT00743444|69619740|FG001|Washout Period|Adverse Event|1|||
37932885|NCT00743366|69619746|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
37932886|NCT00743366|69619747|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
37932887|NCT00721968|69619755|FG000|Overall Study|Lost to Follow-up|2|||
37932888|NCT00721968|69619756|FG001|Overall Study|Lost to Follow-up|0|||
37932889|NCT00743288|69619762|FG000|Overall Study|Adverse Event|1|||
37932890|NCT00743288|69619763|FG001|Overall Study|Adverse Event|1|||
37932891|NCT00743288|69619764|FG002|Overall Study|Adverse Event|2|||
37932892|NCT00743288|69619765|FG003|Overall Study|Adverse Event|2|||
37761238|NCT01545817|69272521|FG000|Everolimus|Adverse Event|0|||
37761239|NCT01545817|69272522|FG001|Everolimus|Adverse Event|6|||
37761240|NCT01512979|69272541|FG000|Overall Study|Adverse Event|2|||
37761241|NCT01512979|69272542|FG001|Overall Study|Adverse Event|2|||
37761242|NCT01512979|69272541|FG000|Overall Study|Protocol Violation|1|||
37761243|NCT01512979|69272542|FG001|Overall Study|Protocol Violation|4|||
37761244|NCT01512979|69272541|FG000|Overall Study|Lost to Follow-up|2|||
37932893|NCT00743288|69619766|FG004|Overall Study|Adverse Event|1|||
38043559|NCT02927262|69731711|FG000|Overall Study|Withdrawal by Subject|3|||
37932894|NCT00743288|69619767|FG005|Overall Study|Adverse Event|1|||
37932895|NCT00743288|69619768|FG006|Overall Study|Adverse Event|2|||
37932896|NCT00743288|69619762|FG000|Overall Study|Withdrawal by Subject|0|||
37932897|NCT00743288|69619763|FG001|Overall Study|Withdrawal by Subject|0|||
37932898|NCT00743288|69619764|FG002|Overall Study|Withdrawal by Subject|1|||
37932899|NCT00743288|69619765|FG003|Overall Study|Withdrawal by Subject|0|||
37932900|NCT00743288|69619766|FG004|Overall Study|Withdrawal by Subject|0|||
37932901|NCT00743288|69619767|FG005|Overall Study|Withdrawal by Subject|1|||
37761245|NCT01512979|69272542|FG001|Overall Study|Lost to Follow-up|5|||
37761246|NCT01512979|69272541|FG000|Overall Study|Withdrawal by Subject|1|||
37761247|NCT01512979|69272542|FG001|Overall Study|Withdrawal by Subject|2|||
37761248|NCT01512979|69272541|FG000|Overall Study|Reason other than stated above|13|||
37761249|NCT01512979|69272542|FG001|Overall Study|Reason other than stated above|9|||
37761250|NCT01512745|69272554|FG000|Overall Study|Adverse Event|22|||
37761251|NCT01512745|69272555|FG001|Overall Study|Adverse Event|3|||
37761252|NCT01512745|69272554|FG000|Overall Study|Death|9|||
37761253|NCT01512745|69272555|FG001|Overall Study|Death|13|||
37761254|NCT01512745|69272554|FG000|Overall Study|Withdrawal by Subject|2|||
37761255|NCT01512745|69272555|FG001|Overall Study|Withdrawal by Subject|2|||
37761256|NCT01512745|69272554|FG000|Overall Study|Lost to Follow-up|4|||
37761257|NCT01512745|69272555|FG001|Overall Study|Lost to Follow-up|0|||
37761258|NCT01512745|69272554|FG000|Overall Study|Lack of Efficacy|2|||
37761259|NCT01512745|69272555|FG001|Overall Study|Lack of Efficacy|2|||
37761260|NCT01512745|69272554|FG000|Overall Study|Protocol Violation|1|||
37761261|NCT01512745|69272555|FG001|Overall Study|Protocol Violation|0|||
37761262|NCT01478321|69272561|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
37761263|NCT01478321|69272561|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
37761264|NCT01478321|69272561|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
37761265|NCT01478321|69272561|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
37761266|NCT01478321|69272561|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
37761267|NCT01478321|69272561|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
37761268|NCT01478321|69272561|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
37761269|NCT01478321|69272561|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
37761270|NCT01544491|69272567|FG000|Overall Study|Withdrawal by Subject|3|||
37761271|NCT01544491|69272568|FG001|Overall Study|Withdrawal by Subject|2|||
37761272|NCT01544491|69272567|FG000|Overall Study|Lost to Follow-up|0|||
37761273|NCT01544491|69272568|FG001|Overall Study|Lost to Follow-up|1|||
37761274|NCT01544491|69272567|FG000|Overall Study|administrative problems|2|||
37761275|NCT01544491|69272568|FG001|Overall Study|administrative problems|0|||
37761276|NCT01478087|69272587|FG000|Overall Study|due to sponsor closing study|1|||
37761277|NCT01477853|69272605|FG000|Phase A|Adverse Event|1|||
37761278|NCT01477853|69272606|FG001|Phase A|Adverse Event|2|||
37761279|NCT01477853|69272607|FG002|Phase A|Adverse Event|2|||
37761280|NCT01477853|69272605|FG000|Phase A|Lost to Follow-up|4|||
37761281|NCT01477853|69272606|FG001|Phase A|Lost to Follow-up|3|||
37761282|NCT01477853|69272607|FG002|Phase A|Lost to Follow-up|2|||
37761283|NCT01477853|69272605|FG000|Phase A|Physician Decision|1|||
37761284|NCT01477853|69272606|FG001|Phase A|Physician Decision|0|||
37761285|NCT01477853|69272607|FG002|Phase A|Physician Decision|1|||
37761286|NCT01477853|69272605|FG000|Phase A|Study terminated by sponsor|37|||
37761287|NCT01477853|69272606|FG001|Phase A|Study terminated by sponsor|40|||
37761288|NCT01477853|69272607|FG002|Phase A|Study terminated by sponsor|39|||
37761289|NCT01477853|69272605|FG000|Phase B|Lost to Follow-up|0|||
37761290|NCT01477853|69272606|FG001|Phase B|Lost to Follow-up|1|||
37761291|NCT01477853|69272607|FG002|Phase B|Lost to Follow-up|0|||
37761292|NCT01477853|69272605|FG000|Phase B|Study terminated by sponsor|12|||
37761293|NCT01477853|69272606|FG001|Phase B|Study terminated by sponsor|10|||
37761294|NCT01477853|69272607|FG002|Phase B|Study terminated by sponsor|11|||
37761295|NCT01511419|69272639|FG000|Dose 2|Physician Decision|1|||
37761296|NCT01511419|69272640|FG001|Dose 2|Physician Decision|0|||
37761297|NCT01511107|69272702|FG000|Overall Study|Ineligible|3|||
37761298|NCT01511107|69272703|FG001|Overall Study|Ineligible|2|||
37761299|NCT01511107|69272702|FG000|Overall Study|Lost to Follow-up|10|||
37761300|NCT01511107|69272703|FG001|Overall Study|Lost to Follow-up|19|||
37761301|NCT01511107|69272702|FG000|Overall Study|Withdrawal by Subject|9|||
37761302|NCT01511107|69272703|FG001|Overall Study|Withdrawal by Subject|20|||
37761303|NCT01484977|69272738|FG000|Overall Study|Adverse Event|8|||
37761304|NCT01484977|69272738|FG000|Overall Study|Lack of Efficacy|4|||
37761305|NCT01484977|69272738|FG000|Overall Study|Protocol Violation|6|||
37761306|NCT01484977|69272738|FG000|Overall Study|Lost to Follow-up|1|||
37761307|NCT01484977|69272738|FG000|Overall Study|Withdrawal by Subject|4|||
37761308|NCT01484977|69272738|FG000|Overall Study|Subject Protocol Non-compliant|1|||
37761309|NCT01484977|69272738|FG000|Overall Study|Moving Overseas|1|||
37761310|NCT01484977|69272738|FG000|Overall Study|Low White Blood Cell Count|1|||
37761311|NCT01484977|69272738|FG000|Overall Study|Lack of Compliance|1|||
37761312|NCT01475825|69272818|FG000|Overall Study|Adverse Event|41|||
37761313|NCT01475825|69272819|FG001|Overall Study|Adverse Event|15|||
37761314|NCT01475825|69272820|FG002|Overall Study|Adverse Event|27|||
37761315|NCT01475825|69272821|FG003|Overall Study|Adverse Event|11|||
37761316|NCT01475825|69272818|FG000|Overall Study|Death|1|||
37761317|NCT01475825|69272819|FG001|Overall Study|Death|0|||
37761318|NCT01475825|69272820|FG002|Overall Study|Death|1|||
37761319|NCT01475825|69272821|FG003|Overall Study|Death|0|||
37761320|NCT01475825|69272818|FG000|Overall Study|Lack of Efficacy|0|||
37761321|NCT01475825|69272819|FG001|Overall Study|Lack of Efficacy|0|||
37761322|NCT01475825|69272820|FG002|Overall Study|Lack of Efficacy|1|||
37761323|NCT01475825|69272821|FG003|Overall Study|Lack of Efficacy|0|||
37761324|NCT01475825|69272818|FG000|Overall Study|Lost to Follow-up|0|||
37761325|NCT01475825|69272819|FG001|Overall Study|Lost to Follow-up|0|||
37761326|NCT01475825|69272820|FG002|Overall Study|Lost to Follow-up|3|||
37761327|NCT01475825|69272821|FG003|Overall Study|Lost to Follow-up|1|||
37761328|NCT01475825|69272818|FG000|Overall Study|Non-compliance with Study Drug|1|||
37761329|NCT01475825|69272819|FG001|Overall Study|Non-compliance with Study Drug|2|||
37761330|NCT01475825|69272820|FG002|Overall Study|Non-compliance with Study Drug|4|||
37761331|NCT01475825|69272821|FG003|Overall Study|Non-compliance with Study Drug|0|||
37932902|NCT00743288|69619768|FG006|Overall Study|Withdrawal by Subject|1|||
37932903|NCT00743288|69619762|FG000|Overall Study|Progressive disease (PD)|2|||
37932904|NCT00743288|69619763|FG001|Overall Study|Progressive disease (PD)|0|||
37932905|NCT00743288|69619764|FG002|Overall Study|Progressive disease (PD)|1|||
37932906|NCT00743288|69619765|FG003|Overall Study|Progressive disease (PD)|4|||
37932907|NCT00743288|69619766|FG004|Overall Study|Progressive disease (PD)|5|||
37932908|NCT00743288|69619767|FG005|Overall Study|Progressive disease (PD)|3|||
37932909|NCT00743288|69619768|FG006|Overall Study|Progressive disease (PD)|6|||
37932910|NCT00743288|69619762|FG000|Overall Study|Worsening of condition (Not PD)|0|||
37932911|NCT00743288|69619763|FG001|Overall Study|Worsening of condition (Not PD)|2|||
37932912|NCT00743288|69619764|FG002|Overall Study|Worsening of condition (Not PD)|1|||
37932913|NCT00743288|69619765|FG003|Overall Study|Worsening of condition (Not PD)|1|||
37932914|NCT00743288|69619766|FG004|Overall Study|Worsening of condition (Not PD)|0|||
37932915|NCT00743288|69619767|FG005|Overall Study|Worsening of condition (Not PD)|0|||
37932916|NCT00743288|69619768|FG006|Overall Study|Worsening of condition (Not PD)|0|||
37932917|NCT00750308|69619779|FG000|First Treatment|Adverse Event|0|||
37932918|NCT00750308|69619780|FG001|First Treatment|Adverse Event|1|||
37932919|NCT00750308|69619781|FG002|First Treatment|Adverse Event|0|||
37932920|NCT00750308|69619782|FG003|First Treatment|Adverse Event|0|||
37932921|NCT00750308|69619783|FG004|First Treatment|Adverse Event|0|||
37932922|NCT00750308|69619784|FG005|First Treatment|Adverse Event|0|||
37932923|NCT00750308|69619785|FG006|First Treatment|Adverse Event|0|||
37932924|NCT00750308|69619786|FG007|First Treatment|Adverse Event|0|||
37932925|NCT00750308|69619787|FG008|First Treatment|Adverse Event|0|||
37932926|NCT00750308|69619788|FG009|First Treatment|Adverse Event|0|||
37932927|NCT00750308|69619789|FG010|First Treatment|Adverse Event|1|||
37932928|NCT00750308|69619790|FG011|First Treatment|Adverse Event|1|||
37932929|NCT00750308|69619779|FG000|First Treatment|Withdrawal by Subject|0|||
37932930|NCT00750308|69619780|FG001|First Treatment|Withdrawal by Subject|0|||
37932931|NCT00750308|69619781|FG002|First Treatment|Withdrawal by Subject|0|||
37932932|NCT00750308|69619782|FG003|First Treatment|Withdrawal by Subject|1|||
37932933|NCT00750308|69619783|FG004|First Treatment|Withdrawal by Subject|0|||
37932934|NCT00750308|69619784|FG005|First Treatment|Withdrawal by Subject|0|||
37932935|NCT00750308|69619785|FG006|First Treatment|Withdrawal by Subject|0|||
37932936|NCT00750308|69619786|FG007|First Treatment|Withdrawal by Subject|1|||
37932937|NCT00750308|69619787|FG008|First Treatment|Withdrawal by Subject|0|||
37932938|NCT00750308|69619788|FG009|First Treatment|Withdrawal by Subject|0|||
37932939|NCT00750308|69619789|FG010|First Treatment|Withdrawal by Subject|0|||
37932940|NCT00750308|69619790|FG011|First Treatment|Withdrawal by Subject|0|||
37932941|NCT00750308|69619779|FG000|Second Treatment|Adverse Event|0|||
37932942|NCT00750308|69619780|FG001|Second Treatment|Adverse Event|0|||
37932943|NCT00750308|69619781|FG002|Second Treatment|Adverse Event|0|||
37932944|NCT00750308|69619782|FG003|Second Treatment|Adverse Event|0|||
37932945|NCT00750308|69619783|FG004|Second Treatment|Adverse Event|0|||
37932946|NCT00750308|69619784|FG005|Second Treatment|Adverse Event|1|||
37932947|NCT00750308|69619785|FG006|Second Treatment|Adverse Event|0|||
37932948|NCT00750308|69619786|FG007|Second Treatment|Adverse Event|0|||
37932949|NCT00750308|69619787|FG008|Second Treatment|Adverse Event|1|||
37932950|NCT00750308|69619788|FG009|Second Treatment|Adverse Event|0|||
37932951|NCT00750308|69619789|FG010|Second Treatment|Adverse Event|0|||
37932952|NCT00750308|69619790|FG011|Second Treatment|Adverse Event|0|||
37761332|NCT01475825|69272818|FG000|Overall Study|Other: Not available|0|||
37761333|NCT01475825|69272819|FG001|Overall Study|Other: Not available|0|||
37932953|NCT00750308|69619779|FG000|Second Treatment|Withdrawal by Subject|0|||
37932954|NCT00750308|69619780|FG001|Second Treatment|Withdrawal by Subject|0|||
37932955|NCT00750308|69619781|FG002|Second Treatment|Withdrawal by Subject|0|||
37932956|NCT00750308|69619782|FG003|Second Treatment|Withdrawal by Subject|0|||
37932957|NCT00750308|69619783|FG004|Second Treatment|Withdrawal by Subject|1|||
37932958|NCT00750308|69619784|FG005|Second Treatment|Withdrawal by Subject|0|||
37932959|NCT00750308|69619785|FG006|Second Treatment|Withdrawal by Subject|0|||
37932960|NCT00750308|69619786|FG007|Second Treatment|Withdrawal by Subject|0|||
37932961|NCT00750308|69619787|FG008|Second Treatment|Withdrawal by Subject|0|||
37932962|NCT00750308|69619788|FG009|Second Treatment|Withdrawal by Subject|0|||
37932963|NCT00750308|69619789|FG010|Second Treatment|Withdrawal by Subject|0|||
37932964|NCT00750308|69619790|FG011|Second Treatment|Withdrawal by Subject|0|||
37932965|NCT00750308|69619779|FG000|Third Treatment|Withdrawal by Subject|0|||
37932966|NCT00750308|69619780|FG001|Third Treatment|Withdrawal by Subject|1|||
37761334|NCT01475825|69272820|FG002|Overall Study|Other: Not available|2|||
37761335|NCT01475825|69272821|FG003|Overall Study|Other: Not available|0|||
37761336|NCT01475825|69272818|FG000|Overall Study|Protocol Violation|1|||
37761337|NCT01475825|69272819|FG001|Overall Study|Protocol Violation|0|||
37761338|NCT01475825|69272820|FG002|Overall Study|Protocol Violation|0|||
37761339|NCT01475825|69272821|FG003|Overall Study|Protocol Violation|0|||
37761340|NCT01475825|69272818|FG000|Overall Study|Physician Decision|0|||
37761341|NCT01475825|69272819|FG001|Overall Study|Physician Decision|1|||
37761342|NCT01475825|69272820|FG002|Overall Study|Physician Decision|0|||
37761343|NCT01475825|69272821|FG003|Overall Study|Physician Decision|0|||
37761344|NCT01475825|69272818|FG000|Overall Study|Withdrawal by Subject|8|||
37761345|NCT01475825|69272819|FG001|Overall Study|Withdrawal by Subject|3|||
37761346|NCT01475825|69272820|FG002|Overall Study|Withdrawal by Subject|11|||
37761347|NCT01475825|69272821|FG003|Overall Study|Withdrawal by Subject|7|||
37761348|NCT01475825|69272818|FG000|Overall Study|Did not enter OLC|15|||
37761349|NCT01475825|69272819|FG001|Overall Study|Did not enter OLC|11|||
37761350|NCT01475825|69272820|FG002|Overall Study|Did not enter OLC|15|||
37761351|NCT01475825|69272821|FG003|Overall Study|Did not enter OLC|11|||
37761352|NCT01484431|69272843|FG000|Period 1: High Dose|Physician Decision|0|||
37761353|NCT01484431|69272844|FG001|Period 1: High Dose|Physician Decision|1|||
37761354|NCT01484431|69272845|FG002|Period 1: High Dose|Physician Decision|0|||
37761355|NCT01484431|69272843|FG000|Period 2|Death|0|||
37761356|NCT01484431|69272844|FG001|Period 2|Death|1|||
37761357|NCT01484431|69272845|FG002|Period 2|Death|1|||
37669429|NCT02039908|69142461|FG002|Phase 2-School Year|Protocol Violation|3|||
37669430|NCT02039908|69142462|FG003|Phase 2-School Year|Protocol Violation|0|||
37669431|NCT02039908|69142459|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
37669432|NCT02039908|69142460|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
37669433|NCT02039908|69142461|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
37669434|NCT02039908|69142462|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
37669435|NCT02058940|69142470|FG000|Overall Study|Discharged from Critical Care Unit|1|||
37669436|NCT02058628|69142476|FG000|Overall Study|Adverse Event|1|||
37669437|NCT02058628|69142477|FG001|Overall Study|Adverse Event|0|||
37669438|NCT02058628|69142476|FG000|Overall Study|Withdrawal by Subject|2|||
37669439|NCT02058628|69142477|FG001|Overall Study|Withdrawal by Subject|2|||
37669440|NCT02058628|69142476|FG000|Overall Study|Lost to Follow-up|2|||
37669441|NCT02058628|69142477|FG001|Overall Study|Lost to Follow-up|4|||
37669442|NCT02058628|69142476|FG000|Overall Study|Not in time schedule|0|||
37669443|NCT02058628|69142477|FG001|Overall Study|Not in time schedule|1|||
37669444|NCT02058628|69142476|FG000|Overall Study|The visit date was not in timeline|0|||
37669445|NCT02058628|69142477|FG001|Overall Study|The visit date was not in timeline|1|||
37669446|NCT02058628|69142476|FG000|Overall Study|A lot of time for study for participant|1|||
37669447|NCT02058628|69142477|FG001|Overall Study|A lot of time for study for participant|0|||
37669448|NCT02058628|69142476|FG000|Overall Study|Non compliance|1|||
37669449|NCT02058628|69142477|FG001|Overall Study|Non compliance|0|||
37669450|NCT02058160|69142488|FG000|Overall Study|Randomized but not treated|2|||
37669451|NCT02058160|69142489|FG001|Overall Study|Randomized but not treated|4|||
37669452|NCT02058160|69142488|FG000|Overall Study|Poor compliance to protocol|4|||
37669453|NCT02058160|69142489|FG001|Overall Study|Poor compliance to protocol|1|||
37669454|NCT02058160|69142488|FG000|Overall Study|Adverse Event|12|||
37669455|NCT02058160|69142489|FG001|Overall Study|Adverse Event|3|||
37669456|NCT02058160|69142488|FG000|Overall Study|Lost to Follow-up|1|||
37669457|NCT02058160|69142489|FG001|Overall Study|Lost to Follow-up|0|||
37669458|NCT02058160|69142488|FG000|Overall Study|Other than specified above|12|||
37669459|NCT02058160|69142489|FG001|Overall Study|Other than specified above|6|||
37669460|NCT02090764|69142497|FG000|Overall Study|Adverse Event|1|||
37669461|NCT02090764|69142498|FG001|Overall Study|Adverse Event|3|||
37669462|NCT02090764|69142497|FG000|Overall Study|Lack of Efficacy|0|||
37669463|NCT02090764|69142498|FG001|Overall Study|Lack of Efficacy|13|||
37669464|NCT02090764|69142497|FG000|Overall Study|Withdrawal by Subject|2|||
37669465|NCT02090764|69142498|FG001|Overall Study|Withdrawal by Subject|1|||
37669466|NCT02090764|69142497|FG000|Overall Study|Intercurrent illness and other|1|||
37669467|NCT02090764|69142498|FG001|Overall Study|Intercurrent illness and other|1|||
37669468|NCT02090764|69142497|FG000|Overall Study|Lost to Follow-up|2|||
37669469|NCT02090764|69142498|FG001|Overall Study|Lost to Follow-up|2|||
37669470|NCT02057692|69142508|FG000|Overall Study|Adverse Event|1|||
37669471|NCT02057692|69142509|FG001|Overall Study|Adverse Event|0|||
37669472|NCT02057692|69142510|FG002|Overall Study|Adverse Event|0|||
37669473|NCT02057692|69142511|FG003|Overall Study|Adverse Event|0|||
37669474|NCT02057692|69142508|FG000|Overall Study|Lost to Follow-up|0|||
37669475|NCT02057692|69142509|FG001|Overall Study|Lost to Follow-up|0|||
37669476|NCT02057692|69142510|FG002|Overall Study|Lost to Follow-up|0|||
37669477|NCT02057692|69142511|FG003|Overall Study|Lost to Follow-up|1|||
37669478|NCT02038036|69142529|FG000|Core Study|Adverse Event|7|||
37669479|NCT02038036|69142530|FG001|Core Study|Adverse Event|7|||
37669480|NCT02038036|69142529|FG000|Core Study|Death|1|||
37669481|NCT02038036|69142530|FG001|Core Study|Death|1|||
37669482|NCT02038036|69142529|FG000|Core Study|Disease progression|2|||
37669483|NCT02038036|69142530|FG001|Core Study|Disease progression|2|||
37669484|NCT02038036|69142529|FG000|Core Study|Lost to Follow-up|0|||
37669485|NCT02038036|69142530|FG001|Core Study|Lost to Follow-up|1|||
37761358|NCT01484431|69272843|FG000|Period 2|Physician Decision|0|||
37669486|NCT02038036|69142529|FG000|Core Study|Physician Decision|2|||
37669487|NCT02038036|69142530|FG001|Core Study|Physician Decision|1|||
37669488|NCT02038036|69142529|FG000|Core Study|Subject/guardian decision|0|||
37669489|NCT02038036|69142530|FG001|Core Study|Subject/guardian decision|1|||
37669490|NCT02038036|69142529|FG000|Core Study|Withdrawal by Subject|3|||
37669491|NCT02038036|69142530|FG001|Core Study|Withdrawal by Subject|1|||
37669492|NCT02038036|69142529|FG000|Crossover Period|Withdrawal by Subject|0|||
37669493|NCT02038036|69142530|FG001|Crossover Period|Withdrawal by Subject|3|||
37669494|NCT02038036|69142529|FG000|Crossover Period|Adverse Event|0|||
37669495|NCT02038036|69142530|FG001|Crossover Period|Adverse Event|9|||
37669496|NCT02038036|69142529|FG000|Crossover Period|Death|0|||
37669497|NCT02038036|69142530|FG001|Crossover Period|Death|2|||
37669498|NCT02038036|69142529|FG000|Crossover Period|Disease progression|0|||
37669499|NCT02038036|69142530|FG001|Crossover Period|Disease progression|3|||
37669500|NCT02038036|69142529|FG000|Crossover Period|Lost to Follow-up|0|||
37669501|NCT02038036|69142530|FG001|Crossover Period|Lost to Follow-up|1|||
37669502|NCT02038036|69142529|FG000|Crossover Period|Physician Decision|0|||
37669503|NCT02038036|69142530|FG001|Crossover Period|Physician Decision|2|||
37669504|NCT02037568|69142541|FG000|Overall Study|Withdrawal by Subject|17|||
37669505|NCT02037568|69142542|FG001|Overall Study|Withdrawal by Subject|24|||
37669506|NCT02037568|69142541|FG000|Overall Study|Lost to Follow-up|16|||
37669507|NCT02037568|69142542|FG001|Overall Study|Lost to Follow-up|13|||
37669508|NCT02037568|69142541|FG000|Overall Study|Screen Failure|3|||
37669509|NCT02037568|69142542|FG001|Overall Study|Screen Failure|1|||
37669510|NCT02037568|69142541|FG000|Overall Study|Patient did not receive transplant|0|||
37669511|NCT02037568|69142542|FG001|Overall Study|Patient did not receive transplant|1|||
37669512|NCT02088034|69142551|FG000|Overall Study|Lost to Follow-up|1|||
37669513|NCT02088034|69142552|FG001|Overall Study|Lost to Follow-up|1|||
37669514|NCT02088034|69142553|FG002|Overall Study|Lost to Follow-up|0|||
37669515|NCT02088034|69142551|FG000|Overall Study|Pregnancy|2|||
37669516|NCT02088034|69142552|FG001|Overall Study|Pregnancy|1|||
37669517|NCT02088034|69142553|FG002|Overall Study|Pregnancy|2|||
37669518|NCT02037256|69142563|FG000|Overall Study|Protocol Violation|0|||
37669519|NCT02037256|69142564|FG001|Overall Study|Protocol Violation|1|||
37761359|NCT01484431|69272844|FG001|Period 2|Physician Decision|0|||
37761360|NCT01484431|69272845|FG002|Period 2|Physician Decision|1|||
37761361|NCT01484431|69272843|FG000|Period 2|Non-Compliance with Study Drug|1|||
37761362|NCT01484431|69272844|FG001|Period 2|Non-Compliance with Study Drug|0|||
37761363|NCT01484431|69272845|FG002|Period 2|Non-Compliance with Study Drug|0|||
37761364|NCT01473953|69272893|FG000|Overall Study|Other|1|||
37761365|NCT01473953|69272894|FG001|Overall Study|Other|0|||
37761366|NCT01473953|69272895|FG002|Overall Study|Other|0|||
37669520|NCT02037256|69142563|FG000|Overall Study|Withdrawn prior to Velcade|0|||
37669521|NCT02037256|69142564|FG001|Overall Study|Withdrawn prior to Velcade|2|||
37669522|NCT02035696|69142576|FG000|Overall Study|Lost to Follow-up|0|||
37669523|NCT02035696|69142577|FG001|Overall Study|Lost to Follow-up|3|||
37669524|NCT02035696|69142578|FG002|Overall Study|Lost to Follow-up|1|||
37669525|NCT02035696|69142579|FG003|Overall Study|Lost to Follow-up|2|||
37669526|NCT02035696|69142576|FG000|Overall Study|Withdrawal by Subject|3|||
37669527|NCT02035696|69142577|FG001|Overall Study|Withdrawal by Subject|0|||
37669528|NCT02035696|69142578|FG002|Overall Study|Withdrawal by Subject|2|||
37669529|NCT02035696|69142579|FG003|Overall Study|Withdrawal by Subject|1|||
37669530|NCT02057458|69142593|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
37669531|NCT02057458|69142594|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
37669532|NCT02057458|69142595|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
37669533|NCT02057458|69142593|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
37669534|NCT02057458|69142594|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
37669535|NCT02057458|69142595|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
37669536|NCT02057458|69142593|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
37669537|NCT02057458|69142594|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
37669538|NCT02057458|69142595|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
37669539|NCT02057068|69142627|FG000|Overall Study|Withdrawal by Subject|2|||
37669540|NCT02057068|69142628|FG001|Overall Study|Withdrawal by Subject|2|||
37669541|NCT02057068|69142627|FG000|Overall Study|Caregiver (CG) Health|0|||
37761367|NCT01473953|69272896|FG003|Overall Study|Other|0|||
37761368|NCT01473953|69272897|FG004|Overall Study|Other|0|||
37761369|NCT01510717|69272911|FG000|Overall Study|Adverse Event|1|||
37669542|NCT02057068|69142628|FG001|Overall Study|Caregiver (CG) Health|2|||
37761370|NCT01510717|69272912|FG001|Overall Study|Adverse Event|2|||
37761371|NCT01510717|69272911|FG000|Overall Study|Death|1|||
37761372|NCT01510717|69272912|FG001|Overall Study|Death|0|||
37761373|NCT01510717|69272911|FG000|Overall Study|Lost to Follow-up|0|||
37761374|NCT01510717|69272912|FG001|Overall Study|Lost to Follow-up|1|||
37761375|NCT01510717|69272911|FG000|Overall Study|Withdrawal by Subject|0|||
37761376|NCT01510717|69272912|FG001|Overall Study|Withdrawal by Subject|2|||
37761377|NCT01473563|69272928|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
37761378|NCT01484275|69272946|FG000|Overall Study|Study terminated by sponsor|28|||
38034963|NCT04247061|69721818|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
37669543|NCT02057068|69142627|FG000|Overall Study|Carepartner (CP) Health|4|||
37669544|NCT02057068|69142628|FG001|Overall Study|Carepartner (CP) Health|2|||
37669545|NCT02057068|69142627|FG000|Overall Study|Lost to Follow-up|2|||
37669546|NCT02057068|69142628|FG001|Overall Study|Lost to Follow-up|2|||
37669547|NCT02056834|69142636|FG000|Overall Study|Lost to Follow-up|7|||
37669548|NCT02087176|69142641|FG000|Overall Study|Withdrawal by Subject|1|||
37669549|NCT02087176|69142641|FG000|Overall Study|Death|10|||
37669550|NCT02087176|69142641|FG000|Overall Study|Censored|19|||
37669551|NCT02087176|69142641|FG000|Overall Study|Study Terminated by Sponsor|2|||
37669552|NCT02056288|69142647|FG000|In-Hospital Data|Surgery cancelled|1|||
37669553|NCT02056288|69142648|FG001|In-Hospital Data|Surgery cancelled|0|||
37669554|NCT02056288|69142647|FG000|In-Hospital Data|Protocol Violation|3|||
37669555|NCT02056288|69142648|FG001|In-Hospital Data|Protocol Violation|0|||
37669556|NCT02056288|69142647|FG000|In-Hospital Data|Physician Decision|1|||
37669557|NCT02056288|69142648|FG001|In-Hospital Data|Physician Decision|0|||
37669558|NCT02056288|69142647|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
37669559|NCT02056288|69142648|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
37669560|NCT02086162|69142656|FG000|Overall Study|Withdrawal by Subject|4|||
37669561|NCT02086162|69142657|FG001|Overall Study|Withdrawal by Subject|4|||
37669562|NCT02086162|69142656|FG000|Overall Study|moved|1|||
37669563|NCT02086162|69142657|FG001|Overall Study|moved|1|||
37669564|NCT02086162|69142656|FG000|Overall Study|Lost to Follow-up|4|||
37669565|NCT02086162|69142657|FG001|Overall Study|Lost to Follow-up|2|||
37669566|NCT02086162|69142656|FG000|Overall Study|Death|1|||
37669567|NCT02086162|69142657|FG001|Overall Study|Death|0|||
37669568|NCT02700815|69142671|FG000|Overall Study|Adverse Event|0|||
37669569|NCT02700815|69142672|FG001|Overall Study|Adverse Event|6|||
37669570|NCT02700815|69142673|FG002|Overall Study|Adverse Event|2|||
37669571|NCT02700815|69142674|FG003|Overall Study|Adverse Event|3|||
37669572|NCT02700815|69142671|FG000|Overall Study|Lack of Efficacy|0|||
37669573|NCT02700815|69142672|FG001|Overall Study|Lack of Efficacy|0|||
37669574|NCT02700815|69142673|FG002|Overall Study|Lack of Efficacy|1|||
37669575|NCT02700815|69142674|FG003|Overall Study|Lack of Efficacy|2|||
37669576|NCT02700815|69142671|FG000|Overall Study|Lost to Follow-up|1|||
37669577|NCT02700815|69142672|FG001|Overall Study|Lost to Follow-up|0|||
37669578|NCT02700815|69142673|FG002|Overall Study|Lost to Follow-up|0|||
37669579|NCT02700815|69142674|FG003|Overall Study|Lost to Follow-up|1|||
37669580|NCT02700815|69142671|FG000|Overall Study|Refusal to continue medication|0|||
37669581|NCT02700815|69142672|FG001|Overall Study|Refusal to continue medication|1|||
37669582|NCT02700815|69142673|FG002|Overall Study|Refusal to continue medication|0|||
37669583|NCT02700815|69142674|FG003|Overall Study|Refusal to continue medication|1|||
37669584|NCT02700815|69142671|FG000|Overall Study|Withdrawal by Subject|0|||
37669585|NCT02700815|69142672|FG001|Overall Study|Withdrawal by Subject|0|||
37669586|NCT02700815|69142673|FG002|Overall Study|Withdrawal by Subject|1|||
37669587|NCT02700815|69142674|FG003|Overall Study|Withdrawal by Subject|0|||
37669588|NCT00708305|69142684|FG000|Period 1|Protocol Violation|1|||
37669589|NCT00708305|69142685|FG001|Period 1|Protocol Violation|0|||
37669590|NCT00708305|69142686|FG002|Period 1|Protocol Violation|1|||
37669591|NCT00708305|69142687|FG003|Period 1|Protocol Violation|0|||
37669592|NCT00708305|69142684|FG000|Period 1|Other Reason|0|||
37669593|NCT00708305|69142685|FG001|Period 1|Other Reason|0|||
37669594|NCT00708305|69142686|FG002|Period 1|Other Reason|0|||
37669595|NCT00708305|69142687|FG003|Period 1|Other Reason|2|||
37669596|NCT00708305|69142684|FG000|Period 2|Lost to Follow-up|0|||
37669597|NCT00708305|69142685|FG001|Period 2|Lost to Follow-up|1|||
37669598|NCT00708305|69142686|FG002|Period 2|Lost to Follow-up|0|||
37669599|NCT00708305|69142687|FG003|Period 2|Lost to Follow-up|0|||
37669600|NCT00708305|69142684|FG000|Period 2|Protocol Violation|0|||
37669601|NCT00708305|69142685|FG001|Period 2|Protocol Violation|1|||
37669602|NCT00708305|69142686|FG002|Period 2|Protocol Violation|0|||
37669603|NCT00708305|69142687|FG003|Period 2|Protocol Violation|0|||
37669604|NCT00708305|69142684|FG000|Period 2|Other Reason|1|||
37669605|NCT00708305|69142685|FG001|Period 2|Other Reason|0|||
37669606|NCT00708305|69142686|FG002|Period 2|Other Reason|0|||
37859447|NCT01287221|69542765|FG001|Overall Study|Adverse Event|3|||
38034964|NCT04247061|69721818|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
37669607|NCT00708305|69142687|FG003|Period 2|Other Reason|1|||
37669608|NCT00708305|69142684|FG000|Period 3|Protocol Violation|0|||
37669609|NCT00708305|69142685|FG001|Period 3|Protocol Violation|2|||
37669610|NCT00708305|69142686|FG002|Period 3|Protocol Violation|0|||
37669611|NCT00708305|69142687|FG003|Period 3|Protocol Violation|0|||
37669612|NCT00708305|69142684|FG000|Period 3|Other Reason|1|||
37669613|NCT00708305|69142685|FG001|Period 3|Other Reason|0|||
37669614|NCT00708305|69142686|FG002|Period 3|Other Reason|0|||
37669615|NCT00708305|69142687|FG003|Period 3|Other Reason|0|||
37669616|NCT02055976|69142709|FG000|Overall Study|Other|0|||
37669617|NCT02055976|69142710|FG001|Overall Study|Other|0|||
37669618|NCT02055976|69142711|FG002|Overall Study|Other|1|||
37761379|NCT01484275|69272947|FG001|Overall Study|Study terminated by sponsor|32|||
37761380|NCT01484275|69272946|FG000|Overall Study|Other|10|||
37761381|NCT01484275|69272947|FG001|Overall Study|Other|0|||
37761382|NCT01484275|69272946|FG000|Overall Study|Death|3|||
37761383|NCT01484275|69272947|FG001|Overall Study|Death|4|||
37761384|NCT01484275|69272946|FG000|Overall Study|Withdrawal by Subject|1|||
37761385|NCT01484275|69272947|FG001|Overall Study|Withdrawal by Subject|5|||
37761386|NCT01484275|69272946|FG000|Overall Study|Lost to Follow-up|1|||
37761387|NCT01484275|69272947|FG001|Overall Study|Lost to Follow-up|1|||
37761388|NCT01544335|69272953|FG000|Overall Study|Lost to Follow-up|27|||
37761389|NCT01544335|69272953|FG000|Overall Study|Death|4|||
37761390|NCT01544335|69272953|FG000|Overall Study|Disease progression|3|||
37761391|NCT01544335|69272953|FG000|Overall Study|Baseline Measurements not Available|19|||
37761392|NCT01484197|69272957|FG000|Treatment Period 1|Adverse Event|1|||
37761393|NCT01484197|69272958|FG001|Treatment Period 1|Adverse Event|0|||
37761394|NCT01484197|69272959|FG002|Treatment Period 1|Adverse Event|0|||
37761395|NCT01484197|69272960|FG003|Treatment Period 1|Adverse Event|0|||
37761396|NCT01484197|69272957|FG000|Treatment Period 2|Subject withdrew consent|0|||
37761397|NCT01484197|69272958|FG001|Treatment Period 2|Subject withdrew consent|0|||
37761398|NCT01484197|69272959|FG002|Treatment Period 2|Subject withdrew consent|0|||
37761399|NCT01484197|69272960|FG003|Treatment Period 2|Subject withdrew consent|1|||
37761400|NCT01473407|69272972|FG000|Overall Study|Physician Decision|1|||
37761401|NCT01473407|69272973|FG001|Overall Study|Physician Decision|4|||
37761402|NCT01473407|69272972|FG000|Overall Study|Lost to Follow-up|10|||
37761403|NCT01473407|69272973|FG001|Overall Study|Lost to Follow-up|4|||
37761404|NCT01473407|69272972|FG000|Overall Study|Adverse Event|8|||
37761405|NCT01473407|69272973|FG001|Overall Study|Adverse Event|8|||
37761406|NCT01473407|69272972|FG000|Overall Study|Randomization Error|3|||
37761407|NCT01473407|69272973|FG001|Overall Study|Randomization Error|1|||
37761408|NCT01473407|69272972|FG000|Overall Study|Withdrawal by Subject|4|||
37761409|NCT01473407|69272973|FG001|Overall Study|Withdrawal by Subject|7|||
37761410|NCT01473407|69272972|FG000|Overall Study|Kidney Transplant|7|||
37761411|NCT01473407|69272973|FG001|Overall Study|Kidney Transplant|6|||
37761412|NCT01473407|69272972|FG000|Overall Study|Vacation/Travel|1|||
37761413|NCT01473407|69272973|FG001|Overall Study|Vacation/Travel|1|||
37761414|NCT01473407|69272972|FG000|Overall Study|Elevated Hemoglobin|1|||
37761415|NCT01473407|69272973|FG001|Overall Study|Elevated Hemoglobin|0|||
37761416|NCT01473407|69272972|FG000|Overall Study|Patient Received Aranesp|1|||
37761417|NCT01473407|69272973|FG001|Overall Study|Patient Received Aranesp|0|||
37761418|NCT01473407|69272972|FG000|Overall Study|Patient Lost Green Card Status|1|||
37761419|NCT01473407|69272973|FG001|Overall Study|Patient Lost Green Card Status|0|||
37761420|NCT01473407|69272972|FG000|Overall Study|Temperature Excursion|2|||
37761421|NCT01473407|69272973|FG001|Overall Study|Temperature Excursion|3|||
37761422|NCT01473407|69272972|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
37761423|NCT01473407|69272973|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
37761424|NCT01473407|69272972|FG000|Overall Study|Sponsor's Decision|10|||
37761425|NCT01473407|69272973|FG001|Overall Study|Sponsor's Decision|10|||
37761426|NCT01473407|69272972|FG000|Overall Study|Site Closure|1|||
37761427|NCT01473407|69272973|FG001|Overall Study|Site Closure|0|||
37761428|NCT01472939|69272983|FG000|Overall Study|Adverse Event|3|||
37761429|NCT01472939|69272984|FG001|Overall Study|Adverse Event|7|||
37761430|NCT01472939|69272985|FG002|Overall Study|Adverse Event|7|||
37761431|NCT01472939|69272986|FG003|Overall Study|Adverse Event|14|||
37761432|NCT01472939|69272983|FG000|Overall Study|Lack of Efficacy|1|||
37761433|NCT01472939|69272984|FG001|Overall Study|Lack of Efficacy|0|||
37761434|NCT01472939|69272985|FG002|Overall Study|Lack of Efficacy|0|||
37761435|NCT01472939|69272986|FG003|Overall Study|Lack of Efficacy|1|||
37761436|NCT01472939|69272983|FG000|Overall Study|Lost to Follow-up|3|||
37761437|NCT01472939|69272984|FG001|Overall Study|Lost to Follow-up|0|||
37761438|NCT01472939|69272985|FG002|Overall Study|Lost to Follow-up|2|||
38034965|NCT04241133|69721824|FG000|Overall Study|COVID19 Precautions|14|||
37761439|NCT01472939|69272986|FG003|Overall Study|Lost to Follow-up|0|||
37761440|NCT01472939|69272983|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
37761441|NCT01472939|69272984|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
37761442|NCT01472939|69272985|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
37761443|NCT01472939|69272986|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
37761444|NCT01472939|69272983|FG000|Overall Study|Prohibited Medication|0|||
37761445|NCT01472939|69272984|FG001|Overall Study|Prohibited Medication|1|||
37761446|NCT01472939|69272985|FG002|Overall Study|Prohibited Medication|0|||
37761447|NCT01472939|69272986|FG003|Overall Study|Prohibited Medication|0|||
37761448|NCT01472939|69272983|FG000|Overall Study|Withdrawal By PI|1|||
37761449|NCT01472939|69272984|FG001|Overall Study|Withdrawal By PI|0|||
37761450|NCT01472939|69272985|FG002|Overall Study|Withdrawal By PI|0|||
37761451|NCT01472939|69272986|FG003|Overall Study|Withdrawal By PI|0|||
37761452|NCT01472939|69272983|FG000|Overall Study|Protocol Violation|3|||
38034966|NCT04241133|69721825|FG001|Overall Study|COVID19 Precautions|34|||
37761453|NCT01472939|69272984|FG001|Overall Study|Protocol Violation|3|||
37761454|NCT01472939|69272985|FG002|Overall Study|Protocol Violation|0|||
37761455|NCT01472939|69272986|FG003|Overall Study|Protocol Violation|1|||
37761456|NCT01472939|69272983|FG000|Overall Study|Withdrawal by Subject|9|||
37761457|NCT01472939|69272984|FG001|Overall Study|Withdrawal by Subject|3|||
37761458|NCT01472939|69272985|FG002|Overall Study|Withdrawal by Subject|1|||
37761459|NCT01472939|69272986|FG003|Overall Study|Withdrawal by Subject|4|||
37761460|NCT01544179|69273001|FG000|Overall Study|Death|50|||
37761461|NCT01544179|69273002|FG001|Overall Study|Death|37|||
37761462|NCT01544179|69273001|FG000|Overall Study|Lost to Follow-up|0|||
37761463|NCT01544179|69273002|FG001|Overall Study|Lost to Follow-up|1|||
37761464|NCT01544179|69273001|FG000|Overall Study|Adverse Event|0|||
37761465|NCT01544179|69273002|FG001|Overall Study|Adverse Event|1|||
37761466|NCT01544179|69273001|FG000|Overall Study|Withdrawal by Subject|12|||
37761467|NCT01544179|69273002|FG001|Overall Study|Withdrawal by Subject|7|||
37761468|NCT01544179|69273001|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
37761469|NCT01544179|69273002|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
37761470|NCT01483651|69273008|FG000|Overall Study|Withdrawal by Subject|0|||
37761471|NCT01483651|69273009|FG001|Overall Study|Withdrawal by Subject|1|||
37761472|NCT01483651|69273010|FG002|Overall Study|Withdrawal by Subject|1|||
37761473|NCT01483651|69273011|FG003|Overall Study|Withdrawal by Subject|0|||
37761474|NCT01483651|69273012|FG004|Overall Study|Withdrawal by Subject|0|||
37761475|NCT01483651|69273013|FG005|Overall Study|Withdrawal by Subject|1|||
37761476|NCT01464307|69273023|FG000|Main Period|Death|0|||
37761477|NCT01464307|69273024|FG001|Main Period|Death|1|||
37761478|NCT01464307|69273023|FG000|Main Period|Adverse Event|6|||
37761479|NCT01464307|69273024|FG001|Main Period|Adverse Event|1|||
37761480|NCT01464307|69273023|FG000|Main Period|Lack of Efficacy|2|||
37761481|NCT01464307|69273024|FG001|Main Period|Lack of Efficacy|0|||
37761482|NCT01464307|69273023|FG000|Main Period|Withdrawal by Subject|5|||
37761483|NCT01464307|69273024|FG001|Main Period|Withdrawal by Subject|2|||
37761484|NCT01464307|69273023|FG000|Main Period|Predefined discontinuation criteria|2|||
37761485|NCT01464307|69273024|FG001|Main Period|Predefined discontinuation criteria|1|||
37761486|NCT01464307|69273023|FG000|Open-Label Extension Period|Adverse Event|15|||
37761487|NCT01464307|69273024|FG001|Open-Label Extension Period|Adverse Event|0|||
37761488|NCT01464307|69273023|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
37761489|NCT01464307|69273024|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
37761490|NCT01464307|69273023|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
37761491|NCT01464307|69273024|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
37761492|NCT01464307|69273023|FG000|Open-Label Extension Period|Death|1|||
37761493|NCT01464307|69273024|FG001|Open-Label Extension Period|Death|0|||
37761494|NCT01464307|69273023|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
37761495|NCT01464307|69273024|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
37761496|NCT01464307|69273023|FG000|Open-Label Extension Period|Non-compliance|9|||
37761497|NCT01464307|69273024|FG001|Open-Label Extension Period|Non-compliance|0|||
37761498|NCT01464307|69273023|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
37761499|NCT01464307|69273024|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
37761500|NCT01483183|69273041|FG000|Overall Study|Physician Decision|0|||
37761501|NCT01483183|69273042|FG001|Overall Study|Physician Decision|0|||
37761502|NCT01483183|69273043|FG002|Overall Study|Physician Decision|0|||
37761503|NCT01483183|69273044|FG003|Overall Study|Physician Decision|0|||
37669619|NCT02055976|69142712|FG003|Overall Study|Other|0|||
37669620|NCT02055976|69142713|FG004|Overall Study|Other|0|||
37669621|NCT02055976|69142714|FG005|Overall Study|Other|0|||
37669622|NCT02055976|69142715|FG006|Overall Study|Other|0|||
37669623|NCT02055976|69142716|FG007|Overall Study|Other|0|||
37669624|NCT02055976|69142717|FG008|Overall Study|Other|0|||
37669625|NCT02055976|69142709|FG000|Overall Study|Adverse Event|0|||
37669626|NCT02055976|69142710|FG001|Overall Study|Adverse Event|0|||
37669627|NCT02055976|69142711|FG002|Overall Study|Adverse Event|0|||
37669628|NCT02055976|69142712|FG003|Overall Study|Adverse Event|0|||
37669629|NCT02055976|69142713|FG004|Overall Study|Adverse Event|0|||
37669630|NCT02055976|69142714|FG005|Overall Study|Adverse Event|1|||
37669631|NCT02055976|69142715|FG006|Overall Study|Adverse Event|1|||
37669632|NCT02055976|69142716|FG007|Overall Study|Adverse Event|0|||
37669633|NCT02055976|69142717|FG008|Overall Study|Adverse Event|0|||
37669634|NCT02055976|69142709|FG000|Overall Study|Does not meet entrance criteria|0|||
37669635|NCT02055976|69142710|FG001|Overall Study|Does not meet entrance criteria|0|||
37669636|NCT02055976|69142711|FG002|Overall Study|Does not meet entrance criteria|0|||
37669637|NCT02055976|69142712|FG003|Overall Study|Does not meet entrance criteria|0|||
37669638|NCT02055976|69142713|FG004|Overall Study|Does not meet entrance criteria|0|||
37669639|NCT02055976|69142714|FG005|Overall Study|Does not meet entrance criteria|0|||
37669640|NCT02055976|69142715|FG006|Overall Study|Does not meet entrance criteria|1|||
37669641|NCT02055976|69142716|FG007|Overall Study|Does not meet entrance criteria|0|||
37669642|NCT02055976|69142717|FG008|Overall Study|Does not meet entrance criteria|0|||
37669643|NCT02055976|69142709|FG000|Overall Study|Lost to Follow-up|0|||
37669644|NCT02055976|69142710|FG001|Overall Study|Lost to Follow-up|0|||
37761504|NCT01483183|69273045|FG004|Overall Study|Physician Decision|0|||
37761505|NCT01483183|69273046|FG005|Overall Study|Physician Decision|0|||
37761506|NCT01483183|69273047|FG006|Overall Study|Physician Decision|2|||
37761507|NCT01483183|69273048|FG007|Overall Study|Physician Decision|0|||
37761508|NCT01483183|69273049|FG008|Overall Study|Physician Decision|0|||
37761509|NCT01483183|69273050|FG009|Overall Study|Physician Decision|0|||
37761510|NCT01483183|69273041|FG000|Overall Study|Withdrawal by Subject|0|||
37761511|NCT01483183|69273042|FG001|Overall Study|Withdrawal by Subject|0|||
37761512|NCT01483183|69273043|FG002|Overall Study|Withdrawal by Subject|0|||
37761513|NCT01483183|69273044|FG003|Overall Study|Withdrawal by Subject|0|||
37761514|NCT01483183|69273045|FG004|Overall Study|Withdrawal by Subject|0|||
37761515|NCT01483183|69273046|FG005|Overall Study|Withdrawal by Subject|0|||
37761516|NCT01483183|69273047|FG006|Overall Study|Withdrawal by Subject|0|||
37761517|NCT01483183|69273048|FG007|Overall Study|Withdrawal by Subject|0|||
37761518|NCT01483183|69273049|FG008|Overall Study|Withdrawal by Subject|0|||
37761519|NCT01483183|69273050|FG009|Overall Study|Withdrawal by Subject|1|||
37761520|NCT01483027|69273080|FG000|Overall Study|Administrative Reasons|2|||
37761521|NCT01483027|69273081|FG001|Overall Study|Administrative Reasons|1|||
37761522|NCT01483027|69273080|FG000|Overall Study|Withdrawal by Subject|21|||
37761523|NCT01483027|69273081|FG001|Overall Study|Withdrawal by Subject|32|||
37761524|NCT01483027|69273080|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
37761525|NCT01483027|69273081|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
37761526|NCT01483027|69273080|FG000|Overall Study|Lost to Follow-up|1|||
37761527|NCT01483027|69273081|FG001|Overall Study|Lost to Follow-up|1|||
37761528|NCT01483027|69273080|FG000|Overall Study|Adverse Event|0|||
37761529|NCT01483027|69273081|FG001|Overall Study|Adverse Event|1|||
37761530|NCT01483027|69273080|FG000|Overall Study|Withdrawal by Subject|0|||
37761531|NCT01483027|69273081|FG001|Overall Study|Withdrawal by Subject|1|||
37761532|NCT01463683|69273090|FG000|Overall Study|Adverse Event|2|||
37761533|NCT01463683|69273091|FG001|Overall Study|Adverse Event|0|||
37761534|NCT01463683|69273092|FG002|Overall Study|Adverse Event|0|||
37761535|NCT01463683|69273090|FG000|Overall Study|Lost to Follow-up|10|||
37761536|NCT01463683|69273091|FG001|Overall Study|Lost to Follow-up|9|||
37761537|NCT01463683|69273092|FG002|Overall Study|Lost to Follow-up|7|||
37761538|NCT01463683|69273090|FG000|Overall Study|Physician Decision|0|||
37761539|NCT01463683|69273091|FG001|Overall Study|Physician Decision|3|||
37761540|NCT01463683|69273092|FG002|Overall Study|Physician Decision|1|||
37761541|NCT01463683|69273090|FG000|Overall Study|Pregnancy|2|||
37761542|NCT01463683|69273091|FG001|Overall Study|Pregnancy|2|||
37761543|NCT01463683|69273092|FG002|Overall Study|Pregnancy|1|||
37761544|NCT01463683|69273090|FG000|Overall Study|Withdrawal by Subject|5|||
37761545|NCT01463683|69273091|FG001|Overall Study|Withdrawal by Subject|17|||
37761546|NCT01463683|69273092|FG002|Overall Study|Withdrawal by Subject|2|||
37761547|NCT01482169|69273100|FG000|Overall Study|Physician Decision|2|||
37761548|NCT01481779|69273109|FG000|Overall Study|Adverse Event|23|||
37761549|NCT01481779|69273110|FG001|Overall Study|Adverse Event|5|||
37761550|NCT01481779|69273109|FG000|Overall Study|Lost to Follow-up|3|||
37761551|NCT01481779|69273110|FG001|Overall Study|Lost to Follow-up|2|||
37761552|NCT01481779|69273109|FG000|Overall Study|Protocol Violation|2|||
37761553|NCT01481779|69273110|FG001|Overall Study|Protocol Violation|3|||
37669645|NCT02055976|69142711|FG002|Overall Study|Lost to Follow-up|0|||
37669646|NCT02055976|69142712|FG003|Overall Study|Lost to Follow-up|1|||
37669647|NCT02055976|69142713|FG004|Overall Study|Lost to Follow-up|0|||
37669648|NCT02055976|69142714|FG005|Overall Study|Lost to Follow-up|0|||
37669649|NCT02055976|69142715|FG006|Overall Study|Lost to Follow-up|0|||
37669650|NCT02055976|69142716|FG007|Overall Study|Lost to Follow-up|0|||
37669651|NCT02055976|69142717|FG008|Overall Study|Lost to Follow-up|0|||
37669652|NCT02055898|69142746|FG000|First Intervention (5 Days)|Physician Decision|2|||
37669653|NCT02055898|69142747|FG001|First Intervention (5 Days)|Physician Decision|0|||
37669654|NCT02055898|69142746|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
37761554|NCT01481779|69273109|FG000|Overall Study|Withdrawal by Subject|26|||
37761555|NCT01481779|69273110|FG001|Overall Study|Withdrawal by Subject|13|||
37761556|NCT01481779|69273109|FG000|Overall Study|Physician Decision|13|||
37761557|NCT01481779|69273110|FG001|Overall Study|Physician Decision|4|||
37761558|NCT01481779|69273109|FG000|Overall Study|Sponsor Decision|3|||
37761559|NCT01481779|69273110|FG001|Overall Study|Sponsor Decision|1|||
37761560|NCT01463527|69273118|FG000|Overall Study|Protocol Violation|1|||
37761561|NCT01463527|69273119|FG001|Overall Study|Protocol Violation|1|||
37761562|NCT01463527|69273118|FG000|Overall Study|Crying >20% of sedation|5|||
37669655|NCT02055898|69142747|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
37669656|NCT02564055|69142759|FG000|Overall Study|Adverse Event|1|||
37669657|NCT02564055|69142760|FG001|Overall Study|Adverse Event|0|||
37669658|NCT02564055|69142761|FG002|Overall Study|Adverse Event|4|||
37761563|NCT01463527|69273119|FG001|Overall Study|Crying >20% of sedation|6|||
37761564|NCT01509547|69273127|FG000|Overall Study|Lost to Follow-up|24|||
37761565|NCT01509547|69273128|FG001|Overall Study|Lost to Follow-up|14|||
37761566|NCT01509547|69273127|FG000|Overall Study|Withdrawal by Subject|11|||
37761567|NCT01509547|69273128|FG001|Overall Study|Withdrawal by Subject|24|||
37761568|NCT01509547|69273127|FG000|Overall Study|Physician Decision|0|||
37761569|NCT01509547|69273128|FG001|Overall Study|Physician Decision|1|||
37761570|NCT01509079|69273136|FG000|Overall Study|Lack of Efficacy|0|||
37761571|NCT01509079|69273137|FG001|Overall Study|Lack of Efficacy|2|||
37761572|NCT01509079|69273136|FG000|Overall Study|started an excluded medication|0|||
37761573|NCT01509079|69273137|FG001|Overall Study|started an excluded medication|1|||
37761574|NCT01463293|69273146|FG000|Overall Study|Lost to Follow-up|1|||
37761575|NCT01463293|69273147|FG001|Overall Study|Lost to Follow-up|4|||
37761576|NCT01463293|69273148|FG002|Overall Study|Lost to Follow-up|5|||
37761577|NCT01463293|69273146|FG000|Overall Study|Adverse Event|1|||
37761578|NCT01463293|69273147|FG001|Overall Study|Adverse Event|2|||
37761579|NCT01463293|69273148|FG002|Overall Study|Adverse Event|0|||
37761580|NCT01463293|69273146|FG000|Overall Study|Withdrawal by Subject|4|||
37761581|NCT01463293|69273147|FG001|Overall Study|Withdrawal by Subject|10|||
37761582|NCT01463293|69273148|FG002|Overall Study|Withdrawal by Subject|5|||
37761583|NCT01463293|69273146|FG000|Overall Study|Other|0|||
37761584|NCT01463293|69273147|FG001|Overall Study|Other|0|||
37761585|NCT01463293|69273148|FG002|Overall Study|Other|2|||
37761586|NCT01479985|69273179|FG000|Overall Study|Tablet malfunction, no data saved|1|||
37761587|NCT01479985|69273180|FG001|Overall Study|Tablet malfunction, no data saved|1|||
37761588|NCT01479985|69273179|FG000|Overall Study|No decisional conflict scale responses|0|||
37761589|NCT01479985|69273180|FG001|Overall Study|No decisional conflict scale responses|2|||
37761590|NCT01479985|69273179|FG000|Overall Study|No post-visit survey|5|||
37761591|NCT01479985|69273180|FG001|Overall Study|No post-visit survey|3|||
37761592|NCT01462435|69273194|FG000|Overall Study|Lack of Efficacy|1|||
37761593|NCT01462435|69273195|FG001|Overall Study|Lack of Efficacy|0|||
37761594|NCT01462435|69273196|FG002|Overall Study|Lack of Efficacy|0|||
37761595|NCT01462435|69273197|FG003|Overall Study|Lack of Efficacy|3|||
37761596|NCT01462435|69273194|FG000|Overall Study|Physician Decision|0|||
37761597|NCT01462435|69273195|FG001|Overall Study|Physician Decision|0|||
37761598|NCT01462435|69273196|FG002|Overall Study|Physician Decision|1|||
37761599|NCT01462435|69273197|FG003|Overall Study|Physician Decision|0|||
37761600|NCT01462435|69273194|FG000|Overall Study|Withdrawal by Subject|0|||
37761601|NCT01462435|69273195|FG001|Overall Study|Withdrawal by Subject|0|||
37761602|NCT01462435|69273196|FG002|Overall Study|Withdrawal by Subject|0|||
37761603|NCT01462435|69273197|FG003|Overall Study|Withdrawal by Subject|1|||
37761604|NCT01462435|69273194|FG000|Overall Study|Lost to Follow-up|0|||
37761605|NCT01462435|69273195|FG001|Overall Study|Lost to Follow-up|0|||
37761606|NCT01462435|69273196|FG002|Overall Study|Lost to Follow-up|0|||
37761607|NCT01462435|69273197|FG003|Overall Study|Lost to Follow-up|1|||
37761608|NCT01472081|69273213|FG000|Overall Study|Continuing treatment at time of analysis|1|||
37761609|NCT01472081|69273214|FG001|Overall Study|Continuing treatment at time of analysis|4|||
37761610|NCT01472081|69273215|FG002|Overall Study|Continuing treatment at time of analysis|1|||
37761611|NCT01472081|69273216|FG003|Overall Study|Continuing treatment at time of analysis|8|||
37761612|NCT01472081|69273217|FG004|Overall Study|Continuing treatment at time of analysis|9|||
37761613|NCT01472081|69273218|FG005|Overall Study|Continuing treatment at time of analysis|0|||
37761614|NCT01472081|69273213|FG000|Overall Study|Disease Progression|4|||
37761615|NCT01472081|69273214|FG001|Overall Study|Disease Progression|10|||
37761616|NCT01472081|69273215|FG002|Overall Study|Disease Progression|12|||
37761617|NCT01472081|69273216|FG003|Overall Study|Disease Progression|31|||
37761618|NCT01472081|69273217|FG004|Overall Study|Disease Progression|22|||
37761619|NCT01472081|69273218|FG005|Overall Study|Disease Progression|3|||
37761620|NCT01472081|69273213|FG000|Overall Study|Study drug toxicity|2|||
37761621|NCT01472081|69273214|FG001|Overall Study|Study drug toxicity|9|||
37761622|NCT01472081|69273215|FG002|Overall Study|Study drug toxicity|4|||
37761623|NCT01472081|69273216|FG003|Overall Study|Study drug toxicity|6|||
37761624|NCT01472081|69273217|FG004|Overall Study|Study drug toxicity|13|||
37761625|NCT01472081|69273218|FG005|Overall Study|Study drug toxicity|2|||
37761626|NCT01472081|69273213|FG000|Overall Study|Death|0|||
37761627|NCT01472081|69273214|FG001|Overall Study|Death|0|||
37761628|NCT01472081|69273215|FG002|Overall Study|Death|0|||
37761629|NCT01472081|69273216|FG003|Overall Study|Death|0|||
37761630|NCT01472081|69273217|FG004|Overall Study|Death|1|||
37761631|NCT01472081|69273218|FG005|Overall Study|Death|0|||
37761632|NCT01472081|69273213|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
37761633|NCT01472081|69273214|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
37761634|NCT01472081|69273215|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
37761635|NCT01472081|69273216|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
38034967|NCT04123665|69721833|FG000|Overall Study|Withdrawal by Subject|7|||
38034968|NCT04123665|69721834|FG001|Overall Study|Withdrawal by Subject|0|||
38034969|NCT04123665|69721833|FG000|Overall Study|Lost to Follow-up|1|||
37761636|NCT01472081|69273217|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
37761637|NCT01472081|69273218|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
37761638|NCT01472081|69273213|FG000|Overall Study|Withdrawal by Subject|0|||
37761639|NCT01472081|69273214|FG001|Overall Study|Withdrawal by Subject|0|||
37761640|NCT01472081|69273215|FG002|Overall Study|Withdrawal by Subject|0|||
37761641|NCT01472081|69273216|FG003|Overall Study|Withdrawal by Subject|0|||
37761642|NCT01472081|69273217|FG004|Overall Study|Withdrawal by Subject|0|||
37761643|NCT01472081|69273218|FG005|Overall Study|Withdrawal by Subject|1|||
37761644|NCT01472081|69273213|FG000|Overall Study|Poor/non-compliance|0|||
37761645|NCT01472081|69273214|FG001|Overall Study|Poor/non-compliance|0|||
37761646|NCT01472081|69273215|FG002|Overall Study|Poor/non-compliance|1|||
37761647|NCT01472081|69273216|FG003|Overall Study|Poor/non-compliance|0|||
37761648|NCT01472081|69273217|FG004|Overall Study|Poor/non-compliance|1|||
37761649|NCT01472081|69273218|FG005|Overall Study|Poor/non-compliance|0|||
37761650|NCT01472081|69273213|FG000|Overall Study|No longer meets study criteria|0|||
37761651|NCT01472081|69273214|FG001|Overall Study|No longer meets study criteria|0|||
37761652|NCT01472081|69273215|FG002|Overall Study|No longer meets study criteria|1|||
37761653|NCT01472081|69273216|FG003|Overall Study|No longer meets study criteria|0|||
37761654|NCT01472081|69273217|FG004|Overall Study|No longer meets study criteria|0|||
37761655|NCT01472081|69273218|FG005|Overall Study|No longer meets study criteria|0|||
37761656|NCT01472081|69273213|FG000|Overall Study|Subject request to discontinue treatment|0|||
37761657|NCT01472081|69273214|FG001|Overall Study|Subject request to discontinue treatment|3|||
37761658|NCT01472081|69273215|FG002|Overall Study|Subject request to discontinue treatment|1|||
37761659|NCT01472081|69273216|FG003|Overall Study|Subject request to discontinue treatment|1|||
37761660|NCT01472081|69273217|FG004|Overall Study|Subject request to discontinue treatment|0|||
37761661|NCT01472081|69273218|FG005|Overall Study|Subject request to discontinue treatment|0|||
37761662|NCT01471691|69273233|FG000|Overall Study|Lack of Efficacy|0|||
37761663|NCT01471691|69273234|FG001|Overall Study|Lack of Efficacy|1|||
37761664|NCT01471379|69273243|FG000|Overall Study|Adverse Event|1|||
37761665|NCT01471379|69273244|FG001|Overall Study|Adverse Event|0|||
37761666|NCT01471379|69273245|FG002|Overall Study|Adverse Event|0|||
37761667|NCT01471379|69273243|FG000|Overall Study|Study terminated|0|||
37761668|NCT01471379|69273244|FG001|Overall Study|Study terminated|1|||
37761669|NCT01471379|69273245|FG002|Overall Study|Study terminated|0|||
37761670|NCT01470989|69273256|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
37761671|NCT01470989|69273257|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
37761672|NCT01470989|69273256|FG000|Overall Study|Adverse Event|2|||
37761673|NCT01470989|69273257|FG001|Overall Study|Adverse Event|5|||
37761674|NCT01470989|69273256|FG000|Overall Study|Abnormal laboratory value|1|||
37761675|NCT01470989|69273257|FG001|Overall Study|Abnormal laboratory value|1|||
37761676|NCT01470989|69273256|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
37761677|NCT01470989|69273257|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
37761678|NCT01470989|69273256|FG000|Overall Study|Withdrawal by Subject|19|||
37761679|NCT01470989|69273257|FG001|Overall Study|Withdrawal by Subject|17|||
37761680|NCT01470989|69273256|FG000|Overall Study|Lost to Follow-up|18|||
37761681|NCT01470989|69273257|FG001|Overall Study|Lost to Follow-up|13|||
37761682|NCT01470989|69273256|FG000|Overall Study|Administrative problems|2|||
37761683|NCT01470989|69273257|FG001|Overall Study|Administrative problems|4|||
37761684|NCT01470989|69273256|FG000|Overall Study|Death|2|||
37761685|NCT01470989|69273257|FG001|Overall Study|Death|2|||
37761686|NCT01470989|69273256|FG000|Overall Study|Protocol deviation|1|||
37761687|NCT01470989|69273257|FG001|Overall Study|Protocol deviation|2|||
37761688|NCT01470599|69273267|FG000|Overall Study|Did not meet entrance criteria|1|||
37761689|NCT01470599|69273268|FG001|Overall Study|Did not meet entrance criteria|0|||
37761690|NCT01470599|69273267|FG000|Overall Study|Lost to Follow-up|2|||
37761691|NCT01470599|69273268|FG001|Overall Study|Lost to Follow-up|1|||
37761692|NCT01470599|69273267|FG000|Overall Study|Withdrawal by Subject|3|||
37761693|NCT01470599|69273268|FG001|Overall Study|Withdrawal by Subject|4|||
37932967|NCT00750308|69619781|FG002|Third Treatment|Withdrawal by Subject|0|||
37932968|NCT00750308|69619782|FG003|Third Treatment|Withdrawal by Subject|0|||
37932969|NCT00750308|69619783|FG004|Third Treatment|Withdrawal by Subject|0|||
37932970|NCT00750308|69619784|FG005|Third Treatment|Withdrawal by Subject|0|||
37932971|NCT00750308|69619785|FG006|Third Treatment|Withdrawal by Subject|0|||
37761694|NCT01470599|69273267|FG000|Overall Study|Other|1|||
37761695|NCT01470599|69273268|FG001|Overall Study|Other|0|||
37761696|NCT01470599|69273267|FG000|Overall Study|Protocol Violation|3|||
37761697|NCT01470599|69273268|FG001|Overall Study|Protocol Violation|1|||
37761698|NCT01470599|69273267|FG000|Overall Study|Adverse event related to study drug|2|||
37761699|NCT01470599|69273268|FG001|Overall Study|Adverse event related to study drug|5|||
37761700|NCT01470599|69273267|FG000|Overall Study|Insufficient clinical response|6|||
37761701|NCT01470599|69273268|FG001|Overall Study|Insufficient clinical response|27|||
37761702|NCT01470599|69273267|FG000|Overall Study|Adverse event not related to study drug|1|||
37761703|NCT01470599|69273268|FG001|Overall Study|Adverse event not related to study drug|5|||
37761704|NCT01469819|69273274|FG000|Overall Study|Withdrawal by Subject|1|||
37761705|NCT01469819|69273274|FG000|Overall Study|Did not meet inclusionary criteria|2|||
37761706|NCT01469819|69273274|FG000|Overall Study|Could not swallow SmartPill|2|||
37761707|NCT01469819|69273274|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
37761708|NCT01507831|69273286|FG000|Overall Study|Randomized but not treated|0|||
37761709|NCT01507831|69273287|FG001|Overall Study|Randomized but not treated|3|||
37932972|NCT00750308|69619786|FG007|Third Treatment|Withdrawal by Subject|0|||
37761710|NCT01507831|69273286|FG000|Overall Study|Adverse Event|48|||
37761711|NCT01507831|69273287|FG001|Overall Study|Adverse Event|113|||
37761712|NCT01507831|69273286|FG000|Overall Study|Death|6|||
37761713|NCT01507831|69273287|FG001|Overall Study|Death|2|||
37761714|NCT01507831|69273286|FG000|Overall Study|Poor compliance to protocol|38|||
37761715|NCT01507831|69273287|FG001|Overall Study|Poor compliance to protocol|60|||
37761716|NCT01507831|69273286|FG000|Overall Study|Physician Decision|0|||
37761717|NCT01507831|69273287|FG001|Overall Study|Physician Decision|4|||
37761718|NCT01507831|69273286|FG000|Overall Study|Participant moved|5|||
37761719|NCT01507831|69273287|FG001|Overall Study|Participant moved|19|||
37761720|NCT01507831|69273286|FG000|Overall Study|Consent withdrawn by participant|34|||
37761721|NCT01507831|69273287|FG001|Overall Study|Consent withdrawn by participant|72|||
37761722|NCT01507831|69273286|FG000|Overall Study|Related to study drug administration|5|||
37761723|NCT01507831|69273287|FG001|Overall Study|Related to study drug administration|14|||
37761724|NCT01507831|69273286|FG000|Overall Study|Last visit outside protocol visit window|51|||
37761725|NCT01507831|69273287|FG001|Overall Study|Last visit outside protocol visit window|143|||
37761726|NCT01507831|69273286|FG000|Overall Study|Selection criteria finally not met|0|||
37761727|NCT01507831|69273287|FG001|Overall Study|Selection criteria finally not met|1|||
37761728|NCT01507831|69273286|FG000|Overall Study|Site closure|0|||
37761729|NCT01507831|69273287|FG001|Overall Study|Site closure|3|||
37761730|NCT01507831|69273286|FG000|Overall Study|Potential lost to follow-up|3|||
37761731|NCT01507831|69273287|FG001|Overall Study|Potential lost to follow-up|0|||
37761732|NCT01507831|69273286|FG000|Overall Study|Other|3|||
37932973|NCT00750308|69619787|FG008|Third Treatment|Withdrawal by Subject|0|||
37932974|NCT00750308|69619788|FG009|Third Treatment|Withdrawal by Subject|0|||
37932975|NCT00750308|69619789|FG010|Third Treatment|Withdrawal by Subject|0|||
37761733|NCT01507831|69273287|FG001|Overall Study|Other|6|||
37761734|NCT01479595|69273295|FG000|Overall Study|Protocol deviation|0|||
37761735|NCT01479595|69273296|FG001|Overall Study|Protocol deviation|1|||
37761736|NCT01479595|69273295|FG000|Overall Study|Adverse Event|2|||
37761737|NCT01479595|69273296|FG001|Overall Study|Adverse Event|1|||
37761738|NCT01462357|69273305|FG000|Overall Study|Death|0|||
37761739|NCT01462357|69273306|FG001|Overall Study|Death|0|||
37761740|NCT01462357|69273307|FG002|Overall Study|Death|1|||
37761741|NCT01462357|69273305|FG000|Overall Study|Withdrawal by Subject|3|||
37761742|NCT01462357|69273306|FG001|Overall Study|Withdrawal by Subject|11|||
37761743|NCT01462357|69273307|FG002|Overall Study|Withdrawal by Subject|3|||
37761744|NCT01462357|69273305|FG000|Overall Study|Migrated/moved from study area|2|||
37761745|NCT01462357|69273306|FG001|Overall Study|Migrated/moved from study area|3|||
37761746|NCT01462357|69273307|FG002|Overall Study|Migrated/moved from study area|1|||
37761747|NCT01462357|69273305|FG000|Overall Study|Lost to Follow-up|3|||
37761748|NCT01462357|69273306|FG001|Overall Study|Lost to Follow-up|5|||
37761749|NCT01462357|69273307|FG002|Overall Study|Lost to Follow-up|7|||
37761750|NCT01479439|69273318|FG000|Overall Study|Adverse Event|1|||
37761751|NCT01479439|69273319|FG001|Overall Study|Adverse Event|0|||
37932976|NCT00750308|69619790|FG011|Third Treatment|Withdrawal by Subject|0|||
37932977|NCT00750152|69619806|FG000|Overall Study|Adverse Event|2|||
37932978|NCT00750152|69619807|FG001|Overall Study|Adverse Event|1|||
37932979|NCT00750152|69619806|FG000|Overall Study|Lost to Follow-up|8|||
37932980|NCT00750152|69619807|FG001|Overall Study|Lost to Follow-up|13|||
37932981|NCT00750152|69619806|FG000|Overall Study|Withdrawal by Subject|3|||
37932982|NCT00750152|69619807|FG001|Overall Study|Withdrawal by Subject|3|||
37932983|NCT00750152|69619806|FG000|Overall Study|Physician Decision|1|||
37932984|NCT00750152|69619807|FG001|Overall Study|Physician Decision|1|||
37932985|NCT00750152|69619806|FG000|Overall Study|Non-compliance|0|||
37932986|NCT00750152|69619807|FG001|Overall Study|Non-compliance|1|||
37932987|NCT00750152|69619806|FG000|Overall Study|Termination by sponsor|1|||
37932988|NCT00750152|69619807|FG001|Overall Study|Termination by sponsor|0|||
37932989|NCT00750152|69619806|FG000|Overall Study|Other|7|||
37932990|NCT00750152|69619807|FG001|Overall Study|Other|8|||
37932991|NCT00749996|69619815|FG000|Overall Study|Lost to Follow-up|7|||
37932992|NCT00749996|69619816|FG001|Overall Study|Lost to Follow-up|4|||
38034970|NCT04123665|69721834|FG001|Overall Study|Lost to Follow-up|0|||
37761752|NCT01479439|69273320|FG002|Overall Study|Adverse Event|0|||
37761753|NCT01479439|69273318|FG000|Overall Study|Lost to Follow-up|0|||
37761754|NCT01479439|69273319|FG001|Overall Study|Lost to Follow-up|1|||
37761755|NCT01479439|69273320|FG002|Overall Study|Lost to Follow-up|0|||
37761756|NCT01479439|69273318|FG000|Overall Study|Protocol Violation|0|||
37761757|NCT01479439|69273319|FG001|Overall Study|Protocol Violation|0|||
37761758|NCT01479439|69273320|FG002|Overall Study|Protocol Violation|2|||
37761759|NCT01478971|69273331|FG000|Standard of Care Period|Adverse Event|1|||
37761760|NCT01478971|69273331|FG000|Standard of Care Period|Withdrawal by Subject|3|||
37932993|NCT00749996|69619815|FG000|Overall Study|Withdrawal by Subject|5|||
37932994|NCT00749996|69619816|FG001|Overall Study|Withdrawal by Subject|4|||
37932995|NCT00749996|69619815|FG000|Overall Study|Protocol Violation|2|||
37932996|NCT00749996|69619816|FG001|Overall Study|Protocol Violation|3|||
37932997|NCT00749996|69619815|FG000|Overall Study|Physician Decision|2|||
37761761|NCT01478971|69273331|FG000|Standard of Care Period|Death|8|||
37761762|NCT01478971|69273331|FG000|Standard of Care Period|Lost to Follow-up|9|||
37761763|NCT01478971|69273331|FG000|Standard of Care Period|Other|4|||
37932998|NCT00749996|69619816|FG001|Overall Study|Physician Decision|0|||
37761764|NCT01478971|69273331|FG000|Peginesatide Treatment Period|Adverse Event|1|||
37761765|NCT01478971|69273331|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
37761766|NCT01478971|69273331|FG000|Peginesatide Treatment Period|Death|4|||
37761767|NCT01478971|69273331|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
37761768|NCT01478971|69273331|FG000|Peginesatide Treatment Period|Other|4|||
37761769|NCT01507051|69273343|FG000|Overall Study|Withdrawal by Subject|1|||
37761770|NCT01507051|69273344|FG001|Overall Study|Withdrawal by Subject|3|||
37761771|NCT01507051|69273345|FG002|Overall Study|Withdrawal by Subject|1|||
37761772|NCT01507051|69273346|FG003|Overall Study|Withdrawal by Subject|6|||
37761773|NCT01507051|69273343|FG000|Overall Study|Physician Decision|0|||
37761774|NCT01507051|69273344|FG001|Overall Study|Physician Decision|0|||
37761775|NCT01507051|69273345|FG002|Overall Study|Physician Decision|0|||
37761776|NCT01507051|69273346|FG003|Overall Study|Physician Decision|1|||
37761777|NCT01507051|69273343|FG000|Overall Study|Adverse Event|1|||
37761778|NCT01507051|69273344|FG001|Overall Study|Adverse Event|0|||
37761779|NCT01507051|69273345|FG002|Overall Study|Adverse Event|0|||
37761780|NCT01507051|69273346|FG003|Overall Study|Adverse Event|0|||
37761781|NCT01478347|69273356|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
37761782|NCT01478347|69273356|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
37761783|NCT01478347|69273356|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
37761784|NCT01478113|69273362|FG000|Overall Study|Withdrawal by Subject|0|||
37761785|NCT01478113|69273363|FG001|Overall Study|Withdrawal by Subject|1|||
37761786|NCT01478113|69273362|FG000|Overall Study|Physician Decision|1|||
37761787|NCT01478113|69273363|FG001|Overall Study|Physician Decision|0|||
37761788|NCT01506271|69273374|FG000|Overall Study|Progressive disease|0|||
37761789|NCT01506271|69273375|FG001|Overall Study|Progressive disease|1|||
37761790|NCT01506271|69273376|FG002|Overall Study|Progressive disease|0|||
37761791|NCT01506271|69273374|FG000|Overall Study|Protocol Violation|3|||
37761792|NCT01506271|69273375|FG001|Overall Study|Protocol Violation|1|||
37761793|NCT01506271|69273376|FG002|Overall Study|Protocol Violation|0|||
37669659|NCT02564055|69142762|FG003|Overall Study|Adverse Event|1|||
37669660|NCT02564055|69142763|FG004|Overall Study|Adverse Event|4|||
37669661|NCT02564055|69142764|FG005|Overall Study|Adverse Event|1|||
37669662|NCT02564055|69142759|FG000|Overall Study|Protocol Violation|1|||
37669663|NCT02564055|69142760|FG001|Overall Study|Protocol Violation|0|||
37669664|NCT02564055|69142761|FG002|Overall Study|Protocol Violation|0|||
37669665|NCT02564055|69142762|FG003|Overall Study|Protocol Violation|0|||
37669666|NCT02564055|69142763|FG004|Overall Study|Protocol Violation|0|||
37669667|NCT02564055|69142764|FG005|Overall Study|Protocol Violation|0|||
37669668|NCT02564055|69142759|FG000|Overall Study|Reached stopping criteria|0|||
37669669|NCT02564055|69142760|FG001|Overall Study|Reached stopping criteria|0|||
37761794|NCT01506271|69273374|FG000|Overall Study|Death|0|||
37761795|NCT01506271|69273375|FG001|Overall Study|Death|1|||
37761796|NCT01506271|69273376|FG002|Overall Study|Death|0|||
37761797|NCT01506271|69273374|FG000|Overall Study|Adverse Event|0|||
37761798|NCT01506271|69273375|FG001|Overall Study|Adverse Event|2|||
37761799|NCT01506271|69273376|FG002|Overall Study|Adverse Event|0|||
37761800|NCT01506271|69273374|FG000|Overall Study|Insufficient supply of study drug|1|||
37761801|NCT01506271|69273375|FG001|Overall Study|Insufficient supply of study drug|0|||
37761802|NCT01506271|69273376|FG002|Overall Study|Insufficient supply of study drug|0|||
37761803|NCT01506271|69273374|FG000|Overall Study|Withdrawal by Subject|0|||
37761804|NCT01506271|69273375|FG001|Overall Study|Withdrawal by Subject|1|||
37761805|NCT01506271|69273376|FG002|Overall Study|Withdrawal by Subject|1|||
37761806|NCT01506271|69273374|FG000|Overall Study|Lost to Follow-up|0|||
37761807|NCT01506271|69273375|FG001|Overall Study|Lost to Follow-up|1|||
37761808|NCT01506271|69273376|FG002|Overall Study|Lost to Follow-up|2|||
37932999|NCT00749996|69619815|FG000|Overall Study|Pregnancy|0|||
37761809|NCT01506193|69273387|FG000|Overall Study|Protocol Violation|1|||
37761810|NCT01506193|69273388|FG001|Overall Study|Protocol Violation|0|||
37761811|NCT01506193|69273389|FG002|Overall Study|Protocol Violation|1|||
37761812|NCT01506193|69273387|FG000|Overall Study|Migrated/moved from study area|0|||
37761813|NCT01506193|69273388|FG001|Overall Study|Migrated/moved from study area|0|||
37761814|NCT01506193|69273389|FG002|Overall Study|Migrated/moved from study area|1|||
37761815|NCT01506193|69273387|FG000|Overall Study|Adverse event, non-fatal|0|||
37761816|NCT01506193|69273388|FG001|Overall Study|Adverse event, non-fatal|0|||
37761817|NCT01506193|69273389|FG002|Overall Study|Adverse event, non-fatal|1|||
37761818|NCT01506193|69273387|FG000|Overall Study|Withdrawal by Subject|5|||
37761819|NCT01506193|69273388|FG001|Overall Study|Withdrawal by Subject|1|||
37933000|NCT00749996|69619816|FG001|Overall Study|Pregnancy|2|||
38034971|NCT04232943|69721843|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
37761820|NCT01506193|69273389|FG002|Overall Study|Withdrawal by Subject|8|||
37761821|NCT01506193|69273387|FG000|Overall Study|Lost to Follow-up|8|||
37761822|NCT01506193|69273388|FG001|Overall Study|Lost to Follow-up|3|||
37761823|NCT01506193|69273389|FG002|Overall Study|Lost to Follow-up|3|||
37669670|NCT02564055|69142761|FG002|Overall Study|Reached stopping criteria|0|||
37669671|NCT02564055|69142762|FG003|Overall Study|Reached stopping criteria|0|||
37669672|NCT02564055|69142763|FG004|Overall Study|Reached stopping criteria|0|||
37761824|NCT01505881|69273400|FG000|Overall Study|Adverse Event|0|||
37761825|NCT01505881|69273401|FG001|Overall Study|Adverse Event|1|||
37761826|NCT01505881|69273400|FG000|Overall Study|Lost to Follow-up|2|||
37761827|NCT01505881|69273401|FG001|Overall Study|Lost to Follow-up|0|||
37761828|NCT01505881|69273400|FG000|Overall Study|Withdrawal by Subject|2|||
37761829|NCT01505881|69273401|FG001|Overall Study|Withdrawal by Subject|0|||
37761830|NCT01462045|69273411|FG000|Overall Study|Family matter|0|||
37761831|NCT01462045|69273412|FG001|Overall Study|Family matter|1|||
37761832|NCT01462045|69273413|FG002|Overall Study|Family matter|0|||
37761833|NCT01505647|69273423|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
37761834|NCT01505647|69273424|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
37761835|NCT01505647|69273423|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
37761836|NCT01505647|69273424|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
37761837|NCT01505647|69273423|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
37761838|NCT01505647|69273424|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
37761839|NCT01505647|69273423|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
37761840|NCT01505647|69273424|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
37761841|NCT01505647|69273423|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
37761842|NCT01505647|69273424|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
37761843|NCT01477333|69273430|FG000|Overall Study|Adverse Event|1|||
37761844|NCT01477333|69273430|FG000|Overall Study|Withdrawal by Subject|1|||
37761845|NCT01477333|69273430|FG000|Overall Study|Clinical Deterioration|1|||
37761846|NCT01461811|69273440|FG000|Overall Study|Adverse Event|2|||
37761847|NCT01461811|69273441|FG001|Overall Study|Adverse Event|1|||
37761848|NCT01461811|69273440|FG000|Overall Study|Subject decision unrelated to an AE|1|||
37761849|NCT01461811|69273441|FG001|Overall Study|Subject decision unrelated to an AE|1|||
37761850|NCT01461811|69273440|FG000|Overall Study|Noncompliance|1|||
37761851|NCT01461811|69273441|FG001|Overall Study|Noncompliance|1|||
37761852|NCT01505491|69273450|FG000|Overall Study|Other reason not listed|1|||
37761853|NCT01505491|69273451|FG001|Overall Study|Other reason not listed|0|||
37761854|NCT01505491|69273452|FG002|Overall Study|Other reason not listed|0|||
37761855|NCT01505491|69273450|FG000|Overall Study|Withdrawal by Subject|1|||
37761856|NCT01505491|69273451|FG001|Overall Study|Withdrawal by Subject|1|||
37761857|NCT01505491|69273452|FG002|Overall Study|Withdrawal by Subject|4|||
37761858|NCT01505491|69273450|FG000|Overall Study|Lost to Follow-up|0|||
37761859|NCT01505491|69273451|FG001|Overall Study|Lost to Follow-up|0|||
37761860|NCT01505491|69273452|FG002|Overall Study|Lost to Follow-up|1|||
37761861|NCT01504867|69273462|FG000|Overall Study|Inclusion criteria not met|2|||
37761862|NCT01504867|69273463|FG001|Overall Study|Inclusion criteria not met|2|||
37761863|NCT01504867|69273462|FG000|Overall Study|Consent revoked|5|||
37761864|NCT01504867|69273463|FG001|Overall Study|Consent revoked|1|||
37761865|NCT01476475|69273471|FG000|Overall Study|Adverse Event|6|||
37761866|NCT01476475|69273472|FG001|Overall Study|Adverse Event|0|||
37761867|NCT01476475|69273471|FG000|Overall Study|Poor compliance to protocol|1|||
37761868|NCT01476475|69273472|FG001|Overall Study|Poor compliance to protocol|1|||
37761869|NCT01476475|69273471|FG000|Overall Study|Other reasons|4|||
37761870|NCT01476475|69273472|FG001|Overall Study|Other reasons|2|||
37761871|NCT01475851|69273481|FG000|Overall Study|Protocol defined stopping criteria|1|||
37761872|NCT01475851|69273482|FG001|Overall Study|Protocol defined stopping criteria|0|||
37933001|NCT00749996|69619815|FG000|Overall Study|Adverse Event|1|||
37933002|NCT00749996|69619816|FG001|Overall Study|Adverse Event|0|||
37669673|NCT02564055|69142764|FG005|Overall Study|Reached stopping criteria|1|||
37669674|NCT02564055|69142759|FG000|Overall Study|Lost to Follow-up|0|||
37669675|NCT02564055|69142760|FG001|Overall Study|Lost to Follow-up|1|||
37669676|NCT02564055|69142761|FG002|Overall Study|Lost to Follow-up|4|||
37669677|NCT02564055|69142762|FG003|Overall Study|Lost to Follow-up|2|||
37669678|NCT02564055|69142763|FG004|Overall Study|Lost to Follow-up|1|||
37669679|NCT02564055|69142764|FG005|Overall Study|Lost to Follow-up|0|||
37669680|NCT02564055|69142759|FG000|Overall Study|Physician Decision|0|||
37761873|NCT01460719|69273488|FG000|Overall Study|Adverse Event|1|||
37761874|NCT01460719|69273488|FG000|Overall Study|Withdrawal by Subject|1|||
37761875|NCT01468181|69273558|FG000|Overall Study|Adverse Event|8|||
37761876|NCT01468181|69273559|FG001|Overall Study|Adverse Event|1|||
37761877|NCT01468181|69273560|FG002|Overall Study|Adverse Event|6|||
37761878|NCT01468181|69273561|FG003|Overall Study|Adverse Event|2|||
37761879|NCT01468181|69273562|FG004|Overall Study|Adverse Event|2|||
37761880|NCT01468181|69273558|FG000|Overall Study|Protocol Violation|2|||
37761881|NCT01468181|69273559|FG001|Overall Study|Protocol Violation|0|||
37761882|NCT01468181|69273560|FG002|Overall Study|Protocol Violation|1|||
37761883|NCT01468181|69273561|FG003|Overall Study|Protocol Violation|0|||
37761884|NCT01468181|69273562|FG004|Overall Study|Protocol Violation|1|||
37933003|NCT00749996|69619815|FG000|Overall Study|Death|1|||
37669681|NCT02564055|69142760|FG001|Overall Study|Physician Decision|0|||
37669682|NCT02564055|69142761|FG002|Overall Study|Physician Decision|1|||
37669683|NCT02564055|69142762|FG003|Overall Study|Physician Decision|0|||
37761885|NCT01468181|69273558|FG000|Overall Study|Physician Decision|0|||
37761886|NCT01468181|69273559|FG001|Overall Study|Physician Decision|0|||
37761887|NCT01468181|69273560|FG002|Overall Study|Physician Decision|0|||
37761888|NCT01468181|69273561|FG003|Overall Study|Physician Decision|1|||
37761889|NCT01468181|69273562|FG004|Overall Study|Physician Decision|1|||
37761890|NCT01468181|69273558|FG000|Overall Study|Lost to Follow-up|0|||
37761891|NCT01468181|69273559|FG001|Overall Study|Lost to Follow-up|0|||
37761892|NCT01468181|69273560|FG002|Overall Study|Lost to Follow-up|1|||
37761893|NCT01468181|69273561|FG003|Overall Study|Lost to Follow-up|0|||
37761894|NCT01468181|69273562|FG004|Overall Study|Lost to Follow-up|1|||
37761895|NCT01468181|69273558|FG000|Overall Study|Withdrawal by Subject|0|||
37761896|NCT01468181|69273559|FG001|Overall Study|Withdrawal by Subject|1|||
37761897|NCT01468181|69273560|FG002|Overall Study|Withdrawal by Subject|0|||
37761898|NCT01468181|69273561|FG003|Overall Study|Withdrawal by Subject|0|||
37761899|NCT01468181|69273562|FG004|Overall Study|Withdrawal by Subject|0|||
37761900|NCT01693562|69273597|FG000|Escalation Phase|Withdrawal by Subject|0|||
37761901|NCT01693562|69273598|FG001|Escalation Phase|Withdrawal by Subject|1|||
37761902|NCT01693562|69273599|FG002|Escalation Phase|Withdrawal by Subject|0|||
37761903|NCT01693562|69273600|FG003|Escalation Phase|Withdrawal by Subject|0|||
37761904|NCT01693562|69273601|FG004|Escalation Phase|Withdrawal by Subject|0|||
37761905|NCT01693562|69273602|FG005|Escalation Phase|Withdrawal by Subject|2|||
37761906|NCT01693562|69273603|FG006|Escalation Phase|Withdrawal by Subject|0|||
37761907|NCT01693562|69273604|FG007|Escalation Phase|Withdrawal by Subject|0|||
37761908|NCT01693562|69273605|FG008|Escalation Phase|Withdrawal by Subject|0|||
37761909|NCT01693562|69273606|FG009|Escalation Phase|Withdrawal by Subject|0|||
37761910|NCT01693562|69273607|FG010|Escalation Phase|Withdrawal by Subject|0|||
37761911|NCT01693562|69273608|FG011|Escalation Phase|Withdrawal by Subject|0|||
37761912|NCT01693562|69273609|FG012|Escalation Phase|Withdrawal by Subject|0|||
37761913|NCT01693562|69273610|FG013|Escalation Phase|Withdrawal by Subject|0|||
37761914|NCT01693562|69273611|FG014|Escalation Phase|Withdrawal by Subject|0|||
37761915|NCT01693562|69273612|FG015|Escalation Phase|Withdrawal by Subject|0|||
37761916|NCT01693562|69273613|FG016|Escalation Phase|Withdrawal by Subject|0|||
37761917|NCT01693562|69273614|FG017|Escalation Phase|Withdrawal by Subject|0|||
37761918|NCT01693562|69273615|FG018|Escalation Phase|Withdrawal by Subject|0|||
37761919|NCT01693562|69273616|FG019|Escalation Phase|Withdrawal by Subject|0|||
37761920|NCT01693562|69273617|FG020|Escalation Phase|Withdrawal by Subject|0|||
37761921|NCT01693562|69273618|FG021|Escalation Phase|Withdrawal by Subject|0|||
37761922|NCT01693562|69273619|FG022|Escalation Phase|Withdrawal by Subject|0|||
37761923|NCT01693562|69273597|FG000|Escalation Phase|Death|4|||
37761924|NCT01693562|69273598|FG001|Escalation Phase|Death|2|||
37761925|NCT01693562|69273599|FG002|Escalation Phase|Death|0|||
37761926|NCT01693562|69273600|FG003|Escalation Phase|Death|3|||
37761927|NCT01693562|69273601|FG004|Escalation Phase|Death|6|||
37761928|NCT01693562|69273602|FG005|Escalation Phase|Death|4|||
37761929|NCT01693562|69273603|FG006|Escalation Phase|Death|0|||
37761930|NCT01693562|69273604|FG007|Escalation Phase|Death|0|||
37933004|NCT00749996|69619816|FG001|Overall Study|Death|0|||
37933005|NCT00749684|69619822|FG000|Overall Study|Death|1|||
37933006|NCT00749684|69619822|FG000|Overall Study|Adverse Event|27|||
37933007|NCT00749684|69619822|FG000|Overall Study|Participant's Wish|10|||
37933008|NCT00749684|69619822|FG000|Overall Study|Not Documented|1|||
37933009|NCT00749684|69619822|FG000|Overall Study|Progressive Desease|31|||
37933010|NCT00749684|69619822|FG000|Overall Study|Therapy according to protocol + AE|2|||
37933011|NCT00749684|69619822|FG000|Overall Study|AE+discontinuation on participants wish|1|||
37933012|NCT00749684|69619822|FG000|Overall Study|Missing|9|||
38034972|NCT04232943|69721844|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
38034973|NCT04232943|69721845|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
38034974|NCT04232943|69721843|FG000|Overall Study|Withdrawal by Subject|1|||
38034975|NCT04232943|69721844|FG001|Overall Study|Withdrawal by Subject|1|||
37761931|NCT01693562|69273605|FG008|Escalation Phase|Death|0|||
37761932|NCT01693562|69273606|FG009|Escalation Phase|Death|0|||
37761933|NCT01693562|69273607|FG010|Escalation Phase|Death|0|||
37761934|NCT01693562|69273608|FG011|Escalation Phase|Death|0|||
37761935|NCT01693562|69273609|FG012|Escalation Phase|Death|0|||
37761936|NCT01693562|69273610|FG013|Escalation Phase|Death|0|||
37761937|NCT01693562|69273611|FG014|Escalation Phase|Death|0|||
37761938|NCT01693562|69273612|FG015|Escalation Phase|Death|0|||
37761939|NCT01693562|69273613|FG016|Escalation Phase|Death|0|||
37761940|NCT01693562|69273614|FG017|Escalation Phase|Death|0|||
37761941|NCT01693562|69273615|FG018|Escalation Phase|Death|0|||
37761942|NCT01693562|69273616|FG019|Escalation Phase|Death|0|||
37933013|NCT00746798|69619830|FG000|Overall Study|Protocol Violation|0|||
37933014|NCT00746798|69619831|FG001|Overall Study|Protocol Violation|1|||
37933015|NCT00746798|69619832|FG002|Overall Study|Protocol Violation|0|||
37761943|NCT01693562|69273617|FG020|Escalation Phase|Death|0|||
37761944|NCT01693562|69273618|FG021|Escalation Phase|Death|0|||
37761945|NCT01693562|69273619|FG022|Escalation Phase|Death|0|||
37761946|NCT01693562|69273597|FG000|Escalation Phase|Lost to Follow-up|0|||
37761947|NCT01693562|69273598|FG001|Escalation Phase|Lost to Follow-up|1|||
37761948|NCT01693562|69273599|FG002|Escalation Phase|Lost to Follow-up|1|||
37761949|NCT01693562|69273600|FG003|Escalation Phase|Lost to Follow-up|0|||
37761950|NCT01693562|69273601|FG004|Escalation Phase|Lost to Follow-up|0|||
37761951|NCT01693562|69273602|FG005|Escalation Phase|Lost to Follow-up|0|||
37761952|NCT01693562|69273603|FG006|Escalation Phase|Lost to Follow-up|0|||
37761953|NCT01693562|69273604|FG007|Escalation Phase|Lost to Follow-up|0|||
37933016|NCT00746798|69619833|FG003|Overall Study|Protocol Violation|0|||
37933017|NCT00746798|69619830|FG000|Overall Study|Withdrawal by Subject|0|||
37933018|NCT00746798|69619831|FG001|Overall Study|Withdrawal by Subject|1|||
37933019|NCT00746798|69619832|FG002|Overall Study|Withdrawal by Subject|1|||
37933020|NCT00746798|69619833|FG003|Overall Study|Withdrawal by Subject|0|||
37933021|NCT00746798|69619830|FG000|Overall Study|Death|0|||
37933022|NCT00746798|69619831|FG001|Overall Study|Death|0|||
37933023|NCT00746798|69619832|FG002|Overall Study|Death|2|||
37933024|NCT00746798|69619833|FG003|Overall Study|Death|0|||
37933025|NCT00746798|69619830|FG000|Overall Study|Participant unable to return for visit|1|||
37933026|NCT00746798|69619831|FG001|Overall Study|Participant unable to return for visit|0|||
37933027|NCT00746798|69619832|FG002|Overall Study|Participant unable to return for visit|0|||
37933028|NCT00746798|69619833|FG003|Overall Study|Participant unable to return for visit|0|||
37761954|NCT01693562|69273605|FG008|Escalation Phase|Lost to Follow-up|0|||
37761955|NCT01693562|69273606|FG009|Escalation Phase|Lost to Follow-up|0|||
37761956|NCT01693562|69273607|FG010|Escalation Phase|Lost to Follow-up|0|||
37761957|NCT01693562|69273608|FG011|Escalation Phase|Lost to Follow-up|0|||
37761958|NCT01693562|69273609|FG012|Escalation Phase|Lost to Follow-up|0|||
37761959|NCT01693562|69273610|FG013|Escalation Phase|Lost to Follow-up|0|||
37761960|NCT01693562|69273611|FG014|Escalation Phase|Lost to Follow-up|0|||
37761961|NCT01693562|69273612|FG015|Escalation Phase|Lost to Follow-up|0|||
37761962|NCT01693562|69273613|FG016|Escalation Phase|Lost to Follow-up|0|||
37761963|NCT01693562|69273614|FG017|Escalation Phase|Lost to Follow-up|0|||
37761964|NCT01693562|69273615|FG018|Escalation Phase|Lost to Follow-up|0|||
37761965|NCT01693562|69273616|FG019|Escalation Phase|Lost to Follow-up|0|||
37761966|NCT01693562|69273617|FG020|Escalation Phase|Lost to Follow-up|0|||
37761967|NCT01693562|69273618|FG021|Escalation Phase|Lost to Follow-up|0|||
37761968|NCT01693562|69273619|FG022|Escalation Phase|Lost to Follow-up|0|||
37761969|NCT01693562|69273597|FG000|Escalation Phase|Other|0|||
37761970|NCT01693562|69273598|FG001|Escalation Phase|Other|0|||
37761971|NCT01693562|69273599|FG002|Escalation Phase|Other|2|||
37761972|NCT01693562|69273600|FG003|Escalation Phase|Other|0|||
37761973|NCT01693562|69273601|FG004|Escalation Phase|Other|0|||
37761974|NCT01693562|69273602|FG005|Escalation Phase|Other|1|||
37761975|NCT01693562|69273603|FG006|Escalation Phase|Other|0|||
37761976|NCT01693562|69273604|FG007|Escalation Phase|Other|0|||
37761977|NCT01693562|69273605|FG008|Escalation Phase|Other|0|||
37761978|NCT01693562|69273606|FG009|Escalation Phase|Other|0|||
37761979|NCT01693562|69273607|FG010|Escalation Phase|Other|0|||
37761980|NCT01693562|69273608|FG011|Escalation Phase|Other|0|||
37761981|NCT01693562|69273609|FG012|Escalation Phase|Other|0|||
37761982|NCT01693562|69273610|FG013|Escalation Phase|Other|0|||
37933029|NCT00716274|69619846|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
37933030|NCT00716274|69619847|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
37933031|NCT00716274|69619848|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
37933032|NCT00716274|69619849|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
37933033|NCT00716274|69619850|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
37933034|NCT00716274|69619851|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
37933035|NCT00716274|69619846|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
37933036|NCT00716274|69619847|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
37933037|NCT00716274|69619848|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
37933038|NCT00716274|69619849|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
37933039|NCT00716274|69619850|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
37933040|NCT00716274|69619851|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
37933041|NCT00716274|69619846|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
37933042|NCT00716274|69619847|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
37933043|NCT00716274|69619848|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
37933044|NCT00716274|69619849|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
37933045|NCT00716274|69619850|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
37933046|NCT00716274|69619851|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
37933047|NCT00716274|69619846|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
37933048|NCT00716274|69619847|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
37933049|NCT00716274|69619848|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
37933050|NCT00716274|69619849|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
37933051|NCT00716274|69619850|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
37761983|NCT01693562|69273611|FG014|Escalation Phase|Other|0|||
37761984|NCT01693562|69273612|FG015|Escalation Phase|Other|0|||
37761985|NCT01693562|69273613|FG016|Escalation Phase|Other|0|||
37761986|NCT01693562|69273614|FG017|Escalation Phase|Other|0|||
37761987|NCT01693562|69273615|FG018|Escalation Phase|Other|0|||
37761988|NCT01693562|69273616|FG019|Escalation Phase|Other|0|||
37761989|NCT01693562|69273617|FG020|Escalation Phase|Other|0|||
37761990|NCT01693562|69273618|FG021|Escalation Phase|Other|0|||
37761991|NCT01693562|69273619|FG022|Escalation Phase|Other|0|||
37761992|NCT01693562|69273597|FG000|Exploration Phase|Withdrawal by Subject|0|||
37761993|NCT01693562|69273598|FG001|Exploration Phase|Withdrawal by Subject|0|||
37761994|NCT01693562|69273599|FG002|Exploration Phase|Withdrawal by Subject|0|||
37761995|NCT01693562|69273600|FG003|Exploration Phase|Withdrawal by Subject|0|||
37761996|NCT01693562|69273601|FG004|Exploration Phase|Withdrawal by Subject|0|||
37761997|NCT01693562|69273602|FG005|Exploration Phase|Withdrawal by Subject|0|||
37761998|NCT01693562|69273603|FG006|Exploration Phase|Withdrawal by Subject|2|||
37761999|NCT01693562|69273604|FG007|Exploration Phase|Withdrawal by Subject|0|||
37762000|NCT01693562|69273605|FG008|Exploration Phase|Withdrawal by Subject|0|||
37762001|NCT01693562|69273606|FG009|Exploration Phase|Withdrawal by Subject|0|||
37762002|NCT01693562|69273607|FG010|Exploration Phase|Withdrawal by Subject|0|||
37762003|NCT01693562|69273608|FG011|Exploration Phase|Withdrawal by Subject|0|||
37762004|NCT01693562|69273609|FG012|Exploration Phase|Withdrawal by Subject|0|||
37762005|NCT01693562|69273610|FG013|Exploration Phase|Withdrawal by Subject|0|||
37762006|NCT01693562|69273611|FG014|Exploration Phase|Withdrawal by Subject|0|||
37762007|NCT01693562|69273612|FG015|Exploration Phase|Withdrawal by Subject|0|||
37762008|NCT01693562|69273613|FG016|Exploration Phase|Withdrawal by Subject|0|||
37762009|NCT01693562|69273614|FG017|Exploration Phase|Withdrawal by Subject|0|||
37762010|NCT01693562|69273615|FG018|Exploration Phase|Withdrawal by Subject|0|||
37762011|NCT01693562|69273616|FG019|Exploration Phase|Withdrawal by Subject|0|||
37762012|NCT01693562|69273617|FG020|Exploration Phase|Withdrawal by Subject|0|||
37762013|NCT01693562|69273618|FG021|Exploration Phase|Withdrawal by Subject|0|||
37762014|NCT01693562|69273619|FG022|Exploration Phase|Withdrawal by Subject|0|||
37762015|NCT01693562|69273597|FG000|Exploration Phase|Death|0|||
37762016|NCT01693562|69273598|FG001|Exploration Phase|Death|0|||
37762017|NCT01693562|69273599|FG002|Exploration Phase|Death|0|||
37762018|NCT01693562|69273600|FG003|Exploration Phase|Death|0|||
37762019|NCT01693562|69273601|FG004|Exploration Phase|Death|0|||
37762020|NCT01693562|69273602|FG005|Exploration Phase|Death|0|||
37762021|NCT01693562|69273603|FG006|Exploration Phase|Death|17|||
37762022|NCT01693562|69273604|FG007|Exploration Phase|Death|0|||
37762023|NCT01693562|69273605|FG008|Exploration Phase|Death|0|||
37762024|NCT01693562|69273606|FG009|Exploration Phase|Death|0|||
37762025|NCT01693562|69273607|FG010|Exploration Phase|Death|0|||
37762026|NCT01693562|69273608|FG011|Exploration Phase|Death|0|||
37762027|NCT01693562|69273609|FG012|Exploration Phase|Death|0|||
37762028|NCT01693562|69273610|FG013|Exploration Phase|Death|0|||
37762029|NCT01693562|69273611|FG014|Exploration Phase|Death|0|||
37762030|NCT01693562|69273612|FG015|Exploration Phase|Death|0|||
37762031|NCT01693562|69273613|FG016|Exploration Phase|Death|0|||
37762032|NCT01693562|69273614|FG017|Exploration Phase|Death|0|||
37762033|NCT01693562|69273615|FG018|Exploration Phase|Death|0|||
37762034|NCT01693562|69273616|FG019|Exploration Phase|Death|0|||
37762035|NCT01693562|69273617|FG020|Exploration Phase|Death|0|||
37762036|NCT01693562|69273618|FG021|Exploration Phase|Death|0|||
37762037|NCT01693562|69273619|FG022|Exploration Phase|Death|0|||
37762038|NCT01693562|69273597|FG000|Exploration Phase|Other|0|||
37762039|NCT01693562|69273598|FG001|Exploration Phase|Other|0|||
37762040|NCT01693562|69273599|FG002|Exploration Phase|Other|0|||
37762041|NCT01693562|69273600|FG003|Exploration Phase|Other|0|||
37762042|NCT01693562|69273601|FG004|Exploration Phase|Other|0|||
37762043|NCT01693562|69273602|FG005|Exploration Phase|Other|0|||
37762044|NCT01693562|69273603|FG006|Exploration Phase|Other|2|||
37762045|NCT01693562|69273604|FG007|Exploration Phase|Other|0|||
37762046|NCT01693562|69273605|FG008|Exploration Phase|Other|0|||
37762047|NCT01693562|69273606|FG009|Exploration Phase|Other|0|||
37762048|NCT01693562|69273607|FG010|Exploration Phase|Other|0|||
37762049|NCT01693562|69273608|FG011|Exploration Phase|Other|0|||
37762050|NCT01693562|69273609|FG012|Exploration Phase|Other|0|||
37762051|NCT01693562|69273610|FG013|Exploration Phase|Other|0|||
37762052|NCT01693562|69273611|FG014|Exploration Phase|Other|0|||
37762053|NCT01693562|69273612|FG015|Exploration Phase|Other|0|||
37762054|NCT01693562|69273613|FG016|Exploration Phase|Other|0|||
37762055|NCT01693562|69273614|FG017|Exploration Phase|Other|0|||
37762056|NCT01693562|69273615|FG018|Exploration Phase|Other|0|||
37762057|NCT01693562|69273616|FG019|Exploration Phase|Other|0|||
37762058|NCT01693562|69273617|FG020|Exploration Phase|Other|0|||
37762059|NCT01693562|69273618|FG021|Exploration Phase|Other|0|||
37762060|NCT01693562|69273619|FG022|Exploration Phase|Other|0|||
37762061|NCT01693562|69273597|FG000|Expansion Phase|Withdrawal by Subject|0|||
37933052|NCT00716274|69619851|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
37762062|NCT01693562|69273598|FG001|Expansion Phase|Withdrawal by Subject|0|||
37762063|NCT01693562|69273599|FG002|Expansion Phase|Withdrawal by Subject|0|||
37762064|NCT01693562|69273600|FG003|Expansion Phase|Withdrawal by Subject|0|||
37762065|NCT01693562|69273601|FG004|Expansion Phase|Withdrawal by Subject|0|||
37762066|NCT01693562|69273602|FG005|Expansion Phase|Withdrawal by Subject|0|||
37933053|NCT00716274|69619846|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
37762067|NCT01693562|69273603|FG006|Expansion Phase|Withdrawal by Subject|0|||
37762068|NCT01693562|69273604|FG007|Expansion Phase|Withdrawal by Subject|16|||
37762069|NCT01693562|69273605|FG008|Expansion Phase|Withdrawal by Subject|2|||
37762070|NCT01693562|69273606|FG009|Expansion Phase|Withdrawal by Subject|54|||
37762071|NCT01693562|69273607|FG010|Expansion Phase|Withdrawal by Subject|2|||
37762072|NCT01693562|69273608|FG011|Expansion Phase|Withdrawal by Subject|2|||
37762073|NCT01693562|69273609|FG012|Expansion Phase|Withdrawal by Subject|3|||
37762074|NCT01693562|69273610|FG013|Expansion Phase|Withdrawal by Subject|5|||
37762075|NCT01693562|69273611|FG014|Expansion Phase|Withdrawal by Subject|16|||
37762076|NCT01693562|69273612|FG015|Expansion Phase|Withdrawal by Subject|7|||
37762077|NCT01693562|69273613|FG016|Expansion Phase|Withdrawal by Subject|40|||
37762078|NCT01693562|69273614|FG017|Expansion Phase|Withdrawal by Subject|4|||
37762079|NCT01693562|69273615|FG018|Expansion Phase|Withdrawal by Subject|8|||
37762080|NCT01693562|69273616|FG019|Expansion Phase|Withdrawal by Subject|3|||
37762081|NCT01693562|69273617|FG020|Expansion Phase|Withdrawal by Subject|1|||
37762082|NCT01693562|69273618|FG021|Expansion Phase|Withdrawal by Subject|8|||
37762083|NCT01693562|69273619|FG022|Expansion Phase|Withdrawal by Subject|1|||
37762084|NCT01693562|69273597|FG000|Expansion Phase|Death|0|||
37762085|NCT01693562|69273598|FG001|Expansion Phase|Death|0|||
37762086|NCT01693562|69273599|FG002|Expansion Phase|Death|0|||
37762087|NCT01693562|69273600|FG003|Expansion Phase|Death|0|||
37762088|NCT01693562|69273601|FG004|Expansion Phase|Death|0|||
37762089|NCT01693562|69273602|FG005|Expansion Phase|Death|0|||
37762090|NCT01693562|69273603|FG006|Expansion Phase|Death|0|||
37762091|NCT01693562|69273604|FG007|Expansion Phase|Death|42|||
37762092|NCT01693562|69273605|FG008|Expansion Phase|Death|17|||
37762093|NCT01693562|69273606|FG009|Expansion Phase|Death|208|||
37762094|NCT01693562|69273607|FG010|Expansion Phase|Death|30|||
37762095|NCT01693562|69273608|FG011|Expansion Phase|Death|8|||
37762096|NCT01693562|69273609|FG012|Expansion Phase|Death|19|||
37762097|NCT01693562|69273610|FG013|Expansion Phase|Death|42|||
37762098|NCT01693562|69273611|FG014|Expansion Phase|Death|23|||
37762099|NCT01693562|69273612|FG015|Expansion Phase|Death|23|||
37762100|NCT01693562|69273613|FG016|Expansion Phase|Death|128|||
37762101|NCT01693562|69273614|FG017|Expansion Phase|Death|16|||
37762102|NCT01693562|69273615|FG018|Expansion Phase|Death|36|||
37762103|NCT01693562|69273616|FG019|Expansion Phase|Death|16|||
37762104|NCT01693562|69273617|FG020|Expansion Phase|Death|17|||
37762105|NCT01693562|69273618|FG021|Expansion Phase|Death|35|||
37762106|NCT01693562|69273619|FG022|Expansion Phase|Death|7|||
37762107|NCT01693562|69273597|FG000|Expansion Phase|Lost to Follow-up|0|||
37762108|NCT01693562|69273598|FG001|Expansion Phase|Lost to Follow-up|0|||
37762109|NCT01693562|69273599|FG002|Expansion Phase|Lost to Follow-up|0|||
37762110|NCT01693562|69273600|FG003|Expansion Phase|Lost to Follow-up|0|||
37762111|NCT01693562|69273601|FG004|Expansion Phase|Lost to Follow-up|0|||
37762112|NCT01693562|69273602|FG005|Expansion Phase|Lost to Follow-up|0|||
37762113|NCT01693562|69273603|FG006|Expansion Phase|Lost to Follow-up|0|||
37762114|NCT01693562|69273604|FG007|Expansion Phase|Lost to Follow-up|1|||
37762115|NCT01693562|69273605|FG008|Expansion Phase|Lost to Follow-up|2|||
37762116|NCT01693562|69273606|FG009|Expansion Phase|Lost to Follow-up|10|||
37762117|NCT01693562|69273607|FG010|Expansion Phase|Lost to Follow-up|4|||
37762118|NCT01693562|69273608|FG011|Expansion Phase|Lost to Follow-up|4|||
37762119|NCT01693562|69273609|FG012|Expansion Phase|Lost to Follow-up|1|||
37762120|NCT01693562|69273610|FG013|Expansion Phase|Lost to Follow-up|3|||
37762121|NCT01693562|69273611|FG014|Expansion Phase|Lost to Follow-up|0|||
37762122|NCT01693562|69273612|FG015|Expansion Phase|Lost to Follow-up|1|||
37933054|NCT00716274|69619847|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
37933055|NCT00716274|69619848|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
37933056|NCT00716274|69619849|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
37933057|NCT00716274|69619850|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
37762123|NCT01693562|69273613|FG016|Expansion Phase|Lost to Follow-up|1|||
37933058|NCT00716274|69619851|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
37933059|NCT00716274|69619846|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
37933060|NCT00716274|69619847|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
37933061|NCT00716274|69619848|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
37933062|NCT00716274|69619849|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
37933063|NCT00716274|69619850|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
37933064|NCT00716274|69619851|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
37933065|NCT00716274|69619846|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
37762124|NCT01693562|69273614|FG017|Expansion Phase|Lost to Follow-up|0|||
37762125|NCT01693562|69273615|FG018|Expansion Phase|Lost to Follow-up|2|||
37762126|NCT01693562|69273616|FG019|Expansion Phase|Lost to Follow-up|1|||
37762127|NCT01693562|69273617|FG020|Expansion Phase|Lost to Follow-up|2|||
37762128|NCT01693562|69273618|FG021|Expansion Phase|Lost to Follow-up|2|||
37762129|NCT01693562|69273619|FG022|Expansion Phase|Lost to Follow-up|1|||
37762130|NCT01693562|69273597|FG000|Expansion Phase|Other|0|||
37762131|NCT01693562|69273598|FG001|Expansion Phase|Other|0|||
37762132|NCT01693562|69273599|FG002|Expansion Phase|Other|0|||
37762133|NCT01693562|69273600|FG003|Expansion Phase|Other|0|||
37762134|NCT01693562|69273601|FG004|Expansion Phase|Other|0|||
37762135|NCT01693562|69273602|FG005|Expansion Phase|Other|0|||
37762136|NCT01693562|69273603|FG006|Expansion Phase|Other|0|||
37762137|NCT01693562|69273604|FG007|Expansion Phase|Other|3|||
37762138|NCT01693562|69273605|FG008|Expansion Phase|Other|1|||
37762139|NCT01693562|69273606|FG009|Expansion Phase|Other|28|||
37762140|NCT01693562|69273607|FG010|Expansion Phase|Other|4|||
37762141|NCT01693562|69273608|FG011|Expansion Phase|Other|7|||
37762142|NCT01693562|69273609|FG012|Expansion Phase|Other|0|||
37762143|NCT01693562|69273610|FG013|Expansion Phase|Other|1|||
37762144|NCT01693562|69273611|FG014|Expansion Phase|Other|1|||
37762145|NCT01693562|69273612|FG015|Expansion Phase|Other|0|||
37762146|NCT01693562|69273613|FG016|Expansion Phase|Other|28|||
37762147|NCT01693562|69273614|FG017|Expansion Phase|Other|0|||
37762148|NCT01693562|69273615|FG018|Expansion Phase|Other|1|||
37762149|NCT01693562|69273616|FG019|Expansion Phase|Other|0|||
37762150|NCT01693562|69273617|FG020|Expansion Phase|Other|1|||
37762151|NCT01693562|69273618|FG021|Expansion Phase|Other|17|||
37762152|NCT01693562|69273619|FG022|Expansion Phase|Other|1|||
37762153|NCT01467713|69273716|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
37762154|NCT01467713|69273717|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
37762155|NCT01467713|69273718|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
37762156|NCT01467713|69273719|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
37762157|NCT01467713|69273716|FG000|Overall Study|Major Protocol Deviation|2|||
37762158|NCT01467713|69273717|FG001|Overall Study|Major Protocol Deviation|4|||
37762159|NCT01467713|69273718|FG002|Overall Study|Major Protocol Deviation|4|||
37762160|NCT01467713|69273719|FG003|Overall Study|Major Protocol Deviation|1|||
37762161|NCT01467713|69273716|FG000|Overall Study|Lost to Follow-up|9|||
37762162|NCT01467713|69273717|FG001|Overall Study|Lost to Follow-up|12|||
37762163|NCT01467713|69273718|FG002|Overall Study|Lost to Follow-up|6|||
37762164|NCT01467713|69273719|FG003|Overall Study|Lost to Follow-up|9|||
37762165|NCT01467713|69273716|FG000|Overall Study|Voluntary Withdrawal|18|||
37762166|NCT01467713|69273717|FG001|Overall Study|Voluntary Withdrawal|14|||
37762167|NCT01467713|69273718|FG002|Overall Study|Voluntary Withdrawal|21|||
37762168|NCT01467713|69273719|FG003|Overall Study|Voluntary Withdrawal|20|||
37933066|NCT00716274|69619847|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
37933067|NCT00716274|69619848|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
37669684|NCT02564055|69142763|FG004|Overall Study|Physician Decision|0|||
37669685|NCT02564055|69142764|FG005|Overall Study|Physician Decision|0|||
37669686|NCT02564055|69142759|FG000|Overall Study|Withdrawal by Subject|4|||
37669687|NCT02564055|69142760|FG001|Overall Study|Withdrawal by Subject|4|||
37669688|NCT02564055|69142761|FG002|Overall Study|Withdrawal by Subject|3|||
37669689|NCT02564055|69142762|FG003|Overall Study|Withdrawal by Subject|3|||
37669690|NCT02564055|69142763|FG004|Overall Study|Withdrawal by Subject|10|||
37669691|NCT02564055|69142764|FG005|Overall Study|Withdrawal by Subject|10|||
37669692|NCT02563899|69142782|FG000|Overall Study|Protocol Violation|1|||
37669693|NCT02563899|69142783|FG001|Overall Study|Protocol Violation|0|||
37669694|NCT02563899|69142784|FG002|Overall Study|Protocol Violation|0|||
37669695|NCT02563899|69142785|FG003|Overall Study|Protocol Violation|0|||
37669696|NCT02563899|69142782|FG000|Overall Study|Withdrawal by Subject|0|||
37669697|NCT02563899|69142783|FG001|Overall Study|Withdrawal by Subject|0|||
37669698|NCT02563899|69142784|FG002|Overall Study|Withdrawal by Subject|1|||
37669699|NCT02563899|69142785|FG003|Overall Study|Withdrawal by Subject|0|||
37669700|NCT02699099|69142799|FG000|Overall Study|Adverse Event|1|||
37669701|NCT02699099|69142800|FG001|Overall Study|Adverse Event|0|||
37669702|NCT02699099|69142801|FG002|Overall Study|Adverse Event|2|||
37669703|NCT02699099|69142799|FG000|Overall Study|Lost to Follow-up|0|||
37669704|NCT02699099|69142800|FG001|Overall Study|Lost to Follow-up|1|||
37669705|NCT02699099|69142801|FG002|Overall Study|Lost to Follow-up|0|||
37669706|NCT02699099|69142799|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
37669707|NCT02699099|69142800|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
37669708|NCT02699099|69142801|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
37669709|NCT02698865|69142813|FG000|Overall Study|Other|11|||
37669710|NCT02698865|69142814|FG001|Overall Study|Other|11|||
37669711|NCT02698865|69142813|FG000|Overall Study|Withdrawal by Subject|20|||
37669712|NCT02698865|69142814|FG001|Overall Study|Withdrawal by Subject|16|||
37669713|NCT02698865|69142813|FG000|Overall Study|Physician Decision|0|||
37669714|NCT02698865|69142814|FG001|Overall Study|Physician Decision|4|||
37669715|NCT02698865|69142813|FG000|Overall Study|Lost to Follow-up|4|||
37669716|NCT02698865|69142814|FG001|Overall Study|Lost to Follow-up|2|||
37669717|NCT02698787|69142822|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
37669718|NCT02698787|69142823|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
37762169|NCT01467713|69273716|FG000|Overall Study|Study Termination|23|||
37762170|NCT01467713|69273717|FG001|Overall Study|Study Termination|33|||
37762171|NCT01467713|69273718|FG002|Overall Study|Study Termination|28|||
37762172|NCT01467713|69273719|FG003|Overall Study|Study Termination|29|||
37762173|NCT01467713|69273716|FG000|Overall Study|Pregnancy|0|||
37762174|NCT01467713|69273717|FG001|Overall Study|Pregnancy|1|||
37859448|NCT01287221|69542764|FG000|Overall Study|Withdrawal by Subject|0|||
37859449|NCT01287221|69542765|FG001|Overall Study|Withdrawal by Subject|1|||
37859450|NCT01168401|69542782|FG000|Overall Study|Lost to Follow-up|1|||
37859451|NCT01168401|69542783|FG001|Overall Study|Lost to Follow-up|1|||
37859452|NCT01168401|69542784|FG002|Overall Study|Lost to Follow-up|2|||
37859453|NCT01168401|69542785|FG003|Overall Study|Lost to Follow-up|1|||
37762175|NCT01467713|69273718|FG002|Overall Study|Pregnancy|1|||
37762176|NCT01467713|69273719|FG003|Overall Study|Pregnancy|3|||
37762177|NCT01467713|69273716|FG000|Overall Study|Relapse|35|||
37762178|NCT01467713|69273717|FG001|Overall Study|Relapse|25|||
37762179|NCT01467713|69273718|FG002|Overall Study|Relapse|28|||
37762180|NCT01467713|69273719|FG003|Overall Study|Relapse|35|||
37762181|NCT01467713|69273716|FG000|Overall Study|Reason not Specified|6|||
37762182|NCT01467713|69273717|FG001|Overall Study|Reason not Specified|11|||
37762183|NCT01467713|69273718|FG002|Overall Study|Reason not Specified|8|||
37762184|NCT01467713|69273719|FG003|Overall Study|Reason not Specified|7|||
37762185|NCT01693250|69273749|FG000|Overall Study|Lost to Follow-up|2|||
37762186|NCT01693250|69273750|FG001|Overall Study|Lost to Follow-up|2|||
37762187|NCT01590758|69273773|FG000|Overall Study|Withdrawal by Subject|0|||
37762188|NCT01590758|69273774|FG001|Overall Study|Withdrawal by Subject|3|||
37762189|NCT01590758|69273773|FG000|Overall Study|Physician Decision|1|||
37762190|NCT01590758|69273774|FG001|Overall Study|Physician Decision|2|||
37762191|NCT01590758|69273773|FG000|Overall Study|Lost to Follow-up|4|||
37762192|NCT01590758|69273774|FG001|Overall Study|Lost to Follow-up|2|||
37762193|NCT01590212|69273783|FG000|Overall Study|Withdrawal by Subject|2|||
37762194|NCT01590212|69273784|FG001|Overall Study|Withdrawal by Subject|2|||
37762195|NCT01590212|69273785|FG002|Overall Study|Withdrawal by Subject|2|||
37762196|NCT01590212|69273783|FG000|Overall Study|Lost to Follow-up|1|||
37762197|NCT01590212|69273784|FG001|Overall Study|Lost to Follow-up|2|||
37762198|NCT01590212|69273785|FG002|Overall Study|Lost to Follow-up|3|||
37762199|NCT01692938|69273796|FG000|Overall Study|Protocol Deviation|1|||
37762200|NCT01692938|69273797|FG001|Overall Study|Protocol Deviation|1|||
37762201|NCT01692938|69273796|FG000|Overall Study|Study completed prior to site completion|3|||
37762202|NCT01692938|69273797|FG001|Overall Study|Study completed prior to site completion|3|||
37762203|NCT01692782|69273810|FG000|Overall Study|Adverse Event|12|||
37762204|NCT01692782|69273811|FG001|Overall Study|Adverse Event|32|||
37762205|NCT01692782|69273812|FG002|Overall Study|Adverse Event|2|||
37762206|NCT01692782|69273810|FG000|Overall Study|Lack of Efficacy|1|||
37762207|NCT01692782|69273811|FG001|Overall Study|Lack of Efficacy|2|||
37762208|NCT01692782|69273812|FG002|Overall Study|Lack of Efficacy|0|||
37762209|NCT01692782|69273810|FG000|Overall Study|Lost to Follow-up|2|||
37762210|NCT01692782|69273811|FG001|Overall Study|Lost to Follow-up|7|||
37762211|NCT01692782|69273812|FG002|Overall Study|Lost to Follow-up|1|||
37762212|NCT01692782|69273810|FG000|Overall Study|Pregnancy|1|||
37762213|NCT01692782|69273811|FG001|Overall Study|Pregnancy|0|||
37762214|NCT01692782|69273812|FG002|Overall Study|Pregnancy|0|||
37762215|NCT01692782|69273810|FG000|Overall Study|Protocol Violation|1|||
37762216|NCT01692782|69273811|FG001|Overall Study|Protocol Violation|0|||
37762217|NCT01692782|69273812|FG002|Overall Study|Protocol Violation|2|||
37762218|NCT01692782|69273810|FG000|Overall Study|Non-complance with study drug|0|||
37762219|NCT01692782|69273811|FG001|Overall Study|Non-complance with study drug|4|||
37762220|NCT01692782|69273812|FG002|Overall Study|Non-complance with study drug|1|||
37762221|NCT01692782|69273810|FG000|Overall Study|Non-compliant with study visits|0|||
37762222|NCT01692782|69273811|FG001|Overall Study|Non-compliant with study visits|0|||
37762223|NCT01692782|69273812|FG002|Overall Study|Non-compliant with study visits|1|||
37762224|NCT01692782|69273810|FG000|Overall Study|SAE not related to study drug|0|||
37762225|NCT01692782|69273811|FG001|Overall Study|SAE not related to study drug|1|||
37762226|NCT01692782|69273812|FG002|Overall Study|SAE not related to study drug|0|||
37762227|NCT01692782|69273810|FG000|Overall Study|Withdrawal by Subject|3|||
37762228|NCT01692782|69273811|FG001|Overall Study|Withdrawal by Subject|10|||
37762229|NCT01692782|69273812|FG002|Overall Study|Withdrawal by Subject|3|||
37762230|NCT01692626|69273820|FG000|Overall Study|Death|0|||
37762231|NCT01692626|69273821|FG001|Overall Study|Death|1|||
37762232|NCT01692626|69273820|FG000|Overall Study|Adverse Event|2|||
37762233|NCT01692626|69273821|FG001|Overall Study|Adverse Event|3|||
37762234|NCT01692626|69273820|FG000|Overall Study|Protocol Violation|1|||
37762235|NCT01692626|69273821|FG001|Overall Study|Protocol Violation|2|||
37762236|NCT01692626|69273820|FG000|Overall Study|Withdrawal by Subject|1|||
37762237|NCT01692626|69273821|FG001|Overall Study|Withdrawal by Subject|0|||
37762238|NCT01475461|69273847|FG000|Run-in Period|Not meet eligibility criteria|16|||
37762239|NCT01475461|69273848|FG001|Run-in Period|Not meet eligibility criteria|0|||
37762240|NCT01475461|69273849|FG002|Run-in Period|Not meet eligibility criteria|0|||
37762241|NCT01475461|69273850|FG003|Run-in Period|Not meet eligibility criteria|0|||
37933068|NCT00716274|69619849|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
37933069|NCT00716274|69619850|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
38034976|NCT04232943|69721845|FG002|Overall Study|Withdrawal by Subject|0|||
37762242|NCT01475461|69273851|FG004|Run-in Period|Not meet eligibility criteria|0|||
37762243|NCT01475461|69273852|FG005|Run-in Period|Not meet eligibility criteria|0|||
37933070|NCT00716274|69619851|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
38034977|NCT03694275|69721856|FG000|Overall Study|Adverse Event|0|||
38034978|NCT03694275|69721857|FG001|Overall Study|Adverse Event|1|||
38034979|NCT03694275|69721856|FG000|Overall Study|Reason not Specified|0|||
38034980|NCT03694275|69721857|FG001|Overall Study|Reason not Specified|1|||
37762244|NCT01475461|69273853|FG006|Run-in Period|Not meet eligibility criteria|0|||
37762245|NCT01475461|69273847|FG000|Run-in Period|Lost to Follow-up|7|||
37762246|NCT01475461|69273848|FG001|Run-in Period|Lost to Follow-up|0|||
37762247|NCT01475461|69273849|FG002|Run-in Period|Lost to Follow-up|0|||
37762248|NCT01475461|69273850|FG003|Run-in Period|Lost to Follow-up|0|||
37762249|NCT01475461|69273851|FG004|Run-in Period|Lost to Follow-up|0|||
37933071|NCT00716274|69619846|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
37933072|NCT00716274|69619847|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
38034981|NCT04230213|69721864|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
37669719|NCT02698475|69142830|FG000|Main Study Period|Lack of Efficacy|1|||
37669720|NCT02698475|69142830|FG000|Main Study Period|Protocol Violation|2|||
37669721|NCT02698475|69142830|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
37669722|NCT02698475|69142830|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
37669723|NCT02698475|69142830|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
37669724|NCT02698475|69142830|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
37669725|NCT02698475|69142830|FG000|Long-Term Extension Period|Other|1|||
37669726|NCT02559687|69142837|FG000|Overall Study|Death|112|||
37669727|NCT02559687|69142837|FG000|Overall Study|Sponsor Decision|5|||
37669728|NCT02559687|69142837|FG000|Overall Study|Withdrawal by Subject|4|||
37669729|NCT04294719|69142851|FG000|Overall Study|Withdrawal by Subject|1|||
37669730|NCT02703311|69142859|FG000|Overall Study|Death|5|||
37669731|NCT02703311|69142859|FG000|Overall Study|Withdrawal by Subject|3|||
37669732|NCT02697617|69142863|FG000|Overall Study|Withdrawal by Subject|0|||
37669733|NCT02697617|69142864|FG001|Overall Study|Withdrawal by Subject|2|||
37669734|NCT02697617|69142863|FG000|Overall Study|Pregnancy|1|||
37669735|NCT02697617|69142864|FG001|Overall Study|Pregnancy|0|||
37669736|NCT02698241|69142874|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
37669737|NCT02698241|69142874|FG000|Overall Study|Screening not met|7|||
37669738|NCT02698241|69142874|FG000|Overall Study|Withdrawal by Subject|7|||
37669739|NCT02698241|69142874|FG000|Overall Study|Physician Decision|2|||
37669740|NCT02698241|69142874|FG000|Overall Study|Subject underwent system modification|2|||
37669741|NCT02698241|69142874|FG000|Overall Study|Lost to Follow-up|3|||
37669742|NCT02698241|69142874|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
37669743|NCT02698241|69142874|FG000|Overall Study|geographic and licensing issue|1|||
37669744|NCT02698241|69142874|FG000|Overall Study|Death|2|||
37669745|NCT01663233|69142880|FG000|Overall Study|Withdrawal by Subject|3|||
37669746|NCT01663233|69142881|FG001|Overall Study|Withdrawal by Subject|2|||
37669747|NCT01663233|69142880|FG000|Overall Study|Protocol Deviation|1|||
37669748|NCT01663233|69142881|FG001|Overall Study|Protocol Deviation|4|||
37669749|NCT01663233|69142880|FG000|Overall Study|Lost to Follow-up|0|||
37669750|NCT01663233|69142881|FG001|Overall Study|Lost to Follow-up|1|||
37669751|NCT02556255|69142900|FG000|Overall Study|Lost to Follow-up|4|||
37669752|NCT02556801|69142908|FG000|Overall Study|Lost to Follow-up|1|||
37669753|NCT02556801|69142909|FG001|Overall Study|Lost to Follow-up|0|||
37669754|NCT02556801|69142910|FG002|Overall Study|Lost to Follow-up|2|||
37669755|NCT02556801|69142911|FG003|Overall Study|Lost to Follow-up|0|||
37669756|NCT02556801|69142908|FG000|Overall Study|Withdrawal by Subject|1|||
37669757|NCT02556801|69142909|FG001|Overall Study|Withdrawal by Subject|1|||
37669758|NCT02556801|69142910|FG002|Overall Study|Withdrawal by Subject|1|||
37669759|NCT02556801|69142911|FG003|Overall Study|Withdrawal by Subject|0|||
37669760|NCT02556801|69142908|FG000|Overall Study|Protocol Violation|0|||
37669761|NCT02556801|69142909|FG001|Overall Study|Protocol Violation|3|||
37669762|NCT02556801|69142910|FG002|Overall Study|Protocol Violation|1|||
37669763|NCT02556801|69142911|FG003|Overall Study|Protocol Violation|1|||
37669764|NCT02556801|69142908|FG000|Overall Study|Adverse Event|0|||
37669765|NCT02556801|69142909|FG001|Overall Study|Adverse Event|2|||
37669766|NCT02556801|69142910|FG002|Overall Study|Adverse Event|0|||
37669767|NCT02556801|69142911|FG003|Overall Study|Adverse Event|3|||
37669768|NCT02556801|69142908|FG000|Overall Study|Pregnancy|0|||
37669769|NCT02556801|69142909|FG001|Overall Study|Pregnancy|1|||
37762250|NCT01475461|69273852|FG005|Run-in Period|Lost to Follow-up|0|||
37762251|NCT01475461|69273853|FG006|Run-in Period|Lost to Follow-up|0|||
37669770|NCT02556801|69142910|FG002|Overall Study|Pregnancy|0|||
37669771|NCT02556801|69142911|FG003|Overall Study|Pregnancy|0|||
37669772|NCT02556801|69142908|FG000|Overall Study|Personal reasons patient|0|||
37669773|NCT02556801|69142909|FG001|Overall Study|Personal reasons patient|0|||
37669774|NCT02556801|69142910|FG002|Overall Study|Personal reasons patient|0|||
37669775|NCT02556801|69142911|FG003|Overall Study|Personal reasons patient|1|||
37669776|NCT02556177|69142923|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
37669777|NCT02556177|69142924|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
37669778|NCT02554929|69142932|FG000|Overall Study|Lost to Follow-up|4|||
37669779|NCT02554929|69142933|FG001|Overall Study|Lost to Follow-up|4|||
37669780|NCT02554929|69142932|FG000|Overall Study|Withdrawal by Subject|2|||
37669781|NCT02554929|69142933|FG001|Overall Study|Withdrawal by Subject|8|||
37669782|NCT02697773|69142951|FG000|Overall Study|Adverse Event|2|||
37669783|NCT02697773|69142952|FG001|Overall Study|Adverse Event|1|||
37859454|NCT01168401|69542786|FG004|Overall Study|Lost to Follow-up|0|||
37762252|NCT01475461|69273847|FG000|Run-in Period|Withdrawal by Subject|11|||
37762253|NCT01475461|69273848|FG001|Run-in Period|Withdrawal by Subject|0|||
37762254|NCT01475461|69273849|FG002|Run-in Period|Withdrawal by Subject|0|||
37762255|NCT01475461|69273850|FG003|Run-in Period|Withdrawal by Subject|0|||
37762256|NCT01475461|69273851|FG004|Run-in Period|Withdrawal by Subject|0|||
37762257|NCT01475461|69273852|FG005|Run-in Period|Withdrawal by Subject|0|||
37762258|NCT01475461|69273853|FG006|Run-in Period|Withdrawal by Subject|0|||
37762259|NCT01475461|69273847|FG000|Run-in Period|Other|3|||
37762260|NCT01475461|69273848|FG001|Run-in Period|Other|0|||
37762261|NCT01475461|69273849|FG002|Run-in Period|Other|0|||
37762262|NCT01475461|69273850|FG003|Run-in Period|Other|0|||
37762263|NCT01475461|69273851|FG004|Run-in Period|Other|0|||
37762264|NCT01475461|69273852|FG005|Run-in Period|Other|0|||
37762265|NCT01475461|69273853|FG006|Run-in Period|Other|0|||
37762266|NCT01475461|69273847|FG000|Run-in Period|Protocol Violation|4|||
37762267|NCT01475461|69273848|FG001|Run-in Period|Protocol Violation|0|||
37762268|NCT01475461|69273849|FG002|Run-in Period|Protocol Violation|0|||
37762269|NCT01475461|69273850|FG003|Run-in Period|Protocol Violation|0|||
37762270|NCT01475461|69273851|FG004|Run-in Period|Protocol Violation|0|||
37762271|NCT01475461|69273852|FG005|Run-in Period|Protocol Violation|0|||
37762272|NCT01475461|69273853|FG006|Run-in Period|Protocol Violation|0|||
37762273|NCT01475461|69273847|FG000|Treatment Period|Death|0|||
37762274|NCT01475461|69273848|FG001|Treatment Period|Death|0|||
37762275|NCT01475461|69273849|FG002|Treatment Period|Death|0|||
37762276|NCT01475461|69273850|FG003|Treatment Period|Death|1|||
37762277|NCT01475461|69273851|FG004|Treatment Period|Death|0|||
37762278|NCT01475461|69273852|FG005|Treatment Period|Death|0|||
37762279|NCT01475461|69273853|FG006|Treatment Period|Death|0|||
37762280|NCT01475461|69273847|FG000|Treatment Period|Lost to Follow-up|0|||
37762281|NCT01475461|69273848|FG001|Treatment Period|Lost to Follow-up|3|||
37762282|NCT01475461|69273849|FG002|Treatment Period|Lost to Follow-up|2|||
37762283|NCT01475461|69273850|FG003|Treatment Period|Lost to Follow-up|3|||
37762284|NCT01475461|69273851|FG004|Treatment Period|Lost to Follow-up|1|||
37762285|NCT01475461|69273852|FG005|Treatment Period|Lost to Follow-up|2|||
37762286|NCT01475461|69273853|FG006|Treatment Period|Lost to Follow-up|1|||
37762287|NCT01475461|69273847|FG000|Treatment Period|Withdrawal by Subject|0|||
37762288|NCT01475461|69273848|FG001|Treatment Period|Withdrawal by Subject|2|||
37933073|NCT00716274|69619848|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
37933074|NCT00716274|69619849|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
37933075|NCT00716274|69619850|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
37933076|NCT00716274|69619851|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
37933077|NCT00716274|69619846|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
37933078|NCT00716274|69619847|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
37933079|NCT00716274|69619848|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
37933080|NCT00716274|69619849|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
37933081|NCT00716274|69619850|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
37933082|NCT00716274|69619851|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
37933083|NCT00716274|69619846|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
37933084|NCT00716274|69619847|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
37933085|NCT00716274|69619848|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
37933086|NCT00716274|69619849|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
37933087|NCT00716274|69619850|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
37933088|NCT00716274|69619851|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
37933089|NCT00746564|69619868|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
37933090|NCT01298193|69619874|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
37933091|NCT01298193|69619874|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
37933092|NCT01298193|69619874|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
37933093|NCT01298193|69619874|FG000|Efficacy Phase (Second Cycle)|Death|1|||
37933094|NCT00719862|69619883|FG000|Overall Study|Adverse Event|1|||
37933095|NCT00719862|69619884|FG001|Overall Study|Adverse Event|2|||
37933096|NCT00719862|69619883|FG000|Overall Study|Lack of Efficacy|3|||
38034982|NCT04230213|69721865|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
38034983|NCT04230213|69721866|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
38034984|NCT04230213|69721864|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
38034985|NCT04230213|69721865|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
37762289|NCT01475461|69273849|FG002|Treatment Period|Withdrawal by Subject|2|||
37762290|NCT01475461|69273850|FG003|Treatment Period|Withdrawal by Subject|0|||
37933097|NCT00719862|69619884|FG001|Overall Study|Lack of Efficacy|0|||
37933098|NCT00719862|69619883|FG000|Overall Study|Non-Compliance|1|||
37933099|NCT00719862|69619884|FG001|Overall Study|Non-Compliance|0|||
37762291|NCT01475461|69273851|FG004|Treatment Period|Withdrawal by Subject|2|||
37762292|NCT01475461|69273852|FG005|Treatment Period|Withdrawal by Subject|2|||
37762293|NCT01475461|69273853|FG006|Treatment Period|Withdrawal by Subject|0|||
37762294|NCT01475461|69273847|FG000|Treatment Period|Other|0|||
37762295|NCT01475461|69273848|FG001|Treatment Period|Other|1|||
37762296|NCT01475461|69273849|FG002|Treatment Period|Other|0|||
37762297|NCT01475461|69273850|FG003|Treatment Period|Other|0|||
37762298|NCT01475461|69273851|FG004|Treatment Period|Other|0|||
37762299|NCT01475461|69273852|FG005|Treatment Period|Other|0|||
37762300|NCT01475461|69273853|FG006|Treatment Period|Other|0|||
37762301|NCT01475461|69273847|FG000|Treatment Period|Protocol Violation|0|||
37762302|NCT01475461|69273848|FG001|Treatment Period|Protocol Violation|1|||
37762303|NCT01475461|69273849|FG002|Treatment Period|Protocol Violation|0|||
37762304|NCT01475461|69273850|FG003|Treatment Period|Protocol Violation|0|||
37762305|NCT01475461|69273851|FG004|Treatment Period|Protocol Violation|0|||
37762306|NCT01475461|69273852|FG005|Treatment Period|Protocol Violation|0|||
37762307|NCT01475461|69273853|FG006|Treatment Period|Protocol Violation|1|||
37762308|NCT01475461|69273847|FG000|Treatment Period|Lack of Efficacy|0|||
37762309|NCT01475461|69273848|FG001|Treatment Period|Lack of Efficacy|2|||
37762310|NCT01475461|69273849|FG002|Treatment Period|Lack of Efficacy|0|||
37762311|NCT01475461|69273850|FG003|Treatment Period|Lack of Efficacy|2|||
37762312|NCT01475461|69273851|FG004|Treatment Period|Lack of Efficacy|1|||
37762313|NCT01475461|69273852|FG005|Treatment Period|Lack of Efficacy|1|||
37762314|NCT01475461|69273853|FG006|Treatment Period|Lack of Efficacy|0|||
37762315|NCT01475461|69273847|FG000|Treatment Period|Medication Error|0|||
37762316|NCT01475461|69273848|FG001|Treatment Period|Medication Error|0|||
37762317|NCT01475461|69273849|FG002|Treatment Period|Medication Error|0|||
37762318|NCT01475461|69273850|FG003|Treatment Period|Medication Error|1|||
37762319|NCT01475461|69273851|FG004|Treatment Period|Medication Error|0|||
37762320|NCT01475461|69273852|FG005|Treatment Period|Medication Error|0|||
37762321|NCT01475461|69273853|FG006|Treatment Period|Medication Error|0|||
37762322|NCT01475461|69273847|FG000|Treatment Period|Adverse Event|0|||
37762323|NCT01475461|69273848|FG001|Treatment Period|Adverse Event|0|||
37762324|NCT01475461|69273849|FG002|Treatment Period|Adverse Event|0|||
37762325|NCT01475461|69273850|FG003|Treatment Period|Adverse Event|1|||
37762326|NCT01475461|69273851|FG004|Treatment Period|Adverse Event|0|||
37762327|NCT01475461|69273852|FG005|Treatment Period|Adverse Event|0|||
37762328|NCT01475461|69273853|FG006|Treatment Period|Adverse Event|0|||
37762329|NCT01589822|69273889|FG000|Overall Study|Withdrawal by Subject|1|||
37762330|NCT01589822|69273890|FG001|Overall Study|Withdrawal by Subject|2|||
37762331|NCT01589822|69273891|FG002|Overall Study|Withdrawal by Subject|0|||
37762332|NCT01589822|69273889|FG000|Overall Study|Death|1|||
37933100|NCT00719862|69619883|FG000|Overall Study|Withdrawal by Subject|1|||
37669784|NCT02697773|69142953|FG002|Overall Study|Adverse Event|2|||
37669785|NCT02697773|69142951|FG000|Overall Study|Death|0|||
37669786|NCT02697773|69142952|FG001|Overall Study|Death|0|||
37669787|NCT02697773|69142953|FG002|Overall Study|Death|2|||
37669788|NCT02697773|69142951|FG000|Overall Study|Lack of Efficacy|4|||
37669789|NCT02697773|69142952|FG001|Overall Study|Lack of Efficacy|6|||
37669790|NCT02697773|69142953|FG002|Overall Study|Lack of Efficacy|6|||
37669791|NCT02697773|69142951|FG000|Overall Study|Lost to Follow-up|5|||
37669792|NCT02697773|69142952|FG001|Overall Study|Lost to Follow-up|5|||
37669793|NCT02697773|69142953|FG002|Overall Study|Lost to Follow-up|7|||
37669794|NCT02697773|69142951|FG000|Overall Study|Other|15|||
37669795|NCT02697773|69142952|FG001|Overall Study|Other|11|||
37669796|NCT02697773|69142953|FG002|Overall Study|Other|10|||
37669797|NCT02697773|69142951|FG000|Overall Study|Protocol Violation|1|||
37669798|NCT02697773|69142952|FG001|Overall Study|Protocol Violation|1|||
37669799|NCT02697773|69142953|FG002|Overall Study|Protocol Violation|0|||
37669800|NCT02697773|69142951|FG000|Overall Study|Withdrawal by Subject|10|||
37669801|NCT02697773|69142952|FG001|Overall Study|Withdrawal by Subject|13|||
37669802|NCT02697773|69142953|FG002|Overall Study|Withdrawal by Subject|13|||
37669803|NCT02697773|69142951|FG000|Overall Study|Randomized but not treated|1|||
37669804|NCT02697773|69142952|FG001|Overall Study|Randomized but not treated|1|||
37669805|NCT02697773|69142953|FG002|Overall Study|Randomized but not treated|0|||
37669806|NCT02693171|69142961|FG000|Overall Study|Adverse Event|1|||
37762333|NCT01589822|69273890|FG001|Overall Study|Death|0|||
37762334|NCT01589822|69273891|FG002|Overall Study|Death|0|||
37762335|NCT01589822|69273889|FG000|Overall Study|Missed 90 day visit|2|||
37762336|NCT01589822|69273890|FG001|Overall Study|Missed 90 day visit|1|||
37762337|NCT01589822|69273891|FG002|Overall Study|Missed 90 day visit|1|||
37762338|NCT01565642|69273903|FG000|Overall Study|Withdrawal by Subject|2|||
37859455|NCT01168401|69542787|FG005|Overall Study|Lost to Follow-up|0|||
37933101|NCT00719862|69619884|FG001|Overall Study|Withdrawal by Subject|0|||
37933102|NCT00719862|69619883|FG000|Overall Study|Lost to Follow-up|0|||
37933103|NCT00719862|69619884|FG001|Overall Study|Lost to Follow-up|1|||
37933104|NCT00719862|69619883|FG000|Overall Study|Other|2|||
37669807|NCT02693171|69142961|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
37669808|NCT02692703|69142965|FG000|Overall Study|Lost to Follow-up|1|||
37669809|NCT02692703|69142965|FG000|Overall Study|Other|1|||
37669810|NCT02692235|69142971|FG000|Overall Study|Withdrawal by Subject|2|||
37669811|NCT02692235|69142972|FG001|Overall Study|Withdrawal by Subject|1|||
37762339|NCT01565642|69273904|FG001|Overall Study|Withdrawal by Subject|1|||
37762340|NCT01475071|69273910|FG000|Overall Study|Physician Decision|1|||
37762341|NCT01475071|69273910|FG000|Overall Study|Withdrawal by Subject|6|||
37859456|NCT01168401|69542788|FG006|Overall Study|Lost to Follow-up|0|||
37762342|NCT01475071|69273910|FG000|Overall Study|Lost to Follow-up|1|||
37762343|NCT01474993|69273918|FG000|Overall Study|Lost to Follow-up|1|||
37762344|NCT01474993|69273919|FG001|Overall Study|Lost to Follow-up|2|||
37762345|NCT01474993|69273918|FG000|Overall Study|Adverse Event|0|||
37762346|NCT01474993|69273919|FG001|Overall Study|Adverse Event|1|||
37762347|NCT01691768|69273929|FG000|Overall Study|Death|0|||
37762348|NCT01691768|69273930|FG001|Overall Study|Death|2|||
37762349|NCT01691768|69273929|FG000|Overall Study|Lost to Follow-up|4|||
37762350|NCT01691768|69273930|FG001|Overall Study|Lost to Follow-up|3|||
37762351|NCT01691768|69273929|FG000|Overall Study|Withdrawal by Subject|10|||
37762352|NCT01691768|69273930|FG001|Overall Study|Withdrawal by Subject|9|||
37762353|NCT01691768|69273929|FG000|Overall Study|Relocated|0|||
37762354|NCT01691768|69273930|FG001|Overall Study|Relocated|1|||
37762355|NCT01691768|69273929|FG000|Overall Study|Investigator decision|1|||
37762356|NCT01691768|69273930|FG001|Overall Study|Investigator decision|1|||
37762357|NCT01503229|69273937|FG000|Overall Study|Withdrew consent|1|||
37762358|NCT01691612|69273941|FG000|Overall Study|deemed ineligible after 1st visit|6|||
37762359|NCT01691612|69273941|FG000|Overall Study|Adverse Event|1|||
37669812|NCT02692235|69142971|FG000|Overall Study|Adverse Event|1|||
37669813|NCT02692235|69142972|FG001|Overall Study|Adverse Event|2|||
37669814|NCT02552121|69142986|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
37669815|NCT02552121|69142987|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
37669816|NCT02552121|69142988|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
37669817|NCT02552121|69142989|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
37669818|NCT02552121|69142990|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
37669819|NCT02552121|69142991|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
37669820|NCT02552121|69142992|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
37669821|NCT02552121|69142993|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
37669822|NCT02552121|69142986|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
37669823|NCT02552121|69142987|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
37669824|NCT02552121|69142988|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
37669825|NCT02552121|69142989|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
37669826|NCT02552121|69142990|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
37669827|NCT02552121|69142991|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
37669828|NCT02552121|69142992|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
37669829|NCT02552121|69142993|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
37669830|NCT02552121|69142986|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
37669831|NCT02552121|69142987|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
37669832|NCT02552121|69142988|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
37669833|NCT02552121|69142989|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
37669834|NCT02552121|69142990|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
37669835|NCT02552121|69142991|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
37669836|NCT02552121|69142992|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
37669837|NCT02552121|69142993|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
37669838|NCT02552121|69142986|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
37669839|NCT02552121|69142987|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
37669840|NCT02552121|69142988|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
37669841|NCT02552121|69142989|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
37669842|NCT02552121|69142990|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
37669843|NCT02552121|69142991|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
37669844|NCT02552121|69142992|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
37669845|NCT02552121|69142993|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
37669846|NCT02552121|69142986|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
37669847|NCT02552121|69142987|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
37669848|NCT02552121|69142988|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
37669849|NCT02552121|69142989|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
37669850|NCT02552121|69142990|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
37669851|NCT02552121|69142991|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
37669852|NCT02552121|69142992|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
37669853|NCT02552121|69142993|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
37669854|NCT02552121|69142986|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
37669855|NCT02552121|69142987|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
37669856|NCT02552121|69142988|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
37669857|NCT02552121|69142989|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
37669858|NCT02552121|69142990|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
37669859|NCT02552121|69142991|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
37669860|NCT02552121|69142992|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
37669861|NCT02552121|69142993|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
37669862|NCT02552121|69142986|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
37669863|NCT02552121|69142987|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
37762360|NCT01565564|69273947|FG000|Overall Study|Lost to Follow-up|5|||
37762361|NCT01565564|69273948|FG001|Overall Study|Lost to Follow-up|1|||
37762362|NCT01460407|69273954|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
37762363|NCT01460407|69273955|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
37762364|NCT01502371|69273967|FG000|Overall Study|Withdrawal by Subject|1|||
37762365|NCT01502371|69273968|FG001|Overall Study|Withdrawal by Subject|2|||
37762366|NCT01502371|69273969|FG002|Overall Study|Withdrawal by Subject|1|||
37762367|NCT01502371|69273970|FG003|Overall Study|Withdrawal by Subject|1|||
37762368|NCT01502371|69273971|FG004|Overall Study|Withdrawal by Subject|1|||
37762369|NCT01502371|69273967|FG000|Overall Study|Adverse Event|2|||
37762370|NCT01502371|69273968|FG001|Overall Study|Adverse Event|1|||
37762371|NCT01502371|69273969|FG002|Overall Study|Adverse Event|0|||
37762372|NCT01502371|69273970|FG003|Overall Study|Adverse Event|4|||
37762373|NCT01502371|69273971|FG004|Overall Study|Adverse Event|3|||
37762374|NCT01502371|69273967|FG000|Overall Study|Treatment Failure|22|||
37762375|NCT01502371|69273968|FG001|Overall Study|Treatment Failure|20|||
37762376|NCT01502371|69273969|FG002|Overall Study|Treatment Failure|12|||
37762377|NCT01502371|69273970|FG003|Overall Study|Treatment Failure|19|||
37762378|NCT01502371|69273971|FG004|Overall Study|Treatment Failure|30|||
37762379|NCT01502371|69273967|FG000|Overall Study|Lack of Efficacy|3|||
37762380|NCT01502371|69273968|FG001|Overall Study|Lack of Efficacy|3|||
37762381|NCT01502371|69273969|FG002|Overall Study|Lack of Efficacy|2|||
37762382|NCT01502371|69273970|FG003|Overall Study|Lack of Efficacy|2|||
37762383|NCT01502371|69273971|FG004|Overall Study|Lack of Efficacy|4|||
37762384|NCT01502371|69273967|FG000|Overall Study|Physician Decision|3|||
37762385|NCT01502371|69273968|FG001|Overall Study|Physician Decision|0|||
37762386|NCT01502371|69273969|FG002|Overall Study|Physician Decision|0|||
37762387|NCT01502371|69273970|FG003|Overall Study|Physician Decision|0|||
37762388|NCT01502371|69273971|FG004|Overall Study|Physician Decision|1|||
37762389|NCT01502371|69273967|FG000|Overall Study|Noncompliance with Study Drug|0|||
37762390|NCT01502371|69273968|FG001|Overall Study|Noncompliance with Study Drug|0|||
37762391|NCT01502371|69273969|FG002|Overall Study|Noncompliance with Study Drug|1|||
37762392|NCT01502371|69273970|FG003|Overall Study|Noncompliance with Study Drug|2|||
37762393|NCT01502371|69273971|FG004|Overall Study|Noncompliance with Study Drug|1|||
37762394|NCT01502371|69273967|FG000|Overall Study|Technical Problems|1|||
37762395|NCT01502371|69273968|FG001|Overall Study|Technical Problems|0|||
37762396|NCT01502371|69273969|FG002|Overall Study|Technical Problems|2|||
37762397|NCT01502371|69273970|FG003|Overall Study|Technical Problems|4|||
37762398|NCT01502371|69273971|FG004|Overall Study|Technical Problems|1|||
37762399|NCT01502371|69273967|FG000|Overall Study|Protocol Violation|9|||
37762400|NCT01502371|69273968|FG001|Overall Study|Protocol Violation|5|||
37762401|NCT01502371|69273969|FG002|Overall Study|Protocol Violation|6|||
37762402|NCT01502371|69273970|FG003|Overall Study|Protocol Violation|5|||
37762403|NCT01502371|69273971|FG004|Overall Study|Protocol Violation|10|||
37762404|NCT01502371|69273967|FG000|Overall Study|Excluded Medication|0|||
37762405|NCT01502371|69273968|FG001|Overall Study|Excluded Medication|1|||
37762406|NCT01502371|69273969|FG002|Overall Study|Excluded Medication|1|||
37762407|NCT01502371|69273970|FG003|Overall Study|Excluded Medication|0|||
37762408|NCT01502371|69273971|FG004|Overall Study|Excluded Medication|1|||
37762409|NCT01588496|69273987|FG000|Overall Study|Withdrawal by Subject|0|||
37762410|NCT01588496|69273988|FG001|Overall Study|Withdrawal by Subject|1|||
37762411|NCT01588496|69273989|FG002|Overall Study|Withdrawal by Subject|0|||
37762412|NCT01502293|69274000|FG000|Overall Study|Progressive Disease|20|||
37762413|NCT01502293|69274001|FG001|Overall Study|Progressive Disease|12|||
37762414|NCT01502293|69274002|FG002|Overall Study|Progressive Disease|2|||
37933105|NCT00719862|69619884|FG001|Overall Study|Other|3|||
37933106|NCT00742508|69619892|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
37933107|NCT00742508|69619893|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
37933108|NCT00742508|69619892|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
37933109|NCT00742508|69619893|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
37933110|NCT00742508|69619892|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
37933111|NCT00742508|69619893|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
37933112|NCT00742508|69619892|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
37933113|NCT00742508|69619893|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
37933114|NCT00742508|69619892|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
37933115|NCT00742508|69619893|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
37933116|NCT00719706|69619901|FG000|Overall Study|Adverse Event|5|||
37933117|NCT00719706|69619902|FG001|Overall Study|Adverse Event|4|||
37933118|NCT00719706|69619901|FG000|Overall Study|Withdrawal by Subject|1|||
37933119|NCT00719706|69619902|FG001|Overall Study|Withdrawal by Subject|2|||
38034986|NCT04230213|69721866|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
37762415|NCT01502293|69274000|FG000|Overall Study|Withdrawal by Subject|3|||
37762416|NCT01502293|69274001|FG001|Overall Study|Withdrawal by Subject|3|||
37762417|NCT01502293|69274002|FG002|Overall Study|Withdrawal by Subject|1|||
37762418|NCT01502293|69274000|FG000|Overall Study|Adverse Event|0|||
37762419|NCT01502293|69274001|FG001|Overall Study|Adverse Event|2|||
37762420|NCT01502293|69274002|FG002|Overall Study|Adverse Event|0|||
37762421|NCT01502293|69274000|FG000|Overall Study|Reason Not Specified|2|||
37762422|NCT01502293|69274001|FG001|Overall Study|Reason Not Specified|0|||
37762423|NCT01502293|69274002|FG002|Overall Study|Reason Not Specified|0|||
37762424|NCT01502293|69274000|FG000|Overall Study|Physician Decision|0|||
37762425|NCT01502293|69274001|FG001|Overall Study|Physician Decision|0|||
37762426|NCT01502293|69274002|FG002|Overall Study|Physician Decision|1|||
37762427|NCT01474681|69274015|FG000|Overall Study|Death|0|||
37762428|NCT01474681|69274016|FG001|Overall Study|Death|3|||
37762429|NCT01474681|69274017|FG002|Overall Study|Death|2|||
37762430|NCT01474681|69274018|FG003|Overall Study|Death|6|||
37762431|NCT01459783|69274034|FG000|Baseline to 6 Months|Death|1|||
37762432|NCT01459783|69274035|FG001|Baseline to 6 Months|Death|0|||
37762433|NCT01459783|69274034|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
37762434|NCT01459783|69274035|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
37762435|NCT01459783|69274034|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
37762436|NCT01459783|69274035|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
37762437|NCT01459783|69274034|FG000|6 Months to 12 Months|Death|0|||
37762438|NCT01459783|69274035|FG001|6 Months to 12 Months|Death|1|||
37762439|NCT01459783|69274034|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
37762440|NCT01459783|69274035|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
37762441|NCT01459783|69274034|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
37762442|NCT01459783|69274035|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
37762443|NCT01459783|69274034|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
37762444|NCT01459783|69274035|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
37762445|NCT01588184|69274047|FG000|Overall Study|Death|1|||
37762446|NCT01588184|69274048|FG001|Overall Study|Death|0|||
37762447|NCT01588184|69274049|FG002|Overall Study|Death|0|||
37762448|NCT01588184|69274050|FG003|Overall Study|Death|1|||
37762449|NCT01588184|69274051|FG004|Overall Study|Death|1|||
37762450|NCT01588184|69274052|FG005|Overall Study|Death|1|||
37762451|NCT01588184|69274047|FG000|Overall Study|Withdrawal by Subject|2|||
37762452|NCT01588184|69274048|FG001|Overall Study|Withdrawal by Subject|4|||
37762453|NCT01588184|69274049|FG002|Overall Study|Withdrawal by Subject|0|||
37762454|NCT01588184|69274050|FG003|Overall Study|Withdrawal by Subject|1|||
37762455|NCT01588184|69274051|FG004|Overall Study|Withdrawal by Subject|0|||
37762456|NCT01588184|69274052|FG005|Overall Study|Withdrawal by Subject|0|||
37762457|NCT01588184|69274047|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
37762458|NCT01588184|69274048|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
37762459|NCT01588184|69274049|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
37762460|NCT01588184|69274050|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
37762461|NCT01588184|69274051|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
37762462|NCT01588184|69274052|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
37762463|NCT01588184|69274047|FG000|Overall Study|multiple reasons|0|||
37762464|NCT01588184|69274048|FG001|Overall Study|multiple reasons|3|||
37762465|NCT01588184|69274049|FG002|Overall Study|multiple reasons|0|||
37933120|NCT00719706|69619901|FG000|Overall Study|Protocol Violation|3|||
37933121|NCT00719706|69619902|FG001|Overall Study|Protocol Violation|0|||
37933122|NCT00742274|69619910|FG000|Overall Study|Death|1|||
37933123|NCT00742274|69619911|FG001|Overall Study|Death|0|||
37933124|NCT00742274|69619910|FG000|Overall Study|Withdrawal by Subject|1|||
37933125|NCT00742274|69619911|FG001|Overall Study|Withdrawal by Subject|2|||
37933126|NCT00742274|69619910|FG000|Overall Study|Removed for medical reasons|1|||
37933127|NCT00742274|69619911|FG001|Overall Study|Removed for medical reasons|1|||
37933128|NCT00719472|69619917|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
37933129|NCT00719472|69619917|FG000|Enrolled in Study|Subject decision to withdraw|8|||
37933130|NCT00719472|69619917|FG000|Enrolled in Study|Various Reasons|17|||
37933131|NCT00719472|69619917|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
37933132|NCT00719472|69619917|FG000|Received Cycle 1 Treatment|Death|5|||
37933133|NCT00719472|69619917|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
37933134|NCT00719472|69619917|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
37933135|NCT00719472|69619917|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
37933136|NCT00719472|69619917|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
37933137|NCT00719472|69619917|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
37762466|NCT01588184|69274050|FG003|Overall Study|multiple reasons|1|||
37762467|NCT01588184|69274051|FG004|Overall Study|multiple reasons|0|||
37762468|NCT01588184|69274052|FG005|Overall Study|multiple reasons|0|||
37762469|NCT01588106|69274068|FG000|Overall Study|Withdrawal by Subject|5|||
37762470|NCT01588106|69274069|FG001|Overall Study|Withdrawal by Subject|4|||
37762471|NCT01564862|69274078|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
37762472|NCT01564862|69274079|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
37762473|NCT01564862|69274080|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
37762474|NCT01564862|69274078|FG000|Overall Study|Major Protocol Deviation|3|||
37933138|NCT00719472|69619917|FG000|Received Cycle 2 Treatment|Death|6|||
37933139|NCT00719472|69619917|FG000|Received Cycle 2 Treatment|Disease progression|3|||
37762475|NCT01564862|69274079|FG001|Overall Study|Major Protocol Deviation|3|||
37762476|NCT01564862|69274080|FG002|Overall Study|Major Protocol Deviation|4|||
37762477|NCT01564862|69274078|FG000|Overall Study|Lost to Follow-up|10|||
37762478|NCT01564862|69274079|FG001|Overall Study|Lost to Follow-up|8|||
37933140|NCT00719472|69619917|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
37933141|NCT00719472|69619917|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
37933142|NCT00719472|69619917|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
37933143|NCT00719472|69619917|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
37933144|NCT00579501|69619921|FG000|Overall Study|Death|1|||
37933145|NCT00579501|69619921|FG000|Overall Study|End of neoadjuvant therapy|25|||
37669864|NCT02552121|69142988|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
37669865|NCT02552121|69142989|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
37669866|NCT02552121|69142990|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
37669867|NCT02552121|69142991|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
37669868|NCT02552121|69142992|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
37669869|NCT02552121|69142993|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
37762479|NCT01564862|69274080|FG002|Overall Study|Lost to Follow-up|6|||
37762480|NCT01564862|69274078|FG000|Overall Study|Voluntary Withdrawal|9|||
37933146|NCT00579501|69619921|FG000|Overall Study|toxicity|1|||
37933147|NCT00579501|69619921|FG000|Overall Study|Secondary lesion|1|||
37933148|NCT00579501|69619921|FG000|Overall Study|Radiation therapy before surgery|1|||
37933149|NCT00741338|69619927|FG000|Overall Study|Adverse Event|0|||
37933150|NCT00741338|69619928|FG001|Overall Study|Adverse Event|1|||
37762481|NCT01564862|69274079|FG001|Overall Study|Voluntary Withdrawal|6|||
37762482|NCT01564862|69274080|FG002|Overall Study|Voluntary Withdrawal|8|||
37762483|NCT01564862|69274078|FG000|Overall Study|Lack of Efficacy|1|||
37762484|NCT01564862|69274079|FG001|Overall Study|Lack of Efficacy|5|||
37762485|NCT01564862|69274080|FG002|Overall Study|Lack of Efficacy|6|||
37762486|NCT01564862|69274078|FG000|Overall Study|Other reason(s)|1|||
37762487|NCT01564862|69274079|FG001|Overall Study|Other reason(s)|0|||
37762488|NCT01564862|69274080|FG002|Overall Study|Other reason(s)|0|||
37762489|NCT01691378|69274090|FG000|Overall Study|Withdrawal by Subject|2|||
37762490|NCT01691378|69274091|FG001|Overall Study|Withdrawal by Subject|0|||
37762491|NCT01691378|69274090|FG000|Overall Study|Lost to Follow-up|5|||
37762492|NCT01691378|69274091|FG001|Overall Study|Lost to Follow-up|2|||
37762493|NCT01467479|69274100|FG000|Overall Study|No Study Medication|1|||
37933151|NCT00746330|69619938|FG000|Period 1|Abnormal test procedure result|0|||
37933152|NCT00746330|69619939|FG001|Period 1|Abnormal test procedure result|0|||
37933153|NCT00746330|69619940|FG002|Period 1|Abnormal test procedure result|1|||
37933154|NCT00746330|69619941|FG003|Period 1|Abnormal test procedure result|0|||
37933155|NCT00746252|69619954|FG000|Overall Study|weight gain >7.5 %|1|||
37933156|NCT00746252|69619955|FG001|Overall Study|weight gain >7.5 %|2|||
37933157|NCT00718770|69619961|FG000|Overall Study|Adverse Event|1|||
37933158|NCT00718770|69619961|FG000|Overall Study|Lack of Efficacy|1|||
37933159|NCT00718770|69619961|FG000|Overall Study|Lack of Efficacy|1|||
37933160|NCT00718770|69619961|FG000|Overall Study|Adverse Event|1|||
37933161|NCT00718770|69619961|FG000|Overall Study|Lack of Efficacy|1|||
37933162|NCT00718770|69619961|FG000|Overall Study|Adverse Event|1|||
37933163|NCT00718770|69619961|FG000|Overall Study|Lack of Efficacy|1|||
37933164|NCT00718770|69619961|FG000|Overall Study|Adverse Event|1|||
37933165|NCT00746096|69619967|FG000|Overall Study|Adverse Event|1|||
37933166|NCT00746096|69619968|FG001|Overall Study|Adverse Event|0|||
37933167|NCT00746096|69619967|FG000|Overall Study|Withdrawal by Subject|5|||
37933168|NCT00746096|69619968|FG001|Overall Study|Withdrawal by Subject|1|||
37933169|NCT00746096|69619967|FG000|Overall Study|Lost to Follow-up|2|||
37933170|NCT00746096|69619968|FG001|Overall Study|Lost to Follow-up|1|||
37933171|NCT00746096|69619967|FG000|Overall Study|Protocol Violation|1|||
37933172|NCT00746096|69619968|FG001|Overall Study|Protocol Violation|0|||
37933173|NCT00746096|69619967|FG000|Overall Study|No study drug treatment|1|||
37933174|NCT00746096|69619968|FG001|Overall Study|No study drug treatment|1|||
37933175|NCT00715026|69619974|FG000|Overall Study|Withdrawal by Subject|5|||
37933176|NCT00715026|69619974|FG000|Overall Study|Lost to Follow-up|3|||
37933177|NCT00715026|69619974|FG000|Overall Study|Protocol Violation|1|||
37933178|NCT00715026|69619974|FG000|Overall Study|Surgery done on non-study consented hip|1|||
37933179|NCT00714948|69619978|FG000|Overall Study|Adverse Event|2|||
37933180|NCT00714870|69619984|FG000|Overall Study|Lost to Follow-up|22|||
37933181|NCT00714870|69619985|FG001|Overall Study|Lost to Follow-up|5|||
37933182|NCT00714870|69619984|FG000|Overall Study|patient unable to come b/c back pain|1|||
37933183|NCT00714870|69619985|FG001|Overall Study|patient unable to come b/c back pain|0|||
37933184|NCT00714870|69619984|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
37933185|NCT00714870|69619985|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
37933186|NCT00714714|69619991|FG000|Overall Study|Adverse Event|1|||
37933187|NCT00441337|69620001|FG000|Overall Study|Disease Progression|6|||
37933188|NCT00441337|69620002|FG001|Overall Study|Disease Progression|6|||
37762494|NCT01467479|69274101|FG001|Overall Study|No Study Medication|0|||
37762495|NCT01467479|69274102|FG002|Overall Study|No Study Medication|2|||
37762496|NCT01467479|69274100|FG000|Overall Study|Adverse Event|1|||
37762497|NCT01467479|69274101|FG001|Overall Study|Adverse Event|2|||
37762498|NCT01467479|69274102|FG002|Overall Study|Adverse Event|0|||
37762499|NCT01467479|69274100|FG000|Overall Study|Death|0|||
37762500|NCT01467479|69274101|FG001|Overall Study|Death|0|||
37762501|NCT01467479|69274102|FG002|Overall Study|Death|1|||
37762502|NCT01467479|69274100|FG000|Overall Study|Lost to Follow-up|2|||
37762503|NCT01467479|69274101|FG001|Overall Study|Lost to Follow-up|5|||
37762504|NCT01467479|69274102|FG002|Overall Study|Lost to Follow-up|3|||
37762505|NCT01467479|69274100|FG000|Overall Study|Withdrawal of Consent|3|||
37762506|NCT01467479|69274101|FG001|Overall Study|Withdrawal of Consent|7|||
37762507|NCT01467479|69274102|FG002|Overall Study|Withdrawal of Consent|7|||
37762508|NCT01467479|69274100|FG000|Overall Study|Study Terminated by Sponsor|1|||
37933189|NCT00441337|69620003|FG002|Overall Study|Disease Progression|4|||
37933190|NCT00441337|69620004|FG003|Overall Study|Disease Progression|18|||
37933191|NCT00441337|69620001|FG000|Overall Study|Lost to Follow-up|0|||
37933192|NCT00441337|69620002|FG001|Overall Study|Lost to Follow-up|0|||
37933193|NCT00441337|69620003|FG002|Overall Study|Lost to Follow-up|0|||
37933194|NCT00441337|69620004|FG003|Overall Study|Lost to Follow-up|1|||
37933195|NCT00441337|69620001|FG000|Overall Study|Sponsor Decision|0|||
37933196|NCT00441337|69620002|FG001|Overall Study|Sponsor Decision|0|||
37933197|NCT00441337|69620003|FG002|Overall Study|Sponsor Decision|1|||
37933198|NCT00441337|69620004|FG003|Overall Study|Sponsor Decision|2|||
37933199|NCT00441337|69620001|FG000|Overall Study|Did not meet inclusion criteria|0|||
37933200|NCT00441337|69620002|FG001|Overall Study|Did not meet inclusion criteria|0|||
37933201|NCT00441337|69620003|FG002|Overall Study|Did not meet inclusion criteria|1|||
37933202|NCT00441337|69620004|FG003|Overall Study|Did not meet inclusion criteria|0|||
37933203|NCT00578877|69620024|FG000|Overall Study|Lost to Follow-up|8|||
37933204|NCT00578877|69620025|FG001|Overall Study|Lost to Follow-up|10|||
37933205|NCT00578877|69620024|FG000|Overall Study|early discontinue|61|||
37933206|NCT00578877|69620025|FG001|Overall Study|early discontinue|101|||
37933207|NCT00578877|69620024|FG000|Overall Study|did not provide follow-up data|12|||
37933208|NCT00578877|69620025|FG001|Overall Study|did not provide follow-up data|17|||
37933209|NCT00468481|69620033|FG000|Overall Study|Adverse Event|13|||
37933210|NCT00468481|69620034|FG001|Overall Study|Adverse Event|3|||
37669870|NCT02552121|69142986|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
37669871|NCT02552121|69142987|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
37669872|NCT02552121|69142988|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
37669873|NCT02552121|69142989|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
37669874|NCT02552121|69142990|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
37669875|NCT02552121|69142991|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
37669876|NCT02552121|69142992|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
37669877|NCT02552121|69142993|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
37669878|NCT02552121|69142986|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
37669879|NCT02552121|69142987|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
37669880|NCT02552121|69142988|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
37669881|NCT02552121|69142989|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
37669882|NCT02552121|69142990|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
37669883|NCT02552121|69142991|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
37669884|NCT02552121|69142992|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
37669885|NCT02552121|69142993|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
37669886|NCT02552121|69142986|FG000|Part 2: Cohort Expansion|Death|0|||
37669887|NCT02552121|69142987|FG001|Part 2: Cohort Expansion|Death|0|||
37669888|NCT02552121|69142988|FG002|Part 2: Cohort Expansion|Death|1|||
37669889|NCT02552121|69142989|FG003|Part 2: Cohort Expansion|Death|0|||
37669890|NCT02552121|69142990|FG004|Part 2: Cohort Expansion|Death|0|||
37669891|NCT02552121|69142991|FG005|Part 2: Cohort Expansion|Death|0|||
37669892|NCT02552121|69142992|FG006|Part 2: Cohort Expansion|Death|0|||
37669893|NCT02552121|69142993|FG007|Part 2: Cohort Expansion|Death|0|||
37669894|NCT02552355|69143038|FG000|Overall Study|Adverse Event|0|||
37669895|NCT02552355|69143039|FG001|Overall Study|Adverse Event|2|||
37669896|NCT02552355|69143040|FG002|Overall Study|Adverse Event|2|||
37762509|NCT01467479|69274101|FG001|Overall Study|Study Terminated by Sponsor|3|||
37762510|NCT01467479|69274102|FG002|Overall Study|Study Terminated by Sponsor|3|||
37762511|NCT01467479|69274100|FG000|Overall Study|Other|1|||
37933211|NCT00468481|69620033|FG000|Overall Study|Lost to Follow-up|25|||
37933212|NCT00468481|69620034|FG001|Overall Study|Lost to Follow-up|8|||
37933213|NCT00468481|69620033|FG000|Overall Study|Pregnancy|2|||
37933214|NCT00468481|69620034|FG001|Overall Study|Pregnancy|0|||
37933215|NCT00468481|69620033|FG000|Overall Study|Protocol Violation|18|||
37933216|NCT00468481|69620034|FG001|Overall Study|Protocol Violation|8|||
37933217|NCT00468481|69620033|FG000|Overall Study|Withdrawal by Subject|12|||
37669897|NCT02552355|69143041|FG003|Overall Study|Adverse Event|0|||
37669898|NCT02552355|69143038|FG000|Overall Study|Withdrawal by Subject|0|||
37669899|NCT02552355|69143039|FG001|Overall Study|Withdrawal by Subject|0|||
37669900|NCT02552355|69143040|FG002|Overall Study|Withdrawal by Subject|0|||
37762512|NCT01467479|69274101|FG001|Overall Study|Other|0|||
37762513|NCT01467479|69274102|FG002|Overall Study|Other|0|||
37933218|NCT00468481|69620034|FG001|Overall Study|Withdrawal by Subject|3|||
37933219|NCT00468481|69620033|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
37933220|NCT00468481|69620034|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
37933221|NCT00468481|69620033|FG000|Overall Study|Prohibited Medication|1|||
37933222|NCT00468481|69620034|FG001|Overall Study|Prohibited Medication|1|||
37933223|NCT00468481|69620033|FG000|Overall Study|Egg Donor|1|||
37933224|NCT00468481|69620034|FG001|Overall Study|Egg Donor|0|||
37933225|NCT00468481|69620033|FG000|Overall Study|Moved out of area|4|||
37933226|NCT00468481|69620034|FG001|Overall Study|Moved out of area|1|||
37933227|NCT00468481|69620033|FG000|Overall Study|Non-Compliance|5|||
37933228|NCT00468481|69620034|FG001|Overall Study|Non-Compliance|0|||
37933229|NCT00468481|69620033|FG000|Overall Study|Other|6|||
37933230|NCT00468481|69620034|FG001|Overall Study|Other|0|||
37933231|NCT00714168|69620042|FG000|Overall Study|Pregnancy|5|||
37933232|NCT00714168|69620043|FG001|Overall Study|Pregnancy|4|||
37933233|NCT00714168|69620042|FG000|Overall Study|Lost to Follow-up|32|||
37933234|NCT00714168|69620043|FG001|Overall Study|Lost to Follow-up|50|||
37933235|NCT00714168|69620042|FG000|Overall Study|Relocation|4|||
37933236|NCT00714168|69620043|FG001|Overall Study|Relocation|3|||
37933237|NCT00714168|69620042|FG000|Overall Study|Non-study medical condition|3|||
37933238|NCT00714168|69620043|FG001|Overall Study|Non-study medical condition|2|||
37933239|NCT00713700|69620049|FG000|Overall Study|Lost to Follow-up|3|||
37933240|NCT00713700|69620049|FG000|Overall Study|Withdrawal by Subject|1|||
37933241|NCT00468169|69620055|FG000|Overall Study|Withdrawal by Subject|1|||
37933242|NCT00468169|69620056|FG001|Overall Study|Withdrawal by Subject|0|||
37933243|NCT00435487|69620066|FG000|Overall Study|Death|3|||
37933244|NCT00435487|69620067|FG001|Overall Study|Death|4|||
37933245|NCT00435487|69620066|FG000|Overall Study|Adverse Event|0|||
37933246|NCT00435487|69620067|FG001|Overall Study|Adverse Event|3|||
37933247|NCT00435487|69620066|FG000|Overall Study|Lost to Follow-up|2|||
37933248|NCT00435487|69620067|FG001|Overall Study|Lost to Follow-up|2|||
37933249|NCT00435487|69620066|FG000|Overall Study|Other|5|||
37933250|NCT00435487|69620067|FG001|Overall Study|Other|2|||
37933251|NCT00435487|69620066|FG000|Overall Study|Withdrawal by Subject|2|||
37933252|NCT00435487|69620067|FG001|Overall Study|Withdrawal by Subject|1|||
37933253|NCT00435487|69620066|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
37933254|NCT00435487|69620067|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
37933255|NCT00435487|69620066|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
37933256|NCT00435487|69620067|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
37933257|NCT00579345|69620081|FG000|Overall Study|Withdrawal by Subject|2|||
37933258|NCT00579345|69620082|FG001|Overall Study|Withdrawal by Subject|0|||
37933259|NCT00579345|69620083|FG002|Overall Study|Withdrawal by Subject|0|||
37933260|NCT00579345|69620084|FG003|Overall Study|Withdrawal by Subject|0|||
37933261|NCT00579345|69620085|FG004|Overall Study|Withdrawal by Subject|0|||
37933262|NCT00579345|69620086|FG005|Overall Study|Withdrawal by Subject|0|||
37933263|NCT00579345|69620087|FG006|Overall Study|Withdrawal by Subject|0|||
37933264|NCT00579345|69620088|FG007|Overall Study|Withdrawal by Subject|1|||
37933265|NCT00579345|69620081|FG000|Overall Study|Lost to Follow-up|1|||
37933266|NCT00579345|69620082|FG001|Overall Study|Lost to Follow-up|0|||
37933267|NCT00579345|69620083|FG002|Overall Study|Lost to Follow-up|0|||
37933268|NCT00579345|69620084|FG003|Overall Study|Lost to Follow-up|0|||
37933269|NCT00579345|69620085|FG004|Overall Study|Lost to Follow-up|0|||
37933270|NCT00579345|69620086|FG005|Overall Study|Lost to Follow-up|0|||
37933271|NCT00579345|69620087|FG006|Overall Study|Lost to Follow-up|0|||
37933272|NCT00579345|69620088|FG007|Overall Study|Lost to Follow-up|0|||
37933273|NCT00579345|69620081|FG000|Overall Study|Adverse Event|0|||
37933274|NCT00579345|69620082|FG001|Overall Study|Adverse Event|0|||
37933275|NCT00579345|69620083|FG002|Overall Study|Adverse Event|1|||
37933276|NCT00579345|69620084|FG003|Overall Study|Adverse Event|0|||
37933277|NCT00579345|69620085|FG004|Overall Study|Adverse Event|0|||
37933278|NCT00579345|69620086|FG005|Overall Study|Adverse Event|0|||
37933279|NCT00579345|69620087|FG006|Overall Study|Adverse Event|0|||
37933280|NCT00579345|69620088|FG007|Overall Study|Adverse Event|0|||
37933281|NCT00579345|69620081|FG000|Overall Study|Protocol Violation|1|||
37933282|NCT00579345|69620082|FG001|Overall Study|Protocol Violation|0|||
37933283|NCT00579345|69620083|FG002|Overall Study|Protocol Violation|0|||
37933284|NCT00579345|69620084|FG003|Overall Study|Protocol Violation|0|||
37933285|NCT00579345|69620085|FG004|Overall Study|Protocol Violation|0|||
37933286|NCT00579345|69620086|FG005|Overall Study|Protocol Violation|0|||
38034987|NCT04230213|69721864|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
37933287|NCT00579345|69620087|FG006|Overall Study|Protocol Violation|0|||
37933288|NCT00579345|69620088|FG007|Overall Study|Protocol Violation|1|||
37933289|NCT00579345|69620081|FG000|Overall Study|Death|1|||
37933290|NCT00579345|69620082|FG001|Overall Study|Death|1|||
37933291|NCT00579345|69620083|FG002|Overall Study|Death|1|||
37933292|NCT00579345|69620084|FG003|Overall Study|Death|1|||
37933293|NCT00579345|69620085|FG004|Overall Study|Death|0|||
37933294|NCT00579345|69620086|FG005|Overall Study|Death|0|||
37933295|NCT00579345|69620087|FG006|Overall Study|Death|0|||
37933296|NCT00579345|69620088|FG007|Overall Study|Death|0|||
37933297|NCT00795821|69620136|FG000|Acute Treatment Phase|Adverse Event|23|||
37933298|NCT00795821|69620137|FG001|Acute Treatment Phase|Adverse Event|4|||
37762514|NCT01466387|69274117|FG000|Overall Study|Adverse Event|0|||
37762515|NCT01466387|69274118|FG001|Overall Study|Adverse Event|0|||
37762516|NCT01466387|69274119|FG002|Overall Study|Adverse Event|1|||
37762517|NCT01466387|69274120|FG003|Overall Study|Adverse Event|1|||
37762518|NCT01466387|69274121|FG004|Overall Study|Adverse Event|0|||
37762519|NCT01466387|69274122|FG005|Overall Study|Adverse Event|0|||
37762520|NCT01466387|69274117|FG000|Overall Study|Lost to Follow-up|0|||
37762521|NCT01466387|69274118|FG001|Overall Study|Lost to Follow-up|0|||
37762522|NCT01466387|69274119|FG002|Overall Study|Lost to Follow-up|0|||
37762523|NCT01466387|69274120|FG003|Overall Study|Lost to Follow-up|0|||
37762524|NCT01466387|69274121|FG004|Overall Study|Lost to Follow-up|0|||
37762525|NCT01466387|69274122|FG005|Overall Study|Lost to Follow-up|1|||
37762526|NCT01466387|69274117|FG000|Overall Study|Protocol Violation|1|||
37762527|NCT01466387|69274118|FG001|Overall Study|Protocol Violation|0|||
37762528|NCT01466387|69274119|FG002|Overall Study|Protocol Violation|0|||
37762529|NCT01466387|69274120|FG003|Overall Study|Protocol Violation|1|||
37762530|NCT01466387|69274121|FG004|Overall Study|Protocol Violation|0|||
37762531|NCT01466387|69274122|FG005|Overall Study|Protocol Violation|0|||
37762532|NCT01564784|69274253|FG000|Overall Study|Other|1|||
37762533|NCT01564784|69274254|FG001|Overall Study|Other|0|||
37762534|NCT01564784|69274253|FG000|Overall Study|Subject refused further follow-up|1|||
37762535|NCT01564784|69274254|FG001|Overall Study|Subject refused further follow-up|6|||
37762536|NCT01564784|69274253|FG000|Overall Study|Lost to Follow-up|1|||
37762537|NCT01564784|69274254|FG001|Overall Study|Lost to Follow-up|1|||
37762538|NCT01564784|69274253|FG000|Overall Study|Death|131|||
37762539|NCT01564784|69274254|FG001|Overall Study|Death|126|||
37762540|NCT01564394|69274305|FG000|Overall Study|Withdrawal by Subject|6|||
37762541|NCT01564394|69274306|FG001|Overall Study|Withdrawal by Subject|10|||
37762542|NCT01690988|69274320|FG000|Overall Study|Withdrawal by Subject|2|||
37762543|NCT01690988|69274321|FG001|Overall Study|Withdrawal by Subject|2|||
37762544|NCT01690988|69274322|FG002|Overall Study|Withdrawal by Subject|3|||
37762545|NCT01690988|69274320|FG000|Overall Study|Physician Decision|0|||
37762546|NCT01690988|69274321|FG001|Overall Study|Physician Decision|0|||
37762547|NCT01690988|69274322|FG002|Overall Study|Physician Decision|1|||
37762548|NCT01690988|69274320|FG000|Overall Study|Operation Cancelled|1|||
37762549|NCT01690988|69274321|FG001|Overall Study|Operation Cancelled|1|||
37762550|NCT01690988|69274322|FG002|Overall Study|Operation Cancelled|0|||
37762551|NCT01690988|69274320|FG000|Overall Study|Determined ineligible|1|||
37762552|NCT01690988|69274321|FG001|Overall Study|Determined ineligible|0|||
37762553|NCT01690988|69274322|FG002|Overall Study|Determined ineligible|0|||
37762554|NCT01690988|69274320|FG000|Overall Study|Death|1|||
37762555|NCT01690988|69274321|FG001|Overall Study|Death|1|||
37762556|NCT01690988|69274322|FG002|Overall Study|Death|1|||
37762557|NCT01690988|69274320|FG000|Overall Study|Sedated|1|||
37762558|NCT01690988|69274321|FG001|Overall Study|Sedated|1|||
37762559|NCT01690988|69274322|FG002|Overall Study|Sedated|2|||
37762560|NCT01466153|69274353|FG000|Overall Study|Disease Progression|2|||
37762561|NCT01466153|69274354|FG001|Overall Study|Disease Progression|2|||
37762562|NCT01466153|69274355|FG002|Overall Study|Disease Progression|0|||
37762563|NCT01466153|69274353|FG000|Overall Study|Adverse Event|14|||
37762564|NCT01466153|69274354|FG001|Overall Study|Adverse Event|13|||
37762565|NCT01466153|69274355|FG002|Overall Study|Adverse Event|17|||
37762566|NCT01466153|69274353|FG000|Overall Study|Withdrawal of Consent|2|||
37762567|NCT01466153|69274354|FG001|Overall Study|Withdrawal of Consent|0|||
37762568|NCT01466153|69274355|FG002|Overall Study|Withdrawal of Consent|0|||
38034988|NCT04230213|69721865|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
37669901|NCT02552355|69143041|FG003|Overall Study|Withdrawal by Subject|1|||
37669902|NCT02551731|69143051|FG000|Overall Study|Withdrawal by Subject|2|||
37669903|NCT02542605|69143055|FG000|Part B: Challenge Phase|Sponsor decision|1|||
37669904|NCT02542605|69143056|FG001|Part B: Challenge Phase|Sponsor decision|0|||
37669905|NCT02542605|69143057|FG002|Part B: Challenge Phase|Sponsor decision|0|||
37669906|NCT02542605|69143055|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
37669907|NCT02542605|69143056|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
37762569|NCT01466153|69274353|FG000|Overall Study|Investigator Discretion|3|||
37762570|NCT01466153|69274354|FG001|Overall Study|Investigator Discretion|2|||
37762571|NCT01466153|69274355|FG002|Overall Study|Investigator Discretion|2|||
37762572|NCT01466153|69274353|FG000|Overall Study|Randomized-Not Treated|2|||
37762573|NCT01466153|69274354|FG001|Overall Study|Randomized-Not Treated|3|||
38034989|NCT04230213|69721866|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
37762574|NCT01466153|69274355|FG002|Overall Study|Randomized-Not Treated|4|||
37762575|NCT01466153|69274353|FG000|Overall Study|Other-Unspecified|6|||
37762576|NCT01466153|69274354|FG001|Overall Study|Other-Unspecified|4|||
37762577|NCT01466153|69274355|FG002|Overall Study|Other-Unspecified|2|||
37762578|NCT01474291|69274376|FG000|Overall Study|Not Evaluable for Efficacy|26|||
37762579|NCT01474291|69274376|FG000|Overall Study|Lack of Treatment Efficacy|88|||
37669908|NCT02542605|69143057|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
37762580|NCT01474291|69274376|FG000|Overall Study|Adverse Event|53|||
37762581|NCT01474291|69274376|FG000|Overall Study|Lost to Follow-up|29|||
37762582|NCT01474291|69274376|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
37762583|NCT01474291|69274376|FG000|Overall Study|No Reason Reported|10|||
37762584|NCT01474291|69274376|FG000|Overall Study|Death|2|||
37762585|NCT01465997|69274385|FG000|Overall Study|Adverse Event|12|||
37762586|NCT01465997|69274386|FG001|Overall Study|Adverse Event|22|||
37762587|NCT01465997|69274385|FG000|Overall Study|Lack of Efficacy|13|||
37762588|NCT01465997|69274386|FG001|Overall Study|Lack of Efficacy|1|||
37762589|NCT01465997|69274385|FG000|Overall Study|Protocol Violation|1|||
37762590|NCT01465997|69274386|FG001|Overall Study|Protocol Violation|4|||
37762591|NCT01465997|69274385|FG000|Overall Study|Lost to Follow-up|6|||
37762592|NCT01465997|69274386|FG001|Overall Study|Lost to Follow-up|9|||
37762593|NCT01465997|69274385|FG000|Overall Study|Withdrawal by Subject|32|||
37762594|NCT01465997|69274386|FG001|Overall Study|Withdrawal by Subject|35|||
37762595|NCT01465997|69274385|FG000|Overall Study|investigator's decision|1|||
37762596|NCT01465997|69274386|FG001|Overall Study|investigator's decision|1|||
37762597|NCT01465997|69274385|FG000|Overall Study|Death|0|||
37762598|NCT01465997|69274386|FG001|Overall Study|Death|1|||
37762599|NCT01465997|69274385|FG000|Overall Study|sponsor's decision|1|||
37762600|NCT01465997|69274386|FG001|Overall Study|sponsor's decision|1|||
37762601|NCT01465997|69274385|FG000|Overall Study|subject withdrew consent|1|||
37762602|NCT01465997|69274386|FG001|Overall Study|subject withdrew consent|0|||
37762603|NCT01465997|69274385|FG000|Overall Study|local lab unblinded site|1|||
37762604|NCT01465997|69274386|FG001|Overall Study|local lab unblinded site|0|||
37762605|NCT01465997|69274385|FG000|Overall Study|withdrew before follow-up|0|||
37762606|NCT01465997|69274386|FG001|Overall Study|withdrew before follow-up|13|||
37762607|NCT01465997|69274385|FG000|Overall Study|decision by site staff|0|||
37762608|NCT01465997|69274386|FG001|Overall Study|decision by site staff|1|||
37762609|NCT01465997|69274385|FG000|Overall Study|subject left participation SP0993|0|||
37762610|NCT01465997|69274386|FG001|Overall Study|subject left participation SP0993|1|||
37762611|NCT01465763|69274407|FG000|Overall Study|Withdrawal by Subject|4|||
37762612|NCT01465763|69274408|FG001|Overall Study|Withdrawal by Subject|0|||
37762613|NCT01465763|69274409|FG002|Overall Study|Withdrawal by Subject|1|||
37762614|NCT01465763|69274407|FG000|Overall Study|Insufficient Clinical Response|11|||
37762615|NCT01465763|69274408|FG001|Overall Study|Insufficient Clinical Response|0|||
37762616|NCT01465763|69274409|FG002|Overall Study|Insufficient Clinical Response|1|||
37762617|NCT01465763|69274407|FG000|Overall Study|Adverse Event|9|||
37762618|NCT01465763|69274408|FG001|Overall Study|Adverse Event|0|||
37762619|NCT01465763|69274409|FG002|Overall Study|Adverse Event|1|||
37762620|NCT01465763|69274407|FG000|Overall Study|Other|2|||
37762621|NCT01465763|69274408|FG001|Overall Study|Other|0|||
37762622|NCT01465763|69274409|FG002|Overall Study|Other|0|||
37762623|NCT01465763|69274407|FG000|Overall Study|Protocol Violation|4|||
37762624|NCT01465763|69274408|FG001|Overall Study|Protocol Violation|1|||
37762625|NCT01465763|69274409|FG002|Overall Study|Protocol Violation|1|||
37762626|NCT01465763|69274407|FG000|Overall Study|Death|1|||
37762627|NCT01465763|69274408|FG001|Overall Study|Death|0|||
37762628|NCT01465763|69274409|FG002|Overall Study|Death|0|||
37762629|NCT01690520|69274442|FG000|Overall Study|Death|25|||
37762630|NCT01690520|69274443|FG001|Overall Study|Death|21|||
37762631|NCT01690520|69274442|FG000|Overall Study|Lost to Follow-up|2|||
37762632|NCT01690520|69274443|FG001|Overall Study|Lost to Follow-up|3|||
37762633|NCT01690520|69274442|FG000|Overall Study|Withdrawal by Subject|2|||
37762634|NCT01690520|69274443|FG001|Overall Study|Withdrawal by Subject|0|||
37762635|NCT01690520|69274442|FG000|Overall Study|Relapse|0|||
37762636|NCT01690520|69274443|FG001|Overall Study|Relapse|1|||
37762637|NCT01690520|69274442|FG000|Overall Study|Other|0|||
37762638|NCT01690520|69274443|FG001|Overall Study|Other|1|||
37762639|NCT01690520|69274442|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
37762640|NCT01690520|69274443|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
37762641|NCT01563536|69274464|FG000|Overall Study|Withdrawal by Subject|0|||
37762642|NCT01563536|69274465|FG001|Overall Study|Withdrawal by Subject|2|||
37762643|NCT01563536|69274464|FG000|Overall Study|Lost to Follow-up|1|||
37762644|NCT01563536|69274465|FG001|Overall Study|Lost to Follow-up|0|||
37762645|NCT01690130|69274473|FG000|Overall Study|Subject have cancelled visit.|1|||
37762646|NCT01690130|69274474|FG001|Overall Study|Subject have cancelled visit.|0|||
37762647|NCT01690052|69274480|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
37933299|NCT00795821|69620136|FG000|Acute Treatment Phase|Death|1|||
37933300|NCT00795821|69620137|FG001|Acute Treatment Phase|Death|0|||
37762648|NCT01690052|69274481|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
37762649|NCT01689974|69274508|FG000|Overall Study|Termination of Study|5|||
37762650|NCT01689974|69274509|FG001|Overall Study|Termination of Study|5|||
37762651|NCT01587014|69274515|FG000|Overall Study|Death|2|||
37762652|NCT01458535|69274619|FG000|Overall Study|Other|0|||
37762653|NCT01458535|69274620|FG001|Overall Study|Other|0|||
37762654|NCT01458535|69274621|FG002|Overall Study|Other|0|||
37762655|NCT01458535|69274622|FG003|Overall Study|Other|0|||
37859457|NCT01168401|69542789|FG007|Overall Study|Lost to Follow-up|0|||
37762656|NCT01458535|69274623|FG004|Overall Study|Other|1|||
37762657|NCT01458535|69274624|FG005|Overall Study|Other|1|||
37859458|NCT01168401|69542790|FG008|Overall Study|Lost to Follow-up|0|||
37762658|NCT01458535|69274619|FG000|Overall Study|Withdrawal by Subject|0|||
37762659|NCT01458535|69274620|FG001|Overall Study|Withdrawal by Subject|0|||
37762660|NCT01458535|69274621|FG002|Overall Study|Withdrawal by Subject|2|||
37762661|NCT01458535|69274622|FG003|Overall Study|Withdrawal by Subject|0|||
37762662|NCT01458535|69274623|FG004|Overall Study|Withdrawal by Subject|1|||
37762663|NCT01458535|69274624|FG005|Overall Study|Withdrawal by Subject|1|||
37762664|NCT01458535|69274619|FG000|Overall Study|Lost to Follow-up|0|||
37762665|NCT01458535|69274620|FG001|Overall Study|Lost to Follow-up|2|||
37762666|NCT01458535|69274621|FG002|Overall Study|Lost to Follow-up|0|||
37762667|NCT01458535|69274622|FG003|Overall Study|Lost to Follow-up|3|||
37762668|NCT01458535|69274623|FG004|Overall Study|Lost to Follow-up|2|||
37762669|NCT01458535|69274624|FG005|Overall Study|Lost to Follow-up|2|||
37762670|NCT01458535|69274619|FG000|Overall Study|Adverse Event|0|||
37762671|NCT01458535|69274620|FG001|Overall Study|Adverse Event|0|||
37762672|NCT01458535|69274621|FG002|Overall Study|Adverse Event|0|||
37762673|NCT01458535|69274622|FG003|Overall Study|Adverse Event|1|||
37762674|NCT01458535|69274623|FG004|Overall Study|Adverse Event|0|||
37762675|NCT01458535|69274624|FG005|Overall Study|Adverse Event|0|||
37762676|NCT01464827|69274652|FG000|Overall Study|Adverse Event|0|||
37933301|NCT00795821|69620136|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
37933302|NCT00795821|69620137|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
37933303|NCT00795821|69620136|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
37933304|NCT00795821|69620137|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
37933305|NCT00795821|69620136|FG000|Acute Treatment Phase|Physician Decision|1|||
37933306|NCT00795821|69620137|FG001|Acute Treatment Phase|Physician Decision|1|||
37933307|NCT00795821|69620136|FG000|Acute Treatment Phase|Protocol Violation|1|||
37933308|NCT00795821|69620137|FG001|Acute Treatment Phase|Protocol Violation|2|||
37933309|NCT00795821|69620136|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
37933310|NCT00795821|69620137|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
37933311|NCT00795821|69620136|FG000|Long-term Extension Phase|Adverse Event|25|||
37933312|NCT00795821|69620137|FG001|Long-term Extension Phase|Adverse Event|32|||
37933313|NCT00795821|69620136|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
37933314|NCT00795821|69620137|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
37933315|NCT00795821|69620136|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
37933316|NCT00795821|69620137|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
37933317|NCT00795821|69620136|FG000|Long-term Extension Phase|Physician Decision|1|||
37933318|NCT00795821|69620137|FG001|Long-term Extension Phase|Physician Decision|2|||
37933319|NCT00795821|69620136|FG000|Long-term Extension Phase|Protocol Violation|3|||
37933320|NCT00795821|69620137|FG001|Long-term Extension Phase|Protocol Violation|5|||
37933321|NCT00795821|69620136|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
37933322|NCT00795821|69620137|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
37933323|NCT00795821|69620136|FG000|Taper Phase|Adverse Event|2|||
37933324|NCT00795821|69620137|FG001|Taper Phase|Adverse Event|0|||
37933325|NCT00795821|69620136|FG000|Taper Phase|Lost to Follow-up|1|||
37933326|NCT00795821|69620137|FG001|Taper Phase|Lost to Follow-up|0|||
37933327|NCT00795821|69620136|FG000|Taper Phase|Physician Decision|2|||
37933328|NCT00795821|69620137|FG001|Taper Phase|Physician Decision|0|||
37933329|NCT00795821|69620136|FG000|Taper Phase|Withdrawal by Subject|4|||
37933330|NCT00795821|69620137|FG001|Taper Phase|Withdrawal by Subject|0|||
37933331|NCT00578643|69620153|FG000|Overall Study|Death|1|||
37933332|NCT00578643|69620153|FG000|Overall Study|Lost to Follow-up|1|||
37933333|NCT00578565|69620157|FG000|Overall Study|Adverse Event|3|||
37933334|NCT00741260|69620169|FG000|Overall Study|Disease Progression|3|||
37933335|NCT00741260|69620170|FG001|Overall Study|Disease Progression|5|||
37933336|NCT00741260|69620171|FG002|Overall Study|Disease Progression|3|||
37933337|NCT00741260|69620172|FG003|Overall Study|Disease Progression|3|||
37933338|NCT00741260|69620173|FG004|Overall Study|Disease Progression|5|||
37933339|NCT00741260|69620174|FG005|Overall Study|Disease Progression|37|||
37933340|NCT00741260|69620175|FG006|Overall Study|Disease Progression|4|||
37933341|NCT00741260|69620169|FG000|Overall Study|Death|0|||
37933342|NCT00741260|69620170|FG001|Overall Study|Death|1|||
37933343|NCT00741260|69620171|FG002|Overall Study|Death|0|||
37933344|NCT00741260|69620172|FG003|Overall Study|Death|1|||
37933345|NCT00741260|69620173|FG004|Overall Study|Death|2|||
37933346|NCT00741260|69620174|FG005|Overall Study|Death|2|||
37933347|NCT00741260|69620175|FG006|Overall Study|Death|1|||
37762677|NCT01464827|69274653|FG001|Overall Study|Adverse Event|0|||
37762678|NCT01464827|69274654|FG002|Overall Study|Adverse Event|0|||
37859459|NCT01168401|69542791|FG009|Overall Study|Lost to Follow-up|0|||
37762679|NCT01464827|69274655|FG003|Overall Study|Adverse Event|0|||
37859460|NCT01168401|69542792|FG010|Overall Study|Lost to Follow-up|0|||
37859461|NCT01168401|69542782|FG000|Overall Study|Withdrawal by Subject|0|||
37859462|NCT01168401|69542783|FG001|Overall Study|Withdrawal by Subject|0|||
37859463|NCT01168401|69542784|FG002|Overall Study|Withdrawal by Subject|0|||
37859464|NCT01168401|69542785|FG003|Overall Study|Withdrawal by Subject|1|||
37859465|NCT01168401|69542786|FG004|Overall Study|Withdrawal by Subject|0|||
37859466|NCT01168401|69542787|FG005|Overall Study|Withdrawal by Subject|0|||
37859467|NCT01168401|69542788|FG006|Overall Study|Withdrawal by Subject|0|||
37933348|NCT00741260|69620169|FG000|Overall Study|Withdrawal by Subject|0|||
37933349|NCT00741260|69620170|FG001|Overall Study|Withdrawal by Subject|0|||
37933350|NCT00741260|69620171|FG002|Overall Study|Withdrawal by Subject|0|||
37933351|NCT00741260|69620172|FG003|Overall Study|Withdrawal by Subject|0|||
37933352|NCT00741260|69620173|FG004|Overall Study|Withdrawal by Subject|1|||
37933353|NCT00741260|69620174|FG005|Overall Study|Withdrawal by Subject|3|||
37933354|NCT00741260|69620175|FG006|Overall Study|Withdrawal by Subject|1|||
37933355|NCT00741260|69620169|FG000|Overall Study|Physician Decision|1|||
37933356|NCT00741260|69620170|FG001|Overall Study|Physician Decision|1|||
37933357|NCT00741260|69620171|FG002|Overall Study|Physician Decision|0|||
37933358|NCT00741260|69620172|FG003|Overall Study|Physician Decision|0|||
37933359|NCT00741260|69620173|FG004|Overall Study|Physician Decision|0|||
37933360|NCT00741260|69620174|FG005|Overall Study|Physician Decision|0|||
37933361|NCT00741260|69620175|FG006|Overall Study|Physician Decision|0|||
37933362|NCT00741260|69620169|FG000|Overall Study|Other|2|||
37933363|NCT00741260|69620170|FG001|Overall Study|Other|1|||
37933364|NCT00741260|69620171|FG002|Overall Study|Other|1|||
37933365|NCT00741260|69620172|FG003|Overall Study|Other|2|||
37933366|NCT00741260|69620173|FG004|Overall Study|Other|1|||
37933367|NCT00741260|69620174|FG005|Overall Study|Other|3|||
37933368|NCT00741260|69620175|FG006|Overall Study|Other|1|||
37933369|NCT00740870|69620196|FG000|Overall Study|Not Catheterized|4|||
37933370|NCT00740870|69620196|FG000|Overall Study|Further testing contraindicated implant|17|||
37933371|NCT00740792|69620207|FG000|Overall Study|Adverse Event|3|||
37933372|NCT00740792|69620208|FG001|Overall Study|Adverse Event|1|||
37933373|NCT00740792|69620209|FG002|Overall Study|Adverse Event|1|||
37933374|NCT00740792|69620210|FG003|Overall Study|Adverse Event|3|||
37669909|NCT02550873|69143068|FG000|Randomized Double Blind|Adverse Event|3|||
37669910|NCT02550873|69143069|FG001|Randomized Double Blind|Adverse Event|1|||
37669911|NCT02550873|69143070|FG002|Randomized Double Blind|Adverse Event|0|||
37762680|NCT01464827|69274656|FG004|Overall Study|Adverse Event|0|||
37762681|NCT01464827|69274657|FG005|Overall Study|Adverse Event|0|||
37762682|NCT01464827|69274658|FG006|Overall Study|Adverse Event|0|||
37762683|NCT01464827|69274659|FG007|Overall Study|Adverse Event|0|||
37933375|NCT00740792|69620207|FG000|Overall Study|Lack of Efficacy|1|||
37933376|NCT00740792|69620208|FG001|Overall Study|Lack of Efficacy|1|||
37933377|NCT00740792|69620209|FG002|Overall Study|Lack of Efficacy|0|||
37933378|NCT00740792|69620210|FG003|Overall Study|Lack of Efficacy|3|||
37933379|NCT00740792|69620207|FG000|Overall Study|Lost to Follow-up|2|||
37933380|NCT00740792|69620208|FG001|Overall Study|Lost to Follow-up|1|||
37933381|NCT00740792|69620209|FG002|Overall Study|Lost to Follow-up|0|||
37933382|NCT00740792|69620210|FG003|Overall Study|Lost to Follow-up|0|||
37933383|NCT00740792|69620207|FG000|Overall Study|Protocol Violation|0|||
37933384|NCT00740792|69620208|FG001|Overall Study|Protocol Violation|1|||
37933385|NCT00740792|69620209|FG002|Overall Study|Protocol Violation|0|||
37933386|NCT00740792|69620210|FG003|Overall Study|Protocol Violation|2|||
37669912|NCT02550873|69143068|FG000|Randomized Double Blind|Disease progression|1|||
37669913|NCT02550873|69143069|FG001|Randomized Double Blind|Disease progression|1|||
37669914|NCT02550873|69143070|FG002|Randomized Double Blind|Disease progression|0|||
37933387|NCT00740792|69620207|FG000|Overall Study|Withdrawal by Subject|1|||
37933388|NCT00740792|69620208|FG001|Overall Study|Withdrawal by Subject|1|||
37933389|NCT00740792|69620209|FG002|Overall Study|Withdrawal by Subject|0|||
37933390|NCT00740792|69620210|FG003|Overall Study|Withdrawal by Subject|0|||
37933391|NCT00740792|69620207|FG000|Overall Study|administrative|3|||
37933392|NCT00740792|69620208|FG001|Overall Study|administrative|3|||
37933393|NCT00740792|69620209|FG002|Overall Study|administrative|8|||
37933394|NCT00740792|69620210|FG003|Overall Study|administrative|2|||
37669915|NCT02550873|69143068|FG000|Open Label Extension|Study ongoing|0|||
37669916|NCT02550873|69143069|FG001|Open Label Extension|Study ongoing|0|||
37669917|NCT02550873|69143070|FG002|Open Label Extension|Study ongoing|111|||
37669918|NCT02535741|69143092|FG000|Overall Study|Adverse Event|3|||
37669919|NCT02535741|69143092|FG000|Overall Study|Withdrawal by Subject|9|||
37669920|NCT02535741|69143092|FG000|Overall Study|Lost to Follow-up|10|||
37669921|NCT02535741|69143092|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
37669922|NCT02535741|69143092|FG000|Overall Study|Missing data|6|||
37669923|NCT02550795|69143113|FG000|Overall Study|Physician Decision|0|||
37669924|NCT02550795|69143114|FG001|Overall Study|Physician Decision|1|||
37669925|NCT02550795|69143115|FG002|Overall Study|Physician Decision|0|||
37669926|NCT02541903|69143123|FG000|Overall Study|Death|1|||
37669927|NCT02541669|69143132|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
37933395|NCT00740714|69620223|FG000|Overall Study|Withdrawal by Subject|17|||
37933396|NCT00740714|69620224|FG001|Overall Study|Withdrawal by Subject|19|||
38034990|NCT04230213|69721864|FG000|TP2: Week 10 to Week 16|Other|0|||
37669928|NCT02541669|69143133|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
37669929|NCT02541669|69143134|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
37933397|NCT00740714|69620225|FG002|Overall Study|Withdrawal by Subject|29|||
37933398|NCT00788957|69620237|FG000|Part 1|Death|8|||
37762684|NCT01464827|69274660|FG008|Overall Study|Adverse Event|0|||
37933399|NCT00788957|69620238|FG001|Part 1|Death|0|||
37762685|NCT01464827|69274661|FG009|Overall Study|Adverse Event|0|||
37762686|NCT01464827|69274662|FG010|Overall Study|Adverse Event|0|||
37762687|NCT01464827|69274663|FG011|Overall Study|Adverse Event|0|||
37762688|NCT01464827|69274664|FG012|Overall Study|Adverse Event|1|||
37762689|NCT01464827|69274665|FG013|Overall Study|Adverse Event|0|||
37762690|NCT01464827|69274652|FG000|Overall Study|Withdrawal by Subject|1|||
37762691|NCT01464827|69274653|FG001|Overall Study|Withdrawal by Subject|0|||
37762692|NCT01464827|69274654|FG002|Overall Study|Withdrawal by Subject|0|||
37762693|NCT01464827|69274655|FG003|Overall Study|Withdrawal by Subject|0|||
37762694|NCT01464827|69274656|FG004|Overall Study|Withdrawal by Subject|1|||
37762695|NCT01464827|69274657|FG005|Overall Study|Withdrawal by Subject|0|||
37762696|NCT01464827|69274658|FG006|Overall Study|Withdrawal by Subject|0|||
37762697|NCT01464827|69274659|FG007|Overall Study|Withdrawal by Subject|1|||
37933400|NCT00788957|69620239|FG002|Part 1|Death|0|||
37933401|NCT00788957|69620240|FG003|Part 1|Death|0|||
37933402|NCT00788957|69620241|FG004|Part 1|Death|0|||
37933403|NCT00788957|69620242|FG005|Part 1|Death|0|||
37933404|NCT00788957|69620237|FG000|Part 1|Lost to Follow-up|1|||
37933405|NCT00788957|69620238|FG001|Part 1|Lost to Follow-up|0|||
37933406|NCT00788957|69620239|FG002|Part 1|Lost to Follow-up|0|||
37933407|NCT00788957|69620240|FG003|Part 1|Lost to Follow-up|0|||
37933408|NCT00788957|69620241|FG004|Part 1|Lost to Follow-up|0|||
37933409|NCT00788957|69620242|FG005|Part 1|Lost to Follow-up|0|||
37933410|NCT00788957|69620237|FG000|Part 2|Withdrawal by Subject|0|||
37933411|NCT00788957|69620238|FG001|Part 2|Withdrawal by Subject|9|||
37933412|NCT00788957|69620239|FG002|Part 2|Withdrawal by Subject|5|||
37933413|NCT00788957|69620240|FG003|Part 2|Withdrawal by Subject|3|||
37933414|NCT00788957|69620241|FG004|Part 2|Withdrawal by Subject|0|||
37933415|NCT00788957|69620242|FG005|Part 2|Withdrawal by Subject|0|||
37933416|NCT00788957|69620237|FG000|Part 2|Death|0|||
37933417|NCT00788957|69620238|FG001|Part 2|Death|32|||
37933418|NCT00788957|69620239|FG002|Part 2|Death|35|||
37933419|NCT00788957|69620240|FG003|Part 2|Death|37|||
37933420|NCT00788957|69620241|FG004|Part 2|Death|0|||
37933421|NCT00788957|69620242|FG005|Part 2|Death|0|||
37933422|NCT00788957|69620237|FG000|Part 2|Lost to Follow-up|0|||
37933423|NCT00788957|69620238|FG001|Part 2|Lost to Follow-up|0|||
37933424|NCT00788957|69620239|FG002|Part 2|Lost to Follow-up|3|||
37933425|NCT00788957|69620240|FG003|Part 2|Lost to Follow-up|0|||
37933426|NCT00788957|69620241|FG004|Part 2|Lost to Follow-up|0|||
37933427|NCT00788957|69620242|FG005|Part 2|Lost to Follow-up|0|||
37933428|NCT00788957|69620237|FG000|Part 2|On-study at time of data cut-off|0|||
37933429|NCT00788957|69620238|FG001|Part 2|On-study at time of data cut-off|1|||
37933430|NCT00788957|69620239|FG002|Part 2|On-study at time of data cut-off|1|||
37933431|NCT00788957|69620240|FG003|Part 2|On-study at time of data cut-off|1|||
37933432|NCT00788957|69620241|FG004|Part 2|On-study at time of data cut-off|0|||
37933433|NCT00788957|69620242|FG005|Part 2|On-study at time of data cut-off|0|||
37933434|NCT00788957|69620237|FG000|Part 3|Withdrawal by Subject|0|||
37933435|NCT00788957|69620238|FG001|Part 3|Withdrawal by Subject|0|||
37933436|NCT00788957|69620239|FG002|Part 3|Withdrawal by Subject|0|||
37933437|NCT00788957|69620240|FG003|Part 3|Withdrawal by Subject|0|||
37933438|NCT00788957|69620241|FG004|Part 3|Withdrawal by Subject|0|||
37933439|NCT00788957|69620242|FG005|Part 3|Withdrawal by Subject|2|||
37933440|NCT00788957|69620237|FG000|Part 3|Death|0|||
37933441|NCT00788957|69620238|FG001|Part 3|Death|0|||
37933442|NCT00788957|69620239|FG002|Part 3|Death|0|||
38034991|NCT04230213|69721865|FG001|TP2: Week 10 to Week 16|Other|2|||
38034992|NCT04230213|69721866|FG002|TP2: Week 10 to Week 16|Other|1|||
38034993|NCT04230213|69721864|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
37762698|NCT01464827|69274660|FG008|Overall Study|Withdrawal by Subject|0|||
37933443|NCT00788957|69620240|FG003|Part 3|Death|0|||
37933444|NCT00788957|69620241|FG004|Part 3|Death|8|||
37933445|NCT00788957|69620242|FG005|Part 3|Death|9|||
37933446|NCT00788957|69620237|FG000|Part 3|On-study at time of data cut-off|0|||
37933447|NCT00788957|69620238|FG001|Part 3|On-study at time of data cut-off|0|||
37933448|NCT00788957|69620239|FG002|Part 3|On-study at time of data cut-off|0|||
38034994|NCT04230213|69721865|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
38034995|NCT04230213|69721866|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
38034996|NCT04230213|69721864|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
37762699|NCT01464827|69274661|FG009|Overall Study|Withdrawal by Subject|0|||
37762700|NCT01464827|69274662|FG010|Overall Study|Withdrawal by Subject|0|||
37933449|NCT00788957|69620240|FG003|Part 3|On-study at time of data cut-off|0|||
37933450|NCT00788957|69620241|FG004|Part 3|On-study at time of data cut-off|1|||
37933451|NCT00788957|69620242|FG005|Part 3|On-study at time of data cut-off|0|||
37933452|NCT00740636|69620261|FG000|Overall Study|Adverse Event|0|||
37933453|NCT00740636|69620262|FG001|Overall Study|Adverse Event|2|||
37933454|NCT00740636|69620261|FG000|Overall Study|Patient Ineligible|0|||
37933455|NCT00740636|69620262|FG001|Overall Study|Patient Ineligible|1|||
37933456|NCT00740636|69620261|FG000|Overall Study|Patient Not Treated|0|||
37933457|NCT00740636|69620262|FG001|Overall Study|Patient Not Treated|1|||
37933458|NCT00740636|69620261|FG000|Overall Study|Progressive Disease|1|||
37933459|NCT00740636|69620262|FG001|Overall Study|Progressive Disease|0|||
37762701|NCT01464827|69274663|FG011|Overall Study|Withdrawal by Subject|0|||
37762702|NCT01464827|69274664|FG012|Overall Study|Withdrawal by Subject|0|||
37762703|NCT01464827|69274665|FG013|Overall Study|Withdrawal by Subject|0|||
37762704|NCT01464827|69274652|FG000|Overall Study|Lost to Follow-up|0|||
37762705|NCT01464827|69274653|FG001|Overall Study|Lost to Follow-up|2|||
37762706|NCT01464827|69274654|FG002|Overall Study|Lost to Follow-up|0|||
37762707|NCT01464827|69274655|FG003|Overall Study|Lost to Follow-up|2|||
37762708|NCT01464827|69274656|FG004|Overall Study|Lost to Follow-up|3|||
37762709|NCT01464827|69274657|FG005|Overall Study|Lost to Follow-up|1|||
37933460|NCT00740636|69620261|FG000|Overall Study|Death|1|||
37933461|NCT00740636|69620262|FG001|Overall Study|Death|0|||
37933462|NCT00735254|69620272|FG000|Overall Study|Protocol Violation|1|||
37933463|NCT00735254|69620273|FG001|Overall Study|Protocol Violation|1|||
37933464|NCT00735254|69620274|FG002|Overall Study|Protocol Violation|1|||
37933465|NCT00735254|69620275|FG003|Overall Study|Protocol Violation|0|||
37933466|NCT00795509|69620285|FG000|Overall Study|Protocol Violation|31|||
37933467|NCT00787787|69620289|FG000|Overall Study|Lack of Efficacy|4|||
37933468|NCT00787787|69620289|FG000|Overall Study|Adverse Event|3|||
37933469|NCT00787319|69620293|FG000|Overall Study|Lost to Follow-up|2|||
37933470|NCT00787319|69620293|FG000|Overall Study|Withdrawal by Subject|15|||
37933471|NCT00787319|69620293|FG000|Overall Study|Adverse Event|3|||
37933472|NCT00787319|69620293|FG000|Overall Study|Objective progression or relapse|30|||
37933473|NCT00787319|69620293|FG000|Overall Study|Lack of Efficacy|1|||
37933474|NCT00787319|69620293|FG000|Overall Study|Budget exhausted/exceeded|1|||
37933475|NCT00787319|69620293|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
37933476|NCT00787319|69620293|FG000|Overall Study|No health insurance reimbursement|2|||
37933477|NCT00787319|69620293|FG000|Overall Study|Stabilized disease findings|3|||
37933478|NCT00787319|69620293|FG000|Overall Study|Inactive disease|5|||
37933479|NCT00794963|69620299|FG000|Overall Study|Withdrawal by Subject|1|||
37933480|NCT00794963|69620300|FG001|Overall Study|Withdrawal by Subject|4|||
37933481|NCT00794573|69620308|FG000|Overall Study|Death|3|||
37933482|NCT00794573|69620309|FG001|Overall Study|Death|0|||
37933483|NCT00794573|69620308|FG000|Overall Study|Withdrawal by Subject|9|||
37933484|NCT00794573|69620309|FG001|Overall Study|Withdrawal by Subject|12|||
37933485|NCT00794573|69620308|FG000|Overall Study|Lost to Follow-up|26|||
37933486|NCT00794573|69620309|FG001|Overall Study|Lost to Follow-up|33|||
37933487|NCT00584844|69620315|FG000|Overall Study|Withdrawal by Subject|59|||
37933488|NCT00584844|69620315|FG000|Overall Study|Screen Failure|20|||
37933489|NCT00739934|69620323|FG000|Voriconazole IV|Adverse Event|6|||
37933490|NCT00739934|69620323|FG000|Voriconazole Oral|Other|3|||
37933491|NCT00739310|69620332|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
37933492|NCT00739310|69620332|FG000|Overall Study|Withdrawal by Subject|1|||
37933493|NCT00739310|69620332|FG000|Overall Study|Lost to Follow-up|2|||
37933494|NCT00734630|69620339|FG000|Overall Study|Lack of Efficacy|4|||
37933495|NCT00734630|69620340|FG001|Overall Study|Lack of Efficacy|4|||
37933496|NCT00734630|69620339|FG000|Overall Study|Withdrawal by Subject|7|||
37933497|NCT00734630|69620340|FG001|Overall Study|Withdrawal by Subject|9|||
37933498|NCT00734630|69620339|FG000|Overall Study|Lost to Follow-up|13|||
37933499|NCT00734630|69620340|FG001|Overall Study|Lost to Follow-up|7|||
37933500|NCT00734630|69620339|FG000|Overall Study|Protocol Violation|0|||
37933501|NCT00734630|69620340|FG001|Overall Study|Protocol Violation|3|||
37933502|NCT00734630|69620339|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
37933503|NCT00734630|69620340|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
37933504|NCT00734630|69620339|FG000|Overall Study|Adverse Event|3|||
37933505|NCT00734630|69620340|FG001|Overall Study|Adverse Event|6|||
37933506|NCT00734630|69620339|FG000|Overall Study|Randomized in Error|0|||
37933507|NCT00734630|69620340|FG001|Overall Study|Randomized in Error|1|||
37669930|NCT02541669|69143135|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
37669931|NCT02541669|69143136|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
37669932|NCT02549859|69143147|FG000|Long-term 60 Hz DBS|Study Closed|1|||
37669933|NCT02688647|69143157|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
37669934|NCT02688647|69143158|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
37669935|NCT02688647|69143157|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
37669936|NCT02688647|69143158|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
37669937|NCT02688647|69143157|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
37677546|NCT02593097|69152519|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
37677547|NCT02593097|69152520|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
37933508|NCT00734630|69620339|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
37677548|NCT02593097|69152519|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
37677549|NCT02593097|69152520|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
37677550|NCT02593097|69152519|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
37677551|NCT02593097|69152520|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
37677552|NCT02593097|69152519|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
37677553|NCT02593097|69152520|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
37669938|NCT02688647|69143158|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
37669939|NCT02688647|69143157|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
37669940|NCT02688647|69143158|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
37933509|NCT00734630|69620340|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
37933510|NCT00734630|69620339|FG000|Overall Study|Poor Compliance|1|||
37933511|NCT00734630|69620340|FG001|Overall Study|Poor Compliance|1|||
37933512|NCT00584454|69620346|FG000|Overall Study|Adverse Event|1|||
37933513|NCT00584454|69620346|FG000|Overall Study|Relocation|1|||
37933514|NCT00584454|69620346|FG000|Overall Study|Clinical Hold|2|||
37933515|NCT00578175|69620353|FG000|Overall Study|Adverse Event|0|||
37933516|NCT00578175|69620354|FG001|Overall Study|Adverse Event|1|||
37933517|NCT00578175|69620355|FG002|Overall Study|Adverse Event|1|||
37933518|NCT00578175|69620353|FG000|Overall Study|Other reasons|70|||
37933519|NCT00578175|69620354|FG001|Overall Study|Other reasons|42|||
37933520|NCT00578175|69620355|FG002|Overall Study|Other reasons|23|||
37933521|NCT00435409|69620367|FG000|Overall Study|Protocol Violation|1|||
37933522|NCT00435409|69620368|FG001|Overall Study|Protocol Violation|2|||
37933523|NCT00435409|69620369|FG002|Overall Study|Protocol Violation|0|||
37933524|NCT00435409|69620367|FG000|Overall Study|Lost to Follow-up|1|||
37933525|NCT00435409|69620368|FG001|Overall Study|Lost to Follow-up|2|||
37933526|NCT00435409|69620369|FG002|Overall Study|Lost to Follow-up|0|||
37933527|NCT00435409|69620367|FG000|Overall Study|Death|8|||
37669941|NCT02688647|69143157|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
37669942|NCT02688647|69143158|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
37669943|NCT02688647|69143157|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
37669944|NCT02688647|69143158|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
37669945|NCT02688647|69143157|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
37677554|NCT01657461|69152528|FG000|Overall Study|Death|9|||
37677555|NCT01657461|69152529|FG001|Overall Study|Death|12|||
37677556|NCT01657461|69152528|FG000|Overall Study|Lost to Follow-up|0|||
37677557|NCT01657461|69152529|FG001|Overall Study|Lost to Follow-up|3|||
37677558|NCT01657461|69152528|FG000|Overall Study|Physician Decision|0|||
37677559|NCT01657461|69152529|FG001|Overall Study|Physician Decision|2|||
37677560|NCT01657461|69152528|FG000|Overall Study|Withdrawal by Subject|1|||
37677561|NCT01657461|69152529|FG001|Overall Study|Withdrawal by Subject|3|||
37677562|NCT02592551|69152538|FG000|Overall Study|Not evaluable|1|||
37677563|NCT02592551|69152539|FG001|Overall Study|Not evaluable|3|||
37677564|NCT02592551|69152540|FG002|Overall Study|Not evaluable|0|||
37677565|NCT02595749|69152551|FG000|Overall Study|Withdrawal by Subject|12|||
37677566|NCT02595749|69152552|FG001|Overall Study|Withdrawal by Subject|7|||
37677567|NCT01657305|69152558|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
37677568|NCT01657305|69152558|FG000|Overall Study|Withdrawal by Subject|4|||
37677569|NCT01657305|69152558|FG000|Overall Study|Adverse Event|1|||
37677570|NCT01657305|69152558|FG000|Overall Study|Lost to Follow-up|1|||
37677571|NCT01657305|69152558|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
37677572|NCT02634307|69152601|FG000|Overall Study|Adverse Event|50|||
37677573|NCT02634307|69152602|FG001|Overall Study|Adverse Event|24|||
37677574|NCT02634307|69152603|FG002|Overall Study|Adverse Event|14|||
37677575|NCT02634307|69152601|FG000|Overall Study|Lost to Follow-up|21|||
37677576|NCT02634307|69152602|FG001|Overall Study|Lost to Follow-up|5|||
37677577|NCT02634307|69152603|FG002|Overall Study|Lost to Follow-up|6|||
37677578|NCT02634307|69152601|FG000|Overall Study|Pregnancy|5|||
37677579|NCT02634307|69152602|FG001|Overall Study|Pregnancy|1|||
37677580|NCT02634307|69152603|FG002|Overall Study|Pregnancy|3|||
37677581|NCT02634307|69152601|FG000|Overall Study|Withdrawal by Subject|38|||
37677582|NCT02634307|69152602|FG001|Overall Study|Withdrawal by Subject|24|||
37677583|NCT02634307|69152603|FG002|Overall Study|Withdrawal by Subject|18|||
37677584|NCT02634307|69152601|FG000|Overall Study|Non-Compliance with Study Drug|0|||
37677585|NCT02634307|69152602|FG001|Overall Study|Non-Compliance with Study Drug|2|||
37677586|NCT02634307|69152603|FG002|Overall Study|Non-Compliance with Study Drug|2|||
37677587|NCT02634307|69152601|FG000|Overall Study|Lack of Efficacy|1|||
37677588|NCT02634307|69152602|FG001|Overall Study|Lack of Efficacy|5|||
37677589|NCT02634307|69152603|FG002|Overall Study|Lack of Efficacy|3|||
37677590|NCT02634307|69152601|FG000|Overall Study|Physician Decision|7|||
37677591|NCT02634307|69152602|FG001|Overall Study|Physician Decision|5|||
37677592|NCT02634307|69152603|FG002|Overall Study|Physician Decision|5|||
37677593|NCT02634307|69152601|FG000|Overall Study|Reason not Specified|3|||
37677594|NCT02634307|69152602|FG001|Overall Study|Reason not Specified|5|||
37677595|NCT02634307|69152603|FG002|Overall Study|Reason not Specified|10|||
37677596|NCT01365273|69152613|FG000|Overall Study|Lost to Follow-up|1|||
37677597|NCT01365273|69152614|FG001|Overall Study|Lost to Follow-up|0|||
37677598|NCT01365273|69152613|FG000|Overall Study|Protocol Violation|0|||
37677599|NCT01365273|69152614|FG001|Overall Study|Protocol Violation|1|||
37677600|NCT01365273|69152613|FG000|Overall Study|Physician Decision|1|||
37677601|NCT01365273|69152614|FG001|Overall Study|Physician Decision|0|||
37677602|NCT02595437|69152620|FG000|Triferic Via IV|Withdrawal by Subject|1|||
37762710|NCT01464827|69274658|FG006|Overall Study|Lost to Follow-up|2|||
37762711|NCT01464827|69274659|FG007|Overall Study|Lost to Follow-up|2|||
37762712|NCT01464827|69274660|FG008|Overall Study|Lost to Follow-up|0|||
37762713|NCT01464827|69274661|FG009|Overall Study|Lost to Follow-up|0|||
37762714|NCT01464827|69274662|FG010|Overall Study|Lost to Follow-up|0|||
37762715|NCT01464827|69274663|FG011|Overall Study|Lost to Follow-up|1|||
37762716|NCT01464827|69274664|FG012|Overall Study|Lost to Follow-up|0|||
37762717|NCT01464827|69274665|FG013|Overall Study|Lost to Follow-up|1|||
37762718|NCT01464827|69274652|FG000|Overall Study|Other|2|||
37762719|NCT01464827|69274653|FG001|Overall Study|Other|3|||
37762720|NCT01464827|69274654|FG002|Overall Study|Other|0|||
37762721|NCT01464827|69274655|FG003|Overall Study|Other|2|||
37762722|NCT01464827|69274656|FG004|Overall Study|Other|3|||
37762723|NCT01464827|69274657|FG005|Overall Study|Other|0|||
37762724|NCT01464827|69274658|FG006|Overall Study|Other|1|||
37762725|NCT01464827|69274659|FG007|Overall Study|Other|0|||
37762726|NCT01464827|69274660|FG008|Overall Study|Other|3|||
37762727|NCT01464827|69274661|FG009|Overall Study|Other|1|||
37762728|NCT01464827|69274662|FG010|Overall Study|Other|2|||
37762729|NCT01464827|69274663|FG011|Overall Study|Other|0|||
37762730|NCT01464827|69274664|FG012|Overall Study|Other|1|||
37762731|NCT01464827|69274665|FG013|Overall Study|Other|0|||
37762732|NCT01464827|69274652|FG000|Overall Study|Not Treated|0|||
37762733|NCT01464827|69274653|FG001|Overall Study|Not Treated|2|||
37762734|NCT01464827|69274654|FG002|Overall Study|Not Treated|0|||
37762735|NCT01464827|69274655|FG003|Overall Study|Not Treated|0|||
37762736|NCT01464827|69274656|FG004|Overall Study|Not Treated|1|||
37762737|NCT01464827|69274657|FG005|Overall Study|Not Treated|0|||
37762738|NCT01464827|69274658|FG006|Overall Study|Not Treated|1|||
37762739|NCT01464827|69274659|FG007|Overall Study|Not Treated|0|||
37762740|NCT01464827|69274660|FG008|Overall Study|Not Treated|0|||
37762741|NCT01464827|69274661|FG009|Overall Study|Not Treated|2|||
37762742|NCT01464827|69274662|FG010|Overall Study|Not Treated|0|||
37762743|NCT01464827|69274663|FG011|Overall Study|Not Treated|1|||
37762744|NCT01464827|69274664|FG012|Overall Study|Not Treated|0|||
37762745|NCT01464827|69274665|FG013|Overall Study|Not Treated|2|||
37762746|NCT01463111|69274706|FG000|Overall Study|Withdrawal by Subject|2|||
37762747|NCT01463111|69274706|FG000|Overall Study|Lost to Follow-up|5|||
37762748|NCT01463111|69274706|FG000|Overall Study|Physician Decision|2|||
37762749|NCT01463033|69274712|FG000|Overall Study|Lost to Follow-up|4|||
37762750|NCT01463033|69274713|FG001|Overall Study|Lost to Follow-up|4|||
37762751|NCT01463033|69274712|FG000|Overall Study|Death|3|||
37762752|NCT01463033|69274713|FG001|Overall Study|Death|2|||
37762753|NCT01461707|69274722|FG000|Overall Study|Withdrawal by Subject|1|||
37762754|NCT01461707|69274723|FG001|Overall Study|Withdrawal by Subject|0|||
37762755|NCT01461551|69274732|FG000|Overall Study|Physician Decision|2|||
37762756|NCT01461551|69274733|FG001|Overall Study|Physician Decision|1|||
37762757|NCT01461551|69274734|FG002|Overall Study|Physician Decision|2|||
37762758|NCT01461005|69274742|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
37762759|NCT01460381|69274749|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
37762760|NCT01460381|69274750|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
37762761|NCT01473589|69274834|FG000|Overall Study|Adverse Event|1|||
37762762|NCT01473589|69274835|FG001|Overall Study|Adverse Event|1|||
37762763|NCT01473589|69274834|FG000|Overall Study|Death|2|||
37762764|NCT01473589|69274835|FG001|Overall Study|Death|0|||
37762765|NCT01473589|69274834|FG000|Overall Study|Lost to Follow-up|2|||
37933528|NCT00435409|69620368|FG001|Overall Study|Death|6|||
37933529|NCT00435409|69620369|FG002|Overall Study|Death|6|||
37933530|NCT00435409|69620367|FG000|Overall Study|Objective progression or relapse|158|||
37933531|NCT00435409|69620368|FG001|Overall Study|Objective progression or relapse|93|||
37933532|NCT00435409|69620369|FG002|Overall Study|Objective progression or relapse|58|||
37933533|NCT00435409|69620367|FG000|Overall Study|Global deterioration of health status|0|||
37933534|NCT00435409|69620368|FG001|Overall Study|Global deterioration of health status|0|||
37933535|NCT00435409|69620369|FG002|Overall Study|Global deterioration of health status|4|||
37933536|NCT00435409|69620367|FG000|Overall Study|Withdrawal by Subject|8|||
37933537|NCT00435409|69620368|FG001|Overall Study|Withdrawal by Subject|7|||
37762766|NCT01473589|69274835|FG001|Overall Study|Lost to Follow-up|2|||
37762767|NCT01473589|69274834|FG000|Overall Study|Protocol Violation|1|||
37762768|NCT01473589|69274835|FG001|Overall Study|Protocol Violation|0|||
37762769|NCT01473589|69274834|FG000|Overall Study|Withdrawal by Subject|5|||
37762770|NCT01473589|69274835|FG001|Overall Study|Withdrawal by Subject|11|||
37762771|NCT01473589|69274834|FG000|Overall Study|Physician Decision|0|||
37762772|NCT01473589|69274835|FG001|Overall Study|Physician Decision|1|||
37762773|NCT01473589|69274834|FG000|Overall Study|Entry criteria not met|0|||
37762774|NCT01473589|69274835|FG001|Overall Study|Entry criteria not met|1|||
37762775|NCT01500187|69274854|FG000|Overall Study|Lost to Follow-up|6|||
37762776|NCT01500187|69274855|FG001|Overall Study|Lost to Follow-up|0|||
37762777|NCT01500031|69274873|FG000|Overall Study|Death|1|||
37762778|NCT01500031|69274873|FG000|Overall Study|Withdrawal by Subject|4|||
37762779|NCT01473355|69274886|FG000|Overall Study|Protocol Violation|2|||
37762780|NCT01473355|69274886|FG000|Overall Study|Adverse Event|2|||
37762781|NCT01473355|69274886|FG000|Overall Study|Lost to Follow-up|2|||
37762782|NCT01472965|69274896|FG000|Overall Study|Withdrawal by Subject|1|||
37762783|NCT01472965|69274897|FG001|Overall Study|Withdrawal by Subject|0|||
37762784|NCT01457053|69274907|FG000|Overall Study|Unable to undergo selected treatment|1|||
37762785|NCT01457053|69274908|FG001|Overall Study|Unable to undergo selected treatment|1|||
37762786|NCT01472341|69274923|FG000|Overall Study|Started insulin therapy|55|||
37762787|NCT01472341|69274923|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
37762788|NCT01472341|69274923|FG000|Overall Study|Withdrawal by Subject|39|||
37762789|NCT01472341|69274923|FG000|Overall Study|Lost to Follow-up|52|||
37762790|NCT01472341|69274923|FG000|Overall Study|Laboratory parameters unavailable|25|||
37762791|NCT01472341|69274923|FG000|Overall Study|Death|9|||
37762792|NCT01472185|69274929|FG000|Overall Study|Randomized but Not Treated|0|||
37762793|NCT01472185|69274930|FG001|Overall Study|Randomized but Not Treated|1|||
37762794|NCT01472185|69274929|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
37762795|NCT01472185|69274930|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
37762796|NCT01472185|69274929|FG000|Overall Study|Hyperglycemia|5|||
37762797|NCT01472185|69274930|FG001|Overall Study|Hyperglycemia|2|||
37762798|NCT01472185|69274929|FG000|Overall Study|Investigator's Discretion|3|||
37762799|NCT01472185|69274930|FG001|Overall Study|Investigator's Discretion|1|||
37762800|NCT01472185|69274929|FG000|Overall Study|Lost to Follow-up|4|||
37762801|NCT01472185|69274930|FG001|Overall Study|Lost to Follow-up|1|||
37762802|NCT01472185|69274929|FG000|Overall Study|Protocol Violation|5|||
37762803|NCT01472185|69274930|FG001|Overall Study|Protocol Violation|1|||
37762804|NCT01472185|69274929|FG000|Overall Study|Subject Noncompliance|8|||
37762805|NCT01472185|69274930|FG001|Overall Study|Subject Noncompliance|15|||
38034997|NCT04230213|69721865|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
37933538|NCT00435409|69620369|FG002|Overall Study|Withdrawal by Subject|1|||
37933539|NCT00435409|69620367|FG000|Overall Study|Other|45|||
37933540|NCT00435409|69620368|FG001|Overall Study|Other|30|||
37933541|NCT00435409|69620369|FG002|Overall Study|Other|1|||
37933542|NCT00435409|69620367|FG000|Overall Study|Adverse Event|0|||
37933543|NCT00435409|69620368|FG001|Overall Study|Adverse Event|0|||
37933544|NCT00435409|69620369|FG002|Overall Study|Adverse Event|8|||
37669946|NCT02688647|69143158|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
37669947|NCT02687711|69143176|FG000|Overall Study|Adverse Event|89|||
37669948|NCT02687711|69143176|FG000|Overall Study|Lack of Efficacy|70|||
37669949|NCT02687711|69143176|FG000|Overall Study|Lost to Follow-up|20|||
37669950|NCT02687711|69143176|FG000|Overall Study|Consent withdrawn|15|||
37669951|NCT02687711|69143176|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
37669952|NCT02687711|69143176|FG000|Overall Study|Too expensive|4|||
37669953|NCT02687711|69143176|FG000|Overall Study|Participant moved abroad|1|||
37669954|NCT02687711|69143176|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
37669955|NCT02687711|69143176|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
37669956|NCT02687711|69143176|FG000|Overall Study|Disliked taste|1|||
37669957|NCT02687711|69143176|FG000|Overall Study|Low mood|1|||
37669958|NCT02687711|69143176|FG000|Overall Study|Side effects|1|||
37669959|NCT02687711|69143176|FG000|Overall Study|Change of Hospital|1|||
37669960|NCT02687711|69143176|FG000|Overall Study|Liver Encephalopathy|1|||
37669961|NCT02687711|69143176|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
37669962|NCT02687711|69143176|FG000|Overall Study|Withdrawn due to intake interruption|1|||
37669963|NCT02687711|69143176|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
37669964|NCT02687711|69143176|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
37669965|NCT02687711|69143176|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
37669966|NCT01662063|69143182|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
37669967|NCT01662063|69143183|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
37669968|NCT01662063|69143184|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
37669969|NCT01662063|69143182|FG000|Overall Study|Lack of Efficacy|1|||
37669970|NCT01662063|69143183|FG001|Overall Study|Lack of Efficacy|6|||
37669971|NCT01662063|69143184|FG002|Overall Study|Lack of Efficacy|0|||
37669972|NCT01662063|69143182|FG000|Overall Study|Lost to Follow-up|0|||
37669973|NCT01662063|69143183|FG001|Overall Study|Lost to Follow-up|4|||
37669974|NCT01662063|69143184|FG002|Overall Study|Lost to Follow-up|0|||
37669975|NCT01662063|69143182|FG000|Overall Study|Protocol Violation|1|||
37669976|NCT01662063|69143183|FG001|Overall Study|Protocol Violation|0|||
37669977|NCT01662063|69143184|FG002|Overall Study|Protocol Violation|0|||
37669978|NCT01662063|69143182|FG000|Overall Study|Withdrawal by Subject|2|||
37669979|NCT01662063|69143183|FG001|Overall Study|Withdrawal by Subject|4|||
37669980|NCT01662063|69143184|FG002|Overall Study|Withdrawal by Subject|1|||
37669981|NCT01662063|69143182|FG000|Overall Study|Physician Decision|0|||
37669982|NCT01662063|69143183|FG001|Overall Study|Physician Decision|2|||
37762806|NCT01472185|69274929|FG000|Overall Study|Subject Withdrew Consent|6|||
37762807|NCT01472185|69274930|FG001|Overall Study|Subject Withdrew Consent|3|||
37762808|NCT01456897|69274951|FG000|Overall Study|Adverse Event|19|||
37762809|NCT01456897|69274952|FG001|Overall Study|Adverse Event|22|||
37762810|NCT01456897|69274951|FG000|Overall Study|Protocol Violation|3|||
37762811|NCT01456897|69274952|FG001|Overall Study|Protocol Violation|4|||
37762812|NCT01456897|69274951|FG000|Overall Study|Physician Decision|5|||
37762813|NCT01456897|69274952|FG001|Overall Study|Physician Decision|3|||
37762814|NCT01456897|69274951|FG000|Overall Study|Withdrawal by Subject|44|||
37762815|NCT01456897|69274952|FG001|Overall Study|Withdrawal by Subject|17|||
37762816|NCT01456897|69274951|FG000|Overall Study|Lack of Efficacy|4|||
37762817|NCT01456897|69274952|FG001|Overall Study|Lack of Efficacy|11|||
37762818|NCT01456195|69274965|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
37762819|NCT01456195|69274966|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
37762820|NCT01456195|69274967|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
37762821|NCT01456195|69274965|FG000|Overall Study|Lost to Follow-up|3|||
37762822|NCT01456195|69274966|FG001|Overall Study|Lost to Follow-up|1|||
37762823|NCT01456195|69274967|FG002|Overall Study|Lost to Follow-up|3|||
37762824|NCT01456195|69274965|FG000|Overall Study|Voluntary Withdrawal|5|||
37762825|NCT01456195|69274966|FG001|Overall Study|Voluntary Withdrawal|3|||
37762826|NCT01456195|69274967|FG002|Overall Study|Voluntary Withdrawal|7|||
37762827|NCT01456195|69274965|FG000|Overall Study|Lack of Efficacy|0|||
37762828|NCT01456195|69274966|FG001|Overall Study|Lack of Efficacy|1|||
37762829|NCT01456195|69274967|FG002|Overall Study|Lack of Efficacy|0|||
37762830|NCT01456195|69274965|FG000|Overall Study|Other Reasons|2|||
37762831|NCT01456195|69274966|FG001|Overall Study|Other Reasons|1|||
37762832|NCT01456195|69274967|FG002|Overall Study|Other Reasons|3|||
37762833|NCT01456039|69275031|FG000|Phase 1 (First Step)|Disease Progression|1|||
37762834|NCT01456039|69275032|FG001|Phase 1 (First Step)|Disease Progression|1|||
37762835|NCT01456039|69275033|FG002|Phase 1 (First Step)|Disease Progression|0|||
37762836|NCT01456039|69275031|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
37762837|NCT01456039|69275032|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
37762838|NCT01456039|69275033|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
37762839|NCT01456039|69275031|FG000|Phase 1 (First Step)|Adverse Event|0|||
37762840|NCT01456039|69275032|FG001|Phase 1 (First Step)|Adverse Event|3|||
37762841|NCT01456039|69275033|FG002|Phase 1 (First Step)|Adverse Event|0|||
37762842|NCT01456039|69275031|FG000|Phase 1 (First Step)|Other|0|||
37762843|NCT01456039|69275032|FG001|Phase 1 (First Step)|Other|1|||
37762844|NCT01456039|69275033|FG002|Phase 1 (First Step)|Other|0|||
37762845|NCT01456039|69275031|FG000|Phase 2 (Second Step)|Disease Progression|0|||
37762846|NCT01456039|69275032|FG001|Phase 2 (Second Step)|Disease Progression|0|||
37762847|NCT01456039|69275033|FG002|Phase 2 (Second Step)|Disease Progression|17|||
37762848|NCT01456039|69275031|FG000|Phase 2 (Second Step)|Adverse Event|0|||
37762849|NCT01456039|69275032|FG001|Phase 2 (Second Step)|Adverse Event|0|||
37762850|NCT01456039|69275033|FG002|Phase 2 (Second Step)|Adverse Event|10|||
37762851|NCT01456039|69275031|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
37762852|NCT01456039|69275032|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
37762853|NCT01456039|69275033|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
37762854|NCT01456039|69275031|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
37762855|NCT01456039|69275032|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
37762856|NCT01456039|69275033|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
37762857|NCT01456039|69275031|FG000|Phase 2 (Second Step)|Other|0|||
37762858|NCT01456039|69275032|FG001|Phase 2 (Second Step)|Other|0|||
37762859|NCT01456039|69275033|FG002|Phase 2 (Second Step)|Other|1|||
37762860|NCT01455415|69275051|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
37762861|NCT01455415|69275052|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
37762862|NCT01455415|69275051|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
37762863|NCT01455415|69275052|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
37762864|NCT01455415|69275051|FG000|Period 1|Drug Error not Associated to AE|0|||
37762865|NCT01455415|69275052|FG001|Period 1|Drug Error not Associated to AE|1|||
37762866|NCT01455415|69275051|FG000|Period 1|AE Not Related to Study Drug|2|||
37762867|NCT01455415|69275052|FG001|Period 1|AE Not Related to Study Drug|6|||
37762868|NCT01455415|69275051|FG000|Period 1|Withdrawal by Subject|4|||
37762869|NCT01455415|69275052|FG001|Period 1|Withdrawal by Subject|5|||
37762870|NCT01455415|69275051|FG000|Period 1|Unspecified Reason|1|||
37762871|NCT01455415|69275052|FG001|Period 1|Unspecified Reason|1|||
37762872|NCT01455415|69275051|FG000|Period 1|Protocol Violation|0|||
37762873|NCT01455415|69275052|FG001|Period 1|Protocol Violation|2|||
37762874|NCT01455415|69275051|FG000|Washout|AE Related to Study Drug|2|||
37762875|NCT01455415|69275052|FG001|Washout|AE Related to Study Drug|0|||
37762876|NCT01455415|69275051|FG000|Washout|Lost to Follow-up|1|||
37762877|NCT01455415|69275052|FG001|Washout|Lost to Follow-up|0|||
37762878|NCT01455415|69275051|FG000|Washout|Drug Error not Associated to AE|2|||
37669983|NCT01662063|69143184|FG002|Overall Study|Physician Decision|0|||
37762879|NCT01455415|69275052|FG001|Washout|Drug Error not Associated to AE|1|||
37762880|NCT01455415|69275051|FG000|Washout|AE Not Related to Study Drug|2|||
37762881|NCT01455415|69275052|FG001|Washout|AE Not Related to Study Drug|3|||
37762882|NCT01455415|69275051|FG000|Washout|Unspecified Reason|1|||
37762883|NCT01455415|69275052|FG001|Washout|Unspecified Reason|2|||
37762884|NCT01455415|69275051|FG000|Washout|Protocol Violation|0|||
37762885|NCT01455415|69275052|FG001|Washout|Protocol Violation|1|||
37762886|NCT01455415|69275051|FG000|Period 2|AE Related to Study Drug|1|||
37762887|NCT01455415|69275052|FG001|Period 2|AE Related to Study Drug|2|||
37762888|NCT01455415|69275051|FG000|Period 2|Lost to Follow-up|2|||
37762889|NCT01455415|69275052|FG001|Period 2|Lost to Follow-up|1|||
37762890|NCT01455415|69275051|FG000|Period 2|AE Not Related to Study Drug|2|||
37762891|NCT01455415|69275052|FG001|Period 2|AE Not Related to Study Drug|1|||
37762892|NCT01455415|69275051|FG000|Period 2|Lack of Efficacy|2|||
37762893|NCT01455415|69275052|FG001|Period 2|Lack of Efficacy|0|||
37762894|NCT01455415|69275051|FG000|Period 2|Withdrawal by Subject|2|||
37762895|NCT01455415|69275052|FG001|Period 2|Withdrawal by Subject|3|||
37762896|NCT01455415|69275051|FG000|Period 2|Unspecified Reason|2|||
37762897|NCT01455415|69275052|FG001|Period 2|Unspecified Reason|3|||
37762898|NCT01455415|69275051|FG000|Period 2|Protocol Violation|2|||
37762899|NCT01455415|69275052|FG001|Period 2|Protocol Violation|0|||
37762900|NCT01455415|69275051|FG000|Follow-up|AE Related to Study Drug|0|||
37762901|NCT01455415|69275052|FG001|Follow-up|AE Related to Study Drug|1|||
37762902|NCT01455415|69275051|FG000|Follow-up|Lack of Efficacy|0|||
37762903|NCT01455415|69275052|FG001|Follow-up|Lack of Efficacy|1|||
37762904|NCT01455415|69275051|FG000|Follow-up|Withdrawal by Subject|2|||
37762905|NCT01455415|69275052|FG001|Follow-up|Withdrawal by Subject|0|||
37762906|NCT01455415|69275051|FG000|Follow-up|Unspecified Reason|1|||
37762907|NCT01455415|69275052|FG001|Follow-up|Unspecified Reason|0|||
37762908|NCT01471171|69275058|FG000|Treatment Period 1|Adverse Event|4|||
37762909|NCT01471171|69275059|FG001|Treatment Period 1|Adverse Event|1|||
37762910|NCT01471171|69275058|FG000|Treatment Period 2|Adverse Event|1|||
37762911|NCT01471171|69275059|FG001|Treatment Period 2|Adverse Event|0|||
37762912|NCT01471093|69275067|FG000|Overall Study|Adverse Event|1|||
37762913|NCT01471093|69275068|FG001|Overall Study|Adverse Event|0|||
37762914|NCT01471093|69275069|FG002|Overall Study|Adverse Event|0|||
37762915|NCT01471093|69275070|FG003|Overall Study|Adverse Event|0|||
37762916|NCT01471015|69275079|FG000|Overall Study|Death|0|||
37762917|NCT01471015|69275080|FG001|Overall Study|Death|1|||
37762918|NCT01471015|69275081|FG002|Overall Study|Death|1|||
37762919|NCT01497067|69275089|FG000|Overall Study|Lost to Follow-up|56|||
37762920|NCT01497067|69275089|FG000|Overall Study|Adverse Event|3|||
37762921|NCT01497067|69275089|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
37762922|NCT01497067|69275089|FG000|Overall Study|Other|13|||
37762923|NCT01470469|69275119|FG000|Overall Study|Withdrawal by Subject|4|||
37762924|NCT01470469|69275120|FG001|Overall Study|Withdrawal by Subject|6|||
37762925|NCT01470469|69275119|FG000|Overall Study|Lack of Efficacy|1|||
37762926|NCT01470469|69275120|FG001|Overall Study|Lack of Efficacy|7|||
37762927|NCT01470469|69275119|FG000|Overall Study|Adverse Event|0|||
37762928|NCT01470469|69275120|FG001|Overall Study|Adverse Event|7|||
37762929|NCT01470469|69275119|FG000|Overall Study|Lost to Follow-up|2|||
37762930|NCT01470469|69275120|FG001|Overall Study|Lost to Follow-up|2|||
37762931|NCT01470469|69275119|FG000|Overall Study|Protocol Violation|1|||
37762932|NCT01470469|69275120|FG001|Overall Study|Protocol Violation|1|||
37762933|NCT01470469|69275119|FG000|Overall Study|Other|2|||
37762934|NCT01470469|69275120|FG001|Overall Study|Other|1|||
37762935|NCT01470001|69275128|FG000|Overall Study|Lost to Follow-up|1|||
37762936|NCT01470001|69275129|FG001|Overall Study|Lost to Follow-up|1|||
37762937|NCT01470001|69275128|FG000|Overall Study|Physician Decision|2|||
37669984|NCT01662063|69143182|FG000|Overall Study|Other|0|||
37669985|NCT01662063|69143183|FG001|Overall Study|Other|1|||
37669986|NCT01662063|69143184|FG002|Overall Study|Other|0|||
37669987|NCT02548455|69143192|FG000|Overall Study|Withdrawal by Subject|27|||
37669988|NCT02548455|69143192|FG000|Overall Study|Death|26|||
37669989|NCT02548455|69143192|FG000|Overall Study|Lost to Follow-up|14|||
37669990|NCT02548455|69143192|FG000|Overall Study|Visit not completed|173|||
37669991|NCT02691455|69143198|FG000|Overall Study|Withdrawal by Subject|1|||
37669992|NCT02691455|69143199|FG001|Overall Study|Withdrawal by Subject|2|||
37762938|NCT01470001|69275129|FG001|Overall Study|Physician Decision|0|||
37762939|NCT01470001|69275128|FG000|Overall Study|Withdrawal by Subject|2|||
37762940|NCT01470001|69275129|FG001|Overall Study|Withdrawal by Subject|1|||
37762941|NCT01469377|69275138|FG000|Overall Study|Protocol Deviation|7|||
37762942|NCT01469377|69275139|FG001|Overall Study|Protocol Deviation|10|||
37762943|NCT01469377|69275140|FG002|Overall Study|Protocol Deviation|10|||
37762944|NCT01469377|69275138|FG000|Overall Study|Lost to Follow-up|3|||
37762945|NCT01469377|69275139|FG001|Overall Study|Lost to Follow-up|2|||
37762946|NCT01469377|69275140|FG002|Overall Study|Lost to Follow-up|5|||
37762947|NCT01469377|69275138|FG000|Overall Study|Withdrawal of Consent|12|||
37762948|NCT01469377|69275139|FG001|Overall Study|Withdrawal of Consent|14|||
37669993|NCT02691455|69143198|FG000|Overall Study|Lost to Follow-up|15|||
37669994|NCT02691455|69143199|FG001|Overall Study|Lost to Follow-up|15|||
37762949|NCT01469377|69275140|FG002|Overall Study|Withdrawal of Consent|15|||
37762950|NCT01469377|69275138|FG000|Overall Study|Adverse Event|8|||
37762951|NCT01469377|69275139|FG001|Overall Study|Adverse Event|18|||
37762952|NCT01469377|69275140|FG002|Overall Study|Adverse Event|36|||
37762953|NCT01469377|69275138|FG000|Overall Study|Insufficient Therapeutic Response|3|||
37933545|NCT00435409|69620367|FG000|Overall Study|Sponsor decision|0|||
37669995|NCT02534883|69143207|FG000|Overall Study|Early Termination|8|||
37762954|NCT01469377|69275139|FG001|Overall Study|Insufficient Therapeutic Response|4|||
37762955|NCT01469377|69275140|FG002|Overall Study|Insufficient Therapeutic Response|0|||
37762956|NCT01469377|69275138|FG000|Overall Study|Other Miscellaneous Reasons|2|||
37762957|NCT01469377|69275139|FG001|Overall Study|Other Miscellaneous Reasons|0|||
37762958|NCT01469377|69275140|FG002|Overall Study|Other Miscellaneous Reasons|0|||
37762959|NCT01469221|69275150|FG000|Double Blind Phase|Protocol Violation|1|||
37762960|NCT01469221|69275151|FG001|Double Blind Phase|Protocol Violation|0|||
37762961|NCT01469221|69275152|FG002|Double Blind Phase|Protocol Violation|0|||
37762962|NCT01469221|69275150|FG000|Double Blind Phase|Physician Decision|1|||
37762963|NCT01469221|69275151|FG001|Double Blind Phase|Physician Decision|1|||
37762964|NCT01469221|69275152|FG002|Double Blind Phase|Physician Decision|0|||
37762965|NCT01469221|69275150|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
37762966|NCT01469221|69275151|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
37762967|NCT01469221|69275152|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
37762968|NCT01453855|69275161|FG000|Overall Study|Adverse Event|3|||
37762969|NCT01453855|69275162|FG001|Overall Study|Adverse Event|4|||
37762970|NCT01453855|69275161|FG000|Overall Study|Lost to Follow-up|2|||
37762971|NCT01453855|69275162|FG001|Overall Study|Lost to Follow-up|1|||
37762972|NCT01453855|69275161|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
37762973|NCT01453855|69275162|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
37762974|NCT01453855|69275161|FG000|Overall Study|Noncompliance|1|||
37762975|NCT01453855|69275162|FG001|Overall Study|Noncompliance|0|||
37762976|NCT01453855|69275161|FG000|Overall Study|Inadequate Control of IOP|1|||
37762977|NCT01453855|69275162|FG001|Overall Study|Inadequate Control of IOP|5|||
37762978|NCT01453855|69275161|FG000|Overall Study|Other|0|||
37762979|NCT01453855|69275162|FG001|Overall Study|Other|1|||
37762980|NCT01469065|69275173|FG000|Overall Study|Lack of Efficacy|0|||
37762981|NCT01469065|69275174|FG001|Overall Study|Lack of Efficacy|0|||
37762982|NCT01469065|69275175|FG002|Overall Study|Lack of Efficacy|0|||
37762983|NCT01469065|69275176|FG003|Overall Study|Lack of Efficacy|0|||
37762984|NCT01469065|69275177|FG004|Overall Study|Lack of Efficacy|1|||
37762985|NCT01469065|69275173|FG000|Overall Study|Other|0|||
37762986|NCT01469065|69275174|FG001|Overall Study|Other|1|||
37762987|NCT01469065|69275175|FG002|Overall Study|Other|0|||
37762988|NCT01469065|69275176|FG003|Overall Study|Other|0|||
37762989|NCT01469065|69275177|FG004|Overall Study|Other|0|||
37762990|NCT01586624|69275201|FG000|Overall Study|Adverse Event|3|||
37762991|NCT01586624|69275202|FG001|Overall Study|Adverse Event|0|||
37762992|NCT01586624|69275203|FG002|Overall Study|Adverse Event|2|||
37762993|NCT01586624|69275204|FG003|Overall Study|Adverse Event|1|||
37762994|NCT01586624|69275205|FG004|Overall Study|Adverse Event|3|||
37762995|NCT01586624|69275206|FG005|Overall Study|Adverse Event|3|||
37762996|NCT01586624|69275207|FG006|Overall Study|Adverse Event|2|||
37762997|NCT01586624|69275208|FG007|Overall Study|Adverse Event|3|||
37762998|NCT01586624|69275201|FG000|Overall Study|Physician Decision|0|||
37762999|NCT01586624|69275202|FG001|Overall Study|Physician Decision|1|||
37763000|NCT01586624|69275203|FG002|Overall Study|Physician Decision|1|||
37763001|NCT01586624|69275204|FG003|Overall Study|Physician Decision|0|||
37763002|NCT01586624|69275205|FG004|Overall Study|Physician Decision|2|||
37763003|NCT01586624|69275206|FG005|Overall Study|Physician Decision|0|||
37763004|NCT01586624|69275207|FG006|Overall Study|Physician Decision|1|||
37763005|NCT01586624|69275208|FG007|Overall Study|Physician Decision|1|||
37763006|NCT01586624|69275201|FG000|Overall Study|Withdrawal by Subject|0|||
37763007|NCT01586624|69275202|FG001|Overall Study|Withdrawal by Subject|0|||
37763008|NCT01586624|69275203|FG002|Overall Study|Withdrawal by Subject|0|||
37763009|NCT01586624|69275204|FG003|Overall Study|Withdrawal by Subject|1|||
37763010|NCT01586624|69275205|FG004|Overall Study|Withdrawal by Subject|0|||
37763011|NCT01586624|69275206|FG005|Overall Study|Withdrawal by Subject|0|||
37763012|NCT01586624|69275207|FG006|Overall Study|Withdrawal by Subject|0|||
37763013|NCT01586624|69275208|FG007|Overall Study|Withdrawal by Subject|0|||
37763014|NCT01586624|69275201|FG000|Overall Study|Evidence of disease progression|1|||
37763015|NCT01586624|69275202|FG001|Overall Study|Evidence of disease progression|3|||
37763016|NCT01586624|69275203|FG002|Overall Study|Evidence of disease progression|2|||
37763017|NCT01586624|69275204|FG003|Overall Study|Evidence of disease progression|5|||
37763018|NCT01586624|69275205|FG004|Overall Study|Evidence of disease progression|3|||
37763019|NCT01586624|69275206|FG005|Overall Study|Evidence of disease progression|5|||
37763020|NCT01586624|69275207|FG006|Overall Study|Evidence of disease progression|4|||
37763021|NCT01586624|69275208|FG007|Overall Study|Evidence of disease progression|6|||
37763022|NCT01586624|69275201|FG000|Overall Study|Screen failure (no treatment received)|0|||
37763023|NCT01586624|69275202|FG001|Overall Study|Screen failure (no treatment received)|0|||
37763024|NCT01586624|69275203|FG002|Overall Study|Screen failure (no treatment received)|0|||
37763025|NCT01586624|69275204|FG003|Overall Study|Screen failure (no treatment received)|0|||
37763026|NCT01586624|69275205|FG004|Overall Study|Screen failure (no treatment received)|0|||
37763027|NCT01586624|69275206|FG005|Overall Study|Screen failure (no treatment received)|0|||
38034998|NCT04230213|69721866|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
37763028|NCT01586624|69275207|FG006|Overall Study|Screen failure (no treatment received)|1|||
37763029|NCT01586624|69275208|FG007|Overall Study|Screen failure (no treatment received)|0|||
37763030|NCT01586156|69275230|FG000|Overall Study|Pregnancy|0|||
37763031|NCT01586156|69275231|FG001|Overall Study|Pregnancy|1|||
37763032|NCT01586156|69275232|FG002|Overall Study|Pregnancy|0|||
37763033|NCT01459913|69275244|FG000|Overall Study|Adverse Event|0|||
37763034|NCT01459913|69275245|FG001|Overall Study|Adverse Event|0|||
37763035|NCT01459913|69275246|FG002|Overall Study|Adverse Event|0|||
37763036|NCT01459913|69275247|FG003|Overall Study|Adverse Event|3|||
37763037|NCT01459913|69275244|FG000|Overall Study|Withdrawal by Subject|4|||
37763038|NCT01459913|69275245|FG001|Overall Study|Withdrawal by Subject|0|||
37763039|NCT01459913|69275246|FG002|Overall Study|Withdrawal by Subject|0|||
37763040|NCT01459913|69275247|FG003|Overall Study|Withdrawal by Subject|5|||
37763041|NCT01459913|69275244|FG000|Overall Study|Lost to Follow-up|7|||
37763042|NCT01459913|69275245|FG001|Overall Study|Lost to Follow-up|4|||
37763043|NCT01459913|69275246|FG002|Overall Study|Lost to Follow-up|1|||
37763044|NCT01459913|69275247|FG003|Overall Study|Lost to Follow-up|8|||
37763045|NCT01459913|69275244|FG000|Overall Study|Death|0|||
37763046|NCT01459913|69275245|FG001|Overall Study|Death|0|||
37763047|NCT01459913|69275246|FG002|Overall Study|Death|0|||
37763048|NCT01459913|69275247|FG003|Overall Study|Death|1|||
37763049|NCT01459913|69275244|FG000|Overall Study|Non- Compliance|0|||
37763050|NCT01459913|69275245|FG001|Overall Study|Non- Compliance|0|||
37763051|NCT01459913|69275246|FG002|Overall Study|Non- Compliance|0|||
37763052|NCT01459913|69275247|FG003|Overall Study|Non- Compliance|3|||
37763053|NCT01459913|69275244|FG000|Overall Study|Physician Decision|0|||
37763054|NCT01459913|69275245|FG001|Overall Study|Physician Decision|1|||
37763055|NCT01459913|69275246|FG002|Overall Study|Physician Decision|0|||
37763056|NCT01459913|69275247|FG003|Overall Study|Physician Decision|0|||
37763057|NCT01459913|69275244|FG000|Overall Study|Study Terminated by Sponsor|30|||
37763058|NCT01459913|69275245|FG001|Overall Study|Study Terminated by Sponsor|15|||
37763059|NCT01459913|69275246|FG002|Overall Study|Study Terminated by Sponsor|9|||
37763060|NCT01459913|69275247|FG003|Overall Study|Study Terminated by Sponsor|11|||
37763061|NCT01459913|69275244|FG000|Overall Study|Other|0|||
37763062|NCT01459913|69275245|FG001|Overall Study|Other|0|||
37763063|NCT01459913|69275246|FG002|Overall Study|Other|3|||
37763064|NCT01459913|69275247|FG003|Overall Study|Other|1|||
37763065|NCT01459913|69275244|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
37763066|NCT01459913|69275245|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
37669996|NCT02534883|69143208|FG001|Overall Study|Early Termination|3|||
37669997|NCT02685995|69143216|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
37669998|NCT02685995|69143217|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
37669999|NCT02548143|69143225|FG000|Overall Study|Adverse Event|1|||
37670000|NCT02548143|69143226|FG001|Overall Study|Adverse Event|0|||
37670001|NCT02548143|69143225|FG000|Overall Study|Withdrawal by Subject|0|||
37670002|NCT02548143|69143226|FG001|Overall Study|Withdrawal by Subject|1|||
37670003|NCT02547441|69143234|FG000|Double-Blind Study Period|Adverse Event|4|||
37670004|NCT02547441|69143235|FG001|Double-Blind Study Period|Adverse Event|9|||
37670005|NCT02547441|69143234|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
37670006|NCT02547441|69143235|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
37670007|NCT02547441|69143234|FG000|Double-Blind Study Period|Physician Decision|1|||
37670008|NCT02547441|69143235|FG001|Double-Blind Study Period|Physician Decision|0|||
37670009|NCT02547441|69143234|FG000|Double-Blind Study Period|Protocol Violation|1|||
37670010|NCT02547441|69143235|FG001|Double-Blind Study Period|Protocol Violation|2|||
37670011|NCT02547441|69143234|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
37670012|NCT02547441|69143235|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
37670013|NCT02547441|69143234|FG000|Double-Blind Study Period|Sponsor Decision|1|||
37670014|NCT02547441|69143235|FG001|Double-Blind Study Period|Sponsor Decision|0|||
37670015|NCT02547441|69143234|FG000|Open-Label Study Period|Adverse Event|10|||
37670016|NCT02547441|69143235|FG001|Open-Label Study Period|Adverse Event|11|||
37670017|NCT02547441|69143234|FG000|Open-Label Study Period|Lack of Efficacy|3|||
37670018|NCT02547441|69143235|FG001|Open-Label Study Period|Lack of Efficacy|2|||
37763067|NCT01459913|69275246|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
37763068|NCT01459913|69275247|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
37763069|NCT01458587|69275261|FG000|Overall Study|Withdrawal by Subject|1|||
37763070|NCT01458587|69275262|FG001|Overall Study|Withdrawal by Subject|0|||
37763071|NCT01458275|69275273|FG000|Overall Study|Adverse Event|3|||
37763072|NCT01458275|69275274|FG001|Overall Study|Adverse Event|4|||
37763073|NCT01458275|69275275|FG002|Overall Study|Adverse Event|1|||
37670019|NCT02547441|69143234|FG000|Open-Label Study Period|Lost to Follow-up|7|||
37763074|NCT01458275|69275273|FG000|Overall Study|Lost to Follow-up|3|||
37763075|NCT01458275|69275274|FG001|Overall Study|Lost to Follow-up|2|||
37763076|NCT01458275|69275275|FG002|Overall Study|Lost to Follow-up|5|||
37763077|NCT01458275|69275273|FG000|Overall Study|Protocol Violation|5|||
37763078|NCT01458275|69275274|FG001|Overall Study|Protocol Violation|5|||
37763079|NCT01458275|69275275|FG002|Overall Study|Protocol Violation|2|||
37763080|NCT01458275|69275273|FG000|Overall Study|Withdrawal by Subject|3|||
37763081|NCT01458275|69275274|FG001|Overall Study|Withdrawal by Subject|2|||
37763082|NCT01458275|69275275|FG002|Overall Study|Withdrawal by Subject|1|||
37763083|NCT01458119|69275285|FG000|Overall Study|Physician Decision|4|||
37763084|NCT01458119|69275285|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
37933546|NCT00435409|69620368|FG001|Overall Study|Sponsor decision|3|||
37933547|NCT00435409|69620369|FG002|Overall Study|Sponsor decision|0|||
37933548|NCT00467857|69620386|FG000|Overall Study|Adverse Event|1|||
37933549|NCT00467857|69620387|FG001|Overall Study|Adverse Event|0|||
37933550|NCT00467857|69620386|FG000|Overall Study|Withdrew consent|2|||
37933551|NCT00467857|69620387|FG001|Overall Study|Withdrew consent|0|||
37933552|NCT00467857|69620386|FG000|Overall Study|Death|0|||
37933553|NCT00467857|69620387|FG001|Overall Study|Death|1|||
37933554|NCT00467857|69620386|FG000|Overall Study|Discharged from court service|0|||
37933555|NCT00467857|69620387|FG001|Overall Study|Discharged from court service|1|||
37933556|NCT00467857|69620386|FG000|Overall Study|Emergency care required|0|||
37933557|NCT00467857|69620387|FG001|Overall Study|Emergency care required|1|||
37933558|NCT00467857|69620386|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
37933559|NCT00467857|69620387|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
37933560|NCT00467857|69620386|FG000|Overall Study|Discontinuation reason missing|0|||
37933561|NCT00467857|69620387|FG001|Overall Study|Discontinuation reason missing|3|||
37933562|NCT00435019|69620395|FG000|Overall Study|Adverse Event|1|||
37933563|NCT00435019|69620396|FG001|Overall Study|Adverse Event|0|||
37933564|NCT00435019|69620395|FG000|Overall Study|Lack of Efficacy|1|||
37933565|NCT00435019|69620396|FG001|Overall Study|Lack of Efficacy|2|||
37933566|NCT00435019|69620395|FG000|Overall Study|Protocol Violation|3|||
37933567|NCT00435019|69620396|FG001|Overall Study|Protocol Violation|1|||
37933568|NCT00435019|69620395|FG000|Overall Study|Personal reasons for withdrawal|8|||
37933569|NCT00435019|69620396|FG001|Overall Study|Personal reasons for withdrawal|7|||
37933570|NCT00577863|69620404|FG000|Overall Study|Adverse Event|4|||
37933571|NCT00577863|69620405|FG001|Overall Study|Adverse Event|2|||
37933572|NCT00577863|69620404|FG000|Overall Study|Death|1|||
37933573|NCT00577863|69620405|FG001|Overall Study|Death|0|||
37933574|NCT00577863|69620404|FG000|Overall Study|Lost to Follow-up|2|||
37933575|NCT00577863|69620405|FG001|Overall Study|Lost to Follow-up|2|||
37933576|NCT00577863|69620404|FG000|Overall Study|Entry Criteria Exclusion|1|||
37933577|NCT00577863|69620405|FG001|Overall Study|Entry Criteria Exclusion|0|||
37933578|NCT00577863|69620404|FG000|Overall Study|Withdrawal by Subject|0|||
37933579|NCT00577863|69620405|FG001|Overall Study|Withdrawal by Subject|2|||
37933580|NCT00577863|69620404|FG000|Overall Study|Sponsor Decision|2|||
37933581|NCT00577863|69620405|FG001|Overall Study|Sponsor Decision|7|||
37933582|NCT00577863|69620404|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
37933583|NCT00577863|69620405|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
37933584|NCT00794417|69620415|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
37933585|NCT00794417|69620416|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
37933586|NCT00794417|69620417|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
37933587|NCT00794417|69620418|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
37933588|NCT00794417|69620415|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
37933589|NCT00794417|69620416|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
37933590|NCT00794417|69620417|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
37933591|NCT00794417|69620418|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
37933592|NCT00794417|69620415|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
37933593|NCT00794417|69620416|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
37933594|NCT00794417|69620417|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
37933595|NCT00794417|69620418|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
37933596|NCT00794417|69620415|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
37933597|NCT00794417|69620416|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
37933598|NCT00794417|69620417|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
37933599|NCT00794417|69620418|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
37933600|NCT00794417|69620415|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
37933601|NCT00794417|69620416|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
37933602|NCT00794417|69620417|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
37670020|NCT02547441|69143235|FG001|Open-Label Study Period|Lost to Follow-up|8|||
37670021|NCT02547441|69143234|FG000|Open-Label Study Period|Physician Decision|1|||
37763085|NCT01458119|69275285|FG000|Overall Study|Pregnancy|1|||
37763086|NCT01458119|69275285|FG000|Overall Study|Death|2|||
37763087|NCT01458119|69275285|FG000|Overall Study|Adverse Event|1|||
37763088|NCT01458119|69275285|FG000|Overall Study|Consent Withdrawn by Participant|8|||
37933603|NCT00794417|69620418|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
37933604|NCT00794417|69620415|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
37933605|NCT00794417|69620416|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
37933606|NCT00794417|69620417|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
37763089|NCT01458119|69275285|FG000|Overall Study|Non-compliance With Study Drug|3|||
37763090|NCT01688882|69275300|FG000|Overall Study|Adverse Event|1|||
37763091|NCT01688882|69275301|FG001|Overall Study|Adverse Event|0|||
37763092|NCT01688882|69275300|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
37763093|NCT01688882|69275301|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
37763094|NCT01688882|69275300|FG000|Overall Study|Administrative problems|1|||
37763095|NCT01688882|69275301|FG001|Overall Study|Administrative problems|0|||
37933607|NCT00794417|69620418|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
37933608|NCT00790907|69620433|FG000|Overall Study|Adverse Event|9|||
37933609|NCT00790907|69620434|FG001|Overall Study|Adverse Event|7|||
37933610|NCT00790907|69620435|FG002|Overall Study|Adverse Event|6|||
37933611|NCT00790907|69620433|FG000|Overall Study|Physician Decision|304|||
37933612|NCT00790907|69620434|FG001|Overall Study|Physician Decision|271|||
37933613|NCT00790907|69620435|FG002|Overall Study|Physician Decision|255|||
37933614|NCT00790907|69620433|FG000|Overall Study|Withdrawal by Subject|1|||
37933615|NCT00790907|69620434|FG001|Overall Study|Withdrawal by Subject|7|||
37933616|NCT00790907|69620435|FG002|Overall Study|Withdrawal by Subject|5|||
37933617|NCT00790907|69620433|FG000|Overall Study|Bleeding Event|11|||
37933618|NCT00790907|69620434|FG001|Overall Study|Bleeding Event|16|||
37933619|NCT00790907|69620435|FG002|Overall Study|Bleeding Event|21|||
37933620|NCT00790907|69620433|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
37933621|NCT00790907|69620434|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
37933622|NCT00790907|69620435|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
37933623|NCT00790907|69620433|FG000|Overall Study|Qualifying Condition Not Present|29|||
37933624|NCT00790907|69620434|FG001|Overall Study|Qualifying Condition Not Present|14|||
37933625|NCT00790907|69620435|FG002|Overall Study|Qualifying Condition Not Present|16|||
37933626|NCT00790907|69620433|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
37933627|NCT00790907|69620434|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
37933628|NCT00790907|69620435|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
37933629|NCT00790907|69620433|FG000|Overall Study|Did Not Receive Study Drug|10|||
37933630|NCT00790907|69620434|FG001|Overall Study|Did Not Receive Study Drug|0|||
37933631|NCT00790907|69620435|FG002|Overall Study|Did Not Receive Study Drug|0|||
37933632|NCT00793871|69620453|FG000|Overall Study|Death|50|||
37933633|NCT00793871|69620453|FG000|Overall Study|Lost to Follow-up|3|||
37933634|NCT00793871|69620453|FG000|Overall Study|Study terminated by the Sponsor|7|||
37933635|NCT00577707|69620461|FG000|Overall Study|Withdrawal by Subject|3|||
37933636|NCT00713349|69620465|FG000|Overall Study|Protocol Violation|1|||
37933637|NCT00712959|69620473|FG000|Overall Study|Protocol Violation|3|||
37933638|NCT00712959|69620474|FG001|Overall Study|Protocol Violation|1|||
37933639|NCT00712959|69620473|FG000|Overall Study|Lost to Follow-up|13|||
37933640|NCT00712959|69620474|FG001|Overall Study|Lost to Follow-up|2|||
37933641|NCT00712959|69620473|FG000|Overall Study|Withdrawal by Subject|3|||
37933642|NCT00712959|69620474|FG001|Overall Study|Withdrawal by Subject|0|||
37933643|NCT00712725|69620488|FG000|Overall Study|Adverse Event|1|||
37763096|NCT01688726|69275313|FG000|Overall Study|Adverse Event|1|||
37763097|NCT01688726|69275314|FG001|Overall Study|Adverse Event|0|||
37763098|NCT01688726|69275313|FG000|Overall Study|Relocated abroad|0|||
37933644|NCT00712725|69620489|FG001|Overall Study|Adverse Event|0|||
37763099|NCT01688726|69275314|FG001|Overall Study|Relocated abroad|1|||
37763100|NCT01585766|69275330|FG000|Overall Study|Withdrawal by Subject|0|||
37763101|NCT01585766|69275331|FG001|Overall Study|Withdrawal by Subject|1|||
37763102|NCT01585766|69275332|FG002|Overall Study|Withdrawal by Subject|1|||
37763103|NCT01585766|69275333|FG003|Overall Study|Withdrawal by Subject|0|||
37763104|NCT01585766|69275334|FG004|Overall Study|Withdrawal by Subject|0|||
37763105|NCT01585766|69275335|FG005|Overall Study|Withdrawal by Subject|0|||
37763106|NCT01585766|69275330|FG000|Overall Study|Death|0|||
37763107|NCT01585766|69275331|FG001|Overall Study|Death|1|||
37763108|NCT01585766|69275332|FG002|Overall Study|Death|0|||
37763109|NCT01585766|69275333|FG003|Overall Study|Death|0|||
37763110|NCT01585766|69275334|FG004|Overall Study|Death|0|||
37763111|NCT01585766|69275335|FG005|Overall Study|Death|0|||
37763112|NCT01585766|69275330|FG000|Overall Study|Physician Decision|0|||
37763113|NCT01585766|69275331|FG001|Overall Study|Physician Decision|0|||
37763114|NCT01585766|69275332|FG002|Overall Study|Physician Decision|1|||
37763115|NCT01585766|69275333|FG003|Overall Study|Physician Decision|0|||
37763116|NCT01585766|69275334|FG004|Overall Study|Physician Decision|0|||
37763117|NCT01585766|69275335|FG005|Overall Study|Physician Decision|0|||
37763118|NCT01562444|69275359|FG000|Overall Study|Did not meet entry criteria|2|||
37763119|NCT01562444|69275360|FG001|Overall Study|Did not meet entry criteria|0|||
37763120|NCT01562444|69275361|FG002|Overall Study|Did not meet entry criteria|3|||
37763121|NCT01562444|69275359|FG000|Overall Study|Did not comply with blood draw schedule|1|||
37763122|NCT01562444|69275360|FG001|Overall Study|Did not comply with blood draw schedule|0|||
37933645|NCT00712725|69620490|FG002|Overall Study|Adverse Event|0|||
37933646|NCT00712725|69620491|FG003|Overall Study|Adverse Event|1|||
37933647|NCT00712725|69620492|FG004|Overall Study|Adverse Event|0|||
37763123|NCT01562444|69275361|FG002|Overall Study|Did not comply with blood draw schedule|1|||
37763124|NCT01562444|69275359|FG000|Overall Study|Unavailable serological results|0|||
37933648|NCT00712725|69620493|FG005|Overall Study|Adverse Event|0|||
37933649|NCT00712725|69620494|FG006|Overall Study|Adverse Event|0|||
37763125|NCT01562444|69275360|FG001|Overall Study|Unavailable serological results|2|||
37763126|NCT01562444|69275361|FG002|Overall Study|Unavailable serological results|2|||
37763127|NCT01562444|69275359|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
37763128|NCT01562444|69275360|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
37763129|NCT01562444|69275361|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
37933650|NCT00712725|69620495|FG007|Overall Study|Adverse Event|0|||
37933651|NCT00712725|69620488|FG000|Overall Study|Lost to Follow-up|3|||
37933652|NCT00712725|69620489|FG001|Overall Study|Lost to Follow-up|2|||
37933653|NCT00712725|69620490|FG002|Overall Study|Lost to Follow-up|1|||
37933654|NCT00712725|69620491|FG003|Overall Study|Lost to Follow-up|1|||
37933655|NCT00712725|69620492|FG004|Overall Study|Lost to Follow-up|2|||
37933656|NCT00712725|69620493|FG005|Overall Study|Lost to Follow-up|2|||
37933657|NCT00712725|69620494|FG006|Overall Study|Lost to Follow-up|3|||
37933658|NCT00712725|69620495|FG007|Overall Study|Lost to Follow-up|1|||
37933659|NCT00712725|69620488|FG000|Overall Study|Physician Decision|2|||
37933660|NCT00712725|69620489|FG001|Overall Study|Physician Decision|0|||
37933661|NCT00712725|69620490|FG002|Overall Study|Physician Decision|0|||
37933662|NCT00712725|69620491|FG003|Overall Study|Physician Decision|0|||
37933663|NCT00712725|69620492|FG004|Overall Study|Physician Decision|1|||
37933664|NCT00712725|69620493|FG005|Overall Study|Physician Decision|0|||
37933665|NCT00712725|69620494|FG006|Overall Study|Physician Decision|2|||
37933666|NCT00712725|69620495|FG007|Overall Study|Physician Decision|0|||
37933667|NCT00712725|69620488|FG000|Overall Study|Pregnancy|0|||
37933668|NCT00712725|69620489|FG001|Overall Study|Pregnancy|1|||
37933669|NCT00712725|69620490|FG002|Overall Study|Pregnancy|0|||
37933670|NCT00712725|69620491|FG003|Overall Study|Pregnancy|0|||
37933671|NCT00712725|69620492|FG004|Overall Study|Pregnancy|1|||
37933672|NCT00712725|69620493|FG005|Overall Study|Pregnancy|0|||
37933673|NCT00712725|69620494|FG006|Overall Study|Pregnancy|2|||
37933674|NCT00712725|69620495|FG007|Overall Study|Pregnancy|0|||
37933675|NCT00712725|69620488|FG000|Overall Study|Protocol Violation|2|||
37933676|NCT00712725|69620489|FG001|Overall Study|Protocol Violation|0|||
37933677|NCT00712725|69620490|FG002|Overall Study|Protocol Violation|1|||
37933678|NCT00712725|69620491|FG003|Overall Study|Protocol Violation|3|||
37933679|NCT00712725|69620492|FG004|Overall Study|Protocol Violation|2|||
37933680|NCT00712725|69620493|FG005|Overall Study|Protocol Violation|0|||
37933681|NCT00712725|69620494|FG006|Overall Study|Protocol Violation|1|||
37933682|NCT00712725|69620495|FG007|Overall Study|Protocol Violation|1|||
37933683|NCT00712725|69620488|FG000|Overall Study|Withdrawal by Subject|2|||
37933684|NCT00712725|69620489|FG001|Overall Study|Withdrawal by Subject|1|||
37933685|NCT00712725|69620490|FG002|Overall Study|Withdrawal by Subject|1|||
37933686|NCT00712725|69620491|FG003|Overall Study|Withdrawal by Subject|2|||
37933687|NCT00712725|69620492|FG004|Overall Study|Withdrawal by Subject|1|||
37933688|NCT00712725|69620493|FG005|Overall Study|Withdrawal by Subject|1|||
37933689|NCT00712725|69620494|FG006|Overall Study|Withdrawal by Subject|1|||
37933690|NCT00712725|69620495|FG007|Overall Study|Withdrawal by Subject|2|||
37933691|NCT00712725|69620488|FG000|Overall Study|Lack of Qualifying Event|16|||
37933692|NCT00712725|69620489|FG001|Overall Study|Lack of Qualifying Event|2|||
37933693|NCT00712725|69620490|FG002|Overall Study|Lack of Qualifying Event|6|||
37933694|NCT00712725|69620491|FG003|Overall Study|Lack of Qualifying Event|8|||
37933695|NCT00712725|69620492|FG004|Overall Study|Lack of Qualifying Event|11|||
37933696|NCT00712725|69620493|FG005|Overall Study|Lack of Qualifying Event|13|||
37933697|NCT00712725|69620494|FG006|Overall Study|Lack of Qualifying Event|11|||
37933698|NCT00712725|69620495|FG007|Overall Study|Lack of Qualifying Event|6|||
37933699|NCT00712725|69620488|FG000|Overall Study|Protocol Specified Criteria|3|||
37933700|NCT00712725|69620489|FG001|Overall Study|Protocol Specified Criteria|0|||
37933701|NCT00712725|69620490|FG002|Overall Study|Protocol Specified Criteria|1|||
37933702|NCT00712725|69620491|FG003|Overall Study|Protocol Specified Criteria|2|||
37933703|NCT00712725|69620492|FG004|Overall Study|Protocol Specified Criteria|1|||
37933704|NCT00712725|69620493|FG005|Overall Study|Protocol Specified Criteria|0|||
37933705|NCT00712725|69620494|FG006|Overall Study|Protocol Specified Criteria|2|||
37933706|NCT00712725|69620495|FG007|Overall Study|Protocol Specified Criteria|1|||
37933707|NCT00712335|69620518|FG000|Overall Study|Withdrawal by Subject|0|||
37933708|NCT00712335|69620519|FG001|Overall Study|Withdrawal by Subject|7|||
37933709|NCT00712335|69620520|FG002|Overall Study|Withdrawal by Subject|2|||
37933710|NCT00712335|69620521|FG003|Overall Study|Withdrawal by Subject|3|||
37933711|NCT00712335|69620522|FG004|Overall Study|Withdrawal by Subject|0|||
37763130|NCT01562444|69275359|FG000|Overall Study|Protocol forbidden medication|1|||
37933712|NCT00712335|69620518|FG000|Overall Study|Lost to Follow-up|2|||
37933713|NCT00712335|69620519|FG001|Overall Study|Lost to Follow-up|5|||
37933714|NCT00712335|69620520|FG002|Overall Study|Lost to Follow-up|0|||
37933715|NCT00712335|69620521|FG003|Overall Study|Lost to Follow-up|1|||
37763131|NCT01562444|69275360|FG001|Overall Study|Protocol forbidden medication|0|||
37763132|NCT01562444|69275361|FG002|Overall Study|Protocol forbidden medication|0|||
37933716|NCT00712335|69620522|FG004|Overall Study|Lost to Follow-up|0|||
37933717|NCT00712335|69620518|FG000|Overall Study|Protocol Violation|1|||
37933718|NCT00712335|69620519|FG001|Overall Study|Protocol Violation|2|||
37933719|NCT00712335|69620520|FG002|Overall Study|Protocol Violation|1|||
37763133|NCT01457339|69275371|FG000|Period 3 (100 mg)|Adverse Event|0|||
37763134|NCT01457339|69275372|FG001|Period 3 (100 mg)|Adverse Event|1|||
37763135|NCT01457339|69275371|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
37763136|NCT01457339|69275372|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
37763137|NCT01457339|69275371|FG000|Period 6 (250 mg)|Family Emergency|1|||
37763138|NCT01457339|69275372|FG001|Period 6 (250 mg)|Family Emergency|0|||
37763139|NCT01457339|69275371|FG000|Period 6 (250 mg)|Personal appointment|0|||
37763140|NCT01457339|69275372|FG001|Period 6 (250 mg)|Personal appointment|1|||
37763141|NCT01456949|69275395|FG000|Enrollment|PI death- incomplete data|6|||
37763142|NCT01456949|69275395|FG000|Enrollment|Death|1|||
37763143|NCT01456949|69275395|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
37763144|NCT01456949|69275395|FG000|Enrollment|Physician Decision|10|||
37763145|NCT01456949|69275395|FG000|Enrollment|Withdrawal by Subject|7|||
37763146|NCT01456949|69275395|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
37763147|NCT01456949|69275395|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
37763148|NCT01456949|69275395|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
37763149|NCT01456949|69275395|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
37763150|NCT01456949|69275395|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
37763151|NCT01456949|69275395|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
37763152|NCT01456949|69275395|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
37763153|NCT01456949|69275395|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
37763154|NCT01456169|69275402|FG000|Overall Study|Adverse Event|1|||
37763155|NCT01456169|69275403|FG001|Overall Study|Adverse Event|2|||
37763156|NCT01456169|69275404|FG002|Overall Study|Adverse Event|7|||
37763157|NCT01456169|69275402|FG000|Overall Study|Major Protocol Deviation|3|||
37763158|NCT01456169|69275403|FG001|Overall Study|Major Protocol Deviation|2|||
37763159|NCT01456169|69275404|FG002|Overall Study|Major Protocol Deviation|3|||
37763160|NCT01456169|69275402|FG000|Overall Study|Voluntary Withdrawal|3|||
37763161|NCT01456169|69275403|FG001|Overall Study|Voluntary Withdrawal|0|||
37763162|NCT01456169|69275404|FG002|Overall Study|Voluntary Withdrawal|2|||
37763163|NCT01456169|69275402|FG000|Overall Study|Lack of Efficacy|2|||
37763164|NCT01456169|69275403|FG001|Overall Study|Lack of Efficacy|0|||
37763165|NCT01456169|69275404|FG002|Overall Study|Lack of Efficacy|0|||
37763166|NCT01456169|69275402|FG000|Overall Study|Other|1|||
37763167|NCT01456169|69275403|FG001|Overall Study|Other|1|||
37763168|NCT01456169|69275404|FG002|Overall Study|Other|0|||
37763169|NCT01454531|69275413|FG000|Overall Study|Adverse Event|14|||
37763170|NCT01454531|69275413|FG000|Overall Study|Withdrawal by Subject|5|||
37763171|NCT01454531|69275413|FG000|Overall Study|Lost to Follow-up|1|||
37763172|NCT01454531|69275413|FG000|Overall Study|Physician Decision|1|||
37933720|NCT00712335|69620521|FG003|Overall Study|Protocol Violation|0|||
37933721|NCT00712335|69620522|FG004|Overall Study|Protocol Violation|0|||
37933722|NCT00712335|69620518|FG000|Overall Study|Lack of Efficacy|0|||
37933723|NCT00712335|69620519|FG001|Overall Study|Lack of Efficacy|0|||
37933724|NCT00712335|69620520|FG002|Overall Study|Lack of Efficacy|1|||
37933725|NCT00712335|69620521|FG003|Overall Study|Lack of Efficacy|1|||
37933726|NCT00712335|69620522|FG004|Overall Study|Lack of Efficacy|0|||
37933727|NCT00712335|69620518|FG000|Overall Study|Other Reason|0|||
37933728|NCT00712335|69620519|FG001|Overall Study|Other Reason|3|||
37933729|NCT00712335|69620520|FG002|Overall Study|Other Reason|1|||
37933730|NCT00712335|69620521|FG003|Overall Study|Other Reason|0|||
37933731|NCT00712335|69620522|FG004|Overall Study|Other Reason|0|||
37933732|NCT00577629|69620534|FG000|Treatment Period|Death|1|||
37933733|NCT00577629|69620534|FG000|Long Term Follow-Up|Death|15|||
37933734|NCT00577629|69620534|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
37933735|NCT00577629|69620534|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
37933736|NCT00577629|69620534|FG000|Long Term Follow-Up|Physician Decision|1|||
37933737|NCT00710385|69620540|FG000|Overall Study|Did not qualify|1|||
37933738|NCT00710385|69620540|FG000|Overall Study|Withdrawal by Subject|1|||
37933739|NCT00710385|69620540|FG000|Overall Study|Undisclosed back pain|1|||
37933740|NCT00710385|69620540|FG000|Overall Study|Physician Decision|1|||
37670022|NCT02547441|69143235|FG001|Open-Label Study Period|Physician Decision|0|||
37670023|NCT02547441|69143234|FG000|Open-Label Study Period|Protocol Violation|2|||
37670024|NCT02547441|69143235|FG001|Open-Label Study Period|Protocol Violation|0|||
37670025|NCT02547441|69143234|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
37670026|NCT02547441|69143235|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
37670027|NCT02547441|69143234|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
37670028|NCT02547441|69143235|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
37670029|NCT02540265|69143245|FG000|Overall Study|Lost to Follow-up|0|||
37763173|NCT01454531|69275413|FG000|Overall Study|Delay in IMP administration|1|||
37933741|NCT00710385|69620540|FG000|Overall Study|Undisclosed excessive methadone use|1|||
37763174|NCT01454531|69275413|FG000|Overall Study|Other|1|||
37763175|NCT01454063|69275419|FG000|Randomized|Adverse Event|1|||
37763176|NCT01454063|69275420|FG001|Randomized|Adverse Event|1|||
37763177|NCT01454063|69275419|FG000|Randomized|Protocol Violation|0|||
37763178|NCT01454063|69275420|FG001|Randomized|Protocol Violation|1|||
37763179|NCT01453595|69275429|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
37763180|NCT01453595|69275430|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
37763181|NCT01453595|69275431|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
37763182|NCT01453439|69275439|FG000|Treatment Phase|Withdrawal by Subject|13|||
37763183|NCT01453439|69275440|FG001|Treatment Phase|Withdrawal by Subject|10|||
37763184|NCT01453439|69275439|FG000|Treatment Phase|Suicidal Ideation|2|||
37763185|NCT01453439|69275440|FG001|Treatment Phase|Suicidal Ideation|0|||
37763186|NCT01453439|69275439|FG000|Treatment Phase|Need for higher level of care|1|||
37763187|NCT01453439|69275440|FG001|Treatment Phase|Need for higher level of care|1|||
37763188|NCT01453439|69275439|FG000|Treatment Phase|Therapist conflict of interest|1|||
37763189|NCT01453439|69275440|FG001|Treatment Phase|Therapist conflict of interest|0|||
37763190|NCT01453439|69275439|FG000|Follow-up|Withdrawal by Subject|0|||
37763191|NCT01453439|69275440|FG001|Follow-up|Withdrawal by Subject|1|||
37763192|NCT01453439|69275439|FG000|Follow-up|Lost to Follow-up|5|||
37763193|NCT01453439|69275440|FG001|Follow-up|Lost to Follow-up|10|||
37763194|NCT01453361|69275446|FG000|Overall Study|Disease Progression|6|||
37763195|NCT01453361|69275446|FG000|Overall Study|Screen-Failures|10|||
37763196|NCT01585298|69275450|FG000|Overall Study|Study completion was not documented.|1|||
37763197|NCT01585298|69275450|FG000|Overall Study|Protocol deviation|1|||
37763198|NCT01585298|69275450|FG000|Overall Study|Administrative problems|4|||
37763199|NCT01585298|69275450|FG000|Overall Study|Lost to Follow-up|2|||
37763200|NCT01585298|69275450|FG000|Overall Study|Withdrawal by Subject|4|||
37763201|NCT01585298|69275450|FG000|Overall Study|Abnormal test procedure results|1|||
37763202|NCT01585298|69275450|FG000|Overall Study|Adverse Event|24|||
37763203|NCT01453205|69275457|FG000|Overall Study|Lost to Follow-up|3|||
37763204|NCT01453205|69275458|FG001|Overall Study|Lost to Follow-up|0|||
37763205|NCT01453205|69275459|FG002|Overall Study|Lost to Follow-up|1|||
37763206|NCT01453205|69275457|FG000|Overall Study|Withdrawal by Subject|8|||
37763207|NCT01453205|69275458|FG001|Overall Study|Withdrawal by Subject|3|||
37763208|NCT01453205|69275459|FG002|Overall Study|Withdrawal by Subject|0|||
37763209|NCT01453205|69275457|FG000|Overall Study|Death|24|||
37763210|NCT01453205|69275458|FG001|Overall Study|Death|22|||
37763211|NCT01453205|69275459|FG002|Overall Study|Death|18|||
37763212|NCT01453205|69275457|FG000|Overall Study|Other|45|||
37763213|NCT01453205|69275458|FG001|Overall Study|Other|27|||
37763214|NCT01453205|69275459|FG002|Overall Study|Other|35|||
37763215|NCT01453049|69275472|FG000|Overall Study|Protocol Violation|2|||
37763216|NCT01453049|69275473|FG001|Overall Study|Protocol Violation|5|||
37763217|NCT01453049|69275472|FG000|Overall Study|Lost to Follow-up|2|||
37763218|NCT01453049|69275473|FG001|Overall Study|Lost to Follow-up|1|||
37763219|NCT01453049|69275472|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
37763220|NCT01453049|69275473|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
37763221|NCT01453049|69275472|FG000|Overall Study|Withdrawal by Subject|1|||
37763222|NCT01453049|69275473|FG001|Overall Study|Withdrawal by Subject|0|||
37763223|NCT01453049|69275472|FG000|Overall Study|Randomized in Error|1|||
37763224|NCT01453049|69275473|FG001|Overall Study|Randomized in Error|0|||
37763225|NCT01452347|69275481|FG000|Overall Study|Adverse Event|2|||
37763226|NCT01452347|69275482|FG001|Overall Study|Adverse Event|1|||
37763227|NCT01452347|69275481|FG000|Overall Study|Non compliance protocol|2|||
37763228|NCT01452347|69275482|FG001|Overall Study|Non compliance protocol|0|||
37763229|NCT01452347|69275481|FG000|Overall Study|Lost to Follow-up|2|||
37763230|NCT01452347|69275482|FG001|Overall Study|Lost to Follow-up|0|||
37763231|NCT01452347|69275481|FG000|Overall Study|Withdrawal by Subject|3|||
37763232|NCT01452347|69275482|FG001|Overall Study|Withdrawal by Subject|3|||
37763233|NCT01452347|69275481|FG000|Overall Study|Not treated|6|||
37763234|NCT01452347|69275482|FG001|Overall Study|Not treated|3|||
37763235|NCT01452347|69275481|FG000|Overall Study|Other reason not defined above|2|||
37763236|NCT01452347|69275482|FG001|Overall Study|Other reason not defined above|0|||
37763237|NCT01451723|69275492|FG000|Overall Study|study halted|6|||
37763238|NCT01451723|69275493|FG001|Overall Study|study halted|5|||
37933742|NCT00701415|69620552|FG000|Overall Study|Adverse Event|0|||
37933743|NCT00701415|69620553|FG001|Overall Study|Adverse Event|1|||
37763239|NCT01451645|69275501|FG000|Overall Study|Protocol Violation|1|||
37763240|NCT01451645|69275502|FG001|Overall Study|Protocol Violation|0|||
37763241|NCT01451645|69275501|FG000|Overall Study|Adverse Event|0|||
37933744|NCT00701415|69620552|FG000|Overall Study|Social/family issues and needle phobia|1|||
37933745|NCT00701415|69620553|FG001|Overall Study|Social/family issues and needle phobia|0|||
37933746|NCT00700011|69620561|FG000|Overall Study|Death|0|||
37763242|NCT01451645|69275502|FG001|Overall Study|Adverse Event|3|||
37763243|NCT01451645|69275501|FG000|Overall Study|Withdrawal by Subject|4|||
37763244|NCT01451645|69275502|FG001|Overall Study|Withdrawal by Subject|2|||
37763245|NCT01451645|69275501|FG000|Overall Study|Lost to Follow-up|4|||
37763246|NCT01451645|69275502|FG001|Overall Study|Lost to Follow-up|3|||
37763247|NCT01450943|69275511|FG000|Overall Study|Screen failure, loss to follow-up|2|||
37763248|NCT01450943|69275512|FG001|Overall Study|Screen failure, loss to follow-up|7|||
37763249|NCT01450943|69275513|FG002|Overall Study|Screen failure, loss to follow-up|6|||
37763250|NCT01450631|69275527|FG000|Overall Study|Lost to Follow-up|2|||
37763251|NCT01450631|69275528|FG001|Overall Study|Lost to Follow-up|4|||
37763252|NCT01450631|69275527|FG000|Overall Study|Withdrawal by Subject|1|||
37763253|NCT01450631|69275528|FG001|Overall Study|Withdrawal by Subject|0|||
37763254|NCT01450007|69275537|FG000|Overall Study|Late exclusion before treatment|2|||
37763255|NCT01450007|69275538|FG001|Overall Study|Late exclusion before treatment|3|||
37763256|NCT01450007|69275539|FG002|Overall Study|Late exclusion before treatment|2|||
37933747|NCT00700011|69620562|FG001|Overall Study|Death|1|||
37933748|NCT00707031|69620570|FG000|Overall Study|Adverse Event|45|||
37933749|NCT00707031|69620571|FG001|Overall Study|Adverse Event|45|||
37933750|NCT00707031|69620570|FG000|Overall Study|Lack of Efficacy|19|||
37933751|NCT00707031|69620571|FG001|Overall Study|Lack of Efficacy|6|||
37933752|NCT00707031|69620570|FG000|Overall Study|Lost to Follow-up|2|||
37933753|NCT00707031|69620571|FG001|Overall Study|Lost to Follow-up|1|||
37933754|NCT00707031|69620570|FG000|Overall Study|Protocol Violation|1|||
37933755|NCT00707031|69620571|FG001|Overall Study|Protocol Violation|0|||
37933756|NCT00707031|69620570|FG000|Overall Study|Withdrawal by Subject|7|||
37933757|NCT00707031|69620571|FG001|Overall Study|Withdrawal by Subject|8|||
37933758|NCT00707031|69620570|FG000|Overall Study|Poor Compliance to Protocol|7|||
37933759|NCT00707031|69620571|FG001|Overall Study|Poor Compliance to Protocol|13|||
37933760|NCT00707031|69620570|FG000|Overall Study|Familial or Personal Reasons|12|||
37933761|NCT00707031|69620571|FG001|Overall Study|Familial or Personal Reasons|15|||
37933762|NCT00707031|69620570|FG000|Overall Study|Serious Noncompliance|2|||
37933763|NCT00707031|69620571|FG001|Overall Study|Serious Noncompliance|3|||
37933764|NCT00707031|69620570|FG000|Overall Study|Sponsor Decision|9|||
37933765|NCT00707031|69620571|FG001|Overall Study|Sponsor Decision|8|||
37933766|NCT00711477|69620580|FG000|Overall Study|Adverse Event|3|||
37933767|NCT00711477|69620581|FG001|Overall Study|Adverse Event|1|||
37933768|NCT00711477|69620580|FG000|Overall Study|Lost to Follow-up|0|||
37933769|NCT00711477|69620581|FG001|Overall Study|Lost to Follow-up|1|||
37933770|NCT00711477|69620580|FG000|Overall Study|Noncompliance|0|||
37933771|NCT00711477|69620581|FG001|Overall Study|Noncompliance|1|||
37933772|NCT00699699|69620589|FG000|Overall Study|Adverse Event|36|||
37933773|NCT00699699|69620589|FG000|Overall Study|Individual different reasons|21|||
37933774|NCT00734474|69620602|FG000|Overall Study|Entry Criteria Not Met|0|||
37933775|NCT00734474|69620603|FG001|Overall Study|Entry Criteria Not Met|0|||
37933776|NCT00734474|69620604|FG002|Overall Study|Entry Criteria Not Met|5|||
37933777|NCT00734474|69620605|FG003|Overall Study|Entry Criteria Not Met|0|||
37933778|NCT00734474|69620606|FG004|Overall Study|Entry Criteria Not Met|3|||
37933779|NCT00734474|69620607|FG005|Overall Study|Entry Criteria Not Met|1|||
37933780|NCT00734474|69620608|FG006|Overall Study|Entry Criteria Not Met|0|||
37933781|NCT00734474|69620609|FG007|Overall Study|Entry Criteria Not Met|1|||
37933782|NCT00734474|69620610|FG008|Overall Study|Entry Criteria Not Met|1|||
37933783|NCT00734474|69620602|FG000|Overall Study|Lost to Follow-up|1|||
37933784|NCT00734474|69620603|FG001|Overall Study|Lost to Follow-up|0|||
37933785|NCT00734474|69620604|FG002|Overall Study|Lost to Follow-up|13|||
37933786|NCT00734474|69620605|FG003|Overall Study|Lost to Follow-up|0|||
37933787|NCT00734474|69620606|FG004|Overall Study|Lost to Follow-up|11|||
37933788|NCT00734474|69620607|FG005|Overall Study|Lost to Follow-up|1|||
37933789|NCT00734474|69620608|FG006|Overall Study|Lost to Follow-up|0|||
37933790|NCT00734474|69620609|FG007|Overall Study|Lost to Follow-up|9|||
37933791|NCT00734474|69620610|FG008|Overall Study|Lost to Follow-up|4|||
37933792|NCT00734474|69620602|FG000|Overall Study|Withdrawal by Subject|2|||
37933793|NCT00734474|69620603|FG001|Overall Study|Withdrawal by Subject|1|||
37933794|NCT00734474|69620604|FG002|Overall Study|Withdrawal by Subject|18|||
37933795|NCT00734474|69620605|FG003|Overall Study|Withdrawal by Subject|0|||
37933796|NCT00734474|69620606|FG004|Overall Study|Withdrawal by Subject|24|||
37933797|NCT00734474|69620607|FG005|Overall Study|Withdrawal by Subject|2|||
37933798|NCT00734474|69620608|FG006|Overall Study|Withdrawal by Subject|0|||
37933799|NCT00734474|69620609|FG007|Overall Study|Withdrawal by Subject|36|||
37933800|NCT00734474|69620610|FG008|Overall Study|Withdrawal by Subject|21|||
37933801|NCT00734474|69620602|FG000|Overall Study|Physician Decision|0|||
37933802|NCT00734474|69620603|FG001|Overall Study|Physician Decision|0|||
37933803|NCT00734474|69620604|FG002|Overall Study|Physician Decision|4|||
37933804|NCT00734474|69620605|FG003|Overall Study|Physician Decision|1|||
37933805|NCT00734474|69620606|FG004|Overall Study|Physician Decision|11|||
37933806|NCT00734474|69620607|FG005|Overall Study|Physician Decision|0|||
37933807|NCT00734474|69620608|FG006|Overall Study|Physician Decision|0|||
37933808|NCT00734474|69620609|FG007|Overall Study|Physician Decision|9|||
37933809|NCT00734474|69620610|FG008|Overall Study|Physician Decision|9|||
37933810|NCT00734474|69620602|FG000|Overall Study|Adverse Event|4|||
37933811|NCT00734474|69620603|FG001|Overall Study|Adverse Event|4|||
37933812|NCT00734474|69620604|FG002|Overall Study|Adverse Event|63|||
37933813|NCT00734474|69620605|FG003|Overall Study|Adverse Event|1|||
37933814|NCT00734474|69620606|FG004|Overall Study|Adverse Event|64|||
37933815|NCT00734474|69620607|FG005|Overall Study|Adverse Event|0|||
37933816|NCT00734474|69620608|FG006|Overall Study|Adverse Event|1|||
37933817|NCT00734474|69620609|FG007|Overall Study|Adverse Event|65|||
37763257|NCT01450007|69275537|FG000|Overall Study|Protocol Violation|0|||
37763258|NCT01450007|69275538|FG001|Overall Study|Protocol Violation|1|||
37763259|NCT01450007|69275539|FG002|Overall Study|Protocol Violation|1|||
37763260|NCT01450007|69275537|FG000|Overall Study|Adverse Event|0|||
37763261|NCT01450007|69275538|FG001|Overall Study|Adverse Event|1|||
37763262|NCT01450007|69275539|FG002|Overall Study|Adverse Event|0|||
37763263|NCT01496365|69275554|FG000|Overall Study|Adverse Event|2|||
37763264|NCT01496365|69275555|FG001|Overall Study|Adverse Event|3|||
37763265|NCT01496365|69275556|FG002|Overall Study|Adverse Event|3|||
37763266|NCT01496365|69275557|FG003|Overall Study|Adverse Event|2|||
37763267|NCT01496365|69275558|FG004|Overall Study|Adverse Event|5|||
37763268|NCT01496365|69275559|FG005|Overall Study|Adverse Event|6|||
37763269|NCT01496365|69275560|FG006|Overall Study|Adverse Event|4|||
37763270|NCT01496365|69275554|FG000|Overall Study|Withdrawal by Subject|6|||
37763271|NCT01496365|69275555|FG001|Overall Study|Withdrawal by Subject|6|||
37763272|NCT01496365|69275556|FG002|Overall Study|Withdrawal by Subject|0|||
37763273|NCT01496365|69275557|FG003|Overall Study|Withdrawal by Subject|1|||
37763274|NCT01496365|69275558|FG004|Overall Study|Withdrawal by Subject|3|||
37763275|NCT01496365|69275559|FG005|Overall Study|Withdrawal by Subject|2|||
37763276|NCT01496365|69275560|FG006|Overall Study|Withdrawal by Subject|1|||
37763277|NCT01496365|69275554|FG000|Overall Study|Protocol Violation|2|||
37763278|NCT01496365|69275555|FG001|Overall Study|Protocol Violation|1|||
37763279|NCT01496365|69275556|FG002|Overall Study|Protocol Violation|1|||
37763280|NCT01496365|69275557|FG003|Overall Study|Protocol Violation|0|||
37763281|NCT01496365|69275558|FG004|Overall Study|Protocol Violation|0|||
37763282|NCT01496365|69275559|FG005|Overall Study|Protocol Violation|1|||
37763283|NCT01496365|69275560|FG006|Overall Study|Protocol Violation|0|||
37763284|NCT01496365|69275554|FG000|Overall Study|Lack of Efficacy|1|||
37763285|NCT01496365|69275555|FG001|Overall Study|Lack of Efficacy|0|||
37763286|NCT01496365|69275556|FG002|Overall Study|Lack of Efficacy|0|||
37763287|NCT01496365|69275557|FG003|Overall Study|Lack of Efficacy|0|||
37763288|NCT01496365|69275558|FG004|Overall Study|Lack of Efficacy|0|||
37763289|NCT01496365|69275559|FG005|Overall Study|Lack of Efficacy|1|||
37763290|NCT01496365|69275560|FG006|Overall Study|Lack of Efficacy|0|||
37763291|NCT01496365|69275554|FG000|Overall Study|Lost to Follow-up|0|||
37763292|NCT01496365|69275555|FG001|Overall Study|Lost to Follow-up|1|||
37763293|NCT01496365|69275556|FG002|Overall Study|Lost to Follow-up|0|||
37763294|NCT01496365|69275557|FG003|Overall Study|Lost to Follow-up|0|||
37763295|NCT01496365|69275558|FG004|Overall Study|Lost to Follow-up|2|||
37763296|NCT01496365|69275559|FG005|Overall Study|Lost to Follow-up|0|||
37763297|NCT01496365|69275560|FG006|Overall Study|Lost to Follow-up|0|||
37763298|NCT01496365|69275554|FG000|Overall Study|Other|4|||
37763299|NCT01496365|69275555|FG001|Overall Study|Other|4|||
37763300|NCT01496365|69275556|FG002|Overall Study|Other|2|||
37763301|NCT01496365|69275557|FG003|Overall Study|Other|1|||
37763302|NCT01496365|69275558|FG004|Overall Study|Other|3|||
37763303|NCT01496365|69275559|FG005|Overall Study|Other|0|||
37763304|NCT01496365|69275560|FG006|Overall Study|Other|1|||
37763305|NCT01496287|69275576|FG000|Overall Study|Lost to Follow-up|1|||
37763306|NCT01496287|69275576|FG000|Overall Study|Incomplete anesthesia|5|||
37763307|NCT01495975|69275583|FG000|Overall Study|Lost to Follow-up|1|||
37763308|NCT01495975|69275584|FG001|Overall Study|Lost to Follow-up|0|||
37763309|NCT01468987|69275592|FG000|Overall Study|Adverse Event|12|||
37763310|NCT01468987|69275593|FG001|Overall Study|Adverse Event|9|||
37763311|NCT01468987|69275592|FG000|Overall Study|Death|4|||
37763312|NCT01468987|69275593|FG001|Overall Study|Death|1|||
37763313|NCT01468987|69275592|FG000|Overall Study|Lost to Follow-up|10|||
37763314|NCT01468987|69275593|FG001|Overall Study|Lost to Follow-up|5|||
37933818|NCT00734474|69620610|FG008|Overall Study|Adverse Event|39|||
37933819|NCT00734474|69620602|FG000|Overall Study|Protocol Violation|0|||
37933820|NCT00734474|69620603|FG001|Overall Study|Protocol Violation|0|||
37933821|NCT00734474|69620604|FG002|Overall Study|Protocol Violation|4|||
37933822|NCT00734474|69620605|FG003|Overall Study|Protocol Violation|0|||
37933823|NCT00734474|69620606|FG004|Overall Study|Protocol Violation|3|||
37763315|NCT01468987|69275592|FG000|Overall Study|Protocol Violation|8|||
37763316|NCT01468987|69275593|FG001|Overall Study|Protocol Violation|2|||
37763317|NCT01468987|69275592|FG000|Overall Study|Withdrawal by Subject|28|||
37763318|NCT01468987|69275593|FG001|Overall Study|Withdrawal by Subject|28|||
37763319|NCT01468987|69275592|FG000|Overall Study|Physician Decision|8|||
37763320|NCT01468987|69275593|FG001|Overall Study|Physician Decision|15|||
37763321|NCT01468987|69275592|FG000|Overall Study|Sponsor Decision|1|||
37763322|NCT01468987|69275593|FG001|Overall Study|Sponsor Decision|0|||
37763323|NCT01687712|69275603|FG000|Cycle 1|Not Biochemically Pregnant|386|||
37763324|NCT01687712|69275604|FG001|Cycle 1|Not Biochemically Pregnant|348|||
37763325|NCT01687712|69275603|FG000|Cycle 1|Early Pregnancy Loss|43|||
37933824|NCT00734474|69620607|FG005|Overall Study|Protocol Violation|0|||
37763326|NCT01687712|69275604|FG001|Cycle 1|Early Pregnancy Loss|60|||
37763327|NCT01687712|69275603|FG000|Cycle 1|Ectopic Pregnancy|5|||
37763328|NCT01687712|69275604|FG001|Cycle 1|Ectopic Pregnancy|5|||
37763329|NCT01687712|69275603|FG000|Cycle 1|Heterotropic Pregnancy|1|||
37763330|NCT01687712|69275604|FG001|Cycle 1|Heterotropic Pregnancy|0|||
37763331|NCT01687712|69275603|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
37763332|NCT01687712|69275604|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
37763333|NCT01687712|69275603|FG000|Cycle 1|Abortion|3|||
37763334|NCT01687712|69275604|FG001|Cycle 1|Abortion|0|||
37763335|NCT01687712|69275603|FG000|Cycle 1|Intrauterine Fetal Death|0|||
37763336|NCT01687712|69275604|FG001|Cycle 1|Intrauterine Fetal Death|1|||
37763337|NCT01687712|69275603|FG000|Cycle 1|Lost to Follow-up|1|||
37763338|NCT01687712|69275604|FG001|Cycle 1|Lost to Follow-up|1|||
37763339|NCT01687712|69275603|FG000|Cycle 2|Not Biochemically Pregnant|74|||
37763340|NCT01687712|69275604|FG001|Cycle 2|Not Biochemically Pregnant|77|||
37763341|NCT01687712|69275603|FG000|Cycle 2|Early Pregnancy Loss|18|||
37763342|NCT01687712|69275604|FG001|Cycle 2|Early Pregnancy Loss|16|||
37763343|NCT01687712|69275603|FG000|Cycle 2|Ectopic Pregnancy|0|||
37763344|NCT01687712|69275604|FG001|Cycle 2|Ectopic Pregnancy|1|||
37763345|NCT01687712|69275603|FG000|Cycle 2|Still Birth|1|||
37763346|NCT01687712|69275604|FG001|Cycle 2|Still Birth|0|||
37763347|NCT01687712|69275603|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
37763348|NCT01687712|69275604|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
37763349|NCT01687712|69275603|FG000|Cycle 3|Not Biochemically Pregnant|21|||
37763350|NCT01687712|69275604|FG001|Cycle 3|Not Biochemically Pregnant|22|||
37763351|NCT01687712|69275603|FG000|Cycle 3|Early Pregnancy Loss|1|||
37763352|NCT01687712|69275604|FG001|Cycle 3|Early Pregnancy Loss|2|||
37763353|NCT01687712|69275603|FG000|Cycle 3|Ectopic Pregnancy|1|||
37763354|NCT01687712|69275604|FG001|Cycle 3|Ectopic Pregnancy|0|||
37763355|NCT01687712|69275603|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
37763356|NCT01687712|69275604|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
37763357|NCT01603628|69275617|FG000|Overall Study|Personal Reasons|1|||
37763358|NCT01603628|69275618|FG001|Overall Study|Personal Reasons|1|||
37763359|NCT01603628|69275619|FG002|Overall Study|Personal Reasons|2|||
37763360|NCT01603628|69275617|FG000|Overall Study|Protocol Violation|1|||
37763361|NCT01603628|69275618|FG001|Overall Study|Protocol Violation|1|||
37763362|NCT01603628|69275619|FG002|Overall Study|Protocol Violation|0|||
37763363|NCT01603628|69275617|FG000|Overall Study|Lost to Follow-up|0|||
37763364|NCT01603628|69275618|FG001|Overall Study|Lost to Follow-up|1|||
37763365|NCT01603628|69275619|FG002|Overall Study|Lost to Follow-up|0|||
37763366|NCT01603628|69275617|FG000|Overall Study|Other Miscellaneous Reason|1|||
37763367|NCT01603628|69275618|FG001|Overall Study|Other Miscellaneous Reason|0|||
37763368|NCT01603628|69275619|FG002|Overall Study|Other Miscellaneous Reason|0|||
37763369|NCT01453153|69275630|FG000|Overall Study|Physician Decision|0|||
37763370|NCT01453153|69275631|FG001|Overall Study|Physician Decision|0|||
37763371|NCT01453153|69275632|FG002|Overall Study|Physician Decision|1|||
37763372|NCT01453153|69275630|FG000|Overall Study|Progressive Disease|3|||
37763373|NCT01453153|69275631|FG001|Overall Study|Progressive Disease|2|||
37763374|NCT01453153|69275632|FG002|Overall Study|Progressive Disease|16|||
37763375|NCT01453153|69275630|FG000|Overall Study|Withdrawal by Subject|0|||
37763376|NCT01453153|69275631|FG001|Overall Study|Withdrawal by Subject|1|||
37763377|NCT01453153|69275632|FG002|Overall Study|Withdrawal by Subject|2|||
37763378|NCT01453153|69275630|FG000|Overall Study|Adverse Event|1|||
37763379|NCT01453153|69275631|FG001|Overall Study|Adverse Event|1|||
37763380|NCT01453153|69275632|FG002|Overall Study|Adverse Event|1|||
37763381|NCT01584440|69275646|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
37763382|NCT01584440|69275647|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
37763383|NCT01584440|69275648|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
37763384|NCT01584440|69275649|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
37763385|NCT01584440|69275650|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
37763386|NCT01584440|69275646|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
37763387|NCT01584440|69275647|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
37763388|NCT01584440|69275648|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
37763389|NCT01584440|69275649|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
37763390|NCT01584440|69275650|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
37933825|NCT00734474|69620608|FG006|Overall Study|Protocol Violation|0|||
37933826|NCT00734474|69620609|FG007|Overall Study|Protocol Violation|3|||
37763391|NCT01584440|69275646|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
37763392|NCT01584440|69275647|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
37763393|NCT01584440|69275648|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
37763394|NCT01584440|69275649|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
37933827|NCT00734474|69620610|FG008|Overall Study|Protocol Violation|1|||
37763395|NCT01584440|69275650|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
37763396|NCT01584440|69275646|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
37763397|NCT01584440|69275647|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
37763398|NCT01584440|69275648|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
37763399|NCT01584440|69275649|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
37763400|NCT01584440|69275650|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
37763401|NCT01584440|69275646|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
37763402|NCT01584440|69275647|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
37763403|NCT01584440|69275648|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
37763404|NCT01584440|69275649|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
37763405|NCT01584440|69275650|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
37763406|NCT01584440|69275646|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
37763407|NCT01584440|69275647|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
37763408|NCT01584440|69275648|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
37763409|NCT01584440|69275649|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
37763410|NCT01584440|69275650|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
37763411|NCT01584440|69275646|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
37763412|NCT01584440|69275647|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
37763413|NCT01584440|69275648|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
37763414|NCT01584440|69275649|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
37763415|NCT01584440|69275650|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
37763416|NCT01584440|69275646|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
37763417|NCT01584440|69275647|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
37763418|NCT01584440|69275648|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
37763419|NCT01584440|69275649|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
37763420|NCT01584440|69275650|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
37763421|NCT01584440|69275646|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
37763422|NCT01584440|69275647|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
37763423|NCT01584440|69275648|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
37763424|NCT01584440|69275649|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
37763425|NCT01584440|69275650|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
37763426|NCT01687478|69275665|FG000|Overall Study|Adverse Event|3|||
37763427|NCT01687478|69275666|FG001|Overall Study|Adverse Event|10|||
37763428|NCT01687478|69275665|FG000|Overall Study|Lost to Follow-up|1|||
37763429|NCT01687478|69275666|FG001|Overall Study|Lost to Follow-up|3|||
37763430|NCT01687478|69275665|FG000|Overall Study|Protocol Violation|0|||
37763431|NCT01687478|69275666|FG001|Overall Study|Protocol Violation|2|||
37763432|NCT01687478|69275665|FG000|Overall Study|Withdrawal by Subject|21|||
37763433|NCT01687478|69275666|FG001|Overall Study|Withdrawal by Subject|19|||
37763434|NCT01687478|69275665|FG000|Overall Study|Physician Decision|1|||
37763435|NCT01687478|69275666|FG001|Overall Study|Physician Decision|3|||
37933828|NCT00734474|69620602|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
37933829|NCT00734474|69620603|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
37763436|NCT01687478|69275665|FG000|Overall Study|Entry Criteria Not Met|6|||
37763437|NCT01687478|69275666|FG001|Overall Study|Entry Criteria Not Met|2|||
37763438|NCT01468909|69275674|FG000|Overall Study|Never Treated|2|||
37763439|NCT01468909|69275675|FG001|Overall Study|Never Treated|2|||
37763440|NCT01468597|69275681|FG000|Overall Study|Found ineligible|17|||
37763441|NCT01468597|69275681|FG000|Overall Study|concomitant valves|12|||
37763442|NCT01468597|69275681|FG000|Overall Study|off-pump CABG|1|||
37763443|NCT01468597|69275681|FG000|Overall Study|no platelet function data|5|||
37763444|NCT01687166|69275689|FG000|Overall Study|Attempt subject|2|||
37933830|NCT00734474|69620604|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
37933831|NCT00734474|69620605|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
37933832|NCT00734474|69620606|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
37933833|NCT00734474|69620607|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
37763445|NCT01687166|69275690|FG001|Overall Study|Attempt subject|3|||
37763446|NCT01687166|69275691|FG002|Overall Study|Attempt subject|2|||
37763447|NCT01687166|69275692|FG003|Overall Study|Attempt subject|0|||
37763448|NCT01687166|69275689|FG000|Overall Study|Did not meet eligibility criteria|4|||
37763449|NCT01687166|69275690|FG001|Overall Study|Did not meet eligibility criteria|6|||
37763450|NCT01687166|69275691|FG002|Overall Study|Did not meet eligibility criteria|1|||
37933834|NCT00734474|69620608|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
37933835|NCT00734474|69620609|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
37933836|NCT00734474|69620610|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
37933837|NCT00734474|69620602|FG000|Overall Study|Sponsor Decision|0|||
37933838|NCT00734474|69620603|FG001|Overall Study|Sponsor Decision|0|||
37933839|NCT00734474|69620604|FG002|Overall Study|Sponsor Decision|0|||
37933840|NCT00734474|69620605|FG003|Overall Study|Sponsor Decision|0|||
37933841|NCT00734474|69620606|FG004|Overall Study|Sponsor Decision|2|||
37933842|NCT00734474|69620607|FG005|Overall Study|Sponsor Decision|0|||
37933843|NCT00734474|69620608|FG006|Overall Study|Sponsor Decision|0|||
37933844|NCT00734474|69620609|FG007|Overall Study|Sponsor Decision|0|||
37933845|NCT00734474|69620610|FG008|Overall Study|Sponsor Decision|0|||
37933846|NCT00734474|69620602|FG000|Overall Study|Death|0|||
37933847|NCT00734474|69620603|FG001|Overall Study|Death|0|||
37670030|NCT02540265|69143246|FG001|Overall Study|Lost to Follow-up|0|||
37763451|NCT01687166|69275692|FG003|Overall Study|Did not meet eligibility criteria|1|||
37763452|NCT01687166|69275689|FG000|Overall Study|Adverse Event|2|||
37763453|NCT01687166|69275690|FG001|Overall Study|Adverse Event|1|||
37763454|NCT01687166|69275691|FG002|Overall Study|Adverse Event|0|||
37763455|NCT01687166|69275692|FG003|Overall Study|Adverse Event|0|||
37763456|NCT01687166|69275689|FG000|Overall Study|Physician Decision|3|||
37763457|NCT01687166|69275690|FG001|Overall Study|Physician Decision|2|||
37933848|NCT00734474|69620604|FG002|Overall Study|Death|1|||
37933849|NCT00734474|69620605|FG003|Overall Study|Death|0|||
37933850|NCT00734474|69620606|FG004|Overall Study|Death|0|||
37763458|NCT01687166|69275691|FG002|Overall Study|Physician Decision|1|||
37763459|NCT01687166|69275692|FG003|Overall Study|Physician Decision|0|||
37763460|NCT01687166|69275689|FG000|Overall Study|Withdrawal by Subject|11|||
37763461|NCT01687166|69275690|FG001|Overall Study|Withdrawal by Subject|4|||
37763462|NCT01687166|69275691|FG002|Overall Study|Withdrawal by Subject|3|||
37763463|NCT01687166|69275692|FG003|Overall Study|Withdrawal by Subject|0|||
37763464|NCT01687166|69275689|FG000|Overall Study|Lost to Follow-up|2|||
37763465|NCT01687166|69275690|FG001|Overall Study|Lost to Follow-up|5|||
37763466|NCT01687166|69275691|FG002|Overall Study|Lost to Follow-up|1|||
37763467|NCT01687166|69275692|FG003|Overall Study|Lost to Follow-up|0|||
37763468|NCT01687166|69275689|FG000|Overall Study|Equipment/Device Availability|0|||
37763469|NCT01687166|69275690|FG001|Overall Study|Equipment/Device Availability|1|||
37763470|NCT01687166|69275691|FG002|Overall Study|Equipment/Device Availability|0|||
37763471|NCT01687166|69275692|FG003|Overall Study|Equipment/Device Availability|0|||
37763472|NCT01687166|69275689|FG000|Overall Study|Death|1|||
37763473|NCT01687166|69275690|FG001|Overall Study|Death|1|||
37763474|NCT01687166|69275691|FG002|Overall Study|Death|0|||
37763475|NCT01687166|69275692|FG003|Overall Study|Death|0|||
37763476|NCT01687166|69275689|FG000|Overall Study|Protocol Violation|1|||
37763477|NCT01687166|69275690|FG001|Overall Study|Protocol Violation|1|||
37763478|NCT01687166|69275691|FG002|Overall Study|Protocol Violation|1|||
37763479|NCT01687166|69275692|FG003|Overall Study|Protocol Violation|0|||
37763480|NCT01687166|69275689|FG000|Overall Study|Subject moved out of state|0|||
37763481|NCT01687166|69275690|FG001|Overall Study|Subject moved out of state|1|||
37763482|NCT01687166|69275691|FG002|Overall Study|Subject moved out of state|0|||
37763483|NCT01687166|69275692|FG003|Overall Study|Subject moved out of state|0|||
37763484|NCT01687166|69275689|FG000|Overall Study|Patient unable to be compliant|1|||
37763485|NCT01687166|69275690|FG001|Overall Study|Patient unable to be compliant|0|||
37763486|NCT01687166|69275691|FG002|Overall Study|Patient unable to be compliant|0|||
37763487|NCT01687166|69275692|FG003|Overall Study|Patient unable to be compliant|0|||
37763488|NCT01687166|69275689|FG000|Overall Study|Physician choice to use different device|1|||
37933851|NCT00734474|69620607|FG005|Overall Study|Death|0|||
37933852|NCT00734474|69620608|FG006|Overall Study|Death|0|||
37933853|NCT00734474|69620609|FG007|Overall Study|Death|2|||
37933854|NCT00734474|69620610|FG008|Overall Study|Death|1|||
37933855|NCT00734474|69620602|FG000|Overall Study|Lack of Efficacy|0|||
37933856|NCT00734474|69620603|FG001|Overall Study|Lack of Efficacy|0|||
37933857|NCT00734474|69620604|FG002|Overall Study|Lack of Efficacy|4|||
37933858|NCT00734474|69620605|FG003|Overall Study|Lack of Efficacy|0|||
37933859|NCT00734474|69620606|FG004|Overall Study|Lack of Efficacy|0|||
37933860|NCT00734474|69620607|FG005|Overall Study|Lack of Efficacy|0|||
37933861|NCT00734474|69620608|FG006|Overall Study|Lack of Efficacy|0|||
37933862|NCT00734474|69620609|FG007|Overall Study|Lack of Efficacy|4|||
37933863|NCT00734474|69620610|FG008|Overall Study|Lack of Efficacy|6|||
37933864|NCT00583362|69620636|FG000|Overall Study|Adverse Event|44|||
37933865|NCT00583362|69620636|FG000|Overall Study|Lack of Efficacy|22|||
37933866|NCT00583362|69620636|FG000|Overall Study|Lost to Follow-up|4|||
37933867|NCT00583362|69620636|FG000|Overall Study|Non-compliance with study drug|28|||
37670031|NCT02540265|69143247|FG002|Overall Study|Lost to Follow-up|1|||
37670032|NCT02547363|69143257|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
37670033|NCT02547363|69143258|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
37670034|NCT02547363|69143257|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
37670035|NCT02547363|69143258|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
37670036|NCT02547363|69143257|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
37670037|NCT02547363|69143258|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
37670038|NCT02547363|69143257|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
37670039|NCT02547363|69143258|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
37670040|NCT02547363|69143257|FG000|12-month Follow-up|Withdrawal by Subject|4|||
37670041|NCT02547363|69143258|FG001|12-month Follow-up|Withdrawal by Subject|3|||
37670042|NCT02547363|69143257|FG000|12-month Follow-up|Lost to Follow-up|4|||
37670043|NCT02547363|69143258|FG001|12-month Follow-up|Lost to Follow-up|1|||
37670044|NCT02547363|69143257|FG000|12-month Follow-up|Lack of Efficacy|1|||
37670045|NCT02547363|69143258|FG001|12-month Follow-up|Lack of Efficacy|1|||
37670046|NCT02547363|69143257|FG000|12-month Follow-up|Other|1|||
37670047|NCT02547363|69143258|FG001|12-month Follow-up|Other|0|||
37763489|NCT01687166|69275690|FG001|Overall Study|Physician choice to use different device|2|||
37763490|NCT01687166|69275691|FG002|Overall Study|Physician choice to use different device|4|||
37763491|NCT01687166|69275692|FG003|Overall Study|Physician choice to use different device|0|||
37763492|NCT01687166|69275689|FG000|Overall Study|Insurance|0|||
37763493|NCT01687166|69275690|FG001|Overall Study|Insurance|0|||
37763494|NCT01687166|69275691|FG002|Overall Study|Insurance|1|||
37763495|NCT01687166|69275692|FG003|Overall Study|Insurance|1|||
37763496|NCT01561976|69275706|FG000|Period 1|Adverse Event|0|||
37933868|NCT00583362|69620636|FG000|Overall Study|Pregnancy|7|||
37933869|NCT00583362|69620636|FG000|Overall Study|Miscommunication of visit window|5|||
37933870|NCT00583362|69620636|FG000|Overall Study|Current site closed|7|||
37933871|NCT00583362|69620636|FG000|Overall Study|Subject not dosed in LBSL99|1|||
37763497|NCT01561976|69275707|FG001|Period 1|Adverse Event|0|||
37763498|NCT01561976|69275708|FG002|Period 1|Adverse Event|1|||
37763499|NCT01561976|69275709|FG003|Period 1|Adverse Event|0|||
37763500|NCT01561976|69275710|FG004|Period 1|Adverse Event|0|||
37763501|NCT01561976|69275711|FG005|Period 1|Adverse Event|0|||
37763502|NCT01561976|69275706|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
37763503|NCT01561976|69275707|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
37763504|NCT01561976|69275708|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
37763505|NCT01561976|69275709|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
37933872|NCT00583362|69620636|FG000|Overall Study|Subject moved out of the country/state|2|||
37933873|NCT00583362|69620636|FG000|Overall Study|Missed visits due to staff changes|1|||
37933874|NCT00583362|69620636|FG000|Overall Study|Misunderstanding of protocol|1|||
37933875|NCT00583362|69620636|FG000|Overall Study|Behavioral problems and non-compliance|1|||
37933876|NCT00583362|69620636|FG000|Overall Study|Sponsor request due to missed doses|1|||
37933877|NCT00583362|69620636|FG000|Overall Study|Physician Decision|19|||
37933878|NCT00583362|69620636|FG000|Overall Study|Protocol Violation|2|||
37933879|NCT00583362|69620636|FG000|Overall Study|Withdrawal by Subject|57|||
37933880|NCT00577473|69620642|FG000|Overall Study|Protocol Violation|1|||
37933881|NCT00577473|69620643|FG001|Overall Study|Protocol Violation|4|||
37933882|NCT00577473|69620642|FG000|Overall Study|Adverse Event|8|||
37933883|NCT00577473|69620643|FG001|Overall Study|Adverse Event|5|||
37933884|NCT00577473|69620642|FG000|Overall Study|Withdrawal by Subject|2|||
37933885|NCT00577473|69620643|FG001|Overall Study|Withdrawal by Subject|6|||
37933886|NCT00577473|69620642|FG000|Overall Study|Physician Decision|2|||
37933887|NCT00577473|69620643|FG001|Overall Study|Physician Decision|2|||
37933888|NCT00577473|69620642|FG000|Overall Study|Lack of Efficacy|8|||
37933889|NCT00577473|69620643|FG001|Overall Study|Lack of Efficacy|7|||
37933890|NCT00785291|69620652|FG000|Overall Study|Never began treatment|8|||
37933891|NCT00785291|69620653|FG001|Overall Study|Never began treatment|4|||
37933892|NCT00785291|69620654|FG002|Overall Study|Never began treatment|4|||
37933893|NCT00785291|69620652|FG000|Overall Study|Adverse Event|39|||
37933894|NCT00785291|69620653|FG001|Overall Study|Adverse Event|70|||
37933895|NCT00785291|69620654|FG002|Overall Study|Adverse Event|56|||
37933896|NCT00785291|69620652|FG000|Overall Study|Death|7|||
37933897|NCT00785291|69620653|FG001|Overall Study|Death|4|||
37763506|NCT01561976|69275710|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
37763507|NCT01561976|69275711|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
37933898|NCT00785291|69620654|FG002|Overall Study|Death|3|||
37933899|NCT00785291|69620652|FG000|Overall Study|Withdrawal by Subject|35|||
37933900|NCT00785291|69620653|FG001|Overall Study|Withdrawal by Subject|36|||
37933901|NCT00785291|69620654|FG002|Overall Study|Withdrawal by Subject|17|||
37933902|NCT00785291|69620652|FG000|Overall Study|Alternative Therapy|12|||
37933903|NCT00785291|69620653|FG001|Overall Study|Alternative Therapy|6|||
37933904|NCT00785291|69620654|FG002|Overall Study|Alternative Therapy|7|||
37933905|NCT00785291|69620652|FG000|Overall Study|Complicating illness|6|||
37933906|NCT00785291|69620653|FG001|Overall Study|Complicating illness|4|||
37763508|NCT01561976|69275706|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
37763509|NCT01561976|69275707|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
37763510|NCT01561976|69275708|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
37763511|NCT01561976|69275709|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
37763512|NCT01561976|69275710|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
37763513|NCT01561976|69275711|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
37763514|NCT01561976|69275706|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
37763515|NCT01561976|69275707|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
37763516|NCT01561976|69275708|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
37763517|NCT01561976|69275709|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
37763518|NCT01561976|69275710|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
37763519|NCT01561976|69275711|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
37763520|NCT01686932|69275721|FG000|Period 1|Adverse Event|1|||
37763521|NCT01686932|69275722|FG001|Period 1|Adverse Event|1|||
37763522|NCT01468207|69275730|FG000|Treatment Period 1|Adverse Event|1|||
37670048|NCT02539797|69143266|FG000|Overall Study|Lost to Follow-up|0|||
37763523|NCT01468207|69275731|FG001|Treatment Period 1|Adverse Event|0|||
37763524|NCT01468207|69275732|FG002|Treatment Period 1|Adverse Event|0|||
37763525|NCT01468207|69275733|FG003|Treatment Period 1|Adverse Event|0|||
37763526|NCT01468207|69275734|FG004|Treatment Period 1|Adverse Event|0|||
37763527|NCT01468207|69275735|FG005|Treatment Period 1|Adverse Event|0|||
37763528|NCT01468207|69275730|FG000|Treatment Period 1|Protocol Violation|1|||
37763529|NCT01468207|69275731|FG001|Treatment Period 1|Protocol Violation|1|||
37933907|NCT00785291|69620654|FG002|Overall Study|Complicating illness|4|||
37933908|NCT00785291|69620652|FG000|Overall Study|Other Medical Reasons|29|||
37933909|NCT00785291|69620653|FG001|Overall Study|Other Medical Reasons|25|||
37763530|NCT01468207|69275732|FG002|Treatment Period 1|Protocol Violation|0|||
37763531|NCT01468207|69275733|FG003|Treatment Period 1|Protocol Violation|0|||
37933910|NCT00785291|69620654|FG002|Overall Study|Other Medical Reasons|15|||
37933911|NCT00705939|69620665|FG000|Overall Study|Protocol Violation|0|||
37933912|NCT00705939|69620666|FG001|Overall Study|Protocol Violation|0|||
37763532|NCT01468207|69275734|FG004|Treatment Period 1|Protocol Violation|0|||
37763533|NCT01468207|69275735|FG005|Treatment Period 1|Protocol Violation|0|||
37763534|NCT01468207|69275730|FG000|Treatment Period 1|Withdrawal by Subject|5|||
37763535|NCT01468207|69275731|FG001|Treatment Period 1|Withdrawal by Subject|4|||
37763536|NCT01468207|69275732|FG002|Treatment Period 1|Withdrawal by Subject|0|||
37763537|NCT01468207|69275733|FG003|Treatment Period 1|Withdrawal by Subject|0|||
37763538|NCT01468207|69275734|FG004|Treatment Period 1|Withdrawal by Subject|0|||
37763539|NCT01468207|69275735|FG005|Treatment Period 1|Withdrawal by Subject|0|||
37763540|NCT01468207|69275730|FG000|Treatment Period 1|Lost to Follow-up|2|||
37763541|NCT01468207|69275731|FG001|Treatment Period 1|Lost to Follow-up|1|||
37763542|NCT01468207|69275732|FG002|Treatment Period 1|Lost to Follow-up|0|||
37763543|NCT01468207|69275733|FG003|Treatment Period 1|Lost to Follow-up|0|||
37763544|NCT01468207|69275734|FG004|Treatment Period 1|Lost to Follow-up|0|||
37763545|NCT01468207|69275735|FG005|Treatment Period 1|Lost to Follow-up|0|||
37763546|NCT01468207|69275730|FG000|Treatment Period 1|Other|0|||
37763547|NCT01468207|69275731|FG001|Treatment Period 1|Other|2|||
37763548|NCT01468207|69275732|FG002|Treatment Period 1|Other|0|||
37763549|NCT01468207|69275733|FG003|Treatment Period 1|Other|0|||
37763550|NCT01468207|69275734|FG004|Treatment Period 1|Other|0|||
37763551|NCT01468207|69275735|FG005|Treatment Period 1|Other|0|||
37763552|NCT01468207|69275730|FG000|Treatment Period 2|Adverse Event|0|||
37763553|NCT01468207|69275731|FG001|Treatment Period 2|Adverse Event|0|||
37763554|NCT01468207|69275732|FG002|Treatment Period 2|Adverse Event|6|||
37763555|NCT01468207|69275733|FG003|Treatment Period 2|Adverse Event|1|||
37763556|NCT01468207|69275734|FG004|Treatment Period 2|Adverse Event|2|||
37763557|NCT01468207|69275735|FG005|Treatment Period 2|Adverse Event|1|||
37763558|NCT01468207|69275730|FG000|Treatment Period 2|Lack of Efficacy|0|||
37763559|NCT01468207|69275731|FG001|Treatment Period 2|Lack of Efficacy|0|||
37763560|NCT01468207|69275732|FG002|Treatment Period 2|Lack of Efficacy|1|||
37763561|NCT01468207|69275733|FG003|Treatment Period 2|Lack of Efficacy|1|||
37763562|NCT01468207|69275734|FG004|Treatment Period 2|Lack of Efficacy|0|||
37763563|NCT01468207|69275735|FG005|Treatment Period 2|Lack of Efficacy|2|||
37763564|NCT01468207|69275730|FG000|Treatment Period 2|Withdrawal by Subject|0|||
37763565|NCT01468207|69275731|FG001|Treatment Period 2|Withdrawal by Subject|0|||
37763566|NCT01468207|69275732|FG002|Treatment Period 2|Withdrawal by Subject|5|||
37763567|NCT01468207|69275733|FG003|Treatment Period 2|Withdrawal by Subject|0|||
37763568|NCT01468207|69275734|FG004|Treatment Period 2|Withdrawal by Subject|0|||
37763569|NCT01468207|69275735|FG005|Treatment Period 2|Withdrawal by Subject|2|||
37763570|NCT01468207|69275730|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
37763571|NCT01468207|69275731|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
37763572|NCT01468207|69275732|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
37763573|NCT01468207|69275733|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
37763574|NCT01468207|69275734|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
37763575|NCT01468207|69275735|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
37763576|NCT01468207|69275730|FG000|Treatment Period 2|Lost to Follow-up|0|||
37763577|NCT01468207|69275731|FG001|Treatment Period 2|Lost to Follow-up|0|||
37763578|NCT01468207|69275732|FG002|Treatment Period 2|Lost to Follow-up|5|||
37763579|NCT01468207|69275733|FG003|Treatment Period 2|Lost to Follow-up|1|||
37763580|NCT01468207|69275734|FG004|Treatment Period 2|Lost to Follow-up|0|||
37763581|NCT01468207|69275735|FG005|Treatment Period 2|Lost to Follow-up|0|||
37763582|NCT01468207|69275730|FG000|Treatment Period 2|Other|0|||
37763583|NCT01468207|69275731|FG001|Treatment Period 2|Other|0|||
37933913|NCT00705939|69620667|FG002|Overall Study|Protocol Violation|1|||
37933914|NCT00705939|69620665|FG000|Overall Study|Withdrawal by Subject|0|||
37933915|NCT00705939|69620666|FG001|Overall Study|Withdrawal by Subject|1|||
37933916|NCT00705939|69620667|FG002|Overall Study|Withdrawal by Subject|3|||
37933917|NCT00705939|69620665|FG000|Overall Study|Physician Decision|0|||
37670049|NCT02539797|69143267|FG001|Overall Study|Lost to Follow-up|1|||
37670050|NCT02539797|69143268|FG002|Overall Study|Lost to Follow-up|0|||
37670051|NCT02684357|69143279|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
37670052|NCT02684357|69143280|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
37670053|NCT02684357|69143281|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
37670054|NCT02684357|69143282|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
37670055|NCT02684357|69143283|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
37670056|NCT02684357|69143284|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
37763584|NCT01468207|69275732|FG002|Treatment Period 2|Other|5|||
38034999|NCT04230213|69721864|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
37763585|NCT01468207|69275733|FG003|Treatment Period 2|Other|1|||
37763586|NCT01468207|69275734|FG004|Treatment Period 2|Other|1|||
37763587|NCT01468207|69275735|FG005|Treatment Period 2|Other|2|||
37763588|NCT01494649|69275755|FG000|Overall Study|Lost to Follow-up|0|||
37763589|NCT01494649|69275756|FG001|Overall Study|Lost to Follow-up|1|||
37763590|NCT01686152|69275767|FG000|Overall Study|Withdrawal by Subject|11|||
37763591|NCT01686152|69275768|FG001|Overall Study|Withdrawal by Subject|11|||
37763592|NCT01686152|69275769|FG002|Overall Study|Withdrawal by Subject|3|||
37670057|NCT02684357|69143279|FG000|Part A|Lost to Follow-up|0|||
37763593|NCT01686152|69275767|FG000|Overall Study|Drug Code Unblinded|0|||
37763594|NCT01686152|69275768|FG001|Overall Study|Drug Code Unblinded|1|||
37763595|NCT01686152|69275769|FG002|Overall Study|Drug Code Unblinded|0|||
37763596|NCT01686152|69275767|FG000|Overall Study|Protocol Violation|6|||
37763597|NCT01686152|69275768|FG001|Overall Study|Protocol Violation|1|||
37763598|NCT01686152|69275769|FG002|Overall Study|Protocol Violation|0|||
37763599|NCT01686152|69275767|FG000|Overall Study|Adverse Event|12|||
37763600|NCT01686152|69275768|FG001|Overall Study|Adverse Event|11|||
37763601|NCT01686152|69275769|FG002|Overall Study|Adverse Event|0|||
37763602|NCT01686152|69275767|FG000|Overall Study|Lack of Efficacy|0|||
37763603|NCT01686152|69275768|FG001|Overall Study|Lack of Efficacy|0|||
37763604|NCT01686152|69275769|FG002|Overall Study|Lack of Efficacy|1|||
37763605|NCT01686152|69275767|FG000|Overall Study|IP Non-compliance|5|||
37763606|NCT01686152|69275768|FG001|Overall Study|IP Non-compliance|5|||
37763607|NCT01686152|69275769|FG002|Overall Study|IP Non-compliance|0|||
37763608|NCT01686152|69275767|FG000|Overall Study|Lost to Follow-up|7|||
37763609|NCT01686152|69275768|FG001|Overall Study|Lost to Follow-up|6|||
37763610|NCT01686152|69275769|FG002|Overall Study|Lost to Follow-up|5|||
37763611|NCT01452919|69275777|FG000|Open-Label Treatment|Adverse Event|5|||
37933918|NCT00705939|69620666|FG001|Overall Study|Physician Decision|1|||
37933919|NCT00705939|69620667|FG002|Overall Study|Physician Decision|0|||
37933920|NCT00785213|69620676|FG000|Quinine Sulfate Alone|Adverse Event|4|||
37933921|NCT00785213|69620676|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
37933922|NCT00577317|69620685|FG000|Overall Study|Study Terminated|0|||
37933923|NCT00577317|69620686|FG001|Overall Study|Study Terminated|2|||
37933924|NCT00734162|69620696|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
37933925|NCT00734162|69620697|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
37933926|NCT00734162|69620698|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
37933927|NCT00734162|69620699|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
37933928|NCT00734162|69620696|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
37933929|NCT00734162|69620697|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
37933930|NCT00734162|69620698|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
37933931|NCT00734162|69620699|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
37933932|NCT00734162|69620696|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
37933933|NCT00734162|69620697|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
37933934|NCT00734162|69620698|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
37933935|NCT00734162|69620699|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
37933936|NCT00734162|69620696|FG000|Open-Label Phase|Withdrew Consent|1|||
37933937|NCT00734162|69620697|FG001|Open-Label Phase|Withdrew Consent|0|||
37933938|NCT00734162|69620698|FG002|Open-Label Phase|Withdrew Consent|1|||
37763612|NCT01452919|69275778|FG001|Open-Label Treatment|Adverse Event|0|||
37763613|NCT01452919|69275779|FG002|Open-Label Treatment|Adverse Event|0|||
37763614|NCT01452919|69275777|FG000|Open-Label Treatment|Lost to Follow-up|4|||
37763615|NCT01452919|69275778|FG001|Open-Label Treatment|Lost to Follow-up|0|||
37763616|NCT01452919|69275779|FG002|Open-Label Treatment|Lost to Follow-up|0|||
37933939|NCT00734162|69620699|FG003|Open-Label Phase|Withdrew Consent|1|||
37933940|NCT00734162|69620696|FG000|Open-Label Phase|Lost to Follow-up|1|||
37933941|NCT00734162|69620697|FG001|Open-Label Phase|Lost to Follow-up|2|||
37933942|NCT00734162|69620698|FG002|Open-Label Phase|Lost to Follow-up|0|||
37933943|NCT00734162|69620699|FG003|Open-Label Phase|Lost to Follow-up|1|||
37933944|NCT00734162|69620696|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
37933945|NCT00734162|69620697|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
37933946|NCT00734162|69620698|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
37933947|NCT00734162|69620699|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
37670058|NCT02684357|69143280|FG001|Part A|Lost to Follow-up|2|||
37670059|NCT02684357|69143281|FG002|Part A|Lost to Follow-up|2|||
37670060|NCT02684357|69143282|FG003|Part A|Lost to Follow-up|0|||
37670061|NCT02684357|69143283|FG004|Part A|Lost to Follow-up|0|||
37670062|NCT02684357|69143284|FG005|Part A|Lost to Follow-up|0|||
37670063|NCT02684357|69143279|FG000|Part A|Withdrawal by Subject|3|||
37670064|NCT02684357|69143280|FG001|Part A|Withdrawal by Subject|0|||
37670065|NCT02684357|69143281|FG002|Part A|Withdrawal by Subject|0|||
37670066|NCT02684357|69143282|FG003|Part A|Withdrawal by Subject|0|||
37670067|NCT02684357|69143283|FG004|Part A|Withdrawal by Subject|0|||
37670068|NCT02684357|69143284|FG005|Part A|Withdrawal by Subject|0|||
37763617|NCT01452919|69275777|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
37763618|NCT01452919|69275778|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
37763619|NCT01452919|69275779|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
37933948|NCT00790751|69620717|FG000|Overall Study|Protocol non-compliance|16|||
37933949|NCT00790751|69620718|FG001|Overall Study|Protocol non-compliance|16|||
37763620|NCT01452919|69275777|FG000|Open-Label Treatment|Protocol Violation|4|||
37670069|NCT02684357|69143279|FG000|Part A|Other|0|||
37670070|NCT02684357|69143280|FG001|Part A|Other|1|||
37670071|NCT02684357|69143281|FG002|Part A|Other|0|||
37670072|NCT02684357|69143282|FG003|Part A|Other|0|||
37670073|NCT02684357|69143283|FG004|Part A|Other|0|||
37763621|NCT01452919|69275778|FG001|Open-Label Treatment|Protocol Violation|0|||
37763622|NCT01452919|69275779|FG002|Open-Label Treatment|Protocol Violation|0|||
37763623|NCT01452919|69275777|FG000|Open-Label Treatment|Sponsor Decision|1|||
37763624|NCT01452919|69275778|FG001|Open-Label Treatment|Sponsor Decision|0|||
37763625|NCT01452919|69275779|FG002|Open-Label Treatment|Sponsor Decision|0|||
37763626|NCT01452919|69275777|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
37763627|NCT01452919|69275778|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
37763628|NCT01452919|69275779|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
37763629|NCT01452919|69275777|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
37763630|NCT01452919|69275778|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
37763631|NCT01452919|69275779|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
37763632|NCT01452919|69275777|FG000|Randomization Treatment|Adverse Event|0|||
37763633|NCT01452919|69275778|FG001|Randomization Treatment|Adverse Event|0|||
37763634|NCT01452919|69275779|FG002|Randomization Treatment|Adverse Event|2|||
37763635|NCT01452919|69275777|FG000|Randomization Treatment|Sponsor Decision|0|||
37763636|NCT01452919|69275778|FG001|Randomization Treatment|Sponsor Decision|1|||
37763637|NCT01452919|69275779|FG002|Randomization Treatment|Sponsor Decision|0|||
37763638|NCT01452919|69275777|FG000|Randomization Treatment|Withdrawal by Subject|0|||
37763639|NCT01452919|69275778|FG001|Randomization Treatment|Withdrawal by Subject|1|||
37763640|NCT01452919|69275779|FG002|Randomization Treatment|Withdrawal by Subject|0|||
37763641|NCT01452919|69275777|FG000|Randomization Treatment|Subject is moving or has moved|0|||
37763642|NCT01452919|69275778|FG001|Randomization Treatment|Subject is moving or has moved|1|||
37763643|NCT01452919|69275779|FG002|Randomization Treatment|Subject is moving or has moved|0|||
37763644|NCT01582178|69275791|FG000|Overall Study|Physician Decision|6|||
37763645|NCT01582178|69275792|FG001|Overall Study|Physician Decision|5|||
37763646|NCT01561898|69275802|FG000|Overall Study|Withdrawal by Subject|0|||
37763647|NCT01561898|69275803|FG001|Overall Study|Withdrawal by Subject|8|||
37763648|NCT01561898|69275804|FG002|Overall Study|Withdrawal by Subject|12|||
37763649|NCT01561898|69275805|FG003|Overall Study|Withdrawal by Subject|5|||
37763650|NCT01561898|69275802|FG000|Overall Study|Lack of Efficacy|0|||
37763651|NCT01561898|69275803|FG001|Overall Study|Lack of Efficacy|8|||
37763652|NCT01561898|69275804|FG002|Overall Study|Lack of Efficacy|10|||
37763653|NCT01561898|69275805|FG003|Overall Study|Lack of Efficacy|5|||
37763654|NCT01561898|69275802|FG000|Overall Study|Worsening of complications|0|||
37763655|NCT01561898|69275803|FG001|Overall Study|Worsening of complications|1|||
37763656|NCT01561898|69275804|FG002|Overall Study|Worsening of complications|0|||
37763657|NCT01561898|69275805|FG003|Overall Study|Worsening of complications|0|||
37763658|NCT01561898|69275802|FG000|Overall Study|Lost to Follow-up|0|||
37763659|NCT01561898|69275803|FG001|Overall Study|Lost to Follow-up|0|||
37763660|NCT01561898|69275804|FG002|Overall Study|Lost to Follow-up|1|||
37763661|NCT01561898|69275805|FG003|Overall Study|Lost to Follow-up|0|||
37763662|NCT01561898|69275802|FG000|Overall Study|Adverse Event|1|||
37763663|NCT01561898|69275803|FG001|Overall Study|Adverse Event|19|||
37763664|NCT01561898|69275804|FG002|Overall Study|Adverse Event|14|||
37763665|NCT01561898|69275805|FG003|Overall Study|Adverse Event|9|||
37763666|NCT01561898|69275802|FG000|Overall Study|Physician Decision|1|||
37763667|NCT01561898|69275803|FG001|Overall Study|Physician Decision|5|||
37763668|NCT01561898|69275804|FG002|Overall Study|Physician Decision|7|||
37763669|NCT01561898|69275805|FG003|Overall Study|Physician Decision|1|||
37763670|NCT01685840|69275815|FG000|Overall Study|Death|77|||
37763671|NCT01685840|69275816|FG001|Overall Study|Death|66|||
37763672|NCT01685840|69275815|FG000|Overall Study|Lost to Follow-up|27|||
37763673|NCT01685840|69275816|FG001|Overall Study|Lost to Follow-up|25|||
37763674|NCT01685840|69275815|FG000|Overall Study|Physician Decision|3|||
37763675|NCT01685840|69275816|FG001|Overall Study|Physician Decision|7|||
37763676|NCT01685840|69275815|FG000|Overall Study|Withdrawal by Subject|14|||
37763677|NCT01685840|69275816|FG001|Overall Study|Withdrawal by Subject|17|||
37763678|NCT01685840|69275815|FG000|Overall Study|Futility|197|||
37763679|NCT01685840|69275816|FG001|Overall Study|Futility|200|||
37763680|NCT01685840|69275815|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
37763681|NCT01685840|69275816|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
37763682|NCT01452529|69275826|FG000|Run-in Period|Adverse Event|96|||
37763683|NCT01452529|69275827|FG001|Run-in Period|Adverse Event|0|||
37763684|NCT01452529|69275828|FG002|Run-in Period|Adverse Event|0|||
37763685|NCT01452529|69275826|FG000|Run-in Period|Withdrawal by Subject|49|||
37933950|NCT00790751|69620719|FG002|Overall Study|Protocol non-compliance|10|||
37933951|NCT00790751|69620720|FG003|Overall Study|Protocol non-compliance|11|||
37763686|NCT01452529|69275827|FG001|Run-in Period|Withdrawal by Subject|0|||
37763687|NCT01452529|69275828|FG002|Run-in Period|Withdrawal by Subject|0|||
37763688|NCT01452529|69275826|FG000|Run-in Period|Lost to Follow-up|19|||
37763689|NCT01452529|69275827|FG001|Run-in Period|Lost to Follow-up|0|||
37763690|NCT01452529|69275828|FG002|Run-in Period|Lost to Follow-up|0|||
37763691|NCT01452529|69275826|FG000|Run-in Period|Lack of Efficacy|46|||
37933952|NCT00790751|69620717|FG000|Overall Study|Lost to Follow-up|4|||
37763692|NCT01452529|69275827|FG001|Run-in Period|Lack of Efficacy|0|||
37763693|NCT01452529|69275828|FG002|Run-in Period|Lack of Efficacy|0|||
37933953|NCT00790751|69620718|FG001|Overall Study|Lost to Follow-up|9|||
37933954|NCT00790751|69620719|FG002|Overall Study|Lost to Follow-up|4|||
37933955|NCT00790751|69620720|FG003|Overall Study|Lost to Follow-up|5|||
37933956|NCT00790751|69620717|FG000|Overall Study|Adverse Event|5|||
37933957|NCT00790751|69620718|FG001|Overall Study|Adverse Event|3|||
37933958|NCT00790751|69620719|FG002|Overall Study|Adverse Event|5|||
37933959|NCT00790751|69620720|FG003|Overall Study|Adverse Event|4|||
37933960|NCT00790751|69620717|FG000|Overall Study|Requirement for restricted medication|0|||
37933961|NCT00790751|69620718|FG001|Overall Study|Requirement for restricted medication|2|||
37933962|NCT00790751|69620719|FG002|Overall Study|Requirement for restricted medication|0|||
37933963|NCT00790751|69620720|FG003|Overall Study|Requirement for restricted medication|0|||
37933964|NCT00790751|69620717|FG000|Overall Study|Death|0|||
37933965|NCT00790751|69620718|FG001|Overall Study|Death|0|||
37933966|NCT00790751|69620719|FG002|Overall Study|Death|1|||
37933967|NCT00790751|69620720|FG003|Overall Study|Death|0|||
37933968|NCT00790751|69620717|FG000|Overall Study|Physician Decision|0|||
37933969|NCT00790751|69620718|FG001|Overall Study|Physician Decision|0|||
37933970|NCT00790751|69620719|FG002|Overall Study|Physician Decision|0|||
37933971|NCT00790751|69620720|FG003|Overall Study|Physician Decision|1|||
37933972|NCT00784979|69620730|FG000|Overall Study|incomplete data|6|||
38035000|NCT04230213|69721865|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
38035001|NCT04230213|69721866|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
38035002|NCT04230213|69721864|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
38035003|NCT04230213|69721865|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
38035004|NCT04230213|69721866|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
38035005|NCT04230213|69721864|FG000|TP3: Week 16 to Week 22|Other|0|||
38035006|NCT04230213|69721865|FG001|TP3: Week 16 to Week 22|Other|1|||
38035007|NCT04230213|69721866|FG002|TP3: Week 16 to Week 22|Other|3|||
38035008|NCT04230213|69721864|FG000|TP4: Week 22 to Week 32|Other|0|||
38035009|NCT04230213|69721865|FG001|TP4: Week 22 to Week 32|Other|5|||
37670074|NCT02684357|69143284|FG005|Part A|Other|0|||
37670075|NCT02684357|69143279|FG000|Part B|Adverse Event (Other)|0|||
37670076|NCT02684357|69143280|FG001|Part B|Adverse Event (Other)|0|||
37670077|NCT02684357|69143281|FG002|Part B|Adverse Event (Other)|0|||
37670078|NCT02684357|69143282|FG003|Part B|Adverse Event (Other)|1|||
37670079|NCT02684357|69143283|FG004|Part B|Adverse Event (Other)|1|||
37670080|NCT02684357|69143284|FG005|Part B|Adverse Event (Other)|1|||
37670081|NCT02684357|69143279|FG000|Part B|Lost to Follow-up|0|||
37670082|NCT02684357|69143280|FG001|Part B|Lost to Follow-up|0|||
37670083|NCT02684357|69143281|FG002|Part B|Lost to Follow-up|0|||
37670084|NCT02684357|69143282|FG003|Part B|Lost to Follow-up|1|||
37670085|NCT02684357|69143283|FG004|Part B|Lost to Follow-up|1|||
37670086|NCT02684357|69143284|FG005|Part B|Lost to Follow-up|7|||
37670087|NCT02684357|69143279|FG000|Part B|Withdrawal by Subject|0|||
37670088|NCT02684357|69143280|FG001|Part B|Withdrawal by Subject|0|||
37670089|NCT02684357|69143281|FG002|Part B|Withdrawal by Subject|0|||
37670090|NCT02684357|69143282|FG003|Part B|Withdrawal by Subject|0|||
37670091|NCT02684357|69143283|FG004|Part B|Withdrawal by Subject|2|||
37670092|NCT02684357|69143284|FG005|Part B|Withdrawal by Subject|4|||
37670093|NCT02684357|69143279|FG000|Part B|Other|0|||
37670094|NCT02684357|69143280|FG001|Part B|Other|0|||
37670095|NCT02684357|69143281|FG002|Part B|Other|0|||
37670096|NCT02684357|69143282|FG003|Part B|Other|1|||
37670097|NCT02684357|69143283|FG004|Part B|Other|0|||
37670098|NCT02684357|69143284|FG005|Part B|Other|1|||
37670099|NCT02684279|69143297|FG000|Overall Study|Adverse Event|87|||
37670100|NCT02684279|69143297|FG000|Overall Study|Lack of Efficacy|4|||
37670101|NCT02684279|69143297|FG000|Overall Study|Lost to Follow-up|61|||
37670102|NCT02684279|69143297|FG000|Overall Study|Protocol Violation|6|||
37670103|NCT02684279|69143297|FG000|Overall Study|Pregnancy|8|||
37670104|NCT02684279|69143297|FG000|Overall Study|Withdrawal by Subject|92|||
37670105|NCT02684279|69143297|FG000|Overall Study|non-compliance with study drug|9|||
37677603|NCT02594735|69152641|FG000|Overall Study|Adverse Event|1|||
37677604|NCT02634151|69152649|FG000|Overall Study|Withdrawal by Subject|1|||
37677605|NCT02634151|69152650|FG001|Overall Study|Withdrawal by Subject|0|||
37677606|NCT02634151|69152649|FG000|Overall Study|Non-Compliance|0|||
37677607|NCT02634151|69152650|FG001|Overall Study|Non-Compliance|1|||
37677608|NCT02634151|69152649|FG000|Overall Study|Other|0|||
37677609|NCT02634151|69152650|FG001|Overall Study|Other|1|||
37677610|NCT01655823|69152661|FG000|Overall Study|Lost to Follow-up|0|||
37677611|NCT01655823|69152662|FG001|Overall Study|Lost to Follow-up|1|||
37677612|NCT01655823|69152663|FG002|Overall Study|Lost to Follow-up|0|||
37677613|NCT01655823|69152664|FG003|Overall Study|Lost to Follow-up|0|||
37677614|NCT01655823|69152665|FG004|Overall Study|Lost to Follow-up|1|||
37677615|NCT01655823|69152661|FG000|Overall Study|Withdrawal by Subject|0|||
37677616|NCT01655823|69152662|FG001|Overall Study|Withdrawal by Subject|1|||
37677617|NCT01655823|69152663|FG002|Overall Study|Withdrawal by Subject|0|||
37677618|NCT01655823|69152664|FG003|Overall Study|Withdrawal by Subject|1|||
37677619|NCT01655823|69152665|FG004|Overall Study|Withdrawal by Subject|0|||
37677620|NCT01360645|69152679|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
37763694|NCT01452529|69275826|FG000|Run-in Period|Confirmed or suspected diversion|23|||
37763695|NCT01452529|69275827|FG001|Run-in Period|Confirmed or suspected diversion|0|||
37763696|NCT01452529|69275828|FG002|Run-in Period|Confirmed or suspected diversion|0|||
37763697|NCT01452529|69275826|FG000|Run-in Period|Administrative|21|||
37763698|NCT01452529|69275827|FG001|Run-in Period|Administrative|0|||
37763699|NCT01452529|69275828|FG002|Run-in Period|Administrative|0|||
37763700|NCT01452529|69275826|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
37763701|NCT01452529|69275827|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
37763702|NCT01452529|69275828|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
37763703|NCT01452529|69275826|FG000|Double-blind (DB) Period|Adverse Event|0|||
37763704|NCT01452529|69275827|FG001|Double-blind (DB) Period|Adverse Event|18|||
37763705|NCT01452529|69275828|FG002|Double-blind (DB) Period|Adverse Event|11|||
37763706|NCT01452529|69275826|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
37763707|NCT01452529|69275827|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
37763708|NCT01452529|69275828|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
37670106|NCT02684279|69143297|FG000|Overall Study|non compliance with study visits|2|||
37670107|NCT02684279|69143297|FG000|Overall Study|subject to have surgery|1|||
37670108|NCT02684279|69143297|FG000|Overall Study|family emergency|1|||
37670109|NCT02684279|69143297|FG000|Overall Study|Site closures|7|||
37670110|NCT02684279|69143297|FG000|Overall Study|Physician Decision|1|||
37670111|NCT02534493|69143301|FG000|Overall Study|Lost to Follow-up|1|||
37670112|NCT02534493|69143301|FG000|Overall Study|Withdrawal by Subject|1|||
37670113|NCT02547129|69143309|FG000|Overall Study|Difficulty with ongoing infection|1|||
37670114|NCT02547129|69143310|FG001|Overall Study|Difficulty with ongoing infection|0|||
37670115|NCT02546193|69143318|FG000|Overall Study|Withdrawal by Subject|2|||
37670116|NCT02546193|69143319|FG001|Overall Study|Withdrawal by Subject|0|||
37670117|NCT02546193|69143320|FG002|Overall Study|Withdrawal by Subject|1|||
37670118|NCT02546193|69143321|FG003|Overall Study|Withdrawal by Subject|0|||
37670119|NCT02546193|69143318|FG000|Overall Study|Not eligible at time of induction|4|||
37670120|NCT02546193|69143319|FG001|Overall Study|Not eligible at time of induction|6|||
37670121|NCT02546193|69143320|FG002|Overall Study|Not eligible at time of induction|1|||
37670122|NCT02546193|69143321|FG003|Overall Study|Not eligible at time of induction|0|||
37670123|NCT02538471|69143327|FG000|Overall Study|Progression of disease|2|||
37670124|NCT01661595|69143335|FG000|Phase 1: Week 0-4|Adverse Event|1|||
37670125|NCT01661595|69143336|FG001|Phase 1: Week 0-4|Adverse Event|0|||
37670126|NCT01661595|69143337|FG002|Phase 1: Week 0-4|Adverse Event|0|||
37670127|NCT01661595|69143338|FG003|Phase 1: Week 0-4|Adverse Event|0|||
37670128|NCT01661595|69143335|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
37670129|NCT01661595|69143336|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
37670130|NCT01661595|69143337|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
37670131|NCT01661595|69143338|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
37670132|NCT02213133|69143358|FG000|Overall Study|Participant discontinued study therapy|2|||
37670133|NCT02213133|69143359|FG001|Overall Study|Participant discontinued study therapy|0|||
37670134|NCT02213133|69143360|FG002|Overall Study|Participant discontinued study therapy|0|||
37670135|NCT02213133|69143358|FG000|Overall Study|Participant withdrew informed consent|2|||
37670136|NCT02213133|69143359|FG001|Overall Study|Participant withdrew informed consent|1|||
37670137|NCT02213133|69143360|FG002|Overall Study|Participant withdrew informed consent|2|||
37670138|NCT02213133|69143358|FG000|Overall Study|Disease progression|11|||
37670139|NCT02213133|69143359|FG001|Overall Study|Disease progression|2|||
37670140|NCT02213133|69143360|FG002|Overall Study|Disease progression|0|||
37670141|NCT02213133|69143358|FG000|Overall Study|Adverse Event (AE)|1|||
37670142|NCT02213133|69143359|FG001|Overall Study|Adverse Event (AE)|0|||
37670143|NCT02213133|69143360|FG002|Overall Study|Adverse Event (AE)|0|||
37670144|NCT02213133|69143358|FG000|Overall Study|Death|16|||
37670145|NCT02213133|69143359|FG001|Overall Study|Death|2|||
37670146|NCT02213133|69143360|FG002|Overall Study|Death|1|||
37670147|NCT02213133|69143358|FG000|Overall Study|Other|5|||
37670148|NCT02213133|69143359|FG001|Overall Study|Other|0|||
37670149|NCT02213133|69143360|FG002|Overall Study|Other|0|||
37670150|NCT02684981|69143372|FG000|Overall Study|Permanently discontinued the treatment|157|||
37670151|NCT02684981|69143373|FG001|Overall Study|Permanently discontinued the treatment|161|||
37670152|NCT02684981|69143374|FG002|Overall Study|Permanently discontinued the treatment|110|||
37670153|NCT02684981|69143372|FG000|Overall Study|Other|83|||
37670154|NCT02684981|69143373|FG001|Overall Study|Other|49|||
37670155|NCT02684981|69143374|FG002|Overall Study|Other|17|||
37670156|NCT02146833|69143388|FG000|Overall Study|Death|10|||
37670157|NCT02146833|69143388|FG000|Overall Study|No longer consented to study treatment|1|||
37670158|NCT02690207|69143392|FG000|Overall Study|Lost to Follow-up|48|||
37670159|NCT02690207|69143392|FG000|Overall Study|Withdrawal by Subject|46|||
37670160|NCT02690207|69143392|FG000|Overall Study|Protocol Violation|2|||
37670161|NCT02690207|69143392|FG000|Overall Study|Serious adverse event|110|||
37670162|NCT02690207|69143392|FG000|Overall Study|Non-serious Adverse Event|18|||
37763709|NCT01452529|69275826|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
37763710|NCT01452529|69275827|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
37763711|NCT01452529|69275828|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
37763712|NCT01452529|69275826|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
37763713|NCT01452529|69275827|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
37763714|NCT01452529|69275828|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
37763715|NCT01452529|69275826|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
37763716|NCT01452529|69275827|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
37763717|NCT01452529|69275828|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
37763718|NCT01452529|69275826|FG000|Double-blind (DB) Period|Administrative|0|||
37763719|NCT01452529|69275827|FG001|Double-blind (DB) Period|Administrative|11|||
37763720|NCT01452529|69275828|FG002|Double-blind (DB) Period|Administrative|7|||
37763721|NCT01685606|69275835|FG000|Overall Study|Withdrawal by Subject|1|||
37763722|NCT01685372|69275841|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
37763723|NCT01685372|69275842|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
37763724|NCT01685216|69275848|FG000|Overall Study|Did not receive study drug|1|||
37763725|NCT01685138|69275852|FG000|Overall Study|Lost to Follow-up|1|||
37763726|NCT01685138|69275852|FG000|Overall Study|Protocol Violation|1|||
37763727|NCT01685138|69275852|FG000|Overall Study|No longer requires treatment|1|||
37763728|NCT01685138|69275852|FG000|Overall Study|Subject/guardian decision|2|||
37763729|NCT01685138|69275852|FG000|Overall Study|Physician Decision|6|||
37763730|NCT01685138|69275852|FG000|Overall Study|Death|10|||
37763731|NCT01685138|69275852|FG000|Overall Study|Adverse Event|18|||
37763732|NCT01685138|69275852|FG000|Overall Study|Progressive disease|53|||
37763733|NCT01685060|69275856|FG000|Overall Study|Rollover patients|16|||
37763734|NCT01685060|69275856|FG000|Overall Study|Adverse Event|12|||
37763735|NCT01685060|69275856|FG000|Overall Study|Progressive disease|69|||
37763736|NCT01685060|69275856|FG000|Overall Study|Physician Decision|14|||
37763737|NCT01685060|69275856|FG000|Overall Study|Subject/guardian decision|20|||
37763738|NCT01685060|69275856|FG000|Overall Study|Lost to Follow-up|1|||
37763739|NCT01685060|69275856|FG000|Overall Study|Death|8|||
37763740|NCT01582100|69275860|FG000|Overall Study|Adverse Event|1|||
37763741|NCT01582100|69275860|FG000|Overall Study|Withdrawal by Subject|1|||
37763742|NCT01579916|69275866|FG000|Overall Study|Lost to Follow-up|6|||
37763743|NCT01579916|69275867|FG001|Overall Study|Lost to Follow-up|1|||
37763744|NCT01579916|69275866|FG000|Overall Study|Withdrawal by Subject|1|||
37763745|NCT01579916|69275867|FG001|Overall Study|Withdrawal by Subject|1|||
37763746|NCT01579916|69275866|FG000|Overall Study|Death|1|||
37763747|NCT01579916|69275867|FG001|Overall Study|Death|0|||
37763748|NCT01684202|69275877|FG000|Dose-escalation Period|Adverse Event|0|||
37763749|NCT01684202|69275878|FG001|Dose-escalation Period|Adverse Event|1|||
37763750|NCT01684202|69275879|FG002|Dose-escalation Period|Adverse Event|0|||
37763751|NCT01684202|69275880|FG003|Dose-escalation Period|Adverse Event|0|||
37763752|NCT01684202|69275877|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
37763753|NCT01684202|69275878|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
37763754|NCT01684202|69275879|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
37763755|NCT01684202|69275880|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
37763756|NCT01684202|69275877|FG000|Maintenance Period|Adverse Event|1|||
37763757|NCT01684202|69275878|FG001|Maintenance Period|Adverse Event|1|||
37763758|NCT01684202|69275879|FG002|Maintenance Period|Adverse Event|1|||
37763759|NCT01684202|69275880|FG003|Maintenance Period|Adverse Event|1|||
37763760|NCT01684202|69275877|FG000|Maintenance Period|Physician Decision|0|||
37763761|NCT01684202|69275878|FG001|Maintenance Period|Physician Decision|1|||
37763762|NCT01684202|69275879|FG002|Maintenance Period|Physician Decision|0|||
37763763|NCT01684202|69275880|FG003|Maintenance Period|Physician Decision|0|||
37763764|NCT01684202|69275877|FG000|Maintenance Period|Withdrawal by Subject|0|||
37763765|NCT01684202|69275878|FG001|Maintenance Period|Withdrawal by Subject|1|||
37763766|NCT01684202|69275879|FG002|Maintenance Period|Withdrawal by Subject|0|||
37763767|NCT01684202|69275880|FG003|Maintenance Period|Withdrawal by Subject|0|||
37763768|NCT01684046|69275890|FG000|Period 1, First 30 Days|Adverse Event|0|||
37763769|NCT01684046|69275891|FG001|Period 1, First 30 Days|Adverse Event|2|||
37763770|NCT01559090|69275900|FG000|Stage I|Withdrawal by Subject|2|||
37670163|NCT02690207|69143392|FG000|Overall Study|Migrated/moved from study area|5|||
37670164|NCT02690207|69143392|FG000|Overall Study|Suspected HZ Episode|1|||
37670165|NCT02690207|69143392|FG000|Overall Study|Other reasons for withdrawal|23|||
37670166|NCT02689349|69143398|FG000|Overall Study|Not implanted|4|||
37670167|NCT02689349|69143399|FG001|Overall Study|Not implanted|0|||
37670168|NCT02689349|69143398|FG000|Overall Study|Withdrawal by Subject|9|||
37670169|NCT02689349|69143399|FG001|Overall Study|Withdrawal by Subject|0|||
37763771|NCT01559090|69275901|FG001|Stage I|Withdrawal by Subject|2|||
37763772|NCT01559090|69275902|FG002|Stage I|Withdrawal by Subject|3|||
37763773|NCT01559090|69275900|FG000|Stage II|Withdrawal by Subject|1|||
37670170|NCT02679287|69143410|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
37670171|NCT02679287|69143411|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
37670172|NCT02679287|69143410|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
37670173|NCT02679287|69143411|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
37670174|NCT02679287|69143410|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
37763774|NCT01559090|69275901|FG001|Stage II|Withdrawal by Subject|0|||
37763775|NCT01559090|69275902|FG002|Stage II|Withdrawal by Subject|0|||
37763776|NCT01683266|69275912|FG000|Overall Study|Adverse Event|5|||
37763777|NCT01683266|69275913|FG001|Overall Study|Adverse Event|4|||
37763778|NCT01683266|69275912|FG000|Overall Study|Lack of Efficacy|5|||
37763779|NCT01683266|69275913|FG001|Overall Study|Lack of Efficacy|2|||
37763780|NCT01683266|69275912|FG000|Overall Study|Protocol Violation|13|||
37763781|NCT01683266|69275913|FG001|Overall Study|Protocol Violation|6|||
37763782|NCT01683266|69275912|FG000|Overall Study|Personal Reason|17|||
37763783|NCT01683266|69275913|FG001|Overall Study|Personal Reason|25|||
37763784|NCT01683266|69275912|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
37763785|NCT01683266|69275913|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
37763786|NCT01683266|69275912|FG000|Overall Study|Lost to Follow-up|5|||
37763787|NCT01683266|69275913|FG001|Overall Study|Lost to Follow-up|0|||
37763788|NCT01683266|69275912|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
37763789|NCT01683266|69275913|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
37763790|NCT01683266|69275912|FG000|Overall Study|Nonserious Hypoglycemia|0|||
37763791|NCT01683266|69275913|FG001|Overall Study|Nonserious Hypoglycemia|3|||
37763792|NCT01683266|69275912|FG000|Overall Study|Perceived Lack of Efficacy|1|||
37763793|NCT01683266|69275913|FG001|Overall Study|Perceived Lack of Efficacy|1|||
37933973|NCT00738920|69620737|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
37933974|NCT00738920|69620738|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
37933975|NCT00738920|69620739|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
37933976|NCT00738920|69620737|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
37933977|NCT00738920|69620738|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
37933978|NCT00738920|69620739|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
37933979|NCT00738920|69620737|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
37933980|NCT00738920|69620738|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
37933981|NCT00738920|69620739|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
37933982|NCT00738920|69620737|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
37933983|NCT00738920|69620738|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
37933984|NCT00738920|69620739|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
37933985|NCT00738920|69620737|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
37933986|NCT00738920|69620738|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
37933987|NCT00738920|69620739|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
37933988|NCT00738920|69620737|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
37933989|NCT00738920|69620738|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
37933990|NCT00738920|69620739|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
37933991|NCT00738920|69620737|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
37933992|NCT00738920|69620738|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
37933993|NCT00738920|69620739|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
37933994|NCT00738920|69620737|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
37933995|NCT00738920|69620738|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
37933996|NCT00738920|69620739|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
37933997|NCT00738920|69620737|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
37933998|NCT00738920|69620738|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
37933999|NCT00738920|69620739|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
37934000|NCT00738920|69620737|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
37934001|NCT00738920|69620738|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
37934002|NCT00738920|69620739|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
37934003|NCT00582972|69620747|FG000|Overall Study|Protocol Violation|2|||
37934004|NCT04319718|69620754|FG000|Overall Study|Adverse Event|0|||
37934005|NCT04319718|69620755|FG001|Overall Study|Adverse Event|2|||
37934006|NCT04319718|69620754|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
37934007|NCT04319718|69620755|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
37934008|NCT04372602|69620763|FG000|Overall Study|Withdrawal by Subject|1|||
37934009|NCT04372602|69620764|FG001|Overall Study|Withdrawal by Subject|1|||
37934010|NCT04372602|69620763|FG000|Overall Study|Adverse Event|0|||
37934011|NCT04372602|69620764|FG001|Overall Study|Adverse Event|1|||
37934012|NCT04372602|69620763|FG000|Overall Study|Transitioned to comfort care|0|||
37934013|NCT04372602|69620764|FG001|Overall Study|Transitioned to comfort care|1|||
37934014|NCT00733304|69620773|FG000|Overall Study|Adverse Event|3|||
37934015|NCT00733304|69620774|FG001|Overall Study|Adverse Event|0|||
37934016|NCT00733304|69620775|FG002|Overall Study|Adverse Event|0|||
37934017|NCT00733304|69620773|FG000|Overall Study|Lack of Efficacy|0|||
37934018|NCT00733304|69620774|FG001|Overall Study|Lack of Efficacy|0|||
37763794|NCT01683266|69275912|FG000|Overall Study|Possibly Hypoglycemia|1|||
37763795|NCT01683266|69275913|FG001|Overall Study|Possibly Hypoglycemia|0|||
37763796|NCT01683266|69275912|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
37763797|NCT01683266|69275913|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
37763798|NCT01467661|69275919|FG000|Overall Study|Adverse Event|16|||
37763799|NCT01467661|69275919|FG000|Overall Study|Withdrawal by Subject|1|||
37763800|NCT01467661|69275919|FG000|Overall Study|Lack of Efficacy|3|||
37763801|NCT01467661|69275919|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
37763802|NCT01577186|69275925|FG000|Overall Study|Adverse Event|23|||
37763803|NCT01577186|69275925|FG000|Overall Study|Death|1|||
37763804|NCT01577186|69275925|FG000|Overall Study|Lost to Follow-up|28|||
37763805|NCT01577186|69275925|FG000|Overall Study|Withdrawal by Subject|35|||
37763806|NCT01577186|69275925|FG000|Overall Study|Insufficient Response|18|||
37763807|NCT01577186|69275925|FG000|Overall Study|Ineligible to Continue|15|||
37763808|NCT01577186|69275925|FG000|Overall Study|Non-Compliant|8|||
37763809|NCT01577186|69275925|FG000|Overall Study|Other|2|||
37763810|NCT01559012|69275931|FG000|Overall Study|Withdrawal by Subject|0|||
37763811|NCT01559012|69275932|FG001|Overall Study|Withdrawal by Subject|1|||
37763812|NCT01451827|69275957|FG000|Overall Study|Adverse Event|2|||
37763813|NCT01451827|69275958|FG001|Overall Study|Adverse Event|0|||
37763814|NCT01451827|69275959|FG002|Overall Study|Adverse Event|1|||
37763815|NCT01451827|69275960|FG003|Overall Study|Adverse Event|1|||
37763816|NCT01451827|69275957|FG000|Overall Study|Protocol deviation|1|||
37763817|NCT01451827|69275958|FG001|Overall Study|Protocol deviation|0|||
37763818|NCT01451827|69275959|FG002|Overall Study|Protocol deviation|0|||
37763819|NCT01451827|69275960|FG003|Overall Study|Protocol deviation|0|||
37763820|NCT01451827|69275957|FG000|Overall Study|Lost to Follow-up|0|||
37763821|NCT01451827|69275958|FG001|Overall Study|Lost to Follow-up|3|||
37763822|NCT01451827|69275959|FG002|Overall Study|Lost to Follow-up|0|||
37763823|NCT01451827|69275960|FG003|Overall Study|Lost to Follow-up|2|||
37763824|NCT01451827|69275957|FG000|Overall Study|Participant met withdrawal criteria|0|||
37763825|NCT01451827|69275958|FG001|Overall Study|Participant met withdrawal criteria|2|||
37763826|NCT01451827|69275959|FG002|Overall Study|Participant met withdrawal criteria|0|||
37763827|NCT01451827|69275960|FG003|Overall Study|Participant met withdrawal criteria|0|||
37763828|NCT01451827|69275957|FG000|Overall Study|Withdrawal by Subject|0|||
37763829|NCT01451827|69275958|FG001|Overall Study|Withdrawal by Subject|0|||
37763830|NCT01451827|69275959|FG002|Overall Study|Withdrawal by Subject|1|||
37763831|NCT01451827|69275960|FG003|Overall Study|Withdrawal by Subject|1|||
37763832|NCT01557920|69275970|FG000|Overall Study|Withdrawal by Subject|2|||
37763833|NCT01557920|69275971|FG001|Overall Study|Withdrawal by Subject|3|||
37763834|NCT01557920|69275970|FG000|Overall Study|Lack of Efficacy|1|||
37763835|NCT01557920|69275971|FG001|Overall Study|Lack of Efficacy|0|||
37763836|NCT01467583|69276007|FG000|Overall Study|Death|1|||
37763837|NCT01467583|69276008|FG001|Overall Study|Death|1|||
37763838|NCT01467583|69276009|FG002|Overall Study|Death|0|||
37763839|NCT01467583|69276007|FG000|Overall Study|Withdrawal by Subject|1|||
37763840|NCT01467583|69276008|FG001|Overall Study|Withdrawal by Subject|0|||
37763841|NCT01467583|69276009|FG002|Overall Study|Withdrawal by Subject|0|||
37763842|NCT01467583|69276007|FG000|Overall Study|Protocol Violation|0|||
37763843|NCT01467583|69276008|FG001|Overall Study|Protocol Violation|0|||
37763844|NCT01467583|69276009|FG002|Overall Study|Protocol Violation|2|||
37763845|NCT01576718|69276026|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
37763846|NCT01576718|69276027|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
37763847|NCT01576718|69276028|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
37763848|NCT01576718|69276029|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
37763849|NCT01576718|69276030|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
37763850|NCT01576718|69276031|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
37763851|NCT01576718|69276032|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
37763852|NCT01576718|69276026|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
37763853|NCT01576718|69276027|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
37763854|NCT01576718|69276028|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
37763855|NCT01576718|69276029|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
37763856|NCT01576718|69276030|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
37763857|NCT01576718|69276031|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
37763858|NCT01576718|69276032|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
37763859|NCT01576718|69276026|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
37934019|NCT00733304|69620775|FG002|Overall Study|Lack of Efficacy|2|||
37763860|NCT01576718|69276027|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
37763861|NCT01576718|69276028|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
37763862|NCT01576718|69276029|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
37763863|NCT01576718|69276030|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
37763864|NCT01576718|69276031|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
37763865|NCT01576718|69276032|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
37763866|NCT01576718|69276026|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
37763867|NCT01576718|69276027|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
37763868|NCT01576718|69276028|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
37763869|NCT01576718|69276029|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
37763870|NCT01576718|69276030|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
37763871|NCT01576718|69276031|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
37763872|NCT01576718|69276032|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
37763873|NCT01576718|69276026|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
37763874|NCT01576718|69276027|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
37763875|NCT01576718|69276028|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
37763876|NCT01576718|69276029|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
37763877|NCT01576718|69276030|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
37763878|NCT01576718|69276031|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
37763879|NCT01576718|69276032|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
37763880|NCT01576718|69276026|FG000|Treatment Period|Adverse Event|0|||
37763881|NCT01576718|69276027|FG001|Treatment Period|Adverse Event|1|||
37934020|NCT00733304|69620773|FG000|Overall Study|Lost to Follow-up|0|||
37934021|NCT00733304|69620774|FG001|Overall Study|Lost to Follow-up|1|||
37934022|NCT00733304|69620775|FG002|Overall Study|Lost to Follow-up|0|||
37934023|NCT00733304|69620773|FG000|Overall Study|Physician Decision|3|||
37934024|NCT00733304|69620774|FG001|Overall Study|Physician Decision|1|||
37934025|NCT00733304|69620775|FG002|Overall Study|Physician Decision|3|||
37934026|NCT00733304|69620773|FG000|Overall Study|Withdrawal by Subject|1|||
37934027|NCT00733304|69620774|FG001|Overall Study|Withdrawal by Subject|1|||
37934028|NCT00733304|69620775|FG002|Overall Study|Withdrawal by Subject|0|||
37934029|NCT00711243|69620789|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
37934030|NCT00711243|69620790|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
37934031|NCT00711243|69620791|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
37934032|NCT00711243|69620792|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
37934033|NCT00711243|69620793|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
37934034|NCT00711243|69620794|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
37934035|NCT00711243|69620789|FG000|Reached First Response/4 Cycles|Death|0|||
37934036|NCT00711243|69620790|FG001|Reached First Response/4 Cycles|Death|0|||
37934037|NCT00711243|69620791|FG002|Reached First Response/4 Cycles|Death|0|||
37934038|NCT00711243|69620792|FG003|Reached First Response/4 Cycles|Death|0|||
37934039|NCT00711243|69620793|FG004|Reached First Response/4 Cycles|Death|0|||
37934040|NCT00711243|69620794|FG005|Reached First Response/4 Cycles|Death|2|||
37934041|NCT00711243|69620789|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
37934042|NCT00711243|69620790|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
37934043|NCT00711243|69620791|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
37934044|NCT00711243|69620792|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
37934045|NCT00711243|69620793|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
37934046|NCT00711243|69620794|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
37934047|NCT00711243|69620789|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
37934048|NCT00711243|69620790|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
37934049|NCT00711243|69620791|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
37934050|NCT00711243|69620792|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
37934051|NCT00711243|69620793|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
37934052|NCT00711243|69620794|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
37934053|NCT00711243|69620789|FG000|Treated Cycle 5 After First Response|Death|0|||
37934054|NCT00711243|69620790|FG001|Treated Cycle 5 After First Response|Death|0|||
37934055|NCT00711243|69620791|FG002|Treated Cycle 5 After First Response|Death|0|||
37934056|NCT00711243|69620792|FG003|Treated Cycle 5 After First Response|Death|0|||
37934057|NCT00711243|69620793|FG004|Treated Cycle 5 After First Response|Death|0|||
37934058|NCT00711243|69620794|FG005|Treated Cycle 5 After First Response|Death|2|||
37934059|NCT00711243|69620789|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
37934060|NCT00711243|69620790|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
37934061|NCT00711243|69620791|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
37934062|NCT00711243|69620792|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
37763882|NCT01576718|69276028|FG002|Treatment Period|Adverse Event|1|||
37763883|NCT01576718|69276029|FG003|Treatment Period|Adverse Event|1|||
37763884|NCT01576718|69276030|FG004|Treatment Period|Adverse Event|1|||
37763885|NCT01576718|69276031|FG005|Treatment Period|Adverse Event|1|||
37763886|NCT01576718|69276032|FG006|Treatment Period|Adverse Event|0|||
38035010|NCT04230213|69721866|FG002|TP4: Week 22 to Week 32|Other|5|||
38035011|NCT04230213|69721864|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
38035012|NCT04230213|69721865|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
38035013|NCT04230213|69721866|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
37763887|NCT01576718|69276026|FG000|Treatment Period|Withdrawal by Subject|0|||
37763888|NCT01576718|69276027|FG001|Treatment Period|Withdrawal by Subject|1|||
37763889|NCT01576718|69276028|FG002|Treatment Period|Withdrawal by Subject|1|||
37763890|NCT01576718|69276029|FG003|Treatment Period|Withdrawal by Subject|0|||
37763891|NCT01576718|69276030|FG004|Treatment Period|Withdrawal by Subject|2|||
37763892|NCT01576718|69276031|FG005|Treatment Period|Withdrawal by Subject|4|||
37763893|NCT01576718|69276032|FG006|Treatment Period|Withdrawal by Subject|2|||
37763894|NCT01576718|69276026|FG000|Treatment Period|Physician Decision|0|||
37763895|NCT01576718|69276027|FG001|Treatment Period|Physician Decision|1|||
37763896|NCT01576718|69276028|FG002|Treatment Period|Physician Decision|1|||
37763897|NCT01576718|69276029|FG003|Treatment Period|Physician Decision|1|||
37763898|NCT01576718|69276030|FG004|Treatment Period|Physician Decision|1|||
37763899|NCT01576718|69276031|FG005|Treatment Period|Physician Decision|0|||
37763900|NCT01576718|69276032|FG006|Treatment Period|Physician Decision|0|||
37763901|NCT01576718|69276026|FG000|Treatment Period|Protocol Violation|0|||
37763902|NCT01576718|69276027|FG001|Treatment Period|Protocol Violation|5|||
37763903|NCT01576718|69276028|FG002|Treatment Period|Protocol Violation|4|||
37763904|NCT01576718|69276029|FG003|Treatment Period|Protocol Violation|10|||
37763905|NCT01576718|69276030|FG004|Treatment Period|Protocol Violation|6|||
37763906|NCT01576718|69276031|FG005|Treatment Period|Protocol Violation|8|||
37763907|NCT01576718|69276032|FG006|Treatment Period|Protocol Violation|12|||
37763908|NCT01576718|69276026|FG000|Treatment Period|Sponsor request|0|||
37763909|NCT01576718|69276027|FG001|Treatment Period|Sponsor request|1|||
37763910|NCT01576718|69276028|FG002|Treatment Period|Sponsor request|0|||
37763911|NCT01576718|69276029|FG003|Treatment Period|Sponsor request|0|||
37763912|NCT01576718|69276030|FG004|Treatment Period|Sponsor request|0|||
37763913|NCT01576718|69276031|FG005|Treatment Period|Sponsor request|1|||
37763914|NCT01576718|69276032|FG006|Treatment Period|Sponsor request|0|||
37763915|NCT01576718|69276026|FG000|Treatment Period|Met stopping criteria|0|||
37763916|NCT01576718|69276027|FG001|Treatment Period|Met stopping criteria|16|||
37763917|NCT01576718|69276028|FG002|Treatment Period|Met stopping criteria|13|||
37763918|NCT01576718|69276029|FG003|Treatment Period|Met stopping criteria|19|||
37763919|NCT01576718|69276030|FG004|Treatment Period|Met stopping criteria|16|||
37763920|NCT01576718|69276031|FG005|Treatment Period|Met stopping criteria|33|||
37763921|NCT01576718|69276032|FG006|Treatment Period|Met stopping criteria|15|||
37763922|NCT01576718|69276026|FG000|Treatment Period|Lost to Follow-up|0|||
37763923|NCT01576718|69276027|FG001|Treatment Period|Lost to Follow-up|0|||
37763924|NCT01576718|69276028|FG002|Treatment Period|Lost to Follow-up|0|||
37763925|NCT01576718|69276029|FG003|Treatment Period|Lost to Follow-up|0|||
37763926|NCT01576718|69276030|FG004|Treatment Period|Lost to Follow-up|1|||
37763927|NCT01576718|69276031|FG005|Treatment Period|Lost to Follow-up|0|||
37763928|NCT01576718|69276032|FG006|Treatment Period|Lost to Follow-up|0|||
37763929|NCT01576718|69276026|FG000|Treatment Period|Noncompliance to study medication|0|||
37763930|NCT01576718|69276027|FG001|Treatment Period|Noncompliance to study medication|0|||
37763931|NCT01576718|69276028|FG002|Treatment Period|Noncompliance to study medication|0|||
37763932|NCT01576718|69276029|FG003|Treatment Period|Noncompliance to study medication|0|||
37763933|NCT01576718|69276030|FG004|Treatment Period|Noncompliance to study medication|0|||
37763934|NCT01576718|69276031|FG005|Treatment Period|Noncompliance to study medication|1|||
37763935|NCT01576718|69276032|FG006|Treatment Period|Noncompliance to study medication|1|||
37763936|NCT01493557|69276049|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
37763937|NCT01493557|69276050|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
37763938|NCT01493557|69276051|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
37763939|NCT01493557|69276049|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
37763940|NCT01493557|69276050|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
37763941|NCT01493557|69276051|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
37763942|NCT01493557|69276049|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
37934063|NCT00711243|69620793|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
37934064|NCT00711243|69620794|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
37934065|NCT00711243|69620789|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
37934066|NCT00711243|69620790|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
37934067|NCT00711243|69620791|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
37934068|NCT00711243|69620792|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
37934069|NCT00711243|69620793|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
37934070|NCT00711243|69620794|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
37934071|NCT00733226|69620812|FG000|Overall Study|Withdrawal by Subject|1|||
37934072|NCT00733226|69620813|FG001|Overall Study|Withdrawal by Subject|0|||
37763943|NCT01493557|69276050|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
37763944|NCT01493557|69276051|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
37763945|NCT01493557|69276049|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
37934073|NCT00733226|69620812|FG000|Overall Study|Lost to Follow-up|2|||
37934074|NCT00733226|69620813|FG001|Overall Study|Lost to Follow-up|0|||
37670175|NCT02679287|69143411|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
37763946|NCT01493557|69276050|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
37763947|NCT01493557|69276051|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
37763948|NCT01493557|69276049|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
37763949|NCT01493557|69276050|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
37763950|NCT01493557|69276051|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
37763951|NCT01493557|69276049|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
37763952|NCT01493557|69276050|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
37763953|NCT01493557|69276051|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
37763954|NCT01493557|69276049|FG000|Not Randomized to Management Strategies|Early termination|0|||
37763955|NCT01493557|69276050|FG001|Not Randomized to Management Strategies|Early termination|0|||
37763956|NCT01493557|69276051|FG002|Not Randomized to Management Strategies|Early termination|34|||
37763957|NCT01493557|69276049|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
37763958|NCT01493557|69276050|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
37763959|NCT01493557|69276051|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
37763960|NCT01493557|69276049|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
37763961|NCT01493557|69276050|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
37763962|NCT01493557|69276051|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
37763963|NCT01493557|69276049|FG000|Randomized to Management Strategies|Other adverse event|8|||
37763964|NCT01493557|69276050|FG001|Randomized to Management Strategies|Other adverse event|5|||
37763965|NCT01493557|69276051|FG002|Randomized to Management Strategies|Other adverse event|0|||
37763966|NCT01493557|69276049|FG000|Randomized to Management Strategies|Protocol Violation|3|||
37763967|NCT01493557|69276050|FG001|Randomized to Management Strategies|Protocol Violation|0|||
37763968|NCT01493557|69276051|FG002|Randomized to Management Strategies|Protocol Violation|0|||
37763969|NCT01493557|69276049|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
37763970|NCT01493557|69276050|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
37763971|NCT01493557|69276051|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
37763972|NCT01493557|69276049|FG000|Randomized to Management Strategies|Other than stated above|1|||
37763973|NCT01493557|69276050|FG001|Randomized to Management Strategies|Other than stated above|3|||
37763974|NCT01493557|69276051|FG002|Randomized to Management Strategies|Other than stated above|0|||
37763975|NCT01493557|69276049|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
37763976|NCT01493557|69276050|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
37763977|NCT01493557|69276051|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
37763978|NCT01493557|69276049|FG000|Adding the Second Strategy|Other adverse event|1|||
37763979|NCT01493557|69276050|FG001|Adding the Second Strategy|Other adverse event|2|||
37763980|NCT01493557|69276051|FG002|Adding the Second Strategy|Other adverse event|0|||
37763981|NCT01493557|69276049|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
37763982|NCT01493557|69276050|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
37763983|NCT01493557|69276051|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
37763984|NCT01451749|69276060|FG000|Overall Study|Protocol Violation|14|||
37763985|NCT01451749|69276061|FG001|Overall Study|Protocol Violation|7|||
37763986|NCT01451749|69276060|FG000|Overall Study|Lost to Follow-up|15|||
37763987|NCT01451749|69276061|FG001|Overall Study|Lost to Follow-up|5|||
37763988|NCT01451749|69276060|FG000|Overall Study|Meet the exclusion criteria,and|1|||
37763989|NCT01451749|69276061|FG001|Overall Study|Meet the exclusion criteria,and|1|||
37763990|NCT01451749|69276060|FG000|Overall Study|Adverse Event|2|||
37763991|NCT01451749|69276061|FG001|Overall Study|Adverse Event|0|||
37763992|NCT01451749|69276060|FG000|Overall Study|Withdrawal by Subject|0|||
37763993|NCT01451749|69276061|FG001|Overall Study|Withdrawal by Subject|1|||
37763994|NCT01576484|69276071|FG000|Overall Study|Adverse Event|1|||
37763995|NCT01576484|69276072|FG001|Overall Study|Adverse Event|1|||
37763996|NCT01576484|69276071|FG000|Overall Study|Protocol Violation|0|||
37763997|NCT01576484|69276072|FG001|Overall Study|Protocol Violation|2|||
37763998|NCT01576484|69276071|FG000|Overall Study|Sponsor Decision|2|||
37763999|NCT01576484|69276072|FG001|Overall Study|Sponsor Decision|8|||
37764000|NCT01576484|69276071|FG000|Overall Study|Withdrawal by Subject|0|||
37934075|NCT00733226|69620812|FG000|Overall Study|moved to another place|2|||
37934076|NCT00733226|69620813|FG001|Overall Study|moved to another place|0|||
37934077|NCT00732992|69620821|FG000|Overall Study|Adverse Event|1|||
37934078|NCT00732992|69620822|FG001|Overall Study|Adverse Event|1|||
37934079|NCT00732992|69620821|FG000|Overall Study|Objective Progression or Relapse|3|||
37934080|NCT00732992|69620822|FG001|Overall Study|Objective Progression or Relapse|5|||
37934081|NCT00732992|69620821|FG000|Overall Study|Global Deterioration of Health Status|1|||
37934082|NCT00732992|69620822|FG001|Overall Study|Global Deterioration of Health Status|0|||
37670176|NCT02679287|69143410|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
37670177|NCT02679287|69143411|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
37764001|NCT01576484|69276072|FG001|Overall Study|Withdrawal by Subject|3|||
37764002|NCT01576484|69276071|FG000|Overall Study|Other|2|||
37764003|NCT01576484|69276072|FG001|Overall Study|Other|5|||
37764004|NCT01467505|69276082|FG000|Overall Study|Adverse Event|1|||
37764005|NCT01467505|69276083|FG001|Overall Study|Adverse Event|0|||
37934083|NCT00732992|69620821|FG000|Overall Study|Withdrawal by Subject|1|||
37764006|NCT01467505|69276082|FG000|Overall Study|Withdrawal by Subject|4|||
37764007|NCT01467505|69276083|FG001|Overall Study|Withdrawal by Subject|0|||
37764008|NCT01467505|69276082|FG000|Overall Study|Study Terminated by Sponsor|28|||
37764009|NCT01467505|69276083|FG001|Overall Study|Study Terminated by Sponsor|3|||
37764010|NCT01467271|69276089|FG000|Overall Study|Death|84|||
37764011|NCT01467271|69276089|FG000|Overall Study|Lost to Follow-up|83|||
37764012|NCT01467271|69276089|FG000|Overall Study|Retraction of patient's consent|21|||
37764013|NCT01467271|69276089|FG000|Overall Study|Other reason|14|||
37764014|NCT01449929|69276095|FG000|Randomization Phase 96 Week|Adverse Event|5|||
37764015|NCT01449929|69276096|FG001|Randomization Phase 96 Week|Adverse Event|13|||
37764016|NCT01449929|69276097|FG002|Randomization Phase 96 Week|Adverse Event|0|||
37764017|NCT01449929|69276095|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
37764018|NCT01449929|69276096|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
37764019|NCT01449929|69276097|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
37764020|NCT01449929|69276095|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
37764021|NCT01449929|69276096|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
37764022|NCT01449929|69276097|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
37764023|NCT01449929|69276095|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
37764024|NCT01449929|69276096|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
37764025|NCT01449929|69276097|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
37764026|NCT01449929|69276095|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
37764027|NCT01449929|69276096|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
37764028|NCT01449929|69276097|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
37764029|NCT01449929|69276095|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
37764030|NCT01449929|69276096|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
37764031|NCT01449929|69276097|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
37764032|NCT01449929|69276095|FG000|Randomization Phase 96 Week|Physician Decision|2|||
37764033|NCT01449929|69276096|FG001|Randomization Phase 96 Week|Physician Decision|3|||
37764034|NCT01449929|69276097|FG002|Randomization Phase 96 Week|Physician Decision|0|||
37764035|NCT01449929|69276095|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
37764036|NCT01449929|69276096|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
37764037|NCT01449929|69276097|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
37764038|NCT01449929|69276095|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
37764039|NCT01449929|69276096|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
37764040|NCT01449929|69276097|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
37764041|NCT01449929|69276095|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
37764042|NCT01449929|69276096|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
37764043|NCT01449929|69276097|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
37764044|NCT01449929|69276095|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
37764045|NCT01449929|69276096|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
37764046|NCT01449929|69276097|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
37764047|NCT01449539|69276107|FG000|Overall Study|Withdrawal by Subject|3|||
37764048|NCT01449539|69276107|FG000|Overall Study|Toxicity not study related|1|||
37764049|NCT01451515|69276114|FG000|Overall Study|Death|0|||
37764050|NCT01451515|69276115|FG001|Overall Study|Death|1|||
37764051|NCT01451515|69276116|FG002|Overall Study|Death|0|||
37764052|NCT01451515|69276114|FG000|Overall Study|Withdrawal by Subject|0|||
37764053|NCT01451515|69276115|FG001|Overall Study|Withdrawal by Subject|1|||
37764054|NCT01451515|69276116|FG002|Overall Study|Withdrawal by Subject|0|||
37764055|NCT01451515|69276114|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
37764056|NCT01451515|69276115|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
37764057|NCT01451515|69276116|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
37764058|NCT01451515|69276114|FG000|Overall Study|Relapse (except CNS)|1|||
37764059|NCT01451515|69276115|FG001|Overall Study|Relapse (except CNS)|1|||
37764060|NCT01451515|69276116|FG002|Overall Study|Relapse (except CNS)|0|||
37670178|NCT02679287|69143410|FG000|Period 2|Work/Scheduling Conflict|1|||
37670179|NCT02679287|69143411|FG001|Period 2|Work/Scheduling Conflict|0|||
37670180|NCT02679287|69143410|FG000|Period 2|Disliked Mobile System|2|||
37670181|NCT02679287|69143411|FG001|Period 2|Disliked Mobile System|0|||
37670182|NCT02679287|69143410|FG000|Period 3|Work/Scheduling Conflict|0|||
37670183|NCT02679287|69143411|FG001|Period 3|Work/Scheduling Conflict|1|||
37670184|NCT02544633|69143427|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
37670185|NCT02544633|69143428|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
37764061|NCT01466881|69276127|FG000|Overall Study|Ineligible|5|||
37764062|NCT01466881|69276127|FG000|Overall Study|Adverse Event|6|||
37764063|NCT01466881|69276127|FG000|Overall Study|Progression/relapse|20|||
37764064|NCT01466881|69276127|FG000|Overall Study|Death|4|||
37764065|NCT01466881|69276127|FG000|Overall Study|Other reason not protocol specified|5|||
37764066|NCT01576406|69276139|FG000|Overall Study|Lost to Follow-up|1|||
37764067|NCT01576406|69276140|FG001|Overall Study|Lost to Follow-up|2|||
37764068|NCT01576406|69276141|FG002|Overall Study|Lost to Follow-up|0|||
37670186|NCT02544633|69143429|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
37670187|NCT02544633|69143430|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
37670188|NCT02544633|69143427|FG000|Treatment Period|Adverse Event|7|||
37670189|NCT02544633|69143428|FG001|Treatment Period|Adverse Event|4|||
37670190|NCT02544633|69143429|FG002|Treatment Period|Adverse Event|0|||
37670191|NCT02544633|69143430|FG003|Treatment Period|Adverse Event|5|||
37670192|NCT02544633|69143427|FG000|Treatment Period|Lack of Efficacy|17|||
37670193|NCT02544633|69143428|FG001|Treatment Period|Lack of Efficacy|11|||
37670194|NCT02544633|69143429|FG002|Treatment Period|Lack of Efficacy|5|||
37670195|NCT02544633|69143430|FG003|Treatment Period|Lack of Efficacy|5|||
37764069|NCT01576406|69276142|FG003|Overall Study|Lost to Follow-up|0|||
37764070|NCT01576406|69276143|FG004|Overall Study|Lost to Follow-up|0|||
37764071|NCT01576406|69276144|FG005|Overall Study|Lost to Follow-up|0|||
37764072|NCT01576406|69276139|FG000|Overall Study|Death|3|||
37764073|NCT01576406|69276140|FG001|Overall Study|Death|4|||
37764074|NCT01576406|69276141|FG002|Overall Study|Death|8|||
37764075|NCT01576406|69276142|FG003|Overall Study|Death|5|||
37764076|NCT01576406|69276143|FG004|Overall Study|Death|7|||
37764077|NCT01576406|69276144|FG005|Overall Study|Death|9|||
37764078|NCT01576406|69276139|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
37764079|NCT01576406|69276140|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
37764080|NCT01576406|69276141|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
37764081|NCT01576406|69276142|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
37764082|NCT01576406|69276143|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
37764083|NCT01576406|69276144|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
37764084|NCT01576406|69276139|FG000|Overall Study|Withdrawal the consent|2|||
37764085|NCT01576406|69276140|FG001|Overall Study|Withdrawal the consent|2|||
37764086|NCT01576406|69276141|FG002|Overall Study|Withdrawal the consent|5|||
37764087|NCT01576406|69276142|FG003|Overall Study|Withdrawal the consent|1|||
37764088|NCT01576406|69276143|FG004|Overall Study|Withdrawal the consent|1|||
37764089|NCT01576406|69276144|FG005|Overall Study|Withdrawal the consent|3|||
37764090|NCT01576406|69276139|FG000|Overall Study|Other|0|||
37764091|NCT01576406|69276140|FG001|Overall Study|Other|0|||
37764092|NCT01576406|69276141|FG002|Overall Study|Other|2|||
37764093|NCT01576406|69276142|FG003|Overall Study|Other|2|||
37764094|NCT01576406|69276143|FG004|Overall Study|Other|0|||
37764095|NCT01576406|69276144|FG005|Overall Study|Other|0|||
37764096|NCT01576172|69276160|FG000|Overall Study|Ineligible|2|||
37764097|NCT01576172|69276161|FG001|Overall Study|Ineligible|1|||
37764098|NCT01576172|69276160|FG000|Overall Study|Withdrawal by Subject|2|||
37764099|NCT01576172|69276161|FG001|Overall Study|Withdrawal by Subject|0|||
37934084|NCT00732992|69620822|FG001|Overall Study|Withdrawal by Subject|0|||
37934085|NCT00732758|69620831|FG000|Overall Study|Lost to Follow-up|8|||
37934086|NCT00732758|69620832|FG001|Overall Study|Lost to Follow-up|16|||
37934087|NCT00699153|69620840|FG000|Overall Study|Lost to Follow-up|1|||
37764100|NCT01576172|69276160|FG000|Overall Study|Insurance issue|1|||
37764101|NCT01576172|69276161|FG001|Overall Study|Insurance issue|0|||
37934088|NCT00699153|69620841|FG001|Overall Study|Lost to Follow-up|0|||
37934089|NCT00699153|69620840|FG000|Overall Study|Adverse Event|0|||
37934090|NCT00699153|69620841|FG001|Overall Study|Adverse Event|2|||
37934091|NCT00699153|69620840|FG000|Overall Study|Protocol Violation|1|||
37934092|NCT00699153|69620841|FG001|Overall Study|Protocol Violation|0|||
37934093|NCT00699153|69620840|FG000|Overall Study|Travel Problem|1|||
37934094|NCT00699153|69620841|FG001|Overall Study|Travel Problem|0|||
37934095|NCT00698997|69620849|FG000|Overall Study|Lost to Follow-up|3|||
37934096|NCT00698997|69620850|FG001|Overall Study|Lost to Follow-up|0|||
37934097|NCT00698997|69620849|FG000|Overall Study|Withdrawal by Subject|7|||
37764102|NCT01542788|69276171|FG000|Overall Study|Randomized but Not Treated|2|||
37764103|NCT01542788|69276172|FG001|Overall Study|Randomized but Not Treated|0|||
37764104|NCT01542788|69276171|FG000|Overall Study|Lack of Efficacy|41|||
37764105|NCT01542788|69276172|FG001|Overall Study|Lack of Efficacy|71|||
37764106|NCT01542788|69276171|FG000|Overall Study|Lost to Follow-up|5|||
37764107|NCT01542788|69276172|FG001|Overall Study|Lost to Follow-up|0|||
37764108|NCT01542788|69276171|FG000|Overall Study|Death|3|||
37764109|NCT01542788|69276172|FG001|Overall Study|Death|0|||
37934098|NCT00698997|69620850|FG001|Overall Study|Withdrawal by Subject|27|||
37934099|NCT00711087|69620859|FG000|Overall Study|Lost to Follow-up|1|||
37934100|NCT00711087|69620860|FG001|Overall Study|Lost to Follow-up|0|||
37670196|NCT02544633|69143427|FG000|Treatment Period|Global Deterioration of Health|3|||
37670197|NCT02544633|69143428|FG001|Treatment Period|Global Deterioration of Health|3|||
37764110|NCT01542788|69276171|FG000|Overall Study|Protocol Violation|2|||
37764111|NCT01542788|69276172|FG001|Overall Study|Protocol Violation|0|||
37764112|NCT01542788|69276171|FG000|Overall Study|Physician Decision|1|||
37764113|NCT01542788|69276172|FG001|Overall Study|Physician Decision|0|||
37764114|NCT01542788|69276171|FG000|Overall Study|Withdrawal by Subject|1|||
37764115|NCT01542788|69276172|FG001|Overall Study|Withdrawal by Subject|0|||
37934101|NCT00738530|69620868|FG000|Overall Study|Death|220|||
37934102|NCT00738530|69620869|FG001|Overall Study|Death|224|||
37934103|NCT00738530|69620868|FG000|Overall Study|Lost to Follow-up|8|||
37934104|NCT00738530|69620869|FG001|Overall Study|Lost to Follow-up|6|||
37764116|NCT01542632|69276184|FG000|Overall Study|Withdrawal of Consent|0|||
37764117|NCT01542632|69276185|FG001|Overall Study|Withdrawal of Consent|0|||
37764118|NCT01542632|69276186|FG002|Overall Study|Withdrawal of Consent|0|||
37764119|NCT01542632|69276187|FG003|Overall Study|Withdrawal of Consent|2|||
37764120|NCT01542632|69276188|FG004|Overall Study|Withdrawal of Consent|3|||
37764121|NCT01542632|69276189|FG005|Overall Study|Withdrawal of Consent|0|||
37764122|NCT01542632|69276184|FG000|Overall Study|Adverse Event|0|||
37764123|NCT01542632|69276185|FG001|Overall Study|Adverse Event|0|||
37764124|NCT01542632|69276186|FG002|Overall Study|Adverse Event|1|||
37764125|NCT01542632|69276187|FG003|Overall Study|Adverse Event|0|||
37764126|NCT01542632|69276188|FG004|Overall Study|Adverse Event|0|||
37764127|NCT01542632|69276189|FG005|Overall Study|Adverse Event|0|||
37764128|NCT01542632|69276184|FG000|Overall Study|Lost to Follow-up|0|||
37764129|NCT01542632|69276185|FG001|Overall Study|Lost to Follow-up|1|||
37764130|NCT01542632|69276186|FG002|Overall Study|Lost to Follow-up|0|||
37764131|NCT01542632|69276187|FG003|Overall Study|Lost to Follow-up|0|||
37764132|NCT01542632|69276188|FG004|Overall Study|Lost to Follow-up|0|||
37764133|NCT01542632|69276189|FG005|Overall Study|Lost to Follow-up|0|||
37764134|NCT01542632|69276184|FG000|Overall Study|Sponsor/Investigator Decision|0|||
37764135|NCT01542632|69276185|FG001|Overall Study|Sponsor/Investigator Decision|0|||
37764136|NCT01542632|69276186|FG002|Overall Study|Sponsor/Investigator Decision|0|||
37764137|NCT01542632|69276187|FG003|Overall Study|Sponsor/Investigator Decision|0|||
37764138|NCT01542632|69276188|FG004|Overall Study|Sponsor/Investigator Decision|1|||
37764139|NCT01542632|69276189|FG005|Overall Study|Sponsor/Investigator Decision|0|||
37764140|NCT01557842|69276210|FG000|Overall Study|Lost to Follow-up|0|||
37764141|NCT01557842|69276211|FG001|Overall Study|Lost to Follow-up|1|||
37764142|NCT01557842|69276210|FG000|Overall Study|Death|1|||
37764143|NCT01557842|69276211|FG001|Overall Study|Death|0|||
37764144|NCT01557842|69276210|FG000|Overall Study|Lack of Efficacy|0|||
37764145|NCT01557842|69276211|FG001|Overall Study|Lack of Efficacy|1|||
37764146|NCT01557842|69276210|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
37764147|NCT01557842|69276211|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
37764148|NCT01557842|69276210|FG000|Overall Study|Study Terminated by Sponsor|3|||
37764149|NCT01557842|69276211|FG001|Overall Study|Study Terminated by Sponsor|4|||
37764150|NCT01557842|69276210|FG000|Overall Study|Not Ablated|2|||
37764151|NCT01557842|69276211|FG001|Overall Study|Not Ablated|0|||
37764152|NCT01541930|69276217|FG000|Overall Study|Withdrawal by Subject|1|||
37764153|NCT01576016|69276234|FG000|Lead Safety|Death|132|||
37764154|NCT01576016|69276235|FG001|Lead Safety|Death|0|||
37764155|NCT01576016|69276234|FG000|Lead Safety|Withdrawal by Subject|81|||
37764156|NCT01576016|69276235|FG001|Lead Safety|Withdrawal by Subject|0|||
37764157|NCT01576016|69276234|FG000|Lead Safety|System Explanted without Replacement|24|||
37764158|NCT01576016|69276235|FG001|Lead Safety|System Explanted without Replacement|0|||
37764159|NCT01576016|69276234|FG000|Lead Safety|Physician Decision|14|||
37764160|NCT01576016|69276235|FG001|Lead Safety|Physician Decision|0|||
37764161|NCT01576016|69276234|FG000|Lead Safety|Lost to Follow-up|13|||
37764162|NCT01576016|69276235|FG001|Lead Safety|Lost to Follow-up|0|||
37764163|NCT01576016|69276234|FG000|Lead Safety|Unsuccessful implant|2|||
37764164|NCT01576016|69276235|FG001|Lead Safety|Unsuccessful implant|0|||
37764165|NCT01576016|69276234|FG000|Lead Safety|Sponsor request|1|||
37764166|NCT01576016|69276235|FG001|Lead Safety|Sponsor request|0|||
37764167|NCT01576016|69276234|FG000|Lead Safety|Device replaced with CRT-D|1|||
37764168|NCT01576016|69276235|FG001|Lead Safety|Device replaced with CRT-D|0|||
37764169|NCT01576016|69276234|FG000|Lead Safety|Patient on Palliative Care|1|||
37764170|NCT01576016|69276235|FG001|Lead Safety|Patient on Palliative Care|0|||
37764171|NCT01576016|69276234|FG000|Lead Safety|Patient noncompliance|1|||
37764172|NCT01576016|69276235|FG001|Lead Safety|Patient noncompliance|0|||
37764173|NCT01576016|69276234|FG000|Lead Safety|Too far from study site|1|||
37764174|NCT01576016|69276235|FG001|Lead Safety|Too far from study site|0|||
37764175|NCT01576016|69276234|FG000|Lead Safety|System deactivated|1|||
37764176|NCT01576016|69276235|FG001|Lead Safety|System deactivated|0|||
38035014|NCT04230213|69721864|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
37764177|NCT01576016|69276234|FG000|Lead Safety|Patient no longer followed by study PI|1|||
37764178|NCT01576016|69276235|FG001|Lead Safety|Patient no longer followed by study PI|0|||
37764179|NCT01576016|69276234|FG000|MRI Safety|Withdrawal by Subject|0|||
37764180|NCT01576016|69276235|FG001|MRI Safety|Withdrawal by Subject|10|||
37764181|NCT01576016|69276234|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
38035015|NCT04230213|69721865|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
38035016|NCT04230213|69721866|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
37764182|NCT01576016|69276235|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
37764183|NCT01576016|69276234|FG000|MRI Safety|Has not yet completed MRI scan|0|||
37764184|NCT01576016|69276235|FG001|MRI Safety|Has not yet completed MRI scan|56|||
37764185|NCT01576016|69276234|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
37764186|NCT01576016|69276235|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
37764187|NCT01540838|69276245|FG000|Overall Study|Open nasogastric tube|9|||
37764188|NCT01540838|69276246|FG001|Overall Study|Open nasogastric tube|7|||
37764189|NCT01540838|69276245|FG000|Overall Study|Treatment doses missing|8|||
37764190|NCT01540838|69276246|FG001|Overall Study|Treatment doses missing|12|||
37764191|NCT01540838|69276245|FG000|Overall Study|Additional antibiotic treatment|1|||
37764192|NCT01540838|69276246|FG001|Overall Study|Additional antibiotic treatment|2|||
37764193|NCT01540838|69276245|FG000|Overall Study|Died before treatment initiation|1|||
37764194|NCT01540838|69276246|FG001|Overall Study|Died before treatment initiation|1|||
37764195|NCT01540838|69276245|FG000|Overall Study|Not BM. Other treatment|3|||
37764196|NCT01540838|69276246|FG001|Overall Study|Not BM. Other treatment|1|||
37764197|NCT01451437|69276261|FG000|Overall Study|Adverse Event|0|||
37764198|NCT01451437|69276262|FG001|Overall Study|Adverse Event|0|||
37764199|NCT01451437|69276263|FG002|Overall Study|Adverse Event|0|||
37764200|NCT01451437|69276264|FG003|Overall Study|Adverse Event|0|||
37764201|NCT01451437|69276265|FG004|Overall Study|Adverse Event|0|||
37764202|NCT01451437|69276266|FG005|Overall Study|Adverse Event|1|||
37764203|NCT01451437|69276267|FG006|Overall Study|Adverse Event|1|||
37764204|NCT01451437|69276268|FG007|Overall Study|Adverse Event|2|||
37764205|NCT01451437|69276269|FG008|Overall Study|Adverse Event|1|||
37764206|NCT01451437|69276261|FG000|Overall Study|Physician Decision|1|||
37764207|NCT01451437|69276262|FG001|Overall Study|Physician Decision|1|||
37764208|NCT01451437|69276263|FG002|Overall Study|Physician Decision|2|||
37764209|NCT01451437|69276264|FG003|Overall Study|Physician Decision|0|||
37764210|NCT01451437|69276265|FG004|Overall Study|Physician Decision|0|||
37764211|NCT01451437|69276266|FG005|Overall Study|Physician Decision|0|||
37764212|NCT01451437|69276267|FG006|Overall Study|Physician Decision|0|||
37764213|NCT01451437|69276268|FG007|Overall Study|Physician Decision|0|||
37764214|NCT01451437|69276269|FG008|Overall Study|Physician Decision|0|||
37764215|NCT01451437|69276261|FG000|Overall Study|Disease Progression|0|||
37764216|NCT01451437|69276262|FG001|Overall Study|Disease Progression|0|||
37764217|NCT01451437|69276263|FG002|Overall Study|Disease Progression|1|||
38035017|NCT04230213|69721864|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
38035018|NCT04230213|69721865|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
38035019|NCT04230213|69721866|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
37764218|NCT01451437|69276264|FG003|Overall Study|Disease Progression|1|||
37764219|NCT01451437|69276265|FG004|Overall Study|Disease Progression|3|||
37764220|NCT01451437|69276266|FG005|Overall Study|Disease Progression|2|||
37764221|NCT01451437|69276267|FG006|Overall Study|Disease Progression|3|||
37764222|NCT01451437|69276268|FG007|Overall Study|Disease Progression|1|||
37764223|NCT01451437|69276269|FG008|Overall Study|Disease Progression|3|||
37764224|NCT01451437|69276261|FG000|Overall Study|Protocol Violation|0|||
37764225|NCT01451437|69276262|FG001|Overall Study|Protocol Violation|0|||
37764226|NCT01451437|69276263|FG002|Overall Study|Protocol Violation|0|||
37764227|NCT01451437|69276264|FG003|Overall Study|Protocol Violation|0|||
37764228|NCT01451437|69276265|FG004|Overall Study|Protocol Violation|0|||
37764229|NCT01451437|69276266|FG005|Overall Study|Protocol Violation|0|||
37764230|NCT01451437|69276267|FG006|Overall Study|Protocol Violation|1|||
37764231|NCT01451437|69276268|FG007|Overall Study|Protocol Violation|0|||
37764232|NCT01451437|69276269|FG008|Overall Study|Protocol Violation|0|||
37764233|NCT01451437|69276261|FG000|Overall Study|Withdrawal by Subject|0|||
37764234|NCT01451437|69276262|FG001|Overall Study|Withdrawal by Subject|0|||
37764235|NCT01451437|69276263|FG002|Overall Study|Withdrawal by Subject|0|||
37764236|NCT01451437|69276264|FG003|Overall Study|Withdrawal by Subject|0|||
37764237|NCT01451437|69276265|FG004|Overall Study|Withdrawal by Subject|1|||
37764238|NCT01451437|69276266|FG005|Overall Study|Withdrawal by Subject|0|||
37764239|NCT01451437|69276267|FG006|Overall Study|Withdrawal by Subject|1|||
37764240|NCT01451437|69276268|FG007|Overall Study|Withdrawal by Subject|0|||
37764241|NCT01451437|69276269|FG008|Overall Study|Withdrawal by Subject|0|||
37764242|NCT01451203|69276300|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
37764243|NCT01451203|69276301|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
37764244|NCT01451203|69276300|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
37764245|NCT01451203|69276301|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
37764246|NCT01451203|69276300|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
37764247|NCT01451203|69276301|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
37764248|NCT01451203|69276300|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
37764249|NCT01451203|69276301|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
37764250|NCT01451203|69276300|FG000|Double-blind Treatment Period|Adverse Event|6|||
37764251|NCT01451203|69276301|FG001|Double-blind Treatment Period|Adverse Event|9|||
37764252|NCT01451203|69276300|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
37764253|NCT01451203|69276301|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
37764254|NCT01451203|69276300|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
37764255|NCT01451203|69276301|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
37764256|NCT01451203|69276300|FG000|Double-blind Treatment Period|Investigator decision|2|||
37764257|NCT01451203|69276301|FG001|Double-blind Treatment Period|Investigator decision|0|||
37764258|NCT01451203|69276300|FG000|Post-treatment Period|Consent withdrawn|2|||
37764259|NCT01451203|69276301|FG001|Post-treatment Period|Consent withdrawn|4|||
37764260|NCT01451203|69276300|FG000|Post-treatment Period|Lack of Efficacy|12|||
37764261|NCT01451203|69276301|FG001|Post-treatment Period|Lack of Efficacy|28|||
37764262|NCT01451203|69276300|FG000|Post-treatment Period|Adverse Event|0|||
37764263|NCT01451203|69276301|FG001|Post-treatment Period|Adverse Event|1|||
37764264|NCT01451203|69276300|FG000|Post-treatment Period|Investigator decision|0|||
37764265|NCT01451203|69276301|FG001|Post-treatment Period|Investigator decision|1|||
37764266|NCT01556438|69276309|FG000|Overall Study|Adverse Event|4|||
37764267|NCT01556438|69276310|FG001|Overall Study|Adverse Event|2|||
37764268|NCT01556438|69276309|FG000|Overall Study|Sponsor Decision|0|||
37764269|NCT01556438|69276310|FG001|Overall Study|Sponsor Decision|2|||
37764270|NCT01556438|69276309|FG000|Overall Study|Progressive Disease|0|||
37764271|NCT01556438|69276310|FG001|Overall Study|Progressive Disease|6|||
37764272|NCT01556438|69276309|FG000|Overall Study|Death|0|||
37764273|NCT01556438|69276310|FG001|Overall Study|Death|1|||
37764274|NCT01554176|69276336|FG000|Treatment Phase|Protocol Violation|1|||
37764275|NCT01554176|69276337|FG001|Treatment Phase|Protocol Violation|2|||
37764276|NCT01554176|69276338|FG002|Treatment Phase|Protocol Violation|0|||
37764277|NCT01554176|69276339|FG003|Treatment Phase|Protocol Violation|0|||
37764278|NCT01554176|69276340|FG004|Treatment Phase|Protocol Violation|0|||
37764279|NCT01554176|69276336|FG000|Treatment Phase|Physician Decision|1|||
37764280|NCT01554176|69276337|FG001|Treatment Phase|Physician Decision|1|||
37764281|NCT01554176|69276338|FG002|Treatment Phase|Physician Decision|0|||
37764282|NCT01554176|69276339|FG003|Treatment Phase|Physician Decision|0|||
37764283|NCT01554176|69276340|FG004|Treatment Phase|Physician Decision|0|||
37764284|NCT01554176|69276336|FG000|Treatment Phase|Lack of Efficacy|0|||
37764285|NCT01554176|69276337|FG001|Treatment Phase|Lack of Efficacy|1|||
37764286|NCT01554176|69276338|FG002|Treatment Phase|Lack of Efficacy|0|||
37764287|NCT01554176|69276339|FG003|Treatment Phase|Lack of Efficacy|0|||
37764288|NCT01554176|69276340|FG004|Treatment Phase|Lack of Efficacy|0|||
37764289|NCT01554176|69276336|FG000|Treatment Phase|Adverse event, non-fatal|1|||
37764290|NCT01554176|69276337|FG001|Treatment Phase|Adverse event, non-fatal|1|||
37764291|NCT01554176|69276338|FG002|Treatment Phase|Adverse event, non-fatal|0|||
37764292|NCT01554176|69276339|FG003|Treatment Phase|Adverse event, non-fatal|0|||
37764293|NCT01554176|69276340|FG004|Treatment Phase|Adverse event, non-fatal|0|||
37764294|NCT01554176|69276336|FG000|Treatment Phase|Non-compliance with study drug|1|||
37764295|NCT01554176|69276337|FG001|Treatment Phase|Non-compliance with study drug|0|||
37764296|NCT01554176|69276338|FG002|Treatment Phase|Non-compliance with study drug|0|||
37764297|NCT01554176|69276339|FG003|Treatment Phase|Non-compliance with study drug|0|||
37764298|NCT01554176|69276340|FG004|Treatment Phase|Non-compliance with study drug|0|||
37764299|NCT01554176|69276336|FG000|Treatment Phase|Withdrawal by Subject|1|||
37764300|NCT01554176|69276337|FG001|Treatment Phase|Withdrawal by Subject|0|||
37764301|NCT01554176|69276338|FG002|Treatment Phase|Withdrawal by Subject|0|||
37764302|NCT01554176|69276339|FG003|Treatment Phase|Withdrawal by Subject|0|||
37764303|NCT01554176|69276340|FG004|Treatment Phase|Withdrawal by Subject|0|||
37764304|NCT01554176|69276336|FG000|Treatment Phase|Lost to Follow-up|3|||
37764305|NCT01554176|69276337|FG001|Treatment Phase|Lost to Follow-up|0|||
37764306|NCT01554176|69276338|FG002|Treatment Phase|Lost to Follow-up|0|||
37764307|NCT01554176|69276339|FG003|Treatment Phase|Lost to Follow-up|0|||
37764308|NCT01554176|69276340|FG004|Treatment Phase|Lost to Follow-up|0|||
37764309|NCT01554176|69276336|FG000|Run-out Phase|Protocol Violation|0|||
37764310|NCT01554176|69276337|FG001|Run-out Phase|Protocol Violation|0|||
37764311|NCT01554176|69276338|FG002|Run-out Phase|Protocol Violation|0|||
37764312|NCT01554176|69276339|FG003|Run-out Phase|Protocol Violation|1|||
37764313|NCT01554176|69276340|FG004|Run-out Phase|Protocol Violation|0|||
37764314|NCT01466491|69276356|FG000|Overall Study|Protocol Violation|0|||
37764315|NCT01466491|69276357|FG001|Overall Study|Protocol Violation|3|||
37934105|NCT00738530|69620868|FG000|Overall Study|Withdrawal by Subject|6|||
37934106|NCT00738530|69620869|FG001|Overall Study|Withdrawal by Subject|8|||
37934107|NCT00711009|69620877|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
37934108|NCT00711009|69620878|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
37934109|NCT00711009|69620877|FG000|Overall Study|Withdrawal by Subject|4|||
37670198|NCT02544633|69143429|FG002|Treatment Period|Global Deterioration of Health|0|||
37670199|NCT02544633|69143430|FG003|Treatment Period|Global Deterioration of Health|1|||
37764316|NCT01466491|69276358|FG002|Overall Study|Protocol Violation|2|||
37764317|NCT01466491|69276359|FG003|Overall Study|Protocol Violation|0|||
37764318|NCT01466491|69276356|FG000|Overall Study|Missing Data|0|||
37764319|NCT01466491|69276357|FG001|Overall Study|Missing Data|0|||
37764320|NCT01466491|69276358|FG002|Overall Study|Missing Data|1|||
37764321|NCT01466491|69276359|FG003|Overall Study|Missing Data|0|||
37764322|NCT01466179|69276369|FG000|Overall Study|Ongoing in core study|2|||
37764323|NCT01466179|69276369|FG000|Overall Study|Physician Decision|46|||
37764324|NCT01466179|69276369|FG000|Overall Study|Progressive disease|43|||
37764325|NCT01466179|69276369|FG000|Overall Study|Adverse Event|32|||
37764326|NCT01466179|69276369|FG000|Overall Study|Disease relapse|23|||
37764327|NCT01466179|69276369|FG000|Overall Study|Lack of Efficacy|14|||
37764328|NCT01466179|69276369|FG000|Overall Study|Death|7|||
37764329|NCT01466179|69276369|FG000|Overall Study|Withdrawal by Subject|7|||
37934110|NCT00711009|69620878|FG001|Overall Study|Withdrawal by Subject|2|||
37934111|NCT00711009|69620877|FG000|Overall Study|Lost to Follow-up|3|||
37764330|NCT01466179|69276369|FG000|Overall Study|Protocol Violation|2|||
37764331|NCT01466179|69276369|FG000|Overall Study|Other|3|||
37764332|NCT01493089|69276378|FG000|Overall Study|Protocol Violation|2|||
37764333|NCT01493089|69276379|FG001|Overall Study|Protocol Violation|2|||
37764334|NCT01493089|69276378|FG000|Overall Study|Withdrawal by Subject|1|||
37764335|NCT01493089|69276379|FG001|Overall Study|Withdrawal by Subject|0|||
37764336|NCT01493089|69276378|FG000|Overall Study|Physician Decision|0|||
37764337|NCT01493089|69276379|FG001|Overall Study|Physician Decision|1|||
37764338|NCT01450813|69276391|FG000|Overall Study|Physician Decision|1|||
37764339|NCT01450813|69276392|FG001|Overall Study|Physician Decision|1|||
37764340|NCT01450813|69276393|FG002|Overall Study|Physician Decision|0|||
37764341|NCT01450813|69276394|FG003|Overall Study|Physician Decision|3|||
37764342|NCT01539512|69276408|FG000|Overall Study|Adverse Event|9|||
37764343|NCT01539512|69276409|FG001|Overall Study|Adverse Event|7|||
37764344|NCT01539512|69276408|FG000|Overall Study|Physician Decision|1|||
37764345|NCT01539512|69276409|FG001|Overall Study|Physician Decision|1|||
37764346|NCT01539512|69276408|FG000|Overall Study|Withdrawal by Subject|12|||
37764347|NCT01539512|69276409|FG001|Overall Study|Withdrawal by Subject|5|||
37764348|NCT01539512|69276408|FG000|Overall Study|Richter's Transformation|1|||
37764349|NCT01539512|69276409|FG001|Overall Study|Richter's Transformation|0|||
37764350|NCT01449955|69276417|FG000|Overall Study|Withdrawal by Subject|1|||
37764351|NCT01449955|69276418|FG001|Overall Study|Withdrawal by Subject|2|||
37764352|NCT01574612|69276431|FG000|Overall Study|Adverse Event|3|||
37764353|NCT01574612|69276431|FG000|Overall Study|non compliant with drug|2|||
37764354|NCT01574612|69276431|FG000|Overall Study|Withdrawal by Subject|1|||
37764355|NCT01574612|69276431|FG000|Overall Study|Lost to Follow-up|2|||
37764356|NCT01573910|69276437|FG000|Overall Study|Adverse Event|4|||
37764357|NCT01573910|69276438|FG001|Overall Study|Adverse Event|4|||
37764358|NCT01573910|69276437|FG000|Overall Study|Lost to Follow-up|2|||
37764359|NCT01573910|69276438|FG001|Overall Study|Lost to Follow-up|1|||
37764360|NCT01573910|69276437|FG000|Overall Study|Withdrawal by Subject|0|||
37764361|NCT01573910|69276438|FG001|Overall Study|Withdrawal by Subject|1|||
37764362|NCT01573910|69276437|FG000|Overall Study|Protocol Violation|3|||
37764363|NCT01573910|69276438|FG001|Overall Study|Protocol Violation|0|||
37764364|NCT01573910|69276437|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
37764365|NCT01573910|69276438|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
37764366|NCT01491919|69276447|FG000|Overall Study|Insufficient PK sampling|1|||
37764367|NCT01491919|69276448|FG001|Overall Study|Insufficient PK sampling|2|||
37764368|NCT01491919|69276449|FG002|Overall Study|Insufficient PK sampling|1|||
37764369|NCT01573442|69276461|FG000|Overall Study|Cancels|9|||
37764370|NCT01573442|69276462|FG001|Overall Study|Cancels|10|||
37764371|NCT01491841|69276531|FG000|Overall Study|Screen Failure|10|||
37764372|NCT01491841|69276531|FG000|Overall Study|Withdrawal by Subject|1|||
37764373|NCT01553318|69276550|FG000|Overall Study|Protocol Violation|3|||
37764374|NCT01553318|69276551|FG001|Overall Study|Protocol Violation|2|||
37764375|NCT01572740|69276570|FG000|Overall Study|Adverse Event|1|||
37764376|NCT01572740|69276571|FG001|Overall Study|Adverse Event|1|||
37764377|NCT01572740|69276570|FG000|Overall Study|Withdrawal by Subject|1|||
37764378|NCT01572740|69276571|FG001|Overall Study|Withdrawal by Subject|1|||
37764379|NCT01572740|69276570|FG000|Overall Study|unclassified|4|||
37764380|NCT01572740|69276571|FG001|Overall Study|unclassified|3|||
37764381|NCT01491607|69276581|FG000|Overall Study|Lost to Follow-up|7|||
37764382|NCT01491607|69276581|FG000|Overall Study|Withdrawal by Subject|3|||
37764383|NCT01449721|69276664|FG000|Overall Study|Physician Decision|0|||
37764384|NCT01449721|69276665|FG001|Overall Study|Physician Decision|1|||
37764385|NCT01449721|69276664|FG000|Overall Study|Physician Decision|0|||
37764386|NCT01449721|69276665|FG001|Overall Study|Physician Decision|1|||
37764387|NCT01553084|69276674|FG000|Overall Study|Withdrawal by Subject|15|||
37764388|NCT01553084|69276675|FG001|Overall Study|Withdrawal by Subject|13|||
37764389|NCT01553084|69276676|FG002|Overall Study|Withdrawal by Subject|35|||
37764390|NCT01536860|69276686|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
37764391|NCT01536860|69276687|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
37764392|NCT01536860|69276688|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
37764393|NCT01552928|69276700|FG000|Period 3|Adverse Event|0|||
37764394|NCT01552928|69276701|FG001|Period 3|Adverse Event|0|||
37764395|NCT01552928|69276702|FG002|Period 3|Adverse Event|1|||
37764396|NCT01552928|69276703|FG003|Period 3|Adverse Event|0|||
37764397|NCT01448707|69276722|FG000|Overall Study|Adverse Event|3|||
37764398|NCT01448707|69276723|FG001|Overall Study|Adverse Event|1|||
37764399|NCT01448707|69276722|FG000|Overall Study|Lost to Follow-up|2|||
37764400|NCT01448707|69276723|FG001|Overall Study|Lost to Follow-up|6|||
37764401|NCT01448707|69276722|FG000|Overall Study|Withdrawal by Subject|6|||
37764402|NCT01448707|69276723|FG001|Overall Study|Withdrawal by Subject|7|||
37764403|NCT01448707|69276722|FG000|Overall Study|Other|7|||
37764404|NCT01448707|69276723|FG001|Overall Study|Other|4|||
37764405|NCT01536704|69276729|FG000|Washout Period 1|Withdrawal by Subject|1|||
37764406|NCT01536704|69276730|FG001|Washout Period 1|Withdrawal by Subject|2|||
37764407|NCT01536704|69276731|FG002|Washout Period 1|Withdrawal by Subject|0|||
37764408|NCT01536704|69276732|FG003|Washout Period 1|Withdrawal by Subject|0|||
37764409|NCT01536704|69276729|FG000|Washout Period 2|Adverse Event|1|||
37764410|NCT01536704|69276730|FG001|Washout Period 2|Adverse Event|0|||
37764411|NCT01536704|69276731|FG002|Washout Period 2|Adverse Event|0|||
37764412|NCT01536704|69276732|FG003|Washout Period 2|Adverse Event|0|||
37764413|NCT01536704|69276729|FG000|Washout Period 2|Withdrawal by Subject|0|||
37764414|NCT01536704|69276730|FG001|Washout Period 2|Withdrawal by Subject|0|||
37764415|NCT01536704|69276731|FG002|Washout Period 2|Withdrawal by Subject|0|||
37764416|NCT01536704|69276732|FG003|Washout Period 2|Withdrawal by Subject|1|||
37764417|NCT01536704|69276729|FG000|Period 3|Adverse Event|0|||
37764418|NCT01536704|69276730|FG001|Period 3|Adverse Event|0|||
37764419|NCT01536704|69276731|FG002|Period 3|Adverse Event|0|||
37764420|NCT01536704|69276732|FG003|Period 3|Adverse Event|1|||
37764421|NCT01536704|69276729|FG000|Washout Period 3|Adverse Event|0|||
37764422|NCT01536704|69276730|FG001|Washout Period 3|Adverse Event|0|||
37764423|NCT01536704|69276731|FG002|Washout Period 3|Adverse Event|1|||
37764424|NCT01536704|69276732|FG003|Washout Period 3|Adverse Event|0|||
37764425|NCT01552772|69276746|FG000|Overall Study|Lost to Follow-up|2|||
37764426|NCT01552772|69276746|FG000|Overall Study|Adverse Event|1|||
37764427|NCT01552772|69276746|FG000|Overall Study|Protocol Deviation|1|||
37764428|NCT01552694|69276753|FG000|Overall Study|Lost to Follow-up|0|||
37764429|NCT01552694|69276754|FG001|Overall Study|Lost to Follow-up|1|||
37764430|NCT01552694|69276753|FG000|Overall Study|Protocol Violation|0|||
37764431|NCT01552694|69276754|FG001|Overall Study|Protocol Violation|1|||
37764432|NCT01464931|69276762|FG000|Overall Study|Withdrawal by Subject|1|||
37764433|NCT01464931|69276763|FG001|Overall Study|Withdrawal by Subject|0|||
37764434|NCT01536392|69276788|FG000|Overall Study|Adverse Event|2|||
37764435|NCT01536392|69276789|FG001|Overall Study|Adverse Event|2|||
37764436|NCT01536392|69276788|FG000|Overall Study|Physician Decision|2|||
37764437|NCT01536392|69276789|FG001|Overall Study|Physician Decision|3|||
37764438|NCT01536392|69276788|FG000|Overall Study|Withdrawal by Subject|3|||
37764439|NCT01536392|69276789|FG001|Overall Study|Withdrawal by Subject|6|||
37764440|NCT01536392|69276788|FG000|Overall Study|Non Compliance|3|||
37764441|NCT01536392|69276789|FG001|Overall Study|Non Compliance|4|||
37764442|NCT01536392|69276788|FG000|Overall Study|Completed therapy early|3|||
37670200|NCT02544633|69143427|FG000|Treatment Period|Withdrawal by Subject|1|||
37670201|NCT02544633|69143428|FG001|Treatment Period|Withdrawal by Subject|0|||
37670202|NCT02544633|69143429|FG002|Treatment Period|Withdrawal by Subject|0|||
37670203|NCT02544633|69143430|FG003|Treatment Period|Withdrawal by Subject|0|||
37670204|NCT02544633|69143427|FG000|Treatment Period|Lost to Follow-up|0|||
37670205|NCT02544633|69143428|FG001|Treatment Period|Lost to Follow-up|1|||
37670206|NCT02544633|69143429|FG002|Treatment Period|Lost to Follow-up|0|||
37670207|NCT02544633|69143430|FG003|Treatment Period|Lost to Follow-up|0|||
37670208|NCT02544633|69143427|FG000|Treatment Period|Death|0|||
37670209|NCT02544633|69143428|FG001|Treatment Period|Death|0|||
37670210|NCT02544633|69143429|FG002|Treatment Period|Death|1|||
37670211|NCT02544633|69143430|FG003|Treatment Period|Death|0|||
37670212|NCT02544633|69143427|FG000|Treatment Period|Non-compliance|0|||
37670213|NCT02544633|69143428|FG001|Treatment Period|Non-compliance|0|||
37670214|NCT02544633|69143429|FG002|Treatment Period|Non-compliance|1|||
37670215|NCT02544633|69143430|FG003|Treatment Period|Non-compliance|0|||
37670216|NCT02544633|69143427|FG000|Treatment Period|Clinical Disease Progression|0|||
37670217|NCT02544633|69143428|FG001|Treatment Period|Clinical Disease Progression|0|||
37670218|NCT02544633|69143429|FG002|Treatment Period|Clinical Disease Progression|0|||
37670219|NCT02544633|69143430|FG003|Treatment Period|Clinical Disease Progression|1|||
37670220|NCT02544633|69143427|FG000|Survival Follow-up Period|Death|12|||
37764443|NCT01536392|69276789|FG001|Overall Study|Completed therapy early|0|||
37764444|NCT01464619|69276797|FG000|Overall Study|Lost to Follow-up|3|||
37764445|NCT01464619|69276798|FG001|Overall Study|Lost to Follow-up|4|||
37764446|NCT01490125|69276864|FG000|Period I|Adverse Event|4|||
37764447|NCT01490125|69276865|FG001|Period I|Adverse Event|1|||
37764448|NCT01490125|69276866|FG002|Period I|Adverse Event|1|||
38035020|NCT04230213|69721864|FG000|Follow up: Week 32 to Week 36|Other|0|||
38035021|NCT04230213|69721865|FG001|Follow up: Week 32 to Week 36|Other|1|||
38035022|NCT04230213|69721866|FG002|Follow up: Week 32 to Week 36|Other|1|||
37670221|NCT02544633|69143428|FG001|Survival Follow-up Period|Death|14|||
37670222|NCT02544633|69143429|FG002|Survival Follow-up Period|Death|3|||
37670223|NCT02544633|69143430|FG003|Survival Follow-up Period|Death|9|||
37670224|NCT02544633|69143427|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
37764449|NCT01490125|69276867|FG003|Period I|Adverse Event|3|||
37764450|NCT01490125|69276868|FG004|Period I|Adverse Event|2|||
37764451|NCT01490125|69276869|FG005|Period I|Adverse Event|4|||
37764452|NCT01490125|69276864|FG000|Period I|Protocol Violation|1|||
38035023|NCT04222725|69721878|FG000|Overall Study|Adverse Event|0|||
37670225|NCT02544633|69143428|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
37670226|NCT02544633|69143429|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
37670227|NCT02544633|69143430|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
37764453|NCT01490125|69276865|FG001|Period I|Protocol Violation|1|||
37764454|NCT01490125|69276866|FG002|Period I|Protocol Violation|1|||
37764455|NCT01490125|69276867|FG003|Period I|Protocol Violation|1|||
37934112|NCT00711009|69620878|FG001|Overall Study|Lost to Follow-up|9|||
37859468|NCT01168401|69542789|FG007|Overall Study|Withdrawal by Subject|0|||
37859469|NCT01168401|69542790|FG008|Overall Study|Withdrawal by Subject|0|||
37859470|NCT01168401|69542791|FG009|Overall Study|Withdrawal by Subject|0|||
37859471|NCT01168401|69542792|FG010|Overall Study|Withdrawal by Subject|0|||
37859472|NCT01287065|69542816|FG000|Treatment Period 1|Adverse Event|0|||
37859473|NCT01287065|69542817|FG001|Treatment Period 1|Adverse Event|0|||
37859474|NCT01287065|69542818|FG002|Treatment Period 1|Adverse Event|0|||
37859475|NCT01287065|69542819|FG003|Treatment Period 1|Adverse Event|0|||
37859476|NCT01287065|69542820|FG004|Treatment Period 1|Adverse Event|1|||
37859477|NCT01287065|69542821|FG005|Treatment Period 1|Adverse Event|0|||
37859478|NCT01287065|69542816|FG000|Treatment Period 1|Withdrawal by Subject|0|||
37859479|NCT01287065|69542817|FG001|Treatment Period 1|Withdrawal by Subject|0|||
37859480|NCT01287065|69542818|FG002|Treatment Period 1|Withdrawal by Subject|0|||
37859481|NCT01287065|69542819|FG003|Treatment Period 1|Withdrawal by Subject|0|||
37859482|NCT01287065|69542820|FG004|Treatment Period 1|Withdrawal by Subject|0|||
37859483|NCT01287065|69542821|FG005|Treatment Period 1|Withdrawal by Subject|1|||
37859484|NCT01167153|69542831|FG000|Overall Study|Non-effective therapy|1|||
37859485|NCT01167153|69542832|FG001|Overall Study|Non-effective therapy|4|||
37859486|NCT01167153|69542831|FG000|Overall Study|AE including clinical laboratory AE|2|||
37859487|NCT01167153|69542832|FG001|Overall Study|AE including clinical laboratory AE|8|||
37859488|NCT01167153|69542831|FG000|Overall Study|Hypotension|1|||
37859489|NCT01167153|69542832|FG001|Overall Study|Hypotension|0|||
37859490|NCT01167153|69542831|FG000|Overall Study|Lost to Follow-up|7|||
37859491|NCT01167153|69542832|FG001|Overall Study|Lost to Follow-up|9|||
37859492|NCT01167153|69542831|FG000|Overall Study|Non-compliance to concomitant medication|0|||
37859493|NCT01167153|69542832|FG001|Overall Study|Non-compliance to concomitant medication|2|||
37859494|NCT01167153|69542831|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
37859495|NCT01167153|69542832|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
37859496|NCT01167153|69542831|FG000|Overall Study|Withdrawal consent|1|||
37859497|NCT01167153|69542832|FG001|Overall Study|Withdrawal consent|1|||
37859498|NCT01167153|69542831|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
37859499|NCT01167153|69542832|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
37859500|NCT01166763|69542838|FG000|Overall Study|Withdrawal by Subject|3|||
37859501|NCT01166373|69542846|FG000|Overall Study|Lost to Follow-up|3|||
37859502|NCT01166373|69542847|FG001|Overall Study|Lost to Follow-up|2|||
37859503|NCT01166373|69542848|FG002|Overall Study|Lost to Follow-up|2|||
37859504|NCT01166373|69542849|FG003|Overall Study|Lost to Follow-up|2|||
37859505|NCT01166373|69542846|FG000|Overall Study|Withdrawal by Subject|1|||
37859506|NCT01166373|69542847|FG001|Overall Study|Withdrawal by Subject|2|||
37859507|NCT01166373|69542848|FG002|Overall Study|Withdrawal by Subject|2|||
37859508|NCT01166373|69542849|FG003|Overall Study|Withdrawal by Subject|3|||
37859509|NCT01166373|69542846|FG000|Overall Study|Physician Decision|1|||
37859510|NCT01166373|69542847|FG001|Overall Study|Physician Decision|0|||
37859511|NCT01166373|69542848|FG002|Overall Study|Physician Decision|0|||
37859512|NCT01166373|69542849|FG003|Overall Study|Physician Decision|0|||
37859513|NCT00963235|69542861|FG000|Overall Study|Withdrawal by Subject|22|||
37859514|NCT00963235|69542861|FG000|Overall Study|Lost to Follow-up|14|||
37859515|NCT00963235|69542861|FG000|Overall Study|Failed to return|9|||
37859516|NCT00963235|69542861|FG000|Overall Study|Protocol Violation|7|||
37859517|NCT00963235|69542861|FG000|Overall Study|Adverse Event|5|||
37934113|NCT00711009|69620877|FG000|Overall Study|Participant Noncompliant|0|||
37934114|NCT00711009|69620878|FG001|Overall Study|Participant Noncompliant|1|||
37934115|NCT00711009|69620877|FG000|Overall Study|Virologic Failure|2|||
37934116|NCT00711009|69620878|FG001|Overall Study|Virologic Failure|1|||
37934117|NCT00711009|69620877|FG000|Overall Study|Pregnancy|1|||
37859518|NCT00963235|69542861|FG000|Overall Study|Physician Decision|2|||
37859519|NCT00963235|69542861|FG000|Overall Study|Other|1|||
37934118|NCT00711009|69620878|FG001|Overall Study|Pregnancy|0|||
37934119|NCT00711009|69620877|FG000|Overall Study|Site closing|0|||
37934120|NCT00711009|69620878|FG001|Overall Study|Site closing|1|||
37934121|NCT00711009|69620877|FG000|Overall Study|Dose adjustment|1|||
37934122|NCT00711009|69620878|FG001|Overall Study|Dose adjustment|0|||
37934123|NCT00577005|69620886|FG000|Overall Study|Lost to Follow-up|3|||
37859520|NCT01165281|69542870|FG000|Overall Study|Adverse Event|12|||
37859521|NCT01165281|69542871|FG001|Overall Study|Adverse Event|14|||
37859522|NCT01165281|69542870|FG000|Overall Study|Death|3|||
37859523|NCT01165281|69542871|FG001|Overall Study|Death|4|||
37859524|NCT01165281|69542870|FG000|Overall Study|Lack of Efficacy|4|||
37859525|NCT01165281|69542871|FG001|Overall Study|Lack of Efficacy|1|||
37859526|NCT01165281|69542870|FG000|Overall Study|Lost to Follow-up|0|||
37859527|NCT01165281|69542871|FG001|Overall Study|Lost to Follow-up|1|||
37859528|NCT01165281|69542870|FG000|Overall Study|Physician Decision|8|||
37859529|NCT01165281|69542871|FG001|Overall Study|Physician Decision|1|||
37934124|NCT00577005|69620887|FG001|Overall Study|Lost to Follow-up|2|||
37934125|NCT00577005|69620886|FG000|Overall Study|Withdrawal by Subject|2|||
37934126|NCT00577005|69620887|FG001|Overall Study|Withdrawal by Subject|1|||
37934127|NCT00576927|69620898|FG000|Clinical Assessment|Lack of Efficacy|24|||
37764456|NCT01490125|69276868|FG004|Period I|Protocol Violation|0|||
37764457|NCT01490125|69276869|FG005|Period I|Protocol Violation|0|||
37764458|NCT01490125|69276864|FG000|Period I|Withdrawal by Subject|1|||
37764459|NCT01490125|69276865|FG001|Period I|Withdrawal by Subject|3|||
37764460|NCT01490125|69276866|FG002|Period I|Withdrawal by Subject|2|||
37764461|NCT01490125|69276867|FG003|Period I|Withdrawal by Subject|1|||
37764462|NCT01490125|69276868|FG004|Period I|Withdrawal by Subject|2|||
37764463|NCT01490125|69276869|FG005|Period I|Withdrawal by Subject|1|||
37764464|NCT01490125|69276864|FG000|Period II|Adverse Event|2|||
37764465|NCT01490125|69276865|FG001|Period II|Adverse Event|3|||
37764466|NCT01490125|69276866|FG002|Period II|Adverse Event|2|||
37764467|NCT01490125|69276867|FG003|Period II|Adverse Event|2|||
37764468|NCT01490125|69276868|FG004|Period II|Adverse Event|4|||
37764469|NCT01490125|69276869|FG005|Period II|Adverse Event|2|||
37764470|NCT01490125|69276864|FG000|Period II|Protocol Violation|0|||
37764471|NCT01490125|69276865|FG001|Period II|Protocol Violation|0|||
37764472|NCT01490125|69276866|FG002|Period II|Protocol Violation|1|||
37764473|NCT01490125|69276867|FG003|Period II|Protocol Violation|1|||
37764474|NCT01490125|69276868|FG004|Period II|Protocol Violation|0|||
37764475|NCT01490125|69276869|FG005|Period II|Protocol Violation|0|||
37764476|NCT01490125|69276864|FG000|Period II|Lost to Follow-up|0|||
37764477|NCT01490125|69276865|FG001|Period II|Lost to Follow-up|1|||
37764478|NCT01490125|69276866|FG002|Period II|Lost to Follow-up|0|||
37764479|NCT01490125|69276867|FG003|Period II|Lost to Follow-up|0|||
37764480|NCT01490125|69276868|FG004|Period II|Lost to Follow-up|0|||
37764481|NCT01490125|69276869|FG005|Period II|Lost to Follow-up|0|||
37764482|NCT01490125|69276864|FG000|Period II|Withdrawal by Subject|1|||
37764483|NCT01490125|69276865|FG001|Period II|Withdrawal by Subject|0|||
37764484|NCT01490125|69276866|FG002|Period II|Withdrawal by Subject|0|||
37764485|NCT01490125|69276867|FG003|Period II|Withdrawal by Subject|0|||
37764486|NCT01490125|69276868|FG004|Period II|Withdrawal by Subject|0|||
37764487|NCT01490125|69276869|FG005|Period II|Withdrawal by Subject|0|||
37764488|NCT01490125|69276864|FG000|Period III|Adverse Event|3|||
37764489|NCT01490125|69276865|FG001|Period III|Adverse Event|1|||
37764490|NCT01490125|69276866|FG002|Period III|Adverse Event|0|||
37764491|NCT01490125|69276867|FG003|Period III|Adverse Event|1|||
37764492|NCT01490125|69276868|FG004|Period III|Adverse Event|0|||
37764493|NCT01490125|69276869|FG005|Period III|Adverse Event|0|||
37764494|NCT01490125|69276864|FG000|Period III|Death|0|||
37764495|NCT01490125|69276865|FG001|Period III|Death|0|||
37764496|NCT01490125|69276866|FG002|Period III|Death|0|||
37764497|NCT01490125|69276867|FG003|Period III|Death|1|||
37764498|NCT01490125|69276868|FG004|Period III|Death|0|||
37764499|NCT01490125|69276869|FG005|Period III|Death|0|||
37764500|NCT01490125|69276864|FG000|Period III|Lack of Efficacy|0|||
37764501|NCT01490125|69276865|FG001|Period III|Lack of Efficacy|0|||
37764502|NCT01490125|69276866|FG002|Period III|Lack of Efficacy|0|||
37764503|NCT01490125|69276867|FG003|Period III|Lack of Efficacy|0|||
37764504|NCT01490125|69276868|FG004|Period III|Lack of Efficacy|1|||
37764505|NCT01490125|69276869|FG005|Period III|Lack of Efficacy|0|||
37764506|NCT01446913|69276880|FG000|Overall Study|Significant illness|1|||
37764507|NCT01446913|69276881|FG001|Overall Study|Significant illness|1|||
37764508|NCT01446913|69276882|FG002|Overall Study|Significant illness|1|||
37764509|NCT01446913|69276880|FG000|Overall Study|Withdrawal by Subject|5|||
37764510|NCT01446913|69276881|FG001|Overall Study|Withdrawal by Subject|3|||
37764511|NCT01446913|69276882|FG002|Overall Study|Withdrawal by Subject|5|||
37764512|NCT01446913|69276880|FG000|Overall Study|Physician Decision|0|||
37764513|NCT01446913|69276881|FG001|Overall Study|Physician Decision|0|||
37764514|NCT01446913|69276882|FG002|Overall Study|Physician Decision|2|||
37764515|NCT01446913|69276880|FG000|Overall Study|Lost to Follow-up|3|||
37764516|NCT01446913|69276881|FG001|Overall Study|Lost to Follow-up|5|||
37764517|NCT01446913|69276882|FG002|Overall Study|Lost to Follow-up|3|||
37764518|NCT01420549|69276913|FG000|Overall Study|Adverse Event|1|||
37764519|NCT01420549|69276914|FG001|Overall Study|Adverse Event|1|||
37764520|NCT01420549|69276913|FG000|Overall Study|Lost to Follow-up|2|||
37764521|NCT01420549|69276914|FG001|Overall Study|Lost to Follow-up|2|||
37764522|NCT01420549|69276913|FG000|Overall Study|Protocol Violation|0|||
37764523|NCT01420549|69276914|FG001|Overall Study|Protocol Violation|1|||
37764524|NCT01420549|69276913|FG000|Overall Study|Non-adherence to medication|4|||
37764525|NCT01420549|69276914|FG001|Overall Study|Non-adherence to medication|1|||
37764526|NCT01440595|69276935|FG000|Overall Study|Lost to Follow-up|0|||
37764527|NCT01440595|69276936|FG001|Overall Study|Lost to Follow-up|1|||
37764528|NCT01440595|69276937|FG002|Overall Study|Lost to Follow-up|0|||
37764529|NCT01440595|69276935|FG000|Overall Study|Study terminated by sponsor.|1|||
37764530|NCT01440595|69276936|FG001|Overall Study|Study terminated by sponsor.|2|||
37764531|NCT01440595|69276937|FG002|Overall Study|Study terminated by sponsor.|1|||
37764532|NCT01440517|69276943|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
37764533|NCT01440283|69276947|FG000|Overall Study|Death|3|||
37764534|NCT01440283|69276947|FG000|Overall Study|Withdrawal by Subject|4|||
37764535|NCT01440283|69276947|FG000|Overall Study|Physician Decision|3|||
37764536|NCT01440049|69276957|FG000|Overall Study|Adverse Event|5|||
37764537|NCT01439971|69277018|FG000|Overall Study|Required number in cohort dosed|0|||
37764538|NCT01439971|69277019|FG001|Overall Study|Required number in cohort dosed|1|||
37764539|NCT01439971|69277020|FG002|Overall Study|Required number in cohort dosed|2|||
37764540|NCT01439971|69277021|FG003|Overall Study|Required number in cohort dosed|0|||
37764541|NCT01439971|69277022|FG004|Overall Study|Required number in cohort dosed|1|||
37764542|NCT01447927|69277085|FG000|Overall Study|Adverse Event|4|||
37764543|NCT01447927|69277086|FG001|Overall Study|Adverse Event|3|||
37764544|NCT01447927|69277085|FG000|Overall Study|Withdrawal by Subject|1|||
37764545|NCT01447927|69277086|FG001|Overall Study|Withdrawal by Subject|0|||
37764546|NCT01551758|69277108|FG000|Overall Study|Adverse Event|29|||
37764547|NCT01551758|69277109|FG001|Overall Study|Adverse Event|43|||
37764548|NCT01551758|69277108|FG000|Overall Study|Lack of Efficacy|0|||
37764549|NCT01551758|69277109|FG001|Overall Study|Lack of Efficacy|1|||
37764550|NCT01551758|69277108|FG000|Overall Study|Protocol Violation|5|||
37764551|NCT01551758|69277109|FG001|Overall Study|Protocol Violation|6|||
37764552|NCT01551758|69277108|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
37764553|NCT01551758|69277109|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
37764554|NCT01551758|69277108|FG000|Overall Study|Lost to Follow-up|29|||
37764555|NCT01551758|69277109|FG001|Overall Study|Lost to Follow-up|25|||
37764556|NCT01551758|69277108|FG000|Overall Study|Physician Decision|9|||
37764557|NCT01551758|69277109|FG001|Overall Study|Physician Decision|3|||
37764558|NCT01551758|69277108|FG000|Overall Study|Withdrawal by Subject|14|||
37764559|NCT01551758|69277109|FG001|Overall Study|Withdrawal by Subject|17|||
37764560|NCT01449461|69277312|FG000|Overall Study|Adverse Event|0|||
37764561|NCT01449461|69277313|FG001|Overall Study|Adverse Event|3|||
37764562|NCT01449461|69277314|FG002|Overall Study|Adverse Event|2|||
37764563|NCT01449461|69277315|FG003|Overall Study|Adverse Event|3|||
37764564|NCT01449461|69277316|FG004|Overall Study|Adverse Event|4|||
37764565|NCT01449461|69277317|FG005|Overall Study|Adverse Event|4|||
37764566|NCT01449461|69277312|FG000|Overall Study|Death|0|||
37764567|NCT01449461|69277313|FG001|Overall Study|Death|2|||
37764568|NCT01449461|69277314|FG002|Overall Study|Death|0|||
37764569|NCT01449461|69277315|FG003|Overall Study|Death|0|||
37764570|NCT01449461|69277316|FG004|Overall Study|Death|7|||
37764571|NCT01449461|69277317|FG005|Overall Study|Death|1|||
37764572|NCT01449461|69277312|FG000|Overall Study|Physician Decision|0|||
37764573|NCT01449461|69277313|FG001|Overall Study|Physician Decision|1|||
37764574|NCT01449461|69277314|FG002|Overall Study|Physician Decision|0|||
37764575|NCT01449461|69277315|FG003|Overall Study|Physician Decision|4|||
37764576|NCT01449461|69277316|FG004|Overall Study|Physician Decision|1|||
37764577|NCT01449461|69277317|FG005|Overall Study|Physician Decision|0|||
37764578|NCT01449461|69277312|FG000|Overall Study|Documented Progressive Disease|4|||
37764579|NCT01449461|69277313|FG001|Overall Study|Documented Progressive Disease|7|||
37764580|NCT01449461|69277314|FG002|Overall Study|Documented Progressive Disease|14|||
37764581|NCT01449461|69277315|FG003|Overall Study|Documented Progressive Disease|15|||
37764582|NCT01449461|69277316|FG004|Overall Study|Documented Progressive Disease|24|||
37764583|NCT01449461|69277317|FG005|Overall Study|Documented Progressive Disease|5|||
37764584|NCT01449461|69277312|FG000|Overall Study|Clinical Progressive Disease|2|||
37764585|NCT01449461|69277313|FG001|Overall Study|Clinical Progressive Disease|2|||
37764586|NCT01449461|69277314|FG002|Overall Study|Clinical Progressive Disease|0|||
37764587|NCT01449461|69277315|FG003|Overall Study|Clinical Progressive Disease|3|||
37764588|NCT01449461|69277316|FG004|Overall Study|Clinical Progressive Disease|4|||
37764589|NCT01449461|69277317|FG005|Overall Study|Clinical Progressive Disease|2|||
37764590|NCT01449461|69277312|FG000|Overall Study|Protocol Violation|0|||
37764591|NCT01449461|69277313|FG001|Overall Study|Protocol Violation|0|||
37764592|NCT01449461|69277314|FG002|Overall Study|Protocol Violation|0|||
37764593|NCT01449461|69277315|FG003|Overall Study|Protocol Violation|1|||
37764594|NCT01449461|69277316|FG004|Overall Study|Protocol Violation|0|||
37764595|NCT01449461|69277317|FG005|Overall Study|Protocol Violation|0|||
37764596|NCT01449461|69277312|FG000|Overall Study|Site Terminated by Sponsor|0|||
37764597|NCT01449461|69277313|FG001|Overall Study|Site Terminated by Sponsor|1|||
37764598|NCT01449461|69277314|FG002|Overall Study|Site Terminated by Sponsor|2|||
37764599|NCT01449461|69277315|FG003|Overall Study|Site Terminated by Sponsor|3|||
37764600|NCT01449461|69277316|FG004|Overall Study|Site Terminated by Sponsor|4|||
37934128|NCT00576927|69620898|FG000|Clinical Assessment|Death|1|||
37934129|NCT00576927|69620898|FG000|Clinical Assessment|Withdrawal by Subject|10|||
37934130|NCT00576927|69620898|FG000|Clinical Assessment|Physician Decision|1|||
37934131|NCT00576927|69620898|FG000|Baseline|Physician Decision|9|||
37764601|NCT01449461|69277317|FG005|Overall Study|Site Terminated by Sponsor|1|||
37764602|NCT01449461|69277312|FG000|Overall Study|Withdrawal by Subject|0|||
37934132|NCT00576927|69620898|FG000|Baseline|Medication Change by PCP of subject|1|||
37764603|NCT01449461|69277313|FG001|Overall Study|Withdrawal by Subject|1|||
37764604|NCT01449461|69277314|FG002|Overall Study|Withdrawal by Subject|0|||
37764605|NCT01449461|69277315|FG003|Overall Study|Withdrawal by Subject|0|||
37764606|NCT01449461|69277316|FG004|Overall Study|Withdrawal by Subject|2|||
37764607|NCT01449461|69277317|FG005|Overall Study|Withdrawal by Subject|1|||
37764608|NCT01449461|69277312|FG000|Overall Study|Reason not Specified|0|||
37934133|NCT00576927|69620898|FG000|Baseline|Withdrawal by Subject|3|||
37764609|NCT01449461|69277313|FG001|Overall Study|Reason not Specified|1|||
37670228|NCT02544633|69143427|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
37670229|NCT02544633|69143428|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
37670230|NCT02544633|69143429|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
37670231|NCT02544633|69143430|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
37670232|NCT02544633|69143427|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
37670233|NCT02544633|69143428|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
37764610|NCT01449461|69277314|FG002|Overall Study|Reason not Specified|0|||
37764611|NCT01449461|69277315|FG003|Overall Study|Reason not Specified|3|||
37764612|NCT01449461|69277316|FG004|Overall Study|Reason not Specified|2|||
37764613|NCT01449461|69277317|FG005|Overall Study|Reason not Specified|1|||
37764614|NCT01572038|69277353|FG000|Overall Study|Death|648|||
37764615|NCT01572038|69277353|FG000|Overall Study|Withdrawal by Subject|204|||
37764616|NCT01572038|69277353|FG000|Overall Study|Lost to Follow-up|81|||
37764617|NCT01572038|69277353|FG000|Overall Study|Physician Decision|20|||
37764618|NCT01572038|69277353|FG000|Overall Study|Patient Decision|14|||
37764619|NCT01572038|69277353|FG000|Overall Study|Progressive Disease|8|||
37764620|NCT01572038|69277353|FG000|Overall Study|Site Closed Before Completing Form|6|||
37764621|NCT01572038|69277353|FG000|Overall Study|Enrolled into Another Trial|3|||
37764622|NCT01572038|69277353|FG000|Overall Study|Participated in Another Trial|3|||
37764623|NCT01572038|69277353|FG000|Overall Study|Termination by Sponsor|2|||
37764624|NCT01572038|69277353|FG000|Overall Study|Patient Deterioration|1|||
37764625|NCT01572038|69277353|FG000|Overall Study|Sponsor Decision|1|||
37764626|NCT01448213|69277381|FG000|Overall Study|Lost to Follow-up|12|||
37764627|NCT01448213|69277382|FG001|Overall Study|Lost to Follow-up|10|||
37764628|NCT01448213|69277381|FG000|Overall Study|Adverse Event|4|||
37764629|NCT01448213|69277382|FG001|Overall Study|Adverse Event|10|||
37764630|NCT01448213|69277381|FG000|Overall Study|Protocol Violation|1|||
37764631|NCT01448213|69277382|FG001|Overall Study|Protocol Violation|2|||
37764632|NCT01448057|69277399|FG000|Overall Study|Protocol Violation|3|||
37764633|NCT01448057|69277400|FG001|Overall Study|Protocol Violation|2|||
37764634|NCT01448057|69277399|FG000|Overall Study|Lost to Follow-up|3|||
37764635|NCT01448057|69277400|FG001|Overall Study|Lost to Follow-up|0|||
37764636|NCT01448057|69277399|FG000|Overall Study|Adverse Event|0|||
37764637|NCT01448057|69277400|FG001|Overall Study|Adverse Event|2|||
37764638|NCT01448057|69277399|FG000|Overall Study|Withdrawal by Subject|2|||
37764639|NCT01448057|69277400|FG001|Overall Study|Withdrawal by Subject|0|||
37764640|NCT01447433|69277408|FG000|Overall Study|Lost to Follow-up|0|||
37764641|NCT01447433|69277409|FG001|Overall Study|Lost to Follow-up|2|||
37764642|NCT01447433|69277408|FG000|Overall Study|Withdrawal by Subject|3|||
37764643|NCT01447433|69277409|FG001|Overall Study|Withdrawal by Subject|3|||
37764644|NCT01447433|69277408|FG000|Overall Study|Protocol Violation|1|||
37764645|NCT01447433|69277409|FG001|Overall Study|Protocol Violation|1|||
37764646|NCT01446965|69277417|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
37934134|NCT00576927|69620898|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
37934135|NCT00576927|69620898|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
37934136|NCT00576927|69620898|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
37934137|NCT00576927|69620898|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
37934138|NCT00576927|69620898|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
37934139|NCT00698841|69620904|FG000|Overall Study|Withdrawal by Subject|2|||
37934140|NCT00698841|69620904|FG000|Overall Study|Adverse Event|3|||
37934141|NCT00698841|69620904|FG000|Overall Study|Disease progression|7|||
37934142|NCT00698841|69620904|FG000|Overall Study|Failure to meet eligibility criteria|2|||
37934143|NCT00698841|69620904|FG000|Overall Study|Study drug toxicity|2|||
37934144|NCT00698841|69620904|FG000|Overall Study|Other|2|||
37934145|NCT00577395|69620910|FG000|Overall Study|Study was terminated early by Sponsor|7|||
37934146|NCT00577395|69620911|FG001|Overall Study|Study was terminated early by Sponsor|6|||
37934147|NCT00738374|69620920|FG000|Induction Treatment Phase|Adverse Event|14|||
37934148|NCT00738374|69620921|FG001|Induction Treatment Phase|Adverse Event|0|||
37934149|NCT00738374|69620922|FG002|Induction Treatment Phase|Adverse Event|0|||
37934150|NCT00738374|69620923|FG003|Induction Treatment Phase|Adverse Event|0|||
37934151|NCT00738374|69620920|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
37934152|NCT00738374|69620921|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
37934153|NCT00738374|69620922|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
37670234|NCT02544633|69143429|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
37670235|NCT02544633|69143430|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
37670236|NCT02678351|69143452|FG000|Overall Study|Withdrawal by Subject|1|||
37670237|NCT02683187|69143456|FG000|Overall Study|Failed IV access|3|||
37670238|NCT02683187|69143456|FG000|Overall Study|Withdrawal by Subject|5|||
37764647|NCT01446965|69277418|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
37764648|NCT01446965|69277417|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
37764649|NCT01446965|69277418|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
37934154|NCT00738374|69620923|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
37764650|NCT01446809|69277426|FG000|Overall Study|Adverse Event|0|||
37764651|NCT01446809|69277427|FG001|Overall Study|Adverse Event|0|||
37764652|NCT01446809|69277428|FG002|Overall Study|Adverse Event|1|||
37764653|NCT01446809|69277426|FG000|Overall Study|Failure to complete study procedures|0|||
37764654|NCT01446809|69277427|FG001|Overall Study|Failure to complete study procedures|0|||
37764655|NCT01446809|69277428|FG002|Overall Study|Failure to complete study procedures|1|||
37764656|NCT01446419|69277439|FG000|Overall Study|Death|1|||
37764657|NCT01446419|69277440|FG001|Overall Study|Death|0|||
37764658|NCT01446419|69277439|FG000|Overall Study|Withdrawal by Subject|1|||
37764659|NCT01446419|69277440|FG001|Overall Study|Withdrawal by Subject|1|||
37764660|NCT01446419|69277439|FG000|Overall Study|Terminated per protocol|3|||
37764661|NCT01446419|69277440|FG001|Overall Study|Terminated per protocol|0|||
37764662|NCT01445951|69277449|FG000|Overall Study|Adverse Event|16|||
37764663|NCT01445951|69277450|FG001|Overall Study|Adverse Event|9|||
37764664|NCT01445951|69277451|FG002|Overall Study|Adverse Event|0|||
37764665|NCT01445951|69277449|FG000|Overall Study|Protocol Violation|2|||
37764666|NCT01445951|69277450|FG001|Overall Study|Protocol Violation|2|||
37764667|NCT01445951|69277451|FG002|Overall Study|Protocol Violation|2|||
37764668|NCT01445951|69277449|FG000|Overall Study|Withdrawal by Subject|21|||
37764669|NCT01445951|69277450|FG001|Overall Study|Withdrawal by Subject|16|||
37764670|NCT01445951|69277451|FG002|Overall Study|Withdrawal by Subject|8|||
37764671|NCT01445951|69277449|FG000|Overall Study|Physician Decision|3|||
37934155|NCT00738374|69620920|FG000|Induction Treatment Phase|Physician Decision|2|||
37934156|NCT00738374|69620921|FG001|Induction Treatment Phase|Physician Decision|0|||
37934157|NCT00738374|69620922|FG002|Induction Treatment Phase|Physician Decision|0|||
37934158|NCT00738374|69620923|FG003|Induction Treatment Phase|Physician Decision|0|||
37934159|NCT00738374|69620920|FG000|Induction Treatment Phase|Protocol Violation|2|||
37670239|NCT02683109|69143466|FG000|Overall Study|Adverse Event|1|||
37670240|NCT02683109|69143467|FG001|Overall Study|Adverse Event|0|||
37670241|NCT02544321|69143476|FG000|Overall Study|Withdrawal by Subject|1|||
37670242|NCT02544321|69143477|FG001|Overall Study|Withdrawal by Subject|2|||
37670243|NCT02544321|69143476|FG000|Overall Study|Adverse Event|1|||
37670244|NCT02544321|69143477|FG001|Overall Study|Adverse Event|1|||
37670245|NCT02544321|69143476|FG000|Overall Study|Protocol Violation|0|||
37670246|NCT02544321|69143477|FG001|Overall Study|Protocol Violation|1|||
37670247|NCT02533401|69143492|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
37670248|NCT02533401|69143492|FG000|Overall Study|Death|5|||
37670249|NCT02533401|69143492|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
37670250|NCT02533401|69143492|FG000|Overall Study|Lost to Follow-up|1|||
37670251|NCT02533401|69143492|FG000|Overall Study|Violation of Selection Criteria|1|||
37670252|NCT02536833|69143500|FG000|Overall Study|Discontinued Before Treatment|0|||
37670253|NCT02536833|69143501|FG001|Overall Study|Discontinued Before Treatment|0|||
37670254|NCT02536833|69143502|FG002|Overall Study|Discontinued Before Treatment|1|||
37670255|NCT02536833|69143503|FG003|Overall Study|Discontinued Before Treatment|2|||
37670256|NCT02536833|69143500|FG000|Overall Study|Adverse Event|1|||
37670257|NCT02536833|69143501|FG001|Overall Study|Adverse Event|3|||
37670258|NCT02536833|69143502|FG002|Overall Study|Adverse Event|4|||
37670259|NCT02536833|69143503|FG003|Overall Study|Adverse Event|1|||
37670260|NCT02536833|69143500|FG000|Overall Study|Lost to Follow-up|2|||
37934160|NCT00738374|69620921|FG001|Induction Treatment Phase|Protocol Violation|0|||
37934161|NCT00738374|69620922|FG002|Induction Treatment Phase|Protocol Violation|0|||
37934162|NCT00738374|69620923|FG003|Induction Treatment Phase|Protocol Violation|0|||
37934163|NCT00738374|69620920|FG000|Induction Treatment Phase|Non-compliance|1|||
37934164|NCT00738374|69620921|FG001|Induction Treatment Phase|Non-compliance|0|||
37934165|NCT00738374|69620922|FG002|Induction Treatment Phase|Non-compliance|0|||
37934166|NCT00738374|69620923|FG003|Induction Treatment Phase|Non-compliance|0|||
37934167|NCT00738374|69620920|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
37934168|NCT00738374|69620921|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
37934169|NCT00738374|69620922|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
37934170|NCT00738374|69620923|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
37934171|NCT00738374|69620920|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
37934172|NCT00738374|69620921|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
37934173|NCT00738374|69620922|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
37670261|NCT02536833|69143501|FG001|Overall Study|Lost to Follow-up|1|||
37670262|NCT02536833|69143502|FG002|Overall Study|Lost to Follow-up|2|||
37764672|NCT01445951|69277450|FG001|Overall Study|Physician Decision|1|||
37764673|NCT01445951|69277451|FG002|Overall Study|Physician Decision|0|||
37670263|NCT02536833|69143503|FG003|Overall Study|Lost to Follow-up|2|||
37670264|NCT02536833|69143500|FG000|Overall Study|Physician Decision|0|||
37764674|NCT01445951|69277449|FG000|Overall Study|Lost to Follow-up|1|||
37764675|NCT01445951|69277450|FG001|Overall Study|Lost to Follow-up|2|||
37670265|NCT02536833|69143501|FG001|Overall Study|Physician Decision|0|||
37934174|NCT00738374|69620923|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
37934175|NCT00738374|69620920|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
37934176|NCT00738374|69620921|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
37764676|NCT01445951|69277451|FG002|Overall Study|Lost to Follow-up|4|||
37764677|NCT01445951|69277449|FG000|Overall Study|Pregnancy|0|||
37764678|NCT01445951|69277450|FG001|Overall Study|Pregnancy|1|||
37764679|NCT01445951|69277451|FG002|Overall Study|Pregnancy|4|||
37764680|NCT01445951|69277449|FG000|Overall Study|Death|0|||
37764681|NCT01445951|69277450|FG001|Overall Study|Death|0|||
37764682|NCT01445951|69277451|FG002|Overall Study|Death|1|||
37764683|NCT01445951|69277449|FG000|Overall Study|Non-compliance with study drug|1|||
37764684|NCT01445951|69277450|FG001|Overall Study|Non-compliance with study drug|2|||
37764685|NCT01445951|69277451|FG002|Overall Study|Non-compliance with study drug|0|||
37764686|NCT01445951|69277449|FG000|Overall Study|Non-compliance with protocol|0|||
37764687|NCT01445951|69277450|FG001|Overall Study|Non-compliance with protocol|1|||
37764688|NCT01445951|69277451|FG002|Overall Study|Non-compliance with protocol|0|||
37764689|NCT01445951|69277449|FG000|Overall Study|Sponsor decision - subject travel|0|||
37764690|NCT01445951|69277450|FG001|Overall Study|Sponsor decision - subject travel|1|||
37764691|NCT01445951|69277451|FG002|Overall Study|Sponsor decision - subject travel|0|||
37764692|NCT01445951|69277449|FG000|Overall Study|Cough|0|||
37764693|NCT01445951|69277450|FG001|Overall Study|Cough|1|||
37764694|NCT01445951|69277451|FG002|Overall Study|Cough|0|||
37764695|NCT01444781|69277466|FG000|Overall Study|Lost to Follow-up|0|||
37764696|NCT01444781|69277467|FG001|Overall Study|Lost to Follow-up|3|||
37764697|NCT01444781|69277468|FG002|Overall Study|Lost to Follow-up|1|||
37764698|NCT01444781|69277466|FG000|Overall Study|Withdrawal by Subject|3|||
37764699|NCT01444781|69277467|FG001|Overall Study|Withdrawal by Subject|1|||
37764700|NCT01444781|69277468|FG002|Overall Study|Withdrawal by Subject|2|||
37764701|NCT01444391|69277483|FG000|Overall Study|Death|1|||
37764702|NCT01443923|69277489|FG000|Overall Study|Adverse Event|1|||
37764703|NCT01443923|69277490|FG001|Overall Study|Adverse Event|0|||
37764704|NCT01551212|69277502|FG000|Overall Study|Graft loss/Retransplantation|0|||
37764705|NCT01551212|69277503|FG001|Overall Study|Graft loss/Retransplantation|1|||
37764706|NCT01551212|69277502|FG000|Overall Study|Administrative problems|1|||
37764707|NCT01551212|69277503|FG001|Overall Study|Administrative problems|2|||
37764708|NCT01551212|69277502|FG000|Overall Study|Lost to Follow-up|0|||
37764709|NCT01551212|69277503|FG001|Overall Study|Lost to Follow-up|1|||
37764710|NCT01551212|69277502|FG000|Overall Study|Protocol Violation|0|||
37764711|NCT01551212|69277503|FG001|Overall Study|Protocol Violation|1|||
37764712|NCT01551212|69277502|FG000|Overall Study|Withdrawal by Subject|0|||
37764713|NCT01551212|69277503|FG001|Overall Study|Withdrawal by Subject|7|||
37764714|NCT01551212|69277502|FG000|Overall Study|Death|2|||
37764715|NCT01551212|69277503|FG001|Overall Study|Death|4|||
37764716|NCT01551212|69277502|FG000|Overall Study|Never Received Study Treatment|2|||
37764717|NCT01551212|69277503|FG001|Overall Study|Never Received Study Treatment|4|||
37764718|NCT01550744|69277563|FG000|Open-Label|Lost to Follow-up|7|||
37764719|NCT01550744|69277564|FG001|Open-Label|Lost to Follow-up|0|||
37764720|NCT01550744|69277565|FG002|Open-Label|Lost to Follow-up|0|||
37764721|NCT01550744|69277563|FG000|Open-Label|Withdrawal by Subject|13|||
37764722|NCT01550744|69277564|FG001|Open-Label|Withdrawal by Subject|0|||
37764723|NCT01550744|69277565|FG002|Open-Label|Withdrawal by Subject|0|||
37764724|NCT01550744|69277563|FG000|Open-Label|Adverse Event|11|||
37764725|NCT01550744|69277564|FG001|Open-Label|Adverse Event|0|||
37764726|NCT01550744|69277565|FG002|Open-Label|Adverse Event|0|||
37764727|NCT01550744|69277563|FG000|Open-Label|Lack of Efficacy|4|||
37764728|NCT01550744|69277564|FG001|Open-Label|Lack of Efficacy|0|||
37764729|NCT01550744|69277565|FG002|Open-Label|Lack of Efficacy|0|||
37764730|NCT01550744|69277563|FG000|Open-Label|Protocol Violation|4|||
37764731|NCT01550744|69277564|FG001|Open-Label|Protocol Violation|0|||
37764732|NCT01550744|69277565|FG002|Open-Label|Protocol Violation|0|||
37764733|NCT01550744|69277563|FG000|Open-Label|Not all 3 study drug injections received|2|||
37764734|NCT01550744|69277564|FG001|Open-Label|Not all 3 study drug injections received|0|||
37764735|NCT01550744|69277565|FG002|Open-Label|Not all 3 study drug injections received|0|||
37764736|NCT01550744|69277563|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
37764737|NCT01550744|69277564|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
37764738|NCT01550744|69277565|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
37934177|NCT00738374|69620922|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
37764739|NCT01550744|69277563|FG000|Open-Label|Other|1|||
37764740|NCT01550744|69277564|FG001|Open-Label|Other|0|||
37764741|NCT01550744|69277565|FG002|Open-Label|Other|0|||
37764742|NCT01550744|69277563|FG000|Double-Blind|Lost to Follow-up|0|||
37764743|NCT01550744|69277564|FG001|Double-Blind|Lost to Follow-up|6|||
37764744|NCT01550744|69277565|FG002|Double-Blind|Lost to Follow-up|12|||
37934178|NCT00738374|69620923|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
37764745|NCT01550744|69277563|FG000|Double-Blind|Withdrawal by Subject|0|||
37764746|NCT01550744|69277564|FG001|Double-Blind|Withdrawal by Subject|2|||
37764747|NCT01550744|69277565|FG002|Double-Blind|Withdrawal by Subject|15|||
37764748|NCT01550744|69277563|FG000|Double-Blind|Adverse Event|0|||
37764749|NCT01550744|69277564|FG001|Double-Blind|Adverse Event|4|||
37764750|NCT01550744|69277565|FG002|Double-Blind|Adverse Event|15|||
37764751|NCT01550744|69277563|FG000|Double-Blind|Death|0|||
37764752|NCT01550744|69277564|FG001|Double-Blind|Death|1|||
37764753|NCT01550744|69277565|FG002|Double-Blind|Death|0|||
37764754|NCT01550744|69277563|FG000|Double-Blind|Lack of Efficacy|0|||
37764755|NCT01550744|69277564|FG001|Double-Blind|Lack of Efficacy|2|||
37764756|NCT01550744|69277565|FG002|Double-Blind|Lack of Efficacy|8|||
37764757|NCT01550744|69277563|FG000|Double-Blind|Protocol Violation|0|||
37764758|NCT01550744|69277564|FG001|Double-Blind|Protocol Violation|0|||
37764759|NCT01550744|69277565|FG002|Double-Blind|Protocol Violation|4|||
37764760|NCT01550744|69277563|FG000|Double-Blind|Pregnancy|0|||
37764761|NCT01550744|69277564|FG001|Double-Blind|Pregnancy|0|||
37764762|NCT01550744|69277565|FG002|Double-Blind|Pregnancy|3|||
37764763|NCT01550744|69277563|FG000|Double-Blind|Other|0|||
37764764|NCT01550744|69277564|FG001|Double-Blind|Other|2|||
37764765|NCT01550744|69277565|FG002|Double-Blind|Other|10|||
37764766|NCT01549964|69277626|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
37764767|NCT01549964|69277627|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
37764768|NCT01549964|69277628|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
37764769|NCT01549964|69277629|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
37764770|NCT01549964|69277626|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
37764771|NCT01549964|69277627|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
37764772|NCT01549964|69277628|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
37764773|NCT01549964|69277629|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
37764774|NCT01549964|69277626|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
37764775|NCT01549964|69277627|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
37764776|NCT01549964|69277628|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
37764777|NCT01549964|69277629|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
37764778|NCT01549964|69277626|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
37764779|NCT01549964|69277627|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
37764780|NCT01549964|69277628|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
37764781|NCT01549964|69277629|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
37934179|NCT00738374|69620920|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
37934180|NCT00738374|69620921|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
37934181|NCT00738374|69620922|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
37934182|NCT00738374|69620923|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
37934183|NCT00738374|69620920|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
37934184|NCT00738374|69620921|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
37934185|NCT00738374|69620922|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
37934186|NCT00738374|69620923|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
37934187|NCT00738374|69620920|FG000|Maintenance Treatment/Observation Phase|Other|0|||
37934188|NCT00738374|69620921|FG001|Maintenance Treatment/Observation Phase|Other|1|||
37934189|NCT00738374|69620922|FG002|Maintenance Treatment/Observation Phase|Other|0|||
37934190|NCT00738374|69620923|FG003|Maintenance Treatment/Observation Phase|Other|0|||
38035024|NCT04222725|69721879|FG001|Overall Study|Adverse Event|1|||
38035025|NCT04222725|69721880|FG002|Overall Study|Adverse Event|0|||
37670266|NCT02536833|69143502|FG002|Overall Study|Physician Decision|0|||
37670267|NCT02536833|69143503|FG003|Overall Study|Physician Decision|1|||
37670268|NCT02536833|69143500|FG000|Overall Study|Site Terminated by Sponsor|2|||
37670269|NCT02536833|69143501|FG001|Overall Study|Site Terminated by Sponsor|2|||
37670270|NCT02536833|69143502|FG002|Overall Study|Site Terminated by Sponsor|2|||
37670271|NCT02536833|69143503|FG003|Overall Study|Site Terminated by Sponsor|2|||
37670272|NCT02536833|69143500|FG000|Overall Study|Subject Non-Compliance|0|||
37764782|NCT01549964|69277626|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
37764783|NCT01549964|69277627|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
37764784|NCT01549964|69277628|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
37764785|NCT01549964|69277629|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
37764786|NCT01549964|69277626|FG000|24-Week Treatment Period|Other|1|||
37764787|NCT01549964|69277627|FG001|24-Week Treatment Period|Other|0|||
37764788|NCT01549964|69277628|FG002|24-Week Treatment Period|Other|1|||
37764789|NCT01549964|69277629|FG003|24-Week Treatment Period|Other|0|||
37764790|NCT01549964|69277626|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
37764791|NCT01549964|69277627|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
37764792|NCT01549964|69277628|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
37934191|NCT00697593|69620932|FG000|Overall Study|Adverse Event|3|||
37934192|NCT00697593|69620932|FG000|Overall Study|Protocol Violation|1|||
37934193|NCT00697593|69620932|FG000|Overall Study|Lack of Efficacy|3|||
37934194|NCT00697593|69620932|FG000|Overall Study|Suspension of the study by sponsor|12|||
37934195|NCT00697515|69620936|FG000|Dose Optimization Period|Adverse Event|4|||
37934196|NCT00697515|69620937|FG001|Dose Optimization Period|Adverse Event|0|||
38035026|NCT04222725|69721881|FG003|Overall Study|Adverse Event|0|||
38035027|NCT04213989|69721893|FG000|Overall Study|Withdrawal by Subject|3|||
37670273|NCT02536833|69143501|FG001|Overall Study|Subject Non-Compliance|1|||
37934197|NCT00697515|69620936|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
37934198|NCT00697515|69620937|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
37764793|NCT01549964|69277629|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
37764794|NCT01549964|69277626|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
37764795|NCT01549964|69277627|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
37764796|NCT01549964|69277628|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
37764797|NCT01549964|69277629|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
37764798|NCT01549964|69277626|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
37764799|NCT01549964|69277627|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
37764800|NCT01549964|69277628|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
37764801|NCT01549964|69277629|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
37764802|NCT01549964|69277626|FG000|80-Week Extension Period|Pregnancy|0|||
37764803|NCT01549964|69277627|FG001|80-Week Extension Period|Pregnancy|0|||
37764804|NCT01549964|69277628|FG002|80-Week Extension Period|Pregnancy|1|||
37764805|NCT01549964|69277629|FG003|80-Week Extension Period|Pregnancy|0|||
37764806|NCT01549964|69277626|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
37764807|NCT01549964|69277627|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
37764808|NCT01549964|69277628|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
37934199|NCT00697515|69620936|FG000|Dose Optimization Period|Lost to Follow-up|2|||
37934200|NCT00697515|69620937|FG001|Dose Optimization Period|Lost to Follow-up|0|||
37934201|NCT00697515|69620936|FG000|Dose Optimization Period|sponsor request|2|||
37934202|NCT00697515|69620937|FG001|Dose Optimization Period|sponsor request|0|||
37934203|NCT00697515|69620936|FG000|Dose Optimization Period|called to active duty|1|||
37934204|NCT00697515|69620937|FG001|Dose Optimization Period|called to active duty|0|||
37934205|NCT00697515|69620936|FG000|Dose Optimization Period|elevated QTc|1|||
37934206|NCT00697515|69620937|FG001|Dose Optimization Period|elevated QTc|0|||
37934207|NCT00697515|69620936|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
37934208|NCT00697515|69620937|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
37934209|NCT00697515|69620936|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
37934210|NCT00697515|69620937|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
37934211|NCT00697515|69620936|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
37934212|NCT00697515|69620937|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
37934213|NCT00697515|69620936|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
37934214|NCT00697515|69620937|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
37934215|NCT00738062|69620946|FG000|Open Label Treatment|Lack of Efficacy|5|||
37934216|NCT00738062|69620947|FG001|Open Label Treatment|Lack of Efficacy|0|||
37934217|NCT00738062|69620948|FG002|Open Label Treatment|Lack of Efficacy|0|||
37934218|NCT00738062|69620946|FG000|Open Label Treatment|Adverse Event|11|||
37934219|NCT00738062|69620947|FG001|Open Label Treatment|Adverse Event|0|||
37934220|NCT00738062|69620948|FG002|Open Label Treatment|Adverse Event|0|||
37934221|NCT00738062|69620946|FG000|Open Label Treatment|Protocol Violation|2|||
37934222|NCT00738062|69620947|FG001|Open Label Treatment|Protocol Violation|0|||
37934223|NCT00738062|69620948|FG002|Open Label Treatment|Protocol Violation|0|||
37934224|NCT00738062|69620946|FG000|Open Label Treatment|Withdrawal by Subject|9|||
37934225|NCT00738062|69620947|FG001|Open Label Treatment|Withdrawal by Subject|0|||
37934226|NCT00738062|69620948|FG002|Open Label Treatment|Withdrawal by Subject|0|||
37934227|NCT00738062|69620946|FG000|Open Label Treatment|Investigator Decision|1|||
37934228|NCT00738062|69620947|FG001|Open Label Treatment|Investigator Decision|0|||
37934229|NCT00738062|69620948|FG002|Open Label Treatment|Investigator Decision|0|||
37670274|NCT02536833|69143502|FG002|Overall Study|Subject Non-Compliance|1|||
37670275|NCT02536833|69143503|FG003|Overall Study|Subject Non-Compliance|0|||
37670276|NCT02536833|69143500|FG000|Overall Study|Withdrawal by Subject|4|||
37670277|NCT02536833|69143501|FG001|Overall Study|Withdrawal by Subject|3|||
37670278|NCT02536833|69143502|FG002|Overall Study|Withdrawal by Subject|5|||
37670279|NCT02536833|69143503|FG003|Overall Study|Withdrawal by Subject|11|||
37670280|NCT02680847|69143517|FG000|Overall Study|Other|2|||
37670281|NCT02680847|69143518|FG001|Overall Study|Other|0|||
37764809|NCT01549964|69277629|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
37934230|NCT00738062|69620946|FG000|Open-Label Extension|Adverse Event|5|||
37934231|NCT00738062|69620947|FG001|Open-Label Extension|Adverse Event|0|||
37934232|NCT00738062|69620948|FG002|Open-Label Extension|Adverse Event|0|||
37934233|NCT00738062|69620946|FG000|Open-Label Extension|Physician Decision|1|||
37934234|NCT00738062|69620947|FG001|Open-Label Extension|Physician Decision|0|||
37934235|NCT00738062|69620948|FG002|Open-Label Extension|Physician Decision|0|||
37670282|NCT02680847|69143519|FG002|Overall Study|Other|0|||
37764810|NCT01549964|69277626|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
37764811|NCT01549964|69277627|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
37934236|NCT00738062|69620946|FG000|Open-Label Extension|Lack of Efficacy|2|||
37934237|NCT00738062|69620947|FG001|Open-Label Extension|Lack of Efficacy|0|||
37934238|NCT00738062|69620948|FG002|Open-Label Extension|Lack of Efficacy|0|||
37934239|NCT00738062|69620946|FG000|Open-Label Extension|Withdrawal by Subject|6|||
37670283|NCT02680847|69143517|FG000|Overall Study|No longer met eligibility criteria|2|||
37934240|NCT00738062|69620947|FG001|Open-Label Extension|Withdrawal by Subject|0|||
37934241|NCT00738062|69620948|FG002|Open-Label Extension|Withdrawal by Subject|0|||
37934242|NCT00738062|69620946|FG000|Open-Label Extension|Protocol Violation|1|||
37934243|NCT00738062|69620947|FG001|Open-Label Extension|Protocol Violation|0|||
37934244|NCT00738062|69620948|FG002|Open-Label Extension|Protocol Violation|0|||
37934245|NCT00738062|69620946|FG000|Open-Label Extension|Study Terminated|2|||
37934246|NCT00738062|69620947|FG001|Open-Label Extension|Study Terminated|0|||
37934247|NCT00738062|69620948|FG002|Open-Label Extension|Study Terminated|0|||
37934248|NCT04245345|69620957|FG000|Overall Study|Death|1|||
37934249|NCT04245345|69620957|FG000|Overall Study|Exited prior to implant|5|||
37934250|NCT04245345|69620957|FG000|Overall Study|Exited prior to 1-month|9|||
37934251|NCT04245345|69620957|FG000|Overall Study|Missed 1-month visit|3|||
37934252|NCT04245345|69620957|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
37934253|NCT04245345|69620957|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
37934254|NCT00698685|69620963|FG000|Overall Study|Sister withdrew as donor|1|||
37934255|NCT00698685|69620963|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
37934256|NCT00737672|69620969|FG000|Overall Study|Graft Abandonment|48|||
37934257|NCT00737672|69620970|FG001|Overall Study|Graft Abandonment|56|||
37934258|NCT00737672|69620969|FG000|Overall Study|Death|23|||
37934259|NCT00737672|69620970|FG001|Overall Study|Death|22|||
37934260|NCT00737672|69620969|FG000|Overall Study|Withdrawal by Subject|1|||
37934261|NCT00737672|69620970|FG001|Overall Study|Withdrawal by Subject|2|||
37934262|NCT00737672|69620969|FG000|Overall Study|Lost to Follow-up|1|||
37934263|NCT00737672|69620970|FG001|Overall Study|Lost to Follow-up|0|||
37934264|NCT00737672|69620969|FG000|Overall Study|Miscellaneous|7|||
37934265|NCT00737672|69620970|FG001|Overall Study|Miscellaneous|1|||
37934266|NCT00737672|69620969|FG000|Overall Study|Physician Decision|0|||
37934267|NCT00737672|69620970|FG001|Overall Study|Physician Decision|2|||
37934268|NCT00737438|69620976|FG000|Overall Study|Withdrawal by Subject|2|||
37934269|NCT00737438|69620976|FG000|Overall Study|Patient ineligible|1|||
37934270|NCT00737282|69620982|FG000|Overall Study|Study prematurely terminated|175|||
37934271|NCT03884478|69620991|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
37934272|NCT03884478|69620992|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
37934273|NCT03884478|69620993|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
37934274|NCT03884478|69620991|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
37934275|NCT03884478|69620992|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
37934276|NCT03884478|69620993|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
37934277|NCT03884478|69620991|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
37934278|NCT03884478|69620992|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
37934279|NCT03884478|69620993|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
37934280|NCT03884478|69620991|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
37934281|NCT03884478|69620992|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
37934282|NCT03884478|69620993|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
37934283|NCT00582816|69621014|FG000|Overall Study|Engraftment Failure|3|||
37934284|NCT00737048|69621021|FG000|Overall Study|Physician Decision|0|||
37934285|NCT00737048|69621022|FG001|Overall Study|Physician Decision|0|||
37934286|NCT00737048|69621023|FG002|Overall Study|Physician Decision|1|||
37934287|NCT00737048|69621021|FG000|Overall Study|Adverse Event|0|||
37934288|NCT00737048|69621022|FG001|Overall Study|Adverse Event|1|||
37934289|NCT00737048|69621023|FG002|Overall Study|Adverse Event|0|||
37934290|NCT00737048|69621021|FG000|Overall Study|Worsening of the symptoms|3|||
37934291|NCT00737048|69621022|FG001|Overall Study|Worsening of the symptoms|5|||
37934292|NCT00737048|69621023|FG002|Overall Study|Worsening of the symptoms|3|||
37934293|NCT00731822|69621033|FG000|Overall Study|Adverse Event|2|||
37934294|NCT00731822|69621034|FG001|Overall Study|Adverse Event|1|||
37934295|NCT00731822|69621033|FG000|Overall Study|Protocol Violation|1|||
37934296|NCT00731822|69621034|FG001|Overall Study|Protocol Violation|0|||
37934297|NCT00731822|69621033|FG000|Overall Study|Lost to Follow-up|1|||
37934298|NCT00731822|69621034|FG001|Overall Study|Lost to Follow-up|0|||
37934299|NCT00731666|69621040|FG000|Overall Study|Adverse Event|2|||
37934300|NCT00731666|69621040|FG000|Overall Study|Lost to Follow-up|8|||
37934301|NCT00731666|69621040|FG000|Overall Study|Withdrawal by Subject|2|||
37934302|NCT00731120|69621047|FG000|Overall Study|Adverse Event|7|||
37934303|NCT00731120|69621048|FG001|Overall Study|Adverse Event|6|||
37934304|NCT00731120|69621049|FG002|Overall Study|Adverse Event|8|||
37934305|NCT00731120|69621047|FG000|Overall Study|Lack of Efficacy|4|||
37934306|NCT00731120|69621048|FG001|Overall Study|Lack of Efficacy|5|||
37934307|NCT00731120|69621049|FG002|Overall Study|Lack of Efficacy|4|||
37934308|NCT00731120|69621047|FG000|Overall Study|Noncompliance with Study Drug|3|||
37934309|NCT00731120|69621048|FG001|Overall Study|Noncompliance with Study Drug|3|||
37934310|NCT00731120|69621049|FG002|Overall Study|Noncompliance with Study Drug|1|||
37934311|NCT00731120|69621047|FG000|Overall Study|Protocol Deviations|1|||
37934312|NCT00731120|69621048|FG001|Overall Study|Protocol Deviations|6|||
37934313|NCT00731120|69621049|FG002|Overall Study|Protocol Deviations|1|||
37934314|NCT00731120|69621047|FG000|Overall Study|Withdrawal of Consent|13|||
37934315|NCT00731120|69621048|FG001|Overall Study|Withdrawal of Consent|8|||
37764812|NCT01549964|69277628|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
37764813|NCT01549964|69277629|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
37764814|NCT01549964|69277626|FG000|80-Week Extension Period|Lost to Follow-up|1|||
37764815|NCT01549964|69277627|FG001|80-Week Extension Period|Lost to Follow-up|0|||
37764816|NCT01549964|69277628|FG002|80-Week Extension Period|Lost to Follow-up|2|||
37764817|NCT01549964|69277629|FG003|80-Week Extension Period|Lost to Follow-up|1|||
37764818|NCT01549964|69277626|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
37764819|NCT01549964|69277627|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
37764820|NCT01549964|69277628|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
37764821|NCT01549964|69277629|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
37764822|NCT01570244|69277711|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
37764823|NCT01535222|69277746|FG000|Overall Study|Inclusion/exclusion|0|||
37764824|NCT01535222|69277747|FG001|Overall Study|Inclusion/exclusion|0|||
37764825|NCT01535222|69277748|FG002|Overall Study|Inclusion/exclusion|1|||
37764826|NCT01535222|69277749|FG003|Overall Study|Inclusion/exclusion|0|||
37764827|NCT01535222|69277750|FG004|Overall Study|Inclusion/exclusion|0|||
37764828|NCT01535222|69277751|FG005|Overall Study|Inclusion/exclusion|0|||
37764829|NCT01549886|69277767|FG000|Overall Study|Sponsor's decision|2|||
37764830|NCT01549886|69277768|FG001|Overall Study|Sponsor's decision|3|||
37764831|NCT01443845|69277797|FG000|Overall Study|Protocol Violation|43|||
37764832|NCT01443845|69277798|FG001|Overall Study|Protocol Violation|45|||
37764833|NCT01443845|69277797|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
37764834|NCT01443845|69277798|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
37764835|NCT01443845|69277797|FG000|Overall Study|Deterioration in pulmonary function|1|||
37764836|NCT01443845|69277798|FG001|Overall Study|Deterioration in pulmonary function|4|||
37764837|NCT01443845|69277797|FG000|Overall Study|Lack of Efficacy|10|||
37764838|NCT01443845|69277798|FG001|Overall Study|Lack of Efficacy|5|||
37764839|NCT01443845|69277797|FG000|Overall Study|Adverse Event|64|||
37764840|NCT01443845|69277798|FG001|Overall Study|Adverse Event|138|||
37764841|NCT01443845|69277797|FG000|Overall Study|Withdrawal by Subject|63|||
37764842|NCT01443845|69277798|FG001|Overall Study|Withdrawal by Subject|67|||
37764843|NCT01443845|69277797|FG000|Overall Study|Military Conflict - Site Terminated|20|||
37764844|NCT01443845|69277798|FG001|Overall Study|Military Conflict - Site Terminated|21|||
37764845|NCT01443845|69277797|FG000|Overall Study|Lost to Follow-up|9|||
37764846|NCT01443845|69277798|FG001|Overall Study|Lost to Follow-up|13|||
37764847|NCT01549652|69277807|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
37764848|NCT01549652|69277808|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
37764849|NCT01549652|69277809|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
37764850|NCT01549652|69277810|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
37764851|NCT01549652|69277807|FG000|Overall Study|Study Drug Titration Failure|5|||
37764852|NCT01549652|69277808|FG001|Overall Study|Study Drug Titration Failure|6|||
37764853|NCT01549652|69277809|FG002|Overall Study|Study Drug Titration Failure|0|||
37764854|NCT01549652|69277810|FG003|Overall Study|Study Drug Titration Failure|0|||
37764855|NCT01549652|69277807|FG000|Overall Study|Withdrawal Effect|0|||
37764856|NCT01549652|69277808|FG001|Overall Study|Withdrawal Effect|2|||
37764857|NCT01549652|69277809|FG002|Overall Study|Withdrawal Effect|0|||
37764858|NCT01549652|69277810|FG003|Overall Study|Withdrawal Effect|0|||
37764859|NCT01549652|69277807|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
37764860|NCT01549652|69277808|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
37764861|NCT01549652|69277809|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
37764862|NCT01549652|69277810|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
37764863|NCT01549652|69277807|FG000|Overall Study|Problem with Infusion|1|||
37764864|NCT01549652|69277808|FG001|Overall Study|Problem with Infusion|0|||
37764865|NCT01549652|69277809|FG002|Overall Study|Problem with Infusion|0|||
37764866|NCT01549652|69277810|FG003|Overall Study|Problem with Infusion|0|||
37764867|NCT01549652|69277807|FG000|Overall Study|Titration Non-Compliance|1|||
37764868|NCT01549652|69277808|FG001|Overall Study|Titration Non-Compliance|3|||
37764869|NCT01549652|69277809|FG002|Overall Study|Titration Non-Compliance|4|||
37764870|NCT01549652|69277810|FG003|Overall Study|Titration Non-Compliance|5|||
37764871|NCT01549652|69277807|FG000|Overall Study|Titration Side Effects|0|||
37764872|NCT01549652|69277808|FG001|Overall Study|Titration Side Effects|0|||
37764873|NCT01549652|69277809|FG002|Overall Study|Titration Side Effects|6|||
37764874|NCT01549652|69277810|FG003|Overall Study|Titration Side Effects|3|||
37764875|NCT01549652|69277807|FG000|Overall Study|Withdrawal by Subject|0|||
37764876|NCT01549652|69277808|FG001|Overall Study|Withdrawal by Subject|0|||
37934316|NCT00731120|69621049|FG002|Overall Study|Withdrawal of Consent|4|||
37934317|NCT00731120|69621047|FG000|Overall Study|Lost to Follow-up|10|||
37764877|NCT01549652|69277809|FG002|Overall Study|Withdrawal by Subject|5|||
37764878|NCT01549652|69277810|FG003|Overall Study|Withdrawal by Subject|3|||
37764879|NCT01569464|69277818|FG000|Overall Study|Adverse Event|4|||
37764880|NCT01569464|69277819|FG001|Overall Study|Adverse Event|0|||
37859530|NCT01165281|69542870|FG000|Overall Study|Protocol Violation|6|||
37859531|NCT01165281|69542871|FG001|Overall Study|Protocol Violation|5|||
37859532|NCT01165281|69542870|FG000|Overall Study|Withdrawal by Subject|8|||
37764881|NCT01569464|69277818|FG000|Overall Study|Lack of Efficacy|1|||
37764882|NCT01569464|69277819|FG001|Overall Study|Lack of Efficacy|0|||
37764883|NCT01569464|69277818|FG000|Overall Study|Protocol Violation|1|||
37764884|NCT01569464|69277819|FG001|Overall Study|Protocol Violation|0|||
37764885|NCT01569464|69277818|FG000|Overall Study|Lost to Follow-up|2|||
37764886|NCT01569464|69277819|FG001|Overall Study|Lost to Follow-up|3|||
37764887|NCT01569464|69277818|FG000|Overall Study|Withdrawal by Subject|1|||
37764888|NCT01569464|69277819|FG001|Overall Study|Withdrawal by Subject|1|||
37764889|NCT01569464|69277818|FG000|Overall Study|Other|1|||
37764890|NCT01569464|69277819|FG001|Overall Study|Other|1|||
37764891|NCT01534676|69277829|FG000|Overall Study|Study closed due to poor enrollment|2|||
37764892|NCT01534676|69277830|FG001|Overall Study|Study closed due to poor enrollment|1|||
37764893|NCT01442675|69277836|FG000|Overall Study|Protocol Violation|6|||
37764894|NCT01442675|69277836|FG000|Overall Study|Lost to Follow-up|2|||
37764895|NCT01442675|69277836|FG000|Overall Study|Withdrawal by Subject|4|||
37764896|NCT01534520|69277843|FG000|Overall Study|Adverse Event|0|||
37764897|NCT01534520|69277844|FG001|Overall Study|Adverse Event|1|||
37764898|NCT01534208|69277874|FG000|Overall Study|Lost to Follow-up|19|||
37764899|NCT01534208|69277875|FG001|Overall Study|Lost to Follow-up|14|||
37764900|NCT01534208|69277874|FG000|Overall Study|Withdrawal by Subject|6|||
37764901|NCT01534208|69277875|FG001|Overall Study|Withdrawal by Subject|20|||
37764902|NCT01534208|69277874|FG000|Overall Study|Adverse Event|15|||
37764903|NCT01534208|69277875|FG001|Overall Study|Adverse Event|8|||
37764904|NCT01534208|69277874|FG000|Overall Study|Physician Decision|2|||
37764905|NCT01534208|69277875|FG001|Overall Study|Physician Decision|0|||
37764906|NCT01534208|69277874|FG000|Overall Study|Lack of Efficacy|0|||
37764907|NCT01534208|69277875|FG001|Overall Study|Lack of Efficacy|3|||
37764908|NCT01534208|69277874|FG000|Overall Study|Protocol Violation|2|||
37764909|NCT01534208|69277875|FG001|Overall Study|Protocol Violation|2|||
37764910|NCT01534208|69277874|FG000|Overall Study|Sponsor decision|4|||
37764911|NCT01534208|69277875|FG001|Overall Study|Sponsor decision|1|||
37764912|NCT01534208|69277874|FG000|Overall Study|Subject relocation|2|||
37764913|NCT01534208|69277875|FG001|Overall Study|Subject relocation|0|||
37764914|NCT01534208|69277874|FG000|Overall Study|Lab assessment|2|||
37764915|NCT01534208|69277875|FG001|Overall Study|Lab assessment|1|||
37934318|NCT00731120|69621048|FG001|Overall Study|Lost to Follow-up|15|||
37934319|NCT00731120|69621049|FG002|Overall Study|Lost to Follow-up|17|||
37934320|NCT00731120|69621047|FG000|Overall Study|Other|4|||
37934321|NCT00731120|69621048|FG001|Overall Study|Other|0|||
37934322|NCT00731120|69621049|FG002|Overall Study|Other|1|||
37934323|NCT00731042|69621059|FG000|Second Intervention|Did not meet inclusion criteria|0|||
37934324|NCT00731042|69621060|FG001|Second Intervention|Did not meet inclusion criteria|2|||
37934325|NCT00726986|69621066|FG000|Induction Phase|Adverse Event|4|||
37670284|NCT02680847|69143518|FG001|Overall Study|No longer met eligibility criteria|2|||
37670285|NCT02680847|69143519|FG002|Overall Study|No longer met eligibility criteria|0|||
37670286|NCT02680847|69143517|FG000|Overall Study|Unwilling to participate in study|1|||
37670287|NCT02680847|69143518|FG001|Overall Study|Unwilling to participate in study|1|||
37670288|NCT02680847|69143519|FG002|Overall Study|Unwilling to participate in study|0|||
37670289|NCT02680847|69143517|FG000|Overall Study|Lack of Efficacy|0|||
37670290|NCT02680847|69143518|FG001|Overall Study|Lack of Efficacy|0|||
37670291|NCT02680847|69143519|FG002|Overall Study|Lack of Efficacy|2|||
37670292|NCT02680847|69143517|FG000|Overall Study|Adverse Event|0|||
37670293|NCT02680847|69143518|FG001|Overall Study|Adverse Event|0|||
37670294|NCT02680847|69143519|FG002|Overall Study|Adverse Event|1|||
37764916|NCT01534208|69277874|FG000|Overall Study|Eligibility error|3|||
37934326|NCT00726986|69621066|FG000|Induction Phase|Withdrawal by Subject|2|||
37934327|NCT00726986|69621066|FG000|Induction Phase|Death|2|||
37934328|NCT00726986|69621066|FG000|Induction Phase|Lack of Efficacy|5|||
37934329|NCT00726986|69621066|FG000|Induction Phase|Secondary Disease|2|||
37934330|NCT00726986|69621066|FG000|Maintenance Phase|Adverse Event|1|||
37934331|NCT00726986|69621066|FG000|Maintenance Phase|Lack of Efficacy|2|||
37934332|NCT00696657|69621079|FG000|Overall Study|Protocol Violation|0|||
37934333|NCT00696657|69621080|FG001|Overall Study|Protocol Violation|0|||
37934334|NCT00696657|69621081|FG002|Overall Study|Protocol Violation|0|||
37764917|NCT01534208|69277875|FG001|Overall Study|Eligibility error|0|||
37764918|NCT01534208|69277874|FG000|Overall Study|PCP decision|1|||
37764919|NCT01534208|69277875|FG001|Overall Study|PCP decision|0|||
37764920|NCT01534208|69277874|FG000|Overall Study|Needed prohibited meds|1|||
37764921|NCT01534208|69277875|FG001|Overall Study|Needed prohibited meds|0|||
37764922|NCT01548638|69277881|FG000|Overall Study|Protocol Violation|3|||
37934335|NCT00696657|69621082|FG003|Overall Study|Protocol Violation|0|||
37934336|NCT00696657|69621083|FG004|Overall Study|Protocol Violation|0|||
37934337|NCT00696657|69621084|FG005|Overall Study|Protocol Violation|1|||
37934338|NCT00696657|69621085|FG006|Overall Study|Protocol Violation|0|||
37934339|NCT00696657|69621086|FG007|Overall Study|Protocol Violation|0|||
37764923|NCT01548638|69277881|FG000|Overall Study|Withdrawal by Subject|1|||
37764924|NCT01533428|69277905|FG000|Overall Study|Adverse Event|0|||
37934340|NCT00696657|69621087|FG008|Overall Study|Protocol Violation|1|||
37764925|NCT01533428|69277906|FG001|Overall Study|Adverse Event|1|||
37764926|NCT01533428|69277905|FG000|Overall Study|Lost to Follow-up|2|||
37764927|NCT01533428|69277906|FG001|Overall Study|Lost to Follow-up|1|||
37764928|NCT01533428|69277905|FG000|Overall Study|Withdrawal by Subject|7|||
37764929|NCT01533428|69277906|FG001|Overall Study|Withdrawal by Subject|6|||
37764930|NCT01517984|69277915|FG000|Overall Study|Lost to Follow-up|0|||
37764931|NCT01517984|69277916|FG001|Overall Study|Lost to Follow-up|1|||
37764932|NCT01517984|69277917|FG002|Overall Study|Lost to Follow-up|0|||
37764933|NCT01517984|69277918|FG003|Overall Study|Lost to Follow-up|0|||
37764934|NCT01517984|69277915|FG000|Overall Study|Withdrawal by Subject|1|||
37764935|NCT01517984|69277916|FG001|Overall Study|Withdrawal by Subject|8|||
37764936|NCT01517984|69277917|FG002|Overall Study|Withdrawal by Subject|4|||
37764937|NCT01517984|69277918|FG003|Overall Study|Withdrawal by Subject|1|||
37764938|NCT01517984|69277915|FG000|Overall Study|Screen Failure|4|||
37764939|NCT01517984|69277916|FG001|Overall Study|Screen Failure|0|||
37764940|NCT01517984|69277917|FG002|Overall Study|Screen Failure|0|||
37764941|NCT01517984|69277918|FG003|Overall Study|Screen Failure|0|||
37764942|NCT01517984|69277915|FG000|Overall Study|Ineligible for randomization|0|||
37764943|NCT01517984|69277916|FG001|Overall Study|Ineligible for randomization|14|||
37764944|NCT01517984|69277917|FG002|Overall Study|Ineligible for randomization|0|||
37764945|NCT01517984|69277918|FG003|Overall Study|Ineligible for randomization|0|||
37764946|NCT01517750|69277946|FG000|Overall Study|Lost to Follow-up|1|||
37764947|NCT01517750|69277947|FG001|Overall Study|Lost to Follow-up|2|||
37764948|NCT01517750|69277948|FG002|Overall Study|Lost to Follow-up|4|||
37764949|NCT01517750|69277949|FG003|Overall Study|Lost to Follow-up|1|||
37764950|NCT01548404|69277974|FG000|Overall Study|Adverse Event|3|||
37764951|NCT01548404|69277975|FG001|Overall Study|Adverse Event|1|||
37764952|NCT01548404|69277974|FG000|Overall Study|Physician Decision|2|||
37764953|NCT01548404|69277975|FG001|Overall Study|Physician Decision|1|||
37764954|NCT01548404|69277974|FG000|Overall Study|Inadequate response to study treatment|23|||
37764955|NCT01548404|69277975|FG001|Overall Study|Inadequate response to study treatment|7|||
37764956|NCT01548404|69277974|FG000|Overall Study|Lost to Follow-up|2|||
37764957|NCT01548404|69277975|FG001|Overall Study|Lost to Follow-up|0|||
37764958|NCT01548404|69277974|FG000|Overall Study|Withdrawal by Subject|0|||
37764959|NCT01548404|69277975|FG001|Overall Study|Withdrawal by Subject|3|||
37764960|NCT01548404|69277974|FG000|Overall Study|Other than specified above|0|||
37764961|NCT01548404|69277975|FG001|Overall Study|Other than specified above|2|||
37764962|NCT01547780|69277989|FG000|Baseline PET Scan|Physician Decision|1|||
37764963|NCT01547780|69277990|FG001|Baseline PET Scan|Physician Decision|0|||
37764964|NCT01547780|69277991|FG002|Baseline PET Scan|Physician Decision|1|||
37764965|NCT01547780|69277992|FG003|Baseline PET Scan|Physician Decision|0|||
37764966|NCT01547780|69277989|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
37934341|NCT00696657|69621079|FG000|Overall Study|Lack of Efficacy|0|||
37934342|NCT00696657|69621080|FG001|Overall Study|Lack of Efficacy|1|||
37670295|NCT02532855|69143529|FG000|Overall Study|Lost to Follow-up|4|||
37670296|NCT02532855|69143530|FG001|Overall Study|Lost to Follow-up|3|||
37670297|NCT02532855|69143529|FG000|Overall Study|Withdrawal by Subject|4|||
37670298|NCT02532855|69143530|FG001|Overall Study|Withdrawal by Subject|8|||
37670299|NCT02530125|69143536|FG000|Completed Treatment|Early termination of study|1|||
37670300|NCT02530125|69143536|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
37670301|NCT01661205|69143540|FG000|Overall Study|Physician Decision|2|||
37670302|NCT02055820|69143554|FG000|Phase I: Dose-Finding|Death|1|||
37670303|NCT02055820|69143555|FG001|Phase I: Dose-Finding|Death|0|||
37670304|NCT02055820|69143556|FG002|Phase I: Dose-Finding|Death|1|||
37764967|NCT01547780|69277990|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
37670305|NCT02055820|69143557|FG003|Phase I: Dose-Finding|Death|2|||
37670306|NCT02055820|69143558|FG004|Phase I: Dose-Finding|Death|0|||
37670307|NCT02055820|69143559|FG005|Phase I: Dose-Finding|Death|1|||
37670308|NCT02055820|69143560|FG006|Phase I: Dose-Finding|Death|1|||
37670309|NCT02055820|69143561|FG007|Phase I: Dose-Finding|Death|0|||
37764968|NCT01547780|69277991|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
37764969|NCT01547780|69277992|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
37934343|NCT00696657|69621081|FG002|Overall Study|Lack of Efficacy|0|||
37934344|NCT00696657|69621082|FG003|Overall Study|Lack of Efficacy|0|||
37934345|NCT00696657|69621083|FG004|Overall Study|Lack of Efficacy|0|||
37934346|NCT00696657|69621084|FG005|Overall Study|Lack of Efficacy|0|||
37934347|NCT00696657|69621085|FG006|Overall Study|Lack of Efficacy|0|||
37934348|NCT00696657|69621086|FG007|Overall Study|Lack of Efficacy|0|||
37934349|NCT00696657|69621087|FG008|Overall Study|Lack of Efficacy|0|||
37934350|NCT00696657|69621079|FG000|Overall Study|Withdrawal criteria|1|||
37934351|NCT00696657|69621080|FG001|Overall Study|Withdrawal criteria|3|||
37670310|NCT02055820|69143562|FG008|Phase I: Dose-Finding|Death|0|||
37670311|NCT02055820|69143563|FG009|Phase I: Dose-Finding|Death|0|||
37670312|NCT02055820|69143554|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
37764970|NCT01547390|69278014|FG000|Overall Study|Withdrawal by Subject|10|||
37934352|NCT00696657|69621081|FG002|Overall Study|Withdrawal criteria|2|||
37934353|NCT00696657|69621082|FG003|Overall Study|Withdrawal criteria|2|||
37934354|NCT00696657|69621083|FG004|Overall Study|Withdrawal criteria|0|||
37934355|NCT00696657|69621084|FG005|Overall Study|Withdrawal criteria|0|||
37764971|NCT01547390|69278015|FG001|Overall Study|Withdrawal by Subject|7|||
37764972|NCT01547390|69278014|FG000|Overall Study|termination of pregnancy|0|||
37764973|NCT01547390|69278015|FG001|Overall Study|termination of pregnancy|1|||
37764974|NCT01547390|69278014|FG000|Overall Study|Lost to Follow-up|0|||
37764975|NCT01547390|69278015|FG001|Overall Study|Lost to Follow-up|2|||
37764976|NCT01547390|69278014|FG000|Overall Study|Adverse Event|3|||
37764977|NCT01547390|69278015|FG001|Overall Study|Adverse Event|0|||
37764978|NCT01546922|69278021|FG000|First Period of 10 Weeks|Protocol Violation|3|||
37764979|NCT01546922|69278022|FG001|First Period of 10 Weeks|Protocol Violation|1|||
37764980|NCT01546922|69278021|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
37764981|NCT01546922|69278022|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
37764982|NCT01546922|69278021|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
37764983|NCT01546922|69278022|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
37764984|NCT01546922|69278021|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
37764985|NCT01546922|69278022|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
37764986|NCT01546922|69278021|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
37764987|NCT01546922|69278022|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
37764988|NCT01532648|69278039|FG000|Overall Study|Lost to Follow-up|3|||
37764989|NCT01532648|69278040|FG001|Overall Study|Lost to Follow-up|4|||
37764990|NCT01532648|69278039|FG000|Overall Study|Lack of Efficacy|4|||
37764991|NCT01532648|69278040|FG001|Overall Study|Lack of Efficacy|1|||
37764992|NCT01532648|69278039|FG000|Overall Study|Protocol Violation|1|||
37764993|NCT01532648|69278040|FG001|Overall Study|Protocol Violation|1|||
37764994|NCT01532648|69278039|FG000|Overall Study|Adverse Event|12|||
37764995|NCT01532648|69278040|FG001|Overall Study|Adverse Event|9|||
37764996|NCT01532648|69278039|FG000|Overall Study|Withdrawal by Subject|16|||
37764997|NCT01532648|69278040|FG001|Overall Study|Withdrawal by Subject|2|||
37764998|NCT01532570|69278070|FG000|Overall Study|Lack of Efficacy|1|||
37764999|NCT01532570|69278071|FG001|Overall Study|Lack of Efficacy|0|||
37765000|NCT01532570|69278072|FG002|Overall Study|Lack of Efficacy|0|||
37765001|NCT01532570|69278073|FG003|Overall Study|Lack of Efficacy|0|||
37765002|NCT01532570|69278070|FG000|Overall Study|Withdrawal by Subject|0|||
37765003|NCT01532570|69278071|FG001|Overall Study|Withdrawal by Subject|1|||
37765004|NCT01532570|69278072|FG002|Overall Study|Withdrawal by Subject|0|||
37765005|NCT01532570|69278073|FG003|Overall Study|Withdrawal by Subject|0|||
37765006|NCT01532414|69278106|FG000|Overall Study|Lost to Follow-up|3|||
37765007|NCT01532414|69278107|FG001|Overall Study|Lost to Follow-up|0|||
37765008|NCT01532414|69278108|FG002|Overall Study|Lost to Follow-up|1|||
37765009|NCT01532414|69278106|FG000|Overall Study|Withdrawal by Subject|3|||
37765010|NCT01532414|69278107|FG001|Overall Study|Withdrawal by Subject|0|||
37765011|NCT01532414|69278108|FG002|Overall Study|Withdrawal by Subject|0|||
37765012|NCT01532414|69278106|FG000|Overall Study|No V6 semen sample|0|||
37765013|NCT01532414|69278107|FG001|Overall Study|No V6 semen sample|1|||
37765014|NCT01532414|69278108|FG002|Overall Study|No V6 semen sample|0|||
37765015|NCT01532414|69278106|FG000|Overall Study|Adverse Event|0|||
37765016|NCT01532414|69278107|FG001|Overall Study|Adverse Event|1|||
37765017|NCT01532414|69278108|FG002|Overall Study|Adverse Event|1|||
37765018|NCT01532414|69278106|FG000|Overall Study|Unable to complete 24 hour PK|0|||
37765019|NCT01532414|69278107|FG001|Overall Study|Unable to complete 24 hour PK|0|||
37765020|NCT01532414|69278108|FG002|Overall Study|Unable to complete 24 hour PK|1|||
37765021|NCT01532414|69278106|FG000|Overall Study|Withdrawn by sponsor|1|||
37765022|NCT01532414|69278107|FG001|Overall Study|Withdrawn by sponsor|0|||
37765023|NCT01532414|69278108|FG002|Overall Study|Withdrawn by sponsor|0|||
37765024|NCT01441973|69278118|FG000|Overall Study|Disease progression|8|||
37765025|NCT01441973|69278119|FG001|Overall Study|Disease progression|6|||
37765026|NCT01441973|69278118|FG000|Overall Study|Adverse event unrelated to study drug|3|||
37765027|NCT01441973|69278119|FG001|Overall Study|Adverse event unrelated to study drug|2|||
37765028|NCT01441973|69278118|FG000|Overall Study|Participant request to discontinue|1|||
37765029|NCT01441973|69278119|FG001|Overall Study|Participant request to discontinue|1|||
37765030|NCT01441973|69278118|FG000|Overall Study|Poor compliance/noncompliance|0|||
37765031|NCT01441973|69278119|FG001|Overall Study|Poor compliance/noncompliance|1|||
37765032|NCT01441973|69278118|FG000|Overall Study|Administrative reason by sponsor|3|||
37765033|NCT01441973|69278119|FG001|Overall Study|Administrative reason by sponsor|5|||
37765034|NCT01441973|69278118|FG000|Overall Study|Participant withdrew consent|0|||
37765035|NCT01441973|69278119|FG001|Overall Study|Participant withdrew consent|1|||
37765036|NCT01575899|69278138|FG000|Overall Study|Lost to Follow-up|3|||
37765037|NCT01575899|69278139|FG001|Overall Study|Lost to Follow-up|4|||
37765038|NCT01575899|69278140|FG002|Overall Study|Lost to Follow-up|2|||
37765039|NCT01575899|69278138|FG000|Overall Study|Protocol Violation|2|||
37765040|NCT01575899|69278139|FG001|Overall Study|Protocol Violation|1|||
37765041|NCT01575899|69278140|FG002|Overall Study|Protocol Violation|0|||
37765042|NCT01440881|69278152|FG000|Overall Study|Death|0|||
37765043|NCT01440881|69278153|FG001|Overall Study|Death|1|||
37765044|NCT01575197|69278168|FG000|Overall Study|Migration out of study area|1|||
37765045|NCT01575197|69278169|FG001|Overall Study|Migration out of study area|5|||
37765046|NCT01575197|69278170|FG002|Overall Study|Migration out of study area|4|||
37765047|NCT01575197|69278168|FG000|Overall Study|SAE|0|||
37765048|NCT01575197|69278169|FG001|Overall Study|SAE|1|||
37765049|NCT01575197|69278170|FG002|Overall Study|SAE|0|||
37765050|NCT01575197|69278168|FG000|Overall Study|Lost to Follow-up|0|||
37765051|NCT01575197|69278169|FG001|Overall Study|Lost to Follow-up|1|||
37765052|NCT01575197|69278170|FG002|Overall Study|Lost to Follow-up|0|||
37765053|NCT01575197|69278168|FG000|Overall Study|Withdrawal by Subject|0|||
37765054|NCT01575197|69278169|FG001|Overall Study|Withdrawal by Subject|1|||
37765055|NCT01575197|69278170|FG002|Overall Study|Withdrawal by Subject|1|||
37765056|NCT01575197|69278168|FG000|Overall Study|Protocol Violation|2|||
37765057|NCT01575197|69278169|FG001|Overall Study|Protocol Violation|1|||
37934356|NCT00696657|69621085|FG006|Overall Study|Withdrawal criteria|1|||
37934357|NCT00696657|69621086|FG007|Overall Study|Withdrawal criteria|1|||
37934358|NCT00696657|69621087|FG008|Overall Study|Withdrawal criteria|2|||
37934359|NCT00696657|69621079|FG000|Overall Study|Unclassified|0|||
37934360|NCT00696657|69621080|FG001|Overall Study|Unclassified|1|||
37934361|NCT00696657|69621081|FG002|Overall Study|Unclassified|3|||
37934362|NCT00696657|69621082|FG003|Overall Study|Unclassified|2|||
37934363|NCT00696657|69621083|FG004|Overall Study|Unclassified|4|||
37934364|NCT00696657|69621084|FG005|Overall Study|Unclassified|2|||
37934365|NCT00696657|69621085|FG006|Overall Study|Unclassified|0|||
37934366|NCT00696657|69621086|FG007|Overall Study|Unclassified|0|||
37934367|NCT00696657|69621087|FG008|Overall Study|Unclassified|1|||
37934368|NCT00696657|69621079|FG000|Overall Study|Adverse Event|0|||
37934369|NCT00696657|69621080|FG001|Overall Study|Adverse Event|0|||
37934370|NCT00696657|69621081|FG002|Overall Study|Adverse Event|3|||
37934371|NCT00696657|69621082|FG003|Overall Study|Adverse Event|7|||
37934372|NCT00696657|69621083|FG004|Overall Study|Adverse Event|6|||
37934373|NCT00696657|69621084|FG005|Overall Study|Adverse Event|9|||
37934374|NCT00696657|69621085|FG006|Overall Study|Adverse Event|14|||
37934375|NCT00696657|69621086|FG007|Overall Study|Adverse Event|2|||
37934376|NCT00696657|69621087|FG008|Overall Study|Adverse Event|5|||
37934377|NCT00730886|69621109|FG000|Overall Study|Lost to Follow-up|1|||
37934378|NCT00730886|69621110|FG001|Overall Study|Lost to Follow-up|0|||
37934379|NCT00730886|69621109|FG000|Overall Study|Physician Decision|1|||
37934380|NCT00730886|69621110|FG001|Overall Study|Physician Decision|0|||
37934381|NCT00726752|69621116|FG000|Overall Study|Lack of Efficacy|6|||
37934382|NCT00730028|69621134|FG000|Overall Study|Adverse Event|23|||
37934383|NCT00730028|69621135|FG001|Overall Study|Adverse Event|26|||
37934384|NCT00730028|69621136|FG002|Overall Study|Adverse Event|16|||
37934385|NCT00730028|69621137|FG003|Overall Study|Adverse Event|20|||
37934386|NCT00730028|69621138|FG004|Overall Study|Adverse Event|43|||
37934387|NCT00730028|69621134|FG000|Overall Study|Lost to Follow-up|13|||
37934388|NCT00730028|69621135|FG001|Overall Study|Lost to Follow-up|26|||
37670313|NCT02055820|69143555|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
37670314|NCT02055820|69143556|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
37765058|NCT01575197|69278170|FG002|Overall Study|Protocol Violation|1|||
37765059|NCT01574651|69278201|FG000|Overall Study|Lost to Follow-up|2|||
37765060|NCT01574651|69278202|FG001|Overall Study|Lost to Follow-up|4|||
37859533|NCT01165281|69542871|FG001|Overall Study|Withdrawal by Subject|7|||
37859534|NCT01165281|69542870|FG000|Overall Study|Noncompliance with Study Drug|1|||
37859535|NCT01165281|69542871|FG001|Overall Study|Noncompliance with Study Drug|4|||
37859536|NCT01165281|69542870|FG000|Overall Study|Progressive Disease|10|||
37859537|NCT01165281|69542871|FG001|Overall Study|Progressive Disease|14|||
37859538|NCT01165281|69542870|FG000|Overall Study|Other|6|||
37859539|NCT01165281|69542871|FG001|Overall Study|Other|0|||
37859540|NCT01165203|69542879|FG000|Active Phase|Serious Adverse Event|1|||
37859541|NCT01165203|69542880|FG001|Active Phase|Serious Adverse Event|0|||
37859542|NCT01165203|69542879|FG000|Active Phase|Withdrawal by Subject|2|||
37859543|NCT01165203|69542880|FG001|Active Phase|Withdrawal by Subject|1|||
37859544|NCT01165203|69542879|FG000|Active Phase|Migrated/moved from study area|0|||
37859545|NCT01165203|69542880|FG001|Active Phase|Migrated/moved from study area|1|||
37859546|NCT01165203|69542879|FG000|Active Phase|Lost to Follow-up|2|||
37859547|NCT01165203|69542880|FG001|Active Phase|Lost to Follow-up|0|||
37859548|NCT01165203|69542879|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
37859549|NCT01165203|69542880|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
37859550|NCT01165203|69542879|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
37859551|NCT01165203|69542880|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
37859552|NCT01165203|69542879|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
37859553|NCT01165203|69542880|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
37859554|NCT01165203|69542879|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
37859555|NCT01165203|69542880|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
37859556|NCT01165203|69542879|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
37859557|NCT01165203|69542880|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
37859558|NCT00960661|69542895|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
37859559|NCT00960661|69542896|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
37934389|NCT00730028|69621136|FG002|Overall Study|Lost to Follow-up|22|||
37934390|NCT00730028|69621137|FG003|Overall Study|Lost to Follow-up|26|||
37934391|NCT00730028|69621138|FG004|Overall Study|Lost to Follow-up|25|||
37934392|NCT00730028|69621134|FG000|Overall Study|Protocol Violation|6|||
37934393|NCT00730028|69621135|FG001|Overall Study|Protocol Violation|1|||
37934394|NCT00730028|69621136|FG002|Overall Study|Protocol Violation|1|||
37934395|NCT00730028|69621137|FG003|Overall Study|Protocol Violation|2|||
37934396|NCT00730028|69621138|FG004|Overall Study|Protocol Violation|0|||
37934397|NCT00730028|69621134|FG000|Overall Study|Withdrawal by Subject|9|||
37934398|NCT00730028|69621135|FG001|Overall Study|Withdrawal by Subject|5|||
37934399|NCT00730028|69621136|FG002|Overall Study|Withdrawal by Subject|4|||
37934400|NCT00730028|69621137|FG003|Overall Study|Withdrawal by Subject|5|||
37934401|NCT00730028|69621138|FG004|Overall Study|Withdrawal by Subject|9|||
37934402|NCT00730028|69621134|FG000|Overall Study|Physician Decision|3|||
37934403|NCT00730028|69621135|FG001|Overall Study|Physician Decision|3|||
37934404|NCT00730028|69621136|FG002|Overall Study|Physician Decision|2|||
37934405|NCT00730028|69621137|FG003|Overall Study|Physician Decision|3|||
37934406|NCT00730028|69621138|FG004|Overall Study|Physician Decision|2|||
37934407|NCT00730028|69621134|FG000|Overall Study|Treatment Failure|5|||
37934408|NCT00730028|69621135|FG001|Overall Study|Treatment Failure|5|||
37934409|NCT00730028|69621136|FG002|Overall Study|Treatment Failure|0|||
37934410|NCT00730028|69621137|FG003|Overall Study|Treatment Failure|0|||
37934411|NCT00730028|69621138|FG004|Overall Study|Treatment Failure|1|||
37934412|NCT00730028|69621134|FG000|Overall Study|Randomization Error|1|||
37934413|NCT00730028|69621135|FG001|Overall Study|Randomization Error|0|||
37934414|NCT00730028|69621136|FG002|Overall Study|Randomization Error|0|||
37934415|NCT00730028|69621137|FG003|Overall Study|Randomization Error|0|||
37934416|NCT00730028|69621138|FG004|Overall Study|Randomization Error|2|||
37934417|NCT00736502|69621150|FG000|Overall Study|Adverse Event|22|||
37934418|NCT00736502|69621150|FG000|Overall Study|Lack of Efficacy|16|||
37934419|NCT00736502|69621150|FG000|Overall Study|Lost to Follow-up|27|||
37934420|NCT00729560|69621154|FG000|Overall Study|Withdrawal by Subject|3|||
37934421|NCT00736190|69621158|FG000|Overall Study|Pregnancy|1|||
37934422|NCT00736190|69621158|FG000|Overall Study|Withdrawal by Subject|1|||
37934423|NCT00736190|69621158|FG000|Overall Study|Adverse Event|1|||
37934424|NCT00729326|69621164|FG000|Overall Study|Lost to Follow-up|2|||
37934425|NCT00729326|69621165|FG001|Overall Study|Lost to Follow-up|0|||
37934426|NCT00729326|69621164|FG000|Overall Study|Physician Decision|0|||
37934427|NCT00729326|69621165|FG001|Overall Study|Physician Decision|1|||
37934428|NCT00729326|69621164|FG000|Overall Study|Protocol Violation|3|||
37934429|NCT00729326|69621165|FG001|Overall Study|Protocol Violation|2|||
37934430|NCT00729326|69621164|FG000|Overall Study|Subject Decision|4|||
37934431|NCT00729326|69621165|FG001|Overall Study|Subject Decision|4|||
37934432|NCT00729326|69621164|FG000|Overall Study|Sponsor Decision|1|||
37934433|NCT00729326|69621165|FG001|Overall Study|Sponsor Decision|2|||
37934434|NCT00729248|69621171|FG000|Overall Study|Physician Decision|2|||
37934435|NCT00696423|69621178|FG000|Overall Study|Lost to Follow-up|0|||
37934436|NCT00696423|69621179|FG001|Overall Study|Lost to Follow-up|5|||
37934437|NCT00736034|69621185|FG000|Overall Study|Adverse Event|2|||
37934438|NCT00576693|69621191|FG000|Overall Study|Lost to Follow-up|7|||
37934439|NCT00576693|69621192|FG001|Overall Study|Lost to Follow-up|11|||
37934440|NCT00576693|69621191|FG000|Overall Study|Withdrawal by Subject|3|||
37934441|NCT00576693|69621192|FG001|Overall Study|Withdrawal by Subject|13|||
37934442|NCT00698451|69621198|FG000|Overall Study|Adverse Event|22|||
37934443|NCT00698451|69621198|FG000|Overall Study|Physician Decision|2|||
37934444|NCT00698451|69621198|FG000|Overall Study|Protocol Violation|6|||
37934445|NCT00698451|69621198|FG000|Overall Study|Withdrawal by Subject|6|||
37934446|NCT00698451|69621198|FG000|Overall Study|Disease progression|3|||
37934447|NCT00697827|69621204|FG000|Overall Study|enrolled but not treated|2|||
37934448|NCT00697827|69621205|FG001|Overall Study|enrolled but not treated|1|||
37934449|NCT00728936|69621218|FG000|Overall Study|Withdrawal by Subject|0|||
37934450|NCT00728936|69621219|FG001|Overall Study|Withdrawal by Subject|0|||
37934451|NCT00728936|69621220|FG002|Overall Study|Withdrawal by Subject|0|||
37934452|NCT00728936|69621221|FG003|Overall Study|Withdrawal by Subject|0|||
37934453|NCT00728936|69621222|FG004|Overall Study|Withdrawal by Subject|0|||
37934454|NCT00728936|69621223|FG005|Overall Study|Withdrawal by Subject|1|||
37934455|NCT00728936|69621224|FG006|Overall Study|Withdrawal by Subject|0|||
37934456|NCT00693693|69621243|FG000|Overall Study|Lost to Follow-up|1|||
37934457|NCT00693693|69621244|FG001|Overall Study|Lost to Follow-up|1|||
37934458|NCT00693693|69621245|FG002|Overall Study|Lost to Follow-up|2|||
37934459|NCT00728468|69621253|FG000|Overall Study|Enrolled but not treated|1|||
37934460|NCT00728468|69621253|FG000|Overall Study|Death|1|||
37934461|NCT00728468|69621253|FG000|Overall Study|Protocol Violation|4|||
37934462|NCT00728468|69621253|FG000|Overall Study|Objective progression or relapse|9|||
37934463|NCT00728468|69621253|FG000|Overall Study|Study terminated by sponsor|1|||
37934464|NCT00727844|69621259|FG000|Initial Randomization|Physician Decision|2|||
37934465|NCT00727844|69621260|FG001|Initial Randomization|Physician Decision|0|||
37934466|NCT00727844|69621261|FG002|Initial Randomization|Physician Decision|0|||
37934467|NCT00727844|69621262|FG003|Initial Randomization|Physician Decision|0|||
37934468|NCT00735878|69621270|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
37934469|NCT00735878|69621271|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
37934470|NCT00735878|69621272|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
37934471|NCT00695955|69621283|FG000|Cohort 1|Adverse Event|26|||
37934472|NCT00695955|69621283|FG000|Cohort 1|Protocol Violation|2|||
37934473|NCT00695955|69621283|FG000|Cohort 1|Lost to Follow-up|30|||
37934474|NCT00695955|69621283|FG000|Cohort 1|Withdrawal by Subject|25|||
37934475|NCT00695955|69621283|FG000|Cohort 1|Lack of Efficacy|3|||
37934476|NCT00695955|69621283|FG000|Cohort 1|Other|16|||
37934477|NCT00695955|69621283|FG000|Cohort 2|Adverse Event|24|||
37934478|NCT00695955|69621283|FG000|Cohort 2|Protocol Violation|5|||
37934479|NCT00695955|69621283|FG000|Cohort 2|Lost to Follow-up|38|||
37934480|NCT00695955|69621283|FG000|Cohort 2|Withdrawal by Subject|28|||
37934481|NCT00695955|69621283|FG000|Cohort 2|Lack of Efficacy|4|||
37934482|NCT00695955|69621283|FG000|Cohort 2|Other|5|||
37934483|NCT00693225|69621291|FG000|Overall Study|Lost to Follow-up|1|||
37934484|NCT00693225|69621292|FG001|Overall Study|Lost to Follow-up|2|||
37934485|NCT00693225|69621291|FG000|Overall Study|Adverse Event|1|||
37934486|NCT00693225|69621292|FG001|Overall Study|Adverse Event|3|||
37934487|NCT00735644|69621303|FG000|Overall Study|Did not receive study vaccine|0|||
37934488|NCT00735644|69621304|FG001|Overall Study|Did not receive study vaccine|1|||
37934489|NCT00735644|69621305|FG002|Overall Study|Did not receive study vaccine|0|||
37934490|NCT00735644|69621306|FG003|Overall Study|Did not receive study vaccine|0|||
37934491|NCT00735644|69621307|FG004|Overall Study|Did not receive study vaccine|0|||
37934492|NCT00735644|69621303|FG000|Overall Study|Withdrawal by Subject|0|||
37934493|NCT00735644|69621304|FG001|Overall Study|Withdrawal by Subject|1|||
37934494|NCT00735644|69621305|FG002|Overall Study|Withdrawal by Subject|1|||
37934495|NCT00735644|69621306|FG003|Overall Study|Withdrawal by Subject|1|||
37934496|NCT00735644|69621307|FG004|Overall Study|Withdrawal by Subject|0|||
37934497|NCT03718299|69621326|FG000|Overall Study|Adverse Event|1|||
37934498|NCT03718299|69621326|FG000|Overall Study|Withdrawal by Subject|6|||
37934499|NCT03718299|69621326|FG000|Overall Study|Physician Decision|2|||
37934500|NCT03718299|69621326|FG000|Overall Study|Lost to Follow-up|1|||
37934501|NCT00724958|69621330|FG000|Overall Study|Adverse Event|28|||
37934502|NCT00724958|69621330|FG000|Overall Study|Loss of Response|40|||
37934503|NCT00724958|69621330|FG000|Overall Study|No Response|18|||
37934504|NCT00724958|69621330|FG000|Overall Study|Remission|7|||
37934505|NCT00724958|69621330|FG000|Overall Study|Other Reason|76|||
37934506|NCT00724958|69621330|FG000|Overall Study|No documentation for end of therapy|13|||
37934507|NCT00695565|69621336|FG000|Overall Study|Lost to Follow-up|4|||
37670315|NCT02055820|69143557|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
37765061|NCT01574651|69278201|FG000|Overall Study|Administrative problems|0|||
37765062|NCT01574651|69278202|FG001|Overall Study|Administrative problems|1|||
37765063|NCT01574651|69278201|FG000|Overall Study|Death|3|||
37765064|NCT01574651|69278202|FG001|Overall Study|Death|3|||
37765065|NCT01574651|69278201|FG000|Overall Study|Patient's inability to use the device|0|||
37765066|NCT01574651|69278202|FG001|Overall Study|Patient's inability to use the device|1|||
37765067|NCT01574651|69278201|FG000|Overall Study|Adverse Event|36|||
37765068|NCT01574651|69278202|FG001|Overall Study|Adverse Event|27|||
37765069|NCT01574651|69278201|FG000|Overall Study|Abnormal laboratory value(s)|1|||
37934508|NCT00695565|69621337|FG001|Overall Study|Lost to Follow-up|4|||
37934509|NCT00695565|69621336|FG000|Overall Study|Adverse Event|3|||
37934510|NCT00695565|69621337|FG001|Overall Study|Adverse Event|1|||
37934511|NCT00695565|69621336|FG000|Overall Study|Protocol Violation|3|||
37934512|NCT00695565|69621337|FG001|Overall Study|Protocol Violation|1|||
37934513|NCT00695565|69621336|FG000|Overall Study|Withdrawal by Subject|1|||
37934514|NCT00695565|69621337|FG001|Overall Study|Withdrawal by Subject|1|||
37934515|NCT00695565|69621336|FG000|Overall Study|Lack of Efficacy|1|||
37934516|NCT00695565|69621337|FG001|Overall Study|Lack of Efficacy|1|||
37934517|NCT00695565|69621336|FG000|Overall Study|Subject did not follow instructions|1|||
37934518|NCT00695565|69621337|FG001|Overall Study|Subject did not follow instructions|1|||
37934519|NCT00727532|69621343|FG000|Overall Study|Adverse Event|1|||
37934520|NCT00727532|69621343|FG000|Overall Study|Withdrawal by Subject|1|||
37934521|NCT00721214|69621347|FG000|Overall Study|Chose another center for transplant|1|||
37934522|NCT00721214|69621347|FG000|Overall Study|Death|3|||
37934523|NCT00720902|69621353|FG000|Overall Study|Withdrawal by Subject|1|||
37934524|NCT00720902|69621354|FG001|Overall Study|Withdrawal by Subject|0|||
37934525|NCT00720902|69621353|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
37934526|NCT00720902|69621354|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
37765070|NCT01574651|69278202|FG001|Overall Study|Abnormal laboratory value(s)|0|||
37765071|NCT01574651|69278201|FG000|Overall Study|Abnormal test procedure result(s)|1|||
37765072|NCT01574651|69278202|FG001|Overall Study|Abnormal test procedure result(s)|1|||
37765073|NCT01574651|69278201|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
37934527|NCT00695019|69621363|FG000|Overall Study|Withdrawal by Subject|8|||
37934528|NCT00695019|69621364|FG001|Overall Study|Withdrawal by Subject|6|||
37934529|NCT00695019|69621365|FG002|Overall Study|Withdrawal by Subject|4|||
37765074|NCT01574651|69278202|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
37765075|NCT01574651|69278201|FG000|Overall Study|Protocol Violation|3|||
37765076|NCT01574651|69278202|FG001|Overall Study|Protocol Violation|5|||
37934530|NCT00695019|69621363|FG000|Overall Study|Protocol Violation|1|||
37934531|NCT00695019|69621364|FG001|Overall Study|Protocol Violation|3|||
37934532|NCT00695019|69621365|FG002|Overall Study|Protocol Violation|1|||
37934533|NCT00695019|69621363|FG000|Overall Study|Lack of Efficacy|0|||
37934534|NCT00695019|69621364|FG001|Overall Study|Lack of Efficacy|0|||
37934535|NCT00695019|69621365|FG002|Overall Study|Lack of Efficacy|1|||
37934536|NCT00695019|69621363|FG000|Overall Study|Various|4|||
37934537|NCT00695019|69621364|FG001|Overall Study|Various|5|||
37934538|NCT00695019|69621365|FG002|Overall Study|Various|4|||
37934539|NCT00694707|69621378|FG000|Overall Study|Did Not Receive Treatment|0|||
37934540|NCT00694707|69621379|FG001|Overall Study|Did Not Receive Treatment|0|||
37934541|NCT00694707|69621380|FG002|Overall Study|Did Not Receive Treatment|1|||
37934542|NCT00694707|69621381|FG003|Overall Study|Did Not Receive Treatment|1|||
37934543|NCT00694707|69621382|FG004|Overall Study|Did Not Receive Treatment|1|||
37934544|NCT00694707|69621378|FG000|Overall Study|Adverse Event|22|||
37934545|NCT00694707|69621379|FG001|Overall Study|Adverse Event|14|||
37934546|NCT00694707|69621380|FG002|Overall Study|Adverse Event|8|||
37934547|NCT00694707|69621381|FG003|Overall Study|Adverse Event|12|||
37934548|NCT00694707|69621382|FG004|Overall Study|Adverse Event|13|||
37934549|NCT00694707|69621378|FG000|Overall Study|Insufficient Therapeutic Response|33|||
37934550|NCT00694707|69621379|FG001|Overall Study|Insufficient Therapeutic Response|18|||
37934551|NCT00694707|69621380|FG002|Overall Study|Insufficient Therapeutic Response|17|||
37934552|NCT00694707|69621381|FG003|Overall Study|Insufficient Therapeutic Response|15|||
37934553|NCT00694707|69621382|FG004|Overall Study|Insufficient Therapeutic Response|10|||
37934554|NCT00694707|69621378|FG000|Overall Study|Protocol Violation|1|||
37934555|NCT00694707|69621379|FG001|Overall Study|Protocol Violation|2|||
37934556|NCT00694707|69621380|FG002|Overall Study|Protocol Violation|1|||
37934557|NCT00694707|69621381|FG003|Overall Study|Protocol Violation|3|||
37934558|NCT00694707|69621382|FG004|Overall Study|Protocol Violation|1|||
37934559|NCT00694707|69621378|FG000|Overall Study|Withdrawal of Consent|14|||
37934560|NCT00694707|69621379|FG001|Overall Study|Withdrawal of Consent|18|||
37934561|NCT00694707|69621380|FG002|Overall Study|Withdrawal of Consent|22|||
37934562|NCT00694707|69621381|FG003|Overall Study|Withdrawal of Consent|16|||
37934563|NCT00694707|69621382|FG004|Overall Study|Withdrawal of Consent|15|||
37934564|NCT00694707|69621378|FG000|Overall Study|Lost to Follow-up|0|||
37934565|NCT00694707|69621379|FG001|Overall Study|Lost to Follow-up|1|||
37934566|NCT00694707|69621380|FG002|Overall Study|Lost to Follow-up|2|||
37934567|NCT00694707|69621381|FG003|Overall Study|Lost to Follow-up|0|||
37934568|NCT00694707|69621382|FG004|Overall Study|Lost to Follow-up|0|||
37934569|NCT00694707|69621378|FG000|Overall Study|Jeopardizing Parole Status|1|||
37934570|NCT00694707|69621379|FG001|Overall Study|Jeopardizing Parole Status|0|||
37934571|NCT00694707|69621380|FG002|Overall Study|Jeopardizing Parole Status|0|||
37934572|NCT00694707|69621381|FG003|Overall Study|Jeopardizing Parole Status|0|||
37934573|NCT00694707|69621382|FG004|Overall Study|Jeopardizing Parole Status|0|||
37934574|NCT00694707|69621378|FG000|Overall Study|Death in the Family|1|||
37934575|NCT00694707|69621379|FG001|Overall Study|Death in the Family|0|||
38035028|NCT04213989|69721894|FG001|Overall Study|Withdrawal by Subject|2|||
38035029|NCT04213989|69721893|FG000|Overall Study|Physician Decision|1|||
38035030|NCT04213989|69721894|FG001|Overall Study|Physician Decision|0|||
38035031|NCT04213989|69721893|FG000|Overall Study|Lost to Follow-up|0|||
38035032|NCT04213989|69721894|FG001|Overall Study|Lost to Follow-up|4|||
38035033|NCT03242252|69721903|FG000|Overall Study|At the Participant's own Request|18|||
38035034|NCT03242252|69721904|FG001|Overall Study|At the Participant's own Request|10|||
38035035|NCT03242252|69721905|FG002|Overall Study|At the Participant's own Request|15|||
38035036|NCT03242252|69721903|FG000|Overall Study|Adverse Event|8|||
38035037|NCT03242252|69721904|FG001|Overall Study|Adverse Event|6|||
38035038|NCT03242252|69721905|FG002|Overall Study|Adverse Event|9|||
38035039|NCT03242252|69721903|FG000|Overall Study|Poor Compliance to Protocol|0|||
38035040|NCT03242252|69721904|FG001|Overall Study|Poor Compliance to Protocol|2|||
38035041|NCT03242252|69721905|FG002|Overall Study|Poor Compliance to Protocol|3|||
38035042|NCT03242252|69721903|FG000|Overall Study|Study Terminated by Sponsor|1|||
38035043|NCT03242252|69721904|FG001|Overall Study|Study Terminated by Sponsor|0|||
38035044|NCT03242252|69721905|FG002|Overall Study|Study Terminated by Sponsor|0|||
38035045|NCT03242252|69721903|FG000|Overall Study|Reason not Specified|4|||
37934576|NCT00694707|69621380|FG002|Overall Study|Death in the Family|0|||
37934577|NCT00694707|69621381|FG003|Overall Study|Death in the Family|0|||
37934578|NCT00694707|69621382|FG004|Overall Study|Death in the Family|0|||
37934579|NCT00694707|69621378|FG000|Overall Study|Arrest by Police|0|||
37934580|NCT00694707|69621379|FG001|Overall Study|Arrest by Police|1|||
37934581|NCT00694707|69621380|FG002|Overall Study|Arrest by Police|0|||
37934582|NCT00694707|69621381|FG003|Overall Study|Arrest by Police|0|||
37934583|NCT00694707|69621382|FG004|Overall Study|Arrest by Police|0|||
37934584|NCT00694707|69621378|FG000|Overall Study|Administrative Reasons|0|||
38035046|NCT03242252|69721904|FG001|Overall Study|Reason not Specified|4|||
37765077|NCT01574651|69278201|FG000|Overall Study|Withdrawal by Subject|9|||
37934585|NCT00694707|69621379|FG001|Overall Study|Administrative Reasons|1|||
37934586|NCT00694707|69621380|FG002|Overall Study|Administrative Reasons|0|||
37934587|NCT00694707|69621381|FG003|Overall Study|Administrative Reasons|2|||
37934588|NCT00694707|69621382|FG004|Overall Study|Administrative Reasons|0|||
37934589|NCT00694707|69621378|FG000|Overall Study|Notification of Past Head Injury|0|||
37934590|NCT00694707|69621379|FG001|Overall Study|Notification of Past Head Injury|0|||
37934591|NCT00694707|69621380|FG002|Overall Study|Notification of Past Head Injury|0|||
37934592|NCT00694707|69621381|FG003|Overall Study|Notification of Past Head Injury|1|||
37934593|NCT00694707|69621382|FG004|Overall Study|Notification of Past Head Injury|0|||
37934594|NCT00692913|69621396|FG000|Overall Study|Adverse Event|8|||
37934595|NCT00692913|69621397|FG001|Overall Study|Adverse Event|4|||
37934596|NCT00692913|69621396|FG000|Overall Study|Lost to Follow-up|3|||
37934597|NCT00692913|69621397|FG001|Overall Study|Lost to Follow-up|5|||
37934598|NCT00692913|69621396|FG000|Overall Study|Physician Decision|2|||
37934599|NCT00692913|69621397|FG001|Overall Study|Physician Decision|0|||
37934600|NCT00692913|69621396|FG000|Overall Study|Protocol Violation|1|||
37934601|NCT00692913|69621397|FG001|Overall Study|Protocol Violation|1|||
37934602|NCT00692913|69621396|FG000|Overall Study|Withdrawal by Subject|15|||
37934603|NCT00692913|69621397|FG001|Overall Study|Withdrawal by Subject|20|||
37934604|NCT00694551|69621406|FG000|Overall Study|Disease Progression|1|||
37934605|NCT00694551|69621407|FG001|Overall Study|Disease Progression|0|||
37934606|NCT00694551|69621408|FG002|Overall Study|Disease Progression|1|||
37934607|NCT00689871|69621421|FG000|Overall Study|Lost to Follow-up|123|||
37934608|NCT00689871|69621422|FG001|Overall Study|Lost to Follow-up|13|||
37934609|NCT00689871|69621423|FG002|Overall Study|Lost to Follow-up|37|||
37934610|NCT00689871|69621424|FG003|Overall Study|Lost to Follow-up|1|||
37934611|NCT00689871|69621421|FG000|Overall Study|Explanted of All Study Devices|36|||
37934612|NCT00689871|69621422|FG001|Overall Study|Explanted of All Study Devices|25|||
37934613|NCT00689871|69621423|FG002|Overall Study|Explanted of All Study Devices|29|||
37934614|NCT00689871|69621424|FG003|Overall Study|Explanted of All Study Devices|3|||
37934615|NCT00689871|69621421|FG000|Overall Study|Withdrawal by Subject|13|||
37934616|NCT00689871|69621422|FG001|Overall Study|Withdrawal by Subject|3|||
37934617|NCT00689871|69621423|FG002|Overall Study|Withdrawal by Subject|4|||
37934618|NCT00689871|69621424|FG003|Overall Study|Withdrawal by Subject|1|||
37934619|NCT00689871|69621421|FG000|Overall Study|Death|1|||
37934620|NCT00689871|69621422|FG001|Overall Study|Death|10|||
37934621|NCT00689871|69621423|FG002|Overall Study|Death|2|||
37934622|NCT00689871|69621424|FG003|Overall Study|Death|2|||
37934623|NCT00689871|69621421|FG000|Overall Study|Physician Decision|2|||
37934624|NCT00689871|69621422|FG001|Overall Study|Physician Decision|1|||
37934625|NCT00689871|69621423|FG002|Overall Study|Physician Decision|1|||
37934626|NCT00689871|69621424|FG003|Overall Study|Physician Decision|0|||
37934627|NCT00793793|69621446|FG000|Overall Study|Adverse Event|0|||
37934628|NCT00793793|69621447|FG001|Overall Study|Adverse Event|0|||
37934629|NCT00793793|69621448|FG002|Overall Study|Adverse Event|1|||
37934630|NCT00793793|69621449|FG003|Overall Study|Adverse Event|1|||
37934631|NCT00793793|69621450|FG004|Overall Study|Adverse Event|0|||
37934632|NCT00793793|69621451|FG005|Overall Study|Adverse Event|1|||
37934633|NCT00793793|69621452|FG006|Overall Study|Adverse Event|2|||
37934634|NCT00793793|69621453|FG007|Overall Study|Adverse Event|0|||
37934635|NCT00793793|69621454|FG008|Overall Study|Adverse Event|0|||
37934636|NCT00793793|69621455|FG009|Overall Study|Adverse Event|0|||
37934637|NCT00793793|69621456|FG010|Overall Study|Adverse Event|0|||
37934638|NCT00793793|69621457|FG011|Overall Study|Adverse Event|2|||
37934639|NCT00793793|69621446|FG000|Overall Study|Protocol Violation|0|||
37934640|NCT00793793|69621447|FG001|Overall Study|Protocol Violation|0|||
37934641|NCT00793793|69621448|FG002|Overall Study|Protocol Violation|0|||
37934642|NCT00793793|69621449|FG003|Overall Study|Protocol Violation|1|||
37934643|NCT00793793|69621450|FG004|Overall Study|Protocol Violation|0|||
37934644|NCT00793793|69621451|FG005|Overall Study|Protocol Violation|0|||
37934645|NCT00793793|69621452|FG006|Overall Study|Protocol Violation|0|||
37934646|NCT00793793|69621453|FG007|Overall Study|Protocol Violation|0|||
38035047|NCT03242252|69721905|FG002|Overall Study|Reason not Specified|1|||
38035048|NCT03242252|69721903|FG000|Overall Study|Lost to Follow-up|5|||
38035049|NCT03242252|69721904|FG001|Overall Study|Lost to Follow-up|1|||
37934647|NCT00793793|69621454|FG008|Overall Study|Protocol Violation|0|||
37934648|NCT00793793|69621455|FG009|Overall Study|Protocol Violation|0|||
37934649|NCT00793793|69621456|FG010|Overall Study|Protocol Violation|0|||
37934650|NCT00793793|69621457|FG011|Overall Study|Protocol Violation|0|||
37934651|NCT00793793|69621446|FG000|Overall Study|Lost to Follow-up|0|||
37934652|NCT00793793|69621447|FG001|Overall Study|Lost to Follow-up|0|||
37934653|NCT00793793|69621448|FG002|Overall Study|Lost to Follow-up|1|||
37934654|NCT00793793|69621449|FG003|Overall Study|Lost to Follow-up|0|||
37934655|NCT00793793|69621450|FG004|Overall Study|Lost to Follow-up|0|||
37934656|NCT00793793|69621451|FG005|Overall Study|Lost to Follow-up|0|||
37934657|NCT00793793|69621452|FG006|Overall Study|Lost to Follow-up|0|||
37934658|NCT00793793|69621453|FG007|Overall Study|Lost to Follow-up|0|||
37934659|NCT00793793|69621454|FG008|Overall Study|Lost to Follow-up|1|||
37934660|NCT00793793|69621455|FG009|Overall Study|Lost to Follow-up|3|||
37934661|NCT00793793|69621456|FG010|Overall Study|Lost to Follow-up|1|||
37934662|NCT00793793|69621457|FG011|Overall Study|Lost to Follow-up|0|||
37934663|NCT00793793|69621446|FG000|Overall Study|Withdrawal by Subject|0|||
37934664|NCT00793793|69621447|FG001|Overall Study|Withdrawal by Subject|0|||
37934665|NCT00793793|69621448|FG002|Overall Study|Withdrawal by Subject|0|||
37934666|NCT00793793|69621449|FG003|Overall Study|Withdrawal by Subject|0|||
37934667|NCT00793793|69621450|FG004|Overall Study|Withdrawal by Subject|1|||
37934668|NCT00793793|69621451|FG005|Overall Study|Withdrawal by Subject|0|||
37934669|NCT00793793|69621452|FG006|Overall Study|Withdrawal by Subject|0|||
37934670|NCT00793793|69621453|FG007|Overall Study|Withdrawal by Subject|0|||
37934671|NCT00793793|69621454|FG008|Overall Study|Withdrawal by Subject|1|||
37934672|NCT00793793|69621455|FG009|Overall Study|Withdrawal by Subject|0|||
37934673|NCT00793793|69621456|FG010|Overall Study|Withdrawal by Subject|0|||
37934674|NCT00793793|69621457|FG011|Overall Study|Withdrawal by Subject|0|||
37934675|NCT00793793|69621446|FG000|Overall Study|reason not specified|0|||
37934676|NCT00793793|69621447|FG001|Overall Study|reason not specified|1|||
37934677|NCT00793793|69621448|FG002|Overall Study|reason not specified|0|||
37934678|NCT00793793|69621449|FG003|Overall Study|reason not specified|1|||
37934679|NCT00793793|69621450|FG004|Overall Study|reason not specified|1|||
37934680|NCT00793793|69621451|FG005|Overall Study|reason not specified|1|||
37934681|NCT00793793|69621452|FG006|Overall Study|reason not specified|2|||
37934682|NCT00793793|69621453|FG007|Overall Study|reason not specified|0|||
37934683|NCT00793793|69621454|FG008|Overall Study|reason not specified|7|||
37934684|NCT00793793|69621455|FG009|Overall Study|reason not specified|6|||
37934685|NCT00793793|69621456|FG010|Overall Study|reason not specified|2|||
37934686|NCT00793793|69621457|FG011|Overall Study|reason not specified|4|||
37934687|NCT00776789|69621505|FG000|Overall Study|Consent refusal|2|||
37934688|NCT00776789|69621506|FG001|Overall Study|Consent refusal|2|||
37934689|NCT00776789|69621505|FG000|Overall Study|Poor quality video|1|||
37934690|NCT00776789|69621506|FG001|Overall Study|Poor quality video|1|||
37934691|NCT00776555|69621516|FG000|Overall Study|Study terminated|3|||
37934692|NCT00776555|69621517|FG001|Overall Study|Study terminated|0|||
37934693|NCT00720434|69621527|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
37934694|NCT00720434|69621528|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
37934695|NCT00720434|69621529|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
37934696|NCT00720434|69621530|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
37934697|NCT00720434|69621527|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
37934698|NCT00720434|69621528|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
37934699|NCT00720434|69621529|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
37934700|NCT00720434|69621530|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
37934701|NCT00720434|69621527|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
37934702|NCT00720434|69621528|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
37934703|NCT00720434|69621529|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
37934704|NCT00720434|69621530|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
37934705|NCT00720434|69621527|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
37934706|NCT00720434|69621528|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
37934707|NCT00720434|69621529|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
37934708|NCT00720434|69621530|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
37934709|NCT00720434|69621527|FG000|Open-Label Period (Week 5-72)|Other|4|||
37934710|NCT00720434|69621528|FG001|Open-Label Period (Week 5-72)|Other|3|||
37934711|NCT00720434|69621529|FG002|Open-Label Period (Week 5-72)|Other|3|||
37934712|NCT00720434|69621530|FG003|Open-Label Period (Week 5-72)|Other|2|||
37934713|NCT00776009|69621546|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
37934714|NCT00776009|69621547|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
37934715|NCT00776009|69621548|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
37934716|NCT00776009|69621549|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
37934717|NCT00776009|69621550|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
37934718|NCT00776009|69621551|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
37934719|NCT00776009|69621546|FG000|Period 1: First Intervention|Protocol Violation|0|||
37934720|NCT00776009|69621547|FG001|Period 1: First Intervention|Protocol Violation|1|||
37934721|NCT00776009|69621548|FG002|Period 1: First Intervention|Protocol Violation|0|||
37934722|NCT00776009|69621549|FG003|Period 1: First Intervention|Protocol Violation|0|||
37934723|NCT00776009|69621550|FG004|Period 1: First Intervention|Protocol Violation|1|||
37934724|NCT00776009|69621551|FG005|Period 1: First Intervention|Protocol Violation|0|||
37934725|NCT00776009|69621546|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
37934726|NCT00776009|69621547|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
37934727|NCT00776009|69621548|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
37934728|NCT00776009|69621549|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
37934729|NCT00776009|69621550|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
37934730|NCT00776009|69621551|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
37934731|NCT00776009|69621546|FG000|Period 2: Second Intervention|Protocol Violation|1|||
37934732|NCT00776009|69621547|FG001|Period 2: Second Intervention|Protocol Violation|0|||
37934733|NCT00776009|69621548|FG002|Period 2: Second Intervention|Protocol Violation|1|||
37934734|NCT00776009|69621549|FG003|Period 2: Second Intervention|Protocol Violation|0|||
37934735|NCT00776009|69621550|FG004|Period 2: Second Intervention|Protocol Violation|0|||
37934736|NCT00776009|69621551|FG005|Period 2: Second Intervention|Protocol Violation|0|||
37934737|NCT00776009|69621546|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
37934738|NCT00776009|69621547|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
37934739|NCT00776009|69621548|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
37934740|NCT00776009|69621549|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
37934741|NCT00776009|69621550|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
37934742|NCT00776009|69621551|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
37934743|NCT00694161|69621559|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
37934744|NCT00694161|69621559|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
37934745|NCT00694161|69621559|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
37934746|NCT00720356|69621563|FG000|Registration to Study|Determined to have methylated MGMT|67|||
37934747|NCT00720356|69621563|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
37934748|NCT00720356|69621563|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
37934749|NCT00720356|69621563|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
37934750|NCT00720356|69621563|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
37934751|NCT00720356|69621563|FG000|Follow up Until Death|Withdrawal by Subject|1|||
37934752|NCT00720356|69621563|FG000|Follow up Until Death|Alive at last data collection|4|||
37934753|NCT00720278|69621570|FG000|Overall Study|Adverse Event|5|||
37934754|NCT00720278|69621571|FG001|Overall Study|Adverse Event|3|||
37934755|NCT00720278|69621572|FG002|Overall Study|Adverse Event|4|||
37934756|NCT00720278|69621570|FG000|Overall Study|Withdrawal by Subject|0|||
37934757|NCT00720278|69621571|FG001|Overall Study|Withdrawal by Subject|1|||
37934758|NCT00720278|69621572|FG002|Overall Study|Withdrawal by Subject|0|||
37934759|NCT00720278|69621570|FG000|Overall Study|Lost to Follow-up|0|||
37934760|NCT00720278|69621571|FG001|Overall Study|Lost to Follow-up|0|||
37934761|NCT00720278|69621572|FG002|Overall Study|Lost to Follow-up|1|||
37934762|NCT00720278|69621570|FG000|Overall Study|Non-compliance|1|||
37934763|NCT00720278|69621571|FG001|Overall Study|Non-compliance|0|||
37934764|NCT00720278|69621572|FG002|Overall Study|Non-compliance|0|||
37934765|NCT00720278|69621570|FG000|Overall Study|eligibility criteria violation|1|||
37934766|NCT00720278|69621571|FG001|Overall Study|eligibility criteria violation|0|||
37934767|NCT00720278|69621572|FG002|Overall Study|eligibility criteria violation|1|||
37934768|NCT00720122|69621580|FG000|Overall Study|Lost to Follow-up|1|||
37934769|NCT00720122|69621580|FG000|Overall Study|Physician Decision|1|||
37934770|NCT00720122|69621580|FG000|Overall Study|Withdrawal by Subject|7|||
37934771|NCT00717860|69621586|FG000|Overall Study|Clinical adverse experience|5|||
37934772|NCT00717860|69621587|FG001|Overall Study|Clinical adverse experience|9|||
37934773|NCT00717860|69621586|FG000|Overall Study|Laboratory adverse experience|2|||
37934774|NCT00717860|69621587|FG001|Overall Study|Laboratory adverse experience|2|||
37934775|NCT00717860|69621586|FG000|Overall Study|Lack of Efficacy|7|||
37934776|NCT00717860|69621587|FG001|Overall Study|Lack of Efficacy|13|||
37934777|NCT00717860|69621586|FG000|Overall Study|Discontinued for other reason|6|||
37934778|NCT00717860|69621587|FG001|Overall Study|Discontinued for other reason|1|||
37934779|NCT00717860|69621586|FG000|Overall Study|Withdrew consent|7|||
37934780|NCT00717860|69621587|FG001|Overall Study|Withdrew consent|3|||
37934781|NCT00717314|69621595|FG000|Overall Study|Adverse Event|3|||
37934782|NCT00717314|69621596|FG001|Overall Study|Adverse Event|2|||
37934783|NCT00717314|69621595|FG000|Overall Study|Protocol Violation|1|||
37934784|NCT00717314|69621596|FG001|Overall Study|Protocol Violation|0|||
37934785|NCT00717314|69621595|FG000|Overall Study|Lost to Follow-up|1|||
37934786|NCT00717314|69621596|FG001|Overall Study|Lost to Follow-up|5|||
37934787|NCT00717314|69621595|FG000|Overall Study|Withdrawal by Subject|1|||
37934788|NCT00717314|69621596|FG001|Overall Study|Withdrawal by Subject|3|||
37934789|NCT00689793|69621604|FG000|Overall Study|Lost to Follow-up|4|||
37934790|NCT00689793|69621605|FG001|Overall Study|Lost to Follow-up|5|||
37934791|NCT00723944|69621615|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
37934792|NCT00723944|69621616|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
37934793|NCT00723944|69621615|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
37934794|NCT00723944|69621616|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
37934795|NCT00723944|69621615|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
37934796|NCT00723944|69621616|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
37934797|NCT00689481|69621624|FG000|Overall Study|Adverse Event|7|||
37934798|NCT00689481|69621625|FG001|Overall Study|Adverse Event|1|||
37934799|NCT00689481|69621624|FG000|Overall Study|Lost to Follow-up|4|||
37934800|NCT00689481|69621625|FG001|Overall Study|Lost to Follow-up|3|||
37934801|NCT00689481|69621624|FG000|Overall Study|Lack of Efficacy|4|||
37934802|NCT00689481|69621625|FG001|Overall Study|Lack of Efficacy|3|||
37934803|NCT00689481|69621624|FG000|Overall Study|Non-compliance with study treatment|1|||
37934804|NCT00689481|69621625|FG001|Overall Study|Non-compliance with study treatment|1|||
37934805|NCT00689481|69621624|FG000|Overall Study|Withdrawal by Subject|8|||
37934806|NCT00689481|69621625|FG001|Overall Study|Withdrawal by Subject|4|||
37934807|NCT00689481|69621624|FG000|Overall Study|Excluded medication started during study|0|||
37934808|NCT00689481|69621625|FG001|Overall Study|Excluded medication started during study|1|||
37934809|NCT00689481|69621624|FG000|Overall Study|Subject early term, left on vacation|0|||
37934810|NCT00689481|69621625|FG001|Overall Study|Subject early term, left on vacation|1|||
37934811|NCT00688701|69621634|FG000|Overall Study|Adverse Event|1|||
37934812|NCT00688701|69621635|FG001|Overall Study|Adverse Event|0|||
37934813|NCT00688701|69621636|FG002|Overall Study|Adverse Event|5|||
37934814|NCT00688701|69621637|FG003|Overall Study|Adverse Event|3|||
37934815|NCT00688701|69621634|FG000|Overall Study|Lack of Efficacy|0|||
37934816|NCT00688701|69621635|FG001|Overall Study|Lack of Efficacy|1|||
37934817|NCT00688701|69621636|FG002|Overall Study|Lack of Efficacy|0|||
37934818|NCT00688701|69621637|FG003|Overall Study|Lack of Efficacy|0|||
37934819|NCT00688701|69621634|FG000|Overall Study|Withdrawal by Subject|3|||
37934820|NCT00688701|69621635|FG001|Overall Study|Withdrawal by Subject|3|||
37934821|NCT00688701|69621636|FG002|Overall Study|Withdrawal by Subject|4|||
37934822|NCT00688701|69621637|FG003|Overall Study|Withdrawal by Subject|8|||
37934823|NCT00688701|69621634|FG000|Overall Study|Poor compliance to protocol|0|||
37934824|NCT00688701|69621635|FG001|Overall Study|Poor compliance to protocol|1|||
37934825|NCT00688701|69621636|FG002|Overall Study|Poor compliance to protocol|1|||
37934826|NCT00688701|69621637|FG003|Overall Study|Poor compliance to protocol|0|||
37934827|NCT00688623|69621657|FG000|Overall Study|Adverse Event|22|||
37934828|NCT00688623|69621657|FG000|Overall Study|abnormal lab value|1|||
37934829|NCT00688623|69621657|FG000|Overall Study|Withdrawal by Subject|4|||
37934830|NCT00688623|69621657|FG000|Overall Study|Death|3|||
37934831|NCT00688623|69621657|FG000|Overall Study|disease progression|23|||
37934832|NCT00688623|69621657|FG000|Overall Study|Protocol Violation|2|||
37934833|NCT00717236|69621663|FG000|Double-Blind Period|Adverse Event|33|||
37934834|NCT00717236|69621664|FG001|Double-Blind Period|Adverse Event|6|||
37934835|NCT00717236|69621663|FG000|Double-Blind Period|Lack of Efficacy|6|||
37934836|NCT00717236|69621664|FG001|Double-Blind Period|Lack of Efficacy|6|||
37934837|NCT00717236|69621663|FG000|Double-Blind Period|Lost to Follow-up|3|||
37934838|NCT00717236|69621664|FG001|Double-Blind Period|Lost to Follow-up|5|||
37934839|NCT00717236|69621663|FG000|Double-Blind Period|Withdrawal by Subject|10|||
37934840|NCT00717236|69621664|FG001|Double-Blind Period|Withdrawal by Subject|2|||
37934841|NCT00717236|69621663|FG000|Double-Blind Period|Loss of efficacy|3|||
37934842|NCT00717236|69621664|FG001|Double-Blind Period|Loss of efficacy|0|||
37934843|NCT00717236|69621663|FG000|Double-Blind Period|Other: Death|1|||
37934844|NCT00717236|69621664|FG001|Double-Blind Period|Other: Death|0|||
37934845|NCT00717236|69621663|FG000|Double-Blind Period|Other: Pregnancy|1|||
37934846|NCT00717236|69621664|FG001|Double-Blind Period|Other: Pregnancy|0|||
37934847|NCT00717236|69621663|FG000|Double-Blind Period|Other: Protocol Violation|2|||
37934848|NCT00717236|69621664|FG001|Double-Blind Period|Other: Protocol Violation|0|||
37934849|NCT00717236|69621663|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
37934850|NCT00717236|69621664|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
37934851|NCT00717236|69621663|FG000|Double-Blind Period|Other: Site withdrew|2|||
37934852|NCT00717236|69621664|FG001|Double-Blind Period|Other: Site withdrew|0|||
37934853|NCT00717236|69621663|FG000|Double-Blind Period|Other: Screening failure|1|||
37934854|NCT00717236|69621664|FG001|Double-Blind Period|Other: Screening failure|0|||
37934855|NCT00717236|69621663|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
37934856|NCT00717236|69621664|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
37934857|NCT00717236|69621663|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
37934858|NCT00717236|69621664|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
37934859|NCT00717236|69621663|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
37934860|NCT00717236|69621664|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
37934861|NCT00717236|69621663|FG000|Double-Blind Period|Other: History of cancer|1|||
37934862|NCT00717236|69621664|FG001|Double-Blind Period|Other: History of cancer|0|||
37934863|NCT00717236|69621663|FG000|Double-Blind Period|Other: Sponsor request|1|||
37934864|NCT00717236|69621664|FG001|Double-Blind Period|Other: Sponsor request|0|||
37934865|NCT00717236|69621663|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
37934866|NCT00717236|69621664|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
37934867|NCT00717236|69621663|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
37934868|NCT00717236|69621664|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
37934869|NCT00717236|69621663|FG000|Double-Blind Period|Other: Subject moved|1|||
37934870|NCT00717236|69621664|FG001|Double-Blind Period|Other: Subject moved|1|||
37934871|NCT00717236|69621663|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
37934872|NCT00717236|69621664|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
37934873|NCT00717236|69621663|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
37934874|NCT00717236|69621664|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
37934875|NCT00717236|69621663|FG000|Double-Blind Period|Other: Transportation problems|0|||
37934876|NCT00717236|69621664|FG001|Double-Blind Period|Other: Transportation problems|1|||
37934877|NCT00717236|69621663|FG000|Double-Blind Period|Other: Investigator Decision|0|||
37934878|NCT00717236|69621664|FG001|Double-Blind Period|Other: Investigator Decision|1|||
37934879|NCT00717236|69621663|FG000|Open-Label Period|Adverse Event|29|||
37934880|NCT00717236|69621664|FG001|Open-Label Period|Adverse Event|4|||
37934881|NCT00717236|69621663|FG000|Open-Label Period|Lack of Efficacy|30|||
37934882|NCT00717236|69621664|FG001|Open-Label Period|Lack of Efficacy|8|||
37934883|NCT00717236|69621663|FG000|Open-Label Period|Lost to Follow-up|28|||
37934884|NCT00717236|69621664|FG001|Open-Label Period|Lost to Follow-up|4|||
37934885|NCT00717236|69621663|FG000|Open-Label Period|Withdrawal by Subject|20|||
37934886|NCT00717236|69621664|FG001|Open-Label Period|Withdrawal by Subject|2|||
38035050|NCT03242252|69721905|FG002|Overall Study|Lost to Follow-up|4|||
38035051|NCT04109391|69721922|FG000|Overall Study|Adverse Event|2|||
38035052|NCT04109391|69721923|FG001|Overall Study|Adverse Event|2|||
38035053|NCT04109391|69721924|FG002|Overall Study|Adverse Event|0|||
38035054|NCT04109391|69721922|FG000|Overall Study|Withdrawal by Subject|2|||
38035055|NCT04109391|69721923|FG001|Overall Study|Withdrawal by Subject|0|||
38035056|NCT04109391|69721924|FG002|Overall Study|Withdrawal by Subject|0|||
38035057|NCT04109391|69721922|FG000|Overall Study|Pregnancy|1|||
38035058|NCT04109391|69721923|FG001|Overall Study|Pregnancy|0|||
38035059|NCT04109391|69721924|FG002|Overall Study|Pregnancy|0|||
38035060|NCT04109391|69721922|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
38035061|NCT04109391|69721923|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
38035062|NCT04109391|69721924|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
38035063|NCT04109391|69721922|FG000|Overall Study|Lost to Follow-up|0|||
38035064|NCT04109391|69721923|FG001|Overall Study|Lost to Follow-up|0|||
38035065|NCT04109391|69721924|FG002|Overall Study|Lost to Follow-up|1|||
38035066|NCT04109391|69721922|FG000|Overall Study|Lack of Efficacy|2|||
38035067|NCT04109391|69721923|FG001|Overall Study|Lack of Efficacy|2|||
38035068|NCT04109391|69721924|FG002|Overall Study|Lack of Efficacy|3|||
38035069|NCT04106817|69721935|FG000|Overall Study|Lost to Follow-up|1|||
38035070|NCT04106817|69721936|FG001|Overall Study|Lost to Follow-up|0|||
38035071|NCT04106817|69721937|FG002|Overall Study|Lost to Follow-up|0|||
38035072|NCT04097925|69721945|FG000|Overall Study|Withdrawal by Subject|1|||
38035073|NCT04195893|69721949|FG000|Second Intervention|Withdrawal by Subject|1|||
38035074|NCT04195893|69721950|FG001|Second Intervention|Withdrawal by Subject|0|||
38035075|NCT04195581|69721956|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
38035076|NCT04195581|69721956|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
38035077|NCT04195581|69721956|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
38035078|NCT04195581|69721956|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
38035079|NCT04195581|69721956|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
38035080|NCT04195581|69721956|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
38035081|NCT04096365|69721974|FG000|Overall Study|Adverse Event|1|||
38035082|NCT04194489|69721978|FG000|Overall Study|Withdrawal by Subject|5|||
38035083|NCT04194489|69721978|FG000|Overall Study|Lost to Follow-up|48|||
38035084|NCT04094883|69721982|FG000|Overall Study|Withdrawal by Subject|1|||
38035085|NCT01368562|69721986|FG000|Overall Study|Adverse Event|1|||
38035086|NCT01368562|69721986|FG000|Overall Study|Disease progression|1|||
38035087|NCT01368562|69721986|FG000|Overall Study|Lost to Follow-up|1|||
38035088|NCT01368562|69721986|FG000|Overall Study|Death|6|||
38035089|NCT01368562|69721986|FG000|Overall Study|Unresponsive to treatment|5|||
38035090|NCT01368562|69721986|FG000|Overall Study|Other|3|||
38035091|NCT01368562|69721986|FG000|Overall Study|Other than specified|2|||
38035092|NCT03242018|69721993|FG000|Overall Study|Adverse Event|7|||
38035093|NCT03242018|69721994|FG001|Overall Study|Adverse Event|7|||
38035094|NCT03242018|69721995|FG002|Overall Study|Adverse Event|6|||
38035095|NCT03242018|69721993|FG000|Overall Study|Lost to Follow-up|2|||
38035096|NCT03242018|69721994|FG001|Overall Study|Lost to Follow-up|2|||
38035097|NCT03242018|69721995|FG002|Overall Study|Lost to Follow-up|2|||
37934887|NCT00717236|69621663|FG000|Open-Label Period|Loss of Efficacy|6|||
38035098|NCT03242018|69721993|FG000|Overall Study|At the Participant's Own Request|5|||
38035099|NCT03242018|69721994|FG001|Overall Study|At the Participant's Own Request|1|||
38035100|NCT03242018|69721995|FG002|Overall Study|At the Participant's Own Request|4|||
38035101|NCT03242018|69721993|FG000|Overall Study|Reason Not Specified|3|||
38035102|NCT03242018|69721994|FG001|Overall Study|Reason Not Specified|4|||
38035103|NCT03242018|69721995|FG002|Overall Study|Reason Not Specified|1|||
38035104|NCT03242018|69721993|FG000|Overall Study|Study Terminated by Sponsor|1|||
38035105|NCT03242018|69721994|FG001|Overall Study|Study Terminated by Sponsor|0|||
38035106|NCT03242018|69721995|FG002|Overall Study|Study Terminated by Sponsor|1|||
38035107|NCT02789176|69722008|FG000|Overall Study|Death|0|||
38035108|NCT02789176|69722009|FG001|Overall Study|Death|0|||
38035109|NCT02789176|69722010|FG002|Overall Study|Death|3|||
38035110|NCT02789176|69722011|FG003|Overall Study|Death|0|||
38035111|NCT02789176|69722008|FG000|Overall Study|Withdrawal by Subject|0|||
37670316|NCT02055820|69143558|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
37934888|NCT00717236|69621664|FG001|Open-Label Period|Loss of Efficacy|1|||
37934889|NCT00717236|69621663|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
38035112|NCT02789176|69722009|FG001|Overall Study|Withdrawal by Subject|0|||
38035113|NCT02789176|69722010|FG002|Overall Study|Withdrawal by Subject|1|||
38035114|NCT02789176|69722011|FG003|Overall Study|Withdrawal by Subject|0|||
37934890|NCT00717236|69621664|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
37934891|NCT00717236|69621663|FG000|Open-Label Period|Other: Lack of Compliance|1|||
37934892|NCT00717236|69621664|FG001|Open-Label Period|Other: Lack of Compliance|1|||
37934893|NCT00717236|69621663|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
37934894|NCT00717236|69621664|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
37934895|NCT00717236|69621663|FG000|Open-Label Period|Other: Moved|1|||
37934896|NCT00717236|69621664|FG001|Open-Label Period|Other: Moved|0|||
37934897|NCT00717236|69621663|FG000|Open-Label Period|Other: Investigator Decision|1|||
37934898|NCT00717236|69621664|FG001|Open-Label Period|Other: Investigator Decision|0|||
37934899|NCT00717236|69621663|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
37934900|NCT00717236|69621664|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
37934901|NCT00717236|69621663|FG000|Open-Label Period|Other: Sponsor Request|3|||
37934902|NCT00717236|69621664|FG001|Open-Label Period|Other: Sponsor Request|0|||
37934903|NCT00717236|69621663|FG000|Open-Label Period|Other: Cataract Surgery|1|||
37934904|NCT00717236|69621664|FG001|Open-Label Period|Other: Cataract Surgery|0|||
37934905|NCT00717236|69621663|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
37934906|NCT00717236|69621664|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
37934907|NCT00717236|69621663|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
37934908|NCT00717236|69621664|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
37934909|NCT00717236|69621663|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
37934910|NCT00717236|69621664|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
37934911|NCT00719810|69621675|FG000|Overall Study|Adverse Event|0|||
37934912|NCT00719810|69621676|FG001|Overall Study|Adverse Event|2|||
37934913|NCT00719810|69621677|FG002|Overall Study|Adverse Event|3|||
37934914|NCT00719810|69621675|FG000|Overall Study|Lost to Follow-up|2|||
37934915|NCT00719810|69621676|FG001|Overall Study|Lost to Follow-up|0|||
37934916|NCT00719810|69621677|FG002|Overall Study|Lost to Follow-up|3|||
37934917|NCT00719810|69621675|FG000|Overall Study|Physician Decision|0|||
37934918|NCT00719810|69621676|FG001|Overall Study|Physician Decision|1|||
37934919|NCT00719810|69621677|FG002|Overall Study|Physician Decision|0|||
37934920|NCT00719810|69621675|FG000|Overall Study|Withdrawal by Subject|1|||
37934921|NCT00719810|69621676|FG001|Overall Study|Withdrawal by Subject|1|||
37934922|NCT00719810|69621677|FG002|Overall Study|Withdrawal by Subject|2|||
37934923|NCT00719732|69621685|FG000|Overall Study|Lost to Follow-up|20|||
37934924|NCT00719732|69621685|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
37934925|NCT00719732|69621685|FG000|Overall Study|Illness not associated with device|1|||
37934926|NCT00723710|69621689|FG000|Overall Study|Disease progression|48|||
37934927|NCT00723710|69621689|FG000|Overall Study|Adverse Event|88|||
37934928|NCT00723710|69621689|FG000|Overall Study|Withdrawal by Subject|36|||
37934929|NCT00723710|69621689|FG000|Overall Study|Physician Decision|2|||
37934930|NCT00688545|69621695|FG000|Overall Study|Lost to Follow-up|1|||
37934931|NCT00688545|69621696|FG001|Overall Study|Lost to Follow-up|4|||
37934932|NCT00688545|69621695|FG000|Overall Study|Insurance/cost of drug|0|||
38035115|NCT02789176|69722008|FG000|Overall Study|Lost to Follow-up|8|||
38035116|NCT02789176|69722009|FG001|Overall Study|Lost to Follow-up|2|||
38035117|NCT02789176|69722010|FG002|Overall Study|Lost to Follow-up|6|||
38035118|NCT02789176|69722011|FG003|Overall Study|Lost to Follow-up|1|||
38035119|NCT03259490|69722023|FG000|Period 1|Withdrawal by Subject|0|||
37934933|NCT00688545|69621696|FG001|Overall Study|Insurance/cost of drug|1|||
37934934|NCT00688545|69621695|FG000|Overall Study|Withdrawal by Subject|2|||
37934935|NCT00688545|69621696|FG001|Overall Study|Withdrawal by Subject|3|||
37934936|NCT00688545|69621695|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
37934937|NCT00688545|69621696|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
37934938|NCT00688467|69621706|FG000|Treatment Period 1|Adverse Event|2|||
37934939|NCT00688467|69621707|FG001|Treatment Period 1|Adverse Event|1|||
37934940|NCT00688467|69621706|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
37934941|NCT00688467|69621707|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
37934942|NCT00688467|69621706|FG000|Treatment Period 2|Protocol Violation|0|||
37934943|NCT00688467|69621707|FG001|Treatment Period 2|Protocol Violation|1|||
37934944|NCT00688467|69621706|FG000|Treatment Period 2|Adverse Event|0|||
37934945|NCT00688467|69621707|FG001|Treatment Period 2|Adverse Event|1|||
37934946|NCT00688155|69621717|FG000|Overall Study|Withdrawal by Subject|2|||
37934947|NCT00688155|69621718|FG001|Overall Study|Withdrawal by Subject|2|||
37934948|NCT00688155|69621719|FG002|Overall Study|Withdrawal by Subject|1|||
37934949|NCT00688155|69621720|FG003|Overall Study|Withdrawal by Subject|1|||
37934950|NCT00690573|69621730|FG000|Overall Study|Lack of Efficacy|8|||
38035120|NCT03259490|69722024|FG001|Period 1|Withdrawal by Subject|1|||
38035121|NCT03259490|69722023|FG000|Period 2|Protocol Violation|1|||
37934951|NCT00690573|69621730|FG000|Overall Study|Withdrawal by Subject|1|||
37934952|NCT00719264|69621736|FG000|Overall Study|Adverse Event|41|||
37934953|NCT00719264|69621737|FG001|Overall Study|Adverse Event|49|||
37934954|NCT00719264|69621736|FG000|Overall Study|Death|13|||
37934955|NCT00719264|69621737|FG001|Overall Study|Death|10|||
37934956|NCT00719264|69621736|FG000|Overall Study|Administrative Problems|6|||
38035122|NCT03259490|69722024|FG001|Period 2|Protocol Violation|0|||
37934957|NCT00719264|69621737|FG001|Overall Study|Administrative Problems|4|||
37934958|NCT00719264|69621736|FG000|Overall Study|Lost to Follow-up|1|||
37934959|NCT00719264|69621737|FG001|Overall Study|Lost to Follow-up|1|||
37934960|NCT00719264|69621736|FG000|Overall Study|Withdrawal by Subject|12|||
37934961|NCT00719264|69621737|FG001|Overall Study|Withdrawal by Subject|7|||
37934962|NCT00719264|69621736|FG000|Overall Study|Protocol Deviation|1|||
37934963|NCT00719264|69621737|FG001|Overall Study|Protocol Deviation|3|||
37934964|NCT00719264|69621736|FG000|Overall Study|New Cancer Therapy|4|||
37934965|NCT00719264|69621737|FG001|Overall Study|New Cancer Therapy|2|||
37934966|NCT00719264|69621736|FG000|Overall Study|Disease Progression|104|||
37934967|NCT00719264|69621737|FG001|Overall Study|Disease Progression|107|||
37934968|NCT00687609|69621743|FG000|Overall Study|Physician Decision|1|||
37934969|NCT00687609|69621743|FG000|Overall Study|Withdrawal by Subject|2|||
37934970|NCT00723554|69621747|FG000|Overall Study|Adverse Event|12|||
37934971|NCT00723554|69621747|FG000|Overall Study|Investigator's judgement|5|||
37934972|NCT00723554|69621747|FG000|Overall Study|Inhaled medication other than iloprost|4|||
37934973|NCT00723554|69621747|FG000|Overall Study|Withdrawal of consent|3|||
37934974|NCT00723554|69621747|FG000|Overall Study|Other|3|||
37934975|NCT00723554|69621747|FG000|Overall Study|Lost to Follow-up|1|||
37934976|NCT00723554|69621747|FG000|Overall Study|Non-compliance|1|||
37934977|NCT00687219|69621753|FG000|Overall Study|Adverse Event|8|||
37934978|NCT00687219|69621753|FG000|Overall Study|Discontinuance criteria met|7|||
37934979|NCT00687219|69621753|FG000|Overall Study|HCV-RNA positive conversion|34|||
37934980|NCT00687219|69621753|FG000|Overall Study|Withdrawal by Subject|1|||
37934981|NCT00687219|69621753|FG000|Overall Study|Lack of Efficacy|1|||
37934982|NCT00723398|69621762|FG000|Overall Study|Withdrawal by Subject|2|||
37934983|NCT00723398|69621763|FG001|Overall Study|Withdrawal by Subject|6|||
37934984|NCT00723398|69621764|FG002|Overall Study|Withdrawal by Subject|4|||
37934985|NCT00723398|69621765|FG003|Overall Study|Withdrawal by Subject|4|||
37934986|NCT00723398|69621766|FG004|Overall Study|Withdrawal by Subject|4|||
37934987|NCT00723398|69621762|FG000|Overall Study|Protocol Violation|2|||
37934988|NCT00723398|69621763|FG001|Overall Study|Protocol Violation|1|||
37934989|NCT00723398|69621764|FG002|Overall Study|Protocol Violation|5|||
37934990|NCT00723398|69621765|FG003|Overall Study|Protocol Violation|0|||
37934991|NCT00723398|69621766|FG004|Overall Study|Protocol Violation|0|||
37934992|NCT00723398|69621762|FG000|Overall Study|Physician Decision|2|||
37934993|NCT00723398|69621763|FG001|Overall Study|Physician Decision|2|||
37934994|NCT00723398|69621764|FG002|Overall Study|Physician Decision|5|||
37934995|NCT00723398|69621765|FG003|Overall Study|Physician Decision|0|||
37934996|NCT00723398|69621766|FG004|Overall Study|Physician Decision|1|||
37934997|NCT00723398|69621762|FG000|Overall Study|Adverse Event|0|||
37934998|NCT00723398|69621763|FG001|Overall Study|Adverse Event|5|||
37934999|NCT00723398|69621764|FG002|Overall Study|Adverse Event|3|||
37765078|NCT01574651|69278202|FG001|Overall Study|Withdrawal by Subject|10|||
37765079|NCT01440803|69278214|FG000|Overall Study|Met study stopping rule|2|||
37765080|NCT01440803|69278215|FG001|Overall Study|Met study stopping rule|1|||
37765081|NCT01440803|69278214|FG000|Overall Study|Lost to Follow-up|0|||
37765082|NCT01440803|69278215|FG001|Overall Study|Lost to Follow-up|2|||
37765083|NCT01440803|69278214|FG000|Overall Study|Withdrawal by Subject|0|||
37765084|NCT01440803|69278215|FG001|Overall Study|Withdrawal by Subject|1|||
37765085|NCT01517282|69278226|FG000|Overall Study|Consent withdrawn|0|||
37765086|NCT01517282|69278227|FG001|Overall Study|Consent withdrawn|1|||
37765087|NCT01517282|69278228|FG002|Overall Study|Consent withdrawn|1|||
37935000|NCT00723398|69621765|FG003|Overall Study|Adverse Event|1|||
37935001|NCT00723398|69621766|FG004|Overall Study|Adverse Event|4|||
37935002|NCT00723398|69621762|FG000|Overall Study|Lost to Follow-up|0|||
37935003|NCT00723398|69621763|FG001|Overall Study|Lost to Follow-up|1|||
37935004|NCT00723398|69621764|FG002|Overall Study|Lost to Follow-up|0|||
37935005|NCT00723398|69621765|FG003|Overall Study|Lost to Follow-up|0|||
37935006|NCT00723398|69621766|FG004|Overall Study|Lost to Follow-up|0|||
37935007|NCT00716456|69621781|FG000|Overall Study|Adverse Event|0|||
37935008|NCT00716456|69621782|FG001|Overall Study|Adverse Event|2|||
37935009|NCT00716456|69621783|FG002|Overall Study|Adverse Event|0|||
37935010|NCT00684645|69621791|FG000|Overall Study|Death|2|||
38035123|NCT03259334|69722033|FG000|Overall Study|Adverse Event|3|||
38035124|NCT03259334|69722034|FG001|Overall Study|Adverse Event|8|||
37765088|NCT01517282|69278229|FG003|Overall Study|Consent withdrawn|1|||
37765089|NCT01517282|69278226|FG000|Overall Study|Physician Decision|1|||
37765090|NCT01517282|69278227|FG001|Overall Study|Physician Decision|0|||
37765091|NCT01517282|69278228|FG002|Overall Study|Physician Decision|0|||
37935011|NCT00684645|69621791|FG000|Overall Study|Progressive disease|67|||
37935012|NCT00684645|69621791|FG000|Overall Study|Adverse Event|27|||
37935013|NCT00684645|69621791|FG000|Overall Study|Lost to Follow-up|3|||
37935014|NCT00684645|69621791|FG000|Overall Study|Other|15|||
37935015|NCT00716144|69621799|FG000|Overall Study|Withdrawal by Subject|4|||
37935016|NCT00716144|69621800|FG001|Overall Study|Withdrawal by Subject|2|||
37935017|NCT00716144|69621801|FG002|Overall Study|Withdrawal by Subject|6|||
37935018|NCT00716144|69621802|FG003|Overall Study|Withdrawal by Subject|6|||
37935019|NCT00716144|69621799|FG000|Overall Study|Lost to Follow-up|2|||
37935020|NCT00716144|69621800|FG001|Overall Study|Lost to Follow-up|2|||
37935021|NCT00716144|69621801|FG002|Overall Study|Lost to Follow-up|1|||
37935022|NCT00716144|69621802|FG003|Overall Study|Lost to Follow-up|2|||
37935023|NCT00716144|69621799|FG000|Overall Study|Adverse Event|0|||
37935024|NCT00716144|69621800|FG001|Overall Study|Adverse Event|0|||
37935025|NCT00716144|69621801|FG002|Overall Study|Adverse Event|0|||
37935026|NCT00716144|69621802|FG003|Overall Study|Adverse Event|2|||
37935027|NCT00716144|69621799|FG000|Overall Study|Non-compliance|1|||
37935028|NCT00716144|69621800|FG001|Overall Study|Non-compliance|0|||
37935029|NCT00716144|69621801|FG002|Overall Study|Non-compliance|0|||
37935030|NCT00716144|69621802|FG003|Overall Study|Non-compliance|0|||
37935031|NCT00716144|69621799|FG000|Overall Study|Protocol Violation|2|||
37935032|NCT00716144|69621800|FG001|Overall Study|Protocol Violation|0|||
37935033|NCT00716144|69621801|FG002|Overall Study|Protocol Violation|1|||
37935034|NCT00716144|69621802|FG003|Overall Study|Protocol Violation|0|||
37935035|NCT00716144|69621799|FG000|Overall Study|Physician Decision|0|||
37935036|NCT00716144|69621800|FG001|Overall Study|Physician Decision|1|||
37935037|NCT00716144|69621801|FG002|Overall Study|Physician Decision|2|||
37935038|NCT00716144|69621802|FG003|Overall Study|Physician Decision|2|||
37935039|NCT00716144|69621799|FG000|Overall Study|Intercurrent illness|0|||
37935040|NCT00716144|69621800|FG001|Overall Study|Intercurrent illness|0|||
37935041|NCT00716144|69621801|FG002|Overall Study|Intercurrent illness|1|||
37935042|NCT00716144|69621802|FG003|Overall Study|Intercurrent illness|0|||
37935043|NCT00716144|69621799|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
37935044|NCT00716144|69621800|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
37935045|NCT00716144|69621801|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
37935046|NCT00716144|69621802|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
37935047|NCT00716144|69621799|FG000|Overall Study|Adverse event: left foot pain|0|||
37935048|NCT00716144|69621800|FG001|Overall Study|Adverse event: left foot pain|1|||
37935049|NCT00716144|69621801|FG002|Overall Study|Adverse event: left foot pain|0|||
37935050|NCT00716144|69621802|FG003|Overall Study|Adverse event: left foot pain|0|||
37935051|NCT00716144|69621799|FG000|Overall Study|Clinical Depression|0|||
37935052|NCT00716144|69621800|FG001|Overall Study|Clinical Depression|1|||
37935053|NCT00716144|69621801|FG002|Overall Study|Clinical Depression|0|||
37935054|NCT00716144|69621802|FG003|Overall Study|Clinical Depression|0|||
37935055|NCT00576381|69621812|FG000|Overall Study|Reoperation|3|||
37935056|NCT00576381|69621812|FG000|Overall Study|Adverse Event|4|||
37935057|NCT00684567|69621816|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
37935058|NCT00684567|69621816|FG000|Monotherapy Period|Adverse Event|2|||
37935059|NCT00684567|69621816|FG000|Monotherapy Period|Death|1|||
37935060|NCT00684567|69621816|FG000|Monotherapy Period|Progression of primary disease|11|||
37935061|NCT00684411|69621820|FG000|Overall Study|New Primary Cancer|1|||
37935062|NCT00684411|69621820|FG000|Overall Study|Disease Progression|10|||
37935063|NCT00684411|69621820|FG000|Overall Study|Adverse Event|1|||
37935064|NCT00686829|69621824|FG000|Overall Study|Adverse Event|5|||
37935065|NCT00686829|69621824|FG000|Overall Study|Lack of Efficacy|6|||
37935066|NCT00686829|69621824|FG000|Overall Study|Lost to Follow-up|4|||
37935067|NCT00686829|69621824|FG000|Overall Study|Withdrawal by Subject|14|||
37935068|NCT00686829|69621824|FG000|Overall Study|Protocol Violation|3|||
37935069|NCT00686829|69621824|FG000|Overall Study|Sponsor discontinued VCV|47|||
37935070|NCT00687297|69621830|FG000|Randomization|Withdrawal by Subject|2|||
37935071|NCT00687297|69621831|FG001|Randomization|Withdrawal by Subject|0|||
37935072|NCT00687297|69621830|FG000|Randomization|Withdrew before treatment, ineligible|1|||
37935073|NCT00687297|69621831|FG001|Randomization|Withdrew before treatment, ineligible|1|||
37935074|NCT00687297|69621830|FG000|Induction|Withdrawal by Subject|4|||
37935075|NCT00687297|69621831|FG001|Induction|Withdrawal by Subject|4|||
37935076|NCT00687297|69621830|FG000|Induction|Adverse Event|16|||
37935077|NCT00687297|69621831|FG001|Induction|Adverse Event|15|||
37935078|NCT00687297|69621830|FG000|Induction|Death|7|||
37935079|NCT00687297|69621831|FG001|Induction|Death|11|||
37935080|NCT00687297|69621830|FG000|Induction|Lack of Efficacy|17|||
37935081|NCT00687297|69621831|FG001|Induction|Lack of Efficacy|21|||
37935082|NCT00687297|69621830|FG000|Induction|Ineligible|0|||
37935083|NCT00687297|69621831|FG001|Induction|Ineligible|1|||
37935084|NCT00687297|69621830|FG000|Induction|Patient Noncompliance|1|||
37935085|NCT00687297|69621831|FG001|Induction|Patient Noncompliance|0|||
37935086|NCT00687297|69621830|FG000|Induction|Physician Decision|0|||
37935087|NCT00687297|69621831|FG001|Induction|Physician Decision|2|||
37935088|NCT00687297|69621830|FG000|Induction|Other|0|||
37935089|NCT00687297|69621831|FG001|Induction|Other|1|||
37935090|NCT00684177|69621841|FG000|Overall Study|Adverse Event|4|||
37935091|NCT00684177|69621842|FG001|Overall Study|Adverse Event|3|||
37935092|NCT00684177|69621841|FG000|Overall Study|Lack of Efficacy|10|||
37935093|NCT00684177|69621842|FG001|Overall Study|Lack of Efficacy|15|||
37935094|NCT00684177|69621841|FG000|Overall Study|Protocol Violation|1|||
37935095|NCT00684177|69621842|FG001|Overall Study|Protocol Violation|0|||
37935096|NCT00684177|69621841|FG000|Overall Study|Lost to Follow-up|2|||
37935097|NCT00684177|69621842|FG001|Overall Study|Lost to Follow-up|1|||
37935098|NCT00684177|69621841|FG000|Overall Study|Physician Decision|2|||
37935099|NCT00684177|69621842|FG001|Overall Study|Physician Decision|0|||
37935100|NCT00684177|69621841|FG000|Overall Study|Withdrawal by Subject|1|||
37935101|NCT00684177|69621842|FG001|Overall Study|Withdrawal by Subject|2|||
37935102|NCT00684177|69621841|FG000|Overall Study|Other|1|||
37935103|NCT00684177|69621842|FG001|Overall Study|Other|2|||
37935104|NCT00684021|69621852|FG000|Overall Study|MRI Contraindicated|1|||
37935105|NCT00684021|69621853|FG001|Overall Study|MRI Contraindicated|1|||
37935106|NCT00684021|69621854|FG002|Overall Study|MRI Contraindicated|1|||
37935107|NCT00684021|69621855|FG003|Overall Study|MRI Contraindicated|0|||
37935108|NCT00684021|69621852|FG000|Overall Study|MRI not performed|0|||
37935109|NCT00684021|69621853|FG001|Overall Study|MRI not performed|1|||
37935110|NCT00684021|69621854|FG002|Overall Study|MRI not performed|1|||
37935111|NCT00684021|69621855|FG003|Overall Study|MRI not performed|2|||
37935112|NCT00684021|69621852|FG000|Overall Study|Death|1|||
37935113|NCT00684021|69621853|FG001|Overall Study|Death|0|||
37935114|NCT00684021|69621854|FG002|Overall Study|Death|0|||
37935115|NCT00684021|69621855|FG003|Overall Study|Death|0|||
37935116|NCT00576303|69621865|FG000|Dose Titration Period|Early withdrawal|17|||
37935117|NCT00576303|69621865|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
37935118|NCT00576303|69621865|FG000|Long Term Safety Period|Early withdrawal|16|||
37935119|NCT00686517|69621872|FG000|Treatment|Serious Adverse Event|1|||
37935120|NCT00686517|69621873|FG001|Treatment|Serious Adverse Event|2|||
37935121|NCT00686517|69621874|FG002|Treatment|Serious Adverse Event|1|||
37935122|NCT00686517|69621872|FG000|Treatment|Adverse Event|2|||
37935123|NCT00686517|69621873|FG001|Treatment|Adverse Event|0|||
37935124|NCT00686517|69621874|FG002|Treatment|Adverse Event|0|||
37935125|NCT00686517|69621872|FG000|Treatment|Poor Protocol Compliance|1|||
37935126|NCT00686517|69621873|FG001|Treatment|Poor Protocol Compliance|0|||
37935127|NCT00686517|69621874|FG002|Treatment|Poor Protocol Compliance|0|||
37935128|NCT00686517|69621872|FG000|Treatment|Protocol Violation|2|||
37935129|NCT00686517|69621873|FG001|Treatment|Protocol Violation|1|||
37935130|NCT00686517|69621874|FG002|Treatment|Protocol Violation|0|||
37935131|NCT00686205|69621884|FG000|Overall Study|Protocol Violation|127|||
37935132|NCT00686205|69621885|FG001|Overall Study|Protocol Violation|0|||
37935133|NCT00686205|69621884|FG000|Overall Study|Withdrawal by Subject|2|||
37935134|NCT00686205|69621885|FG001|Overall Study|Withdrawal by Subject|0|||
37935135|NCT00686205|69621884|FG000|Overall Study|Specimen handling procedure altered|5878|||
37935136|NCT00686205|69621885|FG001|Overall Study|Specimen handling procedure altered|0|||
37935137|NCT00686205|69621884|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
37935138|NCT00686205|69621885|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
37935139|NCT00571701|69621893|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
37935140|NCT00571701|69621894|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
37935141|NCT00571701|69621893|FG000|First Intervention 12 Months|Death|1|||
37935142|NCT00571701|69621894|FG001|First Intervention 12 Months|Death|0|||
37935143|NCT00571701|69621893|FG000|Second Intervention 12 Months|Adverse Event|0|||
37935144|NCT00571701|69621894|FG001|Second Intervention 12 Months|Adverse Event|1|||
37935145|NCT00571701|69621893|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
37935146|NCT00571701|69621894|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
37935147|NCT00686127|69621920|FG000|Overall Study|Withdrawal by Subject|14|||
37935148|NCT00686127|69621921|FG001|Overall Study|Withdrawal by Subject|6|||
37935149|NCT00718718|69621934|FG000|Prior to Week 12|Adverse Event|0|||
37935150|NCT00718718|69621935|FG001|Prior to Week 12|Adverse Event|0|||
37935151|NCT00718718|69621936|FG002|Prior to Week 12|Adverse Event|0|||
37935152|NCT00718718|69621937|FG003|Prior to Week 12|Adverse Event|0|||
37935153|NCT00718718|69621938|FG004|Prior to Week 12|Adverse Event|0|||
37935154|NCT00718718|69621939|FG005|Prior to Week 12|Adverse Event|0|||
37935155|NCT00718718|69621940|FG006|Prior to Week 12|Adverse Event|0|||
37935156|NCT00718718|69621941|FG007|Prior to Week 12|Adverse Event|1|||
37935157|NCT00718718|69621942|FG008|Prior to Week 12|Adverse Event|1|||
37935158|NCT00718718|69621943|FG009|Prior to Week 12|Adverse Event|0|||
37935159|NCT00718718|69621934|FG000|Prior to Week 12|Withdrawal by Subject|0|||
37935160|NCT00718718|69621935|FG001|Prior to Week 12|Withdrawal by Subject|0|||
37935161|NCT00718718|69621936|FG002|Prior to Week 12|Withdrawal by Subject|0|||
37935162|NCT00718718|69621937|FG003|Prior to Week 12|Withdrawal by Subject|0|||
37935163|NCT00718718|69621938|FG004|Prior to Week 12|Withdrawal by Subject|3|||
37935164|NCT00718718|69621939|FG005|Prior to Week 12|Withdrawal by Subject|0|||
37935165|NCT00718718|69621940|FG006|Prior to Week 12|Withdrawal by Subject|1|||
37935166|NCT00718718|69621941|FG007|Prior to Week 12|Withdrawal by Subject|1|||
37935167|NCT00718718|69621942|FG008|Prior to Week 12|Withdrawal by Subject|1|||
37935168|NCT00718718|69621943|FG009|Prior to Week 12|Withdrawal by Subject|0|||
37935169|NCT00718718|69621934|FG000|Prior to Week 12|Other|1|||
37765092|NCT01517282|69278229|FG003|Overall Study|Physician Decision|0|||
37935170|NCT00718718|69621935|FG001|Prior to Week 12|Other|0|||
37935171|NCT00718718|69621936|FG002|Prior to Week 12|Other|1|||
37935172|NCT00718718|69621937|FG003|Prior to Week 12|Other|0|||
37935173|NCT00718718|69621938|FG004|Prior to Week 12|Other|0|||
37935174|NCT00718718|69621939|FG005|Prior to Week 12|Other|0|||
37935175|NCT00718718|69621940|FG006|Prior to Week 12|Other|0|||
37935176|NCT00718718|69621941|FG007|Prior to Week 12|Other|0|||
37935177|NCT00718718|69621942|FG008|Prior to Week 12|Other|0|||
37935178|NCT00718718|69621943|FG009|Prior to Week 12|Other|0|||
37935179|NCT00718718|69621934|FG000|Week 12 to End of Study|Adverse Event|0|||
37935180|NCT00718718|69621935|FG001|Week 12 to End of Study|Adverse Event|0|||
37935181|NCT00718718|69621936|FG002|Week 12 to End of Study|Adverse Event|0|||
37935182|NCT00718718|69621937|FG003|Week 12 to End of Study|Adverse Event|0|||
37935183|NCT00718718|69621938|FG004|Week 12 to End of Study|Adverse Event|0|||
37935184|NCT00718718|69621939|FG005|Week 12 to End of Study|Adverse Event|0|||
37935185|NCT00718718|69621940|FG006|Week 12 to End of Study|Adverse Event|0|||
37935186|NCT00718718|69621941|FG007|Week 12 to End of Study|Adverse Event|1|||
37935187|NCT00718718|69621942|FG008|Week 12 to End of Study|Adverse Event|0|||
37935188|NCT00718718|69621943|FG009|Week 12 to End of Study|Adverse Event|0|||
37935189|NCT00718718|69621934|FG000|Week 12 to End of Study|Death|0|||
37935190|NCT00718718|69621935|FG001|Week 12 to End of Study|Death|0|||
37935191|NCT00718718|69621936|FG002|Week 12 to End of Study|Death|0|||
37935192|NCT00718718|69621937|FG003|Week 12 to End of Study|Death|0|||
37935193|NCT00718718|69621938|FG004|Week 12 to End of Study|Death|0|||
37935194|NCT00718718|69621939|FG005|Week 12 to End of Study|Death|1|||
37935195|NCT00718718|69621940|FG006|Week 12 to End of Study|Death|0|||
37935196|NCT00718718|69621941|FG007|Week 12 to End of Study|Death|0|||
37935197|NCT00718718|69621942|FG008|Week 12 to End of Study|Death|0|||
37935198|NCT00718718|69621943|FG009|Week 12 to End of Study|Death|0|||
37935199|NCT00718718|69621934|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
37935200|NCT00718718|69621935|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
37935201|NCT00718718|69621936|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
37935202|NCT00718718|69621937|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
37935203|NCT00718718|69621938|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
37935204|NCT00718718|69621939|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
37935205|NCT00718718|69621940|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
37935206|NCT00718718|69621941|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
37935207|NCT00718718|69621942|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
37935208|NCT00718718|69621943|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
37935209|NCT00718718|69621934|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
37935210|NCT00718718|69621935|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
37935211|NCT00718718|69621936|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
37935212|NCT00718718|69621937|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
37935213|NCT00718718|69621938|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
37935214|NCT00718718|69621939|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
37935215|NCT00718718|69621940|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
37935216|NCT00718718|69621941|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
37935217|NCT00718718|69621942|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
37935218|NCT00718718|69621943|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
37935219|NCT00718718|69621934|FG000|Week 12 to End of Study|Other|0|||
37935220|NCT00718718|69621935|FG001|Week 12 to End of Study|Other|1|||
37935221|NCT00718718|69621936|FG002|Week 12 to End of Study|Other|0|||
37935222|NCT00718718|69621937|FG003|Week 12 to End of Study|Other|1|||
37935223|NCT00718718|69621938|FG004|Week 12 to End of Study|Other|0|||
37935224|NCT00718718|69621939|FG005|Week 12 to End of Study|Other|0|||
37935225|NCT00718718|69621940|FG006|Week 12 to End of Study|Other|1|||
37935226|NCT00718718|69621941|FG007|Week 12 to End of Study|Other|0|||
37935227|NCT00718718|69621942|FG008|Week 12 to End of Study|Other|0|||
37935228|NCT00718718|69621943|FG009|Week 12 to End of Study|Other|0|||
37935229|NCT00683787|69621972|FG000|Overall Study|Progression|3|||
37935230|NCT00683787|69621973|FG001|Overall Study|Progression|3|||
37935231|NCT00683787|69621974|FG002|Overall Study|Progression|0|||
37935232|NCT00683787|69621972|FG000|Overall Study|Adverse Event|0|||
37935233|NCT00683787|69621973|FG001|Overall Study|Adverse Event|0|||
37935234|NCT00683787|69621974|FG002|Overall Study|Adverse Event|2|||
37935235|NCT00723008|69621984|FG000|Enrollment|Lost to Follow-up|1|||
37935236|NCT00723008|69621985|FG001|Enrollment|Lost to Follow-up|0|||
37935237|NCT00723008|69621984|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
37935238|NCT00723008|69621985|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
37935239|NCT00723008|69621984|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
37935240|NCT00723008|69621985|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
37935241|NCT00723008|69621984|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
37935242|NCT00723008|69621985|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
37935243|NCT00723008|69621984|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
37935244|NCT00723008|69621985|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
37935245|NCT00723008|69621984|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
37670317|NCT02055820|69143559|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
37935246|NCT00723008|69621985|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
37935247|NCT00718640|69621999|FG000|Overall Study|Adverse Event|4|||
37935248|NCT00718640|69621999|FG000|Overall Study|Death|1|||
37935249|NCT00718640|69621999|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
37935250|NCT00715910|69622007|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
37935251|NCT00715910|69622008|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
37935252|NCT00715910|69622009|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
37935253|NCT00715910|69622010|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
37935254|NCT00715910|69622011|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
37935255|NCT00715910|69622012|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
37935256|NCT00715910|69622007|FG000|Booster and ESFU Phase|Other|0|||
37935257|NCT00715910|69622008|FG001|Booster and ESFU Phase|Other|0|||
37935258|NCT00715910|69622009|FG002|Booster and ESFU Phase|Other|0|||
37935259|NCT00715910|69622010|FG003|Booster and ESFU Phase|Other|5|||
37935260|NCT00715910|69622011|FG004|Booster and ESFU Phase|Other|1|||
37935261|NCT00715910|69622012|FG005|Booster and ESFU Phase|Other|0|||
37935262|NCT00715676|69622031|FG000|Overall Study|Adverse Event|3|||
37935263|NCT00715676|69622032|FG001|Overall Study|Adverse Event|5|||
37935264|NCT00715676|69622033|FG002|Overall Study|Adverse Event|21|||
37935265|NCT00715676|69622031|FG000|Overall Study|Withdrawal by Subject|1|||
37935266|NCT00715676|69622032|FG001|Overall Study|Withdrawal by Subject|3|||
37935267|NCT00715676|69622033|FG002|Overall Study|Withdrawal by Subject|8|||
37935268|NCT00715676|69622031|FG000|Overall Study|Lost to Follow-up|1|||
37935269|NCT00715676|69622032|FG001|Overall Study|Lost to Follow-up|2|||
37935270|NCT00715676|69622033|FG002|Overall Study|Lost to Follow-up|1|||
37935271|NCT00715676|69622031|FG000|Overall Study|Terminated by Sponsor|1|||
37935272|NCT00715676|69622032|FG001|Overall Study|Terminated by Sponsor|0|||
37935273|NCT00715676|69622033|FG002|Overall Study|Terminated by Sponsor|0|||
37935274|NCT00715676|69622031|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
37935275|NCT00715676|69622032|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
37935276|NCT00715676|69622033|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
37935277|NCT00715676|69622031|FG000|Overall Study|Use of Exclusionary Medication|0|||
37935278|NCT00715676|69622032|FG001|Overall Study|Use of Exclusionary Medication|0|||
37935279|NCT00715676|69622033|FG002|Overall Study|Use of Exclusionary Medication|1|||
37935280|NCT00715676|69622031|FG000|Overall Study|Elevated Blood Glucose|0|||
37935281|NCT00715676|69622032|FG001|Overall Study|Elevated Blood Glucose|1|||
37935282|NCT00715676|69622033|FG002|Overall Study|Elevated Blood Glucose|0|||
37935283|NCT00718328|69622043|FG000|Overall Study|Lost to Follow-up|1|||
37935284|NCT00718328|69622044|FG001|Overall Study|Lost to Follow-up|0|||
37935285|NCT00715520|69622053|FG000|Overall Study|Screen failure|8|||
37935286|NCT00715520|69622054|FG001|Overall Study|Screen failure|1|||
37935287|NCT00715520|69622055|FG002|Overall Study|Screen failure|1|||
37935288|NCT00715520|69622053|FG000|Overall Study|Withdrawal by Subject|2|||
37935289|NCT00715520|69622054|FG001|Overall Study|Withdrawal by Subject|0|||
37935290|NCT00715520|69622055|FG002|Overall Study|Withdrawal by Subject|1|||
37935291|NCT00790205|69622065|FG000|Overall Study|Lost to Follow-up|61|||
37935292|NCT00790205|69622066|FG001|Overall Study|Lost to Follow-up|71|||
37935293|NCT00790205|69622065|FG000|Overall Study|Withdrawal by Subject|299|||
37935294|NCT00790205|69622066|FG001|Overall Study|Withdrawal by Subject|363|||
37935295|NCT00715208|69622074|FG000|Overall Study|Withdrawal by Subject|1|||
37935296|NCT00715208|69622075|FG001|Overall Study|Withdrawal by Subject|1|||
37935297|NCT00715208|69622074|FG000|Overall Study|Adverse Event|0|||
37935298|NCT00715208|69622075|FG001|Overall Study|Adverse Event|6|||
37935299|NCT00715208|69622074|FG000|Overall Study|Lack of Efficacy|0|||
37935300|NCT00715208|69622075|FG001|Overall Study|Lack of Efficacy|2|||
37935301|NCT00775463|69622083|FG000|Overall Study|Withdrawal by Subject|0|||
37935302|NCT00775463|69622084|FG001|Overall Study|Withdrawal by Subject|1|||
37935303|NCT00775463|69622083|FG000|Overall Study|Adverse Event|7|||
37935304|NCT00775463|69622084|FG001|Overall Study|Adverse Event|9|||
37935305|NCT00775463|69622083|FG000|Overall Study|Protocol Violation|2|||
37935306|NCT00775463|69622084|FG001|Overall Study|Protocol Violation|2|||
37935307|NCT00775463|69622083|FG000|Overall Study|Lost to Follow-up|1|||
37935308|NCT00775463|69622084|FG001|Overall Study|Lost to Follow-up|0|||
37935309|NCT00775463|69622083|FG000|Overall Study|Lack of Efficacy|1|||
37935310|NCT00775463|69622084|FG001|Overall Study|Lack of Efficacy|1|||
37935311|NCT00587795|69622099|FG000|Overall Study|Withdrawal by Subject|1|||
37935312|NCT00587795|69622100|FG001|Overall Study|Withdrawal by Subject|0|||
37935313|NCT00587639|69622106|FG000|Overall Study|Withdrawal by Subject|1|||
37935314|NCT00774995|69622114|FG000|Overall Study|Protocol Violation|0|||
37935315|NCT00774995|69622115|FG001|Overall Study|Protocol Violation|0|||
37935316|NCT00774995|69622116|FG002|Overall Study|Protocol Violation|1|||
37935317|NCT00774995|69622117|FG003|Overall Study|Protocol Violation|0|||
37935318|NCT00713648|69622127|FG000|Overall Study|Adverse Event|1|||
37935319|NCT00713648|69622127|FG000|Overall Study|Unclassified|2|||
37935320|NCT00713648|69622127|FG000|Overall Study|According to Protocol|2|||
37935321|NCT00713648|69622127|FG000|Overall Study|Development of antibodies|3|||
37935322|NCT00768053|69622131|FG000|Overall Study|Adverse Event|10|||
37935323|NCT00768053|69622131|FG000|Overall Study|Lost to Follow-up|1|||
37935324|NCT00683475|69622137|FG000|Overall Study|Withdrawal by Subject|1|||
37935325|NCT00683475|69622138|FG001|Overall Study|Withdrawal by Subject|0|||
37935326|NCT00683475|69622137|FG000|Overall Study|Never Treated: Adverse Event|2|||
37935327|NCT00683475|69622138|FG001|Overall Study|Never Treated: Adverse Event|3|||
37935328|NCT00683475|69622137|FG000|Overall Study|Never Treated: Progressive Disease|1|||
37935329|NCT00683475|69622138|FG001|Overall Study|Never Treated: Progressive Disease|0|||
37935330|NCT00685035|69622145|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
37935331|NCT00685035|69622146|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
37935332|NCT00773747|69622172|FG000|Overall Study|Lack of Efficacy|112|||
37935333|NCT00773747|69622173|FG001|Overall Study|Lack of Efficacy|144|||
37935334|NCT00773747|69622172|FG000|Overall Study|Physician Decision|26|||
37935335|NCT00773747|69622173|FG001|Overall Study|Physician Decision|18|||
37935336|NCT00773747|69622172|FG000|Overall Study|Lost to Follow-up|0|||
37935337|NCT00773747|69622173|FG001|Overall Study|Lost to Follow-up|1|||
37935338|NCT00773747|69622172|FG000|Overall Study|Protocol Violation|2|||
37935339|NCT00773747|69622173|FG001|Overall Study|Protocol Violation|2|||
37935340|NCT00773747|69622172|FG000|Overall Study|Withdrawal by Subject|89|||
37935341|NCT00773747|69622173|FG001|Overall Study|Withdrawal by Subject|61|||
37935342|NCT00773747|69622172|FG000|Overall Study|Adverse Event|61|||
37935343|NCT00773747|69622173|FG001|Overall Study|Adverse Event|62|||
37935344|NCT00773747|69622172|FG000|Overall Study|Death|5|||
37935345|NCT00773747|69622173|FG001|Overall Study|Death|8|||
37935346|NCT00773747|69622172|FG000|Overall Study|Not Treated|2|||
37935347|NCT00773747|69622173|FG001|Overall Study|Not Treated|0|||
37935348|NCT00784277|69622183|FG000|IR Treatment|Adverse Event|4|||
37935349|NCT00784277|69622184|FG001|IR Treatment|Adverse Event|8|||
37935350|NCT00784277|69622185|FG002|IR Treatment|Adverse Event|19|||
37935351|NCT00784277|69622186|FG003|IR Treatment|Adverse Event|35|||
37935352|NCT00784277|69622187|FG004|IR Treatment|Adverse Event|0|||
37935353|NCT00784277|69622188|FG005|IR Treatment|Adverse Event|0|||
37935354|NCT00784277|69622189|FG006|IR Treatment|Adverse Event|0|||
37935355|NCT00784277|69622183|FG000|IR Treatment|Lack of Efficacy|4|||
37935356|NCT00784277|69622184|FG001|IR Treatment|Lack of Efficacy|4|||
37935357|NCT00784277|69622185|FG002|IR Treatment|Lack of Efficacy|1|||
37935358|NCT00784277|69622186|FG003|IR Treatment|Lack of Efficacy|0|||
37935359|NCT00784277|69622187|FG004|IR Treatment|Lack of Efficacy|0|||
37935360|NCT00784277|69622188|FG005|IR Treatment|Lack of Efficacy|0|||
37935361|NCT00784277|69622189|FG006|IR Treatment|Lack of Efficacy|0|||
37935362|NCT00784277|69622183|FG000|IR Treatment|Lost to Follow-up|1|||
37935363|NCT00784277|69622184|FG001|IR Treatment|Lost to Follow-up|0|||
37935364|NCT00784277|69622185|FG002|IR Treatment|Lost to Follow-up|1|||
37935365|NCT00784277|69622186|FG003|IR Treatment|Lost to Follow-up|0|||
37935366|NCT00784277|69622187|FG004|IR Treatment|Lost to Follow-up|0|||
37935367|NCT00784277|69622188|FG005|IR Treatment|Lost to Follow-up|0|||
37765093|NCT01440647|69278250|FG000|Overall Study|Death|2|||
37765094|NCT01440647|69278251|FG001|Overall Study|Death|3|||
37765095|NCT01516970|69278259|FG000|Overall Study|Lost to Follow-up|7|||
37765096|NCT01516970|69278260|FG001|Overall Study|Lost to Follow-up|8|||
37765097|NCT01516970|69278259|FG000|Overall Study|Adverse Event|1|||
37765098|NCT01516970|69278260|FG001|Overall Study|Adverse Event|5|||
37765099|NCT01516970|69278259|FG000|Overall Study|Withdrawal by Subject|1|||
37935368|NCT00784277|69622189|FG006|IR Treatment|Lost to Follow-up|0|||
37935369|NCT00784277|69622183|FG000|IR Treatment|Withdrawal by Subject|5|||
37935370|NCT00784277|69622184|FG001|IR Treatment|Withdrawal by Subject|1|||
37935371|NCT00784277|69622185|FG002|IR Treatment|Withdrawal by Subject|4|||
37935372|NCT00784277|69622186|FG003|IR Treatment|Withdrawal by Subject|6|||
37935373|NCT00784277|69622187|FG004|IR Treatment|Withdrawal by Subject|0|||
37935374|NCT00784277|69622188|FG005|IR Treatment|Withdrawal by Subject|0|||
37935375|NCT00784277|69622189|FG006|IR Treatment|Withdrawal by Subject|0|||
37935376|NCT00784277|69622183|FG000|IR Treatment|Resolution Of Pain|0|||
37935377|NCT00784277|69622184|FG001|IR Treatment|Resolution Of Pain|1|||
37935378|NCT00784277|69622185|FG002|IR Treatment|Resolution Of Pain|0|||
37935379|NCT00784277|69622186|FG003|IR Treatment|Resolution Of Pain|0|||
37935380|NCT00784277|69622187|FG004|IR Treatment|Resolution Of Pain|0|||
37935381|NCT00784277|69622188|FG005|IR Treatment|Resolution Of Pain|0|||
37935382|NCT00784277|69622189|FG006|IR Treatment|Resolution Of Pain|0|||
37935383|NCT00784277|69622183|FG000|IR Treatment|Other|2|||
37935384|NCT00784277|69622184|FG001|IR Treatment|Other|3|||
37935385|NCT00784277|69622185|FG002|IR Treatment|Other|3|||
37670318|NCT02055820|69143560|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
37935386|NCT00784277|69622186|FG003|IR Treatment|Other|2|||
37935387|NCT00784277|69622187|FG004|IR Treatment|Other|0|||
37935388|NCT00784277|69622188|FG005|IR Treatment|Other|0|||
37935389|NCT00784277|69622189|FG006|IR Treatment|Other|0|||
37935390|NCT00784277|69622183|FG000|ER Treatment|Adverse Event|0|||
37935391|NCT00784277|69622184|FG001|ER Treatment|Adverse Event|0|||
37670319|NCT02055820|69143561|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
37935392|NCT00784277|69622185|FG002|ER Treatment|Adverse Event|0|||
37935393|NCT00784277|69622186|FG003|ER Treatment|Adverse Event|0|||
37935394|NCT00784277|69622187|FG004|ER Treatment|Adverse Event|1|||
37935395|NCT00784277|69622188|FG005|ER Treatment|Adverse Event|7|||
37935396|NCT00784277|69622189|FG006|ER Treatment|Adverse Event|7|||
37765100|NCT01516970|69278260|FG001|Overall Study|Withdrawal by Subject|1|||
37765101|NCT01516970|69278259|FG000|Overall Study|Other|9|||
37935397|NCT00784277|69622183|FG000|ER Treatment|Lack of Efficacy|0|||
37935398|NCT00784277|69622184|FG001|ER Treatment|Lack of Efficacy|0|||
37935399|NCT00784277|69622185|FG002|ER Treatment|Lack of Efficacy|0|||
37935400|NCT00784277|69622186|FG003|ER Treatment|Lack of Efficacy|0|||
37935401|NCT00784277|69622187|FG004|ER Treatment|Lack of Efficacy|3|||
37935402|NCT00784277|69622188|FG005|ER Treatment|Lack of Efficacy|4|||
37935403|NCT00784277|69622189|FG006|ER Treatment|Lack of Efficacy|0|||
37935404|NCT00784277|69622183|FG000|ER Treatment|Lost to Follow-up|0|||
37935405|NCT00784277|69622184|FG001|ER Treatment|Lost to Follow-up|0|||
37935406|NCT00784277|69622185|FG002|ER Treatment|Lost to Follow-up|0|||
37935407|NCT00784277|69622186|FG003|ER Treatment|Lost to Follow-up|0|||
37935408|NCT00784277|69622187|FG004|ER Treatment|Lost to Follow-up|0|||
37935409|NCT00784277|69622188|FG005|ER Treatment|Lost to Follow-up|2|||
37935410|NCT00784277|69622189|FG006|ER Treatment|Lost to Follow-up|0|||
37935411|NCT00784277|69622183|FG000|ER Treatment|Withdrawal by Subject|0|||
37935412|NCT00784277|69622184|FG001|ER Treatment|Withdrawal by Subject|0|||
37935413|NCT00784277|69622185|FG002|ER Treatment|Withdrawal by Subject|0|||
37935414|NCT00784277|69622186|FG003|ER Treatment|Withdrawal by Subject|0|||
37935415|NCT00784277|69622187|FG004|ER Treatment|Withdrawal by Subject|2|||
37935416|NCT00784277|69622188|FG005|ER Treatment|Withdrawal by Subject|5|||
37935417|NCT00784277|69622189|FG006|ER Treatment|Withdrawal by Subject|3|||
37935418|NCT00784277|69622183|FG000|ER Treatment|Study Medication Non-Compliant|0|||
37935419|NCT00784277|69622184|FG001|ER Treatment|Study Medication Non-Compliant|0|||
37935420|NCT00784277|69622185|FG002|ER Treatment|Study Medication Non-Compliant|0|||
37935421|NCT00784277|69622186|FG003|ER Treatment|Study Medication Non-Compliant|0|||
37935422|NCT00784277|69622187|FG004|ER Treatment|Study Medication Non-Compliant|2|||
37935423|NCT00784277|69622188|FG005|ER Treatment|Study Medication Non-Compliant|3|||
37935424|NCT00784277|69622189|FG006|ER Treatment|Study Medication Non-Compliant|3|||
37935425|NCT00784277|69622183|FG000|ER Treatment|Other|0|||
37935426|NCT00784277|69622184|FG001|ER Treatment|Other|0|||
37935427|NCT00784277|69622185|FG002|ER Treatment|Other|0|||
37935428|NCT00784277|69622186|FG003|ER Treatment|Other|0|||
37935429|NCT00784277|69622187|FG004|ER Treatment|Other|1|||
37935430|NCT00784277|69622188|FG005|ER Treatment|Other|3|||
37935431|NCT00784277|69622189|FG006|ER Treatment|Other|2|||
37935432|NCT00682929|69622205|FG000|Overall Study|Adverse Event|4|||
37935433|NCT00682929|69622206|FG001|Overall Study|Adverse Event|1|||
37935434|NCT00682929|69622207|FG002|Overall Study|Adverse Event|1|||
37935435|NCT00682929|69622205|FG000|Overall Study|Withdrawal by Subject|1|||
37935436|NCT00682929|69622206|FG001|Overall Study|Withdrawal by Subject|2|||
37935437|NCT00682929|69622207|FG002|Overall Study|Withdrawal by Subject|1|||
37935438|NCT00682929|69622205|FG000|Overall Study|dosing compliance < 80%|0|||
37935439|NCT00682929|69622206|FG001|Overall Study|dosing compliance < 80%|2|||
37935440|NCT00682929|69622207|FG002|Overall Study|dosing compliance < 80%|0|||
37935441|NCT00682929|69622205|FG000|Overall Study|lag in DEA renewal|1|||
37935442|NCT00682929|69622206|FG001|Overall Study|lag in DEA renewal|0|||
37935443|NCT00682929|69622207|FG002|Overall Study|lag in DEA renewal|0|||
37935444|NCT00680745|69622219|FG000|Overall Study|Withdrawal by Subject|8|||
37935445|NCT00680745|69622220|FG001|Overall Study|Withdrawal by Subject|3|||
37935446|NCT00680745|69622221|FG002|Overall Study|Withdrawal by Subject|2|||
37935447|NCT00680745|69622222|FG003|Overall Study|Withdrawal by Subject|8|||
37935448|NCT00680745|69622219|FG000|Overall Study|Lost to Follow-up|0|||
37935449|NCT00680745|69622220|FG001|Overall Study|Lost to Follow-up|1|||
37935450|NCT00680745|69622221|FG002|Overall Study|Lost to Follow-up|1|||
37935451|NCT00680745|69622222|FG003|Overall Study|Lost to Follow-up|0|||
37935452|NCT00680745|69622219|FG000|Overall Study|Death|1|||
37935453|NCT00680745|69622220|FG001|Overall Study|Death|0|||
37935454|NCT00680745|69622221|FG002|Overall Study|Death|1|||
37935455|NCT00680745|69622222|FG003|Overall Study|Death|0|||
37935456|NCT00680745|69622219|FG000|Overall Study|Adverse Event|5|||
37935457|NCT00680745|69622220|FG001|Overall Study|Adverse Event|3|||
37935458|NCT00680745|69622221|FG002|Overall Study|Adverse Event|3|||
37935459|NCT00680745|69622222|FG003|Overall Study|Adverse Event|3|||
37935460|NCT00680745|69622219|FG000|Overall Study|Poor/Non-compliance|0|||
37935461|NCT00680745|69622220|FG001|Overall Study|Poor/Non-compliance|3|||
37935462|NCT00680745|69622221|FG002|Overall Study|Poor/Non-compliance|0|||
37935463|NCT00680745|69622222|FG003|Overall Study|Poor/Non-compliance|0|||
37935464|NCT00680745|69622219|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
37935465|NCT00680745|69622220|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
37935466|NCT00680745|69622221|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
37935467|NCT00680745|69622222|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
37935468|NCT00680745|69622219|FG000|Overall Study|False Treatment|0|||
37935469|NCT00680745|69622220|FG001|Overall Study|False Treatment|1|||
37935470|NCT00680745|69622221|FG002|Overall Study|False Treatment|3|||
37935471|NCT00680745|69622222|FG003|Overall Study|False Treatment|0|||
37935472|NCT00680121|69622235|FG000|Overall Study|Lost to Follow-up|27|||
37935473|NCT00680121|69622236|FG001|Overall Study|Lost to Follow-up|23|||
37935474|NCT00767819|69622245|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
37935475|NCT00767819|69622246|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
37935476|NCT00767819|69622247|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
37935477|NCT00767819|69622245|FG000|Overall Study|Withdrawal by Subject|1|||
37935478|NCT00767819|69622246|FG001|Overall Study|Withdrawal by Subject|1|||
37935479|NCT00767819|69622247|FG002|Overall Study|Withdrawal by Subject|0|||
37935480|NCT00767819|69622245|FG000|Overall Study|Administrative problems|0|||
37935481|NCT00767819|69622246|FG001|Overall Study|Administrative problems|1|||
37935482|NCT00767819|69622247|FG002|Overall Study|Administrative problems|0|||
37935483|NCT00767819|69622245|FG000|Overall Study|Death|2|||
37935484|NCT00767819|69622246|FG001|Overall Study|Death|3|||
37935485|NCT00767819|69622247|FG002|Overall Study|Death|0|||
37935486|NCT00767819|69622245|FG000|Overall Study|Adverse Event|2|||
37935487|NCT00767819|69622246|FG001|Overall Study|Adverse Event|0|||
37935488|NCT00767819|69622247|FG002|Overall Study|Adverse Event|0|||
37935489|NCT00767819|69622245|FG000|Overall Study|Abnormal lab values|1|||
37935490|NCT00767819|69622246|FG001|Overall Study|Abnormal lab values|0|||
37935491|NCT00767819|69622247|FG002|Overall Study|Abnormal lab values|0|||
37935492|NCT00767819|69622245|FG000|Overall Study|Lost to Follow-up|1|||
37765102|NCT01516970|69278260|FG001|Overall Study|Other|7|||
37765103|NCT01516892|69278281|FG000|Overall Study|Adverse Event|25|||
37765104|NCT01516892|69278281|FG000|Overall Study|Lack of Efficacy|35|||
37935493|NCT00767819|69622246|FG001|Overall Study|Lost to Follow-up|0|||
37935494|NCT00767819|69622247|FG002|Overall Study|Lost to Follow-up|0|||
37935495|NCT00584870|69622258|FG000|Overall Study|Adverse Event|4|||
37935496|NCT00584870|69622259|FG001|Overall Study|Adverse Event|3|||
37935497|NCT00584870|69622260|FG002|Overall Study|Adverse Event|2|||
37935498|NCT00584870|69622258|FG000|Overall Study|Lost to Follow-up|4|||
37935499|NCT00584870|69622259|FG001|Overall Study|Lost to Follow-up|1|||
37935500|NCT00584870|69622260|FG002|Overall Study|Lost to Follow-up|1|||
37935501|NCT00584870|69622258|FG000|Overall Study|Lack of Efficacy|7|||
37935502|NCT00584870|69622259|FG001|Overall Study|Lack of Efficacy|14|||
37935503|NCT00584870|69622260|FG002|Overall Study|Lack of Efficacy|8|||
37935504|NCT00584870|69622258|FG000|Overall Study|Withdrawal by Subject|10|||
37935505|NCT00584870|69622259|FG001|Overall Study|Withdrawal by Subject|5|||
37935506|NCT00584870|69622260|FG002|Overall Study|Withdrawal by Subject|3|||
37935507|NCT00584870|69622258|FG000|Overall Study|Protocol Violation|1|||
37935508|NCT00584870|69622259|FG001|Overall Study|Protocol Violation|1|||
37935509|NCT00584870|69622260|FG002|Overall Study|Protocol Violation|2|||
37935510|NCT00584870|69622258|FG000|Overall Study|Did not met entrance criteria|1|||
37935511|NCT00584870|69622259|FG001|Overall Study|Did not met entrance criteria|0|||
37935512|NCT00584870|69622260|FG002|Overall Study|Did not met entrance criteria|0|||
37935513|NCT00584870|69622258|FG000|Overall Study|Other|2|||
37935514|NCT00584870|69622259|FG001|Overall Study|Other|0|||
37935515|NCT00584870|69622260|FG002|Overall Study|Other|0|||
37935516|NCT00584870|69622258|FG000|Overall Study|Randomized but not treated|0|||
37935517|NCT00584870|69622259|FG001|Overall Study|Randomized but not treated|1|||
37935518|NCT00584870|69622260|FG002|Overall Study|Randomized but not treated|2|||
37935519|NCT00679341|69622270|FG000|Overall Study|Disease progression|42|||
37935520|NCT00679341|69622271|FG001|Overall Study|Disease progression|36|||
37935521|NCT00679341|69622270|FG000|Overall Study|Adverse Event|5|||
37935522|NCT00679341|69622271|FG001|Overall Study|Adverse Event|6|||
37935523|NCT00679341|69622270|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
37935524|NCT00679341|69622271|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
37935525|NCT00679341|69622270|FG000|Overall Study|Death|1|||
37935526|NCT00679341|69622271|FG001|Overall Study|Death|1|||
37935527|NCT00679341|69622270|FG000|Overall Study|Other|1|||
37935528|NCT00679341|69622271|FG001|Overall Study|Other|0|||
37935529|NCT00679341|69622270|FG000|Overall Study|Physician Decision|1|||
37935530|NCT00679341|69622271|FG001|Overall Study|Physician Decision|0|||
37935531|NCT00679341|69622270|FG000|Overall Study|Not treated|0|||
37935532|NCT00679341|69622271|FG001|Overall Study|Not treated|2|||
37935533|NCT00679341|69622270|FG000|Overall Study|Physician/patient decision to withdraw|0|||
37935534|NCT00679341|69622271|FG001|Overall Study|Physician/patient decision to withdraw|6|||
37935535|NCT00679263|69622281|FG000|Visit 2/Dose 1|Adverse Event|1|||
37935536|NCT00679263|69622282|FG001|Visit 2/Dose 1|Adverse Event|0|||
37935537|NCT00679263|69622283|FG002|Visit 2/Dose 1|Adverse Event|0|||
37765105|NCT01516892|69278281|FG000|Overall Study|Pregnancy|5|||
37935538|NCT00679263|69622281|FG000|Visit 2/Dose 1|subject not compliance|1|||
37935539|NCT00679263|69622282|FG001|Visit 2/Dose 1|subject not compliance|1|||
37935540|NCT00679263|69622283|FG002|Visit 2/Dose 1|subject not compliance|0|||
37935541|NCT00680043|69622294|FG000|Overall Study|Withdrawal by Subject|1|||
37935542|NCT00680043|69622295|FG001|Overall Study|Withdrawal by Subject|0|||
37935543|NCT00680043|69622296|FG002|Overall Study|Withdrawal by Subject|0|||
37935544|NCT00680043|69622294|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
37935545|NCT00680043|69622295|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
37935546|NCT00680043|69622296|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
37935547|NCT00680043|69622294|FG000|Overall Study|Renal Transplant|1|||
37935548|NCT00680043|69622295|FG001|Overall Study|Renal Transplant|0|||
37935549|NCT00680043|69622296|FG002|Overall Study|Renal Transplant|4|||
38035125|NCT03259334|69722035|FG002|Overall Study|Adverse Event|5|||
37765106|NCT01516892|69278281|FG000|Overall Study|Lost to Follow-up|82|||
37935550|NCT00682539|69622307|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
37935551|NCT00682539|69622308|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
37935552|NCT00682539|69622309|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
37935553|NCT00682539|69622307|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
37935554|NCT00682539|69622308|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
37935555|NCT00682539|69622309|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
37935556|NCT00682461|69622319|FG000|Overall Study|Adverse Event|5|||
37935557|NCT00682461|69622320|FG001|Overall Study|Adverse Event|7|||
37935558|NCT00682461|69622319|FG000|Overall Study|Lost to Follow-up|8|||
37935559|NCT00682461|69622320|FG001|Overall Study|Lost to Follow-up|5|||
37935560|NCT00682461|69622319|FG000|Overall Study|Withdrawal by Subject|12|||
37935561|NCT00682461|69622320|FG001|Overall Study|Withdrawal by Subject|19|||
37935562|NCT00679029|69622327|FG000|Overall Study|Adverse Event|3|||
37935563|NCT00679029|69622327|FG000|Overall Study|Withdrawal by Subject|1|||
37935564|NCT00679029|69622327|FG000|Overall Study|Lost to Follow-up|1|||
37935565|NCT00677235|69622333|FG000|Overall Study|Withdrawal by Subject|1|||
37935566|NCT00677235|69622334|FG001|Overall Study|Withdrawal by Subject|1|||
37935567|NCT00677235|69622333|FG000|Overall Study|Lost to Follow-up|2|||
37935568|NCT00677235|69622334|FG001|Overall Study|Lost to Follow-up|1|||
37935569|NCT00677235|69622333|FG000|Overall Study|Death|37|||
37935570|NCT00677235|69622334|FG001|Overall Study|Death|36|||
37935571|NCT00677235|69622333|FG000|Overall Study|Adverse Experience|1|||
37935572|NCT00677235|69622334|FG001|Overall Study|Adverse Experience|0|||
37935573|NCT00676689|69622340|FG000|Overall Study|Screen Failure|2|||
37935574|NCT00676689|69622340|FG000|Overall Study|Death|2|||
37935575|NCT00676689|69622340|FG000|Overall Study|Lost to Follow-up|4|||
37935576|NCT00676689|69622340|FG000|Overall Study|Physician Decision|1|||
37935577|NCT00676689|69622340|FG000|Overall Study|Withdrawal by Subject|3|||
37935578|NCT00676689|69622340|FG000|Overall Study|Continuing FU|49|||
37935579|NCT00678795|69622346|FG000|Overall Study|Adverse Event|7|||
37935580|NCT00678795|69622347|FG001|Overall Study|Adverse Event|3|||
37935581|NCT00678795|69622346|FG000|Overall Study|Withdrawal by Subject|3|||
37935582|NCT00678795|69622347|FG001|Overall Study|Withdrawal by Subject|0|||
37935583|NCT00678795|69622346|FG000|Overall Study|Protocol Violation|0|||
37935584|NCT00678795|69622347|FG001|Overall Study|Protocol Violation|1|||
37935585|NCT00678795|69622346|FG000|Overall Study|Lost to Follow-up|0|||
37935586|NCT00678795|69622347|FG001|Overall Study|Lost to Follow-up|1|||
37935587|NCT00678795|69622346|FG000|Overall Study|Lack of Efficacy|1|||
37935588|NCT00678795|69622347|FG001|Overall Study|Lack of Efficacy|1|||
37935589|NCT00678639|69622355|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
37935590|NCT00678639|69622356|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
37935591|NCT00678561|69622406|FG000|Overall Study|Adverse Event|0|||
37935592|NCT00678561|69622407|FG001|Overall Study|Adverse Event|1|||
37935593|NCT00678561|69622408|FG002|Overall Study|Adverse Event|1|||
37935594|NCT00678561|69622409|FG003|Overall Study|Adverse Event|0|||
37935595|NCT00678561|69622410|FG004|Overall Study|Adverse Event|1|||
37935596|NCT00678561|69622411|FG005|Overall Study|Adverse Event|0|||
37935597|NCT00678561|69622412|FG006|Overall Study|Adverse Event|0|||
37935598|NCT00678561|69622413|FG007|Overall Study|Adverse Event|0|||
37935599|NCT00678561|69622406|FG000|Overall Study|Protocol Violation|0|||
37935600|NCT00678561|69622407|FG001|Overall Study|Protocol Violation|0|||
37935601|NCT00678561|69622408|FG002|Overall Study|Protocol Violation|0|||
37935602|NCT00678561|69622409|FG003|Overall Study|Protocol Violation|0|||
37935603|NCT00678561|69622410|FG004|Overall Study|Protocol Violation|1|||
37935604|NCT00678561|69622411|FG005|Overall Study|Protocol Violation|1|||
37935605|NCT00678561|69622412|FG006|Overall Study|Protocol Violation|0|||
37935606|NCT00678561|69622413|FG007|Overall Study|Protocol Violation|0|||
37935607|NCT00678561|69622406|FG000|Overall Study|Withdrawal by Subject|0|||
37935608|NCT00678561|69622407|FG001|Overall Study|Withdrawal by Subject|0|||
37935609|NCT00678561|69622408|FG002|Overall Study|Withdrawal by Subject|0|||
37935610|NCT00678561|69622409|FG003|Overall Study|Withdrawal by Subject|0|||
37935611|NCT00678561|69622410|FG004|Overall Study|Withdrawal by Subject|0|||
37935612|NCT00678561|69622411|FG005|Overall Study|Withdrawal by Subject|0|||
37935613|NCT00678561|69622412|FG006|Overall Study|Withdrawal by Subject|0|||
37935614|NCT00678561|69622413|FG007|Overall Study|Withdrawal by Subject|1|||
37935615|NCT00676143|69622440|FG000|Overall Study|Adverse Event|34|||
37935616|NCT00676143|69622441|FG001|Overall Study|Adverse Event|60|||
37935617|NCT00676143|69622440|FG000|Overall Study|Death|4|||
37935618|NCT00676143|69622441|FG001|Overall Study|Death|4|||
37935619|NCT00676143|69622440|FG000|Overall Study|Lack of Efficacy|0|||
37935620|NCT00676143|69622441|FG001|Overall Study|Lack of Efficacy|6|||
37935621|NCT00676143|69622440|FG000|Overall Study|Lost to Follow-up|0|||
37935622|NCT00676143|69622441|FG001|Overall Study|Lost to Follow-up|13|||
37935623|NCT00676143|69622440|FG000|Overall Study|Physician Decision|5|||
37935624|NCT00676143|69622441|FG001|Overall Study|Physician Decision|8|||
37935625|NCT00676143|69622440|FG000|Overall Study|Protocol Violation|4|||
37935626|NCT00676143|69622441|FG001|Overall Study|Protocol Violation|8|||
37935627|NCT00676143|69622440|FG000|Overall Study|Withdrawal by Subject|24|||
37935628|NCT00676143|69622441|FG001|Overall Study|Withdrawal by Subject|42|||
37935629|NCT00676143|69622440|FG000|Overall Study|Discontinuation of study by sponsor|65|||
37935630|NCT00676143|69622441|FG001|Overall Study|Discontinuation of study by sponsor|88|||
37935631|NCT00676143|69622440|FG000|Overall Study|Failed to return|2|||
37935632|NCT00676143|69622441|FG001|Overall Study|Failed to return|1|||
37935633|NCT00676143|69622440|FG000|Overall Study|Loss of caregiver|5|||
37935634|NCT00676143|69622441|FG001|Overall Study|Loss of caregiver|3|||
37935635|NCT00676143|69622440|FG000|Overall Study|Other|11|||
37935636|NCT00676143|69622441|FG001|Overall Study|Other|20|||
37935637|NCT00676143|69622440|FG000|Overall Study|Participant participation unknown|1|||
37935638|NCT00676143|69622441|FG001|Overall Study|Participant participation unknown|4|||
37935639|NCT00676143|69622440|FG000|Overall Study|Vasogenic edema recurrence|1|||
37935640|NCT00676143|69622441|FG001|Overall Study|Vasogenic edema recurrence|3|||
37935641|NCT00675597|69622466|FG000|Overall Study|Withdrawal by Subject|3|||
37935642|NCT00675441|69622474|FG000|Overall Study|Withdrawal by Subject|2|||
37935643|NCT00675441|69622474|FG000|Overall Study|Death|1|||
37935644|NCT00674973|69622489|FG000|Overall Study|Insufficient Therapeutic Response|77|||
37935645|NCT00674973|69622490|FG001|Overall Study|Insufficient Therapeutic Response|72|||
37935646|NCT00674973|69622489|FG000|Overall Study|Refused Treatment|1|||
37935647|NCT00674973|69622490|FG001|Overall Study|Refused Treatment|5|||
37935648|NCT00674973|69622489|FG000|Overall Study|Failure to Return|1|||
37935649|NCT00674973|69622490|FG001|Overall Study|Failure to Return|0|||
37935650|NCT00674973|69622489|FG000|Overall Study|Adverse Event|2|||
37935651|NCT00674973|69622490|FG001|Overall Study|Adverse Event|9|||
37935652|NCT00674973|69622489|FG000|Overall Study|Death|19|||
37935653|NCT00674973|69622490|FG001|Overall Study|Death|15|||
37935654|NCT00674973|69622489|FG000|Overall Study|Protocol Violation|0|||
37935655|NCT00674973|69622490|FG001|Overall Study|Protocol Violation|1|||
37935656|NCT00673179|69622498|FG000|Overall Study|Toxicity/Complications|3|||
37935657|NCT00673179|69622499|FG001|Overall Study|Toxicity/Complications|0|||
37935658|NCT00584012|69622505|FG000|Overall Study|Withdrawal by Subject|1|||
37935659|NCT00674817|69622509|FG000|Period 1|Withdrawal by Subject|2|||
37935660|NCT00674817|69622509|FG000|Period 1|Protocol Violation|1|||
37935661|NCT00674817|69622509|FG000|Period 3|Adverse Event|1|||
37935662|NCT00674817|69622509|FG000|Period 3|Protocol Violation|1|||
37935663|NCT00674817|69622509|FG000|Period 4|Adverse Event|1|||
37935664|NCT00672633|69622525|FG000|Overall Study|Withdrawal by Subject|0|||
37935665|NCT00672633|69622526|FG001|Overall Study|Withdrawal by Subject|1|||
37935666|NCT00672555|69622532|FG000|Overall Study|Lost to Follow-up|4|||
37935667|NCT00672555|69622532|FG000|Overall Study|Did not want to answer questionnaire|2|||
37935668|NCT00672477|69622538|FG000|Overall Study|Adverse Event|10|||
37935669|NCT00672477|69622539|FG001|Overall Study|Adverse Event|7|||
37935670|NCT00672477|69622538|FG000|Overall Study|Death|7|||
37935671|NCT00672477|69622539|FG001|Overall Study|Death|11|||
37935672|NCT00672477|69622538|FG000|Overall Study|Physician Decision|2|||
37935673|NCT00672477|69622539|FG001|Overall Study|Physician Decision|0|||
37935674|NCT00672477|69622538|FG000|Overall Study|Protocol Violation|1|||
37935675|NCT00672477|69622539|FG001|Overall Study|Protocol Violation|1|||
37935676|NCT00672477|69622538|FG000|Overall Study|Withdrawal by Subject|5|||
37935677|NCT00672477|69622539|FG001|Overall Study|Withdrawal by Subject|3|||
37935678|NCT00672477|69622538|FG000|Overall Study|Lack of Efficacy|1|||
37935679|NCT00672477|69622539|FG001|Overall Study|Lack of Efficacy|1|||
37935680|NCT00672477|69622538|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
37935681|NCT00672477|69622539|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
37935682|NCT00674661|69622547|FG000|Overall Study|Other|5|||
37935683|NCT00674661|69622548|FG001|Overall Study|Other|7|||
37935684|NCT00674661|69622547|FG000|Overall Study|Lost to Follow-up|6|||
37935685|NCT00674661|69622548|FG001|Overall Study|Lost to Follow-up|3|||
37935686|NCT00674661|69622547|FG000|Overall Study|Withdrawal by Subject|0|||
37935687|NCT00674661|69622548|FG001|Overall Study|Withdrawal by Subject|5|||
37935688|NCT00671931|69622559|FG000|Overall Study|Physician Decision|1|||
37935689|NCT00671931|69622560|FG001|Overall Study|Physician Decision|0|||
37935690|NCT00671931|69622561|FG002|Overall Study|Physician Decision|0|||
37935691|NCT00671931|69622562|FG003|Overall Study|Physician Decision|2|||
37935692|NCT00671931|69622563|FG004|Overall Study|Physician Decision|1|||
37935693|NCT00673881|69622579|FG000|Overall Study|Withdrawal by Subject|1|||
37935694|NCT00671853|69622585|FG000|Overall Study|Lack of Efficacy|3|||
37935695|NCT00671853|69622586|FG001|Overall Study|Lack of Efficacy|7|||
37935696|NCT00671853|69622585|FG000|Overall Study|Adverse Event|7|||
37935697|NCT00671853|69622586|FG001|Overall Study|Adverse Event|1|||
37935698|NCT00671853|69622585|FG000|Overall Study|Withdrawal by Subject|1|||
37935699|NCT00671853|69622586|FG001|Overall Study|Withdrawal by Subject|5|||
37935700|NCT00671853|69622585|FG000|Overall Study|Lost to Follow-up|8|||
37935701|NCT00671853|69622586|FG001|Overall Study|Lost to Follow-up|8|||
37935702|NCT00671853|69622585|FG000|Overall Study|Physician Decision|0|||
37935703|NCT00671853|69622586|FG001|Overall Study|Physician Decision|2|||
37935704|NCT00671853|69622585|FG000|Overall Study|Non-adherence with study procedures|1|||
37935705|NCT00671853|69622586|FG001|Overall Study|Non-adherence with study procedures|4|||
37935706|NCT00570921|69622594|FG000|Overall Study|Protocol Violation|1|||
37935707|NCT00570921|69622594|FG000|Overall Study|Physician Decision|1|||
37935708|NCT00670449|69622602|FG000|Overall Study|Adverse Event|6|||
37935709|NCT00670449|69622603|FG001|Overall Study|Adverse Event|2|||
37935710|NCT00670449|69622604|FG002|Overall Study|Adverse Event|8|||
37935711|NCT00670449|69622605|FG003|Overall Study|Adverse Event|5|||
37935712|NCT00670449|69622602|FG000|Overall Study|Protocol Deviation|1|||
37935713|NCT00670449|69622603|FG001|Overall Study|Protocol Deviation|2|||
37935714|NCT00670449|69622604|FG002|Overall Study|Protocol Deviation|0|||
37935715|NCT00670449|69622605|FG003|Overall Study|Protocol Deviation|1|||
37935716|NCT00670449|69622602|FG000|Overall Study|Administrative Problems|0|||
37935717|NCT00670449|69622603|FG001|Overall Study|Administrative Problems|2|||
37935718|NCT00670449|69622604|FG002|Overall Study|Administrative Problems|0|||
37935719|NCT00670449|69622605|FG003|Overall Study|Administrative Problems|1|||
37935720|NCT00670449|69622602|FG000|Overall Study|Subject Withdrew Consent|0|||
37935721|NCT00670449|69622603|FG001|Overall Study|Subject Withdrew Consent|2|||
37935722|NCT00670449|69622604|FG002|Overall Study|Subject Withdrew Consent|0|||
37935723|NCT00670449|69622605|FG003|Overall Study|Subject Withdrew Consent|1|||
37935724|NCT00670449|69622602|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
37935725|NCT00670449|69622603|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
37935726|NCT00670449|69622604|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
37935727|NCT00670449|69622605|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
37935728|NCT00670449|69622602|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
37935729|NCT00670449|69622603|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
37935730|NCT00670449|69622604|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
37935731|NCT00670449|69622605|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
37935732|NCT00668733|69622616|FG000|Overall Study|Lost to Follow-up|2|||
37935733|NCT00668733|69622617|FG001|Overall Study|Lost to Follow-up|3|||
37935734|NCT00668733|69622616|FG000|Overall Study|Withdrawal by Subject|0|||
37935735|NCT00668733|69622617|FG001|Overall Study|Withdrawal by Subject|4|||
37935736|NCT00673257|69622623|FG000|Overall Study|Withdrawal by Subject|4|||
37935737|NCT00673257|69622623|FG000|Overall Study|Unable to obtain specimen|1|||
37935738|NCT00667875|69622630|FG000|Overall Study|Adverse Event|0|||
37935739|NCT00667875|69622631|FG001|Overall Study|Adverse Event|2|||
37935740|NCT00667875|69622632|FG002|Overall Study|Adverse Event|6|||
37935741|NCT00667875|69622630|FG000|Overall Study|Withdrawal by Subject|10|||
37935742|NCT00667875|69622631|FG001|Overall Study|Withdrawal by Subject|9|||
37935743|NCT00667875|69622632|FG002|Overall Study|Withdrawal by Subject|7|||
37935744|NCT03468998|69622652|FG000|Overall Study|Withdrawal by Subject|1|||
37935745|NCT03468998|69622653|FG001|Overall Study|Withdrawal by Subject|1|||
37935746|NCT03468998|69622654|FG002|Overall Study|Withdrawal by Subject|0|||
37935747|NCT03468998|69622655|FG003|Overall Study|Withdrawal by Subject|4|||
37935748|NCT03468998|69622656|FG004|Overall Study|Withdrawal by Subject|1|||
37935749|NCT03468998|69622657|FG005|Overall Study|Withdrawal by Subject|0|||
37935750|NCT00667251|69622671|FG000|Overall Study|Adverse Event|13|||
37935751|NCT00667251|69622672|FG001|Overall Study|Adverse Event|4|||
37935752|NCT00667251|69622671|FG000|Overall Study|Withdrawal by Subject|6|||
37935753|NCT00667251|69622672|FG001|Overall Study|Withdrawal by Subject|2|||
37935754|NCT00667251|69622671|FG000|Overall Study|Other/missing|46|||
37935755|NCT00667251|69622672|FG001|Overall Study|Other/missing|84|||
37935756|NCT00667251|69622671|FG000|Overall Study|Intercurrent Illness|4|||
37935757|NCT00667251|69622672|FG001|Overall Study|Intercurrent Illness|3|||
37935758|NCT00667251|69622671|FG000|Overall Study|Symptomatic progression|1|||
37935759|NCT00667251|69622672|FG001|Overall Study|Symptomatic progression|2|||
37935760|NCT00669903|69622690|FG000|Overall Study|Adverse Event|0|||
37935761|NCT00669903|69622691|FG001|Overall Study|Adverse Event|1|||
37935762|NCT00669903|69622692|FG002|Overall Study|Adverse Event|3|||
37935763|NCT00669903|69622693|FG003|Overall Study|Adverse Event|1|||
37935764|NCT00669903|69622690|FG000|Overall Study|Withdrawal by Subject|0|||
37935765|NCT00669903|69622691|FG001|Overall Study|Withdrawal by Subject|2|||
37935766|NCT00669903|69622692|FG002|Overall Study|Withdrawal by Subject|2|||
37935767|NCT00669903|69622693|FG003|Overall Study|Withdrawal by Subject|2|||
37935768|NCT00669903|69622690|FG000|Overall Study|Lost to Follow-up|1|||
37935769|NCT00669903|69622691|FG001|Overall Study|Lost to Follow-up|1|||
37935770|NCT00669903|69622692|FG002|Overall Study|Lost to Follow-up|0|||
37935771|NCT00669903|69622693|FG003|Overall Study|Lost to Follow-up|1|||
37670320|NCT02055820|69143562|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
37670321|NCT02055820|69143563|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
37670322|NCT02055820|69143554|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
37670323|NCT02055820|69143555|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
37670324|NCT02055820|69143556|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
37935772|NCT00669903|69622690|FG000|Overall Study|Protocol Violation|0|||
37935773|NCT00669903|69622691|FG001|Overall Study|Protocol Violation|1|||
37935774|NCT00669903|69622692|FG002|Overall Study|Protocol Violation|0|||
37935775|NCT00669903|69622693|FG003|Overall Study|Protocol Violation|0|||
37935776|NCT03759392|69622705|FG000|Overall Study|Adverse Event|12|||
37935777|NCT03759392|69622706|FG001|Overall Study|Adverse Event|4|||
37935778|NCT03759392|69622705|FG000|Overall Study|Death|2|||
37935779|NCT03759392|69622706|FG001|Overall Study|Death|1|||
37935780|NCT03759392|69622705|FG000|Overall Study|Withdrawal by Subject|2|||
37935781|NCT03759392|69622706|FG001|Overall Study|Withdrawal by Subject|0|||
37935782|NCT03759392|69622705|FG000|Overall Study|Protocol Violation|2|||
37935783|NCT03759392|69622706|FG001|Overall Study|Protocol Violation|0|||
37935784|NCT03759392|69622705|FG000|Overall Study|Physician Decision|0|||
37935785|NCT03759392|69622706|FG001|Overall Study|Physician Decision|1|||
37935786|NCT03759392|69622705|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
37935787|NCT03759392|69622706|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
37935788|NCT03759392|69622705|FG000|Overall Study|No longer able to take medicines|1|||
37935789|NCT03759392|69622706|FG001|Overall Study|No longer able to take medicines|0|||
37935790|NCT03759392|69622705|FG000|Overall Study|Stopped taking study drug|1|||
37935791|NCT03759392|69622706|FG001|Overall Study|Stopped taking study drug|0|||
37935792|NCT00667719|69622712|FG000|Overall Study|Adverse Event|39|||
37935793|NCT00667719|69622712|FG000|Overall Study|Abnormal Test Procedure|1|||
37935794|NCT00667719|69622712|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
37935795|NCT00667719|69622712|FG000|Overall Study|Protocol Violation|3|||
37935796|NCT00667719|69622712|FG000|Overall Study|Withdrawal by Subject|17|||
37935797|NCT00667719|69622712|FG000|Overall Study|Lost to Follow-up|8|||
37935798|NCT00669669|69622721|FG000|Overall Study|To late to start treatment|1|||
37935799|NCT00467779|69622740|FG000|Stage 1|Adverse Event|1|||
37935800|NCT00467779|69622741|FG001|Stage 1|Adverse Event|0|||
37935801|NCT00467779|69622742|FG002|Stage 1|Adverse Event|0|||
37935802|NCT00467779|69622743|FG003|Stage 1|Adverse Event|0|||
37935803|NCT00467779|69622744|FG004|Stage 1|Adverse Event|0|||
37935804|NCT00467779|69622745|FG005|Stage 1|Adverse Event|1|||
37935805|NCT00467779|69622746|FG006|Stage 1|Adverse Event|2|||
37935806|NCT00467779|69622747|FG007|Stage 1|Adverse Event|1|||
37935807|NCT00467779|69622748|FG008|Stage 1|Adverse Event|0|||
37935808|NCT00467779|69622749|FG009|Stage 1|Adverse Event|0|||
37935809|NCT00467779|69622750|FG010|Stage 1|Adverse Event|0|||
37935810|NCT00467779|69622751|FG011|Stage 1|Adverse Event|0|||
37935811|NCT00467779|69622752|FG012|Stage 1|Adverse Event|0|||
37935812|NCT00467779|69622753|FG013|Stage 1|Adverse Event|0|||
37935813|NCT00467779|69622754|FG014|Stage 1|Adverse Event|0|||
37935814|NCT00467779|69622740|FG000|Stage 1|Disease Progression|2|||
37935815|NCT00467779|69622741|FG001|Stage 1|Disease Progression|2|||
37935816|NCT00467779|69622742|FG002|Stage 1|Disease Progression|2|||
37935817|NCT00467779|69622743|FG003|Stage 1|Disease Progression|3|||
37935818|NCT00467779|69622744|FG004|Stage 1|Disease Progression|2|||
37935819|NCT00467779|69622745|FG005|Stage 1|Disease Progression|2|||
37935820|NCT00467779|69622746|FG006|Stage 1|Disease Progression|4|||
37935821|NCT00467779|69622747|FG007|Stage 1|Disease Progression|5|||
37935822|NCT00467779|69622748|FG008|Stage 1|Disease Progression|0|||
37935823|NCT00467779|69622749|FG009|Stage 1|Disease Progression|0|||
37935824|NCT00467779|69622750|FG010|Stage 1|Disease Progression|0|||
37935825|NCT00467779|69622751|FG011|Stage 1|Disease Progression|0|||
37935826|NCT00467779|69622752|FG012|Stage 1|Disease Progression|0|||
37935827|NCT00467779|69622753|FG013|Stage 1|Disease Progression|0|||
37935828|NCT00467779|69622754|FG014|Stage 1|Disease Progression|0|||
37935829|NCT00467779|69622740|FG000|Stage 1|Unspecified Reason|1|||
37935830|NCT00467779|69622741|FG001|Stage 1|Unspecified Reason|0|||
37935831|NCT00467779|69622742|FG002|Stage 1|Unspecified Reason|1|||
37935832|NCT00467779|69622743|FG003|Stage 1|Unspecified Reason|0|||
37935833|NCT00467779|69622744|FG004|Stage 1|Unspecified Reason|1|||
37935834|NCT00467779|69622745|FG005|Stage 1|Unspecified Reason|2|||
37935835|NCT00467779|69622746|FG006|Stage 1|Unspecified Reason|0|||
37935836|NCT00467779|69622747|FG007|Stage 1|Unspecified Reason|0|||
37935837|NCT00467779|69622748|FG008|Stage 1|Unspecified Reason|0|||
37935838|NCT00467779|69622749|FG009|Stage 1|Unspecified Reason|0|||
37935839|NCT00467779|69622750|FG010|Stage 1|Unspecified Reason|0|||
37935840|NCT00467779|69622751|FG011|Stage 1|Unspecified Reason|0|||
37935841|NCT00467779|69622752|FG012|Stage 1|Unspecified Reason|0|||
37935842|NCT00467779|69622753|FG013|Stage 1|Unspecified Reason|0|||
37935843|NCT00467779|69622754|FG014|Stage 1|Unspecified Reason|0|||
37935844|NCT00467779|69622740|FG000|Stage 1|Physician Decision|0|||
37935845|NCT00467779|69622741|FG001|Stage 1|Physician Decision|1|||
37935846|NCT00467779|69622742|FG002|Stage 1|Physician Decision|0|||
37935847|NCT00467779|69622743|FG003|Stage 1|Physician Decision|0|||
37935848|NCT00467779|69622744|FG004|Stage 1|Physician Decision|0|||
37935849|NCT00467779|69622745|FG005|Stage 1|Physician Decision|0|||
37935850|NCT00467779|69622746|FG006|Stage 1|Physician Decision|0|||
37935851|NCT00467779|69622747|FG007|Stage 1|Physician Decision|0|||
37935852|NCT00467779|69622748|FG008|Stage 1|Physician Decision|0|||
37935853|NCT00467779|69622749|FG009|Stage 1|Physician Decision|0|||
37935854|NCT00467779|69622750|FG010|Stage 1|Physician Decision|0|||
37935855|NCT00467779|69622751|FG011|Stage 1|Physician Decision|0|||
37935856|NCT00467779|69622752|FG012|Stage 1|Physician Decision|0|||
37935857|NCT00467779|69622753|FG013|Stage 1|Physician Decision|0|||
37935858|NCT00467779|69622754|FG014|Stage 1|Physician Decision|0|||
37935859|NCT00467779|69622740|FG000|Stage 1|Withdrawal by Subject|0|||
37935860|NCT00467779|69622741|FG001|Stage 1|Withdrawal by Subject|0|||
37935861|NCT00467779|69622742|FG002|Stage 1|Withdrawal by Subject|0|||
37935862|NCT00467779|69622743|FG003|Stage 1|Withdrawal by Subject|0|||
37935863|NCT00467779|69622744|FG004|Stage 1|Withdrawal by Subject|0|||
37935864|NCT00467779|69622745|FG005|Stage 1|Withdrawal by Subject|0|||
37935865|NCT00467779|69622746|FG006|Stage 1|Withdrawal by Subject|1|||
37935866|NCT00467779|69622747|FG007|Stage 1|Withdrawal by Subject|1|||
37935867|NCT00467779|69622748|FG008|Stage 1|Withdrawal by Subject|0|||
37935868|NCT00467779|69622749|FG009|Stage 1|Withdrawal by Subject|0|||
37935869|NCT00467779|69622750|FG010|Stage 1|Withdrawal by Subject|0|||
37935870|NCT00467779|69622751|FG011|Stage 1|Withdrawal by Subject|0|||
37935871|NCT00467779|69622752|FG012|Stage 1|Withdrawal by Subject|0|||
37935872|NCT00467779|69622753|FG013|Stage 1|Withdrawal by Subject|0|||
37935873|NCT00467779|69622754|FG014|Stage 1|Withdrawal by Subject|0|||
37935874|NCT00467779|69622740|FG000|Stage 1A|Adverse Event|0|||
37935875|NCT00467779|69622741|FG001|Stage 1A|Adverse Event|0|||
37935876|NCT00467779|69622742|FG002|Stage 1A|Adverse Event|0|||
37935877|NCT00467779|69622743|FG003|Stage 1A|Adverse Event|0|||
37935878|NCT00467779|69622744|FG004|Stage 1A|Adverse Event|0|||
37935879|NCT00467779|69622745|FG005|Stage 1A|Adverse Event|0|||
37935880|NCT00467779|69622746|FG006|Stage 1A|Adverse Event|0|||
37670325|NCT02055820|69143557|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
37765107|NCT01516892|69278281|FG000|Overall Study|Subject Withdrew Consent|92|||
37935881|NCT00467779|69622747|FG007|Stage 1A|Adverse Event|0|||
37935882|NCT00467779|69622748|FG008|Stage 1A|Adverse Event|0|||
37935883|NCT00467779|69622749|FG009|Stage 1A|Adverse Event|0|||
37935884|NCT00467779|69622750|FG010|Stage 1A|Adverse Event|0|||
37935885|NCT00467779|69622751|FG011|Stage 1A|Adverse Event|0|||
37935886|NCT00467779|69622752|FG012|Stage 1A|Adverse Event|1|||
37935887|NCT00467779|69622753|FG013|Stage 1A|Adverse Event|0|||
37935888|NCT00467779|69622754|FG014|Stage 1A|Adverse Event|0|||
37935889|NCT00467779|69622740|FG000|Stage 1A|Death|0|||
37935890|NCT00467779|69622741|FG001|Stage 1A|Death|0|||
37935891|NCT00467779|69622742|FG002|Stage 1A|Death|0|||
37935892|NCT00467779|69622743|FG003|Stage 1A|Death|0|||
37935893|NCT00467779|69622744|FG004|Stage 1A|Death|0|||
37935894|NCT00467779|69622745|FG005|Stage 1A|Death|0|||
37935895|NCT00467779|69622746|FG006|Stage 1A|Death|0|||
37935896|NCT00467779|69622747|FG007|Stage 1A|Death|0|||
37935897|NCT00467779|69622748|FG008|Stage 1A|Death|0|||
37935898|NCT00467779|69622749|FG009|Stage 1A|Death|0|||
37935899|NCT00467779|69622750|FG010|Stage 1A|Death|0|||
37935900|NCT00467779|69622751|FG011|Stage 1A|Death|1|||
37935901|NCT00467779|69622752|FG012|Stage 1A|Death|1|||
37935902|NCT00467779|69622753|FG013|Stage 1A|Death|0|||
37935903|NCT00467779|69622754|FG014|Stage 1A|Death|0|||
37935904|NCT00467779|69622740|FG000|Stage 1A|Disease Progression|0|||
37935905|NCT00467779|69622741|FG001|Stage 1A|Disease Progression|0|||
37935906|NCT00467779|69622742|FG002|Stage 1A|Disease Progression|0|||
37765108|NCT01516892|69278281|FG000|Overall Study|Protocol Violation|60|||
37765109|NCT01516892|69278281|FG000|Overall Study|Other Miscellaneous Reasons|43|||
37935907|NCT00467779|69622743|FG003|Stage 1A|Disease Progression|0|||
37935908|NCT00467779|69622744|FG004|Stage 1A|Disease Progression|0|||
37935909|NCT00467779|69622745|FG005|Stage 1A|Disease Progression|0|||
37935910|NCT00467779|69622746|FG006|Stage 1A|Disease Progression|0|||
37935911|NCT00467779|69622747|FG007|Stage 1A|Disease Progression|0|||
37935912|NCT00467779|69622748|FG008|Stage 1A|Disease Progression|0|||
37935913|NCT00467779|69622749|FG009|Stage 1A|Disease Progression|2|||
37935914|NCT00467779|69622750|FG010|Stage 1A|Disease Progression|2|||
37935915|NCT00467779|69622751|FG011|Stage 1A|Disease Progression|5|||
37935916|NCT00467779|69622752|FG012|Stage 1A|Disease Progression|2|||
37935917|NCT00467779|69622753|FG013|Stage 1A|Disease Progression|0|||
37935918|NCT00467779|69622754|FG014|Stage 1A|Disease Progression|0|||
37935919|NCT00467779|69622740|FG000|Stage 1A|Physician Decision|0|||
37670326|NCT02055820|69143558|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
37670327|NCT02055820|69143559|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
37670328|NCT02055820|69143560|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
37935920|NCT00467779|69622741|FG001|Stage 1A|Physician Decision|0|||
37935921|NCT00467779|69622742|FG002|Stage 1A|Physician Decision|0|||
37935922|NCT00467779|69622743|FG003|Stage 1A|Physician Decision|0|||
37935923|NCT00467779|69622744|FG004|Stage 1A|Physician Decision|0|||
37935924|NCT00467779|69622745|FG005|Stage 1A|Physician Decision|0|||
37935925|NCT00467779|69622746|FG006|Stage 1A|Physician Decision|0|||
37935926|NCT00467779|69622747|FG007|Stage 1A|Physician Decision|0|||
37765110|NCT01516892|69278281|FG000|Overall Study|Missing|1|||
37935927|NCT00467779|69622748|FG008|Stage 1A|Physician Decision|0|||
37935928|NCT00467779|69622749|FG009|Stage 1A|Physician Decision|1|||
37935929|NCT00467779|69622750|FG010|Stage 1A|Physician Decision|0|||
37935930|NCT00467779|69622751|FG011|Stage 1A|Physician Decision|0|||
37935931|NCT00467779|69622752|FG012|Stage 1A|Physician Decision|0|||
37935932|NCT00467779|69622753|FG013|Stage 1A|Physician Decision|0|||
37935933|NCT00467779|69622754|FG014|Stage 1A|Physician Decision|0|||
37935934|NCT00467779|69622740|FG000|Stage 1A|Withdrawal by Subject|0|||
37935935|NCT00467779|69622741|FG001|Stage 1A|Withdrawal by Subject|0|||
37935936|NCT00467779|69622742|FG002|Stage 1A|Withdrawal by Subject|0|||
37935937|NCT00467779|69622743|FG003|Stage 1A|Withdrawal by Subject|0|||
37935938|NCT00467779|69622744|FG004|Stage 1A|Withdrawal by Subject|0|||
37935939|NCT00467779|69622745|FG005|Stage 1A|Withdrawal by Subject|0|||
37935940|NCT00467779|69622746|FG006|Stage 1A|Withdrawal by Subject|0|||
37935941|NCT00467779|69622747|FG007|Stage 1A|Withdrawal by Subject|0|||
37935942|NCT00467779|69622748|FG008|Stage 1A|Withdrawal by Subject|0|||
37935943|NCT00467779|69622749|FG009|Stage 1A|Withdrawal by Subject|0|||
37935944|NCT00467779|69622750|FG010|Stage 1A|Withdrawal by Subject|1|||
37935945|NCT00467779|69622751|FG011|Stage 1A|Withdrawal by Subject|1|||
37935946|NCT00467779|69622752|FG012|Stage 1A|Withdrawal by Subject|1|||
37935947|NCT00467779|69622753|FG013|Stage 1A|Withdrawal by Subject|0|||
37935948|NCT00467779|69622754|FG014|Stage 1A|Withdrawal by Subject|0|||
37935949|NCT00467779|69622740|FG000|Stage 1A|Unspecified Reason|0|||
37935950|NCT00467779|69622741|FG001|Stage 1A|Unspecified Reason|0|||
37935951|NCT00467779|69622742|FG002|Stage 1A|Unspecified Reason|0|||
37935952|NCT00467779|69622743|FG003|Stage 1A|Unspecified Reason|0|||
37935953|NCT00467779|69622744|FG004|Stage 1A|Unspecified Reason|0|||
37935954|NCT00467779|69622745|FG005|Stage 1A|Unspecified Reason|0|||
37935955|NCT00467779|69622746|FG006|Stage 1A|Unspecified Reason|0|||
37935956|NCT00467779|69622747|FG007|Stage 1A|Unspecified Reason|0|||
37935957|NCT00467779|69622748|FG008|Stage 1A|Unspecified Reason|0|||
37935958|NCT00467779|69622749|FG009|Stage 1A|Unspecified Reason|0|||
37935959|NCT00467779|69622750|FG010|Stage 1A|Unspecified Reason|0|||
37935960|NCT00467779|69622751|FG011|Stage 1A|Unspecified Reason|1|||
37935961|NCT00467779|69622752|FG012|Stage 1A|Unspecified Reason|1|||
37935962|NCT00467779|69622753|FG013|Stage 1A|Unspecified Reason|0|||
37935963|NCT00467779|69622754|FG014|Stage 1A|Unspecified Reason|0|||
37935964|NCT00467779|69622740|FG000|Stage 2|Adverse Event|0|||
37935965|NCT00467779|69622741|FG001|Stage 2|Adverse Event|0|||
37935966|NCT00467779|69622742|FG002|Stage 2|Adverse Event|0|||
37935967|NCT00467779|69622743|FG003|Stage 2|Adverse Event|0|||
37935968|NCT00467779|69622744|FG004|Stage 2|Adverse Event|0|||
37935969|NCT00467779|69622745|FG005|Stage 2|Adverse Event|0|||
37935970|NCT00467779|69622746|FG006|Stage 2|Adverse Event|0|||
37935971|NCT00467779|69622747|FG007|Stage 2|Adverse Event|0|||
37935972|NCT00467779|69622748|FG008|Stage 2|Adverse Event|1|||
37935973|NCT00467779|69622749|FG009|Stage 2|Adverse Event|0|||
37935974|NCT00467779|69622750|FG010|Stage 2|Adverse Event|0|||
37935975|NCT00467779|69622751|FG011|Stage 2|Adverse Event|0|||
37935976|NCT00467779|69622752|FG012|Stage 2|Adverse Event|0|||
37935977|NCT00467779|69622753|FG013|Stage 2|Adverse Event|0|||
37935978|NCT00467779|69622754|FG014|Stage 2|Adverse Event|0|||
37935979|NCT00467779|69622740|FG000|Stage 2|Death|0|||
37935980|NCT00467779|69622741|FG001|Stage 2|Death|0|||
37935981|NCT00467779|69622742|FG002|Stage 2|Death|0|||
37935982|NCT00467779|69622743|FG003|Stage 2|Death|0|||
37935983|NCT00467779|69622744|FG004|Stage 2|Death|0|||
37935984|NCT00467779|69622745|FG005|Stage 2|Death|0|||
37935985|NCT00467779|69622746|FG006|Stage 2|Death|0|||
37935986|NCT00467779|69622747|FG007|Stage 2|Death|0|||
37935987|NCT00467779|69622748|FG008|Stage 2|Death|1|||
37935988|NCT00467779|69622749|FG009|Stage 2|Death|0|||
37935989|NCT00467779|69622750|FG010|Stage 2|Death|0|||
37935990|NCT00467779|69622751|FG011|Stage 2|Death|0|||
37935991|NCT00467779|69622752|FG012|Stage 2|Death|0|||
37935992|NCT00467779|69622753|FG013|Stage 2|Death|0|||
37935993|NCT00467779|69622754|FG014|Stage 2|Death|0|||
37935994|NCT00467779|69622740|FG000|Stage 2|Disease Progression|0|||
37935995|NCT00467779|69622741|FG001|Stage 2|Disease Progression|0|||
37935996|NCT00467779|69622742|FG002|Stage 2|Disease Progression|0|||
37935997|NCT00467779|69622743|FG003|Stage 2|Disease Progression|0|||
37670329|NCT02055820|69143561|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
37935998|NCT00467779|69622744|FG004|Stage 2|Disease Progression|0|||
37935999|NCT00467779|69622745|FG005|Stage 2|Disease Progression|0|||
37936000|NCT00467779|69622746|FG006|Stage 2|Disease Progression|0|||
37936001|NCT00467779|69622747|FG007|Stage 2|Disease Progression|0|||
37936002|NCT00467779|69622748|FG008|Stage 2|Disease Progression|16|||
37936003|NCT00467779|69622749|FG009|Stage 2|Disease Progression|0|||
37936004|NCT00467779|69622750|FG010|Stage 2|Disease Progression|0|||
37936005|NCT00467779|69622751|FG011|Stage 2|Disease Progression|0|||
37936006|NCT00467779|69622752|FG012|Stage 2|Disease Progression|0|||
37936007|NCT00467779|69622753|FG013|Stage 2|Disease Progression|0|||
37936008|NCT00467779|69622754|FG014|Stage 2|Disease Progression|0|||
37936009|NCT00467779|69622740|FG000|Stage 2|Unspecified Reason|0|||
37936010|NCT00467779|69622741|FG001|Stage 2|Unspecified Reason|0|||
37936011|NCT00467779|69622742|FG002|Stage 2|Unspecified Reason|0|||
37936012|NCT00467779|69622743|FG003|Stage 2|Unspecified Reason|0|||
37670330|NCT02055820|69143562|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
37936013|NCT00467779|69622744|FG004|Stage 2|Unspecified Reason|0|||
37936014|NCT00467779|69622745|FG005|Stage 2|Unspecified Reason|0|||
37936015|NCT00467779|69622746|FG006|Stage 2|Unspecified Reason|0|||
37936016|NCT00467779|69622747|FG007|Stage 2|Unspecified Reason|0|||
37936017|NCT00467779|69622748|FG008|Stage 2|Unspecified Reason|3|||
37936018|NCT00467779|69622749|FG009|Stage 2|Unspecified Reason|0|||
37936019|NCT00467779|69622750|FG010|Stage 2|Unspecified Reason|0|||
37936020|NCT00467779|69622751|FG011|Stage 2|Unspecified Reason|0|||
37936021|NCT00467779|69622752|FG012|Stage 2|Unspecified Reason|0|||
37936022|NCT00467779|69622753|FG013|Stage 2|Unspecified Reason|0|||
37936023|NCT00467779|69622754|FG014|Stage 2|Unspecified Reason|0|||
37936024|NCT00467779|69622740|FG000|Stage 2A|Adverse Event|0|||
37936025|NCT00467779|69622741|FG001|Stage 2A|Adverse Event|0|||
37936026|NCT00467779|69622742|FG002|Stage 2A|Adverse Event|0|||
37936027|NCT00467779|69622743|FG003|Stage 2A|Adverse Event|0|||
37936028|NCT00467779|69622744|FG004|Stage 2A|Adverse Event|0|||
37936029|NCT00467779|69622745|FG005|Stage 2A|Adverse Event|0|||
37936030|NCT00467779|69622746|FG006|Stage 2A|Adverse Event|0|||
37936031|NCT00467779|69622747|FG007|Stage 2A|Adverse Event|0|||
37936032|NCT00467779|69622748|FG008|Stage 2A|Adverse Event|0|||
37936033|NCT00467779|69622749|FG009|Stage 2A|Adverse Event|0|||
37936034|NCT00467779|69622750|FG010|Stage 2A|Adverse Event|0|||
37936035|NCT00467779|69622751|FG011|Stage 2A|Adverse Event|0|||
37936036|NCT00467779|69622752|FG012|Stage 2A|Adverse Event|0|||
37936037|NCT00467779|69622753|FG013|Stage 2A|Adverse Event|2|||
37936038|NCT00467779|69622754|FG014|Stage 2A|Adverse Event|0|||
37936039|NCT00467779|69622740|FG000|Stage 2A|Death|0|||
37936040|NCT00467779|69622741|FG001|Stage 2A|Death|0|||
37936041|NCT00467779|69622742|FG002|Stage 2A|Death|0|||
37936042|NCT00467779|69622743|FG003|Stage 2A|Death|0|||
37936043|NCT00467779|69622744|FG004|Stage 2A|Death|0|||
37936044|NCT00467779|69622745|FG005|Stage 2A|Death|0|||
37936045|NCT00467779|69622746|FG006|Stage 2A|Death|0|||
37936046|NCT00467779|69622747|FG007|Stage 2A|Death|0|||
37936047|NCT00467779|69622748|FG008|Stage 2A|Death|0|||
37936048|NCT00467779|69622749|FG009|Stage 2A|Death|0|||
37936049|NCT00467779|69622750|FG010|Stage 2A|Death|0|||
37936050|NCT00467779|69622751|FG011|Stage 2A|Death|0|||
37936051|NCT00467779|69622752|FG012|Stage 2A|Death|0|||
37936052|NCT00467779|69622753|FG013|Stage 2A|Death|1|||
37936053|NCT00467779|69622754|FG014|Stage 2A|Death|0|||
37936054|NCT00467779|69622740|FG000|Stage 2A|Disease Progression|0|||
37936055|NCT00467779|69622741|FG001|Stage 2A|Disease Progression|0|||
37936056|NCT00467779|69622742|FG002|Stage 2A|Disease Progression|0|||
37936057|NCT00467779|69622743|FG003|Stage 2A|Disease Progression|0|||
37936058|NCT00467779|69622744|FG004|Stage 2A|Disease Progression|0|||
37936059|NCT00467779|69622745|FG005|Stage 2A|Disease Progression|0|||
37936060|NCT00467779|69622746|FG006|Stage 2A|Disease Progression|0|||
37936061|NCT00467779|69622747|FG007|Stage 2A|Disease Progression|0|||
37936062|NCT00467779|69622748|FG008|Stage 2A|Disease Progression|0|||
37936063|NCT00467779|69622749|FG009|Stage 2A|Disease Progression|0|||
37936064|NCT00467779|69622750|FG010|Stage 2A|Disease Progression|0|||
37936065|NCT00467779|69622751|FG011|Stage 2A|Disease Progression|0|||
37936066|NCT00467779|69622752|FG012|Stage 2A|Disease Progression|0|||
37936067|NCT00467779|69622753|FG013|Stage 2A|Disease Progression|10|||
37936068|NCT00467779|69622754|FG014|Stage 2A|Disease Progression|0|||
37936069|NCT00467779|69622740|FG000|Stage 2A|Unspecified Reason|0|||
37936070|NCT00467779|69622741|FG001|Stage 2A|Unspecified Reason|0|||
37936071|NCT00467779|69622742|FG002|Stage 2A|Unspecified Reason|0|||
37936072|NCT00467779|69622743|FG003|Stage 2A|Unspecified Reason|0|||
37936073|NCT00467779|69622744|FG004|Stage 2A|Unspecified Reason|0|||
37936074|NCT00467779|69622745|FG005|Stage 2A|Unspecified Reason|0|||
37936075|NCT00467779|69622746|FG006|Stage 2A|Unspecified Reason|0|||
37936076|NCT00467779|69622747|FG007|Stage 2A|Unspecified Reason|0|||
37936077|NCT00467779|69622748|FG008|Stage 2A|Unspecified Reason|0|||
37936078|NCT00467779|69622749|FG009|Stage 2A|Unspecified Reason|0|||
37936079|NCT00467779|69622750|FG010|Stage 2A|Unspecified Reason|0|||
37936080|NCT00467779|69622751|FG011|Stage 2A|Unspecified Reason|0|||
37936081|NCT00467779|69622752|FG012|Stage 2A|Unspecified Reason|0|||
37936082|NCT00467779|69622753|FG013|Stage 2A|Unspecified Reason|7|||
37936083|NCT00467779|69622754|FG014|Stage 2A|Unspecified Reason|0|||
37936084|NCT00467779|69622740|FG000|Stage 2A|Withdrawal by Subject|0|||
37936085|NCT00467779|69622741|FG001|Stage 2A|Withdrawal by Subject|0|||
37936086|NCT00467779|69622742|FG002|Stage 2A|Withdrawal by Subject|0|||
37936087|NCT00467779|69622743|FG003|Stage 2A|Withdrawal by Subject|0|||
37765111|NCT01516736|69278306|FG000|Overall Study|Withdrawal by Subject|10|||
37936088|NCT00467779|69622744|FG004|Stage 2A|Withdrawal by Subject|0|||
37936089|NCT00467779|69622745|FG005|Stage 2A|Withdrawal by Subject|0|||
37936090|NCT00467779|69622746|FG006|Stage 2A|Withdrawal by Subject|0|||
37936091|NCT00467779|69622747|FG007|Stage 2A|Withdrawal by Subject|0|||
37670331|NCT02055820|69143563|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
37936092|NCT00467779|69622748|FG008|Stage 2A|Withdrawal by Subject|0|||
37936093|NCT00467779|69622749|FG009|Stage 2A|Withdrawal by Subject|0|||
37936094|NCT00467779|69622750|FG010|Stage 2A|Withdrawal by Subject|0|||
37936095|NCT00467779|69622751|FG011|Stage 2A|Withdrawal by Subject|0|||
37936096|NCT00467779|69622752|FG012|Stage 2A|Withdrawal by Subject|0|||
37936097|NCT00467779|69622753|FG013|Stage 2A|Withdrawal by Subject|1|||
37936098|NCT00467779|69622754|FG014|Stage 2A|Withdrawal by Subject|0|||
37936099|NCT00467779|69622740|FG000|Stage 3|Adverse Event|0|||
37936100|NCT00467779|69622741|FG001|Stage 3|Adverse Event|0|||
37936101|NCT00467779|69622742|FG002|Stage 3|Adverse Event|0|||
37936102|NCT00467779|69622743|FG003|Stage 3|Adverse Event|0|||
37936103|NCT00467779|69622744|FG004|Stage 3|Adverse Event|0|||
37936104|NCT00467779|69622745|FG005|Stage 3|Adverse Event|0|||
37936105|NCT00467779|69622746|FG006|Stage 3|Adverse Event|0|||
37936106|NCT00467779|69622747|FG007|Stage 3|Adverse Event|0|||
37936107|NCT00467779|69622748|FG008|Stage 3|Adverse Event|0|||
37936108|NCT00467779|69622749|FG009|Stage 3|Adverse Event|0|||
37936109|NCT00467779|69622750|FG010|Stage 3|Adverse Event|0|||
37936110|NCT00467779|69622751|FG011|Stage 3|Adverse Event|0|||
37936111|NCT00467779|69622752|FG012|Stage 3|Adverse Event|0|||
37936112|NCT00467779|69622753|FG013|Stage 3|Adverse Event|0|||
37936113|NCT00467779|69622754|FG014|Stage 3|Adverse Event|2|||
37936114|NCT00467779|69622740|FG000|Stage 3|Death|0|||
37936115|NCT00467779|69622741|FG001|Stage 3|Death|0|||
37936116|NCT00467779|69622742|FG002|Stage 3|Death|0|||
37936117|NCT00467779|69622743|FG003|Stage 3|Death|0|||
37936118|NCT00467779|69622744|FG004|Stage 3|Death|0|||
37936119|NCT00467779|69622745|FG005|Stage 3|Death|0|||
37936120|NCT00467779|69622746|FG006|Stage 3|Death|0|||
37936121|NCT00467779|69622747|FG007|Stage 3|Death|0|||
37936122|NCT00467779|69622748|FG008|Stage 3|Death|0|||
37936123|NCT00467779|69622749|FG009|Stage 3|Death|0|||
37936124|NCT00467779|69622750|FG010|Stage 3|Death|0|||
37936125|NCT00467779|69622751|FG011|Stage 3|Death|0|||
37936126|NCT00467779|69622752|FG012|Stage 3|Death|0|||
37936127|NCT00467779|69622753|FG013|Stage 3|Death|0|||
37936128|NCT00467779|69622754|FG014|Stage 3|Death|1|||
37936129|NCT00467779|69622740|FG000|Stage 3|Disease Progression|0|||
37936130|NCT00467779|69622741|FG001|Stage 3|Disease Progression|0|||
37936131|NCT00467779|69622742|FG002|Stage 3|Disease Progression|0|||
37936132|NCT00467779|69622743|FG003|Stage 3|Disease Progression|0|||
37936133|NCT00467779|69622744|FG004|Stage 3|Disease Progression|0|||
37936134|NCT00467779|69622745|FG005|Stage 3|Disease Progression|0|||
37936135|NCT00467779|69622746|FG006|Stage 3|Disease Progression|0|||
37936136|NCT00467779|69622747|FG007|Stage 3|Disease Progression|0|||
37936137|NCT00467779|69622748|FG008|Stage 3|Disease Progression|0|||
37936138|NCT00467779|69622749|FG009|Stage 3|Disease Progression|0|||
37936139|NCT00467779|69622750|FG010|Stage 3|Disease Progression|0|||
37936140|NCT00467779|69622751|FG011|Stage 3|Disease Progression|0|||
37936141|NCT00467779|69622752|FG012|Stage 3|Disease Progression|0|||
37936142|NCT00467779|69622753|FG013|Stage 3|Disease Progression|0|||
37936143|NCT00467779|69622754|FG014|Stage 3|Disease Progression|9|||
37936144|NCT00467779|69622740|FG000|Stage 3|Unspecified Reason|0|||
37936145|NCT00467779|69622741|FG001|Stage 3|Unspecified Reason|0|||
37936146|NCT00467779|69622742|FG002|Stage 3|Unspecified Reason|0|||
37936147|NCT00467779|69622743|FG003|Stage 3|Unspecified Reason|0|||
37936148|NCT00467779|69622744|FG004|Stage 3|Unspecified Reason|0|||
37936149|NCT00467779|69622745|FG005|Stage 3|Unspecified Reason|0|||
37936150|NCT00467779|69622746|FG006|Stage 3|Unspecified Reason|0|||
37936151|NCT00467779|69622747|FG007|Stage 3|Unspecified Reason|0|||
37936152|NCT00467779|69622748|FG008|Stage 3|Unspecified Reason|0|||
37936153|NCT00467779|69622749|FG009|Stage 3|Unspecified Reason|0|||
37936154|NCT00467779|69622750|FG010|Stage 3|Unspecified Reason|0|||
37936155|NCT00467779|69622751|FG011|Stage 3|Unspecified Reason|0|||
37936156|NCT00467779|69622752|FG012|Stage 3|Unspecified Reason|0|||
37936157|NCT00467779|69622753|FG013|Stage 3|Unspecified Reason|0|||
37936158|NCT00467779|69622754|FG014|Stage 3|Unspecified Reason|5|||
37936159|NCT00570687|69622794|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
37936160|NCT00570687|69622795|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
37936161|NCT00570687|69622796|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
37936162|NCT00570687|69622797|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
37936163|NCT00570687|69622798|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
37936164|NCT00570687|69622799|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
37936165|NCT00570687|69622800|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
37936166|NCT00570687|69622801|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
37936167|NCT00570687|69622802|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
37936168|NCT00570687|69622803|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
37936169|NCT00570687|69622794|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
37936170|NCT00570687|69622795|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
37936171|NCT00570687|69622796|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
37936172|NCT00570687|69622797|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
37936173|NCT00570687|69622798|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
37936174|NCT00570687|69622799|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
37936175|NCT00570687|69622800|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
37936176|NCT00570687|69622801|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
37936177|NCT00570687|69622802|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
37936178|NCT00570687|69622803|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
37936179|NCT00570687|69622794|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
37936180|NCT00570687|69622795|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
37936181|NCT00570687|69622796|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
37936182|NCT00570687|69622797|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
37936183|NCT00570687|69622798|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
37936184|NCT00570687|69622799|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
37936185|NCT00570687|69622800|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
37936186|NCT00570687|69622801|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
37936187|NCT00570687|69622802|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
37936188|NCT00570687|69622803|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
37936189|NCT03836677|69622817|FG000|Period 1|Adverse Event|0|||
37936190|NCT03836677|69622818|FG001|Period 1|Adverse Event|1|||
37936191|NCT03836677|69622817|FG000|Period 2|Severe non-compliance to protocol|1|||
37936192|NCT03836677|69622818|FG001|Period 2|Severe non-compliance to protocol|0|||
37936193|NCT00434161|69622849|FG000|Overall Study|Adverse Event|5|||
37936194|NCT00434161|69622850|FG001|Overall Study|Adverse Event|1|||
37936195|NCT00434161|69622851|FG002|Overall Study|Adverse Event|4|||
37936196|NCT00434161|69622849|FG000|Overall Study|Lost to Follow-up|0|||
37936197|NCT00434161|69622850|FG001|Overall Study|Lost to Follow-up|1|||
37936198|NCT00434161|69622851|FG002|Overall Study|Lost to Follow-up|0|||
37936199|NCT00434161|69622849|FG000|Overall Study|Death|1|||
37936200|NCT00434161|69622850|FG001|Overall Study|Death|0|||
37936201|NCT00434161|69622851|FG002|Overall Study|Death|1|||
37936202|NCT00434161|69622849|FG000|Overall Study|Non-Compliance|1|||
37936203|NCT00434161|69622850|FG001|Overall Study|Non-Compliance|1|||
37936204|NCT00434161|69622851|FG002|Overall Study|Non-Compliance|0|||
37936205|NCT00434161|69622849|FG000|Overall Study|Withdrawal by Subject|2|||
37936206|NCT00434161|69622850|FG001|Overall Study|Withdrawal by Subject|0|||
37936207|NCT00434161|69622851|FG002|Overall Study|Withdrawal by Subject|3|||
37936208|NCT00434161|69622849|FG000|Overall Study|Logistical error study assessments|1|||
37936209|NCT00434161|69622850|FG001|Overall Study|Logistical error study assessments|0|||
37859560|NCT00960661|69542897|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
37859561|NCT00960661|69542895|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
37859562|NCT00960661|69542896|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
37859563|NCT00960661|69542897|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
37859564|NCT00960661|69542895|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
37859565|NCT00960661|69542896|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
37859566|NCT00960661|69542897|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
37859567|NCT00960661|69542895|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
37859568|NCT00960661|69542896|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
37859569|NCT00960661|69542897|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
37859570|NCT00960661|69542895|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
37859571|NCT00960661|69542896|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
37859572|NCT00960661|69542897|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
37859573|NCT00960661|69542895|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
37859574|NCT00960661|69542896|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
37859575|NCT00960661|69542897|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
37859576|NCT00960661|69542895|FG000|Interventional Phase|Adverse Event|0|||
37859577|NCT00960661|69542896|FG001|Interventional Phase|Adverse Event|17|||
37859578|NCT00960661|69542897|FG002|Interventional Phase|Adverse Event|8|||
37859579|NCT00960661|69542895|FG000|Interventional Phase|Death|0|||
37859580|NCT00960661|69542896|FG001|Interventional Phase|Death|1|||
37859581|NCT00960661|69542897|FG002|Interventional Phase|Death|0|||
37859582|NCT00960661|69542895|FG000|Interventional Phase|Lost to Follow-up|0|||
37859583|NCT00960661|69542896|FG001|Interventional Phase|Lost to Follow-up|0|||
37859584|NCT00960661|69542897|FG002|Interventional Phase|Lost to Follow-up|2|||
37859585|NCT00960661|69542895|FG000|Interventional Phase|entry criteria not met|0|||
37859586|NCT00960661|69542896|FG001|Interventional Phase|entry criteria not met|3|||
37859587|NCT00960661|69542897|FG002|Interventional Phase|entry criteria not met|0|||
37859588|NCT00960661|69542895|FG000|Interventional Phase|Protocol Violation|0|||
37859589|NCT00960661|69542896|FG001|Interventional Phase|Protocol Violation|7|||
37859590|NCT00960661|69542897|FG002|Interventional Phase|Protocol Violation|2|||
37859591|NCT00960661|69542895|FG000|Interventional Phase|Withdrawal by Subject|0|||
37859592|NCT00960661|69542896|FG001|Interventional Phase|Withdrawal by Subject|18|||
37859593|NCT00960661|69542897|FG002|Interventional Phase|Withdrawal by Subject|29|||
37859594|NCT00960661|69542895|FG000|Interventional Phase|Physician Decision|0|||
37859595|NCT00960661|69542896|FG001|Interventional Phase|Physician Decision|3|||
37859596|NCT00960661|69542897|FG002|Interventional Phase|Physician Decision|5|||
37859597|NCT00960661|69542895|FG000|Interventional Phase|sponsor decision|0|||
37859598|NCT00960661|69542896|FG001|Interventional Phase|sponsor decision|1|||
37859599|NCT00960661|69542897|FG002|Interventional Phase|sponsor decision|0|||
37859600|NCT00960661|69542895|FG000|Interventional Phase|Lack of Efficacy|0|||
37859601|NCT00960661|69542896|FG001|Interventional Phase|Lack of Efficacy|2|||
37859602|NCT00960661|69542897|FG002|Interventional Phase|Lack of Efficacy|0|||
37936210|NCT00434161|69622851|FG002|Overall Study|Logistical error study assessments|3|||
37936211|NCT00441103|69622868|FG000|Overall Study|Adverse Event|2|||
37936212|NCT00441103|69622869|FG001|Overall Study|Adverse Event|1|||
37936213|NCT00441103|69622868|FG000|Overall Study|Death|1|||
37936214|NCT00441103|69622869|FG001|Overall Study|Death|0|||
37936215|NCT00441103|69622868|FG000|Overall Study|Disease Progression|2|||
37936216|NCT00441103|69622869|FG001|Overall Study|Disease Progression|0|||
37936217|NCT00441103|69622868|FG000|Overall Study|Lost to Follow-up|1|||
37936218|NCT00441103|69622869|FG001|Overall Study|Lost to Follow-up|0|||
37936219|NCT00441103|69622868|FG000|Overall Study|Protocol Violation|1|||
37936220|NCT00441103|69622869|FG001|Overall Study|Protocol Violation|0|||
37936221|NCT00441103|69622868|FG000|Overall Study|Participant unable to use Rebiject II|1|||
37936222|NCT00441103|69622869|FG001|Overall Study|Participant unable to use Rebiject II|0|||
37936223|NCT00441103|69622868|FG000|Overall Study|Participant refused MRI|1|||
37936224|NCT00441103|69622869|FG001|Overall Study|Participant refused MRI|0|||
37936225|NCT00441103|69622868|FG000|Overall Study|Inclusion criteria absent|1|||
37936226|NCT00441103|69622869|FG001|Overall Study|Inclusion criteria absent|0|||
37936227|NCT00441103|69622868|FG000|Overall Study|Non-compliant|0|||
37936228|NCT00441103|69622869|FG001|Overall Study|Non-compliant|1|||
37936229|NCT00441103|69622868|FG000|Overall Study|Participant decided to withdraw|1|||
37936230|NCT00441103|69622869|FG001|Overall Study|Participant decided to withdraw|0|||
37936231|NCT00441103|69622868|FG000|Overall Study|Participant's reason|0|||
37936232|NCT00441103|69622869|FG001|Overall Study|Participant's reason|1|||
37936233|NCT00441103|69622868|FG000|Overall Study|Participant decided to stop|0|||
37936234|NCT00441103|69622869|FG001|Overall Study|Participant decided to stop|1|||
37936235|NCT00433771|69622876|FG000|Overall Study|screen fail|14|||
37936236|NCT00433771|69622876|FG000|Overall Study|Treated and later found to be ineligible|2|||
37936237|NCT00433771|69622876|FG000|Overall Study|Death|2|||
37936238|NCT00433771|69622876|FG000|Overall Study|Failure to deploy stent|1|||
37936239|NCT00433537|69622880|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
37936240|NCT00433537|69622881|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
37936241|NCT00433537|69622882|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
37936242|NCT00433537|69622880|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
37936243|NCT00433537|69622881|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
37936244|NCT00433537|69622882|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
37936245|NCT00433537|69622880|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
37936246|NCT00433537|69622881|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
37936247|NCT00433537|69622882|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
37936248|NCT00433537|69622880|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
37936249|NCT00433537|69622881|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
37936250|NCT00433537|69622882|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
37936251|NCT00433537|69622880|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
37936252|NCT00433537|69622881|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
37936253|NCT00433537|69622882|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
37936254|NCT00433537|69622880|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
37936255|NCT00433537|69622881|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
37936256|NCT00433537|69622882|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
37936257|NCT00433537|69622880|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
37936258|NCT00433537|69622881|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
37936259|NCT00433537|69622882|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
37936260|NCT00433537|69622880|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
37936261|NCT00433537|69622881|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
37936262|NCT00433537|69622882|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
37936263|NCT00433537|69622880|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
37936264|NCT00433537|69622881|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
37936265|NCT00433537|69622882|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
37936266|NCT00570765|69622892|FG000|DB Phase|Withdrawal by Subject|1|||
37936267|NCT00570765|69622893|FG001|DB Phase|Withdrawal by Subject|0|||
37936268|NCT00570765|69622894|FG002|DB Phase|Withdrawal by Subject|0|||
37936269|NCT00570765|69622895|FG003|DB Phase|Withdrawal by Subject|0|||
37936270|NCT00570765|69622892|FG000|DB Phase|Protocol Violation|0|||
37936271|NCT00570765|69622893|FG001|DB Phase|Protocol Violation|1|||
37936272|NCT00570765|69622894|FG002|DB Phase|Protocol Violation|0|||
37936273|NCT00570765|69622895|FG003|DB Phase|Protocol Violation|0|||
37936274|NCT00570765|69622892|FG000|DB Phase|Adverse Event|3|||
37936275|NCT00570765|69622893|FG001|DB Phase|Adverse Event|6|||
37936276|NCT00570765|69622894|FG002|DB Phase|Adverse Event|0|||
37936277|NCT00570765|69622895|FG003|DB Phase|Adverse Event|0|||
37936278|NCT00570765|69622892|FG000|DB Phase|Did Not Receive Study Drug|0|||
37936279|NCT00570765|69622893|FG001|DB Phase|Did Not Receive Study Drug|0|||
37936280|NCT00570765|69622894|FG002|DB Phase|Did Not Receive Study Drug|1|||
37936281|NCT00570765|69622895|FG003|DB Phase|Did Not Receive Study Drug|0|||
37670332|NCT02055820|69143554|FG000|Phase II: Expansion|Death|0|||
37936282|NCT00570765|69622892|FG000|LTSE Phase|Withdrawal by Subject|0|||
37936283|NCT00570765|69622893|FG001|LTSE Phase|Withdrawal by Subject|0|||
37936284|NCT00570765|69622894|FG002|LTSE Phase|Withdrawal by Subject|0|||
37936285|NCT00570765|69622895|FG003|LTSE Phase|Withdrawal by Subject|1|||
37936286|NCT00570765|69622892|FG000|LTSE Phase|Adverse Event|0|||
37936287|NCT00570765|69622893|FG001|LTSE Phase|Adverse Event|0|||
37936288|NCT00570765|69622894|FG002|LTSE Phase|Adverse Event|0|||
37936289|NCT00570765|69622895|FG003|LTSE Phase|Adverse Event|7|||
37936290|NCT00570765|69622892|FG000|LTSE Phase|Physician Decision|0|||
37936291|NCT00570765|69622893|FG001|LTSE Phase|Physician Decision|0|||
37936292|NCT00570765|69622894|FG002|LTSE Phase|Physician Decision|0|||
37936293|NCT00570765|69622895|FG003|LTSE Phase|Physician Decision|4|||
37936294|NCT00667563|69622906|FG000|Overall Study|Protocol Violation|24|||
37936295|NCT00667095|69622912|FG000|Overall Study|Withdrawal by Subject|0|||
37936296|NCT00667095|69622913|FG001|Overall Study|Withdrawal by Subject|1|||
37936297|NCT00433381|69622921|FG000|Overall Study|Ineligible / no protocol treatment|3|||
37936298|NCT00433381|69622922|FG001|Overall Study|Ineligible / no protocol treatment|3|||
37936299|NCT00667017|69622936|FG000|Overall Study|Withdrawal by Subject|1|||
37936300|NCT00666705|69622940|FG000|Overall Study|Withdrawal by Subject|1|||
37936301|NCT00433147|69622953|FG000|Overall Study|Adverse Event|0|||
37936302|NCT00433147|69622954|FG001|Overall Study|Adverse Event|1|||
37936303|NCT00433147|69622955|FG002|Overall Study|Adverse Event|0|||
37936304|NCT00433147|69622956|FG003|Overall Study|Adverse Event|0|||
37936305|NCT00666237|69622968|FG000|Overall Study|Death|5|||
37936306|NCT00666237|69622969|FG001|Overall Study|Death|5|||
37936307|NCT00666237|69622968|FG000|Overall Study|Lost to Follow-up|29|||
37936308|NCT00666237|69622969|FG001|Overall Study|Lost to Follow-up|25|||
37936309|NCT00662025|69622975|FG000|Overall Study|Objective progression or relapse|51|||
37936310|NCT00662025|69622975|FG000|Overall Study|Adverse Event|7|||
37936311|NCT00662025|69622975|FG000|Overall Study|Withdrawal by Subject|1|||
37936312|NCT00662025|69622975|FG000|Overall Study|Results of other clinical study|2|||
37936313|NCT00662025|69622975|FG000|Overall Study|Target lesion cannot be evaluated|1|||
37936314|NCT00662025|69622975|FG000|Overall Study|Domestic circumstances|1|||
37936315|NCT00440947|69622979|FG000|36-Week Induction Phase|Adverse Event|16|||
37936316|NCT00440947|69622980|FG001|36-Week Induction Phase|Adverse Event|0|||
37936317|NCT00440947|69622981|FG002|36-Week Induction Phase|Adverse Event|0|||
37936318|NCT00440947|69622982|FG003|36-Week Induction Phase|Adverse Event|0|||
37936319|NCT00440947|69622983|FG004|36-Week Induction Phase|Adverse Event|0|||
37936320|NCT00440947|69622979|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
37936321|NCT00440947|69622980|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
37936322|NCT00440947|69622981|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
37936323|NCT00440947|69622982|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
37936324|NCT00440947|69622983|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
37936325|NCT00440947|69622979|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
37936326|NCT00440947|69622980|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
37936327|NCT00440947|69622981|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
37936328|NCT00440947|69622982|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
37936329|NCT00440947|69622983|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
37936330|NCT00440947|69622979|FG000|36-Week Induction Phase|Non-compliance|10|||
37936331|NCT00440947|69622980|FG001|36-Week Induction Phase|Non-compliance|0|||
37936332|NCT00440947|69622981|FG002|36-Week Induction Phase|Non-compliance|0|||
37936333|NCT00440947|69622982|FG003|36-Week Induction Phase|Non-compliance|0|||
37936334|NCT00440947|69622983|FG004|36-Week Induction Phase|Non-compliance|0|||
37936335|NCT00440947|69622979|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
37936336|NCT00440947|69622980|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
37936337|NCT00440947|69622981|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
37936338|NCT00440947|69622982|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
37936339|NCT00440947|69622983|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
37936340|NCT00440947|69622979|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
37936341|NCT00440947|69622980|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
37936342|NCT00440947|69622981|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
37936343|NCT00440947|69622982|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
37936344|NCT00440947|69622983|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
37670333|NCT02055820|69143555|FG001|Phase II: Expansion|Death|0|||
37936345|NCT00440947|69622979|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
37936346|NCT00440947|69622980|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
37936347|NCT00440947|69622981|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
37936348|NCT00440947|69622982|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
37936349|NCT00440947|69622983|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
37670334|NCT02055820|69143556|FG002|Phase II: Expansion|Death|0|||
37670335|NCT02055820|69143557|FG003|Phase II: Expansion|Death|0|||
37936350|NCT00440947|69622979|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
37936351|NCT00440947|69622980|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
37936352|NCT00440947|69622981|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
37936353|NCT00440947|69622982|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
37936354|NCT00440947|69622983|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
37936355|NCT00440947|69622979|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
37936356|NCT00440947|69622980|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
37936357|NCT00440947|69622981|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
37936358|NCT00440947|69622982|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
37936359|NCT00440947|69622983|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
37936360|NCT00440947|69622979|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
37936361|NCT00440947|69622980|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
37936362|NCT00440947|69622981|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
37936363|NCT00440947|69622982|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
37936364|NCT00440947|69622983|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
37936365|NCT00440947|69622979|FG000|36-Week Induction Phase|Incarceration|3|||
37936366|NCT00440947|69622980|FG001|36-Week Induction Phase|Incarceration|0|||
37936367|NCT00440947|69622981|FG002|36-Week Induction Phase|Incarceration|0|||
37936368|NCT00440947|69622982|FG003|36-Week Induction Phase|Incarceration|0|||
37936369|NCT00440947|69622983|FG004|36-Week Induction Phase|Incarceration|0|||
37936370|NCT00440947|69622979|FG000|36-Week Induction Phase|Pregnancy|1|||
37936371|NCT00440947|69622980|FG001|36-Week Induction Phase|Pregnancy|0|||
37936372|NCT00440947|69622981|FG002|36-Week Induction Phase|Pregnancy|0|||
37936373|NCT00440947|69622982|FG003|36-Week Induction Phase|Pregnancy|0|||
37936374|NCT00440947|69622983|FG004|36-Week Induction Phase|Pregnancy|0|||
37936375|NCT00440947|69622979|FG000|48-Week Randomization Phase|Adverse Event|0|||
37936376|NCT00440947|69622980|FG001|48-Week Randomization Phase|Adverse Event|2|||
37936377|NCT00440947|69622981|FG002|48-Week Randomization Phase|Adverse Event|5|||
37936378|NCT00440947|69622982|FG003|48-Week Randomization Phase|Adverse Event|0|||
37936379|NCT00440947|69622983|FG004|48-Week Randomization Phase|Adverse Event|0|||
37936380|NCT00440947|69622979|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
37936381|NCT00440947|69622980|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
37936382|NCT00440947|69622981|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
37936383|NCT00440947|69622982|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
37936384|NCT00440947|69622983|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
37936385|NCT00440947|69622979|FG000|48-Week Randomization Phase|Non-compliance|0|||
37936386|NCT00440947|69622980|FG001|48-Week Randomization Phase|Non-compliance|3|||
37936387|NCT00440947|69622981|FG002|48-Week Randomization Phase|Non-compliance|4|||
37936388|NCT00440947|69622982|FG003|48-Week Randomization Phase|Non-compliance|0|||
37936389|NCT00440947|69622983|FG004|48-Week Randomization Phase|Non-compliance|0|||
37936390|NCT00440947|69622979|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
37936391|NCT00440947|69622980|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
37936392|NCT00440947|69622981|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
37936393|NCT00440947|69622982|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
37936394|NCT00440947|69622983|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
37936395|NCT00440947|69622979|FG000|48-Week Randomization Phase|Protocol Violation|0|||
37936396|NCT00440947|69622980|FG001|48-Week Randomization Phase|Protocol Violation|0|||
37936397|NCT00440947|69622981|FG002|48-Week Randomization Phase|Protocol Violation|1|||
37936398|NCT00440947|69622982|FG003|48-Week Randomization Phase|Protocol Violation|0|||
37936399|NCT00440947|69622983|FG004|48-Week Randomization Phase|Protocol Violation|0|||
37936400|NCT00440947|69622979|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
37936401|NCT00440947|69622980|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
37936402|NCT00440947|69622981|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
37936403|NCT00440947|69622982|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
37936404|NCT00440947|69622983|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
37936405|NCT00440947|69622979|FG000|48-Week Randomization Phase|Pregnancy|0|||
37936406|NCT00440947|69622980|FG001|48-Week Randomization Phase|Pregnancy|0|||
37936407|NCT00440947|69622981|FG002|48-Week Randomization Phase|Pregnancy|1|||
37936408|NCT00440947|69622982|FG003|48-Week Randomization Phase|Pregnancy|0|||
37936409|NCT00440947|69622983|FG004|48-Week Randomization Phase|Pregnancy|0|||
37936410|NCT00440947|69622979|FG000|48-Week Randomization Phase|Incarceration|0|||
37936411|NCT00440947|69622980|FG001|48-Week Randomization Phase|Incarceration|3|||
37936412|NCT00440947|69622981|FG002|48-Week Randomization Phase|Incarceration|0|||
37936413|NCT00440947|69622982|FG003|48-Week Randomization Phase|Incarceration|0|||
37936414|NCT00440947|69622983|FG004|48-Week Randomization Phase|Incarceration|0|||
37936415|NCT00440947|69622979|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
37936416|NCT00440947|69622980|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
37936417|NCT00440947|69622981|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
37936418|NCT00440947|69622982|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
37936419|NCT00440947|69622983|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
37936420|NCT00440947|69622979|FG000|48-Week Randomization Phase|Physician Decision|0|||
37936421|NCT00440947|69622980|FG001|48-Week Randomization Phase|Physician Decision|2|||
37936422|NCT00440947|69622981|FG002|48-Week Randomization Phase|Physician Decision|0|||
37936423|NCT00440947|69622982|FG003|48-Week Randomization Phase|Physician Decision|0|||
37936424|NCT00440947|69622983|FG004|48-Week Randomization Phase|Physician Decision|0|||
37936425|NCT00440947|69622979|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
37936426|NCT00440947|69622980|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
37936427|NCT00440947|69622981|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
37936428|NCT00440947|69622982|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
37936429|NCT00440947|69622983|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
37936430|NCT00440947|69622979|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
37936431|NCT00440947|69622980|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
37936432|NCT00440947|69622981|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
37936433|NCT00440947|69622982|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
37936434|NCT00440947|69622983|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
37936435|NCT00440947|69622979|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
37936436|NCT00440947|69622980|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
37936437|NCT00440947|69622981|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
37936438|NCT00440947|69622982|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
37936439|NCT00440947|69622983|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
37936440|NCT00440947|69622979|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
37936441|NCT00440947|69622980|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
37936442|NCT00440947|69622981|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
37936443|NCT00440947|69622982|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
37936444|NCT00440947|69622983|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
37936445|NCT00440947|69622979|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
37936446|NCT00440947|69622980|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
37936447|NCT00440947|69622981|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
37936448|NCT00440947|69622982|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
37936449|NCT00440947|69622983|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
37936450|NCT00440947|69622979|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
37936451|NCT00440947|69622980|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
37936452|NCT00440947|69622981|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
37936453|NCT00440947|69622982|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
37936454|NCT00440947|69622983|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
37936455|NCT00440947|69622979|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
37936456|NCT00440947|69622980|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
37936457|NCT00440947|69622981|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
37936458|NCT00440947|69622982|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
37936459|NCT00440947|69622983|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
37936460|NCT00440947|69622979|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
37936461|NCT00440947|69622980|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
37936462|NCT00440947|69622981|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
37936463|NCT00440947|69622982|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
37936464|NCT00440947|69622983|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
37936465|NCT00440947|69622979|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
37936466|NCT00440947|69622980|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
37936467|NCT00440947|69622981|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
37936468|NCT00440947|69622982|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
37936469|NCT00440947|69622983|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
37936470|NCT00440947|69622979|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
37936471|NCT00440947|69622980|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
37936472|NCT00440947|69622981|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
37936473|NCT00440947|69622982|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
37936474|NCT00440947|69622983|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
37936475|NCT00440947|69622979|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
37936476|NCT00440947|69622980|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
37936477|NCT00440947|69622981|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
37936478|NCT00440947|69622982|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
37936479|NCT00440947|69622983|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
37936480|NCT00440947|69622979|FG000|Optional 60-Week Extension Phase|Other|0|||
37936481|NCT00440947|69622980|FG001|Optional 60-Week Extension Phase|Other|0|||
37936482|NCT00440947|69622981|FG002|Optional 60-Week Extension Phase|Other|0|||
37936483|NCT00440947|69622982|FG003|Optional 60-Week Extension Phase|Other|1|||
37936484|NCT00440947|69622983|FG004|Optional 60-Week Extension Phase|Other|0|||
37936485|NCT00440947|69622979|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
37670336|NCT02055820|69143558|FG004|Phase II: Expansion|Death|33|||
37670337|NCT02055820|69143559|FG005|Phase II: Expansion|Death|0|||
37936486|NCT00440947|69622980|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
37936487|NCT00440947|69622981|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
37936488|NCT00440947|69622982|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
37936489|NCT00440947|69622983|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
37936490|NCT00440947|69622979|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
37936491|NCT00440947|69622980|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
37936492|NCT00440947|69622981|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
37936493|NCT00440947|69622982|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
37936494|NCT00440947|69622983|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
37936495|NCT00664521|69623006|FG000|Overall Study|Adverse Event|4|||
37936496|NCT00664521|69623007|FG001|Overall Study|Adverse Event|1|||
37936497|NCT00664521|69623006|FG000|Overall Study|Lost to Follow-up|1|||
37936498|NCT00664521|69623007|FG001|Overall Study|Lost to Follow-up|0|||
37936499|NCT00664521|69623006|FG000|Overall Study|Other|1|||
37936500|NCT00664521|69623007|FG001|Overall Study|Other|0|||
37936501|NCT00664209|69623013|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
37936502|NCT00664209|69623013|FG000|Study Treatment Period|Physician Decision|4|||
37936503|NCT00664209|69623013|FG000|Study Treatment Period|Withdrawal by Subject|2|||
37936504|NCT00440557|69623021|FG000|Overall Study|Withdrawal by Subject|10|||
37936505|NCT00440557|69623022|FG001|Overall Study|Withdrawal by Subject|5|||
37936506|NCT00440557|69623023|FG002|Overall Study|Withdrawal by Subject|11|||
37936507|NCT00440557|69623021|FG000|Overall Study|Lost to Follow-up|1|||
37936508|NCT00440557|69623022|FG001|Overall Study|Lost to Follow-up|2|||
37936509|NCT00440557|69623023|FG002|Overall Study|Lost to Follow-up|6|||
37936510|NCT00440557|69623021|FG000|Overall Study|Adverse Event|3|||
37936511|NCT00440557|69623022|FG001|Overall Study|Adverse Event|3|||
37936512|NCT00440557|69623023|FG002|Overall Study|Adverse Event|5|||
37936513|NCT00440557|69623021|FG000|Overall Study|Death|2|||
37936514|NCT00440557|69623022|FG001|Overall Study|Death|6|||
37936515|NCT00440557|69623023|FG002|Overall Study|Death|3|||
37936516|NCT00440557|69623021|FG000|Overall Study|Began Dialysis|4|||
37936517|NCT00440557|69623022|FG001|Overall Study|Began Dialysis|1|||
37936518|NCT00440557|69623023|FG002|Overall Study|Began Dialysis|4|||
37936519|NCT00440557|69623021|FG000|Overall Study|Principal Investigator decision|0|||
37936520|NCT00440557|69623022|FG001|Overall Study|Principal Investigator decision|3|||
37936521|NCT00440557|69623023|FG002|Overall Study|Principal Investigator decision|1|||
37936522|NCT00440557|69623021|FG000|Overall Study|Patient moved|1|||
37936523|NCT00440557|69623022|FG001|Overall Study|Patient moved|2|||
37936524|NCT00440557|69623023|FG002|Overall Study|Patient moved|1|||
37936525|NCT00440557|69623021|FG000|Overall Study|Principal Investigator's office closed|3|||
37936526|NCT00440557|69623022|FG001|Overall Study|Principal Investigator's office closed|6|||
37936527|NCT00440557|69623023|FG002|Overall Study|Principal Investigator's office closed|4|||
37936528|NCT00440557|69623021|FG000|Overall Study|Patient transferred to nursing home|0|||
37936529|NCT00440557|69623022|FG001|Overall Study|Patient transferred to nursing home|1|||
37936530|NCT00440557|69623023|FG002|Overall Study|Patient transferred to nursing home|0|||
37936531|NCT00440557|69623021|FG000|Overall Study|Patient had surgery|1|||
37936532|NCT00440557|69623022|FG001|Overall Study|Patient had surgery|0|||
37936533|NCT00440557|69623023|FG002|Overall Study|Patient had surgery|0|||
37936534|NCT00582608|69623083|FG000|Overall Study|Not Treated|7|||
37936535|NCT00582608|69623083|FG000|Overall Study|Patient Ineligible|1|||
37936536|NCT00582608|69623083|FG000|Overall Study|Lack of accrual|4|||
37936537|NCT03014570|69623089|FG000|Overall Study|COVID-19 Restrictions|38|||
37936538|NCT03014570|69623090|FG001|Overall Study|COVID-19 Restrictions|24|||
37936539|NCT03014570|69623089|FG000|Overall Study|Death|70|||
37936540|NCT03014570|69623090|FG001|Overall Study|Death|79|||
37936541|NCT03014570|69623089|FG000|Overall Study|Transfer from facility|11|||
37936542|NCT03014570|69623090|FG001|Overall Study|Transfer from facility|14|||
37936543|NCT03014570|69623089|FG000|Overall Study|Hospitalized|5|||
37936544|NCT03014570|69623090|FG001|Overall Study|Hospitalized|3|||
37936545|NCT03014570|69623089|FG000|Overall Study|Transfer within facility|1|||
37936546|NCT03014570|69623090|FG001|Overall Study|Transfer within facility|0|||
37936547|NCT03014570|69623089|FG000|Overall Study|Site refusal|0|||
37936548|NCT03014570|69623090|FG001|Overall Study|Site refusal|11|||
37936549|NCT00427999|69623097|FG000|Overall Study|Adverse Event|6|||
38035126|NCT03259334|69722033|FG000|Overall Study|Withdrawal by Subject|4|||
37936550|NCT00427999|69623097|FG000|Overall Study|Abnormal laboratory values|1|||
37936551|NCT00427999|69623097|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
37936552|NCT00427999|69623097|FG000|Overall Study|Protocol Violation|2|||
37936553|NCT00427999|69623097|FG000|Overall Study|Withdrawal by Subject|9|||
37936554|NCT00427999|69623097|FG000|Overall Study|Death|1|||
37936555|NCT00661713|69623110|FG000|Overall Study|Death|1|||
37936556|NCT00661713|69623111|FG001|Overall Study|Death|0|||
37936557|NCT00661713|69623112|FG002|Overall Study|Death|0|||
37936558|NCT00661713|69623113|FG003|Overall Study|Death|0|||
37936559|NCT00661713|69623114|FG004|Overall Study|Death|1|||
37936560|NCT00661713|69623115|FG005|Overall Study|Death|0|||
37936561|NCT00661713|69623116|FG006|Overall Study|Death|0|||
37936562|NCT00661713|69623117|FG007|Overall Study|Death|0|||
37936563|NCT00661713|69623110|FG000|Overall Study|Unable to Classify|1|||
37936564|NCT00661713|69623111|FG001|Overall Study|Unable to Classify|0|||
37936565|NCT00661713|69623112|FG002|Overall Study|Unable to Classify|0|||
37936566|NCT00661713|69623113|FG003|Overall Study|Unable to Classify|0|||
37936567|NCT00661713|69623114|FG004|Overall Study|Unable to Classify|0|||
37936568|NCT00661713|69623115|FG005|Overall Study|Unable to Classify|0|||
37936569|NCT00661713|69623116|FG006|Overall Study|Unable to Classify|0|||
37936570|NCT00661713|69623117|FG007|Overall Study|Unable to Classify|0|||
37936571|NCT00661713|69623110|FG000|Overall Study|Protocol Violation|1|||
37936572|NCT00661713|69623111|FG001|Overall Study|Protocol Violation|6|||
37936573|NCT00661713|69623112|FG002|Overall Study|Protocol Violation|3|||
37936574|NCT00661713|69623113|FG003|Overall Study|Protocol Violation|3|||
37936575|NCT00661713|69623114|FG004|Overall Study|Protocol Violation|0|||
37936576|NCT00661713|69623115|FG005|Overall Study|Protocol Violation|2|||
37936577|NCT00661713|69623116|FG006|Overall Study|Protocol Violation|2|||
37936578|NCT00661713|69623117|FG007|Overall Study|Protocol Violation|1|||
37936579|NCT00661713|69623110|FG000|Overall Study|Withdrawal by Subject|11|||
37936580|NCT00661713|69623111|FG001|Overall Study|Withdrawal by Subject|25|||
37936581|NCT00661713|69623112|FG002|Overall Study|Withdrawal by Subject|12|||
37936582|NCT00661713|69623113|FG003|Overall Study|Withdrawal by Subject|21|||
37936583|NCT00661713|69623114|FG004|Overall Study|Withdrawal by Subject|12|||
37936584|NCT00661713|69623115|FG005|Overall Study|Withdrawal by Subject|26|||
37936585|NCT00661713|69623116|FG006|Overall Study|Withdrawal by Subject|45|||
37936586|NCT00661713|69623117|FG007|Overall Study|Withdrawal by Subject|9|||
37936587|NCT00661713|69623110|FG000|Overall Study|Lost to Follow-up|2|||
37936588|NCT00661713|69623111|FG001|Overall Study|Lost to Follow-up|7|||
37936589|NCT00661713|69623112|FG002|Overall Study|Lost to Follow-up|2|||
37936590|NCT00661713|69623113|FG003|Overall Study|Lost to Follow-up|2|||
37936591|NCT00661713|69623114|FG004|Overall Study|Lost to Follow-up|5|||
37936592|NCT00661713|69623115|FG005|Overall Study|Lost to Follow-up|7|||
37936593|NCT00661713|69623116|FG006|Overall Study|Lost to Follow-up|14|||
37936594|NCT00661713|69623117|FG007|Overall Study|Lost to Follow-up|1|||
37936595|NCT00661713|69623110|FG000|Overall Study|Administrative Reason|0|||
37936596|NCT00661713|69623111|FG001|Overall Study|Administrative Reason|1|||
37936597|NCT00661713|69623112|FG002|Overall Study|Administrative Reason|0|||
37936598|NCT00661713|69623113|FG003|Overall Study|Administrative Reason|2|||
37936599|NCT00661713|69623114|FG004|Overall Study|Administrative Reason|2|||
37936600|NCT00661713|69623115|FG005|Overall Study|Administrative Reason|2|||
37936601|NCT00661713|69623116|FG006|Overall Study|Administrative Reason|1|||
37936602|NCT00661713|69623117|FG007|Overall Study|Administrative Reason|0|||
37936603|NCT00661713|69623110|FG000|Overall Study|Adverse Event|0|||
37936604|NCT00661713|69623111|FG001|Overall Study|Adverse Event|0|||
37936605|NCT00661713|69623112|FG002|Overall Study|Adverse Event|0|||
37936606|NCT00661713|69623113|FG003|Overall Study|Adverse Event|0|||
37936607|NCT00661713|69623114|FG004|Overall Study|Adverse Event|0|||
37936608|NCT00661713|69623115|FG005|Overall Study|Adverse Event|0|||
37936609|NCT00661713|69623116|FG006|Overall Study|Adverse Event|1|||
37936610|NCT00661713|69623117|FG007|Overall Study|Adverse Event|0|||
37936611|NCT00661713|69623110|FG000|Overall Study|Inappropriate Enrollment|0|||
37936612|NCT00661713|69623111|FG001|Overall Study|Inappropriate Enrollment|0|||
37936613|NCT00661713|69623112|FG002|Overall Study|Inappropriate Enrollment|0|||
37936614|NCT00661713|69623113|FG003|Overall Study|Inappropriate Enrollment|0|||
37936615|NCT00661713|69623114|FG004|Overall Study|Inappropriate Enrollment|0|||
37936616|NCT00661713|69623115|FG005|Overall Study|Inappropriate Enrollment|0|||
37936617|NCT00661713|69623116|FG006|Overall Study|Inappropriate Enrollment|1|||
37765112|NCT01516736|69278307|FG001|Overall Study|Withdrawal by Subject|4|||
37765113|NCT01516736|69278306|FG000|Overall Study|Adverse Event|4|||
37765114|NCT01516736|69278307|FG001|Overall Study|Adverse Event|5|||
37765115|NCT01516736|69278306|FG000|Overall Study|Death|3|||
37765116|NCT01516736|69278307|FG001|Overall Study|Death|1|||
37765117|NCT01516736|69278306|FG000|Overall Study|Physician Decision|2|||
37765118|NCT01516736|69278307|FG001|Overall Study|Physician Decision|1|||
37765119|NCT01516736|69278306|FG000|Overall Study|Lack of Efficacy|1|||
37765120|NCT01516736|69278307|FG001|Overall Study|Lack of Efficacy|0|||
37765121|NCT01516736|69278306|FG000|Overall Study|Protocol Violation|0|||
37936618|NCT00661713|69623117|FG007|Overall Study|Inappropriate Enrollment|0|||
37765122|NCT01516736|69278307|FG001|Overall Study|Protocol Violation|1|||
37765123|NCT01516736|69278306|FG000|Overall Study|Other (not specified)|0|||
37936619|NCT03835975|69623142|FG000|Overall Study|Lost to Follow-up|1|||
37936620|NCT03835975|69623143|FG001|Overall Study|Lost to Follow-up|1|||
37670338|NCT02055820|69143560|FG006|Phase II: Expansion|Death|0|||
37936621|NCT03835975|69623144|FG002|Overall Study|Lost to Follow-up|0|||
37936622|NCT03835975|69623145|FG003|Overall Study|Lost to Follow-up|0|||
37936623|NCT03835975|69623146|FG004|Overall Study|Lost to Follow-up|0|||
37936624|NCT03835975|69623142|FG000|Overall Study|No longer met eligibility criteria|0|||
37936625|NCT03835975|69623143|FG001|Overall Study|No longer met eligibility criteria|1|||
37936626|NCT03835975|69623144|FG002|Overall Study|No longer met eligibility criteria|0|||
37936627|NCT03835975|69623145|FG003|Overall Study|No longer met eligibility criteria|0|||
37936628|NCT03835975|69623146|FG004|Overall Study|No longer met eligibility criteria|0|||
37936629|NCT03835975|69623142|FG000|Overall Study|Protocol Violation|1|||
37936630|NCT03835975|69623143|FG001|Overall Study|Protocol Violation|1|||
37936631|NCT03835975|69623144|FG002|Overall Study|Protocol Violation|2|||
37936632|NCT03835975|69623145|FG003|Overall Study|Protocol Violation|0|||
37936633|NCT03835975|69623146|FG004|Overall Study|Protocol Violation|0|||
37936634|NCT03835975|69623142|FG000|Overall Study|Withdrawal by Subject|1|||
37936635|NCT03835975|69623143|FG001|Overall Study|Withdrawal by Subject|0|||
37936636|NCT03835975|69623144|FG002|Overall Study|Withdrawal by Subject|1|||
37936637|NCT03835975|69623145|FG003|Overall Study|Withdrawal by Subject|1|||
37936638|NCT03835975|69623146|FG004|Overall Study|Withdrawal by Subject|0|||
37936639|NCT00427921|69623160|FG000|Overall Study|Adverse Event|26|||
37936640|NCT00427921|69623160|FG000|Overall Study|Withdrawal by Subject|4|||
37936641|NCT00427921|69623160|FG000|Overall Study|Lost to Follow-up|2|||
37936642|NCT00427921|69623160|FG000|Overall Study|Other reason not specified|10|||
37936643|NCT00427921|69623160|FG000|Overall Study|Adverse Event + Hospitalization|1|||
37936644|NCT00427921|69623160|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
37936645|NCT00427921|69623160|FG000|Overall Study|Adverse Event + No Response|1|||
37936646|NCT00427921|69623160|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
37936647|NCT00427921|69623160|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
37936648|NCT00427921|69623160|FG000|Overall Study|Adverse Event + Lost Response|1|||
37936649|NCT00427921|69623160|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
37936650|NCT00427921|69623160|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
37936651|NCT00432991|69623166|FG000|Overall Study|Protocol Violation|7|||
37936652|NCT00432991|69623167|FG001|Overall Study|Protocol Violation|12|||
37936653|NCT00432835|69623175|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
37936654|NCT00432835|69623176|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
37936655|NCT00580970|69623184|FG000|Pre-treatment|Non-compliance|1|||
37936656|NCT00580970|69623184|FG000|Treatment (Lovastatin)|Non-compliance|6|||
37936657|NCT00580970|69623184|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
37936658|NCT00580970|69623184|FG000|Treatment (Lovastatin)|Physician Decision|4|||
37936659|NCT00580970|69623184|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
37936660|NCT00580970|69623184|FG000|Treatment (Lovastatin)|Death|1|||
37936661|NCT00665925|69623192|FG000|Overall Study|Lack of Efficacy|10|||
37936662|NCT00665925|69623193|FG001|Overall Study|Lack of Efficacy|8|||
37936663|NCT00665925|69623194|FG002|Overall Study|Lack of Efficacy|9|||
37936664|NCT00665925|69623195|FG003|Overall Study|Lack of Efficacy|8|||
37936665|NCT00665925|69623192|FG000|Overall Study|Lost to Follow-up|1|||
37936666|NCT00665925|69623193|FG001|Overall Study|Lost to Follow-up|2|||
37936667|NCT00665925|69623194|FG002|Overall Study|Lost to Follow-up|2|||
37936668|NCT00665925|69623195|FG003|Overall Study|Lost to Follow-up|2|||
37936669|NCT00665925|69623192|FG000|Overall Study|Withdrawal by Subject|2|||
37936670|NCT00665925|69623193|FG001|Overall Study|Withdrawal by Subject|2|||
37936671|NCT00665925|69623194|FG002|Overall Study|Withdrawal by Subject|3|||
37936672|NCT00665925|69623195|FG003|Overall Study|Withdrawal by Subject|2|||
37936673|NCT00665925|69623192|FG000|Overall Study|Physician Decision|0|||
37936674|NCT00665925|69623193|FG001|Overall Study|Physician Decision|0|||
37936675|NCT00665925|69623194|FG002|Overall Study|Physician Decision|1|||
37936676|NCT00665925|69623195|FG003|Overall Study|Physician Decision|2|||
37936677|NCT00665925|69623192|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
37936678|NCT00665925|69623193|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
37936679|NCT00665925|69623194|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
37936680|NCT00665925|69623195|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
37936681|NCT00665925|69623192|FG000|Overall Study|Adverse Event|1|||
37936682|NCT00665925|69623193|FG001|Overall Study|Adverse Event|5|||
37936683|NCT00665925|69623194|FG002|Overall Study|Adverse Event|10|||
37936684|NCT00665925|69623195|FG003|Overall Study|Adverse Event|5|||
37936685|NCT00665925|69623192|FG000|Overall Study|Enrolled by mistake|0|||
37936686|NCT00665925|69623193|FG001|Overall Study|Enrolled by mistake|0|||
37936687|NCT00665925|69623194|FG002|Overall Study|Enrolled by mistake|0|||
37936688|NCT00665925|69623195|FG003|Overall Study|Enrolled by mistake|1|||
37936689|NCT00665925|69623192|FG000|Overall Study|Due to exclusion criteria|1|||
37936690|NCT00665925|69623193|FG001|Overall Study|Due to exclusion criteria|0|||
37936691|NCT00665925|69623194|FG002|Overall Study|Due to exclusion criteria|0|||
37936692|NCT00665925|69623195|FG003|Overall Study|Due to exclusion criteria|0|||
37936693|NCT00426751|69623208|FG000|Overall Study|Adverse Event|8|||
37936694|NCT00426751|69623209|FG001|Overall Study|Adverse Event|1|||
37936695|NCT00426751|69623208|FG000|Overall Study|Lost to Follow-up|7|||
37936696|NCT00426751|69623209|FG001|Overall Study|Lost to Follow-up|6|||
37936697|NCT00426751|69623208|FG000|Overall Study|Consent Withdrawn|0|||
37670339|NCT02055820|69143561|FG007|Phase II: Expansion|Death|0|||
37936698|NCT00426751|69623209|FG001|Overall Study|Consent Withdrawn|1|||
37936699|NCT00426751|69623208|FG000|Overall Study|Other Reasons|7|||
37936700|NCT00426751|69623209|FG001|Overall Study|Other Reasons|12|||
37936701|NCT00440401|69623217|FG000|Overall Study|Adverse Event|2|||
37936702|NCT00440401|69623218|FG001|Overall Study|Adverse Event|1|||
37936703|NCT00440401|69623217|FG000|Overall Study|Other|2|||
37936704|NCT00440401|69623218|FG001|Overall Study|Other|5|||
37936705|NCT02598960|69623237|FG000|Treatment Period|Disease Progression|4|||
37936706|NCT02598960|69623238|FG001|Treatment Period|Disease Progression|4|||
37936707|NCT02598960|69623239|FG002|Treatment Period|Disease Progression|4|||
37936708|NCT02598960|69623240|FG003|Treatment Period|Disease Progression|6|||
37936709|NCT02598960|69623241|FG004|Treatment Period|Disease Progression|8|||
37936710|NCT02598960|69623242|FG005|Treatment Period|Disease Progression|2|||
37936711|NCT02598960|69623243|FG006|Treatment Period|Disease Progression|2|||
37936712|NCT02598960|69623244|FG007|Treatment Period|Disease Progression|3|||
37936713|NCT02598960|69623245|FG008|Treatment Period|Disease Progression|7|||
37936714|NCT02598960|69623246|FG009|Treatment Period|Disease Progression|9|||
37936715|NCT02598960|69623247|FG010|Treatment Period|Disease Progression|7|||
37936716|NCT02598960|69623248|FG011|Treatment Period|Disease Progression|143|||
37936717|NCT02598960|69623249|FG012|Treatment Period|Disease Progression|23|||
37936718|NCT02598960|69623237|FG000|Treatment Period|Study drug toxicity|0|||
37936719|NCT02598960|69623238|FG001|Treatment Period|Study drug toxicity|0|||
37936720|NCT02598960|69623239|FG002|Treatment Period|Study drug toxicity|0|||
37936721|NCT02598960|69623240|FG003|Treatment Period|Study drug toxicity|0|||
37936722|NCT02598960|69623241|FG004|Treatment Period|Study drug toxicity|0|||
37936723|NCT02598960|69623242|FG005|Treatment Period|Study drug toxicity|0|||
37936724|NCT02598960|69623243|FG006|Treatment Period|Study drug toxicity|0|||
37936725|NCT02598960|69623244|FG007|Treatment Period|Study drug toxicity|0|||
37936726|NCT02598960|69623245|FG008|Treatment Period|Study drug toxicity|0|||
37936727|NCT02598960|69623246|FG009|Treatment Period|Study drug toxicity|1|||
37936728|NCT02598960|69623247|FG010|Treatment Period|Study drug toxicity|0|||
37936729|NCT02598960|69623248|FG011|Treatment Period|Study drug toxicity|3|||
37936730|NCT02598960|69623249|FG012|Treatment Period|Study drug toxicity|0|||
37936731|NCT02598960|69623237|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
37936732|NCT02598960|69623238|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
37936733|NCT02598960|69623239|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
37936734|NCT02598960|69623240|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
37936735|NCT02598960|69623241|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
37936736|NCT02598960|69623242|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
37936737|NCT02598960|69623243|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
37936738|NCT02598960|69623244|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
37936739|NCT02598960|69623245|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
37936740|NCT02598960|69623246|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
37936741|NCT02598960|69623247|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
37936742|NCT02598960|69623248|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
37936743|NCT02598960|69623249|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
37936744|NCT02598960|69623237|FG000|Treatment Period|participant request to discontinue|0|||
37936745|NCT02598960|69623238|FG001|Treatment Period|participant request to discontinue|1|||
37936746|NCT02598960|69623239|FG002|Treatment Period|participant request to discontinue|0|||
37936747|NCT02598960|69623240|FG003|Treatment Period|participant request to discontinue|0|||
37936748|NCT02598960|69623241|FG004|Treatment Period|participant request to discontinue|1|||
37936749|NCT02598960|69623242|FG005|Treatment Period|participant request to discontinue|0|||
37936750|NCT02598960|69623243|FG006|Treatment Period|participant request to discontinue|0|||
37936751|NCT02598960|69623244|FG007|Treatment Period|participant request to discontinue|0|||
37936752|NCT02598960|69623245|FG008|Treatment Period|participant request to discontinue|0|||
37936753|NCT02598960|69623246|FG009|Treatment Period|participant request to discontinue|0|||
37936754|NCT02598960|69623247|FG010|Treatment Period|participant request to discontinue|1|||
38035127|NCT03259334|69722034|FG001|Overall Study|Withdrawal by Subject|2|||
38035128|NCT03259334|69722035|FG002|Overall Study|Withdrawal by Subject|4|||
38035129|NCT03259334|69722033|FG000|Overall Study|Physician Decision|1|||
38035130|NCT03259334|69722034|FG001|Overall Study|Physician Decision|0|||
38035131|NCT03259334|69722035|FG002|Overall Study|Physician Decision|0|||
38035132|NCT03259334|69722033|FG000|Overall Study|Lost to Follow-up|0|||
38035133|NCT03259334|69722034|FG001|Overall Study|Lost to Follow-up|2|||
38035134|NCT03259334|69722035|FG002|Overall Study|Lost to Follow-up|1|||
38035135|NCT03259334|69722033|FG000|Overall Study|Protocol Deviation|0|||
38035136|NCT03259334|69722034|FG001|Overall Study|Protocol Deviation|3|||
37765124|NCT01516736|69278307|FG001|Overall Study|Other (not specified)|1|||
37765125|NCT01546688|69278319|FG000|Overall Study|Adverse Event|0|||
37765126|NCT01546688|69278320|FG001|Overall Study|Adverse Event|4|||
37936755|NCT02598960|69623248|FG011|Treatment Period|participant request to discontinue|4|||
37936756|NCT02598960|69623249|FG012|Treatment Period|participant request to discontinue|0|||
37936757|NCT02598960|69623237|FG000|Treatment Period|participant withdrew consent|0|||
37936758|NCT02598960|69623238|FG001|Treatment Period|participant withdrew consent|0|||
37936759|NCT02598960|69623239|FG002|Treatment Period|participant withdrew consent|0|||
37936760|NCT02598960|69623240|FG003|Treatment Period|participant withdrew consent|0|||
38035137|NCT03259334|69722035|FG002|Overall Study|Protocol Deviation|2|||
38035138|NCT03259334|69722033|FG000|Overall Study|Lack of Efficacy|2|||
38035139|NCT03259334|69722034|FG001|Overall Study|Lack of Efficacy|0|||
37936761|NCT02598960|69623241|FG004|Treatment Period|participant withdrew consent|0|||
37936762|NCT02598960|69623242|FG005|Treatment Period|participant withdrew consent|0|||
37936763|NCT02598960|69623243|FG006|Treatment Period|participant withdrew consent|0|||
37936764|NCT02598960|69623244|FG007|Treatment Period|participant withdrew consent|0|||
37936765|NCT02598960|69623245|FG008|Treatment Period|participant withdrew consent|0|||
37936766|NCT02598960|69623246|FG009|Treatment Period|participant withdrew consent|0|||
37936767|NCT02598960|69623247|FG010|Treatment Period|participant withdrew consent|0|||
37936768|NCT02598960|69623248|FG011|Treatment Period|participant withdrew consent|3|||
37936769|NCT02598960|69623249|FG012|Treatment Period|participant withdrew consent|0|||
37936770|NCT02598960|69623237|FG000|Treatment Period|No longer meets study criteria|0|||
37936771|NCT02598960|69623238|FG001|Treatment Period|No longer meets study criteria|0|||
37936772|NCT02598960|69623239|FG002|Treatment Period|No longer meets study criteria|0|||
37936773|NCT02598960|69623240|FG003|Treatment Period|No longer meets study criteria|0|||
37936774|NCT02598960|69623241|FG004|Treatment Period|No longer meets study criteria|0|||
37936775|NCT02598960|69623242|FG005|Treatment Period|No longer meets study criteria|0|||
37936776|NCT02598960|69623243|FG006|Treatment Period|No longer meets study criteria|0|||
37936777|NCT02598960|69623244|FG007|Treatment Period|No longer meets study criteria|0|||
37936778|NCT02598960|69623245|FG008|Treatment Period|No longer meets study criteria|0|||
37936779|NCT02598960|69623246|FG009|Treatment Period|No longer meets study criteria|0|||
37936780|NCT02598960|69623247|FG010|Treatment Period|No longer meets study criteria|0|||
37936781|NCT02598960|69623248|FG011|Treatment Period|No longer meets study criteria|1|||
37936782|NCT02598960|69623249|FG012|Treatment Period|No longer meets study criteria|0|||
37936783|NCT02598960|69623237|FG000|Treatment Period|Other Reasons|0|||
37936784|NCT02598960|69623238|FG001|Treatment Period|Other Reasons|0|||
37936785|NCT02598960|69623239|FG002|Treatment Period|Other Reasons|0|||
37936786|NCT02598960|69623240|FG003|Treatment Period|Other Reasons|0|||
37936787|NCT02598960|69623241|FG004|Treatment Period|Other Reasons|0|||
37936788|NCT02598960|69623242|FG005|Treatment Period|Other Reasons|0|||
37936789|NCT02598960|69623243|FG006|Treatment Period|Other Reasons|0|||
37936790|NCT02598960|69623244|FG007|Treatment Period|Other Reasons|0|||
37936791|NCT02598960|69623245|FG008|Treatment Period|Other Reasons|0|||
37936792|NCT02598960|69623246|FG009|Treatment Period|Other Reasons|0|||
37936793|NCT02598960|69623247|FG010|Treatment Period|Other Reasons|0|||
37936794|NCT02598960|69623248|FG011|Treatment Period|Other Reasons|0|||
37936795|NCT02598960|69623249|FG012|Treatment Period|Other Reasons|1|||
37936796|NCT02598960|69623237|FG000|Participants Entering Follow Up Period|Death|1|||
37936797|NCT02598960|69623238|FG001|Participants Entering Follow Up Period|Death|0|||
37936798|NCT02598960|69623239|FG002|Participants Entering Follow Up Period|Death|0|||
37936799|NCT02598960|69623240|FG003|Participants Entering Follow Up Period|Death|0|||
37936800|NCT02598960|69623241|FG004|Participants Entering Follow Up Period|Death|0|||
37936801|NCT02598960|69623242|FG005|Participants Entering Follow Up Period|Death|0|||
37936802|NCT02598960|69623243|FG006|Participants Entering Follow Up Period|Death|0|||
37936803|NCT02598960|69623244|FG007|Participants Entering Follow Up Period|Death|0|||
37936804|NCT02598960|69623245|FG008|Participants Entering Follow Up Period|Death|0|||
37936805|NCT02598960|69623246|FG009|Participants Entering Follow Up Period|Death|1|||
37936806|NCT02598960|69623247|FG010|Participants Entering Follow Up Period|Death|0|||
37936807|NCT02598960|69623248|FG011|Participants Entering Follow Up Period|Death|11|||
37936808|NCT02598960|69623249|FG012|Participants Entering Follow Up Period|Death|2|||
37936809|NCT02598960|69623237|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
37936810|NCT02598960|69623238|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
37936811|NCT02598960|69623239|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
37936812|NCT02598960|69623240|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
37936813|NCT02598960|69623241|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
37936814|NCT02598960|69623242|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
37936815|NCT02598960|69623243|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
37936816|NCT02598960|69623244|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
37936817|NCT02598960|69623245|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
37936818|NCT02598960|69623246|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
37936819|NCT02598960|69623247|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
37936820|NCT02598960|69623248|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
37936821|NCT02598960|69623249|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
37936822|NCT02598960|69623237|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
38035140|NCT03259334|69722035|FG002|Overall Study|Lack of Efficacy|1|||
37936823|NCT02598960|69623238|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
38035141|NCT03259334|69722033|FG000|Overall Study|Randomized but never treated|0|||
37936824|NCT02598960|69623239|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
37936825|NCT02598960|69623240|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
37936826|NCT02598960|69623241|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
37936827|NCT02598960|69623242|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
37936828|NCT02598960|69623243|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
37936829|NCT02598960|69623244|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
37936830|NCT02598960|69623245|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
37936831|NCT02598960|69623246|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
37936832|NCT02598960|69623247|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
37936833|NCT02598960|69623248|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
37936834|NCT02598960|69623249|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
37936835|NCT02598960|69623237|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
37936836|NCT02598960|69623238|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
37936837|NCT02598960|69623239|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
37936838|NCT02598960|69623240|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
37936839|NCT02598960|69623241|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
37936840|NCT02598960|69623242|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
37936841|NCT02598960|69623243|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
37936842|NCT02598960|69623244|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
37936843|NCT02598960|69623245|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
37936844|NCT02598960|69623246|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
37936845|NCT02598960|69623247|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
37936846|NCT02598960|69623248|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
37936847|NCT02598960|69623249|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
37936848|NCT02598960|69623237|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
37936849|NCT02598960|69623238|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
37936850|NCT02598960|69623239|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
37936851|NCT02598960|69623240|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
37936852|NCT02598960|69623241|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
37936853|NCT02598960|69623242|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
37936854|NCT02598960|69623243|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
37936855|NCT02598960|69623244|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
37936856|NCT02598960|69623245|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
37936857|NCT02598960|69623246|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
37936858|NCT02598960|69623247|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
37765127|NCT01546688|69278319|FG000|Overall Study|Withdrawal by Subject|2|||
37765128|NCT01546688|69278320|FG001|Overall Study|Withdrawal by Subject|1|||
37765129|NCT01546688|69278319|FG000|Overall Study|Lack of Efficacy|1|||
37765130|NCT01546688|69278320|FG001|Overall Study|Lack of Efficacy|0|||
37765131|NCT01516034|69278326|FG000|Overall Study|Physician Decision|1|||
37765132|NCT01516034|69278326|FG000|Overall Study|Lack of Efficacy|7|||
37765133|NCT01440569|69278337|FG000|Main Study|Enrolled but not treated|1|||
37765134|NCT01440569|69278338|FG001|Main Study|Enrolled but not treated|0|||
37765135|NCT01440569|69278337|FG000|Main Study|Adverse Event|9|||
37765136|NCT01440569|69278338|FG001|Main Study|Adverse Event|0|||
37765137|NCT01440569|69278337|FG000|Main Study|Pregnancy|1|||
37936859|NCT02598960|69623248|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
37936860|NCT02598960|69623249|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
37936861|NCT00426361|69623280|FG000|Overall Study|Lost to Follow-up|3|||
37936862|NCT00426361|69623281|FG001|Overall Study|Lost to Follow-up|2|||
37936863|NCT00426361|69623282|FG002|Overall Study|Lost to Follow-up|5|||
37936864|NCT00426361|69623280|FG000|Overall Study|Withdrawal by Subject|1|||
37936865|NCT00426361|69623281|FG001|Overall Study|Withdrawal by Subject|3|||
37936866|NCT00426361|69623282|FG002|Overall Study|Withdrawal by Subject|0|||
37936867|NCT00665847|69623290|FG000|Overall Study|Adverse Event|8|||
37936868|NCT00665847|69623290|FG000|Overall Study|Withdrawal by Subject|2|||
37936869|NCT00665847|69623290|FG000|Overall Study|Subject non-compliant|8|||
37936870|NCT00665847|69623290|FG000|Overall Study|Subject reached a virologic endpoint|4|||
37936871|NCT00665847|69623290|FG000|Overall Study|Resistance to TMC125|1|||
37936872|NCT00665847|69623290|FG000|Overall Study|Subject ineligible to continue the trial|1|||
37936873|NCT00665847|69623290|FG000|Overall Study|Switch to Commercial Medication|1|||
37936874|NCT00426127|69623294|FG000|Overall Study|Adverse Event|1|||
37936875|NCT00426127|69623294|FG000|Overall Study|Removed due to disease progression|1|||
37936876|NCT00425503|69623298|FG000|Overall Study|Adverse Event|2|||
37936877|NCT00425503|69623298|FG000|Overall Study|Protocol Violation|1|||
37936878|NCT00425269|69623304|FG000|Overall Study|Pregnancy|5|||
37765138|NCT01440569|69278338|FG001|Main Study|Pregnancy|0|||
37765139|NCT01440569|69278337|FG000|Main Study|Investigator's Discretion|1|||
37765140|NCT01440569|69278338|FG001|Main Study|Investigator's Discretion|1|||
37765141|NCT01440569|69278337|FG000|Main Study|Withdrew Consent|7|||
37859603|NCT00960193|69542903|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
37936879|NCT00425269|69623305|FG001|Overall Study|Pregnancy|7|||
37936880|NCT00425269|69623304|FG000|Overall Study|Lost to Follow-up|9|||
37936881|NCT00425269|69623305|FG001|Overall Study|Lost to Follow-up|9|||
37936882|NCT00425269|69623304|FG000|Overall Study|moved or medical reason|5|||
37936883|NCT00425269|69623305|FG001|Overall Study|moved or medical reason|4|||
37936884|NCT00430573|69623311|FG000|Overall Study|Withdrawal by Subject|5|||
37936885|NCT00430495|69623337|FG000|Overall Study|Adverse Event|2|||
37936886|NCT00430495|69623338|FG001|Overall Study|Adverse Event|3|||
37936887|NCT00430495|69623339|FG002|Overall Study|Adverse Event|2|||
37936888|NCT00430495|69623340|FG003|Overall Study|Adverse Event|0|||
37936889|NCT00430495|69623337|FG000|Overall Study|Death|0|||
37936890|NCT00430495|69623338|FG001|Overall Study|Death|0|||
37936891|NCT00430495|69623339|FG002|Overall Study|Death|1|||
37936892|NCT00430495|69623340|FG003|Overall Study|Death|0|||
37936893|NCT00430495|69623337|FG000|Overall Study|Lost to Follow-up|0|||
37936894|NCT00430495|69623338|FG001|Overall Study|Lost to Follow-up|1|||
37936895|NCT00430495|69623339|FG002|Overall Study|Lost to Follow-up|4|||
37936896|NCT00430495|69623340|FG003|Overall Study|Lost to Follow-up|0|||
37936897|NCT00430495|69623337|FG000|Overall Study|Protocol Violation|1|||
37936898|NCT00430495|69623338|FG001|Overall Study|Protocol Violation|0|||
37936899|NCT00430495|69623339|FG002|Overall Study|Protocol Violation|1|||
37936900|NCT00430495|69623340|FG003|Overall Study|Protocol Violation|0|||
37936901|NCT00430495|69623337|FG000|Overall Study|Disease Progression|1|||
37936902|NCT00430495|69623338|FG001|Overall Study|Disease Progression|1|||
37936903|NCT00430495|69623339|FG002|Overall Study|Disease Progression|0|||
37936904|NCT00430495|69623340|FG003|Overall Study|Disease Progression|0|||
37936905|NCT00430495|69623337|FG000|Overall Study|Other|8|||
37936906|NCT00430495|69623338|FG001|Overall Study|Other|2|||
37936907|NCT00430495|69623339|FG002|Overall Study|Other|5|||
37936908|NCT00430495|69623340|FG003|Overall Study|Other|4|||
37936909|NCT00430495|69623337|FG000|Overall Study|Randomized but not Treated|2|||
37936910|NCT00430495|69623338|FG001|Overall Study|Randomized but not Treated|0|||
37936911|NCT00430495|69623339|FG002|Overall Study|Randomized but not Treated|0|||
37936912|NCT00430495|69623340|FG003|Overall Study|Randomized but not Treated|0|||
37936913|NCT00425113|69623352|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
37936914|NCT00425113|69623353|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
37936915|NCT00425113|69623352|FG000|Overall Study|diagnosis of abdominal TB|0|||
37936916|NCT00425113|69623353|FG001|Overall Study|diagnosis of abdominal TB|1|||
37936917|NCT00425113|69623352|FG000|Overall Study|missing study drug more than 14 days|0|||
37936918|NCT00425113|69623353|FG001|Overall Study|missing study drug more than 14 days|1|||
37936919|NCT00425113|69623352|FG000|Overall Study|Withdrawal by Subject|1|||
37936920|NCT00425113|69623353|FG001|Overall Study|Withdrawal by Subject|0|||
37936921|NCT00440011|69623362|FG000|Overall Study|Adverse Event|2|||
37936922|NCT00440011|69623363|FG001|Overall Study|Adverse Event|0|||
37936923|NCT00440011|69623362|FG000|Overall Study|Lost to Follow-up|0|||
37936924|NCT00440011|69623363|FG001|Overall Study|Lost to Follow-up|2|||
37936925|NCT00440011|69623362|FG000|Overall Study|Protocol Violation|1|||
37936926|NCT00440011|69623363|FG001|Overall Study|Protocol Violation|1|||
37936927|NCT00440011|69623362|FG000|Overall Study|Withdrawal by Subject|1|||
37936928|NCT00440011|69623363|FG001|Overall Study|Withdrawal by Subject|0|||
37936929|NCT00663117|69623400|FG000|Overall Study|Lack of Efficacy|1|||
37936930|NCT00663117|69623401|FG001|Overall Study|Lack of Efficacy|0|||
37936931|NCT00570141|69623422|FG000|Overall Study|Adverse Event|1|||
37936932|NCT00570141|69623422|FG000|Overall Study|Missed visits|1|||
37936933|NCT00570141|69623422|FG000|Overall Study|Lost to Follow-up|1|||
37936934|NCT00579254|69623426|FG000|Overall Study|Lost to Follow-up|39|||
37936935|NCT00579254|69623426|FG000|Overall Study|Discontinued when study terminated|73|||
37936936|NCT00661089|69623432|FG000|Overall Study|1 subject withdrawal|0|||
37936937|NCT00661089|69623433|FG001|Overall Study|1 subject withdrawal|1|||
37936938|NCT00661089|69623432|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
37936939|NCT00661089|69623433|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
37936940|NCT00582426|69623446|FG000|Overall Study|Lost to Follow-up|0|||
37936941|NCT00582426|69623447|FG001|Overall Study|Lost to Follow-up|2|||
37936942|NCT00582426|69623446|FG000|Overall Study|Adverse Event|4|||
37936943|NCT00582426|69623447|FG001|Overall Study|Adverse Event|2|||
37936944|NCT00582426|69623446|FG000|Overall Study|Protocol Violation|6|||
37936945|NCT00582426|69623447|FG001|Overall Study|Protocol Violation|2|||
37936946|NCT00582426|69623446|FG000|Overall Study|Death|4|||
37936947|NCT00582426|69623447|FG001|Overall Study|Death|3|||
37936948|NCT00582426|69623446|FG000|Overall Study|Withdrawal by Subject|3|||
37936949|NCT00582426|69623447|FG001|Overall Study|Withdrawal by Subject|2|||
37936950|NCT00582426|69623446|FG000|Overall Study|Disease Progression|2|||
37936951|NCT00582426|69623447|FG001|Overall Study|Disease Progression|2|||
37936952|NCT00582426|69623446|FG000|Overall Study|Use of illicit drugs|1|||
37936953|NCT00582426|69623447|FG001|Overall Study|Use of illicit drugs|0|||
37936954|NCT02387970|69623455|FG000|Overall Study|Did not complete 1-year follow up|1|||
37936955|NCT02387970|69623456|FG001|Overall Study|Did not complete 1-year follow up|2|||
37936956|NCT00580034|69623462|FG000|Overall Study|Toxicity|10|||
37936957|NCT00580034|69623463|FG001|Overall Study|Toxicity|0|||
37936958|NCT00773513|69623469|FG000|Overall Study|Renal Transplant|254|||
37936959|NCT00773513|69623470|FG001|Overall Study|Renal Transplant|263|||
37936960|NCT00773513|69623469|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
37936961|NCT00773513|69623470|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
37936962|NCT00773513|69623469|FG000|Overall Study|Withdrew Consent|68|||
37936963|NCT00773513|69623470|FG001|Overall Study|Withdrew Consent|69|||
37936964|NCT00773513|69623469|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
37936965|NCT00773513|69623470|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
37936966|NCT00773513|69623469|FG000|Overall Study|Failure to Return|22|||
37936967|NCT00773513|69623470|FG001|Overall Study|Failure to Return|8|||
37936968|NCT00773513|69623469|FG000|Overall Study|Insufficient Therapeutic Response|1|||
37936969|NCT00773513|69623470|FG001|Overall Study|Insufficient Therapeutic Response|18|||
37936970|NCT00773513|69623469|FG000|Overall Study|Reason Not Specified|159|||
37936971|NCT00773513|69623470|FG001|Overall Study|Reason Not Specified|126|||
37936972|NCT00773513|69623469|FG000|Overall Study|Death|531|||
37936973|NCT00773513|69623470|FG001|Overall Study|Death|545|||
37936974|NCT00767039|69623478|FG000|Overall Study|Death|5|||
37936975|NCT00767039|69623479|FG001|Overall Study|Death|2|||
37936976|NCT00662649|69623489|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
37936977|NCT00662649|69623490|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
37936978|NCT00662649|69623491|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
37936979|NCT00662649|69623492|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
37936980|NCT00662649|69623493|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
37936981|NCT00662649|69623489|FG000|Core Study (24 Months)|Adverse Event|22|||
37936982|NCT00662649|69623490|FG001|Core Study (24 Months)|Adverse Event|13|||
37936983|NCT00662649|69623491|FG002|Core Study (24 Months)|Adverse Event|18|||
37936984|NCT00662649|69623492|FG003|Core Study (24 Months)|Adverse Event|0|||
37936985|NCT00662649|69623493|FG004|Core Study (24 Months)|Adverse Event|0|||
37936986|NCT00662649|69623489|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
37936987|NCT00662649|69623490|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
37936988|NCT00662649|69623491|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
37936989|NCT00662649|69623492|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
37936990|NCT00662649|69623493|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
37936991|NCT00662649|69623489|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
37936992|NCT00662649|69623490|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
37936993|NCT00662649|69623491|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
37936994|NCT00662649|69623492|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
37936995|NCT00662649|69623493|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
37936996|NCT00662649|69623489|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
37936997|NCT00662649|69623490|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
37936998|NCT00662649|69623491|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
37936999|NCT00662649|69623492|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
37937000|NCT00662649|69623493|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
37937001|NCT00662649|69623489|FG000|Core Study (24 Months)|Protocol Violation|5|||
37937002|NCT00662649|69623490|FG001|Core Study (24 Months)|Protocol Violation|5|||
37937003|NCT00662649|69623491|FG002|Core Study (24 Months)|Protocol Violation|4|||
37937004|NCT00662649|69623492|FG003|Core Study (24 Months)|Protocol Violation|0|||
37937005|NCT00662649|69623493|FG004|Core Study (24 Months)|Protocol Violation|0|||
37937006|NCT00662649|69623489|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
37937007|NCT00662649|69623490|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
37937008|NCT00662649|69623491|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
37937009|NCT00662649|69623492|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
37937010|NCT00662649|69623493|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
37937011|NCT00662649|69623489|FG000|Core Study (24 Months)|Death|1|||
37937012|NCT00662649|69623490|FG001|Core Study (24 Months)|Death|0|||
37937013|NCT00662649|69623491|FG002|Core Study (24 Months)|Death|2|||
37937014|NCT00662649|69623492|FG003|Core Study (24 Months)|Death|0|||
37937015|NCT00662649|69623493|FG004|Core Study (24 Months)|Death|0|||
37937016|NCT00662649|69623489|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
37937017|NCT00662649|69623490|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
37937018|NCT00662649|69623491|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
37937019|NCT00662649|69623492|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
37937020|NCT00662649|69623493|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
37670340|NCT02055820|69143562|FG008|Phase II: Expansion|Death|0|||
37670341|NCT02055820|69143563|FG009|Phase II: Expansion|Death|0|||
37937021|NCT00662649|69623489|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
37937022|NCT00662649|69623490|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
37670342|NCT02055820|69143554|FG000|Phase II: Expansion|Lost to Follow-up|0|||
37937023|NCT00662649|69623491|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
37937024|NCT00662649|69623492|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
37937025|NCT00662649|69623493|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
37937026|NCT00662649|69623489|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
37937027|NCT00662649|69623490|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
37937028|NCT00662649|69623491|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
37937029|NCT00662649|69623492|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
37937030|NCT00662649|69623493|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
37937031|NCT00662649|69623489|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
37937032|NCT00662649|69623490|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
37937033|NCT00662649|69623491|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
37937034|NCT00662649|69623492|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
37937035|NCT00662649|69623493|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
37937036|NCT00662649|69623489|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
37937037|NCT00662649|69623490|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
37937038|NCT00662649|69623491|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
37937039|NCT00662649|69623492|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
37937040|NCT00662649|69623493|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
37937041|NCT00662649|69623489|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
37937042|NCT00662649|69623490|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
37937043|NCT00662649|69623491|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
37937044|NCT00662649|69623492|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
37937045|NCT00662649|69623493|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
37937046|NCT00662649|69623489|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
37937047|NCT00662649|69623490|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
37937048|NCT00662649|69623491|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
37937049|NCT00662649|69623492|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
37937050|NCT00662649|69623493|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
37937051|NCT00662649|69623489|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
37937052|NCT00662649|69623490|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
37937053|NCT00662649|69623491|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
37937054|NCT00662649|69623492|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
37937055|NCT00662649|69623493|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
37937056|NCT00662649|69623489|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
37937057|NCT00662649|69623490|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
37937058|NCT00662649|69623491|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
37937059|NCT00662649|69623492|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
37937060|NCT00662649|69623493|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
37937061|NCT00766493|69623507|FG000|30 Days Post-Procedure|Discontinued|7|||
37937062|NCT00766493|69623507|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
37937063|NCT00766493|69623507|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
37937064|NCT03070392|69623513|FG000|Overall Study|Not Treated|7|||
37937065|NCT03070392|69623514|FG001|Overall Study|Not Treated|0|||
37937066|NCT03070392|69623515|FG002|Overall Study|Not Treated|3|||
37937067|NCT03070392|69623516|FG003|Overall Study|Not Treated|12|||
37937068|NCT03070392|69623513|FG000|Overall Study|Death|3|||
37937069|NCT03070392|69623514|FG001|Overall Study|Death|0|||
37937070|NCT03070392|69623515|FG002|Overall Study|Death|0|||
37937071|NCT03070392|69623516|FG003|Overall Study|Death|1|||
37937072|NCT03070392|69623513|FG000|Overall Study|Withdrawal by Subject|7|||
37937073|NCT03070392|69623514|FG001|Overall Study|Withdrawal by Subject|0|||
37937074|NCT03070392|69623515|FG002|Overall Study|Withdrawal by Subject|0|||
37937075|NCT03070392|69623516|FG003|Overall Study|Withdrawal by Subject|3|||
37937076|NCT03070392|69623513|FG000|Overall Study|Physician Decision|1|||
37937077|NCT03070392|69623514|FG001|Overall Study|Physician Decision|0|||
37937078|NCT03070392|69623515|FG002|Overall Study|Physician Decision|0|||
37937079|NCT03070392|69623516|FG003|Overall Study|Physician Decision|2|||
37937080|NCT03070392|69623513|FG000|Overall Study|Progressive Disease|154|||
37937081|NCT03070392|69623514|FG001|Overall Study|Progressive Disease|6|||
37937082|NCT03070392|69623515|FG002|Overall Study|Progressive Disease|2|||
37937083|NCT03070392|69623516|FG003|Overall Study|Progressive Disease|70|||
37937084|NCT03070392|69623513|FG000|Overall Study|Adverse Event|6|||
37937085|NCT03070392|69623514|FG001|Overall Study|Adverse Event|1|||
37937086|NCT03070392|69623515|FG002|Overall Study|Adverse Event|1|||
38035142|NCT03259334|69722034|FG001|Overall Study|Randomized but never treated|2|||
38035143|NCT03259334|69722035|FG002|Overall Study|Randomized but never treated|0|||
38035144|NCT01331824|69722043|FG000|Overall Study|Adverse Event|2|||
38035145|NCT01331824|69722043|FG000|Overall Study|Death|1|||
37937087|NCT03070392|69623516|FG003|Overall Study|Adverse Event|3|||
37937088|NCT03070392|69623513|FG000|Overall Study|Alternate anticancer treatment|1|||
37937089|NCT03070392|69623514|FG001|Overall Study|Alternate anticancer treatment|0|||
37937090|NCT03070392|69623515|FG002|Overall Study|Alternate anticancer treatment|0|||
37937091|NCT03070392|69623516|FG003|Overall Study|Alternate anticancer treatment|1|||
37937092|NCT03070392|69623513|FG000|Overall Study|Ongoing|73|||
37937093|NCT03070392|69623514|FG001|Overall Study|Ongoing|0|||
37937094|NCT03070392|69623515|FG002|Overall Study|Ongoing|0|||
37937095|NCT03070392|69623516|FG003|Overall Study|Ongoing|11|||
37937096|NCT00784043|69623524|FG000|Overall Study|Withdrawal by Subject|8|||
37937097|NCT00784043|69623525|FG001|Overall Study|Withdrawal by Subject|5|||
37937098|NCT00784043|69623524|FG000|Overall Study|Protocol Terminated|23|||
37937099|NCT00784043|69623525|FG001|Overall Study|Protocol Terminated|1|||
37937100|NCT00773279|69623531|FG000|Period 1|Adverse Event|2|||
37937101|NCT00773279|69623532|FG001|Period 1|Adverse Event|1|||
37937102|NCT00773279|69623531|FG000|Period 1|Lack of Efficacy|0|||
37937103|NCT00773279|69623532|FG001|Period 1|Lack of Efficacy|2|||
37937104|NCT00773279|69623531|FG000|Period 1|Unclassified|5|||
37937105|NCT00773279|69623532|FG001|Period 1|Unclassified|1|||
37937106|NCT00773279|69623531|FG000|Period 2|Adverse Event|0|||
37937107|NCT00773279|69623532|FG001|Period 2|Adverse Event|1|||
37937108|NCT00773279|69623531|FG000|Period 2|Lack of Efficacy|1|||
37937109|NCT00773279|69623532|FG001|Period 2|Lack of Efficacy|0|||
37937110|NCT00773279|69623531|FG000|Period 2|Protocol Violation|0|||
37937111|NCT00773279|69623532|FG001|Period 2|Protocol Violation|3|||
37937112|NCT00773279|69623531|FG000|Period 2|Unclassified|2|||
37937113|NCT00773279|69623532|FG001|Period 2|Unclassified|2|||
37937114|NCT00766415|69623541|FG000|Overall Study|Withdrawal by Subject|0|||
37937115|NCT00766415|69623542|FG001|Overall Study|Withdrawal by Subject|1|||
37937116|NCT00772967|69623548|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
37937117|NCT00772967|69623549|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
37937118|NCT00772967|69623550|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
37937119|NCT00772967|69623551|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
37937120|NCT00772967|69623552|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
37937121|NCT00772967|69623553|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
37937122|NCT00772967|69623548|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
37937123|NCT00772967|69623549|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
37937124|NCT00772967|69623550|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
37937125|NCT00772967|69623551|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
37937126|NCT00772967|69623552|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
37937127|NCT00772967|69623553|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
37937128|NCT00772967|69623548|FG000|Crossover Treatment 3|Adverse Event|0|||
37937129|NCT00772967|69623549|FG001|Crossover Treatment 3|Adverse Event|0|||
37937130|NCT00772967|69623550|FG002|Crossover Treatment 3|Adverse Event|0|||
37937131|NCT00772967|69623551|FG003|Crossover Treatment 3|Adverse Event|0|||
37937132|NCT00772967|69623552|FG004|Crossover Treatment 3|Adverse Event|1|||
37937133|NCT00772967|69623553|FG005|Crossover Treatment 3|Adverse Event|0|||
37937134|NCT00662259|69623576|FG000|Overall Study|Adverse Event|2|||
37937135|NCT00662259|69623577|FG001|Overall Study|Adverse Event|0|||
37937136|NCT00660699|69623583|FG000|Overall Study|Withdrawal by Subject|2|||
37937137|NCT00582114|69623589|FG000|Overall Study|Death|4|||
37937138|NCT00582114|69623590|FG001|Overall Study|Death|4|||
37937139|NCT00582114|69623589|FG000|Overall Study|Kidney Transplant|3|||
37937140|NCT00582114|69623590|FG001|Overall Study|Kidney Transplant|1|||
37937141|NCT00582114|69623589|FG000|Overall Study|Lost to Follow-up|7|||
37937142|NCT00582114|69623590|FG001|Overall Study|Lost to Follow-up|6|||
37937143|NCT00582114|69623589|FG000|Overall Study|Withdrawal by Subject|8|||
37937144|NCT00582114|69623590|FG001|Overall Study|Withdrawal by Subject|16|||
37937145|NCT00582114|69623589|FG000|Overall Study|Adverse Event|1|||
37937146|NCT00582114|69623590|FG001|Overall Study|Adverse Event|1|||
37937147|NCT00582114|69623589|FG000|Overall Study|Physician Decision|0|||
37937148|NCT00582114|69623590|FG001|Overall Study|Physician Decision|6|||
37937149|NCT00582114|69623589|FG000|Overall Study|Stopped by data safety monitoring board|19|||
37937150|NCT00582114|69623590|FG001|Overall Study|Stopped by data safety monitoring board|20|||
37937151|NCT00582036|69623598|FG000|Overall Study|Withdrawal by Subject|0|||
37937152|NCT00582036|69623599|FG001|Overall Study|Withdrawal by Subject|1|||
37937153|NCT00581360|69623605|FG000|Overall Study|Withdrawal by Subject|1|||
37765142|NCT01440569|69278338|FG001|Main Study|Withdrew Consent|1|||
37765143|NCT01440569|69278337|FG000|Main Study|Lost to Follow-up|13|||
37937154|NCT00660387|69623611|FG000|Overall Study|Adverse Event|1|||
37937155|NCT00660387|69623612|FG001|Overall Study|Adverse Event|2|||
37937156|NCT00660387|69623611|FG000|Overall Study|Lack of Efficacy|0|||
37937157|NCT00660387|69623612|FG001|Overall Study|Lack of Efficacy|1|||
37937158|NCT00660387|69623611|FG000|Overall Study|Protocol Violation|1|||
37937159|NCT00660387|69623612|FG001|Overall Study|Protocol Violation|0|||
37937160|NCT00582738|69623620|FG000|Overall Study|Administrative Problems|7|||
37937161|NCT00582738|69623621|FG001|Overall Study|Administrative Problems|8|||
37937162|NCT00582738|69623620|FG000|Overall Study|Adverse Event|0|||
37937163|NCT00582738|69623621|FG001|Overall Study|Adverse Event|5|||
37937164|NCT00582738|69623620|FG000|Overall Study|Graft Lost|0|||
37937165|NCT00582738|69623621|FG001|Overall Study|Graft Lost|1|||
37937166|NCT00582738|69623620|FG000|Overall Study|Other|1|||
37937167|NCT00582738|69623621|FG001|Overall Study|Other|0|||
37937168|NCT00582738|69623620|FG000|Overall Study|Protocol Violation|1|||
37937169|NCT00582738|69623621|FG001|Overall Study|Protocol Violation|1|||
37937170|NCT00582738|69623620|FG000|Overall Study|Withdrawal by Subject|0|||
37937171|NCT00582738|69623621|FG001|Overall Study|Withdrawal by Subject|3|||
37937172|NCT00772889|69623636|FG000|Overall Study|Adverse Event|7|||
37937173|NCT00772889|69623637|FG001|Overall Study|Adverse Event|4|||
37937174|NCT00772889|69623638|FG002|Overall Study|Adverse Event|0|||
37937175|NCT00772889|69623636|FG000|Overall Study|Withdrawal by Subject|9|||
37937176|NCT00772889|69623637|FG001|Overall Study|Withdrawal by Subject|8|||
37937177|NCT00772889|69623638|FG002|Overall Study|Withdrawal by Subject|9|||
37937178|NCT00772889|69623636|FG000|Overall Study|Lost to Follow-up|6|||
37937179|NCT00772889|69623637|FG001|Overall Study|Lost to Follow-up|6|||
37937180|NCT00772889|69623638|FG002|Overall Study|Lost to Follow-up|7|||
37937181|NCT01247324|69623648|FG000|Overall Study|Death|1|||
37937182|NCT01247324|69623649|FG001|Overall Study|Death|0|||
37937183|NCT01247324|69623648|FG000|Overall Study|Physician Decision|0|||
37937184|NCT01247324|69623649|FG001|Overall Study|Physician Decision|1|||
37937185|NCT01247324|69623648|FG000|Overall Study|Non-compliance with study drug|3|||
37937186|NCT01247324|69623649|FG001|Overall Study|Non-compliance with study drug|0|||
37937187|NCT01247324|69623648|FG000|Overall Study|Lack of Efficacy|12|||
37937188|NCT01247324|69623649|FG001|Overall Study|Lack of Efficacy|8|||
37937189|NCT01247324|69623648|FG000|Overall Study|Non-compliance|2|||
37937190|NCT01247324|69623649|FG001|Overall Study|Non-compliance|0|||
37937191|NCT01247324|69623648|FG000|Overall Study|Pregnancy|2|||
37937192|NCT01247324|69623649|FG001|Overall Study|Pregnancy|3|||
37937193|NCT01247324|69623648|FG000|Overall Study|Protocol Violation|1|||
37937194|NCT01247324|69623649|FG001|Overall Study|Protocol Violation|2|||
37937195|NCT01247324|69623648|FG000|Overall Study|Reason not specified|11|||
37937196|NCT01247324|69623649|FG001|Overall Study|Reason not specified|8|||
37937197|NCT01247324|69623648|FG000|Overall Study|Consent withdrawn by participant|13|||
37937198|NCT01247324|69623649|FG001|Overall Study|Consent withdrawn by participant|8|||
37937199|NCT01247324|69623648|FG000|Overall Study|Adverse Event|25|||
37937200|NCT01247324|69623649|FG001|Overall Study|Adverse Event|13|||
37937201|NCT01247324|69623648|FG000|Overall Study|Lost to Follow-up|1|||
37937202|NCT01247324|69623649|FG001|Overall Study|Lost to Follow-up|1|||
37937203|NCT00772577|69623658|FG000|Overall Study|Adverse Event|6|||
37937204|NCT00772577|69623659|FG001|Overall Study|Adverse Event|3|||
37937205|NCT00772577|69623658|FG000|Overall Study|Abnormal laboratory values|0|||
37937206|NCT00772577|69623659|FG001|Overall Study|Abnormal laboratory values|1|||
37937207|NCT00772577|69623658|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
37937208|NCT00772577|69623659|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
37937209|NCT00772577|69623658|FG000|Overall Study|Patient withdrew consent|8|||
37937210|NCT00772577|69623659|FG001|Overall Study|Patient withdrew consent|5|||
37937211|NCT00772577|69623658|FG000|Overall Study|Lost to Follow-up|4|||
37937212|NCT00772577|69623659|FG001|Overall Study|Lost to Follow-up|3|||
37937213|NCT00772577|69623658|FG000|Overall Study|Administrative problems|2|||
37937214|NCT00772577|69623659|FG001|Overall Study|Administrative problems|1|||
37937215|NCT00772577|69623658|FG000|Overall Study|Protocol Deviation|3|||
37937216|NCT00772577|69623659|FG001|Overall Study|Protocol Deviation|2|||
37937217|NCT02345850|69623668|FG000|Overall Study|Not transplanted|10|||
37937218|NCT02345850|69623669|FG001|Overall Study|Not transplanted|5|||
37937219|NCT02345850|69623670|FG002|Overall Study|Not transplanted|4|||
37937220|NCT02345850|69623668|FG000|Overall Study|Lost to Follow-up|2|||
37937221|NCT02345850|69623669|FG001|Overall Study|Lost to Follow-up|3|||
37937222|NCT02345850|69623670|FG002|Overall Study|Lost to Follow-up|2|||
37937223|NCT02345850|69623668|FG000|Overall Study|Withdrawal by Subject|1|||
37937224|NCT02345850|69623669|FG001|Overall Study|Withdrawal by Subject|0|||
37937225|NCT02345850|69623670|FG002|Overall Study|Withdrawal by Subject|0|||
37937226|NCT00659607|69623678|FG000|Overall Study|No blood pressure recorded|147|||
37765144|NCT01440569|69278338|FG001|Main Study|Lost to Follow-up|2|||
37937227|NCT00659607|69623678|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
37937228|NCT00659607|69623678|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
37937229|NCT00659607|69623678|FG000|Overall Study|No recorded efficacy data|15|||
37937230|NCT00659607|69623678|FG000|Overall Study|Inconsistent BP measuring date|2|||
37937231|NCT02848092|69623686|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
37937232|NCT02848092|69623687|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
37937233|NCT02848092|69623686|FG000|1-month Post-training Follow-up|Adverse Event|2|||
37937234|NCT02848092|69623687|FG001|1-month Post-training Follow-up|Adverse Event|1|||
37937235|NCT02848092|69623686|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
37937236|NCT02848092|69623687|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
37937237|NCT02848092|69623686|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
37937238|NCT02848092|69623687|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
37937239|NCT02848092|69623686|FG000|1-month Post-training Follow-up|fatigue|0|||
37937240|NCT02848092|69623687|FG001|1-month Post-training Follow-up|fatigue|1|||
37937241|NCT02848092|69623686|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
37937242|NCT02848092|69623687|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
37937243|NCT02848092|69623686|FG000|6-month Post-training Follow-up|Adverse Event|1|||
37937244|NCT02848092|69623687|FG001|6-month Post-training Follow-up|Adverse Event|1|||
37937245|NCT02848092|69623686|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
37937246|NCT02848092|69623687|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
37937247|NCT02848092|69623686|FG000|6-month Post-training Follow-up|frustrated with task|1|||
37937248|NCT02848092|69623687|FG001|6-month Post-training Follow-up|frustrated with task|0|||
37937249|NCT02848092|69623686|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
37937250|NCT02848092|69623687|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
37937251|NCT02848092|69623686|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
37937252|NCT02848092|69623687|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
37937253|NCT00660309|69623695|FG000|Overall Study|Adverse Event|2|||
37937254|NCT00660309|69623696|FG001|Overall Study|Adverse Event|0|||
37937255|NCT00660309|69623695|FG000|Overall Study|Withdrawal by Subject|0|||
37937256|NCT00660309|69623696|FG001|Overall Study|Withdrawal by Subject|3|||
37937257|NCT00581100|69623705|FG000|Overall Study|Death|1|||
37937258|NCT00581100|69623706|FG001|Overall Study|Death|0|||
37937259|NCT00581100|69623705|FG000|Overall Study|Adverse Event|2|||
37937260|NCT00581100|69623706|FG001|Overall Study|Adverse Event|1|||
37937261|NCT00581100|69623705|FG000|Overall Study|Withdrawal by Subject|1|||
37937262|NCT00581100|69623706|FG001|Overall Study|Withdrawal by Subject|4|||
37937263|NCT00581100|69623705|FG000|Overall Study|Other|3|||
37937264|NCT00581100|69623706|FG001|Overall Study|Other|0|||
37937265|NCT00579098|69623714|FG000|Overall Study|Lost to Follow-up|2|||
37937266|NCT00579098|69623715|FG001|Overall Study|Lost to Follow-up|0|||
37937267|NCT00579098|69623714|FG000|Overall Study|Adverse Event|2|||
37937268|NCT00579098|69623715|FG001|Overall Study|Adverse Event|3|||
37937269|NCT00579098|69623714|FG000|Overall Study|Withdrawal by Subject|2|||
37937270|NCT00579098|69623715|FG001|Overall Study|Withdrawal by Subject|3|||
37937271|NCT00579098|69623714|FG000|Overall Study|AF returned after ablation|3|||
37937272|NCT00579098|69623715|FG001|Overall Study|AF returned after ablation|2|||
37937273|NCT00772109|69623725|FG000|Overall Study|Serious adverse event|1|||
37937274|NCT00772109|69623726|FG001|Overall Study|Serious adverse event|0|||
37937275|NCT00772109|69623727|FG002|Overall Study|Serious adverse event|1|||
37937276|NCT00772109|69623728|FG003|Overall Study|Serious adverse event|0|||
37937277|NCT00772109|69623725|FG000|Overall Study|Protocol Violation|5|||
37937278|NCT00772109|69623726|FG001|Overall Study|Protocol Violation|8|||
37937279|NCT00772109|69623727|FG002|Overall Study|Protocol Violation|7|||
37937280|NCT00772109|69623728|FG003|Overall Study|Protocol Violation|6|||
37937281|NCT00772109|69623725|FG000|Overall Study|Lost to Follow-up|7|||
37937282|NCT00772109|69623726|FG001|Overall Study|Lost to Follow-up|3|||
37937283|NCT00772109|69623727|FG002|Overall Study|Lost to Follow-up|5|||
37937284|NCT00772109|69623728|FG003|Overall Study|Lost to Follow-up|9|||
37937285|NCT00772109|69623725|FG000|Overall Study|Withdrawal by Subject|8|||
37937286|NCT00772109|69623726|FG001|Overall Study|Withdrawal by Subject|8|||
37937287|NCT00772109|69623727|FG002|Overall Study|Withdrawal by Subject|6|||
37937288|NCT00772109|69623728|FG003|Overall Study|Withdrawal by Subject|16|||
37937289|NCT00772031|69623740|FG000|Overall Study|Early termination of trial|12|||
37937290|NCT00772031|69623741|FG001|Overall Study|Early termination of trial|10|||
37937291|NCT00772031|69623740|FG000|Overall Study|Lost to Follow-up|20|||
37937292|NCT00772031|69623741|FG001|Overall Study|Lost to Follow-up|33|||
37937293|NCT00580866|69623755|FG000|Overall Study|Lost to Follow-up|2|||
37937294|NCT00580866|69623756|FG001|Overall Study|Lost to Follow-up|2|||
37937295|NCT00771953|69623764|FG000|Overall Study|Adverse Event|5|||
37937296|NCT00771953|69623765|FG001|Overall Study|Adverse Event|3|||
37937297|NCT00771953|69623764|FG000|Overall Study|Death|2|||
37937298|NCT00771953|69623765|FG001|Overall Study|Death|2|||
37937299|NCT00771953|69623764|FG000|Overall Study|Progression before active Tx|1|||
37937300|NCT00771953|69623765|FG001|Overall Study|Progression before active Tx|2|||
37937301|NCT00771953|69623764|FG000|Overall Study|Sponsor decision|1|||
37937302|NCT00771953|69623765|FG001|Overall Study|Sponsor decision|0|||
37937303|NCT00771953|69623764|FG000|Overall Study|Other complicating disease|1|||
37937304|NCT00771953|69623765|FG001|Overall Study|Other complicating disease|0|||
37937305|NCT00771953|69623764|FG000|Overall Study|Withdrawal by Subject|0|||
37937306|NCT00771953|69623765|FG001|Overall Study|Withdrawal by Subject|3|||
37937307|NCT00621244|69623777|FG000|Overall Study|Withdrawal by Subject|7|||
37937308|NCT00621244|69623778|FG001|Overall Study|Withdrawal by Subject|3|||
37937309|NCT00621244|69623779|FG002|Overall Study|Withdrawal by Subject|3|||
37937310|NCT00621244|69623780|FG003|Overall Study|Withdrawal by Subject|3|||
37937311|NCT00621244|69623777|FG000|Overall Study|Disease progression|44|||
37937312|NCT00621244|69623778|FG001|Overall Study|Disease progression|20|||
37937313|NCT00621244|69623779|FG002|Overall Study|Disease progression|20|||
37937314|NCT00621244|69623780|FG003|Overall Study|Disease progression|15|||
37765145|NCT01440569|69278337|FG000|Main Study|Subject Non-Compliance|3|||
37937315|NCT00621244|69623777|FG000|Overall Study|Death|3|||
37937316|NCT00621244|69623778|FG001|Overall Study|Death|3|||
37937317|NCT00621244|69623779|FG002|Overall Study|Death|1|||
37937318|NCT00621244|69623780|FG003|Overall Study|Death|1|||
37937319|NCT00621244|69623777|FG000|Overall Study|Adverse Event|27|||
37937320|NCT00621244|69623778|FG001|Overall Study|Adverse Event|7|||
37937321|NCT00621244|69623779|FG002|Overall Study|Adverse Event|9|||
37937322|NCT00621244|69623780|FG003|Overall Study|Adverse Event|2|||
37937323|NCT00621244|69623777|FG000|Overall Study|Administrative problems|5|||
37937324|NCT00621244|69623778|FG001|Overall Study|Administrative problems|1|||
37937325|NCT00621244|69623779|FG002|Overall Study|Administrative problems|0|||
37937326|NCT00621244|69623780|FG003|Overall Study|Administrative problems|2|||
37937327|NCT00659529|69623854|FG000|Overall Study|Withdrawal by Subject|4|||
37937328|NCT00659529|69623854|FG000|Overall Study|Protocol Violation|3|||
37937329|NCT00659529|69623854|FG000|Overall Study|Screen failure|9|||
37937330|NCT00578942|69623858|FG000|Overall Study|Lost to Follow-up|1|||
37937331|NCT00765245|69623864|FG000|Overall Study|disease progression|3|||
37937332|NCT00765245|69623865|FG001|Overall Study|disease progression|2|||
37937333|NCT00765245|69623864|FG000|Overall Study|Withdrawal by Subject|3|||
37937334|NCT00765245|69623865|FG001|Overall Study|Withdrawal by Subject|0|||
37937335|NCT00765245|69623864|FG000|Overall Study|Adverse Event|5|||
37937336|NCT00765245|69623865|FG001|Overall Study|Adverse Event|0|||
37937337|NCT00765245|69623864|FG000|Overall Study|Physician Decision|1|||
37937338|NCT00765245|69623865|FG001|Overall Study|Physician Decision|0|||
37937339|NCT00765245|69623864|FG000|Overall Study|Death|1|||
37937340|NCT00765245|69623865|FG001|Overall Study|Death|0|||
37937341|NCT00782795|69623873|FG000|Overall Study|Withdrawal by Subject|1|||
37937342|NCT00782795|69623874|FG001|Overall Study|Withdrawal by Subject|2|||
37937343|NCT00656799|69623880|FG000|Overall Study|Death|2|||
37937344|NCT00764699|69623884|FG000|Overall Study|PI left and study terminated|3|||
37937345|NCT00782717|69623890|FG000|Overall Study|Adverse Event|2|||
37937346|NCT00782717|69623891|FG001|Overall Study|Adverse Event|5|||
37937347|NCT00782717|69623890|FG000|Overall Study|Patient decision unrelated to AE|6|||
37937348|NCT00782717|69623891|FG001|Overall Study|Patient decision unrelated to AE|3|||
37937349|NCT00782717|69623890|FG000|Overall Study|Noncompliance|2|||
37937350|NCT00782717|69623891|FG001|Overall Study|Noncompliance|1|||
37937351|NCT00782717|69623890|FG000|Overall Study|Treatment failure|3|||
37937352|NCT00782717|69623891|FG001|Overall Study|Treatment failure|14|||
37937353|NCT00782717|69623890|FG000|Overall Study|Enrollment close prior to surgery|1|||
37937354|NCT00782717|69623891|FG001|Overall Study|Enrollment close prior to surgery|0|||
37937355|NCT00782717|69623890|FG000|Overall Study|Did not meet entrance criteria|1|||
37937356|NCT00782717|69623891|FG001|Overall Study|Did not meet entrance criteria|3|||
37937357|NCT00782717|69623890|FG000|Overall Study|Exited in error|0|||
37937358|NCT00782717|69623891|FG001|Overall Study|Exited in error|2|||
37937359|NCT00656175|69623899|FG000|Overall Study|Adverse Event|1|||
37937360|NCT00656175|69623900|FG001|Overall Study|Adverse Event|0|||
37937361|NCT00656175|69623899|FG000|Overall Study|Transportation issues|0|||
37937362|NCT00656175|69623900|FG001|Overall Study|Transportation issues|1|||
37937363|NCT00620776|69623908|FG000|Overall Study|Did not receive treatment|3|||
37937364|NCT00620776|69623909|FG001|Overall Study|Did not receive treatment|5|||
37937365|NCT00620776|69623908|FG000|Overall Study|Adverse Event|2|||
37937366|NCT00620776|69623909|FG001|Overall Study|Adverse Event|3|||
37937367|NCT00620776|69623908|FG000|Overall Study|Lack of Efficacy|2|||
37937368|NCT00620776|69623909|FG001|Overall Study|Lack of Efficacy|1|||
38035146|NCT01331824|69722043|FG000|Overall Study|Disease Progression|9|||
38035147|NCT01331824|69722043|FG000|Overall Study|Withdrawal by Subject|1|||
38035148|NCT03258710|69722047|FG000|Overall Study|Adverse Event|1|||
38035149|NCT03258710|69722047|FG000|Overall Study|Protocol-defined stopping criteria|1|||
38035150|NCT03258710|69722047|FG000|Overall Study|Physician Decision|1|||
38035151|NCT03240692|69722051|FG000|Overall Study|Physician Decision|1|||
38035152|NCT03240692|69722051|FG000|Overall Study|Withdrawal by Subject|1|||
38035153|NCT03233048|69722055|FG000|Overall Study|Withdrawal by Subject|1|||
38035154|NCT02937740|69722061|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
38035155|NCT02937740|69722062|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
38035156|NCT02937740|69722061|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
38035157|NCT02937740|69722062|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
38035158|NCT02937740|69722061|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
38035159|NCT02937740|69722062|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
38035160|NCT02937740|69722061|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
38035161|NCT02937740|69722062|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
38035162|NCT02937740|69722061|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
38035163|NCT02937740|69722062|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
38035164|NCT02937740|69722061|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
38035165|NCT02937740|69722062|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
38035166|NCT04173741|69722085|FG000|Overall Study|IVC measurement cannot be done|1|||
38035167|NCT04173741|69722086|FG001|Overall Study|IVC measurement cannot be done|1|||
38035168|NCT03231800|69722094|FG000|Overall Study|Lost to Follow-up|0|||
38035169|NCT03231800|69722095|FG001|Overall Study|Lost to Follow-up|2|||
38035170|NCT03231800|69722094|FG000|Overall Study|Protocol Violation|1|||
38035171|NCT03231800|69722095|FG001|Overall Study|Protocol Violation|1|||
38035172|NCT03231800|69722094|FG000|Overall Study|reason not provided|2|||
38035173|NCT03231800|69722095|FG001|Overall Study|reason not provided|0|||
37937369|NCT00620776|69623908|FG000|Overall Study|Lost to Follow-up|2|||
37937370|NCT00620776|69623909|FG001|Overall Study|Lost to Follow-up|5|||
37937371|NCT00620776|69623908|FG000|Overall Study|Withdrawal by Subject|3|||
37937372|NCT00620776|69623909|FG001|Overall Study|Withdrawal by Subject|2|||
37937373|NCT00656019|69623919|FG000|Overall Study|Not Eligible|10|||
37937374|NCT00656019|69623920|FG001|Overall Study|Not Eligible|0|||
37937375|NCT00656019|69623921|FG002|Overall Study|Not Eligible|0|||
37937376|NCT00656019|69623922|FG003|Overall Study|Not Eligible|0|||
37937377|NCT00656019|69623919|FG000|Overall Study|Withdrawal by Subject|2|||
37937378|NCT00656019|69623920|FG001|Overall Study|Withdrawal by Subject|0|||
37937379|NCT00656019|69623921|FG002|Overall Study|Withdrawal by Subject|0|||
37937380|NCT00656019|69623922|FG003|Overall Study|Withdrawal by Subject|0|||
37937381|NCT00656019|69623919|FG000|Overall Study|Lost to Follow-up|2|||
37937382|NCT00656019|69623920|FG001|Overall Study|Lost to Follow-up|1|||
37937383|NCT00656019|69623921|FG002|Overall Study|Lost to Follow-up|0|||
37937384|NCT00656019|69623922|FG003|Overall Study|Lost to Follow-up|0|||
37937385|NCT00782483|69623932|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
37937386|NCT00782171|69623938|FG000|Overall Study|Lost to Follow-up|2|||
37937387|NCT00782171|69623939|FG001|Overall Study|Lost to Follow-up|2|||
37937388|NCT00782171|69623938|FG000|Overall Study|Withdrawal by Subject|2|||
37937389|NCT00782171|69623939|FG001|Overall Study|Withdrawal by Subject|1|||
37937390|NCT00782171|69623938|FG000|Overall Study|complications|3|||
37937391|NCT00782171|69623939|FG001|Overall Study|complications|1|||
37937392|NCT00782171|69623938|FG000|Overall Study|others|7|||
37937393|NCT00782171|69623939|FG001|Overall Study|others|9|||
37937394|NCT00782171|69623938|FG000|Overall Study|not eligible|8|||
37937395|NCT00782171|69623939|FG001|Overall Study|not eligible|6|||
37937396|NCT00764465|69623951|FG000|Overall Study|Adverse Event|2|||
37937397|NCT00764465|69623952|FG001|Overall Study|Adverse Event|0|||
37937398|NCT00764465|69623953|FG002|Overall Study|Adverse Event|0|||
37937399|NCT00764465|69623954|FG003|Overall Study|Adverse Event|1|||
37937400|NCT00764465|69623955|FG004|Overall Study|Adverse Event|1|||
37937401|NCT00764465|69623956|FG005|Overall Study|Adverse Event|1|||
37937402|NCT00764465|69623951|FG000|Overall Study|Withdrawal by Subject|0|||
37937403|NCT00764465|69623952|FG001|Overall Study|Withdrawal by Subject|1|||
37937404|NCT00764465|69623953|FG002|Overall Study|Withdrawal by Subject|1|||
37937405|NCT00764465|69623954|FG003|Overall Study|Withdrawal by Subject|0|||
37937406|NCT00764465|69623955|FG004|Overall Study|Withdrawal by Subject|0|||
37937407|NCT00764465|69623956|FG005|Overall Study|Withdrawal by Subject|0|||
37937408|NCT00655863|69623976|FG000|Overall Study|Lost to Follow-up|0|||
37937409|NCT00655863|69623977|FG001|Overall Study|Lost to Follow-up|0|||
37937410|NCT00655863|69623978|FG002|Overall Study|Lost to Follow-up|1|||
37937411|NCT00781937|69623988|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
37937412|NCT00781937|69623989|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
37937413|NCT00781937|69623988|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
37937414|NCT00781937|69623989|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
37937415|NCT00781937|69623988|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
37937416|NCT00781937|69623989|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
37937417|NCT00781937|69623988|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
37937418|NCT00781937|69623989|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
37937419|NCT00781937|69623988|FG000|Main Trial Period Through Week 56|Unclassified|10|||
37937420|NCT00781937|69623989|FG001|Main Trial Period Through Week 56|Unclassified|15|||
37937421|NCT00781937|69623988|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
37937422|NCT00781937|69623989|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
37937423|NCT00781937|69623988|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
37937424|NCT00781937|69623989|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
37937425|NCT00659373|69623997|FG000|Overall Study|Withdrawal by Subject|3|||
37937426|NCT00659373|69623998|FG001|Overall Study|Withdrawal by Subject|5|||
37937427|NCT00659373|69623997|FG000|Overall Study|Assessment Missed|2|||
37937428|NCT00659373|69623998|FG001|Overall Study|Assessment Missed|2|||
37937429|NCT00439777|69624006|FG000|Treatment Period|Death|29|||
37937430|NCT00439777|69624007|FG001|Treatment Period|Death|21|||
37937431|NCT00439777|69624006|FG000|Treatment Period|Study terminated by sponsor|125|||
37937432|NCT00439777|69624007|FG001|Treatment Period|Study terminated by sponsor|132|||
37765146|NCT01440569|69278338|FG001|Main Study|Subject Non-Compliance|0|||
37937433|NCT00439777|69624006|FG000|Treatment Period|Site closed by investigator|0|||
37937434|NCT00439777|69624007|FG001|Treatment Period|Site closed by investigator|1|||
37937435|NCT00439777|69624006|FG000|Treatment Period|Did not take study treatment|7|||
37937436|NCT00439777|69624007|FG001|Treatment Period|Did not take study treatment|8|||
37937437|NCT00439777|69624006|FG000|Treatment Period|Adverse Event|111|||
37937438|NCT00439777|69624007|FG001|Treatment Period|Adverse Event|92|||
37937439|NCT00439777|69624006|FG000|Treatment Period|Protocol Violation|23|||
37937440|NCT00439777|69624007|FG001|Treatment Period|Protocol Violation|30|||
37937441|NCT00439777|69624006|FG000|Treatment Period|Withdrawal by Subject|66|||
37937442|NCT00439777|69624007|FG001|Treatment Period|Withdrawal by Subject|118|||
37937443|NCT00439777|69624006|FG000|Treatment Period|Lack of Efficacy|1|||
37937444|NCT00439777|69624007|FG001|Treatment Period|Lack of Efficacy|4|||
37937445|NCT00439777|69624006|FG000|Treatment Period|Lost to Follow-up|8|||
37937446|NCT00439777|69624007|FG001|Treatment Period|Lost to Follow-up|10|||
37937447|NCT00439777|69624006|FG000|Treatment Period|Protocol driven decision point|1|||
37937448|NCT00439777|69624007|FG001|Treatment Period|Protocol driven decision point|3|||
37937449|NCT00439777|69624006|FG000|Treatment Period|Physician Decision|7|||
37937450|NCT00439777|69624007|FG001|Treatment Period|Physician Decision|18|||
37937451|NCT00439777|69624006|FG000|Treatment Period|Clinical endpoint reached|26|||
37937452|NCT00439777|69624007|FG001|Treatment Period|Clinical endpoint reached|13|||
37937453|NCT00439777|69624006|FG000|Treatment Period|Technical problems|3|||
37937454|NCT00439777|69624007|FG001|Treatment Period|Technical problems|1|||
37937455|NCT00439777|69624006|FG000|Treatment Period|Participant convenience|12|||
37937456|NCT00439777|69624007|FG001|Treatment Period|Participant convenience|8|||
37937457|NCT00439777|69624006|FG000|Observational Period|Protocol Violation|0|||
37937458|NCT00439777|69624007|FG001|Observational Period|Protocol Violation|2|||
37937459|NCT00439777|69624006|FG000|Observational Period|Withdrawal by Subject|9|||
37937460|NCT00439777|69624007|FG001|Observational Period|Withdrawal by Subject|5|||
37937461|NCT00439777|69624006|FG000|Observational Period|Lost to Follow-up|1|||
37937462|NCT00439777|69624007|FG001|Observational Period|Lost to Follow-up|11|||
37937463|NCT00439777|69624006|FG000|Observational Period|Death|27|||
37937464|NCT00439777|69624007|FG001|Observational Period|Death|20|||
37937465|NCT00439777|69624006|FG000|Observational Period|Study terminated by sponsor|3|||
37937466|NCT00439777|69624007|FG001|Observational Period|Study terminated by sponsor|1|||
37937467|NCT00439777|69624006|FG000|Observational Period|Protocol driven decision point|0|||
37937468|NCT00439777|69624007|FG001|Observational Period|Protocol driven decision point|1|||
37937469|NCT00439777|69624006|FG000|Observational Period|Lack of Efficacy|1|||
37937470|NCT00439777|69624007|FG001|Observational Period|Lack of Efficacy|0|||
37937471|NCT00439777|69624006|FG000|Observational Period|Technical problems|0|||
37937472|NCT00439777|69624007|FG001|Observational Period|Technical problems|1|||
37937473|NCT00620854|69624019|FG000|Washout 1|Withdrawal by Subject|0|||
37937474|NCT00620854|69624020|FG001|Washout 1|Withdrawal by Subject|0|||
37937475|NCT00620854|69624021|FG002|Washout 1|Withdrawal by Subject|1|||
37937476|NCT00620854|69624022|FG003|Washout 1|Withdrawal by Subject|1|||
37937477|NCT00620854|69624023|FG004|Washout 1|Withdrawal by Subject|0|||
37937478|NCT00620854|69624024|FG005|Washout 1|Withdrawal by Subject|0|||
37937479|NCT00430027|69624035|FG000|Overall Study|Study terminated|8|||
37937480|NCT00429793|69624039|FG000|Overall Study|Improper pre-protocol treatment|3|||
37937481|NCT00429793|69624039|FG000|Overall Study|Required test not done|1|||
37937482|NCT00429793|69624039|FG000|Overall Study|Never treated|1|||
37937483|NCT00429793|69624039|FG000|Overall Study|Non-measurable|1|||
37937484|NCT00424645|69624050|FG000|Overall Study|Death|1|||
37937485|NCT00424645|69624051|FG001|Overall Study|Death|0|||
37937486|NCT00763451|69624061|FG000|Overall Study|Adverse Event|4|||
37670343|NCT02055820|69143555|FG001|Phase II: Expansion|Lost to Follow-up|0|||
37670344|NCT02055820|69143556|FG002|Phase II: Expansion|Lost to Follow-up|0|||
37670345|NCT02055820|69143557|FG003|Phase II: Expansion|Lost to Follow-up|0|||
37670346|NCT02055820|69143558|FG004|Phase II: Expansion|Lost to Follow-up|4|||
37670347|NCT02055820|69143559|FG005|Phase II: Expansion|Lost to Follow-up|0|||
37670348|NCT02055820|69143560|FG006|Phase II: Expansion|Lost to Follow-up|0|||
37670349|NCT02055820|69143561|FG007|Phase II: Expansion|Lost to Follow-up|0|||
37670350|NCT02055820|69143562|FG008|Phase II: Expansion|Lost to Follow-up|0|||
37670351|NCT02055820|69143563|FG009|Phase II: Expansion|Lost to Follow-up|0|||
37670352|NCT02055820|69143554|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
37670353|NCT02055820|69143555|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
37670354|NCT02055820|69143556|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
37670355|NCT02055820|69143557|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
37670356|NCT02055820|69143558|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
37670357|NCT02055820|69143559|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
37670358|NCT02055820|69143560|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
37670359|NCT02055820|69143561|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
37670360|NCT02055820|69143562|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
37670361|NCT02055820|69143563|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
37670362|NCT02055352|69143607|FG000|Overall Study|Adverse Event|0|||
37670363|NCT02055352|69143608|FG001|Overall Study|Adverse Event|1|||
37670364|NCT02055352|69143607|FG000|Overall Study|Non-eligible|0|||
37670365|NCT02055352|69143608|FG001|Overall Study|Non-eligible|1|||
37670366|NCT02055352|69143607|FG000|Overall Study|Poor compliance|1|||
37670367|NCT02055352|69143608|FG001|Overall Study|Poor compliance|1|||
37670368|NCT02055352|69143607|FG000|Overall Study|Death|1|||
37670369|NCT02055352|69143608|FG001|Overall Study|Death|2|||
37670370|NCT02055352|69143607|FG000|Overall Study|Patient decision|1|||
37670371|NCT02055352|69143608|FG001|Overall Study|Patient decision|1|||
37937487|NCT00763451|69624062|FG001|Overall Study|Adverse Event|6|||
37937488|NCT00763451|69624063|FG002|Overall Study|Adverse Event|19|||
37937489|NCT00763451|69624064|FG003|Overall Study|Adverse Event|14|||
37937490|NCT00763451|69624061|FG000|Overall Study|Lack of Efficacy|1|||
37937491|NCT00763451|69624062|FG001|Overall Study|Lack of Efficacy|4|||
37937492|NCT00763451|69624063|FG002|Overall Study|Lack of Efficacy|3|||
37937493|NCT00763451|69624064|FG003|Overall Study|Lack of Efficacy|2|||
37670372|NCT02055352|69143607|FG000|Overall Study|Use of prohibited treatment|0|||
37670373|NCT02055352|69143608|FG001|Overall Study|Use of prohibited treatment|3|||
37670374|NCT02055352|69143607|FG000|Overall Study|AE, study drug would be detrimental|1|||
37670375|NCT02055352|69143608|FG001|Overall Study|AE, study drug would be detrimental|3|||
37670376|NCT02055352|69143607|FG000|Overall Study|Withdrawal of informed consent|1|||
37670377|NCT02055352|69143608|FG001|Overall Study|Withdrawal of informed consent|0|||
37670378|NCT02055352|69143607|FG000|Overall Study|Reason unknown|1|||
37670379|NCT02055352|69143608|FG001|Overall Study|Reason unknown|5|||
37937494|NCT00763451|69624061|FG000|Overall Study|Withdrawal by Subject|1|||
37937495|NCT00763451|69624062|FG001|Overall Study|Withdrawal by Subject|6|||
37937496|NCT00763451|69624063|FG002|Overall Study|Withdrawal by Subject|9|||
37937497|NCT00763451|69624064|FG003|Overall Study|Withdrawal by Subject|7|||
37937498|NCT00763451|69624061|FG000|Overall Study|Protocol Violation|0|||
37937499|NCT00763451|69624062|FG001|Overall Study|Protocol Violation|0|||
37937500|NCT00763451|69624063|FG002|Overall Study|Protocol Violation|1|||
37937501|NCT00763451|69624064|FG003|Overall Study|Protocol Violation|0|||
37937502|NCT00763451|69624061|FG000|Overall Study|Poor Compliance to Protocol|1|||
37937503|NCT00763451|69624062|FG001|Overall Study|Poor Compliance to Protocol|1|||
37937504|NCT00763451|69624063|FG002|Overall Study|Poor Compliance to Protocol|2|||
37937505|NCT00763451|69624064|FG003|Overall Study|Poor Compliance to Protocol|2|||
37937506|NCT00763451|69624061|FG000|Overall Study|Familial and Personal Reasons|5|||
37937507|NCT00763451|69624062|FG001|Overall Study|Familial and Personal Reasons|3|||
37937508|NCT00763451|69624063|FG002|Overall Study|Familial and Personal Reasons|5|||
37937509|NCT00763451|69624064|FG003|Overall Study|Familial and Personal Reasons|4|||
37937510|NCT00763451|69624061|FG000|Overall Study|Randomized but not Treated|1|||
37937511|NCT00763451|69624062|FG001|Overall Study|Randomized but not Treated|1|||
37937512|NCT00763451|69624063|FG002|Overall Study|Randomized but not Treated|0|||
37937513|NCT00763451|69624064|FG003|Overall Study|Randomized but not Treated|0|||
37937514|NCT00763451|69624061|FG000|Overall Study|Study Site Reason|0|||
37937515|NCT00763451|69624062|FG001|Overall Study|Study Site Reason|1|||
37937516|NCT00763451|69624063|FG002|Overall Study|Study Site Reason|1|||
37937517|NCT00763451|69624064|FG003|Overall Study|Study Site Reason|1|||
37937518|NCT00762762|69624077|FG000|Overall Study|Did not return for appointments|6|||
37937519|NCT00762762|69624078|FG001|Overall Study|Did not return for appointments|8|||
37937520|NCT00424489|69624086|FG000|Overall Study|Death|3|||
37937521|NCT00578864|69624092|FG000|Overall Study|Death|1|||
37937522|NCT00578864|69624093|FG001|Overall Study|Death|0|||
37937523|NCT00770315|69624116|FG000|Overall Study|Adverse Event|11|||
37937524|NCT00770315|69624117|FG001|Overall Study|Adverse Event|17|||
37937525|NCT00770315|69624118|FG002|Overall Study|Adverse Event|16|||
37937526|NCT00770315|69624119|FG003|Overall Study|Adverse Event|6|||
37937527|NCT00770315|69624116|FG000|Overall Study|Lost to Follow-up|9|||
37937528|NCT00770315|69624117|FG001|Overall Study|Lost to Follow-up|5|||
37937529|NCT00770315|69624118|FG002|Overall Study|Lost to Follow-up|10|||
37937530|NCT00770315|69624119|FG003|Overall Study|Lost to Follow-up|3|||
37937531|NCT00770315|69624116|FG000|Overall Study|Withdrawal by Subject|13|||
37937532|NCT00770315|69624117|FG001|Overall Study|Withdrawal by Subject|17|||
37937533|NCT00770315|69624118|FG002|Overall Study|Withdrawal by Subject|24|||
37937534|NCT00770315|69624119|FG003|Overall Study|Withdrawal by Subject|20|||
37937535|NCT00770315|69624116|FG000|Overall Study|Noncompliance with Protocol|7|||
37937536|NCT00770315|69624117|FG001|Overall Study|Noncompliance with Protocol|4|||
37937537|NCT00770315|69624118|FG002|Overall Study|Noncompliance with Protocol|7|||
37937538|NCT00770315|69624119|FG003|Overall Study|Noncompliance with Protocol|9|||
37937539|NCT00587171|69624131|FG000|Overall Study|Lost to Follow-up|1|||
37937540|NCT00587171|69624132|FG001|Overall Study|Lost to Follow-up|1|||
37937541|NCT00763139|69624138|FG000|Overall Study|Adverse Event|4|||
37937542|NCT00763139|69624139|FG001|Overall Study|Adverse Event|2|||
37937543|NCT00763139|69624138|FG000|Overall Study|Withdrawal by Subject|0|||
37937544|NCT00763139|69624139|FG001|Overall Study|Withdrawal by Subject|1|||
37937545|NCT00763139|69624138|FG000|Overall Study|med change not allowed by protocol|1|||
37937546|NCT00763139|69624139|FG001|Overall Study|med change not allowed by protocol|0|||
38035174|NCT04085601|69722103|FG000|Overall Study|Lost to Follow-up|1|||
37670380|NCT02034916|69143616|FG000|Overall Study|Death|39|||
37670381|NCT02034916|69143617|FG001|Overall Study|Death|28|||
37670382|NCT02034916|69143616|FG000|Overall Study|Withdrawal by Subject|2|||
37937547|NCT01366092|69624150|FG000|Overall Study|Progressive cGVHD|2|||
37937548|NCT01366092|69624150|FG000|Overall Study|Physician Decision|1|||
37937549|NCT01366092|69624150|FG000|Overall Study|Withdrawal by Subject|1|||
37937550|NCT00781859|69624156|FG000|Overall Study|Adverse Event|2|||
37937551|NCT00781859|69624157|FG001|Overall Study|Adverse Event|2|||
37937552|NCT00781859|69624156|FG000|Overall Study|Withdrawal by Subject|8|||
37937553|NCT00781859|69624157|FG001|Overall Study|Withdrawal by Subject|4|||
37937554|NCT00781859|69624156|FG000|Overall Study|Lost to Follow-up|6|||
37937555|NCT00781859|69624157|FG001|Overall Study|Lost to Follow-up|3|||
37937556|NCT00781859|69624156|FG000|Overall Study|Death|3|||
37937557|NCT00781859|69624157|FG001|Overall Study|Death|0|||
37937558|NCT00580788|69624167|FG000|Overall Study|Adverse Event|0|||
38035175|NCT04085601|69722104|FG001|Overall Study|Lost to Follow-up|0|||
37937559|NCT00580788|69624168|FG001|Overall Study|Adverse Event|0|||
37937560|NCT00580788|69624169|FG002|Overall Study|Adverse Event|0|||
37937561|NCT00580788|69624170|FG003|Overall Study|Adverse Event|1|||
37937562|NCT00417079|69624189|FG000|Overall Study|Disease progression|267|||
37937563|NCT00417079|69624190|FG001|Overall Study|Disease progression|180|||
37937564|NCT00417079|69624189|FG000|Overall Study|Adverse Event|32|||
37937565|NCT00417079|69624190|FG001|Overall Study|Adverse Event|67|||
37937566|NCT00417079|69624189|FG000|Overall Study|Non-compliance to protocol|0|||
37937567|NCT00417079|69624190|FG001|Overall Study|Non-compliance to protocol|1|||
37937568|NCT00417079|69624189|FG000|Overall Study|Lost to Follow-up|2|||
37937569|NCT00417079|69624190|FG001|Overall Study|Lost to Follow-up|0|||
37937570|NCT00417079|69624189|FG000|Overall Study|Withdrawal by Subject|17|||
37937571|NCT00417079|69624190|FG001|Overall Study|Withdrawal by Subject|8|||
37937572|NCT00417079|69624189|FG000|Overall Study|Not treated|6|||
37937573|NCT00417079|69624190|FG001|Overall Study|Not treated|7|||
37937574|NCT00417079|69624189|FG000|Overall Study|Screened failure|2|||
37937575|NCT00417079|69624190|FG001|Overall Study|Screened failure|1|||
37937576|NCT00417079|69624189|FG000|Overall Study|Investigator's decision|1|||
37937577|NCT00417079|69624190|FG001|Overall Study|Investigator's decision|4|||
37937578|NCT00417079|69624189|FG000|Overall Study|Non-confirmed Disease progression|1|||
37937579|NCT00417079|69624190|FG001|Overall Study|Non-confirmed Disease progression|1|||
37937580|NCT00417079|69624189|FG000|Overall Study|Clinical deterioration|1|||
37937581|NCT00417079|69624190|FG001|Overall Study|Clinical deterioration|0|||
37937582|NCT00417079|69624189|FG000|Overall Study|Screening error|2|||
37937583|NCT00417079|69624190|FG001|Overall Study|Screening error|1|||
37937584|NCT00417079|69624189|FG000|Overall Study|Withdrawal by subject's family|0|||
37937585|NCT00417079|69624190|FG001|Overall Study|Withdrawal by subject's family|1|||
37937586|NCT00417079|69624189|FG000|Overall Study|Patient unable to come to the clinic|0|||
37937587|NCT00417079|69624190|FG001|Overall Study|Patient unable to come to the clinic|1|||
37937588|NCT00417079|69624189|FG000|Overall Study|abnormal liver function tests|0|||
37937589|NCT00417079|69624190|FG001|Overall Study|abnormal liver function tests|1|||
37937590|NCT00429169|69624198|FG000|Overall Study|Lost to Follow-up|0|||
37937591|NCT00429169|69624199|FG001|Overall Study|Lost to Follow-up|1|||
37937592|NCT00429169|69624198|FG000|Overall Study|Ineligibility discovered after entry|2|||
37937593|NCT00429169|69624199|FG001|Overall Study|Ineligibility discovered after entry|1|||
37937594|NCT00416455|69624209|FG000|Overall Study|PET / CT not done|3|||
37937595|NCT00416455|69624210|FG001|Overall Study|PET / CT not done|5|||
37937596|NCT00416455|69624209|FG000|Overall Study|PET / CT poor quality|2|||
37937597|NCT00416455|69624210|FG001|Overall Study|PET / CT poor quality|1|||
37937598|NCT00416455|69624209|FG000|Overall Study|Inadequate pathology|11|||
37937599|NCT00416455|69624210|FG001|Overall Study|Inadequate pathology|2|||
37937600|NCT00415909|69624227|FG000|Overall Study|Withdrawal by Subject|2|||
37937601|NCT00415909|69624227|FG000|Overall Study|Death|1|||
37937602|NCT00415597|69624231|FG000|Enrollment|Withdrawal by Subject|1|||
37937603|NCT00415597|69624231|FG000|Enrollment|Protocol Violation|1|||
37937604|NCT00415597|69624231|FG000|Treatment|Adverse Event|110|||
37937605|NCT00415597|69624231|FG000|Treatment|Lack of Efficacy|39|||
37937606|NCT00415597|69624231|FG000|Treatment|Protocol Violation|67|||
37937607|NCT00415597|69624231|FG000|Treatment|Physician Decision|3|||
37937608|NCT00415597|69624231|FG000|Treatment|Withdrawal by Subject|51|||
37937609|NCT00415597|69624231|FG000|Treatment|Lost to Follow-up|28|||
37937610|NCT00415597|69624231|FG000|Treatment|Drug Screen|2|||
37937611|NCT00415597|69624231|FG000|Treatment|Administrative|3|||
37937612|NCT00415597|69624231|FG000|Treatment|Sponsor Decision|1|||
37937613|NCT00415597|69624231|FG000|Treatment|Multiple Reasons|1|||
37937614|NCT00620542|69624237|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
37937615|NCT00620542|69624238|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
37937616|NCT00620542|69624239|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
37937617|NCT00620542|69624240|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
37765147|NCT01440569|69278337|FG000|Main Study|Protocol Violation|1|||
37765148|NCT01440569|69278338|FG001|Main Study|Protocol Violation|0|||
37765149|NCT01440569|69278337|FG000|Open-Label Rollover Phase|Adverse Event|3|||
37765150|NCT01440569|69278338|FG001|Open-Label Rollover Phase|Adverse Event|0|||
37937618|NCT00620542|69624237|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
37937619|NCT00620542|69624238|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
37765151|NCT01440569|69278337|FG000|Open-Label Rollover Phase|Pregnancy|1|||
37937620|NCT00620542|69624239|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
37937621|NCT00620542|69624240|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
37937622|NCT00620542|69624237|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
37937623|NCT00620542|69624238|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
37937624|NCT00620542|69624239|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
37937625|NCT00620542|69624240|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
37937626|NCT00620542|69624237|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
37937627|NCT00620542|69624238|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
37937628|NCT00620542|69624239|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
37937629|NCT00620542|69624240|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
37937630|NCT00620542|69624237|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
37937631|NCT00620542|69624238|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
37937632|NCT00620542|69624239|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
37937633|NCT00620542|69624240|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
37937634|NCT00620542|69624237|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
37937635|NCT00620542|69624238|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
37937636|NCT00620542|69624239|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
37937637|NCT00620542|69624240|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
37937638|NCT00620542|69624237|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
37937639|NCT00620542|69624238|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
37937640|NCT00620542|69624239|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
37937641|NCT00620542|69624240|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
37937642|NCT00620542|69624237|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
37937643|NCT00620542|69624238|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
37937644|NCT00620542|69624239|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
37937645|NCT00620542|69624240|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
37937646|NCT00620542|69624237|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
37937647|NCT00620542|69624238|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
37937648|NCT00620542|69624239|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
37937649|NCT00620542|69624240|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
37937650|NCT00620542|69624237|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
37937651|NCT00620542|69624238|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
37937652|NCT00620542|69624239|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
37937653|NCT00620542|69624240|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
37937654|NCT00620542|69624237|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
37937655|NCT00620542|69624238|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
37937656|NCT00620542|69624239|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
37937657|NCT00620542|69624240|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
37937658|NCT00620542|69624237|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
37937659|NCT00620542|69624238|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
37937660|NCT00620542|69624239|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
37937661|NCT00620542|69624240|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
37937662|NCT00620542|69624237|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
37937663|NCT00620542|69624238|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
37937664|NCT00620542|69624239|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
37937665|NCT00620542|69624240|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
37937666|NCT00620542|69624237|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
37937667|NCT00620542|69624238|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
37937668|NCT00620542|69624239|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
37937669|NCT00620542|69624240|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
37937670|NCT00620542|69624237|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
37937671|NCT00620542|69624238|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
37937672|NCT00620542|69624239|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
37937673|NCT00620542|69624240|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
37937674|NCT05096208|69624252|FG000|Overall Study|Lost to Follow-up|3|||
37937675|NCT05096208|69624253|FG001|Overall Study|Lost to Follow-up|5|||
37937676|NCT05096208|69624254|FG002|Overall Study|Lost to Follow-up|5|||
37937677|NCT05096208|69624255|FG003|Overall Study|Lost to Follow-up|2|||
37937678|NCT05096208|69624252|FG000|Overall Study|Withdrawal by Subject|0|||
37765152|NCT01440569|69278338|FG001|Open-Label Rollover Phase|Pregnancy|0|||
37765153|NCT01440569|69278337|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
37937679|NCT05096208|69624253|FG001|Overall Study|Withdrawal by Subject|1|||
37937680|NCT05096208|69624254|FG002|Overall Study|Withdrawal by Subject|2|||
37937681|NCT05096208|69624255|FG003|Overall Study|Withdrawal by Subject|3|||
37937682|NCT05096208|69624252|FG000|Overall Study|No longer met eligibility criteria|1|||
37937683|NCT05096208|69624253|FG001|Overall Study|No longer met eligibility criteria|0|||
37937684|NCT05096208|69624254|FG002|Overall Study|No longer met eligibility criteria|0|||
37937685|NCT05096208|69624255|FG003|Overall Study|No longer met eligibility criteria|0|||
37937686|NCT05096208|69624252|FG000|Overall Study|Other|0|||
37937687|NCT05096208|69624253|FG001|Overall Study|Other|0|||
37937688|NCT05096208|69624254|FG002|Overall Study|Other|1|||
37765154|NCT01440569|69278338|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
37765155|NCT01440569|69278337|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
37937689|NCT05096208|69624255|FG003|Overall Study|Other|0|||
37937690|NCT04555616|69624274|FG000|Overall Study|Death|1|||
37937691|NCT04555616|69624275|FG001|Overall Study|Death|0|||
37937692|NCT04555616|69624276|FG002|Overall Study|Death|1|||
37937693|NCT04555616|69624274|FG000|Overall Study|Withdrawal by Subject|2|||
37765156|NCT01440569|69278338|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
37937694|NCT04555616|69624275|FG001|Overall Study|Withdrawal by Subject|1|||
37937695|NCT04555616|69624276|FG002|Overall Study|Withdrawal by Subject|0|||
37937696|NCT04177758|69624300|FG000|Overall Study|Lost to Follow-up|19|||
37937697|NCT04177758|69624301|FG001|Overall Study|Lost to Follow-up|11|||
37937698|NCT04003103|69624310|FG000|Overall Study|Death|1|||
37937699|NCT04003103|69624311|FG001|Overall Study|Death|0|||
37937700|NCT04003103|69624312|FG002|Overall Study|Death|0|||
37937701|NCT04003103|69624310|FG000|Overall Study|Lost to Follow-up|4|||
37937702|NCT04003103|69624311|FG001|Overall Study|Lost to Follow-up|3|||
37937703|NCT04003103|69624312|FG002|Overall Study|Lost to Follow-up|2|||
37937704|NCT04003103|69624310|FG000|Overall Study|Withdrawal by Subject|10|||
37937705|NCT04003103|69624311|FG001|Overall Study|Withdrawal by Subject|1|||
37937706|NCT04003103|69624312|FG002|Overall Study|Withdrawal by Subject|1|||
37937707|NCT04003103|69624310|FG000|Overall Study|Status not recorded|0|||
37937708|NCT04003103|69624311|FG001|Overall Study|Status not recorded|2|||
37937709|NCT04003103|69624312|FG002|Overall Study|Status not recorded|0|||
37937710|NCT03921528|69624361|FG000|Overall Study|Withdrawal by Subject|0|||
37937711|NCT03921528|69624362|FG001|Overall Study|Withdrawal by Subject|1|||
37937712|NCT03921528|69624363|FG002|Overall Study|Withdrawal by Subject|0|||
37937713|NCT03921528|69624364|FG003|Overall Study|Withdrawal by Subject|0|||
37937714|NCT03921528|69624365|FG004|Overall Study|Withdrawal by Subject|0|||
37937715|NCT03832322|69624383|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
37937716|NCT03832322|69624384|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
37937717|NCT03642990|69624400|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
37937718|NCT03642990|69624400|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
37937719|NCT03639311|69624406|FG000|Overall Study|Ongoing at the time of analysis|88|||
37937720|NCT03639311|69624407|FG001|Overall Study|Ongoing at the time of analysis|0|||
37937721|NCT03639311|69624406|FG000|Overall Study|Lost to Follow-up|1|||
37937722|NCT03639311|69624407|FG001|Overall Study|Lost to Follow-up|0|||
37937723|NCT03639311|69624406|FG000|Overall Study|Adverse Event|1|||
37937724|NCT03639311|69624407|FG001|Overall Study|Adverse Event|0|||
37937725|NCT03633825|69624418|FG000|Enrollment|Did not post on network|5066|||
37937726|NCT03633825|69624419|FG001|Enrollment|Did not post on network|5080|||
37937727|NCT03633825|69624418|FG000|Enrollment|Post not classified as crisis|13967|||
37937728|NCT03633825|69624419|FG001|Enrollment|Post not classified as crisis|13757|||
37937729|NCT03633825|69624418|FG000|Follow up|Lost to Follow-up|478|||
37937730|NCT03633825|69624419|FG001|Follow up|Lost to Follow-up|450|||
37937731|NCT05427539|69624425|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
37937732|NCT05427539|69624426|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
37937733|NCT05427539|69624425|FG000|Period 1|Withdrawal by Subject|1|||
37937734|NCT05427539|69624426|FG001|Period 1|Withdrawal by Subject|0|||
37937735|NCT05144945|69624434|FG000|Overall Study|Withdrawal by Subject|1|||
37937736|NCT05144945|69624435|FG001|Overall Study|Withdrawal by Subject|0|||
37937737|NCT04439318|69624451|FG000|Overall Study|Ineligible|1|||
37937738|NCT04439318|69624451|FG000|Overall Study|Never Started Treatment|3|||
37937739|NCT04439318|69624451|FG000|Overall Study|Adverse Event|10|||
37937740|NCT04439318|69624451|FG000|Overall Study|Death|2|||
37937741|NCT04439318|69624451|FG000|Overall Study|Disease Progression|25|||
37937742|NCT04439318|69624451|FG000|Overall Study|Other Complicating Disease|2|||
37937743|NCT04439318|69624451|FG000|Overall Study|Withdrawal by Subject|4|||
37937744|NCT04439318|69624451|FG000|Overall Study|Patient Refusal - Prefers Different Therapy|1|||
37937745|NCT04439318|69624451|FG000|Overall Study|Non-Compliance|1|||
37937746|NCT04439318|69624451|FG000|Overall Study|Still on Treatment|1|||
37937766|NCT03768336|69624491|FG000|Overall Study|Lost to Follow-up|3|||
37937767|NCT03768336|69624492|FG001|Overall Study|Lost to Follow-up|2|||
37937768|NCT03768336|69624491|FG000|Overall Study|Became Ineligible|2|||
37937769|NCT03768336|69624492|FG001|Overall Study|Became Ineligible|0|||
37937770|NCT03768336|69624491|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
37937771|NCT03768336|69624492|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
37937772|NCT03768336|69624491|FG000|Overall Study|Missed final survey (post-treatment|0|||
37937773|NCT03768336|69624492|FG001|Overall Study|Missed final survey (post-treatment|1|||
37937774|NCT03742141|69624499|FG000|Overall Study|no surgery or post-operative laryngoscopy|50|||
37937775|NCT02968849|69624505|FG000|Overall Study|Death|8|||
37937776|NCT02968849|69624506|FG001|Overall Study|Death|10|||
37937777|NCT02968849|69624505|FG000|Overall Study|Lost to Follow-up|31|||
37937778|NCT02968849|69624506|FG001|Overall Study|Lost to Follow-up|29|||
37937779|NCT02968849|69624505|FG000|Overall Study|Withdrawal by Subject|73|||
37937780|NCT02968849|69624506|FG001|Overall Study|Withdrawal by Subject|64|||
37937781|NCT02968849|69624505|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
37937782|NCT02968849|69624506|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
37937783|NCT02968849|69624505|FG000|Overall Study|Physician Decision|6|||
37937784|NCT02968849|69624506|FG001|Overall Study|Physician Decision|9|||
37937785|NCT02968849|69624505|FG000|Overall Study|Other|16|||
37937786|NCT02968849|69624506|FG001|Overall Study|Other|10|||
37937787|NCT02795104|69624518|FG000|Overall Study|Determined to be Ineligible with Exit Data|7|||
37937788|NCT02795104|69624519|FG001|Overall Study|Determined to be Ineligible with Exit Data|5|||
37937789|NCT02795104|69624520|FG002|Overall Study|Determined to be Ineligible with Exit Data|7|||
37937790|NCT02795104|69624518|FG000|Overall Study|Withdrawal by Subject|0|||
37937791|NCT02795104|69624519|FG001|Overall Study|Withdrawal by Subject|2|||
37937792|NCT02795104|69624520|FG002|Overall Study|Withdrawal by Subject|0|||
37937793|NCT02795104|69624518|FG000|Overall Study|Lost to Follow-up|0|||
37937794|NCT02795104|69624519|FG001|Overall Study|Lost to Follow-up|0|||
37937795|NCT02795104|69624520|FG002|Overall Study|Lost to Follow-up|1|||
37937796|NCT02675244|69624533|FG000|Overall Study|Death|9|||
37937797|NCT02675244|69624534|FG001|Overall Study|Death|6|||
37937798|NCT02675244|69624533|FG000|Overall Study|Withdrawal by Subject|3|||
37937799|NCT02675244|69624534|FG001|Overall Study|Withdrawal by Subject|6|||
37937800|NCT02675244|69624533|FG000|Overall Study|Lost to Follow-up|1|||
37937801|NCT02675244|69624534|FG001|Overall Study|Lost to Follow-up|1|||
37937802|NCT02675244|69624533|FG000|Overall Study|Ongoing at 2 Years|190|||
37937803|NCT02675244|69624534|FG001|Overall Study|Ongoing at 2 Years|185|||
37937804|NCT02561273|69624548|FG000|Overall Study|Protocol Violation|1|||
37937805|NCT02561273|69624549|FG001|Overall Study|Protocol Violation|0|||
37937806|NCT02152995|69624589|FG000|Overall Study|Withdrawal by Subject|1|||
37937807|NCT02152995|69624590|FG001|Overall Study|Withdrawal by Subject|0|||
37937814|NCT01298323|69624644|FG000|Overall Study|Adverse Event|2|||
37937815|NCT01298323|69624645|FG001|Overall Study|Adverse Event|4|||
37937816|NCT01298323|69624644|FG000|Overall Study|Death|11|||
37937817|NCT01298323|69624645|FG001|Overall Study|Death|16|||
37937818|NCT01298323|69624644|FG000|Overall Study|Lost to Follow-up|1|||
37937819|NCT01298323|69624645|FG001|Overall Study|Lost to Follow-up|0|||
37937820|NCT01298323|69624644|FG000|Overall Study|Withdrawal by Subject|6|||
37937821|NCT01298323|69624645|FG001|Overall Study|Withdrawal by Subject|3|||
37937822|NCT01298323|69624644|FG000|Overall Study|Protocol Violation|1|||
37937823|NCT01298323|69624645|FG001|Overall Study|Protocol Violation|0|||
37937824|NCT01298323|69624644|FG000|Overall Study|Other|10|||
37937825|NCT01298323|69624645|FG001|Overall Study|Other|9|||
37937826|NCT01298323|69624644|FG000|Overall Study|Ongoing|55|||
37937827|NCT01298323|69624645|FG001|Overall Study|Ongoing|55|||
37937828|NCT01298323|69624644|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
37937829|NCT01298323|69624645|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
37937830|NCT01268579|69624651|FG000|Overall Study|Adverse Event|1|||
37937831|NCT01268579|69624651|FG000|Overall Study|Withdrawal by Subject|2|||
37937832|NCT01056523|69624655|FG000|Overall Study|Death|1|||
37937833|NCT01056523|69624656|FG001|Overall Study|Death|0|||
37937834|NCT01056523|69624657|FG002|Overall Study|Death|2|||
37937835|NCT01056523|69624658|FG003|Overall Study|Death|3|||
37937836|NCT01056523|69624659|FG004|Overall Study|Death|0|||
37937837|NCT01056523|69624660|FG005|Overall Study|Death|0|||
37937838|NCT01056523|69624661|FG006|Overall Study|Death|1|||
37937839|NCT00554788|69624682|FG000|Overall Study|Adverse Event|0|||
37670383|NCT02034916|69143617|FG001|Overall Study|Withdrawal by Subject|1|||
37670384|NCT02034916|69143616|FG000|Overall Study|Lost to Follow-up|4|||
37937840|NCT00554788|69624683|FG001|Overall Study|Adverse Event|1|||
38035176|NCT04085601|69722103|FG000|Overall Study|Death|1|||
37670385|NCT02034916|69143617|FG001|Overall Study|Lost to Follow-up|1|||
37670386|NCT02034916|69143616|FG000|Overall Study|Study terminated by sponsor|4|||
37937841|NCT00554788|69624684|FG002|Overall Study|Adverse Event|2|||
37937842|NCT00554788|69624682|FG000|Overall Study|Lost to Follow-up|4|||
37937843|NCT00554788|69624683|FG001|Overall Study|Lost to Follow-up|3|||
37937844|NCT00554788|69624684|FG002|Overall Study|Lost to Follow-up|3|||
37937845|NCT00554788|69624682|FG000|Overall Study|Physician Decision|1|||
37937846|NCT00554788|69624683|FG001|Overall Study|Physician Decision|1|||
37670387|NCT02034916|69143617|FG001|Overall Study|Study terminated by sponsor|5|||
37937847|NCT00554788|69624684|FG002|Overall Study|Physician Decision|3|||
38035177|NCT04085601|69722104|FG001|Overall Study|Death|1|||
37937848|NCT00554788|69624682|FG000|Overall Study|Withdrawal by Subject|0|||
37937849|NCT00554788|69624683|FG001|Overall Study|Withdrawal by Subject|0|||
37937850|NCT00554788|69624684|FG002|Overall Study|Withdrawal by Subject|1|||
37937851|NCT00554788|69624682|FG000|Overall Study|Refusal of further protocol therapy|0|||
37937852|NCT00554788|69624683|FG001|Overall Study|Refusal of further protocol therapy|1|||
37937853|NCT00554788|69624684|FG002|Overall Study|Refusal of further protocol therapy|1|||
37937854|NCT00554788|69624682|FG000|Overall Study|Progressive disease|0|||
37937855|NCT00554788|69624683|FG001|Overall Study|Progressive disease|0|||
37937856|NCT00554788|69624684|FG002|Overall Study|Progressive disease|3|||
37937857|NCT00554788|69624682|FG000|Overall Study|Ineligible|2|||
37937858|NCT00554788|69624683|FG001|Overall Study|Ineligible|0|||
37937859|NCT00554788|69624684|FG002|Overall Study|Ineligible|1|||
37937860|NCT00410761|69624695|FG000|Overall Study|Adverse Event|29|||
37937861|NCT00410761|69624696|FG001|Overall Study|Adverse Event|3|||
37937862|NCT00410761|69624695|FG000|Overall Study|objective disease progression|71|||
37937863|NCT00410761|69624696|FG001|Overall Study|objective disease progression|55|||
37937864|NCT00410761|69624695|FG000|Overall Study|Withdrawal by Subject|8|||
37937865|NCT00410761|69624696|FG001|Overall Study|Withdrawal by Subject|4|||
37937866|NCT00410761|69624695|FG000|Overall Study|Other|12|||
37937867|NCT00410761|69624696|FG001|Overall Study|Other|9|||
37937868|NCT00410761|69624695|FG000|Overall Study|Never received randomised treatment|0|||
37937869|NCT00410761|69624696|FG001|Overall Study|Never received randomised treatment|1|||
37937870|NCT00374595|69624702|FG000|Overall Study|Death|23|||
37937871|NCT00374595|69624702|FG000|Overall Study|Withdrawal by Subject|39|||
37937872|NCT00374595|69624702|FG000|Overall Study|Lost to Follow-up|3|||
37937873|NCT00374595|69624702|FG000|Overall Study|too much time commitment|1|||
37937874|NCT00374595|69624702|FG000|Overall Study|transfer care to other clinical site|1|||
37937875|NCT00374595|69624702|FG000|Overall Study|relocation|3|||
37937876|NCT03465540|69624712|FG000|Overall Study|Withdrawal by Subject|0|||
37937877|NCT03465540|69624713|FG001|Overall Study|Withdrawal by Subject|0|||
37937878|NCT03465540|69624714|FG002|Overall Study|Withdrawal by Subject|1|||
37937879|NCT03465540|69624715|FG003|Overall Study|Withdrawal by Subject|1|||
37937880|NCT03465540|69624716|FG004|Overall Study|Withdrawal by Subject|1|||
37937881|NCT03465540|69624717|FG005|Overall Study|Withdrawal by Subject|0|||
37937882|NCT03465540|69624712|FG000|Overall Study|Lost to Follow-up|0|||
37937883|NCT03465540|69624713|FG001|Overall Study|Lost to Follow-up|1|||
37937884|NCT03465540|69624714|FG002|Overall Study|Lost to Follow-up|0|||
37937885|NCT03465540|69624715|FG003|Overall Study|Lost to Follow-up|0|||
37937886|NCT03465540|69624716|FG004|Overall Study|Lost to Follow-up|1|||
37937887|NCT03465540|69624717|FG005|Overall Study|Lost to Follow-up|0|||
37937888|NCT03465540|69624712|FG000|Overall Study|Death|1|||
37937889|NCT03465540|69624713|FG001|Overall Study|Death|1|||
37937890|NCT03465540|69624714|FG002|Overall Study|Death|0|||
37937891|NCT03465540|69624715|FG003|Overall Study|Death|2|||
37937892|NCT03465540|69624716|FG004|Overall Study|Death|0|||
37937893|NCT03465540|69624717|FG005|Overall Study|Death|2|||
37937894|NCT03465540|69624712|FG000|Overall Study|Protocol specified criteria|0|||
37937895|NCT03465540|69624713|FG001|Overall Study|Protocol specified criteria|2|||
37937896|NCT03465540|69624714|FG002|Overall Study|Protocol specified criteria|2|||
37937897|NCT03465540|69624715|FG003|Overall Study|Protocol specified criteria|0|||
37937898|NCT03465540|69624716|FG004|Overall Study|Protocol specified criteria|2|||
37937899|NCT03465540|69624717|FG005|Overall Study|Protocol specified criteria|0|||
37937900|NCT03055832|69624765|FG000|Week 2|Withdrawal by Subject|1|||
37937901|NCT03055832|69624766|FG001|Week 2|Withdrawal by Subject|0|||
37937902|NCT02771275|69624807|FG000|Overall Study|Reoperation|2|||
37937903|NCT02771275|69624807|FG000|Overall Study|On Study|11|||
37937904|NCT02768870|69624811|FG000|Overall Study|Not Implanted with Device|2|||
37937905|NCT02768870|69624811|FG000|Overall Study|Death|1|||
37937906|NCT02768870|69624811|FG000|Overall Study|Reoperation|4|||
37937907|NCT02768870|69624811|FG000|Overall Study|On Study|19|||
37937908|NCT02750618|69624815|FG000|Overall Study|Withdrawal by Subject|1|||
37937909|NCT02537431|69624819|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
37937910|NCT02526160|69624825|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
37937911|NCT02526160|69624826|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
37937912|NCT02526160|69624825|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
37937913|NCT02526160|69624826|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
37937914|NCT02526160|69624825|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
37937915|NCT02526160|69624826|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
37937916|NCT02526160|69624825|FG000|Open-Label Treatment Extension Period I|Death|0|||
37937917|NCT02526160|69624826|FG001|Open-Label Treatment Extension Period I|Death|1|||
37937918|NCT02526160|69624825|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
37937919|NCT02526160|69624826|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
37937920|NCT02526160|69624825|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
37937921|NCT02526160|69624826|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
37937922|NCT02526160|69624825|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
37937923|NCT02526160|69624826|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
37937924|NCT02526160|69624825|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
37937925|NCT02526160|69624826|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
37937926|NCT02432196|69624837|FG000|Overall Study|Not Implanted with Device|1|||
37937927|NCT02432196|69624837|FG000|Overall Study|Death|2|||
37937928|NCT02432196|69624837|FG000|Overall Study|Reoperation|3|||
37937929|NCT02432196|69624837|FG000|Overall Study|On Study|20|||
37937930|NCT02157610|69624852|FG000|Overall Study|Death|4|||
37937931|NCT02157610|69624853|FG001|Overall Study|Death|4|||
37937932|NCT01511250|69624887|FG000|Overall Study|Withdrawal of Consent|1|||
37937933|NCT01511250|69624888|FG001|Overall Study|Withdrawal of Consent|0|||
37937934|NCT01511250|69624889|FG002|Overall Study|Withdrawal of Consent|0|||
37937935|NCT01511250|69624890|FG003|Overall Study|Withdrawal of Consent|0|||
37937936|NCT01511250|69624891|FG004|Overall Study|Withdrawal of Consent|0|||
37937937|NCT01511250|69624892|FG005|Overall Study|Withdrawal of Consent|0|||
37937938|NCT01511250|69624893|FG006|Overall Study|Withdrawal of Consent|0|||
37937939|NCT01511250|69624894|FG007|Overall Study|Withdrawal of Consent|1|||
37937940|NCT01511250|69624895|FG008|Overall Study|Withdrawal of Consent|1|||
37937941|NCT01511250|69624896|FG009|Overall Study|Withdrawal of Consent|0|||
37937942|NCT01511250|69624887|FG000|Overall Study|Sponsor/Investigator Decision|1|||
37937943|NCT01511250|69624888|FG001|Overall Study|Sponsor/Investigator Decision|0|||
37937944|NCT01511250|69624889|FG002|Overall Study|Sponsor/Investigator Decision|0|||
37937945|NCT01511250|69624890|FG003|Overall Study|Sponsor/Investigator Decision|0|||
37937946|NCT01511250|69624891|FG004|Overall Study|Sponsor/Investigator Decision|0|||
37937947|NCT01511250|69624892|FG005|Overall Study|Sponsor/Investigator Decision|0|||
37937948|NCT01511250|69624893|FG006|Overall Study|Sponsor/Investigator Decision|0|||
37937949|NCT01511250|69624894|FG007|Overall Study|Sponsor/Investigator Decision|0|||
37937950|NCT01511250|69624895|FG008|Overall Study|Sponsor/Investigator Decision|0|||
37937951|NCT01511250|69624896|FG009|Overall Study|Sponsor/Investigator Decision|0|||
37937952|NCT01511250|69624887|FG000|Overall Study|Lost to Follow-up|7|||
37937953|NCT01511250|69624888|FG001|Overall Study|Lost to Follow-up|3|||
37937954|NCT01511250|69624889|FG002|Overall Study|Lost to Follow-up|3|||
37937955|NCT01511250|69624890|FG003|Overall Study|Lost to Follow-up|3|||
37937956|NCT01511250|69624891|FG004|Overall Study|Lost to Follow-up|0|||
37937957|NCT01511250|69624892|FG005|Overall Study|Lost to Follow-up|0|||
37937958|NCT01511250|69624893|FG006|Overall Study|Lost to Follow-up|2|||
37937959|NCT01511250|69624894|FG007|Overall Study|Lost to Follow-up|3|||
37937960|NCT01511250|69624895|FG008|Overall Study|Lost to Follow-up|13|||
37937961|NCT01511250|69624896|FG009|Overall Study|Lost to Follow-up|5|||
37937962|NCT01511250|69624887|FG000|Overall Study|Protocol Violation|0|||
37937963|NCT01511250|69624888|FG001|Overall Study|Protocol Violation|2|||
37937964|NCT01511250|69624889|FG002|Overall Study|Protocol Violation|1|||
37937965|NCT01511250|69624890|FG003|Overall Study|Protocol Violation|0|||
37937966|NCT01511250|69624891|FG004|Overall Study|Protocol Violation|0|||
37937967|NCT01511250|69624892|FG005|Overall Study|Protocol Violation|0|||
37937968|NCT01511250|69624893|FG006|Overall Study|Protocol Violation|0|||
37937969|NCT01511250|69624894|FG007|Overall Study|Protocol Violation|0|||
37937970|NCT01511250|69624895|FG008|Overall Study|Protocol Violation|0|||
37937971|NCT01511250|69624896|FG009|Overall Study|Protocol Violation|0|||
37937972|NCT01424566|69624918|FG000|Single-blind Treatment|Adverse Event|71|||
37937973|NCT01424566|69624919|FG001|Single-blind Treatment|Adverse Event|0|||
37937974|NCT01424566|69624920|FG002|Single-blind Treatment|Adverse Event|0|||
37937975|NCT01424566|69624918|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
37937976|NCT01424566|69624919|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
37937977|NCT01424566|69624920|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
37937978|NCT01424566|69624918|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
37937979|NCT01424566|69624919|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
37937980|NCT01424566|69624920|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
37937981|NCT01424566|69624918|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
37937982|NCT01424566|69624919|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
37937983|NCT01424566|69624920|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
37937984|NCT01424566|69624918|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
37937985|NCT01424566|69624919|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
37937986|NCT01424566|69624920|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
37937987|NCT01424566|69624918|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
37937988|NCT01424566|69624919|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
37937989|NCT01424566|69624920|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
37937990|NCT01424566|69624918|FG000|Double-blind Treatment|Adverse Event|0|||
37937991|NCT01424566|69624919|FG001|Double-blind Treatment|Adverse Event|21|||
37937992|NCT01424566|69624920|FG002|Double-blind Treatment|Adverse Event|13|||
37937993|NCT01424566|69624918|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
37937994|NCT01424566|69624919|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
37937995|NCT01424566|69624920|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
38035178|NCT03230864|69722113|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
37937996|NCT01424566|69624918|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
37937997|NCT01424566|69624919|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
37937998|NCT01424566|69624920|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
37937999|NCT01424566|69624918|FG000|Double-blind Treatment|Lack of Efficacy|0|||
37938000|NCT01424566|69624919|FG001|Double-blind Treatment|Lack of Efficacy|1|||
37938001|NCT01424566|69624920|FG002|Double-blind Treatment|Lack of Efficacy|1|||
37938002|NCT01361607|69624929|FG000|Overall Study|Adverse Event|38|||
37938003|NCT01361607|69624930|FG001|Overall Study|Adverse Event|29|||
37938004|NCT01361607|69624929|FG000|Overall Study|Withdrawal by Subject|19|||
37938005|NCT01361607|69624930|FG001|Overall Study|Withdrawal by Subject|8|||
37938006|NCT01361607|69624929|FG000|Overall Study|Withdrawal by Investigator|5|||
37938007|NCT01361607|69624930|FG001|Overall Study|Withdrawal by Investigator|3|||
37938008|NCT01361607|69624929|FG000|Overall Study|Lost to Follow-up|1|||
37938009|NCT01361607|69624930|FG001|Overall Study|Lost to Follow-up|0|||
37938010|NCT01361607|69624929|FG000|Overall Study|Met Withdrawal Criteria|1|||
37938011|NCT01361607|69624930|FG001|Overall Study|Met Withdrawal Criteria|1|||
37938012|NCT01337089|69624937|FG000|Overall Study|Adverse Event|237|||
37938013|NCT01337089|69624937|FG000|Overall Study|Withdrawal by Subject|129|||
37938014|NCT01337089|69624937|FG000|Overall Study|Withdrawal by Investigator|33|||
37938015|NCT01337089|69624937|FG000|Overall Study|Met Withdrawal Criteria|3|||
37938016|NCT01337089|69624937|FG000|Overall Study|Lost to Follow-up|2|||
37938017|NCT00114530|69624951|FG000|Overall Study|Death|3|||
37938018|NCT00114530|69624952|FG001|Overall Study|Death|11|||
37938019|NCT00114530|69624951|FG000|Overall Study|Lost to Follow-up|1|||
37938020|NCT00114530|69624952|FG001|Overall Study|Lost to Follow-up|1|||
37938021|NCT00114530|69624951|FG000|Overall Study|Physician Decision|1|||
37938022|NCT00114530|69624952|FG001|Overall Study|Physician Decision|1|||
37938023|NCT00114530|69624951|FG000|Overall Study|Withdrawal by Subject|2|||
37938024|NCT00114530|69624952|FG001|Overall Study|Withdrawal by Subject|6|||
37938025|NCT00114530|69624951|FG000|Overall Study|Breast Cancer|1|||
37938026|NCT00114530|69624952|FG001|Overall Study|Breast Cancer|0|||
37938027|NCT00114530|69624951|FG000|Overall Study|Subject decision after endpoint failure|0|||
37938028|NCT00114530|69624952|FG001|Overall Study|Subject decision after endpoint failure|1|||
37938029|NCT00114530|69624951|FG000|Overall Study|Ineligible|1|||
37938030|NCT00114530|69624952|FG001|Overall Study|Ineligible|0|||
37938031|NCT00618982|69624975|FG000|Overall Study|Adverse Event|23|||
37938032|NCT00618982|69624975|FG000|Overall Study|Withdrawal by Subject|1|||
37938033|NCT00618982|69624975|FG000|Overall Study|Protocol Violation|1|||
37938034|NCT00618982|69624975|FG000|Overall Study|ongoing, still treated with study med.|25|||
37938035|NCT00578786|69624985|FG000|Overall Study|Adverse Event|27|||
37938036|NCT00578786|69624986|FG001|Overall Study|Adverse Event|37|||
37938037|NCT00578786|69624987|FG002|Overall Study|Adverse Event|17|||
37938038|NCT00578786|69624985|FG000|Overall Study|Lack of Efficacy|2|||
37938039|NCT00578786|69624986|FG001|Overall Study|Lack of Efficacy|5|||
37938040|NCT00578786|69624987|FG002|Overall Study|Lack of Efficacy|2|||
37938041|NCT00578786|69624985|FG000|Overall Study|Early Escape from Prior Study|2|||
37938042|NCT00578786|69624986|FG001|Overall Study|Early Escape from Prior Study|1|||
37938043|NCT00578786|69624987|FG002|Overall Study|Early Escape from Prior Study|2|||
37938044|NCT00578786|69624985|FG000|Overall Study|Withdrawal by Subject|7|||
37938045|NCT00578786|69624986|FG001|Overall Study|Withdrawal by Subject|8|||
37938046|NCT00578786|69624987|FG002|Overall Study|Withdrawal by Subject|5|||
37938047|NCT00578786|69624985|FG000|Overall Study|Protocol Violation|0|||
37938048|NCT00578786|69624986|FG001|Overall Study|Protocol Violation|3|||
37938049|NCT00578786|69624987|FG002|Overall Study|Protocol Violation|1|||
37938050|NCT00578786|69624985|FG000|Overall Study|Physician Decision|1|||
37938051|NCT00578786|69624986|FG001|Overall Study|Physician Decision|0|||
37938052|NCT00578786|69624987|FG002|Overall Study|Physician Decision|1|||
37938053|NCT00578786|69624985|FG000|Overall Study|Sponsor Decision|0|||
37938054|NCT00578786|69624986|FG001|Overall Study|Sponsor Decision|0|||
37938055|NCT00578786|69624987|FG002|Overall Study|Sponsor Decision|1|||
37938056|NCT00578786|69624985|FG000|Overall Study|Lost to Follow-up|0|||
37938057|NCT00578786|69624986|FG001|Overall Study|Lost to Follow-up|4|||
37938058|NCT00578786|69624987|FG002|Overall Study|Lost to Follow-up|0|||
37938059|NCT00578786|69624985|FG000|Overall Study|Pregnancy|0|||
37938060|NCT00578786|69624986|FG001|Overall Study|Pregnancy|1|||
37938061|NCT00578786|69624987|FG002|Overall Study|Pregnancy|0|||
37938062|NCT00578786|69624985|FG000|Overall Study|Not Otherwise Specified|0|||
37938063|NCT00578786|69624986|FG001|Overall Study|Not Otherwise Specified|4|||
38035179|NCT03230864|69722114|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
38035180|NCT03230864|69722115|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
37938064|NCT00578786|69624987|FG002|Overall Study|Not Otherwise Specified|1|||
37938065|NCT00578786|69624985|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
38035181|NCT03230864|69722116|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
37670388|NCT01374425|69143626|FG000|Overall Study|Radiographic Disease Progression|86|||
37938066|NCT00578786|69624986|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
37938067|NCT00578786|69624987|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
37938068|NCT00424255|69625007|FG000|Overall Study|Death|115|||
37938069|NCT00424255|69625008|FG001|Overall Study|Death|111|||
37938070|NCT00424255|69625007|FG000|Overall Study|Lost to Follow-up|26|||
37938071|NCT00424255|69625008|FG001|Overall Study|Lost to Follow-up|20|||
37938072|NCT00424255|69625007|FG000|Overall Study|Protocol Violation|0|||
37938073|NCT00424255|69625008|FG001|Overall Study|Protocol Violation|1|||
37938074|NCT00424255|69625007|FG000|Overall Study|Withdrawal by Subject|34|||
37938075|NCT00424255|69625008|FG001|Overall Study|Withdrawal by Subject|38|||
37938076|NCT00424255|69625007|FG000|Overall Study|Physician Decision|3|||
37938077|NCT00424255|69625008|FG001|Overall Study|Physician Decision|7|||
37938078|NCT00424255|69625007|FG000|Overall Study|Cognitive Disturbance|1|||
37938079|NCT00424255|69625008|FG001|Overall Study|Cognitive Disturbance|0|||
37938080|NCT00424255|69625007|FG000|Overall Study|Non-compliance by Participants|1|||
37938081|NCT00424255|69625008|FG001|Overall Study|Non-compliance by Participants|0|||
37938082|NCT00424255|69625007|FG000|Overall Study|Fatigue|1|||
37938083|NCT00424255|69625008|FG001|Overall Study|Fatigue|0|||
37938084|NCT00424255|69625007|FG000|Overall Study|Disease Progression|0|||
37938085|NCT00424255|69625008|FG001|Overall Study|Disease Progression|2|||
37938086|NCT00424255|69625007|FG000|Overall Study|Sponsor Terminated Study|161|||
37938087|NCT00424255|69625008|FG001|Overall Study|Sponsor Terminated Study|167|||
37938088|NCT00620074|69625014|FG000|Overall Study|Adverse Event|1|||
37938089|NCT00424177|69625018|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
37938090|NCT00424177|69625018|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
37938091|NCT00424177|69625018|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
37938092|NCT00424177|69625018|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
37938093|NCT00424177|69625018|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
37938094|NCT00424177|69625018|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
37938095|NCT00424177|69625018|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
37938096|NCT00424177|69625018|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
37938097|NCT00424177|69625018|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
37938098|NCT00424177|69625018|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
37938099|NCT00618826|69625030|FG000|Overall Study|Adverse Event|1|||
37938100|NCT00578448|69625035|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
37938101|NCT00578448|69625035|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
37938102|NCT00578448|69625035|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
37938103|NCT00578448|69625035|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
37938104|NCT00578318|69625043|FG000|Overall Study|Lost to Follow-up|2|||
37938105|NCT00578318|69625044|FG001|Overall Study|Lost to Follow-up|0|||
37938106|NCT00578318|69625043|FG000|Overall Study|Physician Decision|1|||
37938107|NCT00578318|69625044|FG001|Overall Study|Physician Decision|0|||
37938108|NCT00618748|69625053|FG000|Overall Study|Adverse Event|4|||
37938109|NCT00618748|69625054|FG001|Overall Study|Adverse Event|3|||
37938110|NCT00618748|69625055|FG002|Overall Study|Adverse Event|8|||
37938111|NCT00618748|69625053|FG000|Overall Study|Physician Decision|3|||
37938112|NCT00618748|69625054|FG001|Overall Study|Physician Decision|1|||
37938113|NCT00618748|69625055|FG002|Overall Study|Physician Decision|1|||
37938114|NCT00618748|69625053|FG000|Overall Study|Withdrawal by Subject|4|||
37938115|NCT00618748|69625054|FG001|Overall Study|Withdrawal by Subject|1|||
37938116|NCT00618748|69625055|FG002|Overall Study|Withdrawal by Subject|5|||
37938117|NCT00658359|69625066|FG000|Overall Study|Death|3|||
37938118|NCT00658359|69625067|FG001|Overall Study|Death|1|||
37938119|NCT00658359|69625068|FG002|Overall Study|Death|2|||
37938120|NCT00658359|69625066|FG000|Overall Study|Adverse Event|13|||
37938121|NCT00658359|69625067|FG001|Overall Study|Adverse Event|6|||
37938122|NCT00658359|69625068|FG002|Overall Study|Adverse Event|9|||
37938123|NCT00658359|69625066|FG000|Overall Study|Protocol Violation|1|||
37938124|NCT00658359|69625067|FG001|Overall Study|Protocol Violation|0|||
37938125|NCT00658359|69625068|FG002|Overall Study|Protocol Violation|0|||
37938126|NCT00658359|69625066|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
37938127|NCT00658359|69625067|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
37938128|NCT00658359|69625068|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
37938129|NCT00658359|69625066|FG000|Overall Study|Withdrawal by Subject|7|||
37938130|NCT00658359|69625067|FG001|Overall Study|Withdrawal by Subject|4|||
37938131|NCT00658359|69625068|FG002|Overall Study|Withdrawal by Subject|2|||
37938132|NCT00658359|69625066|FG000|Overall Study|Lost to Follow-up|2|||
38035182|NCT03230864|69722113|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
38035183|NCT03230864|69722114|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
38035184|NCT03230864|69722115|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
37938133|NCT00658359|69625067|FG001|Overall Study|Lost to Follow-up|2|||
37938134|NCT00658359|69625068|FG002|Overall Study|Lost to Follow-up|4|||
37938135|NCT00658359|69625066|FG000|Overall Study|Lack of Efficacy|0|||
37938136|NCT00658359|69625067|FG001|Overall Study|Lack of Efficacy|1|||
37938137|NCT00658359|69625068|FG002|Overall Study|Lack of Efficacy|0|||
37938138|NCT00619918|69625080|FG000|Overall Study|Withdrawal by Subject|4|||
37938139|NCT00619918|69625081|FG001|Overall Study|Withdrawal by Subject|3|||
37938140|NCT00619918|69625080|FG000|Overall Study|Physician Decision|8|||
37938141|NCT00619918|69625081|FG001|Overall Study|Physician Decision|8|||
37938142|NCT00619918|69625080|FG000|Overall Study|Transfer to outside facility|3|||
37938143|NCT00619918|69625081|FG001|Overall Study|Transfer to outside facility|3|||
37938144|NCT00619918|69625080|FG000|Overall Study|Left before receiving first dose|5|||
37938145|NCT00619918|69625081|FG001|Overall Study|Left before receiving first dose|8|||
37938146|NCT01005914|69625087|FG000|Overall Study|Adverse Event|4|||
37938147|NCT01005914|69625087|FG000|Overall Study|Death|4|||
37938148|NCT01005914|69625087|FG000|Overall Study|Lack of Efficacy|1|||
37938149|NCT01005914|69625087|FG000|Overall Study|Withdrawal by Subject|1|||
37938150|NCT00618514|69625098|FG000|Overall Study|Lost to Follow-up|11|||
37938151|NCT00618514|69625099|FG001|Overall Study|Lost to Follow-up|12|||
37938152|NCT00618514|69625100|FG002|Overall Study|Lost to Follow-up|4|||
37938153|NCT00655629|69625108|FG000|Overall Study|Adverse Event|4|||
37938154|NCT00655629|69625109|FG001|Overall Study|Adverse Event|1|||
37938155|NCT00655629|69625108|FG000|Overall Study|Lack of Efficacy|2|||
37938156|NCT00655629|69625109|FG001|Overall Study|Lack of Efficacy|12|||
37938157|NCT00655629|69625108|FG000|Overall Study|Lost to Follow-up|4|||
37938158|NCT00655629|69625109|FG001|Overall Study|Lost to Follow-up|3|||
37938159|NCT00655629|69625108|FG000|Overall Study|Protocol Violation|5|||
37938160|NCT00655629|69625109|FG001|Overall Study|Protocol Violation|3|||
37938161|NCT00655629|69625108|FG000|Overall Study|consent withdrawn|6|||
37938162|NCT00655629|69625109|FG001|Overall Study|consent withdrawn|4|||
37938163|NCT00578292|69625115|FG000|Overall Study|Death|1|||
37938164|NCT00578292|69625115|FG000|Overall Study|Graft failure|2|||
37938165|NCT00570063|69625121|FG000|Overall Study|Adverse Event|4|||
37938166|NCT00570063|69625122|FG001|Overall Study|Adverse Event|1|||
37938167|NCT00570063|69625121|FG000|Overall Study|Lack of Efficacy|0|||
37938168|NCT00570063|69625122|FG001|Overall Study|Lack of Efficacy|1|||
37938169|NCT00570063|69625121|FG000|Overall Study|Withdrawal by Subject|4|||
37938170|NCT00570063|69625122|FG001|Overall Study|Withdrawal by Subject|3|||
37938171|NCT00570063|69625121|FG000|Overall Study|Sponsor's Decision|7|||
37938172|NCT00570063|69625122|FG001|Overall Study|Sponsor's Decision|3|||
37938173|NCT00577772|69625139|FG000|Overall Study|Lost to Follow-up|0|||
37938174|NCT00577772|69625140|FG001|Overall Study|Lost to Follow-up|1|||
37938175|NCT00578136|69625148|FG000|Overall Study|Not given intervention|1|||
37938176|NCT00578136|69625149|FG001|Overall Study|Not given intervention|1|||
37938177|NCT00655551|69625158|FG000|All Periods Combined|Adverse Event|0|||
37938178|NCT00655551|69625159|FG001|All Periods Combined|Adverse Event|3|||
37938179|NCT00655551|69625160|FG002|All Periods Combined|Adverse Event|4|||
37938180|NCT00655551|69625158|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
37938181|NCT00655551|69625159|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
37938182|NCT00655551|69625160|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
37938183|NCT00655551|69625158|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
37938184|NCT00655551|69625159|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
37938185|NCT00655551|69625160|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
37938186|NCT00655551|69625158|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
37765157|NCT01440569|69278337|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
37938187|NCT00655551|69625159|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
37938188|NCT00655551|69625160|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
37938189|NCT00312728|69625168|FG000|Overall Study|Progressive disease|53|||
37938190|NCT00312728|69625168|FG000|Overall Study|Adverse Event|32|||
37938191|NCT00312728|69625168|FG000|Overall Study|Withdrawal by Subject|10|||
37938192|NCT00312728|69625168|FG000|Overall Study|Required non-protocol cancer treatment|2|||
37938193|NCT00312728|69625168|FG000|Overall Study|Protocol Violation|2|||
37938194|NCT00312728|69625168|FG000|Overall Study|Other|10|||
37938195|NCT00312728|69625168|FG000|Overall Study|Other|1|||
37938196|NCT00577824|69625175|FG000|Overall Study|Adverse Event|6|||
37938197|NCT00577824|69625176|FG001|Overall Study|Adverse Event|18|||
37938198|NCT00577824|69625177|FG002|Overall Study|Adverse Event|1|||
37938199|NCT00577824|69625175|FG000|Overall Study|Patient decision|0|||
37938200|NCT00577824|69625176|FG001|Overall Study|Patient decision|1|||
37938201|NCT00577824|69625177|FG002|Overall Study|Patient decision|1|||
37938202|NCT00577824|69625175|FG000|Overall Study|Protocol Violation|1|||
37938203|NCT00577824|69625176|FG001|Overall Study|Protocol Violation|1|||
37938204|NCT00577824|69625177|FG002|Overall Study|Protocol Violation|0|||
37938205|NCT00617344|69625188|FG000|Overall Study|Serious adverse event|1|||
37938206|NCT00617344|69625189|FG001|Overall Study|Serious adverse event|0|||
37938207|NCT00617344|69625190|FG002|Overall Study|Serious adverse event|0|||
37938208|NCT00617344|69625188|FG000|Overall Study|Other Adverse Event|1|||
37938209|NCT00617344|69625189|FG001|Overall Study|Other Adverse Event|1|||
37938210|NCT00617344|69625190|FG002|Overall Study|Other Adverse Event|0|||
37938211|NCT00617344|69625188|FG000|Overall Study|Protocol Violation|10|||
37938212|NCT00617344|69625189|FG001|Overall Study|Protocol Violation|8|||
37938213|NCT00617344|69625190|FG002|Overall Study|Protocol Violation|5|||
37938214|NCT00617344|69625188|FG000|Overall Study|Lost to Follow-up|5|||
37938215|NCT00617344|69625189|FG001|Overall Study|Lost to Follow-up|4|||
37938216|NCT00617344|69625190|FG002|Overall Study|Lost to Follow-up|1|||
37938217|NCT00617344|69625188|FG000|Overall Study|Withdrawal by Subject|8|||
37938218|NCT00617344|69625189|FG001|Overall Study|Withdrawal by Subject|9|||
37938219|NCT00617344|69625190|FG002|Overall Study|Withdrawal by Subject|2|||
37938220|NCT00654381|69625258|FG000|1st Stage|Adverse Event|3|||
37938221|NCT00654381|69625259|FG001|1st Stage|Adverse Event|3|||
37938222|NCT00654381|69625260|FG002|1st Stage|Adverse Event|3|||
37938223|NCT00654381|69625261|FG003|1st Stage|Adverse Event|3|||
37938224|NCT00654381|69625262|FG004|1st Stage|Adverse Event|2|||
37938225|NCT00654381|69625263|FG005|1st Stage|Adverse Event|1|||
37938226|NCT00654381|69625258|FG000|1st Stage|Withdrawal by Subject|0|||
37938227|NCT00654381|69625259|FG001|1st Stage|Withdrawal by Subject|0|||
37938228|NCT00654381|69625260|FG002|1st Stage|Withdrawal by Subject|0|||
37938229|NCT00654381|69625261|FG003|1st Stage|Withdrawal by Subject|1|||
37938230|NCT00654381|69625262|FG004|1st Stage|Withdrawal by Subject|0|||
37938231|NCT00654381|69625263|FG005|1st Stage|Withdrawal by Subject|1|||
37938232|NCT00654381|69625258|FG000|1st Stage|Investigator's decision|0|||
37938233|NCT00654381|69625259|FG001|1st Stage|Investigator's decision|0|||
37938234|NCT00654381|69625260|FG002|1st Stage|Investigator's decision|0|||
37938235|NCT00654381|69625261|FG003|1st Stage|Investigator's decision|1|||
37938236|NCT00654381|69625262|FG004|1st Stage|Investigator's decision|0|||
37938237|NCT00654381|69625263|FG005|1st Stage|Investigator's decision|0|||
37938238|NCT00654381|69625258|FG000|2nd Stage|Adverse Event|2|||
37938239|NCT00654381|69625259|FG001|2nd Stage|Adverse Event|0|||
37938240|NCT00654381|69625260|FG002|2nd Stage|Adverse Event|2|||
37938241|NCT00654381|69625261|FG003|2nd Stage|Adverse Event|3|||
37938242|NCT00654381|69625262|FG004|2nd Stage|Adverse Event|7|||
37938243|NCT00654381|69625263|FG005|2nd Stage|Adverse Event|2|||
37938244|NCT00654381|69625258|FG000|2nd Stage|Withdrawal by Subject|0|||
37938245|NCT00654381|69625259|FG001|2nd Stage|Withdrawal by Subject|0|||
37938246|NCT00654381|69625260|FG002|2nd Stage|Withdrawal by Subject|0|||
37938247|NCT00654381|69625261|FG003|2nd Stage|Withdrawal by Subject|0|||
37938248|NCT00654381|69625262|FG004|2nd Stage|Withdrawal by Subject|1|||
37938249|NCT00654381|69625263|FG005|2nd Stage|Withdrawal by Subject|1|||
37938250|NCT00654381|69625258|FG000|2nd Stage|Investigator's decision|0|||
37938251|NCT00654381|69625259|FG001|2nd Stage|Investigator's decision|0|||
37938252|NCT00654381|69625260|FG002|2nd Stage|Investigator's decision|1|||
37938253|NCT00654381|69625261|FG003|2nd Stage|Investigator's decision|1|||
37938254|NCT00654381|69625262|FG004|2nd Stage|Investigator's decision|0|||
37938255|NCT00654381|69625263|FG005|2nd Stage|Investigator's decision|0|||
37938256|NCT00654381|69625258|FG000|Extension Stage|Adverse Event|1|||
37938257|NCT00654381|69625259|FG001|Extension Stage|Adverse Event|2|||
37938258|NCT00654381|69625260|FG002|Extension Stage|Adverse Event|9|||
37938259|NCT00654381|69625261|FG003|Extension Stage|Adverse Event|7|||
37938260|NCT00654381|69625262|FG004|Extension Stage|Adverse Event|1|||
37938261|NCT00654381|69625263|FG005|Extension Stage|Adverse Event|1|||
37938262|NCT00654381|69625258|FG000|Extension Stage|Protocol Violation|0|||
37938263|NCT00654381|69625259|FG001|Extension Stage|Protocol Violation|0|||
37938264|NCT00654381|69625260|FG002|Extension Stage|Protocol Violation|0|||
37938265|NCT00654381|69625261|FG003|Extension Stage|Protocol Violation|1|||
37938266|NCT00654381|69625262|FG004|Extension Stage|Protocol Violation|0|||
37938267|NCT00654381|69625263|FG005|Extension Stage|Protocol Violation|0|||
37938268|NCT00654381|69625258|FG000|Extension Stage|Lack of Efficacy|0|||
37938269|NCT00654381|69625259|FG001|Extension Stage|Lack of Efficacy|0|||
37938270|NCT00654381|69625260|FG002|Extension Stage|Lack of Efficacy|1|||
37938271|NCT00654381|69625261|FG003|Extension Stage|Lack of Efficacy|0|||
37938272|NCT00654381|69625262|FG004|Extension Stage|Lack of Efficacy|0|||
37938273|NCT00654381|69625263|FG005|Extension Stage|Lack of Efficacy|0|||
37938274|NCT00654381|69625258|FG000|Extension Stage|Withdrawal by Subject|0|||
37938275|NCT00654381|69625259|FG001|Extension Stage|Withdrawal by Subject|0|||
37938276|NCT00654381|69625260|FG002|Extension Stage|Withdrawal by Subject|1|||
37938277|NCT00654381|69625261|FG003|Extension Stage|Withdrawal by Subject|1|||
37938278|NCT00654381|69625262|FG004|Extension Stage|Withdrawal by Subject|1|||
37938279|NCT00654381|69625263|FG005|Extension Stage|Withdrawal by Subject|1|||
37938280|NCT00654381|69625258|FG000|Extension Stage|Closure of the trial site|0|||
37938281|NCT00654381|69625259|FG001|Extension Stage|Closure of the trial site|0|||
37938282|NCT00654381|69625260|FG002|Extension Stage|Closure of the trial site|0|||
37670389|NCT01374425|69143627|FG001|Overall Study|Radiographic Disease Progression|81|||
37938283|NCT00654381|69625261|FG003|Extension Stage|Closure of the trial site|0|||
37938284|NCT00654381|69625262|FG004|Extension Stage|Closure of the trial site|1|||
37938285|NCT00654381|69625263|FG005|Extension Stage|Closure of the trial site|1|||
37938286|NCT00657267|69625293|FG000|Overall Study|Progressive disease|45|||
37938287|NCT00657267|69625293|FG000|Overall Study|Adverse Event|9|||
37938288|NCT00653991|69625301|FG000|3 Month Follow-up|Participant would not respond|150|||
37938289|NCT00653991|69625302|FG001|3 Month Follow-up|Participant would not respond|157|||
37938290|NCT00653991|69625301|FG000|6 Month Follow-up|Participant would not respond|133|||
37938291|NCT00653991|69625302|FG001|6 Month Follow-up|Participant would not respond|141|||
37938292|NCT00652899|69625310|FG000|Overall Study|Death|1|||
37938293|NCT00652899|69625310|FG000|Overall Study|Treating physician decision|1|||
37938294|NCT00617890|69625322|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
37938295|NCT00617890|69625323|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
37938296|NCT00617890|69625324|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
37938297|NCT00617890|69625325|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
37938298|NCT00617890|69625322|FG000|Overall Study|Lack of Efficacy|23|||
37938299|NCT00617890|69625323|FG001|Overall Study|Lack of Efficacy|26|||
37938300|NCT00617890|69625324|FG002|Overall Study|Lack of Efficacy|30|||
37938301|NCT00617890|69625325|FG003|Overall Study|Lack of Efficacy|97|||
37938302|NCT00617890|69625322|FG000|Overall Study|Lost to Follow-up|0|||
37938303|NCT00617890|69625323|FG001|Overall Study|Lost to Follow-up|0|||
37938304|NCT00617890|69625324|FG002|Overall Study|Lost to Follow-up|1|||
37938305|NCT00617890|69625325|FG003|Overall Study|Lost to Follow-up|2|||
37938306|NCT00617890|69625322|FG000|Overall Study|Withdrawal by Subject|4|||
37938307|NCT00617890|69625323|FG001|Overall Study|Withdrawal by Subject|1|||
37938308|NCT00617890|69625324|FG002|Overall Study|Withdrawal by Subject|0|||
37938309|NCT00617890|69625325|FG003|Overall Study|Withdrawal by Subject|2|||
37938310|NCT00617890|69625322|FG000|Overall Study|Protocol Violation|2|||
37938311|NCT00617890|69625323|FG001|Overall Study|Protocol Violation|1|||
37938312|NCT00617890|69625324|FG002|Overall Study|Protocol Violation|0|||
37938313|NCT00617890|69625325|FG003|Overall Study|Protocol Violation|0|||
37938314|NCT00617890|69625322|FG000|Overall Study|Adverse Event|1|||
37938315|NCT00617890|69625323|FG001|Overall Study|Adverse Event|0|||
37938316|NCT00617890|69625324|FG002|Overall Study|Adverse Event|3|||
37938317|NCT00617890|69625325|FG003|Overall Study|Adverse Event|8|||
37938318|NCT00617890|69625322|FG000|Overall Study|Not treated|1|||
37938319|NCT00617890|69625323|FG001|Overall Study|Not treated|0|||
37938320|NCT00617890|69625324|FG002|Overall Study|Not treated|1|||
37938321|NCT00617890|69625325|FG003|Overall Study|Not treated|1|||
37938322|NCT00712166|69625340|FG000|Overall Study|Noncompliance|0|||
37938323|NCT00712166|69625341|FG001|Overall Study|Noncompliance|1|||
37938324|NCT00652743|69625352|FG000|Months 12-18|Lost to Follow-up|1|||
37938325|NCT00652743|69625353|FG001|Months 12-18|Lost to Follow-up|2|||
37938326|NCT00652743|69625354|FG002|Months 12-18|Lost to Follow-up|7|||
37938327|NCT00652743|69625352|FG000|Months 24-30|Other|5|||
37938328|NCT00652743|69625353|FG001|Months 24-30|Other|1|||
37938329|NCT00652743|69625354|FG002|Months 24-30|Other|11|||
37938330|NCT00652743|69625352|FG000|Months 36-42|Serious Adverse Events|0|||
37938331|NCT00652743|69625353|FG001|Months 36-42|Serious Adverse Events|1|||
37938332|NCT00652743|69625354|FG002|Months 36-42|Serious Adverse Events|1|||
37938333|NCT00652743|69625352|FG000|Months 36-42|Withdrawal by Subject|1|||
37938334|NCT00652743|69625353|FG001|Months 36-42|Withdrawal by Subject|1|||
37938335|NCT00652743|69625354|FG002|Months 36-42|Withdrawal by Subject|0|||
37938336|NCT00652743|69625352|FG000|Months 36-42|Lost to Follow-up|0|||
37938337|NCT00652743|69625353|FG001|Months 36-42|Lost to Follow-up|1|||
37938338|NCT00652743|69625354|FG002|Months 36-42|Lost to Follow-up|0|||
37938339|NCT00652743|69625352|FG000|Months 36-42|Migrated/moved from study area|1|||
37938340|NCT00652743|69625353|FG001|Months 36-42|Migrated/moved from study area|0|||
37938341|NCT00652743|69625354|FG002|Months 36-42|Migrated/moved from study area|0|||
37938342|NCT00652743|69625352|FG000|Months 36-42|Other|4|||
37938343|NCT00652743|69625353|FG001|Months 36-42|Other|2|||
37938344|NCT00652743|69625354|FG002|Months 36-42|Other|8|||
37938345|NCT00712010|69625365|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
37938346|NCT00653523|69625381|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
37938347|NCT00653523|69625381|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
37938348|NCT00653523|69625381|FG000|Overall Study|Adverse Event|7|||
37938349|NCT00653523|69625381|FG000|Overall Study|Withdrawal by Subject|6|||
37938350|NCT00653523|69625381|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
37938351|NCT00653523|69625381|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
37938352|NCT02717442|69625387|FG000|Overall Study|Study Terminated by Sponsor|31|||
37938353|NCT02717442|69625388|FG001|Overall Study|Study Terminated by Sponsor|29|||
37938354|NCT02717442|69625387|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
38035185|NCT03230864|69722116|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
38035186|NCT03230864|69722113|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
37670390|NCT01374425|69143626|FG000|Overall Study|Clinical Disease Progression|9|||
37670391|NCT01374425|69143627|FG001|Overall Study|Clinical Disease Progression|6|||
37938355|NCT02717442|69625388|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
37938356|NCT02717442|69625387|FG000|Overall Study|Other - Not Specified|2|||
37938357|NCT02717442|69625388|FG001|Overall Study|Other - Not Specified|0|||
37938358|NCT05233085|69625438|FG000|Overall Study|Adverse Event|1|||
37938359|NCT05233085|69625439|FG001|Overall Study|Adverse Event|0|||
37938360|NCT05233085|69625440|FG002|Overall Study|Adverse Event|0|||
37938361|NCT05233085|69625441|FG003|Overall Study|Adverse Event|0|||
37938362|NCT04738734|69625468|FG000|Overall Study|Withdrawal by Subject|2|||
37938363|NCT04738734|69625469|FG001|Overall Study|Withdrawal by Subject|4|||
37938364|NCT04738734|69625468|FG000|Overall Study|Lost to Follow-up|5|||
37938365|NCT04738734|69625469|FG001|Overall Study|Lost to Follow-up|2|||
37938366|NCT04738734|69625468|FG000|Overall Study|Physician Decision|0|||
37938367|NCT04738734|69625469|FG001|Overall Study|Physician Decision|1|||
37938368|NCT04738734|69625468|FG000|Overall Study|Mistake of termination of subject by clinical site|0|||
37938369|NCT04738734|69625469|FG001|Overall Study|Mistake of termination of subject by clinical site|1|||
37938370|NCT04707196|69625477|FG000|Overall Study|Withdrawal by Subject|9|||
37938371|NCT04707196|69625478|FG001|Overall Study|Withdrawal by Subject|6|||
37938372|NCT04707196|69625477|FG000|Overall Study|Lost to Follow-up|1|||
37938373|NCT04707196|69625478|FG001|Overall Study|Lost to Follow-up|0|||
37938374|NCT04707196|69625477|FG000|Overall Study|Protocol Violation|4|||
37938375|NCT04707196|69625478|FG001|Overall Study|Protocol Violation|1|||
37938376|NCT04707196|69625477|FG000|Overall Study|Adverse Event|2|||
37938377|NCT04707196|69625478|FG001|Overall Study|Adverse Event|2|||
37938378|NCT04707196|69625477|FG000|Overall Study|Death|3|||
37938379|NCT04707196|69625478|FG001|Overall Study|Death|1|||
37938380|NCT04707196|69625477|FG000|Overall Study|Non-compliance with study drug|1|||
37938381|NCT04707196|69625478|FG001|Overall Study|Non-compliance with study drug|0|||
37938382|NCT04707196|69625477|FG000|Overall Study|Progressive disease|9|||
37938383|NCT04707196|69625478|FG001|Overall Study|Progressive disease|10|||
37938384|NCT04551963|69625496|FG000|Overall Study|Physician Decision|1|||
37938385|NCT04551963|69625497|FG001|Overall Study|Physician Decision|1|||
37938386|NCT04551963|69625496|FG000|Overall Study|Death|1|||
37938387|NCT04551963|69625497|FG001|Overall Study|Death|0|||
37938388|NCT04416555|69625507|FG000|Overall Study|Withdrawal by Subject|0|||
37938389|NCT04416555|69625508|FG001|Overall Study|Withdrawal by Subject|3|||
37938390|NCT04164901|69625516|FG000|Overall Study|Withdrawal by Subject|4|||
37938391|NCT04164901|69625517|FG001|Overall Study|Withdrawal by Subject|4|||
37938392|NCT04102007|69625524|FG000|Overall Study|Adverse Event|4|||
37938393|NCT04102007|69625524|FG000|Overall Study|Lost to Follow-up|3|||
37938394|NCT04102007|69625524|FG000|Overall Study|Withdrawal by Subject|12|||
37938395|NCT04102007|69625524|FG000|Overall Study|Eligibility Violation|5|||
37938396|NCT04102007|69625524|FG000|Overall Study|Lack of Efficacy|6|||
37938397|NCT04102007|69625524|FG000|Overall Study|Protocol Deviation|5|||
37938398|NCT04102007|69625524|FG000|Overall Study|Protocol Compliance|1|||
37938399|NCT04102007|69625524|FG000|Overall Study|Withdrew Treatment|2|||
37938400|NCT04102007|69625524|FG000|Overall Study|Pregnancy|1|||
37938401|NCT03898960|69625528|FG000|Overall Study|Death|10|||
37938402|NCT03734237|69625544|FG000|Overall Study|Lost to Follow-up|1|||
37938403|NCT03734237|69625545|FG001|Overall Study|Lost to Follow-up|3|||
37938404|NCT03734237|69625546|FG002|Overall Study|Lost to Follow-up|0|||
37938405|NCT03734237|69625544|FG000|Overall Study|Withdrawal by Subject|7|||
37938406|NCT03734237|69625545|FG001|Overall Study|Withdrawal by Subject|9|||
37938407|NCT03734237|69625546|FG002|Overall Study|Withdrawal by Subject|10|||
37938408|NCT03496623|69625606|FG000|Run-In Period (2 Weeks)|Death|1|||
37938409|NCT03496623|69625607|FG001|Run-In Period (2 Weeks)|Death|0|||
37938410|NCT03496623|69625608|FG002|Run-In Period (2 Weeks)|Death|0|||
37938411|NCT03496623|69625609|FG003|Run-In Period (2 Weeks)|Death|0|||
37938412|NCT03496623|69625610|FG004|Run-In Period (2 Weeks)|Death|0|||
37938413|NCT03496623|69625606|FG000|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|31|||
37938414|NCT03496623|69625607|FG001|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
37938415|NCT03496623|69625608|FG002|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
37938416|NCT03496623|69625609|FG003|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
37938417|NCT03496623|69625610|FG004|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
37938418|NCT03496623|69625606|FG000|Period 1 (12 Weeks)|Death|0|||
37938419|NCT03496623|69625607|FG001|Period 1 (12 Weeks)|Death|3|||
37938420|NCT03496623|69625608|FG002|Period 1 (12 Weeks)|Death|0|||
37938421|NCT03496623|69625609|FG003|Period 1 (12 Weeks)|Death|0|||
37938422|NCT03496623|69625610|FG004|Period 1 (12 Weeks)|Death|0|||
37938423|NCT03496623|69625606|FG000|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
37938424|NCT03496623|69625607|FG001|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
37938425|NCT03496623|69625608|FG002|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
37938426|NCT03496623|69625609|FG003|Period 1 (12 Weeks)|Study Terminated by Sponsor|1|||
37670392|NCT01374425|69143626|FG000|Overall Study|Adverse Event|29|||
37670393|NCT01374425|69143627|FG001|Overall Study|Adverse Event|18|||
37670394|NCT01374425|69143626|FG000|Overall Study|Death (Progression of Disease)|1|||
37670395|NCT01374425|69143627|FG001|Overall Study|Death (Progression of Disease)|0|||
37670396|NCT01374425|69143626|FG000|Overall Study|Death (Adverse Event)|2|||
37670397|NCT01374425|69143627|FG001|Overall Study|Death (Adverse Event)|4|||
37765158|NCT01440569|69278338|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
37938427|NCT03496623|69625610|FG004|Period 1 (12 Weeks)|Study Terminated by Sponsor|2|||
37938428|NCT03496623|69625606|FG000|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
37938429|NCT03496623|69625607|FG001|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
37670398|NCT01374425|69143626|FG000|Overall Study|Withdrawal by Subject|6|||
37938430|NCT03496623|69625608|FG002|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
37938431|NCT03496623|69625609|FG003|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
37938432|NCT03496623|69625610|FG004|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
37938433|NCT03496623|69625606|FG000|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
37938434|NCT03496623|69625607|FG001|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|4|||
37938435|NCT03496623|69625608|FG002|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|5|||
37938436|NCT03496623|69625609|FG003|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
37938437|NCT03496623|69625610|FG004|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
37938438|NCT03496623|69625606|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
37938439|NCT03496623|69625607|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
37938440|NCT03496623|69625608|FG002|Period 2 (12 Weeks)|Lost to Follow-up|1|||
37938441|NCT03496623|69625609|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
37938442|NCT03496623|69625610|FG004|Period 2 (12 Weeks)|Lost to Follow-up|0|||
37938443|NCT03496623|69625606|FG000|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
37938444|NCT03496623|69625607|FG001|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
37938445|NCT03496623|69625608|FG002|Period 2 (12 Weeks)|Study Terminated by Sponsor|1|||
37938446|NCT03496623|69625609|FG003|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
37938447|NCT03496623|69625610|FG004|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
37938448|NCT03496623|69625606|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
37938449|NCT03496623|69625607|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|3|||
37938450|NCT03496623|69625608|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
37938451|NCT03496623|69625609|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
37938452|NCT03496623|69625610|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
37938453|NCT03224507|69625642|FG000|Overall Study|Death|3|||
37938454|NCT03224507|69625643|FG001|Overall Study|Death|0|||
37938455|NCT03224507|69625642|FG000|Overall Study|Lack of Efficacy|6|||
37938456|NCT03224507|69625643|FG001|Overall Study|Lack of Efficacy|0|||
37938457|NCT03224507|69625642|FG000|Overall Study|Withdrawal by Subject|6|||
37938458|NCT03224507|69625643|FG001|Overall Study|Withdrawal by Subject|0|||
37938459|NCT03194646|69625653|FG000|Overall Study|Adverse Event|24|||
37938460|NCT03194646|69625654|FG001|Overall Study|Adverse Event|25|||
37938461|NCT03194646|69625655|FG002|Overall Study|Adverse Event|14|||
37938462|NCT03194646|69625656|FG003|Overall Study|Adverse Event|17|||
37938463|NCT03194646|69625653|FG000|Overall Study|Lack of Efficacy|4|||
37938464|NCT03194646|69625654|FG001|Overall Study|Lack of Efficacy|2|||
37938465|NCT03194646|69625655|FG002|Overall Study|Lack of Efficacy|2|||
37938466|NCT03194646|69625656|FG003|Overall Study|Lack of Efficacy|12|||
37938467|NCT03194646|69625653|FG000|Overall Study|Lost to Follow-up|30|||
37938468|NCT03194646|69625654|FG001|Overall Study|Lost to Follow-up|22|||
37938469|NCT03194646|69625655|FG002|Overall Study|Lost to Follow-up|12|||
37938470|NCT03194646|69625656|FG003|Overall Study|Lost to Follow-up|35|||
37938471|NCT03194646|69625653|FG000|Overall Study|Non-compliance with study drug|4|||
37938472|NCT03194646|69625654|FG001|Overall Study|Non-compliance with study drug|0|||
37938473|NCT03194646|69625655|FG002|Overall Study|Non-compliance with study drug|1|||
37938474|NCT03194646|69625656|FG003|Overall Study|Non-compliance with study drug|1|||
37938475|NCT03194646|69625653|FG000|Overall Study|Other|89|||
37938476|NCT03194646|69625654|FG001|Overall Study|Other|68|||
37938477|NCT03194646|69625655|FG002|Overall Study|Other|34|||
37938478|NCT03194646|69625656|FG003|Overall Study|Other|31|||
37938479|NCT03194646|69625653|FG000|Overall Study|Physician Decision|7|||
37938480|NCT03194646|69625654|FG001|Overall Study|Physician Decision|9|||
37938481|NCT03194646|69625655|FG002|Overall Study|Physician Decision|5|||
37938482|NCT03194646|69625656|FG003|Overall Study|Physician Decision|4|||
37938483|NCT03194646|69625653|FG000|Overall Study|Pregnancy|4|||
37938484|NCT03194646|69625654|FG001|Overall Study|Pregnancy|5|||
37938485|NCT03194646|69625655|FG002|Overall Study|Pregnancy|1|||
37938486|NCT03194646|69625656|FG003|Overall Study|Pregnancy|2|||
37938487|NCT03194646|69625653|FG000|Overall Study|Protocol Violation|4|||
37938488|NCT03194646|69625654|FG001|Overall Study|Protocol Violation|2|||
37938489|NCT03194646|69625655|FG002|Overall Study|Protocol Violation|1|||
37938490|NCT03194646|69625656|FG003|Overall Study|Protocol Violation|1|||
37938491|NCT03194646|69625653|FG000|Overall Study|Site terminated by sponsor|0|||
37938492|NCT03194646|69625654|FG001|Overall Study|Site terminated by sponsor|0|||
37938493|NCT03194646|69625655|FG002|Overall Study|Site terminated by sponsor|2|||
37938494|NCT03194646|69625656|FG003|Overall Study|Site terminated by sponsor|0|||
37938495|NCT03194646|69625653|FG000|Overall Study|Study terminated by sponsor|62|||
37938496|NCT03194646|69625654|FG001|Overall Study|Study terminated by sponsor|61|||
37938497|NCT03194646|69625655|FG002|Overall Study|Study terminated by sponsor|30|||
37938498|NCT03194646|69625656|FG003|Overall Study|Study terminated by sponsor|34|||
37938499|NCT03194646|69625653|FG000|Overall Study|Withdrawal by Subject|75|||
37938500|NCT03194646|69625654|FG001|Overall Study|Withdrawal by Subject|74|||
37765159|NCT01440569|69278337|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
37765160|NCT01440569|69278338|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
37938501|NCT03194646|69625655|FG002|Overall Study|Withdrawal by Subject|36|||
37670399|NCT01374425|69143627|FG001|Overall Study|Withdrawal by Subject|7|||
37765161|NCT01440569|69278337|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
37938502|NCT03194646|69625656|FG003|Overall Study|Withdrawal by Subject|131|||
37938503|NCT03194646|69625653|FG000|Overall Study|Missing|1|||
37938504|NCT03194646|69625654|FG001|Overall Study|Missing|0|||
37765162|NCT01440569|69278338|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
37938505|NCT03194646|69625655|FG002|Overall Study|Missing|1|||
37938506|NCT03194646|69625656|FG003|Overall Study|Missing|12|||
37938507|NCT02720094|69625711|FG000|Overall Study|Scheduled exit visit/end of study|2|||
37938508|NCT02720094|69625712|FG001|Overall Study|Scheduled exit visit/end of study|1|||
37938509|NCT02720094|69625711|FG000|Overall Study|Death|4|||
37938510|NCT02720094|69625712|FG001|Overall Study|Death|7|||
37938511|NCT02720094|69625711|FG000|Overall Study|Withdrawal by Subject|55|||
37938512|NCT02720094|69625712|FG001|Overall Study|Withdrawal by Subject|56|||
37938513|NCT02720094|69625711|FG000|Overall Study|Lost to Follow-up|2|||
37938514|NCT02720094|69625712|FG001|Overall Study|Lost to Follow-up|7|||
37938515|NCT02720094|69625711|FG000|Overall Study|Physician Decision|1|||
37938516|NCT02720094|69625712|FG001|Overall Study|Physician Decision|3|||
37938517|NCT02720094|69625711|FG000|Overall Study|Inappropriate enrollment|1|||
37938518|NCT02720094|69625712|FG001|Overall Study|Inappropriate enrollment|3|||
37938519|NCT02720094|69625711|FG000|Overall Study|Ongoing|2210|||
37938520|NCT02720094|69625712|FG001|Overall Study|Ongoing|2203|||
37938521|NCT02720094|69625711|FG000|Overall Study|Relocation|1|||
37938522|NCT02720094|69625712|FG001|Overall Study|Relocation|1|||
37938523|NCT02646618|69625740|FG000|Overall Study|Lost to Follow-up|10|||
37938524|NCT02646618|69625741|FG001|Overall Study|Lost to Follow-up|14|||
37938525|NCT02446600|69625762|FG000|Overall Study|Never treated|20|||
37938526|NCT02446600|69625763|FG001|Overall Study|Never treated|2|||
37938527|NCT02446600|69625764|FG002|Overall Study|Never treated|6|||
37938528|NCT02446600|69625765|FG003|Overall Study|Never treated|0|||
37938529|NCT02446600|69625762|FG000|Overall Study|Withdrawal by Subject|19|||
37938530|NCT02446600|69625763|FG001|Overall Study|Withdrawal by Subject|5|||
37938531|NCT02446600|69625764|FG002|Overall Study|Withdrawal by Subject|17|||
37938532|NCT02446600|69625765|FG003|Overall Study|Withdrawal by Subject|0|||
37938533|NCT02446600|69625762|FG000|Overall Study|Ineligible|1|||
37938534|NCT02446600|69625763|FG001|Overall Study|Ineligible|4|||
37938535|NCT02446600|69625764|FG002|Overall Study|Ineligible|4|||
37938536|NCT02446600|69625765|FG003|Overall Study|Ineligible|1|||
37938537|NCT02446600|69625762|FG000|Overall Study|Duplicate Enrollment|0|||
37938538|NCT02446600|69625763|FG001|Overall Study|Duplicate Enrollment|1|||
37938539|NCT02446600|69625764|FG002|Overall Study|Duplicate Enrollment|0|||
37938540|NCT02446600|69625765|FG003|Overall Study|Duplicate Enrollment|0|||
37938541|NCT02362464|69625775|FG000|Overall Study|Switched to alternative therapy|1|||
37938542|NCT02362464|69625775|FG000|Overall Study|Refused further treatment|1|||
37938543|NCT02362464|69625775|FG000|Overall Study|Physician Decision|4|||
37938544|NCT02306161|69625781|FG000|Overall Study|Death|1|||
37938545|NCT02306161|69625782|FG001|Overall Study|Death|3|||
37938546|NCT02306161|69625781|FG000|Overall Study|Lack of Efficacy|20|||
37938547|NCT02306161|69625782|FG001|Overall Study|Lack of Efficacy|43|||
37938548|NCT02306161|69625781|FG000|Overall Study|Physician Decision|30|||
37938549|NCT02306161|69625782|FG001|Overall Study|Physician Decision|18|||
37938550|NCT02306161|69625781|FG000|Overall Study|Withdrawal by Subject|4|||
37938551|NCT02306161|69625782|FG001|Overall Study|Withdrawal by Subject|0|||
37938552|NCT02306161|69625781|FG000|Overall Study|Ineligible|9|||
37938553|NCT02306161|69625782|FG001|Overall Study|Ineligible|5|||
37938554|NCT02294461|69625790|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
37938555|NCT02294461|69625791|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
37938556|NCT02294461|69625790|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
37938557|NCT02294461|69625791|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
37938558|NCT02294461|69625790|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
37938559|NCT02294461|69625791|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
37938560|NCT02294461|69625790|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
37938561|NCT02294461|69625791|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
37938562|NCT02294461|69625790|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
37938563|NCT02294461|69625791|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
37938564|NCT02294461|69625790|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
37938565|NCT02294461|69625791|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
37938566|NCT02294461|69625790|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
37938567|NCT02294461|69625791|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
37938568|NCT02294461|69625790|FG000|Open-label Period (up to 54.3 Months)|Ongoing|19|||
37938569|NCT02294461|69625791|FG001|Open-label Period (up to 54.3 Months)|Ongoing|9|||
37938570|NCT02294461|69625790|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
37938571|NCT02294461|69625791|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|12|||
37938572|NCT02294461|69625790|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|18|||
37938573|NCT02294461|69625791|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|9|||
37938574|NCT02294461|69625790|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
37938575|NCT02294461|69625791|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
37938576|NCT02294461|69625790|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|3|||
37938577|NCT02294461|69625791|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|1|||
37938578|NCT02294461|69625790|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|15|||
37938579|NCT02294461|69625791|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|9|||
37938580|NCT02294461|69625790|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
37938581|NCT02294461|69625791|FG001|Open-label Period (up to 54.3 Months)|Death|5|||
37938582|NCT02294461|69625790|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
37938583|NCT02294461|69625791|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
37938584|NCT02288247|69625809|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Adverse Event|52|||
37938585|NCT02288247|69625810|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Adverse Event|0|||
37938586|NCT02288247|69625809|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Death|35|||
37938587|NCT02288247|69625810|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Death|0|||
37938588|NCT02288247|69625809|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Lost to Follow-up|1|||
37938589|NCT02288247|69625810|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Lost to Follow-up|0|||
37938590|NCT02288247|69625809|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Progressive Disease|392|||
37938591|NCT02288247|69625810|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Progressive Disease|0|||
37938592|NCT02288247|69625809|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Protocol Violation|9|||
37938593|NCT02288247|69625810|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Protocol Violation|0|||
37938594|NCT02288247|69625809|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Withdrawal by Subject|52|||
37938595|NCT02288247|69625810|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Withdrawal by Subject|0|||
37938596|NCT02288247|69625809|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Other|106|||
37938597|NCT02288247|69625810|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Other|0|||
37938598|NCT02288247|69625809|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
37938599|NCT02288247|69625810|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
37938600|NCT02288247|69625809|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
37938601|NCT02288247|69625810|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
37938602|NCT02288247|69625809|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
37938603|NCT02288247|69625810|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
37938604|NCT02288247|69625809|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
37938605|NCT02288247|69625810|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
37938606|NCT02288247|69625809|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
37938607|NCT02288247|69625810|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
37938608|NCT02288247|69625809|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
37938609|NCT02288247|69625810|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
37938610|NCT02288247|69625809|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|20|||
37938611|NCT02288247|69625810|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
37938612|NCT02288247|69625809|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
37938613|NCT02288247|69625810|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
37938614|NCT02285114|69625821|FG000|Overall Study|Investigator's Discretion|0|||
37938615|NCT02285114|69625822|FG001|Overall Study|Investigator's Discretion|2|||
37938616|NCT02285114|69625823|FG002|Overall Study|Investigator's Discretion|0|||
37938617|NCT02285114|69625821|FG000|Overall Study|Withdrew Consent|0|||
37938618|NCT02285114|69625822|FG001|Overall Study|Withdrew Consent|0|||
37938619|NCT02285114|69625823|FG002|Overall Study|Withdrew Consent|1|||
37938620|NCT02285114|69625821|FG000|Overall Study|Enrolled but not treated|1|||
37938621|NCT02285114|69625822|FG001|Overall Study|Enrolled but not treated|0|||
37938622|NCT02285114|69625823|FG002|Overall Study|Enrolled but not treated|0|||
37938623|NCT02285114|69625821|FG000|Overall Study|Still on study|21|||
37938624|NCT02285114|69625822|FG001|Overall Study|Still on study|5|||
37938625|NCT02285114|69625823|FG002|Overall Study|Still on study|2|||
37938626|NCT02091960|69625837|FG000|Overall Study|Death|7|||
37938627|NCT02091960|69625837|FG000|Overall Study|Withdrawal by Subject|1|||
37938628|NCT02091960|69625837|FG000|Overall Study|Miscellaneous Reasons|31|||
37938629|NCT02091960|69625837|FG000|Overall Study|On Study at Data Cut-off|12|||
37938630|NCT01952366|69625841|FG000|Overall Study|Death|22|||
37938631|NCT01952366|69625841|FG000|Overall Study|Withdrawal by Subject|9|||
37938632|NCT01626079|69625851|FG000|Overall Study|Death|167|||
37938633|NCT01626079|69625852|FG001|Overall Study|Death|192|||
37938634|NCT01626079|69625853|FG002|Overall Study|Death|39|||
37938635|NCT01626079|69625851|FG000|Overall Study|Withdrawal by Subject|23|||
37938636|NCT01626079|69625852|FG001|Overall Study|Withdrawal by Subject|37|||
37938637|NCT01626079|69625853|FG002|Overall Study|Withdrawal by Subject|5|||
37938638|NCT01626079|69625851|FG000|Overall Study|Lost to Follow-up|7|||
37938639|NCT01626079|69625852|FG001|Overall Study|Lost to Follow-up|4|||
37938640|NCT01626079|69625853|FG002|Overall Study|Lost to Follow-up|2|||
37938641|NCT01626079|69625851|FG000|Overall Study|Missed Visits|1|||
37938642|NCT01626079|69625852|FG001|Overall Study|Missed Visits|4|||
37938643|NCT01626079|69625853|FG002|Overall Study|Missed Visits|6|||
37938644|NCT01349959|69625864|FG000|Overall Study|Adverse Event|7|||
37938645|NCT01331681|69625871|FG000|Overall Study|Adverse Event|10|||
37938646|NCT01331681|69625872|FG001|Overall Study|Adverse Event|13|||
37938647|NCT01331681|69625873|FG002|Overall Study|Adverse Event|10|||
37938648|NCT01331681|69625871|FG000|Overall Study|Death|6|||
37938649|NCT01331681|69625872|FG001|Overall Study|Death|6|||
37938650|NCT01331681|69625873|FG002|Overall Study|Death|2|||
37938651|NCT01331681|69625871|FG000|Overall Study|Lack of Efficacy|0|||
37938652|NCT01331681|69625872|FG001|Overall Study|Lack of Efficacy|1|||
37938653|NCT01331681|69625873|FG002|Overall Study|Lack of Efficacy|0|||
37938654|NCT01331681|69625871|FG000|Overall Study|Withdrawal by Subject|12|||
37938655|NCT01331681|69625872|FG001|Overall Study|Withdrawal by Subject|8|||
37938656|NCT01331681|69625873|FG002|Overall Study|Withdrawal by Subject|15|||
37938657|NCT01331681|69625871|FG000|Overall Study|Protocol Violation|1|||
37938658|NCT01331681|69625872|FG001|Overall Study|Protocol Violation|1|||
37938659|NCT01331681|69625873|FG002|Overall Study|Protocol Violation|0|||
37938660|NCT01331681|69625871|FG000|Overall Study|Lost to Follow-up|2|||
37938661|NCT01331681|69625872|FG001|Overall Study|Lost to Follow-up|4|||
37938662|NCT01331681|69625873|FG002|Overall Study|Lost to Follow-up|1|||
37938663|NCT01331681|69625871|FG000|Overall Study|Physician Decision|2|||
37938664|NCT01331681|69625872|FG001|Overall Study|Physician Decision|0|||
37938665|NCT01331681|69625873|FG002|Overall Study|Physician Decision|4|||
37938666|NCT01331681|69625871|FG000|Overall Study|Therapeutic procedure required|1|||
37938667|NCT01331681|69625872|FG001|Overall Study|Therapeutic procedure required|0|||
37938668|NCT01331681|69625873|FG002|Overall Study|Therapeutic procedure required|0|||
37938669|NCT01331681|69625871|FG000|Overall Study|Sponsor decision|1|||
37938670|NCT01331681|69625872|FG001|Overall Study|Sponsor decision|1|||
37938671|NCT01331681|69625873|FG002|Overall Study|Sponsor decision|0|||
37938672|NCT01331681|69625871|FG000|Overall Study|Switching to other therapy|0|||
37938673|NCT01331681|69625872|FG001|Overall Study|Switching to other therapy|0|||
37938674|NCT01331681|69625873|FG002|Overall Study|Switching to other therapy|1|||
37938675|NCT01331681|69625871|FG000|Overall Study|Not Received Study Treatment|0|||
37938676|NCT01331681|69625872|FG001|Overall Study|Not Received Study Treatment|0|||
37938677|NCT01331681|69625873|FG002|Overall Study|Not Received Study Treatment|2|||
37938678|NCT01286272|69625883|FG000|Overall Study|Ineligible after beginning treatment|1|||
37938679|NCT01286272|69625884|FG001|Overall Study|Ineligible after beginning treatment|3|||
37938680|NCT01267955|69625890|FG000|Stage 1 (6 Months)|Death|3|||
37938681|NCT01267955|69625890|FG000|Stage 2 (6 Months)|Death|5|||
37938682|NCT01267955|69625890|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
37938683|NCT01215136|69625896|FG000|Overall Study|Adverse Event|2|||
37938684|NCT01215136|69625897|FG001|Overall Study|Adverse Event|9|||
37938685|NCT01215136|69625896|FG000|Overall Study|Disease Progression|3|||
37938686|NCT01215136|69625897|FG001|Overall Study|Disease Progression|14|||
37938687|NCT01215136|69625896|FG000|Overall Study|Symptomatic Deterioration|1|||
37938688|NCT01215136|69625897|FG001|Overall Study|Symptomatic Deterioration|1|||
37938689|NCT01215136|69625896|FG000|Overall Study|Death|0|||
37938690|NCT01215136|69625897|FG001|Overall Study|Death|2|||
37938691|NCT01215136|69625896|FG000|Overall Study|Withdrawal by Subject|0|||
37938692|NCT01215136|69625897|FG001|Overall Study|Withdrawal by Subject|1|||
37938693|NCT01142388|69625922|FG000|Overall Study|Lack of Efficacy|21|||
37938694|NCT01142388|69625923|FG001|Overall Study|Lack of Efficacy|31|||
37938695|NCT01142388|69625922|FG000|Overall Study|Adverse Event|9|||
37938696|NCT01142388|69625923|FG001|Overall Study|Adverse Event|5|||
37938697|NCT01142388|69625922|FG000|Overall Study|Death|3|||
37938698|NCT01142388|69625923|FG001|Overall Study|Death|2|||
37938699|NCT01142388|69625922|FG000|Overall Study|Withdrawal by Subject|5|||
37938700|NCT01142388|69625923|FG001|Overall Study|Withdrawal by Subject|3|||
37938701|NCT01142388|69625922|FG000|Overall Study|Alternative therapy|1|||
37938702|NCT01142388|69625923|FG001|Overall Study|Alternative therapy|0|||
37938703|NCT01142388|69625922|FG000|Overall Study|Other complications|0|||
37938704|NCT01142388|69625923|FG001|Overall Study|Other complications|2|||
37938705|NCT01142388|69625922|FG000|Overall Study|Other|1|||
37938706|NCT01142388|69625923|FG001|Overall Study|Other|1|||
37938707|NCT01142388|69625922|FG000|Overall Study|Never started therapy|7|||
37938708|NCT01142388|69625923|FG001|Overall Study|Never started therapy|3|||
37938709|NCT01134614|69625931|FG000|Overall Study|Still on treatment as of March 2013|21|||
37938710|NCT01134614|69625932|FG001|Overall Study|Still on treatment as of March 2013|13|||
37938711|NCT01134614|69625931|FG000|Overall Study|Progressive disease|60|||
37938712|NCT01134614|69625932|FG001|Overall Study|Progressive disease|54|||
37938713|NCT01134614|69625931|FG000|Overall Study|Adverse Event|26|||
37938714|NCT01134614|69625932|FG001|Overall Study|Adverse Event|39|||
37938715|NCT01134614|69625931|FG000|Overall Study|Death|5|||
37938716|NCT01134614|69625932|FG001|Overall Study|Death|8|||
37938717|NCT01134614|69625931|FG000|Overall Study|Withdrawal by Subject|3|||
37938718|NCT01134614|69625932|FG001|Overall Study|Withdrawal by Subject|2|||
37938719|NCT01134614|69625931|FG000|Overall Study|Alternative therapy|2|||
37938720|NCT01134614|69625932|FG001|Overall Study|Alternative therapy|0|||
37938721|NCT01134614|69625931|FG000|Overall Study|Complicating disease|2|||
37938722|NCT01134614|69625932|FG001|Overall Study|Complicating disease|1|||
37938723|NCT01134614|69625931|FG000|Overall Study|Physician's decision|0|||
37938724|NCT01134614|69625932|FG001|Overall Study|Physician's decision|1|||
37938725|NCT01134614|69625931|FG000|Overall Study|Never started treatment|4|||
37938726|NCT01134614|69625932|FG001|Overall Study|Never started treatment|1|||
37938727|NCT01134614|69625931|FG000|Overall Study|Pt received tx not allowed on study|0|||
37938728|NCT01134614|69625932|FG001|Overall Study|Pt received tx not allowed on study|1|||
37938729|NCT01134614|69625931|FG000|Overall Study|Symptomatic deterioration|0|||
37938730|NCT01134614|69625932|FG001|Overall Study|Symptomatic deterioration|1|||
37938731|NCT01134614|69625931|FG000|Overall Study|Patient in hospice care|0|||
37938732|NCT01134614|69625932|FG001|Overall Study|Patient in hospice care|1|||
38035187|NCT03230864|69722114|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
38035188|NCT03230864|69722115|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
37938733|NCT00616018|69625946|FG000|Overall Study|Protocol Violation|3|||
37938734|NCT00424021|69625955|FG000|NCT00046319 Study Period|Adverse Event|1|||
37938735|NCT00424021|69625956|FG001|NCT00046319 Study Period|Adverse Event|0|||
37938736|NCT00424021|69625957|FG002|NCT00046319 Study Period|Adverse Event|1|||
37938737|NCT00424021|69625958|FG003|NCT00046319 Study Period|Adverse Event|1|||
37938738|NCT00424021|69625955|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
37938739|NCT00424021|69625956|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
37938740|NCT00424021|69625957|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
37938741|NCT00424021|69625958|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
37938742|NCT00424021|69625955|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
37938743|NCT00424021|69625956|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
37938744|NCT00424021|69625957|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
37938745|NCT00424021|69625958|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
37938746|NCT00424021|69625955|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
37938747|NCT00424021|69625956|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
37938748|NCT00424021|69625957|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
37938749|NCT00424021|69625958|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
37938750|NCT00424021|69625955|FG000|AMB-220-E Study Period|Adverse Event|1|||
37938751|NCT00424021|69625956|FG001|AMB-220-E Study Period|Adverse Event|1|||
37938752|NCT00424021|69625957|FG002|AMB-220-E Study Period|Adverse Event|3|||
37938753|NCT00424021|69625958|FG003|AMB-220-E Study Period|Adverse Event|7|||
37938754|NCT00424021|69625955|FG000|AMB-220-E Study Period|Death|0|||
37938755|NCT00424021|69625956|FG001|AMB-220-E Study Period|Death|0|||
37938756|NCT00424021|69625957|FG002|AMB-220-E Study Period|Death|1|||
37938757|NCT00424021|69625958|FG003|AMB-220-E Study Period|Death|1|||
37938758|NCT00424021|69625955|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
37938759|NCT00424021|69625956|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
37938760|NCT00424021|69625957|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
37938761|NCT00424021|69625958|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
37938762|NCT00424021|69625955|FG000|AMB-220-E Study Period|Physician Decision|0|||
37938763|NCT00424021|69625956|FG001|AMB-220-E Study Period|Physician Decision|0|||
37938764|NCT00424021|69625957|FG002|AMB-220-E Study Period|Physician Decision|0|||
37938765|NCT00424021|69625958|FG003|AMB-220-E Study Period|Physician Decision|1|||
37938766|NCT00617734|69625977|FG000|Overall Study|Withdrew Consent|2|||
37938767|NCT00617734|69625978|FG001|Overall Study|Withdrew Consent|0|||
37938768|NCT00617734|69625977|FG000|Overall Study|Adverse Event|4|||
37938769|NCT00617734|69625978|FG001|Overall Study|Adverse Event|1|||
37938770|NCT00617734|69625977|FG000|Overall Study|Protocol Violation|1|||
37938771|NCT00617734|69625978|FG001|Overall Study|Protocol Violation|0|||
37938772|NCT00617734|69625977|FG000|Overall Study|Found Ineligible After Randomization|1|||
37938773|NCT00617734|69625978|FG001|Overall Study|Found Ineligible After Randomization|4|||
37938774|NCT00617734|69625977|FG000|Overall Study|Lost to Follow-up|0|||
37938775|NCT00617734|69625978|FG001|Overall Study|Lost to Follow-up|1|||
37938776|NCT00577460|69625987|FG000|Overall Study|Adverse Event|11|||
37938777|NCT00577460|69625988|FG001|Overall Study|Adverse Event|7|||
37938778|NCT00577460|69625989|FG002|Overall Study|Adverse Event|14|||
37938779|NCT00577460|69625987|FG000|Overall Study|Protocol Violation|0|||
37938780|NCT00577460|69625988|FG001|Overall Study|Protocol Violation|1|||
37938781|NCT00577460|69625989|FG002|Overall Study|Protocol Violation|1|||
37938782|NCT00577460|69625987|FG000|Overall Study|Lost to Follow-up|0|||
37938783|NCT00577460|69625988|FG001|Overall Study|Lost to Follow-up|3|||
37938784|NCT00577460|69625989|FG002|Overall Study|Lost to Follow-up|4|||
37938785|NCT00577460|69625987|FG000|Overall Study|Withdrawal by Subject|5|||
37938786|NCT00577460|69625988|FG001|Overall Study|Withdrawal by Subject|5|||
37938787|NCT00577460|69625989|FG002|Overall Study|Withdrawal by Subject|6|||
37938788|NCT00577460|69625987|FG000|Overall Study|Other|0|||
37938789|NCT00577460|69625988|FG001|Overall Study|Other|3|||
37938790|NCT00577460|69625989|FG002|Overall Study|Other|2|||
37938791|NCT00415519|69626006|FG000|Overall Study|Adverse Event|1|||
37938792|NCT00415519|69626007|FG001|Overall Study|Adverse Event|0|||
37938793|NCT00415519|69626006|FG000|Overall Study|Withdrawal by Subject|2|||
37938794|NCT00415519|69626007|FG001|Overall Study|Withdrawal by Subject|0|||
37938795|NCT00415519|69626006|FG000|Overall Study|Patient's convenience|1|||
37938796|NCT00415519|69626007|FG001|Overall Study|Patient's convenience|0|||
38035189|NCT03230864|69722116|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
38035190|NCT03230864|69722113|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
37938797|NCT00423943|69626015|FG000|Overall Study|Withdrawal by Subject|3|||
37938798|NCT00423943|69626016|FG001|Overall Study|Withdrawal by Subject|1|||
38035191|NCT03230864|69722114|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
37938799|NCT00428389|69626024|FG000|Core Phase|Adverse Event|6|||
37938800|NCT00428389|69626025|FG001|Core Phase|Adverse Event|4|||
37938801|NCT00428389|69626024|FG000|Core Phase|Lack of Efficacy|2|||
37938802|NCT00428389|69626025|FG001|Core Phase|Lack of Efficacy|0|||
37938803|NCT00428389|69626024|FG000|Core Phase|Abnormal test procedure result(s)|0|||
37938804|NCT00428389|69626025|FG001|Core Phase|Abnormal test procedure result(s)|1|||
37938805|NCT00428389|69626024|FG000|Core Phase|Withdrawal by Subject|3|||
37938806|NCT00428389|69626025|FG001|Core Phase|Withdrawal by Subject|4|||
37938807|NCT00428389|69626024|FG000|Core Phase|Protocol deviation|0|||
37938808|NCT00428389|69626025|FG001|Core Phase|Protocol deviation|2|||
37938809|NCT00428389|69626024|FG000|Extension Phase|Adverse Event|17|||
37938810|NCT00428389|69626025|FG001|Extension Phase|Adverse Event|11|||
37938811|NCT00428389|69626024|FG000|Extension Phase|Lack of Efficacy|4|||
37938812|NCT00428389|69626025|FG001|Extension Phase|Lack of Efficacy|3|||
37938813|NCT00428389|69626024|FG000|Extension Phase|Withdrawal by Subject|6|||
37938814|NCT00428389|69626025|FG001|Extension Phase|Withdrawal by Subject|6|||
37938815|NCT00428389|69626024|FG000|Extension Phase|Lost to Follow-up|0|||
37938816|NCT00428389|69626025|FG001|Extension Phase|Lost to Follow-up|3|||
37938817|NCT00428389|69626024|FG000|Extension Phase|Death|1|||
37938818|NCT00428389|69626025|FG001|Extension Phase|Death|0|||
37938819|NCT00428389|69626024|FG000|Extension Phase|Protocol Violation|3|||
37938820|NCT00428389|69626025|FG001|Extension Phase|Protocol Violation|2|||
37938821|NCT00428389|69626024|FG000|Extension Phase|Administrative problems|1|||
37938822|NCT00428389|69626025|FG001|Extension Phase|Administrative problems|1|||
37938823|NCT00616642|69626033|FG000|Overall Study|Withdrawal by Subject|0|||
37938824|NCT00616642|69626034|FG001|Overall Study|Withdrawal by Subject|1|||
37938825|NCT00406315|69626040|FG000|Overall Study|Death|1|||
37938826|NCT00406315|69626040|FG000|Overall Study|Adverse Event|39|||
37938827|NCT00406315|69626040|FG000|Overall Study|Laboratory Abnormality|4|||
37938828|NCT00406315|69626040|FG000|Overall Study|Lack of Efficacy|13|||
37938829|NCT00406315|69626040|FG000|Overall Study|Other|33|||
37938830|NCT00406315|69626040|FG000|Overall Study|Lost to Follow-up|21|||
37938831|NCT00406315|69626040|FG000|Overall Study|Withdrawal by Subject|30|||
37938832|NCT00711594|69626048|FG000|Overall Study|Progressive disease|2|||
37938833|NCT00711594|69626049|FG001|Overall Study|Progressive disease|2|||
37938834|NCT00711594|69626050|FG002|Overall Study|Progressive disease|6|||
37938835|NCT00711594|69626051|FG003|Overall Study|Progressive disease|44|||
37938836|NCT00711594|69626048|FG000|Overall Study|Other Adverse Event|1|||
37938837|NCT00711594|69626049|FG001|Overall Study|Other Adverse Event|0|||
37938838|NCT00711594|69626050|FG002|Overall Study|Other Adverse Event|0|||
37938839|NCT00711594|69626051|FG003|Overall Study|Other Adverse Event|16|||
37938840|NCT00711594|69626048|FG000|Overall Study|Withdrawal by Subject|0|||
37938841|NCT00711594|69626049|FG001|Overall Study|Withdrawal by Subject|1|||
37938842|NCT00711594|69626050|FG002|Overall Study|Withdrawal by Subject|0|||
37938843|NCT00711594|69626051|FG003|Overall Study|Withdrawal by Subject|2|||
37938844|NCT00710762|69626065|FG000|Overall Study|Progressive disease|27|||
37938845|NCT00710762|69626066|FG001|Overall Study|Progressive disease|30|||
37938846|NCT00710762|69626065|FG000|Overall Study|Adverse Event other disease worsening|2|||
37938847|NCT00710762|69626066|FG001|Overall Study|Adverse Event other disease worsening|1|||
37938848|NCT00710762|69626065|FG000|Overall Study|Other Adverse Event|7|||
37938849|NCT00710762|69626066|FG001|Overall Study|Other Adverse Event|7|||
37938850|NCT00710762|69626065|FG000|Overall Study|Lost to Follow-up|1|||
37938851|NCT00710762|69626066|FG001|Overall Study|Lost to Follow-up|0|||
37938852|NCT00710762|69626065|FG000|Overall Study|Reason other than listed above|2|||
37938853|NCT00710762|69626066|FG001|Overall Study|Reason other than listed above|2|||
37938854|NCT00573430|69626075|FG000|Overall Study|Incorrect enrollment of randomization|0|||
37938855|NCT00573430|69626076|FG001|Overall Study|Incorrect enrollment of randomization|4|||
37938856|NCT00573430|69626077|FG002|Overall Study|Incorrect enrollment of randomization|3|||
37938857|NCT00573430|69626075|FG000|Overall Study|Adverse Event|0|||
37938858|NCT00573430|69626076|FG001|Overall Study|Adverse Event|0|||
37938859|NCT00573430|69626077|FG002|Overall Study|Adverse Event|2|||
37938860|NCT00573430|69626075|FG000|Overall Study|Withdrawal by Subject|1|||
37938861|NCT00573430|69626076|FG001|Overall Study|Withdrawal by Subject|0|||
37938862|NCT00573430|69626077|FG002|Overall Study|Withdrawal by Subject|1|||
37938863|NCT00573430|69626075|FG000|Overall Study|Protocol Violation|0|||
37938864|NCT00573430|69626076|FG001|Overall Study|Protocol Violation|1|||
37938865|NCT00573430|69626077|FG002|Overall Study|Protocol Violation|1|||
37938866|NCT00573430|69626075|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
37938867|NCT00573430|69626076|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
38035192|NCT03230864|69722115|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
38035193|NCT03230864|69722116|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
37938868|NCT00573430|69626077|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
37938869|NCT00711516|69626087|FG000|Overall Study|Adverse Event|1|||
37938870|NCT00711516|69626088|FG001|Overall Study|Adverse Event|1|||
37938871|NCT00711516|69626087|FG000|Overall Study|Withdrawal by Subject|0|||
38035194|NCT03230864|69722113|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
37938872|NCT00711516|69626088|FG001|Overall Study|Withdrawal by Subject|1|||
37938873|NCT00711516|69626087|FG000|Overall Study|Protocol Violation|0|||
37938874|NCT00711516|69626088|FG001|Overall Study|Protocol Violation|1|||
37938875|NCT00615550|69626096|FG000|Overall Study|Lost to Follow-up|6|||
37938876|NCT00615550|69626097|FG001|Overall Study|Lost to Follow-up|1|||
37938877|NCT00186888|69626106|FG000|Overall Study|Toxicity|0|||
37938878|NCT00186888|69626107|FG001|Overall Study|Toxicity|1|||
37938879|NCT00186888|69626108|FG002|Overall Study|Toxicity|0|||
37938880|NCT00186888|69626106|FG000|Overall Study|Relapse or progression of disease|4|||
37938881|NCT00186888|69626107|FG001|Overall Study|Relapse or progression of disease|2|||
37938882|NCT00186888|69626108|FG002|Overall Study|Relapse or progression of disease|0|||
37938883|NCT00577382|69626145|FG000|Overall Study|Adverse Event|0|||
37938884|NCT00577382|69626146|FG001|Overall Study|Adverse Event|6|||
37938885|NCT00577382|69626145|FG000|Overall Study|Withdrawal by Subject|0|||
37938886|NCT00577382|69626146|FG001|Overall Study|Withdrawal by Subject|1|||
37938887|NCT00577382|69626145|FG000|Overall Study|Progressive Disease|17|||
37938888|NCT00577382|69626146|FG001|Overall Study|Progressive Disease|19|||
37938889|NCT00577382|69626145|FG000|Overall Study|Intercurrent Illness|1|||
37938890|NCT00577382|69626146|FG001|Overall Study|Intercurrent Illness|2|||
37938891|NCT00577382|69626145|FG000|Overall Study|Death|1|||
37938892|NCT00577382|69626146|FG001|Overall Study|Death|1|||
37938893|NCT00577382|69626145|FG000|Overall Study|Lost to Follow-up|2|||
37938894|NCT00577382|69626146|FG001|Overall Study|Lost to Follow-up|2|||
37938895|NCT00614926|69626154|FG000|Overall Study|Burden of travel|1|||
37938896|NCT00614926|69626155|FG001|Overall Study|Burden of travel|0|||
37938897|NCT00614926|69626154|FG000|Overall Study|Adverse Event|3|||
37938898|NCT00614926|69626155|FG001|Overall Study|Adverse Event|0|||
37938899|NCT00423319|69626163|FG000|Overall Study|Death|2|||
37938900|NCT00423319|69626164|FG001|Overall Study|Death|0|||
37938901|NCT00423319|69626163|FG000|Overall Study|Adverse Event|93|||
37938902|NCT00423319|69626164|FG001|Overall Study|Adverse Event|112|||
37938903|NCT00423319|69626163|FG000|Overall Study|Withdrawal by Subject|86|||
37938904|NCT00423319|69626164|FG001|Overall Study|Withdrawal by Subject|99|||
37938905|NCT00423319|69626163|FG000|Overall Study|Lost to Follow-up|4|||
37938906|NCT00423319|69626164|FG001|Overall Study|Lost to Follow-up|3|||
37938907|NCT00423319|69626163|FG000|Overall Study|Poor compliance or noncompliance|1|||
37938908|NCT00423319|69626164|FG001|Overall Study|Poor compliance or noncompliance|1|||
37938909|NCT00423319|69626163|FG000|Overall Study|No longer meets study criteria|15|||
37938910|NCT00423319|69626164|FG001|Overall Study|No longer meets study criteria|15|||
37938911|NCT00423319|69626163|FG000|Overall Study|Other|23|||
37938912|NCT00423319|69626164|FG001|Overall Study|Other|22|||
37938913|NCT00710684|69626174|FG000|Overall Study|Adverse Event|11|||
37938914|NCT00710684|69626175|FG001|Overall Study|Adverse Event|19|||
37938915|NCT00710684|69626176|FG002|Overall Study|Adverse Event|16|||
37938916|NCT00710684|69626174|FG000|Overall Study|Lack of Efficacy|4|||
37938917|NCT00710684|69626175|FG001|Overall Study|Lack of Efficacy|3|||
37938918|NCT00710684|69626176|FG002|Overall Study|Lack of Efficacy|5|||
37938919|NCT00710684|69626174|FG000|Overall Study|Protocol Violation|5|||
37938920|NCT00710684|69626175|FG001|Overall Study|Protocol Violation|5|||
37938921|NCT00710684|69626176|FG002|Overall Study|Protocol Violation|5|||
37938922|NCT00710684|69626174|FG000|Overall Study|Lost to Follow-up|4|||
37938923|NCT00710684|69626175|FG001|Overall Study|Lost to Follow-up|6|||
37938924|NCT00710684|69626176|FG002|Overall Study|Lost to Follow-up|7|||
37938925|NCT00710684|69626174|FG000|Overall Study|Physician Decision|0|||
37938926|NCT00710684|69626175|FG001|Overall Study|Physician Decision|2|||
37938927|NCT00710684|69626176|FG002|Overall Study|Physician Decision|4|||
37938928|NCT00710684|69626174|FG000|Overall Study|Withdrawal by Subject|24|||
37938929|NCT00710684|69626175|FG001|Overall Study|Withdrawal by Subject|18|||
37938930|NCT00710684|69626176|FG002|Overall Study|Withdrawal by Subject|11|||
37938931|NCT00710684|69626174|FG000|Overall Study|Missing|1|||
37938932|NCT00710684|69626175|FG001|Overall Study|Missing|0|||
37938933|NCT00710684|69626176|FG002|Overall Study|Missing|0|||
37938934|NCT00710684|69626174|FG000|Overall Study|Did not continue after week 24|25|||
37938935|NCT00710684|69626175|FG001|Overall Study|Did not continue after week 24|21|||
37938936|NCT00710684|69626176|FG002|Overall Study|Did not continue after week 24|16|||
37938937|NCT00710606|69626192|FG000|Overall Study|Adverse Event|0|||
37938938|NCT00710606|69626193|FG001|Overall Study|Adverse Event|2|||
37938939|NCT00713544|69626207|FG000|Overall Study|Adverse Event|5|||
37670400|NCT01374425|69143626|FG000|Overall Study|Refused Treatment|10|||
37670401|NCT01374425|69143627|FG001|Overall Study|Refused Treatment|24|||
37765163|NCT01546142|69278361|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
37938940|NCT00713544|69626208|FG001|Overall Study|Adverse Event|3|||
37938941|NCT00713544|69626209|FG002|Overall Study|Adverse Event|7|||
37938942|NCT00713544|69626210|FG003|Overall Study|Adverse Event|7|||
37938943|NCT00713544|69626211|FG004|Overall Study|Adverse Event|3|||
37938944|NCT00713544|69626212|FG005|Overall Study|Adverse Event|5|||
37938945|NCT00713544|69626207|FG000|Overall Study|Withdrawal by Subject|2|||
37938946|NCT00713544|69626208|FG001|Overall Study|Withdrawal by Subject|0|||
37938947|NCT00713544|69626209|FG002|Overall Study|Withdrawal by Subject|3|||
37938948|NCT00713544|69626210|FG003|Overall Study|Withdrawal by Subject|2|||
37938949|NCT00713544|69626211|FG004|Overall Study|Withdrawal by Subject|3|||
37938950|NCT00713544|69626212|FG005|Overall Study|Withdrawal by Subject|1|||
37938951|NCT00713544|69626207|FG000|Overall Study|Protocol Violation|0|||
37938952|NCT00713544|69626208|FG001|Overall Study|Protocol Violation|0|||
37938953|NCT00713544|69626209|FG002|Overall Study|Protocol Violation|0|||
37938954|NCT00713544|69626210|FG003|Overall Study|Protocol Violation|0|||
37938955|NCT00713544|69626211|FG004|Overall Study|Protocol Violation|0|||
37938956|NCT00713544|69626212|FG005|Overall Study|Protocol Violation|1|||
37938957|NCT00713544|69626207|FG000|Overall Study|Physician Decision|0|||
37938958|NCT00713544|69626208|FG001|Overall Study|Physician Decision|0|||
37938959|NCT00713544|69626209|FG002|Overall Study|Physician Decision|0|||
37938960|NCT00713544|69626210|FG003|Overall Study|Physician Decision|0|||
37938961|NCT00713544|69626211|FG004|Overall Study|Physician Decision|0|||
37938962|NCT00713544|69626212|FG005|Overall Study|Physician Decision|2|||
37938963|NCT00713544|69626207|FG000|Overall Study|Lack of Efficacy|0|||
37938964|NCT00713544|69626208|FG001|Overall Study|Lack of Efficacy|1|||
37938965|NCT00713544|69626209|FG002|Overall Study|Lack of Efficacy|0|||
37938966|NCT00713544|69626210|FG003|Overall Study|Lack of Efficacy|1|||
37938967|NCT00713544|69626211|FG004|Overall Study|Lack of Efficacy|1|||
37938968|NCT00713544|69626212|FG005|Overall Study|Lack of Efficacy|0|||
37938969|NCT00713544|69626207|FG000|Overall Study|Lost to Follow-up|0|||
37938970|NCT00713544|69626208|FG001|Overall Study|Lost to Follow-up|0|||
37938971|NCT00713544|69626209|FG002|Overall Study|Lost to Follow-up|1|||
37938972|NCT00713544|69626210|FG003|Overall Study|Lost to Follow-up|0|||
37938973|NCT00713544|69626211|FG004|Overall Study|Lost to Follow-up|0|||
37938974|NCT00713544|69626212|FG005|Overall Study|Lost to Follow-up|0|||
37938975|NCT00713544|69626207|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
37938976|NCT00713544|69626208|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
37938977|NCT00713544|69626209|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
37938978|NCT00713544|69626210|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
37938979|NCT00713544|69626211|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
37938980|NCT00713544|69626212|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
38035195|NCT03230864|69722114|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
38035196|NCT03230864|69722115|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
38035197|NCT03230864|69722116|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
37859604|NCT00960115|69542912|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
37859605|NCT00960115|69542913|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
37859606|NCT00959647|69542919|FG000|Overall Study|Adverse Event|2|||
37859607|NCT00959647|69542919|FG000|Overall Study|Progressive disease|6|||
37859608|NCT00959647|69542919|FG000|Overall Study|Study terminated by sponsor|4|||
37859609|NCT00959647|69542919|FG000|Overall Study|Withdrawal by Subject|7|||
37859610|NCT00957931|69542923|FG000|Overall Study|Death|4|||
37859611|NCT00957853|69542930|FG000|Overall Study|Withdrawal by Subject|1|||
37859612|NCT00957853|69542931|FG001|Overall Study|Withdrawal by Subject|0|||
37859613|NCT00957853|69542932|FG002|Overall Study|Withdrawal by Subject|0|||
37859614|NCT00957229|69542942|FG000|Study Start|Adverse Event|0|||
37859615|NCT00957229|69542943|FG001|Study Start|Adverse Event|3|||
37859616|NCT00957229|69542942|FG000|Study Start|Disease Progression|1|||
37859617|NCT00957229|69542943|FG001|Study Start|Disease Progression|0|||
37859618|NCT00957229|69542942|FG000|Reallocated to or Continued Vismodegib|Death|1|||
37859619|NCT00957229|69542943|FG001|Reallocated to or Continued Vismodegib|Death|1|||
37859620|NCT00957229|69542942|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
37859621|NCT00957229|69542943|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
37859622|NCT02604511|69542949|FG000|Overall Study|Adverse Event|3|||
37859623|NCT02604511|69542949|FG000|Overall Study|Disease Progression|4|||
37938981|NCT00713544|69626207|FG000|Overall Study|Incorrect enrollment|0|||
37938982|NCT00713544|69626208|FG001|Overall Study|Incorrect enrollment|1|||
37938983|NCT00713544|69626209|FG002|Overall Study|Incorrect enrollment|0|||
37938984|NCT00713544|69626210|FG003|Overall Study|Incorrect enrollment|0|||
37938985|NCT00713544|69626211|FG004|Overall Study|Incorrect enrollment|0|||
37938986|NCT00713544|69626212|FG005|Overall Study|Incorrect enrollment|0|||
37859624|NCT02604511|69542949|FG000|Overall Study|Withdrawal by Subject|3|||
37859625|NCT02604511|69542949|FG000|Overall Study|Participant ineligible|1|||
37859626|NCT02604511|69542949|FG000|Overall Study|Intercurrent illness|1|||
37859627|NCT00956839|69542957|FG000|Overall Study|Lost to Follow-up|3|||
37859628|NCT00956839|69542958|FG001|Overall Study|Lost to Follow-up|0|||
37859629|NCT00956839|69542959|FG002|Overall Study|Lost to Follow-up|3|||
37859630|NCT00956293|69542969|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
37859631|NCT00956293|69542970|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
37859632|NCT00956293|69542971|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
37859633|NCT00956293|69542969|FG000|Main Period (Pre-randomization)|Death|0|||
37859634|NCT00956293|69542970|FG001|Main Period (Pre-randomization)|Death|0|||
37859635|NCT00956293|69542971|FG002|Main Period (Pre-randomization)|Death|1|||
37859636|NCT00956293|69542969|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
37859637|NCT00956293|69542970|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
37859638|NCT00956293|69542971|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
37859639|NCT00956293|69542969|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
37859640|NCT00956293|69542970|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
37859641|NCT00956293|69542971|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
37859642|NCT00956293|69542969|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
37938987|NCT00713544|69626207|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
37938988|NCT00713544|69626208|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
37938989|NCT00713544|69626209|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
37938990|NCT00713544|69626210|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
37938991|NCT00713544|69626211|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
37938992|NCT00713544|69626212|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
37938993|NCT00415363|69626228|FG000|Overall Study|Withdrawal by Subject|4|||
37938994|NCT00415363|69626229|FG001|Overall Study|Withdrawal by Subject|4|||
37938995|NCT00415363|69626228|FG000|Overall Study|Adverse Event|4|||
37938996|NCT00415363|69626229|FG001|Overall Study|Adverse Event|4|||
37938997|NCT00415363|69626228|FG000|Overall Study|Lost to Follow-up|2|||
37938998|NCT00415363|69626229|FG001|Overall Study|Lost to Follow-up|1|||
37938999|NCT00415363|69626228|FG000|Overall Study|Physician Decision|3|||
37939000|NCT00415363|69626229|FG001|Overall Study|Physician Decision|1|||
37939001|NCT00415363|69626228|FG000|Overall Study|Death|16|||
37939002|NCT00415363|69626229|FG001|Overall Study|Death|12|||
37939003|NCT00415363|69626228|FG000|Overall Study|Progressive disease|26|||
37939004|NCT00415363|69626229|FG001|Overall Study|Progressive disease|32|||
37939005|NCT00415051|69626236|FG000|Overall Study|Protocol Violation|1|||
37939006|NCT00713258|69626242|FG000|Overall Study|Adverse Event|2|||
37939007|NCT00713258|69626243|FG001|Overall Study|Adverse Event|4|||
37939008|NCT00713258|69626242|FG000|Overall Study|Non-Compliance|2|||
37939009|NCT00713258|69626243|FG001|Overall Study|Non-Compliance|1|||
37939010|NCT00713258|69626242|FG000|Overall Study|Other|1|||
37939011|NCT00713258|69626243|FG001|Overall Study|Other|1|||
37939012|NCT00710034|69626251|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
37939013|NCT00710034|69626252|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
37939014|NCT00710034|69626251|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
37939015|NCT00710034|69626252|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
37939016|NCT00710034|69626251|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
37939017|NCT00710034|69626252|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
37939018|NCT00710034|69626251|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
37939019|NCT00710034|69626252|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
37939020|NCT00710034|69626251|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
37939021|NCT00710034|69626252|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
37939022|NCT00710034|69626251|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
37939023|NCT00710034|69626252|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
37939024|NCT00710034|69626251|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
37939025|NCT00710034|69626252|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
37939026|NCT00710034|69626251|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
37939027|NCT00710034|69626252|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
37939028|NCT00710034|69626251|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
37939029|NCT00710034|69626252|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
37939030|NCT00710034|69626251|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
37939031|NCT00710034|69626252|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
37939032|NCT00710034|69626251|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
37939033|NCT00710034|69626252|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
37939034|NCT00414973|69626262|FG000|Overall Study|Withdrawal by Subject|14|||
37939035|NCT00414973|69626263|FG001|Overall Study|Withdrawal by Subject|4|||
37939036|NCT00414973|69626264|FG002|Overall Study|Withdrawal by Subject|1|||
37939037|NCT00414973|69626265|FG003|Overall Study|Withdrawal by Subject|0|||
37939038|NCT00414973|69626262|FG000|Overall Study|Adverse Event|10|||
37939039|NCT00414973|69626263|FG001|Overall Study|Adverse Event|0|||
38035198|NCT03230864|69722113|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
38035199|NCT03230864|69722114|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
38035200|NCT03230864|69722115|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
38035201|NCT03230864|69722116|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
37939040|NCT00414973|69626264|FG002|Overall Study|Adverse Event|1|||
37939041|NCT00414973|69626265|FG003|Overall Study|Adverse Event|0|||
37939042|NCT00414973|69626262|FG000|Overall Study|Protocol Violation|3|||
37939043|NCT00414973|69626263|FG001|Overall Study|Protocol Violation|4|||
37939044|NCT00414973|69626264|FG002|Overall Study|Protocol Violation|0|||
37939045|NCT00414973|69626265|FG003|Overall Study|Protocol Violation|0|||
37939046|NCT00414973|69626262|FG000|Overall Study|Lost to Follow-up|0|||
37939047|NCT00414973|69626263|FG001|Overall Study|Lost to Follow-up|2|||
37939048|NCT00414973|69626264|FG002|Overall Study|Lost to Follow-up|0|||
37939049|NCT00414973|69626265|FG003|Overall Study|Lost to Follow-up|0|||
37939050|NCT00414973|69626262|FG000|Overall Study|Sponsor Decision|1|||
37939051|NCT00414973|69626263|FG001|Overall Study|Sponsor Decision|0|||
37939052|NCT00414973|69626264|FG002|Overall Study|Sponsor Decision|0|||
37939053|NCT00414973|69626265|FG003|Overall Study|Sponsor Decision|0|||
37939054|NCT00414973|69626262|FG000|Overall Study|Death|0|||
37939055|NCT00414973|69626263|FG001|Overall Study|Death|0|||
37939056|NCT00414973|69626264|FG002|Overall Study|Death|1|||
37939057|NCT00414973|69626265|FG003|Overall Study|Death|0|||
37939058|NCT00423085|69626278|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
37939059|NCT00423085|69626279|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
37939060|NCT00423085|69626280|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
37939061|NCT00423085|69626281|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
37939062|NCT00423085|69626278|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
37939063|NCT00423085|69626279|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
37939064|NCT00423085|69626280|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
37939065|NCT00423085|69626281|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
37939066|NCT00423085|69626278|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
37939067|NCT00423085|69626279|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
37939068|NCT00423085|69626280|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
37939069|NCT00423085|69626281|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
37939070|NCT00423085|69626278|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
37939071|NCT00423085|69626279|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
37939072|NCT00423085|69626280|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
37939073|NCT00423085|69626281|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
37939074|NCT00423085|69626278|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
37939075|NCT00423085|69626279|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
37939076|NCT00423085|69626280|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
37939077|NCT00423085|69626281|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
37939078|NCT00423085|69626278|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
37939079|NCT00423085|69626279|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
37939080|NCT00423085|69626280|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
37939081|NCT00423085|69626281|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
37939082|NCT00423085|69626278|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
37939083|NCT00423085|69626279|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
37939084|NCT00423085|69626280|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
37939085|NCT00423085|69626281|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
37939086|NCT00423085|69626278|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
37939087|NCT00423085|69626279|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
37939088|NCT00423085|69626280|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
37939089|NCT00423085|69626281|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
37939090|NCT00423085|69626278|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
37939091|NCT00423085|69626279|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
37939092|NCT00423085|69626280|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
37939093|NCT00423085|69626281|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
37939094|NCT00423085|69626278|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
37939095|NCT00423085|69626279|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
37939096|NCT00423085|69626280|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
37939097|NCT00423085|69626281|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
37939098|NCT00423085|69626278|FG000|52-Week Open-Label Extension Phase|Death|0|||
37939099|NCT00423085|69626279|FG001|52-Week Open-Label Extension Phase|Death|0|||
37939100|NCT00423085|69626280|FG002|52-Week Open-Label Extension Phase|Death|0|||
37939101|NCT00423085|69626281|FG003|52-Week Open-Label Extension Phase|Death|2|||
37939102|NCT00414661|69626295|FG000|Overall Study|Death|2|||
37939103|NCT00414661|69626296|FG001|Overall Study|Death|5|||
37939104|NCT00414661|69626297|FG002|Overall Study|Death|0|||
37939105|NCT00414661|69626298|FG003|Overall Study|Death|0|||
37939106|NCT00414661|69626295|FG000|Overall Study|Lost to Follow-up|1|||
37939107|NCT00414661|69626296|FG001|Overall Study|Lost to Follow-up|4|||
37939108|NCT00414661|69626297|FG002|Overall Study|Lost to Follow-up|0|||
37765164|NCT01546142|69278362|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
37765165|NCT01546142|69278361|FG000|Overall Study|Subject Noncompliance|1|||
37765166|NCT01546142|69278362|FG001|Overall Study|Subject Noncompliance|1|||
37765167|NCT01546142|69278361|FG000|Overall Study|Adverse Event|6|||
37939109|NCT00414661|69626298|FG003|Overall Study|Lost to Follow-up|1|||
37939110|NCT00414661|69626295|FG000|Overall Study|Withdrawal by Subject|5|||
37939111|NCT00414661|69626296|FG001|Overall Study|Withdrawal by Subject|2|||
37939112|NCT00414661|69626297|FG002|Overall Study|Withdrawal by Subject|2|||
37939113|NCT00414661|69626298|FG003|Overall Study|Withdrawal by Subject|2|||
37939114|NCT00414661|69626295|FG000|Overall Study|Other|6|||
37939115|NCT00414661|69626296|FG001|Overall Study|Other|3|||
37939116|NCT00414661|69626297|FG002|Overall Study|Other|0|||
37939117|NCT00414661|69626298|FG003|Overall Study|Other|0|||
37939118|NCT00405067|69626311|FG000|Overall Study|Adverse Event|4|||
37939119|NCT00405067|69626312|FG001|Overall Study|Adverse Event|9|||
37939120|NCT00405067|69626313|FG002|Overall Study|Adverse Event|4|||
37939121|NCT00405067|69626311|FG000|Overall Study|Lost to Follow-up|0|||
37939122|NCT00405067|69626312|FG001|Overall Study|Lost to Follow-up|0|||
37939123|NCT00405067|69626313|FG002|Overall Study|Lost to Follow-up|1|||
37939124|NCT00708708|69626321|FG000|Overall Study|Another therapy instead of Enbrel|141|||
37939125|NCT00708708|69626321|FG000|Overall Study|Lost to Follow-up|52|||
37939126|NCT00708708|69626321|FG000|Overall Study|Withdrawal by Subject|51|||
37939127|NCT00708708|69626321|FG000|Overall Study|Intolerance|42|||
37939128|NCT00708708|69626321|FG000|Overall Study|Another therapy along with Enbrel|15|||
37939129|NCT00708708|69626321|FG000|Overall Study|Other unspecified|11|||
37939130|NCT00708708|69626321|FG000|Overall Study|Good effectiveness|9|||
37939131|NCT00708708|69626321|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
37939132|NCT00708708|69626321|FG000|Overall Study|Administrative reasons|7|||
37939133|NCT00708708|69626321|FG000|Overall Study|Lack of effectiveness|4|||
37939134|NCT00708708|69626321|FG000|Overall Study|Lack of compliance|3|||
37939135|NCT00708708|69626321|FG000|Overall Study|Pregnancy|3|||
37939136|NCT00708708|69626321|FG000|Overall Study|Adverse Event|3|||
37939137|NCT00708708|69626321|FG000|Overall Study|Missing values|392|||
37939138|NCT00404755|69626328|FG000|Phase I (Bupropion)|Adverse Event|3|||
37939139|NCT00404755|69626328|FG000|Phase I (Bupropion)|Other|1|||
37939140|NCT00404755|69626328|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
37939141|NCT00614614|69626338|FG000|Primary Vaccination Phase|Adverse Event|6|||
37939142|NCT00614614|69626339|FG001|Primary Vaccination Phase|Adverse Event|0|||
37939143|NCT00614614|69626340|FG002|Primary Vaccination Phase|Adverse Event|0|||
37939144|NCT00614614|69626341|FG003|Primary Vaccination Phase|Adverse Event|0|||
37939145|NCT00614614|69626342|FG004|Primary Vaccination Phase|Adverse Event|0|||
37939146|NCT00614614|69626338|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
37939147|NCT00614614|69626339|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
37939148|NCT00614614|69626340|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
37939149|NCT00614614|69626341|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
37939150|NCT00614614|69626342|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
37939151|NCT00614614|69626338|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
37939152|NCT00614614|69626339|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
37939153|NCT00614614|69626340|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
37939154|NCT00614614|69626341|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
37939155|NCT00614614|69626342|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
37939156|NCT00614614|69626338|FG000|Primary Vaccination Phase|Protocol Violation|9|||
37939157|NCT00614614|69626339|FG001|Primary Vaccination Phase|Protocol Violation|3|||
37939158|NCT00614614|69626340|FG002|Primary Vaccination Phase|Protocol Violation|0|||
37939159|NCT00614614|69626341|FG003|Primary Vaccination Phase|Protocol Violation|0|||
37939160|NCT00614614|69626342|FG004|Primary Vaccination Phase|Protocol Violation|0|||
37939161|NCT00614614|69626338|FG000|Primary Vaccination Phase|Other|4|||
37939162|NCT00614614|69626339|FG001|Primary Vaccination Phase|Other|0|||
37939163|NCT00614614|69626340|FG002|Primary Vaccination Phase|Other|0|||
37939164|NCT00614614|69626341|FG003|Primary Vaccination Phase|Other|0|||
37939165|NCT00614614|69626342|FG004|Primary Vaccination Phase|Other|0|||
37939166|NCT00614614|69626338|FG000|Booster Vaccination Phase|Adverse Event|0|||
37939167|NCT00614614|69626339|FG001|Booster Vaccination Phase|Adverse Event|0|||
37939168|NCT00614614|69626340|FG002|Booster Vaccination Phase|Adverse Event|1|||
37939169|NCT00614614|69626341|FG003|Booster Vaccination Phase|Adverse Event|1|||
37939170|NCT00614614|69626342|FG004|Booster Vaccination Phase|Adverse Event|0|||
37939171|NCT00614614|69626338|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
37939172|NCT00614614|69626339|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
37939173|NCT00614614|69626340|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
37939174|NCT00614614|69626341|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
37939175|NCT00614614|69626342|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
37939176|NCT00614614|69626338|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
37939177|NCT00614614|69626339|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
37939178|NCT00614614|69626340|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
37939179|NCT00614614|69626341|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
37939180|NCT00614614|69626342|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
37939181|NCT00614614|69626338|FG000|Booster Vaccination Phase|Protocol Violation|0|||
37939182|NCT00614614|69626339|FG001|Booster Vaccination Phase|Protocol Violation|0|||
37939183|NCT00614614|69626340|FG002|Booster Vaccination Phase|Protocol Violation|2|||
37939184|NCT00614614|69626341|FG003|Booster Vaccination Phase|Protocol Violation|3|||
37939185|NCT00614614|69626342|FG004|Booster Vaccination Phase|Protocol Violation|0|||
37939186|NCT00614614|69626338|FG000|Booster Vaccination Phase|Other|0|||
37939187|NCT00614614|69626339|FG001|Booster Vaccination Phase|Other|1|||
37939188|NCT00614614|69626340|FG002|Booster Vaccination Phase|Other|3|||
37939189|NCT00614614|69626341|FG003|Booster Vaccination Phase|Other|2|||
37939190|NCT00614614|69626342|FG004|Booster Vaccination Phase|Other|1|||
37939191|NCT00713310|69626359|FG000|Overall Study|Adverse Event|5|||
37939192|NCT00713310|69626360|FG001|Overall Study|Adverse Event|2|||
37939193|NCT00713310|69626359|FG000|Overall Study|Lack of Efficacy|0|||
37939194|NCT00713310|69626360|FG001|Overall Study|Lack of Efficacy|2|||
37939195|NCT00713310|69626359|FG000|Overall Study|Withdrawal by Subject|0|||
37939196|NCT00713310|69626360|FG001|Overall Study|Withdrawal by Subject|2|||
37939197|NCT00422461|69626370|FG000|Overall Study|Adverse Event|1|||
37939198|NCT00422461|69626371|FG001|Overall Study|Adverse Event|2|||
37939199|NCT00422461|69626372|FG002|Overall Study|Adverse Event|1|||
37939200|NCT00422461|69626373|FG003|Overall Study|Adverse Event|1|||
37939201|NCT00422461|69626370|FG000|Overall Study|Other|0|||
37939202|NCT00422461|69626371|FG001|Overall Study|Other|0|||
37939203|NCT00422461|69626372|FG002|Overall Study|Other|0|||
37939204|NCT00422461|69626373|FG003|Overall Study|Other|2|||
37939205|NCT00422461|69626370|FG000|Overall Study|Participants no longer willing to participate in study|1|||
37939206|NCT00422461|69626371|FG001|Overall Study|Participants no longer willing to participate in study|0|||
37939207|NCT00422461|69626372|FG002|Overall Study|Participants no longer willing to participate in study|0|||
37939208|NCT00422461|69626373|FG003|Overall Study|Participants no longer willing to participate in study|0|||
37939209|NCT00422461|69626370|FG000|Overall Study|Randomized but not treated|1|||
37939210|NCT00422461|69626371|FG001|Overall Study|Randomized but not treated|1|||
37939211|NCT00422461|69626372|FG002|Overall Study|Randomized but not treated|0|||
37939212|NCT00422461|69626373|FG003|Overall Study|Randomized but not treated|0|||
37939213|NCT00712920|69626386|FG000|Overall Study|Adverse Event|3|||
37939214|NCT00712920|69626387|FG001|Overall Study|Adverse Event|4|||
37939215|NCT00712920|69626388|FG002|Overall Study|Adverse Event|7|||
37765168|NCT01546142|69278362|FG001|Overall Study|Adverse Event|3|||
37765169|NCT01546142|69278361|FG000|Overall Study|Lost to Follow-up|20|||
37765170|NCT01546142|69278362|FG001|Overall Study|Lost to Follow-up|15|||
37765171|NCT01546142|69278361|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
37939216|NCT00712920|69626386|FG000|Overall Study|Withdrawal by Subject|4|||
37939217|NCT00712920|69626387|FG001|Overall Study|Withdrawal by Subject|2|||
37939218|NCT00712920|69626388|FG002|Overall Study|Withdrawal by Subject|1|||
37939219|NCT00712920|69626386|FG000|Overall Study|Lost to Follow-up|1|||
37939220|NCT00712920|69626387|FG001|Overall Study|Lost to Follow-up|4|||
37939221|NCT00712920|69626388|FG002|Overall Study|Lost to Follow-up|0|||
37939222|NCT00712920|69626386|FG000|Overall Study|Lack of Efficacy|1|||
37939223|NCT00712920|69626387|FG001|Overall Study|Lack of Efficacy|0|||
37939224|NCT00712920|69626388|FG002|Overall Study|Lack of Efficacy|1|||
37939225|NCT00712920|69626386|FG000|Overall Study|Other|5|||
37939226|NCT00712920|69626387|FG001|Overall Study|Other|7|||
37939227|NCT00712920|69626388|FG002|Overall Study|Other|3|||
37939228|NCT00712920|69626386|FG000|Overall Study|Non-compliance|3|||
37939229|NCT00712920|69626387|FG001|Overall Study|Non-compliance|0|||
37939230|NCT00712920|69626388|FG002|Overall Study|Non-compliance|0|||
37939231|NCT00612586|69626407|FG000|Overall Study|Adverse Event|6|||
37939232|NCT00612586|69626408|FG001|Overall Study|Adverse Event|2|||
37939233|NCT00612586|69626407|FG000|Overall Study|Death|1|||
37939234|NCT00612586|69626408|FG001|Overall Study|Death|0|||
37939235|NCT00612586|69626407|FG000|Overall Study|Entry Criteria Not Met|0|||
37939236|NCT00612586|69626408|FG001|Overall Study|Entry Criteria Not Met|2|||
37939237|NCT00612586|69626407|FG000|Overall Study|Withdrawal by Subject|7|||
37939238|NCT00612586|69626408|FG001|Overall Study|Withdrawal by Subject|9|||
37939239|NCT00612586|69626407|FG000|Overall Study|Physician Decision|1|||
37939240|NCT00612586|69626408|FG001|Overall Study|Physician Decision|2|||
37939241|NCT00612586|69626407|FG000|Overall Study|Sponsor Decision|1|||
37939242|NCT00612586|69626408|FG001|Overall Study|Sponsor Decision|1|||
37939243|NCT00612586|69626407|FG000|Overall Study|Progressive Disease|26|||
37939244|NCT00612586|69626408|FG001|Overall Study|Progressive Disease|24|||
37939245|NCT00612586|69626407|FG000|Overall Study|Randomized and Not Treated|1|||
37939246|NCT00612586|69626408|FG001|Overall Study|Randomized and Not Treated|1|||
37939247|NCT00614380|69626419|FG000|Overall Study|Adverse Event|14|||
37939248|NCT00614380|69626420|FG001|Overall Study|Adverse Event|4|||
37939249|NCT00614380|69626421|FG002|Overall Study|Adverse Event|0|||
37939250|NCT00614380|69626422|FG003|Overall Study|Adverse Event|0|||
37939251|NCT00614380|69626419|FG000|Overall Study|Lost to Follow-up|6|||
37939252|NCT00614380|69626420|FG001|Overall Study|Lost to Follow-up|1|||
38035202|NCT03230864|69722113|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
37939253|NCT00614380|69626421|FG002|Overall Study|Lost to Follow-up|0|||
37939254|NCT00614380|69626422|FG003|Overall Study|Lost to Follow-up|0|||
37939255|NCT00614380|69626419|FG000|Overall Study|Non compliant with the protocol|12|||
37939256|NCT00614380|69626420|FG001|Overall Study|Non compliant with the protocol|2|||
37939257|NCT00614380|69626421|FG002|Overall Study|Non compliant with the protocol|1|||
37939258|NCT00614380|69626422|FG003|Overall Study|Non compliant with the protocol|2|||
37939259|NCT00614380|69626419|FG000|Overall Study|Consent withdrawn|3|||
37939260|NCT00614380|69626420|FG001|Overall Study|Consent withdrawn|1|||
37939261|NCT00614380|69626421|FG002|Overall Study|Consent withdrawn|0|||
37939262|NCT00614380|69626422|FG003|Overall Study|Consent withdrawn|0|||
37939263|NCT00612508|69626439|FG000|Overall Study|Withdrawal by Subject|3|||
37939264|NCT00612508|69626440|FG001|Overall Study|Withdrawal by Subject|4|||
37939265|NCT00613834|69626450|FG000|Overall Study|Withdrawal by Subject|0|||
37939266|NCT00613834|69626451|FG001|Overall Study|Withdrawal by Subject|3|||
37765172|NCT01546142|69278362|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
37939267|NCT00613366|69626465|FG000|Overall Study|Withdrawal by Subject|3|||
37939268|NCT00613366|69626466|FG001|Overall Study|Withdrawal by Subject|2|||
37939269|NCT00612352|69626474|FG000|Overall Study|Adverse Event|1|||
37939270|NCT00612352|69626475|FG001|Overall Study|Adverse Event|0|||
37939271|NCT00612352|69626474|FG000|Overall Study|Withdrawal by Subject|3|||
37939272|NCT00612352|69626475|FG001|Overall Study|Withdrawal by Subject|5|||
37939273|NCT00612352|69626474|FG000|Overall Study|moved out of state|1|||
37939274|NCT00612352|69626475|FG001|Overall Study|moved out of state|0|||
37939275|NCT00612352|69626474|FG000|Overall Study|didn't return calls/show up on test date|4|||
37939276|NCT00612352|69626475|FG001|Overall Study|didn't return calls/show up on test date|1|||
37939277|NCT00704730|69626483|FG000|Overall Study|Adverse Event|35|||
37939278|NCT00704730|69626484|FG001|Overall Study|Adverse Event|9|||
37939279|NCT00704730|69626483|FG000|Overall Study|Death|11|||
37939280|NCT00704730|69626484|FG001|Overall Study|Death|5|||
37939281|NCT00704730|69626483|FG000|Overall Study|Physician Decision|2|||
37939282|NCT00704730|69626484|FG001|Overall Study|Physician Decision|0|||
37939283|NCT00704730|69626483|FG000|Overall Study|Did not receive drug|5|||
37939284|NCT00704730|69626484|FG001|Overall Study|Did not receive drug|2|||
37939285|NCT00704730|69626483|FG000|Overall Study|Disease progression per PI|58|||
37939286|NCT00704730|69626484|FG001|Overall Study|Disease progression per PI|67|||
37939287|NCT00704730|69626483|FG000|Overall Study|data unavailable|1|||
37939288|NCT00704730|69626484|FG001|Overall Study|data unavailable|0|||
37939289|NCT00704730|69626483|FG000|Overall Study|Withdrawal by Subject|9|||
37939290|NCT00704730|69626484|FG001|Overall Study|Withdrawal by Subject|13|||
37939291|NCT00651261|69626493|FG000|Overall Study|Adverse Event|32|||
37939292|NCT00651261|69626494|FG001|Overall Study|Adverse Event|22|||
37939293|NCT00651261|69626493|FG000|Overall Study|Death|18|||
37939294|NCT00651261|69626494|FG001|Overall Study|Death|18|||
37939295|NCT00651261|69626493|FG000|Overall Study|Withdrawal by Subject|22|||
37939296|NCT00651261|69626494|FG001|Overall Study|Withdrawal by Subject|40|||
37939297|NCT00651261|69626493|FG000|Overall Study|Induction failure|24|||
37939298|NCT00651261|69626494|FG001|Overall Study|Induction failure|35|||
37939299|NCT00651261|69626493|FG000|Overall Study|Disease progression|58|||
37939300|NCT00651261|69626494|FG001|Overall Study|Disease progression|58|||
37939301|NCT00651261|69626493|FG000|Overall Study|Alternative therapy|109|||
37939302|NCT00651261|69626494|FG001|Overall Study|Alternative therapy|107|||
37939303|NCT00651261|69626493|FG000|Overall Study|Other disease or participant decisions|23|||
37939304|NCT00651261|69626494|FG001|Overall Study|Other disease or participant decisions|23|||
37939305|NCT00651261|69626493|FG000|Overall Study|Never treated|5|||
37939306|NCT00651261|69626494|FG001|Overall Study|Never treated|3|||
37939307|NCT00651183|69626502|FG000|Overall Study|Lack of Efficacy|1|||
37939308|NCT00651183|69626503|FG001|Overall Study|Lack of Efficacy|0|||
37939309|NCT00651183|69626502|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
37939310|NCT00651183|69626503|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
37939311|NCT00651183|69626502|FG000|Overall Study|Tolerability insufficient|5|||
37939312|NCT00651183|69626503|FG001|Overall Study|Tolerability insufficient|2|||
37939313|NCT00651183|69626502|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
37939314|NCT00651183|69626503|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
37939315|NCT00651183|69626502|FG000|Overall Study|Withdrawal by Subject|6|||
37939316|NCT00651183|69626503|FG001|Overall Study|Withdrawal by Subject|3|||
37939317|NCT00651183|69626502|FG000|Overall Study|Lost to Follow-up|3|||
37939318|NCT00651183|69626503|FG001|Overall Study|Lost to Follow-up|1|||
37939319|NCT00651183|69626502|FG000|Overall Study|Other reasons|4|||
37939320|NCT00651183|69626503|FG001|Overall Study|Other reasons|2|||
37939321|NCT00651183|69626502|FG000|Overall Study|missing|1|||
37670402|NCT01374425|69143626|FG000|Overall Study|Protocol Violation|2|||
37939322|NCT00651183|69626503|FG001|Overall Study|missing|0|||
37939323|NCT00699972|69626512|FG000|Overall Study|Adverse Event|7|||
37939324|NCT00699972|69626513|FG001|Overall Study|Adverse Event|9|||
37939325|NCT00699972|69626514|FG002|Overall Study|Adverse Event|24|||
37939326|NCT00699972|69626512|FG000|Overall Study|Lost to Follow-up|0|||
37939327|NCT00699972|69626513|FG001|Overall Study|Lost to Follow-up|2|||
37939328|NCT00699972|69626514|FG002|Overall Study|Lost to Follow-up|0|||
37939329|NCT00699972|69626512|FG000|Overall Study|Withdrawal by Subject|3|||
37939330|NCT00699972|69626513|FG001|Overall Study|Withdrawal by Subject|7|||
37939331|NCT00699972|69626514|FG002|Overall Study|Withdrawal by Subject|4|||
37939332|NCT00699972|69626512|FG000|Overall Study|Lack of Efficacy|2|||
37939333|NCT00699972|69626513|FG001|Overall Study|Lack of Efficacy|0|||
37939334|NCT00699972|69626514|FG002|Overall Study|Lack of Efficacy|2|||
37939335|NCT00699972|69626512|FG000|Overall Study|Administrative/Other|3|||
37939336|NCT00699972|69626513|FG001|Overall Study|Administrative/Other|1|||
37939337|NCT00699972|69626514|FG002|Overall Study|Administrative/Other|4|||
37939338|NCT00699972|69626512|FG000|Overall Study|Randomized, Not Treated|1|||
37939339|NCT00699972|69626513|FG001|Overall Study|Randomized, Not Treated|0|||
37939340|NCT00699972|69626514|FG002|Overall Study|Randomized, Not Treated|1|||
37939341|NCT00642759|69626522|FG000|Overall Study|Protocol Violation|1|||
37939342|NCT00611026|69626530|FG000|Randomized to Double-blind Treatment|Not treated|2|||
37939343|NCT00611026|69626531|FG001|Randomized to Double-blind Treatment|Not treated|1|||
37939344|NCT00611026|69626532|FG002|Randomized to Double-blind Treatment|Not treated|3|||
37939345|NCT00611026|69626530|FG000|Double-blind Treatment Period|Death|1|||
37939346|NCT00611026|69626531|FG001|Double-blind Treatment Period|Death|0|||
37939347|NCT00611026|69626532|FG002|Double-blind Treatment Period|Death|0|||
37939348|NCT00611026|69626530|FG000|Double-blind Treatment Period|Adverse Event|9|||
37939349|NCT00611026|69626531|FG001|Double-blind Treatment Period|Adverse Event|28|||
37939350|NCT00611026|69626532|FG002|Double-blind Treatment Period|Adverse Event|46|||
37939351|NCT00611026|69626530|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
37939352|NCT00611026|69626531|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
37939353|NCT00611026|69626532|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
38035203|NCT03230864|69722114|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
38035204|NCT03230864|69722115|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
37939354|NCT00611026|69626530|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
37939355|NCT00611026|69626531|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
37939356|NCT00611026|69626532|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
37939357|NCT00611026|69626530|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
37939358|NCT00611026|69626531|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
37939359|NCT00611026|69626532|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
37939360|NCT00611026|69626530|FG000|Double-blind Treatment Period|Other|13|||
37939361|NCT00611026|69626531|FG001|Double-blind Treatment Period|Other|20|||
37939362|NCT00611026|69626532|FG002|Double-blind Treatment Period|Other|18|||
37939363|NCT00646113|69626542|FG000|Overall Study|Lost to Follow-up|5|||
37939364|NCT00646113|69626542|FG000|Overall Study|Adverse Event|3|||
37939365|NCT00422383|69626551|FG000|Overall Study|Adverse Event|5|||
37939366|NCT00422383|69626552|FG001|Overall Study|Adverse Event|3|||
37939367|NCT00422383|69626553|FG002|Overall Study|Adverse Event|1|||
37939368|NCT00422383|69626554|FG003|Overall Study|Adverse Event|1|||
37939369|NCT00422383|69626555|FG004|Overall Study|Adverse Event|0|||
37939370|NCT00422383|69626551|FG000|Overall Study|Lack of Efficacy|4|||
37939371|NCT00422383|69626552|FG001|Overall Study|Lack of Efficacy|4|||
37939372|NCT00422383|69626553|FG002|Overall Study|Lack of Efficacy|2|||
37939373|NCT00422383|69626554|FG003|Overall Study|Lack of Efficacy|1|||
37939374|NCT00422383|69626555|FG004|Overall Study|Lack of Efficacy|1|||
37939375|NCT00422383|69626551|FG000|Overall Study|Lost to Follow-up|0|||
37939376|NCT00422383|69626552|FG001|Overall Study|Lost to Follow-up|1|||
37939377|NCT00422383|69626553|FG002|Overall Study|Lost to Follow-up|0|||
37939378|NCT00422383|69626554|FG003|Overall Study|Lost to Follow-up|0|||
37939379|NCT00422383|69626555|FG004|Overall Study|Lost to Follow-up|1|||
37939380|NCT00422383|69626551|FG000|Overall Study|Protocol Violation|1|||
37939381|NCT00422383|69626552|FG001|Overall Study|Protocol Violation|1|||
37939382|NCT00422383|69626553|FG002|Overall Study|Protocol Violation|1|||
37939383|NCT00422383|69626554|FG003|Overall Study|Protocol Violation|0|||
37939384|NCT00422383|69626555|FG004|Overall Study|Protocol Violation|0|||
37939385|NCT00422383|69626551|FG000|Overall Study|Withdrawal by Subject|5|||
37939386|NCT00422383|69626552|FG001|Overall Study|Withdrawal by Subject|5|||
37939387|NCT00422383|69626553|FG002|Overall Study|Withdrawal by Subject|0|||
37939388|NCT00422383|69626554|FG003|Overall Study|Withdrawal by Subject|0|||
37939389|NCT00422383|69626555|FG004|Overall Study|Withdrawal by Subject|1|||
37939390|NCT00612040|69626576|FG000|Overall Study|Adverse Event|0|||
37939391|NCT00612040|69626577|FG001|Overall Study|Adverse Event|2|||
37939392|NCT00612040|69626578|FG002|Overall Study|Adverse Event|1|||
37939393|NCT00612040|69626576|FG000|Overall Study|Protocol Violation|1|||
37939394|NCT00612040|69626577|FG001|Overall Study|Protocol Violation|2|||
37939395|NCT00612040|69626578|FG002|Overall Study|Protocol Violation|1|||
37939396|NCT00612040|69626576|FG000|Overall Study|Lack of Efficacy|2|||
37939397|NCT00612040|69626577|FG001|Overall Study|Lack of Efficacy|1|||
37939398|NCT00612040|69626578|FG002|Overall Study|Lack of Efficacy|0|||
37939399|NCT00612040|69626576|FG000|Overall Study|Unclassified|2|||
37939400|NCT00612040|69626577|FG001|Overall Study|Unclassified|2|||
37939401|NCT00612040|69626578|FG002|Overall Study|Unclassified|5|||
37765173|NCT01546142|69278361|FG000|Overall Study|Subject Randomized but Not Treated|1|||
37765174|NCT01546142|69278362|FG001|Overall Study|Subject Randomized but Not Treated|0|||
37939402|NCT00422227|69626588|FG000|Overall Study|Adverse Event|3|||
37939403|NCT00422227|69626589|FG001|Overall Study|Adverse Event|8|||
37939404|NCT00422227|69626588|FG000|Overall Study|Lost to Follow-up|1|||
37939405|NCT00422227|69626589|FG001|Overall Study|Lost to Follow-up|3|||
37939406|NCT00422227|69626588|FG000|Overall Study|Withdrawal by Subject|0|||
37939407|NCT00422227|69626589|FG001|Overall Study|Withdrawal by Subject|4|||
37939408|NCT00421993|69626599|FG000|Overall Study|Withdrawal by Subject|22|||
37939409|NCT00421993|69626600|FG001|Overall Study|Withdrawal by Subject|23|||
37939410|NCT00421993|69626601|FG002|Overall Study|Withdrawal by Subject|23|||
37939411|NCT00421993|69626602|FG003|Overall Study|Withdrawal by Subject|24|||
37939412|NCT00421993|69626599|FG000|Overall Study|Lost to Follow-up|18|||
37939413|NCT00421993|69626600|FG001|Overall Study|Lost to Follow-up|19|||
37939414|NCT00421993|69626601|FG002|Overall Study|Lost to Follow-up|22|||
37939415|NCT00421993|69626602|FG003|Overall Study|Lost to Follow-up|20|||
37939416|NCT00421993|69626599|FG000|Overall Study|Adverse Event|11|||
37939417|NCT00421993|69626600|FG001|Overall Study|Adverse Event|1|||
37939418|NCT00421993|69626601|FG002|Overall Study|Adverse Event|6|||
37939419|NCT00421993|69626602|FG003|Overall Study|Adverse Event|4|||
37939420|NCT00421993|69626599|FG000|Overall Study|Protocol Violation|2|||
37939421|NCT00421993|69626600|FG001|Overall Study|Protocol Violation|2|||
37939422|NCT00421993|69626601|FG002|Overall Study|Protocol Violation|0|||
37939423|NCT00421993|69626602|FG003|Overall Study|Protocol Violation|1|||
37939424|NCT00421993|69626599|FG000|Overall Study|Lack of Efficacy|0|||
37939425|NCT00421993|69626600|FG001|Overall Study|Lack of Efficacy|3|||
37939426|NCT00421993|69626601|FG002|Overall Study|Lack of Efficacy|0|||
37939427|NCT00421993|69626602|FG003|Overall Study|Lack of Efficacy|5|||
37939428|NCT00421993|69626599|FG000|Overall Study|Pregnancy|0|||
37939429|NCT00421993|69626600|FG001|Overall Study|Pregnancy|1|||
37939430|NCT00421993|69626601|FG002|Overall Study|Pregnancy|1|||
37939431|NCT00421993|69626602|FG003|Overall Study|Pregnancy|2|||
37939432|NCT00421993|69626599|FG000|Overall Study|Subject transportation issues|0|||
37939433|NCT00421993|69626600|FG001|Overall Study|Subject transportation issues|0|||
37939434|NCT00421993|69626601|FG002|Overall Study|Subject transportation issues|0|||
37939435|NCT00421993|69626602|FG003|Overall Study|Subject transportation issues|1|||
37939436|NCT00413959|69626612|FG000|Overall Study|Pt had only one cycle.|1|||
37939437|NCT00645567|69626616|FG000|Overall Study|Adverse Event|1|||
37939438|NCT00611884|69626628|FG000|Overall Study|Adverse Event|1|||
37939439|NCT00611884|69626629|FG001|Overall Study|Adverse Event|0|||
37939440|NCT00611884|69626630|FG002|Overall Study|Adverse Event|0|||
37939441|NCT00611884|69626631|FG003|Overall Study|Adverse Event|1|||
37939442|NCT00611884|69626628|FG000|Overall Study|Non-Compliance|1|||
37939443|NCT00611884|69626629|FG001|Overall Study|Non-Compliance|4|||
37939444|NCT00611884|69626630|FG002|Overall Study|Non-Compliance|2|||
37939445|NCT00611884|69626631|FG003|Overall Study|Non-Compliance|2|||
37939446|NCT00611884|69626628|FG000|Overall Study|Lack of Efficacy|0|||
37939447|NCT00611884|69626629|FG001|Overall Study|Lack of Efficacy|1|||
37939448|NCT00611884|69626630|FG002|Overall Study|Lack of Efficacy|0|||
37939449|NCT00611884|69626631|FG003|Overall Study|Lack of Efficacy|0|||
37939450|NCT00611884|69626628|FG000|Overall Study|Unclassified|7|||
37939451|NCT00611884|69626629|FG001|Overall Study|Unclassified|4|||
37939452|NCT00611884|69626630|FG002|Overall Study|Unclassified|2|||
37939453|NCT00611884|69626631|FG003|Overall Study|Unclassified|3|||
37939454|NCT00420745|69626643|FG000|Overall Study|Adverse Event|2|||
37939455|NCT00420745|69626644|FG001|Overall Study|Adverse Event|2|||
37939456|NCT00420745|69626643|FG000|Overall Study|Lost to Follow-up|10|||
37939457|NCT00420745|69626644|FG001|Overall Study|Lost to Follow-up|2|||
37939458|NCT00420745|69626643|FG000|Overall Study|Protocol Violation|1|||
37939459|NCT00420745|69626644|FG001|Overall Study|Protocol Violation|0|||
37939460|NCT00420745|69626643|FG000|Overall Study|Physician Decision|1|||
37939461|NCT00420745|69626644|FG001|Overall Study|Physician Decision|1|||
37939462|NCT00420745|69626643|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
37939463|NCT00420745|69626644|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
37939464|NCT00420745|69626643|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
37939465|NCT00420745|69626644|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
37939466|NCT00611806|69626652|FG000|Overall Study|Withdrawal by Subject|8|||
37939467|NCT00611806|69626653|FG001|Overall Study|Withdrawal by Subject|2|||
37939468|NCT00611806|69626652|FG000|Overall Study|Adverse Event|2|||
37939469|NCT00611806|69626653|FG001|Overall Study|Adverse Event|1|||
37939470|NCT00611806|69626652|FG000|Overall Study|Lost to Follow-up|6|||
37939471|NCT00611806|69626653|FG001|Overall Study|Lost to Follow-up|0|||
37939472|NCT00413413|69626662|FG000|Single-Blind|Adverse Event|0|||
37939473|NCT00413413|69626663|FG001|Single-Blind|Adverse Event|9|||
37939474|NCT00413413|69626664|FG002|Single-Blind|Adverse Event|0|||
37939475|NCT00413413|69626662|FG000|Single-Blind|Lack of Efficacy|0|||
37939476|NCT00413413|69626663|FG001|Single-Blind|Lack of Efficacy|5|||
37939477|NCT00413413|69626664|FG002|Single-Blind|Lack of Efficacy|0|||
37939478|NCT00413413|69626662|FG000|Single-Blind|Subject no longer requires study drug|0|||
37939479|NCT00413413|69626663|FG001|Single-Blind|Subject no longer requires study drug|151|||
37939480|NCT00413413|69626664|FG002|Single-Blind|Subject no longer requires study drug|0|||
37939481|NCT00413413|69626662|FG000|Single-Blind|Protocol Violation|0|||
37939482|NCT00413413|69626663|FG001|Single-Blind|Protocol Violation|16|||
37939483|NCT00413413|69626664|FG002|Single-Blind|Protocol Violation|0|||
37939484|NCT00413413|69626662|FG000|Single-Blind|Withdrawal by Subject|0|||
37939485|NCT00413413|69626663|FG001|Single-Blind|Withdrawal by Subject|27|||
37939486|NCT00413413|69626664|FG002|Single-Blind|Withdrawal by Subject|0|||
37939487|NCT00413413|69626662|FG000|Single-Blind|Lost to Follow-up|0|||
37939488|NCT00413413|69626663|FG001|Single-Blind|Lost to Follow-up|8|||
37939489|NCT00413413|69626664|FG002|Single-Blind|Lost to Follow-up|0|||
37939490|NCT00413413|69626662|FG000|Double-Blind|Adverse Event|6|||
37939491|NCT00413413|69626663|FG001|Double-Blind|Adverse Event|0|||
37939492|NCT00413413|69626664|FG002|Double-Blind|Adverse Event|5|||
37939493|NCT00413413|69626662|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
37939494|NCT00413413|69626663|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
37939495|NCT00413413|69626664|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
37939496|NCT00413413|69626662|FG000|Double-Blind|Protocol deviation|1|||
37939497|NCT00413413|69626663|FG001|Double-Blind|Protocol deviation|2|||
37939498|NCT00413413|69626664|FG002|Double-Blind|Protocol deviation|1|||
37939499|NCT00413413|69626662|FG000|Double-Blind|Subject withdrew consent|4|||
37939500|NCT00413413|69626663|FG001|Double-Blind|Subject withdrew consent|6|||
37939501|NCT00413413|69626664|FG002|Double-Blind|Subject withdrew consent|9|||
37939502|NCT00413413|69626662|FG000|Double-Blind|Lost to Follow-up|3|||
37939503|NCT00413413|69626663|FG001|Double-Blind|Lost to Follow-up|4|||
37939504|NCT00413413|69626664|FG002|Double-Blind|Lost to Follow-up|2|||
37939505|NCT00610714|69626674|FG000|Overall Study|Adverse Event|3|||
37939506|NCT00610714|69626675|FG001|Overall Study|Adverse Event|1|||
37939507|NCT00610714|69626674|FG000|Overall Study|Death|12|||
37939508|NCT00610714|69626675|FG001|Overall Study|Death|18|||
37939509|NCT00610714|69626674|FG000|Overall Study|Withdrawal by Subject|9|||
37939510|NCT00610714|69626675|FG001|Overall Study|Withdrawal by Subject|3|||
37939511|NCT00610714|69626674|FG000|Overall Study|Study completion at 120 PFS events|2|||
37939512|NCT00610714|69626675|FG001|Overall Study|Study completion at 120 PFS events|2|||
37939513|NCT00403585|69626681|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
37939514|NCT00403585|69626681|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
37939515|NCT00403585|69626681|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
37939516|NCT00645411|69626689|FG000|Overall Study|Adverse Event|0|||
37939517|NCT00645411|69626690|FG001|Overall Study|Adverse Event|0|||
37939518|NCT00645411|69626691|FG002|Overall Study|Adverse Event|0|||
37939519|NCT00645411|69626692|FG003|Overall Study|Adverse Event|2|||
37939520|NCT00645411|69626689|FG000|Overall Study|Withdrawal by Subject|2|||
37939521|NCT00645411|69626690|FG001|Overall Study|Withdrawal by Subject|1|||
37939522|NCT00645411|69626691|FG002|Overall Study|Withdrawal by Subject|19|||
37939523|NCT00645411|69626692|FG003|Overall Study|Withdrawal by Subject|21|||
37939524|NCT00645411|69626689|FG000|Overall Study|Lost to Follow-up|10|||
37939525|NCT00645411|69626690|FG001|Overall Study|Lost to Follow-up|5|||
37939526|NCT00645411|69626691|FG002|Overall Study|Lost to Follow-up|124|||
37939527|NCT00645411|69626692|FG003|Overall Study|Lost to Follow-up|75|||
37939528|NCT00645411|69626689|FG000|Overall Study|Protocol Violation|1|||
37939529|NCT00645411|69626690|FG001|Overall Study|Protocol Violation|0|||
37939530|NCT00645411|69626691|FG002|Overall Study|Protocol Violation|1|||
37939531|NCT00645411|69626692|FG003|Overall Study|Protocol Violation|0|||
37939532|NCT00645411|69626689|FG000|Overall Study|Inappropriate enrollment|0|||
37939533|NCT00645411|69626690|FG001|Overall Study|Inappropriate enrollment|0|||
37939534|NCT00645411|69626691|FG002|Overall Study|Inappropriate enrollment|4|||
37939535|NCT00645411|69626692|FG003|Overall Study|Inappropriate enrollment|1|||
37939536|NCT00645411|69626689|FG000|Overall Study|Unable to classify|0|||
37939537|NCT00645411|69626690|FG001|Overall Study|Unable to classify|0|||
37939538|NCT00645411|69626691|FG002|Overall Study|Unable to classify|3|||
37939539|NCT00645411|69626692|FG003|Overall Study|Unable to classify|4|||
37939540|NCT00403273|69626711|FG000|Overall Study|Lost to Follow-up|3|||
37939541|NCT00403273|69626712|FG001|Overall Study|Lost to Follow-up|2|||
37939542|NCT00403273|69626711|FG000|Overall Study|Physician Decision|0|||
37939543|NCT00403273|69626712|FG001|Overall Study|Physician Decision|1|||
37939544|NCT00403273|69626711|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
37939545|NCT00403273|69626712|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
37939546|NCT00402727|69626735|FG000|Overall Study|Adverse Event|10|||
37939547|NCT00402727|69626736|FG001|Overall Study|Adverse Event|6|||
37939548|NCT00402727|69626735|FG000|Overall Study|Death|1|||
37939549|NCT00402727|69626736|FG001|Overall Study|Death|0|||
37939550|NCT00402727|69626735|FG000|Overall Study|Lack of Efficacy|1|||
37939551|NCT00402727|69626736|FG001|Overall Study|Lack of Efficacy|3|||
37939552|NCT00402727|69626735|FG000|Overall Study|Lost to Follow-up|24|||
37939553|NCT00402727|69626736|FG001|Overall Study|Lost to Follow-up|11|||
37939554|NCT00402727|69626735|FG000|Overall Study|Physician Decision|1|||
37939555|NCT00402727|69626736|FG001|Overall Study|Physician Decision|1|||
37939556|NCT00402727|69626735|FG000|Overall Study|Protocol Violation|0|||
37939557|NCT00402727|69626736|FG001|Overall Study|Protocol Violation|4|||
37939558|NCT00402727|69626735|FG000|Overall Study|Withdrawal by Subject|3|||
37939559|NCT00402727|69626736|FG001|Overall Study|Withdrawal by Subject|7|||
37939560|NCT00402727|69626735|FG000|Overall Study|supply problems|2|||
37939561|NCT00402727|69626736|FG001|Overall Study|supply problems|1|||
37939562|NCT00402727|69626735|FG000|Overall Study|non-compliance|0|||
37939563|NCT00402727|69626736|FG001|Overall Study|non-compliance|1|||
37939564|NCT00402649|69626742|FG000|Overall Study|Lost to Follow-up|1|||
37939565|NCT00402649|69626742|FG000|Overall Study|Withdrawal by Subject|1|||
37939566|NCT00402337|69626751|FG000|Overall Study|Adverse Event|0|||
37939567|NCT00402337|69626752|FG001|Overall Study|Adverse Event|2|||
37939568|NCT00402337|69626753|FG002|Overall Study|Adverse Event|2|||
37939569|NCT00402337|69626754|FG003|Overall Study|Adverse Event|3|||
37939570|NCT00402337|69626755|FG004|Overall Study|Adverse Event|2|||
37939571|NCT00402337|69626751|FG000|Overall Study|Noncompliance|0|||
37939572|NCT00402337|69626752|FG001|Overall Study|Noncompliance|0|||
37939573|NCT00402337|69626753|FG002|Overall Study|Noncompliance|0|||
37939574|NCT00402337|69626754|FG003|Overall Study|Noncompliance|0|||
37939575|NCT00402337|69626755|FG004|Overall Study|Noncompliance|2|||
37939576|NCT00402337|69626751|FG000|Overall Study|Withdrawal by Subject|5|||
37939577|NCT00402337|69626752|FG001|Overall Study|Withdrawal by Subject|3|||
37939578|NCT00402337|69626753|FG002|Overall Study|Withdrawal by Subject|1|||
37939579|NCT00402337|69626754|FG003|Overall Study|Withdrawal by Subject|6|||
37939580|NCT00402337|69626755|FG004|Overall Study|Withdrawal by Subject|4|||
37939581|NCT00402337|69626751|FG000|Overall Study|Lost to Follow-up|0|||
37939582|NCT00402337|69626752|FG001|Overall Study|Lost to Follow-up|0|||
37939583|NCT00402337|69626753|FG002|Overall Study|Lost to Follow-up|1|||
37939584|NCT00402337|69626754|FG003|Overall Study|Lost to Follow-up|2|||
37939585|NCT00402337|69626755|FG004|Overall Study|Lost to Follow-up|0|||
37939586|NCT00402337|69626751|FG000|Overall Study|Physician Decision|0|||
37939587|NCT00402337|69626752|FG001|Overall Study|Physician Decision|0|||
37939588|NCT00402337|69626753|FG002|Overall Study|Physician Decision|0|||
37939589|NCT00402337|69626754|FG003|Overall Study|Physician Decision|1|||
37939590|NCT00402337|69626755|FG004|Overall Study|Physician Decision|0|||
37939591|NCT00402337|69626751|FG000|Overall Study|Other Reason|0|||
37939592|NCT00402337|69626752|FG001|Overall Study|Other Reason|1|||
37939593|NCT00402337|69626753|FG002|Overall Study|Other Reason|0|||
37939594|NCT00402337|69626754|FG003|Overall Study|Other Reason|0|||
37939595|NCT00402337|69626755|FG004|Overall Study|Other Reason|0|||
37939596|NCT00650091|69626769|FG000|Amended Study Design|Withdrawal by Subject|12|||
37939597|NCT00650091|69626770|FG001|Amended Study Design|Withdrawal by Subject|11|||
37939598|NCT00650091|69626771|FG002|Amended Study Design|Withdrawal by Subject|0|||
37939599|NCT00650091|69626769|FG000|Amended Study Design|Physician Decision|5|||
37939600|NCT00650091|69626770|FG001|Amended Study Design|Physician Decision|0|||
37939601|NCT00650091|69626771|FG002|Amended Study Design|Physician Decision|0|||
37939602|NCT00650091|69626769|FG000|Amended Study Design|Adverse Event|1|||
37939603|NCT00650091|69626770|FG001|Amended Study Design|Adverse Event|4|||
37939604|NCT00650091|69626771|FG002|Amended Study Design|Adverse Event|0|||
37939605|NCT00650091|69626769|FG000|Amended Study Design|Lung transplantation|4|||
37939606|NCT00650091|69626770|FG001|Amended Study Design|Lung transplantation|2|||
37939607|NCT00650091|69626771|FG002|Amended Study Design|Lung transplantation|0|||
37939608|NCT00650091|69626769|FG000|Amended Study Design|Other|1|||
37939609|NCT00650091|69626770|FG001|Amended Study Design|Other|3|||
37939610|NCT00650091|69626771|FG002|Amended Study Design|Other|0|||
37939611|NCT00642369|69626781|FG000|Overall Study|Adverse Event|2|||
37939612|NCT00642369|69626782|FG001|Overall Study|Adverse Event|3|||
37939613|NCT00642369|69626781|FG000|Overall Study|Withdrawal by Subject|1|||
37939614|NCT00642369|69626782|FG001|Overall Study|Withdrawal by Subject|0|||
37939615|NCT00642369|69626781|FG000|Overall Study|misdiagnosis|0|||
37939616|NCT00642369|69626782|FG001|Overall Study|misdiagnosis|1|||
37939617|NCT00642369|69626781|FG000|Overall Study|Lack of Efficacy|2|||
37939618|NCT00642369|69626782|FG001|Overall Study|Lack of Efficacy|2|||
37939619|NCT00645099|69626807|FG000|Overall Study|Lack of Efficacy|15|||
37939620|NCT00645099|69626808|FG001|Overall Study|Lack of Efficacy|6|||
37939621|NCT00645099|69626807|FG000|Overall Study|Withdrawal by Subject|30|||
37939622|NCT00645099|69626808|FG001|Overall Study|Withdrawal by Subject|22|||
37939623|NCT00645099|69626807|FG000|Overall Study|Lost to Follow-up|6|||
37939624|NCT00645099|69626808|FG001|Overall Study|Lost to Follow-up|4|||
37939625|NCT00645099|69626807|FG000|Overall Study|Adverse Event|11|||
37939626|NCT00645099|69626808|FG001|Overall Study|Adverse Event|5|||
37939627|NCT00645099|69626807|FG000|Overall Study|Other|9|||
37939628|NCT00645099|69626808|FG001|Overall Study|Other|5|||
37939629|NCT00420511|69626816|FG000|Overall Study|Adverse Event|1|||
37939630|NCT00420511|69626817|FG001|Overall Study|Adverse Event|1|||
37939631|NCT00420511|69626816|FG000|Overall Study|Lost to Follow-up|1|||
37939632|NCT00420511|69626817|FG001|Overall Study|Lost to Follow-up|0|||
37939633|NCT00420199|69626827|FG000|Overall Study|Participant no longer met study criteria|1|||
37939634|NCT00420199|69626828|FG001|Overall Study|Participant no longer met study criteria|0|||
37939635|NCT00649389|69626843|FG000|Overall Study|Adverse Event|22|||
37939636|NCT00649389|69626844|FG001|Overall Study|Adverse Event|46|||
37939637|NCT00649389|69626845|FG002|Overall Study|Adverse Event|38|||
37939638|NCT00649389|69626846|FG003|Overall Study|Adverse Event|48|||
37939639|NCT00649389|69626843|FG000|Overall Study|Lost to Follow-up|15|||
37939640|NCT00649389|69626844|FG001|Overall Study|Lost to Follow-up|17|||
37939641|NCT00649389|69626845|FG002|Overall Study|Lost to Follow-up|21|||
37939642|NCT00649389|69626846|FG003|Overall Study|Lost to Follow-up|26|||
37939643|NCT00649389|69626843|FG000|Overall Study|Protocol Violation|11|||
37939644|NCT00649389|69626844|FG001|Overall Study|Protocol Violation|13|||
37939645|NCT00649389|69626845|FG002|Overall Study|Protocol Violation|9|||
37939646|NCT00649389|69626846|FG003|Overall Study|Protocol Violation|8|||
37939647|NCT00649389|69626843|FG000|Overall Study|Withdrawal by Subject|20|||
37939648|NCT00649389|69626844|FG001|Overall Study|Withdrawal by Subject|21|||
37939649|NCT00649389|69626845|FG002|Overall Study|Withdrawal by Subject|19|||
37939650|NCT00649389|69626846|FG003|Overall Study|Withdrawal by Subject|23|||
37939651|NCT00649389|69626843|FG000|Overall Study|Other|3|||
37939652|NCT00649389|69626844|FG001|Overall Study|Other|9|||
37939653|NCT00649389|69626845|FG002|Overall Study|Other|1|||
37939654|NCT00649389|69626846|FG003|Overall Study|Other|6|||
37939655|NCT00402103|69626858|FG000|Overall Study|Adverse Event|60|||
37939656|NCT00402103|69626859|FG001|Overall Study|Adverse Event|7|||
37939657|NCT00402103|69626858|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
37939658|NCT00402103|69626859|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
37939659|NCT00402103|69626858|FG000|Overall Study|Condition no longer requires study drug|2|||
37939660|NCT00402103|69626859|FG001|Overall Study|Condition no longer requires study drug|0|||
37939661|NCT00402103|69626858|FG000|Overall Study|Protocol Deviation|8|||
37939662|NCT00402103|69626859|FG001|Overall Study|Protocol Deviation|0|||
37939663|NCT00402103|69626858|FG000|Overall Study|Patient withdrew consent|12|||
37939664|NCT00402103|69626859|FG001|Overall Study|Patient withdrew consent|1|||
37939665|NCT00402103|69626858|FG000|Overall Study|Lost to Follow-up|6|||
37939666|NCT00402103|69626859|FG001|Overall Study|Lost to Follow-up|3|||
37939667|NCT00402103|69626858|FG000|Overall Study|Administrative problems|2|||
37939668|NCT00402103|69626859|FG001|Overall Study|Administrative problems|0|||
37939669|NCT00641667|69626869|FG000|Overall Study|Withdrawal by Subject|1|||
37939670|NCT00641667|69626869|FG000|Overall Study|Adverse Event|1|||
37939671|NCT00641667|69626869|FG000|Overall Study|Physician Decision|1|||
37939672|NCT00641667|69626869|FG000|Overall Study|Worsening of underlying disease|3|||
37939673|NCT00704184|69626878|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
37939674|NCT00704184|69626879|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
37939675|NCT00704184|69626880|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
37939676|NCT00704184|69626881|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
37939677|NCT00704184|69626882|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
37939678|NCT00704184|69626878|FG000|Open-Label Treatment|Adverse Event|0|||
37939679|NCT00704184|69626879|FG001|Open-Label Treatment|Adverse Event|0|||
37939680|NCT00704184|69626880|FG002|Open-Label Treatment|Adverse Event|2|||
37939681|NCT00704184|69626881|FG003|Open-Label Treatment|Adverse Event|0|||
37939682|NCT00704184|69626882|FG004|Open-Label Treatment|Adverse Event|1|||
37939683|NCT00704184|69626878|FG000|Open-Label Treatment|Lack of Efficacy|0|||
37939684|NCT00704184|69626879|FG001|Open-Label Treatment|Lack of Efficacy|2|||
37939685|NCT00704184|69626880|FG002|Open-Label Treatment|Lack of Efficacy|2|||
37939686|NCT00704184|69626881|FG003|Open-Label Treatment|Lack of Efficacy|2|||
37939687|NCT00704184|69626882|FG004|Open-Label Treatment|Lack of Efficacy|1|||
37939688|NCT00704184|69626878|FG000|Open-Label Treatment|Physician Decision|0|||
37939689|NCT00704184|69626879|FG001|Open-Label Treatment|Physician Decision|0|||
37939690|NCT00704184|69626880|FG002|Open-Label Treatment|Physician Decision|0|||
37939691|NCT00704184|69626881|FG003|Open-Label Treatment|Physician Decision|0|||
37939692|NCT00704184|69626882|FG004|Open-Label Treatment|Physician Decision|1|||
37939693|NCT00704184|69626878|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
37939694|NCT00704184|69626879|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
37939695|NCT00704184|69626880|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
37939696|NCT00704184|69626881|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
37939697|NCT00704184|69626882|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
37939698|NCT00641043|69626896|FG000|Overall Study|Adverse Event|6|||
37939699|NCT00641043|69626897|FG001|Overall Study|Adverse Event|4|||
37939700|NCT00641043|69626896|FG000|Overall Study|Protocol Violation|2|||
37939701|NCT00641043|69626897|FG001|Overall Study|Protocol Violation|3|||
37939702|NCT00641043|69626896|FG000|Overall Study|Lost to Follow-up|3|||
37939703|NCT00641043|69626897|FG001|Overall Study|Lost to Follow-up|2|||
37939704|NCT00641043|69626896|FG000|Overall Study|Withdrawal by Subject|4|||
37939705|NCT00641043|69626897|FG001|Overall Study|Withdrawal by Subject|4|||
37765175|NCT01440101|69278396|FG000|Overall Study|Adverse Event|2|||
37939706|NCT00641043|69626896|FG000|Overall Study|Other incl. lack of efficacy|4|||
37939707|NCT00641043|69626897|FG001|Overall Study|Other incl. lack of efficacy|2|||
37939708|NCT00402025|69626906|FG000|Overall Study|Adverse Event|0|||
37939709|NCT00402025|69626907|FG001|Overall Study|Adverse Event|0|||
37939710|NCT00402025|69626908|FG002|Overall Study|Adverse Event|2|||
37939711|NCT00402025|69626906|FG000|Overall Study|Death|0|||
37939712|NCT00402025|69626907|FG001|Overall Study|Death|1|||
37939713|NCT00402025|69626908|FG002|Overall Study|Death|5|||
37939714|NCT00402025|69626906|FG000|Overall Study|Disease Progression|1|||
37939715|NCT00402025|69626907|FG001|Overall Study|Disease Progression|1|||
37939716|NCT00402025|69626908|FG002|Overall Study|Disease Progression|2|||
37939717|NCT00402025|69626906|FG000|Overall Study|Physician Decision|1|||
37939718|NCT00402025|69626907|FG001|Overall Study|Physician Decision|1|||
37939719|NCT00402025|69626908|FG002|Overall Study|Physician Decision|0|||
37939720|NCT00402025|69626906|FG000|Overall Study|Participant Decision|0|||
37939721|NCT00402025|69626907|FG001|Overall Study|Participant Decision|0|||
37939722|NCT00402025|69626908|FG002|Overall Study|Participant Decision|1|||
37939723|NCT00609622|69626918|FG000|Overall Study|Adverse Event|14|||
37939724|NCT00609622|69626919|FG001|Overall Study|Adverse Event|10|||
37939725|NCT00609622|69626918|FG000|Overall Study|Withdrawal by Subject|4|||
37939726|NCT00609622|69626919|FG001|Overall Study|Withdrawal by Subject|20|||
37939727|NCT00609622|69626918|FG000|Overall Study|Death|1|||
37939728|NCT00609622|69626919|FG001|Overall Study|Death|4|||
37939729|NCT00609622|69626918|FG000|Overall Study|Protocol Violation|1|||
37939730|NCT00609622|69626919|FG001|Overall Study|Protocol Violation|1|||
37939731|NCT00609622|69626918|FG000|Overall Study|Objective progression or relapse|47|||
37939732|NCT00609622|69626919|FG001|Overall Study|Objective progression or relapse|41|||
37939733|NCT00609622|69626918|FG000|Overall Study|Study terminated by sponsor|16|||
37939734|NCT00609622|69626919|FG001|Overall Study|Study terminated by sponsor|3|||
37939735|NCT00609622|69626918|FG000|Overall Study|Other|7|||
37939736|NCT00609622|69626919|FG001|Overall Study|Other|14|||
37939737|NCT00609622|69626918|FG000|Overall Study|Global deterioration of health status|6|||
37939738|NCT00609622|69626919|FG001|Overall Study|Global deterioration of health status|2|||
37939739|NCT00699660|69626927|FG000|Overall Study|Lost to Follow-up|4|||
37939740|NCT00699660|69626928|FG001|Overall Study|Lost to Follow-up|2|||
37939741|NCT00699660|69626927|FG000|Overall Study|missing reports and recording failures|10|||
37939742|NCT00699660|69626928|FG001|Overall Study|missing reports and recording failures|6|||
37939743|NCT00627705|69626936|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
37939744|NCT00627705|69626937|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
37670403|NCT01374425|69143627|FG001|Overall Study|Protocol Violation|3|||
37670404|NCT01374425|69143626|FG000|Overall Study|Sponsor Decision|0|||
37939745|NCT00627705|69626936|FG000|Overall Study|Adverse Event|1|||
37939746|NCT00627705|69626937|FG001|Overall Study|Adverse Event|0|||
37939747|NCT00627705|69626936|FG000|Overall Study|Withdrawal by Subject|0|||
37939748|NCT00627705|69626937|FG001|Overall Study|Withdrawal by Subject|2|||
37939749|NCT00627705|69626936|FG000|Overall Study|Lost to Follow-up|0|||
37939750|NCT00627705|69626937|FG001|Overall Study|Lost to Follow-up|1|||
37939751|NCT00610168|69626945|FG000|Overall Study|Withdrawal by Subject|2|||
37939752|NCT00610168|69626946|FG001|Overall Study|Withdrawal by Subject|0|||
37939753|NCT00644787|69626952|FG000|Period 1: Titration Phase|Adverse Event|11|||
37939754|NCT00644787|69626953|FG001|Period 1: Titration Phase|Adverse Event|0|||
37939755|NCT00644787|69626954|FG002|Period 1: Titration Phase|Adverse Event|0|||
37939756|NCT00644787|69626952|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
37939757|NCT00644787|69626953|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
37939758|NCT00644787|69626954|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
37939759|NCT00644787|69626952|FG000|Period 1: Titration Phase|Physician Decision|1|||
37939760|NCT00644787|69626953|FG001|Period 1: Titration Phase|Physician Decision|0|||
37939761|NCT00644787|69626954|FG002|Period 1: Titration Phase|Physician Decision|0|||
37939762|NCT00644787|69626952|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
37939763|NCT00644787|69626953|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
37939764|NCT00644787|69626954|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
37939765|NCT00644787|69626952|FG000|Period 1: Titration Phase|Worsening of complications|1|||
37939766|NCT00644787|69626953|FG001|Period 1: Titration Phase|Worsening of complications|0|||
37939767|NCT00644787|69626954|FG002|Period 1: Titration Phase|Worsening of complications|0|||
37939768|NCT00644787|69626952|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
37939769|NCT00644787|69626953|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
37939770|NCT00644787|69626954|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
37939771|NCT00644787|69626952|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
37939772|NCT00644787|69626953|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
37939773|NCT00644787|69626954|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
37939774|NCT00644787|69626952|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
37939775|NCT00644787|69626953|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
37939776|NCT00644787|69626954|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
37939777|NCT00644787|69626952|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
37939778|NCT00644787|69626953|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
37939779|NCT00644787|69626954|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
37939780|NCT00644787|69626952|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
37939781|NCT00644787|69626953|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
37939782|NCT00644787|69626954|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
37939783|NCT00644787|69626952|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
37939784|NCT00644787|69626953|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
37939785|NCT00644787|69626954|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
37939786|NCT00644787|69626952|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
37939787|NCT00644787|69626953|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
37939788|NCT00644787|69626954|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
37939789|NCT00699582|69626965|FG000|Overall Study|Adverse Event|4|||
37939790|NCT00699582|69626966|FG001|Overall Study|Adverse Event|11|||
37939791|NCT00699582|69626967|FG002|Overall Study|Adverse Event|23|||
37939792|NCT00699582|69626965|FG000|Overall Study|Withdrawal by Subject|6|||
37939793|NCT00699582|69626966|FG001|Overall Study|Withdrawal by Subject|7|||
38035205|NCT03230864|69722116|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
38035206|NCT03230864|69722113|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
37939794|NCT00699582|69626967|FG002|Overall Study|Withdrawal by Subject|4|||
38035207|NCT03230864|69722114|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
37939795|NCT00699582|69626965|FG000|Overall Study|Lack of Efficacy|1|||
37939796|NCT00699582|69626966|FG001|Overall Study|Lack of Efficacy|0|||
37939797|NCT00699582|69626967|FG002|Overall Study|Lack of Efficacy|1|||
37939798|NCT00699582|69626965|FG000|Overall Study|Progressive Disease|1|||
37939799|NCT00699582|69626966|FG001|Overall Study|Progressive Disease|0|||
37939800|NCT00699582|69626967|FG002|Overall Study|Progressive Disease|0|||
37939801|NCT00699582|69626965|FG000|Overall Study|Administrative/Other|4|||
37939802|NCT00699582|69626966|FG001|Overall Study|Administrative/Other|3|||
37939803|NCT00699582|69626967|FG002|Overall Study|Administrative/Other|0|||
37939804|NCT00699582|69626965|FG000|Overall Study|Randomized, Not Treated|2|||
37939805|NCT00699582|69626966|FG001|Overall Study|Randomized, Not Treated|1|||
37939806|NCT00699582|69626967|FG002|Overall Study|Randomized, Not Treated|0|||
37939807|NCT00640341|69626978|FG000|Overall Study|Adverse Event|0|||
37939808|NCT00640341|69626979|FG001|Overall Study|Adverse Event|0|||
37939809|NCT00640341|69626980|FG002|Overall Study|Adverse Event|1|||
37939810|NCT00640341|69626978|FG000|Overall Study|Positive Slit Lamp Findings|0|||
37939811|NCT00640341|69626979|FG001|Overall Study|Positive Slit Lamp Findings|0|||
37939812|NCT00640341|69626980|FG002|Overall Study|Positive Slit Lamp Findings|1|||
37939813|NCT00640341|69626978|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
37939814|NCT00640341|69626979|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
37939815|NCT00640341|69626980|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
37939816|NCT00640341|69626978|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
37939817|NCT00640341|69626979|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
37939818|NCT00640341|69626980|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
37939819|NCT00640341|69626978|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
37939820|NCT00640341|69626979|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
37939821|NCT00640341|69626980|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
37939822|NCT00640341|69626978|FG000|Overall Study|Lost to Follow-up|2|||
37939823|NCT00640341|69626979|FG001|Overall Study|Lost to Follow-up|0|||
37939824|NCT00640341|69626980|FG002|Overall Study|Lost to Follow-up|0|||
37939825|NCT00640341|69626978|FG000|Overall Study|Withdrawal by Subject|4|||
37939826|NCT00640341|69626979|FG001|Overall Study|Withdrawal by Subject|0|||
37939827|NCT00640341|69626980|FG002|Overall Study|Withdrawal by Subject|1|||
37939828|NCT00640341|69626978|FG000|Overall Study|Unacceptable Lens Movement|1|||
37939829|NCT00640341|69626979|FG001|Overall Study|Unacceptable Lens Movement|0|||
37939830|NCT00640341|69626980|FG002|Overall Study|Unacceptable Lens Movement|0|||
37939831|NCT00640341|69626978|FG000|Overall Study|Poor fit/Uncomfortable|4|||
37939832|NCT00640341|69626979|FG001|Overall Study|Poor fit/Uncomfortable|0|||
37939833|NCT00640341|69626980|FG002|Overall Study|Poor fit/Uncomfortable|0|||
37939834|NCT00640341|69626978|FG000|Overall Study|Ineligable at Baseline|5|||
37939835|NCT00640341|69626979|FG001|Overall Study|Ineligable at Baseline|3|||
37939836|NCT00640341|69626980|FG002|Overall Study|Ineligable at Baseline|2|||
37939837|NCT00640341|69626978|FG000|Overall Study|Adverse event and positive slit lamp|1|||
37939838|NCT00640341|69626979|FG001|Overall Study|Adverse event and positive slit lamp|0|||
37939839|NCT00640341|69626980|FG002|Overall Study|Adverse event and positive slit lamp|0|||
37939840|NCT00699348|69626988|FG000|Overall Study|Death|6|||
37939841|NCT00699348|69626988|FG000|Overall Study|Adverse Event|15|||
37939842|NCT00699348|69626988|FG000|Overall Study|Withdrawal by Subject|11|||
37939843|NCT00699348|69626988|FG000|Overall Study|Protocol Violation|10|||
37939844|NCT00699348|69626988|FG000|Overall Study|Lack of Efficacy|8|||
37939845|NCT00699348|69626988|FG000|Overall Study|Failure to return|1|||
37939846|NCT00699348|69626988|FG000|Overall Study|Blood transfusion|24|||
37939847|NCT00699348|69626988|FG000|Overall Study|Renal transplantation|10|||
37939848|NCT00699348|69626988|FG000|Overall Study|Other|5|||
37939849|NCT00643851|69626995|FG000|Overall Study|Death|0|||
37939850|NCT00643851|69626996|FG001|Overall Study|Death|1|||
37939851|NCT00643851|69626997|FG002|Overall Study|Death|0|||
37939852|NCT00643851|69626995|FG000|Overall Study|Lack of Efficacy|0|||
37939853|NCT00643851|69626996|FG001|Overall Study|Lack of Efficacy|1|||
37939854|NCT00643851|69626997|FG002|Overall Study|Lack of Efficacy|0|||
37939855|NCT00643851|69626995|FG000|Overall Study|Adverse Event|2|||
37939856|NCT00643851|69626996|FG001|Overall Study|Adverse Event|6|||
37939857|NCT00643851|69626997|FG002|Overall Study|Adverse Event|6|||
37939858|NCT00643851|69626995|FG000|Overall Study|Lost to Follow-up|4|||
37939859|NCT00643851|69626996|FG001|Overall Study|Lost to Follow-up|6|||
37670405|NCT01374425|69143627|FG001|Overall Study|Sponsor Decision|1|||
37939860|NCT00643851|69626997|FG002|Overall Study|Lost to Follow-up|9|||
37939861|NCT00643851|69626995|FG000|Overall Study|Withdrawal by Subject|8|||
37939862|NCT00643851|69626996|FG001|Overall Study|Withdrawal by Subject|15|||
37939863|NCT00643851|69626997|FG002|Overall Study|Withdrawal by Subject|9|||
37939864|NCT00643851|69626995|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
37939865|NCT00643851|69626996|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
37939866|NCT00643851|69626997|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
37939867|NCT03667690|69627007|FG000|Overall Study|Adverse Event|0|||
37939868|NCT03667690|69627008|FG001|Overall Study|Adverse Event|3|||
37670406|NCT01374425|69143626|FG000|Overall Study|Lost to Follow-up|2|||
37939869|NCT03667690|69627007|FG000|Overall Study|Death|22|||
37939870|NCT03667690|69627008|FG001|Overall Study|Death|21|||
37939871|NCT03667690|69627007|FG000|Overall Study|Lost to Follow-up|4|||
37939872|NCT03667690|69627008|FG001|Overall Study|Lost to Follow-up|5|||
37939873|NCT03667690|69627007|FG000|Overall Study|Withdrawal by Subject|7|||
37939874|NCT03667690|69627008|FG001|Overall Study|Withdrawal by Subject|8|||
37939875|NCT03667690|69627007|FG000|Overall Study|Subject could not return for additional investigational product|1|||
37939876|NCT03667690|69627008|FG001|Overall Study|Subject could not return for additional investigational product|0|||
37939877|NCT03667690|69627007|FG000|Overall Study|Subject discharged to hospice care|2|||
37939878|NCT03667690|69627008|FG001|Overall Study|Subject discharged to hospice care|0|||
37939879|NCT03667690|69627007|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
37939880|NCT03667690|69627008|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
37939881|NCT03667690|69627007|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
37939882|NCT03667690|69627008|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
37939883|NCT03667690|69627007|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
37939884|NCT03667690|69627008|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
37939885|NCT03667690|69627007|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
37939886|NCT03667690|69627008|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
37939887|NCT03667690|69627007|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
37939888|NCT03667690|69627008|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
37939889|NCT00627393|69627016|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
37939890|NCT00627393|69627017|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
37939891|NCT00627393|69627016|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
37939892|NCT00627393|69627017|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
37939893|NCT00627393|69627016|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
37939894|NCT00627393|69627017|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
37939895|NCT00627393|69627016|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
37939896|NCT00627393|69627017|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
37939897|NCT00696774|69627028|FG000|Period II|Adverse Event|0|||
37939898|NCT00696774|69627029|FG001|Period II|Adverse Event|0|||
37939899|NCT00696774|69627030|FG002|Period II|Adverse Event|15|||
37939900|NCT00696774|69627028|FG000|Period II|Lost to Follow-up|0|||
37939901|NCT00696774|69627029|FG001|Period II|Lost to Follow-up|0|||
37939902|NCT00696774|69627030|FG002|Period II|Lost to Follow-up|4|||
37939903|NCT00696774|69627028|FG000|Period II|Protocol Violation|0|||
37939904|NCT00696774|69627029|FG001|Period II|Protocol Violation|0|||
37939905|NCT00696774|69627030|FG002|Period II|Protocol Violation|11|||
37939906|NCT00696774|69627028|FG000|Period II|Withdrawal by Subject|0|||
37939907|NCT00696774|69627029|FG001|Period II|Withdrawal by Subject|0|||
37939908|NCT00696774|69627030|FG002|Period II|Withdrawal by Subject|4|||
37939909|NCT00696774|69627028|FG000|Period II|Sponsor Decision|0|||
37939910|NCT00696774|69627029|FG001|Period II|Sponsor Decision|0|||
37939911|NCT00696774|69627030|FG002|Period II|Sponsor Decision|0|||
37939912|NCT00696774|69627028|FG000|Period II|Lack of Efficacy|0|||
37939913|NCT00696774|69627029|FG001|Period II|Lack of Efficacy|0|||
37939914|NCT00696774|69627030|FG002|Period II|Lack of Efficacy|2|||
37939915|NCT00696774|69627028|FG000|Period III|Adverse Event|1|||
37939916|NCT00696774|69627029|FG001|Period III|Adverse Event|1|||
37939917|NCT00696774|69627030|FG002|Period III|Adverse Event|0|||
37939918|NCT00696774|69627028|FG000|Period III|Lost to Follow-up|2|||
37939919|NCT00696774|69627029|FG001|Period III|Lost to Follow-up|1|||
37939920|NCT00696774|69627030|FG002|Period III|Lost to Follow-up|0|||
37939921|NCT00696774|69627028|FG000|Period III|Protocol Violation|1|||
37939922|NCT00696774|69627029|FG001|Period III|Protocol Violation|1|||
37939923|NCT00696774|69627030|FG002|Period III|Protocol Violation|0|||
37939924|NCT00696774|69627028|FG000|Period III|Withdrawal by Subject|1|||
37939925|NCT00696774|69627029|FG001|Period III|Withdrawal by Subject|2|||
37939926|NCT00696774|69627030|FG002|Period III|Withdrawal by Subject|0|||
37939927|NCT00696774|69627028|FG000|Period III|Sponsor Decision|2|||
37939928|NCT00696774|69627029|FG001|Period III|Sponsor Decision|0|||
38035208|NCT03230864|69722115|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
38035209|NCT03230864|69722116|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
38035210|NCT03230864|69722113|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
38035211|NCT03230864|69722114|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
37939929|NCT00696774|69627030|FG002|Period III|Sponsor Decision|0|||
37939930|NCT00696774|69627028|FG000|Period III|Lack of Efficacy|0|||
37939931|NCT00696774|69627029|FG001|Period III|Lack of Efficacy|2|||
37939932|NCT00696774|69627030|FG002|Period III|Lack of Efficacy|0|||
37939933|NCT00608842|69627042|FG000|Overall Study|Participant's Request|0|||
37939934|NCT00608842|69627043|FG001|Overall Study|Participant's Request|1|||
37939935|NCT00608842|69627044|FG002|Overall Study|Participant's Request|2|||
37939936|NCT00608842|69627045|FG003|Overall Study|Participant's Request|1|||
37939937|NCT00608842|69627042|FG000|Overall Study|Lost to Follow-up|1|||
37939938|NCT00608842|69627043|FG001|Overall Study|Lost to Follow-up|0|||
37939939|NCT00608842|69627044|FG002|Overall Study|Lost to Follow-up|0|||
37939940|NCT00608842|69627045|FG003|Overall Study|Lost to Follow-up|0|||
37939941|NCT00626925|69627057|FG000|Overall Study|Lost to Follow-up|1|||
37939942|NCT00626925|69627058|FG001|Overall Study|Lost to Follow-up|2|||
37939943|NCT00626925|69627057|FG000|Overall Study|relapse|1|||
37939944|NCT00626925|69627058|FG001|Overall Study|relapse|0|||
37939945|NCT00626925|69627057|FG000|Overall Study|Adverse effect|6|||
37939946|NCT00626925|69627058|FG001|Overall Study|Adverse effect|2|||
37939947|NCT00626925|69627057|FG000|Overall Study|Lack of Efficacy|1|||
37939948|NCT00626925|69627058|FG001|Overall Study|Lack of Efficacy|4|||
37939949|NCT00626925|69627057|FG000|Overall Study|Time constraints|3|||
37939950|NCT00626925|69627058|FG001|Overall Study|Time constraints|1|||
37939951|NCT00698646|69627081|FG000|Overall Study|Adverse Event|8|||
37939952|NCT00698646|69627082|FG001|Overall Study|Adverse Event|7|||
37939953|NCT00698646|69627083|FG002|Overall Study|Adverse Event|8|||
37939954|NCT00698646|69627081|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
37939955|NCT00698646|69627082|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
37939956|NCT00698646|69627083|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
37939957|NCT00698646|69627081|FG000|Overall Study|Protocol Deviation|6|||
37939958|NCT00698646|69627082|FG001|Overall Study|Protocol Deviation|2|||
37939959|NCT00698646|69627083|FG002|Overall Study|Protocol Deviation|3|||
37939960|NCT00698646|69627081|FG000|Overall Study|Withdrawal by Subject|10|||
37939961|NCT00698646|69627082|FG001|Overall Study|Withdrawal by Subject|11|||
37939962|NCT00698646|69627083|FG002|Overall Study|Withdrawal by Subject|8|||
37939963|NCT00698646|69627081|FG000|Overall Study|Lost to Follow-up|0|||
37939964|NCT00698646|69627082|FG001|Overall Study|Lost to Follow-up|0|||
37939965|NCT00698646|69627083|FG002|Overall Study|Lost to Follow-up|2|||
37939966|NCT00698646|69627081|FG000|Overall Study|Administrative problems|1|||
37939967|NCT00698646|69627082|FG001|Overall Study|Administrative problems|0|||
37939968|NCT00698646|69627083|FG002|Overall Study|Administrative problems|1|||
37939969|NCT00609466|69627094|FG000|Overall Study|Withdrawal by Subject|0|||
37939970|NCT00609466|69627095|FG001|Overall Study|Withdrawal by Subject|1|||
37939971|NCT00609466|69627096|FG002|Overall Study|Withdrawal by Subject|1|||
37939972|NCT00609466|69627094|FG000|Overall Study|Adverse Event|2|||
37939973|NCT00609466|69627095|FG001|Overall Study|Adverse Event|3|||
37939974|NCT00609466|69627096|FG002|Overall Study|Adverse Event|1|||
37939975|NCT00609466|69627094|FG000|Overall Study|Lack of Efficacy|0|||
37939976|NCT00609466|69627095|FG001|Overall Study|Lack of Efficacy|2|||
37939977|NCT00609466|69627096|FG002|Overall Study|Lack of Efficacy|2|||
37939978|NCT00608530|69627108|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
37939979|NCT00608530|69627109|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
37939980|NCT00608530|69627110|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
37939981|NCT00608530|69627111|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
37939982|NCT00608530|69627108|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
37939983|NCT00608530|69627109|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
37939984|NCT00608530|69627110|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
37939985|NCT00608530|69627111|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
37939986|NCT00608530|69627108|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
37939987|NCT00608530|69627109|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
37939988|NCT00608530|69627110|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
37939989|NCT00608530|69627111|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
37939990|NCT00608530|69627108|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
37939991|NCT00608530|69627109|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
37939992|NCT00608530|69627110|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
37939993|NCT00608530|69627111|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
37939994|NCT00608530|69627108|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
37939995|NCT00608530|69627109|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
37939996|NCT00608530|69627110|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
37939997|NCT00608530|69627111|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
37939998|NCT00608530|69627108|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
37939999|NCT00608530|69627109|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
37940000|NCT00608530|69627110|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
38035212|NCT03230864|69722115|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
38035213|NCT03230864|69722116|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
38035214|NCT03230864|69722113|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
37940001|NCT00608530|69627111|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
38035215|NCT03230864|69722114|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
37940002|NCT00642993|69627128|FG000|Overall Study|Adverse Event|85|||
37940003|NCT00642993|69627129|FG001|Overall Study|Adverse Event|4|||
38035216|NCT03230864|69722115|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
37940004|NCT00642993|69627128|FG000|Overall Study|Lost to Follow-up|8|||
37940005|NCT00642993|69627129|FG001|Overall Study|Lost to Follow-up|4|||
37940006|NCT00642993|69627128|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
37940007|NCT00642993|69627129|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
37940008|NCT00642993|69627128|FG000|Overall Study|Protocol Violation|1|||
37940009|NCT00642993|69627129|FG001|Overall Study|Protocol Violation|4|||
37940010|NCT00642993|69627128|FG000|Overall Study|Did not meet protocol eligibility|0|||
37940011|NCT00642993|69627129|FG001|Overall Study|Did not meet protocol eligibility|1|||
37940012|NCT00642993|69627128|FG000|Overall Study|Administrative|1|||
37940013|NCT00642993|69627129|FG001|Overall Study|Administrative|0|||
37940014|NCT00696696|69627135|FG000|Overall Study|Adverse Event|5|||
37940015|NCT00696696|69627135|FG000|Overall Study|Withdrawal by Subject|8|||
37940016|NCT00696696|69627135|FG000|Overall Study|Physician Decision|2|||
37940017|NCT00696696|69627135|FG000|Overall Study|Death|3|||
37940018|NCT00699192|69627142|FG000|Overall Study|Missing|1|||
37940019|NCT00699192|69627143|FG001|Overall Study|Missing|1|||
37940020|NCT00699192|69627144|FG002|Overall Study|Missing|1|||
37940021|NCT00699192|69627142|FG000|Overall Study|Adverse Event|9|||
37940022|NCT00699192|69627143|FG001|Overall Study|Adverse Event|4|||
37940023|NCT00699192|69627144|FG002|Overall Study|Adverse Event|3|||
37940024|NCT00699192|69627142|FG000|Overall Study|Abnormal test procedure result(s)|0|||
37940025|NCT00699192|69627143|FG001|Overall Study|Abnormal test procedure result(s)|0|||
37940026|NCT00699192|69627144|FG002|Overall Study|Abnormal test procedure result(s)|1|||
37940027|NCT00699192|69627142|FG000|Overall Study|Lack of Efficacy|0|||
37940028|NCT00699192|69627143|FG001|Overall Study|Lack of Efficacy|0|||
37940029|NCT00699192|69627144|FG002|Overall Study|Lack of Efficacy|1|||
37940030|NCT00699192|69627142|FG000|Overall Study|Withdrawal by Subject|3|||
37940031|NCT00699192|69627143|FG001|Overall Study|Withdrawal by Subject|2|||
37940032|NCT00699192|69627144|FG002|Overall Study|Withdrawal by Subject|4|||
37940033|NCT00699192|69627142|FG000|Overall Study|Administrative problems|1|||
37940034|NCT00699192|69627143|FG001|Overall Study|Administrative problems|3|||
37940035|NCT00699192|69627144|FG002|Overall Study|Administrative problems|1|||
37940036|NCT00699192|69627142|FG000|Overall Study|Protocol Violation|2|||
37940037|NCT00699192|69627143|FG001|Overall Study|Protocol Violation|2|||
37940038|NCT00699192|69627144|FG002|Overall Study|Protocol Violation|0|||
37940039|NCT00401245|69627160|FG000|Double Blind Titration Phase|Adverse Event|3|||
37940040|NCT00401245|69627161|FG001|Double Blind Titration Phase|Adverse Event|2|||
37940041|NCT00401245|69627162|FG002|Double Blind Titration Phase|Adverse Event|5|||
37940042|NCT00401245|69627163|FG003|Double Blind Titration Phase|Adverse Event|12|||
37940043|NCT00401245|69627164|FG004|Double Blind Titration Phase|Adverse Event|0|||
37940044|NCT00401245|69627165|FG005|Double Blind Titration Phase|Adverse Event|0|||
37940045|NCT00401245|69627166|FG006|Double Blind Titration Phase|Adverse Event|0|||
37940046|NCT00401245|69627167|FG007|Double Blind Titration Phase|Adverse Event|0|||
37940047|NCT00401245|69627160|FG000|Double Blind Titration Phase|Other|0|||
37940048|NCT00401245|69627161|FG001|Double Blind Titration Phase|Other|0|||
37940049|NCT00401245|69627162|FG002|Double Blind Titration Phase|Other|1|||
37940050|NCT00401245|69627163|FG003|Double Blind Titration Phase|Other|0|||
37940051|NCT00401245|69627164|FG004|Double Blind Titration Phase|Other|0|||
37940052|NCT00401245|69627165|FG005|Double Blind Titration Phase|Other|0|||
37940053|NCT00401245|69627166|FG006|Double Blind Titration Phase|Other|0|||
37940054|NCT00401245|69627167|FG007|Double Blind Titration Phase|Other|0|||
37940055|NCT00401245|69627160|FG000|Double Blind Titration Phase|Protocol Violation|0|||
37940056|NCT00401245|69627161|FG001|Double Blind Titration Phase|Protocol Violation|0|||
37940057|NCT00401245|69627162|FG002|Double Blind Titration Phase|Protocol Violation|0|||
37940058|NCT00401245|69627163|FG003|Double Blind Titration Phase|Protocol Violation|1|||
37940059|NCT00401245|69627164|FG004|Double Blind Titration Phase|Protocol Violation|0|||
37940060|NCT00401245|69627165|FG005|Double Blind Titration Phase|Protocol Violation|0|||
37940061|NCT00401245|69627166|FG006|Double Blind Titration Phase|Protocol Violation|0|||
37940062|NCT00401245|69627167|FG007|Double Blind Titration Phase|Protocol Violation|0|||
37940063|NCT00401245|69627160|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
37940064|NCT00401245|69627161|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
37940065|NCT00401245|69627162|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
37940066|NCT00401245|69627163|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
37940067|NCT00401245|69627164|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
37940068|NCT00401245|69627165|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
37940069|NCT00401245|69627166|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
37940070|NCT00401245|69627167|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
37940071|NCT00401245|69627160|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
37940072|NCT00401245|69627161|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
37940073|NCT00401245|69627162|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
37940074|NCT00401245|69627163|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
37940075|NCT00401245|69627164|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
37940076|NCT00401245|69627165|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
37940077|NCT00401245|69627166|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
37940078|NCT00401245|69627167|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
37940079|NCT00401245|69627160|FG000|Open Label Phase|Adverse Event|5|||
37940080|NCT00401245|69627161|FG001|Open Label Phase|Adverse Event|14|||
37940081|NCT00401245|69627162|FG002|Open Label Phase|Adverse Event|6|||
37940082|NCT00401245|69627163|FG003|Open Label Phase|Adverse Event|7|||
37940083|NCT00401245|69627164|FG004|Open Label Phase|Adverse Event|0|||
37940084|NCT00401245|69627165|FG005|Open Label Phase|Adverse Event|0|||
37940085|NCT00401245|69627166|FG006|Open Label Phase|Adverse Event|0|||
37940086|NCT00401245|69627167|FG007|Open Label Phase|Adverse Event|0|||
37940087|NCT00401245|69627160|FG000|Open Label Phase|Lost to Follow-up|5|||
37940088|NCT00401245|69627161|FG001|Open Label Phase|Lost to Follow-up|7|||
37940089|NCT00401245|69627162|FG002|Open Label Phase|Lost to Follow-up|5|||
37940090|NCT00401245|69627163|FG003|Open Label Phase|Lost to Follow-up|4|||
37940091|NCT00401245|69627164|FG004|Open Label Phase|Lost to Follow-up|0|||
37940092|NCT00401245|69627165|FG005|Open Label Phase|Lost to Follow-up|0|||
37940093|NCT00401245|69627166|FG006|Open Label Phase|Lost to Follow-up|0|||
37940094|NCT00401245|69627167|FG007|Open Label Phase|Lost to Follow-up|0|||
37940095|NCT00401245|69627160|FG000|Open Label Phase|Other|4|||
37940096|NCT00401245|69627161|FG001|Open Label Phase|Other|8|||
37940097|NCT00401245|69627162|FG002|Open Label Phase|Other|7|||
37940098|NCT00401245|69627163|FG003|Open Label Phase|Other|8|||
37940099|NCT00401245|69627164|FG004|Open Label Phase|Other|0|||
37940100|NCT00401245|69627165|FG005|Open Label Phase|Other|0|||
37940101|NCT00401245|69627166|FG006|Open Label Phase|Other|0|||
37940102|NCT00401245|69627167|FG007|Open Label Phase|Other|0|||
37940103|NCT00401245|69627160|FG000|Open Label Phase|Protocol Violation|0|||
37940104|NCT00401245|69627161|FG001|Open Label Phase|Protocol Violation|1|||
37940105|NCT00401245|69627162|FG002|Open Label Phase|Protocol Violation|0|||
37940106|NCT00401245|69627163|FG003|Open Label Phase|Protocol Violation|1|||
37940107|NCT00401245|69627164|FG004|Open Label Phase|Protocol Violation|0|||
37940108|NCT00401245|69627165|FG005|Open Label Phase|Protocol Violation|0|||
37940109|NCT00401245|69627166|FG006|Open Label Phase|Protocol Violation|0|||
37940110|NCT00401245|69627167|FG007|Open Label Phase|Protocol Violation|0|||
37940111|NCT00401245|69627160|FG000|Open Label Phase|Withdrawal by Subject|3|||
37940112|NCT00401245|69627161|FG001|Open Label Phase|Withdrawal by Subject|3|||
37940113|NCT00401245|69627162|FG002|Open Label Phase|Withdrawal by Subject|2|||
37940114|NCT00401245|69627163|FG003|Open Label Phase|Withdrawal by Subject|1|||
37940115|NCT00401245|69627164|FG004|Open Label Phase|Withdrawal by Subject|0|||
37940116|NCT00401245|69627165|FG005|Open Label Phase|Withdrawal by Subject|0|||
38035217|NCT03230864|69722116|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
38035218|NCT04085367|69722128|FG000|Overall Study|Adverse Event|1|||
38035219|NCT04085367|69722129|FG001|Overall Study|Adverse Event|1|||
38035220|NCT04085367|69722128|FG000|Overall Study|Withdrawal by Subject|13|||
38035221|NCT04085367|69722129|FG001|Overall Study|Withdrawal by Subject|4|||
38035222|NCT04085367|69722128|FG000|Overall Study|Lost to Follow-up|3|||
38035223|NCT04085367|69722129|FG001|Overall Study|Lost to Follow-up|1|||
38035224|NCT04085367|69722128|FG000|Overall Study|Other unspecified|2|||
38035225|NCT04085367|69722129|FG001|Overall Study|Other unspecified|1|||
38035226|NCT04085367|69722128|FG000|Overall Study|Status Unknown|1|||
38035227|NCT04085367|69722129|FG001|Overall Study|Status Unknown|1|||
38035228|NCT03228836|69722135|FG000|Overall Study|Adverse Event|3|||
38035229|NCT03228836|69722135|FG000|Overall Study|Withdrawal by Subject|1|||
38035230|NCT03228836|69722135|FG000|Overall Study|Death|1|||
38035231|NCT03228836|69722135|FG000|Overall Study|Physician Decision|1|||
38035232|NCT03228836|69722135|FG000|Overall Study|Disease Progression|7|||
38035233|NCT03228836|69722135|FG000|Overall Study|Other|4|||
38035234|NCT02937350|69722142|FG000|Overall Study|Withdrawal by Subject|0|||
38035235|NCT02937350|69722143|FG001|Overall Study|Withdrawal by Subject|1|||
38035236|NCT02937350|69722144|FG002|Overall Study|Withdrawal by Subject|0|||
38035237|NCT04085289|69722153|FG000|Overall Study|Withdrawal by Subject|0|||
38035238|NCT04085289|69722154|FG001|Overall Study|Withdrawal by Subject|0|||
38035239|NCT04085289|69722155|FG002|Overall Study|Withdrawal by Subject|1|||
38035240|NCT04080297|69722164|FG000|Overall Study|Adverse Event|1|||
37670407|NCT01374425|69143627|FG001|Overall Study|Lost to Follow-up|1|||
37940117|NCT00401245|69627166|FG006|Open Label Phase|Withdrawal by Subject|0|||
37940118|NCT00401245|69627167|FG007|Open Label Phase|Withdrawal by Subject|0|||
37940119|NCT00401245|69627160|FG000|Open Label Phase|Lack of Efficacy|4|||
37940120|NCT00401245|69627161|FG001|Open Label Phase|Lack of Efficacy|2|||
37940121|NCT00401245|69627162|FG002|Open Label Phase|Lack of Efficacy|3|||
37940122|NCT00401245|69627163|FG003|Open Label Phase|Lack of Efficacy|0|||
37940123|NCT00401245|69627164|FG004|Open Label Phase|Lack of Efficacy|0|||
37940124|NCT00401245|69627165|FG005|Open Label Phase|Lack of Efficacy|0|||
37940125|NCT00401245|69627166|FG006|Open Label Phase|Lack of Efficacy|0|||
37940126|NCT00401245|69627167|FG007|Open Label Phase|Lack of Efficacy|0|||
38035241|NCT04080297|69722165|FG001|Overall Study|Adverse Event|3|||
37670408|NCT01374425|69143626|FG000|Overall Study|Other|41|||
37940127|NCT00401245|69627160|FG000|Double Blind Tapering Phase|Adverse Event|0|||
37940128|NCT00401245|69627161|FG001|Double Blind Tapering Phase|Adverse Event|0|||
37940129|NCT00401245|69627162|FG002|Double Blind Tapering Phase|Adverse Event|0|||
37940130|NCT00401245|69627163|FG003|Double Blind Tapering Phase|Adverse Event|0|||
37940131|NCT00401245|69627164|FG004|Double Blind Tapering Phase|Adverse Event|1|||
37940132|NCT00401245|69627165|FG005|Double Blind Tapering Phase|Adverse Event|1|||
37940133|NCT00401245|69627166|FG006|Double Blind Tapering Phase|Adverse Event|2|||
37940134|NCT00401245|69627167|FG007|Double Blind Tapering Phase|Adverse Event|4|||
37940135|NCT00401245|69627160|FG000|Double Blind Tapering Phase|Investigator request|0|||
37940136|NCT00401245|69627161|FG001|Double Blind Tapering Phase|Investigator request|0|||
37940137|NCT00401245|69627162|FG002|Double Blind Tapering Phase|Investigator request|0|||
37940138|NCT00401245|69627163|FG003|Double Blind Tapering Phase|Investigator request|0|||
37940139|NCT00401245|69627164|FG004|Double Blind Tapering Phase|Investigator request|0|||
37940140|NCT00401245|69627165|FG005|Double Blind Tapering Phase|Investigator request|0|||
37940141|NCT00401245|69627166|FG006|Double Blind Tapering Phase|Investigator request|0|||
37940142|NCT00401245|69627167|FG007|Double Blind Tapering Phase|Investigator request|1|||
37940143|NCT00401245|69627160|FG000|Double Blind Tapering Phase|Other|0|||
37940144|NCT00401245|69627161|FG001|Double Blind Tapering Phase|Other|0|||
37940145|NCT00401245|69627162|FG002|Double Blind Tapering Phase|Other|0|||
37940146|NCT00401245|69627163|FG003|Double Blind Tapering Phase|Other|0|||
37940147|NCT00401245|69627164|FG004|Double Blind Tapering Phase|Other|1|||
37940148|NCT00401245|69627165|FG005|Double Blind Tapering Phase|Other|0|||
37940149|NCT00401245|69627166|FG006|Double Blind Tapering Phase|Other|2|||
37940150|NCT00401245|69627167|FG007|Double Blind Tapering Phase|Other|2|||
37940151|NCT00401245|69627160|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
37940152|NCT00401245|69627161|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
37940153|NCT00401245|69627162|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
37940154|NCT00401245|69627163|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
37940155|NCT00401245|69627164|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
37940156|NCT00401245|69627165|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
37940157|NCT00401245|69627166|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
37940158|NCT00401245|69627167|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
37940159|NCT00401245|69627160|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
37940160|NCT00401245|69627161|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
37940161|NCT00401245|69627162|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
37940162|NCT00401245|69627163|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
37940163|NCT00401245|69627164|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
37940164|NCT00401245|69627165|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
37940165|NCT00401245|69627166|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
37940166|NCT00401245|69627167|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
37940167|NCT00696384|69627187|FG000|Open Label Phase|Adverse Event|27|||
37940168|NCT00696384|69627188|FG001|Open Label Phase|Adverse Event|0|||
37940169|NCT00696384|69627189|FG002|Open Label Phase|Adverse Event|0|||
37940170|NCT00696384|69627187|FG000|Open Label Phase|Protocol Violation|18|||
37940171|NCT00696384|69627188|FG001|Open Label Phase|Protocol Violation|0|||
37940172|NCT00696384|69627189|FG002|Open Label Phase|Protocol Violation|0|||
37940173|NCT00696384|69627187|FG000|Open Label Phase|Lost to Follow-up|24|||
37940174|NCT00696384|69627188|FG001|Open Label Phase|Lost to Follow-up|0|||
37940175|NCT00696384|69627189|FG002|Open Label Phase|Lost to Follow-up|0|||
37940176|NCT00696384|69627187|FG000|Open Label Phase|Withdrawal by Subject|37|||
37940177|NCT00696384|69627188|FG001|Open Label Phase|Withdrawal by Subject|0|||
37940178|NCT00696384|69627189|FG002|Open Label Phase|Withdrawal by Subject|0|||
37940179|NCT00696384|69627187|FG000|Open Label Phase|Other|6|||
37940180|NCT00696384|69627188|FG001|Open Label Phase|Other|0|||
37940181|NCT00696384|69627189|FG002|Open Label Phase|Other|0|||
37940182|NCT00696384|69627187|FG000|Open Label Phase|Lack of Efficacy|3|||
37940183|NCT00696384|69627188|FG001|Open Label Phase|Lack of Efficacy|0|||
37940184|NCT00696384|69627189|FG002|Open Label Phase|Lack of Efficacy|0|||
37940185|NCT00696384|69627187|FG000|Open Label Phase|Physician Decision|4|||
37940186|NCT00696384|69627188|FG001|Open Label Phase|Physician Decision|0|||
37940187|NCT00696384|69627189|FG002|Open Label Phase|Physician Decision|0|||
37940188|NCT00696384|69627187|FG000|Double Blind Phase|Adverse Event|0|||
37940189|NCT00696384|69627188|FG001|Double Blind Phase|Adverse Event|2|||
37940190|NCT00696384|69627189|FG002|Double Blind Phase|Adverse Event|2|||
37940191|NCT00696384|69627187|FG000|Double Blind Phase|Lost to Follow-up|0|||
37940192|NCT00696384|69627188|FG001|Double Blind Phase|Lost to Follow-up|2|||
37940193|NCT00696384|69627189|FG002|Double Blind Phase|Lost to Follow-up|1|||
37940194|NCT00696384|69627187|FG000|Double Blind Phase|Withdrawal by Subject|0|||
37940195|NCT00696384|69627188|FG001|Double Blind Phase|Withdrawal by Subject|4|||
37765176|NCT01440101|69278397|FG001|Overall Study|Adverse Event|0|||
37940196|NCT00696384|69627189|FG002|Double Blind Phase|Withdrawal by Subject|3|||
37940197|NCT00696384|69627187|FG000|Double Blind Phase|Lack of Efficacy|0|||
37940198|NCT00696384|69627188|FG001|Double Blind Phase|Lack of Efficacy|1|||
37940199|NCT00696384|69627189|FG002|Double Blind Phase|Lack of Efficacy|0|||
37940200|NCT00696384|69627187|FG000|Double Blind Phase|Physician Decision|0|||
37940201|NCT00696384|69627188|FG001|Double Blind Phase|Physician Decision|2|||
37940202|NCT00696384|69627189|FG002|Double Blind Phase|Physician Decision|0|||
37940203|NCT00636675|69627200|FG000|Overall Study|Lost to Follow-up|121|||
37940204|NCT00636675|69627201|FG001|Overall Study|Lost to Follow-up|31|||
37940205|NCT00636675|69627200|FG000|Overall Study|Withdrawal by Subject|19|||
37940206|NCT00636675|69627201|FG001|Overall Study|Withdrawal by Subject|10|||
37940207|NCT00699998|69627211|FG000|Overall Study|Withdrawal by Subject|194|||
37940208|NCT00699998|69627212|FG001|Overall Study|Withdrawal by Subject|83|||
37940209|NCT00699998|69627213|FG002|Overall Study|Withdrawal by Subject|202|||
37940210|NCT00699998|69627214|FG003|Overall Study|Withdrawal by Subject|80|||
37940211|NCT00699998|69627211|FG000|Overall Study|Physician Decision|3|||
37940212|NCT00699998|69627212|FG001|Overall Study|Physician Decision|2|||
37940213|NCT00699998|69627213|FG002|Overall Study|Physician Decision|1|||
37940214|NCT00699998|69627214|FG003|Overall Study|Physician Decision|1|||
37940215|NCT00699998|69627211|FG000|Overall Study|Lost to Follow-up|2|||
37940216|NCT00699998|69627212|FG001|Overall Study|Lost to Follow-up|1|||
37940217|NCT00699998|69627213|FG002|Overall Study|Lost to Follow-up|3|||
37940218|NCT00699998|69627214|FG003|Overall Study|Lost to Follow-up|1|||
37940219|NCT00696072|69627231|FG000|Overall Study|continuing active treatment|10|||
37940220|NCT00696072|69627232|FG001|Overall Study|continuing active treatment|13|||
37940221|NCT00696072|69627231|FG000|Overall Study|Adverse Event|10|||
37940222|NCT00696072|69627232|FG001|Overall Study|Adverse Event|6|||
37940223|NCT00696072|69627231|FG000|Overall Study|Patient Request|3|||
37940224|NCT00696072|69627232|FG001|Overall Study|Patient Request|7|||
37940225|NCT00696072|69627231|FG000|Overall Study|Investigator Request|1|||
37940226|NCT00696072|69627232|FG001|Overall Study|Investigator Request|4|||
37940227|NCT00696072|69627231|FG000|Overall Study|Sponsor Request|0|||
37940228|NCT00696072|69627232|FG001|Overall Study|Sponsor Request|1|||
37940229|NCT00696072|69627231|FG000|Overall Study|Disease Progression|32|||
37940230|NCT00696072|69627232|FG001|Overall Study|Disease Progression|30|||
37940231|NCT00696072|69627231|FG000|Overall Study|Non-specified|1|||
37940232|NCT00696072|69627232|FG001|Overall Study|Non-specified|2|||
37940233|NCT00634647|69627239|FG000|Overall Study|death on study|3|||
37940234|NCT00634647|69627239|FG000|Overall Study|refused further treatment|3|||
37940235|NCT00634647|69627239|FG000|Overall Study|declined to participate before treatment|1|||
37940236|NCT00576732|69627246|FG000|DOUBLE BLIND|Adverse Event|0|||
37940237|NCT00576732|69627247|FG001|DOUBLE BLIND|Adverse Event|0|||
37940238|NCT00576732|69627248|FG002|DOUBLE BLIND|Adverse Event|1|||
37940239|NCT00576732|69627249|FG003|DOUBLE BLIND|Adverse Event|0|||
37940240|NCT00576732|69627250|FG004|DOUBLE BLIND|Adverse Event|0|||
37940241|NCT00576732|69627251|FG005|DOUBLE BLIND|Adverse Event|0|||
37940242|NCT00576732|69627246|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
37940243|NCT00576732|69627247|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
37940244|NCT00576732|69627248|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
37940245|NCT00576732|69627249|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
37940246|NCT00576732|69627250|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
37940247|NCT00576732|69627251|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
37940248|NCT00576732|69627246|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
37940249|NCT00576732|69627247|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
37940250|NCT00576732|69627248|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
37940251|NCT00576732|69627249|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
37940252|NCT00576732|69627250|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
37940253|NCT00576732|69627251|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
37940254|NCT00576732|69627246|FG000|DOUBLE BLIND|OTHER|0|||
37940255|NCT00576732|69627247|FG001|DOUBLE BLIND|OTHER|2|||
37940256|NCT00576732|69627248|FG002|DOUBLE BLIND|OTHER|1|||
37940257|NCT00576732|69627249|FG003|DOUBLE BLIND|OTHER|0|||
37940258|NCT00576732|69627250|FG004|DOUBLE BLIND|OTHER|0|||
37940259|NCT00576732|69627251|FG005|DOUBLE BLIND|OTHER|0|||
37940260|NCT00576732|69627246|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
37940261|NCT00576732|69627247|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
37940262|NCT00576732|69627248|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
37940263|NCT00576732|69627249|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
37940264|NCT00576732|69627250|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
37940265|NCT00576732|69627251|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
37940266|NCT00576732|69627246|FG000|DOUBLE BLIND|Protocol Violation|1|||
37940267|NCT00576732|69627247|FG001|DOUBLE BLIND|Protocol Violation|0|||
37940268|NCT00576732|69627248|FG002|DOUBLE BLIND|Protocol Violation|0|||
37940269|NCT00576732|69627249|FG003|DOUBLE BLIND|Protocol Violation|0|||
37940270|NCT00576732|69627250|FG004|DOUBLE BLIND|Protocol Violation|0|||
37940271|NCT00576732|69627251|FG005|DOUBLE BLIND|Protocol Violation|0|||
37940272|NCT00576732|69627246|FG000|OPEN LABEL|Adverse Event|0|||
37940273|NCT00576732|69627247|FG001|OPEN LABEL|Adverse Event|0|||
37940274|NCT00576732|69627248|FG002|OPEN LABEL|Adverse Event|0|||
37940275|NCT00576732|69627249|FG003|OPEN LABEL|Adverse Event|4|||
37940276|NCT00576732|69627250|FG004|OPEN LABEL|Adverse Event|0|||
37940277|NCT00576732|69627251|FG005|OPEN LABEL|Adverse Event|1|||
37940278|NCT00576732|69627246|FG000|OPEN LABEL|Lost to Follow-up|0|||
37940279|NCT00576732|69627247|FG001|OPEN LABEL|Lost to Follow-up|0|||
37940280|NCT00576732|69627248|FG002|OPEN LABEL|Lost to Follow-up|0|||
37940281|NCT00576732|69627249|FG003|OPEN LABEL|Lost to Follow-up|2|||
37940282|NCT00576732|69627250|FG004|OPEN LABEL|Lost to Follow-up|1|||
37940283|NCT00576732|69627251|FG005|OPEN LABEL|Lost to Follow-up|1|||
37940284|NCT00576732|69627246|FG000|OPEN LABEL|Withdrawal by Subject|0|||
37940285|NCT00576732|69627247|FG001|OPEN LABEL|Withdrawal by Subject|0|||
37940286|NCT00576732|69627248|FG002|OPEN LABEL|Withdrawal by Subject|0|||
37940287|NCT00576732|69627249|FG003|OPEN LABEL|Withdrawal by Subject|1|||
37940288|NCT00576732|69627250|FG004|OPEN LABEL|Withdrawal by Subject|0|||
37940289|NCT00576732|69627251|FG005|OPEN LABEL|Withdrawal by Subject|1|||
37940290|NCT00576732|69627246|FG000|OPEN LABEL|OTHER|0|||
37940291|NCT00576732|69627247|FG001|OPEN LABEL|OTHER|0|||
37940292|NCT00576732|69627248|FG002|OPEN LABEL|OTHER|0|||
37940293|NCT00576732|69627249|FG003|OPEN LABEL|OTHER|0|||
37940294|NCT00576732|69627250|FG004|OPEN LABEL|OTHER|0|||
37940295|NCT00576732|69627251|FG005|OPEN LABEL|OTHER|2|||
37940296|NCT00576732|69627246|FG000|OPEN LABEL|Lack of Efficacy|0|||
37940297|NCT00576732|69627247|FG001|OPEN LABEL|Lack of Efficacy|0|||
37940298|NCT00576732|69627248|FG002|OPEN LABEL|Lack of Efficacy|0|||
37940299|NCT00576732|69627249|FG003|OPEN LABEL|Lack of Efficacy|2|||
37940300|NCT00576732|69627250|FG004|OPEN LABEL|Lack of Efficacy|2|||
37940301|NCT00576732|69627251|FG005|OPEN LABEL|Lack of Efficacy|3|||
37940302|NCT00576732|69627246|FG000|OPEN LABEL|Protocol Violation|0|||
37940303|NCT00576732|69627247|FG001|OPEN LABEL|Protocol Violation|0|||
37940304|NCT00576732|69627248|FG002|OPEN LABEL|Protocol Violation|0|||
37940305|NCT00576732|69627249|FG003|OPEN LABEL|Protocol Violation|2|||
37940306|NCT00576732|69627250|FG004|OPEN LABEL|Protocol Violation|1|||
37940307|NCT00576732|69627251|FG005|OPEN LABEL|Protocol Violation|0|||
37940308|NCT00697788|69627263|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
37940309|NCT00697788|69627264|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
37940310|NCT00697788|69627265|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
37940311|NCT00697788|69627266|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
37940312|NCT00697788|69627267|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
37940313|NCT00697788|69627268|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
37940314|NCT00697788|69627269|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
37940315|NCT00697788|69627270|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
37940316|NCT00697788|69627263|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
37940317|NCT00697788|69627264|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
37940318|NCT00697788|69627265|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
37940319|NCT00697788|69627266|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
37940320|NCT00697788|69627267|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
37940321|NCT00697788|69627268|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
37940322|NCT00697788|69627269|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
37940323|NCT00697788|69627270|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
37940324|NCT00400153|69627300|FG000|Overall Study|AE due to study disease worsening|14|||
37940325|NCT00400153|69627301|FG001|Overall Study|AE due to study disease worsening|19|||
37940326|NCT00400153|69627302|FG002|Overall Study|AE due to study disease worsening|20|||
37940327|NCT00400153|69627300|FG000|Overall Study|AE due to other disease worsening|2|||
37940328|NCT00400153|69627301|FG001|Overall Study|AE due to other disease worsening|1|||
37940329|NCT00400153|69627302|FG002|Overall Study|AE due to other disease worsening|0|||
37940330|NCT00400153|69627300|FG000|Overall Study|AE due to other condition|3|||
37940331|NCT00400153|69627301|FG001|Overall Study|AE due to other condition|14|||
37940332|NCT00400153|69627302|FG002|Overall Study|AE due to other condition|15|||
37940333|NCT00400153|69627300|FG000|Overall Study|Protocol Violation|7|||
37940334|NCT00400153|69627301|FG001|Overall Study|Protocol Violation|4|||
37940335|NCT00400153|69627302|FG002|Overall Study|Protocol Violation|9|||
37940336|NCT00400153|69627300|FG000|Overall Study|Lost to Follow-up|2|||
37940337|NCT00400153|69627301|FG001|Overall Study|Lost to Follow-up|1|||
37940338|NCT00400153|69627302|FG002|Overall Study|Lost to Follow-up|4|||
37940339|NCT00400153|69627300|FG000|Overall Study|Withdrawal by Subject|12|||
37940340|NCT00400153|69627301|FG001|Overall Study|Withdrawal by Subject|11|||
37940341|NCT00400153|69627302|FG002|Overall Study|Withdrawal by Subject|10|||
37940342|NCT00400153|69627300|FG000|Overall Study|Other reasons - not mentioned above|8|||
37940343|NCT00400153|69627301|FG001|Overall Study|Other reasons - not mentioned above|5|||
37940344|NCT00400153|69627302|FG002|Overall Study|Other reasons - not mentioned above|3|||
37940345|NCT00631917|69627317|FG000|Overall Study|Adverse Event|34|||
37940346|NCT00631917|69627318|FG001|Overall Study|Adverse Event|45|||
37940347|NCT00631917|69627317|FG000|Overall Study|Abnormal laboratory value(s)|2|||
37940348|NCT00631917|69627318|FG001|Overall Study|Abnormal laboratory value(s)|1|||
37940349|NCT00631917|69627317|FG000|Overall Study|Abnormal test procedure result(s)|3|||
37670409|NCT01374425|69143627|FG001|Overall Study|Other|43|||
37670410|NCT02085460|69143657|FG000|Overall Study|Adverse Event|2|||
37940350|NCT00631917|69627318|FG001|Overall Study|Abnormal test procedure result(s)|2|||
37940351|NCT00631917|69627317|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
37940352|NCT00631917|69627318|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
37670411|NCT02085460|69143658|FG001|Overall Study|Adverse Event|2|||
37940353|NCT00631917|69627317|FG000|Overall Study|No longer required study drug|0|||
37940354|NCT00631917|69627318|FG001|Overall Study|No longer required study drug|1|||
37940355|NCT00631917|69627317|FG000|Overall Study|Protocol deviation|6|||
37940356|NCT00631917|69627318|FG001|Overall Study|Protocol deviation|5|||
37940357|NCT00631917|69627317|FG000|Overall Study|Subject withdrew consent|25|||
37940358|NCT00631917|69627318|FG001|Overall Study|Subject withdrew consent|33|||
37940359|NCT00631917|69627317|FG000|Overall Study|Lost to Follow-up|7|||
37940360|NCT00631917|69627318|FG001|Overall Study|Lost to Follow-up|7|||
37940361|NCT00631917|69627317|FG000|Overall Study|Administrative problems|2|||
37940362|NCT00631917|69627318|FG001|Overall Study|Administrative problems|0|||
37940363|NCT00631917|69627317|FG000|Overall Study|Death|1|||
37940364|NCT00631917|69627318|FG001|Overall Study|Death|0|||
37940365|NCT00419341|69627335|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
37940366|NCT00419341|69627335|FG000|Wash in/Wash Out Period|Adverse Event|2|||
37940367|NCT00419341|69627335|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
37940368|NCT00419341|69627335|FG000|Efficacy Period|Withdrawal by Subject|6|||
37940369|NCT00419341|69627335|FG000|Efficacy Period|Protocol Violation|1|||
37940370|NCT00419341|69627335|FG000|Efficacy Period|Lost to Follow-up|1|||
37940371|NCT00419341|69627335|FG000|Efficacy Period|Non-compliance|1|||
37940372|NCT00419341|69627335|FG000|Efficacy Period|Termination of study site|1|||
37940373|NCT00694122|69627341|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
37940374|NCT00694122|69627342|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
37940375|NCT00694122|69627341|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
37940376|NCT00694122|69627342|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
37940377|NCT00694122|69627341|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
37940378|NCT00694122|69627342|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
37940379|NCT03922620|69627355|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
37940380|NCT03922620|69627356|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
37940381|NCT00419263|69627365|FG000|Overall Study|Lost to Follow-up|2|||
37940382|NCT00419263|69627366|FG001|Overall Study|Lost to Follow-up|1|||
37940383|NCT00419263|69627367|FG002|Overall Study|Lost to Follow-up|1|||
37940384|NCT00419263|69627365|FG000|Overall Study|Randomized in Error, Not Treated|1|||
37940385|NCT00419263|69627366|FG001|Overall Study|Randomized in Error, Not Treated|1|||
37940386|NCT00419263|69627367|FG002|Overall Study|Randomized in Error, Not Treated|0|||
37940387|NCT00419263|69627365|FG000|Overall Study|Adverse Event|0|||
37940388|NCT00419263|69627366|FG001|Overall Study|Adverse Event|0|||
37940389|NCT00419263|69627367|FG002|Overall Study|Adverse Event|1|||
37940390|NCT00419263|69627365|FG000|Overall Study|Withdrawal by Subject|0|||
37940391|NCT00419263|69627366|FG001|Overall Study|Withdrawal by Subject|0|||
37940392|NCT00419263|69627367|FG002|Overall Study|Withdrawal by Subject|1|||
37940393|NCT00399763|69627378|FG000|Overall Study|Lost to Follow-up|2|||
37940394|NCT00399763|69627379|FG001|Overall Study|Lost to Follow-up|3|||
37940395|NCT00699842|69627388|FG000|Overall Study|Death|0|||
37940396|NCT00699842|69627389|FG001|Overall Study|Death|1|||
37940397|NCT00699842|69627390|FG002|Overall Study|Death|0|||
37940398|NCT00399529|69627398|FG000|Overall Study|Off Study Prior to Treatment|2|||
37940399|NCT00712712|69627403|FG000|Overall Study|Protocol Violation|11|||
37940400|NCT00712712|69627403|FG000|Overall Study|Radiofrequency not done|3|||
37940401|NCT00712712|69627403|FG000|Overall Study|Death|8|||
37940402|NCT00712712|69627403|FG000|Overall Study|Withdrawal by Subject|1|||
37940403|NCT00411151|69627407|FG000|Overall Study|Death|38|||
37940404|NCT00411151|69627407|FG000|Overall Study|Withdrawal by Subject|2|||
37940405|NCT00411151|69627407|FG000|Overall Study|Lost to Follow-up|2|||
37940406|NCT00411151|69627407|FG000|Overall Study|Protocol Violation|1|||
37940407|NCT00411151|69627407|FG000|Overall Study|Trial prematurely closed|4|||
37940408|NCT00607048|69627413|FG000|Overall Study|Adverse Event|0|||
37940409|NCT00607048|69627414|FG001|Overall Study|Adverse Event|1|||
37940410|NCT00607048|69627415|FG002|Overall Study|Adverse Event|0|||
37940411|NCT00607048|69627416|FG003|Overall Study|Adverse Event|0|||
37940412|NCT00607048|69627417|FG004|Overall Study|Adverse Event|4|||
37940413|NCT00607048|69627418|FG005|Overall Study|Adverse Event|0|||
37940414|NCT00607048|69627413|FG000|Overall Study|Global deterioration of health|1|||
37940415|NCT00607048|69627414|FG001|Overall Study|Global deterioration of health|0|||
37940416|NCT00607048|69627415|FG002|Overall Study|Global deterioration of health|0|||
37940417|NCT00607048|69627416|FG003|Overall Study|Global deterioration of health|0|||
37940418|NCT00607048|69627417|FG004|Overall Study|Global deterioration of health|0|||
37940419|NCT00607048|69627418|FG005|Overall Study|Global deterioration of health|0|||
37940420|NCT00607048|69627413|FG000|Overall Study|Objective disease progression - relapse|1|||
37940421|NCT00607048|69627414|FG001|Overall Study|Objective disease progression - relapse|2|||
37670412|NCT02085460|69143659|FG002|Overall Study|Adverse Event|1|||
37670413|NCT02085460|69143657|FG000|Overall Study|Physician Decision|1|||
37940422|NCT00607048|69627415|FG002|Overall Study|Objective disease progression - relapse|4|||
37940423|NCT00607048|69627416|FG003|Overall Study|Objective disease progression - relapse|2|||
37940424|NCT00607048|69627417|FG004|Overall Study|Objective disease progression - relapse|2|||
37940425|NCT00607048|69627418|FG005|Overall Study|Objective disease progression - relapse|2|||
37940426|NCT00607048|69627413|FG000|Overall Study|Withdrawal by Subject|0|||
37940427|NCT00607048|69627414|FG001|Overall Study|Withdrawal by Subject|0|||
37940428|NCT00607048|69627415|FG002|Overall Study|Withdrawal by Subject|0|||
37940429|NCT00607048|69627416|FG003|Overall Study|Withdrawal by Subject|1|||
37940430|NCT00607048|69627417|FG004|Overall Study|Withdrawal by Subject|0|||
37940431|NCT00607048|69627418|FG005|Overall Study|Withdrawal by Subject|2|||
37940432|NCT00607048|69627413|FG000|Overall Study|Other|1|||
37940433|NCT00607048|69627414|FG001|Overall Study|Other|1|||
37940434|NCT00607048|69627415|FG002|Overall Study|Other|0|||
37940435|NCT00607048|69627416|FG003|Overall Study|Other|0|||
37940436|NCT00607048|69627417|FG004|Overall Study|Other|0|||
37940437|NCT00607048|69627418|FG005|Overall Study|Other|1|||
37940438|NCT00699608|69627434|FG000|First Intervention|Withdrawal by Subject|0|||
37940439|NCT00699608|69627435|FG001|First Intervention|Withdrawal by Subject|0|||
37940440|NCT00699608|69627436|FG002|First Intervention|Withdrawal by Subject|1|||
37940441|NCT00699608|69627437|FG003|First Intervention|Withdrawal by Subject|0|||
37940442|NCT00699608|69627438|FG004|First Intervention|Withdrawal by Subject|0|||
37940443|NCT00699608|69627439|FG005|First Intervention|Withdrawal by Subject|0|||
37940444|NCT00699608|69627434|FG000|First Intervention|Protocol Violation|0|||
37940445|NCT00699608|69627435|FG001|First Intervention|Protocol Violation|0|||
37940446|NCT00699608|69627436|FG002|First Intervention|Protocol Violation|0|||
37940447|NCT00699608|69627437|FG003|First Intervention|Protocol Violation|0|||
37940448|NCT00699608|69627438|FG004|First Intervention|Protocol Violation|1|||
37940449|NCT00699608|69627439|FG005|First Intervention|Protocol Violation|0|||
37940450|NCT00699608|69627434|FG000|Second Intervention|Adverse Event|0|||
37940451|NCT00699608|69627435|FG001|Second Intervention|Adverse Event|0|||
37940452|NCT00699608|69627436|FG002|Second Intervention|Adverse Event|1|||
37940453|NCT00699608|69627437|FG003|Second Intervention|Adverse Event|0|||
37940454|NCT00699608|69627438|FG004|Second Intervention|Adverse Event|0|||
37940455|NCT00699608|69627439|FG005|Second Intervention|Adverse Event|0|||
37940456|NCT00699608|69627434|FG000|Second Intervention|Withdrawal by Subject|0|||
37940457|NCT00699608|69627435|FG001|Second Intervention|Withdrawal by Subject|0|||
37940458|NCT00699608|69627436|FG002|Second Intervention|Withdrawal by Subject|0|||
37940459|NCT00699608|69627437|FG003|Second Intervention|Withdrawal by Subject|1|||
37940460|NCT00699608|69627438|FG004|Second Intervention|Withdrawal by Subject|0|||
37940461|NCT00699608|69627439|FG005|Second Intervention|Withdrawal by Subject|0|||
37940462|NCT03823404|69627450|FG000|Overall Study|Lost to Follow-up|1|||
37940463|NCT03823404|69627451|FG001|Overall Study|Lost to Follow-up|2|||
37940464|NCT03823404|69627452|FG002|Overall Study|Lost to Follow-up|3|||
37940465|NCT03823404|69627450|FG000|Overall Study|Protocol Violation|2|||
37940466|NCT03823404|69627451|FG001|Overall Study|Protocol Violation|0|||
37940467|NCT03823404|69627452|FG002|Overall Study|Protocol Violation|2|||
37940468|NCT03823404|69627450|FG000|Overall Study|Adverse Event|35|||
37940469|NCT03823404|69627451|FG001|Overall Study|Adverse Event|38|||
37940470|NCT03823404|69627452|FG002|Overall Study|Adverse Event|8|||
37940471|NCT03823404|69627450|FG000|Overall Study|Withdrawal by Subject|38|||
37940472|NCT03823404|69627451|FG001|Overall Study|Withdrawal by Subject|40|||
37940473|NCT03823404|69627452|FG002|Overall Study|Withdrawal by Subject|35|||
37940474|NCT03823404|69627450|FG000|Overall Study|Death|4|||
37940475|NCT03823404|69627451|FG001|Overall Study|Death|0|||
37940476|NCT03823404|69627452|FG002|Overall Study|Death|0|||
37940477|NCT03823404|69627450|FG000|Overall Study|Other: Various reasons provided|5|||
37940478|NCT03823404|69627451|FG001|Overall Study|Other: Various reasons provided|5|||
37940479|NCT03823404|69627452|FG002|Overall Study|Other: Various reasons provided|6|||
37765177|NCT01440101|69278398|FG002|Overall Study|Adverse Event|0|||
37765178|NCT01440101|69278396|FG000|Overall Study|Withdrawal by Subject|0|||
37940480|NCT00706706|69627460|FG000|Overall Study|Death|53|||
37940481|NCT00706706|69627460|FG000|Overall Study|Lost to Follow-up|7|||
37940482|NCT00706706|69627460|FG000|Overall Study|Study endpoint had reached|45|||
37940483|NCT00410605|69627464|FG000|Overall Study|Adverse Event|12|||
37765179|NCT01440101|69278397|FG001|Overall Study|Withdrawal by Subject|3|||
37765180|NCT01440101|69278398|FG002|Overall Study|Withdrawal by Subject|1|||
37765181|NCT01440101|69278396|FG000|Overall Study|Other|0|||
37765182|NCT01440101|69278397|FG001|Overall Study|Other|1|||
37765183|NCT01440101|69278398|FG002|Overall Study|Other|0|||
37940484|NCT00410605|69627464|FG000|Overall Study|Physician Decision|3|||
37940485|NCT00410605|69627464|FG000|Overall Study|Withdrawal by Subject|5|||
37940486|NCT00410605|69627464|FG000|Overall Study|Started Non-Protocol Therapy|3|||
37940487|NCT00410605|69627464|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
37940488|NCT00410605|69627464|FG000|Overall Study|Transferred to another Institution|1|||
37940489|NCT00418717|69627468|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
37940490|NCT00418717|69627468|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
37940491|NCT00572572|69627474|FG000|Overall Study|Withdrawal by Subject|3|||
37765184|NCT01530464|69278409|FG000|Washout (24h)|Withdrawal by Subject|1|||
37940492|NCT00572572|69627475|FG001|Overall Study|Withdrawal by Subject|6|||
37940493|NCT00418561|69627484|FG000|Overall Study|Participant's (guardian's) decision|0|||
37940494|NCT00418561|69627485|FG001|Overall Study|Participant's (guardian's) decision|1|||
37940495|NCT00418561|69627486|FG002|Overall Study|Participant's (guardian's) decision|0|||
37940496|NCT00398047|69627494|FG000|Overall Study|all patient progressed before completion|3|||
37940497|NCT00631371|69627501|FG000|Overall Study|Lost to Follow-up|24|||
37940498|NCT00631371|69627502|FG001|Overall Study|Lost to Follow-up|19|||
37940499|NCT00631371|69627501|FG000|Overall Study|Other reason|5|||
37940500|NCT00631371|69627502|FG001|Overall Study|Other reason|12|||
37940501|NCT00631371|69627501|FG000|Overall Study|subject request|38|||
37940502|NCT00631371|69627502|FG001|Overall Study|subject request|45|||
37940503|NCT00631371|69627501|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
37940504|NCT00631371|69627502|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
37940505|NCT00631371|69627501|FG000|Overall Study|Death|263|||
37940506|NCT00631371|69627502|FG001|Overall Study|Death|239|||
37940507|NCT00409747|69627508|FG000|Overall Study|Withdrawal by Subject|1|||
37940508|NCT00630747|69627512|FG000|Overall Study|Death|1|||
37940509|NCT00630747|69627512|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
37940510|NCT00630747|69627512|FG000|Overall Study|Returned to country of origin|1|||
37940511|NCT00397891|69627521|FG000|Overall Study|Withdrawal by Subject|1|||
37940512|NCT00397891|69627522|FG001|Overall Study|Withdrawal by Subject|0|||
37940513|NCT00397891|69627523|FG002|Overall Study|Withdrawal by Subject|0|||
37940514|NCT00397891|69627524|FG003|Overall Study|Withdrawal by Subject|0|||
37940515|NCT00397891|69627525|FG004|Overall Study|Withdrawal by Subject|1|||
37940516|NCT00397189|69627539|FG000|3 Weeks Period|Lost to Follow-up|5|||
37940517|NCT00397189|69627540|FG001|3 Weeks Period|Lost to Follow-up|4|||
37940518|NCT00397189|69627539|FG000|3 Weeks Period|Adverse Event|3|||
37940519|NCT00397189|69627540|FG001|3 Weeks Period|Adverse Event|2|||
37940520|NCT00397189|69627539|FG000|3 Weeks Period|Withdrawal by Subject|13|||
37940521|NCT00397189|69627540|FG001|3 Weeks Period|Withdrawal by Subject|9|||
37940522|NCT00397189|69627539|FG000|3 Weeks Period|Physician Decision|0|||
37940523|NCT00397189|69627540|FG001|3 Weeks Period|Physician Decision|2|||
37940524|NCT00397189|69627539|FG000|3 Weeks Period|Protocol Violation|0|||
37940525|NCT00397189|69627540|FG001|3 Weeks Period|Protocol Violation|3|||
37940526|NCT00397189|69627539|FG000|3 Weeks Period|Other|0|||
37940527|NCT00397189|69627540|FG001|3 Weeks Period|Other|2|||
37940528|NCT00606034|69627548|FG000|Overall Study|incarceration|1|||
37940529|NCT00397033|69627557|FG000|Overall Study|Adverse Event|7|||
37940530|NCT00397033|69627558|FG001|Overall Study|Adverse Event|10|||
37940531|NCT00397033|69627559|FG002|Overall Study|Adverse Event|4|||
37940532|NCT00397033|69627557|FG000|Overall Study|Lack of Efficacy|22|||
37940533|NCT00397033|69627558|FG001|Overall Study|Lack of Efficacy|12|||
37940534|NCT00397033|69627559|FG002|Overall Study|Lack of Efficacy|9|||
37940535|NCT00397033|69627557|FG000|Overall Study|Lost to Follow-up|3|||
37940536|NCT00397033|69627558|FG001|Overall Study|Lost to Follow-up|3|||
37940537|NCT00397033|69627559|FG002|Overall Study|Lost to Follow-up|3|||
37940538|NCT00397033|69627557|FG000|Overall Study|Withdrawal by Subject|12|||
37940539|NCT00397033|69627558|FG001|Overall Study|Withdrawal by Subject|7|||
37940540|NCT00397033|69627559|FG002|Overall Study|Withdrawal by Subject|5|||
37940541|NCT00397033|69627557|FG000|Overall Study|Other|0|||
37940542|NCT00397033|69627558|FG001|Overall Study|Other|5|||
37940543|NCT00397033|69627559|FG002|Overall Study|Other|2|||
37940544|NCT00572728|69627567|FG000|Overall Study|Withdrawal by Subject|10|||
37940545|NCT00572728|69627567|FG000|Overall Study|Ineligible|3|||
37940546|NCT00572728|69627567|FG000|Overall Study|Enrolled under Amendment 4|5|||
37940547|NCT00572728|69627567|FG000|Overall Study|Offstudy due to complicating disease|1|||
37940548|NCT00572728|69627567|FG000|Overall Study|FLT1 not completed|4|||
37940549|NCT00572728|69627567|FG000|Overall Study|First Chemotherapy not initiated|2|||
37940550|NCT00572728|69627567|FG000|Overall Study|FLT2 not completed|5|||
37940551|NCT00572728|69627567|FG000|Overall Study|Second chemotherapy not initiated|1|||
37940552|NCT00572728|69627567|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
37940553|NCT00572728|69627567|FG000|Overall Study|Pathology missing|1|||
37940554|NCT00699374|69627575|FG000|Overall Study|Death|93|||
37940555|NCT00699374|69627576|FG001|Overall Study|Death|83|||
37940556|NCT00699374|69627575|FG000|Overall Study|Adverse Event|70|||
37940557|NCT00699374|69627576|FG001|Overall Study|Adverse Event|67|||
37940558|NCT00699374|69627575|FG000|Overall Study|Global deterioration of health status|7|||
38035242|NCT04080297|69722164|FG000|Overall Study|concurrent illness|1|||
38035243|NCT04080297|69722165|FG001|Overall Study|concurrent illness|0|||
37940559|NCT00699374|69627576|FG001|Overall Study|Global deterioration of health status|8|||
37940560|NCT00699374|69627575|FG000|Overall Study|Lost to Follow-up|3|||
37940561|NCT00699374|69627576|FG001|Overall Study|Lost to Follow-up|5|||
37940562|NCT00699374|69627575|FG000|Overall Study|Withdrawal by Subject|34|||
37940563|NCT00699374|69627576|FG001|Overall Study|Withdrawal by Subject|44|||
37940564|NCT00699374|69627575|FG000|Overall Study|Objective progression or relapse|281|||
37940565|NCT00699374|69627576|FG001|Overall Study|Objective progression or relapse|277|||
37940566|NCT00699374|69627575|FG000|Overall Study|Other|18|||
37940567|NCT00699374|69627576|FG001|Overall Study|Other|15|||
37940568|NCT00699374|69627575|FG000|Overall Study|Protocol Violation|2|||
37940569|NCT00699374|69627576|FG001|Overall Study|Protocol Violation|6|||
37940570|NCT00699374|69627575|FG000|Overall Study|Study terminated by sponsor|13|||
37940571|NCT00699374|69627576|FG001|Overall Study|Study terminated by sponsor|28|||
37940572|NCT00699374|69627575|FG000|Overall Study|Randomized but not treated|4|||
37940573|NCT00699374|69627576|FG001|Overall Study|Randomized but not treated|2|||
37940574|NCT00699374|69627575|FG000|Overall Study|Died 28 days after last dose|5|||
37940575|NCT00699374|69627576|FG001|Overall Study|Died 28 days after last dose|9|||
37940576|NCT00606892|69627582|FG000|First Intervention|Protocol Violation|1|||
37940577|NCT00606892|69627583|FG001|First Intervention|Protocol Violation|4|||
37940578|NCT00625443|69627618|FG000|Overall Study|Adverse Event|1|||
37940579|NCT00625443|69627619|FG001|Overall Study|Adverse Event|4|||
37940580|NCT00625443|69627620|FG002|Overall Study|Adverse Event|0|||
37940581|NCT00625443|69627618|FG000|Overall Study|Non-compliance with protocol|0|||
37940582|NCT00625443|69627619|FG001|Overall Study|Non-compliance with protocol|1|||
37940583|NCT00625443|69627620|FG002|Overall Study|Non-compliance with protocol|0|||
37940584|NCT00625443|69627618|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
37940585|NCT00625443|69627619|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
37940586|NCT00625443|69627620|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
37940587|NCT00625443|69627618|FG000|Overall Study|Withdrawal by Subject|0|||
37940588|NCT00625443|69627619|FG001|Overall Study|Withdrawal by Subject|1|||
37940589|NCT00625443|69627620|FG002|Overall Study|Withdrawal by Subject|2|||
37940590|NCT00625443|69627618|FG000|Overall Study|Physician Decision|0|||
37940591|NCT00625443|69627619|FG001|Overall Study|Physician Decision|4|||
37940592|NCT00625443|69627620|FG002|Overall Study|Physician Decision|2|||
37940593|NCT00625443|69627618|FG000|Overall Study|Other|0|||
37940594|NCT00625443|69627619|FG001|Overall Study|Other|1|||
37940595|NCT00625443|69627620|FG002|Overall Study|Other|1|||
37940596|NCT00625365|69627631|FG000|Overall Study|Withdrawal by Subject|1|||
37940597|NCT00625365|69627631|FG000|Overall Study|No IV access|5|||
37940598|NCT00625365|69627631|FG000|Overall Study|VSD|1|||
37940599|NCT00606580|69627638|FG000|Overall Study|Lost to Follow-up|1|||
37940600|NCT00606580|69627639|FG001|Overall Study|Lost to Follow-up|1|||
37940601|NCT00606580|69627640|FG002|Overall Study|Lost to Follow-up|4|||
37940602|NCT00606580|69627638|FG000|Overall Study|Clinical failures|1|||
37940603|NCT00606580|69627639|FG001|Overall Study|Clinical failures|0|||
37940604|NCT00606580|69627640|FG002|Overall Study|Clinical failures|12|||
37940605|NCT00606580|69627638|FG000|Overall Study|Withdrawal by investigator|0|||
37940606|NCT00606580|69627639|FG001|Overall Study|Withdrawal by investigator|1|||
37940607|NCT00606580|69627640|FG002|Overall Study|Withdrawal by investigator|6|||
37940608|NCT00606580|69627638|FG000|Overall Study|Withdrawal by Subject|0|||
37940609|NCT00606580|69627639|FG001|Overall Study|Withdrawal by Subject|1|||
37940610|NCT00606580|69627640|FG002|Overall Study|Withdrawal by Subject|0|||
37940611|NCT00629265|69627650|FG000|Overall Study|Lost to Follow-up|4|||
37940612|NCT00629265|69627651|FG001|Overall Study|Lost to Follow-up|5|||
37940613|NCT00629265|69627650|FG000|Overall Study|Withdrawal by Subject|11|||
37940614|NCT00629265|69627651|FG001|Overall Study|Withdrawal by Subject|8|||
37940615|NCT00629265|69627650|FG000|Overall Study|Death|1|||
37940616|NCT00629265|69627651|FG001|Overall Study|Death|0|||
37940617|NCT00629265|69627650|FG000|Overall Study|Adverse Event|2|||
37940618|NCT00629265|69627651|FG001|Overall Study|Adverse Event|0|||
37940619|NCT00629265|69627650|FG000|Overall Study|HNC Recurrence|4|||
37940620|NCT00629265|69627651|FG001|Overall Study|HNC Recurrence|0|||
37940621|NCT00629265|69627650|FG000|Overall Study|Other CA Requiring Treatment|1|||
37940622|NCT00629265|69627651|FG001|Overall Study|Other CA Requiring Treatment|3|||
37940623|NCT00629265|69627650|FG000|Overall Study|Needed Esophageal Dilation|4|||
37940624|NCT00629265|69627651|FG001|Overall Study|Needed Esophageal Dilation|1|||
37940625|NCT00629265|69627650|FG000|Overall Study|Unrelated Medical Complications|3|||
37940626|NCT00629265|69627651|FG001|Overall Study|Unrelated Medical Complications|1|||
37940627|NCT00629265|69627650|FG000|Overall Study|Unknown Reason|2|||
37940628|NCT00629265|69627651|FG001|Overall Study|Unknown Reason|2|||
37940629|NCT00606502|69627659|FG000|Randomization|Randomized but not treated|3|||
37940630|NCT00606502|69627660|FG001|Randomization|Randomized but not treated|0|||
37940631|NCT00606502|69627659|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
37940632|NCT00606502|69627660|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
37940633|NCT00605722|69627666|FG000|Overall Study|Adverse Event|6|||
37940634|NCT00605722|69627666|FG000|Overall Study|Insufficient therapeutic response|44|||
37940635|NCT00605722|69627666|FG000|Overall Study|Failure to return|1|||
37940636|NCT00605566|69627670|FG000|Overall Study|Adverse Event|1|||
37940637|NCT00605566|69627670|FG000|Overall Study|Clinical deterioration|1|||
37940638|NCT00605566|69627670|FG000|Overall Study|Poor compliance in run-in period|1|||
38035244|NCT04013529|69722173|FG000|Overall Study|Withdrawal by Subject|1|||
37670414|NCT02085460|69143658|FG001|Overall Study|Physician Decision|1|||
37940639|NCT00396877|69627676|FG000|Overall Study|Lost to Follow-up|2|||
37940640|NCT00396877|69627677|FG001|Overall Study|Lost to Follow-up|1|||
37940641|NCT00396877|69627676|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
38035245|NCT04013529|69722174|FG001|Overall Study|Withdrawal by Subject|1|||
37940642|NCT00396877|69627677|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
37940643|NCT00628251|69627686|FG000|Randomised Part|Withdrawal by Subject|0|||
37940644|NCT00628251|69627687|FG001|Randomised Part|Withdrawal by Subject|0|||
37940645|NCT00628251|69627688|FG002|Randomised Part|Withdrawal by Subject|1|||
37940646|NCT00628251|69627686|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
37940647|NCT00628251|69627687|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
37940648|NCT00628251|69627688|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
37940649|NCT00628251|69627686|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
37940650|NCT00628251|69627687|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
37940651|NCT00628251|69627688|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
37940652|NCT00628251|69627686|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
37940653|NCT00628251|69627687|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
37940654|NCT00628251|69627688|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
37940655|NCT00628251|69627686|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
37940656|NCT00628251|69627687|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
37940657|NCT00628251|69627688|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
37940658|NCT00628251|69627686|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
37940659|NCT00628251|69627687|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
37940660|NCT00628251|69627688|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
37940661|NCT00625131|69627700|FG000|Overall Study|Lost to Follow-up|3|||
37940662|NCT00625131|69627701|FG001|Overall Study|Lost to Follow-up|2|||
37940663|NCT00625131|69627702|FG002|Overall Study|Lost to Follow-up|0|||
37940664|NCT00625131|69627700|FG000|Overall Study|Withdrawal by Subject|1|||
37940665|NCT00625131|69627701|FG001|Overall Study|Withdrawal by Subject|0|||
37940666|NCT00625131|69627702|FG002|Overall Study|Withdrawal by Subject|5|||
37940667|NCT00408499|69627708|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
37940668|NCT00408499|69627709|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
37940669|NCT00408499|69627710|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
37940670|NCT00408499|69627711|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
37940671|NCT00408499|69627712|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
37940672|NCT00408499|69627708|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
37940673|NCT00408499|69627709|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
37940674|NCT00408499|69627710|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
37940675|NCT00408499|69627711|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
37940676|NCT00408499|69627712|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
37940677|NCT00408499|69627708|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
37940678|NCT00408499|69627709|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
37940679|NCT00408499|69627710|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
37940680|NCT00408499|69627711|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
37940681|NCT00408499|69627712|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
37940682|NCT00408499|69627708|FG000|Phase II- MTD Expansion|Adverse Event|0|||
37940683|NCT00408499|69627709|FG001|Phase II- MTD Expansion|Adverse Event|0|||
37940684|NCT00408499|69627710|FG002|Phase II- MTD Expansion|Adverse Event|0|||
37940685|NCT00408499|69627711|FG003|Phase II- MTD Expansion|Adverse Event|0|||
37940686|NCT00408499|69627712|FG004|Phase II- MTD Expansion|Adverse Event|9|||
37940687|NCT00408499|69627708|FG000|Phase II- MTD Expansion|Death|0|||
37940688|NCT00408499|69627709|FG001|Phase II- MTD Expansion|Death|0|||
37940689|NCT00408499|69627710|FG002|Phase II- MTD Expansion|Death|0|||
37940690|NCT00408499|69627711|FG003|Phase II- MTD Expansion|Death|0|||
37940691|NCT00408499|69627712|FG004|Phase II- MTD Expansion|Death|2|||
37940692|NCT00408499|69627708|FG000|Phase II- MTD Expansion|Physician Decision|0|||
37940693|NCT00408499|69627709|FG001|Phase II- MTD Expansion|Physician Decision|0|||
37940694|NCT00408499|69627710|FG002|Phase II- MTD Expansion|Physician Decision|0|||
37940695|NCT00408499|69627711|FG003|Phase II- MTD Expansion|Physician Decision|0|||
37940696|NCT00408499|69627712|FG004|Phase II- MTD Expansion|Physician Decision|1|||
37940697|NCT00408499|69627708|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
37940698|NCT00408499|69627709|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
37940699|NCT00408499|69627710|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
37940700|NCT00408499|69627711|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
37940701|NCT00408499|69627712|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
37940702|NCT00408499|69627708|FG000|Phase II- MTD Expansion|treatment delay|0|||
37940703|NCT00408499|69627709|FG001|Phase II- MTD Expansion|treatment delay|0|||
37940704|NCT00408499|69627710|FG002|Phase II- MTD Expansion|treatment delay|0|||
37940705|NCT00408499|69627711|FG003|Phase II- MTD Expansion|treatment delay|0|||
37765185|NCT01530464|69278410|FG001|Washout (24h)|Withdrawal by Subject|0|||
37765186|NCT01530464|69278409|FG000|Washout (24h)|Withdrawal by Subject|0|||
37765187|NCT01530464|69278410|FG001|Washout (24h)|Withdrawal by Subject|1|||
37940706|NCT00408499|69627712|FG004|Phase II- MTD Expansion|treatment delay|3|||
37940707|NCT00621777|69627732|FG000|Open Phase|Adverse Event|20|||
37940708|NCT00621777|69627733|FG001|Open Phase|Adverse Event|0|||
37940709|NCT00621777|69627732|FG000|Open Phase|Did not abstain during open phase|56|||
37940710|NCT00621777|69627733|FG001|Open Phase|Did not abstain during open phase|0|||
37940711|NCT00621777|69627732|FG000|Open Phase|Withdrawal by Subject|17|||
37940712|NCT00621777|69627733|FG001|Open Phase|Withdrawal by Subject|0|||
37940713|NCT00621777|69627732|FG000|Open Phase|administrative|13|||
37940714|NCT00621777|69627733|FG001|Open Phase|administrative|0|||
37940715|NCT00621777|69627732|FG000|Open Phase|Lost to Follow-up|10|||
37940716|NCT00621777|69627733|FG001|Open Phase|Lost to Follow-up|0|||
37940717|NCT00621777|69627732|FG000|Randomized Phase|Adverse Event|3|||
37940718|NCT00621777|69627733|FG001|Randomized Phase|Adverse Event|3|||
37940719|NCT00621777|69627732|FG000|Randomized Phase|Lost to Follow-up|3|||
37940720|NCT00621777|69627733|FG001|Randomized Phase|Lost to Follow-up|3|||
37940721|NCT00621777|69627732|FG000|Randomized Phase|Withdrawal by Subject|1|||
37940722|NCT00621777|69627733|FG001|Randomized Phase|Withdrawal by Subject|9|||
37940723|NCT00621777|69627732|FG000|Randomized Phase|administrative|0|||
37940724|NCT00621777|69627733|FG001|Randomized Phase|administrative|3|||
37940725|NCT00621777|69627732|FG000|Randomized Phase|Death|0|||
37940726|NCT00621777|69627733|FG001|Randomized Phase|Death|1|||
37940727|NCT00408421|69627743|FG000|Treatment Initial Randomization|Adverse Event|5|||
37940728|NCT00408421|69627744|FG001|Treatment Initial Randomization|Adverse Event|9|||
37940729|NCT00408421|69627745|FG002|Treatment Initial Randomization|Adverse Event|0|||
37940730|NCT00408421|69627743|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
37940731|NCT00408421|69627744|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
37940732|NCT00408421|69627745|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
37940733|NCT00408421|69627743|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
37940734|NCT00408421|69627744|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
37940735|NCT00408421|69627745|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
37940736|NCT00408421|69627743|FG000|Treatment Initial Randomization|Physician Decision|1|||
37940737|NCT00408421|69627744|FG001|Treatment Initial Randomization|Physician Decision|0|||
37940738|NCT00408421|69627745|FG002|Treatment Initial Randomization|Physician Decision|0|||
37940739|NCT00408421|69627743|FG000|Treatment Initial Randomization|Protocol Violation|0|||
37940740|NCT00408421|69627744|FG001|Treatment Initial Randomization|Protocol Violation|1|||
37940741|NCT00408421|69627745|FG002|Treatment Initial Randomization|Protocol Violation|0|||
37940742|NCT00408421|69627743|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
37940743|NCT00408421|69627744|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
37940744|NCT00408421|69627745|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
37940745|NCT00408421|69627743|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
37940746|NCT00408421|69627744|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
37940747|NCT00408421|69627745|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
37940748|NCT00408421|69627743|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
37940749|NCT00408421|69627744|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
37940750|NCT00408421|69627745|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
37940751|NCT00408421|69627743|FG000|Treatment Re-Randomization|Adverse Event|2|||
37940752|NCT00408421|69627744|FG001|Treatment Re-Randomization|Adverse Event|2|||
37940753|NCT00408421|69627745|FG002|Treatment Re-Randomization|Adverse Event|4|||
37940754|NCT00408421|69627743|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
37940755|NCT00408421|69627744|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
37940756|NCT00408421|69627745|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
37940757|NCT00408421|69627743|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
37940758|NCT00408421|69627744|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
37940759|NCT00408421|69627745|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
37940760|NCT00408421|69627743|FG000|Treatment Re-Randomization|Physician Decision|1|||
37940761|NCT00408421|69627744|FG001|Treatment Re-Randomization|Physician Decision|3|||
37940762|NCT00408421|69627745|FG002|Treatment Re-Randomization|Physician Decision|0|||
37940763|NCT00408421|69627743|FG000|Treatment Re-Randomization|Protocol Violation|1|||
37940764|NCT00408421|69627744|FG001|Treatment Re-Randomization|Protocol Violation|1|||
37940765|NCT00408421|69627745|FG002|Treatment Re-Randomization|Protocol Violation|0|||
37940766|NCT00408421|69627743|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
37940767|NCT00408421|69627744|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
37940768|NCT00408421|69627745|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
37940769|NCT00604786|69627755|FG000|Overall Study|Lost to Follow-up|2|||
37940770|NCT00604786|69627756|FG001|Overall Study|Lost to Follow-up|0|||
37940771|NCT00604708|69627764|FG000|Overall Study|Withdrawal by Subject|9|||
37940772|NCT00604708|69627765|FG001|Overall Study|Withdrawal by Subject|10|||
37940773|NCT00604708|69627764|FG000|Overall Study|Protocol Violation|2|||
37940774|NCT00604708|69627765|FG001|Overall Study|Protocol Violation|8|||
37940775|NCT00604708|69627764|FG000|Overall Study|Lost to Follow-up|5|||
37940776|NCT00604708|69627765|FG001|Overall Study|Lost to Follow-up|5|||
37940777|NCT00604708|69627764|FG000|Overall Study|administrative reasons|9|||
37940778|NCT00604708|69627765|FG001|Overall Study|administrative reasons|11|||
37940779|NCT00604708|69627764|FG000|Overall Study|Adverse Event|6|||
37940780|NCT00604708|69627765|FG001|Overall Study|Adverse Event|6|||
37940781|NCT00407797|69627771|FG000|Overall Study|Lost to Follow-up|2|||
37940782|NCT00407797|69627771|FG000|Overall Study|Adverse Event|6|||
37940783|NCT00407797|69627771|FG000|Overall Study|Other|7|||
37940784|NCT00407797|69627771|FG000|Overall Study|Withdrawal by Subject|3|||
37940785|NCT00568126|69627777|FG000|Overall Study|Adverse Event|3|||
37940786|NCT00568126|69627778|FG001|Overall Study|Adverse Event|0|||
37940787|NCT00568126|69627777|FG000|Overall Study|Withdrawal by Subject|2|||
37940788|NCT00568126|69627778|FG001|Overall Study|Withdrawal by Subject|3|||
37940789|NCT00568126|69627777|FG000|Overall Study|Lost to Follow-up|4|||
37940790|NCT00568126|69627778|FG001|Overall Study|Lost to Follow-up|3|||
37940791|NCT00568126|69627777|FG000|Overall Study|Lack of Efficacy|0|||
37940792|NCT00568126|69627778|FG001|Overall Study|Lack of Efficacy|1|||
37940793|NCT00568126|69627777|FG000|Overall Study|Physician Decision|2|||
37940794|NCT00568126|69627778|FG001|Overall Study|Physician Decision|2|||
37940795|NCT00407563|69627784|FG000|Overall Study|Patient continues on treatment|1|||
37940796|NCT00567892|69627790|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
37940797|NCT00567892|69627791|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
37940798|NCT00567892|69627792|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
37940799|NCT00567892|69627793|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
37940800|NCT00567892|69627790|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
38035246|NCT04011735|69722183|FG000|Overall Study|Withdrawal by Subject|1|||
38035247|NCT04011735|69722184|FG001|Overall Study|Withdrawal by Subject|0|||
38035248|NCT04011735|69722185|FG002|Overall Study|Withdrawal by Subject|1|||
38035249|NCT04011735|69722183|FG000|Overall Study|Met exclusion criteria after study entry|0|||
38035250|NCT04011735|69722184|FG001|Overall Study|Met exclusion criteria after study entry|1|||
38035251|NCT04011735|69722185|FG002|Overall Study|Met exclusion criteria after study entry|0|||
38035252|NCT04009629|69722197|FG000|Overall Study|Withdrawal by Subject|2|||
37859643|NCT00956293|69542970|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
37859644|NCT00956293|69542971|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
37859645|NCT00956293|69542969|FG000|Main Period (Pre-randomization)|Graft loss|0|||
37859646|NCT00956293|69542970|FG001|Main Period (Pre-randomization)|Graft loss|0|||
37859647|NCT00956293|69542971|FG002|Main Period (Pre-randomization)|Graft loss|7|||
37859648|NCT00956293|69542969|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
37859649|NCT00956293|69542970|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
37859650|NCT00956293|69542971|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
37859651|NCT00956293|69542969|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
37859652|NCT00956293|69542970|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
37859653|NCT00956293|69542971|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
37859654|NCT00956293|69542969|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
37859655|NCT00956293|69542970|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
37859656|NCT00956293|69542971|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
37859657|NCT00956293|69542969|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
37859658|NCT00956293|69542970|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
37859659|NCT00956293|69542971|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
37859660|NCT00956293|69542969|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
37859661|NCT00956293|69542970|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
37859662|NCT00956293|69542971|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
37859663|NCT00956293|69542969|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
37859664|NCT00956293|69542970|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
37859665|NCT00956293|69542971|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
37859666|NCT00956293|69542969|FG000|Main Period (Randomization)|Adverse Event|0|||
37859667|NCT00956293|69542970|FG001|Main Period (Randomization)|Adverse Event|15|||
37859668|NCT00956293|69542971|FG002|Main Period (Randomization)|Adverse Event|0|||
37859669|NCT00956293|69542969|FG000|Follow-up Period|Follow-up period was terminated.|20|||
37859670|NCT00956293|69542970|FG001|Follow-up Period|Follow-up period was terminated.|32|||
37859671|NCT00956293|69542971|FG002|Follow-up Period|Follow-up period was terminated.|0|||
37859672|NCT00955825|69542979|FG000|Overall Study|Adverse Event|15|||
37859673|NCT00955825|69542980|FG001|Overall Study|Adverse Event|2|||
37859674|NCT00955825|69542979|FG000|Overall Study|Withdrawal by Subject|4|||
37859675|NCT00955825|69542980|FG001|Overall Study|Withdrawal by Subject|6|||
37859676|NCT00955825|69542979|FG000|Overall Study|Any other reason not above-mentioned|7|||
37859677|NCT00955825|69542980|FG001|Overall Study|Any other reason not above-mentioned|9|||
37859678|NCT01164579|69542989|FG000|Overall Study|Lack of Efficacy|0|||
37859679|NCT01164579|69542990|FG001|Overall Study|Lack of Efficacy|0|||
37859680|NCT01164579|69542991|FG002|Overall Study|Lack of Efficacy|6|||
37859681|NCT01164579|69542989|FG000|Overall Study|Lost to Follow-up|1|||
37859682|NCT01164579|69542990|FG001|Overall Study|Lost to Follow-up|1|||
37859683|NCT01164579|69542991|FG002|Overall Study|Lost to Follow-up|0|||
37859684|NCT01164579|69542989|FG000|Overall Study|Withdrawal by Subject|2|||
37859685|NCT01164579|69542990|FG001|Overall Study|Withdrawal by Subject|5|||
37859686|NCT01164579|69542991|FG002|Overall Study|Withdrawal by Subject|3|||
37859687|NCT01164579|69542989|FG000|Overall Study|Protocol Violation|0|||
37859688|NCT01164579|69542990|FG001|Overall Study|Protocol Violation|1|||
37859689|NCT01164579|69542991|FG002|Overall Study|Protocol Violation|2|||
37859690|NCT01164579|69542989|FG000|Overall Study|Adverse Event|4|||
37940801|NCT00567892|69627791|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
37940802|NCT00567892|69627792|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
37940803|NCT00567892|69627793|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
37940804|NCT00623103|69627807|FG000|Overall Study|Adverse Event|70|||
37940805|NCT00623103|69627808|FG001|Overall Study|Adverse Event|60|||
37940806|NCT00623103|69627807|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
37940807|NCT00623103|69627808|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
37940808|NCT00623103|69627807|FG000|Overall Study|Withdrawal by Subject|18|||
37940809|NCT00623103|69627808|FG001|Overall Study|Withdrawal by Subject|24|||
37940810|NCT00623103|69627807|FG000|Overall Study|Lost to Follow-up|4|||
37940811|NCT00623103|69627808|FG001|Overall Study|Lost to Follow-up|1|||
37940812|NCT00623103|69627807|FG000|Overall Study|Administrative problems|2|||
37940813|NCT00623103|69627808|FG001|Overall Study|Administrative problems|4|||
37940814|NCT00623103|69627807|FG000|Overall Study|Death|11|||
37940815|NCT00623103|69627808|FG001|Overall Study|Death|11|||
37940816|NCT00623103|69627807|FG000|Overall Study|Protocol deviation|2|||
37940817|NCT00623103|69627808|FG001|Overall Study|Protocol deviation|1|||
37940818|NCT00396565|69627817|FG000|Overall Study|Physician Decision|3|||
37940819|NCT00396565|69627818|FG001|Overall Study|Physician Decision|1|||
37940820|NCT00396565|69627819|FG002|Overall Study|Physician Decision|2|||
37940821|NCT00396565|69627817|FG000|Overall Study|Adverse Event|5|||
37940822|NCT00396565|69627818|FG001|Overall Study|Adverse Event|13|||
37940823|NCT00396565|69627819|FG002|Overall Study|Adverse Event|3|||
37940824|NCT00396565|69627817|FG000|Overall Study|Withdrawal by Subject|8|||
37940825|NCT00396565|69627818|FG001|Overall Study|Withdrawal by Subject|13|||
37940826|NCT00396565|69627819|FG002|Overall Study|Withdrawal by Subject|1|||
37940827|NCT00396565|69627817|FG000|Overall Study|Lack of Efficacy|32|||
37940828|NCT00396565|69627818|FG001|Overall Study|Lack of Efficacy|64|||
37940829|NCT00396565|69627819|FG002|Overall Study|Lack of Efficacy|11|||
37940830|NCT00394771|69627831|FG000|Overall Study|Did not meet protocol requirements|1|||
37940831|NCT00394771|69627832|FG001|Overall Study|Did not meet protocol requirements|0|||
37940832|NCT00394771|69627833|FG002|Overall Study|Did not meet protocol requirements|2|||
37940833|NCT00394771|69627834|FG003|Overall Study|Did not meet protocol requirements|0|||
37940834|NCT00394771|69627831|FG000|Overall Study|Protocol Violation|2|||
37940835|NCT00394771|69627832|FG001|Overall Study|Protocol Violation|4|||
37940836|NCT00394771|69627833|FG002|Overall Study|Protocol Violation|9|||
37940837|NCT00394771|69627834|FG003|Overall Study|Protocol Violation|7|||
37940838|NCT00394771|69627831|FG000|Overall Study|Withdrawal by Subject|10|||
37940839|NCT00394771|69627832|FG001|Overall Study|Withdrawal by Subject|6|||
37940840|NCT00394771|69627833|FG002|Overall Study|Withdrawal by Subject|8|||
37940841|NCT00394771|69627834|FG003|Overall Study|Withdrawal by Subject|12|||
37940842|NCT00394771|69627831|FG000|Overall Study|Adverse Event|10|||
37940843|NCT00394771|69627832|FG001|Overall Study|Adverse Event|5|||
37940844|NCT00394771|69627833|FG002|Overall Study|Adverse Event|12|||
37940845|NCT00394771|69627834|FG003|Overall Study|Adverse Event|8|||
37940846|NCT00394771|69627831|FG000|Overall Study|Participant pregnant|0|||
37940847|NCT00394771|69627832|FG001|Overall Study|Participant pregnant|1|||
37940848|NCT00394771|69627833|FG002|Overall Study|Participant pregnant|2|||
37940849|NCT00394771|69627834|FG003|Overall Study|Participant pregnant|2|||
37940850|NCT00394771|69627831|FG000|Overall Study|Lost to Follow-up|15|||
37940851|NCT00394771|69627832|FG001|Overall Study|Lost to Follow-up|15|||
37940852|NCT00394771|69627833|FG002|Overall Study|Lost to Follow-up|13|||
37940853|NCT00394771|69627834|FG003|Overall Study|Lost to Follow-up|10|||
37940854|NCT00394771|69627831|FG000|Overall Study|Other|3|||
37940855|NCT00394771|69627832|FG001|Overall Study|Other|3|||
37940856|NCT00394771|69627833|FG002|Overall Study|Other|1|||
37940857|NCT00394771|69627834|FG003|Overall Study|Other|0|||
37940858|NCT00396409|69627846|FG000|Period 1 - 2007|Adverse Event|0|||
37940859|NCT00396409|69627847|FG001|Period 1 - 2007|Adverse Event|1|||
37940860|NCT00396409|69627846|FG000|Period 1 - 2007|Lack of Efficacy|0|||
37940861|NCT00396409|69627847|FG001|Period 1 - 2007|Lack of Efficacy|1|||
37940862|NCT00396409|69627846|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
37940863|NCT00396409|69627847|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
37940864|NCT00396409|69627846|FG000|Period 1 - 2007|Lost to Follow-up|2|||
37940865|NCT00396409|69627847|FG001|Period 1 - 2007|Lost to Follow-up|3|||
37940866|NCT00396409|69627846|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
37940867|NCT00396409|69627847|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
37940868|NCT00396409|69627846|FG000|Period 2 - 2008|Protocol Violation|1|||
37940869|NCT00396409|69627847|FG001|Period 2 - 2008|Protocol Violation|0|||
37940870|NCT00396409|69627846|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
37940871|NCT00396409|69627847|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
37940872|NCT00396409|69627846|FG000|Period 2 - 2008|Lost to Follow-up|3|||
37940873|NCT00396409|69627847|FG001|Period 2 - 2008|Lost to Follow-up|1|||
37940874|NCT02924376|69627859|FG000|Overall Study|Progressive Disease|4|||
37940875|NCT02924376|69627860|FG001|Overall Study|Progressive Disease|0|||
37940876|NCT02924376|69627861|FG002|Overall Study|Progressive Disease|1|||
37940877|NCT02924376|69627862|FG003|Overall Study|Progressive Disease|0|||
37940878|NCT02924376|69627859|FG000|Overall Study|Death|73|||
37940879|NCT02924376|69627860|FG001|Overall Study|Death|18|||
37940880|NCT02924376|69627861|FG002|Overall Study|Death|15|||
37940881|NCT02924376|69627862|FG003|Overall Study|Death|2|||
37940882|NCT02924376|69627859|FG000|Overall Study|Lost to Follow-up|3|||
37940883|NCT02924376|69627860|FG001|Overall Study|Lost to Follow-up|0|||
37940884|NCT02924376|69627861|FG002|Overall Study|Lost to Follow-up|0|||
37940885|NCT02924376|69627862|FG003|Overall Study|Lost to Follow-up|0|||
37940886|NCT02924376|69627859|FG000|Overall Study|Study Terminated by Sponsor|19|||
37940887|NCT02924376|69627860|FG001|Overall Study|Study Terminated by Sponsor|0|||
37940888|NCT02924376|69627861|FG002|Overall Study|Study Terminated by Sponsor|0|||
37940889|NCT02924376|69627862|FG003|Overall Study|Study Terminated by Sponsor|0|||
37940890|NCT02924376|69627859|FG000|Overall Study|Physician Decision|1|||
37940891|NCT02924376|69627860|FG001|Overall Study|Physician Decision|0|||
37940892|NCT02924376|69627861|FG002|Overall Study|Physician Decision|0|||
37940893|NCT02924376|69627862|FG003|Overall Study|Physician Decision|0|||
37940894|NCT02924376|69627859|FG000|Overall Study|Withdrawal by Subject|7|||
37940895|NCT02924376|69627860|FG001|Overall Study|Withdrawal by Subject|2|||
37940896|NCT02924376|69627861|FG002|Overall Study|Withdrawal by Subject|1|||
37940897|NCT02924376|69627862|FG003|Overall Study|Withdrawal by Subject|0|||
37940898|NCT02924376|69627859|FG000|Overall Study|Rolled Over to Another Study|1|||
37940899|NCT02924376|69627860|FG001|Overall Study|Rolled Over to Another Study|0|||
37940900|NCT02924376|69627861|FG002|Overall Study|Rolled Over to Another Study|0|||
37940901|NCT02924376|69627862|FG003|Overall Study|Rolled Over to Another Study|0|||
37940902|NCT00693420|69627877|FG000|Overall Study|Adverse Event|4|||
37940903|NCT00693420|69627878|FG001|Overall Study|Adverse Event|4|||
37940904|NCT00693420|69627877|FG000|Overall Study|Lost to Follow-up|0|||
37940905|NCT00693420|69627878|FG001|Overall Study|Lost to Follow-up|3|||
37940906|NCT00693420|69627877|FG000|Overall Study|Withdrawal by Subject|1|||
37940907|NCT00693420|69627878|FG001|Overall Study|Withdrawal by Subject|0|||
37940908|NCT00693420|69627877|FG000|Overall Study|Protocol Violation|0|||
37940909|NCT00693420|69627878|FG001|Overall Study|Protocol Violation|2|||
37940910|NCT00693420|69627877|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
37940911|NCT00693420|69627878|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
37940912|NCT00693420|69627877|FG000|Overall Study|Personal Reasons|1|||
37940913|NCT00693420|69627878|FG001|Overall Study|Personal Reasons|4|||
37940914|NCT00695136|69627884|FG000|Overall Study|Withdrawal by Subject|1|||
37940915|NCT00695136|69627884|FG000|Overall Study|unrelated adverse event|1|||
37940916|NCT00605176|69627900|FG000|Overall Study|Adverse Event|2|||
37940917|NCT00605176|69627901|FG001|Overall Study|Adverse Event|1|||
37940918|NCT00605176|69627902|FG002|Overall Study|Adverse Event|3|||
37940919|NCT00605176|69627900|FG000|Overall Study|Withdrawal by Subject|4|||
37940920|NCT00605176|69627901|FG001|Overall Study|Withdrawal by Subject|2|||
37940921|NCT00605176|69627902|FG002|Overall Study|Withdrawal by Subject|4|||
37940922|NCT00605176|69627900|FG000|Overall Study|Lost to Follow-up|2|||
37940923|NCT00605176|69627901|FG001|Overall Study|Lost to Follow-up|2|||
37940924|NCT00605176|69627902|FG002|Overall Study|Lost to Follow-up|1|||
37940925|NCT00605176|69627900|FG000|Overall Study|Non-complicance with study procedures|1|||
37940926|NCT00605176|69627901|FG001|Overall Study|Non-complicance with study procedures|0|||
37940927|NCT00605176|69627902|FG002|Overall Study|Non-complicance with study procedures|0|||
37670415|NCT02085460|69143659|FG002|Overall Study|Physician Decision|2|||
37859691|NCT01164579|69542990|FG001|Overall Study|Adverse Event|2|||
37859692|NCT01164579|69542991|FG002|Overall Study|Adverse Event|5|||
37859693|NCT01164579|69542989|FG000|Overall Study|Reason not specified|1|||
37859694|NCT01164579|69542990|FG001|Overall Study|Reason not specified|0|||
37859695|NCT01164579|69542991|FG002|Overall Study|Reason not specified|0|||
37859696|NCT00958789|69543000|FG000|Overall Study|Death|5|||
37859697|NCT00958789|69543000|FG000|Overall Study|Lost to Follow-up|14|||
37859698|NCT00958789|69543000|FG000|Overall Study|Withdrawal by Subject|17|||
37859699|NCT00958789|69543000|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
37859700|NCT00958789|69543000|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
37859701|NCT00958789|69543000|FG000|Overall Study|Subject terminated|2|||
37859702|NCT00958789|69543000|FG000|Overall Study|Revision|7|||
37859703|NCT02445391|69543011|FG000|Overall Study|No active protocol treatment|3|||
37859704|NCT02445391|69543012|FG001|Overall Study|No active protocol treatment|0|||
37859705|NCT02445391|69543013|FG002|Overall Study|No active protocol treatment|0|||
37859706|NCT02445391|69543011|FG000|Overall Study|Adverse Event|0|||
37859707|NCT02445391|69543012|FG001|Overall Study|Adverse Event|21|||
37859708|NCT02445391|69543013|FG002|Overall Study|Adverse Event|12|||
37859709|NCT02445391|69543011|FG000|Overall Study|Alternative therapy|0|||
37859710|NCT02445391|69543012|FG001|Overall Study|Alternative therapy|0|||
37859711|NCT02445391|69543013|FG002|Overall Study|Alternative therapy|1|||
37859712|NCT02445391|69543011|FG000|Overall Study|Disease progression|0|||
37859713|NCT02445391|69543012|FG001|Overall Study|Disease progression|7|||
37859714|NCT02445391|69543013|FG002|Overall Study|Disease progression|22|||
37859715|NCT02445391|69543011|FG000|Overall Study|Complicating disease|0|||
37859716|NCT02445391|69543012|FG001|Overall Study|Complicating disease|2|||
37940928|NCT00605176|69627900|FG000|Overall Study|Use of concomitant therapy|1|||
37940929|NCT00605176|69627901|FG001|Overall Study|Use of concomitant therapy|0|||
37940930|NCT00605176|69627902|FG002|Overall Study|Use of concomitant therapy|1|||
37940931|NCT00605176|69627900|FG000|Overall Study|Other (not due to AE)|1|||
37940932|NCT00605176|69627901|FG001|Overall Study|Other (not due to AE)|1|||
37940933|NCT00605176|69627902|FG002|Overall Study|Other (not due to AE)|0|||
37940934|NCT00694356|69627913|FG000|Overall Study|Adverse Event|1|||
37940935|NCT00694356|69627914|FG001|Overall Study|Adverse Event|0|||
37940936|NCT00694356|69627915|FG002|Overall Study|Adverse Event|0|||
37940937|NCT00694356|69627913|FG000|Overall Study|Progressive Disease|2|||
37940938|NCT00694356|69627914|FG001|Overall Study|Progressive Disease|6|||
37940939|NCT00694356|69627915|FG002|Overall Study|Progressive Disease|6|||
37940940|NCT00692406|69627923|FG000|Overall Study|PI dropped, bad data|57|||
37940941|NCT00567502|69627940|FG000|Overall Study|Lost to Follow-up|91|||
37940942|NCT00567502|69627941|FG001|Overall Study|Lost to Follow-up|14|||
37940943|NCT00567502|69627942|FG002|Overall Study|Lost to Follow-up|351|||
37940944|NCT00567502|69627943|FG003|Overall Study|Lost to Follow-up|2|||
38035253|NCT04009629|69722198|FG001|Overall Study|Withdrawal by Subject|0|||
38035269|NCT03694197|69722219|FG000|Overall Study|Adverse Event|9|||
38035270|NCT03694197|69722219|FG000|Overall Study|Protocol became inconvenient to participate|1|||
38035271|NCT03694197|69722219|FG000|Overall Study|Physician Decision|4|||
38035272|NCT03694197|69722219|FG000|Overall Study|Study terminated by sponsor|1350|||
38035273|NCT03694197|69722219|FG000|Overall Study|Participant moved|5|||
38035274|NCT03694197|69722219|FG000|Overall Study|Participant withdrew consent|10|||
38035275|NCT03694197|69722219|FG000|Overall Study|Related to IMP administration|1|||
38035276|NCT03694197|69722219|FG000|Overall Study|Not disclosed|5|||
37940945|NCT00567502|69627940|FG000|Overall Study|Death|65|||
37940946|NCT00567502|69627941|FG001|Overall Study|Death|16|||
37940947|NCT00567502|69627942|FG002|Overall Study|Death|360|||
37940948|NCT00567502|69627943|FG003|Overall Study|Death|5|||
37940949|NCT00567502|69627940|FG000|Overall Study|Other|64|||
37940950|NCT00567502|69627941|FG001|Overall Study|Other|2|||
37940951|NCT00567502|69627942|FG002|Overall Study|Other|134|||
37940952|NCT00567502|69627943|FG003|Overall Study|Other|6|||
37940953|NCT00567502|69627940|FG000|Overall Study|Participant request|12|||
37940954|NCT00567502|69627941|FG001|Overall Study|Participant request|1|||
37940955|NCT00567502|69627942|FG002|Overall Study|Participant request|33|||
37940956|NCT00567502|69627943|FG003|Overall Study|Participant request|1|||
37940957|NCT00567502|69627940|FG000|Overall Study|Sponsor request|9|||
37940958|NCT00567502|69627941|FG001|Overall Study|Sponsor request|0|||
37940959|NCT00567502|69627942|FG002|Overall Study|Sponsor request|30|||
37940960|NCT00567502|69627943|FG003|Overall Study|Sponsor request|1|||
37940961|NCT00567502|69627940|FG000|Overall Study|Never Initiated Treatment|0|||
37940962|NCT00567502|69627941|FG001|Overall Study|Never Initiated Treatment|0|||
37940963|NCT00567502|69627942|FG002|Overall Study|Never Initiated Treatment|0|||
37940964|NCT00567502|69627943|FG003|Overall Study|Never Initiated Treatment|72|||
38035277|NCT04365699|69722226|FG000|Overall Study|Death|2|||
38035278|NCT04365699|69722227|FG001|Overall Study|Death|5|||
37940965|NCT00396331|69627968|FG000|Overall Study|Failed to mobilize - no transplant|8|||
37940966|NCT00396331|69627968|FG000|Overall Study|Did not go on to transplant|5|||
37940967|NCT00396331|69627968|FG000|Overall Study|Lost to Follow-up|3|||
37940968|NCT00396331|69627968|FG000|Overall Study|Death|16|||
37940969|NCT00396253|69627980|FG000|Overall Study|Protocol Violation|1|||
38035279|NCT04365699|69722228|FG002|Overall Study|Death|15|||
37940970|NCT00396253|69627980|FG000|Overall Study|Withdrawal by Subject|7|||
37940971|NCT00396253|69627980|FG000|Overall Study|Death|3|||
37940972|NCT00396253|69627980|FG000|Overall Study|Physician Decision|1|||
37940973|NCT00396253|69627980|FG000|Overall Study|Change in eligibility status|1|||
37940974|NCT00604162|69627984|FG000|Overall Study|Physician Decision|3|||
37940975|NCT00604162|69627984|FG000|Overall Study|Withdrawal by Subject|1|||
38035280|NCT04005885|69722236|FG000|First Intervention|Withdrawal by Subject|1|||
37940976|NCT00396097|69627993|FG000|Overall Study|Withdrawal by Subject|17|||
37940977|NCT00396097|69627994|FG001|Overall Study|Withdrawal by Subject|17|||
37940978|NCT00396097|69627993|FG000|Overall Study|Lost to Follow-up|4|||
37940979|NCT00396097|69627994|FG001|Overall Study|Lost to Follow-up|9|||
37940980|NCT00396097|69627993|FG000|Overall Study|Other|3|||
37940981|NCT00396097|69627994|FG001|Overall Study|Other|5|||
37940982|NCT00396097|69627993|FG000|Overall Study|Protocol Violation|0|||
37940983|NCT00396097|69627994|FG001|Overall Study|Protocol Violation|6|||
37940984|NCT00396097|69627993|FG000|Overall Study|Adverse Event|1|||
37940985|NCT00396097|69627994|FG001|Overall Study|Adverse Event|5|||
37940986|NCT00396097|69627993|FG000|Overall Study|Insufficient Clinical Response|1|||
37940987|NCT00396097|69627994|FG001|Overall Study|Insufficient Clinical Response|4|||
37940988|NCT00375505|69628006|FG000|Overall Study|Adverse Event|1|||
37940989|NCT00375505|69628007|FG001|Overall Study|Adverse Event|2|||
37940990|NCT00375427|69628015|FG000|Overall Study|Adverse Event|21|||
37940991|NCT00375427|69628016|FG001|Overall Study|Adverse Event|27|||
37940992|NCT00375427|69628015|FG000|Overall Study|Abnormal test procedure result(s)|0|||
37940993|NCT00375427|69628016|FG001|Overall Study|Abnormal test procedure result(s)|1|||
37940994|NCT00375427|69628015|FG000|Overall Study|Abnormal laboratory value(s)|1|||
37940995|NCT00375427|69628016|FG001|Overall Study|Abnormal laboratory value(s)|2|||
37940996|NCT00375427|69628015|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
37940997|NCT00375427|69628016|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
37940998|NCT00375427|69628015|FG000|Overall Study|Patient no longer requires study drug|3|||
37940999|NCT00375427|69628016|FG001|Overall Study|Patient no longer requires study drug|7|||
37941000|NCT00375427|69628015|FG000|Overall Study|Protocol Violation|10|||
37941001|NCT00375427|69628016|FG001|Overall Study|Protocol Violation|8|||
37941002|NCT00375427|69628015|FG000|Overall Study|Withdrawal by Subject|9|||
37941003|NCT00375427|69628016|FG001|Overall Study|Withdrawal by Subject|13|||
37941004|NCT00375427|69628015|FG000|Overall Study|Lost to Follow-up|1|||
37941005|NCT00375427|69628016|FG001|Overall Study|Lost to Follow-up|1|||
37941006|NCT00375427|69628015|FG000|Overall Study|Administrative reasons|0|||
37941007|NCT00375427|69628016|FG001|Overall Study|Administrative reasons|1|||
37941008|NCT00375427|69628015|FG000|Overall Study|Death|11|||
37941009|NCT00375427|69628016|FG001|Overall Study|Death|10|||
37941010|NCT00393913|69628022|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
37941011|NCT00393913|69628022|FG000|Initial Assessment|Withdrawal by Subject|16|||
37941012|NCT00393913|69628022|FG000|CPAP|Withdrawal by Subject|3|||
37941013|NCT00393913|69628022|FG000|CPAP|Physician Decision|1|||
37941014|NCT00393913|69628022|FG000|CPAP|TEchnical problem with CPAP|3|||
37941015|NCT00567268|69628027|FG000|Overall Study|Protocol Violation|7|||
37941016|NCT00567268|69628027|FG000|Overall Study|Lost to Follow-up|36|||
37941017|NCT00567268|69628027|FG000|Overall Study|No Visit After First Day of Treatment|2|||
37941018|NCT00567268|69628027|FG000|Overall Study|No Drug Administration|4|||
37941019|NCT00567268|69628027|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
37941020|NCT03976648|69628068|FG000|Overall Study|Adverse Event|0|||
37941021|NCT03976648|69628069|FG001|Overall Study|Adverse Event|2|||
37941022|NCT03976648|69628068|FG000|Overall Study|Study terminated by sponsor|21|||
37941023|NCT03976648|69628069|FG001|Overall Study|Study terminated by sponsor|8|||
37941024|NCT00566254|69628077|FG000|Overall Study|Adverse Event|3|||
37941025|NCT00566254|69628078|FG001|Overall Study|Adverse Event|1|||
37941026|NCT00566254|69628077|FG000|Overall Study|Protocol Violation|1|||
37941027|NCT00566254|69628078|FG001|Overall Study|Protocol Violation|3|||
37941028|NCT00566254|69628077|FG000|Overall Study|Withdrawal by Subject|1|||
37941029|NCT00566254|69628078|FG001|Overall Study|Withdrawal by Subject|2|||
37941030|NCT00566254|69628077|FG000|Overall Study|Lack of Efficacy|5|||
37941031|NCT00566254|69628078|FG001|Overall Study|Lack of Efficacy|6|||
37941032|NCT00566254|69628077|FG000|Overall Study|Other|0|||
37941033|NCT00566254|69628078|FG001|Overall Study|Other|2|||
37941034|NCT00393523|69628089|FG000|Overall Study|Lost to Follow-up|0|||
37941035|NCT00393523|69628090|FG001|Overall Study|Lost to Follow-up|0|||
37941036|NCT00393523|69628091|FG002|Overall Study|Lost to Follow-up|0|||
37941037|NCT00393523|69628092|FG003|Overall Study|Lost to Follow-up|2|||
37941038|NCT00393523|69628093|FG004|Overall Study|Lost to Follow-up|1|||
38035281|NCT04005885|69722237|FG001|First Intervention|Withdrawal by Subject|1|||
37941039|NCT00393523|69628089|FG000|Overall Study|Protocol Violation|6|||
37941040|NCT00393523|69628090|FG001|Overall Study|Protocol Violation|2|||
37941041|NCT00393523|69628091|FG002|Overall Study|Protocol Violation|0|||
37941042|NCT00393523|69628092|FG003|Overall Study|Protocol Violation|1|||
37941043|NCT00393523|69628093|FG004|Overall Study|Protocol Violation|0|||
37941044|NCT00393523|69628089|FG000|Overall Study|Withdrawal by Subject|6|||
37941045|NCT00393523|69628090|FG001|Overall Study|Withdrawal by Subject|7|||
37941046|NCT00393523|69628091|FG002|Overall Study|Withdrawal by Subject|2|||
37941047|NCT00393523|69628092|FG003|Overall Study|Withdrawal by Subject|3|||
37941048|NCT00393523|69628093|FG004|Overall Study|Withdrawal by Subject|0|||
37941049|NCT00393523|69628089|FG000|Overall Study|Difficulties in specimen collection|0|||
37941050|NCT00393523|69628090|FG001|Overall Study|Difficulties in specimen collection|0|||
37941051|NCT00393523|69628091|FG002|Overall Study|Difficulties in specimen collection|1|||
37941052|NCT00393523|69628092|FG003|Overall Study|Difficulties in specimen collection|0|||
37941053|NCT00393523|69628093|FG004|Overall Study|Difficulties in specimen collection|0|||
37941054|NCT00393523|69628089|FG000|Overall Study|Vaccine supply issue|0|||
37941055|NCT00393523|69628090|FG001|Overall Study|Vaccine supply issue|0|||
37941056|NCT00393523|69628091|FG002|Overall Study|Vaccine supply issue|1|||
37941057|NCT00393523|69628092|FG003|Overall Study|Vaccine supply issue|0|||
37941058|NCT00393523|69628093|FG004|Overall Study|Vaccine supply issue|0|||
37941059|NCT00393367|69628106|FG000|Overall Study|Protocol Violation|2|||
37941060|NCT00393367|69628107|FG001|Overall Study|Protocol Violation|5|||
37941061|NCT00393367|69628106|FG000|Overall Study|Withdrawal by Subject|0|||
37941062|NCT00393367|69628107|FG001|Overall Study|Withdrawal by Subject|2|||
37941063|NCT00395863|69628117|FG000|Overall Study|Patients did not complete both exams|2|||
37941064|NCT00395863|69628118|FG001|Overall Study|Patients did not complete both exams|3|||
37941065|NCT00395629|69628130|FG000|Core Study|Adverse Event|0|||
37941066|NCT00395629|69628131|FG001|Core Study|Adverse Event|3|||
37941067|NCT00395629|69628132|FG002|Core Study|Adverse Event|4|||
37941068|NCT00395629|69628130|FG000|Core Study|Abnormal laboratory value(s)|0|||
37941069|NCT00395629|69628131|FG001|Core Study|Abnormal laboratory value(s)|0|||
37941070|NCT00395629|69628132|FG002|Core Study|Abnormal laboratory value(s)|1|||
37941071|NCT00395629|69628130|FG000|Core Study|Protocol Violation|1|||
37941072|NCT00395629|69628131|FG001|Core Study|Protocol Violation|0|||
37941073|NCT00395629|69628132|FG002|Core Study|Protocol Violation|0|||
37941074|NCT00395629|69628130|FG000|Core Study|Withdrawal by Subject|0|||
37941075|NCT00395629|69628131|FG001|Core Study|Withdrawal by Subject|1|||
37941076|NCT00395629|69628132|FG002|Core Study|Withdrawal by Subject|1|||
37941077|NCT00395629|69628130|FG000|Core Study|Lost to Follow-up|0|||
37941078|NCT00395629|69628131|FG001|Core Study|Lost to Follow-up|0|||
37941079|NCT00395629|69628132|FG002|Core Study|Lost to Follow-up|1|||
37941080|NCT00395629|69628130|FG000|Extension Study|Adverse Event|0|||
37941081|NCT00395629|69628131|FG001|Extension Study|Adverse Event|0|||
37941082|NCT00395629|69628132|FG002|Extension Study|Adverse Event|2|||
37941083|NCT00395629|69628130|FG000|Extension Study|Administrative problems|0|||
37941084|NCT00395629|69628131|FG001|Extension Study|Administrative problems|0|||
37941085|NCT00395629|69628132|FG002|Extension Study|Administrative problems|1|||
37941086|NCT00392665|69628145|FG000|Overall Study|Death|16|||
37941087|NCT00392665|69628146|FG001|Overall Study|Death|14|||
37941088|NCT00392665|69628145|FG000|Overall Study|Lost to Follow-up|1|||
37941089|NCT00392665|69628146|FG001|Overall Study|Lost to Follow-up|1|||
37941090|NCT00622869|69628155|FG000|Overall Study|Subject Withdrew Consent|13|||
37941091|NCT00622869|69628156|FG001|Overall Study|Subject Withdrew Consent|17|||
37941092|NCT00622869|69628157|FG002|Overall Study|Subject Withdrew Consent|11|||
37941093|NCT00622869|69628155|FG000|Overall Study|Administrative Problems|11|||
37941094|NCT00622869|69628156|FG001|Overall Study|Administrative Problems|17|||
37941095|NCT00622869|69628157|FG002|Overall Study|Administrative Problems|13|||
37941096|NCT00622869|69628155|FG000|Overall Study|Death|12|||
37941097|NCT00622869|69628156|FG001|Overall Study|Death|15|||
37941098|NCT00622869|69628157|FG002|Overall Study|Death|10|||
37941099|NCT00622869|69628155|FG000|Overall Study|Lost to Follow-up|2|||
37941100|NCT00622869|69628156|FG001|Overall Study|Lost to Follow-up|4|||
37941101|NCT00622869|69628157|FG002|Overall Study|Lost to Follow-up|2|||
37941102|NCT00622869|69628155|FG000|Overall Study|Graft Loss|5|||
37941103|NCT00622869|69628156|FG001|Overall Study|Graft Loss|3|||
37941104|NCT00622869|69628157|FG002|Overall Study|Graft Loss|2|||
37765188|NCT01439945|69278477|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
37765189|NCT01439945|69278478|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
37941105|NCT00622869|69628155|FG000|Overall Study|Missing|0|||
37941106|NCT00622869|69628156|FG001|Overall Study|Missing|1|||
37941107|NCT00622869|69628157|FG002|Overall Study|Missing|1|||
37941108|NCT00395083|69628167|FG000|Overall Study|Withdrawal by Subject|6|||
37941109|NCT00395083|69628168|FG001|Overall Study|Withdrawal by Subject|5|||
37941110|NCT00395083|69628167|FG000|Overall Study|Developed another disease|4|||
37941111|NCT00395083|69628168|FG001|Overall Study|Developed another disease|3|||
37765190|NCT01439945|69278479|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
37941112|NCT00366457|69628174|FG000|Overall Study|never began study therapy|2|||
37941113|NCT00624819|69628182|FG000|Follow-up Period: Year 4|Parents decision|0|||
37941114|NCT00624819|69628183|FG001|Follow-up Period: Year 4|Parents decision|0|||
37941115|NCT00624819|69628184|FG002|Follow-up Period: Year 4|Parents decision|1|||
37941116|NCT00624819|69628185|FG003|Follow-up Period: Year 4|Parents decision|0|||
37941117|NCT00624819|69628182|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
37941118|NCT00624819|69628183|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
37941119|NCT00624819|69628184|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
37941120|NCT00624819|69628185|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
37941121|NCT03832387|69628197|FG000|Overall Study|Protocol Violation|2|||
37941122|NCT03832387|69628198|FG001|Overall Study|Protocol Violation|6|||
37941123|NCT03832387|69628197|FG000|Overall Study|EXCLUSION CRITERIA|3|||
37941124|NCT03832387|69628198|FG001|Overall Study|EXCLUSION CRITERIA|1|||
37941125|NCT00366301|69628208|FG000|Overall Study|Lost to Follow-up|4|||
37941126|NCT00366301|69628209|FG001|Overall Study|Lost to Follow-up|4|||
37941127|NCT00366301|69628210|FG002|Overall Study|Lost to Follow-up|3|||
37941128|NCT00366301|69628211|FG003|Overall Study|Lost to Follow-up|7|||
37941129|NCT00366301|69628208|FG000|Overall Study|Withdrawal by Subject|4|||
37941130|NCT00366301|69628209|FG001|Overall Study|Withdrawal by Subject|2|||
37941131|NCT00366301|69628210|FG002|Overall Study|Withdrawal by Subject|1|||
37941132|NCT00366301|69628211|FG003|Overall Study|Withdrawal by Subject|1|||
37941133|NCT00365989|69628221|FG000|Overall Study|Withdrawal by Subject|1|||
37941134|NCT00365989|69628221|FG000|Overall Study|Non-compliance|1|||
37941135|NCT00622713|69628226|FG000|Overall Study|Adverse Event|35|||
37941136|NCT00622713|69628226|FG000|Overall Study|Administrative problems|4|||
37941137|NCT00622713|69628226|FG000|Overall Study|Withdrawal by Subject|11|||
37941138|NCT00622713|69628226|FG000|Overall Study|Lost to Follow-up|5|||
37941139|NCT00622713|69628226|FG000|Overall Study|Death|2|||
37941140|NCT00622713|69628226|FG000|Overall Study|Subject no longer required study drug|1|||
37941141|NCT00622713|69628226|FG000|Overall Study|Did not meet eligibility criteria|1|||
37941142|NCT00392197|69628232|FG000|Overall Study|Adverse Event|4|||
37941143|NCT00392197|69628233|FG001|Overall Study|Adverse Event|12|||
37941144|NCT00392197|69628232|FG000|Overall Study|Lack of Efficacy|3|||
37941145|NCT00392197|69628233|FG001|Overall Study|Lack of Efficacy|4|||
37941146|NCT00392197|69628232|FG000|Overall Study|Lost to Follow-up|0|||
37941147|NCT00392197|69628233|FG001|Overall Study|Lost to Follow-up|1|||
37941148|NCT00392197|69628232|FG000|Overall Study|Physician Decision|3|||
37941149|NCT00392197|69628233|FG001|Overall Study|Physician Decision|2|||
37941150|NCT00392197|69628232|FG000|Overall Study|Protocol Violation|7|||
37941151|NCT00392197|69628233|FG001|Overall Study|Protocol Violation|5|||
37941152|NCT00392197|69628232|FG000|Overall Study|Withdrawal by Subject|4|||
37941153|NCT00392197|69628233|FG001|Overall Study|Withdrawal by Subject|6|||
37941154|NCT00391807|69628239|FG000|Overall Study|Did not receive study medication|23|||
37941155|NCT00391807|69628239|FG000|Overall Study|Adverse Event|177|||
37941156|NCT00391807|69628239|FG000|Overall Study|Pregnancy|25|||
37941157|NCT00391807|69628239|FG000|Overall Study|Lost to Follow-up|227|||
37941158|NCT00391807|69628239|FG000|Overall Study|Withdrawal by Subject|147|||
37941159|NCT00391807|69628239|FG000|Overall Study|Protocol Violation|20|||
37941160|NCT00391807|69628239|FG000|Overall Study|Various|96|||
37941161|NCT00624585|69628243|FG000|Overall Study|Death|3|||
37941162|NCT00624585|69628243|FG000|Overall Study|Disease Progression|6|||
37941163|NCT00624585|69628243|FG000|Overall Study|Adverse Event|3|||
37941164|NCT00622635|69628247|FG000|Treatment Period 1|Adverse Event|0|||
37941165|NCT00622635|69628248|FG001|Treatment Period 1|Adverse Event|0|||
37941166|NCT00622635|69628249|FG002|Treatment Period 1|Adverse Event|1|||
37941167|NCT00622635|69628250|FG003|Treatment Period 1|Adverse Event|0|||
37941168|NCT00622635|69628251|FG004|Treatment Period 1|Adverse Event|0|||
37941169|NCT00622635|69628252|FG005|Treatment Period 1|Adverse Event|0|||
37941170|NCT00622635|69628247|FG000|Treatment Period 1|Withdrawal by Subject|0|||
37941171|NCT00622635|69628248|FG001|Treatment Period 1|Withdrawal by Subject|1|||
37941172|NCT00622635|69628249|FG002|Treatment Period 1|Withdrawal by Subject|0|||
37941173|NCT00622635|69628250|FG003|Treatment Period 1|Withdrawal by Subject|0|||
37941174|NCT00622635|69628251|FG004|Treatment Period 1|Withdrawal by Subject|0|||
37941175|NCT00622635|69628252|FG005|Treatment Period 1|Withdrawal by Subject|0|||
37941176|NCT00622635|69628247|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
37941177|NCT00622635|69628248|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
38035282|NCT04005885|69722236|FG000|Second Intervention|Withdrawal by Subject|0|||
38035283|NCT04005885|69722237|FG001|Second Intervention|Withdrawal by Subject|2|||
38035284|NCT04003623|69722250|FG000|Overall Study|Withdrawal by Subject|1|||
38035285|NCT04003623|69722251|FG001|Overall Study|Withdrawal by Subject|0|||
38035286|NCT04480424|69722259|FG000|Overall Study|Withdrawal by Subject|0|||
38035287|NCT04480424|69722260|FG001|Overall Study|Withdrawal by Subject|2|||
38035288|NCT04480424|69722259|FG000|Overall Study|Lost to Follow-up|3|||
38035289|NCT04480424|69722260|FG001|Overall Study|Lost to Follow-up|3|||
38035290|NCT04480424|69722259|FG000|Overall Study|Death|14|||
37765191|NCT01439945|69278480|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
37941178|NCT00622635|69628249|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
37941179|NCT00622635|69628250|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
37941180|NCT00622635|69628251|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
37941181|NCT00622635|69628252|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
37941182|NCT00622635|69628247|FG000|Treatment Period 2|Adverse Event|1|||
37941183|NCT00622635|69628248|FG001|Treatment Period 2|Adverse Event|0|||
37941184|NCT00622635|69628249|FG002|Treatment Period 2|Adverse Event|0|||
38035291|NCT04480424|69722260|FG001|Overall Study|Death|16|||
38035292|NCT04480424|69722259|FG000|Overall Study|Reason not Specified|5|||
37941185|NCT00622635|69628250|FG003|Treatment Period 2|Adverse Event|0|||
37941186|NCT00622635|69628251|FG004|Treatment Period 2|Adverse Event|0|||
37941187|NCT00622635|69628252|FG005|Treatment Period 2|Adverse Event|0|||
37941188|NCT00622635|69628247|FG000|Treatment Period 3|Adverse Event|0|||
37941189|NCT00622635|69628248|FG001|Treatment Period 3|Adverse Event|0|||
37941190|NCT00622635|69628249|FG002|Treatment Period 3|Adverse Event|0|||
37941191|NCT00622635|69628250|FG003|Treatment Period 3|Adverse Event|2|||
37941192|NCT00622635|69628251|FG004|Treatment Period 3|Adverse Event|0|||
37941193|NCT00622635|69628252|FG005|Treatment Period 3|Adverse Event|0|||
37941194|NCT00622635|69628247|FG000|Treatment Period 3|Withdrawal by Subject|0|||
37941195|NCT00622635|69628248|FG001|Treatment Period 3|Withdrawal by Subject|0|||
37941196|NCT00622635|69628249|FG002|Treatment Period 3|Withdrawal by Subject|0|||
37941197|NCT00622635|69628250|FG003|Treatment Period 3|Withdrawal by Subject|1|||
37941198|NCT00622635|69628251|FG004|Treatment Period 3|Withdrawal by Subject|0|||
37941199|NCT00622635|69628252|FG005|Treatment Period 3|Withdrawal by Subject|0|||
37941200|NCT00391027|69628262|FG000|Overall Study|Adverse Event|8|||
37941201|NCT00391027|69628263|FG001|Overall Study|Adverse Event|8|||
37941202|NCT00391027|69628262|FG000|Overall Study|Lack of Efficacy|3|||
37941203|NCT00391027|69628263|FG001|Overall Study|Lack of Efficacy|0|||
37941204|NCT00391027|69628262|FG000|Overall Study|Withdrawal by Subject|10|||
37941205|NCT00391027|69628263|FG001|Overall Study|Withdrawal by Subject|1|||
37941206|NCT00391027|69628262|FG000|Overall Study|Other|4|||
37941207|NCT00391027|69628263|FG001|Overall Study|Other|3|||
37941208|NCT00622401|69628272|FG000|Overall Study|Disease progression prior to treatment|3|||
37941209|NCT00622401|69628273|FG001|Overall Study|Disease progression prior to treatment|2|||
37941210|NCT00622401|69628274|FG002|Overall Study|Disease progression prior to treatment|0|||
37941211|NCT00621621|69628284|FG000|Overall Study|Subjects were exited at EP study|30|||
37941212|NCT00621621|69628285|FG001|Overall Study|Subjects were exited at EP study|0|||
37941213|NCT00621543|69628293|FG000|Overall Study|Lost to Follow-up|23|||
37941214|NCT00623805|69628299|FG000|Overall Study|Adverse Event|9|||
37941215|NCT00623805|69628300|FG001|Overall Study|Adverse Event|6|||
37941216|NCT00623805|69628299|FG000|Overall Study|Death|2|||
37941217|NCT00623805|69628300|FG001|Overall Study|Death|0|||
37941218|NCT00623805|69628299|FG000|Overall Study|Lack of Efficacy|3|||
37941219|NCT00623805|69628300|FG001|Overall Study|Lack of Efficacy|7|||
37941220|NCT00623805|69628299|FG000|Overall Study|Lost to Follow-up|2|||
37941221|NCT00623805|69628300|FG001|Overall Study|Lost to Follow-up|2|||
37941222|NCT00623805|69628299|FG000|Overall Study|Protocol Violation|1|||
37941223|NCT00623805|69628300|FG001|Overall Study|Protocol Violation|1|||
37941224|NCT00623805|69628299|FG000|Overall Study|Reason not Specified|3|||
37941225|NCT00623805|69628300|FG001|Overall Study|Reason not Specified|6|||
37941226|NCT00621309|69628306|FG000|Overall Study|Withdrawal by Subject|2|||
37941227|NCT00621309|69628307|FG001|Overall Study|Withdrawal by Subject|0|||
37941228|NCT00621309|69628308|FG002|Overall Study|Withdrawal by Subject|1|||
37941229|NCT00621309|69628309|FG003|Overall Study|Withdrawal by Subject|1|||
37941230|NCT00621309|69628310|FG004|Overall Study|Withdrawal by Subject|1|||
37941231|NCT00621309|69628311|FG005|Overall Study|Withdrawal by Subject|1|||
37941232|NCT00567190|69628319|FG000|Overall Study|Death|235|||
37941233|NCT00567190|69628320|FG001|Overall Study|Death|280|||
37941234|NCT00567190|69628319|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
37941235|NCT00567190|69628320|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
37941236|NCT00691938|69628338|FG000|Overall Study|QTc prolongation|1|||
37941237|NCT00691938|69628339|FG001|Overall Study|QTc prolongation|0|||
37941238|NCT00691938|69628340|FG002|Overall Study|QTc prolongation|0|||
37941239|NCT00691938|69628341|FG003|Overall Study|QTc prolongation|0|||
37941240|NCT00691938|69628342|FG004|Overall Study|QTc prolongation|0|||
37941241|NCT00691938|69628343|FG005|Overall Study|QTc prolongation|0|||
37941242|NCT00691938|69628344|FG006|Overall Study|QTc prolongation|0|||
37941243|NCT00365365|69628358|FG000|Overall Study|Randomized but not treated|0|||
37670416|NCT02085460|69143657|FG000|Overall Study|Withdrawal by Subject|11|||
37670417|NCT02085460|69143658|FG001|Overall Study|Withdrawal by Subject|5|||
37765192|NCT01439945|69278477|FG000|Double-Blind Treatment Phase|Ineligible|1|||
37941244|NCT00365365|69628359|FG001|Overall Study|Randomized but not treated|2|||
37941245|NCT00365365|69628360|FG002|Overall Study|Randomized but not treated|0|||
37670418|NCT02085460|69143659|FG002|Overall Study|Withdrawal by Subject|7|||
37670419|NCT02084134|69143669|FG000|Overall Study|Protocol Violation|4|||
37670420|NCT02084134|69143670|FG001|Overall Study|Protocol Violation|2|||
37670421|NCT02084134|69143669|FG000|Overall Study|Death|0|||
37670422|NCT02084134|69143670|FG001|Overall Study|Death|1|||
37670423|NCT02034058|69143676|FG000|Overall Study|Death|3|||
37670424|NCT01374269|69143682|FG000|Overall Study|Withdrawal by Subject|4|||
37670425|NCT01374269|69143683|FG001|Overall Study|Withdrawal by Subject|0|||
37670426|NCT01374269|69143682|FG000|Overall Study|Lost to Follow-up|1|||
37670427|NCT01374269|69143683|FG001|Overall Study|Lost to Follow-up|3|||
37670428|NCT01374269|69143682|FG000|Overall Study|closed research|1|||
37670429|NCT01374269|69143683|FG001|Overall Study|closed research|2|||
37941246|NCT00365365|69628358|FG000|Overall Study|Poor compliance to protocol|0|||
37941247|NCT00365365|69628359|FG001|Overall Study|Poor compliance to protocol|1|||
37941248|NCT00365365|69628360|FG002|Overall Study|Poor compliance to protocol|0|||
37941249|NCT00365365|69628358|FG000|Overall Study|Lost to Follow-up|3|||
37941250|NCT00365365|69628359|FG001|Overall Study|Lost to Follow-up|3|||
37941251|NCT00365365|69628360|FG002|Overall Study|Lost to Follow-up|3|||
37941252|NCT00365365|69628358|FG000|Overall Study|Death|1|||
37670430|NCT02679755|69143691|FG000|Overall Study|Death|0|||
37670431|NCT02679755|69143692|FG001|Overall Study|Death|3|||
37670432|NCT02679755|69143691|FG000|Overall Study|Global deterioration of health status|1|||
37941253|NCT00365365|69628359|FG001|Overall Study|Death|3|||
37941254|NCT00365365|69628360|FG002|Overall Study|Death|0|||
37941255|NCT00365365|69628358|FG000|Overall Study|Subject's request|11|||
37941256|NCT00365365|69628359|FG001|Overall Study|Subject's request|13|||
37941257|NCT00365365|69628360|FG002|Overall Study|Subject's request|1|||
37941258|NCT00365365|69628358|FG000|Overall Study|Disease progression/relapse|9|||
37941259|NCT00365365|69628359|FG001|Overall Study|Disease progression/relapse|6|||
37941260|NCT00365365|69628360|FG002|Overall Study|Disease progression/relapse|7|||
37941261|NCT00365365|69628358|FG000|Overall Study|Adverse Event|6|||
37941262|NCT00365365|69628359|FG001|Overall Study|Adverse Event|6|||
37941263|NCT00365365|69628360|FG002|Overall Study|Adverse Event|3|||
37941264|NCT00365365|69628358|FG000|Overall Study|Moved|2|||
37941265|NCT00365365|69628359|FG001|Overall Study|Moved|0|||
37941266|NCT00365365|69628360|FG002|Overall Study|Moved|0|||
37941267|NCT00365365|69628358|FG000|Overall Study|New cancer|1|||
37941268|NCT00365365|69628359|FG001|Overall Study|New cancer|0|||
37941269|NCT00365365|69628360|FG002|Overall Study|New cancer|0|||
37941270|NCT00365365|69628358|FG000|Overall Study|Withdrew consent|1|||
37941271|NCT00365365|69628359|FG001|Overall Study|Withdrew consent|1|||
37941272|NCT00365365|69628360|FG002|Overall Study|Withdrew consent|0|||
37941273|NCT00365365|69628358|FG000|Overall Study|Second malignancy|0|||
37941274|NCT00365365|69628359|FG001|Overall Study|Second malignancy|1|||
37941275|NCT00365365|69628360|FG002|Overall Study|Second malignancy|0|||
37941276|NCT00365365|69628358|FG000|Overall Study|Patient/physician decision|0|||
37941277|NCT00365365|69628359|FG001|Overall Study|Patient/physician decision|0|||
37941278|NCT00365365|69628360|FG002|Overall Study|Patient/physician decision|1|||
37941279|NCT00623727|69628370|FG000|Double Blind (DB)|Adverse Event|1|||
37941280|NCT00623727|69628371|FG001|Double Blind (DB)|Adverse Event|3|||
37941281|NCT00623727|69628370|FG000|Double Blind (DB)|Physician Decision|0|||
37941282|NCT00623727|69628371|FG001|Double Blind (DB)|Physician Decision|1|||
37941283|NCT00623727|69628370|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
37941284|NCT00623727|69628371|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
37941285|NCT00623727|69628370|FG000|Double Blind (DB)|Lack of Efficacy|2|||
37941286|NCT00623727|69628371|FG001|Double Blind (DB)|Lack of Efficacy|2|||
37941287|NCT00623727|69628370|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
37941288|NCT00623727|69628371|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
37941289|NCT00623727|69628370|FG000|Double Blind (DB)|Lost to Follow-up|1|||
37941290|NCT00623727|69628371|FG001|Double Blind (DB)|Lost to Follow-up|1|||
37941291|NCT00623727|69628370|FG000|Double Blind (DB)|Protocol Violation|2|||
37941292|NCT00623727|69628371|FG001|Double Blind (DB)|Protocol Violation|2|||
37941293|NCT00623727|69628370|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
37941294|NCT00623727|69628371|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
37941295|NCT00623727|69628370|FG000|Open Label Follow-up|Study termination|0|||
37941296|NCT00623727|69628371|FG001|Open Label Follow-up|Study termination|6|||
37941297|NCT00623727|69628370|FG000|Open Label Follow-up|Participant convenience|0|||
37941298|NCT00623727|69628371|FG001|Open Label Follow-up|Participant convenience|1|||
37941299|NCT00372775|69628379|FG000|Overall Study|Adverse Event|8|||
37941300|NCT00372775|69628379|FG000|Overall Study|Death|15|||
37941301|NCT00372775|69628379|FG000|Overall Study|Objective progression or relapse|30|||
37941302|NCT00372775|69628379|FG000|Overall Study|Global deterioration of health status|6|||
37941303|NCT00372775|69628379|FG000|Overall Study|Withdrawal by Subject|1|||
37941304|NCT00372775|69628379|FG000|Overall Study|Other|1|||
37941305|NCT00372775|69628379|FG000|Overall Study|Not Treated|2|||
37941306|NCT00372697|69628385|FG000|Overall Study|Protocol Violation|1|||
37941307|NCT00372697|69628386|FG001|Overall Study|Protocol Violation|1|||
37941308|NCT00690378|69628398|FG000|Overall Study|Adverse Event|1|||
37941309|NCT00690378|69628399|FG001|Overall Study|Adverse Event|0|||
37941310|NCT00690378|69628398|FG000|Overall Study|Withdrawal by Subject|2|||
37941311|NCT00690378|69628399|FG001|Overall Study|Withdrawal by Subject|0|||
37941312|NCT00690378|69628398|FG000|Overall Study|Protocol Violation|1|||
37941313|NCT00690378|69628399|FG001|Overall Study|Protocol Violation|0|||
37941314|NCT00690378|69628398|FG000|Overall Study|Lost to Follow-up|2|||
37941315|NCT00690378|69628399|FG001|Overall Study|Lost to Follow-up|3|||
37941316|NCT00690378|69628398|FG000|Overall Study|Did not meet inc/exc criteria|13|||
37941317|NCT00690378|69628399|FG001|Overall Study|Did not meet inc/exc criteria|11|||
37941318|NCT00690378|69628398|FG000|Overall Study|Social problem|1|||
37941319|NCT00690378|69628399|FG001|Overall Study|Social problem|0|||
37941320|NCT00574275|69628407|FG000|Overall Study|Randomized but not treated|2|||
37941321|NCT00574275|69628408|FG001|Overall Study|Randomized but not treated|3|||
37941322|NCT00574275|69628407|FG000|Overall Study|Adverse Event|32|||
37941323|NCT00574275|69628408|FG001|Overall Study|Adverse Event|76|||
37941324|NCT00574275|69628407|FG000|Overall Study|Disease progression|160|||
37941325|NCT00574275|69628408|FG001|Overall Study|Disease progression|146|||
37941326|NCT00574275|69628407|FG000|Overall Study|Lost to Follow-up|2|||
37941327|NCT00574275|69628408|FG001|Overall Study|Lost to Follow-up|1|||
37941328|NCT00574275|69628407|FG000|Overall Study|Study stopped based on DMC decision|62|||
37941329|NCT00574275|69628408|FG001|Overall Study|Study stopped based on DMC decision|23|||
37941330|NCT00574275|69628407|FG000|Overall Study|Withdrawal by Subject|15|||
37941331|NCT00574275|69628408|FG001|Overall Study|Withdrawal by Subject|17|||
37941332|NCT00574275|69628407|FG000|Overall Study|Error calculating tumor measurement|1|||
37941333|NCT00574275|69628408|FG001|Overall Study|Error calculating tumor measurement|0|||
37941334|NCT00574275|69628407|FG000|Overall Study|Physician Decision|1|||
37941335|NCT00574275|69628408|FG001|Overall Study|Physician Decision|1|||
37941336|NCT00574275|69628407|FG000|Overall Study|Protocol Violation|0|||
37941337|NCT00574275|69628408|FG001|Overall Study|Protocol Violation|1|||
37941338|NCT00574275|69628407|FG000|Overall Study|Patient and Investigator decision|0|||
37941339|NCT00574275|69628408|FG001|Overall Study|Patient and Investigator decision|1|||
37941340|NCT00574275|69628407|FG000|Overall Study|Insurance change|0|||
37941341|NCT00574275|69628408|FG001|Overall Study|Insurance change|1|||
37941342|NCT00574275|69628407|FG000|Overall Study|Operation for curative intent|0|||
37941343|NCT00574275|69628408|FG001|Overall Study|Operation for curative intent|1|||
37941344|NCT00567112|69628414|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
37941345|NCT00567112|69628415|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
37941346|NCT00567112|69628416|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
37941347|NCT00567112|69628414|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
37941348|NCT00567112|69628415|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
37941349|NCT00567112|69628416|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
37941350|NCT00567112|69628414|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
37941351|NCT00567112|69628415|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
37941352|NCT00567112|69628416|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
37941353|NCT01618656|69628436|FG000|Overall Study|Withdrawal by Subject|7|||
37941354|NCT01618656|69628437|FG001|Overall Study|Withdrawal by Subject|3|||
37941355|NCT01618656|69628436|FG000|Overall Study|Physician Decision|1|||
37941356|NCT01618656|69628437|FG001|Overall Study|Physician Decision|1|||
37941357|NCT03978832|69628443|FG000|Overall Study|Adverse Event|1|||
37941358|NCT03978832|69628443|FG000|Overall Study|Lost to Follow-up|1|||
37941359|NCT03978832|69628443|FG000|Overall Study|Withdrawal by Subject|6|||
37941360|NCT03978832|69628443|FG000|Overall Study|Physician Decision|2|||
37941361|NCT03978832|69628443|FG000|Overall Study|did not pass screening criteria|44|||
37941362|NCT00566722|69628450|FG000|Overall Study|Adverse Event|0|||
37941363|NCT00566722|69628451|FG001|Overall Study|Adverse Event|1|||
37941364|NCT00566722|69628452|FG002|Overall Study|Adverse Event|0|||
37941365|NCT00566722|69628450|FG000|Overall Study|Withdrawal by Subject|0|||
37941366|NCT00566722|69628451|FG001|Overall Study|Withdrawal by Subject|0|||
37941367|NCT00566722|69628452|FG002|Overall Study|Withdrawal by Subject|1|||
37941368|NCT00566722|69628450|FG000|Overall Study|Lost to Follow-up|1|||
37941369|NCT00566722|69628451|FG001|Overall Study|Lost to Follow-up|1|||
37941370|NCT00566722|69628452|FG002|Overall Study|Lost to Follow-up|1|||
37941371|NCT00566722|69628450|FG000|Overall Study|Lack of Efficacy|1|||
37941372|NCT00566722|69628451|FG001|Overall Study|Lack of Efficacy|2|||
37941373|NCT00566722|69628452|FG002|Overall Study|Lack of Efficacy|4|||
37941374|NCT00566722|69628450|FG000|Overall Study|Did not meet exclusion criteria|0|||
37941375|NCT00566722|69628451|FG001|Overall Study|Did not meet exclusion criteria|0|||
37941376|NCT00566722|69628452|FG002|Overall Study|Did not meet exclusion criteria|2|||
37941377|NCT00566722|69628450|FG000|Overall Study|Serious adverse event|0|||
37941378|NCT00566722|69628451|FG001|Overall Study|Serious adverse event|1|||
37941379|NCT00566722|69628452|FG002|Overall Study|Serious adverse event|0|||
37941380|NCT00566722|69628450|FG000|Overall Study|Noncompliant with drug administration|0|||
37941381|NCT00566722|69628451|FG001|Overall Study|Noncompliant with drug administration|0|||
37941382|NCT00566722|69628452|FG002|Overall Study|Noncompliant with drug administration|1|||
37941383|NCT00691704|69628463|FG000|Induction Therapy|Disease Progression|1|||
37941384|NCT00691704|69628463|FG000|Induction Therapy|Active Hepatitis|1|||
37941385|NCT00691704|69628463|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
37941386|NCT00691704|69628463|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
37941387|NCT00691704|69628463|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
37941388|NCT00566020|69628467|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
37941389|NCT00566020|69628468|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
37941390|NCT00566020|69628467|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
37941391|NCT00566020|69628468|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
37941392|NCT00566020|69628467|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
37941393|NCT00566020|69628468|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
37941394|NCT00566020|69628467|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
37941395|NCT00566020|69628468|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
37941396|NCT00566020|69628467|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
37941397|NCT00566020|69628468|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
37941398|NCT00566020|69628467|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
37941399|NCT00566020|69628468|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
37941400|NCT00564070|69628475|FG000|Overall Study|Lost to Follow-up|9|||
37941401|NCT00564070|69628476|FG001|Overall Study|Lost to Follow-up|7|||
37941402|NCT00564070|69628475|FG000|Overall Study|Worsening depression, referred to care|3|||
37765193|NCT01439945|69278478|FG001|Double-Blind Treatment Phase|Ineligible|2|||
37941403|NCT00564070|69628476|FG001|Overall Study|Worsening depression, referred to care|0|||
37941404|NCT00690612|69628482|FG000|Overall Study|Adverse Event|1|||
37941405|NCT00690612|69628482|FG000|Overall Study|Withdrawal by Subject|2|||
37941406|NCT00621153|69628488|FG000|Overall Study|Safety Reason|8|||
37941407|NCT00621153|69628489|FG001|Overall Study|Safety Reason|7|||
37941408|NCT00621153|69628488|FG000|Overall Study|Adverse Event|3|||
37941409|NCT00621153|69628489|FG001|Overall Study|Adverse Event|2|||
37941410|NCT00621153|69628488|FG000|Overall Study|Lost to Follow-up|5|||
37941411|NCT00621153|69628489|FG001|Overall Study|Lost to Follow-up|1|||
37941412|NCT00621153|69628488|FG000|Overall Study|Withdrawal by Subject|4|||
37941413|NCT00621153|69628489|FG001|Overall Study|Withdrawal by Subject|5|||
37941414|NCT00574119|69628495|FG000|Overall Study|Adverse Event|1|||
37941415|NCT00574119|69628495|FG000|Overall Study|Protocol Violation|1|||
37941416|NCT00574119|69628495|FG000|Overall Study|Withdrawal by Subject|1|||
37941417|NCT00574119|69628495|FG000|Overall Study|Physician Decision|1|||
37941418|NCT00705614|69628501|FG000|Initial Intervention|Adverse Event|40|||
37941419|NCT00705614|69628502|FG001|Initial Intervention|Adverse Event|21|||
37941420|NCT00705614|69628501|FG000|Initial Intervention|Lost to Follow-up|310|||
37941421|NCT00705614|69628502|FG001|Initial Intervention|Lost to Follow-up|191|||
37941422|NCT00705614|69628501|FG000|Initial Intervention|Withdrawal by Subject|114|||
37941423|NCT00705614|69628502|FG001|Initial Intervention|Withdrawal by Subject|71|||
37941424|NCT00705614|69628501|FG000|Initial Intervention|Administrative Reason|51|||
37941425|NCT00705614|69628502|FG001|Initial Intervention|Administrative Reason|38|||
37941426|NCT00705614|69628501|FG000|Initial Intervention|Status completion unknown|3|||
37941427|NCT00705614|69628502|FG001|Initial Intervention|Status completion unknown|0|||
37941428|NCT00705614|69628501|FG000|Switch to Remicade|Adverse Event|0|||
37941429|NCT00705614|69628502|FG001|Switch to Remicade|Adverse Event|5|||
37941430|NCT00705614|69628501|FG000|Switch to Remicade|Lost to Follow-up|0|||
37941431|NCT00705614|69628502|FG001|Switch to Remicade|Lost to Follow-up|23|||
37941432|NCT00705614|69628501|FG000|Switch to Remicade|Withdrawal by Subject|0|||
37941433|NCT00705614|69628502|FG001|Switch to Remicade|Withdrawal by Subject|12|||
37941434|NCT00705614|69628501|FG000|Switch to Remicade|Administrative Reason|0|||
37941435|NCT00705614|69628502|FG001|Switch to Remicade|Administrative Reason|9|||
37941436|NCT00620763|69628510|FG000|Period: First Intervention|Withdrawal by Subject|0|||
37941437|NCT00620763|69628511|FG001|Period: First Intervention|Withdrawal by Subject|2|||
37941438|NCT00620763|69628510|FG000|Period: First Intervention|Protocol Violation|0|||
37941439|NCT00620763|69628511|FG001|Period: First Intervention|Protocol Violation|3|||
37941440|NCT00620763|69628510|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
37941441|NCT00620763|69628511|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
37941442|NCT00562978|69628519|FG000|Overall Study|Patient had imaging dose only|1|||
37941443|NCT00562978|69628520|FG001|Overall Study|Patient had imaging dose only|11|||
37941444|NCT00620373|69628526|FG000|Overall Study|Unverified cancer status|33|||
37941445|NCT00372619|69628540|FG000|Overall Study|Ineligible|0|||
37941446|NCT00372619|69628541|FG001|Overall Study|Ineligible|0|||
37941447|NCT00372619|69628542|FG002|Overall Study|Ineligible|0|||
37941448|NCT00372619|69628543|FG003|Overall Study|Ineligible|0|||
37941449|NCT00372619|69628544|FG004|Overall Study|Ineligible|0|||
37941450|NCT00372619|69628545|FG005|Overall Study|Ineligible|2|||
37941451|NCT00372619|69628546|FG006|Overall Study|Ineligible|0|||
37941452|NCT00372619|69628540|FG000|Overall Study|Inevaluable|0|||
37941453|NCT00372619|69628541|FG001|Overall Study|Inevaluable|0|||
37941454|NCT00372619|69628542|FG002|Overall Study|Inevaluable|0|||
37941455|NCT00372619|69628543|FG003|Overall Study|Inevaluable|0|||
37941456|NCT00372619|69628544|FG004|Overall Study|Inevaluable|0|||
37941457|NCT00372619|69628545|FG005|Overall Study|Inevaluable|1|||
37941458|NCT00372619|69628546|FG006|Overall Study|Inevaluable|0|||
37941459|NCT00562588|69628564|FG000|Overall Study|Adverse Event|40|||
37941460|NCT00562588|69628565|FG001|Overall Study|Adverse Event|58|||
37941461|NCT00562588|69628564|FG000|Overall Study|Protocol Violation|30|||
37941462|NCT00562588|69628565|FG001|Overall Study|Protocol Violation|26|||
37941463|NCT00562588|69628564|FG000|Overall Study|Lost to Follow-up|12|||
37941464|NCT00562588|69628565|FG001|Overall Study|Lost to Follow-up|4|||
37941465|NCT00562588|69628564|FG000|Overall Study|Withdrawal by Subject|10|||
37941466|NCT00562588|69628565|FG001|Overall Study|Withdrawal by Subject|9|||
37941467|NCT00562588|69628564|FG000|Overall Study|Other|0|||
37941468|NCT00562588|69628565|FG001|Overall Study|Other|2|||
37941469|NCT00622167|69628571|FG000|Overall Study|Did not meet angiographic criteria|20|||
37941470|NCT00562354|69628577|FG000|Overall Study|Physician Decision|0|||
37941471|NCT00562354|69628578|FG001|Overall Study|Physician Decision|1|||
37941472|NCT00562354|69628577|FG000|Overall Study|Lost to Follow-up|0|||
37941473|NCT00562354|69628578|FG001|Overall Study|Lost to Follow-up|1|||
37941474|NCT00372385|69628590|FG000|Overall Study|Adverse Event|6|||
37941475|NCT00372385|69628591|FG001|Overall Study|Adverse Event|11|||
37941476|NCT00372385|69628592|FG002|Overall Study|Adverse Event|9|||
37941477|NCT00372385|69628593|FG003|Overall Study|Adverse Event|7|||
37941478|NCT00372385|69628590|FG000|Overall Study|Noncompliance|0|||
37941479|NCT00372385|69628591|FG001|Overall Study|Noncompliance|1|||
37941480|NCT00372385|69628592|FG002|Overall Study|Noncompliance|1|||
37941481|NCT00372385|69628593|FG003|Overall Study|Noncompliance|1|||
37941482|NCT00372385|69628590|FG000|Overall Study|Physician Decision|1|||
37941483|NCT00372385|69628591|FG001|Overall Study|Physician Decision|0|||
37941484|NCT00372385|69628592|FG002|Overall Study|Physician Decision|0|||
37941485|NCT00372385|69628593|FG003|Overall Study|Physician Decision|0|||
37941486|NCT00372385|69628590|FG000|Overall Study|Lost to Follow-up|2|||
37941487|NCT00372385|69628591|FG001|Overall Study|Lost to Follow-up|0|||
37941488|NCT00372385|69628592|FG002|Overall Study|Lost to Follow-up|0|||
37941489|NCT00372385|69628593|FG003|Overall Study|Lost to Follow-up|0|||
37941490|NCT00372385|69628590|FG000|Overall Study|Withdrawal by Subject|2|||
37941491|NCT00372385|69628591|FG001|Overall Study|Withdrawal by Subject|1|||
37941492|NCT00372385|69628592|FG002|Overall Study|Withdrawal by Subject|0|||
37765194|NCT01439945|69278479|FG002|Double-Blind Treatment Phase|Ineligible|0|||
37765195|NCT01439945|69278480|FG003|Double-Blind Treatment Phase|Ineligible|1|||
37765196|NCT01420081|69278585|FG000|Overall Study|Death|1|||
37765197|NCT01420081|69278586|FG001|Overall Study|Death|0|||
37941493|NCT00372385|69628593|FG003|Overall Study|Withdrawal by Subject|0|||
37941494|NCT00372385|69628590|FG000|Overall Study|Refusal of Treatment|3|||
37941495|NCT00372385|69628591|FG001|Overall Study|Refusal of Treatment|6|||
37941496|NCT00372385|69628592|FG002|Overall Study|Refusal of Treatment|0|||
37941497|NCT00372385|69628593|FG003|Overall Study|Refusal of Treatment|0|||
37941498|NCT00372385|69628590|FG000|Overall Study|No Response|1|||
37941499|NCT00372385|69628591|FG001|Overall Study|No Response|1|||
37941500|NCT00372385|69628592|FG002|Overall Study|No Response|0|||
37941501|NCT00372385|69628593|FG003|Overall Study|No Response|0|||
37941502|NCT00372385|69628590|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
37941503|NCT00372385|69628591|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
37941504|NCT00372385|69628592|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
37941505|NCT00372385|69628593|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
37941506|NCT00372385|69628590|FG000|Overall Study|Virologic Stopping Rule|17|||
37941507|NCT00372385|69628591|FG001|Overall Study|Virologic Stopping Rule|0|||
37941508|NCT00372385|69628592|FG002|Overall Study|Virologic Stopping Rule|0|||
37670433|NCT02679755|69143692|FG001|Overall Study|Global deterioration of health status|8|||
37670434|NCT02679755|69143691|FG000|Overall Study|Lost to Follow-up|1|||
37670435|NCT02679755|69143692|FG001|Overall Study|Lost to Follow-up|0|||
37670436|NCT02679755|69143691|FG000|Overall Study|Objective progression or relapse|24|||
37765198|NCT01420081|69278587|FG002|Overall Study|Death|8|||
37941509|NCT00372385|69628593|FG003|Overall Study|Virologic Stopping Rule|0|||
37941510|NCT03830281|69628606|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
37941511|NCT03830281|69628607|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
37941512|NCT03830281|69628606|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
37941513|NCT03830281|69628607|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
37941514|NCT03830281|69628606|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
37941515|NCT03830281|69628607|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
37941516|NCT03830281|69628606|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
37941517|NCT03830281|69628607|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
37941518|NCT03830281|69628606|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
37941519|NCT03830281|69628607|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
37941520|NCT03830281|69628606|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
37941521|NCT03830281|69628607|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
37941522|NCT03830281|69628606|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
37941523|NCT03830281|69628607|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
37941524|NCT03830281|69628606|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
37941525|NCT03830281|69628607|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
37941526|NCT03830281|69628606|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
37941527|NCT03830281|69628607|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
37941528|NCT00563368|69628621|FG000|Overall Study|Lost to Follow-up|14|||
37941529|NCT00563368|69628622|FG001|Overall Study|Lost to Follow-up|14|||
37941530|NCT00563368|69628623|FG002|Overall Study|Lost to Follow-up|12|||
37941531|NCT00563368|69628624|FG003|Overall Study|Lost to Follow-up|6|||
37941532|NCT00563368|69628625|FG004|Overall Study|Lost to Follow-up|9|||
37670437|NCT02679755|69143692|FG001|Overall Study|Objective progression or relapse|83|||
37670438|NCT02679755|69143691|FG000|Overall Study|Not defined|0|||
37765199|NCT01420081|69278588|FG003|Overall Study|Death|0|||
37941533|NCT00563368|69628626|FG005|Overall Study|Lost to Follow-up|8|||
37941534|NCT00563368|69628627|FG006|Overall Study|Lost to Follow-up|9|||
37941535|NCT00563368|69628621|FG000|Overall Study|Adverse Event|3|||
37941536|NCT00563368|69628622|FG001|Overall Study|Adverse Event|4|||
37941537|NCT00563368|69628623|FG002|Overall Study|Adverse Event|5|||
37941538|NCT00563368|69628624|FG003|Overall Study|Adverse Event|9|||
37941539|NCT00563368|69628625|FG004|Overall Study|Adverse Event|6|||
37941540|NCT00563368|69628626|FG005|Overall Study|Adverse Event|10|||
37941541|NCT00563368|69628627|FG006|Overall Study|Adverse Event|17|||
37941542|NCT00563368|69628621|FG000|Overall Study|Withdrawal by Subject|11|||
37941543|NCT00563368|69628622|FG001|Overall Study|Withdrawal by Subject|6|||
37941544|NCT00563368|69628623|FG002|Overall Study|Withdrawal by Subject|5|||
37941545|NCT00563368|69628624|FG003|Overall Study|Withdrawal by Subject|7|||
37941546|NCT00563368|69628625|FG004|Overall Study|Withdrawal by Subject|8|||
37941547|NCT00563368|69628626|FG005|Overall Study|Withdrawal by Subject|5|||
37941548|NCT00563368|69628627|FG006|Overall Study|Withdrawal by Subject|4|||
37941549|NCT00563368|69628621|FG000|Overall Study|protocol non-compliance|1|||
37941550|NCT00563368|69628622|FG001|Overall Study|protocol non-compliance|1|||
37941551|NCT00563368|69628623|FG002|Overall Study|protocol non-compliance|2|||
37941552|NCT00563368|69628624|FG003|Overall Study|protocol non-compliance|1|||
37941553|NCT00563368|69628625|FG004|Overall Study|protocol non-compliance|0|||
37941554|NCT00563368|69628626|FG005|Overall Study|protocol non-compliance|1|||
37941555|NCT00563368|69628627|FG006|Overall Study|protocol non-compliance|3|||
37941556|NCT00563368|69628621|FG000|Overall Study|Pregnancy|1|||
37941557|NCT00563368|69628622|FG001|Overall Study|Pregnancy|0|||
37941558|NCT00563368|69628623|FG002|Overall Study|Pregnancy|1|||
37941559|NCT00563368|69628624|FG003|Overall Study|Pregnancy|2|||
37941560|NCT00563368|69628625|FG004|Overall Study|Pregnancy|1|||
37941561|NCT00563368|69628626|FG005|Overall Study|Pregnancy|2|||
37941562|NCT00563368|69628627|FG006|Overall Study|Pregnancy|0|||
37941563|NCT00563368|69628621|FG000|Overall Study|requirement for restricted medication|0|||
37941564|NCT00563368|69628622|FG001|Overall Study|requirement for restricted medication|0|||
37941565|NCT00563368|69628623|FG002|Overall Study|requirement for restricted medication|2|||
37941566|NCT00563368|69628624|FG003|Overall Study|requirement for restricted medication|0|||
37941567|NCT00563368|69628625|FG004|Overall Study|requirement for restricted medication|0|||
37941568|NCT00563368|69628626|FG005|Overall Study|requirement for restricted medication|0|||
37941569|NCT00563368|69628627|FG006|Overall Study|requirement for restricted medication|0|||
37941570|NCT00563368|69628621|FG000|Overall Study|Other|5|||
37941571|NCT00563368|69628622|FG001|Overall Study|Other|5|||
37941572|NCT00563368|69628623|FG002|Overall Study|Other|3|||
37941573|NCT00563368|69628624|FG003|Overall Study|Other|4|||
37941574|NCT00563368|69628625|FG004|Overall Study|Other|4|||
37941575|NCT00563368|69628626|FG005|Overall Study|Other|4|||
37941576|NCT00563368|69628627|FG006|Overall Study|Other|0|||
37941577|NCT00390013|69628646|FG000|Phase 1|tired|0|||
37941578|NCT00390013|69628647|FG001|Phase 1|tired|0|||
37941579|NCT00390013|69628648|FG002|Phase 1|tired|0|||
37941580|NCT00390013|69628649|FG003|Phase 1|tired|1|||
37941581|NCT00390013|69628646|FG000|Phase 2 First Treatment|tired|1|||
37941582|NCT00390013|69628647|FG001|Phase 2 First Treatment|tired|0|||
37941583|NCT00390013|69628648|FG002|Phase 2 First Treatment|tired|0|||
37941584|NCT00390013|69628649|FG003|Phase 2 First Treatment|tired|0|||
37941585|NCT00390013|69628646|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
37941586|NCT00390013|69628647|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
37941587|NCT00390013|69628648|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
37941588|NCT00390013|69628649|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
37941589|NCT00561652|69628657|FG000|Overall Study|Withdrawal by Subject|0|||
37941590|NCT00561652|69628658|FG001|Overall Study|Withdrawal by Subject|1|||
37941591|NCT00697346|69628667|FG000|Overall Study|Adverse Event|4|||
37941592|NCT00697346|69628668|FG001|Overall Study|Adverse Event|5|||
37941593|NCT00697346|69628669|FG002|Overall Study|Adverse Event|0|||
37941594|NCT00697346|69628667|FG000|Overall Study|Progressive Disease|19|||
37941595|NCT00697346|69628668|FG001|Overall Study|Progressive Disease|18|||
37941596|NCT00697346|69628669|FG002|Overall Study|Progressive Disease|0|||
37941597|NCT00697346|69628667|FG000|Overall Study|Symptomatic Deterioration|0|||
37941598|NCT00697346|69628668|FG001|Overall Study|Symptomatic Deterioration|1|||
37941599|NCT00697346|69628669|FG002|Overall Study|Symptomatic Deterioration|0|||
37941600|NCT00697346|69628667|FG000|Overall Study|Withdrawal by Subject|2|||
37941601|NCT00697346|69628668|FG001|Overall Study|Withdrawal by Subject|2|||
37941602|NCT00697346|69628669|FG002|Overall Study|Withdrawal by Subject|0|||
37941603|NCT00697346|69628667|FG000|Overall Study|Reason not Specified|3|||
37941604|NCT00697346|69628668|FG001|Overall Study|Reason not Specified|0|||
37941605|NCT00697346|69628669|FG002|Overall Study|Reason not Specified|1|||
37670439|NCT02679755|69143692|FG001|Overall Study|Not defined|2|||
37670440|NCT02679755|69143691|FG000|Overall Study|Withdrawal by participant|6|||
37941606|NCT00562120|69628696|FG000|First Intervention Period|Adverse Event|1|||
37941607|NCT00562120|69628697|FG001|First Intervention Period|Adverse Event|0|||
37941608|NCT00562120|69628698|FG002|First Intervention Period|Adverse Event|0|||
37941609|NCT00562120|69628699|FG003|First Intervention Period|Adverse Event|0|||
37941610|NCT00562120|69628696|FG000|First Intervention Period|Randomized but not Treated|1|||
37941611|NCT00562120|69628697|FG001|First Intervention Period|Randomized but not Treated|0|||
37941612|NCT00562120|69628698|FG002|First Intervention Period|Randomized but not Treated|0|||
37941613|NCT00562120|69628699|FG003|First Intervention Period|Randomized but not Treated|0|||
37941614|NCT00561730|69628709|FG000|Overall Study|Adverse Event|2|||
37941615|NCT00561730|69628709|FG000|Overall Study|Handling of the drug|1|||
37941616|NCT00561730|69628709|FG000|Overall Study|Lost to Follow-up|5|||
37941617|NCT00561730|69628709|FG000|Overall Study|Not specified reasons|1|||
37941618|NCT00697112|69628715|FG000|Overall Study|Adverse Event|8|||
37941619|NCT00697112|69628715|FG000|Overall Study|Lost to Follow-up|1|||
37941620|NCT00697112|69628715|FG000|Overall Study|Did not meet inclusion criteria|1|||
37941621|NCT00621855|69628724|FG000|Overall Study|Adverse Event|32|||
37941622|NCT00621855|69628725|FG001|Overall Study|Adverse Event|31|||
37941623|NCT00621855|69628726|FG002|Overall Study|Adverse Event|48|||
37941624|NCT00621855|69628727|FG003|Overall Study|Adverse Event|34|||
37941625|NCT00621855|69628728|FG004|Overall Study|Adverse Event|31|||
37941626|NCT00621855|69628724|FG000|Overall Study|Lost to Follow-up|0|||
37941627|NCT00621855|69628725|FG001|Overall Study|Lost to Follow-up|1|||
37941628|NCT00621855|69628726|FG002|Overall Study|Lost to Follow-up|3|||
37941629|NCT00621855|69628727|FG003|Overall Study|Lost to Follow-up|4|||
37941630|NCT00621855|69628728|FG004|Overall Study|Lost to Follow-up|1|||
37941631|NCT00621855|69628724|FG000|Overall Study|Protocol Violation|16|||
37941632|NCT00621855|69628725|FG001|Overall Study|Protocol Violation|8|||
37941633|NCT00621855|69628726|FG002|Overall Study|Protocol Violation|6|||
37941634|NCT00621855|69628727|FG003|Overall Study|Protocol Violation|7|||
37941635|NCT00621855|69628728|FG004|Overall Study|Protocol Violation|8|||
37941636|NCT00621855|69628724|FG000|Overall Study|Withdrawal by Subject|16|||
37941637|NCT00621855|69628725|FG001|Overall Study|Withdrawal by Subject|11|||
37941638|NCT00621855|69628726|FG002|Overall Study|Withdrawal by Subject|13|||
37941639|NCT00621855|69628727|FG003|Overall Study|Withdrawal by Subject|13|||
37941640|NCT00621855|69628728|FG004|Overall Study|Withdrawal by Subject|9|||
37941641|NCT00621855|69628724|FG000|Overall Study|Other|9|||
37941642|NCT00621855|69628725|FG001|Overall Study|Other|7|||
37941643|NCT00621855|69628726|FG002|Overall Study|Other|6|||
37941644|NCT00621855|69628727|FG003|Overall Study|Other|5|||
37941645|NCT00621855|69628728|FG004|Overall Study|Other|4|||
37941646|NCT00621855|69628724|FG000|Overall Study|Patients did not receive study drug|3|||
37941647|NCT00621855|69628725|FG001|Overall Study|Patients did not receive study drug|3|||
37941648|NCT00621855|69628726|FG002|Overall Study|Patients did not receive study drug|5|||
37941649|NCT00621855|69628727|FG003|Overall Study|Patients did not receive study drug|4|||
37941650|NCT00621855|69628728|FG004|Overall Study|Patients did not receive study drug|2|||
37941651|NCT00561574|69628742|FG000|Overall Study|Adverse Event|21|||
37941652|NCT00561574|69628743|FG001|Overall Study|Adverse Event|24|||
37941653|NCT00561574|69628742|FG000|Overall Study|Lack of Efficacy|11|||
37941654|NCT00561574|69628743|FG001|Overall Study|Lack of Efficacy|21|||
37941655|NCT00561574|69628742|FG000|Overall Study|Withdrawal by Subject|4|||
37941656|NCT00561574|69628743|FG001|Overall Study|Withdrawal by Subject|4|||
37941657|NCT00561574|69628742|FG000|Overall Study|Reason Unrelated to Trial|6|||
37941658|NCT00561574|69628743|FG001|Overall Study|Reason Unrelated to Trial|2|||
37941659|NCT00561574|69628742|FG000|Overall Study|Lost to Follow-up|1|||
37941660|NCT00561574|69628743|FG001|Overall Study|Lost to Follow-up|0|||
37941661|NCT00561574|69628742|FG000|Overall Study|Other|5|||
37941662|NCT00561574|69628743|FG001|Overall Study|Other|7|||
37941663|NCT00619827|69628751|FG000|Overall Study|Adverse Event|1|||
37941664|NCT00619827|69628752|FG001|Overall Study|Adverse Event|2|||
37941665|NCT00619827|69628751|FG000|Overall Study|Withdrawal by Subject|2|||
37941666|NCT00619827|69628752|FG001|Overall Study|Withdrawal by Subject|2|||
37941667|NCT00687804|69628761|FG000|Core Study|Adverse Event|5|||
37941668|NCT00687804|69628762|FG001|Core Study|Adverse Event|3|||
37941669|NCT00687804|69628763|FG002|Core Study|Adverse Event|3|||
37941670|NCT00687804|69628761|FG000|Core Study|Abnormal laboratory value(s)|1|||
37941671|NCT00687804|69628762|FG001|Core Study|Abnormal laboratory value(s)|0|||
37941672|NCT00687804|69628763|FG002|Core Study|Abnormal laboratory value(s)|0|||
37941673|NCT00687804|69628761|FG000|Core Study|Lack of Efficacy|1|||
37941674|NCT00687804|69628762|FG001|Core Study|Lack of Efficacy|1|||
37941675|NCT00687804|69628763|FG002|Core Study|Lack of Efficacy|1|||
37941676|NCT00687804|69628761|FG000|Core Study|Withdrawal by Subject|4|||
37941677|NCT00687804|69628762|FG001|Core Study|Withdrawal by Subject|7|||
37941678|NCT00687804|69628763|FG002|Core Study|Withdrawal by Subject|7|||
37941679|NCT00687804|69628761|FG000|Core Study|Lost to Follow-up|0|||
37941680|NCT00687804|69628762|FG001|Core Study|Lost to Follow-up|1|||
37941681|NCT00687804|69628763|FG002|Core Study|Lost to Follow-up|0|||
37941682|NCT00687804|69628761|FG000|Core Study|Death|2|||
37941683|NCT00687804|69628762|FG001|Core Study|Death|2|||
37941684|NCT00687804|69628763|FG002|Core Study|Death|2|||
37941685|NCT00687804|69628761|FG000|Core Study|Protocol Violation|1|||
37941686|NCT00687804|69628762|FG001|Core Study|Protocol Violation|1|||
37941687|NCT00687804|69628763|FG002|Core Study|Protocol Violation|0|||
37941688|NCT00687804|69628761|FG000|Open-Label Extension Study|Adverse Event|2|||
37941689|NCT00687804|69628762|FG001|Open-Label Extension Study|Adverse Event|2|||
37941690|NCT00687804|69628763|FG002|Open-Label Extension Study|Adverse Event|2|||
37941691|NCT00687804|69628761|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
37941692|NCT00687804|69628762|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
37941693|NCT00687804|69628763|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
37941694|NCT00687804|69628761|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
37941695|NCT00687804|69628762|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
37941696|NCT00687804|69628763|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
37941697|NCT00687804|69628761|FG000|Open-Label Extension Study|Administrative problems|1|||
37941698|NCT00687804|69628762|FG001|Open-Label Extension Study|Administrative problems|1|||
37941699|NCT00687804|69628763|FG002|Open-Label Extension Study|Administrative problems|0|||
37941700|NCT00687804|69628761|FG000|Open-Label Extension Study|Death|2|||
37941701|NCT00687804|69628762|FG001|Open-Label Extension Study|Death|3|||
37941702|NCT00687804|69628763|FG002|Open-Label Extension Study|Death|3|||
37941703|NCT00689052|69628790|FG000|Overall Study|Adverse Event|4|||
37941704|NCT00689052|69628791|FG001|Overall Study|Adverse Event|6|||
37941705|NCT00689052|69628790|FG000|Overall Study|Protocol Violation|1|||
37941706|NCT00689052|69628791|FG001|Overall Study|Protocol Violation|0|||
37941707|NCT00689052|69628790|FG000|Overall Study|Lost to Follow-up|2|||
37941708|NCT00689052|69628791|FG001|Overall Study|Lost to Follow-up|0|||
37941709|NCT00689052|69628790|FG000|Overall Study|Withdrawal by Subject|2|||
37941710|NCT00689052|69628791|FG001|Overall Study|Withdrawal by Subject|0|||
37941711|NCT00689052|69628790|FG000|Overall Study|Early termination of the trial|22|||
37941712|NCT00689052|69628791|FG001|Overall Study|Early termination of the trial|24|||
37941713|NCT00560950|69628801|FG000|Overall Study|Lost to Follow-up|1|||
37941714|NCT00560950|69628802|FG001|Overall Study|Lost to Follow-up|0|||
37941715|NCT00576758|69628812|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
37941716|NCT00576758|69628813|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
37941717|NCT00576758|69628812|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
37941718|NCT00576758|69628813|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
37941719|NCT00576758|69628812|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
37941720|NCT00576758|69628813|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
37941721|NCT00576758|69628812|FG000|Induction Treatment Period|Death|1|||
37941722|NCT00576758|69628813|FG001|Induction Treatment Period|Death|0|||
37941723|NCT00576758|69628812|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
37941724|NCT00576758|69628813|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
37941725|NCT00576758|69628812|FG000|Induction Treatment Period|Withdrew consent|1|||
37941726|NCT00576758|69628813|FG001|Induction Treatment Period|Withdrew consent|0|||
37941727|NCT00576758|69628812|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
37941728|NCT00576758|69628813|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
37941729|NCT00576758|69628812|FG000|Extension Treatment Period|Death|1|||
37941730|NCT00576758|69628813|FG001|Extension Treatment Period|Death|1|||
37941731|NCT00576758|69628812|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
37941732|NCT00576758|69628813|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
37941733|NCT00576758|69628812|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
37941734|NCT00576758|69628813|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
37941735|NCT00576758|69628812|FG000|Extension Treatment Period|Administrative/Other|3|||
37941736|NCT00576758|69628813|FG001|Extension Treatment Period|Administrative/Other|1|||
37941737|NCT00576758|69628812|FG000|Follow-up Period|Administrative/Other|6|||
37941738|NCT00576758|69628813|FG001|Follow-up Period|Administrative/Other|8|||
37941739|NCT00576758|69628812|FG000|Follow-up Period|Death|3|||
37941740|NCT00576758|69628813|FG001|Follow-up Period|Death|3|||
37941741|NCT00576758|69628812|FG000|Follow-up Period|Insufficient therapeutic response|16|||
37941742|NCT00576758|69628813|FG001|Follow-up Period|Insufficient therapeutic response|5|||
37941743|NCT00576758|69628812|FG000|Follow-up Period|Withdrew consent|2|||
37941744|NCT00576758|69628813|FG001|Follow-up Period|Withdrew consent|1|||
37941745|NCT00560794|69628820|FG000|Overall Study|Adverse Event|2|||
37941746|NCT00560794|69628820|FG000|Overall Study|Patient was not Compliant|1|||
37941747|NCT00560794|69628820|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
37941748|NCT00560794|69628820|FG000|Overall Study|Hematological Relapse|1|||
37941749|NCT00560794|69628820|FG000|Overall Study|Received Bone Marrow Transplant|6|||
37941750|NCT00619359|69628828|FG000|Overall Study|Adverse Event|32|||
37941751|NCT00619359|69628829|FG001|Overall Study|Adverse Event|36|||
37941752|NCT00619359|69628828|FG000|Overall Study|Lost to Follow-up|12|||
37941753|NCT00619359|69628829|FG001|Overall Study|Lost to Follow-up|16|||
37941754|NCT00619359|69628828|FG000|Overall Study|Physician Decision|0|||
37941755|NCT00619359|69628829|FG001|Overall Study|Physician Decision|7|||
37941756|NCT00619359|69628828|FG000|Overall Study|Protocol Violation|1|||
37941757|NCT00619359|69628829|FG001|Overall Study|Protocol Violation|1|||
37941758|NCT00619359|69628828|FG000|Overall Study|Withdrawal by Subject|19|||
37941759|NCT00619359|69628829|FG001|Overall Study|Withdrawal by Subject|20|||
37941760|NCT00619359|69628828|FG000|Overall Study|Progressive Disease|3|||
37941761|NCT00619359|69628829|FG001|Overall Study|Progressive Disease|1|||
37941762|NCT00372229|69628837|FG000|Study Phase|Graft loss|0|||
37941763|NCT00372229|69628838|FG001|Study Phase|Graft loss|3|||
37941764|NCT00372229|69628837|FG000|Study Phase|Protocol Violation|3|||
37941765|NCT00372229|69628838|FG001|Study Phase|Protocol Violation|4|||
37941766|NCT00372229|69628837|FG000|Study Phase|Consent withdrawn|16|||
37941767|NCT00372229|69628838|FG001|Study Phase|Consent withdrawn|14|||
37941768|NCT00372229|69628837|FG000|Study Phase|Refused treatment/did not cooperate|3|||
37941769|NCT00372229|69628838|FG001|Study Phase|Refused treatment/did not cooperate|1|||
37941770|NCT00372229|69628837|FG000|Study Phase|Death|3|||
37941771|NCT00372229|69628838|FG001|Study Phase|Death|2|||
37941772|NCT00372229|69628837|FG000|Study Phase|Reason not specified|3|||
37941773|NCT00372229|69628838|FG001|Study Phase|Reason not specified|2|||
37941774|NCT00372229|69628837|FG000|Study Phase|Lost to Follow-up|3|||
37941775|NCT00372229|69628838|FG001|Study Phase|Lost to Follow-up|3|||
37941776|NCT00372229|69628837|FG000|Follow-Up Phase|Graft loss|8|||
37941777|NCT00372229|69628838|FG001|Follow-Up Phase|Graft loss|7|||
37941778|NCT00372229|69628837|FG000|Follow-Up Phase|Consent withdrawn|13|||
37941779|NCT00372229|69628838|FG001|Follow-Up Phase|Consent withdrawn|19|||
37941780|NCT00372229|69628837|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
37941781|NCT00372229|69628838|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
37941782|NCT00372229|69628837|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
37941783|NCT00372229|69628838|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
37941784|NCT00372229|69628837|FG000|Follow-Up Phase|Death|9|||
37941785|NCT00372229|69628838|FG001|Follow-Up Phase|Death|12|||
37941786|NCT00372229|69628837|FG000|Follow-Up Phase|Administrative|1|||
37941787|NCT00372229|69628838|FG001|Follow-Up Phase|Administrative|0|||
37941788|NCT00372229|69628837|FG000|Follow-Up Phase|Reason not specified|2|||
37941789|NCT00372229|69628838|FG001|Follow-Up Phase|Reason not specified|3|||
37941790|NCT00372229|69628837|FG000|Follow-Up Phase|Lost to Follow-up|12|||
37941791|NCT00372229|69628838|FG001|Follow-Up Phase|Lost to Follow-up|10|||
37941792|NCT00698828|69628851|FG000|Overall Study|Adverse Event|3|||
37941793|NCT00698828|69628852|FG001|Overall Study|Adverse Event|4|||
37941794|NCT00698828|69628853|FG002|Overall Study|Adverse Event|4|||
37941795|NCT00698828|69628851|FG000|Overall Study|Death|0|||
37941796|NCT00698828|69628852|FG001|Overall Study|Death|0|||
37941797|NCT00698828|69628853|FG002|Overall Study|Death|1|||
37941798|NCT00698828|69628851|FG000|Overall Study|Exacerbation of COPD|1|||
37941799|NCT00698828|69628852|FG001|Overall Study|Exacerbation of COPD|3|||
37941800|NCT00698828|69628853|FG002|Overall Study|Exacerbation of COPD|0|||
37941801|NCT00698828|69628851|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
37941802|NCT00698828|69628852|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
37941803|NCT00698828|69628853|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
37941804|NCT00698828|69628851|FG000|Overall Study|Investigator/Sponsor decision|1|||
37941805|NCT00698828|69628852|FG001|Overall Study|Investigator/Sponsor decision|0|||
37941806|NCT00698828|69628853|FG002|Overall Study|Investigator/Sponsor decision|2|||
37941807|NCT00698828|69628851|FG000|Overall Study|Lost to Follow-up|1|||
37941808|NCT00698828|69628852|FG001|Overall Study|Lost to Follow-up|1|||
37941809|NCT00698828|69628853|FG002|Overall Study|Lost to Follow-up|0|||
37941810|NCT00698828|69628851|FG000|Overall Study|Withdrew consent|0|||
37941811|NCT00698828|69628852|FG001|Overall Study|Withdrew consent|7|||
37941812|NCT00698828|69628853|FG002|Overall Study|Withdrew consent|4|||
37941813|NCT00698828|69628851|FG000|Overall Study|Withdrew consent (not treated)|2|||
37941814|NCT00698828|69628852|FG001|Overall Study|Withdrew consent (not treated)|0|||
37941815|NCT00698828|69628853|FG002|Overall Study|Withdrew consent (not treated)|0|||
37941816|NCT00619515|69628861|FG000|Overall Study|Study Termination by IRB|73|||
37941817|NCT03167606|69628867|FG000|Overall Study|Lost to Follow-up|73|||
37941818|NCT03167606|69628868|FG001|Overall Study|Lost to Follow-up|64|||
37941819|NCT03167606|69628867|FG000|Overall Study|Withdrawal by Subject|6|||
37941820|NCT03167606|69628868|FG001|Overall Study|Withdrawal by Subject|5|||
37941821|NCT03167606|69628867|FG000|Overall Study|Withdrawal by Investigator|0|||
37941822|NCT03167606|69628868|FG001|Overall Study|Withdrawal by Investigator|2|||
37941823|NCT00688740|69628876|FG000|Overall Study|Adverse Event|45|||
37941824|NCT00688740|69628877|FG001|Overall Study|Adverse Event|8|||
37941825|NCT00688740|69628876|FG000|Overall Study|Death|2|||
37941826|NCT00688740|69628877|FG001|Overall Study|Death|2|||
37941827|NCT00688740|69628876|FG000|Overall Study|Lost to Follow-up|0|||
37941828|NCT00688740|69628877|FG001|Overall Study|Lost to Follow-up|1|||
37941829|NCT00688740|69628876|FG000|Overall Study|Consent Withdrawn|17|||
37941830|NCT00688740|69628877|FG001|Overall Study|Consent Withdrawn|17|||
37941831|NCT00688740|69628876|FG000|Overall Study|Breast Cancer Relapse|1|||
37941832|NCT00688740|69628877|FG001|Overall Study|Breast Cancer Relapse|4|||
37941833|NCT00688740|69628876|FG000|Overall Study|Violation of Inclusion Criteria|1|||
37941834|NCT00688740|69628877|FG001|Overall Study|Violation of Inclusion Criteria|3|||
37941835|NCT00552760|69628885|FG000|Overall Study|Adverse Event|3|||
37941836|NCT00552760|69628886|FG001|Overall Study|Adverse Event|5|||
37941837|NCT00552760|69628885|FG000|Overall Study|Relapsed- Depressed Event|10|||
37941838|NCT00552760|69628886|FG001|Overall Study|Relapsed- Depressed Event|16|||
37941839|NCT00552760|69628885|FG000|Overall Study|Relapse- Manic Event|3|||
37941840|NCT00552760|69628886|FG001|Overall Study|Relapse- Manic Event|3|||
37941841|NCT00552760|69628885|FG000|Overall Study|Relapsed- Mixed Event|3|||
37941842|NCT00552760|69628886|FG001|Overall Study|Relapsed- Mixed Event|5|||
37941843|NCT00552760|69628885|FG000|Overall Study|Protocol Violation|0|||
37941844|NCT00552760|69628886|FG001|Overall Study|Protocol Violation|1|||
37941845|NCT00552760|69628885|FG000|Overall Study|Lost to Follow-up|1|||
37941846|NCT00552760|69628886|FG001|Overall Study|Lost to Follow-up|1|||
37941847|NCT00552760|69628885|FG000|Overall Study|Non-compliance|1|||
37941848|NCT00552760|69628886|FG001|Overall Study|Non-compliance|1|||
37941849|NCT00552760|69628885|FG000|Overall Study|Medical Condition|1|||
37941850|NCT00552760|69628886|FG001|Overall Study|Medical Condition|1|||
37941851|NCT00552760|69628885|FG000|Overall Study|Withdrawal by Subject|3|||
37941852|NCT00552760|69628886|FG001|Overall Study|Withdrawal by Subject|0|||
37941853|NCT00552760|69628885|FG000|Overall Study|Medication Change|1|||
37941854|NCT00552760|69628886|FG001|Overall Study|Medication Change|0|||
37941855|NCT00686790|69628892|FG000|Overall Study|Adverse Event|2|||
37941856|NCT00686790|69628892|FG000|Overall Study|Withdrawal by Subject|1|||
37941857|NCT00686790|69628892|FG000|Overall Study|Death|1|||
37941858|NCT00686790|69628892|FG000|Overall Study|Lost to Follow-up|12|||
37941859|NCT00686712|69628899|FG000|Overall Study|Protocol Violation|8|||
37941860|NCT00686712|69628900|FG001|Overall Study|Protocol Violation|8|||
37941861|NCT00686712|69628901|FG002|Overall Study|Protocol Violation|10|||
37941862|NCT00686712|69628899|FG000|Overall Study|Lost to Follow-up|1|||
37941863|NCT00686712|69628900|FG001|Overall Study|Lost to Follow-up|2|||
37941864|NCT00686712|69628901|FG002|Overall Study|Lost to Follow-up|3|||
38035293|NCT04480424|69722260|FG001|Overall Study|Reason not Specified|5|||
38035294|NCT03256526|69722269|FG000|Overall Study|Adverse Event|1|||
38035295|NCT03256526|69722270|FG001|Overall Study|Adverse Event|0|||
38035296|NCT03256526|69722271|FG002|Overall Study|Adverse Event|1|||
38035297|NCT03256526|69722269|FG000|Overall Study|Lost to Follow-up|1|||
38035298|NCT03256526|69722270|FG001|Overall Study|Lost to Follow-up|0|||
38035299|NCT03256526|69722271|FG002|Overall Study|Lost to Follow-up|2|||
38035300|NCT03255980|69722283|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
38035301|NCT03255980|69722284|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
38035302|NCT03255980|69722285|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
38035303|NCT03255980|69722286|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
38035304|NCT03255980|69722283|FG000|Overall Study|Adverse Event|1|||
38035305|NCT03255980|69722284|FG001|Overall Study|Adverse Event|1|||
38035306|NCT03255980|69722285|FG002|Overall Study|Adverse Event|0|||
38035307|NCT03255980|69722286|FG003|Overall Study|Adverse Event|1|||
38035308|NCT03255980|69722283|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
38035309|NCT03255980|69722284|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
38035310|NCT03255980|69722285|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
38035311|NCT03255980|69722286|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
38035312|NCT03255980|69722283|FG000|Overall Study|Lost to Follow-up|1|||
38035313|NCT03255980|69722284|FG001|Overall Study|Lost to Follow-up|1|||
38035314|NCT03255980|69722285|FG002|Overall Study|Lost to Follow-up|0|||
37765200|NCT01420081|69278589|FG004|Overall Study|Death|7|||
37765201|NCT01420081|69278590|FG005|Overall Study|Death|12|||
37765202|NCT01420081|69278591|FG006|Overall Study|Death|0|||
37765203|NCT01420081|69278592|FG007|Overall Study|Death|1|||
37765204|NCT01420081|69278593|FG008|Overall Study|Death|1|||
38035315|NCT03255980|69722286|FG003|Overall Study|Lost to Follow-up|3|||
38035316|NCT03255980|69722283|FG000|Overall Study|Withdrawal by Subject|0|||
38035317|NCT03255980|69722284|FG001|Overall Study|Withdrawal by Subject|1|||
38035318|NCT03255980|69722285|FG002|Overall Study|Withdrawal by Subject|0|||
38035319|NCT03255980|69722286|FG003|Overall Study|Withdrawal by Subject|3|||
38035320|NCT03228212|69722296|FG000|Period 1|Adverse Event|1|||
38035321|NCT03228212|69722297|FG001|Period 1|Adverse Event|0|||
38035322|NCT03228212|69722296|FG000|Period 1|no longer meets eligibility criteria|0|||
38035323|NCT03228212|69722297|FG001|Period 1|no longer meets eligibility criteria|1|||
38035324|NCT03228212|69722296|FG000|Period 2|Lost to Follow-up|1|||
38035325|NCT03228212|69722297|FG001|Period 2|Lost to Follow-up|0|||
38035326|NCT04000815|69722306|FG000|Overall Study|Lost to Follow-up|9|||
38035327|NCT04000815|69722307|FG001|Overall Study|Lost to Follow-up|2|||
38035328|NCT04000815|69722308|FG002|Overall Study|Lost to Follow-up|3|||
38035329|NCT04000815|69722306|FG000|Overall Study|Withdrawal by Subject|4|||
38035330|NCT04000815|69722307|FG001|Overall Study|Withdrawal by Subject|3|||
38035331|NCT04000815|69722308|FG002|Overall Study|Withdrawal by Subject|2|||
38035332|NCT04000815|69722306|FG000|Overall Study|Right ovarian cyst occured|1|||
38035333|NCT04000815|69722307|FG001|Overall Study|Right ovarian cyst occured|0|||
38035334|NCT04000815|69722308|FG002|Overall Study|Right ovarian cyst occured|0|||
38035335|NCT04000815|69722306|FG000|Overall Study|Hypertension occured on follow up|0|||
38035336|NCT04000815|69722307|FG001|Overall Study|Hypertension occured on follow up|0|||
38035337|NCT04000815|69722308|FG002|Overall Study|Hypertension occured on follow up|2|||
38035338|NCT04000581|69722318|FG000|Overall Study|Withdrawal by Subject|0|||
38035339|NCT04000581|69722319|FG001|Overall Study|Withdrawal by Subject|1|||
38035340|NCT03848403|69722325|FG000|Period 2 (Day 8)|Adverse Event|1|||
38035341|NCT03848403|69722326|FG001|Period 2 (Day 8)|Adverse Event|2|||
38035342|NCT03848403|69722327|FG002|Period 2 (Day 8)|Adverse Event|2|||
37765205|NCT01420081|69278585|FG000|Overall Study|Lost to Follow-up|0|||
37941865|NCT00686712|69628899|FG000|Overall Study|Adverse Event|1|||
37941866|NCT00686712|69628900|FG001|Overall Study|Adverse Event|1|||
37941867|NCT00686712|69628901|FG002|Overall Study|Adverse Event|0|||
37941868|NCT00686634|69628912|FG000|Overall Study|Protocol Violation|6|||
38035343|NCT03848403|69722325|FG000|Period 2 (Day 8)|Physician Decision|0|||
38035344|NCT03848403|69722326|FG001|Period 2 (Day 8)|Physician Decision|1|||
38035345|NCT03848403|69722327|FG002|Period 2 (Day 8)|Physician Decision|0|||
37941869|NCT00560404|69628919|FG000|Overall Study|Adverse Event|2|||
37941870|NCT00560404|69628920|FG001|Overall Study|Adverse Event|3|||
37941871|NCT00560404|69628919|FG000|Overall Study|Death|3|||
37941872|NCT00560404|69628920|FG001|Overall Study|Death|3|||
37941873|NCT00560404|69628919|FG000|Overall Study|Protocol Violation|12|||
37941874|NCT00560404|69628920|FG001|Overall Study|Protocol Violation|7|||
37941875|NCT00560404|69628919|FG000|Overall Study|Administrative Reasons|1|||
37941876|NCT00560404|69628920|FG001|Overall Study|Administrative Reasons|1|||
37941877|NCT00560404|69628919|FG000|Overall Study|Withdrew Consent|4|||
37941878|NCT00560404|69628920|FG001|Overall Study|Withdrew Consent|0|||
37941879|NCT00560404|69628919|FG000|Overall Study|Failure to return|1|||
37941880|NCT00560404|69628920|FG001|Overall Study|Failure to return|2|||
37941881|NCT00560404|69628919|FG000|Overall Study|Other withdrawal reason|13|||
37941882|NCT00560404|69628920|FG001|Overall Study|Other withdrawal reason|5|||
37941883|NCT03967444|69628928|FG000|Overall Study|Lost to Follow-up|1|||
37941884|NCT03967444|69628929|FG001|Overall Study|Lost to Follow-up|2|||
37941885|NCT00619983|69628939|FG000|Test Drug Alone|Withdrawal by Subject|1|||
37941886|NCT00619983|69628940|FG001|Test Drug Alone|Withdrawal by Subject|0|||
37941887|NCT00619983|69628941|FG002|Test Drug Alone|Withdrawal by Subject|0|||
37941888|NCT00619983|69628942|FG003|Test Drug Alone|Withdrawal by Subject|1|||
37941889|NCT00619983|69628939|FG000|Test Drug Alone|Failure of daily diary device|1|||
37941890|NCT00619983|69628940|FG001|Test Drug Alone|Failure of daily diary device|1|||
37941891|NCT00619983|69628941|FG002|Test Drug Alone|Failure of daily diary device|2|||
37941892|NCT00619983|69628942|FG003|Test Drug Alone|Failure of daily diary device|2|||
37941893|NCT00576420|69628955|FG000|Overall Study|Death|0|||
37941894|NCT00576420|69628956|FG001|Overall Study|Death|0|||
37941895|NCT00576420|69628957|FG002|Overall Study|Death|1|||
37941896|NCT00364351|69629008|FG000|Overall Study|Adverse Event|90|||
37941897|NCT00364351|69629009|FG001|Overall Study|Adverse Event|44|||
37941898|NCT00364351|69629008|FG000|Overall Study|Condition under investigation worsened|469|||
37941899|NCT00364351|69629009|FG001|Overall Study|Condition under investigation worsened|497|||
37941900|NCT00364351|69629008|FG000|Overall Study|Prohibited concomitant medication|0|||
37941901|NCT00364351|69629009|FG001|Overall Study|Prohibited concomitant medication|2|||
37941902|NCT00364351|69629008|FG000|Overall Study|Lost to Follow-up|1|||
37941903|NCT00364351|69629009|FG001|Overall Study|Lost to Follow-up|1|||
37941904|NCT00364351|69629008|FG000|Overall Study|Withdrawal by Subject|30|||
37941905|NCT00364351|69629009|FG001|Overall Study|Withdrawal by Subject|29|||
37941906|NCT00364351|69629008|FG000|Overall Study|Incorrect enrollment|1|||
37941907|NCT00364351|69629009|FG001|Overall Study|Incorrect enrollment|1|||
37941908|NCT00364351|69629008|FG000|Overall Study|Sponsor decision|1|||
37941909|NCT00364351|69629009|FG001|Overall Study|Sponsor decision|0|||
37941910|NCT00364351|69629008|FG000|Overall Study|Poor treatment compliance|0|||
37941911|NCT00364351|69629009|FG001|Overall Study|Poor treatment compliance|3|||
37941912|NCT00364351|69629008|FG000|Overall Study|Investigator error|0|||
37941913|NCT00364351|69629009|FG001|Overall Study|Investigator error|2|||
37941914|NCT00364351|69629008|FG000|Overall Study|Patient could not travel to site|0|||
37941915|NCT00364351|69629009|FG001|Overall Study|Patient could not travel to site|1|||
37941916|NCT00364351|69629008|FG000|Overall Study|Randomised treatment not started|0|||
37941917|NCT00364351|69629009|FG001|Overall Study|Randomised treatment not started|3|||
37941918|NCT00388297|69629019|FG000|Overall Study|Lost to Follow-up|16|||
37941919|NCT00388297|69629020|FG001|Overall Study|Lost to Follow-up|12|||
37941920|NCT00388297|69629021|FG002|Overall Study|Lost to Follow-up|11|||
37941921|NCT00388297|69629022|FG003|Overall Study|Lost to Follow-up|8|||
37941922|NCT00686166|69629032|FG000|Overall Study|Adverse Event|7|||
37941923|NCT00686166|69629032|FG000|Overall Study|Withdrawal by Subject|1|||
37941924|NCT00686166|69629032|FG000|Overall Study|Progression/Relapse|1|||
37941925|NCT00686166|69629032|FG000|Overall Study|Death|1|||
37941926|NCT00686166|69629032|FG000|Overall Study|Not Protocol Specified|1|||
37941927|NCT00686166|69629032|FG000|Overall Study|Ineligible|5|||
37941928|NCT00686166|69629032|FG000|Overall Study|Did not begin protocol therapy|4|||
37941929|NCT00363649|69629043|FG000|Overall Study|Withdrawal by Subject|1|||
37670441|NCT02679755|69143692|FG001|Overall Study|Withdrawal by participant|3|||
37670442|NCT02679755|69143691|FG000|Overall Study|Adverse Event|1|||
37941930|NCT00363649|69629044|FG001|Overall Study|Withdrawal by Subject|1|||
37670443|NCT02679755|69143692|FG001|Overall Study|Adverse Event|4|||
37941931|NCT00363649|69629043|FG000|Overall Study|Adverse Event|6|||
37941932|NCT00363649|69629044|FG001|Overall Study|Adverse Event|0|||
37941933|NCT00684060|69629052|FG000|Overall Study|Lost to Follow-up|1|||
37941934|NCT00684060|69629053|FG001|Overall Study|Lost to Follow-up|0|||
37941935|NCT00684060|69629052|FG000|Overall Study|New stenosis identified|1|||
37941936|NCT00684060|69629053|FG001|Overall Study|New stenosis identified|0|||
37941937|NCT00684060|69629052|FG000|Overall Study|Unable to collect MRI|1|||
37941938|NCT00684060|69629053|FG001|Overall Study|Unable to collect MRI|2|||
37941939|NCT00684060|69629052|FG000|Overall Study|Death|0|||
37941940|NCT00684060|69629053|FG001|Overall Study|Death|1|||
37941941|NCT03131648|69629061|FG000|Initial Treatment Period|Not dosed|2|||
38035346|NCT03848403|69722325|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
37765206|NCT01420081|69278586|FG001|Overall Study|Lost to Follow-up|0|||
37941942|NCT03131648|69629062|FG001|Initial Treatment Period|Not dosed|2|||
37941943|NCT03131648|69629063|FG002|Initial Treatment Period|Not dosed|0|||
37941944|NCT03131648|69629064|FG003|Initial Treatment Period|Not dosed|0|||
37941945|NCT03131648|69629065|FG004|Initial Treatment Period|Not dosed|0|||
37941946|NCT03131648|69629066|FG005|Initial Treatment Period|Not dosed|0|||
37941947|NCT03131648|69629067|FG006|Initial Treatment Period|Not dosed|0|||
37941948|NCT03131648|69629068|FG007|Initial Treatment Period|Not dosed|0|||
37941949|NCT03131648|69629061|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
37941950|NCT03131648|69629062|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
37941951|NCT03131648|69629063|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
37941952|NCT03131648|69629064|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
37941953|NCT03131648|69629065|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
37941954|NCT03131648|69629066|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
37941955|NCT03131648|69629067|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
37941956|NCT03131648|69629068|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
37941957|NCT03131648|69629061|FG000|Open-label Treatment|Discontinued IMP|0|||
37941958|NCT03131648|69629062|FG001|Open-label Treatment|Discontinued IMP|0|||
37941959|NCT03131648|69629063|FG002|Open-label Treatment|Discontinued IMP|0|||
37941960|NCT03131648|69629064|FG003|Open-label Treatment|Discontinued IMP|0|||
37941961|NCT03131648|69629065|FG004|Open-label Treatment|Discontinued IMP|0|||
37941962|NCT03131648|69629066|FG005|Open-label Treatment|Discontinued IMP|0|||
37941963|NCT03131648|69629067|FG006|Open-label Treatment|Discontinued IMP|112|||
37941964|NCT03131648|69629068|FG007|Open-label Treatment|Discontinued IMP|0|||
37941965|NCT03131648|69629061|FG000|Open-label Treatment|Completed Week 50|0|||
37941966|NCT03131648|69629062|FG001|Open-label Treatment|Completed Week 50|0|||
37941967|NCT03131648|69629063|FG002|Open-label Treatment|Completed Week 50|0|||
37941968|NCT03131648|69629064|FG003|Open-label Treatment|Completed Week 50|0|||
37941969|NCT03131648|69629065|FG004|Open-label Treatment|Completed Week 50|0|||
37941970|NCT03131648|69629066|FG005|Open-label Treatment|Completed Week 50|0|||
38035347|NCT03848403|69722326|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
38035348|NCT03848403|69722327|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
37941971|NCT03131648|69629067|FG006|Open-label Treatment|Completed Week 50|6|||
37941972|NCT03131648|69629068|FG007|Open-label Treatment|Completed Week 50|0|||
37941973|NCT03131648|69629061|FG000|Maintenance Treatment Period|Not dosed|0|||
37941974|NCT03131648|69629062|FG001|Maintenance Treatment Period|Not dosed|0|||
37941975|NCT03131648|69629063|FG002|Maintenance Treatment Period|Not dosed|3|||
37941976|NCT03131648|69629064|FG003|Maintenance Treatment Period|Not dosed|2|||
37941977|NCT03131648|69629065|FG004|Maintenance Treatment Period|Not dosed|1|||
37941978|NCT03131648|69629066|FG005|Maintenance Treatment Period|Not dosed|0|||
37941979|NCT03131648|69629067|FG006|Maintenance Treatment Period|Not dosed|0|||
37941980|NCT03131648|69629068|FG007|Maintenance Treatment Period|Not dosed|0|||
37941981|NCT03131648|69629061|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
37941982|NCT03131648|69629062|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
37941983|NCT03131648|69629063|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
37941984|NCT03131648|69629064|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
37941985|NCT03131648|69629065|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
37941986|NCT03131648|69629066|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
37941987|NCT03131648|69629067|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
37941988|NCT03131648|69629068|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
37941989|NCT03131648|69629061|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
37941990|NCT03131648|69629062|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
37941991|NCT03131648|69629063|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
37941992|NCT03131648|69629064|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
37941993|NCT03131648|69629065|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
37941994|NCT03131648|69629066|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
37941995|NCT03131648|69629067|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
37941996|NCT03131648|69629068|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
37941997|NCT03131648|69629061|FG000|Maintenance Treatment Period|Completed Week 50|0|||
37941998|NCT03131648|69629062|FG001|Maintenance Treatment Period|Completed Week 50|0|||
37941999|NCT03131648|69629063|FG002|Maintenance Treatment Period|Completed Week 50|0|||
37942000|NCT03131648|69629064|FG003|Maintenance Treatment Period|Completed Week 50|0|||
37942001|NCT03131648|69629065|FG004|Maintenance Treatment Period|Completed Week 50|1|||
37942002|NCT03131648|69629066|FG005|Maintenance Treatment Period|Completed Week 50|0|||
38035349|NCT04054011|69722335|FG000|Overall Study|COVID|3|||
38035350|NCT04053465|69722343|FG000|Overall Study|Withdrawal by Subject|4|||
38035351|NCT04053465|69722344|FG001|Overall Study|Withdrawal by Subject|4|||
37942003|NCT03131648|69629067|FG006|Maintenance Treatment Period|Completed Week 50|0|||
37942004|NCT03131648|69629068|FG007|Maintenance Treatment Period|Completed Week 50|0|||
37942005|NCT03131648|69629061|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
38035352|NCT00143507|69722352|FG000|Overall Study|Death|572|||
38035353|NCT00143507|69722353|FG001|Overall Study|Death|547|||
37942006|NCT03131648|69629062|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
37942007|NCT03131648|69629063|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
37942008|NCT03131648|69629064|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
37942009|NCT03131648|69629065|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
37942010|NCT03131648|69629066|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
37942011|NCT03131648|69629067|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
37942012|NCT03131648|69629068|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
37942013|NCT00618813|69629085|FG000|Overall Study|Lack of Efficacy|1|||
37942014|NCT00618813|69629085|FG000|Overall Study|Physician Decision|2|||
37942015|NCT00618813|69629085|FG000|Overall Study|Withdrawal by Subject|1|||
37942016|NCT00685698|69629089|FG000|Overall Study|Withdrawal by Subject|1|||
37942017|NCT00685698|69629089|FG000|Overall Study|Protocol Violation|6|||
37942018|NCT00685698|69629089|FG000|Overall Study|Adverse Event|3|||
37942019|NCT00685698|69629089|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
37942020|NCT00685698|69629089|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
37942021|NCT00685698|69629089|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
37942022|NCT00549328|69629105|FG000|Overall Study|Adverse Event|2|||
37942023|NCT00549328|69629105|FG000|Overall Study|Disease Progression|10|||
37942024|NCT00549328|69629105|FG000|Overall Study|Death|1|||
37942025|NCT00549328|69629105|FG000|Overall Study|Use of Prohibited Medication|1|||
37942026|NCT00696410|69629111|FG000|Overall Study|Lost to Follow-up|2|||
37942027|NCT00696410|69629112|FG001|Overall Study|Lost to Follow-up|0|||
37942028|NCT00696410|69629111|FG000|Overall Study|Withdrawal by Subject|8|||
37942029|NCT00696410|69629112|FG001|Overall Study|Withdrawal by Subject|0|||
37942030|NCT00696410|69629111|FG000|Overall Study|Physician Decision|3|||
37942031|NCT00696410|69629112|FG001|Overall Study|Physician Decision|0|||
37942032|NCT00683904|69629125|FG000|Dose Level 1|Disease progression|2|||
37942033|NCT00683904|69629126|FG001|Dose Level 1|Disease progression|0|||
37942034|NCT00683904|69629125|FG000|Dose Level 1|Adverse Event|1|||
37942035|NCT00683904|69629126|FG001|Dose Level 1|Adverse Event|0|||
37942036|NCT00683904|69629125|FG000|Dose Level 2|Adverse Event|0|||
37942037|NCT00683904|69629126|FG001|Dose Level 2|Adverse Event|2|||
37942038|NCT00363415|69629140|FG000|Overall Study|Progressive Disease|196|||
37942039|NCT00363415|69629141|FG001|Overall Study|Progressive Disease|107|||
37942040|NCT00363415|69629140|FG000|Overall Study|Sponsor Decision|67|||
37942041|NCT00363415|69629141|FG001|Overall Study|Sponsor Decision|31|||
37942042|NCT00363415|69629140|FG000|Overall Study|Death|32|||
37942043|NCT00363415|69629141|FG001|Overall Study|Death|29|||
37942044|NCT00363415|69629140|FG000|Overall Study|Adverse Event|24|||
37942045|NCT00363415|69629141|FG001|Overall Study|Adverse Event|15|||
37942046|NCT00363415|69629140|FG000|Overall Study|Physician Decision|18|||
37942047|NCT00363415|69629141|FG001|Overall Study|Physician Decision|35|||
37942048|NCT00363415|69629140|FG000|Overall Study|Entry Criteria Not Met|11|||
37942049|NCT00363415|69629141|FG001|Overall Study|Entry Criteria Not Met|10|||
37942050|NCT00363415|69629140|FG000|Overall Study|Withdrawal by Subject|9|||
37942051|NCT00363415|69629141|FG001|Overall Study|Withdrawal by Subject|15|||
37942052|NCT00363415|69629140|FG000|Overall Study|Lost to Follow-up|3|||
37942053|NCT00363415|69629141|FG001|Overall Study|Lost to Follow-up|3|||
37942054|NCT00363415|69629140|FG000|Overall Study|Protocol Violation|1|||
37942055|NCT00363415|69629141|FG001|Overall Study|Protocol Violation|4|||
37942056|NCT00696020|69629151|FG000|Overall Study|Adverse Event|3|||
37942057|NCT00696020|69629152|FG001|Overall Study|Adverse Event|1|||
37942058|NCT00696020|69629153|FG002|Overall Study|Adverse Event|2|||
37942059|NCT00696020|69629154|FG003|Overall Study|Adverse Event|1|||
37942060|NCT00696020|69629151|FG000|Overall Study|Lack of Efficacy|1|||
37942061|NCT00696020|69629152|FG001|Overall Study|Lack of Efficacy|0|||
37942062|NCT00696020|69629153|FG002|Overall Study|Lack of Efficacy|0|||
37942063|NCT00696020|69629154|FG003|Overall Study|Lack of Efficacy|0|||
37942064|NCT00696020|69629151|FG000|Overall Study|Protocol Violation|0|||
37942065|NCT00696020|69629152|FG001|Overall Study|Protocol Violation|0|||
37942066|NCT00696020|69629153|FG002|Overall Study|Protocol Violation|0|||
37942067|NCT00696020|69629154|FG003|Overall Study|Protocol Violation|1|||
37942068|NCT00696020|69629151|FG000|Overall Study|Withdrawal by Subject|0|||
37942069|NCT00696020|69629152|FG001|Overall Study|Withdrawal by Subject|1|||
37942070|NCT00696020|69629153|FG002|Overall Study|Withdrawal by Subject|0|||
37942071|NCT00696020|69629154|FG003|Overall Study|Withdrawal by Subject|1|||
37942072|NCT00696020|69629151|FG000|Overall Study|Other not stated above|0|||
37942073|NCT00696020|69629152|FG001|Overall Study|Other not stated above|0|||
37942074|NCT00696020|69629153|FG002|Overall Study|Other not stated above|1|||
37942075|NCT00696020|69629154|FG003|Overall Study|Other not stated above|1|||
37942076|NCT00576576|69629166|FG000|Overall Study|Lost to Follow-up|6|||
37942077|NCT00576576|69629166|FG000|Overall Study|Protocol Violation|1|||
37942078|NCT00695864|69629185|FG000|Placebo|Withdrawal by Subject|1|||
37942079|NCT00695864|69629185|FG000|Placebo|Physician Decision|4|||
37942080|NCT00684996|69629191|FG000|Overall Study|Adverse Event|1|||
37942081|NCT00684996|69629191|FG000|Overall Study|Refusal unrelated to adverse event|1|||
37942082|NCT00684996|69629191|FG000|Overall Study|Progression/relapse|2|||
37942083|NCT00684996|69629191|FG000|Overall Study|Other reasons not protocol specified|1|||
37942084|NCT00684762|69629198|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
37942085|NCT00684762|69629199|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
37942086|NCT00695786|69629209|FG000|Overall Study|Adverse Event|0|||
37942087|NCT00695786|69629210|FG001|Overall Study|Adverse Event|3|||
37942088|NCT00695786|69629211|FG002|Overall Study|Adverse Event|4|||
37942089|NCT00695786|69629212|FG003|Overall Study|Adverse Event|2|||
37942090|NCT00695786|69629209|FG000|Overall Study|Lost to Follow-up|0|||
37942091|NCT00695786|69629210|FG001|Overall Study|Lost to Follow-up|5|||
37942092|NCT00695786|69629211|FG002|Overall Study|Lost to Follow-up|1|||
37942093|NCT00695786|69629212|FG003|Overall Study|Lost to Follow-up|1|||
37942094|NCT00695786|69629209|FG000|Overall Study|Withdrawal by Subject|0|||
37942095|NCT00695786|69629210|FG001|Overall Study|Withdrawal by Subject|4|||
37942096|NCT00695786|69629211|FG002|Overall Study|Withdrawal by Subject|3|||
37942097|NCT00695786|69629212|FG003|Overall Study|Withdrawal by Subject|1|||
37942098|NCT00695786|69629209|FG000|Overall Study|Deemed Ineligible|1|||
37942099|NCT00695786|69629210|FG001|Overall Study|Deemed Ineligible|0|||
37942100|NCT00695786|69629211|FG002|Overall Study|Deemed Ineligible|0|||
37942101|NCT00695786|69629212|FG003|Overall Study|Deemed Ineligible|0|||
37942102|NCT00695786|69629209|FG000|Overall Study|Lack of Efficacy|0|||
37942103|NCT00695786|69629210|FG001|Overall Study|Lack of Efficacy|0|||
37942104|NCT00695786|69629211|FG002|Overall Study|Lack of Efficacy|0|||
37942105|NCT00695786|69629212|FG003|Overall Study|Lack of Efficacy|4|||
37942106|NCT00387127|69629224|FG000|Overall Study|Lost to Follow-up|0|||
37942107|NCT00387127|69629225|FG001|Overall Study|Lost to Follow-up|4|||
37942108|NCT00387127|69629224|FG000|Overall Study|Death|16|||
37942109|NCT00387127|69629225|FG001|Overall Study|Death|16|||
37942110|NCT00387127|69629224|FG000|Overall Study|Physician Decision|0|||
37942111|NCT00387127|69629225|FG001|Overall Study|Physician Decision|1|||
37942112|NCT00387127|69629224|FG000|Overall Study|Withdrawal by Subject|3|||
37942113|NCT00387127|69629225|FG001|Overall Study|Withdrawal by Subject|2|||
37942114|NCT00387127|69629224|FG000|Overall Study|Required by Protocol Amendment #4|12|||
37942115|NCT00387127|69629225|FG001|Overall Study|Required by Protocol Amendment #4|10|||
37942116|NCT00387127|69629224|FG000|Overall Study|Serious Adverse Event|1|||
37942117|NCT00387127|69629225|FG001|Overall Study|Serious Adverse Event|1|||
37942118|NCT00387127|69629224|FG000|Overall Study|Sponsor Unblinded|1|||
37942119|NCT00387127|69629225|FG001|Overall Study|Sponsor Unblinded|0|||
37942120|NCT00683592|69629235|FG000|Overall Study|Adverse Event|12|||
37942121|NCT00683592|69629236|FG001|Overall Study|Adverse Event|4|||
37942122|NCT00683592|69629235|FG000|Overall Study|Withdrawal by Subject|11|||
37942123|NCT00683592|69629236|FG001|Overall Study|Withdrawal by Subject|11|||
37942124|NCT00683592|69629235|FG000|Overall Study|Lost to Follow-up|17|||
37942125|NCT00683592|69629236|FG001|Overall Study|Lost to Follow-up|17|||
37942126|NCT00683592|69629235|FG000|Overall Study|Lack of Efficacy|3|||
37942127|NCT00683592|69629236|FG001|Overall Study|Lack of Efficacy|7|||
37942128|NCT00683592|69629235|FG000|Overall Study|Physician Decision|0|||
37942129|NCT00683592|69629236|FG001|Overall Study|Physician Decision|1|||
37942130|NCT00683592|69629235|FG000|Overall Study|Non-compliance|3|||
37942131|NCT00683592|69629236|FG001|Overall Study|Non-compliance|5|||
37942132|NCT00683592|69629235|FG000|Overall Study|Other|1|||
37942133|NCT00683592|69629236|FG001|Overall Study|Other|1|||
37942134|NCT00695396|69629245|FG000|Overall Study|Study Closed Prematurely|5|||
37942135|NCT00695396|69629246|FG001|Overall Study|Study Closed Prematurely|6|||
37942136|NCT00695396|69629247|FG002|Overall Study|Study Closed Prematurely|8|||
37942137|NCT00695396|69629245|FG000|Overall Study|Withdrawal by Subject|2|||
37942138|NCT00695396|69629246|FG001|Overall Study|Withdrawal by Subject|2|||
37942139|NCT00695396|69629247|FG002|Overall Study|Withdrawal by Subject|0|||
37942140|NCT02656706|69629255|FG000|Overall Study|Insurance Denial|1|||
37942141|NCT00575328|69629261|FG000|Overall Study|Adverse Event|1|||
37942142|NCT00575328|69629262|FG001|Overall Study|Adverse Event|1|||
37942143|NCT00575328|69629261|FG000|Overall Study|Lost to Follow-up|2|||
37942144|NCT00575328|69629262|FG001|Overall Study|Lost to Follow-up|1|||
37942145|NCT00575094|69629268|FG000|Overall Study|Adverse Event|2|||
37942146|NCT00575094|69629268|FG000|Overall Study|Withdrawal by Subject|1|||
37942147|NCT00553696|69629276|FG000|Overall Study|Adverse Event|2|||
37942148|NCT00553696|69629277|FG001|Overall Study|Adverse Event|4|||
37942149|NCT00553696|69629278|FG002|Overall Study|Adverse Event|0|||
37942150|NCT00553696|69629279|FG003|Overall Study|Adverse Event|1|||
37942151|NCT00553696|69629276|FG000|Overall Study|Global deterioration of health status|0|||
37942152|NCT00553696|69629277|FG001|Overall Study|Global deterioration of health status|2|||
37942153|NCT00553696|69629278|FG002|Overall Study|Global deterioration of health status|0|||
37942154|NCT00553696|69629279|FG003|Overall Study|Global deterioration of health status|0|||
37942155|NCT00553696|69629276|FG000|Overall Study|Objective progression or relapse|2|||
37942156|NCT00553696|69629277|FG001|Overall Study|Objective progression or relapse|9|||
37942157|NCT00553696|69629278|FG002|Overall Study|Objective progression or relapse|6|||
37942158|NCT00553696|69629279|FG003|Overall Study|Objective progression or relapse|0|||
37942159|NCT00553696|69629276|FG000|Overall Study|Withdrawal by Subject|0|||
37942160|NCT00553696|69629277|FG001|Overall Study|Withdrawal by Subject|1|||
37942161|NCT00553696|69629278|FG002|Overall Study|Withdrawal by Subject|0|||
37942162|NCT00553696|69629279|FG003|Overall Study|Withdrawal by Subject|0|||
37942163|NCT00553540|69629294|FG000|Overall Study|discharged after first visit|2|||
37942164|NCT00553540|69629295|FG001|Overall Study|discharged after first visit|5|||
37942165|NCT00617409|69629304|FG000|Overall Study|Withdrawal by Subject|4|||
37942166|NCT00617409|69629305|FG001|Overall Study|Withdrawal by Subject|1|||
37942167|NCT00617409|69629306|FG002|Overall Study|Withdrawal by Subject|2|||
37942168|NCT00617409|69629304|FG000|Overall Study|Adverse Event|0|||
37942169|NCT00617409|69629305|FG001|Overall Study|Adverse Event|2|||
37942170|NCT00617409|69629306|FG002|Overall Study|Adverse Event|3|||
37942171|NCT00617409|69629304|FG000|Overall Study|Disease Progression|8|||
37942172|NCT00617409|69629305|FG001|Overall Study|Disease Progression|8|||
37942173|NCT00617409|69629306|FG002|Overall Study|Disease Progression|18|||
37942174|NCT00617409|69629304|FG000|Overall Study|Death|3|||
37942175|NCT00617409|69629305|FG001|Overall Study|Death|5|||
37942176|NCT00617409|69629306|FG002|Overall Study|Death|4|||
37942177|NCT00617409|69629304|FG000|Overall Study|Alternative Therapy|1|||
37942178|NCT00617409|69629305|FG001|Overall Study|Alternative Therapy|2|||
37942179|NCT00617409|69629306|FG002|Overall Study|Alternative Therapy|0|||
37942180|NCT00695318|69629317|FG000|Overall Study|Lost to Follow-up|1|||
37942181|NCT00695318|69629318|FG001|Overall Study|Lost to Follow-up|0|||
37942182|NCT00695318|69629317|FG000|Overall Study|Withdrawal by Subject|2|||
37942183|NCT00695318|69629318|FG001|Overall Study|Withdrawal by Subject|0|||
37942184|NCT00695318|69629317|FG000|Overall Study|Death|1|||
37942185|NCT00695318|69629318|FG001|Overall Study|Death|1|||
37942186|NCT00695318|69629317|FG000|Overall Study|Study Terminated|1|||
37942187|NCT00695318|69629318|FG001|Overall Study|Study Terminated|0|||
37942188|NCT00386425|69629332|FG000|Overall Study|Physician Decision|3|||
37942189|NCT00386425|69629333|FG001|Overall Study|Physician Decision|0|||
37942190|NCT00386425|69629334|FG002|Overall Study|Physician Decision|0|||
37942191|NCT00386425|69629332|FG000|Overall Study|Withdrawal by Subject|0|||
37942192|NCT00386425|69629333|FG001|Overall Study|Withdrawal by Subject|1|||
37942193|NCT00386425|69629334|FG002|Overall Study|Withdrawal by Subject|0|||
37942194|NCT00694304|69629346|FG000|Overall Study|Adverse Event|42|||
37942195|NCT00694304|69629346|FG000|Overall Study|Lack of Efficacy|35|||
37942196|NCT00694304|69629346|FG000|Overall Study|Non-compliance With Study Product|16|||
37942197|NCT00694304|69629346|FG000|Overall Study|Protocol Violation|6|||
37942198|NCT00694304|69629346|FG000|Overall Study|Withdrawal of Consent|61|||
37942199|NCT00694304|69629346|FG000|Overall Study|Lost to Follow-up|15|||
37942200|NCT00694304|69629346|FG000|Overall Study|Administrative or Other Reasons|32|||
37942201|NCT00371839|69629353|FG000|Overall Study|Death|4|||
37942202|NCT00371839|69629354|FG001|Overall Study|Death|0|||
37942203|NCT00371839|69629355|FG002|Overall Study|Death|0|||
37942204|NCT00371839|69629353|FG000|Overall Study|Withdrawal by Subject|7|||
37942205|NCT00371839|69629354|FG001|Overall Study|Withdrawal by Subject|4|||
37942206|NCT00371839|69629355|FG002|Overall Study|Withdrawal by Subject|0|||
37942207|NCT00371839|69629353|FG000|Overall Study|Lost to Follow-up|6|||
37942208|NCT00371839|69629354|FG001|Overall Study|Lost to Follow-up|3|||
37942209|NCT00371839|69629355|FG002|Overall Study|Lost to Follow-up|2|||
37942210|NCT00682890|69629363|FG000|Overall Study|Lost to Follow-up|1|||
38035354|NCT00143507|69722352|FG000|Overall Study|Withdrawal by Subject|114|||
38035355|NCT00143507|69722353|FG001|Overall Study|Withdrawal by Subject|102|||
38035356|NCT00143507|69722352|FG000|Overall Study|Lost to Follow-up|1|||
38035357|NCT00143507|69722353|FG001|Overall Study|Lost to Follow-up|0|||
38035358|NCT00143507|69722352|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
38035359|NCT00143507|69722353|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
37942211|NCT00682890|69629364|FG001|Overall Study|Lost to Follow-up|1|||
37942212|NCT00682890|69629363|FG000|Overall Study|subject moved away|0|||
37942213|NCT00682890|69629364|FG001|Overall Study|subject moved away|1|||
37942214|NCT00682890|69629363|FG000|Overall Study|heavy menstrual bleeding|1|||
37942215|NCT00682890|69629364|FG001|Overall Study|heavy menstrual bleeding|0|||
37942216|NCT00385723|69629373|FG000|Overall Study|Lost to Follow-up|1|||
37942217|NCT00385723|69629374|FG001|Overall Study|Lost to Follow-up|1|||
37942218|NCT00385723|69629375|FG002|Overall Study|Lost to Follow-up|0|||
37942219|NCT00385723|69629373|FG000|Overall Study|Withdrawal by Subject|1|||
38035360|NCT03988803|69722359|FG000|Period 2|Prematurely discontinued from medication|2|||
37942220|NCT00385723|69629374|FG001|Overall Study|Withdrawal by Subject|0|||
37942221|NCT00385723|69629375|FG002|Overall Study|Withdrawal by Subject|2|||
37942222|NCT00698516|69629383|FG000|Overall Study|Study Termination|2|||
37942223|NCT00698516|69629383|FG000|Overall Study|Withdrawal by Subject|3|||
37942224|NCT00679302|69629393|FG000|Overall Study|Lost to Follow-up|8|||
37942225|NCT00679302|69629394|FG001|Overall Study|Lost to Follow-up|4|||
37942226|NCT00690482|69629423|FG000|Overall Study|Adverse Event|2|||
37942227|NCT00690482|69629424|FG001|Overall Study|Adverse Event|1|||
37942228|NCT00690482|69629423|FG000|Overall Study|Incorrect enrolment|0|||
37942229|NCT00690482|69629424|FG001|Overall Study|Incorrect enrolment|1|||
37942230|NCT00690482|69629423|FG000|Overall Study|Study-specific discontinuation criteria|1|||
37942231|NCT00690482|69629424|FG001|Overall Study|Study-specific discontinuation criteria|0|||
37942232|NCT00690482|69629423|FG000|Overall Study|Intake of prohibited medicine|1|||
38035361|NCT03988803|69722359|FG000|Period 2|Adverse Event|1|||
38035362|NCT00181883|69722367|FG000|Overall Study|Lack of Efficacy|2|||
38035363|NCT00181883|69722367|FG000|Overall Study|Treatment Limiting AEs|3|||
38035364|NCT00181883|69722367|FG000|Overall Study|Withdrawal by Subject|4|||
38035365|NCT00181883|69722367|FG000|Overall Study|Lost to Follow-up|1|||
38035366|NCT00180713|69722373|FG000|Overall Study|Withdrawal by Subject|2|||
38035367|NCT00180713|69722374|FG001|Overall Study|Withdrawal by Subject|0|||
38035368|NCT00180713|69722373|FG000|Overall Study|Adverse Event|3|||
38035369|NCT00180713|69722374|FG001|Overall Study|Adverse Event|3|||
38035370|NCT03988023|69722382|FG000|Overall Study|Non-compliance|3|||
38035371|NCT03988023|69722383|FG001|Overall Study|Non-compliance|0|||
38035372|NCT03988023|69722382|FG000|Overall Study|Withdrawal by Subject|39|||
38035373|NCT03988023|69722383|FG001|Overall Study|Withdrawal by Subject|37|||
38035374|NCT03988023|69722382|FG000|Overall Study|Adverse Event|0|||
38035375|NCT03988023|69722383|FG001|Overall Study|Adverse Event|2|||
38035376|NCT03988023|69722382|FG000|Overall Study|Physician Decision|0|||
38035377|NCT03988023|69722383|FG001|Overall Study|Physician Decision|1|||
38035378|NCT03988023|69722382|FG000|Overall Study|Lost to Follow-up|5|||
38035379|NCT03988023|69722383|FG001|Overall Study|Lost to Follow-up|8|||
38035380|NCT03988023|69722382|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
38035381|NCT03988023|69722383|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
38035382|NCT03988023|69722382|FG000|Overall Study|Lack of Efficacy|3|||
38035383|NCT03988023|69722383|FG001|Overall Study|Lack of Efficacy|1|||
38035384|NCT03988023|69722382|FG000|Overall Study|COVID-19 pandemic|225|||
38035385|NCT03988023|69722383|FG001|Overall Study|COVID-19 pandemic|227|||
38035386|NCT04052139|69722392|FG000|Overall Study|Lost to Follow-up|2|||
38035387|NCT04052139|69722393|FG001|Overall Study|Lost to Follow-up|0|||
38035388|NCT04052139|69722394|FG002|Overall Study|Lost to Follow-up|0|||
38035389|NCT04052139|69722392|FG000|Overall Study|Withdrawal by Subject|1|||
38035390|NCT04052139|69722393|FG001|Overall Study|Withdrawal by Subject|0|||
38035391|NCT04052139|69722394|FG002|Overall Study|Withdrawal by Subject|0|||
38035392|NCT03984825|69722402|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
38035393|NCT03984825|69722402|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
38035394|NCT03984825|69722402|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
38035395|NCT03981861|69722411|FG000|Overall Study|Withdrawal by Subject|3|||
38035396|NCT01332266|69722420|FG000|Phase 1b|Death|3|||
38035397|NCT01332266|69722421|FG001|Phase 1b|Death|3|||
38035398|NCT01332266|69722422|FG002|Phase 1b|Death|2|||
38035399|NCT01332266|69722423|FG003|Phase 1b|Death|0|||
38035400|NCT01332266|69722424|FG004|Phase 1b|Death|0|||
38035401|NCT01332266|69722420|FG000|Phase 1b|Lost to Follow-up|0|||
38035402|NCT01332266|69722421|FG001|Phase 1b|Lost to Follow-up|1|||
38035403|NCT01332266|69722422|FG002|Phase 1b|Lost to Follow-up|0|||
38035404|NCT01332266|69722423|FG003|Phase 1b|Lost to Follow-up|0|||
37670444|NCT02679755|69143691|FG000|Overall Study|Adverse events not related to study drug|1|||
37670445|NCT02679755|69143692|FG001|Overall Study|Adverse events not related to study drug|2|||
37942233|NCT00690482|69629424|FG001|Overall Study|Intake of prohibited medicine|0|||
37942234|NCT00690482|69629423|FG000|Overall Study|withdrew consent at rand.day|0|||
37942235|NCT00690482|69629424|FG001|Overall Study|withdrew consent at rand.day|1|||
37942236|NCT00385255|69629432|FG000|Overall Study|Serious Adverse Event|1|||
37942237|NCT00385255|69629433|FG001|Overall Study|Serious Adverse Event|2|||
37942238|NCT00385255|69629432|FG000|Overall Study|Protocol Violation|0|||
37942239|NCT00385255|69629433|FG001|Overall Study|Protocol Violation|4|||
37942240|NCT00385255|69629432|FG000|Overall Study|Withdrawal by Subject|0|||
37942241|NCT00385255|69629433|FG001|Overall Study|Withdrawal by Subject|8|||
37942242|NCT00385255|69629432|FG000|Overall Study|Migrated/moved from study area|0|||
37942243|NCT00385255|69629433|FG001|Overall Study|Migrated/moved from study area|1|||
37942244|NCT00385255|69629432|FG000|Overall Study|Lost to Follow-up|20|||
38035405|NCT01332266|69722424|FG004|Phase 1b|Lost to Follow-up|0|||
38035406|NCT01332266|69722420|FG000|Phase 1b|Withdrawal by Subject|1|||
38035407|NCT01332266|69722421|FG001|Phase 1b|Withdrawal by Subject|1|||
38035408|NCT01332266|69722422|FG002|Phase 1b|Withdrawal by Subject|1|||
38035409|NCT01332266|69722423|FG003|Phase 1b|Withdrawal by Subject|0|||
38035410|NCT01332266|69722424|FG004|Phase 1b|Withdrawal by Subject|0|||
38035411|NCT01332266|69722420|FG000|Phase 2|Death|0|||
38035412|NCT01332266|69722421|FG001|Phase 2|Death|0|||
38035413|NCT01332266|69722422|FG002|Phase 2|Death|0|||
38035414|NCT01332266|69722423|FG003|Phase 2|Death|33|||
38035415|NCT01332266|69722424|FG004|Phase 2|Death|36|||
38035416|NCT01332266|69722420|FG000|Phase 2|Lost to Follow-up|0|||
38035417|NCT01332266|69722421|FG001|Phase 2|Lost to Follow-up|0|||
38035418|NCT01332266|69722422|FG002|Phase 2|Lost to Follow-up|0|||
38035419|NCT01332266|69722423|FG003|Phase 2|Lost to Follow-up|2|||
38035420|NCT01332266|69722424|FG004|Phase 2|Lost to Follow-up|0|||
38035421|NCT01332266|69722420|FG000|Phase 2|Physician Decision|0|||
38035422|NCT01332266|69722421|FG001|Phase 2|Physician Decision|0|||
38035423|NCT01332266|69722422|FG002|Phase 2|Physician Decision|0|||
38035424|NCT01332266|69722423|FG003|Phase 2|Physician Decision|3|||
38035425|NCT01332266|69722424|FG004|Phase 2|Physician Decision|1|||
38035426|NCT01332266|69722420|FG000|Phase 2|Symptomatic deterioration|0|||
38035427|NCT01332266|69722421|FG001|Phase 2|Symptomatic deterioration|0|||
38035428|NCT01332266|69722422|FG002|Phase 2|Symptomatic deterioration|0|||
38035429|NCT01332266|69722423|FG003|Phase 2|Symptomatic deterioration|0|||
38035430|NCT01332266|69722424|FG004|Phase 2|Symptomatic deterioration|1|||
38035431|NCT01332266|69722420|FG000|Phase 2|Progression Disease|0|||
38035432|NCT01332266|69722421|FG001|Phase 2|Progression Disease|0|||
38035433|NCT01332266|69722422|FG002|Phase 2|Progression Disease|0|||
38035434|NCT01332266|69722423|FG003|Phase 2|Progression Disease|2|||
38035435|NCT01332266|69722424|FG004|Phase 2|Progression Disease|1|||
38035436|NCT01332266|69722420|FG000|Phase 2|Withdrawal by Subject|0|||
38035437|NCT01332266|69722421|FG001|Phase 2|Withdrawal by Subject|0|||
38035438|NCT01332266|69722422|FG002|Phase 2|Withdrawal by Subject|0|||
38035439|NCT01332266|69722423|FG003|Phase 2|Withdrawal by Subject|2|||
38035440|NCT01332266|69722424|FG004|Phase 2|Withdrawal by Subject|2|||
38035441|NCT03255824|69722439|FG000|Overall Study|Under-sedation|2|||
38035442|NCT03255824|69722440|FG001|Overall Study|Under-sedation|1|||
38035443|NCT03238352|69722449|FG000|Overall Study|Lost to Follow-up|0|||
38035444|NCT03238352|69722450|FG001|Overall Study|Lost to Follow-up|2|||
38035445|NCT03238352|69722451|FG002|Overall Study|Lost to Follow-up|1|||
38035446|NCT03238352|69722449|FG000|Overall Study|Withdrawal by Subject|0|||
38035447|NCT03238352|69722450|FG001|Overall Study|Withdrawal by Subject|1|||
38035448|NCT03238352|69722451|FG002|Overall Study|Withdrawal by Subject|0|||
38035449|NCT00180479|69722465|FG000|Overall Study|Death|4|||
38035450|NCT00180479|69722466|FG001|Overall Study|Death|2|||
38035451|NCT00180479|69722465|FG000|Overall Study|Lost to Follow-up|9|||
38035452|NCT00180479|69722466|FG001|Overall Study|Lost to Follow-up|7|||
38035453|NCT00180479|69722465|FG000|Overall Study|Withdrawal by Subject|3|||
38035454|NCT00180479|69722466|FG001|Overall Study|Withdrawal by Subject|3|||
38035455|NCT00180479|69722465|FG000|Overall Study|Informed consent not signed|0|||
38035456|NCT00180479|69722466|FG001|Overall Study|Informed consent not signed|1|||
38035457|NCT03224234|69722476|FG000|Main Study|Lost to Follow-up|5|||
38035458|NCT03224234|69722477|FG001|Main Study|Lost to Follow-up|5|||
38035459|NCT02955069|69722491|FG000|Overall Study|Adverse Event|7|||
38035460|NCT02955069|69722492|FG001|Overall Study|Adverse Event|2|||
38035461|NCT02955069|69722491|FG000|Overall Study|Death|7|||
38035462|NCT02955069|69722492|FG001|Overall Study|Death|3|||
38035463|NCT02955069|69722491|FG000|Overall Study|Physician Decision|10|||
38035464|NCT02955069|69722492|FG001|Overall Study|Physician Decision|2|||
38035465|NCT02955069|69722491|FG000|Overall Study|Progressive disease|64|||
38035466|NCT02955069|69722492|FG001|Overall Study|Progressive disease|13|||
38035467|NCT02955069|69722491|FG000|Overall Study|Study terminated by sponsor|4|||
37670446|NCT02675075|69143703|FG000|Overall Study|Lost to Follow-up|3|||
37942245|NCT00385255|69629433|FG001|Overall Study|Lost to Follow-up|58|||
37942246|NCT00698204|69629445|FG000|Overall Study|Withdrawal by Subject|1|||
37942247|NCT00698204|69629446|FG001|Overall Study|Withdrawal by Subject|0|||
37942248|NCT00549718|69629458|FG000|Overall Study|Insufficient clinical response|20|||
37942249|NCT00549718|69629459|FG001|Overall Study|Insufficient clinical response|7|||
37942250|NCT00549718|69629460|FG002|Overall Study|Insufficient clinical response|18|||
37942251|NCT00549718|69629461|FG003|Overall Study|Insufficient clinical response|32|||
37942252|NCT00549718|69629458|FG000|Overall Study|Adverse Event|6|||
37942253|NCT00549718|69629459|FG001|Overall Study|Adverse Event|8|||
37942254|NCT00549718|69629460|FG002|Overall Study|Adverse Event|7|||
37942255|NCT00549718|69629461|FG003|Overall Study|Adverse Event|3|||
37942256|NCT00549718|69629458|FG000|Overall Study|Lost to Follow-up|4|||
37942257|NCT00549718|69629459|FG001|Overall Study|Lost to Follow-up|2|||
37942258|NCT00549718|69629460|FG002|Overall Study|Lost to Follow-up|0|||
38035468|NCT02955069|69722492|FG001|Overall Study|Study terminated by sponsor|0|||
38035469|NCT02955069|69722491|FG000|Overall Study|Subject/Guardian decision|3|||
38035470|NCT02955069|69722492|FG001|Overall Study|Subject/Guardian decision|1|||
38035471|NCT03254108|69722505|FG000|Overall Study|Adverse Event|0|||
38035472|NCT03254108|69722506|FG001|Overall Study|Adverse Event|2|||
38035473|NCT03254108|69722507|FG002|Overall Study|Adverse Event|0|||
38035474|NCT03254108|69722508|FG003|Overall Study|Adverse Event|1|||
38035475|NCT03254108|69722509|FG004|Overall Study|Adverse Event|1|||
38035476|NCT03254108|69722505|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
38035477|NCT03254108|69722506|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
38035478|NCT03254108|69722507|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
38035479|NCT03254108|69722508|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
38035480|NCT03254108|69722509|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
38035481|NCT03773978|69722533|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
38035482|NCT03773978|69722534|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
38035483|NCT03773978|69722533|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
38035484|NCT03773978|69722534|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
37942259|NCT00549718|69629461|FG003|Overall Study|Lost to Follow-up|6|||
37942260|NCT00549718|69629458|FG000|Overall Study|Withdrawal by Subject|9|||
37942261|NCT00549718|69629459|FG001|Overall Study|Withdrawal by Subject|18|||
38035485|NCT03773978|69722533|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
38035486|NCT03773978|69722534|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
38035487|NCT03773978|69722533|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
38035488|NCT03773978|69722534|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
38035489|NCT03773978|69722533|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
38035490|NCT03773978|69722534|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
38035491|NCT03773978|69722533|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
38035492|NCT03773978|69722534|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
38035493|NCT03773978|69722533|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
38035494|NCT03773978|69722534|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
38035495|NCT03773978|69722533|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
38035496|NCT03773978|69722534|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
38035497|NCT03773978|69722533|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
38035498|NCT03773978|69722534|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
38035499|NCT03773978|69722533|FG000|DBW Period|Adverse Event|2|||
38035500|NCT03773978|69722534|FG001|DBW Period|Adverse Event|2|||
38035501|NCT03773978|69722533|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
38035502|NCT03773978|69722534|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
38035503|NCT03773978|69722533|FG000|DBW Period|Withdrawal by Subject|2|||
38035504|NCT03773978|69722534|FG001|DBW Period|Withdrawal by Subject|1|||
38035505|NCT03773978|69722533|FG000|DBW Period|Due to epidemic or pandemic|5|||
38035506|NCT03773978|69722534|FG001|DBW Period|Due to epidemic or pandemic|6|||
38035507|NCT03773978|69722533|FG000|DBW Period|Study team decision|1|||
38035508|NCT03773978|69722534|FG001|DBW Period|Study team decision|0|||
37942262|NCT00549718|69629460|FG002|Overall Study|Withdrawal by Subject|12|||
37942263|NCT00549718|69629461|FG003|Overall Study|Withdrawal by Subject|13|||
37942264|NCT00549718|69629458|FG000|Overall Study|Administrative|2|||
37942265|NCT00549718|69629459|FG001|Overall Study|Administrative|2|||
37942266|NCT00549718|69629460|FG002|Overall Study|Administrative|2|||
37942267|NCT00549718|69629461|FG003|Overall Study|Administrative|1|||
38035509|NCT03682107|69722550|FG000|Overall Study|Withdrawal by Subject|0|||
38035510|NCT03682107|69722551|FG001|Overall Study|Withdrawal by Subject|1|||
38035511|NCT03682107|69722552|FG002|Overall Study|Withdrawal by Subject|0|||
37670447|NCT02675075|69143704|FG001|Overall Study|Lost to Follow-up|0|||
37765207|NCT01420081|69278587|FG002|Overall Study|Lost to Follow-up|0|||
37765208|NCT01420081|69278588|FG003|Overall Study|Lost to Follow-up|0|||
37765209|NCT01420081|69278589|FG004|Overall Study|Lost to Follow-up|1|||
37765210|NCT01420081|69278590|FG005|Overall Study|Lost to Follow-up|1|||
37765211|NCT01420081|69278591|FG006|Overall Study|Lost to Follow-up|0|||
37942268|NCT00371761|69629473|FG000|Overall Study|Adverse Event|1|||
37942269|NCT00371761|69629474|FG001|Overall Study|Adverse Event|1|||
37942270|NCT00371761|69629473|FG000|Overall Study|Withdrawal by Subject|1|||
37942271|NCT00371761|69629474|FG001|Overall Study|Withdrawal by Subject|3|||
37942272|NCT00371761|69629473|FG000|Overall Study|Investigator Judgment|2|||
37942273|NCT00371761|69629474|FG001|Overall Study|Investigator Judgment|3|||
37942274|NCT00371761|69629473|FG000|Overall Study|Study termination|4|||
37942275|NCT00371761|69629474|FG001|Overall Study|Study termination|3|||
37942276|NCT00549640|69629482|FG000|Overall Study|Withdrawal by Subject|6|||
37942277|NCT00549640|69629483|FG001|Overall Study|Withdrawal by Subject|12|||
37942278|NCT00549640|69629482|FG000|Overall Study|Adverse Event|5|||
37942279|NCT00549640|69629483|FG001|Overall Study|Adverse Event|0|||
37942280|NCT00549640|69629482|FG000|Overall Study|Lost to Follow-up|7|||
37942281|NCT00549640|69629483|FG001|Overall Study|Lost to Follow-up|4|||
37942282|NCT00549562|69629505|FG000|Overall Study|Adverse Event|1|||
37942283|NCT00549562|69629505|FG000|Overall Study|Lack of Efficacy|1|||
37942284|NCT00681564|69629511|FG000|Overall Study|Lost to Follow-up|6|||
37942285|NCT00681564|69629512|FG001|Overall Study|Lost to Follow-up|6|||
37942286|NCT00681564|69629511|FG000|Overall Study|Withdrawal by Subject|0|||
37942287|NCT00681564|69629512|FG001|Overall Study|Withdrawal by Subject|1|||
37942288|NCT00681564|69629511|FG000|Overall Study|Death|0|||
37942289|NCT00681564|69629512|FG001|Overall Study|Death|1|||
37942290|NCT00677352|69629520|FG000|Treatment Phase|Adverse Event|14|||
37942291|NCT00677352|69629521|FG001|Treatment Phase|Adverse Event|22|||
37942292|NCT00677352|69629520|FG000|Treatment Phase|Lack of Efficacy|2|||
37942293|NCT00677352|69629521|FG001|Treatment Phase|Lack of Efficacy|3|||
37942294|NCT00677352|69629520|FG000|Treatment Phase|Lost to Follow-up|0|||
37942295|NCT00677352|69629521|FG001|Treatment Phase|Lost to Follow-up|1|||
37942296|NCT00677352|69629520|FG000|Treatment Phase|Withdrawal by Subject|7|||
38035512|NCT03682107|69722553|FG003|Overall Study|Withdrawal by Subject|0|||
38035513|NCT03682107|69722554|FG004|Overall Study|Withdrawal by Subject|0|||
38035514|NCT03673046|69722568|FG000|Overall Study|Adverse Event|1|||
38035515|NCT03673046|69722569|FG001|Overall Study|Adverse Event|1|||
38035516|NCT03673046|69722568|FG000|Overall Study|Withdrawal by Subject|8|||
37765212|NCT01420081|69278592|FG007|Overall Study|Lost to Follow-up|0|||
37942297|NCT00677352|69629521|FG001|Treatment Phase|Withdrawal by Subject|7|||
37942298|NCT00677352|69629520|FG000|Treatment Phase|Physician Decision|1|||
38035517|NCT03673046|69722569|FG001|Overall Study|Withdrawal by Subject|2|||
38035518|NCT02956005|69722575|FG000|Overall Study|Not eligible|1|||
38035519|NCT02956005|69722575|FG000|Overall Study|Withdrawal by Subject|3|||
38035520|NCT02956005|69722575|FG000|Overall Study|Physician Decision|12|||
38035521|NCT03253094|69722585|FG000|Overall Study|Adverse Event|2|||
38035522|NCT03253094|69722586|FG001|Overall Study|Adverse Event|0|||
38035523|NCT03253094|69722587|FG002|Overall Study|Adverse Event|0|||
38035524|NCT03253094|69722588|FG003|Overall Study|Adverse Event|0|||
38035525|NCT03253094|69722589|FG004|Overall Study|Adverse Event|0|||
38035526|NCT03253094|69722590|FG005|Overall Study|Adverse Event|0|||
38035527|NCT03253094|69722585|FG000|Overall Study|Lack of Efficacy|0|||
38035528|NCT03253094|69722586|FG001|Overall Study|Lack of Efficacy|0|||
38035529|NCT03253094|69722587|FG002|Overall Study|Lack of Efficacy|2|||
38035530|NCT03253094|69722588|FG003|Overall Study|Lack of Efficacy|1|||
38035531|NCT03253094|69722589|FG004|Overall Study|Lack of Efficacy|2|||
38035532|NCT03253094|69722590|FG005|Overall Study|Lack of Efficacy|1|||
38035533|NCT03253094|69722585|FG000|Overall Study|Lost to Follow-up|0|||
38035534|NCT03253094|69722586|FG001|Overall Study|Lost to Follow-up|0|||
38035535|NCT03253094|69722587|FG002|Overall Study|Lost to Follow-up|1|||
38035536|NCT03253094|69722588|FG003|Overall Study|Lost to Follow-up|1|||
38035537|NCT03253094|69722589|FG004|Overall Study|Lost to Follow-up|0|||
38035538|NCT03253094|69722590|FG005|Overall Study|Lost to Follow-up|1|||
38035539|NCT03253094|69722585|FG000|Overall Study|Physician Decision|1|||
38035540|NCT03253094|69722586|FG001|Overall Study|Physician Decision|0|||
38035541|NCT03253094|69722587|FG002|Overall Study|Physician Decision|0|||
38035542|NCT03253094|69722588|FG003|Overall Study|Physician Decision|1|||
38035543|NCT03253094|69722589|FG004|Overall Study|Physician Decision|0|||
38035544|NCT03253094|69722590|FG005|Overall Study|Physician Decision|2|||
38035545|NCT03253094|69722585|FG000|Overall Study|Withdrawal by Subject|1|||
38035546|NCT03253094|69722586|FG001|Overall Study|Withdrawal by Subject|2|||
38035547|NCT03253094|69722587|FG002|Overall Study|Withdrawal by Subject|1|||
38035548|NCT03253094|69722588|FG003|Overall Study|Withdrawal by Subject|0|||
38035549|NCT03253094|69722589|FG004|Overall Study|Withdrawal by Subject|3|||
38035550|NCT03253094|69722590|FG005|Overall Study|Withdrawal by Subject|0|||
38035551|NCT03253094|69722585|FG000|Overall Study|Other|0|||
38035552|NCT03253094|69722586|FG001|Overall Study|Other|1|||
38035553|NCT03253094|69722587|FG002|Overall Study|Other|2|||
38035554|NCT03253094|69722588|FG003|Overall Study|Other|1|||
38035555|NCT03253094|69722589|FG004|Overall Study|Other|0|||
38035556|NCT03253094|69722590|FG005|Overall Study|Other|0|||
38035557|NCT03654885|69722606|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
38035558|NCT03654885|69722607|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
38035559|NCT03654885|69722606|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
38035560|NCT03654885|69722607|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
38035561|NCT03654885|69722606|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
38035562|NCT03654885|69722607|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
38035563|NCT03654885|69722606|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
38035564|NCT03654885|69722607|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
38035565|NCT03654885|69722606|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
38035566|NCT03654885|69722607|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
37942299|NCT00677352|69629521|FG001|Treatment Phase|Physician Decision|0|||
37942300|NCT00677352|69629520|FG000|Treatment Phase|Pregnancy|0|||
37942301|NCT00677352|69629521|FG001|Treatment Phase|Pregnancy|1|||
37942302|NCT00677352|69629520|FG000|Treatment Phase|Protocol Violation|1|||
37942303|NCT00677352|69629521|FG001|Treatment Phase|Protocol Violation|1|||
37942304|NCT00677352|69629520|FG000|Treatment Phase|Transference or work related matter|0|||
37942305|NCT00677352|69629521|FG001|Treatment Phase|Transference or work related matter|5|||
37942306|NCT00677352|69629520|FG000|Treatment Phase|Not treated|0|||
37942307|NCT00677352|69629521|FG001|Treatment Phase|Not treated|2|||
37942308|NCT00677352|69629520|FG000|Tapering Phase|Adverse Event|1|||
37942309|NCT00677352|69629521|FG001|Tapering Phase|Adverse Event|5|||
37942310|NCT00677352|69629520|FG000|Tapering Phase|Withdrawal by Subject|5|||
37942311|NCT00677352|69629521|FG001|Tapering Phase|Withdrawal by Subject|3|||
37942312|NCT00677352|69629520|FG000|Tapering Phase|Pregnancy|0|||
37942313|NCT00677352|69629521|FG001|Tapering Phase|Pregnancy|1|||
38035567|NCT03654885|69722606|FG000|Overall Study|Adverse Event in Study Eye|3|||
38035568|NCT03654885|69722607|FG001|Overall Study|Adverse Event in Study Eye|0|||
38035569|NCT03654885|69722606|FG000|Overall Study|Consent Withdrawn|1|||
38035570|NCT03654885|69722607|FG001|Overall Study|Consent Withdrawn|0|||
38035571|NCT03654885|69722606|FG000|Overall Study|Death|3|||
38035572|NCT03654885|69722607|FG001|Overall Study|Death|1|||
38035573|NCT03654885|69722606|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
38043560|NCT02927262|69731712|FG001|Overall Study|Withdrawal by Subject|0|||
37942314|NCT00677352|69629520|FG000|Tapering Phase|Job transfer|0|||
37942315|NCT00677352|69629521|FG001|Tapering Phase|Job transfer|1|||
38035574|NCT03654885|69722607|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
38035575|NCT03654885|69722606|FG000|Overall Study|Lost to Follow-up|3|||
38035576|NCT03654885|69722607|FG001|Overall Study|Lost to Follow-up|3|||
38035577|NCT03236246|69722615|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
38035578|NCT03236246|69722616|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
38035579|NCT03236246|69722615|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
38035580|NCT03236246|69722616|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
38035581|NCT03236246|69722615|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
38035582|NCT03236246|69722616|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
38035583|NCT03236246|69722615|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
38035584|NCT03236246|69722616|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
38035585|NCT03236246|69722615|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
38035586|NCT03236246|69722616|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
38035587|NCT03236246|69722615|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
38035588|NCT03236246|69722616|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
38035589|NCT03236246|69722615|FG000|24-Week Dose Titration Period|Death|3|||
38035590|NCT03236246|69722616|FG001|24-Week Dose Titration Period|Death|1|||
38035591|NCT03236246|69722615|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
38035592|NCT03236246|69722616|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
38035593|NCT03236246|69722615|FG000|24-Week Dose Titration Period|Adverse Event|7|||
38035594|NCT03236246|69722616|FG001|24-Week Dose Titration Period|Adverse Event|8|||
38035595|NCT03236246|69722615|FG000|24-Week Dose Titration Period|Captured as Other|1|||
38035596|NCT03236246|69722616|FG001|24-Week Dose Titration Period|Captured as Other|2|||
38035597|NCT03236246|69722615|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
38035598|NCT03236246|69722616|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
38035599|NCT03236246|69722615|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
38035600|NCT03236246|69722616|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
38035601|NCT03236246|69722615|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
38035602|NCT03236246|69722616|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
38035603|NCT03236246|69722615|FG000|24-Week Dose Maintenance Period|Death|0|||
38035604|NCT03236246|69722616|FG001|24-Week Dose Maintenance Period|Death|1|||
38035605|NCT03236246|69722615|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
38035606|NCT03236246|69722616|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
38035607|NCT02937584|69722622|FG000|Period 1|Adverse Event|1|||
38035608|NCT02937584|69722623|FG001|Period 1|Adverse Event|2|||
38035609|NCT02937584|69722622|FG000|Washout|Adverse Event|0|||
38035610|NCT02937584|69722623|FG001|Washout|Adverse Event|1|||
38035611|NCT00179621|69722632|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
38035612|NCT00179621|69722633|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
38035613|NCT00179621|69722634|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
38035614|NCT00179621|69722635|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
38035615|NCT00179621|69722632|FG000|Double-Blind Period|Adverse Event|2|||
38035616|NCT00179621|69722633|FG001|Double-Blind Period|Adverse Event|7|||
38035617|NCT00179621|69722634|FG002|Double-Blind Period|Adverse Event|4|||
38035618|NCT00179621|69722635|FG003|Double-Blind Period|Adverse Event|0|||
38035619|NCT00179621|69722632|FG000|Double-Blind Period|Withdrawal by Subject|2|||
38035620|NCT00179621|69722633|FG001|Double-Blind Period|Withdrawal by Subject|1|||
38035621|NCT00179621|69722634|FG002|Double-Blind Period|Withdrawal by Subject|3|||
38035622|NCT00179621|69722635|FG003|Double-Blind Period|Withdrawal by Subject|0|||
38035623|NCT00179621|69722632|FG000|Double-Blind Period|Death|0|||
38035624|NCT00179621|69722633|FG001|Double-Blind Period|Death|1|||
38035625|NCT00179621|69722634|FG002|Double-Blind Period|Death|2|||
38035626|NCT00179621|69722635|FG003|Double-Blind Period|Death|0|||
38035627|NCT00179621|69722632|FG000|Double-Blind Period|Protocol Violation|1|||
38035628|NCT00179621|69722633|FG001|Double-Blind Period|Protocol Violation|0|||
38035629|NCT00179621|69722634|FG002|Double-Blind Period|Protocol Violation|0|||
38035630|NCT00179621|69722635|FG003|Double-Blind Period|Protocol Violation|0|||
38035631|NCT00179621|69722632|FG000|Double-Blind Period|Other|0|||
38035632|NCT00179621|69722633|FG001|Double-Blind Period|Other|2|||
38035633|NCT00179621|69722634|FG002|Double-Blind Period|Other|2|||
38035634|NCT00179621|69722635|FG003|Double-Blind Period|Other|0|||
38035635|NCT00179621|69722632|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
38035636|NCT00179621|69722633|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
38035637|NCT00179621|69722634|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
38035638|NCT00179621|69722635|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
38035639|NCT00179621|69722632|FG000|Open-Label Period|Adverse Event|0|||
38035640|NCT00179621|69722633|FG001|Open-Label Period|Adverse Event|6|||
38035641|NCT00179621|69722634|FG002|Open-Label Period|Adverse Event|5|||
38035642|NCT00179621|69722635|FG003|Open-Label Period|Adverse Event|6|||
38035643|NCT00179621|69722632|FG000|Open-Label Period|Withdrawal by Subject|0|||
38035644|NCT00179621|69722633|FG001|Open-Label Period|Withdrawal by Subject|2|||
38035645|NCT00179621|69722634|FG002|Open-Label Period|Withdrawal by Subject|2|||
38035646|NCT00179621|69722635|FG003|Open-Label Period|Withdrawal by Subject|2|||
38035647|NCT00179621|69722632|FG000|Open-Label Period|Death|0|||
37670448|NCT02673515|69143714|FG000|Overall Study|Lack of motivation|2|||
37670449|NCT02673515|69143715|FG001|Overall Study|Lack of motivation|1|||
37670450|NCT02667275|69143723|FG000|Overall Study|Protocol Violation|11|||
37670451|NCT02667275|69143724|FG001|Overall Study|Protocol Violation|7|||
37670452|NCT02667275|69143723|FG000|Overall Study|Lost to Follow-up|0|||
37670453|NCT02667275|69143724|FG001|Overall Study|Lost to Follow-up|2|||
37670454|NCT02667275|69143723|FG000|Overall Study|Withdrawal by Subject|0|||
37670455|NCT02667275|69143724|FG001|Overall Study|Withdrawal by Subject|5|||
37670456|NCT02667275|69143723|FG000|Overall Study|Discontinued early without completing|0|||
37942316|NCT00371683|69629534|FG000|DB Treatment Period-Randomized Patients|Death|1|||
37942317|NCT00371683|69629535|FG001|DB Treatment Period-Randomized Patients|Death|1|||
37942318|NCT00371683|69629534|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
37942319|NCT00371683|69629535|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
37942320|NCT00371683|69629534|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
37942321|NCT00371683|69629535|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
37942322|NCT00371683|69629534|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
37942323|NCT00371683|69629535|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
37942324|NCT00371683|69629534|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
37942325|NCT00371683|69629535|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
37942326|NCT00371683|69629534|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
37942327|NCT00371683|69629535|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
37942328|NCT00371683|69629534|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
37942329|NCT00371683|69629535|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
37942330|NCT00371683|69629534|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
37942331|NCT00371683|69629535|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
37942332|NCT00371683|69629534|FG000|Follow-Up Period - Randomized Patients|Death|0|||
37942333|NCT00371683|69629535|FG001|Follow-Up Period - Randomized Patients|Death|2|||
37942334|NCT00371683|69629534|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
37942335|NCT00371683|69629535|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
37942336|NCT00371683|69629534|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
37942337|NCT00371683|69629535|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
37942338|NCT03951766|69629551|FG000|Treatment Phase|Lost to Follow-up|1|||
37942339|NCT03951766|69629551|FG000|Follow-up Phase|Lost to Follow-up|10|||
37942340|NCT00371137|69629560|FG000|Overall Study|Adverse Event|20|||
37942341|NCT00371137|69629561|FG001|Overall Study|Adverse Event|35|||
37942342|NCT00371137|69629562|FG002|Overall Study|Adverse Event|42|||
37942343|NCT00371137|69629560|FG000|Overall Study|Withdrawal by Subject|11|||
37942344|NCT00371137|69629561|FG001|Overall Study|Withdrawal by Subject|10|||
37942345|NCT00371137|69629562|FG002|Overall Study|Withdrawal by Subject|15|||
37942346|NCT00371137|69629560|FG000|Overall Study|Lost to Follow-up|6|||
37942347|NCT00371137|69629561|FG001|Overall Study|Lost to Follow-up|3|||
37942348|NCT00371137|69629562|FG002|Overall Study|Lost to Follow-up|5|||
37942349|NCT00371137|69629560|FG000|Overall Study|Lack of Efficacy|30|||
37942350|NCT00371137|69629561|FG001|Overall Study|Lack of Efficacy|12|||
37942351|NCT00371137|69629562|FG002|Overall Study|Lack of Efficacy|13|||
37942352|NCT00371137|69629560|FG000|Overall Study|Sponsor Decision|2|||
37942353|NCT00371137|69629561|FG001|Overall Study|Sponsor Decision|1|||
37942354|NCT00371137|69629562|FG002|Overall Study|Sponsor Decision|2|||
37942355|NCT00371137|69629560|FG000|Overall Study|Physician Decision|1|||
37942356|NCT00371137|69629561|FG001|Overall Study|Physician Decision|1|||
37942357|NCT00371137|69629562|FG002|Overall Study|Physician Decision|1|||
37942358|NCT00371137|69629560|FG000|Overall Study|Protocol Violation|2|||
37942359|NCT00371137|69629561|FG001|Overall Study|Protocol Violation|1|||
37942360|NCT00371137|69629562|FG002|Overall Study|Protocol Violation|1|||
37942361|NCT00616239|69629570|FG000|Overall Study|Withdrawal by Subject|2|||
37942362|NCT00547534|69629574|FG000|Overall Study|Adverse Event|7|||
37942363|NCT00547534|69629574|FG000|Overall Study|Disease Progression|4|||
37942364|NCT00384397|69629582|FG000|Overall Study|Adverse Event|0|||
37942365|NCT00384397|69629583|FG001|Overall Study|Adverse Event|1|||
37942366|NCT00384397|69629584|FG002|Overall Study|Adverse Event|2|||
37942367|NCT00384397|69629582|FG000|Overall Study|Protocol Violation|7|||
37942368|NCT00384397|69629583|FG001|Overall Study|Protocol Violation|15|||
37942369|NCT00384397|69629584|FG002|Overall Study|Protocol Violation|13|||
37942370|NCT00384397|69629582|FG000|Overall Study|Lost to Follow-up|11|||
37942371|NCT00384397|69629583|FG001|Overall Study|Lost to Follow-up|13|||
37942372|NCT00384397|69629584|FG002|Overall Study|Lost to Follow-up|3|||
37942373|NCT00384397|69629582|FG000|Overall Study|Withdrawal by Subject|14|||
37670457|NCT02667275|69143724|FG001|Overall Study|Discontinued early without completing|1|||
37670458|NCT02672423|69143733|FG000|Period 1|Adverse Event|0|||
37670459|NCT02672423|69143734|FG001|Period 1|Adverse Event|0|||
37670460|NCT02672423|69143735|FG002|Period 1|Adverse Event|0|||
37942374|NCT00384397|69629583|FG001|Overall Study|Withdrawal by Subject|17|||
37942375|NCT00384397|69629584|FG002|Overall Study|Withdrawal by Subject|15|||
37670461|NCT02672423|69143736|FG003|Period 1|Adverse Event|0|||
37670462|NCT02672423|69143737|FG004|Period 1|Adverse Event|1|||
37670463|NCT02672423|69143738|FG005|Period 1|Adverse Event|0|||
37670464|NCT02672423|69143739|FG006|Period 1|Adverse Event|0|||
37670465|NCT02672423|69143740|FG007|Period 1|Adverse Event|0|||
37670466|NCT02672423|69143741|FG008|Period 1|Adverse Event|0|||
37670467|NCT02672423|69143742|FG009|Period 1|Adverse Event|0|||
37670468|NCT02672423|69143733|FG000|Period 2|Withdrawal by Subject|0|||
37670469|NCT02672423|69143734|FG001|Period 2|Withdrawal by Subject|0|||
37670470|NCT02672423|69143735|FG002|Period 2|Withdrawal by Subject|1|||
37670471|NCT02672423|69143736|FG003|Period 2|Withdrawal by Subject|0|||
37670472|NCT02672423|69143737|FG004|Period 2|Withdrawal by Subject|0|||
37670473|NCT02672423|69143738|FG005|Period 2|Withdrawal by Subject|0|||
37670474|NCT02672423|69143739|FG006|Period 2|Withdrawal by Subject|0|||
37670475|NCT02672423|69143740|FG007|Period 2|Withdrawal by Subject|0|||
37670476|NCT02672423|69143741|FG008|Period 2|Withdrawal by Subject|0|||
37670477|NCT02672423|69143742|FG009|Period 2|Withdrawal by Subject|0|||
37670478|NCT02672423|69143733|FG000|Period 3|Withdrawal by Subject|0|||
37670479|NCT02672423|69143734|FG001|Period 3|Withdrawal by Subject|0|||
37670480|NCT02672423|69143735|FG002|Period 3|Withdrawal by Subject|0|||
37670481|NCT02672423|69143736|FG003|Period 3|Withdrawal by Subject|0|||
37670482|NCT02672423|69143737|FG004|Period 3|Withdrawal by Subject|0|||
37670483|NCT02672423|69143738|FG005|Period 3|Withdrawal by Subject|0|||
37670484|NCT02672423|69143739|FG006|Period 3|Withdrawal by Subject|0|||
37670485|NCT02672423|69143740|FG007|Period 3|Withdrawal by Subject|1|||
37670486|NCT02672423|69143741|FG008|Period 3|Withdrawal by Subject|0|||
37670487|NCT02672423|69143742|FG009|Period 3|Withdrawal by Subject|0|||
37670488|NCT02672423|69143733|FG000|Period 3|Physician Decision|0|||
37670489|NCT02672423|69143734|FG001|Period 3|Physician Decision|0|||
37670490|NCT02672423|69143735|FG002|Period 3|Physician Decision|0|||
37670491|NCT02672423|69143736|FG003|Period 3|Physician Decision|0|||
37670492|NCT02672423|69143737|FG004|Period 3|Physician Decision|0|||
37670493|NCT02672423|69143738|FG005|Period 3|Physician Decision|1|||
37670494|NCT02672423|69143739|FG006|Period 3|Physician Decision|0|||
37670495|NCT02672423|69143740|FG007|Period 3|Physician Decision|0|||
37670496|NCT02672423|69143741|FG008|Period 3|Physician Decision|0|||
37670497|NCT02672423|69143742|FG009|Period 3|Physician Decision|0|||
37670498|NCT02670551|69143766|FG000|Overall Study|Adverse Event|4|||
37670499|NCT02670551|69143767|FG001|Overall Study|Adverse Event|7|||
37670500|NCT02670551|69143768|FG002|Overall Study|Adverse Event|9|||
37670501|NCT02670551|69143766|FG000|Overall Study|Lack of Efficacy|2|||
37670502|NCT02670551|69143767|FG001|Overall Study|Lack of Efficacy|0|||
37670503|NCT02670551|69143768|FG002|Overall Study|Lack of Efficacy|3|||
37670504|NCT02670551|69143766|FG000|Overall Study|Withdrawal of Consent|6|||
37670505|NCT02670551|69143767|FG001|Overall Study|Withdrawal of Consent|3|||
37670506|NCT02670551|69143768|FG002|Overall Study|Withdrawal of Consent|8|||
37670507|NCT02670551|69143766|FG000|Overall Study|Lost to Follow-up|5|||
37670508|NCT02670551|69143767|FG001|Overall Study|Lost to Follow-up|7|||
37670509|NCT02670551|69143768|FG002|Overall Study|Lost to Follow-up|6|||
37670510|NCT02670551|69143766|FG000|Overall Study|Protocol Violation|1|||
37670511|NCT02670551|69143767|FG001|Overall Study|Protocol Violation|0|||
37670512|NCT02670551|69143768|FG002|Overall Study|Protocol Violation|0|||
37670513|NCT02670551|69143766|FG000|Overall Study|Noncompliance with study drug|3|||
37942376|NCT00384085|69629595|FG000|Overall Study|Adverse Event|5|||
37942377|NCT00384085|69629596|FG001|Overall Study|Adverse Event|5|||
37942378|NCT00384085|69629597|FG002|Overall Study|Adverse Event|4|||
37670514|NCT02670551|69143767|FG001|Overall Study|Noncompliance with study drug|3|||
37670515|NCT02670551|69143768|FG002|Overall Study|Noncompliance with study drug|2|||
37670516|NCT02670551|69143766|FG000|Overall Study|Other Miscellaneous Reasons|2|||
37670517|NCT02670551|69143767|FG001|Overall Study|Other Miscellaneous Reasons|3|||
37670518|NCT02670551|69143768|FG002|Overall Study|Other Miscellaneous Reasons|3|||
37670519|NCT02670551|69143766|FG000|Overall Study|Did Not Receive Treatment|5|||
37670520|NCT02670551|69143767|FG001|Overall Study|Did Not Receive Treatment|3|||
37670521|NCT02670551|69143768|FG002|Overall Study|Did Not Receive Treatment|0|||
37670522|NCT02670473|69143776|FG000|Overall Study|Withdrawal by Subject|1|||
37670523|NCT02667119|69143791|FG000|Overall Study|Lost to Follow-up|3|||
37670524|NCT02667119|69143792|FG001|Overall Study|Lost to Follow-up|0|||
37670525|NCT02670083|69143800|FG000|Overall Study|Adverse Event|16|||
37670526|NCT02670083|69143801|FG001|Overall Study|Adverse Event|13|||
37670527|NCT02670083|69143800|FG000|Overall Study|Death|4|||
37670528|NCT02670083|69143801|FG001|Overall Study|Death|6|||
37670529|NCT02670083|69143800|FG000|Overall Study|Lost to Follow-up|2|||
37670530|NCT02670083|69143801|FG001|Overall Study|Lost to Follow-up|2|||
37670531|NCT02670083|69143800|FG000|Overall Study|Multiple Reasons|9|||
37670532|NCT02670083|69143801|FG001|Overall Study|Multiple Reasons|9|||
37670533|NCT02670083|69143800|FG000|Overall Study|Physician Decision|0|||
37942379|NCT00384085|69629595|FG000|Overall Study|Lack of Efficacy|0|||
37670534|NCT02670083|69143801|FG001|Overall Study|Physician Decision|2|||
37670535|NCT02670083|69143800|FG000|Overall Study|Study Terminated By Sponsor|257|||
37670536|NCT02670083|69143801|FG001|Overall Study|Study Terminated By Sponsor|254|||
37670537|NCT02670083|69143800|FG000|Overall Study|Symptomatic Deterioration|0|||
37670538|NCT02670083|69143801|FG001|Overall Study|Symptomatic Deterioration|2|||
37670539|NCT02670083|69143800|FG000|Overall Study|Withdrawal by Subject|32|||
37670540|NCT02670083|69143801|FG001|Overall Study|Withdrawal by Subject|31|||
37670541|NCT02670083|69143800|FG000|Overall Study|Non-Compliance With Study Drug|1|||
37670542|NCT02670083|69143801|FG001|Overall Study|Non-Compliance With Study Drug|0|||
37670543|NCT02669849|69143811|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
37670544|NCT02669849|69143812|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
37670545|NCT02669849|69143813|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
37670546|NCT02669849|69143811|FG000|Overall Study|Lost to Follow-up|1|||
37670547|NCT02669849|69143812|FG001|Overall Study|Lost to Follow-up|0|||
37670548|NCT02669849|69143813|FG002|Overall Study|Lost to Follow-up|3|||
37670549|NCT02669849|69143811|FG000|Overall Study|Death|1|||
37670550|NCT02669849|69143812|FG001|Overall Study|Death|1|||
37670551|NCT02669849|69143813|FG002|Overall Study|Death|2|||
37670552|NCT02669849|69143811|FG000|Overall Study|Study terminated by sponsor|16|||
37670553|NCT02669849|69143812|FG001|Overall Study|Study terminated by sponsor|1|||
37670554|NCT02669849|69143813|FG002|Overall Study|Study terminated by sponsor|14|||
37670555|NCT02669849|69143811|FG000|Overall Study|Other|0|||
37670556|NCT02669849|69143812|FG001|Overall Study|Other|0|||
37670557|NCT02669849|69143813|FG002|Overall Study|Other|2|||
37670558|NCT03625895|69143821|FG000|Overall Study|Protocol Violation|585|||
37670559|NCT02663687|69143830|FG000|Overall Study|Adverse Event|1|||
37670560|NCT02663687|69143831|FG001|Overall Study|Adverse Event|0|||
37670561|NCT02663687|69143832|FG002|Overall Study|Adverse Event|0|||
37670562|NCT02663687|69143833|FG003|Overall Study|Adverse Event|0|||
37670563|NCT02663687|69143834|FG004|Overall Study|Adverse Event|0|||
37670564|NCT02663687|69143830|FG000|Overall Study|Other|1|||
37670565|NCT02663687|69143831|FG001|Overall Study|Other|0|||
37670566|NCT02663687|69143832|FG002|Overall Study|Other|1|||
37670567|NCT02663687|69143833|FG003|Overall Study|Other|0|||
37670568|NCT02663687|69143834|FG004|Overall Study|Other|0|||
37670569|NCT02663453|69143865|FG000|Overall Study|Death|4|||
37670570|NCT02663453|69143866|FG001|Overall Study|Death|4|||
37670571|NCT02663453|69143865|FG000|Overall Study|Withdrawal by Subject|1|||
37670572|NCT02663453|69143866|FG001|Overall Study|Withdrawal by Subject|0|||
37670573|NCT02055118|69143875|FG000|Overall Study|Withdrawal by Subject|0|||
37670574|NCT02055118|69143876|FG001|Overall Study|Withdrawal by Subject|2|||
37670575|NCT02055118|69143877|FG002|Overall Study|Withdrawal by Subject|0|||
37670576|NCT02084056|69143888|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
37670577|NCT02084056|69143889|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
37670578|NCT02084056|69143890|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
37670579|NCT02084056|69143891|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
37670580|NCT02084056|69143888|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
37670581|NCT02084056|69143889|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
37670582|NCT02084056|69143890|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
37670583|NCT02084056|69143891|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
37670584|NCT01625182|69143903|FG000|Overall Study|Administrative problems|1|||
37670585|NCT01625182|69143904|FG001|Overall Study|Administrative problems|0|||
37670586|NCT01625182|69143903|FG000|Overall Study|Protocol deviation|0|||
37670587|NCT01625182|69143904|FG001|Overall Study|Protocol deviation|2|||
37670588|NCT01625182|69143903|FG000|Overall Study|Adverse Event|2|||
37670589|NCT01625182|69143904|FG001|Overall Study|Adverse Event|0|||
37670590|NCT01625182|69143903|FG000|Overall Study|Withdrawal by Subject|5|||
37670591|NCT01625182|69143904|FG001|Overall Study|Withdrawal by Subject|1|||
37670592|NCT01625182|69143903|FG000|Overall Study|Lack of Efficacy|12|||
37670593|NCT01625182|69143904|FG001|Overall Study|Lack of Efficacy|8|||
37670594|NCT02661815|69143915|FG000|Overall Study|Withdrawal by Subject|1|||
37670595|NCT02661815|69143916|FG001|Overall Study|Withdrawal by Subject|0|||
37670596|NCT02661815|69143917|FG002|Overall Study|Withdrawal by Subject|0|||
37670597|NCT02661815|69143918|FG003|Overall Study|Withdrawal by Subject|0|||
37670598|NCT02053792|69143934|FG000|Overall Study|Physician Decision|0|||
37670599|NCT02053792|69143935|FG001|Overall Study|Physician Decision|1|||
37670600|NCT02053792|69143934|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
37670601|NCT02053792|69143935|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
37670602|NCT02053792|69143934|FG000|Overall Study|Lack of Efficacy|1|||
37670603|NCT02053792|69143935|FG001|Overall Study|Lack of Efficacy|0|||
37670604|NCT02053792|69143934|FG000|Overall Study|Adverse Event|1|||
37670605|NCT02053792|69143935|FG001|Overall Study|Adverse Event|0|||
37670606|NCT02053792|69143934|FG000|Overall Study|Withdrawal by Subject|2|||
37670607|NCT02053792|69143935|FG001|Overall Study|Withdrawal by Subject|2|||
37670608|NCT02053792|69143934|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
37670609|NCT02053792|69143935|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
37670610|NCT02053792|69143934|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
37670611|NCT02053792|69143935|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
37670612|NCT02082340|69143943|FG000|Overall Study|Lost to Follow-up|1|||
37670613|NCT02082340|69143944|FG001|Overall Study|Lost to Follow-up|1|||
37670614|NCT02053246|69143950|FG000|Overall Study|Withdrawal by Subject|3|||
37670615|NCT02053246|69143950|FG000|Overall Study|Physician Decision|1|||
37670616|NCT02053168|69143954|FG000|Overall Study|Withdrawal by Subject|1|||
37670617|NCT02053168|69143954|FG000|Overall Study|Physician Decision|1|||
37765213|NCT01420081|69278593|FG008|Overall Study|Lost to Follow-up|0|||
37765214|NCT01420081|69278585|FG000|Overall Study|Study Terminated by Sponsor|2|||
37765215|NCT01420081|69278586|FG001|Overall Study|Study Terminated by Sponsor|1|||
37765216|NCT01420081|69278587|FG002|Overall Study|Study Terminated by Sponsor|1|||
37765217|NCT01420081|69278588|FG003|Overall Study|Study Terminated by Sponsor|3|||
37765218|NCT01420081|69278589|FG004|Overall Study|Study Terminated by Sponsor|11|||
37765219|NCT01420081|69278590|FG005|Overall Study|Study Terminated by Sponsor|7|||
37765220|NCT01420081|69278591|FG006|Overall Study|Study Terminated by Sponsor|3|||
37765221|NCT01420081|69278592|FG007|Overall Study|Study Terminated by Sponsor|2|||
37765222|NCT01420081|69278593|FG008|Overall Study|Study Terminated by Sponsor|2|||
37765223|NCT01420081|69278585|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
37765224|NCT01420081|69278586|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
37765225|NCT01420081|69278587|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
37765226|NCT01420081|69278588|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
37765227|NCT01420081|69278589|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
37765228|NCT01420081|69278590|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
37765229|NCT01420081|69278591|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
37765230|NCT01420081|69278592|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
37765231|NCT01420081|69278593|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
37765232|NCT01420081|69278585|FG000|Overall Study|Other Reasons|0|||
37765233|NCT01420081|69278586|FG001|Overall Study|Other Reasons|0|||
37765234|NCT01420081|69278587|FG002|Overall Study|Other Reasons|1|||
37765235|NCT01420081|69278588|FG003|Overall Study|Other Reasons|0|||
37765236|NCT01420081|69278589|FG004|Overall Study|Other Reasons|0|||
37765237|NCT01420081|69278590|FG005|Overall Study|Other Reasons|0|||
37765238|NCT01420081|69278591|FG006|Overall Study|Other Reasons|0|||
37765239|NCT01420081|69278592|FG007|Overall Study|Other Reasons|0|||
37765240|NCT01420081|69278593|FG008|Overall Study|Other Reasons|0|||
37765241|NCT01439867|69278611|FG000|Overall Study|Non-compliance|0|||
37765242|NCT01439867|69278612|FG001|Overall Study|Non-compliance|1|||
37765243|NCT01439867|69278611|FG000|Overall Study|Withdrawal by Subject|1|||
37765244|NCT01439867|69278612|FG001|Overall Study|Withdrawal by Subject|2|||
37765245|NCT01439867|69278611|FG000|Overall Study|Administrative Decision|4|||
37765246|NCT01439867|69278612|FG001|Overall Study|Administrative Decision|5|||
37765247|NCT01439867|69278611|FG000|Overall Study|Protocol-specified Criteria|1|||
37765248|NCT01439867|69278612|FG001|Overall Study|Protocol-specified Criteria|0|||
37765249|NCT01439711|69278629|FG000|Overall Study|Ineligible|13|||
37765250|NCT01439711|69278629|FG000|Overall Study|Cancel|3|||
37765251|NCT01439711|69278629|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
37765252|NCT01439711|69278629|FG000|Overall Study|Adverse Event|5|||
37765253|NCT01439711|69278629|FG000|Overall Study|Withdrawal by Subject|3|||
37765254|NCT01439711|69278629|FG000|Overall Study|Progression During Active Tx|3|||
37765255|NCT01439711|69278629|FG000|Overall Study|Noncompliance|3|||
37765256|NCT01439711|69278629|FG000|Overall Study|No MRI|9|||
37765257|NCT01439555|69278633|FG000|Overall Study|Protocol Violation|1|||
37765258|NCT01544582|69278653|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
37765259|NCT01544582|69278654|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
37765260|NCT01544582|69278655|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
37765261|NCT01544582|69278656|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
37765262|NCT01544582|69278653|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
37765263|NCT01544582|69278654|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
37765264|NCT01544582|69278655|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
37765265|NCT01544582|69278656|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
37765266|NCT01544582|69278653|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
37765267|NCT01544582|69278654|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
37765268|NCT01544582|69278655|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
37765269|NCT01544582|69278656|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
37765270|NCT01544582|69278653|FG000|Analysis Population|Physician Decision|0|||
37765271|NCT01544582|69278654|FG001|Analysis Population|Physician Decision|13|||
37670618|NCT02053168|69143954|FG000|Overall Study|Lost to Follow-up|1|||
37765272|NCT01544582|69278655|FG002|Analysis Population|Physician Decision|10|||
37765273|NCT01544582|69278656|FG003|Analysis Population|Physician Decision|9|||
37765274|NCT01544582|69278653|FG000|Analysis Population|Safety Reason|0|||
37765275|NCT01544582|69278654|FG001|Analysis Population|Safety Reason|33|||
37765276|NCT01544582|69278655|FG002|Analysis Population|Safety Reason|31|||
37765277|NCT01544582|69278656|FG003|Analysis Population|Safety Reason|8|||
37765278|NCT01544582|69278653|FG000|Analysis Population|Effectiveness Reason|0|||
37765279|NCT01544582|69278654|FG001|Analysis Population|Effectiveness Reason|48|||
37765280|NCT01544582|69278655|FG002|Analysis Population|Effectiveness Reason|29|||
37765281|NCT01544582|69278656|FG003|Analysis Population|Effectiveness Reason|12|||
37942380|NCT00384085|69629596|FG001|Overall Study|Lack of Efficacy|3|||
37670619|NCT02052466|69143958|FG000|Overall Study|Withdrawal by Subject|1|||
37670620|NCT02052466|69143958|FG000|Overall Study|Acromial fracture|1|||
37670621|NCT02032888|69143965|FG000|Treatment Period|Poor compliance/noncompliance|1|||
37670622|NCT02032888|69143966|FG001|Treatment Period|Poor compliance/noncompliance|1|||
37670623|NCT02032888|69143967|FG002|Treatment Period|Poor compliance/noncompliance|0|||
37670624|NCT02032888|69143965|FG000|Treatment Period|Other|1|||
37670625|NCT02032888|69143966|FG001|Treatment Period|Other|1|||
37670626|NCT02032888|69143967|FG002|Treatment Period|Other|0|||
37670627|NCT02032888|69143965|FG000|Follow-up Period|Lost to Follow-up|1|||
37670628|NCT02032888|69143966|FG001|Follow-up Period|Lost to Follow-up|1|||
37670629|NCT02032888|69143967|FG002|Follow-up Period|Lost to Follow-up|0|||
37670630|NCT02032888|69143965|FG000|Follow-up Period|Death|1|||
37670631|NCT02032888|69143966|FG001|Follow-up Period|Death|1|||
37670632|NCT02032888|69143967|FG002|Follow-up Period|Death|0|||
37670633|NCT02032888|69143965|FG000|Follow-up Period|Other|1|||
37670634|NCT02032888|69143966|FG001|Follow-up Period|Other|0|||
37670635|NCT02032888|69143967|FG002|Follow-up Period|Other|0|||
37670636|NCT02082262|69143984|FG000|Overall Study|Withdrawal by Subject|3|||
37670637|NCT02082262|69143984|FG000|Overall Study|Adverse Event|48|||
37670638|NCT04697069|69143990|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
37670639|NCT04697069|69143991|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
37670640|NCT04697069|69143990|FG000|Overall Study|Study termination|2|||
37670641|NCT04697069|69143991|FG001|Overall Study|Study termination|1|||
37670642|NCT02082184|69143999|FG000|Overall Study|Adverse Event|1|||
37670643|NCT02082184|69144000|FG001|Overall Study|Adverse Event|0|||
37670644|NCT02082184|69143999|FG000|Overall Study|Medical diagnosis|1|||
37670645|NCT02082184|69144000|FG001|Overall Study|Medical diagnosis|2|||
37670646|NCT02082184|69143999|FG000|Overall Study|Device associated symptoms|5|||
37670647|NCT02082184|69144000|FG001|Overall Study|Device associated symptoms|0|||
37670648|NCT02082184|69143999|FG000|Overall Study|Withdrawal by Subject|3|||
37670649|NCT02082184|69144000|FG001|Overall Study|Withdrawal by Subject|2|||
37670650|NCT02082184|69143999|FG000|Overall Study|Protocol Violation|0|||
37670651|NCT02082184|69144000|FG001|Overall Study|Protocol Violation|6|||
37670652|NCT02082184|69143999|FG000|Overall Study|Lost to Follow-up|0|||
37670653|NCT02082184|69144000|FG001|Overall Study|Lost to Follow-up|2|||
37670654|NCT02082184|69143999|FG000|Overall Study|Subject non-compliance|0|||
37670655|NCT02082184|69144000|FG001|Overall Study|Subject non-compliance|1|||
37670656|NCT01624870|69144006|FG000|Overall Study|Death|19|||
37670657|NCT01624870|69144006|FG000|Overall Study|Withdrawal by Subject|1|||
37670658|NCT01624870|69144006|FG000|Overall Study|CoreValve not implanted|6|||
37670659|NCT01624870|69144006|FG000|Overall Study|Lost to follow up|1|||
37670660|NCT02031640|69144017|FG000|Screening Period|Adverse Event|1|||
37670661|NCT02031640|69144018|FG001|Screening Period|Adverse Event|0|||
37670662|NCT02031640|69144019|FG002|Screening Period|Adverse Event|0|||
37670663|NCT02031640|69144020|FG003|Screening Period|Adverse Event|0|||
37670664|NCT02031640|69144021|FG004|Screening Period|Adverse Event|0|||
37670665|NCT02031640|69144022|FG005|Screening Period|Adverse Event|0|||
37670666|NCT02031640|69144017|FG000|Screening Period|Withdrawal by Subject|29|||
37670667|NCT02031640|69144018|FG001|Screening Period|Withdrawal by Subject|0|||
37670668|NCT02031640|69144019|FG002|Screening Period|Withdrawal by Subject|0|||
37670669|NCT02031640|69144020|FG003|Screening Period|Withdrawal by Subject|0|||
37670670|NCT02031640|69144021|FG004|Screening Period|Withdrawal by Subject|0|||
37670671|NCT02031640|69144022|FG005|Screening Period|Withdrawal by Subject|0|||
37670672|NCT02031640|69144017|FG000|Screening Period|Inclusion criteria not met|312|||
37670673|NCT02031640|69144018|FG001|Screening Period|Inclusion criteria not met|0|||
37670674|NCT02031640|69144019|FG002|Screening Period|Inclusion criteria not met|0|||
37670675|NCT02031640|69144020|FG003|Screening Period|Inclusion criteria not met|0|||
37670676|NCT02031640|69144021|FG004|Screening Period|Inclusion criteria not met|0|||
37670677|NCT02031640|69144022|FG005|Screening Period|Inclusion criteria not met|0|||
37670678|NCT02031640|69144017|FG000|Screening Period|Exclusion criteria met|30|||
37670679|NCT02031640|69144018|FG001|Screening Period|Exclusion criteria met|0|||
37670680|NCT02031640|69144019|FG002|Screening Period|Exclusion criteria met|0|||
37670681|NCT02031640|69144020|FG003|Screening Period|Exclusion criteria met|0|||
37670682|NCT02031640|69144021|FG004|Screening Period|Exclusion criteria met|0|||
37670683|NCT02031640|69144022|FG005|Screening Period|Exclusion criteria met|0|||
37670684|NCT02031640|69144017|FG000|Screening Period|Lost to Follow-up|14|||
37670685|NCT02031640|69144018|FG001|Screening Period|Lost to Follow-up|0|||
37670686|NCT02031640|69144019|FG002|Screening Period|Lost to Follow-up|0|||
37670687|NCT02031640|69144020|FG003|Screening Period|Lost to Follow-up|0|||
37670688|NCT02031640|69144021|FG004|Screening Period|Lost to Follow-up|0|||
37670689|NCT02031640|69144022|FG005|Screening Period|Lost to Follow-up|0|||
37670690|NCT02031640|69144017|FG000|Screening Period|Enrollment closed|26|||
37670691|NCT02031640|69144018|FG001|Screening Period|Enrollment closed|0|||
37670692|NCT02031640|69144019|FG002|Screening Period|Enrollment closed|0|||
37670693|NCT02031640|69144020|FG003|Screening Period|Enrollment closed|0|||
37670694|NCT02031640|69144021|FG004|Screening Period|Enrollment closed|0|||
37942381|NCT00384085|69629597|FG002|Overall Study|Lack of Efficacy|2|||
37670695|NCT02031640|69144022|FG005|Screening Period|Enrollment closed|0|||
37670696|NCT02031640|69144017|FG000|Run-In Period|Adverse Event|4|||
37670697|NCT02031640|69144018|FG001|Run-In Period|Adverse Event|0|||
37670698|NCT02031640|69144019|FG002|Run-In Period|Adverse Event|0|||
37670699|NCT02031640|69144020|FG003|Run-In Period|Adverse Event|0|||
37670700|NCT02031640|69144021|FG004|Run-In Period|Adverse Event|0|||
37670701|NCT02031640|69144022|FG005|Run-In Period|Adverse Event|0|||
37670702|NCT02031640|69144017|FG000|Run-In Period|Withdrawal by Subject|17|||
37670703|NCT02031640|69144018|FG001|Run-In Period|Withdrawal by Subject|0|||
37670704|NCT02031640|69144019|FG002|Run-In Period|Withdrawal by Subject|0|||
37670705|NCT02031640|69144020|FG003|Run-In Period|Withdrawal by Subject|0|||
37670706|NCT02031640|69144021|FG004|Run-In Period|Withdrawal by Subject|0|||
37670707|NCT02031640|69144022|FG005|Run-In Period|Withdrawal by Subject|0|||
37670708|NCT02031640|69144017|FG000|Run-In Period|Inclusion criteria not met|38|||
37670709|NCT02031640|69144018|FG001|Run-In Period|Inclusion criteria not met|0|||
37670710|NCT02031640|69144019|FG002|Run-In Period|Inclusion criteria not met|0|||
37670711|NCT02031640|69144020|FG003|Run-In Period|Inclusion criteria not met|0|||
37670712|NCT02031640|69144021|FG004|Run-In Period|Inclusion criteria not met|0|||
37670713|NCT02031640|69144022|FG005|Run-In Period|Inclusion criteria not met|0|||
37670714|NCT02031640|69144017|FG000|Run-In Period|Exclusion criteria met|8|||
37670715|NCT02031640|69144018|FG001|Run-In Period|Exclusion criteria met|0|||
37670716|NCT02031640|69144019|FG002|Run-In Period|Exclusion criteria met|0|||
37670717|NCT02031640|69144020|FG003|Run-In Period|Exclusion criteria met|0|||
37670718|NCT02031640|69144021|FG004|Run-In Period|Exclusion criteria met|0|||
37670719|NCT02031640|69144022|FG005|Run-In Period|Exclusion criteria met|0|||
37670720|NCT02031640|69144017|FG000|Run-In Period|Randomization criteria not met|85|||
37670721|NCT02031640|69144018|FG001|Run-In Period|Randomization criteria not met|0|||
37670722|NCT02031640|69144019|FG002|Run-In Period|Randomization criteria not met|0|||
37670723|NCT02031640|69144020|FG003|Run-In Period|Randomization criteria not met|0|||
37670724|NCT02031640|69144021|FG004|Run-In Period|Randomization criteria not met|0|||
37670725|NCT02031640|69144022|FG005|Run-In Period|Randomization criteria not met|0|||
37670726|NCT02031640|69144017|FG000|Run-In Period|Various administrative reasons|17|||
37765282|NCT01544582|69278653|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
37765283|NCT01544582|69278654|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
37765284|NCT01544582|69278655|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
37765285|NCT01544582|69278656|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
37765286|NCT01544582|69278653|FG000|Analysis Population|Lost to Follow-up|0|||
37765287|NCT01544582|69278654|FG001|Analysis Population|Lost to Follow-up|6|||
37765288|NCT01544582|69278655|FG002|Analysis Population|Lost to Follow-up|6|||
37765289|NCT01544582|69278656|FG003|Analysis Population|Lost to Follow-up|5|||
37765290|NCT01544582|69278653|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
37765291|NCT01544582|69278654|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
37765292|NCT01544582|69278655|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
37765293|NCT01544582|69278656|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
37765294|NCT01544582|69278653|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
37765295|NCT01544582|69278654|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
37765296|NCT01544582|69278655|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
38035648|NCT00179621|69722633|FG001|Open-Label Period|Death|0|||
38035649|NCT00179621|69722634|FG002|Open-Label Period|Death|1|||
38035650|NCT00179621|69722635|FG003|Open-Label Period|Death|2|||
38035651|NCT00179621|69722632|FG000|Open-Label Period|Other|0|||
38035652|NCT00179621|69722633|FG001|Open-Label Period|Other|1|||
38035653|NCT00179621|69722634|FG002|Open-Label Period|Other|1|||
38035654|NCT00179621|69722635|FG003|Open-Label Period|Other|2|||
38035655|NCT00179309|69722646|FG000|Treatment|Toxicity|2|||
38035656|NCT00179309|69722647|FG001|Treatment|Toxicity|3|||
38035657|NCT00179309|69722646|FG000|Treatment|Withdrawal by Subject|1|||
38035658|NCT00179309|69722647|FG001|Treatment|Withdrawal by Subject|2|||
38035659|NCT00179309|69722646|FG000|Treatment|Allergy|1|||
38035660|NCT00179309|69722647|FG001|Treatment|Allergy|0|||
38035661|NCT00178685|69722668|FG000|Overall Study|Death|3|||
38035662|NCT00178685|69722669|FG001|Overall Study|Death|3|||
38035663|NCT00178685|69722670|FG002|Overall Study|Death|6|||
37670727|NCT02031640|69144018|FG001|Run-In Period|Various administrative reasons|0|||
38035664|NCT00178685|69722668|FG000|Overall Study|Lost to Follow-up|100|||
37670728|NCT02031640|69144019|FG002|Run-In Period|Various administrative reasons|0|||
37670729|NCT02031640|69144020|FG003|Run-In Period|Various administrative reasons|0|||
37670730|NCT02031640|69144021|FG004|Run-In Period|Various administrative reasons|0|||
37765297|NCT01544582|69278656|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
37765298|NCT01544582|69278653|FG000|Analysis Population|Intolerance|0|||
37765299|NCT01544582|69278654|FG001|Analysis Population|Intolerance|1|||
38035665|NCT00178685|69722669|FG001|Overall Study|Lost to Follow-up|187|||
38035666|NCT00178685|69722670|FG002|Overall Study|Lost to Follow-up|183|||
38035667|NCT00178685|69722668|FG000|Overall Study|Withdrawal by Subject|8|||
38035668|NCT00178685|69722669|FG001|Overall Study|Withdrawal by Subject|14|||
38035669|NCT00178685|69722670|FG002|Overall Study|Withdrawal by Subject|7|||
38035670|NCT02933528|69722678|FG000|Overall Study|Lost to Follow-up|2|||
38035671|NCT00177671|69722684|FG000|Overall Study|Withdrawal by Subject|5|||
38035672|NCT00177671|69722685|FG001|Overall Study|Withdrawal by Subject|6|||
38035673|NCT00177671|69722684|FG000|Overall Study|medical complications|2|||
38035674|NCT00177671|69722685|FG001|Overall Study|medical complications|0|||
38035675|NCT00177671|69722684|FG000|Overall Study|Adverse Event|6|||
38035676|NCT00177671|69722685|FG001|Overall Study|Adverse Event|0|||
38035677|NCT00177671|69722684|FG000|Overall Study|Physician Decision|12|||
38035678|NCT00177671|69722685|FG001|Overall Study|Physician Decision|8|||
38035679|NCT02933060|69722693|FG000|Overall Study|Withdrawal by Subject|0|||
38035680|NCT02933060|69722694|FG001|Overall Study|Withdrawal by Subject|1|||
38035681|NCT03235154|69722700|FG000|Overall Study|Withdrawal by Subject|1|||
38035682|NCT03235154|69722700|FG000|Overall Study|Adverse Event|1|||
38035683|NCT03235154|69722700|FG000|Overall Study|Lost to Follow-up|2|||
38035684|NCT03234608|69722708|FG000|Overall Study|Lost to Follow-up|23|||
38035685|NCT03234608|69722709|FG001|Overall Study|Lost to Follow-up|21|||
38035686|NCT03248882|69722720|FG000|Overall Study|Adverse Event|3|||
38035687|NCT03248882|69722721|FG001|Overall Study|Adverse Event|3|||
38035688|NCT03248882|69722722|FG002|Overall Study|Adverse Event|2|||
38035689|NCT03248882|69722723|FG003|Overall Study|Adverse Event|6|||
38035690|NCT03248882|69722724|FG004|Overall Study|Adverse Event|9|||
38035691|NCT03248882|69722720|FG000|Overall Study|Lost to Follow-up|0|||
38035692|NCT03248882|69722721|FG001|Overall Study|Lost to Follow-up|0|||
38035693|NCT03248882|69722722|FG002|Overall Study|Lost to Follow-up|0|||
38035694|NCT03248882|69722723|FG003|Overall Study|Lost to Follow-up|0|||
38035695|NCT03248882|69722724|FG004|Overall Study|Lost to Follow-up|1|||
38035696|NCT03248882|69722720|FG000|Overall Study|Protocol Violation|2|||
38035697|NCT03248882|69722721|FG001|Overall Study|Protocol Violation|0|||
38035698|NCT03248882|69722722|FG002|Overall Study|Protocol Violation|2|||
38035699|NCT03248882|69722723|FG003|Overall Study|Protocol Violation|0|||
38035700|NCT03248882|69722724|FG004|Overall Study|Protocol Violation|1|||
38035701|NCT03248882|69722720|FG000|Overall Study|Withdrawal by Subject|2|||
38035702|NCT03248882|69722721|FG001|Overall Study|Withdrawal by Subject|2|||
38035703|NCT03248882|69722722|FG002|Overall Study|Withdrawal by Subject|3|||
38035704|NCT03248882|69722723|FG003|Overall Study|Withdrawal by Subject|4|||
38035705|NCT03248882|69722724|FG004|Overall Study|Withdrawal by Subject|2|||
38035706|NCT03233438|69722738|FG000|Overall Study|Lost to Follow-up|4|||
38035707|NCT03233438|69722739|FG001|Overall Study|Lost to Follow-up|9|||
38035708|NCT03233438|69722738|FG000|Overall Study|Withdrawal by Subject|2|||
38035709|NCT03233438|69722739|FG001|Overall Study|Withdrawal by Subject|1|||
38035710|NCT03233438|69722738|FG000|Overall Study|No recording of dalbavancin|0|||
38035711|NCT03233438|69722739|FG001|Overall Study|No recording of dalbavancin|1|||
38035712|NCT01368406|69722747|FG000|Overall Study|Lost to Follow-up|8|||
38035713|NCT01368406|69722748|FG001|Overall Study|Lost to Follow-up|4|||
38035714|NCT01368406|69722747|FG000|Overall Study|Withdrawal by Subject|8|||
38035715|NCT01368406|69722748|FG001|Overall Study|Withdrawal by Subject|4|||
38035716|NCT01368406|69722747|FG000|Overall Study|relapse of the disease|3|||
38035717|NCT01368406|69722748|FG001|Overall Study|relapse of the disease|2|||
38035718|NCT01368406|69722747|FG000|Overall Study|started working|2|||
38035719|NCT01368406|69722748|FG001|Overall Study|started working|3|||
38035720|NCT00175877|69722754|FG000|Overall Study|Adverse Event|136|||
38035721|NCT00175877|69722754|FG000|Overall Study|Withdrawal by Subject|141|||
38035722|NCT00175877|69722754|FG000|Overall Study|Lost to Follow-up|9|||
38035723|NCT00175877|69722754|FG000|Overall Study|Lack of Efficacy|26|||
38035724|NCT00175877|69722754|FG000|Overall Study|Protocol Violation|15|||
38035725|NCT00175877|69722754|FG000|Overall Study|Other Reason|20|||
38035726|NCT00175877|69722754|FG000|Overall Study|AE & Other|1|||
38035727|NCT00175877|69722754|FG000|Overall Study|Withdrawal by subject & Other|1|||
37765300|NCT01544582|69278655|FG002|Analysis Population|Intolerance|0|||
37765301|NCT01544582|69278656|FG003|Analysis Population|Intolerance|0|||
37765302|NCT01544582|69278653|FG000|Analysis Population|Liver Transplantation|0|||
37765303|NCT01544582|69278654|FG001|Analysis Population|Liver Transplantation|0|||
37942382|NCT00384085|69629595|FG000|Overall Study|No longer Requires Study Treatment|1|||
37942383|NCT00384085|69629596|FG001|Overall Study|No longer Requires Study Treatment|0|||
37942384|NCT00384085|69629597|FG002|Overall Study|No longer Requires Study Treatment|1|||
37942385|NCT00384085|69629595|FG000|Overall Study|Protocol Violation|2|||
37942386|NCT00384085|69629596|FG001|Overall Study|Protocol Violation|2|||
37942387|NCT00384085|69629597|FG002|Overall Study|Protocol Violation|2|||
37942388|NCT00384085|69629595|FG000|Overall Study|Lost to Follow-up|9|||
37942389|NCT00384085|69629596|FG001|Overall Study|Lost to Follow-up|9|||
38035728|NCT02788474|69722760|FG000|Double Blind Treatment Period|Not treated|1|||
38035729|NCT02788474|69722761|FG001|Double Blind Treatment Period|Not treated|0|||
38035730|NCT02788474|69722760|FG000|Double Blind Treatment Period|Patient's refusal|3|||
38035731|NCT02788474|69722761|FG001|Double Blind Treatment Period|Patient's refusal|0|||
38035732|NCT02788474|69722760|FG000|Double Blind Treatment Period|Adverse Event|6|||
38035733|NCT02788474|69722761|FG001|Double Blind Treatment Period|Adverse Event|4|||
38035734|NCT02788474|69722760|FG000|Open Label Treatment Period|Adverse Event|29|||
38035735|NCT02788474|69722761|FG001|Open Label Treatment Period|Adverse Event|9|||
38035736|NCT02788474|69722760|FG000|Open Label Treatment Period|Other than reason specified|1|||
38035737|NCT02788474|69722761|FG001|Open Label Treatment Period|Other than reason specified|0|||
38035738|NCT02788474|69722760|FG000|Open Label Treatment Period|Patient's refusal|1|||
38035739|NCT02788474|69722761|FG001|Open Label Treatment Period|Patient's refusal|3|||
38035740|NCT02788474|69722760|FG000|Open Label Treatment Period|Non-compliance|1|||
38035741|NCT02788474|69722761|FG001|Open Label Treatment Period|Non-compliance|0|||
38035742|NCT03247556|69722771|FG000|Overall Study|Adverse Event|1|||
38035743|NCT03247556|69722772|FG001|Overall Study|Adverse Event|4|||
38035744|NCT03247556|69722773|FG002|Overall Study|Adverse Event|5|||
38035745|NCT03247556|69722771|FG000|Overall Study|Lost to Follow-up|5|||
38035746|NCT03247556|69722772|FG001|Overall Study|Lost to Follow-up|5|||
38035747|NCT03247556|69722773|FG002|Overall Study|Lost to Follow-up|4|||
38035748|NCT03247556|69722771|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
38035749|NCT03247556|69722772|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
38035750|NCT03247556|69722773|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
38035751|NCT03247556|69722771|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
38035752|NCT03247556|69722772|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
38035753|NCT03247556|69722773|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
38035754|NCT03247556|69722771|FG000|Overall Study|Protocol Violation|2|||
38035755|NCT03247556|69722772|FG001|Overall Study|Protocol Violation|0|||
38035756|NCT03247556|69722773|FG002|Overall Study|Protocol Violation|1|||
38035757|NCT03247556|69722771|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
38035758|NCT03247556|69722772|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
38035759|NCT03247556|69722773|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
38035760|NCT03216746|69722785|FG000|Overall Study|Lost to Follow-up|6|||
38035761|NCT03216746|69722786|FG001|Overall Study|Lost to Follow-up|8|||
38035762|NCT03216746|69722787|FG002|Overall Study|Lost to Follow-up|5|||
38035763|NCT03216746|69722788|FG003|Overall Study|Lost to Follow-up|6|||
38035764|NCT02787304|69722802|FG000|Overall Study|Adverse Event|9|||
38035765|NCT02787304|69722803|FG001|Overall Study|Adverse Event|3|||
38035766|NCT02787304|69722804|FG002|Overall Study|Adverse Event|8|||
38035767|NCT02787304|69722805|FG003|Overall Study|Adverse Event|1|||
38035768|NCT02787304|69722802|FG000|Overall Study|Withdrawal by Subject|1|||
38035769|NCT02787304|69722803|FG001|Overall Study|Withdrawal by Subject|4|||
38035770|NCT02787304|69722804|FG002|Overall Study|Withdrawal by Subject|0|||
38035771|NCT02787304|69722805|FG003|Overall Study|Withdrawal by Subject|0|||
38035772|NCT02787304|69722802|FG000|Overall Study|Lost to Follow-up|1|||
38035773|NCT02787304|69722803|FG001|Overall Study|Lost to Follow-up|0|||
38035774|NCT02787304|69722804|FG002|Overall Study|Lost to Follow-up|0|||
38035775|NCT02787304|69722805|FG003|Overall Study|Lost to Follow-up|1|||
38035776|NCT02787304|69722802|FG000|Overall Study|Noncompliance with study drug|0|||
38035777|NCT02787304|69722803|FG001|Overall Study|Noncompliance with study drug|0|||
38035778|NCT02787304|69722804|FG002|Overall Study|Noncompliance with study drug|1|||
38035779|NCT02787304|69722805|FG003|Overall Study|Noncompliance with study drug|0|||
38035780|NCT02787304|69722802|FG000|Overall Study|Physician Decision|0|||
38035781|NCT02787304|69722803|FG001|Overall Study|Physician Decision|0|||
38035782|NCT02787304|69722804|FG002|Overall Study|Physician Decision|1|||
38035783|NCT02787304|69722805|FG003|Overall Study|Physician Decision|0|||
38035784|NCT02787304|69722802|FG000|Overall Study|Study terminated by sponsor|25|||
38035785|NCT02787304|69722803|FG001|Overall Study|Study terminated by sponsor|31|||
38035786|NCT02787304|69722804|FG002|Overall Study|Study terminated by sponsor|31|||
38035787|NCT02787304|69722805|FG003|Overall Study|Study terminated by sponsor|32|||
38035788|NCT02932904|69722819|FG000|Overall Study|Reason not Specified|1|||
38035789|NCT02932904|69722820|FG001|Overall Study|Reason not Specified|0|||
38035790|NCT02932904|69722821|FG002|Overall Study|Reason not Specified|2|||
38035791|NCT02932904|69722822|FG003|Overall Study|Reason not Specified|2|||
38035792|NCT02932904|69722819|FG000|Overall Study|Noncompliance with Study Drug|2|||
38035793|NCT02932904|69722820|FG001|Overall Study|Noncompliance with Study Drug|3|||
38035794|NCT02932904|69722821|FG002|Overall Study|Noncompliance with Study Drug|3|||
38035795|NCT02932904|69722822|FG003|Overall Study|Noncompliance with Study Drug|4|||
38035796|NCT02932904|69722819|FG000|Overall Study|Pregnancy|0|||
38035797|NCT02932904|69722820|FG001|Overall Study|Pregnancy|1|||
38035798|NCT02932904|69722821|FG002|Overall Study|Pregnancy|1|||
38035799|NCT02932904|69722822|FG003|Overall Study|Pregnancy|0|||
38035800|NCT02932904|69722819|FG000|Overall Study|Study Termination|0|||
38035801|NCT02932904|69722820|FG001|Overall Study|Study Termination|1|||
38035802|NCT02932904|69722821|FG002|Overall Study|Study Termination|0|||
38035803|NCT02932904|69722822|FG003|Overall Study|Study Termination|0|||
38035804|NCT02932904|69722819|FG000|Overall Study|Voluntary Withdrawal|2|||
38035805|NCT02932904|69722820|FG001|Overall Study|Voluntary Withdrawal|1|||
38035806|NCT02932904|69722821|FG002|Overall Study|Voluntary Withdrawal|4|||
38035807|NCT02932904|69722822|FG003|Overall Study|Voluntary Withdrawal|2|||
38035808|NCT02932904|69722819|FG000|Overall Study|Lost to Follow-up|5|||
38035809|NCT02932904|69722820|FG001|Overall Study|Lost to Follow-up|3|||
38035810|NCT02932904|69722821|FG002|Overall Study|Lost to Follow-up|6|||
38035811|NCT02932904|69722822|FG003|Overall Study|Lost to Follow-up|0|||
38035812|NCT02932904|69722819|FG000|Overall Study|Significant Protocol Deviation|2|||
38035813|NCT02932904|69722820|FG001|Overall Study|Significant Protocol Deviation|3|||
38035814|NCT02932904|69722821|FG002|Overall Study|Significant Protocol Deviation|6|||
38035815|NCT02932904|69722822|FG003|Overall Study|Significant Protocol Deviation|1|||
38035816|NCT02932904|69722819|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
38035817|NCT02932904|69722820|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
38035818|NCT02932904|69722821|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
38035819|NCT02932904|69722822|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
38035820|NCT02932904|69722819|FG000|Overall Study|Randomized But Not Treated|1|||
38035821|NCT02932904|69722820|FG001|Overall Study|Randomized But Not Treated|1|||
38035822|NCT02932904|69722821|FG002|Overall Study|Randomized But Not Treated|0|||
38035823|NCT02932904|69722822|FG003|Overall Study|Randomized But Not Treated|2|||
38035824|NCT00688376|69722837|FG000|Double-Blind Phase|Adverse Event|4|||
38035825|NCT00688376|69722838|FG001|Double-Blind Phase|Adverse Event|4|||
38035826|NCT00688376|69722837|FG000|Double-Blind Phase|Protocol Violation|1|||
38035827|NCT00688376|69722838|FG001|Double-Blind Phase|Protocol Violation|2|||
38035828|NCT00688376|69722837|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
38035829|NCT00688376|69722838|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
38035830|NCT00688376|69722837|FG000|Double-Blind Phase|Not treated|0|||
38035831|NCT00688376|69722838|FG001|Double-Blind Phase|Not treated|1|||
38035832|NCT00688376|69722837|FG000|Blinded Extension Phase|Adverse Event|3|||
38035833|NCT00688376|69722838|FG001|Blinded Extension Phase|Adverse Event|4|||
38035834|NCT00688376|69722837|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
38035835|NCT00688376|69722838|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
38035836|NCT00688376|69722837|FG000|Blinded Extension Phase|Physician Decision|1|||
38035837|NCT00688376|69722838|FG001|Blinded Extension Phase|Physician Decision|0|||
38035838|NCT00688376|69722837|FG000|Blinded Extension Phase|Other|1|||
38035839|NCT00688376|69722838|FG001|Blinded Extension Phase|Other|0|||
38035840|NCT03214952|69722846|FG000|Overall Study|Protocol Deviation|45|||
38035841|NCT03214952|69722846|FG000|Overall Study|Case Report Forms Uncollected|13|||
38035842|NCT01367704|69722852|FG000|Overall Study|Lost to Follow-up|47|||
38035843|NCT01367704|69722853|FG001|Overall Study|Lost to Follow-up|161|||
38035844|NCT03214094|69722859|FG000|Overall Study|Case Report Forms Uncollected|14|||
38035845|NCT03214094|69722859|FG000|Overall Study|Protocol Deviation|46|||
38035846|NCT05299359|69722886|FG000|Overall Study|Ongoing in Study|149|||
38035847|NCT05299359|69722886|FG000|Overall Study|Other|1|||
38035848|NCT05069155|69722903|FG000|Overall Study|Withdrawal by Subject|1|||
38035849|NCT05069155|69722904|FG001|Overall Study|Withdrawal by Subject|3|||
38035850|NCT04995419|69722910|FG000|Overall Study|Withdrawal by Subject|3|||
38035851|NCT04995419|69722910|FG000|Overall Study|Progressive Disease|19|||
37670731|NCT02031640|69144022|FG005|Run-In Period|Various administrative reasons|0|||
37670732|NCT02031640|69144017|FG000|Double-blind Treatment Period|Protocol deviation|0|||
37670733|NCT02031640|69144018|FG001|Double-blind Treatment Period|Protocol deviation|2|||
37670734|NCT02031640|69144019|FG002|Double-blind Treatment Period|Protocol deviation|0|||
37670735|NCT02031640|69144020|FG003|Double-blind Treatment Period|Protocol deviation|1|||
37670736|NCT02031640|69144021|FG004|Double-blind Treatment Period|Protocol deviation|3|||
37942390|NCT00384085|69629597|FG002|Overall Study|Lost to Follow-up|10|||
37942391|NCT00384085|69629595|FG000|Overall Study|Progressive Disease|0|||
37942392|NCT00384085|69629596|FG001|Overall Study|Progressive Disease|1|||
37942393|NCT00384085|69629597|FG002|Overall Study|Progressive Disease|0|||
37942394|NCT00384085|69629595|FG000|Overall Study|Withdrawal by Subject|14|||
37942395|NCT00384085|69629596|FG001|Overall Study|Withdrawal by Subject|19|||
37942396|NCT00384085|69629597|FG002|Overall Study|Withdrawal by Subject|29|||
37942397|NCT00384085|69629595|FG000|Overall Study|Patient non-compliant|4|||
37942398|NCT00384085|69629596|FG001|Overall Study|Patient non-compliant|4|||
37942399|NCT00384085|69629597|FG002|Overall Study|Patient non-compliant|5|||
37942400|NCT00384085|69629595|FG000|Overall Study|Physician Decision|1|||
37942401|NCT00384085|69629596|FG001|Overall Study|Physician Decision|0|||
37942402|NCT00384085|69629597|FG002|Overall Study|Physician Decision|0|||
37942403|NCT00384085|69629595|FG000|Overall Study|Loss of site personnel|1|||
37942404|NCT00384085|69629596|FG001|Overall Study|Loss of site personnel|0|||
37942405|NCT00384085|69629597|FG002|Overall Study|Loss of site personnel|1|||
37942406|NCT00384085|69629595|FG000|Overall Study|Sponsor decision|1|||
37942407|NCT00384085|69629596|FG001|Overall Study|Sponsor decision|2|||
37670737|NCT02031640|69144022|FG005|Double-blind Treatment Period|Protocol deviation|1|||
37670738|NCT02031640|69144017|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
37670739|NCT02031640|69144018|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
37942408|NCT00384085|69629597|FG002|Overall Study|Sponsor decision|1|||
37942409|NCT00384085|69629595|FG000|Overall Study|Patient moved|1|||
37942410|NCT00384085|69629596|FG001|Overall Study|Patient moved|0|||
37942411|NCT00384085|69629597|FG002|Overall Study|Patient moved|1|||
37942412|NCT00384085|69629595|FG000|Overall Study|Patient required surgery|0|||
38035852|NCT04995419|69722910|FG000|Overall Study|Adverse Event|2|||
37942413|NCT00384085|69629596|FG001|Overall Study|Patient required surgery|1|||
37670740|NCT02031640|69144019|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
37670741|NCT02031640|69144020|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
37670742|NCT02031640|69144021|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
37670743|NCT02031640|69144022|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
37670744|NCT02031640|69144017|FG000|Double-blind Treatment Period|Non-compliance|0|||
37670745|NCT02031640|69144018|FG001|Double-blind Treatment Period|Non-compliance|1|||
38035853|NCT04995419|69722910|FG000|Overall Study|Ongoing|16|||
38035854|NCT04875533|69722916|FG000|Overall Study|Adverse Event|6|||
38035855|NCT04875533|69722917|FG001|Overall Study|Adverse Event|4|||
38035856|NCT04875533|69722916|FG000|Overall Study|Protocol Violation|4|||
38035857|NCT04875533|69722917|FG001|Overall Study|Protocol Violation|0|||
38035858|NCT04875533|69722916|FG000|Overall Study|Withdrawal by Subject|8|||
38035859|NCT04875533|69722917|FG001|Overall Study|Withdrawal by Subject|5|||
38035860|NCT04875533|69722916|FG000|Overall Study|No longer meets eligibility criteria|1|||
38035861|NCT04875533|69722917|FG001|Overall Study|No longer meets eligibility criteria|0|||
38035862|NCT04875533|69722916|FG000|Overall Study|Other|0|||
38035863|NCT04875533|69722917|FG001|Overall Study|Other|2|||
37942414|NCT00384085|69629597|FG002|Overall Study|Patient required surgery|0|||
37942415|NCT00361231|69629607|FG000|Overall Study|Physician Decision|3|||
37942416|NCT00361231|69629607|FG000|Overall Study|Symptomatic deterioration|5|||
37942417|NCT00361231|69629607|FG000|Overall Study|Radiographic disease progression|16|||
37942418|NCT00361231|69629607|FG000|Overall Study|Withdrawal by Subject|4|||
37942419|NCT00361231|69629607|FG000|Overall Study|Adverse Event|6|||
37942420|NCT00676650|69629613|FG000|Overall Study|Death|45|||
37942421|NCT00676650|69629614|FG001|Overall Study|Death|14|||
37942422|NCT00676650|69629613|FG000|Overall Study|Adverse Event|159|||
37942423|NCT00676650|69629614|FG001|Overall Study|Adverse Event|21|||
37942424|NCT00676650|69629613|FG000|Overall Study|Global deterioration of health status|66|||
37942425|NCT00676650|69629614|FG001|Overall Study|Global deterioration of health status|31|||
37942426|NCT00676650|69629613|FG000|Overall Study|Lost to Follow-up|0|||
37942427|NCT00676650|69629614|FG001|Overall Study|Lost to Follow-up|1|||
37942428|NCT00676650|69629613|FG000|Overall Study|Objective progression or relapse|189|||
37942429|NCT00676650|69629614|FG001|Overall Study|Objective progression or relapse|140|||
37942430|NCT00676650|69629613|FG000|Overall Study|Other|14|||
37942431|NCT00676650|69629614|FG001|Overall Study|Other|10|||
37942432|NCT00676650|69629613|FG000|Overall Study|Protocol Violation|3|||
37942433|NCT00676650|69629614|FG001|Overall Study|Protocol Violation|1|||
37942434|NCT00676650|69629613|FG000|Overall Study|Study terminated by sponsor|57|||
37942435|NCT00676650|69629614|FG001|Overall Study|Study terminated by sponsor|43|||
37942436|NCT00676650|69629613|FG000|Overall Study|Withdrawal by Subject|48|||
37942437|NCT00676650|69629614|FG001|Overall Study|Withdrawal by Subject|24|||
37942438|NCT00676650|69629613|FG000|Overall Study|Randomized but not treated|3|||
37942439|NCT00676650|69629614|FG001|Overall Study|Randomized but not treated|4|||
37942440|NCT00573183|69629622|FG000|Overall Study|Lost to Follow-up|52|||
37942441|NCT00573183|69629623|FG001|Overall Study|Lost to Follow-up|50|||
37942442|NCT00573183|69629622|FG000|Overall Study|Withdrawal by Subject|8|||
37942443|NCT00573183|69629623|FG001|Overall Study|Withdrawal by Subject|2|||
37942444|NCT00573183|69629622|FG000|Overall Study|Death|0|||
37942445|NCT00573183|69629623|FG001|Overall Study|Death|1|||
37942446|NCT00573183|69629622|FG000|Overall Study|Adverse Event|2|||
37942447|NCT00573183|69629623|FG001|Overall Study|Adverse Event|0|||
37942448|NCT00573183|69629622|FG000|Overall Study|Incarceration|5|||
37942449|NCT00573183|69629623|FG001|Overall Study|Incarceration|8|||
37942450|NCT00573183|69629622|FG000|Overall Study|Other|5|||
37942451|NCT00573183|69629623|FG001|Overall Study|Other|2|||
37942452|NCT00615459|69629631|FG000|Period I|Adverse Event|2|||
37942453|NCT00615459|69629632|FG001|Period I|Adverse Event|0|||
37942454|NCT00615459|69629633|FG002|Period I|Adverse Event|1|||
37942455|NCT00615459|69629634|FG003|Period I|Adverse Event|0|||
37942456|NCT00615459|69629631|FG000|Period I|Subject withdrew consent|1|||
37942457|NCT00615459|69629632|FG001|Period I|Subject withdrew consent|0|||
37942458|NCT00615459|69629633|FG002|Period I|Subject withdrew consent|0|||
37942459|NCT00615459|69629634|FG003|Period I|Subject withdrew consent|1|||
37942460|NCT00615459|69629631|FG000|Period I|Abnormal test procedure results|1|||
37942461|NCT00615459|69629632|FG001|Period I|Abnormal test procedure results|1|||
37942462|NCT00615459|69629633|FG002|Period I|Abnormal test procedure results|1|||
37942463|NCT00615459|69629634|FG003|Period I|Abnormal test procedure results|0|||
37942464|NCT00615459|69629631|FG000|Period II|Adverse Event|1|||
37942465|NCT00615459|69629632|FG001|Period II|Adverse Event|0|||
37942466|NCT00615459|69629633|FG002|Period II|Adverse Event|0|||
37942467|NCT00615459|69629634|FG003|Period II|Adverse Event|0|||
37942468|NCT00615459|69629631|FG000|Period II|Lost to Follow-up|0|||
37942469|NCT00615459|69629632|FG001|Period II|Lost to Follow-up|0|||
38035864|NCT04854551|69722927|FG000|Overall Study|Withdrawal by Subject|1|||
37670746|NCT02031640|69144019|FG002|Double-blind Treatment Period|Non-compliance|0|||
37942470|NCT00615459|69629633|FG002|Period II|Lost to Follow-up|0|||
37942471|NCT00615459|69629634|FG003|Period II|Lost to Follow-up|1|||
37942472|NCT00615459|69629631|FG000|Period III|Adverse Event|0|||
37942473|NCT00615459|69629632|FG001|Period III|Adverse Event|1|||
37942474|NCT00615459|69629633|FG002|Period III|Adverse Event|0|||
38035865|NCT04854551|69722928|FG001|Overall Study|Withdrawal by Subject|1|||
38035866|NCT04672941|69722944|FG000|Overall Study|Investigator decision|1|||
38035867|NCT04672941|69722944|FG000|Overall Study|Treatment with Spiolto® Respimat® discontinuation|2|||
38035868|NCT04672941|69722944|FG000|Overall Study|COVID-19 related but no adverse event|1|||
38035869|NCT04672941|69722944|FG000|Overall Study|Adverse Event|2|||
38035870|NCT04672941|69722944|FG000|Overall Study|Lost to Follow-up|2|||
38035871|NCT04599972|69722969|FG000|Overall Study|Withdrawal by Subject|6|||
38035872|NCT04599972|69722970|FG001|Overall Study|Withdrawal by Subject|1|||
38035873|NCT04599972|69722969|FG000|Overall Study|Adverse Event|1|||
38035874|NCT04599972|69722970|FG001|Overall Study|Adverse Event|1|||
38035875|NCT04599972|69722969|FG000|Overall Study|Lost to Follow-up|1|||
38035876|NCT04599972|69722970|FG001|Overall Study|Lost to Follow-up|6|||
38035877|NCT04599972|69722969|FG000|Overall Study|Protocol Violation|1|||
38035878|NCT04599972|69722970|FG001|Overall Study|Protocol Violation|0|||
38035879|NCT04599972|69722969|FG000|Overall Study|Other reason|1|||
38035880|NCT04599972|69722970|FG001|Overall Study|Other reason|0|||
38035881|NCT04599933|69722978|FG000|Overall Study|Adverse Event|4|||
38035882|NCT04599933|69722979|FG001|Overall Study|Adverse Event|1|||
38035883|NCT04599933|69722978|FG000|Overall Study|Withdrawal by Subject|4|||
38035884|NCT04599933|69722979|FG001|Overall Study|Withdrawal by Subject|2|||
38035885|NCT04599933|69722978|FG000|Overall Study|Lost to Follow-up|0|||
38035886|NCT04599933|69722979|FG001|Overall Study|Lost to Follow-up|1|||
38035887|NCT04599933|69722978|FG000|Overall Study|Physician Decision|0|||
38035888|NCT04599933|69722979|FG001|Overall Study|Physician Decision|1|||
38035889|NCT04599933|69722978|FG000|Overall Study|Screen Failure|1|||
38035890|NCT04599933|69722979|FG001|Overall Study|Screen Failure|2|||
38035891|NCT04558918|69722987|FG000|Randomized Treatment Period|Pregnancy|1|||
38035892|NCT04558918|69722988|FG001|Randomized Treatment Period|Pregnancy|0|||
38035893|NCT04558918|69722987|FG000|Extension Treatment Period|Pregnancy|1|||
38035894|NCT04558918|69722988|FG001|Extension Treatment Period|Pregnancy|0|||
38035895|NCT04558918|69722987|FG000|Extension Treatment Period|Participants still ongoing at the time of the data cut-off date 2022-09-26|28|||
38035896|NCT04558918|69722988|FG001|Extension Treatment Period|Participants still ongoing at the time of the data cut-off date 2022-09-26|14|||
38035897|NCT04498910|69722998|FG000|Overall Study|Lost to Follow-up|0|||
38035898|NCT04498910|69722999|FG001|Overall Study|Lost to Follow-up|1|||
38035899|NCT04498910|69722998|FG000|Overall Study|Withdrawal by Subject|2|||
38035900|NCT04498910|69722999|FG001|Overall Study|Withdrawal by Subject|1|||
37942475|NCT00615459|69629634|FG003|Period III|Adverse Event|0|||
37942476|NCT00615459|69629631|FG000|Period III|Administrative problems|0|||
37942477|NCT00615459|69629632|FG001|Period III|Administrative problems|1|||
37942478|NCT00615459|69629633|FG002|Period III|Administrative problems|1|||
37942479|NCT00615459|69629634|FG003|Period III|Administrative problems|0|||
37942480|NCT00615459|69629631|FG000|Period III|Unsatisfactory therapeutic effect|0|||
37942481|NCT00615459|69629632|FG001|Period III|Unsatisfactory therapeutic effect|1|||
37942482|NCT00615459|69629633|FG002|Period III|Unsatisfactory therapeutic effect|0|||
37942483|NCT00615459|69629634|FG003|Period III|Unsatisfactory therapeutic effect|0|||
37942484|NCT00383149|69629648|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
37942485|NCT00383149|69629648|FG000|Overall Study|Death|2|||
37942486|NCT00383149|69629648|FG000|Overall Study|Disease Progression|38|||
37942487|NCT00383149|69629648|FG000|Overall Study|Lost to Follow-up|1|||
37942488|NCT00383149|69629648|FG000|Overall Study|Other|1|||
37942489|NCT00383149|69629648|FG000|Overall Study|Study Drug Toxicity|4|||
37942490|NCT00383149|69629648|FG000|Overall Study|Request to Discontinue Treatment|4|||
37942491|NCT00383149|69629648|FG000|Overall Study|Participant Withdrew Consent|1|||
37942492|NCT00382993|69629654|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
37942493|NCT00382993|69629655|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
37942494|NCT00382993|69629654|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
37942495|NCT00382993|69629655|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
37942496|NCT00382993|69629654|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
37942497|NCT00382993|69629655|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
37942498|NCT00382993|69629654|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
37942499|NCT00382993|69629655|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
37942500|NCT00382993|69629654|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
37942501|NCT00382993|69629655|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
37942502|NCT00382993|69629654|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
37942503|NCT00382993|69629655|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
37942504|NCT00382993|69629654|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
38035901|NCT04498910|69722998|FG000|Overall Study|Adverse Event|1|||
38035902|NCT04498910|69722999|FG001|Overall Study|Adverse Event|0|||
38035903|NCT04439344|69723006|FG000|Overall Study|Never started threapy|3|||
38035904|NCT04439344|69723006|FG000|Overall Study|Ineligible|3|||
37670747|NCT02031640|69144020|FG003|Double-blind Treatment Period|Non-compliance|1|||
37942505|NCT00382993|69629655|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
38035905|NCT04439344|69723006|FG000|Overall Study|Adverse Event|13|||
38035906|NCT04439344|69723006|FG000|Overall Study|Death|2|||
38035907|NCT04439344|69723006|FG000|Overall Study|Disease progression|29|||
38035908|NCT04439344|69723006|FG000|Overall Study|Withdrawal by Subject|2|||
38035909|NCT04439344|69723006|FG000|Overall Study|Alternative therapy|1|||
38035910|NCT04439201|69723010|FG000|Overall Study|Ineligible|2|||
38035911|NCT04439201|69723010|FG000|Overall Study|Never start protocol therapy|1|||
38035912|NCT04439201|69723010|FG000|Overall Study|Ineligible and never start protocol therapy|1|||
38035913|NCT04439201|69723010|FG000|Overall Study|Mutation status not confirmed|4|||
38035914|NCT04439201|69723010|FG000|Overall Study|Adverse Event|1|||
38035915|NCT04439201|69723010|FG000|Overall Study|Death|7|||
38035916|NCT04439201|69723010|FG000|Overall Study|Withdrawal by Subject|2|||
38035917|NCT04439201|69723010|FG000|Overall Study|Disease progression|20|||
38035918|NCT04439201|69723010|FG000|Overall Study|Alternative therapy|1|||
38035919|NCT04439201|69723010|FG000|Overall Study|Physician Decision|1|||
38035920|NCT04439123|69723014|FG000|Overall Study|Adverse Event|11|||
38035921|NCT04439123|69723014|FG000|Overall Study|Death|1|||
38035922|NCT04439123|69723014|FG000|Overall Study|Disease progression|19|||
38035923|NCT04439123|69723014|FG000|Overall Study|Withdrawal by Subject|2|||
38035924|NCT04439123|69723014|FG000|Overall Study|Still on treatment|2|||
38035925|NCT04439110|69723018|FG000|Overall Study|Ineligible|2|||
38035926|NCT04439110|69723018|FG000|Overall Study|Adverse Event|4|||
38035927|NCT04439110|69723018|FG000|Overall Study|Death|2|||
38035928|NCT04439110|69723018|FG000|Overall Study|Disease proression|25|||
38035929|NCT04439110|69723018|FG000|Overall Study|Withdrawal by Subject|1|||
38035930|NCT04439110|69723018|FG000|Overall Study|Alternative therapy|1|||
38035931|NCT04439110|69723018|FG000|Overall Study|Other complicating disease|1|||
38035932|NCT04439110|69723018|FG000|Overall Study|Personal reasons|1|||
38035933|NCT04439110|69723018|FG000|Overall Study|Still on treatment|1|||
38035934|NCT04392167|69723022|FG000|Overall Study|unable to swallow a/LCI-OCT probe|6|||
38035935|NCT03816332|69723063|FG000|Nivolumab, Tacrolimus, and Prednisone|Did not receive Nivolumab|2|||
38035936|NCT03816332|69723063|FG000|Nivolumab, Tacrolimus, and Prednisone|Death|2|||
38035937|NCT03813147|69723071|FG000|Overall Study|Lack of Efficacy|4|||
38035938|NCT03813147|69723072|FG001|Overall Study|Lack of Efficacy|4|||
38035939|NCT03813147|69723071|FG000|Overall Study|Physician Decision|2|||
38035940|NCT03813147|69723072|FG001|Overall Study|Physician Decision|1|||
38035941|NCT03738228|69723122|FG000|Overall Study|Never received study treatment|2|||
38035942|NCT03738228|69723123|FG001|Overall Study|Never received study treatment|2|||
38035943|NCT03689894|69723129|FG000|Overall Study|Adverse Event|1|||
38035944|NCT03640754|69723136|FG000|Overall Study|Withdrawal by Subject|1|||
38035945|NCT03640754|69723137|FG001|Overall Study|Withdrawal by Subject|0|||
38035946|NCT03640754|69723136|FG000|Overall Study|Lost to Follow-up|0|||
38035947|NCT03640754|69723137|FG001|Overall Study|Lost to Follow-up|1|||
38035948|NCT03370913|69723156|FG000|Overall Study|Death|1|||
38035949|NCT03370913|69723156|FG000|Overall Study|Lost to Follow-up|1|||
38035950|NCT03345784|69723162|FG000|Overall Study|Withdrawal by Subject|2|||
38035951|NCT03345784|69723163|FG001|Overall Study|Withdrawal by Subject|1|||
38035952|NCT03255018|69723171|FG000|Overall Study|Death on study|0|||
38035953|NCT03255018|69723172|FG001|Overall Study|Death on study|5|||
38035954|NCT03255018|69723171|FG000|Overall Study|Withdrawal by Subject|0|||
38035955|NCT03255018|69723172|FG001|Overall Study|Withdrawal by Subject|2|||
38035956|NCT03204188|69723178|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
38035957|NCT03204188|69723178|FG000|Immunotherapy Phase (1 Year)|Death|1|||
38035958|NCT03204188|69723178|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
38035959|NCT03204188|69723178|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
38035960|NCT03000530|69723200|FG000|Overall Study|Adverse Event|0|||
37942506|NCT00382993|69629654|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
37942507|NCT00382993|69629655|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
37942508|NCT00382993|69629654|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
37942509|NCT00382993|69629655|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
37942510|NCT00382993|69629654|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
37942511|NCT00382993|69629655|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
37942512|NCT00369967|69629663|FG000|Overall Study|Lost to Follow-up|23|||
37942513|NCT00369967|69629664|FG001|Overall Study|Lost to Follow-up|12|||
37942514|NCT00616629|69629679|FG000|Overall Study|Protocol Violation|1|||
37942515|NCT00616629|69629680|FG001|Overall Study|Protocol Violation|2|||
37942516|NCT00616629|69629681|FG002|Overall Study|Protocol Violation|1|||
37942517|NCT00616629|69629682|FG003|Overall Study|Protocol Violation|0|||
37942518|NCT00616629|69629683|FG004|Overall Study|Protocol Violation|0|||
37942519|NCT00616629|69629679|FG000|Overall Study|AV-block|1|||
37942520|NCT00616629|69629680|FG001|Overall Study|AV-block|0|||
37942521|NCT00616629|69629681|FG002|Overall Study|AV-block|0|||
37942522|NCT00616629|69629682|FG003|Overall Study|AV-block|0|||
38035961|NCT03000530|69723201|FG001|Overall Study|Adverse Event|0|||
38035962|NCT03000530|69723202|FG002|Overall Study|Adverse Event|2|||
37942523|NCT00616629|69629683|FG004|Overall Study|AV-block|0|||
37942524|NCT00369655|69629695|FG000|Overall Study|Refusal of further treatment|2|||
37942525|NCT00615069|69629699|FG000|Overall Study|Death|10|||
38035963|NCT03000530|69723200|FG000|Overall Study|Lost to Follow-up|0|||
38035964|NCT03000530|69723201|FG001|Overall Study|Lost to Follow-up|3|||
38035965|NCT03000530|69723202|FG002|Overall Study|Lost to Follow-up|1|||
38035966|NCT03000530|69723200|FG000|Overall Study|Withdrawal by Subject|0|||
38035967|NCT03000530|69723201|FG001|Overall Study|Withdrawal by Subject|2|||
38035968|NCT03000530|69723202|FG002|Overall Study|Withdrawal by Subject|1|||
38035969|NCT02978781|69723216|FG000|Part A|Adverse Event|1|||
37670748|NCT02031640|69144021|FG004|Double-blind Treatment Period|Non-compliance|1|||
37670749|NCT02031640|69144022|FG005|Double-blind Treatment Period|Non-compliance|0|||
37670750|NCT02031640|69144017|FG000|Double-blind Treatment Period|Adverse Event|0|||
37670751|NCT02031640|69144018|FG001|Double-blind Treatment Period|Adverse Event|0|||
37670752|NCT02031640|69144019|FG002|Double-blind Treatment Period|Adverse Event|0|||
37670753|NCT02031640|69144020|FG003|Double-blind Treatment Period|Adverse Event|2|||
37670754|NCT02031640|69144021|FG004|Double-blind Treatment Period|Adverse Event|0|||
37670755|NCT02031640|69144022|FG005|Double-blind Treatment Period|Adverse Event|0|||
37670756|NCT02031640|69144017|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
37670757|NCT02031640|69144018|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
37670758|NCT02031640|69144019|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
37670759|NCT02031640|69144020|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
37942526|NCT00615069|69629699|FG000|Overall Study|Physician Decision|2|||
37942527|NCT00615069|69629699|FG000|Overall Study|Withdrawal by Subject|4|||
37942528|NCT00676338|69629707|FG000|Overall Study|Adverse Event|6|||
37942529|NCT00676338|69629708|FG001|Overall Study|Adverse Event|6|||
37942530|NCT00676338|69629709|FG002|Overall Study|Adverse Event|5|||
37942531|NCT00676338|69629710|FG003|Overall Study|Adverse Event|1|||
37942532|NCT00676338|69629707|FG000|Overall Study|Lost to Follow-up|4|||
37942533|NCT00676338|69629708|FG001|Overall Study|Lost to Follow-up|1|||
37942534|NCT00676338|69629709|FG002|Overall Study|Lost to Follow-up|3|||
37942535|NCT00676338|69629710|FG003|Overall Study|Lost to Follow-up|4|||
37942536|NCT00676338|69629707|FG000|Overall Study|Physician Decision|3|||
37942537|NCT00676338|69629708|FG001|Overall Study|Physician Decision|3|||
37942538|NCT00676338|69629709|FG002|Overall Study|Physician Decision|2|||
37942539|NCT00676338|69629710|FG003|Overall Study|Physician Decision|3|||
37942540|NCT00676338|69629707|FG000|Overall Study|Protocol Violation|5|||
37942541|NCT00676338|69629708|FG001|Overall Study|Protocol Violation|9|||
37942542|NCT00676338|69629709|FG002|Overall Study|Protocol Violation|2|||
37942543|NCT00676338|69629710|FG003|Overall Study|Protocol Violation|5|||
37942544|NCT00676338|69629707|FG000|Overall Study|Withdrawal by Subject|17|||
37942545|NCT00676338|69629708|FG001|Overall Study|Withdrawal by Subject|9|||
37942546|NCT00676338|69629709|FG002|Overall Study|Withdrawal by Subject|12|||
37942547|NCT00676338|69629710|FG003|Overall Study|Withdrawal by Subject|6|||
37942548|NCT00676338|69629707|FG000|Overall Study|Entry Criteria Not Met|0|||
37942549|NCT00676338|69629708|FG001|Overall Study|Entry Criteria Not Met|2|||
37942550|NCT00676338|69629709|FG002|Overall Study|Entry Criteria Not Met|1|||
37942551|NCT00676338|69629710|FG003|Overall Study|Entry Criteria Not Met|1|||
37942552|NCT00676338|69629707|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
37942553|NCT00676338|69629708|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
37942554|NCT00676338|69629709|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
37942555|NCT00676338|69629710|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
37942556|NCT00382291|69629723|FG000|Overall Study|Adverse Event|1|||
37942557|NCT00382291|69629724|FG001|Overall Study|Adverse Event|2|||
37942558|NCT00382291|69629725|FG002|Overall Study|Adverse Event|2|||
37942559|NCT00382291|69629723|FG000|Overall Study|Protocol Violation|1|||
37942560|NCT00382291|69629724|FG001|Overall Study|Protocol Violation|0|||
37942561|NCT00382291|69629725|FG002|Overall Study|Protocol Violation|0|||
37942562|NCT00382291|69629723|FG000|Overall Study|Temporary study suspension|2|||
37942563|NCT00382291|69629724|FG001|Overall Study|Temporary study suspension|2|||
37942564|NCT00382291|69629725|FG002|Overall Study|Temporary study suspension|5|||
37942565|NCT00382291|69629723|FG000|Overall Study|Withdrawal by Subject|0|||
37942566|NCT00382291|69629724|FG001|Overall Study|Withdrawal by Subject|2|||
37942567|NCT00382291|69629725|FG002|Overall Study|Withdrawal by Subject|0|||
37942568|NCT00382291|69629723|FG000|Overall Study|Physician Decision|0|||
37942569|NCT00382291|69629724|FG001|Overall Study|Physician Decision|1|||
38035970|NCT02978781|69723217|FG001|Part A|Adverse Event|1|||
38035971|NCT02978781|69723218|FG002|Part A|Adverse Event|0|||
38035972|NCT02978781|69723219|FG003|Part A|Adverse Event|0|||
37670760|NCT02031640|69144021|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
37670761|NCT02031640|69144022|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
37670762|NCT02031640|69144017|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
37670763|NCT02031640|69144018|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
37670764|NCT02031640|69144019|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
37670765|NCT02031640|69144020|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
37942570|NCT00382291|69629725|FG002|Overall Study|Physician Decision|0|||
37942571|NCT00382291|69629723|FG000|Overall Study|Lack of Efficacy|0|||
37942572|NCT00382291|69629724|FG001|Overall Study|Lack of Efficacy|0|||
38035973|NCT02978781|69723220|FG004|Part A|Adverse Event|0|||
37670766|NCT02031640|69144021|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
37670767|NCT02031640|69144022|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
37670768|NCT02370173|69144043|FG000|Overall Study|Protocol Violation|1|||
37670769|NCT02370173|69144044|FG001|Overall Study|Protocol Violation|1|||
37670770|NCT02370173|69144043|FG000|Overall Study|Withdrawal by Subject|2|||
37670771|NCT02370173|69144044|FG001|Overall Study|Withdrawal by Subject|2|||
37670772|NCT02660489|69144054|FG000|Overall Study|Lost to Follow-up|1|||
37670773|NCT02660489|69144055|FG001|Overall Study|Lost to Follow-up|1|||
37670774|NCT02660489|69144054|FG000|Overall Study|Adverse Event|1|||
37670775|NCT02660489|69144055|FG001|Overall Study|Adverse Event|3|||
37670776|NCT02660489|69144054|FG000|Overall Study|no rhinovirus infection|4|||
37670777|NCT02660489|69144055|FG001|Overall Study|no rhinovirus infection|4|||
37670778|NCT02052310|69144063|FG000|Overall Study|Death|64|||
37670779|NCT02052310|69144064|FG001|Overall Study|Death|54|||
37670780|NCT02052310|69144063|FG000|Overall Study|Withdrawal by Subject|37|||
37670781|NCT02052310|69144064|FG001|Overall Study|Withdrawal by Subject|49|||
37670782|NCT02052310|69144063|FG000|Overall Study|Other than specified|32|||
37670783|NCT02052310|69144064|FG001|Overall Study|Other than specified|29|||
37670784|NCT02052310|69144063|FG000|Overall Study|Adverse Event|29|||
37670785|NCT02052310|69144064|FG001|Overall Study|Adverse Event|22|||
37670786|NCT02052310|69144063|FG000|Overall Study|Kidney Transplant|23|||
37670787|NCT02052310|69144064|FG001|Overall Study|Kidney Transplant|29|||
37670788|NCT02052310|69144063|FG000|Overall Study|Physician Decision|14|||
37670789|NCT02052310|69144064|FG001|Overall Study|Physician Decision|7|||
37670790|NCT02052310|69144063|FG000|Overall Study|Lack of Efficacy|6|||
37670791|NCT02052310|69144064|FG001|Overall Study|Lack of Efficacy|1|||
37670792|NCT02052310|69144063|FG000|Overall Study|Site Terminated by Sponsor|5|||
37670793|NCT02052310|69144064|FG001|Overall Study|Site Terminated by Sponsor|13|||
37670794|NCT02052310|69144063|FG000|Overall Study|Lost to Follow-up|4|||
37670795|NCT02052310|69144064|FG001|Overall Study|Lost to Follow-up|2|||
37670796|NCT02052310|69144063|FG000|Overall Study|Protocol Violation|1|||
37670797|NCT02052310|69144064|FG001|Overall Study|Protocol Violation|6|||
37670798|NCT02051764|69144072|FG000|Overall Study|Study terminated by sponsor|0|||
37670799|NCT02051764|69144073|FG001|Overall Study|Study terminated by sponsor|7|||
37670800|NCT02051296|69144081|FG000|Overall Study|Lost to Follow-up|1|||
37670801|NCT02051296|69144082|FG001|Overall Study|Lost to Follow-up|2|||
37670802|NCT02051296|69144081|FG000|Overall Study|withdraw prior to treatment|7|||
37670803|NCT02051296|69144082|FG001|Overall Study|withdraw prior to treatment|7|||
37670804|NCT02050048|69144090|FG000|Overall Study|Lost to Follow-up|0|||
37670805|NCT02050048|69144091|FG001|Overall Study|Lost to Follow-up|1|||
37670806|NCT02050048|69144090|FG000|Overall Study|Death|1|||
37670807|NCT02050048|69144091|FG001|Overall Study|Death|0|||
37670808|NCT02050048|69144090|FG000|Overall Study|Ineligible after ERCP|4|||
37670809|NCT02050048|69144091|FG001|Overall Study|Ineligible after ERCP|1|||
37670810|NCT02049814|69144099|FG000|Overall Study|Reason not Specified|4|||
37670811|NCT02049814|69144100|FG001|Overall Study|Reason not Specified|3|||
37670812|NCT02049814|69144099|FG000|Overall Study|Pregnancy|1|||
37670813|NCT02049814|69144100|FG001|Overall Study|Pregnancy|0|||
37670814|NCT02049814|69144099|FG000|Overall Study|Lost to Follow-up|2|||
37670815|NCT02049814|69144100|FG001|Overall Study|Lost to Follow-up|3|||
37670816|NCT02049814|69144099|FG000|Overall Study|Serious Protocol Violation|5|||
37670817|NCT02049814|69144100|FG001|Overall Study|Serious Protocol Violation|7|||
37670818|NCT02049814|69144099|FG000|Overall Study|Study Termination|0|||
37670819|NCT02049814|69144100|FG001|Overall Study|Study Termination|1|||
37670820|NCT02049814|69144099|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
37670821|NCT02049814|69144100|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
37670822|NCT02049814|69144099|FG000|Overall Study|Voluntary withdrawal|9|||
37670823|NCT02049814|69144100|FG001|Overall Study|Voluntary withdrawal|8|||
37670824|NCT02079844|69144118|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
37670825|NCT02079844|69144119|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
37670826|NCT02079844|69144120|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
37670827|NCT02079844|69144118|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
37670828|NCT02079844|69144119|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
37670829|NCT02079844|69144120|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
37670830|NCT02048722|69144140|FG000|2 Cycles of Treatment|Adverse Event|2|||
37765304|NCT01544582|69278655|FG002|Analysis Population|Liver Transplantation|1|||
37670831|NCT02048722|69144140|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
37670832|NCT02048722|69144140|FG000|2 Cycles of Treatment|Progressive Disease|2|||
37670833|NCT02048722|69144140|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
37670834|NCT02048722|69144140|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
37670835|NCT02048722|69144140|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
37765305|NCT01544582|69278656|FG003|Analysis Population|Liver Transplantation|0|||
37942573|NCT00382291|69629725|FG002|Overall Study|Lack of Efficacy|1|||
37670836|NCT02030002|69144144|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
37670837|NCT02030002|69144144|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
37670838|NCT02030002|69144144|FG000|Follow-up|Lost to Follow-up|2|||
37670839|NCT02079610|69144152|FG000|Overall Study|Withdrawal by Subject|1|||
37670840|NCT02079610|69144153|FG001|Overall Study|Withdrawal by Subject|1|||
37670841|NCT02079532|69144159|FG000|Overall Study|Adverse Event|7|||
37670842|NCT02079532|69144159|FG000|Overall Study|Additional or changed therapy|2|||
37670843|NCT02079532|69144159|FG000|Overall Study|Lack of Efficacy|9|||
37670844|NCT02079532|69144159|FG000|Overall Study|Protocol Violation|3|||
37670845|NCT02079532|69144159|FG000|Overall Study|Withdrawal by Subject|1|||
38035974|NCT02978781|69723216|FG000|Part A|Withdrawal by Subject|0|||
38035975|NCT02978781|69723217|FG001|Part A|Withdrawal by Subject|1|||
38035976|NCT02978781|69723218|FG002|Part A|Withdrawal by Subject|0|||
38035977|NCT02978781|69723219|FG003|Part A|Withdrawal by Subject|0|||
38035978|NCT02978781|69723220|FG004|Part A|Withdrawal by Subject|0|||
38035979|NCT02978781|69723216|FG000|Part B|Withdrawal by Subject|0|||
38035980|NCT02978781|69723217|FG001|Part B|Withdrawal by Subject|0|||
38035981|NCT02978781|69723218|FG002|Part B|Withdrawal by Subject|0|||
38035982|NCT02978781|69723219|FG003|Part B|Withdrawal by Subject|1|||
38035983|NCT02978781|69723220|FG004|Part B|Withdrawal by Subject|0|||
37670846|NCT02079532|69144159|FG000|Overall Study|Administrative problems|1|||
37670847|NCT02079532|69144159|FG000|Overall Study|Inclusion into ReFIRST|3|||
37670848|NCT02079532|69144159|FG000|Overall Study|Other|3|||
37670849|NCT02357849|69144176|FG000|Overall Study|Withdrawal by Subject|2|||
37670850|NCT02357849|69144177|FG001|Overall Study|Withdrawal by Subject|3|||
37670851|NCT02709889|69144221|FG000|Overall Study|Withdrawal by Subject|11|||
37670852|NCT02709889|69144222|FG001|Overall Study|Withdrawal by Subject|10|||
37670853|NCT02709889|69144223|FG002|Overall Study|Withdrawal by Subject|2|||
37670854|NCT02709889|69144224|FG003|Overall Study|Withdrawal by Subject|12|||
37670855|NCT02709889|69144221|FG000|Overall Study|Death|25|||
37670856|NCT02709889|69144222|FG001|Overall Study|Death|38|||
37670857|NCT02709889|69144223|FG002|Overall Study|Death|4|||
37670858|NCT02709889|69144224|FG003|Overall Study|Death|44|||
37670859|NCT02709889|69144221|FG000|Overall Study|Physician Decision|1|||
37670860|NCT02709889|69144222|FG001|Overall Study|Physician Decision|2|||
37670861|NCT02709889|69144223|FG002|Overall Study|Physician Decision|3|||
37670862|NCT02709889|69144224|FG003|Overall Study|Physician Decision|5|||
37670863|NCT02709889|69144221|FG000|Overall Study|Lost to Follow-up|2|||
37670864|NCT02709889|69144222|FG001|Overall Study|Lost to Follow-up|0|||
37670865|NCT02709889|69144223|FG002|Overall Study|Lost to Follow-up|0|||
37670866|NCT02709889|69144224|FG003|Overall Study|Lost to Follow-up|4|||
37670867|NCT02709889|69144221|FG000|Overall Study|Study Terminated by Sponsor|4|||
37670868|NCT02709889|69144222|FG001|Overall Study|Study Terminated by Sponsor|6|||
37670869|NCT02709889|69144223|FG002|Overall Study|Study Terminated by Sponsor|2|||
37670870|NCT02709889|69144224|FG003|Overall Study|Study Terminated by Sponsor|17|||
37670871|NCT02709889|69144221|FG000|Overall Study|Other, Not Specified|0|||
37670872|NCT02709889|69144222|FG001|Overall Study|Other, Not Specified|1|||
37670873|NCT02709889|69144223|FG002|Overall Study|Other, Not Specified|1|||
37670874|NCT02709889|69144224|FG003|Overall Study|Other, Not Specified|6|||
37670875|NCT02711995|69144269|FG000|Washout (90 Days)|Conflicting medication|1|||
37670876|NCT02514239|69144307|FG000|Overall Study|Refused to continue trial medication|0|||
37670877|NCT02514239|69144308|FG001|Overall Study|Refused to continue trial medication|0|||
37670878|NCT02514239|69144309|FG002|Overall Study|Refused to continue trial medication|0|||
37670879|NCT02514239|69144310|FG003|Overall Study|Refused to continue trial medication|0|||
37670880|NCT02514239|69144311|FG004|Overall Study|Refused to continue trial medication|0|||
37670881|NCT02514239|69144312|FG005|Overall Study|Refused to continue trial medication|0|||
37670882|NCT02514239|69144313|FG006|Overall Study|Refused to continue trial medication|0|||
37670883|NCT02514239|69144314|FG007|Overall Study|Refused to continue trial medication|0|||
37670884|NCT02514239|69144315|FG008|Overall Study|Refused to continue trial medication|0|||
37670885|NCT02514239|69144316|FG009|Overall Study|Refused to continue trial medication|1|||
37670886|NCT02514239|69144307|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
37670887|NCT02514239|69144308|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
37670888|NCT02514239|69144309|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
37670889|NCT02514239|69144310|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
37670890|NCT02514239|69144311|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
37670891|NCT02514239|69144312|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
37670892|NCT02514239|69144313|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
37670893|NCT02514239|69144314|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
38035984|NCT02978781|69723216|FG000|Part C|Adverse Event|0|||
37670894|NCT02514239|69144315|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
37670895|NCT02514239|69144316|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
37670896|NCT02514239|69144307|FG000|Overall Study|Not treated|0|||
37670897|NCT02514239|69144308|FG001|Overall Study|Not treated|1|||
37670898|NCT02514239|69144309|FG002|Overall Study|Not treated|0|||
37670899|NCT02514239|69144310|FG003|Overall Study|Not treated|0|||
37670900|NCT02514239|69144311|FG004|Overall Study|Not treated|0|||
37670901|NCT02514239|69144312|FG005|Overall Study|Not treated|0|||
37670902|NCT02514239|69144313|FG006|Overall Study|Not treated|0|||
38035985|NCT02978781|69723217|FG001|Part C|Adverse Event|0|||
38035986|NCT02978781|69723218|FG002|Part C|Adverse Event|0|||
37670903|NCT02514239|69144314|FG007|Overall Study|Not treated|0|||
37670904|NCT02514239|69144315|FG008|Overall Study|Not treated|0|||
37670905|NCT02514239|69144316|FG009|Overall Study|Not treated|0|||
37670906|NCT02514239|69144307|FG000|Overall Study|Other Adverse Events|2|||
37670907|NCT02514239|69144308|FG001|Overall Study|Other Adverse Events|0|||
37670908|NCT02514239|69144309|FG002|Overall Study|Other Adverse Events|0|||
37670909|NCT02514239|69144310|FG003|Overall Study|Other Adverse Events|1|||
37670910|NCT02514239|69144311|FG004|Overall Study|Other Adverse Events|0|||
37670911|NCT02514239|69144312|FG005|Overall Study|Other Adverse Events|1|||
37670912|NCT02514239|69144313|FG006|Overall Study|Other Adverse Events|0|||
37670913|NCT02514239|69144314|FG007|Overall Study|Other Adverse Events|1|||
37670914|NCT02514239|69144315|FG008|Overall Study|Other Adverse Events|2|||
37670915|NCT02514239|69144316|FG009|Overall Study|Other Adverse Events|0|||
37670916|NCT02514239|69144307|FG000|Overall Study|Progressive disease|3|||
37670917|NCT02514239|69144308|FG001|Overall Study|Progressive disease|3|||
37670918|NCT02514239|69144309|FG002|Overall Study|Progressive disease|2|||
37670919|NCT02514239|69144310|FG003|Overall Study|Progressive disease|2|||
37670920|NCT02514239|69144311|FG004|Overall Study|Progressive disease|3|||
37670921|NCT02514239|69144312|FG005|Overall Study|Progressive disease|3|||
37670922|NCT02514239|69144313|FG006|Overall Study|Progressive disease|4|||
37670923|NCT02514239|69144314|FG007|Overall Study|Progressive disease|2|||
37670924|NCT02514239|69144315|FG008|Overall Study|Progressive disease|5|||
37670925|NCT02514239|69144316|FG009|Overall Study|Progressive disease|0|||
37670926|NCT02709109|69144360|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
37670927|NCT02709109|69144361|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
37670928|NCT02709109|69144362|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
37670929|NCT02709109|69144363|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
37670930|NCT02709109|69144360|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
37670931|NCT02709109|69144361|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
37670932|NCT02709109|69144362|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
37670933|NCT02709109|69144363|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
37670934|NCT02709109|69144360|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
37670935|NCT02709109|69144361|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
37670936|NCT02709109|69144362|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
37670937|NCT02709109|69144363|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
37670938|NCT02709109|69144360|FG000|Washout Period (28 Days)|Other|2|||
37670939|NCT02709109|69144361|FG001|Washout Period (28 Days)|Other|2|||
37765306|NCT01544582|69278653|FG000|Analysis Population|No Social Insurance|0|||
37765307|NCT01544582|69278654|FG001|Analysis Population|No Social Insurance|0|||
37765308|NCT01544582|69278655|FG002|Analysis Population|No Social Insurance|1|||
37765309|NCT01544582|69278656|FG003|Analysis Population|No Social Insurance|0|||
37765310|NCT01544582|69278653|FG000|Analysis Population|Poor Adherence|0|||
37765311|NCT01544582|69278654|FG001|Analysis Population|Poor Adherence|0|||
37765312|NCT01544582|69278655|FG002|Analysis Population|Poor Adherence|1|||
37765313|NCT01544582|69278656|FG003|Analysis Population|Poor Adherence|0|||
37765314|NCT01544582|69278653|FG000|Analysis Population|Poor Participant Compliance|0|||
37765315|NCT01544582|69278654|FG001|Analysis Population|Poor Participant Compliance|1|||
38035987|NCT02978781|69723219|FG003|Part C|Adverse Event|0|||
38035988|NCT02978781|69723220|FG004|Part C|Adverse Event|2|||
38035989|NCT02978781|69723216|FG000|Part C|Withdrawal by Subject|0|||
37765316|NCT01544582|69278655|FG002|Analysis Population|Poor Participant Compliance|0|||
37765317|NCT01544582|69278656|FG003|Analysis Population|Poor Participant Compliance|0|||
37765318|NCT01544582|69278653|FG000|Analysis Population|Programmed Surgery|0|||
37765319|NCT01544582|69278654|FG001|Analysis Population|Programmed Surgery|1|||
37765320|NCT01544582|69278655|FG002|Analysis Population|Programmed Surgery|0|||
37765321|NCT01544582|69278656|FG003|Analysis Population|Programmed Surgery|0|||
37765322|NCT01544582|69278653|FG000|Analysis Population|Participant in Jail|0|||
37765323|NCT01544582|69278654|FG001|Analysis Population|Participant in Jail|0|||
37765324|NCT01544582|69278655|FG002|Analysis Population|Participant in Jail|1|||
37765325|NCT01544582|69278656|FG003|Analysis Population|Participant in Jail|0|||
37765326|NCT01439165|69278684|FG000|Overall Study|Protocol Violation|3|||
37765327|NCT01439165|69278685|FG001|Overall Study|Protocol Violation|0|||
37765328|NCT01439165|69278684|FG000|Overall Study|Lost to Follow-up|11|||
37765329|NCT01439165|69278685|FG001|Overall Study|Lost to Follow-up|1|||
37765330|NCT01439165|69278684|FG000|Overall Study|Withdrawal by Subject|7|||
38035990|NCT02978781|69723217|FG001|Part C|Withdrawal by Subject|0|||
37765331|NCT01439165|69278685|FG001|Overall Study|Withdrawal by Subject|1|||
37765332|NCT01529606|69278699|FG000|Overall Study|Lost to Follow-up|21|||
37765333|NCT01529606|69278700|FG001|Overall Study|Lost to Follow-up|18|||
37765334|NCT01439009|69278717|FG000|Overall Study|Physician Decision|5|||
37942574|NCT00547378|69629747|FG000|Randomized Cohort|Withdrawal by Subject|7|||
37942575|NCT00547378|69629748|FG001|Randomized Cohort|Withdrawal by Subject|5|||
37942576|NCT00547378|69629749|FG002|Randomized Cohort|Withdrawal by Subject|0|||
37670940|NCT02709109|69144362|FG002|Washout Period (28 Days)|Other|3|||
37670941|NCT02709109|69144363|FG003|Washout Period (28 Days)|Other|0|||
37670942|NCT02709109|69144360|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
37670943|NCT02709109|69144361|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
37670944|NCT02709109|69144362|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
37670945|NCT02709109|69144363|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
37670946|NCT02709109|69144360|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
37670947|NCT02709109|69144361|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
37670948|NCT02709109|69144362|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
37670949|NCT02709109|69144363|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
37670950|NCT02709109|69144360|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
37670951|NCT02709109|69144361|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
37670952|NCT02709109|69144362|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
37670953|NCT02709109|69144363|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
37670954|NCT02709109|69144360|FG000|Treatment Period 2 (28 Days)|Other|0|||
37670955|NCT02709109|69144361|FG001|Treatment Period 2 (28 Days)|Other|0|||
37670956|NCT02709109|69144362|FG002|Treatment Period 2 (28 Days)|Other|1|||
37670957|NCT02709109|69144363|FG003|Treatment Period 2 (28 Days)|Other|0|||
37670958|NCT04289051|69144378|FG000|Overall Study|Lost to Follow-up|0|||
37670959|NCT04289051|69144379|FG001|Overall Study|Lost to Follow-up|0|||
37670960|NCT04289051|69144380|FG002|Overall Study|Lost to Follow-up|2|||
37670961|NCT02709655|69144388|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
37670962|NCT02709655|69144389|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
37670963|NCT02709655|69144390|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
37670964|NCT02709655|69144391|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
37670965|NCT02709655|69144392|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
37670966|NCT02709655|69144388|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
37670967|NCT02709655|69144389|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
37670968|NCT02709655|69144390|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
37670969|NCT02709655|69144391|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
37670970|NCT02709655|69144392|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
37670971|NCT02709655|69144388|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
37670972|NCT02709655|69144389|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
37670973|NCT02709655|69144390|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
37670974|NCT02709655|69144391|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
37670975|NCT02709655|69144392|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
37670976|NCT02709655|69144388|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
37670977|NCT02709655|69144389|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
37670978|NCT02709655|69144390|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
37670979|NCT02709655|69144391|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
37670980|NCT02709655|69144392|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
37670981|NCT02709655|69144388|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
37670982|NCT02709655|69144389|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
37670983|NCT02709655|69144390|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
37670984|NCT02709655|69144391|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
37670985|NCT02709655|69144392|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
37670986|NCT02709655|69144388|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
37670987|NCT02709655|69144389|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
37670988|NCT02709655|69144390|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
37670989|NCT02709655|69144391|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
37670990|NCT02709655|69144392|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
37670991|NCT02709655|69144388|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
37670992|NCT02709655|69144389|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
37670993|NCT02709655|69144390|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
37670994|NCT02709655|69144391|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
37670995|NCT02709655|69144392|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
37670996|NCT02709655|69144388|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
37670997|NCT02709655|69144389|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
37670998|NCT02709655|69144390|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
37670999|NCT02709655|69144391|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
37671000|NCT02709655|69144392|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
37671001|NCT02709655|69144388|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
37671002|NCT02709655|69144389|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
37671003|NCT02709655|69144390|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
37671004|NCT02709655|69144391|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
37671005|NCT02709655|69144392|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
37671006|NCT02709655|69144388|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
37671007|NCT02709655|69144389|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
37671008|NCT02709655|69144390|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
37671009|NCT02709655|69144391|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
37671010|NCT02709655|69144392|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
37671011|NCT02709655|69144388|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
37671012|NCT02709655|69144389|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
37671013|NCT02709655|69144390|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
37671014|NCT02709655|69144391|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
37671015|NCT02709655|69144392|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
37671016|NCT02709655|69144388|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
37671017|NCT02709655|69144389|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
37671018|NCT02709655|69144390|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
37671019|NCT02709655|69144391|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
37671020|NCT02709655|69144392|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
37671021|NCT02709655|69144388|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
37671022|NCT02709655|69144389|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
37671023|NCT02709655|69144390|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
37671024|NCT02709655|69144391|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
37671025|NCT02709655|69144392|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
37671026|NCT02709655|69144388|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
37671027|NCT02709655|69144389|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
37671028|NCT02709655|69144390|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
37671029|NCT02709655|69144391|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
37671030|NCT02709655|69144392|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
37671031|NCT02709655|69144388|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
37671032|NCT02709655|69144389|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
37671033|NCT02709655|69144390|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
37671034|NCT02709655|69144391|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
37671035|NCT02709655|69144392|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
37671036|NCT02709655|69144388|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
37671037|NCT02709655|69144389|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
37671038|NCT02709655|69144390|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
37671039|NCT02709655|69144391|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
37671040|NCT02709655|69144392|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
37671041|NCT02708485|69144406|FG000|Overall Study|Withdrawal by Subject|3|||
37671042|NCT02708485|69144407|FG001|Overall Study|Withdrawal by Subject|2|||
37671043|NCT02709577|69144419|FG000|Overall Study|non-accommodating anatomy|0|||
37671044|NCT02709577|69144420|FG001|Overall Study|non-accommodating anatomy|1|||
37671045|NCT02709577|69144421|FG002|Overall Study|non-accommodating anatomy|0|||
37671046|NCT02709577|69144422|FG003|Overall Study|non-accommodating anatomy|0|||
37671047|NCT02709577|69144419|FG000|Overall Study|procedural complication|0|||
37671048|NCT02709577|69144420|FG001|Overall Study|procedural complication|1|||
37671049|NCT02709577|69144421|FG002|Overall Study|procedural complication|0|||
37671050|NCT02709577|69144422|FG003|Overall Study|procedural complication|0|||
37671051|NCT02709577|69144419|FG000|Overall Study|Withdrawal by Subject|2|||
37671052|NCT02709577|69144420|FG001|Overall Study|Withdrawal by Subject|3|||
37671053|NCT02709577|69144421|FG002|Overall Study|Withdrawal by Subject|2|||
37671054|NCT02709577|69144422|FG003|Overall Study|Withdrawal by Subject|0|||
37671055|NCT02078752|69144443|FG000|Overall Study|Death|0|||
37671056|NCT02078752|69144444|FG001|Overall Study|Death|3|||
37671057|NCT02078752|69144445|FG002|Overall Study|Death|0|||
37671058|NCT02078752|69144446|FG003|Overall Study|Death|0|||
37671059|NCT02078752|69144447|FG004|Overall Study|Death|0|||
37671060|NCT02078752|69144448|FG005|Overall Study|Death|1|||
37671061|NCT02078752|69144449|FG006|Overall Study|Death|0|||
37671062|NCT02078752|69144450|FG007|Overall Study|Death|1|||
37671063|NCT02078752|69144451|FG008|Overall Study|Death|0|||
37671064|NCT02078752|69144452|FG009|Overall Study|Death|4|||
37671065|NCT02078752|69144443|FG000|Overall Study|Lost to Follow-up|1|||
37671066|NCT02078752|69144444|FG001|Overall Study|Lost to Follow-up|0|||
37671067|NCT02078752|69144445|FG002|Overall Study|Lost to Follow-up|0|||
37671068|NCT02078752|69144446|FG003|Overall Study|Lost to Follow-up|1|||
37671069|NCT02078752|69144447|FG004|Overall Study|Lost to Follow-up|0|||
37671070|NCT02078752|69144448|FG005|Overall Study|Lost to Follow-up|0|||
37671071|NCT02078752|69144449|FG006|Overall Study|Lost to Follow-up|0|||
37671072|NCT02078752|69144450|FG007|Overall Study|Lost to Follow-up|0|||
37671073|NCT02078752|69144451|FG008|Overall Study|Lost to Follow-up|0|||
37671074|NCT02078752|69144452|FG009|Overall Study|Lost to Follow-up|0|||
37671075|NCT02078752|69144443|FG000|Overall Study|Withdrawal by Subject|1|||
37765335|NCT01439009|69278718|FG001|Overall Study|Physician Decision|3|||
37765336|NCT01439009|69278717|FG000|Overall Study|Protocol Violation|2|||
37671076|NCT02078752|69144444|FG001|Overall Study|Withdrawal by Subject|1|||
37671077|NCT02078752|69144445|FG002|Overall Study|Withdrawal by Subject|1|||
37671078|NCT02078752|69144446|FG003|Overall Study|Withdrawal by Subject|1|||
37671079|NCT02078752|69144447|FG004|Overall Study|Withdrawal by Subject|0|||
37671080|NCT02078752|69144448|FG005|Overall Study|Withdrawal by Subject|3|||
37671081|NCT02078752|69144449|FG006|Overall Study|Withdrawal by Subject|2|||
37671082|NCT02078752|69144450|FG007|Overall Study|Withdrawal by Subject|1|||
37671083|NCT02078752|69144451|FG008|Overall Study|Withdrawal by Subject|0|||
37671084|NCT02078752|69144452|FG009|Overall Study|Withdrawal by Subject|1|||
37671085|NCT02078752|69144443|FG000|Overall Study|Other|0|||
37671086|NCT02078752|69144444|FG001|Overall Study|Other|3|||
37671087|NCT02078752|69144445|FG002|Overall Study|Other|0|||
37671088|NCT02078752|69144446|FG003|Overall Study|Other|0|||
37671089|NCT02078752|69144447|FG004|Overall Study|Other|1|||
37671090|NCT02078752|69144448|FG005|Overall Study|Other|0|||
37671091|NCT02078752|69144449|FG006|Overall Study|Other|0|||
37671092|NCT02078752|69144450|FG007|Overall Study|Other|1|||
37671093|NCT02078752|69144451|FG008|Overall Study|Other|0|||
37671094|NCT02078752|69144452|FG009|Overall Study|Other|0|||
37671095|NCT02078752|69144443|FG000|Overall Study|Study terminated by sponsor|0|||
37671096|NCT02078752|69144444|FG001|Overall Study|Study terminated by sponsor|0|||
37671097|NCT02078752|69144445|FG002|Overall Study|Study terminated by sponsor|0|||
37671098|NCT02078752|69144446|FG003|Overall Study|Study terminated by sponsor|0|||
37765337|NCT01439009|69278718|FG001|Overall Study|Protocol Violation|0|||
37765338|NCT01439009|69278717|FG000|Overall Study|Deviation of exclusion criteria|1|||
37671099|NCT02078752|69144447|FG004|Overall Study|Study terminated by sponsor|0|||
37671100|NCT02078752|69144448|FG005|Overall Study|Study terminated by sponsor|0|||
37671101|NCT02078752|69144449|FG006|Overall Study|Study terminated by sponsor|0|||
37671102|NCT02078752|69144450|FG007|Overall Study|Study terminated by sponsor|0|||
37671103|NCT02078752|69144451|FG008|Overall Study|Study terminated by sponsor|0|||
37671104|NCT02078752|69144452|FG009|Overall Study|Study terminated by sponsor|5|||
37671105|NCT02022748|69144485|FG000|Overall Study|Adverse Event|1|||
37671106|NCT02022748|69144486|FG001|Overall Study|Adverse Event|1|||
37671107|NCT02022748|69144487|FG002|Overall Study|Adverse Event|0|||
37671108|NCT02022748|69144485|FG000|Overall Study|Withdrawal by Subject|0|||
37671109|NCT02022748|69144486|FG001|Overall Study|Withdrawal by Subject|1|||
37671110|NCT02022748|69144487|FG002|Overall Study|Withdrawal by Subject|0|||
37671111|NCT02022670|69144498|FG000|Overall Study|Adverse Event|1|||
37671112|NCT02022670|69144499|FG001|Overall Study|Adverse Event|0|||
37671113|NCT02022670|69144500|FG002|Overall Study|Adverse Event|1|||
37671114|NCT02076334|69144513|FG000|Overall Study|Protocol Violation|1|||
37671115|NCT02076334|69144514|FG001|Overall Study|Protocol Violation|0|||
37671116|NCT02076334|69144515|FG002|Overall Study|Protocol Violation|0|||
37671117|NCT02076334|69144516|FG003|Overall Study|Protocol Violation|0|||
37671118|NCT02076334|69144513|FG000|Overall Study|Lost to Follow-up|0|||
37671119|NCT02076334|69144514|FG001|Overall Study|Lost to Follow-up|1|||
37671120|NCT02076334|69144515|FG002|Overall Study|Lost to Follow-up|1|||
37671121|NCT02076334|69144516|FG003|Overall Study|Lost to Follow-up|0|||
37671122|NCT02076334|69144513|FG000|Overall Study|muscle soreness|0|||
37671123|NCT02076334|69144514|FG001|Overall Study|muscle soreness|0|||
37671124|NCT02076334|69144515|FG002|Overall Study|muscle soreness|0|||
37671125|NCT02076334|69144516|FG003|Overall Study|muscle soreness|1|||
37671126|NCT02021812|69144526|FG000|Overall Study|Death|8|||
37671127|NCT02021812|69144526|FG000|Overall Study|Withdrawal by Subject|3|||
37671128|NCT02021812|69144526|FG000|Overall Study|Lost to Follow-up|2|||
37671129|NCT02021812|69144526|FG000|Overall Study|Refuse to return, COVD 19|2|||
37671130|NCT02021656|69144530|FG000|Overall Study|Adverse Event|1|||
37671131|NCT02021656|69144530|FG000|Overall Study|Lack of Efficacy|2|||
37671132|NCT02021656|69144530|FG000|Overall Study|Lost to Follow-up|1|||
37671133|NCT02021656|69144530|FG000|Overall Study|Withdrew Consent|2|||
37671134|NCT02076022|69144540|FG000|Overall Study|Withdrawal by Subject|2|||
37671135|NCT02076022|69144541|FG001|Overall Study|Withdrawal by Subject|0|||
37671136|NCT02075632|69144549|FG000|Overall Study|Adverse Event|1|||
37671137|NCT02075632|69144550|FG001|Overall Study|Adverse Event|1|||
37671138|NCT02075632|69144549|FG000|Overall Study|Lost to Follow-up|0|||
37671139|NCT02075632|69144550|FG001|Overall Study|Lost to Follow-up|3|||
37671140|NCT02075632|69144549|FG000|Overall Study|Withdrawal by Subject|0|||
37671141|NCT02075632|69144550|FG001|Overall Study|Withdrawal by Subject|1|||
37671142|NCT02075554|69144556|FG000|Overall Study|Lost to Follow-up|7|||
37671143|NCT02075554|69144556|FG000|Overall Study|Withdrawal by Subject|5|||
37671144|NCT02075554|69144556|FG000|Overall Study|Physician Decision|3|||
37671145|NCT02075476|69144562|FG000|Overall Study|Death|2|||
37671146|NCT02075476|69144563|FG001|Overall Study|Death|2|||
37671147|NCT02075476|69144562|FG000|Overall Study|Lost to Follow-up|1|||
37671148|NCT02075476|69144563|FG001|Overall Study|Lost to Follow-up|3|||
37671149|NCT02075320|69144569|FG000|Overall Study|Withdrawal by Subject|2|||
37671150|NCT02708095|69144576|FG000|Overall Study|Adverse Event|4|||
37671151|NCT02708095|69144577|FG001|Overall Study|Adverse Event|10|||
37671152|NCT02708095|69144578|FG002|Overall Study|Adverse Event|11|||
37671153|NCT02708095|69144576|FG000|Overall Study|Lack of Efficacy|9|||
37671154|NCT02708095|69144577|FG001|Overall Study|Lack of Efficacy|3|||
37671155|NCT02708095|69144578|FG002|Overall Study|Lack of Efficacy|0|||
37671156|NCT02708095|69144576|FG000|Overall Study|Lost to Follow-up|2|||
37671157|NCT02708095|69144577|FG001|Overall Study|Lost to Follow-up|0|||
37671158|NCT02708095|69144578|FG002|Overall Study|Lost to Follow-up|0|||
37671159|NCT02708095|69144576|FG000|Overall Study|Physician Decision|2|||
37671160|NCT02708095|69144577|FG001|Overall Study|Physician Decision|3|||
37671161|NCT02708095|69144578|FG002|Overall Study|Physician Decision|2|||
37671162|NCT02708095|69144576|FG000|Overall Study|Protocol Violation|0|||
37671163|NCT02708095|69144577|FG001|Overall Study|Protocol Violation|0|||
37671164|NCT02708095|69144578|FG002|Overall Study|Protocol Violation|1|||
37671165|NCT02708095|69144576|FG000|Overall Study|Withdrawal by Subject|5|||
37671166|NCT02708095|69144577|FG001|Overall Study|Withdrawal by Subject|3|||
37671167|NCT02708095|69144578|FG002|Overall Study|Withdrawal by Subject|4|||
37671168|NCT02707861|69144590|FG000|Overall Study|Went onto commercial drug|30|||
37671169|NCT02707861|69144591|FG001|Overall Study|Went onto commercial drug|23|||
37671170|NCT02707861|69144590|FG000|Overall Study|Adverse Event|2|||
37671171|NCT02707861|69144591|FG001|Overall Study|Adverse Event|3|||
37671172|NCT02707861|69144590|FG000|Overall Study|Death|5|||
37671173|NCT02707861|69144591|FG001|Overall Study|Death|2|||
37671174|NCT02707861|69144590|FG000|Overall Study|Lack of Efficacy|0|||
37671175|NCT02707861|69144591|FG001|Overall Study|Lack of Efficacy|2|||
37671176|NCT02707861|69144590|FG000|Overall Study|Physician Decision|1|||
37671177|NCT02707861|69144591|FG001|Overall Study|Physician Decision|4|||
37671178|NCT02707861|69144590|FG000|Overall Study|Withdrawal by Subject|2|||
37671179|NCT02707861|69144591|FG001|Overall Study|Withdrawal by Subject|1|||
37671180|NCT02707861|69144590|FG000|Overall Study|Lost to Follow-up|1|||
37671181|NCT02707861|69144591|FG001|Overall Study|Lost to Follow-up|3|||
37671182|NCT02027428|69144599|FG000|Induction|Never treated|7|||
37671183|NCT02027428|69144600|FG001|Induction|Never treated|0|||
37671184|NCT02027428|69144601|FG002|Induction|Never treated|0|||
37671185|NCT02027428|69144599|FG000|Induction|Progressive disease|77|||
37671186|NCT02027428|69144600|FG001|Induction|Progressive disease|0|||
37671187|NCT02027428|69144601|FG002|Induction|Progressive disease|0|||
37671188|NCT02027428|69144599|FG000|Induction|Adverse Event|51|||
37671189|NCT02027428|69144600|FG001|Induction|Adverse Event|0|||
37671190|NCT02027428|69144601|FG002|Induction|Adverse Event|0|||
37671191|NCT02027428|69144599|FG000|Induction|Withdrawal by Subject|22|||
37671192|NCT02027428|69144600|FG001|Induction|Withdrawal by Subject|0|||
37671193|NCT02027428|69144601|FG002|Induction|Withdrawal by Subject|0|||
37671194|NCT02027428|69144599|FG000|Induction|Death|21|||
37671195|NCT02027428|69144600|FG001|Induction|Death|0|||
37671196|NCT02027428|69144601|FG002|Induction|Death|0|||
37671197|NCT02027428|69144599|FG000|Induction|Symptomatic deterioration|16|||
37671198|NCT02027428|69144600|FG001|Induction|Symptomatic deterioration|0|||
37671199|NCT02027428|69144601|FG002|Induction|Symptomatic deterioration|0|||
37671200|NCT02027428|69144599|FG000|Induction|Study terminated by sponsor|12|||
37671201|NCT02027428|69144600|FG001|Induction|Study terminated by sponsor|0|||
37671202|NCT02027428|69144601|FG002|Induction|Study terminated by sponsor|0|||
37671203|NCT02027428|69144599|FG000|Induction|Protocol Violation|1|||
37671204|NCT02027428|69144600|FG001|Induction|Protocol Violation|0|||
37671205|NCT02027428|69144601|FG002|Induction|Protocol Violation|0|||
37671206|NCT02027428|69144599|FG000|Induction|Miscellaneous|14|||
37671207|NCT02027428|69144600|FG001|Induction|Miscellaneous|0|||
37671208|NCT02027428|69144601|FG002|Induction|Miscellaneous|0|||
37671209|NCT02027428|69144599|FG000|Induction|Induction Treatment Ongoing|4|||
37671210|NCT02027428|69144600|FG001|Induction|Induction Treatment Ongoing|0|||
37671211|NCT02027428|69144601|FG002|Induction|Induction Treatment Ongoing|0|||
37671212|NCT02027428|69144599|FG000|Maintenance|Death|0|||
37671213|NCT02027428|69144600|FG001|Maintenance|Death|3|||
37671214|NCT02027428|69144601|FG002|Maintenance|Death|2|||
37671215|NCT02027428|69144599|FG000|Maintenance|Adverse Event|0|||
37671216|NCT02027428|69144600|FG001|Maintenance|Adverse Event|21|||
37671217|NCT02027428|69144601|FG002|Maintenance|Adverse Event|1|||
37671218|NCT02027428|69144599|FG000|Maintenance|Progressive disease|0|||
37671219|NCT02027428|69144600|FG001|Maintenance|Progressive disease|84|||
37671220|NCT02027428|69144601|FG002|Maintenance|Progressive disease|47|||
37671221|NCT02027428|69144599|FG000|Maintenance|Symptomatic deterioration|0|||
37671222|NCT02027428|69144600|FG001|Maintenance|Symptomatic deterioration|4|||
37671223|NCT02027428|69144601|FG002|Maintenance|Symptomatic deterioration|1|||
37671224|NCT02027428|69144599|FG000|Maintenance|Withdrawal by Subject|0|||
37671225|NCT02027428|69144600|FG001|Maintenance|Withdrawal by Subject|6|||
38035991|NCT02978781|69723218|FG002|Part C|Withdrawal by Subject|0|||
37671226|NCT02027428|69144601|FG002|Maintenance|Withdrawal by Subject|5|||
37671227|NCT02027428|69144599|FG000|Maintenance|Protocol Violation|0|||
37671228|NCT02027428|69144600|FG001|Maintenance|Protocol Violation|0|||
37671229|NCT02027428|69144601|FG002|Maintenance|Protocol Violation|1|||
37671230|NCT02027428|69144599|FG000|Maintenance|Other|0|||
37942577|NCT00547378|69629747|FG000|Randomized Cohort|Death|0|||
37671231|NCT02027428|69144600|FG001|Maintenance|Other|6|||
37671232|NCT02027428|69144601|FG002|Maintenance|Other|3|||
37671233|NCT02027428|69144599|FG000|Survival Follow-up|Death|0|||
37671234|NCT02027428|69144600|FG001|Survival Follow-up|Death|78|||
37671235|NCT02027428|69144601|FG002|Survival Follow-up|Death|45|||
37671236|NCT02027428|69144599|FG000|Survival Follow-up|Lost to Follow-up|0|||
37671237|NCT02027428|69144600|FG001|Survival Follow-up|Lost to Follow-up|1|||
37671238|NCT02027428|69144601|FG002|Survival Follow-up|Lost to Follow-up|1|||
37671239|NCT01995136|69144624|FG000|Overall Study|Change in residence|1|||
37671240|NCT01994902|69144628|FG000|Test Period 1|Withdrawal by Subject|3|||
37671241|NCT01994902|69144629|FG001|Test Period 1|Withdrawal by Subject|0|||
37671242|NCT01994902|69144628|FG000|Test Period 1|device deficiency with adverse event|0|||
37671243|NCT01994902|69144629|FG001|Test Period 1|device deficiency with adverse event|1|||
37671244|NCT01994902|69144628|FG000|Test Period 1|Adverse Event|2|||
37671245|NCT01994902|69144629|FG001|Test Period 1|Adverse Event|1|||
37671246|NCT01994902|69144628|FG000|Test Period 1|Lack of Efficacy|0|||
37671247|NCT01994902|69144629|FG001|Test Period 1|Lack of Efficacy|1|||
37671248|NCT01994902|69144628|FG000|Test Period 1|bag too small|1|||
37671249|NCT01994902|69144629|FG001|Test Period 1|bag too small|0|||
37671250|NCT01994902|69144628|FG000|Test Period 2|Withdrawal by Subject|0|||
37671251|NCT01994902|69144629|FG001|Test Period 2|Withdrawal by Subject|2|||
37671252|NCT01994902|69144628|FG000|Test Period 2|Lack of Efficacy|0|||
37671253|NCT01994902|69144629|FG001|Test Period 2|Lack of Efficacy|1|||
37671254|NCT01994902|69144628|FG000|Test Period 2|Other|0|||
37671255|NCT01994902|69144629|FG001|Test Period 2|Other|3|||
37671256|NCT02026258|69144637|FG000|Randomized|Did not start treatment|2|||
37671257|NCT02026258|69144638|FG001|Randomized|Did not start treatment|1|||
37671258|NCT02026258|69144637|FG000|Randomized|Change in treatment plan|1|||
37671259|NCT02026258|69144638|FG001|Randomized|Change in treatment plan|0|||
37671260|NCT02026258|69144637|FG000|Randomized|Presence of periodontal disease|1|||
37671261|NCT02026258|69144638|FG001|Randomized|Presence of periodontal disease|1|||
37671262|NCT02026258|69144637|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
37671263|NCT02026258|69144638|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
37671264|NCT02026258|69144637|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
37671265|NCT02026258|69144638|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
37671266|NCT01994590|69144645|FG000|Overall Study|Adverse Event|1|||
37671267|NCT01994590|69144645|FG000|Overall Study|Trial Terminated|1|||
37671268|NCT02019550|69144651|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
37671269|NCT02019550|69144652|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
37671270|NCT02019472|69144663|FG000|Overall Study|Adverse Event|14|||
37671271|NCT02019472|69144664|FG001|Overall Study|Adverse Event|23|||
37671272|NCT02019472|69144665|FG002|Overall Study|Adverse Event|17|||
37671273|NCT02019472|69144663|FG000|Overall Study|Death|0|||
37671274|NCT02019472|69144664|FG001|Overall Study|Death|1|||
37671275|NCT02019472|69144665|FG002|Overall Study|Death|1|||
37671276|NCT02019472|69144663|FG000|Overall Study|Lack of Efficacy|7|||
37671277|NCT02019472|69144664|FG001|Overall Study|Lack of Efficacy|4|||
37671278|NCT02019472|69144665|FG002|Overall Study|Lack of Efficacy|4|||
37671279|NCT02019472|69144663|FG000|Overall Study|Lost to Follow-up|0|||
37671280|NCT02019472|69144664|FG001|Overall Study|Lost to Follow-up|2|||
37671281|NCT02019472|69144665|FG002|Overall Study|Lost to Follow-up|1|||
37671282|NCT02019472|69144663|FG000|Overall Study|Physician Decision|1|||
37671283|NCT02019472|69144664|FG001|Overall Study|Physician Decision|2|||
37671284|NCT02019472|69144665|FG002|Overall Study|Physician Decision|0|||
37671285|NCT02019472|69144663|FG000|Overall Study|Pregnancy|1|||
37671286|NCT02019472|69144664|FG001|Overall Study|Pregnancy|2|||
37671287|NCT02019472|69144665|FG002|Overall Study|Pregnancy|2|||
37671288|NCT02019472|69144663|FG000|Overall Study|Withdrawal by Subject|11|||
37671289|NCT02019472|69144664|FG001|Overall Study|Withdrawal by Subject|10|||
37671290|NCT02019472|69144665|FG002|Overall Study|Withdrawal by Subject|11|||
37671291|NCT02019472|69144663|FG000|Overall Study|Other|3|||
37671292|NCT02019472|69144664|FG001|Overall Study|Other|8|||
37671293|NCT02019472|69144665|FG002|Overall Study|Other|6|||
37671294|NCT02705755|69144677|FG000|Part A (6 Days)|Adverse Event|1|||
37671295|NCT02705755|69144678|FG001|Part A (6 Days)|Adverse Event|0|||
37671296|NCT02705755|69144679|FG002|Part A (6 Days)|Adverse Event|0|||
37671297|NCT02705755|69144680|FG003|Part A (6 Days)|Adverse Event|0|||
37671298|NCT02705755|69144677|FG000|Part A (6 Days)|Physician Decision|3|||
37671299|NCT02705755|69144678|FG001|Part A (6 Days)|Physician Decision|0|||
37671300|NCT02705755|69144679|FG002|Part A (6 Days)|Physician Decision|0|||
37671301|NCT02705755|69144680|FG003|Part A (6 Days)|Physician Decision|0|||
37671302|NCT02705755|69144677|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
37671303|NCT02705755|69144678|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
37671304|NCT02705755|69144679|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
37671305|NCT02705755|69144680|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
37671306|NCT02705755|69144677|FG000|Part C (20 Weeks)|Physician Decision|0|||
37671307|NCT02705755|69144678|FG001|Part C (20 Weeks)|Physician Decision|0|||
37671308|NCT02705755|69144679|FG002|Part C (20 Weeks)|Physician Decision|0|||
37671309|NCT02705755|69144680|FG003|Part C (20 Weeks)|Physician Decision|2|||
37671310|NCT02705755|69144677|FG000|Part C (20 Weeks)|Adverse Event|0|||
37671311|NCT02705755|69144678|FG001|Part C (20 Weeks)|Adverse Event|0|||
37671312|NCT02705755|69144679|FG002|Part C (20 Weeks)|Adverse Event|0|||
37671313|NCT02705755|69144680|FG003|Part C (20 Weeks)|Adverse Event|6|||
37671314|NCT02705755|69144677|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
37671315|NCT02705755|69144678|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
37671316|NCT02705755|69144679|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
37671317|NCT02705755|69144680|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
37671318|NCT02024932|69144713|FG000|Overall Study|Adverse Event|2|||
37671319|NCT02024932|69144714|FG001|Overall Study|Adverse Event|3|||
37671320|NCT02024932|69144715|FG002|Overall Study|Adverse Event|0|||
37671321|NCT02024932|69144716|FG003|Overall Study|Adverse Event|0|||
37671322|NCT02024932|69144717|FG004|Overall Study|Adverse Event|2|||
37671323|NCT02024932|69144718|FG005|Overall Study|Adverse Event|0|||
37671324|NCT02024932|69144713|FG000|Overall Study|Abnormal laboratory value|0|||
37671325|NCT02024932|69144714|FG001|Overall Study|Abnormal laboratory value|0|||
37671326|NCT02024932|69144715|FG002|Overall Study|Abnormal laboratory value|0|||
37671327|NCT02024932|69144716|FG003|Overall Study|Abnormal laboratory value|2|||
37671328|NCT02024932|69144717|FG004|Overall Study|Abnormal laboratory value|0|||
37671329|NCT02024932|69144718|FG005|Overall Study|Abnormal laboratory value|0|||
37671330|NCT01993888|69144749|FG000|Overall Study|Death|1|||
37671331|NCT01993888|69144750|FG001|Overall Study|Death|1|||
37671332|NCT01993888|69144749|FG000|Overall Study|Lost to Follow-up|1|||
37671333|NCT01993888|69144750|FG001|Overall Study|Lost to Follow-up|1|||
37671334|NCT01993888|69144749|FG000|Overall Study|Withdrawal by Subject|0|||
37671335|NCT01993888|69144750|FG001|Overall Study|Withdrawal by Subject|1|||
37671336|NCT02024698|69144756|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
37671337|NCT02024698|69144757|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
37671338|NCT02018458|69144763|FG000|Overall Study|Death|4|||
37671339|NCT02017522|69144767|FG000|Overall Study|Withdrawal by Subject|1|||
37671340|NCT02017444|69144774|FG000|Overall Study|Physician Decision|1|||
37671341|NCT02017444|69144775|FG001|Overall Study|Physician Decision|0|||
37671342|NCT02017444|69144774|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
37671343|NCT02017444|69144775|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
37671344|NCT01993186|69144783|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
37671345|NCT01993186|69144784|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
37671346|NCT01993186|69144783|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
37671347|NCT01993186|69144784|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
37671348|NCT01993186|69144783|FG000|Open-Label Extension Period|Other, Not Specified|0|||
37671349|NCT01993186|69144784|FG001|Open-Label Extension Period|Other, Not Specified|1|||
37671350|NCT01993186|69144783|FG000|Open-Label Extension Period|Adverse Event|1|||
37671351|NCT01993186|69144784|FG001|Open-Label Extension Period|Adverse Event|0|||
37765339|NCT01439009|69278718|FG001|Overall Study|Deviation of exclusion criteria|0|||
37765340|NCT01572389|69278737|FG000|Overall Study|Death|1|||
37765341|NCT01572389|69278738|FG001|Overall Study|Death|3|||
37765342|NCT01572389|69278737|FG000|Overall Study|Withdrawal by Subject|14|||
37765343|NCT01572389|69278738|FG001|Overall Study|Withdrawal by Subject|2|||
37765344|NCT01572389|69278737|FG000|Overall Study|Lost to Follow-up|25|||
37765345|NCT01572389|69278738|FG001|Overall Study|Lost to Follow-up|14|||
37765346|NCT01572389|69278737|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
37765347|NCT01572389|69278738|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
37765348|NCT01571453|69278750|FG000|Overall Study|Adverse Event|14|||
37765349|NCT01571453|69278751|FG001|Overall Study|Adverse Event|32|||
37765350|NCT01571453|69278750|FG000|Overall Study|Lack of Efficacy|8|||
37765351|NCT01571453|69278751|FG001|Overall Study|Lack of Efficacy|3|||
37765352|NCT01571453|69278750|FG000|Overall Study|Non-compliance|2|||
37765353|NCT01571453|69278751|FG001|Overall Study|Non-compliance|4|||
37765354|NCT01571453|69278750|FG000|Overall Study|Protocol Violation|1|||
37765355|NCT01571453|69278751|FG001|Overall Study|Protocol Violation|5|||
37765356|NCT01571453|69278750|FG000|Overall Study|Withdrawal of consent|5|||
37765357|NCT01571453|69278751|FG001|Overall Study|Withdrawal of consent|13|||
37765358|NCT01571453|69278750|FG000|Overall Study|Lost to Follow-up|4|||
37765359|NCT01571453|69278751|FG001|Overall Study|Lost to Follow-up|2|||
37765360|NCT01571453|69278750|FG000|Overall Study|Administrative or other reason(s)|4|||
37765361|NCT01571453|69278751|FG001|Overall Study|Administrative or other reason(s)|3|||
37765362|NCT01446289|69278761|FG000|Overall Study|Withdrawal by Subject|1|||
37765363|NCT01446289|69278762|FG001|Overall Study|Withdrawal by Subject|0|||
37671352|NCT01993186|69144783|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
37671353|NCT01993186|69144784|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
37671354|NCT01993186|69144783|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
37671355|NCT01993186|69144784|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
37671356|NCT01993186|69144783|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
37671357|NCT01993186|69144784|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
37671358|NCT02016898|69144793|FG000|Overall Study|Death|1|||
37671359|NCT02016898|69144794|FG001|Overall Study|Death|1|||
37671360|NCT02016898|69144793|FG000|Overall Study|Lost to Follow-up|4|||
37765364|NCT01446289|69278763|FG002|Overall Study|Withdrawal by Subject|1|||
37765365|NCT01446289|69278764|FG003|Overall Study|Withdrawal by Subject|0|||
37765366|NCT01438541|69278776|FG000|Overall Study|Physician Decision|1|||
37765367|NCT01438541|69278776|FG000|Overall Study|Withdrawal by Subject|1|||
37765368|NCT01438541|69278776|FG000|Overall Study|discharge from the hospital|5|||
37765369|NCT01419769|69278780|FG000|Overall Study|Did not receive the AXIOS stent|3|||
37671361|NCT02016898|69144794|FG001|Overall Study|Lost to Follow-up|4|||
37671362|NCT01993030|69144802|FG000|Overall Study|Adverse Event|0|||
37671363|NCT01993030|69144803|FG001|Overall Study|Adverse Event|4|||
37671364|NCT01992094|69144812|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
37671365|NCT01992094|69144813|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
37671366|NCT01992094|69144814|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
37671367|NCT01992094|69144812|FG000|Overall Study|Adverse Event|1|||
37671368|NCT01992094|69144813|FG001|Overall Study|Adverse Event|0|||
37671369|NCT01992094|69144814|FG002|Overall Study|Adverse Event|0|||
37671370|NCT01992094|69144812|FG000|Overall Study|Death|5|||
37671371|NCT01992094|69144813|FG001|Overall Study|Death|5|||
37671372|NCT01992094|69144814|FG002|Overall Study|Death|2|||
37671373|NCT01992094|69144812|FG000|Overall Study|Lost to Follow-up|26|||
37671374|NCT01992094|69144813|FG001|Overall Study|Lost to Follow-up|9|||
37671375|NCT01992094|69144814|FG002|Overall Study|Lost to Follow-up|13|||
37671376|NCT01992094|69144812|FG000|Overall Study|OTHER|4|||
37671377|NCT01992094|69144813|FG001|Overall Study|OTHER|0|||
37671378|NCT01992094|69144814|FG002|Overall Study|OTHER|0|||
37765370|NCT01419769|69278780|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
37765371|NCT01438307|69278786|FG000|Overall Study|Death|1|||
37765372|NCT01438307|69278787|FG001|Overall Study|Death|1|||
37765373|NCT01444651|69278795|FG000|Overall Study|Adverse Event|3|||
37765374|NCT01444651|69278796|FG001|Overall Study|Adverse Event|2|||
37765375|NCT01444651|69278795|FG000|Overall Study|Lost to Follow-up|5|||
37765376|NCT01444651|69278796|FG001|Overall Study|Lost to Follow-up|5|||
37765377|NCT01444651|69278795|FG000|Overall Study|Non-fasting|2|||
37765378|NCT01444651|69278796|FG001|Overall Study|Non-fasting|1|||
37765379|NCT01444651|69278795|FG000|Overall Study|Missing data|1|||
37765380|NCT01444651|69278796|FG001|Overall Study|Missing data|1|||
37765381|NCT01570751|69278804|FG000|Period A (16 Weeks)|Protocol Violation|1|||
37765382|NCT01570751|69278805|FG001|Period A (16 Weeks)|Protocol Violation|1|||
37765383|NCT01570751|69278804|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
37765384|NCT01570751|69278805|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
37765385|NCT01570751|69278804|FG000|Period A (16 Weeks)|Unclassified|2|||
37765386|NCT01570751|69278805|FG001|Period A (16 Weeks)|Unclassified|3|||
37765387|NCT01570751|69278804|FG000|Period B (16 Weeks)|Adverse Event|1|||
37765388|NCT01570751|69278805|FG001|Period B (16 Weeks)|Adverse Event|0|||
37765389|NCT01570751|69278804|FG000|Period B (16 Weeks)|Protocol Violation|0|||
37765390|NCT01570751|69278805|FG001|Period B (16 Weeks)|Protocol Violation|1|||
37765391|NCT01419535|69278815|FG000|Overall Study|could not maintain iv line|1|||
37765392|NCT01419535|69278816|FG001|Overall Study|could not maintain iv line|1|||
37765393|NCT01419535|69278815|FG000|Overall Study|Withdrawal by Subject|0|||
37765394|NCT01419535|69278816|FG001|Overall Study|Withdrawal by Subject|1|||
37765395|NCT01438151|69278822|FG000|Overall Study|study terminated|8|||
37765396|NCT01418365|69278848|FG000|First Intervention|Withdrawal by Subject|0|||
37765397|NCT01418365|69278849|FG001|First Intervention|Withdrawal by Subject|1|||
37765398|NCT01418365|69278848|FG000|First Intervention|Non-compliance|1|||
37765399|NCT01418365|69278849|FG001|First Intervention|Non-compliance|0|||
37765400|NCT01418365|69278848|FG000|Second Intervention|Withdrawal by Subject|0|||
37765401|NCT01418365|69278849|FG001|Second Intervention|Withdrawal by Subject|1|||
37765402|NCT01437995|69278884|FG000|Overall Study|Lost to Follow-up|11|||
37765403|NCT01437995|69278885|FG001|Overall Study|Lost to Follow-up|18|||
37765404|NCT01437995|69278886|FG002|Overall Study|Lost to Follow-up|20|||
37765405|NCT01439347|69278935|FG000|Overall Study|Death|10|||
37765406|NCT01439347|69278936|FG001|Overall Study|Death|9|||
37765407|NCT01439347|69278935|FG000|Overall Study|Withdrawal by Subject|0|||
37765408|NCT01439347|69278936|FG001|Overall Study|Withdrawal by Subject|1|||
37765409|NCT01439347|69278935|FG000|Overall Study|Physician Decision|1|||
37765410|NCT01439347|69278936|FG001|Overall Study|Physician Decision|0|||
37765411|NCT01439347|69278935|FG000|Overall Study|Sponsor Terminated Study|2|||
37765412|NCT01439347|69278936|FG001|Overall Study|Sponsor Terminated Study|3|||
37765413|NCT01438957|69278983|FG000|Overall Study|Physician Decision|1|||
37942578|NCT00547378|69629748|FG001|Randomized Cohort|Death|1|||
37942579|NCT00547378|69629749|FG002|Randomized Cohort|Death|0|||
37942580|NCT00547378|69629747|FG000|Randomized Cohort|Lost to Follow-up|1|||
37671379|NCT01992094|69144812|FG000|Overall Study|Protocol Violation|1|||
37671380|NCT01992094|69144813|FG001|Overall Study|Protocol Violation|0|||
37671381|NCT01992094|69144814|FG002|Overall Study|Protocol Violation|1|||
37671382|NCT01992094|69144812|FG000|Overall Study|Withdrawal by Subject|7|||
37765414|NCT01438957|69278984|FG001|Overall Study|Physician Decision|1|||
37765415|NCT01438957|69278985|FG002|Overall Study|Physician Decision|0|||
37765416|NCT01438957|69278986|FG003|Overall Study|Physician Decision|1|||
37765417|NCT01438957|69278987|FG004|Overall Study|Physician Decision|0|||
37671383|NCT01992094|69144813|FG001|Overall Study|Withdrawal by Subject|3|||
37765418|NCT01444417|69279036|FG000|Overall Study|Ineligibility Determined|0|||
37765419|NCT01444417|69279037|FG001|Overall Study|Ineligibility Determined|1|||
37765420|NCT01444417|69279036|FG000|Overall Study|Withdrawal by Subject|2|||
37765421|NCT01444417|69279037|FG001|Overall Study|Withdrawal by Subject|0|||
37765422|NCT01444027|69279064|FG000|Overall Study|Withdrawal by Subject|4|||
37765423|NCT01444027|69279065|FG001|Overall Study|Withdrawal by Subject|10|||
37671384|NCT01992094|69144814|FG002|Overall Study|Withdrawal by Subject|4|||
37671385|NCT02706691|69144838|FG000|Overall Study|Adverse Event|1|||
37671386|NCT01991470|69144843|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
37671387|NCT01991470|69144843|FG000|Enlite 1 Period|Adverse Event|1|||
37671388|NCT01991470|69144843|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
37671389|NCT01991470|69144843|FG000|Enlite 3 Period|Lost to Follow-up|1|||
37671390|NCT01991470|69144843|FG000|Enlite 3 Period|Physician Decision|2|||
37671391|NCT01991470|69144843|FG000|Enlite 3 Period|Physician Decision|8|||
37671392|NCT01991470|69144843|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
37671393|NCT01991314|69144857|FG000|Overall Study|Adverse Event|5|||
37671394|NCT01991314|69144858|FG001|Overall Study|Adverse Event|1|||
37671395|NCT01991314|69144857|FG000|Overall Study|Lost to Follow-up|6|||
37671396|NCT01991314|69144858|FG001|Overall Study|Lost to Follow-up|10|||
37671397|NCT01990768|69144867|FG000|Intervention Started|Found to be ineligible|14|||
37671398|NCT01990768|69144868|FG001|Intervention Started|Found to be ineligible|13|||
37671399|NCT01990768|69144869|FG002|Intervention Started|Found to be ineligible|11|||
37671400|NCT01990768|69144867|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
37671401|NCT01990768|69144868|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
37671402|NCT01990768|69144869|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
37671403|NCT01990768|69144867|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
37671404|NCT01990768|69144868|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
37671405|NCT01990768|69144869|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
37671406|NCT01990768|69144867|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
37671407|NCT01990768|69144868|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
37671408|NCT01990768|69144869|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
37671409|NCT01990768|69144867|FG000|Intervention Started|Patient care priority|1|||
37671410|NCT01990768|69144868|FG001|Intervention Started|Patient care priority|2|||
37671411|NCT01990768|69144869|FG002|Intervention Started|Patient care priority|3|||
37671412|NCT01990768|69144867|FG000|Intervention Started|IV lost|2|||
37671413|NCT01990768|69144868|FG001|Intervention Started|IV lost|2|||
37671414|NCT01990768|69144869|FG002|Intervention Started|IV lost|2|||
37671415|NCT01990768|69144867|FG000|Intervention Started|Required CPR|1|||
37671416|NCT01990768|69144868|FG001|Intervention Started|Required CPR|1|||
37671417|NCT01990768|69144869|FG002|Intervention Started|Required CPR|0|||
37671418|NCT01990768|69144867|FG000|Intervention Started|Seizure or hx of seizure|0|||
37671419|NCT01990768|69144868|FG001|Intervention Started|Seizure or hx of seizure|0|||
37671420|NCT01990768|69144869|FG002|Intervention Started|Seizure or hx of seizure|2|||
37671421|NCT01990768|69144867|FG000|Intervention Started|Discovered to be pregnant|0|||
37671422|NCT01990768|69144868|FG001|Intervention Started|Discovered to be pregnant|1|||
37671423|NCT01990768|69144869|FG002|Intervention Started|Discovered to be pregnant|0|||
37671424|NCT01990768|69144867|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
37671425|NCT01990768|69144868|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
37671426|NCT01990768|69144869|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
37671427|NCT01990768|69144867|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
37671428|NCT01990768|69144868|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
37671429|NCT01990768|69144869|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
37671430|NCT01990768|69144867|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
37671431|NCT01990768|69144868|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
37671432|NCT01990768|69144869|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
37671433|NCT01990768|69144867|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
37671434|NCT01990768|69144868|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
37671435|NCT01990768|69144869|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
37671436|NCT01990768|69144867|FG000|Prehospital Study Drug Infusion|Death|3|||
37671437|NCT01990768|69144868|FG001|Prehospital Study Drug Infusion|Death|1|||
37671438|NCT01990768|69144869|FG002|Prehospital Study Drug Infusion|Death|1|||
37671439|NCT01990768|69144867|FG000|Prehospital Study Drug Infusion|Discharged|2|||
37671440|NCT01990768|69144868|FG001|Prehospital Study Drug Infusion|Discharged|1|||
37671441|NCT01990768|69144869|FG002|Prehospital Study Drug Infusion|Discharged|0|||
37671442|NCT01990768|69144867|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
37671443|NCT01990768|69144868|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
37671444|NCT01990768|69144869|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
37671445|NCT01990768|69144867|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
37671446|NCT01990768|69144868|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
37671447|NCT01990768|69144869|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
37671448|NCT01990768|69144867|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
37671449|NCT01990768|69144868|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
37671450|NCT01990768|69144869|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
37671451|NCT01990768|69144867|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
37671452|NCT01990768|69144868|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
37671453|NCT01990768|69144869|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
37671454|NCT01990768|69144867|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
37671455|NCT01990768|69144868|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
37671456|NCT01990768|69144869|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
37671457|NCT01990768|69144867|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
37671458|NCT01990768|69144868|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
37671459|NCT01990768|69144869|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
37671460|NCT01990768|69144867|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
37671461|NCT01990768|69144868|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
37671462|NCT01990768|69144869|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
37671463|NCT01990768|69144867|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
37671464|NCT01990768|69144868|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
37671465|NCT01990768|69144869|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
37671466|NCT01990768|69144867|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
37671467|NCT01990768|69144868|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
37671468|NCT01990768|69144869|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
37671469|NCT01990768|69144867|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
37671470|NCT01990768|69144868|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
37671471|NCT01990768|69144869|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
37671472|NCT01990768|69144867|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
37671473|NCT01990768|69144868|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
37671474|NCT01990768|69144869|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
37671475|NCT01990768|69144867|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
37671476|NCT01990768|69144868|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
37671477|NCT01990768|69144869|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
37671478|NCT01990768|69144867|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
37671479|NCT01990768|69144868|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
37671480|NCT01990768|69144869|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
37671481|NCT01990768|69144867|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
37671482|NCT01990768|69144868|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
37671483|NCT01990768|69144869|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
37671484|NCT01990768|69144867|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
37671485|NCT01990768|69144868|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
37671486|NCT01990768|69144869|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
37671487|NCT01990768|69144867|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
37671488|NCT01990768|69144868|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
37671489|NCT01990768|69144869|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
37671490|NCT01990768|69144867|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
37671491|NCT01990768|69144868|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
37671492|NCT01990768|69144869|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
37671493|NCT01990768|69144867|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
37671494|NCT01990768|69144868|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
37671495|NCT01990768|69144869|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
37671496|NCT01990768|69144867|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
37671497|NCT01990768|69144868|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
37671498|NCT01990768|69144869|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
37671499|NCT01990768|69144867|FG000|6-Month Follow-up|No contact information|5|||
37671500|NCT01990768|69144868|FG001|6-Month Follow-up|No contact information|6|||
37671501|NCT01990768|69144869|FG002|6-Month Follow-up|No contact information|5|||
37671502|NCT01990768|69144867|FG000|6-Month Follow-up|Homeless|4|||
37671503|NCT01990768|69144868|FG001|6-Month Follow-up|Homeless|3|||
37671504|NCT01990768|69144869|FG002|6-Month Follow-up|Homeless|6|||
37671505|NCT01990768|69144867|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
37671506|NCT01990768|69144868|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
37671507|NCT01990768|69144869|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
37671508|NCT01990768|69144867|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
37671509|NCT01990768|69144868|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
37671510|NCT01990768|69144869|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
37671511|NCT01990768|69144867|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
37671512|NCT01990768|69144868|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
37671513|NCT01990768|69144869|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
37671514|NCT01990612|69144880|FG000|Overall Study|Lost to Follow-up|2|||
37671515|NCT01990612|69144881|FG001|Overall Study|Lost to Follow-up|1|||
37671516|NCT01990612|69144880|FG000|Overall Study|Withdrawal by Subject|5|||
37942581|NCT00547378|69629748|FG001|Randomized Cohort|Lost to Follow-up|0|||
37942582|NCT00547378|69629749|FG002|Randomized Cohort|Lost to Follow-up|0|||
37671517|NCT01990612|69144881|FG001|Overall Study|Withdrawal by Subject|2|||
37671518|NCT01990534|69144887|FG000|Overall Study|Death|22|||
37671519|NCT01990534|69144887|FG000|Overall Study|Progressive disease|3|||
37671520|NCT01990534|69144887|FG000|Overall Study|Protocol Violation|1|||
37671521|NCT01990534|69144887|FG000|Overall Study|Withdrawal of Informed Consent|2|||
37671522|NCT01990534|69144887|FG000|Overall Study|Symptomatic Deterioration|1|||
37671523|NCT01990534|69144887|FG000|Overall Study|Withdrawal by Subject|3|||
37671524|NCT01990534|69144887|FG000|Overall Study|Reason not Specified|2|||
37671525|NCT01990534|69144887|FG000|Overall Study|Lost to Follow-up|1|||
37671526|NCT01967134|69144894|FG000|Overall Study|Lost to Follow-up|0|||
37671527|NCT01967134|69144895|FG001|Overall Study|Lost to Follow-up|1|||
37671528|NCT01967134|69144896|FG002|Overall Study|Lost to Follow-up|0|||
37671529|NCT01966432|69144907|FG000|Overall Study|Lost to Follow-up|3|||
37671530|NCT01966432|69144908|FG001|Overall Study|Lost to Follow-up|2|||
37671531|NCT01966432|69144909|FG002|Overall Study|Lost to Follow-up|5|||
37671532|NCT01966432|69144907|FG000|Overall Study|Withdrawal by Subject|1|||
37671533|NCT01966432|69144908|FG001|Overall Study|Withdrawal by Subject|3|||
37671534|NCT01966432|69144909|FG002|Overall Study|Withdrawal by Subject|0|||
37671535|NCT01966432|69144907|FG000|Overall Study|Subject Incarcerated|0|||
37671536|NCT01966432|69144908|FG001|Overall Study|Subject Incarcerated|0|||
37671537|NCT01966432|69144909|FG002|Overall Study|Subject Incarcerated|1|||
37671538|NCT01966432|69144907|FG000|Overall Study|SBIRT program ended|1|||
37671539|NCT01966432|69144908|FG001|Overall Study|SBIRT program ended|8|||
37671540|NCT01966432|69144909|FG002|Overall Study|SBIRT program ended|20|||
37671541|NCT02702401|69144921|FG000|Overall Study|Death|242|||
37671542|NCT02702401|69144922|FG001|Overall Study|Death|125|||
37671543|NCT02702401|69144921|FG000|Overall Study|Withdrawal by Subject|15|||
37671544|NCT02702401|69144922|FG001|Overall Study|Withdrawal by Subject|5|||
37671545|NCT02702401|69144921|FG000|Overall Study|Sponsor Decision|19|||
37671546|NCT02702401|69144922|FG001|Overall Study|Sponsor Decision|3|||
37671547|NCT02702401|69144921|FG000|Overall Study|Physician Decision|1|||
37671548|NCT02702401|69144922|FG001|Overall Study|Physician Decision|2|||
37671549|NCT02702401|69144921|FG000|Overall Study|Lost to Follow-up|1|||
37671550|NCT02702401|69144922|FG001|Overall Study|Lost to Follow-up|0|||
37671551|NCT02703337|69144929|FG000|Period One (Part A)|Withdrawal by Subject|0|||
37765424|NCT01444027|69279066|FG002|Overall Study|Withdrawal by Subject|24|||
37942583|NCT00547378|69629747|FG000|Randomized Cohort|Adverse Event|1|||
37942584|NCT00547378|69629748|FG001|Randomized Cohort|Adverse Event|0|||
37942585|NCT00547378|69629749|FG002|Randomized Cohort|Adverse Event|0|||
37942586|NCT00547378|69629747|FG000|Randomized Cohort|Other reasons|2|||
37942587|NCT00547378|69629748|FG001|Randomized Cohort|Other reasons|0|||
37942588|NCT00547378|69629749|FG002|Randomized Cohort|Other reasons|0|||
37942589|NCT00547378|69629747|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
37942590|NCT00547378|69629748|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
37942591|NCT00547378|69629749|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
37942592|NCT00547378|69629747|FG000|All Implanted Cohort|Adverse Event|4|||
37671552|NCT02703337|69144930|FG001|Period One (Part A)|Withdrawal by Subject|0|||
37671553|NCT02703337|69144931|FG002|Period One (Part A)|Withdrawal by Subject|0|||
37671554|NCT02703337|69144932|FG003|Period One (Part A)|Withdrawal by Subject|0|||
37671555|NCT02703337|69144933|FG004|Period One (Part A)|Withdrawal by Subject|1|||
37671556|NCT02703337|69144934|FG005|Period One (Part A)|Withdrawal by Subject|0|||
37671557|NCT02703337|69144935|FG006|Period One (Part A)|Withdrawal by Subject|0|||
37671558|NCT02703337|69144936|FG007|Period One (Part A)|Withdrawal by Subject|0|||
37671559|NCT01680497|69144954|FG000|Overall Study|Lost to Follow-up|2|||
37671560|NCT01680341|69144960|FG000|Overall Study|Adverse Event|3|||
37671561|NCT01680341|69144961|FG001|Overall Study|Adverse Event|2|||
37671562|NCT01680341|69144960|FG000|Overall Study|Unclassified|18|||
37671563|NCT01680341|69144961|FG001|Overall Study|Unclassified|15|||
37671564|NCT01679405|69144969|FG000|Overall Study|Death|2|||
37671565|NCT01679405|69144970|FG001|Overall Study|Death|5|||
37671566|NCT01603355|69144976|FG000|Overall Study|Lack of Efficacy|2|||
37671567|NCT02703259|69144982|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
37671568|NCT02703259|69144983|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
37671569|NCT02703259|69144982|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
37671570|NCT02703259|69144983|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
37671571|NCT02703259|69144982|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
37671572|NCT02703259|69144983|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
37671573|NCT00701701|69144991|FG000|Overall Study|Withdrawal by Subject|0|||
37671574|NCT00701701|69144992|FG001|Overall Study|Withdrawal by Subject|1|||
37671575|NCT00701701|69144991|FG000|Overall Study|Adverse Event|0|||
37671576|NCT00701701|69144992|FG001|Overall Study|Adverse Event|1|||
37671577|NCT01989754|69145001|FG000|Overall Study|Withdrawal by Subject|10|||
37671578|NCT01989754|69145002|FG001|Overall Study|Withdrawal by Subject|14|||
37671579|NCT01989754|69145001|FG000|Overall Study|Lost to Follow-up|28|||
37671580|NCT01989754|69145002|FG001|Overall Study|Lost to Follow-up|20|||
37942593|NCT00547378|69629748|FG001|All Implanted Cohort|Adverse Event|10|||
37671581|NCT01989754|69145001|FG000|Overall Study|Closed Site|1|||
37671582|NCT01989754|69145002|FG001|Overall Study|Closed Site|1|||
37671583|NCT01619878|69145008|FG000|6 Week Follow-up Phase|Adverse Event|1|||
37671584|NCT01619878|69145008|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
37671585|NCT01619878|69145008|FG000|Follow-up at 12 Months of Age|Death|2|||
37671586|NCT02015104|69145014|FG000|Overall Study|Withdrew consent after first dose drug|1|||
37671587|NCT02015104|69145015|FG001|Overall Study|Withdrew consent after first dose drug|0|||
37671588|NCT02015104|69145014|FG000|Overall Study|Withdrew consent prior to treatment|0|||
37671589|NCT02015104|69145015|FG001|Overall Study|Withdrew consent prior to treatment|1|||
37671590|NCT01619800|69145026|FG000|Overall Study|study terminated|2|||
37671591|NCT01619800|69145027|FG001|Overall Study|study terminated|0|||
37671592|NCT01989208|69145035|FG000|200 mg (7 Days)|Protocol Violation|0|||
37671593|NCT01989208|69145036|FG001|200 mg (7 Days)|Protocol Violation|1|||
37671594|NCT01619410|69145056|FG000|Overall Study|Lost to Follow-up|7|||
37671595|NCT01619410|69145057|FG001|Overall Study|Lost to Follow-up|4|||
37671596|NCT01966042|69145063|FG000|Overall Study|Death|2|||
37671597|NCT02014480|69145067|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
37671598|NCT02014480|69145068|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
37671599|NCT02014480|69145069|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
37671600|NCT02014480|69145070|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
37671601|NCT02014480|69145071|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
37671602|NCT02014480|69145072|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
37671603|NCT02014480|69145067|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
37671604|NCT02014480|69145068|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
37671605|NCT02014480|69145069|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
37671606|NCT02014480|69145070|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
37671607|NCT02014480|69145071|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
37671608|NCT02014480|69145072|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
37671609|NCT02014480|69145067|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
37671610|NCT02014480|69145068|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
37671611|NCT02014480|69145069|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
37671612|NCT02014480|69145070|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
37671613|NCT02014480|69145071|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
37671614|NCT02014480|69145072|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
37671615|NCT02014480|69145067|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
37671616|NCT02014480|69145068|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
37671617|NCT02014480|69145069|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
37671618|NCT02014480|69145070|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
37671619|NCT02014480|69145071|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
37671620|NCT02014480|69145072|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
37671621|NCT02014480|69145067|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
37671622|NCT02014480|69145068|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
37671623|NCT02014480|69145069|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
37671624|NCT02014480|69145070|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
37671625|NCT02014480|69145071|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
37671626|NCT02014480|69145072|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
37671627|NCT02014480|69145067|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
37671628|NCT02014480|69145068|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
37671629|NCT02014480|69145069|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
37671630|NCT02014480|69145070|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
37671631|NCT02014480|69145071|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
37671632|NCT02014480|69145072|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
37671633|NCT02014480|69145067|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
37671634|NCT02014480|69145068|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
37671635|NCT02014480|69145069|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
37671636|NCT02014480|69145070|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
37671637|NCT02014480|69145071|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
37671638|NCT02014480|69145072|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
37671639|NCT01261247|69145080|FG000|Overall Study|Ineligible|2|||
37671640|NCT01677767|69145084|FG000|Overall Study|Adverse Event|1|||
37671641|NCT01677767|69145084|FG000|Overall Study|Death|4|||
37671642|NCT01677767|69145084|FG000|Overall Study|Protocol Violation|4|||
37671643|NCT01677767|69145084|FG000|Overall Study|Withdrawal by Subject|10|||
37671644|NCT01677767|69145084|FG000|Overall Study|Non-compliance by the participants|3|||
37671645|NCT01603277|69145105|FG000|Overall Study|Adverse Event|1|||
37671646|NCT01603277|69145106|FG001|Overall Study|Adverse Event|2|||
37765425|NCT01444027|69279064|FG000|Overall Study|Lost to Follow-up|26|||
37765426|NCT01444027|69279065|FG001|Overall Study|Lost to Follow-up|20|||
37765427|NCT01444027|69279066|FG002|Overall Study|Lost to Follow-up|14|||
37671647|NCT01603277|69145105|FG000|Overall Study|Physician Decision|0|||
37671648|NCT01603277|69145106|FG001|Overall Study|Physician Decision|1|||
37671649|NCT01603277|69145105|FG000|Overall Study|Protocol Violation|6|||
37671650|NCT01603277|69145106|FG001|Overall Study|Protocol Violation|10|||
37671651|NCT01603277|69145105|FG000|Overall Study|Withdrawal by Subject|5|||
37765428|NCT01438489|69279108|FG000|Overall Study|Lost to Follow-up|4|||
37765429|NCT01438489|69279109|FG001|Overall Study|Lost to Follow-up|2|||
37671652|NCT01603277|69145106|FG001|Overall Study|Withdrawal by Subject|4|||
37671653|NCT01603277|69145105|FG000|Overall Study|Non-Compliance|2|||
37671654|NCT01603277|69145106|FG001|Overall Study|Non-Compliance|1|||
37671655|NCT01678313|69145114|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
37671656|NCT01678313|69145115|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
37671657|NCT01678313|69145114|FG000|Completed the 3-month Therapy|Physician Decision|3|||
37671658|NCT01678313|69145115|FG001|Completed the 3-month Therapy|Physician Decision|4|||
37671659|NCT01678313|69145114|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
37671660|NCT01678313|69145115|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
37671661|NCT01678313|69145114|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
37671662|NCT01678313|69145115|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
37671663|NCT01603121|69145121|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
37671664|NCT01603121|69145122|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
37671665|NCT01603043|69145130|FG000|Overall Study|Study Futility|7|||
37671666|NCT01603043|69145131|FG001|Overall Study|Study Futility|3|||
37671667|NCT02014402|69145141|FG000|Overall Study|Adverse Event|1|||
37671668|NCT02014402|69145142|FG001|Overall Study|Adverse Event|0|||
37671669|NCT02014402|69145143|FG002|Overall Study|Adverse Event|0|||
37671670|NCT02014402|69145144|FG003|Overall Study|Adverse Event|0|||
37671671|NCT02014402|69145141|FG000|Overall Study|Withdrawal by Subject|1|||
37671672|NCT02014402|69145142|FG001|Overall Study|Withdrawal by Subject|2|||
37671673|NCT02014402|69145143|FG002|Overall Study|Withdrawal by Subject|2|||
37671674|NCT02014402|69145144|FG003|Overall Study|Withdrawal by Subject|1|||
37671675|NCT02014402|69145141|FG000|Overall Study|Subject did not have transportation|0|||
37671676|NCT02014402|69145142|FG001|Overall Study|Subject did not have transportation|1|||
37671677|NCT02014402|69145143|FG002|Overall Study|Subject did not have transportation|0|||
37671678|NCT02014402|69145144|FG003|Overall Study|Subject did not have transportation|0|||
37671679|NCT02014402|69145141|FG000|Overall Study|Lost to Follow-up|0|||
37671680|NCT02014402|69145142|FG001|Overall Study|Lost to Follow-up|0|||
37671681|NCT02014402|69145143|FG002|Overall Study|Lost to Follow-up|1|||
37671682|NCT02014402|69145144|FG003|Overall Study|Lost to Follow-up|2|||
37671683|NCT01988662|69145163|FG000|Overall Study|Subject/guardian decision|1|||
37671684|NCT01988662|69145164|FG001|Overall Study|Subject/guardian decision|1|||
37671685|NCT01988662|69145163|FG000|Overall Study|Adverse Event|3|||
37671686|NCT01988662|69145164|FG001|Overall Study|Adverse Event|1|||
37671687|NCT02839343|69145173|FG000|Overall Study|Withdrawal by Subject|3|||
37671688|NCT02839343|69145174|FG001|Overall Study|Withdrawal by Subject|1|||
37671689|NCT02839343|69145173|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
37671690|NCT02839343|69145174|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
37671691|NCT02839343|69145173|FG000|Overall Study|Adverse Event|1|||
37671692|NCT02839343|69145174|FG001|Overall Study|Adverse Event|0|||
37671693|NCT01965652|69145203|FG000|Overall Study|Adverse Event|40|||
37671694|NCT01965652|69145204|FG001|Overall Study|Adverse Event|37|||
37671695|NCT01965652|69145203|FG000|Overall Study|Withdrawal by Subject|62|||
37671696|NCT01965652|69145204|FG001|Overall Study|Withdrawal by Subject|69|||
37671697|NCT01965652|69145203|FG000|Overall Study|Lost to Follow-up|53|||
37671698|NCT01965652|69145204|FG001|Overall Study|Lost to Follow-up|40|||
37671699|NCT01965652|69145203|FG000|Overall Study|Protocol Violation|34|||
37671700|NCT01965652|69145204|FG001|Overall Study|Protocol Violation|38|||
37671701|NCT01965652|69145203|FG000|Overall Study|Death|3|||
37671702|NCT01965652|69145204|FG001|Overall Study|Death|4|||
37671703|NCT01965652|69145203|FG000|Overall Study|Other - Miscellaneous|18|||
37671704|NCT01965652|69145204|FG001|Overall Study|Other - Miscellaneous|21|||
37671705|NCT01965652|69145203|FG000|Overall Study|Pregnancy|0|||
37671706|NCT01965652|69145204|FG001|Overall Study|Pregnancy|1|||
37671707|NCT01602965|69145212|FG000|Overall Study|Lost to Follow-up|4|||
37671708|NCT01602965|69145213|FG001|Overall Study|Lost to Follow-up|2|||
37671709|NCT01987960|69145221|FG000|Period 1|Adverse Event|24|||
37671710|NCT01987960|69145222|FG001|Period 1|Adverse Event|0|||
37671711|NCT01987960|69145223|FG002|Period 1|Adverse Event|0|||
37671712|NCT01987960|69145224|FG003|Period 1|Adverse Event|0|||
37671713|NCT01987960|69145221|FG000|Period 1|Lack of Efficacy|4|||
37671714|NCT01987960|69145222|FG001|Period 1|Lack of Efficacy|0|||
37671715|NCT01987960|69145223|FG002|Period 1|Lack of Efficacy|0|||
37671716|NCT01987960|69145224|FG003|Period 1|Lack of Efficacy|0|||
37671717|NCT01987960|69145221|FG000|Period 1|Non-compliance with IMP|6|||
37671718|NCT01987960|69145222|FG001|Period 1|Non-compliance with IMP|0|||
37671719|NCT01987960|69145223|FG002|Period 1|Non-compliance with IMP|0|||
37671720|NCT01987960|69145224|FG003|Period 1|Non-compliance with IMP|0|||
37671721|NCT01987960|69145221|FG000|Period 1|Protocol Violation|12|||
37671722|NCT01987960|69145222|FG001|Period 1|Protocol Violation|0|||
37671723|NCT01987960|69145223|FG002|Period 1|Protocol Violation|0|||
37671724|NCT01987960|69145224|FG003|Period 1|Protocol Violation|0|||
37671725|NCT01987960|69145221|FG000|Period 1|Withdrawal by Subject|21|||
37671726|NCT01987960|69145222|FG001|Period 1|Withdrawal by Subject|0|||
37671727|NCT01987960|69145223|FG002|Period 1|Withdrawal by Subject|0|||
37671728|NCT01987960|69145224|FG003|Period 1|Withdrawal by Subject|0|||
37671729|NCT01987960|69145221|FG000|Period 1|Lost to Follow-up|40|||
37671730|NCT01987960|69145222|FG001|Period 1|Lost to Follow-up|0|||
37671731|NCT01987960|69145223|FG002|Period 1|Lost to Follow-up|0|||
37671732|NCT01987960|69145224|FG003|Period 1|Lost to Follow-up|0|||
37671733|NCT01987960|69145221|FG000|Period 1|administrative or other reason|75|||
37671734|NCT01987960|69145222|FG001|Period 1|administrative or other reason|0|||
37671735|NCT01987960|69145223|FG002|Period 1|administrative or other reason|0|||
37671736|NCT01987960|69145224|FG003|Period 1|administrative or other reason|0|||
37671737|NCT01987960|69145221|FG000|Period 1|Withdrawal of consent before treatment|4|||
37671738|NCT01987960|69145222|FG001|Period 1|Withdrawal of consent before treatment|0|||
37671739|NCT01987960|69145223|FG002|Period 1|Withdrawal of consent before treatment|0|||
37671740|NCT01987960|69145224|FG003|Period 1|Withdrawal of consent before treatment|0|||
37671741|NCT01987960|69145221|FG000|Period 2|Adverse Event|0|||
37671742|NCT01987960|69145222|FG001|Period 2|Adverse Event|0|||
37671743|NCT01987960|69145223|FG002|Period 2|Adverse Event|1|||
37671744|NCT01987960|69145224|FG003|Period 2|Adverse Event|0|||
37671745|NCT01987960|69145221|FG000|Period 2|Withdrawal by Subject|0|||
37671746|NCT01987960|69145222|FG001|Period 2|Withdrawal by Subject|0|||
37671747|NCT01987960|69145223|FG002|Period 2|Withdrawal by Subject|1|||
37671748|NCT01987960|69145224|FG003|Period 2|Withdrawal by Subject|0|||
37671749|NCT01987960|69145221|FG000|Period 2|Administrative or other reason|0|||
37671750|NCT01987960|69145222|FG001|Period 2|Administrative or other reason|5|||
37671751|NCT01987960|69145223|FG002|Period 2|Administrative or other reason|7|||
37671752|NCT01987960|69145224|FG003|Period 2|Administrative or other reason|0|||
37671753|NCT01987960|69145221|FG000|Period 3|Adverse Event|0|||
37671754|NCT01987960|69145222|FG001|Period 3|Adverse Event|0|||
37671755|NCT01987960|69145223|FG002|Period 3|Adverse Event|0|||
37671756|NCT01987960|69145224|FG003|Period 3|Adverse Event|7|||
37671757|NCT01987960|69145221|FG000|Period 3|Non-compliance with IMP|0|||
37671758|NCT01987960|69145222|FG001|Period 3|Non-compliance with IMP|0|||
37671759|NCT01987960|69145223|FG002|Period 3|Non-compliance with IMP|0|||
37671760|NCT01987960|69145224|FG003|Period 3|Non-compliance with IMP|1|||
37671761|NCT01987960|69145221|FG000|Period 3|Protocol Violation|0|||
37671762|NCT01987960|69145222|FG001|Period 3|Protocol Violation|0|||
37671763|NCT01987960|69145223|FG002|Period 3|Protocol Violation|0|||
37671764|NCT01987960|69145224|FG003|Period 3|Protocol Violation|6|||
37671765|NCT01987960|69145221|FG000|Period 3|Withdrawal by Subject|0|||
37671766|NCT01987960|69145222|FG001|Period 3|Withdrawal by Subject|0|||
37671767|NCT01987960|69145223|FG002|Period 3|Withdrawal by Subject|0|||
37671768|NCT01987960|69145224|FG003|Period 3|Withdrawal by Subject|9|||
37671769|NCT01987960|69145221|FG000|Period 3|Lost to Follow-up|0|||
37671770|NCT01987960|69145222|FG001|Period 3|Lost to Follow-up|0|||
37671771|NCT01987960|69145223|FG002|Period 3|Lost to Follow-up|0|||
37671772|NCT01987960|69145224|FG003|Period 3|Lost to Follow-up|5|||
37671773|NCT01987960|69145221|FG000|Period 3|Administrative or other reason|0|||
37671774|NCT01987960|69145222|FG001|Period 3|Administrative or other reason|0|||
37671775|NCT01987960|69145223|FG002|Period 3|Administrative or other reason|0|||
37671776|NCT01987960|69145224|FG003|Period 3|Administrative or other reason|43|||
37671777|NCT02013778|69145234|FG000|Overall Study|Death|4|||
37671778|NCT02013778|69145234|FG000|Overall Study|Withdrawal by Subject|1|||
37671779|NCT02013778|69145234|FG000|Overall Study|Physician Decision|1|||
37671780|NCT02013778|69145234|FG000|Overall Study|Adverse Event|1|||
37671781|NCT02013622|69145238|FG000|Overall Study|Lost to Follow-up|10|||
37671782|NCT02013622|69145238|FG000|Overall Study|Adverse Event|3|||
37671783|NCT02013622|69145238|FG000|Overall Study|Met Withdrawal Criteria|3|||
37671784|NCT02013622|69145238|FG000|Overall Study|Withdrawal by Subject|6|||
37671785|NCT02013622|69145238|FG000|Overall Study|Protocol Deviation|1|||
37671786|NCT02013622|69145238|FG000|Overall Study|Lack of Efficacy|1|||
37671787|NCT01987102|69145244|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
37671788|NCT01987102|69145245|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
37671789|NCT01987102|69145244|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
37671790|NCT01987102|69145245|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
37671791|NCT01987102|69145244|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
37671792|NCT01987102|69145245|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
37671793|NCT01987102|69145244|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
37671794|NCT01987102|69145245|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
37942594|NCT00547378|69629749|FG002|All Implanted Cohort|Adverse Event|17|||
37942595|NCT00547378|69629747|FG000|All Implanted Cohort|Lost to Follow-up|0|||
37671795|NCT01987102|69145244|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
37671796|NCT01987102|69145245|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
37671797|NCT01987102|69145244|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
37671798|NCT01987102|69145245|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
37671799|NCT02013544|69145254|FG000|Overall Study|Adverse Event|5|||
37671800|NCT02013544|69145255|FG001|Overall Study|Adverse Event|5|||
37671801|NCT02013544|69145254|FG000|Overall Study|Lost to Follow-up|2|||
37671802|NCT02013544|69145255|FG001|Overall Study|Lost to Follow-up|3|||
37671803|NCT02013544|69145254|FG000|Overall Study|Withdrawal by Subject|2|||
37671804|NCT02013544|69145255|FG001|Overall Study|Withdrawal by Subject|8|||
37671805|NCT02013544|69145254|FG000|Overall Study|Physician Decision|0|||
37671806|NCT02013544|69145255|FG001|Overall Study|Physician Decision|1|||
37671807|NCT02013544|69145254|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
37671808|NCT02013544|69145255|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
37671809|NCT02013388|69145269|FG000|Overall Study|work emergency|1|||
37671810|NCT02013388|69145270|FG001|Overall Study|work emergency|0|||
37671811|NCT02013388|69145271|FG002|Overall Study|work emergency|0|||
37671812|NCT02013388|69145272|FG003|Overall Study|work emergency|0|||
37671813|NCT02013388|69145273|FG004|Overall Study|work emergency|1|||
37671814|NCT02013388|69145274|FG005|Overall Study|work emergency|0|||
37671815|NCT02013388|69145275|FG006|Overall Study|work emergency|0|||
37671816|NCT02013388|69145276|FG007|Overall Study|work emergency|0|||
37671817|NCT02012686|69145300|FG000|Overall Study|muscle contraction|0|||
37671818|NCT02012686|69145301|FG001|Overall Study|muscle contraction|1|||
37671819|NCT02012686|69145300|FG000|Overall Study|electrocardiography monitoring noise|0|||
37671820|NCT02012686|69145301|FG001|Overall Study|electrocardiography monitoring noise|1|||
37671821|NCT02012452|69145309|FG000|Overall Study|Lost to Follow-up|2|||
37671822|NCT02012452|69145310|FG001|Overall Study|Lost to Follow-up|1|||
37671823|NCT02012452|69145309|FG000|Overall Study|Withdrawal by Subject|4|||
37671824|NCT02012452|69145310|FG001|Overall Study|Withdrawal by Subject|0|||
37671825|NCT01676909|69145318|FG000|Overall Study|Withdrawal by Subject|3|||
37671826|NCT01676909|69145319|FG001|Overall Study|Withdrawal by Subject|5|||
37671827|NCT01676909|69145318|FG000|Overall Study|Lost to Follow-up|15|||
37671828|NCT01676909|69145319|FG001|Overall Study|Lost to Follow-up|9|||
37671829|NCT02012296|69145330|FG000|Overall Study|Lack of Efficacy|0|||
37671830|NCT02012296|69145331|FG001|Overall Study|Lack of Efficacy|0|||
37671831|NCT02012296|69145332|FG002|Overall Study|Lack of Efficacy|15|||
37671832|NCT02012296|69145330|FG000|Overall Study|Adverse Event|0|||
37671833|NCT02012296|69145331|FG001|Overall Study|Adverse Event|0|||
37671834|NCT02012296|69145332|FG002|Overall Study|Adverse Event|2|||
37671835|NCT02012296|69145330|FG000|Overall Study|Early study closure|0|||
37671836|NCT02012296|69145331|FG001|Overall Study|Early study closure|0|||
37671837|NCT02012296|69145332|FG002|Overall Study|Early study closure|5|||
37671838|NCT02012296|69145330|FG000|Overall Study|Protocol Violation|0|||
37671839|NCT02012296|69145331|FG001|Overall Study|Protocol Violation|1|||
37671840|NCT02012296|69145332|FG002|Overall Study|Protocol Violation|0|||
37671841|NCT02012218|69145349|FG000|Overall Study|Withdrawal by Subject|1|||
37671842|NCT02012218|69145350|FG001|Overall Study|Withdrawal by Subject|0|||
37671843|NCT02012218|69145351|FG002|Overall Study|Withdrawal by Subject|1|||
37671844|NCT02012218|69145352|FG003|Overall Study|Withdrawal by Subject|1|||
37671845|NCT02012218|69145353|FG004|Overall Study|Withdrawal by Subject|1|||
37671846|NCT02012218|69145349|FG000|Overall Study|Adverse Event|1|||
37671847|NCT02012218|69145350|FG001|Overall Study|Adverse Event|0|||
37671848|NCT02012218|69145351|FG002|Overall Study|Adverse Event|0|||
37671849|NCT02012218|69145352|FG003|Overall Study|Adverse Event|1|||
37671850|NCT02012218|69145353|FG004|Overall Study|Adverse Event|0|||
37671851|NCT02012218|69145349|FG000|Overall Study|Lost to Follow-up|0|||
37671852|NCT02012218|69145350|FG001|Overall Study|Lost to Follow-up|1|||
37671853|NCT02012218|69145351|FG002|Overall Study|Lost to Follow-up|1|||
37671854|NCT02012218|69145352|FG003|Overall Study|Lost to Follow-up|0|||
37671855|NCT02012218|69145353|FG004|Overall Study|Lost to Follow-up|0|||
37671856|NCT02012218|69145349|FG000|Overall Study|Protocol Specified|1|||
37671857|NCT02012218|69145350|FG001|Overall Study|Protocol Specified|0|||
37671858|NCT02012218|69145351|FG002|Overall Study|Protocol Specified|0|||
37671859|NCT02012218|69145352|FG003|Overall Study|Protocol Specified|0|||
37671860|NCT02012218|69145353|FG004|Overall Study|Protocol Specified|0|||
37671861|NCT02012218|69145349|FG000|Overall Study|Protocol Deviation|1|||
37671862|NCT02012218|69145350|FG001|Overall Study|Protocol Deviation|0|||
37671863|NCT02012218|69145351|FG002|Overall Study|Protocol Deviation|0|||
37671864|NCT02012218|69145352|FG003|Overall Study|Protocol Deviation|0|||
37671865|NCT02012218|69145353|FG004|Overall Study|Protocol Deviation|0|||
37671866|NCT01965262|69145365|FG000|Second Intervention (7 Days)|Discontinued|0|||
37671867|NCT01965262|69145366|FG001|Second Intervention (7 Days)|Discontinued|1|||
37671868|NCT01965262|69145365|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
37671869|NCT01965262|69145366|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
37671870|NCT01965262|69145365|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
37671871|NCT01965262|69145366|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
37671872|NCT01677377|69145375|FG000|Overall Study|Protocol Violation|1|||
37671873|NCT01677377|69145376|FG001|Overall Study|Protocol Violation|0|||
37942596|NCT00547378|69629748|FG001|All Implanted Cohort|Lost to Follow-up|1|||
37942597|NCT00547378|69629749|FG002|All Implanted Cohort|Lost to Follow-up|14|||
37671874|NCT01677377|69145377|FG002|Overall Study|Protocol Violation|0|||
37671875|NCT01677377|69145375|FG000|Overall Study|Lost to Follow-up|0|||
37671876|NCT01677377|69145376|FG001|Overall Study|Lost to Follow-up|1|||
37671877|NCT01677377|69145377|FG002|Overall Study|Lost to Follow-up|1|||
37671878|NCT01677377|69145375|FG000|Overall Study|Withdrawal by Subject|0|||
37671879|NCT01677377|69145376|FG001|Overall Study|Withdrawal by Subject|0|||
37671880|NCT01677377|69145377|FG002|Overall Study|Withdrawal by Subject|3|||
37671881|NCT01677377|69145375|FG000|Overall Study|Lack of Efficacy|0|||
37671882|NCT01677377|69145376|FG001|Overall Study|Lack of Efficacy|0|||
37671883|NCT01677377|69145377|FG002|Overall Study|Lack of Efficacy|1|||
37671884|NCT01677377|69145375|FG000|Overall Study|Pregnancy|0|||
37671885|NCT01677377|69145376|FG001|Overall Study|Pregnancy|0|||
37671886|NCT01677377|69145377|FG002|Overall Study|Pregnancy|1|||
37671887|NCT01964950|69145387|FG000|Overall Study|Protocol Violation|25|||
37671888|NCT01964716|69145396|FG000|Overall Study|Withdrawal by Subject|2|||
37671889|NCT01964716|69145397|FG001|Overall Study|Withdrawal by Subject|3|||
37671890|NCT01964716|69145396|FG000|Overall Study|Lost to Follow-up|1|||
37671891|NCT01964716|69145397|FG001|Overall Study|Lost to Follow-up|2|||
37671892|NCT01964716|69145396|FG000|Overall Study|No longer met eligibility criteria|1|||
37671893|NCT01964716|69145397|FG001|Overall Study|No longer met eligibility criteria|1|||
37671894|NCT01964716|69145396|FG000|Overall Study|Death|1|||
37671895|NCT01964716|69145397|FG001|Overall Study|Death|0|||
37671896|NCT01964560|69145411|FG000|Overall Study|Adverse Event|23|||
37671897|NCT01964560|69145411|FG000|Overall Study|Lack of Efficacy|46|||
37671898|NCT01964560|69145411|FG000|Overall Study|Protocol deviation|2|||
37671899|NCT01964560|69145411|FG000|Overall Study|Lost to Follow-up|4|||
37671900|NCT01964560|69145411|FG000|Overall Study|Withdrawal by Subject|64|||
37671901|NCT01964560|69145411|FG000|Overall Study|Surgery-hemispherotomy|1|||
37671902|NCT01964560|69145411|FG000|Overall Study|Surgery|1|||
37671903|NCT01964560|69145411|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
37671904|NCT01964560|69145411|FG000|Overall Study|Patient and Investigator choice|1|||
37671905|NCT01964560|69145411|FG000|Overall Study|Patient was prescribed CBD|1|||
37671906|NCT01964560|69145411|FG000|Overall Study|Participant moved to another country|1|||
37671907|NCT02659943|69145422|FG000|Overall Study|Switched to alternative treatment|1|||
37671908|NCT02659943|69145423|FG001|Overall Study|Switched to alternative treatment|1|||
37671909|NCT02659943|69145424|FG002|Overall Study|Switched to alternative treatment|0|||
37671910|NCT02659943|69145425|FG003|Overall Study|Switched to alternative treatment|2|||
37671911|NCT02659943|69145426|FG004|Overall Study|Switched to alternative treatment|1|||
37671912|NCT02659943|69145427|FG005|Overall Study|Switched to alternative treatment|0|||
37671913|NCT02659943|69145428|FG006|Overall Study|Switched to alternative treatment|1|||
37671914|NCT02659943|69145422|FG000|Overall Study|Disease progression on study|0|||
37671915|NCT02659943|69145423|FG001|Overall Study|Disease progression on study|1|||
37671916|NCT02659943|69145424|FG002|Overall Study|Disease progression on study|1|||
37671917|NCT02659943|69145425|FG003|Overall Study|Disease progression on study|1|||
37671918|NCT02659943|69145426|FG004|Overall Study|Disease progression on study|1|||
37671919|NCT02659943|69145427|FG005|Overall Study|Disease progression on study|4|||
37671920|NCT02659943|69145428|FG006|Overall Study|Disease progression on study|0|||
37671921|NCT02659943|69145422|FG000|Overall Study|Patient's condition per principal investigator|0|||
37671922|NCT02659943|69145423|FG001|Overall Study|Patient's condition per principal investigator|0|||
37671923|NCT02659943|69145424|FG002|Overall Study|Patient's condition per principal investigator|0|||
37671924|NCT02659943|69145425|FG003|Overall Study|Patient's condition per principal investigator|0|||
37671925|NCT02659943|69145426|FG004|Overall Study|Patient's condition per principal investigator|0|||
37671926|NCT02659943|69145427|FG005|Overall Study|Patient's condition per principal investigator|1|||
37671927|NCT02659943|69145428|FG006|Overall Study|Patient's condition per principal investigator|0|||
37671928|NCT02659943|69145422|FG000|Overall Study|Ineligible|0|||
37671929|NCT02659943|69145423|FG001|Overall Study|Ineligible|0|||
37671930|NCT02659943|69145424|FG002|Overall Study|Ineligible|0|||
37671931|NCT02659943|69145425|FG003|Overall Study|Ineligible|0|||
37671932|NCT02659943|69145426|FG004|Overall Study|Ineligible|0|||
37671933|NCT02659943|69145427|FG005|Overall Study|Ineligible|0|||
37671934|NCT02659943|69145428|FG006|Overall Study|Ineligible|1|||
37671935|NCT02659943|69145422|FG000|Overall Study|No longer meets eligibility|0|||
37671936|NCT02659943|69145423|FG001|Overall Study|No longer meets eligibility|0|||
37671937|NCT02659943|69145424|FG002|Overall Study|No longer meets eligibility|0|||
37671938|NCT02659943|69145425|FG003|Overall Study|No longer meets eligibility|0|||
37671939|NCT02659943|69145426|FG004|Overall Study|No longer meets eligibility|0|||
37671940|NCT02659943|69145427|FG005|Overall Study|No longer meets eligibility|0|||
37671941|NCT02659943|69145428|FG006|Overall Study|No longer meets eligibility|1|||
37671942|NCT02659943|69145422|FG000|Overall Study|No treatment, per protocol|0|||
37765430|NCT01438489|69279110|FG002|Overall Study|Lost to Follow-up|2|||
37765431|NCT01438489|69279108|FG000|Overall Study|Withdrawal by Subject|11|||
37765432|NCT01438489|69279109|FG001|Overall Study|Withdrawal by Subject|3|||
37765433|NCT01438489|69279110|FG002|Overall Study|Withdrawal by Subject|8|||
37671943|NCT02659943|69145423|FG001|Overall Study|No treatment, per protocol|0|||
37671944|NCT02659943|69145424|FG002|Overall Study|No treatment, per protocol|0|||
37671945|NCT02659943|69145425|FG003|Overall Study|No treatment, per protocol|0|||
37671946|NCT02659943|69145426|FG004|Overall Study|No treatment, per protocol|0|||
37671947|NCT02659943|69145427|FG005|Overall Study|No treatment, per protocol|0|||
37671948|NCT02659943|69145428|FG006|Overall Study|No treatment, per protocol|3|||
37671949|NCT01677299|69145453|FG000|Overall Study|Adverse Event|0|||
37671950|NCT01677299|69145454|FG001|Overall Study|Adverse Event|2|||
37942598|NCT00547378|69629747|FG000|All Implanted Cohort|Death|3|||
37765434|NCT01438489|69279108|FG000|Overall Study|Death|0|||
37671951|NCT01677299|69145455|FG002|Overall Study|Adverse Event|1|||
37671952|NCT01677299|69145456|FG003|Overall Study|Adverse Event|0|||
37671953|NCT01677299|69145453|FG000|Overall Study|Withdrawal by Subject|0|||
37671954|NCT01677299|69145454|FG001|Overall Study|Withdrawal by Subject|1|||
37671955|NCT01677299|69145455|FG002|Overall Study|Withdrawal by Subject|0|||
37671956|NCT01677299|69145456|FG003|Overall Study|Withdrawal by Subject|1|||
37671957|NCT01964326|69145470|FG000|Overall Study|Adverse Event|48|||
37671958|NCT01964326|69145470|FG000|Overall Study|Death|2|||
37671959|NCT01964326|69145470|FG000|Overall Study|Protocol Violation|4|||
37671960|NCT01964326|69145470|FG000|Overall Study|Lost to Follow-up|88|||
37671961|NCT01964326|69145470|FG000|Overall Study|Withdrawal by Subject|87|||
37671962|NCT01964326|69145470|FG000|Overall Study|Pregnancy|1|||
37671963|NCT01964326|69145470|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
37671964|NCT01964326|69145470|FG000|Overall Study|Physician Decision|55|||
37671965|NCT01964326|69145470|FG000|Overall Study|Investigator Discretion|1|||
37671966|NCT01964326|69145470|FG000|Overall Study|Other|9|||
37671967|NCT01964326|69145470|FG000|Overall Study|Did not meet eligibility criteria|1|||
37671968|NCT02699749|69145488|FG000|Overall Study|Other|0|||
37671969|NCT02699749|69145489|FG001|Overall Study|Other|0|||
37671970|NCT02699749|69145490|FG002|Overall Study|Other|2|||
37671971|NCT02699749|69145491|FG003|Overall Study|Other|0|||
37671972|NCT02699749|69145492|FG004|Overall Study|Other|0|||
37671973|NCT02699749|69145493|FG005|Overall Study|Other|1|||
37671974|NCT02699749|69145494|FG006|Overall Study|Other|1|||
37671975|NCT02699749|69145495|FG007|Overall Study|Other|0|||
37671976|NCT02699749|69145496|FG008|Overall Study|Other|0|||
37671977|NCT02699749|69145497|FG009|Overall Study|Other|0|||
37671978|NCT02699749|69145498|FG010|Overall Study|Other|1|||
37671979|NCT02699749|69145499|FG011|Overall Study|Other|0|||
37671980|NCT02699749|69145500|FG012|Overall Study|Other|0|||
37671981|NCT02699749|69145501|FG013|Overall Study|Other|0|||
37671982|NCT02699749|69145488|FG000|Overall Study|Progressive Disease|3|||
37671983|NCT02699749|69145489|FG001|Overall Study|Progressive Disease|3|||
37671984|NCT02699749|69145490|FG002|Overall Study|Progressive Disease|14|||
37671985|NCT02699749|69145491|FG003|Overall Study|Progressive Disease|3|||
37671986|NCT02699749|69145492|FG004|Overall Study|Progressive Disease|3|||
37671987|NCT02699749|69145493|FG005|Overall Study|Progressive Disease|7|||
37671988|NCT02699749|69145494|FG006|Overall Study|Progressive Disease|5|||
37671989|NCT02699749|69145495|FG007|Overall Study|Progressive Disease|5|||
37671990|NCT02699749|69145496|FG008|Overall Study|Progressive Disease|6|||
37671991|NCT02699749|69145497|FG009|Overall Study|Progressive Disease|6|||
37671992|NCT02699749|69145498|FG010|Overall Study|Progressive Disease|5|||
37671993|NCT02699749|69145499|FG011|Overall Study|Progressive Disease|4|||
37671994|NCT02699749|69145500|FG012|Overall Study|Progressive Disease|3|||
37671995|NCT02699749|69145501|FG013|Overall Study|Progressive Disease|5|||
37671996|NCT02699749|69145488|FG000|Overall Study|Death|0|||
37671997|NCT02699749|69145489|FG001|Overall Study|Death|0|||
37671998|NCT02699749|69145490|FG002|Overall Study|Death|0|||
37671999|NCT02699749|69145491|FG003|Overall Study|Death|0|||
37672000|NCT02699749|69145492|FG004|Overall Study|Death|0|||
37672001|NCT02699749|69145493|FG005|Overall Study|Death|0|||
37672002|NCT02699749|69145494|FG006|Overall Study|Death|0|||
37672003|NCT02699749|69145495|FG007|Overall Study|Death|0|||
37672004|NCT02699749|69145496|FG008|Overall Study|Death|0|||
37672005|NCT02699749|69145497|FG009|Overall Study|Death|0|||
37672006|NCT02699749|69145498|FG010|Overall Study|Death|0|||
37672007|NCT02699749|69145499|FG011|Overall Study|Death|0|||
37672008|NCT02699749|69145500|FG012|Overall Study|Death|0|||
37672009|NCT02699749|69145501|FG013|Overall Study|Death|1|||
37672010|NCT02699749|69145488|FG000|Overall Study|Lost to Follow-up|0|||
37672011|NCT02699749|69145489|FG001|Overall Study|Lost to Follow-up|0|||
37672012|NCT02699749|69145490|FG002|Overall Study|Lost to Follow-up|0|||
37672013|NCT02699749|69145491|FG003|Overall Study|Lost to Follow-up|0|||
37765435|NCT01438489|69279109|FG001|Overall Study|Death|0|||
37765436|NCT01438489|69279110|FG002|Overall Study|Death|1|||
37765437|NCT01438489|69279108|FG000|Overall Study|Sponsor decision|4|||
37765438|NCT01438489|69279109|FG001|Overall Study|Sponsor decision|1|||
37765439|NCT01438489|69279110|FG002|Overall Study|Sponsor decision|4|||
37765440|NCT01438489|69279108|FG000|Overall Study|Subject choice/Subject moved|2|||
37765441|NCT01438489|69279109|FG001|Overall Study|Subject choice/Subject moved|1|||
37672014|NCT02699749|69145492|FG004|Overall Study|Lost to Follow-up|0|||
37672015|NCT02699749|69145493|FG005|Overall Study|Lost to Follow-up|1|||
37672016|NCT02699749|69145494|FG006|Overall Study|Lost to Follow-up|0|||
37672017|NCT02699749|69145495|FG007|Overall Study|Lost to Follow-up|1|||
37765442|NCT01438489|69279110|FG002|Overall Study|Subject choice/Subject moved|1|||
37672018|NCT02699749|69145496|FG008|Overall Study|Lost to Follow-up|0|||
37672019|NCT02699749|69145497|FG009|Overall Study|Lost to Follow-up|0|||
37672020|NCT02699749|69145498|FG010|Overall Study|Lost to Follow-up|0|||
37672021|NCT02699749|69145499|FG011|Overall Study|Lost to Follow-up|0|||
37672022|NCT02699749|69145500|FG012|Overall Study|Lost to Follow-up|0|||
37672023|NCT02699749|69145501|FG013|Overall Study|Lost to Follow-up|0|||
37672024|NCT02699593|69145531|FG000|Period 1|Unsatisfactory Visual Response|0|||
37672025|NCT02699593|69145532|FG001|Period 1|Unsatisfactory Visual Response|1|||
37672026|NCT02699593|69145531|FG000|Period 1|Torn Contact Len|4|||
37672027|NCT02699593|69145532|FG001|Period 1|Torn Contact Len|3|||
37672028|NCT02699593|69145531|FG000|Period 1|Protocol Violation|0|||
37672029|NCT02699593|69145532|FG001|Period 1|Protocol Violation|1|||
37672030|NCT02699593|69145531|FG000|Period 1|Withdrawal by Subject|0|||
37672031|NCT02699593|69145532|FG001|Period 1|Withdrawal by Subject|1|||
37672032|NCT02699593|69145531|FG000|Period 1|Adverse Event|1|||
37672033|NCT02699593|69145532|FG001|Period 1|Adverse Event|1|||
37672034|NCT02699593|69145531|FG000|Period 2|Adverse Event|1|||
37672035|NCT02699593|69145532|FG001|Period 2|Adverse Event|1|||
37672036|NCT02699593|69145531|FG000|Period 2|Lost Contact Lens|0|||
37672037|NCT02699593|69145532|FG001|Period 2|Lost Contact Lens|1|||
37672038|NCT02699593|69145531|FG000|Period 2|Torn Contact Lens|1|||
37672039|NCT02699593|69145532|FG001|Period 2|Torn Contact Lens|0|||
37672040|NCT00708097|69145538|FG000|Period 1|Protocol Violation|0|||
37672041|NCT00708097|69145539|FG001|Period 1|Protocol Violation|1|||
37672042|NCT00708097|69145540|FG002|Period 1|Protocol Violation|0|||
37672043|NCT00708097|69145541|FG003|Period 1|Protocol Violation|2|||
37672044|NCT00708097|69145542|FG004|Period 1|Protocol Violation|0|||
37672045|NCT00708097|69145538|FG000|Period 1|Other Reason|0|||
37672046|NCT00708097|69145539|FG001|Period 1|Other Reason|0|||
37672047|NCT00708097|69145540|FG002|Period 1|Other Reason|0|||
37672048|NCT00708097|69145541|FG003|Period 1|Other Reason|0|||
37672049|NCT00708097|69145542|FG004|Period 1|Other Reason|1|||
37672050|NCT00708097|69145538|FG000|Period 2|Protocol Violation|0|||
37672051|NCT00708097|69145539|FG001|Period 2|Protocol Violation|1|||
37672052|NCT00708097|69145540|FG002|Period 2|Protocol Violation|1|||
37672053|NCT00708097|69145541|FG003|Period 2|Protocol Violation|1|||
37672054|NCT00708097|69145542|FG004|Period 2|Protocol Violation|0|||
37672055|NCT02659631|69145569|FG000|Overall Study|Lost to Follow-up|0|||
37672056|NCT02659631|69145570|FG001|Overall Study|Lost to Follow-up|0|||
37672057|NCT02659631|69145571|FG002|Overall Study|Lost to Follow-up|2|||
37672058|NCT02659631|69145572|FG003|Overall Study|Lost to Follow-up|0|||
37672059|NCT02659631|69145573|FG004|Overall Study|Lost to Follow-up|0|||
37672060|NCT02659631|69145574|FG005|Overall Study|Lost to Follow-up|1|||
37672061|NCT02659631|69145575|FG006|Overall Study|Lost to Follow-up|0|||
37672062|NCT02659631|69145576|FG007|Overall Study|Lost to Follow-up|0|||
37672063|NCT02659631|69145577|FG008|Overall Study|Lost to Follow-up|0|||
37672064|NCT02659631|69145578|FG009|Overall Study|Lost to Follow-up|0|||
37672065|NCT02659631|69145569|FG000|Overall Study|Withdrawal prior to treatment|0|||
37672066|NCT02659631|69145570|FG001|Overall Study|Withdrawal prior to treatment|0|||
37672067|NCT02659631|69145571|FG002|Overall Study|Withdrawal prior to treatment|0|||
37672068|NCT02659631|69145572|FG003|Overall Study|Withdrawal prior to treatment|0|||
37672069|NCT02659631|69145573|FG004|Overall Study|Withdrawal prior to treatment|1|||
37672070|NCT02659631|69145574|FG005|Overall Study|Withdrawal prior to treatment|0|||
37672071|NCT02659631|69145575|FG006|Overall Study|Withdrawal prior to treatment|0|||
37672072|NCT02659631|69145576|FG007|Overall Study|Withdrawal prior to treatment|0|||
37672073|NCT02659631|69145577|FG008|Overall Study|Withdrawal prior to treatment|0|||
37672074|NCT02659631|69145578|FG009|Overall Study|Withdrawal prior to treatment|0|||
37672075|NCT02659631|69145569|FG000|Overall Study|Participant refused further follow-up|0|||
37672076|NCT02659631|69145570|FG001|Overall Study|Participant refused further follow-up|0|||
37672077|NCT02659631|69145571|FG002|Overall Study|Participant refused further follow-up|0|||
37672078|NCT02659631|69145572|FG003|Overall Study|Participant refused further follow-up|1|||
37672079|NCT02659631|69145573|FG004|Overall Study|Participant refused further follow-up|0|||
37672080|NCT02659631|69145574|FG005|Overall Study|Participant refused further follow-up|0|||
37672081|NCT02659631|69145575|FG006|Overall Study|Participant refused further follow-up|0|||
37672082|NCT02659631|69145576|FG007|Overall Study|Participant refused further follow-up|0|||
37672083|NCT02659631|69145577|FG008|Overall Study|Participant refused further follow-up|1|||
37672084|NCT02659631|69145578|FG009|Overall Study|Participant refused further follow-up|0|||
37672085|NCT02659631|69145569|FG000|Overall Study|Death (follow-up phase)|1|||
37672086|NCT02659631|69145570|FG001|Overall Study|Death (follow-up phase)|2|||
37672087|NCT02659631|69145571|FG002|Overall Study|Death (follow-up phase)|1|||
37672088|NCT02659631|69145572|FG003|Overall Study|Death (follow-up phase)|1|||
37672089|NCT02659631|69145573|FG004|Overall Study|Death (follow-up phase)|3|||
37672090|NCT02659631|69145574|FG005|Overall Study|Death (follow-up phase)|2|||
37672091|NCT02659631|69145575|FG006|Overall Study|Death (follow-up phase)|0|||
37942599|NCT00547378|69629748|FG001|All Implanted Cohort|Death|1|||
37942600|NCT00547378|69629749|FG002|All Implanted Cohort|Death|4|||
37672092|NCT02659631|69145576|FG007|Overall Study|Death (follow-up phase)|3|||
37672093|NCT02659631|69145577|FG008|Overall Study|Death (follow-up phase)|1|||
37672094|NCT02659631|69145578|FG009|Overall Study|Death (follow-up phase)|0|||
37672095|NCT02659631|69145569|FG000|Overall Study|Death (treatment phase)|0|||
37672096|NCT02659631|69145570|FG001|Overall Study|Death (treatment phase)|0|||
37672097|NCT02659631|69145571|FG002|Overall Study|Death (treatment phase)|0|||
37672098|NCT02659631|69145572|FG003|Overall Study|Death (treatment phase)|0|||
37672099|NCT02659631|69145573|FG004|Overall Study|Death (treatment phase)|1|||
37672100|NCT02659631|69145574|FG005|Overall Study|Death (treatment phase)|0|||
37672101|NCT02659631|69145575|FG006|Overall Study|Death (treatment phase)|1|||
37672102|NCT02659631|69145576|FG007|Overall Study|Death (treatment phase)|0|||
37672103|NCT02659631|69145577|FG008|Overall Study|Death (treatment phase)|0|||
37672104|NCT02659631|69145578|FG009|Overall Study|Death (treatment phase)|0|||
37672105|NCT02699125|69145602|FG000|Placebo|Lost to Follow-up|2|||
37672106|NCT02699125|69145603|FG001|Placebo|Lost to Follow-up|0|||
37672107|NCT02699125|69145602|FG000|Placebo|Protocol Violation|1|||
37672108|NCT02699125|69145603|FG001|Placebo|Protocol Violation|0|||
37672109|NCT02699125|69145602|FG000|Placebo|Withdrawal by Subject|0|||
37672110|NCT02699125|69145603|FG001|Placebo|Withdrawal by Subject|4|||
37672111|NCT02699125|69145602|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
37672112|NCT02699125|69145603|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
37672113|NCT02698891|69145613|FG000|Overall Study|Withdrawal by Subject|2|||
37672114|NCT02698891|69145613|FG000|Overall Study|deemed ineligible|1|||
37672115|NCT02698891|69145613|FG000|Overall Study|Adverse Event|9|||
37672116|NCT02698423|69145619|FG000|Overall Study|Lost to Follow-up|19|||
37672117|NCT02698423|69145620|FG001|Overall Study|Lost to Follow-up|24|||
37672118|NCT02700997|69145628|FG000|Overall Study|Did not undergo CT imaging|1|||
37672119|NCT02700997|69145628|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
37672120|NCT02658149|69145634|FG000|Overall Study|Physician Decision|1|||
37672121|NCT02658149|69145635|FG001|Overall Study|Physician Decision|0|||
37672122|NCT02698189|69145643|FG000|Overall Study|Physician Decision|3|||
37672123|NCT02698189|69145644|FG001|Overall Study|Physician Decision|0|||
37672124|NCT02698189|69145643|FG000|Overall Study|Progressive disease|0|||
37672125|NCT02698189|69145644|FG001|Overall Study|Progressive disease|5|||
37672126|NCT02698189|69145643|FG000|Overall Study|Study terminated by sponsor|0|||
37672127|NCT02698189|69145644|FG001|Overall Study|Study terminated by sponsor|1|||
37672128|NCT02702011|69145656|FG000|Overall Study|Withdrawal by Subject|0|||
37672129|NCT02702011|69145657|FG001|Overall Study|Withdrawal by Subject|1|||
37672130|NCT02702011|69145658|FG002|Overall Study|Withdrawal by Subject|0|||
37672131|NCT02702011|69145659|FG003|Overall Study|Withdrawal by Subject|0|||
37672132|NCT02657369|69145669|FG000|Overall Study|Death|27|||
37672133|NCT02657369|69145669|FG000|Overall Study|Study terminated by sponsor|7|||
37672134|NCT02701777|69145677|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
37672135|NCT02701777|69145678|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
37672136|NCT02701777|69145679|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
37672137|NCT02701777|69145680|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
37672138|NCT02701777|69145677|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
37672139|NCT02701777|69145678|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
37672140|NCT02701777|69145679|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
37672141|NCT02701777|69145680|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
37672142|NCT01675661|69145705|FG000|Overall Study|Lost to Follow-up|22|||
37672143|NCT01675661|69145706|FG001|Overall Study|Lost to Follow-up|23|||
37672144|NCT01675661|69145705|FG000|Overall Study|Practical problems|9|||
37672145|NCT01675661|69145706|FG001|Overall Study|Practical problems|5|||
37672146|NCT01675661|69145705|FG000|Overall Study|Moved away|5|||
37672147|NCT01675661|69145706|FG001|Overall Study|Moved away|6|||
37672148|NCT01675661|69145705|FG000|Overall Study|Withdrawal by Subject|3|||
37672149|NCT01675661|69145706|FG001|Overall Study|Withdrawal by Subject|7|||
37672150|NCT01675661|69145705|FG000|Overall Study|Physician Decision|0|||
37672151|NCT01675661|69145706|FG001|Overall Study|Physician Decision|2|||
37672152|NCT01675661|69145705|FG000|Overall Study|Death|0|||
37672153|NCT01675661|69145706|FG001|Overall Study|Death|1|||
37672154|NCT01675661|69145705|FG000|Overall Study|Other reason|1|||
37672155|NCT01675661|69145706|FG001|Overall Study|Other reason|2|||
37672156|NCT01602341|69145714|FG000|Overall Study|Adverse Event|0|||
37672157|NCT01602341|69145715|FG001|Overall Study|Adverse Event|1|||
37672158|NCT02700919|69145728|FG000|Overall Study|Physician Decision|1|||
37672159|NCT02700919|69145729|FG001|Overall Study|Physician Decision|0|||
37672160|NCT02700919|69145730|FG002|Overall Study|Physician Decision|0|||
37672161|NCT02700919|69145728|FG000|Overall Study|Protocol Violation|1|||
37672162|NCT02700919|69145729|FG001|Overall Study|Protocol Violation|0|||
37672163|NCT02700919|69145730|FG002|Overall Study|Protocol Violation|0|||
37672164|NCT02700919|69145728|FG000|Overall Study|Adverse Event|1|||
37672165|NCT02700919|69145729|FG001|Overall Study|Adverse Event|3|||
37672166|NCT02700919|69145730|FG002|Overall Study|Adverse Event|1|||
37672167|NCT02700919|69145728|FG000|Overall Study|Withdrawal by Subject|5|||
37672168|NCT02700919|69145729|FG001|Overall Study|Withdrawal by Subject|8|||
37672169|NCT02700919|69145730|FG002|Overall Study|Withdrawal by Subject|2|||
37672170|NCT02700919|69145728|FG000|Overall Study|Lost to Follow-up|2|||
37672171|NCT02700919|69145729|FG001|Overall Study|Lost to Follow-up|0|||
37672172|NCT02700919|69145730|FG002|Overall Study|Lost to Follow-up|0|||
37672173|NCT02700919|69145728|FG000|Overall Study|Other|2|||
37672174|NCT02700919|69145729|FG001|Overall Study|Other|1|||
37672175|NCT02700919|69145730|FG002|Overall Study|Other|1|||
37672176|NCT01986010|69145755|FG000|Overall Study|Adverse Event|0|||
37672177|NCT01986010|69145756|FG001|Overall Study|Adverse Event|1|||
37672178|NCT01986010|69145757|FG002|Overall Study|Adverse Event|0|||
37672179|NCT01986010|69145758|FG003|Overall Study|Adverse Event|0|||
37672180|NCT01986010|69145759|FG004|Overall Study|Adverse Event|0|||
37672181|NCT01986010|69145760|FG005|Overall Study|Adverse Event|0|||
37672182|NCT01986010|69145761|FG006|Overall Study|Adverse Event|0|||
37672183|NCT01986010|69145762|FG007|Overall Study|Adverse Event|0|||
37672184|NCT01986010|69145763|FG008|Overall Study|Adverse Event|0|||
37672185|NCT01986010|69145764|FG009|Overall Study|Adverse Event|0|||
37672186|NCT01986010|69145765|FG010|Overall Study|Adverse Event|0|||
37672187|NCT01986010|69145766|FG011|Overall Study|Adverse Event|0|||
37672188|NCT01986010|69145767|FG012|Overall Study|Adverse Event|0|||
37672189|NCT01986010|69145768|FG013|Overall Study|Adverse Event|0|||
37672190|NCT01986010|69145769|FG014|Overall Study|Adverse Event|0|||
37672191|NCT01986010|69145770|FG015|Overall Study|Adverse Event|1|||
37672192|NCT01986010|69145771|FG016|Overall Study|Adverse Event|0|||
37672193|NCT01986010|69145755|FG000|Overall Study|Lost to Follow-up|2|||
37672194|NCT01986010|69145756|FG001|Overall Study|Lost to Follow-up|1|||
37672195|NCT01986010|69145757|FG002|Overall Study|Lost to Follow-up|2|||
37672196|NCT01986010|69145758|FG003|Overall Study|Lost to Follow-up|2|||
37672197|NCT01986010|69145759|FG004|Overall Study|Lost to Follow-up|2|||
37672198|NCT01986010|69145760|FG005|Overall Study|Lost to Follow-up|2|||
37672199|NCT01986010|69145761|FG006|Overall Study|Lost to Follow-up|0|||
37672200|NCT01986010|69145762|FG007|Overall Study|Lost to Follow-up|0|||
37672201|NCT01986010|69145763|FG008|Overall Study|Lost to Follow-up|4|||
37672202|NCT01986010|69145764|FG009|Overall Study|Lost to Follow-up|2|||
37672203|NCT01986010|69145765|FG010|Overall Study|Lost to Follow-up|0|||
37672204|NCT01986010|69145766|FG011|Overall Study|Lost to Follow-up|1|||
37672205|NCT01986010|69145767|FG012|Overall Study|Lost to Follow-up|1|||
37672206|NCT01986010|69145768|FG013|Overall Study|Lost to Follow-up|1|||
37672207|NCT01986010|69145769|FG014|Overall Study|Lost to Follow-up|2|||
37672208|NCT01986010|69145770|FG015|Overall Study|Lost to Follow-up|0|||
37672209|NCT01986010|69145771|FG016|Overall Study|Lost to Follow-up|0|||
37672210|NCT01986010|69145755|FG000|Overall Study|Physician Decision|0|||
37672211|NCT01986010|69145756|FG001|Overall Study|Physician Decision|0|||
37672212|NCT01986010|69145757|FG002|Overall Study|Physician Decision|0|||
37672213|NCT01986010|69145758|FG003|Overall Study|Physician Decision|0|||
37672214|NCT01986010|69145759|FG004|Overall Study|Physician Decision|0|||
37672215|NCT01986010|69145760|FG005|Overall Study|Physician Decision|0|||
37672216|NCT01986010|69145761|FG006|Overall Study|Physician Decision|0|||
37672217|NCT01986010|69145762|FG007|Overall Study|Physician Decision|0|||
37672218|NCT01986010|69145763|FG008|Overall Study|Physician Decision|0|||
37672219|NCT01986010|69145764|FG009|Overall Study|Physician Decision|0|||
37672220|NCT01986010|69145765|FG010|Overall Study|Physician Decision|0|||
37672221|NCT01986010|69145766|FG011|Overall Study|Physician Decision|0|||
37672222|NCT01986010|69145767|FG012|Overall Study|Physician Decision|0|||
37672223|NCT01986010|69145768|FG013|Overall Study|Physician Decision|0|||
37672224|NCT01986010|69145769|FG014|Overall Study|Physician Decision|1|||
37672225|NCT01986010|69145770|FG015|Overall Study|Physician Decision|0|||
37672226|NCT01986010|69145771|FG016|Overall Study|Physician Decision|0|||
37672227|NCT01986010|69145755|FG000|Overall Study|Withdrawal by Subject|2|||
37672228|NCT01986010|69145756|FG001|Overall Study|Withdrawal by Subject|2|||
37672229|NCT01986010|69145757|FG002|Overall Study|Withdrawal by Subject|3|||
37672230|NCT01986010|69145758|FG003|Overall Study|Withdrawal by Subject|0|||
37672231|NCT01986010|69145759|FG004|Overall Study|Withdrawal by Subject|2|||
37672232|NCT01986010|69145760|FG005|Overall Study|Withdrawal by Subject|4|||
37672233|NCT01986010|69145761|FG006|Overall Study|Withdrawal by Subject|0|||
37672234|NCT01986010|69145762|FG007|Overall Study|Withdrawal by Subject|0|||
37672235|NCT01986010|69145763|FG008|Overall Study|Withdrawal by Subject|0|||
37672236|NCT01986010|69145764|FG009|Overall Study|Withdrawal by Subject|0|||
37672237|NCT01986010|69145765|FG010|Overall Study|Withdrawal by Subject|0|||
37672238|NCT01986010|69145766|FG011|Overall Study|Withdrawal by Subject|2|||
37672239|NCT01986010|69145767|FG012|Overall Study|Withdrawal by Subject|0|||
37672240|NCT01986010|69145768|FG013|Overall Study|Withdrawal by Subject|1|||
37672241|NCT01986010|69145769|FG014|Overall Study|Withdrawal by Subject|2|||
37672242|NCT01986010|69145770|FG015|Overall Study|Withdrawal by Subject|0|||
37672243|NCT01986010|69145771|FG016|Overall Study|Withdrawal by Subject|0|||
37672244|NCT01986010|69145755|FG000|Overall Study|Status Not Recorded|2|||
37672245|NCT01986010|69145756|FG001|Overall Study|Status Not Recorded|4|||
37672246|NCT01986010|69145757|FG002|Overall Study|Status Not Recorded|2|||
37672247|NCT01986010|69145758|FG003|Overall Study|Status Not Recorded|0|||
37672248|NCT01986010|69145759|FG004|Overall Study|Status Not Recorded|1|||
37672249|NCT01986010|69145760|FG005|Overall Study|Status Not Recorded|2|||
37672250|NCT01986010|69145761|FG006|Overall Study|Status Not Recorded|0|||
37942601|NCT00547378|69629747|FG000|All Implanted Cohort|Physician Decision|0|||
37942602|NCT00547378|69629748|FG001|All Implanted Cohort|Physician Decision|2|||
37672251|NCT01986010|69145762|FG007|Overall Study|Status Not Recorded|0|||
37672252|NCT01986010|69145763|FG008|Overall Study|Status Not Recorded|2|||
37672253|NCT01986010|69145764|FG009|Overall Study|Status Not Recorded|1|||
37672254|NCT01986010|69145765|FG010|Overall Study|Status Not Recorded|7|||
37672255|NCT01986010|69145766|FG011|Overall Study|Status Not Recorded|7|||
37672256|NCT01986010|69145767|FG012|Overall Study|Status Not Recorded|9|||
37672257|NCT01986010|69145768|FG013|Overall Study|Status Not Recorded|9|||
37672258|NCT01986010|69145769|FG014|Overall Study|Status Not Recorded|5|||
37672259|NCT01986010|69145770|FG015|Overall Study|Status Not Recorded|10|||
37672260|NCT01986010|69145771|FG016|Overall Study|Status Not Recorded|4|||
37672261|NCT01963780|69145817|FG000|Overall Study|Death|7|||
37672262|NCT02009878|69145824|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
37672263|NCT02009878|69145825|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
37672264|NCT02009878|69145826|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
37672265|NCT02009722|69145836|FG000|Overall Study|Protocol Violation|1|||
37672266|NCT02009722|69145837|FG001|Overall Study|Protocol Violation|2|||
37672267|NCT02009722|69145836|FG000|Overall Study|Did not receive intervention|0|||
37672268|NCT02009722|69145837|FG001|Overall Study|Did not receive intervention|1|||
37672269|NCT02655419|69145845|FG000|Overall Study|Enrolled but not treated|1|||
37672270|NCT02655419|69145846|FG001|Overall Study|Enrolled but not treated|5|||
37672271|NCT02655419|69145845|FG000|Overall Study|Withdrawal by Subject|4|||
37672272|NCT02655419|69145846|FG001|Overall Study|Withdrawal by Subject|1|||
37672273|NCT02655419|69145845|FG000|Overall Study|Other|0|||
37672274|NCT02655419|69145846|FG001|Overall Study|Other|1|||
37672275|NCT01962922|69145858|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
37672276|NCT01962922|69145859|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
37672277|NCT01962922|69145858|FG000|PK Portion Day 7|non-compliance|1|||
37672278|NCT01962922|69145859|FG001|PK Portion Day 7|non-compliance|0|||
37672279|NCT01962922|69145858|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
37672280|NCT01962922|69145859|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
37672281|NCT01962922|69145858|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
37672282|NCT01962922|69145859|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
37672283|NCT01984684|69145867|FG000|Overall Study|Lost to Follow-up|25|||
37672284|NCT01984684|69145868|FG001|Overall Study|Lost to Follow-up|24|||
37672285|NCT01984684|69145867|FG000|Overall Study|Adverse Event|8|||
37672286|NCT01984684|69145868|FG001|Overall Study|Adverse Event|12|||
37765443|NCT01438489|69279108|FG000|Overall Study|Investigator decision|0|||
37765444|NCT01438489|69279109|FG001|Overall Study|Investigator decision|1|||
37765445|NCT01438489|69279110|FG002|Overall Study|Investigator decision|0|||
37765446|NCT01438489|69279108|FG000|Overall Study|AE/SAEs|2|||
37765447|NCT01438489|69279109|FG001|Overall Study|AE/SAEs|1|||
37765448|NCT01438489|69279110|FG002|Overall Study|AE/SAEs|1|||
37765449|NCT01438489|69279108|FG000|Overall Study|Received prohibited medication|1|||
37765450|NCT01438489|69279109|FG001|Overall Study|Received prohibited medication|0|||
37765451|NCT01438489|69279110|FG002|Overall Study|Received prohibited medication|0|||
37765452|NCT01438489|69279108|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
37765453|NCT01438489|69279109|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
37765454|NCT01438489|69279110|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
37765455|NCT01438489|69279108|FG000|Overall Study|Inadequate venous access|0|||
37765456|NCT01438489|69279109|FG001|Overall Study|Inadequate venous access|2|||
37765457|NCT01438489|69279110|FG002|Overall Study|Inadequate venous access|0|||
37765458|NCT01418209|69279136|FG000|Overall Study|Withdrawal by Subject|1|||
37765459|NCT01418209|69279137|FG001|Overall Study|Withdrawal by Subject|0|||
37765460|NCT01418209|69279138|FG002|Overall Study|Withdrawal by Subject|1|||
37765461|NCT01418209|69279136|FG000|Overall Study|Did not provide hot flash diary data|1|||
37765462|NCT01418209|69279137|FG001|Overall Study|Did not provide hot flash diary data|3|||
37765463|NCT01418209|69279138|FG002|Overall Study|Did not provide hot flash diary data|3|||
37765464|NCT01570361|69279157|FG000|Overall Study|Subject discontinued|1|||
37765465|NCT01570361|69279158|FG001|Overall Study|Subject discontinued|2|||
37765466|NCT01570361|69279157|FG000|Overall Study|Sponsor closing the study|51|||
37765467|NCT01570361|69279158|FG001|Overall Study|Sponsor closing the study|50|||
37765468|NCT01570361|69279157|FG000|Overall Study|Subject excluded|5|||
37765469|NCT01570361|69279158|FG001|Overall Study|Subject excluded|3|||
37765470|NCT01570361|69279157|FG000|Overall Study|Subject withdrew consent|14|||
37765471|NCT01570361|69279158|FG001|Overall Study|Subject withdrew consent|9|||
37765472|NCT01570361|69279157|FG000|Overall Study|Adverse Event|2|||
37765473|NCT01570361|69279158|FG001|Overall Study|Adverse Event|1|||
37765474|NCT01570361|69279157|FG000|Overall Study|Lost to Follow-up|4|||
37672287|NCT01984684|69145867|FG000|Overall Study|Withdrawal by Subject|9|||
37672288|NCT01984684|69145868|FG001|Overall Study|Withdrawal by Subject|9|||
37672289|NCT01984684|69145867|FG000|Overall Study|Lack of Efficacy|3|||
37672290|NCT01984684|69145868|FG001|Overall Study|Lack of Efficacy|6|||
37672291|NCT01984684|69145867|FG000|Overall Study|Physician Decision|4|||
37672292|NCT01984684|69145868|FG001|Overall Study|Physician Decision|2|||
37765475|NCT01570361|69279158|FG001|Overall Study|Lost to Follow-up|4|||
37765476|NCT01570361|69279157|FG000|Overall Study|Death|5|||
37765477|NCT01570361|69279158|FG001|Overall Study|Death|4|||
37765478|NCT01570361|69279157|FG000|Overall Study|Other|0|||
37765479|NCT01570361|69279158|FG001|Overall Study|Other|2|||
37672293|NCT01984684|69145867|FG000|Overall Study|Protocol Violation|4|||
37765480|NCT01417195|69279169|FG000|Overall Study|Stimulation failure|1|||
37765481|NCT01417195|69279170|FG001|Overall Study|Stimulation failure|0|||
37765482|NCT01417195|69279169|FG000|Overall Study|No embryos for transfer|0|||
37765483|NCT01417195|69279170|FG001|Overall Study|No embryos for transfer|1|||
37765484|NCT01417195|69279169|FG000|Overall Study|No transfer due to risk of OHSS|1|||
37765485|NCT01417195|69279170|FG001|Overall Study|No transfer due to risk of OHSS|0|||
37765486|NCT01417195|69279169|FG000|Overall Study|No transfer due to elevated progesterone|1|||
37765487|NCT01417195|69279170|FG001|Overall Study|No transfer due to elevated progesterone|0|||
37765488|NCT01443403|69279203|FG000|Overall Study|Adverse Event|1|||
37765489|NCT01443403|69279204|FG001|Overall Study|Adverse Event|1|||
37765490|NCT01443403|69279205|FG002|Overall Study|Adverse Event|4|||
37765491|NCT01443403|69279206|FG003|Overall Study|Adverse Event|5|||
37765492|NCT01443403|69279203|FG000|Overall Study|Withdrawal by Subject|0|||
37765493|NCT01443403|69279204|FG001|Overall Study|Withdrawal by Subject|1|||
37765494|NCT01443403|69279205|FG002|Overall Study|Withdrawal by Subject|2|||
37765495|NCT01443403|69279206|FG003|Overall Study|Withdrawal by Subject|1|||
37765496|NCT01443403|69279203|FG000|Overall Study|Lost to Follow-up|0|||
37765497|NCT01443403|69279204|FG001|Overall Study|Lost to Follow-up|0|||
37765498|NCT01443403|69279205|FG002|Overall Study|Lost to Follow-up|0|||
37765499|NCT01443403|69279206|FG003|Overall Study|Lost to Follow-up|1|||
37765500|NCT01443403|69279203|FG000|Overall Study|Protocol Violation|2|||
37765501|NCT01443403|69279204|FG001|Overall Study|Protocol Violation|1|||
37765502|NCT01443403|69279205|FG002|Overall Study|Protocol Violation|1|||
37765503|NCT01443403|69279206|FG003|Overall Study|Protocol Violation|1|||
37765504|NCT01443403|69279203|FG000|Overall Study|Use of Prohibited Treatment|2|||
37765505|NCT01443403|69279204|FG001|Overall Study|Use of Prohibited Treatment|3|||
37765506|NCT01443403|69279205|FG002|Overall Study|Use of Prohibited Treatment|0|||
37765507|NCT01443403|69279206|FG003|Overall Study|Use of Prohibited Treatment|0|||
37765508|NCT01443403|69279203|FG000|Overall Study|Other - Miscellaneous|1|||
37765509|NCT01443403|69279204|FG001|Overall Study|Other - Miscellaneous|0|||
37765510|NCT01443403|69279205|FG002|Overall Study|Other - Miscellaneous|0|||
37765511|NCT01443403|69279206|FG003|Overall Study|Other - Miscellaneous|1|||
37765512|NCT01438177|69279219|FG000|Overall Study|Withdrawal by Subject|1|||
37765513|NCT01438177|69279219|FG000|Overall Study|Initiation of new therapy|1|||
37765514|NCT01442779|69279223|FG000|Overall Study|Withdrawal by Subject|3|||
37765515|NCT01442779|69279223|FG000|Overall Study|Death|3|||
37765516|NCT01442779|69279223|FG000|Overall Study|Non-compliance|1|||
37765517|NCT01416805|69279229|FG000|Overall Study|Lost to Follow-up|4|||
37765518|NCT01416805|69279230|FG001|Overall Study|Lost to Follow-up|4|||
37765519|NCT01437943|69279238|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
37765520|NCT01437943|69279239|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
37765521|NCT01437943|69279238|FG000|Overall Study|Subject expressed pregnancy plans|1|||
37765522|NCT01437943|69279239|FG001|Overall Study|Subject expressed pregnancy plans|0|||
37765523|NCT01437943|69279238|FG000|Overall Study|Adverse Event|2|||
37765524|NCT01437943|69279239|FG001|Overall Study|Adverse Event|0|||
37765525|NCT01570283|69279248|FG000|Cohort 1: Dose Level 1|Death|0|||
37765526|NCT01570283|69279249|FG001|Cohort 1: Dose Level 1|Death|1|||
37765527|NCT01570283|69279250|FG002|Cohort 1: Dose Level 1|Death|0|||
37765528|NCT01570283|69279251|FG003|Cohort 1: Dose Level 1|Death|0|||
37765529|NCT01570283|69279252|FG004|Cohort 1: Dose Level 1|Death|0|||
37672294|NCT01984684|69145868|FG001|Overall Study|Protocol Violation|2|||
37672295|NCT01984684|69145867|FG000|Overall Study|Death|0|||
37672296|NCT01984684|69145868|FG001|Overall Study|Death|1|||
37672297|NCT01984684|69145867|FG000|Overall Study|Noncompliance with study drug|2|||
37672298|NCT01984684|69145868|FG001|Overall Study|Noncompliance with study drug|1|||
37672299|NCT01984684|69145867|FG000|Overall Study|Subject incarcerated|1|||
37672300|NCT01984684|69145868|FG001|Overall Study|Subject incarcerated|0|||
37672301|NCT01984684|69145867|FG000|Overall Study|Study drug not available at site|1|||
37672302|NCT01984684|69145868|FG001|Overall Study|Study drug not available at site|1|||
37672303|NCT01984684|69145867|FG000|Overall Study|Subject had inadequate IV access|0|||
37672304|NCT01984684|69145868|FG001|Overall Study|Subject had inadequate IV access|1|||
37672305|NCT02694523|69145876|FG000|Part A|Adverse Event|7|||
37765530|NCT01570283|69279253|FG005|Cohort 1: Dose Level 1|Death|0|||
37765531|NCT01570283|69279248|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
37765532|NCT01570283|69279249|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
37765533|NCT01570283|69279250|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
37765534|NCT01570283|69279251|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
37765535|NCT01570283|69279252|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
37765536|NCT01570283|69279253|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
37765537|NCT01570283|69279248|FG000|Cohort 2: Dose Level 2|Death|0|||
37942603|NCT00547378|69629749|FG002|All Implanted Cohort|Physician Decision|6|||
37765538|NCT01570283|69279249|FG001|Cohort 2: Dose Level 2|Death|0|||
37672306|NCT02694523|69145877|FG001|Part A|Adverse Event|3|||
37672307|NCT02694523|69145878|FG002|Part A|Adverse Event|0|||
37672308|NCT02694523|69145879|FG003|Part A|Adverse Event|0|||
37672309|NCT02694523|69145880|FG004|Part A|Adverse Event|0|||
37765539|NCT01570283|69279250|FG002|Cohort 2: Dose Level 2|Death|1|||
37765540|NCT01570283|69279251|FG003|Cohort 2: Dose Level 2|Death|0|||
37765541|NCT01570283|69279252|FG004|Cohort 2: Dose Level 2|Death|0|||
37765542|NCT01570283|69279253|FG005|Cohort 2: Dose Level 2|Death|0|||
37765543|NCT01570283|69279248|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
37765544|NCT01570283|69279249|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
37765545|NCT01570283|69279250|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
37765546|NCT01570283|69279251|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
37765547|NCT01570283|69279252|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
37765548|NCT01570283|69279253|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
37765549|NCT01570283|69279248|FG000|Cohort 3: Dose Level 3|Death|0|||
37765550|NCT01570283|69279249|FG001|Cohort 3: Dose Level 3|Death|0|||
37765551|NCT01570283|69279250|FG002|Cohort 3: Dose Level 3|Death|0|||
37765552|NCT01570283|69279251|FG003|Cohort 3: Dose Level 3|Death|0|||
37765553|NCT01570283|69279252|FG004|Cohort 3: Dose Level 3|Death|0|||
37765554|NCT01570283|69279253|FG005|Cohort 3: Dose Level 3|Death|1|||
37765555|NCT01570283|69279248|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
37765556|NCT01570283|69279249|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
37765557|NCT01570283|69279250|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
37765558|NCT01570283|69279251|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
37765559|NCT01570283|69279252|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
37765560|NCT01570283|69279253|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
37765561|NCT01436357|69279269|FG000|Overall Study|Death|5|||
37765562|NCT01436357|69279270|FG001|Overall Study|Death|1|||
37765563|NCT01436357|69279269|FG000|Overall Study|Enrolled but not vaccinated|1|||
37765564|NCT01436357|69279270|FG001|Overall Study|Enrolled but not vaccinated|1|||
37765565|NCT01436357|69279269|FG000|Overall Study|Incarceration|18|||
37765566|NCT01436357|69279270|FG001|Overall Study|Incarceration|20|||
37765567|NCT01436357|69279269|FG000|Overall Study|Lost to Follow-up|67|||
37765568|NCT01436357|69279270|FG001|Overall Study|Lost to Follow-up|61|||
37765569|NCT01436357|69279269|FG000|Overall Study|Protocol Violation|1|||
37765570|NCT01436357|69279270|FG001|Overall Study|Protocol Violation|0|||
37765571|NCT01436357|69279269|FG000|Overall Study|Withdrawal by Subject|26|||
37765572|NCT01436357|69279270|FG001|Overall Study|Withdrawal by Subject|38|||
37765573|NCT01436357|69279269|FG000|Overall Study|Physician Decision|3|||
37765574|NCT01436357|69279270|FG001|Overall Study|Physician Decision|4|||
37765575|NCT01436357|69279269|FG000|Overall Study|Moved out of area|1|||
37765576|NCT01436357|69279270|FG001|Overall Study|Moved out of area|2|||
37765577|NCT01436357|69279269|FG000|Overall Study|Subject in rehab|0|||
37765578|NCT01436357|69279270|FG001|Overall Study|Subject in rehab|1|||
37765579|NCT01436201|69279276|FG000|Overall Study|Adverse Event|2|||
37765580|NCT01436201|69279276|FG000|Overall Study|Withdrawal by Subject|1|||
37765581|NCT01436201|69279276|FG000|Overall Study|Protocol Violation|1|||
37765582|NCT01437397|69279287|FG000|Overall Study|Lost to Follow-up|9|||
37765583|NCT01437397|69279288|FG001|Overall Study|Lost to Follow-up|4|||
37765584|NCT01437397|69279289|FG002|Overall Study|Lost to Follow-up|2|||
37672310|NCT02694523|69145881|FG005|Part A|Adverse Event|0|||
37672311|NCT02694523|69145882|FG006|Part A|Adverse Event|0|||
37672312|NCT02694523|69145876|FG000|Part A|Protocol Violation|1|||
37672313|NCT02694523|69145877|FG001|Part A|Protocol Violation|0|||
37672314|NCT02694523|69145878|FG002|Part A|Protocol Violation|0|||
37672315|NCT02694523|69145879|FG003|Part A|Protocol Violation|0|||
37672316|NCT02694523|69145880|FG004|Part A|Protocol Violation|0|||
37672317|NCT02694523|69145881|FG005|Part A|Protocol Violation|0|||
37672318|NCT02694523|69145882|FG006|Part A|Protocol Violation|0|||
37672319|NCT02694523|69145876|FG000|Part A|Lost to Follow-up|1|||
37672320|NCT02694523|69145877|FG001|Part A|Lost to Follow-up|2|||
37672321|NCT02694523|69145878|FG002|Part A|Lost to Follow-up|0|||
37672322|NCT02694523|69145879|FG003|Part A|Lost to Follow-up|0|||
37672323|NCT02694523|69145880|FG004|Part A|Lost to Follow-up|0|||
37672324|NCT02694523|69145881|FG005|Part A|Lost to Follow-up|0|||
37672325|NCT02694523|69145882|FG006|Part A|Lost to Follow-up|0|||
37672326|NCT02694523|69145876|FG000|Part A|Withdrawal by Subject|3|||
37672327|NCT02694523|69145877|FG001|Part A|Withdrawal by Subject|1|||
37765585|NCT01437397|69279290|FG003|Overall Study|Lost to Follow-up|4|||
37942604|NCT00547378|69629747|FG000|All Implanted Cohort|Site closure|2|||
37942605|NCT00547378|69629748|FG001|All Implanted Cohort|Site closure|0|||
37942606|NCT00547378|69629749|FG002|All Implanted Cohort|Site closure|1|||
37942607|NCT00547378|69629747|FG000|All Implanted Cohort|Other reasons|1|||
37672328|NCT02694523|69145878|FG002|Part A|Withdrawal by Subject|0|||
37672329|NCT02694523|69145879|FG003|Part A|Withdrawal by Subject|0|||
37765586|NCT01437397|69279291|FG004|Overall Study|Lost to Follow-up|5|||
37765587|NCT01437397|69279287|FG000|Overall Study|Withdrawal by Subject|11|||
37672330|NCT02694523|69145880|FG004|Part A|Withdrawal by Subject|0|||
37672331|NCT02694523|69145881|FG005|Part A|Withdrawal by Subject|0|||
37672332|NCT02694523|69145882|FG006|Part A|Withdrawal by Subject|0|||
38035992|NCT02978781|69723219|FG003|Part C|Withdrawal by Subject|0|||
37672333|NCT02694523|69145876|FG000|Part A|Other|1|||
37672334|NCT02694523|69145877|FG001|Part A|Other|1|||
37672335|NCT02694523|69145878|FG002|Part A|Other|0|||
37765588|NCT01437397|69279288|FG001|Overall Study|Withdrawal by Subject|12|||
37765589|NCT01437397|69279289|FG002|Overall Study|Withdrawal by Subject|24|||
37765590|NCT01437397|69279290|FG003|Overall Study|Withdrawal by Subject|11|||
37765591|NCT01437397|69279291|FG004|Overall Study|Withdrawal by Subject|22|||
37765592|NCT01437397|69279287|FG000|Overall Study|Protocol Violation|10|||
37765593|NCT01437397|69279288|FG001|Overall Study|Protocol Violation|12|||
37765594|NCT01437397|69279289|FG002|Overall Study|Protocol Violation|13|||
37765595|NCT01437397|69279290|FG003|Overall Study|Protocol Violation|21|||
37765596|NCT01437397|69279291|FG004|Overall Study|Protocol Violation|19|||
37765597|NCT01437397|69279287|FG000|Overall Study|Lack of Efficacy|5|||
37765598|NCT01437397|69279288|FG001|Overall Study|Lack of Efficacy|4|||
37765599|NCT01437397|69279289|FG002|Overall Study|Lack of Efficacy|8|||
37765600|NCT01437397|69279290|FG003|Overall Study|Lack of Efficacy|10|||
37765601|NCT01437397|69279291|FG004|Overall Study|Lack of Efficacy|20|||
37859717|NCT02445391|69543013|FG002|Overall Study|Complicating disease|1|||
37859718|NCT02445391|69543011|FG000|Overall Study|Withdrawal by Subject|0|||
37859719|NCT02445391|69543012|FG001|Overall Study|Withdrawal by Subject|4|||
37859720|NCT02445391|69543013|FG002|Overall Study|Withdrawal by Subject|9|||
37859721|NCT02445391|69543011|FG000|Overall Study|Financial issue|0|||
37859722|NCT02445391|69543012|FG001|Overall Study|Financial issue|0|||
37859723|NCT02445391|69543013|FG002|Overall Study|Financial issue|2|||
37859724|NCT02445391|69543011|FG000|Overall Study|Still on treatment|0|||
37859725|NCT02445391|69543012|FG001|Overall Study|Still on treatment|7|||
37859726|NCT02445391|69543013|FG002|Overall Study|Still on treatment|16|||
37859727|NCT02445391|69543011|FG000|Overall Study|Not start protocol therapy|0|||
37859728|NCT02445391|69543012|FG001|Overall Study|Not start protocol therapy|12|||
37859729|NCT02445391|69543013|FG002|Overall Study|Not start protocol therapy|9|||
37859730|NCT01246986|69543029|FG000|Overall Study|Lost to Follow-up|0|||
37859731|NCT01246986|69543030|FG001|Overall Study|Lost to Follow-up|1|||
37859732|NCT01246986|69543031|FG002|Overall Study|Lost to Follow-up|3|||
37859733|NCT01246986|69543032|FG003|Overall Study|Lost to Follow-up|0|||
37859734|NCT01246986|69543033|FG004|Overall Study|Lost to Follow-up|0|||
37859735|NCT01246986|69543034|FG005|Overall Study|Lost to Follow-up|1|||
37859736|NCT01246986|69543035|FG006|Overall Study|Lost to Follow-up|0|||
37859737|NCT01246986|69543029|FG000|Overall Study|Withdrawal by Subject|3|||
37859738|NCT01246986|69543030|FG001|Overall Study|Withdrawal by Subject|4|||
37859739|NCT01246986|69543031|FG002|Overall Study|Withdrawal by Subject|3|||
37859740|NCT01246986|69543032|FG003|Overall Study|Withdrawal by Subject|0|||
37859741|NCT01246986|69543033|FG004|Overall Study|Withdrawal by Subject|4|||
37859742|NCT01246986|69543034|FG005|Overall Study|Withdrawal by Subject|0|||
37859743|NCT01246986|69543035|FG006|Overall Study|Withdrawal by Subject|0|||
37859744|NCT01164501|69543069|FG000|Overall Study|Not treated|2|||
37859745|NCT01164501|69543070|FG001|Overall Study|Not treated|0|||
37859746|NCT01164501|69543071|FG002|Overall Study|Not treated|1|||
37859747|NCT01164501|69543069|FG000|Overall Study|Adverse Event|18|||
37859748|NCT01164501|69543070|FG001|Overall Study|Adverse Event|4|||
37859749|NCT01164501|69543071|FG002|Overall Study|Adverse Event|21|||
37859750|NCT01164501|69543069|FG000|Overall Study|Lack of Efficacy|0|||
37859751|NCT01164501|69543070|FG001|Overall Study|Lack of Efficacy|0|||
37942608|NCT00547378|69629748|FG001|All Implanted Cohort|Other reasons|0|||
37942609|NCT00547378|69629749|FG002|All Implanted Cohort|Other reasons|1|||
37942610|NCT00381043|69629759|FG000|Overall Study|Lost to Follow-up|8|||
37942611|NCT00381043|69629760|FG001|Overall Study|Lost to Follow-up|6|||
37942612|NCT00381043|69629759|FG000|Overall Study|Withdrawal by Subject|3|||
37942613|NCT00381043|69629760|FG001|Overall Study|Withdrawal by Subject|1|||
37942614|NCT00381043|69629759|FG000|Overall Study|wanted more care|0|||
37942615|NCT00381043|69629760|FG001|Overall Study|wanted more care|1|||
37942616|NCT00381043|69629759|FG000|Overall Study|incarcerated|1|||
37942617|NCT00381043|69629760|FG001|Overall Study|incarcerated|0|||
37942618|NCT00614991|69629772|FG000|Overall Study|Adverse Event|3|||
37942619|NCT00614991|69629773|FG001|Overall Study|Adverse Event|3|||
37942620|NCT00614991|69629774|FG002|Overall Study|Adverse Event|0|||
37942621|NCT00614991|69629775|FG003|Overall Study|Adverse Event|0|||
37859752|NCT01164501|69543071|FG002|Overall Study|Lack of Efficacy|1|||
37859753|NCT01164501|69543069|FG000|Overall Study|Non compliant with protocol|1|||
37859754|NCT01164501|69543070|FG001|Overall Study|Non compliant with protocol|1|||
37859755|NCT01164501|69543071|FG002|Overall Study|Non compliant with protocol|4|||
37859756|NCT01164501|69543069|FG000|Overall Study|Lost to Follow-up|3|||
37859757|NCT01164501|69543070|FG001|Overall Study|Lost to Follow-up|0|||
37859758|NCT01164501|69543071|FG002|Overall Study|Lost to Follow-up|3|||
37942622|NCT00614991|69629776|FG004|Overall Study|Adverse Event|1|||
37942623|NCT00614991|69629777|FG005|Overall Study|Adverse Event|0|||
37942624|NCT00360529|69629799|FG000|Overall Study|Adverse Event|10|||
37765602|NCT01437397|69279287|FG000|Overall Study|Adverse Event|21|||
37765603|NCT01437397|69279288|FG001|Overall Study|Adverse Event|22|||
37859759|NCT01164501|69543069|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
37859760|NCT01164501|69543070|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
37859761|NCT01164501|69543071|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
37942625|NCT00360529|69629800|FG001|Overall Study|Adverse Event|23|||
37765604|NCT01437397|69279289|FG002|Overall Study|Adverse Event|16|||
37765605|NCT01437397|69279290|FG003|Overall Study|Adverse Event|14|||
37765606|NCT01437397|69279291|FG004|Overall Study|Adverse Event|21|||
37765607|NCT01437397|69279287|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
37765608|NCT01437397|69279288|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
37765609|NCT01437397|69279289|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
37765610|NCT01437397|69279290|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
37765611|NCT01437397|69279291|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
37765612|NCT01437319|69279303|FG000|Phase I|Lost to Follow-up|2|||
37765613|NCT01437319|69279304|FG001|Phase I|Lost to Follow-up|0|||
37765614|NCT01437319|69279305|FG002|Phase I|Lost to Follow-up|0|||
37765615|NCT01437319|69279303|FG000|Phase I|Protocol Violation|1|||
37765616|NCT01437319|69279304|FG001|Phase I|Protocol Violation|0|||
37765617|NCT01437319|69279305|FG002|Phase I|Protocol Violation|0|||
37765618|NCT01437319|69279303|FG000|Phase I|Study related symptoms/complaints|27|||
37765619|NCT01437319|69279304|FG001|Phase I|Study related symptoms/complaints|0|||
37765620|NCT01437319|69279305|FG002|Phase I|Study related symptoms/complaints|0|||
37765621|NCT01437319|69279303|FG000|Phase I|Withdrawal by Subject|25|||
37765622|NCT01437319|69279304|FG001|Phase I|Withdrawal by Subject|0|||
37765623|NCT01437319|69279305|FG002|Phase I|Withdrawal by Subject|0|||
37765624|NCT01437319|69279303|FG000|Phase II|Withdrawal by Subject|0|||
37765625|NCT01437319|69279304|FG001|Phase II|Withdrawal by Subject|8|||
37765626|NCT01437319|69279305|FG002|Phase II|Withdrawal by Subject|16|||
37765627|NCT01437319|69279303|FG000|Phase II|Lost to Follow-up|0|||
37765628|NCT01437319|69279304|FG001|Phase II|Lost to Follow-up|7|||
37765629|NCT01437319|69279305|FG002|Phase II|Lost to Follow-up|2|||
37765630|NCT01437319|69279303|FG000|Phase II|Study related symptoms/complaints|0|||
37765631|NCT01437319|69279304|FG001|Phase II|Study related symptoms/complaints|28|||
37765632|NCT01437319|69279305|FG002|Phase II|Study related symptoms/complaints|19|||
37765633|NCT01437319|69279303|FG000|Phase II|Protocol Violation|0|||
37765634|NCT01437319|69279304|FG001|Phase II|Protocol Violation|1|||
37765635|NCT01437319|69279305|FG002|Phase II|Protocol Violation|0|||
37765636|NCT01416571|69279314|FG000|Overall Study|Lost to Follow-up|2|||
37765637|NCT01442155|69279335|FG000|Overall Study|Complete remission|35|||
37765638|NCT01442155|69279335|FG000|Overall Study|Recurrence|26|||
37765639|NCT01442155|69279335|FG000|Overall Study|Adverse Event|2|||
37765640|NCT01442155|69279335|FG000|Overall Study|Lost to Follow-up|2|||
37765641|NCT01416181|69279341|FG000|Part 1|Other|10|||
37765642|NCT01416181|69279342|FG001|Part 1|Other|24|||
37765643|NCT01416181|69279341|FG000|Part 1|Death|0|||
37765644|NCT01416181|69279342|FG001|Part 1|Death|1|||
37765645|NCT01416181|69279341|FG000|Part 1|Investigator Decision|7|||
37765646|NCT01416181|69279342|FG001|Part 1|Investigator Decision|6|||
37765647|NCT01416181|69279341|FG000|Part 1|Withdrawal by Subject|74|||
37765648|NCT01416181|69279342|FG001|Part 1|Withdrawal by Subject|48|||
37765649|NCT01416181|69279341|FG000|Part 1|Lack of Efficacy|16|||
37765650|NCT01416181|69279342|FG001|Part 1|Lack of Efficacy|8|||
37765651|NCT01416181|69279341|FG000|Part 1|Lost to Follow-up|1|||
37765652|NCT01416181|69279342|FG001|Part 1|Lost to Follow-up|1|||
37765653|NCT01416181|69279341|FG000|Part 1|Adverse Event|15|||
37765654|NCT01416181|69279342|FG001|Part 1|Adverse Event|18|||
37765655|NCT01416181|69279341|FG000|Part 1|Ongoing in Follow-Up|14|||
37765656|NCT01416181|69279342|FG001|Part 1|Ongoing in Follow-Up|8|||
37765657|NCT01416181|69279341|FG000|Part 2|Adverse Event|11|||
37765658|NCT01416181|69279342|FG001|Part 2|Adverse Event|4|||
37765659|NCT01416181|69279341|FG000|Part 2|Other|234|||
37765660|NCT01416181|69279342|FG001|Part 2|Other|267|||
37765661|NCT01416181|69279341|FG000|Part 2|Investigator Decision|6|||
37765662|NCT01416181|69279342|FG001|Part 2|Investigator Decision|7|||
37765663|NCT01416181|69279341|FG000|Part 2|Withdrawal by Subject|14|||
37765664|NCT01416181|69279342|FG001|Part 2|Withdrawal by Subject|5|||
37765665|NCT01416181|69279341|FG000|Part 2|Lack of Efficacy|4|||
37765666|NCT01416181|69279342|FG001|Part 2|Lack of Efficacy|1|||
37765667|NCT01416181|69279341|FG000|Part 2|Lost to Follow-up|2|||
37765668|NCT01416181|69279342|FG001|Part 2|Lost to Follow-up|2|||
37765669|NCT01441765|69279350|FG000|Overall Study|Death|1|||
37765670|NCT01441765|69279351|FG001|Overall Study|Death|0|||
37765671|NCT01419665|69279359|FG000|Combination Treatment|Adverse Event|7|||
37765672|NCT01419665|69279360|FG001|Combination Treatment|Adverse Event|10|||
37765673|NCT01419665|69279359|FG000|Combination Treatment|Physician Decision|5|||
37765674|NCT01419665|69279360|FG001|Combination Treatment|Physician Decision|8|||
37765675|NCT01419665|69279359|FG000|Combination Treatment|Protocol Violation|6|||
38035993|NCT02978781|69723220|FG004|Part C|Withdrawal by Subject|1|||
37765676|NCT01419665|69279360|FG001|Combination Treatment|Protocol Violation|2|||
37765677|NCT01419665|69279359|FG000|Combination Treatment|disease progression|10|||
37765678|NCT01419665|69279360|FG001|Combination Treatment|disease progression|9|||
37765679|NCT01419665|69279359|FG000|Combination Treatment|Death|5|||
37765680|NCT01419665|69279360|FG001|Combination Treatment|Death|7|||
37765681|NCT01419665|69279359|FG000|Combination Treatment|administrative problems|0|||
37765682|NCT01419665|69279360|FG001|Combination Treatment|administrative problems|1|||
37942626|NCT00360529|69629801|FG002|Overall Study|Adverse Event|33|||
37765683|NCT01419665|69279359|FG000|Combination Treatment|Withdrawal by Subject|5|||
37765684|NCT01419665|69279360|FG001|Combination Treatment|Withdrawal by Subject|4|||
37765685|NCT01419665|69279359|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
37765686|NCT01419665|69279360|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
37765687|NCT01419665|69279359|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
37765688|NCT01419665|69279360|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
37765689|NCT01419665|69279359|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
37765690|NCT01419665|69279360|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
37765691|NCT01419665|69279359|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
37765692|NCT01419665|69279360|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
37765693|NCT01419665|69279359|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
37765694|NCT01419665|69279360|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
37765695|NCT01419665|69279359|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
37765696|NCT01419665|69279360|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
37765697|NCT01419665|69279359|FG000|Maintenance Treatment and/or Follow up|Death|1|||
37765698|NCT01419665|69279360|FG001|Maintenance Treatment and/or Follow up|Death|2|||
37765699|NCT01419665|69279359|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
37765700|NCT01419665|69279360|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
37765701|NCT01419665|69279359|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
37765702|NCT01419665|69279360|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
37765703|NCT01419665|69279359|FG000|Open Label Phase|Death|1|||
37765704|NCT01419665|69279360|FG001|Open Label Phase|Death|0|||
37765705|NCT01419665|69279359|FG000|Open Label Phase|disease progression|0|||
37765706|NCT01419665|69279360|FG001|Open Label Phase|disease progression|1|||
37765707|NCT01436305|69279371|FG000|Overall Study|Death|1|||
37765708|NCT01436305|69279372|FG001|Overall Study|Death|0|||
37765709|NCT01436305|69279373|FG002|Overall Study|Death|0|||
37765710|NCT01436305|69279371|FG000|Overall Study|Lost to Follow-up|0|||
37765711|NCT01436305|69279372|FG001|Overall Study|Lost to Follow-up|1|||
37765712|NCT01436305|69279373|FG002|Overall Study|Lost to Follow-up|0|||
37765713|NCT01436305|69279371|FG000|Overall Study|Withdrawal by Subject|1|||
37765714|NCT01436305|69279372|FG001|Overall Study|Withdrawal by Subject|3|||
37765715|NCT01436305|69279373|FG002|Overall Study|Withdrawal by Subject|0|||
37765716|NCT01436149|69279383|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
37765717|NCT01436149|69279384|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
37765718|NCT01436149|69279385|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
37765719|NCT01436149|69279383|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
37765720|NCT01436149|69279384|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
37765721|NCT01436149|69279385|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
37765722|NCT01436149|69279383|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
37765723|NCT01436149|69279384|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
37765724|NCT01436149|69279385|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
37765725|NCT01436149|69279383|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
37765726|NCT01436149|69279384|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
37765727|NCT01436149|69279385|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
37765728|NCT01436149|69279383|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
37765729|NCT01436149|69279384|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
37765730|NCT01436149|69279385|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
37765731|NCT01436149|69279383|FG000|Antidepressant Lead-in Phase|Other|119|||
37765732|NCT01436149|69279384|FG001|Antidepressant Lead-in Phase|Other|0|||
37765733|NCT01436149|69279385|FG002|Antidepressant Lead-in Phase|Other|0|||
37765734|NCT01436149|69279383|FG000|Randomized Phase|Adverse Event|9|||
37765735|NCT01436149|69279384|FG001|Randomized Phase|Adverse Event|10|||
37765736|NCT01436149|69279385|FG002|Randomized Phase|Adverse Event|11|||
37765737|NCT01436149|69279383|FG000|Randomized Phase|Protocol Violation|4|||
37859762|NCT01164501|69543069|FG000|Overall Study|Other reason not defined above|9|||
37672336|NCT02694523|69145879|FG003|Part A|Other|0|||
37672337|NCT02694523|69145880|FG004|Part A|Other|0|||
37672338|NCT02694523|69145881|FG005|Part A|Other|0|||
37672339|NCT02694523|69145882|FG006|Part A|Other|0|||
37672340|NCT02694523|69145876|FG000|Part B|Adverse Event|0|||
37672341|NCT02694523|69145877|FG001|Part B|Adverse Event|0|||
37672342|NCT02694523|69145878|FG002|Part B|Adverse Event|7|||
37672343|NCT02694523|69145879|FG003|Part B|Adverse Event|1|||
37672344|NCT02694523|69145880|FG004|Part B|Adverse Event|1|||
37672345|NCT02694523|69145881|FG005|Part B|Adverse Event|2|||
37672346|NCT02694523|69145882|FG006|Part B|Adverse Event|0|||
37672347|NCT02694523|69145876|FG000|Part B|Protocol Violation|0|||
37672348|NCT02694523|69145877|FG001|Part B|Protocol Violation|0|||
37672349|NCT02694523|69145878|FG002|Part B|Protocol Violation|1|||
37672350|NCT02694523|69145879|FG003|Part B|Protocol Violation|0|||
37672351|NCT02694523|69145880|FG004|Part B|Protocol Violation|0|||
37672352|NCT02694523|69145881|FG005|Part B|Protocol Violation|0|||
37672353|NCT02694523|69145882|FG006|Part B|Protocol Violation|0|||
37765738|NCT01436149|69279384|FG001|Randomized Phase|Protocol Violation|5|||
37765739|NCT01436149|69279385|FG002|Randomized Phase|Protocol Violation|0|||
37765740|NCT01436149|69279383|FG000|Randomized Phase|Withdrawal by Subject|16|||
37765741|NCT01436149|69279384|FG001|Randomized Phase|Withdrawal by Subject|10|||
37765742|NCT01436149|69279385|FG002|Randomized Phase|Withdrawal by Subject|10|||
37765743|NCT01436149|69279383|FG000|Randomized Phase|Lost to Follow-up|34|||
37765744|NCT01436149|69279384|FG001|Randomized Phase|Lost to Follow-up|5|||
37765745|NCT01436149|69279385|FG002|Randomized Phase|Lost to Follow-up|6|||
37765746|NCT01436149|69279383|FG000|Randomized Phase|Lack of Efficacy|0|||
37765747|NCT01436149|69279384|FG001|Randomized Phase|Lack of Efficacy|0|||
37765748|NCT01436149|69279385|FG002|Randomized Phase|Lack of Efficacy|1|||
37765749|NCT01436149|69279383|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
37765750|NCT01436149|69279384|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
37765751|NCT01436149|69279385|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
37765752|NCT01436149|69279383|FG000|Randomized Phase|Other|12|||
37765753|NCT01436149|69279384|FG001|Randomized Phase|Other|5|||
37765754|NCT01436149|69279385|FG002|Randomized Phase|Other|11|||
37765755|NCT01415401|69279391|FG000|Overall Study|Adverse Event|5|||
37765756|NCT01415401|69279391|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
37765757|NCT01415401|69279391|FG000|Overall Study|Terminated by Sponsor|1|||
37765758|NCT01414855|69279395|FG000|Overall Study|Death|17|||
37765759|NCT01414855|69279395|FG000|Overall Study|Lost to Follow-up|5|||
37765760|NCT01414855|69279395|FG000|Overall Study|Withdrawal by Subject|7|||
37765761|NCT01527500|69279403|FG000|Part A|Administrative|11|||
37765762|NCT01527500|69279404|FG001|Part A|Administrative|7|||
37765763|NCT01527500|69279403|FG000|Part A|Adverse Event|4|||
37765764|NCT01527500|69279404|FG001|Part A|Adverse Event|2|||
37765765|NCT01527500|69279403|FG000|Part A|Death|4|||
37765766|NCT01527500|69279404|FG001|Part A|Death|1|||
37765767|NCT01527500|69279403|FG000|Part A|Lost to Follow-up|0|||
37765768|NCT01527500|69279404|FG001|Part A|Lost to Follow-up|1|||
37765769|NCT01527500|69279403|FG000|Part A|Protocol Deviation|9|||
37765770|NCT01527500|69279404|FG001|Part A|Protocol Deviation|2|||
37765771|NCT01527500|69279403|FG000|Part A|Withdrawal by Subject|2|||
37765772|NCT01527500|69279404|FG001|Part A|Withdrawal by Subject|0|||
37765773|NCT01527500|69279403|FG000|Part B|Adverse Event|1|||
37672354|NCT02694523|69145876|FG000|Part B|Lost to Follow-up|0|||
37672355|NCT02694523|69145877|FG001|Part B|Lost to Follow-up|0|||
37672356|NCT02694523|69145878|FG002|Part B|Lost to Follow-up|2|||
37672357|NCT02694523|69145879|FG003|Part B|Lost to Follow-up|3|||
37672358|NCT02694523|69145880|FG004|Part B|Lost to Follow-up|2|||
37672359|NCT02694523|69145881|FG005|Part B|Lost to Follow-up|0|||
37672360|NCT02694523|69145882|FG006|Part B|Lost to Follow-up|1|||
37672361|NCT02694523|69145876|FG000|Part B|Withdrawal by Subject|0|||
37672362|NCT02694523|69145877|FG001|Part B|Withdrawal by Subject|0|||
37672363|NCT02694523|69145878|FG002|Part B|Withdrawal by Subject|9|||
37672364|NCT02694523|69145879|FG003|Part B|Withdrawal by Subject|0|||
37672365|NCT02694523|69145880|FG004|Part B|Withdrawal by Subject|1|||
37672366|NCT02694523|69145881|FG005|Part B|Withdrawal by Subject|3|||
37672367|NCT02694523|69145882|FG006|Part B|Withdrawal by Subject|0|||
37672368|NCT02694523|69145876|FG000|Part B|Other|0|||
37672369|NCT02694523|69145877|FG001|Part B|Other|0|||
37672370|NCT02694523|69145878|FG002|Part B|Other|1|||
37672371|NCT02694523|69145879|FG003|Part B|Other|0|||
37672372|NCT02694523|69145880|FG004|Part B|Other|0|||
37672373|NCT02694523|69145881|FG005|Part B|Other|0|||
37672374|NCT02694523|69145882|FG006|Part B|Other|1|||
37672375|NCT01353703|69145896|FG000|Overall Study|Migrated/moved from study area|1|||
37672376|NCT01353703|69145897|FG001|Overall Study|Migrated/moved from study area|0|||
37672377|NCT02009332|69145911|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
37672378|NCT02009332|69145912|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
37672379|NCT02009332|69145913|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
37672380|NCT02009332|69145914|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
37672381|NCT02009332|69145915|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
37672382|NCT02009332|69145916|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
37672383|NCT02009332|69145911|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
37672384|NCT02009332|69145912|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
37765774|NCT01527500|69279404|FG001|Part B|Adverse Event|0|||
37765775|NCT01527110|69279429|FG000|Overall Study|Adverse Event|1|||
37765776|NCT01441063|69279433|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
37672385|NCT02009332|69145913|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
37672386|NCT02009332|69145914|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
37672387|NCT02009332|69145915|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
37672388|NCT02009332|69145916|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
37672389|NCT02009332|69145911|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
37765777|NCT01441063|69279433|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
37765778|NCT01436071|69279442|FG000|Overall Study|Adverse Event|1|||
37765779|NCT01436071|69279443|FG001|Overall Study|Adverse Event|0|||
37765780|NCT01436071|69279442|FG000|Overall Study|Lack of Efficacy|16|||
37672390|NCT02009332|69145912|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
37672391|NCT02009332|69145913|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
37672392|NCT02009332|69145914|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
37672393|NCT02009332|69145915|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
37672394|NCT02009332|69145916|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
37672395|NCT01984294|69145933|FG000|Overall Study|Randomized but Never Treated|0|||
37672396|NCT01984294|69145934|FG001|Overall Study|Randomized but Never Treated|0|||
37672397|NCT01984294|69145935|FG002|Overall Study|Randomized but Never Treated|1|||
37672398|NCT01984294|69145933|FG000|Overall Study|Lack of Efficacy|4|||
37672399|NCT01984294|69145934|FG001|Overall Study|Lack of Efficacy|2|||
37672400|NCT01984294|69145935|FG002|Overall Study|Lack of Efficacy|6|||
37672401|NCT01984294|69145933|FG000|Overall Study|Adverse Event|0|||
37672402|NCT01984294|69145934|FG001|Overall Study|Adverse Event|1|||
37672403|NCT01984294|69145935|FG002|Overall Study|Adverse Event|0|||
37672404|NCT01962298|69145948|FG000|Overall Study|Protocol Violation|1|||
37672405|NCT01962298|69145949|FG001|Overall Study|Protocol Violation|0|||
37672406|NCT01962298|69145950|FG002|Overall Study|Protocol Violation|1|||
37672407|NCT01962298|69145951|FG003|Overall Study|Protocol Violation|1|||
37672408|NCT01962298|69145952|FG004|Overall Study|Protocol Violation|0|||
37672409|NCT01962298|69145948|FG000|Overall Study|Data quality insufficient|2|||
37672410|NCT01962298|69145949|FG001|Overall Study|Data quality insufficient|0|||
37672411|NCT01962298|69145950|FG002|Overall Study|Data quality insufficient|3|||
37672412|NCT01962298|69145951|FG003|Overall Study|Data quality insufficient|1|||
37672413|NCT01962298|69145952|FG004|Overall Study|Data quality insufficient|4|||
37672414|NCT01962298|69145948|FG000|Overall Study|Insufficient data|0|||
37672415|NCT01962298|69145949|FG001|Overall Study|Insufficient data|2|||
37672416|NCT01962298|69145950|FG002|Overall Study|Insufficient data|1|||
37672417|NCT01962298|69145951|FG003|Overall Study|Insufficient data|0|||
37672418|NCT01962298|69145952|FG004|Overall Study|Insufficient data|1|||
37672419|NCT01962298|69145948|FG000|Overall Study|Incorrect data recorded|0|||
37672420|NCT01962298|69145949|FG001|Overall Study|Incorrect data recorded|1|||
37672421|NCT01962298|69145950|FG002|Overall Study|Incorrect data recorded|0|||
37672422|NCT01962298|69145951|FG003|Overall Study|Incorrect data recorded|0|||
37672423|NCT01962298|69145952|FG004|Overall Study|Incorrect data recorded|0|||
37672424|NCT01962298|69145948|FG000|Overall Study|Physician Decision|0|||
37672425|NCT01962298|69145949|FG001|Overall Study|Physician Decision|1|||
37672426|NCT01962298|69145950|FG002|Overall Study|Physician Decision|0|||
37672427|NCT01962298|69145951|FG003|Overall Study|Physician Decision|0|||
37672428|NCT01962298|69145952|FG004|Overall Study|Physician Decision|1|||
37672429|NCT02693743|69145966|FG000|Overall Study|Physician Decision|1|||
37672430|NCT02693743|69145967|FG001|Overall Study|Physician Decision|0|||
37672431|NCT02655887|69145973|FG000|Overall Study|Lost to Follow-up|3|||
37672432|NCT02655887|69145973|FG000|Overall Study|Death|4|||
37672433|NCT02655887|69145973|FG000|Overall Study|Withdrawal by Subject|3|||
37672434|NCT02655887|69145973|FG000|Overall Study|Missed 12-month follow-up visit|4|||
37672435|NCT02008318|69145979|FG000|Overall Study|Adverse Event|4|||
37672436|NCT02008318|69145980|FG001|Overall Study|Adverse Event|0|||
37672437|NCT02008318|69145979|FG000|Overall Study|Physician Decision|2|||
37672438|NCT02008318|69145980|FG001|Overall Study|Physician Decision|0|||
37765781|NCT01436071|69279443|FG001|Overall Study|Lack of Efficacy|7|||
37765782|NCT01436071|69279442|FG000|Overall Study|Protocol Violation|0|||
37765783|NCT01436071|69279443|FG001|Overall Study|Protocol Violation|1|||
37765784|NCT01436071|69279442|FG000|Overall Study|Lost to Follow-up|3|||
37765785|NCT01436071|69279443|FG001|Overall Study|Lost to Follow-up|1|||
37765786|NCT01436071|69279442|FG000|Overall Study|Physician Decision|1|||
37765787|NCT01436071|69279443|FG001|Overall Study|Physician Decision|0|||
37765788|NCT01436071|69279442|FG000|Overall Study|Withdrawal by Subject|2|||
37765789|NCT01436071|69279443|FG001|Overall Study|Withdrawal by Subject|2|||
37765790|NCT01436071|69279442|FG000|Overall Study|Did Not Receive Trial Medication|3|||
37765791|NCT01436071|69279443|FG001|Overall Study|Did Not Receive Trial Medication|3|||
37765792|NCT01514864|69279451|FG000|Overall Study|Disease progression|7|||
37765793|NCT01514864|69279452|FG001|Overall Study|Disease progression|5|||
37765794|NCT01514864|69279451|FG000|Overall Study|Study drug toxicity|2|||
37765795|NCT01514864|69279452|FG001|Overall Study|Study drug toxicity|0|||
37672439|NCT02008318|69145979|FG000|Overall Study|Progressive Disease|2|||
37672440|NCT02008318|69145980|FG001|Overall Study|Progressive Disease|0|||
37672441|NCT02008318|69145979|FG000|Overall Study|Protocol Violation|1|||
37672442|NCT02008318|69145980|FG001|Overall Study|Protocol Violation|1|||
37672443|NCT02008318|69145979|FG000|Overall Study|Withdrawal by Subject|3|||
37672444|NCT02008318|69145980|FG001|Overall Study|Withdrawal by Subject|0|||
37672445|NCT01982812|69145991|FG000|Overall Study|Death|1|||
37672446|NCT01982812|69145992|FG001|Overall Study|Death|5|||
37672447|NCT01982812|69145991|FG000|Overall Study|Adverse Event|0|||
37672448|NCT01982812|69145992|FG001|Overall Study|Adverse Event|5|||
37672449|NCT02007070|69145998|FG000|Overall Study|Adverse Event|4|||
37672450|NCT02007070|69145998|FG000|Overall Study|Clinical Progression|4|||
37672451|NCT02007070|69145998|FG000|Overall Study|Death|1|||
37765796|NCT01514240|69279461|FG000|Overall Study|Adverse Event|4|||
37765797|NCT01514240|69279462|FG001|Overall Study|Adverse Event|4|||
37765798|NCT01514240|69279461|FG000|Overall Study|Subject Decision|2|||
37765799|NCT01514240|69279462|FG001|Overall Study|Subject Decision|7|||
37765800|NCT01435759|69279473|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
37765801|NCT01435759|69279474|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
37765802|NCT01435759|69279475|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
37765803|NCT01435759|69279476|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
37765804|NCT01435759|69279477|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
37765805|NCT01435759|69279478|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
37765806|NCT01435759|69279473|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
37765807|NCT01435759|69279474|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
37765808|NCT01435759|69279475|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
37765809|NCT01435759|69279476|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
37765810|NCT01435759|69279477|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
37765811|NCT01435759|69279478|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
37765812|NCT01435759|69279473|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
37765813|NCT01435759|69279474|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
37765814|NCT01435759|69279475|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
37765815|NCT01435759|69279476|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
37765816|NCT01435759|69279477|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
37765817|NCT01435759|69279478|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
37765818|NCT01435759|69279473|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
37765819|NCT01435759|69279474|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
37765820|NCT01435759|69279475|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
37765821|NCT01435759|69279476|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
37765822|NCT01435759|69279477|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
37765823|NCT01435759|69279478|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
37765824|NCT01435759|69279473|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
37765825|NCT01435759|69279474|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
37765826|NCT01435759|69279475|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
37765827|NCT01435759|69279476|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
37765828|NCT01435759|69279477|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
37765829|NCT01435759|69279478|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
37765830|NCT01435759|69279473|FG000|Antidepressant Lead-in Phase|Other|119|||
37765831|NCT01435759|69279474|FG001|Antidepressant Lead-in Phase|Other|0|||
37765832|NCT01435759|69279475|FG002|Antidepressant Lead-in Phase|Other|0|||
37765833|NCT01435759|69279476|FG003|Antidepressant Lead-in Phase|Other|0|||
37765834|NCT01435759|69279477|FG004|Antidepressant Lead-in Phase|Other|0|||
37765835|NCT01435759|69279478|FG005|Antidepressant Lead-in Phase|Other|0|||
37765836|NCT01435759|69279473|FG000|Double-blind Phase|Adverse Event|7|||
37765837|NCT01435759|69279474|FG001|Double-blind Phase|Adverse Event|0|||
37765838|NCT01435759|69279475|FG002|Double-blind Phase|Adverse Event|1|||
37765839|NCT01435759|69279476|FG003|Double-blind Phase|Adverse Event|1|||
37765840|NCT01435759|69279477|FG004|Double-blind Phase|Adverse Event|1|||
37765841|NCT01435759|69279478|FG005|Double-blind Phase|Adverse Event|3|||
37765842|NCT01435759|69279473|FG000|Double-blind Phase|Protocol Violation|2|||
37765843|NCT01435759|69279474|FG001|Double-blind Phase|Protocol Violation|0|||
37765844|NCT01435759|69279475|FG002|Double-blind Phase|Protocol Violation|1|||
37765845|NCT01435759|69279476|FG003|Double-blind Phase|Protocol Violation|2|||
37765846|NCT01435759|69279477|FG004|Double-blind Phase|Protocol Violation|0|||
37765847|NCT01435759|69279478|FG005|Double-blind Phase|Protocol Violation|1|||
37765848|NCT01435759|69279473|FG000|Double-blind Phase|Withdrawal by Subject|17|||
37765849|NCT01435759|69279474|FG001|Double-blind Phase|Withdrawal by Subject|4|||
37765850|NCT01435759|69279475|FG002|Double-blind Phase|Withdrawal by Subject|3|||
37765851|NCT01435759|69279476|FG003|Double-blind Phase|Withdrawal by Subject|4|||
37765852|NCT01435759|69279477|FG004|Double-blind Phase|Withdrawal by Subject|2|||
37765853|NCT01435759|69279478|FG005|Double-blind Phase|Withdrawal by Subject|2|||
37765854|NCT01435759|69279473|FG000|Double-blind Phase|Lost to Follow-up|31|||
37765855|NCT01435759|69279474|FG001|Double-blind Phase|Lost to Follow-up|1|||
37765856|NCT01435759|69279475|FG002|Double-blind Phase|Lost to Follow-up|2|||
37765857|NCT01435759|69279476|FG003|Double-blind Phase|Lost to Follow-up|0|||
37765858|NCT01435759|69279477|FG004|Double-blind Phase|Lost to Follow-up|3|||
37765859|NCT01435759|69279478|FG005|Double-blind Phase|Lost to Follow-up|3|||
37765860|NCT01435759|69279473|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
37765861|NCT01435759|69279474|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
37765862|NCT01435759|69279475|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
37765863|NCT01435759|69279476|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
37765864|NCT01435759|69279477|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
37765865|NCT01435759|69279478|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
37765866|NCT01435759|69279473|FG000|Double-blind Phase|Other|8|||
37765867|NCT01435759|69279474|FG001|Double-blind Phase|Other|2|||
38043561|NCT02927262|69731711|FG000|Overall Study|Disease Relapse|23|||
37765868|NCT01435759|69279475|FG002|Double-blind Phase|Other|0|||
37765869|NCT01435759|69279476|FG003|Double-blind Phase|Other|2|||
37942627|NCT00360529|69629799|FG000|Overall Study|Protocol Violation|3|||
37942628|NCT00360529|69629800|FG001|Overall Study|Protocol Violation|3|||
37942629|NCT00360529|69629801|FG002|Overall Study|Protocol Violation|11|||
37942630|NCT00360529|69629799|FG000|Overall Study|Lost to Follow-up|14|||
37942631|NCT00360529|69629800|FG001|Overall Study|Lost to Follow-up|10|||
37942632|NCT00360529|69629801|FG002|Overall Study|Lost to Follow-up|13|||
37942633|NCT00360529|69629799|FG000|Overall Study|Withdrawal by Subject|22|||
37942634|NCT00360529|69629800|FG001|Overall Study|Withdrawal by Subject|14|||
37942635|NCT00360529|69629801|FG002|Overall Study|Withdrawal by Subject|18|||
37942636|NCT00360529|69629799|FG000|Overall Study|Lack of Efficacy|8|||
37942637|NCT00360529|69629800|FG001|Overall Study|Lack of Efficacy|6|||
37942638|NCT00360529|69629801|FG002|Overall Study|Lack of Efficacy|5|||
37942639|NCT00360529|69629799|FG000|Overall Study|Reason discontinued not explained above|4|||
37942640|NCT00360529|69629800|FG001|Overall Study|Reason discontinued not explained above|9|||
37942641|NCT00360529|69629801|FG002|Overall Study|Reason discontinued not explained above|11|||
37942642|NCT00369577|69629812|FG000|Overall Study|Withdrawal by Subject|0|||
37942643|NCT00369577|69629813|FG001|Overall Study|Withdrawal by Subject|0|||
37942644|NCT00369577|69629814|FG002|Overall Study|Withdrawal by Subject|1|||
37942645|NCT00678288|69629824|FG000|Overall Study|Adverse Event|0|||
37942646|NCT00678288|69629825|FG001|Overall Study|Adverse Event|2|||
37942647|NCT00678288|69629824|FG000|Overall Study|Withdrawal by Subject|1|||
37942648|NCT00678288|69629825|FG001|Overall Study|Withdrawal by Subject|1|||
37942649|NCT00678288|69629824|FG000|Overall Study|Study terminated by the sponsor|2|||
37942650|NCT00678288|69629825|FG001|Overall Study|Study terminated by the sponsor|0|||
37942651|NCT00678288|69629824|FG000|Overall Study|Not compliant with study medication|0|||
37942652|NCT00678288|69629825|FG001|Overall Study|Not compliant with study medication|1|||
37942653|NCT00678288|69629824|FG000|Overall Study|Switch to commercial drug|0|||
37942654|NCT00678288|69629825|FG001|Overall Study|Switch to commercial drug|1|||
37942655|NCT00678288|69629824|FG000|Overall Study|Reason not reported|1|||
37942656|NCT00678288|69629825|FG001|Overall Study|Reason not reported|0|||
37942657|NCT00678288|69629824|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
37942658|NCT00678288|69629825|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
37942659|NCT00369343|69629833|FG000|Double-blind Phase|Adverse Event|19|||
37942660|NCT00369343|69629834|FG001|Double-blind Phase|Adverse Event|4|||
37942661|NCT00369343|69629833|FG000|Double-blind Phase|Failed to return|2|||
37942662|NCT00369343|69629834|FG001|Double-blind Phase|Failed to return|0|||
37942663|NCT00369343|69629833|FG000|Double-blind Phase|Lost to Follow-up|9|||
37765870|NCT01435759|69279477|FG004|Double-blind Phase|Other|0|||
37765871|NCT01435759|69279478|FG005|Double-blind Phase|Other|0|||
37765872|NCT01393405|69279490|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
37765873|NCT01393405|69279491|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
37765874|NCT01393405|69279492|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
37765875|NCT01393405|69279490|FG000|Induction Period (week1-16)|Adverse Event|16|||
37765876|NCT01393405|69279491|FG001|Induction Period (week1-16)|Adverse Event|0|||
37765877|NCT01393405|69279492|FG002|Induction Period (week1-16)|Adverse Event|0|||
37765878|NCT01393405|69279490|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
37765879|NCT01393405|69279491|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
37765880|NCT01393405|69279492|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
37765881|NCT01393405|69279490|FG000|Maintenance Period Week|Lack of Efficacy|0|||
37765882|NCT01393405|69279491|FG001|Maintenance Period Week|Lack of Efficacy|22|||
37765883|NCT01393405|69279492|FG002|Maintenance Period Week|Lack of Efficacy|22|||
37765884|NCT01393405|69279490|FG000|Maintenance Period Week|Adverse Event|0|||
37765885|NCT01393405|69279491|FG001|Maintenance Period Week|Adverse Event|5|||
37765886|NCT01393405|69279492|FG002|Maintenance Period Week|Adverse Event|2|||
37765887|NCT01393405|69279490|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
37765888|NCT01393405|69279491|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
37765889|NCT01393405|69279492|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
37765890|NCT01393405|69279490|FG000|Maintenance Period Week|Lost to Follow-up|0|||
37765891|NCT01393405|69279491|FG001|Maintenance Period Week|Lost to Follow-up|1|||
37765892|NCT01393405|69279492|FG002|Maintenance Period Week|Lost to Follow-up|0|||
37765893|NCT01419197|69279504|FG000|Overall Study|Death|247|||
37765894|NCT01419197|69279505|FG001|Overall Study|Death|122|||
37765895|NCT01419197|69279504|FG000|Overall Study|Physician Decision|4|||
37765896|NCT01419197|69279505|FG001|Overall Study|Physician Decision|4|||
37765897|NCT01419197|69279504|FG000|Overall Study|Non-compliance|3|||
37942664|NCT00369343|69629834|FG001|Double-blind Phase|Lost to Follow-up|2|||
37942665|NCT00369343|69629833|FG000|Double-blind Phase|Protocol Violation|2|||
37765898|NCT01419197|69279505|FG001|Overall Study|Non-compliance|1|||
37765899|NCT01419197|69279504|FG000|Overall Study|Withdrawal by Subject|33|||
37765900|NCT01419197|69279505|FG001|Overall Study|Withdrawal by Subject|32|||
37942666|NCT00369343|69629834|FG001|Double-blind Phase|Protocol Violation|0|||
37942667|NCT00369343|69629833|FG000|Double-blind Phase|Withdrawal by Subject|8|||
37942668|NCT00369343|69629834|FG001|Double-blind Phase|Withdrawal by Subject|6|||
37942669|NCT00369343|69629833|FG000|Double-blind Phase|Lack of Efficacy|0|||
37765901|NCT01419197|69279504|FG000|Overall Study|Study Completed by Sponsor|103|||
37765902|NCT01419197|69279505|FG001|Overall Study|Study Completed by Sponsor|34|||
37765903|NCT01419197|69279504|FG000|Overall Study|Reason Not Specified|0|||
37765904|NCT01419197|69279505|FG001|Overall Study|Reason Not Specified|1|||
37765905|NCT01419197|69279504|FG000|Overall Study|Lost to Follow-up|14|||
37765906|NCT01419197|69279505|FG001|Overall Study|Lost to Follow-up|4|||
37765907|NCT01414075|69279516|FG000|Overall Study|Adverse Event|1|||
37765908|NCT01414075|69279517|FG001|Overall Study|Adverse Event|0|||
37765909|NCT01414075|69279518|FG002|Overall Study|Adverse Event|1|||
37765910|NCT01414075|69279519|FG003|Overall Study|Adverse Event|0|||
37765911|NCT01414075|69279516|FG000|Overall Study|Death|1|||
37765912|NCT01414075|69279517|FG001|Overall Study|Death|0|||
37765913|NCT01414075|69279518|FG002|Overall Study|Death|0|||
37765914|NCT01414075|69279519|FG003|Overall Study|Death|1|||
37765915|NCT01414075|69279516|FG000|Overall Study|Withdrawal by Subject|0|||
37765916|NCT01414075|69279517|FG001|Overall Study|Withdrawal by Subject|0|||
37765917|NCT01414075|69279518|FG002|Overall Study|Withdrawal by Subject|0|||
37765918|NCT01414075|69279519|FG003|Overall Study|Withdrawal by Subject|1|||
37765919|NCT01414075|69279516|FG000|Overall Study|Other than specified|1|||
37765920|NCT01414075|69279517|FG001|Overall Study|Other than specified|0|||
37765921|NCT01414075|69279518|FG002|Overall Study|Other than specified|1|||
37765922|NCT01414075|69279519|FG003|Overall Study|Other than specified|0|||
37765923|NCT01434823|69279531|FG000|Overall Study|Incomplete data in medical record|4|||
37765924|NCT01434823|69279532|FG001|Overall Study|Incomplete data in medical record|7|||
37765925|NCT01513460|69279542|FG000|Overall Study|Death|0|||
37765926|NCT01513460|69279543|FG001|Overall Study|Death|0|||
37765927|NCT01513460|69279544|FG002|Overall Study|Death|1|||
37765928|NCT01513460|69279542|FG000|Overall Study|Lost to Follow-up|0|||
37765929|NCT01513460|69279543|FG001|Overall Study|Lost to Follow-up|0|||
37765930|NCT01513460|69279544|FG002|Overall Study|Lost to Follow-up|2|||
37765931|NCT01513460|69279542|FG000|Overall Study|Abnormal laboratory value|1|||
37765932|NCT01513460|69279543|FG001|Overall Study|Abnormal laboratory value|0|||
37765933|NCT01513460|69279544|FG002|Overall Study|Abnormal laboratory value|1|||
37765934|NCT01513460|69279542|FG000|Overall Study|Lack of Efficacy|1|||
37765935|NCT01513460|69279543|FG001|Overall Study|Lack of Efficacy|2|||
37765936|NCT01513460|69279544|FG002|Overall Study|Lack of Efficacy|5|||
37765937|NCT01513460|69279542|FG000|Overall Study|Protocol deviations|3|||
37765938|NCT01513460|69279543|FG001|Overall Study|Protocol deviations|4|||
37765939|NCT01513460|69279544|FG002|Overall Study|Protocol deviations|3|||
37765940|NCT01513460|69279542|FG000|Overall Study|Withdrawal by Subject|7|||
37765941|NCT01513460|69279543|FG001|Overall Study|Withdrawal by Subject|8|||
37765942|NCT01513460|69279544|FG002|Overall Study|Withdrawal by Subject|21|||
37765943|NCT01513460|69279542|FG000|Overall Study|Adverse Event|16|||
37765944|NCT01513460|69279543|FG001|Overall Study|Adverse Event|18|||
37765945|NCT01513460|69279544|FG002|Overall Study|Adverse Event|23|||
37765946|NCT01513460|69279542|FG000|Overall Study|Abnormal test procedure|1|||
37765947|NCT01513460|69279543|FG001|Overall Study|Abnormal test procedure|0|||
37765948|NCT01513460|69279544|FG002|Overall Study|Abnormal test procedure|0|||
37765949|NCT01392547|69279554|FG000|Overall Study|Adverse Event|2|||
37765950|NCT01392547|69279554|FG000|Overall Study|Non-compliance|2|||
37672452|NCT02007070|69145998|FG000|Overall Study|Protocol Violation|2|||
37672453|NCT02007070|69145998|FG000|Overall Study|Physician Decision|1|||
37672454|NCT02007070|69145998|FG000|Overall Study|Progressive Disease|21|||
37672455|NCT02006758|69146002|FG000|Overall Study|Protocol Violation|1|||
37672456|NCT02006758|69146002|FG000|Overall Study|Death|1|||
37672457|NCT02006758|69146002|FG000|Overall Study|Lost to Follow-up|4|||
37672458|NCT02006758|69146002|FG000|Overall Study|Withdrawal by Subject|4|||
37672459|NCT02006758|69146002|FG000|Overall Study|Procedurally excluded|1|||
37672460|NCT02006758|69146002|FG000|Overall Study|Other|2|||
37672461|NCT01960816|69146007|FG000|Overall Study|Lost to Follow-up|1|||
37672462|NCT01602419|69146011|FG000|Overall Study|Not treated with Wilate|9|||
37672463|NCT01602419|69146011|FG000|Overall Study|Adverse Drug Reaction|4|||
37672464|NCT01602419|69146011|FG000|Overall Study|Insurance issues|3|||
37672465|NCT01602419|69146011|FG000|Overall Study|Changed treatment centre|1|||
37672466|NCT01602419|69146011|FG000|Overall Study|Treatment centre closed|1|||
37765951|NCT01392547|69279554|FG000|Overall Study|Withdrawal criteria|3|||
37765952|NCT01392547|69279554|FG000|Overall Study|Unclassified|1|||
37765953|NCT01435655|69279560|FG000|Overall Study|Death|2|||
37765954|NCT01435655|69279560|FG000|Overall Study|Other|1|||
37672467|NCT01602419|69146011|FG000|Overall Study|Withdrawal by Subject|5|||
37672468|NCT01602419|69146011|FG000|Overall Study|Lost to Follow-up|6|||
37672469|NCT01981954|69146056|FG000|Titration Period|Protocol Deviation|1|||
37765955|NCT01434667|69279566|FG000|Overall Study|Lost to Follow-up|5|||
37765956|NCT01434667|69279567|FG001|Overall Study|Lost to Follow-up|10|||
37765957|NCT01513148|69279575|FG000|Overall Study|Protocol Violation|2|||
37765958|NCT01513148|69279576|FG001|Overall Study|Protocol Violation|2|||
37765959|NCT01418339|69279624|FG000|Overall Study|Adverse Event|5|||
37765960|NCT01418339|69279625|FG001|Overall Study|Adverse Event|2|||
37765961|NCT01418339|69279624|FG000|Overall Study|Subject Withdrew Consent|1|||
37672470|NCT01981954|69146056|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
37672471|NCT02693119|69146062|FG000|Open-Label Period|Withdrawal by Subject|0|||
37672472|NCT02693119|69146063|FG001|Open-Label Period|Withdrawal by Subject|1|||
37672473|NCT05641311|69146101|FG000|Dosing Period 1|Adverse Event|1|||
37672474|NCT05641311|69146102|FG001|Dosing Period 1|Adverse Event|0|||
37672475|NCT05502289|69146115|FG000|Period 1|Out Of Window|1|||
37672476|NCT05502289|69146116|FG001|Period 1|Out Of Window|0|||
37672477|NCT04934722|69146128|FG000|Overall Study|Death|4|||
37672478|NCT04934722|69146129|FG001|Overall Study|Death|3|||
37672479|NCT04934722|69146128|FG000|Overall Study|Participants Ongoing|88|||
37672480|NCT04934722|69146129|FG001|Overall Study|Participants Ongoing|91|||
37672481|NCT04778592|69146137|FG000|Overall Study|Adverse Event|1|||
37672482|NCT04778592|69146138|FG001|Overall Study|Adverse Event|2|||
37672483|NCT04778592|69146137|FG000|Overall Study|Withdrawal by Subject|1|||
37672484|NCT04778592|69146138|FG001|Overall Study|Withdrawal by Subject|2|||
37672485|NCT04688671|69146146|FG000|Overall Study|Adverse Event|3|||
37672486|NCT04688671|69146147|FG001|Overall Study|Adverse Event|1|||
37672487|NCT04688671|69146146|FG000|Overall Study|Withdrawal by Subject|3|||
37672488|NCT04688671|69146147|FG001|Overall Study|Withdrawal by Subject|1|||
37672489|NCT04688671|69146146|FG000|Overall Study|Lack of Efficacy|1|||
37672490|NCT04688671|69146147|FG001|Overall Study|Lack of Efficacy|1|||
37672491|NCT04688671|69146146|FG000|Overall Study|Protocol Violation|1|||
37672492|NCT04688671|69146147|FG001|Overall Study|Protocol Violation|0|||
37672493|NCT04688671|69146146|FG000|Overall Study|Lost to Follow-up|0|||
37672494|NCT04688671|69146147|FG001|Overall Study|Lost to Follow-up|1|||
37672495|NCT04676152|69146153|FG000|Overall Study|screen fail|9|||
37672496|NCT04668209|69146159|FG000|Overall Study|Withdrawal by Subject|2|||
37672497|NCT04668209|69146160|FG001|Overall Study|Withdrawal by Subject|2|||
37765962|NCT01418339|69279625|FG001|Overall Study|Subject Withdrew Consent|2|||
37765963|NCT01418339|69279624|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
37765964|NCT01418339|69279625|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
37765965|NCT01512368|69279631|FG000|Overall Study|Protocol Violation|3|||
37765966|NCT01412983|69279635|FG000|1st Period|Ineligible|0|||
37765967|NCT01412983|69279636|FG001|1st Period|Ineligible|1|||
37765968|NCT01412983|69279635|FG000|1st Period|Positive slit lamp finding|0|||
37765969|NCT01412983|69279636|FG001|1st Period|Positive slit lamp finding|1|||
37765970|NCT01412983|69279635|FG000|1st Period|Unacceptable lens movement|0|||
37765971|NCT01412983|69279636|FG001|1st Period|Unacceptable lens movement|1|||
37765972|NCT01412983|69279635|FG000|1st Period|Inability to maintain wear|0|||
37765973|NCT01412983|69279636|FG001|1st Period|Inability to maintain wear|1|||
37765974|NCT01417481|69279645|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
37765975|NCT01417481|69279646|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
37765976|NCT01392469|69279652|FG000|Overall Study|Adverse Event|2|||
37765977|NCT01392469|69279652|FG000|Overall Study|Withdrawal by Subject|1|||
37765978|NCT01392469|69279652|FG000|Overall Study|Protocol Violation|1|||
37765979|NCT01435577|69279669|FG000|Overall Study|Adverse Event|10|||
37765980|NCT01435577|69279670|FG001|Overall Study|Adverse Event|0|||
37765981|NCT01435577|69279669|FG000|Overall Study|Lack of Efficacy|7|||
37765982|NCT01435577|69279670|FG001|Overall Study|Lack of Efficacy|51|||
37765983|NCT01435577|69279669|FG000|Overall Study|Alternative treatment started|0|||
37765984|NCT01435577|69279670|FG001|Overall Study|Alternative treatment started|1|||
37765985|NCT01411891|69279682|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
37765986|NCT01411891|69279683|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
37765987|NCT01416389|69279691|FG000|Overall Study|Lost to Follow-up|1|||
37765988|NCT01416389|69279692|FG001|Overall Study|Lost to Follow-up|0|||
37765989|NCT01416389|69279691|FG000|Overall Study|Started New Therapy|2|||
37765990|NCT01416389|69279692|FG001|Overall Study|Started New Therapy|0|||
37765991|NCT01544348|69279708|FG000|Overall Study|Lost to Follow-up|1|||
37765992|NCT01544348|69279709|FG001|Overall Study|Lost to Follow-up|0|||
37765993|NCT01544348|69279710|FG002|Overall Study|Lost to Follow-up|0|||
37765994|NCT01544348|69279711|FG003|Overall Study|Lost to Follow-up|0|||
37765995|NCT01544348|69279712|FG004|Overall Study|Lost to Follow-up|0|||
37765996|NCT01544348|69279713|FG005|Overall Study|Lost to Follow-up|0|||
37765997|NCT01544348|69279714|FG006|Overall Study|Lost to Follow-up|1|||
37765998|NCT01544348|69279715|FG007|Overall Study|Lost to Follow-up|0|||
37765999|NCT01544348|69279708|FG000|Overall Study|Withdrawal by Subject|1|||
37766000|NCT01544348|69279709|FG001|Overall Study|Withdrawal by Subject|0|||
37766001|NCT01544348|69279710|FG002|Overall Study|Withdrawal by Subject|0|||
37766002|NCT01544348|69279711|FG003|Overall Study|Withdrawal by Subject|0|||
37766003|NCT01544348|69279712|FG004|Overall Study|Withdrawal by Subject|1|||
37766004|NCT01544348|69279713|FG005|Overall Study|Withdrawal by Subject|2|||
37672498|NCT04668209|69146159|FG000|Overall Study|Lost to Follow-up|3|||
37672499|NCT04668209|69146160|FG001|Overall Study|Lost to Follow-up|4|||
37672500|NCT04668209|69146159|FG000|Overall Study|Subject Expired|2|||
37672501|NCT04668209|69146160|FG001|Overall Study|Subject Expired|0|||
37672502|NCT04668209|69146159|FG000|Overall Study|Withdrawn from study|0|||
37672503|NCT04668209|69146160|FG001|Overall Study|Withdrawn from study|1|||
37672504|NCT04668209|69146159|FG000|Overall Study|Adverse Event|0|||
37766005|NCT01544348|69279714|FG006|Overall Study|Withdrawal by Subject|1|||
37766006|NCT01544348|69279715|FG007|Overall Study|Withdrawal by Subject|0|||
37766007|NCT01544348|69279708|FG000|Overall Study|Physician Decision|0|||
37766008|NCT01544348|69279709|FG001|Overall Study|Physician Decision|0|||
37766009|NCT01544348|69279710|FG002|Overall Study|Physician Decision|0|||
37766010|NCT01544348|69279711|FG003|Overall Study|Physician Decision|0|||
37766011|NCT01544348|69279712|FG004|Overall Study|Physician Decision|0|||
37766012|NCT01544348|69279713|FG005|Overall Study|Physician Decision|1|||
37766013|NCT01544348|69279714|FG006|Overall Study|Physician Decision|0|||
37766014|NCT01544348|69279715|FG007|Overall Study|Physician Decision|0|||
37766015|NCT01416155|69279740|FG000|Overall Study|Adverse Event|8|||
37766016|NCT01416155|69279740|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
37766017|NCT01416155|69279740|FG000|Overall Study|Withdrawal by Subject|33|||
37766018|NCT01416155|69279740|FG000|Overall Study|Investigator decision|8|||
37766019|NCT01416155|69279740|FG000|Overall Study|Other|7|||
37766020|NCT01415921|69279746|FG000|Overall Study|Adverse Event|0|||
37766021|NCT01415921|69279747|FG001|Overall Study|Adverse Event|1|||
37766022|NCT01415921|69279746|FG000|Overall Study|Physician Decision|1|||
37766023|NCT01415921|69279747|FG001|Overall Study|Physician Decision|1|||
37766024|NCT01415921|69279746|FG000|Overall Study|Withdrawal by Subject|0|||
37766025|NCT01415921|69279747|FG001|Overall Study|Withdrawal by Subject|1|||
37766026|NCT01415921|69279746|FG000|Overall Study|Other|2|||
37766027|NCT01415921|69279747|FG001|Overall Study|Other|0|||
37766028|NCT01415531|69279755|FG000|Overall Study|Adverse Event|7|||
37766029|NCT01415531|69279756|FG001|Overall Study|Adverse Event|10|||
37766030|NCT01415531|69279755|FG000|Overall Study|Lack of Efficacy|3|||
37766031|NCT01415531|69279756|FG001|Overall Study|Lack of Efficacy|2|||
37766032|NCT01415531|69279755|FG000|Overall Study|Protocol Violation|0|||
37766033|NCT01415531|69279756|FG001|Overall Study|Protocol Violation|1|||
37766034|NCT01415531|69279755|FG000|Overall Study|Withdrawal by Subject|5|||
37766035|NCT01415531|69279756|FG001|Overall Study|Withdrawal by Subject|4|||
37766036|NCT01415531|69279755|FG000|Overall Study|Lost to Follow-up|6|||
37766037|NCT01415531|69279756|FG001|Overall Study|Lost to Follow-up|14|||
37766038|NCT01415531|69279755|FG000|Overall Study|Lack of Compliance|1|||
37766039|NCT01415531|69279756|FG001|Overall Study|Lack of Compliance|4|||
37766040|NCT01415531|69279755|FG000|Overall Study|Other Reasons|3|||
37766041|NCT01415531|69279756|FG001|Overall Study|Other Reasons|2|||
37766042|NCT01544114|69279765|FG000|Overall Study|Withdrawal by Subject|0|||
37766043|NCT01544114|69279766|FG001|Overall Study|Withdrawal by Subject|0|||
37766044|NCT01544114|69279767|FG002|Overall Study|Withdrawal by Subject|3|||
37766045|NCT01544114|69279765|FG000|Overall Study|Lost to Follow-up|0|||
37766046|NCT01544114|69279766|FG001|Overall Study|Lost to Follow-up|2|||
37766047|NCT01544114|69279767|FG002|Overall Study|Lost to Follow-up|0|||
37766048|NCT01544114|69279765|FG000|Overall Study|Adverse Event|1|||
37766049|NCT01544114|69279766|FG001|Overall Study|Adverse Event|1|||
37766050|NCT01544114|69279767|FG002|Overall Study|Adverse Event|2|||
37766051|NCT01544114|69279765|FG000|Overall Study|Protocol Violation|0|||
37766052|NCT01544114|69279766|FG001|Overall Study|Protocol Violation|1|||
37766053|NCT01544114|69279767|FG002|Overall Study|Protocol Violation|0|||
37766054|NCT01435265|69279779|FG000|Overall Study|Lost to Follow-up|0|||
37766055|NCT01435265|69279780|FG001|Overall Study|Lost to Follow-up|1|||
37766056|NCT01433263|69279788|FG000|Overall Study|Adverse Event|3|||
37766057|NCT01433263|69279789|FG001|Overall Study|Adverse Event|1|||
37766058|NCT01433263|69279788|FG000|Overall Study|Death|5|||
37766059|NCT01433263|69279789|FG001|Overall Study|Death|3|||
37766060|NCT01433263|69279788|FG000|Overall Study|Lost to Follow-up|0|||
37766061|NCT01433263|69279789|FG001|Overall Study|Lost to Follow-up|1|||
37766062|NCT01433263|69279788|FG000|Overall Study|Protocol Deviation|1|||
37766063|NCT01433263|69279789|FG001|Overall Study|Protocol Deviation|0|||
37766064|NCT01433263|69279788|FG000|Overall Study|Withdrawal by Subject|10|||
37766065|NCT01433263|69279789|FG001|Overall Study|Withdrawal by Subject|7|||
37766066|NCT01432951|69279798|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
37766067|NCT01432327|69279807|FG000|Posttest 3 Months|depression|3|||
37766068|NCT01432327|69279808|FG001|Posttest 3 Months|depression|0|||
37766069|NCT01432327|69279809|FG002|Posttest 3 Months|depression|0|||
37766070|NCT01432327|69279810|FG003|Posttest 3 Months|depression|0|||
37766071|NCT01432327|69279807|FG000|Posttest 3 Months|Lost to Follow-up|1|||
37766072|NCT01432327|69279808|FG001|Posttest 3 Months|Lost to Follow-up|0|||
37766073|NCT01432327|69279809|FG002|Posttest 3 Months|Lost to Follow-up|2|||
37766074|NCT01432327|69279810|FG003|Posttest 3 Months|Lost to Follow-up|1|||
37766075|NCT01432327|69279807|FG000|Posttest 3 Months|Allergic reaction|0|||
37766076|NCT01432327|69279808|FG001|Posttest 3 Months|Allergic reaction|2|||
37766077|NCT01432327|69279809|FG002|Posttest 3 Months|Allergic reaction|0|||
37766078|NCT01432327|69279810|FG003|Posttest 3 Months|Allergic reaction|0|||
37766079|NCT01432327|69279807|FG000|Posttest 6 Months|Lost to Follow-up|0|||
37766080|NCT01432327|69279808|FG001|Posttest 6 Months|Lost to Follow-up|0|||
37766081|NCT01432327|69279809|FG002|Posttest 6 Months|Lost to Follow-up|3|||
37766082|NCT01432327|69279810|FG003|Posttest 6 Months|Lost to Follow-up|2|||
37766083|NCT01432327|69279807|FG000|Posttest 6 Months|Allergic reaction|0|||
37766084|NCT01432327|69279808|FG001|Posttest 6 Months|Allergic reaction|0|||
37766085|NCT01432327|69279809|FG002|Posttest 6 Months|Allergic reaction|1|||
37766086|NCT01432327|69279810|FG003|Posttest 6 Months|Allergic reaction|0|||
37766087|NCT01432327|69279807|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
37766088|NCT01432327|69279808|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
37766089|NCT01432327|69279809|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
37766090|NCT01432327|69279810|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
37766091|NCT01432327|69279807|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
37766092|NCT01432327|69279808|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
37766093|NCT01432327|69279809|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
37766094|NCT01432327|69279810|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
37766095|NCT01432327|69279807|FG000|Posttest 1 Year|Lost to Follow-up|0|||
37766096|NCT01432327|69279808|FG001|Posttest 1 Year|Lost to Follow-up|0|||
37766097|NCT01432327|69279809|FG002|Posttest 1 Year|Lost to Follow-up|4|||
37766098|NCT01432327|69279810|FG003|Posttest 1 Year|Lost to Follow-up|2|||
37766099|NCT01432327|69279807|FG000|Posttest 1 Year|Allergic reaction|0|||
37766100|NCT01432327|69279808|FG001|Posttest 1 Year|Allergic reaction|0|||
37766101|NCT01432327|69279809|FG002|Posttest 1 Year|Allergic reaction|1|||
37766102|NCT01432327|69279810|FG003|Posttest 1 Year|Allergic reaction|1|||
37766103|NCT01410799|69279820|FG000|Overall Study|PI decision|13|||
37766104|NCT01432171|69279826|FG000|Overall Study|Death|1|||
37766105|NCT01432171|69279827|FG001|Overall Study|Death|2|||
37766106|NCT01432171|69279826|FG000|Overall Study|Lost to Follow-up|6|||
37766107|NCT01432171|69279827|FG001|Overall Study|Lost to Follow-up|5|||
37766108|NCT01432171|69279826|FG000|Overall Study|Withdrawal by Subject|3|||
37766109|NCT01432171|69279827|FG001|Overall Study|Withdrawal by Subject|1|||
37766110|NCT01432171|69279826|FG000|Overall Study|Noncompliance|2|||
37766111|NCT01432171|69279827|FG001|Overall Study|Noncompliance|3|||
37766112|NCT01432171|69279826|FG000|Overall Study|Insurance denial trial coverage|1|||
37766113|NCT01432171|69279827|FG001|Overall Study|Insurance denial trial coverage|0|||
37766114|NCT01432171|69279826|FG000|Overall Study|Patient moved to palliative care|1|||
37766115|NCT01432171|69279827|FG001|Overall Study|Patient moved to palliative care|0|||
37766116|NCT01435031|69279837|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
37766117|NCT01435031|69279837|FG000|ITT at 1 Month|Death|1|||
37766118|NCT01435031|69279837|FG000|ITT at 1 Month|Lost to Follow-up|4|||
37766119|NCT01435031|69279837|FG000|ITT at 6 Months|Death|2|||
37942670|NCT00369343|69629834|FG001|Double-blind Phase|Lack of Efficacy|4|||
37942671|NCT00369343|69629833|FG000|Double-blind Phase|Protocol deviation|4|||
37942672|NCT00369343|69629834|FG001|Double-blind Phase|Protocol deviation|0|||
37942673|NCT00369343|69629833|FG000|Open-label Phase|Adverse Event|19|||
37942674|NCT00369343|69629834|FG001|Open-label Phase|Adverse Event|7|||
37942675|NCT00369343|69629833|FG000|Open-label Phase|Failed to return|4|||
37942676|NCT00369343|69629834|FG001|Open-label Phase|Failed to return|0|||
37942677|NCT00369343|69629833|FG000|Open-label Phase|Physician Decision|2|||
37942678|NCT00369343|69629834|FG001|Open-label Phase|Physician Decision|0|||
37942679|NCT00369343|69629833|FG000|Open-label Phase|Lost to Follow-up|5|||
37942680|NCT00369343|69629834|FG001|Open-label Phase|Lost to Follow-up|3|||
37942681|NCT00369343|69629833|FG000|Open-label Phase|inadvertently reported study completers|3|||
37942682|NCT00369343|69629834|FG001|Open-label Phase|inadvertently reported study completers|2|||
37942683|NCT00369343|69629833|FG000|Open-label Phase|Protocol Violation|1|||
37942684|NCT00369343|69629834|FG001|Open-label Phase|Protocol Violation|3|||
37942685|NCT00369343|69629833|FG000|Open-label Phase|Withdrawal by Subject|15|||
37942686|NCT00369343|69629834|FG001|Open-label Phase|Withdrawal by Subject|6|||
37942687|NCT00369343|69629833|FG000|Open-label Phase|Lack of Efficacy|4|||
37942688|NCT00369343|69629834|FG001|Open-label Phase|Lack of Efficacy|3|||
37942689|NCT00369343|69629833|FG000|Open-label Phase|Lack of continuance tolerability|3|||
37766120|NCT01435031|69279837|FG000|ITT at 6 Months|Lost to Follow-up|3|||
37766121|NCT01435031|69279837|FG000|ITT at 1 Year|Death|1|||
37766122|NCT01435031|69279837|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
37766123|NCT01435031|69279837|FG000|ITT at 1 Year|Lost to Follow-up|6|||
37766124|NCT01435031|69279837|FG000|ITT at 2 Years|Death|7|||
37859763|NCT01164501|69543070|FG001|Overall Study|Other reason not defined above|1|||
37859764|NCT01164501|69543071|FG002|Overall Study|Other reason not defined above|4|||
37859765|NCT00958711|69543083|FG000|Overall Study|Withdrawal by Subject|0|||
37859766|NCT00958711|69543084|FG001|Overall Study|Withdrawal by Subject|4|||
37859767|NCT00958711|69543083|FG000|Overall Study|Physician Decision|5|||
37859768|NCT00958711|69543084|FG001|Overall Study|Physician Decision|7|||
37859769|NCT00958711|69543083|FG000|Overall Study|Lost to Follow-up|4|||
37859770|NCT00958711|69543084|FG001|Overall Study|Lost to Follow-up|1|||
37859771|NCT00958711|69543083|FG000|Overall Study|Other|2|||
37859772|NCT00958711|69543084|FG001|Overall Study|Other|5|||
37859773|NCT00958711|69543083|FG000|Overall Study|Death|1|||
37859774|NCT00958711|69543084|FG001|Overall Study|Death|2|||
37859775|NCT00958711|69543083|FG000|Overall Study|Adverse Event|1|||
37859776|NCT00958711|69543084|FG001|Overall Study|Adverse Event|2|||
37859777|NCT01163721|69543092|FG000|Overall Study|Adverse Event|5|||
37859778|NCT01163721|69543093|FG001|Overall Study|Adverse Event|6|||
37942690|NCT00369343|69629834|FG001|Open-label Phase|Lack of continuance tolerability|4|||
37942691|NCT00369343|69629833|FG000|Open-label Phase|did not take study drug|1|||
37942692|NCT00369343|69629834|FG001|Open-label Phase|did not take study drug|2|||
37942693|NCT00369265|69629849|FG000|Overall Study|Study terminated|4|||
37942694|NCT00369265|69629850|FG001|Overall Study|Study terminated|7|||
37942695|NCT00368875|69629856|FG000|Overall Study|Adverse Event|0|||
37942696|NCT00368875|69629857|FG001|Overall Study|Adverse Event|12|||
37942697|NCT00368875|69629856|FG000|Overall Study|Progressive disease|3|||
37942698|NCT00368875|69629857|FG001|Overall Study|Progressive disease|27|||
37942699|NCT00368875|69629856|FG000|Overall Study|Withdrawal by Subject|2|||
37942700|NCT00368875|69629857|FG001|Overall Study|Withdrawal by Subject|6|||
37942701|NCT00368875|69629856|FG000|Overall Study|Other Reason|0|||
37942702|NCT00368875|69629857|FG001|Overall Study|Other Reason|2|||
37942703|NCT00368875|69629856|FG000|Overall Study|Alternative Therapy|1|||
37942704|NCT00368875|69629857|FG001|Overall Study|Alternative Therapy|1|||
37942705|NCT00614055|69629866|FG000|Overall Study|Adverse Event|1|||
37942706|NCT00614055|69629867|FG001|Overall Study|Adverse Event|0|||
37942707|NCT00614055|69629868|FG002|Overall Study|Adverse Event|0|||
37942708|NCT00614055|69629866|FG000|Overall Study|Protocol Violation|2|||
37942709|NCT00614055|69629867|FG001|Overall Study|Protocol Violation|2|||
37942710|NCT00614055|69629868|FG002|Overall Study|Protocol Violation|1|||
37942711|NCT00614055|69629866|FG000|Overall Study|Lack of Efficacy|0|||
37942712|NCT00614055|69629867|FG001|Overall Study|Lack of Efficacy|0|||
37942713|NCT00614055|69629868|FG002|Overall Study|Lack of Efficacy|2|||
37942714|NCT00614055|69629866|FG000|Overall Study|Unclassified|1|||
37942715|NCT00614055|69629867|FG001|Overall Study|Unclassified|4|||
37942716|NCT00614055|69629868|FG002|Overall Study|Unclassified|2|||
37942717|NCT00613821|69629881|FG000|Overall Study|Withdrawal by Subject|1|||
37942718|NCT00613821|69629882|FG001|Overall Study|Withdrawal by Subject|0|||
37942719|NCT00613821|69629881|FG000|Overall Study|Physician Decision|1|||
37942720|NCT00613821|69629882|FG001|Overall Study|Physician Decision|1|||
37942721|NCT00548548|69629890|FG000|Overall Study|Death|345|||
37942722|NCT00548548|69629891|FG001|Overall Study|Death|348|||
37942723|NCT00548548|69629890|FG000|Overall Study|Lost to Follow-up|17|||
37942724|NCT00548548|69629891|FG001|Overall Study|Lost to Follow-up|18|||
37942725|NCT00613509|69629899|FG000|Cycle 1|Adverse Event|2|||
37942726|NCT00613509|69629900|FG001|Cycle 1|Adverse Event|1|||
37942727|NCT00613509|69629899|FG000|Cycle 1|Disease Progression|2|||
37942728|NCT00613509|69629900|FG001|Cycle 1|Disease Progression|6|||
37942729|NCT00613509|69629899|FG000|Cycle 1|Unacceptable Toxicity|1|||
37942730|NCT00613509|69629900|FG001|Cycle 1|Unacceptable Toxicity|0|||
37942731|NCT00613509|69629899|FG000|Cycle 1|Other administrative reason|0|||
37942732|NCT00613509|69629900|FG001|Cycle 1|Other administrative reason|1|||
37942733|NCT00547300|69629925|FG000|Overall Study|Study was Administratively Terminated|25|||
37942734|NCT00547300|69629926|FG001|Overall Study|Study was Administratively Terminated|24|||
37942735|NCT00547300|69629925|FG000|Overall Study|Did not Meet Entry Criteria|0|||
37942736|NCT00547300|69629926|FG001|Overall Study|Did not Meet Entry Criteria|2|||
37942737|NCT00612807|69629934|FG000|Overall Study|Withdrawal by Subject|2|||
37766125|NCT01435031|69279837|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
37766126|NCT01435031|69279837|FG000|ITT at 2 Years|Lost to Follow-up|4|||
37766127|NCT01435031|69279837|FG000|ITT at 3 Years|Death|5|||
37766128|NCT01435031|69279837|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
37766129|NCT01435031|69279837|FG000|ITT at 3 Years|Lost to Follow-up|4|||
37766130|NCT01435031|69279837|FG000|ITT at 4 Years|Death|4|||
37766131|NCT01435031|69279837|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
37766132|NCT01435031|69279837|FG000|ITT at 4 Years|Lost to Follow-up|1|||
37942738|NCT00612807|69629935|FG001|Overall Study|Withdrawal by Subject|0|||
37942739|NCT00678210|69629945|FG000|Overall Study|Adverse Event|1|||
37942740|NCT00678210|69629946|FG001|Overall Study|Adverse Event|2|||
37942741|NCT00678210|69629947|FG002|Overall Study|Adverse Event|3|||
37942742|NCT00678210|69629948|FG003|Overall Study|Adverse Event|3|||
37942743|NCT00678210|69629945|FG000|Overall Study|Lack of Efficacy|2|||
37942744|NCT00678210|69629946|FG001|Overall Study|Lack of Efficacy|3|||
37942745|NCT00678210|69629947|FG002|Overall Study|Lack of Efficacy|1|||
37942746|NCT00678210|69629948|FG003|Overall Study|Lack of Efficacy|9|||
37942747|NCT00678210|69629945|FG000|Overall Study|Lost to Follow-up|4|||
37942748|NCT00678210|69629946|FG001|Overall Study|Lost to Follow-up|2|||
37942749|NCT00678210|69629947|FG002|Overall Study|Lost to Follow-up|0|||
37942750|NCT00678210|69629948|FG003|Overall Study|Lost to Follow-up|1|||
37942751|NCT00678210|69629945|FG000|Overall Study|Withdrawal by Subject|3|||
37942752|NCT00678210|69629946|FG001|Overall Study|Withdrawal by Subject|4|||
37942753|NCT00678210|69629947|FG002|Overall Study|Withdrawal by Subject|1|||
37942754|NCT00678210|69629948|FG003|Overall Study|Withdrawal by Subject|7|||
37942755|NCT00678210|69629945|FG000|Overall Study|Other|1|||
37942756|NCT00678210|69629946|FG001|Overall Study|Other|0|||
37942757|NCT00678210|69629947|FG002|Overall Study|Other|1|||
37942758|NCT00678210|69629948|FG003|Overall Study|Other|0|||
37942759|NCT00611715|69629960|FG000|Overall Study|Disease Progression|24|||
37766133|NCT01433549|69279841|FG000|Phase 2: Second Study Product|Adverse Event|0|||
37942760|NCT00611715|69629961|FG001|Overall Study|Disease Progression|4|||
38035994|NCT02978781|69723216|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
38035995|NCT02978781|69723217|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
38035996|NCT02978781|69723218|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
38035997|NCT02978781|69723219|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
38035998|NCT02978781|69723220|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
38035999|NCT02549092|69723263|FG000|Treatment Period|Adverse Event|2|||
38036000|NCT02549092|69723264|FG001|Treatment Period|Adverse Event|2|||
38036001|NCT02549092|69723263|FG000|Treatment Period|Withdrawal by Subject|1|||
38036002|NCT02549092|69723264|FG001|Treatment Period|Withdrawal by Subject|3|||
38036003|NCT02549092|69723263|FG000|Treatment Period|Lack of Efficacy|0|||
38036004|NCT02549092|69723264|FG001|Treatment Period|Lack of Efficacy|2|||
38036005|NCT02549092|69723263|FG000|Extension/Transition Period|Adverse Event|1|||
38036006|NCT02549092|69723264|FG001|Extension/Transition Period|Adverse Event|1|||
38036007|NCT02549092|69723263|FG000|Extension/Transition Period|Withdrawal by Subject|0|||
38036008|NCT02549092|69723264|FG001|Extension/Transition Period|Withdrawal by Subject|1|||
38036009|NCT02549092|69723263|FG000|Extension/Transition Period|Other, Not Specified|4|||
38036010|NCT02549092|69723264|FG001|Extension/Transition Period|Other, Not Specified|2|||
38036011|NCT02543281|69723276|FG000|Overall Study|Lost to Follow-up|0|||
38036012|NCT02543281|69723277|FG001|Overall Study|Lost to Follow-up|0|||
38036013|NCT02543281|69723278|FG002|Overall Study|Lost to Follow-up|1|||
38036014|NCT02429791|69723288|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
38036015|NCT02429791|69723289|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
38036016|NCT02429791|69723288|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
37766134|NCT01433549|69279842|FG001|Phase 2: Second Study Product|Adverse Event|1|||
37766135|NCT01414205|69279850|FG000|Overall Study|Death|5|||
37766136|NCT01414205|69279851|FG001|Overall Study|Death|1|||
37942761|NCT00611715|69629960|FG000|Overall Study|Withdrawal by Subject|5|||
38036017|NCT02429791|69723289|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
38036018|NCT02429791|69723288|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
38036019|NCT02429791|69723289|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
38036020|NCT02429791|69723288|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
38036021|NCT02429791|69723289|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
38036022|NCT02429791|69723288|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
38036023|NCT02429791|69723289|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
38036024|NCT02429791|69723288|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
38036025|NCT02429791|69723289|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
38036026|NCT02429791|69723288|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
38036027|NCT02429791|69723289|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
38036028|NCT02429791|69723288|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
38036029|NCT02429791|69723289|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
38036030|NCT02429791|69723288|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
38036031|NCT02429791|69723289|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
38036032|NCT02429791|69723288|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
38036033|NCT02429791|69723289|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
38036034|NCT02429791|69723288|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
38036035|NCT02429791|69723289|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
38036036|NCT02429791|69723288|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
38036037|NCT02429791|69723289|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
37942762|NCT00611715|69629961|FG001|Overall Study|Withdrawal by Subject|1|||
37942763|NCT00611715|69629960|FG000|Overall Study|Adverse Event|9|||
37942764|NCT00611715|69629961|FG001|Overall Study|Adverse Event|1|||
37942765|NCT00611715|69629960|FG000|Overall Study|Death|1|||
37942766|NCT00611715|69629961|FG001|Overall Study|Death|0|||
37942767|NCT00611715|69629960|FG000|Overall Study|two patients are still on treatment|2|||
37942768|NCT00611715|69629961|FG001|Overall Study|two patients are still on treatment|0|||
37942769|NCT00677820|69629975|FG000|Overall Study|Lost to Follow-up|1|||
37942770|NCT00677820|69629976|FG001|Overall Study|Lost to Follow-up|0|||
37942771|NCT00611559|69629985|FG000|Overall Study|Lost to Follow-up|0|||
37942772|NCT00611559|69629986|FG001|Overall Study|Lost to Follow-up|1|||
37942773|NCT00611559|69629987|FG002|Overall Study|Lost to Follow-up|0|||
37942774|NCT00611559|69629985|FG000|Overall Study|Protocol Violation|1|||
37942775|NCT00611559|69629986|FG001|Overall Study|Protocol Violation|0|||
37942776|NCT00611559|69629987|FG002|Overall Study|Protocol Violation|1|||
37942777|NCT00611247|69629997|FG000|Overall Study|Death|1|||
37942778|NCT00611247|69629998|FG001|Overall Study|Death|5|||
37766137|NCT01414205|69279850|FG000|Overall Study|Lost to Follow-up|1|||
37942779|NCT00611247|69629997|FG000|Overall Study|Lack of Efficacy|1|||
37942780|NCT00611247|69629998|FG001|Overall Study|Lack of Efficacy|16|||
37942781|NCT00675948|69630007|FG000|Overall Study|Adverse Event|23|||
37766138|NCT01414205|69279851|FG001|Overall Study|Lost to Follow-up|4|||
37942782|NCT00675948|69630008|FG001|Overall Study|Adverse Event|1|||
37942783|NCT00675948|69630007|FG000|Overall Study|Lack of Efficacy|3|||
38036038|NCT02422797|69723314|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
38036039|NCT02422797|69723315|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
38036040|NCT02422797|69723314|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
38036041|NCT02422797|69723315|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
38043562|NCT02927262|69731712|FG001|Overall Study|Disease Relapse|18|||
37672505|NCT04668209|69146160|FG001|Overall Study|Adverse Event|1|||
37672506|NCT04476030|69146170|FG000|Overall Study|Withdrawal by Subject|20|||
37672507|NCT04476030|69146171|FG001|Overall Study|Withdrawal by Subject|16|||
37672508|NCT04476030|69146170|FG000|Overall Study|Adverse Event|10|||
37672509|NCT04476030|69146171|FG001|Overall Study|Adverse Event|11|||
37672510|NCT04476030|69146170|FG000|Overall Study|Lost to Follow-up|7|||
37672511|NCT04476030|69146171|FG001|Overall Study|Lost to Follow-up|4|||
37672512|NCT04476030|69146170|FG000|Overall Study|Physician Decision|1|||
37672513|NCT04476030|69146171|FG001|Overall Study|Physician Decision|1|||
37672514|NCT04476030|69146170|FG000|Overall Study|Protocol Deviation|2|||
37672515|NCT04476030|69146171|FG001|Overall Study|Protocol Deviation|0|||
37672516|NCT04476030|69146170|FG000|Overall Study|Non-compliance with Investigational Product (IP)|1|||
37672517|NCT04476030|69146171|FG001|Overall Study|Non-compliance with Investigational Product (IP)|0|||
37672518|NCT04476030|69146170|FG000|Overall Study|Randomized but not Dosed|2|||
37672519|NCT04476030|69146171|FG001|Overall Study|Randomized but not Dosed|8|||
37672520|NCT04456998|69146181|FG000|Overall Study|Adverse Event|0|||
37672521|NCT04456998|69146182|FG001|Overall Study|Adverse Event|4|||
37672522|NCT04456998|69146181|FG000|Overall Study|Protocol Deviation|0|||
37672523|NCT04456998|69146182|FG001|Overall Study|Protocol Deviation|1|||
37672524|NCT04456998|69146181|FG000|Overall Study|Withdrawal by Subject|0|||
37672525|NCT04456998|69146182|FG001|Overall Study|Withdrawal by Subject|1|||
37672526|NCT04251221|69146211|FG000|Overall Study|Arterial Line Failure, unable to proceed with PET scan|2|||
37672527|NCT04251221|69146212|FG001|Overall Study|Arterial Line Failure, unable to proceed with PET scan|0|||
37672528|NCT04203238|69146220|FG000|Overall Study|Withdrawal by Subject|1|||
37672529|NCT04203238|69146221|FG001|Overall Study|Withdrawal by Subject|1|||
37672530|NCT04203238|69146220|FG000|Overall Study|Covid-19|3|||
37672531|NCT04203238|69146221|FG001|Overall Study|Covid-19|0|||
37672532|NCT04055844|69146259|FG000|Overall Study|Adverse Event|12|||
37672533|NCT04055844|69146259|FG000|Overall Study|Poor Performance|1|||
37672534|NCT04055844|69146259|FG000|Overall Study|Death|1|||
37672535|NCT04034927|69146265|FG000|Overall Study|Adverse Event|4|||
37672536|NCT04034927|69146266|FG001|Overall Study|Adverse Event|9|||
37672537|NCT04034927|69146265|FG000|Overall Study|Death|0|||
37672538|NCT04034927|69146266|FG001|Overall Study|Death|1|||
37672539|NCT04034927|69146265|FG000|Overall Study|Withdrawal by Subject|0|||
37672540|NCT04034927|69146266|FG001|Overall Study|Withdrawal by Subject|3|||
37672541|NCT04034927|69146265|FG000|Overall Study|Still on Treatment|2|||
37672542|NCT04034927|69146266|FG001|Overall Study|Still on Treatment|1|||
37672543|NCT04034927|69146265|FG000|Overall Study|Other|1|||
37672544|NCT04034927|69146266|FG001|Overall Study|Other|1|||
37672545|NCT03905655|69146290|FG000|Overall Study|Adverse Event|1|||
37672546|NCT03905655|69146291|FG001|Overall Study|Adverse Event|0|||
37672547|NCT03905655|69146292|FG002|Overall Study|Adverse Event|1|||
37672548|NCT03905655|69146293|FG003|Overall Study|Adverse Event|1|||
37672549|NCT03761849|69146318|FG000|Overall Study|transferred to OpenLabelExtension|35|||
37672550|NCT03761849|69146319|FG001|Overall Study|transferred to OpenLabelExtension|34|||
37672551|NCT03761849|69146320|FG002|Overall Study|transferred to OpenLabelExtension|36|||
37672552|NCT03761849|69146321|FG003|Overall Study|transferred to OpenLabelExtension|0|||
37672553|NCT03761849|69146322|FG004|Overall Study|transferred to OpenLabelExtension|0|||
37672554|NCT03761849|69146323|FG005|Overall Study|transferred to OpenLabelExtension|0|||
37672555|NCT03761849|69146318|FG000|Overall Study|Adverse Event|1|||
37672556|NCT03761849|69146319|FG001|Overall Study|Adverse Event|0|||
37672557|NCT03761849|69146320|FG002|Overall Study|Adverse Event|0|||
37672558|NCT03761849|69146321|FG003|Overall Study|Adverse Event|0|||
37672559|NCT03761849|69146322|FG004|Overall Study|Adverse Event|2|||
37672560|NCT03761849|69146323|FG005|Overall Study|Adverse Event|3|||
37672561|NCT03761849|69146318|FG000|Overall Study|Withdrawal by Subject|0|||
37766139|NCT01414205|69279850|FG000|Overall Study|Physician Decision|0|||
37672562|NCT03761849|69146319|FG001|Overall Study|Withdrawal by Subject|0|||
37672563|NCT03761849|69146320|FG002|Overall Study|Withdrawal by Subject|0|||
37672564|NCT03761849|69146321|FG003|Overall Study|Withdrawal by Subject|41|||
37672565|NCT03761849|69146322|FG004|Overall Study|Withdrawal by Subject|43|||
37672566|NCT03761849|69146323|FG005|Overall Study|Withdrawal by Subject|35|||
37672567|NCT03761849|69146318|FG000|Overall Study|Lost to Follow-up|0|||
37672568|NCT03761849|69146319|FG001|Overall Study|Lost to Follow-up|1|||
37672569|NCT03761849|69146320|FG002|Overall Study|Lost to Follow-up|0|||
37672570|NCT03761849|69146321|FG003|Overall Study|Lost to Follow-up|2|||
37672571|NCT03761849|69146322|FG004|Overall Study|Lost to Follow-up|4|||
37672572|NCT03761849|69146323|FG005|Overall Study|Lost to Follow-up|5|||
37672573|NCT03761849|69146318|FG000|Overall Study|Repeated MRI dId not pass QC.|0|||
37672574|NCT03761849|69146319|FG001|Overall Study|Repeated MRI dId not pass QC.|1|||
37672575|NCT03761849|69146320|FG002|Overall Study|Repeated MRI dId not pass QC.|0|||
38036042|NCT02422797|69723314|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
38036043|NCT02422797|69723315|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
38036044|NCT02422797|69723314|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
38036045|NCT02422797|69723315|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
38036046|NCT02422797|69723314|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
38036047|NCT02422797|69723315|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
38036048|NCT02422797|69723314|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
38036049|NCT02422797|69723315|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
38036050|NCT02422797|69723314|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
38036051|NCT02422797|69723315|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
38036052|NCT02422797|69723314|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
38036053|NCT02422797|69723315|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
38036054|NCT02422797|69723314|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
38036055|NCT02422797|69723315|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
38036056|NCT02422797|69723314|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
38036057|NCT02422797|69723315|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
38036058|NCT02422797|69723314|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
38036059|NCT02422797|69723315|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
38036060|NCT02422797|69723314|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
38036061|NCT02422797|69723315|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
38036062|NCT02422797|69723314|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
38036063|NCT02422797|69723315|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
38036064|NCT02422797|69723314|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
38036065|NCT02422797|69723315|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
38036066|NCT02268851|69723337|FG000|Overall Study|Death|0|||
38036067|NCT02268851|69723338|FG001|Overall Study|Death|0|||
38036068|NCT02268851|69723339|FG002|Overall Study|Death|0|||
38036069|NCT02268851|69723340|FG003|Overall Study|Death|1|||
38036070|NCT02268851|69723341|FG004|Overall Study|Death|2|||
38036071|NCT02268851|69723342|FG005|Overall Study|Death|1|||
38036072|NCT02268851|69723337|FG000|Overall Study|Adverse Event|0|||
38036073|NCT02268851|69723338|FG001|Overall Study|Adverse Event|0|||
38036074|NCT02268851|69723339|FG002|Overall Study|Adverse Event|0|||
38036075|NCT02268851|69723340|FG003|Overall Study|Adverse Event|0|||
38036076|NCT02268851|69723341|FG004|Overall Study|Adverse Event|2|||
38036077|NCT02268851|69723342|FG005|Overall Study|Adverse Event|2|||
38036078|NCT02268851|69723337|FG000|Overall Study|Withdrawal by Subject|0|||
38036079|NCT02268851|69723338|FG001|Overall Study|Withdrawal by Subject|0|||
38036080|NCT02268851|69723339|FG002|Overall Study|Withdrawal by Subject|0|||
38036081|NCT02268851|69723340|FG003|Overall Study|Withdrawal by Subject|2|||
38036082|NCT02268851|69723341|FG004|Overall Study|Withdrawal by Subject|0|||
38036083|NCT02268851|69723342|FG005|Overall Study|Withdrawal by Subject|1|||
38036084|NCT02268851|69723337|FG000|Overall Study|Progressive Disease|1|||
38036085|NCT02268851|69723338|FG001|Overall Study|Progressive Disease|3|||
38036086|NCT02268851|69723339|FG002|Overall Study|Progressive Disease|0|||
38036087|NCT02268851|69723340|FG003|Overall Study|Progressive Disease|0|||
38036088|NCT02268851|69723341|FG004|Overall Study|Progressive Disease|1|||
38036089|NCT02268851|69723342|FG005|Overall Study|Progressive Disease|4|||
38036090|NCT02268851|69723337|FG000|Overall Study|Physician Decision|0|||
38036091|NCT02268851|69723338|FG001|Overall Study|Physician Decision|0|||
38036092|NCT02268851|69723339|FG002|Overall Study|Physician Decision|1|||
38036093|NCT02268851|69723340|FG003|Overall Study|Physician Decision|0|||
38036094|NCT02268851|69723341|FG004|Overall Study|Physician Decision|0|||
38036095|NCT02268851|69723342|FG005|Overall Study|Physician Decision|1|||
38036096|NCT02268851|69723337|FG000|Overall Study|Patient Compliance|0|||
38036097|NCT02268851|69723338|FG001|Overall Study|Patient Compliance|0|||
38036098|NCT02268851|69723339|FG002|Overall Study|Patient Compliance|0|||
38036099|NCT02268851|69723340|FG003|Overall Study|Patient Compliance|0|||
38036100|NCT02268851|69723341|FG004|Overall Study|Patient Compliance|1|||
38036101|NCT02268851|69723342|FG005|Overall Study|Patient Compliance|1|||
38036102|NCT02268851|69723337|FG000|Overall Study|Co-Morbid Condition|0|||
38036103|NCT02268851|69723338|FG001|Overall Study|Co-Morbid Condition|0|||
38036104|NCT02268851|69723339|FG002|Overall Study|Co-Morbid Condition|0|||
38036105|NCT02268851|69723340|FG003|Overall Study|Co-Morbid Condition|0|||
38036106|NCT02268851|69723341|FG004|Overall Study|Co-Morbid Condition|1|||
38036107|NCT02268851|69723342|FG005|Overall Study|Co-Morbid Condition|1|||
38036108|NCT02181738|69723360|FG000|Overall Study|Participant Withdrew Consent|2|||
38036109|NCT02181738|69723361|FG001|Overall Study|Participant Withdrew Consent|1|||
38036110|NCT02181738|69723362|FG002|Overall Study|Participant Withdrew Consent|1|||
38036111|NCT02181738|69723363|FG003|Overall Study|Participant Withdrew Consent|1|||
38036112|NCT02181738|69723360|FG000|Overall Study|Lost to Follow-up|1|||
38036113|NCT02181738|69723361|FG001|Overall Study|Lost to Follow-up|2|||
38036114|NCT02181738|69723362|FG002|Overall Study|Lost to Follow-up|1|||
38036115|NCT02181738|69723363|FG003|Overall Study|Lost to Follow-up|1|||
38036116|NCT02181738|69723360|FG000|Overall Study|Participant no Longer Meets Study Criteria|0|||
38036117|NCT02181738|69723361|FG001|Overall Study|Participant no Longer Meets Study Criteria|0|||
38036118|NCT02181738|69723362|FG002|Overall Study|Participant no Longer Meets Study Criteria|0|||
38036119|NCT02181738|69723363|FG003|Overall Study|Participant no Longer Meets Study Criteria|1|||
38036120|NCT02181738|69723360|FG000|Overall Study|Poor/Non-Compliance|1|||
38036121|NCT02181738|69723361|FG001|Overall Study|Poor/Non-Compliance|0|||
38036122|NCT02181738|69723362|FG002|Overall Study|Poor/Non-Compliance|2|||
38036123|NCT02181738|69723363|FG003|Overall Study|Poor/Non-Compliance|1|||
38036124|NCT02181738|69723360|FG000|Overall Study|Disease Progression|28|||
37672576|NCT03761849|69146321|FG003|Overall Study|Repeated MRI dId not pass QC.|0|||
37672577|NCT03761849|69146322|FG004|Overall Study|Repeated MRI dId not pass QC.|0|||
37672578|NCT03761849|69146323|FG005|Overall Study|Repeated MRI dId not pass QC.|0|||
37672579|NCT03761849|69146318|FG000|Overall Study|Physician Decision|0|||
37672580|NCT03761849|69146319|FG001|Overall Study|Physician Decision|0|||
37672581|NCT03761849|69146320|FG002|Overall Study|Physician Decision|0|||
37672582|NCT03761849|69146321|FG003|Overall Study|Physician Decision|1|||
37672583|NCT03761849|69146322|FG004|Overall Study|Physician Decision|4|||
37672584|NCT03761849|69146323|FG005|Overall Study|Physician Decision|4|||
37672585|NCT03761849|69146318|FG000|Overall Study|Death|0|||
37672586|NCT03761849|69146319|FG001|Overall Study|Death|0|||
37672587|NCT03761849|69146320|FG002|Overall Study|Death|0|||
37672588|NCT03761849|69146321|FG003|Overall Study|Death|1|||
37672589|NCT03761849|69146322|FG004|Overall Study|Death|1|||
37672590|NCT03761849|69146323|FG005|Overall Study|Death|3|||
37672591|NCT03761849|69146318|FG000|Overall Study|Protocol Violation|0|||
37672592|NCT03761849|69146319|FG001|Overall Study|Protocol Violation|0|||
37672593|NCT03761849|69146320|FG002|Overall Study|Protocol Violation|0|||
37672594|NCT03761849|69146321|FG003|Overall Study|Protocol Violation|2|||
37672595|NCT03761849|69146322|FG004|Overall Study|Protocol Violation|2|||
37672596|NCT03761849|69146323|FG005|Overall Study|Protocol Violation|1|||
37672597|NCT03761849|69146318|FG000|Overall Study|Participant could not come to site|0|||
37672598|NCT03761849|69146319|FG001|Overall Study|Participant could not come to site|0|||
37672599|NCT03761849|69146320|FG002|Overall Study|Participant could not come to site|0|||
37672600|NCT03761849|69146321|FG003|Overall Study|Participant could not come to site|0|||
37672601|NCT03761849|69146322|FG004|Overall Study|Participant could not come to site|1|||
37672602|NCT03761849|69146323|FG005|Overall Study|Participant could not come to site|0|||
37672603|NCT03761849|69146318|FG000|Overall Study|SF- safety Finding|0|||
37672604|NCT03761849|69146319|FG001|Overall Study|SF- safety Finding|0|||
37672605|NCT03761849|69146320|FG002|Overall Study|SF- safety Finding|0|||
37672606|NCT03761849|69146321|FG003|Overall Study|SF- safety Finding|0|||
37672607|NCT03761849|69146322|FG004|Overall Study|SF- safety Finding|0|||
37672608|NCT03761849|69146323|FG005|Overall Study|SF- safety Finding|1|||
37672609|NCT03761849|69146318|FG000|Overall Study|Patient did not attend visit|0|||
37672610|NCT03761849|69146319|FG001|Overall Study|Patient did not attend visit|0|||
37672611|NCT03761849|69146320|FG002|Overall Study|Patient did not attend visit|0|||
37672612|NCT03761849|69146321|FG003|Overall Study|Patient did not attend visit|0|||
37672613|NCT03761849|69146322|FG004|Overall Study|Patient did not attend visit|0|||
37672614|NCT03761849|69146323|FG005|Overall Study|Patient did not attend visit|1|||
37672615|NCT03698994|69146337|FG000|Overall Study|Adverse Event|2|||
37672616|NCT03698994|69146337|FG000|Overall Study|Death|1|||
37672617|NCT03698994|69146337|FG000|Overall Study|Physician Decision|1|||
37672618|NCT03698994|69146337|FG000|Overall Study|Withdrawal by Subject|3|||
37672619|NCT03698994|69146337|FG000|Overall Study|Progressive Disease|12|||
37672620|NCT03555149|69146362|FG000|Overall Study|Death|18|||
37672621|NCT03555149|69146363|FG001|Overall Study|Death|15|||
37672622|NCT03555149|69146364|FG002|Overall Study|Death|15|||
37672623|NCT03555149|69146365|FG003|Overall Study|Death|4|||
37672624|NCT03555149|69146366|FG004|Overall Study|Death|4|||
37672625|NCT03555149|69146367|FG005|Overall Study|Death|11|||
37672626|NCT03555149|69146368|FG006|Overall Study|Death|12|||
37672627|NCT03555149|69146369|FG007|Overall Study|Death|1|||
37672628|NCT03555149|69146362|FG000|Overall Study|Lost to Follow-up|1|||
38036125|NCT02181738|69723361|FG001|Overall Study|Disease Progression|35|||
38036126|NCT02181738|69723362|FG002|Overall Study|Disease Progression|40|||
37672629|NCT03555149|69146363|FG001|Overall Study|Lost to Follow-up|0|||
37672630|NCT03555149|69146364|FG002|Overall Study|Lost to Follow-up|0|||
37672631|NCT03555149|69146365|FG003|Overall Study|Lost to Follow-up|0|||
37766140|NCT01414205|69279851|FG001|Overall Study|Physician Decision|1|||
37766141|NCT01414205|69279850|FG000|Overall Study|Randomized but not Treated|1|||
37942784|NCT00675948|69630008|FG001|Overall Study|Lack of Efficacy|0|||
37942785|NCT00675948|69630007|FG000|Overall Study|Withdrawal by Subject|7|||
37672632|NCT03555149|69146366|FG004|Overall Study|Lost to Follow-up|0|||
37672633|NCT03555149|69146367|FG005|Overall Study|Lost to Follow-up|1|||
37672634|NCT03555149|69146368|FG006|Overall Study|Lost to Follow-up|0|||
37672635|NCT03555149|69146369|FG007|Overall Study|Lost to Follow-up|0|||
37672636|NCT03555149|69146362|FG000|Overall Study|Physician Decision|1|||
37672637|NCT03555149|69146363|FG001|Overall Study|Physician Decision|0|||
37672638|NCT03555149|69146364|FG002|Overall Study|Physician Decision|0|||
37942786|NCT00675948|69630008|FG001|Overall Study|Withdrawal by Subject|0|||
38036127|NCT02181738|69723363|FG003|Overall Study|Disease Progression|0|||
38036128|NCT02181738|69723360|FG000|Overall Study|Participant Request to Discontinue Study Treatment|5|||
38036129|NCT02181738|69723361|FG001|Overall Study|Participant Request to Discontinue Study Treatment|12|||
38036130|NCT02181738|69723362|FG002|Overall Study|Participant Request to Discontinue Study Treatment|5|||
38036131|NCT02181738|69723363|FG003|Overall Study|Participant Request to Discontinue Study Treatment|1|||
38036132|NCT02181738|69723360|FG000|Overall Study|Study Drug Toxicity|6|||
38036133|NCT02181738|69723361|FG001|Overall Study|Study Drug Toxicity|11|||
38036134|NCT02181738|69723362|FG002|Overall Study|Study Drug Toxicity|8|||
38036135|NCT02181738|69723363|FG003|Overall Study|Study Drug Toxicity|1|||
38036136|NCT02181738|69723360|FG000|Overall Study|Other Reasons|14|||
38036137|NCT02181738|69723361|FG001|Overall Study|Other Reasons|16|||
38036138|NCT02181738|69723362|FG002|Overall Study|Other Reasons|28|||
38036139|NCT02181738|69723363|FG003|Overall Study|Other Reasons|0|||
38036140|NCT02181738|69723360|FG000|Overall Study|Maximum Clinical Benefit|3|||
38036141|NCT02181738|69723361|FG001|Overall Study|Maximum Clinical Benefit|0|||
38036142|NCT02181738|69723362|FG002|Overall Study|Maximum Clinical Benefit|1|||
38036143|NCT02181738|69723363|FG003|Overall Study|Maximum Clinical Benefit|0|||
38036144|NCT02181738|69723360|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
38036145|NCT02181738|69723361|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
38036146|NCT02181738|69723362|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1|||
38036147|NCT02181738|69723363|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
38036148|NCT02142803|69723382|FG000|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
38036149|NCT02142803|69723383|FG001|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
38036150|NCT02142803|69723384|FG002|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
38036151|NCT02142803|69723385|FG003|Registration to Initiation of Therapy|Withdrawal by Subject|1|||
38036152|NCT01856192|69723402|FG000|Overall Study|Adverse Event|12|||
38036153|NCT01856192|69723403|FG001|Overall Study|Adverse Event|4|||
38036154|NCT01856192|69723402|FG000|Overall Study|Alternative therapy|0|||
38036155|NCT01856192|69723403|FG001|Overall Study|Alternative therapy|3|||
38036156|NCT01856192|69723402|FG000|Overall Study|Death|3|||
38036157|NCT01856192|69723403|FG001|Overall Study|Death|5|||
38036158|NCT01856192|69723402|FG000|Overall Study|Lack of Efficacy|0|||
38036159|NCT01856192|69723403|FG001|Overall Study|Lack of Efficacy|5|||
38036160|NCT01856192|69723402|FG000|Overall Study|Withdrawal by Subject|1|||
38036161|NCT01856192|69723403|FG001|Overall Study|Withdrawal by Subject|1|||
38036162|NCT01856192|69723402|FG000|Overall Study|Other diseases|1|||
38036163|NCT01856192|69723403|FG001|Overall Study|Other diseases|0|||
38036164|NCT01856192|69723402|FG000|Overall Study|Never started treatment|7|||
38036165|NCT01856192|69723403|FG001|Overall Study|Never started treatment|5|||
38036166|NCT01856192|69723402|FG000|Overall Study|Path ineligible|20|||
38036167|NCT01856192|69723403|FG001|Overall Study|Path ineligible|34|||
38036168|NCT01856192|69723402|FG000|Overall Study|Non-path ineligible|2|||
38036169|NCT01856192|69723403|FG001|Overall Study|Non-path ineligible|2|||
38036170|NCT01856192|69723402|FG000|Overall Study|Physician Decision|1|||
38036171|NCT01856192|69723403|FG001|Overall Study|Physician Decision|1|||
38036172|NCT01856192|69723402|FG000|Overall Study|Suspicion of progressive disease|1|||
38036173|NCT01856192|69723403|FG001|Overall Study|Suspicion of progressive disease|0|||
38036174|NCT01856192|69723402|FG000|Overall Study|Non-compliance|1|||
38036175|NCT01856192|69723403|FG001|Overall Study|Non-compliance|0|||
38036176|NCT01844986|69723411|FG000|Overall Study (Global Cohort)|Severe non-compliance to protocol|1|||
38036177|NCT01844986|69723412|FG001|Overall Study (Global Cohort)|Severe non-compliance to protocol|0|||
38036178|NCT01844986|69723411|FG000|Overall Study (Global Cohort)|Withdrawal by Subject|21|||
38036179|NCT01844986|69723412|FG001|Overall Study (Global Cohort)|Withdrawal by Subject|14|||
38036180|NCT01844986|69723411|FG000|Overall Study (Global Cohort)|Death|55|||
38036181|NCT01844986|69723412|FG001|Overall Study (Global Cohort)|Death|26|||
38036182|NCT01844986|69723411|FG000|Overall Study (China Cohort)|Withdrawal by Subject|1|||
38036183|NCT01844986|69723412|FG001|Overall Study (China Cohort)|Withdrawal by Subject|0|||
38036184|NCT01844986|69723411|FG000|Overall Study (China Cohort)|Death|10|||
38036185|NCT01844986|69723412|FG001|Overall Study (China Cohort)|Death|6|||
38036186|NCT01828099|69723424|FG000|Overall Study|Adverse Event|15|||
38036187|NCT01828099|69723425|FG001|Overall Study|Adverse Event|18|||
38036188|NCT01828099|69723424|FG000|Overall Study|Death|9|||
38036189|NCT01828099|69723425|FG001|Overall Study|Death|11|||
38036190|NCT01828099|69723424|FG000|Overall Study|Lost to Follow-up|2|||
38036191|NCT01828099|69723425|FG001|Overall Study|Lost to Follow-up|0|||
38036192|NCT01828099|69723424|FG000|Overall Study|Non-compliance with study treatment|2|||
38036193|NCT01828099|69723425|FG001|Overall Study|Non-compliance with study treatment|0|||
38036194|NCT01828099|69723424|FG000|Overall Study|Physician Decision|7|||
38036195|NCT01828099|69723425|FG001|Overall Study|Physician Decision|11|||
38036196|NCT01828099|69723424|FG000|Overall Study|Progressive disease|51|||
38036197|NCT01828099|69723425|FG001|Overall Study|Progressive disease|94|||
38036198|NCT01828099|69723424|FG000|Overall Study|Protocol Violation|1|||
38036199|NCT01828099|69723425|FG001|Overall Study|Protocol Violation|0|||
38036200|NCT01828099|69723424|FG000|Overall Study|Subject/guardian decision|7|||
38036201|NCT01828099|69723425|FG001|Overall Study|Subject/guardian decision|23|||
38036202|NCT01708941|69723435|FG000|Overall Study|Adverse Event|4|||
38036203|NCT01708941|69723436|FG001|Overall Study|Adverse Event|6|||
38036204|NCT01708941|69723437|FG002|Overall Study|Adverse Event|1|||
38036205|NCT01708941|69723438|FG003|Overall Study|Adverse Event|0|||
38036206|NCT01708941|69723435|FG000|Overall Study|Death|1|||
38036207|NCT01708941|69723436|FG001|Overall Study|Death|1|||
38036208|NCT01708941|69723437|FG002|Overall Study|Death|2|||
38036209|NCT01708941|69723438|FG003|Overall Study|Death|14|||
38036210|NCT01708941|69723435|FG000|Overall Study|Withdrawal by Subject|1|||
38036211|NCT01708941|69723436|FG001|Overall Study|Withdrawal by Subject|0|||
38036212|NCT01708941|69723437|FG002|Overall Study|Withdrawal by Subject|3|||
38036213|NCT01708941|69723438|FG003|Overall Study|Withdrawal by Subject|4|||
38036214|NCT01708941|69723435|FG000|Overall Study|Disease progression|9|||
38036215|NCT01708941|69723436|FG001|Overall Study|Disease progression|10|||
38036216|NCT01708941|69723437|FG002|Overall Study|Disease progression|8|||
38036217|NCT01708941|69723438|FG003|Overall Study|Disease progression|0|||
38036218|NCT01708941|69723435|FG000|Overall Study|Alternative therapy|0|||
38036219|NCT01708941|69723436|FG001|Overall Study|Alternative therapy|0|||
38036220|NCT01708941|69723437|FG002|Overall Study|Alternative therapy|2|||
38036221|NCT01708941|69723438|FG003|Overall Study|Alternative therapy|0|||
38036222|NCT01708941|69723435|FG000|Overall Study|Ineligible and never started treatment|1|||
38036223|NCT01708941|69723436|FG001|Overall Study|Ineligible and never started treatment|0|||
38036224|NCT01708941|69723437|FG002|Overall Study|Ineligible and never started treatment|1|||
38036225|NCT01708941|69723438|FG003|Overall Study|Ineligible and never started treatment|0|||
38036226|NCT01708941|69723435|FG000|Overall Study|Never started treatment|2|||
38036227|NCT01708941|69723436|FG001|Overall Study|Never started treatment|1|||
38036228|NCT01708941|69723437|FG002|Overall Study|Never started treatment|0|||
38036229|NCT01708941|69723438|FG003|Overall Study|Never started treatment|0|||
38036230|NCT01708941|69723435|FG000|Overall Study|Ineligible|0|||
38036231|NCT01708941|69723436|FG001|Overall Study|Ineligible|0|||
38036232|NCT01708941|69723437|FG002|Overall Study|Ineligible|2|||
38036233|NCT01708941|69723438|FG003|Overall Study|Ineligible|0|||
38036234|NCT01553149|69723450|FG000|Overall Study|Adverse Event|0|||
38036235|NCT01553149|69723451|FG001|Overall Study|Adverse Event|9|||
38036236|NCT01553149|69723450|FG000|Overall Study|Physician Decision|5|||
38036237|NCT01553149|69723451|FG001|Overall Study|Physician Decision|10|||
38036238|NCT01553149|69723450|FG000|Overall Study|Ineligible|0|||
38036239|NCT01553149|69723451|FG001|Overall Study|Ineligible|1|||
38036240|NCT01522976|69723460|FG000|Overall Study|Ineligible|4|||
38036241|NCT01522976|69723461|FG001|Overall Study|Ineligible|0|||
38036242|NCT01522976|69723462|FG002|Overall Study|Ineligible|1|||
38036243|NCT01522976|69723460|FG000|Overall Study|Death|7|||
38036244|NCT01522976|69723461|FG001|Overall Study|Death|6|||
38036245|NCT01522976|69723462|FG002|Overall Study|Death|2|||
38036246|NCT01522976|69723460|FG000|Overall Study|Still on treatment|9|||
38036247|NCT01522976|69723461|FG001|Overall Study|Still on treatment|9|||
38036248|NCT01522976|69723462|FG002|Overall Study|Still on treatment|6|||
38036249|NCT01522976|69723460|FG000|Overall Study|Disease progression|28|||
38036250|NCT01522976|69723461|FG001|Overall Study|Disease progression|30|||
38036251|NCT01522976|69723462|FG002|Overall Study|Disease progression|25|||
38036252|NCT01522976|69723460|FG000|Overall Study|Adverse Event|17|||
38036253|NCT01522976|69723461|FG001|Overall Study|Adverse Event|7|||
38036254|NCT01522976|69723462|FG002|Overall Study|Adverse Event|18|||
38036255|NCT01522976|69723460|FG000|Overall Study|Refusal unrelated to adverse event|10|||
38036256|NCT01522976|69723461|FG001|Overall Study|Refusal unrelated to adverse event|13|||
38036257|NCT01522976|69723462|FG002|Overall Study|Refusal unrelated to adverse event|14|||
38036258|NCT01522976|69723460|FG000|Overall Study|Not protocol specified|22|||
38036259|NCT01522976|69723461|FG001|Overall Study|Not protocol specified|27|||
38036260|NCT01522976|69723462|FG002|Overall Study|Not protocol specified|27|||
38043563|NCT02927262|69731711|FG000|Overall Study|Miscellaneous|5|||
37766142|NCT01414205|69279851|FG001|Overall Study|Randomized but not Treated|1|||
37766143|NCT01433471|69279859|FG000|Overall Study|Withdrawal by Subject|0|||
37766144|NCT01433471|69279860|FG001|Overall Study|Withdrawal by Subject|1|||
37766145|NCT01433159|69279870|FG000|Overall Study|Adverse Event|1|||
38043564|NCT02927262|69731712|FG001|Overall Study|Miscellaneous|4|||
38043565|NCT02927262|69731711|FG000|Overall Study|Ongoing|4|||
38043566|NCT02927262|69731712|FG001|Overall Study|Ongoing|0|||
38043567|NCT02739035|69731734|FG000|6 Weeks Post-MUA|Withdrawal by Subject|1|||
38043568|NCT02739035|69731735|FG001|6 Weeks Post-MUA|Withdrawal by Subject|3|||
38043569|NCT02739035|69731734|FG000|6 Weeks Post-MUA|Lost to Follow-up|1|||
38043570|NCT02739035|69731735|FG001|6 Weeks Post-MUA|Lost to Follow-up|3|||
38043571|NCT02739035|69731734|FG000|6 Weeks Post-MUA|Protocol Violation|1|||
37766146|NCT01433159|69279871|FG001|Overall Study|Adverse Event|0|||
38043572|NCT02739035|69731735|FG001|6 Weeks Post-MUA|Protocol Violation|4|||
38043573|NCT02739035|69731734|FG000|1 Year Post-MUA|Lost to Follow-up|10|||
38043574|NCT02739035|69731735|FG001|1 Year Post-MUA|Lost to Follow-up|11|||
38043575|NCT02657434|69731755|FG000|Overall Study|Study Terminated By Sponsor|64|||
38043576|NCT02657434|69731756|FG001|Overall Study|Study Terminated By Sponsor|82|||
38043577|NCT02657434|69731755|FG000|Overall Study|Death|189|||
38043578|NCT02657434|69731756|FG001|Overall Study|Death|190|||
38036261|NCT01367236|69723524|FG000|Overall Study|Withdrawal by Subject|3|||
38036262|NCT01367236|69723525|FG001|Overall Study|Withdrawal by Subject|1|||
38036263|NCT03681951|69723539|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
38036264|NCT03681951|69723540|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
38036265|NCT03681951|69723541|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
38036266|NCT03681951|69723542|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
38036267|NCT03681951|69723543|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
38036268|NCT03681951|69723544|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
38036269|NCT03681951|69723545|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
38036270|NCT03681951|69723546|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
38036271|NCT03681951|69723539|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
38036272|NCT03681951|69723540|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
38036273|NCT03681951|69723541|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
38036274|NCT03681951|69723542|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
38036275|NCT03681951|69723543|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
38036276|NCT03681951|69723544|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
38036277|NCT03681951|69723545|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
38036278|NCT03681951|69723546|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
38036279|NCT03681951|69723539|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
38036280|NCT03681951|69723540|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
38036281|NCT03681951|69723541|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
38036282|NCT03681951|69723542|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
38036283|NCT03681951|69723543|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
38036284|NCT03681951|69723544|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
38036285|NCT03681951|69723545|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
38036286|NCT03681951|69723546|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
38036287|NCT03681405|69723571|FG000|Overall Study|Found to be ineligible after randomized|1|||
38036288|NCT03681405|69723572|FG001|Overall Study|Found to be ineligible after randomized|0|||
38036289|NCT00174785|69723582|FG000|Overall Study|Adverse Event|293|||
38036290|NCT00174785|69723583|FG001|Overall Study|Adverse Event|191|||
38036291|NCT00174785|69723582|FG000|Overall Study|Protocol Violation|14|||
38036292|NCT00174785|69723583|FG001|Overall Study|Protocol Violation|14|||
38036293|NCT00174785|69723582|FG000|Overall Study|Withdrawal by Subject|173|||
38036294|NCT00174785|69723583|FG001|Overall Study|Withdrawal by Subject|175|||
38036295|NCT00174785|69723582|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
38036296|NCT00174785|69723583|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
38036297|NCT00174785|69723582|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
38036298|NCT00174785|69723583|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
38036299|NCT00174785|69723582|FG000|Overall Study|Other prohibited medication|5|||
38036300|NCT00174785|69723583|FG001|Overall Study|Other prohibited medication|3|||
38036301|NCT00174785|69723582|FG000|Overall Study|Family request|6|||
38036302|NCT00174785|69723583|FG001|Overall Study|Family request|8|||
38036303|NCT00174785|69723582|FG000|Overall Study|Not pre-specified/Not coded|56|||
38036304|NCT00174785|69723583|FG001|Overall Study|Not pre-specified/Not coded|70|||
38036305|NCT03681093|69723592|FG000|Overall Study|Subject decision|0|||
38036306|NCT03681093|69723593|FG001|Overall Study|Subject decision|2|||
38036307|NCT03681093|69723594|FG002|Overall Study|Subject decision|1|||
38036308|NCT00166517|69723604|FG000|Overall Study|Lost to Follow-up|1|||
38036309|NCT00166517|69723605|FG001|Overall Study|Lost to Follow-up|0|||
38036310|NCT00166517|69723604|FG000|Overall Study|Protocol Violation|4|||
38036311|NCT00166517|69723605|FG001|Overall Study|Protocol Violation|1|||
38036312|NCT00166517|69723604|FG000|Overall Study|Withdrawal by Subject|0|||
38036313|NCT00166517|69723605|FG001|Overall Study|Withdrawal by Subject|1|||
38036314|NCT00166439|69723611|FG000|Overall Study|Ineligible|5|||
38036315|NCT00138671|69723617|FG000|Overall Study|Death|0|||
37766147|NCT01433159|69279870|FG000|Overall Study|Physician Decision|1|||
37766148|NCT01433159|69279871|FG001|Overall Study|Physician Decision|0|||
37766149|NCT01433159|69279870|FG000|Overall Study|Protocol Violation|0|||
37942787|NCT00675948|69630007|FG000|Overall Study|Lost to Follow-up|2|||
37942788|NCT00675948|69630008|FG001|Overall Study|Lost to Follow-up|0|||
37942789|NCT00675948|69630007|FG000|Overall Study|Protocol Violation|1|||
37942790|NCT00675948|69630008|FG001|Overall Study|Protocol Violation|0|||
37942791|NCT00675948|69630007|FG000|Overall Study|Pain under control|1|||
37942792|NCT00675948|69630008|FG001|Overall Study|Pain under control|0|||
37942793|NCT00675948|69630007|FG000|Overall Study|Sponsor decision|0|||
37942794|NCT00675948|69630008|FG001|Overall Study|Sponsor decision|1|||
37942795|NCT00675948|69630007|FG000|Overall Study|Patient died|1|||
37942796|NCT00675948|69630008|FG001|Overall Study|Patient died|0|||
37942797|NCT00675948|69630007|FG000|Overall Study|Patient unable to comply with diaries|1|||
37942798|NCT00675948|69630008|FG001|Overall Study|Patient unable to comply with diaries|0|||
38036316|NCT00138671|69723618|FG001|Overall Study|Death|3|||
38036317|NCT00138671|69723617|FG000|Overall Study|Adverse Event|6|||
38036318|NCT00138671|69723618|FG001|Overall Study|Adverse Event|3|||
38036319|NCT00138671|69723617|FG000|Overall Study|Lost to Follow-up|1|||
38036320|NCT00138671|69723618|FG001|Overall Study|Lost to Follow-up|2|||
38036321|NCT00138671|69723617|FG000|Overall Study|Withdrawal by Subject|3|||
38036322|NCT00138671|69723618|FG001|Overall Study|Withdrawal by Subject|5|||
38036323|NCT00138671|69723617|FG000|Overall Study|Other|3|||
38036324|NCT00138671|69723618|FG001|Overall Study|Other|3|||
38036325|NCT01367158|69723637|FG000|Overall Study|Withdrew consent|0|||
38036326|NCT01367158|69723638|FG001|Overall Study|Withdrew consent|2|||
38036327|NCT01367158|69723639|FG002|Overall Study|Withdrew consent|1|||
38036328|NCT01367158|69723640|FG003|Overall Study|Withdrew consent|0|||
38036329|NCT01367158|69723641|FG004|Overall Study|Withdrew consent|2|||
38036330|NCT01367158|69723642|FG005|Overall Study|Withdrew consent|0|||
38036331|NCT01367158|69723643|FG006|Overall Study|Withdrew consent|0|||
38036332|NCT01367158|69723644|FG007|Overall Study|Withdrew consent|1|||
38036333|NCT01367158|69723645|FG008|Overall Study|Withdrew consent|0|||
38036334|NCT01367158|69723646|FG009|Overall Study|Withdrew consent|0|||
38036335|NCT01367158|69723647|FG010|Overall Study|Withdrew consent|0|||
38036336|NCT01367158|69723637|FG000|Overall Study|Lost to Follow-up|0|||
38036337|NCT01367158|69723638|FG001|Overall Study|Lost to Follow-up|0|||
38036338|NCT01367158|69723639|FG002|Overall Study|Lost to Follow-up|0|||
38036339|NCT01367158|69723640|FG003|Overall Study|Lost to Follow-up|1|||
38036340|NCT01367158|69723641|FG004|Overall Study|Lost to Follow-up|0|||
38036341|NCT01367158|69723642|FG005|Overall Study|Lost to Follow-up|2|||
38036342|NCT01367158|69723643|FG006|Overall Study|Lost to Follow-up|0|||
38036343|NCT01367158|69723644|FG007|Overall Study|Lost to Follow-up|1|||
38036344|NCT01367158|69723645|FG008|Overall Study|Lost to Follow-up|0|||
38036345|NCT01367158|69723646|FG009|Overall Study|Lost to Follow-up|0|||
38036346|NCT01367158|69723647|FG010|Overall Study|Lost to Follow-up|1|||
38036347|NCT01367158|69723637|FG000|Overall Study|Protocol Violation|0|||
38036348|NCT01367158|69723638|FG001|Overall Study|Protocol Violation|1|||
38036349|NCT01367158|69723639|FG002|Overall Study|Protocol Violation|0|||
38036350|NCT01367158|69723640|FG003|Overall Study|Protocol Violation|0|||
38036351|NCT01367158|69723641|FG004|Overall Study|Protocol Violation|0|||
38036352|NCT01367158|69723642|FG005|Overall Study|Protocol Violation|0|||
38036353|NCT01367158|69723643|FG006|Overall Study|Protocol Violation|0|||
38036354|NCT01367158|69723644|FG007|Overall Study|Protocol Violation|0|||
38036355|NCT01367158|69723645|FG008|Overall Study|Protocol Violation|0|||
38036356|NCT01367158|69723646|FG009|Overall Study|Protocol Violation|0|||
38036357|NCT01367158|69723647|FG010|Overall Study|Protocol Violation|0|||
38036358|NCT00130637|69723682|FG000|Overall Study|Adverse Event|2|||
38036359|NCT00130637|69723682|FG000|Overall Study|Withdrawal by Subject|1|||
38036360|NCT03679767|69723690|FG000|Overall Study|Death|16|||
38036361|NCT03679767|69723691|FG001|Overall Study|Death|11|||
38036362|NCT03679767|69723692|FG002|Overall Study|Death|17|||
38036363|NCT03679767|69723693|FG003|Overall Study|Death|10|||
38036364|NCT03679767|69723690|FG000|Overall Study|Lost to Follow-up|1|||
38036365|NCT03679767|69723691|FG001|Overall Study|Lost to Follow-up|1|||
38036366|NCT03679767|69723692|FG002|Overall Study|Lost to Follow-up|1|||
38036367|NCT03679767|69723693|FG003|Overall Study|Lost to Follow-up|1|||
38036368|NCT03679767|69723690|FG000|Overall Study|Withdrawal by Subject|0|||
38036369|NCT03679767|69723691|FG001|Overall Study|Withdrawal by Subject|0|||
38036370|NCT03679767|69723692|FG002|Overall Study|Withdrawal by Subject|0|||
38036371|NCT03679767|69723693|FG003|Overall Study|Withdrawal by Subject|1|||
38036372|NCT03679767|69723690|FG000|Overall Study|Follow-up Completed|18|||
38036373|NCT03679767|69723691|FG001|Overall Study|Follow-up Completed|11|||
38036374|NCT03679767|69723692|FG002|Overall Study|Follow-up Completed|11|||
38036375|NCT03679767|69723693|FG003|Overall Study|Follow-up Completed|20|||
38036376|NCT03679767|69723690|FG000|Overall Study|Entered Hospice Care|0|||
38036377|NCT03679767|69723691|FG001|Overall Study|Entered Hospice Care|0|||
38036378|NCT03679767|69723692|FG002|Overall Study|Entered Hospice Care|0|||
38036379|NCT03679767|69723693|FG003|Overall Study|Entered Hospice Care|1|||
38036380|NCT03679767|69723690|FG000|Overall Study|Progressive Disease|0|||
38036381|NCT03679767|69723691|FG001|Overall Study|Progressive Disease|0|||
38036382|NCT03679767|69723692|FG002|Overall Study|Progressive Disease|0|||
38036383|NCT03679767|69723693|FG003|Overall Study|Progressive Disease|1|||
38036384|NCT00130247|69723707|FG000|Overall Study|Pregnancy|1|||
38036385|NCT00130247|69723708|FG001|Overall Study|Pregnancy|0|||
38036386|NCT00130247|69723707|FG000|Overall Study|Post-randomization exclusion|1|||
38036387|NCT00130247|69723708|FG001|Overall Study|Post-randomization exclusion|2|||
38036388|NCT00130247|69723707|FG000|Overall Study|Not compliant with DOT|0|||
37766150|NCT01433159|69279871|FG001|Overall Study|Protocol Violation|1|||
38036389|NCT00130247|69723708|FG001|Overall Study|Not compliant with DOT|2|||
38036390|NCT03678285|69723714|FG000|Overall Study|Adverse Event|2|||
38036391|NCT03678285|69723714|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
38036392|NCT03678285|69723714|FG000|Overall Study|Dehydrated prior to start of workout|1|||
38036393|NCT04032171|69723720|FG000|Overall Study|Study Termination|1|||
38036394|NCT04032171|69723721|FG001|Overall Study|Study Termination|0|||
38036395|NCT00137423|69723729|FG000|Overall Study|Adverse Event|7|||
38036396|NCT00137423|69723730|FG001|Overall Study|Adverse Event|9|||
38036397|NCT00137423|69723729|FG000|Overall Study|consent withdrawn|1|||
38036398|NCT00137423|69723730|FG001|Overall Study|consent withdrawn|1|||
38036399|NCT00137423|69723729|FG000|Overall Study|Lack of Efficacy|31|||
38036400|NCT00137423|69723730|FG001|Overall Study|Lack of Efficacy|33|||
37672639|NCT03555149|69146365|FG003|Overall Study|Physician Decision|0|||
37942799|NCT00675948|69630007|FG000|Overall Study|Patient feels unable to take medication|0|||
37942800|NCT00675948|69630008|FG001|Overall Study|Patient feels unable to take medication|1|||
37942801|NCT00610935|69630017|FG000|Overall Study|Lost to Follow-up|0|||
37942802|NCT00610935|69630018|FG001|Overall Study|Lost to Follow-up|1|||
37942803|NCT00610935|69630017|FG000|Overall Study|Withdrawal by Subject|0|||
37942804|NCT00610935|69630018|FG001|Overall Study|Withdrawal by Subject|2|||
37942805|NCT00610935|69630017|FG000|Overall Study|Sponsor Discontinuation|1|||
37942806|NCT00610935|69630018|FG001|Overall Study|Sponsor Discontinuation|0|||
37942807|NCT00610857|69630033|FG000|Overall Study|Not evaluable for response|2|||
37942808|NCT00672984|69630040|FG000|First Intervention|Adverse Event|5|||
37942809|NCT00672984|69630041|FG001|First Intervention|Adverse Event|0|||
37942810|NCT00672984|69630042|FG002|First Intervention|Adverse Event|0|||
37942811|NCT00672984|69630040|FG000|First Intervention|Withdrawal by Subject|1|||
37942812|NCT00672984|69630041|FG001|First Intervention|Withdrawal by Subject|2|||
37942813|NCT00672984|69630042|FG002|First Intervention|Withdrawal by Subject|2|||
37942814|NCT00672984|69630040|FG000|First Intervention|Sponsor decision|3|||
37942815|NCT00672984|69630041|FG001|First Intervention|Sponsor decision|0|||
37942816|NCT00672984|69630042|FG002|First Intervention|Sponsor decision|0|||
37942817|NCT00672984|69630040|FG000|Second Intervention|Non-compliance with facility policies|0|||
37942818|NCT00672984|69630041|FG001|Second Intervention|Non-compliance with facility policies|2|||
37942819|NCT00672984|69630042|FG002|Second Intervention|Non-compliance with facility policies|0|||
37942820|NCT00672984|69630040|FG000|Second Intervention|Withdrawal by Subject|0|||
37942821|NCT00672984|69630041|FG001|Second Intervention|Withdrawal by Subject|3|||
37942822|NCT00672984|69630042|FG002|Second Intervention|Withdrawal by Subject|0|||
37942823|NCT00672984|69630040|FG000|Second Intervention|Protocol Violation|0|||
37942824|NCT00672984|69630041|FG001|Second Intervention|Protocol Violation|1|||
37942825|NCT00672984|69630042|FG002|Second Intervention|Protocol Violation|1|||
37942826|NCT00672984|69630040|FG000|Third Intervention|Adverse Event|1|||
37942827|NCT00672984|69630041|FG001|Third Intervention|Adverse Event|0|||
37942828|NCT00672984|69630042|FG002|Third Intervention|Adverse Event|1|||
37942829|NCT00546364|69630055|FG000|Overall Study|Disease progression|5|||
37942830|NCT00546364|69630056|FG001|Overall Study|Disease progression|11|||
37942831|NCT00546364|69630057|FG002|Overall Study|Disease progression|8|||
37942832|NCT00546364|69630055|FG000|Overall Study|Completed and off treatment|1|||
37942833|NCT00546364|69630056|FG001|Overall Study|Completed and off treatment|0|||
37942834|NCT00546364|69630057|FG002|Overall Study|Completed and off treatment|2|||
37942835|NCT00546364|69630055|FG000|Overall Study|Administrative reason by sponsor|1|||
37942836|NCT00546364|69630056|FG001|Overall Study|Administrative reason by sponsor|0|||
37942837|NCT00546364|69630057|FG002|Overall Study|Administrative reason by sponsor|0|||
37942838|NCT00546364|69630055|FG000|Overall Study|Poor compliance/noncompliance|0|||
37942839|NCT00546364|69630056|FG001|Overall Study|Poor compliance/noncompliance|0|||
37942840|NCT00546364|69630057|FG002|Overall Study|Poor compliance/noncompliance|1|||
37942841|NCT00546364|69630055|FG000|Overall Study|No longer meets study criteria|1|||
37942842|NCT00546364|69630056|FG001|Overall Study|No longer meets study criteria|1|||
37942843|NCT00546364|69630057|FG002|Overall Study|No longer meets study criteria|0|||
37942844|NCT00546364|69630055|FG000|Overall Study|Withdrawal by Subject|5|||
37942845|NCT00546364|69630056|FG001|Overall Study|Withdrawal by Subject|6|||
37942846|NCT00546364|69630057|FG002|Overall Study|Withdrawal by Subject|3|||
37942847|NCT00546364|69630055|FG000|Overall Study|Prior taxotere|1|||
37942848|NCT00546364|69630056|FG001|Overall Study|Prior taxotere|0|||
37942849|NCT00546364|69630057|FG002|Overall Study|Prior taxotere|0|||
37942850|NCT00546364|69630055|FG000|Overall Study|Mixed response|1|||
37942851|NCT00546364|69630056|FG001|Overall Study|Mixed response|0|||
37942852|NCT00546364|69630057|FG002|Overall Study|Mixed response|0|||
37942853|NCT00546364|69630055|FG000|Overall Study|Palliative treatment|1|||
37942854|NCT00546364|69630056|FG001|Overall Study|Palliative treatment|0|||
37942855|NCT00546364|69630057|FG002|Overall Study|Palliative treatment|1|||
37942856|NCT00546364|69630055|FG000|Overall Study|Target lesions resected|1|||
37942857|NCT00546364|69630056|FG001|Overall Study|Target lesions resected|0|||
37942858|NCT00546364|69630057|FG002|Overall Study|Target lesions resected|0|||
37942859|NCT00546364|69630055|FG000|Overall Study|Physician Decision|0|||
37942860|NCT00546364|69630056|FG001|Overall Study|Physician Decision|0|||
37942861|NCT00546364|69630057|FG002|Overall Study|Physician Decision|1|||
37942862|NCT00546364|69630055|FG000|Overall Study|Sponsor decision|0|||
37942863|NCT00546364|69630056|FG001|Overall Study|Sponsor decision|0|||
37942864|NCT00546364|69630057|FG002|Overall Study|Sponsor decision|1|||
37942865|NCT05020327|69630076|FG000|Overall Study|Physician Decision|3|||
37942866|NCT05020327|69630077|FG001|Overall Study|Physician Decision|0|||
37942867|NCT05020327|69630078|FG002|Overall Study|Physician Decision|0|||
38036401|NCT00137423|69723729|FG000|Overall Study|Death|0|||
37672640|NCT03555149|69146366|FG004|Overall Study|Physician Decision|0|||
37942868|NCT05020327|69630076|FG000|Overall Study|Withdrawal by Subject|1|||
37942869|NCT05020327|69630077|FG001|Overall Study|Withdrawal by Subject|1|||
37942870|NCT05020327|69630078|FG002|Overall Study|Withdrawal by Subject|0|||
37942871|NCT05020327|69630076|FG000|Overall Study|personal/cultural, ineligible|12|||
37942872|NCT05020327|69630077|FG001|Overall Study|personal/cultural, ineligible|0|||
37942873|NCT05020327|69630078|FG002|Overall Study|personal/cultural, ineligible|0|||
37942874|NCT04907032|69630092|FG000|Overall Study|Withdrawal by Subject|7|||
37942875|NCT04907032|69630093|FG001|Overall Study|Withdrawal by Subject|1|||
37942876|NCT04739709|69630114|FG000|Overall Study|Physician Decision|1|||
37942877|NCT04739709|69630115|FG001|Overall Study|Physician Decision|0|||
37942878|NCT04710927|69630132|FG000|Overall Study|Lost to Follow-up|7|||
37942879|NCT04710927|69630133|FG001|Overall Study|Lost to Follow-up|6|||
38036402|NCT00137423|69723730|FG001|Overall Study|Death|1|||
38036403|NCT02786836|69723740|FG000|Overall Study|Death|1|||
38036404|NCT02786836|69723740|FG000|Overall Study|Lack of Efficacy|2|||
38036405|NCT02786836|69723740|FG000|Overall Study|Protocol Violation|3|||
38036406|NCT02786836|69723740|FG000|Overall Study|Withdrawal by Subject|3|||
38036407|NCT02786836|69723740|FG000|Overall Study|Liver Transplantation|2|||
38036408|NCT02786836|69723740|FG000|Overall Study|Device or Pharmacy Issues|3|||
38036409|NCT00137267|69723747|FG000|Overall Study|Lost to Follow-up|15|||
38036410|NCT00137267|69723748|FG001|Overall Study|Lost to Follow-up|21|||
38036411|NCT00137111|69723758|FG000|Total Therapy|Death|35|||
38036412|NCT00137111|69723759|FG001|Total Therapy|Death|0|||
38036413|NCT00137111|69723760|FG002|Total Therapy|Death|0|||
38036414|NCT00137111|69723761|FG003|Total Therapy|Death|0|||
38036415|NCT00137111|69723758|FG000|Total Therapy|Non Compliance|5|||
38036416|NCT00137111|69723759|FG001|Total Therapy|Non Compliance|0|||
38036417|NCT00137111|69723760|FG002|Total Therapy|Non Compliance|0|||
38036418|NCT00137111|69723761|FG003|Total Therapy|Non Compliance|0|||
38036419|NCT00136955|69723768|FG000|Overall Study|Adverse Event|8|||
38036420|NCT00136955|69723768|FG000|Overall Study|Lost to Follow-up|1|||
38036421|NCT00136955|69723768|FG000|Overall Study|Withdrawal by Subject|2|||
38036422|NCT00136955|69723768|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
38036423|NCT00135707|69723774|FG000|Overall Study|Lost to Follow-up|94|||
38036424|NCT00135707|69723775|FG001|Overall Study|Lost to Follow-up|89|||
38036425|NCT00135707|69723774|FG000|Overall Study|Withdrawal by Subject|0|||
38036426|NCT00135707|69723775|FG001|Overall Study|Withdrawal by Subject|1|||
38036427|NCT00135707|69723774|FG000|Overall Study|Institutional review board request|1|||
38036428|NCT00135707|69723775|FG001|Overall Study|Institutional review board request|0|||
38036429|NCT00129623|69723787|FG000|Overall Study|Adverse Event|3|||
38036430|NCT00129623|69723788|FG001|Overall Study|Adverse Event|7|||
38036431|NCT00129623|69723787|FG000|Overall Study|Refused Treatment|5|||
38036432|NCT00129623|69723788|FG001|Overall Study|Refused Treatment|3|||
38036433|NCT00129623|69723787|FG000|Overall Study|Failure to Return|1|||
38036434|NCT00129623|69723788|FG001|Overall Study|Failure to Return|1|||
38036435|NCT00129623|69723787|FG000|Overall Study|Relocated job out of state|1|||
38036436|NCT00129623|69723788|FG001|Overall Study|Relocated job out of state|0|||
38036437|NCT00129623|69723787|FG000|Overall Study|Uncertainty to return|0|||
38036438|NCT00129623|69723788|FG001|Overall Study|Uncertainty to return|1|||
38036439|NCT00129545|69723799|FG000|Overall Study|Death|5|||
38036440|NCT00129545|69723800|FG001|Overall Study|Death|60|||
38036441|NCT00129545|69723801|FG002|Overall Study|Death|44|||
38036442|NCT00129545|69723799|FG000|Overall Study|Withdrawal by Subject|3|||
38036443|NCT00129545|69723800|FG001|Overall Study|Withdrawal by Subject|18|||
38036444|NCT00129545|69723801|FG002|Overall Study|Withdrawal by Subject|44|||
38036445|NCT00129545|69723799|FG000|Overall Study|Lost to Follow-up|2|||
38036446|NCT00129545|69723800|FG001|Overall Study|Lost to Follow-up|22|||
38036447|NCT00129545|69723801|FG002|Overall Study|Lost to Follow-up|13|||
38036448|NCT00129545|69723799|FG000|Overall Study|Physician Decision|0|||
38036449|NCT00129545|69723800|FG001|Overall Study|Physician Decision|3|||
38036450|NCT00129545|69723801|FG002|Overall Study|Physician Decision|10|||
38036451|NCT00129545|69723799|FG000|Overall Study|Device not implanted|16|||
38036452|NCT00129545|69723800|FG001|Overall Study|Device not implanted|61|||
38036453|NCT00129545|69723801|FG002|Overall Study|Device not implanted|0|||
38036454|NCT00129467|69723811|FG000|Received Intervention|Death|1|||
37942880|NCT04710927|69630134|FG002|Overall Study|Lost to Follow-up|5|||
38036455|NCT00129467|69723812|FG001|Received Intervention|Death|1|||
37942881|NCT04657666|69630145|FG000|Period 1|Withdrawal of participant consent|2|||
38036456|NCT00129467|69723811|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
38036457|NCT00129467|69723812|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
38036458|NCT00129467|69723811|FG000|Received Intervention|Delirium|2|||
37942882|NCT04657666|69630146|FG001|Period 1|Withdrawal of participant consent|1|||
38036459|NCT00129467|69723812|FG001|Received Intervention|Delirium|0|||
38036460|NCT00129467|69723811|FG000|Received Intervention|Withdrawal by Subject|1|||
38036461|NCT00129467|69723812|FG001|Received Intervention|Withdrawal by Subject|0|||
38036462|NCT00129467|69723811|FG000|Received Intervention|Nausea|1|||
38036463|NCT00129467|69723812|FG001|Received Intervention|Nausea|0|||
38036464|NCT00129467|69723811|FG000|Received Intervention|Intolerance to citalopram|0|||
38036465|NCT00129467|69723812|FG001|Received Intervention|Intolerance to citalopram|1|||
38036466|NCT00129467|69723811|FG000|Received Intervention|Dizzyness, fatigue|0|||
38036467|NCT00129467|69723812|FG001|Received Intervention|Dizzyness, fatigue|1|||
38036468|NCT00129467|69723811|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
38036469|NCT00129467|69723812|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
38036470|NCT00129467|69723811|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
38036471|NCT00129467|69723812|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
38036472|NCT00129311|69723820|FG000|Overall Study|Withdrawal by Subject|12|||
38036473|NCT00129311|69723821|FG001|Overall Study|Withdrawal by Subject|19|||
38036474|NCT00133991|69723827|FG000|Overall Study|Death|4|||
38036475|NCT02784106|69723833|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
38036476|NCT02784106|69723834|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
37942883|NCT04657666|69630145|FG000|Period 1|Withdrawn/discontinued due to AE|1|||
37942884|NCT04657666|69630146|FG001|Period 1|Withdrawn/discontinued due to AE|0|||
37942885|NCT04657666|69630145|FG000|Period 1|Administrative decision by investigator, GW, or a regulatory authority|0|||
37942886|NCT04657666|69630146|FG001|Period 1|Administrative decision by investigator, GW, or a regulatory authority|1|||
37942887|NCT04657666|69630145|FG000|Period 2|Other|2|||
37942888|NCT04657666|69630146|FG001|Period 2|Other|0|||
37942889|NCT04657666|69630145|FG000|Period 2|Withdrawn/discontinued due to AE|0|||
38036477|NCT02784106|69723835|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
38036478|NCT02784106|69723836|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
38036479|NCT02784106|69723833|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
38036480|NCT02784106|69723834|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
38036481|NCT02784106|69723835|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
38036482|NCT02784106|69723836|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
38036483|NCT02784106|69723833|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
38036484|NCT02784106|69723834|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
38036485|NCT02784106|69723835|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
38036486|NCT02784106|69723836|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
38036487|NCT02784106|69723833|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
38036488|NCT02784106|69723834|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
38036489|NCT02784106|69723835|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
38036490|NCT02784106|69723836|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
38036491|NCT02784106|69723833|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
38036492|NCT02784106|69723834|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
38036493|NCT02784106|69723835|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
38036494|NCT02784106|69723836|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
38036495|NCT02784106|69723833|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
38036496|NCT02784106|69723834|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
37672641|NCT03555149|69146367|FG005|Overall Study|Physician Decision|0|||
37672642|NCT03555149|69146368|FG006|Overall Study|Physician Decision|0|||
37672643|NCT03555149|69146369|FG007|Overall Study|Physician Decision|0|||
37672644|NCT03555149|69146362|FG000|Overall Study|Study Terminated By Sponsor|1|||
37672645|NCT03555149|69146363|FG001|Overall Study|Study Terminated By Sponsor|0|||
37672646|NCT03555149|69146364|FG002|Overall Study|Study Terminated By Sponsor|0|||
37672647|NCT03555149|69146365|FG003|Overall Study|Study Terminated By Sponsor|0|||
37672648|NCT03555149|69146366|FG004|Overall Study|Study Terminated By Sponsor|0|||
37672649|NCT03555149|69146367|FG005|Overall Study|Study Terminated By Sponsor|2|||
37672650|NCT03555149|69146368|FG006|Overall Study|Study Terminated By Sponsor|3|||
37672651|NCT03555149|69146369|FG007|Overall Study|Study Terminated By Sponsor|1|||
37672652|NCT03555149|69146362|FG000|Overall Study|Withdrawal by Subject|3|||
37672653|NCT03555149|69146363|FG001|Overall Study|Withdrawal by Subject|0|||
37672654|NCT03555149|69146364|FG002|Overall Study|Withdrawal by Subject|0|||
37672655|NCT03555149|69146365|FG003|Overall Study|Withdrawal by Subject|2|||
37672656|NCT03555149|69146366|FG004|Overall Study|Withdrawal by Subject|0|||
37672657|NCT03555149|69146367|FG005|Overall Study|Withdrawal by Subject|1|||
37672658|NCT03555149|69146368|FG006|Overall Study|Withdrawal by Subject|0|||
37672659|NCT03555149|69146369|FG007|Overall Study|Withdrawal by Subject|0|||
37672660|NCT03515811|69146389|FG000|Overall Study|Lost to Follow-up|2|||
37672661|NCT03515811|69146390|FG001|Overall Study|Lost to Follow-up|1|||
37942890|NCT04657666|69630146|FG001|Period 2|Withdrawn/discontinued due to AE|3|||
37942891|NCT04495829|69630165|FG000|Overall Study|Lost to Follow-up|2|||
38036497|NCT02784106|69723835|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
38036498|NCT02784106|69723836|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
37672662|NCT03515811|69146389|FG000|Overall Study|Protocol Violation|1|||
37672663|NCT03515811|69146390|FG001|Overall Study|Protocol Violation|1|||
37672664|NCT03515811|69146389|FG000|Overall Study|Death|1|||
37672665|NCT03515811|69146390|FG001|Overall Study|Death|1|||
37672666|NCT03515811|69146389|FG000|Overall Study|Withdrawal by Subject|0|||
37942892|NCT04495829|69630165|FG000|Overall Study|Inclusion criterion not met|3|||
38036499|NCT02785900|69723847|FG000|Overall Study|Study Termination by Sponsor|64|||
37672667|NCT03515811|69146390|FG001|Overall Study|Withdrawal by Subject|2|||
37672668|NCT03515811|69146389|FG000|Overall Study|Technical Problems|1|||
37672669|NCT03515811|69146390|FG001|Overall Study|Technical Problems|0|||
37672670|NCT03515811|69146389|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
37672671|NCT03515811|69146390|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
37672672|NCT03515811|69146389|FG000|Overall Study|COVID-19|0|||
37672673|NCT03515811|69146390|FG001|Overall Study|COVID-19|1|||
37672674|NCT03246529|69146459|FG000|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
37672675|NCT03246529|69146460|FG001|Core Study (Until 100 d Post-transplant)|Adverse Event|2|||
37672676|NCT03246529|69146461|FG002|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
37672677|NCT03246529|69146459|FG000|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|0|||
37672678|NCT03246529|69146460|FG001|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
37672679|NCT03246529|69146461|FG002|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
37672680|NCT03246529|69146459|FG000|Core Study (Until 100 d Post-transplant)|Other Reasons|0|||
37672681|NCT03246529|69146460|FG001|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
37672682|NCT03246529|69146461|FG002|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
37672683|NCT03246529|69146459|FG000|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
37672684|NCT03246529|69146460|FG001|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
37672685|NCT03246529|69146461|FG002|Core Study (Until 100 d Post-transplant)|Physician Decision|1|||
37672686|NCT03246529|69146459|FG000|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|0|||
37672687|NCT03246529|69146460|FG001|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|1|||
37672688|NCT03246529|69146461|FG002|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|4|||
37672689|NCT03246529|69146459|FG000|Follow-up Period at 1 Year FU Completion|Disease progression|2|||
37672690|NCT03246529|69146460|FG001|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
37672691|NCT03246529|69146461|FG002|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
37672692|NCT03246529|69146459|FG000|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|1|||
37672693|NCT03246529|69146460|FG001|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|3|||
37672694|NCT03246529|69146461|FG002|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|0|||
37672695|NCT03246529|69146459|FG000|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
37672696|NCT03246529|69146460|FG001|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|3|||
37672697|NCT03246529|69146461|FG002|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
37672698|NCT03246529|69146459|FG000|Follow-up Period at 1 Year FU Completion|Death|0|||
37672699|NCT03246529|69146460|FG001|Follow-up Period at 1 Year FU Completion|Death|0|||
37672700|NCT03246529|69146461|FG002|Follow-up Period at 1 Year FU Completion|Death|1|||
37672701|NCT02975934|69146477|FG000|Treatment Phase|Ongoing at data-analysis|33|||
37672702|NCT02975934|69146478|FG001|Treatment Phase|Ongoing at data-analysis|5|||
37672703|NCT02975934|69146477|FG000|Treatment Phase|Discontinued prior to study drug|0|||
37672704|NCT02975934|69146478|FG001|Treatment Phase|Discontinued prior to study drug|5|||
37672705|NCT02975934|69146477|FG000|Cross-Over Phase|Ongoing at data-analysis|0|||
37672706|NCT02975934|69146478|FG001|Cross-Over Phase|Ongoing at data-analysis|7|||
37672707|NCT02847598|69146492|FG000|Overall Study|Adverse Event|0|||
37672708|NCT02847598|69146493|FG001|Overall Study|Adverse Event|0|||
37672709|NCT02847598|69146494|FG002|Overall Study|Adverse Event|0|||
37672710|NCT02847598|69146495|FG003|Overall Study|Adverse Event|0|||
37672711|NCT02847598|69146496|FG004|Overall Study|Adverse Event|0|||
37672712|NCT02847598|69146497|FG005|Overall Study|Adverse Event|0|||
37672713|NCT02847598|69146498|FG006|Overall Study|Adverse Event|0|||
37672714|NCT02847598|69146499|FG007|Overall Study|Adverse Event|1|||
37672715|NCT02847598|69146492|FG000|Overall Study|Consent withdrawn|2|||
37672716|NCT02847598|69146493|FG001|Overall Study|Consent withdrawn|0|||
37672717|NCT02847598|69146494|FG002|Overall Study|Consent withdrawn|0|||
37672718|NCT02847598|69146495|FG003|Overall Study|Consent withdrawn|4|||
37672719|NCT02847598|69146496|FG004|Overall Study|Consent withdrawn|3|||
37672720|NCT02847598|69146497|FG005|Overall Study|Consent withdrawn|2|||
37672721|NCT02847598|69146498|FG006|Overall Study|Consent withdrawn|1|||
37672722|NCT02847598|69146499|FG007|Overall Study|Consent withdrawn|3|||
37672723|NCT02847598|69146492|FG000|Overall Study|Death|3|||
37672724|NCT02847598|69146493|FG001|Overall Study|Death|0|||
37672725|NCT02847598|69146494|FG002|Overall Study|Death|0|||
37672726|NCT02847598|69146495|FG003|Overall Study|Death|0|||
37672727|NCT02847598|69146496|FG004|Overall Study|Death|0|||
38036500|NCT02785900|69723848|FG001|Overall Study|Study Termination by Sponsor|81|||
38036501|NCT02785900|69723847|FG000|Overall Study|Death|46|||
37672728|NCT02847598|69146497|FG005|Overall Study|Death|0|||
37672729|NCT02847598|69146498|FG006|Overall Study|Death|0|||
37672730|NCT02847598|69146499|FG007|Overall Study|Death|0|||
37672731|NCT02847598|69146492|FG000|Overall Study|Lost to Follow-up|0|||
37672732|NCT02847598|69146493|FG001|Overall Study|Lost to Follow-up|0|||
37672733|NCT02847598|69146494|FG002|Overall Study|Lost to Follow-up|0|||
37672734|NCT02847598|69146495|FG003|Overall Study|Lost to Follow-up|0|||
37672735|NCT02847598|69146496|FG004|Overall Study|Lost to Follow-up|0|||
37672736|NCT02847598|69146497|FG005|Overall Study|Lost to Follow-up|1|||
37766151|NCT01413503|69279886|FG000|Overall Study|Lost to Follow-up|1|||
38036502|NCT02785900|69723848|FG001|Overall Study|Death|32|||
37672737|NCT02847598|69146498|FG006|Overall Study|Lost to Follow-up|1|||
37672738|NCT02847598|69146499|FG007|Overall Study|Lost to Follow-up|0|||
37672739|NCT02834975|69146523|FG000|Overall Study|Physician Decision|2|||
37672740|NCT02834975|69146523|FG000|Overall Study|Adverse Event|1|||
37672741|NCT02834975|69146523|FG000|Overall Study|Withdrawal by Subject|1|||
37672742|NCT02834975|69146523|FG000|Overall Study|Lack of Efficacy|1|||
37672743|NCT02684123|69146546|FG000|Phase 1|Lack of Efficacy|5|||
37672744|NCT02684123|69146547|FG001|Phase 1|Lack of Efficacy|0|||
37672745|NCT02684123|69146546|FG000|Phase 1|Adverse Event|3|||
37672746|NCT02684123|69146547|FG001|Phase 1|Adverse Event|0|||
37672747|NCT02684123|69146546|FG000|Phase 1|Lost to Follow-up|0|||
37672748|NCT02684123|69146547|FG001|Phase 1|Lost to Follow-up|1|||
37672749|NCT02684123|69146546|FG000|Phase 2|Lack of Efficacy|1|||
37672750|NCT02684123|69146547|FG001|Phase 2|Lack of Efficacy|8|||
37672751|NCT02667587|69146555|FG000|Pre-Treatment|Not reported|1|||
37672752|NCT02667587|69146556|FG001|Pre-Treatment|Not reported|0|||
37672753|NCT02667587|69146555|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
37672754|NCT02667587|69146556|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
37672755|NCT02667587|69146555|FG000|Pre-Treatment|Participant withdrew consent|0|||
37672756|NCT02667587|69146556|FG001|Pre-Treatment|Participant withdrew consent|1|||
37672757|NCT02667587|69146555|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
37672758|NCT02667587|69146556|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
37672759|NCT02667587|69146555|FG000|End of Treatment|Other reasons|11|||
37672760|NCT02667587|69146556|FG001|End of Treatment|Other reasons|8|||
37672761|NCT02667587|69146555|FG000|End of Treatment|Participant no Longer Meets Study Criteria|1|||
37672762|NCT02667587|69146556|FG001|End of Treatment|Participant no Longer Meets Study Criteria|2|||
37672763|NCT02667587|69146555|FG000|End of Treatment|Poor/Non-Compliance|0|||
37672764|NCT02667587|69146556|FG001|End of Treatment|Poor/Non-Compliance|1|||
37672765|NCT02667587|69146555|FG000|End of Treatment|Maximum Clinical Benefit|3|||
37672766|NCT02667587|69146556|FG001|End of Treatment|Maximum Clinical Benefit|3|||
37672767|NCT02667587|69146555|FG000|End of Treatment|Participant Withdrew Consent|5|||
37672768|NCT02667587|69146556|FG001|End of Treatment|Participant Withdrew Consent|6|||
37672769|NCT02667587|69146555|FG000|End of Treatment|Participants Request to Discontinue Study Treatment|25|||
37672770|NCT02667587|69146556|FG001|End of Treatment|Participants Request to Discontinue Study Treatment|26|||
37672771|NCT02667587|69146555|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
37672772|NCT02667587|69146556|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
37672773|NCT02667587|69146555|FG000|End of Treatment|Death|2|||
37672774|NCT02667587|69146556|FG001|End of Treatment|Death|1|||
37672775|NCT02667587|69146555|FG000|End of Treatment|Study Drug Toxicity|74|||
37672776|NCT02667587|69146556|FG001|End of Treatment|Study Drug Toxicity|18|||
37672777|NCT02667587|69146555|FG000|End of Treatment|Disease progression|177|||
37672778|NCT02667587|69146556|FG001|End of Treatment|Disease progression|222|||
37672779|NCT02667587|69146555|FG000|End of Treatment|Lost to Follow-up|1|||
37672780|NCT02667587|69146556|FG001|End of Treatment|Lost to Follow-up|3|||
37672781|NCT02576574|69146577|FG000|Overall Study|still ongoing|65|||
37672782|NCT02576574|69146578|FG001|Overall Study|still ongoing|66|||
37672783|NCT02576574|69146579|FG002|Overall Study|still ongoing|73|||
37672784|NCT02576574|69146577|FG000|Overall Study|Randomized, not treated|5|||
37672785|NCT02576574|69146578|FG001|Overall Study|Randomized, not treated|4|||
37672786|NCT02576574|69146579|FG002|Overall Study|Randomized, not treated|26|||
37672787|NCT02203331|69146649|FG000|Overall Study|Pregnancy|1|||
37672788|NCT02203331|69146650|FG001|Overall Study|Pregnancy|0|||
37672789|NCT02203331|69146651|FG002|Overall Study|Pregnancy|0|||
37672790|NCT02203331|69146652|FG003|Overall Study|Pregnancy|0|||
37672791|NCT02203331|69146653|FG004|Overall Study|Pregnancy|2|||
37672792|NCT02203331|69146654|FG005|Overall Study|Pregnancy|0|||
37672793|NCT02203331|69146649|FG000|Overall Study|Withdrawal by Subject|1|||
37672794|NCT02203331|69146650|FG001|Overall Study|Withdrawal by Subject|0|||
37672795|NCT02203331|69146651|FG002|Overall Study|Withdrawal by Subject|1|||
37672796|NCT02203331|69146652|FG003|Overall Study|Withdrawal by Subject|0|||
37672797|NCT02203331|69146653|FG004|Overall Study|Withdrawal by Subject|0|||
37672798|NCT02203331|69146654|FG005|Overall Study|Withdrawal by Subject|3|||
37672799|NCT02203331|69146649|FG000|Overall Study|Adverse Event|4|||
37672800|NCT02203331|69146650|FG001|Overall Study|Adverse Event|8|||
37672801|NCT02203331|69146651|FG002|Overall Study|Adverse Event|3|||
37672802|NCT02203331|69146652|FG003|Overall Study|Adverse Event|4|||
37672803|NCT02203331|69146653|FG004|Overall Study|Adverse Event|3|||
37672804|NCT02203331|69146654|FG005|Overall Study|Adverse Event|3|||
37672805|NCT02203331|69146649|FG000|Overall Study|Other Reasons|1|||
37672806|NCT02203331|69146650|FG001|Overall Study|Other Reasons|2|||
37672807|NCT02203331|69146651|FG002|Overall Study|Other Reasons|0|||
37672808|NCT02203331|69146652|FG003|Overall Study|Other Reasons|2|||
37672809|NCT02203331|69146653|FG004|Overall Study|Other Reasons|0|||
37672810|NCT02203331|69146654|FG005|Overall Study|Other Reasons|0|||
37672811|NCT02203331|69146649|FG000|Overall Study|Lack of Efficacy|0|||
37672812|NCT02203331|69146650|FG001|Overall Study|Lack of Efficacy|2|||
37672813|NCT02203331|69146651|FG002|Overall Study|Lack of Efficacy|1|||
37672814|NCT02203331|69146652|FG003|Overall Study|Lack of Efficacy|0|||
37672815|NCT02203331|69146653|FG004|Overall Study|Lack of Efficacy|0|||
37672816|NCT02203331|69146654|FG005|Overall Study|Lack of Efficacy|1|||
37672817|NCT02203331|69146649|FG000|Overall Study|Protocol Violation|0|||
37672818|NCT02203331|69146650|FG001|Overall Study|Protocol Violation|2|||
37672819|NCT02203331|69146651|FG002|Overall Study|Protocol Violation|0|||
37672820|NCT02203331|69146652|FG003|Overall Study|Protocol Violation|1|||
37672821|NCT02203331|69146653|FG004|Overall Study|Protocol Violation|1|||
37672822|NCT02203331|69146654|FG005|Overall Study|Protocol Violation|0|||
37672823|NCT02203331|69146649|FG000|Overall Study|Lost to Follow-up|0|||
37672824|NCT02203331|69146650|FG001|Overall Study|Lost to Follow-up|0|||
37672825|NCT02203331|69146651|FG002|Overall Study|Lost to Follow-up|0|||
37672826|NCT02203331|69146652|FG003|Overall Study|Lost to Follow-up|0|||
37672827|NCT02203331|69146653|FG004|Overall Study|Lost to Follow-up|1|||
37672828|NCT02203331|69146654|FG005|Overall Study|Lost to Follow-up|0|||
37672829|NCT02170025|69146683|FG000|Overall Study|Adverse Event|2|||
37672830|NCT02170025|69146684|FG001|Overall Study|Adverse Event|0|||
37672831|NCT02164578|69146692|FG000|Treatment Period|Withdrawal by Subject|3|||
37672832|NCT02164578|69146693|FG001|Treatment Period|Withdrawal by Subject|3|||
37672833|NCT02164578|69146692|FG000|Treatment Period|Adverse Event|13|||
37672834|NCT02164578|69146693|FG001|Treatment Period|Adverse Event|6|||
37672835|NCT02164578|69146692|FG000|Treatment Period|Early termination due to expiry of study medication|1|||
37672836|NCT02164578|69146693|FG001|Treatment Period|Early termination due to expiry of study medication|0|||
37672837|NCT02164578|69146692|FG000|Treatment Period|Protocol Violation|0|||
37672838|NCT02164578|69146693|FG001|Treatment Period|Protocol Violation|2|||
37672839|NCT02164578|69146692|FG000|Extension Period|Withdrawal by Subject|2|||
37672840|NCT02164578|69146693|FG001|Extension Period|Withdrawal by Subject|0|||
37672841|NCT02164578|69146692|FG000|Extension Period|Adverse Event|4|||
37672842|NCT02164578|69146693|FG001|Extension Period|Adverse Event|0|||
37672843|NCT02164578|69146692|FG000|Extension Period|Expiry of study medication|1|||
37672844|NCT02164578|69146693|FG001|Extension Period|Expiry of study medication|0|||
37672845|NCT02164578|69146692|FG000|Extension Period|Protocol Violation|0|||
37672846|NCT02164578|69146693|FG001|Extension Period|Protocol Violation|1|||
37672847|NCT02107703|69146701|FG000|Overall Study|Withdrawal by Subject|46|||
37672848|NCT02107703|69146702|FG001|Overall Study|Withdrawal by Subject|21|||
37672849|NCT02107703|69146701|FG000|Overall Study|Lost to Follow-up|20|||
37672850|NCT02107703|69146702|FG001|Overall Study|Lost to Follow-up|9|||
37672851|NCT02107703|69146701|FG000|Overall Study|On study treatment/follow up|48|||
37672852|NCT02107703|69146702|FG001|Overall Study|On study treatment/follow up|5|||
37672853|NCT02101034|69146713|FG000|Overall Study|Enrolled but did not start treatment|0|||
37672854|NCT02101034|69146714|FG001|Overall Study|Enrolled but did not start treatment|0|||
37672855|NCT02101034|69146715|FG002|Overall Study|Enrolled but did not start treatment|1|||
37672856|NCT02101034|69146716|FG003|Overall Study|Enrolled but did not start treatment|0|||
37672857|NCT02101034|69146717|FG004|Overall Study|Enrolled but did not start treatment|0|||
37672858|NCT02029443|69146753|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
37672859|NCT02029443|69146754|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
37672860|NCT02029443|69146755|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
37672861|NCT02029443|69146756|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
37672862|NCT02029443|69146757|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
37672863|NCT02029443|69146753|FG000|Overall Study|Death|13|||
37672864|NCT02029443|69146754|FG001|Overall Study|Death|2|||
37672865|NCT02029443|69146755|FG002|Overall Study|Death|2|||
37672866|NCT02029443|69146756|FG003|Overall Study|Death|11|||
37672867|NCT02029443|69146757|FG004|Overall Study|Death|2|||
37672868|NCT02029443|69146753|FG000|Overall Study|Lost to Follow-up|1|||
37672869|NCT02029443|69146754|FG001|Overall Study|Lost to Follow-up|0|||
37672870|NCT02029443|69146755|FG002|Overall Study|Lost to Follow-up|1|||
37672871|NCT02029443|69146756|FG003|Overall Study|Lost to Follow-up|1|||
37672872|NCT02029443|69146757|FG004|Overall Study|Lost to Follow-up|0|||
37672873|NCT02029443|69146753|FG000|Overall Study|Started other anti-cancer therapy|17|||
37672874|NCT02029443|69146754|FG001|Overall Study|Started other anti-cancer therapy|4|||
37672875|NCT02029443|69146755|FG002|Overall Study|Started other anti-cancer therapy|7|||
37672876|NCT02029443|69146756|FG003|Overall Study|Started other anti-cancer therapy|9|||
37672877|NCT02029443|69146757|FG004|Overall Study|Started other anti-cancer therapy|3|||
37672878|NCT02029443|69146753|FG000|Overall Study|Withdrawal by Subject|3|||
37672879|NCT02029443|69146754|FG001|Overall Study|Withdrawal by Subject|1|||
37672880|NCT02029443|69146755|FG002|Overall Study|Withdrawal by Subject|1|||
37672881|NCT02029443|69146756|FG003|Overall Study|Withdrawal by Subject|1|||
37672882|NCT02029443|69146757|FG004|Overall Study|Withdrawal by Subject|0|||
37672883|NCT02029443|69146753|FG000|Overall Study|Other|6|||
37672884|NCT02029443|69146754|FG001|Overall Study|Other|6|||
37672885|NCT02029443|69146755|FG002|Overall Study|Other|4|||
37672886|NCT02029443|69146756|FG003|Overall Study|Other|2|||
37672887|NCT02029443|69146757|FG004|Overall Study|Other|0|||
37672888|NCT01823198|69146798|FG000|Overall Study|Physician Decision|0|||
37672889|NCT01823198|69146799|FG001|Overall Study|Physician Decision|1|||
37672890|NCT01823198|69146800|FG002|Overall Study|Physician Decision|0|||
37672891|NCT01823198|69146801|FG003|Overall Study|Physician Decision|0|||
37672892|NCT01823198|69146802|FG004|Overall Study|Physician Decision|0|||
37672893|NCT01823198|69146803|FG005|Overall Study|Physician Decision|3|||
37672894|NCT01823198|69146804|FG006|Overall Study|Physician Decision|3|||
37672895|NCT01761292|69146822|FG000|Part 1|Adverse Event|1|||
37672896|NCT01761292|69146822|FG000|Part 1|not receiving treatment in Part 1|1|||
37672897|NCT01761292|69146822|FG000|Extension 1|Withdrawal by Subject|1|||
37672898|NCT01725113|69146833|FG000|Overall Study|Kidney Transplant|1|||
37672899|NCT01725113|69146834|FG001|Overall Study|Kidney Transplant|1|||
37672900|NCT01725113|69146833|FG000|Overall Study|Withdrawal by Subject|0|||
37672901|NCT01725113|69146834|FG001|Overall Study|Withdrawal by Subject|1|||
37672902|NCT01580293|69146847|FG000|Part A_Main Trial|Adverse Event|0|||
37672903|NCT01580293|69146848|FG001|Part A_Main Trial|Adverse Event|2|||
37672904|NCT01580293|69146849|FG002|Part A_Main Trial|Adverse Event|0|||
37672905|NCT01580293|69146847|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
37672906|NCT01580293|69146848|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
37672907|NCT01580293|69146849|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
37672908|NCT01580293|69146847|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
37672909|NCT01580293|69146848|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
37672910|NCT01580293|69146849|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
37672911|NCT01580293|69146847|FG000|Part A_Extension|Adverse Event|0|||
37672912|NCT01580293|69146848|FG001|Part A_Extension|Adverse Event|2|||
37672913|NCT01580293|69146849|FG002|Part A_Extension|Adverse Event|0|||
37672914|NCT01580293|69146847|FG000|Part A_Extension|Withdrawal by Subject|0|||
37672915|NCT01580293|69146848|FG001|Part A_Extension|Withdrawal by Subject|3|||
37672916|NCT01580293|69146849|FG002|Part A_Extension|Withdrawal by Subject|0|||
37672917|NCT01580293|69146847|FG000|Part A_Extension|Lost to Follow-up|0|||
37672918|NCT01580293|69146848|FG001|Part A_Extension|Lost to Follow-up|1|||
37672919|NCT01580293|69146849|FG002|Part A_Extension|Lost to Follow-up|0|||
37672920|NCT01580293|69146847|FG000|Part A_Extension|Other Reason|0|||
37672921|NCT01580293|69146848|FG001|Part A_Extension|Other Reason|1|||
37672922|NCT01580293|69146849|FG002|Part A_Extension|Other Reason|0|||
37672923|NCT01580293|69146847|FG000|Part A_Extension|Completed Japan only|0|||
37672924|NCT01580293|69146848|FG001|Part A_Extension|Completed Japan only|5|||
37672925|NCT01580293|69146849|FG002|Part A_Extension|Completed Japan only|0|||
37672926|NCT01580293|69146847|FG000|Part B|Withdrawal by Subject|0|||
37672927|NCT01580293|69146848|FG001|Part B|Withdrawal by Subject|0|||
37672928|NCT01580293|69146849|FG002|Part B|Withdrawal by Subject|1|||
37672929|NCT01580293|69146847|FG000|Part B|Other reason|0|||
37672930|NCT01580293|69146848|FG001|Part B|Other reason|0|||
37672931|NCT01580293|69146849|FG002|Part B|Other reason|1|||
37672938|NCT01960348|69146911|FG000|Overall Study|Adverse event, not serious|2|||
37672939|NCT01960348|69146912|FG001|Overall Study|Adverse event, not serious|2|||
37672940|NCT01960348|69146911|FG000|Overall Study|Adverse event, serious fatal|6|||
37672941|NCT01960348|69146912|FG001|Overall Study|Adverse event, serious fatal|5|||
37672942|NCT01960348|69146911|FG000|Overall Study|Adverse event, serious non-fatal|0|||
37672943|NCT01960348|69146912|FG001|Overall Study|Adverse event, serious non-fatal|3|||
37672944|NCT01960348|69146911|FG000|Overall Study|Withdrawal by Subject|1|||
37672945|NCT01960348|69146912|FG001|Overall Study|Withdrawal by Subject|11|||
37672946|NCT01960348|69146911|FG000|Overall Study|Physician Decision|0|||
37672947|NCT01960348|69146912|FG001|Overall Study|Physician Decision|1|||
37672948|NCT01960348|69146911|FG000|Overall Study|Protocol Violation|1|||
37672949|NCT01960348|69146912|FG001|Overall Study|Protocol Violation|0|||
37672950|NCT02653625|69146918|FG000|Overall Study|Adverse Event|1|||
37672951|NCT02653625|69146918|FG000|Overall Study|Non-compliance with Study Drug|1|||
37672952|NCT02653625|69146918|FG000|Overall Study|Protocol Violation|1|||
37672953|NCT02653625|69146918|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
37672954|NCT01981096|69146924|FG000|Overall Study|Parent illness|1|||
37672955|NCT01981096|69146925|FG001|Overall Study|Parent illness|0|||
37672956|NCT01981096|69146924|FG000|Overall Study|Withdrawal by Subject|0|||
37672957|NCT01981096|69146925|FG001|Overall Study|Withdrawal by Subject|1|||
37672958|NCT01981096|69146924|FG000|Overall Study|Lost to Follow-up|2|||
37672959|NCT01981096|69146925|FG001|Overall Study|Lost to Follow-up|0|||
37672960|NCT02652767|69146931|FG000|Overall Study|Death|2|||
37672961|NCT02652767|69146931|FG000|Overall Study|Lost to Follow-up|1|||
37766152|NCT01413191|69279890|FG000|Overall Study|Lost to Follow-up|5|||
37766153|NCT01413191|69279890|FG000|Overall Study|Disease Progression|5|||
37672962|NCT02652767|69146931|FG000|Overall Study|Withdrawal by Subject|1|||
37672963|NCT01980940|69146945|FG000|Overall Study|Protocol Violation|0|||
37672964|NCT01980940|69146946|FG001|Overall Study|Protocol Violation|0|||
37672965|NCT01980940|69146947|FG002|Overall Study|Protocol Violation|0|||
37672966|NCT01980940|69146948|FG003|Overall Study|Protocol Violation|0|||
37672967|NCT01980940|69146949|FG004|Overall Study|Protocol Violation|0|||
37672968|NCT01980940|69146950|FG005|Overall Study|Protocol Violation|2|||
37672969|NCT01980940|69146951|FG006|Overall Study|Protocol Violation|0|||
37672970|NCT01980940|69146952|FG007|Overall Study|Protocol Violation|0|||
37672971|NCT02699983|69146978|FG000|Overall Study|Withdrawal by Subject|1|||
37672972|NCT02699983|69146979|FG001|Overall Study|Withdrawal by Subject|0|||
37672973|NCT01960114|69146991|FG000|Overall Study|Adverse Event|1|||
37672974|NCT01960114|69146992|FG001|Overall Study|Adverse Event|0|||
37672975|NCT01960114|69146991|FG000|Overall Study|Could not swallow study medication|0|||
37672976|NCT01960114|69146992|FG001|Overall Study|Could not swallow study medication|1|||
37672977|NCT02005276|69147002|FG000|Overall Study|No longer interested|5|||
37672978|NCT02005276|69147003|FG001|Overall Study|No longer interested|2|||
37672979|NCT02005276|69147004|FG002|Overall Study|No longer interested|3|||
37672980|NCT02005276|69147005|FG003|Overall Study|No longer interested|3|||
37672981|NCT01980706|69147020|FG000|Overall Study|Withdrawal by Subject|9|||
37672982|NCT01980706|69147021|FG001|Overall Study|Withdrawal by Subject|6|||
37672983|NCT01980706|69147022|FG002|Overall Study|Withdrawal by Subject|2|||
37672984|NCT01980706|69147020|FG000|Overall Study|Adverse Event|1|||
37672985|NCT01980706|69147021|FG001|Overall Study|Adverse Event|2|||
37672986|NCT01980706|69147022|FG002|Overall Study|Adverse Event|5|||
37672987|NCT01980706|69147020|FG000|Overall Study|Lost to Follow-up|3|||
37672988|NCT01980706|69147021|FG001|Overall Study|Lost to Follow-up|4|||
37672989|NCT01980706|69147022|FG002|Overall Study|Lost to Follow-up|3|||
37672990|NCT01980706|69147020|FG000|Overall Study|miscellaneous|4|||
37672991|NCT01980706|69147021|FG001|Overall Study|miscellaneous|5|||
37672992|NCT01980706|69147022|FG002|Overall Study|miscellaneous|3|||
37672993|NCT02692417|69147032|FG000|Overall Study|Withdrawal by Subject|5|||
37672994|NCT02692417|69147033|FG001|Overall Study|Withdrawal by Subject|1|||
37672995|NCT02692417|69147032|FG000|Overall Study|Adverse Event|1|||
37672996|NCT02692417|69147033|FG001|Overall Study|Adverse Event|0|||
37672997|NCT02004886|69147043|FG000|Overall Study|Adverse Event|0|||
37672998|NCT02004886|69147044|FG001|Overall Study|Adverse Event|1|||
37672999|NCT02004886|69147045|FG002|Overall Study|Adverse Event|0|||
37673000|NCT02004886|69147046|FG003|Overall Study|Adverse Event|0|||
37673001|NCT02004886|69147043|FG000|Overall Study|Unable to attend future visits|1|||
37673002|NCT02004886|69147044|FG001|Overall Study|Unable to attend future visits|0|||
37673003|NCT02004886|69147045|FG002|Overall Study|Unable to attend future visits|0|||
37673004|NCT02004886|69147046|FG003|Overall Study|Unable to attend future visits|0|||
37673005|NCT01959880|69147060|FG000|Overall Study|Withdrawal by Subject|11|||
37673006|NCT01959880|69147061|FG001|Overall Study|Withdrawal by Subject|13|||
37673007|NCT01959880|69147062|FG002|Overall Study|Withdrawal by Subject|8|||
37673008|NCT01959880|69147063|FG003|Overall Study|Withdrawal by Subject|7|||
37673009|NCT01959880|69147060|FG000|Overall Study|Death|1|||
37673010|NCT01959880|69147061|FG001|Overall Study|Death|10|||
37673011|NCT01959880|69147062|FG002|Overall Study|Death|1|||
37673012|NCT01959880|69147063|FG003|Overall Study|Death|2|||
37673013|NCT01959880|69147060|FG000|Overall Study|Lost to Follow-up|95|||
37673014|NCT01959880|69147061|FG001|Overall Study|Lost to Follow-up|18|||
37673015|NCT01959880|69147062|FG002|Overall Study|Lost to Follow-up|15|||
37673016|NCT01959880|69147063|FG003|Overall Study|Lost to Follow-up|8|||
37673017|NCT01959880|69147060|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
37673018|NCT01959880|69147061|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
37673019|NCT01959880|69147062|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
37673020|NCT01959880|69147063|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
37673021|NCT01959880|69147060|FG000|Overall Study|Study completed early-FDA approved|1003|||
37673022|NCT01959880|69147061|FG001|Overall Study|Study completed early-FDA approved|311|||
37673023|NCT01959880|69147062|FG002|Overall Study|Study completed early-FDA approved|179|||
37673024|NCT01959880|69147063|FG003|Overall Study|Study completed early-FDA approved|152|||
37673025|NCT01980628|69147073|FG000|Overall Study|Adverse Event|12|||
37673026|NCT01980628|69147073|FG000|Overall Study|Physician Decision|5|||
37673027|NCT01980628|69147073|FG000|Overall Study|Withdrawal by Subject|4|||
37673028|NCT01980628|69147073|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
37673029|NCT01979614|69147080|FG000|Overall Study|Adverse Event|1|||
37673030|NCT01979614|69147081|FG001|Overall Study|Adverse Event|1|||
37673031|NCT02654717|69147089|FG000|Overall Study|Adverse Event|2|||
37673032|NCT02654717|69147090|FG001|Overall Study|Adverse Event|2|||
37673033|NCT02654717|69147089|FG000|Overall Study|Protocol Violation|1|||
38036503|NCT02785900|69723847|FG000|Overall Study|Withdrawal by Subject|4|||
37673034|NCT02654717|69147090|FG001|Overall Study|Protocol Violation|2|||
37673035|NCT02654717|69147089|FG000|Overall Study|Withdrawal by Subject|0|||
37673036|NCT02654717|69147090|FG001|Overall Study|Withdrawal by Subject|1|||
37673037|NCT02654717|69147089|FG000|Overall Study|Non-permitted medication|3|||
37766154|NCT01413191|69279890|FG000|Overall Study|Death|1|||
37673038|NCT02654717|69147090|FG001|Overall Study|Non-permitted medication|0|||
37673039|NCT03343301|69147098|FG000|Overall Study|Withdrawal by Subject|1|||
37673040|NCT03343301|69147099|FG001|Overall Study|Withdrawal by Subject|1|||
37673041|NCT03343301|69147098|FG000|Overall Study|Death|0|||
37673042|NCT03343301|69147099|FG001|Overall Study|Death|2|||
37673043|NCT03343301|69147098|FG000|Overall Study|Other|0|||
37673044|NCT03343301|69147099|FG001|Overall Study|Other|6|||
37673045|NCT03343301|69147098|FG000|Overall Study|Missing|2|||
37673046|NCT03343301|69147099|FG001|Overall Study|Missing|0|||
37673047|NCT02696785|69147109|FG000|Blinded Treatment Period|Adverse Event|0|||
37673048|NCT02696785|69147110|FG001|Blinded Treatment Period|Adverse Event|1|||
37673049|NCT02696785|69147111|FG002|Blinded Treatment Period|Adverse Event|3|||
37673050|NCT02696785|69147112|FG003|Blinded Treatment Period|Adverse Event|0|||
37673051|NCT02696785|69147109|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
37673052|NCT02696785|69147110|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
37673053|NCT02696785|69147111|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
37673054|NCT02696785|69147112|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
37673055|NCT02696785|69147109|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
37673056|NCT02696785|69147110|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
37673057|NCT02696785|69147111|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
37673058|NCT02696785|69147112|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
37673059|NCT02696785|69147109|FG000|Blinded Treatment Period|Screen Failure|1|||
37673060|NCT02696785|69147110|FG001|Blinded Treatment Period|Screen Failure|0|||
37673061|NCT02696785|69147111|FG002|Blinded Treatment Period|Screen Failure|0|||
37673062|NCT02696785|69147112|FG003|Blinded Treatment Period|Screen Failure|0|||
37673063|NCT02696785|69147109|FG000|Washout Period|Withdrawal by Subject|0|||
37673064|NCT02696785|69147110|FG001|Washout Period|Withdrawal by Subject|1|||
37673065|NCT02696785|69147111|FG002|Washout Period|Withdrawal by Subject|0|||
37673066|NCT02696785|69147112|FG003|Washout Period|Withdrawal by Subject|0|||
37673067|NCT02696785|69147109|FG000|Washout Period|Lack of Efficacy|0|||
37673068|NCT02696785|69147110|FG001|Washout Period|Lack of Efficacy|1|||
37673069|NCT02696785|69147111|FG002|Washout Period|Lack of Efficacy|0|||
37673070|NCT02696785|69147112|FG003|Washout Period|Lack of Efficacy|0|||
37673071|NCT02696785|69147109|FG000|Extended Treatment Period|Adverse Event|2|||
37673072|NCT02696785|69147110|FG001|Extended Treatment Period|Adverse Event|3|||
37673073|NCT02696785|69147111|FG002|Extended Treatment Period|Adverse Event|2|||
37673074|NCT02696785|69147112|FG003|Extended Treatment Period|Adverse Event|1|||
37673075|NCT02696785|69147109|FG000|Extended Treatment Period|Lack of Efficacy|0|||
37673076|NCT02696785|69147110|FG001|Extended Treatment Period|Lack of Efficacy|1|||
37673077|NCT02696785|69147111|FG002|Extended Treatment Period|Lack of Efficacy|0|||
37673078|NCT02696785|69147112|FG003|Extended Treatment Period|Lack of Efficacy|0|||
37673079|NCT02696785|69147109|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
37673080|NCT02696785|69147110|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
37673081|NCT02696785|69147111|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
37673082|NCT02696785|69147112|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
37673083|NCT02696785|69147109|FG000|Follow-up Period|Adverse Event|0|||
37673084|NCT02696785|69147110|FG001|Follow-up Period|Adverse Event|0|||
37673085|NCT02696785|69147111|FG002|Follow-up Period|Adverse Event|8|||
37673086|NCT02696785|69147112|FG003|Follow-up Period|Adverse Event|2|||
37673087|NCT02696785|69147109|FG000|Follow-up Period|Lost to Follow-up|0|||
37673088|NCT02696785|69147110|FG001|Follow-up Period|Lost to Follow-up|0|||
37673089|NCT02696785|69147111|FG002|Follow-up Period|Lost to Follow-up|0|||
37673090|NCT02696785|69147112|FG003|Follow-up Period|Lost to Follow-up|1|||
37673091|NCT02696785|69147109|FG000|Follow-up Period|Lack of Efficacy|0|||
37673092|NCT02696785|69147110|FG001|Follow-up Period|Lack of Efficacy|0|||
37673093|NCT02696785|69147111|FG002|Follow-up Period|Lack of Efficacy|0|||
37673094|NCT02696785|69147112|FG003|Follow-up Period|Lack of Efficacy|1|||
37673095|NCT02696785|69147109|FG000|Follow-up Period|Withdrawal by Subject|1|||
37673096|NCT02696785|69147110|FG001|Follow-up Period|Withdrawal by Subject|0|||
37673097|NCT02696785|69147111|FG002|Follow-up Period|Withdrawal by Subject|5|||
37673098|NCT02696785|69147112|FG003|Follow-up Period|Withdrawal by Subject|4|||
37673099|NCT02004262|69147146|FG000|Overall Study|Death|67|||
37673100|NCT02004262|69147147|FG001|Overall Study|Death|64|||
37673101|NCT02004262|69147148|FG002|Overall Study|Death|66|||
37673102|NCT02004262|69147149|FG003|Overall Study|Death|28|||
37673103|NCT02004262|69147150|FG004|Overall Study|Death|29|||
37673104|NCT02004262|69147151|FG005|Overall Study|Death|22|||
37673105|NCT02004262|69147146|FG000|Overall Study|Withdrawal by Subject|1|||
37673106|NCT02004262|69147147|FG001|Overall Study|Withdrawal by Subject|0|||
37673107|NCT02004262|69147148|FG002|Overall Study|Withdrawal by Subject|4|||
37673108|NCT02004262|69147149|FG003|Overall Study|Withdrawal by Subject|0|||
37673109|NCT02004262|69147150|FG004|Overall Study|Withdrawal by Subject|1|||
37673110|NCT02004262|69147151|FG005|Overall Study|Withdrawal by Subject|3|||
37673111|NCT02004262|69147146|FG000|Overall Study|Lost to Follow-up|1|||
37673112|NCT02004262|69147147|FG001|Overall Study|Lost to Follow-up|1|||
37673113|NCT02004262|69147148|FG002|Overall Study|Lost to Follow-up|0|||
37673114|NCT02004262|69147149|FG003|Overall Study|Lost to Follow-up|0|||
37673115|NCT02004262|69147150|FG004|Overall Study|Lost to Follow-up|0|||
37673116|NCT02004262|69147151|FG005|Overall Study|Lost to Follow-up|0|||
37673117|NCT02004262|69147146|FG000|Overall Study|Study Terminated by Sponsor|4|||
37673118|NCT02004262|69147147|FG001|Overall Study|Study Terminated by Sponsor|3|||
37673119|NCT02004262|69147148|FG002|Overall Study|Study Terminated by Sponsor|2|||
37673120|NCT02004262|69147149|FG003|Overall Study|Study Terminated by Sponsor|1|||
37673121|NCT02004262|69147150|FG004|Overall Study|Study Terminated by Sponsor|1|||
37673122|NCT02004262|69147151|FG005|Overall Study|Study Terminated by Sponsor|5|||
37673123|NCT01675427|69147165|FG000|Overall Study|Withdrawal by Subject|7|||
37673124|NCT01675427|69147165|FG000|Overall Study|Participant Refused Sample Collection|18|||
37673125|NCT01675427|69147165|FG000|Overall Study|Sample not Collected by Mistake|2|||
37673126|NCT01675427|69147165|FG000|Overall Study|Lost to Follow-up|5|||
37673127|NCT01675427|69147165|FG000|Overall Study|Other|2|||
37673128|NCT01978912|69147203|FG000|Overall Study|Adverse Event|0|||
37673129|NCT01978912|69147204|FG001|Overall Study|Adverse Event|1|||
37673130|NCT01978912|69147205|FG002|Overall Study|Adverse Event|0|||
37673131|NCT01978912|69147206|FG003|Overall Study|Adverse Event|0|||
37673132|NCT01978912|69147203|FG000|Overall Study|Lost to Follow-up|1|||
37673133|NCT01978912|69147204|FG001|Overall Study|Lost to Follow-up|1|||
37673134|NCT01978912|69147205|FG002|Overall Study|Lost to Follow-up|0|||
37673135|NCT01978912|69147206|FG003|Overall Study|Lost to Follow-up|1|||
37673136|NCT01978912|69147203|FG000|Overall Study|Withdrawal by Subject|1|||
37673137|NCT01978912|69147204|FG001|Overall Study|Withdrawal by Subject|0|||
37673138|NCT01978912|69147205|FG002|Overall Study|Withdrawal by Subject|2|||
37673139|NCT01978912|69147206|FG003|Overall Study|Withdrawal by Subject|2|||
37673140|NCT01978912|69147203|FG000|Overall Study|Lumbar Surgery|1|||
37673141|NCT01978912|69147204|FG001|Overall Study|Lumbar Surgery|0|||
37673142|NCT01978912|69147205|FG002|Overall Study|Lumbar Surgery|1|||
37673143|NCT01978912|69147206|FG003|Overall Study|Lumbar Surgery|0|||
37673144|NCT01978912|69147203|FG000|Overall Study|Intradiscal Steroid Injection|0|||
37673145|NCT01978912|69147204|FG001|Overall Study|Intradiscal Steroid Injection|1|||
37673146|NCT01978912|69147205|FG002|Overall Study|Intradiscal Steroid Injection|0|||
37673147|NCT01978912|69147206|FG003|Overall Study|Intradiscal Steroid Injection|0|||
37673148|NCT01977898|69147218|FG000|Overall Study|Non functioning catheter|1|||
37673149|NCT01977898|69147219|FG001|Overall Study|Non functioning catheter|1|||
37673150|NCT02003638|69147227|FG000|Overall Study|Withdrawal by Subject|1|||
37673151|NCT02003638|69147228|FG001|Overall Study|Withdrawal by Subject|0|||
37673152|NCT02696317|69147234|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
37673153|NCT02696317|69147235|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
37673154|NCT02696317|69147234|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
37673155|NCT02696317|69147235|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
37673156|NCT01959412|69147243|FG000|Overall Study|Protocol deviation|1|||
37673157|NCT01959412|69147244|FG001|Overall Study|Protocol deviation|1|||
37673158|NCT01959412|69147245|FG002|Overall Study|Protocol deviation|0|||
37673159|NCT01959412|69147246|FG003|Overall Study|Protocol deviation|1|||
37673160|NCT01959412|69147247|FG004|Overall Study|Protocol deviation|3|||
37673161|NCT01959412|69147248|FG005|Overall Study|Protocol deviation|0|||
37673162|NCT01959412|69147243|FG000|Overall Study|Adverse Event|0|||
37673163|NCT01959412|69147244|FG001|Overall Study|Adverse Event|0|||
37673164|NCT01959412|69147245|FG002|Overall Study|Adverse Event|0|||
37673165|NCT01959412|69147246|FG003|Overall Study|Adverse Event|1|||
37673166|NCT01959412|69147247|FG004|Overall Study|Adverse Event|0|||
37673167|NCT01959412|69147248|FG005|Overall Study|Adverse Event|0|||
37673168|NCT01977820|69147264|FG000|Overall Study|Sponsor terminated the study|1|||
37673169|NCT01977820|69147265|FG001|Overall Study|Sponsor terminated the study|1|||
37673170|NCT02003014|69147271|FG000|Overall Study|Case report forms uncollected|9|||
37673171|NCT02003014|69147271|FG000|Overall Study|Treatment started after contract period|1|||
37673172|NCT02003014|69147271|FG000|Overall Study|Patient did not visit the study site|5|||
37673173|NCT02003014|69147271|FG000|Overall Study|Investigator's transfer|4|||
37673174|NCT01977352|69147277|FG000|Overall Study|Lost to Follow-up|1|||
37673175|NCT01977352|69147278|FG001|Overall Study|Lost to Follow-up|2|||
37673176|NCT02001688|69147287|FG000|Overall Study|Withdrawal by Subject|0|||
37673177|NCT02001688|69147288|FG001|Overall Study|Withdrawal by Subject|0|||
37673178|NCT02001688|69147289|FG002|Overall Study|Withdrawal by Subject|1|||
37673179|NCT02001688|69147287|FG000|Overall Study|Adverse Event|0|||
37673180|NCT02001688|69147288|FG001|Overall Study|Adverse Event|1|||
37673181|NCT02001688|69147289|FG002|Overall Study|Adverse Event|0|||
37673182|NCT02001064|69147300|FG000|Overall Study|Withdrawal by Subject|2|||
37673183|NCT02001064|69147301|FG001|Overall Study|Withdrawal by Subject|1|||
37673184|NCT02000752|69147309|FG000|Overall Study|Dystocic delivery|19|||
37673185|NCT02000752|69147310|FG001|Overall Study|Dystocic delivery|8|||
37673186|NCT02000752|69147309|FG000|Overall Study|Shift Changes|12|||
37673187|NCT02000752|69147310|FG001|Overall Study|Shift Changes|5|||
37673188|NCT02000440|69147316|FG000|Overall Study|Adverse Event|3|||
37673189|NCT02000440|69147316|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
37673190|NCT02687815|69147322|FG000|Overall Study|Lost to Follow-up|2|||
37673191|NCT02687815|69147323|FG001|Overall Study|Lost to Follow-up|4|||
37673192|NCT02687815|69147322|FG000|Overall Study|Withdrawal by Subject|2|||
37673193|NCT02687815|69147323|FG001|Overall Study|Withdrawal by Subject|4|||
37673194|NCT01959334|69147331|FG000|Second Dose|Adverse Event|1|||
38043579|NCT02657434|69731755|FG000|Overall Study|Lost to Follow-up|2|||
37673195|NCT01959334|69147332|FG001|Second Dose|Adverse Event|0|||
37673196|NCT01959334|69147331|FG000|Third Dose|Adverse Event|0|||
37673197|NCT01959334|69147332|FG001|Third Dose|Adverse Event|1|||
37766155|NCT01412957|69279896|FG000|Overall Study|Withdrawal by Subject|6|||
37766156|NCT01412957|69279897|FG001|Overall Study|Withdrawal by Subject|22|||
37766157|NCT01412957|69279896|FG000|Overall Study|Lost to Follow-up|7|||
37766158|NCT01412957|69279897|FG001|Overall Study|Lost to Follow-up|2|||
37766159|NCT01412957|69279896|FG000|Overall Study|Death|136|||
37766160|NCT01412957|69279897|FG001|Overall Study|Death|133|||
37766161|NCT01432457|69279910|FG000|Overall Study|Adverse Event|7|||
37766162|NCT01432457|69279911|FG001|Overall Study|Adverse Event|10|||
37766163|NCT01432457|69279912|FG002|Overall Study|Adverse Event|16|||
37766164|NCT01432457|69279910|FG000|Overall Study|Lack of Efficacy|2|||
37766165|NCT01432457|69279911|FG001|Overall Study|Lack of Efficacy|1|||
37766166|NCT01432457|69279912|FG002|Overall Study|Lack of Efficacy|1|||
37766167|NCT01432457|69279910|FG000|Overall Study|Lost to Follow-up|11|||
37766168|NCT01432457|69279911|FG001|Overall Study|Lost to Follow-up|15|||
37766169|NCT01432457|69279912|FG002|Overall Study|Lost to Follow-up|20|||
37766170|NCT01432457|69279910|FG000|Overall Study|Protocol Violation|3|||
37766171|NCT01432457|69279911|FG001|Overall Study|Protocol Violation|2|||
37766172|NCT01432457|69279912|FG002|Overall Study|Protocol Violation|6|||
37766173|NCT01432457|69279910|FG000|Overall Study|Withdrawal by Subject|6|||
37766174|NCT01432457|69279911|FG001|Overall Study|Withdrawal by Subject|11|||
37766175|NCT01432457|69279912|FG002|Overall Study|Withdrawal by Subject|9|||
37766176|NCT01432457|69279910|FG000|Overall Study|Reasons not defined|2|||
37766177|NCT01432457|69279911|FG001|Overall Study|Reasons not defined|3|||
37766178|NCT01432457|69279912|FG002|Overall Study|Reasons not defined|4|||
37766179|NCT01432457|69279910|FG000|Overall Study|Did not take study drug|6|||
37766180|NCT01432457|69279911|FG001|Overall Study|Did not take study drug|6|||
37766181|NCT01432457|69279912|FG002|Overall Study|Did not take study drug|3|||
37766182|NCT01390441|69279934|FG000|Treatment Period|Protocol Violation|0|||
37766183|NCT01390441|69279935|FG001|Treatment Period|Protocol Violation|1|||
37766184|NCT01390441|69279936|FG002|Treatment Period|Protocol Violation|0|||
37766185|NCT01390441|69279937|FG003|Treatment Period|Protocol Violation|0|||
37766186|NCT01390441|69279938|FG004|Treatment Period|Protocol Violation|0|||
37766187|NCT01390441|69279934|FG000|Treatment Period|Physician Decision|0|||
37766188|NCT01390441|69279935|FG001|Treatment Period|Physician Decision|0|||
37766189|NCT01390441|69279936|FG002|Treatment Period|Physician Decision|0|||
37766190|NCT01390441|69279937|FG003|Treatment Period|Physician Decision|1|||
37766191|NCT01390441|69279938|FG004|Treatment Period|Physician Decision|0|||
37766192|NCT01390441|69279934|FG000|Treatment Period|Lack of Efficacy|0|||
37766193|NCT01390441|69279935|FG001|Treatment Period|Lack of Efficacy|0|||
37766194|NCT01390441|69279936|FG002|Treatment Period|Lack of Efficacy|0|||
37766195|NCT01390441|69279937|FG003|Treatment Period|Lack of Efficacy|0|||
37766196|NCT01390441|69279938|FG004|Treatment Period|Lack of Efficacy|1|||
37766197|NCT01390441|69279934|FG000|Treatment Period|Unknown due to early stopping of study|0|||
37766198|NCT01390441|69279935|FG001|Treatment Period|Unknown due to early stopping of study|0|||
37766199|NCT01390441|69279936|FG002|Treatment Period|Unknown due to early stopping of study|8|||
37766200|NCT01390441|69279937|FG003|Treatment Period|Unknown due to early stopping of study|11|||
37766201|NCT01390441|69279938|FG004|Treatment Period|Unknown due to early stopping of study|7|||
37766202|NCT01390441|69279934|FG000|Treatment Period|Adverse Event|0|||
37673198|NCT02687581|69147342|FG000|Overall Study|Withdrawal by Subject|1|||
37673199|NCT02687581|69147343|FG001|Overall Study|Withdrawal by Subject|0|||
37673200|NCT02687581|69147344|FG002|Overall Study|Withdrawal by Subject|0|||
37673201|NCT02687581|69147345|FG003|Overall Study|Withdrawal by Subject|1|||
37673202|NCT02687581|69147342|FG000|Overall Study|Lost to Follow-up|2|||
37673203|NCT02687581|69147343|FG001|Overall Study|Lost to Follow-up|2|||
37673204|NCT02687581|69147344|FG002|Overall Study|Lost to Follow-up|0|||
37673205|NCT02687581|69147345|FG003|Overall Study|Lost to Follow-up|0|||
37673206|NCT02687581|69147342|FG000|Overall Study|the device is too small for the patient.|1|||
37673207|NCT02687581|69147343|FG001|Overall Study|the device is too small for the patient.|0|||
37673208|NCT02687581|69147344|FG002|Overall Study|the device is too small for the patient.|0|||
37673209|NCT02687581|69147345|FG003|Overall Study|the device is too small for the patient.|0|||
37673210|NCT01977040|69147355|FG000|Overall Study|Vasa previa not confirmed|2|||
37673211|NCT01958476|69147365|FG000|Overall Study|Parent requested exclusion from analysis|1|||
37673212|NCT01958476|69147366|FG001|Overall Study|Parent requested exclusion from analysis|0|||
37673213|NCT02695537|69147402|FG000|Overall Study|Adverse Event|3|||
37673214|NCT02695537|69147402|FG000|Overall Study|Lack of Efficacy|28|||
37673215|NCT02695537|69147402|FG000|Overall Study|Withdrawal by Subject|4|||
37673216|NCT02695537|69147402|FG000|Overall Study|Protocol Violation|3|||
37673217|NCT01353313|69147408|FG000|Overall Study|Lost to Follow-up|22|||
37673218|NCT01353313|69147409|FG001|Overall Study|Lost to Follow-up|23|||
37673219|NCT01353313|69147408|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
37766203|NCT01390441|69279935|FG001|Treatment Period|Adverse Event|0|||
37766204|NCT01390441|69279936|FG002|Treatment Period|Adverse Event|1|||
37766205|NCT01390441|69279937|FG003|Treatment Period|Adverse Event|1|||
37766206|NCT01390441|69279938|FG004|Treatment Period|Adverse Event|2|||
37766207|NCT01390441|69279934|FG000|Treatment Period|Withdrawal by Subject|0|||
37766208|NCT01390441|69279935|FG001|Treatment Period|Withdrawal by Subject|0|||
37766209|NCT01390441|69279936|FG002|Treatment Period|Withdrawal by Subject|1|||
37766210|NCT01390441|69279937|FG003|Treatment Period|Withdrawal by Subject|0|||
37766211|NCT01390441|69279938|FG004|Treatment Period|Withdrawal by Subject|1|||
37766212|NCT01390441|69279934|FG000|Treatment Period|Lost to Follow-up|1|||
37766213|NCT01390441|69279935|FG001|Treatment Period|Lost to Follow-up|0|||
37766214|NCT01390441|69279936|FG002|Treatment Period|Lost to Follow-up|0|||
37766215|NCT01390441|69279937|FG003|Treatment Period|Lost to Follow-up|0|||
37766216|NCT01390441|69279938|FG004|Treatment Period|Lost to Follow-up|0|||
37766217|NCT01390441|69279934|FG000|Extension Period|Protocol Violation|3|||
37766218|NCT01390441|69279935|FG001|Extension Period|Protocol Violation|1|||
37766219|NCT01390441|69279936|FG002|Extension Period|Protocol Violation|0|||
37766220|NCT01390441|69279937|FG003|Extension Period|Protocol Violation|1|||
37766221|NCT01390441|69279938|FG004|Extension Period|Protocol Violation|0|||
37766222|NCT01412879|69279987|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
37766223|NCT01412879|69279988|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
37766224|NCT01412879|69279989|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
37766225|NCT01412879|69279987|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
37766226|NCT01412879|69279988|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
37766227|NCT01412879|69279989|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
37766228|NCT01412879|69279987|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
37766229|NCT01412879|69279988|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
37766230|NCT01412879|69279989|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
37766231|NCT01412879|69279987|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
37766232|NCT01412879|69279988|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
37766233|NCT01412879|69279989|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
37766234|NCT01412879|69279987|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
37766235|NCT01412879|69279988|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
37766236|NCT01412879|69279989|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
37766237|NCT01431079|69280001|FG000|Overall Study|Lost to Follow-up|35|||
37766238|NCT01431079|69280002|FG001|Overall Study|Lost to Follow-up|39|||
37766239|NCT01430611|69280034|FG000|Overall Study|Adverse Event|0|||
37766240|NCT01430611|69280035|FG001|Overall Study|Adverse Event|1|||
37766241|NCT01430611|69280034|FG000|Overall Study|Protocol Violation|1|||
37766242|NCT01430611|69280035|FG001|Overall Study|Protocol Violation|0|||
37766243|NCT01430611|69280034|FG000|Overall Study|Lost to Follow-up|1|||
37766244|NCT01430611|69280035|FG001|Overall Study|Lost to Follow-up|0|||
37766245|NCT01430611|69280034|FG000|Overall Study|Withdrawal by Subject|15|||
37766246|NCT01430611|69280035|FG001|Overall Study|Withdrawal by Subject|14|||
37766247|NCT01409707|69280044|FG000|Overall Study|Withdrawal by Subject|5|||
37766248|NCT01409707|69280045|FG001|Overall Study|Withdrawal by Subject|17|||
37766249|NCT01409707|69280046|FG002|Overall Study|Withdrawal by Subject|16|||
37766250|NCT01389973|69280053|FG000|Overall Study|Lost to Follow-up|1|||
37766251|NCT01389973|69280053|FG000|Overall Study|Trial Stopped by Sponsor|9|||
37766252|NCT01389973|69280053|FG000|Overall Study|Other|10|||
37766253|NCT01389817|69280073|FG000|Overall Study|Physician Decision|1|||
37766254|NCT01389817|69280074|FG001|Overall Study|Physician Decision|0|||
37766255|NCT01389817|69280073|FG000|Overall Study|Lost to Follow-up|1|||
37766256|NCT01389817|69280074|FG001|Overall Study|Lost to Follow-up|0|||
37766257|NCT01389817|69280073|FG000|Overall Study|Withdrawal by Subject|2|||
37766258|NCT01389817|69280074|FG001|Overall Study|Withdrawal by Subject|0|||
37766259|NCT01430455|69280089|FG000|Overall Study|Withdrawal by Subject|1|||
37766260|NCT01430455|69280089|FG000|Overall Study|Switched to follow-up phase|1|||
37766261|NCT01429441|69280117|FG000|Overall Study|Adverse Event|5|||
37766262|NCT01429441|69280118|FG001|Overall Study|Adverse Event|1|||
37766263|NCT01429441|69280117|FG000|Overall Study|Death|0|||
37766264|NCT01429441|69280118|FG001|Overall Study|Death|2|||
37766265|NCT01429441|69280117|FG000|Overall Study|Lost to Follow-up|5|||
37766266|NCT01429441|69280118|FG001|Overall Study|Lost to Follow-up|2|||
37766267|NCT01429441|69280117|FG000|Overall Study|Physician Decision|1|||
37766268|NCT01429441|69280118|FG001|Overall Study|Physician Decision|0|||
37766269|NCT01429441|69280117|FG000|Overall Study|Withdrawal by Subject|27|||
37766270|NCT01429441|69280118|FG001|Overall Study|Withdrawal by Subject|18|||
37766271|NCT01429285|69280153|FG000|Overall Study|Protocol Violation|9|||
37766272|NCT01429285|69280154|FG001|Overall Study|Protocol Violation|4|||
37766273|NCT01429285|69280153|FG000|Overall Study|Missing Data|5|||
37766274|NCT01429285|69280154|FG001|Overall Study|Missing Data|3|||
37766275|NCT01429285|69280153|FG000|Overall Study|Erroneously Enrolled Twice|8|||
37766276|NCT01429285|69280154|FG001|Overall Study|Erroneously Enrolled Twice|2|||
37766277|NCT01429051|69280231|FG000|Titration Phase|Death|1|||
37766278|NCT01429051|69280231|FG000|Titration Phase|Withdrawal by Subject|7|||
37766279|NCT01429051|69280231|FG000|Titration Phase|Physician Decision|1|||
37766280|NCT01429051|69280231|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
37766281|NCT01429051|69280231|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
37766282|NCT01429051|69280231|FG000|Efficacy Phase|Adverse Event|1|||
37766283|NCT01429051|69280231|FG000|Efficacy Phase|Death|1|||
37766284|NCT01429051|69280231|FG000|Tolerability Phase|Death|5|||
37766285|NCT01429051|69280231|FG000|Tolerability Phase|Adverse Event|2|||
37766286|NCT01429051|69280231|FG000|Tolerability Phase|Withdrawal by Subject|5|||
37766287|NCT01429051|69280231|FG000|Tolerability Phase|Physician Decision|1|||
37766288|NCT01429051|69280231|FG000|Tolerability Phase|Other|2|||
37766289|NCT01428661|69280264|FG000|Double-Masked Phase|Protocol Violation|9|||
37766290|NCT01428661|69280265|FG001|Double-Masked Phase|Protocol Violation|4|||
37766291|NCT01428661|69280266|FG002|Double-Masked Phase|Protocol Violation|0|||
37766292|NCT01428661|69280264|FG000|Double-Masked Phase|Adverse Event|13|||
37766293|NCT01428661|69280265|FG001|Double-Masked Phase|Adverse Event|4|||
37766294|NCT01428661|69280266|FG002|Double-Masked Phase|Adverse Event|0|||
37766295|NCT01428661|69280264|FG000|Double-Masked Phase|Lost to Follow-up|14|||
37766296|NCT01428661|69280265|FG001|Double-Masked Phase|Lost to Follow-up|14|||
37766297|NCT01428661|69280266|FG002|Double-Masked Phase|Lost to Follow-up|0|||
37766298|NCT01428661|69280264|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
37766299|NCT01428661|69280265|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
37766300|NCT01428661|69280266|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
37766301|NCT01428661|69280264|FG000|Double-Masked Phase|Lack of Efficacy|2|||
37766302|NCT01428661|69280265|FG001|Double-Masked Phase|Lack of Efficacy|1|||
37766303|NCT01428661|69280266|FG002|Double-Masked Phase|Lack of Efficacy|0|||
37766304|NCT01428661|69280264|FG000|Double-Masked Phase|*Various|1|||
37766305|NCT01428661|69280265|FG001|Double-Masked Phase|*Various|6|||
37766306|NCT01428661|69280266|FG002|Double-Masked Phase|*Various|0|||
37766307|NCT01428661|69280264|FG000|Open Label Extension|Protocol Violation|0|||
37766308|NCT01428661|69280265|FG001|Open Label Extension|Protocol Violation|0|||
37766309|NCT01428661|69280266|FG002|Open Label Extension|Protocol Violation|9|||
37766310|NCT01428661|69280264|FG000|Open Label Extension|Adverse Event|0|||
37766311|NCT01428661|69280265|FG001|Open Label Extension|Adverse Event|0|||
37766312|NCT01428661|69280266|FG002|Open Label Extension|Adverse Event|15|||
37766313|NCT01428661|69280264|FG000|Open Label Extension|Lost to Follow-up|0|||
37766314|NCT01428661|69280265|FG001|Open Label Extension|Lost to Follow-up|0|||
37766315|NCT01428661|69280266|FG002|Open Label Extension|Lost to Follow-up|38|||
37766316|NCT01428661|69280264|FG000|Open Label Extension|Withdrawal by Subject|0|||
37766317|NCT01428661|69280265|FG001|Open Label Extension|Withdrawal by Subject|0|||
37766318|NCT01428661|69280266|FG002|Open Label Extension|Withdrawal by Subject|49|||
37766319|NCT01428661|69280264|FG000|Open Label Extension|Lack of Efficacy|0|||
37766320|NCT01428661|69280265|FG001|Open Label Extension|Lack of Efficacy|0|||
37766321|NCT01428661|69280266|FG002|Open Label Extension|Lack of Efficacy|24|||
37766322|NCT01428661|69280264|FG000|Open Label Extension|**Various|0|||
37766323|NCT01428661|69280265|FG001|Open Label Extension|**Various|0|||
37766324|NCT01428661|69280266|FG002|Open Label Extension|**Various|185|||
37766325|NCT01428583|69280274|FG000|Overall Study|Adverse Event|75|||
37766326|NCT01428583|69280274|FG000|Overall Study|Withdrawal by Subject|51|||
37766327|NCT01428583|69280274|FG000|Overall Study|Lack of Efficacy|37|||
37766328|NCT01428583|69280274|FG000|Overall Study|Lost to Follow-up|17|||
37766329|NCT01428583|69280274|FG000|Overall Study|Death|1|||
37766330|NCT01428583|69280274|FG000|Overall Study|Pregnancy|1|||
37766331|NCT01428583|69280274|FG000|Overall Study|Protocol Violation|1|||
37766332|NCT01428583|69280274|FG000|Overall Study|Physician Decision|12|||
37766333|NCT01428583|69280274|FG000|Overall Study|Non-compliant|25|||
37766334|NCT01428583|69280274|FG000|Overall Study|Confirmed positive urine drug test|8|||
37766335|NCT01428583|69280274|FG000|Overall Study|Sponsor's request|3|||
37766336|NCT01428583|69280274|FG000|Overall Study|Other|6|||
37766337|NCT01428193|69280291|FG000|Overall Study|Physician Decision|1|||
37766338|NCT01428193|69280291|FG000|Overall Study|Elevated screening liver enzymes|1|||
37766339|NCT01428115|69280295|FG000|Overall Study|Lack of Efficacy|3|||
37766340|NCT01428115|69280295|FG000|Overall Study|Lost to Follow-up|10|||
37766341|NCT01428115|69280295|FG000|Overall Study|Pregnancy|1|||
37766342|NCT01428115|69280295|FG000|Overall Study|Protocol Violation|3|||
37766343|NCT01428115|69280295|FG000|Overall Study|Withdrawal by Subject|4|||
37766344|NCT01427803|69280302|FG000|Overall Study|Lost to Follow-up|32|||
37766345|NCT01427803|69280303|FG001|Overall Study|Lost to Follow-up|26|||
37766346|NCT01427803|69280302|FG000|Overall Study|Withdrawal by Subject|20|||
37766347|NCT01427803|69280303|FG001|Overall Study|Withdrawal by Subject|0|||
37766348|NCT01427803|69280302|FG000|Overall Study|Unable to complete full treatment period|6|||
37766349|NCT01427803|69280303|FG001|Overall Study|Unable to complete full treatment period|0|||
38043580|NCT02657434|69731756|FG001|Overall Study|Lost to Follow-up|2|||
37766350|NCT01427803|69280302|FG000|Overall Study|Protocol Violation|1|||
37766351|NCT01427803|69280303|FG001|Overall Study|Protocol Violation|0|||
37766352|NCT01427803|69280302|FG000|Overall Study|Physician Decision|3|||
37766353|NCT01427803|69280303|FG001|Overall Study|Physician Decision|0|||
37766354|NCT01427803|69280302|FG000|Overall Study|did not take product|1|||
37766355|NCT01427803|69280303|FG001|Overall Study|did not take product|0|||
37766356|NCT01408537|69280307|FG000|Overall Study|Withdrawal by Subject|2|||
37766357|NCT01408537|69280307|FG000|Overall Study|Protocol Violation|3|||
37766358|NCT01408537|69280307|FG000|Overall Study|Lost to Follow-up|3|||
37766359|NCT01408459|69280340|FG000|Overall Study|Withdrawal by Subject|1|||
37766360|NCT01408459|69280341|FG001|Overall Study|Withdrawal by Subject|1|||
37766361|NCT01408303|69280360|FG000|Overall Study|Adverse Event|3|||
37766362|NCT01408303|69280361|FG001|Overall Study|Adverse Event|7|||
37766363|NCT01408303|69280362|FG002|Overall Study|Adverse Event|2|||
37766364|NCT01408303|69280360|FG000|Overall Study|Lost to Follow-up|0|||
37766365|NCT01408303|69280361|FG001|Overall Study|Lost to Follow-up|1|||
37766366|NCT01408303|69280362|FG002|Overall Study|Lost to Follow-up|2|||
37766367|NCT01408303|69280360|FG000|Overall Study|Withdrawal by Subject|2|||
37942893|NCT04101721|69630180|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
37942894|NCT04101721|69630181|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
37942895|NCT04101721|69630180|FG000|Overall Study|Death|0|||
37942896|NCT04101721|69630181|FG001|Overall Study|Death|1|||
37942897|NCT04101721|69630180|FG000|Overall Study|Lost to Follow-up|0|||
37942898|NCT04101721|69630181|FG001|Overall Study|Lost to Follow-up|3|||
37942899|NCT03864926|69630189|FG000|Overall Study|Death|0|||
37942900|NCT03864926|69630190|FG001|Overall Study|Death|2|||
37942901|NCT03623243|69630205|FG000|Overall Study|Adverse Event|15|||
37942902|NCT03623243|69630205|FG000|Overall Study|Guardian Decision|1|||
37942903|NCT03623243|69630205|FG000|Overall Study|New Therapy for Study Indication|1|||
37942904|NCT03623243|69630205|FG000|Overall Study|Protocol Deviation|3|||
37942905|NCT03623243|69630205|FG000|Overall Study|Physician Decision|4|||
37942906|NCT03623243|69630205|FG000|Overall Study|Patient Decision|15|||
37942907|NCT03258853|69630211|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
37942908|NCT03258853|69630212|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
37942909|NCT03246347|69630218|FG000|Overall Study|On Study|23|||
37942910|NCT03006848|69630268|FG000|Overall Study|Adverse Event|1|||
37942911|NCT03006848|69630268|FG000|Overall Study|Physician Decision|1|||
37942912|NCT03006848|69630268|FG000|Overall Study|Lack of Efficacy|16|||
37942913|NCT02828358|69630308|FG000|Overall Study|Physician Decision|7|||
37942914|NCT02828358|69630309|FG001|Overall Study|Physician Decision|1|||
37942915|NCT02828358|69630308|FG000|Overall Study|Treatment Failure|6|||
37942916|NCT02828358|69630309|FG001|Overall Study|Treatment Failure|0|||
37942917|NCT02828358|69630308|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
37942918|NCT02828358|69630309|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
37942919|NCT02828358|69630308|FG000|Overall Study|Refusal of further protocol therapy|2|||
37942920|NCT02828358|69630309|FG001|Overall Study|Refusal of further protocol therapy|0|||
37942921|NCT02828358|69630308|FG000|Overall Study|Relapse|25|||
37942922|NCT02828358|69630309|FG001|Overall Study|Relapse|0|||
37942923|NCT02828358|69630308|FG000|Overall Study|Still on therapy|5|||
37942924|NCT02828358|69630309|FG001|Overall Study|Still on therapy|0|||
37942925|NCT02810444|69630314|FG000|Overall Study|Screen Failures|14|||
37942926|NCT02810444|69630314|FG000|Overall Study|Withdrawal by Subject|4|||
37942927|NCT02810444|69630314|FG000|Overall Study|Adverse Event|3|||
37942928|NCT02501096|69630340|FG000|Overall Study|Lost to Follow-up|0|||
37942929|NCT02501096|69630341|FG001|Overall Study|Lost to Follow-up|0|||
37673220|NCT01353313|69147409|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
37673221|NCT02691247|69147418|FG000|Overall Study|Withdrawal by Subject|1|||
37673222|NCT02691247|69147419|FG001|Overall Study|Withdrawal by Subject|2|||
37673223|NCT02691247|69147420|FG002|Overall Study|Withdrawal by Subject|2|||
37673224|NCT02691247|69147418|FG000|Overall Study|Lost to Follow-up|2|||
37673225|NCT02691247|69147419|FG001|Overall Study|Lost to Follow-up|0|||
37673226|NCT02691247|69147420|FG002|Overall Study|Lost to Follow-up|1|||
37673227|NCT01362491|69147431|FG000|Overall Study|Ineligible|1|||
37673228|NCT01362491|69147432|FG001|Overall Study|Ineligible|0|||
37673229|NCT01362491|69147433|FG002|Overall Study|Ineligible|0|||
37673230|NCT02687191|69147448|FG000|Overall Study|Death|0|||
37673231|NCT02687191|69147449|FG001|Overall Study|Death|1|||
37673232|NCT02687191|69147450|FG002|Overall Study|Death|1|||
37673233|NCT02687191|69147451|FG003|Overall Study|Death|0|||
37673234|NCT02687191|69147452|FG004|Overall Study|Death|1|||
37673235|NCT02687191|69147453|FG005|Overall Study|Death|1|||
37673236|NCT02687191|69147448|FG000|Overall Study|Withdrawal by Subject|0|||
37766368|NCT01408303|69280361|FG001|Overall Study|Withdrawal by Subject|3|||
37942930|NCT02501096|69630342|FG002|Overall Study|Lost to Follow-up|0|||
37942931|NCT02501096|69630343|FG003|Overall Study|Lost to Follow-up|0|||
38036504|NCT02785900|69723848|FG001|Overall Study|Withdrawal by Subject|8|||
38036505|NCT02785900|69723847|FG000|Overall Study|Physician Decision|3|||
37673237|NCT02687191|69147449|FG001|Overall Study|Withdrawal by Subject|0|||
37673238|NCT02687191|69147450|FG002|Overall Study|Withdrawal by Subject|0|||
37673239|NCT02687191|69147451|FG003|Overall Study|Withdrawal by Subject|1|||
37673240|NCT02687191|69147452|FG004|Overall Study|Withdrawal by Subject|0|||
37673241|NCT02687191|69147453|FG005|Overall Study|Withdrawal by Subject|0|||
37942932|NCT02501096|69630344|FG004|Overall Study|Lost to Follow-up|1|||
37942933|NCT02501096|69630345|FG005|Overall Study|Lost to Follow-up|1|||
37942934|NCT02501096|69630346|FG006|Overall Study|Lost to Follow-up|3|||
37942935|NCT02501096|69630347|FG007|Overall Study|Lost to Follow-up|0|||
37942936|NCT02501096|69630348|FG008|Overall Study|Lost to Follow-up|0|||
37942937|NCT02501096|69630340|FG000|Overall Study|Withdrawal by Subject|1|||
37942938|NCT02501096|69630341|FG001|Overall Study|Withdrawal by Subject|0|||
37942939|NCT02501096|69630342|FG002|Overall Study|Withdrawal by Subject|7|||
37942940|NCT02501096|69630343|FG003|Overall Study|Withdrawal by Subject|13|||
37942941|NCT02501096|69630344|FG004|Overall Study|Withdrawal by Subject|2|||
37942942|NCT02501096|69630345|FG005|Overall Study|Withdrawal by Subject|2|||
37942943|NCT02501096|69630346|FG006|Overall Study|Withdrawal by Subject|2|||
37942944|NCT02501096|69630347|FG007|Overall Study|Withdrawal by Subject|3|||
37942945|NCT02501096|69630348|FG008|Overall Study|Withdrawal by Subject|0|||
37942946|NCT02501096|69630340|FG000|Overall Study|Survival follow-up discontinued by sponsor|0|||
37942947|NCT02501096|69630341|FG001|Overall Study|Survival follow-up discontinued by sponsor|0|||
37942948|NCT02501096|69630342|FG002|Overall Study|Survival follow-up discontinued by sponsor|29|||
37942949|NCT02501096|69630343|FG003|Overall Study|Survival follow-up discontinued by sponsor|58|||
37942950|NCT02501096|69630344|FG004|Overall Study|Survival follow-up discontinued by sponsor|3|||
37942951|NCT02501096|69630345|FG005|Overall Study|Survival follow-up discontinued by sponsor|2|||
37942952|NCT02501096|69630346|FG006|Overall Study|Survival follow-up discontinued by sponsor|2|||
37942953|NCT02501096|69630347|FG007|Overall Study|Survival follow-up discontinued by sponsor|1|||
37942954|NCT02501096|69630348|FG008|Overall Study|Survival follow-up discontinued by sponsor|0|||
37942955|NCT02501096|69630340|FG000|Overall Study|Death|1|||
37942956|NCT02501096|69630341|FG001|Overall Study|Death|1|||
37942957|NCT02501096|69630342|FG002|Overall Study|Death|88|||
37942958|NCT02501096|69630343|FG003|Overall Study|Death|74|||
37942959|NCT02501096|69630344|FG004|Overall Study|Death|15|||
37942960|NCT02501096|69630345|FG005|Overall Study|Death|16|||
37942961|NCT02501096|69630346|FG006|Overall Study|Death|15|||
37942962|NCT02501096|69630347|FG007|Overall Study|Death|16|||
37942963|NCT02501096|69630348|FG008|Overall Study|Death|1|||
37942964|NCT01991977|69630380|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
37942965|NCT01991977|69630380|FG000|Overall Study|Withdrew after start of treatment|5|||
37942966|NCT01633541|69630386|FG000|Overall Study|Death|1|||
37942967|NCT01633541|69630387|FG001|Overall Study|Death|0|||
37942968|NCT01466036|69630397|FG000|Overall Study|Death|1|||
37942969|NCT01466036|69630398|FG001|Overall Study|Death|1|||
37942970|NCT01466036|69630397|FG000|Overall Study|Physician Decision|0|||
37942971|NCT01466036|69630398|FG001|Overall Study|Physician Decision|4|||
37942972|NCT01466036|69630397|FG000|Overall Study|Adverse Event|2|||
37942973|NCT01466036|69630398|FG001|Overall Study|Adverse Event|6|||
37942974|NCT01466036|69630397|FG000|Overall Study|Withdrawal by Subject|2|||
37942975|NCT01466036|69630398|FG001|Overall Study|Withdrawal by Subject|8|||
37942976|NCT01466036|69630397|FG000|Overall Study|progression/relapse|14|||
37942977|NCT01466036|69630398|FG001|Overall Study|progression/relapse|21|||
37942978|NCT01466036|69630397|FG000|Overall Study|prolonged treatment delay|1|||
37942979|NCT01466036|69630398|FG001|Overall Study|prolonged treatment delay|1|||
37942980|NCT01399372|69630407|FG000|Overall Study|Protocol Violation|3|||
37942981|NCT01399372|69630408|FG001|Overall Study|Protocol Violation|1|||
37942982|NCT01063517|69630416|FG000|Overall Study|Consent withdrawal|1|||
37942983|NCT01063517|69630417|FG001|Overall Study|Consent withdrawal|0|||
37942984|NCT01063517|69630416|FG000|Overall Study|Study reached data cut-off|19|||
37942985|NCT01063517|69630417|FG001|Overall Study|Study reached data cut-off|7|||
37942986|NCT01063517|69630416|FG000|Overall Study|Lost to Follow-up|4|||
37942987|NCT01063517|69630417|FG001|Overall Study|Lost to Follow-up|3|||
37942988|NCT01063517|69630416|FG000|Overall Study|Withdrawal by Subject|1|||
37942989|NCT01063517|69630417|FG001|Overall Study|Withdrawal by Subject|2|||
37942990|NCT01063517|69630416|FG000|Overall Study|Death|33|||
37942991|NCT01063517|69630417|FG001|Overall Study|Death|48|||
37942992|NCT00920621|69630427|FG000|Overall Study|Lost to Follow-up|16|||
37942993|NCT00920621|69630428|FG001|Overall Study|Lost to Follow-up|17|||
37942994|NCT00920621|69630429|FG002|Overall Study|Lost to Follow-up|19|||
37942995|NCT00920621|69630430|FG003|Overall Study|Lost to Follow-up|21|||
37942996|NCT00920621|69630427|FG000|Overall Study|Fetal/neonatal deaths|16|||
37942997|NCT00920621|69630428|FG001|Overall Study|Fetal/neonatal deaths|14|||
37942998|NCT00920621|69630429|FG002|Overall Study|Fetal/neonatal deaths|16|||
37942999|NCT00920621|69630430|FG003|Overall Study|Fetal/neonatal deaths|14|||
37943000|NCT00920621|69630427|FG000|Overall Study|Blood sample not collected|22|||
37943001|NCT00920621|69630428|FG001|Overall Study|Blood sample not collected|14|||
37943002|NCT00920621|69630429|FG002|Overall Study|Blood sample not collected|0|||
37943003|NCT00920621|69630430|FG003|Overall Study|Blood sample not collected|0|||
37943004|NCT00612105|69630443|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
37943005|NCT00612105|69630444|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
37943006|NCT00612105|69630443|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
37943007|NCT00612105|69630444|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
37943008|NCT00612105|69630443|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
37943009|NCT00612105|69630444|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
37943010|NCT00612105|69630443|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
37943011|NCT00612105|69630444|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
37943012|NCT00612105|69630443|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
37943013|NCT00612105|69630444|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
37943014|NCT00612105|69630443|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
37943015|NCT00612105|69630444|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
37943016|NCT00612105|69630443|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
37943017|NCT00612105|69630444|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
37943018|NCT00612105|69630443|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
37943019|NCT00612105|69630444|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
37943020|NCT00612105|69630443|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
37943021|NCT00612105|69630444|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
37943022|NCT00612105|69630443|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
37943023|NCT00612105|69630444|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
37943024|NCT00612105|69630443|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
37943025|NCT00612105|69630444|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
37943026|NCT00612105|69630443|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
37943027|NCT00612105|69630444|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
37943028|NCT00546052|69630450|FG000|Overall Study|Adverse Event|47|||
37943029|NCT00546052|69630450|FG000|Overall Study|Lost to Follow-up|144|||
37943030|NCT00546052|69630450|FG000|Overall Study|Protocol Violation|9|||
37943031|NCT00546052|69630450|FG000|Overall Study|Withdrawal by Subject|20|||
37943032|NCT00546052|69630450|FG000|Overall Study|Non Compliance|7|||
37943033|NCT00673920|69630465|FG000|Baseline up to Week 48|Withdrew consent|1|||
37943034|NCT00673920|69630466|FG001|Baseline up to Week 48|Withdrew consent|0|||
37943035|NCT00673920|69630467|FG002|Baseline up to Week 48|Withdrew consent|2|||
37943036|NCT00673920|69630468|FG003|Baseline up to Week 48|Withdrew consent|0|||
37943037|NCT00673920|69630469|FG004|Baseline up to Week 48|Withdrew consent|0|||
37943038|NCT00673920|69630470|FG005|Baseline up to Week 48|Withdrew consent|0|||
37943039|NCT00673920|69630471|FG006|Baseline up to Week 48|Withdrew consent|0|||
37943040|NCT00673920|69630472|FG007|Baseline up to Week 48|Withdrew consent|0|||
37943041|NCT00673920|69630465|FG000|Baseline up to Week 48|Refused treatment|1|||
37943042|NCT00673920|69630466|FG001|Baseline up to Week 48|Refused treatment|0|||
37943043|NCT00673920|69630467|FG002|Baseline up to Week 48|Refused treatment|0|||
37943044|NCT00673920|69630468|FG003|Baseline up to Week 48|Refused treatment|0|||
37943045|NCT00673920|69630469|FG004|Baseline up to Week 48|Refused treatment|0|||
37943046|NCT00673920|69630470|FG005|Baseline up to Week 48|Refused treatment|0|||
37943047|NCT00673920|69630471|FG006|Baseline up to Week 48|Refused treatment|0|||
37943048|NCT00673920|69630472|FG007|Baseline up to Week 48|Refused treatment|0|||
37943049|NCT00673920|69630465|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
37943050|NCT00673920|69630466|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
37943051|NCT00673920|69630467|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
37943052|NCT00673920|69630468|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
37943053|NCT00673920|69630469|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
37943054|NCT00673920|69630470|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
37943055|NCT00673920|69630471|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
37943056|NCT00673920|69630472|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
37943057|NCT00673920|69630465|FG000|Baseline up to Week 48|Protocol Violation|0|||
37943058|NCT00673920|69630466|FG001|Baseline up to Week 48|Protocol Violation|0|||
37943059|NCT00673920|69630467|FG002|Baseline up to Week 48|Protocol Violation|1|||
37943060|NCT00673920|69630468|FG003|Baseline up to Week 48|Protocol Violation|0|||
37943061|NCT00673920|69630469|FG004|Baseline up to Week 48|Protocol Violation|0|||
37943062|NCT00673920|69630470|FG005|Baseline up to Week 48|Protocol Violation|0|||
37943063|NCT00673920|69630471|FG006|Baseline up to Week 48|Protocol Violation|0|||
37943064|NCT00673920|69630472|FG007|Baseline up to Week 48|Protocol Violation|0|||
37943065|NCT00673920|69630465|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
37943066|NCT00673920|69630466|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
38036506|NCT02785900|69723848|FG001|Overall Study|Physician Decision|2|||
38036507|NCT00127205|69723857|FG000|Overall Study|Adverse Event|228|||
38036508|NCT00127205|69723858|FG001|Overall Study|Adverse Event|387|||
38036509|NCT00127205|69723859|FG002|Overall Study|Adverse Event|273|||
38036510|NCT00127205|69723857|FG000|Overall Study|Death|8|||
38036511|NCT00127205|69723858|FG001|Overall Study|Death|6|||
38036512|NCT00127205|69723859|FG002|Overall Study|Death|5|||
38036513|NCT00127205|69723857|FG000|Overall Study|Withdrawal by Subject|318|||
38036514|NCT00127205|69723858|FG001|Overall Study|Withdrawal by Subject|310|||
38036515|NCT00127205|69723859|FG002|Overall Study|Withdrawal by Subject|172|||
38036516|NCT00127205|69723857|FG000|Overall Study|Other-non protocol specified|142|||
37943067|NCT00673920|69630467|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
37943068|NCT00673920|69630468|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
37943069|NCT00673920|69630469|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
38036517|NCT00127205|69723858|FG001|Overall Study|Other-non protocol specified|129|||
38036518|NCT00127205|69723859|FG002|Overall Study|Other-non protocol specified|77|||
38036519|NCT00127205|69723857|FG000|Overall Study|Data not reported|6|||
38036520|NCT00127205|69723858|FG001|Overall Study|Data not reported|10|||
38036521|NCT00127205|69723859|FG002|Overall Study|Data not reported|1|||
38036522|NCT00127205|69723857|FG000|Overall Study|Progression|127|||
38036523|NCT00127205|69723858|FG001|Overall Study|Progression|131|||
38036524|NCT00127205|69723859|FG002|Overall Study|Progression|84|||
38036525|NCT02785588|69723869|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
38036526|NCT02785588|69723869|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
38036527|NCT03670641|69723873|FG000|Overall Study|Lost to Follow-up|3|||
38036528|NCT04029519|69723880|FG000|Overall Study|Protocol Violation|1|||
38036529|NCT04029519|69723880|FG000|Overall Study|Withdrawal by Subject|3|||
38036530|NCT04029519|69723880|FG000|Overall Study|Lost to Follow-up|1|||
38036531|NCT03669861|69723884|FG000|Overall Study|Disease Flare|5|||
38036532|NCT03669861|69723884|FG000|Overall Study|Lack of Efficacy|2|||
38036533|NCT00127127|69723892|FG000|Overall Study|Adverse Event|0|||
38036534|NCT00127127|69723893|FG001|Overall Study|Adverse Event|2|||
38036535|NCT00127127|69723894|FG002|Overall Study|Adverse Event|0|||
38036536|NCT00127127|69723895|FG003|Overall Study|Adverse Event|1|||
38036537|NCT00127127|69723892|FG000|Overall Study|Lack of Efficacy|1|||
38036538|NCT00127127|69723893|FG001|Overall Study|Lack of Efficacy|3|||
38036539|NCT00127127|69723894|FG002|Overall Study|Lack of Efficacy|0|||
38036540|NCT00127127|69723895|FG003|Overall Study|Lack of Efficacy|2|||
38036541|NCT03669549|69723932|FG000|Overall Study|Adverse Event|4|||
38036542|NCT03669549|69723932|FG000|Overall Study|Withdrawal by Subject|1|||
38036543|NCT03669549|69723932|FG000|Overall Study|Study terminated by the Sponsor|1|||
38036544|NCT00126659|69723943|FG000|Overall Study|Adverse Event|0|||
38036545|NCT00126659|69723944|FG001|Overall Study|Adverse Event|0|||
38036546|NCT00126659|69723945|FG002|Overall Study|Adverse Event|2|||
38036547|NCT03669081|69723953|FG000|Overall Study|Data could not be validated|1|||
38036548|NCT03669081|69723954|FG001|Overall Study|Data could not be validated|1|||
38036549|NCT03667053|69723963|FG000|Overall Study|Withdrawal by Subject|1|||
38036550|NCT03667053|69723964|FG001|Overall Study|Withdrawal by Subject|0|||
38036551|NCT03667053|69723965|FG002|Overall Study|Withdrawal by Subject|0|||
38036552|NCT03631407|69723982|FG000|Overall Study|Withdrawal by Subject|3|||
38036553|NCT03631407|69723983|FG001|Overall Study|Withdrawal by Subject|2|||
38036554|NCT03631407|69723982|FG000|Overall Study|Sponsor Decision|0|||
38036555|NCT03631407|69723983|FG001|Overall Study|Sponsor Decision|2|||
38036556|NCT03631407|69723982|FG000|Overall Study|Death|16|||
38036557|NCT03631407|69723983|FG001|Overall Study|Death|16|||
38036558|NCT03631407|69723982|FG000|Overall Study|Randomized by mistake without study treatment|1|||
38036559|NCT03631407|69723983|FG001|Overall Study|Randomized by mistake without study treatment|0|||
38036560|NCT03630393|69724000|FG000|Overall Study|Death|1|||
38036561|NCT03630393|69724001|FG001|Overall Study|Death|0|||
38036562|NCT03628599|69724018|FG000|Overall Study|Adverse Event|0|||
38036563|NCT03628599|69724019|FG001|Overall Study|Adverse Event|1|||
38036564|NCT03627195|69724045|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
38036565|NCT03627195|69724046|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
38036566|NCT03627195|69724047|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
38036567|NCT03627195|69724048|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
38036568|NCT03627195|69724049|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
38036569|NCT03627195|69724050|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
38036570|NCT00126581|69724066|FG000|Overall Study|Adverse Event|3|||
38036571|NCT00126581|69724067|FG001|Overall Study|Adverse Event|7|||
38036572|NCT00126581|69724066|FG000|Overall Study|Death|3|||
38036573|NCT00126581|69724067|FG001|Overall Study|Death|2|||
38036574|NCT00126581|69724066|FG000|Overall Study|Withdrawal by Subject|1|||
38036575|NCT00126581|69724067|FG001|Overall Study|Withdrawal by Subject|4|||
38036576|NCT00126581|69724066|FG000|Overall Study|Alternative therapy|3|||
38036577|NCT00126581|69724067|FG001|Overall Study|Alternative therapy|3|||
38036578|NCT00126581|69724066|FG000|Overall Study|Other illness/MD discretion|3|||
38036579|NCT00126581|69724067|FG001|Overall Study|Other illness/MD discretion|4|||
38036580|NCT03704584|69724077|FG000|Overall Study|Withdrawal by Subject|1|||
38036581|NCT03704584|69724078|FG001|Overall Study|Withdrawal by Subject|0|||
38036582|NCT03662997|69724088|FG000|Overall Study|Adverse Event|0|||
38036583|NCT03662997|69724089|FG001|Overall Study|Adverse Event|2|||
38036584|NCT03662997|69724090|FG002|Overall Study|Adverse Event|0|||
38036585|NCT03662997|69724091|FG003|Overall Study|Adverse Event|0|||
38036586|NCT03648879|69724103|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
38036587|NCT03647709|69724107|FG000|Overall Study|Lost to Follow-up|5|||
38036588|NCT03647709|69724107|FG000|Overall Study|Physician Decision|6|||
38036589|NCT03647709|69724107|FG000|Overall Study|Withdrawal by Subject|3|||
38036590|NCT03661983|69724113|FG000|Open Label Stabilization Phase|Adverse Event|5|||
38036591|NCT03661983|69724114|FG001|Open Label Stabilization Phase|Adverse Event|0|||
38036592|NCT03661983|69724115|FG002|Open Label Stabilization Phase|Adverse Event|0|||
38036593|NCT03661983|69724116|FG003|Open Label Stabilization Phase|Adverse Event|0|||
38036594|NCT03661983|69724113|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
38036595|NCT03661983|69724114|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
38036596|NCT03661983|69724115|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
38036597|NCT03661983|69724116|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
38036598|NCT03661983|69724113|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
38036599|NCT03661983|69724114|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
38036600|NCT03661983|69724115|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
38036601|NCT03661983|69724116|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
38036602|NCT03661983|69724113|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
38036603|NCT03661983|69724114|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
38036604|NCT03661983|69724115|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
38036605|NCT03661983|69724116|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
38036606|NCT03661983|69724113|FG000|Double-blind Randomized Phase|Adverse Event|0|||
38036607|NCT03661983|69724114|FG001|Double-blind Randomized Phase|Adverse Event|1|||
38036608|NCT03661983|69724115|FG002|Double-blind Randomized Phase|Adverse Event|0|||
38036609|NCT03661983|69724116|FG003|Double-blind Randomized Phase|Adverse Event|0|||
38036610|NCT03661983|69724113|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
38036611|NCT03661983|69724114|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
38036612|NCT03661983|69724115|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
38036613|NCT03661983|69724116|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
38036614|NCT03661983|69724113|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
38036615|NCT03661983|69724114|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
38036616|NCT03661983|69724115|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
38036617|NCT03661983|69724116|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
38036618|NCT03661983|69724113|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
38036619|NCT03661983|69724114|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
38036620|NCT03661983|69724115|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
38036621|NCT03661983|69724116|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
38036622|NCT02783170|69724127|FG000|Overall Study|Randomized but not Vaccinated|1|||
38036623|NCT02783170|69724128|FG001|Overall Study|Randomized but not Vaccinated|0|||
38036624|NCT03646305|69724139|FG000|Overall Study|Lost to Follow-up|4|||
38036625|NCT03646305|69724140|FG001|Overall Study|Lost to Follow-up|2|||
38036626|NCT03646305|69724141|FG002|Overall Study|Lost to Follow-up|2|||
38036627|NCT03646305|69724142|FG003|Overall Study|Lost to Follow-up|1|||
38036628|NCT03646305|69724139|FG000|Overall Study|Withdrawal by Subject|1|||
38036629|NCT03646305|69724140|FG001|Overall Study|Withdrawal by Subject|0|||
38036630|NCT03646305|69724141|FG002|Overall Study|Withdrawal by Subject|0|||
38036631|NCT03646305|69724142|FG003|Overall Study|Withdrawal by Subject|1|||
38036632|NCT02782780|69724158|FG000|Overall Study|dropped out after randomization.|7|||
38036633|NCT02782780|69724159|FG001|Overall Study|dropped out after randomization.|5|||
38036634|NCT02782780|69724158|FG000|Overall Study|Protocol Violation|0|||
38036635|NCT02782780|69724159|FG001|Overall Study|Protocol Violation|2|||
38036636|NCT00126503|69724171|FG000|Overall Study|disease progression|23|||
38036637|NCT00126503|69724172|FG001|Overall Study|disease progression|14|||
38036638|NCT00126503|69724171|FG000|Overall Study|Withdrawal by Subject|0|||
38036639|NCT00126503|69724172|FG001|Overall Study|Withdrawal by Subject|1|||
38036640|NCT00126503|69724171|FG000|Overall Study|alternative therapy|1|||
38036641|NCT00126503|69724172|FG001|Overall Study|alternative therapy|1|||
38036642|NCT00126503|69724171|FG000|Overall Study|other complicating disease|4|||
38036643|NCT00126503|69724172|FG001|Overall Study|other complicating disease|1|||
38036644|NCT00126503|69724171|FG000|Overall Study|Death|3|||
38036645|NCT00126503|69724172|FG001|Overall Study|Death|0|||
38036646|NCT00126503|69724171|FG000|Overall Study|Adverse Event|13|||
38036647|NCT00126503|69724172|FG001|Overall Study|Adverse Event|3|||
38036648|NCT00126503|69724171|FG000|Overall Study|non-compliant|1|||
38036649|NCT00126503|69724172|FG001|Overall Study|non-compliant|0|||
38036650|NCT00126503|69724171|FG000|Overall Study|Physician Decision|2|||
38036651|NCT00126503|69724172|FG001|Overall Study|Physician Decision|1|||
38036652|NCT00126425|69724184|FG000|Overall Study|Withdrawal by Subject|17|||
38036653|NCT00126425|69724185|FG001|Overall Study|Withdrawal by Subject|1|||
37943070|NCT00673920|69630470|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
37943071|NCT00673920|69630471|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
37943072|NCT00673920|69630472|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
37943073|NCT00673920|69630465|FG000|Baseline up to Week 48|Administrative/Other|0|||
37943074|NCT00673920|69630466|FG001|Baseline up to Week 48|Administrative/Other|1|||
37943075|NCT00673920|69630467|FG002|Baseline up to Week 48|Administrative/Other|2|||
37943076|NCT00673920|69630468|FG003|Baseline up to Week 48|Administrative/Other|0|||
37943077|NCT00673920|69630469|FG004|Baseline up to Week 48|Administrative/Other|0|||
37943078|NCT00673920|69630470|FG005|Baseline up to Week 48|Administrative/Other|0|||
37943079|NCT00673920|69630471|FG006|Baseline up to Week 48|Administrative/Other|0|||
38036654|NCT00126425|69724184|FG000|Overall Study|Lost to Follow-up|8|||
38036655|NCT00126425|69724185|FG001|Overall Study|Lost to Follow-up|4|||
37943080|NCT00673920|69630472|FG007|Baseline up to Week 48|Administrative/Other|0|||
37943081|NCT00673920|69630465|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
38036656|NCT00126425|69724184|FG000|Overall Study|Protocol Violation|9|||
38036657|NCT00126425|69724185|FG001|Overall Study|Protocol Violation|6|||
38036658|NCT00126425|69724184|FG000|Overall Study|Adverse Event|1|||
38036659|NCT00126425|69724185|FG001|Overall Study|Adverse Event|0|||
38036660|NCT00126425|69724184|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
38036661|NCT00126425|69724185|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
38036662|NCT00126425|69724184|FG000|Overall Study|Other|5|||
38036663|NCT00126425|69724185|FG001|Overall Study|Other|0|||
38036664|NCT00126191|69724193|FG000|Overall Study|Physician Decision|0|||
38036665|NCT00126191|69724194|FG001|Overall Study|Physician Decision|1|||
38036666|NCT00126191|69724193|FG000|Overall Study|Death|0|||
38036667|NCT00126191|69724194|FG001|Overall Study|Death|1|||
38036668|NCT00124943|69724204|FG000|Phase II|Adverse Event|0|||
38036669|NCT00124943|69724205|FG001|Phase II|Adverse Event|2|||
38036670|NCT00124943|69724206|FG002|Phase II|Adverse Event|0|||
38036671|NCT00124943|69724207|FG003|Phase II|Adverse Event|1|||
38036672|NCT00124943|69724204|FG000|Phase II|Protocol Violation|0|||
38036673|NCT00124943|69724205|FG001|Phase II|Protocol Violation|0|||
38036674|NCT00124943|69724206|FG002|Phase II|Protocol Violation|0|||
38036675|NCT00124943|69724207|FG003|Phase II|Protocol Violation|1|||
38036676|NCT00124943|69724204|FG000|Phase II|Lost to Follow-up|0|||
38036677|NCT00124943|69724205|FG001|Phase II|Lost to Follow-up|0|||
38036678|NCT00124943|69724206|FG002|Phase II|Lost to Follow-up|0|||
38036679|NCT00124943|69724207|FG003|Phase II|Lost to Follow-up|1|||
38036680|NCT00124943|69724204|FG000|Phase II|Withdrawal by Subject|0|||
38036681|NCT00124943|69724205|FG001|Phase II|Withdrawal by Subject|0|||
38036682|NCT00124943|69724206|FG002|Phase II|Withdrawal by Subject|0|||
38036683|NCT00124943|69724207|FG003|Phase II|Withdrawal by Subject|2|||
38036684|NCT00124709|69724219|FG000|Overall Study|Randomized but did not take medication|3|||
38036685|NCT00124709|69724220|FG001|Overall Study|Randomized but did not take medication|1|||
38036686|NCT00124709|69724219|FG000|Overall Study|Adverse Event|3|||
38036687|NCT00124709|69724220|FG001|Overall Study|Adverse Event|0|||
38036688|NCT00124709|69724219|FG000|Overall Study|Lack of Efficacy|5|||
38036689|NCT00124709|69724220|FG001|Overall Study|Lack of Efficacy|10|||
38036690|NCT00124709|69724219|FG000|Overall Study|Protocol Violation|3|||
38036691|NCT00124709|69724220|FG001|Overall Study|Protocol Violation|5|||
38036692|NCT00124709|69724219|FG000|Overall Study|Withdrawal by Subject|127|||
37943082|NCT00673920|69630466|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
37943083|NCT00673920|69630467|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
37943084|NCT00673920|69630468|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
37943085|NCT00673920|69630469|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
37943086|NCT00673920|69630470|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
37943087|NCT00673920|69630471|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
37943088|NCT00673920|69630472|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
37943089|NCT00673920|69630465|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
37943090|NCT00673920|69630466|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
37943091|NCT00673920|69630467|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
37943092|NCT00673920|69630468|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
37943093|NCT00673920|69630469|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
37943094|NCT00673920|69630470|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
37943095|NCT00673920|69630471|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
37943096|NCT00673920|69630472|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
37943097|NCT00673920|69630465|FG000|Week 24 to Week 48|Failure to return|0|||
37943098|NCT00673920|69630466|FG001|Week 24 to Week 48|Failure to return|0|||
37943099|NCT00673920|69630467|FG002|Week 24 to Week 48|Failure to return|0|||
38036693|NCT00124709|69724220|FG001|Overall Study|Withdrawal by Subject|136|||
37673242|NCT02687035|69147467|FG000|Overall Study|Withdrawal by Subject|1|||
37673243|NCT02687035|69147467|FG000|Overall Study|Death|87|||
37673244|NCT02687035|69147467|FG000|Overall Study|Lost to Follow-up|1|||
37673245|NCT02687035|69147467|FG000|Overall Study|Missed Visit|87|||
37673246|NCT02687035|69147467|FG000|Overall Study|Did not receive Study Device|8|||
37673247|NCT02691013|69147473|FG000|Overall Study|Withdrawal by Subject|3|||
37943100|NCT00673920|69630468|FG003|Week 24 to Week 48|Failure to return|0|||
38036694|NCT00124709|69724219|FG000|Overall Study|Lost to Follow-up|114|||
38036695|NCT00124709|69724220|FG001|Overall Study|Lost to Follow-up|120|||
38036696|NCT00108862|69724228|FG000|Overall Study|Death|31|||
38036697|NCT00108862|69724229|FG001|Overall Study|Death|37|||
37673248|NCT02691013|69147474|FG001|Overall Study|Withdrawal by Subject|0|||
37673249|NCT02690701|69147484|FG000|Treatment Period 1|Adverse Event|2|||
37673250|NCT02690701|69147485|FG001|Treatment Period 1|Adverse Event|2|||
38036698|NCT00108862|69724228|FG000|Overall Study|Withdrawal by Subject|10|||
38036699|NCT00108862|69724229|FG001|Overall Study|Withdrawal by Subject|6|||
38036700|NCT00108862|69724228|FG000|Overall Study|Lost to Follow-up|27|||
38036701|NCT00108862|69724229|FG001|Overall Study|Lost to Follow-up|19|||
38036702|NCT00564850|69724235|FG000|Overall Study|Protocol Violation|2|||
38036703|NCT00108628|69724241|FG000|Overall Study|Withdrawal by Subject|17|||
37943101|NCT00673920|69630469|FG004|Week 24 to Week 48|Failure to return|0|||
37943102|NCT00673920|69630470|FG005|Week 24 to Week 48|Failure to return|1|||
37943103|NCT00673920|69630471|FG006|Week 24 to Week 48|Failure to return|0|||
37943104|NCT00673920|69630472|FG007|Week 24 to Week 48|Failure to return|0|||
37943105|NCT00673920|69630465|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
37943106|NCT00673920|69630466|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
37943107|NCT00673920|69630467|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
37943108|NCT00673920|69630468|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
37943109|NCT00673920|69630469|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
37943110|NCT00673920|69630470|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
37943111|NCT00673920|69630471|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
37943112|NCT00673920|69630472|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
37943113|NCT00673920|69630465|FG000|Week 24 to Week 48|Death|0|||
37943114|NCT00673920|69630466|FG001|Week 24 to Week 48|Death|0|||
37943115|NCT00673920|69630467|FG002|Week 24 to Week 48|Death|0|||
37943116|NCT00673920|69630468|FG003|Week 24 to Week 48|Death|0|||
37943117|NCT00673920|69630469|FG004|Week 24 to Week 48|Death|0|||
37943118|NCT00673920|69630470|FG005|Week 24 to Week 48|Death|1|||
37943119|NCT00673920|69630471|FG006|Week 24 to Week 48|Death|0|||
37943120|NCT00673920|69630472|FG007|Week 24 to Week 48|Death|0|||
37943121|NCT00673920|69630465|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
37943122|NCT00673920|69630466|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
37943123|NCT00673920|69630467|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
37943124|NCT00673920|69630468|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
37943125|NCT00673920|69630469|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
37943126|NCT00673920|69630470|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
37943127|NCT00673920|69630471|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
37943128|NCT00673920|69630472|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
37943129|NCT00379795|69630499|FG000|Overall Study|Death|31|||
37943130|NCT00379795|69630500|FG001|Overall Study|Death|8|||
37943131|NCT00379795|69630501|FG002|Overall Study|Death|6|||
37943132|NCT00379795|69630502|FG003|Overall Study|Death|4|||
37943133|NCT00379795|69630503|FG004|Overall Study|Death|7|||
37943134|NCT00379795|69630499|FG000|Overall Study|Adverse Event|17|||
37943135|NCT00379795|69630500|FG001|Overall Study|Adverse Event|3|||
37943136|NCT00379795|69630501|FG002|Overall Study|Adverse Event|3|||
37943137|NCT00379795|69630502|FG003|Overall Study|Adverse Event|1|||
37943138|NCT00379795|69630503|FG004|Overall Study|Adverse Event|4|||
37943139|NCT00379795|69630499|FG000|Overall Study|Lost to Follow-up|8|||
37943140|NCT00379795|69630500|FG001|Overall Study|Lost to Follow-up|1|||
37943141|NCT00379795|69630501|FG002|Overall Study|Lost to Follow-up|2|||
37943142|NCT00379795|69630502|FG003|Overall Study|Lost to Follow-up|1|||
37943143|NCT00379795|69630503|FG004|Overall Study|Lost to Follow-up|4|||
37943144|NCT00379795|69630499|FG000|Overall Study|Physician Decision|25|||
37943145|NCT00379795|69630500|FG001|Overall Study|Physician Decision|0|||
37943146|NCT00379795|69630501|FG002|Overall Study|Physician Decision|2|||
37943147|NCT00379795|69630502|FG003|Overall Study|Physician Decision|2|||
37943148|NCT00379795|69630503|FG004|Overall Study|Physician Decision|2|||
37943149|NCT00379795|69630499|FG000|Overall Study|Withdrawal by Subject|94|||
37943150|NCT00379795|69630500|FG001|Overall Study|Withdrawal by Subject|11|||
37943151|NCT00379795|69630501|FG002|Overall Study|Withdrawal by Subject|19|||
37943152|NCT00379795|69630502|FG003|Overall Study|Withdrawal by Subject|7|||
38036704|NCT00108628|69724242|FG001|Overall Study|Withdrawal by Subject|9|||
38036705|NCT00108628|69724241|FG000|Overall Study|Lack of Efficacy|2|||
38036706|NCT00108628|69724242|FG001|Overall Study|Lack of Efficacy|1|||
38036707|NCT00108628|69724241|FG000|Overall Study|Death|1|||
38036708|NCT00108628|69724242|FG001|Overall Study|Death|0|||
38036709|NCT02715856|69724250|FG000|Overall Study|Software Issues|12|||
38036710|NCT02715856|69724251|FG001|Overall Study|Software Issues|7|||
38036711|NCT02715856|69724250|FG000|Overall Study|Death|6|||
37943153|NCT00379795|69630503|FG004|Overall Study|Withdrawal by Subject|14|||
37943154|NCT00379795|69630499|FG000|Overall Study|Subject non-compliance|7|||
37943155|NCT00379795|69630500|FG001|Overall Study|Subject non-compliance|2|||
37943156|NCT00379795|69630501|FG002|Overall Study|Subject non-compliance|0|||
37943157|NCT00379795|69630502|FG003|Overall Study|Subject non-compliance|0|||
38036712|NCT02715856|69724251|FG001|Overall Study|Death|5|||
38036713|NCT02715856|69724250|FG000|Overall Study|Non- Compliant|0|||
38036714|NCT02715856|69724251|FG001|Overall Study|Non- Compliant|40|||
37673251|NCT02690701|69147484|FG000|Treatment Period 1|Withdrawal by Subject|0|||
37943158|NCT00379795|69630503|FG004|Overall Study|Subject non-compliance|1|||
37943159|NCT00379795|69630499|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
37943160|NCT00379795|69630500|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
37943161|NCT00379795|69630501|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
37943162|NCT00379795|69630502|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
37943163|NCT00379795|69630503|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
38036715|NCT00108160|69724259|FG000|Overall Study|Lost to Follow-up|25|||
38036716|NCT00108160|69724260|FG001|Overall Study|Lost to Follow-up|12|||
38036717|NCT00108160|69724259|FG000|Overall Study|Death|1|||
38036718|NCT00108160|69724260|FG001|Overall Study|Death|2|||
38036719|NCT00108160|69724259|FG000|Overall Study|Withdrawal by Subject|4|||
38036720|NCT00108160|69724260|FG001|Overall Study|Withdrawal by Subject|2|||
38036721|NCT00108160|69724259|FG000|Overall Study|Protocol Violation|9|||
38036722|NCT00108160|69724260|FG001|Overall Study|Protocol Violation|5|||
38036723|NCT01366846|69724272|FG000|Overall Study|Withdrawal by Subject|2|||
38036724|NCT01366846|69724273|FG001|Overall Study|Withdrawal by Subject|0|||
38036725|NCT01366846|69724274|FG002|Overall Study|Withdrawal by Subject|0|||
38036726|NCT01366846|69724275|FG003|Overall Study|Withdrawal by Subject|0|||
38036727|NCT01366846|69724272|FG000|Overall Study|Communication Difficulties|1|||
38036728|NCT01366846|69724273|FG001|Overall Study|Communication Difficulties|4|||
38036729|NCT01366846|69724274|FG002|Overall Study|Communication Difficulties|0|||
38036730|NCT01366846|69724275|FG003|Overall Study|Communication Difficulties|1|||
38036731|NCT01366846|69724272|FG000|Overall Study|Scheduling Conflicts|0|||
38036732|NCT01366846|69724273|FG001|Overall Study|Scheduling Conflicts|0|||
38036733|NCT01366846|69724274|FG002|Overall Study|Scheduling Conflicts|1|||
38036734|NCT01366846|69724275|FG003|Overall Study|Scheduling Conflicts|0|||
38036735|NCT00108082|69724291|FG000|Overall Study|Adverse Event|14|||
38036736|NCT00108082|69724292|FG001|Overall Study|Adverse Event|12|||
38036737|NCT00108082|69724293|FG002|Overall Study|Adverse Event|17|||
38036738|NCT00108082|69724291|FG000|Overall Study|Lost to Follow-up|6|||
38036739|NCT00108082|69724292|FG001|Overall Study|Lost to Follow-up|3|||
38036740|NCT00108082|69724293|FG002|Overall Study|Lost to Follow-up|7|||
38036741|NCT00108082|69724291|FG000|Overall Study|Consent Withdrawn|3|||
38036742|NCT00108082|69724292|FG001|Overall Study|Consent Withdrawn|3|||
38036743|NCT00108082|69724293|FG002|Overall Study|Consent Withdrawn|5|||
38036744|NCT00108082|69724291|FG000|Overall Study|Protocol Violation|1|||
38036745|NCT00108082|69724292|FG001|Overall Study|Protocol Violation|2|||
38036746|NCT00108082|69724293|FG002|Overall Study|Protocol Violation|0|||
38036747|NCT00108082|69724291|FG000|Overall Study|Lack of Efficacy|3|||
38036748|NCT00108082|69724292|FG001|Overall Study|Lack of Efficacy|1|||
38036749|NCT00108082|69724293|FG002|Overall Study|Lack of Efficacy|2|||
38036750|NCT00108082|69724291|FG000|Overall Study|Amendment 4: > Month 12|5|||
38036751|NCT00108082|69724292|FG001|Overall Study|Amendment 4: > Month 12|7|||
38036752|NCT00108082|69724293|FG002|Overall Study|Amendment 4: > Month 12|5|||
38036753|NCT00108082|69724291|FG000|Overall Study|Woman of Child-bearing Potential|2|||
38036754|NCT00108082|69724292|FG001|Overall Study|Woman of Child-bearing Potential|0|||
38036755|NCT00108082|69724293|FG002|Overall Study|Woman of Child-bearing Potential|2|||
38036756|NCT00108082|69724291|FG000|Overall Study|Incorrectly Randomized|0|||
38036757|NCT00108082|69724292|FG001|Overall Study|Incorrectly Randomized|0|||
38036758|NCT00108082|69724293|FG002|Overall Study|Incorrectly Randomized|2|||
38036759|NCT00108082|69724291|FG000|Overall Study|Non-compliance|1|||
38036760|NCT00108082|69724292|FG001|Overall Study|Non-compliance|0|||
38036761|NCT00108082|69724293|FG002|Overall Study|Non-compliance|2|||
38036762|NCT00108082|69724291|FG000|Overall Study|Stopped Study Medication|0|||
38036763|NCT00108082|69724292|FG001|Overall Study|Stopped Study Medication|0|||
38036764|NCT00108082|69724293|FG002|Overall Study|Stopped Study Medication|1|||
38036765|NCT00108082|69724291|FG000|Overall Study|Site Closed Study|0|||
38036766|NCT00108082|69724292|FG001|Overall Study|Site Closed Study|2|||
38036767|NCT00108082|69724293|FG002|Overall Study|Site Closed Study|0|||
38036768|NCT00108082|69724291|FG000|Overall Study|Protocol Amendment|0|||
38036769|NCT00108082|69724292|FG001|Overall Study|Protocol Amendment|1|||
38036770|NCT00108082|69724293|FG002|Overall Study|Protocol Amendment|0|||
38036771|NCT00108082|69724291|FG000|Overall Study|Study Medication Not Tapered|0|||
38036772|NCT00108082|69724292|FG001|Overall Study|Study Medication Not Tapered|1|||
38036773|NCT00108082|69724293|FG002|Overall Study|Study Medication Not Tapered|0|||
38036774|NCT00108082|69724291|FG000|Overall Study|Subject Left Site Location|1|||
38036775|NCT00108082|69724292|FG001|Overall Study|Subject Left Site Location|0|||
38036776|NCT00108082|69724293|FG002|Overall Study|Subject Left Site Location|0|||
38036777|NCT00108082|69724291|FG000|Overall Study|Investigator Not at Site|1|||
38036778|NCT00108082|69724292|FG001|Overall Study|Investigator Not at Site|0|||
38036779|NCT00108082|69724293|FG002|Overall Study|Investigator Not at Site|0|||
38036780|NCT00108082|69724291|FG000|Overall Study|Blood Pressure Not Controlled|1|||
38036781|NCT00108082|69724292|FG001|Overall Study|Blood Pressure Not Controlled|0|||
38036782|NCT00108082|69724293|FG002|Overall Study|Blood Pressure Not Controlled|0|||
38036783|NCT00104728|69724305|FG000|Overall Study|screen failures|19|||
38036784|NCT02781844|69724313|FG000|Treatment Period 1|Adverse Event|0|||
38036785|NCT02781844|69724314|FG001|Treatment Period 1|Adverse Event|0|||
38036786|NCT02781844|69724315|FG002|Treatment Period 1|Adverse Event|0|||
38036787|NCT02781844|69724316|FG003|Treatment Period 1|Adverse Event|0|||
38036788|NCT02781844|69724317|FG004|Treatment Period 1|Adverse Event|0|||
38036789|NCT02781844|69724318|FG005|Treatment Period 1|Adverse Event|1|||
38036790|NCT02781844|69724319|FG006|Treatment Period 1|Adverse Event|0|||
38036791|NCT02781844|69724320|FG007|Treatment Period 1|Adverse Event|0|||
38036792|NCT02775916|69724338|FG000|Overall Study|Adverse Event|1|||
38036793|NCT02775916|69724339|FG001|Overall Study|Adverse Event|0|||
38036794|NCT02775916|69724338|FG000|Overall Study|Subject/Guardian Decision|2|||
38036795|NCT02775916|69724339|FG001|Overall Study|Subject/Guardian Decision|0|||
38036796|NCT00122681|69724347|FG000|Overall Study|Adverse Event|20|||
38036797|NCT00122681|69724348|FG001|Overall Study|Adverse Event|16|||
38036798|NCT00122681|69724347|FG000|Overall Study|Lost to Follow-up|1080|||
38036799|NCT00122681|69724348|FG001|Overall Study|Lost to Follow-up|1097|||
38036800|NCT00122681|69724347|FG000|Overall Study|Protocol Violation|7|||
38036801|NCT00122681|69724348|FG001|Overall Study|Protocol Violation|10|||
38036802|NCT00122681|69724347|FG000|Overall Study|Withdrawal by Subject|257|||
38036803|NCT00122681|69724348|FG001|Overall Study|Withdrawal by Subject|251|||
38036804|NCT00122681|69724347|FG000|Overall Study|Personal reasons|150|||
38036805|NCT00122681|69724348|FG001|Overall Study|Personal reasons|147|||
38036806|NCT02774278|69724362|FG000|Overall Study|Lack of Efficacy|199|||
38036807|NCT02774278|69724362|FG000|Overall Study|Death|29|||
38036808|NCT02774278|69724362|FG000|Overall Study|Adverse event/intercurrent illness|16|||
38036809|NCT02774278|69724362|FG000|Overall Study|Refused treatment/did not cooperate|9|||
38036810|NCT02774278|69724362|FG000|Overall Study|Administrative reasons|6|||
38036811|NCT02774278|69724362|FG000|Overall Study|Withdrawal by Subject|3|||
38036812|NCT02774278|69724362|FG000|Overall Study|Protocol Violation|2|||
38036813|NCT03621189|69724368|FG000|Overall Study|Withdrawal by Subject|0|||
38036814|NCT03621189|69724369|FG001|Overall Study|Withdrawal by Subject|3|||
38036815|NCT03621189|69724368|FG000|Overall Study|Physician Decision|0|||
38036816|NCT03621189|69724369|FG001|Overall Study|Physician Decision|2|||
38036817|NCT00122135|69724378|FG000|Overall Study|Withdrawal by Subject|3|||
38036818|NCT00122135|69724379|FG001|Overall Study|Withdrawal by Subject|0|||
38036819|NCT03645057|69724389|FG000|Randomization to Baseline|Lost to Follow-up|1|||
38036820|NCT03645057|69724390|FG001|Randomization to Baseline|Lost to Follow-up|0|||
38036821|NCT03645057|69724391|FG002|Randomization to Baseline|Lost to Follow-up|1|||
38036822|NCT03645057|69724392|FG003|Randomization to Baseline|Lost to Follow-up|0|||
38036823|NCT03645057|69724389|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
38036824|NCT03645057|69724390|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
38036825|NCT03645057|69724391|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
38036826|NCT03645057|69724392|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
38036827|NCT03645057|69724389|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
38036828|NCT03645057|69724390|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
38036829|NCT03645057|69724391|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
38036830|NCT03645057|69724392|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
38036831|NCT03645057|69724389|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
38036832|NCT03645057|69724390|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
38036833|NCT03645057|69724391|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
38036834|NCT03645057|69724392|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
38036835|NCT00132041|69724398|FG000|Baseline|Ineligible|6|||
38036836|NCT00132041|69724398|FG000|3 Months Post Ablation|Transplant|1|||
38036837|NCT00132041|69724398|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
38036838|NCT00132041|69724398|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
38036839|NCT00132041|69724398|FG000|6 Months Post Ablation|Death|2|||
38036840|NCT00132041|69724398|FG000|6 Months Post Ablation|Transplant|6|||
38036841|NCT00132041|69724398|FG000|9 Months Post Ablation|Death|1|||
38036842|NCT00132041|69724398|FG000|9 Months Post Ablation|Transplant|1|||
38036843|NCT00132041|69724398|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
37943164|NCT00379795|69630499|FG000|Overall Study|Subjects condition mandated intervention|34|||
37943165|NCT00379795|69630500|FG001|Overall Study|Subjects condition mandated intervention|9|||
37943166|NCT00379795|69630501|FG002|Overall Study|Subjects condition mandated intervention|7|||
37943167|NCT00379795|69630502|FG003|Overall Study|Subjects condition mandated intervention|5|||
37943168|NCT00379795|69630503|FG004|Overall Study|Subjects condition mandated intervention|7|||
37943169|NCT00379795|69630499|FG000|Overall Study|Sponsor's decision|257|||
38036844|NCT00132041|69724398|FG000|12 Months Post Ablation|Death|1|||
38036845|NCT00132041|69724398|FG000|12 Months Post Ablation|Transplant|1|||
38036846|NCT00132041|69724398|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
38036847|NCT00132041|69724398|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
38036848|NCT00132041|69724398|FG000|15 Months Post Ablation|Death|1|||
38036849|NCT00132041|69724398|FG000|15 Months Post Ablation|Transplant|5|||
38036850|NCT00132041|69724398|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
38036851|NCT00132041|69724398|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
38036852|NCT00132041|69724398|FG000|18 Months Post Ablation|Transplant|1|||
38036853|NCT00132041|69724398|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
38036854|NCT00132041|69724398|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
38036855|NCT03643575|69724408|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
38036856|NCT03643575|69724409|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
38036857|NCT03643575|69724410|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
38036858|NCT03643575|69724411|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
38036859|NCT03643575|69724412|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
38036860|NCT03643575|69724413|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
38036861|NCT03643575|69724408|FG000|Washout: 7 Days|Adverse Event|1|||
38036862|NCT03643575|69724409|FG001|Washout: 7 Days|Adverse Event|0|||
38036863|NCT03643575|69724410|FG002|Washout: 7 Days|Adverse Event|0|||
37943170|NCT00379795|69630500|FG001|Overall Study|Sponsor's decision|17|||
37943171|NCT00379795|69630501|FG002|Overall Study|Sponsor's decision|54|||
37943172|NCT00379795|69630502|FG003|Overall Study|Sponsor's decision|47|||
37943173|NCT00379795|69630503|FG004|Overall Study|Sponsor's decision|10|||
37943174|NCT00610155|69630518|FG000|Period 1|Withdrawal by Subject|0|||
37943175|NCT00610155|69630519|FG001|Period 1|Withdrawal by Subject|0|||
37943176|NCT00610155|69630520|FG002|Period 1|Withdrawal by Subject|1|||
37943177|NCT00610155|69630521|FG003|Period 1|Withdrawal by Subject|0|||
37943178|NCT00610155|69630522|FG004|Period 1|Withdrawal by Subject|0|||
37943179|NCT00610155|69630523|FG005|Period 1|Withdrawal by Subject|0|||
37943180|NCT00610155|69630518|FG000|Period 3|Adverse Event|1|||
37943181|NCT00610155|69630519|FG001|Period 3|Adverse Event|0|||
37943182|NCT00610155|69630520|FG002|Period 3|Adverse Event|0|||
37943183|NCT00610155|69630521|FG003|Period 3|Adverse Event|0|||
37943184|NCT00610155|69630522|FG004|Period 3|Adverse Event|0|||
37943185|NCT00610155|69630523|FG005|Period 3|Adverse Event|0|||
37943186|NCT00674700|69630534|FG000|Year 1|Adverse Event|17|||
37943187|NCT00674700|69630535|FG001|Year 1|Adverse Event|20|||
37943188|NCT00674700|69630536|FG002|Year 1|Adverse Event|5|||
37943189|NCT00674700|69630534|FG000|Year 1|Withdrawal by Subject|7|||
37943190|NCT00674700|69630535|FG001|Year 1|Withdrawal by Subject|7|||
37943191|NCT00674700|69630536|FG002|Year 1|Withdrawal by Subject|6|||
37943192|NCT00674700|69630534|FG000|Year 1|Any other reason not above-mentioned|7|||
37943193|NCT00674700|69630535|FG001|Year 1|Any other reason not above-mentioned|7|||
37943194|NCT00674700|69630536|FG002|Year 1|Any other reason not above-mentioned|6|||
37943195|NCT00674700|69630534|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
37943196|NCT00674700|69630535|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
37943197|NCT00674700|69630536|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
37943198|NCT00674700|69630534|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
37943199|NCT00674700|69630535|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
37943200|NCT00674700|69630536|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
37943201|NCT00674700|69630534|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
37943202|NCT00674700|69630535|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
37943203|NCT00674700|69630536|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
37943204|NCT00546910|69630546|FG000|Overall Study|Adverse Event|2|||
37943205|NCT00546910|69630547|FG001|Overall Study|Adverse Event|3|||
37943206|NCT00546910|69630546|FG000|Overall Study|Lack of Efficacy|5|||
37943207|NCT00546910|69630547|FG001|Overall Study|Lack of Efficacy|7|||
37943208|NCT00546910|69630546|FG000|Overall Study|Physician Decision|0|||
37943209|NCT00546910|69630547|FG001|Overall Study|Physician Decision|1|||
37943210|NCT00546910|69630546|FG000|Overall Study|Withdrawal by Subject|2|||
37943211|NCT00546910|69630547|FG001|Overall Study|Withdrawal by Subject|0|||
37943212|NCT00379639|69630558|FG000|Overall Study|Disease Progression|3|||
37943213|NCT00379639|69630559|FG001|Overall Study|Disease Progression|3|||
37943214|NCT00379639|69630560|FG002|Overall Study|Disease Progression|3|||
37943215|NCT00379639|69630561|FG003|Overall Study|Disease Progression|4|||
37943216|NCT00379639|69630562|FG004|Overall Study|Disease Progression|4|||
37943217|NCT00379639|69630558|FG000|Overall Study|Physician Decision|0|||
37943218|NCT00379639|69630559|FG001|Overall Study|Physician Decision|2|||
37943219|NCT00379639|69630560|FG002|Overall Study|Physician Decision|1|||
37943220|NCT00379639|69630561|FG003|Overall Study|Physician Decision|1|||
37943221|NCT00379639|69630562|FG004|Overall Study|Physician Decision|0|||
37943222|NCT00379639|69630558|FG000|Overall Study|Symptomatic Deterioration|0|||
37943223|NCT00379639|69630559|FG001|Overall Study|Symptomatic Deterioration|0|||
37943224|NCT00379639|69630560|FG002|Overall Study|Symptomatic Deterioration|1|||
37943225|NCT00379639|69630561|FG003|Overall Study|Symptomatic Deterioration|0|||
37943226|NCT00379639|69630562|FG004|Overall Study|Symptomatic Deterioration|1|||
37943227|NCT00379639|69630558|FG000|Overall Study|Adverse Event|0|||
37943228|NCT00379639|69630559|FG001|Overall Study|Adverse Event|0|||
37943229|NCT00379639|69630560|FG002|Overall Study|Adverse Event|1|||
37943230|NCT00379639|69630561|FG003|Overall Study|Adverse Event|0|||
37943231|NCT00379639|69630562|FG004|Overall Study|Adverse Event|1|||
37943232|NCT00379639|69630558|FG000|Overall Study|Lost to Follow-up|0|||
37943233|NCT00379639|69630559|FG001|Overall Study|Lost to Follow-up|0|||
37943234|NCT00379639|69630560|FG002|Overall Study|Lost to Follow-up|0|||
37943235|NCT00379639|69630561|FG003|Overall Study|Lost to Follow-up|1|||
37943236|NCT00379639|69630562|FG004|Overall Study|Lost to Follow-up|0|||
37943237|NCT00379639|69630558|FG000|Overall Study|Other|0|||
37943238|NCT00379639|69630559|FG001|Overall Study|Other|0|||
37673252|NCT02690701|69147485|FG001|Treatment Period 1|Withdrawal by Subject|1|||
37943239|NCT00379639|69630560|FG002|Overall Study|Other|3|||
37943240|NCT00379639|69630561|FG003|Overall Study|Other|0|||
37943241|NCT00379639|69630562|FG004|Overall Study|Other|0|||
37943242|NCT03948334|69630576|FG000|Overall Study|Adverse Event|1|||
37673253|NCT02690701|69147484|FG000|Treatment Period 2|Adverse Event|2|||
37943243|NCT03948334|69630577|FG001|Overall Study|Adverse Event|4|||
37943244|NCT03948334|69630576|FG000|Overall Study|Lack of Efficacy|2|||
37943245|NCT03948334|69630577|FG001|Overall Study|Lack of Efficacy|0|||
37943246|NCT03948334|69630576|FG000|Overall Study|Lost to Follow-up|1|||
37943247|NCT03948334|69630577|FG001|Overall Study|Lost to Follow-up|0|||
37943248|NCT03948334|69630576|FG000|Overall Study|Physician Decision|1|||
37943249|NCT03948334|69630577|FG001|Overall Study|Physician Decision|0|||
37943250|NCT03948334|69630576|FG000|Overall Study|Pregnancy|0|||
37943251|NCT03948334|69630577|FG001|Overall Study|Pregnancy|1|||
37943252|NCT03948334|69630576|FG000|Overall Study|Protocol Deviation|1|||
37943253|NCT03948334|69630577|FG001|Overall Study|Protocol Deviation|0|||
37943254|NCT03948334|69630576|FG000|Overall Study|Study terminated by Sponsor|50|||
37943255|NCT03948334|69630577|FG001|Overall Study|Study terminated by Sponsor|51|||
37943256|NCT03948334|69630576|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
37943257|NCT03948334|69630577|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
37943258|NCT00609765|69630591|FG000|Overall Study|Study ended prior to 12 months|1|||
37943259|NCT00608829|69630595|FG000|Overall Study|Death|6|||
37943260|NCT00608829|69630595|FG000|Overall Study|Withdrawal by Subject|4|||
37943261|NCT00608829|69630595|FG000|Overall Study|Subject refuses to follow up or return.|5|||
37943262|NCT00545818|69630601|FG000|Overall Study|Protocol Violation|1|||
37943263|NCT00545818|69630602|FG001|Overall Study|Protocol Violation|0|||
37943264|NCT00545818|69630601|FG000|Overall Study|Adverse Event|1|||
37943265|NCT00545818|69630602|FG001|Overall Study|Adverse Event|1|||
37943266|NCT00545818|69630601|FG000|Overall Study|Lost to Follow-up|1|||
37943267|NCT00545818|69630602|FG001|Overall Study|Lost to Follow-up|6|||
37943268|NCT00674154|69630610|FG000|Overall Study|Withdrawal by Subject|3|||
37943269|NCT00674154|69630611|FG001|Overall Study|Withdrawal by Subject|1|||
37943270|NCT00674154|69630610|FG000|Overall Study|Did not want parathyroidectomy|0|||
37943271|NCT00674154|69630611|FG001|Overall Study|Did not want parathyroidectomy|2|||
37943272|NCT00608517|69630620|FG000|Overall Study|Death|1|||
37943273|NCT00608517|69630621|FG001|Overall Study|Death|0|||
37943274|NCT00608517|69630622|FG002|Overall Study|Death|0|||
37943275|NCT00608205|69630633|FG000|Overall Study|Adverse Event|3|||
37943276|NCT00608205|69630634|FG001|Overall Study|Adverse Event|2|||
37943277|NCT00608205|69630633|FG000|Overall Study|Patient non-compliant|0|||
37943278|NCT00608205|69630634|FG001|Overall Study|Patient non-compliant|1|||
37943279|NCT00670800|69630644|FG000|Overall Study|2 controls were insulin resistant|0|||
37943280|NCT00670800|69630645|FG001|Overall Study|2 controls were insulin resistant|2|||
37943281|NCT00607893|69630655|FG000|Overall Study|Lost to Follow-up|4|||
37943282|NCT00607893|69630656|FG001|Overall Study|Lost to Follow-up|0|||
37943283|NCT00607893|69630655|FG000|Overall Study|withdrew due to loss of interest|0|||
37943284|NCT00607893|69630656|FG001|Overall Study|withdrew due to loss of interest|1|||
37943285|NCT00607893|69630655|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
37943286|NCT00607893|69630656|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
37943287|NCT00607893|69630655|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
37943288|NCT00607893|69630656|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
37943289|NCT00607893|69630655|FG000|Overall Study|Declined to be treated|1|||
37943290|NCT00607893|69630656|FG001|Overall Study|Declined to be treated|0|||
37943291|NCT00607893|69630655|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
37943292|NCT00607893|69630656|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
37943293|NCT00571038|69630666|FG000|Overall Study|Lost to Follow-up|1|||
37943294|NCT00571038|69630667|FG001|Overall Study|Lost to Follow-up|4|||
37943295|NCT00571038|69630666|FG000|Overall Study|Death|7|||
37943296|NCT00571038|69630667|FG001|Overall Study|Death|5|||
37943297|NCT00571038|69630666|FG000|Overall Study|Withdrawal by Subject|1|||
37943298|NCT00571038|69630667|FG001|Overall Study|Withdrawal by Subject|3|||
37943299|NCT00571038|69630666|FG000|Overall Study|Moved out of state|2|||
37943300|NCT00571038|69630667|FG001|Overall Study|Moved out of state|2|||
37943301|NCT00545740|69630677|FG000|Overall Study|Lack of Efficacy|34|||
37943302|NCT00545740|69630678|FG001|Overall Study|Lack of Efficacy|35|||
37943303|NCT00545740|69630679|FG002|Overall Study|Lack of Efficacy|47|||
37943304|NCT00545740|69630680|FG003|Overall Study|Lack of Efficacy|36|||
37943305|NCT00545740|69630677|FG000|Overall Study|Withdrawal by Subject|17|||
37943306|NCT00545740|69630678|FG001|Overall Study|Withdrawal by Subject|15|||
37943307|NCT00545740|69630679|FG002|Overall Study|Withdrawal by Subject|16|||
37943308|NCT00545740|69630680|FG003|Overall Study|Withdrawal by Subject|18|||
37943309|NCT00545740|69630677|FG000|Overall Study|Adverse Event|10|||
37943310|NCT00545740|69630678|FG001|Overall Study|Adverse Event|18|||
37943311|NCT00545740|69630679|FG002|Overall Study|Adverse Event|19|||
37943312|NCT00545740|69630680|FG003|Overall Study|Adverse Event|9|||
37943313|NCT00545740|69630677|FG000|Overall Study|Lost to Follow-up|7|||
37943314|NCT00545740|69630678|FG001|Overall Study|Lost to Follow-up|5|||
37943315|NCT00545740|69630679|FG002|Overall Study|Lost to Follow-up|5|||
37943316|NCT00545740|69630680|FG003|Overall Study|Lost to Follow-up|6|||
37943317|NCT00545740|69630677|FG000|Overall Study|Protocol Violation|1|||
37943318|NCT00545740|69630678|FG001|Overall Study|Protocol Violation|3|||
37943319|NCT00545740|69630679|FG002|Overall Study|Protocol Violation|1|||
37943320|NCT00545740|69630680|FG003|Overall Study|Protocol Violation|0|||
37943321|NCT00545740|69630677|FG000|Overall Study|Non-compliance|0|||
37943322|NCT00545740|69630678|FG001|Overall Study|Non-compliance|2|||
37943323|NCT00545740|69630679|FG002|Overall Study|Non-compliance|1|||
37943324|NCT00545740|69630680|FG003|Overall Study|Non-compliance|0|||
37943325|NCT00545740|69630677|FG000|Overall Study|Moved|2|||
37943326|NCT00545740|69630678|FG001|Overall Study|Moved|0|||
37943327|NCT00545740|69630679|FG002|Overall Study|Moved|1|||
37943328|NCT00545740|69630680|FG003|Overall Study|Moved|0|||
37943329|NCT00545740|69630677|FG000|Overall Study|Diverticulitis attack|0|||
37943330|NCT00545740|69630678|FG001|Overall Study|Diverticulitis attack|0|||
37943331|NCT00545740|69630679|FG002|Overall Study|Diverticulitis attack|1|||
37943332|NCT00545740|69630680|FG003|Overall Study|Diverticulitis attack|1|||
37943333|NCT00545740|69630677|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
37943334|NCT00545740|69630678|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
37943335|NCT00545740|69630679|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
37943336|NCT00545740|69630680|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
37943337|NCT00545740|69630677|FG000|Overall Study|Site closure|1|||
37943338|NCT00545740|69630678|FG001|Overall Study|Site closure|0|||
37943339|NCT00545740|69630679|FG002|Overall Study|Site closure|0|||
37943340|NCT00545740|69630680|FG003|Overall Study|Site closure|0|||
37943341|NCT00545740|69630677|FG000|Overall Study|Missed visit|1|||
37943342|NCT00545740|69630678|FG001|Overall Study|Missed visit|0|||
37943343|NCT00545740|69630679|FG002|Overall Study|Missed visit|0|||
37943344|NCT00545740|69630680|FG003|Overall Study|Missed visit|0|||
37943345|NCT00545740|69630677|FG000|Overall Study|Physician Decision|0|||
37943346|NCT00545740|69630678|FG001|Overall Study|Physician Decision|0|||
37943347|NCT00545740|69630679|FG002|Overall Study|Physician Decision|3|||
37943348|NCT00545740|69630680|FG003|Overall Study|Physician Decision|0|||
37943349|NCT00545740|69630677|FG000|Overall Study|Accepted only monthly telephone calls|1|||
37943350|NCT00545740|69630678|FG001|Overall Study|Accepted only monthly telephone calls|0|||
37943351|NCT00545740|69630679|FG002|Overall Study|Accepted only monthly telephone calls|0|||
37943352|NCT00545740|69630680|FG003|Overall Study|Accepted only monthly telephone calls|0|||
37943353|NCT00545740|69630677|FG000|Overall Study|Sponsor decision|0|||
37943354|NCT00545740|69630678|FG001|Overall Study|Sponsor decision|1|||
37943355|NCT00545740|69630679|FG002|Overall Study|Sponsor decision|0|||
37943356|NCT00545740|69630680|FG003|Overall Study|Sponsor decision|0|||
37943357|NCT00545740|69630677|FG000|Overall Study|Lack of time|0|||
37943358|NCT00545740|69630678|FG001|Overall Study|Lack of time|1|||
37943359|NCT00545740|69630679|FG002|Overall Study|Lack of time|0|||
37943360|NCT00545740|69630680|FG003|Overall Study|Lack of time|0|||
37943361|NCT00545740|69630677|FG000|Overall Study|Non-adherence to visits|0|||
37943362|NCT00545740|69630678|FG001|Overall Study|Non-adherence to visits|1|||
37943363|NCT00545740|69630679|FG002|Overall Study|Non-adherence to visits|0|||
37943364|NCT00545740|69630680|FG003|Overall Study|Non-adherence to visits|0|||
37943365|NCT00545740|69630677|FG000|Overall Study|Patient difficulties|0|||
37943366|NCT00545740|69630678|FG001|Overall Study|Patient difficulties|1|||
37943367|NCT00545740|69630679|FG002|Overall Study|Patient difficulties|0|||
37943368|NCT00545740|69630680|FG003|Overall Study|Patient difficulties|0|||
37943369|NCT00545740|69630677|FG000|Overall Study|Husband against study|0|||
37943370|NCT00545740|69630678|FG001|Overall Study|Husband against study|0|||
37943371|NCT00545740|69630679|FG002|Overall Study|Husband against study|1|||
37943372|NCT00545740|69630680|FG003|Overall Study|Husband against study|0|||
37943373|NCT00609609|69630692|FG000|Overall Study|Withdrawal by Subject|2|||
37943374|NCT00609609|69630693|FG001|Overall Study|Withdrawal by Subject|0|||
37943375|NCT00609609|69630692|FG000|Overall Study|Progression|4|||
37943376|NCT00609609|69630693|FG001|Overall Study|Progression|2|||
37943377|NCT00673452|69630701|FG000|Acute Double-Blind Phase|Adverse Event|41|||
37943378|NCT00673452|69630702|FG001|Acute Double-Blind Phase|Adverse Event|24|||
37943379|NCT00673452|69630701|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
37943380|NCT00673452|69630702|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
37943381|NCT00673452|69630701|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
37943382|NCT00673452|69630702|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
37943383|NCT00673452|69630701|FG000|Acute Double-Blind Phase|Physician Decision|0|||
37943384|NCT00673452|69630702|FG001|Acute Double-Blind Phase|Physician Decision|6|||
37943385|NCT00673452|69630701|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
37943386|NCT00673452|69630702|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
37943387|NCT00673452|69630701|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
37943388|NCT00673452|69630702|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
37943389|NCT00673452|69630701|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
37943390|NCT00673452|69630702|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
37943391|NCT00673452|69630701|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
37943392|NCT00673452|69630702|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
37943393|NCT00673452|69630701|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
37943394|NCT00673452|69630702|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
37943395|NCT00673452|69630701|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
37943396|NCT00673452|69630702|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
37943397|NCT00673452|69630701|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
37943398|NCT00673452|69630702|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
37943399|NCT00673452|69630701|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
37943400|NCT00673452|69630702|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
37943401|NCT00673452|69630701|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
37943402|NCT00673452|69630702|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
37943403|NCT00673452|69630701|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
37943404|NCT00673452|69630702|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
37943405|NCT00673452|69630701|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
37943406|NCT00673452|69630702|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
37943407|NCT00545584|69630711|FG000|Overall Study|Only one reason for discontinuation|62|||
37943408|NCT00545584|69630712|FG001|Overall Study|Only one reason for discontinuation|61|||
37943409|NCT00545584|69630713|FG002|Overall Study|Only one reason for discontinuation|48|||
37943410|NCT00545584|69630711|FG000|Overall Study|Two or more reasons for discontinuation|17|||
37943411|NCT00545584|69630712|FG001|Overall Study|Two or more reasons for discontinuation|19|||
37943412|NCT00545584|69630713|FG002|Overall Study|Two or more reasons for discontinuation|8|||
37943413|NCT00378703|69630725|FG000|Overall Study|Disease progression|59|||
37943414|NCT00378703|69630726|FG001|Overall Study|Disease progression|43|||
37943415|NCT00378703|69630727|FG002|Overall Study|Disease progression|48|||
37943416|NCT00378703|69630728|FG003|Overall Study|Disease progression|49|||
37943417|NCT00378703|69630725|FG000|Overall Study|Adverse Event|11|||
37943418|NCT00378703|69630726|FG001|Overall Study|Adverse Event|17|||
37943419|NCT00378703|69630727|FG002|Overall Study|Adverse Event|20|||
37943420|NCT00378703|69630728|FG003|Overall Study|Adverse Event|18|||
37943421|NCT00378703|69630725|FG000|Overall Study|Death|2|||
37943422|NCT00378703|69630726|FG001|Overall Study|Death|2|||
37943423|NCT00378703|69630727|FG002|Overall Study|Death|4|||
37943424|NCT00378703|69630728|FG003|Overall Study|Death|3|||
37943425|NCT00378703|69630725|FG000|Overall Study|Withdrawal by Subject|4|||
37943426|NCT00378703|69630726|FG001|Overall Study|Withdrawal by Subject|8|||
37943427|NCT00378703|69630727|FG002|Overall Study|Withdrawal by Subject|5|||
37943428|NCT00378703|69630728|FG003|Overall Study|Withdrawal by Subject|7|||
37943429|NCT00378703|69630725|FG000|Overall Study|Physician Decision|1|||
37943430|NCT00378703|69630726|FG001|Overall Study|Physician Decision|4|||
37943431|NCT00378703|69630727|FG002|Overall Study|Physician Decision|1|||
37943432|NCT00378703|69630728|FG003|Overall Study|Physician Decision|0|||
37943433|NCT00378703|69630725|FG000|Overall Study|Alternative therapy|4|||
37943434|NCT00378703|69630726|FG001|Overall Study|Alternative therapy|2|||
37943435|NCT00378703|69630727|FG002|Overall Study|Alternative therapy|0|||
37943436|NCT00378703|69630728|FG003|Overall Study|Alternative therapy|0|||
37943437|NCT00378703|69630725|FG000|Overall Study|Other complicated disease|0|||
37943438|NCT00378703|69630726|FG001|Overall Study|Other complicated disease|2|||
37943439|NCT00378703|69630727|FG002|Overall Study|Other complicated disease|2|||
37943440|NCT00378703|69630728|FG003|Overall Study|Other complicated disease|0|||
37943441|NCT00378703|69630725|FG000|Overall Study|Symptomatic deterioration|0|||
37943442|NCT00378703|69630726|FG001|Overall Study|Symptomatic deterioration|1|||
37943443|NCT00378703|69630727|FG002|Overall Study|Symptomatic deterioration|0|||
37943444|NCT00378703|69630728|FG003|Overall Study|Symptomatic deterioration|2|||
37943445|NCT00378703|69630725|FG000|Overall Study|Surgery|1|||
37943446|NCT00378703|69630726|FG001|Overall Study|Surgery|0|||
37943447|NCT00378703|69630727|FG002|Overall Study|Surgery|0|||
37943448|NCT00378703|69630728|FG003|Overall Study|Surgery|1|||
37943449|NCT00378703|69630725|FG000|Overall Study|Joint decision of physician and patient|1|||
37943450|NCT00378703|69630726|FG001|Overall Study|Joint decision of physician and patient|0|||
37943451|NCT00378703|69630727|FG002|Overall Study|Joint decision of physician and patient|0|||
37943452|NCT00378703|69630728|FG003|Overall Study|Joint decision of physician and patient|0|||
37943453|NCT00378703|69630725|FG000|Overall Study|Adverse events and progressive disease|0|||
37943454|NCT00378703|69630726|FG001|Overall Study|Adverse events and progressive disease|0|||
37943455|NCT00378703|69630727|FG002|Overall Study|Adverse events and progressive disease|0|||
37943456|NCT00378703|69630728|FG003|Overall Study|Adverse events and progressive disease|1|||
37943457|NCT00378703|69630725|FG000|Overall Study|Relocation|0|||
37943458|NCT00378703|69630726|FG001|Overall Study|Relocation|0|||
37943459|NCT00378703|69630727|FG002|Overall Study|Relocation|1|||
37943460|NCT00378703|69630728|FG003|Overall Study|Relocation|0|||
37943461|NCT00378703|69630725|FG000|Overall Study|Ineligible|4|||
37943462|NCT00378703|69630726|FG001|Overall Study|Ineligible|7|||
37943463|NCT00378703|69630727|FG002|Overall Study|Ineligible|7|||
37943464|NCT00378703|69630728|FG003|Overall Study|Ineligible|7|||
37943465|NCT00378703|69630725|FG000|Overall Study|Never started treatment|1|||
37943466|NCT00378703|69630726|FG001|Overall Study|Never started treatment|4|||
37943467|NCT00378703|69630727|FG002|Overall Study|Never started treatment|0|||
37943468|NCT00378703|69630728|FG003|Overall Study|Never started treatment|0|||
37943469|NCT00378703|69630725|FG000|Overall Study|Other|1|||
37943470|NCT00378703|69630726|FG001|Overall Study|Other|1|||
37943471|NCT00378703|69630727|FG002|Overall Study|Other|2|||
37943472|NCT00378703|69630728|FG003|Overall Study|Other|3|||
37943473|NCT00368641|69630744|FG000|Overall Study|Adverse Event|2|||
37943474|NCT00368641|69630745|FG001|Overall Study|Adverse Event|1|||
37943475|NCT00368641|69630744|FG000|Overall Study|Death|1|||
37943476|NCT00368641|69630745|FG001|Overall Study|Death|0|||
37943477|NCT00368641|69630744|FG000|Overall Study|Withdrawal by Subject|1|||
37943478|NCT00368641|69630745|FG001|Overall Study|Withdrawal by Subject|0|||
37943479|NCT00368641|69630744|FG000|Overall Study|Sponsor decision to terminate study|2|||
37943480|NCT00368641|69630745|FG001|Overall Study|Sponsor decision to terminate study|5|||
37943481|NCT00608985|69630755|FG000|Overall Study|Adverse Event|2|||
37943482|NCT00608985|69630756|FG001|Overall Study|Adverse Event|7|||
37943483|NCT00608985|69630757|FG002|Overall Study|Adverse Event|4|||
37943484|NCT00608985|69630758|FG003|Overall Study|Adverse Event|6|||
37943485|NCT00608985|69630755|FG000|Overall Study|Administrative/Other|7|||
37943486|NCT00608985|69630756|FG001|Overall Study|Administrative/Other|4|||
37943487|NCT00608985|69630757|FG002|Overall Study|Administrative/Other|1|||
37943488|NCT00608985|69630758|FG003|Overall Study|Administrative/Other|2|||
37943489|NCT00608985|69630755|FG000|Overall Study|Withdrawal of Consent|5|||
37943490|NCT00608985|69630756|FG001|Overall Study|Withdrawal of Consent|1|||
37943491|NCT00608985|69630757|FG002|Overall Study|Withdrawal of Consent|1|||
37943492|NCT00608985|69630758|FG003|Overall Study|Withdrawal of Consent|1|||
37943493|NCT00608985|69630755|FG000|Overall Study|Lost to Follow-up|2|||
37943494|NCT00608985|69630756|FG001|Overall Study|Lost to Follow-up|1|||
37943495|NCT00608985|69630757|FG002|Overall Study|Lost to Follow-up|0|||
37943496|NCT00608985|69630758|FG003|Overall Study|Lost to Follow-up|0|||
37943497|NCT00368251|69630771|FG000|Overall Study|SAE, non-fatal|1|||
37943498|NCT00368251|69630772|FG001|Overall Study|SAE, non-fatal|0|||
37943499|NCT00368251|69630773|FG002|Overall Study|SAE, non-fatal|0|||
37943500|NCT00368251|69630771|FG000|Overall Study|AE, non-serious non-fatal|0|||
37943501|NCT00368251|69630772|FG001|Overall Study|AE, non-serious non-fatal|0|||
37943502|NCT00368251|69630773|FG002|Overall Study|AE, non-serious non-fatal|1|||
37943503|NCT00378079|69630784|FG000|Overall Study|Lost to Follow-up|6|||
37943504|NCT00378079|69630785|FG001|Overall Study|Lost to Follow-up|1|||
37943505|NCT00378079|69630786|FG002|Overall Study|Lost to Follow-up|0|||
37943506|NCT03936244|69630796|FG000|Overall Study|Lost to Follow-up|5|||
37943507|NCT03936244|69630797|FG001|Overall Study|Lost to Follow-up|1|||
37943508|NCT03936244|69630796|FG000|Overall Study|Physician Decision|7|||
37943509|NCT03936244|69630797|FG001|Overall Study|Physician Decision|3|||
37943510|NCT03923530|69630804|FG000|Overall Study|Withdrawal by Subject|1|||
37943511|NCT03923530|69630804|FG000|Overall Study|screen failure|3|||
37943512|NCT00608907|69630811|FG000|Overall Study|Adverse Event|6|||
37943513|NCT00608907|69630812|FG001|Overall Study|Adverse Event|0|||
37943514|NCT00608907|69630813|FG002|Overall Study|Adverse Event|1|||
37943515|NCT00608907|69630811|FG000|Overall Study|Death|1|||
37943516|NCT00608907|69630812|FG001|Overall Study|Death|0|||
37943517|NCT00608907|69630813|FG002|Overall Study|Death|0|||
37943518|NCT00608907|69630811|FG000|Overall Study|Withdrawal by Subject|4|||
37943519|NCT00608907|69630812|FG001|Overall Study|Withdrawal by Subject|0|||
37943520|NCT00608907|69630813|FG002|Overall Study|Withdrawal by Subject|0|||
37943521|NCT00608907|69630811|FG000|Overall Study|Progressive Disease|1|||
37943522|NCT00608907|69630812|FG001|Overall Study|Progressive Disease|0|||
37943523|NCT00608907|69630813|FG002|Overall Study|Progressive Disease|0|||
37943524|NCT00377611|69630823|FG000|Overall Study|Adverse Event|2|||
37943525|NCT00377611|69630824|FG001|Overall Study|Adverse Event|9|||
37943526|NCT00377611|69630823|FG000|Overall Study|Protocol Violation|2|||
37943527|NCT00377611|69630824|FG001|Overall Study|Protocol Violation|0|||
37943528|NCT00377611|69630823|FG000|Overall Study|Withdrawal by Subject|0|||
37943529|NCT00377611|69630824|FG001|Overall Study|Withdrawal by Subject|5|||
37943530|NCT00377611|69630823|FG000|Overall Study|Lost to Follow-up|18|||
37943531|NCT00377611|69630824|FG001|Overall Study|Lost to Follow-up|16|||
37943532|NCT00377611|69630823|FG000|Overall Study|Other|0|||
37943533|NCT00377611|69630824|FG001|Overall Study|Other|3|||
37943534|NCT00545272|69630837|FG000|Overall Study|Protocol deviation|0|||
37943535|NCT00545272|69630838|FG001|Overall Study|Protocol deviation|1|||
37943536|NCT00545272|69630839|FG002|Overall Study|Protocol deviation|0|||
37943537|NCT00545272|69630840|FG003|Overall Study|Protocol deviation|1|||
37943538|NCT00545272|69630841|FG004|Overall Study|Protocol deviation|0|||
37943539|NCT00545272|69630842|FG005|Overall Study|Protocol deviation|1|||
37943540|NCT00545272|69630837|FG000|Overall Study|Adverse Event|0|||
37943541|NCT00545272|69630838|FG001|Overall Study|Adverse Event|0|||
37943542|NCT00545272|69630839|FG002|Overall Study|Adverse Event|1|||
37943543|NCT00545272|69630840|FG003|Overall Study|Adverse Event|0|||
37943544|NCT00545272|69630841|FG004|Overall Study|Adverse Event|0|||
37943545|NCT00545272|69630842|FG005|Overall Study|Adverse Event|1|||
37943546|NCT00545272|69630837|FG000|Overall Study|Abnormal laboratory value(s)|0|||
37943547|NCT00545272|69630838|FG001|Overall Study|Abnormal laboratory value(s)|0|||
37943548|NCT00545272|69630839|FG002|Overall Study|Abnormal laboratory value(s)|0|||
37943549|NCT00545272|69630840|FG003|Overall Study|Abnormal laboratory value(s)|0|||
37943550|NCT00545272|69630841|FG004|Overall Study|Abnormal laboratory value(s)|0|||
37943551|NCT00545272|69630842|FG005|Overall Study|Abnormal laboratory value(s)|1|||
37943552|NCT00545272|69630837|FG000|Overall Study|Abnormal test procedure result(s)|0|||
37943553|NCT00545272|69630838|FG001|Overall Study|Abnormal test procedure result(s)|0|||
37943554|NCT00545272|69630839|FG002|Overall Study|Abnormal test procedure result(s)|0|||
37943555|NCT00545272|69630840|FG003|Overall Study|Abnormal test procedure result(s)|0|||
37943556|NCT00545272|69630841|FG004|Overall Study|Abnormal test procedure result(s)|1|||
37943557|NCT00545272|69630842|FG005|Overall Study|Abnormal test procedure result(s)|0|||
37943558|NCT00545272|69630837|FG000|Overall Study|Lost to Follow-up|0|||
37943559|NCT00545272|69630838|FG001|Overall Study|Lost to Follow-up|0|||
37943560|NCT00545272|69630839|FG002|Overall Study|Lost to Follow-up|0|||
37943561|NCT00545272|69630840|FG003|Overall Study|Lost to Follow-up|0|||
37943562|NCT00545272|69630841|FG004|Overall Study|Lost to Follow-up|1|||
37943563|NCT00545272|69630842|FG005|Overall Study|Lost to Follow-up|0|||
37943564|NCT00377455|69630856|FG000|Overall Study|Withdrawal by Subject|1|||
37943565|NCT00377299|69630862|FG000|Overall Study|Lost to Follow-up|14|||
37943566|NCT00377299|69630863|FG001|Overall Study|Lost to Follow-up|19|||
37943567|NCT00377299|69630862|FG000|Overall Study|Adverse Event|0|||
37943568|NCT00377299|69630863|FG001|Overall Study|Adverse Event|1|||
37943569|NCT00377299|69630862|FG000|Overall Study|Withdrawal by Subject|5|||
37943570|NCT00377299|69630863|FG001|Overall Study|Withdrawal by Subject|4|||
37943571|NCT00376675|69630872|FG000|Overall Study|Withdrawal by Subject|9|||
37943572|NCT00376675|69630873|FG001|Overall Study|Withdrawal by Subject|2|||
37943573|NCT00376675|69630872|FG000|Overall Study|Adverse Event|10|||
37943574|NCT00376675|69630873|FG001|Overall Study|Adverse Event|5|||
37943575|NCT00376675|69630872|FG000|Overall Study|Other Reason|1|||
37943576|NCT00376675|69630873|FG001|Overall Study|Other Reason|7|||
37943577|NCT03931330|69630879|FG000|Overall Study|Physician Decision|1|||
37943578|NCT00367237|69630886|FG000|Overall Study|Adverse Event|7|||
37943579|NCT00367237|69630887|FG001|Overall Study|Adverse Event|2|||
37943580|NCT00367237|69630886|FG000|Overall Study|Lost to Follow-up|1|||
37943581|NCT00367237|69630887|FG001|Overall Study|Lost to Follow-up|0|||
37943582|NCT00367237|69630886|FG000|Overall Study|Withdrawal by Subject|0|||
37943583|NCT00367237|69630887|FG001|Overall Study|Withdrawal by Subject|4|||
37943584|NCT00367237|69630886|FG000|Overall Study|Protocol Violation|2|||
37943585|NCT00367237|69630887|FG001|Overall Study|Protocol Violation|5|||
37943586|NCT00544882|69630895|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
37943587|NCT00544882|69630896|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
37943588|NCT00544882|69630897|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
37943589|NCT00544882|69630895|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
37943590|NCT00544882|69630896|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
37943591|NCT00544882|69630897|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
37943592|NCT00544882|69630895|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
37943593|NCT00544882|69630896|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
37943594|NCT00544882|69630897|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
37943595|NCT00544882|69630895|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
37943596|NCT00544882|69630896|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
37943597|NCT00544882|69630897|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
37943598|NCT00544882|69630895|FG000|Cycle 3: Follow-up|Noncompliance|0|||
37943599|NCT00544882|69630896|FG001|Cycle 3: Follow-up|Noncompliance|1|||
37943600|NCT00544882|69630897|FG002|Cycle 3: Follow-up|Noncompliance|0|||
37943601|NCT00544882|69630895|FG000|Cycle 3: Follow-up|Pregnancy|0|||
37943602|NCT00544882|69630896|FG001|Cycle 3: Follow-up|Pregnancy|1|||
37943603|NCT00544882|69630897|FG002|Cycle 3: Follow-up|Pregnancy|0|||
37943604|NCT00606801|69630905|FG000|Intervention|Protocol Violation|3|||
37943605|NCT00606801|69630906|FG001|Intervention|Protocol Violation|3|||
37943606|NCT00606177|69630918|FG000|Overall Study|Adverse Event|9|||
37943607|NCT00606177|69630919|FG001|Overall Study|Adverse Event|5|||
37943608|NCT00606177|69630918|FG000|Overall Study|Lack of Efficacy|3|||
37943609|NCT00606177|69630919|FG001|Overall Study|Lack of Efficacy|7|||
37943610|NCT00606177|69630918|FG000|Overall Study|Physician Decision|1|||
37943611|NCT00606177|69630919|FG001|Overall Study|Physician Decision|0|||
37943612|NCT00606177|69630918|FG000|Overall Study|Protocol Violation|1|||
37943613|NCT00606177|69630919|FG001|Overall Study|Protocol Violation|4|||
37943614|NCT00606177|69630918|FG000|Overall Study|Withdrawal by Subject|5|||
37943615|NCT00606177|69630919|FG001|Overall Study|Withdrawal by Subject|6|||
37943616|NCT00606177|69630918|FG000|Overall Study|Progression to depressive phase|6|||
37943617|NCT00606177|69630919|FG001|Overall Study|Progression to depressive phase|1|||
37943618|NCT00606177|69630918|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
37943619|NCT00606177|69630919|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
37943620|NCT00606177|69630918|FG000|Overall Study|Change of residence or other commitments|1|||
37943621|NCT00606177|69630919|FG001|Overall Study|Change of residence or other commitments|1|||
37943622|NCT00359281|69630934|FG000|Overall Study|Adverse Event|1|||
37943623|NCT00359281|69630935|FG001|Overall Study|Adverse Event|0|||
37943624|NCT00359281|69630936|FG002|Overall Study|Adverse Event|0|||
37943625|NCT00359281|69630937|FG003|Overall Study|Adverse Event|0|||
37943626|NCT00359281|69630938|FG004|Overall Study|Adverse Event|0|||
37943627|NCT00359281|69630939|FG005|Overall Study|Adverse Event|0|||
37943628|NCT00359281|69630940|FG006|Overall Study|Adverse Event|1|||
37943629|NCT00359281|69630941|FG007|Overall Study|Adverse Event|0|||
37943630|NCT00359281|69630942|FG008|Overall Study|Adverse Event|0|||
37943631|NCT00359281|69630934|FG000|Overall Study|Withdrawal by Subject|0|||
37943632|NCT00359281|69630935|FG001|Overall Study|Withdrawal by Subject|0|||
37943633|NCT00359281|69630936|FG002|Overall Study|Withdrawal by Subject|0|||
37943634|NCT00359281|69630937|FG003|Overall Study|Withdrawal by Subject|0|||
37943635|NCT00359281|69630938|FG004|Overall Study|Withdrawal by Subject|0|||
37943636|NCT00359281|69630939|FG005|Overall Study|Withdrawal by Subject|0|||
37943637|NCT00359281|69630940|FG006|Overall Study|Withdrawal by Subject|1|||
37943638|NCT00359281|69630941|FG007|Overall Study|Withdrawal by Subject|0|||
37943639|NCT00359281|69630942|FG008|Overall Study|Withdrawal by Subject|0|||
37943640|NCT00366535|69630971|FG000|First Phase: 12 Weeks|Adverse Event|1|||
37943641|NCT00366535|69630972|FG001|First Phase: 12 Weeks|Adverse Event|3|||
37943642|NCT00366535|69630971|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
37943643|NCT00366535|69630972|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
37943644|NCT00366535|69630971|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
37943645|NCT00366535|69630972|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
37943646|NCT00366535|69630971|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
37943647|NCT00366535|69630972|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
37943648|NCT00350545|69630986|FG000|Overall Study|Withdrawal by Subject|2|||
37943649|NCT00349921|69630994|FG000|First Spinal Injection|Physician Decision|1|||
37943650|NCT00349921|69630995|FG001|First Spinal Injection|Physician Decision|0|||
37943651|NCT00349921|69630996|FG002|First Spinal Injection|Physician Decision|0|||
37943652|NCT00349921|69630997|FG003|First Spinal Injection|Physician Decision|0|||
37943653|NCT00349921|69630994|FG000|First Spinal Injection|Adverse Event|0|||
37943654|NCT00349921|69630995|FG001|First Spinal Injection|Adverse Event|0|||
37943655|NCT00349921|69630996|FG002|First Spinal Injection|Adverse Event|1|||
37943656|NCT00349921|69630997|FG003|First Spinal Injection|Adverse Event|0|||
37943657|NCT00606021|69631008|FG000|Induction Phase|Death|73|||
37943658|NCT00606021|69631009|FG001|Induction Phase|Death|0|||
37943659|NCT00606021|69631010|FG002|Induction Phase|Death|0|||
37943660|NCT00606021|69631008|FG000|Induction Phase|Physician Decision|2|||
37943661|NCT00606021|69631009|FG001|Induction Phase|Physician Decision|0|||
37943662|NCT00606021|69631010|FG002|Induction Phase|Physician Decision|0|||
37943663|NCT00606021|69631008|FG000|Induction Phase|Withdrawal by Subject|2|||
37943664|NCT00606021|69631009|FG001|Induction Phase|Withdrawal by Subject|0|||
37943665|NCT00606021|69631010|FG002|Induction Phase|Withdrawal by Subject|0|||
37943666|NCT00606021|69631008|FG000|Induction Phase|Lost to Follow-up|10|||
37943667|NCT00606021|69631009|FG001|Induction Phase|Lost to Follow-up|0|||
37943668|NCT00606021|69631010|FG002|Induction Phase|Lost to Follow-up|0|||
37943669|NCT00606021|69631008|FG000|Maintenance Phase|Death|0|||
37943670|NCT00606021|69631009|FG001|Maintenance Phase|Death|17|||
37943671|NCT00606021|69631010|FG002|Maintenance Phase|Death|15|||
37943672|NCT00606021|69631008|FG000|Maintenance Phase|Physician Decision|0|||
37943673|NCT00606021|69631009|FG001|Maintenance Phase|Physician Decision|1|||
37943674|NCT00606021|69631010|FG002|Maintenance Phase|Physician Decision|0|||
37943675|NCT00606021|69631008|FG000|Maintenance Phase|Lost to Follow-up|0|||
37943676|NCT00606021|69631009|FG001|Maintenance Phase|Lost to Follow-up|5|||
37943677|NCT00606021|69631010|FG002|Maintenance Phase|Lost to Follow-up|2|||
37943678|NCT00337675|69631021|FG000|Overall Study|Adverse Event|10|||
37943679|NCT00337675|69631022|FG001|Overall Study|Adverse Event|9|||
37943680|NCT00337675|69631023|FG002|Overall Study|Adverse Event|19|||
37943681|NCT00337675|69631021|FG000|Overall Study|Lack of Efficacy|10|||
37943682|NCT00337675|69631022|FG001|Overall Study|Lack of Efficacy|7|||
37943683|NCT00337675|69631023|FG002|Overall Study|Lack of Efficacy|9|||
37943684|NCT00337675|69631021|FG000|Overall Study|Lost to Follow-up|22|||
37943685|NCT00337675|69631022|FG001|Overall Study|Lost to Follow-up|19|||
37943686|NCT00337675|69631023|FG002|Overall Study|Lost to Follow-up|17|||
37943687|NCT00337675|69631021|FG000|Overall Study|Physician Decision|9|||
37943688|NCT00337675|69631022|FG001|Overall Study|Physician Decision|17|||
37943689|NCT00337675|69631023|FG002|Overall Study|Physician Decision|14|||
37943690|NCT00337675|69631021|FG000|Overall Study|Protocol Violation|21|||
37943691|NCT00337675|69631022|FG001|Overall Study|Protocol Violation|24|||
37943692|NCT00337675|69631023|FG002|Overall Study|Protocol Violation|19|||
37943693|NCT00337675|69631021|FG000|Overall Study|Withdrawal by Subject|25|||
37943694|NCT00337675|69631022|FG001|Overall Study|Withdrawal by Subject|25|||
37943695|NCT00337675|69631023|FG002|Overall Study|Withdrawal by Subject|19|||
37943696|NCT00337675|69631021|FG000|Overall Study|Progressive Disease|0|||
37943697|NCT00337675|69631022|FG001|Overall Study|Progressive Disease|2|||
37943698|NCT00337675|69631023|FG002|Overall Study|Progressive Disease|0|||
37943699|NCT00337675|69631021|FG000|Overall Study|Trial Terminated|0|||
37943700|NCT00337675|69631022|FG001|Overall Study|Trial Terminated|0|||
37943701|NCT00337675|69631023|FG002|Overall Study|Trial Terminated|2|||
37943702|NCT00337285|69631031|FG000|Overall Study|Withdrawal by Subject|42|||
37943703|NCT00337285|69631031|FG000|Overall Study|Lost to Follow-up|41|||
37943704|NCT00337285|69631031|FG000|Overall Study|Adverse Event|28|||
37943705|NCT00337285|69631031|FG000|Overall Study|Protocol Violation|27|||
37943706|NCT00337285|69631031|FG000|Overall Study|Lack of Efficacy|11|||
37943707|NCT00337285|69631031|FG000|Overall Study|Death|1|||
37943708|NCT00337285|69631031|FG000|Overall Study|Physician Decision|1|||
37943709|NCT00337285|69631031|FG000|Overall Study|Lack of protocol compliance|7|||
37943710|NCT00605865|69631035|FG000|Overall Study|Protocol Violation|115|||
37943711|NCT00348673|69631075|FG000|Stage 1|Randomized but not Treated|0|||
37943712|NCT00348673|69631076|FG001|Stage 1|Randomized but not Treated|0|||
37943713|NCT00348673|69631077|FG002|Stage 1|Randomized but not Treated|1|||
37943714|NCT00348673|69631078|FG003|Stage 1|Randomized but not Treated|0|||
37943715|NCT00348673|69631079|FG004|Stage 1|Randomized but not Treated|0|||
37943716|NCT00348673|69631080|FG005|Stage 1|Randomized but not Treated|0|||
37943717|NCT00348673|69631081|FG006|Stage 1|Randomized but not Treated|0|||
37943718|NCT00348673|69631082|FG007|Stage 1|Randomized but not Treated|0|||
37943719|NCT00348673|69631083|FG008|Stage 1|Randomized but not Treated|0|||
37943720|NCT00337207|69631101|FG000|Overall Study|Withdrawal by Subject|3|||
37943721|NCT00604695|69631108|FG000|Overall Study|Did not receive first bolus.|0|||
37943722|NCT00604695|69631109|FG001|Overall Study|Did not receive first bolus.|4|||
37943723|NCT00348595|69631117|FG000|Overall Study|Adverse Event|5|||
37943724|NCT00348595|69631118|FG001|Overall Study|Adverse Event|8|||
37943725|NCT00337129|69631124|FG000|Overall Study|Adverse Event|4|||
37943726|NCT00337129|69631124|FG000|Overall Study|Withdrawal by Subject|1|||
37943727|NCT00337129|69631124|FG000|Overall Study|Lack of Efficacy|32|||
37943728|NCT00337129|69631124|FG000|Overall Study|Death|2|||
37943729|NCT00337129|69631124|FG000|Overall Study|not protocol specified|1|||
37943730|NCT00605085|69631130|FG000|Overall Study|Withdrawal by Subject|8|||
37943731|NCT00605085|69631131|FG001|Overall Study|Withdrawal by Subject|5|||
37943732|NCT00605085|69631130|FG000|Overall Study|Adverse Event|9|||
37943733|NCT00605085|69631131|FG001|Overall Study|Adverse Event|5|||
37943734|NCT00605085|69631130|FG000|Overall Study|Pregnancy|2|||
37943735|NCT00605085|69631131|FG001|Overall Study|Pregnancy|0|||
37943736|NCT00605085|69631130|FG000|Overall Study|Protocol Violation|3|||
37943737|NCT00605085|69631131|FG001|Overall Study|Protocol Violation|2|||
37943738|NCT00605085|69631130|FG000|Overall Study|Lost to Follow-up|10|||
37943739|NCT00605085|69631131|FG001|Overall Study|Lost to Follow-up|5|||
37943740|NCT00605085|69631130|FG000|Overall Study|administrative reasons|18|||
37943741|NCT00605085|69631131|FG001|Overall Study|administrative reasons|8|||
37943742|NCT00348283|69631139|FG000|Induction|Adverse Event|0|||
37943743|NCT00348283|69631140|FG001|Induction|Adverse Event|2|||
37943744|NCT00348283|69631139|FG000|Induction|Protocol Violation|0|||
37943745|NCT00348283|69631140|FG001|Induction|Protocol Violation|4|||
37943746|NCT00348283|69631139|FG000|Double Blind|Adverse Event|2|||
37943747|NCT00348283|69631140|FG001|Double Blind|Adverse Event|5|||
37943748|NCT00348283|69631139|FG000|Double Blind|Withdrawal by Subject|1|||
37943749|NCT00348283|69631140|FG001|Double Blind|Withdrawal by Subject|1|||
37943750|NCT00348283|69631139|FG000|Double Blind|Protocol Violation|0|||
37943751|NCT00348283|69631140|FG001|Double Blind|Protocol Violation|1|||
37943752|NCT00348283|69631139|FG000|Double Blind|Lack of Efficacy|2|||
37943753|NCT00348283|69631140|FG001|Double Blind|Lack of Efficacy|2|||
37943754|NCT00348283|69631139|FG000|Double Blind|Pregnancy|0|||
37943755|NCT00348283|69631140|FG001|Double Blind|Pregnancy|1|||
37943756|NCT00348283|69631139|FG000|Open Label|Adverse Event|0|||
37943757|NCT00348283|69631140|FG001|Open Label|Adverse Event|8|||
37943758|NCT00348283|69631139|FG000|Open Label|Withdrawal by Subject|0|||
37943759|NCT00348283|69631140|FG001|Open Label|Withdrawal by Subject|4|||
37943760|NCT00348283|69631139|FG000|Open Label|Lost to Follow-up|0|||
37943761|NCT00348283|69631140|FG001|Open Label|Lost to Follow-up|1|||
37943762|NCT00348283|69631139|FG000|Open Label|Lack of Efficacy|0|||
37943763|NCT00348283|69631140|FG001|Open Label|Lack of Efficacy|13|||
37943764|NCT00348283|69631139|FG000|Open Label|Administrative reasons|0|||
37943765|NCT00348283|69631140|FG001|Open Label|Administrative reasons|5|||
37943766|NCT00348283|69631139|FG000|Open Label|Subject moved to the United States|0|||
37943767|NCT00348283|69631140|FG001|Open Label|Subject moved to the United States|1|||
37943768|NCT00348283|69631139|FG000|Open Label|Pregnancy|0|||
37943769|NCT00348283|69631140|FG001|Open Label|Pregnancy|1|||
37943770|NCT00348283|69631139|FG000|Open Label|Sponsor decision|0|||
37943771|NCT00348283|69631140|FG001|Open Label|Sponsor decision|1|||
37943772|NCT00336895|69631146|FG000|Overall Study|diarrhea|1|||
37943773|NCT00336895|69631146|FG000|Overall Study|nausea and upset stomach|1|||
37943774|NCT00336895|69631146|FG000|Overall Study|Physician Decision|1|||
37943775|NCT00336895|69631146|FG000|Overall Study|screen failed|1|||
37943776|NCT00336583|69631150|FG000|Overall Study|Lost to Follow-up|1|||
37943777|NCT00336583|69631150|FG000|Overall Study|Death|1|||
37943778|NCT00336505|69631156|FG000|Overall Study|Adverse Event|10|||
37943779|NCT00336505|69631157|FG001|Overall Study|Adverse Event|9|||
37943780|NCT00336505|69631156|FG000|Overall Study|Lack of Efficacy|8|||
37943781|NCT00336505|69631157|FG001|Overall Study|Lack of Efficacy|4|||
37943782|NCT00336505|69631156|FG000|Overall Study|Lost to Follow-up|7|||
37943783|NCT00336505|69631157|FG001|Overall Study|Lost to Follow-up|4|||
37943784|NCT00336505|69631156|FG000|Overall Study|Withdrawal by Subject|5|||
37943785|NCT00336505|69631157|FG001|Overall Study|Withdrawal by Subject|3|||
37943786|NCT00336505|69631156|FG000|Overall Study|Other|7|||
37943787|NCT00336505|69631157|FG001|Overall Study|Other|7|||
37943788|NCT00357877|69631165|FG000|Overall Study|Death|2|||
37943789|NCT00357877|69631166|FG001|Overall Study|Death|1|||
37943790|NCT00357877|69631165|FG000|Overall Study|Lost to Follow-up|20|||
37943791|NCT00357877|69631166|FG001|Overall Study|Lost to Follow-up|23|||
37943792|NCT00357877|69631165|FG000|Overall Study|Withdrawal by Subject|3|||
37943793|NCT00357877|69631166|FG001|Overall Study|Withdrawal by Subject|3|||
37943794|NCT00357877|69631165|FG000|Overall Study|Administrative withdrawal|1|||
37943795|NCT00357877|69631166|FG001|Overall Study|Administrative withdrawal|1|||
37943796|NCT00357877|69631165|FG000|Overall Study|Other|0|||
37943797|NCT00357877|69631166|FG001|Overall Study|Other|2|||
37943798|NCT00335959|69631174|FG000|Overall Study|Adverse Event|2|||
37943799|NCT00335959|69631174|FG000|Overall Study|Ineligible|1|||
37943800|NCT00670488|69631189|FG000|Overall Study|Adverse Event|0|||
37943801|NCT00670488|69631190|FG001|Overall Study|Adverse Event|7|||
37943802|NCT00670488|69631191|FG002|Overall Study|Adverse Event|0|||
37943803|NCT00670488|69631192|FG003|Overall Study|Adverse Event|3|||
37943804|NCT00670488|69631193|FG004|Overall Study|Adverse Event|1|||
37943805|NCT00670488|69631194|FG005|Overall Study|Adverse Event|1|||
37943806|NCT00670488|69631195|FG006|Overall Study|Adverse Event|5|||
37943807|NCT00670488|69631196|FG007|Overall Study|Adverse Event|1|||
37943808|NCT00670488|69631197|FG008|Overall Study|Adverse Event|0|||
37943809|NCT00670488|69631198|FG009|Overall Study|Adverse Event|1|||
37943810|NCT00670488|69631189|FG000|Overall Study|Physician Decision|1|||
37943811|NCT00670488|69631190|FG001|Overall Study|Physician Decision|9|||
37943812|NCT00670488|69631191|FG002|Overall Study|Physician Decision|0|||
37943813|NCT00670488|69631192|FG003|Overall Study|Physician Decision|1|||
37943814|NCT00670488|69631193|FG004|Overall Study|Physician Decision|0|||
37943815|NCT00670488|69631194|FG005|Overall Study|Physician Decision|0|||
37943816|NCT00670488|69631195|FG006|Overall Study|Physician Decision|0|||
37943817|NCT00670488|69631196|FG007|Overall Study|Physician Decision|0|||
37943818|NCT00670488|69631197|FG008|Overall Study|Physician Decision|0|||
37943819|NCT00670488|69631198|FG009|Overall Study|Physician Decision|0|||
37943820|NCT00670488|69631189|FG000|Overall Study|Progressive Disease|2|||
37943821|NCT00670488|69631190|FG001|Overall Study|Progressive Disease|41|||
37943822|NCT00670488|69631191|FG002|Overall Study|Progressive Disease|3|||
37943823|NCT00670488|69631192|FG003|Overall Study|Progressive Disease|2|||
37943824|NCT00670488|69631193|FG004|Overall Study|Progressive Disease|2|||
37943825|NCT00670488|69631194|FG005|Overall Study|Progressive Disease|4|||
37943826|NCT00670488|69631195|FG006|Overall Study|Progressive Disease|11|||
37943827|NCT00670488|69631196|FG007|Overall Study|Progressive Disease|2|||
37943828|NCT00670488|69631197|FG008|Overall Study|Progressive Disease|2|||
37943829|NCT00670488|69631198|FG009|Overall Study|Progressive Disease|1|||
37943830|NCT00670488|69631189|FG000|Overall Study|Withdrawal by Subject|0|||
37943831|NCT00670488|69631190|FG001|Overall Study|Withdrawal by Subject|1|||
37943832|NCT00670488|69631191|FG002|Overall Study|Withdrawal by Subject|0|||
37943833|NCT00670488|69631192|FG003|Overall Study|Withdrawal by Subject|1|||
37943834|NCT00670488|69631193|FG004|Overall Study|Withdrawal by Subject|0|||
37943835|NCT00670488|69631194|FG005|Overall Study|Withdrawal by Subject|0|||
37943836|NCT00670488|69631195|FG006|Overall Study|Withdrawal by Subject|1|||
37943837|NCT00670488|69631196|FG007|Overall Study|Withdrawal by Subject|0|||
37943838|NCT00670488|69631197|FG008|Overall Study|Withdrawal by Subject|1|||
37943839|NCT00670488|69631198|FG009|Overall Study|Withdrawal by Subject|0|||
37943840|NCT00671658|69631220|FG000|Overall Study|Physician Decision|5|||
37943841|NCT00542386|69631230|FG000|Overall Study|Adverse Event|1|||
37943842|NCT00542386|69631231|FG001|Overall Study|Adverse Event|7|||
37943843|NCT00542386|69631232|FG002|Overall Study|Adverse Event|7|||
37943844|NCT00542386|69631233|FG003|Overall Study|Adverse Event|8|||
37943845|NCT00542386|69631234|FG004|Overall Study|Adverse Event|13|||
37943846|NCT00542386|69631235|FG005|Overall Study|Adverse Event|4|||
37943847|NCT00542386|69631230|FG000|Overall Study|Death|0|||
37943848|NCT00542386|69631231|FG001|Overall Study|Death|0|||
37943849|NCT00542386|69631232|FG002|Overall Study|Death|1|||
37943850|NCT00542386|69631233|FG003|Overall Study|Death|2|||
37943851|NCT00542386|69631234|FG004|Overall Study|Death|1|||
37943852|NCT00542386|69631235|FG005|Overall Study|Death|2|||
37943853|NCT00542386|69631230|FG000|Overall Study|Lack of Efficacy|32|||
37943854|NCT00542386|69631231|FG001|Overall Study|Lack of Efficacy|12|||
37943855|NCT00542386|69631232|FG002|Overall Study|Lack of Efficacy|10|||
37943856|NCT00542386|69631233|FG003|Overall Study|Lack of Efficacy|13|||
37943857|NCT00542386|69631234|FG004|Overall Study|Lack of Efficacy|7|||
38036864|NCT03643575|69724411|FG003|Washout: 7 Days|Adverse Event|0|||
37943858|NCT00542386|69631235|FG005|Overall Study|Lack of Efficacy|31|||
37943859|NCT00542386|69631230|FG000|Overall Study|Physician Decision|1|||
37943860|NCT00542386|69631231|FG001|Overall Study|Physician Decision|0|||
37943861|NCT00542386|69631232|FG002|Overall Study|Physician Decision|0|||
37943862|NCT00542386|69631233|FG003|Overall Study|Physician Decision|1|||
37943863|NCT00542386|69631234|FG004|Overall Study|Physician Decision|0|||
37943864|NCT00542386|69631235|FG005|Overall Study|Physician Decision|0|||
38036865|NCT03643575|69724412|FG004|Washout: 7 Days|Adverse Event|0|||
37943865|NCT00542386|69631230|FG000|Overall Study|Protocol Violation|0|||
37943866|NCT00542386|69631231|FG001|Overall Study|Protocol Violation|0|||
37943867|NCT00542386|69631232|FG002|Overall Study|Protocol Violation|1|||
37943868|NCT00542386|69631233|FG003|Overall Study|Protocol Violation|0|||
37943869|NCT00542386|69631234|FG004|Overall Study|Protocol Violation|0|||
37943870|NCT00542386|69631235|FG005|Overall Study|Protocol Violation|4|||
37943871|NCT00542386|69631230|FG000|Overall Study|Withdrawal by Subject|5|||
37943872|NCT00542386|69631231|FG001|Overall Study|Withdrawal by Subject|8|||
37943873|NCT00542386|69631232|FG002|Overall Study|Withdrawal by Subject|10|||
37943874|NCT00542386|69631233|FG003|Overall Study|Withdrawal by Subject|11|||
37943875|NCT00542386|69631234|FG004|Overall Study|Withdrawal by Subject|15|||
37943876|NCT00542386|69631235|FG005|Overall Study|Withdrawal by Subject|7|||
37943877|NCT00542386|69631230|FG000|Overall Study|Other Reasons|4|||
37943878|NCT00542386|69631231|FG001|Overall Study|Other Reasons|1|||
37943879|NCT00542386|69631232|FG002|Overall Study|Other Reasons|4|||
37943880|NCT00542386|69631233|FG003|Overall Study|Other Reasons|3|||
37943881|NCT00542386|69631234|FG004|Overall Study|Other Reasons|4|||
37943882|NCT00542386|69631235|FG005|Overall Study|Other Reasons|2|||
37943883|NCT00604383|69631251|FG000|Overall Study|Withdrawal by Subject|33|||
37943884|NCT00604383|69631252|FG001|Overall Study|Withdrawal by Subject|31|||
37943885|NCT00604383|69631251|FG000|Overall Study|Lost to Follow-up|24|||
37943886|NCT00604383|69631252|FG001|Overall Study|Lost to Follow-up|19|||
37943887|NCT00604383|69631251|FG000|Overall Study|Death|14|||
37943888|NCT00604383|69631252|FG001|Overall Study|Death|22|||
37943889|NCT00604383|69631251|FG000|Overall Study|Adverse Event|16|||
37943890|NCT00604383|69631252|FG001|Overall Study|Adverse Event|9|||
37943891|NCT00604383|69631251|FG000|Overall Study|Physician Decision|0|||
37943892|NCT00604383|69631252|FG001|Overall Study|Physician Decision|3|||
37943893|NCT00333775|69631261|FG000|Overall Study|Death|144|||
37943894|NCT00333775|69631262|FG001|Overall Study|Death|149|||
37943895|NCT00333775|69631263|FG002|Overall Study|Death|143|||
37943896|NCT00333775|69631261|FG000|Overall Study|In Follow-up When Study Stopped|87|||
37943897|NCT00333775|69631262|FG001|Overall Study|In Follow-up When Study Stopped|92|||
37943898|NCT00333775|69631263|FG002|Overall Study|In Follow-up When Study Stopped|96|||
37943899|NCT00333775|69631261|FG000|Overall Study|Lost to Follow-up|10|||
37943900|NCT00333775|69631262|FG001|Overall Study|Lost to Follow-up|7|||
37943901|NCT00333775|69631263|FG002|Overall Study|Lost to Follow-up|8|||
37943902|NCT00605475|69631281|FG000|Overall Study|Abnormal Laboratory Values|0|||
37943903|NCT00605475|69631282|FG001|Overall Study|Abnormal Laboratory Values|0|||
37943904|NCT00605475|69631283|FG002|Overall Study|Abnormal Laboratory Values|0|||
37943905|NCT00605475|69631284|FG003|Overall Study|Abnormal Laboratory Values|0|||
37943906|NCT00605475|69631285|FG004|Overall Study|Abnormal Laboratory Values|0|||
37943907|NCT00605475|69631286|FG005|Overall Study|Abnormal Laboratory Values|0|||
37943908|NCT00605475|69631287|FG006|Overall Study|Abnormal Laboratory Values|0|||
37943909|NCT00605475|69631288|FG007|Overall Study|Abnormal Laboratory Values|0|||
37943910|NCT00605475|69631289|FG008|Overall Study|Abnormal Laboratory Values|1|||
37943911|NCT00605475|69631290|FG009|Overall Study|Abnormal Laboratory Values|0|||
37943912|NCT00605475|69631281|FG000|Overall Study|Administrative problems|0|||
37943913|NCT00605475|69631282|FG001|Overall Study|Administrative problems|0|||
37943914|NCT00605475|69631283|FG002|Overall Study|Administrative problems|0|||
37943915|NCT00605475|69631284|FG003|Overall Study|Administrative problems|0|||
37943916|NCT00605475|69631285|FG004|Overall Study|Administrative problems|0|||
37943917|NCT00605475|69631286|FG005|Overall Study|Administrative problems|0|||
37943918|NCT00605475|69631287|FG006|Overall Study|Administrative problems|1|||
37943919|NCT00605475|69631288|FG007|Overall Study|Administrative problems|0|||
37943920|NCT00605475|69631289|FG008|Overall Study|Administrative problems|0|||
37943921|NCT00605475|69631290|FG009|Overall Study|Administrative problems|0|||
37943922|NCT00605475|69631281|FG000|Overall Study|Lost to Follow-up|0|||
37943923|NCT00605475|69631282|FG001|Overall Study|Lost to Follow-up|0|||
37943924|NCT00605475|69631283|FG002|Overall Study|Lost to Follow-up|0|||
37943925|NCT00605475|69631284|FG003|Overall Study|Lost to Follow-up|0|||
37943926|NCT00605475|69631285|FG004|Overall Study|Lost to Follow-up|0|||
37943927|NCT00605475|69631286|FG005|Overall Study|Lost to Follow-up|0|||
37943928|NCT00605475|69631287|FG006|Overall Study|Lost to Follow-up|0|||
37943929|NCT00605475|69631288|FG007|Overall Study|Lost to Follow-up|0|||
37943930|NCT00605475|69631289|FG008|Overall Study|Lost to Follow-up|1|||
37943931|NCT00605475|69631290|FG009|Overall Study|Lost to Follow-up|1|||
37943932|NCT00605475|69631281|FG000|Overall Study|Protocol Violation|0|||
37943933|NCT00605475|69631282|FG001|Overall Study|Protocol Violation|0|||
37943934|NCT00605475|69631283|FG002|Overall Study|Protocol Violation|0|||
37943935|NCT00605475|69631284|FG003|Overall Study|Protocol Violation|0|||
37943936|NCT00605475|69631285|FG004|Overall Study|Protocol Violation|1|||
37943937|NCT00605475|69631286|FG005|Overall Study|Protocol Violation|0|||
37943938|NCT00605475|69631287|FG006|Overall Study|Protocol Violation|0|||
37943939|NCT00605475|69631288|FG007|Overall Study|Protocol Violation|0|||
37943940|NCT00605475|69631289|FG008|Overall Study|Protocol Violation|0|||
37943941|NCT00605475|69631290|FG009|Overall Study|Protocol Violation|0|||
37943942|NCT00605475|69631281|FG000|Overall Study|Withdrawal by Subject|0|||
37943943|NCT00605475|69631282|FG001|Overall Study|Withdrawal by Subject|0|||
37943944|NCT00605475|69631283|FG002|Overall Study|Withdrawal by Subject|0|||
37943945|NCT00605475|69631284|FG003|Overall Study|Withdrawal by Subject|0|||
37943946|NCT00605475|69631285|FG004|Overall Study|Withdrawal by Subject|0|||
37943947|NCT00605475|69631286|FG005|Overall Study|Withdrawal by Subject|2|||
37943948|NCT00605475|69631287|FG006|Overall Study|Withdrawal by Subject|0|||
37943949|NCT00605475|69631288|FG007|Overall Study|Withdrawal by Subject|0|||
37943950|NCT00605475|69631289|FG008|Overall Study|Withdrawal by Subject|0|||
37943951|NCT00605475|69631290|FG009|Overall Study|Withdrawal by Subject|1|||
37943952|NCT00333619|69631335|FG000|Overall Study|Death|12|||
37943953|NCT00333619|69631336|FG001|Overall Study|Death|6|||
37943954|NCT00333619|69631335|FG000|Overall Study|Withdrawal by Subject|6|||
37943955|NCT00333619|69631336|FG001|Overall Study|Withdrawal by Subject|1|||
37943956|NCT00333619|69631335|FG000|Overall Study|Lost to Follow-up|3|||
37943957|NCT00333619|69631336|FG001|Overall Study|Lost to Follow-up|3|||
37943958|NCT00605319|69631344|FG000|Overall Study|Adverse Event|6|||
37943959|NCT00333229|69631356|FG000|Overall Study|Lack of Efficacy|0|||
37943960|NCT00333229|69631357|FG001|Overall Study|Lack of Efficacy|1|||
37943961|NCT00332839|69631365|FG000|Core (Months 0 - 12)|Administrative problems|1|||
37943962|NCT00332839|69631366|FG001|Core (Months 0 - 12)|Administrative problems|1|||
37943963|NCT00332839|69631365|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
37943964|NCT00332839|69631366|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
37943965|NCT00332839|69631365|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
37943966|NCT00332839|69631366|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
37943967|NCT00332839|69631365|FG000|Core (Months 0 - 12)|Adverse Event|5|||
37943968|NCT00332839|69631366|FG001|Core (Months 0 - 12)|Adverse Event|15|||
37943969|NCT00332839|69631365|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
37943970|NCT00332839|69631366|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
37943971|NCT00332839|69631365|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
37943972|NCT00332839|69631366|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
37943973|NCT00332839|69631365|FG000|Follow-up (Months 12 - 60)|Death|1|||
37943974|NCT00332839|69631366|FG001|Follow-up (Months 12 - 60)|Death|1|||
37943975|NCT00357097|69631374|FG000|Overall Study|Did not meet inclusion criteria|5|||
37943976|NCT00357097|69631375|FG001|Overall Study|Did not meet inclusion criteria|3|||
37943977|NCT00357097|69631374|FG000|Overall Study|Adverse Event|34|||
37943978|NCT00357097|69631375|FG001|Overall Study|Adverse Event|6|||
37943979|NCT00357097|69631374|FG000|Overall Study|Withdrawal by Subject|8|||
37943980|NCT00357097|69631375|FG001|Overall Study|Withdrawal by Subject|7|||
37943981|NCT00357097|69631374|FG000|Overall Study|Non-compliance|1|||
37943982|NCT00357097|69631375|FG001|Overall Study|Non-compliance|2|||
38036866|NCT03643575|69724413|FG005|Washout: 7 Days|Adverse Event|0|||
38036867|NCT03643575|69724408|FG000|Washout: 7 Days|Non compliance check in|0|||
38036868|NCT03643575|69724409|FG001|Washout: 7 Days|Non compliance check in|1|||
38036869|NCT03643575|69724410|FG002|Washout: 7 Days|Non compliance check in|0|||
38036870|NCT03643575|69724411|FG003|Washout: 7 Days|Non compliance check in|0|||
38036871|NCT03643575|69724412|FG004|Washout: 7 Days|Non compliance check in|0|||
37673254|NCT02690701|69147485|FG001|Treatment Period 2|Adverse Event|0|||
37673255|NCT02690701|69147484|FG000|Treatment Period 2|Lack of Efficacy|1|||
37673256|NCT02690701|69147485|FG001|Treatment Period 2|Lack of Efficacy|0|||
37673257|NCT02690701|69147484|FG000|Treatment Period 2|Lost to Follow-up|0|||
37673258|NCT02690701|69147485|FG001|Treatment Period 2|Lost to Follow-up|2|||
37673259|NCT02690701|69147484|FG000|Treatment Period 2|Withdrawal by Subject|0|||
37673260|NCT02690701|69147485|FG001|Treatment Period 2|Withdrawal by Subject|2|||
37673261|NCT02690701|69147484|FG000|Treatment Period 2|Protocol Violation|0|||
37673262|NCT02690701|69147485|FG001|Treatment Period 2|Protocol Violation|1|||
37673263|NCT02694757|69147492|FG000|Overall Study|Lack of Efficacy|3|||
37673264|NCT03805841|69147499|FG000|Overall Study|Clinical Progression|2|||
37673265|NCT03805841|69147500|FG001|Overall Study|Clinical Progression|0|||
37673266|NCT03805841|69147501|FG002|Overall Study|Clinical Progression|0|||
37673267|NCT03805841|69147499|FG000|Overall Study|Death|0|||
37943983|NCT00357097|69631374|FG000|Overall Study|Lack of Efficacy|2|||
37943984|NCT00357097|69631375|FG001|Overall Study|Lack of Efficacy|8|||
37943985|NCT00357097|69631374|FG000|Overall Study|Met Exclusion Criteria|3|||
37943986|NCT00357097|69631375|FG001|Overall Study|Met Exclusion Criteria|1|||
37943987|NCT00357097|69631374|FG000|Overall Study|Other|1|||
37943988|NCT00357097|69631375|FG001|Overall Study|Other|1|||
37943989|NCT00357097|69631374|FG000|Overall Study|Increase of RLS Symptoms|0|||
37943990|NCT00357097|69631375|FG001|Overall Study|Increase of RLS Symptoms|1|||
37943991|NCT00356863|69631383|FG000|Overall Study|Death|16|||
37943992|NCT00356863|69631384|FG001|Overall Study|Death|32|||
38036872|NCT03643575|69724413|FG005|Washout: 7 Days|Non compliance check in|0|||
37673268|NCT03805841|69147500|FG001|Overall Study|Death|3|||
37673269|NCT03805841|69147501|FG002|Overall Study|Death|1|||
37943993|NCT00356863|69631383|FG000|Overall Study|Lost to Follow-up|76|||
37943994|NCT00356863|69631384|FG001|Overall Study|Lost to Follow-up|43|||
37943995|NCT00355615|69631407|FG000|Randomized Double Blind Period|Adverse Event|1|||
37943996|NCT00355615|69631408|FG001|Randomized Double Blind Period|Adverse Event|0|||
37943997|NCT00355615|69631409|FG002|Randomized Double Blind Period|Adverse Event|0|||
37943998|NCT00355615|69631410|FG003|Randomized Double Blind Period|Adverse Event|0|||
37673270|NCT03805841|69147499|FG000|Overall Study|Lost to Follow-up|0|||
37673271|NCT03805841|69147500|FG001|Overall Study|Lost to Follow-up|0|||
38036873|NCT02768194|69724421|FG000|Period 1|Adverse Event|0|||
38036874|NCT02768194|69724422|FG001|Period 1|Adverse Event|0|||
38036875|NCT02768194|69724423|FG002|Period 1|Adverse Event|0|||
38036876|NCT02768194|69724424|FG003|Period 1|Adverse Event|1|||
38036877|NCT02768194|69724425|FG004|Period 1|Adverse Event|0|||
37943999|NCT00355615|69631411|FG004|Randomized Double Blind Period|Adverse Event|0|||
37944000|NCT00355615|69631407|FG000|Randomized Double Blind Period|Protocol Violation|0|||
37944001|NCT00355615|69631408|FG001|Randomized Double Blind Period|Protocol Violation|0|||
37944002|NCT00355615|69631409|FG002|Randomized Double Blind Period|Protocol Violation|1|||
37944003|NCT00355615|69631410|FG003|Randomized Double Blind Period|Protocol Violation|1|||
37944004|NCT00355615|69631411|FG004|Randomized Double Blind Period|Protocol Violation|0|||
37944005|NCT00355615|69631407|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
37944006|NCT00355615|69631408|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
37944007|NCT00355615|69631409|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
37944008|NCT00355615|69631410|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
37944009|NCT00355615|69631411|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
37944010|NCT00355615|69631407|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
37944011|NCT00355615|69631408|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
37944012|NCT00355615|69631409|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
37944013|NCT00355615|69631410|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
37944014|NCT00355615|69631411|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
37944015|NCT00355615|69631407|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
37944016|NCT00355615|69631408|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
37944017|NCT00355615|69631409|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
37944018|NCT00355615|69631410|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
37944019|NCT00355615|69631411|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
37944020|NCT00355615|69631407|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
37944021|NCT00355615|69631408|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
37944022|NCT00355615|69631409|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
38036878|NCT02768194|69724426|FG005|Period 1|Adverse Event|0|||
38036879|NCT02768194|69724421|FG000|Period 2|Other (Reason not specified)|1|||
38036880|NCT02768194|69724422|FG001|Period 2|Other (Reason not specified)|0|||
38036881|NCT02768194|69724423|FG002|Period 2|Other (Reason not specified)|0|||
38036882|NCT02768194|69724424|FG003|Period 2|Other (Reason not specified)|0|||
38036883|NCT02768194|69724425|FG004|Period 2|Other (Reason not specified)|0|||
38036884|NCT02768194|69724426|FG005|Period 2|Other (Reason not specified)|0|||
38036885|NCT02768194|69724421|FG000|Period 3|Other (Reason not specified)|0|||
38036886|NCT02768194|69724422|FG001|Period 3|Other (Reason not specified)|1|||
38036887|NCT02768194|69724423|FG002|Period 3|Other (Reason not specified)|0|||
38036888|NCT02768194|69724424|FG003|Period 3|Other (Reason not specified)|0|||
38036889|NCT02768194|69724425|FG004|Period 3|Other (Reason not specified)|0|||
38036890|NCT02768194|69724426|FG005|Period 3|Other (Reason not specified)|0|||
38036891|NCT00130793|69724436|FG000|Overall Study|Lost to Follow-up|1|||
38036892|NCT00130793|69724437|FG001|Overall Study|Lost to Follow-up|4|||
38036893|NCT00130793|69724436|FG000|Overall Study|Withdrew consent|2|||
38036894|NCT00130793|69724437|FG001|Overall Study|Withdrew consent|0|||
38036895|NCT03818399|69724444|FG000|Overall Study|Lost to Follow-up|11|||
38036896|NCT03818399|69724444|FG000|Overall Study|Withdrawal by Subject|1|||
38036897|NCT03818399|69724444|FG000|Overall Study|Protocol Violation|2|||
38036898|NCT03642873|69724448|FG000|Third Intervention (1 Day)|Screen failure|0|||
38036899|NCT03642873|69724449|FG001|Third Intervention (1 Day)|Screen failure|0|||
38036900|NCT03642873|69724450|FG002|Third Intervention (1 Day)|Screen failure|0|||
38036901|NCT03642873|69724451|FG003|Third Intervention (1 Day)|Screen failure|0|||
38036902|NCT03642873|69724452|FG004|Third Intervention (1 Day)|Screen failure|1|||
38036903|NCT03642873|69724453|FG005|Third Intervention (1 Day)|Screen failure|0|||
38036904|NCT03818321|69724467|FG000|Overall Study|Withdrawal by Subject|1|||
38036905|NCT03818321|69724468|FG001|Overall Study|Withdrawal by Subject|2|||
38036906|NCT03616977|69724474|FG000|Period 1|Physician Decision|0|||
38036907|NCT03616977|69724475|FG001|Period 1|Physician Decision|1|||
38036908|NCT03616977|69724474|FG000|Period 3|Adverse Event|1|||
38036909|NCT03616977|69724475|FG001|Period 3|Adverse Event|1|||
38036910|NCT02767570|69724484|FG000|Overall Study|Lost to Follow-up|3|||
38036911|NCT02767570|69724485|FG001|Overall Study|Lost to Follow-up|0|||
38036912|NCT02767570|69724484|FG000|Overall Study|COVID shutdown|2|||
38036913|NCT02767570|69724485|FG001|Overall Study|COVID shutdown|5|||
38036914|NCT02767570|69724484|FG000|Overall Study|Increased pain|2|||
38036915|NCT02767570|69724485|FG001|Overall Study|Increased pain|0|||
38036916|NCT02767570|69724484|FG000|Overall Study|Withdrawal by Subject|1|||
38036917|NCT02767570|69724485|FG001|Overall Study|Withdrawal by Subject|3|||
38036918|NCT02767570|69724484|FG000|Overall Study|Unrelated medical issue|1|||
38036919|NCT02767570|69724485|FG001|Overall Study|Unrelated medical issue|1|||
38036920|NCT02767570|69724484|FG000|Overall Study|Received intra-articular injection|0|||
38036921|NCT02767570|69724485|FG001|Overall Study|Received intra-articular injection|1|||
37944023|NCT00355615|69631410|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
37944024|NCT00355615|69631411|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
37944025|NCT00347269|69631424|FG000|Overall Study|Lost to Follow-up|74|||
37944026|NCT00347269|69631425|FG001|Overall Study|Lost to Follow-up|65|||
37944027|NCT00347269|69631424|FG000|Overall Study|Withdrawal by Subject|18|||
37944028|NCT00347269|69631425|FG001|Overall Study|Withdrawal by Subject|38|||
37944029|NCT00347269|69631424|FG000|Overall Study|Death|2|||
37944030|NCT00347269|69631425|FG001|Overall Study|Death|3|||
37944031|NCT00544648|69631433|FG000|Overall Study|Withdrawal by Subject|1|||
37944032|NCT00544648|69631434|FG001|Overall Study|Withdrawal by Subject|0|||
37944033|NCT00544648|69631433|FG000|Overall Study|Adverse Event|1|||
37944034|NCT00544648|69631434|FG001|Overall Study|Adverse Event|1|||
37944035|NCT00544648|69631433|FG000|Overall Study|progression of disease|1|||
37944036|NCT00544648|69631434|FG001|Overall Study|progression of disease|0|||
37944037|NCT00346333|69631444|FG000|Overall Study|Death|1|||
37944038|NCT00346333|69631445|FG001|Overall Study|Death|0|||
37944039|NCT00346333|69631444|FG000|Overall Study|unwilling or unable to continue|4|||
37944040|NCT00346333|69631445|FG001|Overall Study|unwilling or unable to continue|8|||
37944041|NCT00330967|69631455|FG000|Overall Study|Withdrawal by Subject|0|||
37944042|NCT00330967|69631456|FG001|Overall Study|Withdrawal by Subject|5|||
37944043|NCT00330967|69631455|FG000|Overall Study|Physician Decision|0|||
37944044|NCT00330967|69631456|FG001|Overall Study|Physician Decision|9|||
37944045|NCT00330343|69631462|FG000|Overall Study|Lost to Follow-up|5|||
37944046|NCT00330187|69631470|FG000|Overall Study|Lost to Follow-up|12|||
37944047|NCT00330187|69631471|FG001|Overall Study|Lost to Follow-up|13|||
37944048|NCT00330187|69631472|FG002|Overall Study|Lost to Follow-up|14|||
37944049|NCT00330187|69631473|FG003|Overall Study|Lost to Follow-up|10|||
37944050|NCT00330187|69631470|FG000|Overall Study|Withdrawal by Subject|8|||
37944051|NCT00330187|69631471|FG001|Overall Study|Withdrawal by Subject|5|||
37944052|NCT00330187|69631472|FG002|Overall Study|Withdrawal by Subject|4|||
37944053|NCT00330187|69631473|FG003|Overall Study|Withdrawal by Subject|4|||
37944054|NCT03914950|69631483|FG000|Overall Study|Physician Decision|54|||
37944055|NCT00329797|69631495|FG000|Overall Study|Protocol Violation|1|||
37944056|NCT00329797|69631496|FG001|Overall Study|Protocol Violation|0|||
37944057|NCT00329797|69631495|FG000|Overall Study|Withdrawal by Subject|6|||
37944058|NCT00329797|69631496|FG001|Overall Study|Withdrawal by Subject|6|||
37944059|NCT00541450|69631504|FG000|Phase A|Adverse Event|3|||
37944060|NCT00541450|69631505|FG001|Phase A|Adverse Event|0|||
37944061|NCT00541450|69631504|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
37944062|NCT00541450|69631505|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
37944063|NCT00541450|69631504|FG000|Phase A|Hyperglycemia|0|||
37944064|NCT00541450|69631505|FG001|Phase A|Hyperglycemia|1|||
37944065|NCT00541450|69631504|FG000|Phase A|Lost to Follow-up|6|||
37944066|NCT00541450|69631505|FG001|Phase A|Lost to Follow-up|4|||
37944067|NCT00541450|69631504|FG000|Phase A|Physician Decision|2|||
37944068|NCT00541450|69631505|FG001|Phase A|Physician Decision|0|||
37944069|NCT00541450|69631504|FG000|Phase A|Protocol Violation|2|||
37944070|NCT00541450|69631505|FG001|Phase A|Protocol Violation|3|||
37944071|NCT00541450|69631504|FG000|Phase A|Withdrawal by Subject|7|||
37944072|NCT00541450|69631505|FG001|Phase A|Withdrawal by Subject|7|||
37944073|NCT00541450|69631504|FG000|Phase B|Adverse Event|6|||
37944074|NCT00541450|69631505|FG001|Phase B|Adverse Event|6|||
37944075|NCT00541450|69631504|FG000|Phase B|Hyperglycemia|10|||
37944076|NCT00541450|69631505|FG001|Phase B|Hyperglycemia|9|||
37944077|NCT00541450|69631504|FG000|Phase B|Lost to Follow-up|6|||
37944078|NCT00541450|69631505|FG001|Phase B|Lost to Follow-up|4|||
37944079|NCT00541450|69631504|FG000|Phase B|Physician Decision|4|||
37944080|NCT00541450|69631505|FG001|Phase B|Physician Decision|2|||
37944081|NCT00541450|69631504|FG000|Phase B|Pregnancy|0|||
37944082|NCT00541450|69631505|FG001|Phase B|Pregnancy|1|||
37944083|NCT00541450|69631504|FG000|Phase B|Protocol Violation|3|||
37944084|NCT00541450|69631505|FG001|Phase B|Protocol Violation|3|||
37944085|NCT00541450|69631504|FG000|Phase B|Withdrawal by Subject|8|||
37944086|NCT00541450|69631505|FG001|Phase B|Withdrawal by Subject|6|||
37944087|NCT00355147|69631517|FG000|Overall Study|Lost to Follow-up|10|||
37944088|NCT00355147|69631518|FG001|Overall Study|Lost to Follow-up|8|||
37944089|NCT00355147|69631517|FG000|Overall Study|Withdrawal by Subject|8|||
37944090|NCT00355147|69631518|FG001|Overall Study|Withdrawal by Subject|12|||
37944091|NCT00540124|69631531|FG000|Overall Study|Adverse Event|0|||
37944092|NCT00540124|69631532|FG001|Overall Study|Adverse Event|2|||
37673272|NCT03805841|69147501|FG002|Overall Study|Lost to Follow-up|1|||
37944093|NCT00540124|69631533|FG002|Overall Study|Adverse Event|1|||
37944094|NCT00540124|69631531|FG000|Overall Study|Entry Criteria Not Met|2|||
37944095|NCT00540124|69631532|FG001|Overall Study|Entry Criteria Not Met|0|||
37944096|NCT00540124|69631533|FG002|Overall Study|Entry Criteria Not Met|0|||
37944097|NCT00540124|69631531|FG000|Overall Study|Lack of Efficacy|1|||
37944098|NCT00540124|69631532|FG001|Overall Study|Lack of Efficacy|0|||
37944099|NCT00540124|69631533|FG002|Overall Study|Lack of Efficacy|0|||
37944100|NCT00540124|69631531|FG000|Overall Study|Withdrawal by Subject|1|||
37944101|NCT00540124|69631532|FG001|Overall Study|Withdrawal by Subject|1|||
37944102|NCT00540124|69631533|FG002|Overall Study|Withdrawal by Subject|0|||
37944103|NCT00540046|69631543|FG000|Overall Study|Lost to Follow-up|33|||
37944104|NCT00540046|69631544|FG001|Overall Study|Lost to Follow-up|23|||
37944105|NCT00689936|69631555|FG000|Active Treatment Phase|Adverse Event|68|||
37944106|NCT00689936|69631556|FG001|Active Treatment Phase|Adverse Event|71|||
37944107|NCT00689936|69631557|FG002|Active Treatment Phase|Adverse Event|76|||
37944108|NCT00689936|69631555|FG000|Active Treatment Phase|Disease Progression|273|||
37944109|NCT00689936|69631556|FG001|Active Treatment Phase|Disease Progression|362|||
37944110|NCT00689936|69631557|FG002|Active Treatment Phase|Disease Progression|339|||
37944111|NCT00689936|69631555|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
37944112|NCT00689936|69631556|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
37944113|NCT00689936|69631557|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
37944114|NCT00689936|69631555|FG000|Active Treatment Phase|Death|60|||
37944115|NCT00689936|69631556|FG001|Active Treatment Phase|Death|28|||
37944116|NCT00689936|69631557|FG002|Active Treatment Phase|Death|37|||
37944117|NCT00689936|69631555|FG000|Active Treatment Phase|Lost to Follow-up|0|||
37944118|NCT00689936|69631556|FG001|Active Treatment Phase|Lost to Follow-up|2|||
37944119|NCT00689936|69631557|FG002|Active Treatment Phase|Lost to Follow-up|2|||
37944120|NCT00689936|69631555|FG000|Active Treatment Phase|Protocol Violation|2|||
37944121|NCT00689936|69631556|FG001|Active Treatment Phase|Protocol Violation|2|||
37944122|NCT00689936|69631557|FG002|Active Treatment Phase|Protocol Violation|4|||
37944123|NCT00689936|69631555|FG000|Active Treatment Phase|Study Close Out|64|||
37944124|NCT00689936|69631556|FG001|Active Treatment Phase|Study Close Out|26|||
37944125|NCT00689936|69631557|FG002|Active Treatment Phase|Study Close Out|21|||
37944126|NCT00689936|69631555|FG000|Active Treatment Phase|Miscellaneous|52|||
37944127|NCT00689936|69631556|FG001|Active Treatment Phase|Miscellaneous|34|||
37944128|NCT00689936|69631557|FG002|Active Treatment Phase|Miscellaneous|47|||
37944129|NCT00689936|69631555|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
37944130|NCT00689936|69631556|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
37944131|NCT00689936|69631557|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
37944132|NCT00671034|69631568|FG000|Overall Study|Adverse Event|5|||
37944133|NCT00671034|69631569|FG001|Overall Study|Adverse Event|7|||
37944134|NCT00671034|69631570|FG002|Overall Study|Adverse Event|1|||
37944135|NCT00671034|69631568|FG000|Overall Study|Death|3|||
37944136|NCT00671034|69631569|FG001|Overall Study|Death|2|||
37944137|NCT00671034|69631570|FG002|Overall Study|Death|1|||
37944138|NCT00671034|69631568|FG000|Overall Study|Physician Decision|12|||
37944139|NCT00671034|69631569|FG001|Overall Study|Physician Decision|4|||
37944140|NCT00671034|69631570|FG002|Overall Study|Physician Decision|5|||
37944141|NCT00671034|69631568|FG000|Overall Study|VHR ALL feature|8|||
37944142|NCT00671034|69631569|FG001|Overall Study|VHR ALL feature|3|||
37944143|NCT00671034|69631570|FG002|Overall Study|VHR ALL feature|5|||
37944144|NCT00671034|69631568|FG000|Overall Study|Refusal|5|||
37944145|NCT00671034|69631569|FG001|Overall Study|Refusal|3|||
37944146|NCT00671034|69631570|FG002|Overall Study|Refusal|5|||
37944147|NCT00671034|69631568|FG000|Overall Study|includes Alternative therapy, etc.|6|||
37944148|NCT00671034|69631569|FG001|Overall Study|includes Alternative therapy, etc.|1|||
37944149|NCT00671034|69631570|FG002|Overall Study|includes Alternative therapy, etc.|7|||
37944150|NCT04404478|69631581|FG000|Overall Study|Withdrawal by Subject|1|||
37944151|NCT04404478|69631582|FG001|Overall Study|Withdrawal by Subject|3|||
37944152|NCT00539734|69631590|FG000|Overall Study|Protocol Violation|1|||
37944153|NCT03907072|69631597|FG000|Overall Study|Study Terminated by Sponsor|2|||
37944154|NCT03907072|69631598|FG001|Overall Study|Study Terminated by Sponsor|2|||
37944155|NCT03907072|69631599|FG002|Overall Study|Study Terminated by Sponsor|2|||
37944156|NCT00329719|69631624|FG000|Overall Study|Lost to Follow-up|0|||
37944157|NCT00329719|69631625|FG001|Overall Study|Lost to Follow-up|0|||
37944158|NCT00329719|69631626|FG002|Overall Study|Lost to Follow-up|0|||
37944159|NCT00329719|69631627|FG003|Overall Study|Lost to Follow-up|1|||
37944160|NCT00329641|69631637|FG000|Overall Study|Did not start treatment|1|||
37944161|NCT00329641|69631637|FG000|Overall Study|Not eligible|1|||
37944162|NCT00329641|69631637|FG000|Overall Study|Adverse Event|3|||
37944163|NCT00329641|69631637|FG000|Overall Study|Other reason, not protocol specified|1|||
37944164|NCT00329407|69631651|FG000|Overall Study|Withdrawal by Subject|1|||
37944165|NCT00328783|69631655|FG000|Overall Study|Could not tolerate ABC|21|||
37944166|NCT00328783|69631655|FG000|Overall Study|No heart in RT field|4|||
37944167|NCT00328783|69631655|FG000|Overall Study|Withdrawal by Subject|1|||
37944168|NCT00567489|69631663|FG000|Overall Study|Adverse Event|6|||
37944169|NCT00567489|69631664|FG001|Overall Study|Adverse Event|14|||
37944170|NCT00567489|69631663|FG000|Overall Study|Physician Decision|0|||
37944171|NCT00567489|69631664|FG001|Overall Study|Physician Decision|4|||
37944172|NCT00567489|69631663|FG000|Overall Study|Withdrawal by Subject|0|||
37944173|NCT00567489|69631664|FG001|Overall Study|Withdrawal by Subject|2|||
37944174|NCT00567489|69631663|FG000|Overall Study|Renal Transplantation|0|||
37944175|NCT00567489|69631664|FG001|Overall Study|Renal Transplantation|3|||
37944176|NCT00567489|69631663|FG000|Overall Study|Other|1|||
37944177|NCT00567489|69631664|FG001|Overall Study|Other|0|||
37944178|NCT00669942|69631682|FG000|Parts 2 and 3|Adverse Event|0|||
37944179|NCT00669942|69631683|FG001|Parts 2 and 3|Adverse Event|0|||
37944180|NCT00669942|69631684|FG002|Parts 2 and 3|Adverse Event|0|||
37944181|NCT00669942|69631685|FG003|Parts 2 and 3|Adverse Event|0|||
37944182|NCT00669942|69631686|FG004|Parts 2 and 3|Adverse Event|0|||
37944183|NCT00669942|69631687|FG005|Parts 2 and 3|Adverse Event|0|||
37944184|NCT00669942|69631688|FG006|Parts 2 and 3|Adverse Event|0|||
37944185|NCT00669942|69631689|FG007|Parts 2 and 3|Adverse Event|2|||
37944186|NCT00669942|69631690|FG008|Parts 2 and 3|Adverse Event|1|||
37944187|NCT00669942|69631691|FG009|Parts 2 and 3|Adverse Event|0|||
37944188|NCT00669942|69631692|FG010|Parts 2 and 3|Adverse Event|0|||
37944189|NCT00669942|69631693|FG011|Parts 2 and 3|Adverse Event|0|||
37944190|NCT00669942|69631682|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
37944191|NCT00669942|69631683|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
37944192|NCT00669942|69631684|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
37944193|NCT00669942|69631685|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
37944194|NCT00669942|69631686|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
37944195|NCT00669942|69631687|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
37944196|NCT00669942|69631688|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
37944197|NCT00669942|69631689|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
37944198|NCT00669942|69631690|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
37944199|NCT00669942|69631691|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
37944200|NCT00669942|69631692|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
37944201|NCT00669942|69631693|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
37944202|NCT00669942|69631682|FG000|Parts 2 and 3|Protocol Violation|0|||
37944203|NCT00669942|69631683|FG001|Parts 2 and 3|Protocol Violation|0|||
37944204|NCT00669942|69631684|FG002|Parts 2 and 3|Protocol Violation|0|||
37944205|NCT00669942|69631685|FG003|Parts 2 and 3|Protocol Violation|0|||
37944206|NCT00669942|69631686|FG004|Parts 2 and 3|Protocol Violation|0|||
37944207|NCT00669942|69631687|FG005|Parts 2 and 3|Protocol Violation|1|||
37944208|NCT00669942|69631688|FG006|Parts 2 and 3|Protocol Violation|0|||
37944209|NCT00669942|69631689|FG007|Parts 2 and 3|Protocol Violation|0|||
37944210|NCT00669942|69631690|FG008|Parts 2 and 3|Protocol Violation|0|||
37944211|NCT00669942|69631691|FG009|Parts 2 and 3|Protocol Violation|0|||
37944212|NCT00669942|69631692|FG010|Parts 2 and 3|Protocol Violation|0|||
37944213|NCT00669942|69631693|FG011|Parts 2 and 3|Protocol Violation|0|||
37944214|NCT00669864|69631716|FG000|Overall Study|Lost to Follow-up|2|||
37944215|NCT00669864|69631716|FG000|Overall Study|Protocol Violation|2|||
37944216|NCT00669864|69631716|FG000|Overall Study|Withdrawal by Subject|3|||
37944217|NCT00669864|69631716|FG000|Overall Study|Other|2|||
37944218|NCT00668148|69631720|FG000|Overall Study|Adverse Event|5|||
37944219|NCT00668148|69631720|FG000|Overall Study|Subject Non-compliance|1|||
37944220|NCT00668148|69631720|FG000|Overall Study|Progressive Disease Before Treatment|2|||
37944221|NCT00668148|69631720|FG000|Overall Study|Withdrawal of Consent|2|||
37944222|NCT00667992|69631737|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
37944223|NCT00667992|69631738|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
37944224|NCT00667992|69631737|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
37944225|NCT00667992|69631738|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
37944226|NCT00667992|69631737|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
37944227|NCT00667992|69631738|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
37944228|NCT00667992|69631737|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
37944229|NCT00667992|69631738|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
37944230|NCT00667992|69631737|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
37944231|NCT00667992|69631738|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
37944232|NCT00667992|69631737|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
37944233|NCT00667992|69631738|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
37944234|NCT00667992|69631737|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
37944235|NCT00667992|69631738|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
37944236|NCT00667992|69631737|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
37944237|NCT00667992|69631738|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
37944238|NCT00667992|69631737|FG000|Wash-out|Not within one doubling dilution|4|||
37944239|NCT00667992|69631738|FG001|Wash-out|Not within one doubling dilution|3|||
37944240|NCT00667992|69631737|FG000|Wash-out|Failure to wash-out|2|||
37944241|NCT00667992|69631738|FG001|Wash-out|Failure to wash-out|2|||
37944242|NCT00667992|69631737|FG000|Wash-out|Withdrawal by Subject|1|||
37944243|NCT00667992|69631738|FG001|Wash-out|Withdrawal by Subject|0|||
37944244|NCT00667992|69631737|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
37944245|NCT00667992|69631738|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
37944246|NCT00667992|69631737|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
37944247|NCT00667992|69631738|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
37944248|NCT00669396|69631756|FG000|Overall Study|Lost to Follow-up|10|||
37944249|NCT00669396|69631757|FG001|Overall Study|Lost to Follow-up|12|||
37944250|NCT00669318|69631763|FG000|Overall Study|Withdrawal by Subject|2|||
37944251|NCT00669240|69631767|FG000|Overall Study|Lack of Efficacy|33|||
37944252|NCT00669240|69631767|FG000|Overall Study|Withdrawal by Subject|42|||
37944253|NCT00669240|69631767|FG000|Overall Study|Lost to Follow-up|34|||
37944254|NCT00669240|69631767|FG000|Overall Study|Adverse Event|21|||
37944255|NCT00669240|69631767|FG000|Overall Study|Other|19|||
37944256|NCT00669240|69631767|FG000|Overall Study|Enrolled but not treated|15|||
37944257|NCT00669240|69631767|FG000|Overall Study|Enrolled but no dosing record|1|||
37944258|NCT00669162|69631771|FG000|Overall Study|Withdrawal by Subject|1|||
37944259|NCT00666588|69631788|FG000|Overall Study|ineligible|2|||
37944260|NCT00666588|69631789|FG001|Overall Study|ineligible|0|||
37944261|NCT00666588|69631790|FG002|Overall Study|ineligible|0|||
37944262|NCT00666588|69631791|FG003|Overall Study|ineligible|2|||
37944263|NCT00666588|69631788|FG000|Overall Study|inevaluable|2|||
37944264|NCT00666588|69631789|FG001|Overall Study|inevaluable|0|||
37944265|NCT00666588|69631790|FG002|Overall Study|inevaluable|0|||
37944266|NCT00666588|69631791|FG003|Overall Study|inevaluable|0|||
37944267|NCT00689390|69631803|FG000|Overall Study|Adverse Event|19|||
37944268|NCT00689390|69631804|FG001|Overall Study|Adverse Event|0|||
37944269|NCT00689390|69631803|FG000|Overall Study|Lost to Follow-up|179|||
37944270|NCT00689390|69631804|FG001|Overall Study|Lost to Follow-up|7|||
37944271|NCT00689390|69631803|FG000|Overall Study|Withdrawal by Subject|117|||
37944272|NCT00689390|69631804|FG001|Overall Study|Withdrawal by Subject|3|||
37944273|NCT00689390|69631803|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
37944274|NCT00689390|69631804|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
37944275|NCT00689390|69631803|FG000|Overall Study|Non-Compliance With Protocol|21|||
37944276|NCT00689390|69631804|FG001|Overall Study|Non-Compliance With Protocol|0|||
37944277|NCT00689390|69631803|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
37944278|NCT00689390|69631804|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
37944279|NCT00689390|69631803|FG000|Overall Study|Administrative|37|||
37944280|NCT00689390|69631804|FG001|Overall Study|Administrative|0|||
37944281|NCT00567879|69631821|FG000|Overall Study|Adverse Event|2|||
37944282|NCT00567879|69631822|FG001|Overall Study|Adverse Event|0|||
37944283|NCT00567879|69631823|FG002|Overall Study|Adverse Event|1|||
37944284|NCT00567879|69631824|FG003|Overall Study|Adverse Event|0|||
37944285|NCT00567879|69631825|FG004|Overall Study|Adverse Event|1|||
37944286|NCT00567879|69631826|FG005|Overall Study|Adverse Event|0|||
37944287|NCT00567879|69631821|FG000|Overall Study|Abnormal test procedure(s)|0|||
37944288|NCT00567879|69631822|FG001|Overall Study|Abnormal test procedure(s)|0|||
37944289|NCT00567879|69631823|FG002|Overall Study|Abnormal test procedure(s)|1|||
37944290|NCT00567879|69631824|FG003|Overall Study|Abnormal test procedure(s)|0|||
37944291|NCT00567879|69631825|FG004|Overall Study|Abnormal test procedure(s)|0|||
37944292|NCT00567879|69631826|FG005|Overall Study|Abnormal test procedure(s)|0|||
37944293|NCT00567879|69631821|FG000|Overall Study|Withdrawal by Subject|0|||
37944294|NCT00567879|69631822|FG001|Overall Study|Withdrawal by Subject|0|||
37944295|NCT00567879|69631823|FG002|Overall Study|Withdrawal by Subject|3|||
37944296|NCT00567879|69631824|FG003|Overall Study|Withdrawal by Subject|1|||
37944297|NCT00567879|69631825|FG004|Overall Study|Withdrawal by Subject|0|||
37944298|NCT00567879|69631826|FG005|Overall Study|Withdrawal by Subject|0|||
37944299|NCT00567879|69631821|FG000|Overall Study|New cancer therapy|0|||
37944300|NCT00567879|69631822|FG001|Overall Study|New cancer therapy|0|||
37944301|NCT00567879|69631823|FG002|Overall Study|New cancer therapy|1|||
37944302|NCT00567879|69631824|FG003|Overall Study|New cancer therapy|0|||
37944303|NCT00567879|69631825|FG004|Overall Study|New cancer therapy|0|||
37944304|NCT00567879|69631826|FG005|Overall Study|New cancer therapy|0|||
37944305|NCT00567879|69631821|FG000|Overall Study|Disease progression|5|||
37944306|NCT00567879|69631822|FG001|Overall Study|Disease progression|7|||
37944307|NCT00567879|69631823|FG002|Overall Study|Disease progression|15|||
37944308|NCT00567879|69631824|FG003|Overall Study|Disease progression|5|||
37944309|NCT00567879|69631825|FG004|Overall Study|Disease progression|11|||
38036922|NCT03816761|69724494|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
38036923|NCT03816761|69724495|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
38036924|NCT03816761|69724496|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
38036925|NCT03816761|69724497|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
37944310|NCT00567879|69631826|FG005|Overall Study|Disease progression|3|||
37944311|NCT00603915|69631844|FG000|Overall Study|Physician Decision|1|||
37944312|NCT00603837|69631850|FG000|Overall Study|Physician Decision|3|||
37944313|NCT00603837|69631851|FG001|Overall Study|Physician Decision|0|||
37944314|NCT00667602|69631860|FG000|Overall Study|Withdrawal by Subject|4|||
37944315|NCT00667602|69631861|FG001|Overall Study|Withdrawal by Subject|9|||
37944316|NCT00667602|69631862|FG002|Overall Study|Withdrawal by Subject|10|||
37944317|NCT00667602|69631860|FG000|Overall Study|Lost to Follow-up|4|||
37944318|NCT00667602|69631861|FG001|Overall Study|Lost to Follow-up|5|||
37944319|NCT00667602|69631862|FG002|Overall Study|Lost to Follow-up|6|||
38036926|NCT03816761|69724498|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
37944320|NCT00667602|69631860|FG000|Overall Study|Administrative reason|0|||
37944321|NCT00667602|69631861|FG001|Overall Study|Administrative reason|0|||
37944322|NCT00667602|69631862|FG002|Overall Study|Administrative reason|2|||
37944323|NCT00667602|69631860|FG000|Overall Study|Protocol Violation|0|||
37944324|NCT00667602|69631861|FG001|Overall Study|Protocol Violation|1|||
38036927|NCT03816761|69724499|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
38036928|NCT03816761|69724494|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
38036929|NCT03816761|69724495|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
38036930|NCT03816761|69724496|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
38036931|NCT03816761|69724497|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
37944325|NCT00667602|69631862|FG002|Overall Study|Protocol Violation|0|||
37944326|NCT00691028|69631878|FG000|Open-label Period|Adverse Event|0|||
37944327|NCT00691028|69631879|FG001|Open-label Period|Adverse Event|0|||
37944328|NCT00691028|69631880|FG002|Open-label Period|Adverse Event|0|||
37944329|NCT00691028|69631881|FG003|Open-label Period|Adverse Event|16|||
37944330|NCT00691028|69631878|FG000|Open-label Period|Withdrawal by Subject|0|||
37944331|NCT00691028|69631879|FG001|Open-label Period|Withdrawal by Subject|0|||
37944332|NCT00691028|69631880|FG002|Open-label Period|Withdrawal by Subject|0|||
37944333|NCT00691028|69631881|FG003|Open-label Period|Withdrawal by Subject|3|||
37944334|NCT00691028|69631878|FG000|Open-label Period|not come to a hospital|0|||
37944335|NCT00691028|69631879|FG001|Open-label Period|not come to a hospital|0|||
37944336|NCT00691028|69631880|FG002|Open-label Period|not come to a hospital|0|||
37944337|NCT00691028|69631881|FG003|Open-label Period|not come to a hospital|1|||
37944338|NCT00691028|69631878|FG000|Double-blind Period|Adverse Event|8|||
37944339|NCT00691028|69631879|FG001|Double-blind Period|Adverse Event|9|||
37944340|NCT00691028|69631880|FG002|Double-blind Period|Adverse Event|6|||
37944341|NCT00691028|69631881|FG003|Double-blind Period|Adverse Event|0|||
37944342|NCT00691028|69631878|FG000|Double-blind Period|Lack of Efficacy|4|||
37944343|NCT00691028|69631879|FG001|Double-blind Period|Lack of Efficacy|3|||
37944344|NCT00691028|69631880|FG002|Double-blind Period|Lack of Efficacy|2|||
37944345|NCT00691028|69631881|FG003|Double-blind Period|Lack of Efficacy|0|||
37944346|NCT00691028|69631878|FG000|Double-blind Period|Withdrawal by Subject|1|||
37944347|NCT00691028|69631879|FG001|Double-blind Period|Withdrawal by Subject|0|||
37944348|NCT00691028|69631880|FG002|Double-blind Period|Withdrawal by Subject|1|||
37944349|NCT00691028|69631881|FG003|Double-blind Period|Withdrawal by Subject|0|||
38036932|NCT03816761|69724498|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
38036933|NCT03816761|69724499|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
38036934|NCT02770612|69724521|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
38036935|NCT03575871|69724528|FG000|Overall Study|Adverse Event|5|||
38036936|NCT03575871|69724529|FG001|Overall Study|Adverse Event|5|||
38036937|NCT03575871|69724530|FG002|Overall Study|Adverse Event|8|||
38036938|NCT03575871|69724528|FG000|Overall Study|Death|1|||
38036939|NCT03575871|69724529|FG001|Overall Study|Death|0|||
38036940|NCT03575871|69724530|FG002|Overall Study|Death|0|||
38036941|NCT03575871|69724528|FG000|Overall Study|Lack of Efficacy|5|||
38036942|NCT03575871|69724529|FG001|Overall Study|Lack of Efficacy|4|||
38036943|NCT03575871|69724530|FG002|Overall Study|Lack of Efficacy|7|||
38036944|NCT03575871|69724528|FG000|Overall Study|Lost to Follow-up|1|||
38036945|NCT03575871|69724529|FG001|Overall Study|Lost to Follow-up|1|||
38036946|NCT03575871|69724530|FG002|Overall Study|Lost to Follow-up|1|||
38036947|NCT03575871|69724528|FG000|Overall Study|Protocol Deviation|1|||
38036948|NCT03575871|69724529|FG001|Overall Study|Protocol Deviation|1|||
38036949|NCT03575871|69724530|FG002|Overall Study|Protocol Deviation|1|||
38036950|NCT03575871|69724528|FG000|Overall Study|Withdrawal by Subject|6|||
38036951|NCT03575871|69724529|FG001|Overall Study|Withdrawal by Subject|1|||
38036952|NCT03575871|69724530|FG002|Overall Study|Withdrawal by Subject|9|||
38036953|NCT03575871|69724528|FG000|Overall Study|Other than specified|2|||
38036954|NCT03575871|69724529|FG001|Overall Study|Other than specified|2|||
38036955|NCT03575871|69724530|FG002|Overall Study|Other than specified|0|||
38036956|NCT03642717|69724538|FG000|Overall Study|Lost to Follow-up|2|||
38036957|NCT03642717|69724538|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
38036958|NCT03642717|69724538|FG000|Overall Study|Taken study drug prior to contract date|3|||
38036959|NCT02766478|69724545|FG000|Overall Study|Withdrawal by Subject|1|||
38036960|NCT02766478|69724546|FG001|Overall Study|Withdrawal by Subject|1|||
38036961|NCT02766400|69724554|FG000|Overall Study|Death|1|||
38036962|NCT02766400|69724555|FG001|Overall Study|Death|2|||
38036963|NCT02766400|69724554|FG000|Overall Study|Withdrawal by Subject|1|||
38036964|NCT02766400|69724555|FG001|Overall Study|Withdrawal by Subject|0|||
38036965|NCT00104650|69724564|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
38036966|NCT00104650|69724565|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
38036967|NCT00104650|69724566|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
38036968|NCT00104650|69724564|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
38036969|NCT00104650|69724565|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
37944350|NCT00691028|69631878|FG000|Double-blind Period|not come to a hospital.|0|||
37944351|NCT00691028|69631879|FG001|Double-blind Period|not come to a hospital.|1|||
37944352|NCT00691028|69631880|FG002|Double-blind Period|not come to a hospital.|0|||
37944353|NCT00691028|69631881|FG003|Double-blind Period|not come to a hospital.|0|||
37944354|NCT00690794|69631895|FG000|Overall Study|Adverse Event|12|||
37944355|NCT00690794|69631896|FG001|Overall Study|Adverse Event|10|||
38036970|NCT00104650|69724566|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
38036971|NCT00104650|69724564|FG000|Treatment Period (25 Weeks)|Death|7|||
37944356|NCT00690794|69631895|FG000|Overall Study|Lost to Follow-up|1|||
37944357|NCT00690794|69631896|FG001|Overall Study|Lost to Follow-up|4|||
37944358|NCT00690794|69631895|FG000|Overall Study|Withdrawal by Subject|0|||
37944359|NCT00690794|69631896|FG001|Overall Study|Withdrawal by Subject|9|||
37944360|NCT00690794|69631895|FG000|Overall Study|Protocol Violation|6|||
37944361|NCT00690794|69631896|FG001|Overall Study|Protocol Violation|7|||
37944362|NCT00690794|69631895|FG000|Overall Study|Noncompliance|1|||
37944363|NCT00690794|69631896|FG001|Overall Study|Noncompliance|2|||
37944364|NCT00690794|69631895|FG000|Overall Study|Other not specified|1|||
37944365|NCT00690794|69631896|FG001|Overall Study|Other not specified|3|||
37944366|NCT00666276|69631902|FG000|Overall Study|Protocol Violation|34|||
37944367|NCT00567255|69631927|FG000|Overall Study|Adverse Event|241|||
37944368|NCT00567255|69631928|FG001|Overall Study|Adverse Event|68|||
37944369|NCT00567255|69631927|FG000|Overall Study|Lost to Follow-up|77|||
37944370|NCT00567255|69631928|FG001|Overall Study|Lost to Follow-up|48|||
37944371|NCT00567255|69631927|FG000|Overall Study|Withdrawal by Subject|75|||
37944372|NCT00567255|69631928|FG001|Overall Study|Withdrawal by Subject|56|||
37944373|NCT00567255|69631927|FG000|Overall Study|Lack of Efficacy|19|||
37944374|NCT00567255|69631928|FG001|Overall Study|Lack of Efficacy|33|||
37944375|NCT00567255|69631927|FG000|Overall Study|Protocol Violation|20|||
37944376|NCT00567255|69631928|FG001|Overall Study|Protocol Violation|8|||
37944377|NCT00567255|69631927|FG000|Overall Study|Pregnancy|6|||
37944378|NCT00567255|69631928|FG001|Overall Study|Pregnancy|0|||
37944379|NCT00567255|69631927|FG000|Overall Study|Drug noncompliance,moved,other|25|||
37944380|NCT00567255|69631928|FG001|Overall Study|Drug noncompliance,moved,other|15|||
37944381|NCT00667446|69631936|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
37944382|NCT00667446|69631937|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
37944383|NCT00667446|69631936|FG000|Treatment Period (36 Months)|Other|2|||
37944384|NCT00667446|69631937|FG001|Treatment Period (36 Months)|Other|2|||
37944385|NCT00667446|69631936|FG000|Treatment Period (36 Months)|Personal reasons|2|||
37944386|NCT00667446|69631937|FG001|Treatment Period (36 Months)|Personal reasons|2|||
37944387|NCT00667446|69631936|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
37944388|NCT00667446|69631937|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
37944389|NCT00667446|69631936|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
37944390|NCT00667446|69631937|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
37944391|NCT00667446|69631936|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
37944392|NCT00667446|69631937|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
37944393|NCT00667446|69631936|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
37944394|NCT00667446|69631937|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
37944395|NCT00667446|69631936|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
37944396|NCT00667446|69631937|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
37944397|NCT00667446|69631936|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
37944398|NCT00667446|69631937|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
37944399|NCT00688844|69631943|FG000|Overall Study|Lost to Follow-up|10|||
37944400|NCT00667368|69631949|FG000|Overall Study|Lost to Follow-up|176|||
37944401|NCT00667368|69631950|FG001|Overall Study|Lost to Follow-up|155|||
37944402|NCT00667368|69631949|FG000|Overall Study|Discontinued early|24|||
37944403|NCT00667368|69631950|FG001|Overall Study|Discontinued early|17|||
37944404|NCT00567567|69631959|FG000|Overall Study|Adverse Event|0|||
37944405|NCT00567567|69631960|FG001|Overall Study|Adverse Event|2|||
37944406|NCT00567567|69631961|FG002|Overall Study|Adverse Event|5|||
37944407|NCT00567567|69631959|FG000|Overall Study|Death|8|||
37944408|NCT00567567|69631960|FG001|Overall Study|Death|1|||
37944409|NCT00567567|69631961|FG002|Overall Study|Death|5|||
37944410|NCT00567567|69631959|FG000|Overall Study|Lack of Efficacy|16|||
37944411|NCT00567567|69631960|FG001|Overall Study|Lack of Efficacy|17|||
37944412|NCT00567567|69631961|FG002|Overall Study|Lack of Efficacy|48|||
37944413|NCT00567567|69631959|FG000|Overall Study|Lost to Follow-up|0|||
37944414|NCT00567567|69631960|FG001|Overall Study|Lost to Follow-up|0|||
37944415|NCT00567567|69631961|FG002|Overall Study|Lost to Follow-up|1|||
37944416|NCT00567567|69631959|FG000|Overall Study|Physician Decision|16|||
37944417|NCT00567567|69631960|FG001|Overall Study|Physician Decision|18|||
37944418|NCT00567567|69631961|FG002|Overall Study|Physician Decision|84|||
37944419|NCT00567567|69631959|FG000|Overall Study|Withdrawal by Subject|0|||
37944420|NCT00567567|69631960|FG001|Overall Study|Withdrawal by Subject|0|||
37944421|NCT00567567|69631961|FG002|Overall Study|Withdrawal by Subject|2|||
37944422|NCT00567567|69631959|FG000|Overall Study|Ineligible|4|||
37944423|NCT00567567|69631960|FG001|Overall Study|Ineligible|0|||
37944424|NCT00567567|69631961|FG002|Overall Study|Ineligible|9|||
38036972|NCT00104650|69724565|FG001|Treatment Period (25 Weeks)|Death|5|||
37944425|NCT00567567|69631959|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
37944426|NCT00567567|69631960|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
37944427|NCT00567567|69631961|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
37944428|NCT00567567|69631959|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
37944429|NCT00567567|69631960|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
37944430|NCT00567567|69631961|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
37944431|NCT00567567|69631959|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
37944432|NCT00567567|69631960|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
37944433|NCT00567567|69631961|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
37944434|NCT00666198|69631971|FG000|Overall Study|Protocol Violation|10|||
37944435|NCT00666198|69631971|FG000|Overall Study|No Visit After First Day of Treatment|13|||
37944436|NCT00666198|69631971|FG000|Overall Study|Safety Not Assessable|6|||
37944437|NCT00666198|69631971|FG000|Overall Study|No Drug Administration|4|||
37944438|NCT00664560|69631978|FG000|Overall Study|Adverse Event|19|||
37944439|NCT00664560|69631979|FG001|Overall Study|Adverse Event|16|||
37944440|NCT00664560|69631980|FG002|Overall Study|Adverse Event|7|||
37944441|NCT00664560|69631978|FG000|Overall Study|Withdrawal by Subject|9|||
37944442|NCT00664560|69631979|FG001|Overall Study|Withdrawal by Subject|13|||
37944443|NCT00664560|69631980|FG002|Overall Study|Withdrawal by Subject|7|||
37944444|NCT00664560|69631978|FG000|Overall Study|Lost to Follow-up|0|||
37944445|NCT00664560|69631979|FG001|Overall Study|Lost to Follow-up|2|||
37944446|NCT00664560|69631980|FG002|Overall Study|Lost to Follow-up|0|||
37944447|NCT00664560|69631978|FG000|Overall Study|Other|11|||
37944448|NCT00664560|69631979|FG001|Overall Study|Other|4|||
37944449|NCT00664560|69631980|FG002|Overall Study|Other|5|||
37944450|NCT00566709|69631990|FG000|Overall Study|Protocol Violation|5|||
37944451|NCT00566709|69631991|FG001|Overall Study|Protocol Violation|0|||
37944452|NCT00688688|69632000|FG000|Overall Study|Eligibility criterion not met|7|||
37944453|NCT00688688|69632001|FG001|Overall Study|Eligibility criterion not met|7|||
37944454|NCT00688688|69632002|FG002|Overall Study|Eligibility criterion not met|10|||
37944455|NCT00688688|69632000|FG000|Overall Study|Adverse Event|52|||
37944456|NCT00688688|69632001|FG001|Overall Study|Adverse Event|51|||
37944457|NCT00688688|69632002|FG002|Overall Study|Adverse Event|50|||
37944458|NCT00688688|69632000|FG000|Overall Study|Lack of Efficacy|34|||
37944459|NCT00688688|69632001|FG001|Overall Study|Lack of Efficacy|25|||
37944460|NCT00688688|69632002|FG002|Overall Study|Lack of Efficacy|45|||
37944461|NCT00688688|69632000|FG000|Overall Study|Withdrawal by Subject|66|||
37944462|NCT00688688|69632001|FG001|Overall Study|Withdrawal by Subject|75|||
37944463|NCT00688688|69632002|FG002|Overall Study|Withdrawal by Subject|65|||
37944464|NCT00688688|69632000|FG000|Overall Study|Lost to Follow-up|14|||
37944465|NCT00688688|69632001|FG001|Overall Study|Lost to Follow-up|7|||
37944466|NCT00688688|69632002|FG002|Overall Study|Lost to Follow-up|7|||
37944467|NCT00688688|69632000|FG000|Overall Study|Protocol Violation|6|||
37944468|NCT00688688|69632001|FG001|Overall Study|Protocol Violation|9|||
37944469|NCT00688688|69632002|FG002|Overall Study|Protocol Violation|11|||
37944470|NCT00688688|69632000|FG000|Overall Study|Randomized but never received study drug|1|||
37944471|NCT00688688|69632001|FG001|Overall Study|Randomized but never received study drug|0|||
37944472|NCT00688688|69632002|FG002|Overall Study|Randomized but never received study drug|0|||
37944473|NCT00688688|69632000|FG000|Overall Study|Non-compliance with study procedures|5|||
37944474|NCT00688688|69632001|FG001|Overall Study|Non-compliance with study procedures|3|||
37944475|NCT00688688|69632002|FG002|Overall Study|Non-compliance with study procedures|4|||
37944476|NCT00688688|69632000|FG000|Overall Study|Taking exclusionary medications|1|||
37944477|NCT00688688|69632001|FG001|Overall Study|Taking exclusionary medications|0|||
37944478|NCT00688688|69632002|FG002|Overall Study|Taking exclusionary medications|0|||
37944479|NCT00688688|69632000|FG000|Overall Study|Site closure|0|||
37944480|NCT00688688|69632001|FG001|Overall Study|Site closure|1|||
37944481|NCT00688688|69632002|FG002|Overall Study|Site closure|0|||
37944482|NCT00688688|69632000|FG000|Overall Study|Violation of exclusion criterion|0|||
37944483|NCT00688688|69632001|FG001|Overall Study|Violation of exclusion criterion|1|||
37944484|NCT00688688|69632002|FG002|Overall Study|Violation of exclusion criterion|0|||
37944485|NCT00664326|69632010|FG000|Overall Study|Adverse Event|14|||
37766369|NCT01408303|69280362|FG002|Overall Study|Withdrawal by Subject|1|||
37766370|NCT01408303|69280360|FG000|Overall Study|Protocol Violation|0|||
37944486|NCT00664326|69632010|FG000|Overall Study|Noncompliance with study medication|3|||
37944487|NCT00664326|69632010|FG000|Overall Study|Withdrawal by Subject|1|||
37944488|NCT00664326|69632010|FG000|Overall Study|Physician Decision|1|||
37944489|NCT00664326|69632010|FG000|Overall Study|Other Reasons|3|||
37944490|NCT00664326|69632010|FG000|Overall Study|Death|2|||
37944491|NCT00664326|69632010|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
37944492|NCT00686972|69632014|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
37944493|NCT00665652|69632018|FG000|Overall Study|Adverse Event|4|||
37944494|NCT00665652|69632018|FG000|Overall Study|Death|1|||
37944495|NCT00665652|69632018|FG000|Overall Study|No longer met inclusion criteria.|1|||
37944496|NCT00566631|69632022|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
37944497|NCT00566631|69632022|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
37944498|NCT00566631|69632022|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
37944499|NCT00566631|69632022|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
37944500|NCT00566631|69632022|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
37944501|NCT00566631|69632022|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
37766371|NCT01408303|69280361|FG001|Overall Study|Protocol Violation|1|||
37944502|NCT00566631|69632022|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
37944503|NCT00566631|69632022|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
37944504|NCT00566631|69632022|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
37944505|NCT00566631|69632022|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
37944506|NCT00566631|69632022|FG000|Part 2: Extension Phase|Adverse Event|11|||
37944507|NCT00566631|69632022|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
37944508|NCT00566631|69632022|FG000|Part 2: Extension Phase|Death|1|||
37944509|NCT00566631|69632022|FG000|Part 2: Extension Phase|Other|5|||
37944510|NCT00661830|69632028|FG000|Overall Study|Death|37|||
37944511|NCT00661830|69632029|FG001|Overall Study|Death|33|||
37944512|NCT00661830|69632028|FG000|Overall Study|Lost to Follow-up|1|||
37944513|NCT00661830|69632029|FG001|Overall Study|Lost to Follow-up|3|||
37944514|NCT00661830|69632028|FG000|Overall Study|Withdrawal by Subject|1|||
37944515|NCT00661830|69632029|FG001|Overall Study|Withdrawal by Subject|1|||
37944516|NCT00661830|69632028|FG000|Overall Study|Other reason|1|||
37944517|NCT00661830|69632029|FG001|Overall Study|Other reason|5|||
37944518|NCT00540592|69632045|FG000|Overall Study|Adverse Event|0|||
37944519|NCT00540592|69632046|FG001|Overall Study|Adverse Event|1|||
37944520|NCT00540592|69632047|FG002|Overall Study|Adverse Event|0|||
37944521|NCT00540592|69632048|FG003|Overall Study|Adverse Event|0|||
37944522|NCT00540592|69632049|FG004|Overall Study|Adverse Event|1|||
37944523|NCT00540592|69632050|FG005|Overall Study|Adverse Event|0|||
37944524|NCT00540592|69632051|FG006|Overall Study|Adverse Event|0|||
37944525|NCT00540592|69632052|FG007|Overall Study|Adverse Event|1|||
37944526|NCT00540592|69632053|FG008|Overall Study|Adverse Event|1|||
37944527|NCT00540592|69632054|FG009|Overall Study|Adverse Event|2|||
37944528|NCT00540592|69632045|FG000|Overall Study|Lost to Follow-up|2|||
37944529|NCT00540592|69632046|FG001|Overall Study|Lost to Follow-up|0|||
37944530|NCT00540592|69632047|FG002|Overall Study|Lost to Follow-up|0|||
37944531|NCT00540592|69632048|FG003|Overall Study|Lost to Follow-up|0|||
37944532|NCT00540592|69632049|FG004|Overall Study|Lost to Follow-up|0|||
37944533|NCT00540592|69632050|FG005|Overall Study|Lost to Follow-up|0|||
37944534|NCT00540592|69632051|FG006|Overall Study|Lost to Follow-up|0|||
37944535|NCT00540592|69632052|FG007|Overall Study|Lost to Follow-up|0|||
37944536|NCT00540592|69632053|FG008|Overall Study|Lost to Follow-up|0|||
37944537|NCT00540592|69632054|FG009|Overall Study|Lost to Follow-up|0|||
37944538|NCT00540592|69632045|FG000|Overall Study|Withdrawal by Subject|0|||
37944539|NCT00540592|69632046|FG001|Overall Study|Withdrawal by Subject|0|||
37944540|NCT00540592|69632047|FG002|Overall Study|Withdrawal by Subject|1|||
37944541|NCT00540592|69632048|FG003|Overall Study|Withdrawal by Subject|1|||
37944542|NCT00540592|69632049|FG004|Overall Study|Withdrawal by Subject|0|||
37944543|NCT00540592|69632050|FG005|Overall Study|Withdrawal by Subject|0|||
37944544|NCT00540592|69632051|FG006|Overall Study|Withdrawal by Subject|0|||
37944545|NCT00540592|69632052|FG007|Overall Study|Withdrawal by Subject|0|||
37944546|NCT00540592|69632053|FG008|Overall Study|Withdrawal by Subject|0|||
37944547|NCT00540592|69632054|FG009|Overall Study|Withdrawal by Subject|0|||
37944548|NCT03970395|69632078|FG000|Overall Study|Withdrawal by Subject|3|||
37944549|NCT03970395|69632079|FG001|Overall Study|Withdrawal by Subject|4|||
37944550|NCT03970395|69632078|FG000|Overall Study|Lost to Follow-up|4|||
37944551|NCT03970395|69632079|FG001|Overall Study|Lost to Follow-up|8|||
37944552|NCT00565773|69632089|FG000|Overall Study|Withdrawal by Subject|1|||
37944553|NCT00565773|69632089|FG000|Overall Study|Physician Decision|1|||
37944554|NCT00570492|69632095|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
37944555|NCT00570492|69632096|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
37944556|NCT00570492|69632097|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
37944557|NCT00570492|69632095|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
37944558|NCT00570492|69632096|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
37944559|NCT00570492|69632097|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
37944560|NCT00570492|69632095|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
37944561|NCT00570492|69632096|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
37944562|NCT00570492|69632097|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
37944563|NCT00570492|69632095|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
37944564|NCT00570492|69632096|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
37944565|NCT00570492|69632097|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
37944566|NCT00570492|69632095|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
37944567|NCT00570492|69632096|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
37944568|NCT00570492|69632097|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
37944569|NCT00570492|69632095|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
37944570|NCT00570492|69632096|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
37944571|NCT00570492|69632097|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
37944572|NCT00570492|69632095|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
37944573|NCT00570492|69632096|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
37944574|NCT00570492|69632097|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
37944575|NCT00570492|69632095|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
37944576|NCT00570492|69632096|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
37944577|NCT00570492|69632097|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
37944578|NCT00570492|69632095|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
37944579|NCT00570492|69632096|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
37944580|NCT00570492|69632097|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
37944581|NCT00570492|69632095|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
37944582|NCT00570492|69632096|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
37944583|NCT00570492|69632097|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
37944584|NCT00570492|69632095|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
37944585|NCT00570492|69632096|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
37944586|NCT00570492|69632097|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
37944587|NCT00570492|69632095|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
37944588|NCT00570492|69632096|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
37944589|NCT00570492|69632097|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
37944590|NCT00570492|69632095|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
37944591|NCT00570492|69632096|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
37944592|NCT00570492|69632097|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
37944593|NCT00570492|69632095|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
37944594|NCT00570492|69632096|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
37944595|NCT00570492|69632097|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
37944596|NCT00571922|69632105|FG000|Overall Study|Completion unknown|36|||
37944597|NCT00571922|69632106|FG001|Overall Study|Completion unknown|36|||
37944598|NCT00686894|69632112|FG000|Overall Study|Relapse|2|||
37944599|NCT00686894|69632112|FG000|Overall Study|Protocol Violation|4|||
37944600|NCT00328627|69632128|FG000|Overall Study|Hyperglycemic Rescue|41|||
37944601|NCT00328627|69632129|FG001|Overall Study|Hyperglycemic Rescue|18|||
37944602|NCT00328627|69632130|FG002|Overall Study|Hyperglycemic Rescue|16|||
37944603|NCT00328627|69632131|FG003|Overall Study|Hyperglycemic Rescue|13|||
37944604|NCT00328627|69632132|FG004|Overall Study|Hyperglycemic Rescue|6|||
37944605|NCT00328627|69632133|FG005|Overall Study|Hyperglycemic Rescue|5|||
37944606|NCT00328627|69632134|FG006|Overall Study|Hyperglycemic Rescue|19|||
37944607|NCT00328627|69632135|FG007|Overall Study|Hyperglycemic Rescue|6|||
37944608|NCT00328627|69632136|FG008|Overall Study|Hyperglycemic Rescue|6|||
37944609|NCT00328627|69632137|FG009|Overall Study|Hyperglycemic Rescue|11|||
37944610|NCT00328627|69632138|FG010|Overall Study|Hyperglycemic Rescue|3|||
37944611|NCT00328627|69632139|FG011|Overall Study|Hyperglycemic Rescue|2|||
37944612|NCT00328627|69632128|FG000|Overall Study|Adverse Event|3|||
37944613|NCT00328627|69632129|FG001|Overall Study|Adverse Event|1|||
37944614|NCT00328627|69632130|FG002|Overall Study|Adverse Event|2|||
37944615|NCT00328627|69632131|FG003|Overall Study|Adverse Event|3|||
37944616|NCT00328627|69632132|FG004|Overall Study|Adverse Event|1|||
37944617|NCT00328627|69632133|FG005|Overall Study|Adverse Event|2|||
37944618|NCT00328627|69632134|FG006|Overall Study|Adverse Event|1|||
37944619|NCT00328627|69632135|FG007|Overall Study|Adverse Event|2|||
37944620|NCT00328627|69632136|FG008|Overall Study|Adverse Event|0|||
37944621|NCT00328627|69632137|FG009|Overall Study|Adverse Event|7|||
37944622|NCT00328627|69632138|FG010|Overall Study|Adverse Event|5|||
37944623|NCT00328627|69632139|FG011|Overall Study|Adverse Event|4|||
37944624|NCT00328627|69632128|FG000|Overall Study|Protocol Violation|2|||
37944625|NCT00328627|69632129|FG001|Overall Study|Protocol Violation|2|||
37944626|NCT00328627|69632130|FG002|Overall Study|Protocol Violation|2|||
37944627|NCT00328627|69632131|FG003|Overall Study|Protocol Violation|8|||
37944628|NCT00328627|69632132|FG004|Overall Study|Protocol Violation|5|||
37944629|NCT00328627|69632133|FG005|Overall Study|Protocol Violation|5|||
37944630|NCT00328627|69632134|FG006|Overall Study|Protocol Violation|6|||
37944631|NCT00328627|69632135|FG007|Overall Study|Protocol Violation|2|||
37944632|NCT00328627|69632136|FG008|Overall Study|Protocol Violation|1|||
37944633|NCT00328627|69632137|FG009|Overall Study|Protocol Violation|4|||
38036973|NCT00104650|69724566|FG002|Treatment Period (25 Weeks)|Death|6|||
38036974|NCT00104650|69724564|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
38036975|NCT00104650|69724565|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
38036976|NCT00104650|69724566|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
38036977|NCT00104650|69724564|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
38036978|NCT00104650|69724565|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
37944634|NCT00328627|69632138|FG010|Overall Study|Protocol Violation|6|||
37944635|NCT00328627|69632139|FG011|Overall Study|Protocol Violation|2|||
37944636|NCT00328627|69632128|FG000|Overall Study|Lost to Follow-up|4|||
37944637|NCT00328627|69632129|FG001|Overall Study|Lost to Follow-up|2|||
37944638|NCT00328627|69632130|FG002|Overall Study|Lost to Follow-up|2|||
37944639|NCT00328627|69632131|FG003|Overall Study|Lost to Follow-up|4|||
37944640|NCT00328627|69632132|FG004|Overall Study|Lost to Follow-up|0|||
37944641|NCT00328627|69632133|FG005|Overall Study|Lost to Follow-up|2|||
37944642|NCT00328627|69632134|FG006|Overall Study|Lost to Follow-up|3|||
37944643|NCT00328627|69632135|FG007|Overall Study|Lost to Follow-up|0|||
37944644|NCT00328627|69632136|FG008|Overall Study|Lost to Follow-up|3|||
37944645|NCT00328627|69632137|FG009|Overall Study|Lost to Follow-up|2|||
37944646|NCT00328627|69632138|FG010|Overall Study|Lost to Follow-up|0|||
37944647|NCT00328627|69632139|FG011|Overall Study|Lost to Follow-up|1|||
37944648|NCT00328627|69632128|FG000|Overall Study|Withdrawal by Subject|5|||
37944649|NCT00328627|69632129|FG001|Overall Study|Withdrawal by Subject|4|||
37944650|NCT00328627|69632130|FG002|Overall Study|Withdrawal by Subject|5|||
37944651|NCT00328627|69632131|FG003|Overall Study|Withdrawal by Subject|6|||
37944652|NCT00328627|69632132|FG004|Overall Study|Withdrawal by Subject|2|||
37944653|NCT00328627|69632133|FG005|Overall Study|Withdrawal by Subject|5|||
37944654|NCT00328627|69632134|FG006|Overall Study|Withdrawal by Subject|4|||
37944655|NCT00328627|69632135|FG007|Overall Study|Withdrawal by Subject|4|||
37944656|NCT00328627|69632136|FG008|Overall Study|Withdrawal by Subject|4|||
37944657|NCT00328627|69632137|FG009|Overall Study|Withdrawal by Subject|5|||
37944658|NCT00328627|69632138|FG010|Overall Study|Withdrawal by Subject|2|||
37944659|NCT00328627|69632139|FG011|Overall Study|Withdrawal by Subject|7|||
37944660|NCT00328627|69632128|FG000|Overall Study|Pregnancy|0|||
37944661|NCT00328627|69632129|FG001|Overall Study|Pregnancy|1|||
37944662|NCT00328627|69632130|FG002|Overall Study|Pregnancy|0|||
37944663|NCT00328627|69632131|FG003|Overall Study|Pregnancy|0|||
37944664|NCT00328627|69632132|FG004|Overall Study|Pregnancy|0|||
37944665|NCT00328627|69632133|FG005|Overall Study|Pregnancy|0|||
37944666|NCT00328627|69632134|FG006|Overall Study|Pregnancy|0|||
37944667|NCT00328627|69632135|FG007|Overall Study|Pregnancy|0|||
37944668|NCT00328627|69632136|FG008|Overall Study|Pregnancy|0|||
37944669|NCT00328627|69632137|FG009|Overall Study|Pregnancy|0|||
37944670|NCT00328627|69632138|FG010|Overall Study|Pregnancy|0|||
37944671|NCT00328627|69632139|FG011|Overall Study|Pregnancy|0|||
37944672|NCT00328627|69632128|FG000|Overall Study|Physician Decision|4|||
37944673|NCT00328627|69632129|FG001|Overall Study|Physician Decision|3|||
37944674|NCT00328627|69632130|FG002|Overall Study|Physician Decision|1|||
37944675|NCT00328627|69632131|FG003|Overall Study|Physician Decision|2|||
37944676|NCT00328627|69632132|FG004|Overall Study|Physician Decision|1|||
37944677|NCT00328627|69632133|FG005|Overall Study|Physician Decision|1|||
37944678|NCT00328627|69632134|FG006|Overall Study|Physician Decision|1|||
37944679|NCT00328627|69632135|FG007|Overall Study|Physician Decision|0|||
37944680|NCT00328627|69632136|FG008|Overall Study|Physician Decision|3|||
37944681|NCT00328627|69632137|FG009|Overall Study|Physician Decision|2|||
37944682|NCT00328627|69632138|FG010|Overall Study|Physician Decision|1|||
37944683|NCT00328627|69632139|FG011|Overall Study|Physician Decision|0|||
37944684|NCT00328627|69632128|FG000|Overall Study|Other|0|||
37944685|NCT00328627|69632129|FG001|Overall Study|Other|0|||
37944686|NCT00328627|69632130|FG002|Overall Study|Other|0|||
37944687|NCT00328627|69632131|FG003|Overall Study|Other|1|||
37944688|NCT00328627|69632132|FG004|Overall Study|Other|0|||
37944689|NCT00328627|69632133|FG005|Overall Study|Other|0|||
37944690|NCT00328627|69632134|FG006|Overall Study|Other|1|||
37944691|NCT00328627|69632135|FG007|Overall Study|Other|0|||
37944692|NCT00328627|69632136|FG008|Overall Study|Other|0|||
37944693|NCT00328627|69632137|FG009|Overall Study|Other|1|||
37944694|NCT00328627|69632138|FG010|Overall Study|Other|1|||
37944695|NCT00328627|69632139|FG011|Overall Study|Other|0|||
37944696|NCT03977727|69632175|FG000|Second Treatment|Lost to Follow-up|0|||
37944697|NCT03977727|69632176|FG001|Second Treatment|Lost to Follow-up|3|||
37944698|NCT00663858|69632185|FG000|Overall Study|Adverse Event|9|||
37944699|NCT00663858|69632186|FG001|Overall Study|Adverse Event|1|||
37944700|NCT00663858|69632187|FG002|Overall Study|Adverse Event|6|||
37944701|NCT00663858|69632185|FG000|Overall Study|Lack of Efficacy|5|||
37944702|NCT00663858|69632186|FG001|Overall Study|Lack of Efficacy|1|||
37944703|NCT00663858|69632187|FG002|Overall Study|Lack of Efficacy|3|||
37944704|NCT00663858|69632185|FG000|Overall Study|Withdrawal by Subject|7|||
37944705|NCT00663858|69632186|FG001|Overall Study|Withdrawal by Subject|3|||
37944706|NCT00663858|69632187|FG002|Overall Study|Withdrawal by Subject|3|||
37944707|NCT00663858|69632185|FG000|Overall Study|Protocol Violation|5|||
37944708|NCT00663858|69632186|FG001|Overall Study|Protocol Violation|3|||
37944709|NCT00663858|69632187|FG002|Overall Study|Protocol Violation|4|||
37766372|NCT01408303|69280362|FG002|Overall Study|Protocol Violation|0|||
37944710|NCT00663858|69632185|FG000|Overall Study|Other|8|||
37944711|NCT00663858|69632186|FG001|Overall Study|Other|2|||
37944712|NCT00663858|69632187|FG002|Overall Study|Other|4|||
37944713|NCT00659880|69632195|FG000|Overall Study|Lost to Follow-up|5|||
37944714|NCT00683774|69632202|FG000|Overall Study|Withdrawal by Subject|0|||
37944715|NCT00683774|69632203|FG001|Overall Study|Withdrawal by Subject|1|||
37944716|NCT00683774|69632202|FG000|Overall Study|Physician Decision|3|||
37944717|NCT00683774|69632203|FG001|Overall Study|Physician Decision|0|||
37944718|NCT00354679|69632209|FG000|Overall Study|Patient Not Treated|1|||
37944719|NCT00683696|69632215|FG000|Overall Study|Withdrawn due to study closure|337|||
37944720|NCT00683696|69632216|FG001|Overall Study|Withdrawn due to study closure|338|||
37944721|NCT00683696|69632215|FG000|Overall Study|Withdrawn prior to study closure|13|||
37944722|NCT00683696|69632216|FG001|Overall Study|Withdrawn prior to study closure|28|||
37944723|NCT00683696|69632215|FG000|Overall Study|Lost to Follow-up|5|||
37944724|NCT00683696|69632216|FG001|Overall Study|Lost to Follow-up|6|||
37944725|NCT00683696|69632215|FG000|Overall Study|Vital status follow-up only|3|||
37944726|NCT00683696|69632216|FG001|Overall Study|Vital status follow-up only|3|||
37944727|NCT00683696|69632215|FG000|Overall Study|Death|46|||
37944728|NCT00683696|69632216|FG001|Overall Study|Death|30|||
37944729|NCT00345631|69632226|FG000|Overall Study|Withdrawal by Subject|1|||
37944730|NCT00345631|69632227|FG001|Overall Study|Withdrawal by Subject|0|||
37944731|NCT00345631|69632228|FG002|Overall Study|Withdrawal by Subject|1|||
37944732|NCT00345631|69632226|FG000|Overall Study|Adverse Event|0|||
37944733|NCT00345631|69632227|FG001|Overall Study|Adverse Event|1|||
37944734|NCT00345631|69632228|FG002|Overall Study|Adverse Event|0|||
37944735|NCT00345631|69632226|FG000|Overall Study|Lost to Follow-up|3|||
37944736|NCT00345631|69632227|FG001|Overall Study|Lost to Follow-up|7|||
37944737|NCT00345631|69632228|FG002|Overall Study|Lost to Follow-up|4|||
37944738|NCT00345631|69632226|FG000|Overall Study|Other reasons|0|||
37944739|NCT00345631|69632227|FG001|Overall Study|Other reasons|0|||
37944740|NCT00345631|69632228|FG002|Overall Study|Other reasons|1|||
37944741|NCT00540514|69632240|FG000|Overall Study|Still on treatment|3|||
37944742|NCT00540514|69632241|FG001|Overall Study|Still on treatment|0|||
37944743|NCT00540514|69632240|FG000|Overall Study|Unacceptable Toxicity|61|||
37944744|NCT00540514|69632241|FG001|Overall Study|Unacceptable Toxicity|62|||
37944745|NCT00540514|69632240|FG000|Overall Study|Adverse Event|20|||
37944746|NCT00540514|69632241|FG001|Overall Study|Adverse Event|24|||
37944747|NCT00540514|69632240|FG000|Overall Study|Physician Decision|86|||
37944748|NCT00540514|69632241|FG001|Overall Study|Physician Decision|99|||
37944749|NCT00540514|69632240|FG000|Overall Study|Protocol Deviation|3|||
37944750|NCT00540514|69632241|FG001|Overall Study|Protocol Deviation|4|||
37944751|NCT00540514|69632240|FG000|Overall Study|Lost to Follow-up|1|||
37944752|NCT00540514|69632241|FG001|Overall Study|Lost to Follow-up|1|||
37944753|NCT00540514|69632240|FG000|Overall Study|Withdrawal by Subject|65|||
37944754|NCT00540514|69632241|FG001|Overall Study|Withdrawal by Subject|67|||
37944755|NCT00540514|69632240|FG000|Overall Study|Excluded prior to treatment|7|||
37944756|NCT00540514|69632241|FG001|Overall Study|Excluded prior to treatment|7|||
37944757|NCT00540514|69632240|FG000|Overall Study|Paclitaxel not available|0|||
38036979|NCT00104650|69724566|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
38036980|NCT00104650|69724564|FG000|Treatment Period (25 Weeks)|Other|1|||
38036981|NCT00104650|69724565|FG001|Treatment Period (25 Weeks)|Other|0|||
38036982|NCT00104650|69724566|FG002|Treatment Period (25 Weeks)|Other|0|||
38036983|NCT00104650|69724564|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
38036984|NCT00104650|69724565|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
38036985|NCT00104650|69724566|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
38036986|NCT00104650|69724564|FG000|Follow-up Period|Physician Decision|1|||
37944758|NCT00540514|69632241|FG001|Overall Study|Paclitaxel not available|2|||
37944759|NCT00663702|69632250|FG000|Overall Study|Adverse Event|8|||
37944760|NCT00663702|69632251|FG001|Overall Study|Adverse Event|4|||
37944761|NCT00663702|69632250|FG000|Overall Study|Withdrawal by Subject|3|||
37944762|NCT00663702|69632251|FG001|Overall Study|Withdrawal by Subject|1|||
37944763|NCT00663702|69632250|FG000|Overall Study|Pregnancy|0|||
37944764|NCT00663702|69632251|FG001|Overall Study|Pregnancy|1|||
37944765|NCT00663702|69632250|FG000|Overall Study|Lost to Follow-up|3|||
37944766|NCT00663702|69632251|FG001|Overall Study|Lost to Follow-up|0|||
37944767|NCT00663702|69632250|FG000|Overall Study|Death|1|||
37944768|NCT00663702|69632251|FG001|Overall Study|Death|1|||
37944769|NCT00663702|69632250|FG000|Overall Study|Lack of Efficacy|3|||
37944770|NCT00663702|69632251|FG001|Overall Study|Lack of Efficacy|3|||
37944771|NCT00683618|69632260|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
37944772|NCT00683618|69632261|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
37944773|NCT00683618|69632262|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
37944774|NCT00683618|69632260|FG000|Randomised Treatment Period|Protocol Violation|0|||
37944775|NCT00683618|69632261|FG001|Randomised Treatment Period|Protocol Violation|1|||
37944776|NCT00683618|69632262|FG002|Randomised Treatment Period|Protocol Violation|0|||
38036987|NCT00104650|69724565|FG001|Follow-up Period|Physician Decision|1|||
37944777|NCT00683618|69632260|FG000|Randomised Treatment Period|Adverse Event|2|||
37944778|NCT00683618|69632261|FG001|Randomised Treatment Period|Adverse Event|0|||
37944779|NCT00683618|69632262|FG002|Randomised Treatment Period|Adverse Event|2|||
37944780|NCT00683618|69632260|FG000|Randomised Treatment Period|Reason not provided|0|||
37944781|NCT00683618|69632261|FG001|Randomised Treatment Period|Reason not provided|0|||
38036988|NCT00104650|69724566|FG002|Follow-up Period|Physician Decision|0|||
38036989|NCT00104650|69724564|FG000|Follow-up Period|Adverse Event|1|||
37673273|NCT03805841|69147499|FG000|Overall Study|Withdrawal by Subject|2|||
37944782|NCT00683618|69632262|FG002|Randomised Treatment Period|Reason not provided|2|||
37944783|NCT00683618|69632260|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
37944784|NCT00683618|69632261|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
37944785|NCT00683618|69632262|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
37944786|NCT00683618|69632260|FG000|Extension Treatment Period|Adverse Event|1|||
38036990|NCT00104650|69724565|FG001|Follow-up Period|Adverse Event|0|||
38036991|NCT00104650|69724566|FG002|Follow-up Period|Adverse Event|1|||
38036992|NCT00104650|69724564|FG000|Follow-up Period|Withdrawal by Subject|0|||
38036993|NCT00104650|69724565|FG001|Follow-up Period|Withdrawal by Subject|3|||
38036994|NCT00104650|69724566|FG002|Follow-up Period|Withdrawal by Subject|3|||
38036995|NCT00104650|69724564|FG000|Follow-up Period|Death|6|||
38036996|NCT00104650|69724565|FG001|Follow-up Period|Death|6|||
38036997|NCT00104650|69724566|FG002|Follow-up Period|Death|4|||
38036998|NCT00104650|69724564|FG000|Follow-up Period|Disease progression|3|||
38036999|NCT00104650|69724565|FG001|Follow-up Period|Disease progression|1|||
38037000|NCT00104650|69724566|FG002|Follow-up Period|Disease progression|0|||
38037001|NCT00104650|69724564|FG000|Follow-up Period|Lost to Follow-up|0|||
38037002|NCT00104650|69724565|FG001|Follow-up Period|Lost to Follow-up|1|||
38037003|NCT00104650|69724566|FG002|Follow-up Period|Lost to Follow-up|2|||
38037004|NCT00104650|69724564|FG000|Follow-up Period|Other|0|||
38037005|NCT00104650|69724565|FG001|Follow-up Period|Other|1|||
38037006|NCT00104650|69724566|FG002|Follow-up Period|Other|0|||
38037007|NCT03732807|69724581|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
38037008|NCT03732807|69724582|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
38037009|NCT03732807|69724583|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
38037010|NCT03732807|69724584|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
38037011|NCT03732807|69724585|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
38037012|NCT03732807|69724586|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
38037013|NCT03732807|69724587|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
38037014|NCT03732807|69724581|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
38037015|NCT03732807|69724582|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
38037016|NCT03732807|69724583|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
38037017|NCT03732807|69724584|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
38037018|NCT03732807|69724585|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
38037019|NCT03732807|69724586|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
38037020|NCT03732807|69724587|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
38037021|NCT03732807|69724581|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
38037022|NCT03732807|69724582|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
38037023|NCT03732807|69724583|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
38037024|NCT03732807|69724584|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
38037025|NCT03732807|69724585|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
38037026|NCT03732807|69724586|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
38037027|NCT03732807|69724587|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
38037028|NCT03732807|69724581|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
38037029|NCT03732807|69724582|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
38037030|NCT03732807|69724583|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
38037031|NCT03732807|69724584|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
38037032|NCT03732807|69724585|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
38037033|NCT03732807|69724586|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
38037034|NCT03732807|69724587|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
38037035|NCT03732807|69724581|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
38037036|NCT03732807|69724582|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
38037037|NCT03732807|69724583|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
38037038|NCT03732807|69724584|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
38037039|NCT03732807|69724585|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
38037040|NCT03732807|69724586|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
38037041|NCT03732807|69724587|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
38037042|NCT03732807|69724581|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
38037043|NCT03732807|69724582|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
38037044|NCT03732807|69724583|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
38037045|NCT03732807|69724584|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
38037046|NCT03732807|69724585|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
38037047|NCT03732807|69724586|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
38037048|NCT03732807|69724587|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
38037049|NCT03732807|69724581|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
38037050|NCT03732807|69724582|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
38037051|NCT03732807|69724583|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
38037052|NCT03732807|69724584|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
38037053|NCT03732807|69724585|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
38037054|NCT03732807|69724586|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
38037055|NCT03732807|69724587|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
37766373|NCT01408303|69280360|FG000|Overall Study|Noncompliance|1|||
38037056|NCT03732807|69724581|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
38037057|NCT03732807|69724582|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
37766374|NCT01408303|69280361|FG001|Overall Study|Noncompliance|0|||
38037058|NCT03732807|69724583|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
38037059|NCT03732807|69724584|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
38037060|NCT03732807|69724585|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
38037061|NCT03732807|69724586|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
38037062|NCT03732807|69724587|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
38037063|NCT03732807|69724581|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
38037064|NCT03732807|69724582|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
38037065|NCT03732807|69724583|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
38037066|NCT03732807|69724584|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
38037067|NCT03732807|69724585|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
38037068|NCT03732807|69724586|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
38037069|NCT03732807|69724587|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
38037070|NCT03732807|69724581|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
38037071|NCT03732807|69724582|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
38037072|NCT03732807|69724583|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
38037073|NCT03732807|69724584|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
38037074|NCT03732807|69724585|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
38037075|NCT03732807|69724586|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
38037076|NCT03732807|69724587|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
38037077|NCT03732807|69724581|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
38037078|NCT03732807|69724582|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
38037079|NCT03732807|69724583|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
38037080|NCT03732807|69724584|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
38037081|NCT03732807|69724585|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
38037082|NCT03732807|69724586|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
38037083|NCT03732807|69724587|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
38037084|NCT03732807|69724581|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
38037085|NCT03732807|69724582|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
38037086|NCT03732807|69724583|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
38037087|NCT03732807|69724584|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
38037088|NCT03732807|69724585|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
38037089|NCT03732807|69724586|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
38037090|NCT03732807|69724587|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
38037091|NCT03732807|69724581|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
38037092|NCT03732807|69724582|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
38037093|NCT03732807|69724583|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
38037094|NCT03732807|69724584|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
38037095|NCT03732807|69724585|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
38037096|NCT03732807|69724586|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
38037097|NCT03732807|69724587|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
38037098|NCT03732807|69724581|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
38037099|NCT03732807|69724582|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
38037100|NCT03732807|69724583|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
38037101|NCT03732807|69724584|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
38037102|NCT03732807|69724585|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
38037103|NCT03732807|69724586|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
38037104|NCT03732807|69724587|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
38037105|NCT00104416|69724606|FG000|Double-Blind Phase|Adverse Event|2|||
38037106|NCT00104416|69724607|FG001|Double-Blind Phase|Adverse Event|1|||
38037107|NCT00104416|69724608|FG002|Double-Blind Phase|Adverse Event|0|||
38037108|NCT00104416|69724609|FG003|Double-Blind Phase|Adverse Event|0|||
38037109|NCT00104416|69724610|FG004|Double-Blind Phase|Adverse Event|0|||
38037110|NCT00104416|69724606|FG000|Double-Blind Phase|Lost to Follow-up|0|||
38037111|NCT00104416|69724607|FG001|Double-Blind Phase|Lost to Follow-up|1|||
38037112|NCT00104416|69724608|FG002|Double-Blind Phase|Lost to Follow-up|0|||
38037113|NCT00104416|69724609|FG003|Double-Blind Phase|Lost to Follow-up|0|||
38037114|NCT00104416|69724610|FG004|Double-Blind Phase|Lost to Follow-up|0|||
38037115|NCT00104416|69724606|FG000|Double-Blind Phase|Protocol Violation|0|||
38037116|NCT00104416|69724607|FG001|Double-Blind Phase|Protocol Violation|1|||
38037117|NCT00104416|69724608|FG002|Double-Blind Phase|Protocol Violation|0|||
38037118|NCT00104416|69724609|FG003|Double-Blind Phase|Protocol Violation|0|||
38037119|NCT00104416|69724610|FG004|Double-Blind Phase|Protocol Violation|0|||
38037120|NCT00104416|69724606|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
38037121|NCT00104416|69724607|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
38037122|NCT00104416|69724608|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
37766375|NCT01408303|69280362|FG002|Overall Study|Noncompliance|1|||
38037123|NCT00104416|69724609|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
38037124|NCT00104416|69724610|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
37766376|NCT01408147|69280383|FG000|Overall Study|Withdrawal by Subject|0|||
37944787|NCT00683618|69632261|FG001|Extension Treatment Period|Adverse Event|0|||
37944788|NCT00683618|69632262|FG002|Extension Treatment Period|Adverse Event|0|||
37944789|NCT00683618|69632260|FG000|Extension Treatment Period|Protocol Violation|1|||
37944790|NCT00683618|69632261|FG001|Extension Treatment Period|Protocol Violation|0|||
37944791|NCT00683618|69632262|FG002|Extension Treatment Period|Protocol Violation|0|||
37944792|NCT00688064|69632274|FG000|Overall Study|Protocol Violation|0|||
37944793|NCT00688064|69632275|FG001|Overall Study|Protocol Violation|1|||
37944794|NCT00688064|69632274|FG000|Overall Study|Adverse Event|2|||
37944795|NCT00688064|69632275|FG001|Overall Study|Adverse Event|4|||
37944796|NCT00688064|69632274|FG000|Overall Study|Withdrawal by Subject|7|||
37944797|NCT00688064|69632275|FG001|Overall Study|Withdrawal by Subject|7|||
37944798|NCT00688064|69632274|FG000|Overall Study|Lost to Follow-up|10|||
37944799|NCT00688064|69632275|FG001|Overall Study|Lost to Follow-up|10|||
37944800|NCT00688064|69632274|FG000|Overall Study|Lack of Efficacy|0|||
37944801|NCT00688064|69632275|FG001|Overall Study|Lack of Efficacy|1|||
37944802|NCT00688064|69632274|FG000|Overall Study|Pregnancy|1|||
37944803|NCT00688064|69632275|FG001|Overall Study|Pregnancy|0|||
37944804|NCT00688064|69632274|FG000|Overall Study|Any other reasons|1|||
37944805|NCT00688064|69632275|FG001|Overall Study|Any other reasons|3|||
37944806|NCT00663234|69632281|FG000|Overall Study|Not willing to adhere to requirements|1|||
37944807|NCT00683384|69632289|FG000|Overall Study|Death|1|||
37944808|NCT00683384|69632289|FG000|Overall Study|Adverse Event|1|||
37944809|NCT00326911|69632295|FG000|Overall Study|Hospitalization prior to treatment|0|||
37944810|NCT00326911|69632296|FG001|Overall Study|Hospitalization prior to treatment|1|||
37944811|NCT00326911|69632295|FG000|Overall Study|Physician decision prior to treatment|1|||
37944812|NCT00326911|69632296|FG001|Overall Study|Physician decision prior to treatment|0|||
37944813|NCT00326911|69632295|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
37944814|NCT00326911|69632296|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
37944815|NCT00540436|69632302|FG000|First 12-Week Treatment Period|Adverse Event|1|||
37944816|NCT00540436|69632302|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
37944817|NCT00540436|69632302|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
37944818|NCT00540436|69632302|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
37944819|NCT00687440|69632306|FG000|Overall Study|Adverse Event|3|||
37944820|NCT00687440|69632306|FG000|Overall Study|Lost to Follow-up|3|||
37944821|NCT00687440|69632306|FG000|Overall Study|Lack of Efficacy|2|||
37944822|NCT00687440|69632306|FG000|Overall Study|Death|2|||
37944823|NCT00687440|69632306|FG000|Overall Study|Other|1|||
37944824|NCT00687440|69632306|FG000|Overall Study|Missing|1|||
37944825|NCT00659490|69632313|FG000|Overall Study|Lost to Follow-up|2|||
37944826|NCT00659490|69632314|FG001|Overall Study|Lost to Follow-up|0|||
37944827|NCT00659490|69632315|FG002|Overall Study|Lost to Follow-up|1|||
37944828|NCT00539500|69632323|FG000|Overall Study|Disease Progression|1|||
37944829|NCT00539500|69632323|FG000|Overall Study|Lost to Follow-up|2|||
37944830|NCT00662532|69632329|FG000|Overall Study|Adverse Event|0|||
37944831|NCT00662532|69632330|FG001|Overall Study|Adverse Event|1|||
37944832|NCT00662532|69632329|FG000|Overall Study|Lost to Follow-up|0|||
37944833|NCT00662532|69632330|FG001|Overall Study|Lost to Follow-up|1|||
37944834|NCT00686036|69632338|FG000|Overall Study|Adverse Event|3|||
37944835|NCT00686036|69632339|FG001|Overall Study|Adverse Event|0|||
37944836|NCT00686036|69632338|FG000|Overall Study|Withdrawal by Subject|3|||
37944837|NCT00686036|69632339|FG001|Overall Study|Withdrawal by Subject|1|||
37944838|NCT00686036|69632338|FG000|Overall Study|Study terminated by AstraZeneca|2|||
37944839|NCT00686036|69632339|FG001|Overall Study|Study terminated by AstraZeneca|1|||
37944840|NCT00686036|69632338|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
37944841|NCT00686036|69632339|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
37944842|NCT00686036|69632338|FG000|Overall Study|Other reasons not identified|0|||
37944843|NCT00686036|69632339|FG001|Overall Study|Other reasons not identified|4|||
37944844|NCT00682448|69632347|FG000|Overall Study|Adverse Event|1|||
37944845|NCT00682448|69632348|FG001|Overall Study|Adverse Event|2|||
37944846|NCT00682448|69632347|FG000|Overall Study|Lack of Efficacy|1|||
37944847|NCT00682448|69632348|FG001|Overall Study|Lack of Efficacy|0|||
37944848|NCT00682448|69632347|FG000|Overall Study|Lost to Follow-up|1|||
37944849|NCT00682448|69632348|FG001|Overall Study|Lost to Follow-up|3|||
37944850|NCT00682448|69632347|FG000|Overall Study|Pregnancy|0|||
37944851|NCT00682448|69632348|FG001|Overall Study|Pregnancy|1|||
37944852|NCT00682448|69632347|FG000|Overall Study|Withdrawal by Subject|2|||
37944853|NCT00682448|69632348|FG001|Overall Study|Withdrawal by Subject|0|||
37944854|NCT00681824|69632357|FG000|Overall Study|withdrawn by investigator|0|||
37944855|NCT00681824|69632358|FG001|Overall Study|withdrawn by investigator|0|||
37944856|NCT00681824|69632359|FG002|Overall Study|withdrawn by investigator|1|||
37944857|NCT00681824|69632357|FG000|Overall Study|scheduling conflict|1|||
37944858|NCT00681824|69632358|FG001|Overall Study|scheduling conflict|0|||
37944859|NCT00681824|69632359|FG002|Overall Study|scheduling conflict|0|||
37944860|NCT00681824|69632357|FG000|Overall Study|Death|0|||
37944861|NCT00681824|69632358|FG001|Overall Study|Death|1|||
37944862|NCT00681824|69632359|FG002|Overall Study|Death|0|||
37944863|NCT00681668|69632367|FG000|Overall Study|Protocol Violation|1|||
38037125|NCT00104416|69724606|FG000|Double-Blind Phase|Pregnancy|1|||
38037126|NCT00104416|69724607|FG001|Double-Blind Phase|Pregnancy|0|||
38037127|NCT00104416|69724608|FG002|Double-Blind Phase|Pregnancy|0|||
38037128|NCT00104416|69724609|FG003|Double-Blind Phase|Pregnancy|0|||
38037129|NCT00104416|69724610|FG004|Double-Blind Phase|Pregnancy|0|||
38037130|NCT00104416|69724606|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
38037131|NCT00104416|69724607|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
38037132|NCT00104416|69724608|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
38037133|NCT00104416|69724609|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
38037134|NCT00104416|69724610|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
38037135|NCT00104416|69724606|FG000|Continuation Phase|Adverse Event|0|||
38037136|NCT00104416|69724607|FG001|Continuation Phase|Adverse Event|0|||
38037137|NCT00104416|69724608|FG002|Continuation Phase|Adverse Event|2|||
38037138|NCT00104416|69724609|FG003|Continuation Phase|Adverse Event|0|||
38037139|NCT00104416|69724610|FG004|Continuation Phase|Adverse Event|2|||
38037140|NCT00104416|69724606|FG000|Continuation Phase|Lost to Follow-up|0|||
38037141|NCT00104416|69724607|FG001|Continuation Phase|Lost to Follow-up|0|||
38037142|NCT00104416|69724608|FG002|Continuation Phase|Lost to Follow-up|1|||
38037143|NCT00104416|69724609|FG003|Continuation Phase|Lost to Follow-up|0|||
38037144|NCT00104416|69724610|FG004|Continuation Phase|Lost to Follow-up|1|||
38037145|NCT00104416|69724606|FG000|Continuation Phase|Withdrawal by Subject|0|||
38037146|NCT00104416|69724607|FG001|Continuation Phase|Withdrawal by Subject|0|||
38037147|NCT00104416|69724608|FG002|Continuation Phase|Withdrawal by Subject|2|||
38037148|NCT00104416|69724609|FG003|Continuation Phase|Withdrawal by Subject|1|||
38037149|NCT00104416|69724610|FG004|Continuation Phase|Withdrawal by Subject|1|||
38037150|NCT00104416|69724606|FG000|Continuation Phase|Pregnancy|0|||
38037151|NCT00104416|69724607|FG001|Continuation Phase|Pregnancy|0|||
38037152|NCT00104416|69724608|FG002|Continuation Phase|Pregnancy|1|||
38037153|NCT00104416|69724609|FG003|Continuation Phase|Pregnancy|1|||
38037154|NCT00104416|69724610|FG004|Continuation Phase|Pregnancy|0|||
38037155|NCT00104416|69724606|FG000|Continuation Phase|Non-compliance|0|||
38037156|NCT00104416|69724607|FG001|Continuation Phase|Non-compliance|0|||
38037157|NCT00104416|69724608|FG002|Continuation Phase|Non-compliance|0|||
38037158|NCT00104416|69724609|FG003|Continuation Phase|Non-compliance|0|||
38037159|NCT00104416|69724610|FG004|Continuation Phase|Non-compliance|1|||
38037160|NCT03639987|69724624|FG000|Overall Study|Study terminated by sponsor|26|||
38037161|NCT03639987|69724625|FG001|Overall Study|Study terminated by sponsor|25|||
38037162|NCT03639987|69724624|FG000|Overall Study|Lost to Follow-up|0|||
38037163|NCT03639987|69724625|FG001|Overall Study|Lost to Follow-up|1|||
38037164|NCT02766088|69724631|FG000|Overall Study|Sponsor study termination|498|||
38037165|NCT02766088|69724631|FG000|Overall Study|Migrated/moved from the study area|1|||
37766377|NCT01408147|69280384|FG001|Overall Study|Withdrawal by Subject|1|||
37944864|NCT00681668|69632367|FG000|Overall Study|Withdrawal by Subject|1|||
37944865|NCT00539188|69632373|FG000|Overall Study|Withdrawal by Subject|1|||
37944866|NCT00539188|69632374|FG001|Overall Study|Withdrawal by Subject|0|||
37944867|NCT00539188|69632373|FG000|Overall Study|Lost to Follow-up|2|||
37944868|NCT00539188|69632374|FG001|Overall Study|Lost to Follow-up|1|||
37944869|NCT00681590|69632382|FG000|Overall Study|Withdrawal by Subject|2|||
37944870|NCT00681590|69632383|FG001|Overall Study|Withdrawal by Subject|12|||
37944871|NCT04980456|69632391|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
37944872|NCT04980456|69632392|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
37944873|NCT04980456|69632391|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
37944874|NCT04980456|69632392|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
37944875|NCT04980456|69632391|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
37944876|NCT04980456|69632392|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
37944877|NCT04980456|69632391|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
37944878|NCT04980456|69632392|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
37944879|NCT00326599|69632405|FG000|Overall Study|Withdrawal by Subject|1|||
37944880|NCT00326599|69632406|FG001|Overall Study|Withdrawal by Subject|0|||
37944881|NCT00326599|69632407|FG002|Overall Study|Withdrawal by Subject|5|||
37944882|NCT00326599|69632408|FG003|Overall Study|Withdrawal by Subject|2|||
37944883|NCT00326599|69632405|FG000|Overall Study|Adverse Event|1|||
37944884|NCT00326599|69632406|FG001|Overall Study|Adverse Event|0|||
37944885|NCT00326599|69632407|FG002|Overall Study|Adverse Event|32|||
37944886|NCT00326599|69632408|FG003|Overall Study|Adverse Event|3|||
37944887|NCT00326599|69632405|FG000|Overall Study|Disease Progression|3|||
38037166|NCT02766088|69724631|FG000|Overall Study|Lost to Follow-up|5|||
38037167|NCT02766088|69724631|FG000|Overall Study|Other|1|||
38037168|NCT02766088|69724631|FG000|Overall Study|Death|1|||
38037169|NCT03639675|69724635|FG000|Overall Study|Withdrawal by Subject|1|||
38037170|NCT03635775|69724643|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
38037171|NCT03635775|69724644|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
38037172|NCT03635775|69724645|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
37944888|NCT00326599|69632406|FG001|Overall Study|Disease Progression|1|||
38037173|NCT03635775|69724646|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
38037174|NCT03610581|69724658|FG000|Overall Study|Study terminated by sponsor|2|||
38037175|NCT03610581|69724659|FG001|Overall Study|Study terminated by sponsor|0|||
38037176|NCT03610581|69724658|FG000|Overall Study|Other|0|||
38037177|NCT03610581|69724659|FG001|Overall Study|Other|1|||
38037178|NCT03610581|69724658|FG000|Overall Study|Withdrawal by Subject|1|||
38037179|NCT03610581|69724659|FG001|Overall Study|Withdrawal by Subject|0|||
38037180|NCT03610269|69724665|FG000|Overall Study|Physician Decision|10|||
38037181|NCT03610269|69724665|FG000|Overall Study|Protocol Violation|1|||
38037182|NCT03610269|69724665|FG000|Overall Study|Unable to draw blood|1|||
38037183|NCT03610269|69724665|FG000|Overall Study|Screen fail|4|||
38037184|NCT00121667|69724673|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
38037185|NCT00121667|69724674|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
38037186|NCT00121667|69724675|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
38037187|NCT00121667|69724676|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
38037188|NCT00121667|69724673|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
38037189|NCT00121667|69724674|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
38037190|NCT00121667|69724675|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
38037191|NCT00121667|69724676|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
38037192|NCT00121667|69724673|FG000|Short Term (ST) Period|Adverse Event|5|||
38037193|NCT00121667|69724674|FG001|Short Term (ST) Period|Adverse Event|6|||
38037194|NCT00121667|69724675|FG002|Short Term (ST) Period|Adverse Event|5|||
38037195|NCT00121667|69724676|FG003|Short Term (ST) Period|Adverse Event|3|||
38037196|NCT00121667|69724673|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
38037197|NCT00121667|69724674|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
38037198|NCT00121667|69724675|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
38037199|NCT00121667|69724676|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
38037200|NCT00121667|69724673|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
38037201|NCT00121667|69724674|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
38037202|NCT00121667|69724675|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
38037203|NCT00121667|69724676|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
38037204|NCT00121667|69724673|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
38037205|NCT00121667|69724674|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
38037206|NCT00121667|69724675|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
38037207|NCT00121667|69724676|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
38037208|NCT00121667|69724673|FG000|Short Term (ST) Period|Other Reason|3|||
38037209|NCT00121667|69724674|FG001|Short Term (ST) Period|Other Reason|0|||
38037210|NCT00121667|69724675|FG002|Short Term (ST) Period|Other Reason|0|||
38037211|NCT00121667|69724676|FG003|Short Term (ST) Period|Other Reason|0|||
38037212|NCT00121667|69724673|FG000|Short Term (ST) Period|Death|0|||
38037213|NCT00121667|69724674|FG001|Short Term (ST) Period|Death|0|||
38037214|NCT00121667|69724675|FG002|Short Term (ST) Period|Death|0|||
38037215|NCT00121667|69724676|FG003|Short Term (ST) Period|Death|1|||
38037216|NCT00121667|69724673|FG000|Short Term (ST) Period|Pregnancy|0|||
38037217|NCT00121667|69724674|FG001|Short Term (ST) Period|Pregnancy|0|||
38037218|NCT00121667|69724675|FG002|Short Term (ST) Period|Pregnancy|0|||
38037219|NCT00121667|69724676|FG003|Short Term (ST) Period|Pregnancy|1|||
38037220|NCT00121667|69724673|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
38037221|NCT00121667|69724674|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
38037222|NCT00121667|69724675|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
38037223|NCT00121667|69724676|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
38037224|NCT00121667|69724673|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
38037225|NCT00121667|69724674|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
38037226|NCT00121667|69724675|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
37944889|NCT00326599|69632407|FG002|Overall Study|Disease Progression|13|||
37944890|NCT00326599|69632408|FG003|Overall Study|Disease Progression|11|||
37944891|NCT00326599|69632405|FG000|Overall Study|Alternate Treatment|1|||
37944892|NCT00326599|69632406|FG001|Overall Study|Alternate Treatment|0|||
37944893|NCT00326599|69632407|FG002|Overall Study|Alternate Treatment|0|||
37944894|NCT00326599|69632408|FG003|Overall Study|Alternate Treatment|0|||
37944895|NCT00326599|69632405|FG000|Overall Study|Death|0|||
37944896|NCT00326599|69632406|FG001|Overall Study|Death|0|||
37944897|NCT00326599|69632407|FG002|Overall Study|Death|1|||
37944898|NCT00326599|69632408|FG003|Overall Study|Death|2|||
37673274|NCT03805841|69147500|FG001|Overall Study|Withdrawal by Subject|3|||
38037227|NCT00121667|69724676|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
38037228|NCT00121667|69724673|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
38037229|NCT00121667|69724674|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
38037230|NCT00121667|69724675|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
38037231|NCT00121667|69724676|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
38037232|NCT00121667|69724673|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
38037233|NCT00121667|69724674|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
38037234|NCT00121667|69724675|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
37944899|NCT00326599|69632405|FG000|Overall Study|Other Unspecified Reason|0|||
38037235|NCT00121667|69724676|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
38037236|NCT00121667|69724673|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
38037237|NCT00121667|69724674|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
38037238|NCT00121667|69724675|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
38037239|NCT00121667|69724676|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
38037240|NCT00121667|69724673|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
38037241|NCT00121667|69724674|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
38037242|NCT00121667|69724675|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
38037243|NCT00121667|69724676|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
38037244|NCT00121667|69724673|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
38037245|NCT00121667|69724674|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
38037246|NCT00121667|69724675|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
38037247|NCT00121667|69724676|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
38037248|NCT00121667|69724673|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
38037249|NCT00121667|69724674|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
38037250|NCT00121667|69724675|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
38037251|NCT00121667|69724676|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
38037252|NCT00121667|69724673|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
38037253|NCT00121667|69724674|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
38037254|NCT00121667|69724675|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
38037255|NCT00121667|69724676|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
38037256|NCT02954601|69724690|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
38037257|NCT02954601|69724691|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
38037258|NCT02954601|69724692|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
38037259|NCT02954601|69724693|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
38037260|NCT03633903|69724705|FG000|Overall Study|Withdrawal by Subject|1|||
38037261|NCT03633903|69724706|FG001|Overall Study|Withdrawal by Subject|2|||
38037262|NCT03633903|69724705|FG000|Overall Study|Lost to Follow-up|5|||
38037263|NCT03633903|69724706|FG001|Overall Study|Lost to Follow-up|5|||
38037264|NCT03607695|69724712|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
38037265|NCT03607695|69724712|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
38037266|NCT03557775|69724719|FG000|Overall Study|Withdrawal by Subject|1|||
38037267|NCT03557775|69724720|FG001|Overall Study|Withdrawal by Subject|2|||
38037268|NCT03557775|69724721|FG002|Overall Study|Withdrawal by Subject|4|||
38037269|NCT03557775|69724719|FG000|Overall Study|Physician Decision|0|||
38037270|NCT03557775|69724720|FG001|Overall Study|Physician Decision|1|||
38037271|NCT03557775|69724721|FG002|Overall Study|Physician Decision|0|||
38037272|NCT00121199|69724729|FG000|Overall Study|Adverse Event|11|||
38037273|NCT00121199|69724729|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
38037274|NCT00121199|69724729|FG000|Overall Study|Progression/Relapse|1|||
38037275|NCT00121199|69724729|FG000|Overall Study|Death|3|||
38037276|NCT00121199|69724729|FG000|Overall Study|Other - Not Protocol Specified|3|||
38037277|NCT00121199|69724729|FG000|Overall Study|Ineligible|9|||
38037278|NCT00119405|69724733|FG000|Overall Study|Withdrawal by Subject|1|||
38037279|NCT00119015|69724739|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
38037280|NCT00119015|69724740|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
38037281|NCT00119015|69724741|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
38037282|NCT01981850|69724754|FG000|Main Phase Stage 1|Death|2|||
38037283|NCT01981850|69724755|FG001|Main Phase Stage 1|Death|0|||
38037284|NCT01981850|69724756|FG002|Main Phase Stage 1|Death|0|||
38037285|NCT01981850|69724757|FG003|Main Phase Stage 1|Death|0|||
38037286|NCT01981850|69724758|FG004|Main Phase Stage 1|Death|0|||
38037287|NCT01981850|69724759|FG005|Main Phase Stage 1|Death|0|||
38037288|NCT01981850|69724760|FG006|Main Phase Stage 1|Death|0|||
38037289|NCT01981850|69724761|FG007|Main Phase Stage 1|Death|0|||
38037290|NCT01981850|69724762|FG008|Main Phase Stage 1|Death|0|||
38037291|NCT01981850|69724763|FG009|Main Phase Stage 1|Death|0|||
38037292|NCT01981850|69724754|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
38037293|NCT01981850|69724755|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
38037294|NCT01981850|69724756|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
38037295|NCT01981850|69724757|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
38037296|NCT01981850|69724758|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
38037297|NCT01981850|69724759|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
38037298|NCT01981850|69724760|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
38037299|NCT01981850|69724761|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
38037300|NCT01981850|69724762|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
38037301|NCT01981850|69724763|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
38037302|NCT01981850|69724754|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
38037303|NCT01981850|69724755|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
38037304|NCT01981850|69724756|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
38037305|NCT01981850|69724757|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
38037306|NCT01981850|69724758|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
38037307|NCT01981850|69724759|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
38037308|NCT01981850|69724760|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
38037309|NCT01981850|69724761|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
38037310|NCT01981850|69724762|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
38037311|NCT01981850|69724763|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
38037312|NCT01981850|69724754|FG000|Main Phase Stage 1|Various reasons|0|||
38037313|NCT01981850|69724755|FG001|Main Phase Stage 1|Various reasons|0|||
38037314|NCT01981850|69724756|FG002|Main Phase Stage 1|Various reasons|2|||
38037315|NCT01981850|69724757|FG003|Main Phase Stage 1|Various reasons|0|||
38037316|NCT01981850|69724758|FG004|Main Phase Stage 1|Various reasons|0|||
38037317|NCT01981850|69724759|FG005|Main Phase Stage 1|Various reasons|0|||
38037318|NCT01981850|69724760|FG006|Main Phase Stage 1|Various reasons|0|||
38037319|NCT01981850|69724761|FG007|Main Phase Stage 1|Various reasons|0|||
38037320|NCT01981850|69724762|FG008|Main Phase Stage 1|Various reasons|0|||
38037321|NCT01981850|69724763|FG009|Main Phase Stage 1|Various reasons|0|||
38037322|NCT01981850|69724754|FG000|Main Phase Stage 2|Adverse Event|0|||
38037323|NCT01981850|69724755|FG001|Main Phase Stage 2|Adverse Event|0|||
38037324|NCT01981850|69724756|FG002|Main Phase Stage 2|Adverse Event|0|||
38037325|NCT01981850|69724757|FG003|Main Phase Stage 2|Adverse Event|0|||
38037326|NCT01981850|69724758|FG004|Main Phase Stage 2|Adverse Event|6|||
38037327|NCT01981850|69724759|FG005|Main Phase Stage 2|Adverse Event|5|||
38037328|NCT01981850|69724760|FG006|Main Phase Stage 2|Adverse Event|7|||
38037329|NCT01981850|69724761|FG007|Main Phase Stage 2|Adverse Event|0|||
38037330|NCT01981850|69724762|FG008|Main Phase Stage 2|Adverse Event|0|||
38037331|NCT01981850|69724763|FG009|Main Phase Stage 2|Adverse Event|0|||
38037332|NCT01981850|69724754|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
38037333|NCT01981850|69724755|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
38037334|NCT01981850|69724756|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
38037335|NCT01981850|69724757|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
38037336|NCT01981850|69724758|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
38037337|NCT01981850|69724759|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
38037338|NCT01981850|69724760|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
38037339|NCT01981850|69724761|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
38037340|NCT01981850|69724762|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
38037341|NCT01981850|69724763|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
38037342|NCT01981850|69724754|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
38037343|NCT01981850|69724755|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
38037344|NCT01981850|69724756|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
38037345|NCT01981850|69724757|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
38037346|NCT01981850|69724758|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
38037347|NCT01981850|69724759|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
38037348|NCT01981850|69724760|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
38037349|NCT01981850|69724761|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
38037350|NCT01981850|69724762|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
38037351|NCT01981850|69724763|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
38037352|NCT01981850|69724754|FG000|Main Phase Stage 2|Various reasons|0|||
38037353|NCT01981850|69724755|FG001|Main Phase Stage 2|Various reasons|0|||
38037354|NCT01981850|69724756|FG002|Main Phase Stage 2|Various reasons|0|||
38037355|NCT01981850|69724757|FG003|Main Phase Stage 2|Various reasons|0|||
38037356|NCT01981850|69724758|FG004|Main Phase Stage 2|Various reasons|2|||
38037357|NCT01981850|69724759|FG005|Main Phase Stage 2|Various reasons|0|||
38037358|NCT01981850|69724760|FG006|Main Phase Stage 2|Various reasons|1|||
38037359|NCT01981850|69724761|FG007|Main Phase Stage 2|Various reasons|0|||
38037360|NCT01981850|69724762|FG008|Main Phase Stage 2|Various reasons|0|||
38037361|NCT01981850|69724763|FG009|Main Phase Stage 2|Various reasons|0|||
38037362|NCT01981850|69724754|FG000|Main Phase Stage 2|Progressive Disease|0|||
38037363|NCT01981850|69724755|FG001|Main Phase Stage 2|Progressive Disease|0|||
38037364|NCT01981850|69724756|FG002|Main Phase Stage 2|Progressive Disease|0|||
38037365|NCT01981850|69724757|FG003|Main Phase Stage 2|Progressive Disease|0|||
38037366|NCT01981850|69724758|FG004|Main Phase Stage 2|Progressive Disease|0|||
38037367|NCT01981850|69724759|FG005|Main Phase Stage 2|Progressive Disease|6|||
38037368|NCT01981850|69724760|FG006|Main Phase Stage 2|Progressive Disease|6|||
38037369|NCT01981850|69724761|FG007|Main Phase Stage 2|Progressive Disease|0|||
37766378|NCT01407367|69280392|FG000|Overall Study|Death|24|||
38037370|NCT01981850|69724762|FG008|Main Phase Stage 2|Progressive Disease|0|||
38037371|NCT01981850|69724763|FG009|Main Phase Stage 2|Progressive Disease|0|||
38037372|NCT01981850|69724754|FG000|Open Label Extension (OLE)|Adverse Event|0|||
38037373|NCT01981850|69724755|FG001|Open Label Extension (OLE)|Adverse Event|0|||
38037374|NCT01981850|69724756|FG002|Open Label Extension (OLE)|Adverse Event|0|||
38037375|NCT01981850|69724757|FG003|Open Label Extension (OLE)|Adverse Event|0|||
38037376|NCT01981850|69724758|FG004|Open Label Extension (OLE)|Adverse Event|0|||
38037377|NCT01981850|69724759|FG005|Open Label Extension (OLE)|Adverse Event|0|||
38037378|NCT01981850|69724760|FG006|Open Label Extension (OLE)|Adverse Event|0|||
38037379|NCT01981850|69724761|FG007|Open Label Extension (OLE)|Adverse Event|2|||
38037380|NCT01981850|69724762|FG008|Open Label Extension (OLE)|Adverse Event|1|||
38037381|NCT01981850|69724763|FG009|Open Label Extension (OLE)|Adverse Event|8|||
38037382|NCT01981850|69724754|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
38037383|NCT01981850|69724755|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
38037384|NCT01981850|69724756|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
38037385|NCT01981850|69724757|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
38037386|NCT01981850|69724758|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
38037387|NCT01981850|69724759|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
38037388|NCT01981850|69724760|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
38037389|NCT01981850|69724761|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
38037390|NCT01981850|69724762|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
38037391|NCT01981850|69724763|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
38037392|NCT01981850|69724754|FG000|Open Label Extension (OLE)|Various reasons|0|||
38037393|NCT01981850|69724755|FG001|Open Label Extension (OLE)|Various reasons|0|||
38037394|NCT01981850|69724756|FG002|Open Label Extension (OLE)|Various reasons|0|||
38037395|NCT01981850|69724757|FG003|Open Label Extension (OLE)|Various reasons|0|||
38037396|NCT01981850|69724758|FG004|Open Label Extension (OLE)|Various reasons|0|||
38037397|NCT01981850|69724759|FG005|Open Label Extension (OLE)|Various reasons|0|||
38037398|NCT01981850|69724760|FG006|Open Label Extension (OLE)|Various reasons|0|||
38037399|NCT01981850|69724761|FG007|Open Label Extension (OLE)|Various reasons|3|||
38037400|NCT01981850|69724762|FG008|Open Label Extension (OLE)|Various reasons|1|||
38037401|NCT01981850|69724763|FG009|Open Label Extension (OLE)|Various reasons|3|||
38037402|NCT01981850|69724754|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
38037403|NCT01981850|69724755|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
38037404|NCT01981850|69724756|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
38037405|NCT01981850|69724757|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
38037406|NCT01981850|69724758|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
38037407|NCT01981850|69724759|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
38037408|NCT01981850|69724760|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
38037409|NCT01981850|69724761|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
38037410|NCT01981850|69724762|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
38037411|NCT01981850|69724763|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
38037412|NCT01981850|69724754|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
38037413|NCT01981850|69724755|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
38037414|NCT01981850|69724756|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
38037415|NCT01981850|69724757|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
38037416|NCT01981850|69724758|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
38037417|NCT01981850|69724759|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
38037418|NCT01981850|69724760|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
38037419|NCT01981850|69724761|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
38037420|NCT01981850|69724762|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
38037421|NCT01981850|69724763|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
38037422|NCT01981850|69724754|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
38037423|NCT01981850|69724755|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
38037424|NCT01981850|69724756|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
38037425|NCT01981850|69724757|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
38037426|NCT01981850|69724758|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
38037427|NCT01981850|69724759|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
38037428|NCT01981850|69724760|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
38037429|NCT01981850|69724761|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
38037430|NCT01981850|69724762|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
38037431|NCT01981850|69724763|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
38037432|NCT03557307|69724795|FG000|Period 1: To End of OCS Reduction Phase|Withdrawal by Subject|10|||
38037433|NCT03557307|69724795|FG000|Period 1: To End of OCS Reduction Phase|Adverse Event|7|||
38037434|NCT03557307|69724795|FG000|Period 1: To End of OCS Reduction Phase|Protocol Violation|6|||
38037435|NCT03557307|69724795|FG000|Period 1: To End of OCS Reduction Phase|Lost to Follow-up|5|||
38037436|NCT03557307|69724795|FG000|Period 1: To End of OCS Reduction Phase|other|3|||
38037437|NCT03557307|69724795|FG000|Period 1: To End of OCS Reduction Phase|Death|2|||
38037438|NCT03557307|69724795|FG000|Period 1: To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
38037439|NCT03557307|69724795|FG000|Period 2: Maintenance Phase|Adverse Event|4|||
38037440|NCT03557307|69724795|FG000|Period 2: Maintenance Phase|Death|3|||
38037441|NCT03557307|69724795|FG000|Period 2: Maintenance Phase|Lost to Follow-up|2|||
38037442|NCT03557307|69724795|FG000|Period 2: Maintenance Phase|Pregnancy|2|||
38037443|NCT03557307|69724795|FG000|Period 2: Maintenance Phase|Protocol Violation|11|||
38037444|NCT03557307|69724795|FG000|Period 2: Maintenance Phase|Withdrawal by Subject|2|||
38037445|NCT03557307|69724795|FG000|Period 2: Maintenance Phase|other|3|||
38037446|NCT00118703|69724807|FG000|Overall Study|Protocol Violation|1|||
38037447|NCT00118703|69724808|FG001|Overall Study|Protocol Violation|0|||
38037448|NCT00118703|69724807|FG000|Overall Study|Adverse Event|1|||
38037449|NCT00118703|69724808|FG001|Overall Study|Adverse Event|1|||
38037450|NCT00118703|69724807|FG000|Overall Study|Participant took two different treatment|0|||
38037451|NCT00118703|69724808|FG001|Overall Study|Participant took two different treatment|1|||
38037452|NCT00118703|69724807|FG000|Overall Study|Withdrawal by Subject|2|||
38037453|NCT00118703|69724808|FG001|Overall Study|Withdrawal by Subject|5|||
38037454|NCT00118703|69724807|FG000|Overall Study|Lost to Follow-up|1|||
38037455|NCT00118703|69724808|FG001|Overall Study|Lost to Follow-up|2|||
38037456|NCT00104104|69724816|FG000|Overall Study|Adverse Event|8|||
38037457|NCT00104104|69724817|FG001|Overall Study|Adverse Event|8|||
38037458|NCT00104104|69724816|FG000|Overall Study|Abnormal laboratory value(s)|20|||
38037459|NCT00104104|69724817|FG001|Overall Study|Abnormal laboratory value(s)|14|||
38037460|NCT00104104|69724816|FG000|Overall Study|Lack of Efficacy|0|||
38037461|NCT00104104|69724817|FG001|Overall Study|Lack of Efficacy|3|||
38037462|NCT00104104|69724816|FG000|Overall Study|Condition no longer requires study drug|7|||
38037463|NCT00104104|69724817|FG001|Overall Study|Condition no longer requires study drug|4|||
38037464|NCT00104104|69724816|FG000|Overall Study|Protocol Violation|5|||
38037465|NCT00104104|69724817|FG001|Overall Study|Protocol Violation|2|||
38037466|NCT00104104|69724816|FG000|Overall Study|Withdrawal by Subject|11|||
38037467|NCT00104104|69724817|FG001|Overall Study|Withdrawal by Subject|15|||
38037468|NCT00104104|69724816|FG000|Overall Study|Lost to Follow-up|3|||
38037469|NCT00104104|69724817|FG001|Overall Study|Lost to Follow-up|7|||
38037470|NCT00104104|69724816|FG000|Overall Study|Administrative problems|12|||
38037471|NCT00104104|69724817|FG001|Overall Study|Administrative problems|13|||
38037472|NCT00104104|69724816|FG000|Overall Study|Death|9|||
38037473|NCT00104104|69724817|FG001|Overall Study|Death|6|||
38037474|NCT03557151|69724825|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
38037475|NCT03557151|69724826|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
38037476|NCT03557151|69724825|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
38037477|NCT03557151|69724826|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
38037478|NCT03557151|69724825|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
38037479|NCT03557151|69724826|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
38037480|NCT00115739|69724834|FG000|Overall Study|Lost to Follow-up|3|||
38037481|NCT01347086|69724850|FG000|Overall Study|failed screening visit|0|||
38037482|NCT01347086|69724851|FG001|Overall Study|failed screening visit|0|||
38037483|NCT01347086|69724852|FG002|Overall Study|failed screening visit|1|||
38037484|NCT01347086|69724853|FG003|Overall Study|failed screening visit|0|||
38037485|NCT01347086|69724854|FG004|Overall Study|failed screening visit|0|||
38037486|NCT01347086|69724855|FG005|Overall Study|failed screening visit|0|||
38037487|NCT01347086|69724856|FG006|Overall Study|failed screening visit|1|||
38037488|NCT01347086|69724857|FG007|Overall Study|failed screening visit|1|||
38037489|NCT01347086|69724858|FG008|Overall Study|failed screening visit|0|||
38037490|NCT01347086|69724859|FG009|Overall Study|failed screening visit|1|||
38037491|NCT03605745|69724891|FG000|Overall Study|Study was terminated for business reasons|47|||
38037492|NCT03246152|69724895|FG000|Overall Study|Lost to Follow-up|2|||
38037493|NCT03246152|69724895|FG000|Overall Study|Protocol Violation|1|||
38037494|NCT03571581|69724899|FG000|Overall Study|Death|2|||
38037495|NCT03571581|69724899|FG000|Overall Study|Withdrawal by Subject|2|||
38037496|NCT00115349|69724908|FG000|Overall Study|Study closed due to low enrollment.|11|||
38037497|NCT00115349|69724909|FG001|Overall Study|Study closed due to low enrollment.|9|||
38037498|NCT00115037|69724917|FG000|Phase1|Lost to Follow-up|16|||
38037499|NCT00115037|69724918|FG001|Phase1|Lost to Follow-up|23|||
38037500|NCT00115037|69724919|FG002|Phase1|Lost to Follow-up|0|||
38037501|NCT00115037|69724920|FG003|Phase1|Lost to Follow-up|0|||
38037502|NCT00115037|69724921|FG004|Phase1|Lost to Follow-up|0|||
38037503|NCT00115037|69724922|FG005|Phase1|Lost to Follow-up|0|||
38037504|NCT00115037|69724917|FG000|Phase1|Withdrawal by Subject|9|||
38037505|NCT00115037|69724918|FG001|Phase1|Withdrawal by Subject|4|||
38037506|NCT00115037|69724919|FG002|Phase1|Withdrawal by Subject|0|||
38037507|NCT00115037|69724920|FG003|Phase1|Withdrawal by Subject|0|||
38037508|NCT00115037|69724921|FG004|Phase1|Withdrawal by Subject|0|||
38037509|NCT00115037|69724922|FG005|Phase1|Withdrawal by Subject|0|||
38037510|NCT00115037|69724917|FG000|Phase2|Death|0|||
38037511|NCT00115037|69724918|FG001|Phase2|Death|0|||
38037512|NCT00115037|69724919|FG002|Phase2|Death|1|||
38037513|NCT00115037|69724920|FG003|Phase2|Death|0|||
38037514|NCT00115037|69724921|FG004|Phase2|Death|0|||
38037515|NCT00115037|69724922|FG005|Phase2|Death|1|||
38037516|NCT00115037|69724917|FG000|Phase2|Withdrawal by Subject|0|||
38037517|NCT00115037|69724918|FG001|Phase2|Withdrawal by Subject|0|||
38037518|NCT00115037|69724919|FG002|Phase2|Withdrawal by Subject|2|||
38037519|NCT00115037|69724920|FG003|Phase2|Withdrawal by Subject|1|||
38037520|NCT00115037|69724921|FG004|Phase2|Withdrawal by Subject|2|||
38037521|NCT00115037|69724922|FG005|Phase2|Withdrawal by Subject|1|||
38037522|NCT00115037|69724917|FG000|Phase2|Lost to Follow-up|0|||
38037523|NCT00115037|69724918|FG001|Phase2|Lost to Follow-up|0|||
38037524|NCT00115037|69724919|FG002|Phase2|Lost to Follow-up|12|||
38037525|NCT00115037|69724920|FG003|Phase2|Lost to Follow-up|14|||
38037526|NCT00115037|69724921|FG004|Phase2|Lost to Follow-up|4|||
38037527|NCT00115037|69724922|FG005|Phase2|Lost to Follow-up|10|||
38037528|NCT03214640|69724940|FG000|Overall Study|Protocol Violation|1|||
38037529|NCT03214640|69724941|FG001|Overall Study|Protocol Violation|2|||
38037530|NCT03214640|69724942|FG002|Overall Study|Protocol Violation|1|||
38037531|NCT03214640|69724943|FG003|Overall Study|Protocol Violation|4|||
38037532|NCT03214406|69724955|FG000|Overall Study|did not meet enrollment criteria|9|||
38037533|NCT03214406|69724956|FG001|Overall Study|did not meet enrollment criteria|13|||
38037534|NCT03214406|69724955|FG000|Overall Study|Withdrawal by Subject|1|||
38037535|NCT03214406|69724956|FG001|Overall Study|Withdrawal by Subject|0|||
38037536|NCT03214406|69724955|FG000|Overall Study|Lost to Follow-up|0|||
38037537|NCT03214406|69724956|FG001|Overall Study|Lost to Follow-up|2|||
38037538|NCT03213938|69724964|FG000|Overall Study|Lost to Follow-up|4|||
38037539|NCT03213938|69724965|FG001|Overall Study|Lost to Follow-up|3|||
38037540|NCT03213938|69724964|FG000|Overall Study|Lack of Efficacy|1|||
38037541|NCT03213938|69724965|FG001|Overall Study|Lack of Efficacy|0|||
38037542|NCT03213938|69724964|FG000|Overall Study|Decline to participate|5|||
38037543|NCT03213938|69724965|FG001|Overall Study|Decline to participate|4|||
38037544|NCT03213938|69724964|FG000|Overall Study|Without reason|4|||
38037545|NCT03213938|69724965|FG001|Overall Study|Without reason|5|||
38037546|NCT03604497|69724971|FG000|Overall Study|Protocol Violation|52|||
38037547|NCT03213626|69724979|FG000|Overall Study|Adverse Event|1|||
38037548|NCT03213626|69724979|FG000|Overall Study|Progressive Disease|6|||
38037549|NCT03604341|69724985|FG000|Overall Study|Withdrawal by Subject|1|||
38037550|NCT03604341|69724986|FG001|Overall Study|Withdrawal by Subject|1|||
38037551|NCT03604341|69724985|FG000|Overall Study|Adverse Event|1|||
38037552|NCT03604341|69724986|FG001|Overall Study|Adverse Event|0|||
38037553|NCT03604341|69724985|FG000|Overall Study|Protocol Violation|0|||
38037554|NCT03604341|69724986|FG001|Overall Study|Protocol Violation|1|||
38037555|NCT03603639|69724992|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
38037556|NCT03603639|69724993|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
38037557|NCT03603639|69724994|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
38037558|NCT03603639|69724995|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
38037559|NCT03603639|69724996|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
38037560|NCT03603639|69724997|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
38037561|NCT03603639|69724992|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
38037562|NCT03603639|69724993|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
38037563|NCT03603639|69724994|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
38037564|NCT03603639|69724995|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
38037565|NCT03603639|69724996|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
38037566|NCT03603639|69724997|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
38037567|NCT00114959|69725007|FG000|Overall Study|Lack of Efficacy|6|||
38037568|NCT00114959|69725007|FG000|Overall Study|Physician Decision|1|||
38037569|NCT00114959|69725007|FG000|Overall Study|Death|1|||
38037570|NCT02778100|69725013|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
38037571|NCT02778100|69725014|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
38037572|NCT00118157|69725022|FG000|Overall Study|Adverse Event|2|||
38037573|NCT00118157|69725022|FG000|Overall Study|Death|8|||
38037574|NCT00118157|69725022|FG000|Overall Study|Withdrawal by Subject|2|||
38037575|NCT02762500|69725029|FG000|Overall Study|Lack of Efficacy|1|||
38037576|NCT02762500|69725030|FG001|Overall Study|Lack of Efficacy|0|||
38037577|NCT02762500|69725029|FG000|Overall Study|Withdrawal by Subject|1|||
38037578|NCT02762500|69725030|FG001|Overall Study|Withdrawal by Subject|1|||
38037579|NCT02762500|69725029|FG000|Overall Study|Adverse Event|0|||
38037580|NCT02762500|69725030|FG001|Overall Study|Adverse Event|2|||
38037581|NCT03552549|69725038|FG000|Overall Study|Disease progression|25|||
38037582|NCT03552549|69725039|FG001|Overall Study|Disease progression|17|||
38037583|NCT03552549|69725038|FG000|Overall Study|Adverse event in first 12 months|12|||
38037584|NCT03552549|69725039|FG001|Overall Study|Adverse event in first 12 months|8|||
38037585|NCT03552549|69725038|FG000|Overall Study|Withdrawal by Subject|7|||
38037586|NCT03552549|69725039|FG001|Overall Study|Withdrawal by Subject|7|||
38037587|NCT03552549|69725038|FG000|Overall Study|Unknown (no reason provided)|4|||
38037588|NCT03552549|69725039|FG001|Overall Study|Unknown (no reason provided)|2|||
38037589|NCT03552549|69725038|FG000|Overall Study|Not in participant's best interest|2|||
38037590|NCT03552549|69725039|FG001|Overall Study|Not in participant's best interest|1|||
38037591|NCT03552549|69725038|FG000|Overall Study|Did not complete study treatment|2|||
38037592|NCT03552549|69725039|FG001|Overall Study|Did not complete study treatment|3|||
38037593|NCT03552549|69725038|FG000|Overall Study|Did not meet eligibility criteria|1|||
38037594|NCT03552549|69725039|FG001|Overall Study|Did not meet eligibility criteria|0|||
38037595|NCT03552549|69725038|FG000|Overall Study|Administrative|0|||
38037596|NCT03552549|69725039|FG001|Overall Study|Administrative|14|||
38037597|NCT00117845|69725045|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
38037598|NCT02761642|69725049|FG000|Overall Study|Did not Receive Study Treatment|3|||
38037599|NCT02761642|69725049|FG000|Overall Study|Adverse Event|13|||
38037600|NCT02761642|69725049|FG000|Overall Study|Withdrawal by Subject|2|||
38037601|NCT02761642|69725049|FG000|Overall Study|Non-compliant|7|||
38037602|NCT02761642|69725049|FG000|Overall Study|Death|3|||
38037603|NCT02761642|69725049|FG000|Overall Study|Lack of Efficacy|20|||
38037604|NCT02761642|69725049|FG000|Overall Study|Physician Decision|1|||
38037605|NCT02761642|69725049|FG000|Overall Study|Reason Unspecified|21|||
38037606|NCT00113555|69725053|FG000|Overall Study|Baseline Failure|59|||
38037607|NCT00113555|69725053|FG000|Overall Study|Permanently Explanted|7|||
38037608|NCT00113555|69725053|FG000|Overall Study|Death|1|||
38037609|NCT00113555|69725053|FG000|Overall Study|Missed Followup|4|||
38037610|NCT00113555|69725053|FG000|Overall Study|Lost to Follow-up|8|||
38037611|NCT03189524|69725061|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
38037612|NCT03189524|69725062|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
38037613|NCT03189524|69725063|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
38037614|NCT03189524|69725061|FG000|Overall Study|Death|2|||
38037615|NCT03189524|69725062|FG001|Overall Study|Death|2|||
38037616|NCT03189524|69725063|FG002|Overall Study|Death|1|||
38037617|NCT03189524|69725061|FG000|Overall Study|Lost to Follow-up|1|||
38037618|NCT03189524|69725062|FG001|Overall Study|Lost to Follow-up|0|||
38037619|NCT03189524|69725063|FG002|Overall Study|Lost to Follow-up|8|||
38037620|NCT03189524|69725061|FG000|Overall Study|Withdrawal by Subject|1|||
38037621|NCT03189524|69725062|FG001|Overall Study|Withdrawal by Subject|1|||
38037622|NCT03189524|69725063|FG002|Overall Study|Withdrawal by Subject|3|||
38037623|NCT03189524|69725061|FG000|Overall Study|Progressive Disease|0|||
38037624|NCT03189524|69725062|FG001|Overall Study|Progressive Disease|2|||
38037625|NCT03189524|69725063|FG002|Overall Study|Progressive Disease|0|||
38037626|NCT03600909|69725078|FG000|Overall Study|Not treated|0|||
38037627|NCT03600909|69725079|FG001|Overall Study|Not treated|3|||
38037628|NCT03600909|69725080|FG002|Overall Study|Not treated|0|||
38037629|NCT03189446|69725088|FG000|Overall Study|Adverse Event|2|||
38037630|NCT03189446|69725088|FG000|Overall Study|Withdrawal by Subject|2|||
38037631|NCT03189446|69725088|FG000|Overall Study|Physician Decision|1|||
38037632|NCT03212690|69725092|FG000|Overall Study|Protocol Violation|1|||
38037633|NCT03188120|69725096|FG000|Overall Study|Adverse Event|4|||
38037634|NCT03188120|69725096|FG000|Overall Study|Insufficient Effectiveness|8|||
38037635|NCT03188120|69725096|FG000|Overall Study|Improved|12|||
38037636|NCT03188120|69725096|FG000|Overall Study|Lost to Follow-up|7|||
38037637|NCT03188120|69725096|FG000|Overall Study|Other than specified|3|||
38037638|NCT03188120|69725096|FG000|Overall Study|No visit after the first visit|13|||
38037639|NCT02895945|69725102|FG000|Overall Study|Physician Decision|2|||
38037640|NCT02895945|69725103|FG001|Overall Study|Physician Decision|1|||
37944900|NCT00326599|69632406|FG001|Overall Study|Other Unspecified Reason|0|||
37944901|NCT00326599|69632407|FG002|Overall Study|Other Unspecified Reason|2|||
37944902|NCT00326599|69632408|FG003|Overall Study|Other Unspecified Reason|1|||
37944903|NCT00539032|69632419|FG000|Overall Study|Withdrawal by Subject|2|||
37944904|NCT00539032|69632420|FG001|Overall Study|Withdrawal by Subject|1|||
37944905|NCT00685802|69632426|FG000|Washout Period of 7 Days|Protocol Violation|2|||
37944906|NCT00685802|69632427|FG001|Washout Period of 7 Days|Protocol Violation|0|||
37944907|NCT00685802|69632426|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
37944908|NCT00685802|69632427|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
37944909|NCT00354601|69632433|FG000|Overall Study|Protocol Violation|1|||
37944910|NCT00354601|69632433|FG000|Overall Study|progression|1|||
37944911|NCT03827473|69632439|FG000|Overall Study|Withdrawal by Subject|1|||
37944912|NCT03827473|69632440|FG001|Overall Study|Withdrawal by Subject|0|||
37944913|NCT00345397|69632446|FG000|Overall Study|Death|1|||
37944914|NCT00326209|69632451|FG000|Overall Study|Adverse Event|28|||
37944915|NCT00326209|69632451|FG000|Overall Study|Withdrawal by Subject|22|||
37944916|NCT00326209|69632451|FG000|Overall Study|Lack of Efficacy|31|||
37944917|NCT00326209|69632451|FG000|Overall Study|Lost to Follow-up|18|||
37944918|NCT00326209|69632451|FG000|Overall Study|Participant non-compliant|6|||
37944919|NCT00326209|69632451|FG000|Overall Study|Sponsor closed study|173|||
37944920|NCT00326209|69632451|FG000|Overall Study|Prohibited medication use|1|||
37944921|NCT00326209|69632451|FG000|Overall Study|Violation of entry criteria|1|||
37944922|NCT00326209|69632451|FG000|Overall Study|Withdrawn in error|1|||
37944923|NCT00326209|69632451|FG000|Overall Study|Pregnancy|1|||
37944924|NCT00537940|69632457|FG000|Overall Study|Adverse Event|20|||
37944925|NCT00537940|69632458|FG001|Overall Study|Adverse Event|19|||
37944926|NCT00537940|69632457|FG000|Overall Study|Lack of Efficacy|8|||
37944927|NCT00537940|69632458|FG001|Overall Study|Lack of Efficacy|16|||
38037641|NCT02777554|69725111|FG000|Overall Study|Adverse Event|4|||
37944928|NCT00537940|69632457|FG000|Overall Study|Lost to Follow-up|23|||
37944929|NCT00537940|69632458|FG001|Overall Study|Lost to Follow-up|29|||
38037642|NCT02777554|69725112|FG001|Overall Study|Adverse Event|4|||
38037643|NCT02777554|69725113|FG002|Overall Study|Adverse Event|0|||
38037644|NCT02777554|69725114|FG003|Overall Study|Adverse Event|1|||
38037645|NCT02777554|69725115|FG004|Overall Study|Adverse Event|0|||
38037646|NCT02777554|69725116|FG005|Overall Study|Adverse Event|0|||
38037647|NCT02777554|69725111|FG000|Overall Study|Withdrawal by Subject|3|||
38037648|NCT02777554|69725112|FG001|Overall Study|Withdrawal by Subject|1|||
37944930|NCT00537940|69632457|FG000|Overall Study|Withdrawal by Subject|113|||
38037649|NCT02777554|69725113|FG002|Overall Study|Withdrawal by Subject|1|||
38037650|NCT02777554|69725114|FG003|Overall Study|Withdrawal by Subject|0|||
38037651|NCT02777554|69725115|FG004|Overall Study|Withdrawal by Subject|0|||
38037652|NCT02777554|69725116|FG005|Overall Study|Withdrawal by Subject|0|||
38037653|NCT02777554|69725111|FG000|Overall Study|Discharged early due to hurricane|22|||
38037654|NCT02777554|69725112|FG001|Overall Study|Discharged early due to hurricane|20|||
38037655|NCT02777554|69725113|FG002|Overall Study|Discharged early due to hurricane|0|||
38037656|NCT02777554|69725114|FG003|Overall Study|Discharged early due to hurricane|0|||
38037657|NCT02777554|69725115|FG004|Overall Study|Discharged early due to hurricane|0|||
38037658|NCT02777554|69725116|FG005|Overall Study|Discharged early due to hurricane|0|||
38037659|NCT02777554|69725111|FG000|Overall Study|Other - Miscellaneous|1|||
38037660|NCT02777554|69725112|FG001|Overall Study|Other - Miscellaneous|0|||
38037661|NCT02777554|69725113|FG002|Overall Study|Other - Miscellaneous|0|||
38037662|NCT02777554|69725114|FG003|Overall Study|Other - Miscellaneous|0|||
38037663|NCT02777554|69725115|FG004|Overall Study|Other - Miscellaneous|0|||
38037664|NCT02777554|69725116|FG005|Overall Study|Other - Miscellaneous|0|||
38037665|NCT03550209|69725140|FG000|Overall Study|Lost to Follow-up|1|||
38037666|NCT03550209|69725141|FG001|Overall Study|Lost to Follow-up|0|||
38037667|NCT03550209|69725142|FG002|Overall Study|Lost to Follow-up|1|||
38037668|NCT03550209|69725143|FG003|Overall Study|Lost to Follow-up|0|||
38037669|NCT03550209|69725140|FG000|Overall Study|Withdrawal by Subject|0|||
38037670|NCT03550209|69725141|FG001|Overall Study|Withdrawal by Subject|3|||
38037671|NCT03550209|69725142|FG002|Overall Study|Withdrawal by Subject|1|||
38037672|NCT03550209|69725143|FG003|Overall Study|Withdrawal by Subject|2|||
38037673|NCT03550209|69725140|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
38037674|NCT03550209|69725141|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
38037675|NCT03550209|69725142|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
38037676|NCT03550209|69725143|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
38037677|NCT03032510|69725155|FG000|Overall Study|Adverse Event|5|||
38037678|NCT03032510|69725156|FG001|Overall Study|Adverse Event|2|||
38037679|NCT03032510|69725155|FG000|Overall Study|Lost to Follow-up|8|||
38037680|NCT03032510|69725156|FG001|Overall Study|Lost to Follow-up|7|||
38037681|NCT03032510|69725155|FG000|Overall Study|Withdrawal by Subject|8|||
38037682|NCT03032510|69725156|FG001|Overall Study|Withdrawal by Subject|7|||
38037683|NCT03032510|69725155|FG000|Overall Study|Subject noncompliance|4|||
38037684|NCT03032510|69725156|FG001|Overall Study|Subject noncompliance|2|||
38037685|NCT03032510|69725155|FG000|Overall Study|Physician Decision|2|||
38037686|NCT03032510|69725156|FG001|Overall Study|Physician Decision|0|||
38037687|NCT03599349|69725166|FG000|Overall Study|Lost to Follow-up|1|||
38037688|NCT03599193|69725176|FG000|Overall Study|Adverse Event|0|||
38037689|NCT03599193|69725177|FG001|Overall Study|Adverse Event|2|||
38037690|NCT03599193|69725176|FG000|Overall Study|Withdrawal by Subject|1|||
38037691|NCT03599193|69725177|FG001|Overall Study|Withdrawal by Subject|0|||
38037692|NCT03599193|69725176|FG000|Overall Study|Protocol Violation|1|||
38037693|NCT03599193|69725177|FG001|Overall Study|Protocol Violation|0|||
38037694|NCT03599193|69725176|FG000|Overall Study|Lost to Follow-up|0|||
38037695|NCT03599193|69725177|FG001|Overall Study|Lost to Follow-up|1|||
38037696|NCT03166124|69725186|FG000|Treatment Period 1|Adverse Event|0|||
38037697|NCT03166124|69725187|FG001|Treatment Period 1|Adverse Event|0|||
38037698|NCT03166124|69725188|FG002|Treatment Period 1|Adverse Event|1|||
38037699|NCT03166124|69725189|FG003|Treatment Period 1|Adverse Event|0|||
38037700|NCT03166124|69725186|FG000|Wash-out Period|Withdrawal by Subject|0|||
38037701|NCT03166124|69725187|FG001|Wash-out Period|Withdrawal by Subject|1|||
38037702|NCT03166124|69725188|FG002|Wash-out Period|Withdrawal by Subject|0|||
38037703|NCT03166124|69725189|FG003|Wash-out Period|Withdrawal by Subject|1|||
38037704|NCT03166124|69725186|FG000|Wash-out Period|Adverse Event|0|||
38037705|NCT03166124|69725187|FG001|Wash-out Period|Adverse Event|1|||
38037706|NCT03166124|69725188|FG002|Wash-out Period|Adverse Event|1|||
38037707|NCT03166124|69725189|FG003|Wash-out Period|Adverse Event|0|||
38037708|NCT03567291|69725200|FG000|Period I|Adverse Event|14|||
38037709|NCT03567291|69725201|FG001|Period I|Adverse Event|0|||
38037710|NCT03567291|69725202|FG002|Period I|Adverse Event|0|||
38037711|NCT03567291|69725203|FG003|Period I|Adverse Event|0|||
38037712|NCT03567291|69725200|FG000|Period I|Protocol Violation|1|||
38037713|NCT03567291|69725201|FG001|Period I|Protocol Violation|0|||
38037714|NCT03567291|69725202|FG002|Period I|Protocol Violation|0|||
38037715|NCT03567291|69725203|FG003|Period I|Protocol Violation|0|||
38037716|NCT03567291|69725200|FG000|Period I|Withdrawal by Subject|23|||
38037717|NCT03567291|69725201|FG001|Period I|Withdrawal by Subject|0|||
38037718|NCT03567291|69725202|FG002|Period I|Withdrawal by Subject|0|||
38037719|NCT03567291|69725203|FG003|Period I|Withdrawal by Subject|0|||
38037720|NCT03567291|69725200|FG000|Period I|Lost to Follow-up|2|||
38037721|NCT03567291|69725201|FG001|Period I|Lost to Follow-up|0|||
38037722|NCT03567291|69725202|FG002|Period I|Lost to Follow-up|0|||
38037723|NCT03567291|69725203|FG003|Period I|Lost to Follow-up|0|||
38037724|NCT03567291|69725200|FG000|Period I|Terminated by sponsor|44|||
38037725|NCT03567291|69725201|FG001|Period I|Terminated by sponsor|0|||
38037726|NCT03567291|69725202|FG002|Period I|Terminated by sponsor|0|||
38037727|NCT03567291|69725203|FG003|Period I|Terminated by sponsor|0|||
38037728|NCT03567291|69725200|FG000|Period I|Missing or unknown|7|||
38037729|NCT03567291|69725201|FG001|Period I|Missing or unknown|0|||
38037730|NCT03567291|69725202|FG002|Period I|Missing or unknown|0|||
38037731|NCT03567291|69725203|FG003|Period I|Missing or unknown|0|||
38037732|NCT03567291|69725200|FG000|Period II|Adverse Event|0|||
38037733|NCT03567291|69725201|FG001|Period II|Adverse Event|1|||
38037734|NCT03567291|69725202|FG002|Period II|Adverse Event|0|||
38037735|NCT03567291|69725203|FG003|Period II|Adverse Event|0|||
38037736|NCT03567291|69725200|FG000|Period II|Missing or unknown|0|||
38037737|NCT03567291|69725201|FG001|Period II|Missing or unknown|2|||
38037738|NCT03567291|69725202|FG002|Period II|Missing or unknown|1|||
38037739|NCT03567291|69725203|FG003|Period II|Missing or unknown|0|||
38037740|NCT03567291|69725200|FG000|Period III|Adverse Event|0|||
38037741|NCT03567291|69725201|FG001|Period III|Adverse Event|0|||
38037742|NCT03567291|69725202|FG002|Period III|Adverse Event|0|||
38037743|NCT03567291|69725203|FG003|Period III|Adverse Event|4|||
38037744|NCT03567291|69725200|FG000|Period III|Withdrawal by Subject|0|||
38037745|NCT03567291|69725201|FG001|Period III|Withdrawal by Subject|0|||
38037746|NCT03567291|69725202|FG002|Period III|Withdrawal by Subject|0|||
38037747|NCT03567291|69725203|FG003|Period III|Withdrawal by Subject|4|||
38037748|NCT03567291|69725200|FG000|Period III|Lost to Follow-up|0|||
38037749|NCT03567291|69725201|FG001|Period III|Lost to Follow-up|0|||
38037750|NCT03567291|69725202|FG002|Period III|Lost to Follow-up|0|||
38037751|NCT03567291|69725203|FG003|Period III|Lost to Follow-up|1|||
38037752|NCT03567291|69725200|FG000|Period III|Terminated by sponsor|0|||
38037753|NCT03567291|69725201|FG001|Period III|Terminated by sponsor|0|||
38037754|NCT03567291|69725202|FG002|Period III|Terminated by sponsor|0|||
38037755|NCT03567291|69725203|FG003|Period III|Terminated by sponsor|68|||
38037756|NCT03567291|69725200|FG000|Period III|Missing or unknown|0|||
38037757|NCT03567291|69725201|FG001|Period III|Missing or unknown|0|||
38037758|NCT03567291|69725202|FG002|Period III|Missing or unknown|0|||
38037759|NCT03567291|69725203|FG003|Period III|Missing or unknown|8|||
38037760|NCT02777242|69725209|FG000|Overall Study|Other|2|||
38037761|NCT02777242|69725209|FG000|Overall Study|Lost to Follow-up|1|||
38037762|NCT02777242|69725209|FG000|Overall Study|Multiple|1|||
38037763|NCT02777242|69725209|FG000|Overall Study|Sponsor's request|1|||
38037764|NCT02777242|69725209|FG000|Overall Study|Withdrawal by Subject|1|||
38037765|NCT03212144|69725215|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
38037766|NCT03212144|69725216|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
38037767|NCT03212144|69725215|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
38037768|NCT03212144|69725216|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
38037769|NCT03566979|69725226|FG000|Overall Study|Withdrawal by Subject|2|||
38037770|NCT03566979|69725227|FG001|Overall Study|Withdrawal by Subject|0|||
38037771|NCT03566979|69725228|FG002|Overall Study|Withdrawal by Subject|1|||
38037772|NCT03566979|69725229|FG003|Overall Study|Withdrawal by Subject|1|||
38037773|NCT03566979|69725226|FG000|Overall Study|Lost to Follow-up|2|||
38037774|NCT03566979|69725227|FG001|Overall Study|Lost to Follow-up|7|||
38037775|NCT03566979|69725228|FG002|Overall Study|Lost to Follow-up|9|||
38037776|NCT03566979|69725229|FG003|Overall Study|Lost to Follow-up|5|||
38037777|NCT03566979|69725226|FG000|Overall Study|Adverse Event|1|||
38037778|NCT03566979|69725227|FG001|Overall Study|Adverse Event|0|||
38037779|NCT03566979|69725228|FG002|Overall Study|Adverse Event|0|||
38037780|NCT03566979|69725229|FG003|Overall Study|Adverse Event|0|||
38037781|NCT00116831|69725241|FG000|Overall Study|Adverse Event|14|||
38037782|NCT00116831|69725242|FG001|Overall Study|Adverse Event|16|||
38037783|NCT00116831|69725241|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
38037784|NCT00116831|69725242|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
38037785|NCT00116831|69725241|FG000|Overall Study|Lost to Follow-up|8|||
38037786|NCT00116831|69725242|FG001|Overall Study|Lost to Follow-up|6|||
38037787|NCT00116831|69725241|FG000|Overall Study|Protocol Violation|3|||
38037788|NCT00116831|69725242|FG001|Overall Study|Protocol Violation|6|||
38037789|NCT00116831|69725241|FG000|Overall Study|Hypoglycaemic events|1|||
38037790|NCT00116831|69725242|FG001|Overall Study|Hypoglycaemic events|0|||
38037791|NCT00116831|69725241|FG000|Overall Study|Low haemoglobin on screening|1|||
38037792|NCT00116831|69725242|FG001|Overall Study|Low haemoglobin on screening|0|||
38037793|NCT00116831|69725241|FG000|Overall Study|Withdrawn investigational product|1|||
38037794|NCT00116831|69725242|FG001|Overall Study|Withdrawn investigational product|0|||
38037795|NCT00116831|69725241|FG000|Overall Study|Withdrawal by Subject|32|||
38037796|NCT00116831|69725242|FG001|Overall Study|Withdrawal by Subject|32|||
38037797|NCT00116831|69725241|FG000|Overall Study|Insufficient therapeutic effect|0|||
38037798|NCT00116831|69725242|FG001|Overall Study|Insufficient therapeutic effect|1|||
37766379|NCT01407367|69280393|FG001|Overall Study|Death|32|||
38037799|NCT00116831|69725241|FG000|Overall Study|Missing data for participant|1|||
38037800|NCT00116831|69725242|FG001|Overall Study|Missing data for participant|0|||
38037801|NCT02777086|69725250|FG000|Overall Study|Lost to Follow-up|96|||
38037802|NCT02777086|69725251|FG001|Overall Study|Lost to Follow-up|99|||
38037803|NCT03549429|69725259|FG000|Overall Study|Protocol Violation|5|||
38037804|NCT03549429|69725260|FG001|Overall Study|Protocol Violation|3|||
38037805|NCT02784704|69725270|FG000|Overall Study|Adverse Event|4|||
38037806|NCT02784704|69725271|FG001|Overall Study|Adverse Event|2|||
38037807|NCT02784704|69725270|FG000|Overall Study|Lost to Follow-up|6|||
38037808|NCT02784704|69725271|FG001|Overall Study|Lost to Follow-up|4|||
38037809|NCT02784704|69725270|FG000|Overall Study|Withdrawal by Subject|1|||
38037810|NCT02784704|69725271|FG001|Overall Study|Withdrawal by Subject|3|||
38037811|NCT02784704|69725270|FG000|Overall Study|Subject Non Compliance|2|||
38037812|NCT02784704|69725271|FG001|Overall Study|Subject Non Compliance|0|||
38037813|NCT03566823|69725282|FG000|Overall Study|Lack of Efficacy|0|||
38037814|NCT03566823|69725283|FG001|Overall Study|Lack of Efficacy|1|||
38037815|NCT03566823|69725284|FG002|Overall Study|Lack of Efficacy|0|||
38037816|NCT03566823|69725282|FG000|Overall Study|Withdrawal by Subject|1|||
38037817|NCT03566823|69725283|FG001|Overall Study|Withdrawal by Subject|2|||
38037818|NCT03566823|69725284|FG002|Overall Study|Withdrawal by Subject|0|||
38037819|NCT03566823|69725282|FG000|Overall Study|Adverse Event|1|||
38037820|NCT03566823|69725283|FG001|Overall Study|Adverse Event|0|||
38037821|NCT03566823|69725284|FG002|Overall Study|Adverse Event|2|||
38037822|NCT03549117|69725294|FG000|Overall Study|Withdrawal by Subject|1|||
38037823|NCT03549117|69725295|FG001|Overall Study|Withdrawal by Subject|0|||
38037824|NCT03183908|69725303|FG000|Overall Study|Missing Symptom Diary Data|0|||
38037825|NCT03183908|69725304|FG001|Overall Study|Missing Symptom Diary Data|2|||
38037826|NCT03565887|69725316|FG000|Overall Study|Adverse Event|1|||
38037827|NCT03565887|69725317|FG001|Overall Study|Adverse Event|0|||
38037828|NCT03565887|69725316|FG000|Overall Study|Withdrawal by Subject|0|||
38037829|NCT03565887|69725317|FG001|Overall Study|Withdrawal by Subject|2|||
38037830|NCT03183518|69725323|FG000|Overall Study|Other (Not specified)|2|||
38037831|NCT03183518|69725323|FG000|Overall Study|Other (Withdrawal of consent)|1|||
38037832|NCT00116753|69725331|FG000|Overall Study|Adverse Event|16|||
38037833|NCT00116753|69725332|FG001|Overall Study|Adverse Event|10|||
38037834|NCT00116753|69725333|FG002|Overall Study|Adverse Event|7|||
38037835|NCT00116753|69725331|FG000|Overall Study|Withdrawal by Subject|11|||
38037836|NCT00116753|69725332|FG001|Overall Study|Withdrawal by Subject|12|||
38037837|NCT00116753|69725333|FG002|Overall Study|Withdrawal by Subject|8|||
38037838|NCT00116753|69725331|FG000|Overall Study|Lost to Follow-up|0|||
38037839|NCT00116753|69725332|FG001|Overall Study|Lost to Follow-up|2|||
38037840|NCT00116753|69725333|FG002|Overall Study|Lost to Follow-up|1|||
38037841|NCT00116753|69725331|FG000|Overall Study|Protocol Violation|0|||
38037842|NCT00116753|69725332|FG001|Overall Study|Protocol Violation|0|||
38037843|NCT00116753|69725333|FG002|Overall Study|Protocol Violation|1|||
38037844|NCT00116753|69725331|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
38037845|NCT00116753|69725332|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
38037846|NCT00116753|69725333|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
38037847|NCT00116753|69725331|FG000|Overall Study|Disease Progression|3|||
38037848|NCT00116753|69725332|FG001|Overall Study|Disease Progression|4|||
38037849|NCT00116753|69725333|FG002|Overall Study|Disease Progression|3|||
38037850|NCT00116753|69725331|FG000|Overall Study|Abnormal Echocardiogram|0|||
38037851|NCT00116753|69725332|FG001|Overall Study|Abnormal Echocardiogram|0|||
38037852|NCT00116753|69725333|FG002|Overall Study|Abnormal Echocardiogram|1|||
38037853|NCT00116753|69725331|FG000|Overall Study|Progressive Parkinson's Disease|1|||
38037854|NCT00116753|69725332|FG001|Overall Study|Progressive Parkinson's Disease|0|||
38037855|NCT00116753|69725333|FG002|Overall Study|Progressive Parkinson's Disease|0|||
38037856|NCT00116753|69725331|FG000|Overall Study|Dosing Error|0|||
38037857|NCT00116753|69725332|FG001|Overall Study|Dosing Error|1|||
38037858|NCT00116753|69725333|FG002|Overall Study|Dosing Error|0|||
38037859|NCT00113399|69725352|FG000|Overall Study|Death|1|||
38037860|NCT00113399|69725353|FG001|Overall Study|Death|1|||
38037861|NCT00113399|69725352|FG000|Overall Study|Withdrawal by Subject|1|||
38037862|NCT00113399|69725353|FG001|Overall Study|Withdrawal by Subject|2|||
38037863|NCT00113399|69725352|FG000|Overall Study|Complete Response|0|||
38037864|NCT00113399|69725353|FG001|Overall Study|Complete Response|1|||
38037865|NCT00113399|69725352|FG000|Overall Study|Other|0|||
38037866|NCT00113399|69725353|FG001|Overall Study|Other|1|||
38037867|NCT00113087|69725361|FG000|Overall Study|Death or Transplant|14|||
38037868|NCT00113087|69725362|FG001|Overall Study|Death or Transplant|16|||
38037869|NCT00113087|69725361|FG000|Overall Study|Family or MD withdrew subject|10|||
38037870|NCT00113087|69725362|FG001|Overall Study|Family or MD withdrew subject|5|||
38037871|NCT00112463|69725368|FG000|Overall Study|Physician Decision|1|||
38037872|NCT00112463|69725368|FG000|Overall Study|Progression|30|||
38037873|NCT00112463|69725368|FG000|Overall Study|Second Primary|1|||
38037874|NCT00112463|69725368|FG000|Overall Study|Toxicity|3|||
38037875|NCT00112463|69725368|FG000|Overall Study|Withdrawal by Subject|2|||
38037876|NCT00112463|69725368|FG000|Overall Study|Never started treatment|2|||
38037877|NCT03548415|69725378|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
38037878|NCT03548415|69725379|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
38037879|NCT03548415|69725380|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
38037880|NCT03548415|69725381|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
38037881|NCT03548415|69725382|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
38037882|NCT00112385|69725398|FG000|Overall Study|Lost to Follow-up|1|||
38037883|NCT00112385|69725399|FG001|Overall Study|Lost to Follow-up|0|||
38037884|NCT00112385|69725398|FG000|Overall Study|Withdrawal by Subject|0|||
38037885|NCT00112385|69725399|FG001|Overall Study|Withdrawal by Subject|1|||
38037886|NCT03548337|69725407|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
38037887|NCT03548337|69725408|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
38037888|NCT03548337|69725407|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
38037889|NCT03548337|69725408|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
38037890|NCT03548337|69725407|FG000|Infant Series|Lost to Follow-up|2|||
38037891|NCT03548337|69725408|FG001|Infant Series|Lost to Follow-up|1|||
38037892|NCT03548337|69725407|FG000|Infant Series|Adverse Event|0|||
38037893|NCT03548337|69725408|FG001|Infant Series|Adverse Event|2|||
38037894|NCT03548337|69725407|FG000|Infant Series|Randomized but Not Vaccinated|1|||
38037895|NCT03548337|69725408|FG001|Infant Series|Randomized but Not Vaccinated|0|||
38037896|NCT03548337|69725407|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
38037897|NCT03548337|69725408|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
38037898|NCT03596151|69725420|FG000|Overall Study|Withdrawal by Subject|1|||
38037899|NCT03547635|69725427|FG000|Overall Study|Adverse Event|5|||
38037900|NCT03547635|69725428|FG001|Overall Study|Adverse Event|2|||
38037901|NCT03547635|69725429|FG002|Overall Study|Adverse Event|3|||
38037902|NCT03547635|69725427|FG000|Overall Study|Lost to Follow-up|1|||
38037903|NCT03547635|69725428|FG001|Overall Study|Lost to Follow-up|3|||
38037904|NCT03547635|69725429|FG002|Overall Study|Lost to Follow-up|4|||
38037905|NCT03547635|69725427|FG000|Overall Study|Withdrawal by Subject|1|||
38037906|NCT03547635|69725428|FG001|Overall Study|Withdrawal by Subject|0|||
38037907|NCT03547635|69725429|FG002|Overall Study|Withdrawal by Subject|0|||
38037908|NCT03547635|69725427|FG000|Overall Study|Withdrawal By PI|0|||
38037909|NCT03547635|69725428|FG001|Overall Study|Withdrawal By PI|1|||
38037910|NCT03547635|69725429|FG002|Overall Study|Withdrawal By PI|0|||
38037911|NCT03547635|69725427|FG000|Overall Study|Withdrawal by Sponsor|0|||
38037912|NCT03547635|69725428|FG001|Overall Study|Withdrawal by Sponsor|0|||
38037913|NCT03547635|69725429|FG002|Overall Study|Withdrawal by Sponsor|1|||
38037914|NCT03547635|69725427|FG000|Overall Study|Errant Randomization before Treatment|0|||
38037915|NCT03547635|69725428|FG001|Overall Study|Errant Randomization before Treatment|1|||
38037916|NCT03547635|69725429|FG002|Overall Study|Errant Randomization before Treatment|0|||
38037917|NCT03547635|69725427|FG000|Overall Study|Withdrawal by Subject|1|||
38037918|NCT03547635|69725428|FG001|Overall Study|Withdrawal by Subject|0|||
38037919|NCT03547635|69725429|FG002|Overall Study|Withdrawal by Subject|0|||
38037920|NCT03182738|69725483|FG000|Overall Study|Lost to Follow-up|9|||
38037921|NCT03182738|69725484|FG001|Overall Study|Lost to Follow-up|3|||
38037922|NCT03182738|69725483|FG000|Overall Study|Pregnancy|0|||
38037923|NCT03182738|69725484|FG001|Overall Study|Pregnancy|1|||
38037924|NCT03182738|69725483|FG000|Overall Study|Withdrawal by Subject|0|||
38037925|NCT03182738|69725484|FG001|Overall Study|Withdrawal by Subject|1|||
38037926|NCT03547167|69725492|FG000|Overall Study|Withdrawal by Subject|34|||
38037927|NCT03547167|69725493|FG001|Overall Study|Withdrawal by Subject|12|||
38037928|NCT03547167|69725492|FG000|Overall Study|Screen Failure|0|||
38037929|NCT03547167|69725493|FG001|Overall Study|Screen Failure|1|||
38037930|NCT03547167|69725492|FG000|Overall Study|Lost to Follow-up|59|||
38037931|NCT03547167|69725493|FG001|Overall Study|Lost to Follow-up|15|||
38037932|NCT03547167|69725492|FG000|Overall Study|Death|4|||
38037933|NCT03547167|69725493|FG001|Overall Study|Death|2|||
38037934|NCT03560739|69725507|FG000|Overall Study|Adverse Event|0|||
38037935|NCT03560739|69725508|FG001|Overall Study|Adverse Event|1|||
38037936|NCT03560739|69725509|FG002|Overall Study|Adverse Event|0|||
38037937|NCT03560739|69725510|FG003|Overall Study|Adverse Event|0|||
38037938|NCT00101686|69725530|FG000|Overall Study|Progressive Disease|37|||
38037939|NCT00101686|69725531|FG001|Overall Study|Progressive Disease|28|||
38037940|NCT00101686|69725532|FG002|Overall Study|Progressive Disease|37|||
38037941|NCT00101686|69725533|FG003|Overall Study|Progressive Disease|38|||
38037942|NCT00101686|69725534|FG004|Overall Study|Progressive Disease|28|||
38037943|NCT00101686|69725535|FG005|Overall Study|Progressive Disease|25|||
38037944|NCT00101686|69725536|FG006|Overall Study|Progressive Disease|5|||
38037945|NCT00101686|69725537|FG007|Overall Study|Progressive Disease|7|||
38037946|NCT00101686|69725538|FG008|Overall Study|Progressive Disease|10|||
38037947|NCT00101686|69725539|FG009|Overall Study|Progressive Disease|8|||
38037948|NCT00101686|69725530|FG000|Overall Study|initiation other anti-cancer treatment|4|||
38037949|NCT00101686|69725531|FG001|Overall Study|initiation other anti-cancer treatment|3|||
38037950|NCT00101686|69725532|FG002|Overall Study|initiation other anti-cancer treatment|4|||
38037951|NCT00101686|69725533|FG003|Overall Study|initiation other anti-cancer treatment|3|||
38037952|NCT00101686|69725534|FG004|Overall Study|initiation other anti-cancer treatment|1|||
38037953|NCT00101686|69725535|FG005|Overall Study|initiation other anti-cancer treatment|1|||
38037954|NCT00101686|69725536|FG006|Overall Study|initiation other anti-cancer treatment|2|||
38037955|NCT00101686|69725537|FG007|Overall Study|initiation other anti-cancer treatment|2|||
38037956|NCT00101686|69725538|FG008|Overall Study|initiation other anti-cancer treatment|3|||
38037957|NCT00101686|69725539|FG009|Overall Study|initiation other anti-cancer treatment|3|||
38037958|NCT00101686|69725530|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
38037959|NCT00101686|69725531|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
38037960|NCT00101686|69725532|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
38037961|NCT00101686|69725533|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
38037962|NCT00101686|69725534|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
38037963|NCT00101686|69725535|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
38037964|NCT00101686|69725536|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
38037965|NCT00101686|69725537|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
38037966|NCT00101686|69725538|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
38037967|NCT00101686|69725539|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
38037968|NCT00101686|69725530|FG000|Overall Study|unacceptable toxicity|3|||
38037969|NCT00101686|69725531|FG001|Overall Study|unacceptable toxicity|9|||
38037970|NCT00101686|69725532|FG002|Overall Study|unacceptable toxicity|10|||
38037971|NCT00101686|69725533|FG003|Overall Study|unacceptable toxicity|6|||
38037972|NCT00101686|69725534|FG004|Overall Study|unacceptable toxicity|16|||
38037973|NCT00101686|69725535|FG005|Overall Study|unacceptable toxicity|10|||
38037974|NCT00101686|69725536|FG006|Overall Study|unacceptable toxicity|4|||
38037975|NCT00101686|69725537|FG007|Overall Study|unacceptable toxicity|2|||
38037976|NCT00101686|69725538|FG008|Overall Study|unacceptable toxicity|1|||
38037977|NCT00101686|69725539|FG009|Overall Study|unacceptable toxicity|4|||
38037978|NCT00101686|69725530|FG000|Overall Study|Randomized but did not receive treament|1|||
38037979|NCT00101686|69725531|FG001|Overall Study|Randomized but did not receive treament|6|||
38037980|NCT00101686|69725532|FG002|Overall Study|Randomized but did not receive treament|2|||
38037981|NCT00101686|69725533|FG003|Overall Study|Randomized but did not receive treament|2|||
38037982|NCT00101686|69725534|FG004|Overall Study|Randomized but did not receive treament|2|||
38037983|NCT00101686|69725535|FG005|Overall Study|Randomized but did not receive treament|2|||
38037984|NCT00101686|69725536|FG006|Overall Study|Randomized but did not receive treament|0|||
38037985|NCT00101686|69725537|FG007|Overall Study|Randomized but did not receive treament|1|||
38037986|NCT00101686|69725538|FG008|Overall Study|Randomized but did not receive treament|0|||
38037987|NCT00101686|69725539|FG009|Overall Study|Randomized but did not receive treament|1|||
38037988|NCT00101686|69725530|FG000|Overall Study|intercurrent non-cancer related illness|0|||
38037989|NCT00101686|69725531|FG001|Overall Study|intercurrent non-cancer related illness|0|||
38037990|NCT00101686|69725532|FG002|Overall Study|intercurrent non-cancer related illness|2|||
38037991|NCT00101686|69725533|FG003|Overall Study|intercurrent non-cancer related illness|0|||
38037992|NCT00101686|69725534|FG004|Overall Study|intercurrent non-cancer related illness|1|||
38037993|NCT00101686|69725535|FG005|Overall Study|intercurrent non-cancer related illness|3|||
38037994|NCT00101686|69725536|FG006|Overall Study|intercurrent non-cancer related illness|1|||
38037995|NCT00101686|69725537|FG007|Overall Study|intercurrent non-cancer related illness|0|||
38037996|NCT00101686|69725538|FG008|Overall Study|intercurrent non-cancer related illness|1|||
38037997|NCT00101686|69725539|FG009|Overall Study|intercurrent non-cancer related illness|1|||
38037998|NCT00101686|69725530|FG000|Overall Study|Physician Decision|10|||
38037999|NCT00101686|69725531|FG001|Overall Study|Physician Decision|13|||
38038000|NCT00101686|69725532|FG002|Overall Study|Physician Decision|6|||
38038001|NCT00101686|69725533|FG003|Overall Study|Physician Decision|7|||
38038002|NCT00101686|69725534|FG004|Overall Study|Physician Decision|8|||
38038003|NCT00101686|69725535|FG005|Overall Study|Physician Decision|9|||
38038004|NCT00101686|69725536|FG006|Overall Study|Physician Decision|5|||
38038005|NCT00101686|69725537|FG007|Overall Study|Physician Decision|5|||
38038006|NCT00101686|69725538|FG008|Overall Study|Physician Decision|1|||
38038007|NCT00101686|69725539|FG009|Overall Study|Physician Decision|1|||
38038008|NCT00101686|69725530|FG000|Overall Study|Other|1|||
38038009|NCT00101686|69725531|FG001|Overall Study|Other|4|||
38038010|NCT00101686|69725532|FG002|Overall Study|Other|1|||
38038011|NCT00101686|69725533|FG003|Overall Study|Other|6|||
38038012|NCT00101686|69725534|FG004|Overall Study|Other|2|||
38038013|NCT00101686|69725535|FG005|Overall Study|Other|12|||
38038014|NCT00101686|69725536|FG006|Overall Study|Other|1|||
38038015|NCT00101686|69725537|FG007|Overall Study|Other|5|||
38038016|NCT00101686|69725538|FG008|Overall Study|Other|3|||
38038017|NCT00101686|69725539|FG009|Overall Study|Other|3|||
38038018|NCT00101686|69725530|FG000|Overall Study|Withdrawal by Subject|9|||
38038019|NCT00101686|69725531|FG001|Overall Study|Withdrawal by Subject|8|||
37673275|NCT03805841|69147501|FG002|Overall Study|Withdrawal by Subject|0|||
37673276|NCT03805841|69147499|FG000|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
38038020|NCT00101686|69725532|FG002|Overall Study|Withdrawal by Subject|6|||
37673277|NCT03805841|69147500|FG001|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|4|||
37673278|NCT03805841|69147501|FG002|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
37673279|NCT02684617|69147512|FG000|Overall Study|Adverse Event|1|||
37673280|NCT02684617|69147513|FG001|Overall Study|Adverse Event|0|||
37673281|NCT02684617|69147514|FG002|Overall Study|Adverse Event|1|||
38038021|NCT00101686|69725533|FG003|Overall Study|Withdrawal by Subject|8|||
38038022|NCT00101686|69725534|FG004|Overall Study|Withdrawal by Subject|8|||
38038023|NCT00101686|69725535|FG005|Overall Study|Withdrawal by Subject|7|||
38038024|NCT00101686|69725536|FG006|Overall Study|Withdrawal by Subject|7|||
38038025|NCT00101686|69725537|FG007|Overall Study|Withdrawal by Subject|7|||
38038026|NCT00101686|69725538|FG008|Overall Study|Withdrawal by Subject|8|||
38038027|NCT00101686|69725539|FG009|Overall Study|Withdrawal by Subject|9|||
38038028|NCT00101452|69725559|FG000|Overall Study|Adverse Event|2|||
38038029|NCT00101452|69725560|FG001|Overall Study|Adverse Event|0|||
38038030|NCT00101452|69725561|FG002|Overall Study|Adverse Event|1|||
38038031|NCT00101452|69725559|FG000|Overall Study|Lost to Follow-up|13|||
38038032|NCT00101452|69725560|FG001|Overall Study|Lost to Follow-up|8|||
38038033|NCT00101452|69725561|FG002|Overall Study|Lost to Follow-up|14|||
38038034|NCT00101452|69725559|FG000|Overall Study|Withdrawal by Subject|10|||
38038035|NCT00101452|69725560|FG001|Overall Study|Withdrawal by Subject|14|||
38038036|NCT00101452|69725561|FG002|Overall Study|Withdrawal by Subject|9|||
38038037|NCT00101452|69725559|FG000|Overall Study|Baseline Fail|2|||
38038038|NCT00101452|69725560|FG001|Overall Study|Baseline Fail|1|||
38038039|NCT00101452|69725561|FG002|Overall Study|Baseline Fail|2|||
38038040|NCT00101452|69725559|FG000|Overall Study|Physician Decision|0|||
38038041|NCT00101452|69725560|FG001|Overall Study|Physician Decision|3|||
38038042|NCT00101452|69725561|FG002|Overall Study|Physician Decision|2|||
38038043|NCT00101452|69725559|FG000|Overall Study|Protocol Violation|2|||
38038044|NCT00101452|69725560|FG001|Overall Study|Protocol Violation|1|||
38038045|NCT00101452|69725561|FG002|Overall Study|Protocol Violation|3|||
38038046|NCT00101452|69725559|FG000|Overall Study|Other|15|||
38038047|NCT00101452|69725560|FG001|Overall Study|Other|16|||
38038048|NCT00101452|69725561|FG002|Overall Study|Other|12|||
38038049|NCT03546621|69725577|FG000|Overall Study|Withdrawal by Subject|0|||
38038050|NCT03546621|69725578|FG001|Overall Study|Withdrawal by Subject|1|||
38038051|NCT03546621|69725579|FG002|Overall Study|Withdrawal by Subject|2|||
38038052|NCT03546621|69725580|FG003|Overall Study|Withdrawal by Subject|1|||
38038053|NCT03546621|69725577|FG000|Overall Study|Lost to Follow-up|0|||
38038054|NCT03546621|69725578|FG001|Overall Study|Lost to Follow-up|1|||
38038055|NCT03546621|69725579|FG002|Overall Study|Lost to Follow-up|0|||
38038056|NCT03546621|69725580|FG003|Overall Study|Lost to Follow-up|0|||
38038057|NCT03546621|69725577|FG000|Overall Study|Adverse Event|0|||
37944931|NCT00537940|69632458|FG001|Overall Study|Withdrawal by Subject|95|||
37944932|NCT00537940|69632457|FG000|Overall Study|Protocol Violation|6|||
37944933|NCT00537940|69632458|FG001|Overall Study|Protocol Violation|4|||
37944934|NCT00537940|69632457|FG000|Overall Study|Pregnancy|1|||
37944935|NCT00537940|69632458|FG001|Overall Study|Pregnancy|1|||
37944936|NCT00537940|69632457|FG000|Overall Study|Study terminated by sponsor|2|||
37944937|NCT00537940|69632458|FG001|Overall Study|Study terminated by sponsor|3|||
37944938|NCT00537940|69632457|FG000|Overall Study|Other|10|||
37944939|NCT00537940|69632458|FG001|Overall Study|Other|12|||
37944940|NCT00661362|69632466|FG000|Overall Study|Adverse Event|5|||
37944941|NCT00661362|69632467|FG001|Overall Study|Adverse Event|4|||
37944942|NCT00661362|69632466|FG000|Overall Study|Incorrect enrollment|2|||
37944943|NCT00661362|69632467|FG001|Overall Study|Incorrect enrollment|0|||
37944944|NCT00661362|69632466|FG000|Overall Study|Study specific discontinuation criteria|4|||
37944945|NCT00661362|69632467|FG001|Overall Study|Study specific discontinuation criteria|11|||
37944946|NCT00661362|69632466|FG000|Overall Study|Withdrawal by Subject|13|||
37944947|NCT00661362|69632467|FG001|Overall Study|Withdrawal by Subject|23|||
37944948|NCT00661362|69632466|FG000|Overall Study|Lost to Follow-up|3|||
37944949|NCT00661362|69632467|FG001|Overall Study|Lost to Follow-up|1|||
37944950|NCT00661362|69632466|FG000|Overall Study|Severe non-compliance to protocol|0|||
37944951|NCT00661362|69632467|FG001|Overall Study|Severe non-compliance to protocol|1|||
37944952|NCT00661362|69632466|FG000|Overall Study|Safety reasons|1|||
37944953|NCT00661362|69632467|FG001|Overall Study|Safety reasons|0|||
37944954|NCT00661362|69632466|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
37944955|NCT00661362|69632467|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
37944956|NCT00325897|69632475|FG000|Overall Study|Lost to Follow-up|12|||
37944957|NCT00325897|69632476|FG001|Overall Study|Lost to Follow-up|13|||
37944958|NCT00344773|69632485|FG000|Overall Study|Adverse Event|2|||
37944959|NCT00344773|69632485|FG000|Overall Study|Objective Disease Progression|16|||
37944960|NCT00344773|69632485|FG000|Overall Study|Withdrawal by Subject|1|||
37944961|NCT00344773|69632485|FG000|Overall Study|Not Eligible for the study|2|||
37944962|NCT00325819|69632491|FG000|Overall Study|Study product lost in mail|2|||
37944963|NCT00325819|69632492|FG001|Overall Study|Study product lost in mail|1|||
37944964|NCT00325819|69632491|FG000|Overall Study|Did not take a dose of study product|4|||
38038058|NCT03546621|69725578|FG001|Overall Study|Adverse Event|1|||
38038059|NCT03546621|69725579|FG002|Overall Study|Adverse Event|0|||
37944965|NCT00325819|69632492|FG001|Overall Study|Did not take a dose of study product|9|||
37944966|NCT00325819|69632491|FG000|Overall Study|Lost to Follow-up|3|||
37944967|NCT00325819|69632492|FG001|Overall Study|Lost to Follow-up|3|||
37944968|NCT00687362|69632500|FG000|Overall Study|Protocol Violation|2|||
37944969|NCT00687362|69632500|FG000|Overall Study|Withdrawal by Subject|1|||
38038060|NCT03546621|69725580|FG003|Overall Study|Adverse Event|1|||
38038061|NCT03546621|69725577|FG000|Overall Study|Progressive disease|0|||
38038062|NCT03546621|69725578|FG001|Overall Study|Progressive disease|0|||
38038063|NCT03546621|69725579|FG002|Overall Study|Progressive disease|0|||
38038064|NCT03546621|69725580|FG003|Overall Study|Progressive disease|1|||
38038065|NCT02761330|69725590|FG000|Treatment Week 1|Withdrawal by Subject|0|||
38038066|NCT02761330|69725591|FG001|Treatment Week 1|Withdrawal by Subject|0|||
38038067|NCT02761330|69725592|FG002|Treatment Week 1|Withdrawal by Subject|0|||
38038068|NCT02761330|69725593|FG003|Treatment Week 1|Withdrawal by Subject|1|||
38038069|NCT02761330|69725594|FG004|Treatment Week 1|Withdrawal by Subject|0|||
38038070|NCT02761330|69725595|FG005|Treatment Week 1|Withdrawal by Subject|1|||
38038071|NCT03559257|69725611|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
38038072|NCT03559257|69725612|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
38038073|NCT03559257|69725611|FG000|Double Blind Treatment Period|Protocol Violation|1|||
38038074|NCT03559257|69725612|FG001|Double Blind Treatment Period|Protocol Violation|4|||
38038075|NCT03559257|69725611|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
38038076|NCT03559257|69725612|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
38038077|NCT03559257|69725611|FG000|Double Blind Treatment Period|Adverse Event|0|||
38038078|NCT03559257|69725612|FG001|Double Blind Treatment Period|Adverse Event|1|||
38038079|NCT03559257|69725611|FG000|Double Blind Treatment Period|Screen Failure|0|||
38038080|NCT03559257|69725612|FG001|Double Blind Treatment Period|Screen Failure|1|||
38038081|NCT03559257|69725611|FG000|Open-label Treatment Period|Adverse Event|1|||
38038082|NCT03559257|69725612|FG001|Open-label Treatment Period|Adverse Event|4|||
38038083|NCT03559257|69725611|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
38038084|NCT03559257|69725612|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
38038085|NCT03559257|69725611|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
38038086|NCT03559257|69725612|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
38038087|NCT03559257|69725611|FG000|Open-label Treatment Period|Protocol Violation|2|||
38038088|NCT03559257|69725612|FG001|Open-label Treatment Period|Protocol Violation|0|||
38038089|NCT03559257|69725611|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
38038090|NCT03559257|69725612|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
38038091|NCT03559257|69725611|FG000|Open-label Treatment Period|Physician Decision|0|||
38038092|NCT03559257|69725612|FG001|Open-label Treatment Period|Physician Decision|1|||
38038093|NCT02892513|69725623|FG000|Overall Study|Withdrawal by Subject|0|||
38038094|NCT02892513|69725624|FG001|Overall Study|Withdrawal by Subject|1|||
38038095|NCT03558555|69725632|FG000|Overall Study|Lost to Follow-up|2|||
38038096|NCT03558555|69725633|FG001|Overall Study|Lost to Follow-up|1|||
38038097|NCT03541317|69725641|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
38038098|NCT03541317|69725642|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
38038099|NCT03541317|69725643|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
38038100|NCT03541317|69725644|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
38038101|NCT03541317|69725645|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
38038102|NCT03541317|69725646|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
38038103|NCT03557931|69725661|FG000|Overall Study|Adverse Event|4|||
38038104|NCT03557931|69725662|FG001|Overall Study|Adverse Event|6|||
38038105|NCT03557931|69725663|FG002|Overall Study|Adverse Event|1|||
38038106|NCT03557931|69725661|FG000|Overall Study|Lost to Follow-up|4|||
38038107|NCT03557931|69725662|FG001|Overall Study|Lost to Follow-up|4|||
38038108|NCT03557931|69725663|FG002|Overall Study|Lost to Follow-up|1|||
38038109|NCT03557931|69725661|FG000|Overall Study|Protocol Violation|1|||
38038110|NCT03557931|69725662|FG001|Overall Study|Protocol Violation|4|||
38038111|NCT03557931|69725663|FG002|Overall Study|Protocol Violation|1|||
38038112|NCT03557931|69725661|FG000|Overall Study|Withdrawal by Subject|14|||
38038113|NCT03557931|69725662|FG001|Overall Study|Withdrawal by Subject|0|||
38038114|NCT03557931|69725663|FG002|Overall Study|Withdrawal by Subject|7|||
38038115|NCT03557931|69725661|FG000|Overall Study|Miscellaneous|8|||
38038116|NCT03557931|69725662|FG001|Overall Study|Miscellaneous|5|||
38038117|NCT03557931|69725663|FG002|Overall Study|Miscellaneous|3|||
38038118|NCT03522675|69725673|FG000|Overall Study|Screen fail|1|||
38038119|NCT03522675|69725673|FG000|Overall Study|Non-reactive to histamine|1|||
38038120|NCT00294047|69725683|FG000|Month 48|Adverse Event|28|||
38038121|NCT00294047|69725684|FG001|Month 48|Adverse Event|13|||
38038122|NCT00294047|69725683|FG000|Month 48|Protocol Violation|4|||
38038123|NCT00294047|69725684|FG001|Month 48|Protocol Violation|4|||
38038124|NCT00294047|69725683|FG000|Month 48|Withdrawal by Subject|111|||
38038125|NCT00294047|69725684|FG001|Month 48|Withdrawal by Subject|115|||
38038126|NCT00294047|69725683|FG000|Month 48|Lost to Follow-up|272|||
38038127|NCT00294047|69725684|FG001|Month 48|Lost to Follow-up|287|||
38038128|NCT00294047|69725683|FG000|Month 48|Other|10|||
38038129|NCT00294047|69725684|FG001|Month 48|Other|14|||
38038130|NCT00294047|69725683|FG000|Month 84|Adverse Event|4|||
38038131|NCT00294047|69725684|FG001|Month 84|Adverse Event|2|||
38038132|NCT00294047|69725683|FG000|Month 84|Protocol Violation|1|||
38038133|NCT00294047|69725684|FG001|Month 84|Protocol Violation|1|||
38038134|NCT00294047|69725683|FG000|Month 84|Withdrawal by Subject|33|||
37944970|NCT00325195|69632507|FG000|Randomized|Not dosed|5|||
38038135|NCT00294047|69725684|FG001|Month 84|Withdrawal by Subject|31|||
38038136|NCT00294047|69725683|FG000|Month 84|Lost to Follow-up|187|||
38038137|NCT00294047|69725684|FG001|Month 84|Lost to Follow-up|190|||
38038138|NCT00294047|69725683|FG000|Month 84|Absent Cervix|2|||
38038139|NCT00294047|69725684|FG001|Month 84|Absent Cervix|0|||
38038140|NCT00294047|69725683|FG000|Month 84|Work related reasons|4|||
38038141|NCT00294047|69725684|FG001|Month 84|Work related reasons|2|||
38038142|NCT00294047|69725683|FG000|Month 84|Center closed, subject did not transfer|1|||
38038143|NCT00294047|69725684|FG001|Month 84|Center closed, subject did not transfer|0|||
38038144|NCT00294047|69725683|FG000|Month 84|Family problems|2|||
38038145|NCT00294047|69725684|FG001|Month 84|Family problems|2|||
38038146|NCT00294047|69725683|FG000|Month 84|Lack of time|3|||
38038147|NCT00294047|69725684|FG001|Month 84|Lack of time|1|||
38038148|NCT00294047|69725683|FG000|Month 84|Personal reason|2|||
38038149|NCT00294047|69725684|FG001|Month 84|Personal reason|4|||
38038150|NCT00294047|69725683|FG000|Month 84|Subject does not want male physician|1|||
38038151|NCT00294047|69725684|FG001|Month 84|Subject does not want male physician|0|||
38038152|NCT00294047|69725683|FG000|Month 84|Transport reimbursement delayed|0|||
38038153|NCT00294047|69725684|FG001|Month 84|Transport reimbursement delayed|1|||
38038154|NCT00294047|69725683|FG000|Month 84|Unable to reach study site|1|||
38038155|NCT00294047|69725684|FG001|Month 84|Unable to reach study site|0|||
38038156|NCT00294047|69725683|FG000|Month 84|Under investigation locally|1|||
38038157|NCT00294047|69725684|FG001|Month 84|Under investigation locally|0|||
38038158|NCT00294047|69725683|FG000|Month 84|Visit missed|0|||
38038159|NCT00294047|69725684|FG001|Month 84|Visit missed|1|||
38038160|NCT00294047|69725683|FG000|Month 84|No consent for Month 84 Follow-up|731|||
38038161|NCT00294047|69725684|FG001|Month 84|No consent for Month 84 Follow-up|754|||
38038162|NCT00293813|69725694|FG000|Overall Study|Physician Decision|0|||
38038163|NCT00293813|69725695|FG001|Overall Study|Physician Decision|1|||
38038164|NCT00293813|69725696|FG002|Overall Study|Physician Decision|0|||
38038165|NCT00293813|69725694|FG000|Overall Study|Adverse Event|3|||
38038166|NCT00293813|69725695|FG001|Overall Study|Adverse Event|1|||
38038167|NCT00293813|69725696|FG002|Overall Study|Adverse Event|1|||
38038168|NCT00293813|69725694|FG000|Overall Study|Withdrawal by Subject|7|||
38038169|NCT00293813|69725695|FG001|Overall Study|Withdrawal by Subject|4|||
38038170|NCT00293813|69725696|FG002|Overall Study|Withdrawal by Subject|4|||
38038171|NCT00293813|69725694|FG000|Overall Study|Lost to Follow-up|3|||
38038172|NCT00293813|69725695|FG001|Overall Study|Lost to Follow-up|2|||
38038173|NCT00293813|69725696|FG002|Overall Study|Lost to Follow-up|3|||
38038174|NCT00293813|69725694|FG000|Overall Study|Noncompliance|0|||
38038175|NCT00293813|69725695|FG001|Overall Study|Noncompliance|1|||
38038176|NCT00293813|69725696|FG002|Overall Study|Noncompliance|0|||
38038177|NCT00293579|69725704|FG000|Overall Study|Withdrawal by Subject|1|||
38038178|NCT00293423|69725711|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
38038179|NCT00293423|69725712|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
38038180|NCT00293423|69725711|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
38038181|NCT00293423|69725712|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
38038182|NCT00293423|69725711|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
38038183|NCT00293423|69725712|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
38038184|NCT00293423|69725711|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
38038185|NCT00293423|69725712|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
38038186|NCT00293423|69725711|FG000|Surgical Resection|processing error during surgical resection|1|||
38038187|NCT00293423|69725712|FG001|Surgical Resection|processing error during surgical resection|0|||
38038188|NCT00293423|69725711|FG000|Surgical Resection|Withdrawal by Subject|4|||
38038189|NCT00293423|69725712|FG001|Surgical Resection|Withdrawal by Subject|0|||
38038190|NCT00293423|69725711|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
38038191|NCT00293423|69725712|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
38038192|NCT03538743|69725727|FG000|Overall Study|Adverse Event|0|||
38038193|NCT03538743|69725728|FG001|Overall Study|Adverse Event|0|||
38038194|NCT03538743|69725729|FG002|Overall Study|Adverse Event|1|||
38038195|NCT03538743|69725730|FG003|Overall Study|Adverse Event|1|||
38038196|NCT03538743|69725731|FG004|Overall Study|Adverse Event|0|||
37673282|NCT02684617|69147512|FG000|Overall Study|Death|8|||
37673283|NCT02684617|69147513|FG001|Overall Study|Death|16|||
37673284|NCT02684617|69147514|FG002|Overall Study|Death|28|||
38038197|NCT03538743|69725732|FG005|Overall Study|Adverse Event|0|||
38038198|NCT03538743|69725733|FG006|Overall Study|Adverse Event|0|||
38038199|NCT03538743|69725734|FG007|Overall Study|Adverse Event|0|||
38038200|NCT03538743|69725735|FG008|Overall Study|Adverse Event|0|||
38038201|NCT03538743|69725727|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
38038202|NCT03538743|69725728|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
38038203|NCT03538743|69725729|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
38038204|NCT03538743|69725730|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
38038205|NCT03538743|69725731|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
37673285|NCT02684617|69147512|FG000|Overall Study|Withdrawal by Subject|2|||
38038206|NCT03538743|69725732|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
38038207|NCT03538743|69725733|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
38038208|NCT03538743|69725734|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
38038209|NCT03538743|69725735|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
38038210|NCT03538743|69725727|FG000|Overall Study|Withdrawal by Subject|0|||
38038211|NCT03538743|69725728|FG001|Overall Study|Withdrawal by Subject|0|||
38038212|NCT03538743|69725729|FG002|Overall Study|Withdrawal by Subject|0|||
38038213|NCT03538743|69725730|FG003|Overall Study|Withdrawal by Subject|1|||
38038214|NCT03538743|69725731|FG004|Overall Study|Withdrawal by Subject|0|||
38038215|NCT03538743|69725732|FG005|Overall Study|Withdrawal by Subject|0|||
38038216|NCT03538743|69725733|FG006|Overall Study|Withdrawal by Subject|0|||
38038217|NCT03538743|69725734|FG007|Overall Study|Withdrawal by Subject|0|||
38038218|NCT03538743|69725735|FG008|Overall Study|Withdrawal by Subject|0|||
38038219|NCT03521817|69725765|FG000|Overall Study|Protocol Violation|0|||
38038220|NCT03521817|69725766|FG001|Overall Study|Protocol Violation|1|||
38038221|NCT03538431|69725772|FG000|Overall Study|Physician Decision|0|||
38038222|NCT03538431|69725773|FG001|Overall Study|Physician Decision|1|||
38038223|NCT03538431|69725772|FG000|Overall Study|Withdrawal by Subject|1|||
38038224|NCT03538431|69725773|FG001|Overall Study|Withdrawal by Subject|0|||
38038225|NCT03521193|69725783|FG000|Overall Study|Withdrawal by Subject|8|||
38038226|NCT03521193|69725784|FG001|Overall Study|Withdrawal by Subject|0|||
38038227|NCT03521193|69725783|FG000|Overall Study|non compliant to ASA treatment|8|||
38038228|NCT03521193|69725784|FG001|Overall Study|non compliant to ASA treatment|0|||
37673286|NCT02684617|69147513|FG001|Overall Study|Withdrawal by Subject|0|||
37673287|NCT02684617|69147514|FG002|Overall Study|Withdrawal by Subject|4|||
37673288|NCT02684617|69147512|FG000|Overall Study|Screen Failure|1|||
37673289|NCT02684617|69147513|FG001|Overall Study|Screen Failure|0|||
37673290|NCT02684617|69147514|FG002|Overall Study|Screen Failure|2|||
37673291|NCT02684617|69147512|FG000|Overall Study|Study Terminated by Sponsor|6|||
37673292|NCT02684617|69147513|FG001|Overall Study|Study Terminated by Sponsor|1|||
37673293|NCT02684617|69147514|FG002|Overall Study|Study Terminated by Sponsor|5|||
37673294|NCT01999972|69147528|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
37673295|NCT01999972|69147529|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
37673296|NCT01999972|69147530|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
37673297|NCT01999972|69147531|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
37673298|NCT01999972|69147532|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
37673299|NCT01999972|69147533|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
37673300|NCT01999972|69147528|FG000|Dose Escalation Part|Death|0|||
37673301|NCT01999972|69147529|FG001|Dose Escalation Part|Death|1|||
37673302|NCT01999972|69147530|FG002|Dose Escalation Part|Death|0|||
37673303|NCT01999972|69147531|FG003|Dose Escalation Part|Death|0|||
37673304|NCT01999972|69147532|FG004|Dose Escalation Part|Death|0|||
37673305|NCT01999972|69147533|FG005|Dose Escalation Part|Death|0|||
37673306|NCT01999972|69147528|FG000|Dose Escalation Part|Enrolled but not treated|0|||
37673307|NCT01999972|69147529|FG001|Dose Escalation Part|Enrolled but not treated|0|||
37673308|NCT01999972|69147530|FG002|Dose Escalation Part|Enrolled but not treated|1|||
37673309|NCT01999972|69147531|FG003|Dose Escalation Part|Enrolled but not treated|1|||
37673310|NCT01999972|69147532|FG004|Dose Escalation Part|Enrolled but not treated|0|||
37673311|NCT01999972|69147533|FG005|Dose Escalation Part|Enrolled but not treated|0|||
37673312|NCT01999972|69147528|FG000|Dose Escalation Part|Disease progression|3|||
37673313|NCT01999972|69147529|FG001|Dose Escalation Part|Disease progression|2|||
37673314|NCT01999972|69147530|FG002|Dose Escalation Part|Disease progression|3|||
37673315|NCT01999972|69147531|FG003|Dose Escalation Part|Disease progression|6|||
37673316|NCT01999972|69147532|FG004|Dose Escalation Part|Disease progression|0|||
37673317|NCT01999972|69147533|FG005|Dose Escalation Part|Disease progression|0|||
37673318|NCT01999972|69147528|FG000|Dose Escalation Part|Adverse Event|0|||
37673319|NCT01999972|69147529|FG001|Dose Escalation Part|Adverse Event|0|||
37673320|NCT01999972|69147530|FG002|Dose Escalation Part|Adverse Event|0|||
37673321|NCT01999972|69147531|FG003|Dose Escalation Part|Adverse Event|2|||
37673322|NCT01999972|69147532|FG004|Dose Escalation Part|Adverse Event|0|||
37673323|NCT01999972|69147533|FG005|Dose Escalation Part|Adverse Event|0|||
37673324|NCT01999972|69147528|FG000|Dose Escalation Part|Global deterioration of health status|1|||
37673325|NCT01999972|69147529|FG001|Dose Escalation Part|Global deterioration of health status|0|||
37673326|NCT01999972|69147530|FG002|Dose Escalation Part|Global deterioration of health status|0|||
37673327|NCT01999972|69147531|FG003|Dose Escalation Part|Global deterioration of health status|1|||
37673328|NCT01999972|69147532|FG004|Dose Escalation Part|Global deterioration of health status|0|||
37673329|NCT01999972|69147533|FG005|Dose Escalation Part|Global deterioration of health status|0|||
38038229|NCT00293267|69725793|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
37673330|NCT01999972|69147528|FG000|Dose Expansion Part|Death|0|||
37673331|NCT01999972|69147529|FG001|Dose Expansion Part|Death|0|||
37673332|NCT01999972|69147530|FG002|Dose Expansion Part|Death|0|||
37673333|NCT01999972|69147531|FG003|Dose Expansion Part|Death|0|||
38038230|NCT00293267|69725794|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
38038231|NCT00293267|69725793|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
38038232|NCT00293267|69725794|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
38038233|NCT00293267|69725793|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
38038234|NCT00293267|69725794|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
38038235|NCT00293267|69725793|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
38038236|NCT00293267|69725794|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
38038237|NCT00293267|69725793|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
38038238|NCT00293267|69725794|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
38038239|NCT00293267|69725793|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
38038240|NCT00293267|69725794|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
38038241|NCT00293267|69725793|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
38038242|NCT00293267|69725794|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
38038243|NCT00293267|69725793|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
38038244|NCT00293267|69725794|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
38038245|NCT00293267|69725793|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
38038246|NCT00293267|69725794|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
38038247|NCT00293267|69725793|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
38038248|NCT00293267|69725794|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
38038249|NCT00293267|69725793|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
38038250|NCT00293267|69725794|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
38038251|NCT00293267|69725793|FG000|Extension - Double-Blind Week 49-156|Death|3|||
38038252|NCT00293267|69725794|FG001|Extension - Double-Blind Week 49-156|Death|0|||
38038253|NCT00293267|69725793|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
38038254|NCT00293267|69725794|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
38038255|NCT00293267|69725793|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
38038256|NCT00293267|69725794|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
38038257|NCT00293267|69725793|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
38038258|NCT00293267|69725794|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
38038259|NCT00293267|69725793|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
38038260|NCT00293267|69725794|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
38038261|NCT00293267|69725793|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
38038262|NCT00293267|69725794|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
38038263|NCT00293267|69725793|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
38038264|NCT00293267|69725794|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
38038265|NCT00293267|69725793|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
38038266|NCT00293267|69725794|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
38038267|NCT00293267|69725793|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
38038268|NCT00293267|69725794|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
38038269|NCT00293267|69725793|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
38038270|NCT00293267|69725794|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
38038271|NCT00293267|69725793|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
38038272|NCT00293267|69725794|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
38038273|NCT00293267|69725793|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
38038274|NCT00293267|69725794|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
38038275|NCT00293267|69725793|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
38038276|NCT00293267|69725794|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
38038277|NCT00293267|69725793|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
38038278|NCT00293267|69725794|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
38038279|NCT00293267|69725793|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
38038280|NCT00293267|69725794|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
38038281|NCT00293267|69725793|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
38038282|NCT00293267|69725794|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
38038283|NCT00293267|69725793|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
38038284|NCT00293267|69725794|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
38038285|NCT03520959|69725804|FG000|Overall Study|Study terminated by Sponsor|0|||
38038286|NCT03520959|69725805|FG001|Overall Study|Study terminated by Sponsor|1|||
38038287|NCT03537261|69725813|FG000|Overall Study|Lost to Follow-up|4|||
38038288|NCT03537261|69725814|FG001|Overall Study|Lost to Follow-up|5|||
38038289|NCT03537261|69725813|FG000|Overall Study|Withdrawal by Subject|4|||
38038290|NCT03537261|69725814|FG001|Overall Study|Withdrawal by Subject|6|||
38038291|NCT03537261|69725813|FG000|Overall Study|Did not return study questionnaires|0|||
38038292|NCT03537261|69725814|FG001|Overall Study|Did not return study questionnaires|1|||
38038293|NCT03536949|69725822|FG000|Overall Study|Adverse Event|4|||
38038294|NCT03536949|69725823|FG001|Overall Study|Adverse Event|0|||
38038295|NCT03536949|69725822|FG000|Overall Study|Lost to Follow-up|2|||
37673334|NCT01999972|69147532|FG004|Dose Expansion Part|Death|2|||
38038296|NCT03536949|69725823|FG001|Overall Study|Lost to Follow-up|1|||
38038297|NCT03536949|69725822|FG000|Overall Study|Withdrawal by Subject|6|||
38038298|NCT03536949|69725823|FG001|Overall Study|Withdrawal by Subject|0|||
38038299|NCT03536949|69725822|FG000|Overall Study|Non-compliance|2|||
38038300|NCT03536949|69725823|FG001|Overall Study|Non-compliance|1|||
38038301|NCT03588741|69725829|FG000|Overall Study|Withdrawal by Subject|1|||
38038302|NCT00111917|69725835|FG000|Overall Study|Withdrawal by Subject|1|||
38038303|NCT00111917|69725836|FG001|Overall Study|Withdrawal by Subject|1|||
38038304|NCT03520569|69725846|FG000|Overall Study|Withdrawal by Subject|1|||
38038305|NCT00111839|69725859|FG000|Overall Study|Disease Progression|30|||
38038306|NCT00111839|69725860|FG001|Overall Study|Disease Progression|33|||
38038307|NCT00111839|69725861|FG002|Overall Study|Disease Progression|33|||
38038308|NCT00111839|69725859|FG000|Overall Study|Adverse Event|5|||
38038309|NCT00111839|69725860|FG001|Overall Study|Adverse Event|3|||
38038310|NCT00111839|69725861|FG002|Overall Study|Adverse Event|1|||
38038311|NCT00111839|69725859|FG000|Overall Study|Protocol Violation|2|||
38038312|NCT00111839|69725860|FG001|Overall Study|Protocol Violation|4|||
38038313|NCT00111839|69725861|FG002|Overall Study|Protocol Violation|2|||
38038314|NCT00111839|69725859|FG000|Overall Study|Death|1|||
38038315|NCT00111839|69725860|FG001|Overall Study|Death|1|||
38038316|NCT00111839|69725861|FG002|Overall Study|Death|6|||
38038317|NCT00111839|69725859|FG000|Overall Study|Withdrawal by Subject|2|||
38038318|NCT00111839|69725860|FG001|Overall Study|Withdrawal by Subject|2|||
38038319|NCT00111839|69725861|FG002|Overall Study|Withdrawal by Subject|2|||
38038320|NCT00111839|69725859|FG000|Overall Study|Lost to Follow-up|1|||
38038321|NCT00111839|69725860|FG001|Overall Study|Lost to Follow-up|0|||
38038322|NCT00111839|69725861|FG002|Overall Study|Lost to Follow-up|0|||
38038323|NCT00111839|69725859|FG000|Overall Study|Logistical Constraint|1|||
38038324|NCT00111839|69725860|FG001|Overall Study|Logistical Constraint|0|||
38038325|NCT00111839|69725861|FG002|Overall Study|Logistical Constraint|0|||
38038326|NCT00111839|69725859|FG000|Overall Study|Other|6|||
38038327|NCT00111839|69725860|FG001|Overall Study|Other|3|||
38038328|NCT00111839|69725861|FG002|Overall Study|Other|3|||
38038329|NCT00111839|69725859|FG000|Overall Study|Randomized but Not Treated|0|||
38038330|NCT00111839|69725860|FG001|Overall Study|Randomized but Not Treated|0|||
38038331|NCT00111839|69725861|FG002|Overall Study|Randomized but Not Treated|2|||
38038332|NCT00111761|69725871|FG000|Part 1|Physician Decision|0|||
38038333|NCT00111761|69725872|FG001|Part 1|Physician Decision|1|||
38038334|NCT00111761|69725871|FG000|Part 1|Death|0|||
38038335|NCT00111761|69725872|FG001|Part 1|Death|2|||
38038336|NCT00111761|69725871|FG000|Part 1|Other|0|||
38038337|NCT00111761|69725872|FG001|Part 1|Other|1|||
38038338|NCT00111761|69725871|FG000|Part 1|Withdrawal by Subject|0|||
38038339|NCT00111761|69725872|FG001|Part 1|Withdrawal by Subject|1|||
38038340|NCT00111761|69725871|FG000|Part 2|Adverse Event|1|||
38038341|NCT00111761|69725872|FG001|Part 2|Adverse Event|0|||
38038342|NCT00111761|69725871|FG000|Part 2|Physician Decision|1|||
38038343|NCT00111761|69725872|FG001|Part 2|Physician Decision|0|||
38038344|NCT00111761|69725871|FG000|Part 2|Death|1|||
38038345|NCT00111761|69725872|FG001|Part 2|Death|0|||
38038346|NCT00111761|69725871|FG000|Part 2|Disease progression|3|||
38038347|NCT00111761|69725872|FG001|Part 2|Disease progression|0|||
38038348|NCT00111761|69725871|FG000|Part 2|Protocol-specified criteria|1|||
38038349|NCT00111761|69725872|FG001|Part 2|Protocol-specified criteria|0|||
38038350|NCT00111761|69725871|FG000|Part 2|Other|1|||
38038351|NCT00111761|69725872|FG001|Part 2|Other|0|||
38038352|NCT03519867|69725888|FG000|Overall Study|Adverse Event|1|||
38038353|NCT03519867|69725889|FG001|Overall Study|Adverse Event|1|||
38038354|NCT03519867|69725890|FG002|Overall Study|Adverse Event|0|||
38038355|NCT03519867|69725891|FG003|Overall Study|Adverse Event|0|||
38038356|NCT03519867|69725892|FG004|Overall Study|Adverse Event|0|||
38038357|NCT03519867|69725893|FG005|Overall Study|Adverse Event|0|||
38038358|NCT03519867|69725894|FG006|Overall Study|Adverse Event|0|||
37673335|NCT01999972|69147533|FG005|Dose Expansion Part|Death|1|||
38038359|NCT03519867|69725895|FG007|Overall Study|Adverse Event|0|||
38038360|NCT03519867|69725896|FG008|Overall Study|Adverse Event|0|||
38038361|NCT03519867|69725897|FG009|Overall Study|Adverse Event|0|||
38038362|NCT03519867|69725888|FG000|Overall Study|Protocol Violation|0|||
38038363|NCT03519867|69725889|FG001|Overall Study|Protocol Violation|0|||
38038364|NCT03519867|69725890|FG002|Overall Study|Protocol Violation|0|||
37673336|NCT01999972|69147528|FG000|Dose Expansion Part|Disease progression|0|||
37673337|NCT01999972|69147529|FG001|Dose Expansion Part|Disease progression|0|||
38038365|NCT03519867|69725891|FG003|Overall Study|Protocol Violation|0|||
38038366|NCT03519867|69725892|FG004|Overall Study|Protocol Violation|0|||
38038367|NCT03519867|69725893|FG005|Overall Study|Protocol Violation|1|||
38038368|NCT03519867|69725894|FG006|Overall Study|Protocol Violation|0|||
38038369|NCT03519867|69725895|FG007|Overall Study|Protocol Violation|0|||
38038370|NCT03519867|69725896|FG008|Overall Study|Protocol Violation|0|||
38038371|NCT03519867|69725897|FG009|Overall Study|Protocol Violation|0|||
38038372|NCT03519867|69725888|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
38038373|NCT03519867|69725889|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
38038374|NCT03519867|69725890|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
38038375|NCT03519867|69725891|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
38038376|NCT03519867|69725892|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
38038377|NCT03519867|69725893|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
38038378|NCT03519867|69725894|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
38038379|NCT03519867|69725895|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
38038380|NCT03519867|69725896|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
38038381|NCT03519867|69725897|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
38038382|NCT03519867|69725888|FG000|Overall Study|Admin. of other reversal agent|1|||
38038383|NCT03519867|69725889|FG001|Overall Study|Admin. of other reversal agent|1|||
38038384|NCT03519867|69725890|FG002|Overall Study|Admin. of other reversal agent|0|||
38038385|NCT03519867|69725891|FG003|Overall Study|Admin. of other reversal agent|0|||
38038386|NCT03519867|69725892|FG004|Overall Study|Admin. of other reversal agent|0|||
38038387|NCT03519867|69725893|FG005|Overall Study|Admin. of other reversal agent|1|||
38038388|NCT03519867|69725894|FG006|Overall Study|Admin. of other reversal agent|0|||
38038389|NCT03519867|69725895|FG007|Overall Study|Admin. of other reversal agent|0|||
38038390|NCT03519867|69725896|FG008|Overall Study|Admin. of other reversal agent|0|||
38038391|NCT03519867|69725897|FG009|Overall Study|Admin. of other reversal agent|0|||
38038392|NCT03519867|69725888|FG000|Overall Study|Reason not provided|1|||
38038393|NCT03519867|69725889|FG001|Overall Study|Reason not provided|1|||
38038394|NCT03519867|69725890|FG002|Overall Study|Reason not provided|1|||
38038395|NCT03519867|69725891|FG003|Overall Study|Reason not provided|1|||
38038396|NCT03519867|69725892|FG004|Overall Study|Reason not provided|0|||
38038397|NCT03519867|69725893|FG005|Overall Study|Reason not provided|1|||
38038398|NCT03519867|69725894|FG006|Overall Study|Reason not provided|0|||
38038399|NCT03519867|69725895|FG007|Overall Study|Reason not provided|1|||
38038400|NCT03519867|69725896|FG008|Overall Study|Reason not provided|1|||
38038401|NCT03519867|69725897|FG009|Overall Study|Reason not provided|0|||
38038402|NCT03519087|69725921|FG000|Clinic Evaluation|Physician Decision|15|||
38038403|NCT03519087|69725922|FG001|Clinic Evaluation|Physician Decision|18|||
38038404|NCT03519087|69725923|FG002|Clinic Evaluation|Physician Decision|0|||
38038405|NCT03519087|69725924|FG003|Clinic Evaluation|Physician Decision|0|||
38038406|NCT03519087|69725925|FG004|Clinic Evaluation|Physician Decision|0|||
38038407|NCT03519087|69725921|FG000|Clinic Evaluation|Protocol Violation|1|||
38038408|NCT03519087|69725922|FG001|Clinic Evaluation|Protocol Violation|0|||
38038409|NCT03519087|69725923|FG002|Clinic Evaluation|Protocol Violation|0|||
38038410|NCT03519087|69725924|FG003|Clinic Evaluation|Protocol Violation|0|||
38038411|NCT03519087|69725925|FG004|Clinic Evaluation|Protocol Violation|0|||
38038412|NCT03519087|69725921|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
38038413|NCT03519087|69725922|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
38038414|NCT03519087|69725923|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
38038415|NCT03519087|69725924|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
38038416|NCT03519087|69725925|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
38038417|NCT03519087|69725921|FG000|Re-randomization for Treatment|Not appropriate|2|||
38038418|NCT03519087|69725922|FG001|Re-randomization for Treatment|Not appropriate|3|||
37944971|NCT00325195|69632508|FG001|Randomized|Not dosed|5|||
37944972|NCT00325195|69632509|FG002|Randomized|Not dosed|3|||
37944973|NCT00325195|69632507|FG000|Received Intervention: ITT Population|Adverse Event|15|||
37944974|NCT00325195|69632508|FG001|Received Intervention: ITT Population|Adverse Event|17|||
37944975|NCT00325195|69632509|FG002|Received Intervention: ITT Population|Adverse Event|1|||
37944976|NCT00325195|69632507|FG000|Received Intervention: ITT Population|Death|3|||
37944977|NCT00325195|69632508|FG001|Received Intervention: ITT Population|Death|1|||
37944978|NCT00325195|69632509|FG002|Received Intervention: ITT Population|Death|0|||
37944979|NCT00325195|69632507|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
37944980|NCT00325195|69632508|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
37944981|NCT00325195|69632509|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
37944982|NCT00325195|69632507|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
37944983|NCT00325195|69632508|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
37944984|NCT00325195|69632509|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
37944985|NCT00325195|69632507|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
37944986|NCT00325195|69632508|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
37944987|NCT00325195|69632509|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
37944988|NCT03976401|69632523|FG000|Overall Study|Adverse Event|2|||
37944989|NCT03976401|69632524|FG001|Overall Study|Adverse Event|0|||
37944990|NCT03976401|69632525|FG002|Overall Study|Adverse Event|4|||
37944991|NCT03976401|69632526|FG003|Overall Study|Adverse Event|1|||
37944992|NCT03976401|69632527|FG004|Overall Study|Adverse Event|1|||
38038419|NCT03519087|69725923|FG002|Re-randomization for Treatment|Not appropriate|0|||
38038420|NCT03519087|69725924|FG003|Re-randomization for Treatment|Not appropriate|0|||
38038421|NCT03519087|69725925|FG004|Re-randomization for Treatment|Not appropriate|0|||
38038422|NCT03519087|69725921|FG000|Laboratory Testing|Lost to Follow-up|0|||
38038423|NCT03519087|69725922|FG001|Laboratory Testing|Lost to Follow-up|0|||
38038424|NCT03519087|69725923|FG002|Laboratory Testing|Lost to Follow-up|2|||
38038425|NCT03519087|69725924|FG003|Laboratory Testing|Lost to Follow-up|3|||
38038426|NCT03519087|69725925|FG004|Laboratory Testing|Lost to Follow-up|6|||
38038427|NCT03519087|69725921|FG000|Laboratory Testing|Protocol Violation|0|||
38038428|NCT03519087|69725922|FG001|Laboratory Testing|Protocol Violation|0|||
38038429|NCT03519087|69725923|FG002|Laboratory Testing|Protocol Violation|0|||
38038430|NCT03519087|69725924|FG003|Laboratory Testing|Protocol Violation|1|||
38038431|NCT03519087|69725925|FG004|Laboratory Testing|Protocol Violation|0|||
38038432|NCT02763046|69725944|FG000|Overall Study|Adverse Event|5|||
38038433|NCT02763046|69725945|FG001|Overall Study|Adverse Event|4|||
38038434|NCT02763046|69725946|FG002|Overall Study|Adverse Event|0|||
38038435|NCT02763046|69725944|FG000|Overall Study|Lack of Efficacy|1|||
38038436|NCT02763046|69725945|FG001|Overall Study|Lack of Efficacy|1|||
38038437|NCT02763046|69725946|FG002|Overall Study|Lack of Efficacy|3|||
38038438|NCT02763046|69725944|FG000|Overall Study|Physician Decision|1|||
38038439|NCT02763046|69725945|FG001|Overall Study|Physician Decision|0|||
38038440|NCT02763046|69725946|FG002|Overall Study|Physician Decision|1|||
38038441|NCT02763046|69725944|FG000|Overall Study|Subject/guardian decision|2|||
38038442|NCT02763046|69725945|FG001|Overall Study|Subject/guardian decision|0|||
38038443|NCT02763046|69725946|FG002|Overall Study|Subject/guardian decision|4|||
38038444|NCT03518073|69725963|FG000|Overall Study|Adverse Event|2|||
38038445|NCT03518073|69725964|FG001|Overall Study|Adverse Event|4|||
38038446|NCT03518073|69725965|FG002|Overall Study|Adverse Event|2|||
38038447|NCT03518073|69725963|FG000|Overall Study|Death|2|||
38038448|NCT03518073|69725964|FG001|Overall Study|Death|1|||
38038449|NCT03518073|69725965|FG002|Overall Study|Death|3|||
38038450|NCT03518073|69725963|FG000|Overall Study|Lost to Follow-up|1|||
38038451|NCT03518073|69725964|FG001|Overall Study|Lost to Follow-up|0|||
38038452|NCT03518073|69725965|FG002|Overall Study|Lost to Follow-up|1|||
38038453|NCT03518073|69725963|FG000|Overall Study|Physician Decision|5|||
38038454|NCT03518073|69725964|FG001|Overall Study|Physician Decision|0|||
38038455|NCT03518073|69725965|FG002|Overall Study|Physician Decision|2|||
38038456|NCT03518073|69725963|FG000|Overall Study|Progressive disease|1|||
38038457|NCT03518073|69725964|FG001|Overall Study|Progressive disease|1|||
38038458|NCT03518073|69725965|FG002|Overall Study|Progressive disease|1|||
38038459|NCT03518073|69725963|FG000|Overall Study|Protocol Violation|1|||
38038460|NCT03518073|69725964|FG001|Overall Study|Protocol Violation|0|||
38038461|NCT03518073|69725965|FG002|Overall Study|Protocol Violation|0|||
38038462|NCT03518073|69725963|FG000|Overall Study|Withdrawal by Subject|30|||
38038463|NCT03518073|69725964|FG001|Overall Study|Withdrawal by Subject|34|||
38038464|NCT03518073|69725965|FG002|Overall Study|Withdrawal by Subject|29|||
38038465|NCT03518073|69725963|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
38038466|NCT03518073|69725964|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
38038467|NCT03518073|69725965|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
37673338|NCT01999972|69147530|FG002|Dose Expansion Part|Disease progression|0|||
37766380|NCT01407367|69280392|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
37766381|NCT01407367|69280393|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
37766382|NCT01407367|69280392|FG000|Overall Study|Withdrawal by Subject|4|||
37766383|NCT01407367|69280393|FG001|Overall Study|Withdrawal by Subject|15|||
37766384|NCT01407367|69280392|FG000|Overall Study|Lost to Follow-up|0|||
38038468|NCT03518073|69725963|FG000|Overall Study|Covid-19|1|||
38038469|NCT03518073|69725964|FG001|Overall Study|Covid-19|2|||
38038470|NCT03518073|69725965|FG002|Overall Study|Covid-19|1|||
38038471|NCT02759692|69725975|FG000|Period 1|Test article no longer available|1|||
38038472|NCT02759692|69725976|FG001|Period 1|Test article no longer available|1|||
37673339|NCT01999972|69147531|FG003|Dose Expansion Part|Disease progression|0|||
37673340|NCT01999972|69147532|FG004|Dose Expansion Part|Disease progression|9|||
37673341|NCT01999972|69147533|FG005|Dose Expansion Part|Disease progression|3|||
37673342|NCT01999972|69147528|FG000|Dose Expansion Part|Sponsor decision|0|||
37673343|NCT01999972|69147529|FG001|Dose Expansion Part|Sponsor decision|0|||
37673344|NCT01999972|69147530|FG002|Dose Expansion Part|Sponsor decision|0|||
37673345|NCT01999972|69147531|FG003|Dose Expansion Part|Sponsor decision|0|||
37673346|NCT01999972|69147532|FG004|Dose Expansion Part|Sponsor decision|1|||
37673347|NCT01999972|69147533|FG005|Dose Expansion Part|Sponsor decision|0|||
37673348|NCT01999972|69147528|FG000|Dose Expansion Part|Adverse Event|0|||
37673349|NCT01999972|69147529|FG001|Dose Expansion Part|Adverse Event|0|||
37673350|NCT01999972|69147530|FG002|Dose Expansion Part|Adverse Event|0|||
37673351|NCT01999972|69147531|FG003|Dose Expansion Part|Adverse Event|0|||
37673352|NCT01999972|69147532|FG004|Dose Expansion Part|Adverse Event|4|||
37766385|NCT01407367|69280393|FG001|Overall Study|Lost to Follow-up|2|||
37944993|NCT03976401|69632528|FG005|Overall Study|Adverse Event|0|||
37673353|NCT01999972|69147533|FG005|Dose Expansion Part|Adverse Event|2|||
38038473|NCT02759692|69725975|FG000|Period 1|No longer meets eligibility criteria.|1|||
38038474|NCT02759692|69725976|FG001|Period 1|No longer meets eligibility criteria.|0|||
38038475|NCT02759692|69725975|FG000|Period 1|Miss-Randomized|1|||
38038476|NCT02759692|69725976|FG001|Period 1|Miss-Randomized|1|||
38038477|NCT02759692|69725975|FG000|Period 2|Lost to Follow-up|1|||
38038478|NCT02759692|69725976|FG001|Period 2|Lost to Follow-up|0|||
38038479|NCT02759692|69725975|FG000|Period 2|Test article no longer available|0|||
38038480|NCT02759692|69725976|FG001|Period 2|Test article no longer available|1|||
38038481|NCT03586167|69725984|FG000|Overall Study|Other|1|||
38038482|NCT03586167|69725985|FG001|Overall Study|Other|0|||
38038483|NCT02762578|69725993|FG000|Overall Study|Adverse Event|1|||
38038484|NCT02762578|69725994|FG001|Overall Study|Adverse Event|6|||
38038485|NCT02762578|69725993|FG000|Overall Study|Protocol Violation|4|||
38038486|NCT02762578|69725994|FG001|Overall Study|Protocol Violation|2|||
38038487|NCT02762578|69725993|FG000|Overall Study|Withdrawal by Subject|4|||
38038488|NCT02762578|69725994|FG001|Overall Study|Withdrawal by Subject|2|||
38038489|NCT02762578|69725993|FG000|Overall Study|Unclassified|6|||
38038490|NCT02762578|69725994|FG001|Overall Study|Unclassified|0|||
38038491|NCT03514641|69726004|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
38038492|NCT03514641|69726005|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
38038493|NCT03514641|69726006|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
38038494|NCT03514641|69726007|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
38038495|NCT03514641|69726004|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
38038496|NCT03514641|69726005|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
38038497|NCT03514641|69726006|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
38038498|NCT03514641|69726007|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
38038499|NCT03514641|69726004|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
38038500|NCT03514641|69726005|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
38038501|NCT03514641|69726006|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
38038502|NCT03514641|69726007|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
38038503|NCT03514641|69726004|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
38038504|NCT03514641|69726005|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
38038505|NCT03514641|69726006|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
38038506|NCT03514641|69726007|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
38038507|NCT03514641|69726004|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
38038508|NCT03514641|69726005|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
38038509|NCT03514641|69726006|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
38038510|NCT03514641|69726007|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
38038511|NCT03514641|69726004|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
38038512|NCT03514641|69726005|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
38038513|NCT03514641|69726006|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
38038514|NCT03514641|69726007|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
38038515|NCT03514641|69726004|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
38038516|NCT03514641|69726005|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
38038517|NCT03514641|69726006|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
38038518|NCT03514641|69726007|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
38038519|NCT03514641|69726004|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
38038520|NCT03514641|69726005|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
38038521|NCT03514641|69726006|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
38038522|NCT03514641|69726007|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
38038523|NCT03514641|69726004|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
38038524|NCT03514641|69726005|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
38038525|NCT03514641|69726006|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
38038526|NCT03514641|69726007|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
38038527|NCT03514641|69726004|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
38038528|NCT03514641|69726005|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
38038529|NCT03514641|69726006|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
38038530|NCT03514641|69726007|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
38038531|NCT03514641|69726004|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
38038532|NCT03514641|69726005|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
38038533|NCT03514641|69726006|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
38038534|NCT03514641|69726007|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
38038535|NCT03514641|69726004|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
38038536|NCT03514641|69726005|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
38038537|NCT03514641|69726006|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
38038538|NCT03514641|69726007|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
38038539|NCT00100828|69726019|FG000|Overall Study|Physician Decision|6|||
38038540|NCT00100048|69726028|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
38038541|NCT00100048|69726029|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
38038542|NCT00100048|69726030|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
38038543|NCT00100048|69726031|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
38038544|NCT00100048|69726032|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
38038545|NCT00100048|69726033|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
38038546|NCT00100048|69726028|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
38038547|NCT00100048|69726029|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
38038548|NCT00100048|69726030|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
38038549|NCT00100048|69726031|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
38038550|NCT00100048|69726032|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
38038551|NCT00100048|69726033|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
38038552|NCT00100048|69726028|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
38038553|NCT00100048|69726029|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
38038554|NCT00100048|69726030|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
38038555|NCT00100048|69726031|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
38038556|NCT00100048|69726032|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
38038557|NCT00100048|69726033|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
38038558|NCT00100048|69726028|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
38038559|NCT00100048|69726029|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
38038560|NCT00100048|69726030|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
38038561|NCT00100048|69726031|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
38038562|NCT00100048|69726032|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
38038563|NCT00100048|69726033|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
38038564|NCT00100048|69726028|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
38038565|NCT00100048|69726029|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
38038566|NCT00100048|69726030|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
38038567|NCT00100048|69726031|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
38038568|NCT00100048|69726032|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
38038569|NCT00100048|69726033|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
38038570|NCT00100048|69726028|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
38038571|NCT00100048|69726029|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
38038572|NCT00100048|69726030|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
38038573|NCT00100048|69726031|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
38038574|NCT00100048|69726032|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
38038575|NCT00100048|69726033|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
38038576|NCT00100048|69726028|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
38038577|NCT00100048|69726029|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
38038578|NCT00100048|69726030|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
38038579|NCT00100048|69726031|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
38038580|NCT00100048|69726032|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
38038581|NCT00100048|69726033|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
38038582|NCT00100048|69726028|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
38038583|NCT00100048|69726029|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
38038584|NCT00100048|69726030|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
38038585|NCT00100048|69726031|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
38038586|NCT00100048|69726032|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
38038587|NCT00100048|69726033|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
38038588|NCT02757430|69726058|FG000|Overall Study|Physician Decision|6|||
38038589|NCT02757430|69726058|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
38038590|NCT02757430|69726058|FG000|Overall Study|No informed consent|1|||
38038591|NCT02757430|69726058|FG000|Overall Study|No procedure performed|2|||
38038592|NCT02757352|69726074|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
38038593|NCT02757352|69726075|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
38038594|NCT02757352|69726076|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
38038595|NCT02757352|69726077|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
38038596|NCT02757352|69726078|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
38038597|NCT02757352|69726079|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
38038598|NCT02757352|69726080|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
38038599|NCT02757352|69726081|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
38038600|NCT02757352|69726082|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
38038601|NCT02757352|69726083|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
38038602|NCT02757352|69726074|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
38038603|NCT02757352|69726075|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
38038604|NCT02757352|69726076|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
38038605|NCT02757352|69726077|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
38038606|NCT02757352|69726078|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
38038607|NCT02757352|69726079|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
38038608|NCT02757352|69726080|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
38038609|NCT02757352|69726081|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
38038610|NCT02757352|69726082|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
38038611|NCT02757352|69726083|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
38038612|NCT02757352|69726074|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
38038613|NCT02757352|69726075|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
38038614|NCT02757352|69726076|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
38038615|NCT02757352|69726077|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
38038616|NCT02757352|69726078|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
38038617|NCT02757352|69726079|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
38038618|NCT02757352|69726080|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
38038619|NCT02757352|69726081|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
38038620|NCT02757352|69726082|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
38038621|NCT02757352|69726083|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
38038622|NCT02757352|69726074|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
38038623|NCT02757352|69726075|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
38038624|NCT02757352|69726076|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
38038625|NCT02757352|69726077|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
38038626|NCT02757352|69726078|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
38038627|NCT02757352|69726079|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
38038628|NCT02757352|69726080|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
38038629|NCT02757352|69726081|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
38038630|NCT02757352|69726082|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
38038631|NCT02757352|69726083|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
38038632|NCT02757352|69726074|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
38038633|NCT02757352|69726075|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
38038634|NCT02757352|69726076|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
38038635|NCT02757352|69726077|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
38038636|NCT02757352|69726078|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
38038637|NCT02757352|69726079|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
38038638|NCT02757352|69726080|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
38038639|NCT02757352|69726081|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
38038640|NCT02757352|69726082|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
38038641|NCT02757352|69726083|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
38038642|NCT02757352|69726074|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
38038643|NCT02757352|69726075|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
38038644|NCT02757352|69726076|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
38038645|NCT02757352|69726077|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
38038646|NCT02757352|69726078|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
38038647|NCT02757352|69726079|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
38038648|NCT02757352|69726080|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
38038649|NCT02757352|69726081|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
38038650|NCT02757352|69726082|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
38038651|NCT02757352|69726083|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
38038652|NCT02757352|69726074|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
38038653|NCT02757352|69726075|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
37673354|NCT01999972|69147528|FG000|Dose Expansion Part|Participant's non-compliance|0|||
37673355|NCT01999972|69147529|FG001|Dose Expansion Part|Participant's non-compliance|0|||
37673356|NCT01999972|69147530|FG002|Dose Expansion Part|Participant's non-compliance|0|||
37673357|NCT01999972|69147531|FG003|Dose Expansion Part|Participant's non-compliance|0|||
37673358|NCT01999972|69147532|FG004|Dose Expansion Part|Participant's non-compliance|0|||
37673359|NCT01999972|69147533|FG005|Dose Expansion Part|Participant's non-compliance|1|||
37673360|NCT01999972|69147528|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
37673361|NCT01999972|69147529|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
37673362|NCT01999972|69147530|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
37673363|NCT01999972|69147531|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
37673364|NCT01999972|69147532|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
37673365|NCT01999972|69147533|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
37673366|NCT01999972|69147528|FG000|Dose Expansion Part|Changed to standard of care|0|||
37673367|NCT01999972|69147529|FG001|Dose Expansion Part|Changed to standard of care|0|||
37673368|NCT01999972|69147530|FG002|Dose Expansion Part|Changed to standard of care|0|||
37673369|NCT01999972|69147531|FG003|Dose Expansion Part|Changed to standard of care|0|||
37673370|NCT01999972|69147532|FG004|Dose Expansion Part|Changed to standard of care|1|||
37673371|NCT01999972|69147533|FG005|Dose Expansion Part|Changed to standard of care|0|||
37673372|NCT01999894|69147549|FG000|Overall Study|Adverse Event|9|||
37673373|NCT01999894|69147549|FG000|Overall Study|Lack of Efficacy|5|||
37673374|NCT01999894|69147549|FG000|Overall Study|Protocol Violation|1|||
37673375|NCT01999894|69147549|FG000|Overall Study|Withdrawal by Subject|7|||
37673376|NCT01999894|69147549|FG000|Overall Study|Lost to Follow-up|10|||
38038654|NCT02757352|69726076|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
38038655|NCT02757352|69726077|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
38038656|NCT02757352|69726078|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
38038657|NCT02757352|69726079|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
38038658|NCT02757352|69726080|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
37673377|NCT01999894|69147549|FG000|Overall Study|Other Reason|3|||
37673378|NCT01999894|69147549|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
37673379|NCT02679235|69147554|FG000|Overall Study|Withdrawal by Subject|3|||
37673380|NCT02679235|69147554|FG000|Overall Study|Adverse Event|1|||
37673381|NCT01976806|69147560|FG000|Overall Study|Lost to Follow-up|1|||
37673382|NCT01976806|69147561|FG001|Overall Study|Lost to Follow-up|4|||
37673383|NCT01976806|69147560|FG000|Overall Study|Adverse Event|1|||
37673384|NCT01976806|69147561|FG001|Overall Study|Adverse Event|1|||
37673385|NCT01976806|69147560|FG000|Overall Study|Withdrawal by Subject|1|||
37673386|NCT01976806|69147561|FG001|Overall Study|Withdrawal by Subject|1|||
37673387|NCT02679079|69147570|FG000|Overall Study|Adverse Event|2|||
37673388|NCT02679079|69147571|FG001|Overall Study|Adverse Event|0|||
37673389|NCT02679079|69147572|FG002|Overall Study|Adverse Event|2|||
37673390|NCT02679079|69147570|FG000|Overall Study|Protocol Violation|0|||
37673391|NCT02679079|69147571|FG001|Overall Study|Protocol Violation|1|||
37673392|NCT02679079|69147572|FG002|Overall Study|Protocol Violation|0|||
37673393|NCT02679079|69147570|FG000|Overall Study|Withdrawal by Subject|2|||
37673394|NCT02679079|69147571|FG001|Overall Study|Withdrawal by Subject|1|||
37673395|NCT02679079|69147572|FG002|Overall Study|Withdrawal by Subject|0|||
37673396|NCT02678923|69147582|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
37673397|NCT02678923|69147583|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
37673398|NCT02678923|69147582|FG000|Overall Study|Withdrawal by Subject|3|||
37673399|NCT02678923|69147583|FG001|Overall Study|Withdrawal by Subject|2|||
37673400|NCT02678923|69147582|FG000|Overall Study|Lost to Follow-up|1|||
37673401|NCT02678923|69147583|FG001|Overall Study|Lost to Follow-up|0|||
37673402|NCT02678923|69147582|FG000|Overall Study|Did Not Return for Study Visits|1|||
37673403|NCT02678923|69147583|FG001|Overall Study|Did Not Return for Study Visits|0|||
37673404|NCT01976728|69147593|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
37673405|NCT01976728|69147594|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
37673406|NCT01976728|69147595|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
37673407|NCT01976728|69147596|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
37673408|NCT02689219|69147624|FG000|Overall Study|Death|1|||
37673409|NCT02689219|69147625|FG001|Overall Study|Death|1|||
37673410|NCT02689219|69147624|FG000|Overall Study|Disease Progression|10|||
37673411|NCT02689219|69147625|FG001|Overall Study|Disease Progression|6|||
37673412|NCT02683525|69147631|FG000|Overall Study|Lost to Follow-up|1|||
37673413|NCT02683525|69147631|FG000|Overall Study|Physician Decision|1|||
37673414|NCT02683525|69147631|FG000|Overall Study|Disease Progression|6|||
37673415|NCT01976338|69147637|FG000|Overall Study|Physician Decision|0|||
37673416|NCT01976338|69147638|FG001|Overall Study|Physician Decision|1|||
37673417|NCT01976338|69147637|FG000|Overall Study|Lost to Follow-up|3|||
37673418|NCT01976338|69147638|FG001|Overall Study|Lost to Follow-up|0|||
37673419|NCT01976338|69147637|FG000|Overall Study|Withdrawal by Subject|5|||
37673420|NCT01976338|69147638|FG001|Overall Study|Withdrawal by Subject|2|||
37673421|NCT01976338|69147637|FG000|Overall Study|Adverse Event|5|||
37673422|NCT01976338|69147638|FG001|Overall Study|Adverse Event|1|||
37673423|NCT02674633|69147647|FG000|Overall Study|Lost to Follow-up|3|||
37673424|NCT02674633|69147648|FG001|Overall Study|Lost to Follow-up|2|||
37766386|NCT01405027|69280429|FG000|Overall Study|Withdrawn consent|3|||
37673425|NCT02674633|69147647|FG000|Overall Study|Physician Decision|1|||
37673426|NCT02674633|69147648|FG001|Overall Study|Physician Decision|0|||
37673427|NCT02674633|69147647|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
37673428|NCT02674633|69147648|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
37673429|NCT02651987|69147656|FG000|Overall Study|Adverse Event|2|||
37673430|NCT02651987|69147657|FG001|Overall Study|Adverse Event|2|||
37673431|NCT02651987|69147656|FG000|Overall Study|Consent Withdrawn|2|||
37673432|NCT02651987|69147657|FG001|Overall Study|Consent Withdrawn|0|||
37673433|NCT02651987|69147656|FG000|Overall Study|Local PD|0|||
37673434|NCT02651987|69147657|FG001|Overall Study|Local PD|2|||
37673435|NCT02651987|69147656|FG000|Overall Study|Investigator Decision|1|||
37766387|NCT01405027|69280430|FG001|Overall Study|Withdrawn consent|0|||
37673436|NCT02651987|69147657|FG001|Overall Study|Investigator Decision|1|||
37673437|NCT02677987|69147668|FG000|Overall Study|Withdrawal by Subject|3|||
37673438|NCT02677987|69147669|FG001|Overall Study|Withdrawal by Subject|0|||
37673439|NCT02677987|69147668|FG000|Overall Study|Lost to Follow-up|1|||
37766388|NCT01405027|69280429|FG000|Overall Study|Lost to Follow-up|16|||
37766389|NCT01405027|69280430|FG001|Overall Study|Lost to Follow-up|24|||
37673440|NCT02677987|69147669|FG001|Overall Study|Lost to Follow-up|0|||
37673441|NCT01999114|69147688|FG000|Overall Study|Adverse Event|8|||
37673442|NCT01999114|69147689|FG001|Overall Study|Adverse Event|7|||
37673443|NCT01999114|69147690|FG002|Overall Study|Adverse Event|2|||
38038659|NCT02757352|69726081|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
38038660|NCT02757352|69726082|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
38038661|NCT02757352|69726083|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
38038662|NCT02757352|69726074|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
38038663|NCT02757352|69726075|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
38038664|NCT02757352|69726076|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
38038665|NCT02757352|69726077|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
38038666|NCT02757352|69726078|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
38038667|NCT02757352|69726079|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
38038668|NCT02757352|69726080|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
38038669|NCT02757352|69726081|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
38038670|NCT02757352|69726082|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
38038671|NCT02757352|69726083|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
38038672|NCT02757352|69726074|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
38038673|NCT02757352|69726075|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
38038674|NCT02757352|69726076|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
38038675|NCT02757352|69726077|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
38038676|NCT02757352|69726078|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
38038677|NCT02757352|69726079|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
38038678|NCT02757352|69726080|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
38038679|NCT02757352|69726081|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
38038680|NCT02757352|69726082|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
38038681|NCT02757352|69726083|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
38038682|NCT02757352|69726074|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
38038683|NCT02757352|69726075|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
38038684|NCT02757352|69726076|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
38038685|NCT02757352|69726077|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
38038686|NCT02757352|69726078|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
38038687|NCT02757352|69726079|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
38038688|NCT02757352|69726080|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
38038689|NCT02757352|69726081|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
38038690|NCT02757352|69726082|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
38038691|NCT02757352|69726083|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
38038692|NCT02757352|69726074|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
38038693|NCT02757352|69726075|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
38038694|NCT02757352|69726076|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
38038695|NCT02757352|69726077|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
38038696|NCT02757352|69726078|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
38038697|NCT02757352|69726079|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
38038698|NCT02757352|69726080|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
38038699|NCT02757352|69726081|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
38038700|NCT02757352|69726082|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
38038701|NCT02757352|69726083|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
38038702|NCT02757352|69726074|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
38038703|NCT02757352|69726075|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
38038704|NCT02757352|69726076|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
38038705|NCT02757352|69726077|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
38038706|NCT02757352|69726078|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
38038707|NCT02757352|69726079|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
38038708|NCT02757352|69726080|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
38038709|NCT02757352|69726081|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
38038710|NCT02757352|69726082|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
38038711|NCT02757352|69726083|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
38038712|NCT02757352|69726074|FG000|Follow-Up Period|Adverse Event|0|||
38038713|NCT02757352|69726075|FG001|Follow-Up Period|Adverse Event|0|||
38038714|NCT02757352|69726076|FG002|Follow-Up Period|Adverse Event|0|||
38038715|NCT02757352|69726077|FG003|Follow-Up Period|Adverse Event|0|||
38038716|NCT02757352|69726078|FG004|Follow-Up Period|Adverse Event|0|||
38038717|NCT02757352|69726079|FG005|Follow-Up Period|Adverse Event|0|||
38038718|NCT02757352|69726080|FG006|Follow-Up Period|Adverse Event|1|||
38038719|NCT02757352|69726081|FG007|Follow-Up Period|Adverse Event|0|||
38038720|NCT02757352|69726082|FG008|Follow-Up Period|Adverse Event|2|||
37673444|NCT01999114|69147691|FG003|Overall Study|Adverse Event|2|||
38038721|NCT02757352|69726083|FG009|Follow-Up Period|Adverse Event|0|||
38038722|NCT02757352|69726074|FG000|Follow-Up Period|Lost to Follow-up|0|||
38038723|NCT02757352|69726075|FG001|Follow-Up Period|Lost to Follow-up|0|||
38038724|NCT02757352|69726076|FG002|Follow-Up Period|Lost to Follow-up|0|||
38038725|NCT02757352|69726077|FG003|Follow-Up Period|Lost to Follow-up|0|||
38038726|NCT02757352|69726078|FG004|Follow-Up Period|Lost to Follow-up|0|||
38038727|NCT02757352|69726079|FG005|Follow-Up Period|Lost to Follow-up|0|||
38038728|NCT02757352|69726080|FG006|Follow-Up Period|Lost to Follow-up|0|||
38038729|NCT02757352|69726081|FG007|Follow-Up Period|Lost to Follow-up|0|||
38038730|NCT02757352|69726082|FG008|Follow-Up Period|Lost to Follow-up|1|||
38038731|NCT02757352|69726083|FG009|Follow-Up Period|Lost to Follow-up|0|||
38038732|NCT02757352|69726074|FG000|Follow-Up Period|Lack of Efficacy|0|||
38038733|NCT02757352|69726075|FG001|Follow-Up Period|Lack of Efficacy|0|||
38038734|NCT02757352|69726076|FG002|Follow-Up Period|Lack of Efficacy|0|||
38038735|NCT02757352|69726077|FG003|Follow-Up Period|Lack of Efficacy|0|||
38038736|NCT02757352|69726078|FG004|Follow-Up Period|Lack of Efficacy|0|||
38038737|NCT02757352|69726079|FG005|Follow-Up Period|Lack of Efficacy|0|||
38038738|NCT02757352|69726080|FG006|Follow-Up Period|Lack of Efficacy|0|||
38038739|NCT02757352|69726081|FG007|Follow-Up Period|Lack of Efficacy|0|||
38038740|NCT02757352|69726082|FG008|Follow-Up Period|Lack of Efficacy|1|||
38038741|NCT02757352|69726083|FG009|Follow-Up Period|Lack of Efficacy|1|||
38038742|NCT02757352|69726074|FG000|Follow-Up Period|Withdrawal by Subject|0|||
38038743|NCT02757352|69726075|FG001|Follow-Up Period|Withdrawal by Subject|0|||
38038744|NCT02757352|69726076|FG002|Follow-Up Period|Withdrawal by Subject|0|||
38038745|NCT02757352|69726077|FG003|Follow-Up Period|Withdrawal by Subject|0|||
38038746|NCT02757352|69726078|FG004|Follow-Up Period|Withdrawal by Subject|0|||
38038747|NCT02757352|69726079|FG005|Follow-Up Period|Withdrawal by Subject|0|||
38038748|NCT02757352|69726080|FG006|Follow-Up Period|Withdrawal by Subject|0|||
38038749|NCT02757352|69726081|FG007|Follow-Up Period|Withdrawal by Subject|1|||
38038750|NCT02757352|69726082|FG008|Follow-Up Period|Withdrawal by Subject|6|||
38038751|NCT02757352|69726083|FG009|Follow-Up Period|Withdrawal by Subject|2|||
38038752|NCT04588480|69726116|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
38038753|NCT04588480|69726117|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
38038754|NCT04588480|69726118|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
38038755|NCT04588480|69726116|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
38038756|NCT04588480|69726117|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
38038757|NCT04588480|69726118|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
38038758|NCT02756650|69726125|FG000|Overall Study|Physician Decision|1|||
38038759|NCT02756650|69726125|FG000|Overall Study|Adverse Event|1|||
38038760|NCT00110357|69726131|FG000|Overall Study|Deterioration without progression|2|||
38038761|NCT00110357|69726132|FG001|Overall Study|Deterioration without progression|0|||
38038762|NCT00110357|69726131|FG000|Overall Study|Disease progression/relapse|20|||
38038763|NCT00110357|69726132|FG001|Overall Study|Disease progression/relapse|15|||
38038764|NCT00110357|69726131|FG000|Overall Study|Study Closure|1|||
38038765|NCT00110357|69726132|FG001|Overall Study|Study Closure|0|||
38038766|NCT00110357|69726131|FG000|Overall Study|Study Drug Toxicity|1|||
38038767|NCT00110357|69726132|FG001|Overall Study|Study Drug Toxicity|3|||
38038768|NCT00110357|69726131|FG000|Overall Study|Withdrawal by Subject|3|||
38038769|NCT00110357|69726132|FG001|Overall Study|Withdrawal by Subject|1|||
38038770|NCT02752906|69726167|FG000|Overall Study|Protocol Violation|2|||
38038771|NCT02752906|69726168|FG001|Overall Study|Protocol Violation|1|||
38038772|NCT02752906|69726167|FG000|Overall Study|Withdrawal by Subject|2|||
38038773|NCT02752906|69726168|FG001|Overall Study|Withdrawal by Subject|2|||
38038774|NCT02752906|69726167|FG000|Overall Study|Lost to Follow-up|3|||
38038775|NCT02752906|69726168|FG001|Overall Study|Lost to Follow-up|2|||
38038776|NCT02756338|69726174|FG000|Overall Study|Withdrawn by Investigator|1|||
38038777|NCT02756338|69726174|FG000|Overall Study|Device Replaced with Pacemaker|4|||
38038778|NCT00293033|69726178|FG000|Open-label Titration Period|Adverse Event|10|||
38038779|NCT00293033|69726178|FG000|Open-label Titration Period|Death|3|||
38038780|NCT00293033|69726178|FG000|Open-label Titration Period|Lack of Efficacy|5|||
38038781|NCT00293033|69726178|FG000|Open-label Titration Period|Protocol Violation|2|||
38038782|NCT00293033|69726178|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
38038783|NCT00293033|69726178|FG000|Open-label Titration Period|Noncompliance and other|27|||
38038784|NCT00293033|69726178|FG000|Double-blind Treatment Period|Adverse Event|3|||
38038785|NCT00293033|69726178|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
38038786|NCT00293033|69726178|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
38038787|NCT00293033|69726178|FG000|Double-blind Treatment Period|Noncompliance|4|||
38038788|NCT02756182|69726186|FG000|Overall Study|StudyTechnical Difficulties|4|||
38038789|NCT03823703|69726195|FG000|Overall Study|Sponsor request|0|||
38038790|NCT03823703|69726196|FG001|Overall Study|Sponsor request|3|||
38038791|NCT03823703|69726197|FG002|Overall Study|Sponsor request|4|||
38038792|NCT03823703|69726195|FG000|Overall Study|Adverse Event|3|||
37673445|NCT01999114|69147692|FG004|Overall Study|Adverse Event|1|||
37673446|NCT01999114|69147688|FG000|Overall Study|Withdrawal by Subject|0|||
38038793|NCT03823703|69726196|FG001|Overall Study|Adverse Event|1|||
37673447|NCT01999114|69147689|FG001|Overall Study|Withdrawal by Subject|0|||
38038794|NCT03823703|69726197|FG002|Overall Study|Adverse Event|0|||
38038795|NCT03823703|69726195|FG000|Overall Study|Withdrawal by Subject|0|||
38038796|NCT03823703|69726196|FG001|Overall Study|Withdrawal by Subject|1|||
38038797|NCT03823703|69726197|FG002|Overall Study|Withdrawal by Subject|0|||
38038798|NCT00109577|69726207|FG000|Overall Study|Withdrawal by Subject|3|||
38038799|NCT00109577|69726208|FG001|Overall Study|Withdrawal by Subject|3|||
38038800|NCT02755090|69726216|FG000|Overall Study|equipment malfunction|1|||
38038801|NCT02755090|69726217|FG001|Overall Study|equipment malfunction|0|||
38038802|NCT00109343|69726226|FG000|Overall Study|Adverse Event|1|||
38038803|NCT00109343|69726227|FG001|Overall Study|Adverse Event|0|||
38038804|NCT00109343|69726228|FG002|Overall Study|Adverse Event|2|||
38038805|NCT00109343|69726226|FG000|Overall Study|Lack of Efficacy|1|||
38038806|NCT00109343|69726227|FG001|Overall Study|Lack of Efficacy|0|||
38038807|NCT00109343|69726228|FG002|Overall Study|Lack of Efficacy|0|||
38038808|NCT00109343|69726226|FG000|Overall Study|Lost to Follow-up|35|||
38038809|NCT00109343|69726227|FG001|Overall Study|Lost to Follow-up|20|||
38038810|NCT00109343|69726228|FG002|Overall Study|Lost to Follow-up|14|||
38038811|NCT00109343|69726226|FG000|Overall Study|Protocol Violation|1|||
38038812|NCT00109343|69726227|FG001|Overall Study|Protocol Violation|2|||
38038813|NCT00109343|69726228|FG002|Overall Study|Protocol Violation|2|||
38038814|NCT00109343|69726226|FG000|Overall Study|Withdrawal by Subject|15|||
38038815|NCT00109343|69726227|FG001|Overall Study|Withdrawal by Subject|11|||
38038816|NCT00109343|69726228|FG002|Overall Study|Withdrawal by Subject|10|||
38038817|NCT00109343|69726226|FG000|Overall Study|Subject Moved|6|||
38038818|NCT00109343|69726227|FG001|Overall Study|Subject Moved|2|||
38038819|NCT00109343|69726228|FG002|Overall Study|Subject Moved|1|||
38038820|NCT00109343|69726226|FG000|Overall Study|Other|5|||
38038821|NCT00109343|69726227|FG001|Overall Study|Other|2|||
38038822|NCT00109343|69726228|FG002|Overall Study|Other|1|||
38038823|NCT00108485|69726238|FG000|Overall Study|Withdrawal by Subject|3|||
38038824|NCT00108485|69726239|FG001|Overall Study|Withdrawal by Subject|0|||
38038825|NCT00108485|69726238|FG000|Overall Study|Lost to Follow-up|0|||
38038826|NCT00108485|69726239|FG001|Overall Study|Lost to Follow-up|2|||
38038827|NCT00107783|69726247|FG000|Overall Study|Adverse Event|0|||
38038828|NCT00107783|69726248|FG001|Overall Study|Adverse Event|2|||
38038829|NCT00107783|69726247|FG000|Overall Study|Death|0|||
38038830|NCT00107783|69726248|FG001|Overall Study|Death|1|||
38038831|NCT00107783|69726247|FG000|Overall Study|Withdrawal by Subject|2|||
38038832|NCT00107783|69726248|FG001|Overall Study|Withdrawal by Subject|0|||
38038833|NCT00107783|69726247|FG000|Overall Study|Second hip replacement|1|||
38038834|NCT00107783|69726248|FG001|Overall Study|Second hip replacement|1|||
38038835|NCT00095303|69726256|FG000|Main Study|Lost to Follow-up|91|||
38038836|NCT00095303|69726257|FG001|Main Study|Lost to Follow-up|87|||
38038837|NCT00095303|69726256|FG000|Follow Up Study|Lost to Follow-up|59|||
38038838|NCT00095303|69726257|FG001|Follow Up Study|Lost to Follow-up|58|||
38038839|NCT00105521|69726267|FG000|Overall Study|Other|1|||
38038840|NCT00105521|69726268|FG001|Overall Study|Other|1|||
38038841|NCT00105521|69726269|FG002|Overall Study|Other|2|||
38038842|NCT00105521|69726270|FG003|Overall Study|Other|0|||
38038843|NCT00105521|69726267|FG000|Overall Study|Adverse Event|10|||
38038844|NCT00105521|69726268|FG001|Overall Study|Adverse Event|4|||
38038845|NCT00105521|69726269|FG002|Overall Study|Adverse Event|10|||
38038846|NCT00105521|69726270|FG003|Overall Study|Adverse Event|8|||
38038847|NCT00105521|69726267|FG000|Overall Study|Withdrawal by Subject|1|||
38038848|NCT00105521|69726268|FG001|Overall Study|Withdrawal by Subject|0|||
38038849|NCT00105521|69726269|FG002|Overall Study|Withdrawal by Subject|1|||
38038850|NCT00105521|69726270|FG003|Overall Study|Withdrawal by Subject|4|||
38038851|NCT00105521|69726267|FG000|Overall Study|Lack of Efficacy|0|||
38038852|NCT00105521|69726268|FG001|Overall Study|Lack of Efficacy|0|||
38038853|NCT00105521|69726269|FG002|Overall Study|Lack of Efficacy|0|||
38038854|NCT00105521|69726270|FG003|Overall Study|Lack of Efficacy|1|||
38038855|NCT00105521|69726267|FG000|Overall Study|Protocol Violation|3|||
38038856|NCT00105521|69726268|FG001|Overall Study|Protocol Violation|5|||
38038857|NCT00105521|69726269|FG002|Overall Study|Protocol Violation|4|||
38038858|NCT00105521|69726270|FG003|Overall Study|Protocol Violation|4|||
38038859|NCT00105521|69726267|FG000|Overall Study|Lost to Follow-up|0|||
38038860|NCT00105521|69726268|FG001|Overall Study|Lost to Follow-up|1|||
38038861|NCT00105521|69726269|FG002|Overall Study|Lost to Follow-up|0|||
38038862|NCT00105521|69726270|FG003|Overall Study|Lost to Follow-up|0|||
38038863|NCT00291551|69726280|FG000|Overall Study|Death|7|||
38038864|NCT00291551|69726280|FG000|Overall Study|Withdrawal by Subject|6|||
37766390|NCT01405027|69280429|FG000|Overall Study|Investigator judgement|0|||
38038865|NCT02752048|69726309|FG000|Overall Study|Withdrawal by Subject|0|||
38038866|NCT02752048|69726310|FG001|Overall Study|Withdrawal by Subject|0|||
38038867|NCT02752048|69726311|FG002|Overall Study|Withdrawal by Subject|3|||
38038868|NCT00095147|69726326|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
38038869|NCT00095147|69726327|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
38038870|NCT00095147|69726328|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
38038871|NCT00095147|69726329|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
38038872|NCT00095147|69726330|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
37766391|NCT01405027|69280430|FG001|Overall Study|Investigator judgement|2|||
38038873|NCT00095147|69726326|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
38038874|NCT00095147|69726327|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
38038875|NCT00095147|69726328|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
38038876|NCT00095147|69726329|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
38038877|NCT00095147|69726330|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
38038878|NCT00095147|69726326|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
38038879|NCT00095147|69726327|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
38038880|NCT00095147|69726328|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
38038881|NCT00095147|69726329|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
38038882|NCT00095147|69726330|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
38038883|NCT00095147|69726326|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
38038884|NCT00095147|69726327|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
38038885|NCT00095147|69726328|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
38038886|NCT00095147|69726329|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
38038887|NCT00095147|69726330|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
38038888|NCT00095147|69726326|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
38038889|NCT00095147|69726327|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
38038890|NCT00095147|69726328|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
38038891|NCT00095147|69726329|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
38038892|NCT00095147|69726330|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
38038893|NCT00095147|69726326|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
38038894|NCT00095147|69726327|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
38038895|NCT00095147|69726328|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
38038896|NCT00095147|69726329|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
38038897|NCT00095147|69726330|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
38038898|NCT00095147|69726326|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
38038899|NCT00095147|69726327|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
38038900|NCT00095147|69726328|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
38038901|NCT00095147|69726329|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
38038902|NCT00095147|69726330|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
38038903|NCT00095147|69726326|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
38038904|NCT00095147|69726327|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
38038905|NCT00095147|69726328|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
38038906|NCT00095147|69726329|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
38038907|NCT00095147|69726330|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
38038908|NCT00095147|69726326|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
38038909|NCT00095147|69726327|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
38038910|NCT00095147|69726328|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
38038911|NCT00095147|69726329|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
38038912|NCT00095147|69726330|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
38038913|NCT00095147|69726326|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
38038914|NCT00095147|69726327|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
38038915|NCT00095147|69726328|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
38038916|NCT00095147|69726329|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
38038917|NCT00095147|69726330|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
38038918|NCT00095147|69726326|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
38038919|NCT00095147|69726327|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
38038920|NCT00095147|69726328|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
38038921|NCT00095147|69726329|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
38038922|NCT00095147|69726330|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
38038923|NCT00095147|69726326|FG000|Long-term Extension Period|Death|0|||
38038924|NCT00095147|69726327|FG001|Long-term Extension Period|Death|0|||
38038925|NCT00095147|69726328|FG002|Long-term Extension Period|Death|0|||
38038926|NCT00095147|69726329|FG003|Long-term Extension Period|Death|0|||
38038927|NCT00095147|69726330|FG004|Long-term Extension Period|Death|3|||
38038928|NCT00095147|69726326|FG000|Long-term Extension Period|Adverse Event|0|||
38038929|NCT00095147|69726327|FG001|Long-term Extension Period|Adverse Event|0|||
38038930|NCT00095147|69726328|FG002|Long-term Extension Period|Adverse Event|0|||
38038931|NCT00095147|69726329|FG003|Long-term Extension Period|Adverse Event|0|||
38038932|NCT00095147|69726330|FG004|Long-term Extension Period|Adverse Event|11|||
38038933|NCT00095147|69726326|FG000|Long-term Extension Period|Lack of Efficacy|0|||
38038934|NCT00095147|69726327|FG001|Long-term Extension Period|Lack of Efficacy|0|||
38038935|NCT00095147|69726328|FG002|Long-term Extension Period|Lack of Efficacy|0|||
38038936|NCT00095147|69726329|FG003|Long-term Extension Period|Lack of Efficacy|0|||
38038937|NCT00095147|69726330|FG004|Long-term Extension Period|Lack of Efficacy|9|||
38038938|NCT00095147|69726326|FG000|Long-term Extension Period|Lost to Follow-up|0|||
38038939|NCT00095147|69726327|FG001|Long-term Extension Period|Lost to Follow-up|0|||
38038940|NCT00095147|69726328|FG002|Long-term Extension Period|Lost to Follow-up|0|||
37766392|NCT01405027|69280429|FG000|Overall Study|Death|1|||
38038941|NCT00095147|69726329|FG003|Long-term Extension Period|Lost to Follow-up|0|||
38038942|NCT00095147|69726330|FG004|Long-term Extension Period|Lost to Follow-up|6|||
38038943|NCT00095147|69726326|FG000|Long-term Extension Period|Withdrawal of consent|0|||
38038944|NCT00095147|69726327|FG001|Long-term Extension Period|Withdrawal of consent|0|||
38038945|NCT00095147|69726328|FG002|Long-term Extension Period|Withdrawal of consent|0|||
38038946|NCT00095147|69726329|FG003|Long-term Extension Period|Withdrawal of consent|0|||
38038947|NCT00095147|69726330|FG004|Long-term Extension Period|Withdrawal of consent|12|||
38038948|NCT00095147|69726326|FG000|Long-term Extension Period|Pregnancy|0|||
38038949|NCT00095147|69726327|FG001|Long-term Extension Period|Pregnancy|0|||
38038950|NCT00095147|69726328|FG002|Long-term Extension Period|Pregnancy|0|||
38038951|NCT00095147|69726329|FG003|Long-term Extension Period|Pregnancy|0|||
38038952|NCT00095147|69726330|FG004|Long-term Extension Period|Pregnancy|1|||
37673448|NCT01999114|69147690|FG002|Overall Study|Withdrawal by Subject|1|||
37673449|NCT01999114|69147691|FG003|Overall Study|Withdrawal by Subject|0|||
37673450|NCT01999114|69147692|FG004|Overall Study|Withdrawal by Subject|1|||
37673451|NCT01999114|69147688|FG000|Overall Study|Lost to Follow-up|0|||
37673452|NCT01999114|69147689|FG001|Overall Study|Lost to Follow-up|0|||
37673453|NCT01999114|69147690|FG002|Overall Study|Lost to Follow-up|1|||
37673454|NCT01999114|69147691|FG003|Overall Study|Lost to Follow-up|0|||
37673455|NCT01999114|69147692|FG004|Overall Study|Lost to Follow-up|0|||
37673456|NCT01999114|69147688|FG000|Overall Study|Administrative|0|||
37673457|NCT01999114|69147689|FG001|Overall Study|Administrative|0|||
37673458|NCT01999114|69147690|FG002|Overall Study|Administrative|1|||
37673459|NCT01999114|69147691|FG003|Overall Study|Administrative|1|||
37673460|NCT01999114|69147692|FG004|Overall Study|Administrative|2|||
37673461|NCT02682823|69147723|FG000|Overall Study|Withdrawal by Subject|0|||
37673462|NCT02682823|69147724|FG001|Overall Study|Withdrawal by Subject|0|||
37673463|NCT02682823|69147725|FG002|Overall Study|Withdrawal by Subject|1|||
37673464|NCT02682823|69147726|FG003|Overall Study|Withdrawal by Subject|0|||
37673465|NCT02682823|69147727|FG004|Overall Study|Withdrawal by Subject|1|||
37673466|NCT02682823|69147723|FG000|Overall Study|Protocol Deviation|0|||
37673467|NCT02682823|69147724|FG001|Overall Study|Protocol Deviation|1|||
37673468|NCT02682823|69147725|FG002|Overall Study|Protocol Deviation|0|||
37673469|NCT02682823|69147726|FG003|Overall Study|Protocol Deviation|0|||
37673470|NCT02682823|69147727|FG004|Overall Study|Protocol Deviation|0|||
37673471|NCT02682823|69147723|FG000|Overall Study|Adverse Event|0|||
37673472|NCT02682823|69147724|FG001|Overall Study|Adverse Event|0|||
37673473|NCT02682823|69147725|FG002|Overall Study|Adverse Event|0|||
37673474|NCT02682823|69147726|FG003|Overall Study|Adverse Event|1|||
37673475|NCT02682823|69147727|FG004|Overall Study|Adverse Event|0|||
37673476|NCT01374451|69147741|FG000|Overall Study|Administrative problems|1|||
37673477|NCT01374451|69147742|FG001|Overall Study|Administrative problems|0|||
37673478|NCT02674477|69147750|FG000|Overall Study|Protocol Violation|8|||
37673479|NCT02674477|69147751|FG001|Overall Study|Protocol Violation|2|||
37673480|NCT01352845|69147759|FG000|Overall Study|Lost to Follow-up|313|||
37673481|NCT01352845|69147760|FG001|Overall Study|Lost to Follow-up|92|||
37673482|NCT01352845|69147759|FG000|Overall Study|No Longer Willing to Participate|205|||
37673483|NCT01352845|69147760|FG001|Overall Study|No Longer Willing to Participate|58|||
37673484|NCT01352845|69147759|FG000|Overall Study|Withdrawal by Subject|48|||
37673485|NCT01352845|69147760|FG001|Overall Study|Withdrawal by Subject|16|||
37673486|NCT01352845|69147759|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
37673487|NCT01352845|69147760|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
37673488|NCT01352845|69147759|FG000|Overall Study|Pregnancy|27|||
37673489|NCT01352845|69147760|FG001|Overall Study|Pregnancy|7|||
37673490|NCT01352845|69147759|FG000|Overall Study|Adverse Event|22|||
37673491|NCT01352845|69147760|FG001|Overall Study|Adverse Event|6|||
37673492|NCT01352845|69147759|FG000|Overall Study|Other|17|||
37673493|NCT01352845|69147760|FG001|Overall Study|Other|7|||
37673494|NCT01352845|69147759|FG000|Overall Study|Protocol Violation|12|||
37673495|NCT01352845|69147760|FG001|Overall Study|Protocol Violation|6|||
37673496|NCT01352845|69147759|FG000|Overall Study|Death|3|||
37673497|NCT01352845|69147760|FG001|Overall Study|Death|0|||
37673498|NCT02674399|69147768|FG000|Overall Study|Lost to Follow-up|2|||
37673499|NCT02674399|69147769|FG001|Overall Study|Lost to Follow-up|0|||
37673500|NCT02676895|69147778|FG000|Overall Study|Administrative reason|1|||
37673501|NCT02676895|69147779|FG001|Overall Study|Administrative reason|0|||
37673502|NCT02676895|69147780|FG002|Overall Study|Administrative reason|0|||
37673503|NCT02676895|69147778|FG000|Overall Study|Protocol Violation|1|||
37673504|NCT02676895|69147779|FG001|Overall Study|Protocol Violation|0|||
37673505|NCT02676895|69147780|FG002|Overall Study|Protocol Violation|0|||
37673506|NCT02676895|69147778|FG000|Overall Study|Adverse Event|0|||
37673507|NCT02676895|69147779|FG001|Overall Study|Adverse Event|3|||
37673508|NCT02676895|69147780|FG002|Overall Study|Adverse Event|1|||
37673509|NCT02676895|69147778|FG000|Overall Study|Lost to Follow-up|0|||
37673510|NCT02676895|69147779|FG001|Overall Study|Lost to Follow-up|0|||
37673511|NCT02676895|69147780|FG002|Overall Study|Lost to Follow-up|1|||
37673512|NCT02676895|69147778|FG000|Overall Study|Withdrawal by Subject|0|||
38038953|NCT00095147|69726326|FG000|Long-term Extension Period|No longer meets study criteria|0|||
37673513|NCT02676895|69147779|FG001|Overall Study|Withdrawal by Subject|0|||
37673514|NCT02676895|69147780|FG002|Overall Study|Withdrawal by Subject|1|||
37673515|NCT02673697|69147791|FG000|Overall Study|Adverse Event|2|||
37673516|NCT02673697|69147792|FG001|Overall Study|Adverse Event|0|||
37673517|NCT02673697|69147791|FG000|Overall Study|Death|32|||
37673518|NCT02673697|69147792|FG001|Overall Study|Death|24|||
37673519|NCT02673697|69147791|FG000|Overall Study|Lost to Follow-up|5|||
37673520|NCT02673697|69147792|FG001|Overall Study|Lost to Follow-up|2|||
37673521|NCT02673697|69147791|FG000|Overall Study|Physician Decision|2|||
37673522|NCT02673697|69147792|FG001|Overall Study|Physician Decision|1|||
37673523|NCT02673697|69147791|FG000|Overall Study|Withdrawal by Subject|10|||
37673524|NCT02673697|69147792|FG001|Overall Study|Withdrawal by Subject|7|||
37673525|NCT02673697|69147791|FG000|Overall Study|Change subj medical status|1|||
37673526|NCT02673697|69147792|FG001|Overall Study|Change subj medical status|2|||
37673527|NCT02673697|69147791|FG000|Overall Study|Explant|10|||
37673528|NCT02673697|69147792|FG001|Overall Study|Explant|5|||
37673529|NCT02673697|69147791|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
37673530|NCT02673697|69147792|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
37673531|NCT05168579|69147800|FG000|Overall Study|Lack of Consent|1|||
37673532|NCT05168579|69147801|FG001|Overall Study|Lack of Consent|0|||
37673533|NCT05168579|69147800|FG000|Overall Study|Conflicts with time|2|||
37673534|NCT05168579|69147801|FG001|Overall Study|Conflicts with time|0|||
37673535|NCT05168579|69147800|FG000|Overall Study|Time slots were full|3|||
37673536|NCT05168579|69147801|FG001|Overall Study|Time slots were full|0|||
37673537|NCT05168579|69147800|FG000|Overall Study|Lost to Follow-up|0|||
37673538|NCT05168579|69147801|FG001|Overall Study|Lost to Follow-up|15|||
37673539|NCT02673619|69147814|FG000|Overall Study|Lost to Follow-up|1|||
37673540|NCT02673619|69147815|FG001|Overall Study|Lost to Follow-up|0|||
37673541|NCT02673619|69147816|FG002|Overall Study|Lost to Follow-up|0|||
37673542|NCT02673619|69147817|FG003|Overall Study|Lost to Follow-up|0|||
37673543|NCT02673619|69147814|FG000|Overall Study|Withdrawal by Subject|1|||
37673544|NCT02673619|69147815|FG001|Overall Study|Withdrawal by Subject|1|||
37673545|NCT02673619|69147816|FG002|Overall Study|Withdrawal by Subject|1|||
37673546|NCT02673619|69147817|FG003|Overall Study|Withdrawal by Subject|0|||
37673547|NCT02673619|69147814|FG000|Overall Study|Adverse Event|0|||
37673548|NCT02673619|69147815|FG001|Overall Study|Adverse Event|0|||
37673549|NCT02673619|69147816|FG002|Overall Study|Adverse Event|1|||
37673550|NCT02673619|69147817|FG003|Overall Study|Adverse Event|0|||
37673551|NCT02673619|69147814|FG000|Overall Study|Lack of Efficacy|0|||
37673552|NCT02673619|69147815|FG001|Overall Study|Lack of Efficacy|0|||
37673553|NCT02673619|69147816|FG002|Overall Study|Lack of Efficacy|1|||
37673554|NCT02673619|69147817|FG003|Overall Study|Lack of Efficacy|0|||
37673555|NCT02680639|69147839|FG000|Screening Period|Screen Failure|7|||
37673556|NCT02680639|69147840|FG001|Screening Period|Screen Failure|0|||
37673557|NCT02680639|69147841|FG002|Screening Period|Screen Failure|0|||
37673558|NCT01674725|69147853|FG000|Overall Study|Adverse Event|1|||
37673559|NCT01674725|69147854|FG001|Overall Study|Adverse Event|0|||
37673560|NCT01674725|69147853|FG000|Overall Study|Did not receive study drug|1|||
37673561|NCT01674725|69147854|FG001|Overall Study|Did not receive study drug|0|||
37673562|NCT01674725|69147853|FG000|Overall Study|Withdrawal by Subject|1|||
37673563|NCT01674725|69147854|FG001|Overall Study|Withdrawal by Subject|0|||
37673564|NCT01674725|69147853|FG000|Overall Study|Lost to Follow-up|0|||
37673565|NCT01674725|69147854|FG001|Overall Study|Lost to Follow-up|1|||
37673566|NCT01674569|69147860|FG000|Overall Study|Adverse Event|0|||
37673567|NCT01674569|69147861|FG001|Overall Study|Adverse Event|2|||
37673568|NCT01674569|69147862|FG002|Overall Study|Adverse Event|0|||
37673569|NCT01674569|69147863|FG003|Overall Study|Adverse Event|1|||
37673570|NCT01674569|69147864|FG004|Overall Study|Adverse Event|2|||
37673571|NCT01674569|69147865|FG005|Overall Study|Adverse Event|2|||
37673572|NCT01674569|69147860|FG000|Overall Study|Protocol Violation|0|||
37673573|NCT01674569|69147861|FG001|Overall Study|Protocol Violation|1|||
37673574|NCT01674569|69147862|FG002|Overall Study|Protocol Violation|1|||
37673575|NCT01674569|69147863|FG003|Overall Study|Protocol Violation|0|||
37673576|NCT01674569|69147864|FG004|Overall Study|Protocol Violation|0|||
37673577|NCT01674569|69147865|FG005|Overall Study|Protocol Violation|0|||
37673578|NCT01674569|69147860|FG000|Overall Study|Withdrawal by Subject|0|||
37673579|NCT01674569|69147861|FG001|Overall Study|Withdrawal by Subject|0|||
37673580|NCT01674569|69147862|FG002|Overall Study|Withdrawal by Subject|1|||
37673581|NCT01674569|69147863|FG003|Overall Study|Withdrawal by Subject|0|||
37673582|NCT01674569|69147864|FG004|Overall Study|Withdrawal by Subject|0|||
37673583|NCT01674569|69147865|FG005|Overall Study|Withdrawal by Subject|0|||
37673584|NCT01374217|69147869|FG000|Overall Study|Lack of Efficacy|13|||
37673585|NCT01674647|69147875|FG000|Treatment Period|Death|4|||
37673586|NCT01674647|69147876|FG001|Treatment Period|Death|1|||
37673587|NCT01674647|69147875|FG000|Treatment Period|Efficacy outcome reached|0|||
37673588|NCT01674647|69147876|FG001|Treatment Period|Efficacy outcome reached|1|||
37673589|NCT01674647|69147875|FG000|Treatment Period|Physician Decision|3|||
37673590|NCT01674647|69147876|FG001|Treatment Period|Physician Decision|1|||
37673591|NCT01674647|69147875|FG000|Treatment Period|Adverse Event|60|||
37673592|NCT01674647|69147876|FG001|Treatment Period|Adverse Event|22|||
37673593|NCT01674647|69147875|FG000|Treatment Period|Non-compliance with study drug|3|||
37673594|NCT01674647|69147876|FG001|Treatment Period|Non-compliance with study drug|0|||
37673595|NCT01674647|69147875|FG000|Treatment Period|Lost to Follow-up|1|||
37673596|NCT01674647|69147876|FG001|Treatment Period|Lost to Follow-up|1|||
37673597|NCT01674647|69147875|FG000|Treatment Period|Withdrawal by Subject|19|||
37673598|NCT01674647|69147876|FG001|Treatment Period|Withdrawal by Subject|16|||
37673599|NCT01674647|69147875|FG000|Treatment Period|Switching to other therapy|5|||
37673600|NCT01674647|69147876|FG001|Treatment Period|Switching to other therapy|2|||
37673601|NCT01674647|69147875|FG000|Treatment Period|Logistical difficulties|5|||
37673602|NCT01674647|69147876|FG001|Treatment Period|Logistical difficulties|8|||
37673603|NCT01674647|69147875|FG000|Treatment Period|Treatment failure|0|||
37673604|NCT01674647|69147876|FG001|Treatment Period|Treatment failure|14|||
37673605|NCT01674647|69147875|FG000|Treatment Period|Protocol Violation|56|||
37673606|NCT01674647|69147876|FG001|Treatment Period|Protocol Violation|36|||
37673607|NCT01674647|69147875|FG000|30-day Safety Follow-up Period|Death|3|||
37673608|NCT01674647|69147876|FG001|30-day Safety Follow-up Period|Death|2|||
37673609|NCT01674647|69147875|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
37673610|NCT01674647|69147876|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
37673611|NCT01674647|69147875|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
37673612|NCT01674647|69147876|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
37673613|NCT01674647|69147875|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
37673614|NCT01674647|69147876|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
37673615|NCT01674647|69147875|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
37673616|NCT01674647|69147876|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
37673617|NCT01674647|69147875|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
37673618|NCT01674647|69147876|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
37673619|NCT02669407|69147882|FG000|Overall Study|Physician Decision|3|||
37673620|NCT02667457|69147888|FG000|Overall Study|Withdrawal by Subject|1|||
37673621|NCT02667457|69147889|FG001|Overall Study|Withdrawal by Subject|0|||
37673622|NCT02667457|69147888|FG000|Overall Study|Other Reason|0|||
37673623|NCT02667457|69147889|FG001|Overall Study|Other Reason|2|||
37673624|NCT02669095|69147898|FG000|Overall Study|Adverse Event|1|||
37673625|NCT02669095|69147899|FG001|Overall Study|Adverse Event|0|||
37673626|NCT02669095|69147898|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
37673627|NCT02669095|69147899|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
37673628|NCT02669095|69147898|FG000|Overall Study|Torn Lens|0|||
37673629|NCT02669095|69147899|FG001|Overall Study|Torn Lens|1|||
37673630|NCT02669095|69147898|FG000|Overall Study|Visit 5 assessments not completed|0|||
37673631|NCT02669095|69147899|FG001|Overall Study|Visit 5 assessments not completed|1|||
37673632|NCT02667301|69147905|FG000|Overall Study|Adverse Event|1|||
37673633|NCT02667301|69147905|FG000|Overall Study|Lack of Efficacy|1|||
37673634|NCT05274165|69147913|FG000|Overall Study|Withdrawal by Subject|3|||
37673635|NCT05274165|69147914|FG001|Overall Study|Withdrawal by Subject|3|||
37673636|NCT04510090|69147956|FG000|FE-HS|Withdrawal by Subject|0|||
37673637|NCT04510090|69147957|FG001|FE-HS|Withdrawal by Subject|0|||
37673638|NCT04510090|69147958|FG002|FE-HS|Withdrawal by Subject|0|||
37673639|NCT04510090|69147959|FG003|FE-HS|Withdrawal by Subject|0|||
37673640|NCT04510090|69147960|FG004|FE-HS|Withdrawal by Subject|1|||
37673641|NCT04510090|69147961|FG005|FE-HS|Withdrawal by Subject|0|||
37673642|NCT04510090|69147962|FG006|FE-HS|Withdrawal by Subject|0|||
37673643|NCT04510090|69147963|FG007|FE-HS|Withdrawal by Subject|0|||
37673644|NCT04491006|69147993|FG000|Overall Study|Adverse Event|0|||
37673645|NCT04491006|69147994|FG001|Overall Study|Adverse Event|3|||
37673646|NCT04491006|69147995|FG002|Overall Study|Adverse Event|5|||
37673647|NCT04491006|69147993|FG000|Overall Study|Withdrawal by Subject|1|||
37673648|NCT04491006|69147994|FG001|Overall Study|Withdrawal by Subject|0|||
37673649|NCT04491006|69147995|FG002|Overall Study|Withdrawal by Subject|2|||
37673650|NCT04162470|69148038|FG000|Overall Study|Withdrawn due to sponsor's decision|24|||
37673651|NCT04122625|69148048|FG000|Part A (up to 2.92 Years)|Death|2|||
37673652|NCT04122625|69148049|FG001|Part A (up to 2.92 Years)|Death|4|||
37673653|NCT04122625|69148050|FG002|Part A (up to 2.92 Years)|Death|0|||
37673654|NCT04122625|69148051|FG003|Part A (up to 2.92 Years)|Death|0|||
37673655|NCT04122625|69148052|FG004|Part A (up to 2.92 Years)|Death|0|||
37673656|NCT04122625|69148053|FG005|Part A (up to 2.92 Years)|Death|0|||
37673657|NCT04122625|69148048|FG000|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
37673658|NCT04122625|69148049|FG001|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
37673659|NCT04122625|69148050|FG002|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
37673660|NCT04122625|69148051|FG003|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
37673661|NCT04122625|69148052|FG004|Part B (up to 2.33 Years)|Patient lost to follow-up|2|||
37673662|NCT04122625|69148053|FG005|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
37673663|NCT04122625|69148048|FG000|Part B (up to 2.33 Years)|Death|0|||
37673664|NCT04122625|69148049|FG001|Part B (up to 2.33 Years)|Death|0|||
37673665|NCT04122625|69148050|FG002|Part B (up to 2.33 Years)|Death|5|||
37673666|NCT04122625|69148051|FG003|Part B (up to 2.33 Years)|Death|7|||
37673667|NCT04122625|69148052|FG004|Part B (up to 2.33 Years)|Death|6|||
37673668|NCT04122625|69148053|FG005|Part B (up to 2.33 Years)|Death|7|||
37673669|NCT03824704|69148071|FG000|Overall Study|Study Terminated by Sponsor|1|||
37673670|NCT03766581|69148087|FG000|Randomization|Other reasons|2|||
37673671|NCT03766581|69148088|FG001|Randomization|Other reasons|1|||
37673672|NCT03766581|69148089|FG002|Randomization|Other reasons|0|||
37673673|NCT03766581|69148090|FG003|Randomization|Other reasons|1|||
37673674|NCT03766581|69148091|FG004|Randomization|Other reasons|0|||
37673675|NCT03766581|69148092|FG005|Randomization|Other reasons|0|||
37673676|NCT03766581|69148093|FG006|Randomization|Other reasons|0|||
37673677|NCT03766581|69148094|FG007|Randomization|Other reasons|0|||
37673678|NCT03766581|69148087|FG000|Randomization|Participant no longer meets study criteria|5|||
37673679|NCT03766581|69148088|FG001|Randomization|Participant no longer meets study criteria|3|||
37673680|NCT03766581|69148089|FG002|Randomization|Participant no longer meets study criteria|4|||
37673681|NCT03766581|69148090|FG003|Randomization|Participant no longer meets study criteria|0|||
37673682|NCT03766581|69148091|FG004|Randomization|Participant no longer meets study criteria|2|||
37673683|NCT03766581|69148092|FG005|Randomization|Participant no longer meets study criteria|3|||
37673684|NCT03766581|69148093|FG006|Randomization|Participant no longer meets study criteria|0|||
37673685|NCT03766581|69148094|FG007|Randomization|Participant no longer meets study criteria|1|||
37673686|NCT03766581|69148087|FG000|Randomization|Participant request to discontinue study treatment|1|||
37673687|NCT03766581|69148088|FG001|Randomization|Participant request to discontinue study treatment|0|||
37673688|NCT03766581|69148089|FG002|Randomization|Participant request to discontinue study treatment|0|||
37673689|NCT03766581|69148090|FG003|Randomization|Participant request to discontinue study treatment|0|||
37673690|NCT03766581|69148091|FG004|Randomization|Participant request to discontinue study treatment|1|||
37673691|NCT03766581|69148092|FG005|Randomization|Participant request to discontinue study treatment|2|||
37673692|NCT03766581|69148093|FG006|Randomization|Participant request to discontinue study treatment|0|||
37673693|NCT03766581|69148094|FG007|Randomization|Participant request to discontinue study treatment|0|||
37673694|NCT03766581|69148087|FG000|Randomization|Participant withdrew consent|1|||
37673695|NCT03766581|69148088|FG001|Randomization|Participant withdrew consent|0|||
37673696|NCT03766581|69148089|FG002|Randomization|Participant withdrew consent|1|||
37673697|NCT03766581|69148090|FG003|Randomization|Participant withdrew consent|2|||
37673698|NCT03766581|69148091|FG004|Randomization|Participant withdrew consent|1|||
37673699|NCT03766581|69148092|FG005|Randomization|Participant withdrew consent|1|||
37673700|NCT03766581|69148093|FG006|Randomization|Participant withdrew consent|0|||
37673701|NCT03766581|69148094|FG007|Randomization|Participant withdrew consent|0|||
37673702|NCT03766581|69148087|FG000|Treatment|Adverse Event|82|||
37673703|NCT03766581|69148088|FG001|Treatment|Adverse Event|44|||
37673704|NCT03766581|69148089|FG002|Treatment|Adverse Event|47|||
37673705|NCT03766581|69148090|FG003|Treatment|Adverse Event|46|||
37673706|NCT03766581|69148091|FG004|Treatment|Adverse Event|50|||
37673707|NCT03766581|69148092|FG005|Treatment|Adverse Event|77|||
37673708|NCT03766581|69148093|FG006|Treatment|Adverse Event|5|||
37673709|NCT03766581|69148094|FG007|Treatment|Adverse Event|2|||
37673710|NCT03766581|69148087|FG000|Treatment|Participant request to discontinue treatment|34|||
37673711|NCT03766581|69148088|FG001|Treatment|Participant request to discontinue treatment|6|||
37673712|NCT03766581|69148089|FG002|Treatment|Participant request to discontinue treatment|10|||
37673713|NCT03766581|69148090|FG003|Treatment|Participant request to discontinue treatment|10|||
37673714|NCT03766581|69148091|FG004|Treatment|Participant request to discontinue treatment|14|||
37673715|NCT03766581|69148092|FG005|Treatment|Participant request to discontinue treatment|15|||
37673716|NCT03766581|69148093|FG006|Treatment|Participant request to discontinue treatment|0|||
37673717|NCT03766581|69148094|FG007|Treatment|Participant request to discontinue treatment|1|||
37673718|NCT03766581|69148087|FG000|Treatment|Participant withdrew consent|11|||
37673719|NCT03766581|69148088|FG001|Treatment|Participant withdrew consent|4|||
37673720|NCT03766581|69148089|FG002|Treatment|Participant withdrew consent|5|||
37673721|NCT03766581|69148090|FG003|Treatment|Participant withdrew consent|5|||
37673722|NCT03766581|69148091|FG004|Treatment|Participant withdrew consent|4|||
37673723|NCT03766581|69148092|FG005|Treatment|Participant withdrew consent|4|||
37673724|NCT03766581|69148093|FG006|Treatment|Participant withdrew consent|0|||
37673725|NCT03766581|69148094|FG007|Treatment|Participant withdrew consent|0|||
37673726|NCT03766581|69148087|FG000|Treatment|Death|1|||
37673727|NCT03766581|69148088|FG001|Treatment|Death|0|||
37673728|NCT03766581|69148089|FG002|Treatment|Death|0|||
37673729|NCT03766581|69148090|FG003|Treatment|Death|0|||
37673730|NCT03766581|69148091|FG004|Treatment|Death|0|||
37673731|NCT03766581|69148092|FG005|Treatment|Death|0|||
37673732|NCT03766581|69148093|FG006|Treatment|Death|0|||
37673733|NCT03766581|69148094|FG007|Treatment|Death|0|||
37673734|NCT03766581|69148087|FG000|Treatment|Lost to Follow-up|1|||
37673735|NCT03766581|69148088|FG001|Treatment|Lost to Follow-up|0|||
37673736|NCT03766581|69148089|FG002|Treatment|Lost to Follow-up|0|||
37673737|NCT03766581|69148090|FG003|Treatment|Lost to Follow-up|1|||
37673738|NCT03766581|69148091|FG004|Treatment|Lost to Follow-up|0|||
37673739|NCT03766581|69148092|FG005|Treatment|Lost to Follow-up|0|||
37673740|NCT03766581|69148093|FG006|Treatment|Lost to Follow-up|0|||
37673741|NCT03766581|69148094|FG007|Treatment|Lost to Follow-up|0|||
37673742|NCT03766581|69148087|FG000|Treatment|Poor/Non compliance|2|||
37673743|NCT03766581|69148088|FG001|Treatment|Poor/Non compliance|2|||
37673744|NCT03766581|69148089|FG002|Treatment|Poor/Non compliance|1|||
37673745|NCT03766581|69148090|FG003|Treatment|Poor/Non compliance|1|||
37673746|NCT03766581|69148091|FG004|Treatment|Poor/Non compliance|1|||
37673747|NCT03766581|69148092|FG005|Treatment|Poor/Non compliance|1|||
37673748|NCT03766581|69148093|FG006|Treatment|Poor/Non compliance|0|||
37673749|NCT03766581|69148094|FG007|Treatment|Poor/Non compliance|0|||
37673750|NCT03766581|69148087|FG000|Treatment|Participant no longer meets study criteria|9|||
37673751|NCT03766581|69148088|FG001|Treatment|Participant no longer meets study criteria|1|||
37673752|NCT03766581|69148089|FG002|Treatment|Participant no longer meets study criteria|5|||
37673753|NCT03766581|69148090|FG003|Treatment|Participant no longer meets study criteria|4|||
37673754|NCT03766581|69148091|FG004|Treatment|Participant no longer meets study criteria|4|||
37673755|NCT03766581|69148092|FG005|Treatment|Participant no longer meets study criteria|4|||
37673756|NCT03766581|69148093|FG006|Treatment|Participant no longer meets study criteria|2|||
37673757|NCT03766581|69148094|FG007|Treatment|Participant no longer meets study criteria|0|||
37673758|NCT03766581|69148087|FG000|Treatment|Other reasons|13|||
37673759|NCT03766581|69148088|FG001|Treatment|Other reasons|8|||
37673760|NCT03766581|69148089|FG002|Treatment|Other reasons|3|||
37673761|NCT03766581|69148090|FG003|Treatment|Other reasons|7|||
37673762|NCT03766581|69148091|FG004|Treatment|Other reasons|3|||
37673763|NCT03766581|69148092|FG005|Treatment|Other reasons|3|||
37673764|NCT03766581|69148093|FG006|Treatment|Other reasons|0|||
37673765|NCT03766581|69148094|FG007|Treatment|Other reasons|0|||
37673766|NCT03675321|69148119|FG000|Overall Study|Lack of Efficacy|2|||
37673767|NCT03675321|69148120|FG001|Overall Study|Lack of Efficacy|2|||
37673768|NCT03675321|69148119|FG000|Overall Study|Withdrawal by Subject|1|||
37673769|NCT03675321|69148120|FG001|Overall Study|Withdrawal by Subject|3|||
37673770|NCT03527745|69148166|FG000|Overall Study|Lost to Follow-up|3|||
37673771|NCT03527745|69148167|FG001|Overall Study|Lost to Follow-up|6|||
37673772|NCT03527745|69148168|FG002|Overall Study|Lost to Follow-up|7|||
37673773|NCT03527745|69148169|FG003|Overall Study|Lost to Follow-up|9|||
37673774|NCT03527745|69148170|FG004|Overall Study|Lost to Follow-up|0|||
37673775|NCT03527745|69148171|FG005|Overall Study|Lost to Follow-up|2|||
37673776|NCT03527745|69148172|FG006|Overall Study|Lost to Follow-up|3|||
37673777|NCT03527745|69148173|FG007|Overall Study|Lost to Follow-up|2|||
37673778|NCT03527745|69148174|FG008|Overall Study|Lost to Follow-up|3|||
37673779|NCT03527745|69148175|FG009|Overall Study|Lost to Follow-up|2|||
37673780|NCT03527745|69148176|FG010|Overall Study|Lost to Follow-up|1|||
37673781|NCT03527745|69148177|FG011|Overall Study|Lost to Follow-up|1|||
37673782|NCT03527745|69148178|FG012|Overall Study|Lost to Follow-up|0|||
37673783|NCT03527745|69148179|FG013|Overall Study|Lost to Follow-up|0|||
37673784|NCT03527745|69148180|FG014|Overall Study|Lost to Follow-up|0|||
37673785|NCT03527745|69148181|FG015|Overall Study|Lost to Follow-up|0|||
37673786|NCT03527745|69148182|FG016|Overall Study|Lost to Follow-up|1|||
37673787|NCT03527745|69148183|FG017|Overall Study|Lost to Follow-up|0|||
37673788|NCT03527745|69148184|FG018|Overall Study|Lost to Follow-up|0|||
37673789|NCT03527745|69148185|FG019|Overall Study|Lost to Follow-up|1|||
37673790|NCT03527745|69148186|FG020|Overall Study|Lost to Follow-up|1|||
37673791|NCT03527745|69148187|FG021|Overall Study|Lost to Follow-up|5|||
37673792|NCT03527745|69148188|FG022|Overall Study|Lost to Follow-up|6|||
37673793|NCT03527745|69148189|FG023|Overall Study|Lost to Follow-up|8|||
37673794|NCT03527745|69148190|FG024|Overall Study|Lost to Follow-up|1|||
37673795|NCT03527745|69148191|FG025|Overall Study|Lost to Follow-up|3|||
37673796|NCT03174782|69148273|FG000|Overall Study|Protocol Violation|1|||
37673797|NCT03174782|69148274|FG001|Overall Study|Protocol Violation|0|||
37673798|NCT03174782|69148273|FG000|Overall Study|Unable to perform procedure by medical staff|0|||
37673799|NCT03174782|69148274|FG001|Overall Study|Unable to perform procedure by medical staff|1|||
37673800|NCT02919969|69148280|FG000|Overall Study|Lack of Efficacy|22|||
37673801|NCT02919969|69148280|FG000|Overall Study|Death|4|||
37673802|NCT02919969|69148280|FG000|Overall Study|Physician Decision|3|||
37673803|NCT02919969|69148280|FG000|Overall Study|Withdrawal by Subject|2|||
37673804|NCT01891344|69148302|FG000|Overall Study|Ongoing|6|||
37673805|NCT01891344|69148303|FG001|Overall Study|Ongoing|2|||
37673806|NCT01891344|69148304|FG002|Overall Study|Ongoing|0|||
37673807|NCT01891344|69148305|FG003|Overall Study|Ongoing|1|||
37673808|NCT01891344|69148306|FG004|Overall Study|Ongoing|4|||
37673809|NCT01891344|69148307|FG005|Overall Study|Ongoing|1|||
37673810|NCT01891344|69148308|FG006|Overall Study|Ongoing|0|||
37673811|NCT01891344|69148309|FG007|Overall Study|Ongoing|0|||
37673812|NCT01188096|69148327|FG000|Overall Study|progression of disease|4|||
37673813|NCT01188096|69148327|FG000|Overall Study|Withdrawal by Subject|2|||
37673814|NCT00579826|69148347|FG000|Overall Study|Withdrawal by Subject|5|||
37673815|NCT00579826|69148348|FG001|Overall Study|Withdrawal by Subject|3|||
37673816|NCT00106691|69148356|FG000|Overall Study|Adverse Event|60|||
37673817|NCT00106691|69148357|FG001|Overall Study|Adverse Event|64|||
37673818|NCT00106691|69148356|FG000|Overall Study|Lost to Follow-up|23|||
37673819|NCT00106691|69148357|FG001|Overall Study|Lost to Follow-up|18|||
37673820|NCT00106691|69148356|FG000|Overall Study|Physician Decision|18|||
37673821|NCT00106691|69148357|FG001|Overall Study|Physician Decision|21|||
37673822|NCT00106691|69148356|FG000|Overall Study|Protocol Violation|13|||
37673823|NCT00106691|69148357|FG001|Overall Study|Protocol Violation|18|||
37673824|NCT00106691|69148356|FG000|Overall Study|Withdrawal by Subject|75|||
37673825|NCT00106691|69148357|FG001|Overall Study|Withdrawal by Subject|70|||
37673826|NCT00106691|69148356|FG000|Overall Study|Failure to comply w/dosing regimen|6|||
37673827|NCT00106691|69148357|FG001|Overall Study|Failure to comply w/dosing regimen|4|||
37673828|NCT00106691|69148356|FG000|Overall Study|QTc>480|3|||
37673829|NCT00106691|69148357|FG001|Overall Study|QTc>480|1|||
37673830|NCT00106691|69148356|FG000|Overall Study|mililtary deployment|2|||
37673831|NCT00106691|69148357|FG001|Overall Study|mililtary deployment|0|||
37673832|NCT00106691|69148356|FG000|Overall Study|Study Site Closing/PI Moved|1|||
37673833|NCT00106691|69148357|FG001|Overall Study|Study Site Closing/PI Moved|2|||
37673834|NCT00106691|69148356|FG000|Overall Study|Cardiologist recommendation|1|||
37673835|NCT00106691|69148357|FG001|Overall Study|Cardiologist recommendation|0|||
37673836|NCT00106691|69148356|FG000|Overall Study|Pt. moved to another state|1|||
37673837|NCT00106691|69148357|FG001|Overall Study|Pt. moved to another state|0|||
37673838|NCT00106691|69148356|FG000|Overall Study|Taking exclusionary avodart|1|||
37673839|NCT00106691|69148357|FG001|Overall Study|Taking exclusionary avodart|0|||
37673840|NCT00106691|69148356|FG000|Overall Study|Not able to discontinue plavix|0|||
37673841|NCT00106691|69148357|FG001|Overall Study|Not able to discontinue plavix|1|||
37673842|NCT04209725|69148365|FG000|Overall Study|Adverse Event|1|||
37673843|NCT02644967|69148458|FG000|Overall Study|Death|26|||
37673844|NCT02644967|69148458|FG000|Overall Study|Physician Decision|1|||
37673845|NCT02644967|69148458|FG000|Overall Study|Withdrawal by Subject|2|||
37673846|NCT02644967|69148458|FG000|Overall Study|Protocol Violation|1|||
37673847|NCT02644967|69148458|FG000|Overall Study|Progressive Disease|1|||
37673848|NCT02644967|69148458|FG000|Overall Study|Study Terminated by Sponsor|4|||
37673849|NCT02644343|69148462|FG000|Overall Study|Withdrawal by Subject|1|||
37673850|NCT02644109|69148468|FG000|Overall Study|Adverse Event|0|||
37673851|NCT02644109|69148469|FG001|Overall Study|Adverse Event|4|||
37673852|NCT02642159|69148477|FG000|Overall Study|Randomized but not treated|1|||
37673853|NCT02642159|69148478|FG001|Overall Study|Randomized but not treated|0|||
37673854|NCT02642159|69148477|FG000|Overall Study|Adverse Event|10|||
37673855|NCT02642159|69148478|FG001|Overall Study|Adverse Event|4|||
37673856|NCT02642159|69148477|FG000|Overall Study|Withdrawal by Subject|9|||
37673857|NCT02642159|69148478|FG001|Overall Study|Withdrawal by Subject|1|||
37673858|NCT02642159|69148477|FG000|Overall Study|Poor compliance to study protocol|1|||
37673859|NCT02642159|69148478|FG001|Overall Study|Poor compliance to study protocol|0|||
37673860|NCT02642159|69148477|FG000|Overall Study|Other than specified above|10|||
37673861|NCT02642159|69148478|FG001|Overall Study|Other than specified above|3|||
37673862|NCT02669017|69148494|FG000|Overall Study|Death|1|||
37673863|NCT02669017|69148495|FG001|Overall Study|Death|2|||
37673864|NCT02669017|69148496|FG002|Overall Study|Death|2|||
37673865|NCT02669017|69148497|FG003|Overall Study|Death|3|||
37673866|NCT02669017|69148498|FG004|Overall Study|Death|8|||
37673867|NCT02669017|69148499|FG005|Overall Study|Death|18|||
37673868|NCT02669017|69148500|FG006|Overall Study|Death|10|||
37673869|NCT02669017|69148501|FG007|Overall Study|Death|47|||
37673870|NCT02669017|69148502|FG008|Overall Study|Death|20|||
37673871|NCT02669017|69148494|FG000|Overall Study|Withdrawal by Subject|0|||
37673872|NCT02669017|69148495|FG001|Overall Study|Withdrawal by Subject|0|||
37673873|NCT02669017|69148496|FG002|Overall Study|Withdrawal by Subject|0|||
37673874|NCT02669017|69148497|FG003|Overall Study|Withdrawal by Subject|1|||
37673875|NCT02669017|69148498|FG004|Overall Study|Withdrawal by Subject|2|||
37673876|NCT02669017|69148499|FG005|Overall Study|Withdrawal by Subject|0|||
37673877|NCT02669017|69148500|FG006|Overall Study|Withdrawal by Subject|0|||
37673878|NCT02669017|69148501|FG007|Overall Study|Withdrawal by Subject|2|||
37673879|NCT02669017|69148502|FG008|Overall Study|Withdrawal by Subject|2|||
37673880|NCT02669017|69148494|FG000|Overall Study|Lost to Follow-up|0|||
37673881|NCT02669017|69148495|FG001|Overall Study|Lost to Follow-up|0|||
37673882|NCT02669017|69148496|FG002|Overall Study|Lost to Follow-up|0|||
37673883|NCT02669017|69148497|FG003|Overall Study|Lost to Follow-up|0|||
37673884|NCT02669017|69148498|FG004|Overall Study|Lost to Follow-up|0|||
37673885|NCT02669017|69148499|FG005|Overall Study|Lost to Follow-up|0|||
37673886|NCT02669017|69148500|FG006|Overall Study|Lost to Follow-up|0|||
37673887|NCT02669017|69148501|FG007|Overall Study|Lost to Follow-up|0|||
37673888|NCT02669017|69148502|FG008|Overall Study|Lost to Follow-up|1|||
37673889|NCT02669017|69148494|FG000|Overall Study|Miscellaneous|0|||
37673890|NCT02669017|69148495|FG001|Overall Study|Miscellaneous|0|||
37673891|NCT02669017|69148496|FG002|Overall Study|Miscellaneous|0|||
37673892|NCT02669017|69148497|FG003|Overall Study|Miscellaneous|0|||
37673893|NCT02669017|69148498|FG004|Overall Study|Miscellaneous|2|||
37673894|NCT02669017|69148499|FG005|Overall Study|Miscellaneous|1|||
37673895|NCT02669017|69148500|FG006|Overall Study|Miscellaneous|1|||
37673896|NCT02669017|69148501|FG007|Overall Study|Miscellaneous|13|||
37673897|NCT02669017|69148502|FG008|Overall Study|Miscellaneous|2|||
37673898|NCT02668393|69148532|FG000|Overall Study|Progressive disease|6|||
37673899|NCT02668393|69148533|FG001|Overall Study|Progressive disease|3|||
37673900|NCT02668393|69148532|FG000|Overall Study|Adverse Event|0|||
37673901|NCT02668393|69148533|FG001|Overall Study|Adverse Event|2|||
37673902|NCT02668393|69148532|FG000|Overall Study|Withdrawal from the trial|0|||
37673903|NCT02668393|69148533|FG001|Overall Study|Withdrawal from the trial|1|||
37673904|NCT02668393|69148532|FG000|Overall Study|Lack of benefit and side effects|1|||
37673905|NCT02668393|69148533|FG001|Overall Study|Lack of benefit and side effects|0|||
37673906|NCT01998958|69148547|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
37673907|NCT01998958|69148548|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
37673908|NCT01998958|69148549|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
37673909|NCT01998958|69148550|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
37673910|NCT01998958|69148551|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
37673911|NCT01998958|69148552|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
37673912|NCT01998958|69148553|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
37673913|NCT01998958|69148554|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
37673914|NCT01998958|69148555|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
37673915|NCT01998958|69148556|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
37673916|NCT01998958|69148557|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
37673917|NCT01998958|69148558|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
37673918|NCT01998958|69148559|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
37673919|NCT01998958|69148560|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
37673920|NCT01998958|69148561|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
37673921|NCT01998958|69148562|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
37673922|NCT01998958|69148563|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
37673923|NCT01998958|69148564|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
37673924|NCT01998958|69148565|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
37673925|NCT01998958|69148566|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
37673926|NCT01998958|69148567|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
37673927|NCT01998958|69148568|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
37673928|NCT01998958|69148569|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
37673929|NCT01998958|69148570|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
37673930|NCT01998958|69148571|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
37673931|NCT01998958|69148572|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
37673932|NCT01998958|69148573|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
37673933|NCT01998958|69148574|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
37673934|NCT01998958|69148575|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
37673935|NCT01998958|69148576|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
37673936|NCT01998958|69148577|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
37673937|NCT01998958|69148578|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
37673938|NCT01998958|69148547|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
37673939|NCT01998958|69148548|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
37673940|NCT01998958|69148549|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
37673941|NCT01998958|69148550|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
37673942|NCT01998958|69148551|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
37673943|NCT01998958|69148552|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
37673944|NCT01998958|69148553|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
37673945|NCT01998958|69148554|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
37673946|NCT01998958|69148555|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
37673947|NCT01998958|69148556|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
37673948|NCT01998958|69148557|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
37673949|NCT01998958|69148558|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
37673950|NCT01998958|69148559|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
37673951|NCT01998958|69148560|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
37673952|NCT01998958|69148561|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
37673953|NCT01998958|69148562|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
37673954|NCT01998958|69148563|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
37673955|NCT01998958|69148564|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
37673956|NCT01998958|69148565|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
37673957|NCT01998958|69148566|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
37673958|NCT01998958|69148567|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
37673959|NCT01998958|69148568|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
37673960|NCT01998958|69148569|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
37673961|NCT01998958|69148570|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
37673962|NCT01998958|69148571|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
37673963|NCT01998958|69148572|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
37673964|NCT01998958|69148573|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
37673965|NCT01998958|69148574|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
37673966|NCT01998958|69148575|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
37673967|NCT01998958|69148576|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
37673968|NCT01998958|69148577|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
37673969|NCT01998958|69148578|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
37673970|NCT01998958|69148547|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
37673971|NCT01998958|69148548|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
37673972|NCT01998958|69148549|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
37673973|NCT01998958|69148550|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
37673974|NCT01998958|69148551|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
37673975|NCT01998958|69148552|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
37673976|NCT01998958|69148553|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
37673977|NCT01998958|69148554|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
37673978|NCT01998958|69148555|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
37673979|NCT01998958|69148556|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
37673980|NCT01998958|69148557|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
37673981|NCT01998958|69148558|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
37673982|NCT01998958|69148559|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
37673983|NCT01998958|69148560|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
37673984|NCT01998958|69148561|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
37673985|NCT01998958|69148562|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
37673986|NCT01998958|69148563|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
37673987|NCT01998958|69148564|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
37673988|NCT01998958|69148565|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
37673989|NCT01998958|69148566|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
37673990|NCT01998958|69148567|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
37673991|NCT01998958|69148568|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
37673992|NCT01998958|69148569|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
37673993|NCT01998958|69148570|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
37673994|NCT01998958|69148571|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
37673995|NCT01998958|69148572|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
37673996|NCT01998958|69148573|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
37673997|NCT01998958|69148574|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
37673998|NCT01998958|69148575|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
37673999|NCT01998958|69148576|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
37674000|NCT01998958|69148577|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
37674001|NCT01998958|69148578|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
37674002|NCT01998958|69148547|FG000|Period 1 (Panel A and B)|Other|1|||
37674003|NCT01998958|69148548|FG001|Period 1 (Panel A and B)|Other|0|||
37674004|NCT01998958|69148549|FG002|Period 1 (Panel A and B)|Other|0|||
37674005|NCT01998958|69148550|FG003|Period 1 (Panel A and B)|Other|0|||
37674006|NCT01998958|69148551|FG004|Period 1 (Panel A and B)|Other|0|||
37674007|NCT01998958|69148552|FG005|Period 1 (Panel A and B)|Other|0|||
37674008|NCT01998958|69148553|FG006|Period 1 (Panel A and B)|Other|0|||
37674009|NCT01998958|69148554|FG007|Period 1 (Panel A and B)|Other|0|||
37674010|NCT01998958|69148555|FG008|Period 1 (Panel A and B)|Other|0|||
37674011|NCT01998958|69148556|FG009|Period 1 (Panel A and B)|Other|0|||
37674012|NCT01998958|69148557|FG010|Period 1 (Panel A and B)|Other|0|||
37674013|NCT01998958|69148558|FG011|Period 1 (Panel A and B)|Other|0|||
37674014|NCT01998958|69148559|FG012|Period 1 (Panel A and B)|Other|0|||
37674015|NCT01998958|69148560|FG013|Period 1 (Panel A and B)|Other|0|||
37674016|NCT01998958|69148561|FG014|Period 1 (Panel A and B)|Other|0|||
37674017|NCT01998958|69148562|FG015|Period 1 (Panel A and B)|Other|0|||
37674018|NCT01998958|69148563|FG016|Period 1 (Panel A and B)|Other|0|||
37674019|NCT01998958|69148564|FG017|Period 1 (Panel A and B)|Other|0|||
37674020|NCT01998958|69148565|FG018|Period 1 (Panel A and B)|Other|0|||
37674021|NCT01998958|69148566|FG019|Period 1 (Panel A and B)|Other|0|||
37674022|NCT01998958|69148567|FG020|Period 1 (Panel A and B)|Other|0|||
37674023|NCT01998958|69148568|FG021|Period 1 (Panel A and B)|Other|0|||
37674024|NCT01998958|69148569|FG022|Period 1 (Panel A and B)|Other|0|||
37674025|NCT01998958|69148570|FG023|Period 1 (Panel A and B)|Other|0|||
37674026|NCT01998958|69148571|FG024|Period 1 (Panel A and B)|Other|0|||
37674027|NCT01998958|69148572|FG025|Period 1 (Panel A and B)|Other|0|||
37674028|NCT01998958|69148573|FG026|Period 1 (Panel A and B)|Other|0|||
37674029|NCT01998958|69148574|FG027|Period 1 (Panel A and B)|Other|0|||
37674030|NCT01998958|69148575|FG028|Period 1 (Panel A and B)|Other|0|||
37674031|NCT01998958|69148576|FG029|Period 1 (Panel A and B)|Other|0|||
37674032|NCT01998958|69148577|FG030|Period 1 (Panel A and B)|Other|0|||
37674033|NCT01998958|69148578|FG031|Period 1 (Panel A and B)|Other|0|||
37674034|NCT01998958|69148547|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
37674035|NCT01998958|69148548|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
37674036|NCT01998958|69148549|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
37674037|NCT01998958|69148550|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
37674038|NCT01998958|69148551|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
37674039|NCT01998958|69148552|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
37674040|NCT01998958|69148553|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
37674041|NCT01998958|69148554|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
37674042|NCT01998958|69148555|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
37674043|NCT01998958|69148556|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
37674044|NCT01998958|69148557|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
37674045|NCT01998958|69148558|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
37674046|NCT01998958|69148559|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
37674047|NCT01998958|69148560|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
37674048|NCT01998958|69148561|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
37674049|NCT01998958|69148562|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
37674050|NCT01998958|69148563|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
37674051|NCT01998958|69148564|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
37674052|NCT01998958|69148565|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
37674053|NCT01998958|69148566|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
37674054|NCT01998958|69148567|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
37674055|NCT01998958|69148568|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
37674056|NCT01998958|69148569|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
37674057|NCT01998958|69148570|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
37674058|NCT01998958|69148571|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
37674059|NCT01998958|69148572|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
37674060|NCT01998958|69148573|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
37674061|NCT01998958|69148574|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
37674062|NCT01998958|69148575|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
37674063|NCT01998958|69148576|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
37674064|NCT01998958|69148577|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
37674065|NCT01998958|69148578|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
37674066|NCT01998958|69148547|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
37674067|NCT01998958|69148548|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
37674068|NCT01998958|69148549|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
37674069|NCT01998958|69148550|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
37674070|NCT01998958|69148551|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
37674071|NCT01998958|69148552|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
37674072|NCT01998958|69148553|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
37674073|NCT01998958|69148554|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
37674074|NCT01998958|69148555|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
37674075|NCT01998958|69148556|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
37674076|NCT01998958|69148557|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
37674077|NCT01998958|69148558|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
37674078|NCT01998958|69148559|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
37674079|NCT01998958|69148560|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
37674080|NCT01998958|69148561|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
37674081|NCT01998958|69148562|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
37674082|NCT01998958|69148563|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
37674083|NCT01998958|69148564|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
37674084|NCT01998958|69148565|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
37674085|NCT01998958|69148566|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
37674086|NCT01998958|69148567|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
37674087|NCT01998958|69148568|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
37674088|NCT01998958|69148569|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
37674089|NCT01998958|69148570|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
37674090|NCT01998958|69148571|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
37674091|NCT01998958|69148572|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
37674092|NCT01998958|69148573|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
37674093|NCT01998958|69148574|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
37674094|NCT01998958|69148575|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
37674095|NCT01998958|69148576|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
37674096|NCT01998958|69148577|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
37674097|NCT01998958|69148578|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
37674098|NCT01998958|69148547|FG000|Open Label Phase (Optional)|Adverse Event|0|||
38038954|NCT00095147|69726327|FG001|Long-term Extension Period|No longer meets study criteria|0|||
38038955|NCT00095147|69726328|FG002|Long-term Extension Period|No longer meets study criteria|0|||
38038956|NCT00095147|69726329|FG003|Long-term Extension Period|No longer meets study criteria|0|||
38038957|NCT00095147|69726330|FG004|Long-term Extension Period|No longer meets study criteria|1|||
38038958|NCT00095147|69726326|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
38038959|NCT00095147|69726327|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
38038960|NCT00095147|69726328|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
38038961|NCT00095147|69726329|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
38038962|NCT00095147|69726330|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
38038963|NCT00095147|69726326|FG000|Long-term Extension Period|Leaving country|0|||
38038964|NCT00095147|69726327|FG001|Long-term Extension Period|Leaving country|0|||
38038965|NCT00095147|69726328|FG002|Long-term Extension Period|Leaving country|0|||
38038966|NCT00095147|69726329|FG003|Long-term Extension Period|Leaving country|0|||
38038967|NCT00095147|69726330|FG004|Long-term Extension Period|Leaving country|1|||
38038968|NCT02751580|69726348|FG000|Overall Study|Lost to Follow-up|4|||
38038969|NCT02751580|69726348|FG000|Overall Study|Death|2|||
38038970|NCT02751502|69726352|FG000|Overall Study|Lack of funding|4|||
38038971|NCT02257918|69726359|FG000|Overall Study|Lost to Follow-up|4|||
37674099|NCT01998958|69148548|FG001|Open Label Phase (Optional)|Adverse Event|0|||
37674100|NCT01998958|69148549|FG002|Open Label Phase (Optional)|Adverse Event|0|||
38038972|NCT02257918|69726360|FG001|Overall Study|Lost to Follow-up|1|||
37674101|NCT01998958|69148550|FG003|Open Label Phase (Optional)|Adverse Event|0|||
38038973|NCT02257918|69726361|FG002|Overall Study|Lost to Follow-up|0|||
38038974|NCT02257918|69726359|FG000|Overall Study|Withdrawal by Subject|0|||
38038975|NCT02257918|69726360|FG001|Overall Study|Withdrawal by Subject|0|||
38038976|NCT02257918|69726361|FG002|Overall Study|Withdrawal by Subject|1|||
38038977|NCT02257918|69726359|FG000|Overall Study|Pregnancy|0|||
38038978|NCT02257918|69726360|FG001|Overall Study|Pregnancy|0|||
38038979|NCT02257918|69726361|FG002|Overall Study|Pregnancy|1|||
38038980|NCT02751424|69726378|FG000|Part 2|Adverse Event|0|||
38038981|NCT02751424|69726379|FG001|Part 2|Adverse Event|0|||
38038982|NCT02751424|69726380|FG002|Part 2|Adverse Event|0|||
38038983|NCT02751424|69726381|FG003|Part 2|Adverse Event|0|||
38038984|NCT02751424|69726382|FG004|Part 2|Adverse Event|0|||
38038985|NCT02751424|69726383|FG005|Part 2|Adverse Event|0|||
38038986|NCT02751424|69726384|FG006|Part 2|Adverse Event|0|||
38038987|NCT02751424|69726385|FG007|Part 2|Adverse Event|5|||
38038988|NCT02751424|69726386|FG008|Part 2|Adverse Event|0|||
38038989|NCT00094835|69726416|FG000|Overall Study|Physician Decision|1|||
38038990|NCT00094835|69726417|FG001|Overall Study|Physician Decision|0|||
38038991|NCT00094835|69726418|FG002|Overall Study|Physician Decision|0|||
38038992|NCT00094835|69726419|FG003|Overall Study|Physician Decision|0|||
38038993|NCT00094835|69726420|FG004|Overall Study|Physician Decision|0|||
38038994|NCT00094835|69726421|FG005|Overall Study|Physician Decision|1|||
38038995|NCT00094835|69726422|FG006|Overall Study|Physician Decision|0|||
38038996|NCT00094835|69726416|FG000|Overall Study|Withdrawal by Subject|0|||
38038997|NCT00094835|69726417|FG001|Overall Study|Withdrawal by Subject|0|||
38038998|NCT00094835|69726418|FG002|Overall Study|Withdrawal by Subject|0|||
38038999|NCT00094835|69726419|FG003|Overall Study|Withdrawal by Subject|0|||
38039000|NCT00094835|69726420|FG004|Overall Study|Withdrawal by Subject|0|||
38039001|NCT00094835|69726421|FG005|Overall Study|Withdrawal by Subject|0|||
38039002|NCT00094835|69726422|FG006|Overall Study|Withdrawal by Subject|1|||
38039003|NCT00094835|69726416|FG000|Overall Study|Lost to Follow-up|0|||
38039004|NCT00094835|69726417|FG001|Overall Study|Lost to Follow-up|0|||
38039005|NCT00094835|69726418|FG002|Overall Study|Lost to Follow-up|0|||
38039006|NCT00094835|69726419|FG003|Overall Study|Lost to Follow-up|0|||
38039007|NCT00094835|69726420|FG004|Overall Study|Lost to Follow-up|1|||
38039008|NCT00094835|69726421|FG005|Overall Study|Lost to Follow-up|0|||
38039009|NCT00094835|69726422|FG006|Overall Study|Lost to Follow-up|0|||
38039010|NCT00094835|69726416|FG000|Overall Study|Death|1|||
38039011|NCT00094835|69726417|FG001|Overall Study|Death|0|||
38039012|NCT00094835|69726418|FG002|Overall Study|Death|0|||
38039013|NCT00094835|69726419|FG003|Overall Study|Death|0|||
38039014|NCT00094835|69726420|FG004|Overall Study|Death|1|||
38039015|NCT00094835|69726421|FG005|Overall Study|Death|0|||
38039016|NCT00094835|69726422|FG006|Overall Study|Death|0|||
38039017|NCT00094835|69726416|FG000|Overall Study|Non-compliance|1|||
38039018|NCT00094835|69726417|FG001|Overall Study|Non-compliance|2|||
38039019|NCT00094835|69726418|FG002|Overall Study|Non-compliance|2|||
38039020|NCT00094835|69726419|FG003|Overall Study|Non-compliance|0|||
38039021|NCT00094835|69726420|FG004|Overall Study|Non-compliance|2|||
38039022|NCT00094835|69726421|FG005|Overall Study|Non-compliance|2|||
38039023|NCT00094835|69726422|FG006|Overall Study|Non-compliance|1|||
38039024|NCT00094835|69726416|FG000|Overall Study|Other|1|||
38039025|NCT00094835|69726417|FG001|Overall Study|Other|1|||
37674102|NCT01998958|69148551|FG004|Open Label Phase (Optional)|Adverse Event|0|||
37674103|NCT01998958|69148552|FG005|Open Label Phase (Optional)|Adverse Event|0|||
37674104|NCT01998958|69148553|FG006|Open Label Phase (Optional)|Adverse Event|0|||
37674105|NCT01998958|69148554|FG007|Open Label Phase (Optional)|Adverse Event|0|||
37674106|NCT01998958|69148555|FG008|Open Label Phase (Optional)|Adverse Event|0|||
37674107|NCT01998958|69148556|FG009|Open Label Phase (Optional)|Adverse Event|0|||
37674108|NCT01998958|69148557|FG010|Open Label Phase (Optional)|Adverse Event|0|||
37674109|NCT01998958|69148558|FG011|Open Label Phase (Optional)|Adverse Event|0|||
37674110|NCT01998958|69148559|FG012|Open Label Phase (Optional)|Adverse Event|0|||
37674111|NCT01998958|69148560|FG013|Open Label Phase (Optional)|Adverse Event|0|||
37674112|NCT01998958|69148561|FG014|Open Label Phase (Optional)|Adverse Event|0|||
37674113|NCT01998958|69148562|FG015|Open Label Phase (Optional)|Adverse Event|0|||
38039026|NCT00094835|69726418|FG002|Overall Study|Other|1|||
38039027|NCT00094835|69726419|FG003|Overall Study|Other|1|||
38039028|NCT00094835|69726420|FG004|Overall Study|Other|0|||
38039029|NCT00094835|69726421|FG005|Overall Study|Other|0|||
38039030|NCT00094835|69726422|FG006|Overall Study|Other|0|||
38039031|NCT00094757|69726446|FG000|Overall Study|Adverse Event|11|||
37674114|NCT01998958|69148563|FG016|Open Label Phase (Optional)|Adverse Event|0|||
37674115|NCT01998958|69148564|FG017|Open Label Phase (Optional)|Adverse Event|0|||
37674116|NCT01998958|69148565|FG018|Open Label Phase (Optional)|Adverse Event|0|||
38039032|NCT00094757|69726447|FG001|Overall Study|Adverse Event|9|||
38039033|NCT00094757|69726448|FG002|Overall Study|Adverse Event|6|||
38039034|NCT00094757|69726446|FG000|Overall Study|Lack of Efficacy|11|||
38039035|NCT00094757|69726447|FG001|Overall Study|Lack of Efficacy|15|||
38039036|NCT00094757|69726448|FG002|Overall Study|Lack of Efficacy|8|||
38039037|NCT00094757|69726446|FG000|Overall Study|Lost to Follow-up|3|||
38039038|NCT00094757|69726447|FG001|Overall Study|Lost to Follow-up|5|||
37674117|NCT01998958|69148566|FG019|Open Label Phase (Optional)|Adverse Event|0|||
37674118|NCT01998958|69148567|FG020|Open Label Phase (Optional)|Adverse Event|0|||
37674119|NCT01998958|69148568|FG021|Open Label Phase (Optional)|Adverse Event|0|||
37674120|NCT01998958|69148569|FG022|Open Label Phase (Optional)|Adverse Event|0|||
37674121|NCT01998958|69148570|FG023|Open Label Phase (Optional)|Adverse Event|1|||
37674122|NCT01998958|69148571|FG024|Open Label Phase (Optional)|Adverse Event|0|||
37674123|NCT01998958|69148572|FG025|Open Label Phase (Optional)|Adverse Event|0|||
37674124|NCT01998958|69148573|FG026|Open Label Phase (Optional)|Adverse Event|0|||
37674125|NCT01998958|69148574|FG027|Open Label Phase (Optional)|Adverse Event|0|||
37674126|NCT01998958|69148575|FG028|Open Label Phase (Optional)|Adverse Event|0|||
37674127|NCT01998958|69148576|FG029|Open Label Phase (Optional)|Adverse Event|0|||
37674128|NCT01998958|69148577|FG030|Open Label Phase (Optional)|Adverse Event|0|||
37674129|NCT01998958|69148578|FG031|Open Label Phase (Optional)|Adverse Event|0|||
37674130|NCT01998958|69148547|FG000|Open Label Phase (Optional)|Other|0|||
37674131|NCT01998958|69148548|FG001|Open Label Phase (Optional)|Other|0|||
37674132|NCT01998958|69148549|FG002|Open Label Phase (Optional)|Other|0|||
37674133|NCT01998958|69148550|FG003|Open Label Phase (Optional)|Other|0|||
37674134|NCT01998958|69148551|FG004|Open Label Phase (Optional)|Other|0|||
37674135|NCT01998958|69148552|FG005|Open Label Phase (Optional)|Other|0|||
37674136|NCT01998958|69148553|FG006|Open Label Phase (Optional)|Other|0|||
37674137|NCT01998958|69148554|FG007|Open Label Phase (Optional)|Other|0|||
37674138|NCT01998958|69148555|FG008|Open Label Phase (Optional)|Other|0|||
37674139|NCT01998958|69148556|FG009|Open Label Phase (Optional)|Other|0|||
37674140|NCT01998958|69148557|FG010|Open Label Phase (Optional)|Other|0|||
37674141|NCT01998958|69148558|FG011|Open Label Phase (Optional)|Other|0|||
37674142|NCT01998958|69148559|FG012|Open Label Phase (Optional)|Other|0|||
37674143|NCT01998958|69148560|FG013|Open Label Phase (Optional)|Other|0|||
37674144|NCT01998958|69148561|FG014|Open Label Phase (Optional)|Other|0|||
37674145|NCT01998958|69148562|FG015|Open Label Phase (Optional)|Other|0|||
37674146|NCT01998958|69148563|FG016|Open Label Phase (Optional)|Other|0|||
37674147|NCT01998958|69148564|FG017|Open Label Phase (Optional)|Other|0|||
37674148|NCT01998958|69148565|FG018|Open Label Phase (Optional)|Other|0|||
37674149|NCT01998958|69148566|FG019|Open Label Phase (Optional)|Other|0|||
37674150|NCT01998958|69148567|FG020|Open Label Phase (Optional)|Other|0|||
37674151|NCT01998958|69148568|FG021|Open Label Phase (Optional)|Other|0|||
37674152|NCT01998958|69148569|FG022|Open Label Phase (Optional)|Other|5|||
37674153|NCT01998958|69148570|FG023|Open Label Phase (Optional)|Other|1|||
37674154|NCT01998958|69148571|FG024|Open Label Phase (Optional)|Other|0|||
37674155|NCT01998958|69148572|FG025|Open Label Phase (Optional)|Other|0|||
37674156|NCT01998958|69148573|FG026|Open Label Phase (Optional)|Other|0|||
37674157|NCT01998958|69148574|FG027|Open Label Phase (Optional)|Other|0|||
37674158|NCT01998958|69148575|FG028|Open Label Phase (Optional)|Other|0|||
37674159|NCT01998958|69148576|FG029|Open Label Phase (Optional)|Other|0|||
37674160|NCT01998958|69148577|FG030|Open Label Phase (Optional)|Other|0|||
37674161|NCT01998958|69148578|FG031|Open Label Phase (Optional)|Other|0|||
37674162|NCT01998958|69148547|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
37674163|NCT01998958|69148548|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
37674164|NCT01998958|69148549|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
37674165|NCT01998958|69148550|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
37674166|NCT01998958|69148551|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
37674167|NCT01998958|69148552|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
37674168|NCT01998958|69148553|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
37674169|NCT01998958|69148554|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
37674170|NCT01998958|69148555|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
37674171|NCT01998958|69148556|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
37674172|NCT01998958|69148557|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
37674173|NCT01998958|69148558|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
37674174|NCT01998958|69148559|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
37674175|NCT01998958|69148560|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
37674176|NCT01998958|69148561|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
37674177|NCT01998958|69148562|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
37674178|NCT01998958|69148563|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
37674179|NCT01998958|69148564|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
37674180|NCT01998958|69148565|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
37674181|NCT01998958|69148566|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
37674182|NCT01998958|69148567|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
37674183|NCT01998958|69148568|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
37674184|NCT01998958|69148569|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
37674185|NCT01998958|69148570|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
37674186|NCT01998958|69148571|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
37674187|NCT01998958|69148572|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
37674188|NCT01998958|69148573|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
37674189|NCT01998958|69148574|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
37944994|NCT03976401|69632523|FG000|Overall Study|Withdrawal by Subject|0|||
38039039|NCT00094757|69726448|FG002|Overall Study|Lost to Follow-up|6|||
38039040|NCT00094757|69726446|FG000|Overall Study|Patient Moved|2|||
37674190|NCT01998958|69148575|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
37674191|NCT01998958|69148576|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
37674192|NCT01998958|69148577|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
37674193|NCT01998958|69148578|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
37674194|NCT01998958|69148547|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
37674195|NCT01998958|69148548|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
37674196|NCT01998958|69148549|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
37674197|NCT01998958|69148550|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
37674198|NCT01998958|69148551|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
37674199|NCT01998958|69148552|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
37674200|NCT01998958|69148553|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
37674201|NCT01998958|69148554|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
37674202|NCT01998958|69148555|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
37674203|NCT01998958|69148556|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
37674204|NCT01998958|69148557|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
37674205|NCT01998958|69148558|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
37674206|NCT01998958|69148559|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
37674207|NCT01998958|69148560|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
37674208|NCT01998958|69148561|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
37674209|NCT01998958|69148562|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
37674210|NCT01998958|69148563|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
37674211|NCT01998958|69148564|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
37674212|NCT01998958|69148565|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
37674213|NCT01998958|69148566|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
37674214|NCT01998958|69148567|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
37674215|NCT01998958|69148568|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
37674216|NCT01998958|69148569|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
37674217|NCT01998958|69148570|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
37674218|NCT01998958|69148571|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
37674219|NCT01998958|69148572|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
37674220|NCT01998958|69148573|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
37674221|NCT01998958|69148574|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
37674222|NCT01998958|69148575|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
37674223|NCT01998958|69148576|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
37674224|NCT01998958|69148577|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
37674225|NCT01998958|69148578|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
37674226|NCT01998958|69148547|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
37674227|NCT01998958|69148548|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
37674228|NCT01998958|69148549|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
37674229|NCT01998958|69148550|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
37674230|NCT01998958|69148551|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
37674231|NCT01998958|69148552|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
37674232|NCT01998958|69148553|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
37674233|NCT01998958|69148554|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
37674234|NCT01998958|69148555|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
37674235|NCT01998958|69148556|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
37674236|NCT01998958|69148557|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
37674237|NCT01998958|69148558|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
37674238|NCT01998958|69148559|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
37674239|NCT01998958|69148560|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
37674240|NCT01998958|69148561|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
37674241|NCT01998958|69148562|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
37674242|NCT01998958|69148563|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
37674243|NCT01998958|69148564|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
37674244|NCT01998958|69148565|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
37674245|NCT01998958|69148566|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
37674246|NCT01998958|69148567|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
37944995|NCT03976401|69632524|FG001|Overall Study|Withdrawal by Subject|1|||
37944996|NCT03976401|69632525|FG002|Overall Study|Withdrawal by Subject|0|||
37944997|NCT03976401|69632526|FG003|Overall Study|Withdrawal by Subject|0|||
37944998|NCT03976401|69632527|FG004|Overall Study|Withdrawal by Subject|0|||
37944999|NCT03976401|69632528|FG005|Overall Study|Withdrawal by Subject|1|||
37945000|NCT03976401|69632523|FG000|Overall Study|Physician Decision|0|||
37945001|NCT03976401|69632524|FG001|Overall Study|Physician Decision|0|||
37945002|NCT03976401|69632525|FG002|Overall Study|Physician Decision|1|||
37945003|NCT03976401|69632526|FG003|Overall Study|Physician Decision|0|||
37945004|NCT03976401|69632527|FG004|Overall Study|Physician Decision|0|||
37945005|NCT03976401|69632528|FG005|Overall Study|Physician Decision|0|||
37945006|NCT03976401|69632523|FG000|Overall Study|Lost to Follow-up|1|||
37674247|NCT01998958|69148568|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
37945007|NCT03976401|69632524|FG001|Overall Study|Lost to Follow-up|2|||
37945008|NCT03976401|69632525|FG002|Overall Study|Lost to Follow-up|0|||
37945009|NCT03976401|69632526|FG003|Overall Study|Lost to Follow-up|0|||
37945010|NCT03976401|69632527|FG004|Overall Study|Lost to Follow-up|0|||
37945011|NCT03976401|69632528|FG005|Overall Study|Lost to Follow-up|0|||
37945012|NCT03976401|69632523|FG000|Overall Study|Protocol Violation|0|||
37945013|NCT03976401|69632524|FG001|Overall Study|Protocol Violation|1|||
37945014|NCT03976401|69632525|FG002|Overall Study|Protocol Violation|0|||
37945015|NCT03976401|69632526|FG003|Overall Study|Protocol Violation|0|||
37945016|NCT03976401|69632527|FG004|Overall Study|Protocol Violation|0|||
37945017|NCT03976401|69632528|FG005|Overall Study|Protocol Violation|0|||
37945018|NCT03976401|69632523|FG000|Overall Study|Withdrew Consent|0|||
37945019|NCT03976401|69632524|FG001|Overall Study|Withdrew Consent|0|||
37945020|NCT03976401|69632525|FG002|Overall Study|Withdrew Consent|0|||
37945021|NCT03976401|69632526|FG003|Overall Study|Withdrew Consent|1|||
37945022|NCT03976401|69632527|FG004|Overall Study|Withdrew Consent|0|||
37945023|NCT03976401|69632528|FG005|Overall Study|Withdrew Consent|0|||
37945024|NCT00685334|69632544|FG000|Overall Study|Withdrawal by Subject|5|||
37945025|NCT00685334|69632545|FG001|Overall Study|Withdrawal by Subject|6|||
37945026|NCT00685334|69632544|FG000|Overall Study|Lost to Follow-up|4|||
37945027|NCT00685334|69632545|FG001|Overall Study|Lost to Follow-up|0|||
37945028|NCT00685334|69632544|FG000|Overall Study|Chose to enter hospital|1|||
37945029|NCT00685334|69632545|FG001|Overall Study|Chose to enter hospital|1|||
37945030|NCT00325039|69632553|FG000|Overall Study|Lost to Follow-up|18|||
37945031|NCT00325039|69632554|FG001|Overall Study|Lost to Follow-up|14|||
37945032|NCT00344461|69632560|FG000|Overall Study|Adverse Event|6|||
37945033|NCT00344461|69632560|FG000|Overall Study|Death|1|||
37945034|NCT00344461|69632560|FG000|Overall Study|Lack of Efficacy|2|||
37945035|NCT00344461|69632560|FG000|Overall Study|Lost to Follow-up|2|||
37945036|NCT00344461|69632560|FG000|Overall Study|Physician Decision|2|||
37945037|NCT00344461|69632560|FG000|Overall Study|Protocol Violation|6|||
38039041|NCT00094757|69726447|FG001|Overall Study|Patient Moved|1|||
37674248|NCT01998958|69148569|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
37674249|NCT01998958|69148570|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
37674250|NCT01998958|69148571|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
37674251|NCT01998958|69148572|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
37674252|NCT01998958|69148573|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
37674253|NCT01998958|69148574|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
37674254|NCT01998958|69148575|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
37674255|NCT01998958|69148576|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
37674256|NCT01998958|69148577|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
37674257|NCT01998958|69148578|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
37674258|NCT01958164|69148630|FG000|Overall Study|Adverse Event|0|||
37674259|NCT01958164|69148631|FG001|Overall Study|Adverse Event|2|||
38039042|NCT00094757|69726448|FG002|Overall Study|Patient Moved|1|||
38039043|NCT00094757|69726446|FG000|Overall Study|Protocol Violation|8|||
38039044|NCT00094757|69726447|FG001|Overall Study|Protocol Violation|5|||
38039045|NCT00094757|69726448|FG002|Overall Study|Protocol Violation|3|||
38039046|NCT00094757|69726446|FG000|Overall Study|Withdrawal by Subject|14|||
38039047|NCT00094757|69726447|FG001|Overall Study|Withdrawal by Subject|21|||
38039048|NCT00094757|69726448|FG002|Overall Study|Withdrawal by Subject|5|||
38039049|NCT00094757|69726446|FG000|Overall Study|Other|3|||
38039050|NCT00094757|69726447|FG001|Overall Study|Other|3|||
38039051|NCT00094757|69726448|FG002|Overall Study|Other|1|||
37674260|NCT01958164|69148630|FG000|Overall Study|Lost to Follow-up|2|||
37674261|NCT01958164|69148631|FG001|Overall Study|Lost to Follow-up|3|||
37674262|NCT01976104|69148641|FG000|Overall Study|Adverse Event|0|||
37674263|NCT01976104|69148642|FG001|Overall Study|Adverse Event|0|||
37674264|NCT01976104|69148643|FG002|Overall Study|Adverse Event|1|||
37674265|NCT01976104|69148644|FG003|Overall Study|Adverse Event|0|||
37674266|NCT01976104|69148641|FG000|Overall Study|Lost to Follow-up|3|||
37674267|NCT01976104|69148642|FG001|Overall Study|Lost to Follow-up|0|||
37674268|NCT01976104|69148643|FG002|Overall Study|Lost to Follow-up|1|||
37674269|NCT01976104|69148644|FG003|Overall Study|Lost to Follow-up|1|||
37674270|NCT01976104|69148641|FG000|Overall Study|Subject Choice|0|||
37674271|NCT01976104|69148642|FG001|Overall Study|Subject Choice|1|||
37674272|NCT01976104|69148643|FG002|Overall Study|Subject Choice|0|||
37674273|NCT01976104|69148644|FG003|Overall Study|Subject Choice|1|||
37674274|NCT01976104|69148641|FG000|Overall Study|Withdrawal by Subject|3|||
37674275|NCT01976104|69148642|FG001|Overall Study|Withdrawal by Subject|0|||
37945038|NCT00344461|69632560|FG000|Overall Study|Withdrawal by Subject|2|||
37945039|NCT00685178|69632569|FG000|Overall Study|Adverse Event|1|||
38039052|NCT00094757|69726446|FG000|Overall Study|Protocol specified discontinuation|1|||
38039053|NCT00094757|69726447|FG001|Overall Study|Protocol specified discontinuation|3|||
37945040|NCT00685178|69632570|FG001|Overall Study|Adverse Event|5|||
37945041|NCT00685178|69632571|FG002|Overall Study|Adverse Event|2|||
37945042|NCT00685178|69632572|FG003|Overall Study|Adverse Event|4|||
37945043|NCT00685178|69632569|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
38039054|NCT00094757|69726448|FG002|Overall Study|Protocol specified discontinuation|0|||
38039055|NCT04378114|69726456|FG000|Overall Study|Withdrawal by Subject|5|||
37674276|NCT01976104|69148643|FG002|Overall Study|Withdrawal by Subject|0|||
37674277|NCT01976104|69148644|FG003|Overall Study|Withdrawal by Subject|1|||
37674278|NCT01976104|69148641|FG000|Overall Study|Other|0|||
37674279|NCT01976104|69148642|FG001|Overall Study|Other|1|||
37674280|NCT01976104|69148643|FG002|Overall Study|Other|0|||
37674281|NCT01976104|69148644|FG003|Overall Study|Other|0|||
37674282|NCT01372501|69148655|FG000|Overall Study|Adverse Event|4|||
37674283|NCT01372501|69148655|FG000|Overall Study|Device migration|1|||
37674284|NCT01958008|69148664|FG000|Overall Study|Worsening of disease under study|0|||
37674285|NCT01958008|69148665|FG001|Overall Study|Worsening of disease under study|0|||
37674286|NCT01958008|69148666|FG002|Overall Study|Worsening of disease under study|1|||
37674287|NCT01958008|69148667|FG003|Overall Study|Worsening of disease under study|0|||
37674288|NCT01958008|69148664|FG000|Overall Study|Other adverse event|1|||
37674289|NCT01958008|69148665|FG001|Overall Study|Other adverse event|0|||
37674290|NCT01958008|69148666|FG002|Overall Study|Other adverse event|0|||
37674291|NCT01958008|69148667|FG003|Overall Study|Other adverse event|0|||
37674292|NCT01998880|69148695|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
37674293|NCT01998880|69148696|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
37674294|NCT01998880|69148695|FG000|Overall Study|Disease Progression|1|||
37674295|NCT01998880|69148696|FG001|Overall Study|Disease Progression|8|||
37674296|NCT01998880|69148695|FG000|Overall Study|Withdrew Consent|2|||
37674297|NCT01998880|69148696|FG001|Overall Study|Withdrew Consent|1|||
37674298|NCT01998880|69148695|FG000|Overall Study|Death|3|||
37674299|NCT01998880|69148696|FG001|Overall Study|Death|6|||
37674300|NCT01998880|69148695|FG000|Overall Study|Insufficient Therapeutic Response|1|||
37674301|NCT01998880|69148696|FG001|Overall Study|Insufficient Therapeutic Response|5|||
37674302|NCT01998880|69148695|FG000|Overall Study|Administrative/Other|1|||
37674303|NCT01998880|69148696|FG001|Overall Study|Administrative/Other|1|||
37674304|NCT01998880|69148695|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
37674305|NCT01998880|69148696|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
37674306|NCT01998880|69148695|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
37674307|NCT01998880|69148696|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
37674308|NCT01998880|69148695|FG000|Overall Study|Did Not Receive Treatment|3|||
37674309|NCT01998880|69148696|FG001|Overall Study|Did Not Receive Treatment|2|||
37674310|NCT01975948|69148706|FG000|Overall Study|Withdrawal by Subject|17|||
37674311|NCT01975948|69148707|FG001|Overall Study|Withdrawal by Subject|21|||
37674312|NCT01975948|69148708|FG002|Overall Study|Withdrawal by Subject|7|||
37674313|NCT01975948|69148709|FG003|Overall Study|Withdrawal by Subject|6|||
37674314|NCT01975246|69148721|FG000|Overall Study|Adverse Event|2|||
37674315|NCT01975246|69148722|FG001|Overall Study|Adverse Event|1|||
37674316|NCT01975246|69148721|FG000|Overall Study|Lack of Efficacy|1|||
37674317|NCT01975246|69148722|FG001|Overall Study|Lack of Efficacy|0|||
37674318|NCT01975246|69148721|FG000|Overall Study|Protocol Violation|1|||
37674319|NCT01975246|69148722|FG001|Overall Study|Protocol Violation|0|||
37674320|NCT01975246|69148721|FG000|Overall Study|Other than stated|0|||
37674321|NCT01975246|69148722|FG001|Overall Study|Other than stated|1|||
37674322|NCT01621126|69148728|FG000|Overall Study|Physician Decision|6|||
37674323|NCT01973998|69148734|FG000|Overall Study|Death|2|||
37674324|NCT01973998|69148735|FG001|Overall Study|Death|2|||
37674325|NCT02664415|69148743|FG000|Overall Study|Adverse Event|1|||
37674326|NCT02664415|69148744|FG001|Overall Study|Adverse Event|0|||
37674327|NCT02661061|69148752|FG000|Overall Study|Lack of Efficacy|1|||
37674328|NCT02661061|69148753|FG001|Overall Study|Lack of Efficacy|1|||
37674329|NCT02661061|69148752|FG000|Overall Study|Withdrawal by Subject|1|||
37674330|NCT02661061|69148753|FG001|Overall Study|Withdrawal by Subject|1|||
37674331|NCT01995838|69148766|FG000|Overall Study|Lost to Follow-up|0|||
37674332|NCT01995838|69148767|FG001|Overall Study|Lost to Follow-up|1|||
37674333|NCT01995838|69148768|FG002|Overall Study|Lost to Follow-up|0|||
37674334|NCT01995838|69148769|FG003|Overall Study|Lost to Follow-up|0|||
37674335|NCT01995838|69148770|FG004|Overall Study|Lost to Follow-up|0|||
37674336|NCT01995838|69148771|FG005|Overall Study|Lost to Follow-up|0|||
37674337|NCT01995838|69148772|FG006|Overall Study|Lost to Follow-up|1|||
37674338|NCT01995838|69148766|FG000|Overall Study|Participant choice|2|||
37674339|NCT01995838|69148767|FG001|Overall Study|Participant choice|0|||
37674340|NCT01995838|69148768|FG002|Overall Study|Participant choice|0|||
37674341|NCT01995838|69148769|FG003|Overall Study|Participant choice|0|||
37674342|NCT01995838|69148770|FG004|Overall Study|Participant choice|0|||
37674343|NCT01995838|69148771|FG005|Overall Study|Participant choice|1|||
37674344|NCT01995838|69148772|FG006|Overall Study|Participant choice|1|||
37674345|NCT01995838|69148766|FG000|Overall Study|Adverse Event|0|||
37674346|NCT01995838|69148767|FG001|Overall Study|Adverse Event|0|||
37674347|NCT01995838|69148768|FG002|Overall Study|Adverse Event|0|||
37674348|NCT01995838|69148769|FG003|Overall Study|Adverse Event|0|||
37674349|NCT01995838|69148770|FG004|Overall Study|Adverse Event|0|||
37674350|NCT01995838|69148771|FG005|Overall Study|Adverse Event|0|||
37674351|NCT01995838|69148772|FG006|Overall Study|Adverse Event|1|||
37674352|NCT01995838|69148766|FG000|Overall Study|Withdrawal by Subject|0|||
37674353|NCT01995838|69148767|FG001|Overall Study|Withdrawal by Subject|0|||
37674354|NCT01995838|69148768|FG002|Overall Study|Withdrawal by Subject|0|||
37674355|NCT01995838|69148769|FG003|Overall Study|Withdrawal by Subject|0|||
37674356|NCT01995838|69148770|FG004|Overall Study|Withdrawal by Subject|1|||
37674357|NCT01995838|69148771|FG005|Overall Study|Withdrawal by Subject|0|||
37674358|NCT01995838|69148772|FG006|Overall Study|Withdrawal by Subject|0|||
37674359|NCT01995838|69148766|FG000|Overall Study|Other|3|||
37674360|NCT01995838|69148767|FG001|Overall Study|Other|1|||
37674361|NCT01995838|69148768|FG002|Overall Study|Other|0|||
37674362|NCT01995838|69148769|FG003|Overall Study|Other|2|||
37674363|NCT01995838|69148770|FG004|Overall Study|Other|1|||
37674364|NCT01995838|69148771|FG005|Overall Study|Other|1|||
37674365|NCT01995838|69148772|FG006|Overall Study|Other|2|||
37674366|NCT01957462|69148793|FG000|Test Period 1|Withdrawal by Subject|1|||
37674367|NCT01957462|69148794|FG001|Test Period 1|Withdrawal by Subject|0|||
37674368|NCT01957462|69148793|FG000|Test Period 1|Adverse Event|1|||
37674369|NCT01957462|69148794|FG001|Test Period 1|Adverse Event|0|||
37674370|NCT01957150|69148802|FG000|Overall Study|Adverse Event|23|||
37674371|NCT01957150|69148803|FG001|Overall Study|Adverse Event|20|||
37674372|NCT01957150|69148802|FG000|Overall Study|Withdrawal by Subject|13|||
37674373|NCT01957150|69148803|FG001|Overall Study|Withdrawal by Subject|17|||
37674374|NCT01957150|69148802|FG000|Overall Study|Physician Decision|3|||
37674375|NCT01957150|69148803|FG001|Overall Study|Physician Decision|6|||
37674376|NCT01957150|69148802|FG000|Overall Study|Lost to Follow-up|4|||
37766393|NCT01405027|69280430|FG001|Overall Study|Death|0|||
37766394|NCT01405027|69280429|FG000|Overall Study|Other or Unknown|12|||
37766395|NCT01405027|69280430|FG001|Overall Study|Other or Unknown|25|||
37766396|NCT01412801|69280451|FG000|Overall Study|Death|0|||
37766397|NCT01412801|69280452|FG001|Overall Study|Death|1|||
37766398|NCT01412801|69280453|FG002|Overall Study|Death|0|||
37766399|NCT01412801|69280454|FG003|Overall Study|Death|4|||
37766400|NCT01412801|69280455|FG004|Overall Study|Death|2|||
37766401|NCT01412801|69280456|FG005|Overall Study|Death|2|||
37766402|NCT01412801|69280451|FG000|Overall Study|Lost to Follow-up|1|||
37766403|NCT01412801|69280452|FG001|Overall Study|Lost to Follow-up|2|||
37766404|NCT01412801|69280453|FG002|Overall Study|Lost to Follow-up|4|||
37766405|NCT01412801|69280454|FG003|Overall Study|Lost to Follow-up|0|||
37766406|NCT01412801|69280455|FG004|Overall Study|Lost to Follow-up|1|||
37766407|NCT01412801|69280456|FG005|Overall Study|Lost to Follow-up|1|||
37766408|NCT01412801|69280451|FG000|Overall Study|Withdrawal by Subject|3|||
37766409|NCT01412801|69280452|FG001|Overall Study|Withdrawal by Subject|2|||
37766410|NCT01412801|69280453|FG002|Overall Study|Withdrawal by Subject|1|||
37766411|NCT01412801|69280454|FG003|Overall Study|Withdrawal by Subject|0|||
37766412|NCT01412801|69280455|FG004|Overall Study|Withdrawal by Subject|0|||
37766413|NCT01412801|69280456|FG005|Overall Study|Withdrawal by Subject|0|||
37766414|NCT01412801|69280451|FG000|Overall Study|Relocated to another area|0|||
37766415|NCT01412801|69280452|FG001|Overall Study|Relocated to another area|0|||
37766416|NCT01412801|69280453|FG002|Overall Study|Relocated to another area|2|||
37766417|NCT01412801|69280454|FG003|Overall Study|Relocated to another area|0|||
37766418|NCT01412801|69280455|FG004|Overall Study|Relocated to another area|0|||
37766419|NCT01412801|69280456|FG005|Overall Study|Relocated to another area|0|||
37766420|NCT01525628|69280504|FG000|Overall Study|Adverse Event|1|||
37766421|NCT01525628|69280505|FG001|Overall Study|Adverse Event|1|||
37766422|NCT01525628|69280506|FG002|Overall Study|Adverse Event|2|||
37766423|NCT01525628|69280507|FG003|Overall Study|Adverse Event|0|||
37766424|NCT01525628|69280508|FG004|Overall Study|Adverse Event|1|||
37766425|NCT01525628|69280504|FG000|Overall Study|Lack of Efficacy|0|||
37766426|NCT01525628|69280505|FG001|Overall Study|Lack of Efficacy|2|||
37766427|NCT01525628|69280506|FG002|Overall Study|Lack of Efficacy|2|||
37766428|NCT01525628|69280507|FG003|Overall Study|Lack of Efficacy|1|||
37766429|NCT01525628|69280508|FG004|Overall Study|Lack of Efficacy|2|||
37766430|NCT01525628|69280504|FG000|Overall Study|Protocol Violation|0|||
37766431|NCT01525628|69280505|FG001|Overall Study|Protocol Violation|0|||
37766432|NCT01525628|69280506|FG002|Overall Study|Protocol Violation|1|||
37674377|NCT01957150|69148803|FG001|Overall Study|Lost to Follow-up|4|||
37766433|NCT01525628|69280507|FG003|Overall Study|Protocol Violation|0|||
37674378|NCT01957150|69148802|FG000|Overall Study|Protocol Violation|1|||
37674379|NCT01957150|69148803|FG001|Overall Study|Protocol Violation|0|||
37674380|NCT01957150|69148802|FG000|Overall Study|Lack of Efficacy|11|||
37674381|NCT01957150|69148803|FG001|Overall Study|Lack of Efficacy|11|||
37766434|NCT01525628|69280508|FG004|Overall Study|Protocol Violation|0|||
37674382|NCT01955122|69148811|FG000|Overall Study|Physician Decision|5|||
37674383|NCT01955122|69148812|FG001|Overall Study|Physician Decision|5|||
37674384|NCT01995526|69148824|FG000|Overall Study|Physician Decision|1|||
37674385|NCT01955044|69148831|FG000|Overall Study|Death|1|||
37674386|NCT01955044|69148832|FG001|Overall Study|Death|1|||
37674387|NCT01955044|69148833|FG002|Overall Study|Death|0|||
37674388|NCT01973218|69148843|FG000|Overall Study|Adverse Event|1|||
37766435|NCT01525628|69280504|FG000|Overall Study|Lost to Follow-up|1|||
37766436|NCT01525628|69280505|FG001|Overall Study|Lost to Follow-up|1|||
37766437|NCT01525628|69280506|FG002|Overall Study|Lost to Follow-up|0|||
37766438|NCT01525628|69280507|FG003|Overall Study|Lost to Follow-up|0|||
37766439|NCT01525628|69280508|FG004|Overall Study|Lost to Follow-up|0|||
37766440|NCT01525628|69280504|FG000|Overall Study|Withdrawal by Subject|0|||
37766441|NCT01525628|69280505|FG001|Overall Study|Withdrawal by Subject|1|||
37766442|NCT01525628|69280506|FG002|Overall Study|Withdrawal by Subject|0|||
37766443|NCT01525628|69280507|FG003|Overall Study|Withdrawal by Subject|0|||
37766444|NCT01525628|69280508|FG004|Overall Study|Withdrawal by Subject|0|||
37766445|NCT01525628|69280504|FG000|Overall Study|Other reason not defined above|0|||
37766446|NCT01525628|69280505|FG001|Overall Study|Other reason not defined above|0|||
37766447|NCT01525628|69280506|FG002|Overall Study|Other reason not defined above|0|||
37766448|NCT01525628|69280507|FG003|Overall Study|Other reason not defined above|3|||
37766449|NCT01525628|69280508|FG004|Overall Study|Other reason not defined above|0|||
37766450|NCT01412021|69280522|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
37766451|NCT01412021|69280522|FG000|Overall Study|Treatment Prior to Approval|3|||
37766452|NCT01412021|69280522|FG000|Overall Study|Transferred to Other Hospital|9|||
37766453|NCT01426789|69280528|FG000|Part 1|Protocol deviation|0|||
37766454|NCT01426789|69280529|FG001|Part 1|Protocol deviation|1|||
37766455|NCT01426789|69280530|FG002|Part 1|Protocol deviation|0|||
37766456|NCT01426789|69280531|FG003|Part 1|Protocol deviation|0|||
37766457|NCT01426789|69280532|FG004|Part 1|Protocol deviation|0|||
37766458|NCT01426789|69280533|FG005|Part 1|Protocol deviation|0|||
37766459|NCT01426789|69280528|FG000|Part 1|Lost to Follow-up|1|||
37766460|NCT01426789|69280529|FG001|Part 1|Lost to Follow-up|2|||
37766461|NCT01426789|69280530|FG002|Part 1|Lost to Follow-up|0|||
37766462|NCT01426789|69280531|FG003|Part 1|Lost to Follow-up|0|||
37766463|NCT01426789|69280532|FG004|Part 1|Lost to Follow-up|0|||
37766464|NCT01426789|69280533|FG005|Part 1|Lost to Follow-up|0|||
37766465|NCT01426789|69280528|FG000|Part 1|Lack of Efficacy|2|||
37766466|NCT01426789|69280529|FG001|Part 1|Lack of Efficacy|1|||
37766467|NCT01426789|69280530|FG002|Part 1|Lack of Efficacy|0|||
37766468|NCT01426789|69280531|FG003|Part 1|Lack of Efficacy|0|||
37766469|NCT01426789|69280532|FG004|Part 1|Lack of Efficacy|0|||
37674389|NCT01973218|69148844|FG001|Overall Study|Adverse Event|0|||
37674390|NCT01973218|69148843|FG000|Overall Study|Withdrawal by Subject|1|||
37674391|NCT01973218|69148844|FG001|Overall Study|Withdrawal by Subject|0|||
37674392|NCT01954342|69148856|FG000|Overall Study|Missing data from 13-16week study visit|0|||
37674393|NCT01954342|69148857|FG001|Overall Study|Missing data from 13-16week study visit|0|||
37674394|NCT01954342|69148858|FG002|Overall Study|Missing data from 13-16week study visit|0|||
37674395|NCT01954342|69148859|FG003|Overall Study|Missing data from 13-16week study visit|1|||
37766470|NCT01426789|69280533|FG005|Part 1|Lack of Efficacy|0|||
37766471|NCT01426789|69280528|FG000|Part 1|Adverse Event|3|||
37766472|NCT01426789|69280529|FG001|Part 1|Adverse Event|0|||
37766473|NCT01426789|69280530|FG002|Part 1|Adverse Event|0|||
37766474|NCT01426789|69280531|FG003|Part 1|Adverse Event|0|||
37766475|NCT01426789|69280532|FG004|Part 1|Adverse Event|0|||
37766476|NCT01426789|69280533|FG005|Part 1|Adverse Event|0|||
37766477|NCT01426789|69280528|FG000|Part 2|Protocol deviation|0|||
37766478|NCT01426789|69280529|FG001|Part 2|Protocol deviation|0|||
37766479|NCT01426789|69280530|FG002|Part 2|Protocol deviation|1|||
37766480|NCT01426789|69280531|FG003|Part 2|Protocol deviation|0|||
37766481|NCT01426789|69280532|FG004|Part 2|Protocol deviation|0|||
37766482|NCT01426789|69280533|FG005|Part 2|Protocol deviation|0|||
37766483|NCT01426789|69280528|FG000|Part 2|Death|0|||
37766484|NCT01426789|69280529|FG001|Part 2|Death|0|||
37766485|NCT01426789|69280530|FG002|Part 2|Death|1|||
37766486|NCT01426789|69280531|FG003|Part 2|Death|0|||
37766487|NCT01426789|69280532|FG004|Part 2|Death|1|||
37766488|NCT01426789|69280533|FG005|Part 2|Death|0|||
37766489|NCT01426789|69280528|FG000|Part 2|Administrative problems|0|||
37766490|NCT01426789|69280529|FG001|Part 2|Administrative problems|0|||
37766491|NCT01426789|69280530|FG002|Part 2|Administrative problems|2|||
37766492|NCT01426789|69280531|FG003|Part 2|Administrative problems|0|||
37766493|NCT01426789|69280532|FG004|Part 2|Administrative problems|1|||
37766494|NCT01426789|69280533|FG005|Part 2|Administrative problems|0|||
37766495|NCT01426789|69280528|FG000|Part 2|Lost to Follow-up|0|||
37766496|NCT01426789|69280529|FG001|Part 2|Lost to Follow-up|0|||
37766497|NCT01426789|69280530|FG002|Part 2|Lost to Follow-up|4|||
37945044|NCT00685178|69632570|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
37674396|NCT01954342|69148856|FG000|Overall Study|Miscarriage|0|||
37766498|NCT01426789|69280531|FG003|Part 2|Lost to Follow-up|0|||
37766499|NCT01426789|69280532|FG004|Part 2|Lost to Follow-up|1|||
37766500|NCT01426789|69280533|FG005|Part 2|Lost to Follow-up|0|||
37766501|NCT01426789|69280528|FG000|Part 2|Withdrawal by Subject|0|||
37766502|NCT01426789|69280529|FG001|Part 2|Withdrawal by Subject|0|||
37674397|NCT01954342|69148857|FG001|Overall Study|Miscarriage|0|||
37766503|NCT01426789|69280530|FG002|Part 2|Withdrawal by Subject|0|||
37766504|NCT01426789|69280531|FG003|Part 2|Withdrawal by Subject|1|||
37766505|NCT01426789|69280532|FG004|Part 2|Withdrawal by Subject|2|||
37766506|NCT01426789|69280533|FG005|Part 2|Withdrawal by Subject|0|||
37766507|NCT01426789|69280528|FG000|Part 2|Lack of Efficacy|0|||
37766508|NCT01426789|69280529|FG001|Part 2|Lack of Efficacy|0|||
37766509|NCT01426789|69280530|FG002|Part 2|Lack of Efficacy|5|||
37766510|NCT01426789|69280531|FG003|Part 2|Lack of Efficacy|0|||
38039056|NCT00082433|69726465|FG000|Overall Study|Adverse Event|12|||
37766511|NCT01426789|69280532|FG004|Part 2|Lack of Efficacy|2|||
37766512|NCT01426789|69280533|FG005|Part 2|Lack of Efficacy|0|||
37766513|NCT01426789|69280528|FG000|Part 2|Adverse Event|0|||
37766514|NCT01426789|69280529|FG001|Part 2|Adverse Event|0|||
37766515|NCT01426789|69280530|FG002|Part 2|Adverse Event|2|||
37766516|NCT01426789|69280531|FG003|Part 2|Adverse Event|0|||
37766517|NCT01426789|69280532|FG004|Part 2|Adverse Event|1|||
37766518|NCT01426789|69280533|FG005|Part 2|Adverse Event|0|||
37766519|NCT01426009|69280554|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
37766520|NCT01426009|69280554|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
37766521|NCT01426009|69280554|FG000|Washout 1|Withdrawal by Subject|1|||
37766522|NCT01426009|69280554|FG000|Washout 1|Personal Reasons|1|||
37766523|NCT01426009|69280554|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
37766524|NCT01426009|69280554|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
37766525|NCT01426009|69280554|FG000|Washout 2|electrive surgery|1|||
37766526|NCT01426009|69280554|FG000|Washout 3|personal reasons|1|||
37766527|NCT01426009|69280554|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
37766528|NCT01426009|69280554|FG000|Washout 4|Lost to Follow-up|1|||
37766529|NCT01411319|69280583|FG000|Overall Study|Lost to Follow-up|1|||
37766530|NCT01543958|69280587|FG000|Overall Study|Loss to follow-up|3|||
37766531|NCT01543958|69280587|FG000|Overall Study|ART initiation|1|||
37766532|NCT01411085|69280591|FG000|Overall Study|Physician Decision|1|||
37766533|NCT01411085|69280591|FG000|Overall Study|Protocol Violation|1|||
37766534|NCT01411085|69280591|FG000|Overall Study|Adverse Event|1|||
37766535|NCT01543490|69280597|FG000|Overall Study|Adverse Event|4|||
37766536|NCT01543490|69280598|FG001|Overall Study|Adverse Event|0|||
37766537|NCT01543490|69280597|FG000|Overall Study|Physician Decision|1|||
37766538|NCT01543490|69280598|FG001|Overall Study|Physician Decision|0|||
37766539|NCT01543490|69280597|FG000|Overall Study|Lack of Efficacy|3|||
37766540|NCT01543490|69280598|FG001|Overall Study|Lack of Efficacy|3|||
37766541|NCT01543490|69280597|FG000|Overall Study|Lost to Follow-up|5|||
37766542|NCT01543490|69280598|FG001|Overall Study|Lost to Follow-up|0|||
37766543|NCT01543490|69280597|FG000|Overall Study|Withdrawal by Subject|2|||
37766544|NCT01543490|69280598|FG001|Overall Study|Withdrawal by Subject|0|||
37766545|NCT01543490|69280597|FG000|Overall Study|Other-Various Administrative Reasons|1|||
37766546|NCT01543490|69280598|FG001|Overall Study|Other-Various Administrative Reasons|2|||
37766547|NCT01404949|69280604|FG000|Overall Study|Not Treated|1|||
37766548|NCT01431521|69280612|FG000|Overall Study|Withdrawal by Subject|0|||
37766549|NCT01431521|69280613|FG001|Overall Study|Withdrawal by Subject|0|||
37766550|NCT01431521|69280614|FG002|Overall Study|Withdrawal by Subject|1|||
37766551|NCT01431521|69280615|FG003|Overall Study|Withdrawal by Subject|0|||
37766552|NCT01404325|69280691|FG000|Overall Study|Lost to Follow-up|1|||
37766553|NCT01404325|69280692|FG001|Overall Study|Lost to Follow-up|0|||
37766554|NCT01404325|69280691|FG000|Overall Study|Death|2|||
37766555|NCT01404325|69280692|FG001|Overall Study|Death|0|||
37766556|NCT01404325|69280691|FG000|Overall Study|Graft loss/Retransplantation|1|||
37766557|NCT01404325|69280692|FG001|Overall Study|Graft loss/Retransplantation|0|||
37766558|NCT01404325|69280691|FG000|Overall Study|non-specified reason|0|||
37766559|NCT01404325|69280692|FG001|Overall Study|non-specified reason|2|||
37766560|NCT01425463|69280713|FG000|Overall Study|Adverse Event|5|||
37766561|NCT01425463|69280714|FG001|Overall Study|Adverse Event|7|||
37766562|NCT01425463|69280713|FG000|Overall Study|Lack of Efficacy|1|||
37766563|NCT01425463|69280714|FG001|Overall Study|Lack of Efficacy|1|||
37766564|NCT01425463|69280713|FG000|Overall Study|Protocol Violation|2|||
37766565|NCT01425463|69280714|FG001|Overall Study|Protocol Violation|2|||
37766566|NCT01425463|69280713|FG000|Overall Study|Lost to Follow-up|5|||
37766567|NCT01425463|69280714|FG001|Overall Study|Lost to Follow-up|2|||
37766568|NCT01425463|69280713|FG000|Overall Study|Withdrawal by Subject|7|||
37766569|NCT01425463|69280714|FG001|Overall Study|Withdrawal by Subject|5|||
37766570|NCT01425463|69280713|FG000|Overall Study|Unknown Reason|4|||
37766571|NCT01425463|69280714|FG001|Overall Study|Unknown Reason|7|||
37766572|NCT04655586|69280736|FG000|Overall Study|Physician Decision|1|||
37766573|NCT04655586|69280737|FG001|Overall Study|Physician Decision|3|||
37766574|NCT04655586|69280738|FG002|Overall Study|Physician Decision|4|||
37766575|NCT04655586|69280736|FG000|Overall Study|Withdrawal by Subject|1|||
37766576|NCT04655586|69280737|FG001|Overall Study|Withdrawal by Subject|3|||
37766577|NCT04655586|69280738|FG002|Overall Study|Withdrawal by Subject|1|||
37766578|NCT01388647|69280761|FG000|Overall Study|Adverse Event|1|||
37766579|NCT01388647|69280762|FG001|Overall Study|Adverse Event|2|||
37766580|NCT01402063|69280837|FG000|Overall Study|Withdrawal by Subject|3|||
37766581|NCT01402063|69280838|FG001|Overall Study|Withdrawal by Subject|3|||
37766582|NCT01796301|69280846|FG000|Overall Study|Withdrawal by Subject|15|||
37766583|NCT01796301|69280847|FG001|Overall Study|Withdrawal by Subject|15|||
37766584|NCT01796301|69280846|FG000|Overall Study|Lost to Follow-up|3|||
37766585|NCT01796301|69280847|FG001|Overall Study|Lost to Follow-up|3|||
37766586|NCT01796301|69280846|FG000|Overall Study|Death|0|||
37766587|NCT01796301|69280847|FG001|Overall Study|Death|1|||
37766588|NCT01796301|69280846|FG000|Overall Study|Decision by Sponsor|0|||
37766589|NCT01796301|69280847|FG001|Overall Study|Decision by Sponsor|1|||
37766590|NCT01388335|69280866|FG000|Period 1|Progressive Disease|1|||
37766591|NCT01388335|69280866|FG000|Period 2|Progressive Disease|2|||
37766592|NCT01388335|69280866|FG000|Period 2|Sponsor Decision|1|||
37766593|NCT01388335|69280866|FG000|Safety Extension|Progressive Disease|7|||
37766594|NCT01401361|69280913|FG000|Overall Study|Withdrawal by Subject|16|||
37766595|NCT01401361|69280913|FG000|Overall Study|Lack of Efficacy|6|||
37766596|NCT01401361|69280913|FG000|Overall Study|Physician Decision|1|||
37766597|NCT01401361|69280913|FG000|Overall Study|Lost to Follow-up|3|||
37766598|NCT01401361|69280913|FG000|Overall Study|Subject/family decision post procedure|2|||
37766599|NCT01401283|69280919|FG000|Overall Study|surgery cancelled|5|||
37766600|NCT01401283|69280920|FG001|Overall Study|surgery cancelled|8|||
37766601|NCT01401283|69280919|FG000|Overall Study|preoperative arrhythmia|5|||
37766602|NCT01401283|69280920|FG001|Overall Study|preoperative arrhythmia|0|||
37766603|NCT01401283|69280919|FG000|Overall Study|no central venous access|0|||
37766604|NCT01401283|69280920|FG001|Overall Study|no central venous access|1|||
37766605|NCT01401283|69280919|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
37766606|NCT01401283|69280920|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
37766607|NCT01422889|69280943|FG000|Overall Study|No Data Entered for Study Stent|9|||
37766608|NCT01400971|69280947|FG000|Overall Study|Death|82|||
37766609|NCT01400971|69280947|FG000|Overall Study|Lost to Follow-up|196|||
37766610|NCT01400971|69280947|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
37766611|NCT01400971|69280947|FG000|Overall Study|Physician Decision|57|||
37766612|NCT01400971|69280947|FG000|Overall Study|Withdrawal by Subject|158|||
37766613|NCT01400971|69280947|FG000|Overall Study|Other|422|||
37766614|NCT01387789|69280951|FG000|Overall Study|Adverse Event|5|||
37766615|NCT01387789|69280951|FG000|Overall Study|Lack of Efficacy|2|||
37766616|NCT01387789|69280951|FG000|Overall Study|Lost to Follow-up|1|||
37766617|NCT01400893|69280962|FG000|Overall Study|Death|27|||
37766618|NCT01400893|69280963|FG001|Overall Study|Death|21|||
37766619|NCT01400893|69280962|FG000|Overall Study|Lost to Follow-up|0|||
37766620|NCT01400893|69280963|FG001|Overall Study|Lost to Follow-up|6|||
37766621|NCT01400815|69281003|FG000|Overall Study|Adverse Event|3|||
37766622|NCT01400815|69281004|FG001|Overall Study|Adverse Event|0|||
37766623|NCT01400815|69281003|FG000|Overall Study|Death|0|||
37766624|NCT01400815|69281004|FG001|Overall Study|Death|1|||
37766625|NCT01400815|69281003|FG000|Overall Study|Lost to Follow-up|18|||
37766626|NCT01400815|69281004|FG001|Overall Study|Lost to Follow-up|11|||
37766627|NCT01400815|69281003|FG000|Overall Study|Protocol Violation|0|||
37766628|NCT01400815|69281004|FG001|Overall Study|Protocol Violation|1|||
37766629|NCT01400815|69281003|FG000|Overall Study|Physician Decision|1|||
37766630|NCT01400815|69281004|FG001|Overall Study|Physician Decision|0|||
37766631|NCT01400815|69281003|FG000|Overall Study|Withdrawal by Subject|15|||
37766632|NCT01400815|69281004|FG001|Overall Study|Withdrawal by Subject|8|||
37766633|NCT01400815|69281003|FG000|Overall Study|Subject in jail|1|||
37766634|NCT01400815|69281004|FG001|Overall Study|Subject in jail|0|||
37766635|NCT01400503|69281058|FG000|Overall Study|Withdrawal by Subject|1|||
37766636|NCT01400503|69281058|FG000|Overall Study|Study Terminated by Sponsor|58|||
37766637|NCT01400503|69281058|FG000|Overall Study|Other|1|||
37766638|NCT01400425|69281074|FG000|Overall Study|Withdrawal by Subject|10|||
37766639|NCT01421719|69281080|FG000|Overall Study|Withdrawal by Subject|4|||
37766640|NCT01421641|69281087|FG000|Overall Study|Protocol Violation|2|||
37766641|NCT01421641|69281088|FG001|Overall Study|Protocol Violation|2|||
37766642|NCT01385995|69281096|FG000|Period 1, 2 Months|Physician Decision|1|||
37766643|NCT01385995|69281097|FG001|Period 1, 2 Months|Physician Decision|0|||
37766644|NCT01421017|69281108|FG000|Overall Study|Withdrawal by Subject|2|||
37766645|NCT01421017|69281109|FG001|Overall Study|Withdrawal by Subject|0|||
37766646|NCT01421017|69281110|FG002|Overall Study|Withdrawal by Subject|0|||
37766647|NCT01421017|69281108|FG000|Overall Study|POD|0|||
37766648|NCT01421017|69281109|FG001|Overall Study|POD|6|||
37766649|NCT01421017|69281110|FG002|Overall Study|POD|3|||
37766650|NCT01420627|69281157|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
37766651|NCT01400113|69281167|FG000|Overall Study|Withdrawal by Subject|1|||
37766652|NCT01400113|69281168|FG001|Overall Study|Withdrawal by Subject|1|||
37766653|NCT01399723|69281176|FG000|Overall Study|Lost to Follow-up|0|||
37766654|NCT01399723|69281177|FG001|Overall Study|Lost to Follow-up|1|||
37766655|NCT01385371|69281186|FG000|Overall Study|Adverse Event|54|||
37766656|NCT01385371|69281187|FG001|Overall Study|Adverse Event|19|||
37766657|NCT01385371|69281186|FG000|Overall Study|Lost to Follow-up|16|||
37766658|NCT01385371|69281187|FG001|Overall Study|Lost to Follow-up|16|||
37766659|NCT01385371|69281186|FG000|Overall Study|Withdrawal by Subject|52|||
37766660|NCT01385371|69281187|FG001|Overall Study|Withdrawal by Subject|39|||
37766661|NCT01385371|69281186|FG000|Overall Study|Protocol Violation|25|||
37766662|NCT01385371|69281187|FG001|Overall Study|Protocol Violation|21|||
37766663|NCT01385371|69281186|FG000|Overall Study|Administrative|2|||
37766664|NCT01385371|69281187|FG001|Overall Study|Administrative|2|||
37766665|NCT01399099|69281193|FG000|Overall Study|Lost to Follow-up|11|||
37766666|NCT01399099|69281193|FG000|Overall Study|Physician Decision|1|||
37766667|NCT01399099|69281193|FG000|Overall Study|Protocol Violation|1|||
37766668|NCT01399099|69281193|FG000|Overall Study|Skin Irritation|13|||
37766669|NCT01399099|69281193|FG000|Overall Study|Infection|1|||
37766670|NCT01399099|69281193|FG000|Overall Study|Miscellaneous|4|||
37766671|NCT01398787|69281198|FG000|Overall Study|Adverse Event|1|||
37766672|NCT01383499|69281204|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
37766673|NCT01383499|69281205|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
37766674|NCT01383499|69281206|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
37766675|NCT01383499|69281207|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
37766676|NCT01397461|69281223|FG000|Overall Study|Withdrawal by Subject|2|||
37766677|NCT01397461|69281224|FG001|Overall Study|Withdrawal by Subject|1|||
37766678|NCT01397461|69281225|FG002|Overall Study|Withdrawal by Subject|0|||
37766679|NCT01397461|69281223|FG000|Overall Study|Lost to Follow-up|0|||
37766680|NCT01397461|69281224|FG001|Overall Study|Lost to Follow-up|2|||
37766681|NCT01397461|69281225|FG002|Overall Study|Lost to Follow-up|1|||
37766682|NCT01397461|69281223|FG000|Overall Study|Lack of Efficacy|0|||
37766683|NCT01397461|69281224|FG001|Overall Study|Lack of Efficacy|3|||
37766684|NCT01397461|69281225|FG002|Overall Study|Lack of Efficacy|0|||
37766685|NCT01397461|69281223|FG000|Overall Study|Not treated|0|||
37766686|NCT01397461|69281224|FG001|Overall Study|Not treated|0|||
37766687|NCT01397461|69281225|FG002|Overall Study|Not treated|1|||
37766688|NCT01382251|69281235|FG000|Overall Study|Surgeries cancelled or delayed|16|||
37766689|NCT01382251|69281236|FG001|Overall Study|Surgeries cancelled or delayed|16|||
37766690|NCT01382251|69281235|FG000|Overall Study|Lost to Follow-up|4|||
37766691|NCT01382251|69281236|FG001|Overall Study|Lost to Follow-up|4|||
37766692|NCT01382251|69281235|FG000|Overall Study|Contacted after study closed|1|||
37766693|NCT01382251|69281236|FG001|Overall Study|Contacted after study closed|1|||
37766694|NCT01396525|69281241|FG000|Overall Study|Withdrawal by Subject|8|||
37766695|NCT01396525|69281241|FG000|Overall Study|Death|14|||
37766696|NCT01396525|69281241|FG000|Overall Study|Lost to Follow-up|4|||
37766697|NCT02849652|69281253|FG000|Overall Study|Lost to Follow-up|104|||
37766698|NCT02849652|69281254|FG001|Overall Study|Lost to Follow-up|35|||
37766699|NCT02849652|69281255|FG002|Overall Study|Lost to Follow-up|116|||
37766700|NCT02849652|69281256|FG003|Overall Study|Lost to Follow-up|22|||
37766701|NCT02849652|69281253|FG000|Overall Study|Withdrawal by Subject|10|||
37766702|NCT02849652|69281254|FG001|Overall Study|Withdrawal by Subject|2|||
37766703|NCT02849652|69281255|FG002|Overall Study|Withdrawal by Subject|8|||
37766704|NCT02849652|69281256|FG003|Overall Study|Withdrawal by Subject|4|||
37766705|NCT01396447|69281268|FG000|Overall Study|Did Not Receive Treatment|3|||
37766706|NCT01396447|69281269|FG001|Overall Study|Did Not Receive Treatment|2|||
37766707|NCT01396447|69281270|FG002|Overall Study|Did Not Receive Treatment|1|||
37766708|NCT01396447|69281271|FG003|Overall Study|Did Not Receive Treatment|0|||
37766709|NCT01396447|69281268|FG000|Overall Study|Adverse Event|15|||
37766710|NCT01396447|69281269|FG001|Overall Study|Adverse Event|12|||
37766711|NCT01396447|69281270|FG002|Overall Study|Adverse Event|12|||
37766712|NCT01396447|69281271|FG003|Overall Study|Adverse Event|17|||
37766713|NCT01396447|69281268|FG000|Overall Study|Insufficient Therapeutic Response|5|||
37766714|NCT01396447|69281269|FG001|Overall Study|Insufficient Therapeutic Response|5|||
37766715|NCT01396447|69281270|FG002|Overall Study|Insufficient Therapeutic Response|2|||
37766716|NCT01396447|69281271|FG003|Overall Study|Insufficient Therapeutic Response|4|||
37766717|NCT01396447|69281268|FG000|Overall Study|Protocol Violation|5|||
37766718|NCT01396447|69281269|FG001|Overall Study|Protocol Violation|2|||
37766719|NCT01396447|69281270|FG002|Overall Study|Protocol Violation|3|||
37766720|NCT01396447|69281271|FG003|Overall Study|Protocol Violation|7|||
37766721|NCT01396447|69281268|FG000|Overall Study|Withdrawal of Consent|11|||
37766722|NCT01396447|69281269|FG001|Overall Study|Withdrawal of Consent|9|||
37766723|NCT01396447|69281270|FG002|Overall Study|Withdrawal of Consent|4|||
37766724|NCT01396447|69281271|FG003|Overall Study|Withdrawal of Consent|15|||
37766725|NCT01396447|69281268|FG000|Overall Study|Lost to Follow-up|4|||
37674398|NCT01954342|69148858|FG002|Overall Study|Miscarriage|0|||
37674399|NCT01954342|69148859|FG003|Overall Study|Miscarriage|3|||
37674400|NCT01954342|69148856|FG000|Overall Study|Lost to Follow-up|0|||
37674401|NCT01954342|69148857|FG001|Overall Study|Lost to Follow-up|0|||
37674402|NCT01954342|69148858|FG002|Overall Study|Lost to Follow-up|0|||
37674403|NCT01954342|69148859|FG003|Overall Study|Lost to Follow-up|5|||
37674404|NCT01954342|69148856|FG000|Overall Study|Preterm delivery|0|||
37674405|NCT01954342|69148857|FG001|Overall Study|Preterm delivery|0|||
37674406|NCT01954342|69148858|FG002|Overall Study|Preterm delivery|0|||
37674407|NCT01954342|69148859|FG003|Overall Study|Preterm delivery|3|||
37674408|NCT01954342|69148856|FG000|Overall Study|Pre-eclampsia|0|||
37674409|NCT01954342|69148857|FG001|Overall Study|Pre-eclampsia|0|||
37766726|NCT01396447|69281269|FG001|Overall Study|Lost to Follow-up|8|||
37766727|NCT01396447|69281270|FG002|Overall Study|Lost to Follow-up|7|||
37766728|NCT01396447|69281271|FG003|Overall Study|Lost to Follow-up|9|||
37674410|NCT01954342|69148858|FG002|Overall Study|Pre-eclampsia|0|||
37674411|NCT01954342|69148859|FG003|Overall Study|Pre-eclampsia|4|||
37674412|NCT01954342|69148856|FG000|Overall Study|Unreliable Data|0|||
37766729|NCT01396447|69281268|FG000|Overall Study|Other Miscellaneous Reasons|0|||
37766730|NCT01396447|69281269|FG001|Overall Study|Other Miscellaneous Reasons|2|||
37766731|NCT01396447|69281270|FG002|Overall Study|Other Miscellaneous Reasons|1|||
37766732|NCT01396447|69281271|FG003|Overall Study|Other Miscellaneous Reasons|0|||
37766733|NCT01678560|69281344|FG000|Overall Study|Physician Decision|4|||
37766734|NCT01678560|69281345|FG001|Overall Study|Physician Decision|4|||
37766735|NCT01678560|69281344|FG000|Overall Study|Death|0|||
37766736|NCT01678560|69281345|FG001|Overall Study|Death|1|||
37766737|NCT01678560|69281344|FG000|Overall Study|Withdrawal by Subject|0|||
37766738|NCT01678560|69281345|FG001|Overall Study|Withdrawal by Subject|1|||
37766739|NCT01381549|69281384|FG000|Overall Study|Ineligible: No organisms isolated|0|||
37766740|NCT01381549|69281385|FG001|Overall Study|Ineligible: No organisms isolated|0|||
37766741|NCT01381549|69281386|FG002|Overall Study|Ineligible: No organisms isolated|1|||
37766742|NCT00159432|69281395|FG000|Overall Study|Adverse Event|1|||
37766743|NCT00159432|69281395|FG000|Overall Study|Death|1|||
37766744|NCT00159432|69281395|FG000|Overall Study|Lack of Efficacy|8|||
37766745|NCT01396057|69281401|FG000|Overall Study|Adverse Event|2|||
37766746|NCT01396057|69281402|FG001|Overall Study|Adverse Event|6|||
37766747|NCT01396057|69281401|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
37766748|NCT01396057|69281402|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
37766749|NCT01396057|69281401|FG000|Overall Study|Protocol deviation|4|||
37766750|NCT01396057|69281402|FG001|Overall Study|Protocol deviation|4|||
37766751|NCT01396057|69281401|FG000|Overall Study|Consent withdrawn|3|||
37766752|NCT01396057|69281402|FG001|Overall Study|Consent withdrawn|2|||
37766753|NCT01380769|69281419|FG000|Overall Study|Withdrawal by Subject|7|||
37766754|NCT01380769|69281420|FG001|Overall Study|Withdrawal by Subject|11|||
37766755|NCT01380769|69281419|FG000|Overall Study|Physician Decision|1|||
37766756|NCT01380769|69281420|FG001|Overall Study|Physician Decision|1|||
37766757|NCT01380769|69281419|FG000|Overall Study|Adverse Event|1|||
37766758|NCT01380769|69281420|FG001|Overall Study|Adverse Event|1|||
37766759|NCT01380769|69281419|FG000|Overall Study|Protocol Violation|0|||
37766760|NCT01380769|69281420|FG001|Overall Study|Protocol Violation|1|||
37766761|NCT01395901|69281428|FG000|Overall Study|Lost to Follow-up|4|||
37766762|NCT01395901|69281429|FG001|Overall Study|Lost to Follow-up|0|||
37766763|NCT01395901|69281428|FG000|Overall Study|Randomized but not received study drug|5|||
37674413|NCT01954342|69148857|FG001|Overall Study|Unreliable Data|0|||
37674414|NCT01954342|69148858|FG002|Overall Study|Unreliable Data|0|||
37674415|NCT01954342|69148859|FG003|Overall Study|Unreliable Data|2|||
37674416|NCT01972438|69148871|FG000|Baseline-Month 3 Crossover Period|Death|1|||
37674417|NCT01972438|69148872|FG001|Baseline-Month 3 Crossover Period|Death|0|||
37674418|NCT01972438|69148871|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
37674419|NCT01972438|69148872|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
37674420|NCT01972438|69148871|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
37674421|NCT01972438|69148872|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
37674422|NCT01972438|69148871|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
37674423|NCT01972438|69148872|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
37674424|NCT01972438|69148871|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
37674425|NCT01972438|69148872|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
37674426|NCT01972438|69148871|FG000|Months 6-12 Study Period|Death|1|||
37674427|NCT01972438|69148872|FG001|Months 6-12 Study Period|Death|0|||
37674428|NCT01972438|69148871|FG000|Months 6-12 Study Period|Early Study Closure|2|||
37674429|NCT01972438|69148872|FG001|Months 6-12 Study Period|Early Study Closure|2|||
37674430|NCT01972438|69148871|FG000|Post Month 12 Study Period|Early Study Closure|3|||
37674431|NCT01972438|69148872|FG001|Post Month 12 Study Period|Early Study Closure|4|||
37674432|NCT01946152|69148884|FG000|Overall Study|Adverse Event|1|||
37674433|NCT01946152|69148885|FG001|Overall Study|Adverse Event|0|||
37674434|NCT01946152|69148886|FG002|Overall Study|Adverse Event|0|||
37674435|NCT01946152|69148887|FG003|Overall Study|Adverse Event|0|||
37674436|NCT01946152|69148884|FG000|Overall Study|Withdrawal by Subject|0|||
37674437|NCT01946152|69148885|FG001|Overall Study|Withdrawal by Subject|2|||
37674438|NCT01946152|69148886|FG002|Overall Study|Withdrawal by Subject|0|||
37674439|NCT01946152|69148887|FG003|Overall Study|Withdrawal by Subject|0|||
37674440|NCT01946152|69148884|FG000|Overall Study|Progression|0|||
37674441|NCT01946152|69148885|FG001|Overall Study|Progression|1|||
37674442|NCT01946152|69148886|FG002|Overall Study|Progression|4|||
37674443|NCT01946152|69148887|FG003|Overall Study|Progression|7|||
37674444|NCT01946152|69148884|FG000|Overall Study|Physician Decision|0|||
37674445|NCT01946152|69148885|FG001|Overall Study|Physician Decision|0|||
37674446|NCT01946152|69148886|FG002|Overall Study|Physician Decision|1|||
37674447|NCT01946152|69148887|FG003|Overall Study|Physician Decision|0|||
37674448|NCT01946152|69148884|FG000|Overall Study|Second malignancy|0|||
37766764|NCT01395901|69281429|FG001|Overall Study|Randomized but not received study drug|4|||
37766765|NCT01395901|69281428|FG000|Overall Study|Adverse Event|0|||
37674449|NCT01946152|69148885|FG001|Overall Study|Second malignancy|0|||
37674450|NCT01946152|69148886|FG002|Overall Study|Second malignancy|1|||
37674451|NCT01946152|69148887|FG003|Overall Study|Second malignancy|0|||
37674452|NCT01946152|69148884|FG000|Overall Study|Adverse Event|0|||
37674453|NCT01946152|69148885|FG001|Overall Study|Adverse Event|0|||
37766766|NCT01395901|69281429|FG001|Overall Study|Adverse Event|1|||
37766767|NCT01395901|69281428|FG000|Overall Study|Withdrawal of consent|1|||
38039057|NCT00082433|69726466|FG001|Overall Study|Adverse Event|17|||
37766768|NCT01395901|69281429|FG001|Overall Study|Withdrawal of consent|0|||
37766769|NCT01395823|69281437|FG000|Overall Study|Death|4|||
37766770|NCT01395823|69281438|FG001|Overall Study|Death|4|||
37766771|NCT01395823|69281437|FG000|Overall Study|Physician Decision|3|||
37766772|NCT01395823|69281438|FG001|Overall Study|Physician Decision|1|||
37766773|NCT01395823|69281437|FG000|Overall Study|Lost to Follow-up|1|||
37766774|NCT01395823|69281438|FG001|Overall Study|Lost to Follow-up|0|||
37766775|NCT01395823|69281437|FG000|Overall Study|Transplant|1|||
37766776|NCT01395823|69281438|FG001|Overall Study|Transplant|0|||
37766777|NCT01395823|69281437|FG000|Overall Study|GI symptoms|1|||
37766778|NCT01395823|69281438|FG001|Overall Study|GI symptoms|0|||
37766779|NCT01395823|69281437|FG000|Overall Study|Withdrawal by Subject|5|||
37766780|NCT01395823|69281438|FG001|Overall Study|Withdrawal by Subject|4|||
37766781|NCT00158184|69281446|FG000|Overall Study|personal issues|3|||
37766782|NCT00158184|69281447|FG001|Overall Study|personal issues|1|||
37766783|NCT00158184|69281446|FG000|Overall Study|failed for follow unit/study rules|2|||
37766784|NCT00158184|69281447|FG001|Overall Study|failed for follow unit/study rules|0|||
37766785|NCT00158184|69281446|FG000|Overall Study|Adverse Event|1|||
37766786|NCT00158184|69281447|FG001|Overall Study|Adverse Event|1|||
37766787|NCT01380691|69281455|FG000|Washout (7 Days)|Protocol Violation|0|||
37766788|NCT01380691|69281456|FG001|Washout (7 Days)|Protocol Violation|0|||
37766789|NCT01380691|69281457|FG002|Washout (7 Days)|Protocol Violation|0|||
37766790|NCT01380691|69281458|FG003|Washout (7 Days)|Protocol Violation|1|||
37766791|NCT01380691|69281455|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
37766792|NCT01380691|69281456|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
37766793|NCT01380691|69281457|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
37766794|NCT01380691|69281458|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
37766795|NCT01380535|69281484|FG000|Overall Study|Adverse Event|3|||
37766796|NCT01380535|69281485|FG001|Overall Study|Adverse Event|3|||
37766797|NCT01380535|69281484|FG000|Overall Study|Death|3|||
37766798|NCT01380535|69281485|FG001|Overall Study|Death|0|||
37766799|NCT01380535|69281484|FG000|Overall Study|Study site closed|0|||
37766800|NCT01380535|69281485|FG001|Overall Study|Study site closed|5|||
37766801|NCT01380535|69281484|FG000|Overall Study|Withdrawal by Subject|1|||
37766802|NCT01380535|69281485|FG001|Overall Study|Withdrawal by Subject|2|||
37766803|NCT01380535|69281484|FG000|Overall Study|Protocol Violation|0|||
37766804|NCT01380535|69281485|FG001|Overall Study|Protocol Violation|2|||
37766805|NCT01380535|69281484|FG000|Overall Study|Lack of Efficacy|0|||
37766806|NCT01380535|69281485|FG001|Overall Study|Lack of Efficacy|3|||
37766807|NCT01380379|69281495|FG000|Overall Study|Pregnancy|1|||
37766808|NCT01380145|69281499|FG000|Overall Study|Progressive disease|4|||
37766809|NCT03420222|69281525|FG000|Overall Study|Withdrawal by Subject|5|||
37766810|NCT03420222|69281526|FG001|Overall Study|Withdrawal by Subject|0|||
37766811|NCT03420222|69281525|FG000|Overall Study|Physician Decision|0|||
37766812|NCT03420222|69281526|FG001|Overall Study|Physician Decision|1|||
37766813|NCT01394185|69281532|FG000|Overall Study|Withdrawal by Subject|2|||
37766814|NCT01394185|69281533|FG001|Overall Study|Withdrawal by Subject|0|||
37766815|NCT01394185|69281534|FG002|Overall Study|Withdrawal by Subject|0|||
37766816|NCT01394185|69281535|FG003|Overall Study|Withdrawal by Subject|0|||
37766817|NCT01394185|69281536|FG004|Overall Study|Withdrawal by Subject|1|||
37766818|NCT01394185|69281537|FG005|Overall Study|Withdrawal by Subject|0|||
37766819|NCT01394185|69281532|FG000|Overall Study|Change in protocol|3|||
37766820|NCT01394185|69281533|FG001|Overall Study|Change in protocol|0|||
37766821|NCT01394185|69281534|FG002|Overall Study|Change in protocol|0|||
37766822|NCT01394185|69281535|FG003|Overall Study|Change in protocol|0|||
37766823|NCT01394185|69281536|FG004|Overall Study|Change in protocol|3|||
37766824|NCT01394185|69281537|FG005|Overall Study|Change in protocol|0|||
37766825|NCT01394185|69281532|FG000|Overall Study|Protocol Violation|1|||
37766826|NCT01394185|69281533|FG001|Overall Study|Protocol Violation|0|||
37766827|NCT01394185|69281534|FG002|Overall Study|Protocol Violation|0|||
37766828|NCT01394185|69281535|FG003|Overall Study|Protocol Violation|1|||
37766829|NCT01394185|69281536|FG004|Overall Study|Protocol Violation|0|||
37766830|NCT01394185|69281537|FG005|Overall Study|Protocol Violation|1|||
37766831|NCT01677936|69281570|FG000|Overall Study|Lost to Follow-up|4|||
37766832|NCT01677936|69281571|FG001|Overall Study|Lost to Follow-up|1|||
37766833|NCT01677936|69281570|FG000|Overall Study|Protocol Violation|3|||
37766834|NCT01677936|69281571|FG001|Overall Study|Protocol Violation|0|||
37766835|NCT01677936|69281570|FG000|Overall Study|Adverse Event|1|||
37766836|NCT01677936|69281571|FG001|Overall Study|Adverse Event|0|||
37766837|NCT01677936|69281570|FG000|Overall Study|Lost to Follow-up|1|||
37766838|NCT01677936|69281571|FG001|Overall Study|Lost to Follow-up|0|||
37766839|NCT01677936|69281570|FG000|Overall Study|Protocol Violation|0|||
37766840|NCT01677936|69281571|FG001|Overall Study|Protocol Violation|4|||
37766841|NCT01525550|69281602|FG000|Overall Study|Lost to Follow-up|8|||
37766842|NCT01525550|69281603|FG001|Overall Study|Lost to Follow-up|2|||
37766843|NCT01525550|69281602|FG000|Overall Study|Death|19|||
37766844|NCT01525550|69281603|FG001|Overall Study|Death|28|||
37766845|NCT01525550|69281602|FG000|Overall Study|Other|0|||
37766846|NCT01525550|69281603|FG001|Overall Study|Other|4|||
37766847|NCT01525550|69281602|FG000|Overall Study|Sponsor's Decision|30|||
37766848|NCT01525550|69281603|FG001|Overall Study|Sponsor's Decision|11|||
37766849|NCT01525550|69281602|FG000|Overall Study|Withdrawal by Subject|4|||
37766850|NCT01525550|69281603|FG001|Overall Study|Withdrawal by Subject|0|||
37766851|NCT00211237|69281624|FG000|Baseline|Withdrew|1|||
37766852|NCT00211237|69281625|FG001|Baseline|Withdrew|3|||
37766853|NCT00211237|69281626|FG002|Baseline|Withdrew|0|||
37766854|NCT00211237|69281624|FG000|Baseline|Refused random assignment|1|||
37674454|NCT01946152|69148886|FG002|Overall Study|Adverse Event|0|||
37674455|NCT01946152|69148887|FG003|Overall Study|Adverse Event|1|||
37674456|NCT01945996|69148901|FG000|Overall Study|Lost to Follow-up|3|||
37674457|NCT01945996|69148902|FG001|Overall Study|Lost to Follow-up|5|||
37674458|NCT01971346|69148910|FG000|Overall Study|Protocol Violation|3|||
37674459|NCT01971346|69148910|FG000|Overall Study|Lost to Follow-up|2|||
37674460|NCT01971346|69148910|FG000|Overall Study|Withdrawal by Subject|2|||
37674461|NCT01971346|69148910|FG000|Overall Study|Physician Decision|1|||
37674462|NCT01945216|69148925|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
37674463|NCT01945216|69148925|FG000|Overall Study|Protocol Violation|42|||
37674464|NCT01945216|69148925|FG000|Overall Study|CRF not assured by investigators|5|||
37674465|NCT02641379|69148944|FG000|Overall Study|Exclusion criterion during screening|1|||
37674466|NCT02641379|69148945|FG001|Overall Study|Exclusion criterion during screening|0|||
37674467|NCT02641379|69148946|FG002|Overall Study|Exclusion criterion during screening|0|||
37674468|NCT02641379|69148947|FG003|Overall Study|Exclusion criterion during screening|1|||
37674469|NCT02641379|69148948|FG004|Overall Study|Exclusion criterion during screening|2|||
37674470|NCT02641379|69148949|FG005|Overall Study|Exclusion criterion during screening|0|||
37674471|NCT02641379|69148950|FG006|Overall Study|Exclusion criterion during screening|0|||
37674472|NCT02641379|69148951|FG007|Overall Study|Exclusion criterion during screening|0|||
37674473|NCT02641379|69148952|FG008|Overall Study|Exclusion criterion during screening|0|||
37674474|NCT02641379|69148953|FG009|Overall Study|Exclusion criterion during screening|0|||
37674475|NCT02641379|69148954|FG010|Overall Study|Exclusion criterion during screening|0|||
37674476|NCT02641379|69148944|FG000|Overall Study|Withdrawal of informed consent|0|||
37674477|NCT02641379|69148945|FG001|Overall Study|Withdrawal of informed consent|1|||
37674478|NCT02641379|69148946|FG002|Overall Study|Withdrawal of informed consent|0|||
37674479|NCT02641379|69148947|FG003|Overall Study|Withdrawal of informed consent|0|||
37674480|NCT02641379|69148948|FG004|Overall Study|Withdrawal of informed consent|0|||
37674481|NCT02641379|69148949|FG005|Overall Study|Withdrawal of informed consent|0|||
37674482|NCT02641379|69148950|FG006|Overall Study|Withdrawal of informed consent|0|||
37674483|NCT02641379|69148951|FG007|Overall Study|Withdrawal of informed consent|1|||
37674484|NCT02641379|69148952|FG008|Overall Study|Withdrawal of informed consent|0|||
37674485|NCT02641379|69148953|FG009|Overall Study|Withdrawal of informed consent|0|||
37674486|NCT02641379|69148954|FG010|Overall Study|Withdrawal of informed consent|0|||
37674487|NCT02641379|69148944|FG000|Overall Study|Adverse Event|7|||
37674488|NCT02641379|69148945|FG001|Overall Study|Adverse Event|8|||
37674489|NCT02641379|69148946|FG002|Overall Study|Adverse Event|2|||
37674490|NCT02641379|69148947|FG003|Overall Study|Adverse Event|2|||
37674491|NCT02641379|69148948|FG004|Overall Study|Adverse Event|5|||
37674492|NCT02641379|69148949|FG005|Overall Study|Adverse Event|1|||
37674493|NCT02641379|69148950|FG006|Overall Study|Adverse Event|5|||
37674494|NCT02641379|69148951|FG007|Overall Study|Adverse Event|0|||
37674495|NCT02641379|69148952|FG008|Overall Study|Adverse Event|1|||
37674496|NCT02641379|69148953|FG009|Overall Study|Adverse Event|1|||
37674497|NCT02641379|69148954|FG010|Overall Study|Adverse Event|5|||
37674498|NCT02641379|69148944|FG000|Overall Study|Lack of Efficacy|0|||
37674499|NCT02641379|69148945|FG001|Overall Study|Lack of Efficacy|0|||
37674500|NCT02641379|69148946|FG002|Overall Study|Lack of Efficacy|2|||
37674501|NCT02641379|69148947|FG003|Overall Study|Lack of Efficacy|0|||
37674502|NCT02641379|69148948|FG004|Overall Study|Lack of Efficacy|0|||
37674503|NCT02641379|69148949|FG005|Overall Study|Lack of Efficacy|2|||
37674504|NCT02641379|69148950|FG006|Overall Study|Lack of Efficacy|0|||
37674505|NCT02641379|69148951|FG007|Overall Study|Lack of Efficacy|5|||
37674506|NCT02641379|69148952|FG008|Overall Study|Lack of Efficacy|0|||
37674507|NCT02641379|69148953|FG009|Overall Study|Lack of Efficacy|0|||
37674508|NCT02641379|69148954|FG010|Overall Study|Lack of Efficacy|0|||
37674509|NCT02641379|69148944|FG000|Overall Study|Participant unable to attend study visit|4|||
37674510|NCT02641379|69148945|FG001|Overall Study|Participant unable to attend study visit|10|||
37766855|NCT00211237|69281625|FG001|Baseline|Refused random assignment|0|||
37766856|NCT00211237|69281626|FG002|Baseline|Refused random assignment|0|||
37674511|NCT02641379|69148946|FG002|Overall Study|Participant unable to attend study visit|1|||
37674512|NCT02641379|69148947|FG003|Overall Study|Participant unable to attend study visit|2|||
37766857|NCT00211237|69281624|FG000|1 Month|Death|2|||
37766858|NCT00211237|69281625|FG001|1 Month|Death|1|||
37766859|NCT00211237|69281626|FG002|1 Month|Death|0|||
37674513|NCT02641379|69148948|FG004|Overall Study|Participant unable to attend study visit|5|||
37674514|NCT02641379|69148949|FG005|Overall Study|Participant unable to attend study visit|1|||
37674515|NCT02641379|69148950|FG006|Overall Study|Participant unable to attend study visit|1|||
37766860|NCT00211237|69281624|FG000|1 Month|Lost to Follow-up|0|||
37674516|NCT02641379|69148951|FG007|Overall Study|Participant unable to attend study visit|1|||
37674517|NCT02641379|69148952|FG008|Overall Study|Participant unable to attend study visit|0|||
37674518|NCT02641379|69148953|FG009|Overall Study|Participant unable to attend study visit|2|||
37674519|NCT02641379|69148954|FG010|Overall Study|Participant unable to attend study visit|0|||
37674520|NCT02641379|69148944|FG000|Overall Study|Participant's compliance|0|||
37674521|NCT02641379|69148945|FG001|Overall Study|Participant's compliance|1|||
37674522|NCT02641379|69148946|FG002|Overall Study|Participant's compliance|0|||
37674523|NCT02641379|69148947|FG003|Overall Study|Participant's compliance|1|||
37674524|NCT02641379|69148948|FG004|Overall Study|Participant's compliance|0|||
37674525|NCT02641379|69148949|FG005|Overall Study|Participant's compliance|2|||
37674526|NCT02641379|69148950|FG006|Overall Study|Participant's compliance|0|||
37674527|NCT02641379|69148951|FG007|Overall Study|Participant's compliance|0|||
37674528|NCT02641379|69148952|FG008|Overall Study|Participant's compliance|1|||
37674529|NCT02641379|69148953|FG009|Overall Study|Participant's compliance|1|||
37674530|NCT02641379|69148954|FG010|Overall Study|Participant's compliance|1|||
37674531|NCT02641379|69148944|FG000|Overall Study|Participant cannot be reached|4|||
37674532|NCT02641379|69148945|FG001|Overall Study|Participant cannot be reached|4|||
37674533|NCT02641379|69148946|FG002|Overall Study|Participant cannot be reached|0|||
37674534|NCT02641379|69148947|FG003|Overall Study|Participant cannot be reached|8|||
37674535|NCT02641379|69148948|FG004|Overall Study|Participant cannot be reached|2|||
37674536|NCT02641379|69148949|FG005|Overall Study|Participant cannot be reached|1|||
37674537|NCT02641379|69148950|FG006|Overall Study|Participant cannot be reached|0|||
37674538|NCT02641379|69148951|FG007|Overall Study|Participant cannot be reached|1|||
37674539|NCT02641379|69148952|FG008|Overall Study|Participant cannot be reached|0|||
37674540|NCT02641379|69148953|FG009|Overall Study|Participant cannot be reached|2|||
37674541|NCT02641379|69148954|FG010|Overall Study|Participant cannot be reached|1|||
37674542|NCT02641379|69148944|FG000|Overall Study|PCR positive at Week 24|15|||
37674543|NCT02641379|69148945|FG001|Overall Study|PCR positive at Week 24|21|||
37674544|NCT02641379|69148946|FG002|Overall Study|PCR positive at Week 24|62|||
37674545|NCT02641379|69148947|FG003|Overall Study|PCR positive at Week 24|0|||
37674546|NCT02641379|69148948|FG004|Overall Study|PCR positive at Week 24|0|||
37674547|NCT02641379|69148949|FG005|Overall Study|PCR positive at Week 24|6|||
37674548|NCT02641379|69148950|FG006|Overall Study|PCR positive at Week 24|3|||
37674549|NCT02641379|69148951|FG007|Overall Study|PCR positive at Week 24|8|||
37674550|NCT02641379|69148952|FG008|Overall Study|PCR positive at Week 24|0|||
37674551|NCT02641379|69148953|FG009|Overall Study|PCR positive at Week 24|1|||
37674552|NCT02641379|69148954|FG010|Overall Study|PCR positive at Week 24|0|||
37674553|NCT02641379|69148944|FG000|Overall Study|PCR positive at follow up 2|1|||
37674554|NCT02641379|69148945|FG001|Overall Study|PCR positive at follow up 2|0|||
37674555|NCT02641379|69148946|FG002|Overall Study|PCR positive at follow up 2|0|||
37674556|NCT02641379|69148947|FG003|Overall Study|PCR positive at follow up 2|0|||
37674557|NCT02641379|69148948|FG004|Overall Study|PCR positive at follow up 2|0|||
37674558|NCT02641379|69148949|FG005|Overall Study|PCR positive at follow up 2|0|||
37674559|NCT02641379|69148950|FG006|Overall Study|PCR positive at follow up 2|0|||
37674560|NCT02641379|69148951|FG007|Overall Study|PCR positive at follow up 2|0|||
37674561|NCT02641379|69148952|FG008|Overall Study|PCR positive at follow up 2|0|||
37674562|NCT02641379|69148953|FG009|Overall Study|PCR positive at follow up 2|0|||
37674563|NCT02641379|69148954|FG010|Overall Study|PCR positive at follow up 2|0|||
37674564|NCT02641379|69148944|FG000|Overall Study|Participant showed relapse|1|||
37674565|NCT02641379|69148945|FG001|Overall Study|Participant showed relapse|0|||
37674566|NCT02641379|69148946|FG002|Overall Study|Participant showed relapse|0|||
37674567|NCT02641379|69148947|FG003|Overall Study|Participant showed relapse|0|||
37674568|NCT02641379|69148948|FG004|Overall Study|Participant showed relapse|0|||
37674569|NCT02641379|69148949|FG005|Overall Study|Participant showed relapse|0|||
37674570|NCT02641379|69148950|FG006|Overall Study|Participant showed relapse|1|||
37674571|NCT02641379|69148951|FG007|Overall Study|Participant showed relapse|0|||
37674572|NCT02641379|69148952|FG008|Overall Study|Participant showed relapse|0|||
37674573|NCT02641379|69148953|FG009|Overall Study|Participant showed relapse|0|||
37674574|NCT02641379|69148954|FG010|Overall Study|Participant showed relapse|0|||
37674575|NCT02641379|69148944|FG000|Overall Study|Participant stopped study/treatment|1|||
37674576|NCT02641379|69148945|FG001|Overall Study|Participant stopped study/treatment|3|||
37674577|NCT02641379|69148946|FG002|Overall Study|Participant stopped study/treatment|1|||
37674578|NCT02641379|69148947|FG003|Overall Study|Participant stopped study/treatment|0|||
37674579|NCT02641379|69148948|FG004|Overall Study|Participant stopped study/treatment|0|||
37674580|NCT02641379|69148949|FG005|Overall Study|Participant stopped study/treatment|1|||
37674581|NCT02641379|69148950|FG006|Overall Study|Participant stopped study/treatment|2|||
37674582|NCT02641379|69148951|FG007|Overall Study|Participant stopped study/treatment|0|||
37674583|NCT02641379|69148952|FG008|Overall Study|Participant stopped study/treatment|1|||
37674584|NCT02641379|69148953|FG009|Overall Study|Participant stopped study/treatment|0|||
37674585|NCT02641379|69148954|FG010|Overall Study|Participant stopped study/treatment|0|||
37674586|NCT02641379|69148944|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
37674587|NCT02641379|69148945|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
37766861|NCT00211237|69281625|FG001|1 Month|Lost to Follow-up|2|||
37674588|NCT02641379|69148946|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
37674589|NCT02641379|69148947|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
37674590|NCT02641379|69148948|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
37674591|NCT02641379|69148949|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
37674592|NCT02641379|69148950|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
37674593|NCT02641379|69148951|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
37674594|NCT02641379|69148952|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
37674595|NCT02641379|69148953|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
37674596|NCT02641379|69148954|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
37674597|NCT02641379|69148944|FG000|Overall Study|Financial problems|0|||
37674598|NCT02641379|69148945|FG001|Overall Study|Financial problems|1|||
37674599|NCT02641379|69148946|FG002|Overall Study|Financial problems|0|||
37674600|NCT02641379|69148947|FG003|Overall Study|Financial problems|0|||
37674601|NCT02641379|69148948|FG004|Overall Study|Financial problems|0|||
37674602|NCT02641379|69148949|FG005|Overall Study|Financial problems|0|||
37674603|NCT02641379|69148950|FG006|Overall Study|Financial problems|0|||
37674604|NCT02641379|69148951|FG007|Overall Study|Financial problems|0|||
37674605|NCT02641379|69148952|FG008|Overall Study|Financial problems|0|||
37674606|NCT02641379|69148953|FG009|Overall Study|Financial problems|0|||
37674607|NCT02641379|69148954|FG010|Overall Study|Financial problems|0|||
37674608|NCT02641379|69148944|FG000|Overall Study|PCR positive at Week 68|0|||
37674609|NCT02641379|69148945|FG001|Overall Study|PCR positive at Week 68|1|||
37674610|NCT02641379|69148946|FG002|Overall Study|PCR positive at Week 68|0|||
37674611|NCT02641379|69148947|FG003|Overall Study|PCR positive at Week 68|0|||
37674612|NCT02641379|69148948|FG004|Overall Study|PCR positive at Week 68|0|||
37674613|NCT02641379|69148949|FG005|Overall Study|PCR positive at Week 68|0|||
37674614|NCT02641379|69148950|FG006|Overall Study|PCR positive at Week 68|0|||
37674615|NCT02641379|69148951|FG007|Overall Study|PCR positive at Week 68|0|||
37674616|NCT02641379|69148952|FG008|Overall Study|PCR positive at Week 68|0|||
37674617|NCT02641379|69148953|FG009|Overall Study|PCR positive at Week 68|0|||
37674618|NCT02641379|69148954|FG010|Overall Study|PCR positive at Week 68|0|||
37674619|NCT02641379|69148944|FG000|Overall Study|PCR positive at Week 48|0|||
37674620|NCT02641379|69148945|FG001|Overall Study|PCR positive at Week 48|1|||
37674621|NCT02641379|69148946|FG002|Overall Study|PCR positive at Week 48|0|||
37674622|NCT02641379|69148947|FG003|Overall Study|PCR positive at Week 48|0|||
37674623|NCT02641379|69148948|FG004|Overall Study|PCR positive at Week 48|0|||
37674624|NCT02641379|69148949|FG005|Overall Study|PCR positive at Week 48|0|||
37674625|NCT02641379|69148950|FG006|Overall Study|PCR positive at Week 48|0|||
37674626|NCT02641379|69148951|FG007|Overall Study|PCR positive at Week 48|0|||
37674627|NCT02641379|69148952|FG008|Overall Study|PCR positive at Week 48|0|||
37674628|NCT02641379|69148953|FG009|Overall Study|PCR positive at Week 48|0|||
37674629|NCT02641379|69148954|FG010|Overall Study|PCR positive at Week 48|0|||
37674630|NCT02641379|69148944|FG000|Overall Study|PCR not performed at Week 12|0|||
37674631|NCT02641379|69148945|FG001|Overall Study|PCR not performed at Week 12|0|||
37674632|NCT02641379|69148946|FG002|Overall Study|PCR not performed at Week 12|1|||
37674633|NCT02641379|69148947|FG003|Overall Study|PCR not performed at Week 12|0|||
37674634|NCT02641379|69148948|FG004|Overall Study|PCR not performed at Week 12|0|||
37674635|NCT02641379|69148949|FG005|Overall Study|PCR not performed at Week 12|0|||
37674636|NCT02641379|69148950|FG006|Overall Study|PCR not performed at Week 12|0|||
37674637|NCT02641379|69148951|FG007|Overall Study|PCR not performed at Week 12|0|||
37674638|NCT02641379|69148952|FG008|Overall Study|PCR not performed at Week 12|0|||
37674639|NCT02641379|69148953|FG009|Overall Study|PCR not performed at Week 12|0|||
37674640|NCT02641379|69148954|FG010|Overall Study|PCR not performed at Week 12|0|||
37674641|NCT02641379|69148944|FG000|Overall Study|No PCR at baseline|0|||
37674642|NCT02641379|69148945|FG001|Overall Study|No PCR at baseline|0|||
37674643|NCT02641379|69148946|FG002|Overall Study|No PCR at baseline|1|||
37674644|NCT02641379|69148947|FG003|Overall Study|No PCR at baseline|0|||
37674645|NCT02641379|69148948|FG004|Overall Study|No PCR at baseline|0|||
37674646|NCT02641379|69148949|FG005|Overall Study|No PCR at baseline|0|||
37674647|NCT02641379|69148950|FG006|Overall Study|No PCR at baseline|0|||
37674648|NCT02641379|69148951|FG007|Overall Study|No PCR at baseline|0|||
37674649|NCT02641379|69148952|FG008|Overall Study|No PCR at baseline|0|||
37674650|NCT02641379|69148953|FG009|Overall Study|No PCR at baseline|0|||
37766862|NCT00211237|69281626|FG002|1 Month|Lost to Follow-up|0|||
37766863|NCT00211237|69281624|FG000|1 Month|Withdrew|0|||
37766864|NCT00211237|69281625|FG001|1 Month|Withdrew|4|||
37674651|NCT02641379|69148954|FG010|Overall Study|No PCR at baseline|0|||
37674652|NCT02641379|69148944|FG000|Overall Study|PCR positive at Week 28|0|||
37674653|NCT02641379|69148945|FG001|Overall Study|PCR positive at Week 28|0|||
37674654|NCT02641379|69148946|FG002|Overall Study|PCR positive at Week 28|1|||
37674655|NCT02641379|69148947|FG003|Overall Study|PCR positive at Week 28|0|||
37674656|NCT02641379|69148948|FG004|Overall Study|PCR positive at Week 28|0|||
37674657|NCT02641379|69148949|FG005|Overall Study|PCR positive at Week 28|0|||
37674658|NCT02641379|69148950|FG006|Overall Study|PCR positive at Week 28|0|||
37766865|NCT00211237|69281626|FG002|1 Month|Withdrew|0|||
37766866|NCT00211237|69281624|FG000|1 Month|Additional surgery needed|1|||
37674659|NCT02641379|69148951|FG007|Overall Study|PCR positive at Week 28|0|||
37674660|NCT02641379|69148952|FG008|Overall Study|PCR positive at Week 28|0|||
37674661|NCT02641379|69148953|FG009|Overall Study|PCR positive at Week 28|0|||
37674662|NCT02641379|69148954|FG010|Overall Study|PCR positive at Week 28|0|||
37674663|NCT02641379|69148944|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
37674664|NCT02641379|69148945|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
37674665|NCT02641379|69148946|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
37674666|NCT02641379|69148947|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
37674667|NCT02641379|69148948|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
37674668|NCT02641379|69148949|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
37674669|NCT02641379|69148950|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
37674670|NCT02641379|69148951|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
37674671|NCT02641379|69148952|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
37674672|NCT02641379|69148953|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
37674673|NCT02641379|69148954|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
37674674|NCT02641379|69148944|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
37674675|NCT02641379|69148945|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
37674676|NCT02641379|69148946|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
37674677|NCT02641379|69148947|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
37674678|NCT02641379|69148948|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
37674679|NCT02641379|69148949|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
37674680|NCT02641379|69148950|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
37674681|NCT02641379|69148951|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
37674682|NCT02641379|69148952|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
37674683|NCT02641379|69148953|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
37674684|NCT02641379|69148954|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
37674685|NCT02641379|69148944|FG000|Overall Study|Baseline viral load unavailable|0|||
37674686|NCT02641379|69148945|FG001|Overall Study|Baseline viral load unavailable|0|||
37674687|NCT02641379|69148946|FG002|Overall Study|Baseline viral load unavailable|0|||
37674688|NCT02641379|69148947|FG003|Overall Study|Baseline viral load unavailable|1|||
37674689|NCT02641379|69148948|FG004|Overall Study|Baseline viral load unavailable|0|||
37674690|NCT02641379|69148949|FG005|Overall Study|Baseline viral load unavailable|0|||
37674691|NCT02641379|69148950|FG006|Overall Study|Baseline viral load unavailable|0|||
37674692|NCT02641379|69148951|FG007|Overall Study|Baseline viral load unavailable|0|||
37674693|NCT02641379|69148952|FG008|Overall Study|Baseline viral load unavailable|0|||
37674694|NCT02641379|69148953|FG009|Overall Study|Baseline viral load unavailable|0|||
37674695|NCT02641379|69148954|FG010|Overall Study|Baseline viral load unavailable|0|||
37674696|NCT02641379|69148944|FG000|Overall Study|Blood could not be drawn|0|||
37674697|NCT02641379|69148945|FG001|Overall Study|Blood could not be drawn|0|||
37674698|NCT02641379|69148946|FG002|Overall Study|Blood could not be drawn|0|||
37674699|NCT02641379|69148947|FG003|Overall Study|Blood could not be drawn|0|||
37674700|NCT02641379|69148948|FG004|Overall Study|Blood could not be drawn|1|||
37674701|NCT02641379|69148949|FG005|Overall Study|Blood could not be drawn|0|||
37674702|NCT02641379|69148950|FG006|Overall Study|Blood could not be drawn|0|||
37674703|NCT02641379|69148951|FG007|Overall Study|Blood could not be drawn|0|||
37674704|NCT02641379|69148952|FG008|Overall Study|Blood could not be drawn|0|||
37674705|NCT02641379|69148953|FG009|Overall Study|Blood could not be drawn|0|||
37674706|NCT02641379|69148954|FG010|Overall Study|Blood could not be drawn|0|||
37674707|NCT02641379|69148944|FG000|Overall Study|Protocol Violation|0|||
37674708|NCT02641379|69148945|FG001|Overall Study|Protocol Violation|0|||
37674709|NCT02641379|69148946|FG002|Overall Study|Protocol Violation|0|||
37674710|NCT02641379|69148947|FG003|Overall Study|Protocol Violation|0|||
37674711|NCT02641379|69148948|FG004|Overall Study|Protocol Violation|2|||
37674712|NCT02641379|69148949|FG005|Overall Study|Protocol Violation|0|||
37674713|NCT02641379|69148950|FG006|Overall Study|Protocol Violation|0|||
37674714|NCT02641379|69148951|FG007|Overall Study|Protocol Violation|0|||
37674715|NCT02641379|69148952|FG008|Overall Study|Protocol Violation|1|||
37674716|NCT02641379|69148953|FG009|Overall Study|Protocol Violation|0|||
37674717|NCT02641379|69148954|FG010|Overall Study|Protocol Violation|0|||
37674718|NCT02641379|69148944|FG000|Overall Study|Participation in sili rescue study|0|||
37674719|NCT02641379|69148945|FG001|Overall Study|Participation in sili rescue study|0|||
37674720|NCT02641379|69148946|FG002|Overall Study|Participation in sili rescue study|0|||
37674721|NCT02641379|69148947|FG003|Overall Study|Participation in sili rescue study|0|||
37674722|NCT02641379|69148948|FG004|Overall Study|Participation in sili rescue study|0|||
37674723|NCT02641379|69148949|FG005|Overall Study|Participation in sili rescue study|1|||
37674724|NCT02641379|69148950|FG006|Overall Study|Participation in sili rescue study|0|||
37674725|NCT02641379|69148951|FG007|Overall Study|Participation in sili rescue study|0|||
37674726|NCT02641379|69148952|FG008|Overall Study|Participation in sili rescue study|0|||
37674727|NCT02641379|69148953|FG009|Overall Study|Participation in sili rescue study|0|||
37674728|NCT02641379|69148954|FG010|Overall Study|Participation in sili rescue study|0|||
37674729|NCT02641379|69148944|FG000|Overall Study|Lost to Follow-up|0|||
37674730|NCT02641379|69148945|FG001|Overall Study|Lost to Follow-up|0|||
37674731|NCT02641379|69148946|FG002|Overall Study|Lost to Follow-up|0|||
37674732|NCT02641379|69148947|FG003|Overall Study|Lost to Follow-up|0|||
37674733|NCT02641379|69148948|FG004|Overall Study|Lost to Follow-up|0|||
37674734|NCT02641379|69148949|FG005|Overall Study|Lost to Follow-up|0|||
37674735|NCT02641379|69148950|FG006|Overall Study|Lost to Follow-up|0|||
37674736|NCT02641379|69148951|FG007|Overall Study|Lost to Follow-up|0|||
37674737|NCT02641379|69148952|FG008|Overall Study|Lost to Follow-up|1|||
37674738|NCT02641379|69148953|FG009|Overall Study|Lost to Follow-up|0|||
37674739|NCT02641379|69148954|FG010|Overall Study|Lost to Follow-up|0|||
37674740|NCT02641379|69148944|FG000|Overall Study|Source data not found|0|||
37674741|NCT02641379|69148945|FG001|Overall Study|Source data not found|0|||
37674742|NCT02641379|69148946|FG002|Overall Study|Source data not found|0|||
37674743|NCT02641379|69148947|FG003|Overall Study|Source data not found|0|||
37674744|NCT02641379|69148948|FG004|Overall Study|Source data not found|0|||
37674745|NCT02641379|69148949|FG005|Overall Study|Source data not found|1|||
37674746|NCT02641379|69148950|FG006|Overall Study|Source data not found|0|||
37674747|NCT02641379|69148951|FG007|Overall Study|Source data not found|0|||
37674748|NCT02641379|69148952|FG008|Overall Study|Source data not found|0|||
37674749|NCT02641379|69148953|FG009|Overall Study|Source data not found|0|||
37674750|NCT02641379|69148954|FG010|Overall Study|Source data not found|0|||
37674751|NCT02641379|69148944|FG000|Overall Study|Participant showed weight reduction|0|||
37674752|NCT02641379|69148945|FG001|Overall Study|Participant showed weight reduction|0|||
37674753|NCT02641379|69148946|FG002|Overall Study|Participant showed weight reduction|0|||
37674754|NCT02641379|69148947|FG003|Overall Study|Participant showed weight reduction|0|||
37674755|NCT02641379|69148948|FG004|Overall Study|Participant showed weight reduction|0|||
37674756|NCT02641379|69148949|FG005|Overall Study|Participant showed weight reduction|0|||
37674757|NCT02641379|69148950|FG006|Overall Study|Participant showed weight reduction|0|||
37674758|NCT02641379|69148951|FG007|Overall Study|Participant showed weight reduction|1|||
37674759|NCT02641379|69148952|FG008|Overall Study|Participant showed weight reduction|0|||
37674760|NCT02641379|69148953|FG009|Overall Study|Participant showed weight reduction|0|||
37674761|NCT02641379|69148954|FG010|Overall Study|Participant showed weight reduction|0|||
37674762|NCT02641379|69148944|FG000|Overall Study|Non-response Week 12|0|||
37674763|NCT02641379|69148945|FG001|Overall Study|Non-response Week 12|0|||
37674764|NCT02641379|69148946|FG002|Overall Study|Non-response Week 12|0|||
37674765|NCT02641379|69148947|FG003|Overall Study|Non-response Week 12|0|||
37674766|NCT02641379|69148948|FG004|Overall Study|Non-response Week 12|0|||
37674767|NCT02641379|69148949|FG005|Overall Study|Non-response Week 12|0|||
37674768|NCT02641379|69148950|FG006|Overall Study|Non-response Week 12|0|||
37674769|NCT02641379|69148951|FG007|Overall Study|Non-response Week 12|1|||
37674770|NCT02641379|69148952|FG008|Overall Study|Non-response Week 12|0|||
37674771|NCT02641379|69148953|FG009|Overall Study|Non-response Week 12|0|||
37674772|NCT02641379|69148954|FG010|Overall Study|Non-response Week 12|0|||
37674773|NCT02641379|69148944|FG000|Overall Study|No 2 Log drop at Week 12|0|||
37674774|NCT02641379|69148945|FG001|Overall Study|No 2 Log drop at Week 12|0|||
37674775|NCT02641379|69148946|FG002|Overall Study|No 2 Log drop at Week 12|0|||
37674776|NCT02641379|69148947|FG003|Overall Study|No 2 Log drop at Week 12|0|||
37674777|NCT02641379|69148948|FG004|Overall Study|No 2 Log drop at Week 12|0|||
37674778|NCT02641379|69148949|FG005|Overall Study|No 2 Log drop at Week 12|0|||
37674779|NCT02641379|69148950|FG006|Overall Study|No 2 Log drop at Week 12|0|||
37674780|NCT02641379|69148951|FG007|Overall Study|No 2 Log drop at Week 12|0|||
37674781|NCT02641379|69148952|FG008|Overall Study|No 2 Log drop at Week 12|0|||
37674782|NCT02641379|69148953|FG009|Overall Study|No 2 Log drop at Week 12|0|||
37674783|NCT02641379|69148954|FG010|Overall Study|No 2 Log drop at Week 12|1|||
37674784|NCT02641379|69148944|FG000|Overall Study|Negative PCR result|0|||
37674785|NCT02641379|69148945|FG001|Overall Study|Negative PCR result|0|||
37674786|NCT02641379|69148946|FG002|Overall Study|Negative PCR result|0|||
37674787|NCT02641379|69148947|FG003|Overall Study|Negative PCR result|0|||
37674788|NCT02641379|69148948|FG004|Overall Study|Negative PCR result|0|||
37674789|NCT02641379|69148949|FG005|Overall Study|Negative PCR result|0|||
37674790|NCT02641379|69148950|FG006|Overall Study|Negative PCR result|0|||
37674791|NCT02641379|69148951|FG007|Overall Study|Negative PCR result|0|||
37674792|NCT02641379|69148952|FG008|Overall Study|Negative PCR result|0|||
37674793|NCT02641379|69148953|FG009|Overall Study|Negative PCR result|1|||
37674794|NCT02641379|69148954|FG010|Overall Study|Negative PCR result|0|||
37674795|NCT02641379|69148944|FG000|Overall Study|Participant's PCR high|0|||
37674796|NCT02641379|69148945|FG001|Overall Study|Participant's PCR high|0|||
37674797|NCT02641379|69148946|FG002|Overall Study|Participant's PCR high|0|||
37674798|NCT02641379|69148947|FG003|Overall Study|Participant's PCR high|0|||
37674799|NCT02641379|69148948|FG004|Overall Study|Participant's PCR high|0|||
37674800|NCT02641379|69148949|FG005|Overall Study|Participant's PCR high|0|||
37674801|NCT02641379|69148950|FG006|Overall Study|Participant's PCR high|0|||
37674802|NCT02641379|69148951|FG007|Overall Study|Participant's PCR high|1|||
37674803|NCT02641379|69148952|FG008|Overall Study|Participant's PCR high|0|||
37674804|NCT02641379|69148953|FG009|Overall Study|Participant's PCR high|0|||
37674805|NCT02641379|69148954|FG010|Overall Study|Participant's PCR high|0|||
37674806|NCT02641379|69148944|FG000|Overall Study|Participant treated after Week 24|0|||
37674807|NCT02641379|69148945|FG001|Overall Study|Participant treated after Week 24|0|||
37674808|NCT02641379|69148946|FG002|Overall Study|Participant treated after Week 24|0|||
37674809|NCT02641379|69148947|FG003|Overall Study|Participant treated after Week 24|0|||
37674810|NCT02641379|69148948|FG004|Overall Study|Participant treated after Week 24|0|||
37674811|NCT02641379|69148949|FG005|Overall Study|Participant treated after Week 24|0|||
37674812|NCT02641379|69148950|FG006|Overall Study|Participant treated after Week 24|0|||
37674813|NCT02641379|69148951|FG007|Overall Study|Participant treated after Week 24|0|||
37674814|NCT02641379|69148952|FG008|Overall Study|Participant treated after Week 24|1|||
37674815|NCT02641379|69148953|FG009|Overall Study|Participant treated after Week 24|0|||
37674816|NCT02641379|69148954|FG010|Overall Study|Participant treated after Week 24|0|||
37674817|NCT02641379|69148944|FG000|Overall Study|Missing PCR result at Week 8|0|||
37674818|NCT02641379|69148945|FG001|Overall Study|Missing PCR result at Week 8|0|||
37674819|NCT02641379|69148946|FG002|Overall Study|Missing PCR result at Week 8|0|||
37674820|NCT02641379|69148947|FG003|Overall Study|Missing PCR result at Week 8|0|||
37674821|NCT02641379|69148948|FG004|Overall Study|Missing PCR result at Week 8|0|||
37674822|NCT02641379|69148949|FG005|Overall Study|Missing PCR result at Week 8|0|||
37674823|NCT02641379|69148950|FG006|Overall Study|Missing PCR result at Week 8|0|||
37674824|NCT02641379|69148951|FG007|Overall Study|Missing PCR result at Week 8|0|||
37674825|NCT02641379|69148952|FG008|Overall Study|Missing PCR result at Week 8|0|||
37674826|NCT02641379|69148953|FG009|Overall Study|Missing PCR result at Week 8|1|||
37674827|NCT02641379|69148954|FG010|Overall Study|Missing PCR result at Week 8|0|||
37674828|NCT02641379|69148944|FG000|Overall Study|PCR positive|0|||
37674829|NCT02641379|69148945|FG001|Overall Study|PCR positive|0|||
37674830|NCT02641379|69148946|FG002|Overall Study|PCR positive|0|||
37674831|NCT02641379|69148947|FG003|Overall Study|PCR positive|0|||
37674832|NCT02641379|69148948|FG004|Overall Study|PCR positive|0|||
37674833|NCT02641379|69148949|FG005|Overall Study|PCR positive|0|||
37674834|NCT02641379|69148950|FG006|Overall Study|PCR positive|1|||
37674835|NCT02641379|69148951|FG007|Overall Study|PCR positive|0|||
37674836|NCT02641379|69148952|FG008|Overall Study|PCR positive|0|||
37674837|NCT02641379|69148953|FG009|Overall Study|PCR positive|0|||
37674838|NCT02641379|69148954|FG010|Overall Study|PCR positive|0|||
37674839|NCT02660983|69148985|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
37674840|NCT02660983|69148986|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
37674841|NCT02660983|69148985|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
37674842|NCT02660983|69148986|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
37674843|NCT02660983|69148985|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
37674844|NCT02660983|69148986|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
37674845|NCT02660983|69148985|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
37674846|NCT02660983|69148986|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
37674847|NCT02660983|69148985|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
37674848|NCT02660983|69148986|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
37674849|NCT02660983|69148985|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
37674850|NCT02660983|69148986|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
37674851|NCT02660983|69148985|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
37674852|NCT02660983|69148986|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
37674853|NCT01953328|69149001|FG000|Overall Study|Withdrawal by Subject|0|||
37674854|NCT01953328|69149002|FG001|Overall Study|Withdrawal by Subject|0|||
37674855|NCT01953328|69149003|FG002|Overall Study|Withdrawal by Subject|0|||
37674856|NCT01953328|69149004|FG003|Overall Study|Withdrawal by Subject|0|||
37674857|NCT01953328|69149005|FG004|Overall Study|Withdrawal by Subject|1|||
37674858|NCT01953328|69149006|FG005|Overall Study|Withdrawal by Subject|0|||
37674859|NCT01953328|69149007|FG006|Overall Study|Withdrawal by Subject|0|||
37674860|NCT01953328|69149008|FG007|Overall Study|Withdrawal by Subject|0|||
37674861|NCT01953328|69149001|FG000|Overall Study|Lost to Follow-up|0|||
37674862|NCT01953328|69149002|FG001|Overall Study|Lost to Follow-up|0|||
37674863|NCT01953328|69149003|FG002|Overall Study|Lost to Follow-up|0|||
37674864|NCT01953328|69149004|FG003|Overall Study|Lost to Follow-up|0|||
37674865|NCT01953328|69149005|FG004|Overall Study|Lost to Follow-up|1|||
37674866|NCT01953328|69149006|FG005|Overall Study|Lost to Follow-up|0|||
37674867|NCT01953328|69149007|FG006|Overall Study|Lost to Follow-up|0|||
37674868|NCT01953328|69149008|FG007|Overall Study|Lost to Follow-up|0|||
37674869|NCT02640755|69149028|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
37674870|NCT02640755|69149029|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
37674871|NCT02640755|69149028|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
37674872|NCT02640755|69149029|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
37674873|NCT02640755|69149028|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
37674874|NCT02640755|69149029|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
37674875|NCT02640677|69149036|FG000|Overall Study|Lost to Follow-up|1|||
37674876|NCT02640677|69149036|FG000|Overall Study|Withdrawal by Subject|1|||
37766867|NCT00211237|69281625|FG001|1 Month|Additional surgery needed|0|||
37766868|NCT00211237|69281626|FG002|1 Month|Additional surgery needed|0|||
37766869|NCT00211237|69281624|FG000|1 Month|Non-medical problem|0|||
37674877|NCT02643251|69149042|FG000|Overall Study|Adverse Event|3|||
37674878|NCT02643251|69149043|FG001|Overall Study|Adverse Event|1|||
37674879|NCT02643251|69149042|FG000|Overall Study|Withdrawal by Subject|2|||
37674880|NCT02643251|69149043|FG001|Overall Study|Withdrawal by Subject|0|||
37674881|NCT02643251|69149042|FG000|Overall Study|Lost to Follow-up|4|||
37674882|NCT02643251|69149043|FG001|Overall Study|Lost to Follow-up|1|||
37674883|NCT02643251|69149042|FG000|Overall Study|Protocol Violation|1|||
37674884|NCT02643251|69149043|FG001|Overall Study|Protocol Violation|0|||
37674885|NCT02643251|69149042|FG000|Overall Study|PI Decision to terminate patient|1|||
37674886|NCT02643251|69149043|FG001|Overall Study|PI Decision to terminate patient|0|||
37674887|NCT01970878|69149053|FG000|Overall Study|Withdrawal by Subject|11|||
37674888|NCT01970878|69149054|FG001|Overall Study|Withdrawal by Subject|10|||
37674889|NCT01970878|69149055|FG002|Overall Study|Withdrawal by Subject|14|||
37674890|NCT01970878|69149056|FG003|Overall Study|Withdrawal by Subject|7|||
37674891|NCT01970878|69149053|FG000|Overall Study|Lost to Follow-up|1|||
37674892|NCT01970878|69149054|FG001|Overall Study|Lost to Follow-up|3|||
37674893|NCT01970878|69149055|FG002|Overall Study|Lost to Follow-up|2|||
37674894|NCT01970878|69149056|FG003|Overall Study|Lost to Follow-up|4|||
37674895|NCT01970878|69149053|FG000|Overall Study|Administrative Reasons|1|||
37674896|NCT01970878|69149054|FG001|Overall Study|Administrative Reasons|0|||
37674897|NCT01970878|69149055|FG002|Overall Study|Administrative Reasons|0|||
37674898|NCT01970878|69149056|FG003|Overall Study|Administrative Reasons|4|||
37674899|NCT01970878|69149053|FG000|Overall Study|Lack of Efficacy|2|||
37674900|NCT01970878|69149054|FG001|Overall Study|Lack of Efficacy|1|||
37674901|NCT01970878|69149055|FG002|Overall Study|Lack of Efficacy|2|||
37674902|NCT01970878|69149056|FG003|Overall Study|Lack of Efficacy|0|||
37674903|NCT01970878|69149053|FG000|Overall Study|Adverse Event|12|||
37674904|NCT01970878|69149054|FG001|Overall Study|Adverse Event|7|||
37674905|NCT01970878|69149055|FG002|Overall Study|Adverse Event|4|||
37674906|NCT01970878|69149056|FG003|Overall Study|Adverse Event|3|||
37674907|NCT01970878|69149053|FG000|Overall Study|Protocol Specified Criteria|10|||
37674908|NCT01970878|69149054|FG001|Overall Study|Protocol Specified Criteria|4|||
37674909|NCT01970878|69149055|FG002|Overall Study|Protocol Specified Criteria|3|||
37674910|NCT01970878|69149056|FG003|Overall Study|Protocol Specified Criteria|6|||
37674911|NCT01970878|69149053|FG000|Overall Study|Physician Decision|0|||
37674912|NCT01970878|69149054|FG001|Overall Study|Physician Decision|1|||
37674913|NCT01970878|69149055|FG002|Overall Study|Physician Decision|1|||
37674914|NCT01970878|69149056|FG003|Overall Study|Physician Decision|0|||
37674915|NCT01970878|69149053|FG000|Overall Study|No Completion Status|0|||
37674916|NCT01970878|69149054|FG001|Overall Study|No Completion Status|1|||
37674917|NCT01970878|69149055|FG002|Overall Study|No Completion Status|0|||
37674918|NCT01970878|69149056|FG003|Overall Study|No Completion Status|0|||
37674919|NCT01970488|69149068|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
37766870|NCT00211237|69281625|FG001|1 Month|Non-medical problem|2|||
37766871|NCT00211237|69281626|FG002|1 Month|Non-medical problem|0|||
37766872|NCT00211237|69281624|FG000|3 Months|Death|7|||
37766873|NCT00211237|69281625|FG001|3 Months|Death|3|||
37766874|NCT00211237|69281626|FG002|3 Months|Death|0|||
37766875|NCT00211237|69281624|FG000|3 Months|Could not comply with protocol|1|||
37766876|NCT00211237|69281625|FG001|3 Months|Could not comply with protocol|0|||
37674920|NCT01970488|69149069|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
37674921|NCT01970488|69149070|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
37674922|NCT01970488|69149071|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
37674923|NCT01970488|69149072|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
37674924|NCT01970488|69149068|FG000|Part 1: Through Week 16|Protocol Violation|1|||
37674925|NCT01970488|69149069|FG001|Part 1: Through Week 16|Protocol Violation|2|||
37674926|NCT01970488|69149070|FG002|Part 1: Through Week 16|Protocol Violation|0|||
37674927|NCT01970488|69149071|FG003|Part 1: Through Week 16|Protocol Violation|0|||
37674928|NCT01970488|69149072|FG004|Part 1: Through Week 16|Protocol Violation|0|||
37674929|NCT01970488|69149068|FG000|Part 1: Through Week 16|Adverse Event|6|||
37674930|NCT01970488|69149069|FG001|Part 1: Through Week 16|Adverse Event|5|||
37674931|NCT01970488|69149070|FG002|Part 1: Through Week 16|Adverse Event|0|||
37674932|NCT01970488|69149071|FG003|Part 1: Through Week 16|Adverse Event|0|||
37674933|NCT01970488|69149072|FG004|Part 1: Through Week 16|Adverse Event|0|||
37674934|NCT01970488|69149068|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
37674935|NCT01970488|69149069|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
37674936|NCT01970488|69149070|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
37674937|NCT01970488|69149071|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
37674938|NCT01970488|69149072|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
37766877|NCT00211237|69281626|FG002|3 Months|Could not comply with protocol|0|||
37766878|NCT00211237|69281624|FG000|3 Months|Withdrew|0|||
37674939|NCT01970488|69149068|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
37674940|NCT01970488|69149069|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
37674941|NCT01970488|69149070|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
37674942|NCT01970488|69149071|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
37674943|NCT01970488|69149072|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
37766879|NCT00211237|69281625|FG001|3 Months|Withdrew|1|||
37766880|NCT00211237|69281626|FG002|3 Months|Withdrew|0|||
37766881|NCT00211237|69281624|FG000|3 Months|Non-medical problem|0|||
37766882|NCT00211237|69281625|FG001|3 Months|Non-medical problem|0|||
37766883|NCT00211237|69281626|FG002|3 Months|Non-medical problem|1|||
37766884|NCT00211237|69281624|FG000|6 Months|Death|6|||
37766885|NCT00211237|69281625|FG001|6 Months|Death|0|||
37766886|NCT00211237|69281626|FG002|6 Months|Death|3|||
37766887|NCT00211237|69281624|FG000|6 Months|Lost to Follow-up|2|||
37766888|NCT00211237|69281625|FG001|6 Months|Lost to Follow-up|0|||
37766889|NCT00211237|69281626|FG002|6 Months|Lost to Follow-up|0|||
37766890|NCT00211237|69281624|FG000|6 Months|Could not comply with protocol|0|||
37766891|NCT00211237|69281625|FG001|6 Months|Could not comply with protocol|2|||
37766892|NCT00211237|69281626|FG002|6 Months|Could not comply with protocol|0|||
37766893|NCT00211237|69281624|FG000|12 Months|Death|8|||
37766894|NCT00211237|69281625|FG001|12 Months|Death|2|||
37766895|NCT00211237|69281626|FG002|12 Months|Death|3|||
37766896|NCT00211237|69281624|FG000|12 Months|Lost to Follow-up|1|||
37766897|NCT00211237|69281625|FG001|12 Months|Lost to Follow-up|0|||
37766898|NCT00211237|69281626|FG002|12 Months|Lost to Follow-up|1|||
37766899|NCT00211237|69281624|FG000|12 Months|Withdrew|0|||
37766900|NCT00211237|69281625|FG001|12 Months|Withdrew|0|||
37766901|NCT00211237|69281626|FG002|12 Months|Withdrew|1|||
37766902|NCT00211237|69281624|FG000|12 Months|unrelated medical problem|0|||
37766903|NCT00211237|69281625|FG001|12 Months|unrelated medical problem|0|||
37766904|NCT00211237|69281626|FG002|12 Months|unrelated medical problem|1|||
37766905|NCT01489358|69281646|FG000|Overall Study|Lost to Follow-up|0|||
37766906|NCT01489358|69281647|FG001|Overall Study|Lost to Follow-up|0|||
37766907|NCT01489358|69281648|FG002|Overall Study|Lost to Follow-up|2|||
37766908|NCT01525238|69281659|FG000|Overall Study|Withdrawal by Subject|1|||
37766909|NCT01525238|69281660|FG001|Overall Study|Withdrawal by Subject|0|||
37766910|NCT01525238|69281661|FG002|Overall Study|Withdrawal by Subject|0|||
37766911|NCT01525082|69281682|FG000|Overall Study|Death|1|||
37766912|NCT01488578|69281689|FG000|Overall Study|Protocol Violation|1836|||
37766913|NCT01524770|69281730|FG000|First Intervention|Withdrawal by Subject|1|||
37766914|NCT01524770|69281731|FG001|First Intervention|Withdrawal by Subject|0|||
37766915|NCT01524770|69281730|FG000|First Intervention|Adverse Event|1|||
37766916|NCT01524770|69281731|FG001|First Intervention|Adverse Event|1|||
37766917|NCT01524770|69281730|FG000|First Intervention|Protocol Violation|1|||
37766918|NCT01524770|69281731|FG001|First Intervention|Protocol Violation|0|||
37766919|NCT05166876|69281755|FG000|Overall Study|Withdrawal by Subject|1|||
37766920|NCT05166876|69281756|FG001|Overall Study|Withdrawal by Subject|0|||
37766921|NCT05166876|69281757|FG002|Overall Study|Withdrawal by Subject|0|||
37766922|NCT05065619|69281771|FG000|Up to Day 42|Lost to Follow-up|1|||
37766923|NCT05065619|69281772|FG001|Up to Day 42|Lost to Follow-up|0|||
37674944|NCT01970488|69149068|FG000|Part 2: Post Week 16|Physician Decision|0|||
37674945|NCT01970488|69149069|FG001|Part 2: Post Week 16|Physician Decision|0|||
37674946|NCT01970488|69149070|FG002|Part 2: Post Week 16|Physician Decision|0|||
37674947|NCT01970488|69149071|FG003|Part 2: Post Week 16|Physician Decision|0|||
37674948|NCT01970488|69149072|FG004|Part 2: Post Week 16|Physician Decision|1|||
37674949|NCT01970488|69149068|FG000|Part 2: Post Week 16|Non-compliance|0|||
37674950|NCT01970488|69149069|FG001|Part 2: Post Week 16|Non-compliance|0|||
37674951|NCT01970488|69149070|FG002|Part 2: Post Week 16|Non-compliance|1|||
37674952|NCT01970488|69149071|FG003|Part 2: Post Week 16|Non-compliance|0|||
37674953|NCT01970488|69149072|FG004|Part 2: Post Week 16|Non-compliance|0|||
37674954|NCT01970488|69149068|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
37674955|NCT01970488|69149069|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
37674956|NCT01970488|69149070|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
37674957|NCT01970488|69149071|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
37674958|NCT01970488|69149072|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
37674959|NCT01970488|69149068|FG000|Part 2: Post Week 16|Adverse Event|0|||
37674960|NCT01970488|69149069|FG001|Part 2: Post Week 16|Adverse Event|0|||
37674961|NCT01970488|69149070|FG002|Part 2: Post Week 16|Adverse Event|5|||
37674962|NCT01970488|69149071|FG003|Part 2: Post Week 16|Adverse Event|1|||
37674963|NCT01970488|69149072|FG004|Part 2: Post Week 16|Adverse Event|1|||
37674964|NCT01970488|69149068|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
37766924|NCT05065619|69281771|FG000|Up to Day 42|Withdrawal by Subject|1|||
37766925|NCT05065619|69281772|FG001|Up to Day 42|Withdrawal by Subject|0|||
37766926|NCT05065619|69281771|FG000|After Day 43|Lost to Follow-up|1|||
37766927|NCT05065619|69281772|FG001|After Day 43|Lost to Follow-up|0|||
37766928|NCT05065619|69281771|FG000|After Day 43|Physician Decision|3|||
37766929|NCT05065619|69281772|FG001|After Day 43|Physician Decision|0|||
37766930|NCT05065619|69281771|FG000|After Day 43|Withdrawal by Subject|1|||
37766931|NCT05065619|69281772|FG001|After Day 43|Withdrawal by Subject|2|||
37766932|NCT05065619|69281771|FG000|After Day 43|Public vaccination|6|||
37766933|NCT05065619|69281772|FG001|After Day 43|Public vaccination|8|||
37766934|NCT05065619|69281771|FG000|After Day 43|Difficult to go to the hospital due to moving|1|||
37766935|NCT05065619|69281772|FG001|After Day 43|Difficult to go to the hospital due to moving|0|||
37766936|NCT05065619|69281771|FG000|After Day 43|Study Terminated by Sponsor|88|||
37766937|NCT05065619|69281772|FG001|After Day 43|Study Terminated by Sponsor|16|||
37766938|NCT04618770|69281796|FG000|Overall Study|Censored from Analysis|12|||
37766939|NCT04618770|69281796|FG000|Overall Study|Early Termination|25|||
37766940|NCT04581200|69281802|FG000|Overall Study|Lost to Follow-up|6|||
37766941|NCT04581200|69281803|FG001|Overall Study|Lost to Follow-up|5|||
37766942|NCT04576455|69281812|FG000|Overall Study|Ongoing in the Study|122|||
37766943|NCT04576455|69281813|FG001|Overall Study|Ongoing in the Study|135|||
37766944|NCT04576455|69281812|FG000|Overall Study|Death|18|||
37766945|NCT04576455|69281813|FG001|Overall Study|Death|12|||
37766946|NCT04576455|69281812|FG000|Overall Study|Lost to Follow-up|1|||
37766947|NCT04576455|69281813|FG001|Overall Study|Lost to Follow-up|0|||
37766948|NCT04576455|69281812|FG000|Overall Study|Withdrawal by Subject|10|||
37766949|NCT04576455|69281813|FG001|Overall Study|Withdrawal by Subject|5|||
37766950|NCT04481243|69281824|FG000|Overall Study|Withdrawal by Subject|4|||
37766951|NCT04468230|69281828|FG000|Overall Study|Adverse Event|2|||
37766952|NCT04439175|69281845|FG000|Overall Study|Never started treatment|4|||
37766953|NCT04439175|69281845|FG000|Overall Study|Ineligible|5|||
37766954|NCT04439175|69281845|FG000|Overall Study|Adverse Event|6|||
37766955|NCT04439175|69281845|FG000|Overall Study|Death|4|||
37766956|NCT04439175|69281845|FG000|Overall Study|Disease progression|44|||
37766957|NCT04439175|69281845|FG000|Overall Study|Withdrawal by Subject|4|||
37766958|NCT04439175|69281845|FG000|Overall Study|Alternative Therapy|1|||
37766959|NCT04439175|69281845|FG000|Overall Study|Other|2|||
37766960|NCT04439136|69281849|FG000|Overall Study|Ineligible|1|||
37766961|NCT04439136|69281849|FG000|Overall Study|Never Started Treatment|2|||
37766962|NCT04439136|69281849|FG000|Overall Study|Adverse Event|4|||
37766963|NCT04439136|69281849|FG000|Overall Study|Death|3|||
37766964|NCT04439136|69281849|FG000|Overall Study|Disease Progression|27|||
37766965|NCT04439136|69281849|FG000|Overall Study|Alternative Therapy|1|||
37766966|NCT04439136|69281849|FG000|Overall Study|Increased Tumor Burden|1|||
37766967|NCT04439136|69281849|FG000|Overall Study|Symptomatic Detrioration|1|||
37766968|NCT04204902|69281882|FG000|Treatment Period 2 (Day 22)|Withdrawal by Subject|0|||
37766969|NCT04204902|69281883|FG001|Treatment Period 2 (Day 22)|Withdrawal by Subject|1|||
37766970|NCT04191616|69281889|FG000|Overall Study|Death|26|||
37766971|NCT04191616|69281889|FG000|Overall Study|Withdrawal by Subject|1|||
37766972|NCT04191616|69281889|FG000|Overall Study|Sponsor decision|2|||
37766973|NCT04191616|69281889|FG000|Overall Study|Continuing study|25|||
37766974|NCT04166383|69281893|FG000|Drug Administration|Prior to treatment (tx), had a medical emergency requiring surgery & was unable to have further tx.|1|||
37766975|NCT04166383|69281893|FG000|TAC 1 - Second Biopsy Cycle 2 Day 1|Did not complete 2nd biopsy.|2|||
37766976|NCT04166383|69281893|FG000|TAC 2 - Second Biopsy Cycle 4 Day 1|Did not complete 2nd biopsy.|1|||
37766977|NCT04163458|69281914|FG000|Overall Study|Protocol Deviation|7|||
37766978|NCT04163458|69281915|FG001|Overall Study|Protocol Deviation|13|||
37766979|NCT04163458|69281914|FG000|Overall Study|Adverse Event|5|||
37766980|NCT04163458|69281915|FG001|Overall Study|Adverse Event|8|||
37766981|NCT04163458|69281914|FG000|Overall Study|Due to COVID-19 pandemic|4|||
37766982|NCT04163458|69281915|FG001|Overall Study|Due to COVID-19 pandemic|2|||
37766983|NCT04163458|69281914|FG000|Overall Study|Participant withdrew consent|2|||
37766984|NCT04163458|69281915|FG001|Overall Study|Participant withdrew consent|3|||
37766985|NCT04163458|69281914|FG000|Overall Study|Randomization failure|2|||
37766986|NCT04163458|69281915|FG001|Overall Study|Randomization failure|2|||
37766987|NCT04163458|69281914|FG000|Overall Study|Other|4|||
37766988|NCT04163458|69281915|FG001|Overall Study|Other|2|||
37766989|NCT03834519|69281968|FG000|Overall Study|Ongoing|234|||
37766990|NCT03834519|69281969|FG001|Overall Study|Ongoing|111|||
37766991|NCT03834519|69281968|FG000|Overall Study|Withdrawal by Subject|4|||
37766992|NCT03834519|69281969|FG001|Overall Study|Withdrawal by Subject|7|||
37766993|NCT03834519|69281968|FG000|Overall Study|Death|291|||
37766994|NCT03834519|69281969|FG001|Overall Study|Death|146|||
38039058|NCT00082433|69726465|FG000|Overall Study|Death|8|||
37766995|NCT03783442|69281977|FG000|Overall Study|Remained on study (ongoing at time of DCO)|114|||
37766996|NCT03783442|69281978|FG001|Overall Study|Remained on study (ongoing at time of DCO)|77|||
37766997|NCT03783442|69281977|FG000|Overall Study|Death|196|||
37766998|NCT03783442|69281978|FG001|Overall Study|Death|226|||
37766999|NCT03783442|69281977|FG000|Overall Study|Withdrawal by Subject|14|||
37767000|NCT03783442|69281978|FG001|Overall Study|Withdrawal by Subject|17|||
37767001|NCT03783442|69281977|FG000|Overall Study|Lost to Follow-up|2|||
37767002|NCT03783442|69281978|FG001|Overall Study|Lost to Follow-up|3|||
37767003|NCT03734016|69281986|FG000|Overall Study|Participants Remaining in the Study|260|||
37767004|NCT03734016|69281987|FG001|Overall Study|Participants Remaining in the Study|240|||
37767005|NCT03734016|69281986|FG000|Overall Study|Death|48|||
37767006|NCT03734016|69281987|FG001|Overall Study|Death|60|||
37767007|NCT03734016|69281986|FG000|Overall Study|Withdrawal by Subject|14|||
37767008|NCT03734016|69281987|FG001|Overall Study|Withdrawal by Subject|16|||
37767009|NCT03734016|69281986|FG000|Overall Study|Physician Decision|0|||
37767010|NCT03734016|69281987|FG001|Overall Study|Physician Decision|7|||
37767011|NCT03734016|69281986|FG000|Overall Study|Lost to Follow-up|3|||
37767012|NCT03734016|69281987|FG001|Overall Study|Lost to Follow-up|1|||
37767013|NCT03734016|69281986|FG000|Overall Study|Adverse Event|2|||
37767014|NCT03734016|69281987|FG001|Overall Study|Adverse Event|1|||
37767015|NCT03725605|69281994|FG000|Overall Study|Unsuccessful TIL expansion|2|||
37767016|NCT03693300|69282000|FG000|Overall Study|Patients ongoing study|43|||
37767017|NCT03693300|69282001|FG001|Overall Study|Patients ongoing study|1|||
37767018|NCT03671564|69282012|FG000|Overall Study|Progressive Disease|3|||
37767019|NCT03671564|69282013|FG001|Overall Study|Progressive Disease|5|||
37767020|NCT03671564|69282014|FG002|Overall Study|Progressive Disease|3|||
37767021|NCT03671564|69282012|FG000|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
37767022|NCT03671564|69282013|FG001|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
37767023|NCT03671564|69282014|FG002|Overall Study|Confirmed TP53 Genotyping Mutation|1|||
37767024|NCT03671564|69282012|FG000|Overall Study|Withdrawal by Subject|1|||
37767025|NCT03671564|69282013|FG001|Overall Study|Withdrawal by Subject|1|||
37767026|NCT03671564|69282014|FG002|Overall Study|Withdrawal by Subject|0|||
37767027|NCT03632720|69282034|FG000|Overall Study|Adverse Event|2|||
37767028|NCT03632720|69282035|FG001|Overall Study|Adverse Event|0|||
37767029|NCT03632720|69282036|FG002|Overall Study|Adverse Event|0|||
37767030|NCT03632720|69282034|FG000|Overall Study|Lost to Follow-up|0|||
37767031|NCT03632720|69282035|FG001|Overall Study|Lost to Follow-up|1|||
37767032|NCT03632720|69282036|FG002|Overall Study|Lost to Follow-up|0|||
37767033|NCT03632720|69282034|FG000|Overall Study|Withdrawal by parent/legally acceptable representative|11|||
37767034|NCT03632720|69282035|FG001|Overall Study|Withdrawal by parent/legally acceptable representative|9|||
37767035|NCT03632720|69282036|FG002|Overall Study|Withdrawal by parent/legally acceptable representative|8|||
37767036|NCT03632720|69282034|FG000|Overall Study|Screen failure|0|||
37767037|NCT03632720|69282035|FG001|Overall Study|Screen failure|1|||
37767038|NCT03632720|69282036|FG002|Overall Study|Screen failure|0|||
37767039|NCT03606512|69282071|FG000|Overall Study|Lost to Follow-up|0|||
37767040|NCT03606512|69282072|FG001|Overall Study|Lost to Follow-up|1|||
37767041|NCT03606512|69282071|FG000|Overall Study|'moved from study area|0|||
37767042|NCT03606512|69282072|FG001|Overall Study|'moved from study area|1|||
37767043|NCT03398200|69282095|FG000|Overall Study|Withdrawal by Subject|0|||
37767044|NCT03398200|69282096|FG001|Overall Study|Withdrawal by Subject|1|||
37767045|NCT03323099|69282122|FG000|Overall Study|Withdrawal by Subject|6|||
37767046|NCT03323099|69282123|FG001|Overall Study|Withdrawal by Subject|12|||
37767047|NCT03323099|69282122|FG000|Overall Study|Did not complete AFEQT, or failed to start the study period|109|||
37767048|NCT03323099|69282123|FG001|Overall Study|Did not complete AFEQT, or failed to start the study period|52|||
37767049|NCT03323034|69282134|FG000|Overall Study|Lack of Efficacy|5|||
37767050|NCT03323034|69282135|FG001|Overall Study|Lack of Efficacy|5|||
37767051|NCT03323034|69282136|FG002|Overall Study|Lack of Efficacy|6|||
37767052|NCT03323034|69282137|FG003|Overall Study|Lack of Efficacy|5|||
37767053|NCT03323034|69282138|FG004|Overall Study|Lack of Efficacy|5|||
37767054|NCT03323034|69282134|FG000|Overall Study|Physician Decision|0|||
37767055|NCT03323034|69282135|FG001|Overall Study|Physician Decision|0|||
37767056|NCT03323034|69282136|FG002|Overall Study|Physician Decision|0|||
37767057|NCT03323034|69282137|FG003|Overall Study|Physician Decision|0|||
37767058|NCT03323034|69282138|FG004|Overall Study|Physician Decision|1|||
37767059|NCT03323034|69282134|FG000|Overall Study|Withdrawal by Subject|1|||
37767060|NCT03323034|69282135|FG001|Overall Study|Withdrawal by Subject|1|||
37767061|NCT03323034|69282136|FG002|Overall Study|Withdrawal by Subject|0|||
37767062|NCT03323034|69282137|FG003|Overall Study|Withdrawal by Subject|1|||
37767063|NCT03323034|69282138|FG004|Overall Study|Withdrawal by Subject|0|||
37767064|NCT03307252|69282162|FG000|Part 2, Period 1|Treatment not received|0|||
37767065|NCT03307252|69282163|FG001|Part 2, Period 1|Treatment not received|0|||
37767066|NCT03307252|69282164|FG002|Part 2, Period 1|Treatment not received|0|||
37767067|NCT03307252|69282165|FG003|Part 2, Period 1|Treatment not received|0|||
37767068|NCT03307252|69282166|FG004|Part 2, Period 1|Treatment not received|0|||
37767069|NCT03307252|69282167|FG005|Part 2, Period 1|Treatment not received|1|||
37767070|NCT03307252|69282168|FG006|Part 2, Period 1|Treatment not received|0|||
37767071|NCT03307252|69282169|FG007|Part 2, Period 1|Treatment not received|0|||
37767072|NCT03307252|69282170|FG008|Part 2, Period 1|Treatment not received|0|||
37767073|NCT03307252|69282171|FG009|Part 2, Period 1|Treatment not received|0|||
38039059|NCT00082433|69726466|FG001|Overall Study|Death|18|||
38039060|NCT00082433|69726465|FG000|Overall Study|Disease Progression/Relapse|270|||
38039061|NCT00082433|69726466|FG001|Overall Study|Disease Progression/Relapse|388|||
38039062|NCT00082433|69726465|FG000|Overall Study|Physician Decision|50|||
38039063|NCT00082433|69726466|FG001|Overall Study|Physician Decision|61|||
38039064|NCT00082433|69726465|FG000|Overall Study|Lost to Follow-up|1|||
37674965|NCT01970488|69149069|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
37674966|NCT01970488|69149070|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
37767074|NCT03307252|69282172|FG010|Part 2, Period 1|Treatment not received|0|||
37767075|NCT03307252|69282162|FG000|Part 2, Period 3|Other than listed|0|||
37767076|NCT03307252|69282163|FG001|Part 2, Period 3|Other than listed|0|||
37767077|NCT03307252|69282164|FG002|Part 2, Period 3|Other than listed|0|||
37767078|NCT03307252|69282165|FG003|Part 2, Period 3|Other than listed|0|||
37767079|NCT03307252|69282166|FG004|Part 2, Period 3|Other than listed|1|||
38039065|NCT00082433|69726466|FG001|Overall Study|Lost to Follow-up|2|||
38039066|NCT00082433|69726465|FG000|Overall Study|Study Drug Toxicity|179|||
37767080|NCT03307252|69282167|FG005|Part 2, Period 3|Other than listed|0|||
37767081|NCT03307252|69282168|FG006|Part 2, Period 3|Other than listed|0|||
37767082|NCT03307252|69282169|FG007|Part 2, Period 3|Other than listed|0|||
37767083|NCT03307252|69282170|FG008|Part 2, Period 3|Other than listed|0|||
37767084|NCT03307252|69282171|FG009|Part 2, Period 3|Other than listed|0|||
37767085|NCT03307252|69282172|FG010|Part 2, Period 3|Other than listed|0|||
37767086|NCT03307252|69282162|FG000|Part 2, Period 4|Other than listed|0|||
37767087|NCT03307252|69282163|FG001|Part 2, Period 4|Other than listed|0|||
37767088|NCT03307252|69282164|FG002|Part 2, Period 4|Other than listed|0|||
37767089|NCT03307252|69282165|FG003|Part 2, Period 4|Other than listed|0|||
37767090|NCT03307252|69282166|FG004|Part 2, Period 4|Other than listed|0|||
37767091|NCT03307252|69282167|FG005|Part 2, Period 4|Other than listed|0|||
37767092|NCT03307252|69282168|FG006|Part 2, Period 4|Other than listed|1|||
37767093|NCT03307252|69282169|FG007|Part 2, Period 4|Other than listed|0|||
37767094|NCT03307252|69282170|FG008|Part 2, Period 4|Other than listed|0|||
37767095|NCT03307252|69282171|FG009|Part 2, Period 4|Other than listed|0|||
37767096|NCT03307252|69282172|FG010|Part 2, Period 4|Other than listed|0|||
37767097|NCT03307252|69282162|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
37767098|NCT03307252|69282163|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
37767099|NCT03307252|69282164|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
37767100|NCT03307252|69282165|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
37767101|NCT03307252|69282166|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
37767102|NCT03307252|69282167|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
37767103|NCT03307252|69282168|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
37767104|NCT03307252|69282169|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
37767105|NCT03307252|69282170|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
37767106|NCT03307252|69282171|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
37767107|NCT03307252|69282172|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
37767108|NCT03286504|69282190|FG000|Overall Study|Lost to Follow-up|19|||
37767109|NCT03286504|69282191|FG001|Overall Study|Lost to Follow-up|16|||
37767110|NCT03191786|69282208|FG000|Overall Study|Death|236|||
37767111|NCT03191786|69282209|FG001|Overall Study|Death|127|||
37767112|NCT03191786|69282208|FG000|Overall Study|Lost to Follow-up|9|||
37767113|NCT03191786|69282209|FG001|Overall Study|Lost to Follow-up|3|||
37767114|NCT03191786|69282208|FG000|Overall Study|Physician Decision|1|||
37767115|NCT03191786|69282209|FG001|Overall Study|Physician Decision|0|||
37767116|NCT03191786|69282208|FG000|Overall Study|Study Terminated By Sponsor|15|||
37767117|NCT03191786|69282209|FG001|Overall Study|Study Terminated By Sponsor|5|||
37767118|NCT03191786|69282208|FG000|Overall Study|Withdrawal by Subject|26|||
37767119|NCT03191786|69282209|FG001|Overall Study|Withdrawal by Subject|16|||
37767120|NCT03138733|69282217|FG000|Overall Study|Death|17|||
37767121|NCT03138733|69282218|FG001|Overall Study|Death|18|||
37767122|NCT03138733|69282217|FG000|Overall Study|Withdrawal by Subject|11|||
37767123|NCT03138733|69282218|FG001|Overall Study|Withdrawal by Subject|6|||
37767124|NCT03138733|69282217|FG000|Overall Study|Lost to Follow-up|3|||
37767125|NCT03138733|69282218|FG001|Overall Study|Lost to Follow-up|2|||
37767126|NCT03138733|69282217|FG000|Overall Study|Adverse Event|1|||
37767127|NCT03138733|69282218|FG001|Overall Study|Adverse Event|0|||
37767128|NCT03138733|69282217|FG000|Overall Study|Protocol Violation|1|||
37767129|NCT03138733|69282218|FG001|Overall Study|Protocol Violation|3|||
37767130|NCT03138733|69282217|FG000|Overall Study|Administrative or logistical reason|1|||
37767131|NCT03138733|69282218|FG001|Overall Study|Administrative or logistical reason|0|||
37767132|NCT03138733|69282217|FG000|Overall Study|The patient was transferred to another hospital|1|||
37767133|NCT03138733|69282218|FG001|Overall Study|The patient was transferred to another hospital|0|||
37767134|NCT03117049|69282226|FG000|Overall Study|Continued the follow-up period|109|||
37767135|NCT03117049|69282227|FG001|Overall Study|Continued the follow-up period|129|||
37767136|NCT03117049|69282226|FG000|Overall Study|Died|82|||
37767137|NCT03117049|69282227|FG001|Overall Study|Died|93|||
37767138|NCT03117049|69282226|FG000|Overall Study|Consent withdrawal|7|||
37767139|NCT03117049|69282227|FG001|Overall Study|Consent withdrawal|6|||
37767140|NCT03117049|69282226|FG000|Overall Study|Missing contact|3|||
37767141|NCT03117049|69282227|FG001|Overall Study|Missing contact|3|||
37767142|NCT03057054|69282235|FG000|Overall Study|Death|4|||
37767143|NCT03057054|69282236|FG001|Overall Study|Death|4|||
37767144|NCT03057054|69282235|FG000|Overall Study|Withdrawal by Subject|6|||
37767145|NCT03057054|69282236|FG001|Overall Study|Withdrawal by Subject|3|||
37767146|NCT03057054|69282235|FG000|Overall Study|Ineligible|1|||
37767147|NCT03057054|69282236|FG001|Overall Study|Ineligible|1|||
37767148|NCT02854527|69282313|FG000|Overall Study|Adverse Event|0|||
37767149|NCT02854527|69282314|FG001|Overall Study|Adverse Event|0|||
37767150|NCT02854527|69282315|FG002|Overall Study|Adverse Event|0|||
37767151|NCT02854527|69282316|FG003|Overall Study|Adverse Event|0|||
37767152|NCT02854527|69282317|FG004|Overall Study|Adverse Event|1|||
37767153|NCT02854527|69282318|FG005|Overall Study|Adverse Event|0|||
37767154|NCT02854527|69282319|FG006|Overall Study|Adverse Event|0|||
37767155|NCT02854527|69282320|FG007|Overall Study|Adverse Event|0|||
37767156|NCT02854527|69282321|FG008|Overall Study|Adverse Event|0|||
37767157|NCT02854527|69282322|FG009|Overall Study|Adverse Event|0|||
37767158|NCT02854527|69282313|FG000|Overall Study|Lost to Follow-up|0|||
37767159|NCT02854527|69282314|FG001|Overall Study|Lost to Follow-up|0|||
37767160|NCT02854527|69282315|FG002|Overall Study|Lost to Follow-up|0|||
37767161|NCT02854527|69282316|FG003|Overall Study|Lost to Follow-up|1|||
37767162|NCT02854527|69282317|FG004|Overall Study|Lost to Follow-up|0|||
37767163|NCT02854527|69282318|FG005|Overall Study|Lost to Follow-up|0|||
37767164|NCT02854527|69282319|FG006|Overall Study|Lost to Follow-up|0|||
37767165|NCT02854527|69282320|FG007|Overall Study|Lost to Follow-up|0|||
37767166|NCT02854527|69282321|FG008|Overall Study|Lost to Follow-up|0|||
37767167|NCT02854527|69282322|FG009|Overall Study|Lost to Follow-up|0|||
37767168|NCT02842086|69282336|FG000|Overall Study|Randomized but Never Treated|6|||
37767169|NCT02842086|69282337|FG001|Overall Study|Randomized but Never Treated|6|||
37767170|NCT02842086|69282336|FG000|Overall Study|Still in Double-Blind Phase|7|||
37767171|NCT02842086|69282337|FG001|Overall Study|Still in Double-Blind Phase|3|||
37767172|NCT02842086|69282336|FG000|Overall Study|Adverse Event|18|||
37674967|NCT01970488|69149071|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
37674968|NCT01970488|69149072|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
37674969|NCT01970488|69149068|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
37674970|NCT01970488|69149069|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
37674971|NCT01970488|69149070|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
37674972|NCT01970488|69149071|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
37674973|NCT01970488|69149072|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
37674974|NCT02661217|69149089|FG000|Overall Study|Physician Decision|12|||
37674975|NCT02661217|69149090|FG001|Overall Study|Physician Decision|15|||
37674976|NCT02661217|69149089|FG000|Overall Study|Lost to Follow-up|1|||
37674977|NCT02661217|69149090|FG001|Overall Study|Lost to Follow-up|4|||
37674978|NCT02661217|69149089|FG000|Overall Study|Protocol Deviation|0|||
37674979|NCT02661217|69149090|FG001|Overall Study|Protocol Deviation|4|||
37674980|NCT02661217|69149089|FG000|Overall Study|Non-compliance with study treatment|5|||
37674981|NCT02661217|69149090|FG001|Overall Study|Non-compliance with study treatment|5|||
37674982|NCT02661217|69149089|FG000|Overall Study|Death|21|||
37674983|NCT02661217|69149090|FG001|Overall Study|Death|15|||
37674984|NCT02661217|69149089|FG000|Overall Study|Adverse Event|10|||
37674985|NCT02661217|69149090|FG001|Overall Study|Adverse Event|8|||
37674986|NCT02661217|69149089|FG000|Overall Study|Withdrawal by Subject|15|||
37674987|NCT02661217|69149090|FG001|Overall Study|Withdrawal by Subject|19|||
37674988|NCT02661217|69149089|FG000|Overall Study|Did not enter follow-up epoch|7|||
37674989|NCT02661217|69149090|FG001|Overall Study|Did not enter follow-up epoch|10|||
37674990|NCT02661217|69149089|FG000|Overall Study|Death - no study drug received|1|||
37674991|NCT02661217|69149090|FG001|Overall Study|Death - no study drug received|2|||
37674992|NCT02661217|69149089|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
37674993|NCT02661217|69149090|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
37674994|NCT01952080|69149101|FG000|Overall Study|Withdrawal by Subject|0|||
37674995|NCT01952080|69149102|FG001|Overall Study|Withdrawal by Subject|0|||
37674996|NCT01952080|69149103|FG002|Overall Study|Withdrawal by Subject|0|||
37674997|NCT01952080|69149104|FG003|Overall Study|Withdrawal by Subject|1|||
37674998|NCT01952080|69149101|FG000|Overall Study|Protocol Non-compliance|0|||
37674999|NCT01952080|69149102|FG001|Overall Study|Protocol Non-compliance|1|||
37675000|NCT01952080|69149103|FG002|Overall Study|Protocol Non-compliance|0|||
37675001|NCT01952080|69149104|FG003|Overall Study|Protocol Non-compliance|0|||
37675002|NCT01951378|69149116|FG000|Overall Study|Study Terminated-Not completed|23|||
37675003|NCT01951378|69149117|FG001|Overall Study|Study Terminated-Not completed|17|||
37675004|NCT01944670|69149123|FG000|Overall Study|Lost to Follow-up|2|||
37675005|NCT01361009|69149127|FG000|Overall Study|Protocol Violation|116|||
37675006|NCT01944046|69149133|FG000|Randomized to DB|Adverse Event|5|||
37675007|NCT01944046|69149134|FG001|Randomized to DB|Adverse Event|2|||
37675008|NCT01944046|69149133|FG000|Randomized to DB|Clinical Worsening|3|||
37675009|NCT01944046|69149134|FG001|Randomized to DB|Clinical Worsening|2|||
37675010|NCT01944046|69149133|FG000|Randomized to DB|Lost to Follow-up|3|||
37675011|NCT01944046|69149134|FG001|Randomized to DB|Lost to Follow-up|3|||
37675012|NCT01944046|69149133|FG000|Randomized to DB|Withdrawal by Subject|2|||
37675013|NCT01944046|69149134|FG001|Randomized to DB|Withdrawal by Subject|4|||
37675014|NCT01944046|69149133|FG000|Randomized to DB|Physician Decision|1|||
37675015|NCT01944046|69149134|FG001|Randomized to DB|Physician Decision|2|||
37675016|NCT01944046|69149133|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
37675017|NCT01944046|69149134|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
37945045|NCT00685178|69632571|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
37945046|NCT00685178|69632572|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
37945047|NCT00685178|69632569|FG000|Overall Study|voluntary study discharge|4|||
37945048|NCT00685178|69632570|FG001|Overall Study|voluntary study discharge|5|||
37675018|NCT01944046|69149133|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
37945049|NCT00685178|69632571|FG002|Overall Study|voluntary study discharge|1|||
37767173|NCT02842086|69282337|FG001|Overall Study|Adverse Event|20|||
37767174|NCT02842086|69282336|FG000|Overall Study|Death|3|||
37767175|NCT02842086|69282337|FG001|Overall Study|Death|3|||
37767176|NCT02842086|69282336|FG000|Overall Study|Investigator's Discretion|9|||
37767177|NCT02842086|69282337|FG001|Overall Study|Investigator's Discretion|13|||
37767178|NCT02842086|69282336|FG000|Overall Study|Non-Compliance with Study Drug|9|||
37767179|NCT02842086|69282337|FG001|Overall Study|Non-Compliance with Study Drug|8|||
37767180|NCT02842086|69282336|FG000|Overall Study|Protocol Violation|8|||
37767181|NCT02842086|69282337|FG001|Overall Study|Protocol Violation|4|||
37767182|NCT02842086|69282336|FG000|Overall Study|Withdrew Consent|205|||
37767183|NCT02842086|69282337|FG001|Overall Study|Withdrew Consent|194|||
37945050|NCT00685178|69632572|FG003|Overall Study|voluntary study discharge|1|||
37945051|NCT00685178|69632569|FG000|Overall Study|incarcerated|1|||
37945052|NCT00685178|69632570|FG001|Overall Study|incarcerated|3|||
37945053|NCT00685178|69632571|FG002|Overall Study|incarcerated|7|||
37945054|NCT00685178|69632572|FG003|Overall Study|incarcerated|0|||
37945055|NCT00685178|69632569|FG000|Overall Study|administrative (disciplinary) discharge|0|||
37945056|NCT00685178|69632570|FG001|Overall Study|administrative (disciplinary) discharge|1|||
37945057|NCT00685178|69632571|FG002|Overall Study|administrative (disciplinary) discharge|0|||
37945058|NCT00685178|69632572|FG003|Overall Study|administrative (disciplinary) discharge|2|||
37945059|NCT00685178|69632569|FG000|Overall Study|Pregnancy|0|||
37945060|NCT00685178|69632570|FG001|Overall Study|Pregnancy|0|||
37945061|NCT00685178|69632571|FG002|Overall Study|Pregnancy|0|||
37945062|NCT00685178|69632572|FG003|Overall Study|Pregnancy|1|||
37945063|NCT00537394|69632585|FG000|First Year of Follow-up|Death|7|||
37945064|NCT00537394|69632586|FG001|First Year of Follow-up|Death|0|||
37945065|NCT00537394|69632587|FG002|First Year of Follow-up|Death|0|||
37945066|NCT00537394|69632585|FG000|First Year of Follow-up|Severe debilitation|1|||
37945067|NCT00537394|69632586|FG001|First Year of Follow-up|Severe debilitation|0|||
37945068|NCT00537394|69632587|FG002|First Year of Follow-up|Severe debilitation|1|||
37945069|NCT00537394|69632585|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
37945070|NCT00537394|69632586|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
37945071|NCT00537394|69632587|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
37945072|NCT00537394|69632585|FG000|First Year of Follow-up|Lost to Follow-up|1|||
37945073|NCT00537394|69632586|FG001|First Year of Follow-up|Lost to Follow-up|5|||
37945074|NCT00537394|69632587|FG002|First Year of Follow-up|Lost to Follow-up|1|||
37945075|NCT00537394|69632585|FG000|2nd Year of Follow-up|Death|4|||
37945076|NCT00537394|69632586|FG001|2nd Year of Follow-up|Death|1|||
37945077|NCT00537394|69632587|FG002|2nd Year of Follow-up|Death|2|||
37945078|NCT00537394|69632585|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
37945079|NCT00537394|69632586|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
37945080|NCT00537394|69632587|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
37945081|NCT00537394|69632585|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
37945082|NCT00537394|69632586|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
37945083|NCT00537394|69632587|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
37945084|NCT00537394|69632585|FG000|2nd Year of Follow-up|Clinic site closure|1|||
37945085|NCT00537394|69632586|FG001|2nd Year of Follow-up|Clinic site closure|0|||
37945086|NCT00537394|69632587|FG002|2nd Year of Follow-up|Clinic site closure|0|||
37945087|NCT00352885|69632595|FG000|Overall Study|Withdrawal by Subject|0|||
37945088|NCT00352885|69632596|FG001|Overall Study|Withdrawal by Subject|3|||
37945089|NCT00352885|69632595|FG000|Overall Study|Development of major depression|0|||
37945090|NCT00352885|69632596|FG001|Overall Study|Development of major depression|1|||
37945091|NCT00352885|69632595|FG000|Overall Study|Progression of metastatic melanoma|5|||
37945092|NCT00352885|69632596|FG001|Overall Study|Progression of metastatic melanoma|3|||
37945093|NCT00352885|69632595|FG000|Overall Study|Side effects of IL-2 administration|1|||
37945094|NCT00352885|69632596|FG001|Overall Study|Side effects of IL-2 administration|0|||
37945095|NCT00660660|69632604|FG000|Overall Study|Adverse Event|1|||
37945096|NCT00660660|69632605|FG001|Overall Study|Adverse Event|0|||
37945097|NCT00660660|69632604|FG000|Overall Study|Lost to Follow-up|0|||
37945098|NCT00660660|69632605|FG001|Overall Study|Lost to Follow-up|6|||
37945099|NCT00660660|69632604|FG000|Overall Study|Lack of Efficacy|0|||
37675019|NCT01944046|69149134|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
37767184|NCT02842086|69282336|FG000|Overall Study|Lost to Follow-up|274|||
37767185|NCT02842086|69282337|FG001|Overall Study|Lost to Follow-up|236|||
37767186|NCT02842086|69282336|FG000|Overall Study|HIV-1 Infection|5|||
37767187|NCT02842086|69282337|FG001|Overall Study|HIV-1 Infection|6|||
37767188|NCT02772081|69282345|FG000|Overall Study|Physician Decision|1|||
37945100|NCT00660660|69632605|FG001|Overall Study|Lack of Efficacy|2|||
37945101|NCT00660660|69632604|FG000|Overall Study|Withdrawal by Subject|3|||
37945102|NCT00660660|69632605|FG001|Overall Study|Withdrawal by Subject|0|||
37945103|NCT00660660|69632604|FG000|Overall Study|Incorrect enrollment and other|0|||
37945104|NCT00660660|69632605|FG001|Overall Study|Incorrect enrollment and other|1|||
37945105|NCT00660660|69632604|FG000|Overall Study|New medication after randomization|1|||
37945106|NCT00660660|69632605|FG001|Overall Study|New medication after randomization|0|||
37945107|NCT00344305|69632613|FG000|Overall Study|Lost to Follow-up|2|||
37945108|NCT00344305|69632614|FG001|Overall Study|Lost to Follow-up|0|||
38039067|NCT00082433|69726466|FG001|Overall Study|Study Drug Toxicity|66|||
38039068|NCT00082433|69726465|FG000|Overall Study|Withdrawal by Subject|55|||
38039069|NCT00082433|69726466|FG001|Overall Study|Withdrawal by Subject|30|||
38039070|NCT00082433|69726465|FG000|Overall Study|Still On Treatment|2|||
38039071|NCT00082433|69726466|FG001|Overall Study|Still On Treatment|1|||
38039072|NCT00082433|69726465|FG000|Overall Study|Not Treated|12|||
38039073|NCT00082433|69726466|FG001|Overall Study|Not Treated|11|||
38039074|NCT00082433|69726465|FG000|Overall Study|Ineligible|2|||
38039075|NCT00082433|69726466|FG001|Overall Study|Ineligible|1|||
38039076|NCT00082433|69726465|FG000|Overall Study|Noncompliance|2|||
38039077|NCT00082433|69726466|FG001|Overall Study|Noncompliance|1|||
38039078|NCT00082433|69726465|FG000|Overall Study|New primary cancer|1|||
38039079|NCT00082433|69726466|FG001|Overall Study|New primary cancer|0|||
38039080|NCT00082433|69726465|FG000|Overall Study|Impending surgery|0|||
38039081|NCT00082433|69726466|FG001|Overall Study|Impending surgery|1|||
38039082|NCT00094445|69726472|FG000|Overall Study|Withdrawal by Subject|3|||
38039083|NCT00094445|69726472|FG000|Overall Study|Lost to Follow-up|1|||
38039084|NCT00094445|69726472|FG000|Overall Study|Progressive Disease|2|||
37675020|NCT01944046|69149133|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
37675021|NCT01944046|69149134|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
37675022|NCT01944046|69149133|FG000|Open Label Eligible and Consented|Adverse Event|6|||
37675023|NCT01944046|69149134|FG001|Open Label Eligible and Consented|Adverse Event|1|||
37675024|NCT01944046|69149133|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
37675025|NCT01944046|69149134|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
37675026|NCT01944046|69149133|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
37675027|NCT01944046|69149134|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
37675028|NCT01969084|69149146|FG000|Overall Study|Adverse Event|0|||
37675029|NCT01969084|69149147|FG001|Overall Study|Adverse Event|1|||
37675030|NCT01942486|69149157|FG000|Overall Study|Lost to Follow-up|27|||
37675031|NCT01941940|69149161|FG000|Overall Study|Adverse Event|11|||
37675032|NCT01941940|69149161|FG000|Overall Study|Lost to Follow-up|2|||
37675033|NCT01941940|69149161|FG000|Overall Study|Physician Decision|2|||
37675034|NCT01941940|69149161|FG000|Overall Study|Withdrawal by Subject|15|||
37675035|NCT01941940|69149161|FG000|Overall Study|Death|1|||
37675036|NCT01941940|69149161|FG000|Overall Study|Other|1|||
37675037|NCT01941940|69149161|FG000|Overall Study|Other|1|||
37675038|NCT01968694|69149167|FG000|Washout (1 Month)|Lost to Follow-up|0|||
37675039|NCT01968694|69149168|FG001|Washout (1 Month)|Lost to Follow-up|1|||
37675040|NCT01968226|69149176|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
37675041|NCT02640053|69149182|FG000|Overall Study|Withdrawal by Subject|2|||
37675042|NCT02640053|69149183|FG001|Overall Study|Withdrawal by Subject|1|||
37675043|NCT02640053|69149182|FG000|Overall Study|Adverse Event|1|||
37675044|NCT02640053|69149183|FG001|Overall Study|Adverse Event|1|||
37675045|NCT02640053|69149182|FG000|Overall Study|Alternative Therapy|1|||
37675046|NCT02640053|69149183|FG001|Overall Study|Alternative Therapy|1|||
37675047|NCT02640053|69149182|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
37945109|NCT00344305|69632613|FG000|Overall Study|Participant was not contacted in window|0|||
37945110|NCT00344305|69632614|FG001|Overall Study|Participant was not contacted in window|1|||
37945111|NCT00660816|69632623|FG000|Overall Study|Adverse Event|1|||
37945112|NCT00660816|69632624|FG001|Overall Study|Adverse Event|2|||
37945113|NCT00660816|69632623|FG000|Overall Study|Withdrawal by Subject|1|||
37945114|NCT00660816|69632624|FG001|Overall Study|Withdrawal by Subject|0|||
37945115|NCT00660816|69632623|FG000|Overall Study|Death|0|||
37945116|NCT00660816|69632624|FG001|Overall Study|Death|2|||
37945117|NCT00660816|69632623|FG000|Overall Study|Lack of Efficacy|1|||
37945118|NCT00660816|69632624|FG001|Overall Study|Lack of Efficacy|0|||
37945119|NCT00660816|69632623|FG000|Overall Study|Physician Decision|0|||
37945120|NCT00660816|69632624|FG001|Overall Study|Physician Decision|2|||
37945121|NCT00660816|69632623|FG000|Overall Study|Protocol Violation|1|||
37945122|NCT00660816|69632624|FG001|Overall Study|Protocol Violation|0|||
37945123|NCT00660816|69632623|FG000|Overall Study|Disease Progression|16|||
37945124|NCT00660816|69632624|FG001|Overall Study|Disease Progression|12|||
38039085|NCT00082355|69726476|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
37767189|NCT02772081|69282346|FG001|Overall Study|Physician Decision|1|||
37767190|NCT02772081|69282345|FG000|Overall Study|Death|1|||
38039086|NCT00082355|69726476|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
38039087|NCT00082355|69726476|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
38039088|NCT00094055|69726480|FG000|Overall Study|Adverse Event|11|||
38039089|NCT00094055|69726480|FG000|Overall Study|Death|4|||
37675048|NCT02640053|69149183|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
37675049|NCT01950364|69149191|FG000|Overall Study|Adverse Event|3|||
37675050|NCT01950364|69149192|FG001|Overall Study|Adverse Event|0|||
37675051|NCT01950364|69149191|FG000|Overall Study|Stem Cell Transplant|2|||
37767191|NCT02772081|69282346|FG001|Overall Study|Death|1|||
37945125|NCT00660816|69632623|FG000|Overall Study|Complicating Disease|0|||
37945126|NCT00660816|69632624|FG001|Overall Study|Complicating Disease|1|||
37945127|NCT00576056|69632630|FG000|Overall Study|Adverse Event|1|||
37945128|NCT00576056|69632630|FG000|Overall Study|Death|1|||
37945129|NCT00576056|69632630|FG000|Overall Study|Lack of Efficacy|1|||
37945130|NCT00576056|69632630|FG000|Overall Study|Withdrawal by Subject|2|||
37945131|NCT00576056|69632630|FG000|Overall Study|did not meet eligibility criteria|8|||
37945132|NCT00576056|69632630|FG000|Overall Study|Physician Decision|1|||
37945133|NCT00575510|69632637|FG000|Overall Study|Lost to Follow-up|4|||
37945134|NCT00575510|69632638|FG001|Overall Study|Lost to Follow-up|6|||
37945135|NCT00575510|69632639|FG002|Overall Study|Lost to Follow-up|9|||
37945136|NCT00575510|69632637|FG000|Overall Study|Withdrawal by Subject|1|||
37945137|NCT00575510|69632638|FG001|Overall Study|Withdrawal by Subject|0|||
37945138|NCT00575510|69632639|FG002|Overall Study|Withdrawal by Subject|0|||
37945139|NCT00575510|69632637|FG000|Overall Study|Clinic Called Patient|7|||
37945140|NCT00575510|69632638|FG001|Overall Study|Clinic Called Patient|7|||
37945141|NCT00575510|69632639|FG002|Overall Study|Clinic Called Patient|7|||
37945142|NCT00575510|69632637|FG000|Overall Study|Pregnancy|0|||
37945143|NCT00575510|69632638|FG001|Overall Study|Pregnancy|0|||
37945144|NCT00575510|69632639|FG002|Overall Study|Pregnancy|1|||
37945145|NCT02636439|69632650|FG000|Overall Study|Adverse Event|2|||
37945146|NCT02636439|69632651|FG001|Overall Study|Adverse Event|2|||
37945147|NCT02636439|69632650|FG000|Overall Study|Lost to Follow-up|1|||
37945148|NCT02636439|69632651|FG001|Overall Study|Lost to Follow-up|0|||
37945149|NCT02636439|69632650|FG000|Overall Study|Non-compliance|1|||
37945150|NCT02636439|69632651|FG001|Overall Study|Non-compliance|1|||
37945151|NCT02636439|69632650|FG000|Overall Study|Personal reasons|2|||
37945152|NCT02636439|69632651|FG001|Overall Study|Personal reasons|0|||
37945153|NCT00343915|69632659|FG000|Primary Study|Withdrawal by Subject|1|||
37945154|NCT00343915|69632660|FG001|Primary Study|Withdrawal by Subject|0|||
37945155|NCT00343915|69632659|FG000|Primary Study|Lost to Follow-up|2|||
37945156|NCT00343915|69632660|FG001|Primary Study|Lost to Follow-up|3|||
37945157|NCT00343915|69632659|FG000|Primary Study|Other|1|||
37945158|NCT00343915|69632660|FG001|Primary Study|Other|0|||
37945159|NCT00575666|69632671|FG000|Overall Study|Withdrawal by Subject|3|||
37945160|NCT00575666|69632672|FG001|Overall Study|Withdrawal by Subject|2|||
37945161|NCT00575666|69632671|FG000|Overall Study|Physician Decision|1|||
37945162|NCT00575666|69632672|FG001|Overall Study|Physician Decision|1|||
37945163|NCT00658632|69632680|FG000|Overall Study|Adverse Event|13|||
37945164|NCT00658632|69632681|FG001|Overall Study|Adverse Event|11|||
37945165|NCT00658632|69632680|FG000|Overall Study|Lost to Follow-up|25|||
37945166|NCT00658632|69632681|FG001|Overall Study|Lost to Follow-up|23|||
37945167|NCT00658632|69632680|FG000|Overall Study|Withdrawal by Subject|10|||
37945168|NCT00658632|69632681|FG001|Overall Study|Withdrawal by Subject|7|||
37945169|NCT00658632|69632680|FG000|Overall Study|Lack of Efficacy|0|||
37945170|NCT00658632|69632681|FG001|Overall Study|Lack of Efficacy|1|||
37945171|NCT00658632|69632680|FG000|Overall Study|Withdrawal of consent|8|||
37945172|NCT00658632|69632681|FG001|Overall Study|Withdrawal of consent|14|||
37945173|NCT00658632|69632680|FG000|Overall Study|Pregnancy|1|||
37945174|NCT00658632|69632681|FG001|Overall Study|Pregnancy|1|||
37945175|NCT00658632|69632680|FG000|Overall Study|Other|7|||
37945176|NCT00658632|69632681|FG001|Overall Study|Other|8|||
37945177|NCT00677534|69632687|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
37945178|NCT00677534|69632687|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
37945179|NCT00677534|69632687|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
37945180|NCT00660348|69632693|FG000|Overall Study|Withdrawal by Subject|1|||
37945181|NCT00660348|69632694|FG001|Overall Study|Withdrawal by Subject|0|||
37945182|NCT00660192|69632702|FG000|Overall Study|Lost to Follow-up|2|||
37945183|NCT00660192|69632703|FG001|Overall Study|Lost to Follow-up|3|||
37945184|NCT00571688|69632711|FG000|Overall Study|Lost to Follow-up|3|||
37945185|NCT00571688|69632712|FG001|Overall Study|Lost to Follow-up|6|||
37945186|NCT00571688|69632711|FG000|Overall Study|subject did not tolerate Consta|1|||
37945187|NCT00571688|69632712|FG001|Overall Study|subject did not tolerate Consta|0|||
37945188|NCT00571688|69632711|FG000|Overall Study|subject moved out of the area|1|||
37945189|NCT00571688|69632712|FG001|Overall Study|subject moved out of the area|0|||
37945190|NCT00343291|69632720|FG000|Overall Study|Adverse Event|13|||
38039090|NCT00094055|69726480|FG000|Overall Study|Lack of Efficacy|17|||
37945191|NCT00343291|69632721|FG001|Overall Study|Adverse Event|13|||
37945192|NCT00343291|69632720|FG000|Overall Study|Death|3|||
37945193|NCT00343291|69632721|FG001|Overall Study|Death|2|||
37945194|NCT00343291|69632720|FG000|Overall Study|Progressive disease|33|||
37945195|NCT00343291|69632721|FG001|Overall Study|Progressive disease|34|||
37945196|NCT00343291|69632720|FG000|Overall Study|Withdrawal by Subject|0|||
37945197|NCT00343291|69632721|FG001|Overall Study|Withdrawal by Subject|2|||
38039091|NCT00094055|69726480|FG000|Overall Study|Lost to Follow-up|2|||
37945198|NCT00343291|69632720|FG000|Overall Study|Other|8|||
37945199|NCT00343291|69632721|FG001|Overall Study|Other|5|||
37945200|NCT00658788|69632727|FG000|Overall Study|Adverse Event|11|||
37945201|NCT00658788|69632727|FG000|Overall Study|Withdrawal by Subject|13|||
37945202|NCT00658788|69632727|FG000|Overall Study|Lost to Follow-up|18|||
38039092|NCT00094055|69726480|FG000|Overall Study|progressive disease|2|||
37945203|NCT00658788|69632727|FG000|Overall Study|Treatment Discontinuation|32|||
37945204|NCT04829214|69632742|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
37945205|NCT04829214|69632743|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
37945206|NCT04829214|69632742|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
37945207|NCT04829214|69632743|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
37945208|NCT00562965|69632753|FG000|Overall Study|Withdrawal by Subject|0|||
37945209|NCT00562965|69632754|FG001|Overall Study|Withdrawal by Subject|1|||
37945210|NCT00562965|69632753|FG000|Overall Study|Death|2|||
37945211|NCT00562965|69632754|FG001|Overall Study|Death|4|||
37945212|NCT00562965|69632753|FG000|Overall Study|Lost to Follow-up|1|||
37945213|NCT00562965|69632754|FG001|Overall Study|Lost to Follow-up|0|||
37945214|NCT00562965|69632753|FG000|Overall Study|Other|0|||
37945215|NCT00562965|69632754|FG001|Overall Study|Other|1|||
37945216|NCT00537082|69632763|FG000|Overall Study|Adverse Event|6|||
37945217|NCT00537082|69632764|FG001|Overall Study|Adverse Event|6|||
37945218|NCT00537082|69632765|FG002|Overall Study|Adverse Event|3|||
37945219|NCT00537082|69632763|FG000|Overall Study|Protocol Violation|0|||
37945220|NCT00537082|69632764|FG001|Overall Study|Protocol Violation|2|||
37945221|NCT00537082|69632765|FG002|Overall Study|Protocol Violation|1|||
37945222|NCT00537082|69632763|FG000|Overall Study|Lack of Efficacy|0|||
37945223|NCT00537082|69632764|FG001|Overall Study|Lack of Efficacy|0|||
37945224|NCT00537082|69632765|FG002|Overall Study|Lack of Efficacy|2|||
37945225|NCT00537082|69632763|FG000|Overall Study|Withdrawal by Subject|0|||
37945226|NCT00537082|69632764|FG001|Overall Study|Withdrawal by Subject|1|||
37945227|NCT00537082|69632765|FG002|Overall Study|Withdrawal by Subject|0|||
37945228|NCT00537082|69632763|FG000|Overall Study|Discontinued before initiating treatment|3|||
37945229|NCT00537082|69632764|FG001|Overall Study|Discontinued before initiating treatment|0|||
37945230|NCT00537082|69632765|FG002|Overall Study|Discontinued before initiating treatment|0|||
37945231|NCT03828487|69632773|FG000|Overall Study|Physician Decision|1|||
37945232|NCT00324961|69632777|FG000|Overall Study|Adverse Event|5|||
37945233|NCT00324961|69632777|FG000|Overall Study|Consent Withdrawn|11|||
37945234|NCT00324961|69632777|FG000|Overall Study|Lost to Follow-up|22|||
37945235|NCT00324961|69632777|FG000|Overall Study|Protocol Violation|3|||
37945236|NCT00324961|69632777|FG000|Overall Study|Other|2|||
37945237|NCT00324649|69632785|FG000|Overall Study|Adverse Event|1|||
37945238|NCT00324649|69632786|FG001|Overall Study|Adverse Event|4|||
37945239|NCT00324649|69632785|FG000|Overall Study|Withdrawal by Subject|0|||
37945240|NCT00324649|69632786|FG001|Overall Study|Withdrawal by Subject|1|||
37945241|NCT00324649|69632785|FG000|Overall Study|Noncompliance|1|||
37945242|NCT00324649|69632786|FG001|Overall Study|Noncompliance|0|||
37945243|NCT00656370|69632792|FG000|Overall Study|Screen Failures|7|||
37945244|NCT00656370|69632792|FG000|Overall Study|Alternates|3|||
37945245|NCT00680186|69632800|FG000|Overall Study|Adverse Event|47|||
37945246|NCT00680186|69632801|FG001|Overall Study|Adverse Event|44|||
37945247|NCT00680186|69632800|FG000|Overall Study|Protocol Violation|31|||
37945248|NCT00680186|69632801|FG001|Overall Study|Protocol Violation|26|||
37945249|NCT00680186|69632800|FG000|Overall Study|Lost to Follow-up|11|||
37945250|NCT00680186|69632801|FG001|Overall Study|Lost to Follow-up|6|||
37945251|NCT00680186|69632800|FG000|Overall Study|Withdrawal by Subject|32|||
37945252|NCT00680186|69632801|FG001|Overall Study|Withdrawal by Subject|39|||
37945253|NCT00680186|69632800|FG000|Overall Study|Other|4|||
37945254|NCT00680186|69632801|FG001|Overall Study|Other|1|||
37945255|NCT00656292|69632809|FG000|Overall Study|Withdrawal by Subject|2|||
37945256|NCT00656292|69632810|FG001|Overall Study|Withdrawal by Subject|3|||
37945257|NCT00656292|69632809|FG000|Overall Study|Screen failure|1|||
37945258|NCT00656292|69632810|FG001|Overall Study|Screen failure|2|||
37945259|NCT00352417|69632818|FG000|Overall Study|Adverse Event|1|||
37945260|NCT00352417|69632819|FG001|Overall Study|Adverse Event|0|||
37945261|NCT00352417|69632818|FG000|Overall Study|Protocol Violation|0|||
37945262|NCT00352417|69632819|FG001|Overall Study|Protocol Violation|2|||
37945263|NCT00352417|69632818|FG000|Overall Study|Withdrawal by Subject|1|||
37945264|NCT00352417|69632819|FG001|Overall Study|Withdrawal by Subject|2|||
37945265|NCT00352417|69632818|FG000|Overall Study|Lost to Follow-up|1|||
37945266|NCT00352417|69632819|FG001|Overall Study|Lost to Follow-up|0|||
37945267|NCT00352417|69632818|FG000|Overall Study|Schedule Change|2|||
37945268|NCT00352417|69632819|FG001|Overall Study|Schedule Change|1|||
37945269|NCT00323869|69632825|FG000|Overall Study|Death|1|||
37945270|NCT00323557|69632831|FG000|Overall Study|Physician Decision|1|||
37945271|NCT00323557|69632832|FG001|Overall Study|Physician Decision|0|||
37945272|NCT00558363|69632841|FG000|Overall Study|Physician Decision|18|||
37945273|NCT00558363|69632842|FG001|Overall Study|Physician Decision|4|||
37945274|NCT00558363|69632841|FG000|Overall Study|Withdrawal by Subject|11|||
37945275|NCT00558363|69632842|FG001|Overall Study|Withdrawal by Subject|4|||
37945276|NCT00558363|69632841|FG000|Overall Study|Adverse Event|5|||
37945277|NCT00558363|69632842|FG001|Overall Study|Adverse Event|5|||
37945278|NCT00558363|69632841|FG000|Overall Study|Lack of Efficacy|2|||
37945279|NCT00558363|69632842|FG001|Overall Study|Lack of Efficacy|2|||
37945280|NCT00558363|69632841|FG000|Overall Study|Protocol Violation|2|||
37945281|NCT00558363|69632842|FG001|Overall Study|Protocol Violation|1|||
37945282|NCT00558363|69632841|FG000|Overall Study|Lost to Follow-up|0|||
37945283|NCT00558363|69632842|FG001|Overall Study|Lost to Follow-up|1|||
37945284|NCT00558363|69632841|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
37945285|NCT00558363|69632842|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
37945286|NCT00558363|69632841|FG000|Overall Study|Randomized in Error|1|||
37945287|NCT00558363|69632842|FG001|Overall Study|Randomized in Error|2|||
37945288|NCT00558363|69632841|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
37945289|NCT00558363|69632842|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
37945290|NCT00323479|69632848|FG000|Overall Study|Adverse Event|2|||
37945291|NCT00323479|69632848|FG000|Overall Study|Withdrawal by Subject|2|||
37945292|NCT00323479|69632848|FG000|Overall Study|Protocol Violation|3|||
37945293|NCT00323479|69632848|FG000|Overall Study|house moving|1|||
37945294|NCT00352105|69632852|FG000|Overall Study|Death|5|||
37945295|NCT00352105|69632852|FG000|Overall Study|Withdrawal by Subject|5|||
37945296|NCT00352105|69632852|FG000|Overall Study|Lack of Efficacy|9|||
37945297|NCT00352105|69632852|FG000|Overall Study|Adverse Event|19|||
37945298|NCT00352105|69632852|FG000|Overall Study|Protocol Violation|2|||
37945299|NCT00350779|69632858|FG000|Overall Study|Adverse Event|4|||
37945300|NCT00350779|69632859|FG001|Overall Study|Adverse Event|2|||
37945301|NCT00350779|69632858|FG000|Overall Study|Lack of Efficacy|0|||
37945302|NCT00350779|69632859|FG001|Overall Study|Lack of Efficacy|4|||
37945303|NCT00350779|69632858|FG000|Overall Study|Lost to Follow-up|2|||
37945304|NCT00350779|69632859|FG001|Overall Study|Lost to Follow-up|0|||
37945305|NCT00350779|69632858|FG000|Overall Study|Physician Decision|2|||
37945306|NCT00350779|69632859|FG001|Overall Study|Physician Decision|4|||
37945307|NCT00350779|69632858|FG000|Overall Study|Protocol Violation|3|||
37945308|NCT00350779|69632859|FG001|Overall Study|Protocol Violation|1|||
37945309|NCT00350779|69632858|FG000|Overall Study|Withdrawal by Subject|9|||
37945310|NCT00350779|69632859|FG001|Overall Study|Withdrawal by Subject|8|||
37945311|NCT00350779|69632858|FG000|Overall Study|Patient Moved|2|||
37945312|NCT00350779|69632859|FG001|Overall Study|Patient Moved|1|||
37945313|NCT00350779|69632858|FG000|Overall Study|Non-compliance with study procedures|0|||
37945314|NCT00350779|69632859|FG001|Overall Study|Non-compliance with study procedures|1|||
37945315|NCT00350623|69632870|FG000|Overall Study|Lost to Follow-up|8|||
37945316|NCT00350623|69632871|FG001|Overall Study|Lost to Follow-up|3|||
37945317|NCT00350623|69632872|FG002|Overall Study|Lost to Follow-up|4|||
37945318|NCT00350623|69632870|FG000|Overall Study|Withdrawal by Subject|0|||
37945319|NCT00350623|69632871|FG001|Overall Study|Withdrawal by Subject|1|||
37945320|NCT00350623|69632872|FG002|Overall Study|Withdrawal by Subject|1|||
37945321|NCT00350623|69632870|FG000|Overall Study|patient traveling outside the country|0|||
37945322|NCT00350623|69632871|FG001|Overall Study|patient traveling outside the country|0|||
37945323|NCT00350623|69632872|FG002|Overall Study|patient traveling outside the country|1|||
37945324|NCT00656136|69632882|FG000|Overall Study|Progressive disease|177|||
37945325|NCT00656136|69632883|FG001|Overall Study|Progressive disease|322|||
37945326|NCT00656136|69632882|FG000|Overall Study|Other Adverse Event|5|||
37945327|NCT00656136|69632883|FG001|Overall Study|Other Adverse Event|51|||
37945328|NCT00656136|69632882|FG000|Overall Study|Protocol Violation|2|||
37945329|NCT00656136|69632883|FG001|Overall Study|Protocol Violation|3|||
37945330|NCT00656136|69632882|FG000|Overall Study|Patient refused to take study medication|7|||
37945331|NCT00656136|69632883|FG001|Overall Study|Patient refused to take study medication|10|||
37945332|NCT00656136|69632882|FG000|Overall Study|Unknown and others|4|||
37945333|NCT00656136|69632883|FG001|Overall Study|Unknown and others|4|||
37945334|NCT00676520|69632889|FG000|Overall Study|Withdrawal by Subject|163|||
37945335|NCT00676520|69632889|FG000|Overall Study|Lost to Follow-up|162|||
37945336|NCT00676520|69632889|FG000|Overall Study|Death|159|||
37945337|NCT00676520|69632889|FG000|Overall Study|Physician Decision|20|||
37945338|NCT00676520|69632889|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
37945339|NCT00676520|69632889|FG000|Overall Study|Other Reason|18|||
37945340|NCT00652938|69632901|FG000|Overall Study|Adverse Event|1|||
37945341|NCT00652938|69632902|FG001|Overall Study|Adverse Event|0|||
37945342|NCT00652938|69632903|FG002|Overall Study|Adverse Event|2|||
37945343|NCT00652938|69632901|FG000|Overall Study|Withdrawal by Subject|0|||
37945344|NCT00652938|69632902|FG001|Overall Study|Withdrawal by Subject|6|||
37767192|NCT02639559|69282363|FG000|Overall Study|Mobilization failure|0|||
37767193|NCT02639559|69282364|FG001|Overall Study|Mobilization failure|3|||
37945345|NCT00652938|69632903|FG002|Overall Study|Withdrawal by Subject|1|||
37945346|NCT00652938|69632901|FG000|Overall Study|Lost to Follow-up|0|||
37945347|NCT00652938|69632902|FG001|Overall Study|Lost to Follow-up|0|||
37945348|NCT00652938|69632903|FG002|Overall Study|Lost to Follow-up|2|||
37945349|NCT00652938|69632901|FG000|Overall Study|fear of blood sampling|0|||
37945350|NCT00652938|69632902|FG001|Overall Study|fear of blood sampling|1|||
37945351|NCT00652938|69632903|FG002|Overall Study|fear of blood sampling|0|||
37945352|NCT00322621|69632911|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
37945353|NCT00322621|69632912|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
37945354|NCT00322621|69632913|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
37945355|NCT00322621|69632911|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
37945356|NCT00322621|69632912|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
37945357|NCT00322621|69632913|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
37945358|NCT00322621|69632911|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
37945359|NCT00322621|69632912|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
37945360|NCT00322621|69632913|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
37945361|NCT00322621|69632911|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
37945362|NCT00322621|69632912|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
37945363|NCT00322621|69632913|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
37945364|NCT00322621|69632911|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
37945365|NCT00322621|69632912|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
37945366|NCT00322621|69632913|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
37945367|NCT00322621|69632911|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
37945368|NCT00322621|69632912|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
37945369|NCT00322621|69632913|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
37945370|NCT00322621|69632911|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
37945371|NCT00322621|69632912|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
37945372|NCT00322621|69632913|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
37945373|NCT00322621|69632911|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
37945374|NCT00322621|69632912|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
37945375|NCT00322621|69632913|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
37945376|NCT00322621|69632911|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
37945377|NCT00322621|69632912|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
37945378|NCT00322621|69632913|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
37945379|NCT00322621|69632911|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
37945380|NCT00322621|69632912|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
37945381|NCT00322621|69632913|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
37945382|NCT00322621|69632911|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
37945383|NCT00322621|69632912|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
37945384|NCT00322621|69632913|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
37945385|NCT00575042|69632926|FG000|Overall Study|Adverse Event|2|||
37945386|NCT00575042|69632926|FG000|Overall Study|Lost to Follow-up|1|||
37945387|NCT00676208|69632933|FG000|Overall Study|Lost to Follow-up|0|||
37945388|NCT00676208|69632934|FG001|Overall Study|Lost to Follow-up|2|||
37945389|NCT00676208|69632933|FG000|Overall Study|Incomplete data|2|||
37945390|NCT00676208|69632934|FG001|Overall Study|Incomplete data|4|||
37945391|NCT00656058|69632942|FG000|Overall Study|Withdrawal by Subject|2|||
37945392|NCT00656058|69632942|FG000|Overall Study|Withdrawal by Subject|4|||
37945393|NCT00537316|69632952|FG000|Part 1|Adverse Event|7|||
37945394|NCT00537316|69632953|FG001|Part 1|Adverse Event|11|||
37945395|NCT00537316|69632954|FG002|Part 1|Adverse Event|8|||
37945396|NCT00537316|69632955|FG003|Part 1|Adverse Event|0|||
37945397|NCT00537316|69632956|FG004|Part 1|Adverse Event|0|||
37945398|NCT00537316|69632957|FG005|Part 1|Adverse Event|0|||
37945399|NCT00537316|69632958|FG006|Part 1|Adverse Event|0|||
37945400|NCT00537316|69632952|FG000|Part 1|Protocol defined clinical event|1|||
37945401|NCT00537316|69632953|FG001|Part 1|Protocol defined clinical event|0|||
37945402|NCT00537316|69632954|FG002|Part 1|Protocol defined clinical event|0|||
37945403|NCT00537316|69632955|FG003|Part 1|Protocol defined clinical event|0|||
37945404|NCT00537316|69632956|FG004|Part 1|Protocol defined clinical event|0|||
37945405|NCT00537316|69632957|FG005|Part 1|Protocol defined clinical event|0|||
37945406|NCT00537316|69632958|FG006|Part 1|Protocol defined clinical event|0|||
37945407|NCT00537316|69632952|FG000|Part 1|Lost to Follow-up|1|||
37945408|NCT00537316|69632953|FG001|Part 1|Lost to Follow-up|0|||
37945409|NCT00537316|69632954|FG002|Part 1|Lost to Follow-up|0|||
37945410|NCT00537316|69632955|FG003|Part 1|Lost to Follow-up|0|||
37945411|NCT00537316|69632956|FG004|Part 1|Lost to Follow-up|0|||
37945412|NCT00537316|69632957|FG005|Part 1|Lost to Follow-up|0|||
37945413|NCT00537316|69632958|FG006|Part 1|Lost to Follow-up|0|||
37945414|NCT00537316|69632952|FG000|Part 1|Withdrawal by Subject|3|||
37945415|NCT00537316|69632953|FG001|Part 1|Withdrawal by Subject|8|||
37945416|NCT00537316|69632954|FG002|Part 1|Withdrawal by Subject|4|||
37945417|NCT00537316|69632955|FG003|Part 1|Withdrawal by Subject|0|||
37945418|NCT00537316|69632956|FG004|Part 1|Withdrawal by Subject|0|||
37945419|NCT00537316|69632957|FG005|Part 1|Withdrawal by Subject|0|||
37945420|NCT00537316|69632958|FG006|Part 1|Withdrawal by Subject|0|||
37945421|NCT00537316|69632952|FG000|Part 1|Protocol Violation|1|||
37945422|NCT00537316|69632953|FG001|Part 1|Protocol Violation|5|||
37945423|NCT00537316|69632954|FG002|Part 1|Protocol Violation|1|||
37945424|NCT00537316|69632955|FG003|Part 1|Protocol Violation|0|||
37945425|NCT00537316|69632956|FG004|Part 1|Protocol Violation|0|||
37945426|NCT00537316|69632957|FG005|Part 1|Protocol Violation|0|||
37945427|NCT00537316|69632958|FG006|Part 1|Protocol Violation|0|||
37945428|NCT00537316|69632952|FG000|Part 1|Did not meet protocol eligibility|1|||
37945429|NCT00537316|69632953|FG001|Part 1|Did not meet protocol eligibility|3|||
37945430|NCT00537316|69632954|FG002|Part 1|Did not meet protocol eligibility|2|||
37945431|NCT00537316|69632955|FG003|Part 1|Did not meet protocol eligibility|0|||
37945432|NCT00537316|69632956|FG004|Part 1|Did not meet protocol eligibility|0|||
37945433|NCT00537316|69632957|FG005|Part 1|Did not meet protocol eligibility|0|||
37945434|NCT00537316|69632958|FG006|Part 1|Did not meet protocol eligibility|0|||
37945435|NCT00537316|69632952|FG000|Part 1|Administrative|0|||
37945436|NCT00537316|69632953|FG001|Part 1|Administrative|0|||
37945437|NCT00537316|69632954|FG002|Part 1|Administrative|2|||
37945438|NCT00537316|69632955|FG003|Part 1|Administrative|0|||
37945439|NCT00537316|69632956|FG004|Part 1|Administrative|0|||
37945440|NCT00537316|69632957|FG005|Part 1|Administrative|0|||
37945441|NCT00537316|69632958|FG006|Part 1|Administrative|0|||
37945442|NCT00537316|69632952|FG000|Part 2|Never entered follow-up|0|||
37945443|NCT00537316|69632953|FG001|Part 2|Never entered follow-up|0|||
37945444|NCT00537316|69632954|FG002|Part 2|Never entered follow-up|0|||
37945445|NCT00537316|69632955|FG003|Part 2|Never entered follow-up|0|||
37945446|NCT00537316|69632956|FG004|Part 2|Never entered follow-up|0|||
37945447|NCT00537316|69632957|FG005|Part 2|Never entered follow-up|0|||
37945448|NCT00537316|69632958|FG006|Part 2|Never entered follow-up|1|||
37945449|NCT00537316|69632952|FG000|Part 2|Adverse Event|4|||
37945450|NCT00537316|69632953|FG001|Part 2|Adverse Event|0|||
37945451|NCT00537316|69632954|FG002|Part 2|Adverse Event|2|||
37945452|NCT00537316|69632955|FG003|Part 2|Adverse Event|0|||
37945453|NCT00537316|69632956|FG004|Part 2|Adverse Event|0|||
37945454|NCT00537316|69632957|FG005|Part 2|Adverse Event|0|||
37945455|NCT00537316|69632958|FG006|Part 2|Adverse Event|0|||
37945456|NCT00537316|69632952|FG000|Part 2|Lost to Follow-up|1|||
37945457|NCT00537316|69632953|FG001|Part 2|Lost to Follow-up|0|||
37945458|NCT00537316|69632954|FG002|Part 2|Lost to Follow-up|2|||
37945459|NCT00537316|69632955|FG003|Part 2|Lost to Follow-up|0|||
37945460|NCT00537316|69632956|FG004|Part 2|Lost to Follow-up|0|||
37945461|NCT00537316|69632957|FG005|Part 2|Lost to Follow-up|0|||
37945462|NCT00537316|69632958|FG006|Part 2|Lost to Follow-up|0|||
37945463|NCT00537316|69632952|FG000|Part 2|Withdrawal by Subject|5|||
37945464|NCT00537316|69632953|FG001|Part 2|Withdrawal by Subject|1|||
37945465|NCT00537316|69632954|FG002|Part 2|Withdrawal by Subject|4|||
37945466|NCT00537316|69632955|FG003|Part 2|Withdrawal by Subject|0|||
37945467|NCT00537316|69632956|FG004|Part 2|Withdrawal by Subject|0|||
37945468|NCT00537316|69632957|FG005|Part 2|Withdrawal by Subject|0|||
37945469|NCT00537316|69632958|FG006|Part 2|Withdrawal by Subject|0|||
37945470|NCT00537316|69632952|FG000|Part 2|Administrative|16|||
37945471|NCT00537316|69632953|FG001|Part 2|Administrative|8|||
37945472|NCT00537316|69632954|FG002|Part 2|Administrative|24|||
37945473|NCT00537316|69632955|FG003|Part 2|Administrative|3|||
37945474|NCT00537316|69632956|FG004|Part 2|Administrative|1|||
37945475|NCT00537316|69632957|FG005|Part 2|Administrative|4|||
37945476|NCT00537316|69632958|FG006|Part 2|Administrative|1|||
37945477|NCT03827395|69632979|FG000|Overall Study|Lost to Follow-up|1|||
37945478|NCT03827395|69632980|FG001|Overall Study|Lost to Follow-up|0|||
37945479|NCT03827395|69632979|FG000|Overall Study|Protocol Violation|1|||
37945480|NCT03827395|69632980|FG001|Overall Study|Protocol Violation|0|||
37945481|NCT03827395|69632979|FG000|Overall Study|Became ineligible after enrollment|1|||
37945482|NCT03827395|69632980|FG001|Overall Study|Became ineligible after enrollment|2|||
37945483|NCT00655980|69632989|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
37945484|NCT00655980|69632990|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
37945485|NCT00655980|69632991|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
37945486|NCT00679172|69633007|FG000|Overall Study|Non-compliance|1|||
37945487|NCT00679172|69633008|FG001|Overall Study|Non-compliance|1|||
37945488|NCT00679172|69633009|FG002|Overall Study|Non-compliance|0|||
37945489|NCT00679172|69633010|FG003|Overall Study|Non-compliance|1|||
37945490|NCT00679172|69633011|FG004|Overall Study|Non-compliance|0|||
37945491|NCT00679172|69633007|FG000|Overall Study|Other not specified|0|||
37945492|NCT00679172|69633008|FG001|Overall Study|Other not specified|0|||
37945493|NCT00679172|69633009|FG002|Overall Study|Other not specified|1|||
37945494|NCT00679172|69633010|FG003|Overall Study|Other not specified|0|||
37945495|NCT00679172|69633011|FG004|Overall Study|Other not specified|0|||
37945496|NCT00676130|69633028|FG000|Overall Study|Lost to Follow-up|0|||
37945497|NCT00676130|69633029|FG001|Overall Study|Lost to Follow-up|1|||
37945498|NCT00676130|69633028|FG000|Overall Study|Found ineligible|3|||
37945499|NCT00676130|69633029|FG001|Overall Study|Found ineligible|2|||
37945500|NCT00676130|69633028|FG000|Overall Study|Withdrawal by Subject|0|||
37945501|NCT00676130|69633029|FG001|Overall Study|Withdrawal by Subject|1|||
37945502|NCT00676052|69633041|FG000|Overall Study|Adverse Event|0|||
37945503|NCT00676052|69633042|FG001|Overall Study|Adverse Event|1|||
37945504|NCT00676052|69633043|FG002|Overall Study|Adverse Event|1|||
37945505|NCT00676052|69633044|FG003|Overall Study|Adverse Event|2|||
37945506|NCT00676052|69633045|FG004|Overall Study|Adverse Event|2|||
37945507|NCT00676052|69633046|FG005|Overall Study|Adverse Event|2|||
37945508|NCT00676052|69633041|FG000|Overall Study|Lack of Efficacy|2|||
37945509|NCT00676052|69633042|FG001|Overall Study|Lack of Efficacy|2|||
37945510|NCT00676052|69633043|FG002|Overall Study|Lack of Efficacy|1|||
37945511|NCT00676052|69633044|FG003|Overall Study|Lack of Efficacy|1|||
37945512|NCT00676052|69633045|FG004|Overall Study|Lack of Efficacy|2|||
37945513|NCT00676052|69633046|FG005|Overall Study|Lack of Efficacy|1|||
37945514|NCT00676052|69633041|FG000|Overall Study|Protocol Violation|5|||
37945515|NCT00676052|69633042|FG001|Overall Study|Protocol Violation|3|||
37945516|NCT00676052|69633043|FG002|Overall Study|Protocol Violation|2|||
37945517|NCT00676052|69633044|FG003|Overall Study|Protocol Violation|2|||
37945518|NCT00676052|69633045|FG004|Overall Study|Protocol Violation|1|||
37945519|NCT00676052|69633046|FG005|Overall Study|Protocol Violation|2|||
37945520|NCT00676052|69633041|FG000|Overall Study|Lost to Follow-up|0|||
37945521|NCT00676052|69633042|FG001|Overall Study|Lost to Follow-up|0|||
37945522|NCT00676052|69633043|FG002|Overall Study|Lost to Follow-up|0|||
37945523|NCT00676052|69633044|FG003|Overall Study|Lost to Follow-up|0|||
37945524|NCT00676052|69633045|FG004|Overall Study|Lost to Follow-up|1|||
37945525|NCT00676052|69633046|FG005|Overall Study|Lost to Follow-up|0|||
37945526|NCT00676052|69633041|FG000|Overall Study|Physician Decision|1|||
37945527|NCT00676052|69633042|FG001|Overall Study|Physician Decision|1|||
37945528|NCT00676052|69633043|FG002|Overall Study|Physician Decision|1|||
37945529|NCT00676052|69633044|FG003|Overall Study|Physician Decision|0|||
37945530|NCT00676052|69633045|FG004|Overall Study|Physician Decision|0|||
37945531|NCT00676052|69633046|FG005|Overall Study|Physician Decision|1|||
37945532|NCT00676052|69633041|FG000|Overall Study|Withdrawal by Subject|1|||
37945533|NCT00676052|69633042|FG001|Overall Study|Withdrawal by Subject|0|||
37945534|NCT00676052|69633043|FG002|Overall Study|Withdrawal by Subject|1|||
37945535|NCT00676052|69633044|FG003|Overall Study|Withdrawal by Subject|0|||
37945536|NCT00676052|69633045|FG004|Overall Study|Withdrawal by Subject|0|||
37945537|NCT00676052|69633046|FG005|Overall Study|Withdrawal by Subject|0|||
37945538|NCT00535288|69633065|FG000|Overall Study|Adverse Event|20|||
37945539|NCT00535288|69633066|FG001|Overall Study|Adverse Event|19|||
37945540|NCT00535288|69633067|FG002|Overall Study|Adverse Event|25|||
37945541|NCT00535288|69633068|FG003|Overall Study|Adverse Event|20|||
37945542|NCT00535288|69633069|FG004|Overall Study|Adverse Event|30|||
37945543|NCT00535288|69633065|FG000|Overall Study|Lost to Follow-up|0|||
37945544|NCT00535288|69633066|FG001|Overall Study|Lost to Follow-up|3|||
37945545|NCT00535288|69633067|FG002|Overall Study|Lost to Follow-up|0|||
37945546|NCT00535288|69633068|FG003|Overall Study|Lost to Follow-up|0|||
37945547|NCT00535288|69633069|FG004|Overall Study|Lost to Follow-up|0|||
37945548|NCT00535288|69633065|FG000|Overall Study|Lack of Efficacy|26|||
37945549|NCT00535288|69633066|FG001|Overall Study|Lack of Efficacy|3|||
37945550|NCT00535288|69633067|FG002|Overall Study|Lack of Efficacy|4|||
37945551|NCT00535288|69633068|FG003|Overall Study|Lack of Efficacy|4|||
37945552|NCT00535288|69633069|FG004|Overall Study|Lack of Efficacy|7|||
37945553|NCT00535288|69633065|FG000|Overall Study|Unwilling to cooperate|6|||
37945554|NCT00535288|69633066|FG001|Overall Study|Unwilling to cooperate|6|||
37945555|NCT00535288|69633067|FG002|Overall Study|Unwilling to cooperate|3|||
38039093|NCT00094055|69726480|FG000|Overall Study|clinical progression|1|||
38039094|NCT00094055|69726480|FG000|Overall Study|roll-over to another study|14|||
38039095|NCT00094055|69726480|FG000|Overall Study|Withdrawal by Subject|9|||
38039096|NCT00099983|69726486|FG000|Overall Study|Lost to Follow-up|2|||
38039097|NCT00099983|69726487|FG001|Overall Study|Lost to Follow-up|3|||
38039098|NCT00099983|69726486|FG000|Overall Study|Missing Source Documents|14|||
38039099|NCT00099983|69726487|FG001|Overall Study|Missing Source Documents|15|||
38039100|NCT00099983|69726486|FG000|Overall Study|Withdrawal by Subject|3|||
38039101|NCT00099983|69726487|FG001|Overall Study|Withdrawal by Subject|2|||
38039102|NCT00099983|69726486|FG000|Overall Study|Adverse Event|1|||
38039103|NCT00099983|69726487|FG001|Overall Study|Adverse Event|1|||
38039104|NCT00099983|69726486|FG000|Overall Study|Lack of Efficacy|0|||
38039105|NCT00099983|69726487|FG001|Overall Study|Lack of Efficacy|1|||
38039106|NCT00099983|69726486|FG000|Overall Study|Unable to return for appointments|1|||
38039107|NCT00099983|69726487|FG001|Overall Study|Unable to return for appointments|1|||
38039108|NCT00099983|69726486|FG000|Overall Study|Moved|1|||
38039109|NCT00099983|69726487|FG001|Overall Study|Moved|0|||
38039110|NCT00099983|69726486|FG000|Overall Study|Other psychiatric problem|1|||
38039111|NCT00099983|69726487|FG001|Overall Study|Other psychiatric problem|0|||
38039112|NCT00099983|69726486|FG000|Overall Study|Incarcerated|0|||
38039113|NCT00099983|69726487|FG001|Overall Study|Incarcerated|1|||
38039114|NCT00099983|69726486|FG000|Overall Study|Intolerant of burden of visits|0|||
38039115|NCT00099983|69726487|FG001|Overall Study|Intolerant of burden of visits|1|||
38039116|NCT00099983|69726486|FG000|Overall Study|Other issue|1|||
38039117|NCT00099983|69726487|FG001|Overall Study|Other issue|0|||
38039118|NCT00099359|69726496|FG000|Overall Study|Death|11|||
37945556|NCT00535288|69633068|FG003|Overall Study|Unwilling to cooperate|3|||
37945557|NCT00535288|69633069|FG004|Overall Study|Unwilling to cooperate|4|||
37945558|NCT00535288|69633065|FG000|Overall Study|Other|2|||
37945559|NCT00535288|69633066|FG001|Overall Study|Other|1|||
37945560|NCT00535288|69633067|FG002|Overall Study|Other|1|||
38039119|NCT00099359|69726497|FG001|Overall Study|Death|15|||
38039120|NCT00099359|69726498|FG002|Overall Study|Death|17|||
38039121|NCT00099359|69726496|FG000|Overall Study|Withdrawal by Subject|19|||
38039122|NCT00099359|69726497|FG001|Overall Study|Withdrawal by Subject|19|||
38039123|NCT00099359|69726498|FG002|Overall Study|Withdrawal by Subject|23|||
38039124|NCT00099359|69726496|FG000|Overall Study|Lost to Follow-up|15|||
38039125|NCT00099359|69726497|FG001|Overall Study|Lost to Follow-up|24|||
38039126|NCT00099359|69726498|FG002|Overall Study|Lost to Follow-up|24|||
38039127|NCT00099359|69726496|FG000|Overall Study|moved out of area|9|||
38039128|NCT00099359|69726497|FG001|Overall Study|moved out of area|7|||
38039129|NCT00099359|69726498|FG002|Overall Study|moved out of area|4|||
38039130|NCT00092495|69726520|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
38039131|NCT00092495|69726521|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
38039132|NCT00092495|69726522|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
38039133|NCT00092495|69726523|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
38039134|NCT00092495|69726524|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
38039135|NCT00092495|69726520|FG000|Base Study Vaccination Period|Extended|0|||
38039136|NCT00092495|69726521|FG001|Base Study Vaccination Period|Extended|0|||
38039137|NCT00092495|69726522|FG002|Base Study Vaccination Period|Extended|0|||
38039138|NCT00092495|69726523|FG003|Base Study Vaccination Period|Extended|1|||
38039139|NCT00092495|69726524|FG004|Base Study Vaccination Period|Extended|0|||
38039140|NCT00092495|69726520|FG000|Base Study Vaccination Period|*Clinical AE|1|||
38039141|NCT00092495|69726521|FG001|Base Study Vaccination Period|*Clinical AE|0|||
38039142|NCT00092495|69726522|FG002|Base Study Vaccination Period|*Clinical AE|1|||
38039143|NCT00092495|69726523|FG003|Base Study Vaccination Period|*Clinical AE|2|||
38039144|NCT00092495|69726524|FG004|Base Study Vaccination Period|*Clinical AE|0|||
38039145|NCT00092495|69726520|FG000|Base Study Vaccination Period|*Other reasons|1|||
38039146|NCT00092495|69726521|FG001|Base Study Vaccination Period|*Other reasons|0|||
38039147|NCT00092495|69726522|FG002|Base Study Vaccination Period|*Other reasons|0|||
38039148|NCT00092495|69726523|FG003|Base Study Vaccination Period|*Other reasons|1|||
38039149|NCT00092495|69726524|FG004|Base Study Vaccination Period|*Other reasons|0|||
38039150|NCT00092495|69726520|FG000|Base Study Vaccination Period|*Pregnancy|0|||
38039151|NCT00092495|69726521|FG001|Base Study Vaccination Period|*Pregnancy|2|||
38039152|NCT00092495|69726522|FG002|Base Study Vaccination Period|*Pregnancy|5|||
38039153|NCT00092495|69726523|FG003|Base Study Vaccination Period|*Pregnancy|7|||
38039154|NCT00092495|69726524|FG004|Base Study Vaccination Period|*Pregnancy|0|||
38039155|NCT00092495|69726520|FG000|Base Study Vaccination Period|Adverse Event|1|||
38039156|NCT00092495|69726521|FG001|Base Study Vaccination Period|Adverse Event|0|||
38039157|NCT00092495|69726522|FG002|Base Study Vaccination Period|Adverse Event|0|||
38039158|NCT00092495|69726523|FG003|Base Study Vaccination Period|Adverse Event|3|||
38039159|NCT00092495|69726524|FG004|Base Study Vaccination Period|Adverse Event|0|||
38039160|NCT00092495|69726520|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
38039161|NCT00092495|69726521|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
38039162|NCT00092495|69726522|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
38039163|NCT00092495|69726523|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
38039164|NCT00092495|69726524|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
38039165|NCT00092495|69726520|FG000|Base Study Vaccination Period|Moved|3|||
38039166|NCT00092495|69726521|FG001|Base Study Vaccination Period|Moved|1|||
38039167|NCT00092495|69726522|FG002|Base Study Vaccination Period|Moved|2|||
38039168|NCT00092495|69726523|FG003|Base Study Vaccination Period|Moved|2|||
38039169|NCT00092495|69726524|FG004|Base Study Vaccination Period|Moved|0|||
38039170|NCT00092495|69726520|FG000|Base Study Vaccination Period|Other|1|||
38039171|NCT00092495|69726521|FG001|Base Study Vaccination Period|Other|1|||
38039172|NCT00092495|69726522|FG002|Base Study Vaccination Period|Other|0|||
38039173|NCT00092495|69726523|FG003|Base Study Vaccination Period|Other|2|||
38039174|NCT00092495|69726524|FG004|Base Study Vaccination Period|Other|0|||
38039175|NCT00092495|69726520|FG000|Base Study Vaccination Period|Pregnancy|2|||
38039176|NCT00092495|69726521|FG001|Base Study Vaccination Period|Pregnancy|0|||
38039177|NCT00092495|69726522|FG002|Base Study Vaccination Period|Pregnancy|0|||
38039178|NCT00092495|69726523|FG003|Base Study Vaccination Period|Pregnancy|0|||
38039179|NCT00092495|69726524|FG004|Base Study Vaccination Period|Pregnancy|0|||
38039180|NCT00092495|69726520|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
38039181|NCT00092495|69726521|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
38039182|NCT00092495|69726522|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
38039183|NCT00092495|69726523|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
38039184|NCT00092495|69726524|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
38039185|NCT00092495|69726520|FG000|Base Study Vaccination Period|Protocol Violation|1|||
38039186|NCT00092495|69726521|FG001|Base Study Vaccination Period|Protocol Violation|0|||
38039187|NCT00092495|69726522|FG002|Base Study Vaccination Period|Protocol Violation|0|||
38039188|NCT00092495|69726523|FG003|Base Study Vaccination Period|Protocol Violation|0|||
38039189|NCT00092495|69726524|FG004|Base Study Vaccination Period|Protocol Violation|0|||
38039190|NCT00092495|69726520|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
38039191|NCT00092495|69726521|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
38039192|NCT00092495|69726522|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
38039193|NCT00092495|69726523|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
38039194|NCT00092495|69726524|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
38039195|NCT00092495|69726520|FG000|Base Study Follow-up Period|Extended|0|||
38039196|NCT00092495|69726521|FG001|Base Study Follow-up Period|Extended|0|||
38039197|NCT00092495|69726522|FG002|Base Study Follow-up Period|Extended|1|||
38039198|NCT00092495|69726523|FG003|Base Study Follow-up Period|Extended|2|||
38039199|NCT00092495|69726524|FG004|Base Study Follow-up Period|Extended|0|||
38039200|NCT00092495|69726520|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
38039201|NCT00092495|69726521|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
38039202|NCT00092495|69726522|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
38039203|NCT00092495|69726523|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
38039204|NCT00092495|69726524|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
38039205|NCT00092495|69726520|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
38039206|NCT00092495|69726521|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
38039207|NCT00092495|69726522|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
38039208|NCT00092495|69726523|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
38039209|NCT00092495|69726524|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
38039210|NCT00092417|69726539|FG000|Overall Study|Lost to Follow-up|2|||
38039211|NCT00092417|69726540|FG001|Overall Study|Lost to Follow-up|0|||
38039212|NCT00092417|69726539|FG000|Overall Study|Withdrawal by Subject|2|||
38039213|NCT00092417|69726540|FG001|Overall Study|Withdrawal by Subject|1|||
38039214|NCT00092417|69726539|FG000|Overall Study|Other|1|||
38039215|NCT00092417|69726540|FG001|Overall Study|Other|0|||
38039216|NCT00091949|69726548|FG000|Overall Study|Withdrawal by Subject|117|||
38039217|NCT00091949|69726549|FG001|Overall Study|Withdrawal by Subject|110|||
38039218|NCT00091949|69726548|FG000|Overall Study|Lost to Follow-up|58|||
38039219|NCT00091949|69726549|FG001|Overall Study|Lost to Follow-up|41|||
38039220|NCT02258542|69726559|FG000|Overall Study|eg. not made to the visit|7|||
38039221|NCT02258542|69726560|FG001|Overall Study|eg. not made to the visit|4|||
38039222|NCT02258542|69726561|FG002|Overall Study|eg. not made to the visit|0|||
38039223|NCT02258542|69726562|FG003|Overall Study|eg. not made to the visit|1|||
38039224|NCT02258542|69726559|FG000|Overall Study|study specific discount. criteria|1|||
38039225|NCT02258542|69726560|FG001|Overall Study|study specific discount. criteria|1|||
37675052|NCT01950364|69149192|FG001|Overall Study|Stem Cell Transplant|6|||
37675053|NCT01950364|69149191|FG000|Overall Study|Disease Progression|5|||
37675054|NCT01950364|69149192|FG001|Overall Study|Disease Progression|2|||
37675055|NCT01950364|69149191|FG000|Overall Study|Withdrawal by Subject|0|||
37675056|NCT01950364|69149192|FG001|Overall Study|Withdrawal by Subject|1|||
37675057|NCT01950364|69149191|FG000|Overall Study|Protocol Violation|0|||
37675058|NCT01950364|69149192|FG001|Overall Study|Protocol Violation|1|||
37675059|NCT01968070|69149216|FG000|Period 1|Withdrawal by Subject|0|||
37675060|NCT01968070|69149217|FG001|Period 1|Withdrawal by Subject|1|||
37675061|NCT01968070|69149218|FG002|Period 1|Withdrawal by Subject|0|||
37675062|NCT01968070|69149219|FG003|Period 1|Withdrawal by Subject|0|||
37675063|NCT01968070|69149220|FG004|Period 1|Withdrawal by Subject|0|||
37675064|NCT01968070|69149221|FG005|Period 1|Withdrawal by Subject|0|||
37675065|NCT01968070|69149222|FG006|Period 1|Withdrawal by Subject|1|||
37675066|NCT01968070|69149223|FG007|Period 1|Withdrawal by Subject|0|||
37675067|NCT01968070|69149224|FG008|Period 1|Withdrawal by Subject|0|||
37675068|NCT01968070|69149225|FG009|Period 1|Withdrawal by Subject|0|||
37675069|NCT01968070|69149226|FG010|Period 1|Withdrawal by Subject|0|||
37675070|NCT01968070|69149227|FG011|Period 1|Withdrawal by Subject|0|||
37675071|NCT01968070|69149228|FG012|Period 1|Withdrawal by Subject|0|||
37675072|NCT01968070|69149229|FG013|Period 1|Withdrawal by Subject|0|||
37675073|NCT01968070|69149230|FG014|Period 1|Withdrawal by Subject|0|||
37675074|NCT01968070|69149231|FG015|Period 1|Withdrawal by Subject|1|||
37675075|NCT01968070|69149232|FG016|Period 1|Withdrawal by Subject|0|||
37675076|NCT01968070|69149233|FG017|Period 1|Withdrawal by Subject|0|||
37675077|NCT01968070|69149216|FG000|Period 1|Protocol Violation|0|||
37675078|NCT01968070|69149217|FG001|Period 1|Protocol Violation|0|||
37675079|NCT01968070|69149218|FG002|Period 1|Protocol Violation|0|||
37675080|NCT01968070|69149219|FG003|Period 1|Protocol Violation|1|||
37675081|NCT01968070|69149220|FG004|Period 1|Protocol Violation|1|||
37675082|NCT01968070|69149221|FG005|Period 1|Protocol Violation|0|||
37675083|NCT01968070|69149222|FG006|Period 1|Protocol Violation|0|||
37945561|NCT00535288|69633068|FG003|Overall Study|Other|2|||
37945562|NCT00535288|69633069|FG004|Overall Study|Other|1|||
37945563|NCT03904420|69633088|FG000|Overall Study|Study terminated|2|||
37945564|NCT03904420|69633089|FG001|Overall Study|Study terminated|2|||
37945565|NCT00675506|69633097|FG000|Overall Study|Lost to Follow-up|1|||
37945566|NCT00675506|69633098|FG001|Overall Study|Lost to Follow-up|5|||
37945567|NCT00675506|69633097|FG000|Overall Study|Lost interest|3|||
37945568|NCT00675506|69633098|FG001|Overall Study|Lost interest|5|||
37945569|NCT00675506|69633097|FG000|Overall Study|Elevated fasting glucose|2|||
37945570|NCT00675506|69633098|FG001|Overall Study|Elevated fasting glucose|1|||
37945571|NCT00675506|69633097|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
37945572|NCT00675506|69633098|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
38039226|NCT02258542|69726561|FG002|Overall Study|study specific discount. criteria|0|||
38039227|NCT02258542|69726562|FG003|Overall Study|study specific discount. criteria|0|||
38039228|NCT02258542|69726559|FG000|Overall Study|Withdrawal by Subject|20|||
38039229|NCT02258542|69726560|FG001|Overall Study|Withdrawal by Subject|20|||
37675084|NCT01968070|69149223|FG007|Period 1|Protocol Violation|0|||
37675085|NCT01968070|69149224|FG008|Period 1|Protocol Violation|0|||
37675086|NCT01968070|69149225|FG009|Period 1|Protocol Violation|0|||
37675087|NCT01968070|69149226|FG010|Period 1|Protocol Violation|0|||
37675088|NCT01968070|69149227|FG011|Period 1|Protocol Violation|0|||
37675089|NCT01968070|69149228|FG012|Period 1|Protocol Violation|0|||
37675090|NCT01968070|69149229|FG013|Period 1|Protocol Violation|0|||
37675091|NCT01968070|69149230|FG014|Period 1|Protocol Violation|0|||
37675092|NCT01968070|69149231|FG015|Period 1|Protocol Violation|0|||
37675093|NCT01968070|69149232|FG016|Period 1|Protocol Violation|0|||
37675094|NCT01968070|69149233|FG017|Period 1|Protocol Violation|0|||
37675095|NCT01968070|69149216|FG000|Period 1|Lost to Follow-up|0|||
37675096|NCT01968070|69149217|FG001|Period 1|Lost to Follow-up|0|||
37675097|NCT01968070|69149218|FG002|Period 1|Lost to Follow-up|0|||
37675098|NCT01968070|69149219|FG003|Period 1|Lost to Follow-up|1|||
37675099|NCT01968070|69149220|FG004|Period 1|Lost to Follow-up|0|||
37675100|NCT01968070|69149221|FG005|Period 1|Lost to Follow-up|0|||
37675101|NCT01968070|69149222|FG006|Period 1|Lost to Follow-up|0|||
37675102|NCT01968070|69149223|FG007|Period 1|Lost to Follow-up|0|||
37675103|NCT01968070|69149224|FG008|Period 1|Lost to Follow-up|0|||
37675104|NCT01968070|69149225|FG009|Period 1|Lost to Follow-up|0|||
37675105|NCT01968070|69149226|FG010|Period 1|Lost to Follow-up|0|||
37675106|NCT01968070|69149227|FG011|Period 1|Lost to Follow-up|0|||
37675107|NCT01968070|69149228|FG012|Period 1|Lost to Follow-up|0|||
37675108|NCT01968070|69149229|FG013|Period 1|Lost to Follow-up|0|||
37675109|NCT01968070|69149230|FG014|Period 1|Lost to Follow-up|0|||
37675110|NCT01968070|69149231|FG015|Period 1|Lost to Follow-up|0|||
37675111|NCT01968070|69149232|FG016|Period 1|Lost to Follow-up|0|||
37675112|NCT01968070|69149233|FG017|Period 1|Lost to Follow-up|0|||
37675113|NCT01968070|69149216|FG000|Period 1|Adverse Event|0|||
37675114|NCT01968070|69149217|FG001|Period 1|Adverse Event|0|||
37675115|NCT01968070|69149218|FG002|Period 1|Adverse Event|0|||
37675116|NCT01968070|69149219|FG003|Period 1|Adverse Event|0|||
37675117|NCT01968070|69149220|FG004|Period 1|Adverse Event|0|||
37675118|NCT01968070|69149221|FG005|Period 1|Adverse Event|0|||
37675119|NCT01968070|69149222|FG006|Period 1|Adverse Event|1|||
37675120|NCT01968070|69149223|FG007|Period 1|Adverse Event|0|||
37675121|NCT01968070|69149224|FG008|Period 1|Adverse Event|0|||
37675122|NCT01968070|69149225|FG009|Period 1|Adverse Event|0|||
37675123|NCT01968070|69149226|FG010|Period 1|Adverse Event|0|||
37675124|NCT01968070|69149227|FG011|Period 1|Adverse Event|0|||
37675125|NCT01968070|69149228|FG012|Period 1|Adverse Event|0|||
37675126|NCT01968070|69149229|FG013|Period 1|Adverse Event|0|||
37675127|NCT01968070|69149230|FG014|Period 1|Adverse Event|0|||
37675128|NCT01968070|69149231|FG015|Period 1|Adverse Event|0|||
37675129|NCT01968070|69149232|FG016|Period 1|Adverse Event|0|||
37675130|NCT01968070|69149233|FG017|Period 1|Adverse Event|0|||
37675131|NCT01968070|69149216|FG000|Period 1|Physician Decision|0|||
37675132|NCT01968070|69149217|FG001|Period 1|Physician Decision|0|||
37675133|NCT01968070|69149218|FG002|Period 1|Physician Decision|0|||
37675134|NCT01968070|69149219|FG003|Period 1|Physician Decision|0|||
37675135|NCT01968070|69149220|FG004|Period 1|Physician Decision|0|||
37675136|NCT01968070|69149221|FG005|Period 1|Physician Decision|0|||
37675137|NCT01968070|69149222|FG006|Period 1|Physician Decision|0|||
37675138|NCT01968070|69149223|FG007|Period 1|Physician Decision|0|||
37675139|NCT01968070|69149224|FG008|Period 1|Physician Decision|0|||
37675140|NCT01968070|69149225|FG009|Period 1|Physician Decision|0|||
37675141|NCT01968070|69149226|FG010|Period 1|Physician Decision|0|||
37675142|NCT01968070|69149227|FG011|Period 1|Physician Decision|1|||
37675143|NCT01968070|69149228|FG012|Period 1|Physician Decision|0|||
37675144|NCT01968070|69149229|FG013|Period 1|Physician Decision|0|||
37675145|NCT01968070|69149230|FG014|Period 1|Physician Decision|0|||
37675146|NCT01968070|69149231|FG015|Period 1|Physician Decision|0|||
37675147|NCT01968070|69149232|FG016|Period 1|Physician Decision|0|||
37675148|NCT01968070|69149233|FG017|Period 1|Physician Decision|0|||
37675149|NCT01968070|69149216|FG000|Period 2|Withdrawal by Subject|0|||
37675150|NCT01968070|69149217|FG001|Period 2|Withdrawal by Subject|0|||
37675151|NCT01968070|69149218|FG002|Period 2|Withdrawal by Subject|0|||
37675152|NCT01968070|69149219|FG003|Period 2|Withdrawal by Subject|0|||
37675153|NCT01968070|69149220|FG004|Period 2|Withdrawal by Subject|1|||
37675154|NCT01968070|69149221|FG005|Period 2|Withdrawal by Subject|0|||
37675155|NCT01968070|69149222|FG006|Period 2|Withdrawal by Subject|0|||
37675156|NCT01968070|69149223|FG007|Period 2|Withdrawal by Subject|0|||
37675157|NCT01968070|69149224|FG008|Period 2|Withdrawal by Subject|0|||
37675158|NCT01968070|69149225|FG009|Period 2|Withdrawal by Subject|0|||
37675159|NCT01968070|69149226|FG010|Period 2|Withdrawal by Subject|0|||
37675160|NCT01968070|69149227|FG011|Period 2|Withdrawal by Subject|0|||
37675161|NCT01968070|69149228|FG012|Period 2|Withdrawal by Subject|0|||
37675162|NCT01968070|69149229|FG013|Period 2|Withdrawal by Subject|0|||
37675163|NCT01968070|69149230|FG014|Period 2|Withdrawal by Subject|0|||
37675164|NCT01968070|69149231|FG015|Period 2|Withdrawal by Subject|0|||
37675165|NCT01968070|69149232|FG016|Period 2|Withdrawal by Subject|0|||
37675166|NCT01968070|69149233|FG017|Period 2|Withdrawal by Subject|0|||
37675167|NCT01918774|69149271|FG000|Overall Study|Lost prior to first CBTw session|4|||
37675168|NCT01918774|69149271|FG000|Overall Study|Lost to Follow-up|1|||
37675169|NCT01949116|69149277|FG000|Overall Study|Death|2|||
37675170|NCT01949116|69149278|FG001|Overall Study|Death|0|||
37675171|NCT01949116|69149277|FG000|Overall Study|Lost to Follow-up|1|||
37675172|NCT01949116|69149278|FG001|Overall Study|Lost to Follow-up|3|||
37675173|NCT01949116|69149277|FG000|Overall Study|Withdrawal by Subject|5|||
37675174|NCT01949116|69149278|FG001|Overall Study|Withdrawal by Subject|3|||
37675175|NCT01673009|69149288|FG000|Overall Study|Physician Decision|5|||
37675176|NCT01673009|69149288|FG000|Overall Study|Withdrawal by Subject|8|||
37675177|NCT01939366|69149297|FG000|Overall Study|Adverse Event|8|||
37675178|NCT01939366|69149298|FG001|Overall Study|Adverse Event|17|||
37675179|NCT01939366|69149299|FG002|Overall Study|Adverse Event|30|||
37675180|NCT01939366|69149300|FG003|Overall Study|Adverse Event|8|||
37675181|NCT01939366|69149301|FG004|Overall Study|Adverse Event|5|||
37675182|NCT01939366|69149297|FG000|Overall Study|Lack of Efficacy|2|||
37675183|NCT01939366|69149298|FG001|Overall Study|Lack of Efficacy|1|||
37675184|NCT01939366|69149299|FG002|Overall Study|Lack of Efficacy|1|||
37675185|NCT01939366|69149300|FG003|Overall Study|Lack of Efficacy|1|||
37675186|NCT01939366|69149301|FG004|Overall Study|Lack of Efficacy|3|||
37675187|NCT01939366|69149297|FG000|Overall Study|Lost to Follow-up|1|||
37675188|NCT01939366|69149298|FG001|Overall Study|Lost to Follow-up|1|||
37675189|NCT01939366|69149299|FG002|Overall Study|Lost to Follow-up|0|||
37675190|NCT01939366|69149300|FG003|Overall Study|Lost to Follow-up|0|||
37675191|NCT01939366|69149301|FG004|Overall Study|Lost to Follow-up|0|||
37675192|NCT01939366|69149297|FG000|Overall Study|Withdrawal by Subject|1|||
37675193|NCT01939366|69149298|FG001|Overall Study|Withdrawal by Subject|0|||
37675194|NCT01939366|69149299|FG002|Overall Study|Withdrawal by Subject|2|||
37675195|NCT01939366|69149300|FG003|Overall Study|Withdrawal by Subject|2|||
37675196|NCT01939366|69149301|FG004|Overall Study|Withdrawal by Subject|3|||
37675197|NCT01939366|69149297|FG000|Overall Study|Inclusion criteria not met|0|||
37675198|NCT01939366|69149298|FG001|Overall Study|Inclusion criteria not met|1|||
37675199|NCT01939366|69149299|FG002|Overall Study|Inclusion criteria not met|1|||
37675200|NCT01939366|69149300|FG003|Overall Study|Inclusion criteria not met|0|||
37675201|NCT01939366|69149301|FG004|Overall Study|Inclusion criteria not met|1|||
37675202|NCT01939366|69149297|FG000|Overall Study|Other|0|||
37675203|NCT01939366|69149298|FG001|Overall Study|Other|0|||
37675204|NCT01939366|69149299|FG002|Overall Study|Other|2|||
37675205|NCT01939366|69149300|FG003|Overall Study|Other|2|||
37675206|NCT01939366|69149301|FG004|Overall Study|Other|1|||
37675207|NCT01939366|69149297|FG000|Overall Study|Protocol Violation|0|||
37675208|NCT01939366|69149298|FG001|Overall Study|Protocol Violation|0|||
37675209|NCT01939366|69149299|FG002|Overall Study|Protocol Violation|0|||
37675210|NCT01939366|69149300|FG003|Overall Study|Protocol Violation|1|||
37675211|NCT01939366|69149301|FG004|Overall Study|Protocol Violation|0|||
37675212|NCT01939366|69149297|FG000|Overall Study|Sponsor decision|0|||
37675213|NCT01939366|69149298|FG001|Overall Study|Sponsor decision|0|||
37675214|NCT01939366|69149299|FG002|Overall Study|Sponsor decision|0|||
37675215|NCT01939366|69149300|FG003|Overall Study|Sponsor decision|0|||
37675216|NCT01939366|69149301|FG004|Overall Study|Sponsor decision|2|||
37675217|NCT01939366|69149297|FG000|Overall Study|GCP non-compliance at site|2|||
37675218|NCT01939366|69149298|FG001|Overall Study|GCP non-compliance at site|3|||
37675219|NCT01939366|69149299|FG002|Overall Study|GCP non-compliance at site|2|||
37675220|NCT01939366|69149300|FG003|Overall Study|GCP non-compliance at site|3|||
37675221|NCT01939366|69149301|FG004|Overall Study|GCP non-compliance at site|3|||
37675222|NCT01918306|69149315|FG000|Overall Study|progresive disease|4|||
37675223|NCT01918306|69149316|FG001|Overall Study|progresive disease|0|||
37675224|NCT01918306|69149317|FG002|Overall Study|progresive disease|1|||
37675225|NCT01918306|69149318|FG003|Overall Study|progresive disease|1|||
37675226|NCT01918306|69149315|FG000|Overall Study|Withdrawal by Subject|0|||
37675227|NCT01918306|69149316|FG001|Overall Study|Withdrawal by Subject|0|||
37675228|NCT01918306|69149317|FG002|Overall Study|Withdrawal by Subject|0|||
37675229|NCT01918306|69149318|FG003|Overall Study|Withdrawal by Subject|2|||
37675230|NCT01918306|69149315|FG000|Overall Study|neutropenia|1|||
37675231|NCT01918306|69149316|FG001|Overall Study|neutropenia|0|||
37675232|NCT01918306|69149317|FG002|Overall Study|neutropenia|0|||
37675233|NCT01918306|69149318|FG003|Overall Study|neutropenia|0|||
37675234|NCT01918306|69149315|FG000|Overall Study|Lack of Efficacy|1|||
37675235|NCT01918306|69149316|FG001|Overall Study|Lack of Efficacy|0|||
37675236|NCT01918306|69149317|FG002|Overall Study|Lack of Efficacy|0|||
37675237|NCT01918306|69149318|FG003|Overall Study|Lack of Efficacy|0|||
37675238|NCT01918306|69149315|FG000|Overall Study|progress disease, crossover|0|||
37675239|NCT01918306|69149316|FG001|Overall Study|progress disease, crossover|0|||
37675240|NCT01918306|69149317|FG002|Overall Study|progress disease, crossover|1|||
37675241|NCT01918306|69149318|FG003|Overall Study|progress disease, crossover|0|||
37675242|NCT01917526|69149340|FG000|Overall Study|Protocol Violation|1|||
37675243|NCT01917526|69149341|FG001|Overall Study|Protocol Violation|1|||
37675244|NCT01948258|69149347|FG000|Overall Study|Pregnancy|41|||
37675245|NCT01948258|69149347|FG000|Overall Study|Did not complete by cut-off date|35|||
37675246|NCT01948258|69149347|FG000|Overall Study|Lost to Follow-up|27|||
37675247|NCT01948258|69149347|FG000|Overall Study|Withdrawal by SPD|8|||
37675248|NCT01948258|69149347|FG000|Overall Study|Withdrawal by Subject|6|||
37675249|NCT01948258|69149347|FG000|Overall Study|Health Care Professional|43|||
37675250|NCT01948258|69149347|FG000|Overall Study|Removed from statistical analysis|2|||
37675251|NCT01916980|69149353|FG000|Overall Study|Adverse Event|4|||
37675252|NCT01916980|69149354|FG001|Overall Study|Adverse Event|2|||
37675253|NCT01916980|69149353|FG000|Overall Study|Lack of Efficacy|2|||
37675254|NCT01916980|69149354|FG001|Overall Study|Lack of Efficacy|2|||
37675255|NCT01916980|69149353|FG000|Overall Study|Withdrawal by Subject|1|||
37675256|NCT01916980|69149354|FG001|Overall Study|Withdrawal by Subject|0|||
37675257|NCT05940077|69149360|FG000|Overall Study|the presence of definite dementia, determined by Montreal Cognitive Assessment (MoCA < 21)|1|||
37675258|NCT05011513|69149374|FG000|Overall Study|Death|0|||
37675259|NCT05011513|69149375|FG001|Overall Study|Death|1|||
37675260|NCT05011513|69149374|FG000|Overall Study|Lost to Follow-up|4|||
37675261|NCT05011513|69149375|FG001|Overall Study|Lost to Follow-up|0|||
37675262|NCT05011513|69149374|FG000|Overall Study|Withdrawal by Subject|18|||
37675263|NCT05011513|69149375|FG001|Overall Study|Withdrawal by Subject|17|||
37675264|NCT05011513|69149374|FG000|Overall Study|Other|4|||
37675265|NCT05011513|69149375|FG001|Overall Study|Other|2|||
37675266|NCT04750239|69149381|FG000|Overall Study|Withdrawal by Subject|2|||
37675267|NCT04750239|69149381|FG000|Overall Study|Trial terminated by sponsor|1|||
37675268|NCT04590248|69149386|FG000|Overall Study|Lost to Follow-up|1|||
37675269|NCT04590248|69149386|FG000|Overall Study|Withdrawal by Subject|16|||
37675270|NCT04590248|69149386|FG000|Overall Study|Other|2|||
37675271|NCT04560816|69149390|FG000|Overall Study|Withdrawal by Subject|1|||
37675272|NCT04560816|69149391|FG001|Overall Study|Withdrawal by Subject|1|||
37675273|NCT04560816|69149392|FG002|Overall Study|Withdrawal by Subject|1|||
37675274|NCT04560816|69149393|FG003|Overall Study|Withdrawal by Subject|0|||
37675275|NCT04560816|69149394|FG004|Overall Study|Withdrawal by Subject|3|||
37675276|NCT04560816|69149395|FG005|Overall Study|Withdrawal by Subject|0|||
37675277|NCT04560816|69149390|FG000|Overall Study|Lost to Follow-up|1|||
37675278|NCT04560816|69149391|FG001|Overall Study|Lost to Follow-up|0|||
37675279|NCT04560816|69149392|FG002|Overall Study|Lost to Follow-up|0|||
37675280|NCT04560816|69149393|FG003|Overall Study|Lost to Follow-up|0|||
37675281|NCT04560816|69149394|FG004|Overall Study|Lost to Follow-up|0|||
37675282|NCT04560816|69149395|FG005|Overall Study|Lost to Follow-up|0|||
37675283|NCT04560816|69149390|FG000|Overall Study|Protocol Violation|1|||
37675284|NCT04560816|69149391|FG001|Overall Study|Protocol Violation|0|||
37675285|NCT04560816|69149392|FG002|Overall Study|Protocol Violation|0|||
37675286|NCT04560816|69149393|FG003|Overall Study|Protocol Violation|0|||
37675287|NCT04560816|69149394|FG004|Overall Study|Protocol Violation|0|||
37675288|NCT04560816|69149395|FG005|Overall Study|Protocol Violation|0|||
37675289|NCT04092582|69149409|FG000|Overall Study|Death|1|||
37675290|NCT04092582|69149410|FG001|Overall Study|Death|1|||
37675291|NCT04092582|69149409|FG000|Overall Study|Withdrawal by Subject|4|||
37675292|NCT04092582|69149410|FG001|Overall Study|Withdrawal by Subject|1|||
37675293|NCT04092582|69149409|FG000|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|0|||
37675294|NCT04092582|69149410|FG001|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|1|||
37675295|NCT03636256|69149446|FG000|Overall Study|Lost to Follow-up|3|||
37675296|NCT03636256|69149447|FG001|Overall Study|Lost to Follow-up|0|||
37675297|NCT03636256|69149448|FG002|Overall Study|Lost to Follow-up|2|||
37675298|NCT03636256|69149449|FG003|Overall Study|Lost to Follow-up|1|||
37675299|NCT03636256|69149450|FG004|Overall Study|Lost to Follow-up|0|||
37675300|NCT03636256|69149451|FG005|Overall Study|Lost to Follow-up|4|||
37675301|NCT03636256|69149452|FG006|Overall Study|Lost to Follow-up|2|||
37675302|NCT03636256|69149453|FG007|Overall Study|Lost to Follow-up|0|||
37675303|NCT03636256|69149454|FG008|Overall Study|Lost to Follow-up|4|||
37675304|NCT03636256|69149446|FG000|Overall Study|Withdrawal by Subject|0|||
37675305|NCT03636256|69149447|FG001|Overall Study|Withdrawal by Subject|0|||
37675306|NCT03636256|69149448|FG002|Overall Study|Withdrawal by Subject|0|||
37675307|NCT03636256|69149449|FG003|Overall Study|Withdrawal by Subject|0|||
37675308|NCT03636256|69149450|FG004|Overall Study|Withdrawal by Subject|0|||
37675309|NCT03636256|69149451|FG005|Overall Study|Withdrawal by Subject|0|||
37675310|NCT03636256|69149452|FG006|Overall Study|Withdrawal by Subject|0|||
37945573|NCT00675506|69633097|FG000|Overall Study|Elevated IGF-1|2|||
37945574|NCT00675506|69633098|FG001|Overall Study|Elevated IGF-1|0|||
37675311|NCT03636256|69149453|FG007|Overall Study|Withdrawal by Subject|0|||
37675312|NCT03636256|69149454|FG008|Overall Study|Withdrawal by Subject|1|||
37675313|NCT03614676|69149485|FG000|Overall Study|Delivery before planned visit|2|||
37675314|NCT03614676|69149486|FG001|Overall Study|Delivery before planned visit|0|||
37675315|NCT03614676|69149485|FG000|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|34|||
37675316|NCT03614676|69149486|FG001|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|0|||
37675317|NCT03614676|69149485|FG000|Overall Study|Migrated / moved from the study area|30|||
37675318|NCT03614676|69149486|FG001|Overall Study|Migrated / moved from the study area|22|||
37675319|NCT03614676|69149485|FG000|Overall Study|Lost to Follow-up|17|||
37675320|NCT03614676|69149486|FG001|Overall Study|Lost to Follow-up|42|||
37675321|NCT03614676|69149485|FG000|Overall Study|Not willing/ not able to participate in this visit|17|||
37675322|NCT03614676|69149486|FG001|Overall Study|Not willing/ not able to participate in this visit|16|||
37675323|NCT03614676|69149485|FG000|Overall Study|Other|16|||
37675324|NCT03614676|69149486|FG001|Overall Study|Other|47|||
37675325|NCT03614676|69149485|FG000|Overall Study|Protocol Violation|0|||
37675326|NCT03614676|69149486|FG001|Overall Study|Protocol Violation|2|||
37675327|NCT03614676|69149485|FG000|Overall Study|Neonatal event of interest|0|||
37675328|NCT03614676|69149486|FG001|Overall Study|Neonatal event of interest|6|||
37675329|NCT03614676|69149485|FG000|Overall Study|Death in infant greater than 28 days old|0|||
37675330|NCT03614676|69149486|FG001|Overall Study|Death in infant greater than 28 days old|12|||
37675331|NCT03614676|69149485|FG000|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|0|||
37675332|NCT03614676|69149486|FG001|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|17|||
37675333|NCT02727478|69149498|FG000|Overall Study|Withdrawal by Subject|8|||
37675334|NCT02727478|69149499|FG001|Overall Study|Withdrawal by Subject|10|||
37675335|NCT02614794|69149507|FG000|Overall Study|Death|258|||
37675336|NCT02614794|69149508|FG001|Overall Study|Death|151|||
37675337|NCT02614794|69149507|FG000|Overall Study|Study closure by Sponsor|119|||
37675338|NCT02614794|69149508|FG001|Overall Study|Study closure by Sponsor|45|||
37675339|NCT02614794|69149507|FG000|Overall Study|Withdrawal by Subject|24|||
37675340|NCT02614794|69149508|FG001|Overall Study|Withdrawal by Subject|5|||
37675341|NCT02614794|69149507|FG000|Overall Study|Lost to Follow-up|7|||
37675342|NCT02614794|69149508|FG001|Overall Study|Lost to Follow-up|0|||
37675343|NCT02614794|69149507|FG000|Overall Study|Physician Decision|1|||
37675344|NCT02614794|69149508|FG001|Overall Study|Physician Decision|1|||
37675345|NCT02614794|69149507|FG000|Overall Study|Hospital closure|1|||
37675346|NCT02614794|69149508|FG001|Overall Study|Hospital closure|0|||
37675347|NCT02361944|69149516|FG000|Overall Study|surgery cancellation|0|||
37675348|NCT02361944|69149517|FG001|Overall Study|surgery cancellation|1|||
37675349|NCT01649232|69149530|FG000|Overall Study|Physician Decision|2|||
37675350|NCT01649232|69149531|FG001|Overall Study|Physician Decision|0|||
37675351|NCT00955968|69149545|FG000|Overall Study|Death|2|||
37675352|NCT00955968|69149546|FG001|Overall Study|Death|4|||
37675353|NCT00955968|69149545|FG000|Overall Study|Withdrawal by Subject|35|||
37675354|NCT00955968|69149546|FG001|Overall Study|Withdrawal by Subject|31|||
37675355|NCT00955968|69149545|FG000|Overall Study|Lost to Follow-up|45|||
37675356|NCT00955968|69149546|FG001|Overall Study|Lost to Follow-up|39|||
37675357|NCT00955968|69149545|FG000|Overall Study|Site closed|55|||
37675358|NCT00955968|69149546|FG001|Overall Study|Site closed|52|||
37767194|NCT02639559|69282363|FG000|Overall Study|Issues with vascular acess|1|||
37767195|NCT02639559|69282364|FG001|Overall Study|Issues with vascular acess|0|||
37767196|NCT02581891|69282372|FG000|Overall Study|Adverse Event|4|||
37677621|NCT01360645|69152680|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
37677622|NCT01360645|69152681|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
37677623|NCT01360645|69152682|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
37677624|NCT01360645|69152679|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
37677625|NCT01360645|69152680|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
37677626|NCT01360645|69152681|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
37677627|NCT01360645|69152682|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
37677628|NCT01360645|69152679|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
37677629|NCT01360645|69152680|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
37677630|NCT01360645|69152681|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
37677631|NCT01360645|69152682|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
37677632|NCT01360645|69152679|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
37677633|NCT01360645|69152680|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
37677634|NCT01360645|69152681|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
37677635|NCT01360645|69152682|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
37677636|NCT01360645|69152679|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
37677637|NCT01360645|69152680|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
37677638|NCT01360645|69152681|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
37677639|NCT01360645|69152682|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
37677640|NCT01360645|69152679|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
37677641|NCT01360645|69152680|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
37677642|NCT01360645|69152681|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
37677643|NCT01360645|69152682|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
37677644|NCT01360645|69152679|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
37677645|NCT01360645|69152680|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
37677646|NCT01360645|69152681|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
37677647|NCT01360645|69152682|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
37677648|NCT01360645|69152679|FG000|Phase B (6 Weeks)|Adverse Event|0|||
37677649|NCT01360645|69152680|FG001|Phase B (6 Weeks)|Adverse Event|6|||
37675359|NCT05062759|69149570|FG000|Overall Study|Death|0|||
37675360|NCT05062759|69149571|FG001|Overall Study|Death|1|||
37675361|NCT05062759|69149570|FG000|Overall Study|Lost to Follow-up|1|||
37675362|NCT05062759|69149571|FG001|Overall Study|Lost to Follow-up|0|||
37675363|NCT05033262|69149590|FG000|Overall Study|Lost to Follow-up|1|||
37675364|NCT05033262|69149591|FG001|Overall Study|Lost to Follow-up|0|||
37675365|NCT05033262|69149592|FG002|Overall Study|Lost to Follow-up|0|||
37675366|NCT05033262|69149593|FG003|Overall Study|Lost to Follow-up|1|||
37675367|NCT04963062|69149607|FG000|Overall Study|withdrew by the study team|4|||
37675368|NCT04963062|69149608|FG001|Overall Study|withdrew by the study team|2|||
37675369|NCT04900220|69149620|FG000|Overall Study|Lost to Follow-up|1|||
37675370|NCT04900220|69149621|FG001|Overall Study|Lost to Follow-up|1|||
37675371|NCT04599062|69149633|FG000|Overall Study|Physician Decision|1|||
37675372|NCT04599062|69149634|FG001|Overall Study|Physician Decision|0|||
37675373|NCT04537208|69149651|FG000|Overall Study|Adverse Event|0|||
37675374|NCT04537208|69149652|FG001|Overall Study|Adverse Event|0|||
37675375|NCT04537208|69149653|FG002|Overall Study|Adverse Event|0|||
37945575|NCT00675506|69633097|FG000|Overall Study|Hypersensitivity Reaction|1|||
37945576|NCT00675506|69633098|FG001|Overall Study|Hypersensitivity Reaction|0|||
37945577|NCT00675506|69633097|FG000|Overall Study|Disclosed history of cancer|1|||
37945578|NCT00675506|69633098|FG001|Overall Study|Disclosed history of cancer|0|||
37945579|NCT00675506|69633097|FG000|Overall Study|Declined participation|1|||
37945580|NCT00675506|69633098|FG001|Overall Study|Declined participation|0|||
37675376|NCT04537208|69149654|FG003|Overall Study|Adverse Event|0|||
37675377|NCT04537208|69149655|FG004|Overall Study|Adverse Event|0|||
37675378|NCT04537208|69149656|FG005|Overall Study|Adverse Event|0|||
37675379|NCT04537208|69149657|FG006|Overall Study|Adverse Event|0|||
37675380|NCT04537208|69149658|FG007|Overall Study|Adverse Event|0|||
37675381|NCT04537208|69149659|FG008|Overall Study|Adverse Event|1|||
37675382|NCT04537208|69149660|FG009|Overall Study|Adverse Event|0|||
37675383|NCT04537208|69149661|FG010|Overall Study|Adverse Event|0|||
37675384|NCT04537208|69149651|FG000|Overall Study|Protocol deviation|0|||
37675385|NCT04537208|69149652|FG001|Overall Study|Protocol deviation|0|||
37675386|NCT04537208|69149653|FG002|Overall Study|Protocol deviation|2|||
37675387|NCT04537208|69149654|FG003|Overall Study|Protocol deviation|0|||
37675388|NCT04537208|69149655|FG004|Overall Study|Protocol deviation|0|||
37675389|NCT04537208|69149656|FG005|Overall Study|Protocol deviation|2|||
37675390|NCT04537208|69149657|FG006|Overall Study|Protocol deviation|4|||
37675391|NCT04537208|69149658|FG007|Overall Study|Protocol deviation|0|||
37675392|NCT04537208|69149659|FG008|Overall Study|Protocol deviation|1|||
37675393|NCT04537208|69149660|FG009|Overall Study|Protocol deviation|0|||
37675394|NCT04537208|69149661|FG010|Overall Study|Protocol deviation|2|||
37675395|NCT04537208|69149651|FG000|Overall Study|Withdrawal by Subject|4|||
37675396|NCT04537208|69149652|FG001|Overall Study|Withdrawal by Subject|2|||
37675397|NCT04537208|69149653|FG002|Overall Study|Withdrawal by Subject|1|||
37675398|NCT04537208|69149654|FG003|Overall Study|Withdrawal by Subject|3|||
37675399|NCT04537208|69149655|FG004|Overall Study|Withdrawal by Subject|5|||
37675400|NCT04537208|69149656|FG005|Overall Study|Withdrawal by Subject|1|||
37675401|NCT04537208|69149657|FG006|Overall Study|Withdrawal by Subject|6|||
37675402|NCT04537208|69149658|FG007|Overall Study|Withdrawal by Subject|1|||
37675403|NCT04537208|69149659|FG008|Overall Study|Withdrawal by Subject|7|||
37675404|NCT04537208|69149660|FG009|Overall Study|Withdrawal by Subject|2|||
37675405|NCT04537208|69149661|FG010|Overall Study|Withdrawal by Subject|4|||
37675406|NCT04537208|69149651|FG000|Overall Study|Lost to Follow-up|4|||
37675407|NCT04537208|69149652|FG001|Overall Study|Lost to Follow-up|1|||
37675408|NCT04537208|69149653|FG002|Overall Study|Lost to Follow-up|3|||
37675409|NCT04537208|69149654|FG003|Overall Study|Lost to Follow-up|4|||
37675410|NCT04537208|69149655|FG004|Overall Study|Lost to Follow-up|3|||
37675411|NCT04537208|69149656|FG005|Overall Study|Lost to Follow-up|2|||
37675412|NCT04537208|69149657|FG006|Overall Study|Lost to Follow-up|3|||
37675413|NCT04537208|69149658|FG007|Overall Study|Lost to Follow-up|2|||
37675414|NCT04537208|69149659|FG008|Overall Study|Lost to Follow-up|7|||
37945581|NCT00675506|69633097|FG000|Overall Study|Schedule conflict|0|||
37675415|NCT04537208|69149660|FG009|Overall Study|Lost to Follow-up|2|||
37675416|NCT04537208|69149661|FG010|Overall Study|Lost to Follow-up|2|||
37675417|NCT04502433|69149690|FG000|Overall Study|Death|2|||
37675418|NCT04502433|69149691|FG001|Overall Study|Death|4|||
37675419|NCT04502433|69149690|FG000|Overall Study|Lost to Follow-up|1|||
37675420|NCT04502433|69149691|FG001|Overall Study|Lost to Follow-up|0|||
37675421|NCT04502433|69149690|FG000|Overall Study|Physician Decision|0|||
37675422|NCT04502433|69149691|FG001|Overall Study|Physician Decision|1|||
37675423|NCT04442503|69149699|FG000|Overall Study|Adverse Event|1|||
37675424|NCT04442503|69149700|FG001|Overall Study|Adverse Event|1|||
37675425|NCT04442503|69149699|FG000|Overall Study|Lost to Follow-up|8|||
37675426|NCT04442503|69149700|FG001|Overall Study|Lost to Follow-up|6|||
37675427|NCT04442503|69149699|FG000|Overall Study|Physician Decision|0|||
37675428|NCT04442503|69149700|FG001|Overall Study|Physician Decision|2|||
37675429|NCT04442503|69149699|FG000|Overall Study|Withdrawal by Subject|3|||
37675430|NCT04442503|69149700|FG001|Overall Study|Withdrawal by Subject|4|||
37945582|NCT00675506|69633098|FG001|Overall Study|Schedule conflict|1|||
37675431|NCT04442503|69149699|FG000|Overall Study|Reason not Specified|0|||
37675432|NCT04442503|69149700|FG001|Overall Study|Reason not Specified|1|||
37675433|NCT04442503|69149699|FG000|Overall Study|Randomized but not Treated|3|||
37675434|NCT04442503|69149700|FG001|Overall Study|Randomized but not Treated|1|||
37675435|NCT04411914|69149708|FG000|CLAV 500mg/Day for Days 1-3|Adverse Event|1|||
37675436|NCT04411914|69149709|FG001|CLAV 500mg/Day for Days 1-3|Adverse Event|0|||
37675437|NCT04389671|69149728|FG000|Overall Study|Death|7|||
37675438|NCT04381494|69149732|FG000|Overall Study|Early termination of trial|19|||
37675439|NCT04381494|69149732|FG000|Overall Study|Investigator's discretion|1|||
37675440|NCT04381494|69149732|FG000|Overall Study|Withdrawal by Subject|9|||
37675441|NCT04381494|69149732|FG000|Overall Study|NSCLC disease progression|4|||
37675442|NCT04381494|69149732|FG000|Overall Study|Device-Related Adverse Event|2|||
37675443|NCT04094584|69149787|FG000|Overall Study|No interest in study|88|||
37675444|NCT04094584|69149787|FG000|Overall Study|Unwilling to undergo screening tests|36|||
37675445|NCT04094584|69149787|FG000|Overall Study|Liver disease (enzymes >5 times upper limit of cirrhosis)|8|||
37675446|NCT04094584|69149787|FG000|Overall Study|Opioid use|7|||
37675447|NCT04094584|69149787|FG000|Overall Study|Need for major surgery in study period|4|||
37675448|NCT04094584|69149787|FG000|Overall Study|eligible but declined enrollment|4|||
37675449|NCT04094584|69149787|FG000|Overall Study|Chose to stop injections after week 4 but continued case management and provided complete data|2|||
37675450|NCT04094584|69149787|FG000|Overall Study|Missed study visits resulting. in incomplete data but sufficient for a pre-post comparison|2|||
37675451|NCT04094584|69149787|FG000|Overall Study|Lost to Follow-up|3|||
37675452|NCT04094584|69149787|FG000|Overall Study|Withdrawal by Subject|2|||
37675453|NCT04020341|69149802|FG000|Overall Study|Adverse Event|8|||
37675454|NCT04020341|69149803|FG001|Overall Study|Adverse Event|6|||
37675455|NCT04020341|69149802|FG000|Overall Study|Lost to Follow-up|8|||
37675456|NCT04020341|69149803|FG001|Overall Study|Lost to Follow-up|2|||
37675457|NCT04020341|69149802|FG000|Overall Study|Withdrawal by Subject|16|||
37675458|NCT04020341|69149803|FG001|Overall Study|Withdrawal by Subject|16|||
37675459|NCT04020341|69149802|FG000|Overall Study|Participant not able to swallow the tablet|1|||
37675460|NCT04020341|69149803|FG001|Overall Study|Participant not able to swallow the tablet|0|||
37675461|NCT04020341|69149802|FG000|Overall Study|Physician Decision|0|||
37675462|NCT04020341|69149803|FG001|Overall Study|Physician Decision|2|||
37675463|NCT04020341|69149802|FG000|Overall Study|Protocol Deviation|0|||
37675464|NCT04020341|69149803|FG001|Overall Study|Protocol Deviation|2|||
37675465|NCT03868891|69149825|FG000|Overall Study|Adverse Event|1|||
37675466|NCT03868891|69149826|FG001|Overall Study|Adverse Event|0|||
37675467|NCT03868891|69149825|FG000|Overall Study|Lost to Follow-up|2|||
37675468|NCT03868891|69149826|FG001|Overall Study|Lost to Follow-up|1|||
37675469|NCT03868891|69149825|FG000|Overall Study|COVID-19 Restrictions|1|||
37675470|NCT03868891|69149826|FG001|Overall Study|COVID-19 Restrictions|2|||
37675471|NCT03827655|69149846|FG000|Overall Study|Death|0|||
37675472|NCT03827655|69149847|FG001|Overall Study|Death|0|||
37675473|NCT03827655|69149848|FG002|Overall Study|Death|0|||
37675474|NCT03827655|69149849|FG003|Overall Study|Death|0|||
37675475|NCT03827655|69149850|FG004|Overall Study|Death|1|||
37675476|NCT03827655|69149846|FG000|Overall Study|Protocol Deviation|1|||
37675477|NCT03827655|69149847|FG001|Overall Study|Protocol Deviation|0|||
37675478|NCT03827655|69149848|FG002|Overall Study|Protocol Deviation|1|||
37675479|NCT03827655|69149849|FG003|Overall Study|Protocol Deviation|1|||
37675480|NCT03827655|69149850|FG004|Overall Study|Protocol Deviation|0|||
37675481|NCT03827655|69149846|FG000|Overall Study|Withdrawal by Subject|3|||
37675482|NCT03827655|69149847|FG001|Overall Study|Withdrawal by Subject|2|||
37675483|NCT03827655|69149848|FG002|Overall Study|Withdrawal by Subject|2|||
37675484|NCT03827655|69149849|FG003|Overall Study|Withdrawal by Subject|0|||
37675485|NCT03827655|69149850|FG004|Overall Study|Withdrawal by Subject|1|||
37675486|NCT03827655|69149846|FG000|Overall Study|Reason not Specified|3|||
37675487|NCT03827655|69149847|FG001|Overall Study|Reason not Specified|1|||
37767197|NCT02581891|69282373|FG001|Overall Study|Adverse Event|6|||
38039230|NCT02258542|69726561|FG002|Overall Study|Withdrawal by Subject|7|||
38039231|NCT02258542|69726562|FG003|Overall Study|Withdrawal by Subject|1|||
37675488|NCT03827655|69149848|FG002|Overall Study|Reason not Specified|1|||
37675489|NCT03827655|69149849|FG003|Overall Study|Reason not Specified|1|||
37675490|NCT03827655|69149850|FG004|Overall Study|Reason not Specified|1|||
37675491|NCT03782064|69149885|FG000|Overall Study|Lack of Efficacy|2|||
37675492|NCT03782064|69149885|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
37675493|NCT03772522|69149891|FG000|Pre-intervention|Withdrawal by Subject|3|||
37675494|NCT03772522|69149892|FG001|Pre-intervention|Withdrawal by Subject|4|||
37675495|NCT03772522|69149891|FG000|Intervention|Withdrawal by Subject|1|||
37675496|NCT03772522|69149892|FG001|Intervention|Withdrawal by Subject|0|||
37675497|NCT03772522|69149891|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
37675498|NCT03772522|69149892|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
37675499|NCT03755518|69149902|FG000|Overall Study|Adverse Event|6|||
37675500|NCT03755518|69149902|FG000|Overall Study|Lack of Efficacy|6|||
37675501|NCT03755518|69149902|FG000|Overall Study|Bone Marrow Transplant|4|||
37675502|NCT03755518|69149902|FG000|Overall Study|Withdrawal by participant|4|||
37675503|NCT03755518|69149902|FG000|Overall Study|Progressive Disease|2|||
37675504|NCT03755518|69149902|FG000|Overall Study|Death|1|||
37675505|NCT03755518|69149902|FG000|Overall Study|Physician Decision|1|||
37675506|NCT03755518|69149902|FG000|Overall Study|Withdrawal by investigator for non compliance|1|||
37675507|NCT03739112|69149908|FG000|Overall Study|Adverse Event|2|||
37675508|NCT03739112|69149909|FG001|Overall Study|Adverse Event|2|||
37675509|NCT03739112|69149908|FG000|Overall Study|Withdrawal by Subject|38|||
37675510|NCT03739112|69149909|FG001|Overall Study|Withdrawal by Subject|19|||
37675511|NCT03739112|69149908|FG000|Overall Study|Lost to Follow-up|31|||
37675512|NCT03739112|69149909|FG001|Overall Study|Lost to Follow-up|33|||
37675513|NCT03739112|69149908|FG000|Overall Study|Protocol Deviation|12|||
37675514|NCT03739112|69149909|FG001|Overall Study|Protocol Deviation|9|||
37675515|NCT03739112|69149908|FG000|Overall Study|Physician Decision|1|||
37675516|NCT03739112|69149909|FG001|Overall Study|Physician Decision|0|||
37675517|NCT03739112|69149908|FG000|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|12|||
37675518|NCT03739112|69149909|FG001|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|16|||
37675519|NCT03739112|69149908|FG000|Overall Study|Site went on hold|65|||
37675520|NCT03739112|69149909|FG001|Overall Study|Site went on hold|67|||
37675521|NCT03739112|69149908|FG000|Overall Study|Other than specified|8|||
37675522|NCT03739112|69149909|FG001|Overall Study|Other than specified|5|||
37675523|NCT03739112|69149908|FG000|Overall Study|Randomized but not vaccinated|31|||
37675524|NCT03739112|69149909|FG001|Overall Study|Randomized but not vaccinated|25|||
37675525|NCT03622593|69149918|FG000|Overall Study|Withdrawal by Subject|11|||
37675526|NCT03622593|69149919|FG001|Overall Study|Withdrawal by Subject|9|||
37675527|NCT03622593|69149920|FG002|Overall Study|Withdrawal by Subject|13|||
37675528|NCT03622593|69149918|FG000|Overall Study|Death|12|||
37675529|NCT03622593|69149919|FG001|Overall Study|Death|9|||
37675530|NCT03622593|69149920|FG002|Overall Study|Death|10|||
37675531|NCT03622593|69149918|FG000|Overall Study|Lost to Follow-up|11|||
37675532|NCT03622593|69149919|FG001|Overall Study|Lost to Follow-up|5|||
37675533|NCT03622593|69149920|FG002|Overall Study|Lost to Follow-up|8|||
37675534|NCT03622593|69149918|FG000|Overall Study|Adverse Event|4|||
37675535|NCT03622593|69149919|FG001|Overall Study|Adverse Event|5|||
37675536|NCT03622593|69149920|FG002|Overall Study|Adverse Event|6|||
37675537|NCT03622593|69149918|FG000|Overall Study|Physician Decision|2|||
37675538|NCT03622593|69149919|FG001|Overall Study|Physician Decision|1|||
37675539|NCT03622593|69149920|FG002|Overall Study|Physician Decision|6|||
37675540|NCT03622593|69149918|FG000|Overall Study|Other|2|||
37675541|NCT03622593|69149919|FG001|Overall Study|Other|2|||
37675542|NCT03622593|69149920|FG002|Overall Study|Other|3|||
37675543|NCT03622593|69149918|FG000|Overall Study|Protocol Violation|0|||
37675544|NCT03622593|69149919|FG001|Overall Study|Protocol Violation|0|||
37675545|NCT03622593|69149920|FG002|Overall Study|Protocol Violation|1|||
37675546|NCT03622593|69149918|FG000|Overall Study|Pregnancy|0|||
37675547|NCT03622593|69149919|FG001|Overall Study|Pregnancy|0|||
37675548|NCT03622593|69149920|FG002|Overall Study|Pregnancy|1|||
37675549|NCT03593655|69149931|FG000|First Product Use Period|Withdrawal by Subject|1|||
37675550|NCT03593655|69149932|FG001|First Product Use Period|Withdrawal by Subject|1|||
37675551|NCT03593655|69149931|FG000|First Product Use Period|Lost to Follow-up|1|||
37675552|NCT03593655|69149932|FG001|First Product Use Period|Lost to Follow-up|3|||
37675553|NCT03593655|69149931|FG000|Second Product Use Period|Withdrawal by Subject|1|||
37675554|NCT03593655|69149932|FG001|Second Product Use Period|Withdrawal by Subject|1|||
37675555|NCT03593655|69149931|FG000|Second Product Use Period|Lost to Follow-up|1|||
37675556|NCT03593655|69149932|FG001|Second Product Use Period|Lost to Follow-up|0|||
37675557|NCT03593655|69149931|FG000|Third Product Use Period|Lost to Follow-up|1|||
37675558|NCT03593655|69149932|FG001|Third Product Use Period|Lost to Follow-up|2|||
37675559|NCT03593655|69149931|FG000|Third Product Use Period|Physician Decision|0|||
37675560|NCT03593655|69149932|FG001|Third Product Use Period|Physician Decision|1|||
37675561|NCT03593655|69149931|FG000|Third Product Use Period|Withdrawal by Subject|0|||
37675562|NCT03593655|69149932|FG001|Third Product Use Period|Withdrawal by Subject|1|||
37675563|NCT03577106|69149941|FG000|Overall Study|Withdrawal by Subject|3|||
37675564|NCT03364231|69149951|FG000|Overall Study|Adverse Event|1|||
37945583|NCT03895840|69633105|FG000|Overall Study|Withdrawal by Subject|21|||
37945584|NCT00310375|69633111|FG000|Primary Reporting Phase|Adverse Event|28|||
37945585|NCT00310375|69633112|FG001|Primary Reporting Phase|Adverse Event|22|||
37675565|NCT03364231|69149952|FG001|Overall Study|Adverse Event|4|||
37675566|NCT03364231|69149951|FG000|Overall Study|Death|1|||
37675567|NCT03364231|69149952|FG001|Overall Study|Death|0|||
37675568|NCT03364231|69149951|FG000|Overall Study|Investigator Decision|2|||
37675569|NCT03364231|69149952|FG001|Overall Study|Investigator Decision|2|||
37675570|NCT03364231|69149951|FG000|Overall Study|Sponsor Discontinuation of the Study|2|||
37675571|NCT03364231|69149952|FG001|Overall Study|Sponsor Discontinuation of the Study|1|||
37675572|NCT03364231|69149951|FG000|Overall Study|Withdrawal of Subject Consent|1|||
37675573|NCT03364231|69149952|FG001|Overall Study|Withdrawal of Subject Consent|0|||
37675574|NCT03364231|69149951|FG000|Overall Study|Reason Not Specified|1|||
37675575|NCT03364231|69149952|FG001|Overall Study|Reason Not Specified|0|||
37675576|NCT03364231|69149951|FG000|Overall Study|Disease Progression|0|||
37675577|NCT03364231|69149952|FG001|Overall Study|Disease Progression|6|||
37675578|NCT03303625|69149963|FG000|Overall Study|Withdrawal by Subject|2|||
37675579|NCT03303625|69149964|FG001|Overall Study|Withdrawal by Subject|0|||
37675580|NCT03303625|69149965|FG002|Overall Study|Withdrawal by Subject|0|||
37675581|NCT03303625|69149966|FG003|Overall Study|Withdrawal by Subject|0|||
37675582|NCT03299816|69149978|FG000|Phase 1: 4-month Intervention Period|Withdrawal by Subject|1|||
37675583|NCT03299816|69149979|FG001|Phase 1: 4-month Intervention Period|Withdrawal by Subject|0|||
37675584|NCT03299816|69149978|FG000|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|1|||
37675585|NCT03299816|69149979|FG001|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|0|||
37675586|NCT03299816|69149978|FG000|Phase 2: 12-month Follow-up Period|Lost to Follow-up|2|||
37675587|NCT03299816|69149979|FG001|Phase 2: 12-month Follow-up Period|Lost to Follow-up|3|||
37675588|NCT03288493|69149992|FG000|Overall Study|Withdrawal by Subject|4|||
37675589|NCT03288493|69149993|FG001|Overall Study|Withdrawal by Subject|0|||
37675590|NCT03288493|69149994|FG002|Overall Study|Withdrawal by Subject|0|||
37675591|NCT03288493|69149995|FG003|Overall Study|Withdrawal by Subject|0|||
37675592|NCT03288493|69149996|FG004|Overall Study|Withdrawal by Subject|0|||
37675593|NCT03288493|69149997|FG005|Overall Study|Withdrawal by Subject|2|||
37675594|NCT03288493|69149998|FG006|Overall Study|Withdrawal by Subject|0|||
37675595|NCT03288493|69149992|FG000|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|52|||
37675596|NCT03288493|69149993|FG001|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
37675597|NCT03288493|69149994|FG002|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|1|||
37675598|NCT03288493|69149995|FG003|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|6|||
37675599|NCT03288493|69149996|FG004|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|5|||
37675600|NCT03288493|69149997|FG005|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|10|||
37675601|NCT03288493|69149998|FG006|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
37675602|NCT03288493|69149992|FG000|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|6|||
37675603|NCT03288493|69149993|FG001|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
37675604|NCT03288493|69149994|FG002|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
37675605|NCT03288493|69149995|FG003|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|2|||
37675606|NCT03288493|69149996|FG004|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
37675607|NCT03288493|69149997|FG005|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|4|||
37675608|NCT03288493|69149998|FG006|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
37675609|NCT03288493|69149992|FG000|Overall Study|Death|2|||
37675610|NCT03288493|69149993|FG001|Overall Study|Death|0|||
37675611|NCT03288493|69149994|FG002|Overall Study|Death|0|||
37675612|NCT03288493|69149995|FG003|Overall Study|Death|0|||
37675613|NCT03288493|69149996|FG004|Overall Study|Death|0|||
37675614|NCT03288493|69149997|FG005|Overall Study|Death|0|||
37675615|NCT03288493|69149998|FG006|Overall Study|Death|0|||
37675616|NCT03288493|69149992|FG000|Overall Study|other reason not listed above|2|||
37675617|NCT03288493|69149993|FG001|Overall Study|other reason not listed above|0|||
37675618|NCT03288493|69149994|FG002|Overall Study|other reason not listed above|0|||
37675619|NCT03288493|69149995|FG003|Overall Study|other reason not listed above|0|||
37675620|NCT03288493|69149996|FG004|Overall Study|other reason not listed above|0|||
37675621|NCT03288493|69149997|FG005|Overall Study|other reason not listed above|0|||
37675622|NCT03288493|69149998|FG006|Overall Study|other reason not listed above|0|||
37675623|NCT03238300|69150018|FG000|Baseline (Before Intervention)|Physician Decision|0|||
37675624|NCT03238300|69150019|FG001|Baseline (Before Intervention)|Physician Decision|1|||
37675625|NCT03238300|69150018|FG000|Washout Period (11-Days)|Withdrawal by Subject|1|||
37675626|NCT03238300|69150019|FG001|Washout Period (11-Days)|Withdrawal by Subject|0|||
37675627|NCT03238300|69150018|FG000|Second Intervention (10-Days)|Lost to Follow-up|1|||
37675628|NCT03238300|69150019|FG001|Second Intervention (10-Days)|Lost to Follow-up|0|||
37675629|NCT03238300|69150018|FG000|Second Intervention (10-Days)|Withdrawal by Subject|1|||
37675630|NCT03238300|69150019|FG001|Second Intervention (10-Days)|Withdrawal by Subject|0|||
37675631|NCT03178045|69150031|FG000|Overall Study|Withdrawal by Subject|5|||
37675632|NCT03178045|69150032|FG001|Overall Study|Withdrawal by Subject|7|||
37675633|NCT03178045|69150031|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
37675634|NCT03178045|69150032|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
37675635|NCT03178045|69150031|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
37675636|NCT03178045|69150032|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
37675637|NCT03113500|69150056|FG000|Overall Study|Withdrawal by Subject|1|||
37675638|NCT02924727|69150077|FG000|Overall Study|Withdrawal by Subject|2|||
37675639|NCT02924727|69150078|FG001|Overall Study|Withdrawal by Subject|4|||
37675640|NCT02924727|69150077|FG000|Overall Study|Lost to Follow-up|2|||
37675641|NCT02924727|69150078|FG001|Overall Study|Lost to Follow-up|5|||
37675642|NCT02924727|69150077|FG000|Overall Study|Death|221|||
37675643|NCT02924727|69150078|FG001|Overall Study|Death|247|||
37675644|NCT02924727|69150077|FG000|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|4|||
37675645|NCT02924727|69150078|FG001|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|3|||
37675646|NCT02901626|69150088|FG000|Overall Study|Lost to Follow-up|1|||
37675647|NCT02901626|69150089|FG001|Overall Study|Lost to Follow-up|1|||
37675648|NCT02720692|69150128|FG000|Overall Study|Withdrawal by Subject|3|||
37675649|NCT02720692|69150129|FG001|Overall Study|Withdrawal by Subject|0|||
37675650|NCT02720692|69150128|FG000|Overall Study|Physician Decision|1|||
37675651|NCT02720692|69150129|FG001|Overall Study|Physician Decision|0|||
37675652|NCT02720692|69150128|FG000|Overall Study|Lost to Follow-up|8|||
37675653|NCT02720692|69150129|FG001|Overall Study|Lost to Follow-up|3|||
37675654|NCT02720692|69150128|FG000|Overall Study|Subject unable to return for visit|1|||
37675655|NCT02720692|69150129|FG001|Overall Study|Subject unable to return for visit|0|||
37675656|NCT02656303|69150138|FG000|Overall Study|Adverse Event|3|||
37675657|NCT02656303|69150139|FG001|Overall Study|Adverse Event|2|||
37675658|NCT02656303|69150140|FG002|Overall Study|Adverse Event|0|||
38039232|NCT02258542|69726559|FG000|Overall Study|Lost to Follow-up|5|||
38039233|NCT02258542|69726560|FG001|Overall Study|Lost to Follow-up|12|||
37675659|NCT02656303|69150138|FG000|Overall Study|Death|12|||
37675660|NCT02656303|69150139|FG001|Overall Study|Death|4|||
37675661|NCT02656303|69150140|FG002|Overall Study|Death|1|||
37675662|NCT02656303|69150138|FG000|Overall Study|Lack of Efficacy|1|||
37675663|NCT02656303|69150139|FG001|Overall Study|Lack of Efficacy|0|||
37675664|NCT02656303|69150140|FG002|Overall Study|Lack of Efficacy|0|||
37675665|NCT02656303|69150138|FG000|Overall Study|Non-Compliance with Study|1|||
37675666|NCT02656303|69150139|FG001|Overall Study|Non-Compliance with Study|1|||
37675667|NCT02656303|69150140|FG002|Overall Study|Non-Compliance with Study|0|||
37675668|NCT02656303|69150138|FG000|Overall Study|Investigator Decision|2|||
37675669|NCT02656303|69150139|FG001|Overall Study|Investigator Decision|1|||
37675670|NCT02656303|69150140|FG002|Overall Study|Investigator Decision|0|||
37675671|NCT02656303|69150138|FG000|Overall Study|Progressive Disease|25|||
37675672|NCT02656303|69150139|FG001|Overall Study|Progressive Disease|14|||
37675673|NCT02656303|69150140|FG002|Overall Study|Progressive Disease|10|||
37675674|NCT02656303|69150138|FG000|Overall Study|Study Terminated by Sponsor|20|||
37675675|NCT02656303|69150139|FG001|Overall Study|Study Terminated by Sponsor|7|||
37675676|NCT02656303|69150140|FG002|Overall Study|Study Terminated by Sponsor|5|||
37675677|NCT02656303|69150138|FG000|Overall Study|Withdrawal of Consent by Participants|1|||
37675678|NCT02656303|69150139|FG001|Overall Study|Withdrawal of Consent by Participants|1|||
37675679|NCT02656303|69150140|FG002|Overall Study|Withdrawal of Consent by Participants|0|||
38039234|NCT02258542|69726561|FG002|Overall Study|Lost to Follow-up|1|||
37675680|NCT02656303|69150138|FG000|Overall Study|Initiation of Non-protocol Intervention|1|||
37675681|NCT02656303|69150139|FG001|Overall Study|Initiation of Non-protocol Intervention|0|||
37675682|NCT02656303|69150140|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
37675683|NCT02656303|69150138|FG000|Overall Study|Reason not Specified|1|||
37675684|NCT02656303|69150139|FG001|Overall Study|Reason not Specified|1|||
37675685|NCT02656303|69150140|FG002|Overall Study|Reason not Specified|2|||
37675686|NCT02628626|69150150|FG000|Overall Study|Withdrawal by Subject|2|||
37675687|NCT02628626|69150151|FG001|Overall Study|Withdrawal by Subject|2|||
37675688|NCT02527707|69150183|FG000|Overall Study|Adverse Event|1|||
37675689|NCT02527707|69150183|FG000|Overall Study|Adverse Event|1|||
37675690|NCT02453191|69150194|FG000|Overall Study|Withdrawal by Subject|1|||
37675691|NCT02352090|69150202|FG000|Overall Study|general malaise|1|||
37675692|NCT02352090|69150203|FG001|Overall Study|general malaise|0|||
37675693|NCT02352090|69150204|FG002|Overall Study|general malaise|0|||
37675694|NCT02352090|69150202|FG000|Overall Study|non-specified mild side-effects|0|||
37675695|NCT02352090|69150203|FG001|Overall Study|non-specified mild side-effects|0|||
37945586|NCT00310375|69633113|FG002|Primary Reporting Phase|Adverse Event|0|||
37945587|NCT00310375|69633111|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
37945588|NCT00310375|69633112|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
37945589|NCT00310375|69633113|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
37945590|NCT00310375|69633111|FG000|Primary Reporting Phase|Pregnancy|2|||
37945591|NCT00310375|69633112|FG001|Primary Reporting Phase|Pregnancy|2|||
37945592|NCT00310375|69633113|FG002|Primary Reporting Phase|Pregnancy|0|||
37945593|NCT00310375|69633111|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
37675696|NCT02352090|69150204|FG002|Overall Study|non-specified mild side-effects|2|||
37675697|NCT02135107|69150214|FG000|Treatment Period|Withdrawal by Subject|11|||
37675698|NCT02135107|69150215|FG001|Treatment Period|Withdrawal by Subject|0|||
37675699|NCT02135107|69150216|FG002|Treatment Period|Withdrawal by Subject|0|||
37675700|NCT02135107|69150217|FG003|Treatment Period|Withdrawal by Subject|0|||
38039235|NCT02258542|69726562|FG003|Overall Study|Lost to Follow-up|2|||
37675701|NCT02135107|69150214|FG000|Treatment Period|Adverse Event|5|||
37945594|NCT00310375|69633112|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
38039236|NCT02258542|69726559|FG000|Overall Study|Death|5|||
37945595|NCT00310375|69633113|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
37945596|NCT00310375|69633111|FG000|Primary Reporting Phase|Protocol Violation|8|||
38039237|NCT02258542|69726560|FG001|Overall Study|Death|4|||
38039238|NCT02258542|69726561|FG002|Overall Study|Death|0|||
38039239|NCT02258542|69726562|FG003|Overall Study|Death|1|||
38039240|NCT02258542|69726559|FG000|Overall Study|Adverse Event|3|||
38039241|NCT02258542|69726560|FG001|Overall Study|Adverse Event|4|||
38039242|NCT02258542|69726561|FG002|Overall Study|Adverse Event|0|||
38039243|NCT02258542|69726562|FG003|Overall Study|Adverse Event|0|||
38039244|NCT02258542|69726559|FG000|Overall Study|Protocol Violation|1|||
38039245|NCT02258542|69726560|FG001|Overall Study|Protocol Violation|2|||
38039246|NCT02258542|69726561|FG002|Overall Study|Protocol Violation|0|||
38039247|NCT02258542|69726562|FG003|Overall Study|Protocol Violation|0|||
38039248|NCT02258542|69726559|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
38039249|NCT02258542|69726560|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
38039250|NCT02258542|69726561|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
38039251|NCT02258542|69726562|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
38039252|NCT00091793|69726592|FG000|Overall Study|Adverse Event|1|||
38039253|NCT00091793|69726593|FG001|Overall Study|Adverse Event|2|||
38039254|NCT00091793|69726592|FG000|Overall Study|Withdrawal by Subject|10|||
38039255|NCT00091793|69726593|FG001|Overall Study|Withdrawal by Subject|15|||
38039256|NCT00091793|69726592|FG000|Overall Study|Ineligibility determined|2|||
38039257|NCT00091793|69726593|FG001|Overall Study|Ineligibility determined|0|||
38039258|NCT00091793|69726592|FG000|Overall Study|Lost to Follow-up|7|||
38039259|NCT00091793|69726593|FG001|Overall Study|Lost to Follow-up|5|||
38039260|NCT00091793|69726592|FG000|Overall Study|Noncompliance|2|||
38039261|NCT00091793|69726593|FG001|Overall Study|Noncompliance|0|||
38039262|NCT00091793|69726592|FG000|Overall Study|Other|2|||
38039263|NCT00091793|69726593|FG001|Overall Study|Other|0|||
38039264|NCT00098813|69726599|FG000|Overall Study|Death|8|||
38039265|NCT00098813|69726599|FG000|Overall Study|Protocol Violation|1|||
38039266|NCT00098813|69726599|FG000|Overall Study|Withdrawal by Subject|7|||
38039267|NCT00098813|69726599|FG000|Overall Study|Progression of Disease|1|||
38039268|NCT00098813|69726599|FG000|Overall Study|Other complicating disease|1|||
38039269|NCT00098813|69726599|FG000|Overall Study|Reversal of RAI resistance|1|||
38039270|NCT00090857|69726605|FG000|Overall Study|Lost to Follow-up|0|||
38039271|NCT00090857|69726606|FG001|Overall Study|Lost to Follow-up|1|||
38039272|NCT00090857|69726605|FG000|Overall Study|Withdrawal by Subject|2|||
38039273|NCT00090857|69726606|FG001|Overall Study|Withdrawal by Subject|0|||
38039274|NCT00090857|69726605|FG000|Overall Study|Adverse Event|2|||
38039275|NCT00090857|69726606|FG001|Overall Study|Adverse Event|2|||
38039276|NCT00090779|69726618|FG000|Step 1|Withdrawal by Subject|4|||
38039277|NCT00090779|69726619|FG001|Step 1|Withdrawal by Subject|2|||
38039278|NCT00090779|69726618|FG000|Step 1|Lost to Follow-up|3|||
38039279|NCT00090779|69726619|FG001|Step 1|Lost to Follow-up|2|||
38039280|NCT00090779|69726618|FG000|Step 1|Death|0|||
38039281|NCT00090779|69726619|FG001|Step 1|Death|2|||
38039282|NCT00090779|69726618|FG000|Step 1|Physician Decision|1|||
38039283|NCT00090779|69726619|FG001|Step 1|Physician Decision|0|||
38039284|NCT00090779|69726618|FG000|Step 1|Pregnancy|1|||
38039285|NCT00090779|69726619|FG001|Step 1|Pregnancy|0|||
38039286|NCT00090779|69726618|FG000|Step 1|Non-compliance to study requirements|0|||
38039287|NCT00090779|69726619|FG001|Step 1|Non-compliance to study requirements|1|||
38039288|NCT00090779|69726618|FG000|Step 1|Subject relocated|2|||
37945597|NCT00310375|69633112|FG001|Primary Reporting Phase|Protocol Violation|5|||
37945598|NCT00310375|69633113|FG002|Primary Reporting Phase|Protocol Violation|0|||
37945599|NCT00310375|69633111|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
37945600|NCT00310375|69633112|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
37945601|NCT00310375|69633113|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
37945602|NCT00310375|69633111|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
37945603|NCT00310375|69633112|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
37945604|NCT00310375|69633113|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
37945605|NCT00310375|69633111|FG000|Primary Reporting Phase|Physician Decision|5|||
37945606|NCT00310375|69633112|FG001|Primary Reporting Phase|Physician Decision|3|||
37945607|NCT00310375|69633113|FG002|Primary Reporting Phase|Physician Decision|0|||
38039289|NCT00090779|69726619|FG001|Step 1|Subject relocated|8|||
37675702|NCT02135107|69150215|FG001|Treatment Period|Adverse Event|2|||
37945608|NCT00310375|69633111|FG000|Primary Reporting Phase|Request of the sponsor|2|||
38039290|NCT00090779|69726618|FG000|Step 2|Off study per study closure|6|||
38039291|NCT00090779|69726619|FG001|Step 2|Off study per study closure|16|||
38039292|NCT00090779|69726618|FG000|Step 2|Subject relocated|0|||
38039293|NCT00090779|69726619|FG001|Step 2|Subject relocated|1|||
38039294|NCT00090779|69726618|FG000|Step 2|Non-compliance to study requirements|0|||
38039295|NCT00090779|69726619|FG001|Step 2|Non-compliance to study requirements|1|||
38039296|NCT00090779|69726618|FG000|Step 3|Initiation of ART and off extended study|3|||
38039297|NCT00090779|69726619|FG001|Step 3|Initiation of ART and off extended study|2|||
38039298|NCT00090779|69726618|FG000|Step 3|Off extended study due to study closure|4|||
38039299|NCT00090779|69726619|FG001|Step 3|Off extended study due to study closure|3|||
38039300|NCT00098345|69726625|FG000|Overall Study|Adverse Event|7|||
38039301|NCT00098345|69726625|FG000|Overall Study|Withdrawal by Subject|2|||
38039302|NCT00098345|69726625|FG000|Overall Study|progression|4|||
38039303|NCT02224456|69726629|FG000|Overall Study|Lack of Efficacy|1|||
38039304|NCT02224456|69726629|FG000|Overall Study|Lost to Follow-up|15|||
38039305|NCT02224456|69726629|FG000|Overall Study|Withdrawal by Subject|9|||
38039306|NCT02224456|69726629|FG000|Overall Study|Physician Decision|3|||
38039307|NCT02224456|69726629|FG000|Overall Study|Death|2|||
38039308|NCT02224456|69726629|FG000|Overall Study|Pregnancy|4|||
38039309|NCT02224456|69726629|FG000|Overall Study|Protocol Violation|1|||
38039310|NCT02224456|69726629|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
38039311|NCT00097721|69726635|FG000|Overall Study|Adverse Event|8|||
38039312|NCT00097721|69726636|FG001|Overall Study|Adverse Event|1|||
38039313|NCT00097721|69726635|FG000|Overall Study|Withdrawal by Subject|6|||
38039314|NCT00097721|69726636|FG001|Overall Study|Withdrawal by Subject|1|||
38039315|NCT00097721|69726635|FG000|Overall Study|Progressive Disease|55|||
38039316|NCT00097721|69726636|FG001|Overall Study|Progressive Disease|27|||
38039317|NCT00097721|69726635|FG000|Overall Study|Physician Decision|1|||
38039318|NCT00097721|69726636|FG001|Overall Study|Physician Decision|3|||
37675703|NCT02135107|69150216|FG002|Treatment Period|Adverse Event|0|||
37675704|NCT02135107|69150217|FG003|Treatment Period|Adverse Event|0|||
37767198|NCT02581891|69282372|FG000|Overall Study|Death|3|||
37945609|NCT00310375|69633112|FG001|Primary Reporting Phase|Request of the sponsor|2|||
37945610|NCT00310375|69633113|FG002|Primary Reporting Phase|Request of the sponsor|0|||
37945611|NCT00310375|69633111|FG000|Primary Reporting Phase|Failed to return|1|||
37945612|NCT00310375|69633112|FG001|Primary Reporting Phase|Failed to return|3|||
37945613|NCT00310375|69633113|FG002|Primary Reporting Phase|Failed to return|0|||
37945614|NCT00310375|69633111|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
37945615|NCT00310375|69633112|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
37945616|NCT00310375|69633113|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
37945617|NCT00310375|69633111|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
37945618|NCT00310375|69633112|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
37945619|NCT00310375|69633113|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
37945620|NCT00310375|69633111|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
37945621|NCT00310375|69633112|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
37945622|NCT00310375|69633113|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
37945623|NCT00310375|69633111|FG000|Primary Reporting Phase|Site closure|3|||
37945624|NCT00310375|69633112|FG001|Primary Reporting Phase|Site closure|0|||
37945625|NCT00310375|69633113|FG002|Primary Reporting Phase|Site closure|0|||
37945626|NCT00310375|69633111|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
37945627|NCT00310375|69633112|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
37945628|NCT00310375|69633113|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
37945629|NCT00310375|69633111|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
37945630|NCT00310375|69633112|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
37945631|NCT00310375|69633113|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
37945632|NCT00310375|69633111|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
37945633|NCT00310375|69633112|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
37945634|NCT00310375|69633113|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
37945635|NCT00310375|69633111|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
37945636|NCT00310375|69633112|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
37945637|NCT00310375|69633113|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
37945638|NCT00309907|69633122|FG000|Overall Study|Death|4|||
37945639|NCT00309907|69633122|FG000|Overall Study|Physician Decision|1|||
37945640|NCT00309907|69633122|FG000|Overall Study|Ineligible|11|||
37945641|NCT00309907|69633122|FG000|Overall Study|Major infectious event|4|||
37945642|NCT00655824|69633127|FG000|Overall Study|Adverse Event|3|||
37945643|NCT00655824|69633127|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
37945644|NCT00655824|69633127|FG000|Overall Study|Protocol Violation|1|||
37945645|NCT00655824|69633127|FG000|Overall Study|Withdrawal by Subject|4|||
37945646|NCT00655824|69633127|FG000|Overall Study|Deterioration of Trial Disease|2|||
37945647|NCT00575588|69633133|FG000|Overall Study|Adverse Event|11|||
37945648|NCT00575588|69633134|FG001|Overall Study|Adverse Event|13|||
37945649|NCT00575588|69633133|FG000|Overall Study|Withdrawal by Subject|27|||
37945650|NCT00575588|69633134|FG001|Overall Study|Withdrawal by Subject|31|||
37945651|NCT00575588|69633133|FG000|Overall Study|Lost to Follow-up|1|||
37945652|NCT00575588|69633134|FG001|Overall Study|Lost to Follow-up|3|||
37945653|NCT00575588|69633133|FG000|Overall Study|Death|4|||
37945654|NCT00575588|69633134|FG001|Overall Study|Death|2|||
37945655|NCT00575588|69633133|FG000|Overall Study|Incorrect enrollment|8|||
38039319|NCT00097721|69726635|FG000|Overall Study|Reason not given|1|||
38039320|NCT00097721|69726636|FG001|Overall Study|Reason not given|1|||
38039321|NCT03553498|69726644|FG000|Overall Study|Missing primary outcome|1|||
38039322|NCT03553498|69726645|FG001|Overall Study|Missing primary outcome|2|||
38039323|NCT00096941|69726651|FG000|Overall Study|disease progression|3|||
38039324|NCT00096785|69726657|FG000|Overall Study|Lost to Follow-up|1|||
38039325|NCT00096785|69726658|FG001|Overall Study|Lost to Follow-up|0|||
38039326|NCT00096785|69726657|FG000|Overall Study|Withdrawal by Subject|0|||
38039327|NCT00096785|69726658|FG001|Overall Study|Withdrawal by Subject|1|||
37675705|NCT02135107|69150214|FG000|Treatment Period|Pregnancy|1|||
37675706|NCT02135107|69150215|FG001|Treatment Period|Pregnancy|0|||
37675707|NCT02135107|69150216|FG002|Treatment Period|Pregnancy|0|||
37675708|NCT02135107|69150217|FG003|Treatment Period|Pregnancy|0|||
37675709|NCT02135107|69150214|FG000|Treatment Period|Other|115|||
37675710|NCT02135107|69150215|FG001|Treatment Period|Other|24|||
37675711|NCT02135107|69150216|FG002|Treatment Period|Other|0|||
37675712|NCT02135107|69150217|FG003|Treatment Period|Other|0|||
37675713|NCT02135107|69150214|FG000|Maintenance Therapy Period|Adverse Event|0|||
37675714|NCT02135107|69150215|FG001|Maintenance Therapy Period|Adverse Event|0|||
37675715|NCT02135107|69150216|FG002|Maintenance Therapy Period|Adverse Event|3|||
37675716|NCT02135107|69150217|FG003|Maintenance Therapy Period|Adverse Event|7|||
37675717|NCT02135107|69150214|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
37675718|NCT02135107|69150215|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
37675719|NCT02135107|69150216|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
37675720|NCT02135107|69150217|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
37675721|NCT02135107|69150214|FG000|Maintenance Therapy Period|Pregnancy|0|||
37675722|NCT02135107|69150215|FG001|Maintenance Therapy Period|Pregnancy|0|||
37675723|NCT02135107|69150216|FG002|Maintenance Therapy Period|Pregnancy|0|||
37675724|NCT02135107|69150217|FG003|Maintenance Therapy Period|Pregnancy|1|||
37675725|NCT02135107|69150214|FG000|Maintenance Therapy Period|Other|0|||
37675726|NCT02135107|69150215|FG001|Maintenance Therapy Period|Other|0|||
37675727|NCT02135107|69150216|FG002|Maintenance Therapy Period|Other|7|||
37675728|NCT02135107|69150217|FG003|Maintenance Therapy Period|Other|8|||
37675729|NCT02030847|69150229|FG000|Overall Study|Death|10|||
37675730|NCT02030847|69150229|FG000|Overall Study|Disease Progression|15|||
37675731|NCT02030847|69150229|FG000|Overall Study|New Cancer Therapy|8|||
37675732|NCT02030847|69150229|FG000|Overall Study|Physician Decision|3|||
37675733|NCT02030847|69150229|FG000|Overall Study|Withdrawal by Subject|1|||
37675734|NCT02030834|69150237|FG000|Overall Study|Death|4|||
37675735|NCT02030834|69150238|FG001|Overall Study|Death|0|||
37675736|NCT02030834|69150239|FG002|Overall Study|Death|0|||
37675737|NCT02030834|69150237|FG000|Overall Study|Manufacturing failure|2|||
37675738|NCT02030834|69150238|FG001|Overall Study|Manufacturing failure|0|||
37675739|NCT02030834|69150239|FG002|Overall Study|Manufacturing failure|1|||
37675740|NCT02030834|69150237|FG000|Overall Study|Disease progression|2|||
37675741|NCT02030834|69150238|FG001|Overall Study|Disease progression|0|||
37675742|NCT02030834|69150239|FG002|Overall Study|Disease progression|2|||
37675743|NCT02030834|69150237|FG000|Overall Study|Lost to Follow-up|1|||
37675744|NCT02030834|69150238|FG001|Overall Study|Lost to Follow-up|0|||
37675745|NCT02030834|69150239|FG002|Overall Study|Lost to Follow-up|0|||
37675746|NCT02030834|69150237|FG000|Overall Study|Withdrawal by Subject|1|||
38039328|NCT00096785|69726657|FG000|Overall Study|Relocated|1|||
38039329|NCT00096785|69726658|FG001|Overall Study|Relocated|0|||
38039330|NCT03285178|69726693|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|3|||
38039331|NCT03285178|69726694|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
38039332|NCT03285178|69726695|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
38039333|NCT03285178|69726696|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
38039334|NCT03285178|69726697|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
38039335|NCT03285178|69726698|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
38039336|NCT03285178|69726699|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
38039337|NCT03285178|69726693|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|1|||
38039338|NCT03285178|69726694|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
38039339|NCT03285178|69726695|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
38039340|NCT03285178|69726696|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
38039341|NCT03285178|69726697|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
37675747|NCT02030834|69150238|FG001|Overall Study|Withdrawal by Subject|0|||
37675748|NCT02030834|69150239|FG002|Overall Study|Withdrawal by Subject|0|||
37675749|NCT02030834|69150237|FG000|Overall Study|Lack of funding|1|||
37675750|NCT02030834|69150238|FG001|Overall Study|Lack of funding|0|||
37675751|NCT02030834|69150239|FG002|Overall Study|Lack of funding|0|||
37675752|NCT01982448|69150249|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
37675753|NCT01982448|69150250|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
37675754|NCT01982448|69150249|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
37675755|NCT01982448|69150250|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
37675756|NCT01982448|69150249|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
37675757|NCT01982448|69150250|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
37675758|NCT01982448|69150249|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
37675759|NCT01982448|69150250|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
37675760|NCT01773421|69150264|FG000|Treatment Phase|Other|0|||
37675761|NCT01773421|69150265|FG001|Treatment Phase|Other|0|||
37675762|NCT01773421|69150266|FG002|Treatment Phase|Other|2|||
37675763|NCT01773421|69150267|FG003|Treatment Phase|Other|0|||
37675764|NCT01773421|69150268|FG004|Treatment Phase|Other|0|||
37675765|NCT01773421|69150269|FG005|Treatment Phase|Other|0|||
37675766|NCT01773421|69150270|FG006|Treatment Phase|Other|0|||
37675767|NCT01773421|69150264|FG000|Treatment Phase|Adverse Event|0|||
37675768|NCT01773421|69150265|FG001|Treatment Phase|Adverse Event|0|||
37675769|NCT01773421|69150266|FG002|Treatment Phase|Adverse Event|3|||
37675770|NCT01773421|69150267|FG003|Treatment Phase|Adverse Event|1|||
37675771|NCT01773421|69150268|FG004|Treatment Phase|Adverse Event|0|||
37675772|NCT01773421|69150269|FG005|Treatment Phase|Adverse Event|0|||
37675773|NCT01773421|69150270|FG006|Treatment Phase|Adverse Event|0|||
37675774|NCT01773421|69150264|FG000|Treatment Phase|Withdrawal by Subject|0|||
37675775|NCT01773421|69150265|FG001|Treatment Phase|Withdrawal by Subject|0|||
37675776|NCT01773421|69150266|FG002|Treatment Phase|Withdrawal by Subject|1|||
37675777|NCT01773421|69150267|FG003|Treatment Phase|Withdrawal by Subject|1|||
37675778|NCT01773421|69150268|FG004|Treatment Phase|Withdrawal by Subject|0|||
37675779|NCT01773421|69150269|FG005|Treatment Phase|Withdrawal by Subject|0|||
37675780|NCT01773421|69150270|FG006|Treatment Phase|Withdrawal by Subject|0|||
37675781|NCT01773421|69150264|FG000|Extension Phase|Other|0|||
37675782|NCT01773421|69150265|FG001|Extension Phase|Other|0|||
37675783|NCT01773421|69150266|FG002|Extension Phase|Other|0|||
37675784|NCT01773421|69150267|FG003|Extension Phase|Other|0|||
37675785|NCT01773421|69150268|FG004|Extension Phase|Other|1|||
37675786|NCT01773421|69150269|FG005|Extension Phase|Other|2|||
37675787|NCT01773421|69150270|FG006|Extension Phase|Other|0|||
37675788|NCT01773421|69150264|FG000|Extension Phase|Adverse Event|0|||
37675789|NCT01773421|69150265|FG001|Extension Phase|Adverse Event|0|||
37675790|NCT01773421|69150266|FG002|Extension Phase|Adverse Event|0|||
37675791|NCT01773421|69150267|FG003|Extension Phase|Adverse Event|0|||
37675792|NCT01773421|69150268|FG004|Extension Phase|Adverse Event|2|||
37945656|NCT00575588|69633134|FG001|Overall Study|Incorrect enrollment|4|||
37945657|NCT00575588|69633133|FG000|Overall Study|Study specific discontinuation criteria|203|||
37945658|NCT00575588|69633134|FG001|Overall Study|Study specific discontinuation criteria|218|||
37945659|NCT00575588|69633133|FG000|Overall Study|Severe non-compliance to protocol|5|||
37945660|NCT00575588|69633134|FG001|Overall Study|Severe non-compliance to protocol|7|||
37675793|NCT01773421|69150269|FG005|Extension Phase|Adverse Event|0|||
37675794|NCT01773421|69150270|FG006|Extension Phase|Adverse Event|0|||
37675795|NCT01747486|69150288|FG000|Stage 1|Physician Decision|3|||
37675796|NCT01747486|69150289|FG001|Stage 1|Physician Decision|0|||
37675797|NCT01747486|69150288|FG000|Stage 1|Withdrawal by Subject|4|||
37675798|NCT01747486|69150289|FG001|Stage 1|Withdrawal by Subject|3|||
37675799|NCT01747486|69150288|FG000|Stage 1|Disease progression|4|||
37675800|NCT01747486|69150289|FG001|Stage 1|Disease progression|9|||
37675801|NCT01747486|69150288|FG000|Stage 1|Death|1|||
37675802|NCT01747486|69150289|FG001|Stage 1|Death|1|||
37675803|NCT01747486|69150288|FG000|Stage 2|Physician Decision|2|||
37675804|NCT01747486|69150289|FG001|Stage 2|Physician Decision|0|||
37675805|NCT01747486|69150288|FG000|Stage 2|Withdrawal by Subject|1|||
37675806|NCT01747486|69150289|FG001|Stage 2|Withdrawal by Subject|0|||
37675807|NCT01747486|69150288|FG000|Stage 2|New Cancer Therapy|3|||
37675808|NCT01747486|69150289|FG001|Stage 2|New Cancer Therapy|0|||
37675809|NCT01747486|69150288|FG000|Stage 2|Disease Progression|3|||
37675810|NCT01747486|69150289|FG001|Stage 2|Disease Progression|0|||
37675811|NCT01659151|69150299|FG000|Overall Study|Inadequate TIL growth|1|||
37675812|NCT01593254|69150305|FG000|Overall Study|Disease progression|2|||
37675813|NCT01593254|69150306|FG001|Overall Study|Disease progression|7|||
37675814|NCT01593254|69150305|FG000|Overall Study|Study drug toxicity|6|||
37675815|NCT01593254|69150306|FG001|Overall Study|Study drug toxicity|20|||
37767199|NCT02581891|69282373|FG001|Overall Study|Death|4|||
37945661|NCT00575588|69633133|FG000|Overall Study|Safety reasons|2|||
37675816|NCT01593254|69150305|FG000|Overall Study|Death|3|||
37675817|NCT01593254|69150306|FG001|Overall Study|Death|3|||
37675818|NCT01593254|69150305|FG000|Overall Study|AE unrelated to study drug|0|||
37675819|NCT01593254|69150306|FG001|Overall Study|AE unrelated to study drug|1|||
37675820|NCT01593254|69150305|FG000|Overall Study|participant request to discontinue study treatment|1|||
37675821|NCT01593254|69150306|FG001|Overall Study|participant request to discontinue study treatment|3|||
37675822|NCT01593254|69150305|FG000|Overall Study|participant withdrew consent|0|||
37675823|NCT01593254|69150306|FG001|Overall Study|participant withdrew consent|9|||
37675824|NCT01593254|69150305|FG000|Overall Study|lost to follow up|1|||
37675825|NCT01593254|69150306|FG001|Overall Study|lost to follow up|6|||
37675826|NCT01593254|69150305|FG000|Overall Study|maximum clinical benefit|1|||
37675827|NCT01593254|69150306|FG001|Overall Study|maximum clinical benefit|2|||
37675828|NCT01593254|69150305|FG000|Overall Study|Poor/non compliance|1|||
37675829|NCT01593254|69150306|FG001|Overall Study|Poor/non compliance|1|||
37675830|NCT01593254|69150305|FG000|Overall Study|Pregnancy|0|||
37675831|NCT01593254|69150306|FG001|Overall Study|Pregnancy|3|||
37675832|NCT01593254|69150305|FG000|Overall Study|participant no longer meets study criteria|1|||
37675833|NCT01593254|69150306|FG001|Overall Study|participant no longer meets study criteria|1|||
37675834|NCT01593254|69150305|FG000|Overall Study|Admin reason by sponsor|7|||
37675835|NCT01593254|69150306|FG001|Overall Study|Admin reason by sponsor|3|||
37675836|NCT01593254|69150305|FG000|Overall Study|Imatinib treatment failure|2|||
37675837|NCT01593254|69150306|FG001|Overall Study|Imatinib treatment failure|0|||
37675838|NCT01593254|69150305|FG000|Overall Study|Other Reasons|61|||
37675839|NCT01593254|69150306|FG001|Overall Study|Other Reasons|115|||
37675840|NCT01559818|69150313|FG000|Overall Study|Physician Decision|1|||
37675841|NCT01559818|69150313|FG000|Overall Study|Pregnancy|1|||
37675842|NCT01559818|69150313|FG000|Overall Study|Study terminated by Sponsor|4|||
37675843|NCT01559818|69150313|FG000|Overall Study|Withdrawal by Subject|1|||
37675844|NCT01454934|69150320|FG000|Overall Study|Clinical progression|28|||
37675845|NCT01454934|69150321|FG001|Overall Study|Clinical progression|25|||
37675846|NCT01454934|69150320|FG000|Overall Study|Other|6|||
37675847|NCT01454934|69150321|FG001|Overall Study|Other|17|||
37675848|NCT01454934|69150320|FG000|Overall Study|Adverse Event|28|||
37675849|NCT01454934|69150321|FG001|Overall Study|Adverse Event|24|||
37675850|NCT01454934|69150320|FG000|Overall Study|Withdrawn consent|2|||
37675851|NCT01454934|69150321|FG001|Overall Study|Withdrawn consent|5|||
37675852|NCT01454934|69150320|FG000|Overall Study|Withdrawal by Subject|11|||
37675853|NCT01454934|69150321|FG001|Overall Study|Withdrawal by Subject|15|||
37675854|NCT01454934|69150320|FG000|Overall Study|Disease progression|194|||
37675855|NCT01454934|69150321|FG001|Overall Study|Disease progression|181|||
37675856|NCT01454934|69150320|FG000|Overall Study|Lost to Follow-up|0|||
37675857|NCT01454934|69150321|FG001|Overall Study|Lost to Follow-up|1|||
37675858|NCT01454934|69150320|FG000|Overall Study|Not treated|1|||
37675859|NCT01454934|69150321|FG001|Overall Study|Not treated|2|||
37675860|NCT01439282|69150329|FG000|Overall Study|Adverse Event|5|||
37675861|NCT01439282|69150330|FG001|Overall Study|Adverse Event|0|||
37675862|NCT01439282|69150329|FG000|Overall Study|Withdrawal by Subject|2|||
37675863|NCT01439282|69150330|FG001|Overall Study|Withdrawal by Subject|0|||
37675864|NCT01439282|69150329|FG000|Overall Study|Other|1|||
37675865|NCT01439282|69150330|FG001|Overall Study|Other|1|||
37675866|NCT01326312|69150340|FG000|Overall Study|Adverse Event|11|||
37675867|NCT01326312|69150341|FG001|Overall Study|Adverse Event|11|||
37675868|NCT01326312|69150342|FG002|Overall Study|Adverse Event|1|||
37675869|NCT01326312|69150340|FG000|Overall Study|Withdrawal by Subject|1|||
37767200|NCT02581891|69282372|FG000|Overall Study|Lost to Follow-up|1|||
37767201|NCT02581891|69282373|FG001|Overall Study|Lost to Follow-up|2|||
37767202|NCT02581891|69282372|FG000|Overall Study|Physician Decision|0|||
37767203|NCT02581891|69282373|FG001|Overall Study|Physician Decision|1|||
37767204|NCT02581891|69282372|FG000|Overall Study|Withdrawal by Subject|4|||
37767205|NCT02581891|69282373|FG001|Overall Study|Withdrawal by Subject|5|||
37767206|NCT02581891|69282372|FG000|Overall Study|Other Reasons|3|||
37767207|NCT02581891|69282373|FG001|Overall Study|Other Reasons|1|||
37767208|NCT02581891|69282372|FG000|Overall Study|Discontinued during followup|1|||
37767209|NCT02581891|69282373|FG001|Overall Study|Discontinued during followup|0|||
37767210|NCT02576535|69282380|FG000|Overall Study|Withdrawal by Subject|2|||
37767211|NCT02574845|69282390|FG000|Overall Study|Consent withdrawn further participation|0|||
37767212|NCT02574845|69282391|FG001|Overall Study|Consent withdrawn further participation|0|||
37767213|NCT02574845|69282392|FG002|Overall Study|Consent withdrawn further participation|0|||
37767214|NCT02574845|69282393|FG003|Overall Study|Consent withdrawn further participation|0|||
37767215|NCT02574845|69282394|FG004|Overall Study|Consent withdrawn further participation|1|||
37767216|NCT02574845|69282395|FG005|Overall Study|Consent withdrawn further participation|0|||
37767217|NCT02574845|69282390|FG000|Overall Study|Adverse Event|0|||
37767218|NCT02574845|69282391|FG001|Overall Study|Adverse Event|1|||
37767219|NCT02574845|69282392|FG002|Overall Study|Adverse Event|0|||
37767220|NCT02574845|69282393|FG003|Overall Study|Adverse Event|0|||
37767221|NCT02574845|69282394|FG004|Overall Study|Adverse Event|0|||
38039342|NCT03285178|69726698|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
37767222|NCT02574845|69282395|FG005|Overall Study|Adverse Event|1|||
37675870|NCT01326312|69150341|FG001|Overall Study|Withdrawal by Subject|2|||
37675871|NCT01326312|69150342|FG002|Overall Study|Withdrawal by Subject|1|||
37675872|NCT01326312|69150340|FG000|Overall Study|Protocol Violation|0|||
37675873|NCT01326312|69150341|FG001|Overall Study|Protocol Violation|1|||
37675874|NCT01326312|69150342|FG002|Overall Study|Protocol Violation|0|||
37675875|NCT01326312|69150340|FG000|Overall Study|Lack of Efficacy|13|||
37675876|NCT01326312|69150341|FG001|Overall Study|Lack of Efficacy|7|||
37675877|NCT01326312|69150342|FG002|Overall Study|Lack of Efficacy|1|||
37675878|NCT01326312|69150340|FG000|Overall Study|Death|1|||
37675879|NCT01326312|69150341|FG001|Overall Study|Death|0|||
37675880|NCT01326312|69150342|FG002|Overall Study|Death|1|||
37675881|NCT01326312|69150340|FG000|Overall Study|progressive disease|0|||
37675882|NCT01326312|69150341|FG001|Overall Study|progressive disease|1|||
37767223|NCT02063724|69282424|FG000|Overall Study|Disease progression|1|||
37767224|NCT01946139|69282471|FG000|Overall Study|Withdrawal by Subject|8|||
37767225|NCT01946139|69282471|FG000|Overall Study|ineligible|8|||
37767226|NCT01946139|69282471|FG000|Overall Study|Specimens not available|4|||
37767227|NCT01828112|69282477|FG000|Overall Study|Adverse Event|6|||
37767228|NCT01828112|69282478|FG001|Overall Study|Adverse Event|8|||
37767229|NCT01828112|69282477|FG000|Overall Study|Death|9|||
37767230|NCT01828112|69282478|FG001|Overall Study|Death|5|||
37767231|NCT01828112|69282477|FG000|Overall Study|Physician Decision|5|||
37767232|NCT01828112|69282478|FG001|Overall Study|Physician Decision|5|||
37767233|NCT01828112|69282477|FG000|Overall Study|Progressive disease|56|||
37767234|NCT01828112|69282478|FG001|Overall Study|Progressive disease|82|||
37767235|NCT01828112|69282477|FG000|Overall Study|Subject/guardian decision|6|||
37767236|NCT01828112|69282478|FG001|Overall Study|Subject/guardian decision|8|||
37767237|NCT01685008|69282488|FG000|Main Study Treatment (Cycles 1 - 2)|Adverse Event|2|||
37767238|NCT01685008|69282489|FG001|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
37767239|NCT01685008|69282490|FG002|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
37767240|NCT01685008|69282491|FG003|Main Study Treatment (Cycles 1 - 2)|Adverse Event|1|||
37767241|NCT01685008|69282488|FG000|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
38039343|NCT03285178|69726699|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
38039344|NCT03285178|69726693|FG000|Single-Blind Run-In Period|Protocol Violation|11|||
38039345|NCT03285178|69726694|FG001|Single-Blind Run-In Period|Protocol Violation|0|||
38039346|NCT03285178|69726695|FG002|Single-Blind Run-In Period|Protocol Violation|0|||
38039347|NCT03285178|69726696|FG003|Single-Blind Run-In Period|Protocol Violation|0|||
38039348|NCT03285178|69726697|FG004|Single-Blind Run-In Period|Protocol Violation|0|||
38039349|NCT03285178|69726698|FG005|Single-Blind Run-In Period|Protocol Violation|0|||
38039350|NCT03285178|69726699|FG006|Single-Blind Run-In Period|Protocol Violation|0|||
38039351|NCT03285178|69726693|FG000|Single-Blind Run-In Period|Withdrawal by Subject|1|||
38039352|NCT03285178|69726694|FG001|Single-Blind Run-In Period|Withdrawal by Subject|0|||
38039353|NCT03285178|69726695|FG002|Single-Blind Run-In Period|Withdrawal by Subject|0|||
38039354|NCT03285178|69726696|FG003|Single-Blind Run-In Period|Withdrawal by Subject|0|||
38039355|NCT03285178|69726697|FG004|Single-Blind Run-In Period|Withdrawal by Subject|0|||
38039356|NCT03285178|69726698|FG005|Single-Blind Run-In Period|Withdrawal by Subject|0|||
38039357|NCT03285178|69726699|FG006|Single-Blind Run-In Period|Withdrawal by Subject|0|||
38039358|NCT03285178|69726693|FG000|Single-Blind Run-In Period|Physician Decision|2|||
38039359|NCT03285178|69726694|FG001|Single-Blind Run-In Period|Physician Decision|0|||
38039360|NCT03285178|69726695|FG002|Single-Blind Run-In Period|Physician Decision|0|||
38039361|NCT03285178|69726696|FG003|Single-Blind Run-In Period|Physician Decision|0|||
38039362|NCT03285178|69726697|FG004|Single-Blind Run-In Period|Physician Decision|0|||
38039363|NCT03285178|69726698|FG005|Single-Blind Run-In Period|Physician Decision|0|||
38039364|NCT03285178|69726699|FG006|Single-Blind Run-In Period|Physician Decision|0|||
38039365|NCT03285178|69726693|FG000|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
38039366|NCT03285178|69726694|FG001|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
38039367|NCT03285178|69726695|FG002|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
38039368|NCT03285178|69726696|FG003|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
38039369|NCT03285178|69726697|FG004|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
38039370|NCT03285178|69726698|FG005|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
38039371|NCT03285178|69726699|FG006|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
38039372|NCT03285178|69726693|FG000|Double-Blind Treatment Period|Adverse Event|0|||
38039373|NCT03285178|69726694|FG001|Double-Blind Treatment Period|Adverse Event|0|||
38039374|NCT03285178|69726695|FG002|Double-Blind Treatment Period|Adverse Event|0|||
38039375|NCT03285178|69726696|FG003|Double-Blind Treatment Period|Adverse Event|0|||
38039376|NCT03285178|69726697|FG004|Double-Blind Treatment Period|Adverse Event|0|||
38039377|NCT03285178|69726698|FG005|Double-Blind Treatment Period|Adverse Event|0|||
38039378|NCT03285178|69726699|FG006|Double-Blind Treatment Period|Adverse Event|2|||
38039379|NCT03285178|69726693|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
38039380|NCT03285178|69726694|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
37675883|NCT01326312|69150342|FG002|Overall Study|progressive disease|1|||
37675884|NCT01326312|69150340|FG000|Overall Study|Study terminated by Sponsor|8|||
37675885|NCT01326312|69150341|FG001|Overall Study|Study terminated by Sponsor|32|||
37675886|NCT01326312|69150342|FG002|Overall Study|Study terminated by Sponsor|46|||
37675887|NCT01326312|69150340|FG000|Overall Study|Treatment arm terminated|19|||
37675888|NCT01326312|69150341|FG001|Overall Study|Treatment arm terminated|0|||
37675889|NCT01326312|69150342|FG002|Overall Study|Treatment arm terminated|0|||
37675890|NCT01326312|69150340|FG000|Overall Study|QTc > 500|0|||
37675891|NCT01326312|69150341|FG001|Overall Study|QTc > 500|1|||
37675892|NCT01326312|69150342|FG002|Overall Study|QTc > 500|0|||
37675893|NCT01269346|69150364|FG000|Treatment Phase|Disease progression|3|||
37767242|NCT01685008|69282489|FG001|Main Study Treatment (Cycles 1 - 2)|Physician Decision|2|||
38039381|NCT03285178|69726695|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
38039382|NCT03285178|69726696|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
38039383|NCT03285178|69726697|FG004|Double-Blind Treatment Period|Lost to Follow-up|2|||
38039384|NCT03285178|69726698|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
38039385|NCT03285178|69726699|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
38039386|NCT03285178|69726693|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
38039387|NCT03285178|69726694|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
38039388|NCT03285178|69726695|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
38039389|NCT03285178|69726696|FG003|Double-Blind Treatment Period|Withdrawal by Subject|1|||
38039390|NCT03285178|69726697|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
38039391|NCT03285178|69726698|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
38039392|NCT03285178|69726699|FG006|Double-Blind Treatment Period|Withdrawal by Subject|1|||
38039393|NCT03285178|69726693|FG000|Double-Blind Treatment Period|COVID-19|0|||
38039394|NCT03285178|69726694|FG001|Double-Blind Treatment Period|COVID-19|0|||
38039395|NCT03285178|69726695|FG002|Double-Blind Treatment Period|COVID-19|1|||
38039396|NCT03285178|69726696|FG003|Double-Blind Treatment Period|COVID-19|0|||
38039397|NCT03285178|69726697|FG004|Double-Blind Treatment Period|COVID-19|0|||
38039398|NCT03285178|69726698|FG005|Double-Blind Treatment Period|COVID-19|0|||
38039399|NCT03285178|69726699|FG006|Double-Blind Treatment Period|COVID-19|0|||
38039400|NCT00090545|69726723|FG000|Overall Study|Disease progression on study|21|||
38039401|NCT00090545|69726724|FG001|Overall Study|Disease progression on study|17|||
38039402|NCT00090545|69726723|FG000|Overall Study|Refused further treatment|1|||
38039403|NCT00090545|69726724|FG001|Overall Study|Refused further treatment|4|||
38039404|NCT00090545|69726723|FG000|Overall Study|Death|0|||
38039405|NCT00090545|69726724|FG001|Overall Study|Death|1|||
38039406|NCT00090545|69726723|FG000|Overall Study|Adverse Event|0|||
38039407|NCT00090545|69726724|FG001|Overall Study|Adverse Event|2|||
38039408|NCT03249376|69726734|FG000|Overall Study|Adverse Event|11|||
38039409|NCT03249376|69726735|FG001|Overall Study|Adverse Event|5|||
38039410|NCT03249376|69726734|FG000|Overall Study|Lack of Efficacy|2|||
38039411|NCT03249376|69726735|FG001|Overall Study|Lack of Efficacy|4|||
38039412|NCT03249376|69726734|FG000|Overall Study|Protocol Violation|3|||
38039413|NCT03249376|69726735|FG001|Overall Study|Protocol Violation|2|||
38039414|NCT03249376|69726734|FG000|Overall Study|Physician Decision|0|||
38039415|NCT03249376|69726735|FG001|Overall Study|Physician Decision|2|||
38039416|NCT03249376|69726734|FG000|Overall Study|Withdrawal by Subject|3|||
38039417|NCT03249376|69726735|FG001|Overall Study|Withdrawal by Subject|9|||
38039418|NCT03249376|69726734|FG000|Overall Study|LTFU|2|||
38039419|NCT03249376|69726735|FG001|Overall Study|LTFU|1|||
38039420|NCT00070109|69726746|FG000|Overall Study|Death|1|||
38039421|NCT00070109|69726747|FG001|Overall Study|Death|1|||
38039422|NCT00070109|69726748|FG002|Overall Study|Death|0|||
38039423|NCT00070109|69726749|FG003|Overall Study|Death|0|||
38039424|NCT00070109|69726750|FG004|Overall Study|Death|1|||
38039425|NCT00070109|69726746|FG000|Overall Study|Lack of Efficacy|6|||
38039426|NCT00070109|69726747|FG001|Overall Study|Lack of Efficacy|4|||
38039427|NCT00070109|69726748|FG002|Overall Study|Lack of Efficacy|5|||
38039428|NCT00070109|69726749|FG003|Overall Study|Lack of Efficacy|15|||
38039429|NCT00070109|69726750|FG004|Overall Study|Lack of Efficacy|5|||
38039430|NCT00070109|69726746|FG000|Overall Study|Physician Decision|1|||
38039431|NCT00070109|69726747|FG001|Overall Study|Physician Decision|0|||
38039432|NCT00070109|69726748|FG002|Overall Study|Physician Decision|0|||
38039433|NCT00070109|69726749|FG003|Overall Study|Physician Decision|0|||
38039434|NCT00070109|69726750|FG004|Overall Study|Physician Decision|0|||
38039435|NCT00070109|69726746|FG000|Overall Study|Withdrawal by Subject|0|||
38039436|NCT00070109|69726747|FG001|Overall Study|Withdrawal by Subject|1|||
38039437|NCT00070109|69726748|FG002|Overall Study|Withdrawal by Subject|1|||
38039438|NCT00070109|69726749|FG003|Overall Study|Withdrawal by Subject|0|||
38039439|NCT00070109|69726750|FG004|Overall Study|Withdrawal by Subject|0|||
38039440|NCT00070109|69726746|FG000|Overall Study|Adverse Event|0|||
38039441|NCT00070109|69726747|FG001|Overall Study|Adverse Event|0|||
38039442|NCT00070109|69726748|FG002|Overall Study|Adverse Event|2|||
38039443|NCT00070109|69726749|FG003|Overall Study|Adverse Event|4|||
38039444|NCT00070109|69726750|FG004|Overall Study|Adverse Event|2|||
38039445|NCT00070109|69726746|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
38039446|NCT00070109|69726747|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
38039447|NCT00070109|69726748|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
38039448|NCT00070109|69726749|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
38039449|NCT00070109|69726750|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
38039450|NCT00090233|69726771|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
38039451|NCT00090233|69726772|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
38039452|NCT00090233|69726771|FG000|Overall Study|Adverse Event|214|||
38039453|NCT00090233|69726772|FG001|Overall Study|Adverse Event|198|||
38039454|NCT00090233|69726771|FG000|Overall Study|Lost to Follow-up|68|||
38039455|NCT00090233|69726772|FG001|Overall Study|Lost to Follow-up|95|||
38039456|NCT00090233|69726771|FG000|Overall Study|Protocol Violation|960|||
38039457|NCT00090233|69726772|FG001|Overall Study|Protocol Violation|1022|||
38039458|NCT00090233|69726771|FG000|Overall Study|Withdrawal by Subject|182|||
38039459|NCT00090233|69726772|FG001|Overall Study|Withdrawal by Subject|211|||
38039460|NCT00090233|69726771|FG000|Overall Study|Moved|203|||
38039461|NCT00090233|69726772|FG001|Overall Study|Moved|189|||
38039462|NCT00090233|69726771|FG000|Overall Study|Other|1211|||
38039463|NCT00090233|69726772|FG001|Overall Study|Other|1160|||
38039464|NCT00090233|69726771|FG000|Overall Study|Data not available at data cut-off point|1552|||
38039465|NCT00090233|69726772|FG001|Overall Study|Data not available at data cut-off point|1563|||
38039466|NCT00069953|69726782|FG000|Overall Study|Protocol Violation|2|||
38039467|NCT02750800|69726792|FG000|Overall Study|Adverse Event|18|||
38039468|NCT02750800|69726792|FG000|Overall Study|Lost to Follow-up|12|||
38039469|NCT02750800|69726792|FG000|Overall Study|Investigator decision|53|||
38039470|NCT02750800|69726792|FG000|Overall Study|Patient request|12|||
38039471|NCT02750800|69726792|FG000|Overall Study|Other, not specified|3|||
38039472|NCT01329562|69726812|FG000|Overall Study|Protocol Violation|5|||
38039473|NCT01329562|69726813|FG001|Overall Study|Protocol Violation|3|||
38039474|NCT01329562|69726812|FG000|Overall Study|Lost to Follow-up|1|||
38039475|NCT01329562|69726813|FG001|Overall Study|Lost to Follow-up|1|||
38039476|NCT01329562|69726812|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
38039477|NCT01329562|69726813|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
38039478|NCT01329562|69726812|FG000|Overall Study|Physician Decision|0|||
38039479|NCT01329562|69726813|FG001|Overall Study|Physician Decision|1|||
38039480|NCT00069641|69726824|FG000|Overall Study|Death|1|||
38039481|NCT00069641|69726825|FG001|Overall Study|Death|0|||
38039482|NCT00069641|69726826|FG002|Overall Study|Death|1|||
38039483|NCT03653026|69726837|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
38039484|NCT03653026|69726838|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
38039485|NCT03653026|69726839|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
38039486|NCT03653026|69726840|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
38039487|NCT03653026|69726837|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
38039488|NCT03653026|69726838|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
38039489|NCT03653026|69726839|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
38039490|NCT03653026|69726840|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
38039491|NCT03653026|69726837|FG000|Part 1: Placebo-controlled Period|Other|0|||
38039492|NCT03653026|69726838|FG001|Part 1: Placebo-controlled Period|Other|3|||
38039493|NCT03653026|69726839|FG002|Part 1: Placebo-controlled Period|Other|0|||
38039494|NCT03653026|69726840|FG003|Part 1: Placebo-controlled Period|Other|0|||
38039495|NCT03653026|69726837|FG000|Part 2: Open-label Extension|Adverse Event|0|||
38039496|NCT03653026|69726838|FG001|Part 2: Open-label Extension|Adverse Event|0|||
38039497|NCT03653026|69726839|FG002|Part 2: Open-label Extension|Adverse Event|1|||
38039498|NCT03653026|69726840|FG003|Part 2: Open-label Extension|Adverse Event|1|||
38039499|NCT03653026|69726837|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
38039500|NCT03653026|69726838|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
38039501|NCT03653026|69726839|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
38039502|NCT03653026|69726840|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
38039503|NCT03653026|69726837|FG000|Part 2: Open-label Extension|Other|0|||
38039504|NCT03653026|69726838|FG001|Part 2: Open-label Extension|Other|0|||
38039505|NCT03653026|69726839|FG002|Part 2: Open-label Extension|Other|1|||
38039506|NCT03653026|69726840|FG003|Part 2: Open-label Extension|Other|2|||
38039507|NCT01329328|69726851|FG000|Overall Study|Withdrawal by Subject|2|||
38039508|NCT01329328|69726852|FG001|Overall Study|Withdrawal by Subject|4|||
38039509|NCT01329328|69726853|FG002|Overall Study|Withdrawal by Subject|3|||
38039510|NCT01337986|69726863|FG000|Overall Study|Adverse Event|2|||
38039511|NCT01337986|69726864|FG001|Overall Study|Adverse Event|2|||
38039512|NCT01337986|69726863|FG000|Overall Study|Lost to Follow-up|1|||
38039513|NCT01337986|69726864|FG001|Overall Study|Lost to Follow-up|0|||
38039514|NCT01337986|69726863|FG000|Overall Study|Protocol Violation|0|||
38039515|NCT01337986|69726864|FG001|Overall Study|Protocol Violation|3|||
38039516|NCT01337674|69726888|FG000|Treatment Period 1|Adverse Event|0|||
38039517|NCT01337674|69726889|FG001|Treatment Period 1|Adverse Event|1|||
38039518|NCT01337674|69726890|FG002|Treatment Period 1|Adverse Event|0|||
38039519|NCT01337674|69726891|FG003|Treatment Period 1|Adverse Event|0|||
38039520|NCT01337674|69726888|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
38039521|NCT01337674|69726889|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
38039522|NCT01337674|69726890|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
38039523|NCT01337674|69726891|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
38039524|NCT01337674|69726888|FG000|Treatment Period 2|Withdrawal by Subject|0|||
38039525|NCT01337674|69726889|FG001|Treatment Period 2|Withdrawal by Subject|0|||
38039526|NCT01337674|69726890|FG002|Treatment Period 2|Withdrawal by Subject|1|||
38039527|NCT01337674|69726891|FG003|Treatment Period 2|Withdrawal by Subject|0|||
38039528|NCT02750410|69726906|FG000|Double-Blind Treatment Period|Adverse Event|2|||
38039529|NCT02750410|69726907|FG001|Double-Blind Treatment Period|Adverse Event|2|||
37675894|NCT01269346|69150364|FG000|Treatment Phase|Adverse Event|3|||
38039530|NCT02750410|69726906|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
38039531|NCT02750410|69726907|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
38039532|NCT02750410|69726906|FG000|Open-Label Extension Period|Adverse Event|5|||
38039533|NCT02750410|69726907|FG001|Open-Label Extension Period|Adverse Event|3|||
38039534|NCT02750410|69726906|FG000|Open-Label Extension Period|Protocol Violation|0|||
38039535|NCT02750410|69726907|FG001|Open-Label Extension Period|Protocol Violation|1|||
38039536|NCT02750410|69726906|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
38039537|NCT02750410|69726907|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
38039538|NCT02750332|69726917|FG000|Treatment Period 1|Withdrawal by Subject|0|||
38039539|NCT02750332|69726918|FG001|Treatment Period 1|Withdrawal by Subject|1|||
38039540|NCT01337596|69726933|FG000|Overall Study|Withdrawal by Subject|0|||
38039541|NCT01337596|69726934|FG001|Overall Study|Withdrawal by Subject|0|||
38039542|NCT01337596|69726935|FG002|Overall Study|Withdrawal by Subject|0|||
38039543|NCT01337596|69726936|FG003|Overall Study|Withdrawal by Subject|0|||
38039544|NCT01337596|69726937|FG004|Overall Study|Withdrawal by Subject|2|||
38039545|NCT01337596|69726938|FG005|Overall Study|Withdrawal by Subject|0|||
38039546|NCT01337596|69726939|FG006|Overall Study|Withdrawal by Subject|0|||
38039547|NCT01337596|69726940|FG007|Overall Study|Withdrawal by Subject|0|||
38039548|NCT01337596|69726941|FG008|Overall Study|Withdrawal by Subject|0|||
38039549|NCT00069095|69726970|FG000|Primary Treatment Phase|Ongoing|0|||
38039550|NCT00069095|69726971|FG001|Primary Treatment Phase|Ongoing|0|||
38039551|NCT00069095|69726972|FG002|Primary Treatment Phase|Ongoing|5|||
38039552|NCT00069095|69726973|FG003|Primary Treatment Phase|Ongoing|7|||
38039553|NCT00069095|69726974|FG004|Primary Treatment Phase|Ongoing|7|||
38039554|NCT00069095|69726975|FG005|Primary Treatment Phase|Ongoing|4|||
38039555|NCT00069095|69726970|FG000|Primary Treatment Phase|Admin/Other|29|||
38039556|NCT00069095|69726971|FG001|Primary Treatment Phase|Admin/Other|38|||
38039557|NCT00069095|69726972|FG002|Primary Treatment Phase|Admin/Other|31|||
38039558|NCT00069095|69726973|FG003|Primary Treatment Phase|Admin/Other|45|||
38039559|NCT00069095|69726974|FG004|Primary Treatment Phase|Admin/Other|48|||
38039560|NCT00069095|69726975|FG005|Primary Treatment Phase|Admin/Other|42|||
38039561|NCT00069095|69726970|FG000|Primary Treatment Phase|Adverse Event|99|||
38039562|NCT00069095|69726971|FG001|Primary Treatment Phase|Adverse Event|92|||
38039563|NCT00069095|69726972|FG002|Primary Treatment Phase|Adverse Event|71|||
38039564|NCT00069095|69726973|FG003|Primary Treatment Phase|Adverse Event|72|||
38039565|NCT00069095|69726974|FG004|Primary Treatment Phase|Adverse Event|109|||
38039566|NCT00069095|69726975|FG005|Primary Treatment Phase|Adverse Event|101|||
38039567|NCT00069095|69726970|FG000|Primary Treatment Phase|Death|14|||
38039568|NCT00069095|69726971|FG001|Primary Treatment Phase|Death|8|||
38039569|NCT00069095|69726972|FG002|Primary Treatment Phase|Death|2|||
38039570|NCT00069095|69726973|FG003|Primary Treatment Phase|Death|5|||
38039571|NCT00069095|69726974|FG004|Primary Treatment Phase|Death|8|||
38039572|NCT00069095|69726975|FG005|Primary Treatment Phase|Death|8|||
38039573|NCT00069095|69726970|FG000|Primary Treatment Phase|Failure to return|5|||
38039574|NCT00069095|69726971|FG001|Primary Treatment Phase|Failure to return|5|||
38039575|NCT00069095|69726972|FG002|Primary Treatment Phase|Failure to return|0|||
38039576|NCT00069095|69726973|FG003|Primary Treatment Phase|Failure to return|0|||
38039577|NCT00069095|69726974|FG004|Primary Treatment Phase|Failure to return|0|||
38039578|NCT00069095|69726975|FG005|Primary Treatment Phase|Failure to return|2|||
38039579|NCT00069095|69726970|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
38039580|NCT00069095|69726971|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
38039581|NCT00069095|69726972|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
38039582|NCT00069095|69726973|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
38039583|NCT00069095|69726974|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
38039584|NCT00069095|69726975|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
38039585|NCT00069095|69726970|FG000|Primary Treatment Phase|Refused treatment|15|||
38039586|NCT00069095|69726971|FG001|Primary Treatment Phase|Refused treatment|26|||
38039587|NCT00069095|69726972|FG002|Primary Treatment Phase|Refused treatment|17|||
38039588|NCT00069095|69726973|FG003|Primary Treatment Phase|Refused treatment|31|||
38039589|NCT00069095|69726974|FG004|Primary Treatment Phase|Refused treatment|24|||
38039590|NCT00069095|69726975|FG005|Primary Treatment Phase|Refused treatment|27|||
38039591|NCT00069095|69726970|FG000|Primary Treatment Phase|Withdrew|2|||
38039592|NCT00069095|69726971|FG001|Primary Treatment Phase|Withdrew|3|||
38039593|NCT00069095|69726972|FG002|Primary Treatment Phase|Withdrew|8|||
38039594|NCT00069095|69726973|FG003|Primary Treatment Phase|Withdrew|2|||
38039595|NCT00069095|69726974|FG004|Primary Treatment Phase|Withdrew|4|||
38039596|NCT00069095|69726975|FG005|Primary Treatment Phase|Withdrew|9|||
38039597|NCT00069095|69726970|FG000|Primary Treatment Phase|Other Violation|0|||
38039598|NCT00069095|69726971|FG001|Primary Treatment Phase|Other Violation|1|||
38039599|NCT00069095|69726972|FG002|Primary Treatment Phase|Other Violation|1|||
38039600|NCT00069095|69726973|FG003|Primary Treatment Phase|Other Violation|1|||
38039601|NCT00069095|69726974|FG004|Primary Treatment Phase|Other Violation|0|||
38039602|NCT00069095|69726975|FG005|Primary Treatment Phase|Other Violation|1|||
38039603|NCT00069095|69726970|FG000|Primary Treatment Phase|Violation criteria|0|||
38039604|NCT00069095|69726971|FG001|Primary Treatment Phase|Violation criteria|2|||
38039605|NCT00069095|69726972|FG002|Primary Treatment Phase|Violation criteria|4|||
38039606|NCT00069095|69726973|FG003|Primary Treatment Phase|Violation criteria|3|||
38039607|NCT00069095|69726974|FG004|Primary Treatment Phase|Violation criteria|1|||
38039608|NCT00069095|69726975|FG005|Primary Treatment Phase|Violation criteria|5|||
38039609|NCT00069095|69726970|FG000|Post-study Treatment Phase|Missing reason|1|||
38039610|NCT00069095|69726971|FG001|Post-study Treatment Phase|Missing reason|3|||
38039611|NCT00069095|69726972|FG002|Post-study Treatment Phase|Missing reason|12|||
38039612|NCT00069095|69726973|FG003|Post-study Treatment Phase|Missing reason|8|||
38039613|NCT00069095|69726974|FG004|Post-study Treatment Phase|Missing reason|18|||
38039614|NCT00069095|69726975|FG005|Post-study Treatment Phase|Missing reason|17|||
38039615|NCT00069095|69726970|FG000|Post-study Treatment Phase|Adverse Event|2|||
38039616|NCT00069095|69726971|FG001|Post-study Treatment Phase|Adverse Event|3|||
38039617|NCT00069095|69726972|FG002|Post-study Treatment Phase|Adverse Event|1|||
38039618|NCT00069095|69726973|FG003|Post-study Treatment Phase|Adverse Event|0|||
38039619|NCT00069095|69726974|FG004|Post-study Treatment Phase|Adverse Event|5|||
38039620|NCT00069095|69726975|FG005|Post-study Treatment Phase|Adverse Event|1|||
38039621|NCT00069095|69726970|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
38039622|NCT00069095|69726971|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
38039623|NCT00069095|69726972|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
38039624|NCT00069095|69726973|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
38039625|NCT00069095|69726974|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
38039626|NCT00069095|69726975|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
38039627|NCT00069095|69726970|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
38039628|NCT00069095|69726971|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
37767243|NCT01685008|69282490|FG002|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
37767244|NCT01685008|69282491|FG003|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
37767245|NCT01685008|69282488|FG000|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
37767246|NCT01685008|69282489|FG001|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|1|||
37767247|NCT01685008|69282490|FG002|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
37767248|NCT01685008|69282491|FG003|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
37767249|NCT01685008|69282488|FG000|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|2|||
37767250|NCT01685008|69282489|FG001|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|4|||
37767251|NCT01685008|69282490|FG002|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|1|||
37767252|NCT01685008|69282491|FG003|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|0|||
37767253|NCT01685008|69282488|FG000|Main Study Treatment (Cycles 1 - 2)|Death|0|||
37767254|NCT01685008|69282489|FG001|Main Study Treatment (Cycles 1 - 2)|Death|3|||
37767255|NCT01685008|69282490|FG002|Main Study Treatment (Cycles 1 - 2)|Death|1|||
37767256|NCT01685008|69282491|FG003|Main Study Treatment (Cycles 1 - 2)|Death|0|||
37767257|NCT01556490|69282520|FG000|Randomized Patients Summary|Protocol Violation|22|||
37767258|NCT01556490|69282521|FG001|Randomized Patients Summary|Protocol Violation|23|||
37767259|NCT01556490|69282520|FG000|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|12|||
37767260|NCT01556490|69282521|FG001|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|18|||
37767261|NCT01133990|69282540|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|1|||
37767262|NCT01133990|69282541|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
37767263|NCT01133990|69282542|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
37767264|NCT01133990|69282543|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
37767265|NCT01133990|69282544|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
37767266|NCT01133990|69282545|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
37767267|NCT01133990|69282540|FG000|Phase 1b (Dose Escalation Phase)|Physician Decision|1|||
37767268|NCT01133990|69282541|FG001|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
37767269|NCT01133990|69282542|FG002|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
37767270|NCT01133990|69282543|FG003|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
37767271|NCT01133990|69282544|FG004|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
37767272|NCT01133990|69282545|FG005|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
37767273|NCT01133990|69282540|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
37767274|NCT01133990|69282541|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
37767275|NCT01133990|69282542|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
37767276|NCT01133990|69282543|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
37767277|NCT01133990|69282544|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
37767278|NCT01133990|69282545|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
37767279|NCT01133990|69282540|FG000|Phase 1b (Dose Escalation Phase)|Progression of disease|1|||
37767280|NCT01133990|69282541|FG001|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
37767281|NCT01133990|69282542|FG002|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
37767282|NCT01133990|69282543|FG003|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
38039629|NCT00069095|69726972|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
38039630|NCT00069095|69726973|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
38039631|NCT00069095|69726974|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
38039632|NCT00069095|69726975|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
37767283|NCT01133990|69282544|FG004|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
37767284|NCT01133990|69282545|FG005|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
37767285|NCT01005745|69282556|FG000|Overall Study|No TIL growth|1|||
37767286|NCT01005745|69282556|FG000|Overall Study|Disease progressed during TIL growth|3|||
37767287|NCT01005745|69282556|FG000|Overall Study|Death prior to treatment|1|||
37767288|NCT01005745|69282556|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
37767289|NCT00980538|69282560|FG000|Overall Study|Lost to Follow-up|20|||
37767290|NCT00980538|69282560|FG000|Overall Study|Sponsor's Decision|4|||
37767291|NCT00980538|69282560|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
37767292|NCT00980538|69282560|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
37767293|NCT00980538|69282560|FG000|Overall Study|Switch to Commercially Available Medication|25|||
37767294|NCT00980538|69282560|FG000|Overall Study|Participant Non-Compliant|9|||
37767295|NCT00980538|69282560|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
37767296|NCT00980538|69282560|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
37767297|NCT00980538|69282560|FG000|Overall Study|Other|60|||
37767298|NCT00980538|69282560|FG000|Overall Study|Other|1|||
37767299|NCT00910429|69282566|FG000|Overall Study|Death|18|||
37767300|NCT00910429|69282567|FG001|Overall Study|Death|12|||
37767301|NCT00910429|69282566|FG000|Overall Study|Withdrawal by Subject|3|||
37767302|NCT00910429|69282567|FG001|Overall Study|Withdrawal by Subject|2|||
37767303|NCT00910429|69282566|FG000|Overall Study|Protocol Violation|1|||
37767304|NCT00910429|69282567|FG001|Overall Study|Protocol Violation|0|||
37767305|NCT00910429|69282566|FG000|Overall Study|Lost to Follow-up|2|||
37767306|NCT00910429|69282567|FG001|Overall Study|Lost to Follow-up|1|||
37767307|NCT00910429|69282566|FG000|Overall Study|Adverse Event|10|||
37767308|NCT00910429|69282567|FG001|Overall Study|Adverse Event|5|||
37767309|NCT00910429|69282566|FG000|Overall Study|Drug non-compliance|1|||
37767310|NCT00910429|69282567|FG001|Overall Study|Drug non-compliance|0|||
37767311|NCT00910429|69282566|FG000|Overall Study|Lack of Efficacy|4|||
37767312|NCT00910429|69282567|FG001|Overall Study|Lack of Efficacy|1|||
37767313|NCT00863681|69282576|FG000|Overall Study|Other|2|||
37767314|NCT00863681|69282577|FG001|Overall Study|Other|0|||
37767315|NCT00863681|69282578|FG002|Overall Study|Other|0|||
37767316|NCT00863681|69282576|FG000|Overall Study|Missing|1|||
37767317|NCT00863681|69282577|FG001|Overall Study|Missing|0|||
37767318|NCT00863681|69282578|FG002|Overall Study|Missing|0|||
37767319|NCT00863681|69282576|FG000|Overall Study|Death|40|||
37767320|NCT00863681|69282577|FG001|Overall Study|Death|23|||
37767321|NCT00863681|69282578|FG002|Overall Study|Death|6|||
37767322|NCT00863681|69282576|FG000|Overall Study|Withdrawal by Subject|12|||
37767323|NCT00863681|69282577|FG001|Overall Study|Withdrawal by Subject|5|||
37767324|NCT00863681|69282578|FG002|Overall Study|Withdrawal by Subject|2|||
37767325|NCT00863681|69282576|FG000|Overall Study|Protocol Violation|2|||
37767326|NCT00863681|69282577|FG001|Overall Study|Protocol Violation|0|||
37767327|NCT00863681|69282578|FG002|Overall Study|Protocol Violation|0|||
37767328|NCT00863681|69282576|FG000|Overall Study|Lost to Follow-up|3|||
37767329|NCT00863681|69282577|FG001|Overall Study|Lost to Follow-up|0|||
37767330|NCT00863681|69282578|FG002|Overall Study|Lost to Follow-up|3|||
37767331|NCT00863681|69282576|FG000|Overall Study|Adverse Event|28|||
37767332|NCT00863681|69282577|FG001|Overall Study|Adverse Event|10|||
37767333|NCT00863681|69282578|FG002|Overall Study|Adverse Event|6|||
37767334|NCT00863681|69282576|FG000|Overall Study|Lack of Efficacy|2|||
37767335|NCT00863681|69282577|FG001|Overall Study|Lack of Efficacy|2|||
37767336|NCT00863681|69282578|FG002|Overall Study|Lack of Efficacy|1|||
37767337|NCT00863681|69282576|FG000|Overall Study|Non-compliance with study drug|1|||
37767338|NCT00863681|69282577|FG001|Overall Study|Non-compliance with study drug|3|||
37767339|NCT00863681|69282578|FG002|Overall Study|Non-compliance with study drug|0|||
37767340|NCT00846742|69282586|FG000|Overall Study|Withdrawal by Subject|1|||
37767341|NCT00734149|69282591|FG000|Overall Study|Withdrawal by Subject|1|||
37767342|NCT00587431|69282599|FG000|Overall Study|Adverse Event|1|||
37767343|NCT00587431|69282600|FG001|Overall Study|Adverse Event|0|||
37767344|NCT00587431|69282599|FG000|Overall Study|Withdrawal by Subject|0|||
37767345|NCT00587431|69282600|FG001|Overall Study|Withdrawal by Subject|1|||
37767346|NCT00097786|69282622|FG000|Overall Study|lost to follow-up for all-cause death|296|||
37767347|NCT00097786|69282623|FG001|Overall Study|lost to follow-up for all-cause death|292|||
37767348|NCT00097786|69282624|FG002|Overall Study|lost to follow-up for all-cause death|313|||
37767349|NCT00097786|69282625|FG003|Overall Study|lost to follow-up for all-cause death|310|||
37767350|NCT01524692|69282635|FG000|Overall Study|Withdrawal by Subject|3|||
37767351|NCT01431287|69282654|FG000|Overall Study|not treated|0|||
37767352|NCT01431287|69282655|FG001|Overall Study|not treated|0|||
37767353|NCT01431287|69282656|FG002|Overall Study|not treated|1|||
37767354|NCT01431287|69282657|FG003|Overall Study|not treated|0|||
38039633|NCT00069095|69726970|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
37767355|NCT01431287|69282658|FG004|Overall Study|not treated|0|||
37767356|NCT01431287|69282654|FG000|Overall Study|Adverse Event|59|||
37767357|NCT01431287|69282655|FG001|Overall Study|Adverse Event|57|||
37767358|NCT01431287|69282656|FG002|Overall Study|Adverse Event|53|||
37767359|NCT01431287|69282657|FG003|Overall Study|Adverse Event|33|||
37767360|NCT01431287|69282658|FG004|Overall Study|Adverse Event|41|||
37767361|NCT01431287|69282654|FG000|Overall Study|Non compliant with protocol|6|||
37767362|NCT01431287|69282655|FG001|Overall Study|Non compliant with protocol|6|||
37767363|NCT01431287|69282656|FG002|Overall Study|Non compliant with protocol|5|||
37767364|NCT01431287|69282657|FG003|Overall Study|Non compliant with protocol|6|||
37767365|NCT01431287|69282658|FG004|Overall Study|Non compliant with protocol|5|||
37767366|NCT01431287|69282654|FG000|Overall Study|Lost to Follow-up|0|||
37767367|NCT01431287|69282655|FG001|Overall Study|Lost to Follow-up|3|||
37767368|NCT01431287|69282656|FG002|Overall Study|Lost to Follow-up|2|||
37767369|NCT01431287|69282657|FG003|Overall Study|Lost to Follow-up|3|||
37767370|NCT01431287|69282658|FG004|Overall Study|Lost to Follow-up|1|||
37767371|NCT01431287|69282654|FG000|Overall Study|Consent withdrawn not due to AE|29|||
37767372|NCT01431287|69282655|FG001|Overall Study|Consent withdrawn not due to AE|30|||
37767373|NCT01431287|69282656|FG002|Overall Study|Consent withdrawn not due to AE|34|||
37767374|NCT01431287|69282657|FG003|Overall Study|Consent withdrawn not due to AE|19|||
37767375|NCT01431287|69282658|FG004|Overall Study|Consent withdrawn not due to AE|29|||
37767376|NCT01431287|69282654|FG000|Overall Study|not stated above|4|||
37767377|NCT01431287|69282655|FG001|Overall Study|not stated above|2|||
37767378|NCT01431287|69282656|FG002|Overall Study|not stated above|2|||
37767379|NCT01431287|69282657|FG003|Overall Study|not stated above|2|||
37767380|NCT01431287|69282658|FG004|Overall Study|not stated above|1|||
37767381|NCT01274715|69282704|FG000|Overall Study|Lost to Follow-up|1|||
37767382|NCT01274715|69282704|FG000|Overall Study|After consent, met exclusion criteria.|1|||
37767383|NCT01274715|69282704|FG000|Overall Study|After consent, met exclusion criteria.|1|||
37767384|NCT01274715|69282704|FG000|Overall Study|After consent, met exclusion criteria.|1|||
37767385|NCT01410227|69282708|FG000|Overall Study|Adverse Event|1|||
37767386|NCT01410227|69282709|FG001|Overall Study|Adverse Event|0|||
37767387|NCT01410227|69282710|FG002|Overall Study|Adverse Event|0|||
37767388|NCT01410227|69282711|FG003|Overall Study|Adverse Event|0|||
37767389|NCT01410227|69282708|FG000|Overall Study|Withdrawal by Subject|3|||
37767390|NCT01410227|69282709|FG001|Overall Study|Withdrawal by Subject|0|||
37767391|NCT01410227|69282710|FG002|Overall Study|Withdrawal by Subject|1|||
37767392|NCT01410227|69282711|FG003|Overall Study|Withdrawal by Subject|0|||
37767393|NCT01410227|69282708|FG000|Overall Study|Pregnancy|0|||
37767394|NCT01410227|69282709|FG001|Overall Study|Pregnancy|0|||
37767395|NCT01410227|69282710|FG002|Overall Study|Pregnancy|0|||
37767396|NCT01410227|69282711|FG003|Overall Study|Pregnancy|1|||
37767397|NCT01410227|69282708|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
37767398|NCT01410227|69282709|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
37767399|NCT01410227|69282710|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
37767400|NCT01410227|69282711|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
37767401|NCT01274559|69282723|FG000|Overall Study|Adverse Event|57|||
38039634|NCT00069095|69726971|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
38039635|NCT00069095|69726972|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
37675895|NCT01269346|69150364|FG000|Treatment Phase|Withdrawal by Subject|1|||
37675896|NCT01269346|69150364|FG000|Treatment Phase|Other|2|||
37675897|NCT01269346|69150364|FG000|Extension Phase|Adverse Event|6|||
37675898|NCT01269346|69150364|FG000|Extension Phase|Withdrawal by Subject|4|||
37675899|NCT01269346|69150364|FG000|Extension Phase|Disease progression|22|||
37675900|NCT01269346|69150364|FG000|Extension Phase|Physician decision or participant choice|9|||
37675901|NCT01269346|69150364|FG000|Extension Phase|Clinical progression|1|||
37675902|NCT01269346|69150364|FG000|Extension Phase|Started a prohibited con med|1|||
37675903|NCT01268293|69150369|FG000|Overall Study|Disease progression|7|||
37675904|NCT01268293|69150369|FG000|Overall Study|Adverse Event|1|||
37675905|NCT01268293|69150369|FG000|Overall Study|Subject choice|1|||
37675906|NCT01268150|69150373|FG000|Treatment Phase|Progression of disease|18|||
37675907|NCT01268150|69150373|FG000|Treatment Phase|Adverse Event|3|||
37675908|NCT01268150|69150373|FG000|Treatment Phase|Withdrawal by Subject|3|||
37675909|NCT01268150|69150373|FG000|Treatment Phase|Other|4|||
37675910|NCT01268150|69150373|FG000|Extension Phase|Adverse Event|3|||
37675911|NCT01268150|69150373|FG000|Extension Phase|Disease progression|18|||
37675912|NCT01268150|69150373|FG000|Extension Phase|Other|6|||
37675913|NCT01267175|69150377|FG000|Overall Study|Withdrawal by Subject|1|||
37675914|NCT01267175|69150377|FG000|Overall Study|Lost to Follow-up|1|||
37675915|NCT01133756|69150388|FG000|Overall Study|Adverse Event|1|||
37767402|NCT01274559|69282724|FG001|Overall Study|Adverse Event|13|||
37767403|NCT01274559|69282723|FG000|Overall Study|Death|1|||
37767404|NCT01274559|69282724|FG001|Overall Study|Death|1|||
37767405|NCT01274559|69282723|FG000|Overall Study|Lost to Follow-up|3|||
37767406|NCT01274559|69282724|FG001|Overall Study|Lost to Follow-up|3|||
37767407|NCT01274559|69282723|FG000|Overall Study|Non-compliance with Study Drug|2|||
37767408|NCT01274559|69282724|FG001|Overall Study|Non-compliance with Study Drug|4|||
37767409|NCT01274559|69282723|FG000|Overall Study|Physician Decision|2|||
37767410|NCT01274559|69282724|FG001|Overall Study|Physician Decision|1|||
37767411|NCT01274559|69282723|FG000|Overall Study|Protocol Violation|28|||
37767412|NCT01274559|69282724|FG001|Overall Study|Protocol Violation|23|||
38039636|NCT00069095|69726973|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
38039637|NCT00069095|69726974|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
38039638|NCT00069095|69726975|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
38039639|NCT00069095|69726970|FG000|Post-study Treatment Phase|Participant had complete response|1|||
38039640|NCT00069095|69726971|FG001|Post-study Treatment Phase|Participant had complete response|1|||
38039641|NCT00069095|69726972|FG002|Post-study Treatment Phase|Participant had complete response|0|||
38039642|NCT00069095|69726973|FG003|Post-study Treatment Phase|Participant had complete response|0|||
38039643|NCT00069095|69726974|FG004|Post-study Treatment Phase|Participant had complete response|0|||
38039644|NCT00069095|69726975|FG005|Post-study Treatment Phase|Participant had complete response|0|||
38039645|NCT00069095|69726970|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
38039646|NCT00069095|69726971|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
38039647|NCT00069095|69726972|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
38039648|NCT00069095|69726973|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
38039649|NCT00069095|69726974|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
37767413|NCT01274559|69282723|FG000|Overall Study|Study Terminated by Sponsor|79|||
37767414|NCT01274559|69282724|FG001|Overall Study|Study Terminated by Sponsor|87|||
37767415|NCT01274559|69282723|FG000|Overall Study|Withdrawal by Subject|25|||
37767416|NCT01274559|69282724|FG001|Overall Study|Withdrawal by Subject|13|||
37767417|NCT01409993|69282732|FG000|Overall Study|Adverse Event|4|||
37767418|NCT01409993|69282733|FG001|Overall Study|Adverse Event|4|||
37767419|NCT01409993|69282734|FG002|Overall Study|Adverse Event|3|||
37767420|NCT01409993|69282735|FG003|Overall Study|Adverse Event|1|||
37767421|NCT01409993|69282732|FG000|Overall Study|Withdrawal by Subject|0|||
37767422|NCT01409993|69282733|FG001|Overall Study|Withdrawal by Subject|0|||
37767423|NCT01409993|69282734|FG002|Overall Study|Withdrawal by Subject|0|||
37767424|NCT01409993|69282735|FG003|Overall Study|Withdrawal by Subject|4|||
37767425|NCT01409993|69282732|FG000|Overall Study|Lost to Follow-up|0|||
37767426|NCT01409993|69282733|FG001|Overall Study|Lost to Follow-up|1|||
37767427|NCT01409993|69282734|FG002|Overall Study|Lost to Follow-up|0|||
37767428|NCT01409993|69282735|FG003|Overall Study|Lost to Follow-up|0|||
37767429|NCT01273623|69282749|FG000|Overall Study|did not meet IVUS criteria|29|||
37767430|NCT01409915|69282757|FG000|Overall Study|Adverse Event|0|||
37767431|NCT01409915|69282758|FG001|Overall Study|Adverse Event|2|||
37767432|NCT01409915|69282757|FG000|Overall Study|Withdrawal by Subject|0|||
37767433|NCT01409915|69282758|FG001|Overall Study|Withdrawal by Subject|1|||
37767434|NCT01409915|69282757|FG000|Overall Study|Protocol Violation|1|||
37767435|NCT01409915|69282758|FG001|Overall Study|Protocol Violation|0|||
37767436|NCT01272921|69282766|FG000|Overall Study|Protocol Violation|2|||
37767437|NCT01272921|69282767|FG001|Overall Study|Protocol Violation|1|||
37767438|NCT01409837|69282777|FG000|Overall Study|Withdrawal by Subject|2|||
37767439|NCT01409837|69282778|FG001|Overall Study|Withdrawal by Subject|1|||
37767440|NCT01409837|69282777|FG000|Overall Study|Lost to Follow-up|1|||
37767441|NCT01409837|69282778|FG001|Overall Study|Lost to Follow-up|0|||
37767442|NCT01409837|69282777|FG000|Overall Study|Physician Decision|0|||
37767443|NCT01409837|69282778|FG001|Overall Study|Physician Decision|1|||
37767444|NCT01430585|69282797|FG000|Overall Study|Death|1|||
37767445|NCT01430585|69282797|FG000|Overall Study|Objective Progression or Relapse|3|||
37767446|NCT01430585|69282797|FG000|Overall Study|Study Terminated by Sponsor|3|||
37767447|NCT01430585|69282797|FG000|Overall Study|Other|7|||
37767448|NCT01408901|69282820|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
37767449|NCT01408901|69282821|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
37767450|NCT01408901|69282822|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
37767451|NCT01408901|69282823|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
37767452|NCT01408901|69282820|FG000|6-Week Follow-Up|Death|1|||
37767453|NCT01408901|69282821|FG001|6-Week Follow-Up|Death|0|||
37767454|NCT01408901|69282822|FG002|6-Week Follow-Up|Death|0|||
37767455|NCT01408901|69282823|FG003|6-Week Follow-Up|Death|0|||
37767456|NCT01408901|69282820|FG000|6-Week Follow-Up|Cancelled visit|0|||
37767457|NCT01408901|69282821|FG001|6-Week Follow-Up|Cancelled visit|1|||
37767458|NCT01408901|69282822|FG002|6-Week Follow-Up|Cancelled visit|0|||
37767459|NCT01408901|69282823|FG003|6-Week Follow-Up|Cancelled visit|2|||
37767460|NCT01408901|69282820|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
37767461|NCT01408901|69282821|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
37767462|NCT01408901|69282822|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
37767463|NCT01408901|69282823|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
37767464|NCT01408901|69282820|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
37767465|NCT01408901|69282821|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
37767466|NCT01408901|69282822|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
37767467|NCT01408901|69282823|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
37767468|NCT01408901|69282820|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
37767469|NCT01408901|69282821|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
37767470|NCT01408901|69282822|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
37767471|NCT01408901|69282823|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
37767472|NCT01408901|69282820|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
37767473|NCT01408901|69282821|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
37767474|NCT01408901|69282822|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
37767475|NCT01408901|69282823|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
37767476|NCT01408901|69282820|FG000|26-Week Follow-Up|Death|0|||
37767477|NCT01408901|69282821|FG001|26-Week Follow-Up|Death|1|||
37767478|NCT01408901|69282822|FG002|26-Week Follow-Up|Death|0|||
37767479|NCT01408901|69282823|FG003|26-Week Follow-Up|Death|0|||
37767480|NCT01428713|69282839|FG000|Overall Study|Non-compliance|2|||
37767481|NCT01428713|69282840|FG001|Overall Study|Non-compliance|2|||
37767482|NCT01428713|69282839|FG000|Overall Study|Withdrawal by Subject|1|||
37767483|NCT01428713|69282840|FG001|Overall Study|Withdrawal by Subject|1|||
37767484|NCT01428713|69282839|FG000|Overall Study|Adverse Event|0|||
37767485|NCT01428713|69282840|FG001|Overall Study|Adverse Event|2|||
37767486|NCT01408277|69282848|FG000|Overall Study|Adverse Event|3|||
37767487|NCT01408277|69282849|FG001|Overall Study|Adverse Event|4|||
37767488|NCT01408277|69282848|FG000|Overall Study|Lost to Follow-up|1|||
37767489|NCT01408277|69282849|FG001|Overall Study|Lost to Follow-up|0|||
37767490|NCT01408277|69282848|FG000|Overall Study|Withdrawal by Subject|2|||
37767491|NCT01408277|69282849|FG001|Overall Study|Withdrawal by Subject|0|||
37767492|NCT01408277|69282848|FG000|Overall Study|Protocol Violation|2|||
37767493|NCT01408277|69282849|FG001|Overall Study|Protocol Violation|0|||
37767494|NCT01408043|69282855|FG000|Overall Study|unable to collect cells|1|||
37767495|NCT01524224|69282867|FG000|Overall Study|Progressive Disease|1|||
37767496|NCT01524224|69282868|FG001|Overall Study|Progressive Disease|0|||
37767497|NCT01524224|69282869|FG002|Overall Study|Progressive Disease|2|||
37767498|NCT01524224|69282870|FG003|Overall Study|Progressive Disease|1|||
37767499|NCT01524224|69282871|FG004|Overall Study|Progressive Disease|2|||
37767500|NCT01524224|69282872|FG005|Overall Study|Progressive Disease|1|||
37767501|NCT01524224|69282873|FG006|Overall Study|Progressive Disease|1|||
37767502|NCT01524224|69282874|FG007|Overall Study|Progressive Disease|5|||
37767503|NCT01524224|69282867|FG000|Overall Study|Withdrawal by Subject|2|||
37767504|NCT01524224|69282868|FG001|Overall Study|Withdrawal by Subject|0|||
37767505|NCT01524224|69282869|FG002|Overall Study|Withdrawal by Subject|0|||
37767506|NCT01524224|69282870|FG003|Overall Study|Withdrawal by Subject|0|||
37767507|NCT01524224|69282871|FG004|Overall Study|Withdrawal by Subject|0|||
37767508|NCT01524224|69282872|FG005|Overall Study|Withdrawal by Subject|0|||
37767509|NCT01524224|69282873|FG006|Overall Study|Withdrawal by Subject|2|||
37767510|NCT01524224|69282874|FG007|Overall Study|Withdrawal by Subject|0|||
37767511|NCT01524224|69282867|FG000|Overall Study|Adverse Event|0|||
37767512|NCT01524224|69282868|FG001|Overall Study|Adverse Event|1|||
37767513|NCT01524224|69282869|FG002|Overall Study|Adverse Event|0|||
37767514|NCT01524224|69282870|FG003|Overall Study|Adverse Event|0|||
37767515|NCT01524224|69282871|FG004|Overall Study|Adverse Event|0|||
37767516|NCT01524224|69282872|FG005|Overall Study|Adverse Event|1|||
37767517|NCT01524224|69282873|FG006|Overall Study|Adverse Event|0|||
37767518|NCT01524224|69282874|FG007|Overall Study|Adverse Event|0|||
37767519|NCT01524224|69282867|FG000|Overall Study|Physician Decision|0|||
37767520|NCT01524224|69282868|FG001|Overall Study|Physician Decision|0|||
37767521|NCT01524224|69282869|FG002|Overall Study|Physician Decision|0|||
37767522|NCT01524224|69282870|FG003|Overall Study|Physician Decision|1|||
37767523|NCT01524224|69282871|FG004|Overall Study|Physician Decision|1|||
37767524|NCT01524224|69282872|FG005|Overall Study|Physician Decision|0|||
37767525|NCT01524224|69282873|FG006|Overall Study|Physician Decision|0|||
37767526|NCT01524224|69282874|FG007|Overall Study|Physician Decision|1|||
37767527|NCT01524224|69282867|FG000|Overall Study|Sponsor Decision|0|||
37767528|NCT01524224|69282868|FG001|Overall Study|Sponsor Decision|0|||
37767529|NCT01524224|69282869|FG002|Overall Study|Sponsor Decision|0|||
37767530|NCT01524224|69282870|FG003|Overall Study|Sponsor Decision|0|||
37767531|NCT01524224|69282871|FG004|Overall Study|Sponsor Decision|1|||
37767532|NCT01524224|69282872|FG005|Overall Study|Sponsor Decision|0|||
37767533|NCT01524224|69282873|FG006|Overall Study|Sponsor Decision|0|||
37675916|NCT01133756|69150389|FG001|Overall Study|Adverse Event|2|||
37675917|NCT01133756|69150390|FG002|Overall Study|Adverse Event|1|||
37675918|NCT01133756|69150388|FG000|Overall Study|Investigator Decision|1|||
37675919|NCT01133756|69150389|FG001|Overall Study|Investigator Decision|0|||
37675920|NCT01133756|69150390|FG002|Overall Study|Investigator Decision|0|||
37675921|NCT01133756|69150388|FG000|Overall Study|Withdrawal by Subject|0|||
37675922|NCT01133756|69150389|FG001|Overall Study|Withdrawal by Subject|1|||
37675923|NCT01133756|69150390|FG002|Overall Study|Withdrawal by Subject|0|||
37675924|NCT01133756|69150388|FG000|Overall Study|Progression of Disease|0|||
37675925|NCT01133756|69150389|FG001|Overall Study|Progression of Disease|0|||
37675926|NCT01133756|69150390|FG002|Overall Study|Progression of Disease|1|||
37675927|NCT01126736|69150403|FG000|Overall Study|Death|2|||
37675928|NCT01126736|69150404|FG001|Overall Study|Death|2|||
37675929|NCT01126736|69150405|FG002|Overall Study|Death|1|||
37675930|NCT01126736|69150406|FG003|Overall Study|Death|19|||
37675931|NCT01126736|69150407|FG004|Overall Study|Death|19|||
37675932|NCT01126736|69150403|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
37767534|NCT01524224|69282874|FG007|Overall Study|Sponsor Decision|0|||
38039650|NCT00069095|69726975|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
38039651|NCT00069095|69726970|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
38039652|NCT00069095|69726971|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
38039653|NCT00069095|69726972|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
38039654|NCT00069095|69726973|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
38039655|NCT00069095|69726974|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
38039656|NCT00069095|69726975|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
38039657|NCT00069095|69726970|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
38039658|NCT00069095|69726971|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
38039659|NCT00069095|69726972|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
38039660|NCT00069095|69726973|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
38039661|NCT00069095|69726974|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
38039662|NCT00069095|69726975|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
38039663|NCT00069095|69726970|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
38039664|NCT00069095|69726971|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
38039665|NCT00069095|69726972|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
38039666|NCT00069095|69726973|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
38039667|NCT00069095|69726974|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
38039668|NCT00069095|69726975|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
38039669|NCT00069095|69726970|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
38039670|NCT00069095|69726971|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
38039671|NCT00069095|69726972|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
38039672|NCT00069095|69726973|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
38039673|NCT00069095|69726974|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
38039674|NCT00069095|69726975|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
38039675|NCT00069095|69726970|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
38039676|NCT00069095|69726971|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
38039677|NCT00069095|69726972|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
38039678|NCT00069095|69726973|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
38039679|NCT00069095|69726974|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
38039680|NCT00069095|69726975|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
38039681|NCT00069095|69726970|FG000|Post-study Treatment Phase|Surgery|0|||
38039682|NCT00069095|69726971|FG001|Post-study Treatment Phase|Surgery|0|||
38039683|NCT00069095|69726972|FG002|Post-study Treatment Phase|Surgery|0|||
38039684|NCT00069095|69726973|FG003|Post-study Treatment Phase|Surgery|1|||
38039685|NCT00069095|69726974|FG004|Post-study Treatment Phase|Surgery|1|||
38039686|NCT00069095|69726975|FG005|Post-study Treatment Phase|Surgery|0|||
38039687|NCT00069095|69726970|FG000|Post-study Treatment Phase|Death|0|||
38039688|NCT00069095|69726971|FG001|Post-study Treatment Phase|Death|0|||
38039689|NCT00069095|69726972|FG002|Post-study Treatment Phase|Death|0|||
38039690|NCT00069095|69726973|FG003|Post-study Treatment Phase|Death|0|||
38039691|NCT00069095|69726974|FG004|Post-study Treatment Phase|Death|1|||
38039692|NCT00069095|69726975|FG005|Post-study Treatment Phase|Death|0|||
38039693|NCT00069095|69726970|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
38039694|NCT00069095|69726971|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
38039695|NCT00069095|69726972|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
38039696|NCT00069095|69726973|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
38039697|NCT00069095|69726974|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
38039698|NCT00069095|69726975|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
38039699|NCT00069095|69726970|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
38039700|NCT00069095|69726971|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
38039701|NCT00069095|69726972|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
38039702|NCT00069095|69726973|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
38039703|NCT00069095|69726974|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
38039704|NCT00069095|69726975|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
38039705|NCT00069095|69726970|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
38039706|NCT00069095|69726971|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
38039707|NCT00069095|69726972|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
38039708|NCT00069095|69726973|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
38039709|NCT00069095|69726974|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
38039710|NCT00069095|69726975|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
38039711|NCT00069095|69726970|FG000|Post-study Treatment Phase|Investigator decision|0|||
38039712|NCT00069095|69726971|FG001|Post-study Treatment Phase|Investigator decision|0|||
37767535|NCT00219349|69282892|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
38039713|NCT00069095|69726972|FG002|Post-study Treatment Phase|Investigator decision|0|||
38039714|NCT00069095|69726973|FG003|Post-study Treatment Phase|Investigator decision|0|||
38039715|NCT00069095|69726974|FG004|Post-study Treatment Phase|Investigator decision|0|||
38039716|NCT00069095|69726975|FG005|Post-study Treatment Phase|Investigator decision|1|||
38039717|NCT00069095|69726970|FG000|Follow-up Phase|Death|174|||
38039718|NCT00069095|69726971|FG001|Follow-up Phase|Death|206|||
38039719|NCT00069095|69726972|FG002|Follow-up Phase|Death|120|||
38039720|NCT00069095|69726973|FG003|Follow-up Phase|Death|112|||
38039721|NCT00069095|69726974|FG004|Follow-up Phase|Death|92|||
38039722|NCT00069095|69726975|FG005|Follow-up Phase|Death|101|||
38039723|NCT00086411|69726991|FG000|Overall Study|Lost to Follow-up|11|||
38039724|NCT00086411|69726992|FG001|Overall Study|Lost to Follow-up|11|||
38039725|NCT00086411|69726993|FG002|Overall Study|Lost to Follow-up|13|||
38039726|NCT00086411|69726994|FG003|Overall Study|Lost to Follow-up|12|||
38039727|NCT00068237|69727005|FG000|Overall Study|Ineligible|3|||
38039728|NCT00068237|69727005|FG000|Overall Study|No protocol treatment received|2|||
38039729|NCT00055601|69727011|FG000|Overall Study|Protocol Violation|1|||
38039730|NCT00055601|69727012|FG001|Overall Study|Protocol Violation|1|||
38039731|NCT00055601|69727011|FG000|Overall Study|No protocol treatment received|1|||
38039732|NCT00055601|69727012|FG001|Overall Study|No protocol treatment received|1|||
38039733|NCT03806231|69727020|FG000|Overall Study|Physician Decision|1|||
38039734|NCT03806231|69727021|FG001|Overall Study|Physician Decision|0|||
38039735|NCT03806231|69727020|FG000|Overall Study|Withdrawal by Subject|1|||
38039736|NCT03806231|69727021|FG001|Overall Study|Withdrawal by Subject|0|||
38039737|NCT00054275|69727027|FG000|Overall Study|Withdrawal by Subject|4|||
38039738|NCT00054275|69727027|FG000|Overall Study|Adverse Event|5|||
38039739|NCT00054275|69727027|FG000|Overall Study|Progressive disease in cycle 1|1|||
38039740|NCT00054275|69727027|FG000|Overall Study|Physician Decision|1|||
38039741|NCT00053417|69727035|FG000|Overall Study|Adverse Event|1|||
38039742|NCT00053417|69727036|FG001|Overall Study|Adverse Event|0|||
38039743|NCT00053417|69727037|FG002|Overall Study|Adverse Event|1|||
38039744|NCT00053417|69727038|FG003|Overall Study|Adverse Event|5|||
38039745|NCT00053417|69727035|FG000|Overall Study|Non-Compliance|0|||
38039746|NCT00053417|69727036|FG001|Overall Study|Non-Compliance|0|||
38039747|NCT00053417|69727037|FG002|Overall Study|Non-Compliance|0|||
38039748|NCT00053417|69727038|FG003|Overall Study|Non-Compliance|1|||
38039749|NCT00053417|69727035|FG000|Overall Study|Withdrawal by Subject|0|||
38039750|NCT00053417|69727036|FG001|Overall Study|Withdrawal by Subject|1|||
38039751|NCT00053417|69727037|FG002|Overall Study|Withdrawal by Subject|0|||
38039752|NCT00053417|69727038|FG003|Overall Study|Withdrawal by Subject|0|||
38039753|NCT00053417|69727035|FG000|Overall Study|Lost to Follow-up|1|||
38039754|NCT00053417|69727036|FG001|Overall Study|Lost to Follow-up|1|||
38039755|NCT00053417|69727037|FG002|Overall Study|Lost to Follow-up|0|||
38039756|NCT00053417|69727038|FG003|Overall Study|Lost to Follow-up|0|||
38039757|NCT00052715|69727048|FG000|Overall Study|wrong histology|1|||
38039758|NCT00051311|69727054|FG000|Overall Study|Starting new study|0|||
38039759|NCT00051311|69727055|FG001|Overall Study|Starting new study|1|||
38039760|NCT00051311|69727054|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
38039761|NCT00051311|69727055|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
38039762|NCT00051311|69727054|FG000|Overall Study|Death of recipient|8|||
38039763|NCT00051311|69727055|FG001|Overall Study|Death of recipient|8|||
38039764|NCT00051311|69727054|FG000|Overall Study|Recipient taken off study|4|||
38039765|NCT00051311|69727055|FG001|Overall Study|Recipient taken off study|4|||
38039766|NCT00049673|69727061|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
38039767|NCT00049673|69727062|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
38039768|NCT00049127|69727073|FG000|Overall Study|Withdrawal by Subject|0|||
38039769|NCT00049127|69727074|FG001|Overall Study|Withdrawal by Subject|0|||
38039770|NCT00049127|69727075|FG002|Overall Study|Withdrawal by Subject|1|||
38039771|NCT00049127|69727076|FG003|Overall Study|Withdrawal by Subject|0|||
38039772|NCT00049127|69727077|FG004|Overall Study|Withdrawal by Subject|0|||
38039773|NCT00066365|69727091|FG000|Overall Study|Adverse Event|1|||
37675933|NCT01126736|69150404|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
37675934|NCT01126736|69150405|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
37675935|NCT01126736|69150406|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
37675936|NCT01126736|69150407|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
37675937|NCT01126736|69150403|FG000|Overall Study|Lost to Follow-up|0|||
37675938|NCT01126736|69150404|FG001|Overall Study|Lost to Follow-up|0|||
37675939|NCT01126736|69150405|FG002|Overall Study|Lost to Follow-up|0|||
37675940|NCT01126736|69150406|FG003|Overall Study|Lost to Follow-up|1|||
38039774|NCT00066365|69727092|FG001|Overall Study|Adverse Event|0|||
38039775|NCT00066365|69727091|FG000|Overall Study|Lack of Efficacy|15|||
38039776|NCT00066365|69727092|FG001|Overall Study|Lack of Efficacy|12|||
38039777|NCT00066365|69727091|FG000|Overall Study|Physician Decision|1|||
38039778|NCT00066365|69727092|FG001|Overall Study|Physician Decision|0|||
38039779|NCT00066365|69727091|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
38039780|NCT00066365|69727092|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
38039781|NCT00066365|69727091|FG000|Overall Study|Ineligible|4|||
37675941|NCT01126736|69150407|FG004|Overall Study|Lost to Follow-up|1|||
37675942|NCT01126736|69150403|FG000|Overall Study|Administrative reasons|0|||
37675943|NCT01126736|69150404|FG001|Overall Study|Administrative reasons|0|||
37675944|NCT01126736|69150405|FG002|Overall Study|Administrative reasons|0|||
37675945|NCT01126736|69150406|FG003|Overall Study|Administrative reasons|0|||
37675946|NCT01126736|69150407|FG004|Overall Study|Administrative reasons|1|||
37675947|NCT01126736|69150403|FG000|Overall Study|Progressive disease|0|||
37675948|NCT01126736|69150404|FG001|Overall Study|Progressive disease|0|||
37675949|NCT01126736|69150405|FG002|Overall Study|Progressive disease|0|||
37675950|NCT01126736|69150406|FG003|Overall Study|Progressive disease|2|||
37675951|NCT01126736|69150407|FG004|Overall Study|Progressive disease|1|||
37675952|NCT01126736|69150403|FG000|Overall Study|Withdrawal by Subject|0|||
37675953|NCT01126736|69150404|FG001|Overall Study|Withdrawal by Subject|0|||
37675954|NCT01126736|69150405|FG002|Overall Study|Withdrawal by Subject|0|||
37675955|NCT01126736|69150406|FG003|Overall Study|Withdrawal by Subject|1|||
37675956|NCT01126736|69150407|FG004|Overall Study|Withdrawal by Subject|1|||
37675957|NCT01126736|69150403|FG000|Overall Study|Other|2|||
37675958|NCT01126736|69150404|FG001|Overall Study|Other|4|||
37675959|NCT01126736|69150405|FG002|Overall Study|Other|4|||
37675960|NCT01126736|69150406|FG003|Overall Study|Other|16|||
37675961|NCT01126736|69150407|FG004|Overall Study|Other|15|||
37675962|NCT01111461|69150419|FG000|Overall Study|Adverse Event|32|||
37675963|NCT01111461|69150419|FG000|Overall Study|Participant choice|11|||
37675964|NCT01111461|69150419|FG000|Overall Study|Lost to Follow-up|1|||
37675965|NCT01111461|69150419|FG000|Overall Study|Withdrawal by Subject|1|||
37675966|NCT01111461|69150419|FG000|Overall Study|Other|6|||
37675967|NCT01104155|69150425|FG000|Overall Study|Adverse Event|15|||
37675968|NCT01104155|69150426|FG001|Overall Study|Adverse Event|8|||
37675969|NCT01104155|69150425|FG000|Overall Study|Participant choice|6|||
37675970|NCT01104155|69150426|FG001|Overall Study|Participant choice|5|||
37675971|NCT01104155|69150425|FG000|Overall Study|Withdrawal of consent|1|||
37675972|NCT01104155|69150426|FG001|Overall Study|Withdrawal of consent|1|||
37675973|NCT01104155|69150425|FG000|Overall Study|Other|3|||
37675974|NCT01104155|69150426|FG001|Overall Study|Other|4|||
37675975|NCT01065597|69150432|FG000|Overall Study|Adverse Event|1|||
37675976|NCT01051856|69150438|FG000|Overall Study|Withdrawal by Subject|1|||
37675977|NCT01051856|69150439|FG001|Overall Study|Withdrawal by Subject|0|||
37675978|NCT01029366|69150447|FG000|Overall Study|Withdrawal by Subject|1|||
37675979|NCT01029366|69150448|FG001|Overall Study|Withdrawal by Subject|0|||
37675980|NCT01029366|69150447|FG000|Overall Study|Death|1|||
37675981|NCT01029366|69150448|FG001|Overall Study|Death|1|||
37675982|NCT01029366|69150447|FG000|Overall Study|disease progression|2|||
37675983|NCT01029366|69150448|FG001|Overall Study|disease progression|0|||
37675984|NCT01029366|69150447|FG000|Overall Study|manufacturing failure|0|||
37675985|NCT01029366|69150448|FG001|Overall Study|manufacturing failure|1|||
37675986|NCT00879086|69150457|FG000|Overall Study|Adverse Event|3|||
37675987|NCT00879086|69150458|FG001|Overall Study|Adverse Event|15|||
37675988|NCT00879086|69150457|FG000|Overall Study|Participant choice|2|||
37675989|NCT00879086|69150458|FG001|Overall Study|Participant choice|2|||
37675990|NCT00879086|69150457|FG000|Overall Study|Progression of disease|40|||
37675991|NCT00879086|69150458|FG001|Overall Study|Progression of disease|26|||
37675992|NCT00879086|69150457|FG000|Overall Study|Withdrawal of consent|2|||
37675993|NCT00879086|69150458|FG001|Overall Study|Withdrawal of consent|1|||
37675994|NCT00879086|69150457|FG000|Overall Study|Other|4|||
37675995|NCT00879086|69150458|FG001|Overall Study|Other|6|||
37675996|NCT00879086|69150457|FG000|Overall Study|Death|1|||
37675997|NCT00879086|69150458|FG001|Overall Study|Death|2|||
37675998|NCT00244933|69150474|FG000|Overall Study|Not response evaluable|2|||
37675999|NCT02637557|69150555|FG000|Overall Study|Adverse Event|3|||
37676000|NCT02637557|69150556|FG001|Overall Study|Adverse Event|1|||
37676001|NCT02637557|69150557|FG002|Overall Study|Adverse Event|3|||
37676002|NCT02637557|69150558|FG003|Overall Study|Adverse Event|3|||
37676003|NCT02637557|69150555|FG000|Overall Study|Lost to Follow-up|1|||
37676004|NCT02637557|69150556|FG001|Overall Study|Lost to Follow-up|1|||
37676005|NCT02637557|69150557|FG002|Overall Study|Lost to Follow-up|0|||
37676006|NCT02637557|69150558|FG003|Overall Study|Lost to Follow-up|1|||
37676007|NCT02637557|69150555|FG000|Overall Study|Physician Decision|1|||
37676008|NCT02637557|69150556|FG001|Overall Study|Physician Decision|0|||
37676009|NCT02637557|69150557|FG002|Overall Study|Physician Decision|0|||
37676010|NCT02637557|69150558|FG003|Overall Study|Physician Decision|0|||
37676011|NCT02637557|69150555|FG000|Overall Study|Protocol Violation|2|||
37676012|NCT02637557|69150556|FG001|Overall Study|Protocol Violation|0|||
37676013|NCT02637557|69150557|FG002|Overall Study|Protocol Violation|2|||
37676014|NCT02637557|69150558|FG003|Overall Study|Protocol Violation|1|||
37676015|NCT02637557|69150555|FG000|Overall Study|Withdrawal by Subject|1|||
37676016|NCT02637557|69150556|FG001|Overall Study|Withdrawal by Subject|3|||
37676017|NCT02637557|69150557|FG002|Overall Study|Withdrawal by Subject|4|||
37676018|NCT02637557|69150558|FG003|Overall Study|Withdrawal by Subject|2|||
37676019|NCT02638493|69150571|FG000|Overall Study|Inability to provide semen samples|2|||
37676020|NCT02638493|69150572|FG001|Overall Study|Inability to provide semen samples|0|||
37676021|NCT02638493|69150573|FG002|Overall Study|Inability to provide semen samples|0|||
37676022|NCT02638337|69150583|FG000|Overall Study|Adverse Event|6|||
37676023|NCT02638337|69150584|FG001|Overall Study|Adverse Event|10|||
37676024|NCT02638337|69150583|FG000|Overall Study|Protocol Violation|3|||
37676025|NCT02638337|69150584|FG001|Overall Study|Protocol Violation|0|||
37676026|NCT02638337|69150583|FG000|Overall Study|Withdrawal by Subject|13|||
37676027|NCT02638337|69150584|FG001|Overall Study|Withdrawal by Subject|16|||
37676028|NCT02638337|69150583|FG000|Overall Study|Lost to Follow-up|7|||
37676029|NCT02638337|69150584|FG001|Overall Study|Lost to Follow-up|7|||
37676030|NCT02638337|69150583|FG000|Overall Study|Other - Miscellaneous|4|||
37676031|NCT02638337|69150584|FG001|Overall Study|Other - Miscellaneous|3|||
37676032|NCT02638259|69150592|FG000|Treatment Period 1|Adverse Event|1|||
37676033|NCT02638259|69150593|FG001|Treatment Period 1|Adverse Event|5|||
37676034|NCT02638259|69150592|FG000|Treatment Period 1|Death|0|||
37676035|NCT02638259|69150593|FG001|Treatment Period 1|Death|1|||
37676036|NCT02638259|69150592|FG000|Treatment Period 1|Lack of Efficacy|0|||
37676037|NCT02638259|69150593|FG001|Treatment Period 1|Lack of Efficacy|1|||
37676038|NCT02638259|69150592|FG000|Treatment Period 1|Protocol Violation|0|||
37676039|NCT02638259|69150593|FG001|Treatment Period 1|Protocol Violation|3|||
37676040|NCT02638259|69150592|FG000|Treatment Period 1|Withdrawal by Subject|4|||
37676041|NCT02638259|69150593|FG001|Treatment Period 1|Withdrawal by Subject|6|||
37676042|NCT02638259|69150592|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
37676043|NCT02638259|69150593|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
37676044|NCT02638259|69150592|FG000|Treatment Period 2|Adverse Event|5|||
37676045|NCT02638259|69150593|FG001|Treatment Period 2|Adverse Event|4|||
37676046|NCT02638259|69150592|FG000|Treatment Period 2|Withdrawal by Subject|1|||
37676047|NCT02638259|69150593|FG001|Treatment Period 2|Withdrawal by Subject|7|||
37676048|NCT02637323|69150605|FG000|Overall Study|Lost to Follow-up|2|||
37676049|NCT02637323|69150606|FG001|Overall Study|Lost to Follow-up|0|||
37676050|NCT02637323|69150605|FG000|Overall Study|Protocol Violation|0|||
37676051|NCT02637323|69150606|FG001|Overall Study|Protocol Violation|1|||
37676052|NCT03573817|69150615|FG000|Overall Study|Adverse Event|0|||
37676053|NCT03573817|69150616|FG001|Overall Study|Adverse Event|2|||
37676054|NCT03573817|69150615|FG000|Overall Study|Protocol Violation|0|||
37676055|NCT03573817|69150616|FG001|Overall Study|Protocol Violation|1|||
37676056|NCT03573817|69150615|FG000|Overall Study|Withdrawal by Subject|1|||
37676057|NCT03573817|69150616|FG001|Overall Study|Withdrawal by Subject|1|||
37676058|NCT02638103|69150631|FG000|Overall Study|Adverse Event|13|||
37676059|NCT02638103|69150632|FG001|Overall Study|Adverse Event|12|||
37676060|NCT02638103|69150633|FG002|Overall Study|Adverse Event|19|||
37676061|NCT02638103|69150634|FG003|Overall Study|Adverse Event|12|||
37676062|NCT02638103|69150631|FG000|Overall Study|Withdrawal by Subject|43|||
37676063|NCT02638103|69150632|FG001|Overall Study|Withdrawal by Subject|53|||
37676064|NCT02638103|69150633|FG002|Overall Study|Withdrawal by Subject|30|||
37676065|NCT02638103|69150634|FG003|Overall Study|Withdrawal by Subject|61|||
37676066|NCT02638103|69150631|FG000|Overall Study|Protocol Violation|1|||
37676067|NCT02638103|69150632|FG001|Overall Study|Protocol Violation|2|||
37676068|NCT02638103|69150633|FG002|Overall Study|Protocol Violation|1|||
37676069|NCT02638103|69150634|FG003|Overall Study|Protocol Violation|4|||
37676070|NCT02638103|69150631|FG000|Overall Study|Pregnancy|2|||
37676071|NCT02638103|69150632|FG001|Overall Study|Pregnancy|3|||
37676072|NCT02638103|69150633|FG002|Overall Study|Pregnancy|0|||
37676073|NCT02638103|69150634|FG003|Overall Study|Pregnancy|1|||
37676074|NCT02638103|69150631|FG000|Overall Study|Non-compliance to Study Procedures|2|||
37676075|NCT02638103|69150632|FG001|Overall Study|Non-compliance to Study Procedures|1|||
37676076|NCT02638103|69150633|FG002|Overall Study|Non-compliance to Study Procedures|1|||
37676077|NCT02638103|69150634|FG003|Overall Study|Non-compliance to Study Procedures|1|||
37676078|NCT02638103|69150631|FG000|Overall Study|Lost to Follow-up|26|||
37676079|NCT02638103|69150632|FG001|Overall Study|Lost to Follow-up|33|||
37676080|NCT02638103|69150633|FG002|Overall Study|Lost to Follow-up|20|||
37676081|NCT02638103|69150634|FG003|Overall Study|Lost to Follow-up|37|||
37676082|NCT02638103|69150631|FG000|Overall Study|Lack of Efficacy|14|||
37676083|NCT02638103|69150632|FG001|Overall Study|Lack of Efficacy|10|||
37676084|NCT02638103|69150633|FG002|Overall Study|Lack of Efficacy|12|||
37676085|NCT02638103|69150634|FG003|Overall Study|Lack of Efficacy|22|||
37676086|NCT02638103|69150631|FG000|Overall Study|Other than specified|5|||
37676087|NCT02638103|69150632|FG001|Overall Study|Other than specified|4|||
37676088|NCT02638103|69150633|FG002|Overall Study|Other than specified|2|||
37676089|NCT02638103|69150634|FG003|Overall Study|Other than specified|4|||
37676090|NCT03551743|69150656|FG000|Overall Study|Adverse Event|1|||
37676091|NCT03551743|69150657|FG001|Overall Study|Adverse Event|0|||
37676092|NCT03551743|69150658|FG002|Overall Study|Adverse Event|0|||
37676093|NCT03551743|69150659|FG003|Overall Study|Adverse Event|0|||
37676094|NCT03551743|69150656|FG000|Overall Study|Withdrawal by Subject|1|||
37676095|NCT03551743|69150657|FG001|Overall Study|Withdrawal by Subject|0|||
37676096|NCT03551743|69150658|FG002|Overall Study|Withdrawal by Subject|0|||
37676097|NCT03551743|69150659|FG003|Overall Study|Withdrawal by Subject|0|||
37676098|NCT02636699|69150671|FG000|Overall Study|Adverse Event|4|||
37676099|NCT02636699|69150672|FG001|Overall Study|Adverse Event|0|||
37676100|NCT02636699|69150671|FG000|Overall Study|Lost to Follow-up|3|||
37676101|NCT02636699|69150672|FG001|Overall Study|Lost to Follow-up|3|||
37676102|NCT02636699|69150671|FG000|Overall Study|Non-compliance with the investigational product (IP)|2|||
37676103|NCT02636699|69150672|FG001|Overall Study|Non-compliance with the investigational product (IP)|0|||
37676104|NCT02636699|69150671|FG000|Overall Study|Physician Decision|0|||
37676105|NCT02636699|69150672|FG001|Overall Study|Physician Decision|1|||
37676106|NCT02636699|69150671|FG000|Overall Study|Withdrawal by Subject|13|||
37676107|NCT02636699|69150672|FG001|Overall Study|Withdrawal by Subject|6|||
37676108|NCT02636699|69150671|FG000|Overall Study|Other|3|||
37676109|NCT02636699|69150672|FG001|Overall Study|Other|1|||
37676110|NCT02634983|69150678|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
37676111|NCT02634983|69150679|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
37676112|NCT02633501|69150691|FG000|Overall Study|Adverse Event|0|||
37676113|NCT02633501|69150692|FG001|Overall Study|Adverse Event|0|||
37676114|NCT02633501|69150693|FG002|Overall Study|Adverse Event|1|||
37676115|NCT02633501|69150694|FG003|Overall Study|Adverse Event|0|||
37676116|NCT02633501|69150695|FG004|Overall Study|Adverse Event|1|||
37676117|NCT02633501|69150696|FG005|Overall Study|Adverse Event|1|||
37676118|NCT02633501|69150691|FG000|Overall Study|Withdrawal by Subject|2|||
37676119|NCT02633501|69150692|FG001|Overall Study|Withdrawal by Subject|1|||
37676120|NCT02633501|69150693|FG002|Overall Study|Withdrawal by Subject|2|||
37676121|NCT02633501|69150694|FG003|Overall Study|Withdrawal by Subject|2|||
37676122|NCT02633501|69150695|FG004|Overall Study|Withdrawal by Subject|1|||
37676123|NCT02633501|69150696|FG005|Overall Study|Withdrawal by Subject|3|||
37676124|NCT02633501|69150691|FG000|Overall Study|Various other reasons|0|||
37676125|NCT02633501|69150692|FG001|Overall Study|Various other reasons|2|||
37676126|NCT02633501|69150693|FG002|Overall Study|Various other reasons|4|||
37676127|NCT02633501|69150694|FG003|Overall Study|Various other reasons|1|||
37676128|NCT02633501|69150695|FG004|Overall Study|Various other reasons|7|||
37676129|NCT02633501|69150696|FG005|Overall Study|Various other reasons|11|||
37676130|NCT02633501|69150691|FG000|Overall Study|Lost to Follow-up|0|||
37676131|NCT02633501|69150692|FG001|Overall Study|Lost to Follow-up|0|||
37676132|NCT02633501|69150693|FG002|Overall Study|Lost to Follow-up|0|||
37676133|NCT02633501|69150694|FG003|Overall Study|Lost to Follow-up|1|||
37676134|NCT02633501|69150695|FG004|Overall Study|Lost to Follow-up|2|||
37676135|NCT02633501|69150696|FG005|Overall Study|Lost to Follow-up|0|||
37676136|NCT03138499|69150717|FG000|Overall Study|Lost to Follow-up|1|||
37676137|NCT03138499|69150718|FG001|Overall Study|Lost to Follow-up|0|||
37676138|NCT03138499|69150717|FG000|Overall Study|Participants withdrew consent|1|||
37676139|NCT03138499|69150718|FG001|Overall Study|Participants withdrew consent|0|||
37676140|NCT03138499|69150717|FG000|Overall Study|Participant discontinued study before treatment|0|||
37676141|NCT03138499|69150718|FG001|Overall Study|Participant discontinued study before treatment|1|||
37676142|NCT03138499|69150717|FG000|Overall Study|Disease Progression|2|||
37676143|NCT03138499|69150718|FG001|Overall Study|Disease Progression|6|||
37676144|NCT03138499|69150717|FG000|Overall Study|Study drug toxicity|2|||
37676145|NCT03138499|69150718|FG001|Overall Study|Study drug toxicity|2|||
37676146|NCT03138499|69150717|FG000|Overall Study|Participant request to discontinue study treatment|1|||
37676147|NCT03138499|69150718|FG001|Overall Study|Participant request to discontinue study treatment|1|||
37676148|NCT03138499|69150717|FG000|Overall Study|Other reasons|2|||
37767536|NCT00219349|69282892|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
37767537|NCT00219349|69282892|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
37767538|NCT00219349|69282892|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
37767539|NCT01523756|69282896|FG000|Baseline Period|Adverse Event|0|||
37767540|NCT01523756|69282897|FG001|Baseline Period|Adverse Event|1|||
37767541|NCT01523756|69282896|FG000|Test Period 1|Adverse Event|1|||
37767542|NCT01523756|69282897|FG001|Test Period 1|Adverse Event|0|||
37767543|NCT01523756|69282896|FG000|Test Period 2|Withdrawal by Subject|0|||
37767544|NCT01523756|69282897|FG001|Test Period 2|Withdrawal by Subject|1|||
37767545|NCT00218257|69282905|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
37767546|NCT00218257|69282906|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
37767547|NCT01523366|69282917|FG000|Treatment Period 1|Withdrawal by Subject|1|||
37767548|NCT01523366|69282918|FG001|Treatment Period 1|Withdrawal by Subject|0|||
38039782|NCT00066365|69727092|FG001|Overall Study|Ineligible|2|||
38039783|NCT00048581|69727102|FG000|Double-Blind Period|Adverse Event|9|||
37676149|NCT03138499|69150718|FG001|Overall Study|Other reasons|0|||
37676150|NCT04508621|69150727|FG000|Overall Study|Adverse Event|39|||
37676151|NCT04508621|69150728|FG001|Overall Study|Adverse Event|16|||
37676152|NCT04508621|69150727|FG000|Overall Study|Lack of Efficacy|2|||
37676153|NCT04508621|69150728|FG001|Overall Study|Lack of Efficacy|8|||
38039784|NCT00048581|69727103|FG001|Double-Blind Period|Adverse Event|5|||
38039785|NCT00048581|69727104|FG002|Double-Blind Period|Adverse Event|0|||
37767549|NCT01523366|69282917|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
37676154|NCT04508621|69150727|FG000|Overall Study|Physician Decision|0|||
37676155|NCT04508621|69150728|FG001|Overall Study|Physician Decision|1|||
37676156|NCT04508621|69150727|FG000|Overall Study|Withdrawal by Subject|10|||
37767550|NCT01523366|69282918|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
37767551|NCT01427933|69282928|FG000|Overall Study|Withdrawal by Subject|5|||
37767552|NCT01427933|69282929|FG001|Overall Study|Withdrawal by Subject|8|||
37767553|NCT01427933|69282928|FG000|Overall Study|Lost to Follow-up|1|||
37859779|NCT01163721|69543092|FG000|Overall Study|Withdrawal by Subject|3|||
37859780|NCT01163721|69543093|FG001|Overall Study|Withdrawal by Subject|4|||
37859781|NCT01163721|69543092|FG000|Overall Study|Lost to Follow-up|0|||
37859782|NCT01163721|69543093|FG001|Overall Study|Lost to Follow-up|1|||
37859783|NCT01163721|69543092|FG000|Overall Study|Physician Decision|0|||
37859784|NCT01163721|69543093|FG001|Overall Study|Physician Decision|1|||
37859785|NCT00958243|69543105|FG000|Overall Study|Withdrawal by Subject|0|||
37859786|NCT00958243|69543106|FG001|Overall Study|Withdrawal by Subject|1|||
37945662|NCT00575588|69633134|FG001|Overall Study|Safety reasons|1|||
37945663|NCT00575588|69633133|FG000|Overall Study|Elevated triglyceride|1|||
37767554|NCT01427933|69282929|FG001|Overall Study|Lost to Follow-up|5|||
37767555|NCT01427933|69282928|FG000|Overall Study|Other|1|||
37767556|NCT01427933|69282929|FG001|Overall Study|Other|0|||
37767557|NCT01427933|69282928|FG000|Overall Study|Investigator's Decision|1|||
37767558|NCT01427933|69282929|FG001|Overall Study|Investigator's Decision|0|||
37767559|NCT00217087|69282938|FG000|Overall Study|decided to have esophagectomy|1|||
37767560|NCT00217087|69282939|FG001|Overall Study|decided to have esophagectomy|2|||
37767561|NCT00217087|69282938|FG000|Overall Study|completed less than 12 months return|10|||
37767562|NCT00217087|69282939|FG001|Overall Study|completed less than 12 months return|18|||
37767563|NCT01406873|69282953|FG000|Overall Study|Withdrawal by Subject|1|||
37767564|NCT01406873|69282954|FG001|Overall Study|Withdrawal by Subject|1|||
37767565|NCT01406795|69282970|FG000|Overall Study|Withdrawal by Subject|1|||
37767566|NCT01406717|69282976|FG000|Overall Study|Subject non-compliance|4|||
37767567|NCT01406717|69282977|FG001|Overall Study|Subject non-compliance|3|||
37767568|NCT01406717|69282976|FG000|Overall Study|Protocol Violation|5|||
37767569|NCT01406717|69282977|FG001|Overall Study|Protocol Violation|1|||
37767570|NCT01406717|69282976|FG000|Overall Study|Lost to Follow-up|14|||
37767571|NCT01406717|69282977|FG001|Overall Study|Lost to Follow-up|8|||
37767572|NCT01406717|69282976|FG000|Overall Study|Withdrawal by Subject|19|||
37767573|NCT01406717|69282977|FG001|Overall Study|Withdrawal by Subject|15|||
37767574|NCT01406717|69282976|FG000|Overall Study|Adverse Event|1|||
37767575|NCT01406717|69282977|FG001|Overall Study|Adverse Event|2|||
37767576|NCT01406717|69282976|FG000|Overall Study|Lack of Efficacy|0|||
37767577|NCT01406717|69282977|FG001|Overall Study|Lack of Efficacy|1|||
37767578|NCT01406717|69282976|FG000|Overall Study|Non-completion of visit activity|0|||
37767579|NCT01406717|69282977|FG001|Overall Study|Non-completion of visit activity|1|||
37767580|NCT01406015|69282995|FG000|Overall Study|Withdrawal by Subject|3|||
37767581|NCT01406015|69282996|FG001|Overall Study|Withdrawal by Subject|3|||
37767582|NCT00215683|69283005|FG000|Overall Study|Adverse Event|15|||
37767583|NCT00215683|69283006|FG001|Overall Study|Adverse Event|16|||
37767584|NCT00215683|69283007|FG002|Overall Study|Adverse Event|15|||
37767585|NCT00215683|69283005|FG000|Overall Study|Lack of Efficacy|5|||
37767586|NCT00215683|69283006|FG001|Overall Study|Lack of Efficacy|1|||
37767587|NCT00215683|69283007|FG002|Overall Study|Lack of Efficacy|2|||
37767588|NCT00215683|69283005|FG000|Overall Study|Lost to Follow-up|0|||
37767589|NCT00215683|69283006|FG001|Overall Study|Lost to Follow-up|2|||
37767590|NCT00215683|69283007|FG002|Overall Study|Lost to Follow-up|1|||
37767591|NCT00215683|69283005|FG000|Overall Study|Withdrawal by Subject|9|||
37767592|NCT00215683|69283006|FG001|Overall Study|Withdrawal by Subject|4|||
37767593|NCT00215683|69283007|FG002|Overall Study|Withdrawal by Subject|13|||
37767594|NCT00215683|69283005|FG000|Overall Study|Physician Decision|0|||
37767595|NCT00215683|69283006|FG001|Overall Study|Physician Decision|0|||
37767596|NCT00215683|69283007|FG002|Overall Study|Physician Decision|1|||
37767597|NCT00215683|69283005|FG000|Overall Study|Difficult to attend visits|0|||
37767598|NCT00215683|69283006|FG001|Overall Study|Difficult to attend visits|1|||
37767599|NCT00215683|69283007|FG002|Overall Study|Difficult to attend visits|0|||
37767600|NCT00215683|69283005|FG000|Overall Study|No study drug available|0|||
37767601|NCT00215683|69283006|FG001|Overall Study|No study drug available|1|||
37767602|NCT00215683|69283007|FG002|Overall Study|No study drug available|0|||
37767603|NCT00215683|69283005|FG000|Overall Study|Intermittent therapy required|0|||
37767604|NCT00215683|69283006|FG001|Overall Study|Intermittent therapy required|1|||
37767605|NCT00215683|69283007|FG002|Overall Study|Intermittent therapy required|0|||
37767606|NCT00215137|69283015|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
37767607|NCT00215137|69283016|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
37767608|NCT00215137|69283017|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
37767609|NCT00215137|69283015|FG000|Randomization Period|Lost to Follow-up|0|||
37767610|NCT00215137|69283016|FG001|Randomization Period|Lost to Follow-up|1|||
37767611|NCT00215137|69283017|FG002|Randomization Period|Lost to Follow-up|0|||
37767612|NCT00215137|69283015|FG000|Randomization Period|Withdrawal by Subject|0|||
37767613|NCT00215137|69283016|FG001|Randomization Period|Withdrawal by Subject|1|||
37767614|NCT00215137|69283017|FG002|Randomization Period|Withdrawal by Subject|0|||
37767615|NCT00214201|69283027|FG000|Overall Study|Withdrawal by Subject|2|||
37767616|NCT00214201|69283028|FG001|Overall Study|Withdrawal by Subject|0|||
37767617|NCT00214201|69283027|FG000|Overall Study|Death|0|||
37767618|NCT00214201|69283028|FG001|Overall Study|Death|2|||
37767619|NCT01486784|69283041|FG000|Overall Study|Withdrawal by Subject|0|||
37767620|NCT01486784|69283042|FG001|Overall Study|Withdrawal by Subject|0|||
37767621|NCT01486784|69283043|FG002|Overall Study|Withdrawal by Subject|1|||
37767622|NCT01486784|69283044|FG003|Overall Study|Withdrawal by Subject|0|||
37767623|NCT01486784|69283045|FG004|Overall Study|Withdrawal by Subject|1|||
37767624|NCT01486784|69283046|FG005|Overall Study|Withdrawal by Subject|2|||
37767625|NCT01486784|69283041|FG000|Overall Study|Subject did not meet entry criteria|0|||
37767626|NCT01486784|69283042|FG001|Overall Study|Subject did not meet entry criteria|0|||
37767627|NCT01486784|69283043|FG002|Overall Study|Subject did not meet entry criteria|0|||
37767628|NCT01486784|69283044|FG003|Overall Study|Subject did not meet entry criteria|0|||
37767629|NCT01486784|69283045|FG004|Overall Study|Subject did not meet entry criteria|1|||
37767630|NCT01486784|69283046|FG005|Overall Study|Subject did not meet entry criteria|0|||
37767631|NCT01486784|69283041|FG000|Overall Study|Death|0|||
37767632|NCT01486784|69283042|FG001|Overall Study|Death|0|||
37767633|NCT01486784|69283043|FG002|Overall Study|Death|0|||
37767634|NCT01486784|69283044|FG003|Overall Study|Death|0|||
37767635|NCT01486784|69283045|FG004|Overall Study|Death|0|||
37767636|NCT01486784|69283046|FG005|Overall Study|Death|1|||
37767637|NCT01521884|69283060|FG000|Overall Study|Non Responders|10|||
37767638|NCT01521884|69283060|FG000|Overall Study|Adverse Event|5|||
37767639|NCT01521884|69283060|FG000|Overall Study|Pregnancy|1|||
37767640|NCT01521884|69283060|FG000|Overall Study|Withdrawal by Subject|1|||
37767641|NCT01521884|69283060|FG000|Overall Study|Physician Decision|2|||
37767642|NCT01521884|69283060|FG000|Overall Study|Protocol Violation|3|||
37767643|NCT01521884|69283060|FG000|Overall Study|Participant non-eligible|1|||
37767644|NCT01521884|69283060|FG000|Overall Study|Lost to Follow-up|4|||
37767645|NCT01677858|69283069|FG000|Overall Study|Adverse Event|0|||
37767646|NCT01677858|69283070|FG001|Overall Study|Adverse Event|0|||
37767647|NCT01677858|69283071|FG002|Overall Study|Adverse Event|2|||
37767648|NCT01677858|69283072|FG003|Overall Study|Adverse Event|3|||
37767649|NCT01677858|69283073|FG004|Overall Study|Adverse Event|13|||
37767650|NCT01677858|69283069|FG000|Overall Study|Death|0|||
37767651|NCT01677858|69283070|FG001|Overall Study|Death|0|||
37767652|NCT01677858|69283071|FG002|Overall Study|Death|0|||
37767653|NCT01677858|69283072|FG003|Overall Study|Death|0|||
37767654|NCT01677858|69283073|FG004|Overall Study|Death|1|||
37767655|NCT01677858|69283069|FG000|Overall Study|Physician Decision|1|||
37767656|NCT01677858|69283070|FG001|Overall Study|Physician Decision|0|||
37767657|NCT01677858|69283071|FG002|Overall Study|Physician Decision|2|||
37767658|NCT01677858|69283072|FG003|Overall Study|Physician Decision|0|||
37767659|NCT01677858|69283073|FG004|Overall Study|Physician Decision|12|||
37767660|NCT01677858|69283069|FG000|Overall Study|Progressive Disease|2|||
37767661|NCT01677858|69283070|FG001|Overall Study|Progressive Disease|1|||
37767662|NCT01677858|69283071|FG002|Overall Study|Progressive Disease|9|||
37767663|NCT01677858|69283072|FG003|Overall Study|Progressive Disease|3|||
37767664|NCT01677858|69283073|FG004|Overall Study|Progressive Disease|43|||
37767665|NCT01677858|69283069|FG000|Overall Study|Withdrawal by Subject|0|||
37767666|NCT01677858|69283070|FG001|Overall Study|Withdrawal by Subject|1|||
37767667|NCT01677858|69283071|FG002|Overall Study|Withdrawal by Subject|1|||
37767668|NCT01677858|69283072|FG003|Overall Study|Withdrawal by Subject|0|||
37767669|NCT01677858|69283073|FG004|Overall Study|Withdrawal by Subject|15|||
37767670|NCT01677858|69283069|FG000|Overall Study|Lost to Follow-up|0|||
37945664|NCT00575588|69633134|FG001|Overall Study|Elevated triglyceride|0|||
37676157|NCT04508621|69150728|FG001|Overall Study|Withdrawal by Subject|14|||
37676158|NCT04508621|69150727|FG000|Overall Study|Lost to Follow-up|12|||
37676159|NCT04508621|69150728|FG001|Overall Study|Lost to Follow-up|9|||
37676160|NCT04508621|69150727|FG000|Overall Study|COVID-19 related crisis|3|||
37676161|NCT04508621|69150728|FG001|Overall Study|COVID-19 related crisis|0|||
37676162|NCT04508621|69150727|FG000|Overall Study|Subject non-compliance|1|||
37676163|NCT04508621|69150728|FG001|Overall Study|Subject non-compliance|0|||
37676164|NCT03591107|69150736|FG000|Overall Study|Same patient in both arms|1|||
37767671|NCT01677858|69283070|FG001|Overall Study|Lost to Follow-up|0|||
37767672|NCT01677858|69283071|FG002|Overall Study|Lost to Follow-up|0|||
37767673|NCT01677858|69283072|FG003|Overall Study|Lost to Follow-up|0|||
37767674|NCT01677858|69283073|FG004|Overall Study|Lost to Follow-up|1|||
37767675|NCT01486316|69283093|FG000|Overall Study|Device explanted with/without re-implant|3|||
37767676|NCT01486316|69283094|FG001|Overall Study|Device explanted with/without re-implant|2|||
37767677|NCT01486316|69283095|FG002|Overall Study|Device explanted with/without re-implant|0|||
37767678|NCT01486316|69283096|FG003|Overall Study|Device explanted with/without re-implant|2|||
37767679|NCT01486316|69283093|FG000|Overall Study|Not meeting eligibility criteria|0|||
37767680|NCT01486316|69283094|FG001|Overall Study|Not meeting eligibility criteria|0|||
37767681|NCT01486316|69283095|FG002|Overall Study|Not meeting eligibility criteria|1|||
37767682|NCT01486316|69283096|FG003|Overall Study|Not meeting eligibility criteria|0|||
37767683|NCT01486316|69283093|FG000|Overall Study|Withdrawal by Subject|1|||
37767684|NCT01486316|69283094|FG001|Overall Study|Withdrawal by Subject|0|||
37767685|NCT01486316|69283095|FG002|Overall Study|Withdrawal by Subject|3|||
37767686|NCT01486316|69283096|FG003|Overall Study|Withdrawal by Subject|0|||
37767687|NCT01486316|69283093|FG000|Overall Study|Physician Decision|0|||
37767688|NCT01486316|69283094|FG001|Overall Study|Physician Decision|0|||
37767689|NCT01486316|69283095|FG002|Overall Study|Physician Decision|1|||
37767690|NCT01486316|69283096|FG003|Overall Study|Physician Decision|0|||
37767691|NCT01486316|69283093|FG000|Overall Study|Death|0|||
37767692|NCT01486316|69283094|FG001|Overall Study|Death|1|||
37767693|NCT01486316|69283095|FG002|Overall Study|Death|0|||
37767694|NCT01486316|69283096|FG003|Overall Study|Death|0|||
37767695|NCT01486238|69283107|FG000|Overall Study|Death|0|||
37767696|NCT01486238|69283108|FG001|Overall Study|Death|2|||
37767697|NCT01486238|69283107|FG000|Overall Study|Withdrawal by Subject|2|||
37767698|NCT01486238|69283108|FG001|Overall Study|Withdrawal by Subject|1|||
37767699|NCT01486238|69283107|FG000|Overall Study|Lost to Follow-up|0|||
37767700|NCT01486238|69283108|FG001|Overall Study|Lost to Follow-up|3|||
37767701|NCT01602744|69283116|FG000|Overall Study|Death|17|||
37767702|NCT01602744|69283117|FG001|Overall Study|Death|15|||
37767703|NCT01602744|69283116|FG000|Overall Study|Lost to Follow-up|13|||
37767704|NCT01602744|69283117|FG001|Overall Study|Lost to Follow-up|8|||
37767705|NCT03598777|69283128|FG000|Overall Study|Study Terminated by Sponsor|3|||
37767706|NCT03598777|69283129|FG001|Overall Study|Study Terminated by Sponsor|0|||
37767707|NCT03598777|69283130|FG002|Overall Study|Study Terminated by Sponsor|0|||
37767708|NCT03598777|69283131|FG003|Overall Study|Study Terminated by Sponsor|0|||
37767709|NCT03598777|69283132|FG004|Overall Study|Study Terminated by Sponsor|15|||
37767710|NCT03598777|69283128|FG000|Overall Study|Withdrawal by Subject|1|||
37767711|NCT03598777|69283129|FG001|Overall Study|Withdrawal by Subject|1|||
37767712|NCT03598777|69283130|FG002|Overall Study|Withdrawal by Subject|0|||
37767713|NCT03598777|69283131|FG003|Overall Study|Withdrawal by Subject|0|||
37767714|NCT03598777|69283132|FG004|Overall Study|Withdrawal by Subject|0|||
37767715|NCT03598777|69283128|FG000|Overall Study|Adverse Event|1|||
37767716|NCT03598777|69283129|FG001|Overall Study|Adverse Event|0|||
37767717|NCT03598777|69283130|FG002|Overall Study|Adverse Event|0|||
37767718|NCT03598777|69283131|FG003|Overall Study|Adverse Event|0|||
37767719|NCT03598777|69283132|FG004|Overall Study|Adverse Event|0|||
37767720|NCT03598777|69283128|FG000|Overall Study|Lost to Follow-up|1|||
37767721|NCT03598777|69283129|FG001|Overall Study|Lost to Follow-up|0|||
37767722|NCT03598777|69283130|FG002|Overall Study|Lost to Follow-up|0|||
37767723|NCT03598777|69283131|FG003|Overall Study|Lost to Follow-up|0|||
37767724|NCT03598777|69283132|FG004|Overall Study|Lost to Follow-up|0|||
37767725|NCT04348591|69283187|FG000|Imaging Session (120 Min)|Lost to Follow-up|0|||
37767726|NCT04348591|69283188|FG001|Imaging Session (120 Min)|Lost to Follow-up|2|||
37767727|NCT04348591|69283187|FG000|Imaging Session (120 Min)|Physician Decision|0|||
37767728|NCT04348591|69283188|FG001|Imaging Session (120 Min)|Physician Decision|1|||
37767729|NCT04348591|69283187|FG000|Imaging Session (120 Min)|Withdrawal by Subject|2|||
37767730|NCT04348591|69283188|FG001|Imaging Session (120 Min)|Withdrawal by Subject|0|||
37767731|NCT04046250|69283207|FG000|Overall Study|Death|0|||
37767732|NCT04046250|69283208|FG001|Overall Study|Death|1|||
37767733|NCT04046250|69283207|FG000|Overall Study|Withdrawal by Subject|3|||
37767734|NCT04046250|69283208|FG001|Overall Study|Withdrawal by Subject|3|||
37767735|NCT03841526|69283216|FG000|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
37767736|NCT03841526|69283217|FG001|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
37767737|NCT03841526|69283218|FG002|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
37767738|NCT03841526|69283219|FG003|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
37767739|NCT03841526|69283220|FG004|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
37767740|NCT03841526|69283221|FG005|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
37767741|NCT03841526|69283216|FG000|CRC Phase: Second Treatment|Adverse Event|0|||
37676165|NCT03591107|69150737|FG001|Overall Study|Same patient in both arms|1|||
37676166|NCT03591107|69150736|FG000|Overall Study|Sought care at other clinics|0|||
37676167|NCT03591107|69150737|FG001|Overall Study|Sought care at other clinics|2|||
37676168|NCT03591107|69150736|FG000|Overall Study|Discharged from clinic|0|||
37676169|NCT03591107|69150737|FG001|Overall Study|Discharged from clinic|1|||
37676170|NCT03591107|69150736|FG000|Overall Study|Withdrawal by Subject|0|||
37676171|NCT03591107|69150737|FG001|Overall Study|Withdrawal by Subject|1|||
37676172|NCT02922023|69150750|FG000|Overall Study|Lost to Follow-up|2|||
37676173|NCT02922023|69150751|FG001|Overall Study|Lost to Follow-up|0|||
37676174|NCT01672853|69150760|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
37676175|NCT01672853|69150761|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
37676176|NCT01672853|69150762|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
37676177|NCT01672853|69150760|FG000|Overall Study|Pregnancy|0|||
37676178|NCT01672853|69150761|FG001|Overall Study|Pregnancy|1|||
37676179|NCT01672853|69150762|FG002|Overall Study|Pregnancy|0|||
37767742|NCT03841526|69283217|FG001|CRC Phase: Second Treatment|Adverse Event|0|||
37767743|NCT03841526|69283218|FG002|CRC Phase: Second Treatment|Adverse Event|0|||
37767744|NCT03841526|69283219|FG003|CRC Phase: Second Treatment|Adverse Event|1|||
37767745|NCT03841526|69283220|FG004|CRC Phase: Second Treatment|Adverse Event|0|||
37767746|NCT03841526|69283221|FG005|CRC Phase: Second Treatment|Adverse Event|0|||
37767747|NCT03841526|69283216|FG000|Outpatient Phase Treatment|Physician Decision|0|||
37767748|NCT03841526|69283217|FG001|Outpatient Phase Treatment|Physician Decision|1|||
37767749|NCT03841526|69283218|FG002|Outpatient Phase Treatment|Physician Decision|0|||
37767750|NCT03841526|69283219|FG003|Outpatient Phase Treatment|Physician Decision|0|||
37767751|NCT03841526|69283220|FG004|Outpatient Phase Treatment|Physician Decision|0|||
37767752|NCT03841526|69283221|FG005|Outpatient Phase Treatment|Physician Decision|0|||
37767753|NCT03841526|69283216|FG000|Outpatient Phase Treatment|Withdrawal by Subject|0|||
37767754|NCT03841526|69283217|FG001|Outpatient Phase Treatment|Withdrawal by Subject|0|||
37767755|NCT03841526|69283218|FG002|Outpatient Phase Treatment|Withdrawal by Subject|1|||
37767756|NCT03841526|69283219|FG003|Outpatient Phase Treatment|Withdrawal by Subject|0|||
37767757|NCT03841526|69283220|FG004|Outpatient Phase Treatment|Withdrawal by Subject|0|||
37767758|NCT03841526|69283221|FG005|Outpatient Phase Treatment|Withdrawal by Subject|1|||
37767759|NCT03834506|69283244|FG000|Overall Study|Death|268|||
37767760|NCT03834506|69283245|FG001|Overall Study|Death|285|||
37767761|NCT03834506|69283244|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
37767762|NCT03834506|69283245|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
37767763|NCT03834506|69283244|FG000|Overall Study|Withdrawal by Subject|12|||
37767764|NCT03834506|69283245|FG001|Overall Study|Withdrawal by Subject|8|||
37767765|NCT03834506|69283244|FG000|Overall Study|Participants ongoing in the study|234|||
37767766|NCT03834506|69283245|FG001|Overall Study|Participants ongoing in the study|221|||
37767767|NCT03535740|69283251|FG000|Overall Study|Ongoing at Data Cut-off Date: 30 September 2020|55|||
37767768|NCT03535740|69283251|FG000|Overall Study|Death|34|||
37767769|NCT03535740|69283251|FG000|Overall Study|Lost to Follow-up|1|||
37767770|NCT03535740|69283251|FG000|Overall Study|Withdrawal by Subject|13|||
37767771|NCT03351049|69283262|FG000|Overall Study|Withdrawal|26|||
37767772|NCT03351049|69283263|FG001|Overall Study|Withdrawal|22|||
37767773|NCT03288506|69283284|FG000|Overall Study|Withdrawal by Subject|52|||
37767774|NCT03180684|69283292|FG000|Overall Study|Withdrawal by Subject (Not Related to AE)|5|||
37767775|NCT03180684|69283293|FG001|Overall Study|Withdrawal by Subject (Not Related to AE)|0|||
37767776|NCT03180684|69283292|FG000|Overall Study|Physician Decision|1|||
37767777|NCT03180684|69283293|FG001|Overall Study|Physician Decision|0|||
37767778|NCT03180684|69283292|FG000|Overall Study|Lost to Follow-up|1|||
37767779|NCT03180684|69283293|FG001|Overall Study|Lost to Follow-up|0|||
37767780|NCT03180684|69283292|FG000|Overall Study|Progressive Disease|1|||
37767781|NCT03180684|69283293|FG001|Overall Study|Progressive Disease|0|||
37767782|NCT02747927|69283337|FG000|Overall Study|Adverse Event|5|||
37767783|NCT02747927|69283338|FG001|Overall Study|Adverse Event|14|||
37767784|NCT02747927|69283337|FG000|Overall Study|Lost to Follow-up|22|||
37767785|NCT02747927|69283338|FG001|Overall Study|Lost to Follow-up|43|||
37767786|NCT02747927|69283337|FG000|Overall Study|Pregnancy|34|||
37767787|NCT02747927|69283338|FG001|Overall Study|Pregnancy|66|||
37767788|NCT02747927|69283337|FG000|Overall Study|Protocol Violation|2|||
37767789|NCT02747927|69283338|FG001|Overall Study|Protocol Violation|4|||
37767790|NCT02747927|69283337|FG000|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|147|||
37767791|NCT02747927|69283338|FG001|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|304|||
37767792|NCT02747927|69283337|FG000|Overall Study|Reason not Specified|11|||
37767793|NCT02747927|69283338|FG001|Overall Study|Reason not Specified|27|||
37767794|NCT02515227|69283350|FG000|Overall Study|Adverse Event|0|||
37767795|NCT02515227|69283351|FG001|Overall Study|Adverse Event|2|||
37767796|NCT02515227|69283350|FG000|Overall Study|Progressive disease|2|||
37767797|NCT02515227|69283351|FG001|Overall Study|Progressive disease|9|||
37767798|NCT02369458|69283361|FG000|Overall Study|Determined to be not eligible|1|||
37767799|NCT02369458|69283362|FG001|Overall Study|Determined to be not eligible|0|||
37945665|NCT00575588|69633133|FG000|Overall Study|Patient moved|1|||
37945666|NCT00575588|69633134|FG001|Overall Study|Patient moved|3|||
37945667|NCT00575588|69633133|FG000|Overall Study|Impossible to determine HbA1c|0|||
37767800|NCT01266642|69283374|FG000|Overall Study|Protocol Violation|0|||
37767801|NCT01266642|69283375|FG001|Overall Study|Protocol Violation|1|||
37767802|NCT00070499|69283415|FG000|Overall Study|Adverse Event|6|||
37767803|NCT00070499|69283416|FG001|Overall Study|Adverse Event|6|||
37767804|NCT00070499|69283417|FG002|Overall Study|Adverse Event|19|||
37767805|NCT00070499|69283418|FG003|Overall Study|Adverse Event|15|||
37767806|NCT00070499|69283415|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
37767807|NCT00070499|69283416|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
37767808|NCT00070499|69283417|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
37767809|NCT00070499|69283418|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
37767810|NCT00070499|69283415|FG000|Overall Study|Progression/relapse|4|||
37767811|NCT00070499|69283416|FG001|Overall Study|Progression/relapse|2|||
37767812|NCT00070499|69283417|FG002|Overall Study|Progression/relapse|1|||
37767813|NCT00070499|69283418|FG003|Overall Study|Progression/relapse|4|||
37767814|NCT00070499|69283415|FG000|Overall Study|Death|1|||
37767815|NCT00070499|69283416|FG001|Overall Study|Death|1|||
37945668|NCT00575588|69633134|FG001|Overall Study|Impossible to determine HbA1c|1|||
37767816|NCT00070499|69283417|FG002|Overall Study|Death|1|||
37945669|NCT00675428|69633142|FG000|Overall Study|Disease Progression|2|||
37945670|NCT00675428|69633143|FG001|Overall Study|Disease Progression|2|||
37767817|NCT00070499|69283418|FG003|Overall Study|Death|2|||
37767818|NCT00070499|69283415|FG000|Overall Study|Other - not protocol specified|7|||
37767819|NCT00070499|69283416|FG001|Overall Study|Other - not protocol specified|3|||
37767820|NCT00070499|69283417|FG002|Overall Study|Other - not protocol specified|12|||
37767821|NCT00070499|69283418|FG003|Overall Study|Other - not protocol specified|20|||
37767822|NCT00070499|69283415|FG000|Overall Study|Still on protocol treatment|10|||
37767823|NCT00070499|69283416|FG001|Overall Study|Still on protocol treatment|4|||
37767824|NCT00070499|69283417|FG002|Overall Study|Still on protocol treatment|79|||
37767825|NCT00070499|69283418|FG003|Overall Study|Still on protocol treatment|57|||
37767826|NCT00070499|69283415|FG000|Overall Study|Did not start treatment|1|||
37767827|NCT00070499|69283416|FG001|Overall Study|Did not start treatment|0|||
37859787|NCT00958243|69543107|FG002|Overall Study|Withdrawal by Subject|3|||
37859788|NCT00958243|69543108|FG003|Overall Study|Withdrawal by Subject|1|||
37859789|NCT00958243|69543109|FG004|Overall Study|Withdrawal by Subject|1|||
37859790|NCT00958243|69543110|FG005|Overall Study|Withdrawal by Subject|5|||
37859791|NCT00958243|69543105|FG000|Overall Study|Lost to Follow-up|2|||
37859792|NCT00958243|69543106|FG001|Overall Study|Lost to Follow-up|5|||
37859793|NCT00958243|69543107|FG002|Overall Study|Lost to Follow-up|11|||
37859794|NCT00958243|69543108|FG003|Overall Study|Lost to Follow-up|2|||
37859795|NCT00958243|69543109|FG004|Overall Study|Lost to Follow-up|8|||
37859796|NCT00958243|69543110|FG005|Overall Study|Lost to Follow-up|5|||
37859797|NCT01241760|69543132|FG000|Overall Study|Adverse Event|1|||
37859798|NCT01241760|69543133|FG001|Overall Study|Adverse Event|0|||
37859799|NCT01241760|69543132|FG000|Overall Study|Lost to Follow-up|18|||
37859800|NCT01241760|69543133|FG001|Overall Study|Lost to Follow-up|22|||
37859801|NCT01241760|69543132|FG000|Overall Study|Withdrawal by Subject|13|||
37859802|NCT01241760|69543133|FG001|Overall Study|Withdrawal by Subject|13|||
37859803|NCT01241760|69543132|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
37859804|NCT01241760|69543133|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
37859805|NCT01241760|69543132|FG000|Overall Study|Other|1|||
37859806|NCT01241760|69543133|FG001|Overall Study|Other|1|||
37859807|NCT00958165|69543140|FG000|Overall Study|Lost to Follow-up|5|||
37859808|NCT00958165|69543140|FG000|Overall Study|Not eligible|9|||
37859809|NCT00958009|69543144|FG000|Overall Study|Adverse Event|1|||
37859810|NCT00958009|69543144|FG000|Overall Study|Subject found device difficult to use|1|||
37859811|NCT00953407|69543153|FG000|Overall Study|Failed inclusion criteria|1|||
37859812|NCT00953407|69543154|FG001|Overall Study|Failed inclusion criteria|1|||
37859813|NCT00953407|69543155|FG002|Overall Study|Failed inclusion criteria|1|||
37859814|NCT00953407|69543156|FG003|Overall Study|Failed inclusion criteria|1|||
37859815|NCT00953407|69543157|FG004|Overall Study|Failed inclusion criteria|1|||
37859816|NCT00953407|69543153|FG000|Overall Study|Lost to Follow-up|0|||
37859817|NCT00953407|69543154|FG001|Overall Study|Lost to Follow-up|0|||
37859818|NCT00953407|69543155|FG002|Overall Study|Lost to Follow-up|0|||
37859819|NCT00953407|69543156|FG003|Overall Study|Lost to Follow-up|1|||
37859820|NCT00953407|69543157|FG004|Overall Study|Lost to Follow-up|0|||
37859821|NCT00953329|69543169|FG000|Overall Study|Lack of Efficacy|1|||
37859822|NCT00953017|69543177|FG000|Overall Study|DId not show up for colonoscopy|4|||
37859823|NCT00953017|69543178|FG001|Overall Study|DId not show up for colonoscopy|4|||
37859824|NCT00953017|69543179|FG002|Overall Study|DId not show up for colonoscopy|5|||
37859825|NCT00953017|69543180|FG003|Overall Study|DId not show up for colonoscopy|4|||
37859826|NCT00953017|69543177|FG000|Overall Study|Incomplete data|1|||
37859827|NCT00953017|69543178|FG001|Overall Study|Incomplete data|1|||
37859828|NCT00953017|69543179|FG002|Overall Study|Incomplete data|0|||
37859829|NCT00953017|69543180|FG003|Overall Study|Incomplete data|0|||
37859830|NCT00953017|69543177|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
37859831|NCT00953017|69543178|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
37859832|NCT00953017|69543179|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
37859833|NCT00953017|69543180|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
37859834|NCT00953017|69543177|FG000|Overall Study|Brown stool prior to procedure|0|||
37859835|NCT00953017|69543178|FG001|Overall Study|Brown stool prior to procedure|0|||
37859836|NCT00953017|69543179|FG002|Overall Study|Brown stool prior to procedure|1|||
37859837|NCT00953017|69543180|FG003|Overall Study|Brown stool prior to procedure|0|||
37859838|NCT00952705|69543193|FG000|Overall Study|Lost to Follow-up|24|||
37859839|NCT00952705|69543194|FG001|Overall Study|Lost to Follow-up|8|||
37859840|NCT00952705|69543195|FG002|Overall Study|Lost to Follow-up|9|||
37859841|NCT00952705|69543193|FG000|Overall Study|Withdrawal by Subject|2|||
37859842|NCT00952705|69543194|FG001|Overall Study|Withdrawal by Subject|1|||
37859843|NCT00952705|69543195|FG002|Overall Study|Withdrawal by Subject|1|||
37859844|NCT00952705|69543193|FG000|Overall Study|Death|2|||
38039786|NCT00048581|69727102|FG000|Double-Blind Period|Lack of Efficacy|14|||
37945671|NCT00675428|69633142|FG000|Overall Study|No Disease Response After Cycle 6|0|||
38039787|NCT00048581|69727103|FG001|Double-Blind Period|Lack of Efficacy|27|||
37859845|NCT00952705|69543194|FG001|Overall Study|Death|0|||
37859846|NCT00952705|69543195|FG002|Overall Study|Death|0|||
37859847|NCT00952705|69543193|FG000|Overall Study|Incarcerated post dose|5|||
37859848|NCT00952705|69543194|FG001|Overall Study|Incarcerated post dose|0|||
37945672|NCT00675428|69633143|FG001|Overall Study|No Disease Response After Cycle 6|1|||
37945673|NCT00675428|69633142|FG000|Overall Study|Physician Decision|1|||
37945674|NCT00675428|69633143|FG001|Overall Study|Physician Decision|0|||
37945675|NCT00557505|69633167|FG000|Overall Study|Death|0|||
37945676|NCT00557505|69633168|FG001|Overall Study|Death|0|||
37945677|NCT00557505|69633169|FG002|Overall Study|Death|0|||
37945678|NCT00557505|69633170|FG003|Overall Study|Death|0|||
37945679|NCT00557505|69633171|FG004|Overall Study|Death|0|||
37945680|NCT00557505|69633172|FG005|Overall Study|Death|0|||
37945681|NCT00557505|69633173|FG006|Overall Study|Death|0|||
37945682|NCT00557505|69633174|FG007|Overall Study|Death|0|||
37945683|NCT00557505|69633175|FG008|Overall Study|Death|1|||
37945684|NCT00557505|69633167|FG000|Overall Study|Adverse Event|0|||
37945685|NCT00557505|69633168|FG001|Overall Study|Adverse Event|0|||
37945686|NCT00557505|69633169|FG002|Overall Study|Adverse Event|1|||
37945687|NCT00557505|69633170|FG003|Overall Study|Adverse Event|0|||
37945688|NCT00557505|69633171|FG004|Overall Study|Adverse Event|0|||
37945689|NCT00557505|69633172|FG005|Overall Study|Adverse Event|0|||
37945690|NCT00557505|69633173|FG006|Overall Study|Adverse Event|1|||
37945691|NCT00557505|69633174|FG007|Overall Study|Adverse Event|0|||
37945692|NCT00557505|69633175|FG008|Overall Study|Adverse Event|0|||
37859849|NCT00952705|69543195|FG002|Overall Study|Incarcerated post dose|0|||
37859850|NCT00952705|69543193|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
37859851|NCT00952705|69543194|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
37859852|NCT00952705|69543195|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
38039788|NCT00048581|69727104|FG002|Double-Blind Period|Lack of Efficacy|0|||
38039789|NCT00048581|69727102|FG000|Double-Blind Period|Lost to Follow-up|5|||
38039790|NCT00048581|69727103|FG001|Double-Blind Period|Lost to Follow-up|0|||
38039791|NCT00048581|69727104|FG002|Double-Blind Period|Lost to Follow-up|0|||
38039792|NCT00048581|69727102|FG000|Double-Blind Period|Withdrawal by Subject|5|||
38039793|NCT00048581|69727103|FG001|Double-Blind Period|Withdrawal by Subject|2|||
38039794|NCT00048581|69727104|FG002|Double-Blind Period|Withdrawal by Subject|0|||
38039795|NCT00048581|69727102|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
38039796|NCT00048581|69727103|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
38039797|NCT00048581|69727104|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
38039798|NCT00048581|69727102|FG000|Double-Blind Period|Investigator Decision|1|||
38039799|NCT00048581|69727103|FG001|Double-Blind Period|Investigator Decision|0|||
38039800|NCT00048581|69727104|FG002|Double-Blind Period|Investigator Decision|0|||
38039801|NCT00048581|69727102|FG000|Open-Label Period|Death|0|||
38039802|NCT00048581|69727103|FG001|Open-Label Period|Death|0|||
38039803|NCT00048581|69727104|FG002|Open-Label Period|Death|4|||
38039804|NCT00048581|69727102|FG000|Open-Label Period|Adverse Event|0|||
38039805|NCT00048581|69727103|FG001|Open-Label Period|Adverse Event|0|||
38039806|NCT00048581|69727104|FG002|Open-Label Period|Adverse Event|37|||
38039807|NCT00048581|69727102|FG000|Open-Label Period|Lack of Efficacy|0|||
38039808|NCT00048581|69727103|FG001|Open-Label Period|Lack of Efficacy|0|||
38039809|NCT00048581|69727104|FG002|Open-Label Period|Lack of Efficacy|69|||
38039810|NCT00048581|69727102|FG000|Open-Label Period|Lost to Follow-up|0|||
38039811|NCT00048581|69727103|FG001|Open-Label Period|Lost to Follow-up|0|||
38039812|NCT00048581|69727104|FG002|Open-Label Period|Lost to Follow-up|14|||
38039813|NCT00048581|69727102|FG000|Open-Label Period|Withdrawal by Subject|0|||
38039814|NCT00048581|69727103|FG001|Open-Label Period|Withdrawal by Subject|0|||
38039815|NCT00048581|69727104|FG002|Open-Label Period|Withdrawal by Subject|20|||
38039816|NCT00048581|69727102|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
38039817|NCT00048581|69727103|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
38039818|NCT00048581|69727104|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
38039819|NCT00048581|69727102|FG000|Open-Label Period|Poor/Non-compliance|0|||
37859853|NCT00955357|69543209|FG000|Titration Phase|Adverse Event|9|||
37859854|NCT00955357|69543210|FG001|Titration Phase|Adverse Event|46|||
37859855|NCT00955357|69543209|FG000|Titration Phase|Lack of Efficacy|0|||
37859856|NCT00955357|69543210|FG001|Titration Phase|Lack of Efficacy|2|||
37859857|NCT00955357|69543209|FG000|Titration Phase|Protocol Violation|3|||
37859858|NCT00955357|69543210|FG001|Titration Phase|Protocol Violation|7|||
37859859|NCT00955357|69543209|FG000|Titration Phase|Lost to Follow-up|1|||
37859860|NCT00955357|69543210|FG001|Titration Phase|Lost to Follow-up|3|||
37859861|NCT00955357|69543209|FG000|Titration Phase|Withdrawal by Subject|3|||
37859862|NCT00955357|69543210|FG001|Titration Phase|Withdrawal by Subject|5|||
37859863|NCT00955357|69543209|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
37859864|NCT00955357|69543210|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
37859865|NCT00955357|69543209|FG000|Titration Phase|Study medication not tolerated|0|||
37945693|NCT00557505|69633167|FG000|Overall Study|Global deterioration of health|1|||
37945694|NCT00557505|69633168|FG001|Overall Study|Global deterioration of health|0|||
37945695|NCT00557505|69633169|FG002|Overall Study|Global deterioration of health|0|||
37945696|NCT00557505|69633170|FG003|Overall Study|Global deterioration of health|0|||
37945697|NCT00557505|69633171|FG004|Overall Study|Global deterioration of health|0|||
37945698|NCT00557505|69633172|FG005|Overall Study|Global deterioration of health|0|||
38039820|NCT00048581|69727103|FG001|Open-Label Period|Poor/Non-compliance|0|||
38039821|NCT00048581|69727104|FG002|Open-Label Period|Poor/Non-compliance|5|||
38039822|NCT00048581|69727102|FG000|Open-Label Period|Pregnancy|0|||
38039823|NCT00048581|69727103|FG001|Open-Label Period|Pregnancy|0|||
38039824|NCT00048581|69727104|FG002|Open-Label Period|Pregnancy|7|||
38039825|NCT00048581|69727102|FG000|Open-Label Period|Study Site Closure|0|||
38039826|NCT00048581|69727103|FG001|Open-Label Period|Study Site Closure|0|||
38039827|NCT00048581|69727104|FG002|Open-Label Period|Study Site Closure|2|||
38039828|NCT00048581|69727102|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
38039829|NCT00048581|69727103|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
38039830|NCT00048581|69727104|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
38039831|NCT00048581|69727102|FG000|Open-Label Period|Problem With Transportation To Site|0|||
38039832|NCT00048581|69727103|FG001|Open-Label Period|Problem With Transportation To Site|0|||
38039833|NCT00048581|69727104|FG002|Open-Label Period|Problem With Transportation To Site|1|||
38039834|NCT00048581|69727102|FG000|Open-Label Period|Primary Investigator Retired|0|||
38039835|NCT00048581|69727103|FG001|Open-Label Period|Primary Investigator Retired|0|||
38039836|NCT00048581|69727104|FG002|Open-Label Period|Primary Investigator Retired|2|||
38039837|NCT00048581|69727102|FG000|Open-Label Period|Study Ended By Sponsor|0|||
38039838|NCT00048581|69727103|FG001|Open-Label Period|Study Ended By Sponsor|0|||
38039839|NCT00048581|69727104|FG002|Open-Label Period|Study Ended By Sponsor|1|||
38039840|NCT00048347|69727117|FG000|Overall Study|Screen failure|2|||
38039841|NCT00065507|69727123|FG000|Overall Study|Death|16|||
38039842|NCT00065507|69727124|FG001|Overall Study|Death|17|||
38039843|NCT00065507|69727123|FG000|Overall Study|Adverse Event|4|||
38039844|NCT00065507|69727124|FG001|Overall Study|Adverse Event|3|||
38039845|NCT00065507|69727123|FG000|Overall Study|Lack of Efficacy|0|||
38039846|NCT00065507|69727124|FG001|Overall Study|Lack of Efficacy|6|||
38039847|NCT00065507|69727123|FG000|Overall Study|Poor/Non-compliance|3|||
38039848|NCT00065507|69727124|FG001|Overall Study|Poor/Non-compliance|2|||
38039849|NCT00065507|69727123|FG000|Overall Study|Lost to Follow-up|3|||
38039850|NCT00065507|69727124|FG001|Overall Study|Lost to Follow-up|0|||
38039851|NCT00065507|69727123|FG000|Overall Study|Subject Withdrew Consent|2|||
38039852|NCT00065507|69727124|FG001|Overall Study|Subject Withdrew Consent|1|||
38039853|NCT00065507|69727123|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
38039854|NCT00065507|69727124|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
38039855|NCT00065429|69727141|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
38039856|NCT00065429|69727142|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
38039857|NCT00065429|69727143|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
38039858|NCT00065429|69727144|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
38039859|NCT00065429|69727145|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
38039860|NCT00065429|69727146|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
38039861|NCT00065429|69727147|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
38039862|NCT00065429|69727141|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
38039863|NCT00065429|69727142|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
38039864|NCT00065429|69727143|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
38039865|NCT00065429|69727144|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
38039866|NCT00065429|69727145|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
38039867|NCT00065429|69727146|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
38039868|NCT00065429|69727147|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
38039869|NCT00065429|69727141|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
38039870|NCT00065429|69727142|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
38039871|NCT00065429|69727143|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
38039872|NCT00065429|69727144|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
38039873|NCT00065429|69727145|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
38039874|NCT00065429|69727146|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
38039875|NCT00065429|69727147|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
38039876|NCT00065429|69727141|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
38039877|NCT00065429|69727142|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
38039878|NCT00065429|69727143|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
38039879|NCT00065429|69727144|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
38039880|NCT00065429|69727145|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
38039881|NCT00065429|69727146|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
38039882|NCT00065429|69727147|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
38039883|NCT00065429|69727141|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
38039884|NCT00065429|69727142|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
38039885|NCT00065429|69727143|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
38039886|NCT00065429|69727144|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
38039887|NCT00065429|69727145|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
38039888|NCT00065429|69727146|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
38039889|NCT00065429|69727147|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
38039890|NCT00065429|69727141|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
38039891|NCT00065429|69727142|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
38039892|NCT00065429|69727143|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
38039893|NCT00065429|69727144|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
38039894|NCT00065429|69727145|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
38039895|NCT00065429|69727146|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
38039896|NCT00065429|69727147|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
38039897|NCT00065429|69727141|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
38039898|NCT00065429|69727142|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
38039899|NCT00065429|69727143|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
38039900|NCT00065429|69727144|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
38039901|NCT00065429|69727145|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
38039902|NCT00065429|69727146|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
38039903|NCT00065429|69727147|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
38039904|NCT00048035|69727164|FG000|Core Period|Early Withdrawals|4|||
38039905|NCT00048035|69727165|FG001|Core Period|Early Withdrawals|2|||
38039906|NCT00048035|69727166|FG002|Core Period|Early Withdrawals|1|||
38039907|NCT00048035|69727167|FG003|Core Period|Early Withdrawals|1|||
38039908|NCT00048035|69727168|FG004|Core Period|Early Withdrawals|1|||
38039909|NCT00048035|69727169|FG005|Core Period|Early Withdrawals|1|||
38039910|NCT00048035|69727170|FG006|Core Period|Early Withdrawals|0|||
38039911|NCT00048035|69727171|FG007|Core Period|Early Withdrawals|0|||
38039912|NCT00048035|69727164|FG000|Extension Year 1|Early Withdrawals|0|||
38039913|NCT00048035|69727165|FG001|Extension Year 1|Early Withdrawals|0|||
38039914|NCT00048035|69727166|FG002|Extension Year 1|Early Withdrawals|0|||
38039915|NCT00048035|69727167|FG003|Extension Year 1|Early Withdrawals|0|||
38039916|NCT00048035|69727168|FG004|Extension Year 1|Early Withdrawals|0|||
38039917|NCT00048035|69727169|FG005|Extension Year 1|Early Withdrawals|0|||
38039918|NCT00048035|69727170|FG006|Extension Year 1|Early Withdrawals|11|||
38039919|NCT00048035|69727171|FG007|Extension Year 1|Early Withdrawals|11|||
38039920|NCT00048035|69727164|FG000|Extension Year 2|Early Withdrawals|0|||
38039921|NCT00048035|69727165|FG001|Extension Year 2|Early Withdrawals|0|||
38039922|NCT00048035|69727166|FG002|Extension Year 2|Early Withdrawals|0|||
38039923|NCT00048035|69727167|FG003|Extension Year 2|Early Withdrawals|0|||
38039924|NCT00048035|69727168|FG004|Extension Year 2|Early Withdrawals|0|||
38039925|NCT00048035|69727169|FG005|Extension Year 2|Early Withdrawals|0|||
38039926|NCT00048035|69727170|FG006|Extension Year 2|Early Withdrawals|3|||
38039927|NCT00048035|69727171|FG007|Extension Year 2|Early Withdrawals|3|||
38039928|NCT00047879|69727188|FG000|Overall Study|Progressive disease|4|||
37676180|NCT01672853|69150760|FG000|Overall Study|Investigator's Discretion|1|||
37676181|NCT01672853|69150761|FG001|Overall Study|Investigator's Discretion|0|||
37676182|NCT01672853|69150762|FG002|Overall Study|Investigator's Discretion|0|||
37676183|NCT01672853|69150760|FG000|Overall Study|Withdrew Consent|5|||
37676184|NCT01672853|69150761|FG001|Overall Study|Withdrew Consent|5|||
37676185|NCT01672853|69150762|FG002|Overall Study|Withdrew Consent|5|||
37676186|NCT01672853|69150760|FG000|Overall Study|Adverse Event|4|||
37676187|NCT01672853|69150761|FG001|Overall Study|Adverse Event|6|||
37676188|NCT01672853|69150762|FG002|Overall Study|Adverse Event|8|||
37676189|NCT01672853|69150760|FG000|Overall Study|Lost to Follow-up|0|||
37676190|NCT01672853|69150761|FG001|Overall Study|Lost to Follow-up|1|||
37676191|NCT01672853|69150762|FG002|Overall Study|Lost to Follow-up|0|||
37676192|NCT01672853|69150760|FG000|Overall Study|Randomized but Never Treated|0|||
37676193|NCT01672853|69150761|FG001|Overall Study|Randomized but Never Treated|0|||
37676194|NCT01672853|69150762|FG002|Overall Study|Randomized but Never Treated|1|||
37676195|NCT01603459|69150770|FG000|Overall Study|Adverse Event|5|||
37676196|NCT01603459|69150770|FG000|Overall Study|Withdrawal by Subject|5|||
37676197|NCT01603459|69150770|FG000|Overall Study|Lost to Follow-up|3|||
37676198|NCT01603459|69150770|FG000|Overall Study|Predefined discontinuation criteria|3|||
37676199|NCT01603459|69150770|FG000|Overall Study|Non-compliance|1|||
37676200|NCT01603459|69150770|FG000|Overall Study|Administrative reason|1|||
37676201|NCT01678807|69150809|FG000|Overall Study|Adverse Event|4|||
37676202|NCT01678807|69150810|FG001|Overall Study|Adverse Event|4|||
37676203|NCT01678807|69150811|FG002|Overall Study|Adverse Event|0|||
37676204|NCT01678807|69150809|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
37676205|NCT01678807|69150810|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
37676206|NCT01678807|69150811|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
38039929|NCT00047879|69727189|FG001|Overall Study|Progressive disease|3|||
38039930|NCT00064337|69727195|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
37676207|NCT03073525|69150822|FG000|Overall Study|Withdrawal by Subject|0|||
37676208|NCT03073525|69150823|FG001|Overall Study|Withdrawal by Subject|0|||
37676209|NCT03073525|69150824|FG002|Overall Study|Withdrawal by Subject|3|||
37676210|NCT02631551|69150845|FG000|Overall Study|Adverse Event|1|||
37676211|NCT02631551|69150846|FG001|Overall Study|Adverse Event|2|||
37676212|NCT02631551|69150847|FG002|Overall Study|Adverse Event|4|||
37676213|NCT02631551|69150848|FG003|Overall Study|Adverse Event|0|||
38039931|NCT00064337|69727195|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
38039932|NCT00064337|69727195|FG000|PBSCC or Induction/PBSCC|Progression|3|||
38039933|NCT00064337|69727195|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
37676214|NCT02631551|69150845|FG000|Overall Study|Lack of Efficacy|0|||
37676215|NCT02631551|69150846|FG001|Overall Study|Lack of Efficacy|0|||
37676216|NCT02631551|69150847|FG002|Overall Study|Lack of Efficacy|1|||
37676217|NCT02631551|69150848|FG003|Overall Study|Lack of Efficacy|0|||
37676218|NCT02631551|69150845|FG000|Overall Study|Lost to Follow-up|1|||
37676219|NCT02631551|69150846|FG001|Overall Study|Lost to Follow-up|2|||
37676220|NCT02631551|69150847|FG002|Overall Study|Lost to Follow-up|0|||
37676221|NCT02631551|69150848|FG003|Overall Study|Lost to Follow-up|3|||
37676222|NCT02631551|69150845|FG000|Overall Study|Withdrawal by Subject|2|||
37676223|NCT02631551|69150846|FG001|Overall Study|Withdrawal by Subject|2|||
37676224|NCT02631551|69150847|FG002|Overall Study|Withdrawal by Subject|0|||
37676225|NCT02631551|69150848|FG003|Overall Study|Withdrawal by Subject|5|||
37676226|NCT02631551|69150845|FG000|Overall Study|Protocol deviation|3|||
37767828|NCT00070499|69283417|FG002|Overall Study|Did not start treatment|0|||
37767829|NCT00070499|69283418|FG003|Overall Study|Did not start treatment|2|||
37859866|NCT00955357|69543210|FG001|Titration Phase|Study medication not tolerated|1|||
37859867|NCT00955357|69543209|FG000|Titration Phase|Non compliance to study procedures|0|||
37859868|NCT00955357|69543210|FG001|Titration Phase|Non compliance to study procedures|1|||
37859869|NCT00955357|69543209|FG000|Maintenance Phase|Adverse Event|3|||
37859870|NCT00955357|69543210|FG001|Maintenance Phase|Adverse Event|23|||
37859871|NCT00955357|69543209|FG000|Maintenance Phase|Lack of Efficacy|0|||
37859872|NCT00955357|69543210|FG001|Maintenance Phase|Lack of Efficacy|4|||
37859873|NCT00955357|69543209|FG000|Maintenance Phase|Protocol Violation|2|||
37859874|NCT00955357|69543210|FG001|Maintenance Phase|Protocol Violation|6|||
37859875|NCT00955357|69543209|FG000|Maintenance Phase|Lost to Follow-up|2|||
37859876|NCT00955357|69543210|FG001|Maintenance Phase|Lost to Follow-up|7|||
37859877|NCT00955357|69543209|FG000|Maintenance Phase|Withdrawal by Subject|4|||
38039934|NCT00064337|69727195|FG000|PBSCC or Induction/PBSCC|Death|2|||
38039935|NCT00064337|69727195|FG000|Transplant|Adverse Event|9|||
38039936|NCT00064337|69727195|FG000|Transplant|Not protocol-specified|5|||
38039937|NCT00064337|69727195|FG000|Transplant|Death|3|||
38039938|NCT00064337|69727195|FG000|Transplant|Patient Refusal|2|||
38039939|NCT00064337|69727195|FG000|Transplant|Progression|2|||
38039940|NCT00064337|69727195|FG000|Maintenance|Adverse Event|3|||
38039941|NCT00064337|69727195|FG000|Maintenance|Progression|2|||
38039942|NCT00064337|69727195|FG000|Maintenance|On treatment at time of analysis|2|||
38039943|NCT00064337|69727195|FG000|Maintenance|Not protocol-specified|2|||
38039944|NCT00064337|69727195|FG000|Maintenance|Death|1|||
38039945|NCT00064259|69727202|FG000|Overall Study|Adverse Event|1|||
38039946|NCT00064259|69727203|FG001|Overall Study|Adverse Event|0|||
38039947|NCT00064259|69727204|FG002|Overall Study|Adverse Event|0|||
38039948|NCT00064259|69727205|FG003|Overall Study|Adverse Event|1|||
38039949|NCT00044213|69727214|FG000|Overall Study|Withdrawal by Subject|50|||
38039950|NCT00044213|69727215|FG001|Overall Study|Withdrawal by Subject|65|||
38039951|NCT00044213|69727216|FG002|Overall Study|Withdrawal by Subject|91|||
38039952|NCT00044213|69727217|FG003|Overall Study|Withdrawal by Subject|83|||
38039953|NCT00044213|69727214|FG000|Overall Study|Death|42|||
38039954|NCT00044213|69727215|FG001|Overall Study|Death|42|||
38039955|NCT00044213|69727216|FG002|Overall Study|Death|42|||
38039956|NCT00044213|69727217|FG003|Overall Study|Death|49|||
38039957|NCT00044213|69727214|FG000|Overall Study|Lost to Follow-up|8|||
38039958|NCT00044213|69727215|FG001|Overall Study|Lost to Follow-up|5|||
38039959|NCT00044213|69727216|FG002|Overall Study|Lost to Follow-up|5|||
38039960|NCT00044213|69727217|FG003|Overall Study|Lost to Follow-up|4|||
38039961|NCT00064025|69727227|FG000|Overall Study|Ineligible|4|||
38039962|NCT00064025|69727227|FG000|Overall Study|Inevaluable|3|||
38039963|NCT00043979|69727235|FG000|Period 1|recipient with progressive disease|7|||
38039964|NCT00043979|69727236|FG001|Period 1|recipient with progressive disease|4|||
38039965|NCT00043979|69727237|FG002|Period 1|recipient with progressive disease|3|||
38039966|NCT00039377|69727254|FG000|Initial Registration|Adverse Event|2|||
38039967|NCT00039377|69727255|FG001|Initial Registration|Adverse Event|0|||
37676227|NCT02631551|69150846|FG001|Overall Study|Protocol deviation|6|||
37676228|NCT02631551|69150847|FG002|Overall Study|Protocol deviation|3|||
37676229|NCT02631551|69150848|FG003|Overall Study|Protocol deviation|0|||
37767830|NCT00070499|69283415|FG000|Overall Study|Not eligible|2|||
37767831|NCT00070499|69283416|FG001|Overall Study|Not eligible|5|||
37767832|NCT00070499|69283417|FG002|Overall Study|Not eligible|3|||
37767833|NCT00070499|69283418|FG003|Overall Study|Not eligible|2|||
37767834|NCT00066573|69283438|FG000|Overall Study|Did not received protocol treatment|28|||
37767835|NCT00066573|69283439|FG001|Overall Study|Did not received protocol treatment|28|||
37767836|NCT03594955|69283445|FG000|Overall Study|Adverse Event|1|||
37767837|NCT03594955|69283445|FG000|Overall Study|Progressive disease|5|||
37677650|NCT01360645|69152681|FG002|Phase B (6 Weeks)|Adverse Event|0|||
37767838|NCT03594955|69283445|FG000|Overall Study|Sponsor's decision|1|||
37859878|NCT00955357|69543210|FG001|Maintenance Phase|Withdrawal by Subject|4|||
37859879|NCT00955357|69543209|FG000|Maintenance Phase|Patient moving out of area|0|||
38039968|NCT00039377|69727256|FG002|Initial Registration|Adverse Event|0|||
38039969|NCT00039377|69727257|FG003|Initial Registration|Adverse Event|0|||
38039970|NCT00039377|69727254|FG000|Initial Registration|Relapsed|6|||
37859880|NCT00955357|69543210|FG001|Maintenance Phase|Patient moving out of area|1|||
37859881|NCT00955357|69543209|FG000|Maintenance Phase|Non compliance to study procedures|1|||
37859882|NCT00955357|69543210|FG001|Maintenance Phase|Non compliance to study procedures|0|||
37859883|NCT00955279|69543219|FG000|Overall Study|Other|0|||
37859884|NCT00955279|69543220|FG001|Overall Study|Other|0|||
37859885|NCT00955279|69543221|FG002|Overall Study|Other|3|||
37859886|NCT00955279|69543219|FG000|Overall Study|Death|1|||
37859887|NCT00955279|69543220|FG001|Overall Study|Death|1|||
37859888|NCT00955279|69543221|FG002|Overall Study|Death|1|||
37859889|NCT00955279|69543219|FG000|Overall Study|Lost to Follow-up|0|||
37859890|NCT00955279|69543220|FG001|Overall Study|Lost to Follow-up|3|||
37859891|NCT00955279|69543221|FG002|Overall Study|Lost to Follow-up|1|||
37859892|NCT00955279|69543219|FG000|Overall Study|Withdrawal by Subject|2|||
37859893|NCT00955279|69543220|FG001|Overall Study|Withdrawal by Subject|0|||
37859894|NCT00955279|69543221|FG002|Overall Study|Withdrawal by Subject|3|||
37859895|NCT00954733|69543229|FG000|Overall Study|blood gas machine did not work|1|||
37859896|NCT00954421|69543233|FG000|Screening|screen failures|3|||
37859897|NCT00954421|69543233|FG000|6 Months of DBS|Withdrawal by Subject|1|||
37859898|NCT00954421|69543233|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
37859899|NCT01241448|69543243|FG000|Overall Study|Adverse Event|1|||
37859900|NCT01241448|69543244|FG001|Overall Study|Adverse Event|0|||
37859901|NCT01241448|69543245|FG002|Overall Study|Adverse Event|2|||
37859902|NCT01241448|69543246|FG003|Overall Study|Adverse Event|2|||
37859903|NCT01241448|69543243|FG000|Overall Study|Lost to Follow-up|2|||
37859904|NCT01241448|69543244|FG001|Overall Study|Lost to Follow-up|1|||
37859905|NCT01241448|69543245|FG002|Overall Study|Lost to Follow-up|1|||
37859906|NCT01241448|69543246|FG003|Overall Study|Lost to Follow-up|1|||
37859907|NCT01241448|69543243|FG000|Overall Study|Physician Decision|0|||
37859908|NCT01241448|69543244|FG001|Overall Study|Physician Decision|2|||
37859909|NCT01241448|69543245|FG002|Overall Study|Physician Decision|0|||
37859910|NCT01241448|69543246|FG003|Overall Study|Physician Decision|0|||
37859911|NCT01241448|69543243|FG000|Overall Study|Protocol Violation|10|||
37859912|NCT01241448|69543244|FG001|Overall Study|Protocol Violation|5|||
37859913|NCT01241448|69543245|FG002|Overall Study|Protocol Violation|3|||
37859914|NCT01241448|69543246|FG003|Overall Study|Protocol Violation|6|||
37859915|NCT01241448|69543243|FG000|Overall Study|Sponsor Decision|17|||
37859916|NCT01241448|69543244|FG001|Overall Study|Sponsor Decision|14|||
37859917|NCT01241448|69543245|FG002|Overall Study|Sponsor Decision|12|||
37859918|NCT01241448|69543246|FG003|Overall Study|Sponsor Decision|6|||
37859919|NCT01241448|69543243|FG000|Overall Study|Withdrawal by Subject|4|||
37859920|NCT01241448|69543244|FG001|Overall Study|Withdrawal by Subject|5|||
37859921|NCT01241448|69543245|FG002|Overall Study|Withdrawal by Subject|3|||
37859922|NCT01241448|69543246|FG003|Overall Study|Withdrawal by Subject|6|||
37859923|NCT01241448|69543243|FG000|Overall Study|Excluded due to data integrity issues|3|||
37859924|NCT01241448|69543244|FG001|Overall Study|Excluded due to data integrity issues|2|||
37859925|NCT01241448|69543245|FG002|Overall Study|Excluded due to data integrity issues|2|||
37859926|NCT01241448|69543246|FG003|Overall Study|Excluded due to data integrity issues|2|||
37859927|NCT01240356|69543259|FG000|Overall Study|Withdrawal by Subject|2|||
37859928|NCT01240356|69543260|FG001|Overall Study|Withdrawal by Subject|0|||
37859929|NCT01240356|69543259|FG000|Overall Study|MRI contraindication|1|||
37859930|NCT01240356|69543260|FG001|Overall Study|MRI contraindication|0|||
37859931|NCT01239732|69543269|FG000|Overall Study|Termination of study per protocol|667|||
37859932|NCT01239732|69543269|FG000|Overall Study|Death|226|||
37859933|NCT01239732|69543269|FG000|Overall Study|Withdrawal by Subject|87|||
37859934|NCT01239732|69543269|FG000|Overall Study|Adverse Event|6|||
37859935|NCT01239732|69543269|FG000|Overall Study|Protocol Violation|3|||
38039971|NCT00039377|69727255|FG001|Initial Registration|Relapsed|0|||
38039972|NCT00039377|69727256|FG002|Initial Registration|Relapsed|0|||
38039973|NCT00039377|69727257|FG003|Initial Registration|Relapsed|0|||
38039974|NCT00039377|69727254|FG000|Initial Registration|Received non-protocol therapy|11|||
38039975|NCT00039377|69727255|FG001|Initial Registration|Received non-protocol therapy|0|||
38039976|NCT00039377|69727256|FG002|Initial Registration|Received non-protocol therapy|0|||
37676230|NCT02631551|69150845|FG000|Overall Study|Non-compliance with study procedures|0|||
37859936|NCT01239732|69543269|FG000|Overall Study|Participant non compliance|5|||
37859937|NCT01239732|69543269|FG000|Overall Study|Study termination by sponsor|2|||
37859938|NCT01239732|69543269|FG000|Overall Study|Investigator's decision|4|||
37859939|NCT01239732|69543269|FG000|Overall Study|Treatment failure|2|||
37859940|NCT01239732|69543269|FG000|Overall Study|Other|19|||
37859941|NCT02227147|69543275|FG000|Controlled Treatment Period|Adverse Event|4|||
37859942|NCT02227147|69543276|FG001|Controlled Treatment Period|Adverse Event|3|||
37859943|NCT02227147|69543275|FG000|Controlled Treatment Period|Other|2|||
37859944|NCT02227147|69543276|FG001|Controlled Treatment Period|Other|0|||
37859945|NCT02227147|69543275|FG000|Follow-up Period|Other|3|||
37859946|NCT02227147|69543276|FG001|Follow-up Period|Other|5|||
37859947|NCT00948025|69543288|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
37859948|NCT00948025|69543289|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
37859949|NCT00948025|69543288|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
37859950|NCT00948025|69543289|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
37859951|NCT00948025|69543288|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
37859952|NCT00948025|69543289|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
37859953|NCT00947011|69543296|FG000|Overall Study|Study was terminated,PI left institution|12|||
37859954|NCT01239342|69543304|FG000|Overall Study|Adverse Event|1|||
37859955|NCT01239342|69543305|FG001|Overall Study|Adverse Event|0|||
37859956|NCT01239342|69543304|FG000|Overall Study|Withdrawal by Subject|1|||
37859957|NCT01239342|69543305|FG001|Overall Study|Withdrawal by Subject|5|||
37859958|NCT01239342|69543304|FG000|Overall Study|Reason Unknown|1|||
37859959|NCT01239342|69543305|FG001|Overall Study|Reason Unknown|1|||
37859960|NCT00946309|69543313|FG000|Overall Study|Protocol Violation|1|||
37859961|NCT00946309|69543314|FG001|Overall Study|Protocol Violation|0|||
37859962|NCT00946309|69543313|FG000|Overall Study|Lost to Follow-up|0|||
37859963|NCT00946309|69543314|FG001|Overall Study|Lost to Follow-up|1|||
37859964|NCT00946309|69543313|FG000|Overall Study|Procedure cancelled/discontinued|0|||
37859965|NCT00946309|69543314|FG001|Overall Study|Procedure cancelled/discontinued|3|||
37859966|NCT01236534|69543323|FG000|Overall Study|Adverse Event|3|||
37859967|NCT01236534|69543324|FG001|Overall Study|Adverse Event|0|||
37859968|NCT01235598|69543332|FG000|Overall Study|Adverse Event|0|||
37859969|NCT01235598|69543333|FG001|Overall Study|Adverse Event|3|||
37859970|NCT01235598|69543332|FG000|Overall Study|Lack of Efficacy|0|||
37859971|NCT01235598|69543333|FG001|Overall Study|Lack of Efficacy|1|||
37859972|NCT01235598|69543332|FG000|Overall Study|Withdrawal by Subject|1|||
37859973|NCT01235598|69543333|FG001|Overall Study|Withdrawal by Subject|0|||
37859974|NCT01235442|69543342|FG000|Overall Study|Lost to Follow-up|12|||
37859975|NCT01235442|69543343|FG001|Overall Study|Lost to Follow-up|10|||
37859976|NCT01235442|69543342|FG000|Overall Study|Death|0|||
37859977|NCT01235442|69543343|FG001|Overall Study|Death|2|||
37859978|NCT01235442|69543342|FG000|Overall Study|Pregnancy|1|||
37859979|NCT01235442|69543343|FG001|Overall Study|Pregnancy|1|||
37859980|NCT01235442|69543342|FG000|Overall Study|Ineligibility determined|5|||
37859981|NCT01235442|69543343|FG001|Overall Study|Ineligibility determined|4|||
37859982|NCT01235442|69543342|FG000|Overall Study|Protocol Violation|3|||
37859983|NCT01235442|69543343|FG001|Overall Study|Protocol Violation|3|||
37859984|NCT01235442|69543342|FG000|Overall Study|Adverse Event|4|||
37859985|NCT01235442|69543343|FG001|Overall Study|Adverse Event|6|||
37859986|NCT01235442|69543342|FG000|Overall Study|Withdrawal by Subject|15|||
37859987|NCT01235442|69543343|FG001|Overall Study|Withdrawal by Subject|9|||
37945699|NCT00557505|69633173|FG006|Overall Study|Global deterioration of health|0|||
37945700|NCT00557505|69633174|FG007|Overall Study|Global deterioration of health|0|||
37945701|NCT00557505|69633175|FG008|Overall Study|Global deterioration of health|0|||
37945702|NCT00557505|69633167|FG000|Overall Study|Objective progression or relapse|2|||
37945703|NCT00557505|69633168|FG001|Overall Study|Objective progression or relapse|3|||
37945704|NCT00557505|69633169|FG002|Overall Study|Objective progression or relapse|3|||
37945705|NCT00557505|69633170|FG003|Overall Study|Objective progression or relapse|2|||
37945706|NCT00557505|69633171|FG004|Overall Study|Objective progression or relapse|2|||
37945707|NCT00557505|69633172|FG005|Overall Study|Objective progression or relapse|3|||
37945708|NCT00557505|69633173|FG006|Overall Study|Objective progression or relapse|2|||
37945709|NCT00557505|69633174|FG007|Overall Study|Objective progression or relapse|5|||
37945710|NCT00557505|69633175|FG008|Overall Study|Objective progression or relapse|15|||
37945711|NCT00557505|69633167|FG000|Overall Study|Withdrawal by Subject|0|||
37945712|NCT00557505|69633168|FG001|Overall Study|Withdrawal by Subject|0|||
37945713|NCT00557505|69633169|FG002|Overall Study|Withdrawal by Subject|0|||
37945714|NCT00557505|69633170|FG003|Overall Study|Withdrawal by Subject|1|||
37945715|NCT00557505|69633171|FG004|Overall Study|Withdrawal by Subject|0|||
37945716|NCT00557505|69633172|FG005|Overall Study|Withdrawal by Subject|0|||
37945717|NCT00557505|69633173|FG006|Overall Study|Withdrawal by Subject|0|||
37945718|NCT00557505|69633174|FG007|Overall Study|Withdrawal by Subject|0|||
37945719|NCT00557505|69633175|FG008|Overall Study|Withdrawal by Subject|1|||
37945720|NCT00674570|69633201|FG000|Overall Study|Withdrawal by Subject|0|||
37945721|NCT00674570|69633202|FG001|Overall Study|Withdrawal by Subject|2|||
37945722|NCT00674570|69633203|FG002|Overall Study|Withdrawal by Subject|0|||
37945723|NCT00561951|69633214|FG000|Overall Study|Adverse Event|11|||
37945724|NCT00561951|69633215|FG001|Overall Study|Adverse Event|14|||
37945725|NCT00561951|69633216|FG002|Overall Study|Adverse Event|14|||
37945726|NCT00561951|69633214|FG000|Overall Study|Lack of Efficacy|5|||
37945727|NCT00561951|69633215|FG001|Overall Study|Lack of Efficacy|3|||
37945728|NCT00561951|69633216|FG002|Overall Study|Lack of Efficacy|2|||
37859988|NCT01235442|69543342|FG000|Overall Study|Lack of Efficacy|1|||
37859989|NCT01235442|69543343|FG001|Overall Study|Lack of Efficacy|3|||
37859990|NCT01235442|69543342|FG000|Overall Study|Noncompliance|1|||
37859991|NCT01235442|69543343|FG001|Overall Study|Noncompliance|2|||
37859992|NCT01235442|69543342|FG000|Overall Study|Administrative decision|1|||
37859993|NCT01235442|69543343|FG001|Overall Study|Administrative decision|2|||
37859994|NCT01235442|69543342|FG000|Overall Study|Other unspecified|1|||
37945729|NCT00561951|69633214|FG000|Overall Study|Lost to Follow-up|1|||
37945730|NCT00561951|69633215|FG001|Overall Study|Lost to Follow-up|1|||
37945731|NCT00561951|69633216|FG002|Overall Study|Lost to Follow-up|0|||
37945732|NCT00561951|69633214|FG000|Overall Study|Withdrawal by Subject|10|||
37945733|NCT00561951|69633215|FG001|Overall Study|Withdrawal by Subject|9|||
37945734|NCT00561951|69633216|FG002|Overall Study|Withdrawal by Subject|10|||
37945735|NCT00561951|69633214|FG000|Overall Study|Protocol Violation|4|||
37945736|NCT00561951|69633215|FG001|Overall Study|Protocol Violation|3|||
37945737|NCT00561951|69633216|FG002|Overall Study|Protocol Violation|4|||
37945738|NCT00561951|69633214|FG000|Overall Study|Physician Decision|1|||
37945739|NCT00561951|69633215|FG001|Overall Study|Physician Decision|0|||
37945740|NCT00561951|69633216|FG002|Overall Study|Physician Decision|0|||
37945741|NCT00561951|69633214|FG000|Overall Study|Pregnancy|0|||
37945742|NCT00561951|69633215|FG001|Overall Study|Pregnancy|1|||
37945743|NCT00561951|69633216|FG002|Overall Study|Pregnancy|0|||
37945744|NCT00561951|69633214|FG000|Overall Study|Meet Withdrawal Criterion|0|||
37945745|NCT00561951|69633215|FG001|Overall Study|Meet Withdrawal Criterion|1|||
37945746|NCT00561951|69633216|FG002|Overall Study|Meet Withdrawal Criterion|1|||
37945747|NCT00561951|69633214|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
37945748|NCT00561951|69633215|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
37945749|NCT00561951|69633216|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
37945750|NCT00322387|69633226|FG000|Treatment Period|Adverse Event|0|||
37945751|NCT00322387|69633227|FG001|Treatment Period|Adverse Event|1|||
37945752|NCT00322387|69633226|FG000|Follow-up Period|Final assessment not done|1|||
37945753|NCT00322387|69633227|FG001|Follow-up Period|Final assessment not done|3|||
37945754|NCT00322387|69633226|FG000|Follow-up Period|Death|1|||
37945755|NCT00322387|69633227|FG001|Follow-up Period|Death|0|||
37945756|NCT00561015|69633250|FG000|Overall Study|Adverse Event|0|||
37945757|NCT00561015|69633251|FG001|Overall Study|Adverse Event|0|||
37945758|NCT00561015|69633252|FG002|Overall Study|Adverse Event|0|||
37945759|NCT00561015|69633253|FG003|Overall Study|Adverse Event|0|||
37945760|NCT00561015|69633254|FG004|Overall Study|Adverse Event|1|||
37945761|NCT00561015|69633255|FG005|Overall Study|Adverse Event|0|||
37945762|NCT00561015|69633250|FG000|Overall Study|Lost to Follow-up|2|||
37945763|NCT00561015|69633251|FG001|Overall Study|Lost to Follow-up|0|||
37945764|NCT00561015|69633252|FG002|Overall Study|Lost to Follow-up|0|||
37945765|NCT00561015|69633253|FG003|Overall Study|Lost to Follow-up|1|||
37945766|NCT00561015|69633254|FG004|Overall Study|Lost to Follow-up|0|||
37945767|NCT00561015|69633255|FG005|Overall Study|Lost to Follow-up|3|||
37945768|NCT00561015|69633250|FG000|Overall Study|Participant non-compliance|2|||
37945769|NCT00561015|69633251|FG001|Overall Study|Participant non-compliance|0|||
37945770|NCT00561015|69633252|FG002|Overall Study|Participant non-compliance|0|||
37945771|NCT00561015|69633253|FG003|Overall Study|Participant non-compliance|0|||
37945772|NCT00561015|69633254|FG004|Overall Study|Participant non-compliance|0|||
37945773|NCT00561015|69633255|FG005|Overall Study|Participant non-compliance|0|||
37945774|NCT00560937|69633275|FG000|Overall Study|Withdrawal by Subject|0|||
37945775|NCT00560937|69633276|FG001|Overall Study|Withdrawal by Subject|1|||
37945776|NCT00560937|69633275|FG000|Overall Study|Physician Decision|1|||
37945777|NCT00560937|69633276|FG001|Overall Study|Physician Decision|1|||
37945778|NCT00561795|69633284|FG000|Overall Study|Adverse Event|3|||
37945779|NCT00561795|69633285|FG001|Overall Study|Adverse Event|3|||
37945780|NCT00561795|69633286|FG002|Overall Study|Adverse Event|0|||
37945781|NCT00561795|69633287|FG003|Overall Study|Adverse Event|0|||
37945782|NCT00561795|69633284|FG000|Overall Study|Study Closed/Terminated|0|||
37945783|NCT00561795|69633285|FG001|Overall Study|Study Closed/Terminated|3|||
37945784|NCT00561795|69633286|FG002|Overall Study|Study Closed/Terminated|0|||
37945785|NCT00561795|69633287|FG003|Overall Study|Study Closed/Terminated|0|||
37945786|NCT00561795|69633284|FG000|Overall Study|Physician Decision|1|||
38039977|NCT00039377|69727257|FG003|Initial Registration|Received non-protocol therapy|0|||
38039978|NCT00039377|69727254|FG000|Initial Registration|Withdrawal by Subject|3|||
38039979|NCT00039377|69727255|FG001|Initial Registration|Withdrawal by Subject|0|||
38039980|NCT00039377|69727256|FG002|Initial Registration|Withdrawal by Subject|0|||
38039981|NCT00039377|69727257|FG003|Initial Registration|Withdrawal by Subject|0|||
38039982|NCT00154102|69727267|FG000|Overall Study|investigational study phase ongoing|7|||
38039983|NCT00154102|69727268|FG001|Overall Study|investigational study phase ongoing|2|||
38039984|NCT03687502|69727291|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
37945787|NCT00561795|69633285|FG001|Overall Study|Physician Decision|0|||
37945788|NCT00561795|69633286|FG002|Overall Study|Physician Decision|0|||
37945789|NCT00561795|69633287|FG003|Overall Study|Physician Decision|0|||
37945790|NCT00652626|69633302|FG000|Initial Treatment Phase|Adverse Event|0|||
37945791|NCT00652626|69633303|FG001|Initial Treatment Phase|Adverse Event|0|||
37945792|NCT00652626|69633304|FG002|Initial Treatment Phase|Adverse Event|0|||
37945793|NCT00652626|69633305|FG003|Initial Treatment Phase|Adverse Event|0|||
37945794|NCT00652626|69633306|FG004|Initial Treatment Phase|Adverse Event|1|||
37945795|NCT00652626|69633307|FG005|Initial Treatment Phase|Adverse Event|0|||
37945796|NCT00652626|69633308|FG006|Initial Treatment Phase|Adverse Event|0|||
37945797|NCT00652626|69633302|FG000|Initial Treatment Phase|Protocol Violation|0|||
37945798|NCT00652626|69633303|FG001|Initial Treatment Phase|Protocol Violation|0|||
38039985|NCT03687502|69727291|FG000|Overall Study|Lumason not available|1|||
38039986|NCT03654976|69727299|FG000|Overall Study|Withdrawal by Subject|12|||
38039987|NCT03654976|69727300|FG001|Overall Study|Withdrawal by Subject|11|||
38039988|NCT03654976|69727299|FG000|Overall Study|Reason stated as 'Other' in CRF|10|||
38039989|NCT03654976|69727300|FG001|Overall Study|Reason stated as 'Other' in CRF|6|||
38039990|NCT03654976|69727299|FG000|Overall Study|Adverse Event|5|||
38039991|NCT03654976|69727300|FG001|Overall Study|Adverse Event|0|||
38039992|NCT03654976|69727299|FG000|Overall Study|Lost to Follow-up|2|||
38039993|NCT03654976|69727300|FG001|Overall Study|Lost to Follow-up|0|||
38039994|NCT03654976|69727299|FG000|Overall Study|Lack of Efficacy|0|||
38039995|NCT03654976|69727300|FG001|Overall Study|Lack of Efficacy|1|||
38039996|NCT00035555|69727309|FG000|Overall Study|Adverse Event|5|||
38039997|NCT00035555|69727310|FG001|Overall Study|Adverse Event|8|||
38039998|NCT00035555|69727311|FG002|Overall Study|Adverse Event|9|||
38039999|NCT00035555|69727309|FG000|Overall Study|Allograft loss|1|||
38040000|NCT00035555|69727310|FG001|Overall Study|Allograft loss|1|||
38040001|NCT00035555|69727311|FG002|Overall Study|Allograft loss|2|||
38040002|NCT00035555|69727309|FG000|Overall Study|Death|0|||
38040003|NCT00035555|69727310|FG001|Overall Study|Death|0|||
38040004|NCT00035555|69727311|FG002|Overall Study|Death|2|||
38040005|NCT00035555|69727309|FG000|Overall Study|Lost to Follow-up|0|||
38040006|NCT00035555|69727310|FG001|Overall Study|Lost to Follow-up|0|||
38040007|NCT00035555|69727311|FG002|Overall Study|Lost to Follow-up|1|||
38040008|NCT00035555|69727309|FG000|Overall Study|Noncompliance|0|||
38040009|NCT00035555|69727310|FG001|Overall Study|Noncompliance|1|||
38040010|NCT00035555|69727311|FG002|Overall Study|Noncompliance|1|||
38040011|NCT00035555|69727309|FG000|Overall Study|Prohibited medication|1|||
38040012|NCT00035555|69727310|FG001|Overall Study|Prohibited medication|1|||
38040013|NCT00035555|69727311|FG002|Overall Study|Prohibited medication|0|||
38040014|NCT00035555|69727309|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
38040015|NCT00035555|69727310|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
38040016|NCT00035555|69727311|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
38040017|NCT00035555|69727309|FG000|Overall Study|Withdrawal by Subject|2|||
38040018|NCT00035555|69727310|FG001|Overall Study|Withdrawal by Subject|0|||
38040019|NCT00035555|69727311|FG002|Overall Study|Withdrawal by Subject|2|||
38040020|NCT00035555|69727309|FG000|Overall Study|Investigator deemed not a good candidate|0|||
38040021|NCT00035555|69727310|FG001|Overall Study|Investigator deemed not a good candidate|0|||
38040022|NCT00035555|69727311|FG002|Overall Study|Investigator deemed not a good candidate|1|||
38040023|NCT00035555|69727309|FG000|Overall Study|Received cyclosporin in error|0|||
38040024|NCT00035555|69727310|FG001|Overall Study|Received cyclosporin in error|0|||
38040025|NCT00035555|69727311|FG002|Overall Study|Received cyclosporin in error|1|||
38040026|NCT03894046|69727323|FG000|Overall Study|Protocol Violation|1|||
38040027|NCT03894046|69727324|FG001|Overall Study|Protocol Violation|0|||
38040028|NCT03894046|69727325|FG002|Overall Study|Protocol Violation|0|||
38040029|NCT03894046|69727323|FG000|Overall Study|Adverse Event|0|||
38040030|NCT03894046|69727324|FG001|Overall Study|Adverse Event|1|||
37945799|NCT00652626|69633304|FG002|Initial Treatment Phase|Protocol Violation|0|||
37945800|NCT00652626|69633305|FG003|Initial Treatment Phase|Protocol Violation|1|||
37945801|NCT00652626|69633306|FG004|Initial Treatment Phase|Protocol Violation|0|||
37945802|NCT00652626|69633307|FG005|Initial Treatment Phase|Protocol Violation|0|||
37945803|NCT00652626|69633308|FG006|Initial Treatment Phase|Protocol Violation|0|||
37945804|NCT00652626|69633302|FG000|Initial Treatment Phase|Physician Decision|0|||
37945805|NCT00652626|69633303|FG001|Initial Treatment Phase|Physician Decision|0|||
37945806|NCT00652626|69633304|FG002|Initial Treatment Phase|Physician Decision|0|||
37945807|NCT00652626|69633305|FG003|Initial Treatment Phase|Physician Decision|0|||
37945808|NCT00652626|69633306|FG004|Initial Treatment Phase|Physician Decision|1|||
37945809|NCT00652626|69633307|FG005|Initial Treatment Phase|Physician Decision|0|||
37945810|NCT00652626|69633308|FG006|Initial Treatment Phase|Physician Decision|0|||
37945811|NCT00652626|69633302|FG000|Initial Treatment Phase|Sponsor Request|0|||
37945812|NCT00652626|69633303|FG001|Initial Treatment Phase|Sponsor Request|0|||
37945813|NCT00652626|69633304|FG002|Initial Treatment Phase|Sponsor Request|1|||
37945814|NCT00652626|69633305|FG003|Initial Treatment Phase|Sponsor Request|0|||
37945815|NCT00652626|69633306|FG004|Initial Treatment Phase|Sponsor Request|0|||
37945816|NCT00652626|69633307|FG005|Initial Treatment Phase|Sponsor Request|0|||
37945817|NCT00652626|69633308|FG006|Initial Treatment Phase|Sponsor Request|0|||
37945818|NCT00652626|69633302|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
37945819|NCT00652626|69633303|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
37945820|NCT00652626|69633304|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
37945821|NCT00652626|69633305|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
37945822|NCT00652626|69633306|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
37945823|NCT00652626|69633307|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
37945824|NCT00652626|69633308|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
37945825|NCT00652626|69633302|FG000|Extension Phase|Withdrawal by Subject|0|||
37945826|NCT00652626|69633303|FG001|Extension Phase|Withdrawal by Subject|0|||
37945827|NCT00652626|69633304|FG002|Extension Phase|Withdrawal by Subject|0|||
38040031|NCT03894046|69727325|FG002|Overall Study|Adverse Event|0|||
38040032|NCT03894046|69727323|FG000|Overall Study|Withdrawal by Subject|2|||
38040033|NCT03894046|69727324|FG001|Overall Study|Withdrawal by Subject|3|||
38040034|NCT03894046|69727325|FG002|Overall Study|Withdrawal by Subject|1|||
38040035|NCT03894046|69727323|FG000|Overall Study|Death|15|||
38040036|NCT03894046|69727324|FG001|Overall Study|Death|21|||
38040037|NCT03894046|69727325|FG002|Overall Study|Death|4|||
38040038|NCT03894046|69727323|FG000|Overall Study|No growth of ABC|2|||
38040039|NCT03894046|69727324|FG001|Overall Study|No growth of ABC|1|||
38040040|NCT03894046|69727325|FG002|Overall Study|No growth of ABC|0|||
38040041|NCT03894046|69727323|FG000|Overall Study|Physician Decision|1|||
38040042|NCT03894046|69727324|FG001|Overall Study|Physician Decision|1|||
38040043|NCT03894046|69727325|FG002|Overall Study|Physician Decision|1|||
38040044|NCT03894046|69727323|FG000|Overall Study|Prohibited concomitant medication|1|||
38040045|NCT03894046|69727324|FG001|Overall Study|Prohibited concomitant medication|0|||
38040046|NCT03894046|69727325|FG002|Overall Study|Prohibited concomitant medication|0|||
38040047|NCT03894046|69727323|FG000|Overall Study|Transferred to other arm/group|1|||
38040048|NCT03894046|69727324|FG001|Overall Study|Transferred to other arm/group|1|||
38040049|NCT03894046|69727325|FG002|Overall Study|Transferred to other arm/group|0|||
38040050|NCT00033371|69727334|FG000|Overall Study|Adverse Event|1|||
38040051|NCT00033371|69727335|FG001|Overall Study|Adverse Event|5|||
38040052|NCT00033371|69727334|FG000|Overall Study|Lost to Follow-up|2|||
38040053|NCT00033371|69727335|FG001|Overall Study|Lost to Follow-up|1|||
38040054|NCT00033371|69727334|FG000|Overall Study|Withdrawal by Subject|3|||
38040055|NCT00033371|69727335|FG001|Overall Study|Withdrawal by Subject|3|||
38040056|NCT00033371|69727334|FG000|Overall Study|Disease Progression|0|||
38040057|NCT00033371|69727335|FG001|Overall Study|Disease Progression|1|||
38040058|NCT00081731|69727347|FG000|Overall Study|scientific integrity issue|8|||
38040059|NCT00081731|69727348|FG001|Overall Study|scientific integrity issue|8|||
38040060|NCT00079937|69727356|FG000|Overall Study|Adverse Event|2|||
38040061|NCT00079937|69727357|FG001|Overall Study|Adverse Event|1|||
38040062|NCT00079937|69727356|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
38040063|NCT00079937|69727357|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
38040064|NCT00079937|69727356|FG000|Overall Study|Subject no longer requires study drug|3|||
38040065|NCT00079937|69727357|FG001|Overall Study|Subject no longer requires study drug|0|||
38040066|NCT00079937|69727356|FG000|Overall Study|Protocol Violation|8|||
38040067|NCT00079937|69727357|FG001|Overall Study|Protocol Violation|6|||
38040068|NCT00079937|69727356|FG000|Overall Study|Withdrawal by Subject|21|||
38040069|NCT00079937|69727357|FG001|Overall Study|Withdrawal by Subject|7|||
38040070|NCT00079937|69727356|FG000|Overall Study|Lost to Follow-up|12|||
38040071|NCT00079937|69727357|FG001|Overall Study|Lost to Follow-up|5|||
38040072|NCT00079937|69727356|FG000|Overall Study|Administrative problems|22|||
38040073|NCT00079937|69727357|FG001|Overall Study|Administrative problems|11|||
38040074|NCT00909610|69727365|FG000|Period: First Intervention|Adverse Event|0|||
38040075|NCT00909610|69727366|FG001|Period: First Intervention|Adverse Event|1|||
38040076|NCT00909610|69727365|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
38040077|NCT00909610|69727366|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
38040078|NCT00909610|69727365|FG000|Period: Second Intervention|Adverse Event|1|||
38040079|NCT00909610|69727366|FG001|Period: Second Intervention|Adverse Event|0|||
38040080|NCT03126110|69727388|FG000|Phase 1|Death|2|||
38040081|NCT03126110|69727389|FG001|Phase 1|Death|2|||
38040082|NCT03126110|69727390|FG002|Phase 1|Death|4|||
38040083|NCT03126110|69727391|FG003|Phase 1|Death|3|||
38040084|NCT03126110|69727392|FG004|Phase 1|Death|4|||
38040085|NCT03126110|69727393|FG005|Phase 1|Death|4|||
38040086|NCT03126110|69727394|FG006|Phase 1|Death|3|||
38040087|NCT03126110|69727395|FG007|Phase 1|Death|4|||
38040088|NCT03126110|69727396|FG008|Phase 1|Death|5|||
38040089|NCT03126110|69727397|FG009|Phase 1|Death|2|||
38040090|NCT03126110|69727398|FG010|Phase 1|Death|6|||
38040091|NCT03126110|69727399|FG011|Phase 1|Death|0|||
38040092|NCT03126110|69727400|FG012|Phase 1|Death|0|||
38040093|NCT03126110|69727401|FG013|Phase 1|Death|0|||
38040094|NCT03126110|69727402|FG014|Phase 1|Death|0|||
38040095|NCT03126110|69727403|FG015|Phase 1|Death|0|||
38040096|NCT03126110|69727404|FG016|Phase 1|Death|0|||
38040097|NCT03126110|69727388|FG000|Phase 1|Lost to Follow-up|0|||
38040098|NCT03126110|69727389|FG001|Phase 1|Lost to Follow-up|1|||
38040099|NCT03126110|69727390|FG002|Phase 1|Lost to Follow-up|0|||
38040100|NCT03126110|69727391|FG003|Phase 1|Lost to Follow-up|0|||
38040101|NCT03126110|69727392|FG004|Phase 1|Lost to Follow-up|0|||
38040102|NCT03126110|69727393|FG005|Phase 1|Lost to Follow-up|0|||
38040103|NCT03126110|69727394|FG006|Phase 1|Lost to Follow-up|0|||
38040104|NCT03126110|69727395|FG007|Phase 1|Lost to Follow-up|0|||
38040105|NCT03126110|69727396|FG008|Phase 1|Lost to Follow-up|1|||
38040106|NCT03126110|69727397|FG009|Phase 1|Lost to Follow-up|0|||
38040107|NCT03126110|69727398|FG010|Phase 1|Lost to Follow-up|0|||
38040108|NCT03126110|69727399|FG011|Phase 1|Lost to Follow-up|0|||
38040109|NCT03126110|69727400|FG012|Phase 1|Lost to Follow-up|0|||
38040110|NCT03126110|69727401|FG013|Phase 1|Lost to Follow-up|0|||
38040111|NCT03126110|69727402|FG014|Phase 1|Lost to Follow-up|0|||
38040112|NCT03126110|69727403|FG015|Phase 1|Lost to Follow-up|0|||
38040113|NCT03126110|69727404|FG016|Phase 1|Lost to Follow-up|0|||
38040114|NCT03126110|69727388|FG000|Phase 1|Withdrawal by Subject|1|||
38040115|NCT03126110|69727389|FG001|Phase 1|Withdrawal by Subject|0|||
38040116|NCT03126110|69727390|FG002|Phase 1|Withdrawal by Subject|0|||
38040117|NCT03126110|69727391|FG003|Phase 1|Withdrawal by Subject|1|||
38040118|NCT03126110|69727392|FG004|Phase 1|Withdrawal by Subject|1|||
38040119|NCT03126110|69727393|FG005|Phase 1|Withdrawal by Subject|0|||
38040120|NCT03126110|69727394|FG006|Phase 1|Withdrawal by Subject|0|||
38040121|NCT03126110|69727395|FG007|Phase 1|Withdrawal by Subject|0|||
38040122|NCT03126110|69727396|FG008|Phase 1|Withdrawal by Subject|2|||
38040123|NCT03126110|69727397|FG009|Phase 1|Withdrawal by Subject|1|||
38040124|NCT03126110|69727398|FG010|Phase 1|Withdrawal by Subject|0|||
38040125|NCT03126110|69727399|FG011|Phase 1|Withdrawal by Subject|0|||
38040126|NCT03126110|69727400|FG012|Phase 1|Withdrawal by Subject|0|||
38040127|NCT03126110|69727401|FG013|Phase 1|Withdrawal by Subject|0|||
38040128|NCT03126110|69727402|FG014|Phase 1|Withdrawal by Subject|0|||
38040129|NCT03126110|69727403|FG015|Phase 1|Withdrawal by Subject|0|||
38040130|NCT03126110|69727404|FG016|Phase 1|Withdrawal by Subject|0|||
38040131|NCT03126110|69727388|FG000|Phase 1|Safety follow-up no longer necessary|1|||
38040132|NCT03126110|69727389|FG001|Phase 1|Safety follow-up no longer necessary|0|||
38040133|NCT03126110|69727390|FG002|Phase 1|Safety follow-up no longer necessary|0|||
38040134|NCT03126110|69727391|FG003|Phase 1|Safety follow-up no longer necessary|0|||
38040135|NCT03126110|69727392|FG004|Phase 1|Safety follow-up no longer necessary|0|||
38040136|NCT03126110|69727393|FG005|Phase 1|Safety follow-up no longer necessary|0|||
38040137|NCT03126110|69727394|FG006|Phase 1|Safety follow-up no longer necessary|0|||
38040138|NCT03126110|69727395|FG007|Phase 1|Safety follow-up no longer necessary|0|||
38040139|NCT03126110|69727396|FG008|Phase 1|Safety follow-up no longer necessary|0|||
38040140|NCT03126110|69727397|FG009|Phase 1|Safety follow-up no longer necessary|0|||
38040141|NCT03126110|69727398|FG010|Phase 1|Safety follow-up no longer necessary|0|||
38040142|NCT03126110|69727399|FG011|Phase 1|Safety follow-up no longer necessary|0|||
38040143|NCT03126110|69727400|FG012|Phase 1|Safety follow-up no longer necessary|0|||
38040144|NCT03126110|69727401|FG013|Phase 1|Safety follow-up no longer necessary|0|||
38040145|NCT03126110|69727402|FG014|Phase 1|Safety follow-up no longer necessary|0|||
38040146|NCT03126110|69727403|FG015|Phase 1|Safety follow-up no longer necessary|0|||
38040147|NCT03126110|69727404|FG016|Phase 1|Safety follow-up no longer necessary|0|||
38040148|NCT03126110|69727388|FG000|Phase 1|Survival follow-up no longer necessary|0|||
38040149|NCT03126110|69727389|FG001|Phase 1|Survival follow-up no longer necessary|0|||
38040150|NCT03126110|69727390|FG002|Phase 1|Survival follow-up no longer necessary|1|||
38040151|NCT03126110|69727391|FG003|Phase 1|Survival follow-up no longer necessary|0|||
38040152|NCT03126110|69727392|FG004|Phase 1|Survival follow-up no longer necessary|0|||
38040153|NCT03126110|69727393|FG005|Phase 1|Survival follow-up no longer necessary|0|||
38040154|NCT03126110|69727394|FG006|Phase 1|Survival follow-up no longer necessary|0|||
38040155|NCT03126110|69727395|FG007|Phase 1|Survival follow-up no longer necessary|0|||
38040156|NCT03126110|69727396|FG008|Phase 1|Survival follow-up no longer necessary|0|||
38040157|NCT03126110|69727397|FG009|Phase 1|Survival follow-up no longer necessary|0|||
38040158|NCT03126110|69727398|FG010|Phase 1|Survival follow-up no longer necessary|0|||
38040159|NCT03126110|69727399|FG011|Phase 1|Survival follow-up no longer necessary|0|||
38040160|NCT03126110|69727400|FG012|Phase 1|Survival follow-up no longer necessary|0|||
38040161|NCT03126110|69727401|FG013|Phase 1|Survival follow-up no longer necessary|0|||
38040162|NCT03126110|69727402|FG014|Phase 1|Survival follow-up no longer necessary|0|||
38040163|NCT03126110|69727403|FG015|Phase 1|Survival follow-up no longer necessary|0|||
38040164|NCT03126110|69727404|FG016|Phase 1|Survival follow-up no longer necessary|0|||
37859995|NCT01235442|69543343|FG001|Overall Study|Other unspecified|2|||
37859996|NCT01163253|69543351|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
37859997|NCT01163253|69543352|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
38040165|NCT03126110|69727388|FG000|Phase 2|Study terminated by the sponsor|0|||
38040166|NCT03126110|69727389|FG001|Phase 2|Study terminated by the sponsor|0|||
38040167|NCT03126110|69727390|FG002|Phase 2|Study terminated by the sponsor|0|||
38040168|NCT03126110|69727391|FG003|Phase 2|Study terminated by the sponsor|0|||
38040169|NCT03126110|69727392|FG004|Phase 2|Study terminated by the sponsor|0|||
38040170|NCT03126110|69727393|FG005|Phase 2|Study terminated by the sponsor|0|||
38040171|NCT03126110|69727394|FG006|Phase 2|Study terminated by the sponsor|0|||
38040172|NCT03126110|69727395|FG007|Phase 2|Study terminated by the sponsor|0|||
38040173|NCT03126110|69727396|FG008|Phase 2|Study terminated by the sponsor|0|||
38040174|NCT03126110|69727397|FG009|Phase 2|Study terminated by the sponsor|0|||
38040175|NCT03126110|69727398|FG010|Phase 2|Study terminated by the sponsor|0|||
38040176|NCT03126110|69727399|FG011|Phase 2|Study terminated by the sponsor|0|||
38040177|NCT03126110|69727400|FG012|Phase 2|Study terminated by the sponsor|0|||
38040178|NCT03126110|69727401|FG013|Phase 2|Study terminated by the sponsor|4|||
38040179|NCT03126110|69727402|FG014|Phase 2|Study terminated by the sponsor|0|||
38040180|NCT03126110|69727403|FG015|Phase 2|Study terminated by the sponsor|0|||
38040181|NCT03126110|69727404|FG016|Phase 2|Study terminated by the sponsor|0|||
37859998|NCT01163253|69543351|FG000|Overall Study|Study Terminated by Sponsor|978|||
37859999|NCT01163253|69543352|FG001|Overall Study|Study Terminated by Sponsor|349|||
38040182|NCT03126110|69727388|FG000|Phase 2|Withdrawal by Subject|0|||
38040183|NCT03126110|69727389|FG001|Phase 2|Withdrawal by Subject|0|||
38040184|NCT03126110|69727390|FG002|Phase 2|Withdrawal by Subject|0|||
38040185|NCT03126110|69727391|FG003|Phase 2|Withdrawal by Subject|0|||
38040186|NCT03126110|69727392|FG004|Phase 2|Withdrawal by Subject|0|||
38040187|NCT03126110|69727393|FG005|Phase 2|Withdrawal by Subject|0|||
38040188|NCT03126110|69727394|FG006|Phase 2|Withdrawal by Subject|0|||
38040189|NCT03126110|69727395|FG007|Phase 2|Withdrawal by Subject|0|||
38040190|NCT03126110|69727396|FG008|Phase 2|Withdrawal by Subject|0|||
38040191|NCT03126110|69727397|FG009|Phase 2|Withdrawal by Subject|0|||
38040192|NCT03126110|69727398|FG010|Phase 2|Withdrawal by Subject|0|||
38040193|NCT03126110|69727399|FG011|Phase 2|Withdrawal by Subject|1|||
38040194|NCT03126110|69727400|FG012|Phase 2|Withdrawal by Subject|3|||
38040195|NCT03126110|69727401|FG013|Phase 2|Withdrawal by Subject|3|||
38040196|NCT03126110|69727402|FG014|Phase 2|Withdrawal by Subject|2|||
37676231|NCT02631551|69150846|FG001|Overall Study|Non-compliance with study procedures|0|||
37676232|NCT02631551|69150847|FG002|Overall Study|Non-compliance with study procedures|1|||
37860000|NCT01163253|69543351|FG000|Overall Study|Protocol Violation|43|||
37860001|NCT01163253|69543352|FG001|Overall Study|Protocol Violation|12|||
37860002|NCT01163253|69543351|FG000|Overall Study|Withdrawal by Subject|199|||
37860003|NCT01163253|69543352|FG001|Overall Study|Withdrawal by Subject|50|||
37860004|NCT01163253|69543351|FG000|Overall Study|Medication Error|1|||
37860005|NCT01163253|69543352|FG001|Overall Study|Medication Error|0|||
37860006|NCT01163253|69543351|FG000|Overall Study|Lost to Follow-up|125|||
37860007|NCT01163253|69543352|FG001|Overall Study|Lost to Follow-up|23|||
37860008|NCT01163253|69543351|FG000|Overall Study|Insufficient Clinical Response|423|||
37860009|NCT01163253|69543352|FG001|Overall Study|Insufficient Clinical Response|29|||
37860010|NCT01163253|69543351|FG000|Overall Study|Adverse Event|300|||
37860011|NCT01163253|69543352|FG001|Overall Study|Adverse Event|78|||
37860012|NCT01163253|69543351|FG000|Overall Study|Death|17|||
37860013|NCT01163253|69543352|FG001|Overall Study|Death|5|||
37860014|NCT01163253|69543351|FG000|Overall Study|Ongoing|13|||
37860015|NCT01163253|69543352|FG001|Overall Study|Ongoing|4|||
37860016|NCT01163253|69543351|FG000|Overall Study|Other Unspecified|170|||
37860017|NCT01163253|69543352|FG001|Overall Study|Other Unspecified|34|||
37860018|NCT01162863|69543361|FG000|Overall Study|Lack of Efficacy|1|||
37860019|NCT01162863|69543362|FG001|Overall Study|Lack of Efficacy|0|||
37860020|NCT01162863|69543363|FG002|Overall Study|Lack of Efficacy|0|||
37860021|NCT01162863|69543361|FG000|Overall Study|Adverse Event|0|||
37945828|NCT00652626|69633305|FG003|Extension Phase|Withdrawal by Subject|0|||
37945829|NCT00652626|69633306|FG004|Extension Phase|Withdrawal by Subject|0|||
37945830|NCT00652626|69633307|FG005|Extension Phase|Withdrawal by Subject|2|||
37945831|NCT00652626|69633308|FG006|Extension Phase|Withdrawal by Subject|0|||
37945832|NCT00652626|69633302|FG000|Extension Phase|Adverse Event|0|||
37945833|NCT00652626|69633303|FG001|Extension Phase|Adverse Event|0|||
37945834|NCT00652626|69633304|FG002|Extension Phase|Adverse Event|0|||
37945835|NCT00652626|69633305|FG003|Extension Phase|Adverse Event|0|||
37945836|NCT00652626|69633306|FG004|Extension Phase|Adverse Event|0|||
37945837|NCT00652626|69633307|FG005|Extension Phase|Adverse Event|2|||
37945838|NCT00652626|69633308|FG006|Extension Phase|Adverse Event|1|||
37676233|NCT02631551|69150848|FG003|Overall Study|Non-compliance with study procedures|1|||
37676234|NCT02631551|69150845|FG000|Overall Study|Non-compliance with study drug|1|||
37676235|NCT02631551|69150846|FG001|Overall Study|Non-compliance with study drug|0|||
37676236|NCT02631551|69150847|FG002|Overall Study|Non-compliance with study drug|0|||
37945839|NCT00652626|69633302|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
37945840|NCT00652626|69633303|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
37945841|NCT00652626|69633304|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
37945842|NCT00652626|69633305|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
37945843|NCT00652626|69633306|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
37945844|NCT00652626|69633307|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
37945845|NCT00652626|69633308|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
37676237|NCT02631551|69150848|FG003|Overall Study|Non-compliance with study drug|0|||
37676238|NCT02631551|69150845|FG000|Overall Study|Other, specific reasons not collected|5|||
37676239|NCT02631551|69150846|FG001|Overall Study|Other, specific reasons not collected|7|||
37676240|NCT02631551|69150847|FG002|Overall Study|Other, specific reasons not collected|2|||
37676241|NCT02631551|69150848|FG003|Overall Study|Other, specific reasons not collected|2|||
37860022|NCT01162863|69543362|FG001|Overall Study|Adverse Event|1|||
37860023|NCT01162863|69543363|FG002|Overall Study|Adverse Event|0|||
37860024|NCT01162473|69543373|FG000|Overall Study|Adverse Event|2|||
37945846|NCT00652626|69633302|FG000|Extension Phase|Physician Decision|0|||
38040197|NCT03126110|69727403|FG015|Phase 2|Withdrawal by Subject|1|||
37860025|NCT01162473|69543374|FG001|Overall Study|Adverse Event|1|||
37860026|NCT01162473|69543373|FG000|Overall Study|Withdrawal by Subject|0|||
37945847|NCT00652626|69633303|FG001|Extension Phase|Physician Decision|0|||
37945848|NCT00652626|69633304|FG002|Extension Phase|Physician Decision|0|||
37945849|NCT00652626|69633305|FG003|Extension Phase|Physician Decision|0|||
37945850|NCT00652626|69633306|FG004|Extension Phase|Physician Decision|0|||
37945851|NCT00652626|69633307|FG005|Extension Phase|Physician Decision|1|||
37945852|NCT00652626|69633308|FG006|Extension Phase|Physician Decision|1|||
37945853|NCT00652626|69633302|FG000|Extension Phase|Death|0|||
37945854|NCT00652626|69633303|FG001|Extension Phase|Death|0|||
37945855|NCT00652626|69633304|FG002|Extension Phase|Death|0|||
37945856|NCT00652626|69633305|FG003|Extension Phase|Death|0|||
37945857|NCT00652626|69633306|FG004|Extension Phase|Death|0|||
37945858|NCT00652626|69633307|FG005|Extension Phase|Death|1|||
37945859|NCT00652626|69633308|FG006|Extension Phase|Death|1|||
37945860|NCT00560703|69633328|FG000|Overall Study|Adverse Event|0|||
37945861|NCT00560703|69633329|FG001|Overall Study|Adverse Event|2|||
37945862|NCT00560703|69633328|FG000|Overall Study|Protocol Violation|0|||
37945863|NCT00560703|69633329|FG001|Overall Study|Protocol Violation|2|||
37945864|NCT00560703|69633328|FG000|Overall Study|Withdrawal by Subject|0|||
37945865|NCT00560703|69633329|FG001|Overall Study|Withdrawal by Subject|1|||
37945866|NCT00560703|69633328|FG000|Overall Study|non-compliance|0|||
37945867|NCT00560703|69633329|FG001|Overall Study|non-compliance|1|||
37945868|NCT00308737|69633338|FG000|Overall Study|Adverse Event|104|||
37945869|NCT00308737|69633339|FG001|Overall Study|Adverse Event|9|||
37945870|NCT00308737|69633340|FG002|Overall Study|Adverse Event|0|||
37945871|NCT00308737|69633338|FG000|Overall Study|Death|4|||
37945872|NCT00308737|69633339|FG001|Overall Study|Death|3|||
37945873|NCT00308737|69633340|FG002|Overall Study|Death|0|||
37945874|NCT00308737|69633338|FG000|Overall Study|Lost to Follow-up|56|||
37945875|NCT00308737|69633339|FG001|Overall Study|Lost to Follow-up|80|||
37945876|NCT00308737|69633340|FG002|Overall Study|Lost to Follow-up|5|||
37945877|NCT00308737|69633338|FG000|Overall Study|Physician Decision|15|||
37945878|NCT00308737|69633339|FG001|Overall Study|Physician Decision|2|||
37945879|NCT00308737|69633340|FG002|Overall Study|Physician Decision|1|||
37945880|NCT00308737|69633338|FG000|Overall Study|Protocol Violation|34|||
37945881|NCT00308737|69633339|FG001|Overall Study|Protocol Violation|9|||
37945882|NCT00308737|69633340|FG002|Overall Study|Protocol Violation|5|||
37945883|NCT00308737|69633338|FG000|Overall Study|Withdrawal by Subject|218|||
37945884|NCT00308737|69633339|FG001|Overall Study|Withdrawal by Subject|166|||
37945885|NCT00308737|69633340|FG002|Overall Study|Withdrawal by Subject|18|||
37945886|NCT00308737|69633338|FG000|Overall Study|Various|32|||
37945887|NCT00308737|69633339|FG001|Overall Study|Various|20|||
37945888|NCT00308737|69633340|FG002|Overall Study|Various|8|||
37945889|NCT00655746|69633348|FG000|Overall Study|Withdrawal by Subject|1|||
37945890|NCT00338455|69633358|FG000|Overall Study|Death|2|||
37945891|NCT00338455|69633359|FG001|Overall Study|Death|1|||
37945892|NCT00338455|69633358|FG000|Overall Study|Physician Decision|1|||
37945893|NCT00338455|69633359|FG001|Overall Study|Physician Decision|0|||
37945894|NCT00651924|69633367|FG000|Overall Study|Withdrawal by PI|0|||
37945895|NCT00651924|69633368|FG001|Overall Study|Withdrawal by PI|2|||
37945896|NCT00651924|69633367|FG000|Overall Study|Withdrawal by Subject|0|||
37945897|NCT00651924|69633368|FG001|Overall Study|Withdrawal by Subject|5|||
37945898|NCT00678392|69633376|FG000|Overall Study|Adverse Event|0|||
37945899|NCT00678392|69633377|FG001|Overall Study|Adverse Event|6|||
37945900|NCT00678392|69633376|FG000|Overall Study|Death|280|||
37945901|NCT00678392|69633377|FG001|Overall Study|Death|269|||
37945902|NCT00678392|69633376|FG000|Overall Study|Lost to Follow-up|15|||
37945903|NCT00678392|69633377|FG001|Overall Study|Lost to Follow-up|13|||
37945904|NCT00678392|69633376|FG000|Overall Study|Objective Progression or Relapse|3|||
37945905|NCT00678392|69633377|FG001|Overall Study|Objective Progression or Relapse|8|||
37945906|NCT00678392|69633376|FG000|Overall Study|Sponsor's Decision|1|||
37945907|NCT00678392|69633377|FG001|Overall Study|Sponsor's Decision|2|||
37945908|NCT00678392|69633376|FG000|Overall Study|Withdrawal by Subject|4|||
37945909|NCT00678392|69633377|FG001|Overall Study|Withdrawal by Subject|4|||
37945910|NCT00678392|69633376|FG000|Overall Study|Randomized But Not Treated|2|||
37945911|NCT00678392|69633377|FG001|Overall Study|Randomized But Not Treated|7|||
37945912|NCT00678392|69633376|FG000|Overall Study|Other|56|||
37945913|NCT00678392|69633377|FG001|Overall Study|Other|53|||
37945914|NCT00308581|69633383|FG000|Induction Phase|Adverse Event|0|||
37945915|NCT00308581|69633384|FG001|Induction Phase|Adverse Event|0|||
37945916|NCT00308581|69633385|FG002|Induction Phase|Adverse Event|37|||
37945917|NCT00308581|69633383|FG000|Induction Phase|Lack of Efficacy|0|||
37945918|NCT00308581|69633384|FG001|Induction Phase|Lack of Efficacy|0|||
37945919|NCT00308581|69633385|FG002|Induction Phase|Lack of Efficacy|121|||
37945920|NCT00308581|69633383|FG000|Induction Phase|Withdrawal by Subject|0|||
37945921|NCT00308581|69633384|FG001|Induction Phase|Withdrawal by Subject|0|||
37945922|NCT00308581|69633385|FG002|Induction Phase|Withdrawal by Subject|5|||
37945923|NCT00308581|69633383|FG000|Induction Phase|Unknown reason|0|||
37945924|NCT00308581|69633384|FG001|Induction Phase|Unknown reason|0|||
37945925|NCT00308581|69633385|FG002|Induction Phase|Unknown reason|3|||
37945926|NCT00308581|69633383|FG000|Randomized Maintenance Phase|Adverse Event|10|||
37945927|NCT00308581|69633384|FG001|Randomized Maintenance Phase|Adverse Event|17|||
37945928|NCT00308581|69633385|FG002|Randomized Maintenance Phase|Adverse Event|0|||
37945929|NCT00308581|69633383|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
37945930|NCT00308581|69633384|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
37945931|NCT00308581|69633385|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
37945932|NCT00308581|69633383|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
37945933|NCT00308581|69633384|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
37945934|NCT00308581|69633385|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
37945935|NCT00308581|69633383|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
37945936|NCT00308581|69633384|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
37945937|NCT00308581|69633385|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
37945938|NCT00308581|69633383|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
37945939|NCT00308581|69633384|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
37945940|NCT00308581|69633385|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
37945941|NCT00308581|69633383|FG000|Randomized Maintenance Phase|Unknown reason|3|||
37945942|NCT00308581|69633384|FG001|Randomized Maintenance Phase|Unknown reason|0|||
37945943|NCT00308581|69633385|FG002|Randomized Maintenance Phase|Unknown reason|0|||
37945944|NCT00678080|69633395|FG000|Overall Study|Physician Decision|2|||
37945945|NCT00678080|69633396|FG001|Overall Study|Physician Decision|0|||
37945946|NCT00678080|69633395|FG000|Overall Study|Lost to Follow-up|1|||
37945947|NCT00678080|69633396|FG001|Overall Study|Lost to Follow-up|0|||
37945948|NCT00678080|69633395|FG000|Overall Study|Withdrawal by Subject|0|||
37945949|NCT00678080|69633396|FG001|Overall Study|Withdrawal by Subject|1|||
37945950|NCT00658320|69633404|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
37945951|NCT00658320|69633405|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
37945952|NCT00658320|69633404|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
37945953|NCT00658320|69633405|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
37945954|NCT00658320|69633404|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
37945955|NCT00658320|69633405|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
37945956|NCT00658320|69633404|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
37945957|NCT00658320|69633405|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
37945958|NCT00322153|69633415|FG000|Overall Study|Adverse Event|21|||
37945959|NCT00322153|69633416|FG001|Overall Study|Adverse Event|34|||
37945960|NCT00322153|69633415|FG000|Overall Study|Protocol Violation|6|||
37945961|NCT00322153|69633416|FG001|Overall Study|Protocol Violation|14|||
37945962|NCT00322153|69633415|FG000|Overall Study|Withdrawal by Subject|18|||
37945963|NCT00322153|69633416|FG001|Overall Study|Withdrawal by Subject|10|||
37945964|NCT00322153|69633415|FG000|Overall Study|Lack of Efficacy|8|||
37945965|NCT00322153|69633416|FG001|Overall Study|Lack of Efficacy|3|||
37945966|NCT00322153|69633415|FG000|Overall Study|Lost to Follow-up|5|||
37945967|NCT00322153|69633416|FG001|Overall Study|Lost to Follow-up|4|||
37945968|NCT00322153|69633415|FG000|Overall Study|Withdrawn for other reasons|5|||
37945969|NCT00322153|69633416|FG001|Overall Study|Withdrawn for other reasons|4|||
37945970|NCT00657618|69633422|FG000|Overall Study|Adverse Event|32|||
37945971|NCT00657618|69633422|FG000|Overall Study|Withdrawal by Subject|8|||
37945972|NCT00657618|69633422|FG000|Overall Study|negative for leishmaniasis|2|||
37945973|NCT00657618|69633422|FG000|Overall Study|didn't start due to schedule conflicts|1|||
37945974|NCT00657540|69633428|FG000|Overall Study|Lost to Follow-up|1|||
37945975|NCT00657540|69633429|FG001|Overall Study|Lost to Follow-up|4|||
37945976|NCT00672620|69633439|FG000|Overall Study|Adverse Event|7|||
37945977|NCT00672620|69633440|FG001|Overall Study|Adverse Event|7|||
37945978|NCT00672620|69633441|FG002|Overall Study|Adverse Event|12|||
37945979|NCT00672620|69633442|FG003|Overall Study|Adverse Event|17|||
37945980|NCT00672620|69633439|FG000|Overall Study|Lack of Efficacy|1|||
37945981|NCT00672620|69633440|FG001|Overall Study|Lack of Efficacy|2|||
37945982|NCT00672620|69633441|FG002|Overall Study|Lack of Efficacy|2|||
37945983|NCT00672620|69633442|FG003|Overall Study|Lack of Efficacy|0|||
37945984|NCT00672620|69633439|FG000|Overall Study|Noncompliance with Study Drug|3|||
37945985|NCT00672620|69633440|FG001|Overall Study|Noncompliance with Study Drug|4|||
37945986|NCT00672620|69633441|FG002|Overall Study|Noncompliance with Study Drug|0|||
37945987|NCT00672620|69633442|FG003|Overall Study|Noncompliance with Study Drug|2|||
37945988|NCT00672620|69633439|FG000|Overall Study|Protocol Deviations|5|||
37945989|NCT00672620|69633440|FG001|Overall Study|Protocol Deviations|7|||
37945990|NCT00672620|69633441|FG002|Overall Study|Protocol Deviations|2|||
37945991|NCT00672620|69633442|FG003|Overall Study|Protocol Deviations|5|||
37945992|NCT00672620|69633439|FG000|Overall Study|Withdrawal of Consent|6|||
37945993|NCT00672620|69633440|FG001|Overall Study|Withdrawal of Consent|12|||
37945994|NCT00672620|69633441|FG002|Overall Study|Withdrawal of Consent|5|||
37945995|NCT00672620|69633442|FG003|Overall Study|Withdrawal of Consent|6|||
37945996|NCT00672620|69633439|FG000|Overall Study|Lost to Follow-up|8|||
37945997|NCT00672620|69633440|FG001|Overall Study|Lost to Follow-up|19|||
37945998|NCT00672620|69633441|FG002|Overall Study|Lost to Follow-up|8|||
37945999|NCT00672620|69633442|FG003|Overall Study|Lost to Follow-up|11|||
37946000|NCT00672620|69633439|FG000|Overall Study|Reason not Specified|3|||
37946001|NCT00672620|69633440|FG001|Overall Study|Reason not Specified|3|||
37946002|NCT00672620|69633441|FG002|Overall Study|Reason not Specified|2|||
37946003|NCT00672620|69633442|FG003|Overall Study|Reason not Specified|1|||
37946004|NCT00673790|69633455|FG000|Overall Study|Adverse Event|23|||
37946005|NCT00673790|69633456|FG001|Overall Study|Adverse Event|14|||
37946006|NCT00673790|69633457|FG002|Overall Study|Adverse Event|2|||
37946007|NCT00673790|69633455|FG000|Overall Study|Lack of Efficacy|2|||
37946008|NCT00673790|69633456|FG001|Overall Study|Lack of Efficacy|2|||
37946009|NCT00673790|69633457|FG002|Overall Study|Lack of Efficacy|2|||
37946010|NCT00673790|69633455|FG000|Overall Study|Protocol Violation|6|||
37946011|NCT00673790|69633456|FG001|Overall Study|Protocol Violation|9|||
37946012|NCT00673790|69633457|FG002|Overall Study|Protocol Violation|1|||
37946013|NCT00673790|69633455|FG000|Overall Study|Withdrawal by Subject|7|||
37946014|NCT00673790|69633456|FG001|Overall Study|Withdrawal by Subject|4|||
37946015|NCT00673790|69633457|FG002|Overall Study|Withdrawal by Subject|1|||
37946016|NCT00673790|69633455|FG000|Overall Study|Lost to Follow-up|6|||
37946017|NCT00673790|69633456|FG001|Overall Study|Lost to Follow-up|6|||
37946018|NCT00673790|69633457|FG002|Overall Study|Lost to Follow-up|5|||
37946019|NCT00673790|69633455|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
37946020|NCT00673790|69633456|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
37946021|NCT00673790|69633457|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
37946022|NCT00673790|69633455|FG000|Overall Study|Poor compliance|1|||
37946023|NCT00673790|69633456|FG001|Overall Study|Poor compliance|0|||
37946024|NCT00673790|69633457|FG002|Overall Study|Poor compliance|0|||
37946025|NCT00673790|69633455|FG000|Overall Study|Participated in two Nebivolol studies|0|||
37946026|NCT00673790|69633456|FG001|Overall Study|Participated in two Nebivolol studies|0|||
37946027|NCT00673790|69633457|FG002|Overall Study|Participated in two Nebivolol studies|1|||
37946028|NCT00673790|69633455|FG000|Overall Study|Unconfirmed pregnancy|0|||
37946029|NCT00673790|69633456|FG001|Overall Study|Unconfirmed pregnancy|1|||
37946030|NCT00673790|69633457|FG002|Overall Study|Unconfirmed pregnancy|0|||
37946031|NCT00673790|69633455|FG000|Overall Study|Randomization criteria not met|0|||
37946032|NCT00673790|69633456|FG001|Overall Study|Randomization criteria not met|1|||
37946033|NCT00673790|69633457|FG002|Overall Study|Randomization criteria not met|0|||
37946034|NCT00657150|69633468|FG000|Overall Study|Adverse Event|19|||
37946035|NCT00657150|69633469|FG001|Overall Study|Adverse Event|10|||
37946036|NCT00657150|69633468|FG000|Overall Study|Non-compliant with protocol|5|||
37946037|NCT00657150|69633469|FG001|Overall Study|Non-compliant with protocol|9|||
37946038|NCT00657150|69633468|FG000|Overall Study|Lost to Follow-up|2|||
37946039|NCT00657150|69633469|FG001|Overall Study|Lost to Follow-up|0|||
37946040|NCT00657150|69633468|FG000|Overall Study|Withdrawal by Subject|51|||
37946041|NCT00657150|69633469|FG001|Overall Study|Withdrawal by Subject|36|||
37946042|NCT00657150|69633468|FG000|Overall Study|Other|38|||
37946043|NCT00657150|69633469|FG001|Overall Study|Other|38|||
37946044|NCT00657150|69633468|FG000|Treatment|Adverse Event|60|||
37946045|NCT00657150|69633469|FG001|Treatment|Adverse Event|53|||
37946046|NCT00657150|69633468|FG000|Treatment|Non-compliant with protocol|10|||
37946047|NCT00657150|69633469|FG001|Treatment|Non-compliant with protocol|9|||
37946048|NCT00657150|69633468|FG000|Treatment|Lost to Follow-up|1|||
37946049|NCT00657150|69633469|FG001|Treatment|Lost to Follow-up|0|||
37946050|NCT00657150|69633468|FG000|Treatment|Withdrawal by Subject|23|||
37946051|NCT00657150|69633469|FG001|Treatment|Withdrawal by Subject|20|||
37946052|NCT00657150|69633468|FG000|Treatment|Other|13|||
37946053|NCT00657150|69633469|FG001|Treatment|Other|15|||
37946054|NCT00670748|69633479|FG000|Overall Study|Death during treatment|1|||
37946055|NCT00670748|69633480|FG001|Overall Study|Death during treatment|1|||
37946056|NCT00670748|69633481|FG002|Overall Study|Death during treatment|1|||
37946057|NCT00670748|69633482|FG003|Overall Study|Death during treatment|0|||
37946058|NCT00670748|69633479|FG000|Overall Study|Not off study|2|||
37946059|NCT00670748|69633480|FG001|Overall Study|Not off study|1|||
37946060|NCT00670748|69633481|FG002|Overall Study|Not off study|1|||
37946061|NCT00670748|69633482|FG003|Overall Study|Not off study|1|||
37946062|NCT00646776|69633494|FG000|Overall Study|Adverse Event|1|||
37946063|NCT00646776|69633495|FG001|Overall Study|Adverse Event|9|||
37946064|NCT00646776|69633494|FG000|Overall Study|Investigator discretion|0|||
37946065|NCT00646776|69633495|FG001|Overall Study|Investigator discretion|4|||
37946066|NCT00655668|69633504|FG000|Overall Study|Adverse Event|6|||
37946067|NCT00655668|69633504|FG000|Overall Study|Death|5|||
37946068|NCT00655668|69633504|FG000|Overall Study|Disease Progression|27|||
37946069|NCT00655668|69633504|FG000|Overall Study|Study Terminated|9|||
37946070|NCT00655668|69633504|FG000|Overall Study|Other|1|||
37946071|NCT00655668|69633504|FG000|Overall Study|New Lymphoma Treatment Started|4|||
37946072|NCT00655668|69633504|FG000|Overall Study|Withdrawal by Subject|2|||
37946073|NCT00569166|69633511|FG000|Overall Study|Withdrawal by Subject|7|||
37946074|NCT00569166|69633512|FG001|Overall Study|Withdrawal by Subject|5|||
37946075|NCT00569166|69633513|FG002|Overall Study|Withdrawal by Subject|3|||
37946076|NCT00569166|69633511|FG000|Overall Study|Lost to Follow-up|2|||
37946077|NCT00569166|69633512|FG001|Overall Study|Lost to Follow-up|1|||
37946078|NCT00569166|69633513|FG002|Overall Study|Lost to Follow-up|1|||
37946079|NCT00655356|69633523|FG000|Overall Study|Withdrawal by Subject|3|||
37946080|NCT00655356|69633524|FG001|Overall Study|Withdrawal by Subject|4|||
37946081|NCT00655356|69633523|FG000|Overall Study|Sponsor Request|10|||
37946082|NCT00655356|69633524|FG001|Overall Study|Sponsor Request|4|||
37946083|NCT00655356|69633523|FG000|Overall Study|Adverse Event|1|||
37946084|NCT00655356|69633524|FG001|Overall Study|Adverse Event|1|||
37946085|NCT00655356|69633523|FG000|Overall Study|Protocol Violation|2|||
37946086|NCT00655356|69633524|FG001|Overall Study|Protocol Violation|1|||
37946087|NCT00655356|69633523|FG000|Overall Study|Other Reason|1|||
37946088|NCT00655356|69633524|FG001|Overall Study|Other Reason|0|||
37946089|NCT00571064|69633530|FG000|Overall Study|Adverse Event|13|||
37946090|NCT00571064|69633530|FG000|Overall Study|Protocol Violation|4|||
37946091|NCT00571064|69633530|FG000|Overall Study|Withdrawal by Subject|2|||
37946092|NCT00571064|69633530|FG000|Overall Study|Other|2|||
37946093|NCT03895372|69633543|FG000|Investigational Treatment Period|Adverse Event|1|||
37946094|NCT03895372|69633544|FG001|Investigational Treatment Period|Adverse Event|0|||
37946095|NCT03895372|69633545|FG002|Investigational Treatment Period|Adverse Event|0|||
37946096|NCT03895372|69633546|FG003|Investigational Treatment Period|Adverse Event|0|||
37946097|NCT03895372|69633547|FG004|Investigational Treatment Period|Adverse Event|0|||
37946098|NCT03895372|69633548|FG005|Investigational Treatment Period|Adverse Event|0|||
37946099|NCT03895372|69633549|FG006|Investigational Treatment Period|Adverse Event|4|||
37946100|NCT03895372|69633550|FG007|Investigational Treatment Period|Adverse Event|3|||
37946101|NCT03895372|69633543|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
37946102|NCT03895372|69633544|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
37946103|NCT03895372|69633545|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
37946104|NCT03895372|69633546|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
37946105|NCT03895372|69633547|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
37946106|NCT03895372|69633548|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
37946107|NCT03895372|69633549|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
37946108|NCT03895372|69633550|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
37946109|NCT03895372|69633543|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
37946110|NCT03895372|69633544|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
37946111|NCT03895372|69633545|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
37946112|NCT03895372|69633546|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
37946113|NCT03895372|69633547|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
37946114|NCT03895372|69633548|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
37946115|NCT03895372|69633549|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
37946116|NCT03895372|69633550|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
37946117|NCT03895372|69633543|FG000|Investigational Treatment Period|Other|0|||
37946118|NCT03895372|69633544|FG001|Investigational Treatment Period|Other|0|||
37946119|NCT03895372|69633545|FG002|Investigational Treatment Period|Other|0|||
37946120|NCT03895372|69633546|FG003|Investigational Treatment Period|Other|0|||
37946121|NCT03895372|69633547|FG004|Investigational Treatment Period|Other|0|||
38040198|NCT03126110|69727404|FG016|Phase 2|Withdrawal by Subject|0|||
38040199|NCT03126110|69727388|FG000|Phase 2|Lost to Follow-up|0|||
38040200|NCT03126110|69727389|FG001|Phase 2|Lost to Follow-up|0|||
38040201|NCT03126110|69727390|FG002|Phase 2|Lost to Follow-up|0|||
38040202|NCT03126110|69727391|FG003|Phase 2|Lost to Follow-up|0|||
38040203|NCT03126110|69727392|FG004|Phase 2|Lost to Follow-up|0|||
38040204|NCT03126110|69727393|FG005|Phase 2|Lost to Follow-up|0|||
38040205|NCT03126110|69727394|FG006|Phase 2|Lost to Follow-up|0|||
37676242|NCT01680991|69150861|FG000|Overall Study|Adverse Event|1|||
37946122|NCT03895372|69633548|FG005|Investigational Treatment Period|Other|1|||
37946123|NCT03895372|69633549|FG006|Investigational Treatment Period|Other|0|||
37946124|NCT03895372|69633550|FG007|Investigational Treatment Period|Other|2|||
37946125|NCT03895372|69633543|FG000|Investigational Treatment Period|Protocol Violation|0|||
37946126|NCT03895372|69633544|FG001|Investigational Treatment Period|Protocol Violation|0|||
37946127|NCT03895372|69633545|FG002|Investigational Treatment Period|Protocol Violation|0|||
37946128|NCT03895372|69633546|FG003|Investigational Treatment Period|Protocol Violation|1|||
37946129|NCT03895372|69633547|FG004|Investigational Treatment Period|Protocol Violation|0|||
37946130|NCT03895372|69633548|FG005|Investigational Treatment Period|Protocol Violation|0|||
37946131|NCT03895372|69633549|FG006|Investigational Treatment Period|Protocol Violation|0|||
37946132|NCT03895372|69633550|FG007|Investigational Treatment Period|Protocol Violation|0|||
37946133|NCT03895372|69633543|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
37946134|NCT03895372|69633544|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
37946135|NCT03895372|69633545|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
37946136|NCT03895372|69633546|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
37946137|NCT03895372|69633547|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
37946138|NCT03895372|69633548|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
37946139|NCT03895372|69633549|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
37946140|NCT03895372|69633550|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
37946141|NCT03895372|69633543|FG000|Extension Treatment Period|Adverse Event|0|||
37946142|NCT03895372|69633544|FG001|Extension Treatment Period|Adverse Event|1|||
38040206|NCT03126110|69727395|FG007|Phase 2|Lost to Follow-up|0|||
38040207|NCT03126110|69727396|FG008|Phase 2|Lost to Follow-up|0|||
38040208|NCT03126110|69727397|FG009|Phase 2|Lost to Follow-up|0|||
37946143|NCT03895372|69633545|FG002|Extension Treatment Period|Adverse Event|0|||
37946144|NCT03895372|69633546|FG003|Extension Treatment Period|Adverse Event|1|||
37946145|NCT03895372|69633547|FG004|Extension Treatment Period|Adverse Event|0|||
37946146|NCT03895372|69633548|FG005|Extension Treatment Period|Adverse Event|0|||
37946147|NCT03895372|69633549|FG006|Extension Treatment Period|Adverse Event|3|||
37946148|NCT03895372|69633550|FG007|Extension Treatment Period|Adverse Event|3|||
37946149|NCT03895372|69633543|FG000|Extension Treatment Period|Other|1|||
37946150|NCT03895372|69633544|FG001|Extension Treatment Period|Other|3|||
37946151|NCT03895372|69633545|FG002|Extension Treatment Period|Other|0|||
37946152|NCT03895372|69633546|FG003|Extension Treatment Period|Other|0|||
37946153|NCT03895372|69633547|FG004|Extension Treatment Period|Other|1|||
37946154|NCT03895372|69633548|FG005|Extension Treatment Period|Other|0|||
37946155|NCT03895372|69633549|FG006|Extension Treatment Period|Other|0|||
37946156|NCT03895372|69633550|FG007|Extension Treatment Period|Other|2|||
37946157|NCT03895372|69633543|FG000|Extension Treatment Period|Pregnancy|0|||
37946158|NCT03895372|69633544|FG001|Extension Treatment Period|Pregnancy|0|||
37946159|NCT03895372|69633545|FG002|Extension Treatment Period|Pregnancy|0|||
37946160|NCT03895372|69633546|FG003|Extension Treatment Period|Pregnancy|0|||
37946161|NCT03895372|69633547|FG004|Extension Treatment Period|Pregnancy|1|||
37946162|NCT03895372|69633548|FG005|Extension Treatment Period|Pregnancy|0|||
37946163|NCT03895372|69633549|FG006|Extension Treatment Period|Pregnancy|0|||
37946164|NCT03895372|69633550|FG007|Extension Treatment Period|Pregnancy|0|||
37946165|NCT03895372|69633543|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
37946166|NCT03895372|69633544|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
37946167|NCT03895372|69633545|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
37946168|NCT03895372|69633546|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
37946169|NCT03895372|69633547|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
37946170|NCT03895372|69633548|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
37946171|NCT03895372|69633549|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
37946172|NCT03895372|69633550|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
37946173|NCT00669110|69633575|FG000|Overall Study|Adverse Event|4|||
37946174|NCT00669110|69633576|FG001|Overall Study|Adverse Event|3|||
37946175|NCT00669110|69633575|FG000|Overall Study|Caregiver request|3|||
37946176|NCT00669110|69633576|FG001|Overall Study|Caregiver request|2|||
37946177|NCT00669110|69633575|FG000|Overall Study|Physician Decision|0|||
37946178|NCT00669110|69633576|FG001|Overall Study|Physician Decision|1|||
37946179|NCT00669110|69633575|FG000|Overall Study|Lost to Follow-up|1|||
37946180|NCT00669110|69633576|FG001|Overall Study|Lost to Follow-up|0|||
37946181|NCT00669110|69633575|FG000|Overall Study|Protocol Violation|0|||
37946182|NCT00669110|69633576|FG001|Overall Study|Protocol Violation|5|||
37946183|NCT00669110|69633575|FG000|Overall Study|Withdrawal by Subject|0|||
37946184|NCT00669110|69633576|FG001|Overall Study|Withdrawal by Subject|2|||
37946185|NCT00654732|69633584|FG000|Overall Study|Adverse Event|4|||
37946186|NCT00654732|69633585|FG001|Overall Study|Adverse Event|6|||
37946187|NCT00649428|69633593|FG000|Overall Study|Adverse Event|2|||
37946188|NCT00649428|69633594|FG001|Overall Study|Adverse Event|2|||
37946189|NCT00649428|69633593|FG000|Overall Study|Withdrawal by Subject|6|||
37946190|NCT00649428|69633594|FG001|Overall Study|Withdrawal by Subject|6|||
37946191|NCT00649428|69633593|FG000|Overall Study|Lost to Follow-up|1|||
37946192|NCT00649428|69633594|FG001|Overall Study|Lost to Follow-up|3|||
37946193|NCT00649428|69633593|FG000|Overall Study|Insufficient manufacturing yield|5|||
37946194|NCT00649428|69633594|FG001|Overall Study|Insufficient manufacturing yield|1|||
37946195|NCT00649428|69633593|FG000|Overall Study|Protocol Violation|6|||
37946196|NCT00649428|69633594|FG001|Overall Study|Protocol Violation|2|||
37946197|NCT00649428|69633593|FG000|Overall Study|Physician Decision|0|||
37946198|NCT00649428|69633594|FG001|Overall Study|Physician Decision|1|||
37946199|NCT00669032|69633603|FG000|Overall Study|Lost to Follow-up|6|||
37946200|NCT00669032|69633604|FG001|Overall Study|Lost to Follow-up|5|||
37946201|NCT00669032|69633603|FG000|Overall Study|Lack of Efficacy|8|||
37946202|NCT00669032|69633604|FG001|Overall Study|Lack of Efficacy|19|||
37946203|NCT00669032|69633603|FG000|Overall Study|Withdrawal by Subject|12|||
37946204|NCT00669032|69633604|FG001|Overall Study|Withdrawal by Subject|13|||
37946205|NCT00669032|69633603|FG000|Overall Study|Adverse Event|12|||
37946206|NCT00669032|69633604|FG001|Overall Study|Adverse Event|16|||
37946207|NCT00669032|69633603|FG000|Overall Study|Physician Decision|1|||
37946208|NCT00669032|69633604|FG001|Overall Study|Physician Decision|1|||
37946209|NCT00669032|69633603|FG000|Overall Study|No fulfilment of the selection criteria|5|||
38040209|NCT03126110|69727398|FG010|Phase 2|Lost to Follow-up|0|||
38040210|NCT03126110|69727399|FG011|Phase 2|Lost to Follow-up|1|||
38040211|NCT03126110|69727400|FG012|Phase 2|Lost to Follow-up|1|||
37946210|NCT00669032|69633604|FG001|Overall Study|No fulfilment of the selection criteria|5|||
37946211|NCT00654498|69633612|FG000|Overall Study|Not Treated|1|||
37946212|NCT00654498|69633613|FG001|Overall Study|Not Treated|0|||
37946213|NCT00654498|69633612|FG000|Overall Study|Adverse Event|6|||
37946214|NCT00654498|69633613|FG001|Overall Study|Adverse Event|1|||
37946215|NCT00654498|69633612|FG000|Overall Study|Protocol Violation|1|||
37946216|NCT00654498|69633613|FG001|Overall Study|Protocol Violation|1|||
37946217|NCT00654498|69633612|FG000|Overall Study|Lost to Follow-up|1|||
37946218|NCT00654498|69633613|FG001|Overall Study|Lost to Follow-up|5|||
37946219|NCT00654498|69633612|FG000|Overall Study|Withdrawal by Subject|1|||
37946220|NCT00654498|69633613|FG001|Overall Study|Withdrawal by Subject|0|||
37946221|NCT00654498|69633612|FG000|Overall Study|Other reason not defined above|4|||
37946222|NCT00654498|69633613|FG001|Overall Study|Other reason not defined above|5|||
37946223|NCT00670046|69633621|FG000|Overall Study|Lost to Follow-up|1|||
37946224|NCT00670046|69633622|FG001|Overall Study|Lost to Follow-up|1|||
37946225|NCT00670046|69633621|FG000|Overall Study|Withdrawal by Subject|0|||
37946226|NCT00670046|69633622|FG001|Overall Study|Withdrawal by Subject|1|||
37946227|NCT00560391|69633633|FG000|Overall Study|Still on treatment|0|||
37946228|NCT00560391|69633634|FG001|Overall Study|Still on treatment|0|||
37946229|NCT00560391|69633635|FG002|Overall Study|Still on treatment|0|||
37946230|NCT00560391|69633636|FG003|Overall Study|Still on treatment|1|||
37946231|NCT00560391|69633637|FG004|Overall Study|Still on treatment|2|||
37946232|NCT00537238|69633652|FG000|Overall Study|Death|1|||
37946233|NCT00537238|69633653|FG001|Overall Study|Death|2|||
37946234|NCT00537238|69633652|FG000|Overall Study|Adverse Event|31|||
37946235|NCT00537238|69633653|FG001|Overall Study|Adverse Event|22|||
37946236|NCT00537238|69633652|FG000|Overall Study|Lack of Efficacy|20|||
37946237|NCT00537238|69633653|FG001|Overall Study|Lack of Efficacy|21|||
37946238|NCT00537238|69633652|FG000|Overall Study|Lost to Follow-up|12|||
37946239|NCT00537238|69633653|FG001|Overall Study|Lost to Follow-up|8|||
37946240|NCT00537238|69633652|FG000|Overall Study|Withdrawal by Subject|51|||
37946241|NCT00537238|69633653|FG001|Overall Study|Withdrawal by Subject|47|||
37946242|NCT00537238|69633652|FG000|Overall Study|Protocol Violation|15|||
37946243|NCT00537238|69633653|FG001|Overall Study|Protocol Violation|19|||
37946244|NCT00537238|69633652|FG000|Overall Study|Does not meet entrance criteria|0|||
37946245|NCT00537238|69633653|FG001|Overall Study|Does not meet entrance criteria|2|||
37946246|NCT00537238|69633652|FG000|Overall Study|Other|44|||
37946247|NCT00537238|69633653|FG001|Overall Study|Other|52|||
37946248|NCT03966885|69633661|FG000|Overall Study|Death|1|||
37946249|NCT03966885|69633662|FG001|Overall Study|Death|0|||
37946250|NCT03966885|69633661|FG000|Overall Study|Lost to Follow-up|1|||
37946251|NCT03966885|69633662|FG001|Overall Study|Lost to Follow-up|2|||
37946252|NCT03966885|69633661|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
37946253|NCT03966885|69633662|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
37946254|NCT03966885|69633661|FG000|Overall Study|Moved from study area.|0|||
37946255|NCT03966885|69633662|FG001|Overall Study|Moved from study area.|2|||
37946256|NCT03965403|69633669|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
37946257|NCT00552669|69633675|FG000|Overall Study|Death|3|||
37946258|NCT00552669|69633676|FG001|Overall Study|Death|7|||
37946259|NCT00552513|69633684|FG000|Overall Study|Lost to Follow-up|5|||
37946260|NCT00552513|69633685|FG001|Overall Study|Lost to Follow-up|1|||
37946261|NCT00560313|69633693|FG000|Overall Study|Adverse Events or Death|2|||
37946262|NCT00560313|69633693|FG000|Overall Study|Withdrawal by Subject|2|||
37946263|NCT00560313|69633693|FG000|Overall Study|Lost to Follow-up|1|||
37946264|NCT00560313|69633693|FG000|Overall Study|Protocol Violation|1|||
37946265|NCT00667862|69633712|FG000|Overall Study|Adverse Event|9|||
37946266|NCT00667862|69633712|FG000|Overall Study|Death|1|||
37946267|NCT00667862|69633712|FG000|Overall Study|Disease Progression|22|||
37946268|NCT00667862|69633712|FG000|Overall Study|Withdrawal by Subject|3|||
37946269|NCT00535132|69633718|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
37946270|NCT00535132|69633719|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
37946271|NCT00535132|69633718|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
37946272|NCT00535132|69633719|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
37946273|NCT00570908|69633727|FG000|Overall Study|Adverse Event|5|||
37946274|NCT00570908|69633727|FG000|Overall Study|Withdrawal by Subject|2|||
37946275|NCT00321919|69633733|FG000|Overall Study|Adverse Event|17|||
37946276|NCT00321919|69633734|FG001|Overall Study|Adverse Event|10|||
37946277|NCT00321919|69633733|FG000|Overall Study|Death|21|||
37946278|NCT00321919|69633734|FG001|Overall Study|Death|17|||
37946279|NCT00321919|69633733|FG000|Overall Study|Insufficient Therapeutic Response|1|||
37946280|NCT00321919|69633734|FG001|Overall Study|Insufficient Therapeutic Response|0|||
37946281|NCT00321919|69633733|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
37946282|NCT00321919|69633734|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
37946283|NCT00321919|69633733|FG000|Overall Study|Refused Treatment|23|||
37946284|NCT00321919|69633734|FG001|Overall Study|Refused Treatment|14|||
37946285|NCT00321919|69633733|FG000|Overall Study|Other Protocol Violation|2|||
37946286|NCT00321919|69633734|FG001|Overall Study|Other Protocol Violation|3|||
37946287|NCT00321919|69633733|FG000|Overall Study|Failure to Return|3|||
37946288|NCT00321919|69633734|FG001|Overall Study|Failure to Return|1|||
37946289|NCT00321919|69633733|FG000|Overall Study|Other withdrawal reason|7|||
37946290|NCT00321919|69633734|FG001|Overall Study|Other withdrawal reason|6|||
37676243|NCT01680991|69150862|FG001|Overall Study|Adverse Event|0|||
37946291|NCT00781391|69633744|FG000|Overall Study|never received study drug|24|||
37946292|NCT00781391|69633745|FG001|Overall Study|never received study drug|23|||
37946293|NCT00781391|69633746|FG002|Overall Study|never received study drug|32|||
37946294|NCT00781391|69633744|FG000|Overall Study|Protocol Violation|19|||
37946295|NCT00781391|69633745|FG001|Overall Study|Protocol Violation|17|||
37946296|NCT00781391|69633746|FG002|Overall Study|Protocol Violation|20|||
37946297|NCT00781391|69633744|FG000|Overall Study|Death|789|||
37946298|NCT00781391|69633745|FG001|Overall Study|Death|730|||
37946299|NCT00781391|69633746|FG002|Overall Study|Death|706|||
37946300|NCT00781391|69633744|FG000|Overall Study|Withdrawal by Subject|47|||
37946301|NCT00781391|69633745|FG001|Overall Study|Withdrawal by Subject|37|||
37946302|NCT00781391|69633746|FG002|Overall Study|Withdrawal by Subject|25|||
37946303|NCT00781391|69633744|FG000|Overall Study|Lost to Follow-up|0|||
37946304|NCT00781391|69633745|FG001|Overall Study|Lost to Follow-up|0|||
37946305|NCT00781391|69633746|FG002|Overall Study|Lost to Follow-up|1|||
37946306|NCT00534976|69633756|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
37946307|NCT00534976|69633757|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
37946308|NCT00534976|69633756|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
37946309|NCT00534976|69633757|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
37946310|NCT00534976|69633756|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
37946311|NCT00534976|69633757|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
37946312|NCT00321763|69633767|FG000|Overall Study|Adverse Event|1|||
37946313|NCT00321763|69633768|FG001|Overall Study|Adverse Event|1|||
37946314|NCT00321763|69633769|FG002|Overall Study|Adverse Event|0|||
37946315|NCT00321763|69633770|FG003|Overall Study|Adverse Event|1|||
37946316|NCT00321763|69633767|FG000|Overall Study|Withdrawal by Subject|2|||
37946317|NCT00321763|69633768|FG001|Overall Study|Withdrawal by Subject|0|||
37946318|NCT00321763|69633769|FG002|Overall Study|Withdrawal by Subject|1|||
37946319|NCT00321763|69633770|FG003|Overall Study|Withdrawal by Subject|0|||
37946320|NCT00321763|69633767|FG000|Overall Study|Lost to Follow-up|3|||
37946321|NCT00321763|69633768|FG001|Overall Study|Lost to Follow-up|1|||
37946322|NCT00321763|69633769|FG002|Overall Study|Lost to Follow-up|5|||
37946323|NCT00321763|69633770|FG003|Overall Study|Lost to Follow-up|4|||
37946324|NCT00308113|69633786|FG000|Overall Study|Protocol closure|0|||
37946325|NCT00308113|69633787|FG001|Overall Study|Protocol closure|0|||
37946326|NCT00308113|69633788|FG002|Overall Study|Protocol closure|0|||
37946327|NCT00308113|69633789|FG003|Overall Study|Protocol closure|1|||
37946328|NCT00307801|69633805|FG000|Overall Study|Adverse Event|12|||
37946329|NCT00307801|69633806|FG001|Overall Study|Adverse Event|4|||
37946330|NCT00307801|69633805|FG000|Overall Study|Withdrawal by Subject|9|||
37946331|NCT00307801|69633806|FG001|Overall Study|Withdrawal by Subject|4|||
37946332|NCT00307801|69633805|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
37946333|NCT00307801|69633806|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
37946334|NCT00307801|69633805|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
37946335|NCT00307801|69633806|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
37946336|NCT00307801|69633805|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
37946337|NCT00307801|69633806|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
37946338|NCT00307801|69633805|FG000|Overall Study|Wrong Randomization|1|||
37946339|NCT00307801|69633806|FG001|Overall Study|Wrong Randomization|0|||
37946340|NCT00307801|69633805|FG000|Overall Study|Lack of Efficacy|0|||
37946341|NCT00307801|69633806|FG001|Overall Study|Lack of Efficacy|2|||
37946342|NCT00307801|69633805|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
37946343|NCT00307801|69633806|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
37946344|NCT00307801|69633805|FG000|Overall Study|Frustration with e-diary|1|||
37946345|NCT00307801|69633806|FG001|Overall Study|Frustration with e-diary|0|||
37946346|NCT00307801|69633805|FG000|Overall Study|Protocol Violation|3|||
37946347|NCT00307801|69633806|FG001|Overall Study|Protocol Violation|2|||
37946348|NCT00307801|69633805|FG000|Overall Study|No reason specified|2|||
37946349|NCT00307801|69633806|FG001|Overall Study|No reason specified|0|||
37946350|NCT00307801|69633805|FG000|Overall Study|Pregnancy|0|||
37946351|NCT00307801|69633806|FG001|Overall Study|Pregnancy|1|||
37946352|NCT00671060|69633815|FG000|Overall Study|Protocol Violation|1|||
37946353|NCT00671060|69633816|FG001|Overall Study|Protocol Violation|0|||
37946354|NCT00671060|69633815|FG000|Overall Study|Physician Decision|0|||
37946355|NCT00671060|69633816|FG001|Overall Study|Physician Decision|1|||
37946356|NCT00654420|69633826|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
37946357|NCT00654420|69633827|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
37946358|NCT00654420|69633828|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
37946359|NCT00654420|69633829|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
37946360|NCT00654420|69633826|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
37946361|NCT00654420|69633827|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
37946362|NCT00654420|69633828|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
37946363|NCT00654420|69633829|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
37946364|NCT00654420|69633826|FG000|Phase II|Adverse Event|0|||
37946365|NCT00654420|69633827|FG001|Phase II|Adverse Event|0|||
37946366|NCT00654420|69633828|FG002|Phase II|Adverse Event|3|||
37676244|NCT01680991|69150863|FG002|Overall Study|Adverse Event|0|||
37946367|NCT00654420|69633829|FG003|Phase II|Adverse Event|3|||
37946368|NCT00654420|69633826|FG000|Phase II|Lost to Follow-up|0|||
37946369|NCT00654420|69633827|FG001|Phase II|Lost to Follow-up|0|||
37946370|NCT00654420|69633828|FG002|Phase II|Lost to Follow-up|0|||
37946371|NCT00654420|69633829|FG003|Phase II|Lost to Follow-up|1|||
37946372|NCT00654420|69633826|FG000|Phase II|Physician Decision|0|||
37946373|NCT00654420|69633827|FG001|Phase II|Physician Decision|0|||
37946374|NCT00654420|69633828|FG002|Phase II|Physician Decision|0|||
37946375|NCT00654420|69633829|FG003|Phase II|Physician Decision|4|||
37946376|NCT00654420|69633826|FG000|Phase II|Progressive Disease|0|||
37946377|NCT00654420|69633827|FG001|Phase II|Progressive Disease|0|||
37946378|NCT00654420|69633828|FG002|Phase II|Progressive Disease|29|||
37946379|NCT00654420|69633829|FG003|Phase II|Progressive Disease|29|||
37946380|NCT00654420|69633826|FG000|Phase II|Withdrawal by Subject|0|||
37946381|NCT00654420|69633827|FG001|Phase II|Withdrawal by Subject|0|||
37946382|NCT00654420|69633828|FG002|Phase II|Withdrawal by Subject|4|||
37946383|NCT00654420|69633829|FG003|Phase II|Withdrawal by Subject|1|||
37946384|NCT00654420|69633826|FG000|Phase II|Missing Disposition Record|0|||
37946385|NCT00654420|69633827|FG001|Phase II|Missing Disposition Record|0|||
37946386|NCT00654420|69633828|FG002|Phase II|Missing Disposition Record|1|||
37946387|NCT00654420|69633829|FG003|Phase II|Missing Disposition Record|0|||
37946388|NCT00307489|69633841|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
37946389|NCT00307489|69633842|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
37946390|NCT00307489|69633841|FG000|Baseline Through Week 48|Physician Decision|1|||
37946391|NCT00307489|69633842|FG001|Baseline Through Week 48|Physician Decision|0|||
37946392|NCT00307489|69633841|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
37946393|NCT00307489|69633842|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
37946394|NCT00307489|69633841|FG000|Week 48 Through Week 168|Adverse Event|1|||
37946395|NCT00307489|69633842|FG001|Week 48 Through Week 168|Adverse Event|0|||
37946396|NCT00307489|69633841|FG000|Week 48 Through Week 168|Physician Decision|1|||
37946397|NCT00307489|69633842|FG001|Week 48 Through Week 168|Physician Decision|0|||
37946398|NCT00307489|69633841|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
37946399|NCT00307489|69633842|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
37946400|NCT00307489|69633841|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
37946401|NCT00307489|69633842|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
37946402|NCT00307489|69633841|FG000|Week 48 Through Week 168|Death|0|||
37946403|NCT00307489|69633842|FG001|Week 48 Through Week 168|Death|1|||
37946404|NCT00307489|69633841|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
37946405|NCT00307489|69633842|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
37946406|NCT00307489|69633841|FG000|Week 48 Through Week 168|Seroconversion|1|||
37946407|NCT00307489|69633842|FG001|Week 48 Through Week 168|Seroconversion|0|||
37946408|NCT00645840|69633848|FG000|Overall Study|Protocol Violation|3|||
37946409|NCT00307333|69633854|FG000|Overall Study|Lost to Follow-up|11|||
37946410|NCT00307333|69633855|FG001|Overall Study|Lost to Follow-up|3|||
37946411|NCT00762359|69633863|FG000|Overall Study|Adverse Event|20|||
37946412|NCT00762359|69633864|FG001|Overall Study|Adverse Event|23|||
37946413|NCT00762359|69633863|FG000|Overall Study|Protocol Violation|21|||
37946414|NCT00762359|69633864|FG001|Overall Study|Protocol Violation|13|||
37946415|NCT00762359|69633863|FG000|Overall Study|Withdrawal by Subject|13|||
37946416|NCT00762359|69633864|FG001|Overall Study|Withdrawal by Subject|10|||
37946417|NCT00762359|69633863|FG000|Overall Study|Lack of Efficacy|0|||
37946418|NCT00762359|69633864|FG001|Overall Study|Lack of Efficacy|4|||
37946419|NCT00762359|69633863|FG000|Overall Study|Institution closed|2|||
37946420|NCT00762359|69633864|FG001|Overall Study|Institution closed|3|||
37946421|NCT00762359|69633863|FG000|Overall Study|Physician Decision|2|||
37946422|NCT00762359|69633864|FG001|Overall Study|Physician Decision|3|||
37946423|NCT00762359|69633863|FG000|Overall Study|Removal|0|||
37946424|NCT00762359|69633864|FG001|Overall Study|Removal|1|||
37946425|NCT00762359|69633863|FG000|Overall Study|Withdrew consent|1|||
37946426|NCT00762359|69633864|FG001|Overall Study|Withdrew consent|0|||
37946427|NCT00654186|69633870|FG000|Overall Study|Withdrawal by Subject|5|||
37946428|NCT00761969|69633876|FG000|Overall Study|Death|112|||
37946429|NCT00761969|69633877|FG001|Overall Study|Death|47|||
37767839|NCT01677624|69283473|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
37946430|NCT00761969|69633876|FG000|Overall Study|Lost to Follow-up|88|||
37946431|NCT00761969|69633877|FG001|Overall Study|Lost to Follow-up|93|||
37946432|NCT00761891|69633888|FG000|Overall Study|Withdrawal by Subject|10|||
37946433|NCT00321685|69633893|FG000|Overall Study|Adverse Event|18|||
37946434|NCT00321685|69633893|FG000|Overall Study|Death|2|||
37946435|NCT00321685|69633893|FG000|Overall Study|Withdrawal by Subject|8|||
37946436|NCT00321685|69633893|FG000|Overall Study|Alternative therapy|1|||
37946437|NCT00321685|69633893|FG000|Overall Study|Complicating disese|1|||
37946438|NCT00321685|69633893|FG000|Overall Study|Other|5|||
37946439|NCT00321685|69633893|FG000|Overall Study|Not start protocol therapy|2|||
37946440|NCT00321685|69633893|FG000|Overall Study|Ineligible|2|||
37946441|NCT03902392|69633899|FG000|Overall Study|Lost to Follow-up|7|||
37946442|NCT03902392|69633900|FG001|Overall Study|Lost to Follow-up|7|||
37946443|NCT00306787|69633908|FG000|Overall Study|Discontinued without taking study drug|208|||
37946444|NCT00306787|69633909|FG001|Overall Study|Discontinued without taking study drug|215|||
37946445|NCT00306787|69633908|FG000|Overall Study|Adverse Event|1|||
37946446|NCT00306787|69633909|FG001|Overall Study|Adverse Event|1|||
37946447|NCT00306787|69633908|FG000|Overall Study|Lack of Efficacy|1|||
37946448|NCT00306787|69633909|FG001|Overall Study|Lack of Efficacy|0|||
37946449|NCT00306787|69633908|FG000|Overall Study|Protocol Violation|8|||
37946450|NCT00306787|69633909|FG001|Overall Study|Protocol Violation|10|||
37946451|NCT00306787|69633908|FG000|Overall Study|Withdrawal by Subject|2|||
37946452|NCT00306787|69633909|FG001|Overall Study|Withdrawal by Subject|9|||
37946453|NCT00306787|69633908|FG000|Overall Study|Lost to Follow-up|9|||
37946454|NCT00306787|69633909|FG001|Overall Study|Lost to Follow-up|6|||
37946455|NCT00306787|69633908|FG000|Overall Study|Administrative problems|4|||
37946456|NCT00306787|69633909|FG001|Overall Study|Administrative problems|0|||
37946457|NCT00306787|69633908|FG000|Overall Study|Abnormal laboratory value(s)|1|||
37946458|NCT00306787|69633909|FG001|Overall Study|Abnormal laboratory value(s)|0|||
37946459|NCT00769067|69633917|FG000|Overall Study|Death|89|||
37946460|NCT00769067|69633918|FG001|Overall Study|Death|86|||
37946461|NCT00769067|69633917|FG000|Overall Study|Lost to Follow-up|3|||
37946462|NCT00769067|69633918|FG001|Overall Study|Lost to Follow-up|1|||
37946463|NCT00769067|69633917|FG000|Overall Study|Study terminated by sponsor|1|||
37946464|NCT00769067|69633918|FG001|Overall Study|Study terminated by sponsor|3|||
37946465|NCT00769067|69633917|FG000|Overall Study|Other|1|||
37946466|NCT00769067|69633918|FG001|Overall Study|Other|3|||
37946467|NCT00769067|69633917|FG000|Overall Study|Withdrawal by Subject|0|||
37946468|NCT00769067|69633918|FG001|Overall Study|Withdrawal by Subject|1|||
37946469|NCT00321373|69633928|FG000|Overall Study|Adverse Event|0|||
37946470|NCT00321373|69633929|FG001|Overall Study|Adverse Event|0|||
37946471|NCT00321373|69633930|FG002|Overall Study|Adverse Event|1|||
37946472|NCT00321373|69633928|FG000|Overall Study|Lost to Follow-up|1|||
37946473|NCT00321373|69633929|FG001|Overall Study|Lost to Follow-up|0|||
37946474|NCT00321373|69633930|FG002|Overall Study|Lost to Follow-up|1|||
37946475|NCT00321373|69633928|FG000|Overall Study|Withdrawal by Subject|1|||
37946476|NCT00321373|69633929|FG001|Overall Study|Withdrawal by Subject|0|||
37946477|NCT00321373|69633930|FG002|Overall Study|Withdrawal by Subject|0|||
37946478|NCT00321373|69633928|FG000|Overall Study|Other|0|||
37946479|NCT00321373|69633929|FG001|Overall Study|Other|0|||
37946480|NCT00321373|69633930|FG002|Overall Study|Other|1|||
37946481|NCT00667394|69633940|FG000|Overall Study|Adverse Event|3|||
37946482|NCT00667394|69633941|FG001|Overall Study|Adverse Event|0|||
37946483|NCT00667394|69633940|FG000|Overall Study|Progressive disease|1|||
37946484|NCT00667394|69633941|FG001|Overall Study|Progressive disease|0|||
37946485|NCT00761735|69633947|FG000|Overall Study|Lost to Follow-up|6|||
37946486|NCT00761735|69633947|FG000|Overall Study|Withdrawal by Subject|6|||
37946487|NCT00761735|69633947|FG000|Overall Study|Non-compliance with protocol|1|||
37946488|NCT00761735|69633947|FG000|Overall Study|Administrative|1|||
37946489|NCT00569946|69633955|FG000|Overall Study|Adverse Event|16|||
37946490|NCT00569946|69633955|FG000|Overall Study|Objective Progression or Relapse|42|||
37946491|NCT00569946|69633955|FG000|Overall Study|Global Deterioration of Health Status|1|||
37946492|NCT00645528|69633959|FG000|Overall Study|Did not show up for Visit 2|7|||
37946493|NCT00295633|69633966|FG000|Overall Study|Lack of Efficacy|19|||
37946494|NCT00295633|69633967|FG001|Overall Study|Lack of Efficacy|7|||
37946495|NCT00295633|69633968|FG002|Overall Study|Lack of Efficacy|16|||
37946496|NCT00295633|69633966|FG000|Overall Study|Withdrawal of consent by subject|16|||
37946497|NCT00295633|69633967|FG001|Overall Study|Withdrawal of consent by subject|16|||
37946498|NCT00295633|69633968|FG002|Overall Study|Withdrawal of consent by subject|26|||
37946499|NCT00295633|69633966|FG000|Overall Study|Adverse Event|9|||
37946500|NCT00295633|69633967|FG001|Overall Study|Adverse Event|17|||
37946501|NCT00295633|69633968|FG002|Overall Study|Adverse Event|9|||
37946502|NCT00295633|69633966|FG000|Overall Study|Lost to Follow-up|6|||
37946503|NCT00295633|69633967|FG001|Overall Study|Lost to Follow-up|11|||
37946504|NCT00295633|69633968|FG002|Overall Study|Lost to Follow-up|7|||
37946505|NCT00295633|69633966|FG000|Overall Study|Physician Decision|9|||
37946506|NCT00295633|69633967|FG001|Overall Study|Physician Decision|10|||
37946507|NCT00295633|69633968|FG002|Overall Study|Physician Decision|8|||
37946508|NCT00295633|69633966|FG000|Overall Study|Poor/Noncompliance|2|||
37946509|NCT00295633|69633967|FG001|Overall Study|Poor/Noncompliance|2|||
37946510|NCT00295633|69633968|FG002|Overall Study|Poor/Noncompliance|6|||
37946511|NCT00295633|69633966|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
37946512|NCT00295633|69633967|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
37946513|NCT00295633|69633968|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
37946514|NCT00295633|69633966|FG000|Overall Study|Death|1|||
37946515|NCT00295633|69633967|FG001|Overall Study|Death|1|||
37946516|NCT00295633|69633968|FG002|Overall Study|Death|0|||
37946517|NCT00295633|69633966|FG000|Overall Study|Administrative reason by sponsor|0|||
37946518|NCT00295633|69633967|FG001|Overall Study|Administrative reason by sponsor|0|||
37946519|NCT00295633|69633968|FG002|Overall Study|Administrative reason by sponsor|1|||
37946520|NCT00570674|69633976|FG000|Overall Study|Withdrawal by Subject|0|||
37946521|NCT00570674|69633977|FG001|Overall Study|Withdrawal by Subject|0|||
37946522|NCT00570674|69633978|FG002|Overall Study|Withdrawal by Subject|1|||
37946523|NCT00570674|69633979|FG003|Overall Study|Withdrawal by Subject|0|||
37946524|NCT00570674|69633980|FG004|Overall Study|Withdrawal by Subject|0|||
37946525|NCT00570674|69633981|FG005|Overall Study|Withdrawal by Subject|0|||
37946526|NCT00570674|69633982|FG006|Overall Study|Withdrawal by Subject|0|||
37946527|NCT00768989|69633995|FG000|Prior to Week 24|Withdrawal by Subject|1|||
37946528|NCT00768989|69633996|FG001|Prior to Week 24|Withdrawal by Subject|0|||
37946529|NCT00768989|69633995|FG000|Prior to Week 24|Adverse Event|3|||
37946530|NCT00768989|69633996|FG001|Prior to Week 24|Adverse Event|0|||
37946531|NCT00768989|69633995|FG000|Prior to Week 24|Lost to Follow-up|0|||
37946532|NCT00768989|69633996|FG001|Prior to Week 24|Lost to Follow-up|1|||
37946533|NCT00768989|69633995|FG000|Prior to Week 24|Protocol Violation|0|||
37946534|NCT00768989|69633996|FG001|Prior to Week 24|Protocol Violation|2|||
37946535|NCT00768989|69633995|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
37946536|NCT00768989|69633996|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
37946537|NCT00768989|69633995|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
37946538|NCT00768989|69633996|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
37946539|NCT00768989|69633995|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
37946540|NCT00768989|69633996|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
37946541|NCT00768989|69633995|FG000|On or After Week 36|Lack of Efficacy|1|||
37946542|NCT00768989|69633996|FG001|On or After Week 36|Lack of Efficacy|0|||
37946543|NCT00768989|69633995|FG000|On or After Week 36|Adverse Event|0|||
37946544|NCT00768989|69633996|FG001|On or After Week 36|Adverse Event|1|||
37946545|NCT00768989|69633995|FG000|On or After Week 36|Lost to Follow-up|1|||
37946546|NCT00768989|69633996|FG001|On or After Week 36|Lost to Follow-up|0|||
37946547|NCT00768989|69633995|FG000|On or After Week 36|Poor Compliance|1|||
37946548|NCT00768989|69633996|FG001|On or After Week 36|Poor Compliance|0|||
37946549|NCT00768989|69633995|FG000|On or After Week 36|Protocol Violation|1|||
37946550|NCT00768989|69633996|FG001|On or After Week 36|Protocol Violation|0|||
37946551|NCT00768989|69633995|FG000|On or After Week 36|Did not attend termination visit|2|||
37946552|NCT00768989|69633996|FG001|On or After Week 36|Did not attend termination visit|0|||
37946553|NCT00768989|69633995|FG000|On or After Week 36|Sponsor Termination|45|||
37946554|NCT00768989|69633996|FG001|On or After Week 36|Sponsor Termination|26|||
37946555|NCT00305773|69634006|FG000|Overall Study|Death|3|||
37946556|NCT00305773|69634007|FG001|Overall Study|Death|2|||
37946557|NCT00305773|69634006|FG000|Overall Study|Adverse Event|1|||
37946558|NCT00305773|69634007|FG001|Overall Study|Adverse Event|2|||
37946559|NCT00305773|69634006|FG000|Overall Study|Alternative Treatment|4|||
37946560|NCT00305773|69634007|FG001|Overall Study|Alternative Treatment|4|||
37946561|NCT00305773|69634006|FG000|Overall Study|Physician Decision|1|||
37946562|NCT00305773|69634007|FG001|Overall Study|Physician Decision|1|||
37946563|NCT00305773|69634006|FG000|Overall Study|Withdrawal by Subject|1|||
37946564|NCT00305773|69634007|FG001|Overall Study|Withdrawal by Subject|4|||
37946565|NCT00305773|69634006|FG000|Overall Study|Disease Progression|1|||
37946566|NCT00305773|69634007|FG001|Overall Study|Disease Progression|3|||
37946567|NCT00305773|69634006|FG000|Overall Study|All other reasons|3|||
37946568|NCT00305773|69634007|FG001|Overall Study|All other reasons|2|||
37946569|NCT00305695|69634015|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
37946570|NCT00305695|69634016|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
37946571|NCT00305695|69634015|FG000|Overall Study|Did not have baseline scan|1|||
37946572|NCT00305695|69634016|FG001|Overall Study|Did not have baseline scan|1|||
37946573|NCT00647556|69634024|FG000|Overall Study|Adverse Event|0|||
37946574|NCT00647556|69634025|FG001|Overall Study|Adverse Event|1|||
37946575|NCT00647556|69634024|FG000|Overall Study|Lost to Follow-up|1|||
37946576|NCT00647556|69634025|FG001|Overall Study|Lost to Follow-up|0|||
37946577|NCT00647556|69634024|FG000|Overall Study|Protocol Violation|0|||
37946578|NCT00647556|69634025|FG001|Overall Study|Protocol Violation|1|||
37946579|NCT00647556|69634024|FG000|Overall Study|Withdrawal by Subject|1|||
37946580|NCT00647556|69634025|FG001|Overall Study|Withdrawal by Subject|0|||
37946581|NCT00647556|69634024|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
37946582|NCT00647556|69634025|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
37946583|NCT00320593|69634033|FG000|Overall Study|Lost to Follow-up|3|||
37946584|NCT00320593|69634034|FG001|Overall Study|Lost to Follow-up|0|||
37946585|NCT00320593|69634033|FG000|Overall Study|Moved to another state|1|||
37946586|NCT00320593|69634034|FG001|Overall Study|Moved to another state|0|||
37946587|NCT00320593|69634033|FG000|Overall Study|Withdrawal by Subject|2|||
37946588|NCT00320593|69634034|FG001|Overall Study|Withdrawal by Subject|1|||
37946589|NCT00320593|69634033|FG000|Overall Study|Withdrawal by clinical center|1|||
37946590|NCT00320593|69634034|FG001|Overall Study|Withdrawal by clinical center|0|||
37946591|NCT00320515|69634040|FG000|Overall Study|Death|33|||
37946592|NCT00320515|69634040|FG000|Overall Study|Lost to Follow-up|6|||
37946593|NCT00320515|69634040|FG000|Overall Study|Physician Decision|2|||
37946594|NCT00320515|69634040|FG000|Overall Study|Withdrawal by Subject|8|||
37946595|NCT00662012|69634044|FG000|Overall Study|Lost to Follow-up|85|||
37946596|NCT00662012|69634044|FG000|Overall Study|Death|1|||
37946597|NCT00662012|69634044|FG000|Overall Study|Withdrawal by Subject|1|||
37946598|NCT00661778|69634048|FG000|Overall Study|Disease Progression|23|||
37946599|NCT00661778|69634048|FG000|Overall Study|Adverse Event|18|||
37946600|NCT00661778|69634048|FG000|Overall Study|Reason not Specified|6|||
37946601|NCT00661778|69634048|FG000|Overall Study|Protocol Violation|2|||
37946602|NCT00661778|69634048|FG000|Overall Study|Withdrawal of Consent|1|||
37946603|NCT00319735|69634052|FG000|Overall Study|Death|2|||
37946604|NCT00653328|69634057|FG000|Overall Study|Withdrawal by Subject|1|||
37946605|NCT00653328|69634057|FG000|Overall Study|Adverse Event|2|||
37946606|NCT00653328|69634057|FG000|Overall Study|Disease progression|10|||
37946607|NCT00653328|69634057|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
37946608|NCT00642642|69634070|FG000|Treatment & Follow Up|Adverse Event|2|||
37946609|NCT00642642|69634070|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
37946610|NCT00642642|69634070|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
37946611|NCT00534352|69634080|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
37946612|NCT00534352|69634080|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
37946613|NCT00534352|69634080|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
37946614|NCT00534352|69634080|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
37946615|NCT00534352|69634080|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
37946616|NCT00534352|69634080|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
37946617|NCT00642174|69634095|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
37946618|NCT00642174|69634096|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
37946619|NCT00665366|69634104|FG000|Overall Study|Lack of Efficacy|11|||
37946620|NCT00665366|69634105|FG001|Overall Study|Lack of Efficacy|10|||
37946621|NCT00665366|69634104|FG000|Overall Study|Adverse Event|25|||
37946622|NCT00665366|69634105|FG001|Overall Study|Adverse Event|23|||
37946623|NCT00665366|69634104|FG000|Overall Study|Withdrawal by Subject|11|||
37946624|NCT00665366|69634105|FG001|Overall Study|Withdrawal by Subject|14|||
37946625|NCT00665366|69634104|FG000|Overall Study|Lost to Follow-up|3|||
37946626|NCT00665366|69634105|FG001|Overall Study|Lost to Follow-up|5|||
37946627|NCT00665366|69634104|FG000|Overall Study|Poor compliance/noncompliance|3|||
37946628|NCT00665366|69634105|FG001|Overall Study|Poor compliance/noncompliance|5|||
37946629|NCT00665366|69634104|FG000|Overall Study|Pregnancy|1|||
37946630|NCT00665366|69634105|FG001|Overall Study|Pregnancy|0|||
37946631|NCT00665366|69634104|FG000|Overall Study|No longer meets study criteria|0|||
37946632|NCT00665366|69634105|FG001|Overall Study|No longer meets study criteria|1|||
37946633|NCT00665366|69634104|FG000|Overall Study|Other reasons|4|||
37946634|NCT00665366|69634105|FG001|Overall Study|Other reasons|1|||
37946635|NCT00642018|69634135|FG000|Overall Study|Adverse Event|11|||
37946636|NCT00642018|69634136|FG001|Overall Study|Adverse Event|36|||
37946637|NCT00642018|69634135|FG000|Overall Study|Withdrawal by Subject|4|||
37946638|NCT00642018|69634136|FG001|Overall Study|Withdrawal by Subject|10|||
37946639|NCT00642018|69634135|FG000|Overall Study|Progressive Disease|13|||
37946640|NCT00642018|69634136|FG001|Overall Study|Progressive Disease|18|||
37946641|NCT00642018|69634135|FG000|Overall Study|Physician Decision|0|||
37946642|NCT00642018|69634136|FG001|Overall Study|Physician Decision|10|||
37946643|NCT00642018|69634135|FG000|Overall Study|Protocol Violation|0|||
37946644|NCT00642018|69634136|FG001|Overall Study|Protocol Violation|1|||
37946645|NCT00642018|69634135|FG000|Overall Study|Death|0|||
37946646|NCT00642018|69634136|FG001|Overall Study|Death|3|||
37946647|NCT00642018|69634135|FG000|Overall Study|Entry Criteria Not Met|0|||
37946648|NCT00642018|69634136|FG001|Overall Study|Entry Criteria Not Met|1|||
37946649|NCT00532948|69634146|FG000|Overall Study|Protocol Violation|1|||
37946650|NCT00532948|69634147|FG001|Overall Study|Protocol Violation|0|||
37946651|NCT00532948|69634148|FG002|Overall Study|Protocol Violation|0|||
37946652|NCT00532948|69634146|FG000|Overall Study|Death|3|||
37946653|NCT00532948|69634147|FG001|Overall Study|Death|3|||
37946654|NCT00532948|69634148|FG002|Overall Study|Death|4|||
37946655|NCT00532948|69634146|FG000|Overall Study|Violation of selection criteria at entry|0|||
37946656|NCT00532948|69634147|FG001|Overall Study|Violation of selection criteria at entry|1|||
37946657|NCT00532948|69634148|FG002|Overall Study|Violation of selection criteria at entry|0|||
37946658|NCT00532948|69634146|FG000|Overall Study|Failure to return|0|||
37946659|NCT00532948|69634147|FG001|Overall Study|Failure to return|1|||
37946660|NCT00532948|69634148|FG002|Overall Study|Failure to return|0|||
37946661|NCT00641706|69634162|FG000|Overall Study|Adverse Event|2|||
37946662|NCT00641706|69634163|FG001|Overall Study|Adverse Event|1|||
37946663|NCT00641706|69634162|FG000|Overall Study|Withdrawal by Subject|6|||
37946664|NCT00641706|69634163|FG001|Overall Study|Withdrawal by Subject|1|||
37946665|NCT00641706|69634162|FG000|Overall Study|Clinical Decline|1|||
37946666|NCT00641706|69634163|FG001|Overall Study|Clinical Decline|0|||
37946667|NCT00641706|69634162|FG000|Overall Study|Lead Investigator Decision|0|||
37767840|NCT01272219|69283494|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
37946668|NCT00641706|69634163|FG001|Overall Study|Lead Investigator Decision|1|||
37946669|NCT00644358|69634169|FG000|Overall Study|Adverse Event|124|||
37946670|NCT00644358|69634169|FG000|Overall Study|Lost to Follow-up|105|||
37946671|NCT00644358|69634169|FG000|Overall Study|Consent Withdrawal|64|||
37946672|NCT00644358|69634169|FG000|Overall Study|Lack of Effectiveness|39|||
37946673|NCT00644358|69634169|FG000|Overall Study|Protocol Violation|5|||
37946674|NCT00644358|69634169|FG000|Overall Study|Noncompliance|14|||
37946675|NCT00644358|69634169|FG000|Overall Study|Other Unspecified|11|||
37946676|NCT00640926|69634176|FG000|Overall Study|Adverse Event|2|||
37946677|NCT00640926|69634177|FG001|Overall Study|Adverse Event|3|||
37946678|NCT00640926|69634178|FG002|Overall Study|Adverse Event|2|||
37946679|NCT00640926|69634176|FG000|Overall Study|Lack of Efficacy|0|||
37946680|NCT00640926|69634177|FG001|Overall Study|Lack of Efficacy|2|||
37946681|NCT00640926|69634178|FG002|Overall Study|Lack of Efficacy|1|||
37946682|NCT00640926|69634176|FG000|Overall Study|Protocol Violation|2|||
37946683|NCT00640926|69634177|FG001|Overall Study|Protocol Violation|0|||
37946684|NCT00640926|69634178|FG002|Overall Study|Protocol Violation|2|||
37946685|NCT00640926|69634176|FG000|Overall Study|Lost to Follow-up|3|||
37946686|NCT00640926|69634177|FG001|Overall Study|Lost to Follow-up|1|||
37946687|NCT00640926|69634178|FG002|Overall Study|Lost to Follow-up|2|||
37946688|NCT00640926|69634176|FG000|Overall Study|Withdrawal by Subject|1|||
37946689|NCT00640926|69634177|FG001|Overall Study|Withdrawal by Subject|0|||
37946690|NCT00640926|69634178|FG002|Overall Study|Withdrawal by Subject|1|||
37946691|NCT03892564|69634186|FG000|Overall Study|Withdrawal by Subject|2|||
37946692|NCT03891862|69634193|FG000|Open-label Period|Adverse Event|2|||
37946693|NCT03891862|69634194|FG001|Open-label Period|Adverse Event|0|||
37946694|NCT03891862|69634195|FG002|Open-label Period|Adverse Event|0|||
37946695|NCT03891862|69634193|FG000|Open-label Period|Protocol Violation|5|||
37946696|NCT03891862|69634194|FG001|Open-label Period|Protocol Violation|0|||
37946697|NCT03891862|69634195|FG002|Open-label Period|Protocol Violation|0|||
37946698|NCT03891862|69634193|FG000|Open-label Period|Withdrawal by Subject|6|||
37946699|NCT03891862|69634194|FG001|Open-label Period|Withdrawal by Subject|0|||
37946700|NCT03891862|69634195|FG002|Open-label Period|Withdrawal by Subject|0|||
37946701|NCT03891862|69634193|FG000|Open-label Period|Death|1|||
37946702|NCT03891862|69634194|FG001|Open-label Period|Death|0|||
37946703|NCT03891862|69634195|FG002|Open-label Period|Death|0|||
37946704|NCT03891862|69634193|FG000|Open-label Period|Lost to Follow-up|2|||
37946705|NCT03891862|69634194|FG001|Open-label Period|Lost to Follow-up|0|||
37946706|NCT03891862|69634195|FG002|Open-label Period|Lost to Follow-up|0|||
37946707|NCT03891862|69634193|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
37946708|NCT03891862|69634194|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
37946709|NCT03891862|69634195|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
37946710|NCT03891862|69634193|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
37946711|NCT03891862|69634194|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
37946712|NCT03891862|69634195|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
37946713|NCT03891862|69634193|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
37946714|NCT03891862|69634194|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
37946715|NCT03891862|69634195|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
37946716|NCT03891862|69634193|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
37946717|NCT03891862|69634194|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
37946718|NCT03891862|69634195|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
37946719|NCT00640614|69634204|FG000|Overall Study|Lost to Follow-up|1|||
37946720|NCT00640614|69634205|FG001|Overall Study|Lost to Follow-up|0|||
37946721|NCT00761657|69634243|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
37946722|NCT00761657|69634244|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
37946723|NCT00761657|69634245|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
37946724|NCT00761657|69634246|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
37946725|NCT00761657|69634247|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
37946726|NCT00761657|69634248|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
37946727|NCT00761657|69634249|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
37946728|NCT00761657|69634250|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
37946729|NCT00761657|69634251|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
37946730|NCT00761657|69634243|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
37946731|NCT00761657|69634244|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
37946732|NCT00761657|69634245|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
37946733|NCT00761657|69634246|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
37946734|NCT00761657|69634247|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
37946735|NCT00761657|69634248|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
37946736|NCT00761657|69634249|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
37946737|NCT00761657|69634250|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
37946738|NCT00761657|69634251|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
37946739|NCT00761657|69634243|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
37946740|NCT00761657|69634244|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
37946741|NCT00761657|69634245|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
37946742|NCT00761657|69634246|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
37946743|NCT00761657|69634247|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
37946744|NCT00761657|69634248|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
37946745|NCT00761657|69634249|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
37946746|NCT00761657|69634250|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
37946747|NCT00761657|69634251|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
37676245|NCT01680991|69150861|FG000|Overall Study|Death|1|||
37946748|NCT00761657|69634243|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
37946749|NCT00761657|69634244|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
37946750|NCT00761657|69634245|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
37946751|NCT00761657|69634246|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
37946752|NCT00761657|69634247|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
37946753|NCT00761657|69634248|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
37946754|NCT00761657|69634249|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
37946755|NCT00761657|69634250|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
37946756|NCT00761657|69634251|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
37946757|NCT00319501|69634283|FG000|Double-blind Period|Withdrawal by Subject|0|||
37946758|NCT00319501|69634284|FG001|Double-blind Period|Withdrawal by Subject|3|||
37946759|NCT00319501|69634283|FG000|Double-blind Period|Sponsor Request|1|||
37946760|NCT00319501|69634284|FG001|Double-blind Period|Sponsor Request|0|||
37946761|NCT00319501|69634283|FG000|Double-blind Period|Did not receive treatment|42|||
37946762|NCT00319501|69634284|FG001|Double-blind Period|Did not receive treatment|29|||
37946763|NCT00319501|69634283|FG000|Open-label Period|Adverse Event|5|||
38040212|NCT03126110|69727401|FG013|Phase 2|Lost to Follow-up|1|||
38040213|NCT03126110|69727402|FG014|Phase 2|Lost to Follow-up|2|||
38040214|NCT03126110|69727403|FG015|Phase 2|Lost to Follow-up|0|||
38040215|NCT03126110|69727404|FG016|Phase 2|Lost to Follow-up|0|||
38040216|NCT03126110|69727388|FG000|Phase 2|Death|0|||
38040217|NCT03126110|69727389|FG001|Phase 2|Death|0|||
38040218|NCT03126110|69727390|FG002|Phase 2|Death|0|||
38040219|NCT03126110|69727391|FG003|Phase 2|Death|0|||
38040220|NCT03126110|69727392|FG004|Phase 2|Death|0|||
38040221|NCT03126110|69727393|FG005|Phase 2|Death|0|||
38040222|NCT03126110|69727394|FG006|Phase 2|Death|0|||
38040223|NCT03126110|69727395|FG007|Phase 2|Death|0|||
38040224|NCT03126110|69727396|FG008|Phase 2|Death|0|||
38040225|NCT03126110|69727397|FG009|Phase 2|Death|0|||
38040226|NCT03126110|69727398|FG010|Phase 2|Death|0|||
38040227|NCT03126110|69727399|FG011|Phase 2|Death|6|||
38040228|NCT03126110|69727400|FG012|Phase 2|Death|12|||
38040229|NCT03126110|69727401|FG013|Phase 2|Death|25|||
38040230|NCT03126110|69727402|FG014|Phase 2|Death|11|||
38040231|NCT03126110|69727403|FG015|Phase 2|Death|3|||
38040232|NCT03126110|69727404|FG016|Phase 2|Death|2|||
38040233|NCT03126110|69727388|FG000|Phase 2|Progressive Disease|0|||
38040234|NCT03126110|69727389|FG001|Phase 2|Progressive Disease|0|||
38040235|NCT03126110|69727390|FG002|Phase 2|Progressive Disease|0|||
38040236|NCT03126110|69727391|FG003|Phase 2|Progressive Disease|0|||
38040237|NCT03126110|69727392|FG004|Phase 2|Progressive Disease|0|||
38040238|NCT03126110|69727393|FG005|Phase 2|Progressive Disease|0|||
38040239|NCT03126110|69727394|FG006|Phase 2|Progressive Disease|0|||
38040240|NCT03126110|69727395|FG007|Phase 2|Progressive Disease|0|||
38040241|NCT03126110|69727396|FG008|Phase 2|Progressive Disease|0|||
38040242|NCT03126110|69727397|FG009|Phase 2|Progressive Disease|0|||
38040243|NCT03126110|69727398|FG010|Phase 2|Progressive Disease|0|||
37767841|NCT01272219|69283495|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
37946764|NCT00319501|69634284|FG001|Open-label Period|Adverse Event|0|||
37946765|NCT00319501|69634283|FG000|Open-label Period|Protocol Violation|6|||
37946766|NCT00319501|69634284|FG001|Open-label Period|Protocol Violation|0|||
37946767|NCT00319501|69634283|FG000|Open-label Period|Withdrawal by Subject|38|||
37946768|NCT00319501|69634284|FG001|Open-label Period|Withdrawal by Subject|0|||
37946769|NCT00319501|69634283|FG000|Open-label Period|Principal Investigator decision|6|||
37946770|NCT00319501|69634284|FG001|Open-label Period|Principal Investigator decision|0|||
37946771|NCT00319501|69634283|FG000|Open-label Period|Sponsor request|12|||
37946772|NCT00319501|69634284|FG001|Open-label Period|Sponsor request|0|||
37946773|NCT00319501|69634283|FG000|Open-label Period|Lost to Follow-up|5|||
37946774|NCT00319501|69634284|FG001|Open-label Period|Lost to Follow-up|0|||
37946775|NCT00319501|69634283|FG000|Open-label Period|Did not receive treatment|33|||
37946776|NCT00319501|69634284|FG001|Open-label Period|Did not receive treatment|0|||
37946777|NCT00319501|69634283|FG000|Open-label Period|Other|11|||
37946778|NCT00319501|69634284|FG001|Open-label Period|Other|0|||
37946779|NCT00319501|69634283|FG000|Open-label Extension Period|Adverse Event|2|||
37946780|NCT00319501|69634284|FG001|Open-label Extension Period|Adverse Event|0|||
37946781|NCT00319501|69634283|FG000|Open-label Extension Period|Did not receive treatment|18|||
37946782|NCT00319501|69634284|FG001|Open-label Extension Period|Did not receive treatment|0|||
37946783|NCT00319501|69634283|FG000|Open-label Extension Period|Other|1|||
37946784|NCT00319501|69634284|FG001|Open-label Extension Period|Other|0|||
37946785|NCT00319501|69634283|FG000|Open-label Extension Period|Principal investigator decision|2|||
37946786|NCT00319501|69634284|FG001|Open-label Extension Period|Principal investigator decision|0|||
37946787|NCT00319501|69634283|FG000|Open-label Extension Period|Sponsor request|26|||
37946788|NCT00319501|69634284|FG001|Open-label Extension Period|Sponsor request|0|||
38040244|NCT03126110|69727399|FG011|Phase 2|Progressive Disease|0|||
38040245|NCT03126110|69727400|FG012|Phase 2|Progressive Disease|0|||
38040246|NCT03126110|69727401|FG013|Phase 2|Progressive Disease|1|||
38040247|NCT03126110|69727402|FG014|Phase 2|Progressive Disease|0|||
38040248|NCT03126110|69727403|FG015|Phase 2|Progressive Disease|0|||
38040249|NCT03126110|69727404|FG016|Phase 2|Progressive Disease|0|||
38040250|NCT03126110|69727388|FG000|Phase 2|Started new treatment|0|||
38040251|NCT03126110|69727389|FG001|Phase 2|Started new treatment|0|||
38040252|NCT03126110|69727390|FG002|Phase 2|Started new treatment|0|||
38040253|NCT03126110|69727391|FG003|Phase 2|Started new treatment|0|||
38040254|NCT03126110|69727392|FG004|Phase 2|Started new treatment|0|||
38040255|NCT03126110|69727393|FG005|Phase 2|Started new treatment|0|||
38040256|NCT03126110|69727394|FG006|Phase 2|Started new treatment|0|||
38040257|NCT03126110|69727395|FG007|Phase 2|Started new treatment|0|||
38040258|NCT03126110|69727396|FG008|Phase 2|Started new treatment|0|||
38040259|NCT03126110|69727397|FG009|Phase 2|Started new treatment|0|||
38040260|NCT03126110|69727398|FG010|Phase 2|Started new treatment|0|||
38040261|NCT03126110|69727399|FG011|Phase 2|Started new treatment|0|||
38040262|NCT03126110|69727400|FG012|Phase 2|Started new treatment|0|||
38040263|NCT03126110|69727401|FG013|Phase 2|Started new treatment|0|||
38040264|NCT03126110|69727402|FG014|Phase 2|Started new treatment|1|||
38040265|NCT03126110|69727403|FG015|Phase 2|Started new treatment|0|||
38040266|NCT03126110|69727404|FG016|Phase 2|Started new treatment|0|||
38040267|NCT00905164|69727454|FG000|Period 1|Protocol Violation|0|||
38040268|NCT00905164|69727455|FG001|Period 1|Protocol Violation|1|||
38040269|NCT03181958|69727462|FG000|Overall Study|Lost to Follow-up|17|||
38040270|NCT03181958|69727463|FG001|Overall Study|Lost to Follow-up|21|||
38040271|NCT03181958|69727464|FG002|Overall Study|Lost to Follow-up|15|||
38040272|NCT03165110|69727472|FG000|Overall Study|Anroid phone software incompatibility|1|||
38040273|NCT00079781|69727479|FG000|Pre-implant Period|Withdrawal by Subject|2|||
38040274|NCT00079781|69727480|FG001|Pre-implant Period|Withdrawal by Subject|0|||
38040275|NCT00079781|69727481|FG002|Pre-implant Period|Withdrawal by Subject|0|||
38040276|NCT00079781|69727479|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
38040277|NCT00079781|69727480|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
38040278|NCT00079781|69727481|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
38040279|NCT00079781|69727479|FG000|Follow-up Period|Withdrawal by Subject|3|||
38040280|NCT00079781|69727480|FG001|Follow-up Period|Withdrawal by Subject|0|||
38040281|NCT00079781|69727481|FG002|Follow-up Period|Withdrawal by Subject|1|||
38040282|NCT00079781|69727479|FG000|Follow-up Period|Lost to Follow-up|1|||
38040283|NCT00079781|69727480|FG001|Follow-up Period|Lost to Follow-up|0|||
38040284|NCT00079781|69727481|FG002|Follow-up Period|Lost to Follow-up|0|||
38040285|NCT00079781|69727479|FG000|Follow-up Period|Death|0|||
38040286|NCT00079781|69727480|FG001|Follow-up Period|Death|0|||
38040287|NCT00079781|69727481|FG002|Follow-up Period|Death|1|||
38040288|NCT03176966|69727489|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
38040289|NCT03176966|69727490|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
38040290|NCT03176966|69727489|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
38040291|NCT03176966|69727490|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
38040292|NCT03176966|69727489|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
38040293|NCT03176966|69727490|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
38040294|NCT03176966|69727489|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
38040295|NCT03176966|69727490|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
38040296|NCT03176966|69727489|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
38040297|NCT03176966|69727490|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
38040298|NCT03176966|69727489|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
38040299|NCT03176966|69727490|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
38040300|NCT03176966|69727489|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
38040301|NCT03176966|69727490|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
38040302|NCT03175562|69727496|FG000|Overall Study|Adverse Event|1|||
38040303|NCT03175562|69727496|FG000|Overall Study|Lost to Follow-up|3|||
38040304|NCT03175562|69727496|FG000|Overall Study|Withdrawal by Subject|7|||
38040305|NCT03175562|69727496|FG000|Overall Study|Other (Not Specified)|5|||
38040306|NCT00079391|69727503|FG000|Overall Study|Withdrawal by Subject|1|||
38040307|NCT03209570|69727511|FG000|Overall Study|Death|1|||
38040308|NCT03209570|69727512|FG001|Overall Study|Death|0|||
38040309|NCT03209570|69727511|FG000|Overall Study|Incomplete Data|8|||
38040310|NCT03209570|69727512|FG001|Overall Study|Incomplete Data|10|||
38040311|NCT03209570|69727511|FG000|Overall Study|Protocol Violation|1|||
38040312|NCT03209570|69727512|FG001|Overall Study|Protocol Violation|0|||
38040313|NCT03209570|69727511|FG000|Overall Study|Withdrawal by Subject|0|||
38040314|NCT03209570|69727512|FG001|Overall Study|Withdrawal by Subject|3|||
38040315|NCT03209492|69727518|FG000|Overall Study|Case Report Forms Uncollected|5|||
38040316|NCT03208244|69727522|FG000|Overall Study|Death|1|||
38040317|NCT03175172|69727526|FG000|Overall Study|Death|3|||
38040318|NCT03175172|69727526|FG000|Overall Study|Withdrawal by Subject|3|||
38040319|NCT03175172|69727526|FG000|Overall Study|Lost to Follow-up|1|||
38040320|NCT03175172|69727526|FG000|Overall Study|Study Terminated by Sponsor|3|||
38040321|NCT03172364|69727532|FG000|Overall Study|Adverse Event|1|||
38040322|NCT03172364|69727533|FG001|Overall Study|Adverse Event|1|||
38040323|NCT03172364|69727532|FG000|Overall Study|Protocol Violation|1|||
38040324|NCT03172364|69727533|FG001|Overall Study|Protocol Violation|0|||
38040325|NCT00078767|69727541|FG000|Overall Study|Withdrawal by Subject|1|||
38040326|NCT00078767|69727542|FG001|Overall Study|Withdrawal by Subject|1|||
38040327|NCT03208088|69727548|FG000|Period 2|Withdrawal by Subject|0|||
38040328|NCT03208088|69727549|FG001|Period 2|Withdrawal by Subject|0|||
38040329|NCT03208088|69727550|FG002|Period 2|Withdrawal by Subject|0|||
38040330|NCT03208088|69727551|FG003|Period 2|Withdrawal by Subject|0|||
38040331|NCT03208088|69727552|FG004|Period 2|Withdrawal by Subject|0|||
38040332|NCT03208088|69727553|FG005|Period 2|Withdrawal by Subject|0|||
38040333|NCT03208088|69727554|FG006|Period 2|Withdrawal by Subject|0|||
38040334|NCT03208088|69727555|FG007|Period 2|Withdrawal by Subject|0|||
38040335|NCT03208088|69727556|FG008|Period 2|Withdrawal by Subject|1|||
38040336|NCT03208088|69727557|FG009|Period 2|Withdrawal by Subject|0|||
38040337|NCT03208088|69727548|FG000|Period 3|Unsatisfactory Test Article|0|||
38040338|NCT03208088|69727549|FG001|Period 3|Unsatisfactory Test Article|0|||
38040339|NCT03208088|69727550|FG002|Period 3|Unsatisfactory Test Article|0|||
38040340|NCT03208088|69727551|FG003|Period 3|Unsatisfactory Test Article|1|||
38040341|NCT03208088|69727552|FG004|Period 3|Unsatisfactory Test Article|0|||
38040342|NCT03208088|69727553|FG005|Period 3|Unsatisfactory Test Article|0|||
38040343|NCT03208088|69727554|FG006|Period 3|Unsatisfactory Test Article|0|||
38040344|NCT03208088|69727555|FG007|Period 3|Unsatisfactory Test Article|0|||
38040345|NCT03208088|69727556|FG008|Period 3|Unsatisfactory Test Article|0|||
38040346|NCT03208088|69727557|FG009|Period 3|Unsatisfactory Test Article|0|||
38040347|NCT03208088|69727548|FG000|Period 4|Unsatisfactory Test Article|0|||
38040348|NCT03208088|69727549|FG001|Period 4|Unsatisfactory Test Article|0|||
38040349|NCT03208088|69727550|FG002|Period 4|Unsatisfactory Test Article|0|||
38040350|NCT03208088|69727551|FG003|Period 4|Unsatisfactory Test Article|1|||
38040351|NCT03208088|69727552|FG004|Period 4|Unsatisfactory Test Article|0|||
38040352|NCT03208088|69727553|FG005|Period 4|Unsatisfactory Test Article|0|||
38040353|NCT03208088|69727554|FG006|Period 4|Unsatisfactory Test Article|0|||
38040354|NCT03208088|69727555|FG007|Period 4|Unsatisfactory Test Article|0|||
38040355|NCT03208088|69727556|FG008|Period 4|Unsatisfactory Test Article|0|||
38040356|NCT03208088|69727557|FG009|Period 4|Unsatisfactory Test Article|0|||
38040357|NCT00078377|69727572|FG000|Overall Study|Adverse Event|2|||
38040358|NCT00078377|69727573|FG001|Overall Study|Adverse Event|5|||
38040359|NCT00078377|69727574|FG002|Overall Study|Adverse Event|1|||
38040360|NCT00078377|69727572|FG000|Overall Study|Lack of Efficacy|2|||
38040361|NCT00078377|69727573|FG001|Overall Study|Lack of Efficacy|0|||
38040362|NCT00078377|69727574|FG002|Overall Study|Lack of Efficacy|2|||
38040363|NCT00078377|69727572|FG000|Overall Study|Lost to Follow-up|0|||
38040364|NCT00078377|69727573|FG001|Overall Study|Lost to Follow-up|1|||
38040365|NCT00078377|69727574|FG002|Overall Study|Lost to Follow-up|1|||
38040366|NCT00078377|69727572|FG000|Overall Study|Physician Decision|2|||
38040367|NCT00078377|69727573|FG001|Overall Study|Physician Decision|0|||
38040368|NCT00078377|69727574|FG002|Overall Study|Physician Decision|0|||
38040369|NCT00078377|69727572|FG000|Overall Study|Withdrawal by Subject|3|||
38040370|NCT00078377|69727573|FG001|Overall Study|Withdrawal by Subject|4|||
38040371|NCT00078377|69727574|FG002|Overall Study|Withdrawal by Subject|4|||
38040372|NCT00078377|69727572|FG000|Overall Study|Miscellaneous|2|||
38040373|NCT00078377|69727573|FG001|Overall Study|Miscellaneous|6|||
38040374|NCT00078377|69727574|FG002|Overall Study|Miscellaneous|1|||
38040375|NCT00886600|69727587|FG000|Double-blind Monotherapy|Adverse Event|1|||
38040376|NCT00886600|69727588|FG001|Double-blind Monotherapy|Adverse Event|1|||
38040377|NCT00886600|69727589|FG002|Double-blind Monotherapy|Adverse Event|1|||
38040378|NCT00886600|69727590|FG003|Double-blind Monotherapy|Adverse Event|1|||
38040379|NCT00886600|69727587|FG000|Double-blind Monotherapy|Protocol Violation|0|||
38040380|NCT00886600|69727588|FG001|Double-blind Monotherapy|Protocol Violation|0|||
38040381|NCT00886600|69727589|FG002|Double-blind Monotherapy|Protocol Violation|0|||
38040382|NCT00886600|69727590|FG003|Double-blind Monotherapy|Protocol Violation|1|||
38040383|NCT00886600|69727587|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
38040384|NCT00886600|69727588|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
38040385|NCT00886600|69727589|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
38040386|NCT00886600|69727590|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
38040387|NCT00886600|69727587|FG000|Combination Therapy Period|Adverse Event|0|||
38040388|NCT00886600|69727588|FG001|Combination Therapy Period|Adverse Event|0|||
38040389|NCT00886600|69727589|FG002|Combination Therapy Period|Adverse Event|1|||
38040390|NCT00886600|69727590|FG003|Combination Therapy Period|Adverse Event|0|||
38040391|NCT00886600|69727587|FG000|Combination Therapy Period|Protocol Violation|0|||
38040392|NCT00886600|69727588|FG001|Combination Therapy Period|Protocol Violation|0|||
38040393|NCT00886600|69727589|FG002|Combination Therapy Period|Protocol Violation|1|||
38040394|NCT00886600|69727590|FG003|Combination Therapy Period|Protocol Violation|0|||
38040395|NCT03172130|69727598|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
38040396|NCT03172130|69727599|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
38040397|NCT00870688|69727615|FG000|Overall Study|Lost to Follow-up|2|||
38040398|NCT00870688|69727615|FG000|Overall Study|Death, Unrelated|1|||
38040399|NCT00870688|69727615|FG000|Overall Study|Granules in the Stools|1|||
38040400|NCT00869128|69727618|FG000|Overall Study|lack of Compliance|6|||
38040401|NCT00869128|69727619|FG001|Overall Study|lack of Compliance|6|||
38040402|NCT00077675|69727625|FG000|Overall Study|Adverse Event|1|||
38040403|NCT00077675|69727626|FG001|Overall Study|Adverse Event|2|||
38040404|NCT00077675|69727625|FG000|Overall Study|Lost to Follow-up|6|||
38040405|NCT00077675|69727626|FG001|Overall Study|Lost to Follow-up|3|||
38040406|NCT00077675|69727625|FG000|Overall Study|Withdrawal by Subject|1|||
38040407|NCT00077675|69727626|FG001|Overall Study|Withdrawal by Subject|0|||
38040408|NCT00077675|69727625|FG000|Overall Study|Other|0|||
38040409|NCT00077675|69727626|FG001|Overall Study|Other|1|||
38040410|NCT00077675|69727625|FG000|Overall Study|Never received study treatment|3|||
38040411|NCT00077675|69727626|FG001|Overall Study|Never received study treatment|3|||
38040412|NCT02576444|69727643|FG000|Overall Study|Death|1|||
38040413|NCT02576444|69727644|FG001|Overall Study|Death|1|||
38040414|NCT02576444|69727645|FG002|Overall Study|Death|0|||
38040415|NCT02576444|69727646|FG003|Overall Study|Death|0|||
38040416|NCT02576444|69727643|FG000|Overall Study|Withdrawal by Subject|0|||
38040417|NCT02576444|69727644|FG001|Overall Study|Withdrawal by Subject|0|||
38040418|NCT02576444|69727645|FG002|Overall Study|Withdrawal by Subject|2|||
38040419|NCT02576444|69727646|FG003|Overall Study|Withdrawal by Subject|0|||
38040420|NCT02576444|69727643|FG000|Overall Study|Adverse Event|0|||
38040421|NCT02576444|69727644|FG001|Overall Study|Adverse Event|0|||
38040422|NCT02576444|69727645|FG002|Overall Study|Adverse Event|1|||
38040423|NCT02576444|69727646|FG003|Overall Study|Adverse Event|0|||
38040424|NCT02576444|69727643|FG000|Overall Study|Physician Decision|0|||
38040425|NCT02576444|69727644|FG001|Overall Study|Physician Decision|0|||
38040426|NCT02576444|69727645|FG002|Overall Study|Physician Decision|1|||
38040427|NCT02576444|69727646|FG003|Overall Study|Physician Decision|0|||
38040428|NCT00850174|69727657|FG000|Washout: One Week|Withdrawal by Subject|0|||
38040429|NCT00850174|69727658|FG001|Washout: One Week|Withdrawal by Subject|2|||
38040430|NCT00850174|69727657|FG000|Second Intervention|Withdrawal by Subject|1|||
38040431|NCT00850174|69727658|FG001|Second Intervention|Withdrawal by Subject|0|||
38040432|NCT00077207|69727669|FG000|Overall Study|Adverse Event|5|||
38040433|NCT00077207|69727669|FG000|Overall Study|Lack of Efficacy|12|||
38040434|NCT00077207|69727669|FG000|Overall Study|Physician Decision|6|||
38040435|NCT00077207|69727669|FG000|Overall Study|Withdrawal by Subject|6|||
38040436|NCT00077207|69727669|FG000|Overall Study|Ineligible|1|||
38040437|NCT03206918|69727674|FG000|Overall Study|Death|11|||
38040438|NCT03206918|69727674|FG000|Overall Study|Withdrawal by Subject|5|||
38040439|NCT03206918|69727674|FG000|Overall Study|Study terminated by sponsor|12|||
38040440|NCT03206918|69727674|FG000|Overall Study|Lost to Follow-up|3|||
38040441|NCT03206918|69727674|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
38040442|NCT03206216|69727681|FG000|Overall Study|Withdrawal by Subject|0|||
38040443|NCT03206216|69727682|FG001|Overall Study|Withdrawal by Subject|1|||
38040444|NCT03169244|69727690|FG000|Overall Study|Lost to Follow-up|1|||
38040445|NCT03169244|69727691|FG001|Overall Study|Lost to Follow-up|2|||
38040446|NCT03169244|69727690|FG000|Overall Study|Adverse Event|1|||
38040447|NCT03169244|69727691|FG001|Overall Study|Adverse Event|0|||
38040448|NCT03169244|69727690|FG000|Overall Study|Withdrawal by Subject|2|||
38040449|NCT03169244|69727691|FG001|Overall Study|Withdrawal by Subject|2|||
38040450|NCT03169244|69727690|FG000|Overall Study|Physician Decision|1|||
38040451|NCT03169244|69727691|FG001|Overall Study|Physician Decision|0|||
38040452|NCT02486042|69727699|FG000|Overall Study|Physician Decision|1|||
38040453|NCT02486042|69727700|FG001|Overall Study|Physician Decision|7|||
38040454|NCT02486042|69727699|FG000|Overall Study|Hospital transfer|2|||
38040455|NCT02486042|69727700|FG001|Overall Study|Hospital transfer|2|||
38040456|NCT02486042|69727699|FG000|Overall Study|Withdrawal by Subject|0|||
38040457|NCT02486042|69727700|FG001|Overall Study|Withdrawal by Subject|2|||
38040458|NCT00057941|69727708|FG000|Overall Study|Death|1|||
38040459|NCT00057941|69727709|FG001|Overall Study|Death|2|||
38040460|NCT00057941|69727708|FG000|Overall Study|Adverse Event|7|||
38040461|NCT00057941|69727709|FG001|Overall Study|Adverse Event|9|||
38040462|NCT00057941|69727708|FG000|Overall Study|Lack of Efficacy|54|||
38040463|NCT00057941|69727709|FG001|Overall Study|Lack of Efficacy|53|||
38040464|NCT00057941|69727708|FG000|Overall Study|Withdrawal by Subject|6|||
38040465|NCT00057941|69727709|FG001|Overall Study|Withdrawal by Subject|1|||
38040466|NCT00057941|69727708|FG000|Overall Study|still on treatment|3|||
38040467|NCT00057941|69727709|FG001|Overall Study|still on treatment|1|||
38040468|NCT00057941|69727708|FG000|Overall Study|insurance, symptomatic deterioration|1|||
38040469|NCT00057941|69727709|FG001|Overall Study|insurance, symptomatic deterioration|3|||
38040470|NCT00057941|69727708|FG000|Overall Study|Ineligible|2|||
38040471|NCT00057941|69727709|FG001|Overall Study|Ineligible|5|||
38040472|NCT00075881|69727724|FG000|Overall Study|Lack of Efficacy|18|||
38040473|NCT00075881|69727724|FG000|Overall Study|Adverse Event|7|||
38040474|NCT00075881|69727724|FG000|Overall Study|Death|1|||
38040475|NCT00075881|69727724|FG000|Overall Study|Withdrawal by Subject|2|||
38040476|NCT00075881|69727724|FG000|Overall Study|Protocol Violation|4|||
38040477|NCT00075881|69727724|FG000|Overall Study|other complicating disease|3|||
38040478|NCT00075881|69727724|FG000|Overall Study|other|4|||
38040479|NCT00075881|69727724|FG000|Overall Study|missing data|2|||
38040480|NCT00075881|69727724|FG000|Overall Study|Ineligible|1|||
38040481|NCT00075881|69727724|FG000|Overall Study|never start protocol therapy|1|||
38040482|NCT00838630|69727732|FG000|First Intervention|Adverse Event|1|||
38040483|NCT00838630|69727733|FG001|First Intervention|Adverse Event|0|||
38040484|NCT00838630|69727732|FG000|Washout: 7 Days|Protocol Violation|1|||
38040485|NCT00838630|69727733|FG001|Washout: 7 Days|Protocol Violation|0|||
38040486|NCT02996474|69727737|FG000|Overall Study|Physician Decision|5|||
38040487|NCT03667924|69727744|FG000|Baseline Completed|Lost to Follow-up|0|||
38040488|NCT03667924|69727745|FG001|Baseline Completed|Lost to Follow-up|2|||
38040489|NCT03667924|69727746|FG002|Baseline Completed|Lost to Follow-up|0|||
38040490|NCT03667924|69727744|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
38040491|NCT03667924|69727745|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
38040492|NCT03667924|69727746|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
38040493|NCT03667924|69727744|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
38040494|NCT03667924|69727745|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
38040495|NCT03667924|69727746|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
38040496|NCT03667924|69727744|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
38040497|NCT03667924|69727745|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
38040498|NCT03667924|69727746|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
38040499|NCT03667924|69727744|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
38040500|NCT03667924|69727745|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
38040501|NCT03667924|69727746|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
38040502|NCT03667924|69727744|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
38040503|NCT03667924|69727745|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
38040504|NCT03667924|69727746|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
38040505|NCT03667924|69727744|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
38040506|NCT03667924|69727745|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
38040507|NCT03667924|69727746|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
38040508|NCT03205046|69727758|FG000|Overall Study|Death|10|||
38040509|NCT03205046|69727759|FG001|Overall Study|Death|6|||
38040510|NCT03205046|69727758|FG000|Overall Study|Withdrawal by Subject|1|||
38040511|NCT03205046|69727759|FG001|Overall Study|Withdrawal by Subject|2|||
38040512|NCT03205046|69727758|FG000|Overall Study|Lost to Follow-up|0|||
38040513|NCT03205046|69727759|FG001|Overall Study|Lost to Follow-up|1|||
38040514|NCT03205046|69727758|FG000|Overall Study|Study terminated by sponsor|2|||
38040515|NCT03205046|69727759|FG001|Overall Study|Study terminated by sponsor|1|||
38040516|NCT02339090|69727767|FG000|Overall Study|Adverse Event|1|||
38040517|NCT02339090|69727768|FG001|Overall Study|Adverse Event|0|||
38040518|NCT02339090|69727767|FG000|Overall Study|Lost to Follow-up|0|||
38040519|NCT02339090|69727768|FG001|Overall Study|Lost to Follow-up|1|||
38040520|NCT02339090|69727767|FG000|Overall Study|Non-compliance With Study Drug|0|||
38040521|NCT02339090|69727768|FG001|Overall Study|Non-compliance With Study Drug|1|||
38040522|NCT02339090|69727767|FG000|Overall Study|Withdrawal by Subject|2|||
38040523|NCT02339090|69727768|FG001|Overall Study|Withdrawal by Subject|1|||
38040524|NCT02339090|69727767|FG000|Overall Study|Poor Growth|3|||
38040525|NCT02339090|69727768|FG001|Overall Study|Poor Growth|0|||
38040526|NCT02339090|69727767|FG000|Overall Study|Randomized but not treated|0|||
38040527|NCT02339090|69727768|FG001|Overall Study|Randomized but not treated|2|||
38040528|NCT03331562|69727787|FG000|Overall Study|Adverse Event|2|||
38040529|NCT03331562|69727788|FG001|Overall Study|Adverse Event|0|||
38040530|NCT03331562|69727787|FG000|Overall Study|Death|1|||
38040531|NCT03331562|69727788|FG001|Overall Study|Death|0|||
38040532|NCT02038634|69727800|FG000|Overall Study|Lost to Follow-up|0|||
38040533|NCT02038634|69727801|FG001|Overall Study|Lost to Follow-up|1|||
38040534|NCT00836056|69727809|FG000|First Intervention|Adverse Event|1|||
38040535|NCT00836056|69727810|FG001|First Intervention|Adverse Event|0|||
38040536|NCT03200912|69727817|FG000|Overall Study|Adverse Event|3|||
38040537|NCT03200912|69727818|FG001|Overall Study|Adverse Event|0|||
38040538|NCT03200912|69727819|FG002|Overall Study|Adverse Event|0|||
38040539|NCT03200912|69727817|FG000|Overall Study|Withdrawal by Subject|1|||
38040540|NCT03200912|69727818|FG001|Overall Study|Withdrawal by Subject|2|||
38040541|NCT03200912|69727819|FG002|Overall Study|Withdrawal by Subject|4|||
38040542|NCT03200912|69727817|FG000|Overall Study|Non-compliance with study drug|0|||
38040543|NCT03200912|69727818|FG001|Overall Study|Non-compliance with study drug|1|||
38040544|NCT03200912|69727819|FG002|Overall Study|Non-compliance with study drug|0|||
38040545|NCT00835666|69727829|FG000|Washout|Protocol Violation|1|||
38040546|NCT00835666|69727830|FG001|Washout|Protocol Violation|0|||
38040547|NCT00835666|69727829|FG000|Washout|Withdrawal by Subject|1|||
38040548|NCT00835666|69727830|FG001|Washout|Withdrawal by Subject|0|||
38040549|NCT03200366|69727844|FG000|Patient Navigation Intervention Given|Death|0|||
38040550|NCT03200366|69727845|FG001|Patient Navigation Intervention Given|Death|2|||
38040551|NCT03200366|69727846|FG002|Patient Navigation Intervention Given|Death|0|||
38040552|NCT03200366|69727844|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
38040553|NCT03200366|69727845|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
38040554|NCT03200366|69727846|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
38040555|NCT03200366|69727844|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
38040556|NCT03200366|69727845|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
38040557|NCT03200366|69727846|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
38040558|NCT03200366|69727844|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
38040559|NCT03200366|69727845|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
38040560|NCT03200366|69727846|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
38040561|NCT03200366|69727844|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
38040562|NCT03200366|69727845|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
38040563|NCT03200366|69727846|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
38040564|NCT03200366|69727844|FG000|6 Month Post-Baseline Interview|Death|1|||
38040565|NCT03200366|69727845|FG001|6 Month Post-Baseline Interview|Death|1|||
38040566|NCT03200366|69727846|FG002|6 Month Post-Baseline Interview|Death|1|||
38040567|NCT03200366|69727844|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
38040568|NCT03200366|69727845|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
38040569|NCT03200366|69727846|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
38040570|NCT03200366|69727844|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
38040571|NCT03200366|69727845|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
38040572|NCT03200366|69727846|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
38040573|NCT03200366|69727844|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
38040574|NCT03200366|69727845|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
38040575|NCT03200366|69727846|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
38040576|NCT03200366|69727844|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
38040577|NCT03200366|69727845|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
38040578|NCT03200366|69727846|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
38040579|NCT03200366|69727844|FG000|9 Month Post-Baseline Interview|Death|1|||
38040580|NCT03200366|69727845|FG001|9 Month Post-Baseline Interview|Death|1|||
38040581|NCT03200366|69727846|FG002|9 Month Post-Baseline Interview|Death|1|||
38040582|NCT03200366|69727844|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
38040583|NCT03200366|69727845|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
38040584|NCT03200366|69727846|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
38040585|NCT03200366|69727844|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
38040586|NCT03200366|69727845|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
38040587|NCT03200366|69727846|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
38040588|NCT03200366|69727844|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
38040589|NCT03200366|69727845|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
38040590|NCT03200366|69727846|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
38040591|NCT00835354|69727858|FG000|First Intervention|Adverse Event|0|||
38040592|NCT00835354|69727859|FG001|First Intervention|Adverse Event|1|||
38040593|NCT00835042|69727890|FG000|First Intervention|Withdrawal by Subject|3|||
38040594|NCT00835042|69727891|FG001|First Intervention|Withdrawal by Subject|0|||
38040595|NCT00835042|69727890|FG000|First Intervention|Adverse Event|1|||
38040596|NCT00835042|69727891|FG001|First Intervention|Adverse Event|2|||
38040597|NCT00835042|69727890|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
38040598|NCT00835042|69727891|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
38040599|NCT00834418|69727928|FG000|Overall Study|Adverse Event|0|||
38040600|NCT00834418|69727929|FG001|Overall Study|Adverse Event|2|||
38040601|NCT00834340|69727935|FG000|Washout|Adverse Event|1|||
38040602|NCT00834340|69727936|FG001|Washout|Adverse Event|0|||
38040603|NCT00834340|69727935|FG000|Washout|Withdrawal by Subject|1|||
38040604|NCT00834340|69727936|FG001|Washout|Withdrawal by Subject|0|||
38040605|NCT00151996|69727942|FG000|Overall Study|Adverse Event|3|||
38040606|NCT00151996|69727943|FG001|Overall Study|Adverse Event|2|||
38040607|NCT00151996|69727942|FG000|Overall Study|Withdrawal by Subject|1|||
38040608|NCT00151996|69727943|FG001|Overall Study|Withdrawal by Subject|1|||
38040609|NCT00151996|69727942|FG000|Overall Study|Protocol Violation|1|||
38040610|NCT00151996|69727943|FG001|Overall Study|Protocol Violation|2|||
38040611|NCT00151996|69727942|FG000|Overall Study|Sponsor's decision|0|||
38040612|NCT00151996|69727943|FG001|Overall Study|Sponsor's decision|2|||
38040613|NCT00830206|69727951|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
38040614|NCT00830206|69727952|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
38040615|NCT00829504|69727958|FG000|First Intervention|Adverse Event|1|||
38040616|NCT00829504|69727959|FG001|First Intervention|Adverse Event|0|||
38040617|NCT00829504|69727958|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
38040618|NCT00829504|69727959|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
38040619|NCT00829504|69727958|FG000|Second Intervention|Physician Decision|1|||
38040620|NCT00829504|69727959|FG001|Second Intervention|Physician Decision|0|||
38040621|NCT00829426|69727965|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
38040622|NCT00829426|69727966|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
38040623|NCT00152464|69727972|FG000|Overall Study|Adverse Event|3|||
38040624|NCT00152464|69727973|FG001|Overall Study|Adverse Event|6|||
38040625|NCT00152464|69727972|FG000|Overall Study|Lost to Follow-up|8|||
38040626|NCT00152464|69727973|FG001|Overall Study|Lost to Follow-up|4|||
38040627|NCT00152464|69727972|FG000|Overall Study|Protocol Violation|3|||
38040628|NCT00152464|69727973|FG001|Overall Study|Protocol Violation|1|||
38040629|NCT00152464|69727972|FG000|Overall Study|Withdrawal by Subject|21|||
38040630|NCT00152464|69727973|FG001|Overall Study|Withdrawal by Subject|22|||
38040631|NCT00152464|69727972|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
38040632|NCT00152464|69727973|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
38040633|NCT00152464|69727972|FG000|Overall Study|Eczema deterioration|0|||
38040634|NCT00152464|69727973|FG001|Overall Study|Eczema deterioration|1|||
38040635|NCT00152464|69727972|FG000|Overall Study|Parent decision|1|||
38040636|NCT00152464|69727973|FG001|Overall Study|Parent decision|1|||
38040637|NCT00152464|69727972|FG000|Overall Study|Investigator decision|1|||
38040638|NCT00152464|69727973|FG001|Overall Study|Investigator decision|0|||
38040639|NCT00152464|69727972|FG000|Overall Study|Lack of Efficacy|1|||
38040640|NCT00152464|69727973|FG001|Overall Study|Lack of Efficacy|0|||
38040641|NCT00152464|69727972|FG000|Overall Study|Eczema poorly controlled|1|||
38040642|NCT00152464|69727973|FG001|Overall Study|Eczema poorly controlled|0|||
38040643|NCT00152464|69727972|FG000|Overall Study|Patient relocated|1|||
38040644|NCT00152464|69727973|FG001|Overall Study|Patient relocated|0|||
38040645|NCT00674440|69727979|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
38040646|NCT00674440|69727979|FG000|Overall Study|did not have surgery, so unevaluable|7|||
38040647|NCT00674440|69727979|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
38040648|NCT02742766|69728003|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
38040649|NCT02742766|69728004|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
38040650|NCT02742766|69728005|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
38040651|NCT02742766|69728006|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
38040652|NCT02742766|69728007|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
38040653|NCT02742766|69728008|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
38040654|NCT02742766|69728009|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
38040655|NCT02742766|69728010|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
38040656|NCT02742766|69728011|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
38040657|NCT02742766|69728012|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
38040658|NCT02742766|69728013|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
38040659|NCT02742766|69728014|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
38040660|NCT02742766|69728015|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
38040661|NCT02742766|69728016|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
38040662|NCT02742766|69728017|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
38040663|NCT02742766|69728018|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
38040664|NCT02742766|69728019|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
38040665|NCT02742766|69728020|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
38040666|NCT02742766|69728021|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
38040667|NCT02742766|69728003|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
38040668|NCT02742766|69728004|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
38040669|NCT02742766|69728005|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
38040670|NCT02742766|69728006|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
38040671|NCT02742766|69728007|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
38040672|NCT02742766|69728008|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
38040673|NCT02742766|69728009|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
38040674|NCT02742766|69728010|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
38040675|NCT02742766|69728011|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
38040676|NCT02742766|69728012|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
38040677|NCT02742766|69728013|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
38040678|NCT02742766|69728014|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
38040679|NCT02742766|69728015|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
38040680|NCT02742766|69728016|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
38040681|NCT02742766|69728017|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
38040682|NCT02742766|69728018|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
38040683|NCT02742766|69728019|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
38040684|NCT02742766|69728020|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
38040685|NCT02742766|69728021|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
38040686|NCT01468922|69728099|FG000|Overall Study|Screening failure|0|||
38040687|NCT01468922|69728100|FG001|Overall Study|Screening failure|0|||
38040688|NCT01468922|69728101|FG002|Overall Study|Screening failure|0|||
38040689|NCT01468922|69728102|FG003|Overall Study|Screening failure|0|||
38040690|NCT01468922|69728103|FG004|Overall Study|Screening failure|0|||
38040691|NCT01468922|69728104|FG005|Overall Study|Screening failure|0|||
38040692|NCT01468922|69728105|FG006|Overall Study|Screening failure|0|||
38040693|NCT01468922|69728106|FG007|Overall Study|Screening failure|0|||
37676246|NCT01680991|69150862|FG001|Overall Study|Death|0|||
37676247|NCT01680991|69150863|FG002|Overall Study|Death|1|||
37676248|NCT01680991|69150861|FG000|Overall Study|Protocol Violation|0|||
38040694|NCT01468922|69728107|FG008|Overall Study|Screening failure|1|||
38040695|NCT01468922|69728099|FG000|Overall Study|Per patient choice|1|||
38040696|NCT01468922|69728100|FG001|Overall Study|Per patient choice|0|||
38040697|NCT01468922|69728101|FG002|Overall Study|Per patient choice|0|||
38040698|NCT01468922|69728102|FG003|Overall Study|Per patient choice|0|||
38040699|NCT01468922|69728103|FG004|Overall Study|Per patient choice|0|||
38040700|NCT01468922|69728104|FG005|Overall Study|Per patient choice|0|||
38040701|NCT01468922|69728105|FG006|Overall Study|Per patient choice|0|||
38040702|NCT01468922|69728106|FG007|Overall Study|Per patient choice|0|||
38040703|NCT01468922|69728107|FG008|Overall Study|Per patient choice|0|||
38040704|NCT01468922|69728099|FG000|Overall Study|Switched to alternative treatment|1|||
38040705|NCT01468922|69728100|FG001|Overall Study|Switched to alternative treatment|0|||
38040706|NCT01468922|69728101|FG002|Overall Study|Switched to alternative treatment|0|||
38040707|NCT01468922|69728102|FG003|Overall Study|Switched to alternative treatment|0|||
38040708|NCT01468922|69728103|FG004|Overall Study|Switched to alternative treatment|1|||
38040709|NCT01468922|69728104|FG005|Overall Study|Switched to alternative treatment|0|||
38040710|NCT01468922|69728105|FG006|Overall Study|Switched to alternative treatment|0|||
38040711|NCT01468922|69728106|FG007|Overall Study|Switched to alternative treatment|0|||
38040712|NCT01468922|69728107|FG008|Overall Study|Switched to alternative treatment|0|||
38040713|NCT01468922|69728099|FG000|Overall Study|Enrolled on new protocol|0|||
38040714|NCT01468922|69728100|FG001|Overall Study|Enrolled on new protocol|0|||
38040715|NCT01468922|69728101|FG002|Overall Study|Enrolled on new protocol|0|||
38040716|NCT01468922|69728102|FG003|Overall Study|Enrolled on new protocol|0|||
38040717|NCT01468922|69728103|FG004|Overall Study|Enrolled on new protocol|1|||
38040718|NCT01468922|69728104|FG005|Overall Study|Enrolled on new protocol|0|||
38040719|NCT01468922|69728105|FG006|Overall Study|Enrolled on new protocol|0|||
38040720|NCT01468922|69728106|FG007|Overall Study|Enrolled on new protocol|0|||
38040721|NCT01468922|69728107|FG008|Overall Study|Enrolled on new protocol|0|||
38040722|NCT01468922|69728099|FG000|Overall Study|Adverse Event|0|||
38040723|NCT01468922|69728100|FG001|Overall Study|Adverse Event|0|||
38040724|NCT01468922|69728101|FG002|Overall Study|Adverse Event|0|||
38040725|NCT01468922|69728102|FG003|Overall Study|Adverse Event|0|||
38040726|NCT01468922|69728103|FG004|Overall Study|Adverse Event|0|||
38040727|NCT01468922|69728104|FG005|Overall Study|Adverse Event|0|||
38040728|NCT01468922|69728105|FG006|Overall Study|Adverse Event|0|||
38040729|NCT01468922|69728106|FG007|Overall Study|Adverse Event|1|||
38040730|NCT01468922|69728107|FG008|Overall Study|Adverse Event|0|||
38040731|NCT01468922|69728099|FG000|Overall Study|Infection of blood|0|||
38040732|NCT01468922|69728100|FG001|Overall Study|Infection of blood|0|||
38040733|NCT01468922|69728101|FG002|Overall Study|Infection of blood|0|||
38040734|NCT01468922|69728102|FG003|Overall Study|Infection of blood|0|||
38040735|NCT01468922|69728103|FG004|Overall Study|Infection of blood|0|||
38040736|NCT01468922|69728104|FG005|Overall Study|Infection of blood|0|||
38040737|NCT01468922|69728105|FG006|Overall Study|Infection of blood|0|||
38040738|NCT01468922|69728106|FG007|Overall Study|Infection of blood|1|||
38040739|NCT01468922|69728107|FG008|Overall Study|Infection of blood|0|||
38040740|NCT01468922|69728099|FG000|Overall Study|Patient choice - surgery|0|||
38040741|NCT01468922|69728100|FG001|Overall Study|Patient choice - surgery|0|||
38040742|NCT01468922|69728101|FG002|Overall Study|Patient choice - surgery|0|||
38040743|NCT01468922|69728102|FG003|Overall Study|Patient choice - surgery|0|||
38040744|NCT01468922|69728103|FG004|Overall Study|Patient choice - surgery|0|||
38040745|NCT01468922|69728104|FG005|Overall Study|Patient choice - surgery|0|||
38040746|NCT01468922|69728105|FG006|Overall Study|Patient choice - surgery|0|||
38040747|NCT01468922|69728106|FG007|Overall Study|Patient choice - surgery|1|||
38040748|NCT01468922|69728107|FG008|Overall Study|Patient choice - surgery|0|||
38040749|NCT01468922|69728099|FG000|Overall Study|Refused further treatment|0|||
38040750|NCT01468922|69728100|FG001|Overall Study|Refused further treatment|0|||
38040751|NCT01468922|69728101|FG002|Overall Study|Refused further treatment|0|||
38040752|NCT01468922|69728102|FG003|Overall Study|Refused further treatment|0|||
38040753|NCT01468922|69728103|FG004|Overall Study|Refused further treatment|0|||
38040754|NCT01468922|69728104|FG005|Overall Study|Refused further treatment|0|||
38040755|NCT01468922|69728105|FG006|Overall Study|Refused further treatment|0|||
38040756|NCT01468922|69728106|FG007|Overall Study|Refused further treatment|1|||
38040757|NCT01468922|69728107|FG008|Overall Study|Refused further treatment|0|||
38040758|NCT01381094|69728130|FG000|Overall Study|Adverse Event|1|||
38040759|NCT01381094|69728131|FG001|Overall Study|Adverse Event|2|||
38040760|NCT01381094|69728132|FG002|Overall Study|Adverse Event|0|||
38040761|NCT01381094|69728133|FG003|Overall Study|Adverse Event|1|||
38040762|NCT01381094|69728134|FG004|Overall Study|Adverse Event|0|||
38040763|NCT01381094|69728130|FG000|Overall Study|Lost to Follow-up|0|||
38040764|NCT01381094|69728131|FG001|Overall Study|Lost to Follow-up|0|||
38040765|NCT01381094|69728132|FG002|Overall Study|Lost to Follow-up|0|||
38040766|NCT01381094|69728133|FG003|Overall Study|Lost to Follow-up|0|||
38040767|NCT01381094|69728134|FG004|Overall Study|Lost to Follow-up|1|||
38040768|NCT01381094|69728130|FG000|Overall Study|Withdrawal of informed consent|0|||
38040769|NCT01381094|69728131|FG001|Overall Study|Withdrawal of informed consent|1|||
38040770|NCT01381094|69728132|FG002|Overall Study|Withdrawal of informed consent|0|||
38040771|NCT01381094|69728133|FG003|Overall Study|Withdrawal of informed consent|0|||
38040772|NCT01381094|69728134|FG004|Overall Study|Withdrawal of informed consent|0|||
38040773|NCT01381094|69728130|FG000|Overall Study|Participant given Aranesp injection|1|||
38040774|NCT01381094|69728131|FG001|Overall Study|Participant given Aranesp injection|0|||
38040775|NCT01381094|69728132|FG002|Overall Study|Participant given Aranesp injection|0|||
38040776|NCT01381094|69728133|FG003|Overall Study|Participant given Aranesp injection|0|||
38040777|NCT01381094|69728134|FG004|Overall Study|Participant given Aranesp injection|0|||
38040778|NCT03197558|69728146|FG000|Overall Study|Tubes not placed|1|||
38040779|NCT03197324|69728152|FG000|Overall Study|Adverse Event|0|||
38040780|NCT03197324|69728153|FG001|Overall Study|Adverse Event|1|||
38040781|NCT03162614|69728165|FG000|Overall Study|Lost to Follow-up|2|||
38040782|NCT03162614|69728166|FG001|Overall Study|Lost to Follow-up|1|||
38040783|NCT03162614|69728167|FG002|Overall Study|Lost to Follow-up|1|||
38040784|NCT03162614|69728168|FG003|Overall Study|Lost to Follow-up|1|||
38040785|NCT03162614|69728169|FG004|Overall Study|Lost to Follow-up|2|||
38040786|NCT03162614|69728170|FG005|Overall Study|Lost to Follow-up|0|||
38040787|NCT03162614|69728165|FG000|Overall Study|Protocol Violation|0|||
38040788|NCT03162614|69728166|FG001|Overall Study|Protocol Violation|1|||
38040789|NCT03162614|69728167|FG002|Overall Study|Protocol Violation|0|||
38040790|NCT03162614|69728168|FG003|Overall Study|Protocol Violation|1|||
38040791|NCT03162614|69728169|FG004|Overall Study|Protocol Violation|0|||
38040792|NCT03162614|69728170|FG005|Overall Study|Protocol Violation|0|||
38040793|NCT03162614|69728165|FG000|Overall Study|Withdrawal by Subject|2|||
38040794|NCT03162614|69728166|FG001|Overall Study|Withdrawal by Subject|1|||
38040795|NCT03162614|69728167|FG002|Overall Study|Withdrawal by Subject|1|||
38040796|NCT03162614|69728168|FG003|Overall Study|Withdrawal by Subject|1|||
38040797|NCT03162614|69728169|FG004|Overall Study|Withdrawal by Subject|0|||
38040798|NCT03162614|69728170|FG005|Overall Study|Withdrawal by Subject|0|||
38040799|NCT03162614|69728165|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
38040800|NCT03162614|69728166|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
38040801|NCT03162614|69728167|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
38040802|NCT03162614|69728168|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
38040803|NCT03162614|69728169|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
38040804|NCT03162614|69728170|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
38040805|NCT03160898|69728188|FG000|Overall Study|Adverse Event|4|||
38040806|NCT03160898|69728189|FG001|Overall Study|Adverse Event|8|||
38040807|NCT03160898|69728190|FG002|Overall Study|Adverse Event|7|||
38040808|NCT03160898|69728191|FG003|Overall Study|Adverse Event|10|||
38040809|NCT03160898|69728188|FG000|Overall Study|Death|1|||
38040810|NCT03160898|69728189|FG001|Overall Study|Death|0|||
38040811|NCT03160898|69728190|FG002|Overall Study|Death|0|||
38040812|NCT03160898|69728191|FG003|Overall Study|Death|1|||
38040813|NCT03160898|69728188|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
38040814|NCT03160898|69728189|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
38040815|NCT03160898|69728190|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
38040816|NCT03160898|69728191|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
38040817|NCT03160898|69728188|FG000|Overall Study|Lost to Follow-up|1|||
38040818|NCT03160898|69728189|FG001|Overall Study|Lost to Follow-up|1|||
38040819|NCT03160898|69728190|FG002|Overall Study|Lost to Follow-up|1|||
38040820|NCT03160898|69728191|FG003|Overall Study|Lost to Follow-up|2|||
38040821|NCT03160898|69728188|FG000|Overall Study|Physician Decision|1|||
38040822|NCT03160898|69728189|FG001|Overall Study|Physician Decision|0|||
38040823|NCT03160898|69728190|FG002|Overall Study|Physician Decision|0|||
38040824|NCT03160898|69728191|FG003|Overall Study|Physician Decision|1|||
38040825|NCT03160898|69728188|FG000|Overall Study|Progressive Disease|4|||
38040826|NCT03160898|69728189|FG001|Overall Study|Progressive Disease|1|||
38040827|NCT03160898|69728190|FG002|Overall Study|Progressive Disease|2|||
38040828|NCT03160898|69728191|FG003|Overall Study|Progressive Disease|1|||
38040829|NCT03160898|69728188|FG000|Overall Study|Protocol Violation|1|||
38040830|NCT03160898|69728189|FG001|Overall Study|Protocol Violation|0|||
38040831|NCT03160898|69728190|FG002|Overall Study|Protocol Violation|2|||
38040832|NCT03160898|69728191|FG003|Overall Study|Protocol Violation|0|||
38040833|NCT03160898|69728188|FG000|Overall Study|Sponsor Discretion|2|||
38040834|NCT03160898|69728189|FG001|Overall Study|Sponsor Discretion|0|||
38040835|NCT03160898|69728190|FG002|Overall Study|Sponsor Discretion|0|||
38040836|NCT03160898|69728191|FG003|Overall Study|Sponsor Discretion|0|||
38040837|NCT03160898|69728188|FG000|Overall Study|Withdrawal by Subject|1|||
38040838|NCT03160898|69728189|FG001|Overall Study|Withdrawal by Subject|3|||
38040839|NCT03160898|69728190|FG002|Overall Study|Withdrawal by Subject|2|||
38040840|NCT03160898|69728191|FG003|Overall Study|Withdrawal by Subject|1|||
38040841|NCT03160898|69728188|FG000|Overall Study|Other|2|||
38040842|NCT03160898|69728189|FG001|Overall Study|Other|0|||
38040843|NCT03160898|69728190|FG002|Overall Study|Other|2|||
38040844|NCT03160898|69728191|FG003|Overall Study|Other|2|||
38040845|NCT03193736|69728202|FG000|Overall Study|Death|2|||
38040846|NCT03193736|69728202|FG000|Overall Study|Withdrawal by Subject|1|||
38040847|NCT03193736|69728202|FG000|Overall Study|Lost to Follow-up|1|||
38040848|NCT03193736|69728202|FG000|Overall Study|implant not received|1|||
38040849|NCT03192488|69728210|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
38040850|NCT03192488|69728211|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
38040851|NCT03192488|69728212|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
38040852|NCT03192488|69728213|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
38040853|NCT03192488|69728214|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
38040854|NCT03192488|69728215|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
38040855|NCT03192488|69728210|FG000|Third Intervention (d1)|Adverse Event|0|||
38040856|NCT03192488|69728211|FG001|Third Intervention (d1)|Adverse Event|0|||
38040857|NCT03192488|69728212|FG002|Third Intervention (d1)|Adverse Event|0|||
38040858|NCT03192488|69728213|FG003|Third Intervention (d1)|Adverse Event|0|||
38040859|NCT03192488|69728214|FG004|Third Intervention (d1)|Adverse Event|1|||
38040860|NCT03192488|69728215|FG005|Third Intervention (d1)|Adverse Event|0|||
38040861|NCT01642004|69728231|FG000|Randomization|Adverse Event unrelated to study drug|1|||
38040862|NCT01642004|69728232|FG001|Randomization|Adverse Event unrelated to study drug|0|||
38040863|NCT01642004|69728231|FG000|Randomization|Participant withdrew consent|1|||
38040864|NCT01642004|69728232|FG001|Randomization|Participant withdrew consent|6|||
38040865|NCT01642004|69728231|FG000|Randomization|No longer meets study criteria|2|||
38040866|NCT01642004|69728232|FG001|Randomization|No longer meets study criteria|2|||
38040867|NCT01642004|69728231|FG000|Treatment|Disease progression|95|||
38040868|NCT01642004|69728232|FG001|Treatment|Disease progression|79|||
38040869|NCT01642004|69728231|FG000|Treatment|Study drug toxicity|10|||
38040870|NCT01642004|69728232|FG001|Treatment|Study drug toxicity|13|||
38040871|NCT01642004|69728231|FG000|Treatment|Death|1|||
38040872|NCT01642004|69728232|FG001|Treatment|Death|1|||
38040873|NCT01642004|69728231|FG000|Treatment|Adverse event unrelated to study drug|9|||
38040874|NCT01642004|69728232|FG001|Treatment|Adverse event unrelated to study drug|13|||
38040875|NCT01642004|69728231|FG000|Treatment|Maximum clinical benefit|1|||
38040876|NCT01642004|69728232|FG001|Treatment|Maximum clinical benefit|9|||
38040877|NCT01642004|69728231|FG000|Treatment|Poor/non-compliance|1|||
38040878|NCT01642004|69728232|FG001|Treatment|Poor/non-compliance|0|||
38040879|NCT01642004|69728231|FG000|Treatment|No longer meets study criteria|1|||
38040880|NCT01642004|69728232|FG001|Treatment|No longer meets study criteria|2|||
38040881|NCT01642004|69728231|FG000|Treatment|Other reasons|2|||
38040882|NCT01642004|69728232|FG001|Treatment|Other reasons|0|||
38040883|NCT01642004|69728231|FG000|Treatment|Not reported|0|||
38040884|NCT01642004|69728232|FG001|Treatment|Not reported|3|||
38040885|NCT01642004|69728231|FG000|Treatment|Participant request to discontinue study treatment|6|||
38040886|NCT01642004|69728232|FG001|Treatment|Participant request to discontinue study treatment|4|||
38040887|NCT01642004|69728231|FG000|Treatment|Participant withdrew consent|5|||
38040888|NCT01642004|69728232|FG001|Treatment|Participant withdrew consent|5|||
38040889|NCT00042289|69728288|FG000|Overall Study|Lost to Follow-up|3|||
38040890|NCT00042289|69728289|FG001|Overall Study|Lost to Follow-up|0|||
38040891|NCT00042289|69728290|FG002|Overall Study|Lost to Follow-up|0|||
38040892|NCT00042289|69728291|FG003|Overall Study|Lost to Follow-up|1|||
38040893|NCT00042289|69728292|FG004|Overall Study|Lost to Follow-up|3|||
38040894|NCT00042289|69728293|FG005|Overall Study|Lost to Follow-up|3|||
38040895|NCT00042289|69728294|FG006|Overall Study|Lost to Follow-up|6|||
38040896|NCT00042289|69728295|FG007|Overall Study|Lost to Follow-up|1|||
38040897|NCT00042289|69728296|FG008|Overall Study|Lost to Follow-up|1|||
38040898|NCT00042289|69728297|FG009|Overall Study|Lost to Follow-up|0|||
38040899|NCT00042289|69728298|FG010|Overall Study|Lost to Follow-up|0|||
38040900|NCT00042289|69728299|FG011|Overall Study|Lost to Follow-up|0|||
38040901|NCT00042289|69728300|FG012|Overall Study|Lost to Follow-up|0|||
38040902|NCT00042289|69728301|FG013|Overall Study|Lost to Follow-up|0|||
38040903|NCT00042289|69728302|FG014|Overall Study|Lost to Follow-up|0|||
38040904|NCT00042289|69728303|FG015|Overall Study|Lost to Follow-up|1|||
38040905|NCT00042289|69728304|FG016|Overall Study|Lost to Follow-up|1|||
38040906|NCT00042289|69728305|FG017|Overall Study|Lost to Follow-up|0|||
38040907|NCT00042289|69728306|FG018|Overall Study|Lost to Follow-up|3|||
38040908|NCT00042289|69728307|FG019|Overall Study|Lost to Follow-up|2|||
38040909|NCT00042289|69728308|FG020|Overall Study|Lost to Follow-up|0|||
38040910|NCT00042289|69728309|FG021|Overall Study|Lost to Follow-up|0|||
38040911|NCT00042289|69728310|FG022|Overall Study|Lost to Follow-up|0|||
38040912|NCT00042289|69728311|FG023|Overall Study|Lost to Follow-up|0|||
38040913|NCT00042289|69728312|FG024|Overall Study|Lost to Follow-up|0|||
38040914|NCT00042289|69728313|FG025|Overall Study|Lost to Follow-up|0|||
38040915|NCT00042289|69728314|FG026|Overall Study|Lost to Follow-up|2|||
38040916|NCT00042289|69728315|FG027|Overall Study|Lost to Follow-up|2|||
38040917|NCT00042289|69728316|FG028|Overall Study|Lost to Follow-up|2|||
38040918|NCT00042289|69728317|FG029|Overall Study|Lost to Follow-up|0|||
38040919|NCT00042289|69728318|FG030|Overall Study|Lost to Follow-up|0|||
38040920|NCT00042289|69728319|FG031|Overall Study|Lost to Follow-up|2|||
38040921|NCT00042289|69728320|FG032|Overall Study|Lost to Follow-up|1|||
38040922|NCT00042289|69728321|FG033|Overall Study|Lost to Follow-up|1|||
38040923|NCT00042289|69728322|FG034|Overall Study|Lost to Follow-up|1|||
38040924|NCT00042289|69728323|FG035|Overall Study|Lost to Follow-up|2|||
38040925|NCT00042289|69728324|FG036|Overall Study|Lost to Follow-up|1|||
38040926|NCT00042289|69728325|FG037|Overall Study|Lost to Follow-up|1|||
38040927|NCT00042289|69728326|FG038|Overall Study|Lost to Follow-up|0|||
38040928|NCT00042289|69728327|FG039|Overall Study|Lost to Follow-up|5|||
38040929|NCT00042289|69728328|FG040|Overall Study|Lost to Follow-up|0|||
38040930|NCT00042289|69728329|FG041|Overall Study|Lost to Follow-up|2|||
38040931|NCT00042289|69728330|FG042|Overall Study|Lost to Follow-up|2|||
38040932|NCT00042289|69728331|FG043|Overall Study|Lost to Follow-up|0|||
38040933|NCT00042289|69728332|FG044|Overall Study|Lost to Follow-up|0|||
38040934|NCT00042289|69728333|FG045|Overall Study|Lost to Follow-up|1|||
38040935|NCT00042289|69728334|FG046|Overall Study|Lost to Follow-up|0|||
38040936|NCT00042289|69728288|FG000|Overall Study|Other reason|0|||
38040937|NCT00042289|69728289|FG001|Overall Study|Other reason|0|||
38040938|NCT00042289|69728290|FG002|Overall Study|Other reason|0|||
38040939|NCT00042289|69728291|FG003|Overall Study|Other reason|2|||
38040940|NCT00042289|69728292|FG004|Overall Study|Other reason|0|||
38040941|NCT00042289|69728293|FG005|Overall Study|Other reason|0|||
38040942|NCT00042289|69728294|FG006|Overall Study|Other reason|0|||
38040943|NCT00042289|69728295|FG007|Overall Study|Other reason|0|||
38040944|NCT00042289|69728296|FG008|Overall Study|Other reason|0|||
38040945|NCT00042289|69728297|FG009|Overall Study|Other reason|0|||
38040946|NCT00042289|69728298|FG010|Overall Study|Other reason|0|||
38040947|NCT00042289|69728299|FG011|Overall Study|Other reason|0|||
38040948|NCT00042289|69728300|FG012|Overall Study|Other reason|0|||
38040949|NCT00042289|69728301|FG013|Overall Study|Other reason|0|||
38040950|NCT00042289|69728302|FG014|Overall Study|Other reason|0|||
38040951|NCT00042289|69728303|FG015|Overall Study|Other reason|0|||
38040952|NCT00042289|69728304|FG016|Overall Study|Other reason|0|||
38040953|NCT00042289|69728305|FG017|Overall Study|Other reason|0|||
38040954|NCT00042289|69728306|FG018|Overall Study|Other reason|1|||
38040955|NCT00042289|69728307|FG019|Overall Study|Other reason|0|||
38040956|NCT00042289|69728308|FG020|Overall Study|Other reason|0|||
38040957|NCT00042289|69728309|FG021|Overall Study|Other reason|0|||
38040958|NCT00042289|69728310|FG022|Overall Study|Other reason|0|||
38040959|NCT00042289|69728311|FG023|Overall Study|Other reason|1|||
38040960|NCT00042289|69728312|FG024|Overall Study|Other reason|0|||
38040961|NCT00042289|69728313|FG025|Overall Study|Other reason|0|||
38040962|NCT00042289|69728314|FG026|Overall Study|Other reason|1|||
38040963|NCT00042289|69728315|FG027|Overall Study|Other reason|0|||
38040964|NCT00042289|69728316|FG028|Overall Study|Other reason|3|||
38040965|NCT00042289|69728317|FG029|Overall Study|Other reason|0|||
38040966|NCT00042289|69728318|FG030|Overall Study|Other reason|0|||
38040967|NCT00042289|69728319|FG031|Overall Study|Other reason|1|||
38040968|NCT00042289|69728320|FG032|Overall Study|Other reason|0|||
38040969|NCT00042289|69728321|FG033|Overall Study|Other reason|1|||
38040970|NCT00042289|69728322|FG034|Overall Study|Other reason|0|||
38040971|NCT00042289|69728323|FG035|Overall Study|Other reason|2|||
38040972|NCT00042289|69728324|FG036|Overall Study|Other reason|0|||
38040973|NCT00042289|69728325|FG037|Overall Study|Other reason|0|||
38040974|NCT00042289|69728326|FG038|Overall Study|Other reason|0|||
38040975|NCT00042289|69728327|FG039|Overall Study|Other reason|0|||
38040976|NCT00042289|69728328|FG040|Overall Study|Other reason|0|||
38040977|NCT00042289|69728329|FG041|Overall Study|Other reason|0|||
38040978|NCT00042289|69728330|FG042|Overall Study|Other reason|0|||
38040979|NCT00042289|69728331|FG043|Overall Study|Other reason|1|||
38040980|NCT00042289|69728332|FG044|Overall Study|Other reason|0|||
38040981|NCT00042289|69728333|FG045|Overall Study|Other reason|0|||
38040982|NCT00042289|69728334|FG046|Overall Study|Other reason|0|||
38040983|NCT00042289|69728288|FG000|Overall Study|Severe debilitation, unable to continue|0|||
38040984|NCT00042289|69728289|FG001|Overall Study|Severe debilitation, unable to continue|0|||
38040985|NCT00042289|69728290|FG002|Overall Study|Severe debilitation, unable to continue|0|||
38040986|NCT00042289|69728291|FG003|Overall Study|Severe debilitation, unable to continue|0|||
38040987|NCT00042289|69728292|FG004|Overall Study|Severe debilitation, unable to continue|0|||
38040988|NCT00042289|69728293|FG005|Overall Study|Severe debilitation, unable to continue|0|||
38040989|NCT00042289|69728294|FG006|Overall Study|Severe debilitation, unable to continue|0|||
38040990|NCT00042289|69728295|FG007|Overall Study|Severe debilitation, unable to continue|0|||
38040991|NCT00042289|69728296|FG008|Overall Study|Severe debilitation, unable to continue|0|||
38040992|NCT00042289|69728297|FG009|Overall Study|Severe debilitation, unable to continue|0|||
38040993|NCT00042289|69728298|FG010|Overall Study|Severe debilitation, unable to continue|0|||
38040994|NCT00042289|69728299|FG011|Overall Study|Severe debilitation, unable to continue|0|||
38040995|NCT00042289|69728300|FG012|Overall Study|Severe debilitation, unable to continue|0|||
38040996|NCT00042289|69728301|FG013|Overall Study|Severe debilitation, unable to continue|0|||
38040997|NCT00042289|69728302|FG014|Overall Study|Severe debilitation, unable to continue|0|||
38040998|NCT00042289|69728303|FG015|Overall Study|Severe debilitation, unable to continue|0|||
38040999|NCT00042289|69728304|FG016|Overall Study|Severe debilitation, unable to continue|0|||
38041000|NCT00042289|69728305|FG017|Overall Study|Severe debilitation, unable to continue|0|||
37676249|NCT01680991|69150862|FG001|Overall Study|Protocol Violation|1|||
38041001|NCT00042289|69728306|FG018|Overall Study|Severe debilitation, unable to continue|0|||
38041002|NCT00042289|69728307|FG019|Overall Study|Severe debilitation, unable to continue|0|||
38041003|NCT00042289|69728308|FG020|Overall Study|Severe debilitation, unable to continue|0|||
38041004|NCT00042289|69728309|FG021|Overall Study|Severe debilitation, unable to continue|1|||
38041005|NCT00042289|69728310|FG022|Overall Study|Severe debilitation, unable to continue|0|||
38041006|NCT00042289|69728311|FG023|Overall Study|Severe debilitation, unable to continue|1|||
38041007|NCT00042289|69728312|FG024|Overall Study|Severe debilitation, unable to continue|0|||
38041008|NCT00042289|69728313|FG025|Overall Study|Severe debilitation, unable to continue|0|||
38041009|NCT00042289|69728314|FG026|Overall Study|Severe debilitation, unable to continue|0|||
38041010|NCT00042289|69728315|FG027|Overall Study|Severe debilitation, unable to continue|1|||
38041011|NCT00042289|69728316|FG028|Overall Study|Severe debilitation, unable to continue|0|||
38041012|NCT00042289|69728317|FG029|Overall Study|Severe debilitation, unable to continue|0|||
38041013|NCT00042289|69728318|FG030|Overall Study|Severe debilitation, unable to continue|0|||
38041014|NCT00042289|69728319|FG031|Overall Study|Severe debilitation, unable to continue|1|||
38041015|NCT00042289|69728320|FG032|Overall Study|Severe debilitation, unable to continue|1|||
38041016|NCT00042289|69728321|FG033|Overall Study|Severe debilitation, unable to continue|0|||
38041017|NCT00042289|69728322|FG034|Overall Study|Severe debilitation, unable to continue|0|||
38041018|NCT00042289|69728323|FG035|Overall Study|Severe debilitation, unable to continue|0|||
38041019|NCT00042289|69728324|FG036|Overall Study|Severe debilitation, unable to continue|0|||
38041020|NCT00042289|69728325|FG037|Overall Study|Severe debilitation, unable to continue|0|||
38041021|NCT00042289|69728326|FG038|Overall Study|Severe debilitation, unable to continue|0|||
38041022|NCT00042289|69728327|FG039|Overall Study|Severe debilitation, unable to continue|0|||
38041023|NCT00042289|69728328|FG040|Overall Study|Severe debilitation, unable to continue|0|||
38041024|NCT00042289|69728329|FG041|Overall Study|Severe debilitation, unable to continue|0|||
38041025|NCT00042289|69728330|FG042|Overall Study|Severe debilitation, unable to continue|0|||
38041026|NCT00042289|69728331|FG043|Overall Study|Severe debilitation, unable to continue|0|||
38041027|NCT00042289|69728332|FG044|Overall Study|Severe debilitation, unable to continue|0|||
38041028|NCT00042289|69728333|FG045|Overall Study|Severe debilitation, unable to continue|0|||
38041029|NCT00042289|69728334|FG046|Overall Study|Severe debilitation, unable to continue|0|||
38041030|NCT00042289|69728288|FG000|Overall Study|Site closed|0|||
38041031|NCT00042289|69728289|FG001|Overall Study|Site closed|0|||
38041032|NCT00042289|69728290|FG002|Overall Study|Site closed|0|||
38041033|NCT00042289|69728291|FG003|Overall Study|Site closed|0|||
38041034|NCT00042289|69728292|FG004|Overall Study|Site closed|0|||
38041035|NCT00042289|69728293|FG005|Overall Study|Site closed|0|||
38041036|NCT00042289|69728294|FG006|Overall Study|Site closed|0|||
38041037|NCT00042289|69728295|FG007|Overall Study|Site closed|0|||
38041038|NCT00042289|69728296|FG008|Overall Study|Site closed|0|||
38041039|NCT00042289|69728297|FG009|Overall Study|Site closed|0|||
38041040|NCT00042289|69728298|FG010|Overall Study|Site closed|0|||
38041041|NCT00042289|69728299|FG011|Overall Study|Site closed|0|||
38041042|NCT00042289|69728300|FG012|Overall Study|Site closed|0|||
38041043|NCT00042289|69728301|FG013|Overall Study|Site closed|0|||
38041044|NCT00042289|69728302|FG014|Overall Study|Site closed|0|||
38041045|NCT00042289|69728303|FG015|Overall Study|Site closed|0|||
38041046|NCT00042289|69728304|FG016|Overall Study|Site closed|0|||
38041047|NCT00042289|69728305|FG017|Overall Study|Site closed|0|||
38041048|NCT00042289|69728306|FG018|Overall Study|Site closed|0|||
38041049|NCT00042289|69728307|FG019|Overall Study|Site closed|0|||
38041050|NCT00042289|69728308|FG020|Overall Study|Site closed|0|||
38041051|NCT00042289|69728309|FG021|Overall Study|Site closed|0|||
38041052|NCT00042289|69728310|FG022|Overall Study|Site closed|0|||
38041053|NCT00042289|69728311|FG023|Overall Study|Site closed|0|||
38041054|NCT00042289|69728312|FG024|Overall Study|Site closed|0|||
38041055|NCT00042289|69728313|FG025|Overall Study|Site closed|0|||
38041056|NCT00042289|69728314|FG026|Overall Study|Site closed|0|||
38041057|NCT00042289|69728315|FG027|Overall Study|Site closed|0|||
38041058|NCT00042289|69728316|FG028|Overall Study|Site closed|0|||
38041059|NCT00042289|69728317|FG029|Overall Study|Site closed|0|||
38041060|NCT00042289|69728318|FG030|Overall Study|Site closed|0|||
38041061|NCT00042289|69728319|FG031|Overall Study|Site closed|3|||
38041062|NCT00042289|69728320|FG032|Overall Study|Site closed|0|||
38041063|NCT00042289|69728321|FG033|Overall Study|Site closed|0|||
38041064|NCT00042289|69728322|FG034|Overall Study|Site closed|0|||
38041065|NCT00042289|69728323|FG035|Overall Study|Site closed|0|||
38041066|NCT00042289|69728324|FG036|Overall Study|Site closed|1|||
38041067|NCT00042289|69728325|FG037|Overall Study|Site closed|0|||
38041068|NCT00042289|69728326|FG038|Overall Study|Site closed|0|||
38041069|NCT00042289|69728327|FG039|Overall Study|Site closed|0|||
38041070|NCT00042289|69728328|FG040|Overall Study|Site closed|0|||
38041071|NCT00042289|69728329|FG041|Overall Study|Site closed|0|||
38041072|NCT00042289|69728330|FG042|Overall Study|Site closed|1|||
38041073|NCT00042289|69728331|FG043|Overall Study|Site closed|0|||
38041074|NCT00042289|69728332|FG044|Overall Study|Site closed|0|||
38041075|NCT00042289|69728333|FG045|Overall Study|Site closed|0|||
38041076|NCT00042289|69728334|FG046|Overall Study|Site closed|0|||
38041077|NCT00042289|69728288|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
38041078|NCT00042289|69728289|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
38041079|NCT00042289|69728290|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
38041080|NCT00042289|69728291|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
38041081|NCT00042289|69728292|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
38041082|NCT00042289|69728293|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
38041083|NCT00042289|69728294|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
38041084|NCT00042289|69728295|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
38041085|NCT00042289|69728296|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
38041086|NCT00042289|69728297|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
38041087|NCT00042289|69728298|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
38041088|NCT00042289|69728299|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
38041089|NCT00042289|69728300|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
38041090|NCT00042289|69728301|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
38041091|NCT00042289|69728302|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
38041092|NCT00042289|69728303|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
38041093|NCT00042289|69728304|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
38041094|NCT00042289|69728305|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
38041095|NCT00042289|69728306|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
38041096|NCT00042289|69728307|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
38041097|NCT00042289|69728308|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
38041098|NCT00042289|69728309|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
38041099|NCT00042289|69728310|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
38041100|NCT00042289|69728311|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
38041101|NCT00042289|69728312|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
38041102|NCT00042289|69728313|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
38041103|NCT00042289|69728314|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
38041104|NCT00042289|69728315|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
38041105|NCT00042289|69728316|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
38041106|NCT00042289|69728317|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
38041107|NCT00042289|69728318|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
38041108|NCT00042289|69728319|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
38041109|NCT00042289|69728320|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
38041110|NCT00042289|69728321|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
38041111|NCT00042289|69728322|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
38041112|NCT00042289|69728323|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
38041113|NCT00042289|69728324|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
38041114|NCT00042289|69728325|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
38041115|NCT00042289|69728326|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
38041116|NCT00042289|69728327|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
38041117|NCT00042289|69728328|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
38041118|NCT00042289|69728329|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
38041119|NCT00042289|69728330|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
38041120|NCT00042289|69728331|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
38041121|NCT00042289|69728332|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
38041122|NCT00042289|69728333|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
38041123|NCT00042289|69728334|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
38041124|NCT00042289|69728288|FG000|Overall Study|Protocol Violation|0|||
38041125|NCT00042289|69728289|FG001|Overall Study|Protocol Violation|0|||
37676250|NCT01680991|69150863|FG002|Overall Study|Protocol Violation|0|||
37676251|NCT01680991|69150861|FG000|Overall Study|Withdrawal by Subject|5|||
37676252|NCT01680991|69150862|FG001|Overall Study|Withdrawal by Subject|1|||
37676253|NCT01680991|69150863|FG002|Overall Study|Withdrawal by Subject|0|||
37676254|NCT01680991|69150861|FG000|Overall Study|Progressive disease (PD)|0|||
37676255|NCT01680991|69150862|FG001|Overall Study|Progressive disease (PD)|10|||
37676256|NCT01680991|69150863|FG002|Overall Study|Progressive disease (PD)|0|||
37676257|NCT01680991|69150861|FG000|Overall Study|Physician Decision|0|||
37676258|NCT01680991|69150862|FG001|Overall Study|Physician Decision|7|||
37676259|NCT01680991|69150863|FG002|Overall Study|Physician Decision|2|||
37676260|NCT01680991|69150861|FG000|Overall Study|Bad physical condition|0|||
37676261|NCT01680991|69150862|FG001|Overall Study|Bad physical condition|0|||
37676262|NCT01680991|69150863|FG002|Overall Study|Bad physical condition|1|||
37676263|NCT01680991|69150861|FG000|Overall Study|PD confirmed in other hospital|1|||
37767842|NCT01272219|69283496|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
37676264|NCT01680991|69150862|FG001|Overall Study|PD confirmed in other hospital|0|||
37676265|NCT01680991|69150863|FG002|Overall Study|PD confirmed in other hospital|0|||
38041126|NCT00042289|69728290|FG002|Overall Study|Protocol Violation|0|||
38041127|NCT00042289|69728291|FG003|Overall Study|Protocol Violation|0|||
38041128|NCT00042289|69728292|FG004|Overall Study|Protocol Violation|0|||
38041129|NCT00042289|69728293|FG005|Overall Study|Protocol Violation|1|||
38041130|NCT00042289|69728294|FG006|Overall Study|Protocol Violation|0|||
38041131|NCT00042289|69728295|FG007|Overall Study|Protocol Violation|1|||
38041132|NCT00042289|69728296|FG008|Overall Study|Protocol Violation|0|||
38041133|NCT00042289|69728297|FG009|Overall Study|Protocol Violation|0|||
38041134|NCT00042289|69728298|FG010|Overall Study|Protocol Violation|0|||
38041135|NCT00042289|69728299|FG011|Overall Study|Protocol Violation|0|||
38041136|NCT00042289|69728300|FG012|Overall Study|Protocol Violation|0|||
38041137|NCT00042289|69728301|FG013|Overall Study|Protocol Violation|0|||
38041138|NCT00042289|69728302|FG014|Overall Study|Protocol Violation|0|||
38041139|NCT00042289|69728303|FG015|Overall Study|Protocol Violation|0|||
38041140|NCT00042289|69728304|FG016|Overall Study|Protocol Violation|0|||
38041141|NCT00042289|69728305|FG017|Overall Study|Protocol Violation|0|||
38041142|NCT00042289|69728306|FG018|Overall Study|Protocol Violation|0|||
38041143|NCT00042289|69728307|FG019|Overall Study|Protocol Violation|0|||
38041144|NCT00042289|69728308|FG020|Overall Study|Protocol Violation|0|||
38041145|NCT00042289|69728309|FG021|Overall Study|Protocol Violation|0|||
38041146|NCT00042289|69728310|FG022|Overall Study|Protocol Violation|0|||
38041147|NCT00042289|69728311|FG023|Overall Study|Protocol Violation|1|||
38041148|NCT00042289|69728312|FG024|Overall Study|Protocol Violation|1|||
38041149|NCT00042289|69728313|FG025|Overall Study|Protocol Violation|0|||
38041150|NCT00042289|69728314|FG026|Overall Study|Protocol Violation|2|||
38041151|NCT00042289|69728315|FG027|Overall Study|Protocol Violation|0|||
38041152|NCT00042289|69728316|FG028|Overall Study|Protocol Violation|0|||
38041153|NCT00042289|69728317|FG029|Overall Study|Protocol Violation|0|||
38041154|NCT00042289|69728318|FG030|Overall Study|Protocol Violation|1|||
38041155|NCT00042289|69728319|FG031|Overall Study|Protocol Violation|0|||
38041156|NCT00042289|69728320|FG032|Overall Study|Protocol Violation|0|||
38041157|NCT00042289|69728321|FG033|Overall Study|Protocol Violation|0|||
38041158|NCT00042289|69728322|FG034|Overall Study|Protocol Violation|0|||
38041159|NCT00042289|69728323|FG035|Overall Study|Protocol Violation|0|||
38041160|NCT00042289|69728324|FG036|Overall Study|Protocol Violation|0|||
38041161|NCT00042289|69728325|FG037|Overall Study|Protocol Violation|0|||
38041162|NCT00042289|69728326|FG038|Overall Study|Protocol Violation|0|||
38041163|NCT00042289|69728327|FG039|Overall Study|Protocol Violation|0|||
38041164|NCT00042289|69728328|FG040|Overall Study|Protocol Violation|0|||
38041165|NCT00042289|69728329|FG041|Overall Study|Protocol Violation|1|||
38041166|NCT00042289|69728330|FG042|Overall Study|Protocol Violation|1|||
38041167|NCT00042289|69728331|FG043|Overall Study|Protocol Violation|1|||
38041168|NCT00042289|69728332|FG044|Overall Study|Protocol Violation|0|||
38041169|NCT00042289|69728333|FG045|Overall Study|Protocol Violation|0|||
38041170|NCT00042289|69728334|FG046|Overall Study|Protocol Violation|0|||
38041171|NCT00042289|69728288|FG000|Overall Study|Withdrawal by Subject|4|||
38041172|NCT00042289|69728289|FG001|Overall Study|Withdrawal by Subject|1|||
38041173|NCT00042289|69728290|FG002|Overall Study|Withdrawal by Subject|0|||
38041174|NCT00042289|69728291|FG003|Overall Study|Withdrawal by Subject|2|||
38041175|NCT00042289|69728292|FG004|Overall Study|Withdrawal by Subject|0|||
38041176|NCT00042289|69728293|FG005|Overall Study|Withdrawal by Subject|2|||
38041177|NCT00042289|69728294|FG006|Overall Study|Withdrawal by Subject|0|||
38041178|NCT00042289|69728295|FG007|Overall Study|Withdrawal by Subject|0|||
38041179|NCT00042289|69728296|FG008|Overall Study|Withdrawal by Subject|0|||
38041180|NCT00042289|69728297|FG009|Overall Study|Withdrawal by Subject|1|||
38041181|NCT00042289|69728298|FG010|Overall Study|Withdrawal by Subject|0|||
38041182|NCT00042289|69728299|FG011|Overall Study|Withdrawal by Subject|0|||
38041183|NCT00042289|69728300|FG012|Overall Study|Withdrawal by Subject|2|||
38041184|NCT00042289|69728301|FG013|Overall Study|Withdrawal by Subject|0|||
38041185|NCT00042289|69728302|FG014|Overall Study|Withdrawal by Subject|0|||
38041186|NCT00042289|69728303|FG015|Overall Study|Withdrawal by Subject|0|||
38041187|NCT00042289|69728304|FG016|Overall Study|Withdrawal by Subject|0|||
38041188|NCT00042289|69728305|FG017|Overall Study|Withdrawal by Subject|0|||
38041189|NCT00042289|69728306|FG018|Overall Study|Withdrawal by Subject|0|||
38041190|NCT00042289|69728307|FG019|Overall Study|Withdrawal by Subject|0|||
38041191|NCT00042289|69728308|FG020|Overall Study|Withdrawal by Subject|0|||
38041192|NCT00042289|69728309|FG021|Overall Study|Withdrawal by Subject|1|||
38041193|NCT00042289|69728310|FG022|Overall Study|Withdrawal by Subject|1|||
38041194|NCT00042289|69728311|FG023|Overall Study|Withdrawal by Subject|1|||
38041195|NCT00042289|69728312|FG024|Overall Study|Withdrawal by Subject|0|||
38041196|NCT00042289|69728313|FG025|Overall Study|Withdrawal by Subject|0|||
38041197|NCT00042289|69728314|FG026|Overall Study|Withdrawal by Subject|1|||
38041198|NCT00042289|69728315|FG027|Overall Study|Withdrawal by Subject|0|||
38041199|NCT00042289|69728316|FG028|Overall Study|Withdrawal by Subject|2|||
38041200|NCT00042289|69728317|FG029|Overall Study|Withdrawal by Subject|0|||
37676266|NCT02819479|69150873|FG000|Overall Study|Adverse Event|2|||
38041201|NCT00042289|69728318|FG030|Overall Study|Withdrawal by Subject|0|||
38041202|NCT00042289|69728319|FG031|Overall Study|Withdrawal by Subject|1|||
38041203|NCT00042289|69728320|FG032|Overall Study|Withdrawal by Subject|2|||
38041204|NCT00042289|69728321|FG033|Overall Study|Withdrawal by Subject|1|||
38041205|NCT00042289|69728322|FG034|Overall Study|Withdrawal by Subject|0|||
38041206|NCT00042289|69728323|FG035|Overall Study|Withdrawal by Subject|0|||
38041207|NCT00042289|69728324|FG036|Overall Study|Withdrawal by Subject|0|||
38041208|NCT00042289|69728325|FG037|Overall Study|Withdrawal by Subject|1|||
38041209|NCT00042289|69728326|FG038|Overall Study|Withdrawal by Subject|0|||
38041210|NCT00042289|69728327|FG039|Overall Study|Withdrawal by Subject|0|||
38041211|NCT00042289|69728328|FG040|Overall Study|Withdrawal by Subject|0|||
38041212|NCT00042289|69728329|FG041|Overall Study|Withdrawal by Subject|0|||
38041213|NCT00042289|69728330|FG042|Overall Study|Withdrawal by Subject|1|||
38041214|NCT00042289|69728331|FG043|Overall Study|Withdrawal by Subject|0|||
38041215|NCT00042289|69728332|FG044|Overall Study|Withdrawal by Subject|0|||
38041216|NCT00042289|69728333|FG045|Overall Study|Withdrawal by Subject|0|||
38041217|NCT00042289|69728334|FG046|Overall Study|Withdrawal by Subject|0|||
38041218|NCT02886728|69728506|FG000|Overall Study|Withdrew Consent|31|||
38041219|NCT02886728|69728507|FG001|Overall Study|Withdrew Consent|13|||
38041220|NCT02886728|69728508|FG002|Overall Study|Withdrew Consent|11|||
38041221|NCT02886728|69728509|FG003|Overall Study|Withdrew Consent|47|||
38041222|NCT02886728|69728506|FG000|Overall Study|Lost to Follow-up|12|||
38041223|NCT02886728|69728507|FG001|Overall Study|Lost to Follow-up|6|||
38041224|NCT02886728|69728508|FG002|Overall Study|Lost to Follow-up|13|||
38041225|NCT02886728|69728509|FG003|Overall Study|Lost to Follow-up|12|||
38041226|NCT02886728|69728506|FG000|Overall Study|Adverse Event|13|||
38041227|NCT02886728|69728507|FG001|Overall Study|Adverse Event|5|||
38041228|NCT02886728|69728508|FG002|Overall Study|Adverse Event|5|||
38041229|NCT02886728|69728509|FG003|Overall Study|Adverse Event|11|||
38041230|NCT02886728|69728506|FG000|Overall Study|Investigator's Discretion|11|||
38041231|NCT02886728|69728507|FG001|Overall Study|Investigator's Discretion|7|||
38041232|NCT02886728|69728508|FG002|Overall Study|Investigator's Discretion|5|||
38041233|NCT02886728|69728509|FG003|Overall Study|Investigator's Discretion|11|||
38041234|NCT02886728|69728506|FG000|Overall Study|Death|3|||
38041235|NCT02886728|69728507|FG001|Overall Study|Death|1|||
38041236|NCT02886728|69728508|FG002|Overall Study|Death|0|||
38041237|NCT02886728|69728509|FG003|Overall Study|Death|0|||
38041238|NCT02886728|69728506|FG000|Overall Study|Protocol Violation|0|||
38041239|NCT02886728|69728507|FG001|Overall Study|Protocol Violation|0|||
38041240|NCT02886728|69728508|FG002|Overall Study|Protocol Violation|0|||
38041241|NCT02886728|69728509|FG003|Overall Study|Protocol Violation|4|||
38041242|NCT02886728|69728506|FG000|Overall Study|Non-Compliance with Study Drug|1|||
38041243|NCT02886728|69728507|FG001|Overall Study|Non-Compliance with Study Drug|0|||
38041244|NCT02886728|69728508|FG002|Overall Study|Non-Compliance with Study Drug|1|||
38041245|NCT02886728|69728509|FG003|Overall Study|Non-Compliance with Study Drug|0|||
38041246|NCT02886728|69728506|FG000|Overall Study|Pregnancy|0|||
38041247|NCT02886728|69728507|FG001|Overall Study|Pregnancy|0|||
38041248|NCT02886728|69728508|FG002|Overall Study|Pregnancy|1|||
38041249|NCT02886728|69728509|FG003|Overall Study|Pregnancy|0|||
38041250|NCT02886728|69728506|FG000|Overall Study|Randomized but Not Dosed|1|||
38041251|NCT02886728|69728507|FG001|Overall Study|Randomized but Not Dosed|0|||
38041252|NCT02886728|69728508|FG002|Overall Study|Randomized but Not Dosed|0|||
38041253|NCT02886728|69728509|FG003|Overall Study|Randomized but Not Dosed|2|||
38041254|NCT00039871|69728519|FG000|Overall Study|Adverse Event|165|||
38041255|NCT00039871|69728519|FG000|Overall Study|Lost to Follow-up|18|||
38041256|NCT00039871|69728519|FG000|Overall Study|Protocol Violation|24|||
38041257|NCT00039871|69728519|FG000|Overall Study|Withdrawal by Subject|97|||
38041258|NCT00039871|69728519|FG000|Overall Study|Did not meet eligibility criteria|11|||
38041259|NCT00039871|69728519|FG000|Overall Study|Administrative|1|||
38041260|NCT00039871|69728519|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
38041261|NCT00039871|69728519|FG000|Overall Study|Never entered follow-up|7|||
38041262|NCT00015457|69728523|FG000|First Intervention|Adverse Event|0|||
38041263|NCT00015457|69728524|FG001|First Intervention|Adverse Event|2|||
38041264|NCT00015457|69728523|FG000|First Intervention|Lack of Efficacy|0|||
38041265|NCT00015457|69728524|FG001|First Intervention|Lack of Efficacy|1|||
38041266|NCT00015457|69728523|FG000|Second Intervention|Withdrawal by Subject|1|||
38041267|NCT00015457|69728524|FG001|Second Intervention|Withdrawal by Subject|0|||
38041268|NCT03191630|69728537|FG000|Overall Study|Lost to Follow-up|7|||
38041269|NCT03191630|69728538|FG001|Overall Study|Lost to Follow-up|7|||
38041270|NCT03191552|69728549|FG000|Overall Study|Lost to Follow-up|1|||
38041271|NCT03191552|69728550|FG001|Overall Study|Lost to Follow-up|0|||
38041272|NCT03191552|69728551|FG002|Overall Study|Lost to Follow-up|0|||
38041273|NCT03191552|69728549|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
38041274|NCT03191552|69728550|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
38041275|NCT03191552|69728551|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
38041276|NCT03191396|69728565|FG000|Overall Study|Lost to Follow-up|0|||
38041277|NCT03191396|69728566|FG001|Overall Study|Lost to Follow-up|3|||
38041278|NCT03191396|69728565|FG000|Overall Study|Withdrawal by Subject|3|||
38041279|NCT03191396|69728566|FG001|Overall Study|Withdrawal by Subject|2|||
38041280|NCT00007345|69728574|FG000|Overall Study|Refused further treatment|0|||
38041281|NCT00007345|69728575|FG001|Overall Study|Refused further treatment|7|||
38041282|NCT00007345|69728574|FG000|Overall Study|Switched to alternative treatment|0|||
38041283|NCT00007345|69728575|FG001|Overall Study|Switched to alternative treatment|3|||
38041284|NCT00007345|69728574|FG000|Overall Study|Intercurrent illness|1|||
38041285|NCT00007345|69728575|FG001|Overall Study|Intercurrent illness|0|||
38041286|NCT00007345|69728574|FG000|Overall Study|Death on study|1|||
38041287|NCT00007345|69728575|FG001|Overall Study|Death on study|1|||
38041288|NCT03405662|69728583|FG000|Overall Study|COVID-19 restriction|1|||
38041289|NCT03405662|69728584|FG001|Overall Study|COVID-19 restriction|0|||
38041290|NCT03405662|69728583|FG000|Overall Study|unblinding|0|||
38041291|NCT03405662|69728584|FG001|Overall Study|unblinding|1|||
38041292|NCT03405662|69728583|FG000|Overall Study|placement in memory care facility|0|||
37946789|NCT00319501|69634283|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
37946790|NCT00319501|69634284|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
37946791|NCT00761579|69634295|FG000|Overall Study|Adverse Event|10|||
37946792|NCT00761579|69634295|FG000|Overall Study|Death|2|||
38041293|NCT03405662|69728584|FG001|Overall Study|placement in memory care facility|2|||
38041294|NCT00031447|69728592|FG000|Overall Study|Lost to Follow-up|0|||
38041295|NCT00031447|69728593|FG001|Overall Study|Lost to Follow-up|1|||
38041296|NCT00031447|69728592|FG000|Overall Study|Non-compliant|1|||
38041297|NCT00031447|69728593|FG001|Overall Study|Non-compliant|1|||
38041298|NCT00031447|69728592|FG000|Overall Study|Re-activation of Disease|2|||
38041299|NCT00031447|69728593|FG001|Overall Study|Re-activation of Disease|1|||
38041300|NCT00031447|69728592|FG000|Overall Study|Disruption of blinded study drug supply|7|||
38041301|NCT00031447|69728593|FG001|Overall Study|Disruption of blinded study drug supply|4|||
38041302|NCT00006409|69728605|FG000|Baseline|Protocol Violation|48|||
38041303|NCT00006409|69728606|FG001|Baseline|Protocol Violation|70|||
38041304|NCT00006409|69728607|FG002|Baseline|Protocol Violation|0|||
38041305|NCT00006409|69728608|FG003|Baseline|Protocol Violation|0|||
38041306|NCT00006409|69728609|FG004|Baseline|Protocol Violation|0|||
38041307|NCT00006409|69728610|FG005|Baseline|Protocol Violation|0|||
38041308|NCT00006409|69728605|FG000|Post-2 Year Intervention|Protocol Violation|0|||
38041309|NCT00006409|69728606|FG001|Post-2 Year Intervention|Protocol Violation|0|||
38041310|NCT00006409|69728607|FG002|Post-2 Year Intervention|Protocol Violation|251|||
38041311|NCT00006409|69728608|FG003|Post-2 Year Intervention|Protocol Violation|168|||
38041312|NCT00006409|69728609|FG004|Post-2 Year Intervention|Protocol Violation|0|||
38041313|NCT00006409|69728610|FG005|Post-2 Year Intervention|Protocol Violation|0|||
38041314|NCT00006409|69728605|FG000|Post-3 Year Intervention|Protocol Violation|0|||
38041315|NCT00006409|69728606|FG001|Post-3 Year Intervention|Protocol Violation|0|||
38041316|NCT00006409|69728607|FG002|Post-3 Year Intervention|Protocol Violation|0|||
38041317|NCT00006409|69728608|FG003|Post-3 Year Intervention|Protocol Violation|0|||
38041318|NCT00006409|69728609|FG004|Post-3 Year Intervention|Protocol Violation|62|||
38041319|NCT00006409|69728610|FG005|Post-3 Year Intervention|Protocol Violation|62|||
38041320|NCT00006289|69728626|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
38041321|NCT00006289|69728627|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
38041322|NCT00006289|69728626|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
38041323|NCT00006289|69728627|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
38041324|NCT00005947|69728645|FG000|Overall Study|Death|54|||
38041325|NCT00005947|69728646|FG001|Overall Study|Death|40|||
38041326|NCT00005947|69728645|FG000|Overall Study|Patient Refused to Continue|2|||
38041327|NCT00005947|69728646|FG001|Overall Study|Patient Refused to Continue|1|||
38041328|NCT00005947|69728645|FG000|Overall Study|Site Closure|1|||
38041329|NCT00005947|69728646|FG001|Overall Study|Site Closure|0|||
38041330|NCT00005047|69728658|FG000|Overall Study|Withdrawal by Subject|12|||
38041331|NCT00005047|69728659|FG001|Overall Study|Withdrawal by Subject|0|||
38041332|NCT00005047|69728660|FG002|Overall Study|Withdrawal by Subject|0|||
38041333|NCT00005047|69728661|FG003|Overall Study|Withdrawal by Subject|0|||
38041334|NCT00005047|69728658|FG000|Overall Study|Adverse Event|5|||
38041335|NCT00005047|69728659|FG001|Overall Study|Adverse Event|0|||
37946793|NCT00761579|69634295|FG000|Overall Study|Lack of Efficacy|21|||
37946794|NCT00761579|69634295|FG000|Overall Study|Lost to Follow-up|16|||
37946795|NCT00761579|69634295|FG000|Overall Study|Pregnancy|1|||
37946796|NCT00761579|69634295|FG000|Overall Study|Withdrawal by Subject|34|||
37946797|NCT00761579|69634295|FG000|Overall Study|Lack of compliance|2|||
37946798|NCT00761579|69634295|FG000|Overall Study|Protocol deviation|1|||
37946799|NCT00761579|69634295|FG000|Overall Study|Drug overdose|1|||
37946800|NCT00761579|69634295|FG000|Overall Study|Aggravation of depression|1|||
37946801|NCT00761579|69634295|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
37946802|NCT00761579|69634295|FG000|Overall Study|Lost survey form|1|||
37946803|NCT00761579|69634295|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
38041336|NCT00005047|69728660|FG002|Overall Study|Adverse Event|0|||
38041337|NCT00005047|69728661|FG003|Overall Study|Adverse Event|0|||
38041338|NCT00005047|69728658|FG000|Overall Study|Lost to Follow-up|1|||
38041339|NCT00005047|69728659|FG001|Overall Study|Lost to Follow-up|0|||
38041340|NCT00005047|69728660|FG002|Overall Study|Lost to Follow-up|0|||
38041341|NCT00005047|69728661|FG003|Overall Study|Lost to Follow-up|0|||
37946804|NCT00627042|69634301|FG000|Overall Study|Withdrawal by Subject|2|||
38041342|NCT00005047|69728658|FG000|Overall Study|Lack of Efficacy|1|||
38041343|NCT00005047|69728659|FG001|Overall Study|Lack of Efficacy|0|||
38041344|NCT00005047|69728660|FG002|Overall Study|Lack of Efficacy|0|||
38041345|NCT00005047|69728661|FG003|Overall Study|Lack of Efficacy|0|||
38041346|NCT00003901|69728671|FG000|Overall Study|Adverse Event|1|||
38041347|NCT00003901|69728671|FG000|Overall Study|Withdrawal by Subject|1|||
38041348|NCT00003901|69728671|FG000|Overall Study|Ineligible|6|||
38041349|NCT00003901|69728671|FG000|Overall Study|CT Scan not within protocol requirement|2|||
38041350|NCT00003901|69728671|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
38041351|NCT00003901|69728671|FG000|Overall Study|Medical problems|6|||
38041352|NCT00003895|69728680|FG000|Overall Study|Adverse Event|4|||
38041353|NCT00003895|69728681|FG001|Overall Study|Adverse Event|0|||
38041354|NCT00003895|69728680|FG000|Overall Study|Lack of Efficacy|1|||
38041355|NCT00003895|69728681|FG001|Overall Study|Lack of Efficacy|1|||
38041356|NCT00003895|69728680|FG000|Overall Study|Patient Vacation|2|||
38041357|NCT00003895|69728681|FG001|Overall Study|Patient Vacation|0|||
38041358|NCT00003895|69728680|FG000|Overall Study|Withdrawal by Subject|0|||
38041359|NCT00003895|69728681|FG001|Overall Study|Withdrawal by Subject|3|||
38041360|NCT03800173|69728692|FG000|Overall Study|Lost to Follow-up|0|||
38041361|NCT03800173|69728693|FG001|Overall Study|Lost to Follow-up|0|||
38041362|NCT03800173|69728694|FG002|Overall Study|Lost to Follow-up|0|||
38041363|NCT03800173|69728695|FG003|Overall Study|Lost to Follow-up|0|||
38041364|NCT03800173|69728696|FG004|Overall Study|Lost to Follow-up|1|||
38041365|NCT00003631|69728715|FG000|Overall Study|Patient not treated|1|||
38041366|NCT00003631|69728716|FG001|Overall Study|Patient not treated|0|||
38041367|NCT00003631|69728717|FG002|Overall Study|Patient not treated|1|||
38041368|NCT00003631|69728715|FG000|Overall Study|Protocol Violation|1|||
38041369|NCT00003631|69728716|FG001|Overall Study|Protocol Violation|0|||
38041370|NCT00003631|69728717|FG002|Overall Study|Protocol Violation|0|||
38041371|NCT00003631|69728715|FG000|Overall Study|Adverse Event|1|||
38041372|NCT00003631|69728716|FG001|Overall Study|Adverse Event|1|||
38041373|NCT00003631|69728717|FG002|Overall Study|Adverse Event|5|||
38041374|NCT00003631|69728715|FG000|Overall Study|Death|0|||
38041375|NCT00003631|69728716|FG001|Overall Study|Death|0|||
38041376|NCT00003631|69728717|FG002|Overall Study|Death|1|||
38041377|NCT00003631|69728715|FG000|Overall Study|Evaluable for toxicity only|0|||
38041378|NCT00003631|69728716|FG001|Overall Study|Evaluable for toxicity only|0|||
38041379|NCT00003631|69728717|FG002|Overall Study|Evaluable for toxicity only|2|||
38041380|NCT00003535|69728725|FG000|Overall Study|Not evaluable|5|||
38041381|NCT00003511|69728729|FG000|Overall Study|Not evaluable|4|||
38041382|NCT00003499|69728733|FG000|Overall Study|Not evaluable|8|||
38041383|NCT00003487|69728737|FG000|Overall Study|Not evaluable|2|||
38041384|NCT00003475|69728741|FG000|Overall Study|Not evaluable|13|||
38041385|NCT00003457|69728746|FG000|Overall Study|Not evaluable|9|||
38041386|NCT00030901|69728752|FG000|Initial Registration|Ineligible|167|||
38041387|NCT00030901|69728753|FG001|Initial Registration|Ineligible|0|||
38041388|NCT00030901|69728754|FG002|Initial Registration|Ineligible|0|||
38041389|NCT00030901|69728752|FG000|Randomization|Adverse Event|0|||
38041390|NCT00030901|69728753|FG001|Randomization|Adverse Event|11|||
38041391|NCT00030901|69728754|FG002|Randomization|Adverse Event|7|||
38041392|NCT00030901|69728752|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
38041393|NCT00030901|69728753|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
38041394|NCT00030901|69728754|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
38041395|NCT00030901|69728752|FG000|Randomization|Progression/Relapse|0|||
38041396|NCT00030901|69728753|FG001|Randomization|Progression/Relapse|22|||
38041397|NCT00030901|69728754|FG002|Randomization|Progression/Relapse|21|||
38041398|NCT00030901|69728752|FG000|Randomization|Death|0|||
38041399|NCT00030901|69728753|FG001|Randomization|Death|1|||
38041400|NCT00030901|69728754|FG002|Randomization|Death|3|||
38041401|NCT00030901|69728752|FG000|Randomization|Other|0|||
38041402|NCT00030901|69728753|FG001|Randomization|Other|36|||
38041403|NCT00030901|69728754|FG002|Randomization|Other|33|||
38041404|NCT00030901|69728752|FG000|Randomization|Ineligible|0|||
38041405|NCT00030901|69728753|FG001|Randomization|Ineligible|15|||
38041406|NCT00030901|69728754|FG002|Randomization|Ineligible|14|||
38041407|NCT00003199|69728760|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
38041408|NCT00003199|69728760|FG000|Overall Study|Lack of insurance clearance|2|||
38041409|NCT00003199|69728760|FG000|Overall Study|Screen fail|15|||
38041410|NCT00030823|69728764|FG000|Overall Study|Withdrawal by Subject|1|||
38041411|NCT00001849|69728768|FG000|Overall Study|Death|4|||
38041412|NCT00001849|69728768|FG000|Overall Study|Lost to Follow-up|2|||
38041413|NCT00001849|69728768|FG000|Overall Study|Withdrawal by Subject|2|||
38041414|NCT00001849|69728768|FG000|Overall Study|tumor remained occult|6|||
38041415|NCT01342952|69728785|FG000|Overall Study|Adverse Event|0|||
38041416|NCT01342952|69728786|FG001|Overall Study|Adverse Event|5|||
38041417|NCT01342952|69728787|FG002|Overall Study|Adverse Event|1|||
38041418|NCT01342952|69728788|FG003|Overall Study|Adverse Event|0|||
38041419|NCT01342952|69728785|FG000|Overall Study|Lost to Follow-up|0|||
38041420|NCT01342952|69728786|FG001|Overall Study|Lost to Follow-up|2|||
38041421|NCT01342952|69728787|FG002|Overall Study|Lost to Follow-up|0|||
38041422|NCT01342952|69728788|FG003|Overall Study|Lost to Follow-up|0|||
38041423|NCT01342952|69728785|FG000|Overall Study|Withdrawal by Subject|1|||
38041424|NCT01342952|69728786|FG001|Overall Study|Withdrawal by Subject|1|||
38041425|NCT01342952|69728787|FG002|Overall Study|Withdrawal by Subject|0|||
38041426|NCT01342952|69728788|FG003|Overall Study|Withdrawal by Subject|0|||
38041427|NCT01342952|69728785|FG000|Overall Study|Physician Decision|3|||
38041428|NCT01342952|69728786|FG001|Overall Study|Physician Decision|3|||
38041429|NCT01342952|69728787|FG002|Overall Study|Physician Decision|1|||
38041430|NCT01342952|69728788|FG003|Overall Study|Physician Decision|0|||
38041431|NCT02886884|69728815|FG000|Follow-up|Withdrawal by Subject|0|||
38041432|NCT02886884|69728816|FG001|Follow-up|Withdrawal by Subject|0|||
38041433|NCT02886884|69728817|FG002|Follow-up|Withdrawal by Subject|0|||
38041434|NCT02886884|69728818|FG003|Follow-up|Withdrawal by Subject|1|||
38041435|NCT01240694|69728837|FG000|Overall Study|Adverse Event|9|||
38041436|NCT01240694|69728837|FG000|Overall Study|Lack of Efficacy|6|||
38041437|NCT01240694|69728837|FG000|Overall Study|Withdrawal by Subject|6|||
38041438|NCT01240694|69728837|FG000|Overall Study|Protocol Violation|2|||
38041439|NCT01240694|69728837|FG000|Overall Study|Lost to Follow-up|2|||
38041440|NCT01240694|69728837|FG000|Overall Study|Other than specified|3|||
38041441|NCT01240694|69728837|FG000|Overall Study|Withdrawn due to early study termination|107|||
38041442|NCT03162224|69728844|FG000|Overall Study|Death|4|||
38041443|NCT03162224|69728845|FG001|Overall Study|Death|5|||
38041444|NCT03162224|69728846|FG002|Overall Study|Death|8|||
38041445|NCT03162224|69728844|FG000|Overall Study|Withdrawal by Subject|1|||
38041446|NCT03162224|69728845|FG001|Overall Study|Withdrawal by Subject|0|||
38041447|NCT03162224|69728846|FG002|Overall Study|Withdrawal by Subject|1|||
38041448|NCT03162224|69728844|FG000|Overall Study|Lost to Follow-up|0|||
38041449|NCT03162224|69728845|FG001|Overall Study|Lost to Follow-up|1|||
38041450|NCT03162224|69728846|FG002|Overall Study|Lost to Follow-up|0|||
38041451|NCT03162224|69728844|FG000|Overall Study|Other|6|||
38041452|NCT03162224|69728845|FG001|Overall Study|Other|2|||
38041453|NCT03162224|69728846|FG002|Overall Study|Other|1|||
38041454|NCT02886338|69728885|FG000|Overall Study|Withdrawal by Subject|1|||
38041455|NCT00004124|69728891|FG000|Overall Study|Received no protocol therapy|12|||
38041456|NCT00004124|69728892|FG001|Overall Study|Received no protocol therapy|20|||
38041457|NCT00383552|69728902|FG000|Overall Study|Adverse Event|7|||
38041458|NCT00383552|69728903|FG001|Overall Study|Adverse Event|6|||
38041459|NCT00383552|69728904|FG002|Overall Study|Adverse Event|9|||
38041460|NCT00383552|69728905|FG003|Overall Study|Adverse Event|6|||
38041461|NCT00383552|69728902|FG000|Overall Study|Lack of Efficacy|4|||
38041462|NCT00383552|69728903|FG001|Overall Study|Lack of Efficacy|13|||
38041463|NCT00383552|69728904|FG002|Overall Study|Lack of Efficacy|29|||
38041464|NCT00383552|69728905|FG003|Overall Study|Lack of Efficacy|42|||
38041465|NCT00383552|69728902|FG000|Overall Study|Lost to Follow-up|0|||
38041466|NCT00383552|69728903|FG001|Overall Study|Lost to Follow-up|1|||
38041467|NCT00383552|69728904|FG002|Overall Study|Lost to Follow-up|5|||
38041468|NCT00383552|69728905|FG003|Overall Study|Lost to Follow-up|1|||
38041469|NCT00383552|69728902|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
38041470|NCT00383552|69728903|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
38041471|NCT00383552|69728904|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
38041472|NCT00383552|69728905|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
38041473|NCT00383552|69728902|FG000|Overall Study|Did not wish to continue (related)|1|||
38041474|NCT00383552|69728903|FG001|Overall Study|Did not wish to continue (related)|0|||
38041475|NCT00383552|69728904|FG002|Overall Study|Did not wish to continue (related)|2|||
38041476|NCT00383552|69728905|FG003|Overall Study|Did not wish to continue (related)|3|||
38041477|NCT00383552|69728902|FG000|Overall Study|Noncompliance with the protocol|11|||
38041478|NCT00383552|69728903|FG001|Overall Study|Noncompliance with the protocol|6|||
38041479|NCT00383552|69728904|FG002|Overall Study|Noncompliance with the protocol|8|||
38041480|NCT00383552|69728905|FG003|Overall Study|Noncompliance with the protocol|10|||
38041481|NCT00383552|69728902|FG000|Overall Study|Did not meet protocol eligibility|8|||
38041482|NCT00383552|69728903|FG001|Overall Study|Did not meet protocol eligibility|6|||
38041483|NCT00383552|69728904|FG002|Overall Study|Did not meet protocol eligibility|2|||
38041484|NCT00383552|69728905|FG003|Overall Study|Did not meet protocol eligibility|3|||
38041485|NCT00383552|69728902|FG000|Overall Study|Administrative|1|||
38041486|NCT00383552|69728903|FG001|Overall Study|Administrative|0|||
38041487|NCT00383552|69728904|FG002|Overall Study|Administrative|1|||
38041488|NCT00383552|69728905|FG003|Overall Study|Administrative|1|||
38041489|NCT03158012|69728922|FG000|Overall Study|Withdrawal by Subject|0|||
38041490|NCT03158012|69728923|FG001|Overall Study|Withdrawal by Subject|1|||
38041491|NCT01776424|69728932|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
38041492|NCT01776424|69728933|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
38041493|NCT01776424|69728934|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
38041494|NCT01776424|69728932|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
38041495|NCT01776424|69728933|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
38041496|NCT01776424|69728934|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
38041497|NCT01776424|69728932|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
38041498|NCT01776424|69728933|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
38041499|NCT01776424|69728934|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
38041500|NCT01776424|69728932|FG000|LTOLE Part (Open Label)|Refused|5|||
38041501|NCT01776424|69728933|FG001|LTOLE Part (Open Label)|Refused|2|||
38041502|NCT01776424|69728934|FG002|LTOLE Part (Open Label)|Refused|11|||
38041503|NCT01776424|69728932|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
38041504|NCT01776424|69728933|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
38041505|NCT01776424|69728934|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
38041506|NCT03799627|69728960|FG000|Overall Study|Adverse Event|1|||
38041507|NCT03799627|69728961|FG001|Overall Study|Adverse Event|2|||
38041508|NCT03799627|69728962|FG002|Overall Study|Adverse Event|0|||
38041509|NCT03799627|69728963|FG003|Overall Study|Adverse Event|0|||
38041510|NCT03799627|69728964|FG004|Overall Study|Adverse Event|2|||
38041511|NCT03799627|69728965|FG005|Overall Study|Adverse Event|5|||
38041512|NCT03799627|69728966|FG006|Overall Study|Adverse Event|0|||
38041513|NCT03799627|69728967|FG007|Overall Study|Adverse Event|2|||
38041514|NCT03799627|69728968|FG008|Overall Study|Adverse Event|0|||
38041515|NCT03799627|69728960|FG000|Overall Study|Physician Decision|2|||
38041516|NCT03799627|69728961|FG001|Overall Study|Physician Decision|2|||
38041517|NCT03799627|69728962|FG002|Overall Study|Physician Decision|0|||
38041518|NCT03799627|69728963|FG003|Overall Study|Physician Decision|0|||
38041519|NCT03799627|69728964|FG004|Overall Study|Physician Decision|2|||
38041520|NCT03799627|69728965|FG005|Overall Study|Physician Decision|2|||
38041521|NCT03799627|69728966|FG006|Overall Study|Physician Decision|0|||
38041522|NCT03799627|69728967|FG007|Overall Study|Physician Decision|0|||
38041523|NCT03799627|69728968|FG008|Overall Study|Physician Decision|0|||
38041524|NCT03799627|69728960|FG000|Overall Study|Withdrawal by Subject|1|||
38041525|NCT03799627|69728961|FG001|Overall Study|Withdrawal by Subject|1|||
38041526|NCT03799627|69728962|FG002|Overall Study|Withdrawal by Subject|0|||
38041527|NCT03799627|69728963|FG003|Overall Study|Withdrawal by Subject|2|||
38041528|NCT03799627|69728964|FG004|Overall Study|Withdrawal by Subject|0|||
38041529|NCT03799627|69728965|FG005|Overall Study|Withdrawal by Subject|3|||
38041530|NCT03799627|69728966|FG006|Overall Study|Withdrawal by Subject|0|||
38041531|NCT03799627|69728967|FG007|Overall Study|Withdrawal by Subject|0|||
38041532|NCT03799627|69728968|FG008|Overall Study|Withdrawal by Subject|0|||
38041533|NCT03799627|69728960|FG000|Overall Study|Lack of Efficacy|0|||
38041534|NCT03799627|69728961|FG001|Overall Study|Lack of Efficacy|0|||
38041535|NCT03799627|69728962|FG002|Overall Study|Lack of Efficacy|0|||
38041536|NCT03799627|69728963|FG003|Overall Study|Lack of Efficacy|1|||
38041537|NCT03799627|69728964|FG004|Overall Study|Lack of Efficacy|0|||
38041538|NCT03799627|69728965|FG005|Overall Study|Lack of Efficacy|0|||
38041539|NCT03799627|69728966|FG006|Overall Study|Lack of Efficacy|0|||
38041540|NCT03799627|69728967|FG007|Overall Study|Lack of Efficacy|0|||
38041541|NCT03799627|69728968|FG008|Overall Study|Lack of Efficacy|0|||
38041542|NCT03799627|69728960|FG000|Overall Study|Lost to Follow-up|0|||
38041543|NCT03799627|69728961|FG001|Overall Study|Lost to Follow-up|0|||
38041544|NCT03799627|69728962|FG002|Overall Study|Lost to Follow-up|0|||
38041545|NCT03799627|69728963|FG003|Overall Study|Lost to Follow-up|0|||
38041546|NCT03799627|69728964|FG004|Overall Study|Lost to Follow-up|0|||
38041547|NCT03799627|69728965|FG005|Overall Study|Lost to Follow-up|0|||
38041548|NCT03799627|69728966|FG006|Overall Study|Lost to Follow-up|1|||
38041549|NCT03799627|69728967|FG007|Overall Study|Lost to Follow-up|0|||
38041550|NCT03799627|69728968|FG008|Overall Study|Lost to Follow-up|1|||
38041551|NCT03799627|69728960|FG000|Overall Study|Death|0|||
38041552|NCT03799627|69728961|FG001|Overall Study|Death|0|||
38041553|NCT03799627|69728962|FG002|Overall Study|Death|0|||
38041554|NCT03799627|69728963|FG003|Overall Study|Death|1|||
38041555|NCT03799627|69728964|FG004|Overall Study|Death|0|||
38041556|NCT03799627|69728965|FG005|Overall Study|Death|0|||
38041557|NCT03799627|69728966|FG006|Overall Study|Death|0|||
38041558|NCT03799627|69728967|FG007|Overall Study|Death|0|||
38041559|NCT03799627|69728968|FG008|Overall Study|Death|0|||
38041560|NCT03799627|69728960|FG000|Overall Study|Study Drug Put on Hold|1|||
38041561|NCT03799627|69728961|FG001|Overall Study|Study Drug Put on Hold|0|||
38041562|NCT03799627|69728962|FG002|Overall Study|Study Drug Put on Hold|0|||
38041563|NCT03799627|69728963|FG003|Overall Study|Study Drug Put on Hold|0|||
38041564|NCT03799627|69728964|FG004|Overall Study|Study Drug Put on Hold|0|||
38041565|NCT03799627|69728965|FG005|Overall Study|Study Drug Put on Hold|0|||
38041566|NCT03799627|69728966|FG006|Overall Study|Study Drug Put on Hold|0|||
38041567|NCT03799627|69728967|FG007|Overall Study|Study Drug Put on Hold|0|||
38041568|NCT03799627|69728968|FG008|Overall Study|Study Drug Put on Hold|0|||
38041569|NCT03799627|69728960|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
38041570|NCT03799627|69728961|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
38041571|NCT03799627|69728962|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
38041572|NCT03799627|69728963|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
38041573|NCT03799627|69728964|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
38041574|NCT03799627|69728965|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
38041575|NCT03799627|69728966|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
38041576|NCT03799627|69728967|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
38041577|NCT03799627|69728968|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
38041578|NCT03799627|69728960|FG000|Overall Study|Kidney Transplantation|1|||
38041579|NCT03799627|69728961|FG001|Overall Study|Kidney Transplantation|0|||
38041580|NCT03799627|69728962|FG002|Overall Study|Kidney Transplantation|0|||
38041581|NCT03799627|69728963|FG003|Overall Study|Kidney Transplantation|1|||
38041582|NCT03799627|69728964|FG004|Overall Study|Kidney Transplantation|1|||
38041583|NCT03799627|69728965|FG005|Overall Study|Kidney Transplantation|0|||
38041584|NCT03799627|69728966|FG006|Overall Study|Kidney Transplantation|0|||
38041585|NCT03799627|69728967|FG007|Overall Study|Kidney Transplantation|0|||
38041586|NCT03799627|69728968|FG008|Overall Study|Kidney Transplantation|0|||
38041587|NCT03799627|69728960|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
38041588|NCT03799627|69728961|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
38041589|NCT03799627|69728962|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
38041590|NCT03799627|69728963|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
38041591|NCT03799627|69728964|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
38041592|NCT03799627|69728965|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
38041593|NCT03799627|69728966|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
38041594|NCT03799627|69728967|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
38041595|NCT03799627|69728968|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
38041596|NCT03799627|69728960|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
38041597|NCT03799627|69728961|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
38041598|NCT03799627|69728962|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
38041599|NCT03799627|69728963|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
38041600|NCT03799627|69728964|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
38041601|NCT03799627|69728965|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
38041602|NCT03799627|69728966|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
38041603|NCT03799627|69728967|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
38041604|NCT03799627|69728968|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
38041605|NCT03799627|69728960|FG000|Overall Study|Met Exclusion Criteria|0|||
38041606|NCT03799627|69728961|FG001|Overall Study|Met Exclusion Criteria|0|||
38041607|NCT03799627|69728962|FG002|Overall Study|Met Exclusion Criteria|0|||
38041608|NCT03799627|69728963|FG003|Overall Study|Met Exclusion Criteria|1|||
38041609|NCT03799627|69728964|FG004|Overall Study|Met Exclusion Criteria|0|||
38041610|NCT03799627|69728965|FG005|Overall Study|Met Exclusion Criteria|0|||
38041611|NCT03799627|69728966|FG006|Overall Study|Met Exclusion Criteria|0|||
38041612|NCT03799627|69728967|FG007|Overall Study|Met Exclusion Criteria|0|||
38041613|NCT03799627|69728968|FG008|Overall Study|Met Exclusion Criteria|0|||
38041614|NCT03799627|69728960|FG000|Overall Study|Investigational Product Noncompliance|0|||
38041615|NCT03799627|69728961|FG001|Overall Study|Investigational Product Noncompliance|0|||
38041616|NCT03799627|69728962|FG002|Overall Study|Investigational Product Noncompliance|0|||
38041617|NCT03799627|69728963|FG003|Overall Study|Investigational Product Noncompliance|1|||
38041618|NCT03799627|69728964|FG004|Overall Study|Investigational Product Noncompliance|0|||
38041619|NCT03799627|69728965|FG005|Overall Study|Investigational Product Noncompliance|0|||
38041620|NCT03799627|69728966|FG006|Overall Study|Investigational Product Noncompliance|0|||
38041621|NCT03799627|69728967|FG007|Overall Study|Investigational Product Noncompliance|0|||
38041622|NCT03799627|69728968|FG008|Overall Study|Investigational Product Noncompliance|0|||
38041623|NCT03799627|69728960|FG000|Overall Study|Participant Relocation|0|||
38041624|NCT03799627|69728961|FG001|Overall Study|Participant Relocation|0|||
38041625|NCT03799627|69728962|FG002|Overall Study|Participant Relocation|0|||
38041626|NCT03799627|69728963|FG003|Overall Study|Participant Relocation|1|||
38041627|NCT03799627|69728964|FG004|Overall Study|Participant Relocation|0|||
38041628|NCT03799627|69728965|FG005|Overall Study|Participant Relocation|1|||
38041629|NCT03799627|69728966|FG006|Overall Study|Participant Relocation|0|||
38041630|NCT03799627|69728967|FG007|Overall Study|Participant Relocation|0|||
38041631|NCT03799627|69728968|FG008|Overall Study|Participant Relocation|0|||
38041632|NCT03799627|69728960|FG000|Overall Study|Eurofin Issue|0|||
38041633|NCT03799627|69728961|FG001|Overall Study|Eurofin Issue|0|||
38041634|NCT03799627|69728962|FG002|Overall Study|Eurofin Issue|0|||
38041635|NCT03799627|69728963|FG003|Overall Study|Eurofin Issue|0|||
38041636|NCT03799627|69728964|FG004|Overall Study|Eurofin Issue|1|||
38041637|NCT03799627|69728965|FG005|Overall Study|Eurofin Issue|0|||
38041638|NCT03799627|69728966|FG006|Overall Study|Eurofin Issue|0|||
38041639|NCT03799627|69728967|FG007|Overall Study|Eurofin Issue|0|||
38041640|NCT03799627|69728968|FG008|Overall Study|Eurofin Issue|0|||
38041641|NCT03799627|69728960|FG000|Overall Study|Noncompliance with Site Instructions|0|||
38041642|NCT03799627|69728961|FG001|Overall Study|Noncompliance with Site Instructions|0|||
38041643|NCT03799627|69728962|FG002|Overall Study|Noncompliance with Site Instructions|0|||
38041644|NCT03799627|69728963|FG003|Overall Study|Noncompliance with Site Instructions|0|||
38041645|NCT03799627|69728964|FG004|Overall Study|Noncompliance with Site Instructions|1|||
38041646|NCT03799627|69728965|FG005|Overall Study|Noncompliance with Site Instructions|0|||
38041647|NCT03799627|69728966|FG006|Overall Study|Noncompliance with Site Instructions|0|||
38041648|NCT03799627|69728967|FG007|Overall Study|Noncompliance with Site Instructions|0|||
38041649|NCT03799627|69728968|FG008|Overall Study|Noncompliance with Site Instructions|0|||
38041650|NCT03799627|69728960|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
38041651|NCT03799627|69728961|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
38041652|NCT03799627|69728962|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
38041653|NCT03799627|69728963|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
38041654|NCT03799627|69728964|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
38041655|NCT03799627|69728965|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
38041656|NCT03799627|69728966|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
38041657|NCT03799627|69728967|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
38041658|NCT03799627|69728968|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
38041659|NCT03799627|69728960|FG000|Overall Study|Changes In Hemoglobin Values|1|||
38041660|NCT03799627|69728961|FG001|Overall Study|Changes In Hemoglobin Values|2|||
38041661|NCT03799627|69728962|FG002|Overall Study|Changes In Hemoglobin Values|1|||
38041662|NCT03799627|69728963|FG003|Overall Study|Changes In Hemoglobin Values|0|||
38041663|NCT03799627|69728964|FG004|Overall Study|Changes In Hemoglobin Values|0|||
38041664|NCT03799627|69728965|FG005|Overall Study|Changes In Hemoglobin Values|2|||
38041665|NCT03799627|69728966|FG006|Overall Study|Changes In Hemoglobin Values|1|||
38041666|NCT03799627|69728967|FG007|Overall Study|Changes In Hemoglobin Values|0|||
38041667|NCT03799627|69728968|FG008|Overall Study|Changes In Hemoglobin Values|1|||
38041668|NCT00756574|69729009|FG000|Overall Study|Withdrawal by Subject|9|||
38041669|NCT00756574|69729010|FG001|Overall Study|Withdrawal by Subject|7|||
38041670|NCT00756574|69729009|FG000|Overall Study|Lost to Follow-up|4|||
38041671|NCT00756574|69729010|FG001|Overall Study|Lost to Follow-up|4|||
38041672|NCT02743780|69729019|FG000|Part 3 (7 Days)|Adverse Event|0|||
38041673|NCT02743780|69729020|FG001|Part 3 (7 Days)|Adverse Event|0|||
38041674|NCT02743780|69729021|FG002|Part 3 (7 Days)|Adverse Event|1|||
38041675|NCT02743780|69729022|FG003|Part 3 (7 Days)|Adverse Event|0|||
38041676|NCT02743780|69729023|FG004|Part 3 (7 Days)|Adverse Event|0|||
38041677|NCT02880956|69729047|FG000|Overall Study|Adverse Event|3|||
38041678|NCT02880956|69729048|FG001|Overall Study|Adverse Event|6|||
38041679|NCT02880956|69729049|FG002|Overall Study|Adverse Event|5|||
38041680|NCT02880956|69729050|FG003|Overall Study|Adverse Event|4|||
38041681|NCT02880956|69729047|FG000|Overall Study|Withdrawal by Subject|9|||
38041682|NCT02880956|69729048|FG001|Overall Study|Withdrawal by Subject|4|||
38041683|NCT02880956|69729049|FG002|Overall Study|Withdrawal by Subject|6|||
38041684|NCT02880956|69729050|FG003|Overall Study|Withdrawal by Subject|11|||
38041685|NCT02880956|69729047|FG000|Overall Study|Lost to Follow-up|0|||
38041686|NCT02880956|69729048|FG001|Overall Study|Lost to Follow-up|1|||
38041687|NCT02880956|69729049|FG002|Overall Study|Lost to Follow-up|0|||
38041688|NCT02880956|69729050|FG003|Overall Study|Lost to Follow-up|0|||
38041689|NCT02880956|69729047|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
38041690|NCT02880956|69729048|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
38041691|NCT02880956|69729049|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
38041692|NCT02880956|69729050|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
38041693|NCT02880956|69729047|FG000|Overall Study|Other, Not Specified|4|||
38041694|NCT02880956|69729048|FG001|Overall Study|Other, Not Specified|2|||
38041695|NCT02880956|69729049|FG002|Overall Study|Other, Not Specified|0|||
38041696|NCT02880956|69729050|FG003|Overall Study|Other, Not Specified|3|||
38041697|NCT01352416|69729067|FG000|Overall Study|Physician Decision|1|||
38041698|NCT01352416|69729068|FG001|Overall Study|Physician Decision|2|||
38041699|NCT01352416|69729069|FG002|Overall Study|Physician Decision|2|||
38041700|NCT01352416|69729070|FG003|Overall Study|Physician Decision|1|||
38041701|NCT00439738|69729082|FG000|Overall Study|Withdrawal by Subject|16|||
38041702|NCT00439738|69729083|FG001|Overall Study|Withdrawal by Subject|13|||
38041703|NCT00439738|69729082|FG000|Overall Study|Adverse Event|6|||
38041704|NCT00439738|69729083|FG001|Overall Study|Adverse Event|4|||
38041705|NCT00439738|69729082|FG000|Overall Study|Lost to Follow-up|5|||
38041706|NCT00439738|69729083|FG001|Overall Study|Lost to Follow-up|6|||
38041707|NCT00439738|69729082|FG000|Overall Study|Protocol Violation|6|||
38041708|NCT00439738|69729083|FG001|Overall Study|Protocol Violation|3|||
38041709|NCT00439738|69729082|FG000|Overall Study|Lack of Efficacy|2|||
38041710|NCT00439738|69729083|FG001|Overall Study|Lack of Efficacy|2|||
38041711|NCT00439738|69729082|FG000|Overall Study|Abnormal Lab Values|1|||
38041712|NCT00439738|69729083|FG001|Overall Study|Abnormal Lab Values|0|||
38041713|NCT00338104|69729090|FG000|Overall Study|Protocol Violation|2|||
38041714|NCT00338104|69729091|FG001|Overall Study|Protocol Violation|1|||
38041715|NCT00338104|69729092|FG002|Overall Study|Protocol Violation|3|||
38041716|NCT05590000|69729097|FG000|Overall Study|The patient was indicated for peripheral nerve stimulation|1|||
38041717|NCT05333965|69729105|FG000|First Intervention|Adverse Event|0|||
38041718|NCT05333965|69729106|FG001|First Intervention|Adverse Event|1|||
38041719|NCT05333965|69729105|FG000|First Intervention|Withdrawal by Subject|0|||
38041720|NCT05333965|69729106|FG001|First Intervention|Withdrawal by Subject|1|||
38041721|NCT05109702|69729123|FG000|Treatment Period (8 Weeks)|Adverse Event|0|||
38041722|NCT05109702|69729124|FG001|Treatment Period (8 Weeks)|Adverse Event|5|||
38041723|NCT05109702|69729125|FG002|Treatment Period (8 Weeks)|Adverse Event|2|||
38041724|NCT05109702|69729123|FG000|Treatment Period (8 Weeks)|Protocol Violation|0|||
38041725|NCT05109702|69729124|FG001|Treatment Period (8 Weeks)|Protocol Violation|0|||
38041726|NCT05109702|69729125|FG002|Treatment Period (8 Weeks)|Protocol Violation|1|||
38041727|NCT05109702|69729123|FG000|Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
38041728|NCT05109702|69729124|FG001|Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
38041729|NCT05109702|69729125|FG002|Treatment Period (8 Weeks)|Withdrawal by Subject|3|||
38041730|NCT05109702|69729123|FG000|Treatment Period (8 Weeks)|Administrative reasons|0|||
38041731|NCT05109702|69729124|FG001|Treatment Period (8 Weeks)|Administrative reasons|1|||
38041732|NCT05109702|69729125|FG002|Treatment Period (8 Weeks)|Administrative reasons|1|||
38041733|NCT05109702|69729123|FG000|Treatment Period (8 Weeks)|Other than specified|0|||
38041734|NCT05109702|69729124|FG001|Treatment Period (8 Weeks)|Other than specified|3|||
38041735|NCT05109702|69729125|FG002|Treatment Period (8 Weeks)|Other than specified|1|||
38041736|NCT04699461|69729138|FG000|Overall Study|Withdrawal by Subject|1|||
38041737|NCT04699461|69729139|FG001|Overall Study|Withdrawal by Subject|0|||
38041738|NCT04699461|69729138|FG000|Overall Study|Study termination by sponsor|2|||
38041739|NCT04699461|69729139|FG001|Overall Study|Study termination by sponsor|1|||
38041740|NCT04699461|69729138|FG000|Overall Study|Death|1|||
38041741|NCT04699461|69729139|FG001|Overall Study|Death|0|||
38041742|NCT04699461|69729138|FG000|Overall Study|Radiographic progression|0|||
38041743|NCT04699461|69729139|FG001|Overall Study|Radiographic progression|1|||
38041744|NCT04399551|69729145|FG000|Overall Study|Adverse Event|15|||
38041745|NCT04399551|69729145|FG000|Overall Study|Withdrawal by Subject|6|||
38041746|NCT04399551|69729145|FG000|Overall Study|Physician Decision|3|||
38041747|NCT04399551|69729145|FG000|Overall Study|Lost to Follow-up|2|||
38041748|NCT04399551|69729145|FG000|Overall Study|Protocol Deviation|2|||
38041749|NCT04343235|69729176|FG000|Overall Study|Lost to Follow-up|3|||
38041750|NCT04343235|69729177|FG001|Overall Study|Lost to Follow-up|2|||
38041751|NCT04338321|69729185|FG000|Overall Study|Adverse Event|4|||
38041752|NCT04338321|69729186|FG001|Overall Study|Adverse Event|10|||
38041753|NCT04338321|69729185|FG000|Overall Study|Death|1|||
38041754|NCT04338321|69729186|FG001|Overall Study|Death|1|||
38041755|NCT04338321|69729185|FG000|Overall Study|Lost to Follow-up|4|||
38041756|NCT04338321|69729186|FG001|Overall Study|Lost to Follow-up|9|||
38041757|NCT04338321|69729185|FG000|Overall Study|Withdrawal by Subject|45|||
37946805|NCT00319111|69634305|FG000|Overall Study|Adverse Event|20|||
37946806|NCT00319111|69634305|FG000|Overall Study|Withdrawal of consent|11|||
37946807|NCT00319111|69634305|FG000|Overall Study|Death|9|||
37946808|NCT00319111|69634305|FG000|Overall Study|Lack of clinical improvement|4|||
37946809|NCT00319111|69634305|FG000|Overall Study|Administrative|2|||
37946810|NCT00319111|69634305|FG000|Overall Study|Treatment failure|1|||
37946811|NCT00640224|69634313|FG000|Overall Study|Lost to Follow-up|5|||
37946812|NCT00640224|69634314|FG001|Overall Study|Lost to Follow-up|2|||
37946813|NCT00640224|69634315|FG002|Overall Study|Lost to Follow-up|0|||
37946814|NCT00640224|69634316|FG003|Overall Study|Lost to Follow-up|0|||
37946815|NCT00640224|69634313|FG000|Overall Study|Withdrawal by Subject|1|||
37946816|NCT00640224|69634314|FG001|Overall Study|Withdrawal by Subject|0|||
37946817|NCT00640224|69634315|FG002|Overall Study|Withdrawal by Subject|0|||
37946818|NCT00640224|69634316|FG003|Overall Study|Withdrawal by Subject|0|||
37946819|NCT00640224|69634313|FG000|Overall Study|Headaches|0|||
37946820|NCT00640224|69634314|FG001|Overall Study|Headaches|1|||
37946821|NCT00640224|69634315|FG002|Overall Study|Headaches|0|||
37946822|NCT00640224|69634316|FG003|Overall Study|Headaches|0|||
37946823|NCT00318643|69634331|FG000|Overall Study|Adverse Event|0|||
37946824|NCT00318643|69634332|FG001|Overall Study|Adverse Event|0|||
37946825|NCT00318643|69634333|FG002|Overall Study|Adverse Event|0|||
37946826|NCT00318643|69634334|FG003|Overall Study|Adverse Event|0|||
37946827|NCT00318643|69634335|FG004|Overall Study|Adverse Event|1|||
37946828|NCT00318643|69634331|FG000|Overall Study|Participant's Decision|0|||
37946829|NCT00318643|69634332|FG001|Overall Study|Participant's Decision|0|||
37946830|NCT00318643|69634333|FG002|Overall Study|Participant's Decision|0|||
37946831|NCT00318643|69634334|FG003|Overall Study|Participant's Decision|0|||
37946832|NCT00318643|69634335|FG004|Overall Study|Participant's Decision|1|||
37946833|NCT00318643|69634331|FG000|Overall Study|Investigator's Decision|0|||
38041758|NCT04338321|69729186|FG001|Overall Study|Withdrawal by Subject|69|||
38041759|NCT04338321|69729185|FG000|Overall Study|Physician Decision|5|||
38041760|NCT04338321|69729186|FG001|Overall Study|Physician Decision|9|||
38041761|NCT04338321|69729185|FG000|Overall Study|Other|3|||
38041762|NCT04338321|69729186|FG001|Overall Study|Other|10|||
38041763|NCT04303780|69729194|FG000|Overall Study|Death|104|||
37946834|NCT00318643|69634332|FG001|Overall Study|Investigator's Decision|0|||
37946835|NCT00318643|69634333|FG002|Overall Study|Investigator's Decision|0|||
37946836|NCT00318643|69634334|FG003|Overall Study|Investigator's Decision|0|||
37946837|NCT00318643|69634335|FG004|Overall Study|Investigator's Decision|1|||
37946838|NCT00318565|69634348|FG000|Overall Study|Excluded per protocol|24|||
37946839|NCT00304915|69634354|FG000|Overall Study|Lost to Follow-up|11|||
38041764|NCT04303780|69729195|FG001|Overall Study|Death|85|||
38041765|NCT04303780|69729194|FG000|Overall Study|Lost to Follow-up|5|||
38041766|NCT04303780|69729195|FG001|Overall Study|Lost to Follow-up|2|||
38041767|NCT04303780|69729194|FG000|Overall Study|Withdrawal by Subject|12|||
38041768|NCT04303780|69729195|FG001|Overall Study|Withdrawal by Subject|39|||
38041769|NCT04303780|69729194|FG000|Overall Study|Ongoing in study|50|||
38041770|NCT04303780|69729195|FG001|Overall Study|Ongoing in study|45|||
38041771|NCT04068181|69729206|FG000|Overall Study|Withdrawal by Subject|2|||
38041772|NCT04068181|69729207|FG001|Overall Study|Withdrawal by Subject|0|||
38041773|NCT04068181|69729208|FG002|Overall Study|Withdrawal by Subject|0|||
38041774|NCT04068181|69729209|FG003|Overall Study|Withdrawal by Subject|0|||
38041775|NCT04068181|69729206|FG000|Overall Study|Lost to Follow-up|1|||
38041776|NCT04068181|69729207|FG001|Overall Study|Lost to Follow-up|0|||
38041777|NCT04068181|69729208|FG002|Overall Study|Lost to Follow-up|0|||
38041778|NCT04068181|69729209|FG003|Overall Study|Lost to Follow-up|0|||
38041779|NCT04068181|69729206|FG000|Overall Study|Death|8|||
38041780|NCT04068181|69729207|FG001|Overall Study|Death|8|||
38041781|NCT04068181|69729208|FG002|Overall Study|Death|4|||
38041782|NCT04068181|69729209|FG003|Overall Study|Death|2|||
38041783|NCT04068181|69729206|FG000|Overall Study|Continuing Study|16|||
38041784|NCT04068181|69729207|FG001|Overall Study|Continuing Study|7|||
38041785|NCT04068181|69729208|FG002|Overall Study|Continuing Study|11|||
38041786|NCT04068181|69729209|FG003|Overall Study|Continuing Study|13|||
38041787|NCT03910673|69729238|FG000|Overall Study|Adverse Event|0|||
38041788|NCT03910673|69729239|FG001|Overall Study|Adverse Event|0|||
38041789|NCT03910673|69729240|FG002|Overall Study|Adverse Event|0|||
38041790|NCT03910673|69729241|FG003|Overall Study|Adverse Event|2|||
38041791|NCT03910673|69729242|FG004|Overall Study|Adverse Event|0|||
38041792|NCT03781167|69729252|FG000|Overall Study|Adverse Event|23|||
38041793|NCT03781167|69729253|FG001|Overall Study|Adverse Event|25|||
38041794|NCT03781167|69729252|FG000|Overall Study|Withdrew consent|16|||
38041795|NCT03781167|69729253|FG001|Overall Study|Withdrew consent|12|||
38041796|NCT03781167|69729252|FG000|Overall Study|Lost to Follow-up|0|||
38041797|NCT03781167|69729253|FG001|Overall Study|Lost to Follow-up|1|||
38041798|NCT03781167|69729252|FG000|Overall Study|Lack of Efficacy|4|||
38041799|NCT03781167|69729253|FG001|Overall Study|Lack of Efficacy|5|||
38041800|NCT03781167|69729252|FG000|Overall Study|Difficulty with drug delivery system|2|||
38041801|NCT03781167|69729253|FG001|Overall Study|Difficulty with drug delivery system|3|||
38041802|NCT03781167|69729252|FG000|Overall Study|Other, not specified|2|||
38041803|NCT03781167|69729253|FG001|Overall Study|Other, not specified|2|||
38041804|NCT03689712|69729301|FG000|Overall Study|Adverse Event|1|||
38041805|NCT03689712|69729302|FG001|Overall Study|Adverse Event|0|||
38041806|NCT03689712|69729301|FG000|Overall Study|Death|20|||
38041807|NCT03689712|69729302|FG001|Overall Study|Death|10|||
38041808|NCT03689712|69729301|FG000|Overall Study|Lost to Follow-up|6|||
38041809|NCT03689712|69729302|FG001|Overall Study|Lost to Follow-up|6|||
38041810|NCT03689712|69729301|FG000|Overall Study|Other|1|||
38041811|NCT03689712|69729302|FG001|Overall Study|Other|0|||
38041812|NCT03689712|69729301|FG000|Overall Study|Patient Non-Compliance|0|||
38041813|NCT03689712|69729302|FG001|Overall Study|Patient Non-Compliance|1|||
38041814|NCT03689712|69729301|FG000|Overall Study|Withdrawal by Subject|20|||
38041815|NCT03689712|69729302|FG001|Overall Study|Withdrawal by Subject|4|||
38041816|NCT03689712|69729301|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
38041817|NCT03689712|69729302|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
38041818|NCT03689712|69729301|FG000|Overall Study|Randomized but not Treated|13|||
38041819|NCT03689712|69729302|FG001|Overall Study|Randomized but not Treated|7|||
38041820|NCT03689712|69729301|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
38041821|NCT03689712|69729302|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
38041822|NCT03679624|69729310|FG000|Overall Study|Adverse Event|1|||
38041823|NCT03679624|69729311|FG001|Overall Study|Adverse Event|0|||
38041824|NCT03602586|69729317|FG000|Overall Study|Withdrawal by Subject|3|||
38041825|NCT03524092|69729334|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
38041826|NCT03524092|69729335|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
38041827|NCT03524092|69729336|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
38041828|NCT03524092|69729337|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
38041829|NCT03524092|69729338|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
38041830|NCT03524092|69729339|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
38041831|NCT03524092|69729334|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
38041832|NCT03524092|69729335|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
38041833|NCT03524092|69729336|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
38041834|NCT03524092|69729337|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
38041835|NCT03524092|69729338|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
38041836|NCT03524092|69729339|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
38041837|NCT03524092|69729334|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
38041838|NCT03524092|69729335|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
38041839|NCT03524092|69729336|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
38041840|NCT03524092|69729337|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
38041841|NCT03524092|69729338|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
38041842|NCT03524092|69729339|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
38041843|NCT03524092|69729334|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
38041844|NCT03524092|69729335|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
38041845|NCT03524092|69729336|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
38041846|NCT03524092|69729337|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
38041847|NCT03524092|69729338|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
38041848|NCT03524092|69729339|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
38041849|NCT03524092|69729334|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
38041850|NCT03524092|69729335|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
38041851|NCT03524092|69729336|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
38041852|NCT03524092|69729337|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
38041853|NCT03524092|69729338|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
38041854|NCT03524092|69729339|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
38041855|NCT03524092|69729334|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
38041856|NCT03524092|69729335|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
38041857|NCT03524092|69729336|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
38041858|NCT03524092|69729337|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
38041859|NCT03524092|69729338|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
38041860|NCT03524092|69729339|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
38041861|NCT03524092|69729334|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
37860027|NCT01162473|69543374|FG001|Overall Study|Withdrawal by Subject|4|||
37860028|NCT01162239|69543384|FG000|Treatment Phase|Withdrawal by Subject|1|||
38041862|NCT03524092|69729335|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
38041863|NCT03524092|69729336|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
38041864|NCT03524092|69729337|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
38041865|NCT03524092|69729338|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
38041866|NCT03524092|69729339|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
38041867|NCT03524092|69729334|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
38041868|NCT03524092|69729335|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
38041869|NCT03524092|69729336|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
38041870|NCT03524092|69729337|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
38041871|NCT03524092|69729338|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
38041872|NCT03524092|69729339|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
38041873|NCT03524092|69729334|FG000|Loss of Response Rescue Period|Adverse Event|0|||
38041874|NCT03524092|69729335|FG001|Loss of Response Rescue Period|Adverse Event|0|||
38041875|NCT03524092|69729336|FG002|Loss of Response Rescue Period|Adverse Event|0|||
38041876|NCT03524092|69729337|FG003|Loss of Response Rescue Period|Adverse Event|2|||
38041877|NCT03524092|69729338|FG004|Loss of Response Rescue Period|Adverse Event|0|||
38041878|NCT03524092|69729339|FG005|Loss of Response Rescue Period|Adverse Event|0|||
38041879|NCT03524092|69729334|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
38041880|NCT03524092|69729335|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
38041881|NCT03524092|69729336|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
38041882|NCT03524092|69729337|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
38041883|NCT03524092|69729338|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
38041884|NCT03524092|69729339|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
38041885|NCT03524092|69729334|FG000|Loss of Response Rescue Period|Pregnancy|0|||
38041886|NCT03524092|69729335|FG001|Loss of Response Rescue Period|Pregnancy|0|||
38041887|NCT03524092|69729336|FG002|Loss of Response Rescue Period|Pregnancy|0|||
38041888|NCT03524092|69729337|FG003|Loss of Response Rescue Period|Pregnancy|1|||
38041889|NCT03524092|69729338|FG004|Loss of Response Rescue Period|Pregnancy|0|||
38041890|NCT03524092|69729339|FG005|Loss of Response Rescue Period|Pregnancy|0|||
38041891|NCT03524092|69729334|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
38041892|NCT03524092|69729335|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
38041893|NCT03524092|69729336|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
38041894|NCT03524092|69729337|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
38041895|NCT03524092|69729338|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
38041896|NCT03524092|69729339|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
38041897|NCT03524092|69729334|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
38041898|NCT03524092|69729335|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
38041899|NCT03524092|69729336|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
38041900|NCT03524092|69729337|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
38041901|NCT03524092|69729338|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
38041902|NCT03524092|69729339|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
37767843|NCT01272219|69283497|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
38041903|NCT03524092|69729334|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
38041904|NCT03524092|69729335|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
38041905|NCT03524092|69729336|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
38041906|NCT03524092|69729337|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
38041907|NCT03524092|69729338|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
38041908|NCT03524092|69729339|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
38041909|NCT03524092|69729334|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
38041910|NCT03524092|69729335|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
38041911|NCT03524092|69729336|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
38041912|NCT03524092|69729337|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
38041913|NCT03524092|69729338|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
38041914|NCT03524092|69729339|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
38041915|NCT03524092|69729334|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
38041916|NCT03524092|69729335|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
38041917|NCT03524092|69729336|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
38041918|NCT03524092|69729337|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
38041919|NCT03524092|69729338|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
38041920|NCT03524092|69729339|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
38041921|NCT03524092|69729334|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
38041922|NCT03524092|69729335|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
38041923|NCT03524092|69729336|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
38041924|NCT03524092|69729337|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
38041925|NCT03524092|69729338|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
38041926|NCT03524092|69729339|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
38041927|NCT03524092|69729334|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
38041928|NCT03524092|69729335|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
38041929|NCT03524092|69729336|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
38041930|NCT03524092|69729337|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
38041931|NCT03524092|69729338|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
38041932|NCT03524092|69729339|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
38041933|NCT03524092|69729334|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
38041934|NCT03524092|69729335|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
38041935|NCT03524092|69729336|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
38041936|NCT03524092|69729337|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
38041937|NCT03524092|69729338|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
38041938|NCT03524092|69729339|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
38041939|NCT03524092|69729334|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
38041940|NCT03524092|69729335|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
38041941|NCT03524092|69729336|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
38041942|NCT03524092|69729337|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
38041943|NCT03524092|69729338|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
38041944|NCT03524092|69729339|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
38041945|NCT03524092|69729334|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
38041946|NCT03524092|69729335|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
38041947|NCT03524092|69729336|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
38041948|NCT03524092|69729337|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
38041949|NCT03524092|69729338|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
38041950|NCT03524092|69729339|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
38041951|NCT03524092|69729334|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
38041952|NCT03524092|69729335|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
38041953|NCT03524092|69729336|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
38041954|NCT03524092|69729337|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
38041955|NCT03524092|69729338|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
38041956|NCT03524092|69729339|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
37860029|NCT01162239|69543385|FG001|Treatment Phase|Withdrawal by Subject|3|||
37860030|NCT01162239|69543386|FG002|Treatment Phase|Withdrawal by Subject|2|||
37860031|NCT01162239|69543387|FG003|Treatment Phase|Withdrawal by Subject|3|||
37860032|NCT01162239|69543384|FG000|Treatment Phase|Death|0|||
37860033|NCT01162239|69543385|FG001|Treatment Phase|Death|0|||
37860034|NCT01162239|69543386|FG002|Treatment Phase|Death|0|||
37860035|NCT01162239|69543387|FG003|Treatment Phase|Death|1|||
37860036|NCT01162239|69543384|FG000|Treatment Phase|Lost to Follow-up|5|||
38041957|NCT03524092|69729334|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
38041958|NCT03524092|69729335|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
38041959|NCT03524092|69729336|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
38041960|NCT03524092|69729337|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
38041961|NCT03524092|69729338|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
38041962|NCT03524092|69729339|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
38041963|NCT03399552|69729350|FG000|Overall Study|No evidence of disease|1|||
38041964|NCT03399552|69729350|FG000|Overall Study|Unevaluable|1|||
38041965|NCT03382561|69729356|FG000|Overall Study|Disease progression|47|||
37676267|NCT04064411|69150880|FG000|Overall Study|Adverse Event|29|||
37676268|NCT04064411|69150881|FG001|Overall Study|Adverse Event|19|||
37676269|NCT04064411|69150880|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
37676270|NCT04064411|69150881|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
37676271|NCT04064411|69150880|FG000|Overall Study|Protocol Deviation|0|||
37676272|NCT04064411|69150881|FG001|Overall Study|Protocol Deviation|2|||
37676273|NCT04064411|69150880|FG000|Overall Study|Withdrawal by Subject|25|||
37676274|NCT04064411|69150881|FG001|Overall Study|Withdrawal by Subject|29|||
37676275|NCT04064411|69150880|FG000|Overall Study|Lost to Follow-up|5|||
37676276|NCT04064411|69150881|FG001|Overall Study|Lost to Follow-up|2|||
37676277|NCT04064411|69150880|FG000|Overall Study|Other than Specified|4|||
37676278|NCT04064411|69150881|FG001|Overall Study|Other than Specified|1|||
37676279|NCT04064411|69150880|FG000|Overall Study|Death|1|||
37676280|NCT04064411|69150881|FG001|Overall Study|Death|0|||
37676281|NCT02629133|69150889|FG000|Overall Study|Lost to Follow-up|3|||
37676282|NCT02629133|69150890|FG001|Overall Study|Lost to Follow-up|1|||
37676283|NCT02629133|69150889|FG000|Overall Study|Withdrawal by Subject|1|||
37676284|NCT02629133|69150890|FG001|Overall Study|Withdrawal by Subject|1|||
37676285|NCT02660359|69150899|FG000|Overall Study|Protocol Deviation|0|||
37676286|NCT02660359|69150900|FG001|Overall Study|Protocol Deviation|0|||
37676287|NCT02660359|69150901|FG002|Overall Study|Protocol Deviation|1|||
37676288|NCT02660359|69150899|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
37676289|NCT02660359|69150900|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
37676290|NCT02660359|69150901|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
37676291|NCT02660359|69150899|FG000|Overall Study|Lack of Efficacy|1|||
37676292|NCT02660359|69150900|FG001|Overall Study|Lack of Efficacy|1|||
37676293|NCT02660359|69150901|FG002|Overall Study|Lack of Efficacy|1|||
37676294|NCT02660359|69150899|FG000|Overall Study|Adverse Event|0|||
37676295|NCT02660359|69150900|FG001|Overall Study|Adverse Event|1|||
37676296|NCT02660359|69150901|FG002|Overall Study|Adverse Event|0|||
37676297|NCT02660359|69150899|FG000|Overall Study|Other|2|||
37676298|NCT02660359|69150900|FG001|Overall Study|Other|1|||
37676299|NCT02660359|69150901|FG002|Overall Study|Other|3|||
37676300|NCT02660359|69150899|FG000|Overall Study|Withdrawal by Subject|7|||
37676301|NCT02660359|69150900|FG001|Overall Study|Withdrawal by Subject|5|||
37676302|NCT02660359|69150901|FG002|Overall Study|Withdrawal by Subject|8|||
37676303|NCT02660359|69150899|FG000|Overall Study|Lost to Follow-up|3|||
37676304|NCT02660359|69150900|FG001|Overall Study|Lost to Follow-up|3|||
37676305|NCT02660359|69150901|FG002|Overall Study|Lost to Follow-up|0|||
37676306|NCT02628743|69150909|FG000|Overall Study|Other|3|||
37676307|NCT02628743|69150909|FG000|Overall Study|Withdrawal by Subject|50|||
37676308|NCT02628743|69150909|FG000|Overall Study|Study Terminated by Sponsor|76|||
37676309|NCT02628743|69150909|FG000|Overall Study|Physician Decision|2|||
37676310|NCT03839459|69150913|FG000|Overall Study|Withdrawal by Subject|2|||
37676311|NCT03839459|69150913|FG000|Overall Study|progression of disease|3|||
37676312|NCT02630693|69150919|FG000|Overall Study|No receive treatment|0|||
37676313|NCT02630693|69150920|FG001|Overall Study|No receive treatment|1|||
37676314|NCT05059301|69150929|FG000|Overall Study|Adverse Event|0|||
37676315|NCT05059301|69150930|FG001|Overall Study|Adverse Event|2|||
37676316|NCT05059301|69150931|FG002|Overall Study|Adverse Event|2|||
37676317|NCT05059301|69150929|FG000|Overall Study|Lost to Follow-up|2|||
37676318|NCT05059301|69150930|FG001|Overall Study|Lost to Follow-up|3|||
37676319|NCT05059301|69150931|FG002|Overall Study|Lost to Follow-up|3|||
37676320|NCT01938430|69150957|FG000|Overall Study|Randomized but Not Treated|0|||
37676321|NCT01938430|69150958|FG001|Overall Study|Randomized but Not Treated|0|||
37676322|NCT01938430|69150959|FG002|Overall Study|Randomized but Not Treated|0|||
37676323|NCT01938430|69150960|FG003|Overall Study|Randomized but Not Treated|0|||
37676324|NCT01938430|69150961|FG004|Overall Study|Randomized but Not Treated|0|||
37676325|NCT01938430|69150962|FG005|Overall Study|Randomized but Not Treated|0|||
37676326|NCT01938430|69150963|FG006|Overall Study|Randomized but Not Treated|0|||
37676327|NCT01938430|69150964|FG007|Overall Study|Randomized but Not Treated|0|||
37676328|NCT01938430|69150965|FG008|Overall Study|Randomized but Not Treated|0|||
37676329|NCT01938430|69150966|FG009|Overall Study|Randomized but Not Treated|0|||
37676330|NCT01938430|69150967|FG010|Overall Study|Randomized but Not Treated|1|||
37676331|NCT01938430|69150968|FG011|Overall Study|Randomized but Not Treated|0|||
37676332|NCT01938430|69150969|FG012|Overall Study|Randomized but Not Treated|0|||
37676333|NCT01938430|69150970|FG013|Overall Study|Randomized but Not Treated|1|||
37676334|NCT01938430|69150957|FG000|Overall Study|Adverse Event|0|||
37676335|NCT01938430|69150958|FG001|Overall Study|Adverse Event|0|||
37676336|NCT01938430|69150959|FG002|Overall Study|Adverse Event|0|||
37676337|NCT01938430|69150960|FG003|Overall Study|Adverse Event|0|||
37676338|NCT01938430|69150961|FG004|Overall Study|Adverse Event|0|||
37676339|NCT01938430|69150962|FG005|Overall Study|Adverse Event|0|||
37676340|NCT01938430|69150963|FG006|Overall Study|Adverse Event|1|||
37676341|NCT01938430|69150964|FG007|Overall Study|Adverse Event|0|||
37676342|NCT01938430|69150965|FG008|Overall Study|Adverse Event|0|||
37676343|NCT01938430|69150966|FG009|Overall Study|Adverse Event|0|||
37676344|NCT01938430|69150967|FG010|Overall Study|Adverse Event|0|||
37676345|NCT01938430|69150968|FG011|Overall Study|Adverse Event|0|||
37676346|NCT01938430|69150969|FG012|Overall Study|Adverse Event|0|||
37676347|NCT01938430|69150970|FG013|Overall Study|Adverse Event|0|||
37676348|NCT01938430|69150957|FG000|Overall Study|Death|1|||
37676349|NCT01938430|69150958|FG001|Overall Study|Death|2|||
37676350|NCT01938430|69150959|FG002|Overall Study|Death|2|||
37676351|NCT01938430|69150960|FG003|Overall Study|Death|1|||
37676352|NCT01938430|69150961|FG004|Overall Study|Death|0|||
37676353|NCT01938430|69150962|FG005|Overall Study|Death|0|||
37676354|NCT01938430|69150963|FG006|Overall Study|Death|1|||
37676355|NCT01938430|69150964|FG007|Overall Study|Death|1|||
37676356|NCT01938430|69150965|FG008|Overall Study|Death|2|||
37676357|NCT01938430|69150966|FG009|Overall Study|Death|3|||
37676358|NCT01938430|69150967|FG010|Overall Study|Death|0|||
37676359|NCT01938430|69150968|FG011|Overall Study|Death|0|||
37676360|NCT01938430|69150969|FG012|Overall Study|Death|0|||
37676361|NCT01938430|69150970|FG013|Overall Study|Death|0|||
37676362|NCT01938430|69150957|FG000|Overall Study|Investigator's Discretion|0|||
37676363|NCT01938430|69150958|FG001|Overall Study|Investigator's Discretion|0|||
37676364|NCT01938430|69150959|FG002|Overall Study|Investigator's Discretion|1|||
37676365|NCT01938430|69150960|FG003|Overall Study|Investigator's Discretion|0|||
37676366|NCT01938430|69150961|FG004|Overall Study|Investigator's Discretion|0|||
37676367|NCT01938430|69150962|FG005|Overall Study|Investigator's Discretion|0|||
37676368|NCT01938430|69150963|FG006|Overall Study|Investigator's Discretion|0|||
37676369|NCT01938430|69150964|FG007|Overall Study|Investigator's Discretion|0|||
37676370|NCT01938430|69150965|FG008|Overall Study|Investigator's Discretion|0|||
37676371|NCT01938430|69150966|FG009|Overall Study|Investigator's Discretion|0|||
37676372|NCT01938430|69150967|FG010|Overall Study|Investigator's Discretion|0|||
37676373|NCT01938430|69150968|FG011|Overall Study|Investigator's Discretion|0|||
37676374|NCT01938430|69150969|FG012|Overall Study|Investigator's Discretion|0|||
37676375|NCT01938430|69150970|FG013|Overall Study|Investigator's Discretion|0|||
37676376|NCT01938430|69150957|FG000|Overall Study|Lack of Efficacy|3|||
37676377|NCT01938430|69150958|FG001|Overall Study|Lack of Efficacy|1|||
37676378|NCT01938430|69150959|FG002|Overall Study|Lack of Efficacy|1|||
37676379|NCT01938430|69150960|FG003|Overall Study|Lack of Efficacy|1|||
37676380|NCT01938430|69150961|FG004|Overall Study|Lack of Efficacy|0|||
37676381|NCT01938430|69150962|FG005|Overall Study|Lack of Efficacy|0|||
37676382|NCT01938430|69150963|FG006|Overall Study|Lack of Efficacy|0|||
37676383|NCT01938430|69150964|FG007|Overall Study|Lack of Efficacy|0|||
37676384|NCT01938430|69150965|FG008|Overall Study|Lack of Efficacy|1|||
37676385|NCT01938430|69150966|FG009|Overall Study|Lack of Efficacy|0|||
37676386|NCT01938430|69150967|FG010|Overall Study|Lack of Efficacy|2|||
37676387|NCT01938430|69150968|FG011|Overall Study|Lack of Efficacy|1|||
37676388|NCT01938430|69150969|FG012|Overall Study|Lack of Efficacy|0|||
37676389|NCT01938430|69150970|FG013|Overall Study|Lack of Efficacy|0|||
37676390|NCT01938430|69150957|FG000|Overall Study|Lost to Follow-up|0|||
37676391|NCT01938430|69150958|FG001|Overall Study|Lost to Follow-up|0|||
37676392|NCT01938430|69150959|FG002|Overall Study|Lost to Follow-up|1|||
37676393|NCT01938430|69150960|FG003|Overall Study|Lost to Follow-up|0|||
37676394|NCT01938430|69150961|FG004|Overall Study|Lost to Follow-up|0|||
37676395|NCT01938430|69150962|FG005|Overall Study|Lost to Follow-up|1|||
37676396|NCT01938430|69150963|FG006|Overall Study|Lost to Follow-up|0|||
37676397|NCT01938430|69150964|FG007|Overall Study|Lost to Follow-up|0|||
37676398|NCT01938430|69150965|FG008|Overall Study|Lost to Follow-up|0|||
37676399|NCT01938430|69150966|FG009|Overall Study|Lost to Follow-up|0|||
37946840|NCT00304915|69634355|FG001|Overall Study|Lost to Follow-up|11|||
37676400|NCT01938430|69150967|FG010|Overall Study|Lost to Follow-up|0|||
37676401|NCT01938430|69150968|FG011|Overall Study|Lost to Follow-up|0|||
37676402|NCT01938430|69150969|FG012|Overall Study|Lost to Follow-up|0|||
37676403|NCT01938430|69150970|FG013|Overall Study|Lost to Follow-up|0|||
37676404|NCT01938430|69150957|FG000|Overall Study|Withdrew Consent|0|||
37676405|NCT01938430|69150958|FG001|Overall Study|Withdrew Consent|0|||
37676406|NCT01938430|69150959|FG002|Overall Study|Withdrew Consent|0|||
37676407|NCT01938430|69150960|FG003|Overall Study|Withdrew Consent|0|||
37946841|NCT00304915|69634354|FG000|Overall Study|Death|4|||
37676408|NCT01938430|69150961|FG004|Overall Study|Withdrew Consent|0|||
37676409|NCT01938430|69150962|FG005|Overall Study|Withdrew Consent|0|||
37676410|NCT01938430|69150963|FG006|Overall Study|Withdrew Consent|0|||
37676411|NCT01938430|69150964|FG007|Overall Study|Withdrew Consent|0|||
37676412|NCT01938430|69150965|FG008|Overall Study|Withdrew Consent|1|||
37676413|NCT01938430|69150966|FG009|Overall Study|Withdrew Consent|0|||
37676414|NCT01938430|69150967|FG010|Overall Study|Withdrew Consent|0|||
37676415|NCT01938430|69150968|FG011|Overall Study|Withdrew Consent|0|||
37676416|NCT01938430|69150969|FG012|Overall Study|Withdrew Consent|0|||
37676417|NCT01938430|69150970|FG013|Overall Study|Withdrew Consent|0|||
37676418|NCT01937884|69151027|FG000|Overall Study|Withdrawal by Subject|1|||
37676419|NCT01937884|69151028|FG001|Overall Study|Withdrawal by Subject|0|||
37676420|NCT01916824|69151038|FG000|Overall Study|Lost to Follow-up|3|||
37676421|NCT01916824|69151039|FG001|Overall Study|Lost to Follow-up|6|||
37676422|NCT01916824|69151038|FG000|Overall Study|Physician Decision|2|||
37676423|NCT01916824|69151039|FG001|Overall Study|Physician Decision|0|||
37676424|NCT01916824|69151038|FG000|Overall Study|Withdrawal by Subject|2|||
37676425|NCT01916824|69151039|FG001|Overall Study|Withdrawal by Subject|3|||
37676426|NCT01915732|69151047|FG000|Overall Study|Withdrawal by Subject|18|||
37676427|NCT01915732|69151048|FG001|Overall Study|Withdrawal by Subject|18|||
37676428|NCT01915732|69151047|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
37676429|NCT01915732|69151048|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
37676430|NCT01915732|69151047|FG000|Overall Study|Adverse Event|12|||
37676431|NCT01915732|69151048|FG001|Overall Study|Adverse Event|4|||
37676432|NCT01915732|69151047|FG000|Overall Study|Protocol Violation|5|||
37676433|NCT01915732|69151048|FG001|Overall Study|Protocol Violation|5|||
37676434|NCT01915732|69151047|FG000|Overall Study|Lack of Efficacy|6|||
37676435|NCT01915732|69151048|FG001|Overall Study|Lack of Efficacy|11|||
37676436|NCT01915732|69151047|FG000|Overall Study|Lost to Follow-up|22|||
37676437|NCT01915732|69151048|FG001|Overall Study|Lost to Follow-up|26|||
37676438|NCT01915732|69151047|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
37676439|NCT01915732|69151048|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
37676440|NCT01915732|69151047|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
37676441|NCT01915732|69151048|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
37676442|NCT01915732|69151047|FG000|Overall Study|Drug Release Error|1|||
37676443|NCT01915732|69151048|FG001|Overall Study|Drug Release Error|0|||
37676444|NCT01915732|69151047|FG000|Overall Study|Recovered|1|||
37676445|NCT01915732|69151048|FG001|Overall Study|Recovered|0|||
37676446|NCT01915732|69151047|FG000|Overall Study|Pregnancy|1|||
37676447|NCT01915732|69151048|FG001|Overall Study|Pregnancy|0|||
37676448|NCT01915732|69151047|FG000|Overall Study|Poor Perceived Efficacy|1|||
37676449|NCT01915732|69151048|FG001|Overall Study|Poor Perceived Efficacy|0|||
37676450|NCT01915732|69151047|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
37676451|NCT01915732|69151048|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
37676452|NCT01915732|69151047|FG000|Overall Study|Got Well|0|||
37676453|NCT01915732|69151048|FG001|Overall Study|Got Well|1|||
37676454|NCT01915732|69151047|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
37767844|NCT01272219|69283498|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
37767845|NCT01272219|69283499|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
37767846|NCT01272219|69283494|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
37767847|NCT01272219|69283495|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
37767848|NCT01272219|69283496|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
37767849|NCT01272219|69283497|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
37767850|NCT01272219|69283498|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
37767851|NCT01272219|69283499|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
37767852|NCT01272219|69283494|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
37767853|NCT01272219|69283495|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
37767854|NCT01272219|69283496|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
37767855|NCT01272219|69283497|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
37767856|NCT01272219|69283498|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
37767857|NCT01272219|69283499|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
37767858|NCT01272219|69283494|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
37767859|NCT01272219|69283495|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
37767860|NCT01272219|69283496|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
37767861|NCT01272219|69283497|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
37767862|NCT01272219|69283498|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
37767863|NCT01272219|69283499|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
37767864|NCT01272219|69283494|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
37767865|NCT01272219|69283495|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
37767866|NCT01272219|69283496|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
37767867|NCT01272219|69283497|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
37767868|NCT01272219|69283498|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
37767869|NCT01272219|69283499|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
37767870|NCT01272219|69283494|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
37767871|NCT01272219|69283495|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
37767872|NCT01272219|69283496|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
37767873|NCT01272219|69283497|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
37767874|NCT01272219|69283498|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
37676455|NCT01915732|69151048|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
37676456|NCT01915732|69151047|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
37676457|NCT01915732|69151048|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
37676458|NCT01915732|69151047|FG000|Overall Study|Job Transfer|0|||
37676459|NCT01915732|69151048|FG001|Overall Study|Job Transfer|1|||
37676460|NCT01915732|69151047|FG000|Overall Study|Improper Facial Procedure|0|||
37676461|NCT01915732|69151048|FG001|Overall Study|Improper Facial Procedure|1|||
37676462|NCT01915732|69151047|FG000|Overall Study|Poor Conscious Effect|0|||
37676463|NCT01915732|69151048|FG001|Overall Study|Poor Conscious Effect|1|||
37676464|NCT01936948|69151058|FG000|Overall Study|no 30-day follow-up data|0|||
37676465|NCT01936948|69151059|FG001|Overall Study|no 30-day follow-up data|3|||
37676466|NCT01936948|69151060|FG002|Overall Study|no 30-day follow-up data|3|||
37676467|NCT01936948|69151061|FG003|Overall Study|no 30-day follow-up data|3|||
37676468|NCT01936870|69151069|FG000|Overall Study|No Visit After Treatment|176|||
37676469|NCT01936870|69151069|FG000|Overall Study|Protocol Violation|12|||
37676470|NCT01936870|69151069|FG000|Overall Study|No Drug Administration|1|||
37676471|NCT01618864|69151073|FG000|Overall Study|Withdrawal by Subject|2|||
37676472|NCT01618864|69151073|FG000|Overall Study|Lost to Follow-up|2|||
37676473|NCT01618708|69151084|FG000|Overall Study|Adverse Event|10|||
37676474|NCT01618708|69151085|FG001|Overall Study|Adverse Event|10|||
37676475|NCT01618708|69151084|FG000|Overall Study|Lost to Follow-up|3|||
37676476|NCT01618708|69151085|FG001|Overall Study|Lost to Follow-up|3|||
37676477|NCT01618708|69151084|FG000|Overall Study|Withdrawal by Subject|17|||
37676478|NCT01618708|69151085|FG001|Overall Study|Withdrawal by Subject|22|||
37676479|NCT01618708|69151084|FG000|Overall Study|Lack of Efficacy|8|||
37676480|NCT01618708|69151085|FG001|Overall Study|Lack of Efficacy|8|||
37676481|NCT01618708|69151084|FG000|Overall Study|Technical problems|2|||
37676482|NCT01618708|69151085|FG001|Overall Study|Technical problems|0|||
37676483|NCT01618708|69151084|FG000|Overall Study|Other than specified above|1|||
37676484|NCT01618708|69151085|FG001|Overall Study|Other than specified above|1|||
37676485|NCT01618708|69151084|FG000|Overall Study|Randomized but not treated|3|||
37676486|NCT01618708|69151085|FG001|Overall Study|Randomized but not treated|2|||
37676487|NCT00790933|69151101|FG000|Overall Study|Adverse Event|94|||
37676488|NCT00790933|69151102|FG001|Overall Study|Adverse Event|119|||
37676489|NCT00790933|69151103|FG002|Overall Study|Adverse Event|65|||
37676490|NCT00790933|69151104|FG003|Overall Study|Adverse Event|5|||
37676491|NCT00790933|69151105|FG004|Overall Study|Adverse Event|69|||
37676492|NCT00790933|69151101|FG000|Overall Study|Protocol Violation(s)|8|||
37676493|NCT00790933|69151102|FG001|Overall Study|Protocol Violation(s)|18|||
37676494|NCT00790933|69151103|FG002|Overall Study|Protocol Violation(s)|7|||
37676495|NCT00790933|69151104|FG003|Overall Study|Protocol Violation(s)|0|||
37676496|NCT00790933|69151105|FG004|Overall Study|Protocol Violation(s)|12|||
37676497|NCT00790933|69151101|FG000|Overall Study|Lack of Efficacy|192|||
37676498|NCT00790933|69151102|FG001|Overall Study|Lack of Efficacy|176|||
37676499|NCT00790933|69151103|FG002|Overall Study|Lack of Efficacy|130|||
37676500|NCT00790933|69151104|FG003|Overall Study|Lack of Efficacy|1|||
37676501|NCT00790933|69151105|FG004|Overall Study|Lack of Efficacy|121|||
37676502|NCT00790933|69151101|FG000|Overall Study|Study Terminated by Sponsor|0|||
37676503|NCT00790933|69151102|FG001|Overall Study|Study Terminated by Sponsor|0|||
37676504|NCT00790933|69151103|FG002|Overall Study|Study Terminated by Sponsor|1|||
37676505|NCT00790933|69151104|FG003|Overall Study|Study Terminated by Sponsor|0|||
37676506|NCT00790933|69151105|FG004|Overall Study|Study Terminated by Sponsor|0|||
37676507|NCT00790933|69151101|FG000|Overall Study|Withdrawal by Subject|123|||
37676508|NCT00790933|69151102|FG001|Overall Study|Withdrawal by Subject|120|||
37676509|NCT00790933|69151103|FG002|Overall Study|Withdrawal by Subject|52|||
37676510|NCT00790933|69151104|FG003|Overall Study|Withdrawal by Subject|6|||
37676511|NCT00790933|69151105|FG004|Overall Study|Withdrawal by Subject|50|||
37676512|NCT00790933|69151101|FG000|Overall Study|Lost to Follow-up|13|||
37676513|NCT00790933|69151102|FG001|Overall Study|Lost to Follow-up|31|||
37676514|NCT00790933|69151103|FG002|Overall Study|Lost to Follow-up|10|||
37676515|NCT00790933|69151104|FG003|Overall Study|Lost to Follow-up|1|||
37676516|NCT00790933|69151105|FG004|Overall Study|Lost to Follow-up|15|||
37676517|NCT00790933|69151101|FG000|Overall Study|Reason Not Specified|8|||
37676518|NCT00790933|69151102|FG001|Overall Study|Reason Not Specified|16|||
37676519|NCT00790933|69151103|FG002|Overall Study|Reason Not Specified|4|||
37676520|NCT00790933|69151104|FG003|Overall Study|Reason Not Specified|1|||
37676521|NCT00790933|69151105|FG004|Overall Study|Reason Not Specified|9|||
37676522|NCT02161211|69151124|FG000|Overall Study|Lost to Follow-up|21|||
37676523|NCT02161211|69151125|FG001|Overall Study|Lost to Follow-up|27|||
37676524|NCT02161211|69151126|FG002|Overall Study|Lost to Follow-up|21|||
37676525|NCT02161211|69151124|FG000|Overall Study|Dropped|12|||
37676526|NCT02161211|69151125|FG001|Overall Study|Dropped|5|||
37676527|NCT02161211|69151126|FG002|Overall Study|Dropped|9|||
37676528|NCT01676701|69151136|FG000|Overall Study|Protocol Violation|1|||
37676529|NCT01676701|69151137|FG001|Overall Study|Protocol Violation|0|||
37676530|NCT01676701|69151136|FG000|Overall Study|Sponsor Decision|3|||
37676531|NCT01676701|69151137|FG001|Overall Study|Sponsor Decision|4|||
37676532|NCT01670279|69151148|FG000|Overall Study|Adverse Event|0|||
37676533|NCT01670279|69151149|FG001|Overall Study|Adverse Event|1|||
37676534|NCT01670279|69151150|FG002|Overall Study|Adverse Event|0|||
37676535|NCT01670279|69151151|FG003|Overall Study|Adverse Event|0|||
37676536|NCT01670279|69151148|FG000|Overall Study|Physician Decision|0|||
37676537|NCT01670279|69151149|FG001|Overall Study|Physician Decision|1|||
37676538|NCT01670279|69151150|FG002|Overall Study|Physician Decision|0|||
37676539|NCT01670279|69151151|FG003|Overall Study|Physician Decision|0|||
37676540|NCT01670279|69151148|FG000|Overall Study|Participant met withdrawal criteria|0|||
37676541|NCT01670279|69151149|FG001|Overall Study|Participant met withdrawal criteria|0|||
37676542|NCT01670279|69151150|FG002|Overall Study|Participant met withdrawal criteria|0|||
37676543|NCT01670279|69151151|FG003|Overall Study|Participant met withdrawal criteria|1|||
37676544|NCT02627495|69151159|FG000|Overall Study|Withdrawal by Subject|4|||
37676545|NCT01670045|69151163|FG000|Overall Study|Withdrawal by Subject|3|||
37676546|NCT01670045|69151163|FG000|Overall Study|Adverse Event|1|||
37676547|NCT01670045|69151163|FG000|Overall Study|Death|1|||
37676548|NCT01670045|69151163|FG000|Overall Study|Lost to Follow-up|11|||
37676549|NCT01669421|69151167|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
37676550|NCT01669421|69151167|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
37676551|NCT01671059|69151181|FG000|Overall Study|Adverse Event|4|||
37676552|NCT01671059|69151181|FG000|Overall Study|Lack of Efficacy|1|||
37676553|NCT01669811|69151197|FG000|Overall Study|Investigator decision|0|||
37676554|NCT01669811|69151198|FG001|Overall Study|Investigator decision|1|||
37676555|NCT01669811|69151197|FG000|Overall Study|Withdrawal by Subject|1|||
37676556|NCT01669811|69151198|FG001|Overall Study|Withdrawal by Subject|2|||
37676557|NCT01669811|69151197|FG000|Overall Study|Adverse Event|2|||
37676558|NCT01669811|69151198|FG001|Overall Study|Adverse Event|6|||
37676559|NCT01669811|69151197|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
37676560|NCT01669811|69151198|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
37676561|NCT01669577|69151204|FG000|Overall Study|Death|22|||
37676562|NCT01669577|69151204|FG000|Overall Study|Lost to Follow-up|78|||
37676563|NCT01669577|69151204|FG000|Overall Study|Physician Decision|34|||
37676564|NCT02658175|69151211|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
37676565|NCT02658175|69151212|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
37676566|NCT02658175|69151213|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
37676567|NCT02658175|69151211|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
37676568|NCT02658175|69151212|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
37676569|NCT02658175|69151213|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
37676570|NCT02658175|69151211|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
37676571|NCT02658175|69151212|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
37676572|NCT02658175|69151213|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
37676573|NCT02658175|69151211|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
37676574|NCT02658175|69151212|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
37676575|NCT02658175|69151213|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
37676576|NCT02658175|69151211|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
37676577|NCT02658175|69151212|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
37676578|NCT02658175|69151213|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
37676579|NCT02658175|69151211|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
37676580|NCT02658175|69151212|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
37676581|NCT02658175|69151213|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
37676582|NCT02658175|69151211|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
37676583|NCT02658175|69151212|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
37676584|NCT02658175|69151213|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
37676585|NCT02658175|69151211|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
37676586|NCT02658175|69151212|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
37676587|NCT02658175|69151213|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
37676588|NCT02658175|69151211|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
37676589|NCT02658175|69151212|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
37676590|NCT02658175|69151213|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
37676591|NCT02658175|69151211|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
37676592|NCT02658175|69151212|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
37676593|NCT02658175|69151213|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
37676594|NCT02625623|69151223|FG000|Overall Study|Participants randomized but not treated|9|||
37676595|NCT02625623|69151224|FG001|Overall Study|Participants randomized but not treated|1|||
37676596|NCT02658019|69151232|FG000|Overall Study|Adverse Event|1|||
37676597|NCT02624687|69151238|FG000|Overall Study|Withdrawal by Subject|1|||
37676598|NCT02624687|69151239|FG001|Overall Study|Withdrawal by Subject|1|||
37676599|NCT02624687|69151238|FG000|Overall Study|medical leave from work|0|||
37676600|NCT02624687|69151239|FG001|Overall Study|medical leave from work|1|||
37676601|NCT01675765|69151247|FG000|Overall Study|Progressive disease|4|||
37676602|NCT01675765|69151248|FG001|Overall Study|Progressive disease|4|||
37676603|NCT01675765|69151247|FG000|Overall Study|Adverse Event|1|||
37676604|NCT01675765|69151248|FG001|Overall Study|Adverse Event|2|||
37676605|NCT01675765|69151247|FG000|Overall Study|Withdrawal by Subject|2|||
37676606|NCT01675765|69151248|FG001|Overall Study|Withdrawal by Subject|0|||
37676607|NCT01675765|69151247|FG000|Overall Study|Death|1|||
37676608|NCT01675765|69151248|FG001|Overall Study|Death|0|||
37676609|NCT01675765|69151247|FG000|Overall Study|Clinical progression|3|||
37676610|NCT01675765|69151248|FG001|Overall Study|Clinical progression|2|||
37676611|NCT02625233|69151256|FG000|Overall Study|Adverse Event|2|||
37676612|NCT02625233|69151257|FG001|Overall Study|Adverse Event|0|||
37676613|NCT02656693|69151266|FG000|Overall Study|Pregnancy|1|||
37676614|NCT02656693|69151267|FG001|Overall Study|Pregnancy|1|||
37676615|NCT02656693|69151268|FG002|Overall Study|Pregnancy|1|||
37676616|NCT02656693|69151266|FG000|Overall Study|Bariatric surgery|0|||
37676617|NCT02656693|69151267|FG001|Overall Study|Bariatric surgery|1|||
37676618|NCT02656693|69151268|FG002|Overall Study|Bariatric surgery|2|||
37676619|NCT02633293|69151276|FG000|Overall Study|Death|56|||
37676620|NCT02633293|69151276|FG000|Overall Study|Progressive Disease|12|||
37946842|NCT00304915|69634355|FG001|Overall Study|Death|5|||
37676621|NCT02633293|69151276|FG000|Overall Study|Adverse Event|29|||
37676622|NCT02633293|69151276|FG000|Overall Study|Withdrawal by Subject|41|||
37676623|NCT02633293|69151276|FG000|Overall Study|Protocol Violation|1|||
37676624|NCT02633293|69151276|FG000|Overall Study|Lost to Follow-up|1|||
37676625|NCT02633293|69151276|FG000|Overall Study|Study Terminated by Sponsor|24|||
37676626|NCT02633293|69151276|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
37676627|NCT02633293|69151276|FG000|Overall Study|Lung Transplant|5|||
37676628|NCT02633293|69151276|FG000|Overall Study|Lack of Efficacy|2|||
37676629|NCT02633293|69151276|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
37676630|NCT02623829|69151282|FG000|Overall Study|Lost to Follow-up|1|||
37676631|NCT02623829|69151283|FG001|Overall Study|Lost to Follow-up|1|||
37676632|NCT02655679|69151294|FG000|Overall Study|Adverse Event|0|||
37676633|NCT02655679|69151295|FG001|Overall Study|Adverse Event|1|||
37676634|NCT02655679|69151296|FG002|Overall Study|Adverse Event|0|||
37676635|NCT02655679|69151297|FG003|Overall Study|Adverse Event|0|||
37676636|NCT02655679|69151298|FG004|Overall Study|Adverse Event|0|||
37676637|NCT02655679|69151294|FG000|Overall Study|Withdrawal by Subject|1|||
37676638|NCT02655679|69151295|FG001|Overall Study|Withdrawal by Subject|1|||
37676639|NCT02655679|69151296|FG002|Overall Study|Withdrawal by Subject|0|||
37676640|NCT02655679|69151297|FG003|Overall Study|Withdrawal by Subject|3|||
37676641|NCT02655679|69151298|FG004|Overall Study|Withdrawal by Subject|1|||
37676642|NCT02655679|69151294|FG000|Overall Study|Inability to Comply with the Protocol|1|||
37676643|NCT02655679|69151295|FG001|Overall Study|Inability to Comply with the Protocol|0|||
37676644|NCT02655679|69151296|FG002|Overall Study|Inability to Comply with the Protocol|0|||
37676645|NCT02655679|69151297|FG003|Overall Study|Inability to Comply with the Protocol|0|||
37676646|NCT02655679|69151298|FG004|Overall Study|Inability to Comply with the Protocol|0|||
37676647|NCT02655679|69151294|FG000|Overall Study|Lost to Follow-up|0|||
37676648|NCT02655679|69151295|FG001|Overall Study|Lost to Follow-up|1|||
37676649|NCT02655679|69151296|FG002|Overall Study|Lost to Follow-up|1|||
37676650|NCT02655679|69151297|FG003|Overall Study|Lost to Follow-up|1|||
37676651|NCT02655679|69151298|FG004|Overall Study|Lost to Follow-up|0|||
37676652|NCT02655679|69151294|FG000|Overall Study|Other Miscellaneous Reasons|1|||
37676653|NCT02655679|69151295|FG001|Overall Study|Other Miscellaneous Reasons|0|||
37676654|NCT02655679|69151296|FG002|Overall Study|Other Miscellaneous Reasons|0|||
37676655|NCT02655679|69151297|FG003|Overall Study|Other Miscellaneous Reasons|0|||
37676656|NCT02655679|69151298|FG004|Overall Study|Other Miscellaneous Reasons|0|||
37676657|NCT02623361|69151313|FG000|Overall Study|Protocol Violation|0|||
37676658|NCT02623361|69151314|FG001|Overall Study|Protocol Violation|1|||
37676659|NCT02623361|69151313|FG000|Overall Study|Withdrawal by Subject|0|||
37676660|NCT02623361|69151314|FG001|Overall Study|Withdrawal by Subject|1|||
37676661|NCT01675531|69151361|FG000|Overall Study|Adverse Event|9|||
37676662|NCT01675531|69151361|FG000|Overall Study|Withdrawal by Subject|7|||
37676663|NCT01675531|69151361|FG000|Overall Study|Lack of Efficacy|1|||
37676664|NCT01675531|69151361|FG000|Overall Study|Protocol Violation|8|||
37676665|NCT02532543|69151370|FG000|Overall Study|Lost to Follow-up|0|||
37676666|NCT02532543|69151371|FG001|Overall Study|Lost to Follow-up|0|||
37676667|NCT02532543|69151372|FG002|Overall Study|Lost to Follow-up|1|||
37676668|NCT02532543|69151373|FG003|Overall Study|Lost to Follow-up|0|||
37676669|NCT02532465|69151385|FG000|Overall Study|Protocol Violation|1|||
37676670|NCT02532465|69151386|FG001|Overall Study|Protocol Violation|0|||
37676671|NCT02532465|69151385|FG000|Overall Study|Lack of Efficacy|0|||
37676672|NCT02532465|69151386|FG001|Overall Study|Lack of Efficacy|1|||
37676673|NCT02528331|69151392|FG000|Overall Study|Withdrawal by Subject|2|||
37676674|NCT02654977|69151396|FG000|Overall Study|Death|1|||
37676675|NCT02654977|69151396|FG000|Overall Study|Lost to Follow-up|1|||
37676676|NCT02654977|69151396|FG000|Overall Study|Adverse Event|1|||
37676677|NCT02654977|69151396|FG000|Overall Study|Withdrawal by Subject|1|||
37676678|NCT02654977|69151396|FG000|Overall Study|Lack of Efficacy|3|||
37676679|NCT01362517|69151400|FG000|Overall Study|Protocol Violation|1|||
37676680|NCT01362517|69151400|FG000|Overall Study|Lost to Follow-up|1|||
37676681|NCT01362439|69151407|FG000|Overall Study|Adverse Event|1|||
37676682|NCT01362439|69151407|FG000|Overall Study|Lack of Efficacy|3|||
37676683|NCT01362439|69151407|FG000|Overall Study|Lost to Follow-up|2|||
37676684|NCT01362439|69151407|FG000|Overall Study|Study medication non-compliant|1|||
37676685|NCT01362439|69151407|FG000|Overall Study|Participant who withdrew consent|8|||
37676686|NCT02653495|69151414|FG000|Overall Study|Lost to Follow-up|2|||
37676687|NCT02653495|69151415|FG001|Overall Study|Lost to Follow-up|0|||
37676688|NCT02653495|69151414|FG000|Overall Study|Screening Failure|10|||
37676689|NCT02653495|69151415|FG001|Overall Study|Screening Failure|0|||
37676690|NCT01675141|69151421|FG000|Overall Study|Lenalidomide outside NIH|3|||
37676691|NCT01675141|69151421|FG000|Overall Study|Withdrawal by Subject|3|||
37676692|NCT01675141|69151421|FG000|Overall Study|Physician Decision|4|||
37676693|NCT01675141|69151421|FG000|Overall Study|No treatment, per protocol|1|||
37676694|NCT03367819|69151456|FG000|Overall Study|Adverse Event|4|||
37676695|NCT03367819|69151457|FG001|Overall Study|Adverse Event|4|||
37676696|NCT03367819|69151456|FG000|Overall Study|Progressive Disease|15|||
37676697|NCT03367819|69151457|FG001|Overall Study|Progressive Disease|13|||
37676698|NCT03367819|69151456|FG000|Overall Study|Withdrawal by Subject|1|||
37676699|NCT03367819|69151457|FG001|Overall Study|Withdrawal by Subject|0|||
37676700|NCT03367819|69151456|FG000|Overall Study|Other|4|||
37676701|NCT03367819|69151457|FG001|Overall Study|Other|2|||
37676702|NCT01597193|69151500|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
37676703|NCT01597193|69151501|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
37676704|NCT01597193|69151502|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
37676705|NCT01597193|69151503|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
37676706|NCT01597193|69151504|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
37676707|NCT01597193|69151505|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
37676708|NCT01597193|69151506|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
37676709|NCT01597193|69151500|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
37676710|NCT01597193|69151501|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
37676711|NCT01597193|69151502|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
37676712|NCT01597193|69151503|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
37676713|NCT01597193|69151504|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
37676714|NCT01597193|69151505|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
37676715|NCT01597193|69151506|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
37676716|NCT01597193|69151500|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
37676717|NCT01597193|69151501|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
37676718|NCT01597193|69151502|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
37676719|NCT01597193|69151503|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
37676720|NCT01597193|69151504|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
37676721|NCT01597193|69151505|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
37676722|NCT01597193|69151506|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
37676723|NCT01597193|69151500|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
37676724|NCT01597193|69151501|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
37676725|NCT01597193|69151502|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
37676726|NCT01597193|69151503|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
37676727|NCT01597193|69151504|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
37676728|NCT01597193|69151505|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
37676729|NCT01597193|69151506|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
37676730|NCT01597193|69151500|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
37676731|NCT01597193|69151501|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
37676732|NCT01597193|69151502|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
37676733|NCT01597193|69151503|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
37676734|NCT01597193|69151504|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
37676735|NCT01597193|69151505|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
37676736|NCT01597193|69151506|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
37676737|NCT02649439|69151529|FG000|Overall Study|Switched to alternative treatment|6|||
37676738|NCT02649439|69151530|FG001|Overall Study|Switched to alternative treatment|4|||
37676739|NCT02649439|69151529|FG000|Overall Study|Patient decision|1|||
37676740|NCT02649439|69151530|FG001|Overall Study|Patient decision|0|||
37676741|NCT02649439|69151529|FG000|Overall Study|Patient going out of country|1|||
37676742|NCT02649439|69151530|FG001|Overall Study|Patient going out of country|0|||
37676743|NCT02649439|69151529|FG000|Overall Study|To start finasteride|1|||
37676744|NCT02649439|69151530|FG001|Overall Study|To start finasteride|0|||
37676745|NCT02649439|69151529|FG000|Overall Study|Physician Decision|1|||
37676746|NCT02649439|69151530|FG001|Overall Study|Physician Decision|0|||
37676747|NCT02649439|69151529|FG000|Overall Study|Disease progression on study|12|||
37677651|NCT01360645|69152682|FG003|Phase B (6 Weeks)|Adverse Event|0|||
37767875|NCT01272219|69283499|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
37767876|NCT01272219|69283494|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
37860037|NCT01162239|69543385|FG001|Treatment Phase|Lost to Follow-up|4|||
37676748|NCT02649439|69151530|FG001|Overall Study|Disease progression on study|13|||
37676749|NCT02649439|69151529|FG000|Overall Study|Refused further treatment|1|||
37676750|NCT02649439|69151530|FG001|Overall Study|Refused further treatment|0|||
37676751|NCT02649439|69151529|FG000|Overall Study|Refused further follow up|2|||
37676752|NCT02649439|69151530|FG001|Overall Study|Refused further follow up|7|||
37676753|NCT02649439|69151529|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
37676754|NCT02649439|69151530|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
37676755|NCT02649439|69151529|FG000|Overall Study|No treatment, per protocol|1|||
37676756|NCT02649439|69151530|FG001|Overall Study|No treatment, per protocol|0|||
37676757|NCT02649439|69151529|FG000|Overall Study|PSA DT makes ineligible|0|||
37676758|NCT02649439|69151530|FG001|Overall Study|PSA DT makes ineligible|1|||
37676759|NCT02649439|69151529|FG000|Overall Study|Rising PSA No Mets|0|||
37676760|NCT02649439|69151530|FG001|Overall Study|Rising PSA No Mets|1|||
37676761|NCT02649439|69151529|FG000|Overall Study|Rising PSA|0|||
37676762|NCT02649439|69151530|FG001|Overall Study|Rising PSA|1|||
37676763|NCT02649439|69151529|FG000|Overall Study|Signed follow up protocol|0|||
37676764|NCT02649439|69151530|FG001|Overall Study|Signed follow up protocol|1|||
37676765|NCT02622113|69151545|FG000|Overall Study|Adverse Event|4|||
37676766|NCT02622113|69151546|FG001|Overall Study|Adverse Event|4|||
37676767|NCT02622113|69151545|FG000|Overall Study|Physician Decision|0|||
37676768|NCT02622113|69151546|FG001|Overall Study|Physician Decision|1|||
37676769|NCT02622113|69151545|FG000|Overall Study|Withdrawal by Subject|0|||
37676770|NCT02622113|69151546|FG001|Overall Study|Withdrawal by Subject|2|||
37676771|NCT02622113|69151545|FG000|Overall Study|Stopping Criteria|1|||
37676772|NCT02622113|69151546|FG001|Overall Study|Stopping Criteria|3|||
37676773|NCT02651467|69151555|FG000|Overall Study|Withdrawal by Subject|0|||
37676774|NCT02651467|69151556|FG001|Overall Study|Withdrawal by Subject|0|||
37676775|NCT02651467|69151557|FG002|Overall Study|Withdrawal by Subject|2|||
37676776|NCT02651467|69151555|FG000|Overall Study|Other (Not specified)|1|||
37676777|NCT02651467|69151556|FG001|Overall Study|Other (Not specified)|0|||
37676778|NCT02651467|69151557|FG002|Overall Study|Other (Not specified)|2|||
37676779|NCT02620787|69151586|FG000|Overall Study|Adverse Event|1|||
37676780|NCT02620787|69151587|FG001|Overall Study|Adverse Event|0|||
37676781|NCT02620787|69151586|FG000|Overall Study|Eligibility Criteria Not Met|1|||
37676782|NCT02620787|69151587|FG001|Overall Study|Eligibility Criteria Not Met|0|||
37676783|NCT02651155|69151595|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
37676784|NCT02651155|69151596|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
37676785|NCT02651155|69151595|FG000|Overall Study|Voluntary Withdrawal|5|||
37676786|NCT02651155|69151596|FG001|Overall Study|Voluntary Withdrawal|0|||
37676787|NCT02619617|69151602|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
37676788|NCT02619617|69151603|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
37676789|NCT02619617|69151602|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
37676790|NCT02619617|69151603|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
37676791|NCT02650921|69151624|FG000|Overall Study|Withdrawal by Subject|4|||
37676792|NCT02650921|69151624|FG000|Overall Study|Lost to Follow-up|2|||
37676793|NCT02650921|69151624|FG000|Overall Study|Adverse Event|1|||
37676794|NCT02650921|69151624|FG000|Overall Study|Due to Medical Condition|1|||
37676795|NCT01596335|69151632|FG000|Overall Study|exacerbation of primary disease|5|||
37676796|NCT01596335|69151633|FG001|Overall Study|exacerbation of primary disease|9|||
37676797|NCT02618759|69151641|FG000|Overall Study|Lost to Follow-up|0|||
37676798|NCT02618759|69151642|FG001|Overall Study|Lost to Follow-up|1|||
37676799|NCT02618759|69151641|FG000|Overall Study|Withdrawal by Subject|1|||
37676800|NCT02618759|69151642|FG001|Overall Study|Withdrawal by Subject|0|||
37676801|NCT02618759|69151641|FG000|Overall Study|Other Reasons|1|||
37676802|NCT02618759|69151642|FG001|Overall Study|Other Reasons|4|||
37676803|NCT02614079|69151657|FG000|Overall Study|Withdrawal by Subject|1|||
37676804|NCT02616029|69151663|FG000|Overall Study|Adverse Event|1|||
37676805|NCT02616029|69151664|FG001|Overall Study|Adverse Event|0|||
37676806|NCT02616029|69151663|FG000|Overall Study|Death|0|||
37676807|NCT02616029|69151664|FG001|Overall Study|Death|1|||
37676808|NCT02616029|69151663|FG000|Overall Study|Protocol Violation|1|||
37676809|NCT02616029|69151664|FG001|Overall Study|Protocol Violation|0|||
37676810|NCT02616029|69151663|FG000|Overall Study|Withdrew Consent|1|||
37676811|NCT02616029|69151664|FG001|Overall Study|Withdrew Consent|0|||
37676812|NCT02616029|69151663|FG000|Overall Study|Enrolled and Never Treated|1|||
37676813|NCT02616029|69151664|FG001|Overall Study|Enrolled and Never Treated|1|||
37676814|NCT02614859|69151672|FG000|Overall Study|Physician Decision|0|||
37676815|NCT02614859|69151673|FG001|Overall Study|Physician Decision|1|||
37676816|NCT02615249|69151681|FG000|Overall Study|Withdrawal by Subject|1|||
37676817|NCT02615171|69151688|FG000|Overall Study|Lost to Follow-up|2|||
37676818|NCT02615171|69151689|FG001|Overall Study|Lost to Follow-up|1|||
37676819|NCT02648347|69151697|FG000|Overall Study|Death|174|||
37676820|NCT02648347|69151698|FG001|Overall Study|Death|167|||
37676821|NCT02648347|69151697|FG000|Overall Study|Withdrawal by Subject|16|||
37676822|NCT02648347|69151698|FG001|Overall Study|Withdrawal by Subject|9|||
37676823|NCT02648347|69151697|FG000|Overall Study|Lost to Follow-up|18|||
37676824|NCT02648347|69151698|FG001|Overall Study|Lost to Follow-up|21|||
37676825|NCT02648347|69151697|FG000|Overall Study|Missing|1|||
37676826|NCT02648347|69151698|FG001|Overall Study|Missing|0|||
37676827|NCT02614703|69151706|FG000|Overall Study|Withdrawal by Subject|7|||
37676828|NCT02614703|69151707|FG001|Overall Study|Withdrawal by Subject|1|||
37676829|NCT01669343|69151713|FG000|Part A: All Patients|Withdrawal by Subject|7|||
37676830|NCT01669343|69151713|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
37676831|NCT01669343|69151713|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
37676832|NCT01669343|69151713|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
37676833|NCT01669343|69151713|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
37676834|NCT01594931|69151723|FG000|Overall Study|Adverse Event|3|||
37676835|NCT01594931|69151724|FG001|Overall Study|Adverse Event|1|||
37676836|NCT01594931|69151725|FG002|Overall Study|Adverse Event|1|||
37676837|NCT01594931|69151723|FG000|Overall Study|Withdrawal by Subject|2|||
37676838|NCT01594931|69151724|FG001|Overall Study|Withdrawal by Subject|1|||
37676839|NCT01594931|69151725|FG002|Overall Study|Withdrawal by Subject|1|||
37676840|NCT01594931|69151723|FG000|Overall Study|Lack of Efficacy|7|||
37676841|NCT01594931|69151724|FG001|Overall Study|Lack of Efficacy|2|||
37676842|NCT01594931|69151725|FG002|Overall Study|Lack of Efficacy|2|||
37676843|NCT01594931|69151723|FG000|Overall Study|Lost to Follow-up|4|||
37676844|NCT01594931|69151724|FG001|Overall Study|Lost to Follow-up|3|||
37676845|NCT01594931|69151725|FG002|Overall Study|Lost to Follow-up|3|||
37676846|NCT01594931|69151723|FG000|Overall Study|Protocol Violation|2|||
37676847|NCT01594931|69151724|FG001|Overall Study|Protocol Violation|1|||
37676848|NCT01594931|69151725|FG002|Overall Study|Protocol Violation|0|||
37676849|NCT01594931|69151723|FG000|Overall Study|No defiined|11|||
37676850|NCT01594931|69151724|FG001|Overall Study|No defiined|4|||
37676851|NCT01594931|69151725|FG002|Overall Study|No defiined|7|||
37676852|NCT01594853|69151735|FG000|Overall Study|Withdrawal by Subject|1|||
37676853|NCT01594853|69151736|FG001|Overall Study|Withdrawal by Subject|1|||
37676854|NCT01594853|69151735|FG000|Overall Study|Lost to Follow-up|1|||
37676855|NCT01594853|69151736|FG001|Overall Study|Lost to Follow-up|1|||
37676856|NCT01594853|69151735|FG000|Overall Study|noncompliance with exercise|0|||
37676857|NCT01594853|69151736|FG001|Overall Study|noncompliance with exercise|1|||
37676858|NCT01668797|69151753|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
37676859|NCT01668797|69151754|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
37676860|NCT01668797|69151755|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
37676861|NCT01668797|69151756|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
37676862|NCT01668797|69151753|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
37676863|NCT01668797|69151754|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
37676864|NCT01668797|69151755|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
37676865|NCT01668797|69151756|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
37676866|NCT01668797|69151753|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
37676867|NCT01668797|69151754|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
37676868|NCT01668797|69151755|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
37676869|NCT01668797|69151756|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
37676870|NCT01668797|69151753|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
37676871|NCT01668797|69151754|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
37676872|NCT01668797|69151755|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
37676873|NCT01668797|69151756|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
37676874|NCT01668797|69151753|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
37676875|NCT01668797|69151754|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
37676876|NCT01668797|69151755|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
37676877|NCT01668797|69151756|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
37676878|NCT01668797|69151753|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
37676879|NCT01668797|69151754|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
37676880|NCT01668797|69151755|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
37676881|NCT01668797|69151756|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
37676882|NCT01668797|69151753|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
37676883|NCT01668797|69151754|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
37676884|NCT01668797|69151755|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
37676885|NCT01668797|69151756|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
37676886|NCT01668797|69151753|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
37767877|NCT01272219|69283495|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
37860038|NCT01162239|69543386|FG002|Treatment Phase|Lost to Follow-up|2|||
37676887|NCT01668797|69151754|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
37676888|NCT01668797|69151755|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
37676889|NCT01668797|69151756|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
37676890|NCT01668797|69151753|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
37676891|NCT01668797|69151754|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
37676892|NCT01668797|69151755|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
37676893|NCT01668797|69151756|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
37676894|NCT01668797|69151753|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
37676895|NCT01668797|69151754|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
37676896|NCT01668797|69151755|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
37676897|NCT01668797|69151756|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
37676898|NCT01668797|69151753|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
37676899|NCT01668797|69151754|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
37676900|NCT01668797|69151755|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
37676901|NCT01668797|69151756|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
37676902|NCT01668797|69151753|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
37676903|NCT01668797|69151754|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
37676904|NCT01668797|69151755|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
37676905|NCT01668797|69151756|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
37676906|NCT01668797|69151753|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
37676907|NCT01668797|69151754|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
37676908|NCT01668797|69151755|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
37676909|NCT01668797|69151756|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
37676910|NCT01668797|69151753|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
37676911|NCT01668797|69151754|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
37676912|NCT01668797|69151755|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
37676913|NCT01668797|69151756|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
37676914|NCT01668797|69151753|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
37676915|NCT01668797|69151754|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
37676916|NCT01668797|69151755|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
37676917|NCT01668797|69151756|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
37676918|NCT01668797|69151753|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
37676919|NCT01668797|69151754|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
37676920|NCT01668797|69151755|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
37676921|NCT01668797|69151756|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
37676922|NCT01668797|69151753|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
37676923|NCT01668797|69151754|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
37676924|NCT01668797|69151755|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
37676925|NCT01668797|69151756|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
37676926|NCT01668797|69151753|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
37676927|NCT01668797|69151754|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
37676928|NCT01668797|69151755|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
37676929|NCT01668797|69151756|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
37676930|NCT01668797|69151753|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
37676931|NCT01668797|69151754|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
37676932|NCT01668797|69151755|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
37676933|NCT01668797|69151756|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
37676934|NCT01668797|69151753|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
37676935|NCT01668797|69151754|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
37676936|NCT01668797|69151755|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
37676937|NCT01668797|69151756|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
37676938|NCT01668797|69151753|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
37676939|NCT01668797|69151754|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
37676940|NCT01668797|69151755|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
37676941|NCT01668797|69151756|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
37676942|NCT01668797|69151753|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
37676943|NCT01668797|69151754|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
37676944|NCT01668797|69151755|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
37676945|NCT01668797|69151756|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
37676946|NCT01668797|69151753|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
37676947|NCT01668797|69151754|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
37676948|NCT01668797|69151755|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
37676949|NCT01668797|69151756|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
37676950|NCT01668797|69151753|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
37676951|NCT01668797|69151754|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
37676952|NCT01668797|69151755|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
37676953|NCT01668797|69151756|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
37676954|NCT01668797|69151753|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
37860039|NCT01162239|69543387|FG003|Treatment Phase|Lost to Follow-up|1|||
37676955|NCT01668797|69151754|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
37676956|NCT01668797|69151755|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
37676957|NCT01668797|69151756|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
37676958|NCT02613221|69151763|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
37676959|NCT02613221|69151763|FG000|Overall Study|Adverse Event|2|||
37676960|NCT02613221|69151763|FG000|Overall Study|Voluntary Discontinuation|1|||
37676961|NCT02613221|69151763|FG000|Overall Study|Delayed Treatment|1|||
37676962|NCT02613221|69151763|FG000|Overall Study|Enrolled but Not Treated|1|||
37676963|NCT01362049|69151771|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
37676964|NCT01362049|69151772|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
37676965|NCT01362049|69151773|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
37676966|NCT01362049|69151774|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
37676967|NCT01362049|69151771|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
37676968|NCT01362049|69151772|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
37676969|NCT01362049|69151773|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
37676970|NCT01362049|69151774|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
37676971|NCT02612909|69151806|FG000|Phase 2|Withdrawal by Subject|2|||
37676972|NCT02612909|69151807|FG001|Phase 2|Withdrawal by Subject|5|||
37676973|NCT02612909|69151808|FG002|Phase 2|Withdrawal by Subject|0|||
37676974|NCT02612909|69151809|FG003|Phase 2|Withdrawal by Subject|0|||
37676975|NCT02612909|69151810|FG004|Phase 2|Withdrawal by Subject|0|||
37676976|NCT02612909|69151806|FG000|Phase 2|Pregnancy|0|||
37676977|NCT02612909|69151807|FG001|Phase 2|Pregnancy|0|||
37676978|NCT02612909|69151808|FG002|Phase 2|Pregnancy|1|||
37676979|NCT02612909|69151809|FG003|Phase 2|Pregnancy|0|||
37860040|NCT01162239|69543384|FG000|Extended Follow-up|Lost to Follow-up|8|||
37860041|NCT01162239|69543385|FG001|Extended Follow-up|Lost to Follow-up|13|||
37860042|NCT01162239|69543386|FG002|Extended Follow-up|Lost to Follow-up|8|||
37860043|NCT01162239|69543387|FG003|Extended Follow-up|Lost to Follow-up|6|||
37860044|NCT01161537|69543398|FG000|Part B|Withdrawal by Subject|2|||
37860045|NCT01234350|69543409|FG000|Overall Study|Adverse Event|277|||
37860046|NCT01234350|69543410|FG001|Overall Study|Adverse Event|92|||
37860047|NCT01234350|69543409|FG000|Overall Study|Withdrawal by Subject|61|||
37860048|NCT01234350|69543410|FG001|Overall Study|Withdrawal by Subject|36|||
37860049|NCT01234350|69543409|FG000|Overall Study|Lost to Follow-up|115|||
37860050|NCT01234350|69543410|FG001|Overall Study|Lost to Follow-up|47|||
37860051|NCT01234350|69543409|FG000|Overall Study|Covers a diverse set of reasons|234|||
37860052|NCT01234350|69543410|FG001|Overall Study|Covers a diverse set of reasons|92|||
37860053|NCT01233258|69543421|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
37860054|NCT01233258|69543422|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
37860055|NCT01233258|69543423|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
37860056|NCT01233258|69543424|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
37676980|NCT02612909|69151810|FG004|Phase 2|Pregnancy|0|||
37676981|NCT02612909|69151806|FG000|Phase 3|Withdrawal by Subject|0|||
37676982|NCT02612909|69151807|FG001|Phase 3|Withdrawal by Subject|0|||
37676983|NCT02612909|69151808|FG002|Phase 3|Withdrawal by Subject|0|||
37676984|NCT02612909|69151809|FG003|Phase 3|Withdrawal by Subject|1|||
37676985|NCT02612909|69151810|FG004|Phase 3|Withdrawal by Subject|0|||
37676986|NCT02612285|69151824|FG000|Overall Study|Withdrawal by Subject|1|||
37676987|NCT02609633|69151830|FG000|Overall Study|Consent Withdrawn|0|||
37676988|NCT02609633|69151831|FG001|Overall Study|Consent Withdrawn|1|||
37676989|NCT02609633|69151830|FG000|Overall Study|Protocol Deviation|1|||
37676990|NCT02609633|69151831|FG001|Overall Study|Protocol Deviation|0|||
37676991|NCT02609633|69151830|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
37676992|NCT02609633|69151831|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
37676993|NCT02609633|69151830|FG000|Overall Study|Reason not Specified|2|||
37676994|NCT02609633|69151831|FG001|Overall Study|Reason not Specified|1|||
37676995|NCT01597375|69151853|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
37676996|NCT01597375|69151854|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
37676997|NCT01597375|69151853|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
37676998|NCT01597375|69151854|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
37676999|NCT01597375|69151853|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
37677000|NCT01597375|69151854|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
37677001|NCT01597375|69151853|FG000|Washout (2 Weeks)|Adverse Event|1|||
37677002|NCT01597375|69151854|FG001|Washout (2 Weeks)|Adverse Event|0|||
37677003|NCT01597375|69151853|FG000|Second Intervention|Failed to react at both Aspirin|1|||
37677004|NCT01597375|69151854|FG001|Second Intervention|Failed to react at both Aspirin|1|||
37677005|NCT02527161|69151861|FG000|Overall Study|Failed MRI|52|||
37677006|NCT02527161|69151861|FG000|Overall Study|Withdrawal by Subject|19|||
37677007|NCT02527161|69151861|FG000|Overall Study|Delay in or unfit for surgery|16|||
37677008|NCT02527161|69151861|FG000|Overall Study|MRI contraindication|6|||
37767878|NCT01272219|69283496|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
37677009|NCT02527161|69151861|FG000|Overall Study|Consent violation|4|||
37677010|NCT02527161|69151861|FG000|Overall Study|Only Recruited to Part A|27|||
37677011|NCT02527161|69151861|FG000|Overall Study|Physician Decision|1|||
37677012|NCT02527161|69151861|FG000|Overall Study|Adverse Event|1|||
37677013|NCT02527161|69151861|FG000|Overall Study|Lost to Follow-up|6|||
37677014|NCT02609399|69151868|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
37677015|NCT02609399|69151869|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
37677016|NCT02609399|69151868|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
37677017|NCT02609399|69151869|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
37677018|NCT02609399|69151868|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
37677019|NCT02609399|69151869|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
37677020|NCT02720185|69151877|FG000|Overall Study|Lost to Follow-up|1|||
37677021|NCT02526693|69151900|FG000|Overall Study|Physician Decision|3|||
37677022|NCT02526693|69151901|FG001|Overall Study|Physician Decision|1|||
37677023|NCT02710669|69151919|FG000|Overall Study|Physician Decision|2|||
37677024|NCT02710669|69151920|FG001|Overall Study|Physician Decision|1|||
37677025|NCT02710669|69151921|FG002|Overall Study|Physician Decision|0|||
37677026|NCT02710669|69151919|FG000|Overall Study|Institutional delays (including COVID)|2|||
37677027|NCT02710669|69151920|FG001|Overall Study|Institutional delays (including COVID)|2|||
37677028|NCT02710669|69151921|FG002|Overall Study|Institutional delays (including COVID)|0|||
37677029|NCT02710669|69151919|FG000|Overall Study|arrived in afib/aflutter|10|||
37677030|NCT02710669|69151920|FG001|Overall Study|arrived in afib/aflutter|8|||
37677031|NCT02710669|69151921|FG002|Overall Study|arrived in afib/aflutter|2|||
37677032|NCT02610725|69151929|FG000|Overall Study|Lost to Follow-up|197|||
37677033|NCT02610725|69151929|FG000|Overall Study|self-reported contraindication|9|||
37677034|NCT02684461|69151936|FG000|Overall Study|Adverse Event|1|||
37677035|NCT02684461|69151937|FG001|Overall Study|Adverse Event|0|||
37677036|NCT02684461|69151938|FG002|Overall Study|Adverse Event|0|||
37767879|NCT01272219|69283497|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
37767880|NCT01272219|69283498|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
37767881|NCT01272219|69283499|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
37767882|NCT01272219|69283494|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
37767883|NCT01272219|69283495|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
37767884|NCT01272219|69283496|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
37767885|NCT01272219|69283497|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
37767886|NCT01272219|69283498|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
37767887|NCT01272219|69283499|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
37767888|NCT01272219|69283494|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
37767889|NCT01272219|69283495|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
37767890|NCT01272219|69283496|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
37767891|NCT01272219|69283497|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
37767892|NCT01272219|69283498|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
37767893|NCT01272219|69283499|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
37767894|NCT01272219|69283494|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
37767895|NCT01272219|69283495|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
37767896|NCT01272219|69283496|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
37767897|NCT01272219|69283497|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
37767898|NCT01272219|69283498|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
37767899|NCT01272219|69283499|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
37767900|NCT01272219|69283494|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
37767901|NCT01272219|69283495|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
37767902|NCT01272219|69283496|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
37767903|NCT01272219|69283497|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
37767904|NCT01272219|69283498|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
37767905|NCT01272219|69283499|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
37767906|NCT01272219|69283494|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
37767907|NCT01272219|69283495|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
37767908|NCT01272219|69283496|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
37767909|NCT01272219|69283497|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
37767910|NCT01272219|69283498|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
37767911|NCT01272219|69283499|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
37767912|NCT01272219|69283494|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
37767913|NCT01272219|69283495|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
37767914|NCT01272219|69283496|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
37767915|NCT01272219|69283497|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
37767916|NCT01272219|69283498|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
37767917|NCT01272219|69283499|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
37677037|NCT02684461|69151936|FG000|Overall Study|Lack of Efficacy|1|||
37677038|NCT02684461|69151937|FG001|Overall Study|Lack of Efficacy|2|||
37677039|NCT02684461|69151938|FG002|Overall Study|Lack of Efficacy|0|||
37677040|NCT02647645|69151963|FG000|Overall Study|Lost to Follow-up|2|||
37677041|NCT02647645|69151964|FG001|Overall Study|Lost to Follow-up|1|||
37767918|NCT01272219|69283494|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
37767919|NCT01272219|69283495|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
37767920|NCT01272219|69283496|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
37767921|NCT01272219|69283497|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
37767922|NCT01272219|69283498|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
37767923|NCT01272219|69283499|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
37767924|NCT01272219|69283494|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
37767925|NCT01272219|69283495|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
37767926|NCT01272219|69283496|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
37767927|NCT01272219|69283497|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
37767928|NCT01272219|69283498|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
37767929|NCT01272219|69283499|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
37767930|NCT01272219|69283494|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
37767931|NCT01272219|69283495|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
37767932|NCT01272219|69283496|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
37767933|NCT01272219|69283497|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
37767934|NCT01272219|69283498|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
37767935|NCT01272219|69283499|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
37767936|NCT01510028|69283516|FG000|Overall Study|Lack of Efficacy|1|||
37767937|NCT01510028|69283517|FG001|Overall Study|Lack of Efficacy|0|||
37767938|NCT01510028|69283518|FG002|Overall Study|Lack of Efficacy|0|||
37767939|NCT01510028|69283519|FG003|Overall Study|Lack of Efficacy|0|||
37767940|NCT01521494|69283540|FG000|Overall Study|Adverse Event|1|||
37767941|NCT01521494|69283541|FG001|Overall Study|Adverse Event|2|||
37767942|NCT01521494|69283542|FG002|Overall Study|Adverse Event|9|||
37767943|NCT01521494|69283543|FG003|Overall Study|Adverse Event|6|||
37767944|NCT01521494|69283544|FG004|Overall Study|Adverse Event|2|||
37767945|NCT01521494|69283540|FG000|Overall Study|Lack of Efficacy|0|||
37767946|NCT01521494|69283541|FG001|Overall Study|Lack of Efficacy|0|||
37767947|NCT01521494|69283542|FG002|Overall Study|Lack of Efficacy|0|||
37767948|NCT01521494|69283543|FG003|Overall Study|Lack of Efficacy|0|||
37767949|NCT01521494|69283544|FG004|Overall Study|Lack of Efficacy|2|||
37767950|NCT01521494|69283540|FG000|Overall Study|Withdrawal by Subject|1|||
37767951|NCT01521494|69283541|FG001|Overall Study|Withdrawal by Subject|1|||
37767952|NCT01521494|69283542|FG002|Overall Study|Withdrawal by Subject|0|||
37767953|NCT01521494|69283543|FG003|Overall Study|Withdrawal by Subject|2|||
37767954|NCT01521494|69283544|FG004|Overall Study|Withdrawal by Subject|0|||
37767955|NCT01521494|69283540|FG000|Overall Study|Decrease in serum phosphate|0|||
37767956|NCT01521494|69283541|FG001|Overall Study|Decrease in serum phosphate|2|||
37767957|NCT01521494|69283542|FG002|Overall Study|Decrease in serum phosphate|3|||
37767958|NCT01521494|69283543|FG003|Overall Study|Decrease in serum phosphate|12|||
37767959|NCT01521494|69283544|FG004|Overall Study|Decrease in serum phosphate|0|||
37767960|NCT01521494|69283540|FG000|Overall Study|Decrease in serum calcium|0|||
37767961|NCT01521494|69283541|FG001|Overall Study|Decrease in serum calcium|0|||
37767962|NCT01521494|69283542|FG002|Overall Study|Decrease in serum calcium|0|||
37767963|NCT01521494|69283543|FG003|Overall Study|Decrease in serum calcium|1|||
37767964|NCT01521494|69283544|FG004|Overall Study|Decrease in serum calcium|1|||
37767965|NCT01521494|69283540|FG000|Overall Study|Physician Decision|0|||
37767966|NCT01521494|69283541|FG001|Overall Study|Physician Decision|0|||
37767967|NCT01521494|69283542|FG002|Overall Study|Physician Decision|0|||
37767968|NCT01521494|69283543|FG003|Overall Study|Physician Decision|0|||
37767969|NCT01521494|69283544|FG004|Overall Study|Physician Decision|2|||
37767970|NCT01270971|69283558|FG000|Overall Study|Withdrawal by Subject|24|||
37767971|NCT01270971|69283559|FG001|Overall Study|Withdrawal by Subject|11|||
37767972|NCT01270971|69283558|FG000|Overall Study|Lost to Follow-up|18|||
37767973|NCT01270971|69283559|FG001|Overall Study|Lost to Follow-up|5|||
37767974|NCT01270971|69283558|FG000|Overall Study|Adverse Event|1|||
37767975|NCT01270971|69283559|FG001|Overall Study|Adverse Event|2|||
37767976|NCT01270971|69283558|FG000|Overall Study|Non compliance|2|||
37767977|NCT01270971|69283559|FG001|Overall Study|Non compliance|2|||
37767978|NCT01270971|69283558|FG000|Overall Study|Non-specific|7|||
37767979|NCT01270971|69283559|FG001|Overall Study|Non-specific|3|||
37767980|NCT01270503|69283586|FG000|Overall Study|Lost to Follow-up|1|||
37767981|NCT01277211|69283603|FG000|Overall Study|Adverse Event|60|||
37767982|NCT01277211|69283604|FG001|Overall Study|Adverse Event|22|||
37767983|NCT01277211|69283603|FG000|Overall Study|Pregnancy|9|||
37767984|NCT01277211|69283604|FG001|Overall Study|Pregnancy|4|||
37767985|NCT01277211|69283603|FG000|Overall Study|Lost to Follow-up|14|||
37767986|NCT01277211|69283604|FG001|Overall Study|Lost to Follow-up|9|||
37767987|NCT01277211|69283603|FG000|Overall Study|Did not wish to continue|17|||
37767988|NCT01277211|69283604|FG001|Overall Study|Did not wish to continue|0|||
37767989|NCT01277211|69283603|FG000|Overall Study|Withdrew Consent|9|||
38041966|NCT03382561|69729357|FG001|Overall Study|Disease progression|6|||
37767990|NCT01277211|69283604|FG001|Overall Study|Withdrew Consent|9|||
37767991|NCT01277211|69283603|FG000|Overall Study|Non-compliance with protocol|13|||
37767992|NCT01277211|69283604|FG001|Overall Study|Non-compliance with protocol|4|||
37767993|NCT01277211|69283603|FG000|Overall Study|Did not meet protocol eligibility|1|||
37767994|NCT01277211|69283604|FG001|Overall Study|Did not meet protocol eligibility|0|||
37767995|NCT01277211|69283603|FG000|Overall Study|Administrative|3|||
37767996|NCT01277211|69283604|FG001|Overall Study|Administrative|0|||
37767997|NCT01277211|69283603|FG000|Overall Study|Pregnancy wish|0|||
37767998|NCT01277211|69283604|FG001|Overall Study|Pregnancy wish|2|||
37767999|NCT01277211|69283603|FG000|Overall Study|Discontinued prior to treatment|24|||
37768000|NCT01277211|69283604|FG001|Overall Study|Discontinued prior to treatment|13|||
37768001|NCT01676220|69283612|FG000|Overall Study|Randomized But Not Treated|4|||
37768002|NCT01676220|69283613|FG001|Overall Study|Randomized But Not Treated|1|||
37768003|NCT01676220|69283612|FG000|Overall Study|Adverse Event|10|||
37768004|NCT01676220|69283613|FG001|Overall Study|Adverse Event|8|||
37768005|NCT01676220|69283612|FG000|Overall Study|Lack of Efficacy|2|||
37768006|NCT01676220|69283613|FG001|Overall Study|Lack of Efficacy|5|||
37768007|NCT01676220|69283612|FG000|Overall Study|Protocol Violation|11|||
37768008|NCT01676220|69283613|FG001|Overall Study|Protocol Violation|12|||
37768009|NCT01676220|69283612|FG000|Overall Study|Received Rescue Therapy|14|||
37768010|NCT01676220|69283613|FG001|Overall Study|Received Rescue Therapy|22|||
37768011|NCT01676220|69283612|FG000|Overall Study|Personal Reason|34|||
37768012|NCT01676220|69283613|FG001|Overall Study|Personal Reason|45|||
37768013|NCT01676220|69283612|FG000|Overall Study|Lost to Follow-up|11|||
37768014|NCT01676220|69283613|FG001|Overall Study|Lost to Follow-up|18|||
37768015|NCT01676220|69283612|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
37768016|NCT01676220|69283613|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
37768017|NCT01676220|69283612|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
37768018|NCT01676220|69283613|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
37768019|NCT01676220|69283612|FG000|Overall Study|Perceived Lack of Efficacy|3|||
37768020|NCT01676220|69283613|FG001|Overall Study|Perceived Lack of Efficacy|1|||
37768021|NCT01676220|69283612|FG000|Overall Study|Non Serious Hypoglycemia|2|||
37768022|NCT01676220|69283613|FG001|Overall Study|Non Serious Hypoglycemia|0|||
37768023|NCT01676220|69283612|FG000|Overall Study|No More Need of Insulin|1|||
37768024|NCT01676220|69283613|FG001|Overall Study|No More Need of Insulin|0|||
37768025|NCT01485614|69283643|FG000|Randomization|Not Treated|1|||
37768026|NCT01485614|69283644|FG001|Randomization|Not Treated|0|||
37768027|NCT01485614|69283645|FG002|Randomization|Not Treated|0|||
37768028|NCT01485614|69283646|FG003|Randomization|Not Treated|0|||
37768029|NCT01485614|69283643|FG000|Weeks 0-20|Lost to Follow-up|2|||
37768030|NCT01485614|69283644|FG001|Weeks 0-20|Lost to Follow-up|0|||
37768031|NCT01485614|69283645|FG002|Weeks 0-20|Lost to Follow-up|0|||
37768032|NCT01485614|69283646|FG003|Weeks 0-20|Lost to Follow-up|0|||
37768033|NCT01485614|69283643|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
37768034|NCT01485614|69283644|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
37768035|NCT01485614|69283645|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
37768036|NCT01485614|69283646|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
37768037|NCT01485614|69283643|FG000|Weeks 0-20|Withdrawal by Subject|3|||
37768038|NCT01485614|69283644|FG001|Weeks 0-20|Withdrawal by Subject|2|||
37768039|NCT01485614|69283645|FG002|Weeks 0-20|Withdrawal by Subject|1|||
37768040|NCT01485614|69283646|FG003|Weeks 0-20|Withdrawal by Subject|0|||
37768041|NCT01485614|69283643|FG000|Weeks 20-54|Lost to Follow-up|4|||
37768042|NCT01485614|69283644|FG001|Weeks 20-54|Lost to Follow-up|3|||
37768043|NCT01485614|69283645|FG002|Weeks 20-54|Lost to Follow-up|1|||
37768044|NCT01485614|69283646|FG003|Weeks 20-54|Lost to Follow-up|0|||
37768045|NCT01485614|69283643|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
37768046|NCT01485614|69283644|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
37768047|NCT01485614|69283645|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
37768048|NCT01485614|69283646|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
37768049|NCT01485614|69283643|FG000|Weeks 20-54|Withdrawal by Subject|5|||
37768050|NCT01485614|69283644|FG001|Weeks 20-54|Withdrawal by Subject|3|||
37768051|NCT01485614|69283645|FG002|Weeks 20-54|Withdrawal by Subject|0|||
37768052|NCT01485614|69283646|FG003|Weeks 20-54|Withdrawal by Subject|0|||
37768053|NCT01485536|69283696|FG000|Overall Study|Withdrawal by Subject|3|||
37768054|NCT01485536|69283696|FG000|Overall Study|Adverse Event|1|||
37768055|NCT02658630|69283700|FG000|Overall Study|Withdrawal by Subject|4|||
37768056|NCT01484912|69283706|FG000|Overall Study|Withdrawal by Subject|1|||
37768057|NCT01484912|69283707|FG001|Overall Study|Withdrawal by Subject|0|||
37768058|NCT01484912|69283706|FG000|Overall Study|Physician Decision|0|||
37768059|NCT01484912|69283707|FG001|Overall Study|Physician Decision|1|||
37768060|NCT01520870|69283713|FG000|Overall Study|Withdrawal by Subject|2|||
37768061|NCT01520714|69283719|FG000|Overall Study|Protocol Violation|0|||
37768062|NCT01520714|69283720|FG001|Overall Study|Protocol Violation|3|||
37768063|NCT01520714|69283719|FG000|Overall Study|Adverse Event|0|||
37768064|NCT01520714|69283720|FG001|Overall Study|Adverse Event|2|||
37768065|NCT01520714|69283719|FG000|Overall Study|Lack of Efficacy|0|||
37768066|NCT01520714|69283720|FG001|Overall Study|Lack of Efficacy|1|||
37768067|NCT02659098|69283739|FG000|Overall Study|Withdrawal by Subject|7|||
37768068|NCT01508936|69283750|FG000|Overall Study|Adverse Event|11|||
37768069|NCT01508936|69283751|FG001|Overall Study|Adverse Event|32|||
37768070|NCT01508936|69283750|FG000|Overall Study|Lack of Efficacy|0|||
37768071|NCT01508936|69283751|FG001|Overall Study|Lack of Efficacy|1|||
37860057|NCT01233258|69543425|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
37768072|NCT01508936|69283750|FG000|Overall Study|Withdrawal by Subject|4|||
37768073|NCT01508936|69283751|FG001|Overall Study|Withdrawal by Subject|18|||
37768074|NCT01508936|69283750|FG000|Overall Study|Protocol Violation|2|||
37768075|NCT01508936|69283751|FG001|Overall Study|Protocol Violation|3|||
37768076|NCT01508936|69283750|FG000|Overall Study|Lost to Follow-up|2|||
37768077|NCT01508936|69283751|FG001|Overall Study|Lost to Follow-up|9|||
37768078|NCT01508936|69283750|FG000|Overall Study|Other|0|||
37768079|NCT01508936|69283751|FG001|Overall Study|Other|5|||
37768080|NCT01508936|69283750|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
37768081|NCT01508936|69283751|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
37768082|NCT01508702|69283772|FG000|Overall Study|Adverse Event|7|||
37768083|NCT01508702|69283773|FG001|Overall Study|Adverse Event|3|||
37768084|NCT01508702|69283772|FG000|Overall Study|Gout flare|2|||
37768085|NCT01508702|69283773|FG001|Overall Study|Gout flare|0|||
37768086|NCT01508702|69283772|FG000|Overall Study|Protocol Violation|2|||
37768087|NCT01508702|69283773|FG001|Overall Study|Protocol Violation|1|||
37768088|NCT01508702|69283772|FG000|Overall Study|Lost to Follow-up|1|||
37768089|NCT01508702|69283773|FG001|Overall Study|Lost to Follow-up|2|||
37768090|NCT01508702|69283772|FG000|Overall Study|Withdrawal by Subject|11|||
37768091|NCT01508702|69283773|FG001|Overall Study|Withdrawal by Subject|7|||
37768092|NCT01484834|69283787|FG000|Overall Study|Lost to Follow-up|5|||
37768093|NCT01484834|69283788|FG001|Overall Study|Lost to Follow-up|8|||
37768094|NCT01484834|69283789|FG002|Overall Study|Lost to Follow-up|1|||
37768095|NCT01484834|69283790|FG003|Overall Study|Lost to Follow-up|4|||
37768096|NCT01484132|69283800|FG000|Overall Study|Lost to Follow-up|8|||
37768097|NCT01484132|69283800|FG000|Overall Study|Difficulty with time commitment|2|||
37768098|NCT01484132|69283800|FG000|Overall Study|Ineligible|1|||
37768099|NCT01484132|69283800|FG000|Overall Study|No pre-treatment urine sample collected|1|||
37768100|NCT01484132|69283800|FG000|Overall Study|No post-treatment urine sample collected|10|||
37768101|NCT01276041|69283804|FG000|Overall Study|Adverse Event|2|||
37768102|NCT01276041|69283804|FG000|Overall Study|Protocol Violation|1|||
37768103|NCT01275339|69283812|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
37768104|NCT01275339|69283813|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
37768105|NCT01275339|69283814|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
37768106|NCT01275339|69283815|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
37768107|NCT01275339|69283812|FG000|Overall Study|Withdrawal by Subject|0|||
37768108|NCT01275339|69283813|FG001|Overall Study|Withdrawal by Subject|0|||
37768109|NCT01275339|69283814|FG002|Overall Study|Withdrawal by Subject|1|||
37768110|NCT01275339|69283815|FG003|Overall Study|Withdrawal by Subject|0|||
37768111|NCT01520402|69283825|FG000|Overall Study|Withdrawal by Subject|2|||
37768112|NCT01520402|69283825|FG000|Overall Study|Physician Decision|3|||
37768113|NCT01520324|69283840|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
37768114|NCT01519934|69283844|FG000|Overall Study|Lost to Follow-up|3|||
37768115|NCT01484054|69283848|FG000|Period 1|Withdrawal by Subject|0|||
37768116|NCT01484054|69283849|FG001|Period 1|Withdrawal by Subject|1|||
37768117|NCT01507298|69283867|FG000|Overall Study|Protocol Violation|0|||
37768118|NCT01507298|69283868|FG001|Overall Study|Protocol Violation|6|||
37768119|NCT01483118|69283877|FG000|Overall Study|Lost to Follow-up|12|||
37860058|NCT01233258|69543426|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
37860059|NCT01233258|69543421|FG000|First Intervention (6 Months)|Protocol Violation|0|||
37860060|NCT01233258|69543422|FG001|First Intervention (6 Months)|Protocol Violation|0|||
37860061|NCT01233258|69543423|FG002|First Intervention (6 Months)|Protocol Violation|1|||
37860062|NCT01233258|69543424|FG003|First Intervention (6 Months)|Protocol Violation|0|||
37860063|NCT01233258|69543425|FG004|First Intervention (6 Months)|Protocol Violation|0|||
37860064|NCT01233258|69543426|FG005|First Intervention (6 Months)|Protocol Violation|0|||
37860065|NCT01233258|69543421|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
37860066|NCT01233258|69543422|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
37677042|NCT02531373|69151979|FG000|Overall Study|Lack of Efficacy|0|||
37677043|NCT02531373|69151980|FG001|Overall Study|Lack of Efficacy|0|||
37677044|NCT02531373|69151981|FG002|Overall Study|Lack of Efficacy|0|||
37677045|NCT02531373|69151982|FG003|Overall Study|Lack of Efficacy|0|||
37677046|NCT02531373|69151983|FG004|Overall Study|Lack of Efficacy|3|||
37677047|NCT02531373|69151984|FG005|Overall Study|Lack of Efficacy|2|||
37677048|NCT02531373|69151985|FG006|Overall Study|Lack of Efficacy|4|||
37677049|NCT02531373|69151986|FG007|Overall Study|Lack of Efficacy|8|||
37677050|NCT02531373|69151987|FG008|Overall Study|Lack of Efficacy|5|||
37677051|NCT02531373|69151979|FG000|Overall Study|Lost to Follow-up|0|||
37677052|NCT02531373|69151980|FG001|Overall Study|Lost to Follow-up|0|||
37677053|NCT02531373|69151981|FG002|Overall Study|Lost to Follow-up|0|||
37677054|NCT02531373|69151982|FG003|Overall Study|Lost to Follow-up|0|||
37677055|NCT02531373|69151983|FG004|Overall Study|Lost to Follow-up|0|||
37677056|NCT02531373|69151984|FG005|Overall Study|Lost to Follow-up|2|||
37677057|NCT02531373|69151985|FG006|Overall Study|Lost to Follow-up|2|||
37677058|NCT02531373|69151986|FG007|Overall Study|Lost to Follow-up|0|||
37768120|NCT01483118|69283878|FG001|Overall Study|Lost to Follow-up|16|||
37768121|NCT01506908|69283888|FG000|Overall Study|Adverse Event|1|||
37768122|NCT01506908|69283889|FG001|Overall Study|Adverse Event|0|||
37768123|NCT01519778|69283897|FG000|Overall Study|Withdrawal by Subject|3|||
37768124|NCT01519778|69283897|FG000|Overall Study|Lost to Follow-up|10|||
37768125|NCT01519778|69283897|FG000|Overall Study|Physician Decision|1|||
37768126|NCT01519700|69283905|FG000|Overall Study|Death|1|||
37768127|NCT01519700|69283906|FG001|Overall Study|Death|0|||
37768128|NCT01519700|69283907|FG002|Overall Study|Death|0|||
37768129|NCT01519700|69283908|FG003|Overall Study|Death|0|||
37768130|NCT01519700|69283905|FG000|Overall Study|Lost to Follow-up|0|||
37768131|NCT01519700|69283906|FG001|Overall Study|Lost to Follow-up|0|||
37768132|NCT01519700|69283907|FG002|Overall Study|Lost to Follow-up|1|||
37768133|NCT01519700|69283908|FG003|Overall Study|Lost to Follow-up|1|||
37768134|NCT01519700|69283905|FG000|Overall Study|Physician Decision|1|||
37768135|NCT01519700|69283906|FG001|Overall Study|Physician Decision|1|||
37768136|NCT01519700|69283907|FG002|Overall Study|Physician Decision|3|||
37768137|NCT01519700|69283908|FG003|Overall Study|Physician Decision|0|||
37768138|NCT01519700|69283905|FG000|Overall Study|Withdrawal by Subject|5|||
37768139|NCT01519700|69283906|FG001|Overall Study|Withdrawal by Subject|3|||
37768140|NCT01519700|69283907|FG002|Overall Study|Withdrawal by Subject|3|||
37768141|NCT01519700|69283908|FG003|Overall Study|Withdrawal by Subject|2|||
37768142|NCT01519700|69283905|FG000|Overall Study|Other Reason|2|||
37768143|NCT01519700|69283906|FG001|Overall Study|Other Reason|2|||
37768144|NCT01519700|69283907|FG002|Overall Study|Other Reason|0|||
37768145|NCT01519700|69283908|FG003|Overall Study|Other Reason|4|||
37768146|NCT02656680|69283926|FG000|Overall Study|Lost to Follow-up|0|||
37768147|NCT02656680|69283927|FG001|Overall Study|Lost to Follow-up|1|||
37768148|NCT02658084|69283963|FG000|Overall Study|Withdrawal by Subject|1|||
37768149|NCT02658084|69283964|FG001|Overall Study|Withdrawal by Subject|0|||
37768150|NCT02658084|69283963|FG000|Overall Study|Study Termination|1|||
37768151|NCT02658084|69283964|FG001|Overall Study|Study Termination|0|||
37768152|NCT01482962|69283980|FG000|Overall Study|Progressive Disease|65|||
37768153|NCT01482962|69283981|FG001|Overall Study|Progressive Disease|53|||
37768154|NCT01482962|69283980|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
37768155|NCT01482962|69283981|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
37768156|NCT01482962|69283980|FG000|Overall Study|Adverse Event|18|||
37768157|NCT01482962|69283981|FG001|Overall Study|Adverse Event|22|||
37768158|NCT01482962|69283980|FG000|Overall Study|Withdrawal by Participant|8|||
37768159|NCT01482962|69283981|FG001|Overall Study|Withdrawal by Participant|13|||
37768160|NCT01482962|69283980|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
37768161|NCT01482962|69283981|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
37768162|NCT01482962|69283980|FG000|Overall Study|Other Reason|1|||
37768163|NCT01482962|69283981|FG001|Overall Study|Other Reason|5|||
37768164|NCT01482962|69283980|FG000|Overall Study|Study Terminated by Sponsor|5|||
37768165|NCT01482962|69283981|FG001|Overall Study|Study Terminated by Sponsor|2|||
37768166|NCT01482962|69283980|FG000|Overall Study|Did not Receive Study Drug|1|||
37768167|NCT01482962|69283981|FG001|Overall Study|Did not Receive Study Drug|6|||
37946843|NCT00304915|69634354|FG000|Overall Study|Withdrawal by Subject|3|||
37946844|NCT00304915|69634355|FG001|Overall Study|Withdrawal by Subject|0|||
37768168|NCT02655666|69283989|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
37768169|NCT01506596|69283993|FG000|Overall Study|ineligible pathology|1|||
37768170|NCT01482884|69284012|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
37768171|NCT01482884|69284013|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
37768172|NCT01482884|69284012|FG000|Overall Study|Protocol Violation|1|||
37768173|NCT01482884|69284013|FG001|Overall Study|Protocol Violation|0|||
37768174|NCT01482884|69284012|FG000|Overall Study|Lost to Follow-up|2|||
37768175|NCT01482884|69284013|FG001|Overall Study|Lost to Follow-up|2|||
37768176|NCT01482884|69284012|FG000|Overall Study|Lack of Efficacy|0|||
37768177|NCT01482884|69284013|FG001|Overall Study|Lack of Efficacy|1|||
37768178|NCT01482884|69284012|FG000|Overall Study|Adverse Event|2|||
37768179|NCT01482884|69284013|FG001|Overall Study|Adverse Event|1|||
37768180|NCT01482884|69284012|FG000|Overall Study|Withdrawal by Subject|8|||
37768181|NCT01482884|69284013|FG001|Overall Study|Withdrawal by Subject|13|||
37768182|NCT01518374|69284019|FG000|Overall Study|Withdrawal by Subject|2|||
37768183|NCT01518374|69284019|FG000|Overall Study|Protocol Violation|3|||
37768184|NCT01518374|69284019|FG000|Overall Study|Lost to Follow-up|2|||
37768185|NCT01481324|69284026|FG000|Overall Study|Missing Data|0|||
37768186|NCT01481324|69284027|FG001|Overall Study|Missing Data|2|||
37768187|NCT01481324|69284028|FG002|Overall Study|Missing Data|2|||
37768188|NCT04591626|69284038|FG000|Overall Study|Adverse Event|4|||
37768189|NCT04591626|69284039|FG001|Overall Study|Adverse Event|0|||
37768190|NCT04591626|69284038|FG000|Overall Study|Withdrawal by Subject|5|||
37768191|NCT04591626|69284039|FG001|Overall Study|Withdrawal by Subject|3|||
37768192|NCT04591626|69284038|FG000|Overall Study|Physician Decision|0|||
37768193|NCT04591626|69284039|FG001|Overall Study|Physician Decision|1|||
37768194|NCT04591626|69284038|FG000|Overall Study|Death|0|||
37768195|NCT04591626|69284039|FG001|Overall Study|Death|1|||
37946845|NCT03687970|69634363|FG000|Overall Study|visit scheduling conflicts|2|||
37768196|NCT04591626|69284038|FG000|Overall Study|Non-Compliance with Study Drug|1|||
37768197|NCT04591626|69284039|FG001|Overall Study|Non-Compliance with Study Drug|0|||
37768198|NCT03583333|69284047|FG000|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|8|||
37768199|NCT03583333|69284048|FG001|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|6|||
37768200|NCT03583333|69284047|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
37768201|NCT03583333|69284048|FG001|Overall Study|Withdrawal by Parent/Guardian|10|||
37768202|NCT03583333|69284047|FG000|Overall Study|Withdrawal by Subject|9|||
37768203|NCT03583333|69284048|FG001|Overall Study|Withdrawal by Subject|5|||
37768204|NCT03583333|69284047|FG000|Overall Study|Physician Decision|3|||
37768205|NCT03583333|69284048|FG001|Overall Study|Physician Decision|2|||
37768206|NCT03583333|69284047|FG000|Overall Study|Death|12|||
37768207|NCT03583333|69284048|FG001|Overall Study|Death|7|||
37768208|NCT01602510|69284054|FG000|Open Label Phase|Adverse Event|46|||
37768209|NCT01602510|69284055|FG001|Open Label Phase|Adverse Event|0|||
37768210|NCT01602510|69284056|FG002|Open Label Phase|Adverse Event|0|||
37768211|NCT01602510|69284054|FG000|Open Label Phase|Lack of Efficacy|22|||
37768212|NCT01602510|69284055|FG001|Open Label Phase|Lack of Efficacy|0|||
37768213|NCT01602510|69284056|FG002|Open Label Phase|Lack of Efficacy|0|||
37768214|NCT01602510|69284054|FG000|Open Label Phase|Protocol Violation|15|||
37768215|NCT01602510|69284055|FG001|Open Label Phase|Protocol Violation|0|||
37768216|NCT01602510|69284056|FG002|Open Label Phase|Protocol Violation|0|||
37768217|NCT01602510|69284054|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
37768218|NCT01602510|69284055|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
37768219|NCT01602510|69284056|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
37768220|NCT01602510|69284054|FG000|Open Label Phase|Lost to Follow-up|22|||
37768221|NCT01602510|69284055|FG001|Open Label Phase|Lost to Follow-up|0|||
37768222|NCT01602510|69284056|FG002|Open Label Phase|Lost to Follow-up|0|||
37768223|NCT01602510|69284054|FG000|Open Label Phase|Physician Decision|19|||
37768224|NCT01602510|69284055|FG001|Open Label Phase|Physician Decision|0|||
37768225|NCT01602510|69284056|FG002|Open Label Phase|Physician Decision|0|||
37768226|NCT01602510|69284054|FG000|Open Label Phase|Withdrawal by Subject|57|||
37768227|NCT01602510|69284055|FG001|Open Label Phase|Withdrawal by Subject|0|||
37768228|NCT01602510|69284056|FG002|Open Label Phase|Withdrawal by Subject|0|||
37768229|NCT01602510|69284054|FG000|Randomized Phase|Adverse Event|0|||
37768230|NCT01602510|69284055|FG001|Randomized Phase|Adverse Event|2|||
37768231|NCT01602510|69284056|FG002|Randomized Phase|Adverse Event|6|||
37768232|NCT01602510|69284054|FG000|Randomized Phase|Lack of Efficacy|0|||
37768233|NCT01602510|69284055|FG001|Randomized Phase|Lack of Efficacy|4|||
37768234|NCT01602510|69284056|FG002|Randomized Phase|Lack of Efficacy|4|||
37768235|NCT01602510|69284054|FG000|Randomized Phase|Protocol Violation|0|||
37768236|NCT01602510|69284055|FG001|Randomized Phase|Protocol Violation|3|||
37768237|NCT01602510|69284056|FG002|Randomized Phase|Protocol Violation|3|||
37768238|NCT01602510|69284054|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
37768239|NCT01602510|69284055|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
37768240|NCT01602510|69284056|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
37768241|NCT01602510|69284054|FG000|Randomized Phase|Lost to Follow-up|0|||
37768242|NCT01602510|69284055|FG001|Randomized Phase|Lost to Follow-up|1|||
37768243|NCT01602510|69284056|FG002|Randomized Phase|Lost to Follow-up|3|||
37768244|NCT01602510|69284054|FG000|Randomized Phase|Physician Decision|0|||
37768245|NCT01602510|69284055|FG001|Randomized Phase|Physician Decision|0|||
37768246|NCT01602510|69284056|FG002|Randomized Phase|Physician Decision|2|||
37768247|NCT01602510|69284054|FG000|Randomized Phase|Withdrawal by Subject|0|||
37768248|NCT01602510|69284055|FG001|Randomized Phase|Withdrawal by Subject|6|||
37768249|NCT01602510|69284056|FG002|Randomized Phase|Withdrawal by Subject|7|||
37768250|NCT01675596|69284071|FG000|Overall Study|Death|6|||
37768251|NCT01675596|69284071|FG000|Overall Study|Exit with other reason|1|||
37768252|NCT01675596|69284071|FG000|Overall Study|Missed Visit|1|||
37768253|NCT02653326|69284081|FG000|Overall Study|Lost to Follow-up|10|||
37768254|NCT02653326|69284082|FG001|Overall Study|Lost to Follow-up|7|||
37768255|NCT02653170|69284091|FG000|Overall Study|Withdrawal by Subject|3|||
37768256|NCT02653170|69284092|FG001|Overall Study|Withdrawal by Subject|8|||
37768257|NCT02653170|69284093|FG002|Overall Study|Withdrawal by Subject|3|||
37768258|NCT02653170|69284091|FG000|Overall Study|withdrawn by study team|2|||
37768259|NCT02653170|69284092|FG001|Overall Study|withdrawn by study team|4|||
37768260|NCT02653170|69284093|FG002|Overall Study|withdrawn by study team|5|||
37768261|NCT02653170|69284091|FG000|Overall Study|Lost to Follow-up|12|||
37768262|NCT02653170|69284092|FG001|Overall Study|Lost to Follow-up|4|||
37768263|NCT02653170|69284093|FG002|Overall Study|Lost to Follow-up|10|||
37768264|NCT01463696|69284113|FG000|Overall Study|Adverse Event|0|||
37768265|NCT01463696|69284114|FG001|Overall Study|Adverse Event|1|||
37768266|NCT01463696|69284115|FG002|Overall Study|Adverse Event|0|||
37768267|NCT01463696|69284116|FG003|Overall Study|Adverse Event|2|||
37946846|NCT03687970|69634364|FG001|Overall Study|visit scheduling conflicts|0|||
37768268|NCT01463696|69284117|FG004|Overall Study|Adverse Event|0|||
37768269|NCT01463696|69284118|FG005|Overall Study|Adverse Event|1|||
38041967|NCT03382561|69729356|FG000|Overall Study|Adverse Event|10|||
37768270|NCT01463696|69284119|FG006|Overall Study|Adverse Event|3|||
37768271|NCT01463696|69284120|FG007|Overall Study|Adverse Event|2|||
37768272|NCT01463696|69284113|FG000|Overall Study|Lost to Follow-up|0|||
37768273|NCT01463696|69284114|FG001|Overall Study|Lost to Follow-up|0|||
37768274|NCT01463696|69284115|FG002|Overall Study|Lost to Follow-up|1|||
37768275|NCT01463696|69284116|FG003|Overall Study|Lost to Follow-up|0|||
37768276|NCT01463696|69284117|FG004|Overall Study|Lost to Follow-up|0|||
37768277|NCT01463696|69284118|FG005|Overall Study|Lost to Follow-up|0|||
37768278|NCT01463696|69284119|FG006|Overall Study|Lost to Follow-up|0|||
37768279|NCT01463696|69284120|FG007|Overall Study|Lost to Follow-up|0|||
37768280|NCT01463696|69284113|FG000|Overall Study|Progressive Disease|0|||
37768281|NCT01463696|69284114|FG001|Overall Study|Progressive Disease|1|||
37768282|NCT01463696|69284115|FG002|Overall Study|Progressive Disease|0|||
37768283|NCT01463696|69284116|FG003|Overall Study|Progressive Disease|1|||
37768284|NCT01463696|69284117|FG004|Overall Study|Progressive Disease|0|||
37768285|NCT01463696|69284118|FG005|Overall Study|Progressive Disease|1|||
37768286|NCT01463696|69284119|FG006|Overall Study|Progressive Disease|4|||
37768287|NCT01463696|69284120|FG007|Overall Study|Progressive Disease|2|||
37768288|NCT01463696|69284113|FG000|Overall Study|Withdrawal by Subject|0|||
37768289|NCT01463696|69284114|FG001|Overall Study|Withdrawal by Subject|0|||
37768290|NCT01463696|69284115|FG002|Overall Study|Withdrawal by Subject|0|||
37768291|NCT01463696|69284116|FG003|Overall Study|Withdrawal by Subject|1|||
37768292|NCT01463696|69284117|FG004|Overall Study|Withdrawal by Subject|1|||
37768293|NCT01463696|69284118|FG005|Overall Study|Withdrawal by Subject|1|||
37768294|NCT01463696|69284119|FG006|Overall Study|Withdrawal by Subject|2|||
37768295|NCT01463696|69284120|FG007|Overall Study|Withdrawal by Subject|0|||
37768296|NCT01463696|69284113|FG000|Overall Study|Not Treated|0|||
37768297|NCT01463696|69284114|FG001|Overall Study|Not Treated|0|||
37768298|NCT01463696|69284115|FG002|Overall Study|Not Treated|0|||
37768299|NCT01463696|69284116|FG003|Overall Study|Not Treated|0|||
37768300|NCT01463696|69284117|FG004|Overall Study|Not Treated|0|||
37768301|NCT01463696|69284118|FG005|Overall Study|Not Treated|0|||
37768302|NCT01463696|69284119|FG006|Overall Study|Not Treated|1|||
37768303|NCT01463696|69284120|FG007|Overall Study|Not Treated|0|||
37768304|NCT02653482|69284144|FG000|Overall Study|Death|1|||
37768305|NCT02653482|69284145|FG001|Overall Study|Death|1|||
37768306|NCT01362348|69284151|FG000|Overall Study|Protocol-defined stopping criteria|9|||
37768307|NCT01362348|69284151|FG000|Overall Study|Study closed/terminated|5|||
37768308|NCT01675128|69284221|FG000|Overall Study|Disease progression on study|1|||
37768309|NCT01675128|69284222|FG001|Overall Study|Disease progression on study|1|||
37768310|NCT01675128|69284223|FG002|Overall Study|Disease progression on study|1|||
37768311|NCT01675128|69284221|FG000|Overall Study|Refused further treatment|1|||
37768312|NCT01675128|69284222|FG001|Overall Study|Refused further treatment|0|||
37768313|NCT01675128|69284223|FG002|Overall Study|Refused further treatment|0|||
37768314|NCT01675128|69284221|FG000|Overall Study|Pulmonary complication; off study|0|||
37768315|NCT01675128|69284222|FG001|Overall Study|Pulmonary complication; off study|1|||
37768316|NCT01675128|69284223|FG002|Overall Study|Pulmonary complication; off study|0|||
37768317|NCT01427309|69284269|FG000|Overall Study|Lost to Follow-up|130|||
37768318|NCT01427309|69284270|FG001|Overall Study|Lost to Follow-up|145|||
37768319|NCT01427309|69284271|FG002|Overall Study|Lost to Follow-up|122|||
37768320|NCT01427309|69284272|FG003|Overall Study|Lost to Follow-up|135|||
37768321|NCT01427309|69284269|FG000|Overall Study|Protocol Violation|42|||
37768322|NCT01427309|69284270|FG001|Overall Study|Protocol Violation|69|||
37768323|NCT01427309|69284271|FG002|Overall Study|Protocol Violation|125|||
37768324|NCT01427309|69284272|FG003|Overall Study|Protocol Violation|124|||
37768325|NCT01427309|69284269|FG000|Overall Study|Adverse Event|0|||
37768326|NCT01427309|69284270|FG001|Overall Study|Adverse Event|0|||
37768327|NCT01427309|69284271|FG002|Overall Study|Adverse Event|3|||
37768328|NCT01427309|69284272|FG003|Overall Study|Adverse Event|1|||
37768329|NCT01427309|69284269|FG000|Overall Study|Serious adverse event|52|||
37768330|NCT01427309|69284270|FG001|Overall Study|Serious adverse event|45|||
37768331|NCT01427309|69284271|FG002|Overall Study|Serious adverse event|50|||
37768332|NCT01427309|69284272|FG003|Overall Study|Serious adverse event|61|||
37768333|NCT01427309|69284269|FG000|Overall Study|Withdrawal by Subject|148|||
37768334|NCT01427309|69284270|FG001|Overall Study|Withdrawal by Subject|148|||
37768335|NCT01427309|69284271|FG002|Overall Study|Withdrawal by Subject|61|||
37768336|NCT01427309|69284272|FG003|Overall Study|Withdrawal by Subject|55|||
37768337|NCT01426373|69284282|FG000|Overall Study|Adverse Event|6|||
37768338|NCT01426373|69284282|FG000|Overall Study|Lost to Follow-up|14|||
37768339|NCT01426373|69284282|FG000|Overall Study|Participant Convenience|10|||
37768340|NCT01426373|69284282|FG000|Overall Study|Miscellaneous Reasons|4|||
37768341|NCT01426217|69284290|FG000|Overall Study|lost sample|8|||
37946847|NCT00530920|69634375|FG000|Overall Study|Randomized but not treated|0|||
37768342|NCT01426217|69284291|FG001|Overall Study|lost sample|14|||
37768343|NCT01425749|69284299|FG000|Overall Study|progression of melanoma|0|||
37768344|NCT01425749|69284300|FG001|Overall Study|progression of melanoma|1|||
37768345|NCT01403987|69284316|FG000|Overall Study|Residents forgot their secret PIN|18|||
37768346|NCT01403987|69284317|FG001|Overall Study|Residents forgot their secret PIN|17|||
37946848|NCT00530920|69634376|FG001|Overall Study|Randomized but not treated|2|||
37768347|NCT01403987|69284318|FG002|Overall Study|Residents forgot their secret PIN|18|||
37768348|NCT01425359|69284328|FG000|Overall Study|Randomized but Not Treated|2|||
37768349|NCT01425359|69284329|FG001|Overall Study|Randomized but Not Treated|3|||
37768350|NCT01425359|69284328|FG000|Overall Study|Adverse Event|9|||
37768351|NCT01425359|69284329|FG001|Overall Study|Adverse Event|8|||
37768352|NCT01425359|69284328|FG000|Overall Study|Revascularization|0|||
37768353|NCT01425359|69284329|FG001|Overall Study|Revascularization|1|||
37768354|NCT01425359|69284328|FG000|Overall Study|Death|0|||
37768355|NCT01425359|69284329|FG001|Overall Study|Death|1|||
37768356|NCT01425359|69284328|FG000|Overall Study|Unsatisfactory Response|1|||
37768357|NCT01425359|69284329|FG001|Overall Study|Unsatisfactory Response|0|||
37768358|NCT01425359|69284328|FG000|Overall Study|Protocol Violation|1|||
37768359|NCT01425359|69284329|FG001|Overall Study|Protocol Violation|2|||
37768360|NCT01425359|69284328|FG000|Overall Study|Subject Withdrew Consent|1|||
37768361|NCT01425359|69284329|FG001|Overall Study|Subject Withdrew Consent|2|||
37768362|NCT01425359|69284328|FG000|Overall Study|Investigator's Discretion|2|||
37768363|NCT01425359|69284329|FG001|Overall Study|Investigator's Discretion|0|||
37768364|NCT01425359|69284328|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
37768365|NCT01425359|69284329|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
37768366|NCT01403051|69284349|FG000|Overall Study|Protocol Violation|2|||
37768367|NCT01403051|69284350|FG001|Overall Study|Protocol Violation|0|||
37768368|NCT01403051|69284349|FG000|Overall Study|Death|1|||
37768369|NCT01403051|69284350|FG001|Overall Study|Death|0|||
37768370|NCT01403051|69284349|FG000|Overall Study|Withdrawal by Subject|2|||
37768371|NCT01403051|69284350|FG001|Overall Study|Withdrawal by Subject|1|||
37768372|NCT01403051|69284349|FG000|Overall Study|Lost to Follow-up|5|||
37768373|NCT01403051|69284350|FG001|Overall Study|Lost to Follow-up|5|||
37768374|NCT04115748|69284365|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
37768375|NCT04115748|69284366|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
37768376|NCT04115748|69284367|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
37768377|NCT04115748|69284368|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
37768378|NCT04115748|69284369|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
37768379|NCT04115748|69284370|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
37768380|NCT04115748|69284371|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
37768381|NCT04115748|69284372|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
37768382|NCT04115748|69284373|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
37768383|NCT04115748|69284374|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
37768384|NCT04115748|69284365|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
37768385|NCT04115748|69284366|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
37768386|NCT04115748|69284367|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
37768387|NCT04115748|69284368|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
37768388|NCT04115748|69284369|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
37768389|NCT04115748|69284370|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
37768390|NCT04115748|69284371|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
37768391|NCT04115748|69284372|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
37768392|NCT04115748|69284373|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
37768393|NCT04115748|69284374|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
37768394|NCT04115748|69284365|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
37768395|NCT04115748|69284366|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
37768396|NCT04115748|69284367|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
37768397|NCT04115748|69284368|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
37768398|NCT04115748|69284369|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
37768399|NCT04115748|69284370|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
37768400|NCT04115748|69284371|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
37768401|NCT04115748|69284372|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
37768402|NCT04115748|69284373|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
37768403|NCT04115748|69284374|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
37768404|NCT04115748|69284365|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
37768405|NCT04115748|69284366|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
37768406|NCT04115748|69284367|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
37768407|NCT04115748|69284368|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
37768408|NCT04115748|69284369|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
37768409|NCT04115748|69284370|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
37768410|NCT04115748|69284371|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
37768411|NCT04115748|69284372|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
37768412|NCT04115748|69284373|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
37768413|NCT04115748|69284374|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
37768414|NCT02652624|69284431|FG000|Randomized Phase|Pregnancy|3|||
37768415|NCT02652624|69284432|FG001|Randomized Phase|Pregnancy|1|||
37768416|NCT02652624|69284431|FG000|Randomized Phase|Investigator's Discretion|0|||
37768417|NCT02652624|69284432|FG001|Randomized Phase|Investigator's Discretion|2|||
37768418|NCT02652624|69284431|FG000|Randomized Phase|Death|0|||
37768419|NCT02652624|69284432|FG001|Randomized Phase|Death|1|||
37768420|NCT02652624|69284431|FG000|Randomized Phase|Lost to Follow-up|0|||
37768421|NCT02652624|69284432|FG001|Randomized Phase|Lost to Follow-up|1|||
37768422|NCT02652624|69284431|FG000|Extension Phase|Lost to Follow-up|3|||
37768423|NCT02652624|69284432|FG001|Extension Phase|Lost to Follow-up|1|||
37768424|NCT02652624|69284431|FG000|Extension Phase|Pregnancy|1|||
37768425|NCT02652624|69284432|FG001|Extension Phase|Pregnancy|1|||
37768426|NCT02652624|69284431|FG000|Extension Phase|Adverse Event|0|||
37768427|NCT02652624|69284432|FG001|Extension Phase|Adverse Event|1|||
37768428|NCT02652624|69284431|FG000|Extension Phase|Withdrew Consent|0|||
37768429|NCT02652624|69284432|FG001|Extension Phase|Withdrew Consent|1|||
37768430|NCT00249795|69284442|FG000|Overall Study|Not treated|16|||
37768431|NCT00249795|69284443|FG001|Overall Study|Not treated|14|||
37768432|NCT00249795|69284442|FG000|Overall Study|Symptomatic hypotension|127|||
37768433|NCT00249795|69284443|FG001|Overall Study|Symptomatic hypotension|64|||
37768434|NCT00249795|69284442|FG000|Overall Study|Other Serious Adverse Event|84|||
37768435|NCT00249795|69284443|FG001|Overall Study|Other Serious Adverse Event|93|||
37768436|NCT00249795|69284442|FG000|Overall Study|Qualifying condition not present|26|||
37768437|NCT00249795|69284443|FG001|Overall Study|Qualifying condition not present|29|||
37768438|NCT00249795|69284442|FG000|Overall Study|Withdrawal by Subject|678|||
37768439|NCT00249795|69284443|FG001|Overall Study|Withdrawal by Subject|742|||
37768440|NCT00249795|69284442|FG000|Overall Study|Thromboembolic / outcome event|39|||
37768441|NCT00249795|69284443|FG001|Overall Study|Thromboembolic / outcome event|45|||
37768442|NCT00249795|69284442|FG000|Overall Study|Oral anticoagulant required|2|||
37768443|NCT00249795|69284443|FG001|Overall Study|Oral anticoagulant required|0|||
37768444|NCT00249795|69284442|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
37768445|NCT00249795|69284443|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
37768446|NCT00249795|69284442|FG000|Overall Study|Non-compliance|71|||
37768447|NCT00249795|69284443|FG001|Overall Study|Non-compliance|69|||
37768448|NCT00249795|69284442|FG000|Overall Study|Study drug intolerance|3|||
37768449|NCT00249795|69284443|FG001|Overall Study|Study drug intolerance|3|||
37768450|NCT00249795|69284442|FG000|Overall Study|Other adverse events (non-serious)|188|||
37768451|NCT00249795|69284443|FG001|Overall Study|Other adverse events (non-serious)|159|||
37768452|NCT00249795|69284442|FG000|Overall Study|Physician withdrew consent|71|||
37768453|NCT00249795|69284443|FG001|Overall Study|Physician withdrew consent|63|||
37768454|NCT00249795|69284442|FG000|Overall Study|Surgery / procedure|4|||
37768455|NCT00249795|69284443|FG001|Overall Study|Surgery / procedure|5|||
37768456|NCT00249795|69284442|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
37768457|NCT00249795|69284443|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
37768458|NCT00249795|69284442|FG000|Overall Study|Lightheadedness / dizziness|15|||
37860067|NCT01233258|69543423|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
37677059|NCT02531373|69151987|FG008|Overall Study|Lost to Follow-up|0|||
37677060|NCT02531373|69151979|FG000|Overall Study|Physician Decision|0|||
37677061|NCT02531373|69151980|FG001|Overall Study|Physician Decision|0|||
37677062|NCT02531373|69151981|FG002|Overall Study|Physician Decision|0|||
37677063|NCT02531373|69151982|FG003|Overall Study|Physician Decision|0|||
37677064|NCT02531373|69151983|FG004|Overall Study|Physician Decision|2|||
37677065|NCT02531373|69151984|FG005|Overall Study|Physician Decision|1|||
37677066|NCT02531373|69151985|FG006|Overall Study|Physician Decision|0|||
37677067|NCT02531373|69151986|FG007|Overall Study|Physician Decision|0|||
37677068|NCT02531373|69151987|FG008|Overall Study|Physician Decision|0|||
37677069|NCT02531373|69151979|FG000|Overall Study|Protocol Violation|0|||
37677070|NCT02531373|69151980|FG001|Overall Study|Protocol Violation|0|||
37677071|NCT02531373|69151981|FG002|Overall Study|Protocol Violation|0|||
37677072|NCT02531373|69151982|FG003|Overall Study|Protocol Violation|0|||
37677073|NCT02531373|69151983|FG004|Overall Study|Protocol Violation|0|||
37677074|NCT02531373|69151984|FG005|Overall Study|Protocol Violation|1|||
37677075|NCT02531373|69151985|FG006|Overall Study|Protocol Violation|1|||
37677076|NCT02531373|69151986|FG007|Overall Study|Protocol Violation|0|||
37677077|NCT02531373|69151987|FG008|Overall Study|Protocol Violation|1|||
37677078|NCT02531373|69151979|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
37860068|NCT01233258|69543424|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
37860069|NCT01233258|69543425|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
37860070|NCT01233258|69543426|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
37860071|NCT01232868|69543443|FG000|Overall Study|Lost to Follow-up|2|||
37860072|NCT01232868|69543444|FG001|Overall Study|Lost to Follow-up|4|||
37860073|NCT01232790|69543450|FG000|Randomization|Withdrawal by Subject|2|||
37860074|NCT01232790|69543451|FG001|Randomization|Withdrawal by Subject|0|||
37860075|NCT01232790|69543450|FG000|Randomization|Protocol Violation|0|||
37860076|NCT01232790|69543451|FG001|Randomization|Protocol Violation|1|||
37860077|NCT01232790|69543450|FG000|Randomization|Physician Decision|0|||
37946849|NCT00530920|69634377|FG002|Overall Study|Randomized but not treated|0|||
37860078|NCT01232790|69543451|FG001|Randomization|Physician Decision|1|||
37677079|NCT02531373|69151980|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
37677080|NCT02531373|69151981|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
37860079|NCT01232790|69543450|FG000|Initial Assessment|Withdrawal by Subject|0|||
37860080|NCT01232790|69543451|FG001|Initial Assessment|Withdrawal by Subject|1|||
37860081|NCT01232790|69543450|FG000|First Crossover|Withdrawal by Subject|1|||
37860082|NCT01232790|69543451|FG001|First Crossover|Withdrawal by Subject|0|||
37860083|NCT01232790|69543450|FG000|Second Crossover|Withdrawal by Subject|1|||
37860084|NCT01232790|69543451|FG001|Second Crossover|Withdrawal by Subject|2|||
37860085|NCT01232556|69543469|FG000|Overall Study|Withdrawal by Subject|21|||
37860086|NCT01232556|69543470|FG001|Overall Study|Withdrawal by Subject|17|||
37860087|NCT01232556|69543469|FG000|Overall Study|Death|97|||
37860088|NCT01232556|69543470|FG001|Overall Study|Death|97|||
37860089|NCT01232556|69543469|FG000|Overall Study|Lost to Follow-up|0|||
37860090|NCT01232556|69543470|FG001|Overall Study|Lost to Follow-up|2|||
37860091|NCT01232556|69543469|FG000|Overall Study|Terminated by Sponsor|35|||
37860092|NCT01232556|69543470|FG001|Overall Study|Terminated by Sponsor|51|||
37860093|NCT01232556|69543469|FG000|Overall Study|Other|6|||
37860094|NCT01232556|69543470|FG001|Overall Study|Other|4|||
37860095|NCT00946153|69543481|FG000|Phase 2|Adverse Event|0|||
37860096|NCT00946153|69543482|FG001|Phase 2|Adverse Event|0|||
37860097|NCT00946153|69543483|FG002|Phase 2|Adverse Event|0|||
37860098|NCT00946153|69543484|FG003|Phase 2|Adverse Event|0|||
37860099|NCT00946153|69543485|FG004|Phase 2|Adverse Event|6|||
37860100|NCT00946153|69543481|FG000|Phase 2|Need more reduction of dose|0|||
37860101|NCT00946153|69543482|FG001|Phase 2|Need more reduction of dose|0|||
37860102|NCT00946153|69543483|FG002|Phase 2|Need more reduction of dose|0|||
37860103|NCT00946153|69543484|FG003|Phase 2|Need more reduction of dose|0|||
37860104|NCT00946153|69543485|FG004|Phase 2|Need more reduction of dose|2|||
37860105|NCT00946153|69543481|FG000|Phase 2|Physician Decision|0|||
37860106|NCT00946153|69543482|FG001|Phase 2|Physician Decision|0|||
37860107|NCT00946153|69543483|FG002|Phase 2|Physician Decision|0|||
37860108|NCT00946153|69543484|FG003|Phase 2|Physician Decision|0|||
37860109|NCT00946153|69543485|FG004|Phase 2|Physician Decision|1|||
37860110|NCT00946153|69543481|FG000|Phase 2|14 days washout for recovery due to AE|0|||
37860111|NCT00946153|69543482|FG001|Phase 2|14 days washout for recovery due to AE|0|||
37860112|NCT00946153|69543483|FG002|Phase 2|14 days washout for recovery due to AE|0|||
37860113|NCT00946153|69543484|FG003|Phase 2|14 days washout for recovery due to AE|0|||
37860114|NCT00946153|69543485|FG004|Phase 2|14 days washout for recovery due to AE|4|||
37860115|NCT01160289|69543507|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
37860116|NCT01160289|69543508|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
37860117|NCT01160289|69543509|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
37860118|NCT01160289|69543510|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
37860119|NCT01160289|69543511|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
37860120|NCT01160289|69543512|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
37860121|NCT01160289|69543507|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
37860122|NCT01160289|69543508|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
37860123|NCT01160289|69543509|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
37860124|NCT01160289|69543510|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
37860125|NCT01160289|69543511|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
37860126|NCT01160289|69543512|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
37860127|NCT01160289|69543507|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
37860128|NCT01160289|69543508|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
37860129|NCT01160289|69543509|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
37860130|NCT01160289|69543510|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
37860131|NCT01160289|69543511|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
37860132|NCT01160289|69543512|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
37860133|NCT01160289|69543507|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
37860134|NCT01160289|69543508|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
37860135|NCT01160289|69543509|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
37860136|NCT01160289|69543510|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
37860137|NCT01160289|69543511|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
37860138|NCT01160289|69543512|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
37860139|NCT01160289|69543507|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
37860140|NCT01160289|69543508|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
37860141|NCT01160289|69543509|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
37860142|NCT01160289|69543510|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
37860143|NCT01160289|69543511|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
37860144|NCT01160289|69543512|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
37860145|NCT01160289|69543507|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
37860146|NCT01160289|69543508|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
37860147|NCT01160289|69543509|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
37860148|NCT01160289|69543510|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
37860149|NCT01160289|69543511|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
37860150|NCT01160289|69543512|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
37860151|NCT01160289|69543507|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
37860152|NCT01160289|69543508|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
37860153|NCT01160289|69543509|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
37860154|NCT01160289|69543510|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
37860155|NCT01160289|69543511|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
37860156|NCT01160289|69543512|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
37860157|NCT01160289|69543507|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
37860158|NCT01160289|69543508|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
37860159|NCT01160289|69543509|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
37860160|NCT01160289|69543510|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
37860161|NCT01160289|69543511|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
37860162|NCT01160289|69543512|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
37860163|NCT01160289|69543507|FG000|Post-Randomization Period|Adverse Event|0|||
37860164|NCT01160289|69543508|FG001|Post-Randomization Period|Adverse Event|4|||
37860165|NCT01160289|69543509|FG002|Post-Randomization Period|Adverse Event|4|||
37860166|NCT01160289|69543510|FG003|Post-Randomization Period|Adverse Event|2|||
37860167|NCT01160289|69543511|FG004|Post-Randomization Period|Adverse Event|0|||
37860168|NCT01160289|69543512|FG005|Post-Randomization Period|Adverse Event|0|||
37860169|NCT01160289|69543507|FG000|Post-Randomization Period|Death|0|||
37860170|NCT01160289|69543508|FG001|Post-Randomization Period|Death|0|||
37860171|NCT01160289|69543509|FG002|Post-Randomization Period|Death|0|||
37860172|NCT01160289|69543510|FG003|Post-Randomization Period|Death|1|||
37860173|NCT01160289|69543511|FG004|Post-Randomization Period|Death|0|||
37860174|NCT01160289|69543512|FG005|Post-Randomization Period|Death|0|||
37860175|NCT01160289|69543507|FG000|Post-Randomization Period|Lack of Efficacy|0|||
37860176|NCT01160289|69543508|FG001|Post-Randomization Period|Lack of Efficacy|1|||
37860177|NCT01160289|69543509|FG002|Post-Randomization Period|Lack of Efficacy|0|||
37860178|NCT01160289|69543510|FG003|Post-Randomization Period|Lack of Efficacy|3|||
37860179|NCT01160289|69543511|FG004|Post-Randomization Period|Lack of Efficacy|0|||
37860180|NCT01160289|69543512|FG005|Post-Randomization Period|Lack of Efficacy|0|||
37860181|NCT01160289|69543507|FG000|Post-Randomization Period|Lost to Follow-up|0|||
37860182|NCT01160289|69543508|FG001|Post-Randomization Period|Lost to Follow-up|3|||
37860183|NCT01160289|69543509|FG002|Post-Randomization Period|Lost to Follow-up|2|||
37860184|NCT01160289|69543510|FG003|Post-Randomization Period|Lost to Follow-up|5|||
37860185|NCT01160289|69543511|FG004|Post-Randomization Period|Lost to Follow-up|3|||
37860186|NCT01160289|69543512|FG005|Post-Randomization Period|Lost to Follow-up|4|||
37860187|NCT01160289|69543507|FG000|Post-Randomization Period|Physician Decision|0|||
37860188|NCT01160289|69543508|FG001|Post-Randomization Period|Physician Decision|0|||
37860189|NCT01160289|69543509|FG002|Post-Randomization Period|Physician Decision|1|||
37860190|NCT01160289|69543510|FG003|Post-Randomization Period|Physician Decision|0|||
37860191|NCT01160289|69543511|FG004|Post-Randomization Period|Physician Decision|0|||
37860192|NCT01160289|69543512|FG005|Post-Randomization Period|Physician Decision|0|||
37860193|NCT01160289|69543507|FG000|Post-Randomization Period|Protocol Violation|0|||
37860194|NCT01160289|69543508|FG001|Post-Randomization Period|Protocol Violation|4|||
37860195|NCT01160289|69543509|FG002|Post-Randomization Period|Protocol Violation|2|||
37860196|NCT01160289|69543510|FG003|Post-Randomization Period|Protocol Violation|0|||
37860197|NCT01160289|69543511|FG004|Post-Randomization Period|Protocol Violation|1|||
37860198|NCT01160289|69543512|FG005|Post-Randomization Period|Protocol Violation|3|||
37860199|NCT01160289|69543507|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
37860200|NCT01160289|69543508|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
37860201|NCT01160289|69543509|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
37860202|NCT01160289|69543510|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
37860203|NCT01160289|69543511|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
37860204|NCT01160289|69543512|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
37860205|NCT01160289|69543507|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
37860206|NCT01160289|69543508|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
37860207|NCT01160289|69543509|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
37860208|NCT01160289|69543510|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
37860209|NCT01160289|69543511|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
37860210|NCT01160289|69543512|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
37860211|NCT01160289|69543507|FG000|Post-Randomization Period|Sponsor Decision|0|||
37860212|NCT01160289|69543508|FG001|Post-Randomization Period|Sponsor Decision|1|||
37860213|NCT01160289|69543509|FG002|Post-Randomization Period|Sponsor Decision|0|||
37860214|NCT01160289|69543510|FG003|Post-Randomization Period|Sponsor Decision|0|||
37860215|NCT01160289|69543511|FG004|Post-Randomization Period|Sponsor Decision|0|||
37860216|NCT01160289|69543512|FG005|Post-Randomization Period|Sponsor Decision|0|||
37860217|NCT01159665|69543531|FG000|Overall Study|Withdrawal by Subject|0|||
37946850|NCT00530920|69634375|FG000|Overall Study|Adverse Event|0|||
37860218|NCT01159665|69543532|FG001|Overall Study|Withdrawal by Subject|1|||
37860219|NCT01159665|69543533|FG002|Overall Study|Withdrawal by Subject|0|||
37860220|NCT01159665|69543534|FG003|Overall Study|Withdrawal by Subject|0|||
37860221|NCT01159665|69543535|FG004|Overall Study|Withdrawal by Subject|0|||
37860222|NCT01159665|69543536|FG005|Overall Study|Withdrawal by Subject|0|||
37860223|NCT01159431|69543552|FG000|Overall Study|Adverse Event|1|||
37860224|NCT01159431|69543553|FG001|Overall Study|Adverse Event|2|||
37860225|NCT01159431|69543552|FG000|Overall Study|non-compliance|1|||
37860226|NCT01159431|69543553|FG001|Overall Study|non-compliance|1|||
37860227|NCT01159431|69543552|FG000|Overall Study|Lack of Efficacy|0|||
37860228|NCT01159431|69543553|FG001|Overall Study|Lack of Efficacy|3|||
37860229|NCT01158261|69543566|FG000|Overall Study|Lost to Follow-up|9|||
37860230|NCT01158261|69543566|FG000|Overall Study|Death|7|||
37860231|NCT01158261|69543566|FG000|Overall Study|Withdrawal by Subject|1|||
37860232|NCT01157169|69543572|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
37860233|NCT01157169|69543573|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
37860234|NCT01157169|69543572|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
37860235|NCT01157169|69543573|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
37860236|NCT01231620|69543582|FG000|Overall Study|Physician Decision|3|||
37860237|NCT01231620|69543583|FG001|Overall Study|Physician Decision|5|||
37860238|NCT01231620|69543584|FG002|Overall Study|Physician Decision|10|||
37860239|NCT01231620|69543582|FG000|Overall Study|Death|12|||
37860240|NCT01231620|69543583|FG001|Overall Study|Death|14|||
37860241|NCT01231620|69543584|FG002|Overall Study|Death|11|||
37860242|NCT01231620|69543582|FG000|Overall Study|Adverse Event|2|||
37860243|NCT01231620|69543583|FG001|Overall Study|Adverse Event|2|||
37860244|NCT01231620|69543584|FG002|Overall Study|Adverse Event|1|||
37860245|NCT01231620|69543582|FG000|Overall Study|Withdrawal by Subject|6|||
37860246|NCT01231620|69543583|FG001|Overall Study|Withdrawal by Subject|6|||
37860247|NCT01231620|69543584|FG002|Overall Study|Withdrawal by Subject|8|||
37860248|NCT01231620|69543582|FG000|Overall Study|Lost to Follow-up|3|||
37860249|NCT01231620|69543583|FG001|Overall Study|Lost to Follow-up|4|||
37860250|NCT01231620|69543584|FG002|Overall Study|Lost to Follow-up|9|||
37860251|NCT01231464|69543594|FG000|Overall Study|Adverse Event|0|||
37860252|NCT01231464|69543595|FG001|Overall Study|Adverse Event|1|||
37860253|NCT01231464|69543594|FG000|Overall Study|Protocol Violation|1|||
37860254|NCT01231464|69543595|FG001|Overall Study|Protocol Violation|2|||
37860255|NCT01231464|69543594|FG000|Overall Study|Lost to Follow-up|1|||
37860256|NCT01231464|69543595|FG001|Overall Study|Lost to Follow-up|2|||
37860257|NCT01231464|69543594|FG000|Overall Study|Withdrawal by Subject|3|||
37860258|NCT01231464|69543595|FG001|Overall Study|Withdrawal by Subject|2|||
37860259|NCT01156311|69543605|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
37860260|NCT01156311|69543606|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
37860261|NCT01156311|69543607|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
37860262|NCT01156311|69543608|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
37860263|NCT01156311|69543605|FG000|2-Month Monotherapy Period|Physician Decision|0|||
37860264|NCT01156311|69543606|FG001|2-Month Monotherapy Period|Physician Decision|1|||
37860265|NCT01156311|69543607|FG002|2-Month Monotherapy Period|Physician Decision|0|||
37860266|NCT01156311|69543608|FG003|2-Month Monotherapy Period|Physician Decision|0|||
37860267|NCT01156311|69543605|FG000|2-Month Monotherapy Period|Other|1|||
37860268|NCT01156311|69543606|FG001|2-Month Monotherapy Period|Other|0|||
37860269|NCT01156311|69543607|FG002|2-Month Monotherapy Period|Other|0|||
37860270|NCT01156311|69543608|FG003|2-Month Monotherapy Period|Other|0|||
37860271|NCT01156311|69543605|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
37860272|NCT01156311|69543606|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
37860273|NCT01156311|69543607|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
37860274|NCT01156311|69543608|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
37860275|NCT01156311|69543605|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
37860276|NCT01156311|69543606|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
37860277|NCT01156311|69543607|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
37860278|NCT01156311|69543608|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
37860279|NCT01156311|69543605|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
37860280|NCT01156311|69543606|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
37860281|NCT01156311|69543607|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
37860282|NCT01156311|69543608|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
37860283|NCT01156311|69543605|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
37860284|NCT01156311|69543606|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
37860285|NCT01156311|69543607|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
37860286|NCT01156311|69543608|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
37860287|NCT01156311|69543605|FG000|6-month Add-on Therapy Period|Other|0|||
37860288|NCT01156311|69543606|FG001|6-month Add-on Therapy Period|Other|0|||
37860289|NCT01156311|69543607|FG002|6-month Add-on Therapy Period|Other|1|||
37860290|NCT01156311|69543608|FG003|6-month Add-on Therapy Period|Other|2|||
37860291|NCT01230060|69543619|FG000|Overall Study|Withdrawal by Subject|1|||
37860292|NCT01155531|69543627|FG000|Overall Study|Adverse Event|0|||
37860293|NCT01155531|69543628|FG001|Overall Study|Adverse Event|0|||
37860294|NCT01155531|69543629|FG002|Overall Study|Adverse Event|1|||
37860295|NCT01155531|69543630|FG003|Overall Study|Adverse Event|0|||
37860296|NCT01155531|69543627|FG000|Overall Study|Lost to Follow-up|0|||
37860297|NCT01155531|69543628|FG001|Overall Study|Lost to Follow-up|0|||
37860298|NCT01155531|69543629|FG002|Overall Study|Lost to Follow-up|0|||
37860299|NCT01155531|69543630|FG003|Overall Study|Lost to Follow-up|1|||
37860300|NCT01155531|69543627|FG000|Overall Study|Withdrawal by Subject|1|||
37860301|NCT01155531|69543628|FG001|Overall Study|Withdrawal by Subject|0|||
37860302|NCT01155531|69543629|FG002|Overall Study|Withdrawal by Subject|1|||
37860303|NCT01155531|69543630|FG003|Overall Study|Withdrawal by Subject|0|||
37860304|NCT01155219|69543642|FG000|Overall Study|Adverse Event|3|||
37860305|NCT01155219|69543643|FG001|Overall Study|Adverse Event|1|||
37860306|NCT01155219|69543642|FG000|Overall Study|non-medical reason|1|||
37860307|NCT01155219|69543643|FG001|Overall Study|non-medical reason|2|||
37860308|NCT01229436|69543649|FG000|Overall Study|Withdrawal by Subject|2|||
37860309|NCT01229436|69543649|FG000|Overall Study|Lost to Follow-up|3|||
37860310|NCT01155141|69543653|FG000|Overall Study|Withdrawal by Subject|1|||
37860311|NCT01155141|69543653|FG000|Overall Study|Screen Failure|1|||
37860312|NCT01155063|69543657|FG000|Overall Study|Adverse Event|1|||
37860313|NCT01155063|69543657|FG000|Overall Study|Withdrawal by Subject|1|||
37860314|NCT01155063|69543657|FG000|Overall Study|Study terminated by sponsor|87|||
37860315|NCT01154673|69543663|FG000|Overall Study|Lost to Follow-up|1|||
37860316|NCT01154673|69543664|FG001|Overall Study|Lost to Follow-up|0|||
37860317|NCT01154673|69543663|FG000|Overall Study|moved out of province|1|||
37860318|NCT01154673|69543664|FG001|Overall Study|moved out of province|0|||
37860319|NCT01154283|69543672|FG000|0-6 Weeks|Withdrawal by Subject|7|||
37860320|NCT01154283|69543673|FG001|0-6 Weeks|Withdrawal by Subject|2|||
37860321|NCT01154283|69543672|FG000|0-6 Weeks|Death|0|||
37860322|NCT01154283|69543673|FG001|0-6 Weeks|Death|1|||
37860323|NCT01154283|69543672|FG000|7-12 Weeks|Death|1|||
37860324|NCT01154283|69543673|FG001|7-12 Weeks|Death|0|||
37860325|NCT01154283|69543672|FG000|7-12 Weeks|Withdrawal by Subject|0|||
37860326|NCT01154283|69543673|FG001|7-12 Weeks|Withdrawal by Subject|1|||
37860327|NCT00944125|69543679|FG000|3 to 6 Months|Withdrawal by Subject|0|||
37860328|NCT00944125|69543680|FG001|3 to 6 Months|Withdrawal by Subject|2|||
37860329|NCT00944125|69543679|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
37860330|NCT00944125|69543680|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
37860331|NCT00912223|69543686|FG000|Overall Study|Withdrawal by Subject|1|||
37860332|NCT00912223|69543686|FG000|Overall Study|Not transplanted|1|||
37860333|NCT00912223|69543686|FG000|Overall Study|Transformed disease|1|||
37860334|NCT01154127|69543692|FG000|Period 1 (21 Days)|Adverse Event|3|||
37860335|NCT01154127|69543693|FG001|Period 1 (21 Days)|Adverse Event|4|||
37860336|NCT01154127|69543692|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
37860337|NCT01154127|69543693|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
37860338|NCT01154127|69543692|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
37860339|NCT01154127|69543693|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
37860340|NCT01154127|69543692|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
37860341|NCT01154127|69543693|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
37860342|NCT01154127|69543692|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
37860343|NCT01154127|69543693|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
37860344|NCT01228734|69543701|FG000|Overall Study|Randomized, but not treated|0|||
37860345|NCT01228734|69543702|FG001|Overall Study|Randomized, but not treated|4|||
37860346|NCT01227954|69543708|FG000|Overall Study|Protocol Violation|6|||
37860347|NCT01227954|69543708|FG000|Overall Study|No protocol treatment|7|||
37860348|NCT01153971|69543712|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
37860349|NCT01153971|69543712|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
37860350|NCT01153971|69543712|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
37860351|NCT01153971|69543712|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
37860352|NCT01153971|69543712|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
37860353|NCT01153971|69543712|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
37860354|NCT01153971|69543712|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
37860355|NCT01153893|69543718|FG000|Overall Study|Adverse Event|1|||
37860356|NCT01153893|69543719|FG001|Overall Study|Adverse Event|0|||
37860357|NCT00951379|69543727|FG000|Overall Study|Adverse Event|4|||
37860358|NCT00951379|69543728|FG001|Overall Study|Adverse Event|1|||
37860359|NCT00951379|69543727|FG000|Overall Study|Withdrawal by Subject|1|||
37860360|NCT00951379|69543728|FG001|Overall Study|Withdrawal by Subject|0|||
37860361|NCT00951379|69543727|FG000|Overall Study|Noncompliance|1|||
37860362|NCT00951379|69543728|FG001|Overall Study|Noncompliance|0|||
37860363|NCT00951379|69543727|FG000|Overall Study|Disease Progression|0|||
37860364|NCT00951379|69543728|FG001|Overall Study|Disease Progression|1|||
37860365|NCT01153815|69543744|FG000|Overall Study|Adverse Event|3|||
37860366|NCT01153815|69543745|FG001|Overall Study|Adverse Event|1|||
37860367|NCT01153815|69543744|FG000|Overall Study|Withdrawal by Subject|6|||
37860368|NCT01153815|69543745|FG001|Overall Study|Withdrawal by Subject|4|||
37860369|NCT01153425|69543753|FG000|Overall Study|Withdrawal by Subject|3|||
37860370|NCT01153425|69543754|FG001|Overall Study|Withdrawal by Subject|3|||
37860371|NCT01153347|69543765|FG000|Overall Study|Withdrawal by Subject|7|||
37860372|NCT01153347|69543766|FG001|Overall Study|Withdrawal by Subject|7|||
37860373|NCT01153347|69543767|FG002|Overall Study|Withdrawal by Subject|7|||
37860374|NCT01153347|69543768|FG003|Overall Study|Withdrawal by Subject|7|||
37860375|NCT01153347|69543765|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
37860376|NCT01153347|69543766|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
37860377|NCT01153347|69543767|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
37860378|NCT01153347|69543768|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
37860379|NCT01153347|69543765|FG000|Overall Study|Adverse Event|3|||
37860380|NCT01153347|69543766|FG001|Overall Study|Adverse Event|9|||
37860381|NCT01153347|69543767|FG002|Overall Study|Adverse Event|21|||
37860382|NCT01153347|69543768|FG003|Overall Study|Adverse Event|7|||
37860383|NCT01153347|69543765|FG000|Overall Study|Severe non-compliance to protocol|6|||
37860384|NCT01153347|69543766|FG001|Overall Study|Severe non-compliance to protocol|7|||
37860385|NCT01153347|69543767|FG002|Overall Study|Severe non-compliance to protocol|4|||
37860386|NCT01153347|69543768|FG003|Overall Study|Severe non-compliance to protocol|3|||
37860387|NCT01153347|69543765|FG000|Overall Study|Condition under investigation worsened|1|||
37860388|NCT01153347|69543766|FG001|Overall Study|Condition under investigation worsened|1|||
37860389|NCT01153347|69543767|FG002|Overall Study|Condition under investigation worsened|0|||
37860390|NCT01153347|69543768|FG003|Overall Study|Condition under investigation worsened|0|||
37860391|NCT01153347|69543765|FG000|Overall Study|Lack of Efficacy|2|||
37860392|NCT01153347|69543766|FG001|Overall Study|Lack of Efficacy|2|||
37860393|NCT01153347|69543767|FG002|Overall Study|Lack of Efficacy|0|||
37860394|NCT01153347|69543768|FG003|Overall Study|Lack of Efficacy|4|||
37860395|NCT01153347|69543765|FG000|Overall Study|Study-specific withdrawal criteria|4|||
37860396|NCT01153347|69543766|FG001|Overall Study|Study-specific withdrawal criteria|3|||
37860397|NCT01153347|69543767|FG002|Overall Study|Study-specific withdrawal criteria|1|||
37860398|NCT01153347|69543768|FG003|Overall Study|Study-specific withdrawal criteria|2|||
37860399|NCT01153347|69543765|FG000|Overall Study|Lost to Follow-up|4|||
37860400|NCT01153347|69543766|FG001|Overall Study|Lost to Follow-up|9|||
37860401|NCT01153347|69543767|FG002|Overall Study|Lost to Follow-up|11|||
37860402|NCT01153347|69543768|FG003|Overall Study|Lost to Follow-up|8|||
37860403|NCT01153347|69543765|FG000|Overall Study|Other|5|||
37860404|NCT01153347|69543766|FG001|Overall Study|Other|5|||
37860405|NCT01153347|69543767|FG002|Overall Study|Other|4|||
37860406|NCT01153347|69543768|FG003|Overall Study|Other|0|||
37860407|NCT01153347|69543765|FG000|Overall Study|Death|1|||
37860408|NCT01153347|69543766|FG001|Overall Study|Death|0|||
37860409|NCT01153347|69543767|FG002|Overall Study|Death|0|||
37860410|NCT01153347|69543768|FG003|Overall Study|Death|0|||
37860411|NCT01153269|69543778|FG000|Overall Study|Withdrawal by Subject|1|||
37860412|NCT01153269|69543778|FG000|Overall Study|Antiretroviral therapy break|1|||
37860413|NCT01152021|69543787|FG000|Overall Study|Adverse Event|4|||
37860414|NCT01152021|69543788|FG001|Overall Study|Adverse Event|4|||
37860415|NCT01152021|69543787|FG000|Overall Study|Study drug had expired|1|||
37860416|NCT01152021|69543788|FG001|Overall Study|Study drug had expired|0|||
37860417|NCT01152021|69543787|FG000|Overall Study|Physician Decision|1|||
37860418|NCT01152021|69543788|FG001|Overall Study|Physician Decision|1|||
37860419|NCT01152021|69543787|FG000|Overall Study|No access to study drug in Pharmacy|0|||
37860420|NCT01152021|69543788|FG001|Overall Study|No access to study drug in Pharmacy|1|||
37860421|NCT01151085|69543796|FG000|Overall Study|Lost to Follow-up|31|||
37860422|NCT01151085|69543796|FG000|Overall Study|Protocol Violation|25|||
37860423|NCT01149681|69543807|FG000|Overall Study|Withdrawal by Subject|7|||
37860424|NCT01149681|69543807|FG000|Overall Study|Progressive disease|1|||
37860425|NCT01149681|69543807|FG000|Overall Study|Physician Decision|2|||
37860426|NCT01149681|69543807|FG000|Overall Study|adverse events nonrelated study drug|2|||
37860427|NCT01149369|69543814|FG000|Overall Study|Adverse Event|6|||
37860428|NCT01149369|69543815|FG001|Overall Study|Adverse Event|3|||
37860429|NCT01740427|69543823|FG000|Overall Study|Ongoing|45|||
37860430|NCT01740427|69543824|FG001|Overall Study|Ongoing|5|||
37860431|NCT01740427|69543823|FG000|Overall Study|Objective Progression or Relapse|281|||
37860432|NCT01740427|69543824|FG001|Overall Study|Objective Progression or Relapse|171|||
37860433|NCT01740427|69543823|FG000|Overall Study|Adverse Event|31|||
37860434|NCT01740427|69543824|FG001|Overall Study|Adverse Event|9|||
37860435|NCT01740427|69543823|FG000|Overall Study|Global Deterioration of Health Status|28|||
37860436|NCT01740427|69543824|FG001|Overall Study|Global Deterioration of Health Status|12|||
37860437|NCT01740427|69543823|FG000|Overall Study|Participant Refused Continued Treatment|26|||
37860438|NCT01740427|69543824|FG001|Overall Study|Participant Refused Continued Treatment|15|||
37860439|NCT01740427|69543823|FG000|Overall Study|Unspecified reasons|15|||
37860440|NCT01740427|69543824|FG001|Overall Study|Unspecified reasons|4|||
37860441|NCT01740427|69543823|FG000|Overall Study|Death|10|||
37860442|NCT01740427|69543824|FG001|Overall Study|Death|3|||
37860443|NCT01740427|69543823|FG000|Overall Study|Protocol Violation|5|||
37860444|NCT01740427|69543824|FG001|Overall Study|Protocol Violation|3|||
37860445|NCT01740427|69543823|FG000|Overall Study|Lost to Follow-up|2|||
37860446|NCT01740427|69543824|FG001|Overall Study|Lost to Follow-up|0|||
37860447|NCT01740427|69543823|FG000|Overall Study|Site Terminated by Sponsor|1|||
37860448|NCT01740427|69543824|FG001|Overall Study|Site Terminated by Sponsor|0|||
37860449|NCT01149057|69543830|FG000|Overall Study|Lack of Efficacy|16|||
37860450|NCT01149057|69543830|FG000|Overall Study|Adverse Event|13|||
37860451|NCT01149057|69543830|FG000|Overall Study|Withdrawal by Subject|9|||
37860452|NCT01149057|69543830|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
37946851|NCT00530920|69634376|FG001|Overall Study|Adverse Event|0|||
37946852|NCT00530920|69634377|FG002|Overall Study|Adverse Event|3|||
37946853|NCT00530920|69634375|FG000|Overall Study|Withdrawal by Subject|0|||
37946854|NCT00530920|69634376|FG001|Overall Study|Withdrawal by Subject|0|||
37946855|NCT00530920|69634377|FG002|Overall Study|Withdrawal by Subject|1|||
37946856|NCT03878758|69634386|FG000|Overall Study|Withdrawal by Subject|1|||
37946857|NCT03878758|69634386|FG000|Overall Study|Protocol defined|2|||
37946858|NCT03878758|69634386|FG000|Overall Study|Improper consent documentation|1|||
37946859|NCT03878602|69634401|FG000|Overall Study|cord blood donation|7|||
37946860|NCT03878602|69634402|FG001|Overall Study|cord blood donation|1|||
37946861|NCT03878602|69634401|FG000|Overall Study|incomplete data collection|2|||
37946862|NCT03878602|69634402|FG001|Overall Study|incomplete data collection|0|||
37946863|NCT00768755|69634414|FG000|Phase 1|Death|6|||
37946864|NCT00768755|69634415|FG001|Phase 1|Death|0|||
37946865|NCT00768755|69634416|FG002|Phase 1|Death|0|||
37946866|NCT00768755|69634417|FG003|Phase 1|Death|0|||
37946867|NCT00768755|69634414|FG000|Phase 1|Other|4|||
37946868|NCT00768755|69634415|FG001|Phase 1|Other|0|||
37946869|NCT00768755|69634416|FG002|Phase 1|Other|0|||
37946870|NCT00768755|69634417|FG003|Phase 1|Other|0|||
37946871|NCT00768755|69634414|FG000|Phase 2|Death|0|||
37946872|NCT00768755|69634415|FG001|Phase 2|Death|37|||
37946873|NCT00768755|69634416|FG002|Phase 2|Death|48|||
37946874|NCT00768755|69634417|FG003|Phase 2|Death|31|||
37946875|NCT00768755|69634414|FG000|Phase 2|Protocol Violation|0|||
37946876|NCT00768755|69634415|FG001|Phase 2|Protocol Violation|2|||
37946877|NCT00768755|69634416|FG002|Phase 2|Protocol Violation|0|||
37946878|NCT00768755|69634417|FG003|Phase 2|Protocol Violation|1|||
37946879|NCT00768755|69634414|FG000|Phase 2|Lost to Follow-up|0|||
37946880|NCT00768755|69634415|FG001|Phase 2|Lost to Follow-up|1|||
37946881|NCT00768755|69634416|FG002|Phase 2|Lost to Follow-up|1|||
37946882|NCT00768755|69634417|FG003|Phase 2|Lost to Follow-up|4|||
37946883|NCT00768755|69634414|FG000|Phase 2|Withdrawal by Subject|0|||
37946884|NCT00768755|69634415|FG001|Phase 2|Withdrawal by Subject|1|||
37946885|NCT00768755|69634416|FG002|Phase 2|Withdrawal by Subject|0|||
37946886|NCT00768755|69634417|FG003|Phase 2|Withdrawal by Subject|1|||
37946887|NCT00768755|69634414|FG000|Phase 2|Other|0|||
37946888|NCT00768755|69634415|FG001|Phase 2|Other|1|||
37946889|NCT00768755|69634416|FG002|Phase 2|Other|2|||
37946890|NCT00768755|69634417|FG003|Phase 2|Other|4|||
37946891|NCT00768755|69634414|FG000|Phase 2|Study Terminated by Sponsor|0|||
37946892|NCT00768755|69634415|FG001|Phase 2|Study Terminated by Sponsor|13|||
37946893|NCT00768755|69634416|FG002|Phase 2|Study Terminated by Sponsor|7|||
37946894|NCT00768755|69634417|FG003|Phase 2|Study Terminated by Sponsor|14|||
37946895|NCT00768755|69634414|FG000|Phase 2|Randomized but not treated|0|||
37946896|NCT00768755|69634415|FG001|Phase 2|Randomized but not treated|0|||
37946897|NCT00768755|69634416|FG002|Phase 2|Randomized but not treated|0|||
37946898|NCT00768755|69634417|FG003|Phase 2|Randomized but not treated|2|||
37946899|NCT00530842|69634428|FG000|Overall Study|Adverse Event|10|||
37946900|NCT00530842|69634429|FG001|Overall Study|Adverse Event|6|||
37946901|NCT00530842|69634428|FG000|Overall Study|Lack of Efficacy|2|||
37946902|NCT00530842|69634429|FG001|Overall Study|Lack of Efficacy|1|||
37946903|NCT00530842|69634428|FG000|Overall Study|Lost to Follow-up|0|||
37946904|NCT00530842|69634429|FG001|Overall Study|Lost to Follow-up|4|||
37946905|NCT00530842|69634428|FG000|Overall Study|Protocol Violation|3|||
37946906|NCT00530842|69634429|FG001|Overall Study|Protocol Violation|2|||
37946907|NCT00530842|69634428|FG000|Overall Study|Withdrawal by Subject|4|||
37946908|NCT00530842|69634429|FG001|Overall Study|Withdrawal by Subject|5|||
37946909|NCT00530842|69634428|FG000|Overall Study|Individual different reasons|4|||
37860453|NCT01149057|69543830|FG000|Overall Study|B Cell Depletion|4|||
37860454|NCT01149057|69543830|FG000|Overall Study|Participant Non-Compliance|2|||
37860455|NCT01149057|69543830|FG000|Overall Study|Lost to Follow-up|1|||
37946910|NCT00530842|69634429|FG001|Overall Study|Individual different reasons|3|||
37946911|NCT00530842|69634428|FG000|Period 1|Adverse Event|7|||
37946912|NCT00530842|69634429|FG001|Period 1|Adverse Event|3|||
37946913|NCT00530842|69634428|FG000|Period 1|Lack of Efficacy|1|||
37946914|NCT00530842|69634429|FG001|Period 1|Lack of Efficacy|1|||
37946915|NCT00530842|69634428|FG000|Period 1|Protocol Violation|2|||
37946916|NCT00530842|69634429|FG001|Period 1|Protocol Violation|1|||
37946917|NCT00530842|69634428|FG000|Period 1|Withdrawal by Subject|2|||
37946918|NCT00530842|69634429|FG001|Period 1|Withdrawal by Subject|3|||
37946919|NCT00530842|69634428|FG000|Period 1|Individual different reasons|2|||
37946920|NCT00530842|69634429|FG001|Period 1|Individual different reasons|3|||
37946921|NCT00530842|69634428|FG000|Period 2|Adverse Event|3|||
37946922|NCT00530842|69634429|FG001|Period 2|Adverse Event|3|||
37946923|NCT00530842|69634428|FG000|Period 2|Lack of Efficacy|1|||
37946924|NCT00530842|69634429|FG001|Period 2|Lack of Efficacy|0|||
37946925|NCT00530842|69634428|FG000|Period 2|Lost to Follow-up|0|||
37946926|NCT00530842|69634429|FG001|Period 2|Lost to Follow-up|4|||
37946927|NCT00530842|69634428|FG000|Period 2|Protocol Violation|1|||
37946928|NCT00530842|69634429|FG001|Period 2|Protocol Violation|0|||
37946929|NCT00530842|69634428|FG000|Period 2|Withdrawal by Subject|1|||
37946930|NCT00530842|69634429|FG001|Period 2|Withdrawal by Subject|2|||
37946931|NCT00530842|69634428|FG000|Period 2|Individual different reasons|2|||
37946932|NCT00530842|69634429|FG001|Period 2|Individual different reasons|0|||
37946933|NCT03882424|69634440|FG000|Overall Study|Lost to Follow-up|3|||
37946934|NCT03882424|69634441|FG001|Overall Study|Lost to Follow-up|0|||
37946935|NCT03882424|69634442|FG002|Overall Study|Lost to Follow-up|0|||
37946936|NCT03882424|69634440|FG000|Overall Study|schedule conflict|1|||
37946937|NCT03882424|69634441|FG001|Overall Study|schedule conflict|0|||
37946938|NCT03882424|69634442|FG002|Overall Study|schedule conflict|0|||
37946939|NCT03879772|69634455|FG000|Overall Study|Adverse Event|2|||
37946940|NCT03879772|69634456|FG001|Overall Study|Adverse Event|2|||
37946941|NCT03879772|69634457|FG002|Overall Study|Adverse Event|3|||
37946942|NCT03879772|69634458|FG003|Overall Study|Adverse Event|4|||
37946943|NCT03879772|69634459|FG004|Overall Study|Adverse Event|3|||
37946944|NCT03879772|69634455|FG000|Overall Study|Treatment Failure|1|||
37946945|NCT03879772|69634456|FG001|Overall Study|Treatment Failure|0|||
37946946|NCT03879772|69634457|FG002|Overall Study|Treatment Failure|0|||
37946947|NCT03879772|69634458|FG003|Overall Study|Treatment Failure|2|||
37946948|NCT03879772|69634459|FG004|Overall Study|Treatment Failure|1|||
37946949|NCT03879772|69634455|FG000|Overall Study|Lost to Follow-up|0|||
37946950|NCT03879772|69634456|FG001|Overall Study|Lost to Follow-up|0|||
37946951|NCT03879772|69634457|FG002|Overall Study|Lost to Follow-up|0|||
37946952|NCT03879772|69634458|FG003|Overall Study|Lost to Follow-up|0|||
37946953|NCT03879772|69634459|FG004|Overall Study|Lost to Follow-up|1|||
37946954|NCT03879772|69634455|FG000|Overall Study|Withdrawal by Subject|0|||
37946955|NCT03879772|69634456|FG001|Overall Study|Withdrawal by Subject|1|||
37946956|NCT03879772|69634457|FG002|Overall Study|Withdrawal by Subject|3|||
37946957|NCT03879772|69634458|FG003|Overall Study|Withdrawal by Subject|1|||
37946958|NCT03879772|69634459|FG004|Overall Study|Withdrawal by Subject|1|||
37946959|NCT03879772|69634455|FG000|Overall Study|Protocol Violation|0|||
37946960|NCT03879772|69634456|FG001|Overall Study|Protocol Violation|0|||
37946961|NCT03879772|69634457|FG002|Overall Study|Protocol Violation|3|||
37946962|NCT03879772|69634458|FG003|Overall Study|Protocol Violation|1|||
37946963|NCT03879772|69634459|FG004|Overall Study|Protocol Violation|2|||
37946964|NCT03879772|69634455|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
37946965|NCT03879772|69634456|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
37946966|NCT03879772|69634457|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
37946967|NCT03879772|69634458|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
37946968|NCT03879772|69634459|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
37946969|NCT00642954|69634476|FG000|Overall Study|Progressive Disease|3|||
37946970|NCT00642954|69634477|FG001|Overall Study|Progressive Disease|3|||
37946971|NCT00642954|69634478|FG002|Overall Study|Progressive Disease|3|||
37946972|NCT00642954|69634479|FG003|Overall Study|Progressive Disease|3|||
37946973|NCT00642954|69634480|FG004|Overall Study|Progressive Disease|9|||
37946974|NCT00642954|69634476|FG000|Overall Study|Withdrawal by Subject|0|||
37946975|NCT00642954|69634477|FG001|Overall Study|Withdrawal by Subject|0|||
37946976|NCT00642954|69634478|FG002|Overall Study|Withdrawal by Subject|0|||
37946977|NCT00642954|69634479|FG003|Overall Study|Withdrawal by Subject|0|||
37946978|NCT00642954|69634480|FG004|Overall Study|Withdrawal by Subject|1|||
37946979|NCT00642954|69634476|FG000|Overall Study|Adverse Event|1|||
37946980|NCT00642954|69634477|FG001|Overall Study|Adverse Event|1|||
37946981|NCT00642954|69634478|FG002|Overall Study|Adverse Event|0|||
37946982|NCT00642954|69634479|FG003|Overall Study|Adverse Event|0|||
37946983|NCT00642954|69634480|FG004|Overall Study|Adverse Event|6|||
37946984|NCT00640146|69634494|FG000|Overall Study|Adverse Event|2|||
37946985|NCT00640146|69634495|FG001|Overall Study|Adverse Event|0|||
37946986|NCT00640146|69634494|FG000|Overall Study|Lost to Follow-up|0|||
37946987|NCT00640146|69634495|FG001|Overall Study|Lost to Follow-up|1|||
37946988|NCT00640146|69634494|FG000|Overall Study|Lack of Efficacy|0|||
37946989|NCT00640146|69634495|FG001|Overall Study|Lack of Efficacy|1|||
37946990|NCT00640146|69634494|FG000|Overall Study|Withdrawal by Subject|1|||
37946991|NCT00640146|69634495|FG001|Overall Study|Withdrawal by Subject|1|||
37946992|NCT00640146|69634494|FG000|Overall Study|Randomized but not treated|1|||
37946993|NCT00640146|69634495|FG001|Overall Study|Randomized but not treated|3|||
37946994|NCT00317473|69634507|FG000|Overall Study|Withdrawal by Subject|2|||
37946995|NCT00317473|69634508|FG001|Overall Study|Withdrawal by Subject|1|||
37946996|NCT00317473|69634509|FG002|Overall Study|Withdrawal by Subject|2|||
37946997|NCT00317473|69634510|FG003|Overall Study|Withdrawal by Subject|1|||
37946998|NCT00317473|69634511|FG004|Overall Study|Withdrawal by Subject|3|||
37946999|NCT00317473|69634512|FG005|Overall Study|Withdrawal by Subject|1|||
37947000|NCT00317473|69634507|FG000|Overall Study|Relocation|1|||
37947001|NCT00317473|69634508|FG001|Overall Study|Relocation|0|||
37947002|NCT00317473|69634509|FG002|Overall Study|Relocation|1|||
37947003|NCT00317473|69634510|FG003|Overall Study|Relocation|1|||
37947004|NCT00317473|69634511|FG004|Overall Study|Relocation|5|||
37947005|NCT00317473|69634512|FG005|Overall Study|Relocation|2|||
37947006|NCT00317473|69634507|FG000|Overall Study|Death|1|||
37947007|NCT00317473|69634508|FG001|Overall Study|Death|0|||
37947008|NCT00317473|69634509|FG002|Overall Study|Death|0|||
37947009|NCT00317473|69634510|FG003|Overall Study|Death|0|||
37947010|NCT00317473|69634511|FG004|Overall Study|Death|0|||
37947011|NCT00317473|69634512|FG005|Overall Study|Death|0|||
37947012|NCT00317473|69634507|FG000|Overall Study|Other|0|||
37947013|NCT00317473|69634508|FG001|Overall Study|Other|2|||
37947014|NCT00317473|69634509|FG002|Overall Study|Other|0|||
37947015|NCT00317473|69634510|FG003|Overall Study|Other|0|||
37947016|NCT00317473|69634511|FG004|Overall Study|Other|0|||
37947017|NCT00317473|69634512|FG005|Overall Study|Other|0|||
37947018|NCT00530218|69634536|FG000|Overall Study|CMV Not Detected|13|||
37947019|NCT00530218|69634536|FG000|Overall Study|Death|12|||
37947020|NCT00761267|69634546|FG000|Overall Study|Death|1|||
37947021|NCT00761267|69634547|FG001|Overall Study|Death|2|||
37947022|NCT00761267|69634548|FG002|Overall Study|Death|5|||
37947023|NCT00761267|69634546|FG000|Overall Study|Lost to Follow-up|0|||
37947024|NCT00761267|69634547|FG001|Overall Study|Lost to Follow-up|0|||
37947025|NCT00761267|69634548|FG002|Overall Study|Lost to Follow-up|1|||
37947026|NCT00761267|69634546|FG000|Overall Study|Randomized but not treated|1|||
37947027|NCT00761267|69634547|FG001|Overall Study|Randomized but not treated|1|||
37947028|NCT00761267|69634548|FG002|Overall Study|Randomized but not treated|0|||
37947029|NCT00761267|69634546|FG000|Overall Study|Withdrawal by Subject|0|||
37947030|NCT00761267|69634547|FG001|Overall Study|Withdrawal by Subject|1|||
37947031|NCT00761267|69634548|FG002|Overall Study|Withdrawal by Subject|0|||
37947032|NCT00303667|69634569|FG000|Overall Study|Death|0|||
37947033|NCT00303667|69634570|FG001|Overall Study|Death|4|||
37947034|NCT00761189|69634576|FG000|Overall Study|Adverse Event|42|||
37947035|NCT00761189|69634576|FG000|Overall Study|Lack of Efficacy|45|||
37947036|NCT00761189|69634576|FG000|Overall Study|Lost to Follow-up|36|||
37947037|NCT00761189|69634576|FG000|Overall Study|Withdrawal by Subject|49|||
37947038|NCT00761189|69634576|FG000|Overall Study|Other|13|||
37947039|NCT00529516|69634583|FG000|Overall Study|Adverse Event|2|||
37947040|NCT00529516|69634584|FG001|Overall Study|Adverse Event|1|||
37947041|NCT00529516|69634585|FG002|Overall Study|Adverse Event|0|||
37947042|NCT00529516|69634583|FG000|Overall Study|Withdrawal by Subject|1|||
37947043|NCT00529516|69634584|FG001|Overall Study|Withdrawal by Subject|1|||
37947044|NCT00529516|69634585|FG002|Overall Study|Withdrawal by Subject|0|||
37947045|NCT00529516|69634583|FG000|Overall Study|Lost to Follow-up|0|||
37947046|NCT00529516|69634584|FG001|Overall Study|Lost to Follow-up|0|||
37947047|NCT00529516|69634585|FG002|Overall Study|Lost to Follow-up|1|||
37947048|NCT00316693|69634595|FG000|Overall Study|Adverse Event|6|||
37947049|NCT00316693|69634596|FG001|Overall Study|Adverse Event|1|||
37947050|NCT00316693|69634595|FG000|Overall Study|Protocol Violation|1|||
37947051|NCT00316693|69634596|FG001|Overall Study|Protocol Violation|0|||
37947052|NCT00316693|69634595|FG000|Overall Study|Withdrawal by Subject|6|||
37947053|NCT00316693|69634596|FG001|Overall Study|Withdrawal by Subject|6|||
37947054|NCT00316693|69634595|FG000|Overall Study|Lost to Follow-up|26|||
37947055|NCT00316693|69634596|FG001|Overall Study|Lost to Follow-up|34|||
37947056|NCT00316693|69634595|FG000|Overall Study|Other|38|||
37947057|NCT00316693|69634596|FG001|Overall Study|Other|44|||
37947058|NCT00316303|69634604|FG000|Overall Study|Lost to Follow-up|11|||
37947059|NCT00316303|69634605|FG001|Overall Study|Lost to Follow-up|16|||
37947060|NCT00760877|69634616|FG000|Overall Study|Protocol Violation|1|||
37947061|NCT00760877|69634617|FG001|Overall Study|Protocol Violation|0|||
37947062|NCT00760877|69634616|FG000|Overall Study|Non-compliance with protocol treatment|2|||
37947063|NCT00760877|69634617|FG001|Overall Study|Non-compliance with protocol treatment|1|||
37947064|NCT00760877|69634616|FG000|Overall Study|Pregnancy|1|||
37947065|NCT00760877|69634617|FG001|Overall Study|Pregnancy|4|||
37947066|NCT00760877|69634616|FG000|Overall Study|Death|2|||
37947067|NCT00760877|69634617|FG001|Overall Study|Death|1|||
37947068|NCT00760877|69634616|FG000|Overall Study|Withdrawal by Subject|7|||
37947069|NCT00760877|69634617|FG001|Overall Study|Withdrawal by Subject|3|||
37947070|NCT00760877|69634616|FG000|Overall Study|Adverse Event|19|||
37947071|NCT00760877|69634617|FG001|Overall Study|Adverse Event|12|||
37947072|NCT00760877|69634616|FG000|Overall Study|Participant diagnosed with AML|0|||
37947073|NCT00760877|69634617|FG001|Overall Study|Participant diagnosed with AML|1|||
37947074|NCT00760877|69634616|FG000|Overall Study|Participant not eligible to cross-over|0|||
37947075|NCT00760877|69634617|FG001|Overall Study|Participant not eligible to cross-over|1|||
37947076|NCT00760877|69634616|FG000|Overall Study|Physician Decision|1|||
37947077|NCT00760877|69634617|FG001|Overall Study|Physician Decision|2|||
37947078|NCT00760877|69634616|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
37947079|NCT00760877|69634617|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
37947080|NCT00760877|69634616|FG000|Overall Study|Treatment failure|1|||
37947081|NCT00760877|69634617|FG001|Overall Study|Treatment failure|0|||
37947082|NCT00302731|69634628|FG000|Overall Study|Lost to Follow-up|1|||
37947083|NCT00302731|69634629|FG001|Overall Study|Lost to Follow-up|2|||
37947084|NCT00302731|69634630|FG002|Overall Study|Lost to Follow-up|0|||
37947085|NCT00302731|69634631|FG003|Overall Study|Lost to Follow-up|0|||
37947086|NCT00302731|69634628|FG000|Overall Study|Adverse Event|0|||
37947087|NCT00302731|69634629|FG001|Overall Study|Adverse Event|2|||
37947088|NCT00302731|69634630|FG002|Overall Study|Adverse Event|2|||
37947089|NCT00302731|69634631|FG003|Overall Study|Adverse Event|0|||
37947090|NCT00302731|69634628|FG000|Overall Study|Withdrawal by Subject|1|||
37947091|NCT00302731|69634629|FG001|Overall Study|Withdrawal by Subject|1|||
37947092|NCT00302731|69634630|FG002|Overall Study|Withdrawal by Subject|0|||
37947093|NCT00302731|69634631|FG003|Overall Study|Withdrawal by Subject|0|||
37947094|NCT00302731|69634628|FG000|Overall Study|Protocol Violation|1|||
37947095|NCT00302731|69634629|FG001|Overall Study|Protocol Violation|0|||
37947096|NCT00302731|69634630|FG002|Overall Study|Protocol Violation|0|||
37947097|NCT00302731|69634631|FG003|Overall Study|Protocol Violation|0|||
37947098|NCT00302731|69634628|FG000|Overall Study|cancer unrelated to study discovered|1|||
37947099|NCT00302731|69634629|FG001|Overall Study|cancer unrelated to study discovered|0|||
37947100|NCT00302731|69634630|FG002|Overall Study|cancer unrelated to study discovered|1|||
37947101|NCT00302731|69634631|FG003|Overall Study|cancer unrelated to study discovered|0|||
37947102|NCT00780143|69634641|FG000|Overall Study|Progressive disease|1|||
37947103|NCT00780143|69634641|FG000|Overall Study|Toxicity|1|||
37947104|NCT00780143|69634641|FG000|Overall Study|Adverse Event|1|||
37947105|NCT00779909|69634649|FG000|Overall Study|Lost to Follow-up|1|||
37947106|NCT00779909|69634650|FG001|Overall Study|Lost to Follow-up|0|||
37947107|NCT00779909|69634651|FG002|Overall Study|Lost to Follow-up|0|||
37768459|NCT00249795|69284443|FG001|Overall Study|Lightheadedness / dizziness|11|||
37768460|NCT00249795|69284442|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
37768461|NCT00249795|69284443|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
37768462|NCT00249795|69284442|FG000|Overall Study|Other contraindicated medication|1|||
37768463|NCT00249795|69284443|FG001|Overall Study|Other contraindicated medication|1|||
37768464|NCT00249795|69284442|FG000|Overall Study|Event related to cardiac condition|17|||
37768465|NCT00249795|69284443|FG001|Overall Study|Event related to cardiac condition|16|||
37768466|NCT00249795|69284442|FG000|Overall Study|Patient not wish to continue after May08|4|||
37768467|NCT00249795|69284443|FG001|Overall Study|Patient not wish to continue after May08|6|||
37768468|NCT00249795|69284442|FG000|Overall Study|Site not agree to continue after May08|1|||
37768469|NCT00249795|69284443|FG001|Overall Study|Site not agree to continue after May08|1|||
37768470|NCT00249795|69284442|FG000|Overall Study|Lost to Follow-up|0|||
37768471|NCT00249795|69284443|FG001|Overall Study|Lost to Follow-up|2|||
37768472|NCT00249795|69284442|FG000|Overall Study|Missing|0|||
37768473|NCT00249795|69284443|FG001|Overall Study|Missing|1|||
37768474|NCT02651220|69284452|FG000|Overall Study|Adverse Event|1|||
37768475|NCT02651220|69284453|FG001|Overall Study|Adverse Event|5|||
37768476|NCT02651220|69284454|FG002|Overall Study|Adverse Event|1|||
37768477|NCT02651220|69284452|FG000|Overall Study|Lost to Follow-up|8|||
37768478|NCT02651220|69284453|FG001|Overall Study|Lost to Follow-up|14|||
37768479|NCT02651220|69284454|FG002|Overall Study|Lost to Follow-up|14|||
37768480|NCT02651220|69284452|FG000|Overall Study|Non-Compliance with Study Drug|4|||
37768481|NCT02651220|69284453|FG001|Overall Study|Non-Compliance with Study Drug|0|||
37768482|NCT02651220|69284454|FG002|Overall Study|Non-Compliance with Study Drug|1|||
37768483|NCT02651220|69284452|FG000|Overall Study|Pregnancy|1|||
37768484|NCT02651220|69284453|FG001|Overall Study|Pregnancy|0|||
37768485|NCT02651220|69284454|FG002|Overall Study|Pregnancy|1|||
37768486|NCT02651220|69284452|FG000|Overall Study|Protocol Violation|0|||
37768487|NCT02651220|69284453|FG001|Overall Study|Protocol Violation|0|||
37768488|NCT02651220|69284454|FG002|Overall Study|Protocol Violation|1|||
37768489|NCT02651220|69284452|FG000|Overall Study|Withdrawal by Subject|5|||
37768490|NCT02651220|69284453|FG001|Overall Study|Withdrawal by Subject|6|||
37768491|NCT02651220|69284454|FG002|Overall Study|Withdrawal by Subject|8|||
37768492|NCT02651220|69284452|FG000|Overall Study|Miscellaneous|4|||
37768493|NCT02651220|69284453|FG001|Overall Study|Miscellaneous|1|||
37768494|NCT02651220|69284454|FG002|Overall Study|Miscellaneous|2|||
37768495|NCT02651220|69284452|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
37768496|NCT02651220|69284453|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
37768497|NCT02651220|69284454|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
37768498|NCT00247611|69284502|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
37947108|NCT00779909|69634652|FG003|Overall Study|Lost to Follow-up|1|||
37947109|NCT00779909|69634649|FG000|Overall Study|Withdrawal by Subject|0|||
37947110|NCT00779909|69634650|FG001|Overall Study|Withdrawal by Subject|1|||
37947111|NCT00779909|69634651|FG002|Overall Study|Withdrawal by Subject|0|||
37947112|NCT00779909|69634652|FG003|Overall Study|Withdrawal by Subject|0|||
37947113|NCT00302107|69634671|FG000|Overall Study|Lost to Follow-up|6|||
37947114|NCT00302107|69634672|FG001|Overall Study|Lost to Follow-up|5|||
37768499|NCT00247611|69284503|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
37768500|NCT00247611|69284502|FG000|Baselined|Completed baseline only|9|||
37768501|NCT00247611|69284503|FG001|Baselined|Completed baseline only|8|||
37947115|NCT00302107|69634671|FG000|Overall Study|Protocol Violation|1|||
37947116|NCT00302107|69634672|FG001|Overall Study|Protocol Violation|0|||
37947117|NCT00302107|69634671|FG000|Overall Study|Relocation|0|||
37947118|NCT00302107|69634672|FG001|Overall Study|Relocation|1|||
37947119|NCT00302107|69634671|FG000|Overall Study|Withdrawal by Subject|0|||
37947120|NCT00302107|69634672|FG001|Overall Study|Withdrawal by Subject|3|||
37947121|NCT00302107|69634671|FG000|Overall Study|Adverse Event|1|||
37947122|NCT00302107|69634672|FG001|Overall Study|Adverse Event|0|||
37947123|NCT00760487|69634678|FG000|Overall Study|Unilateral implantation|3|||
37947124|NCT00316225|69634682|FG000|Overall Study|Adverse Event|2|||
37947125|NCT00316225|69634682|FG000|Overall Study|Physician Decision|3|||
37947126|NCT00316225|69634682|FG000|Overall Study|Progressive Disease|15|||
37947127|NCT00316225|69634682|FG000|Overall Study|Withdrawal by Subject|3|||
37947128|NCT00316225|69634682|FG000|Overall Study|Death|2|||
37947129|NCT00586703|69634686|FG000|Overall Study|Death|12|||
37947130|NCT00586625|69634692|FG000|Overall Study|Adverse Event|6|||
37947131|NCT00586625|69634693|FG001|Overall Study|Adverse Event|6|||
37947132|NCT00586625|69634692|FG000|Overall Study|Protocol Violation|3|||
37947133|NCT00586625|69634693|FG001|Overall Study|Protocol Violation|0|||
37947134|NCT00586625|69634692|FG000|Overall Study|Withdrawal by Subject|32|||
37947135|NCT00586625|69634693|FG001|Overall Study|Withdrawal by Subject|10|||
37947136|NCT00586625|69634692|FG000|Overall Study|Subject non-compliance|0|||
37947137|NCT00586625|69634693|FG001|Overall Study|Subject non-compliance|1|||
37947138|NCT00586625|69634692|FG000|Overall Study|Subject unable to return for visit|2|||
37947139|NCT00586625|69634693|FG001|Overall Study|Subject unable to return for visit|0|||
37947140|NCT00636168|69634701|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
37947141|NCT00636168|69634702|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
37947142|NCT00636168|69634701|FG000|Randomized to Study Drug|Adverse Event|1|||
37947143|NCT00636168|69634702|FG001|Randomized to Study Drug|Adverse Event|0|||
37947144|NCT00636168|69634701|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
37947145|NCT00636168|69634702|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
37947146|NCT00636168|69634701|FG000|Treated With Study Drug|Recurrence of disease|135|||
37947147|NCT00636168|69634702|FG001|Treated With Study Drug|Recurrence of disease|282|||
37947148|NCT00636168|69634701|FG000|Treated With Study Drug|Adverse Event|250|||
37947149|NCT00636168|69634702|FG001|Treated With Study Drug|Adverse Event|22|||
37947150|NCT00636168|69634701|FG000|Treated With Study Drug|Participant withdrew consent|16|||
37947151|NCT00636168|69634702|FG001|Treated With Study Drug|Participant withdrew consent|21|||
37947152|NCT00636168|69634701|FG000|Treated With Study Drug|Poor/non-compliance|1|||
37947153|NCT00636168|69634702|FG001|Treated With Study Drug|Poor/non-compliance|3|||
37947154|NCT00636168|69634701|FG000|Treated With Study Drug|Death|3|||
37947155|NCT00636168|69634702|FG001|Treated With Study Drug|Death|0|||
37947156|NCT00636168|69634701|FG000|Treated With Study Drug|Pregnancy|1|||
37947157|NCT00636168|69634702|FG001|Treated With Study Drug|Pregnancy|0|||
37947158|NCT00636168|69634701|FG000|Treated With Study Drug|No longer meets study criteria|1|||
37947159|NCT00636168|69634702|FG001|Treated With Study Drug|No longer meets study criteria|0|||
37947160|NCT00636168|69634701|FG000|Treated With Study Drug|Other reason|1|||
37947161|NCT00636168|69634702|FG001|Treated With Study Drug|Other reason|3|||
37947162|NCT00636168|69634701|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
37947163|NCT00636168|69634702|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
37947164|NCT00636168|69634701|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
37947165|NCT00636168|69634702|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
37947166|NCT00636168|69634701|FG000|Long Term Follow-Up|Death|8|||
37947167|NCT00636168|69634702|FG001|Long Term Follow-Up|Death|9|||
37947168|NCT00759941|69634710|FG000|Overall Study|Use of medication|1|||
37947169|NCT00759941|69634711|FG001|Overall Study|Use of medication|0|||
37947170|NCT00759941|69634710|FG000|Overall Study|Adverse Event|1|||
37947171|NCT00759941|69634711|FG001|Overall Study|Adverse Event|0|||
37947172|NCT00759941|69634710|FG000|Overall Study|Exited in error by site|1|||
37947173|NCT00759941|69634711|FG001|Overall Study|Exited in error by site|1|||
37947174|NCT00528424|69634717|FG000|Overall Study|Lost to Follow-up|13|||
37947175|NCT00528424|69634717|FG000|Overall Study|Withdrew consent|2|||
37947176|NCT00528424|69634717|FG000|Overall Study|Administrative reason|2|||
37947177|NCT00528424|69634717|FG000|Overall Study|Other|12|||
37947178|NCT00315445|69634724|FG000|Overall Study|Adverse Event|7|||
37947179|NCT00315445|69634725|FG001|Overall Study|Adverse Event|12|||
37947180|NCT00315445|69634726|FG002|Overall Study|Adverse Event|15|||
37947181|NCT00315445|69634724|FG000|Overall Study|Lack of Efficacy|16|||
37947182|NCT00315445|69634725|FG001|Overall Study|Lack of Efficacy|1|||
37947183|NCT00315445|69634726|FG002|Overall Study|Lack of Efficacy|7|||
37947184|NCT00315445|69634724|FG000|Overall Study|Lost to Follow-up|1|||
37947185|NCT00315445|69634725|FG001|Overall Study|Lost to Follow-up|0|||
37947186|NCT00315445|69634726|FG002|Overall Study|Lost to Follow-up|1|||
37947187|NCT00315445|69634724|FG000|Overall Study|Protocol Violation|2|||
37947188|NCT00315445|69634725|FG001|Overall Study|Protocol Violation|0|||
37947189|NCT00315445|69634726|FG002|Overall Study|Protocol Violation|1|||
37947190|NCT00315445|69634724|FG000|Overall Study|Other|1|||
37947191|NCT00315445|69634725|FG001|Overall Study|Other|3|||
37947192|NCT00315445|69634726|FG002|Overall Study|Other|0|||
37947193|NCT03687736|69634734|FG000|Overall Study|Lost to Follow-up|7|||
37947194|NCT03687736|69634734|FG000|Overall Study|Withdrawal by Subject|3|||
37947195|NCT00779675|69634740|FG000|Treatment Period|Adverse Event|87|||
37947196|NCT00779675|69634740|FG000|Treatment Period|Treatment Failure|80|||
37947197|NCT00779675|69634740|FG000|Treatment Period|Transferred to Another Study|38|||
37947198|NCT00779675|69634740|FG000|Treatment Period|Lost to Follow-up|23|||
37947199|NCT00779675|69634740|FG000|Treatment Period|Withdrawal by Subject|46|||
37947200|NCT00779675|69634740|FG000|Treatment Period|Protocol Violation|54|||
37947201|NCT00779675|69634740|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
37947202|NCT00779675|69634740|FG000|Treatment Period|Administrative|3|||
37947203|NCT00779675|69634740|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
37947204|NCT00779675|69634740|FG000|Extended Treatment Period|Protocol Violation|13|||
37947205|NCT00779675|69634740|FG000|Extended Treatment Period|Adverse Event|6|||
37947206|NCT00779675|69634740|FG000|Extended Treatment Period|Treatment Failure|11|||
37947207|NCT00779675|69634740|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
37947208|NCT00779675|69634740|FG000|Extended Treatment Period|Lost to Follow-up|6|||
37947209|NCT00759863|69634750|FG000|Overall Study|Death, moved, or lost contact|20|||
37947210|NCT00759863|69634751|FG001|Overall Study|Death, moved, or lost contact|18|||
37947211|NCT00759785|69634759|FG000|Overall Study|Participant sample not evaluable|11|||
37947212|NCT00759785|69634760|FG001|Overall Study|Participant sample not evaluable|2|||
37947213|NCT00759785|69634759|FG000|Overall Study|Participant sample lost|0|||
37947214|NCT00759785|69634760|FG001|Overall Study|Participant sample lost|1|||
37947215|NCT00759785|69634759|FG000|Overall Study|Protocol Violation|1|||
37947216|NCT00759785|69634760|FG001|Overall Study|Protocol Violation|0|||
37947217|NCT00759785|69634759|FG000|Overall Study|Physician Decision|0|||
37947218|NCT00759785|69634760|FG001|Overall Study|Physician Decision|1|||
37947219|NCT00759785|69634759|FG000|Overall Study|Withdrawal by Subject|0|||
37947220|NCT00759785|69634760|FG001|Overall Study|Withdrawal by Subject|1|||
37947221|NCT00300781|69634768|FG000|Overall Study|Disease Progression|55|||
37947222|NCT00300781|69634769|FG001|Overall Study|Disease Progression|52|||
37947223|NCT00300781|69634768|FG000|Overall Study|Adverse Event|5|||
37947224|NCT00300781|69634769|FG001|Overall Study|Adverse Event|6|||
37947225|NCT00300781|69634768|FG000|Overall Study|Withdrawal by Subject|1|||
37947226|NCT00300781|69634769|FG001|Overall Study|Withdrawal by Subject|2|||
37947227|NCT00300781|69634768|FG000|Overall Study|Physician Decision|1|||
37947228|NCT00300781|69634769|FG001|Overall Study|Physician Decision|0|||
37947229|NCT00300781|69634768|FG000|Overall Study|Not Recorded|0|||
37947230|NCT00300781|69634769|FG001|Overall Study|Not Recorded|1|||
37947231|NCT00300781|69634768|FG000|Overall Study|Symptomatic Deterioration|1|||
37947232|NCT00300781|69634769|FG001|Overall Study|Symptomatic Deterioration|0|||
37947233|NCT00300781|69634768|FG000|Overall Study|Lost to Follow-up|0|||
37947234|NCT00300781|69634769|FG001|Overall Study|Lost to Follow-up|1|||
37947235|NCT00315055|69634777|FG000|Overall Study|Protocol Violation|2|||
37947236|NCT00315055|69634778|FG001|Overall Study|Protocol Violation|4|||
37947237|NCT00315055|69634777|FG000|Overall Study|Lost to Follow-up|1|||
37947238|NCT00315055|69634778|FG001|Overall Study|Lost to Follow-up|1|||
37947239|NCT00528970|69634790|FG000|Overall Study|Adverse Event|6|||
37947240|NCT00528970|69634791|FG001|Overall Study|Adverse Event|8|||
37947241|NCT00528970|69634792|FG002|Overall Study|Adverse Event|5|||
37947242|NCT00528970|69634790|FG000|Overall Study|Lost to Follow-up|0|||
37947243|NCT00528970|69634791|FG001|Overall Study|Lost to Follow-up|0|||
37947244|NCT00528970|69634792|FG002|Overall Study|Lost to Follow-up|1|||
37947245|NCT00528970|69634790|FG000|Overall Study|Other than specified|2|||
37947246|NCT00528970|69634791|FG001|Overall Study|Other than specified|3|||
37947247|NCT00528970|69634792|FG002|Overall Study|Other than specified|3|||
37947248|NCT00528970|69634790|FG000|Overall Study|Protocol Violation|2|||
37947249|NCT00528970|69634791|FG001|Overall Study|Protocol Violation|1|||
37947250|NCT00528970|69634792|FG002|Overall Study|Protocol Violation|4|||
37947251|NCT00528970|69634790|FG000|Overall Study|Lack of Efficacy|0|||
37947252|NCT00528970|69634791|FG001|Overall Study|Lack of Efficacy|0|||
37947253|NCT00528970|69634792|FG002|Overall Study|Lack of Efficacy|1|||
37947254|NCT00528970|69634790|FG000|Overall Study|Withdrawal by Subject|4|||
37947255|NCT00528970|69634791|FG001|Overall Study|Withdrawal by Subject|3|||
37947256|NCT00528970|69634792|FG002|Overall Study|Withdrawal by Subject|5|||
37947257|NCT00528970|69634790|FG000|Overall Study|Randomized but not treated|0|||
37947258|NCT00528970|69634791|FG001|Overall Study|Randomized but not treated|0|||
37947259|NCT00528970|69634792|FG002|Overall Study|Randomized but not treated|1|||
37947260|NCT00759395|69634802|FG000|Overall Study|Adverse Event|1|||
37947261|NCT00759395|69634803|FG001|Overall Study|Adverse Event|0|||
37947262|NCT00759395|69634802|FG000|Overall Study|Withdrawal by Subject|1|||
37947263|NCT00759395|69634803|FG001|Overall Study|Withdrawal by Subject|0|||
37947264|NCT00759395|69634802|FG000|Overall Study|Lack of Efficacy|0|||
37947265|NCT00759395|69634803|FG001|Overall Study|Lack of Efficacy|2|||
37947266|NCT00293293|69634811|FG000|Overall Study|Withdrawal by Subject|1|||
37947267|NCT00293293|69634812|FG001|Overall Study|Withdrawal by Subject|1|||
37947268|NCT00293293|69634811|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
38041968|NCT03382561|69729357|FG001|Overall Study|Adverse Event|2|||
38041969|NCT03382561|69729356|FG000|Overall Study|Death|8|||
37947269|NCT00293293|69634812|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
37947270|NCT00293293|69634811|FG000|Overall Study|Patient discontinued chemotherapy|0|||
37947271|NCT00293293|69634812|FG001|Overall Study|Patient discontinued chemotherapy|1|||
37947272|NCT04864639|69634819|FG000|Overall Study|Death|1|||
37947273|NCT04864639|69634819|FG000|Overall Study|Lost to Follow-up|1|||
37947274|NCT04245449|69634845|FG000|Overall Study|COVID shutdown|7|||
37947275|NCT03887221|69634855|FG000|Overall Study|Protocol Violation|1|||
37947276|NCT03887221|69634856|FG001|Overall Study|Protocol Violation|0|||
37947277|NCT02782741|69634876|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
37947278|NCT02782741|69634877|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
37947279|NCT02782741|69634876|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
37947280|NCT02782741|69634877|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
37947281|NCT02782741|69634876|FG000|Open-label Long-term: Week 50 to 145|Adverse Event|2|||
37947282|NCT02782741|69634877|FG001|Open-label Long-term: Week 50 to 145|Adverse Event|1|||
37947283|NCT02782741|69634876|FG000|Open-label Long-term: Week 50 to 145|Other|1|||
37947284|NCT02782741|69634877|FG001|Open-label Long-term: Week 50 to 145|Other|0|||
37947285|NCT02782741|69634876|FG000|Open-label Long-term: Week 50 to 145|Ongoing|48|||
37947286|NCT02782741|69634877|FG001|Open-label Long-term: Week 50 to 145|Ongoing|43|||
37947287|NCT02771626|69634893|FG000|Overall Study|Adverse Event|1|||
37947288|NCT02771626|69634894|FG001|Overall Study|Adverse Event|5|||
37947289|NCT02771626|69634895|FG002|Overall Study|Adverse Event|3|||
37947290|NCT02771626|69634896|FG003|Overall Study|Adverse Event|0|||
37947291|NCT02771626|69634897|FG004|Overall Study|Adverse Event|1|||
37947292|NCT02771626|69634898|FG005|Overall Study|Adverse Event|1|||
37947293|NCT02771626|69634893|FG000|Overall Study|Radiologic Disease Progression|6|||
37947294|NCT02771626|69634894|FG001|Overall Study|Radiologic Disease Progression|13|||
37947295|NCT02771626|69634895|FG002|Overall Study|Radiologic Disease Progression|10|||
37947296|NCT02771626|69634896|FG003|Overall Study|Radiologic Disease Progression|7|||
37947297|NCT02771626|69634897|FG004|Overall Study|Radiologic Disease Progression|28|||
37947298|NCT02771626|69634898|FG005|Overall Study|Radiologic Disease Progression|15|||
37947299|NCT02771626|69634893|FG000|Overall Study|Symptomatic Deterioration|0|||
37947300|NCT02771626|69634894|FG001|Overall Study|Symptomatic Deterioration|4|||
37947301|NCT02771626|69634895|FG002|Overall Study|Symptomatic Deterioration|2|||
37947302|NCT02771626|69634896|FG003|Overall Study|Symptomatic Deterioration|0|||
37947303|NCT02771626|69634897|FG004|Overall Study|Symptomatic Deterioration|5|||
37947304|NCT02771626|69634898|FG005|Overall Study|Symptomatic Deterioration|2|||
37947305|NCT02771626|69634893|FG000|Overall Study|Participant Request|0|||
37947306|NCT02771626|69634894|FG001|Overall Study|Participant Request|1|||
37947307|NCT02771626|69634895|FG002|Overall Study|Participant Request|0|||
37947308|NCT02771626|69634896|FG003|Overall Study|Participant Request|2|||
37947309|NCT02771626|69634897|FG004|Overall Study|Participant Request|0|||
37947310|NCT02771626|69634898|FG005|Overall Study|Participant Request|1|||
37947311|NCT02771626|69634893|FG000|Overall Study|Investigator Decision|0|||
37947312|NCT02771626|69634894|FG001|Overall Study|Investigator Decision|1|||
37947313|NCT02771626|69634895|FG002|Overall Study|Investigator Decision|0|||
37947314|NCT02771626|69634896|FG003|Overall Study|Investigator Decision|0|||
37947315|NCT02771626|69634897|FG004|Overall Study|Investigator Decision|1|||
37947316|NCT02771626|69634898|FG005|Overall Study|Investigator Decision|0|||
37947317|NCT02771626|69634893|FG000|Overall Study|Study Termination by Sponsor|0|||
37947318|NCT02771626|69634894|FG001|Overall Study|Study Termination by Sponsor|2|||
37947319|NCT02771626|69634895|FG002|Overall Study|Study Termination by Sponsor|1|||
37947320|NCT02771626|69634896|FG003|Overall Study|Study Termination by Sponsor|0|||
37947321|NCT02771626|69634897|FG004|Overall Study|Study Termination by Sponsor|1|||
37947322|NCT02771626|69634898|FG005|Overall Study|Study Termination by Sponsor|0|||
37947323|NCT02771626|69634893|FG000|Overall Study|Informed Consent Withdrawn|0|||
37947324|NCT02771626|69634894|FG001|Overall Study|Informed Consent Withdrawn|0|||
37947325|NCT02771626|69634895|FG002|Overall Study|Informed Consent Withdrawn|1|||
37947326|NCT02771626|69634896|FG003|Overall Study|Informed Consent Withdrawn|0|||
37947327|NCT02771626|69634897|FG004|Overall Study|Informed Consent Withdrawn|1|||
37947328|NCT02771626|69634898|FG005|Overall Study|Informed Consent Withdrawn|1|||
37947329|NCT02771626|69634893|FG000|Overall Study|Other, Not Specified|1|||
37947330|NCT02771626|69634894|FG001|Overall Study|Other, Not Specified|0|||
37947331|NCT02771626|69634895|FG002|Overall Study|Other, Not Specified|0|||
37947332|NCT02771626|69634896|FG003|Overall Study|Other, Not Specified|0|||
37947333|NCT02771626|69634897|FG004|Overall Study|Other, Not Specified|0|||
37947334|NCT02771626|69634898|FG005|Overall Study|Other, Not Specified|1|||
37947335|NCT01464164|69634919|FG000|Overall Study|Screen failure|0|||
37947336|NCT01464164|69634920|FG001|Overall Study|Screen failure|1|||
37947337|NCT01464164|69634921|FG002|Overall Study|Screen failure|2|||
37947338|NCT01464164|69634922|FG003|Overall Study|Screen failure|0|||
37947339|NCT01464164|69634923|FG004|Overall Study|Screen failure|0|||
37947340|NCT01464164|69634924|FG005|Overall Study|Screen failure|0|||
37947341|NCT01464164|69634925|FG006|Overall Study|Screen failure|0|||
38041970|NCT03382561|69729357|FG001|Overall Study|Death|3|||
37947342|NCT01464164|69634919|FG000|Overall Study|Physician Decision|0|||
37947343|NCT01464164|69634920|FG001|Overall Study|Physician Decision|1|||
37947344|NCT01464164|69634921|FG002|Overall Study|Physician Decision|0|||
37947345|NCT01464164|69634922|FG003|Overall Study|Physician Decision|0|||
37947346|NCT01464164|69634923|FG004|Overall Study|Physician Decision|0|||
37947347|NCT01464164|69634924|FG005|Overall Study|Physician Decision|0|||
37947348|NCT01464164|69634925|FG006|Overall Study|Physician Decision|2|||
37947349|NCT00568776|69634968|FG000|Overall Study|Adverse Event|8|||
37947350|NCT00568776|69634969|FG001|Overall Study|Adverse Event|8|||
37947351|NCT00568776|69634970|FG002|Overall Study|Adverse Event|10|||
37947352|NCT00568776|69634971|FG003|Overall Study|Adverse Event|8|||
37947353|NCT00568776|69634968|FG000|Overall Study|Death|0|||
37947354|NCT00568776|69634969|FG001|Overall Study|Death|1|||
37947355|NCT00568776|69634970|FG002|Overall Study|Death|4|||
37947356|NCT00568776|69634971|FG003|Overall Study|Death|3|||
37947357|NCT00568776|69634968|FG000|Overall Study|Physician Decision|0|||
37947358|NCT00568776|69634969|FG001|Overall Study|Physician Decision|2|||
37947359|NCT00568776|69634970|FG002|Overall Study|Physician Decision|0|||
37947360|NCT00568776|69634971|FG003|Overall Study|Physician Decision|0|||
37947361|NCT00568776|69634968|FG000|Overall Study|Lack of Efficacy|2|||
37947362|NCT00568776|69634969|FG001|Overall Study|Lack of Efficacy|2|||
37947363|NCT00568776|69634970|FG002|Overall Study|Lack of Efficacy|2|||
37947364|NCT00568776|69634971|FG003|Overall Study|Lack of Efficacy|4|||
37947365|NCT00568776|69634968|FG000|Overall Study|Lost to Follow-up|1|||
37947366|NCT00568776|69634969|FG001|Overall Study|Lost to Follow-up|1|||
37947367|NCT00568776|69634970|FG002|Overall Study|Lost to Follow-up|1|||
37947368|NCT00568776|69634971|FG003|Overall Study|Lost to Follow-up|1|||
37947369|NCT00568776|69634968|FG000|Overall Study|Protocol Violation|1|||
37947370|NCT00568776|69634969|FG001|Overall Study|Protocol Violation|0|||
37947371|NCT00568776|69634970|FG002|Overall Study|Protocol Violation|1|||
37947372|NCT00568776|69634971|FG003|Overall Study|Protocol Violation|1|||
37947373|NCT00568776|69634968|FG000|Overall Study|Withdrawal by Subject|13|||
37947374|NCT00568776|69634969|FG001|Overall Study|Withdrawal by Subject|15|||
37947375|NCT00568776|69634970|FG002|Overall Study|Withdrawal by Subject|13|||
37947376|NCT00568776|69634971|FG003|Overall Study|Withdrawal by Subject|7|||
37947377|NCT00568776|69634968|FG000|Overall Study|Loss of Caregiver|0|||
37947378|NCT00568776|69634969|FG001|Overall Study|Loss of Caregiver|2|||
37947379|NCT00568776|69634970|FG002|Overall Study|Loss of Caregiver|1|||
37947380|NCT00568776|69634971|FG003|Overall Study|Loss of Caregiver|2|||
37947381|NCT00568776|69634968|FG000|Overall Study|Sponsor Decision|2|||
37947382|NCT00568776|69634969|FG001|Overall Study|Sponsor Decision|2|||
37947383|NCT00568776|69634970|FG002|Overall Study|Sponsor Decision|41|||
37947384|NCT00568776|69634971|FG003|Overall Study|Sponsor Decision|42|||
37947385|NCT00568776|69634968|FG000|Overall Study|Miscellaeneous|3|||
37947386|NCT00568776|69634969|FG001|Overall Study|Miscellaeneous|3|||
37947387|NCT00568776|69634970|FG002|Overall Study|Miscellaeneous|1|||
37947388|NCT00568776|69634971|FG003|Overall Study|Miscellaeneous|4|||
37947389|NCT00758771|69634983|FG000|Overall Study|Withdrawal by Subject|1|||
37947390|NCT00758771|69634984|FG001|Overall Study|Withdrawal by Subject|1|||
37947391|NCT00758771|69634983|FG000|Overall Study|Did not meet eligibility criteria|2|||
37947392|NCT00758771|69634984|FG001|Overall Study|Did not meet eligibility criteria|4|||
37947393|NCT00635154|69634990|FG000|Overall Study|Alternative Treatment|8|||
37947394|NCT00635154|69634990|FG000|Overall Study|Other|4|||
37947395|NCT00635154|69634990|FG000|Overall Study|Still on treatment|21|||
37947396|NCT00778895|69634999|FG000|Active Phase|Adverse Event|3|||
37947397|NCT00778895|69635000|FG001|Active Phase|Adverse Event|1|||
37947398|NCT00778895|69635001|FG002|Active Phase|Adverse Event|0|||
37947399|NCT00778895|69634999|FG000|Active Phase|Withdrawal by Subject|1|||
37947400|NCT00778895|69635000|FG001|Active Phase|Withdrawal by Subject|4|||
37947401|NCT00778895|69635001|FG002|Active Phase|Withdrawal by Subject|0|||
37947402|NCT00778895|69634999|FG000|Active Phase|Lost to Follow-up|1|||
37947403|NCT00778895|69635000|FG001|Active Phase|Lost to Follow-up|1|||
37947404|NCT00778895|69635001|FG002|Active Phase|Lost to Follow-up|0|||
37947405|NCT00778895|69634999|FG000|Active Phase|Other|2|||
37947406|NCT00778895|69635000|FG001|Active Phase|Other|0|||
37947407|NCT00778895|69635001|FG002|Active Phase|Other|0|||
37947408|NCT00778895|69634999|FG000|ESFU Phase|Adverse Event|2|||
37947409|NCT00778895|69635000|FG001|ESFU Phase|Adverse Event|1|||
37947410|NCT00778895|69635001|FG002|ESFU Phase|Adverse Event|0|||
37947411|NCT00778895|69634999|FG000|ESFU Phase|Withdrawal by Subject|1|||
37947412|NCT00778895|69635000|FG001|ESFU Phase|Withdrawal by Subject|4|||
37947413|NCT00778895|69635001|FG002|ESFU Phase|Withdrawal by Subject|0|||
37947414|NCT00778895|69634999|FG000|ESFU Phase|Lost to Follow-up|6|||
37947415|NCT00778895|69635000|FG001|ESFU Phase|Lost to Follow-up|7|||
37947416|NCT00778895|69635001|FG002|ESFU Phase|Lost to Follow-up|2|||
37947417|NCT00778895|69634999|FG000|ESFU Phase|Other|2|||
37947418|NCT00778895|69635000|FG001|ESFU Phase|Other|0|||
37947419|NCT00778895|69635001|FG002|ESFU Phase|Other|0|||
37947420|NCT00293215|69635012|FG000|Overall Study|Progressive disease|3|||
37947421|NCT00293215|69635013|FG001|Overall Study|Progressive disease|1|||
37947422|NCT00293215|69635012|FG000|Overall Study|Adverse Event|2|||
37947423|NCT00293215|69635013|FG001|Overall Study|Adverse Event|2|||
37947424|NCT00778817|69635019|FG000|Overall Study|Adverse Event|2|||
37947425|NCT00778817|69635019|FG000|Overall Study|Withdrawal by Subject|2|||
37947426|NCT00293059|69635025|FG000|Overall Study|Adverse Event|12|||
37947427|NCT00293059|69635026|FG001|Overall Study|Adverse Event|4|||
37947428|NCT00293059|69635025|FG000|Overall Study|Lack of Efficacy|2|||
37947429|NCT00293059|69635026|FG001|Overall Study|Lack of Efficacy|0|||
37947430|NCT00293059|69635025|FG000|Overall Study|Lost to Follow-up|2|||
37947431|NCT00293059|69635026|FG001|Overall Study|Lost to Follow-up|3|||
37947432|NCT00293059|69635025|FG000|Overall Study|Pregnancy|1|||
37947433|NCT00293059|69635026|FG001|Overall Study|Pregnancy|1|||
37947434|NCT00293059|69635025|FG000|Overall Study|Protocol Violation|2|||
37947435|NCT00293059|69635026|FG001|Overall Study|Protocol Violation|0|||
37947436|NCT00293059|69635025|FG000|Overall Study|Withdrawal by Subject|11|||
37947437|NCT00293059|69635026|FG001|Overall Study|Withdrawal by Subject|5|||
37947438|NCT00293059|69635025|FG000|Overall Study|Participant moved out of state|1|||
37947439|NCT00293059|69635026|FG001|Overall Study|Participant moved out of state|0|||
37947440|NCT00293059|69635025|FG000|Overall Study|Participant stopped study drug|1|||
37947441|NCT00293059|69635026|FG001|Overall Study|Participant stopped study drug|0|||
37947442|NCT00293059|69635025|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
37947443|NCT00293059|69635026|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
37947444|NCT00293059|69635025|FG000|Overall Study|missing|3|||
37947445|NCT00293059|69635026|FG001|Overall Study|missing|5|||
37947446|NCT00756275|69635034|FG000|Overall Study|Lost to Follow-up|25|||
37947447|NCT00756275|69635035|FG001|Overall Study|Lost to Follow-up|21|||
37947448|NCT00756275|69635034|FG000|Overall Study|Withdrawal by Subject|4|||
37947449|NCT00756275|69635035|FG001|Overall Study|Withdrawal by Subject|7|||
37947450|NCT00758459|69635043|FG000|Overall Study|Adverse Event|3|||
37947451|NCT00758459|69635044|FG001|Overall Study|Adverse Event|2|||
37947452|NCT00758459|69635043|FG000|Overall Study|Protocol Violation|0|||
37947453|NCT00758459|69635044|FG001|Overall Study|Protocol Violation|1|||
37947454|NCT00758459|69635043|FG000|Overall Study|Withdrawal by Subject|0|||
37947455|NCT00758459|69635044|FG001|Overall Study|Withdrawal by Subject|1|||
37947456|NCT00298831|69635050|FG000|Overall Study|Adverse Event|1|||
37947457|NCT00298831|69635050|FG000|Overall Study|Lost to Follow-up|3|||
37947458|NCT00298831|69635050|FG000|Overall Study|Withdrawal by Subject|1|||
37947459|NCT00298831|69635050|FG000|Overall Study|Participants did not receive treatment|27|||
37947460|NCT00758069|69635057|FG000|Overall Study|Lack of Efficacy|0|||
37947461|NCT00758069|69635058|FG001|Overall Study|Lack of Efficacy|0|||
37947462|NCT00758069|69635059|FG002|Overall Study|Lack of Efficacy|1|||
37947463|NCT00758069|69635057|FG000|Overall Study|Incorrect Study Drug|1|||
37947464|NCT00758069|69635058|FG001|Overall Study|Incorrect Study Drug|0|||
37947465|NCT00758069|69635059|FG002|Overall Study|Incorrect Study Drug|0|||
37947466|NCT00311623|69635070|FG000|Overall Study|Physician Decision|0|||
37947467|NCT00311623|69635071|FG001|Overall Study|Physician Decision|0|||
37947468|NCT00311623|69635072|FG002|Overall Study|Physician Decision|2|||
37947469|NCT00528112|69635083|FG000|Treatment up to 3 Years|Adverse Event|313|||
37947470|NCT00528112|69635084|FG001|Treatment up to 3 Years|Adverse Event|278|||
37947471|NCT00528112|69635083|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
37947472|NCT00528112|69635084|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
37947473|NCT00528112|69635083|FG000|Treatment up to 3 Years|Protocol Violation|16|||
37947474|NCT00528112|69635084|FG001|Treatment up to 3 Years|Protocol Violation|16|||
37947475|NCT00528112|69635083|FG000|Treatment up to 3 Years|Death|0|||
37947476|NCT00528112|69635084|FG001|Treatment up to 3 Years|Death|1|||
37947477|NCT00528112|69635083|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
37947478|NCT00528112|69635084|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
37947479|NCT00528112|69635083|FG000|Treatment up to 3 Years|Pregnancy|9|||
37947480|NCT00528112|69635084|FG001|Treatment up to 3 Years|Pregnancy|10|||
37947481|NCT00528112|69635083|FG000|Treatment up to 3 Years|Other reasons|186|||
37947482|NCT00528112|69635084|FG001|Treatment up to 3 Years|Other reasons|186|||
37947483|NCT00528112|69635083|FG000|Extension Phase|Withdrawal by Subject|0|||
37947484|NCT00528112|69635084|FG001|Extension Phase|Withdrawal by Subject|3|||
37947485|NCT00528112|69635083|FG000|Extension Phase|Other reasons|0|||
38041971|NCT03382561|69729356|FG000|Overall Study|Withdrawal by Subject|6|||
37947486|NCT00528112|69635084|FG001|Extension Phase|Other reasons|100|||
37947487|NCT00528112|69635083|FG000|Extension Phase|Pregnancy|0|||
37947488|NCT00528112|69635084|FG001|Extension Phase|Pregnancy|3|||
37947489|NCT00528112|69635083|FG000|Extension Phase|Lost to Follow-up|0|||
37947490|NCT00528112|69635084|FG001|Extension Phase|Lost to Follow-up|12|||
37947491|NCT00528112|69635083|FG000|Extension Phase|Death|0|||
37947492|NCT00528112|69635084|FG001|Extension Phase|Death|1|||
37947493|NCT00528112|69635083|FG000|Extension Phase|Adverse Event|0|||
38041972|NCT03382561|69729357|FG001|Overall Study|Withdrawal by Subject|5|||
38041973|NCT03382561|69729356|FG000|Overall Study|Alternative therapy|2|||
38041974|NCT03382561|69729357|FG001|Overall Study|Alternative therapy|8|||
38041975|NCT03382561|69729356|FG000|Overall Study|Never started treatment|3|||
37947494|NCT00528112|69635084|FG001|Extension Phase|Adverse Event|36|||
37947495|NCT00528112|69635083|FG000|Extension Phase|Protocol Violation|0|||
38041976|NCT03382561|69729357|FG001|Overall Study|Never started treatment|6|||
37947496|NCT00528112|69635084|FG001|Extension Phase|Protocol Violation|2|||
37947497|NCT00633594|69635095|FG000|Overall Study|Adverse Event|0|||
37947498|NCT00633594|69635096|FG001|Overall Study|Adverse Event|4|||
37947499|NCT00633594|69635097|FG002|Overall Study|Adverse Event|7|||
37947500|NCT00633594|69635095|FG000|Overall Study|Death|0|||
37947501|NCT00633594|69635096|FG001|Overall Study|Death|1|||
37947502|NCT00633594|69635097|FG002|Overall Study|Death|2|||
37947503|NCT00633594|69635095|FG000|Overall Study|Disease Progression|0|||
37947504|NCT00633594|69635096|FG001|Overall Study|Disease Progression|0|||
37947505|NCT00633594|69635097|FG002|Overall Study|Disease Progression|1|||
37947506|NCT00755807|69635110|FG000|Acute Phase|Adverse Event|16|||
37947507|NCT00755807|69635111|FG001|Acute Phase|Adverse Event|5|||
37947508|NCT00755807|69635110|FG000|Acute Phase|Protocol Violation|1|||
37947509|NCT00755807|69635111|FG001|Acute Phase|Protocol Violation|3|||
37947510|NCT00755807|69635110|FG000|Acute Phase|Withdrawal by Subject|1|||
37947511|NCT00755807|69635111|FG001|Acute Phase|Withdrawal by Subject|2|||
37947512|NCT00755807|69635110|FG000|Acute Phase|Lack of Efficacy|0|||
37947513|NCT00755807|69635111|FG001|Acute Phase|Lack of Efficacy|1|||
37947514|NCT00755807|69635110|FG000|Acute Phase|Physician Decision|0|||
37947515|NCT00755807|69635111|FG001|Acute Phase|Physician Decision|1|||
37947516|NCT00755807|69635110|FG000|Open-label Extension Phase|Adverse Event|7|||
37947517|NCT00755807|69635111|FG001|Open-label Extension Phase|Adverse Event|7|||
37947518|NCT00755807|69635110|FG000|Open-label Extension Phase|Protocol Violation|5|||
37947519|NCT00755807|69635111|FG001|Open-label Extension Phase|Protocol Violation|2|||
37947520|NCT00755807|69635110|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
37947521|NCT00755807|69635111|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
37947522|NCT00755807|69635110|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
37947523|NCT00755807|69635111|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
37947524|NCT00755807|69635110|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
37947525|NCT00755807|69635111|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
37947526|NCT00755807|69635110|FG000|Open-label Extension Phase|Sponsor Decision|0|||
37947527|NCT00755807|69635111|FG001|Open-label Extension Phase|Sponsor Decision|1|||
37947528|NCT00631410|69635123|FG000|Overall Study|Adverse Event|1|||
37947529|NCT00631410|69635124|FG001|Overall Study|Adverse Event|3|||
37947530|NCT00631410|69635123|FG000|Overall Study|Objective Progression or Relapse|4|||
37947531|NCT00631410|69635124|FG001|Overall Study|Objective Progression or Relapse|3|||
37947532|NCT00631410|69635123|FG000|Overall Study|Surgery|1|||
37947533|NCT00631410|69635124|FG001|Overall Study|Surgery|0|||
37947534|NCT03686176|69635136|FG000|Overall Study|Procedure cancelled|1|||
37947535|NCT03686176|69635137|FG001|Overall Study|Procedure cancelled|0|||
37947536|NCT03686176|69635138|FG002|Overall Study|Procedure cancelled|0|||
37947537|NCT03686176|69635136|FG000|Overall Study|VR Malfunction|1|||
37947538|NCT03686176|69635137|FG001|Overall Study|VR Malfunction|0|||
37947539|NCT03686176|69635138|FG002|Overall Study|VR Malfunction|0|||
37947540|NCT00755417|69635149|FG000|Overall Study|Adverse Event|28|||
37947541|NCT00755417|69635150|FG001|Overall Study|Adverse Event|20|||
37947542|NCT00755417|69635151|FG002|Overall Study|Adverse Event|7|||
37947543|NCT00755417|69635149|FG000|Overall Study|Lack of Efficacy|8|||
37947544|NCT00755417|69635150|FG001|Overall Study|Lack of Efficacy|4|||
37947545|NCT00755417|69635151|FG002|Overall Study|Lack of Efficacy|9|||
37947546|NCT00755417|69635149|FG000|Overall Study|Protocol Violation|2|||
37947547|NCT00755417|69635150|FG001|Overall Study|Protocol Violation|1|||
37947548|NCT00755417|69635151|FG002|Overall Study|Protocol Violation|1|||
37947549|NCT00755417|69635149|FG000|Overall Study|Lost to Follow-up|3|||
37947550|NCT00755417|69635150|FG001|Overall Study|Lost to Follow-up|0|||
37947551|NCT00755417|69635151|FG002|Overall Study|Lost to Follow-up|1|||
37947552|NCT00755417|69635149|FG000|Overall Study|Withdrawal by Subject|12|||
37947553|NCT00755417|69635150|FG001|Overall Study|Withdrawal by Subject|12|||
37947554|NCT00755417|69635151|FG002|Overall Study|Withdrawal by Subject|12|||
37947555|NCT00755417|69635149|FG000|Overall Study|Not specified or missing data|9|||
37947556|NCT00755417|69635150|FG001|Overall Study|Not specified or missing data|18|||
37947557|NCT00755417|69635151|FG002|Overall Study|Not specified or missing data|12|||
37947558|NCT03685708|69635162|FG000|Overall Study|Withdrawal by Subject|0|||
37947559|NCT03685708|69635163|FG001|Overall Study|Withdrawal by Subject|0|||
37947560|NCT03685708|69635164|FG002|Overall Study|Withdrawal by Subject|1|||
37947561|NCT03685708|69635162|FG000|Overall Study|Screen Fail|0|||
37947562|NCT03685708|69635163|FG001|Overall Study|Screen Fail|1|||
37947563|NCT03685708|69635164|FG002|Overall Study|Screen Fail|1|||
37947564|NCT03685708|69635162|FG000|Overall Study|COVID 19 Pandemic|1|||
37947565|NCT03685708|69635163|FG001|Overall Study|COVID 19 Pandemic|1|||
37947566|NCT03685708|69635164|FG002|Overall Study|COVID 19 Pandemic|6|||
37947567|NCT03685708|69635162|FG000|Overall Study|Disease Progression|0|||
37947568|NCT03685708|69635163|FG001|Overall Study|Disease Progression|0|||
37947569|NCT03685708|69635164|FG002|Overall Study|Disease Progression|1|||
37947570|NCT03684928|69635172|FG000|First Intervention|Lost to Follow-up|0|||
37947571|NCT03684928|69635173|FG001|First Intervention|Lost to Follow-up|1|||
37947572|NCT03684928|69635172|FG000|First Intervention|Withdrawal by Subject|0|||
37947573|NCT03684928|69635173|FG001|First Intervention|Withdrawal by Subject|2|||
38041977|NCT03382561|69729356|FG000|Overall Study|Lack of Efficacy|0|||
37947574|NCT03684928|69635172|FG000|Second Intervention|Soft Tissue Injury|1|||
37947575|NCT03684928|69635173|FG001|Second Intervention|Soft Tissue Injury|0|||
37947576|NCT00777803|69635181|FG000|Overall Study|Lost to Follow-up|12|||
37947577|NCT00777803|69635182|FG001|Overall Study|Lost to Follow-up|5|||
37947578|NCT00777803|69635181|FG000|Overall Study|Adverse Event|1|||
37947579|NCT00777803|69635182|FG001|Overall Study|Adverse Event|0|||
37947580|NCT00777803|69635181|FG000|Overall Study|Non-compliance|2|||
37947581|NCT00777803|69635182|FG001|Overall Study|Non-compliance|2|||
37947582|NCT00527488|69635192|FG000|Overall Study|Withdrawn prior to dosing|0|||
37947583|NCT00527488|69635193|FG001|Overall Study|Withdrawn prior to dosing|1|||
37947584|NCT00527488|69635194|FG002|Overall Study|Withdrawn prior to dosing|1|||
37947585|NCT00527488|69635195|FG003|Overall Study|Withdrawn prior to dosing|0|||
37947586|NCT00527332|69635207|FG000|Overall Study|Protocol Violation|4|||
37947587|NCT00527332|69635208|FG001|Overall Study|Protocol Violation|8|||
37947588|NCT00527332|69635207|FG000|Overall Study|Withdrew consent|5|||
37947589|NCT00527332|69635208|FG001|Overall Study|Withdrew consent|1|||
37947590|NCT00752609|69635216|FG000|Overall Study|Adverse Event|2|||
37947591|NCT00752609|69635217|FG001|Overall Study|Adverse Event|2|||
37947592|NCT00752609|69635216|FG000|Overall Study|Withdrawal by Subject|3|||
37947593|NCT00752609|69635217|FG001|Overall Study|Withdrawal by Subject|0|||
37947594|NCT00752609|69635216|FG000|Overall Study|Physician Decision|1|||
37947595|NCT00752609|69635217|FG001|Overall Study|Physician Decision|0|||
37947596|NCT00752609|69635216|FG000|Overall Study|Death|1|||
37947597|NCT00752609|69635217|FG001|Overall Study|Death|0|||
37947598|NCT00752609|69635216|FG000|Overall Study|Met exclusion criteria|1|||
37947599|NCT00752609|69635217|FG001|Overall Study|Met exclusion criteria|0|||
37947600|NCT00752609|69635216|FG000|Overall Study|Received Aranesp in error|1|||
37947601|NCT00752609|69635217|FG001|Overall Study|Received Aranesp in error|0|||
37947602|NCT03684304|69635228|FG000|Overall Study|Lost to Follow-up|19|||
37947603|NCT03684304|69635229|FG001|Overall Study|Lost to Follow-up|17|||
37947604|NCT00629772|69635237|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
37947605|NCT00629772|69635238|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
37947606|NCT00629772|69635237|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
37947607|NCT00629772|69635238|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
37947608|NCT00526630|69635245|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
37947609|NCT00526630|69635246|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
37947610|NCT00526630|69635245|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
37947611|NCT00526630|69635246|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
37947612|NCT00755183|69635256|FG000|Overall Study|Adverse Event|5|||
37947613|NCT00755183|69635257|FG001|Overall Study|Adverse Event|2|||
37947614|NCT00755183|69635256|FG000|Overall Study|Protocol Violation|0|||
37947615|NCT00755183|69635257|FG001|Overall Study|Protocol Violation|1|||
37947616|NCT00755183|69635256|FG000|Overall Study|Withdrawal by Subject|0|||
37947617|NCT00755183|69635257|FG001|Overall Study|Withdrawal by Subject|2|||
37947618|NCT00755183|69635256|FG000|Overall Study|Administrative|2|||
37947619|NCT00755183|69635257|FG001|Overall Study|Administrative|1|||
37947620|NCT00755105|69635268|FG000|Overall Study|Withdrawal by Subject|9|||
37947621|NCT00755105|69635269|FG001|Overall Study|Withdrawal by Subject|11|||
37947622|NCT00755105|69635270|FG002|Overall Study|Withdrawal by Subject|4|||
37947623|NCT00526162|69635278|FG000|Overall Study|Device not implanted|3|||
37947624|NCT03875482|69635288|FG000|Overall Study|Adverse Event|0|||
37947625|NCT03875482|69635289|FG001|Overall Study|Adverse Event|1|||
37947626|NCT03875482|69635288|FG000|Overall Study|Withdrew consent|5|||
37947627|NCT03875482|69635289|FG001|Overall Study|Withdrew consent|6|||
37947628|NCT03875482|69635288|FG000|Overall Study|Lost to Follow-up|8|||
37947629|NCT03875482|69635289|FG001|Overall Study|Lost to Follow-up|2|||
37947630|NCT03875482|69635288|FG000|Overall Study|Lack of Efficacy|0|||
37947631|NCT03875482|69635289|FG001|Overall Study|Lack of Efficacy|11|||
37947632|NCT00754793|69635297|FG000|Overall Study|voluntary withdrawn from study|0|||
37947633|NCT00754793|69635298|FG001|Overall Study|voluntary withdrawn from study|1|||
37947634|NCT00586469|69635306|FG000|Overall Study|Adverse Event|0|||
37947635|NCT00586469|69635307|FG001|Overall Study|Adverse Event|1|||
37947636|NCT00626028|69635315|FG000|Overall Study|Adverse Event|1|||
37947637|NCT00626028|69635316|FG001|Overall Study|Adverse Event|1|||
37947638|NCT00626028|69635315|FG000|Overall Study|Device Failure|0|||
37947639|NCT00626028|69635316|FG001|Overall Study|Device Failure|1|||
37947640|NCT00626028|69635315|FG000|Overall Study|Physician Decision|2|||
37947641|NCT00626028|69635316|FG001|Overall Study|Physician Decision|1|||
37947642|NCT00626028|69635315|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
37947643|NCT00626028|69635316|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
37947644|NCT00777257|69635325|FG000|Overall Study|Adverse Event|3|||
37947645|NCT00777257|69635326|FG001|Overall Study|Adverse Event|1|||
37947646|NCT00777257|69635327|FG002|Overall Study|Adverse Event|0|||
37947647|NCT00777257|69635325|FG000|Overall Study|Lost to Follow-up|3|||
37947648|NCT00777257|69635326|FG001|Overall Study|Lost to Follow-up|3|||
37947649|NCT00777257|69635327|FG002|Overall Study|Lost to Follow-up|2|||
37947650|NCT00777257|69635325|FG000|Overall Study|Protocol Violation|2|||
37947651|NCT00777257|69635326|FG001|Overall Study|Protocol Violation|2|||
37947652|NCT00777257|69635327|FG002|Overall Study|Protocol Violation|2|||
37947653|NCT00777257|69635325|FG000|Overall Study|Withdrawal by Subject|3|||
37947654|NCT00777257|69635326|FG001|Overall Study|Withdrawal by Subject|6|||
37947655|NCT00777257|69635327|FG002|Overall Study|Withdrawal by Subject|5|||
37947656|NCT00628758|69635337|FG000|Overall Study|Adverse Event|2|||
37947657|NCT00628758|69635338|FG001|Overall Study|Adverse Event|3|||
37947658|NCT00628758|69635337|FG000|Overall Study|Withdrawal by Subject|6|||
37947659|NCT00628758|69635338|FG001|Overall Study|Withdrawal by Subject|3|||
37947660|NCT00628758|69635337|FG000|Overall Study|Death|1|||
37947661|NCT00628758|69635338|FG001|Overall Study|Death|0|||
37947662|NCT00628758|69635337|FG000|Overall Study|Protocol Violation|5|||
37947663|NCT00628758|69635338|FG001|Overall Study|Protocol Violation|1|||
37947664|NCT00628758|69635337|FG000|Overall Study|Lost to Follow-up|25|||
37947665|NCT00628758|69635338|FG001|Overall Study|Lost to Follow-up|31|||
37947666|NCT00628758|69635337|FG000|Overall Study|Pregnancy|2|||
37947667|NCT00628758|69635338|FG001|Overall Study|Pregnancy|2|||
37947668|NCT00628758|69635337|FG000|Overall Study|Investigator Moved|3|||
37947669|NCT00628758|69635338|FG001|Overall Study|Investigator Moved|0|||
37947670|NCT00628758|69635337|FG000|Overall Study|Treatment Failure|0|||
37947671|NCT00628758|69635338|FG001|Overall Study|Treatment Failure|2|||
37947672|NCT04491604|69635346|FG000|Overall Study|Withdrawal by Subject|3|||
37947673|NCT00628446|69635351|FG000|Overall Study|Lost to Follow-up|3|||
37947674|NCT00628446|69635351|FG000|Overall Study|Withdrawal by Subject|1|||
37947675|NCT00628446|69635351|FG000|Overall Study|Protocol Violation|3|||
37947676|NCT00754559|69635356|FG000|Overall Study|Adverse Event|15|||
37947677|NCT00754559|69635356|FG000|Overall Study|Protocol Violation|11|||
37947678|NCT00754559|69635356|FG000|Overall Study|Lack of Efficacy|10|||
37947679|NCT00754559|69635356|FG000|Overall Study|Lost to Follow-up|2|||
37947680|NCT00754559|69635356|FG000|Overall Study|Administrative reason|1|||
37947681|NCT00754559|69635356|FG000|Overall Study|Other|5|||
37947682|NCT00754559|69635356|FG000|Overall Study|Withdrawal by Subject|3|||
37947683|NCT00525148|69635367|FG000|Overall Study|Other Adverse Event|3|||
37947684|NCT00525148|69635368|FG001|Overall Study|Other Adverse Event|5|||
37947685|NCT00525148|69635369|FG002|Overall Study|Other Adverse Event|1|||
37947686|NCT00525148|69635370|FG003|Overall Study|Other Adverse Event|8|||
37947687|NCT00525148|69635367|FG000|Overall Study|Progressive disease|18|||
37947688|NCT00525148|69635368|FG001|Overall Study|Progressive disease|30|||
37947689|NCT00525148|69635369|FG002|Overall Study|Progressive disease|6|||
37947690|NCT00525148|69635370|FG003|Overall Study|Progressive disease|49|||
37947691|NCT00525148|69635367|FG000|Overall Study|Refused continuation of study medication|0|||
37947692|NCT00525148|69635368|FG001|Overall Study|Refused continuation of study medication|2|||
37947693|NCT00525148|69635369|FG002|Overall Study|Refused continuation of study medication|0|||
37947694|NCT00525148|69635370|FG003|Overall Study|Refused continuation of study medication|1|||
37947695|NCT00525148|69635367|FG000|Overall Study|Other than stated|2|||
37947696|NCT00525148|69635368|FG001|Overall Study|Other than stated|1|||
37947697|NCT00525148|69635369|FG002|Overall Study|Other than stated|0|||
37947698|NCT00525148|69635370|FG003|Overall Study|Other than stated|3|||
37947699|NCT00754325|69635382|FG000|Initial Treatment|Continuing Active Treatment|4|||
37947700|NCT00754325|69635383|FG001|Initial Treatment|Continuing Active Treatment|5|||
37947701|NCT00754325|69635382|FG000|Initial Treatment|Adverse Event|7|||
37947702|NCT00754325|69635383|FG001|Initial Treatment|Adverse Event|6|||
37947703|NCT00754325|69635382|FG000|Initial Treatment|Withdrawal by Subject|2|||
37947704|NCT00754325|69635383|FG001|Initial Treatment|Withdrawal by Subject|2|||
37947705|NCT00754325|69635382|FG000|Initial Treatment|Physician Decision|2|||
37947706|NCT00754325|69635383|FG001|Initial Treatment|Physician Decision|0|||
37947707|NCT00754325|69635382|FG000|Initial Treatment|Sponsor Request|0|||
37947708|NCT00754325|69635383|FG001|Initial Treatment|Sponsor Request|1|||
37947709|NCT00754325|69635382|FG000|Initial Treatment|Disease Progression|35|||
37947710|NCT00754325|69635383|FG001|Initial Treatment|Disease Progression|35|||
37947711|NCT00524680|69635394|FG000|Overall Study|progression|0|||
37947712|NCT00524680|69635395|FG001|Overall Study|progression|0|||
37947713|NCT00524680|69635396|FG002|Overall Study|progression|0|||
37947714|NCT00524680|69635397|FG003|Overall Study|progression|1|||
37947715|NCT00524680|69635394|FG000|Overall Study|Adverse Event|2|||
37947716|NCT00524680|69635395|FG001|Overall Study|Adverse Event|0|||
37947717|NCT00524680|69635396|FG002|Overall Study|Adverse Event|0|||
37947718|NCT00524680|69635397|FG003|Overall Study|Adverse Event|1|||
37947719|NCT00524680|69635394|FG000|Overall Study|Other|0|||
37947720|NCT00524680|69635395|FG001|Overall Study|Other|1|||
37947721|NCT00524680|69635396|FG002|Overall Study|Other|2|||
37947722|NCT00524680|69635397|FG003|Overall Study|Other|3|||
37947723|NCT00524680|69635394|FG000|Overall Study|Withdrawal by Subject|1|||
37947724|NCT00524680|69635395|FG001|Overall Study|Withdrawal by Subject|0|||
37947725|NCT00524680|69635396|FG002|Overall Study|Withdrawal by Subject|1|||
37947726|NCT00524680|69635397|FG003|Overall Study|Withdrawal by Subject|1|||
37947727|NCT00628212|69635411|FG000|Overall Study|Adverse Event|2|||
37947728|NCT00628212|69635412|FG001|Overall Study|Adverse Event|0|||
37947729|NCT00628212|69635413|FG002|Overall Study|Adverse Event|1|||
37947730|NCT00628212|69635414|FG003|Overall Study|Adverse Event|2|||
38041978|NCT03382561|69729357|FG001|Overall Study|Lack of Efficacy|1|||
38041979|NCT03382561|69729356|FG000|Overall Study|Physician Decision|0|||
38041980|NCT03382561|69729357|FG001|Overall Study|Physician Decision|1|||
38041981|NCT03382561|69729356|FG000|Overall Study|Other complicating disease|0|||
38041982|NCT03382561|69729357|FG001|Overall Study|Other complicating disease|1|||
38041983|NCT03370276|69729366|FG000|Overall Study|Death|0|||
38041984|NCT03370276|69729367|FG001|Overall Study|Death|2|||
38041985|NCT03370276|69729368|FG002|Overall Study|Death|5|||
38041986|NCT03312231|69729407|FG000|Overall Study|Lost to Follow-up|2|||
38041987|NCT03312231|69729408|FG001|Overall Study|Lost to Follow-up|6|||
38041988|NCT03312231|69729409|FG002|Overall Study|Lost to Follow-up|1|||
38041989|NCT03312231|69729410|FG003|Overall Study|Lost to Follow-up|3|||
38041990|NCT03312231|69729411|FG004|Overall Study|Lost to Follow-up|1|||
38041991|NCT03312231|69729407|FG000|Overall Study|Withdrawal by Subject|0|||
38041992|NCT03312231|69729408|FG001|Overall Study|Withdrawal by Subject|3|||
38041993|NCT03312231|69729409|FG002|Overall Study|Withdrawal by Subject|1|||
38041994|NCT03312231|69729410|FG003|Overall Study|Withdrawal by Subject|0|||
38041995|NCT03312231|69729411|FG004|Overall Study|Withdrawal by Subject|0|||
38041996|NCT03312231|69729407|FG000|Overall Study|Death|0|||
38041997|NCT03312231|69729408|FG001|Overall Study|Death|1|||
38041998|NCT03312231|69729409|FG002|Overall Study|Death|1|||
38041999|NCT03312231|69729410|FG003|Overall Study|Death|0|||
38042000|NCT03312231|69729411|FG004|Overall Study|Death|0|||
38042001|NCT03312231|69729407|FG000|Overall Study|Study Vaccination not Received|1|||
38042002|NCT03312231|69729408|FG001|Overall Study|Study Vaccination not Received|1|||
38042003|NCT03312231|69729409|FG002|Overall Study|Study Vaccination not Received|1|||
38042004|NCT03312231|69729410|FG003|Overall Study|Study Vaccination not Received|0|||
38042005|NCT03312231|69729411|FG004|Overall Study|Study Vaccination not Received|0|||
38042006|NCT03294590|69729425|FG000|Overall Study|Lost to Follow-up|105|||
38042007|NCT03294590|69729426|FG001|Overall Study|Lost to Follow-up|107|||
38042008|NCT03292731|69729437|FG000|Overall Study|Protocol Violation|4|||
38042009|NCT03292731|69729438|FG001|Overall Study|Protocol Violation|11|||
38042010|NCT03292731|69729439|FG002|Overall Study|Protocol Violation|1|||
38042011|NCT03277313|69729464|FG000|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|1|||
38042012|NCT03277313|69729465|FG001|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|0|||
38042013|NCT03277313|69729464|FG000|Epoch 2 (36 Months After Epoch 1)|Adverse Event|0|||
38042014|NCT03277313|69729465|FG001|Epoch 2 (36 Months After Epoch 1)|Adverse Event|1|||
38042015|NCT03277313|69729464|FG000|Epoch 2 (36 Months After Epoch 1)|Physician Decision|0|||
38042016|NCT03277313|69729465|FG001|Epoch 2 (36 Months After Epoch 1)|Physician Decision|1|||
38042017|NCT03277313|69729464|FG000|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|0|||
38042018|NCT03277313|69729465|FG001|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|6|||
38042019|NCT03277313|69729464|FG000|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|0|||
38042020|NCT03277313|69729465|FG001|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|1|||
38042021|NCT03220035|69729473|FG000|Overall Study|Adverse Event|1|||
38042022|NCT03220035|69729473|FG000|Overall Study|Protocol Violation|1|||
38042023|NCT03220035|69729473|FG000|Overall Study|Progressive Disease|2|||
38042024|NCT03206073|69729481|FG000|Overall Study|Participant Noncompliance|0|||
38042025|NCT03206073|69729482|FG001|Overall Study|Participant Noncompliance|1|||
38042026|NCT03206073|69729483|FG002|Overall Study|Participant Noncompliance|0|||
38042027|NCT03206073|69729484|FG003|Overall Study|Participant Noncompliance|0|||
38042028|NCT03206073|69729481|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
38042029|NCT03206073|69729482|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
38042030|NCT03206073|69729483|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
38042031|NCT03206073|69729484|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
38042032|NCT03206073|69729481|FG000|Overall Study|Death|0|||
38042033|NCT03206073|69729482|FG001|Overall Study|Death|0|||
38042034|NCT03206073|69729483|FG002|Overall Study|Death|1|||
38042035|NCT03206073|69729484|FG003|Overall Study|Death|0|||
38042036|NCT03206073|69729481|FG000|Overall Study|Taken off active treatment|0|||
38042037|NCT03206073|69729482|FG001|Overall Study|Taken off active treatment|0|||
38042038|NCT03206073|69729483|FG002|Overall Study|Taken off active treatment|3|||
38042039|NCT03206073|69729484|FG003|Overall Study|Taken off active treatment|0|||
38042040|NCT03193801|69729494|FG000|Overall Study|Physician Decision|2|||
38042041|NCT03193801|69729494|FG000|Overall Study|Withdrawal by Subject|1|||
38042042|NCT03043872|69729501|FG000|Overall Study|Withdrawal by Subject|6|||
38042043|NCT03043872|69729502|FG001|Overall Study|Withdrawal by Subject|6|||
38042044|NCT03043872|69729503|FG002|Overall Study|Withdrawal by Subject|15|||
38042045|NCT03043872|69729501|FG000|Overall Study|Lost to Follow-up|2|||
38042046|NCT03043872|69729502|FG001|Overall Study|Lost to Follow-up|1|||
38042047|NCT03043872|69729503|FG002|Overall Study|Lost to Follow-up|1|||
38042048|NCT03043872|69729501|FG000|Overall Study|Death|270|||
38042049|NCT03043872|69729502|FG001|Overall Study|Death|269|||
38042050|NCT03043872|69729503|FG002|Overall Study|Death|296|||
38042051|NCT02973997|69729523|FG000|Overall Study|Withdrawal by Subject|4|||
38042052|NCT02973997|69729524|FG001|Overall Study|Withdrawal by Subject|0|||
38042053|NCT02973997|69729523|FG000|Overall Study|Adverse Event|4|||
38042054|NCT02973997|69729524|FG001|Overall Study|Adverse Event|1|||
38042055|NCT02973997|69729523|FG000|Overall Study|Disease Progression|11|||
38042056|NCT02973997|69729524|FG001|Overall Study|Disease Progression|20|||
38042057|NCT02973997|69729523|FG000|Overall Study|Alternative Therapy|3|||
38042058|NCT02973997|69729524|FG001|Overall Study|Alternative Therapy|0|||
38042059|NCT02973997|69729523|FG000|Overall Study|Other complicating disease|0|||
38042060|NCT02973997|69729524|FG001|Overall Study|Other complicating disease|1|||
38042061|NCT02973997|69729523|FG000|Overall Study|Death|0|||
38042062|NCT02973997|69729524|FG001|Overall Study|Death|1|||
38042063|NCT02941926|69729532|FG000|Core Phase|Progressive disease|1109|||
38042064|NCT02941926|69729532|FG000|Core Phase|Adverse Event|504|||
38042065|NCT02941926|69729532|FG000|Core Phase|Subject/guardian decision|127|||
38042066|NCT02941926|69729532|FG000|Core Phase|Physician Decision|112|||
38042067|NCT02941926|69729532|FG000|Core Phase|Death|46|||
38042068|NCT02941926|69729532|FG000|Core Phase|Protocol deviation|34|||
38042069|NCT02941926|69729532|FG000|Core Phase|Lost to Follow-up|8|||
38042070|NCT02941926|69729532|FG000|Core Phase|Technical problems|5|||
38042071|NCT02941926|69729532|FG000|Extension Phase|Physician Decision|155|||
38042072|NCT02941926|69729532|FG000|Extension Phase|Progressive disease|115|||
38042073|NCT02941926|69729532|FG000|Extension Phase|Adverse Event|13|||
38042074|NCT02941926|69729532|FG000|Extension Phase|Subject/Guardian decision|12|||
38042075|NCT02941926|69729532|FG000|Extension Phase|Death|6|||
38042076|NCT02846415|69729547|FG000|Overall Study|Lost to Follow-up|2|||
38042077|NCT02846415|69729548|FG001|Overall Study|Lost to Follow-up|0|||
38042078|NCT02846415|69729547|FG000|Overall Study|Withdrawal by Subject|1|||
38042079|NCT02846415|69729548|FG001|Overall Study|Withdrawal by Subject|1|||
38042080|NCT02671435|69729577|FG000|Overall Study|Death|1|||
38042081|NCT02671435|69729578|FG001|Overall Study|Death|3|||
38042082|NCT02671435|69729579|FG002|Overall Study|Death|0|||
38042083|NCT02671435|69729580|FG003|Overall Study|Death|16|||
38042084|NCT02671435|69729581|FG004|Overall Study|Death|14|||
38042085|NCT02671435|69729582|FG005|Overall Study|Death|29|||
38042086|NCT02671435|69729583|FG006|Overall Study|Death|34|||
38042087|NCT02671435|69729584|FG007|Overall Study|Death|28|||
38042088|NCT02671435|69729585|FG008|Overall Study|Death|19|||
38042089|NCT02671435|69729586|FG009|Overall Study|Death|10|||
38042090|NCT02671435|69729587|FG010|Overall Study|Death|8|||
38042091|NCT02671435|69729588|FG011|Overall Study|Death|29|||
38042092|NCT02671435|69729589|FG012|Overall Study|Death|29|||
38042093|NCT02671435|69729590|FG013|Overall Study|Death|29|||
38042094|NCT02671435|69729591|FG014|Overall Study|Death|27|||
38042095|NCT02671435|69729577|FG000|Overall Study|Lost to Follow-up|0|||
38042096|NCT02671435|69729578|FG001|Overall Study|Lost to Follow-up|0|||
38042097|NCT02671435|69729579|FG002|Overall Study|Lost to Follow-up|1|||
38042098|NCT02671435|69729580|FG003|Overall Study|Lost to Follow-up|0|||
38042099|NCT02671435|69729581|FG004|Overall Study|Lost to Follow-up|1|||
38042100|NCT02671435|69729582|FG005|Overall Study|Lost to Follow-up|1|||
38042101|NCT02671435|69729583|FG006|Overall Study|Lost to Follow-up|2|||
38042102|NCT02671435|69729584|FG007|Overall Study|Lost to Follow-up|2|||
38042103|NCT02671435|69729585|FG008|Overall Study|Lost to Follow-up|0|||
38042104|NCT02671435|69729586|FG009|Overall Study|Lost to Follow-up|2|||
38042105|NCT02671435|69729587|FG010|Overall Study|Lost to Follow-up|0|||
38042106|NCT02671435|69729588|FG011|Overall Study|Lost to Follow-up|3|||
38042107|NCT02671435|69729589|FG012|Overall Study|Lost to Follow-up|3|||
38042108|NCT02671435|69729590|FG013|Overall Study|Lost to Follow-up|2|||
38042109|NCT02671435|69729591|FG014|Overall Study|Lost to Follow-up|0|||
38042110|NCT02671435|69729577|FG000|Overall Study|Withdrawal by Subject|2|||
38042111|NCT02671435|69729578|FG001|Overall Study|Withdrawal by Subject|0|||
38042112|NCT02671435|69729579|FG002|Overall Study|Withdrawal by Subject|2|||
38042113|NCT02671435|69729580|FG003|Overall Study|Withdrawal by Subject|2|||
38042114|NCT02671435|69729581|FG004|Overall Study|Withdrawal by Subject|2|||
38042115|NCT02671435|69729582|FG005|Overall Study|Withdrawal by Subject|7|||
38042116|NCT02671435|69729583|FG006|Overall Study|Withdrawal by Subject|2|||
38042117|NCT02671435|69729584|FG007|Overall Study|Withdrawal by Subject|7|||
38042118|NCT02671435|69729585|FG008|Overall Study|Withdrawal by Subject|1|||
38042119|NCT02671435|69729586|FG009|Overall Study|Withdrawal by Subject|1|||
38042120|NCT02671435|69729587|FG010|Overall Study|Withdrawal by Subject|2|||
38042121|NCT02671435|69729588|FG011|Overall Study|Withdrawal by Subject|4|||
38042122|NCT02671435|69729589|FG012|Overall Study|Withdrawal by Subject|4|||
38042123|NCT02671435|69729590|FG013|Overall Study|Withdrawal by Subject|4|||
38042124|NCT02671435|69729591|FG014|Overall Study|Withdrawal by Subject|2|||
38042125|NCT02671435|69729577|FG000|Overall Study|Un-specified|0|||
38042126|NCT02671435|69729578|FG001|Overall Study|Un-specified|0|||
38042127|NCT02671435|69729579|FG002|Overall Study|Un-specified|0|||
38042128|NCT02671435|69729580|FG003|Overall Study|Un-specified|0|||
38042129|NCT02671435|69729581|FG004|Overall Study|Un-specified|1|||
38042130|NCT02671435|69729582|FG005|Overall Study|Un-specified|3|||
38042131|NCT02671435|69729583|FG006|Overall Study|Un-specified|2|||
38042132|NCT02671435|69729584|FG007|Overall Study|Un-specified|3|||
38042133|NCT02671435|69729585|FG008|Overall Study|Un-specified|0|||
38042134|NCT02671435|69729586|FG009|Overall Study|Un-specified|5|||
38042135|NCT02671435|69729587|FG010|Overall Study|Un-specified|8|||
38042136|NCT02671435|69729588|FG011|Overall Study|Un-specified|4|||
38042137|NCT02671435|69729589|FG012|Overall Study|Un-specified|5|||
38042138|NCT02671435|69729590|FG013|Overall Study|Un-specified|9|||
38042139|NCT02671435|69729591|FG014|Overall Study|Un-specified|8|||
38042140|NCT02519348|69729653|FG000|Overall Study|Death|31|||
38042141|NCT02519348|69729654|FG001|Overall Study|Death|74|||
38042142|NCT02519348|69729655|FG002|Overall Study|Death|47|||
38042143|NCT02519348|69729656|FG003|Overall Study|Death|54|||
38042144|NCT02519348|69729657|FG004|Overall Study|Death|63|||
38042145|NCT02519348|69729658|FG005|Overall Study|Death|18|||
38042146|NCT02519348|69729659|FG006|Overall Study|Death|2|||
38042147|NCT02519348|69729660|FG007|Overall Study|Death|5|||
38042148|NCT02519348|69729661|FG008|Overall Study|Death|5|||
38042149|NCT02519348|69729653|FG000|Overall Study|Withdrawal by Subject|4|||
38042150|NCT02519348|69729654|FG001|Overall Study|Withdrawal by Subject|7|||
38042151|NCT02519348|69729655|FG002|Overall Study|Withdrawal by Subject|4|||
38042152|NCT02519348|69729656|FG003|Overall Study|Withdrawal by Subject|3|||
38042153|NCT02519348|69729657|FG004|Overall Study|Withdrawal by Subject|3|||
38042154|NCT02519348|69729658|FG005|Overall Study|Withdrawal by Subject|2|||
38042155|NCT02519348|69729659|FG006|Overall Study|Withdrawal by Subject|0|||
38042156|NCT02519348|69729660|FG007|Overall Study|Withdrawal by Subject|0|||
38042157|NCT02519348|69729661|FG008|Overall Study|Withdrawal by Subject|1|||
38042158|NCT02519348|69729653|FG000|Overall Study|Lost to Follow-up|0|||
38042159|NCT02519348|69729654|FG001|Overall Study|Lost to Follow-up|0|||
38042160|NCT02519348|69729655|FG002|Overall Study|Lost to Follow-up|1|||
38042161|NCT02519348|69729656|FG003|Overall Study|Lost to Follow-up|0|||
38042162|NCT02519348|69729657|FG004|Overall Study|Lost to Follow-up|2|||
38042163|NCT02519348|69729658|FG005|Overall Study|Lost to Follow-up|1|||
38042164|NCT02519348|69729659|FG006|Overall Study|Lost to Follow-up|1|||
38042165|NCT02519348|69729660|FG007|Overall Study|Lost to Follow-up|0|||
38042166|NCT02519348|69729661|FG008|Overall Study|Lost to Follow-up|0|||
38042167|NCT02519348|69729653|FG000|Overall Study|Other|0|||
38042168|NCT02519348|69729654|FG001|Overall Study|Other|3|||
38042169|NCT02519348|69729655|FG002|Overall Study|Other|0|||
38042170|NCT02519348|69729656|FG003|Overall Study|Other|0|||
38042171|NCT02519348|69729657|FG004|Overall Study|Other|1|||
38042172|NCT02519348|69729658|FG005|Overall Study|Other|0|||
38042173|NCT02519348|69729659|FG006|Overall Study|Other|0|||
38042174|NCT02519348|69729660|FG007|Overall Study|Other|0|||
38042175|NCT02519348|69729661|FG008|Overall Study|Other|0|||
38042176|NCT02519348|69729653|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
38042177|NCT02519348|69729654|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
38042178|NCT02519348|69729655|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
38042179|NCT02519348|69729656|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
38042180|NCT02519348|69729657|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
38042181|NCT02519348|69729658|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
38042182|NCT02519348|69729659|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
38042183|NCT02519348|69729660|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
38042184|NCT02519348|69729661|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
38042185|NCT02485639|69729682|FG000|Overall Study|8 participants did not complete study. Study halted due to CoronaVIrus Disease COVID-19 pandemic.|8|||
38042186|NCT02485639|69729682|FG000|Overall Study|Early termination|4|||
38042187|NCT02485639|69729682|FG000|Overall Study|Withdrawal by Subject|4|||
38042188|NCT02418949|69729690|FG000|Overall Study|Withdrawal by Subject|1|||
38042189|NCT02418949|69729691|FG001|Overall Study|Withdrawal by Subject|0|||
38042190|NCT02418949|69729692|FG002|Overall Study|Withdrawal by Subject|1|||
38042191|NCT02418949|69729693|FG003|Overall Study|Withdrawal by Subject|1|||
38042192|NCT02418949|69729690|FG000|Overall Study|Lost to Follow-up|1|||
38042193|NCT02418949|69729691|FG001|Overall Study|Lost to Follow-up|0|||
38042194|NCT02418949|69729692|FG002|Overall Study|Lost to Follow-up|1|||
38042195|NCT02418949|69729693|FG003|Overall Study|Lost to Follow-up|0|||
38042196|NCT02418949|69729690|FG000|Overall Study|Physician Decision|1|||
38042197|NCT02418949|69729691|FG001|Overall Study|Physician Decision|1|||
38042198|NCT02418949|69729692|FG002|Overall Study|Physician Decision|1|||
38042199|NCT02418949|69729693|FG003|Overall Study|Physician Decision|0|||
38042200|NCT02388906|69729705|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
38042201|NCT02388906|69729706|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
38042202|NCT02388906|69729705|FG000|Treatment Period|Disease progression|121|||
38042203|NCT02388906|69729706|FG001|Treatment Period|Disease progression|101|||
38042204|NCT02388906|69729705|FG000|Treatment Period|Study drug toxicity|41|||
38042205|NCT02388906|69729706|FG001|Treatment Period|Study drug toxicity|208|||
38042206|NCT02388906|69729705|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
38042207|NCT02388906|69729706|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
38042208|NCT02388906|69729705|FG000|Treatment Period|Participant request to stop treatment|5|||
38042209|NCT02388906|69729706|FG001|Treatment Period|Participant request to stop treatment|9|||
38042210|NCT02388906|69729705|FG000|Treatment Period|Participant withdrew consent|2|||
38042211|NCT02388906|69729706|FG001|Treatment Period|Participant withdrew consent|3|||
38042212|NCT02388906|69729705|FG000|Treatment Period|Poor/non-compliance|0|||
38042213|NCT02388906|69729706|FG001|Treatment Period|Poor/non-compliance|1|||
38042214|NCT02388906|69729705|FG000|Treatment Period|Participant no longer meets study criteria|0|||
38042215|NCT02388906|69729706|FG001|Treatment Period|Participant no longer meets study criteria|1|||
38042216|NCT02388906|69729705|FG000|Treatment Period|Other reasons|3|||
38042217|NCT02388906|69729706|FG001|Treatment Period|Other reasons|3|||
38042218|NCT02383433|69729712|FG000|Overall Study|Disease progression|2|||
38042219|NCT02336074|69729727|FG000|Overall Study|Adverse Event|0|||
38042220|NCT02336074|69729728|FG001|Overall Study|Adverse Event|2|||
38042221|NCT02286089|69729757|FG000|Overall Study|Ongoing in Study|1|||
38042222|NCT02286089|69729758|FG001|Overall Study|Ongoing in Study|1|||
38042223|NCT02286089|69729759|FG002|Overall Study|Ongoing in Study|4|||
38042224|NCT02286089|69729760|FG003|Overall Study|Ongoing in Study|10|||
38042225|NCT02286089|69729757|FG000|Overall Study|Withdrawal by Subject|0|||
38042226|NCT02286089|69729758|FG001|Overall Study|Withdrawal by Subject|0|||
38042227|NCT02286089|69729759|FG002|Overall Study|Withdrawal by Subject|2|||
38042228|NCT02286089|69729760|FG003|Overall Study|Withdrawal by Subject|2|||
38042229|NCT02255435|69729780|FG000|Overall Study|Patient's Limited Time Availability|0|||
38042230|NCT02255435|69729781|FG001|Overall Study|Patient's Limited Time Availability|0|||
38042231|NCT02255435|69729782|FG002|Overall Study|Patient's Limited Time Availability|0|||
38042232|NCT02255435|69729783|FG003|Overall Study|Patient's Limited Time Availability|0|||
38042233|NCT02255435|69729784|FG004|Overall Study|Patient's Limited Time Availability|0|||
38042234|NCT02255435|69729785|FG005|Overall Study|Patient's Limited Time Availability|0|||
38042235|NCT02255435|69729786|FG006|Overall Study|Patient's Limited Time Availability|0|||
38042236|NCT02255435|69729787|FG007|Overall Study|Patient's Limited Time Availability|1|||
38042237|NCT02255435|69729788|FG008|Overall Study|Patient's Limited Time Availability|0|||
38042238|NCT02255435|69729789|FG009|Overall Study|Patient's Limited Time Availability|0|||
38042239|NCT02255435|69729780|FG000|Overall Study|Withdrawal by Subject|0|||
38042240|NCT02255435|69729781|FG001|Overall Study|Withdrawal by Subject|0|||
38042241|NCT02255435|69729782|FG002|Overall Study|Withdrawal by Subject|0|||
38042242|NCT02255435|69729783|FG003|Overall Study|Withdrawal by Subject|0|||
38042243|NCT02255435|69729784|FG004|Overall Study|Withdrawal by Subject|0|||
38042244|NCT02255435|69729785|FG005|Overall Study|Withdrawal by Subject|0|||
38042245|NCT02255435|69729786|FG006|Overall Study|Withdrawal by Subject|0|||
38042246|NCT02255435|69729787|FG007|Overall Study|Withdrawal by Subject|0|||
38042247|NCT02255435|69729788|FG008|Overall Study|Withdrawal by Subject|1|||
38042248|NCT02255435|69729789|FG009|Overall Study|Withdrawal by Subject|4|||
38042249|NCT02255435|69729780|FG000|Overall Study|Administrative reasons|0|||
38042250|NCT02255435|69729781|FG001|Overall Study|Administrative reasons|0|||
38042251|NCT02255435|69729782|FG002|Overall Study|Administrative reasons|0|||
38042252|NCT02255435|69729783|FG003|Overall Study|Administrative reasons|0|||
38042253|NCT02255435|69729784|FG004|Overall Study|Administrative reasons|0|||
38042254|NCT02255435|69729785|FG005|Overall Study|Administrative reasons|0|||
38042255|NCT02255435|69729786|FG006|Overall Study|Administrative reasons|0|||
38042256|NCT02255435|69729787|FG007|Overall Study|Administrative reasons|0|||
38042257|NCT02255435|69729788|FG008|Overall Study|Administrative reasons|0|||
38042258|NCT02255435|69729789|FG009|Overall Study|Administrative reasons|2|||
38042259|NCT02229825|69729813|FG000|Overall Study|Personal Reasons|0|||
38042260|NCT02229825|69729814|FG001|Overall Study|Personal Reasons|1|||
38042261|NCT02229825|69729813|FG000|Overall Study|Refused continuing medication|7|||
38042262|NCT02229825|69729814|FG001|Overall Study|Refused continuing medication|6|||
38042263|NCT02229825|69729813|FG000|Overall Study|Lost to Follow-up|1|||
38042264|NCT02229825|69729814|FG001|Overall Study|Lost to Follow-up|2|||
38042265|NCT02229825|69729813|FG000|Overall Study|Protocol Violation|1|||
38042266|NCT02229825|69729814|FG001|Overall Study|Protocol Violation|1|||
38042267|NCT02229825|69729813|FG000|Overall Study|Lack of Efficacy|4|||
38042268|NCT02229825|69729814|FG001|Overall Study|Lack of Efficacy|10|||
38042269|NCT02229825|69729813|FG000|Overall Study|Adverse Event|11|||
38042270|NCT02229825|69729814|FG001|Overall Study|Adverse Event|9|||
38042271|NCT02229825|69729813|FG000|Overall Study|Not treated|0|||
38042272|NCT02229825|69729814|FG001|Overall Study|Not treated|1|||
38042273|NCT02112916|69729835|FG000|Overall Study|Adverse Event|6|||
38042274|NCT02112916|69729836|FG001|Overall Study|Adverse Event|9|||
38042275|NCT02112916|69729837|FG002|Overall Study|Adverse Event|3|||
38042276|NCT02112916|69729838|FG003|Overall Study|Adverse Event|2|||
38042277|NCT02112916|69729835|FG000|Overall Study|Death|9|||
38042278|NCT02112916|69729836|FG001|Overall Study|Death|9|||
38042279|NCT02112916|69729837|FG002|Overall Study|Death|3|||
38042280|NCT02112916|69729838|FG003|Overall Study|Death|4|||
38042281|NCT02112916|69729835|FG000|Overall Study|Lost to Follow-up|1|||
38042282|NCT02112916|69729836|FG001|Overall Study|Lost to Follow-up|0|||
38042283|NCT02112916|69729837|FG002|Overall Study|Lost to Follow-up|0|||
38042284|NCT02112916|69729838|FG003|Overall Study|Lost to Follow-up|0|||
38042285|NCT02112916|69729835|FG000|Overall Study|Physician Decision|94|||
38042286|NCT02112916|69729836|FG001|Overall Study|Physician Decision|72|||
38042287|NCT02112916|69729837|FG002|Overall Study|Physician Decision|24|||
38042288|NCT02112916|69729838|FG003|Overall Study|Physician Decision|15|||
38042289|NCT02112916|69729835|FG000|Overall Study|Withdrawal by Subject|5|||
38042290|NCT02112916|69729836|FG001|Overall Study|Withdrawal by Subject|3|||
38042291|NCT02112916|69729837|FG002|Overall Study|Withdrawal by Subject|1|||
38042292|NCT02112916|69729838|FG003|Overall Study|Withdrawal by Subject|1|||
38042293|NCT02112916|69729835|FG000|Overall Study|Ineligible|4|||
38042294|NCT02112916|69729836|FG001|Overall Study|Ineligible|8|||
38042295|NCT02112916|69729837|FG002|Overall Study|Ineligible|3|||
38042296|NCT02112916|69729838|FG003|Overall Study|Ineligible|8|||
37768502|NCT00246753|69284526|FG000|Overall Study|Withdrawal by Subject|2|||
37768503|NCT00246753|69284526|FG000|Overall Study|Physician Decision|2|||
37768504|NCT00246753|69284526|FG000|Overall Study|Adverse Event|2|||
37768505|NCT00246753|69284526|FG000|Overall Study|Unacceptable toxicity|2|||
37768506|NCT00246129|69284543|FG000|Overall Study|Lost to Follow-up|1|||
37768507|NCT00246129|69284544|FG001|Overall Study|Lost to Follow-up|0|||
37768508|NCT00246129|69284543|FG000|Overall Study|Death|2|||
37768509|NCT00246129|69284544|FG001|Overall Study|Death|1|||
37768510|NCT00246129|69284543|FG000|Overall Study|suffered primary non-function|1|||
37768511|NCT00246129|69284544|FG001|Overall Study|suffered primary non-function|0|||
37768512|NCT00246129|69284543|FG000|Overall Study|grafts failed|3|||
37768513|NCT00246129|69284544|FG001|Overall Study|grafts failed|1|||
37768514|NCT03182868|69284567|FG000|Overall Study|Protocol Violation|3|||
37768515|NCT03182868|69284568|FG001|Overall Study|Protocol Violation|0|||
37768516|NCT03182868|69284569|FG002|Overall Study|Protocol Violation|4|||
37768517|NCT03182868|69284570|FG003|Overall Study|Protocol Violation|1|||
37768518|NCT03182868|69284571|FG004|Overall Study|Protocol Violation|8|||
37768519|NCT00245583|69284595|FG000|Overall Study|Lost to Follow-up|1|||
37768520|NCT00245583|69284596|FG001|Overall Study|Lost to Follow-up|5|||
37768521|NCT00245583|69284595|FG000|Overall Study|Adverse Event|2|||
37768522|NCT00245583|69284596|FG001|Overall Study|Adverse Event|1|||
37768523|NCT00245583|69284595|FG000|Overall Study|Lack of Efficacy|1|||
37768524|NCT00245583|69284596|FG001|Overall Study|Lack of Efficacy|0|||
37768525|NCT00245583|69284595|FG000|Overall Study|Withdrawal by Subject|2|||
37768526|NCT00245583|69284596|FG001|Overall Study|Withdrawal by Subject|3|||
37768527|NCT02652156|69284605|FG000|Overall Study|Physician Decision|1|||
37768528|NCT02652156|69284606|FG001|Overall Study|Physician Decision|0|||
37768529|NCT02652156|69284607|FG002|Overall Study|Physician Decision|0|||
37768530|NCT01675050|69284654|FG000|Period One Treatment|Withdrawal by Subject|1|||
37768531|NCT01675050|69284655|FG001|Period One Treatment|Withdrawal by Subject|0|||
37768532|NCT00244881|69284674|FG000|Overall Study|Withdrawal by Subject|3|||
37768533|NCT00244725|69284705|FG000|Overall Study|Lost to Follow-up|3|||
37768534|NCT00244725|69284706|FG001|Overall Study|Lost to Follow-up|4|||
37768535|NCT00244725|69284707|FG002|Overall Study|Lost to Follow-up|9|||
37768536|NCT00244725|69284708|FG003|Overall Study|Lost to Follow-up|2|||
37768537|NCT00244725|69284705|FG000|Overall Study|Withdrawal by Subject|9|||
37768538|NCT00244725|69284706|FG001|Overall Study|Withdrawal by Subject|7|||
37768539|NCT00244725|69284707|FG002|Overall Study|Withdrawal by Subject|7|||
37768540|NCT00244725|69284708|FG003|Overall Study|Withdrawal by Subject|8|||
37768541|NCT00244725|69284705|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
37768542|NCT00244725|69284706|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
37768543|NCT00244725|69284707|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
37768544|NCT00244725|69284708|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
37768545|NCT00244725|69284705|FG000|Overall Study|Physician Decision|3|||
37768546|NCT00244725|69284706|FG001|Overall Study|Physician Decision|0|||
37768547|NCT00244725|69284707|FG002|Overall Study|Physician Decision|1|||
37768548|NCT00244725|69284708|FG003|Overall Study|Physician Decision|2|||
37768549|NCT00244725|69284705|FG000|Overall Study|Adverse Events|3|||
37768550|NCT00244725|69284706|FG001|Overall Study|Adverse Events|1|||
37768551|NCT00244725|69284707|FG002|Overall Study|Adverse Events|4|||
37768552|NCT00244725|69284708|FG003|Overall Study|Adverse Events|4|||
37768553|NCT00244725|69284705|FG000|Overall Study|Withdrwal by participant|1|||
37768554|NCT00244725|69284706|FG001|Overall Study|Withdrwal by participant|0|||
37768555|NCT00244725|69284707|FG002|Overall Study|Withdrwal by participant|0|||
37768556|NCT00244725|69284708|FG003|Overall Study|Withdrwal by participant|1|||
37768557|NCT00244725|69284705|FG000|Overall Study|Liver function test abnormality|2|||
37768558|NCT00244725|69284706|FG001|Overall Study|Liver function test abnormality|0|||
37768559|NCT00244725|69284707|FG002|Overall Study|Liver function test abnormality|0|||
37768560|NCT00244725|69284708|FG003|Overall Study|Liver function test abnormality|1|||
37768561|NCT00244725|69284705|FG000|Overall Study|Sponsor withdrew the participant|1|||
37768562|NCT00244725|69284706|FG001|Overall Study|Sponsor withdrew the participant|0|||
37768563|NCT00244725|69284707|FG002|Overall Study|Sponsor withdrew the participant|0|||
37768564|NCT00244725|69284708|FG003|Overall Study|Sponsor withdrew the participant|1|||
38042297|NCT02112916|69729835|FG000|Overall Study|Inevaluable|6|||
38042298|NCT02112916|69729836|FG001|Overall Study|Inevaluable|4|||
38042299|NCT02112916|69729837|FG002|Overall Study|Inevaluable|5|||
37768565|NCT00244725|69284705|FG000|Overall Study|Mediciation Error|0|||
37768566|NCT00244725|69284706|FG001|Overall Study|Mediciation Error|1|||
38042300|NCT02112916|69729838|FG003|Overall Study|Inevaluable|5|||
37768567|NCT00244725|69284707|FG002|Overall Study|Mediciation Error|0|||
37768568|NCT00244725|69284708|FG003|Overall Study|Mediciation Error|0|||
37768569|NCT00244725|69284705|FG000|Overall Study|Rehab Refused to allow participantion|0|||
37768570|NCT00244725|69284706|FG001|Overall Study|Rehab Refused to allow participantion|1|||
37768571|NCT00244725|69284707|FG002|Overall Study|Rehab Refused to allow participantion|0|||
37768572|NCT00244725|69284708|FG003|Overall Study|Rehab Refused to allow participantion|0|||
37768573|NCT00244725|69284705|FG000|Overall Study|Headache|0|||
37768574|NCT00244725|69284706|FG001|Overall Study|Headache|1|||
37768575|NCT00244725|69284707|FG002|Overall Study|Headache|0|||
37768576|NCT00244725|69284708|FG003|Overall Study|Headache|0|||
37768577|NCT00244725|69284705|FG000|Overall Study|Received prohibited medication|0|||
37768578|NCT00244725|69284706|FG001|Overall Study|Received prohibited medication|1|||
37768579|NCT00244725|69284707|FG002|Overall Study|Received prohibited medication|0|||
37768580|NCT00244725|69284708|FG003|Overall Study|Received prohibited medication|1|||
37768581|NCT00244725|69284705|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
37768582|NCT00244725|69284706|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
37768583|NCT00244725|69284707|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
37768584|NCT00244725|69284708|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
37768585|NCT00244725|69284705|FG000|Overall Study|Administrative reason|0|||
37768586|NCT00244725|69284706|FG001|Overall Study|Administrative reason|0|||
37768587|NCT00244725|69284707|FG002|Overall Study|Administrative reason|1|||
37768588|NCT00244725|69284708|FG003|Overall Study|Administrative reason|0|||
37768589|NCT00244725|69284705|FG000|Overall Study|Vomit|0|||
37768590|NCT00244725|69284706|FG001|Overall Study|Vomit|0|||
37768591|NCT00244725|69284707|FG002|Overall Study|Vomit|1|||
37768592|NCT00244725|69284708|FG003|Overall Study|Vomit|0|||
37768593|NCT00244725|69284705|FG000|Overall Study|Failed to follow-up|0|||
37860456|NCT01149057|69543830|FG000|Overall Study|High Parathyroid Hormone Value|1|||
37860457|NCT01149057|69543830|FG000|Overall Study|Other|6|||
37860458|NCT01227564|69543837|FG000|Overall Study|No Longer Willing to Participate|4|||
37860459|NCT01227564|69543838|FG001|Overall Study|No Longer Willing to Participate|2|||
37860460|NCT01227564|69543839|FG002|Overall Study|No Longer Willing to Participate|5|||
37860461|NCT01227564|69543837|FG000|Overall Study|Participant moved to another town|0|||
37947731|NCT00628212|69635411|FG000|Overall Study|Physician Decision|1|||
37947732|NCT00628212|69635412|FG001|Overall Study|Physician Decision|1|||
37947733|NCT00628212|69635413|FG002|Overall Study|Physician Decision|2|||
37947734|NCT00628212|69635414|FG003|Overall Study|Physician Decision|3|||
37947735|NCT00298363|69635427|FG000|Overall Study|Lost to Follow-up|0|||
37947736|NCT00298363|69635428|FG001|Overall Study|Lost to Follow-up|0|||
37947737|NCT00298363|69635429|FG002|Overall Study|Lost to Follow-up|1|||
37947738|NCT00298363|69635427|FG000|Overall Study|Physician Decision|4|||
37947739|NCT00298363|69635428|FG001|Overall Study|Physician Decision|1|||
37947740|NCT00298363|69635429|FG002|Overall Study|Physician Decision|0|||
37947741|NCT00298363|69635427|FG000|Overall Study|Protocol Violation|1|||
37947742|NCT00298363|69635428|FG001|Overall Study|Protocol Violation|1|||
37947743|NCT00298363|69635429|FG002|Overall Study|Protocol Violation|0|||
37947744|NCT00298363|69635427|FG000|Overall Study|Withdrawal by Subject|5|||
37947745|NCT00298363|69635428|FG001|Overall Study|Withdrawal by Subject|1|||
37768594|NCT00244725|69284706|FG001|Overall Study|Failed to follow-up|0|||
37768595|NCT00244725|69284707|FG002|Overall Study|Failed to follow-up|1|||
37768596|NCT00244725|69284708|FG003|Overall Study|Failed to follow-up|1|||
37768597|NCT02649894|69284720|FG000|Overall Study|Adverse Event|1|||
37768598|NCT02649894|69284721|FG001|Overall Study|Adverse Event|0|||
37860462|NCT01227564|69543838|FG001|Overall Study|Participant moved to another town|0|||
37860463|NCT01227564|69543839|FG002|Overall Study|Participant moved to another town|1|||
37860464|NCT01148979|69543855|FG000|Overall Study|Lost to Follow-up|0|||
37860465|NCT01148979|69543856|FG001|Overall Study|Lost to Follow-up|1|||
37860466|NCT01148511|69543864|FG000|Exposed to Study Drug|Protocol Violation|2|||
37860467|NCT01148511|69543865|FG001|Exposed to Study Drug|Protocol Violation|0|||
37860468|NCT01148511|69543866|FG002|Exposed to Study Drug|Protocol Violation|0|||
37860469|NCT01148511|69543864|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
37860470|NCT01148511|69543865|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
37860471|NCT01148511|69543866|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
37860472|NCT01148511|69543864|FG000|Randomized|Adverse Event|0|||
37860473|NCT01148511|69543865|FG001|Randomized|Adverse Event|1|||
37860474|NCT01148511|69543866|FG002|Randomized|Adverse Event|0|||
37860475|NCT01148511|69543864|FG000|Randomized|Protocol Violation|0|||
37860476|NCT01148511|69543865|FG001|Randomized|Protocol Violation|2|||
37860477|NCT01148511|69543866|FG002|Randomized|Protocol Violation|1|||
37860478|NCT01148511|69543864|FG000|Randomized|Lost to Follow-up|0|||
37860479|NCT01148511|69543865|FG001|Randomized|Lost to Follow-up|1|||
37860480|NCT01148511|69543866|FG002|Randomized|Lost to Follow-up|1|||
37860481|NCT01148511|69543864|FG000|Randomized|Consent withdrawal|0|||
37860482|NCT01148511|69543865|FG001|Randomized|Consent withdrawal|5|||
37860483|NCT01148511|69543866|FG002|Randomized|Consent withdrawal|3|||
37860484|NCT01148511|69543864|FG000|Randomized|Other|0|||
37860485|NCT01148511|69543865|FG001|Randomized|Other|1|||
37947746|NCT00298363|69635429|FG002|Overall Study|Withdrawal by Subject|3|||
37947747|NCT00298363|69635427|FG000|Overall Study|Adverse Event|5|||
37947748|NCT00298363|69635428|FG001|Overall Study|Adverse Event|2|||
37947749|NCT00298363|69635429|FG002|Overall Study|Adverse Event|2|||
37947750|NCT00298363|69635427|FG000|Overall Study|Lack of Efficacy|2|||
37947751|NCT00298363|69635428|FG001|Overall Study|Lack of Efficacy|3|||
37947752|NCT00298363|69635429|FG002|Overall Study|Lack of Efficacy|0|||
37947753|NCT00524368|69635445|FG000|Overall Study|Adverse Event|10|||
37947754|NCT00524368|69635446|FG001|Overall Study|Adverse Event|12|||
37947755|NCT00524368|69635445|FG000|Overall Study|Lost to Follow-up|9|||
37947756|NCT00524368|69635446|FG001|Overall Study|Lost to Follow-up|13|||
37947757|NCT00524368|69635445|FG000|Overall Study|Withdrawal by Subject|4|||
37947758|NCT00524368|69635446|FG001|Overall Study|Withdrawal by Subject|5|||
37947759|NCT00524368|69635445|FG000|Overall Study|Non-compliant|8|||
37947760|NCT00524368|69635446|FG001|Overall Study|Non-compliant|9|||
37947761|NCT00524368|69635445|FG000|Overall Study|Reached a Virologic Endpoint|3|||
37947762|NCT00524368|69635446|FG001|Overall Study|Reached a Virologic Endpoint|2|||
37947763|NCT00524368|69635445|FG000|Overall Study|Sponsor's Decision|2|||
37947764|NCT00524368|69635446|FG001|Overall Study|Sponsor's Decision|0|||
37947765|NCT00524368|69635445|FG000|Overall Study|Ineligible to Continue the study|2|||
37947766|NCT00524368|69635446|FG001|Overall Study|Ineligible to Continue the study|5|||
37947767|NCT00524368|69635445|FG000|Overall Study|Other|3|||
37947768|NCT00524368|69635446|FG001|Overall Study|Other|2|||
37947769|NCT00777101|69635454|FG000|Overall Study|Death|48|||
37947770|NCT00777101|69635455|FG001|Overall Study|Death|43|||
37947771|NCT00777101|69635454|FG000|Overall Study|Withdrawal by Subject|11|||
37947772|NCT00777101|69635455|FG001|Overall Study|Withdrawal by Subject|6|||
37947773|NCT00777101|69635454|FG000|Overall Study|Lost to Follow-up|2|||
37947774|NCT00777101|69635455|FG001|Overall Study|Lost to Follow-up|1|||
37947775|NCT00777101|69635454|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
37947776|NCT00777101|69635455|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
37947777|NCT00777101|69635454|FG000|Overall Study|Failed to Return|0|||
37947778|NCT00777101|69635455|FG001|Overall Study|Failed to Return|1|||
37947779|NCT00297427|69635464|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
37947780|NCT00297427|69635465|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
37947781|NCT00297427|69635464|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
37947782|NCT00297427|69635465|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
37947783|NCT00297427|69635464|FG000|Phase 1: Initial Intervention|Death|0|||
37947784|NCT00297427|69635465|FG001|Phase 1: Initial Intervention|Death|1|||
37947785|NCT00297427|69635464|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
37947786|NCT00297427|69635465|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
37947787|NCT00297427|69635464|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
37947788|NCT00297427|69635465|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
37947789|NCT00297427|69635464|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
37947790|NCT00297427|69635465|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
37947791|NCT00297427|69635464|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
37947792|NCT00297427|69635465|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
37947793|NCT00297427|69635464|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
37947794|NCT00297427|69635465|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
37947795|NCT00524134|69635479|FG000|Overall Study|Withdrawal by Subject|1|||
37947796|NCT00524134|69635479|FG000|Overall Study|Physician Decision|1|||
37947797|NCT00777023|69635486|FG000|Overall Study|Adverse Event|15|||
37947798|NCT00777023|69635487|FG001|Overall Study|Adverse Event|21|||
37947799|NCT00777023|69635488|FG002|Overall Study|Adverse Event|8|||
37947800|NCT00777023|69635486|FG000|Overall Study|Lack of Efficacy|1|||
37947801|NCT00777023|69635487|FG001|Overall Study|Lack of Efficacy|0|||
37947802|NCT00777023|69635488|FG002|Overall Study|Lack of Efficacy|14|||
37947803|NCT00777023|69635486|FG000|Overall Study|Protocol Violation|2|||
37947804|NCT00777023|69635487|FG001|Overall Study|Protocol Violation|1|||
37947805|NCT00777023|69635488|FG002|Overall Study|Protocol Violation|1|||
37947806|NCT00777023|69635486|FG000|Overall Study|Lost to Follow-up|2|||
37947807|NCT00777023|69635487|FG001|Overall Study|Lost to Follow-up|3|||
37947808|NCT00777023|69635488|FG002|Overall Study|Lost to Follow-up|3|||
37947809|NCT00777023|69635486|FG000|Overall Study|Death|0|||
37947810|NCT00777023|69635487|FG001|Overall Study|Death|1|||
37947811|NCT00777023|69635488|FG002|Overall Study|Death|0|||
37947812|NCT00777023|69635486|FG000|Overall Study|Withdrawal by Subject|7|||
37947813|NCT00777023|69635487|FG001|Overall Study|Withdrawal by Subject|7|||
37947814|NCT00777023|69635488|FG002|Overall Study|Withdrawal by Subject|8|||
37768599|NCT02649894|69284720|FG000|Overall Study|Physician Decision|0|||
37947815|NCT00777023|69635486|FG000|Overall Study|Missing data|1|||
37947816|NCT00777023|69635487|FG001|Overall Study|Missing data|1|||
37947817|NCT00777023|69635488|FG002|Overall Study|Missing data|0|||
37947818|NCT00777023|69635486|FG000|Overall Study|Reasons not specified|4|||
37947819|NCT00777023|69635487|FG001|Overall Study|Reasons not specified|4|||
37947820|NCT00777023|69635488|FG002|Overall Study|Reasons not specified|2|||
37947821|NCT00777023|69635486|FG000|Overall Study|Last dose date unknown|3|||
37947822|NCT00777023|69635487|FG001|Overall Study|Last dose date unknown|3|||
37947823|NCT00777023|69635488|FG002|Overall Study|Last dose date unknown|1|||
37947824|NCT00297037|69635498|FG000|Overall Study|Withdrawal by Subject|2|||
37947825|NCT00297037|69635499|FG001|Overall Study|Withdrawal by Subject|0|||
37947826|NCT00292981|69635507|FG000|Overall Study|Adverse Event|1|||
37947827|NCT00292981|69635507|FG000|Overall Study|Lost to Follow-up|13|||
37947828|NCT00292981|69635507|FG000|Overall Study|Withdrawal by Subject|22|||
37947829|NCT00292981|69635507|FG000|Overall Study|Other|3|||
37947830|NCT00296725|69635511|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
37947831|NCT00296725|69635511|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
37947832|NCT00296725|69635511|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
37947833|NCT00625872|69635519|FG000|Overall Study|Withdrawal by Subject|1|||
37947834|NCT00625872|69635520|FG001|Overall Study|Withdrawal by Subject|0|||
37947835|NCT00625872|69635519|FG000|Overall Study|Does not meet inclusion criteria|1|||
37947836|NCT00625872|69635520|FG001|Overall Study|Does not meet inclusion criteria|0|||
37947837|NCT00625872|69635519|FG000|Overall Study|Terminated by sponsor|2|||
37947838|NCT00625872|69635520|FG001|Overall Study|Terminated by sponsor|5|||
37947839|NCT00625872|69635519|FG000|Overall Study|Randomized but not treated|0|||
37947840|NCT00625872|69635520|FG001|Overall Study|Randomized but not treated|1|||
37947841|NCT00523978|69635528|FG000|Overall Study|Withdrawal by Subject|3|||
37947842|NCT00523978|69635529|FG001|Overall Study|Withdrawal by Subject|7|||
37947843|NCT00523978|69635528|FG000|Overall Study|Screen Failures|5|||
37947844|NCT00523978|69635529|FG001|Overall Study|Screen Failures|1|||
37947845|NCT00523978|69635528|FG000|Overall Study|Death|1|||
37947846|NCT00523978|69635529|FG001|Overall Study|Death|0|||
37947847|NCT00296647|69635541|FG000|Overall Study|Death|4|||
37947848|NCT00296647|69635542|FG001|Overall Study|Death|1|||
37947849|NCT00296647|69635543|FG002|Overall Study|Death|2|||
37947850|NCT00296647|69635544|FG003|Overall Study|Death|1|||
37947851|NCT00296647|69635545|FG004|Overall Study|Death|1|||
37947852|NCT00296647|69635541|FG000|Overall Study|Withdrawal by Subject|28|||
37947853|NCT00296647|69635542|FG001|Overall Study|Withdrawal by Subject|27|||
37947854|NCT00296647|69635543|FG002|Overall Study|Withdrawal by Subject|32|||
37947855|NCT00296647|69635544|FG003|Overall Study|Withdrawal by Subject|16|||
37947856|NCT00296647|69635545|FG004|Overall Study|Withdrawal by Subject|19|||
37947857|NCT00754013|69635559|FG000|Overall Study|Lost to Follow-up|1|||
37947858|NCT00754013|69635560|FG001|Overall Study|Lost to Follow-up|1|||
37947859|NCT00754013|69635559|FG000|Overall Study|didn't return after study termed|3|||
37947860|NCT00754013|69635560|FG001|Overall Study|didn't return after study termed|4|||
37947861|NCT00523744|69635566|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
37947862|NCT00523744|69635566|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
37947863|NCT00523744|69635566|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
37947864|NCT00523744|69635566|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
37947865|NCT00523744|69635566|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
37947866|NCT00523744|69635566|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
37947867|NCT00752219|69635584|FG000|Overall Study|Clinical failure|0|||
37947868|NCT00752219|69635585|FG001|Overall Study|Clinical failure|1|||
37947869|NCT00752219|69635584|FG000|Overall Study|Adverse Event|5|||
37947870|NCT00752219|69635585|FG001|Overall Study|Adverse Event|3|||
37947871|NCT00752219|69635584|FG000|Overall Study|Protocol deviation|1|||
37947872|NCT00752219|69635585|FG001|Overall Study|Protocol deviation|0|||
37947873|NCT00752219|69635584|FG000|Overall Study|Lost to Follow-up|1|||
37947874|NCT00752219|69635585|FG001|Overall Study|Lost to Follow-up|2|||
37947875|NCT00752219|69635584|FG000|Overall Study|Randomized but not treated|1|||
37947876|NCT00752219|69635585|FG001|Overall Study|Randomized but not treated|0|||
37947877|NCT00752219|69635584|FG000|Overall Study|Other|3|||
37947878|NCT00752219|69635585|FG001|Overall Study|Other|0|||
37947879|NCT00622908|69635593|FG000|Overall Study|Protocol Violation|1|||
37947880|NCT00622908|69635594|FG001|Overall Study|Protocol Violation|0|||
37947881|NCT00622908|69635593|FG000|Overall Study|Adverse Event|0|||
37947882|NCT00622908|69635594|FG001|Overall Study|Adverse Event|1|||
37947883|NCT00622908|69635593|FG000|Overall Study|Lack of Efficacy|1|||
37947884|NCT00622908|69635594|FG001|Overall Study|Lack of Efficacy|7|||
37947885|NCT00622908|69635593|FG000|Overall Study|Lost to Follow-up|1|||
37947886|NCT00622908|69635594|FG001|Overall Study|Lost to Follow-up|0|||
37947887|NCT00622908|69635593|FG000|Overall Study|Refusal|0|||
37947888|NCT00622908|69635594|FG001|Overall Study|Refusal|1|||
37947889|NCT00622908|69635593|FG000|Overall Study|Termination by study sponser|0|||
37947890|NCT00622908|69635594|FG001|Overall Study|Termination by study sponser|1|||
37947891|NCT00296491|69635604|FG000|Overall Study|Low Pollen Counts|18|||
37947892|NCT00296491|69635605|FG001|Overall Study|Low Pollen Counts|26|||
37947893|NCT00296491|69635606|FG002|Overall Study|Low Pollen Counts|25|||
37947894|NCT00296491|69635607|FG003|Overall Study|Low Pollen Counts|16|||
37947895|NCT00296491|69635604|FG000|Overall Study|Protocol Violation|4|||
37947896|NCT00296491|69635605|FG001|Overall Study|Protocol Violation|6|||
37947897|NCT00296491|69635606|FG002|Overall Study|Protocol Violation|2|||
38042301|NCT02112916|69729835|FG000|Overall Study|Refusal of further protocol therapy|19|||
37947898|NCT00296491|69635607|FG003|Overall Study|Protocol Violation|3|||
37947899|NCT00296491|69635604|FG000|Overall Study|Adverse Event|1|||
37947900|NCT00296491|69635605|FG001|Overall Study|Adverse Event|3|||
37947901|NCT00296491|69635606|FG002|Overall Study|Adverse Event|1|||
37947902|NCT00296491|69635607|FG003|Overall Study|Adverse Event|4|||
37947903|NCT00296491|69635604|FG000|Overall Study|Withdrawn due to Asthma|0|||
37947904|NCT00296491|69635605|FG001|Overall Study|Withdrawn due to Asthma|0|||
37947905|NCT00296491|69635606|FG002|Overall Study|Withdrawn due to Asthma|0|||
37947906|NCT00296491|69635607|FG003|Overall Study|Withdrawn due to Asthma|4|||
37947907|NCT00296491|69635604|FG000|Overall Study|Withdrawal by Subject|7|||
37947908|NCT00296491|69635605|FG001|Overall Study|Withdrawal by Subject|3|||
37947909|NCT00296491|69635606|FG002|Overall Study|Withdrawal by Subject|3|||
37947910|NCT00296491|69635607|FG003|Overall Study|Withdrawal by Subject|2|||
37947911|NCT00296491|69635604|FG000|Overall Study|Non-Compliance|12|||
37947912|NCT00296491|69635605|FG001|Overall Study|Non-Compliance|13|||
37947913|NCT00296491|69635606|FG002|Overall Study|Non-Compliance|10|||
37947914|NCT00296491|69635607|FG003|Overall Study|Non-Compliance|14|||
37947915|NCT00296491|69635604|FG000|Overall Study|Lost to Follow-up|0|||
37947916|NCT00296491|69635605|FG001|Overall Study|Lost to Follow-up|2|||
37947917|NCT00296491|69635606|FG002|Overall Study|Lost to Follow-up|2|||
37947918|NCT00296491|69635607|FG003|Overall Study|Lost to Follow-up|0|||
37947919|NCT00747617|69635626|FG000|Overall Study|Lost to Follow-up|3|||
37947920|NCT00747617|69635627|FG001|Overall Study|Lost to Follow-up|1|||
37947921|NCT00296335|69635635|FG000|Overall Study|Recurrence|3|||
37947922|NCT00296335|69635636|FG001|Overall Study|Recurrence|51|||
37947923|NCT00296335|69635635|FG000|Overall Study|Adverse Event|17|||
37947924|NCT00296335|69635636|FG001|Overall Study|Adverse Event|27|||
37947925|NCT00296335|69635635|FG000|Overall Study|Lost to Follow-up|7|||
37947926|NCT00296335|69635636|FG001|Overall Study|Lost to Follow-up|33|||
37947927|NCT00296335|69635635|FG000|Overall Study|Physician Decision|3|||
37947928|NCT00296335|69635636|FG001|Overall Study|Physician Decision|11|||
37947929|NCT00747461|69635644|FG000|Overall Study|study terminated by sponsor|5|||
37947930|NCT03683758|69635651|FG000|Overall Study|Non-study commitment conflict|1|||
37947931|NCT03683758|69635652|FG001|Overall Study|Non-study commitment conflict|3|||
37947932|NCT03683758|69635651|FG000|Overall Study|Illness preventing participation|1|||
37947933|NCT03683758|69635652|FG001|Overall Study|Illness preventing participation|0|||
37947934|NCT03683758|69635651|FG000|Overall Study|Adverse Event|1|||
37947935|NCT03683758|69635652|FG001|Overall Study|Adverse Event|0|||
37947936|NCT00522418|69635660|FG000|Overall Study|Local IRB Consent Violation|5|||
37947937|NCT00522418|69635661|FG001|Overall Study|Local IRB Consent Violation|5|||
37947938|NCT00522418|69635660|FG000|Overall Study|Early Study Termination|46|||
37947939|NCT00522418|69635661|FG001|Overall Study|Early Study Termination|47|||
37947940|NCT00522418|69635660|FG000|Overall Study|Noncompliance|2|||
37947941|NCT00522418|69635661|FG001|Overall Study|Noncompliance|2|||
37947942|NCT00522418|69635660|FG000|Overall Study|Reason Not Specified|3|||
37947943|NCT00522418|69635661|FG001|Overall Study|Reason Not Specified|1|||
37947944|NCT00522418|69635660|FG000|Overall Study|Consent Withdraw|1|||
37947945|NCT00522418|69635661|FG001|Overall Study|Consent Withdraw|2|||
37947946|NCT00522418|69635660|FG000|Overall Study|Lack of Efficacy|0|||
37947947|NCT00522418|69635661|FG001|Overall Study|Lack of Efficacy|1|||
37947948|NCT00624780|69635675|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
37947949|NCT00624780|69635676|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
37947950|NCT00624780|69635677|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
37947951|NCT00624780|69635678|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
37947952|NCT00624780|69635679|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
37947953|NCT00624780|69635680|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
37947954|NCT00624780|69635675|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
37947955|NCT00624780|69635676|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
37947956|NCT00624780|69635677|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
37947957|NCT00624780|69635678|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
37947958|NCT00624780|69635679|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
37947959|NCT00624780|69635680|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
37947960|NCT00624780|69635675|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
37947961|NCT00624780|69635676|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
37947962|NCT00624780|69635677|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
37947963|NCT00624780|69635678|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
37947964|NCT00624780|69635679|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
37947965|NCT00624780|69635680|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
37947966|NCT00624780|69635675|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
37947967|NCT00624780|69635676|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
37947968|NCT00624780|69635677|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
37947969|NCT00624780|69635678|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
37768600|NCT02649894|69284721|FG001|Overall Study|Physician Decision|1|||
37947970|NCT00624780|69635679|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
37947971|NCT00624780|69635680|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
37947972|NCT00624780|69635675|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
37947973|NCT00624780|69635676|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
37947974|NCT00624780|69635677|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
37947975|NCT00624780|69635678|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
37947976|NCT00624780|69635679|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
37947977|NCT00624780|69635680|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
37947978|NCT00624780|69635675|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
37947979|NCT00624780|69635676|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
37947980|NCT00624780|69635677|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
37947981|NCT00624780|69635678|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
37947982|NCT00624780|69635679|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
37947983|NCT00624780|69635680|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
37947984|NCT00624780|69635675|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
37947985|NCT00624780|69635676|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
37947986|NCT00624780|69635677|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
37947987|NCT00624780|69635678|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
37947988|NCT00624780|69635679|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
37947989|NCT00624780|69635680|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
37947990|NCT00624780|69635675|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
37947991|NCT00624780|69635676|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
37947992|NCT00624780|69635677|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
37947993|NCT00624780|69635678|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
37947994|NCT00624780|69635679|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
37947995|NCT00624780|69635680|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
37947996|NCT00624780|69635675|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
37947997|NCT00624780|69635676|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
37947998|NCT00624780|69635677|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
37947999|NCT00624780|69635678|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
37948000|NCT00624780|69635679|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
37948001|NCT00624780|69635680|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
37948002|NCT00624780|69635675|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
37948003|NCT00624780|69635676|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
37948004|NCT00624780|69635677|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
37948005|NCT00624780|69635678|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
37948006|NCT00624780|69635679|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
37948007|NCT00624780|69635680|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
37948008|NCT00624780|69635675|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
37948009|NCT00624780|69635676|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
37948010|NCT00624780|69635677|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
37948011|NCT00624780|69635678|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
37948012|NCT00624780|69635679|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
37948013|NCT00624780|69635680|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
37948014|NCT00624780|69635675|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
37948015|NCT00624780|69635676|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
37948016|NCT00624780|69635677|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
37948017|NCT00624780|69635678|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
37948018|NCT00624780|69635679|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
37948019|NCT00624780|69635680|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
37948020|NCT00624780|69635675|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
37948021|NCT00624780|69635676|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
37948022|NCT00624780|69635677|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
37948023|NCT00624780|69635678|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
37948024|NCT00624780|69635679|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
37948025|NCT00624780|69635680|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
37948026|NCT00624780|69635675|FG000|Follow-up (Week 26)|Death|0|||
37948027|NCT00624780|69635676|FG001|Follow-up (Week 26)|Death|0|||
37948028|NCT00624780|69635677|FG002|Follow-up (Week 26)|Death|1|||
37948029|NCT00624780|69635678|FG003|Follow-up (Week 26)|Death|0|||
37948030|NCT00624780|69635679|FG004|Follow-up (Week 26)|Death|0|||
37948031|NCT00624780|69635680|FG005|Follow-up (Week 26)|Death|0|||
37948032|NCT00624780|69635675|FG000|Follow-up (Week 26)|Adverse Event|0|||
37948033|NCT00624780|69635676|FG001|Follow-up (Week 26)|Adverse Event|0|||
37948034|NCT00624780|69635677|FG002|Follow-up (Week 26)|Adverse Event|0|||
37948035|NCT00624780|69635678|FG003|Follow-up (Week 26)|Adverse Event|0|||
37948036|NCT00624780|69635679|FG004|Follow-up (Week 26)|Adverse Event|1|||
37948037|NCT00624780|69635680|FG005|Follow-up (Week 26)|Adverse Event|0|||
37948038|NCT00624780|69635675|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
37948039|NCT00624780|69635676|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
37948040|NCT00624780|69635677|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
37948041|NCT00624780|69635678|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
37948042|NCT00624780|69635679|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
37948043|NCT00624780|69635680|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
37948044|NCT00624780|69635675|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
37948045|NCT00624780|69635676|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
37948046|NCT00624780|69635677|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
37948047|NCT00624780|69635678|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
37948048|NCT00624780|69635679|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
37948049|NCT00624780|69635680|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
37948050|NCT00624780|69635675|FG000|Follow-up (Week 26)|Other|1|||
37948051|NCT00624780|69635676|FG001|Follow-up (Week 26)|Other|1|||
37948052|NCT00624780|69635677|FG002|Follow-up (Week 26)|Other|0|||
37948053|NCT00624780|69635678|FG003|Follow-up (Week 26)|Other|0|||
37948054|NCT00624780|69635679|FG004|Follow-up (Week 26)|Other|0|||
37948055|NCT00624780|69635680|FG005|Follow-up (Week 26)|Other|0|||
37948056|NCT00750893|69635697|FG000|Overall Study|Adverse Event|5|||
37948057|NCT00750893|69635697|FG000|Overall Study|Withdrawal by Subject|10|||
37948058|NCT00750893|69635697|FG000|Overall Study|Lost to Follow-up|510|||
37948059|NCT00750893|69635697|FG000|Overall Study|Other|17|||
37948060|NCT00753623|69635703|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
37948061|NCT00753623|69635704|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
37948062|NCT00753623|69635703|FG000|Phase I (14 Days)|Physician Decision|1|||
37948063|NCT00753623|69635704|FG001|Phase I (14 Days)|Physician Decision|2|||
37948064|NCT00753623|69635703|FG000|Phase I (14 Days)|Adverse Event|0|||
37948065|NCT00753623|69635704|FG001|Phase I (14 Days)|Adverse Event|1|||
37948066|NCT00753623|69635703|FG000|Washout (7 Days)|Physician Decision|1|||
37948067|NCT00753623|69635704|FG001|Washout (7 Days)|Physician Decision|0|||
37948068|NCT00753623|69635703|FG000|Phase II (14 Days)|Physician Decision|0|||
37948069|NCT00753623|69635704|FG001|Phase II (14 Days)|Physician Decision|1|||
37948070|NCT00750737|69635712|FG000|Overall Study|Withdrawal by Subject|3|||
37948071|NCT00750737|69635713|FG001|Overall Study|Withdrawal by Subject|3|||
37948072|NCT00622440|69635721|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
37948073|NCT00622440|69635722|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
37948074|NCT00622440|69635721|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
37948075|NCT00622440|69635722|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
37948076|NCT00622440|69635721|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
37948077|NCT00622440|69635722|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
37948078|NCT00622440|69635721|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
37948079|NCT00622440|69635722|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
37948080|NCT00744653|69635728|FG000|Overall Study|antineoplastic treatment|11|||
37948081|NCT00744653|69635728|FG000|Overall Study|Death|1|||
37948082|NCT00744653|69635728|FG000|Overall Study|Lost to Follow-up|1|||
37948083|NCT00744653|69635728|FG000|Overall Study|Physician Decision|3|||
37948084|NCT00311311|69635735|FG000|Overall Study|Adverse Event|3|||
37948085|NCT00311311|69635736|FG001|Overall Study|Adverse Event|2|||
37948086|NCT00311311|69635735|FG000|Overall Study|Withdrawal by Subject|1|||
37948087|NCT00311311|69635736|FG001|Overall Study|Withdrawal by Subject|1|||
37948088|NCT00311311|69635735|FG000|Overall Study|Noncompliance|0|||
37948089|NCT00311311|69635736|FG001|Overall Study|Noncompliance|1|||
37948090|NCT00311311|69635735|FG000|Overall Study|Study Termination by Sponsor|3|||
37948091|NCT00311311|69635736|FG001|Overall Study|Study Termination by Sponsor|4|||
37948092|NCT00311311|69635735|FG000|Overall Study|Death|1|||
37948093|NCT00311311|69635736|FG001|Overall Study|Death|0|||
37948094|NCT00311311|69635735|FG000|Overall Study|Lack of ancillary assistance|0|||
37948095|NCT00311311|69635736|FG001|Overall Study|Lack of ancillary assistance|1|||
37948096|NCT00521404|69635742|FG000|Overall Study|Adverse Event|13|||
37948097|NCT00521404|69635742|FG000|Overall Study|Disease Progression|33|||
37948098|NCT00521404|69635742|FG000|Overall Study|Investigator decision|5|||
37948099|NCT00521404|69635742|FG000|Overall Study|Withdrawal of consent|3|||
37948100|NCT00521404|69635742|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
37948101|NCT00521404|69635742|FG000|Overall Study|Other|7|||
37948102|NCT00311155|69635746|FG000|Overall Study|Adverse Event|21|||
37948103|NCT00311155|69635746|FG000|Overall Study|Withdrawal by Subject|17|||
37948104|NCT00311155|69635746|FG000|Overall Study|Did not meet entry criteria|55|||
37948105|NCT00274651|69635752|FG000|Overall Study|Adverse Event|6|||
37948106|NCT00274651|69635753|FG001|Overall Study|Adverse Event|3|||
37948107|NCT00274651|69635752|FG000|Overall Study|Lack of Efficacy|13|||
37948108|NCT00274651|69635753|FG001|Overall Study|Lack of Efficacy|6|||
37948109|NCT00274651|69635752|FG000|Overall Study|Death|1|||
37948110|NCT00274651|69635753|FG001|Overall Study|Death|3|||
37948111|NCT00274651|69635752|FG000|Overall Study|Withdrawal by Subject|0|||
37948112|NCT00274651|69635753|FG001|Overall Study|Withdrawal by Subject|1|||
37948113|NCT00274651|69635752|FG000|Overall Study|Physician Decision|8|||
37948114|NCT00274651|69635753|FG001|Overall Study|Physician Decision|7|||
37948115|NCT00274261|69635762|FG000|Overall Study|Adverse Event|19|||
37948116|NCT00274261|69635763|FG001|Overall Study|Adverse Event|11|||
37948117|NCT00274261|69635762|FG000|Overall Study|Pregnancy|114|||
37948118|NCT00274261|69635763|FG001|Overall Study|Pregnancy|83|||
37948119|NCT00274261|69635762|FG000|Overall Study|Withdrawal by Subject|179|||
37948120|NCT00274261|69635763|FG001|Overall Study|Withdrawal by Subject|126|||
37948121|NCT00274261|69635762|FG000|Overall Study|Protocol Violation|71|||
37948122|NCT00274261|69635763|FG001|Overall Study|Protocol Violation|42|||
37948123|NCT00274261|69635762|FG000|Overall Study|Lost to Follow-up|106|||
37948124|NCT00274261|69635763|FG001|Overall Study|Lost to Follow-up|75|||
37948125|NCT00624468|69635773|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
37948126|NCT00624468|69635774|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
37948127|NCT00624468|69635775|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
37948128|NCT00624468|69635776|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
37948129|NCT00624468|69635773|FG000|Double-blind Period|Withdrew Prematurely|1|||
37948130|NCT00624468|69635774|FG001|Double-blind Period|Withdrew Prematurely|1|||
37948131|NCT00624468|69635775|FG002|Double-blind Period|Withdrew Prematurely|0|||
37948132|NCT00624468|69635776|FG003|Double-blind Period|Withdrew Prematurely|0|||
37948133|NCT00624468|69635773|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
37948134|NCT00624468|69635774|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
37948135|NCT00624468|69635775|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
37948136|NCT00624468|69635776|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
37948137|NCT00624468|69635773|FG000|Safety Follow-up (SFU) Period|Other|0|||
37948138|NCT00624468|69635774|FG001|Safety Follow-up (SFU) Period|Other|0|||
37948139|NCT00624468|69635775|FG002|Safety Follow-up (SFU) Period|Other|1|||
37948140|NCT00624468|69635776|FG003|Safety Follow-up (SFU) Period|Other|1|||
37948141|NCT00521014|69635784|FG000|Overall Study|Inevaluable, not treated|1|||
37948142|NCT00560235|69635791|FG000|Phase 1|Discontinued|8|||
37948143|NCT00560235|69635792|FG001|Phase 1|Discontinued|0|||
37948144|NCT00560235|69635793|FG002|Phase 1|Discontinued|0|||
37948145|NCT00560235|69635791|FG000|Phase 1B|Discontinued|0|||
37948146|NCT00560235|69635792|FG001|Phase 1B|Discontinued|19|||
37948147|NCT00560235|69635793|FG002|Phase 1B|Discontinued|0|||
37948148|NCT00560235|69635791|FG000|Phase 2|Discontinued|0|||
37948149|NCT00560235|69635792|FG001|Phase 2|Discontinued|0|||
37948150|NCT00560235|69635793|FG002|Phase 2|Discontinued|96|||
37948151|NCT00560235|69635791|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
37948152|NCT00560235|69635792|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
37948153|NCT00560235|69635793|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
37948154|NCT00291577|69635811|FG000|Overall Study|Adverse Event|1|||
37948155|NCT00291577|69635811|FG000|Overall Study|Other|4|||
37948156|NCT00291577|69635811|FG000|Overall Study|Withdrawal by Subject|2|||
37948157|NCT00291577|69635811|FG000|Overall Study|Lack of Efficacy|14|||
37948158|NCT00520936|69635823|FG000|Overall Study|Physician Decision|0|||
37948159|NCT00520936|69635824|FG001|Overall Study|Physician Decision|2|||
37948160|NCT00520936|69635825|FG002|Overall Study|Physician Decision|1|||
37948161|NCT00520936|69635826|FG003|Overall Study|Physician Decision|0|||
37948162|NCT00520936|69635827|FG004|Overall Study|Physician Decision|0|||
37948163|NCT00520936|69635828|FG005|Overall Study|Physician Decision|0|||
37948164|NCT00520936|69635829|FG006|Overall Study|Physician Decision|0|||
37948165|NCT00520936|69635830|FG007|Overall Study|Physician Decision|0|||
37948166|NCT00520936|69635823|FG000|Overall Study|Withdrawal by Subject|0|||
37948167|NCT00520936|69635824|FG001|Overall Study|Withdrawal by Subject|0|||
37948168|NCT00520936|69635825|FG002|Overall Study|Withdrawal by Subject|0|||
37948169|NCT00520936|69635826|FG003|Overall Study|Withdrawal by Subject|0|||
37948170|NCT00520936|69635827|FG004|Overall Study|Withdrawal by Subject|0|||
37948171|NCT00520936|69635828|FG005|Overall Study|Withdrawal by Subject|0|||
37948172|NCT00520936|69635829|FG006|Overall Study|Withdrawal by Subject|0|||
37948173|NCT00520936|69635830|FG007|Overall Study|Withdrawal by Subject|1|||
37948174|NCT00520936|69635823|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
37948175|NCT00520936|69635824|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
37948176|NCT00520936|69635825|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
37948177|NCT00520936|69635826|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
37948178|NCT00520936|69635827|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
37948179|NCT00520936|69635828|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
37948180|NCT00520936|69635829|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
37948181|NCT00520936|69635830|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
37948182|NCT00520936|69635823|FG000|Overall Study|Death|0|||
37948183|NCT00520936|69635824|FG001|Overall Study|Death|0|||
37948184|NCT00520936|69635825|FG002|Overall Study|Death|0|||
37948185|NCT00520936|69635826|FG003|Overall Study|Death|0|||
37948186|NCT00520936|69635827|FG004|Overall Study|Death|0|||
37948187|NCT00520936|69635828|FG005|Overall Study|Death|0|||
37948188|NCT00520936|69635829|FG006|Overall Study|Death|1|||
37948189|NCT00520936|69635830|FG007|Overall Study|Death|0|||
37948190|NCT00520936|69635823|FG000|Overall Study|Protocol Violation|0|||
37948191|NCT00520936|69635824|FG001|Overall Study|Protocol Violation|1|||
37948192|NCT00520936|69635825|FG002|Overall Study|Protocol Violation|1|||
37948193|NCT00520936|69635826|FG003|Overall Study|Protocol Violation|0|||
37948194|NCT00520936|69635827|FG004|Overall Study|Protocol Violation|1|||
37948195|NCT00520936|69635828|FG005|Overall Study|Protocol Violation|0|||
37948196|NCT00520936|69635829|FG006|Overall Study|Protocol Violation|1|||
37948197|NCT00520936|69635830|FG007|Overall Study|Protocol Violation|0|||
37948198|NCT03867760|69635843|FG000|Overall Study|Lost to Follow-up|2|||
37948199|NCT03867760|69635844|FG001|Overall Study|Lost to Follow-up|3|||
37948200|NCT03867760|69635843|FG000|Overall Study|Withdrawal by Subject|1|||
37948201|NCT03867760|69635844|FG001|Overall Study|Withdrawal by Subject|2|||
37948202|NCT03867760|69635843|FG000|Overall Study|subject could not meet study logistics|3|||
37948203|NCT03867760|69635844|FG001|Overall Study|subject could not meet study logistics|3|||
37948204|NCT03865732|69635854|FG000|Overall Study|Adverse Event|0|||
37948205|NCT03865732|69635855|FG001|Overall Study|Adverse Event|1|||
37948206|NCT00520546|69635862|FG000|Overall Study|Withdrawal by Subject|1|||
37948207|NCT00520546|69635862|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
37948208|NCT00555009|69635873|FG000|Overall Study|Withdrawal by Subject|0|||
37948209|NCT00555009|69635874|FG001|Overall Study|Withdrawal by Subject|1|||
37948210|NCT00555009|69635873|FG000|Overall Study|Terminated by Sponsor|2|||
37948211|NCT00555009|69635874|FG001|Overall Study|Terminated by Sponsor|5|||
37948212|NCT00623766|69635882|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
37948213|NCT00623766|69635883|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
37948214|NCT00623766|69635882|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
37948215|NCT00623766|69635883|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
37948216|NCT00623766|69635882|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
37948217|NCT00623766|69635883|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
37948218|NCT00623766|69635882|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
37948219|NCT00623766|69635883|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
37948220|NCT00623766|69635882|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
37948221|NCT00623766|69635883|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
37948222|NCT00550407|69635895|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
37948223|NCT00550407|69635896|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
37948224|NCT00550407|69635897|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
37948225|NCT00550407|69635895|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
37948226|NCT00550407|69635896|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
37948227|NCT00550407|69635897|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
37948228|NCT00550407|69635895|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
37948229|NCT00550407|69635896|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
37948230|NCT00550407|69635897|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
37948231|NCT00550407|69635895|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
37948232|NCT00550407|69635896|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
37948233|NCT00550407|69635897|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
37948234|NCT00550407|69635895|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
37948235|NCT00550407|69635896|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
37948236|NCT00550407|69635897|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
37948237|NCT00550407|69635895|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
37948238|NCT00550407|69635896|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
37948239|NCT00550407|69635897|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
37948240|NCT00550407|69635895|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
37948241|NCT00550407|69635896|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
37948242|NCT00550407|69635897|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
37948243|NCT00550407|69635895|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
37948244|NCT00550407|69635896|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
37948245|NCT00550407|69635897|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
37948246|NCT00550407|69635895|FG000|26-Week Randomized Phase|Adverse Event|0|||
37948247|NCT00550407|69635896|FG001|26-Week Randomized Phase|Adverse Event|5|||
37948248|NCT00550407|69635897|FG002|26-Week Randomized Phase|Adverse Event|2|||
37948249|NCT00550407|69635895|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
37948250|NCT00550407|69635896|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
37948251|NCT00550407|69635897|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
37948252|NCT00550407|69635895|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
37948253|NCT00550407|69635896|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
37948254|NCT00550407|69635897|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
37948255|NCT00550407|69635895|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
37948256|NCT00550407|69635896|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
37948257|NCT00550407|69635897|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
37948258|NCT00531934|69635907|FG000|Overall Study|Adverse Event|4|||
37948259|NCT00531934|69635908|FG001|Overall Study|Adverse Event|8|||
37948260|NCT00531934|69635907|FG000|Overall Study|Progression|52|||
37948261|NCT00531934|69635908|FG001|Overall Study|Progression|42|||
37948262|NCT00531934|69635907|FG000|Overall Study|Death|7|||
37948263|NCT00531934|69635908|FG001|Overall Study|Death|10|||
37948264|NCT00531934|69635907|FG000|Overall Study|Withdrawal by Subject|1|||
37948265|NCT00531934|69635908|FG001|Overall Study|Withdrawal by Subject|1|||
37948266|NCT00531934|69635907|FG000|Overall Study|Other|2|||
37948267|NCT00531934|69635908|FG001|Overall Study|Other|2|||
38042302|NCT02112916|69729836|FG001|Overall Study|Refusal of further protocol therapy|16|||
38042303|NCT02112916|69729837|FG002|Overall Study|Refusal of further protocol therapy|1|||
38042304|NCT02112916|69729838|FG003|Overall Study|Refusal of further protocol therapy|7|||
38042305|NCT02112916|69729835|FG000|Overall Study|Development of SMN|1|||
38042306|NCT02112916|69729836|FG001|Overall Study|Development of SMN|0|||
38042307|NCT02112916|69729837|FG002|Overall Study|Development of SMN|0|||
38042308|NCT02112916|69729838|FG003|Overall Study|Development of SMN|1|||
38042309|NCT02112916|69729835|FG000|Overall Study|Relapse/Progression|10|||
38042310|NCT02112916|69729836|FG001|Overall Study|Relapse/Progression|18|||
38042311|NCT02112916|69729837|FG002|Overall Study|Relapse/Progression|15|||
38042312|NCT02112916|69729838|FG003|Overall Study|Relapse/Progression|2|||
38042313|NCT02112916|69729835|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
38042314|NCT02112916|69729836|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
38042315|NCT02112916|69729837|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
38042316|NCT02112916|69729838|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
38042317|NCT02112916|69729835|FG000|Overall Study|Still on Therapy|44|||
38042318|NCT02112916|69729836|FG001|Overall Study|Still on Therapy|47|||
38042319|NCT02112916|69729837|FG002|Overall Study|Still on Therapy|3|||
38042320|NCT02112916|69729838|FG003|Overall Study|Still on Therapy|2|||
38042321|NCT02112916|69729835|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
38042322|NCT02112916|69729836|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
38042323|NCT02112916|69729837|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
38042324|NCT02112916|69729838|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
38042325|NCT02112916|69729835|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
38042326|NCT02112916|69729836|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
38042327|NCT02112916|69729837|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
38042328|NCT02112916|69729838|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
38042329|NCT02057718|69729855|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
38042330|NCT02057718|69729856|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
38042331|NCT02057718|69729855|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
38042332|NCT02057718|69729856|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
38042333|NCT02057718|69729855|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
38042334|NCT02057718|69729856|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
38042335|NCT02057718|69729855|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
38042336|NCT02057718|69729856|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
38042337|NCT02057718|69729855|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
38042338|NCT02057718|69729856|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
38042339|NCT02057718|69729855|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
38042340|NCT02057718|69729856|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
38042341|NCT02057718|69729855|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
38042342|NCT02057718|69729856|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
38042343|NCT02057718|69729855|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
38042344|NCT02057718|69729856|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
38042345|NCT02057718|69729855|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
38042346|NCT02057718|69729856|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
38042347|NCT02057718|69729855|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
38042348|NCT02057718|69729856|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
38042349|NCT02057718|69729855|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
38042350|NCT02057718|69729856|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
38042351|NCT01981551|69729862|FG000|Overall Study|Refused further treatment|8|||
38042352|NCT01981551|69729862|FG000|Overall Study|Adverse Event|1|||
38042353|NCT01874353|69729868|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
38042354|NCT01874353|69729869|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
37948268|NCT00549939|69635917|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
37948269|NCT00549939|69635918|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
37948270|NCT00549939|69635919|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
37948271|NCT00549939|69635917|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
37948272|NCT00549939|69635918|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
37948273|NCT00549939|69635919|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
37948274|NCT00549939|69635917|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
37948275|NCT00549939|69635918|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
37948276|NCT00549939|69635919|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
37948277|NCT00549939|69635917|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
37948278|NCT00549939|69635918|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
37948279|NCT00549939|69635919|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
37948280|NCT00549939|69635917|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
37948281|NCT00549939|69635918|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
37948282|NCT00549939|69635919|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
37948283|NCT00549939|69635917|FG000|40-week Open Label Treatment Period|Other|0|||
37948284|NCT00549939|69635918|FG001|40-week Open Label Treatment Period|Other|1|||
37948285|NCT00549939|69635919|FG002|40-week Open Label Treatment Period|Other|4|||
37948286|NCT00272779|69635931|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
37948287|NCT00272779|69635932|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
37948288|NCT00272779|69635931|FG000|Baseline Through Week 48|Death before Week 48|4|||
37948289|NCT00272779|69635932|FG001|Baseline Through Week 48|Death before Week 48|4|||
37948290|NCT00272779|69635931|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
37948291|NCT00272779|69635932|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
37948292|NCT00272779|69635931|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
37948293|NCT00272779|69635932|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
37948294|NCT00272779|69635931|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
37948295|NCT00272779|69635932|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
37948296|NCT00272779|69635931|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
37948297|NCT00272779|69635932|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
37948298|NCT00272779|69635931|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
37948299|NCT00272779|69635932|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
37948300|NCT00272779|69635931|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
37948301|NCT00272779|69635932|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
37948302|NCT00272779|69635931|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
37948303|NCT00272779|69635932|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
37948304|NCT00272779|69635931|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
37948305|NCT00272779|69635932|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
37948306|NCT00272779|69635931|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
37948307|NCT00272779|69635932|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
37948308|NCT00272779|69635931|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
37948309|NCT00272779|69635932|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
37948310|NCT00272779|69635931|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
37948311|NCT00272779|69635932|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
37948312|NCT00272779|69635931|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
37948313|NCT00272779|69635932|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
37948314|NCT00272779|69635931|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
37948315|NCT00272779|69635932|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
37948316|NCT00272779|69635931|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
37948317|NCT00272779|69635932|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
37948318|NCT00272779|69635931|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
37948319|NCT00272779|69635932|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
37948320|NCT00272779|69635931|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
37948321|NCT00272779|69635932|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
37948322|NCT00272779|69635931|FG000|Baseline Through Week 48|Continuing treatment|385|||
37948323|NCT00272779|69635932|FG001|Baseline Through Week 48|Continuing treatment|368|||
37948324|NCT00272779|69635931|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
37948325|NCT00272779|69635932|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
37948326|NCT00272779|69635931|FG000|Baseline Through Week 48|Never treated|2|||
37948327|NCT00272779|69635932|FG001|Baseline Through Week 48|Never treated|3|||
37948328|NCT00272779|69635931|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
37948329|NCT00272779|69635932|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
37948330|NCT00272779|69635931|FG000|Baseline Through Week 96|Death before Week 96|6|||
37948331|NCT00272779|69635932|FG001|Baseline Through Week 96|Death before Week 96|5|||
37948332|NCT00272779|69635931|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
37948333|NCT00272779|69635932|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
37948334|NCT00272779|69635931|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
37948335|NCT00272779|69635932|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
37948336|NCT00272779|69635931|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
37948337|NCT00272779|69635932|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
37948338|NCT00272779|69635931|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
37948339|NCT00272779|69635932|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
37948340|NCT00272779|69635931|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
37948341|NCT00272779|69635932|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
37948342|NCT00272779|69635931|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
37948343|NCT00272779|69635932|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
37948344|NCT00272779|69635931|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
37948345|NCT00272779|69635932|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
37948346|NCT00272779|69635931|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
37948347|NCT00272779|69635932|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
37948348|NCT00272779|69635931|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
37948349|NCT00272779|69635932|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
37948350|NCT00272779|69635931|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
37948351|NCT00272779|69635932|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
37948352|NCT00272779|69635931|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
37948353|NCT00272779|69635932|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
37948354|NCT00272779|69635931|FG000|Baseline Through Week 96|Never treated|2|||
37948355|NCT00272779|69635932|FG001|Baseline Through Week 96|Never treated|3|||
37948356|NCT00272779|69635931|FG000|Baseline Through Week 96|Continuing on treatment|61|||
37948357|NCT00272779|69635932|FG001|Baseline Through Week 96|Continuing on treatment|38|||
37948358|NCT00511810|69635941|FG000|Overall Study|Lost to Follow-up|1|||
37948359|NCT00511810|69635942|FG001|Overall Study|Lost to Follow-up|2|||
37948360|NCT00511810|69635941|FG000|Overall Study|Lack of Efficacy|0|||
37948361|NCT00511810|69635942|FG001|Overall Study|Lack of Efficacy|2|||
37948362|NCT00511810|69635941|FG000|Overall Study|Refused second scn|0|||
37948363|NCT00511810|69635942|FG001|Overall Study|Refused second scn|1|||
37948364|NCT00291499|69635950|FG000|Overall Study|Adverse Event|3|||
37948365|NCT00291499|69635951|FG001|Overall Study|Adverse Event|8|||
37948366|NCT00291499|69635950|FG000|Overall Study|Change to other therapy|2|||
37948367|NCT00291499|69635951|FG001|Overall Study|Change to other therapy|1|||
37948368|NCT00291499|69635950|FG000|Overall Study|Intercurrent illness|1|||
37948369|NCT00291499|69635951|FG001|Overall Study|Intercurrent illness|0|||
37948370|NCT00291499|69635950|FG000|Overall Study|Protocol Violation|2|||
37948371|NCT00291499|69635951|FG001|Overall Study|Protocol Violation|2|||
37948372|NCT00291499|69635950|FG000|Overall Study|Other reasons|1|||
37948373|NCT00291499|69635951|FG001|Overall Study|Other reasons|4|||
37948374|NCT00553605|69635959|FG000|Overall Study|Did not meet entrance criteria|1|||
37948375|NCT00553605|69635960|FG001|Overall Study|Did not meet entrance criteria|3|||
37948376|NCT00553605|69635959|FG000|Overall Study|Did not receive full dose|1|||
37948377|NCT00553605|69635960|FG001|Overall Study|Did not receive full dose|0|||
37948378|NCT00553605|69635959|FG000|Overall Study|Randomized but not treated|2|||
37948379|NCT00553605|69635960|FG001|Overall Study|Randomized but not treated|0|||
37948380|NCT00621582|69635966|FG000|Overall Study|Adverse Event|7|||
37948381|NCT00621582|69635966|FG000|Overall Study|Protocol Violation|57|||
37948382|NCT00621582|69635966|FG000|Overall Study|Lost to Follow-up|24|||
37948383|NCT00621582|69635966|FG000|Overall Study|issues not identified by investigators|18|||
37948384|NCT00744497|69635972|FG000|Overall Study|Withdrawal by Subject|21|||
37948385|NCT00744497|69635973|FG001|Overall Study|Withdrawal by Subject|18|||
37948386|NCT00744497|69635972|FG000|Overall Study|Death|11|||
37948387|NCT00744497|69635973|FG001|Overall Study|Death|9|||
37948388|NCT00744497|69635972|FG000|Overall Study|Lost to Follow-up|4|||
37948389|NCT00744497|69635973|FG001|Overall Study|Lost to Follow-up|2|||
37948390|NCT00744497|69635972|FG000|Overall Study|Poor compliance/noncompliance|9|||
37948391|NCT00744497|69635973|FG001|Overall Study|Poor compliance/noncompliance|5|||
37948392|NCT00744497|69635972|FG000|Overall Study|No longer meets study criteria|7|||
37948393|NCT00744497|69635973|FG001|Overall Study|No longer meets study criteria|3|||
37948394|NCT00744497|69635972|FG000|Overall Study|Administrative Reason By Sponsor|25|||
37948395|NCT00744497|69635973|FG001|Overall Study|Administrative Reason By Sponsor|8|||
38042355|NCT01874353|69729870|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
38042356|NCT01874353|69729871|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
38042357|NCT01874353|69729868|FG000|Overall Study|Lost to Follow-up|2|||
38042358|NCT01874353|69729869|FG001|Overall Study|Lost to Follow-up|2|||
38042359|NCT01874353|69729870|FG002|Overall Study|Lost to Follow-up|2|||
38042360|NCT01874353|69729871|FG003|Overall Study|Lost to Follow-up|0|||
38042361|NCT01874353|69729868|FG000|Overall Study|Death|110|||
38042362|NCT01874353|69729869|FG001|Overall Study|Death|60|||
38042363|NCT01874353|69729870|FG002|Overall Study|Death|13|||
38042364|NCT01874353|69729871|FG003|Overall Study|Death|7|||
38042365|NCT01874353|69729868|FG000|Overall Study|Withdrawal by Subject|13|||
38042366|NCT01874353|69729869|FG001|Overall Study|Withdrawal by Subject|11|||
38042367|NCT01874353|69729870|FG002|Overall Study|Withdrawal by Subject|0|||
38042368|NCT01874353|69729871|FG003|Overall Study|Withdrawal by Subject|0|||
38042369|NCT01750281|69729886|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
38042370|NCT01750281|69729887|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
38042371|NCT01750281|69729888|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
37948396|NCT00744497|69635972|FG000|Overall Study|Disease progression|312|||
37948397|NCT00744497|69635973|FG001|Overall Study|Disease progression|219|||
37948398|NCT00744497|69635972|FG000|Overall Study|Study drug toxicity|68|||
37948399|NCT00744497|69635973|FG001|Overall Study|Study drug toxicity|141|||
37948400|NCT00744497|69635972|FG000|Overall Study|Adverse event unrelated to study drug|78|||
37948401|NCT00744497|69635973|FG001|Overall Study|Adverse event unrelated to study drug|122|||
37948402|NCT00744497|69635972|FG000|Overall Study|Patient requested to stop study drug|65|||
37948403|NCT00744497|69635973|FG001|Overall Study|Patient requested to stop study drug|80|||
37948404|NCT00744497|69635972|FG000|Overall Study|Maximum clinical benefit|141|||
37948405|NCT00744497|69635973|FG001|Overall Study|Maximum clinical benefit|142|||
37948406|NCT00744497|69635972|FG000|Overall Study|Not defined|19|||
37948407|NCT00744497|69635973|FG001|Overall Study|Not defined|13|||
37948408|NCT00747227|69635981|FG000|Overall Study|Death|3|||
37948409|NCT00747227|69635982|FG001|Overall Study|Death|1|||
37948410|NCT00747227|69635981|FG000|Overall Study|Withdrawal by Subject|1|||
37948411|NCT00747227|69635982|FG001|Overall Study|Withdrawal by Subject|0|||
37948412|NCT00747227|69635981|FG000|Overall Study|Lost to Follow-up|1|||
37948413|NCT00747227|69635982|FG001|Overall Study|Lost to Follow-up|2|||
37948414|NCT00747227|69635981|FG000|Overall Study|Illness|1|||
37948415|NCT00747227|69635982|FG001|Overall Study|Illness|1|||
37948416|NCT00747149|69635990|FG000|Overall Study|Adverse Event|0|||
37948417|NCT00747149|69635991|FG001|Overall Study|Adverse Event|15|||
37948418|NCT00747149|69635990|FG000|Overall Study|Lost to Follow-up|0|||
37948419|NCT00747149|69635991|FG001|Overall Study|Lost to Follow-up|10|||
37948420|NCT00747149|69635990|FG000|Overall Study|Withdrawal by Subject|0|||
37948421|NCT00747149|69635991|FG001|Overall Study|Withdrawal by Subject|6|||
37948422|NCT00747149|69635990|FG000|Overall Study|Did not receive treatment|0|||
37948423|NCT00747149|69635991|FG001|Overall Study|Did not receive treatment|1|||
37948424|NCT00747149|69635990|FG000|Overall Study|Incorrect enrollment|0|||
37948425|NCT00747149|69635991|FG001|Overall Study|Incorrect enrollment|6|||
37948426|NCT00747149|69635990|FG000|Overall Study|Severe non-compliance to protocol|0|||
37948427|NCT00747149|69635991|FG001|Overall Study|Severe non-compliance to protocol|1|||
37948428|NCT00747149|69635990|FG000|Overall Study|Not reported|1|||
37948429|NCT00747149|69635991|FG001|Overall Study|Not reported|4|||
37948430|NCT00271609|69636005|FG000|Overall Study|Adverse Event|11|||
37948431|NCT00271609|69636006|FG001|Overall Study|Adverse Event|3|||
37948432|NCT00271609|69636005|FG000|Overall Study|Withdrawal by Subject|2|||
37948433|NCT00271609|69636006|FG001|Overall Study|Withdrawal by Subject|0|||
37948434|NCT00548847|69636012|FG000|Overall Study|Disease progression|7|||
37948435|NCT00290407|69636016|FG000|Overall Study|Physician Decision|2|||
37948436|NCT00749411|69636022|FG000|Overall Study|Adverse Event|0|||
37948437|NCT00749411|69636023|FG001|Overall Study|Adverse Event|2|||
37948438|NCT00749411|69636022|FG000|Overall Study|Lack of Efficacy|0|||
37948439|NCT00749411|69636023|FG001|Overall Study|Lack of Efficacy|1|||
37948440|NCT00749411|69636022|FG000|Overall Study|Protocol Violation|1|||
37948441|NCT00749411|69636023|FG001|Overall Study|Protocol Violation|1|||
37948442|NCT00749411|69636022|FG000|Overall Study|Protocol-defined stopping criteria|0|||
37948443|NCT00749411|69636023|FG001|Overall Study|Protocol-defined stopping criteria|1|||
37948444|NCT03958149|69636031|FG000|Overall Study|Withdrawal by Subject|0|||
37948445|NCT03958149|69636032|FG001|Overall Study|Withdrawal by Subject|1|||
37948446|NCT00549549|69636046|FG000|Overall Study|Adverse Event|5|||
37948447|NCT00549549|69636047|FG001|Overall Study|Adverse Event|3|||
37948448|NCT00549549|69636048|FG002|Overall Study|Adverse Event|1|||
37948449|NCT00549549|69636049|FG003|Overall Study|Adverse Event|9|||
37948450|NCT00549549|69636046|FG000|Overall Study|Lack of Efficacy|9|||
37948451|NCT00549549|69636047|FG001|Overall Study|Lack of Efficacy|6|||
37948452|NCT00549549|69636048|FG002|Overall Study|Lack of Efficacy|4|||
37948453|NCT00549549|69636049|FG003|Overall Study|Lack of Efficacy|2|||
37948454|NCT00549549|69636046|FG000|Overall Study|Lost to Follow-up|1|||
37948455|NCT00549549|69636047|FG001|Overall Study|Lost to Follow-up|0|||
37948456|NCT00549549|69636048|FG002|Overall Study|Lost to Follow-up|1|||
37948457|NCT00549549|69636049|FG003|Overall Study|Lost to Follow-up|2|||
37948458|NCT00549549|69636046|FG000|Overall Study|Withdrawal by Subject|0|||
37948459|NCT00549549|69636047|FG001|Overall Study|Withdrawal by Subject|4|||
37948460|NCT00549549|69636048|FG002|Overall Study|Withdrawal by Subject|1|||
37948461|NCT00549549|69636049|FG003|Overall Study|Withdrawal by Subject|0|||
37948462|NCT00549549|69636046|FG000|Overall Study|Other|9|||
37948463|NCT00549549|69636047|FG001|Overall Study|Other|9|||
37948464|NCT00549549|69636048|FG002|Overall Study|Other|9|||
37948465|NCT00549549|69636049|FG003|Overall Study|Other|11|||
37948466|NCT00549549|69636046|FG000|Overall Study|Randomized but not treated|0|||
37948467|NCT00549549|69636047|FG001|Overall Study|Randomized but not treated|0|||
37948468|NCT00549549|69636048|FG002|Overall Study|Randomized but not treated|1|||
37948469|NCT00549549|69636049|FG003|Overall Study|Randomized but not treated|1|||
37948470|NCT00270205|69636063|FG000|Overall Study|Lost to Follow-up|1|||
37948471|NCT00270205|69636064|FG001|Overall Study|Lost to Follow-up|0|||
37948472|NCT00270205|69636065|FG002|Overall Study|Lost to Follow-up|0|||
37948473|NCT00270205|69636066|FG003|Overall Study|Lost to Follow-up|1|||
37948474|NCT00622284|69636078|FG000|Overall Study|Lack of Efficacy|45|||
37948475|NCT00622284|69636079|FG001|Overall Study|Lack of Efficacy|15|||
37948476|NCT00622284|69636078|FG000|Overall Study|Adverse Event|61|||
37948477|NCT00622284|69636079|FG001|Overall Study|Adverse Event|90|||
37948478|NCT00622284|69636078|FG000|Overall Study|Protocol Violation|12|||
37948479|NCT00622284|69636079|FG001|Overall Study|Protocol Violation|5|||
37948480|NCT00622284|69636078|FG000|Overall Study|Lost to Follow-up|11|||
37948481|NCT00622284|69636079|FG001|Overall Study|Lost to Follow-up|13|||
37948482|NCT00622284|69636078|FG000|Overall Study|Withdrawal by Subject|27|||
37948483|NCT00622284|69636079|FG001|Overall Study|Withdrawal by Subject|24|||
37948484|NCT00622284|69636078|FG000|Overall Study|Other reason (not specified)|33|||
37948485|NCT00622284|69636079|FG001|Overall Study|Other reason (not specified)|24|||
37948486|NCT00269113|69636087|FG000|Overall Study|Adverse Event|14|||
37948487|NCT00269113|69636088|FG001|Overall Study|Adverse Event|7|||
37948488|NCT00269113|69636087|FG000|Overall Study|Lack of Efficacy|35|||
37948489|NCT00269113|69636088|FG001|Overall Study|Lack of Efficacy|18|||
37948490|NCT00269113|69636087|FG000|Overall Study|Early Improvement|2|||
37948491|NCT00269113|69636088|FG001|Overall Study|Early Improvement|0|||
37948492|NCT00269113|69636087|FG000|Overall Study|Withdrawal by Subject|0|||
37948493|NCT00269113|69636088|FG001|Overall Study|Withdrawal by Subject|2|||
37948494|NCT00269113|69636087|FG000|Overall Study|Death|6|||
37948495|NCT00269113|69636088|FG001|Overall Study|Death|2|||
37948496|NCT00269113|69636087|FG000|Overall Study|Lost to Follow-up|2|||
37948497|NCT00269113|69636088|FG001|Overall Study|Lost to Follow-up|1|||
37948498|NCT00269113|69636087|FG000|Overall Study|Protocol Violation|15|||
37948499|NCT00269113|69636088|FG001|Overall Study|Protocol Violation|5|||
37948500|NCT00269113|69636087|FG000|Overall Study|Other|0|||
37948501|NCT00269113|69636088|FG001|Overall Study|Other|2|||
37948502|NCT00291187|69636098|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
37948503|NCT00291187|69636099|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
37948504|NCT00291187|69636100|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
37948505|NCT00291187|69636101|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
37948506|NCT00546819|69636117|FG000|Overall Study|Adverse Event|2|||
37948507|NCT00546819|69636118|FG001|Overall Study|Adverse Event|3|||
37948508|NCT00546819|69636117|FG000|Overall Study|Lost to Follow-up|2|||
37948509|NCT00546819|69636118|FG001|Overall Study|Lost to Follow-up|1|||
37948510|NCT00546819|69636117|FG000|Overall Study|Withdrawal by Subject|4|||
37948511|NCT00546819|69636118|FG001|Overall Study|Withdrawal by Subject|2|||
37948512|NCT00621504|69636126|FG000|Overall Study|Adverse Event|1|||
37948513|NCT00621504|69636127|FG001|Overall Study|Adverse Event|3|||
37948514|NCT00621504|69636126|FG000|Overall Study|At the request of sponsor/investigator|1|||
37948515|NCT00621504|69636127|FG001|Overall Study|At the request of sponsor/investigator|0|||
37948516|NCT00621504|69636126|FG000|Overall Study|Withdrew consent|9|||
37948517|NCT00621504|69636127|FG001|Overall Study|Withdrew consent|6|||
37948518|NCT00621504|69636126|FG000|Overall Study|Lost to Follow-up|8|||
37948519|NCT00621504|69636127|FG001|Overall Study|Lost to Follow-up|10|||
37948520|NCT00621504|69636126|FG000|Overall Study|Other|1|||
37948521|NCT00621504|69636127|FG001|Overall Study|Other|0|||
37948522|NCT00621504|69636126|FG000|Overall Study|Death|6|||
37948523|NCT00621504|69636127|FG001|Overall Study|Death|6|||
37948524|NCT00548145|69636135|FG000|Overall Study|Death|0|||
37948525|NCT00548145|69636136|FG001|Overall Study|Death|1|||
37948526|NCT00548145|69636135|FG000|Overall Study|Withdrawal by Subject|0|||
37948527|NCT00548145|69636136|FG001|Overall Study|Withdrawal by Subject|2|||
37948528|NCT00548145|69636135|FG000|Overall Study|Physician Decision|1|||
37948529|NCT00548145|69636136|FG001|Overall Study|Physician Decision|1|||
37948530|NCT00547911|69636146|FG000|Overall Study|Adverse Event|0|||
37948531|NCT00547911|69636147|FG001|Overall Study|Adverse Event|0|||
37948532|NCT00547911|69636148|FG002|Overall Study|Adverse Event|0|||
37948533|NCT00547911|69636149|FG003|Overall Study|Adverse Event|1|||
37948534|NCT00547911|69636150|FG004|Overall Study|Adverse Event|0|||
37948535|NCT00547911|69636151|FG005|Overall Study|Adverse Event|0|||
37948536|NCT00289783|69636166|FG000|Primary Phase|Adverse Event|10|||
37948537|NCT00289783|69636167|FG001|Primary Phase|Adverse Event|1|||
37948538|NCT00289783|69636166|FG000|Primary Phase|Protocol Violation|27|||
37948539|NCT00289783|69636167|FG001|Primary Phase|Protocol Violation|6|||
37948540|NCT00289783|69636166|FG000|Primary Phase|Withdrawal by Subject|93|||
37948541|NCT00289783|69636167|FG001|Primary Phase|Withdrawal by Subject|40|||
37948542|NCT00289783|69636166|FG000|Primary Phase|Lost to Follow-up|60|||
37948543|NCT00289783|69636167|FG001|Primary Phase|Lost to Follow-up|14|||
37948544|NCT00289783|69636166|FG000|Primary Phase|Migration from the study area|26|||
37948545|NCT00289783|69636167|FG001|Primary Phase|Migration from the study area|10|||
38042372|NCT01750281|69729886|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
37948546|NCT00289783|69636166|FG000|Primary Phase|Other|32|||
37948547|NCT00289783|69636167|FG001|Primary Phase|Other|12|||
37948548|NCT00289783|69636166|FG000|Fourth Dose Phase|Adverse Event|1|||
37948549|NCT00289783|69636167|FG001|Fourth Dose Phase|Adverse Event|0|||
37948550|NCT00289783|69636166|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
37948551|NCT00289783|69636167|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
37948552|NCT00289783|69636166|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
37948553|NCT00289783|69636167|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
37948554|NCT00289783|69636166|FG000|Fourth Dose Phase|Migration from the study area|1|||
37948555|NCT00289783|69636167|FG001|Fourth Dose Phase|Migration from the study area|1|||
37948556|NCT00289783|69636166|FG000|Fourth Dose Phase|Other|22|||
37948557|NCT00289783|69636167|FG001|Fourth Dose Phase|Other|10|||
37948558|NCT00574080|69636183|FG000|Overall Study|Death|10|||
37948559|NCT00574080|69636184|FG001|Overall Study|Death|10|||
37948560|NCT00267865|69636190|FG000|Induction Treatment|Died before completing.|2|||
37948561|NCT00267865|69636190|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
37948562|NCT00546117|69636196|FG000|Overall Study|Withdrawal by Subject|3|||
37948563|NCT00546117|69636197|FG001|Overall Study|Withdrawal by Subject|0|||
37948564|NCT00546117|69636196|FG000|Overall Study|Inability to schedule follow-up visit|1|||
37948565|NCT00546117|69636197|FG001|Overall Study|Inability to schedule follow-up visit|0|||
37948566|NCT00251719|69636208|FG000|Overall Study|Adverse Event|14|||
37948567|NCT00251719|69636209|FG001|Overall Study|Adverse Event|8|||
37948568|NCT00251719|69636210|FG002|Overall Study|Adverse Event|7|||
37948569|NCT00251719|69636208|FG000|Overall Study|Protocol Violation|1|||
37948570|NCT00251719|69636209|FG001|Overall Study|Protocol Violation|1|||
37948571|NCT00251719|69636210|FG002|Overall Study|Protocol Violation|1|||
37948572|NCT00251719|69636208|FG000|Overall Study|Lost to Follow-up|5|||
37948573|NCT00251719|69636209|FG001|Overall Study|Lost to Follow-up|11|||
37948574|NCT00251719|69636210|FG002|Overall Study|Lost to Follow-up|8|||
37948575|NCT00251719|69636208|FG000|Overall Study|Withdrawal by Subject|14|||
37948576|NCT00251719|69636209|FG001|Overall Study|Withdrawal by Subject|12|||
37948577|NCT00251719|69636210|FG002|Overall Study|Withdrawal by Subject|11|||
37948578|NCT00251719|69636208|FG000|Overall Study|Lack of Efficacy|2|||
37948579|NCT00251719|69636209|FG001|Overall Study|Lack of Efficacy|1|||
37948580|NCT00251719|69636210|FG002|Overall Study|Lack of Efficacy|0|||
37948581|NCT00251719|69636208|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
37948582|NCT00251719|69636209|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
37948583|NCT00251719|69636210|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
37948584|NCT00251719|69636208|FG000|Overall Study|Investigator decision|1|||
37948585|NCT00251719|69636209|FG001|Overall Study|Investigator decision|1|||
37948586|NCT00251719|69636210|FG002|Overall Study|Investigator decision|0|||
37948587|NCT00251719|69636208|FG000|Overall Study|Noncompliance|2|||
37948588|NCT00251719|69636209|FG001|Overall Study|Noncompliance|3|||
37948589|NCT00251719|69636210|FG002|Overall Study|Noncompliance|1|||
37948590|NCT00251719|69636208|FG000|Overall Study|Barrett's esophagus|2|||
37948591|NCT00251719|69636209|FG001|Overall Study|Barrett's esophagus|2|||
37948592|NCT00251719|69636210|FG002|Overall Study|Barrett's esophagus|0|||
37948593|NCT03952143|69636220|FG000|Lead-In Period|Adverse Event|2|||
37948594|NCT03952143|69636221|FG001|Lead-In Period|Adverse Event|0|||
37948595|NCT03952143|69636222|FG002|Lead-In Period|Adverse Event|0|||
37948596|NCT03952143|69636220|FG000|Lead-In Period|Lack of Efficacy|2|||
37948597|NCT03952143|69636221|FG001|Lead-In Period|Lack of Efficacy|0|||
37948598|NCT03952143|69636222|FG002|Lead-In Period|Lack of Efficacy|0|||
37948599|NCT03952143|69636220|FG000|Lead-In Period|Physician Decision|5|||
37948600|NCT03952143|69636221|FG001|Lead-In Period|Physician Decision|0|||
37948601|NCT03952143|69636222|FG002|Lead-In Period|Physician Decision|0|||
37948602|NCT03952143|69636220|FG000|Lead-In Period|Protocol Violation|5|||
37948603|NCT03952143|69636221|FG001|Lead-In Period|Protocol Violation|0|||
37948604|NCT03952143|69636222|FG002|Lead-In Period|Protocol Violation|0|||
37948605|NCT03952143|69636220|FG000|Lead-In Period|Withdrawal by Subject|19|||
37948606|NCT03952143|69636221|FG001|Lead-In Period|Withdrawal by Subject|0|||
37948607|NCT03952143|69636222|FG002|Lead-In Period|Withdrawal by Subject|0|||
37948608|NCT03952143|69636220|FG000|Treatment Period|Adverse Event|0|||
37948609|NCT03952143|69636221|FG001|Treatment Period|Adverse Event|0|||
37948610|NCT03952143|69636222|FG002|Treatment Period|Adverse Event|1|||
37948611|NCT03952143|69636220|FG000|Treatment Period|Lost to Follow-up|0|||
37948612|NCT03952143|69636221|FG001|Treatment Period|Lost to Follow-up|2|||
37948613|NCT03952143|69636222|FG002|Treatment Period|Lost to Follow-up|0|||
37948614|NCT03952143|69636220|FG000|Treatment Period|Physician Decision|0|||
37948615|NCT03952143|69636221|FG001|Treatment Period|Physician Decision|0|||
37948616|NCT03952143|69636222|FG002|Treatment Period|Physician Decision|2|||
37948617|NCT03952143|69636220|FG000|Treatment Period|Protocol Violation|0|||
37948618|NCT03952143|69636221|FG001|Treatment Period|Protocol Violation|0|||
37948619|NCT03952143|69636222|FG002|Treatment Period|Protocol Violation|1|||
37948620|NCT03952143|69636220|FG000|Treatment Period|Withdrawal by Subject|0|||
37948621|NCT03952143|69636221|FG001|Treatment Period|Withdrawal by Subject|5|||
37948622|NCT03952143|69636222|FG002|Treatment Period|Withdrawal by Subject|26|||
37948623|NCT03952143|69636220|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
37948624|NCT03952143|69636221|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
37948625|NCT03952143|69636222|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
37948626|NCT03952143|69636220|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
37948627|NCT03952143|69636221|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
37948628|NCT03952143|69636222|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
37948629|NCT00267007|69636231|FG000|Overall Study|Withdrawal by Subject|6|||
37948630|NCT00267007|69636232|FG001|Overall Study|Withdrawal by Subject|0|||
37948631|NCT00267007|69636231|FG000|Overall Study|Lost to Follow-up|1|||
37948632|NCT00267007|69636232|FG001|Overall Study|Lost to Follow-up|0|||
37948633|NCT00267007|69636231|FG000|Overall Study|Non-compliance|0|||
37948634|NCT00267007|69636232|FG001|Overall Study|Non-compliance|1|||
37948635|NCT00267007|69636231|FG000|Overall Study|Adverse Event|1|||
37948636|NCT00267007|69636232|FG001|Overall Study|Adverse Event|0|||
37948637|NCT03943095|69636240|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
37948638|NCT03943095|69636241|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
37948639|NCT03943095|69636240|FG000|Overall Study|Withdrawal by Subject|1|||
37948640|NCT03943095|69636241|FG001|Overall Study|Withdrawal by Subject|0|||
37948641|NCT00251641|69636250|FG000|Overall Study|Adverse Event|80|||
37948642|NCT00251641|69636251|FG001|Overall Study|Adverse Event|8|||
37948643|NCT00251641|69636250|FG000|Overall Study|Lack of Efficacy|2|||
37948644|NCT00251641|69636251|FG001|Overall Study|Lack of Efficacy|1|||
37948645|NCT00251641|69636250|FG000|Overall Study|Progression of Disease|0|||
37948646|NCT00251641|69636251|FG001|Overall Study|Progression of Disease|2|||
37948647|NCT00251641|69636250|FG000|Overall Study|Lost to Follow-up|3|||
37948648|NCT00251641|69636251|FG001|Overall Study|Lost to Follow-up|3|||
37948649|NCT00251641|69636250|FG000|Overall Study|Withdrawal by Subject|6|||
37948650|NCT00251641|69636251|FG001|Overall Study|Withdrawal by Subject|8|||
37948651|NCT00251641|69636250|FG000|Overall Study|Protocol Violation|10|||
37948652|NCT00251641|69636251|FG001|Overall Study|Protocol Violation|2|||
37948653|NCT00251641|69636250|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
37948654|NCT00251641|69636251|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
37948655|NCT00251641|69636250|FG000|Overall Study|Switched Treatment|9|||
37948656|NCT00251641|69636251|FG001|Overall Study|Switched Treatment|63|||
37948657|NCT00250705|69636259|FG000|Overall Study|Lack of Efficacy|2|||
37948658|NCT00266695|69636265|FG000|Overall Study|Adverse Event|1|||
37948659|NCT00266695|69636265|FG000|Overall Study|Death|9|||
37948660|NCT00266695|69636265|FG000|Overall Study|Physician Decision|1|||
37948661|NCT00266695|69636265|FG000|Overall Study|Lost to Follow-up|3|||
37948662|NCT00266695|69636265|FG000|Overall Study|Withdrawal by Subject|15|||
37948663|NCT00620022|69636269|FG000|Treatment Period 1|Adverse Event|4|||
37948664|NCT00620022|69636270|FG001|Treatment Period 1|Adverse Event|6|||
37948665|NCT00620022|69636269|FG000|Treatment Period 1|Subject withdrew consent|1|||
37948666|NCT00620022|69636270|FG001|Treatment Period 1|Subject withdrew consent|0|||
37948667|NCT00620022|69636269|FG000|Treatment Period 2|Adverse Event|2|||
37948668|NCT00620022|69636270|FG001|Treatment Period 2|Adverse Event|2|||
37948669|NCT00547521|69636278|FG000|Short Term Study (4 Months)|Adverse Event|1|||
37948670|NCT00547521|69636279|FG001|Short Term Study (4 Months)|Adverse Event|0|||
37948671|NCT00547521|69636278|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
37948672|NCT00547521|69636279|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
37948673|NCT00547521|69636278|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
37948674|NCT00547521|69636279|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
37948675|NCT00547521|69636278|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
37948676|NCT00547521|69636279|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
37948677|NCT00547521|69636278|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
37948678|NCT00547521|69636279|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
37948679|NCT00547521|69636278|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
37948680|NCT00547521|69636279|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
37948681|NCT00547521|69636278|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
37948682|NCT00547521|69636279|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
37948683|NCT00547521|69636278|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
37948684|NCT00547521|69636279|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
37948685|NCT00547521|69636278|FG000|Long Term Extension (LTE) Study|Other|0|||
37948686|NCT00547521|69636279|FG001|Long Term Extension (LTE) Study|Other|2|||
37948687|NCT00547521|69636278|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
37948688|NCT00547521|69636279|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
37948689|NCT00266227|69636294|FG000|Initial Treatment|Adverse Event|0|||
37948690|NCT00266227|69636295|FG001|Initial Treatment|Adverse Event|0|||
37948691|NCT00266227|69636296|FG002|Initial Treatment|Adverse Event|13|||
37948692|NCT00266227|69636294|FG000|Initial Treatment|Lost to Follow-up|0|||
37948693|NCT00266227|69636295|FG001|Initial Treatment|Lost to Follow-up|0|||
37948694|NCT00266227|69636296|FG002|Initial Treatment|Lost to Follow-up|6|||
37948695|NCT00266227|69636294|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
37948696|NCT00266227|69636295|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
37948697|NCT00266227|69636296|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
37948698|NCT00266227|69636294|FG000|Initial Treatment|Physician decision to withdraw|0|||
37948699|NCT00266227|69636295|FG001|Initial Treatment|Physician decision to withdraw|0|||
37948700|NCT00266227|69636296|FG002|Initial Treatment|Physician decision to withdraw|12|||
37948701|NCT00266227|69636294|FG000|Initial Treatment|Pregnancy|0|||
37948702|NCT00266227|69636295|FG001|Initial Treatment|Pregnancy|0|||
37948703|NCT00266227|69636296|FG002|Initial Treatment|Pregnancy|1|||
37948704|NCT00266227|69636294|FG000|Retreatment: Up to Week 48|Death|1|||
37948705|NCT00266227|69636295|FG001|Retreatment: Up to Week 48|Death|0|||
37948706|NCT00266227|69636296|FG002|Retreatment: Up to Week 48|Death|0|||
37948707|NCT00266227|69636294|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
37948708|NCT00266227|69636295|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
37948709|NCT00266227|69636296|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
37948710|NCT00266227|69636294|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
37948711|NCT00266227|69636295|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
37948712|NCT00266227|69636296|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
37948713|NCT00266227|69636294|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
37948714|NCT00266227|69636295|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
37948715|NCT00266227|69636296|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
37948716|NCT00266227|69636294|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
37948717|NCT00266227|69636295|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
37948718|NCT00266227|69636296|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
37948719|NCT00266227|69636294|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
37948720|NCT00266227|69636295|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
37948721|NCT00266227|69636296|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
37948722|NCT00266227|69636294|FG000|Retreatment: Week 48 to Week 72|Death|1|||
37948723|NCT00266227|69636295|FG001|Retreatment: Week 48 to Week 72|Death|1|||
37948724|NCT00266227|69636296|FG002|Retreatment: Week 48 to Week 72|Death|0|||
37948725|NCT00266227|69636294|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
37948726|NCT00266227|69636295|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
37948727|NCT00266227|69636296|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
37948728|NCT00266227|69636294|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
37948729|NCT00266227|69636295|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
37948730|NCT00266227|69636296|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
37948731|NCT00266227|69636294|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
37948732|NCT00266227|69636295|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
37948733|NCT00266227|69636296|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
37948734|NCT00266227|69636294|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
37948735|NCT00266227|69636295|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
37948736|NCT00266227|69636296|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
37948737|NCT00287365|69636305|FG000|Overall Study|sample not acquired|13|||
37948738|NCT00573768|69636313|FG000|Overall Study|Adverse Event|1|||
37948739|NCT00573768|69636314|FG001|Overall Study|Adverse Event|1|||
37948740|NCT00573768|69636315|FG002|Overall Study|Adverse Event|2|||
37948741|NCT00573768|69636313|FG000|Overall Study|Protocol Violation|1|||
37948742|NCT00573768|69636314|FG001|Overall Study|Protocol Violation|0|||
37948743|NCT00573768|69636315|FG002|Overall Study|Protocol Violation|1|||
37948744|NCT00573768|69636313|FG000|Overall Study|Withdrawal by Subject|0|||
37948745|NCT00573768|69636314|FG001|Overall Study|Withdrawal by Subject|1|||
37948746|NCT00573768|69636315|FG002|Overall Study|Withdrawal by Subject|0|||
37948747|NCT00573768|69636313|FG000|Overall Study|Lost to Follow-up|0|||
37948748|NCT00573768|69636314|FG001|Overall Study|Lost to Follow-up|0|||
37948749|NCT00573768|69636315|FG002|Overall Study|Lost to Follow-up|1|||
37948750|NCT00547365|69636323|FG000|Overall Study|Physician Decision|1|||
37948751|NCT00547365|69636323|FG000|Overall Study|Lost to Follow-up|1|||
37948752|NCT00547365|69636323|FG000|Overall Study|Protocol Violation|2|||
37948753|NCT00547365|69636323|FG000|Overall Study|death (not related to study)|4|||
37948754|NCT00619866|69636331|FG000|Weeks 1 - 12|Adverse Event|0|||
37948755|NCT00619866|69636332|FG001|Weeks 1 - 12|Adverse Event|1|||
37948756|NCT00619866|69636333|FG002|Weeks 1 - 12|Adverse Event|2|||
37948757|NCT00619866|69636334|FG003|Weeks 1 - 12|Adverse Event|0|||
37948758|NCT00619866|69636335|FG004|Weeks 1 - 12|Adverse Event|0|||
37948759|NCT00619866|69636331|FG000|Weeks 1 - 12|Non-compliance|0|||
37948760|NCT00619866|69636332|FG001|Weeks 1 - 12|Non-compliance|0|||
37948761|NCT00619866|69636333|FG002|Weeks 1 - 12|Non-compliance|1|||
37948762|NCT00619866|69636334|FG003|Weeks 1 - 12|Non-compliance|0|||
37948763|NCT00619866|69636335|FG004|Weeks 1 - 12|Non-compliance|0|||
37948764|NCT00619866|69636331|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
37948765|NCT00619866|69636332|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
37948766|NCT00619866|69636333|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
37948767|NCT00619866|69636334|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
37948768|NCT00619866|69636335|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
37948769|NCT00619866|69636331|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
37948770|NCT00619866|69636332|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
37948771|NCT00619866|69636333|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
37948772|NCT00619866|69636334|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
37948773|NCT00619866|69636335|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
37948774|NCT00619866|69636331|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
37948775|NCT00619866|69636332|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
37948776|NCT00619866|69636333|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
37948777|NCT00619866|69636334|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
37948778|NCT00619866|69636335|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
37948779|NCT00619866|69636331|FG000|Weeks 1 - 12|Sponsor Decision|0|||
37948780|NCT00619866|69636332|FG001|Weeks 1 - 12|Sponsor Decision|1|||
37948781|NCT00619866|69636333|FG002|Weeks 1 - 12|Sponsor Decision|0|||
37948782|NCT00619866|69636334|FG003|Weeks 1 - 12|Sponsor Decision|0|||
37948783|NCT00619866|69636335|FG004|Weeks 1 - 12|Sponsor Decision|0|||
37948784|NCT00619866|69636331|FG000|Weeks 13 - 24|Adverse Event|0|||
37948785|NCT00619866|69636332|FG001|Weeks 13 - 24|Adverse Event|0|||
37948786|NCT00619866|69636333|FG002|Weeks 13 - 24|Adverse Event|2|||
37948787|NCT00619866|69636334|FG003|Weeks 13 - 24|Adverse Event|1|||
37948788|NCT00619866|69636335|FG004|Weeks 13 - 24|Adverse Event|0|||
37948789|NCT00619866|69636331|FG000|Weeks 13 - 24|Protocol Deviation|0|||
37948790|NCT00619866|69636332|FG001|Weeks 13 - 24|Protocol Deviation|0|||
37948791|NCT00619866|69636333|FG002|Weeks 13 - 24|Protocol Deviation|0|||
37948792|NCT00619866|69636334|FG003|Weeks 13 - 24|Protocol Deviation|1|||
37948793|NCT00619866|69636335|FG004|Weeks 13 - 24|Protocol Deviation|0|||
37948794|NCT00619866|69636331|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
37948795|NCT00619866|69636332|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
37948796|NCT00619866|69636333|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
37948797|NCT00619866|69636334|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
37948798|NCT00619866|69636335|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
37948799|NCT00619866|69636331|FG000|Weeks 13 - 24|Non-compliance|0|||
37948800|NCT00619866|69636332|FG001|Weeks 13 - 24|Non-compliance|1|||
37948801|NCT00619866|69636333|FG002|Weeks 13 - 24|Non-compliance|1|||
37948802|NCT00619866|69636334|FG003|Weeks 13 - 24|Non-compliance|0|||
37948803|NCT00619866|69636335|FG004|Weeks 13 - 24|Non-compliance|0|||
37948804|NCT00619866|69636331|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
37948805|NCT00619866|69636332|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
37948806|NCT00619866|69636333|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
37948807|NCT00619866|69636334|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
37948808|NCT00619866|69636335|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
37948809|NCT03937479|69636363|FG000|Overall Study|Adverse Event|2|||
37948810|NCT03937479|69636364|FG001|Overall Study|Adverse Event|3|||
37948811|NCT03937479|69636365|FG002|Overall Study|Adverse Event|0|||
37948812|NCT03937479|69636366|FG003|Overall Study|Adverse Event|0|||
37948813|NCT03937479|69636367|FG004|Overall Study|Adverse Event|1|||
37948814|NCT03937479|69636363|FG000|Overall Study|Withdrawal by Subject|3|||
37948815|NCT03937479|69636364|FG001|Overall Study|Withdrawal by Subject|5|||
37948816|NCT03937479|69636365|FG002|Overall Study|Withdrawal by Subject|2|||
37948817|NCT03937479|69636366|FG003|Overall Study|Withdrawal by Subject|2|||
37948818|NCT03937479|69636367|FG004|Overall Study|Withdrawal by Subject|1|||
37948819|NCT03937479|69636363|FG000|Overall Study|Protocol Violation|5|||
37948820|NCT03937479|69636364|FG001|Overall Study|Protocol Violation|6|||
37948821|NCT03937479|69636365|FG002|Overall Study|Protocol Violation|4|||
37948822|NCT03937479|69636366|FG003|Overall Study|Protocol Violation|3|||
37948823|NCT03937479|69636367|FG004|Overall Study|Protocol Violation|2|||
37948824|NCT03937479|69636363|FG000|Overall Study|Lost to Follow-up|0|||
37948825|NCT03937479|69636364|FG001|Overall Study|Lost to Follow-up|1|||
37948826|NCT03937479|69636365|FG002|Overall Study|Lost to Follow-up|0|||
37948827|NCT03937479|69636366|FG003|Overall Study|Lost to Follow-up|1|||
37948828|NCT03937479|69636367|FG004|Overall Study|Lost to Follow-up|0|||
37948829|NCT03937479|69636363|FG000|Overall Study|Physician Decision|0|||
37948830|NCT03937479|69636364|FG001|Overall Study|Physician Decision|0|||
37948831|NCT03937479|69636365|FG002|Overall Study|Physician Decision|1|||
37948832|NCT03937479|69636366|FG003|Overall Study|Physician Decision|0|||
37948833|NCT03937479|69636367|FG004|Overall Study|Physician Decision|1|||
37948834|NCT00619476|69636383|FG000|Overall Study|Adverse Event|12|||
37948835|NCT00619476|69636384|FG001|Overall Study|Adverse Event|6|||
37948836|NCT00619476|69636385|FG002|Overall Study|Adverse Event|12|||
37948837|NCT00619476|69636386|FG003|Overall Study|Adverse Event|16|||
37948838|NCT00619476|69636383|FG000|Overall Study|Lack of Efficacy|6|||
37948839|NCT00619476|69636384|FG001|Overall Study|Lack of Efficacy|1|||
37948840|NCT00619476|69636385|FG002|Overall Study|Lack of Efficacy|1|||
37948841|NCT00619476|69636386|FG003|Overall Study|Lack of Efficacy|4|||
37948842|NCT00619476|69636383|FG000|Overall Study|Protocol Violation|5|||
37948843|NCT00619476|69636384|FG001|Overall Study|Protocol Violation|4|||
37948844|NCT00619476|69636385|FG002|Overall Study|Protocol Violation|4|||
37948845|NCT00619476|69636386|FG003|Overall Study|Protocol Violation|9|||
37948846|NCT00619476|69636383|FG000|Overall Study|Lost to Follow-up|1|||
37948847|NCT00619476|69636384|FG001|Overall Study|Lost to Follow-up|2|||
37948848|NCT00619476|69636385|FG002|Overall Study|Lost to Follow-up|0|||
37948849|NCT00619476|69636386|FG003|Overall Study|Lost to Follow-up|1|||
37948850|NCT00619476|69636383|FG000|Overall Study|Investigator Discretion|2|||
37948851|NCT00619476|69636384|FG001|Overall Study|Investigator Discretion|2|||
37948852|NCT00619476|69636385|FG002|Overall Study|Investigator Discretion|2|||
37948853|NCT00619476|69636386|FG003|Overall Study|Investigator Discretion|0|||
37948854|NCT00619476|69636383|FG000|Overall Study|Withdrawal by Subject|5|||
37948855|NCT00619476|69636384|FG001|Overall Study|Withdrawal by Subject|7|||
37948856|NCT00619476|69636385|FG002|Overall Study|Withdrawal by Subject|5|||
37948857|NCT00619476|69636386|FG003|Overall Study|Withdrawal by Subject|4|||
37948858|NCT00618072|69636399|FG000|Overall Study|Lost to Follow-up|2|||
37948859|NCT00618072|69636400|FG001|Overall Study|Lost to Follow-up|0|||
37948860|NCT00618072|69636401|FG002|Overall Study|Lost to Follow-up|3|||
37948861|NCT00618072|69636399|FG000|Overall Study|Physician Decision|0|||
37948862|NCT00618072|69636400|FG001|Overall Study|Physician Decision|1|||
38042373|NCT01750281|69729887|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
38042374|NCT01750281|69729888|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
38042375|NCT01750281|69729886|FG000|Overall Study|Did not receive treatment|0|||
38042376|NCT01750281|69729887|FG001|Overall Study|Did not receive treatment|1|||
38042377|NCT01750281|69729888|FG002|Overall Study|Did not receive treatment|0|||
38042378|NCT01205061|69729898|FG000|Overall Study|Adverse Event|4|||
38042379|NCT01205061|69729898|FG000|Overall Study|Withdrawal by Subject|11|||
38042380|NCT01205061|69729898|FG000|Overall Study|Clinical Investigational Plan Violation|1|||
38042381|NCT01205061|69729898|FG000|Overall Study|Lost to Follow-up|9|||
38042382|NCT01205061|69729898|FG000|Overall Study|Other|1|||
38042383|NCT01169337|69729907|FG000|Overall Study|Lack of Efficacy|5|||
38042384|NCT01169337|69729908|FG001|Overall Study|Lack of Efficacy|7|||
38042385|NCT01169337|69729909|FG002|Overall Study|Lack of Efficacy|0|||
38042386|NCT01169337|69729907|FG000|Overall Study|Adverse Event|12|||
38042387|NCT01169337|69729908|FG001|Overall Study|Adverse Event|18|||
38042388|NCT01169337|69729909|FG002|Overall Study|Adverse Event|0|||
38042389|NCT01169337|69729907|FG000|Overall Study|Death|2|||
38042390|NCT01169337|69729908|FG001|Overall Study|Death|0|||
38042391|NCT01169337|69729909|FG002|Overall Study|Death|0|||
38042392|NCT01169337|69729907|FG000|Overall Study|Withdrawal by Subject|11|||
38042393|NCT01169337|69729908|FG001|Overall Study|Withdrawal by Subject|11|||
38042394|NCT01169337|69729909|FG002|Overall Study|Withdrawal by Subject|6|||
38042395|NCT01169337|69729907|FG000|Overall Study|Noncompliance|2|||
38042396|NCT01169337|69729908|FG001|Overall Study|Noncompliance|0|||
38042397|NCT01169337|69729909|FG002|Overall Study|Noncompliance|0|||
38042398|NCT01169337|69729907|FG000|Overall Study|Other complicating disease|1|||
38042399|NCT01169337|69729908|FG001|Overall Study|Other complicating disease|1|||
38042400|NCT01169337|69729909|FG002|Overall Study|Other complicating disease|0|||
38042401|NCT01169337|69729907|FG000|Overall Study|Physician Decision|1|||
38042402|NCT01169337|69729908|FG001|Overall Study|Physician Decision|5|||
38042403|NCT01169337|69729909|FG002|Overall Study|Physician Decision|0|||
38042404|NCT01169337|69729907|FG000|Overall Study|Alternative therapy|0|||
38042405|NCT01169337|69729908|FG001|Overall Study|Alternative therapy|2|||
38042406|NCT01169337|69729909|FG002|Overall Study|Alternative therapy|0|||
38042407|NCT01169337|69729907|FG000|Overall Study|Changed hospital|0|||
38042408|NCT01169337|69729908|FG001|Overall Study|Changed hospital|1|||
38042409|NCT01169337|69729909|FG002|Overall Study|Changed hospital|0|||
38042410|NCT01169337|69729907|FG000|Overall Study|Never started treatment|0|||
38042411|NCT01169337|69729908|FG001|Overall Study|Never started treatment|2|||
38042412|NCT01169337|69729909|FG002|Overall Study|Never started treatment|0|||
38042413|NCT01169337|69729907|FG000|Overall Study|Reason not reported|1|||
38042414|NCT01169337|69729908|FG001|Overall Study|Reason not reported|0|||
38042415|NCT01169337|69729909|FG002|Overall Study|Reason not reported|0|||
38042416|NCT01169337|69729907|FG000|Overall Study|Continuing lenalidomide|9|||
38042417|NCT01169337|69729908|FG001|Overall Study|Continuing lenalidomide|43|||
38042418|NCT01169337|69729909|FG002|Overall Study|Continuing lenalidomide|0|||
38042419|NCT01108237|69729919|FG000|Overall Study|No alignment data|2|||
38042420|NCT01108237|69729920|FG001|Overall Study|No alignment data|15|||
38042421|NCT01108237|69729919|FG000|Overall Study|Did not meet criteria for analysis|7|||
38042422|NCT01108237|69729920|FG001|Overall Study|Did not meet criteria for analysis|0|||
38042423|NCT01064648|69729943|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
38042424|NCT01064648|69729944|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
38042425|NCT01064648|69729945|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
38042426|NCT01064648|69729946|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
38042427|NCT01064648|69729943|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
38042428|NCT01064648|69729944|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
38042429|NCT01064648|69729945|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
38042430|NCT01064648|69729946|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
38042431|NCT01064648|69729943|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
38042432|NCT01064648|69729944|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
38042433|NCT01064648|69729945|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
38042434|NCT01064648|69729946|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
38042435|NCT01064648|69729943|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
38042436|NCT01064648|69729944|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
38042437|NCT01064648|69729945|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
37860486|NCT01148511|69543866|FG002|Randomized|Other|1|||
38042438|NCT01064648|69729946|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
37860487|NCT00547339|69543877|FG000|Overall Study|Physician Decision|0|||
37860488|NCT00547339|69543878|FG001|Overall Study|Physician Decision|0|||
37860489|NCT00547339|69543879|FG002|Overall Study|Physician Decision|1|||
37860490|NCT00547339|69543880|FG003|Overall Study|Physician Decision|0|||
37860491|NCT01227252|69543903|FG000|Overall Study|Sponsor Decision|0|||
38042439|NCT01064648|69729943|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
38042440|NCT01064648|69729944|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
38042441|NCT01064648|69729945|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
38042442|NCT01064648|69729946|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
38042443|NCT01064648|69729943|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
38042444|NCT01064648|69729944|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
38042445|NCT01064648|69729945|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
38042446|NCT01064648|69729946|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
38042447|NCT01064648|69729943|FG000|Phase II|Adverse Event|0|||
38042448|NCT01064648|69729944|FG001|Phase II|Adverse Event|0|||
38042449|NCT01064648|69729945|FG002|Phase II|Adverse Event|15|||
38042450|NCT01064648|69729946|FG003|Phase II|Adverse Event|8|||
38042451|NCT01064648|69729943|FG000|Phase II|Death|0|||
38042452|NCT01064648|69729944|FG001|Phase II|Death|0|||
38042453|NCT01064648|69729945|FG002|Phase II|Death|4|||
38042454|NCT01064648|69729946|FG003|Phase II|Death|5|||
38042455|NCT01064648|69729943|FG000|Phase II|Withdrawal by Subject|0|||
38042456|NCT01064648|69729944|FG001|Phase II|Withdrawal by Subject|0|||
38042457|NCT01064648|69729945|FG002|Phase II|Withdrawal by Subject|2|||
38042458|NCT01064648|69729946|FG003|Phase II|Withdrawal by Subject|5|||
38042459|NCT01064648|69729943|FG000|Phase II|Progression|0|||
38042460|NCT01064648|69729944|FG001|Phase II|Progression|0|||
38042461|NCT01064648|69729945|FG002|Phase II|Progression|21|||
38042462|NCT01064648|69729946|FG003|Phase II|Progression|27|||
38042463|NCT01064648|69729943|FG000|Phase II|Non-protocol specified|0|||
38042464|NCT01064648|69729944|FG001|Phase II|Non-protocol specified|0|||
38042465|NCT01064648|69729945|FG002|Phase II|Non-protocol specified|5|||
38042466|NCT01064648|69729946|FG003|Phase II|Non-protocol specified|3|||
38042467|NCT01064648|69729943|FG000|Phase II|Under Review|0|||
38042468|NCT01064648|69729944|FG001|Phase II|Under Review|0|||
38042469|NCT01064648|69729945|FG002|Phase II|Under Review|2|||
38042470|NCT01064648|69729946|FG003|Phase II|Under Review|0|||
38042471|NCT00972478|69729961|FG000|Overall Study|Adverse Event|3|||
38042472|NCT00972478|69729962|FG001|Overall Study|Adverse Event|16|||
38042473|NCT00972478|69729961|FG000|Overall Study|Withdrawal by Subject|1|||
38042474|NCT00972478|69729962|FG001|Overall Study|Withdrawal by Subject|8|||
38042475|NCT00972478|69729961|FG000|Overall Study|Progression/Relapse|0|||
38042476|NCT00972478|69729962|FG001|Overall Study|Progression/Relapse|2|||
38042477|NCT00972478|69729961|FG000|Overall Study|Death|0|||
38042478|NCT00972478|69729962|FG001|Overall Study|Death|2|||
38042479|NCT00972478|69729961|FG000|Overall Study|Not protocol specified|1|||
38042480|NCT00972478|69729962|FG001|Overall Study|Not protocol specified|1|||
38042481|NCT00972478|69729961|FG000|Overall Study|Ineligible|1|||
38042482|NCT00972478|69729962|FG001|Overall Study|Ineligible|7|||
38042483|NCT00972478|69729961|FG000|Overall Study|Not start protocol treatment|1|||
38042484|NCT00972478|69729962|FG001|Overall Study|Not start protocol treatment|2|||
38042485|NCT00769379|69729980|FG000|Overall Study|No follow up data mapped to Other.|3|||
38042486|NCT00769379|69729981|FG001|Overall Study|No follow up data mapped to Other.|13|||
38042487|NCT00736450|69729987|FG000|Overall Study|Not ABC gene eligible|19|||
38042488|NCT00736450|69729987|FG000|Overall Study|Withdrawal by Subject|5|||
38042489|NCT00736450|69729987|FG000|Overall Study|Physician Decision|1|||
38042490|NCT00571662|69730008|FG000|Overall Study|Withdrawal by Subject|2|||
38042491|NCT00571662|69730008|FG000|Overall Study|psychiatric instability|1|||
38042492|NCT00571662|69730008|FG000|Overall Study|Adverse Event|5|||
38042493|NCT05091307|69730031|FG000|Overall Study|Death|0|||
38042494|NCT05091307|69730032|FG001|Overall Study|Death|0|||
38042495|NCT05091307|69730033|FG002|Overall Study|Death|1|||
38042496|NCT05091307|69730034|FG003|Overall Study|Death|0|||
38042497|NCT05091307|69730031|FG000|Overall Study|Lost to Follow-up|33|||
38042498|NCT05091307|69730032|FG001|Overall Study|Lost to Follow-up|33|||
38042499|NCT05091307|69730033|FG002|Overall Study|Lost to Follow-up|2|||
38042500|NCT05091307|69730034|FG003|Overall Study|Lost to Follow-up|0|||
38042501|NCT05091307|69730031|FG000|Overall Study|Physician Decision|1|||
38042502|NCT05091307|69730032|FG001|Overall Study|Physician Decision|0|||
38042503|NCT05091307|69730033|FG002|Overall Study|Physician Decision|0|||
38042504|NCT05091307|69730034|FG003|Overall Study|Physician Decision|0|||
38042505|NCT05091307|69730031|FG000|Overall Study|Protocol Violation|1|||
38042506|NCT05091307|69730032|FG001|Overall Study|Protocol Violation|0|||
38042507|NCT05091307|69730033|FG002|Overall Study|Protocol Violation|0|||
38042508|NCT05091307|69730034|FG003|Overall Study|Protocol Violation|0|||
38042509|NCT05091307|69730031|FG000|Overall Study|Withdrawal by Subject|16|||
38042510|NCT05091307|69730032|FG001|Overall Study|Withdrawal by Subject|16|||
38042511|NCT05091307|69730033|FG002|Overall Study|Withdrawal by Subject|0|||
38042512|NCT05091307|69730034|FG003|Overall Study|Withdrawal by Subject|1|||
38042513|NCT05091307|69730031|FG000|Overall Study|Covid-19 Vaccine/Treatment|14|||
38042514|NCT05091307|69730032|FG001|Overall Study|Covid-19 Vaccine/Treatment|15|||
38042515|NCT05091307|69730033|FG002|Overall Study|Covid-19 Vaccine/Treatment|1|||
38042516|NCT05091307|69730034|FG003|Overall Study|Covid-19 Vaccine/Treatment|1|||
38042517|NCT05091307|69730031|FG000|Overall Study|Initiated Prohibited Medication|1|||
38042518|NCT05091307|69730032|FG001|Overall Study|Initiated Prohibited Medication|0|||
38042519|NCT05091307|69730033|FG002|Overall Study|Initiated Prohibited Medication|0|||
37948863|NCT00618072|69636401|FG002|Overall Study|Physician Decision|1|||
37948864|NCT00666926|69636409|FG000|Overall Study|Adverse Event|0|||
37948865|NCT00666926|69636410|FG001|Overall Study|Adverse Event|0|||
37948866|NCT00666926|69636411|FG002|Overall Study|Adverse Event|0|||
37948867|NCT00666926|69636412|FG003|Overall Study|Adverse Event|0|||
37948868|NCT00666926|69636413|FG004|Overall Study|Adverse Event|0|||
37948869|NCT00666926|69636414|FG005|Overall Study|Adverse Event|0|||
37948870|NCT00666926|69636415|FG006|Overall Study|Adverse Event|0|||
37948871|NCT00666926|69636416|FG007|Overall Study|Adverse Event|0|||
37948872|NCT00666926|69636417|FG008|Overall Study|Adverse Event|0|||
37948873|NCT00666926|69636418|FG009|Overall Study|Adverse Event|2|||
37948874|NCT00666926|69636419|FG010|Overall Study|Adverse Event|2|||
37948875|NCT00666926|69636420|FG011|Overall Study|Adverse Event|2|||
37948876|NCT00666926|69636421|FG012|Overall Study|Adverse Event|0|||
37948877|NCT00666926|69636422|FG013|Overall Study|Adverse Event|1|||
37948878|NCT00666926|69636423|FG014|Overall Study|Adverse Event|0|||
37948879|NCT00666926|69636424|FG015|Overall Study|Adverse Event|0|||
37948880|NCT00666926|69636409|FG000|Overall Study|Laboratory abnormality|0|||
37948881|NCT00666926|69636410|FG001|Overall Study|Laboratory abnormality|0|||
37948882|NCT00666926|69636411|FG002|Overall Study|Laboratory abnormality|0|||
37948883|NCT00666926|69636412|FG003|Overall Study|Laboratory abnormality|0|||
37948884|NCT00666926|69636413|FG004|Overall Study|Laboratory abnormality|0|||
37948885|NCT00666926|69636414|FG005|Overall Study|Laboratory abnormality|0|||
37948886|NCT00666926|69636415|FG006|Overall Study|Laboratory abnormality|0|||
37948887|NCT00666926|69636416|FG007|Overall Study|Laboratory abnormality|0|||
37948888|NCT00666926|69636417|FG008|Overall Study|Laboratory abnormality|0|||
37948889|NCT00666926|69636418|FG009|Overall Study|Laboratory abnormality|0|||
37948890|NCT00666926|69636419|FG010|Overall Study|Laboratory abnormality|1|||
37948891|NCT00666926|69636420|FG011|Overall Study|Laboratory abnormality|0|||
37948892|NCT00666926|69636421|FG012|Overall Study|Laboratory abnormality|0|||
37948893|NCT00666926|69636422|FG013|Overall Study|Laboratory abnormality|0|||
37948894|NCT00666926|69636423|FG014|Overall Study|Laboratory abnormality|0|||
37948895|NCT00666926|69636424|FG015|Overall Study|Laboratory abnormality|1|||
37948896|NCT00666926|69636409|FG000|Overall Study|Lack of Efficacy|0|||
37948897|NCT00666926|69636410|FG001|Overall Study|Lack of Efficacy|0|||
37948898|NCT00666926|69636411|FG002|Overall Study|Lack of Efficacy|0|||
37948899|NCT00666926|69636412|FG003|Overall Study|Lack of Efficacy|0|||
37948900|NCT00666926|69636413|FG004|Overall Study|Lack of Efficacy|0|||
37948901|NCT00666926|69636414|FG005|Overall Study|Lack of Efficacy|1|||
37948902|NCT00666926|69636415|FG006|Overall Study|Lack of Efficacy|0|||
37948903|NCT00666926|69636416|FG007|Overall Study|Lack of Efficacy|0|||
38042520|NCT05091307|69730034|FG003|Overall Study|Initiated Prohibited Medication|0|||
38042521|NCT05091307|69730031|FG000|Overall Study|Other|4|||
38042522|NCT05091307|69730032|FG001|Overall Study|Other|4|||
38042523|NCT05091307|69730033|FG002|Overall Study|Other|0|||
38042524|NCT05091307|69730034|FG003|Overall Study|Other|0|||
38042525|NCT05091307|69730031|FG000|Overall Study|Randomized but not vaccinated|0|||
38042526|NCT05091307|69730032|FG001|Overall Study|Randomized but not vaccinated|2|||
38042527|NCT05091307|69730033|FG002|Overall Study|Randomized but not vaccinated|0|||
38042528|NCT05091307|69730034|FG003|Overall Study|Randomized but not vaccinated|0|||
38042529|NCT04446377|69730052|FG000|Overall Study|Withdrawal by Subject|6|||
38042530|NCT04446377|69730053|FG001|Overall Study|Withdrawal by Subject|1|||
38042531|NCT04446377|69730052|FG000|Overall Study|Physician Decision|1|||
38042532|NCT04446377|69730053|FG001|Overall Study|Physician Decision|1|||
38042533|NCT04446377|69730052|FG000|Overall Study|Lost to Follow-up|0|||
38042534|NCT04446377|69730053|FG001|Overall Study|Lost to Follow-up|2|||
38042535|NCT04446377|69730052|FG000|Overall Study|Not eligible|0|||
38042536|NCT04446377|69730053|FG001|Overall Study|Not eligible|1|||
38042537|NCT04398368|69730063|FG000|Overall Study|Withdrawal by Subject|2|||
38042538|NCT04275297|69730069|FG000|Overall Study|Lost to Follow-up|1|||
38042539|NCT04275297|69730070|FG001|Overall Study|Lost to Follow-up|1|||
38042540|NCT04247282|69730080|FG000|Overall Study|Participant declined to participate before treatment started.|0|||
38042541|NCT04247282|69730081|FG001|Overall Study|Participant declined to participate before treatment started.|0|||
38042542|NCT04247282|69730082|FG002|Overall Study|Participant declined to participate before treatment started.|0|||
38042543|NCT04247282|69730083|FG003|Overall Study|Participant declined to participate before treatment started.|1|||
38042544|NCT04247282|69730080|FG000|Overall Study|Refused further treatment|0|||
38042545|NCT04247282|69730081|FG001|Overall Study|Refused further treatment|1|||
38042546|NCT04247282|69730082|FG002|Overall Study|Refused further treatment|0|||
38042547|NCT04247282|69730083|FG003|Overall Study|Refused further treatment|0|||
38042548|NCT04224688|69730094|FG000|Overall Study|Withdrawal by Subject|1|||
37948904|NCT00666926|69636417|FG008|Overall Study|Lack of Efficacy|0|||
37948905|NCT00666926|69636418|FG009|Overall Study|Lack of Efficacy|0|||
37948906|NCT00666926|69636419|FG010|Overall Study|Lack of Efficacy|0|||
37948907|NCT00666926|69636420|FG011|Overall Study|Lack of Efficacy|1|||
37948908|NCT00666926|69636421|FG012|Overall Study|Lack of Efficacy|0|||
37948909|NCT00666926|69636422|FG013|Overall Study|Lack of Efficacy|0|||
37948910|NCT00666926|69636423|FG014|Overall Study|Lack of Efficacy|0|||
37948911|NCT00666926|69636424|FG015|Overall Study|Lack of Efficacy|0|||
37948912|NCT00666926|69636409|FG000|Overall Study|Lost to Follow-up|0|||
37948913|NCT00666926|69636410|FG001|Overall Study|Lost to Follow-up|0|||
37948914|NCT00666926|69636411|FG002|Overall Study|Lost to Follow-up|0|||
37948915|NCT00666926|69636412|FG003|Overall Study|Lost to Follow-up|1|||
37948916|NCT00666926|69636413|FG004|Overall Study|Lost to Follow-up|0|||
37948917|NCT00666926|69636414|FG005|Overall Study|Lost to Follow-up|0|||
37948918|NCT00666926|69636415|FG006|Overall Study|Lost to Follow-up|0|||
37948919|NCT00666926|69636416|FG007|Overall Study|Lost to Follow-up|0|||
37948920|NCT00666926|69636417|FG008|Overall Study|Lost to Follow-up|0|||
37677081|NCT02531373|69151982|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
37677082|NCT02531373|69151983|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
37677083|NCT02531373|69151984|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
37948921|NCT00666926|69636418|FG009|Overall Study|Lost to Follow-up|0|||
37948922|NCT00666926|69636419|FG010|Overall Study|Lost to Follow-up|0|||
37948923|NCT00666926|69636420|FG011|Overall Study|Lost to Follow-up|0|||
37948924|NCT00666926|69636421|FG012|Overall Study|Lost to Follow-up|0|||
37948925|NCT00666926|69636422|FG013|Overall Study|Lost to Follow-up|0|||
37948926|NCT00666926|69636423|FG014|Overall Study|Lost to Follow-up|0|||
37948927|NCT00666926|69636424|FG015|Overall Study|Lost to Follow-up|0|||
37948928|NCT00666926|69636409|FG000|Overall Study|Other|2|||
37948929|NCT00666926|69636410|FG001|Overall Study|Other|4|||
37677084|NCT02531373|69151985|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
37948930|NCT00666926|69636411|FG002|Overall Study|Other|3|||
37948931|NCT00666926|69636412|FG003|Overall Study|Other|3|||
37948932|NCT00666926|69636413|FG004|Overall Study|Other|3|||
37948933|NCT00666926|69636414|FG005|Overall Study|Other|3|||
37948934|NCT00666926|69636415|FG006|Overall Study|Other|4|||
37948935|NCT00666926|69636416|FG007|Overall Study|Other|0|||
37948936|NCT00666926|69636417|FG008|Overall Study|Other|3|||
37948937|NCT00666926|69636418|FG009|Overall Study|Other|5|||
37948938|NCT00666926|69636419|FG010|Overall Study|Other|3|||
37948939|NCT00666926|69636420|FG011|Overall Study|Other|26|||
37948940|NCT00666926|69636421|FG012|Overall Study|Other|3|||
37948941|NCT00666926|69636422|FG013|Overall Study|Other|2|||
37948942|NCT00666926|69636423|FG014|Overall Study|Other|4|||
37948943|NCT00666926|69636424|FG015|Overall Study|Other|4|||
37948944|NCT00666926|69636409|FG000|Overall Study|Withdrawal by Subject|0|||
37948945|NCT00666926|69636410|FG001|Overall Study|Withdrawal by Subject|0|||
37948946|NCT00666926|69636411|FG002|Overall Study|Withdrawal by Subject|0|||
37948947|NCT00666926|69636412|FG003|Overall Study|Withdrawal by Subject|0|||
37948948|NCT00666926|69636413|FG004|Overall Study|Withdrawal by Subject|0|||
37948949|NCT00666926|69636414|FG005|Overall Study|Withdrawal by Subject|0|||
37948950|NCT00666926|69636415|FG006|Overall Study|Withdrawal by Subject|0|||
37948951|NCT00666926|69636416|FG007|Overall Study|Withdrawal by Subject|1|||
37948952|NCT00666926|69636417|FG008|Overall Study|Withdrawal by Subject|0|||
37948953|NCT00666926|69636418|FG009|Overall Study|Withdrawal by Subject|3|||
37948954|NCT00666926|69636419|FG010|Overall Study|Withdrawal by Subject|0|||
37948955|NCT00666926|69636420|FG011|Overall Study|Withdrawal by Subject|3|||
37948956|NCT00666926|69636421|FG012|Overall Study|Withdrawal by Subject|0|||
37948957|NCT00666926|69636422|FG013|Overall Study|Withdrawal by Subject|1|||
37948958|NCT00666926|69636423|FG014|Overall Study|Withdrawal by Subject|3|||
37948959|NCT00666926|69636424|FG015|Overall Study|Withdrawal by Subject|3|||
37948960|NCT00666926|69636409|FG000|Overall Study|Death|0|||
37948961|NCT00666926|69636410|FG001|Overall Study|Death|0|||
37948962|NCT00666926|69636411|FG002|Overall Study|Death|0|||
37948963|NCT00666926|69636412|FG003|Overall Study|Death|0|||
37948964|NCT00666926|69636413|FG004|Overall Study|Death|0|||
37948965|NCT00666926|69636414|FG005|Overall Study|Death|0|||
37948966|NCT00666926|69636415|FG006|Overall Study|Death|0|||
37948967|NCT00666926|69636416|FG007|Overall Study|Death|0|||
37948968|NCT00666926|69636417|FG008|Overall Study|Death|0|||
37948969|NCT00666926|69636418|FG009|Overall Study|Death|0|||
37948970|NCT00666926|69636419|FG010|Overall Study|Death|0|||
37948971|NCT00666926|69636420|FG011|Overall Study|Death|1|||
37948972|NCT00666926|69636421|FG012|Overall Study|Death|0|||
37948973|NCT00666926|69636422|FG013|Overall Study|Death|0|||
37948974|NCT00666926|69636423|FG014|Overall Study|Death|0|||
37948975|NCT00666926|69636424|FG015|Overall Study|Death|0|||
37948976|NCT03861052|69636479|FG000|Overall Study|Adverse Event|1|||
37948977|NCT03861052|69636480|FG001|Overall Study|Adverse Event|1|||
37948978|NCT03861052|69636481|FG002|Overall Study|Adverse Event|2|||
37677085|NCT02531373|69151986|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
37948979|NCT03861052|69636482|FG003|Overall Study|Adverse Event|4|||
37948980|NCT03861052|69636479|FG000|Overall Study|Lost to Follow-up|0|||
37948981|NCT03861052|69636480|FG001|Overall Study|Lost to Follow-up|0|||
37948982|NCT03861052|69636481|FG002|Overall Study|Lost to Follow-up|0|||
37948983|NCT03861052|69636482|FG003|Overall Study|Lost to Follow-up|1|||
37948984|NCT03861052|69636479|FG000|Overall Study|Physician Decision|0|||
37948985|NCT03861052|69636480|FG001|Overall Study|Physician Decision|1|||
37948986|NCT03861052|69636481|FG002|Overall Study|Physician Decision|0|||
37948987|NCT03861052|69636482|FG003|Overall Study|Physician Decision|0|||
37948988|NCT03861052|69636479|FG000|Overall Study|Withdrawal by Subject|2|||
37948989|NCT03861052|69636480|FG001|Overall Study|Withdrawal by Subject|5|||
37948990|NCT03861052|69636481|FG002|Overall Study|Withdrawal by Subject|3|||
37948991|NCT03861052|69636482|FG003|Overall Study|Withdrawal by Subject|0|||
37948992|NCT03861052|69636479|FG000|Overall Study|Relocation to other city|1|||
37948993|NCT03861052|69636480|FG001|Overall Study|Relocation to other city|0|||
37948994|NCT03861052|69636481|FG002|Overall Study|Relocation to other city|0|||
37948995|NCT03861052|69636482|FG003|Overall Study|Relocation to other city|0|||
37948996|NCT00664742|69636497|FG000|Overall Study|Withdrawn due to adverse events|3|||
37948997|NCT00664742|69636497|FG000|Overall Study|Withdrawal by Subject|31|||
37948998|NCT00664742|69636497|FG000|Overall Study|Lost to Follow-up|92|||
37948999|NCT00511342|69636503|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
37949000|NCT00511342|69636504|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
37949001|NCT00511342|69636503|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
37949002|NCT00511342|69636504|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
37949003|NCT00511342|69636503|FG000|Overall Study|Pregnancy|0|||
37949004|NCT00511342|69636504|FG001|Overall Study|Pregnancy|1|||
37949005|NCT00511342|69636503|FG000|Overall Study|Pregnancy wish|0|||
37949006|NCT00511342|69636504|FG001|Overall Study|Pregnancy wish|1|||
37949007|NCT00511342|69636503|FG000|Overall Study|Lost to Follow-up|1|||
37949008|NCT00511342|69636504|FG001|Overall Study|Lost to Follow-up|5|||
37949009|NCT00511342|69636503|FG000|Overall Study|Other Reason|2|||
37949010|NCT00511342|69636504|FG001|Overall Study|Other Reason|2|||
37949011|NCT03931785|69636514|FG000|Overall Study|Lost to Follow-up|4|||
37949012|NCT03931785|69636515|FG001|Overall Study|Lost to Follow-up|1|||
37949013|NCT03931785|69636516|FG002|Overall Study|Lost to Follow-up|4|||
37949014|NCT03931785|69636517|FG003|Overall Study|Lost to Follow-up|3|||
37949015|NCT03931785|69636514|FG000|Overall Study|Adverse Event|1|||
37949016|NCT03931785|69636515|FG001|Overall Study|Adverse Event|0|||
37949017|NCT03931785|69636516|FG002|Overall Study|Adverse Event|3|||
37949018|NCT03931785|69636517|FG003|Overall Study|Adverse Event|4|||
37949019|NCT03931785|69636514|FG000|Overall Study|Protocol Violation|0|||
37949020|NCT03931785|69636515|FG001|Overall Study|Protocol Violation|1|||
37949021|NCT03931785|69636516|FG002|Overall Study|Protocol Violation|0|||
37949022|NCT03931785|69636517|FG003|Overall Study|Protocol Violation|0|||
37949023|NCT03931785|69636514|FG000|Overall Study|Noncompliance With Study drug|0|||
37949024|NCT03931785|69636515|FG001|Overall Study|Noncompliance With Study drug|1|||
37949025|NCT03931785|69636516|FG002|Overall Study|Noncompliance With Study drug|0|||
37949026|NCT03931785|69636517|FG003|Overall Study|Noncompliance With Study drug|0|||
37949027|NCT03931785|69636514|FG000|Overall Study|Other Not specified|0|||
37949028|NCT03931785|69636515|FG001|Overall Study|Other Not specified|2|||
37949029|NCT03931785|69636516|FG002|Overall Study|Other Not specified|2|||
37949030|NCT03931785|69636517|FG003|Overall Study|Other Not specified|2|||
37949031|NCT03931785|69636514|FG000|Overall Study|Withdrawal by Subject|0|||
37949032|NCT03931785|69636515|FG001|Overall Study|Withdrawal by Subject|2|||
37949033|NCT03931785|69636516|FG002|Overall Study|Withdrawal by Subject|4|||
37949034|NCT03931785|69636517|FG003|Overall Study|Withdrawal by Subject|1|||
37949035|NCT03931785|69636514|FG000|Overall Study|Pregnancy|0|||
37949036|NCT03931785|69636515|FG001|Overall Study|Pregnancy|0|||
37949037|NCT03931785|69636516|FG002|Overall Study|Pregnancy|0|||
37949038|NCT03931785|69636517|FG003|Overall Study|Pregnancy|1|||
37949039|NCT00666536|69636529|FG000|Overall Study|Adverse Event|9|||
37949040|NCT00666536|69636530|FG001|Overall Study|Adverse Event|19|||
37949041|NCT00666536|69636529|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
37949042|NCT00666536|69636530|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
37949043|NCT00666536|69636529|FG000|Overall Study|Protocol deviation(s)|8|||
37949044|NCT00666536|69636530|FG001|Overall Study|Protocol deviation(s)|6|||
37949045|NCT00666536|69636529|FG000|Overall Study|Withdrawal by Subject|10|||
37949046|NCT00666536|69636530|FG001|Overall Study|Withdrawal by Subject|9|||
37949047|NCT00666536|69636529|FG000|Overall Study|Lost to Follow-up|4|||
37949048|NCT00666536|69636530|FG001|Overall Study|Lost to Follow-up|3|||
37949049|NCT00519532|69636536|FG000|Overall Study|Adverse Event|11|||
37949050|NCT00519532|69636536|FG000|Overall Study|Withdrawal by Subject|5|||
37949051|NCT00519532|69636536|FG000|Overall Study|Lost to Follow-up|2|||
37949052|NCT00666458|69636542|FG000|Overall Study|Adverse Event|8|||
37949053|NCT00666458|69636543|FG001|Overall Study|Adverse Event|7|||
37949054|NCT00666458|69636542|FG000|Overall Study|Withdrawal by Subject|5|||
37949055|NCT00666458|69636543|FG001|Overall Study|Withdrawal by Subject|4|||
37949056|NCT00666458|69636542|FG000|Overall Study|Lost to Follow-up|0|||
37949057|NCT00666458|69636543|FG001|Overall Study|Lost to Follow-up|3|||
37949058|NCT00666458|69636542|FG000|Overall Study|Administrative reason by sponsor|1|||
37949059|NCT00666458|69636543|FG001|Overall Study|Administrative reason by sponsor|1|||
37949060|NCT00666458|69636542|FG000|Overall Study|Incorrect enrollment|7|||
37949061|NCT00666458|69636543|FG001|Overall Study|Incorrect enrollment|1|||
37949062|NCT00666458|69636542|FG000|Overall Study|Study specific discontinuation criteria|14|||
37949063|NCT00666458|69636543|FG001|Overall Study|Study specific discontinuation criteria|7|||
37949064|NCT00666458|69636542|FG000|Overall Study|Severe non-compliance to the protocol|1|||
37949065|NCT00666458|69636543|FG001|Overall Study|Severe non-compliance to the protocol|1|||
37949066|NCT00666458|69636542|FG000|Overall Study|Safety reasons|1|||
37949067|NCT00666458|69636543|FG001|Overall Study|Safety reasons|0|||
37949068|NCT00666458|69636542|FG000|Overall Study|Medical history of anemia|1|||
37949069|NCT00666458|69636543|FG001|Overall Study|Medical history of anemia|0|||
37949070|NCT00511108|69636553|FG000|Overall Study|Adverse Event|2|||
37949071|NCT00511108|69636554|FG001|Overall Study|Adverse Event|0|||
37949072|NCT00511108|69636555|FG002|Overall Study|Adverse Event|1|||
37949073|NCT00511108|69636556|FG003|Overall Study|Adverse Event|2|||
37949074|NCT00511108|69636553|FG000|Overall Study|Lost to Follow-up|0|||
37949075|NCT00511108|69636554|FG001|Overall Study|Lost to Follow-up|2|||
37949076|NCT00511108|69636555|FG002|Overall Study|Lost to Follow-up|1|||
37949077|NCT00511108|69636556|FG003|Overall Study|Lost to Follow-up|0|||
37949078|NCT00511108|69636553|FG000|Overall Study|Physician Decision|0|||
37949079|NCT00511108|69636554|FG001|Overall Study|Physician Decision|0|||
37949080|NCT00511108|69636555|FG002|Overall Study|Physician Decision|0|||
37949081|NCT00511108|69636556|FG003|Overall Study|Physician Decision|1|||
37949082|NCT00511108|69636553|FG000|Overall Study|Withdrawal by Subject|4|||
37949083|NCT00511108|69636554|FG001|Overall Study|Withdrawal by Subject|0|||
37949084|NCT00511108|69636555|FG002|Overall Study|Withdrawal by Subject|3|||
37949085|NCT00511108|69636556|FG003|Overall Study|Withdrawal by Subject|2|||
37949086|NCT00510952|69636568|FG000|Overall Study|Adverse Event|1|||
37949087|NCT00510952|69636569|FG001|Overall Study|Adverse Event|0|||
37949088|NCT00510952|69636568|FG000|Overall Study|Entry Criteria Not Met|3|||
37949089|NCT00510952|69636569|FG001|Overall Study|Entry Criteria Not Met|1|||
37949090|NCT00510952|69636568|FG000|Overall Study|Lost to Follow-up|5|||
37949091|NCT00510952|69636569|FG001|Overall Study|Lost to Follow-up|3|||
37949092|NCT00510952|69636568|FG000|Overall Study|Physician Decision|1|||
37949093|NCT00510952|69636569|FG001|Overall Study|Physician Decision|1|||
37949094|NCT00510952|69636568|FG000|Overall Study|Protocol Violation|7|||
37949095|NCT00510952|69636569|FG001|Overall Study|Protocol Violation|4|||
37949096|NCT00510952|69636568|FG000|Overall Study|Sponsor Decision|1|||
37949097|NCT00510952|69636569|FG001|Overall Study|Sponsor Decision|0|||
37949098|NCT00510952|69636568|FG000|Overall Study|Withdrawal by Subject|6|||
37949099|NCT00510952|69636569|FG001|Overall Study|Withdrawal by Subject|7|||
37949100|NCT00510952|69636568|FG000|Overall Study|Did Not Receive Study Drug|2|||
37677086|NCT02531373|69151987|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
37677087|NCT02531373|69151979|FG000|Overall Study|Withdrawal by Subject|0|||
37677088|NCT02531373|69151980|FG001|Overall Study|Withdrawal by Subject|0|||
37677089|NCT02531373|69151981|FG002|Overall Study|Withdrawal by Subject|0|||
37677090|NCT02531373|69151982|FG003|Overall Study|Withdrawal by Subject|0|||
37677091|NCT02531373|69151983|FG004|Overall Study|Withdrawal by Subject|3|||
37677092|NCT02531373|69151984|FG005|Overall Study|Withdrawal by Subject|0|||
37677093|NCT02531373|69151985|FG006|Overall Study|Withdrawal by Subject|0|||
37677094|NCT02531373|69151986|FG007|Overall Study|Withdrawal by Subject|0|||
37677095|NCT02531373|69151987|FG008|Overall Study|Withdrawal by Subject|0|||
37677096|NCT02606279|69152010|FG000|Overall Study|Lost to Follow-up|0|||
37677097|NCT02606279|69152011|FG001|Overall Study|Lost to Follow-up|1|||
37677098|NCT02643355|69152025|FG000|Overall Study|Withdrawal by Subject|1|||
37677099|NCT02643355|69152026|FG001|Overall Study|Withdrawal by Subject|3|||
37677100|NCT02643355|69152025|FG000|Overall Study|Protocol Violation|0|||
37677101|NCT02643355|69152026|FG001|Overall Study|Protocol Violation|2|||
37677102|NCT02604017|69152034|FG000|Overall Study|Withdrew Consent|0|||
37677103|NCT02604017|69152035|FG001|Overall Study|Withdrew Consent|2|||
37677104|NCT02604017|69152034|FG000|Overall Study|Lost to Follow-up|5|||
37949101|NCT00510952|69636569|FG001|Overall Study|Did Not Receive Study Drug|0|||
37949102|NCT00617604|69636577|FG000|Overall Study|Death|2|||
37949103|NCT00617604|69636578|FG001|Overall Study|Death|1|||
37949104|NCT00617604|69636577|FG000|Overall Study|Lost to Follow-up|1|||
37949105|NCT00617604|69636578|FG001|Overall Study|Lost to Follow-up|0|||
37949106|NCT00617604|69636577|FG000|Overall Study|Miscellaneous Reasons|8|||
37949107|NCT00617604|69636578|FG001|Overall Study|Miscellaneous Reasons|10|||
37949108|NCT00617604|69636577|FG000|Overall Study|Withdrawal by Subject|4|||
37949109|NCT00617604|69636578|FG001|Overall Study|Withdrawal by Subject|6|||
37949110|NCT00617604|69636577|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
37949111|NCT00617604|69636578|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
37949112|NCT00661622|69636586|FG000|Overall Study|Protocol Violation|1|||
37949113|NCT00661622|69636587|FG001|Overall Study|Protocol Violation|0|||
37949114|NCT04093752|69636598|FG000|Overall Study|Adverse Event|7|||
37949115|NCT04093752|69636599|FG001|Overall Study|Adverse Event|19|||
37677105|NCT02604017|69152035|FG001|Overall Study|Lost to Follow-up|6|||
37677106|NCT02604017|69152034|FG000|Overall Study|Other|1|||
37677107|NCT02604017|69152035|FG001|Overall Study|Other|0|||
37677108|NCT02640547|69152041|FG000|Overall Study|Failure to Return|1|||
37677109|NCT02640547|69152041|FG000|Overall Study|Withdrawal by Subject|1|||
37677110|NCT02640547|69152041|FG000|Overall Study|Death|6|||
37949116|NCT04093752|69636600|FG002|Overall Study|Adverse Event|18|||
37949117|NCT04093752|69636601|FG003|Overall Study|Adverse Event|4|||
37949118|NCT04093752|69636598|FG000|Overall Study|Withdrawal by Subject|6|||
37949119|NCT04093752|69636599|FG001|Overall Study|Withdrawal by Subject|6|||
37949120|NCT04093752|69636600|FG002|Overall Study|Withdrawal by Subject|8|||
37949121|NCT04093752|69636601|FG003|Overall Study|Withdrawal by Subject|20|||
37949122|NCT04093752|69636598|FG000|Overall Study|Lost to Follow-up|2|||
37949123|NCT04093752|69636599|FG001|Overall Study|Lost to Follow-up|1|||
37949124|NCT04093752|69636600|FG002|Overall Study|Lost to Follow-up|1|||
37949125|NCT04093752|69636601|FG003|Overall Study|Lost to Follow-up|1|||
37949126|NCT04093752|69636598|FG000|Overall Study|Death|0|||
37949127|NCT04093752|69636599|FG001|Overall Study|Death|0|||
37949128|NCT04093752|69636600|FG002|Overall Study|Death|1|||
37949129|NCT04093752|69636601|FG003|Overall Study|Death|2|||
37949130|NCT04093752|69636598|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
37949131|NCT04093752|69636599|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
37949132|NCT04093752|69636600|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
37949133|NCT04093752|69636601|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
37949134|NCT04093752|69636598|FG000|Overall Study|Covid 19|0|||
37949135|NCT04093752|69636599|FG001|Overall Study|Covid 19|0|||
37949136|NCT04093752|69636600|FG002|Overall Study|Covid 19|0|||
37949137|NCT04093752|69636601|FG003|Overall Study|Covid 19|1|||
37949138|NCT04093752|69636598|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
37949139|NCT04093752|69636599|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
37949140|NCT04093752|69636600|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
37949141|NCT04093752|69636601|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
37949142|NCT04093752|69636598|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
37949143|NCT04093752|69636599|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
37949144|NCT04093752|69636600|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
37949145|NCT04093752|69636601|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
37949146|NCT04093752|69636598|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
37949147|NCT04093752|69636599|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
37949148|NCT04093752|69636600|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
37949149|NCT04093752|69636601|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
37949150|NCT03928821|69636619|FG000|Overall Study|Death|0|||
37949151|NCT03928821|69636620|FG001|Overall Study|Death|1|||
37949152|NCT03928821|69636621|FG002|Overall Study|Death|0|||
37949153|NCT03928821|69636622|FG003|Overall Study|Death|0|||
37949154|NCT03928821|69636619|FG000|Overall Study|Lost to Follow-up|0|||
37949155|NCT03928821|69636620|FG001|Overall Study|Lost to Follow-up|2|||
37949156|NCT03928821|69636621|FG002|Overall Study|Lost to Follow-up|3|||
37949157|NCT03928821|69636622|FG003|Overall Study|Lost to Follow-up|0|||
37949158|NCT03928821|69636619|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
37949159|NCT03928821|69636620|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
37949160|NCT03928821|69636621|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
37949161|NCT03928821|69636622|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
37949162|NCT00666224|69636634|FG000|Double-Blind|Adverse Event|15|||
37949163|NCT00666224|69636635|FG001|Double-Blind|Adverse Event|5|||
37949164|NCT00666224|69636634|FG000|Double-Blind|Lost to Follow-up|2|||
37949165|NCT00666224|69636635|FG001|Double-Blind|Lost to Follow-up|2|||
37949166|NCT00666224|69636634|FG000|Double-Blind|Withdrawal by Subject|18|||
37949167|NCT00666224|69636635|FG001|Double-Blind|Withdrawal by Subject|14|||
37949168|NCT00666224|69636634|FG000|Double-Blind|Physician Decision|0|||
37949169|NCT00666224|69636635|FG001|Double-Blind|Physician Decision|3|||
37949170|NCT00666224|69636634|FG000|Double-Blind|Sponsor decision|1|||
37949171|NCT00666224|69636635|FG001|Double-Blind|Sponsor decision|0|||
37949172|NCT00666224|69636634|FG000|Double-Blind|Pregnancy|3|||
37949173|NCT00666224|69636635|FG001|Double-Blind|Pregnancy|2|||
37949174|NCT00666224|69636634|FG000|Double-Blind|Noncompliance|1|||
37949175|NCT00666224|69636635|FG001|Double-Blind|Noncompliance|0|||
37949176|NCT00666224|69636634|FG000|Double-Blind|Death|1|||
37949177|NCT00666224|69636635|FG001|Double-Blind|Death|0|||
37949178|NCT00666224|69636634|FG000|Double-Blind|Undefined/Unknown|4|||
37949179|NCT00666224|69636635|FG001|Double-Blind|Undefined/Unknown|1|||
37949180|NCT00666224|69636634|FG000|Open-Label|Adverse Event|8|||
37949181|NCT00666224|69636635|FG001|Open-Label|Adverse Event|43|||
37949182|NCT00666224|69636634|FG000|Open-Label|Lost to Follow-up|4|||
37949183|NCT00666224|69636635|FG001|Open-Label|Lost to Follow-up|5|||
37949184|NCT00666224|69636634|FG000|Open-Label|Withdrawal by Subject|12|||
37949185|NCT00666224|69636635|FG001|Open-Label|Withdrawal by Subject|25|||
37949186|NCT00666224|69636634|FG000|Open-Label|Physician Decision|7|||
37949187|NCT00666224|69636635|FG001|Open-Label|Physician Decision|5|||
37949188|NCT00666224|69636634|FG000|Open-Label|Pregnancy|1|||
37949189|NCT00666224|69636635|FG001|Open-Label|Pregnancy|5|||
37949190|NCT00666224|69636634|FG000|Open-Label|Noncompliance|2|||
37949191|NCT00666224|69636635|FG001|Open-Label|Noncompliance|1|||
37949192|NCT00666224|69636634|FG000|Open-Label|Undefined/Unknown|1|||
37949193|NCT00666224|69636635|FG001|Open-Label|Undefined/Unknown|1|||
37949194|NCT00663962|69636644|FG000|Overall Study|somnolence|1|||
37949195|NCT00663962|69636645|FG001|Overall Study|somnolence|0|||
37949196|NCT00265759|69636657|FG000|Overall Study|Withdrawal by Subject|0|||
37949197|NCT00265759|69636658|FG001|Overall Study|Withdrawal by Subject|1|||
37949198|NCT00265759|69636659|FG002|Overall Study|Withdrawal by Subject|2|||
37949199|NCT00265759|69636660|FG003|Overall Study|Withdrawal by Subject|2|||
37949200|NCT00265759|69636657|FG000|Overall Study|Cancel|0|||
37949201|NCT00265759|69636658|FG001|Overall Study|Cancel|0|||
37949202|NCT00265759|69636659|FG002|Overall Study|Cancel|0|||
37949203|NCT00265759|69636660|FG003|Overall Study|Cancel|3|||
37949204|NCT00265759|69636657|FG000|Overall Study|Ineligible|0|||
37949205|NCT00265759|69636658|FG001|Overall Study|Ineligible|0|||
37949206|NCT00265759|69636659|FG002|Overall Study|Ineligible|0|||
37949207|NCT00265759|69636660|FG003|Overall Study|Ineligible|1|||
37949208|NCT00265759|69636657|FG000|Overall Study|Bilateral disease|0|||
37949209|NCT00265759|69636658|FG001|Overall Study|Bilateral disease|0|||
37949210|NCT00265759|69636659|FG002|Overall Study|Bilateral disease|0|||
37949211|NCT00265759|69636660|FG003|Overall Study|Bilateral disease|2|||
37949212|NCT00265759|69636657|FG000|Overall Study|Discontinued due to intolerability|0|||
37949213|NCT00265759|69636658|FG001|Overall Study|Discontinued due to intolerability|0|||
37949214|NCT00265759|69636659|FG002|Overall Study|Discontinued due to intolerability|0|||
37949215|NCT00265759|69636660|FG003|Overall Study|Discontinued due to intolerability|1|||
37949216|NCT00744263|69636673|FG000|Overall Study|Death|3006|||
37949217|NCT00744263|69636674|FG001|Overall Study|Death|3005|||
37949218|NCT00744263|69636673|FG000|Overall Study|Lost to Follow-up|2038|||
37949219|NCT00744263|69636674|FG001|Overall Study|Lost to Follow-up|2135|||
37949220|NCT00744263|69636673|FG000|Overall Study|Withdrawal by Subject|166|||
37949221|NCT00744263|69636674|FG001|Overall Study|Withdrawal by Subject|150|||
37949222|NCT00744263|69636673|FG000|Overall Study|Physician Decision|20|||
37949223|NCT00744263|69636674|FG001|Overall Study|Physician Decision|23|||
37949224|NCT00744263|69636673|FG000|Overall Study|Protocol Violation|3|||
37949225|NCT00744263|69636674|FG001|Overall Study|Protocol Violation|5|||
37949226|NCT00744263|69636673|FG000|Overall Study|Adverse Event|1|||
37949227|NCT00744263|69636674|FG001|Overall Study|Adverse Event|0|||
37949228|NCT00744263|69636673|FG000|Overall Study|Other|2|||
37949229|NCT00744263|69636674|FG001|Overall Study|Other|2|||
37949230|NCT00618774|69636684|FG000|Overall Study|Adverse Event|5|||
37949231|NCT00618774|69636685|FG001|Overall Study|Adverse Event|3|||
37949232|NCT00618774|69636684|FG000|Overall Study|Withdrawal by Subject|1|||
37949233|NCT00618774|69636685|FG001|Overall Study|Withdrawal by Subject|0|||
37949234|NCT00545571|69636691|FG000|Overall Study|Administrative Reasons|1|||
37949235|NCT00545571|69636691|FG000|Overall Study|Adverse Event|2|||
37949236|NCT00545571|69636691|FG000|Overall Study|Death|5|||
37949237|NCT00545571|69636691|FG000|Overall Study|Lack of Efficacy|1|||
37949238|NCT00545571|69636691|FG000|Overall Study|Protocol Violation|2|||
37949239|NCT00545571|69636691|FG000|Overall Study|Refused Treatment|1|||
37949240|NCT00545571|69636691|FG000|Overall Study|Screen Failure|16|||
37949241|NCT00545571|69636691|FG000|Overall Study|Transfusion|12|||
37949242|NCT00545571|69636691|FG000|Overall Study|Early Termination of Study|24|||
37949243|NCT00545571|69636691|FG000|Overall Study|Kidney Transplantation|3|||
37949244|NCT00748709|69636695|FG000|Overall Study|Progressive disease|15|||
37949245|NCT00748709|69636695|FG000|Overall Study|Drug reducing Toxity|2|||
37949246|NCT00748709|69636695|FG000|Overall Study|Other Adverse Event|1|||
37949247|NCT00748709|69636695|FG000|Overall Study|Withdrawal by Subject|1|||
37949248|NCT00748709|69636695|FG000|Overall Study|Other Reasons|1|||
37949249|NCT00263887|69636701|FG000|Overall Study|Withdrawal by Subject|1|||
37949250|NCT00263887|69636702|FG001|Overall Study|Withdrawal by Subject|1|||
37949251|NCT00263887|69636701|FG000|Overall Study|Lung transplantation|1|||
37949252|NCT00263887|69636702|FG001|Overall Study|Lung transplantation|2|||
37949253|NCT00263887|69636701|FG000|Overall Study|Too ill to attend visit|1|||
37949254|NCT00263887|69636702|FG001|Overall Study|Too ill to attend visit|0|||
37949255|NCT00263887|69636701|FG000|Overall Study|Adverse Event|0|||
37949256|NCT00263887|69636702|FG001|Overall Study|Adverse Event|2|||
37949257|NCT00263887|69636701|FG000|Overall Study|Disease progression|0|||
37949258|NCT00263887|69636702|FG001|Overall Study|Disease progression|1|||
37949259|NCT00263887|69636701|FG000|Overall Study|Lack of Efficacy|0|||
37949260|NCT00263887|69636702|FG001|Overall Study|Lack of Efficacy|1|||
38042549|NCT04224688|69730095|FG001|Overall Study|Withdrawal by Subject|3|||
37949261|NCT00748553|69636710|FG000|Overall Study|Adverse Event|0|||
37949262|NCT00748553|69636711|FG001|Overall Study|Adverse Event|1|||
37949263|NCT00748553|69636710|FG000|Overall Study|disease progression|2|||
37949264|NCT00748553|69636711|FG001|Overall Study|disease progression|0|||
37949265|NCT00748553|69636710|FG000|Overall Study|noncompliance|1|||
37768601|NCT02649894|69284720|FG000|Overall Study|Withdrawal by Subject|5|||
37949266|NCT00748553|69636711|FG001|Overall Study|noncompliance|0|||
37949267|NCT00661388|69636716|FG000|Overall Study|Adverse Event|14|||
37949268|NCT00661388|69636716|FG000|Overall Study|Protocol Violation|7|||
37949269|NCT00661388|69636716|FG000|Overall Study|Renal transplantation|1|||
37949270|NCT00661388|69636716|FG000|Overall Study|Dialysis initiation|1|||
37949271|NCT00661388|69636716|FG000|Overall Study|Administrative reasons|1|||
37949272|NCT00743483|69636720|FG000|Baseline Period|Physician Decision|1|||
37949273|NCT00743483|69636720|FG000|Treatment Period|Adverse Event|1|||
37949274|NCT00263575|69636724|FG000|Titration Period|Adverse Event|14|||
37949275|NCT00263575|69636724|FG000|Titration Period|Withdrawal by Subject|10|||
37949276|NCT00263575|69636724|FG000|Titration Period|Protocol Violation|9|||
37949277|NCT00263575|69636724|FG000|Titration Period|Sponsor Decision|2|||
37949278|NCT00263575|69636724|FG000|Titration Period|Other|2|||
37949279|NCT00263575|69636724|FG000|Titration Period|Lack of Efficacy|6|||
37949280|NCT00263575|69636724|FG000|Maintence Period|Adverse Event|23|||
37949281|NCT00263575|69636724|FG000|Maintence Period|Withdrawal by Subject|8|||
37949282|NCT00263575|69636724|FG000|Maintence Period|Protocol Violation|4|||
37949283|NCT00263575|69636724|FG000|Maintence Period|Lack of Efficacy|4|||
37949284|NCT00263575|69636724|FG000|Maintence Period|Physician Decision|6|||
37949285|NCT00263575|69636724|FG000|Maintence Period|Lost to Follow-up|1|||
37949286|NCT00263575|69636724|FG000|Maintence Period|Sponsor Decision|24|||
37949287|NCT00263575|69636724|FG000|Maintence Period|Other|7|||
37949288|NCT00748241|69636730|FG000|Overall Study|Implant failure|1|||
37949289|NCT00748241|69636730|FG000|Overall Study|Lost to Follow-up|5|||
37949290|NCT00748241|69636730|FG000|Overall Study|Death|2|||
37949291|NCT00570128|69636736|FG000|Overall Study|Adverse Event|1|||
37949292|NCT00570128|69636737|FG001|Overall Study|Adverse Event|0|||
37949293|NCT00570128|69636736|FG000|Overall Study|Lost to Follow-up|1|||
37949294|NCT00570128|69636737|FG001|Overall Study|Lost to Follow-up|0|||
37949295|NCT00570128|69636736|FG000|Overall Study|Withdrawal by Subject|2|||
37949296|NCT00570128|69636737|FG001|Overall Study|Withdrawal by Subject|0|||
37949297|NCT00743249|69636745|FG000|Overall Study|Adverse Event|0|||
37949298|NCT00743249|69636746|FG001|Overall Study|Adverse Event|4|||
37949299|NCT00743249|69636745|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
37949300|NCT00743249|69636746|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
37949301|NCT00743249|69636745|FG000|Overall Study|Unsuccessful insertion of stent|2|||
37949302|NCT00743249|69636746|FG001|Overall Study|Unsuccessful insertion of stent|1|||
37949303|NCT00262951|69636752|FG000|Overall Study|Progressive disease/relapse|3|||
37949304|NCT00262951|69636752|FG000|Overall Study|Adverse Event|7|||
37949305|NCT00262951|69636752|FG000|Overall Study|Death|1|||
37949306|NCT00262951|69636752|FG000|Overall Study|Withdrawal by Subject|1|||
37949307|NCT00262951|69636752|FG000|Overall Study|Alternative treatment|3|||
37949308|NCT00262951|69636752|FG000|Overall Study|Off treatment for other disease|1|||
37949309|NCT00262873|69636756|FG000|Overall Study|Adverse Event|3|||
37949310|NCT00262873|69636756|FG000|Overall Study|Withdrawal by Subject|5|||
37949311|NCT00573534|69636760|FG000|Overall Study|oppositional behavior|3|||
37949312|NCT00260533|69636767|FG000|Overall Study|Other|3|||
37949313|NCT00260533|69636768|FG001|Overall Study|Other|3|||
37949314|NCT03945981|69636774|FG000|Overall Study|Lost to Follow-up|12|||
37949315|NCT03945981|69636774|FG000|Overall Study|Physician Decision|4|||
37949316|NCT03945981|69636774|FG000|Overall Study|Withdrawal by Subject|6|||
37949317|NCT03945981|69636774|FG000|Overall Study|Protocol Violation|1|||
37949318|NCT00745901|69636801|FG000|Overall Study|Adverse Event|3|||
37949319|NCT00745901|69636802|FG001|Overall Study|Adverse Event|4|||
37949320|NCT00745901|69636801|FG000|Overall Study|Protocol Violation|0|||
37949321|NCT00745901|69636802|FG001|Overall Study|Protocol Violation|1|||
37949322|NCT00745901|69636801|FG000|Overall Study|Withdrawal by Subject|1|||
37949323|NCT00745901|69636802|FG001|Overall Study|Withdrawal by Subject|0|||
37949324|NCT00745901|69636801|FG000|Overall Study|Lost to Follow-up|7|||
37949325|NCT00745901|69636802|FG001|Overall Study|Lost to Follow-up|4|||
37949326|NCT00745901|69636801|FG000|Overall Study|Pregnancy|2|||
37949327|NCT00745901|69636802|FG001|Overall Study|Pregnancy|4|||
37949328|NCT00745901|69636801|FG000|Overall Study|Lack of compliance|2|||
37949329|NCT00745901|69636802|FG001|Overall Study|Lack of compliance|2|||
37949330|NCT00745901|69636801|FG000|Overall Study|Patient's next menses did not start with|1|||
37949331|NCT00745901|69636802|FG001|Overall Study|Patient's next menses did not start with|0|||
37949332|NCT00745901|69636801|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
37949333|NCT00745901|69636802|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
37949334|NCT00745901|69636801|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
37949335|NCT00745901|69636802|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
37949336|NCT00745901|69636801|FG000|Overall Study|Patient didn't take any study medication|7|||
37949337|NCT00745901|69636802|FG001|Overall Study|Patient didn't take any study medication|3|||
37949338|NCT00286429|69636811|FG000|Overall Study|Adverse Event|4|||
37949339|NCT00286429|69636812|FG001|Overall Study|Adverse Event|1|||
37949340|NCT00286429|69636813|FG002|Overall Study|Adverse Event|6|||
37949341|NCT00286429|69636811|FG000|Overall Study|Lack of Efficacy|52|||
37949342|NCT00286429|69636812|FG001|Overall Study|Lack of Efficacy|27|||
37949343|NCT00286429|69636813|FG002|Overall Study|Lack of Efficacy|25|||
37949344|NCT00286429|69636811|FG000|Overall Study|Lost to Follow-up|2|||
37949345|NCT00286429|69636812|FG001|Overall Study|Lost to Follow-up|4|||
37949346|NCT00286429|69636813|FG002|Overall Study|Lost to Follow-up|3|||
37949347|NCT00286429|69636811|FG000|Overall Study|Physician Decision|10|||
37949348|NCT00286429|69636812|FG001|Overall Study|Physician Decision|7|||
37949349|NCT00286429|69636813|FG002|Overall Study|Physician Decision|7|||
37949350|NCT00286429|69636811|FG000|Overall Study|Protocol Violation|3|||
37949351|NCT00286429|69636812|FG001|Overall Study|Protocol Violation|5|||
37949352|NCT00286429|69636813|FG002|Overall Study|Protocol Violation|4|||
37949353|NCT00286429|69636811|FG000|Overall Study|Withdrawal by Subject|3|||
37949354|NCT00286429|69636812|FG001|Overall Study|Withdrawal by Subject|2|||
37949355|NCT00286429|69636813|FG002|Overall Study|Withdrawal by Subject|6|||
37949356|NCT00286429|69636811|FG000|Overall Study|Administrative Error|1|||
37949357|NCT00286429|69636812|FG001|Overall Study|Administrative Error|1|||
37949358|NCT00286429|69636813|FG002|Overall Study|Administrative Error|1|||
37949359|NCT00286429|69636811|FG000|Overall Study|Administrative Decision|0|||
37949360|NCT00286429|69636812|FG001|Overall Study|Administrative Decision|1|||
37949361|NCT00286429|69636813|FG002|Overall Study|Administrative Decision|0|||
37949362|NCT00665444|69636821|FG000|Overall Study|Physician Decision|1|||
37949363|NCT00665444|69636821|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
37949364|NCT03926169|69636828|FG000|Period A|Adverse Event|2|||
37949365|NCT03926169|69636829|FG001|Period A|Adverse Event|2|||
37949366|NCT03926169|69636830|FG002|Period A|Adverse Event|1|||
37949367|NCT03926169|69636828|FG000|Period A|Withdrawal by Subject|2|||
37949368|NCT03926169|69636829|FG001|Period A|Withdrawal by Subject|2|||
37949369|NCT03926169|69636830|FG002|Period A|Withdrawal by Subject|2|||
37949370|NCT03926169|69636828|FG000|Period A|Lost to Follow-up|3|||
37949371|NCT03926169|69636829|FG001|Period A|Lost to Follow-up|1|||
37949372|NCT03926169|69636830|FG002|Period A|Lost to Follow-up|0|||
37949373|NCT03926169|69636828|FG000|Period A|Lack of Efficacy|0|||
37949374|NCT03926169|69636829|FG001|Period A|Lack of Efficacy|2|||
37949375|NCT03926169|69636830|FG002|Period A|Lack of Efficacy|2|||
37949376|NCT03926169|69636828|FG000|Period A|COVID-19 Infection|0|||
37949377|NCT03926169|69636829|FG001|Period A|COVID-19 Infection|1|||
37949378|NCT03926169|69636830|FG002|Period A|COVID-19 Infection|0|||
37949379|NCT03926169|69636828|FG000|Period A|COVID-19 Logistical Restrictions|0|||
37949380|NCT03926169|69636829|FG001|Period A|COVID-19 Logistical Restrictions|2|||
37949381|NCT03926169|69636830|FG002|Period A|COVID-19 Logistical Restrictions|1|||
37949382|NCT03926169|69636828|FG000|Period A|Other, Not Specified|1|||
37949383|NCT03926169|69636829|FG001|Period A|Other, Not Specified|0|||
37949384|NCT03926169|69636830|FG002|Period A|Other, Not Specified|0|||
37949385|NCT03926169|69636828|FG000|Period B|Adverse Event|3|||
37949386|NCT03926169|69636829|FG001|Period B|Adverse Event|1|||
37949387|NCT03926169|69636830|FG002|Period B|Adverse Event|1|||
37949388|NCT03926169|69636828|FG000|Period B|Withdrawal by Subject|1|||
37949389|NCT03926169|69636829|FG001|Period B|Withdrawal by Subject|3|||
37949390|NCT03926169|69636830|FG002|Period B|Withdrawal by Subject|0|||
37949391|NCT03926169|69636828|FG000|Period B|Lack of Efficacy|3|||
37949392|NCT03926169|69636829|FG001|Period B|Lack of Efficacy|1|||
37949393|NCT03926169|69636830|FG002|Period B|Lack of Efficacy|1|||
37949394|NCT03926169|69636828|FG000|Period B|Lost to Follow-up|1|||
37949395|NCT03926169|69636829|FG001|Period B|Lost to Follow-up|1|||
37949396|NCT03926169|69636830|FG002|Period B|Lost to Follow-up|4|||
37949397|NCT03926169|69636828|FG000|Period B|Other, Not Specified|62|||
37949398|NCT03926169|69636829|FG001|Period B|Other, Not Specified|57|||
37949399|NCT03926169|69636830|FG002|Period B|Other, Not Specified|65|||
37949400|NCT00285649|69636844|FG000|Overall Study|Lost to Follow-up|6|||
37949401|NCT00285649|69636845|FG001|Overall Study|Lost to Follow-up|4|||
37949402|NCT00285649|69636846|FG002|Overall Study|Lost to Follow-up|4|||
37949403|NCT00285649|69636844|FG000|Overall Study|Withdrawal by Subject|3|||
37949404|NCT00285649|69636845|FG001|Overall Study|Withdrawal by Subject|2|||
37949405|NCT00285649|69636846|FG002|Overall Study|Withdrawal by Subject|2|||
37949406|NCT00745823|69636856|FG000|Overall Study|Adverse Event|5|||
37949407|NCT00745823|69636857|FG001|Overall Study|Adverse Event|3|||
37949408|NCT00745823|69636856|FG000|Overall Study|Lack of Efficacy|20|||
37949409|NCT00745823|69636857|FG001|Overall Study|Lack of Efficacy|6|||
37949410|NCT00745823|69636856|FG000|Overall Study|Lost to Follow-up|10|||
37949411|NCT00745823|69636857|FG001|Overall Study|Lost to Follow-up|11|||
37949412|NCT00745823|69636856|FG000|Overall Study|Physician Decision|10|||
37949413|NCT00745823|69636857|FG001|Overall Study|Physician Decision|5|||
37949414|NCT00745823|69636856|FG000|Overall Study|Pregnancy|0|||
37949415|NCT00745823|69636857|FG001|Overall Study|Pregnancy|4|||
37949416|NCT00745823|69636856|FG000|Overall Study|Withdrawal by Subject|14|||
37949417|NCT00745823|69636857|FG001|Overall Study|Withdrawal by Subject|8|||
37949418|NCT00745823|69636856|FG000|Overall Study|Study Terminated by Sponsor|326|||
37949419|NCT00745823|69636857|FG001|Overall Study|Study Terminated by Sponsor|349|||
37949420|NCT00663260|69636868|FG000|Overall Study|Lack of Efficacy|2|||
37949421|NCT00663260|69636869|FG001|Overall Study|Lack of Efficacy|0|||
37949422|NCT00663260|69636870|FG002|Overall Study|Lack of Efficacy|0|||
37949423|NCT00663260|69636868|FG000|Overall Study|Adverse Event|12|||
37949424|NCT00663260|69636869|FG001|Overall Study|Adverse Event|7|||
37949425|NCT00663260|69636870|FG002|Overall Study|Adverse Event|6|||
37949426|NCT00663260|69636868|FG000|Overall Study|Withdrawal by Subject|3|||
38042550|NCT04224688|69730094|FG000|Overall Study|Lack of Efficacy|1|||
37949427|NCT00663260|69636869|FG001|Overall Study|Withdrawal by Subject|1|||
37949428|NCT00663260|69636870|FG002|Overall Study|Withdrawal by Subject|6|||
37949429|NCT00663260|69636868|FG000|Overall Study|Death|1|||
37949430|NCT00663260|69636869|FG001|Overall Study|Death|0|||
37949431|NCT00663260|69636870|FG002|Overall Study|Death|1|||
37949432|NCT00663260|69636868|FG000|Overall Study|Lost to Follow-up|0|||
37949433|NCT00663260|69636869|FG001|Overall Study|Lost to Follow-up|1|||
37949434|NCT00663260|69636870|FG002|Overall Study|Lost to Follow-up|0|||
37949435|NCT00663260|69636868|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
37949436|NCT00663260|69636869|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
37949437|NCT00663260|69636870|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
37949438|NCT00740597|69636878|FG000|Overall Study|insurance would not cover treatment|1|||
37949439|NCT00284089|69636886|FG000|Multiple Dose Phase|Adverse Event|1|||
37949440|NCT00284089|69636887|FG001|Multiple Dose Phase|Adverse Event|0|||
37949441|NCT00284089|69636888|FG002|Multiple Dose Phase|Adverse Event|1|||
37949442|NCT00284089|69636889|FG003|Multiple Dose Phase|Adverse Event|1|||
37949443|NCT00284089|69636886|FG000|Multiple Dose Phase|Protocol Violation|0|||
37949444|NCT00284089|69636887|FG001|Multiple Dose Phase|Protocol Violation|0|||
37949445|NCT00284089|69636888|FG002|Multiple Dose Phase|Protocol Violation|1|||
37949446|NCT00284089|69636889|FG003|Multiple Dose Phase|Protocol Violation|0|||
37949447|NCT00284089|69636886|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
37949448|NCT00284089|69636887|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
37949449|NCT00284089|69636888|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
37949450|NCT00284089|69636889|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
37949451|NCT00284089|69636886|FG000|Multiple Dose Phase|Death|0|||
37949452|NCT00284089|69636887|FG001|Multiple Dose Phase|Death|0|||
37949453|NCT00284089|69636888|FG002|Multiple Dose Phase|Death|1|||
37949454|NCT00284089|69636889|FG003|Multiple Dose Phase|Death|1|||
37949455|NCT00284089|69636886|FG000|Extension Phase|Adverse Event|0|||
37949456|NCT00284089|69636887|FG001|Extension Phase|Adverse Event|0|||
37949457|NCT00284089|69636888|FG002|Extension Phase|Adverse Event|2|||
37949458|NCT00284089|69636889|FG003|Extension Phase|Adverse Event|2|||
37949459|NCT00284089|69636886|FG000|Extension Phase|condition no longer requires study drug|2|||
37949460|NCT00284089|69636887|FG001|Extension Phase|condition no longer requires study drug|0|||
37949461|NCT00284089|69636888|FG002|Extension Phase|condition no longer requires study drug|2|||
37949462|NCT00284089|69636889|FG003|Extension Phase|condition no longer requires study drug|7|||
37949463|NCT00284089|69636886|FG000|Extension Phase|Protocol Violation|0|||
37949464|NCT00284089|69636887|FG001|Extension Phase|Protocol Violation|0|||
37949465|NCT00284089|69636888|FG002|Extension Phase|Protocol Violation|1|||
37949466|NCT00284089|69636889|FG003|Extension Phase|Protocol Violation|0|||
37949467|NCT00284089|69636886|FG000|Extension Phase|Withdrawal by Subject|0|||
37949468|NCT00284089|69636887|FG001|Extension Phase|Withdrawal by Subject|0|||
37949469|NCT00284089|69636888|FG002|Extension Phase|Withdrawal by Subject|1|||
37949470|NCT00284089|69636889|FG003|Extension Phase|Withdrawal by Subject|3|||
37949471|NCT00659984|69636899|FG000|Overall Study|Adverse Event|1|||
37949472|NCT00283387|69636913|FG000|First Intervention|Subject non-compliant|1|||
37949473|NCT00283387|69636914|FG001|First Intervention|Subject non-compliant|1|||
37949474|NCT00283387|69636913|FG000|First Intervention|Withdrawal by Subject|0|||
37949475|NCT00283387|69636914|FG001|First Intervention|Withdrawal by Subject|1|||
37949476|NCT00282919|69636920|FG000|Overall Study|Lack of Efficacy|4|||
37949477|NCT00282919|69636920|FG000|Overall Study|Withdrawal by Subject|1|||
37949478|NCT00282919|69636920|FG000|Overall Study|Asymptomatic Parasitemia|2|||
37949479|NCT00282295|69636927|FG000|Overall Study|Adverse Event|0|||
37949480|NCT00282295|69636928|FG001|Overall Study|Adverse Event|1|||
37949481|NCT00282295|69636929|FG002|Overall Study|Adverse Event|0|||
37949482|NCT00282295|69636927|FG000|Overall Study|Serious Adverse Events|0|||
37949483|NCT00282295|69636928|FG001|Overall Study|Serious Adverse Events|0|||
37949484|NCT00282295|69636929|FG002|Overall Study|Serious Adverse Events|1|||
37949485|NCT00282295|69636927|FG000|Overall Study|Protocol Violation|0|||
37949486|NCT00282295|69636928|FG001|Overall Study|Protocol Violation|2|||
37949487|NCT00282295|69636929|FG002|Overall Study|Protocol Violation|1|||
37949488|NCT00282295|69636927|FG000|Overall Study|Withdrawal by Subject|2|||
37949489|NCT00282295|69636928|FG001|Overall Study|Withdrawal by Subject|6|||
37949490|NCT00282295|69636929|FG002|Overall Study|Withdrawal by Subject|4|||
37949491|NCT00282295|69636927|FG000|Overall Study|Lost to Follow-up|1|||
37949492|NCT00282295|69636928|FG001|Overall Study|Lost to Follow-up|7|||
37949493|NCT00282295|69636929|FG002|Overall Study|Lost to Follow-up|2|||
37949494|NCT00282295|69636927|FG000|Overall Study|Other|0|||
37949495|NCT00282295|69636928|FG001|Overall Study|Other|1|||
37949496|NCT00282295|69636929|FG002|Overall Study|Other|0|||
37949497|NCT00742781|69636942|FG000|Overall Study|Withdrawal by Subject|3|||
37949498|NCT00663026|69636950|FG000|Overall Study|Lost to Follow-up|1|||
37949499|NCT00663026|69636951|FG001|Overall Study|Lost to Follow-up|0|||
37949500|NCT00663026|69636952|FG002|Overall Study|Lost to Follow-up|0|||
37949501|NCT00663026|69636950|FG000|Overall Study|Other|1|||
37949502|NCT00663026|69636951|FG001|Overall Study|Other|2|||
37949503|NCT00663026|69636952|FG002|Overall Study|Other|0|||
37949504|NCT00663026|69636950|FG000|Overall Study|Adverse Event|0|||
37949505|NCT00663026|69636951|FG001|Overall Study|Adverse Event|2|||
37949506|NCT00663026|69636952|FG002|Overall Study|Adverse Event|3|||
37949507|NCT00663026|69636950|FG000|Overall Study|Caregiver Request|0|||
37949508|NCT00663026|69636951|FG001|Overall Study|Caregiver Request|2|||
37949509|NCT00663026|69636952|FG002|Overall Study|Caregiver Request|0|||
37949510|NCT00663026|69636950|FG000|Overall Study|Withdrawal by Subject|0|||
37949511|NCT00663026|69636951|FG001|Overall Study|Withdrawal by Subject|0|||
37949512|NCT00663026|69636952|FG002|Overall Study|Withdrawal by Subject|1|||
37949513|NCT00280735|69636962|FG000|Overall Study|Adverse Event|5|||
37949514|NCT00280735|69636962|FG000|Overall Study|Lack of Efficacy|3|||
37949515|NCT00280735|69636962|FG000|Overall Study|Withdrawal by Subject|8|||
37949516|NCT00280735|69636962|FG000|Overall Study|Intercurrent Illness|2|||
37949517|NCT00260065|69636970|FG000|Overall Study|Progressive Disease|22|||
37949518|NCT00260065|69636970|FG000|Overall Study|Adverse Event|17|||
37949519|NCT00260065|69636970|FG000|Overall Study|Death|13|||
37949520|NCT00260065|69636970|FG000|Overall Study|Withdrawal by Subject|13|||
37949521|NCT00260065|69636970|FG000|Overall Study|Physician Decision|19|||
37949522|NCT00260065|69636970|FG000|Overall Study|Not otherwise specified|8|||
37949523|NCT00260065|69636970|FG000|Overall Study|Medication Noncompliance|1|||
37949524|NCT00506350|69636983|FG000|Overall Study|Serious Adverse Event|1|||
37949525|NCT00506350|69636984|FG001|Overall Study|Serious Adverse Event|0|||
37949526|NCT00506350|69636985|FG002|Overall Study|Serious Adverse Event|0|||
37949527|NCT00506350|69636986|FG003|Overall Study|Serious Adverse Event|0|||
37949528|NCT00506350|69636987|FG004|Overall Study|Serious Adverse Event|0|||
37949529|NCT00506350|69636988|FG005|Overall Study|Serious Adverse Event|0|||
37949530|NCT00506350|69636989|FG006|Overall Study|Serious Adverse Event|0|||
37949531|NCT00506350|69636990|FG007|Overall Study|Serious Adverse Event|0|||
37949532|NCT00506350|69636991|FG008|Overall Study|Serious Adverse Event|0|||
37949533|NCT00506350|69636983|FG000|Overall Study|Adverse Event|0|||
37949534|NCT00506350|69636984|FG001|Overall Study|Adverse Event|0|||
37949535|NCT00506350|69636985|FG002|Overall Study|Adverse Event|0|||
37949536|NCT00506350|69636986|FG003|Overall Study|Adverse Event|0|||
37949537|NCT00506350|69636987|FG004|Overall Study|Adverse Event|0|||
37949538|NCT00506350|69636988|FG005|Overall Study|Adverse Event|0|||
37949539|NCT00506350|69636989|FG006|Overall Study|Adverse Event|0|||
37949540|NCT00506350|69636990|FG007|Overall Study|Adverse Event|1|||
37949541|NCT00506350|69636991|FG008|Overall Study|Adverse Event|1|||
37949542|NCT00506350|69636983|FG000|Overall Study|Protocol Violation|0|||
37949543|NCT00506350|69636984|FG001|Overall Study|Protocol Violation|0|||
37949544|NCT00506350|69636985|FG002|Overall Study|Protocol Violation|1|||
37949545|NCT00506350|69636986|FG003|Overall Study|Protocol Violation|0|||
37949546|NCT00506350|69636987|FG004|Overall Study|Protocol Violation|0|||
37949547|NCT00506350|69636988|FG005|Overall Study|Protocol Violation|0|||
37949548|NCT00506350|69636989|FG006|Overall Study|Protocol Violation|1|||
37949549|NCT00506350|69636990|FG007|Overall Study|Protocol Violation|0|||
37949550|NCT00506350|69636991|FG008|Overall Study|Protocol Violation|0|||
37949551|NCT00506350|69636983|FG000|Overall Study|Withdrawal by Subject|0|||
37949552|NCT00506350|69636984|FG001|Overall Study|Withdrawal by Subject|1|||
37949553|NCT00506350|69636985|FG002|Overall Study|Withdrawal by Subject|1|||
37949554|NCT00506350|69636986|FG003|Overall Study|Withdrawal by Subject|1|||
37949555|NCT00506350|69636987|FG004|Overall Study|Withdrawal by Subject|4|||
37949556|NCT00506350|69636988|FG005|Overall Study|Withdrawal by Subject|1|||
37949557|NCT00506350|69636989|FG006|Overall Study|Withdrawal by Subject|1|||
37949558|NCT00506350|69636990|FG007|Overall Study|Withdrawal by Subject|2|||
37949559|NCT00506350|69636991|FG008|Overall Study|Withdrawal by Subject|0|||
37949560|NCT00506350|69636983|FG000|Overall Study|Lost to Follow-up|1|||
37949561|NCT00506350|69636984|FG001|Overall Study|Lost to Follow-up|1|||
37949562|NCT00506350|69636985|FG002|Overall Study|Lost to Follow-up|1|||
37949563|NCT00506350|69636986|FG003|Overall Study|Lost to Follow-up|1|||
37949564|NCT00506350|69636987|FG004|Overall Study|Lost to Follow-up|2|||
37949565|NCT00506350|69636988|FG005|Overall Study|Lost to Follow-up|1|||
37949566|NCT00506350|69636989|FG006|Overall Study|Lost to Follow-up|0|||
37949567|NCT00506350|69636990|FG007|Overall Study|Lost to Follow-up|0|||
37949568|NCT00506350|69636991|FG008|Overall Study|Lost to Follow-up|2|||
37949569|NCT00506350|69636983|FG000|Overall Study|Medical Reason|0|||
37949570|NCT00506350|69636984|FG001|Overall Study|Medical Reason|0|||
37949571|NCT00506350|69636985|FG002|Overall Study|Medical Reason|0|||
37949572|NCT00506350|69636986|FG003|Overall Study|Medical Reason|0|||
37949573|NCT00506350|69636987|FG004|Overall Study|Medical Reason|1|||
37949574|NCT00506350|69636988|FG005|Overall Study|Medical Reason|0|||
37949575|NCT00506350|69636989|FG006|Overall Study|Medical Reason|0|||
37949576|NCT00506350|69636990|FG007|Overall Study|Medical Reason|0|||
37949577|NCT00506350|69636991|FG008|Overall Study|Medical Reason|0|||
37949578|NCT00506350|69636983|FG000|Overall Study|Other|1|||
37949579|NCT00506350|69636984|FG001|Overall Study|Other|1|||
37949580|NCT00506350|69636985|FG002|Overall Study|Other|3|||
37949581|NCT00506350|69636986|FG003|Overall Study|Other|0|||
37949582|NCT00506350|69636987|FG004|Overall Study|Other|3|||
37949583|NCT00506350|69636988|FG005|Overall Study|Other|0|||
37949584|NCT00506350|69636989|FG006|Overall Study|Other|0|||
37949585|NCT00506350|69636990|FG007|Overall Study|Other|2|||
37949586|NCT00506350|69636991|FG008|Overall Study|Other|2|||
37949587|NCT00258895|69637020|FG000|Overall Study|Lost to Follow-up|3|||
37949588|NCT00258895|69637021|FG001|Overall Study|Lost to Follow-up|1|||
37949589|NCT00258895|69637020|FG000|Overall Study|Protocol Violation|6|||
37949590|NCT00258895|69637021|FG001|Overall Study|Protocol Violation|2|||
37949591|NCT00258895|69637020|FG000|Overall Study|Withdrawal by Subject|1|||
37949592|NCT00258895|69637021|FG001|Overall Study|Withdrawal by Subject|0|||
37949593|NCT00742625|69637027|FG000|Remission Induction|Progression|6|||
37949594|NCT00742625|69637027|FG000|Remission Induction|Failed induction|8|||
37949595|NCT00742625|69637027|FG000|Remission Induction|Adverse Event|3|||
37949596|NCT00742625|69637027|FG000|Remission Induction|Death|10|||
37949597|NCT00742625|69637027|FG000|Remission Induction|Refusal|5|||
37949598|NCT00742625|69637027|FG000|Remission Induction|Non protocol treatment|17|||
37949599|NCT00742625|69637027|FG000|Remission Induction|Other, not specified|5|||
37949600|NCT00742625|69637027|FG000|Consolidation|Progression|5|||
37949601|NCT00742625|69637027|FG000|Consolidation|Adverse Event|1|||
37949602|NCT00742625|69637027|FG000|Consolidation|Death|1|||
37949603|NCT00742625|69637027|FG000|Consolidation|Refused|1|||
37949604|NCT00742625|69637027|FG000|Consolidation|Non protocol therapy|13|||
37949605|NCT00618618|69637038|FG000|Overall Study|Patient Request|0|||
37949606|NCT00618618|69637039|FG001|Overall Study|Patient Request|0|||
37949607|NCT00618618|69637040|FG002|Overall Study|Patient Request|2|||
37949608|NCT00618618|69637041|FG003|Overall Study|Patient Request|0|||
37949609|NCT00618618|69637038|FG000|Overall Study|Inability to Complete Study Procedures|0|||
37949610|NCT00618618|69637039|FG001|Overall Study|Inability to Complete Study Procedures|1|||
37949611|NCT00618618|69637040|FG002|Overall Study|Inability to Complete Study Procedures|0|||
37949612|NCT00618618|69637041|FG003|Overall Study|Inability to Complete Study Procedures|0|||
37949613|NCT00618618|69637038|FG000|Overall Study|Lost to Follow-up|3|||
37949614|NCT00618618|69637039|FG001|Overall Study|Lost to Follow-up|0|||
37949615|NCT00618618|69637040|FG002|Overall Study|Lost to Follow-up|0|||
37949616|NCT00618618|69637041|FG003|Overall Study|Lost to Follow-up|1|||
37949617|NCT00618618|69637038|FG000|Overall Study|Non-compliance|1|||
37949618|NCT00618618|69637039|FG001|Overall Study|Non-compliance|1|||
37949619|NCT00618618|69637040|FG002|Overall Study|Non-compliance|0|||
37949620|NCT00618618|69637041|FG003|Overall Study|Non-compliance|0|||
37949621|NCT00618618|69637038|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
37949622|NCT00618618|69637039|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
37949623|NCT00618618|69637040|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
37949624|NCT00618618|69637041|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
37949625|NCT00618618|69637038|FG000|Overall Study|Death|0|||
37949626|NCT00618618|69637039|FG001|Overall Study|Death|1|||
37949627|NCT00618618|69637040|FG002|Overall Study|Death|0|||
37949628|NCT00618618|69637041|FG003|Overall Study|Death|0|||
37949629|NCT00246805|69637054|FG000|Phase 1|Lost to Follow-up|1|||
37949630|NCT00246805|69637055|FG001|Phase 1|Lost to Follow-up|0|||
37949631|NCT00519376|69637061|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
37949632|NCT00519376|69637062|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
37949633|NCT00519376|69637063|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
37949634|NCT00519376|69637064|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
37949635|NCT00519376|69637065|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
37949636|NCT00519376|69637066|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
37949637|NCT00519376|69637067|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
37949638|NCT00519376|69637068|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
37949639|NCT00519376|69637069|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
37949640|NCT00519376|69637070|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
37949641|NCT00519376|69637071|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
37949642|NCT00519376|69637072|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
37949643|NCT00519376|69637073|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
37949644|NCT00519376|69637074|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
37949645|NCT00519376|69637075|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
37949646|NCT00519376|69637076|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
37677111|NCT02640547|69152041|FG000|Overall Study|Miscellaneous|3|||
37949647|NCT00519376|69637061|FG000|Treatment Period 4|Lost to Follow-up|0|||
37949648|NCT00519376|69637062|FG001|Treatment Period 4|Lost to Follow-up|0|||
37949649|NCT00519376|69637063|FG002|Treatment Period 4|Lost to Follow-up|1|||
37949650|NCT00519376|69637064|FG003|Treatment Period 4|Lost to Follow-up|0|||
37949651|NCT00519376|69637065|FG004|Treatment Period 4|Lost to Follow-up|0|||
37949652|NCT00519376|69637066|FG005|Treatment Period 4|Lost to Follow-up|0|||
37949653|NCT00519376|69637067|FG006|Treatment Period 4|Lost to Follow-up|0|||
37949654|NCT00519376|69637068|FG007|Treatment Period 4|Lost to Follow-up|0|||
37949655|NCT00519376|69637069|FG008|Treatment Period 4|Lost to Follow-up|0|||
37949656|NCT00519376|69637070|FG009|Treatment Period 4|Lost to Follow-up|0|||
37949657|NCT00519376|69637071|FG010|Treatment Period 4|Lost to Follow-up|0|||
37949658|NCT00519376|69637072|FG011|Treatment Period 4|Lost to Follow-up|0|||
37949659|NCT00519376|69637073|FG012|Treatment Period 4|Lost to Follow-up|0|||
37949660|NCT00519376|69637074|FG013|Treatment Period 4|Lost to Follow-up|0|||
37949661|NCT00519376|69637075|FG014|Treatment Period 4|Lost to Follow-up|0|||
37949662|NCT00519376|69637076|FG015|Treatment Period 4|Lost to Follow-up|0|||
37949663|NCT00745121|69637090|FG000|Overall Study|Death|3|||
37949664|NCT00745121|69637091|FG001|Overall Study|Death|0|||
37949665|NCT00745121|69637090|FG000|Overall Study|Adverse Event|1|||
37949666|NCT00745121|69637091|FG001|Overall Study|Adverse Event|0|||
37949667|NCT00745121|69637090|FG000|Overall Study|Lost to Follow-up|1|||
37949668|NCT00745121|69637091|FG001|Overall Study|Lost to Follow-up|0|||
37949669|NCT00745121|69637090|FG000|Overall Study|Withdrawal by Subject|4|||
37949670|NCT00745121|69637091|FG001|Overall Study|Withdrawal by Subject|2|||
37949671|NCT00740051|69637099|FG000|Overall Study|Lack of Efficacy|2|||
37949672|NCT00740051|69637100|FG001|Overall Study|Lack of Efficacy|5|||
37949673|NCT00740051|69637099|FG000|Overall Study|Adverse Event|1|||
37949674|NCT00740051|69637100|FG001|Overall Study|Adverse Event|4|||
37949675|NCT00740051|69637099|FG000|Overall Study|Protocol Violation|2|||
37949676|NCT00740051|69637100|FG001|Overall Study|Protocol Violation|6|||
37949677|NCT00740051|69637099|FG000|Overall Study|Lost to Follow-up|3|||
37949678|NCT00740051|69637100|FG001|Overall Study|Lost to Follow-up|8|||
37949679|NCT00740051|69637099|FG000|Overall Study|Withdrawal by Subject|6|||
37949680|NCT00740051|69637100|FG001|Overall Study|Withdrawal by Subject|8|||
37949681|NCT00740051|69637099|FG000|Overall Study|Other reason (not specified)|4|||
37949682|NCT00740051|69637100|FG001|Overall Study|Other reason (not specified)|1|||
37949683|NCT00518986|69637109|FG000|Overall Study|Adverse Event|12|||
37949684|NCT00518986|69637110|FG001|Overall Study|Adverse Event|7|||
37949685|NCT00518986|69637109|FG000|Overall Study|Lack of Efficacy|0|||
37949686|NCT00518986|69637110|FG001|Overall Study|Lack of Efficacy|2|||
37949687|NCT00518986|69637109|FG000|Overall Study|Lost to Follow-up|3|||
37949688|NCT00518986|69637110|FG001|Overall Study|Lost to Follow-up|2|||
37949689|NCT00518986|69637109|FG000|Overall Study|Physician Decision|0|||
37949690|NCT00518986|69637110|FG001|Overall Study|Physician Decision|3|||
37949691|NCT00518986|69637109|FG000|Overall Study|Protocol Violation|5|||
37949692|NCT00518986|69637110|FG001|Overall Study|Protocol Violation|7|||
37949693|NCT00518986|69637109|FG000|Overall Study|Withdrawal by Subject|4|||
37949694|NCT00518986|69637110|FG001|Overall Study|Withdrawal by Subject|4|||
37949695|NCT00518986|69637109|FG000|Overall Study|Non-Specific|2|||
37949696|NCT00518986|69637110|FG001|Overall Study|Non-Specific|1|||
37949697|NCT00742391|69637118|FG000|Overall Study|Adverse Event|2|||
37949698|NCT00742391|69637119|FG001|Overall Study|Adverse Event|1|||
37949699|NCT00742391|69637118|FG000|Overall Study|Lost to Follow-up|1|||
37949700|NCT00742391|69637119|FG001|Overall Study|Lost to Follow-up|0|||
37949701|NCT00742391|69637118|FG000|Overall Study|Protocol Violation|1|||
37949702|NCT00742391|69637119|FG001|Overall Study|Protocol Violation|0|||
37949703|NCT00742235|69637127|FG000|Overall Study|Lost to Follow-up|0|||
37949704|NCT00742235|69637128|FG001|Overall Study|Lost to Follow-up|31|||
37949705|NCT00742079|69637136|FG000|Overall Study|Lost to Follow-up|0|||
37949706|NCT00742079|69637137|FG001|Overall Study|Lost to Follow-up|1|||
37949707|NCT00662792|69637143|FG000|Period 1|Personal Reasons|0|||
37949708|NCT00662792|69637144|FG001|Period 1|Personal Reasons|0|||
37949709|NCT00662792|69637145|FG002|Period 1|Personal Reasons|1|||
37949710|NCT00662792|69637146|FG003|Period 1|Personal Reasons|0|||
37949711|NCT00662792|69637143|FG000|Period 1|Refused continuing medication|0|||
37949712|NCT00662792|69637144|FG001|Period 1|Refused continuing medication|1|||
37949713|NCT00662792|69637145|FG002|Period 1|Refused continuing medication|1|||
37949714|NCT00662792|69637146|FG003|Period 1|Refused continuing medication|0|||
37949715|NCT00662792|69637143|FG000|Period 1|Lost to Follow-up|1|||
37949716|NCT00662792|69637144|FG001|Period 1|Lost to Follow-up|0|||
37949717|NCT00662792|69637145|FG002|Period 1|Lost to Follow-up|0|||
37949718|NCT00662792|69637146|FG003|Period 1|Lost to Follow-up|0|||
37949719|NCT00662792|69637143|FG000|Period 1|Other adverse event (AE)|0|||
37949720|NCT00662792|69637144|FG001|Period 1|Other adverse event (AE)|2|||
37949721|NCT00662792|69637145|FG002|Period 1|Other adverse event (AE)|0|||
37949722|NCT00662792|69637146|FG003|Period 1|Other adverse event (AE)|0|||
37949723|NCT00662792|69637143|FG000|Period 1|Worsening of disease under study (AE)|1|||
37949724|NCT00662792|69637144|FG001|Period 1|Worsening of disease under study (AE)|3|||
37949725|NCT00662792|69637145|FG002|Period 1|Worsening of disease under study (AE)|2|||
37949726|NCT00662792|69637146|FG003|Period 1|Worsening of disease under study (AE)|0|||
37949727|NCT00662792|69637143|FG000|Period 1|Not treated|0|||
37949728|NCT00662792|69637144|FG001|Period 1|Not treated|1|||
37949729|NCT00662792|69637145|FG002|Period 1|Not treated|0|||
37949730|NCT00662792|69637146|FG003|Period 1|Not treated|0|||
37949731|NCT00662792|69637143|FG000|Period 2|Worsening of disease under study|1|||
37949732|NCT00662792|69637144|FG001|Period 2|Worsening of disease under study|0|||
38042551|NCT04224688|69730095|FG001|Overall Study|Lack of Efficacy|1|||
37949733|NCT00662792|69637145|FG002|Period 2|Worsening of disease under study|0|||
37949734|NCT00662792|69637146|FG003|Period 2|Worsening of disease under study|3|||
37949735|NCT00662792|69637143|FG000|Period 3|Refused continuing medication|1|||
37949736|NCT00662792|69637144|FG001|Period 3|Refused continuing medication|0|||
37949737|NCT00662792|69637145|FG002|Period 3|Refused continuing medication|1|||
37949738|NCT00662792|69637146|FG003|Period 3|Refused continuing medication|0|||
37949739|NCT00662792|69637143|FG000|Period 3|Other adverse event (AE)|0|||
37949740|NCT00662792|69637144|FG001|Period 3|Other adverse event (AE)|0|||
37949741|NCT00662792|69637145|FG002|Period 3|Other adverse event (AE)|1|||
37949742|NCT00662792|69637146|FG003|Period 3|Other adverse event (AE)|1|||
37949743|NCT00662792|69637143|FG000|Period 4|Refused continuing medication|0|||
37949744|NCT00662792|69637144|FG001|Period 4|Refused continuing medication|1|||
37949745|NCT00662792|69637145|FG002|Period 4|Refused continuing medication|0|||
37949746|NCT00662792|69637146|FG003|Period 4|Refused continuing medication|0|||
37949747|NCT00662792|69637143|FG000|Period 4|Other adverse event (AE)|1|||
37949748|NCT00662792|69637144|FG001|Period 4|Other adverse event (AE)|0|||
37949749|NCT00662792|69637145|FG002|Period 4|Other adverse event (AE)|0|||
37949750|NCT00662792|69637146|FG003|Period 4|Other adverse event (AE)|0|||
37949751|NCT00662792|69637143|FG000|Period 4|Worsening of disease under study (AE)|0|||
37949752|NCT00662792|69637144|FG001|Period 4|Worsening of disease under study (AE)|0|||
37949753|NCT00662792|69637145|FG002|Period 4|Worsening of disease under study (AE)|0|||
37949754|NCT00662792|69637146|FG003|Period 4|Worsening of disease under study (AE)|1|||
37949755|NCT00742001|69637161|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
37949756|NCT00742001|69637162|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
37949757|NCT00742001|69637163|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
37949758|NCT00616902|69637176|FG000|Overall Study|Termination of study|6|||
37949759|NCT00616902|69637177|FG001|Overall Study|Termination of study|6|||
37949760|NCT00741611|69637186|FG000|Overall Study|Death|0|||
37949761|NCT00741611|69637187|FG001|Overall Study|Death|0|||
37949762|NCT00741611|69637188|FG002|Overall Study|Death|1|||
37949763|NCT00741611|69637186|FG000|Overall Study|Withdrawal by Subject|0|||
37949764|NCT00741611|69637187|FG001|Overall Study|Withdrawal by Subject|2|||
37949765|NCT00741611|69637188|FG002|Overall Study|Withdrawal by Subject|2|||
37949766|NCT00662558|69637199|FG000|Overall Study|Adverse Event|21|||
37949767|NCT00662558|69637200|FG001|Overall Study|Adverse Event|59|||
37949768|NCT00662558|69637199|FG000|Overall Study|Lack of Efficacy|4|||
37949769|NCT00662558|69637200|FG001|Overall Study|Lack of Efficacy|7|||
37949770|NCT00662558|69637199|FG000|Overall Study|Lost to Follow-up|13|||
37949771|NCT00662558|69637200|FG001|Overall Study|Lost to Follow-up|10|||
37949772|NCT00662558|69637199|FG000|Overall Study|Other|9|||
37949773|NCT00662558|69637200|FG001|Overall Study|Other|14|||
37949774|NCT00662558|69637199|FG000|Overall Study|Withdrawal by Subject|7|||
37949775|NCT00662558|69637200|FG001|Overall Study|Withdrawal by Subject|12|||
37949776|NCT00662558|69637199|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
37949777|NCT00662558|69637200|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
37949778|NCT00739973|69637215|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
37949779|NCT00739973|69637216|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
37949780|NCT00739973|69637217|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
37949781|NCT00739973|69637218|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
37949782|NCT00739973|69637219|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
37949783|NCT00739973|69637220|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
37949784|NCT00739973|69637221|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
37949785|NCT00739973|69637222|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
37949786|NCT00739973|69637223|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
37949787|NCT00739973|69637215|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
37949788|NCT00739973|69637216|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
37949789|NCT00739973|69637217|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
37949790|NCT00739973|69637218|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
37949791|NCT00739973|69637219|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
37949792|NCT00739973|69637220|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
37949793|NCT00739973|69637221|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
37949794|NCT00739973|69637222|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
37949795|NCT00739973|69637223|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
37949796|NCT00739973|69637215|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
37949797|NCT00739973|69637216|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
37949798|NCT00739973|69637217|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
37949799|NCT00739973|69637218|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
37949800|NCT00739973|69637219|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
37949801|NCT00739973|69637220|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
37949802|NCT00739973|69637221|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
37949803|NCT00739973|69637222|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
37949804|NCT00739973|69637223|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
37949805|NCT00739973|69637215|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
37949806|NCT00739973|69637216|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
37949807|NCT00739973|69637217|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
37949808|NCT00739973|69637218|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
37949809|NCT00739973|69637219|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
37949810|NCT00739973|69637220|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
37949811|NCT00739973|69637221|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
37949812|NCT00739973|69637222|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
37949813|NCT00739973|69637223|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
37949814|NCT00739973|69637215|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
37949815|NCT00739973|69637216|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
37949816|NCT00739973|69637217|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
37949817|NCT00739973|69637218|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
37949818|NCT00739973|69637219|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
37949819|NCT00739973|69637220|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
37949820|NCT00739973|69637221|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
37949821|NCT00739973|69637222|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
37949822|NCT00739973|69637223|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
37949823|NCT00739973|69637215|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
37949824|NCT00739973|69637216|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
37949825|NCT00739973|69637217|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
37949826|NCT00739973|69637218|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
37949827|NCT00739973|69637219|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
37949828|NCT00739973|69637220|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
37949829|NCT00739973|69637221|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
37949830|NCT00739973|69637222|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
37949831|NCT00739973|69637223|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
37949832|NCT00739973|69637215|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
37949833|NCT00739973|69637216|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
37949834|NCT00739973|69637217|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
37949835|NCT00739973|69637218|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
37949836|NCT00739973|69637219|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
37949837|NCT00739973|69637220|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
37949838|NCT00739973|69637221|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
37949839|NCT00739973|69637222|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
37949840|NCT00739973|69637223|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
37677112|NCT02530905|69152055|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
37677113|NCT02530905|69152056|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
37677114|NCT02530905|69152057|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
37677115|NCT02530671|69152081|FG000|Overall Study|Lost to Follow-up|2|||
37677116|NCT02530671|69152082|FG001|Overall Study|Lost to Follow-up|0|||
37677117|NCT02530671|69152081|FG000|Overall Study|Withdrawal by Subject|1|||
37677118|NCT02530671|69152082|FG001|Overall Study|Withdrawal by Subject|0|||
37677119|NCT02603393|69152090|FG000|Overall Study|Patient/guardian decision|32|||
37677120|NCT02603393|69152091|FG001|Overall Study|Patient/guardian decision|18|||
37677121|NCT02603393|69152090|FG000|Overall Study|Adverse Event|17|||
37677122|NCT02603393|69152091|FG001|Overall Study|Adverse Event|15|||
37677123|NCT02603393|69152090|FG000|Overall Study|Technical problems|4|||
37677124|NCT02603393|69152091|FG001|Overall Study|Technical problems|7|||
37949841|NCT00739973|69637215|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
37677125|NCT02603393|69152090|FG000|Overall Study|Lack of Efficacy|7|||
37677126|NCT02603393|69152091|FG001|Overall Study|Lack of Efficacy|2|||
37677127|NCT02603393|69152090|FG000|Overall Study|Death|3|||
37677128|NCT02603393|69152091|FG001|Overall Study|Death|4|||
37677129|NCT02603393|69152090|FG000|Overall Study|Physician Decision|3|||
37677130|NCT02603393|69152091|FG001|Overall Study|Physician Decision|3|||
37677131|NCT02603393|69152090|FG000|Overall Study|Protocol deviation|2|||
37677132|NCT02603393|69152091|FG001|Overall Study|Protocol deviation|3|||
37677133|NCT02603393|69152090|FG000|Overall Study|Lost to Follow-up|1|||
37677134|NCT02603393|69152091|FG001|Overall Study|Lost to Follow-up|2|||
37677135|NCT02603393|69152090|FG000|Overall Study|Non-compliance with study treatment|1|||
37677136|NCT02603393|69152091|FG001|Overall Study|Non-compliance with study treatment|0|||
37677137|NCT02603393|69152090|FG000|Overall Study|Sponsor decision|1|||
37677138|NCT02603393|69152091|FG001|Overall Study|Sponsor decision|0|||
37677139|NCT02642653|69152099|FG000|Overall Study|Adverse Event|2|||
37677140|NCT02642653|69152100|FG001|Overall Study|Adverse Event|0|||
37677141|NCT01659567|69152106|FG000|Overall Study|Lack of Efficacy|22|||
37677142|NCT01659567|69152106|FG000|Overall Study|Switched to Pegferon|6|||
37677143|NCT01659567|69152106|FG000|Overall Study|Adverse Event|12|||
37677144|NCT01659567|69152106|FG000|Overall Study|Good result at early stage of treatment|5|||
37677145|NCT01659567|69152106|FG000|Overall Study|Withdrawal by Subject|64|||
37677146|NCT01659567|69152106|FG000|Overall Study|Progression of the main disease|1|||
37677147|NCT01659567|69152106|FG000|Overall Study|Other|13|||
37677148|NCT02605967|69152122|FG000|Overall Study|subject / guardian decision|1|||
37677149|NCT02605967|69152123|FG001|Overall Study|subject / guardian decision|2|||
37677150|NCT02605967|69152122|FG000|Overall Study|Physician Decision|10|||
37677151|NCT02605967|69152123|FG001|Overall Study|Physician Decision|1|||
37677152|NCT02605967|69152122|FG000|Overall Study|Death|4|||
37677153|NCT02605967|69152123|FG001|Overall Study|Death|2|||
37677154|NCT02605967|69152122|FG000|Overall Study|Adverse Event|1|||
37677155|NCT02605967|69152123|FG001|Overall Study|Adverse Event|0|||
37677156|NCT02605967|69152122|FG000|Overall Study|progressive disease|66|||
37677157|NCT02605967|69152123|FG001|Overall Study|progressive disease|35|||
37677158|NCT01668173|69152133|FG000|Overall Study|Adverse Event|3|||
37677159|NCT01668173|69152133|FG000|Overall Study|Trial suspension|4|||
37677160|NCT02600351|69152150|FG000|Overall Study|Lack of Efficacy|3|||
37677161|NCT02600351|69152151|FG001|Overall Study|Lack of Efficacy|0|||
37677162|NCT02600351|69152152|FG002|Overall Study|Lack of Efficacy|5|||
37677163|NCT02600351|69152153|FG003|Overall Study|Lack of Efficacy|2|||
37677164|NCT02600351|69152150|FG000|Overall Study|Lost to Follow-up|1|||
37677165|NCT02600351|69152151|FG001|Overall Study|Lost to Follow-up|0|||
37677166|NCT02600351|69152152|FG002|Overall Study|Lost to Follow-up|0|||
37677167|NCT02600351|69152153|FG003|Overall Study|Lost to Follow-up|0|||
37677168|NCT02600351|69152150|FG000|Overall Study|Randomized but Not Treated|1|||
37677169|NCT02600351|69152151|FG001|Overall Study|Randomized but Not Treated|0|||
37677170|NCT02600351|69152152|FG002|Overall Study|Randomized but Not Treated|1|||
37677171|NCT02600351|69152153|FG003|Overall Study|Randomized but Not Treated|3|||
37677172|NCT02640235|69152167|FG000|Overall Study|Withdrawal by Subject|7|||
37677173|NCT02640235|69152168|FG001|Overall Study|Withdrawal by Subject|6|||
37677174|NCT02640235|69152167|FG000|Overall Study|Lost to Follow-up|4|||
37677175|NCT02640235|69152168|FG001|Overall Study|Lost to Follow-up|3|||
37677176|NCT02640235|69152167|FG000|Overall Study|Death|2|||
37677177|NCT02640235|69152168|FG001|Overall Study|Death|3|||
37677178|NCT02640235|69152167|FG000|Overall Study|Other|1|||
37677179|NCT02640235|69152168|FG001|Overall Study|Other|2|||
37677180|NCT02599961|69152174|FG000|Overall Study|Withdrawal by Subject|1|||
37677181|NCT02599961|69152174|FG000|Overall Study|Subject Non-Compliance|2|||
37677182|NCT02599961|69152174|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
37677183|NCT02599961|69152174|FG000|Overall Study|Other, Not Specified|3|||
37677184|NCT02640157|69152199|FG000|Overall Study|Adverse Event|2|||
37677185|NCT02640157|69152200|FG001|Overall Study|Adverse Event|2|||
37677186|NCT02640157|69152201|FG002|Overall Study|Adverse Event|1|||
37677187|NCT02640157|69152199|FG000|Overall Study|Withdrew consent|2|||
37677188|NCT02640157|69152200|FG001|Overall Study|Withdrew consent|0|||
37677189|NCT02640157|69152201|FG002|Overall Study|Withdrew consent|2|||
37677190|NCT02640157|69152199|FG000|Overall Study|Lost to Follow-up|9|||
37677191|NCT02640157|69152200|FG001|Overall Study|Lost to Follow-up|2|||
37677192|NCT02640157|69152201|FG002|Overall Study|Lost to Follow-up|7|||
37677193|NCT02640157|69152199|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
37677194|NCT02640157|69152200|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
37949842|NCT00739973|69637216|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
37949843|NCT00739973|69637217|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
37949844|NCT00739973|69637218|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
37949845|NCT00739973|69637219|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
37949846|NCT00739973|69637220|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
37949847|NCT00739973|69637221|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
37949848|NCT00739973|69637222|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
37949849|NCT00739973|69637223|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
37949850|NCT00739973|69637215|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
37949851|NCT00739973|69637216|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
37949852|NCT00739973|69637217|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
37949853|NCT00739973|69637218|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
37949854|NCT00739973|69637219|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
37949855|NCT00739973|69637220|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
37949856|NCT00739973|69637221|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
37949857|NCT00739973|69637222|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
37949858|NCT00739973|69637223|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
37949859|NCT00739973|69637215|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
37949860|NCT00739973|69637216|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
37949861|NCT00739973|69637217|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
38042552|NCT04224688|69730094|FG000|Overall Study|Adverse event, not fatal|0|||
38042553|NCT04224688|69730095|FG001|Overall Study|Adverse event, not fatal|2|||
37677195|NCT02640157|69152201|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
37949862|NCT00739973|69637218|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
37949863|NCT00739973|69637219|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
37949864|NCT00739973|69637220|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
37949865|NCT00739973|69637221|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
37949866|NCT00739973|69637222|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
37949867|NCT00739973|69637223|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
37949868|NCT00739973|69637215|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
37949869|NCT00739973|69637216|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
37949870|NCT00739973|69637217|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
37949871|NCT00739973|69637218|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
37949872|NCT00739973|69637219|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
37949873|NCT00739973|69637220|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
37949874|NCT00739973|69637221|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
37949875|NCT00739973|69637222|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
37949876|NCT00739973|69637223|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
37949877|NCT00739973|69637215|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
37949878|NCT00739973|69637216|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
37949879|NCT00739973|69637217|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
37949880|NCT00739973|69637218|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
37949881|NCT00739973|69637219|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
37949882|NCT00739973|69637220|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
37949883|NCT00739973|69637221|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
37949884|NCT00739973|69637222|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
37949885|NCT00739973|69637223|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
37949886|NCT00739973|69637215|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
37949887|NCT00739973|69637216|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
37949888|NCT00739973|69637217|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
37949889|NCT00739973|69637218|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
37949890|NCT00739973|69637219|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
37949891|NCT00739973|69637220|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
37949892|NCT00739973|69637221|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
37949893|NCT00739973|69637222|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
37949894|NCT00739973|69637223|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
37949895|NCT00739973|69637215|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
37949896|NCT00739973|69637216|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
37949897|NCT00739973|69637217|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
37949898|NCT00739973|69637218|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
37949899|NCT00739973|69637219|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
37949900|NCT00739973|69637220|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
37949901|NCT00739973|69637221|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
37949902|NCT00739973|69637222|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
37949903|NCT00739973|69637223|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
37949904|NCT00739973|69637215|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
37949905|NCT00739973|69637216|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
37949906|NCT00739973|69637217|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
37949907|NCT00739973|69637218|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
37949908|NCT00739973|69637219|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
37949909|NCT00739973|69637220|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
37949910|NCT00739973|69637221|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
37949911|NCT00739973|69637222|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
37949912|NCT00739973|69637223|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
37949913|NCT00739973|69637215|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
37949914|NCT00739973|69637216|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
37949915|NCT00739973|69637217|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
37949916|NCT00739973|69637218|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
37949917|NCT00739973|69637219|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
37949918|NCT00739973|69637220|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
37949919|NCT00739973|69637221|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
37949920|NCT00739973|69637222|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
37949921|NCT00739973|69637223|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
37949922|NCT00739973|69637215|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
37949923|NCT00739973|69637216|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
37949924|NCT00739973|69637217|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
37949925|NCT00739973|69637218|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
37949926|NCT00739973|69637219|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
37949927|NCT00739973|69637220|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
37949928|NCT00739973|69637221|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
37949929|NCT00739973|69637222|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
37949930|NCT00739973|69637223|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
37949931|NCT00510874|69637258|FG000|Overall Study|Withdrawal by Subject|1|||
37949932|NCT00510874|69637259|FG001|Overall Study|Withdrawal by Subject|1|||
37949933|NCT00510874|69637260|FG002|Overall Study|Withdrawal by Subject|0|||
37949934|NCT00510874|69637261|FG003|Overall Study|Withdrawal by Subject|0|||
37949935|NCT00510874|69637262|FG004|Overall Study|Withdrawal by Subject|3|||
37949936|NCT00510874|69637263|FG005|Overall Study|Withdrawal by Subject|0|||
37949937|NCT00510874|69637264|FG006|Overall Study|Withdrawal by Subject|0|||
37949938|NCT00510874|69637258|FG000|Overall Study|Lost to Follow-up|2|||
37949939|NCT00510874|69637259|FG001|Overall Study|Lost to Follow-up|3|||
37949940|NCT00510874|69637260|FG002|Overall Study|Lost to Follow-up|1|||
37949941|NCT00510874|69637261|FG003|Overall Study|Lost to Follow-up|3|||
37949942|NCT00510874|69637262|FG004|Overall Study|Lost to Follow-up|4|||
37949943|NCT00510874|69637263|FG005|Overall Study|Lost to Follow-up|0|||
37949944|NCT00510874|69637264|FG006|Overall Study|Lost to Follow-up|1|||
37949945|NCT00739661|69637283|FG000|Overall Study|Adverse Event|2|||
37949946|NCT00739661|69637284|FG001|Overall Study|Adverse Event|0|||
37949947|NCT00739661|69637283|FG000|Overall Study|Physician decision to withdraw patient|1|||
37949948|NCT00739661|69637284|FG001|Overall Study|Physician decision to withdraw patient|0|||
37949949|NCT00739661|69637283|FG000|Overall Study|Patient decision to withdraw|9|||
37949950|NCT00739661|69637284|FG001|Overall Study|Patient decision to withdraw|4|||
37949951|NCT00739661|69637283|FG000|Overall Study|Disease progression, radiographic|33|||
37949952|NCT00739661|69637284|FG001|Overall Study|Disease progression, radiographic|37|||
37949953|NCT00739661|69637283|FG000|Overall Study|Reason for discontinuation not available|1|||
37949954|NCT00739661|69637284|FG001|Overall Study|Reason for discontinuation not available|1|||
37949955|NCT00615030|69637290|FG000|Period I|Administrative problem|0|||
37949956|NCT00615030|69637291|FG001|Period I|Administrative problem|0|||
37949957|NCT00615030|69637292|FG002|Period I|Administrative problem|0|||
37949958|NCT00615030|69637293|FG003|Period I|Administrative problem|0|||
37949959|NCT00615030|69637294|FG004|Period I|Administrative problem|1|||
37949960|NCT00615030|69637295|FG005|Period I|Administrative problem|0|||
37949961|NCT00615030|69637296|FG006|Period I|Administrative problem|0|||
37949962|NCT00615030|69637297|FG007|Period I|Administrative problem|0|||
37949963|NCT00615030|69637298|FG008|Period I|Administrative problem|0|||
37949964|NCT00615030|69637299|FG009|Period I|Administrative problem|0|||
37949965|NCT00615030|69637300|FG010|Period I|Administrative problem|0|||
37949966|NCT00615030|69637301|FG011|Period I|Administrative problem|0|||
37949967|NCT00615030|69637290|FG000|Period I|Protocol deviation|1|||
37949968|NCT00615030|69637291|FG001|Period I|Protocol deviation|0|||
37949969|NCT00615030|69637292|FG002|Period I|Protocol deviation|0|||
37949970|NCT00615030|69637293|FG003|Period I|Protocol deviation|0|||
37949971|NCT00615030|69637294|FG004|Period I|Protocol deviation|0|||
37949972|NCT00615030|69637295|FG005|Period I|Protocol deviation|0|||
37949973|NCT00615030|69637296|FG006|Period I|Protocol deviation|0|||
37949974|NCT00615030|69637297|FG007|Period I|Protocol deviation|0|||
37949975|NCT00615030|69637298|FG008|Period I|Protocol deviation|0|||
37949976|NCT00615030|69637299|FG009|Period I|Protocol deviation|0|||
37949977|NCT00615030|69637300|FG010|Period I|Protocol deviation|0|||
37949978|NCT00615030|69637301|FG011|Period I|Protocol deviation|0|||
37949979|NCT00615030|69637290|FG000|Period I|Subject withdrew consent|0|||
37949980|NCT00615030|69637291|FG001|Period I|Subject withdrew consent|0|||
37949981|NCT00615030|69637292|FG002|Period I|Subject withdrew consent|0|||
37949982|NCT00615030|69637293|FG003|Period I|Subject withdrew consent|0|||
37949983|NCT00615030|69637294|FG004|Period I|Subject withdrew consent|0|||
37949984|NCT00615030|69637295|FG005|Period I|Subject withdrew consent|0|||
38042554|NCT04224688|69730094|FG000|Overall Study|COVID-19|0|||
38042555|NCT04224688|69730095|FG001|Overall Study|COVID-19|1|||
37677196|NCT01673347|69152210|FG000|Overall Study|failure of allograft|7|||
37677197|NCT02528253|69152219|FG000|Overall Study|Adverse Event|3|||
37677198|NCT02528253|69152220|FG001|Overall Study|Adverse Event|4|||
37677199|NCT02528253|69152221|FG002|Overall Study|Adverse Event|4|||
37677200|NCT02528253|69152222|FG003|Overall Study|Adverse Event|8|||
37677201|NCT02528253|69152223|FG004|Overall Study|Adverse Event|18|||
37677202|NCT02528253|69152219|FG000|Overall Study|Death|2|||
37677203|NCT02528253|69152220|FG001|Overall Study|Death|2|||
37677204|NCT02528253|69152221|FG002|Overall Study|Death|1|||
37677205|NCT02528253|69152222|FG003|Overall Study|Death|0|||
37949985|NCT00615030|69637296|FG006|Period I|Subject withdrew consent|0|||
37949986|NCT00615030|69637297|FG007|Period I|Subject withdrew consent|0|||
37949987|NCT00615030|69637298|FG008|Period I|Subject withdrew consent|1|||
37949988|NCT00615030|69637299|FG009|Period I|Subject withdrew consent|0|||
37949989|NCT00615030|69637300|FG010|Period I|Subject withdrew consent|1|||
37949990|NCT00615030|69637301|FG011|Period I|Subject withdrew consent|1|||
37949991|NCT00615030|69637290|FG000|Period I|Abnormal laboratory value(s)|0|||
37949992|NCT00615030|69637291|FG001|Period I|Abnormal laboratory value(s)|0|||
37949993|NCT00615030|69637292|FG002|Period I|Abnormal laboratory value(s)|0|||
37949994|NCT00615030|69637293|FG003|Period I|Abnormal laboratory value(s)|0|||
37949995|NCT00615030|69637294|FG004|Period I|Abnormal laboratory value(s)|0|||
37949996|NCT00615030|69637295|FG005|Period I|Abnormal laboratory value(s)|1|||
37949997|NCT00615030|69637296|FG006|Period I|Abnormal laboratory value(s)|0|||
37949998|NCT00615030|69637297|FG007|Period I|Abnormal laboratory value(s)|0|||
37949999|NCT00615030|69637298|FG008|Period I|Abnormal laboratory value(s)|0|||
37950000|NCT00615030|69637299|FG009|Period I|Abnormal laboratory value(s)|0|||
37950001|NCT00615030|69637300|FG010|Period I|Abnormal laboratory value(s)|0|||
37950002|NCT00615030|69637301|FG011|Period I|Abnormal laboratory value(s)|0|||
37950003|NCT00615030|69637290|FG000|Period II|Adverse Event|0|||
37950004|NCT00615030|69637291|FG001|Period II|Adverse Event|0|||
37950005|NCT00615030|69637292|FG002|Period II|Adverse Event|1|||
37950006|NCT00615030|69637293|FG003|Period II|Adverse Event|0|||
37950007|NCT00615030|69637294|FG004|Period II|Adverse Event|0|||
37950008|NCT00615030|69637295|FG005|Period II|Adverse Event|0|||
37950009|NCT00615030|69637296|FG006|Period II|Adverse Event|0|||
37950010|NCT00615030|69637297|FG007|Period II|Adverse Event|0|||
37950011|NCT00615030|69637298|FG008|Period II|Adverse Event|1|||
37950012|NCT00615030|69637299|FG009|Period II|Adverse Event|0|||
37950013|NCT00615030|69637300|FG010|Period II|Adverse Event|0|||
37950014|NCT00615030|69637301|FG011|Period II|Adverse Event|0|||
37950015|NCT00615030|69637290|FG000|Period II|Subject withdrew consent|0|||
37950016|NCT00615030|69637291|FG001|Period II|Subject withdrew consent|0|||
37950017|NCT00615030|69637292|FG002|Period II|Subject withdrew consent|0|||
37950018|NCT00615030|69637293|FG003|Period II|Subject withdrew consent|1|||
37950019|NCT00615030|69637294|FG004|Period II|Subject withdrew consent|0|||
37950020|NCT00615030|69637295|FG005|Period II|Subject withdrew consent|0|||
37950021|NCT00615030|69637296|FG006|Period II|Subject withdrew consent|1|||
37950022|NCT00615030|69637297|FG007|Period II|Subject withdrew consent|0|||
37950023|NCT00615030|69637298|FG008|Period II|Subject withdrew consent|0|||
37950024|NCT00615030|69637299|FG009|Period II|Subject withdrew consent|0|||
37950025|NCT00615030|69637300|FG010|Period II|Subject withdrew consent|0|||
37950026|NCT00615030|69637301|FG011|Period II|Subject withdrew consent|0|||
37950027|NCT00615030|69637290|FG000|Period III|Administrative problems|1|||
37950028|NCT00615030|69637291|FG001|Period III|Administrative problems|0|||
37950029|NCT00615030|69637292|FG002|Period III|Administrative problems|0|||
37950030|NCT00615030|69637293|FG003|Period III|Administrative problems|1|||
37950031|NCT00615030|69637294|FG004|Period III|Administrative problems|0|||
37950032|NCT00615030|69637295|FG005|Period III|Administrative problems|0|||
37950033|NCT00615030|69637296|FG006|Period III|Administrative problems|0|||
37950034|NCT00615030|69637297|FG007|Period III|Administrative problems|0|||
37950035|NCT00615030|69637298|FG008|Period III|Administrative problems|0|||
37950036|NCT00615030|69637299|FG009|Period III|Administrative problems|0|||
37950037|NCT00615030|69637300|FG010|Period III|Administrative problems|0|||
37950038|NCT00615030|69637301|FG011|Period III|Administrative problems|0|||
37950039|NCT00518284|69637319|FG000|Overall Study|Adverse Event|0|||
37950040|NCT00518284|69637320|FG001|Overall Study|Adverse Event|1|||
37950041|NCT00518284|69637321|FG002|Overall Study|Adverse Event|0|||
37950042|NCT00518284|69637322|FG003|Overall Study|Adverse Event|0|||
37950043|NCT00518284|69637319|FG000|Overall Study|Study Termination|0|||
37950044|NCT00518284|69637320|FG001|Overall Study|Study Termination|2|||
37950045|NCT00518284|69637321|FG002|Overall Study|Study Termination|1|||
37950046|NCT00518284|69637322|FG003|Overall Study|Study Termination|2|||
37950047|NCT00614874|69637332|FG000|Overall Study|Protocol Violation|1|||
37950048|NCT00614874|69637332|FG000|Overall Study|Withdrawal by Subject|1|||
37950049|NCT00727415|69637336|FG000|Phase I|Dose Limiting Toxicity|2|||
37950050|NCT00544557|69637340|FG000|Overall Study|Adverse Event|140|||
37950051|NCT00544557|69637340|FG000|Overall Study|Lack of Efficacy|196|||
37950052|NCT00544557|69637340|FG000|Overall Study|Other|98|||
37950053|NCT00727259|69637344|FG000|Overall Study|Not all questionnaires completed|1055|||
37950054|NCT00735371|69637353|FG000|Overall Study|Adverse Event|3|||
37950055|NCT00735371|69637354|FG001|Overall Study|Adverse Event|3|||
37950056|NCT00735371|69637355|FG002|Overall Study|Adverse Event|4|||
37950057|NCT00735371|69637356|FG003|Overall Study|Adverse Event|1|||
37950058|NCT00735371|69637353|FG000|Overall Study|Protocol Violation|2|||
37950059|NCT00735371|69637354|FG001|Overall Study|Protocol Violation|2|||
37677206|NCT02528253|69152223|FG004|Overall Study|Death|1|||
37950060|NCT00735371|69637355|FG002|Overall Study|Protocol Violation|0|||
37950061|NCT00735371|69637356|FG003|Overall Study|Protocol Violation|3|||
37950062|NCT00735371|69637353|FG000|Overall Study|Withdrawal by Subject|0|||
37950063|NCT00735371|69637354|FG001|Overall Study|Withdrawal by Subject|2|||
37950064|NCT00735371|69637355|FG002|Overall Study|Withdrawal by Subject|2|||
37950065|NCT00735371|69637356|FG003|Overall Study|Withdrawal by Subject|0|||
37950066|NCT00735371|69637353|FG000|Overall Study|Lost to Follow-up|1|||
37950067|NCT00735371|69637354|FG001|Overall Study|Lost to Follow-up|1|||
37950068|NCT00735371|69637355|FG002|Overall Study|Lost to Follow-up|3|||
37950069|NCT00735371|69637356|FG003|Overall Study|Lost to Follow-up|1|||
37950070|NCT00735371|69637353|FG000|Overall Study|Lack of Efficacy|4|||
37950071|NCT00735371|69637354|FG001|Overall Study|Lack of Efficacy|2|||
37950072|NCT00735371|69637355|FG002|Overall Study|Lack of Efficacy|0|||
37950073|NCT00735371|69637356|FG003|Overall Study|Lack of Efficacy|4|||
37950074|NCT00735371|69637353|FG000|Overall Study|Sponsor Decision|3|||
37950075|NCT00735371|69637354|FG001|Overall Study|Sponsor Decision|1|||
37950076|NCT00735371|69637355|FG002|Overall Study|Sponsor Decision|0|||
37950077|NCT00735371|69637356|FG003|Overall Study|Sponsor Decision|1|||
37950078|NCT00735371|69637353|FG000|Overall Study|Protocol Violation|0|||
37950079|NCT00735371|69637354|FG001|Overall Study|Protocol Violation|1|||
37950080|NCT00735371|69637355|FG002|Overall Study|Protocol Violation|2|||
37950081|NCT00735371|69637356|FG003|Overall Study|Protocol Violation|0|||
37950082|NCT00735371|69637353|FG000|Overall Study|Prior Vyvanse Exposure|1|||
37950083|NCT00735371|69637354|FG001|Overall Study|Prior Vyvanse Exposure|1|||
37950084|NCT00735371|69637355|FG002|Overall Study|Prior Vyvanse Exposure|0|||
37950085|NCT00735371|69637356|FG003|Overall Study|Prior Vyvanse Exposure|0|||
37950086|NCT00735371|69637353|FG000|Overall Study|Exclusion criteria|1|||
37950087|NCT00735371|69637354|FG001|Overall Study|Exclusion criteria|0|||
37950088|NCT00735371|69637355|FG002|Overall Study|Exclusion criteria|0|||
37950089|NCT00735371|69637356|FG003|Overall Study|Exclusion criteria|0|||
37950090|NCT00518206|69637368|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
37950091|NCT00518206|69637369|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
37950092|NCT00518206|69637368|FG000|Overall Study|Withdrawal by Subject|2|||
37950093|NCT00518206|69637369|FG001|Overall Study|Withdrawal by Subject|0|||
37950094|NCT00518206|69637368|FG000|Overall Study|Drug Supply Issue|1|||
37950095|NCT00518206|69637369|FG001|Overall Study|Drug Supply Issue|0|||
37950096|NCT00518206|69637368|FG000|Overall Study|Reason Unknown|1|||
37950097|NCT00518206|69637369|FG001|Overall Study|Reason Unknown|0|||
37950098|NCT00518206|69637368|FG000|Overall Study|Completion Status Unknown|1|||
37950099|NCT00518206|69637369|FG001|Overall Study|Completion Status Unknown|0|||
37950100|NCT00586313|69637375|FG000|Overall Study|Lack of Efficacy|2|||
37950101|NCT00734747|69637379|FG000|SRS Procedure|No staples placed|3|||
37950102|NCT00734747|69637379|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
37950103|NCT00726557|69637383|FG000|Overall Study|Screening failure|4|||
37950104|NCT00726557|69637383|FG000|Overall Study|No end of treatment documentation|37|||
37950105|NCT00726557|69637383|FG000|Overall Study|No follow-up documentation available|55|||
37950106|NCT00726557|69637383|FG000|Overall Study|Treatment less than 3 months|17|||
37950107|NCT00726557|69637383|FG000|Overall Study|Inclusion criteria not met|15|||
37950108|NCT00738881|69637390|FG000|Overall Study|Withdrawal by Subject|0|||
37950109|NCT00738881|69637391|FG001|Overall Study|Withdrawal by Subject|2|||
37950110|NCT00657020|69637397|FG000|PERIOD 1|Adverse Event|0|||
37950111|NCT00657020|69637398|FG001|PERIOD 1|Adverse Event|1|||
37950112|NCT03921723|69637410|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
37950113|NCT03921723|69637410|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
37950114|NCT00544167|69637418|FG000|Overall Study|Adverse Event|21|||
37950115|NCT00544167|69637418|FG000|Overall Study|Physician Decision|8|||
37950116|NCT00659438|69637424|FG000|Overall Study|Withdrawal by Subject|2|||
37950117|NCT00659438|69637425|FG001|Overall Study|Withdrawal by Subject|2|||
37950118|NCT00659438|69637424|FG000|Overall Study|Death|11|||
37950119|NCT00659438|69637425|FG001|Overall Study|Death|6|||
37950120|NCT00659438|69637424|FG000|Overall Study|Lost to Follow-up|1|||
37950121|NCT00659438|69637425|FG001|Overall Study|Lost to Follow-up|0|||
37950122|NCT00543855|69637435|FG000|Overall Study|Adverse Event|3|||
37950123|NCT00543855|69637436|FG001|Overall Study|Adverse Event|1|||
37950124|NCT00543855|69637437|FG002|Overall Study|Adverse Event|3|||
37950125|NCT00543855|69637438|FG003|Overall Study|Adverse Event|4|||
37950126|NCT00543855|69637435|FG000|Overall Study|Lost to Follow-up|0|||
37950127|NCT00543855|69637436|FG001|Overall Study|Lost to Follow-up|0|||
37950128|NCT00543855|69637437|FG002|Overall Study|Lost to Follow-up|1|||
37950129|NCT00543855|69637438|FG003|Overall Study|Lost to Follow-up|0|||
37950130|NCT00543855|69637435|FG000|Overall Study|Withdrawal by Subject|0|||
37950131|NCT00543855|69637436|FG001|Overall Study|Withdrawal by Subject|1|||
37950132|NCT00543855|69637437|FG002|Overall Study|Withdrawal by Subject|2|||
37950133|NCT00543855|69637438|FG003|Overall Study|Withdrawal by Subject|0|||
37950134|NCT00543855|69637435|FG000|Overall Study|Protocol Violation|1|||
37950135|NCT00543855|69637436|FG001|Overall Study|Protocol Violation|0|||
37950136|NCT00543855|69637437|FG002|Overall Study|Protocol Violation|0|||
37950137|NCT00543855|69637438|FG003|Overall Study|Protocol Violation|0|||
37950138|NCT00656474|69637448|FG000|Overall Study|Other Reason|1|||
37950139|NCT00656084|69637453|FG000|Overall Study|Adverse Event|4|||
37950140|NCT00656084|69637453|FG000|Overall Study|Withdrawal by Subject|1|||
37950141|NCT00656084|69637453|FG000|Overall Study|Patient Request|1|||
37950142|NCT00656084|69637453|FG000|Overall Study|Investigator Request|1|||
37950143|NCT00613938|69637461|FG000|Overall Study|Withdrawal by Subject|2|||
37950144|NCT00613938|69637462|FG001|Overall Study|Withdrawal by Subject|4|||
37950145|NCT00613938|69637463|FG002|Overall Study|Withdrawal by Subject|9|||
37950146|NCT00613938|69637464|FG003|Overall Study|Withdrawal by Subject|9|||
37950147|NCT00613938|69637461|FG000|Overall Study|Adverse Event|1|||
37950148|NCT00613938|69637462|FG001|Overall Study|Adverse Event|4|||
37950149|NCT00613938|69637463|FG002|Overall Study|Adverse Event|8|||
37950150|NCT00613938|69637464|FG003|Overall Study|Adverse Event|5|||
37950151|NCT00613938|69637461|FG000|Overall Study|Lack of Efficacy|16|||
37950152|NCT00613938|69637462|FG001|Overall Study|Lack of Efficacy|18|||
37950153|NCT00613938|69637463|FG002|Overall Study|Lack of Efficacy|5|||
37950154|NCT00613938|69637464|FG003|Overall Study|Lack of Efficacy|9|||
37950155|NCT00613938|69637461|FG000|Overall Study|Other|1|||
37950156|NCT00613938|69637462|FG001|Overall Study|Other|2|||
37950157|NCT00613938|69637463|FG002|Overall Study|Other|1|||
37950158|NCT00613938|69637464|FG003|Overall Study|Other|3|||
37950159|NCT00655928|69637476|FG000|Overall Study|Withdrawal by Subject|2|||
37950160|NCT00655928|69637477|FG001|Overall Study|Withdrawal by Subject|1|||
37950161|NCT00655928|69637476|FG000|Overall Study|Physician Decision|1|||
37950162|NCT00655928|69637477|FG001|Overall Study|Physician Decision|1|||
37950163|NCT00655850|69637483|FG000|Overall Study|Death|2|||
37950164|NCT00655850|69637483|FG000|Overall Study|Withdrawal by Subject|1|||
37950165|NCT00726323|69637491|FG000|Overall Study|Withdrawal by Subject|3|||
37950166|NCT00726323|69637492|FG001|Overall Study|Withdrawal by Subject|1|||
37950167|NCT00726323|69637491|FG000|Overall Study|Physician Decision|1|||
37950168|NCT00726323|69637492|FG001|Overall Study|Physician Decision|0|||
37950169|NCT00726323|69637491|FG000|Overall Study|Progressive disease|23|||
37950170|NCT00726323|69637492|FG001|Overall Study|Progressive disease|16|||
37950171|NCT00726323|69637491|FG000|Overall Study|Clinical progression|0|||
37950172|NCT00726323|69637492|FG001|Overall Study|Clinical progression|3|||
37950173|NCT00726323|69637491|FG000|Overall Study|Adverse Event|9|||
37950174|NCT00726323|69637492|FG001|Overall Study|Adverse Event|9|||
37950175|NCT00726323|69637491|FG000|Overall Study|Death|1|||
37950176|NCT00726323|69637492|FG001|Overall Study|Death|0|||
37950177|NCT00726323|69637491|FG000|Overall Study|Participant wished to discontinue|0|||
37950178|NCT00726323|69637492|FG001|Overall Study|Participant wished to discontinue|1|||
37950179|NCT00726323|69637491|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
37950180|NCT00726323|69637492|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
37950181|NCT00246571|69637500|FG000|Overall Study|Adverse Event|7|||
37950182|NCT00246571|69637501|FG001|Overall Study|Adverse Event|0|||
37950183|NCT00246571|69637500|FG000|Overall Study|Protocol Violation|0|||
37950184|NCT00246571|69637501|FG001|Overall Study|Protocol Violation|1|||
37950185|NCT00246571|69637500|FG000|Overall Study|Withdrawal by Subject|2|||
37950186|NCT00246571|69637501|FG001|Overall Study|Withdrawal by Subject|3|||
37950187|NCT00246571|69637500|FG000|Overall Study|Lack of Efficacy|84|||
37950188|NCT00246571|69637501|FG001|Overall Study|Lack of Efficacy|21|||
37950189|NCT00246571|69637500|FG000|Overall Study|Death|17|||
37950190|NCT00246571|69637501|FG001|Overall Study|Death|3|||
37950191|NCT00246571|69637500|FG000|Overall Study|Sponsor|0|||
37950192|NCT00246571|69637501|FG001|Overall Study|Sponsor|1|||
37950193|NCT00246571|69637500|FG000|Overall Study|Did not meet entrance criteria|2|||
37950194|NCT00246571|69637501|FG001|Overall Study|Did not meet entrance criteria|1|||
37950195|NCT00246571|69637500|FG000|Overall Study|Laboratory abnormalities|1|||
37950196|NCT00246571|69637501|FG001|Overall Study|Laboratory abnormalities|0|||
37950197|NCT00246571|69637500|FG000|Overall Study|Crossover participants|0|||
37950198|NCT00246571|69637501|FG001|Overall Study|Crossover participants|74|||
37950199|NCT00734591|69637509|FG000|Screening for Prospective Period|Site did not participate|1604|||
37950200|NCT00734591|69637510|FG001|Screening for Prospective Period|Site did not participate|1488|||
37950201|NCT00734591|69637509|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
37950202|NCT00734591|69637510|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
37950203|NCT00734591|69637509|FG000|Prospective Period|Withdrawal by Subject|11|||
37950204|NCT00734591|69637510|FG001|Prospective Period|Withdrawal by Subject|9|||
37950205|NCT00734591|69637509|FG000|Prospective Period|Lost to Follow-up|37|||
37950206|NCT00734591|69637510|FG001|Prospective Period|Lost to Follow-up|33|||
37950207|NCT00734591|69637509|FG000|Prospective Period|Study Terminated|1|||
37950208|NCT00734591|69637510|FG001|Prospective Period|Study Terminated|0|||
37950209|NCT00734591|69637509|FG000|Prospective Period|Other|2|||
37950210|NCT00734591|69637510|FG001|Prospective Period|Other|2|||
37950211|NCT00569270|69637516|FG000|Period: First Intervention|Protocol Violation|0|||
37950212|NCT00569270|69637517|FG001|Period: First Intervention|Protocol Violation|1|||
37950213|NCT00545103|69637536|FG000|Overall Study|Lack of Efficacy|48|||
37950214|NCT00545103|69637537|FG001|Overall Study|Lack of Efficacy|45|||
37950215|NCT00545103|69637538|FG002|Overall Study|Lack of Efficacy|31|||
37950216|NCT00545103|69637539|FG003|Overall Study|Lack of Efficacy|27|||
37950217|NCT00545103|69637536|FG000|Overall Study|Withdrawal by Subject|6|||
37950218|NCT00545103|69637537|FG001|Overall Study|Withdrawal by Subject|10|||
37950219|NCT00545103|69637538|FG002|Overall Study|Withdrawal by Subject|18|||
37950220|NCT00545103|69637539|FG003|Overall Study|Withdrawal by Subject|22|||
37950221|NCT00545103|69637536|FG000|Overall Study|Adverse Event|11|||
37950222|NCT00545103|69637537|FG001|Overall Study|Adverse Event|12|||
37950223|NCT00545103|69637538|FG002|Overall Study|Adverse Event|17|||
37950224|NCT00545103|69637539|FG003|Overall Study|Adverse Event|10|||
37950225|NCT00545103|69637536|FG000|Overall Study|Lost to Follow-up|4|||
37950226|NCT00545103|69637537|FG001|Overall Study|Lost to Follow-up|6|||
37950227|NCT00545103|69637538|FG002|Overall Study|Lost to Follow-up|3|||
37950228|NCT00545103|69637539|FG003|Overall Study|Lost to Follow-up|4|||
37950229|NCT00545103|69637536|FG000|Overall Study|Protocol Violation|1|||
37950230|NCT00545103|69637537|FG001|Overall Study|Protocol Violation|2|||
37950231|NCT00545103|69637538|FG002|Overall Study|Protocol Violation|3|||
37950232|NCT00545103|69637539|FG003|Overall Study|Protocol Violation|0|||
37950233|NCT00545103|69637536|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
37950234|NCT00545103|69637537|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
37950235|NCT00545103|69637538|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
37950236|NCT00545103|69637539|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
37950237|NCT00545103|69637536|FG000|Overall Study|Difficult to open package|0|||
37950238|NCT00545103|69637537|FG001|Overall Study|Difficult to open package|0|||
37950239|NCT00545103|69637538|FG002|Overall Study|Difficult to open package|0|||
37950240|NCT00545103|69637539|FG003|Overall Study|Difficult to open package|1|||
37950241|NCT00545103|69637536|FG000|Overall Study|Investigational product not taken|1|||
37950242|NCT00545103|69637537|FG001|Overall Study|Investigational product not taken|0|||
37950243|NCT00545103|69637538|FG002|Overall Study|Investigational product not taken|0|||
37950244|NCT00545103|69637539|FG003|Overall Study|Investigational product not taken|1|||
37950245|NCT00545103|69637536|FG000|Overall Study|Wish to start a family|0|||
37950246|NCT00545103|69637537|FG001|Overall Study|Wish to start a family|0|||
37950247|NCT00545103|69637538|FG002|Overall Study|Wish to start a family|0|||
37950248|NCT00545103|69637539|FG003|Overall Study|Wish to start a family|1|||
37950249|NCT00545103|69637536|FG000|Overall Study|Diverticulitis crisis|0|||
37950250|NCT00545103|69637537|FG001|Overall Study|Diverticulitis crisis|0|||
37950251|NCT00545103|69637538|FG002|Overall Study|Diverticulitis crisis|0|||
37950252|NCT00545103|69637539|FG003|Overall Study|Diverticulitis crisis|1|||
37950253|NCT00545103|69637536|FG000|Overall Study|Personal reasons|1|||
37950254|NCT00545103|69637537|FG001|Overall Study|Personal reasons|0|||
37950255|NCT00545103|69637538|FG002|Overall Study|Personal reasons|0|||
37950256|NCT00545103|69637539|FG003|Overall Study|Personal reasons|0|||
37950257|NCT00545103|69637536|FG000|Overall Study|Subject's decision|1|||
37950258|NCT00545103|69637537|FG001|Overall Study|Subject's decision|0|||
37950259|NCT00545103|69637538|FG002|Overall Study|Subject's decision|0|||
37950260|NCT00545103|69637539|FG003|Overall Study|Subject's decision|0|||
37950261|NCT00545103|69637536|FG000|Overall Study|Noncompliance|0|||
37950262|NCT00545103|69637537|FG001|Overall Study|Noncompliance|1|||
37950263|NCT00545103|69637538|FG002|Overall Study|Noncompliance|0|||
37950264|NCT00545103|69637539|FG003|Overall Study|Noncompliance|0|||
37950265|NCT00545103|69637536|FG000|Overall Study|Investigator decision|0|||
37950266|NCT00545103|69637537|FG001|Overall Study|Investigator decision|0|||
37950267|NCT00545103|69637538|FG002|Overall Study|Investigator decision|1|||
37950268|NCT00545103|69637539|FG003|Overall Study|Investigator decision|0|||
37950269|NCT00545103|69637536|FG000|Overall Study|Subject moved|0|||
37950270|NCT00545103|69637537|FG001|Overall Study|Subject moved|1|||
37950271|NCT00545103|69637538|FG002|Overall Study|Subject moved|0|||
37950272|NCT00545103|69637539|FG003|Overall Study|Subject moved|0|||
37950273|NCT00545103|69637536|FG000|Overall Study|Use of prohibited medication|0|||
37950274|NCT00545103|69637537|FG001|Overall Study|Use of prohibited medication|0|||
37950275|NCT00545103|69637538|FG002|Overall Study|Use of prohibited medication|1|||
37950276|NCT00545103|69637539|FG003|Overall Study|Use of prohibited medication|0|||
37950277|NCT00545103|69637536|FG000|Overall Study|Does not want to take study drug anymore|1|||
37950278|NCT00545103|69637537|FG001|Overall Study|Does not want to take study drug anymore|0|||
37950279|NCT00545103|69637538|FG002|Overall Study|Does not want to take study drug anymore|1|||
37950280|NCT00545103|69637539|FG003|Overall Study|Does not want to take study drug anymore|0|||
37950281|NCT00545103|69637536|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
37950282|NCT00545103|69637537|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
37950283|NCT00545103|69637538|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
37950284|NCT00545103|69637539|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
37950285|NCT00545103|69637536|FG000|Overall Study|Death|0|||
37950286|NCT00545103|69637537|FG001|Overall Study|Death|1|||
37950287|NCT00545103|69637538|FG002|Overall Study|Death|0|||
37950288|NCT00545103|69637539|FG003|Overall Study|Death|0|||
37950289|NCT00586157|69637549|FG000|First Intervention|Worsening behavior|1|||
37950290|NCT00586157|69637550|FG001|First Intervention|Worsening behavior|0|||
37950291|NCT00586157|69637549|FG000|Second Intervention|Withdrawal by Subject|1|||
37950292|NCT00586157|69637550|FG001|Second Intervention|Withdrawal by Subject|0|||
38042556|NCT04200456|69730103|FG000|Overall Study|Physician Decision|0|||
37950293|NCT00586157|69637549|FG000|Second Intervention|Worsening behavior|1|||
37950294|NCT00586157|69637550|FG001|Second Intervention|Worsening behavior|0|||
37950295|NCT00586157|69637549|FG000|Second Intervention|Adverse Event|0|||
37950296|NCT00586157|69637550|FG001|Second Intervention|Adverse Event|1|||
37950297|NCT00246337|69637565|FG000|Overall Study|Lost to Follow-up|3|||
37950298|NCT00246337|69637566|FG001|Overall Study|Lost to Follow-up|0|||
37950299|NCT00246337|69637567|FG002|Overall Study|Lost to Follow-up|0|||
37950300|NCT00246337|69637568|FG003|Overall Study|Lost to Follow-up|0|||
37950301|NCT00246337|69637569|FG004|Overall Study|Lost to Follow-up|2|||
37950302|NCT00246337|69637570|FG005|Overall Study|Lost to Follow-up|2|||
37950303|NCT00246337|69637571|FG006|Overall Study|Lost to Follow-up|1|||
37950304|NCT00246337|69637572|FG007|Overall Study|Lost to Follow-up|2|||
37950305|NCT00246337|69637573|FG008|Overall Study|Lost to Follow-up|0|||
37950306|NCT00246337|69637565|FG000|Overall Study|Protocol Violation|1|||
37950307|NCT00246337|69637566|FG001|Overall Study|Protocol Violation|0|||
37950308|NCT00246337|69637567|FG002|Overall Study|Protocol Violation|0|||
37950309|NCT00246337|69637568|FG003|Overall Study|Protocol Violation|0|||
37950310|NCT00246337|69637569|FG004|Overall Study|Protocol Violation|1|||
37950311|NCT00246337|69637570|FG005|Overall Study|Protocol Violation|0|||
37950312|NCT00246337|69637571|FG006|Overall Study|Protocol Violation|1|||
37950313|NCT00246337|69637572|FG007|Overall Study|Protocol Violation|1|||
37950314|NCT00246337|69637573|FG008|Overall Study|Protocol Violation|0|||
37950315|NCT00246337|69637565|FG000|Overall Study|Withdrawal by Subject|2|||
37950316|NCT00246337|69637566|FG001|Overall Study|Withdrawal by Subject|0|||
37950317|NCT00246337|69637567|FG002|Overall Study|Withdrawal by Subject|0|||
37950318|NCT00246337|69637568|FG003|Overall Study|Withdrawal by Subject|0|||
37950319|NCT00246337|69637569|FG004|Overall Study|Withdrawal by Subject|0|||
37950320|NCT00246337|69637570|FG005|Overall Study|Withdrawal by Subject|0|||
37950321|NCT00246337|69637571|FG006|Overall Study|Withdrawal by Subject|1|||
37950322|NCT00246337|69637572|FG007|Overall Study|Withdrawal by Subject|1|||
37950323|NCT00246337|69637573|FG008|Overall Study|Withdrawal by Subject|0|||
37950324|NCT00246337|69637565|FG000|Overall Study|Lack of Qualifying Event|8|||
37950325|NCT00246337|69637566|FG001|Overall Study|Lack of Qualifying Event|2|||
37950326|NCT00246337|69637567|FG002|Overall Study|Lack of Qualifying Event|1|||
37950327|NCT00246337|69637568|FG003|Overall Study|Lack of Qualifying Event|1|||
37950328|NCT00246337|69637569|FG004|Overall Study|Lack of Qualifying Event|1|||
37950329|NCT00246337|69637570|FG005|Overall Study|Lack of Qualifying Event|3|||
37950330|NCT00246337|69637571|FG006|Overall Study|Lack of Qualifying Event|3|||
37950331|NCT00246337|69637572|FG007|Overall Study|Lack of Qualifying Event|2|||
37950332|NCT00246337|69637573|FG008|Overall Study|Lack of Qualifying Event|5|||
37950333|NCT00246337|69637565|FG000|Overall Study|Site Terminated|10|||
37950334|NCT00246337|69637566|FG001|Overall Study|Site Terminated|0|||
37950335|NCT00246337|69637567|FG002|Overall Study|Site Terminated|0|||
37950336|NCT00246337|69637568|FG003|Overall Study|Site Terminated|0|||
37950337|NCT00246337|69637569|FG004|Overall Study|Site Terminated|0|||
37950338|NCT00246337|69637570|FG005|Overall Study|Site Terminated|7|||
37950339|NCT00246337|69637571|FG006|Overall Study|Site Terminated|1|||
37950340|NCT00246337|69637572|FG007|Overall Study|Site Terminated|6|||
37950341|NCT00246337|69637573|FG008|Overall Study|Site Terminated|2|||
37950342|NCT00246337|69637565|FG000|Overall Study|Abnormal baseline lab values|7|||
37950343|NCT00246337|69637566|FG001|Overall Study|Abnormal baseline lab values|0|||
37950344|NCT00246337|69637567|FG002|Overall Study|Abnormal baseline lab values|2|||
37950345|NCT00246337|69637568|FG003|Overall Study|Abnormal baseline lab values|0|||
37950346|NCT00246337|69637569|FG004|Overall Study|Abnormal baseline lab values|0|||
37950347|NCT00246337|69637570|FG005|Overall Study|Abnormal baseline lab values|2|||
37950348|NCT00246337|69637571|FG006|Overall Study|Abnormal baseline lab values|2|||
37950349|NCT00246337|69637572|FG007|Overall Study|Abnormal baseline lab values|0|||
37950350|NCT00246337|69637573|FG008|Overall Study|Abnormal baseline lab values|4|||
37950351|NCT00246337|69637565|FG000|Overall Study|Overwhelmed|0|||
37950352|NCT00246337|69637566|FG001|Overall Study|Overwhelmed|0|||
37950353|NCT00246337|69637567|FG002|Overall Study|Overwhelmed|0|||
37950354|NCT00246337|69637568|FG003|Overall Study|Overwhelmed|0|||
37950355|NCT00246337|69637569|FG004|Overall Study|Overwhelmed|0|||
37950356|NCT00246337|69637570|FG005|Overall Study|Overwhelmed|1|||
37950357|NCT00246337|69637571|FG006|Overall Study|Overwhelmed|0|||
37950358|NCT00246337|69637572|FG007|Overall Study|Overwhelmed|0|||
37950359|NCT00246337|69637573|FG008|Overall Study|Overwhelmed|0|||
37950360|NCT00246337|69637565|FG000|Overall Study|Protocol Violator|1|||
37950361|NCT00246337|69637566|FG001|Overall Study|Protocol Violator|0|||
37950362|NCT00246337|69637567|FG002|Overall Study|Protocol Violator|0|||
37950363|NCT00246337|69637568|FG003|Overall Study|Protocol Violator|0|||
37950364|NCT00246337|69637569|FG004|Overall Study|Protocol Violator|0|||
37950365|NCT00246337|69637570|FG005|Overall Study|Protocol Violator|0|||
37950366|NCT00246337|69637571|FG006|Overall Study|Protocol Violator|0|||
37950367|NCT00246337|69637572|FG007|Overall Study|Protocol Violator|0|||
37950368|NCT00246337|69637573|FG008|Overall Study|Protocol Violator|0|||
37950369|NCT00246337|69637565|FG000|Overall Study|Reported as completing trial in error|0|||
37950370|NCT00246337|69637566|FG001|Overall Study|Reported as completing trial in error|0|||
37950371|NCT00246337|69637567|FG002|Overall Study|Reported as completing trial in error|0|||
37950372|NCT00246337|69637568|FG003|Overall Study|Reported as completing trial in error|0|||
37950373|NCT00246337|69637569|FG004|Overall Study|Reported as completing trial in error|0|||
37950374|NCT00246337|69637570|FG005|Overall Study|Reported as completing trial in error|0|||
37950375|NCT00246337|69637571|FG006|Overall Study|Reported as completing trial in error|0|||
37950376|NCT00246337|69637572|FG007|Overall Study|Reported as completing trial in error|1|||
37950377|NCT00246337|69637573|FG008|Overall Study|Reported as completing trial in error|0|||
37950378|NCT00243919|69637596|FG000|Overall Study|Death|3|||
37950379|NCT00243919|69637597|FG001|Overall Study|Death|4|||
37950380|NCT00243919|69637598|FG002|Overall Study|Death|6|||
37950381|NCT00243919|69637596|FG000|Overall Study|Withdrawal by Subject|6|||
37950382|NCT00243919|69637597|FG001|Overall Study|Withdrawal by Subject|6|||
37950383|NCT00243919|69637598|FG002|Overall Study|Withdrawal by Subject|2|||
37950384|NCT00243919|69637596|FG000|Overall Study|Lost to Follow-up|6|||
37950385|NCT00243919|69637597|FG001|Overall Study|Lost to Follow-up|7|||
37950386|NCT00243919|69637598|FG002|Overall Study|Lost to Follow-up|3|||
37950387|NCT00243919|69637596|FG000|Overall Study|Administrative Error|1|||
37950388|NCT00243919|69637597|FG001|Overall Study|Administrative Error|0|||
37950389|NCT00243919|69637598|FG002|Overall Study|Administrative Error|0|||
37950390|NCT00243919|69637596|FG000|Overall Study|Physician Decision|1|||
37950391|NCT00243919|69637597|FG001|Overall Study|Physician Decision|1|||
37950392|NCT00243919|69637598|FG002|Overall Study|Physician Decision|0|||
37950393|NCT00725621|69637606|FG000|Overall Study|Adverse Event|25|||
37950394|NCT00725621|69637606|FG000|Overall Study|Lack of Efficacy|46|||
37950395|NCT00725621|69637606|FG000|Overall Study|Withdrawal by Subject|57|||
37950396|NCT00725621|69637606|FG000|Overall Study|Physician Decision|19|||
37950397|NCT00725621|69637606|FG000|Overall Study|Lost to Follow-up|52|||
37950398|NCT00725621|69637606|FG000|Overall Study|Non-compliance|8|||
37950399|NCT00725621|69637606|FG000|Overall Study|Continued treatment by other physician|6|||
37950400|NCT00725621|69637606|FG000|Overall Study|Switched to other study|1|||
37950401|NCT00725621|69637606|FG000|Overall Study|Switched to other drug|1|||
37950402|NCT00725621|69637606|FG000|Overall Study|Prepared for elective surgery|1|||
37950403|NCT00725621|69637606|FG000|Overall Study|Reason not specified|55|||
37950404|NCT00613626|69637617|FG000|Overall Study|Ineligible|0|||
37950405|NCT00613626|69637618|FG001|Overall Study|Ineligible|1|||
37950406|NCT00613626|69637619|FG002|Overall Study|Ineligible|0|||
37950407|NCT00725543|69637626|FG000|Overall Study|Adverse Event|10|||
37950408|NCT00725543|69637626|FG000|Overall Study|Lack of Efficacy|3|||
37950409|NCT00725543|69637626|FG000|Overall Study|Withdrawal by Subject|10|||
37950410|NCT00725543|69637626|FG000|Overall Study|Physician Decision|5|||
37950411|NCT00725543|69637626|FG000|Overall Study|Lost to Follow-up|4|||
37950412|NCT00725543|69637626|FG000|Overall Study|Non-compliance|2|||
37950413|NCT00725543|69637626|FG000|Overall Study|Other|119|||
37950414|NCT00239005|69637632|FG000|Overall Study|Adverse Event|6|||
37950415|NCT00239005|69637633|FG001|Overall Study|Adverse Event|6|||
37950416|NCT00239005|69637632|FG000|Overall Study|Withdrawal by Subject|3|||
37950417|NCT00239005|69637633|FG001|Overall Study|Withdrawal by Subject|4|||
37950418|NCT00239005|69637632|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
38042557|NCT04200456|69730104|FG001|Overall Study|Physician Decision|1|||
38042558|NCT04200456|69730103|FG000|Overall Study|Withdrawal by Subject|2|||
38042559|NCT04200456|69730104|FG001|Overall Study|Withdrawal by Subject|2|||
38042560|NCT04200456|69730103|FG000|Overall Study|Lack of Efficacy|1|||
38042561|NCT04200456|69730104|FG001|Overall Study|Lack of Efficacy|1|||
38042562|NCT04200456|69730103|FG000|Overall Study|Adverse event, non-fatal|0|||
38042563|NCT04200456|69730104|FG001|Overall Study|Adverse event, non-fatal|1|||
38042564|NCT04200456|69730103|FG000|Overall Study|Administration of Rescue and concern about IMP|0|||
38042565|NCT04200456|69730104|FG001|Overall Study|Administration of Rescue and concern about IMP|1|||
38042566|NCT03766685|69730114|FG000|Overall Study|Lost to Follow-up|1|||
38042567|NCT03766685|69730115|FG001|Overall Study|Lost to Follow-up|1|||
38042568|NCT03766685|69730116|FG002|Overall Study|Lost to Follow-up|0|||
38042569|NCT03766685|69730117|FG003|Overall Study|Lost to Follow-up|0|||
38042570|NCT03766685|69730114|FG000|Overall Study|Adverse Event, not fatal|0|||
38042571|NCT03766685|69730115|FG001|Overall Study|Adverse Event, not fatal|1|||
38042572|NCT03766685|69730116|FG002|Overall Study|Adverse Event, not fatal|0|||
38042573|NCT03766685|69730117|FG003|Overall Study|Adverse Event, not fatal|1|||
38042574|NCT03766685|69730114|FG000|Overall Study|Withdrawal by Subject|0|||
37950419|NCT00239005|69637633|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
37950420|NCT00239005|69637632|FG000|Overall Study|Protocol Violation|1|||
37950421|NCT00239005|69637633|FG001|Overall Study|Protocol Violation|0|||
37950422|NCT00239005|69637632|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
37950423|NCT00239005|69637633|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
37950424|NCT00239005|69637632|FG000|Overall Study|Lost to Follow-up|0|||
37950425|NCT00239005|69637633|FG001|Overall Study|Lost to Follow-up|1|||
37950426|NCT00616434|69637641|FG000|Overall Study|Adverse Event|5|||
37950427|NCT00616434|69637642|FG001|Overall Study|Adverse Event|2|||
37950428|NCT00616434|69637641|FG000|Overall Study|Physician Decision|0|||
38042575|NCT03766685|69730115|FG001|Overall Study|Withdrawal by Subject|2|||
38042576|NCT03766685|69730116|FG002|Overall Study|Withdrawal by Subject|0|||
38042577|NCT03766685|69730117|FG003|Overall Study|Withdrawal by Subject|0|||
38042578|NCT03766685|69730114|FG000|Overall Study|Protocol Violation|0|||
38042579|NCT03766685|69730115|FG001|Overall Study|Protocol Violation|1|||
38042580|NCT03766685|69730116|FG002|Overall Study|Protocol Violation|0|||
38042581|NCT03766685|69730117|FG003|Overall Study|Protocol Violation|0|||
38042582|NCT03766685|69730114|FG000|Overall Study|Non-compliance|0|||
38042583|NCT03766685|69730115|FG001|Overall Study|Non-compliance|2|||
38042584|NCT03766685|69730116|FG002|Overall Study|Non-compliance|0|||
38042585|NCT03766685|69730117|FG003|Overall Study|Non-compliance|0|||
38042586|NCT03654274|69730131|FG000|Overall Study|Adverse Event|19|||
38042587|NCT03654274|69730132|FG001|Overall Study|Adverse Event|23|||
38042588|NCT03654274|69730133|FG002|Overall Study|Adverse Event|24|||
38042589|NCT03654274|69730131|FG000|Overall Study|Protocol Deviation|0|||
38042590|NCT03654274|69730132|FG001|Overall Study|Protocol Deviation|2|||
38042591|NCT03654274|69730133|FG002|Overall Study|Protocol Deviation|0|||
38042592|NCT03654274|69730131|FG000|Overall Study|Lost to Follow-up|8|||
38042593|NCT03654274|69730132|FG001|Overall Study|Lost to Follow-up|6|||
38042594|NCT03654274|69730133|FG002|Overall Study|Lost to Follow-up|5|||
38042595|NCT03654274|69730131|FG000|Overall Study|Withdrawal by Subject|46|||
38042596|NCT03654274|69730132|FG001|Overall Study|Withdrawal by Subject|25|||
38042597|NCT03654274|69730133|FG002|Overall Study|Withdrawal by Subject|33|||
38042598|NCT03654274|69730131|FG000|Overall Study|Lack of Efficacy|4|||
38042599|NCT03654274|69730132|FG001|Overall Study|Lack of Efficacy|5|||
38042600|NCT03654274|69730133|FG002|Overall Study|Lack of Efficacy|7|||
38042601|NCT03654274|69730131|FG000|Overall Study|Pregnancy|2|||
38042602|NCT03654274|69730132|FG001|Overall Study|Pregnancy|2|||
38042603|NCT03654274|69730133|FG002|Overall Study|Pregnancy|1|||
38042604|NCT03654274|69730131|FG000|Overall Study|Other|27|||
38042605|NCT03654274|69730132|FG001|Overall Study|Other|29|||
38042606|NCT03654274|69730133|FG002|Overall Study|Other|32|||
38042607|NCT03654274|69730131|FG000|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
38042608|NCT03654274|69730132|FG001|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
38042609|NCT03654274|69730133|FG002|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|1|||
38042610|NCT03533686|69730151|FG000|Overall Study|Withdrawal by Subject|1|||
38042611|NCT03533686|69730152|FG001|Overall Study|Withdrawal by Subject|0|||
38042612|NCT03533686|69730153|FG002|Overall Study|Withdrawal by Subject|0|||
38042613|NCT03533686|69730154|FG003|Overall Study|Withdrawal by Subject|3|||
38042614|NCT03533686|69730155|FG004|Overall Study|Withdrawal by Subject|5|||
38042615|NCT03533686|69730156|FG005|Overall Study|Withdrawal by Subject|1|||
38042616|NCT03533686|69730151|FG000|Overall Study|Lost to Follow-up|0|||
38042617|NCT03533686|69730152|FG001|Overall Study|Lost to Follow-up|1|||
38042618|NCT03533686|69730153|FG002|Overall Study|Lost to Follow-up|0|||
38042619|NCT03533686|69730154|FG003|Overall Study|Lost to Follow-up|0|||
38042620|NCT03533686|69730155|FG004|Overall Study|Lost to Follow-up|2|||
38042621|NCT03533686|69730156|FG005|Overall Study|Lost to Follow-up|0|||
38042622|NCT03533686|69730151|FG000|Overall Study|Screen Failure|0|||
38042623|NCT03533686|69730152|FG001|Overall Study|Screen Failure|0|||
38042624|NCT03533686|69730153|FG002|Overall Study|Screen Failure|0|||
38042625|NCT03533686|69730154|FG003|Overall Study|Screen Failure|2|||
38042626|NCT03533686|69730155|FG004|Overall Study|Screen Failure|0|||
38042627|NCT03533686|69730156|FG005|Overall Study|Screen Failure|0|||
38042628|NCT03154359|69730214|FG000|Overall Study|Adverse Event|1|||
38042629|NCT03154359|69730214|FG000|Overall Study|Lack of Efficacy|2|||
38042630|NCT03154359|69730214|FG000|Overall Study|Lost to Follow-up|3|||
38042631|NCT03154359|69730214|FG000|Overall Study|Physician Decision|3|||
38042632|NCT03154359|69730214|FG000|Overall Study|Protocol Violation|4|||
38042633|NCT03154359|69730214|FG000|Overall Study|Withdrawal by Subject|5|||
38042634|NCT03154359|69730214|FG000|Overall Study|Disruption of study due to COVID-19|4|||
38042635|NCT03135834|69730233|FG000|Stage 1|Adverse Event|1|||
38042636|NCT03135834|69730234|FG001|Stage 1|Adverse Event|2|||
38042637|NCT03135834|69730235|FG002|Stage 1|Adverse Event|2|||
38042638|NCT03135834|69730236|FG003|Stage 1|Adverse Event|1|||
38042639|NCT03135834|69730233|FG000|Stage 1|Death|1|||
38042640|NCT03135834|69730234|FG001|Stage 1|Death|0|||
38042641|NCT03135834|69730235|FG002|Stage 1|Death|0|||
38042642|NCT03135834|69730236|FG003|Stage 1|Death|0|||
38042643|NCT03135834|69730233|FG000|Stage 1|Lost to Follow-up|17|||
37768602|NCT02649894|69284721|FG001|Overall Study|Withdrawal by Subject|2|||
38042644|NCT03135834|69730234|FG001|Stage 1|Lost to Follow-up|24|||
38042645|NCT03135834|69730235|FG002|Stage 1|Lost to Follow-up|21|||
38042646|NCT03135834|69730236|FG003|Stage 1|Lost to Follow-up|38|||
38042647|NCT03135834|69730233|FG000|Stage 1|No longer met eligibility criteria|1|||
38042648|NCT03135834|69730234|FG001|Stage 1|No longer met eligibility criteria|6|||
38042649|NCT03135834|69730235|FG002|Stage 1|No longer met eligibility criteria|2|||
38042650|NCT03135834|69730236|FG003|Stage 1|No longer met eligibility criteria|5|||
38042651|NCT03135834|69730233|FG000|Stage 1|Other|0|||
38042652|NCT03135834|69730234|FG001|Stage 1|Other|2|||
38042653|NCT03135834|69730235|FG002|Stage 1|Other|1|||
38042654|NCT03135834|69730236|FG003|Stage 1|Other|0|||
38042655|NCT03135834|69730233|FG000|Stage 1|Physician Decision|0|||
38042656|NCT03135834|69730234|FG001|Stage 1|Physician Decision|1|||
38042657|NCT03135834|69730235|FG002|Stage 1|Physician Decision|0|||
38042658|NCT03135834|69730236|FG003|Stage 1|Physician Decision|0|||
38042659|NCT03135834|69730233|FG000|Stage 1|Pregnancy|0|||
38042660|NCT03135834|69730234|FG001|Stage 1|Pregnancy|4|||
38042661|NCT03135834|69730235|FG002|Stage 1|Pregnancy|2|||
38042662|NCT03135834|69730236|FG003|Stage 1|Pregnancy|4|||
38042663|NCT03135834|69730233|FG000|Stage 1|Protocol Violation|1|||
38042664|NCT03135834|69730234|FG001|Stage 1|Protocol Violation|1|||
38042665|NCT03135834|69730235|FG002|Stage 1|Protocol Violation|2|||
38042666|NCT03135834|69730236|FG003|Stage 1|Protocol Violation|1|||
38042667|NCT03135834|69730233|FG000|Stage 1|Withdrawal by parent/guardian|2|||
38042668|NCT03135834|69730234|FG001|Stage 1|Withdrawal by parent/guardian|10|||
38042669|NCT03135834|69730235|FG002|Stage 1|Withdrawal by parent/guardian|2|||
38042670|NCT03135834|69730236|FG003|Stage 1|Withdrawal by parent/guardian|1|||
38042671|NCT03135834|69730233|FG000|Stage 1|Withdrawal by Subject|16|||
38042672|NCT03135834|69730234|FG001|Stage 1|Withdrawal by Subject|22|||
38042673|NCT03135834|69730235|FG002|Stage 1|Withdrawal by Subject|7|||
38042674|NCT03135834|69730236|FG003|Stage 1|Withdrawal by Subject|10|||
38042675|NCT03135834|69730233|FG000|Stage 1|Randomized but not Vaccinated|0|||
38042676|NCT03135834|69730234|FG001|Stage 1|Randomized but not Vaccinated|3|||
38042677|NCT03135834|69730235|FG002|Stage 1|Randomized but not Vaccinated|1|||
38042678|NCT03135834|69730236|FG003|Stage 1|Randomized but not Vaccinated|6|||
38042679|NCT03135834|69730233|FG000|Stage 2|Lost to Follow-up|0|||
38042680|NCT03135834|69730234|FG001|Stage 2|Lost to Follow-up|1|||
38042681|NCT03135834|69730235|FG002|Stage 2|Lost to Follow-up|0|||
38042682|NCT03135834|69730236|FG003|Stage 2|Lost to Follow-up|0|||
38042683|NCT03135834|69730233|FG000|Stage 2|Withdrawal by Subject|0|||
38042684|NCT03135834|69730234|FG001|Stage 2|Withdrawal by Subject|1|||
38042685|NCT03135834|69730235|FG002|Stage 2|Withdrawal by Subject|0|||
38042686|NCT03135834|69730236|FG003|Stage 2|Withdrawal by Subject|0|||
38042687|NCT03135834|69730233|FG000|Stage 2|Withdrawn Before Booster Vaccination|46|||
38042688|NCT03135834|69730234|FG001|Stage 2|Withdrawn Before Booster Vaccination|24|||
38042689|NCT03135834|69730235|FG002|Stage 2|Withdrawn Before Booster Vaccination|24|||
38042690|NCT03135834|69730236|FG003|Stage 2|Withdrawn Before Booster Vaccination|15|||
38042691|NCT03135834|69730233|FG000|Stage 2|Did not receive Booster Vaccination|1|||
38042692|NCT03135834|69730234|FG001|Stage 2|Did not receive Booster Vaccination|1|||
38042693|NCT03135834|69730235|FG002|Stage 2|Did not receive Booster Vaccination|0|||
38042694|NCT03135834|69730236|FG003|Stage 2|Did not receive Booster Vaccination|0|||
38042695|NCT03130777|69730269|FG000|Overall Study|Death|0|||
38042696|NCT03130777|69730270|FG001|Overall Study|Death|1|||
38042697|NCT03130777|69730269|FG000|Overall Study|Did not meet eligibility criteria|1|||
38042698|NCT03130777|69730270|FG001|Overall Study|Did not meet eligibility criteria|0|||
38042699|NCT02207725|69730311|FG000|Overall Study|Did Not Receive Treatment|0|||
38042700|NCT02207725|69730312|FG001|Overall Study|Did Not Receive Treatment|1|||
38042701|NCT02207725|69730313|FG002|Overall Study|Did Not Receive Treatment|1|||
38042702|NCT02207725|69730314|FG003|Overall Study|Did Not Receive Treatment|1|||
38042703|NCT00968799|69730348|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
38042704|NCT02883452|69730358|FG000|Overall Study|Withdrawal by Subject|1|||
38042705|NCT02883452|69730359|FG001|Overall Study|Withdrawal by Subject|1|||
38042706|NCT02883452|69730360|FG002|Overall Study|Withdrawal by Subject|3|||
38042707|NCT02883452|69730361|FG003|Overall Study|Withdrawal by Subject|0|||
38042708|NCT02883452|69730362|FG004|Overall Study|Withdrawal by Subject|2|||
38042709|NCT02883452|69730363|FG005|Overall Study|Withdrawal by Subject|5|||
38042710|NCT02883452|69730358|FG000|Overall Study|Disease progression|1|||
38042711|NCT02883452|69730359|FG001|Overall Study|Disease progression|0|||
38042712|NCT02883452|69730360|FG002|Overall Study|Disease progression|0|||
38042713|NCT02883452|69730361|FG003|Overall Study|Disease progression|1|||
38042714|NCT02883452|69730362|FG004|Overall Study|Disease progression|4|||
38042715|NCT02883452|69730363|FG005|Overall Study|Disease progression|5|||
38042716|NCT02883452|69730358|FG000|Overall Study|Adverse Event|2|||
38042717|NCT02883452|69730359|FG001|Overall Study|Adverse Event|1|||
38042718|NCT02883452|69730360|FG002|Overall Study|Adverse Event|1|||
38042719|NCT02883452|69730361|FG003|Overall Study|Adverse Event|1|||
37950429|NCT00616434|69637642|FG001|Overall Study|Physician Decision|4|||
37950430|NCT00616434|69637641|FG000|Overall Study|Withdrawal by Subject|1|||
37950431|NCT00616434|69637642|FG001|Overall Study|Withdrawal by Subject|1|||
37768603|NCT02649894|69284720|FG000|Overall Study|Lost to Follow-up|2|||
37768604|NCT02649894|69284721|FG001|Overall Study|Lost to Follow-up|1|||
37768605|NCT02649894|69284720|FG000|Overall Study|Death|30|||
37768606|NCT02649894|69284721|FG001|Overall Study|Death|7|||
37768607|NCT02649894|69284720|FG000|Overall Study|Other, not specified|6|||
37768608|NCT02649894|69284721|FG001|Overall Study|Other, not specified|0|||
37768609|NCT01278615|69284727|FG000|Overall Study|Withdrawal by Subject|2|||
37768610|NCT01505114|69284753|FG000|Overall Study|Withdrawal by Subject|5|||
37768611|NCT01505114|69284754|FG001|Overall Study|Withdrawal by Subject|4|||
37768612|NCT01505114|69284755|FG002|Overall Study|Withdrawal by Subject|4|||
37768613|NCT01505114|69284756|FG003|Overall Study|Withdrawal by Subject|7|||
37768614|NCT01505114|69284753|FG000|Overall Study|Death|1|||
37768615|NCT01505114|69284754|FG001|Overall Study|Death|0|||
37768616|NCT01505114|69284755|FG002|Overall Study|Death|0|||
37768617|NCT01505114|69284756|FG003|Overall Study|Death|1|||
37768618|NCT01505114|69284753|FG000|Overall Study|unable to adhere to visit schedule|3|||
37768619|NCT01505114|69284754|FG001|Overall Study|unable to adhere to visit schedule|2|||
37768620|NCT01505114|69284755|FG002|Overall Study|unable to adhere to visit schedule|3|||
37768621|NCT01505114|69284756|FG003|Overall Study|unable to adhere to visit schedule|3|||
37768622|NCT01505114|69284753|FG000|Overall Study|Lost to Follow-up|11|||
37768623|NCT01505114|69284754|FG001|Overall Study|Lost to Follow-up|5|||
37768624|NCT01505114|69284755|FG002|Overall Study|Lost to Follow-up|8|||
37768625|NCT01505114|69284756|FG003|Overall Study|Lost to Follow-up|7|||
37768626|NCT01505114|69284753|FG000|Overall Study|relocated|4|||
37768627|NCT01505114|69284754|FG001|Overall Study|relocated|2|||
37768628|NCT01505114|69284755|FG002|Overall Study|relocated|2|||
37768629|NCT01505114|69284756|FG003|Overall Study|relocated|3|||
37768630|NCT01505114|69284753|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
37768631|NCT01505114|69284754|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
37768632|NCT01505114|69284755|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
37768633|NCT01505114|69284756|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
37768634|NCT01505114|69284753|FG000|Overall Study|staff safety concerns|0|||
37768635|NCT01505114|69284754|FG001|Overall Study|staff safety concerns|0|||
37768636|NCT01505114|69284755|FG002|Overall Study|staff safety concerns|0|||
37768637|NCT01505114|69284756|FG003|Overall Study|staff safety concerns|1|||
37768638|NCT01505114|69284753|FG000|Overall Study|investigator decision|1|||
37768639|NCT01505114|69284754|FG001|Overall Study|investigator decision|0|||
37768640|NCT01505114|69284755|FG002|Overall Study|investigator decision|1|||
37768641|NCT01505114|69284756|FG003|Overall Study|investigator decision|0|||
37768642|NCT02651922|69284788|FG000|Overall Study|due to exclusion criteria|2|||
37677207|NCT02528253|69152219|FG000|Overall Study|Insufficient clinical response|7|||
37677208|NCT02528253|69152220|FG001|Overall Study|Insufficient clinical response|10|||
37677209|NCT02528253|69152221|FG002|Overall Study|Insufficient clinical response|13|||
37677210|NCT02528253|69152222|FG003|Overall Study|Insufficient clinical response|12|||
37677211|NCT02528253|69152223|FG004|Overall Study|Insufficient clinical response|16|||
37677212|NCT02528253|69152219|FG000|Overall Study|Lost to Follow-up|16|||
37677213|NCT02528253|69152220|FG001|Overall Study|Lost to Follow-up|9|||
37677214|NCT02528253|69152221|FG002|Overall Study|Lost to Follow-up|31|||
37677215|NCT02528253|69152222|FG003|Overall Study|Lost to Follow-up|16|||
37677216|NCT02528253|69152223|FG004|Overall Study|Lost to Follow-up|34|||
37677217|NCT02528253|69152219|FG000|Overall Study|Other|21|||
37677218|NCT02528253|69152220|FG001|Overall Study|Other|22|||
37677219|NCT02528253|69152221|FG002|Overall Study|Other|58|||
37677220|NCT02528253|69152222|FG003|Overall Study|Other|52|||
37677221|NCT02528253|69152223|FG004|Overall Study|Other|76|||
37677222|NCT02528253|69152219|FG000|Overall Study|Withdrawal by Subject|25|||
37677223|NCT02528253|69152220|FG001|Overall Study|Withdrawal by Subject|20|||
37677224|NCT02528253|69152221|FG002|Overall Study|Withdrawal by Subject|29|||
37677225|NCT02528253|69152222|FG003|Overall Study|Withdrawal by Subject|48|||
37677226|NCT02528253|69152223|FG004|Overall Study|Withdrawal by Subject|73|||
37677227|NCT02528253|69152219|FG000|Overall Study|Protocol Violation|1|||
37677228|NCT02528253|69152220|FG001|Overall Study|Protocol Violation|2|||
37677229|NCT02528253|69152221|FG002|Overall Study|Protocol Violation|4|||
37677230|NCT02528253|69152222|FG003|Overall Study|Protocol Violation|0|||
37677231|NCT02528253|69152223|FG004|Overall Study|Protocol Violation|4|||
37677232|NCT02528253|69152219|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
37677233|NCT02528253|69152220|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
37677234|NCT02528253|69152221|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
37677235|NCT02528253|69152222|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
37677236|NCT02528253|69152223|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
37677237|NCT01672957|69152254|FG000|Overall Study|Protocol Violation|48|||
37677238|NCT01672957|69152254|FG000|Overall Study|Death|2|||
37677239|NCT01672957|69152254|FG000|Overall Study|ICF Signed After Transplantation|5|||
37677240|NCT02525133|69152260|FG000|Overall Study|Adverse Event|0|||
37677241|NCT02525133|69152261|FG001|Overall Study|Adverse Event|1|||
37677242|NCT02525133|69152260|FG000|Overall Study|Death|0|||
37677243|NCT02525133|69152261|FG001|Overall Study|Death|1|||
37677244|NCT02525133|69152260|FG000|Overall Study|did not meet randomization criteria|1|||
37677245|NCT02525133|69152261|FG001|Overall Study|did not meet randomization criteria|0|||
37677246|NCT02525133|69152260|FG000|Overall Study|Lost to Follow-up|5|||
37677247|NCT02525133|69152261|FG001|Overall Study|Lost to Follow-up|1|||
37677248|NCT02525133|69152260|FG000|Overall Study|randomized not enrolled|3|||
37677249|NCT02525133|69152261|FG001|Overall Study|randomized not enrolled|0|||
37677250|NCT02525133|69152260|FG000|Overall Study|Withdrawal by Subject|1|||
37677251|NCT02525133|69152261|FG001|Overall Study|Withdrawal by Subject|0|||
37677252|NCT01659255|69152288|FG000|Overall Study|Adverse Event|0|||
37677253|NCT01659255|69152289|FG001|Overall Study|Adverse Event|0|||
37677254|NCT01659255|69152290|FG002|Overall Study|Adverse Event|0|||
37677255|NCT01659255|69152291|FG003|Overall Study|Adverse Event|0|||
37677256|NCT01659255|69152292|FG004|Overall Study|Adverse Event|0|||
37677257|NCT01659255|69152293|FG005|Overall Study|Adverse Event|1|||
37677258|NCT01659255|69152294|FG006|Overall Study|Adverse Event|1|||
37677259|NCT01659255|69152295|FG007|Overall Study|Adverse Event|0|||
37677260|NCT01659255|69152296|FG008|Overall Study|Adverse Event|0|||
37677261|NCT01659255|69152297|FG009|Overall Study|Adverse Event|1|||
37677262|NCT01659255|69152298|FG010|Overall Study|Adverse Event|0|||
37677263|NCT01659255|69152299|FG011|Overall Study|Adverse Event|1|||
37677264|NCT01659255|69152300|FG012|Overall Study|Adverse Event|0|||
37677265|NCT01659255|69152301|FG013|Overall Study|Adverse Event|2|||
37677266|NCT01659255|69152302|FG014|Overall Study|Adverse Event|0|||
37677267|NCT01659255|69152303|FG015|Overall Study|Adverse Event|1|||
37677268|NCT01659255|69152304|FG016|Overall Study|Adverse Event|0|||
37677269|NCT01659255|69152288|FG000|Overall Study|Death|0|||
37677270|NCT01659255|69152289|FG001|Overall Study|Death|1|||
37677271|NCT01659255|69152290|FG002|Overall Study|Death|0|||
37677272|NCT01659255|69152291|FG003|Overall Study|Death|0|||
37677273|NCT01659255|69152292|FG004|Overall Study|Death|0|||
37677274|NCT01659255|69152293|FG005|Overall Study|Death|0|||
37677275|NCT01659255|69152294|FG006|Overall Study|Death|0|||
37677276|NCT01659255|69152295|FG007|Overall Study|Death|1|||
37677277|NCT01659255|69152296|FG008|Overall Study|Death|1|||
37677278|NCT01659255|69152297|FG009|Overall Study|Death|0|||
37677279|NCT01659255|69152298|FG010|Overall Study|Death|0|||
37677280|NCT01659255|69152299|FG011|Overall Study|Death|0|||
37677281|NCT01659255|69152300|FG012|Overall Study|Death|1|||
37677282|NCT01659255|69152301|FG013|Overall Study|Death|1|||
37677283|NCT01659255|69152302|FG014|Overall Study|Death|2|||
37677284|NCT01659255|69152303|FG015|Overall Study|Death|1|||
37677285|NCT01659255|69152304|FG016|Overall Study|Death|0|||
37677286|NCT01659255|69152288|FG000|Overall Study|Progressive Disease|2|||
37677287|NCT01659255|69152289|FG001|Overall Study|Progressive Disease|0|||
37677288|NCT01659255|69152290|FG002|Overall Study|Progressive Disease|0|||
37677289|NCT01659255|69152291|FG003|Overall Study|Progressive Disease|0|||
37677290|NCT01659255|69152292|FG004|Overall Study|Progressive Disease|0|||
37677291|NCT01659255|69152293|FG005|Overall Study|Progressive Disease|0|||
37677292|NCT01659255|69152294|FG006|Overall Study|Progressive Disease|0|||
37677293|NCT01659255|69152295|FG007|Overall Study|Progressive Disease|1|||
37677294|NCT01659255|69152296|FG008|Overall Study|Progressive Disease|0|||
37677295|NCT01659255|69152297|FG009|Overall Study|Progressive Disease|2|||
37677296|NCT01659255|69152298|FG010|Overall Study|Progressive Disease|2|||
37677297|NCT01659255|69152299|FG011|Overall Study|Progressive Disease|3|||
37677298|NCT01659255|69152300|FG012|Overall Study|Progressive Disease|5|||
37677299|NCT01659255|69152301|FG013|Overall Study|Progressive Disease|13|||
37677300|NCT01659255|69152302|FG014|Overall Study|Progressive Disease|6|||
37677301|NCT01659255|69152303|FG015|Overall Study|Progressive Disease|2|||
37677302|NCT01659255|69152304|FG016|Overall Study|Progressive Disease|3|||
37677303|NCT01659255|69152288|FG000|Overall Study|Withdrew Consent|0|||
37677304|NCT01659255|69152289|FG001|Overall Study|Withdrew Consent|0|||
37677305|NCT01659255|69152290|FG002|Overall Study|Withdrew Consent|0|||
37677306|NCT01659255|69152291|FG003|Overall Study|Withdrew Consent|0|||
37677307|NCT01659255|69152292|FG004|Overall Study|Withdrew Consent|0|||
37677308|NCT01659255|69152293|FG005|Overall Study|Withdrew Consent|0|||
37677309|NCT01659255|69152294|FG006|Overall Study|Withdrew Consent|0|||
37677310|NCT01659255|69152295|FG007|Overall Study|Withdrew Consent|0|||
37677311|NCT01659255|69152296|FG008|Overall Study|Withdrew Consent|0|||
37677312|NCT01659255|69152297|FG009|Overall Study|Withdrew Consent|0|||
37677313|NCT01659255|69152298|FG010|Overall Study|Withdrew Consent|1|||
37677314|NCT01659255|69152299|FG011|Overall Study|Withdrew Consent|0|||
37677315|NCT01659255|69152300|FG012|Overall Study|Withdrew Consent|0|||
37677316|NCT01659255|69152301|FG013|Overall Study|Withdrew Consent|1|||
37677317|NCT01659255|69152302|FG014|Overall Study|Withdrew Consent|0|||
37677318|NCT01659255|69152303|FG015|Overall Study|Withdrew Consent|0|||
37677319|NCT01659255|69152304|FG016|Overall Study|Withdrew Consent|0|||
37677320|NCT01659255|69152288|FG000|Overall Study|Investigator Decision|0|||
37677321|NCT01659255|69152289|FG001|Overall Study|Investigator Decision|0|||
37677322|NCT01659255|69152290|FG002|Overall Study|Investigator Decision|0|||
37677323|NCT01659255|69152291|FG003|Overall Study|Investigator Decision|0|||
37677324|NCT01659255|69152292|FG004|Overall Study|Investigator Decision|0|||
37677325|NCT01659255|69152293|FG005|Overall Study|Investigator Decision|0|||
37677326|NCT01659255|69152294|FG006|Overall Study|Investigator Decision|0|||
37677327|NCT01659255|69152295|FG007|Overall Study|Investigator Decision|0|||
37677328|NCT01659255|69152296|FG008|Overall Study|Investigator Decision|0|||
37677329|NCT01659255|69152297|FG009|Overall Study|Investigator Decision|0|||
37677330|NCT01659255|69152298|FG010|Overall Study|Investigator Decision|0|||
37677331|NCT01659255|69152299|FG011|Overall Study|Investigator Decision|0|||
37677332|NCT01659255|69152300|FG012|Overall Study|Investigator Decision|1|||
37677333|NCT01659255|69152301|FG013|Overall Study|Investigator Decision|1|||
37677334|NCT01659255|69152302|FG014|Overall Study|Investigator Decision|0|||
37677335|NCT01659255|69152303|FG015|Overall Study|Investigator Decision|0|||
37677336|NCT01659255|69152304|FG016|Overall Study|Investigator Decision|0|||
37677337|NCT01659255|69152288|FG000|Overall Study|Sponsor's Decision|0|||
37677338|NCT01659255|69152289|FG001|Overall Study|Sponsor's Decision|0|||
37677339|NCT01659255|69152290|FG002|Overall Study|Sponsor's Decision|0|||
37677340|NCT01659255|69152291|FG003|Overall Study|Sponsor's Decision|0|||
37677341|NCT01659255|69152292|FG004|Overall Study|Sponsor's Decision|0|||
37768643|NCT01277757|69284792|FG000|Overall Study|Disease Progression|1|||
37768644|NCT01277757|69284792|FG000|Overall Study|Withdrawal by Subject|1|||
37768645|NCT01276821|69284798|FG000|Overall Study|Protocol Violation|0|||
37768646|NCT01276821|69284799|FG001|Overall Study|Protocol Violation|1|||
37768647|NCT00245037|69284805|FG000|Overall Study|Death|17|||
37768648|NCT00241839|69284811|FG000|Overall Study|Withdrawal by Subject|18|||
37768649|NCT00241839|69284812|FG001|Overall Study|Withdrawal by Subject|17|||
37768650|NCT00241839|69284811|FG000|Overall Study|Adverse Event|1|||
37768651|NCT00241839|69284812|FG001|Overall Study|Adverse Event|1|||
37768652|NCT02651688|69284821|FG000|Overall Study|Non-compliance|0|||
37768653|NCT02651688|69284822|FG001|Overall Study|Non-compliance|0|||
37768654|NCT02651688|69284823|FG002|Overall Study|Non-compliance|1|||
37768655|NCT02651688|69284821|FG000|Overall Study|Principal Investigator (PI) decision|0|||
37768656|NCT02651688|69284822|FG001|Overall Study|Principal Investigator (PI) decision|2|||
37768657|NCT02651688|69284823|FG002|Overall Study|Principal Investigator (PI) decision|0|||
37768658|NCT02651688|69284821|FG000|Overall Study|Lost to Follow-up|1|||
37768659|NCT02651688|69284822|FG001|Overall Study|Lost to Follow-up|3|||
37768660|NCT02651688|69284823|FG002|Overall Study|Lost to Follow-up|0|||
37768661|NCT02651688|69284821|FG000|Overall Study|Withdrawal by Subject|1|||
37768662|NCT02651688|69284822|FG001|Overall Study|Withdrawal by Subject|0|||
37768663|NCT02651688|69284823|FG002|Overall Study|Withdrawal by Subject|2|||
37768664|NCT01276353|69284833|FG000|Double-blind|Adverse Event|2|||
37677342|NCT01659255|69152293|FG005|Overall Study|Sponsor's Decision|0|||
37677343|NCT01659255|69152294|FG006|Overall Study|Sponsor's Decision|1|||
37768665|NCT01276353|69284834|FG001|Double-blind|Adverse Event|0|||
37768666|NCT01276353|69284833|FG000|Double-blind|Withdrawal by Subject|1|||
37768667|NCT01276353|69284834|FG001|Double-blind|Withdrawal by Subject|0|||
37768668|NCT01276353|69284833|FG000|Extension|Adverse Event|2|||
37768669|NCT01276353|69284834|FG001|Extension|Adverse Event|5|||
37768670|NCT01276353|69284833|FG000|Extension|Withdrawal by Subject|1|||
37768671|NCT01276353|69284834|FG001|Extension|Withdrawal by Subject|2|||
37768672|NCT01276353|69284833|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
37768673|NCT01276353|69284834|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
37768674|NCT01276353|69284833|FG000|Extension|Physician Decision|1|||
37768675|NCT01276353|69284834|FG001|Extension|Physician Decision|0|||
37768676|NCT01276353|69284833|FG000|Extension|Prohibited concomitant medications|0|||
37768677|NCT01276353|69284834|FG001|Extension|Prohibited concomitant medications|1|||
37768678|NCT02536794|69284869|FG000|Reached 1st Response Assessment|Adverse Event|2|||
37768679|NCT02536794|69284869|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
37768680|NCT02536794|69284869|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
37768681|NCT02536794|69284869|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
37768682|NCT02536794|69284869|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
37768683|NCT02536794|69284869|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
37768684|NCT01480076|69284948|FG000|Overall Study|Run-in Failure|52|||
37768685|NCT01480076|69284948|FG000|Overall Study|Adverse Event|39|||
37768686|NCT01480076|69284948|FG000|Overall Study|Death|2|||
37768687|NCT01480076|69284948|FG000|Overall Study|Disease Progression|5|||
37768688|NCT01480076|69284948|FG000|Overall Study|Non-compliance With Study Protocol|15|||
37768689|NCT01480076|69284948|FG000|Overall Study|Withdrawal by Subject|105|||
37768690|NCT01480076|69284948|FG000|Overall Study|Lost to Follow-up|7|||
37768691|NCT01480076|69284948|FG000|Overall Study|Investigator Decision|13|||
37768692|NCT01480076|69284948|FG000|Overall Study|Other|52|||
37768693|NCT02650128|69285036|FG000|Overall Study|Death|2|||
37768694|NCT01362270|69285051|FG000|Overall Study|Withdrawal by Subject|1|||
37768695|NCT01362270|69285052|FG001|Overall Study|Withdrawal by Subject|0|||
37768696|NCT01362270|69285051|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
37768697|NCT01362270|69285052|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
37768698|NCT01362270|69285051|FG000|Overall Study|Met excl. criteria before 1st session|1|||
37768699|NCT01362270|69285052|FG001|Overall Study|Met excl. criteria before 1st session|1|||
37768700|NCT00089479|69285073|FG000|Overall Study|Death|108|||
37768701|NCT00089479|69285074|FG001|Overall Study|Death|75|||
37768702|NCT00089479|69285073|FG000|Overall Study|Withdrawal by Subject|86|||
37768703|NCT00089479|69285074|FG001|Overall Study|Withdrawal by Subject|107|||
37768704|NCT00089479|69285073|FG000|Overall Study|Lost to Follow-up|137|||
37768705|NCT00089479|69285074|FG001|Overall Study|Lost to Follow-up|107|||
37768706|NCT01463306|69285083|FG000|Overall Study|Adverse Event|6|||
37768707|NCT01463306|69285084|FG001|Overall Study|Adverse Event|9|||
37768708|NCT01463306|69285085|FG002|Overall Study|Adverse Event|3|||
37768709|NCT01463306|69285083|FG000|Overall Study|Death|3|||
37768710|NCT01463306|69285084|FG001|Overall Study|Death|3|||
37768711|NCT01463306|69285085|FG002|Overall Study|Death|0|||
37768712|NCT01463306|69285083|FG000|Overall Study|Lack of Efficacy|22|||
37768713|NCT01463306|69285084|FG001|Overall Study|Lack of Efficacy|16|||
37768714|NCT01463306|69285085|FG002|Overall Study|Lack of Efficacy|1|||
37768715|NCT01463306|69285083|FG000|Overall Study|Lost to Follow-up|5|||
37768716|NCT01463306|69285084|FG001|Overall Study|Lost to Follow-up|2|||
37768717|NCT01463306|69285085|FG002|Overall Study|Lost to Follow-up|0|||
37768718|NCT01463306|69285083|FG000|Overall Study|Protocol Violation|4|||
37768719|NCT01463306|69285084|FG001|Overall Study|Protocol Violation|0|||
37768720|NCT01463306|69285085|FG002|Overall Study|Protocol Violation|0|||
37768721|NCT01463306|69285083|FG000|Overall Study|Withdrawal by Subject|19|||
37768722|NCT01463306|69285084|FG001|Overall Study|Withdrawal by Subject|9|||
37768723|NCT01463306|69285085|FG002|Overall Study|Withdrawal by Subject|1|||
37768724|NCT01463306|69285083|FG000|Overall Study|Other|26|||
37768725|NCT01463306|69285084|FG001|Overall Study|Other|13|||
37768726|NCT01463306|69285085|FG002|Overall Study|Other|0|||
37768727|NCT01463306|69285083|FG000|Overall Study|Approval expiry at site|1|||
37768728|NCT01463306|69285084|FG001|Overall Study|Approval expiry at site|0|||
37950432|NCT00616434|69637641|FG000|Overall Study|Protocol deviation|0|||
37768729|NCT01463306|69285085|FG002|Overall Study|Approval expiry at site|0|||
37768730|NCT01504412|69285114|FG000|Overall Study|Adverse Event|1|||
37768731|NCT01504412|69285115|FG001|Overall Study|Adverse Event|8|||
37768732|NCT01504412|69285116|FG002|Overall Study|Adverse Event|1|||
37768733|NCT01504412|69285117|FG003|Overall Study|Adverse Event|7|||
37768734|NCT01504412|69285118|FG004|Overall Study|Adverse Event|10|||
37768735|NCT01504412|69285114|FG000|Overall Study|Withdrawal by Subject|2|||
37768736|NCT01504412|69285115|FG001|Overall Study|Withdrawal by Subject|1|||
37768737|NCT01504412|69285116|FG002|Overall Study|Withdrawal by Subject|1|||
37768738|NCT01504412|69285117|FG003|Overall Study|Withdrawal by Subject|5|||
37768739|NCT01504412|69285118|FG004|Overall Study|Withdrawal by Subject|1|||
37768740|NCT01504412|69285114|FG000|Overall Study|Other|2|||
37768741|NCT01504412|69285115|FG001|Overall Study|Other|1|||
37768742|NCT01504412|69285116|FG002|Overall Study|Other|1|||
37768743|NCT01504412|69285117|FG003|Overall Study|Other|6|||
37768744|NCT01504412|69285118|FG004|Overall Study|Other|1|||
37768745|NCT01504412|69285114|FG000|Overall Study|Lost to Follow-up|0|||
37768746|NCT01504412|69285115|FG001|Overall Study|Lost to Follow-up|2|||
37768747|NCT01504412|69285116|FG002|Overall Study|Lost to Follow-up|0|||
37768748|NCT01504412|69285117|FG003|Overall Study|Lost to Follow-up|0|||
37768749|NCT01504412|69285118|FG004|Overall Study|Lost to Follow-up|0|||
37768750|NCT01504412|69285114|FG000|Overall Study|Lack of Efficacy|0|||
37768751|NCT01504412|69285115|FG001|Overall Study|Lack of Efficacy|0|||
37768752|NCT01504412|69285116|FG002|Overall Study|Lack of Efficacy|1|||
37768753|NCT01504412|69285117|FG003|Overall Study|Lack of Efficacy|0|||
37768754|NCT01504412|69285118|FG004|Overall Study|Lack of Efficacy|1|||
37768755|NCT01504412|69285114|FG000|Overall Study|Death|0|||
37768756|NCT01504412|69285115|FG001|Overall Study|Death|0|||
37768757|NCT01504412|69285116|FG002|Overall Study|Death|0|||
37768758|NCT01504412|69285117|FG003|Overall Study|Death|1|||
37768759|NCT01504412|69285118|FG004|Overall Study|Death|0|||
37768760|NCT01503164|69285148|FG000|Overall Study|Withdrawal by Subject|2|||
37768761|NCT01503164|69285149|FG001|Overall Study|Withdrawal by Subject|1|||
37768762|NCT00088465|69285155|FG000|Overall Study|Withdrawal by Subject|290|||
37768763|NCT00088465|69285155|FG000|Overall Study|Adverse Event|77|||
37768764|NCT00088465|69285155|FG000|Overall Study|Lost to Follow-up|57|||
37768765|NCT00088465|69285155|FG000|Overall Study|Physician Decision|45|||
37768766|NCT00088465|69285155|FG000|Overall Study|Sponsor Decision|37|||
37768767|NCT00088465|69285155|FG000|Overall Study|Lack of Efficacy|27|||
37768768|NCT00088465|69285155|FG000|Overall Study|Protocol Violation|17|||
37768769|NCT00088465|69285155|FG000|Overall Study|Death|11|||
37768770|NCT00088153|69285183|FG000|Overall Study|Physician Decision|3|||
37768771|NCT00088153|69285184|FG001|Overall Study|Physician Decision|3|||
37768772|NCT00088153|69285183|FG000|Overall Study|Withdrawal by Subject|10|||
37768773|NCT00088153|69285184|FG001|Overall Study|Withdrawal by Subject|10|||
37768774|NCT00088153|69285183|FG000|Overall Study|Lost to Follow-up|11|||
37768775|NCT00088153|69285184|FG001|Overall Study|Lost to Follow-up|12|||
37768776|NCT01502228|69285203|FG000|Overall Study|Death|1|||
37768777|NCT01502072|69285210|FG000|Overall Study|Withdrawal by Subject|1|||
37768778|NCT01502072|69285211|FG001|Overall Study|Withdrawal by Subject|0|||
37768779|NCT01502072|69285212|FG002|Overall Study|Withdrawal by Subject|0|||
37768780|NCT01502072|69285210|FG000|Overall Study|Death|0|||
37768781|NCT01502072|69285211|FG001|Overall Study|Death|1|||
37768782|NCT01502072|69285212|FG002|Overall Study|Death|0|||
37768783|NCT01462370|69285220|FG000|Overall Study|Lack of Qualifying Event|1|||
37768784|NCT01462370|69285221|FG001|Overall Study|Lack of Qualifying Event|1|||
37768785|NCT01462370|69285220|FG000|Overall Study|Physician Decision|0|||
37768786|NCT01462370|69285221|FG001|Overall Study|Physician Decision|1|||
37768787|NCT01462370|69285220|FG000|Overall Study|Withdrawal by Subject|0|||
37768788|NCT01462370|69285221|FG001|Overall Study|Withdrawal by Subject|3|||
37768789|NCT01479764|69285229|FG000|Randomized|Adverse Event|1|||
37768790|NCT01479764|69285230|FG001|Randomized|Adverse Event|1|||
37768791|NCT01479764|69285229|FG000|Randomized|Withdrawal by Subject|1|||
37768792|NCT01479764|69285230|FG001|Randomized|Withdrawal by Subject|0|||
37768793|NCT01479764|69285229|FG000|Treated|Lost to Follow-up|0|||
37768794|NCT01479764|69285230|FG001|Treated|Lost to Follow-up|2|||
37768795|NCT01479530|69285238|FG000|Overall Study|Adverse Event|5|||
37768796|NCT01479530|69285239|FG001|Overall Study|Adverse Event|6|||
37768797|NCT01479530|69285238|FG000|Overall Study|Lack of Efficacy|0|||
37768798|NCT01479530|69285239|FG001|Overall Study|Lack of Efficacy|1|||
37768799|NCT01479530|69285238|FG000|Overall Study|Protocol Violation|2|||
37768800|NCT01479530|69285239|FG001|Overall Study|Protocol Violation|3|||
37768801|NCT01479530|69285238|FG000|Overall Study|Withdrawal of Consent|3|||
37768802|NCT01479530|69285239|FG001|Overall Study|Withdrawal of Consent|2|||
37768803|NCT01479374|69285248|FG000|Overall Study|Adverse Event|2|||
37768804|NCT01479374|69285249|FG001|Overall Study|Adverse Event|1|||
37768805|NCT01479374|69285250|FG002|Overall Study|Adverse Event|0|||
37768806|NCT01479374|69285248|FG000|Overall Study|Lost to Follow-up|1|||
37768807|NCT01479374|69285249|FG001|Overall Study|Lost to Follow-up|2|||
37768808|NCT01479374|69285250|FG002|Overall Study|Lost to Follow-up|0|||
37768809|NCT01479374|69285248|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
37768810|NCT01479374|69285249|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
37950433|NCT00616434|69637642|FG001|Overall Study|Protocol deviation|1|||
37768811|NCT01479374|69285250|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
37768812|NCT01479374|69285248|FG000|Overall Study|Other|0|||
37768813|NCT01479374|69285249|FG001|Overall Study|Other|4|||
37768814|NCT01479374|69285250|FG002|Overall Study|Other|5|||
37768815|NCT00087529|69285260|FG000|Overall Study|Death|1|||
37768816|NCT00087529|69285261|FG001|Overall Study|Death|0|||
37768817|NCT00087529|69285260|FG000|Overall Study|Adverse Event|0|||
37768818|NCT00087529|69285261|FG001|Overall Study|Adverse Event|8|||
37768819|NCT00087529|69285260|FG000|Overall Study|Pregnancy|0|||
37768820|NCT00087529|69285261|FG001|Overall Study|Pregnancy|1|||
37768821|NCT00087529|69285260|FG000|Overall Study|Lost to Follow-up|2|||
37768822|NCT00087529|69285261|FG001|Overall Study|Lost to Follow-up|3|||
37768823|NCT00087529|69285260|FG000|Overall Study|Participant Decision|14|||
37768824|NCT00087529|69285261|FG001|Overall Study|Participant Decision|37|||
37768825|NCT00087529|69285260|FG000|Overall Study|Physician Decision|4|||
37768826|NCT00087529|69285261|FG001|Overall Study|Physician Decision|8|||
37950434|NCT00652340|69637650|FG000|Overall Study|Had not progressed.|4|||
37950435|NCT00652340|69637651|FG001|Overall Study|Had not progressed.|3|||
37950436|NCT00613314|69637657|FG000|Overall Study|Adverse Event|5|||
37950437|NCT00613314|69637657|FG000|Overall Study|Protocol Violation|14|||
37950438|NCT00613314|69637657|FG000|Overall Study|Lost to Follow-up|46|||
37950439|NCT00613314|69637657|FG000|Overall Study|Other reason not defined above|90|||
37950440|NCT00257725|69637661|FG000|Overall Study|Adverse Event|3|||
37950441|NCT00544869|69637669|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
37950442|NCT00544869|69637670|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
37950443|NCT00544869|69637671|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
37950444|NCT00544869|69637669|FG000|Overall Study|Adverse Event|6|||
37950445|NCT00544869|69637670|FG001|Overall Study|Adverse Event|1|||
37950446|NCT00544869|69637671|FG002|Overall Study|Adverse Event|0|||
37950447|NCT00544869|69637669|FG000|Overall Study|Lack of Efficacy|1|||
37950448|NCT00544869|69637670|FG001|Overall Study|Lack of Efficacy|1|||
37950449|NCT00544869|69637671|FG002|Overall Study|Lack of Efficacy|0|||
37950450|NCT00544869|69637669|FG000|Overall Study|Physician Decision|2|||
37950451|NCT00544869|69637670|FG001|Overall Study|Physician Decision|0|||
37950452|NCT00544869|69637671|FG002|Overall Study|Physician Decision|0|||
37950453|NCT00725075|69637682|FG000|Overall Study|Use of Excluded Medication|0|||
37950454|NCT00725075|69637683|FG001|Overall Study|Use of Excluded Medication|1|||
37950455|NCT00725075|69637684|FG002|Overall Study|Use of Excluded Medication|0|||
37950456|NCT00725075|69637682|FG000|Overall Study|Protocol Violation|0|||
37950457|NCT00725075|69637683|FG001|Overall Study|Protocol Violation|0|||
37950458|NCT00725075|69637684|FG002|Overall Study|Protocol Violation|1|||
37950459|NCT00725075|69637682|FG000|Overall Study|Lost to Follow-up|1|||
37950460|NCT00725075|69637683|FG001|Overall Study|Lost to Follow-up|0|||
37950461|NCT00725075|69637684|FG002|Overall Study|Lost to Follow-up|0|||
37950462|NCT00725075|69637682|FG000|Overall Study|Withdrawal by Subject|4|||
37950463|NCT00725075|69637683|FG001|Overall Study|Withdrawal by Subject|5|||
37950464|NCT00725075|69637684|FG002|Overall Study|Withdrawal by Subject|4|||
37950465|NCT00725075|69637682|FG000|Overall Study|Adverse Event|2|||
37950466|NCT00725075|69637683|FG001|Overall Study|Adverse Event|1|||
37950467|NCT00725075|69637684|FG002|Overall Study|Adverse Event|1|||
37950468|NCT00725075|69637682|FG000|Overall Study|Worsening of Disease|2|||
37950469|NCT00725075|69637683|FG001|Overall Study|Worsening of Disease|1|||
37950470|NCT00725075|69637684|FG002|Overall Study|Worsening of Disease|2|||
37950471|NCT00725075|69637682|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
37950472|NCT00725075|69637683|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
37950473|NCT00725075|69637684|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
37950474|NCT00725075|69637682|FG000|Overall Study|Other|1|||
37950475|NCT00725075|69637683|FG001|Overall Study|Other|0|||
37950476|NCT00725075|69637684|FG002|Overall Study|Other|0|||
37950477|NCT00733499|69637694|FG000|Pre-operative|Protocol Violation|0|||
37950478|NCT00733499|69637695|FG001|Pre-operative|Protocol Violation|1|||
37950479|NCT00733499|69637694|FG000|3 Months Follow-up|Death|1|||
37950480|NCT00733499|69637695|FG001|3 Months Follow-up|Death|2|||
37950481|NCT00733499|69637694|FG000|6 Months Follow-up|Death|0|||
37950482|NCT00733499|69637695|FG001|6 Months Follow-up|Death|2|||
37950483|NCT00733499|69637694|FG000|6 Months Follow-up|Adverse Event|0|||
37950484|NCT00733499|69637695|FG001|6 Months Follow-up|Adverse Event|1|||
37950485|NCT00733499|69637694|FG000|12 Months Follow-up|Death|2|||
37950486|NCT00733499|69637695|FG001|12 Months Follow-up|Death|1|||
37950487|NCT00733499|69637694|FG000|24 Months Follow-up|Death|0|||
37950488|NCT00733499|69637695|FG001|24 Months Follow-up|Death|1|||
37950489|NCT00733499|69637694|FG000|5 Year Followup|Adverse Event|2|||
37950490|NCT00733499|69637695|FG001|5 Year Followup|Adverse Event|2|||
37950491|NCT00733499|69637694|FG000|5 Year Followup|Non device related AE|0|||
37950492|NCT00733499|69637695|FG001|5 Year Followup|Non device related AE|1|||
37950493|NCT00733499|69637694|FG000|5 Year Followup|Revision of Study Implant|0|||
37768827|NCT00087529|69285260|FG000|Overall Study|Initiation of Excluded Therapy|0|||
37768828|NCT00087529|69285261|FG001|Overall Study|Initiation of Excluded Therapy|1|||
37768829|NCT00087529|69285260|FG000|Overall Study|Participant Noncompliance|0|||
37768830|NCT00087529|69285261|FG001|Overall Study|Participant Noncompliance|1|||
37768831|NCT00087529|69285260|FG000|Overall Study|Disease Progression|5|||
37768832|NCT00087529|69285261|FG001|Overall Study|Disease Progression|4|||
37768833|NCT00087529|69285260|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
37950494|NCT00733499|69637695|FG001|5 Year Followup|Revision of Study Implant|1|||
37950495|NCT00733499|69637694|FG000|5 Year Followup|Lost to Follow-up|2|||
37950496|NCT00733499|69637695|FG001|5 Year Followup|Lost to Follow-up|0|||
37950497|NCT00733499|69637694|FG000|5 Year Followup|Death|13|||
37950498|NCT00733499|69637695|FG001|5 Year Followup|Death|19|||
37950499|NCT00733499|69637694|FG000|5 Year Followup|missing, unable to locate|0|||
37950500|NCT00733499|69637695|FG001|5 Year Followup|missing, unable to locate|1|||
37950501|NCT00733499|69637694|FG000|5 Year Followup|Withdrawal by Subject|4|||
37950502|NCT00733499|69637695|FG001|5 Year Followup|Withdrawal by Subject|1|||
37950503|NCT00733499|69637694|FG000|10 Year Followup|Death|9|||
37950504|NCT00733499|69637695|FG001|10 Year Followup|Death|7|||
37950505|NCT00733499|69637694|FG000|10 Year Followup|Adverse Event|3|||
37950506|NCT00733499|69637695|FG001|10 Year Followup|Adverse Event|3|||
37950507|NCT00733499|69637694|FG000|10 Year Followup|Lost to Follow-up|3|||
37950508|NCT00733499|69637695|FG001|10 Year Followup|Lost to Follow-up|2|||
37950509|NCT00733499|69637694|FG000|10 Year Followup|Withdrawal by Subject|5|||
37950510|NCT00733499|69637695|FG001|10 Year Followup|Withdrawal by Subject|5|||
37950511|NCT00733499|69637694|FG000|10 Year Followup|missing, unable to locate|0|||
37950512|NCT00733499|69637695|FG001|10 Year Followup|missing, unable to locate|2|||
37950513|NCT00652028|69637705|FG000|Overall Study|Adverse Event|1|||
37950514|NCT00652028|69637706|FG001|Overall Study|Adverse Event|0|||
37950515|NCT00652028|69637707|FG002|Overall Study|Adverse Event|0|||
37950516|NCT00652028|69637708|FG003|Overall Study|Adverse Event|0|||
37950517|NCT00652028|69637705|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
37950518|NCT00652028|69637706|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
37950519|NCT00652028|69637707|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
37950520|NCT00652028|69637708|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
37950521|NCT00652028|69637705|FG000|Overall Study|Physician Decision|0|||
37950522|NCT00652028|69637706|FG001|Overall Study|Physician Decision|0|||
37950523|NCT00652028|69637707|FG002|Overall Study|Physician Decision|1|||
37950524|NCT00652028|69637708|FG003|Overall Study|Physician Decision|0|||
37950525|NCT00738101|69637718|FG000|Overall Study|Physician Decision|5|||
37950526|NCT00738101|69637718|FG000|Overall Study|Death|1|||
37950527|NCT00738101|69637718|FG000|Overall Study|Repeat enrollment|1|||
37950528|NCT00733421|69637724|FG000|Overall Study|Withdrawal by Subject|1|||
37950529|NCT00733421|69637725|FG001|Overall Study|Withdrawal by Subject|1|||
37950530|NCT00613080|69637731|FG000|Overall Study|Ineligible / no protocol treatment|11|||
37950531|NCT00732875|69637735|FG000|Overall Study|Adverse Event|16|||
37950532|NCT00732875|69637735|FG000|Overall Study|Withdrawal by Subject|6|||
37950533|NCT00732875|69637735|FG000|Overall Study|Lack of Efficacy|13|||
37950534|NCT00615264|69637745|FG000|Overall Study|Withdrawal by Subject|17|||
37950535|NCT00615264|69637746|FG001|Overall Study|Withdrawal by Subject|19|||
37950536|NCT00615264|69637745|FG000|Overall Study|Lost to Follow-up|6|||
37950537|NCT00615264|69637746|FG001|Overall Study|Lost to Follow-up|13|||
37950538|NCT00615264|69637745|FG000|Overall Study|Adverse Event|8|||
37950539|NCT00615264|69637746|FG001|Overall Study|Adverse Event|5|||
37950540|NCT00615264|69637745|FG000|Overall Study|Death|1|||
37950541|NCT00615264|69637746|FG001|Overall Study|Death|1|||
37950542|NCT00615264|69637745|FG000|Overall Study|Protocol Violation|11|||
37950543|NCT00615264|69637746|FG001|Overall Study|Protocol Violation|7|||
37950544|NCT00615264|69637745|FG000|Overall Study|Not defined|7|||
37950545|NCT00615264|69637746|FG001|Overall Study|Not defined|4|||
37950546|NCT00615264|69637745|FG000|Overall Study|Dermal Hypersensitivity|0|||
37950547|NCT00615264|69637746|FG001|Overall Study|Dermal Hypersensitivity|3|||
37950548|NCT00732641|69637754|FG000|Overall Study|Relapse or Progressive Disease|65|||
37950549|NCT00732641|69637755|FG001|Overall Study|Relapse or Progressive Disease|101|||
37950550|NCT00732641|69637754|FG000|Overall Study|Serious Adverse Events|12|||
37950551|NCT00732641|69637755|FG001|Overall Study|Serious Adverse Events|3|||
37950552|NCT00732641|69637754|FG000|Overall Study|Physician Decision|6|||
37950553|NCT00732641|69637755|FG001|Overall Study|Physician Decision|0|||
37950554|NCT00732641|69637754|FG000|Overall Study|Withdrawal by Subject|4|||
37950555|NCT00732641|69637755|FG001|Overall Study|Withdrawal by Subject|2|||
37950556|NCT00732641|69637754|FG000|Overall Study|Unable to Complete|1|||
37950557|NCT00732641|69637755|FG001|Overall Study|Unable to Complete|1|||
37950558|NCT00732641|69637754|FG000|Overall Study|Other|18|||
37950559|NCT00732641|69637755|FG001|Overall Study|Other|5|||
37950560|NCT00737711|69637761|FG000|Overall Study|Adverse Event|2|||
37950561|NCT00737711|69637761|FG000|Overall Study|Death|8|||
37950562|NCT00737711|69637761|FG000|Overall Study|Failure to return|4|||
37950563|NCT00737711|69637761|FG000|Overall Study|Protocol Violation|1|||
37950564|NCT00737711|69637761|FG000|Overall Study|Withdrawal by Subject|5|||
37950565|NCT00737711|69637761|FG000|Overall Study|Blood transfusion|6|||
37950566|NCT00737711|69637761|FG000|Overall Study|Other|5|||
37950567|NCT00615108|69637765|FG000|Overall Study|Adverse Event|122|||
37950568|NCT00615108|69637765|FG000|Overall Study|Other|370|||
37950569|NCT00615108|69637765|FG000|Overall Study|Lost to Follow-up|15|||
37950570|NCT00238303|69637774|FG000|Overall Study|Withdrawal by Subject|11|||
37950571|NCT00238303|69637775|FG001|Overall Study|Withdrawal by Subject|1|||
37950572|NCT00238303|69637776|FG002|Overall Study|Withdrawal by Subject|2|||
37950573|NCT00238303|69637774|FG000|Overall Study|Death|1|||
37950574|NCT00238303|69637775|FG001|Overall Study|Death|0|||
37677344|NCT01659255|69152295|FG007|Overall Study|Sponsor's Decision|0|||
37950575|NCT00238303|69637776|FG002|Overall Study|Death|1|||
37950576|NCT00238303|69637774|FG000|Overall Study|Other Medical Problems|2|||
37950577|NCT00238303|69637775|FG001|Overall Study|Other Medical Problems|0|||
37950578|NCT00238303|69637776|FG002|Overall Study|Other Medical Problems|2|||
37950579|NCT00238303|69637774|FG000|Overall Study|Poor tolerance of study treatment|1|||
37677345|NCT01659255|69152296|FG008|Overall Study|Sponsor's Decision|0|||
37950580|NCT00238303|69637775|FG001|Overall Study|Poor tolerance of study treatment|0|||
37950581|NCT00238303|69637776|FG002|Overall Study|Poor tolerance of study treatment|1|||
37950582|NCT00238303|69637774|FG000|Overall Study|Adverse Event|0|||
37950583|NCT00238303|69637775|FG001|Overall Study|Adverse Event|1|||
37950584|NCT00238303|69637776|FG002|Overall Study|Adverse Event|3|||
37950585|NCT00737633|69637787|FG000|Overall Study|Study terminated by sponsor|44|||
37950586|NCT00737633|69637788|FG001|Overall Study|Study terminated by sponsor|55|||
37950587|NCT00737633|69637787|FG000|Overall Study|Lost to Follow-up|0|||
37950588|NCT00737633|69637788|FG001|Overall Study|Lost to Follow-up|1|||
37950589|NCT00737633|69637787|FG000|Overall Study|protocol non-compliance|0|||
37950590|NCT00737633|69637788|FG001|Overall Study|protocol non-compliance|1|||
37950591|NCT00732251|69637794|FG000|Overall Study|Lost to Follow-up|3|||
37950592|NCT00732251|69637794|FG000|Overall Study|Withdrawal by Subject|3|||
37950593|NCT00732251|69637794|FG000|Overall Study|Early Term due to Site Closure|1|||
37950594|NCT00737477|69637798|FG000|Overall Study|Adverse Event|9|||
37950595|NCT00737477|69637798|FG000|Overall Study|Death|9|||
37950596|NCT00737477|69637798|FG000|Overall Study|Treatment Refusal|1|||
37950597|NCT00737477|69637798|FG000|Overall Study|Withdrawal by Subject|1|||
37950598|NCT00737477|69637798|FG000|Overall Study|Renal Transplantation|10|||
37950599|NCT00737477|69637798|FG000|Overall Study|Other|4|||
37950600|NCT00256867|69637810|FG000|Overall Study|Adverse Event|0|||
37950601|NCT00256867|69637811|FG001|Overall Study|Adverse Event|1|||
37950602|NCT00256867|69637812|FG002|Overall Study|Adverse Event|1|||
37950603|NCT00256867|69637813|FG003|Overall Study|Adverse Event|1|||
37950604|NCT00256867|69637814|FG004|Overall Study|Adverse Event|2|||
37950605|NCT00256867|69637815|FG005|Overall Study|Adverse Event|2|||
37950606|NCT00256867|69637816|FG006|Overall Study|Adverse Event|1|||
37950607|NCT00256867|69637817|FG007|Overall Study|Adverse Event|4|||
37950608|NCT00256867|69637810|FG000|Overall Study|Lost to Follow-up|2|||
37950609|NCT00256867|69637811|FG001|Overall Study|Lost to Follow-up|2|||
37950610|NCT00256867|69637812|FG002|Overall Study|Lost to Follow-up|2|||
37950611|NCT00256867|69637813|FG003|Overall Study|Lost to Follow-up|3|||
37950612|NCT00256867|69637814|FG004|Overall Study|Lost to Follow-up|2|||
37950613|NCT00256867|69637815|FG005|Overall Study|Lost to Follow-up|0|||
37950614|NCT00256867|69637816|FG006|Overall Study|Lost to Follow-up|1|||
37950615|NCT00256867|69637817|FG007|Overall Study|Lost to Follow-up|2|||
37950616|NCT00256867|69637810|FG000|Overall Study|Protocol Violation|0|||
37950617|NCT00256867|69637811|FG001|Overall Study|Protocol Violation|0|||
37950618|NCT00256867|69637812|FG002|Overall Study|Protocol Violation|0|||
37950619|NCT00256867|69637813|FG003|Overall Study|Protocol Violation|1|||
37768834|NCT00087529|69285261|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
37768835|NCT01500434|69285284|FG000|Overall Study|Death|1|||
37768836|NCT01500434|69285284|FG000|Overall Study|Withdrawal by Subject|1|||
37768837|NCT01500434|69285284|FG000|Overall Study|Missed 12-month follow-up|5|||
37768838|NCT00087139|69285291|FG000|Overall Study|Adverse Event|18|||
37677346|NCT01659255|69152297|FG009|Overall Study|Sponsor's Decision|0|||
37768839|NCT00087139|69285292|FG001|Overall Study|Adverse Event|17|||
37768840|NCT00087139|69285293|FG002|Overall Study|Adverse Event|13|||
37768841|NCT00087139|69285291|FG000|Overall Study|Death|2|||
37768842|NCT00087139|69285292|FG001|Overall Study|Death|1|||
37768843|NCT00087139|69285293|FG002|Overall Study|Death|0|||
37768844|NCT00087139|69285291|FG000|Overall Study|Withdrawal by Subject|3|||
37768845|NCT00087139|69285292|FG001|Overall Study|Withdrawal by Subject|2|||
37768846|NCT00087139|69285293|FG002|Overall Study|Withdrawal by Subject|2|||
37768847|NCT00087139|69285291|FG000|Overall Study|Physician Decision|1|||
37768848|NCT00087139|69285292|FG001|Overall Study|Physician Decision|1|||
37768849|NCT00087139|69285293|FG002|Overall Study|Physician Decision|1|||
37768850|NCT00087139|69285291|FG000|Overall Study|Disease progression|9|||
37768851|NCT00087139|69285292|FG001|Overall Study|Disease progression|19|||
37768852|NCT00087139|69285293|FG002|Overall Study|Disease progression|12|||
37768853|NCT00087139|69285291|FG000|Overall Study|Ineligible|4|||
37768854|NCT00087139|69285292|FG001|Overall Study|Ineligible|7|||
37768855|NCT00087139|69285293|FG002|Overall Study|Ineligible|4|||
37768856|NCT00087139|69285291|FG000|Overall Study|Symptomatic deterioration|1|||
37768857|NCT00087139|69285292|FG001|Overall Study|Symptomatic deterioration|1|||
37768858|NCT00087139|69285293|FG002|Overall Study|Symptomatic deterioration|3|||
37768859|NCT00087139|69285291|FG000|Overall Study|Use of coumadin|1|||
37768860|NCT00087139|69285292|FG001|Overall Study|Use of coumadin|0|||
37768861|NCT00087139|69285293|FG002|Overall Study|Use of coumadin|0|||
37768862|NCT00087139|69285291|FG000|Overall Study|Response achieved|0|||
37768863|NCT00087139|69285292|FG001|Overall Study|Response achieved|1|||
37768864|NCT00087139|69285293|FG002|Overall Study|Response achieved|0|||
37768865|NCT00087139|69285291|FG000|Overall Study|Extradural disease|0|||
37768866|NCT00087139|69285292|FG001|Overall Study|Extradural disease|0|||
37768867|NCT00087139|69285293|FG002|Overall Study|Extradural disease|1|||
37768868|NCT01500278|69285345|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
37768869|NCT01500278|69285346|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
37768870|NCT01500278|69285345|FG000|Week 0 - Week 12|Protocol Violation|10|||
37768871|NCT01500278|69285346|FG001|Week 0 - Week 12|Protocol Violation|16|||
37768872|NCT01500278|69285345|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
37768873|NCT01500278|69285346|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
37768874|NCT01500278|69285345|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
37768875|NCT01500278|69285346|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
37768876|NCT01500278|69285345|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
37768877|NCT01500278|69285346|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
37768878|NCT01500278|69285345|FG000|Week 0 - Week 12|Patient decision|1|||
37768879|NCT01500278|69285346|FG001|Week 0 - Week 12|Patient decision|0|||
37768880|NCT01500278|69285345|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
37768881|NCT01500278|69285346|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
37768882|NCT01500278|69285345|FG000|Week 0 - Week 12|Investigator decision|1|||
37768883|NCT01500278|69285346|FG001|Week 0 - Week 12|Investigator decision|0|||
37768884|NCT01500278|69285345|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
37768885|NCT01500278|69285346|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
37768886|NCT01500278|69285345|FG000|Week 0 - Week 12|Sponsor decision|1|||
37768887|NCT01500278|69285346|FG001|Week 0 - Week 12|Sponsor decision|0|||
37768888|NCT01500278|69285345|FG000|Week 0 - Week 12|Personal reason|0|||
37768889|NCT01500278|69285346|FG001|Week 0 - Week 12|Personal reason|1|||
37768890|NCT01500278|69285345|FG000|Week 0 - Week 12|Other serious disease|0|||
37768891|NCT01500278|69285346|FG001|Week 0 - Week 12|Other serious disease|1|||
37768892|NCT01500278|69285345|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
37768893|NCT01500278|69285346|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
37768894|NCT01500278|69285345|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
37768895|NCT01500278|69285346|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
37768896|NCT01500278|69285345|FG000|Week 13 - Week 104|Protocol Violation|6|||
37768897|NCT01500278|69285346|FG001|Week 13 - Week 104|Protocol Violation|6|||
37768898|NCT01500278|69285345|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
37768899|NCT01500278|69285346|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
37768900|NCT01500278|69285345|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
37768901|NCT01500278|69285346|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
37768902|NCT01500278|69285345|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
37768903|NCT01500278|69285346|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
37768904|NCT01500278|69285345|FG000|Week 13 - Week 104|Non/bad compliance|7|||
37768905|NCT01500278|69285346|FG001|Week 13 - Week 104|Non/bad compliance|5|||
37768906|NCT01500278|69285345|FG000|Week 13 - Week 104|Recurrent infections|1|||
37768907|NCT01500278|69285346|FG001|Week 13 - Week 104|Recurrent infections|0|||
37950620|NCT00256867|69637814|FG004|Overall Study|Protocol Violation|0|||
37950621|NCT00256867|69637815|FG005|Overall Study|Protocol Violation|1|||
37950622|NCT00256867|69637816|FG006|Overall Study|Protocol Violation|0|||
37950623|NCT00256867|69637817|FG007|Overall Study|Protocol Violation|1|||
37950624|NCT00256867|69637810|FG000|Overall Study|Withdrawal by Subject|0|||
37950625|NCT00256867|69637811|FG001|Overall Study|Withdrawal by Subject|0|||
37950626|NCT00256867|69637812|FG002|Overall Study|Withdrawal by Subject|1|||
37950627|NCT00256867|69637813|FG003|Overall Study|Withdrawal by Subject|1|||
37950628|NCT00256867|69637814|FG004|Overall Study|Withdrawal by Subject|2|||
37950629|NCT00256867|69637815|FG005|Overall Study|Withdrawal by Subject|2|||
37950630|NCT00256867|69637816|FG006|Overall Study|Withdrawal by Subject|3|||
37950631|NCT00256867|69637817|FG007|Overall Study|Withdrawal by Subject|2|||
37950632|NCT00256867|69637810|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
37950633|NCT00256867|69637811|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
37950634|NCT00256867|69637812|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
37950635|NCT00256867|69637813|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
37950636|NCT00256867|69637814|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
37950637|NCT00256867|69637815|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
37950638|NCT00256867|69637816|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
37950639|NCT00256867|69637817|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
37950640|NCT00256867|69637810|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
37950641|NCT00256867|69637811|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
37950642|NCT00256867|69637812|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
37950643|NCT00256867|69637813|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
37950644|NCT00256867|69637814|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
37950645|NCT00256867|69637815|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
37950646|NCT00256867|69637816|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
37768908|NCT01500278|69285345|FG000|Week 13 - Week 104|False positive test|1|||
37768909|NCT01500278|69285346|FG001|Week 13 - Week 104|False positive test|2|||
37768910|NCT01500278|69285345|FG000|Week 13 - Week 104|Sponsor request|4|||
37768911|NCT01500278|69285346|FG001|Week 13 - Week 104|Sponsor request|0|||
37768912|NCT01500278|69285345|FG000|Week 13 - Week 104|Withdrawn in error|1|||
37768913|NCT01500278|69285346|FG001|Week 13 - Week 104|Withdrawn in error|0|||
37768914|NCT01500278|69285345|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
37768915|NCT01500278|69285346|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
37768916|NCT01500278|69285345|FG000|Week 13 - Week 104|Protocol deviation|1|||
37950647|NCT00256867|69637817|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
37950648|NCT00256867|69637810|FG000|Overall Study|Investigator's Decision|0|||
37950649|NCT00256867|69637811|FG001|Overall Study|Investigator's Decision|0|||
37950650|NCT00256867|69637812|FG002|Overall Study|Investigator's Decision|0|||
37950651|NCT00256867|69637813|FG003|Overall Study|Investigator's Decision|0|||
37950652|NCT00256867|69637814|FG004|Overall Study|Investigator's Decision|1|||
37950653|NCT00256867|69637815|FG005|Overall Study|Investigator's Decision|0|||
37950654|NCT00256867|69637816|FG006|Overall Study|Investigator's Decision|0|||
37950655|NCT00256867|69637817|FG007|Overall Study|Investigator's Decision|0|||
37950656|NCT00256867|69637810|FG000|Overall Study|Non-compliance with study medication|0|||
37950657|NCT00256867|69637811|FG001|Overall Study|Non-compliance with study medication|0|||
37950658|NCT00256867|69637812|FG002|Overall Study|Non-compliance with study medication|0|||
37950659|NCT00256867|69637813|FG003|Overall Study|Non-compliance with study medication|0|||
37950660|NCT00256867|69637814|FG004|Overall Study|Non-compliance with study medication|0|||
37950661|NCT00256867|69637815|FG005|Overall Study|Non-compliance with study medication|0|||
37950662|NCT00256867|69637816|FG006|Overall Study|Non-compliance with study medication|0|||
37950663|NCT00256867|69637817|FG007|Overall Study|Non-compliance with study medication|1|||
37950664|NCT00256867|69637810|FG000|Overall Study|Participant travelled Overseas|0|||
37950665|NCT00256867|69637811|FG001|Overall Study|Participant travelled Overseas|1|||
37950666|NCT00256867|69637812|FG002|Overall Study|Participant travelled Overseas|0|||
37950667|NCT00256867|69637813|FG003|Overall Study|Participant travelled Overseas|0|||
37950668|NCT00256867|69637814|FG004|Overall Study|Participant travelled Overseas|0|||
37950669|NCT00256867|69637815|FG005|Overall Study|Participant travelled Overseas|0|||
37950670|NCT00256867|69637816|FG006|Overall Study|Participant travelled Overseas|0|||
37950671|NCT00256867|69637817|FG007|Overall Study|Participant travelled Overseas|0|||
37950672|NCT00256867|69637810|FG000|Overall Study|Participant out of assessment window|0|||
37950673|NCT00256867|69637811|FG001|Overall Study|Participant out of assessment window|0|||
37950674|NCT00256867|69637812|FG002|Overall Study|Participant out of assessment window|1|||
37950675|NCT00256867|69637813|FG003|Overall Study|Participant out of assessment window|0|||
37768917|NCT01500278|69285346|FG001|Week 13 - Week 104|Protocol deviation|0|||
37768918|NCT01500278|69285345|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
37768919|NCT01500278|69285346|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
37768920|NCT01500278|69285345|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
37768921|NCT01500278|69285346|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
37768922|NCT01500278|69285345|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
37768923|NCT01500278|69285346|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
37768924|NCT01500278|69285345|FG000|Week 13 - Week 104|Relocation|0|||
37768925|NCT01500278|69285346|FG001|Week 13 - Week 104|Relocation|1|||
37768926|NCT01500278|69285345|FG000|Week 13 - Week 104|Sponsor decision|0|||
37768927|NCT01500278|69285346|FG001|Week 13 - Week 104|Sponsor decision|2|||
37768928|NCT01500278|69285345|FG000|Week 13 - Week 104|Medical monitor decision|0|||
37768929|NCT01500278|69285346|FG001|Week 13 - Week 104|Medical monitor decision|2|||
37768930|NCT01500278|69285345|FG000|Week 13 - Week 104|Personal reason|0|||
37768931|NCT01500278|69285346|FG001|Week 13 - Week 104|Personal reason|1|||
37768932|NCT01500278|69285345|FG000|Week 13 - Week 104|Not completed|0|||
37768933|NCT01500278|69285346|FG001|Week 13 - Week 104|Not completed|1|||
37768934|NCT01500278|69285345|FG000|Week 13 - Week 104|Death|2|||
37768935|NCT01500278|69285346|FG001|Week 13 - Week 104|Death|4|||
37768936|NCT01500278|69285345|FG000|Week 13 - Week 104|Adverse Event|54|||
37768937|NCT01500278|69285346|FG001|Week 13 - Week 104|Adverse Event|54|||
37768938|NCT00086281|69285369|FG000|Phase 1|Adverse Event|0|||
37768939|NCT00086281|69285370|FG001|Phase 1|Adverse Event|0|||
37768940|NCT00086281|69285371|FG002|Phase 1|Adverse Event|0|||
37768941|NCT00086281|69285372|FG003|Phase 1|Adverse Event|0|||
37768942|NCT00086281|69285373|FG004|Phase 1|Adverse Event|0|||
37768943|NCT00086281|69285374|FG005|Phase 1|Adverse Event|0|||
37768944|NCT00086281|69285375|FG006|Phase 1|Adverse Event|0|||
37768945|NCT00086281|69285376|FG007|Phase 1|Adverse Event|0|||
37768946|NCT00086281|69285377|FG008|Phase 1|Adverse Event|0|||
37768947|NCT00086281|69285378|FG009|Phase 1|Adverse Event|1|||
37768948|NCT00086281|69285379|FG010|Phase 1|Adverse Event|2|||
37768949|NCT00086281|69285380|FG011|Phase 1|Adverse Event|1|||
37768950|NCT00086281|69285381|FG012|Phase 1|Adverse Event|1|||
37768951|NCT00086281|69285382|FG013|Phase 1|Adverse Event|1|||
37768952|NCT00086281|69285383|FG014|Phase 1|Adverse Event|2|||
37768953|NCT00086281|69285369|FG000|Phase 1|Protocol Violation|0|||
37768954|NCT00086281|69285370|FG001|Phase 1|Protocol Violation|0|||
37768955|NCT00086281|69285371|FG002|Phase 1|Protocol Violation|0|||
37768956|NCT00086281|69285372|FG003|Phase 1|Protocol Violation|0|||
37768957|NCT00086281|69285373|FG004|Phase 1|Protocol Violation|0|||
37768958|NCT00086281|69285374|FG005|Phase 1|Protocol Violation|0|||
37768959|NCT00086281|69285375|FG006|Phase 1|Protocol Violation|0|||
37768960|NCT00086281|69285376|FG007|Phase 1|Protocol Violation|0|||
37768961|NCT00086281|69285377|FG008|Phase 1|Protocol Violation|0|||
37768962|NCT00086281|69285378|FG009|Phase 1|Protocol Violation|0|||
37950676|NCT00256867|69637814|FG004|Overall Study|Participant out of assessment window|0|||
37950677|NCT00256867|69637815|FG005|Overall Study|Participant out of assessment window|0|||
37950678|NCT00256867|69637816|FG006|Overall Study|Participant out of assessment window|0|||
37950679|NCT00256867|69637817|FG007|Overall Study|Participant out of assessment window|0|||
37950680|NCT00256867|69637810|FG000|Overall Study|Withdrawal by participant|0|||
37950681|NCT00256867|69637811|FG001|Overall Study|Withdrawal by participant|0|||
37950682|NCT00256867|69637812|FG002|Overall Study|Withdrawal by participant|0|||
37950683|NCT00256867|69637813|FG003|Overall Study|Withdrawal by participant|0|||
37950684|NCT00256867|69637814|FG004|Overall Study|Withdrawal by participant|0|||
37950685|NCT00256867|69637815|FG005|Overall Study|Withdrawal by participant|1|||
37950686|NCT00256867|69637816|FG006|Overall Study|Withdrawal by participant|0|||
37950687|NCT00256867|69637817|FG007|Overall Study|Withdrawal by participant|0|||
37950688|NCT00731939|69637840|FG000|Overall Study|Adverse Event|6|||
37950689|NCT00731939|69637840|FG000|Overall Study|Lost to Follow-up|15|||
37950690|NCT00731939|69637840|FG000|Overall Study|Not implanted with study device|9|||
37950691|NCT00731939|69637840|FG000|Overall Study|Withdrawal by Subject|2|||
37950692|NCT00731939|69637840|FG000|Overall Study|Did not meet enrollment criteria|2|||
37950693|NCT00731783|69637846|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
37950694|NCT00731783|69637847|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
37950695|NCT00731783|69637846|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
37950696|NCT00731783|69637847|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
37950697|NCT00731783|69637846|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
37950698|NCT00731783|69637847|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
37950699|NCT00731783|69637846|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
37950700|NCT00731783|69637847|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
37950701|NCT00724451|69637853|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
37950702|NCT00724451|69637853|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
37950703|NCT00724451|69637853|FG000|Overall Study|Not Eligible for Treatment|431|||
37950704|NCT00724451|69637853|FG000|Overall Study|Participant Refused Treatment|89|||
37950705|NCT00724451|69637853|FG000|Overall Study|Never Started Treatment|89|||
37950706|NCT00724451|69637853|FG000|Overall Study|Unknown; No Data Sources Available|9|||
37950707|NCT00724451|69637853|FG000|Overall Study|Physician Decision|116|||
37950708|NCT00724451|69637853|FG000|Overall Study|Withdrawal by Subject|45|||
37950709|NCT00724451|69637853|FG000|Overall Study|Investigator + Participant Decision|13|||
37950710|NCT00724373|69637857|FG000|Overall Study|Adverse Event|41|||
37950711|NCT00724373|69637857|FG000|Overall Study|Lack of Efficacy|82|||
37950712|NCT00724373|69637857|FG000|Overall Study|Lost to Follow-up|7|||
37950713|NCT00724373|69637857|FG000|Overall Study|Non-compliance|2|||
37950714|NCT00724373|69637857|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
37950715|NCT00724373|69637857|FG000|Overall Study|Participant moved away|1|||
37950716|NCT00724373|69637857|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
37950717|NCT00724373|69637857|FG000|Overall Study|Only to have 24 week regimen|1|||
37950718|NCT00724373|69637857|FG000|Overall Study|Viral Relapse|1|||
37950719|NCT00724373|69637857|FG000|Overall Study|Acute HCV infection|1|||
37950720|NCT00724373|69637857|FG000|Overall Study|Drug Relapse|1|||
37950721|NCT00724373|69637857|FG000|Overall Study|Tolerability|23|||
37950722|NCT00724061|69637861|FG000|Dose Escalation Phase|Adverse Event|2|||
37950723|NCT00724061|69637861|FG000|Dose Escalation Phase|Disease Progression|3|||
37950724|NCT00731549|69637865|FG000|Overall Study|Lost to Follow-up|19|||
37950725|NCT00731549|69637865|FG000|Overall Study|Met withdrawal criteria|24|||
37950726|NCT00731549|69637865|FG000|Overall Study|Physician Decision|16|||
37950727|NCT00731549|69637865|FG000|Overall Study|Withdrawal by Subject|89|||
37950728|NCT00731549|69637865|FG000|Overall Study|Protocol deviation|1|||
37768963|NCT00086281|69285379|FG010|Phase 1|Protocol Violation|1|||
37768964|NCT00086281|69285380|FG011|Phase 1|Protocol Violation|0|||
37768965|NCT00086281|69285381|FG012|Phase 1|Protocol Violation|0|||
37768966|NCT00086281|69285382|FG013|Phase 1|Protocol Violation|0|||
37768967|NCT00086281|69285383|FG014|Phase 1|Protocol Violation|0|||
37768968|NCT00086281|69285369|FG000|Phase 1|Serious Adverse Event|0|||
37768969|NCT00086281|69285370|FG001|Phase 1|Serious Adverse Event|0|||
37768970|NCT00086281|69285371|FG002|Phase 1|Serious Adverse Event|0|||
37768971|NCT00086281|69285372|FG003|Phase 1|Serious Adverse Event|0|||
37768972|NCT00086281|69285373|FG004|Phase 1|Serious Adverse Event|0|||
37768973|NCT00086281|69285374|FG005|Phase 1|Serious Adverse Event|0|||
37768974|NCT00086281|69285375|FG006|Phase 1|Serious Adverse Event|0|||
37768975|NCT00086281|69285376|FG007|Phase 1|Serious Adverse Event|0|||
37768976|NCT00086281|69285377|FG008|Phase 1|Serious Adverse Event|0|||
37768977|NCT00086281|69285378|FG009|Phase 1|Serious Adverse Event|0|||
37768978|NCT00086281|69285379|FG010|Phase 1|Serious Adverse Event|0|||
37768979|NCT00086281|69285380|FG011|Phase 1|Serious Adverse Event|0|||
37768980|NCT00086281|69285381|FG012|Phase 1|Serious Adverse Event|0|||
37768981|NCT00086281|69285382|FG013|Phase 1|Serious Adverse Event|0|||
37768982|NCT00086281|69285383|FG014|Phase 1|Serious Adverse Event|1|||
37768983|NCT00086281|69285369|FG000|Phase 2|Adverse Event|0|||
37768984|NCT00086281|69285370|FG001|Phase 2|Adverse Event|0|||
37768985|NCT00086281|69285371|FG002|Phase 2|Adverse Event|0|||
37950729|NCT00731549|69637865|FG000|Overall Study|Adverse Event|31|||
37950730|NCT00731549|69637865|FG000|Overall Study|Lack of efficacy with AE|37|||
37950731|NCT00731549|69637865|FG000|Overall Study|Lack of efficacy without AE|6|||
37950732|NCT00730925|69637910|FG000|Overall Study|Progressive Disease|21|||
37950733|NCT00730925|69637910|FG000|Overall Study|Dose reducing Event|2|||
37950734|NCT00730925|69637910|FG000|Overall Study|Other Averse Event|7|||
37950735|NCT00730925|69637910|FG000|Overall Study|Protocol Violation|1|||
37950736|NCT00730925|69637910|FG000|Overall Study|Withdrawal by Subject|1|||
37950737|NCT00730925|69637910|FG000|Overall Study|Switch to combination therapy|8|||
37950738|NCT00730925|69637910|FG000|Overall Study|Other|1|||
37950739|NCT00236899|69637918|FG000|Overall Study|Adverse Event (Study Related)|1|||
37950740|NCT00236899|69637919|FG001|Overall Study|Adverse Event (Study Related)|1|||
37950741|NCT00236899|69637920|FG002|Overall Study|Adverse Event (Study Related)|2|||
37950742|NCT00236899|69637921|FG003|Overall Study|Adverse Event (Study Related)|1|||
37950743|NCT00236899|69637918|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
37950744|NCT00236899|69637919|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
37950745|NCT00236899|69637920|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
37950746|NCT00236899|69637921|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
37950747|NCT00236899|69637918|FG000|Overall Study|Death (Study Disease)|1|||
37950748|NCT00236899|69637919|FG001|Overall Study|Death (Study Disease)|4|||
37950749|NCT00236899|69637920|FG002|Overall Study|Death (Study Disease)|0|||
37950750|NCT00236899|69637921|FG003|Overall Study|Death (Study Disease)|0|||
37950751|NCT00236899|69637918|FG000|Overall Study|Death (Not Study Related)|2|||
37950752|NCT00236899|69637919|FG001|Overall Study|Death (Not Study Related)|0|||
37950753|NCT00236899|69637920|FG002|Overall Study|Death (Not Study Related)|0|||
37950754|NCT00236899|69637921|FG003|Overall Study|Death (Not Study Related)|0|||
37950755|NCT00236899|69637918|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
37950756|NCT00236899|69637919|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
37950757|NCT00236899|69637920|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
37950758|NCT00236899|69637921|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
37950759|NCT00236899|69637918|FG000|Overall Study|Lost to Follow-up|0|||
37950760|NCT00236899|69637919|FG001|Overall Study|Lost to Follow-up|1|||
37950761|NCT00236899|69637920|FG002|Overall Study|Lost to Follow-up|0|||
37950762|NCT00236899|69637921|FG003|Overall Study|Lost to Follow-up|0|||
37950763|NCT00236899|69637918|FG000|Overall Study|Entry Criteria Exclusion|0|||
37950764|NCT00236899|69637919|FG001|Overall Study|Entry Criteria Exclusion|1|||
37950765|NCT00236899|69637920|FG002|Overall Study|Entry Criteria Exclusion|1|||
37950766|NCT00236899|69637921|FG003|Overall Study|Entry Criteria Exclusion|0|||
37950767|NCT00236899|69637918|FG000|Overall Study|Protocol Violation|1|||
37950768|NCT00236899|69637919|FG001|Overall Study|Protocol Violation|0|||
37950769|NCT00236899|69637920|FG002|Overall Study|Protocol Violation|0|||
37950770|NCT00236899|69637921|FG003|Overall Study|Protocol Violation|0|||
37950771|NCT00236899|69637918|FG000|Overall Study|Withdrawal by Subject|6|||
37950772|NCT00236899|69637919|FG001|Overall Study|Withdrawal by Subject|4|||
37950773|NCT00236899|69637920|FG002|Overall Study|Withdrawal by Subject|5|||
37950774|NCT00236899|69637921|FG003|Overall Study|Withdrawal by Subject|2|||
37950775|NCT00236899|69637918|FG000|Overall Study|Physician Decision|7|||
37950776|NCT00236899|69637919|FG001|Overall Study|Physician Decision|8|||
37950777|NCT00236899|69637920|FG002|Overall Study|Physician Decision|7|||
37950778|NCT00236899|69637921|FG003|Overall Study|Physician Decision|6|||
37950779|NCT00236899|69637918|FG000|Overall Study|Satisfactory Response|2|||
37950780|NCT00236899|69637919|FG001|Overall Study|Satisfactory Response|0|||
37950781|NCT00236899|69637920|FG002|Overall Study|Satisfactory Response|0|||
37950782|NCT00236899|69637921|FG003|Overall Study|Satisfactory Response|1|||
37950783|NCT00236899|69637918|FG000|Overall Study|Lack of Efficacy|18|||
37950784|NCT00236899|69637919|FG001|Overall Study|Lack of Efficacy|18|||
37950785|NCT00236899|69637920|FG002|Overall Study|Lack of Efficacy|25|||
37950786|NCT00236899|69637921|FG003|Overall Study|Lack of Efficacy|23|||
37950787|NCT00611130|69637940|FG000|Overall Study|Lost to Follow-up|25|||
37950788|NCT00611130|69637941|FG001|Overall Study|Lost to Follow-up|29|||
37950789|NCT00611130|69637940|FG000|Overall Study|Protocol noncompliance|7|||
37950790|NCT00611130|69637941|FG001|Overall Study|Protocol noncompliance|6|||
37950791|NCT00611130|69637940|FG000|Overall Study|Withdrawal by Subject|6|||
37950792|NCT00611130|69637941|FG001|Overall Study|Withdrawal by Subject|5|||
37950793|NCT00611130|69637940|FG000|Overall Study|Other|5|||
37950794|NCT00611130|69637941|FG001|Overall Study|Other|4|||
37950795|NCT00611130|69637940|FG000|Overall Study|Incarceration|3|||
37950796|NCT00611130|69637941|FG001|Overall Study|Incarceration|2|||
37950797|NCT00611130|69637940|FG000|Overall Study|Administrative|1|||
37950798|NCT00611130|69637941|FG001|Overall Study|Administrative|1|||
37950799|NCT00611130|69637940|FG000|Overall Study|Adverse Event|1|||
37950800|NCT00611130|69637941|FG001|Overall Study|Adverse Event|0|||
37950801|NCT00611130|69637940|FG000|Overall Study|Death|1|||
37950802|NCT00611130|69637941|FG001|Overall Study|Death|0|||
37950803|NCT00256243|69637948|FG000|Overall Study|Lost to Follow-up|2|||
37950804|NCT00256243|69637948|FG000|Overall Study|Death|7|||
37950805|NCT00256243|69637948|FG000|Overall Study|Not treated|1|||
37950806|NCT00236197|69637955|FG000|Overall Study|Withdrawal by Subject|3|||
37950807|NCT00236197|69637956|FG001|Overall Study|Withdrawal by Subject|2|||
37950808|NCT00236197|69637955|FG000|Overall Study|Lost to Follow-up|1|||
37950809|NCT00236197|69637956|FG001|Overall Study|Lost to Follow-up|5|||
37950810|NCT00236197|69637955|FG000|Overall Study|Protocol Violation|0|||
37950811|NCT00236197|69637956|FG001|Overall Study|Protocol Violation|3|||
37950812|NCT00236197|69637955|FG000|Overall Study|Medication non-compliance|1|||
37950813|NCT00236197|69637956|FG001|Overall Study|Medication non-compliance|2|||
37950814|NCT00236197|69637955|FG000|Overall Study|Other|0|||
37950815|NCT00236197|69637956|FG001|Overall Study|Other|2|||
37950816|NCT00278629|69637962|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
37950817|NCT00612690|69637969|FG000|Overall Study|Lost to Follow-up|72|||
37950818|NCT00612690|69637970|FG001|Overall Study|Lost to Follow-up|98|||
37950819|NCT00612690|69637969|FG000|Overall Study|Withdrawal by Subject|32|||
37950820|NCT00612690|69637970|FG001|Overall Study|Withdrawal by Subject|20|||
37950821|NCT00612690|69637969|FG000|Overall Study|Withdrawal by Site|11|||
37950822|NCT00612690|69637970|FG001|Overall Study|Withdrawal by Site|0|||
37950823|NCT00278473|69637980|FG000|Overall Study|drop out|4|||
37950824|NCT00278473|69637981|FG001|Overall Study|drop out|3|||
37950825|NCT00278395|69637987|FG000|Overall Study|Adverse Event|2|||
37950826|NCT00278395|69637987|FG000|Overall Study|Nonevaluable|1|||
37950827|NCT00612534|69637998|FG000|Overall Study|Adverse Event|0|||
37950828|NCT00612534|69637999|FG001|Overall Study|Adverse Event|4|||
37950829|NCT00612534|69638000|FG002|Overall Study|Adverse Event|2|||
37950830|NCT00612534|69638001|FG003|Overall Study|Adverse Event|1|||
37950831|NCT00612534|69637998|FG000|Overall Study|Lack of Efficacy|13|||
37950832|NCT00612534|69637999|FG001|Overall Study|Lack of Efficacy|12|||
37950833|NCT00612534|69638000|FG002|Overall Study|Lack of Efficacy|5|||
37950834|NCT00612534|69638001|FG003|Overall Study|Lack of Efficacy|16|||
37950835|NCT00612534|69637998|FG000|Overall Study|Other Reason|0|||
37950836|NCT00612534|69637999|FG001|Overall Study|Other Reason|1|||
37950837|NCT00612534|69638000|FG002|Overall Study|Other Reason|0|||
37950838|NCT00612534|69638001|FG003|Overall Study|Other Reason|0|||
37950839|NCT00736853|69638011|FG000|Open-Label Period|Physician Decision|2|||
37950840|NCT00736853|69638012|FG001|Open-Label Period|Physician Decision|0|||
37950841|NCT00736853|69638013|FG002|Open-Label Period|Physician Decision|0|||
37950842|NCT00736853|69638011|FG000|Open-Label Period|Adverse Event|31|||
37950843|NCT00736853|69638012|FG001|Open-Label Period|Adverse Event|0|||
37950844|NCT00736853|69638013|FG002|Open-Label Period|Adverse Event|0|||
37950845|NCT00736853|69638011|FG000|Open-Label Period|Withdrawal by Subject|16|||
37950846|NCT00736853|69638012|FG001|Open-Label Period|Withdrawal by Subject|0|||
37950847|NCT00736853|69638013|FG002|Open-Label Period|Withdrawal by Subject|0|||
37950848|NCT00736853|69638011|FG000|Open-Label Period|Started but not treated|42|||
37950849|NCT00736853|69638012|FG001|Open-Label Period|Started but not treated|0|||
37950850|NCT00736853|69638013|FG002|Open-Label Period|Started but not treated|0|||
37950851|NCT00736853|69638011|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
37950852|NCT00736853|69638012|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
37950853|NCT00736853|69638013|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
37950854|NCT00736853|69638011|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
37950855|NCT00736853|69638012|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
37950856|NCT00736853|69638013|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
37950857|NCT00736853|69638011|FG000|Double-Blind Period|Lack of Efficacy|0|||
37950858|NCT00736853|69638012|FG001|Double-Blind Period|Lack of Efficacy|19|||
37950859|NCT00736853|69638013|FG002|Double-Blind Period|Lack of Efficacy|42|||
37950860|NCT00736853|69638011|FG000|Double-Blind Period|Adverse Event|0|||
37950861|NCT00736853|69638012|FG001|Double-Blind Period|Adverse Event|3|||
37950862|NCT00736853|69638013|FG002|Double-Blind Period|Adverse Event|2|||
37950863|NCT00736853|69638011|FG000|Double-Blind Period|Withdrawal by Subject|0|||
37950864|NCT00736853|69638012|FG001|Double-Blind Period|Withdrawal by Subject|1|||
37950865|NCT00736853|69638013|FG002|Double-Blind Period|Withdrawal by Subject|4|||
37950866|NCT00736853|69638011|FG000|Double-Blind Period|Ineligible to participate the study|0|||
37950867|NCT00736853|69638012|FG001|Double-Blind Period|Ineligible to participate the study|1|||
37950868|NCT00736853|69638013|FG002|Double-Blind Period|Ineligible to participate the study|0|||
37950869|NCT00730847|69638022|FG000|Overall Study|Adverse Event|1|||
37950870|NCT00730847|69638022|FG000|Overall Study|Protocol Violation|2|||
37950871|NCT00730847|69638022|FG000|Overall Study|Withdrawal by Subject|16|||
37950872|NCT00730847|69638022|FG000|Overall Study|Lost to Follow-up|67|||
37950873|NCT00730847|69638022|FG000|Overall Study|Unknown completion status|21|||
37950874|NCT00730847|69638022|FG000|Overall Study|Other|24|||
37950875|NCT00573066|69638026|FG000|Overall Study|Exclusion criteria|18|||
37950876|NCT00573066|69638026|FG000|Overall Study|IV malfunction|1|||
37950877|NCT00573066|69638026|FG000|Overall Study|Postoperative bleeding|1|||
37950878|NCT00612456|69638033|FG000|Overall Study|Adverse Event|1|||
37768986|NCT00086281|69285372|FG003|Phase 2|Adverse Event|0|||
37950879|NCT00612456|69638034|FG001|Overall Study|Adverse Event|0|||
37950880|NCT00612456|69638035|FG002|Overall Study|Adverse Event|0|||
37950881|NCT00612456|69638033|FG000|Overall Study|Lack of Efficacy|1|||
37950882|NCT00612456|69638034|FG001|Overall Study|Lack of Efficacy|1|||
37950883|NCT00612456|69638035|FG002|Overall Study|Lack of Efficacy|0|||
37950884|NCT00612456|69638033|FG000|Overall Study|Withdrawal by Subject|0|||
37950885|NCT00612456|69638034|FG001|Overall Study|Withdrawal by Subject|1|||
37950886|NCT00612456|69638035|FG002|Overall Study|Withdrawal by Subject|0|||
37950887|NCT00730691|69638050|FG000|Overall Study|Adverse Event|4|||
37950888|NCT00730691|69638051|FG001|Overall Study|Adverse Event|8|||
37950889|NCT00730691|69638052|FG002|Overall Study|Adverse Event|11|||
37950890|NCT00730691|69638053|FG003|Overall Study|Adverse Event|11|||
37950891|NCT00730691|69638054|FG004|Overall Study|Adverse Event|23|||
37950892|NCT00730691|69638050|FG000|Overall Study|Lack of Efficacy|4|||
37950893|NCT00730691|69638051|FG001|Overall Study|Lack of Efficacy|4|||
37950894|NCT00730691|69638052|FG002|Overall Study|Lack of Efficacy|2|||
37950895|NCT00730691|69638053|FG003|Overall Study|Lack of Efficacy|1|||
37950896|NCT00730691|69638054|FG004|Overall Study|Lack of Efficacy|1|||
37950897|NCT00730691|69638050|FG000|Overall Study|Non-compliance with Study Drug|6|||
37950898|NCT00730691|69638051|FG001|Overall Study|Non-compliance with Study Drug|1|||
37950899|NCT00730691|69638052|FG002|Overall Study|Non-compliance with Study Drug|6|||
37950900|NCT00730691|69638053|FG003|Overall Study|Non-compliance with Study Drug|3|||
37950901|NCT00730691|69638054|FG004|Overall Study|Non-compliance with Study Drug|3|||
37950902|NCT00730691|69638050|FG000|Overall Study|Protocol Deviations|3|||
37950903|NCT00730691|69638051|FG001|Overall Study|Protocol Deviations|5|||
37950904|NCT00730691|69638052|FG002|Overall Study|Protocol Deviations|3|||
37950905|NCT00730691|69638053|FG003|Overall Study|Protocol Deviations|7|||
37950906|NCT00730691|69638054|FG004|Overall Study|Protocol Deviations|5|||
37950907|NCT00730691|69638050|FG000|Overall Study|Withdrawal of Consent|7|||
37950908|NCT00730691|69638051|FG001|Overall Study|Withdrawal of Consent|9|||
37950909|NCT00730691|69638052|FG002|Overall Study|Withdrawal of Consent|3|||
37950910|NCT00730691|69638053|FG003|Overall Study|Withdrawal of Consent|6|||
37950911|NCT00730691|69638054|FG004|Overall Study|Withdrawal of Consent|3|||
37950912|NCT00730691|69638050|FG000|Overall Study|Lost to Follow-up|11|||
37950913|NCT00730691|69638051|FG001|Overall Study|Lost to Follow-up|8|||
37950914|NCT00730691|69638052|FG002|Overall Study|Lost to Follow-up|13|||
37950915|NCT00730691|69638053|FG003|Overall Study|Lost to Follow-up|15|||
37950916|NCT00730691|69638054|FG004|Overall Study|Lost to Follow-up|13|||
37950917|NCT00730691|69638050|FG000|Overall Study|Other|1|||
37950918|NCT00730691|69638051|FG001|Overall Study|Other|1|||
37950919|NCT00730691|69638052|FG002|Overall Study|Other|1|||
37950920|NCT00730691|69638053|FG003|Overall Study|Other|2|||
37950921|NCT00730691|69638054|FG004|Overall Study|Other|2|||
37950922|NCT00235495|69638068|FG000|Overall Study|Death|52|||
37950923|NCT00235495|69638069|FG001|Overall Study|Death|42|||
37950924|NCT00235495|69638068|FG000|Overall Study|Withdrawal by Subject|5|||
37950925|NCT00235495|69638069|FG001|Overall Study|Withdrawal by Subject|3|||
37950926|NCT00235495|69638068|FG000|Overall Study|Lost to Follow-up|11|||
37950927|NCT00235495|69638069|FG001|Overall Study|Lost to Follow-up|13|||
37950928|NCT00235495|69638068|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
37950929|NCT00235495|69638069|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
37950930|NCT00278161|69638075|FG000|Overall Study|Death|11|||
37950931|NCT00255151|69638082|FG000|Overall Study|Adverse Event|10|||
37950932|NCT00255151|69638083|FG001|Overall Study|Adverse Event|6|||
37950933|NCT00255151|69638084|FG002|Overall Study|Adverse Event|9|||
37950934|NCT00255151|69638082|FG000|Overall Study|Lost to Follow-up|4|||
37950935|NCT00255151|69638083|FG001|Overall Study|Lost to Follow-up|3|||
37950936|NCT00255151|69638084|FG002|Overall Study|Lost to Follow-up|4|||
37950937|NCT00255151|69638082|FG000|Overall Study|Withdrawal by Subject|18|||
37950938|NCT00255151|69638083|FG001|Overall Study|Withdrawal by Subject|17|||
37950939|NCT00255151|69638084|FG002|Overall Study|Withdrawal by Subject|8|||
37950940|NCT00255151|69638082|FG000|Overall Study|Noncompliance|0|||
37950941|NCT00255151|69638083|FG001|Overall Study|Noncompliance|1|||
37950942|NCT00255151|69638084|FG002|Overall Study|Noncompliance|2|||
37950943|NCT00255151|69638082|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
37950944|NCT00255151|69638083|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
37950945|NCT00255151|69638084|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
37950946|NCT00255151|69638082|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
37950947|NCT00255151|69638083|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
37950948|NCT00255151|69638084|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
37950949|NCT00255151|69638082|FG000|Overall Study|Possible Barrett's Esophagus|1|||
37950950|NCT00255151|69638083|FG001|Overall Study|Possible Barrett's Esophagus|3|||
37950951|NCT00255151|69638084|FG002|Overall Study|Possible Barrett's Esophagus|8|||
37950952|NCT00255151|69638082|FG000|Overall Study|Esophageal Stricture|0|||
37950953|NCT00255151|69638083|FG001|Overall Study|Esophageal Stricture|0|||
37950954|NCT00255151|69638084|FG002|Overall Study|Esophageal Stricture|1|||
37950955|NCT00255151|69638082|FG000|Overall Study|Therapeutic Failure|11|||
37950956|NCT00255151|69638083|FG001|Overall Study|Therapeutic Failure|2|||
37950957|NCT00255151|69638084|FG002|Overall Study|Therapeutic Failure|3|||
37950958|NCT00658658|69638097|FG000|Overall Study|Withdrawal by Subject|0|||
37950959|NCT00658658|69638098|FG001|Overall Study|Withdrawal by Subject|1|||
37950960|NCT00658658|69638099|FG002|Overall Study|Withdrawal by Subject|0|||
37950961|NCT00658658|69638100|FG003|Overall Study|Withdrawal by Subject|0|||
37950962|NCT00658658|69638101|FG004|Overall Study|Withdrawal by Subject|0|||
37950963|NCT00658658|69638097|FG000|Overall Study|Death|4|||
37950964|NCT00658658|69638098|FG001|Overall Study|Death|0|||
37950965|NCT00658658|69638099|FG002|Overall Study|Death|0|||
37950966|NCT00658658|69638100|FG003|Overall Study|Death|1|||
37950967|NCT00658658|69638101|FG004|Overall Study|Death|1|||
37950968|NCT00658658|69638097|FG000|Overall Study|Disease Progression|0|||
37950969|NCT00658658|69638098|FG001|Overall Study|Disease Progression|1|||
37950970|NCT00658658|69638099|FG002|Overall Study|Disease Progression|0|||
37950971|NCT00658658|69638100|FG003|Overall Study|Disease Progression|1|||
37950972|NCT00658658|69638101|FG004|Overall Study|Disease Progression|3|||
37950973|NCT00658658|69638097|FG000|Overall Study|Protocol-specified Criteria|1|||
37950974|NCT00658658|69638098|FG001|Overall Study|Protocol-specified Criteria|0|||
37950975|NCT00658658|69638099|FG002|Overall Study|Protocol-specified Criteria|0|||
37950976|NCT00658658|69638100|FG003|Overall Study|Protocol-specified Criteria|0|||
37950977|NCT00658658|69638101|FG004|Overall Study|Protocol-specified Criteria|0|||
37950978|NCT00658658|69638097|FG000|Overall Study|Other|0|||
37950979|NCT00658658|69638098|FG001|Overall Study|Other|0|||
37950980|NCT00658658|69638099|FG002|Overall Study|Other|0|||
37950981|NCT00658658|69638100|FG003|Overall Study|Other|0|||
37950982|NCT00658658|69638101|FG004|Overall Study|Other|1|||
37950983|NCT00723203|69638113|FG000|Overall Study|Withdrawal by Subject|3|||
37950984|NCT00233389|69638119|FG000|Overall Study|Adverse Event|5|||
37950985|NCT00233389|69638120|FG001|Overall Study|Adverse Event|5|||
37950986|NCT00233389|69638119|FG000|Overall Study|Lack of Efficacy|11|||
37950987|NCT00233389|69638120|FG001|Overall Study|Lack of Efficacy|8|||
37950988|NCT00233389|69638119|FG000|Overall Study|Lost to Follow-up|1|||
37950989|NCT00233389|69638120|FG001|Overall Study|Lost to Follow-up|1|||
37950990|NCT00233389|69638119|FG000|Overall Study|Physician Decision|1|||
37950991|NCT00233389|69638120|FG001|Overall Study|Physician Decision|0|||
37950992|NCT00233389|69638119|FG000|Overall Study|Protocol Violation|0|||
37950993|NCT00233389|69638120|FG001|Overall Study|Protocol Violation|1|||
37950994|NCT00233389|69638119|FG000|Overall Study|Withdrawal by Subject|0|||
37950995|NCT00233389|69638120|FG001|Overall Study|Withdrawal by Subject|1|||
37950996|NCT00649220|69638126|FG000|Overall Study|Adverse Event|2|||
37950997|NCT00649220|69638126|FG000|Overall Study|Withdrawal by Subject|1|||
37950998|NCT00654368|69638133|FG000|Overall Study|Ineligibility determined|6|||
37950999|NCT00654368|69638134|FG001|Overall Study|Ineligibility determined|0|||
37951000|NCT00654368|69638135|FG002|Overall Study|Ineligibility determined|0|||
37951001|NCT00654368|69638133|FG000|Overall Study|Protocol deviation|3|||
37951002|NCT00654368|69638134|FG001|Overall Study|Protocol deviation|2|||
37951003|NCT00654368|69638135|FG002|Overall Study|Protocol deviation|1|||
37951004|NCT00654368|69638133|FG000|Overall Study|Non-compliance|2|||
37951005|NCT00654368|69638134|FG001|Overall Study|Non-compliance|1|||
37951006|NCT00654368|69638135|FG002|Overall Study|Non-compliance|2|||
37951007|NCT00654368|69638133|FG000|Overall Study|Withdrawal by Subject|5|||
37951008|NCT00654368|69638134|FG001|Overall Study|Withdrawal by Subject|2|||
37951009|NCT00654368|69638135|FG002|Overall Study|Withdrawal by Subject|2|||
37951010|NCT00654368|69638133|FG000|Overall Study|Disease progression|21|||
37951011|NCT00654368|69638134|FG001|Overall Study|Disease progression|31|||
37951012|NCT00654368|69638135|FG002|Overall Study|Disease progression|13|||
37951013|NCT00654368|69638133|FG000|Overall Study|Requirement for alternative therapy|1|||
37951014|NCT00654368|69638134|FG001|Overall Study|Requirement for alternative therapy|1|||
37951015|NCT00654368|69638135|FG002|Overall Study|Requirement for alternative therapy|1|||
37951016|NCT00654368|69638133|FG000|Overall Study|Physician Decision|0|||
37951017|NCT00654368|69638134|FG001|Overall Study|Physician Decision|0|||
37951018|NCT00654368|69638135|FG002|Overall Study|Physician Decision|2|||
37951019|NCT00654368|69638133|FG000|Overall Study|Death|1|||
37951020|NCT00654368|69638134|FG001|Overall Study|Death|0|||
37951021|NCT00654368|69638135|FG002|Overall Study|Death|0|||
37951022|NCT00654368|69638133|FG000|Overall Study|Pregnancy|0|||
37951023|NCT00654368|69638134|FG001|Overall Study|Pregnancy|0|||
37951024|NCT00654368|69638135|FG002|Overall Study|Pregnancy|2|||
37951025|NCT00654368|69638133|FG000|Overall Study|Other|0|||
37951026|NCT00654368|69638134|FG001|Overall Study|Other|2|||
37951027|NCT00654368|69638135|FG002|Overall Study|Other|3|||
37951028|NCT00654368|69638133|FG000|Overall Study|Adverse Event|14|||
37951029|NCT00654368|69638134|FG001|Overall Study|Adverse Event|9|||
37951030|NCT00654368|69638135|FG002|Overall Study|Adverse Event|6|||
37951031|NCT00647426|69638142|FG000|Overall Study|Withdrawal by Subject|2|||
37951032|NCT00647348|69638149|FG000|Overall Study|Lost to Follow-up|3|||
37951033|NCT00647348|69638150|FG001|Overall Study|Lost to Follow-up|6|||
37951034|NCT00647270|69638159|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
37951035|NCT00647270|69638160|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
37951036|NCT00647270|69638161|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
37951037|NCT00647270|69638159|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
37951038|NCT00647270|69638160|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
37951039|NCT00647270|69638161|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
37951040|NCT00647270|69638159|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
37951041|NCT00647270|69638160|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
37951042|NCT00647270|69638161|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
37951043|NCT00647270|69638159|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
37951044|NCT00647270|69638160|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
37951045|NCT00647270|69638161|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
37951046|NCT00647270|69638159|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
37951047|NCT00647270|69638160|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
37951048|NCT00647270|69638161|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
37951049|NCT00647270|69638159|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
37951050|NCT00647270|69638160|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
37951051|NCT00647270|69638161|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
37951052|NCT00647270|69638159|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
37951053|NCT00647270|69638160|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
37951054|NCT00647270|69638161|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
37951055|NCT00645944|69638174|FG000|Randomized|Withdrawal by Subject|1|||
37951056|NCT00645944|69638175|FG001|Randomized|Withdrawal by Subject|2|||
37951057|NCT00645944|69638174|FG000|Received Medication|Adverse Event|2|||
37951058|NCT00645944|69638175|FG001|Received Medication|Adverse Event|1|||
37951059|NCT00645944|69638174|FG000|Received Medication|Withdrawal by Subject|1|||
37951060|NCT00645944|69638175|FG001|Received Medication|Withdrawal by Subject|1|||
37951061|NCT00645944|69638174|FG000|Received Medication|Lost to Follow-up|1|||
37951062|NCT00645944|69638175|FG001|Received Medication|Lost to Follow-up|0|||
37768987|NCT00086281|69285373|FG004|Phase 2|Adverse Event|0|||
37768988|NCT00086281|69285374|FG005|Phase 2|Adverse Event|0|||
37768989|NCT00086281|69285375|FG006|Phase 2|Adverse Event|0|||
37768990|NCT00086281|69285376|FG007|Phase 2|Adverse Event|0|||
37768991|NCT00086281|69285377|FG008|Phase 2|Adverse Event|0|||
37768992|NCT00086281|69285378|FG009|Phase 2|Adverse Event|0|||
37768993|NCT00086281|69285379|FG010|Phase 2|Adverse Event|0|||
37768994|NCT00086281|69285380|FG011|Phase 2|Adverse Event|0|||
37768995|NCT00086281|69285381|FG012|Phase 2|Adverse Event|1|||
37768996|NCT00086281|69285382|FG013|Phase 2|Adverse Event|1|||
37768997|NCT00086281|69285383|FG014|Phase 2|Adverse Event|0|||
37768998|NCT00086047|69285395|FG000|Overall Study|Lost to Follow-up|7|||
37768999|NCT00086047|69285396|FG001|Overall Study|Lost to Follow-up|6|||
37769000|NCT00086047|69285395|FG000|Overall Study|Physician Decision|0|||
37769001|NCT00086047|69285396|FG001|Overall Study|Physician Decision|1|||
37769002|NCT01478828|69285408|FG000|Overall Study|Adverse Event|1|||
37769003|NCT00085423|69285413|FG000|Overall Study|Withdrawal by Subject|1|||
37769004|NCT00085423|69285413|FG000|Overall Study|screen failure|1|||
37769005|NCT00084487|69285417|FG000|Overall Study|Death|1|||
37769006|NCT01425281|69285457|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
37769007|NCT01425281|69285458|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
37769008|NCT01425281|69285457|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
37769009|NCT01425281|69285458|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
37769010|NCT01425281|69285457|FG000|At 180-day Clinical Follow-up|Death|0|||
37769011|NCT01425281|69285458|FG001|At 180-day Clinical Follow-up|Death|1|||
37769012|NCT01425281|69285457|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
37769013|NCT01425281|69285458|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
37769014|NCT01425281|69285457|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
37769015|NCT01425281|69285458|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
37769016|NCT01425281|69285457|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
37769017|NCT01425281|69285458|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
37769018|NCT01425281|69285457|FG000|At 2-year Clinical Follow-up|Death|2|||
37769019|NCT01425281|69285458|FG001|At 2-year Clinical Follow-up|Death|0|||
37769020|NCT01425281|69285457|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
37769021|NCT01425281|69285458|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
37769022|NCT01425281|69285457|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
37769023|NCT01425281|69285458|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
37860492|NCT01227252|69543904|FG001|Overall Study|Sponsor Decision|1|||
37860493|NCT01227252|69543905|FG002|Overall Study|Sponsor Decision|0|||
37860494|NCT01227252|69543906|FG003|Overall Study|Sponsor Decision|0|||
37860495|NCT01227252|69543903|FG000|Overall Study|Lost to Follow-up|0|||
37860496|NCT01227252|69543904|FG001|Overall Study|Lost to Follow-up|1|||
37860497|NCT01227252|69543905|FG002|Overall Study|Lost to Follow-up|0|||
37860498|NCT01227252|69543906|FG003|Overall Study|Lost to Follow-up|0|||
37860499|NCT01227252|69543903|FG000|Overall Study|Withdrawal by Subject|0|||
37860500|NCT01227252|69543904|FG001|Overall Study|Withdrawal by Subject|1|||
37860501|NCT01227252|69543905|FG002|Overall Study|Withdrawal by Subject|0|||
37860502|NCT01227252|69543906|FG003|Overall Study|Withdrawal by Subject|0|||
37860503|NCT01227018|69543919|FG000|Overall Study|Disease progression|9|||
37860504|NCT01227018|69543919|FG000|Overall Study|Toxicity|2|||
37769024|NCT01425281|69285457|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
37769025|NCT01425281|69285458|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
37769026|NCT01425281|69285457|FG000|At 3-year Clinical Follow-up|Death|2|||
37769027|NCT01425281|69285458|FG001|At 3-year Clinical Follow-up|Death|3|||
37769028|NCT01425281|69285457|FG000|At 4-year Clinical Follow-up|Death|7|||
37769029|NCT01425281|69285458|FG001|At 4-year Clinical Follow-up|Death|3|||
37769030|NCT01425281|69285457|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
37769031|NCT01425281|69285458|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
37769032|NCT01425281|69285457|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
37769033|NCT01425281|69285458|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
37769034|NCT01425281|69285457|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
37769035|NCT01425281|69285458|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
37769036|NCT01425281|69285457|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
37769037|NCT01425281|69285458|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
37769038|NCT01425281|69285457|FG000|At 5-year Clinical Follow-up|Death|2|||
37769039|NCT01425281|69285458|FG001|At 5-year Clinical Follow-up|Death|0|||
37769040|NCT01425281|69285457|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
37769041|NCT01425281|69285458|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
37769042|NCT01425281|69285457|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
37769043|NCT01425281|69285458|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
37769044|NCT01425281|69285457|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
37769045|NCT01425281|69285458|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
37769046|NCT02648724|69285486|FG000|Overall Study|Withdrawal by Subject|0|||
37769047|NCT02648724|69285487|FG001|Overall Study|Withdrawal by Subject|1|||
37769048|NCT02648724|69285488|FG002|Overall Study|Withdrawal by Subject|1|||
37769049|NCT02648724|69285489|FG003|Overall Study|Withdrawal by Subject|0|||
37769050|NCT02648724|69285490|FG004|Overall Study|Withdrawal by Subject|1|||
37769051|NCT02648724|69285491|FG005|Overall Study|Withdrawal by Subject|0|||
37769052|NCT02648724|69285492|FG006|Overall Study|Withdrawal by Subject|0|||
37769053|NCT02648724|69285486|FG000|Overall Study|Progressive disease|2|||
37769054|NCT02648724|69285487|FG001|Overall Study|Progressive disease|2|||
37769055|NCT02648724|69285488|FG002|Overall Study|Progressive disease|2|||
37769056|NCT02648724|69285489|FG003|Overall Study|Progressive disease|3|||
37769057|NCT02648724|69285490|FG004|Overall Study|Progressive disease|22|||
37769058|NCT02648724|69285491|FG005|Overall Study|Progressive disease|7|||
37769059|NCT02648724|69285492|FG006|Overall Study|Progressive disease|8|||
37769060|NCT02648724|69285486|FG000|Overall Study|Other reason (unknown)|1|||
37769061|NCT02648724|69285487|FG001|Overall Study|Other reason (unknown)|0|||
37769062|NCT02648724|69285488|FG002|Overall Study|Other reason (unknown)|0|||
37769063|NCT02648724|69285489|FG003|Overall Study|Other reason (unknown)|0|||
37769064|NCT02648724|69285490|FG004|Overall Study|Other reason (unknown)|0|||
37769065|NCT02648724|69285491|FG005|Overall Study|Other reason (unknown)|0|||
37769066|NCT02648724|69285492|FG006|Overall Study|Other reason (unknown)|0|||
37769067|NCT02648724|69285486|FG000|Overall Study|Protocol Violation|0|||
37769068|NCT02648724|69285487|FG001|Overall Study|Protocol Violation|0|||
37769069|NCT02648724|69285488|FG002|Overall Study|Protocol Violation|0|||
37769070|NCT02648724|69285489|FG003|Overall Study|Protocol Violation|0|||
37769071|NCT02648724|69285490|FG004|Overall Study|Protocol Violation|1|||
37769072|NCT02648724|69285491|FG005|Overall Study|Protocol Violation|0|||
37769073|NCT02648724|69285492|FG006|Overall Study|Protocol Violation|0|||
37769074|NCT02648724|69285486|FG000|Overall Study|Death|0|||
37769075|NCT02648724|69285487|FG001|Overall Study|Death|0|||
37769076|NCT02648724|69285488|FG002|Overall Study|Death|0|||
37769077|NCT02648724|69285489|FG003|Overall Study|Death|0|||
37769078|NCT02648724|69285490|FG004|Overall Study|Death|0|||
37769079|NCT02648724|69285491|FG005|Overall Study|Death|0|||
37769080|NCT02648724|69285492|FG006|Overall Study|Death|3|||
37769081|NCT02648724|69285486|FG000|Overall Study|Physician Decision|0|||
37769082|NCT02648724|69285487|FG001|Overall Study|Physician Decision|0|||
37769083|NCT02648724|69285488|FG002|Overall Study|Physician Decision|0|||
37769084|NCT02648724|69285489|FG003|Overall Study|Physician Decision|0|||
37769085|NCT02648724|69285490|FG004|Overall Study|Physician Decision|1|||
37769086|NCT02648724|69285491|FG005|Overall Study|Physician Decision|0|||
37769087|NCT02648724|69285492|FG006|Overall Study|Physician Decision|1|||
37769088|NCT02648724|69285486|FG000|Overall Study|Transferred to named patient program|0|||
37769089|NCT02648724|69285487|FG001|Overall Study|Transferred to named patient program|0|||
37769090|NCT02648724|69285488|FG002|Overall Study|Transferred to named patient program|0|||
37769091|NCT02648724|69285489|FG003|Overall Study|Transferred to named patient program|0|||
37769092|NCT02648724|69285490|FG004|Overall Study|Transferred to named patient program|0|||
37769093|NCT02648724|69285491|FG005|Overall Study|Transferred to named patient program|1|||
37769094|NCT02648724|69285492|FG006|Overall Study|Transferred to named patient program|0|||
37769095|NCT01402817|69285524|FG000|Overall Study|Withdrawal by Subject|3|||
37769096|NCT01402817|69285524|FG000|Overall Study|Study Suspended by FDA|8|||
37769097|NCT01425203|69285531|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
37769098|NCT01425203|69285532|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
37769099|NCT01425203|69285533|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
37769100|NCT01425203|69285531|FG000|Treatment Phase|Failure at futility timepoint|8|||
37769101|NCT01425203|69285532|FG001|Treatment Phase|Failure at futility timepoint|27|||
37769102|NCT01425203|69285533|FG002|Treatment Phase|Failure at futility timepoint|0|||
37769103|NCT01425203|69285531|FG000|Treatment Phase|Other virologic failure criteria|5|||
37769104|NCT01425203|69285532|FG001|Treatment Phase|Other virologic failure criteria|3|||
37769105|NCT01425203|69285533|FG002|Treatment Phase|Other virologic failure criteria|0|||
37769106|NCT01425203|69285531|FG000|Treatment Phase|Unidentified reasons|11|||
37769107|NCT01425203|69285532|FG001|Treatment Phase|Unidentified reasons|5|||
37769108|NCT01425203|69285533|FG002|Treatment Phase|Unidentified reasons|0|||
37769109|NCT01425203|69285531|FG000|Treatment Phase|Did not receive treatment|0|||
37769110|NCT01425203|69285532|FG001|Treatment Phase|Did not receive treatment|1|||
37769111|NCT01425203|69285533|FG002|Treatment Phase|Did not receive treatment|0|||
37769112|NCT01425203|69285531|FG000|Crossover Phase|Failure at futility timepoint|0|||
37769113|NCT01425203|69285532|FG001|Crossover Phase|Failure at futility timepoint|0|||
37769114|NCT01425203|69285533|FG002|Crossover Phase|Failure at futility timepoint|3|||
37769115|NCT01425203|69285531|FG000|Crossover Phase|Other virologic failure criteria|0|||
37769116|NCT01425203|69285532|FG001|Crossover Phase|Other virologic failure criteria|0|||
37769117|NCT01425203|69285533|FG002|Crossover Phase|Other virologic failure criteria|3|||
37769118|NCT00081289|69285543|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
37769119|NCT00081289|69285544|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
37769120|NCT00081289|69285543|FG000|Overall Study|Ineligible / no protocol treatment|3|||
37769121|NCT00081289|69285544|FG001|Overall Study|Ineligible / no protocol treatment|4|||
37769122|NCT01478594|69285553|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
37769123|NCT01478594|69285554|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
37769124|NCT01478594|69285553|FG000|Overall Study|Death|45|||
37769125|NCT01478594|69285554|FG001|Overall Study|Death|18|||
37769126|NCT01478594|69285553|FG000|Overall Study|Lost to Follow-up|3|||
37769127|NCT01478594|69285554|FG001|Overall Study|Lost to Follow-up|1|||
37769128|NCT01478594|69285553|FG000|Overall Study|Withdrawal by Subject|9|||
37769129|NCT01478594|69285554|FG001|Overall Study|Withdrawal by Subject|3|||
37769130|NCT01478594|69285553|FG000|Overall Study|Study Closed by Sponsor|8|||
37769131|NCT01478594|69285554|FG001|Overall Study|Study Closed by Sponsor|5|||
37769132|NCT01424813|69285615|FG000|Overall Study|Withdrawal by Subject|3|||
37769133|NCT01424813|69285616|FG001|Overall Study|Withdrawal by Subject|0|||
37769134|NCT01424813|69285615|FG000|Overall Study|Protocol Violation|1|||
37769135|NCT01424813|69285616|FG001|Overall Study|Protocol Violation|0|||
37769136|NCT01424813|69285615|FG000|Overall Study|Other|1|||
37769137|NCT01424813|69285616|FG001|Overall Study|Other|2|||
37769138|NCT00080899|69285622|FG000|Overall Study|Adverse Event|1|||
37769139|NCT00089635|69285626|FG000|Overall Study|Adverse Event|2|||
37769140|NCT00089635|69285626|FG000|Overall Study|Death|17|||
37769141|NCT00089635|69285626|FG000|Overall Study|Disease Progression|12|||
37769142|NCT00089635|69285626|FG000|Overall Study|Lost to Follow-up|3|||
37769143|NCT00089635|69285626|FG000|Overall Study|Withdrawal by Subject|6|||
37769144|NCT00089635|69285626|FG000|Overall Study|Ineligibility determined|1|||
37769145|NCT00089635|69285626|FG000|Overall Study|Other|2|||
37769146|NCT01500200|69285640|FG000|Stage 1|Adverse Event|1|||
37769147|NCT01500200|69285641|FG001|Stage 1|Adverse Event|4|||
37769148|NCT01500200|69285642|FG002|Stage 1|Adverse Event|5|||
37769149|NCT01500200|69285643|FG003|Stage 1|Adverse Event|0|||
37769150|NCT01500200|69285644|FG004|Stage 1|Adverse Event|0|||
37769151|NCT01500200|69285645|FG005|Stage 1|Adverse Event|0|||
37769152|NCT01500200|69285640|FG000|Stage 1|Lost to Follow-up|2|||
37769153|NCT01500200|69285641|FG001|Stage 1|Lost to Follow-up|2|||
37769154|NCT01500200|69285642|FG002|Stage 1|Lost to Follow-up|1|||
37769155|NCT01500200|69285643|FG003|Stage 1|Lost to Follow-up|0|||
37769156|NCT01500200|69285644|FG004|Stage 1|Lost to Follow-up|0|||
37769157|NCT01500200|69285645|FG005|Stage 1|Lost to Follow-up|0|||
37769158|NCT01500200|69285640|FG000|Stage 1|Withdrawal by Subject|3|||
37769159|NCT01500200|69285641|FG001|Stage 1|Withdrawal by Subject|0|||
37769160|NCT01500200|69285642|FG002|Stage 1|Withdrawal by Subject|0|||
37769161|NCT01500200|69285643|FG003|Stage 1|Withdrawal by Subject|0|||
37769162|NCT01500200|69285644|FG004|Stage 1|Withdrawal by Subject|0|||
37769163|NCT01500200|69285645|FG005|Stage 1|Withdrawal by Subject|0|||
37769164|NCT01500200|69285640|FG000|Stage 1|Noncompliance with Study Drug|1|||
37769165|NCT01500200|69285641|FG001|Stage 1|Noncompliance with Study Drug|0|||
37769166|NCT01500200|69285642|FG002|Stage 1|Noncompliance with Study Drug|0|||
37769167|NCT01500200|69285643|FG003|Stage 1|Noncompliance with Study Drug|0|||
37769168|NCT01500200|69285644|FG004|Stage 1|Noncompliance with Study Drug|0|||
37769169|NCT01500200|69285645|FG005|Stage 1|Noncompliance with Study Drug|0|||
37769170|NCT01500200|69285640|FG000|Stage 1|Physician Decision|1|||
37769171|NCT01500200|69285641|FG001|Stage 1|Physician Decision|0|||
37769172|NCT01500200|69285642|FG002|Stage 1|Physician Decision|0|||
37769173|NCT01500200|69285643|FG003|Stage 1|Physician Decision|0|||
37769174|NCT01500200|69285644|FG004|Stage 1|Physician Decision|0|||
37769175|NCT01500200|69285645|FG005|Stage 1|Physician Decision|0|||
37769176|NCT01500200|69285640|FG000|Stage 2|Adverse Event|0|||
37769177|NCT01500200|69285641|FG001|Stage 2|Adverse Event|0|||
37769178|NCT01500200|69285642|FG002|Stage 2|Adverse Event|0|||
37769179|NCT01500200|69285643|FG003|Stage 2|Adverse Event|0|||
37769180|NCT01500200|69285644|FG004|Stage 2|Adverse Event|5|||
37769181|NCT01500200|69285645|FG005|Stage 2|Adverse Event|4|||
37769182|NCT01478360|69285661|FG000|Overall Study|Lost to Follow-up|1|||
37769183|NCT01478360|69285662|FG001|Overall Study|Lost to Follow-up|0|||
37769184|NCT01478360|69285661|FG000|Overall Study|Adverse Event|0|||
37769185|NCT01478360|69285662|FG001|Overall Study|Adverse Event|1|||
37769186|NCT01478360|69285661|FG000|Overall Study|Administrative problems|1|||
37769187|NCT01478360|69285662|FG001|Overall Study|Administrative problems|2|||
37860505|NCT01227018|69543919|FG000|Overall Study|Withdrew after beginning treatment|4|||
37860506|NCT01226472|69543933|FG000|Overall Study|Progressive Disease|1|||
37860507|NCT01225146|69543939|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
37860508|NCT01225146|69543940|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
37860509|NCT01223196|69543950|FG000|Overall Study|Lost to Follow-up|2|||
37860510|NCT01223196|69543951|FG001|Overall Study|Lost to Follow-up|0|||
37860511|NCT01223196|69543950|FG000|Overall Study|Physician Decision|1|||
37860512|NCT01223196|69543951|FG001|Overall Study|Physician Decision|0|||
37860513|NCT01223196|69543950|FG000|Overall Study|Withdrawal by Subject|1|||
37860514|NCT01223196|69543951|FG001|Overall Study|Withdrawal by Subject|0|||
37860515|NCT01222416|69543961|FG000|Overall Study|ineligible;metastasis|3|||
37860516|NCT01222416|69543962|FG001|Overall Study|ineligible;metastasis|0|||
37860517|NCT01222416|69543961|FG000|Overall Study|Adverse Event|4|||
37860518|NCT01222416|69543962|FG001|Overall Study|Adverse Event|0|||
37860519|NCT01222416|69543961|FG000|Overall Study|Withdrawal by Subject|5|||
37860520|NCT01222416|69543962|FG001|Overall Study|Withdrawal by Subject|0|||
37860521|NCT01222416|69543961|FG000|Overall Study|scheduling|6|||
37860522|NCT01222416|69543962|FG001|Overall Study|scheduling|0|||
37860523|NCT01222416|69543961|FG000|Overall Study|missed view/scan|1|||
37860524|NCT01222416|69543962|FG001|Overall Study|missed view/scan|0|||
37860525|NCT01222416|69543961|FG000|Overall Study|Death|1|||
37860526|NCT01222416|69543962|FG001|Overall Study|Death|0|||
37860527|NCT01222104|69543968|FG000|Overall Study|Lost to Follow-up|37|||
37860528|NCT01222104|69543968|FG000|Overall Study|Death|10|||
37860529|NCT01221948|69543978|FG000|Overall Study|Physician Decision|5|||
37860530|NCT01221948|69543978|FG000|Overall Study|Withdrawal by Subject|2|||
37860531|NCT01221948|69543978|FG000|Overall Study|not disclosed|2|||
37860532|NCT01221948|69543978|FG000|Overall Study|Death|1|||
37860533|NCT01221948|69543978|FG000|Overall Study|Protocol Violation|4|||
37860534|NCT01221090|69543986|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
37860535|NCT01221090|69543987|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
37860536|NCT01221090|69543988|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
37860537|NCT01221090|69543989|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
37860538|NCT01221090|69543986|FG000|Overall Study|Withdrawal by Subject|0|||
37860539|NCT01221090|69543987|FG001|Overall Study|Withdrawal by Subject|22|||
37860540|NCT01221090|69543988|FG002|Overall Study|Withdrawal by Subject|27|||
37860541|NCT01221090|69543989|FG003|Overall Study|Withdrawal by Subject|2|||
37860542|NCT00950911|69544001|FG000|Overall Study|Adverse Event|0|||
37860543|NCT00950911|69544002|FG001|Overall Study|Adverse Event|2|||
37860544|NCT00950911|69544001|FG000|Overall Study|Death|4|||
37860545|NCT00950911|69544002|FG001|Overall Study|Death|6|||
37860546|NCT00950911|69544001|FG000|Overall Study|Disease progression|2|||
37860547|NCT00950911|69544002|FG001|Overall Study|Disease progression|2|||
37860548|NCT00950911|69544001|FG000|Overall Study|Consent withdrawn|1|||
37860549|NCT00950911|69544002|FG001|Overall Study|Consent withdrawn|3|||
37860550|NCT00950911|69544001|FG000|Overall Study|Administrative decision|3|||
37860551|NCT00950911|69544002|FG001|Overall Study|Administrative decision|1|||
37860552|NCT00950911|69544001|FG000|Overall Study|Ineligibility determined|1|||
37860553|NCT00950911|69544002|FG001|Overall Study|Ineligibility determined|0|||
37860554|NCT00950911|69544001|FG000|Overall Study|Noncompliance|1|||
37860555|NCT00950911|69544002|FG001|Overall Study|Noncompliance|0|||
37860556|NCT00950911|69544001|FG000|Overall Study|Poor performance status|0|||
37860557|NCT00950911|69544002|FG001|Overall Study|Poor performance status|1|||
37860558|NCT01220856|69544010|FG000|Overall Study|graft loss|3|||
37860559|NCT01220856|69544011|FG001|Overall Study|graft loss|3|||
37860560|NCT01220856|69544010|FG000|Overall Study|Lost to Follow-up|1|||
37860561|NCT01220856|69544011|FG001|Overall Study|Lost to Follow-up|0|||
37860562|NCT01218594|69544020|FG000|Overall Study|Death|1|||
37860563|NCT01218594|69544020|FG000|Overall Study|Withdrawal by Subject|3|||
37860564|NCT01218594|69544020|FG000|Overall Study|Adverse Event|2|||
37860565|NCT01218594|69544020|FG000|Overall Study|Physician Decision|6|||
37860566|NCT01610557|69544028|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
37860567|NCT01610557|69544029|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
37860568|NCT01610557|69544030|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
37860569|NCT01610557|69544031|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
37860570|NCT01610557|69544032|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
37860571|NCT01610557|69544028|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
37860572|NCT01610557|69544029|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
37860573|NCT01610557|69544030|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
37860574|NCT01610557|69544031|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
37860575|NCT01610557|69544032|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
37860576|NCT00943735|69544043|FG000|Overall Study|Adverse Event|12|||
37860577|NCT00943735|69544043|FG000|Overall Study|Withdrawal by Subject|8|||
37860578|NCT00943735|69544043|FG000|Overall Study|Death|1|||
37860579|NCT00943735|69544043|FG000|Overall Study|Other|8|||
37860580|NCT00943735|69544043|FG000|Overall Study|Other|3|||
37860581|NCT00943579|69544049|FG000|Overall Study|Adverse Event|4|||
37860582|NCT00943579|69544050|FG001|Overall Study|Adverse Event|3|||
37860583|NCT00943579|69544049|FG000|Overall Study|Lack of Efficacy|2|||
37860584|NCT00943579|69544050|FG001|Overall Study|Lack of Efficacy|2|||
37860585|NCT01147809|69544065|FG000|Phase I (168 Days)|Adverse Event|0|||
37860586|NCT01147809|69544066|FG001|Phase I (168 Days)|Adverse Event|0|||
37860587|NCT01147809|69544067|FG002|Phase I (168 Days)|Adverse Event|0|||
37860588|NCT01147809|69544068|FG003|Phase I (168 Days)|Adverse Event|1|||
37860589|NCT01147809|69544069|FG004|Phase I (168 Days)|Adverse Event|0|||
37860590|NCT01147809|69544070|FG005|Phase I (168 Days)|Adverse Event|0|||
37860591|NCT01147809|69544065|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
37860592|NCT01147809|69544066|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
37860593|NCT01147809|69544067|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
37860594|NCT01147809|69544068|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
37860595|NCT01147809|69544069|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
37860596|NCT01147809|69544070|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
37860597|NCT01147809|69544065|FG000|Phase I (168 Days)|Physician Decision|0|||
37860598|NCT01147809|69544066|FG001|Phase I (168 Days)|Physician Decision|1|||
37860599|NCT01147809|69544067|FG002|Phase I (168 Days)|Physician Decision|2|||
37860600|NCT01147809|69544068|FG003|Phase I (168 Days)|Physician Decision|0|||
37860601|NCT01147809|69544069|FG004|Phase I (168 Days)|Physician Decision|0|||
37860602|NCT01147809|69544070|FG005|Phase I (168 Days)|Physician Decision|0|||
37860603|NCT01147809|69544065|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
37860604|NCT01147809|69544066|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
37860605|NCT01147809|69544067|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
37860606|NCT01147809|69544068|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
37860607|NCT01147809|69544069|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
37860608|NCT01147809|69544070|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
37860609|NCT01147809|69544065|FG000|Phase II (168 Days)|Adverse Event|0|||
37860610|NCT01147809|69544066|FG001|Phase II (168 Days)|Adverse Event|0|||
37860611|NCT01147809|69544067|FG002|Phase II (168 Days)|Adverse Event|0|||
37860612|NCT01147809|69544068|FG003|Phase II (168 Days)|Adverse Event|0|||
37860613|NCT01147809|69544069|FG004|Phase II (168 Days)|Adverse Event|3|||
37860614|NCT01147809|69544070|FG005|Phase II (168 Days)|Adverse Event|6|||
37860615|NCT01147809|69544065|FG000|Phase II (168 Days)|Protocol Violation|0|||
37860616|NCT01147809|69544066|FG001|Phase II (168 Days)|Protocol Violation|0|||
37860617|NCT01147809|69544067|FG002|Phase II (168 Days)|Protocol Violation|0|||
37860618|NCT01147809|69544068|FG003|Phase II (168 Days)|Protocol Violation|0|||
37860619|NCT01147809|69544069|FG004|Phase II (168 Days)|Protocol Violation|0|||
37860620|NCT01147809|69544070|FG005|Phase II (168 Days)|Protocol Violation|1|||
37860621|NCT01147809|69544065|FG000|Phase II (168 Days)|Physician Decision|0|||
37860622|NCT01147809|69544066|FG001|Phase II (168 Days)|Physician Decision|0|||
37860623|NCT01147809|69544067|FG002|Phase II (168 Days)|Physician Decision|0|||
37860624|NCT01147809|69544068|FG003|Phase II (168 Days)|Physician Decision|0|||
37860625|NCT01147809|69544069|FG004|Phase II (168 Days)|Physician Decision|5|||
37860626|NCT01147809|69544070|FG005|Phase II (168 Days)|Physician Decision|11|||
37860627|NCT01147809|69544065|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
37860628|NCT01147809|69544066|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
37860629|NCT01147809|69544067|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
37860630|NCT01147809|69544068|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
37860631|NCT01147809|69544069|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
37860632|NCT01147809|69544070|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
37860633|NCT01147809|69544065|FG000|Phase II (168 Days)|Ongoing|0|||
37860634|NCT01147809|69544066|FG001|Phase II (168 Days)|Ongoing|0|||
37860635|NCT01147809|69544067|FG002|Phase II (168 Days)|Ongoing|0|||
37860636|NCT01147809|69544068|FG003|Phase II (168 Days)|Ongoing|0|||
37860637|NCT01147809|69544069|FG004|Phase II (168 Days)|Ongoing|1|||
37860638|NCT01147809|69544070|FG005|Phase II (168 Days)|Ongoing|0|||
37860639|NCT00943111|69544087|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
37860640|NCT00943111|69544088|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
37860641|NCT00943111|69544089|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
37860642|NCT00943111|69544087|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
37860643|NCT00943111|69544088|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
37860644|NCT00943111|69544089|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
37860645|NCT00943111|69544087|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
37860646|NCT00943111|69544088|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
37860647|NCT00943111|69544089|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
37860648|NCT00943111|69544087|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
37860649|NCT00943111|69544088|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
37860650|NCT00943111|69544089|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
37860651|NCT00943111|69544087|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
37860652|NCT00943111|69544088|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
37860653|NCT00943111|69544089|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
37860654|NCT00943111|69544087|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
37860655|NCT00943111|69544088|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
37860656|NCT00943111|69544089|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
37860657|NCT00943111|69544087|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
37860658|NCT00943111|69544088|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
37860659|NCT00943111|69544089|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
37860660|NCT00943111|69544087|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
37860661|NCT00943111|69544088|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
37860662|NCT00943111|69544089|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
37860663|NCT01147497|69544098|FG000|Overall Study|failed insertion|2|||
37860664|NCT01147497|69544099|FG001|Overall Study|failed insertion|0|||
37860665|NCT01147341|69544107|FG000|Double Blind Period|Lack of Efficacy|1|||
37860666|NCT01147341|69544108|FG001|Double Blind Period|Lack of Efficacy|1|||
37860667|NCT01147341|69544107|FG000|Double Blind Period|Withdrawal by Subject|0|||
37860668|NCT01147341|69544108|FG001|Double Blind Period|Withdrawal by Subject|1|||
37860669|NCT01147341|69544107|FG000|Open Label Period|Lack of Efficacy|3|||
37860670|NCT01147341|69544108|FG001|Open Label Period|Lack of Efficacy|0|||
37860671|NCT01147341|69544107|FG000|Open Label Period|Subject moved|1|||
37860672|NCT01147341|69544108|FG001|Open Label Period|Subject moved|0|||
37860673|NCT00950755|69544114|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
37860674|NCT00950755|69544114|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
37860675|NCT00950755|69544114|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
37860676|NCT00950755|69544114|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
37860677|NCT00950755|69544114|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
37860678|NCT00950755|69544114|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
37860679|NCT00950755|69544114|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
37860680|NCT00950755|69544114|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
37860681|NCT00950755|69544114|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
37860682|NCT00950755|69544114|FG000|Long-Term Follow-Up|Death|8|||
37860683|NCT01147107|69544120|FG000|Overall Study|Lack of Efficacy|5|||
37860684|NCT01147107|69544121|FG001|Overall Study|Lack of Efficacy|0|||
37860685|NCT01147107|69544120|FG000|Overall Study|Withdrawal by Subject|1|||
37860686|NCT01147107|69544121|FG001|Overall Study|Withdrawal by Subject|1|||
37860687|NCT00942409|69544127|FG000|Overall Study|Lack of Efficacy|1|||
37860688|NCT00942409|69544127|FG000|Overall Study|study drug unavailable|2|||
37860689|NCT01146951|69544133|FG000|Overall Study|Adverse Event|4|||
37860690|NCT01146951|69544134|FG001|Overall Study|Adverse Event|1|||
37860691|NCT01146873|69544142|FG000|Overall Study|Transfer out|0|||
37860692|NCT01146873|69544143|FG001|Overall Study|Transfer out|6|||
37860693|NCT01146795|69544149|FG000|Overall Study|Withdrawal by Subject|4|||
37860694|NCT01146795|69544149|FG000|Overall Study|Adverse Event|6|||
37860695|NCT01146795|69544149|FG000|Overall Study|Still in treatment at study closure|10|||
37860696|NCT01146561|69544153|FG000|Overall Study|Withdrawal by Subject|1|||
37860697|NCT01146561|69544153|FG000|Overall Study|Lost to Follow-up|1|||
37860698|NCT00942175|69544161|FG000|Overall Study|Adverse Event|2|||
37860699|NCT00942175|69544162|FG001|Overall Study|Adverse Event|1|||
37860700|NCT00942175|69544163|FG002|Overall Study|Adverse Event|0|||
37860701|NCT00942175|69544164|FG003|Overall Study|Adverse Event|0|||
37860702|NCT00942175|69544161|FG000|Overall Study|Protocol Violation|0|||
37860703|NCT00942175|69544162|FG001|Overall Study|Protocol Violation|1|||
37860704|NCT00942175|69544163|FG002|Overall Study|Protocol Violation|2|||
37860705|NCT00942175|69544164|FG003|Overall Study|Protocol Violation|0|||
37860706|NCT00942175|69544161|FG000|Overall Study|Pregnancy|0|||
37860707|NCT00942175|69544162|FG001|Overall Study|Pregnancy|0|||
37860708|NCT00942175|69544163|FG002|Overall Study|Pregnancy|0|||
37860709|NCT00942175|69544164|FG003|Overall Study|Pregnancy|1|||
37860710|NCT00942175|69544161|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
37860711|NCT00942175|69544162|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
37860712|NCT00942175|69544163|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
37860713|NCT00942175|69544164|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
37860714|NCT00942175|69544161|FG000|Overall Study|Low Platelet Count|0|||
37860715|NCT00942175|69544162|FG001|Overall Study|Low Platelet Count|2|||
37860716|NCT00942175|69544163|FG002|Overall Study|Low Platelet Count|0|||
37860717|NCT00942175|69544164|FG003|Overall Study|Low Platelet Count|0|||
37860718|NCT01145625|69544184|FG000|Overall Study|Lost to Follow-up|8|||
37951063|NCT00645944|69638174|FG000|Received Medication|Protocol Violation|2|||
37951064|NCT00645944|69638175|FG001|Received Medication|Protocol Violation|1|||
37951065|NCT00646958|69638184|FG000|Overall Study|Lack of Efficacy|1|||
37951066|NCT00646958|69638185|FG001|Overall Study|Lack of Efficacy|0|||
37951067|NCT00646958|69638186|FG002|Overall Study|Lack of Efficacy|0|||
37951068|NCT00646958|69638184|FG000|Overall Study|Adverse Event|4|||
37951069|NCT00646958|69638185|FG001|Overall Study|Adverse Event|0|||
37951070|NCT00646958|69638186|FG002|Overall Study|Adverse Event|0|||
37951071|NCT00646958|69638184|FG000|Overall Study|Lost to Follow-up|1|||
37951072|NCT00646958|69638185|FG001|Overall Study|Lost to Follow-up|5|||
37951073|NCT00646958|69638186|FG002|Overall Study|Lost to Follow-up|7|||
37951074|NCT00646958|69638184|FG000|Overall Study|Protocol Violation|1|||
37951075|NCT00646958|69638185|FG001|Overall Study|Protocol Violation|1|||
37951076|NCT00646958|69638186|FG002|Overall Study|Protocol Violation|0|||
37951077|NCT00646958|69638184|FG000|Overall Study|Abnormal screening lab tests|1|||
37951078|NCT00646958|69638185|FG001|Overall Study|Abnormal screening lab tests|1|||
37951079|NCT00646958|69638186|FG002|Overall Study|Abnormal screening lab tests|0|||
37951080|NCT00646958|69638184|FG000|Overall Study|Withdrawal by Subject|1|||
37951081|NCT00646958|69638185|FG001|Overall Study|Withdrawal by Subject|2|||
37951082|NCT00646958|69638186|FG002|Overall Study|Withdrawal by Subject|0|||
37951083|NCT00646958|69638184|FG000|Overall Study|Did not receive study drug|2|||
37951084|NCT00646958|69638185|FG001|Overall Study|Did not receive study drug|0|||
37951085|NCT00646958|69638186|FG002|Overall Study|Did not receive study drug|2|||
37951086|NCT00642746|69638196|FG000|Overall Study|Patient unevaluable|1|||
37951087|NCT00642746|69638197|FG001|Overall Study|Patient unevaluable|0|||
37951088|NCT00642668|69638203|FG000|Overall Study|Lost to Follow-up|1|||
37951089|NCT00642668|69638203|FG000|Overall Study|Adverse Event|2|||
37951090|NCT00642668|69638203|FG000|Overall Study|Death|2|||
37951091|NCT00642668|69638203|FG000|Overall Study|Insufficient Therapeutic Response|1|||
37951092|NCT00642668|69638203|FG000|Overall Study|Failure to Return|1|||
37951093|NCT00642668|69638203|FG000|Overall Study|Dialysis Initiation|5|||
37951094|NCT00642668|69638203|FG000|Overall Study|Blood Transfusion|2|||
37951095|NCT00729833|69638207|FG000|Overall Study|Death|5|||
37951096|NCT00729833|69638208|FG001|Overall Study|Death|1|||
37951097|NCT00729833|69638209|FG002|Overall Study|Death|3|||
37951098|NCT00729833|69638210|FG003|Overall Study|Death|5|||
37951099|NCT00729833|69638207|FG000|Overall Study|Study Terminated by Sponsor|0|||
37951100|NCT00729833|69638208|FG001|Overall Study|Study Terminated by Sponsor|0|||
37951101|NCT00729833|69638209|FG002|Overall Study|Study Terminated by Sponsor|1|||
37951102|NCT00729833|69638210|FG003|Overall Study|Study Terminated by Sponsor|0|||
37951103|NCT00729833|69638207|FG000|Overall Study|Lost to Follow-up|1|||
37951104|NCT00729833|69638208|FG001|Overall Study|Lost to Follow-up|0|||
37951105|NCT00729833|69638209|FG002|Overall Study|Lost to Follow-up|0|||
37951106|NCT00729833|69638210|FG003|Overall Study|Lost to Follow-up|0|||
37951107|NCT00729833|69638207|FG000|Overall Study|Withdrawal by Subject|3|||
37951108|NCT00729833|69638208|FG001|Overall Study|Withdrawal by Subject|1|||
37951109|NCT00729833|69638209|FG002|Overall Study|Withdrawal by Subject|3|||
37951110|NCT00729833|69638210|FG003|Overall Study|Withdrawal by Subject|0|||
37951111|NCT00729833|69638207|FG000|Overall Study|Unspecified Reasons|11|||
37951112|NCT00729833|69638208|FG001|Overall Study|Unspecified Reasons|5|||
37951113|NCT00729833|69638209|FG002|Overall Study|Unspecified Reasons|5|||
37951114|NCT00729833|69638210|FG003|Overall Study|Unspecified Reasons|1|||
37951115|NCT00645788|69638225|FG000|Overall Study|Did not receive study drug|1|||
37951116|NCT00645788|69638226|FG001|Overall Study|Did not receive study drug|1|||
37951117|NCT00645788|69638227|FG002|Overall Study|Did not receive study drug|0|||
37951118|NCT00645788|69638228|FG003|Overall Study|Did not receive study drug|0|||
37951119|NCT00645788|69638225|FG000|Overall Study|Adverse Event|4|||
37951120|NCT00645788|69638226|FG001|Overall Study|Adverse Event|9|||
37951121|NCT00645788|69638227|FG002|Overall Study|Adverse Event|5|||
37951122|NCT00645788|69638228|FG003|Overall Study|Adverse Event|3|||
37951123|NCT00645788|69638225|FG000|Overall Study|Lost to Follow-up|1|||
37951124|NCT00645788|69638226|FG001|Overall Study|Lost to Follow-up|0|||
37951125|NCT00645788|69638227|FG002|Overall Study|Lost to Follow-up|0|||
37951126|NCT00645788|69638228|FG003|Overall Study|Lost to Follow-up|0|||
37951127|NCT00645788|69638225|FG000|Overall Study|Protocol Violation|1|||
37951128|NCT00645788|69638226|FG001|Overall Study|Protocol Violation|0|||
37951129|NCT00645788|69638227|FG002|Overall Study|Protocol Violation|2|||
37951130|NCT00645788|69638228|FG003|Overall Study|Protocol Violation|0|||
37860719|NCT01145625|69544185|FG001|Overall Study|Lost to Follow-up|9|||
37951131|NCT00645788|69638225|FG000|Overall Study|Withdrawal by Subject|0|||
37951132|NCT00645788|69638226|FG001|Overall Study|Withdrawal by Subject|1|||
37860720|NCT01145625|69544184|FG000|Overall Study|Adverse Event|6|||
37860721|NCT01145625|69544185|FG001|Overall Study|Adverse Event|4|||
37860722|NCT01145625|69544184|FG000|Overall Study|Protocol Violation|3|||
37860723|NCT01145625|69544185|FG001|Overall Study|Protocol Violation|1|||
37860724|NCT01145625|69544184|FG000|Overall Study|Withdrawal by Subject|7|||
37860725|NCT01145625|69544185|FG001|Overall Study|Withdrawal by Subject|16|||
37860726|NCT01145625|69544184|FG000|Overall Study|Pregnancy|0|||
37860727|NCT01145625|69544185|FG001|Overall Study|Pregnancy|1|||
37951133|NCT00645788|69638227|FG002|Overall Study|Withdrawal by Subject|0|||
37951134|NCT00645788|69638228|FG003|Overall Study|Withdrawal by Subject|2|||
37951135|NCT00645788|69638225|FG000|Overall Study|Pulmonary exacerbation|13|||
37951136|NCT00645788|69638226|FG001|Overall Study|Pulmonary exacerbation|16|||
37951137|NCT00645788|69638227|FG002|Overall Study|Pulmonary exacerbation|11|||
37951138|NCT00645788|69638228|FG003|Overall Study|Pulmonary exacerbation|9|||
37951139|NCT00642356|69638240|FG000|Overall Study|Adverse Event|1|||
37951140|NCT00642356|69638241|FG001|Overall Study|Adverse Event|0|||
37951141|NCT00642356|69638240|FG000|Overall Study|Protocol Violation|0|||
37951142|NCT00642356|69638241|FG001|Overall Study|Protocol Violation|3|||
37951143|NCT00642356|69638240|FG000|Overall Study|Lack of Efficacy|1|||
37951144|NCT00642356|69638241|FG001|Overall Study|Lack of Efficacy|0|||
37951145|NCT00642278|69638254|FG000|Overall Study|Adverse Event|2|||
37951146|NCT00642278|69638255|FG001|Overall Study|Adverse Event|1|||
37951147|NCT00642278|69638256|FG002|Overall Study|Adverse Event|3|||
37951148|NCT00642278|69638257|FG003|Overall Study|Adverse Event|1|||
37951149|NCT00642278|69638258|FG004|Overall Study|Adverse Event|2|||
37951150|NCT00642278|69638259|FG005|Overall Study|Adverse Event|2|||
37951151|NCT00642278|69638260|FG006|Overall Study|Adverse Event|0|||
37951152|NCT00642278|69638254|FG000|Overall Study|Lack of Efficacy|0|||
37951153|NCT00642278|69638255|FG001|Overall Study|Lack of Efficacy|1|||
37951154|NCT00642278|69638256|FG002|Overall Study|Lack of Efficacy|0|||
37951155|NCT00642278|69638257|FG003|Overall Study|Lack of Efficacy|0|||
37951156|NCT00642278|69638258|FG004|Overall Study|Lack of Efficacy|0|||
37951157|NCT00642278|69638259|FG005|Overall Study|Lack of Efficacy|0|||
37951158|NCT00642278|69638260|FG006|Overall Study|Lack of Efficacy|0|||
37951159|NCT00642278|69638254|FG000|Overall Study|Lost to Follow-up|5|||
37951160|NCT00642278|69638255|FG001|Overall Study|Lost to Follow-up|1|||
37951161|NCT00642278|69638256|FG002|Overall Study|Lost to Follow-up|0|||
37951162|NCT00642278|69638257|FG003|Overall Study|Lost to Follow-up|1|||
37951163|NCT00642278|69638258|FG004|Overall Study|Lost to Follow-up|0|||
37951164|NCT00642278|69638259|FG005|Overall Study|Lost to Follow-up|1|||
37951165|NCT00642278|69638260|FG006|Overall Study|Lost to Follow-up|1|||
37951166|NCT00642278|69638254|FG000|Overall Study|Physician Decision|0|||
37951167|NCT00642278|69638255|FG001|Overall Study|Physician Decision|0|||
37951168|NCT00642278|69638256|FG002|Overall Study|Physician Decision|0|||
37951169|NCT00642278|69638257|FG003|Overall Study|Physician Decision|1|||
37951170|NCT00642278|69638258|FG004|Overall Study|Physician Decision|0|||
37951171|NCT00642278|69638259|FG005|Overall Study|Physician Decision|0|||
37951172|NCT00642278|69638260|FG006|Overall Study|Physician Decision|0|||
37951173|NCT00642278|69638254|FG000|Overall Study|Protocol Violation|0|||
37951174|NCT00642278|69638255|FG001|Overall Study|Protocol Violation|0|||
37951175|NCT00642278|69638256|FG002|Overall Study|Protocol Violation|1|||
37951176|NCT00642278|69638257|FG003|Overall Study|Protocol Violation|1|||
37951177|NCT00642278|69638258|FG004|Overall Study|Protocol Violation|0|||
37951178|NCT00642278|69638259|FG005|Overall Study|Protocol Violation|1|||
37951179|NCT00642278|69638260|FG006|Overall Study|Protocol Violation|2|||
37951180|NCT00642278|69638254|FG000|Overall Study|Withdrawal by Subject|1|||
37951181|NCT00642278|69638255|FG001|Overall Study|Withdrawal by Subject|1|||
37951182|NCT00642278|69638256|FG002|Overall Study|Withdrawal by Subject|1|||
37951183|NCT00642278|69638257|FG003|Overall Study|Withdrawal by Subject|3|||
37951184|NCT00642278|69638258|FG004|Overall Study|Withdrawal by Subject|6|||
37951185|NCT00642278|69638259|FG005|Overall Study|Withdrawal by Subject|2|||
37951186|NCT00642278|69638260|FG006|Overall Study|Withdrawal by Subject|2|||
37951187|NCT00642278|69638254|FG000|Overall Study|Noncompliance with study drug regimen|0|||
37951188|NCT00642278|69638255|FG001|Overall Study|Noncompliance with study drug regimen|0|||
37951189|NCT00642278|69638256|FG002|Overall Study|Noncompliance with study drug regimen|0|||
37951190|NCT00642278|69638257|FG003|Overall Study|Noncompliance with study drug regimen|1|||
37951191|NCT00642278|69638258|FG004|Overall Study|Noncompliance with study drug regimen|0|||
37951192|NCT00642278|69638259|FG005|Overall Study|Noncompliance with study drug regimen|0|||
37951193|NCT00642278|69638260|FG006|Overall Study|Noncompliance with study drug regimen|0|||
37951194|NCT00642278|69638254|FG000|Overall Study|Other|2|||
37951195|NCT00642278|69638255|FG001|Overall Study|Other|1|||
37951196|NCT00642278|69638256|FG002|Overall Study|Other|0|||
37951197|NCT00642278|69638257|FG003|Overall Study|Other|1|||
37951198|NCT00642278|69638258|FG004|Overall Study|Other|0|||
37951199|NCT00642278|69638259|FG005|Overall Study|Other|1|||
37951200|NCT00642278|69638260|FG006|Overall Study|Other|0|||
37951201|NCT00543543|69638280|FG000|Base Study|Adverse Event|1|||
37951202|NCT00543543|69638281|FG001|Base Study|Adverse Event|11|||
37951203|NCT00543543|69638282|FG002|Base Study|Adverse Event|0|||
37951204|NCT00543543|69638283|FG003|Base Study|Adverse Event|5|||
37951205|NCT00543543|69638280|FG000|Base Study|Lost to Follow-up|12|||
37951206|NCT00543543|69638281|FG001|Base Study|Lost to Follow-up|749|||
37951207|NCT00543543|69638282|FG002|Base Study|Lost to Follow-up|9|||
37951208|NCT00543543|69638283|FG003|Base Study|Lost to Follow-up|701|||
37951209|NCT00543543|69638280|FG000|Base Study|Physician Decision|0|||
37951210|NCT00543543|69638281|FG001|Base Study|Physician Decision|4|||
37951211|NCT00543543|69638282|FG002|Base Study|Physician Decision|0|||
37951212|NCT00543543|69638283|FG003|Base Study|Physician Decision|7|||
37951213|NCT00543543|69638280|FG000|Base Study|Protocol Violation|0|||
37951214|NCT00543543|69638281|FG001|Base Study|Protocol Violation|6|||
37951215|NCT00543543|69638282|FG002|Base Study|Protocol Violation|0|||
37951216|NCT00543543|69638283|FG003|Base Study|Protocol Violation|6|||
37951217|NCT00543543|69638280|FG000|Base Study|Withdrawal by Subject|7|||
37951218|NCT00543543|69638281|FG001|Base Study|Withdrawal by Subject|482|||
37951219|NCT00543543|69638282|FG002|Base Study|Withdrawal by Subject|5|||
37951220|NCT00543543|69638283|FG003|Base Study|Withdrawal by Subject|503|||
37951221|NCT00543543|69638280|FG000|Extension Study|Adverse Event|0|||
37951222|NCT00543543|69638281|FG001|Extension Study|Adverse Event|0|||
37951223|NCT00543543|69638282|FG002|Extension Study|Adverse Event|0|||
37951224|NCT00543543|69638283|FG003|Extension Study|Adverse Event|5|||
37951225|NCT00543543|69638280|FG000|Extension Study|Lost to Follow-up|0|||
37951226|NCT00543543|69638281|FG001|Extension Study|Lost to Follow-up|0|||
37951227|NCT00543543|69638282|FG002|Extension Study|Lost to Follow-up|0|||
37951228|NCT00543543|69638283|FG003|Extension Study|Lost to Follow-up|77|||
37951229|NCT00543543|69638280|FG000|Extension Study|Physician Decision|0|||
37951230|NCT00543543|69638281|FG001|Extension Study|Physician Decision|0|||
37951231|NCT00543543|69638282|FG002|Extension Study|Physician Decision|0|||
37951232|NCT00543543|69638283|FG003|Extension Study|Physician Decision|7|||
37951233|NCT00543543|69638280|FG000|Extension Study|Pregnancy|0|||
37951234|NCT00543543|69638281|FG001|Extension Study|Pregnancy|0|||
37951235|NCT00543543|69638282|FG002|Extension Study|Pregnancy|0|||
37951236|NCT00543543|69638283|FG003|Extension Study|Pregnancy|6|||
37951237|NCT00543543|69638280|FG000|Extension Study|Protocol Violation|0|||
37951238|NCT00543543|69638281|FG001|Extension Study|Protocol Violation|0|||
37951239|NCT00543543|69638282|FG002|Extension Study|Protocol Violation|0|||
37951240|NCT00543543|69638283|FG003|Extension Study|Protocol Violation|11|||
37951241|NCT00543543|69638280|FG000|Extension Study|Withdrawal by Subject|0|||
37951242|NCT00543543|69638281|FG001|Extension Study|Withdrawal by Subject|0|||
37951243|NCT00543543|69638282|FG002|Extension Study|Withdrawal by Subject|0|||
37951244|NCT00543543|69638283|FG003|Extension Study|Withdrawal by Subject|120|||
37951245|NCT00645164|69638298|FG000|Overall Study|Lost to Follow-up|2|||
37951246|NCT00645164|69638298|FG000|Overall Study|Withdrawal by Subject|4|||
37951247|NCT00645164|69638298|FG000|Overall Study|Protocol Violation|1|||
37951248|NCT00723125|69638304|FG000|Overall Study|Met Dx|1|||
37951249|NCT00723125|69638305|FG001|Overall Study|Met Dx|0|||
37951250|NCT00723125|69638304|FG000|Overall Study|Withdrawal by Subject|15|||
37951251|NCT00723125|69638305|FG001|Overall Study|Withdrawal by Subject|6|||
37951252|NCT00723125|69638304|FG000|Overall Study|Adverse Event|2|||
37951253|NCT00723125|69638305|FG001|Overall Study|Adverse Event|0|||
37951254|NCT00722423|69638319|FG000|Overall Study|Protocol Violation|0|||
37951255|NCT00722423|69638320|FG001|Overall Study|Protocol Violation|1|||
37951256|NCT00640562|69638330|FG000|Overall Study|Adverse Event|8|||
37951257|NCT00640562|69638331|FG001|Overall Study|Adverse Event|5|||
37951258|NCT00640562|69638330|FG000|Overall Study|Lack of Efficacy|1|||
37951259|NCT00640562|69638331|FG001|Overall Study|Lack of Efficacy|4|||
37951260|NCT00640562|69638330|FG000|Overall Study|Protocol Violation|2|||
37951261|NCT00640562|69638331|FG001|Overall Study|Protocol Violation|4|||
37951262|NCT00640562|69638330|FG000|Overall Study|Withdrawal by Subject|6|||
37951263|NCT00640562|69638331|FG001|Overall Study|Withdrawal by Subject|10|||
37951264|NCT00640562|69638330|FG000|Overall Study|Known risperidone intolerance|0|||
37951265|NCT00640562|69638331|FG001|Overall Study|Known risperidone intolerance|1|||
37951266|NCT00640562|69638330|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
37951267|NCT00640562|69638331|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
37951268|NCT00640562|69638330|FG000|Overall Study|Low study drug dose|0|||
37951269|NCT00640562|69638331|FG001|Overall Study|Low study drug dose|1|||
37951270|NCT00640562|69638330|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
37951271|NCT00640562|69638331|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
37677347|NCT01659255|69152298|FG010|Overall Study|Sponsor's Decision|0|||
37677348|NCT01659255|69152299|FG011|Overall Study|Sponsor's Decision|0|||
37951272|NCT00585923|69638339|FG000|Overall Study|Physician decided not to continue|31|||
37951273|NCT00585923|69638340|FG001|Overall Study|Physician decided not to continue|33|||
37951274|NCT00721955|69638349|FG000|Overall Study|Adverse Event|0|||
37951275|NCT00721955|69638350|FG001|Overall Study|Adverse Event|0|||
37951276|NCT00721955|69638351|FG002|Overall Study|Adverse Event|2|||
37951277|NCT00585689|69638359|FG000|Overall Study|Received different ABI-007 schedule|3|||
37951278|NCT00585689|69638359|FG000|Overall Study|Adverse Event|1|||
37951279|NCT00585689|69638359|FG000|Overall Study|Patient Declined Surgery|1|||
37951280|NCT00585689|69638359|FG000|Overall Study|Patient had unresectable disease|1|||
37951281|NCT00585689|69638359|FG000|Overall Study|Death|1|||
37951282|NCT00721799|69638363|FG000|Overall Study|Withdrawal by Subject|7|||
37951283|NCT00721799|69638363|FG000|Overall Study|withdraw by subject after scan 1|1|||
37951284|NCT00729365|69638370|FG000|Overall Study|Physician Decision|33|||
37951285|NCT00729365|69638371|FG001|Overall Study|Physician Decision|6|||
37951286|NCT00729365|69638372|FG002|Overall Study|Physician Decision|7|||
37951287|NCT00254293|69638388|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
37951288|NCT00254293|69638389|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
37951289|NCT00254293|69638390|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
37951290|NCT00254293|69638391|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
37951291|NCT00254293|69638392|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
37951292|NCT00254293|69638393|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
37951293|NCT00254293|69638394|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
37951294|NCT00254293|69638388|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
37951295|NCT00254293|69638389|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
37951296|NCT00254293|69638390|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
37951297|NCT00254293|69638391|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
37951298|NCT00254293|69638392|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
37951299|NCT00254293|69638393|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
37951300|NCT00254293|69638394|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
37951301|NCT00254293|69638388|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
37951302|NCT00254293|69638389|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
37951303|NCT00254293|69638390|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
37951304|NCT00254293|69638391|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
37951305|NCT00254293|69638392|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
37951306|NCT00254293|69638393|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
37951307|NCT00254293|69638394|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
37951308|NCT00254293|69638388|FG000|LTE Open Label Variable SC Dosing|Death|0|||
37951309|NCT00254293|69638389|FG001|LTE Open Label Variable SC Dosing|Death|0|||
37951310|NCT00254293|69638390|FG002|LTE Open Label Variable SC Dosing|Death|1|||
37951311|NCT00254293|69638391|FG003|LTE Open Label Variable SC Dosing|Death|0|||
37951312|NCT00254293|69638392|FG004|LTE Open Label Variable SC Dosing|Death|0|||
37951313|NCT00254293|69638393|FG005|LTE Open Label Variable SC Dosing|Death|0|||
37951314|NCT00254293|69638394|FG006|LTE Open Label Variable SC Dosing|Death|0|||
37951315|NCT00254293|69638388|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
37951316|NCT00254293|69638389|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
37951317|NCT00254293|69638390|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
37951318|NCT00254293|69638391|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
37951319|NCT00254293|69638392|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
37951320|NCT00254293|69638393|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
37951321|NCT00254293|69638394|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
37951322|NCT00254293|69638388|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
37951323|NCT00254293|69638389|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
37951324|NCT00254293|69638390|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
37951325|NCT00254293|69638391|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
37951326|NCT00254293|69638392|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
37951327|NCT00254293|69638393|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
37951328|NCT00254293|69638394|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
37951329|NCT00254293|69638388|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
37951330|NCT00254293|69638389|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
37951331|NCT00254293|69638390|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
37951332|NCT00254293|69638391|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
37951333|NCT00254293|69638392|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
37951334|NCT00254293|69638393|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
37951335|NCT00254293|69638394|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
37951336|NCT00254293|69638388|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
37951337|NCT00254293|69638389|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
37951338|NCT00254293|69638390|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
37951339|NCT00254293|69638391|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
37951340|NCT00254293|69638392|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
37951341|NCT00254293|69638393|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
37951342|NCT00254293|69638394|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
37951343|NCT00254293|69638388|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
37951344|NCT00254293|69638389|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
37951345|NCT00254293|69638390|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
37951346|NCT00254293|69638391|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
37951347|NCT00254293|69638392|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
37951348|NCT00254293|69638393|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
37951349|NCT00254293|69638394|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
37951350|NCT00254293|69638388|FG000|LTE Open Label Variable SC Dosing|Other|0|||
37951351|NCT00254293|69638389|FG001|LTE Open Label Variable SC Dosing|Other|0|||
37951352|NCT00254293|69638390|FG002|LTE Open Label Variable SC Dosing|Other|2|||
37951353|NCT00254293|69638391|FG003|LTE Open Label Variable SC Dosing|Other|0|||
37951354|NCT00254293|69638392|FG004|LTE Open Label Variable SC Dosing|Other|0|||
37951355|NCT00254293|69638393|FG005|LTE Open Label Variable SC Dosing|Other|0|||
37951356|NCT00254293|69638394|FG006|LTE Open Label Variable SC Dosing|Other|0|||
37951357|NCT00254293|69638388|FG000|LTE Open Label Fixed Dosing|Death|0|||
37951358|NCT00254293|69638389|FG001|LTE Open Label Fixed Dosing|Death|0|||
37951359|NCT00254293|69638390|FG002|LTE Open Label Fixed Dosing|Death|0|||
37951360|NCT00254293|69638391|FG003|LTE Open Label Fixed Dosing|Death|0|||
37951361|NCT00254293|69638392|FG004|LTE Open Label Fixed Dosing|Death|0|||
37951362|NCT00254293|69638393|FG005|LTE Open Label Fixed Dosing|Death|0|||
37951363|NCT00254293|69638394|FG006|LTE Open Label Fixed Dosing|Death|3|||
37951364|NCT00254293|69638388|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
37951365|NCT00254293|69638389|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
37951366|NCT00254293|69638390|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
37951367|NCT00254293|69638391|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
37951368|NCT00254293|69638392|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
37951369|NCT00254293|69638393|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
37951370|NCT00254293|69638394|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
37951371|NCT00254293|69638388|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
37951372|NCT00254293|69638389|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
37951373|NCT00254293|69638390|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
37951374|NCT00254293|69638391|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
37951375|NCT00254293|69638392|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
37951376|NCT00254293|69638393|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
37951377|NCT00254293|69638394|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
37951378|NCT00254293|69638388|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
37951379|NCT00254293|69638389|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
37951380|NCT00254293|69638390|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
37951381|NCT00254293|69638391|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
37951382|NCT00254293|69638392|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
37951383|NCT00254293|69638393|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
37951384|NCT00254293|69638394|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
37951385|NCT00254293|69638388|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
37951386|NCT00254293|69638389|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
37951387|NCT00254293|69638390|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
37951388|NCT00254293|69638391|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
37951389|NCT00254293|69638392|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
37951390|NCT00254293|69638393|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
37951391|NCT00254293|69638394|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
37951392|NCT00254293|69638388|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
37951393|NCT00254293|69638389|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
37951394|NCT00254293|69638390|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
37951395|NCT00254293|69638391|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
37951396|NCT00254293|69638392|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
37951397|NCT00254293|69638393|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
37951398|NCT00254293|69638394|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
37951399|NCT00254293|69638388|FG000|LTE Open Label Fixed Dosing|Other|0|||
37951400|NCT00254293|69638389|FG001|LTE Open Label Fixed Dosing|Other|0|||
37951401|NCT00254293|69638390|FG002|LTE Open Label Fixed Dosing|Other|0|||
37951402|NCT00254293|69638391|FG003|LTE Open Label Fixed Dosing|Other|0|||
37951403|NCT00254293|69638392|FG004|LTE Open Label Fixed Dosing|Other|0|||
37951404|NCT00254293|69638393|FG005|LTE Open Label Fixed Dosing|Other|0|||
37951405|NCT00254293|69638394|FG006|LTE Open Label Fixed Dosing|Other|1|||
37951406|NCT00736385|69638439|FG000|Overall Study|Withdrawal by Subject|2|||
37951407|NCT00736385|69638440|FG001|Overall Study|Withdrawal by Subject|2|||
37951408|NCT00736385|69638439|FG000|Overall Study|Adverse Event|0|||
37951409|NCT00736385|69638440|FG001|Overall Study|Adverse Event|1|||
37951410|NCT00585221|69638446|FG000|Overall Study|Protocol Violation|8|||
37951411|NCT00253747|69638452|FG000|Overall Study|Lost to Follow-up|13|||
37951412|NCT00253747|69638453|FG001|Overall Study|Lost to Follow-up|14|||
37951413|NCT00253747|69638452|FG000|Overall Study|Withdrawal by Subject|10|||
37951414|NCT00253747|69638453|FG001|Overall Study|Withdrawal by Subject|11|||
37951415|NCT00253747|69638452|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
37951416|NCT00253747|69638453|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
37951417|NCT00252733|69638471|FG000|Overall Study|Withdrawal by Subject|73|||
37951418|NCT00252733|69638472|FG001|Overall Study|Withdrawal by Subject|67|||
37951419|NCT00252733|69638471|FG000|Overall Study|Death|7|||
37951420|NCT00252733|69638472|FG001|Overall Study|Death|5|||
37951421|NCT00252733|69638471|FG000|Overall Study|Lost to Follow-up|12|||
37951422|NCT00252733|69638472|FG001|Overall Study|Lost to Follow-up|6|||
37951423|NCT00252733|69638471|FG000|Overall Study|Multiple Reasons|14|||
37951424|NCT00252733|69638472|FG001|Overall Study|Multiple Reasons|14|||
37951425|NCT00275821|69638481|FG000|Overall Study|Adverse Event|4|||
37951426|NCT00275821|69638482|FG001|Overall Study|Adverse Event|12|||
37951427|NCT00275821|69638483|FG002|Overall Study|Adverse Event|5|||
37951428|NCT00275821|69638481|FG000|Overall Study|Administrative problems|3|||
38042720|NCT02883452|69730362|FG004|Overall Study|Adverse Event|1|||
37951429|NCT00275821|69638482|FG001|Overall Study|Administrative problems|4|||
37951430|NCT00275821|69638483|FG002|Overall Study|Administrative problems|4|||
37951431|NCT00275821|69638481|FG000|Overall Study|Withdrawal by Subject|0|||
37951432|NCT00275821|69638482|FG001|Overall Study|Withdrawal by Subject|2|||
37951433|NCT00275821|69638483|FG002|Overall Study|Withdrawal by Subject|1|||
37951434|NCT00275821|69638481|FG000|Overall Study|Lost to Follow-up|0|||
37951435|NCT00275821|69638482|FG001|Overall Study|Lost to Follow-up|1|||
37951436|NCT00275821|69638483|FG002|Overall Study|Lost to Follow-up|1|||
37951437|NCT00275821|69638481|FG000|Overall Study|Death|0|||
37951438|NCT00275821|69638482|FG001|Overall Study|Death|2|||
37951439|NCT00275821|69638483|FG002|Overall Study|Death|1|||
37951440|NCT00275821|69638481|FG000|Overall Study|Lack of Efficacy|2|||
37951441|NCT00275821|69638482|FG001|Overall Study|Lack of Efficacy|1|||
37951442|NCT00275821|69638483|FG002|Overall Study|Lack of Efficacy|0|||
37951443|NCT00275821|69638481|FG000|Overall Study|Protocol Violation|5|||
37951444|NCT00275821|69638482|FG001|Overall Study|Protocol Violation|1|||
37951445|NCT00275821|69638483|FG002|Overall Study|Protocol Violation|0|||
37951446|NCT00275509|69638493|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
37951447|NCT00275509|69638494|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
37951448|NCT00252577|69638500|FG000|Overall Study|Lost to Follow-up|20|||
37951449|NCT00252499|69638507|FG000|Overall Study|Lost to Follow-up|1|||
37951450|NCT00252499|69638508|FG001|Overall Study|Lost to Follow-up|0|||
37951451|NCT00252499|69638509|FG002|Overall Study|Lost to Follow-up|0|||
37951452|NCT00252187|69638519|FG000|Overall Study|Adverse Event|3|||
37951453|NCT00252187|69638520|FG001|Overall Study|Adverse Event|1|||
37951454|NCT00252187|69638519|FG000|Overall Study|Withdrawal by Subject|1|||
37951455|NCT00252187|69638520|FG001|Overall Study|Withdrawal by Subject|0|||
37951456|NCT00572910|69638532|FG000|Overall Study|Adverse Event|1|||
37951457|NCT00572910|69638533|FG001|Overall Study|Adverse Event|2|||
37951458|NCT00572910|69638534|FG002|Overall Study|Adverse Event|0|||
37951459|NCT00572910|69638535|FG003|Overall Study|Adverse Event|2|||
37951460|NCT00572910|69638536|FG004|Overall Study|Adverse Event|0|||
37951461|NCT00572910|69638537|FG005|Overall Study|Adverse Event|0|||
37951462|NCT00572910|69638538|FG006|Overall Study|Adverse Event|4|||
37951463|NCT00572910|69638539|FG007|Overall Study|Adverse Event|2|||
37951464|NCT00572910|69638540|FG008|Overall Study|Adverse Event|1|||
37951465|NCT00572910|69638541|FG009|Overall Study|Adverse Event|3|||
37951466|NCT00572910|69638542|FG010|Overall Study|Adverse Event|2|||
37951467|NCT00572910|69638532|FG000|Overall Study|Lost to Follow-up|0|||
37951468|NCT00572910|69638533|FG001|Overall Study|Lost to Follow-up|1|||
37951469|NCT00572910|69638534|FG002|Overall Study|Lost to Follow-up|1|||
37951470|NCT00572910|69638535|FG003|Overall Study|Lost to Follow-up|2|||
37951471|NCT00572910|69638536|FG004|Overall Study|Lost to Follow-up|1|||
37951472|NCT00572910|69638537|FG005|Overall Study|Lost to Follow-up|0|||
37951473|NCT00572910|69638538|FG006|Overall Study|Lost to Follow-up|0|||
37951474|NCT00572910|69638539|FG007|Overall Study|Lost to Follow-up|0|||
37951475|NCT00572910|69638540|FG008|Overall Study|Lost to Follow-up|0|||
37951476|NCT00572910|69638541|FG009|Overall Study|Lost to Follow-up|1|||
37951477|NCT00572910|69638542|FG010|Overall Study|Lost to Follow-up|0|||
37951478|NCT00572910|69638532|FG000|Overall Study|Withdrawal by Subject|3|||
37951479|NCT00572910|69638533|FG001|Overall Study|Withdrawal by Subject|0|||
37951480|NCT00572910|69638534|FG002|Overall Study|Withdrawal by Subject|1|||
37951481|NCT00572910|69638535|FG003|Overall Study|Withdrawal by Subject|0|||
37951482|NCT00572910|69638536|FG004|Overall Study|Withdrawal by Subject|1|||
37951483|NCT00572910|69638537|FG005|Overall Study|Withdrawal by Subject|3|||
37951484|NCT00572910|69638538|FG006|Overall Study|Withdrawal by Subject|0|||
37951485|NCT00572910|69638539|FG007|Overall Study|Withdrawal by Subject|2|||
37951486|NCT00572910|69638540|FG008|Overall Study|Withdrawal by Subject|2|||
37951487|NCT00572910|69638541|FG009|Overall Study|Withdrawal by Subject|2|||
37951488|NCT00572910|69638542|FG010|Overall Study|Withdrawal by Subject|1|||
37951489|NCT00163657|69638580|FG000|Overall Study|Death|12|||
37951490|NCT00163657|69638581|FG001|Overall Study|Death|14|||
37951491|NCT00163657|69638582|FG002|Overall Study|Death|19|||
37951492|NCT00163657|69638580|FG000|Overall Study|graft loss|4|||
37951493|NCT00163657|69638581|FG001|Overall Study|graft loss|1|||
37951494|NCT00163657|69638582|FG002|Overall Study|graft loss|2|||
37951495|NCT00163657|69638580|FG000|Overall Study|Withdrawal by Subject|2|||
37951496|NCT00163657|69638581|FG001|Overall Study|Withdrawal by Subject|3|||
37951497|NCT00163657|69638582|FG002|Overall Study|Withdrawal by Subject|2|||
37951498|NCT00163657|69638580|FG000|Overall Study|Physician Decision|0|||
37951499|NCT00163657|69638581|FG001|Overall Study|Physician Decision|1|||
37951500|NCT00163657|69638582|FG002|Overall Study|Physician Decision|1|||
37951501|NCT00163657|69638580|FG000|Overall Study|Non Compliance|1|||
37951502|NCT00163657|69638581|FG001|Overall Study|Non Compliance|0|||
37951503|NCT00163657|69638582|FG002|Overall Study|Non Compliance|0|||
37951504|NCT00163657|69638580|FG000|Overall Study|Lost to Follow-up|1|||
37951505|NCT00163657|69638581|FG001|Overall Study|Lost to Follow-up|3|||
37951506|NCT00163657|69638582|FG002|Overall Study|Lost to Follow-up|10|||
37951507|NCT00163657|69638580|FG000|Overall Study|Other reason|0|||
37951508|NCT00163657|69638581|FG001|Overall Study|Other reason|1|||
37951509|NCT00163657|69638582|FG002|Overall Study|Other reason|3|||
37951510|NCT00609492|69638593|FG000|Overall Study|Withdrawal by Subject|0|||
37951511|NCT00609492|69638594|FG001|Overall Study|Withdrawal by Subject|2|||
37951512|NCT00609492|69638595|FG002|Overall Study|Withdrawal by Subject|3|||
37951513|NCT00609492|69638593|FG000|Overall Study|Lost to Follow-up|1|||
37951514|NCT00609492|69638594|FG001|Overall Study|Lost to Follow-up|1|||
37951515|NCT00609492|69638595|FG002|Overall Study|Lost to Follow-up|4|||
37951516|NCT00230971|69638607|FG000|Randomization|No study drug administered|3|||
37951517|NCT00230971|69638608|FG001|Randomization|No study drug administered|3|||
37951518|NCT00230971|69638607|FG000|Baseline Participants|Lost to Follow-up|5|||
37951519|NCT00230971|69638608|FG001|Baseline Participants|Lost to Follow-up|12|||
37951520|NCT00230971|69638607|FG000|Baseline Participants|Death|6|||
37951521|NCT00230971|69638608|FG001|Baseline Participants|Death|5|||
37951522|NCT00230971|69638607|FG000|Baseline Participants|Withdrawal by Subject|7|||
37951523|NCT00230971|69638608|FG001|Baseline Participants|Withdrawal by Subject|1|||
37951524|NCT00230971|69638607|FG000|Baseline Participants|Adverse Event|1|||
37951525|NCT00230971|69638608|FG001|Baseline Participants|Adverse Event|0|||
37951526|NCT00230971|69638607|FG000|Baseline Participants|No bacteria observed|1|||
37951527|NCT00230971|69638608|FG001|Baseline Participants|No bacteria observed|0|||
37951528|NCT00230971|69638607|FG000|Baseline Participants|Failure to return|1|||
37951529|NCT00230971|69638608|FG001|Baseline Participants|Failure to return|1|||
37951530|NCT00230971|69638607|FG000|Baseline Participants|Reintervention|1|||
37951531|NCT00230971|69638608|FG001|Baseline Participants|Reintervention|0|||
37951532|NCT00211081|69638614|FG000|Overall Study|Withdrawal by Subject|2|||
37951533|NCT00609336|69638618|FG000|Overall Study|Protocol Violation|3|||
37951534|NCT00609336|69638618|FG000|Overall Study|Death|1|||
37951535|NCT00609336|69638618|FG000|Overall Study|LA or Met at Surgery|9|||
37951536|NCT00612066|69638623|FG000|Overall Study|Adverse Event|1|||
37951537|NCT00573144|69638629|FG000|Overall Study|Withdrawal by Subject|2|||
37951538|NCT00573144|69638630|FG001|Overall Study|Withdrawal by Subject|3|||
37951539|NCT00640328|69638642|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
37951540|NCT00640328|69638643|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
37951541|NCT00640328|69638644|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
37951542|NCT00640328|69638645|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
37951543|NCT00640328|69638646|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
37951544|NCT00640328|69638647|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
37951545|NCT00640328|69638642|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
37951546|NCT00640328|69638643|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
37951547|NCT00640328|69638644|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
37951548|NCT00640328|69638645|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
37951549|NCT00640328|69638646|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
37951550|NCT00640328|69638647|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
37951551|NCT00640328|69638642|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
37951552|NCT00640328|69638643|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
37951553|NCT00640328|69638644|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
37951554|NCT00640328|69638645|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
37951555|NCT00640328|69638646|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
37951556|NCT00640328|69638647|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
37951557|NCT00640328|69638642|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
37951558|NCT00640328|69638643|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
37951559|NCT00640328|69638644|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
37951560|NCT00640328|69638645|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
37951561|NCT00640328|69638646|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
37951562|NCT00640328|69638647|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
37951563|NCT00163189|69638668|FG000|Overall Study|Other|6|||
37951564|NCT00163189|69638668|FG000|Overall Study|Lost to Follow-up|1|||
37951565|NCT00163189|69638668|FG000|Overall Study|Protocol Violation|2|||
37951566|NCT00163189|69638668|FG000|Overall Study|Death|3|||
37951567|NCT00163189|69638668|FG000|Overall Study|Adverse Event|6|||
37951568|NCT00163189|69638668|FG000|Overall Study|Lack of Efficacy|7|||
37951569|NCT00163189|69638668|FG000|Overall Study|Study terminated by sponsor|11|||
37951570|NCT00163189|69638668|FG000|Overall Study|Withdrawal by Subject|11|||
37951571|NCT00163189|69638668|FG000|Overall Study|Did not meet continuation criterion|16|||
37951572|NCT00162097|69638676|FG000|Overall Study|Participant no longer met study criteria|0|||
37951573|NCT00162097|69638677|FG001|Overall Study|Participant no longer met study criteria|0|||
37951574|NCT00162097|69638678|FG002|Overall Study|Participant no longer met study criteria|0|||
37951575|NCT00162097|69638679|FG003|Overall Study|Participant no longer met study criteria|1|||
37951576|NCT00640016|69638699|FG000|Overall Study|Withdrawal by Subject|0|||
37951577|NCT00640016|69638700|FG001|Overall Study|Withdrawal by Subject|1|||
37951578|NCT00640016|69638701|FG002|Overall Study|Withdrawal by Subject|0|||
37951579|NCT00640016|69638702|FG003|Overall Study|Withdrawal by Subject|0|||
37951580|NCT00640016|69638699|FG000|Overall Study|Study termination|2|||
37951581|NCT00640016|69638700|FG001|Overall Study|Study termination|1|||
37951582|NCT00640016|69638701|FG002|Overall Study|Study termination|3|||
37951583|NCT00640016|69638702|FG003|Overall Study|Study termination|2|||
37951584|NCT00640016|69638699|FG000|Overall Study|Adverse Event|0|||
37951585|NCT00640016|69638700|FG001|Overall Study|Adverse Event|0|||
37951586|NCT00640016|69638701|FG002|Overall Study|Adverse Event|0|||
37951587|NCT00640016|69638702|FG003|Overall Study|Adverse Event|1|||
37951588|NCT00608868|69638719|FG000|Overall Study|Withdrawal by Subject|7|||
37951589|NCT00608868|69638719|FG000|Overall Study|Protocol Violation|3|||
37951590|NCT00608868|69638719|FG000|Overall Study|Lost to Follow-up|2|||
37951591|NCT00608868|69638719|FG000|Overall Study|Adverse Event|1|||
37951592|NCT00608868|69638719|FG000|Overall Study|Physician Decision|2|||
37951593|NCT00608322|69638725|FG000|Overall Study|Death|2|||
37951594|NCT00608322|69638726|FG001|Overall Study|Death|1|||
37951595|NCT00608244|69638732|FG000|Overall Study|Adverse Event|1|||
37951596|NCT00608244|69638732|FG000|Overall Study|Low trough levels|1|||
37951597|NCT00605280|69638742|FG000|Year 1|Protocol Violation|0|||
37951598|NCT00605280|69638743|FG001|Year 1|Protocol Violation|0|||
37951599|NCT00605280|69638744|FG002|Year 1|Protocol Violation|0|||
37951600|NCT00605280|69638745|FG003|Year 1|Protocol Violation|1|||
37951601|NCT00605280|69638742|FG000|Year 1|Adverse Event|3|||
37951602|NCT00605280|69638743|FG001|Year 1|Adverse Event|1|||
37951603|NCT00605280|69638744|FG002|Year 1|Adverse Event|1|||
37951604|NCT00605280|69638745|FG003|Year 1|Adverse Event|5|||
37951605|NCT00605280|69638742|FG000|Year 1|Physician Decision|7|||
37951606|NCT00605280|69638743|FG001|Year 1|Physician Decision|4|||
37951607|NCT00605280|69638744|FG002|Year 1|Physician Decision|0|||
37951608|NCT00605280|69638745|FG003|Year 1|Physician Decision|6|||
37951609|NCT00605280|69638742|FG000|Year 1|Withdrawal by Subject|2|||
37951610|NCT00605280|69638743|FG001|Year 1|Withdrawal by Subject|4|||
37951611|NCT00605280|69638744|FG002|Year 1|Withdrawal by Subject|0|||
37951612|NCT00605280|69638745|FG003|Year 1|Withdrawal by Subject|4|||
37951613|NCT00605280|69638742|FG000|Year 1|Other|2|||
37951614|NCT00605280|69638743|FG001|Year 1|Other|1|||
37951615|NCT00605280|69638744|FG002|Year 1|Other|0|||
37951616|NCT00605280|69638745|FG003|Year 1|Other|1|||
37951617|NCT00605280|69638742|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
37951618|NCT00605280|69638743|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
37951619|NCT00605280|69638744|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
37951620|NCT00605280|69638745|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
37951621|NCT00605280|69638742|FG000|Year 2|Adverse Event|4|||
37951622|NCT00605280|69638743|FG001|Year 2|Adverse Event|0|||
37951623|NCT00605280|69638744|FG002|Year 2|Adverse Event|2|||
37951624|NCT00605280|69638745|FG003|Year 2|Adverse Event|4|||
37951625|NCT00605280|69638742|FG000|Year 2|Physician Decision|11|||
37951626|NCT00605280|69638743|FG001|Year 2|Physician Decision|6|||
37951627|NCT00605280|69638744|FG002|Year 2|Physician Decision|4|||
37951628|NCT00605280|69638745|FG003|Year 2|Physician Decision|11|||
37951629|NCT00605280|69638742|FG000|Year 2|Withdrawal by Subject|4|||
37951630|NCT00605280|69638743|FG001|Year 2|Withdrawal by Subject|0|||
37951631|NCT00605280|69638744|FG002|Year 2|Withdrawal by Subject|0|||
37951632|NCT00605280|69638745|FG003|Year 2|Withdrawal by Subject|4|||
37951633|NCT00605280|69638742|FG000|Year 2|Other|1|||
37951634|NCT00605280|69638743|FG001|Year 2|Other|0|||
37951635|NCT00605280|69638744|FG002|Year 2|Other|0|||
37951636|NCT00605280|69638745|FG003|Year 2|Other|1|||
37951637|NCT00605280|69638742|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
37951638|NCT00605280|69638743|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
37951639|NCT00605280|69638744|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
37951640|NCT00605280|69638745|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
37951641|NCT00605280|69638742|FG000|Year 3 Extension|Adverse Event|2|||
37951642|NCT00605280|69638743|FG001|Year 3 Extension|Adverse Event|0|||
37951643|NCT00605280|69638744|FG002|Year 3 Extension|Adverse Event|0|||
37951644|NCT00605280|69638745|FG003|Year 3 Extension|Adverse Event|2|||
37951645|NCT00605280|69638742|FG000|Year 3 Extension|Physician Decision|0|||
37951646|NCT00605280|69638743|FG001|Year 3 Extension|Physician Decision|0|||
37951647|NCT00605280|69638744|FG002|Year 3 Extension|Physician Decision|0|||
37951648|NCT00605280|69638745|FG003|Year 3 Extension|Physician Decision|2|||
37951649|NCT00605280|69638742|FG000|Year 3 Extension|Withdrawal by Subject|2|||
37951650|NCT00605280|69638743|FG001|Year 3 Extension|Withdrawal by Subject|0|||
37951651|NCT00605280|69638744|FG002|Year 3 Extension|Withdrawal by Subject|0|||
37951652|NCT00605280|69638745|FG003|Year 3 Extension|Withdrawal by Subject|5|||
37951653|NCT00605280|69638742|FG000|Year 3 Extension|Other|2|||
37951654|NCT00605280|69638743|FG001|Year 3 Extension|Other|0|||
37951655|NCT00605280|69638744|FG002|Year 3 Extension|Other|0|||
37951656|NCT00605280|69638745|FG003|Year 3 Extension|Other|0|||
37951657|NCT00605280|69638742|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
37951658|NCT00605280|69638743|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
37951659|NCT00605280|69638744|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
37951660|NCT00605280|69638745|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
37951661|NCT00607386|69638755|FG000|Overall Study|Physician Decision|1|||
37951662|NCT00638690|69638761|FG000|Overall Study|Death|655|||
37951663|NCT00638690|69638762|FG001|Overall Study|Death|335|||
37951664|NCT00638690|69638761|FG000|Overall Study|Withdrawal by Subject|22|||
37951665|NCT00638690|69638762|FG001|Overall Study|Withdrawal by Subject|5|||
37951666|NCT00638690|69638761|FG000|Overall Study|Lost to Follow-up|4|||
37951667|NCT00638690|69638762|FG001|Overall Study|Lost to Follow-up|2|||
37951668|NCT00543387|69638778|FG000|Panel 1 + Panel 2|Adverse Event|0|||
37951669|NCT00543387|69638779|FG001|Panel 1 + Panel 2|Adverse Event|1|||
37951670|NCT00543387|69638780|FG002|Panel 1 + Panel 2|Adverse Event|0|||
37951671|NCT00543387|69638781|FG003|Panel 1 + Panel 2|Adverse Event|0|||
37951672|NCT00543387|69638782|FG004|Panel 1 + Panel 2|Adverse Event|0|||
37951673|NCT00543387|69638783|FG005|Panel 1 + Panel 2|Adverse Event|0|||
37951674|NCT00543387|69638784|FG006|Panel 1 + Panel 2|Adverse Event|0|||
37951675|NCT00543387|69638785|FG007|Panel 1 + Panel 2|Adverse Event|1|||
37951676|NCT00543387|69638786|FG008|Panel 1 + Panel 2|Adverse Event|1|||
37951677|NCT00543387|69638787|FG009|Panel 1 + Panel 2|Adverse Event|0|||
37951678|NCT00543387|69638788|FG010|Panel 1 + Panel 2|Adverse Event|0|||
37951679|NCT00543387|69638778|FG000|Panel 1 + Panel 2|Physician Decision|0|||
37951680|NCT00543387|69638779|FG001|Panel 1 + Panel 2|Physician Decision|0|||
37951681|NCT00543387|69638780|FG002|Panel 1 + Panel 2|Physician Decision|1|||
37951682|NCT00543387|69638781|FG003|Panel 1 + Panel 2|Physician Decision|0|||
37951683|NCT00543387|69638782|FG004|Panel 1 + Panel 2|Physician Decision|0|||
37951684|NCT00543387|69638783|FG005|Panel 1 + Panel 2|Physician Decision|0|||
37951685|NCT00543387|69638784|FG006|Panel 1 + Panel 2|Physician Decision|0|||
37951686|NCT00543387|69638785|FG007|Panel 1 + Panel 2|Physician Decision|1|||
37951687|NCT00543387|69638786|FG008|Panel 1 + Panel 2|Physician Decision|0|||
37951688|NCT00543387|69638787|FG009|Panel 1 + Panel 2|Physician Decision|0|||
37951689|NCT00543387|69638788|FG010|Panel 1 + Panel 2|Physician Decision|0|||
37951690|NCT00543387|69638778|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
37951691|NCT00543387|69638779|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
37951692|NCT00543387|69638780|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
37951693|NCT00543387|69638781|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
37951694|NCT00543387|69638782|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
37951695|NCT00543387|69638783|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
37951696|NCT00543387|69638784|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
37951697|NCT00543387|69638785|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
37951698|NCT00543387|69638786|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
37951699|NCT00543387|69638787|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
37951700|NCT00543387|69638788|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
37951701|NCT00543387|69638778|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
37951702|NCT00543387|69638779|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
37951703|NCT00543387|69638780|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
37951704|NCT00543387|69638781|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
37951705|NCT00543387|69638782|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
37951706|NCT00543387|69638783|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
37951707|NCT00543387|69638784|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
37951708|NCT00543387|69638785|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
37951709|NCT00543387|69638786|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
37951710|NCT00543387|69638787|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
37951711|NCT00543387|69638788|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
37951712|NCT00543387|69638778|FG000|Crossover Participants|Progressive Disease|0|||
37951713|NCT00543387|69638779|FG001|Crossover Participants|Progressive Disease|0|||
37951714|NCT00543387|69638780|FG002|Crossover Participants|Progressive Disease|0|||
37951715|NCT00543387|69638781|FG003|Crossover Participants|Progressive Disease|0|||
37951716|NCT00543387|69638782|FG004|Crossover Participants|Progressive Disease|0|||
37951717|NCT00543387|69638783|FG005|Crossover Participants|Progressive Disease|0|||
37951718|NCT00543387|69638784|FG006|Crossover Participants|Progressive Disease|0|||
37951719|NCT00543387|69638785|FG007|Crossover Participants|Progressive Disease|0|||
37951720|NCT00543387|69638786|FG008|Crossover Participants|Progressive Disease|0|||
37951721|NCT00543387|69638787|FG009|Crossover Participants|Progressive Disease|1|||
37951722|NCT00543387|69638788|FG010|Crossover Participants|Progressive Disease|2|||
37951723|NCT00543387|69638778|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
37951724|NCT00543387|69638779|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
37951725|NCT00543387|69638780|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
37951726|NCT00543387|69638781|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
37951727|NCT00543387|69638782|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
37951728|NCT00543387|69638783|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
37951729|NCT00543387|69638784|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
37951730|NCT00543387|69638785|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
37951731|NCT00543387|69638786|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
37951732|NCT00543387|69638787|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
37951733|NCT00543387|69638788|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
37951734|NCT00635570|69638818|FG000|Overall Study|Lost to Follow-up|8|||
37951735|NCT00635570|69638819|FG001|Overall Study|Lost to Follow-up|8|||
37951736|NCT00635570|69638818|FG000|Overall Study|Withdrawal by Subject|1|||
37951737|NCT00635570|69638819|FG001|Overall Study|Withdrawal by Subject|1|||
37951738|NCT00635570|69638818|FG000|Overall Study|Adverse Event|2|||
37951739|NCT00635570|69638819|FG001|Overall Study|Adverse Event|0|||
37951740|NCT00635570|69638818|FG000|Overall Study|Physician Decision|1|||
37951741|NCT00635570|69638819|FG001|Overall Study|Physician Decision|0|||
37951742|NCT00635570|69638818|FG000|Overall Study|Did not complete survey|2|||
37951743|NCT00635570|69638819|FG001|Overall Study|Did not complete survey|1|||
37951744|NCT00635570|69638818|FG000|Overall Study|Early termination(No sexual activity)|1|||
37951745|NCT00635570|69638819|FG001|Overall Study|Early termination(No sexual activity)|1|||
37951746|NCT00635492|69638827|FG000|Overall Study|Death|12|||
37951747|NCT00635492|69638828|FG001|Overall Study|Death|40|||
37951748|NCT00635492|69638827|FG000|Overall Study|Lost to Follow-up|151|||
37951749|NCT00635492|69638828|FG001|Overall Study|Lost to Follow-up|172|||
37951750|NCT00635492|69638827|FG000|Overall Study|Physician Decision|32|||
37951751|NCT00635492|69638828|FG001|Overall Study|Physician Decision|22|||
37951752|NCT00635492|69638827|FG000|Overall Study|Sponsor decision|2|||
37951753|NCT00635492|69638828|FG001|Overall Study|Sponsor decision|3|||
37951754|NCT00635492|69638827|FG000|Overall Study|Withdrawal by Subject|82|||
37951755|NCT00635492|69638828|FG001|Overall Study|Withdrawal by Subject|45|||
37951756|NCT00543309|69638841|FG000|Overall Study|Physician Decision|0|||
37951757|NCT00543309|69638842|FG001|Overall Study|Physician Decision|1|||
37951758|NCT00543309|69638843|FG002|Overall Study|Physician Decision|0|||
37951759|NCT00569582|69638852|FG000|Overall Study|Withdrawal by Subject|5|||
37951760|NCT00569582|69638852|FG000|Overall Study|Death|2|||
37951761|NCT00569582|69638852|FG000|Overall Study|Adverse Event|7|||
37951762|NCT00569582|69638852|FG000|Overall Study|Subject was too ill to travel.|1|||
37951763|NCT00569582|69638852|FG000|Overall Study|Subject was non-compliant.|1|||
37951764|NCT00721409|69638859|FG000|Overall Study|Global deterioration of health status|2|||
37951765|NCT00721409|69638860|FG001|Overall Study|Global deterioration of health status|6|||
37951766|NCT00721409|69638861|FG002|Overall Study|Global deterioration of health status|3|||
37951767|NCT00721409|69638859|FG000|Overall Study|Death|0|||
37951768|NCT00721409|69638860|FG001|Overall Study|Death|1|||
37951769|NCT00721409|69638861|FG002|Overall Study|Death|0|||
37951770|NCT00721409|69638859|FG000|Overall Study|Randomized not Treated|0|||
37951771|NCT00721409|69638860|FG001|Overall Study|Randomized not Treated|1|||
37951772|NCT00721409|69638861|FG002|Overall Study|Randomized not Treated|4|||
37951773|NCT00721409|69638859|FG000|Overall Study|Reason not specified|1|||
37951774|NCT00721409|69638860|FG001|Overall Study|Reason not specified|0|||
37951775|NCT00721409|69638861|FG002|Overall Study|Reason not specified|2|||
37951776|NCT00721409|69638859|FG000|Overall Study|Adverse Event|0|||
37951777|NCT00721409|69638860|FG001|Overall Study|Adverse Event|13|||
37951778|NCT00721409|69638861|FG002|Overall Study|Adverse Event|2|||
37951779|NCT00721409|69638859|FG000|Overall Study|Lost to Follow-up|0|||
37951780|NCT00721409|69638860|FG001|Overall Study|Lost to Follow-up|0|||
37951781|NCT00721409|69638861|FG002|Overall Study|Lost to Follow-up|1|||
37951782|NCT00721409|69638859|FG000|Overall Study|Withdrawal by Subject|1|||
37951783|NCT00721409|69638860|FG001|Overall Study|Withdrawal by Subject|6|||
37951784|NCT00721409|69638861|FG002|Overall Study|Withdrawal by Subject|5|||
37951785|NCT00721409|69638859|FG000|Overall Study|Objective progression or relapse|8|||
37951786|NCT00721409|69638860|FG001|Overall Study|Objective progression or relapse|55|||
37951787|NCT00721409|69638861|FG002|Overall Study|Objective progression or relapse|62|||
37951788|NCT00542997|69638885|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
37951789|NCT00542997|69638885|FG000|Wash in / Wash Out Period|Adverse Event|3|||
37951790|NCT00542997|69638885|FG000|Efficacy Period|Adverse Event|3|||
37951791|NCT00572832|69638894|FG000|Overall Study|Lost to Follow-up|0|||
37951792|NCT00572832|69638895|FG001|Overall Study|Lost to Follow-up|11|||
37951793|NCT00572832|69638894|FG000|Overall Study|Pregnancy|0|||
37951794|NCT00572832|69638895|FG001|Overall Study|Pregnancy|1|||
37951795|NCT03917823|69638903|FG000|Overall Study|Lost to Follow-up|1|||
37951796|NCT03917823|69638904|FG001|Overall Study|Lost to Follow-up|1|||
37951797|NCT03917823|69638903|FG000|Overall Study|Withdrawal by Subject|0|||
37951798|NCT03917823|69638904|FG001|Overall Study|Withdrawal by Subject|1|||
37951799|NCT00229723|69638917|FG000|Concomitant Phase|Adverse Event|4|||
37951800|NCT00229723|69638918|FG001|Concomitant Phase|Adverse Event|2|||
37951801|NCT00229723|69638919|FG002|Concomitant Phase|Adverse Event|5|||
37951802|NCT00229723|69638920|FG003|Concomitant Phase|Adverse Event|2|||
37951803|NCT00229723|69638921|FG004|Concomitant Phase|Adverse Event|0|||
37951804|NCT00229723|69638922|FG005|Concomitant Phase|Adverse Event|1|||
37951805|NCT00229723|69638923|FG006|Concomitant Phase|Adverse Event|2|||
37951806|NCT00229723|69638917|FG000|Concomitant Phase|Objective disease progression|0|||
37951807|NCT00229723|69638918|FG001|Concomitant Phase|Objective disease progression|0|||
37951808|NCT00229723|69638919|FG002|Concomitant Phase|Objective disease progression|0|||
37951809|NCT00229723|69638920|FG003|Concomitant Phase|Objective disease progression|0|||
37951810|NCT00229723|69638921|FG004|Concomitant Phase|Objective disease progression|0|||
37951811|NCT00229723|69638922|FG005|Concomitant Phase|Objective disease progression|0|||
37951812|NCT00229723|69638923|FG006|Concomitant Phase|Objective disease progression|0|||
37951813|NCT00229723|69638917|FG000|Concomitant Phase|Clinical progression|0|||
37951814|NCT00229723|69638918|FG001|Concomitant Phase|Clinical progression|0|||
37951815|NCT00229723|69638919|FG002|Concomitant Phase|Clinical progression|0|||
37951816|NCT00229723|69638920|FG003|Concomitant Phase|Clinical progression|0|||
37951817|NCT00229723|69638921|FG004|Concomitant Phase|Clinical progression|0|||
37951818|NCT00229723|69638922|FG005|Concomitant Phase|Clinical progression|0|||
37951819|NCT00229723|69638923|FG006|Concomitant Phase|Clinical progression|1|||
37951820|NCT00229723|69638917|FG000|Concomitant Phase|Lost to Follow-up|0|||
37951821|NCT00229723|69638918|FG001|Concomitant Phase|Lost to Follow-up|0|||
37951822|NCT00229723|69638919|FG002|Concomitant Phase|Lost to Follow-up|0|||
37951823|NCT00229723|69638920|FG003|Concomitant Phase|Lost to Follow-up|0|||
37951824|NCT00229723|69638921|FG004|Concomitant Phase|Lost to Follow-up|1|||
37951825|NCT00229723|69638922|FG005|Concomitant Phase|Lost to Follow-up|0|||
37951826|NCT00229723|69638923|FG006|Concomitant Phase|Lost to Follow-up|0|||
37951827|NCT00229723|69638917|FG000|Concomitant Phase|Informed consent withdrawn|3|||
37951828|NCT00229723|69638918|FG001|Concomitant Phase|Informed consent withdrawn|2|||
37951829|NCT00229723|69638919|FG002|Concomitant Phase|Informed consent withdrawn|0|||
37951830|NCT00229723|69638920|FG003|Concomitant Phase|Informed consent withdrawn|2|||
37951831|NCT00229723|69638921|FG004|Concomitant Phase|Informed consent withdrawn|0|||
37951832|NCT00229723|69638922|FG005|Concomitant Phase|Informed consent withdrawn|0|||
37951833|NCT00229723|69638923|FG006|Concomitant Phase|Informed consent withdrawn|0|||
37951834|NCT00229723|69638917|FG000|Concomitant Phase|Severe non-compliance|0|||
37951835|NCT00229723|69638918|FG001|Concomitant Phase|Severe non-compliance|1|||
37951836|NCT00229723|69638919|FG002|Concomitant Phase|Severe non-compliance|0|||
37951837|NCT00229723|69638920|FG003|Concomitant Phase|Severe non-compliance|0|||
37951838|NCT00229723|69638921|FG004|Concomitant Phase|Severe non-compliance|1|||
37951839|NCT00229723|69638922|FG005|Concomitant Phase|Severe non-compliance|0|||
37951840|NCT00229723|69638923|FG006|Concomitant Phase|Severe non-compliance|0|||
37951841|NCT00229723|69638917|FG000|Concomitant Phase|Other|3|||
37951842|NCT00229723|69638918|FG001|Concomitant Phase|Other|0|||
37951843|NCT00229723|69638919|FG002|Concomitant Phase|Other|1|||
37951844|NCT00229723|69638920|FG003|Concomitant Phase|Other|1|||
37951845|NCT00229723|69638921|FG004|Concomitant Phase|Other|0|||
37951846|NCT00229723|69638922|FG005|Concomitant Phase|Other|2|||
37951847|NCT00229723|69638923|FG006|Concomitant Phase|Other|0|||
37951848|NCT00229723|69638917|FG000|Maintenance Phase|Adverse Event|7|||
37951849|NCT00229723|69638918|FG001|Maintenance Phase|Adverse Event|2|||
37951850|NCT00229723|69638919|FG002|Maintenance Phase|Adverse Event|1|||
37951851|NCT00229723|69638920|FG003|Maintenance Phase|Adverse Event|4|||
37951852|NCT00229723|69638921|FG004|Maintenance Phase|Adverse Event|7|||
37951853|NCT00229723|69638922|FG005|Maintenance Phase|Adverse Event|5|||
37951854|NCT00229723|69638923|FG006|Maintenance Phase|Adverse Event|2|||
37951855|NCT00229723|69638917|FG000|Maintenance Phase|Objective disease progression|5|||
37951856|NCT00229723|69638918|FG001|Maintenance Phase|Objective disease progression|5|||
37951857|NCT00229723|69638919|FG002|Maintenance Phase|Objective disease progression|3|||
37951858|NCT00229723|69638920|FG003|Maintenance Phase|Objective disease progression|6|||
37951859|NCT00229723|69638921|FG004|Maintenance Phase|Objective disease progression|2|||
37951860|NCT00229723|69638922|FG005|Maintenance Phase|Objective disease progression|9|||
37951861|NCT00229723|69638923|FG006|Maintenance Phase|Objective disease progression|5|||
37951862|NCT00229723|69638917|FG000|Maintenance Phase|Clinical progression|4|||
37951863|NCT00229723|69638918|FG001|Maintenance Phase|Clinical progression|1|||
37951864|NCT00229723|69638919|FG002|Maintenance Phase|Clinical progression|2|||
37951865|NCT00229723|69638920|FG003|Maintenance Phase|Clinical progression|2|||
37951866|NCT00229723|69638921|FG004|Maintenance Phase|Clinical progression|1|||
37677349|NCT01659255|69152300|FG012|Overall Study|Sponsor's Decision|0|||
37951867|NCT00229723|69638922|FG005|Maintenance Phase|Clinical progression|1|||
37951868|NCT00229723|69638923|FG006|Maintenance Phase|Clinical progression|1|||
37951869|NCT00229723|69638917|FG000|Maintenance Phase|Lost to Follow-up|0|||
37951870|NCT00229723|69638918|FG001|Maintenance Phase|Lost to Follow-up|1|||
37951871|NCT00229723|69638919|FG002|Maintenance Phase|Lost to Follow-up|2|||
37951872|NCT00229723|69638920|FG003|Maintenance Phase|Lost to Follow-up|2|||
37951873|NCT00229723|69638921|FG004|Maintenance Phase|Lost to Follow-up|0|||
37951874|NCT00229723|69638922|FG005|Maintenance Phase|Lost to Follow-up|0|||
37951875|NCT00229723|69638923|FG006|Maintenance Phase|Lost to Follow-up|1|||
37951876|NCT00229723|69638917|FG000|Maintenance Phase|Informed consent withdrawn|1|||
37951877|NCT00229723|69638918|FG001|Maintenance Phase|Informed consent withdrawn|0|||
37951878|NCT00229723|69638919|FG002|Maintenance Phase|Informed consent withdrawn|0|||
37951879|NCT00229723|69638920|FG003|Maintenance Phase|Informed consent withdrawn|1|||
37951880|NCT00229723|69638921|FG004|Maintenance Phase|Informed consent withdrawn|1|||
37951881|NCT00229723|69638922|FG005|Maintenance Phase|Informed consent withdrawn|1|||
37951882|NCT00229723|69638923|FG006|Maintenance Phase|Informed consent withdrawn|0|||
37951883|NCT00229723|69638917|FG000|Maintenance Phase|Severe non-compliance|3|||
37951884|NCT00229723|69638918|FG001|Maintenance Phase|Severe non-compliance|1|||
37951885|NCT00229723|69638919|FG002|Maintenance Phase|Severe non-compliance|0|||
37951886|NCT00229723|69638920|FG003|Maintenance Phase|Severe non-compliance|0|||
37951887|NCT00229723|69638921|FG004|Maintenance Phase|Severe non-compliance|1|||
37951888|NCT00229723|69638922|FG005|Maintenance Phase|Severe non-compliance|0|||
37951889|NCT00229723|69638923|FG006|Maintenance Phase|Severe non-compliance|0|||
37951890|NCT00229723|69638917|FG000|Maintenance Phase|Other|5|||
37951891|NCT00229723|69638918|FG001|Maintenance Phase|Other|4|||
37951892|NCT00229723|69638919|FG002|Maintenance Phase|Other|1|||
37951893|NCT00229723|69638920|FG003|Maintenance Phase|Other|2|||
37951894|NCT00229723|69638921|FG004|Maintenance Phase|Other|3|||
37951895|NCT00229723|69638922|FG005|Maintenance Phase|Other|3|||
37951896|NCT00229723|69638923|FG006|Maintenance Phase|Other|1|||
37951897|NCT00606684|69638945|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
37951898|NCT00606684|69638946|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
37951899|NCT00606684|69638947|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
37951900|NCT00606684|69638948|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
37951901|NCT00606684|69638949|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
37951902|NCT00606684|69638950|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
37951903|NCT00606684|69638951|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
37951904|NCT00606684|69638945|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
37951905|NCT00606684|69638946|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
37951906|NCT00606684|69638947|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
37951907|NCT00606684|69638948|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
37951908|NCT00606684|69638949|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
37951909|NCT00606684|69638950|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
37951910|NCT00606684|69638951|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
37951911|NCT00606684|69638945|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
37951912|NCT00606684|69638946|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
37951913|NCT00606684|69638947|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
37951914|NCT00606684|69638948|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
37951915|NCT00606684|69638949|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
37951916|NCT00606684|69638950|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
37951917|NCT00606684|69638951|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
37951918|NCT00606684|69638945|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
37951919|NCT00606684|69638946|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
37951920|NCT00606684|69638947|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
37951921|NCT00606684|69638948|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
37951922|NCT00606684|69638949|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
37951923|NCT00606684|69638950|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
37951924|NCT00606684|69638951|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
37951925|NCT00606684|69638945|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
37951926|NCT00606684|69638946|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
37951927|NCT00606684|69638947|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
37951928|NCT00606684|69638948|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
37951929|NCT00606684|69638949|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
37951930|NCT00606684|69638950|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
37951931|NCT00606684|69638951|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
37951932|NCT00606684|69638945|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
37951933|NCT00606684|69638946|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
37951934|NCT00606684|69638947|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
37951935|NCT00606684|69638948|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
37951936|NCT00606684|69638949|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
37951937|NCT00606684|69638950|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
37951938|NCT00606684|69638951|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
37951939|NCT00606684|69638945|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
37951940|NCT00606684|69638946|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
37951941|NCT00606684|69638947|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
37951942|NCT00606684|69638948|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
37951943|NCT00606684|69638949|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
37951944|NCT00606684|69638950|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
37951945|NCT00606684|69638951|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
37951946|NCT00606684|69638945|FG000|Double-Blind Treatment Period|Adverse Event|0|||
37951947|NCT00606684|69638946|FG001|Double-Blind Treatment Period|Adverse Event|3|||
37951948|NCT00606684|69638947|FG002|Double-Blind Treatment Period|Adverse Event|2|||
37951949|NCT00606684|69638948|FG003|Double-Blind Treatment Period|Adverse Event|4|||
37951950|NCT00606684|69638949|FG004|Double-Blind Treatment Period|Adverse Event|2|||
37951951|NCT00606684|69638950|FG005|Double-Blind Treatment Period|Adverse Event|0|||
37951952|NCT00606684|69638951|FG006|Double-Blind Treatment Period|Adverse Event|1|||
37951953|NCT00606684|69638945|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
37951954|NCT00606684|69638946|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
37951955|NCT00606684|69638947|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
37951956|NCT00606684|69638948|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
37951957|NCT00606684|69638949|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
37951958|NCT00606684|69638950|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
37951959|NCT00606684|69638951|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
37951960|NCT00606684|69638945|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
37951961|NCT00606684|69638946|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
37951962|NCT00606684|69638947|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
37951963|NCT00606684|69638948|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
37951964|NCT00606684|69638949|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
37951965|NCT00606684|69638950|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
37951966|NCT00606684|69638951|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
37951967|NCT00606684|69638945|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
37951968|NCT00606684|69638946|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
37951969|NCT00606684|69638947|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
37951970|NCT00606684|69638948|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
37951971|NCT00606684|69638949|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
37951972|NCT00606684|69638950|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
37951973|NCT00606684|69638951|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
37951974|NCT00606684|69638945|FG000|Double-Blind Treatment Period|Physician Decision|0|||
37951975|NCT00606684|69638946|FG001|Double-Blind Treatment Period|Physician Decision|5|||
37951976|NCT00606684|69638947|FG002|Double-Blind Treatment Period|Physician Decision|1|||
37951977|NCT00606684|69638948|FG003|Double-Blind Treatment Period|Physician Decision|0|||
37951978|NCT00606684|69638949|FG004|Double-Blind Treatment Period|Physician Decision|3|||
37951979|NCT00606684|69638950|FG005|Double-Blind Treatment Period|Physician Decision|1|||
37951980|NCT00606684|69638951|FG006|Double-Blind Treatment Period|Physician Decision|2|||
37951981|NCT00606684|69638945|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
37951982|NCT00606684|69638946|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
37951983|NCT00606684|69638947|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
37951984|NCT00606684|69638948|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
37951985|NCT00606684|69638949|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
37951986|NCT00606684|69638950|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
37951987|NCT00606684|69638951|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
37951988|NCT00627926|69638968|FG000|Overall Study|Adverse Event|26|||
37951989|NCT00627926|69638969|FG001|Overall Study|Adverse Event|37|||
37951990|NCT00627926|69638970|FG002|Overall Study|Adverse Event|36|||
37951991|NCT00627926|69638968|FG000|Overall Study|Death|1|||
37951992|NCT00627926|69638969|FG001|Overall Study|Death|0|||
37951993|NCT00627926|69638970|FG002|Overall Study|Death|0|||
37951994|NCT00627926|69638968|FG000|Overall Study|Lost to Follow-up|4|||
37951995|NCT00627926|69638969|FG001|Overall Study|Lost to Follow-up|3|||
37951996|NCT00627926|69638970|FG002|Overall Study|Lost to Follow-up|4|||
37951997|NCT00627926|69638968|FG000|Overall Study|Withdrawal by Subject|2|||
37951998|NCT00627926|69638969|FG001|Overall Study|Withdrawal by Subject|1|||
37951999|NCT00627926|69638970|FG002|Overall Study|Withdrawal by Subject|0|||
37952000|NCT00627926|69638968|FG000|Overall Study|Lack of Efficacy|118|||
37952001|NCT00627926|69638969|FG001|Overall Study|Lack of Efficacy|40|||
37952002|NCT00627926|69638970|FG002|Overall Study|Lack of Efficacy|38|||
37952003|NCT00627926|69638968|FG000|Overall Study|Noncompliance/unspecified|8|||
37952004|NCT00627926|69638969|FG001|Overall Study|Noncompliance/unspecified|23|||
37952005|NCT00627926|69638970|FG002|Overall Study|Noncompliance/unspecified|17|||
37952006|NCT00228553|69638978|FG000|Overall Study|Adverse Event|112|||
37952007|NCT00228553|69638978|FG000|Overall Study|Lack of Efficacy|34|||
37952008|NCT00228553|69638978|FG000|Overall Study|Lost to Follow-up|67|||
37952009|NCT00228553|69638978|FG000|Overall Study|Physician Decision|48|||
37952010|NCT00228553|69638978|FG000|Overall Study|Protocol Violation|6|||
37952011|NCT00228553|69638978|FG000|Overall Study|Withdrawal by Subject|115|||
37952012|NCT00228553|69638978|FG000|Overall Study|Pregnancy|2|||
37952013|NCT00228553|69638978|FG000|Overall Study|Miscellaneous|46|||
37952014|NCT00643916|69638988|FG000|Overall Study|Protocol Violation|0|||
37952015|NCT00643916|69638989|FG001|Overall Study|Protocol Violation|1|||
37952016|NCT00643916|69638990|FG002|Overall Study|Protocol Violation|1|||
37952017|NCT00643916|69638991|FG003|Overall Study|Protocol Violation|1|||
37952018|NCT00643916|69638992|FG004|Overall Study|Protocol Violation|0|||
37952019|NCT00643916|69638993|FG005|Overall Study|Protocol Violation|0|||
37952020|NCT00643916|69638988|FG000|Overall Study|Lost to Follow-up|0|||
37952021|NCT00643916|69638989|FG001|Overall Study|Lost to Follow-up|1|||
37952022|NCT00643916|69638990|FG002|Overall Study|Lost to Follow-up|0|||
37952023|NCT00643916|69638991|FG003|Overall Study|Lost to Follow-up|0|||
37952024|NCT00643916|69638992|FG004|Overall Study|Lost to Follow-up|0|||
37952025|NCT00643916|69638993|FG005|Overall Study|Lost to Follow-up|0|||
37952026|NCT00643916|69638988|FG000|Overall Study|Withdrawal by Subject|2|||
37952027|NCT00643916|69638989|FG001|Overall Study|Withdrawal by Subject|2|||
37952028|NCT00643916|69638990|FG002|Overall Study|Withdrawal by Subject|2|||
37952029|NCT00643916|69638991|FG003|Overall Study|Withdrawal by Subject|1|||
37952030|NCT00643916|69638992|FG004|Overall Study|Withdrawal by Subject|0|||
37952031|NCT00643916|69638993|FG005|Overall Study|Withdrawal by Subject|1|||
37952032|NCT00643916|69638988|FG000|Overall Study|Not Vaccinated|2|||
37952033|NCT00643916|69638989|FG001|Overall Study|Not Vaccinated|2|||
37952034|NCT00643916|69638990|FG002|Overall Study|Not Vaccinated|3|||
37952035|NCT00643916|69638991|FG003|Overall Study|Not Vaccinated|0|||
37952036|NCT00643916|69638992|FG004|Overall Study|Not Vaccinated|2|||
37952037|NCT00643916|69638993|FG005|Overall Study|Not Vaccinated|0|||
37952038|NCT00160693|69639007|FG000|Overall Study|Adverse Event|97|||
37952039|NCT00160693|69639007|FG000|Overall Study|Lack of Efficacy|30|||
37952040|NCT00160693|69639007|FG000|Overall Study|Protocol Violation|24|||
37952041|NCT00160693|69639007|FG000|Overall Study|Lost to Follow-up|15|||
37952042|NCT00160693|69639007|FG000|Overall Study|Withdrawal by Subject|54|||
37952043|NCT00160693|69639007|FG000|Overall Study|Study terminated by sponsor|15|||
37952044|NCT00643760|69639016|FG000|Overall Study|Adverse Event|11|||
37952045|NCT00643760|69639017|FG001|Overall Study|Adverse Event|5|||
37952046|NCT00643760|69639018|FG002|Overall Study|Adverse Event|12|||
37952047|NCT00643760|69639019|FG003|Overall Study|Adverse Event|21|||
37952048|NCT00643760|69639020|FG004|Overall Study|Adverse Event|6|||
37952049|NCT00643760|69639016|FG000|Overall Study|Lack of Efficacy|3|||
37952050|NCT00643760|69639017|FG001|Overall Study|Lack of Efficacy|1|||
37952051|NCT00643760|69639018|FG002|Overall Study|Lack of Efficacy|0|||
37952052|NCT00643760|69639019|FG003|Overall Study|Lack of Efficacy|4|||
37952053|NCT00643760|69639020|FG004|Overall Study|Lack of Efficacy|3|||
37952054|NCT00643760|69639016|FG000|Overall Study|Protocol Violation|7|||
37952055|NCT00643760|69639017|FG001|Overall Study|Protocol Violation|6|||
37952056|NCT00643760|69639018|FG002|Overall Study|Protocol Violation|4|||
37952057|NCT00643760|69639019|FG003|Overall Study|Protocol Violation|4|||
37952058|NCT00643760|69639020|FG004|Overall Study|Protocol Violation|6|||
37952059|NCT00643760|69639016|FG000|Overall Study|Lost to Follow-up|6|||
37952060|NCT00643760|69639017|FG001|Overall Study|Lost to Follow-up|2|||
37952061|NCT00643760|69639018|FG002|Overall Study|Lost to Follow-up|1|||
37952062|NCT00643760|69639019|FG003|Overall Study|Lost to Follow-up|3|||
37952063|NCT00643760|69639020|FG004|Overall Study|Lost to Follow-up|3|||
37952064|NCT00643760|69639016|FG000|Overall Study|Investigator Discretion|0|||
37952065|NCT00643760|69639017|FG001|Overall Study|Investigator Discretion|0|||
37952066|NCT00643760|69639018|FG002|Overall Study|Investigator Discretion|0|||
37952067|NCT00643760|69639019|FG003|Overall Study|Investigator Discretion|2|||
37952068|NCT00643760|69639020|FG004|Overall Study|Investigator Discretion|0|||
37952069|NCT00643760|69639016|FG000|Overall Study|Withdrawal by Subject|3|||
37952070|NCT00643760|69639017|FG001|Overall Study|Withdrawal by Subject|1|||
37952071|NCT00643760|69639018|FG002|Overall Study|Withdrawal by Subject|2|||
37952072|NCT00643760|69639019|FG003|Overall Study|Withdrawal by Subject|4|||
37952073|NCT00643760|69639020|FG004|Overall Study|Withdrawal by Subject|1|||
37952074|NCT00643682|69639034|FG000|Overall Study|did not keep appointment|522|||
37952075|NCT00643682|69639035|FG001|Overall Study|did not keep appointment|509|||
37952076|NCT00643604|69639041|FG000|Overall Study|Death|1|||
37952077|NCT00603798|69639048|FG000|Overall Study|Adverse Event|4|||
37952078|NCT00603798|69639049|FG001|Overall Study|Adverse Event|2|||
37952079|NCT00603798|69639050|FG002|Overall Study|Adverse Event|1|||
37952080|NCT00603798|69639048|FG000|Overall Study|Withdrawal by Subject|4|||
37952081|NCT00603798|69639049|FG001|Overall Study|Withdrawal by Subject|3|||
37952082|NCT00603798|69639050|FG002|Overall Study|Withdrawal by Subject|4|||
37952083|NCT00603798|69639048|FG000|Overall Study|Lost to Follow-up|1|||
37952084|NCT00603798|69639049|FG001|Overall Study|Lost to Follow-up|0|||
37952085|NCT00603798|69639050|FG002|Overall Study|Lost to Follow-up|1|||
37952086|NCT00603798|69639048|FG000|Overall Study|Non-compliance with study procedures|0|||
37952087|NCT00603798|69639049|FG001|Overall Study|Non-compliance with study procedures|1|||
37952088|NCT00603798|69639050|FG002|Overall Study|Non-compliance with study procedures|0|||
37952089|NCT00603798|69639048|FG000|Overall Study|Not due to AE|1|||
37952090|NCT00603798|69639049|FG001|Overall Study|Not due to AE|1|||
37952091|NCT00603798|69639050|FG002|Overall Study|Not due to AE|4|||
37952092|NCT00630812|69639060|FG000|Randomisation to First Dose|Adverse Event|1|||
37952093|NCT00630812|69639061|FG001|Randomisation to First Dose|Adverse Event|1|||
37952094|NCT00630812|69639060|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
37952095|NCT00630812|69639061|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
37952096|NCT00630812|69639060|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
37952097|NCT00630812|69639061|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
37952098|NCT00630812|69639060|FG000|Randomisation to First Dose|Protocol Violation|4|||
37952099|NCT00630812|69639061|FG001|Randomisation to First Dose|Protocol Violation|1|||
37952100|NCT00630812|69639060|FG000|Double Blind Treatment Period|Adverse Event|13|||
37952101|NCT00630812|69639061|FG001|Double Blind Treatment Period|Adverse Event|5|||
37952102|NCT00630812|69639060|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
37952103|NCT00630812|69639061|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
37952104|NCT00630812|69639060|FG000|Double Blind Treatment Period|Physician Decision|2|||
37952105|NCT00630812|69639061|FG001|Double Blind Treatment Period|Physician Decision|1|||
37952106|NCT00630812|69639060|FG000|Double Blind Treatment Period|Protocol Violation|1|||
37952107|NCT00630812|69639061|FG001|Double Blind Treatment Period|Protocol Violation|0|||
37952108|NCT00630812|69639060|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
37952109|NCT00630812|69639061|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
37952110|NCT00630812|69639060|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
37952111|NCT00630812|69639061|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
37952112|NCT00630812|69639060|FG000|Double Blind Treatment Period|Non-compliance|0|||
37952113|NCT00630812|69639061|FG001|Double Blind Treatment Period|Non-compliance|1|||
37952114|NCT00629798|69639067|FG000|Overall Study|Not Treated|4|||
37952115|NCT00160615|69639073|FG000|Overall Study|Adverse Event|5|||
37952116|NCT00160615|69639074|FG001|Overall Study|Adverse Event|12|||
37952117|NCT00160615|69639073|FG000|Overall Study|Withdrawal by Subject|0|||
37952118|NCT00160615|69639074|FG001|Overall Study|Withdrawal by Subject|2|||
37952119|NCT00160615|69639073|FG000|Overall Study|Lack of Efficacy|11|||
37952120|NCT00160615|69639074|FG001|Overall Study|Lack of Efficacy|23|||
37952121|NCT00160615|69639073|FG000|Overall Study|Patient decision|1|||
37952122|NCT00160615|69639074|FG001|Overall Study|Patient decision|2|||
37952123|NCT00160615|69639073|FG000|Overall Study|Investigator decision|1|||
37952124|NCT00160615|69639074|FG001|Overall Study|Investigator decision|1|||
37952125|NCT00160615|69639073|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
37952126|NCT00160615|69639074|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
37952127|NCT00160615|69639073|FG000|Overall Study|Switch to surgical treatment|0|||
37952128|NCT00160615|69639074|FG001|Overall Study|Switch to surgical treatment|2|||
37952129|NCT00160615|69639073|FG000|Overall Study|Non-compliance was suspected|0|||
37952130|NCT00160615|69639074|FG001|Overall Study|Non-compliance was suspected|1|||
37952131|NCT00160615|69639073|FG000|Overall Study|Poor compliance|0|||
37952132|NCT00160615|69639074|FG001|Overall Study|Poor compliance|1|||
37952133|NCT00643448|69639085|FG000|Overall Study|Lack of Efficacy|2|||
37952134|NCT00643448|69639086|FG001|Overall Study|Lack of Efficacy|0|||
37952135|NCT00643448|69639087|FG002|Overall Study|Lack of Efficacy|4|||
37952136|NCT00643448|69639085|FG000|Overall Study|Adverse Event|2|||
37952137|NCT00643448|69639086|FG001|Overall Study|Adverse Event|2|||
37952138|NCT00643448|69639087|FG002|Overall Study|Adverse Event|2|||
37952139|NCT00643448|69639085|FG000|Overall Study|QTcF>550 ms|0|||
37952140|NCT00643448|69639086|FG001|Overall Study|QTcF>550 ms|3|||
37952141|NCT00643448|69639087|FG002|Overall Study|QTcF>550 ms|0|||
37952142|NCT00604500|69639097|FG000|Overall Study|Adverse Event|2|||
37952143|NCT00604500|69639097|FG000|Overall Study|Protocol Violation|2|||
37952144|NCT00604500|69639097|FG000|Overall Study|Treatment Failure|1|||
37952145|NCT00604500|69639097|FG000|Overall Study|Withdrawal by Subject|4|||
37952146|NCT00604500|69639097|FG000|Overall Study|Administrative|1|||
37952147|NCT00604500|69639097|FG000|Overall Study|Did not meet protocol eligibility|1|||
37952148|NCT00627458|69639104|FG000|Overall Study|Migrated from study area|1|||
37952149|NCT00627458|69639105|FG001|Overall Study|Migrated from study area|0|||
37952150|NCT00627458|69639106|FG002|Overall Study|Migrated from study area|1|||
37952151|NCT00627458|69639104|FG000|Overall Study|Withdrawal by Subject|2|||
37952152|NCT00627458|69639105|FG001|Overall Study|Withdrawal by Subject|6|||
37952153|NCT00627458|69639106|FG002|Overall Study|Withdrawal by Subject|5|||
37952154|NCT00627458|69639104|FG000|Overall Study|Lost to Follow-up|1|||
37952155|NCT00627458|69639105|FG001|Overall Study|Lost to Follow-up|1|||
37952156|NCT00627458|69639106|FG002|Overall Study|Lost to Follow-up|0|||
37952157|NCT00542919|69639118|FG000|Overall Study|Adverse Event|1|||
37952158|NCT00542919|69639119|FG001|Overall Study|Adverse Event|5|||
37952159|NCT00542919|69639120|FG002|Overall Study|Adverse Event|1|||
37952160|NCT00542919|69639118|FG000|Overall Study|Withdrawal by Subject|1|||
37952161|NCT00542919|69639119|FG001|Overall Study|Withdrawal by Subject|0|||
37952162|NCT00542919|69639120|FG002|Overall Study|Withdrawal by Subject|3|||
37952163|NCT00542919|69639118|FG000|Overall Study|Physician Decision|2|||
37952164|NCT00542919|69639119|FG001|Overall Study|Physician Decision|2|||
37952165|NCT00542919|69639120|FG002|Overall Study|Physician Decision|1|||
37952166|NCT00542919|69639118|FG000|Overall Study|Sponsor Decision|1|||
37952167|NCT00542919|69639119|FG001|Overall Study|Sponsor Decision|0|||
37952168|NCT00542919|69639120|FG002|Overall Study|Sponsor Decision|0|||
37952169|NCT00542919|69639118|FG000|Overall Study|Lost to Follow-up|2|||
37952170|NCT00542919|69639119|FG001|Overall Study|Lost to Follow-up|0|||
37952171|NCT00542919|69639120|FG002|Overall Study|Lost to Follow-up|1|||
37952172|NCT00159913|69639147|FG000|Overall Study|Adverse Event|1|||
37952173|NCT00159913|69639148|FG001|Overall Study|Adverse Event|0|||
37952174|NCT00159913|69639149|FG002|Overall Study|Adverse Event|1|||
37952175|NCT00159913|69639150|FG003|Overall Study|Adverse Event|0|||
37952176|NCT00159913|69639147|FG000|Overall Study|Withdrawal by Subject|0|||
37952177|NCT00159913|69639148|FG001|Overall Study|Withdrawal by Subject|0|||
37952178|NCT00159913|69639149|FG002|Overall Study|Withdrawal by Subject|0|||
37952179|NCT00159913|69639150|FG003|Overall Study|Withdrawal by Subject|1|||
37952180|NCT00159913|69639147|FG000|Overall Study|Lost to Follow-up|0|||
37952181|NCT00159913|69639148|FG001|Overall Study|Lost to Follow-up|0|||
37952182|NCT00159913|69639149|FG002|Overall Study|Lost to Follow-up|0|||
37952183|NCT00159913|69639150|FG003|Overall Study|Lost to Follow-up|1|||
37952184|NCT00159913|69639147|FG000|Overall Study|Protocol Violation|1|||
37952185|NCT00159913|69639148|FG001|Overall Study|Protocol Violation|0|||
37952186|NCT00159913|69639149|FG002|Overall Study|Protocol Violation|1|||
37952187|NCT00159913|69639150|FG003|Overall Study|Protocol Violation|0|||
37952188|NCT00604188|69639164|FG000|Overall Study|Adverse Event|1|||
37952189|NCT00604188|69639165|FG001|Overall Study|Adverse Event|4|||
37952190|NCT00604188|69639164|FG000|Overall Study|Lost to Follow-up|17|||
37952191|NCT00604188|69639165|FG001|Overall Study|Lost to Follow-up|15|||
37952192|NCT00604188|69639164|FG000|Overall Study|Withdrawal by Subject|5|||
37952193|NCT00604188|69639165|FG001|Overall Study|Withdrawal by Subject|1|||
37952194|NCT00604188|69639164|FG000|Overall Study|Non-compliance with protocol|4|||
37952195|NCT00604188|69639165|FG001|Overall Study|Non-compliance with protocol|4|||
37952196|NCT00604188|69639164|FG000|Overall Study|Did not receive study drug|0|||
37952197|NCT00604188|69639165|FG001|Overall Study|Did not receive study drug|1|||
37952198|NCT03913377|69639173|FG000|Period 1|Test Article no longer available|0|||
37952199|NCT03913377|69639174|FG001|Period 1|Test Article no longer available|1|||
37952200|NCT03913377|69639175|FG002|Period 1|Test Article no longer available|0|||
37952201|NCT03913377|69639173|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
37952202|NCT03913377|69639174|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
37952203|NCT03913377|69639175|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
37952204|NCT00227539|69639182|FG000|Overall Study|Protocol Violation|1|||
37952205|NCT00227305|69639186|FG000|Overall Study|Adverse Event|40|||
37952206|NCT00227305|69639186|FG000|Overall Study|Withdrawal by Subject|42|||
37952207|NCT00227305|69639186|FG000|Overall Study|Lost to Follow-up|33|||
37952208|NCT00227305|69639186|FG000|Overall Study|Study specific discontinuation|13|||
37952209|NCT00227305|69639186|FG000|Overall Study|MOVED OUT OF AREA|3|||
37952210|NCT00227305|69639186|FG000|Overall Study|Lack of Efficacy|7|||
37952211|NCT00227305|69639186|FG000|Overall Study|Physician Decision|3|||
38042721|NCT02883452|69730363|FG005|Overall Study|Adverse Event|3|||
37952212|NCT00227305|69639186|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
37952213|NCT00227305|69639186|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
37952214|NCT00227305|69639186|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
37952215|NCT00720941|69639192|FG000|Overall Study|Death|334|||
37952216|NCT00720941|69639193|FG001|Overall Study|Death|335|||
37952217|NCT00720941|69639192|FG000|Overall Study|Protocol Violation|0|||
37952218|NCT00720941|69639193|FG001|Overall Study|Protocol Violation|2|||
37952219|NCT00720941|69639192|FG000|Overall Study|Lost to Follow-up|17|||
37952220|NCT00720941|69639193|FG001|Overall Study|Lost to Follow-up|15|||
37952221|NCT00720941|69639192|FG000|Overall Study|Physician Decision|1|||
37952222|NCT00720941|69639193|FG001|Overall Study|Physician Decision|5|||
37952223|NCT00720941|69639192|FG000|Overall Study|Withdrawal by Subject|27|||
37952224|NCT00720941|69639193|FG001|Overall Study|Withdrawal by Subject|35|||
37952225|NCT00720941|69639192|FG000|Overall Study|Ongoing|34|||
37952226|NCT00720941|69639193|FG001|Overall Study|Ongoing|23|||
38042722|NCT02883452|69730358|FG000|Overall Study|Physician Decision|0|||
38042723|NCT02883452|69730359|FG001|Overall Study|Physician Decision|0|||
38042724|NCT02883452|69730360|FG002|Overall Study|Physician Decision|0|||
38042725|NCT02883452|69730361|FG003|Overall Study|Physician Decision|0|||
38042726|NCT02883452|69730362|FG004|Overall Study|Physician Decision|4|||
38042727|NCT02883452|69730363|FG005|Overall Study|Physician Decision|1|||
38042728|NCT02883452|69730358|FG000|Overall Study|Death|1|||
38042729|NCT02883452|69730359|FG001|Overall Study|Death|0|||
38042730|NCT02883452|69730360|FG002|Overall Study|Death|1|||
38042731|NCT02883452|69730361|FG003|Overall Study|Death|0|||
38042732|NCT02883452|69730362|FG004|Overall Study|Death|0|||
38042733|NCT02883452|69730363|FG005|Overall Study|Death|0|||
38042734|NCT02883452|69730358|FG000|Overall Study|Other|0|||
38042735|NCT02883452|69730359|FG001|Overall Study|Other|0|||
38042736|NCT02883452|69730360|FG002|Overall Study|Other|0|||
38042737|NCT02883452|69730361|FG003|Overall Study|Other|0|||
38042738|NCT02883452|69730362|FG004|Overall Study|Other|0|||
38042739|NCT02883452|69730363|FG005|Overall Study|Other|1|||
38042740|NCT00151372|69730380|FG000|Overall Study|Death|12|||
38042741|NCT00151372|69730381|FG001|Overall Study|Death|11|||
38042742|NCT00151372|69730380|FG000|Overall Study|Lost to Follow-up|5|||
38042743|NCT00151372|69730381|FG001|Overall Study|Lost to Follow-up|5|||
38042744|NCT00151372|69730380|FG000|Overall Study|Too sick medically to continue|5|||
38042745|NCT00151372|69730381|FG001|Overall Study|Too sick medically to continue|6|||
38042746|NCT00151372|69730380|FG000|Overall Study|Withdrawal by Subject|7|||
38042747|NCT00151372|69730381|FG001|Overall Study|Withdrawal by Subject|7|||
38042748|NCT02603809|69730393|FG000|Overall Study|Withdrawal by Subject|4|||
38042749|NCT02603809|69730394|FG001|Overall Study|Withdrawal by Subject|1|||
38042750|NCT02603809|69730395|FG002|Overall Study|Withdrawal by Subject|2|||
38042751|NCT02603809|69730396|FG003|Overall Study|Withdrawal by Subject|3|||
38042752|NCT02603809|69730397|FG004|Overall Study|Withdrawal by Subject|3|||
38042753|NCT02603809|69730398|FG005|Overall Study|Withdrawal by Subject|4|||
38042754|NCT02603809|69730393|FG000|Overall Study|Lost to Follow-up|2|||
38042755|NCT02603809|69730394|FG001|Overall Study|Lost to Follow-up|3|||
38042756|NCT02603809|69730395|FG002|Overall Study|Lost to Follow-up|1|||
38042757|NCT02603809|69730396|FG003|Overall Study|Lost to Follow-up|4|||
38042758|NCT02603809|69730397|FG004|Overall Study|Lost to Follow-up|2|||
38042759|NCT02603809|69730398|FG005|Overall Study|Lost to Follow-up|2|||
38042760|NCT02603809|69730393|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
38042761|NCT02603809|69730394|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
38042762|NCT02603809|69730395|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
38042763|NCT02603809|69730396|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
38042764|NCT02603809|69730397|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
38042765|NCT02603809|69730398|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
38042766|NCT02603809|69730393|FG000|Overall Study|Physician Decision|0|||
38042767|NCT02603809|69730394|FG001|Overall Study|Physician Decision|0|||
38042768|NCT02603809|69730395|FG002|Overall Study|Physician Decision|0|||
38042769|NCT02603809|69730396|FG003|Overall Study|Physician Decision|1|||
38042770|NCT02603809|69730397|FG004|Overall Study|Physician Decision|2|||
38042771|NCT02603809|69730398|FG005|Overall Study|Physician Decision|1|||
38042772|NCT02603809|69730393|FG000|Overall Study|Adverse Event|3|||
38042773|NCT02603809|69730394|FG001|Overall Study|Adverse Event|0|||
38042774|NCT02603809|69730395|FG002|Overall Study|Adverse Event|2|||
38042775|NCT02603809|69730396|FG003|Overall Study|Adverse Event|2|||
38042776|NCT02603809|69730397|FG004|Overall Study|Adverse Event|1|||
38042777|NCT02603809|69730398|FG005|Overall Study|Adverse Event|1|||
38042778|NCT02603809|69730393|FG000|Overall Study|Lack of Efficacy|0|||
38042779|NCT02603809|69730394|FG001|Overall Study|Lack of Efficacy|1|||
38042780|NCT02603809|69730395|FG002|Overall Study|Lack of Efficacy|0|||
38042781|NCT02603809|69730396|FG003|Overall Study|Lack of Efficacy|0|||
38042782|NCT02603809|69730397|FG004|Overall Study|Lack of Efficacy|0|||
38042783|NCT02603809|69730398|FG005|Overall Study|Lack of Efficacy|1|||
38042784|NCT02741596|69730429|FG000|Overall Study|Adverse Event|1|||
38042785|NCT02741596|69730430|FG001|Overall Study|Adverse Event|5|||
38042786|NCT02741596|69730429|FG000|Overall Study|Lost to Follow-up|1|||
38042787|NCT02741596|69730430|FG001|Overall Study|Lost to Follow-up|1|||
38042788|NCT02741596|69730429|FG000|Overall Study|Physician Decision|2|||
38042789|NCT02741596|69730430|FG001|Overall Study|Physician Decision|1|||
38042790|NCT02741596|69730429|FG000|Overall Study|Pregnancy|3|||
38042791|NCT02741596|69730430|FG001|Overall Study|Pregnancy|1|||
38042792|NCT02741596|69730429|FG000|Overall Study|Other (Unspecified)|0|||
38042793|NCT02741596|69730430|FG001|Overall Study|Other (Unspecified)|3|||
38042794|NCT02741596|69730429|FG000|Overall Study|Subject withdrawn-Other|17|||
38042795|NCT02741596|69730430|FG001|Overall Study|Subject withdrawn-Other|4|||
38042796|NCT02741596|69730429|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
38042797|NCT02741596|69730430|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
38042798|NCT03147248|69730442|FG000|Overall Study|Adverse Event|0|||
38042799|NCT03147248|69730443|FG001|Overall Study|Adverse Event|2|||
38042800|NCT03147248|69730444|FG002|Overall Study|Adverse Event|2|||
38042801|NCT03147248|69730445|FG003|Overall Study|Adverse Event|2|||
38042802|NCT03147248|69730446|FG004|Overall Study|Adverse Event|6|||
38042803|NCT03147248|69730447|FG005|Overall Study|Adverse Event|11|||
38042804|NCT03147248|69730442|FG000|Overall Study|Disease progression|1|||
38042805|NCT03147248|69730443|FG001|Overall Study|Disease progression|0|||
38042806|NCT03147248|69730444|FG002|Overall Study|Disease progression|0|||
38042807|NCT03147248|69730445|FG003|Overall Study|Disease progression|0|||
38042808|NCT03147248|69730446|FG004|Overall Study|Disease progression|0|||
38042809|NCT03147248|69730447|FG005|Overall Study|Disease progression|2|||
38042810|NCT03147248|69730442|FG000|Overall Study|Withdrawal by Subject|0|||
38042811|NCT03147248|69730443|FG001|Overall Study|Withdrawal by Subject|0|||
38042812|NCT03147248|69730444|FG002|Overall Study|Withdrawal by Subject|0|||
38042813|NCT03147248|69730445|FG003|Overall Study|Withdrawal by Subject|0|||
38042814|NCT03147248|69730446|FG004|Overall Study|Withdrawal by Subject|12|||
38042815|NCT03147248|69730447|FG005|Overall Study|Withdrawal by Subject|9|||
38042816|NCT03147248|69730442|FG000|Overall Study|Protocol Violation|0|||
38042817|NCT03147248|69730443|FG001|Overall Study|Protocol Violation|0|||
38042818|NCT03147248|69730444|FG002|Overall Study|Protocol Violation|0|||
38042819|NCT03147248|69730445|FG003|Overall Study|Protocol Violation|0|||
38042820|NCT03147248|69730446|FG004|Overall Study|Protocol Violation|2|||
38042821|NCT03147248|69730447|FG005|Overall Study|Protocol Violation|0|||
38042822|NCT03147248|69730442|FG000|Overall Study|Lost to Follow-up|0|||
38042823|NCT03147248|69730443|FG001|Overall Study|Lost to Follow-up|0|||
38042824|NCT03147248|69730444|FG002|Overall Study|Lost to Follow-up|0|||
38042825|NCT03147248|69730445|FG003|Overall Study|Lost to Follow-up|0|||
38042826|NCT03147248|69730446|FG004|Overall Study|Lost to Follow-up|2|||
38042827|NCT03147248|69730447|FG005|Overall Study|Lost to Follow-up|0|||
38042828|NCT03147248|69730442|FG000|Overall Study|Pregnancy|0|||
38042829|NCT03147248|69730443|FG001|Overall Study|Pregnancy|0|||
38042830|NCT03147248|69730444|FG002|Overall Study|Pregnancy|0|||
38042831|NCT03147248|69730445|FG003|Overall Study|Pregnancy|0|||
38042832|NCT03147248|69730446|FG004|Overall Study|Pregnancy|1|||
38042833|NCT03147248|69730447|FG005|Overall Study|Pregnancy|0|||
38042834|NCT03147248|69730442|FG000|Overall Study|Death|0|||
38042835|NCT03147248|69730443|FG001|Overall Study|Death|0|||
38042836|NCT03147248|69730444|FG002|Overall Study|Death|0|||
38042837|NCT03147248|69730445|FG003|Overall Study|Death|0|||
38042838|NCT03147248|69730446|FG004|Overall Study|Death|0|||
38042839|NCT03147248|69730447|FG005|Overall Study|Death|4|||
38042840|NCT03147248|69730442|FG000|Overall Study|Physician Decision|0|||
38042841|NCT03147248|69730443|FG001|Overall Study|Physician Decision|0|||
38042842|NCT03147248|69730444|FG002|Overall Study|Physician Decision|0|||
38042843|NCT03147248|69730445|FG003|Overall Study|Physician Decision|0|||
38042844|NCT03147248|69730446|FG004|Overall Study|Physician Decision|2|||
38042845|NCT03147248|69730447|FG005|Overall Study|Physician Decision|4|||
38042846|NCT03147248|69730442|FG000|Overall Study|Prolonged Dosing Interval|0|||
38042847|NCT03147248|69730443|FG001|Overall Study|Prolonged Dosing Interval|0|||
38042848|NCT03147248|69730444|FG002|Overall Study|Prolonged Dosing Interval|0|||
38042849|NCT03147248|69730445|FG003|Overall Study|Prolonged Dosing Interval|0|||
38042850|NCT03147248|69730446|FG004|Overall Study|Prolonged Dosing Interval|1|||
38042851|NCT03147248|69730447|FG005|Overall Study|Prolonged Dosing Interval|1|||
38042852|NCT03796039|69730463|FG000|Overall Study|Death|2|||
38042853|NCT03796039|69730464|FG001|Overall Study|Death|1|||
38042854|NCT03796039|69730463|FG000|Overall Study|Withdrawal by Subject|7|||
38042855|NCT03796039|69730464|FG001|Overall Study|Withdrawal by Subject|4|||
38042856|NCT03151304|69730470|FG000|Overall Study|Termination of study by Sponsor|23|||
38042857|NCT03151304|69730470|FG000|Overall Study|missing|3|||
38042858|NCT03151304|69730470|FG000|Overall Study|Withdrawal by Subject|8|||
38042859|NCT03151304|69730470|FG000|Overall Study|multiple reasons|30|||
38042860|NCT03152552|69730479|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
38042861|NCT03152552|69730480|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
38042862|NCT03152552|69730481|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
38042863|NCT03152552|69730482|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
38042864|NCT03152552|69730483|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
38042865|NCT03152552|69730479|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
38042866|NCT03152552|69730480|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
38042867|NCT03152552|69730481|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
38042868|NCT03152552|69730482|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
38042869|NCT03152552|69730483|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
38042870|NCT03152552|69730479|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
38042871|NCT03152552|69730480|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
38042872|NCT03152552|69730481|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
38042873|NCT03152552|69730482|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
38042874|NCT03152552|69730483|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
38042875|NCT03152552|69730479|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
38042876|NCT03152552|69730480|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
38042877|NCT03152552|69730481|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
38042878|NCT03152552|69730482|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
38042879|NCT03152552|69730483|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
38042880|NCT03152552|69730479|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
38042881|NCT03152552|69730480|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
38042882|NCT03152552|69730481|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
38042883|NCT03152552|69730482|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
38042884|NCT03152552|69730483|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
38042885|NCT03152552|69730479|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
38042886|NCT03152552|69730480|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
38042887|NCT03152552|69730481|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
38042888|NCT03152552|69730482|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
38042889|NCT03152552|69730483|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
38042890|NCT03152552|69730479|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
38042891|NCT03152552|69730480|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
38042892|NCT03152552|69730481|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
38042893|NCT03152552|69730482|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
38042894|NCT03152552|69730483|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
38042895|NCT03151226|69730496|FG000|Overall Study|Withdrawal by Subject|2|||
38042896|NCT03151226|69730496|FG000|Overall Study|not wear device correctly|1|||
38042897|NCT03151148|69730502|FG000|Overall Study|Lost to Follow-up|1|||
38042898|NCT03151148|69730503|FG001|Overall Study|Lost to Follow-up|0|||
38042899|NCT03151148|69730502|FG000|Overall Study|Withdrawal by Subject|1|||
38042900|NCT03151148|69730503|FG001|Overall Study|Withdrawal by Subject|0|||
38042901|NCT02741518|69730512|FG000|Overall Study|Withdrawal by Subject|1|||
38042902|NCT02741518|69730513|FG001|Overall Study|Withdrawal by Subject|1|||
38042903|NCT03145766|69730524|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
38042904|NCT03145766|69730525|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
38042905|NCT03145766|69730526|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
38042906|NCT03145766|69730527|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
38042907|NCT03145766|69730528|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
38042908|NCT03145766|69730524|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
38042909|NCT03145766|69730525|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
38042910|NCT03145766|69730526|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
38042911|NCT03145766|69730527|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
38042912|NCT03145766|69730528|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
38042913|NCT03145766|69730524|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
38042914|NCT03145766|69730525|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
38042915|NCT03145766|69730526|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
38042916|NCT03145766|69730527|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
38042917|NCT03145766|69730528|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
38042918|NCT03145766|69730524|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
38042919|NCT03145766|69730525|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
38042920|NCT03145766|69730526|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
38042921|NCT03145766|69730527|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
38042922|NCT03145766|69730528|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
38042923|NCT03145766|69730524|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
38042924|NCT03145766|69730525|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
38042925|NCT03145766|69730526|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
38042926|NCT03145766|69730527|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
38042927|NCT03145766|69730528|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
38042928|NCT03145766|69730524|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
38042929|NCT03145766|69730525|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
38042930|NCT03145766|69730526|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
38042931|NCT03145766|69730527|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
38042932|NCT03145766|69730528|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
38042933|NCT03145766|69730524|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
38042934|NCT03145766|69730525|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
38042935|NCT03145766|69730526|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
38042936|NCT03145766|69730527|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
38042937|NCT03145766|69730528|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
38042938|NCT03145064|69730541|FG000|Overall Study|Death|24|||
38042939|NCT03145064|69730541|FG000|Overall Study|Lost to Follow-up|3|||
38042940|NCT03145064|69730541|FG000|Overall Study|Withdrawal by Subject|6|||
38042941|NCT03145064|69730541|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
38042942|NCT03145064|69730541|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
38042943|NCT03787615|69730566|FG000|Overall Study|Withdrawal by Subject|2|||
38042944|NCT03787615|69730566|FG000|Overall Study|Lost to Follow-up|2|||
38042945|NCT03784963|69730575|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
38042946|NCT03784963|69730576|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
38042947|NCT03784963|69730577|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
38042948|NCT03784963|69730578|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
38042949|NCT03787303|69730588|FG000|Overall Study|Death|1|||
38042950|NCT03787303|69730588|FG000|Overall Study|Premature Termination of Study|1|||
38042951|NCT04170296|69730594|FG000|Overall Study|Adverse Event|1|||
38042952|NCT04170296|69730595|FG001|Overall Study|Adverse Event|0|||
38042953|NCT04170296|69730594|FG000|Overall Study|Withdrawal by Subject|3|||
38042954|NCT04170296|69730595|FG001|Overall Study|Withdrawal by Subject|2|||
38042955|NCT04170296|69730594|FG000|Overall Study|Lost to Follow-up|4|||
38042956|NCT04170296|69730595|FG001|Overall Study|Lost to Follow-up|2|||
38042957|NCT03141788|69730631|FG000|Overall Study|Lost to Follow-up|1|||
38042958|NCT03141788|69730631|FG000|Overall Study|Protocol Violation|3|||
38042959|NCT03141788|69730631|FG000|Overall Study|Withdrawal by Subject|4|||
38042960|NCT03781375|69730640|FG000|Double-blind Phase|Adverse Event|0|||
38042961|NCT03781375|69730641|FG001|Double-blind Phase|Adverse Event|1|||
38042962|NCT03781375|69730640|FG000|Double-blind Phase|Lack of Response|6|||
38042963|NCT03781375|69730641|FG001|Double-blind Phase|Lack of Response|2|||
38042964|NCT03781375|69730640|FG000|Double-blind Phase|Other|1|||
38042965|NCT03781375|69730641|FG001|Double-blind Phase|Other|3|||
38042966|NCT03781375|69730640|FG000|Open-label Phase|Protocol Issues|0|||
38042967|NCT03781375|69730641|FG001|Open-label Phase|Protocol Issues|1|||
38042968|NCT03781375|69730640|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
38042969|NCT03781375|69730641|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
38042970|NCT03781375|69730640|FG000|Open-label Phase|Other|2|||
38042971|NCT03781375|69730641|FG001|Open-label Phase|Other|2|||
38042972|NCT03779503|69730648|FG000|First Intervention|Adverse Event|0|||
38042973|NCT03779503|69730649|FG001|First Intervention|Adverse Event|1|||
38042974|NCT03779503|69730648|FG000|First Intervention|Withdrawal by Subject|1|||
38042975|NCT03779503|69730649|FG001|First Intervention|Withdrawal by Subject|0|||
38042976|NCT03150056|69730661|FG000|Overall Study|Withdrawal by Subject|0|||
38042977|NCT03150056|69730662|FG001|Overall Study|Withdrawal by Subject|0|||
38042978|NCT03150056|69730663|FG002|Overall Study|Withdrawal by Subject|0|||
38042979|NCT03150056|69730664|FG003|Overall Study|Withdrawal by Subject|0|||
38042980|NCT03150056|69730665|FG004|Overall Study|Withdrawal by Subject|0|||
38042981|NCT03150056|69730666|FG005|Overall Study|Withdrawal by Subject|2|||
38042982|NCT03150056|69730661|FG000|Overall Study|Study terminated by Sponsor|1|||
38042983|NCT03150056|69730662|FG001|Overall Study|Study terminated by Sponsor|3|||
38042984|NCT03150056|69730663|FG002|Overall Study|Study terminated by Sponsor|1|||
38042985|NCT03150056|69730664|FG003|Overall Study|Study terminated by Sponsor|1|||
38042986|NCT03150056|69730665|FG004|Overall Study|Study terminated by Sponsor|5|||
38042987|NCT03150056|69730666|FG005|Overall Study|Study terminated by Sponsor|6|||
38042988|NCT03150056|69730661|FG000|Overall Study|Death|9|||
38042989|NCT03150056|69730662|FG001|Overall Study|Death|2|||
38042990|NCT03150056|69730663|FG002|Overall Study|Death|2|||
38042991|NCT03150056|69730664|FG003|Overall Study|Death|7|||
38042992|NCT03150056|69730665|FG004|Overall Study|Death|8|||
38042993|NCT03150056|69730666|FG005|Overall Study|Death|10|||
38042994|NCT02640664|69730686|FG000|Epoch 1|Withdrawal of informed consent|1|||
38042995|NCT02640664|69730687|FG001|Epoch 1|Withdrawal of informed consent|0|||
38042996|NCT02640664|69730688|FG002|Epoch 1|Withdrawal of informed consent|0|||
38042997|NCT02640664|69730686|FG000|Epoch 1|Death|0|||
38042998|NCT02640664|69730687|FG001|Epoch 1|Death|0|||
38042999|NCT02640664|69730688|FG002|Epoch 1|Death|1|||
38043000|NCT02640664|69730686|FG000|Epoch 2|Withdrawal of informed consent|3|||
38043001|NCT02640664|69730687|FG001|Epoch 2|Withdrawal of informed consent|4|||
38043002|NCT02640664|69730688|FG002|Epoch 2|Withdrawal of informed consent|2|||
38043003|NCT02640664|69730686|FG000|Epoch 2|Subject/guardian decision|0|||
37677350|NCT01659255|69152301|FG013|Overall Study|Sponsor's Decision|0|||
38043004|NCT02640664|69730687|FG001|Epoch 2|Subject/guardian decision|2|||
38043005|NCT02640664|69730688|FG002|Epoch 2|Subject/guardian decision|2|||
38043006|NCT02640664|69730686|FG000|Epoch 2|Lost to Follow-up|3|||
38043007|NCT02640664|69730687|FG001|Epoch 2|Lost to Follow-up|4|||
38043008|NCT02640664|69730688|FG002|Epoch 2|Lost to Follow-up|1|||
38043009|NCT02640664|69730686|FG000|Epoch 2|Death|0|||
38043010|NCT02640664|69730687|FG001|Epoch 2|Death|0|||
38043011|NCT02640664|69730688|FG002|Epoch 2|Death|1|||
38043012|NCT00812006|69730700|FG000|Overall Study|Lost to Follow-up|0|||
38043013|NCT00812006|69730701|FG001|Overall Study|Lost to Follow-up|0|||
38043014|NCT00812006|69730702|FG002|Overall Study|Lost to Follow-up|2|||
38043015|NCT00812006|69730700|FG000|Overall Study|Physician Decision|0|||
38043016|NCT00812006|69730701|FG001|Overall Study|Physician Decision|0|||
38043017|NCT00812006|69730702|FG002|Overall Study|Physician Decision|1|||
38043018|NCT00812006|69730700|FG000|Overall Study|Withdrawal by Subject|2|||
38043019|NCT00812006|69730701|FG001|Overall Study|Withdrawal by Subject|1|||
38043020|NCT00812006|69730702|FG002|Overall Study|Withdrawal by Subject|1|||
38043021|NCT00812006|69730700|FG000|Overall Study|Lack of Qualifying Event|4|||
38043022|NCT00812006|69730701|FG001|Overall Study|Lack of Qualifying Event|2|||
38043023|NCT00812006|69730702|FG002|Overall Study|Lack of Qualifying Event|2|||
38043024|NCT04988308|69730736|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|2|||
38043025|NCT04988308|69730737|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
38043026|NCT04988308|69730738|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
38043027|NCT04988308|69730739|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
38043028|NCT04988308|69730740|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
38043029|NCT04988308|69730741|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
38043030|NCT04988308|69730736|FG000|Placebo Controlled Period (Weeks 0-16)|Death|0|||
38043031|NCT04988308|69730737|FG001|Placebo Controlled Period (Weeks 0-16)|Death|0|||
38043032|NCT04988308|69730738|FG002|Placebo Controlled Period (Weeks 0-16)|Death|1|||
38043033|NCT04988308|69730739|FG003|Placebo Controlled Period (Weeks 0-16)|Death|0|||
38043034|NCT04988308|69730740|FG004|Placebo Controlled Period (Weeks 0-16)|Death|0|||
38043035|NCT04988308|69730741|FG005|Placebo Controlled Period (Weeks 0-16)|Death|0|||
38043036|NCT04988308|69730736|FG000|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
38043037|NCT04988308|69730737|FG001|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
38043038|NCT04988308|69730738|FG002|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
38043039|NCT04988308|69730739|FG003|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
38043040|NCT04988308|69730740|FG004|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
38043041|NCT04988308|69730741|FG005|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
38043042|NCT04988308|69730736|FG000|Placebo Controlled Period (Weeks 0-16)|Other|10|||
38043043|NCT04988308|69730737|FG001|Placebo Controlled Period (Weeks 0-16)|Other|9|||
38043044|NCT04988308|69730738|FG002|Placebo Controlled Period (Weeks 0-16)|Other|14|||
38043045|NCT04988308|69730739|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
38043046|NCT04988308|69730740|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
38043047|NCT04988308|69730741|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
38043048|NCT04988308|69730736|FG000|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|6|||
38043049|NCT04988308|69730737|FG001|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|4|||
38043050|NCT04988308|69730738|FG002|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|3|||
38043051|NCT04988308|69730739|FG003|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
38043052|NCT04988308|69730740|FG004|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
38043053|NCT04988308|69730741|FG005|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
38043054|NCT04988308|69730736|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
38043055|NCT04988308|69730737|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
38043056|NCT04988308|69730738|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
38043057|NCT04988308|69730739|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|3|||
38043058|NCT04988308|69730740|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
38043059|NCT04988308|69730741|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
38043060|NCT04988308|69730736|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
38043061|NCT04988308|69730737|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
38043062|NCT04988308|69730738|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
38043063|NCT04988308|69730739|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
38043064|NCT04988308|69730740|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
38043065|NCT04988308|69730741|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
38043066|NCT04988308|69730736|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
38043067|NCT04988308|69730737|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
38043068|NCT04988308|69730738|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
38043069|NCT04988308|69730739|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
38043070|NCT04988308|69730740|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
38043071|NCT04988308|69730741|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|14|||
38043072|NCT04988308|69730736|FG000|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
38043073|NCT04988308|69730737|FG001|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
38043074|NCT04988308|69730738|FG002|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
38043075|NCT04988308|69730739|FG003|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|5|||
38043076|NCT04988308|69730740|FG004|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|6|||
38043077|NCT04988308|69730741|FG005|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|2|||
38043078|NCT04737109|69730754|FG000|Study Treatment|Disease Progression|5|||
38043079|NCT04737109|69730755|FG001|Study Treatment|Disease Progression|0|||
38043080|NCT04737109|69730756|FG002|Study Treatment|Disease Progression|0|||
38043081|NCT04737109|69730757|FG003|Study Treatment|Disease Progression|0|||
38043082|NCT04737109|69730754|FG000|Study Treatment|Death on study|1|||
38043083|NCT04737109|69730755|FG001|Study Treatment|Death on study|0|||
38043084|NCT04737109|69730756|FG002|Study Treatment|Death on study|0|||
38043085|NCT04737109|69730757|FG003|Study Treatment|Death on study|0|||
38043086|NCT04582669|69730775|FG000|Overall Study|Subject missed appointment(s).|1|||
38043087|NCT04582669|69730776|FG001|Overall Study|Subject missed appointment(s).|0|||
38043088|NCT04582669|69730777|FG002|Overall Study|Subject missed appointment(s).|1|||
38043089|NCT04582669|69730778|FG003|Overall Study|Subject missed appointment(s).|2|||
38043090|NCT04582669|69730775|FG000|Overall Study|Protocol Violation|0|||
38043091|NCT04582669|69730776|FG001|Overall Study|Protocol Violation|1|||
38043092|NCT04582669|69730777|FG002|Overall Study|Protocol Violation|1|||
38043093|NCT04582669|69730778|FG003|Overall Study|Protocol Violation|0|||
38043094|NCT04560309|69730790|FG000|Overall Study|Meet drop out criteria|1|||
38043095|NCT04560309|69730791|FG001|Overall Study|Meet drop out criteria|1|||
38043096|NCT04535986|69730799|FG000|Overall Study|Death|4|||
38043097|NCT04535986|69730800|FG001|Overall Study|Death|5|||
38043098|NCT04535986|69730799|FG000|Overall Study|COPD exacerbation withdrawal criteria|7|||
38043099|NCT04535986|69730800|FG001|Overall Study|COPD exacerbation withdrawal criteria|5|||
38043100|NCT04535986|69730799|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|8|||
38043101|NCT04535986|69730800|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|6|||
38043102|NCT04535986|69730799|FG000|Overall Study|Adverse Event|10|||
38043103|NCT04535986|69730800|FG001|Overall Study|Adverse Event|1|||
38043104|NCT04535986|69730799|FG000|Overall Study|Lack of Efficacy|3|||
38043105|NCT04535986|69730800|FG001|Overall Study|Lack of Efficacy|2|||
38043106|NCT04535986|69730799|FG000|Overall Study|Investigator discretion|3|||
38043107|NCT04535986|69730800|FG001|Overall Study|Investigator discretion|0|||
38043108|NCT04535986|69730799|FG000|Overall Study|Withdrawal by Subject|32|||
38043109|NCT04535986|69730800|FG001|Overall Study|Withdrawal by Subject|14|||
38043110|NCT04535986|69730799|FG000|Overall Study|Lost to Follow-up|5|||
38043111|NCT04535986|69730800|FG001|Overall Study|Lost to Follow-up|3|||
38043112|NCT04535986|69730799|FG000|Overall Study|Other|7|||
38043113|NCT04535986|69730800|FG001|Overall Study|Other|3|||
38043114|NCT04187196|69730810|FG000|Overall Study|Screen Failure|2|||
38043115|NCT04187196|69730811|FG001|Overall Study|Screen Failure|0|||
38043116|NCT04091971|69730817|FG000|Overall Study|Withdrawal by Subject|1|||
38043117|NCT04091971|69730817|FG000|Overall Study|No longer met eligibility criteria after enrollment.|2|||
38043118|NCT04091971|69730817|FG000|Overall Study|Panic attack during MRI; no MRI or PET but completed ketamine and other procedures|1|||
38043119|NCT03902613|69730846|FG000|Overall Study|Physician Decision|1|||
38043120|NCT03299842|69730894|FG000|Overall Study|Caregiver withdrew consent|2|||
38043121|NCT03299842|69730894|FG000|Overall Study|Child would not keep the watch on|3|||
38043122|NCT03237611|69730898|FG000|Overall Study|Withdrawal by Subject|1|||
38043123|NCT03237611|69730898|FG000|Overall Study|Ineligible|1|||
38043124|NCT03104374|69730905|FG000|Overall Study|Adverse Event|7|||
38043125|NCT03104374|69730906|FG001|Overall Study|Adverse Event|6|||
38043126|NCT03104374|69730907|FG002|Overall Study|Adverse Event|12|||
38043127|NCT03104374|69730908|FG003|Overall Study|Adverse Event|15|||
38043128|NCT03104374|69730905|FG000|Overall Study|Withdrawal by Subject|18|||
38043129|NCT03104374|69730906|FG001|Overall Study|Withdrawal by Subject|10|||
38043130|NCT03104374|69730907|FG002|Overall Study|Withdrawal by Subject|10|||
38043131|NCT03104374|69730908|FG003|Overall Study|Withdrawal by Subject|17|||
38043132|NCT03104374|69730905|FG000|Overall Study|Lost to Follow-up|4|||
38043133|NCT03104374|69730906|FG001|Overall Study|Lost to Follow-up|4|||
38043134|NCT03104374|69730907|FG002|Overall Study|Lost to Follow-up|6|||
38043135|NCT03104374|69730908|FG003|Overall Study|Lost to Follow-up|8|||
38043136|NCT03104374|69730905|FG000|Overall Study|Lack of Efficacy|6|||
38043137|NCT03104374|69730906|FG001|Overall Study|Lack of Efficacy|7|||
38043138|NCT03104374|69730907|FG002|Overall Study|Lack of Efficacy|12|||
38043139|NCT03104374|69730908|FG003|Overall Study|Lack of Efficacy|6|||
38043140|NCT03104374|69730905|FG000|Overall Study|Other|2|||
38043141|NCT03104374|69730906|FG001|Overall Study|Other|2|||
38043142|NCT03104374|69730907|FG002|Overall Study|Other|4|||
38043143|NCT03104374|69730908|FG003|Overall Study|Other|7|||
38043144|NCT03043313|69730941|FG000|Overall Study|Withdrawal by Subject|4|||
38043145|NCT03043313|69730942|FG001|Overall Study|Withdrawal by Subject|1|||
38043146|NCT03043313|69730943|FG002|Overall Study|Withdrawal by Subject|1|||
38043147|NCT03043313|69730941|FG000|Overall Study|Lost to Follow-up|1|||
38043148|NCT03043313|69730942|FG001|Overall Study|Lost to Follow-up|0|||
38043149|NCT03043313|69730943|FG002|Overall Study|Lost to Follow-up|0|||
38043150|NCT03043313|69730941|FG000|Overall Study|Death|26|||
38043151|NCT03043313|69730942|FG001|Overall Study|Death|13|||
38043152|NCT03043313|69730943|FG002|Overall Study|Death|8|||
38043153|NCT03043313|69730941|FG000|Overall Study|On Treatment|7|||
38043154|NCT03043313|69730942|FG001|Overall Study|On Treatment|12|||
38043155|NCT03043313|69730943|FG002|Overall Study|On Treatment|11|||
38043156|NCT03043313|69730941|FG000|Overall Study|In follow up|7|||
38043157|NCT03043313|69730942|FG001|Overall Study|In follow up|15|||
38043158|NCT03043313|69730943|FG002|Overall Study|In follow up|11|||
38043159|NCT02834780|69730963|FG000|Overall Study|Disease Progression -Radiologically Confirmed|1|||
38043160|NCT02834780|69730964|FG001|Overall Study|Disease Progression -Radiologically Confirmed|3|||
38043161|NCT02834780|69730965|FG002|Overall Study|Disease Progression -Radiologically Confirmed|2|||
38043162|NCT02834780|69730966|FG003|Overall Study|Disease Progression -Radiologically Confirmed|7|||
38043163|NCT02834780|69730967|FG004|Overall Study|Disease Progression -Radiologically Confirmed|1|||
38043164|NCT02834780|69730968|FG005|Overall Study|Disease Progression -Radiologically Confirmed|6|||
38043165|NCT02834780|69730969|FG006|Overall Study|Disease Progression -Radiologically Confirmed|2|||
38043166|NCT02834780|69730970|FG007|Overall Study|Disease Progression -Radiologically Confirmed|4|||
38043167|NCT02834780|69730971|FG008|Overall Study|Disease Progression -Radiologically Confirmed|3|||
38043168|NCT02834780|69730972|FG009|Overall Study|Disease Progression -Radiologically Confirmed|6|||
38043169|NCT02834780|69730973|FG010|Overall Study|Disease Progression -Radiologically Confirmed|3|||
38043170|NCT02834780|69730974|FG011|Overall Study|Disease Progression -Radiologically Confirmed|24|||
38043171|NCT02834780|69730975|FG012|Overall Study|Disease Progression -Radiologically Confirmed|32|||
38043172|NCT02834780|69730963|FG000|Overall Study|Withdrawal by Subject|0|||
38043173|NCT02834780|69730964|FG001|Overall Study|Withdrawal by Subject|0|||
38043174|NCT02834780|69730965|FG002|Overall Study|Withdrawal by Subject|1|||
38043175|NCT02834780|69730966|FG003|Overall Study|Withdrawal by Subject|0|||
38043176|NCT02834780|69730967|FG004|Overall Study|Withdrawal by Subject|0|||
38043177|NCT02834780|69730968|FG005|Overall Study|Withdrawal by Subject|0|||
38043178|NCT02834780|69730969|FG006|Overall Study|Withdrawal by Subject|0|||
38043179|NCT02834780|69730970|FG007|Overall Study|Withdrawal by Subject|0|||
38043180|NCT02834780|69730971|FG008|Overall Study|Withdrawal by Subject|0|||
38043181|NCT02834780|69730972|FG009|Overall Study|Withdrawal by Subject|0|||
38043182|NCT02834780|69730973|FG010|Overall Study|Withdrawal by Subject|1|||
38043183|NCT02834780|69730974|FG011|Overall Study|Withdrawal by Subject|0|||
38043184|NCT02834780|69730975|FG012|Overall Study|Withdrawal by Subject|0|||
38043185|NCT02834780|69730963|FG000|Overall Study|Adverse Event|0|||
38043186|NCT02834780|69730964|FG001|Overall Study|Adverse Event|0|||
38043187|NCT02834780|69730965|FG002|Overall Study|Adverse Event|0|||
38043188|NCT02834780|69730966|FG003|Overall Study|Adverse Event|0|||
38043189|NCT02834780|69730967|FG004|Overall Study|Adverse Event|1|||
38043190|NCT02834780|69730968|FG005|Overall Study|Adverse Event|0|||
38043191|NCT02834780|69730969|FG006|Overall Study|Adverse Event|1|||
38043192|NCT02834780|69730970|FG007|Overall Study|Adverse Event|1|||
38043193|NCT02834780|69730971|FG008|Overall Study|Adverse Event|0|||
38043194|NCT02834780|69730972|FG009|Overall Study|Adverse Event|2|||
38043195|NCT02834780|69730973|FG010|Overall Study|Adverse Event|0|||
38043196|NCT02834780|69730974|FG011|Overall Study|Adverse Event|3|||
38043197|NCT02834780|69730975|FG012|Overall Study|Adverse Event|2|||
38043198|NCT02834780|69730963|FG000|Overall Study|Disease Progression - Clinically Confirmed|1|||
38043199|NCT02834780|69730964|FG001|Overall Study|Disease Progression - Clinically Confirmed|0|||
38043200|NCT02834780|69730965|FG002|Overall Study|Disease Progression - Clinically Confirmed|0|||
38043201|NCT02834780|69730966|FG003|Overall Study|Disease Progression - Clinically Confirmed|1|||
38043202|NCT02834780|69730967|FG004|Overall Study|Disease Progression - Clinically Confirmed|1|||
38043203|NCT02834780|69730968|FG005|Overall Study|Disease Progression - Clinically Confirmed|1|||
38043204|NCT02834780|69730969|FG006|Overall Study|Disease Progression - Clinically Confirmed|1|||
38043205|NCT02834780|69730970|FG007|Overall Study|Disease Progression - Clinically Confirmed|2|||
38043206|NCT02834780|69730971|FG008|Overall Study|Disease Progression - Clinically Confirmed|0|||
38043207|NCT02834780|69730972|FG009|Overall Study|Disease Progression - Clinically Confirmed|2|||
38043208|NCT02834780|69730973|FG010|Overall Study|Disease Progression - Clinically Confirmed|1|||
38043209|NCT02834780|69730974|FG011|Overall Study|Disease Progression - Clinically Confirmed|2|||
38043210|NCT02834780|69730975|FG012|Overall Study|Disease Progression - Clinically Confirmed|5|||
38043211|NCT02834780|69730963|FG000|Overall Study|Other|1|||
38043212|NCT02834780|69730964|FG001|Overall Study|Other|0|||
38043213|NCT02834780|69730965|FG002|Overall Study|Other|1|||
38043214|NCT02834780|69730966|FG003|Overall Study|Other|2|||
38043215|NCT02834780|69730967|FG004|Overall Study|Other|0|||
38043216|NCT02834780|69730968|FG005|Overall Study|Other|0|||
37677351|NCT01659255|69152302|FG014|Overall Study|Sponsor's Decision|0|||
38043217|NCT02834780|69730969|FG006|Overall Study|Other|0|||
38043218|NCT02834780|69730970|FG007|Overall Study|Other|0|||
38043219|NCT02834780|69730971|FG008|Overall Study|Other|0|||
38043220|NCT02834780|69730972|FG009|Overall Study|Other|0|||
38043221|NCT02834780|69730973|FG010|Overall Study|Other|0|||
38043222|NCT02834780|69730974|FG011|Overall Study|Other|0|||
38043223|NCT02834780|69730975|FG012|Overall Study|Other|1|||
38043224|NCT02829957|69731011|FG000|Overall Study|Lost to Follow-up|2|||
38043225|NCT02829957|69731012|FG001|Overall Study|Lost to Follow-up|1|||
38043226|NCT01984346|69731031|FG000|Overall Study|Physician Decision|4|||
38043227|NCT01984346|69731032|FG001|Overall Study|Physician Decision|2|||
38043228|NCT01984346|69731031|FG000|Overall Study|Withdrawal by Subject|2|||
38043229|NCT01984346|69731032|FG001|Overall Study|Withdrawal by Subject|2|||
38043230|NCT01984346|69731031|FG000|Overall Study|Enrollment Closed|8|||
38043231|NCT01984346|69731032|FG001|Overall Study|Enrollment Closed|1|||
38043232|NCT01984346|69731031|FG000|Overall Study|Insurance Coverage|1|||
38043233|NCT01984346|69731032|FG001|Overall Study|Insurance Coverage|0|||
38043234|NCT01984346|69731031|FG000|Overall Study|Intra-operative Exclusion|2|||
38043235|NCT01984346|69731032|FG001|Overall Study|Intra-operative Exclusion|0|||
38043236|NCT03772327|69731070|FG000|Overall Study|Lost to Follow-up|3|||
38043237|NCT03772327|69731071|FG001|Overall Study|Lost to Follow-up|4|||
38043238|NCT03772327|69731070|FG000|Overall Study|Withdrawal by Subject|2|||
38043239|NCT03772327|69731071|FG001|Overall Study|Withdrawal by Subject|3|||
38043240|NCT04364763|69731114|FG000|Overall Study|Death|1|||
38043241|NCT04364763|69731115|FG001|Overall Study|Death|2|||
38043242|NCT04364763|69731114|FG000|Overall Study|Lost to Follow-up|1|||
38043243|NCT04364763|69731115|FG001|Overall Study|Lost to Follow-up|0|||
38043244|NCT04247815|69731132|FG000|Overall Study|Adverse Event|1|||
38043245|NCT04247815|69731133|FG001|Overall Study|Adverse Event|0|||
38043246|NCT04247815|69731132|FG000|Overall Study|Withdrawal by Subject|1|||
38043247|NCT04247815|69731133|FG001|Overall Study|Withdrawal by Subject|0|||
38043248|NCT04247815|69731132|FG000|Overall Study|Protocol Violation|0|||
38043249|NCT04247815|69731133|FG001|Overall Study|Protocol Violation|1|||
38043250|NCT03432819|69731168|FG000|Overall Study|Lost to Follow-up|2|||
38043251|NCT03432819|69731169|FG001|Overall Study|Lost to Follow-up|2|||
38043252|NCT03432819|69731168|FG000|Overall Study|Withdrawal by Subject|5|||
38043253|NCT03432819|69731169|FG001|Overall Study|Withdrawal by Subject|3|||
38043254|NCT03272347|69731188|FG000|Overall Study|Death|0|||
38043255|NCT03272347|69731189|FG001|Overall Study|Death|0|||
38043256|NCT03272347|69731190|FG002|Overall Study|Death|0|||
38043257|NCT03272347|69731191|FG003|Overall Study|Death|1|||
38043258|NCT03272347|69731188|FG000|Overall Study|Lost to Follow-up|1|||
38043259|NCT03272347|69731189|FG001|Overall Study|Lost to Follow-up|3|||
38043260|NCT03272347|69731190|FG002|Overall Study|Lost to Follow-up|5|||
38043261|NCT03272347|69731191|FG003|Overall Study|Lost to Follow-up|1|||
38043262|NCT03272347|69731188|FG000|Overall Study|Physician Decision|4|||
38043263|NCT03272347|69731189|FG001|Overall Study|Physician Decision|2|||
38043264|NCT03272347|69731190|FG002|Overall Study|Physician Decision|5|||
38043265|NCT03272347|69731191|FG003|Overall Study|Physician Decision|4|||
38043266|NCT03272347|69731188|FG000|Overall Study|Screen Failure|1|||
38043267|NCT03272347|69731189|FG001|Overall Study|Screen Failure|0|||
38043268|NCT03272347|69731190|FG002|Overall Study|Screen Failure|0|||
38043269|NCT03272347|69731191|FG003|Overall Study|Screen Failure|0|||
38043270|NCT03272347|69731188|FG000|Overall Study|Withdrawal by Subject|5|||
38043271|NCT03272347|69731189|FG001|Overall Study|Withdrawal by Subject|1|||
38043272|NCT03272347|69731190|FG002|Overall Study|Withdrawal by Subject|2|||
38043273|NCT03272347|69731191|FG003|Overall Study|Withdrawal by Subject|1|||
38043274|NCT03259568|69731213|FG000|Overall Study|Participant performance was low|3|||
38043275|NCT03239470|69731223|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
38043276|NCT03239470|69731224|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
38043277|NCT03167723|69731230|FG000|Overall Study|Protocol Violation|4|||
38043278|NCT03167723|69731231|FG001|Overall Study|Protocol Violation|6|||
38043279|NCT03103152|69731243|FG000|Overall Study|Physician Decision|5|||
38043280|NCT03103152|69731244|FG001|Overall Study|Physician Decision|2|||
38043281|NCT03103152|69731245|FG002|Overall Study|Physician Decision|6|||
38043282|NCT03103152|69731246|FG003|Overall Study|Physician Decision|3|||
38043283|NCT03103152|69731247|FG004|Overall Study|Physician Decision|3|||
38043284|NCT03103152|69731248|FG005|Overall Study|Physician Decision|1|||
38043285|NCT03103152|69731243|FG000|Overall Study|Protocol Violation|2|||
38043286|NCT03103152|69731244|FG001|Overall Study|Protocol Violation|2|||
38043287|NCT03103152|69731245|FG002|Overall Study|Protocol Violation|1|||
38043288|NCT03103152|69731246|FG003|Overall Study|Protocol Violation|2|||
38043289|NCT03103152|69731247|FG004|Overall Study|Protocol Violation|1|||
38043290|NCT03103152|69731248|FG005|Overall Study|Protocol Violation|1|||
38043291|NCT03103152|69731243|FG000|Overall Study|Inter-current illness|0|||
38043292|NCT03103152|69731244|FG001|Overall Study|Inter-current illness|0|||
38043293|NCT03103152|69731245|FG002|Overall Study|Inter-current illness|1|||
38043294|NCT03103152|69731246|FG003|Overall Study|Inter-current illness|0|||
38043295|NCT03103152|69731247|FG004|Overall Study|Inter-current illness|0|||
38043296|NCT03103152|69731248|FG005|Overall Study|Inter-current illness|0|||
38043297|NCT03103152|69731243|FG000|Overall Study|Death|0|||
38043298|NCT03103152|69731244|FG001|Overall Study|Death|1|||
38043299|NCT03103152|69731245|FG002|Overall Study|Death|0|||
38043300|NCT03103152|69731246|FG003|Overall Study|Death|0|||
38043301|NCT03103152|69731247|FG004|Overall Study|Death|0|||
38043302|NCT03103152|69731248|FG005|Overall Study|Death|0|||
38043303|NCT03103152|69731243|FG000|Overall Study|Adverse Event|0|||
38043304|NCT03103152|69731244|FG001|Overall Study|Adverse Event|0|||
38043305|NCT03103152|69731245|FG002|Overall Study|Adverse Event|1|||
38043306|NCT03103152|69731246|FG003|Overall Study|Adverse Event|0|||
38043307|NCT03103152|69731247|FG004|Overall Study|Adverse Event|0|||
38043308|NCT03103152|69731248|FG005|Overall Study|Adverse Event|1|||
38043309|NCT03103152|69731243|FG000|Overall Study|Withdrawal by Subject|1|||
38043310|NCT03103152|69731244|FG001|Overall Study|Withdrawal by Subject|0|||
38043311|NCT03103152|69731245|FG002|Overall Study|Withdrawal by Subject|1|||
38043312|NCT03103152|69731246|FG003|Overall Study|Withdrawal by Subject|1|||
38043313|NCT03103152|69731247|FG004|Overall Study|Withdrawal by Subject|1|||
38043314|NCT03103152|69731248|FG005|Overall Study|Withdrawal by Subject|1|||
38043315|NCT03103152|69731243|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
38043316|NCT03103152|69731244|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
38043317|NCT03103152|69731245|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
38043318|NCT03103152|69731246|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
38043319|NCT03103152|69731247|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
38043320|NCT03103152|69731248|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
38043321|NCT03103152|69731243|FG000|Overall Study|Unacceptable side effects|0|||
38043322|NCT03103152|69731244|FG001|Overall Study|Unacceptable side effects|0|||
38043323|NCT03103152|69731245|FG002|Overall Study|Unacceptable side effects|0|||
38043324|NCT03103152|69731246|FG003|Overall Study|Unacceptable side effects|0|||
38043325|NCT03103152|69731247|FG004|Overall Study|Unacceptable side effects|0|||
38043326|NCT03103152|69731248|FG005|Overall Study|Unacceptable side effects|1|||
38043327|NCT03103152|69731243|FG000|Overall Study|Lost to Follow-up|0|||
38043328|NCT03103152|69731244|FG001|Overall Study|Lost to Follow-up|1|||
38043329|NCT03103152|69731245|FG002|Overall Study|Lost to Follow-up|0|||
38043330|NCT03103152|69731246|FG003|Overall Study|Lost to Follow-up|1|||
38043331|NCT03103152|69731247|FG004|Overall Study|Lost to Follow-up|0|||
38043332|NCT03103152|69731248|FG005|Overall Study|Lost to Follow-up|1|||
38043333|NCT03103152|69731243|FG000|Overall Study|Testicular pain|0|||
38043334|NCT03103152|69731244|FG001|Overall Study|Testicular pain|0|||
38043335|NCT03103152|69731245|FG002|Overall Study|Testicular pain|0|||
38043336|NCT03103152|69731246|FG003|Overall Study|Testicular pain|1|||
38043337|NCT03103152|69731247|FG004|Overall Study|Testicular pain|0|||
38043338|NCT03103152|69731248|FG005|Overall Study|Testicular pain|0|||
38043339|NCT03033901|69731262|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
38043340|NCT03033901|69731262|FG000|Overall Study|Refused PSG|23|||
38043341|NCT03033901|69731262|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
38043342|NCT03033901|69731262|FG000|Overall Study|Missing Oximetry Data|3|||
38043343|NCT02315196|69731305|FG000|Overall Study|Withdrew consent|9|||
38043344|NCT02059005|69731311|FG000|Overall Study|Death|1|||
38043345|NCT02059005|69731312|FG001|Overall Study|Death|3|||
38043346|NCT02059005|69731311|FG000|Overall Study|Lost to Follow-up|19|||
38043347|NCT02059005|69731312|FG001|Overall Study|Lost to Follow-up|19|||
38043348|NCT02059005|69731311|FG000|Overall Study|Incarceration|0|||
38043349|NCT02059005|69731312|FG001|Overall Study|Incarceration|1|||
38043350|NCT02059005|69731311|FG000|Overall Study|Inpatient|0|||
38043351|NCT02059005|69731312|FG001|Overall Study|Inpatient|1|||
38043352|NCT01393821|69731322|FG000|Overall Study|Cancel|1|||
38043353|NCT01393821|69731323|FG001|Overall Study|Cancel|1|||
38043354|NCT01393821|69731322|FG000|Overall Study|not evaluable for primary endpoint|4|||
38043355|NCT01393821|69731323|FG001|Overall Study|not evaluable for primary endpoint|2|||
38043356|NCT00496873|69731335|FG000|Overall Study|Ineligible|2|||
38043357|NCT00496873|69731335|FG000|Overall Study|Death|2|||
38043358|NCT00496873|69731335|FG000|Overall Study|Withdrawal by Subject|3|||
38043359|NCT00492778|69731341|FG000|Overall Study|Ineligible by Pathology Review|8|||
38043360|NCT00492778|69731342|FG001|Overall Study|Ineligible by Pathology Review|1|||
38043361|NCT03775681|69731376|FG000|Overall Study|Physician Decision|3|||
38043362|NCT03774823|69731382|FG000|Overall Study|Withdrawal by Subject|1|||
38043363|NCT03774823|69731383|FG001|Overall Study|Withdrawal by Subject|1|||
38043364|NCT03149042|69731389|FG000|Overall Study|Invasive FFR not performed|21|||
38043365|NCT03149042|69731389|FG000|Overall Study|Poor CT Image Quality|1|||
38043366|NCT03149042|69731389|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
38043367|NCT03774433|69731394|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
38043368|NCT05061992|69731409|FG000|Overall Study|Excess bowel movements|1|||
38043369|NCT05061992|69731410|FG001|Overall Study|Excess bowel movements|0|||
38043370|NCT05061992|69731409|FG000|Overall Study|Complications of Medical Care|1|||
38043371|NCT05061992|69731410|FG001|Overall Study|Complications of Medical Care|0|||
38043372|NCT05061992|69731409|FG000|Overall Study|Diarrhea Prior to Starting Therapy|1|||
38043373|NCT05061992|69731410|FG001|Overall Study|Diarrhea Prior to Starting Therapy|0|||
38043374|NCT05061992|69731409|FG000|Overall Study|Withdrawal by Subject|0|||
38043375|NCT05061992|69731410|FG001|Overall Study|Withdrawal by Subject|1|||
38043376|NCT04814823|69731425|FG000|Overall Study|Could not obtain valid arterial line for subject|2|||
38043377|NCT04762160|69731442|FG000|Overall Study|Study terminated early due to business reasons|5|||
38043378|NCT04625972|69731448|FG000|Overall Study|Death|3|||
38043379|NCT04625972|69731449|FG001|Overall Study|Death|2|||
38043380|NCT04625972|69731448|FG000|Overall Study|Lost to Follow-up|82|||
38043381|NCT04625972|69731449|FG001|Overall Study|Lost to Follow-up|38|||
38043382|NCT04625972|69731448|FG000|Overall Study|Physician Decision|2|||
38043383|NCT04625972|69731449|FG001|Overall Study|Physician Decision|0|||
38043384|NCT04625972|69731448|FG000|Overall Study|Protocol Violation|0|||
38043385|NCT04625972|69731449|FG001|Overall Study|Protocol Violation|1|||
38043386|NCT04625972|69731448|FG000|Overall Study|Withdrawal by Subject|37|||
38043387|NCT04625972|69731449|FG001|Overall Study|Withdrawal by Subject|24|||
38043388|NCT04625972|69731448|FG000|Overall Study|Not specified elsewhere|8|||
38043389|NCT04625972|69731449|FG001|Overall Study|Not specified elsewhere|6|||
38043390|NCT04482647|69731455|FG000|Overall Study|Time constraints|2|||
38043391|NCT04482647|69731455|FG000|Overall Study|Health issues|1|||
38043392|NCT04482647|69731455|FG000|Overall Study|Death in the family|1|||
38043393|NCT04482647|69731455|FG000|Overall Study|Disliked the intervention|1|||
38043394|NCT04482647|69731455|FG000|Overall Study|No reasons specified|7|||
38043395|NCT04429503|69731462|FG000|Overall Study|Non-compliance with protocol by the subject|1|||
38043396|NCT04429503|69731463|FG001|Overall Study|Non-compliance with protocol by the subject|1|||
38043397|NCT04429503|69731464|FG002|Overall Study|Non-compliance with protocol by the subject|0|||
38043398|NCT04429503|69731462|FG000|Overall Study|Adverse Event|0|||
38043399|NCT04429503|69731463|FG001|Overall Study|Adverse Event|4|||
38043400|NCT04429503|69731464|FG002|Overall Study|Adverse Event|2|||
38043401|NCT04429503|69731462|FG000|Overall Study|Decision by the investigator/sponsor|0|||
38043402|NCT04429503|69731463|FG001|Overall Study|Decision by the investigator/sponsor|6|||
38043403|NCT04429503|69731464|FG002|Overall Study|Decision by the investigator/sponsor|2|||
38043404|NCT04429503|69731462|FG000|Overall Study|Withdrawal by Subject|4|||
38043405|NCT04429503|69731463|FG001|Overall Study|Withdrawal by Subject|12|||
38043406|NCT04429503|69731464|FG002|Overall Study|Withdrawal by Subject|2|||
38043407|NCT04429503|69731462|FG000|Overall Study|Lost to Follow-up|2|||
38043408|NCT04429503|69731463|FG001|Overall Study|Lost to Follow-up|8|||
38043409|NCT04429503|69731464|FG002|Overall Study|Lost to Follow-up|2|||
38043410|NCT04429503|69731462|FG000|Overall Study|Death|5|||
38043411|NCT04429503|69731463|FG001|Overall Study|Death|9|||
38043412|NCT04429503|69731464|FG002|Overall Study|Death|4|||
38043413|NCT04408924|69731472|FG000|Overall Study|On Study Treatment|3|||
38043414|NCT04408924|69731472|FG000|Overall Study|Off Treatment on Post-Treatment-Discontinuation Follow-up|14|||
37677352|NCT01659255|69152303|FG015|Overall Study|Sponsor's Decision|0|||
37677353|NCT01659255|69152304|FG016|Overall Study|Sponsor's Decision|0|||
37677354|NCT01659255|69152288|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
37677355|NCT01659255|69152289|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
37677356|NCT01659255|69152290|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
37677357|NCT01659255|69152291|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
37677358|NCT01659255|69152292|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
37677359|NCT01659255|69152293|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
37677360|NCT01659255|69152294|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
37677361|NCT01659255|69152295|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
37677652|NCT01360645|69152679|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
37677653|NCT01360645|69152680|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
37677654|NCT01360645|69152681|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
37677655|NCT01360645|69152682|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
37677656|NCT01360645|69152679|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
37677657|NCT01360645|69152680|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
37677658|NCT01360645|69152681|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
37677659|NCT01360645|69152682|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
37677660|NCT01360645|69152679|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
37677661|NCT01360645|69152680|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
37677662|NCT01360645|69152681|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
37677663|NCT01360645|69152682|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
37677664|NCT01360645|69152679|FG000|Phase A+|Lost to Follow-up|0|||
37677665|NCT01360645|69152680|FG001|Phase A+|Lost to Follow-up|0|||
37677666|NCT01360645|69152681|FG002|Phase A+|Lost to Follow-up|0|||
37677667|NCT01360645|69152682|FG003|Phase A+|Lost to Follow-up|7|||
37677668|NCT01360645|69152679|FG000|Phase A+|Adverse Event|0|||
37677669|NCT01360645|69152680|FG001|Phase A+|Adverse Event|0|||
37677670|NCT01360645|69152681|FG002|Phase A+|Adverse Event|0|||
37677671|NCT01360645|69152682|FG003|Phase A+|Adverse Event|2|||
37677672|NCT01360645|69152679|FG000|Phase A+|Met Withdrawal Criteria|0|||
37677673|NCT01360645|69152680|FG001|Phase A+|Met Withdrawal Criteria|0|||
37677674|NCT01360645|69152681|FG002|Phase A+|Met Withdrawal Criteria|0|||
37677675|NCT01360645|69152682|FG003|Phase A+|Met Withdrawal Criteria|4|||
37677676|NCT01360645|69152679|FG000|Phase A+|Physician Decision|0|||
37677677|NCT01360645|69152680|FG001|Phase A+|Physician Decision|0|||
37677678|NCT01360645|69152681|FG002|Phase A+|Physician Decision|0|||
37677679|NCT01360645|69152682|FG003|Phase A+|Physician Decision|2|||
37677680|NCT01360645|69152679|FG000|Phase A+|Withdrawal by Subject|0|||
37677681|NCT01360645|69152680|FG001|Phase A+|Withdrawal by Subject|0|||
37677682|NCT01360645|69152681|FG002|Phase A+|Withdrawal by Subject|0|||
37677683|NCT01360645|69152682|FG003|Phase A+|Withdrawal by Subject|5|||
37677684|NCT01360645|69152679|FG000|Phase A+|Protocol Deviation|0|||
37677685|NCT01360645|69152680|FG001|Phase A+|Protocol Deviation|0|||
37677686|NCT01360645|69152681|FG002|Phase A+|Protocol Deviation|0|||
37677687|NCT01360645|69152682|FG003|Phase A+|Protocol Deviation|4|||
37677688|NCT02633527|69152697|FG000|Overall Study|Failed to meet eligibility|0|||
37677689|NCT02633527|69152698|FG001|Overall Study|Failed to meet eligibility|1|||
37677690|NCT02633527|69152699|FG002|Overall Study|Failed to meet eligibility|1|||
37677691|NCT02633527|69152700|FG003|Overall Study|Failed to meet eligibility|0|||
37677692|NCT02633527|69152701|FG004|Overall Study|Failed to meet eligibility|1|||
37677693|NCT02633527|69152697|FG000|Overall Study|Adverse Event|0|||
37677694|NCT02633527|69152698|FG001|Overall Study|Adverse Event|4|||
37677695|NCT02633527|69152699|FG002|Overall Study|Adverse Event|3|||
37677696|NCT02633527|69152700|FG003|Overall Study|Adverse Event|1|||
37677697|NCT02633527|69152701|FG004|Overall Study|Adverse Event|5|||
37677698|NCT02633527|69152697|FG000|Overall Study|Lost to Follow-up|1|||
37677699|NCT02633527|69152698|FG001|Overall Study|Lost to Follow-up|2|||
37677700|NCT02633527|69152699|FG002|Overall Study|Lost to Follow-up|5|||
37677701|NCT02633527|69152700|FG003|Overall Study|Lost to Follow-up|5|||
37677702|NCT02633527|69152701|FG004|Overall Study|Lost to Follow-up|4|||
37677703|NCT02633527|69152697|FG000|Overall Study|Withdrawal by Subject|0|||
37677704|NCT02633527|69152698|FG001|Overall Study|Withdrawal by Subject|3|||
37677705|NCT02633527|69152699|FG002|Overall Study|Withdrawal by Subject|5|||
37677706|NCT02633527|69152700|FG003|Overall Study|Withdrawal by Subject|4|||
37677707|NCT02633527|69152701|FG004|Overall Study|Withdrawal by Subject|4|||
37677708|NCT02633527|69152697|FG000|Overall Study|Protocol Violation|0|||
37677709|NCT02633527|69152698|FG001|Overall Study|Protocol Violation|1|||
37677710|NCT02633527|69152699|FG002|Overall Study|Protocol Violation|1|||
37677711|NCT02633527|69152700|FG003|Overall Study|Protocol Violation|1|||
37677712|NCT02633527|69152701|FG004|Overall Study|Protocol Violation|1|||
37677713|NCT02633527|69152697|FG000|Overall Study|Physician Decision|0|||
37677714|NCT02633527|69152698|FG001|Overall Study|Physician Decision|0|||
37677715|NCT02633527|69152699|FG002|Overall Study|Physician Decision|0|||
37677716|NCT02633527|69152700|FG003|Overall Study|Physician Decision|0|||
37677717|NCT02633527|69152701|FG004|Overall Study|Physician Decision|1|||
37677718|NCT02633527|69152697|FG000|Overall Study|Administrative reason|1|||
37677719|NCT02633527|69152698|FG001|Overall Study|Administrative reason|0|||
37677720|NCT02633527|69152699|FG002|Overall Study|Administrative reason|0|||
37677721|NCT02633527|69152700|FG003|Overall Study|Administrative reason|1|||
37677722|NCT02633527|69152701|FG004|Overall Study|Administrative reason|0|||
37677723|NCT02633527|69152697|FG000|Overall Study|Multiple reasons|1|||
37677724|NCT02633527|69152698|FG001|Overall Study|Multiple reasons|0|||
37677725|NCT02633527|69152699|FG002|Overall Study|Multiple reasons|2|||
37677726|NCT02633527|69152700|FG003|Overall Study|Multiple reasons|2|||
37677727|NCT02633527|69152701|FG004|Overall Study|Multiple reasons|1|||
37677728|NCT01667549|69152718|FG000|Overall Study|Withdrawal by Subject|3|||
37677729|NCT01667549|69152719|FG001|Overall Study|Withdrawal by Subject|5|||
37677730|NCT01667549|69152720|FG002|Overall Study|Withdrawal by Subject|7|||
37677731|NCT01667549|69152721|FG003|Overall Study|Withdrawal by Subject|6|||
37677732|NCT01667549|69152722|FG004|Overall Study|Withdrawal by Subject|1|||
37677733|NCT01672801|69152761|FG000|Overall Study|Screen Failure|0|||
37677734|NCT01672801|69152762|FG001|Overall Study|Screen Failure|1|||
37677735|NCT01655901|69152768|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
37677736|NCT01655901|69152769|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
37677737|NCT01655901|69152770|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
37677738|NCT01655901|69152771|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
37677739|NCT01655901|69152772|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
37677740|NCT01655901|69152773|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
37677741|NCT01656759|69152784|FG000|Overall Study|Protocol Violation|2|||
37677742|NCT01656759|69152785|FG001|Overall Study|Protocol Violation|3|||
37677743|NCT02631577|69152793|FG000|Overall Study|Death|1|||
37677744|NCT02631577|69152794|FG001|Overall Study|Death|7|||
37677745|NCT02631577|69152793|FG000|Overall Study|Withdrawal by Subject|0|||
37677746|NCT02631577|69152794|FG001|Overall Study|Withdrawal by Subject|3|||
37677747|NCT01667081|69152802|FG000|Overall Study|Death|43|||
37677748|NCT01667081|69152803|FG001|Overall Study|Death|3|||
37677749|NCT01667081|69152802|FG000|Overall Study|Lost to Follow-up|99|||
37677750|NCT01667081|69152803|FG001|Overall Study|Lost to Follow-up|48|||
37677751|NCT01667081|69152802|FG000|Overall Study|Physician Decision|16|||
37677752|NCT01667081|69152803|FG001|Overall Study|Physician Decision|2|||
37677753|NCT01667081|69152802|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
37677754|NCT01667081|69152803|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
37677755|NCT01667081|69152802|FG000|Overall Study|Withdrawal by Subject|90|||
37677756|NCT01667081|69152803|FG001|Overall Study|Withdrawal by Subject|35|||
37677757|NCT04545619|69152820|FG000|Overall Study|due to equipment challenges|1|||
37677758|NCT02518971|69152826|FG000|Overall Study|Lost to Follow-up|0|||
37677759|NCT02518971|69152827|FG001|Overall Study|Lost to Follow-up|1|||
37677760|NCT02518971|69152826|FG000|Overall Study|Physician Decision|6|||
37677761|NCT02518971|69152827|FG001|Overall Study|Physician Decision|6|||
37677762|NCT02518971|69152826|FG000|Overall Study|Protocol Violation|6|||
37677763|NCT02518971|69152827|FG001|Overall Study|Protocol Violation|4|||
37677764|NCT02518971|69152826|FG000|Overall Study|Withdrawal by Subject|4|||
37677765|NCT02518971|69152827|FG001|Overall Study|Withdrawal by Subject|5|||
37677766|NCT02518971|69152826|FG000|Overall Study|Side effects|1|||
37677767|NCT02518971|69152827|FG001|Overall Study|Side effects|0|||
37677768|NCT02518971|69152826|FG000|Overall Study|medication lost in mail|0|||
37677769|NCT02518971|69152827|FG001|Overall Study|medication lost in mail|1|||
37677770|NCT02518971|69152826|FG000|Overall Study|eligibility criteria no longer met|6|||
37677771|NCT02518971|69152827|FG001|Overall Study|eligibility criteria no longer met|3|||
37677772|NCT01365039|69152836|FG000|Overall Study|Study related symptoms and complaints|1|||
37677773|NCT01365039|69152837|FG001|Overall Study|Study related symptoms and complaints|0|||
38043415|NCT04408924|69731472|FG000|Overall Study|Lost to Follow-up|1|||
38043416|NCT04408924|69731472|FG000|Overall Study|Withdrawal by Subject|7|||
38043417|NCT04400487|69731476|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
38043418|NCT04400487|69731476|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
38043419|NCT04400487|69731476|FG000|Follow-up Period (28 Days)|Started commercial product|2|||
38043420|NCT04258254|69731484|FG000|Overall Study|Withdrawal by Subject|0|||
38043421|NCT04258254|69731485|FG001|Overall Study|Withdrawal by Subject|1|||
38043422|NCT04258254|69731486|FG002|Overall Study|Withdrawal by Subject|0|||
38043423|NCT04247594|69731494|FG000|Overall Study|Withdrawal by Subject|4|||
38043424|NCT03954704|69731545|FG000|Overall Study|Death|1|||
38043425|NCT03954704|69731546|FG001|Overall Study|Death|1|||
38043426|NCT03954704|69731547|FG002|Overall Study|Death|1|||
38043427|NCT03954704|69731548|FG003|Overall Study|Death|3|||
38043428|NCT03954704|69731549|FG004|Overall Study|Death|2|||
38043429|NCT03954704|69731550|FG005|Overall Study|Death|2|||
38043430|NCT03954704|69731551|FG006|Overall Study|Death|0|||
38043431|NCT03954704|69731545|FG000|Overall Study|Withdrew Consent|0|||
38043432|NCT03954704|69731546|FG001|Overall Study|Withdrew Consent|0|||
38043433|NCT03954704|69731547|FG002|Overall Study|Withdrew Consent|1|||
38043434|NCT03954704|69731548|FG003|Overall Study|Withdrew Consent|0|||
38043435|NCT03954704|69731549|FG004|Overall Study|Withdrew Consent|0|||
38043436|NCT03954704|69731550|FG005|Overall Study|Withdrew Consent|1|||
38043437|NCT03954704|69731551|FG006|Overall Study|Withdrew Consent|0|||
38043438|NCT03954704|69731545|FG000|Overall Study|Lost to Follow-up|0|||
38043439|NCT03954704|69731546|FG001|Overall Study|Lost to Follow-up|0|||
38043440|NCT03954704|69731547|FG002|Overall Study|Lost to Follow-up|0|||
38043441|NCT03954704|69731548|FG003|Overall Study|Lost to Follow-up|0|||
38043442|NCT03954704|69731549|FG004|Overall Study|Lost to Follow-up|0|||
38043443|NCT03954704|69731550|FG005|Overall Study|Lost to Follow-up|0|||
38043444|NCT03954704|69731551|FG006|Overall Study|Lost to Follow-up|1|||
38043445|NCT03954704|69731545|FG000|Overall Study|Study Terminated by Sponsor|0|||
38043446|NCT03954704|69731546|FG001|Overall Study|Study Terminated by Sponsor|0|||
38043447|NCT03954704|69731547|FG002|Overall Study|Study Terminated by Sponsor|1|||
38043448|NCT03954704|69731548|FG003|Overall Study|Study Terminated by Sponsor|0|||
38043695|NCT02115282|69731863|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
38043696|NCT02115282|69731864|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
38043697|NCT02115282|69731863|FG000|Overall Study|Not start protocol therapy|9|||
38043698|NCT02115282|69731864|FG001|Overall Study|Not start protocol therapy|10|||
38043699|NCT02101853|69731872|FG000|Block 1 Induction|Adverse Event|11|||
38043700|NCT02101853|69731873|FG001|Block 1 Induction|Adverse Event|0|||
38043701|NCT02101853|69731874|FG002|Block 1 Induction|Adverse Event|0|||
38043702|NCT02101853|69731875|FG003|Block 1 Induction|Adverse Event|0|||
38043703|NCT02101853|69731876|FG004|Block 1 Induction|Adverse Event|0|||
38043704|NCT02101853|69731877|FG005|Block 1 Induction|Adverse Event|0|||
38043705|NCT02101853|69731872|FG000|Block 1 Induction|Death|20|||
38043706|NCT02101853|69731873|FG001|Block 1 Induction|Death|0|||
38043707|NCT02101853|69731874|FG002|Block 1 Induction|Death|0|||
38043708|NCT02101853|69731875|FG003|Block 1 Induction|Death|0|||
38043709|NCT02101853|69731876|FG004|Block 1 Induction|Death|0|||
38043710|NCT02101853|69731877|FG005|Block 1 Induction|Death|0|||
38043711|NCT02101853|69731872|FG000|Block 1 Induction|Lack of Efficacy|6|||
38043712|NCT02101853|69731873|FG001|Block 1 Induction|Lack of Efficacy|0|||
38043713|NCT02101853|69731874|FG002|Block 1 Induction|Lack of Efficacy|0|||
38043714|NCT02101853|69731875|FG003|Block 1 Induction|Lack of Efficacy|0|||
38043715|NCT02101853|69731876|FG004|Block 1 Induction|Lack of Efficacy|0|||
38043716|NCT02101853|69731877|FG005|Block 1 Induction|Lack of Efficacy|0|||
38043717|NCT02101853|69731872|FG000|Block 1 Induction|Physician Decision|61|||
38043718|NCT02101853|69731873|FG001|Block 1 Induction|Physician Decision|0|||
38043719|NCT02101853|69731874|FG002|Block 1 Induction|Physician Decision|0|||
38043720|NCT02101853|69731875|FG003|Block 1 Induction|Physician Decision|0|||
38043721|NCT02101853|69731876|FG004|Block 1 Induction|Physician Decision|0|||
38043722|NCT02101853|69731877|FG005|Block 1 Induction|Physician Decision|0|||
38043723|NCT02101853|69731872|FG000|Block 1 Induction|Protocol Violation|2|||
38043724|NCT02101853|69731873|FG001|Block 1 Induction|Protocol Violation|0|||
38043725|NCT02101853|69731874|FG002|Block 1 Induction|Protocol Violation|0|||
38043726|NCT02101853|69731875|FG003|Block 1 Induction|Protocol Violation|0|||
38043727|NCT02101853|69731876|FG004|Block 1 Induction|Protocol Violation|0|||
38043728|NCT02101853|69731877|FG005|Block 1 Induction|Protocol Violation|0|||
38043729|NCT02101853|69731872|FG000|Block 1 Induction|Withdrawal by Subject|65|||
38043730|NCT02101853|69731873|FG001|Block 1 Induction|Withdrawal by Subject|0|||
38043731|NCT02101853|69731874|FG002|Block 1 Induction|Withdrawal by Subject|0|||
38043732|NCT02101853|69731875|FG003|Block 1 Induction|Withdrawal by Subject|0|||
38043733|NCT02101853|69731876|FG004|Block 1 Induction|Withdrawal by Subject|0|||
38043734|NCT02101853|69731877|FG005|Block 1 Induction|Withdrawal by Subject|0|||
38043735|NCT02101853|69731872|FG000|Block 1 Induction|Ineligible|8|||
38043736|NCT02101853|69731873|FG001|Block 1 Induction|Ineligible|0|||
38043737|NCT02101853|69731874|FG002|Block 1 Induction|Ineligible|0|||
38043738|NCT02101853|69731875|FG003|Block 1 Induction|Ineligible|0|||
38043739|NCT02101853|69731876|FG004|Block 1 Induction|Ineligible|0|||
38043740|NCT02101853|69731877|FG005|Block 1 Induction|Ineligible|0|||
38043741|NCT02101853|69731872|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
38043742|NCT02101853|69731873|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
38043743|NCT02101853|69731874|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
38043744|NCT02101853|69731875|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
38043745|NCT02101853|69731876|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
38043746|NCT02101853|69731877|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
38043747|NCT02101853|69731872|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
38043748|NCT02101853|69731873|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
38043749|NCT02101853|69731874|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
38043750|NCT02101853|69731875|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
38043751|NCT02101853|69731876|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
38043752|NCT02101853|69731877|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
38043753|NCT02101853|69731872|FG000|Post Induction Randomization|Adverse Event|0|||
38043754|NCT02101853|69731873|FG001|Post Induction Randomization|Adverse Event|3|||
38043755|NCT02101853|69731874|FG002|Post Induction Randomization|Adverse Event|8|||
38043756|NCT02101853|69731875|FG003|Post Induction Randomization|Adverse Event|4|||
38043757|NCT02101853|69731876|FG004|Post Induction Randomization|Adverse Event|4|||
38043758|NCT02101853|69731877|FG005|Post Induction Randomization|Adverse Event|0|||
38043759|NCT02101853|69731872|FG000|Post Induction Randomization|Death|0|||
38043760|NCT02101853|69731873|FG001|Post Induction Randomization|Death|9|||
38043761|NCT02101853|69731874|FG002|Post Induction Randomization|Death|2|||
38043762|NCT02101853|69731875|FG003|Post Induction Randomization|Death|2|||
38043763|NCT02101853|69731876|FG004|Post Induction Randomization|Death|0|||
38043789|NCT02101853|69731872|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
38043790|NCT02101853|69731873|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
38043791|NCT02101853|69731874|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
38043792|NCT02101853|69731875|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
38043793|NCT02101853|69731876|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
38043794|NCT02101853|69731877|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
38043795|NCT02101853|69731872|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
38043796|NCT02101853|69731873|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
38043797|NCT02101853|69731874|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
38043798|NCT02101853|69731875|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
38043799|NCT02101853|69731876|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
38043800|NCT02101853|69731877|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
38043801|NCT02101853|69731872|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
38043802|NCT02101853|69731873|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
38043803|NCT02101853|69731874|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
38043804|NCT02101853|69731875|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
38043805|NCT02101853|69731876|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
38043806|NCT02101853|69731877|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
38043807|NCT02101853|69731872|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
38043808|NCT02101853|69731873|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
38043809|NCT02101853|69731874|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
38043810|NCT02101853|69731875|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
38043811|NCT02101853|69731876|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
38043812|NCT02101853|69731877|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
38043813|NCT02101853|69731872|FG000|Blinatumomab Salvage Therapy|Death|0|||
38043814|NCT02101853|69731873|FG001|Blinatumomab Salvage Therapy|Death|0|||
38043815|NCT02101853|69731874|FG002|Blinatumomab Salvage Therapy|Death|0|||
38043816|NCT02101853|69731875|FG003|Blinatumomab Salvage Therapy|Death|0|||
38043817|NCT02101853|69731876|FG004|Blinatumomab Salvage Therapy|Death|0|||
38043818|NCT02101853|69731877|FG005|Blinatumomab Salvage Therapy|Death|2|||
38043819|NCT02101853|69731872|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
38043820|NCT02101853|69731873|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
38043821|NCT02101853|69731874|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
38043822|NCT02101853|69731875|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
38043823|NCT02101853|69731876|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
38043824|NCT02101853|69731877|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
38043825|NCT02101853|69731872|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
38043826|NCT02101853|69731873|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
38043827|NCT02101853|69731874|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
38043828|NCT02101853|69731875|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
38043829|NCT02101853|69731876|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
38043830|NCT02101853|69731877|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
38043831|NCT02101853|69731872|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
38043832|NCT02101853|69731873|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
38043833|NCT02101853|69731874|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
38043834|NCT02101853|69731875|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
38043835|NCT02101853|69731876|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
38043836|NCT02101853|69731877|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
38043837|NCT02076009|69731891|FG000|Overall Study|Death|172|||
38043838|NCT02076009|69731892|FG001|Overall Study|Death|153|||
38043839|NCT02076009|69731891|FG000|Overall Study|Withdrawal by Subject|16|||
38043840|NCT02076009|69731892|FG001|Overall Study|Withdrawal by Subject|12|||
38043841|NCT02076009|69731891|FG000|Overall Study|Lost to Follow-up|4|||
38043842|NCT02076009|69731892|FG001|Overall Study|Lost to Follow-up|2|||
38043843|NCT02076009|69731891|FG000|Overall Study|Progressive Disease|1|||
38043844|NCT02076009|69731892|FG001|Overall Study|Progressive Disease|0|||
38043845|NCT02076009|69731891|FG000|Overall Study|Physician Decision|0|||
38043846|NCT02076009|69731892|FG001|Overall Study|Physician Decision|1|||
38043847|NCT02076009|69731891|FG000|Overall Study|End of data collection|90|||
38043848|NCT02076009|69731892|FG001|Overall Study|End of data collection|118|||
38043849|NCT02048813|69731900|FG000|Overall Study|Still on treatment|279|||
38043850|NCT02048813|69731901|FG001|Overall Study|Still on treatment|0|||
38043851|NCT02048813|69731900|FG000|Overall Study|Adverse Event|40|||
38043852|NCT02048813|69731901|FG001|Overall Study|Adverse Event|38|||
38043853|NCT02048813|69731900|FG000|Overall Study|Disease progression|13|||
38043854|NCT02048813|69731901|FG001|Overall Study|Disease progression|3|||
38043868|NCT02048813|69731901|FG001|Overall Study|Wound infection/healing|0|||
38043869|NCT02048813|69731900|FG000|Overall Study|Missed appointment|3|||
38043870|NCT02048813|69731901|FG001|Overall Study|Missed appointment|0|||
38043871|NCT02048813|69731900|FG000|Overall Study|Never started treatment|2|||
38043872|NCT02048813|69731901|FG001|Overall Study|Never started treatment|17|||
38043873|NCT02003209|69731909|FG000|Overall Study|Patient not at risk for primary endpoint|5|||
38043874|NCT02003209|69731910|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
